country,term,count
AF,BENIGN UTERINE NEOPLASM,5
AF,DRUG INEFFECTIVE,3
AF,BRUCELLOSIS,2
AF,CONTRAINDICATED PRODUCT ADMINISTERED,2
AF,DEPRESSION,2
AF,FATIGUE,2
AF,FEELING ABNORMAL,2
AF,HEADACHE,2
AF,HYPERSENSITIVITY,2
AF,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
AF,PREGNANCY WITH IMPLANT CONTRACEPTIVE,2
AF,PYREXIA,2
AF,ABDOMINAL CAVITY DRAINAGE,1
AF,ABDOMINAL DISTENSION,1
AF,ADVERSE DRUG REACTION,1
AF,ADVERSE EVENT,1
AF,AGGRESSION,1
AF,AGITATION,1
AF,ALCOHOL PROBLEM,1
AF,AMENORRHOEA,1
AF,AMNESIA,1
AF,ANXIETY,1
AF,APPENDICITIS PERFORATED,1
AF,ASTHENIA,1
AF,ASTHMA,1
AF,AUTOIMMUNE HEPATITIS,1
AF,BLOOD CHOLESTEROL INCREASED,1
AF,BLOOD CREATININE INCREASED,1
AF,BLOOD PRESSURE INCREASED,1
AF,BONE MARROW FAILURE,1
AF,BREAST MALFORMATION,1
AF,CHEST PAIN,1
AF,DRUG DOSE OMISSION,1
AF,DRUG EFFECT DECREASED,1
AF,DRUG INTOLERANCE,1
AF,DRUG PRESCRIBING ERROR,1
AF,DYSPEPSIA,1
AF,FEAR,1
AF,HEPATIC CANCER,1
AF,HEPATIC CIRRHOSIS,1
AF,HEPATIC NECROSIS,1
AF,IMMOBILE,1
AF,IMPAIRED DRIVING ABILITY,1
AF,IMPAIRED WORK ABILITY,1
AF,INJECTION SITE BRUISING,1
AF,INJECTION SITE PRURITUS,1
AF,INSOMNIA,1
AF,LIVER FUNCTION TEST ABNORMAL,1
AF,LOSS OF CONSCIOUSNESS,1
AF,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
AF,MENTAL STATUS CHANGES,1
AF,METABOLIC ACIDOSIS,1
AF,MUSCLE CONTRACTIONS INVOLUNTARY,1
AF,MUSCULOSKELETAL STIFFNESS,1
AF,MYASTHENIA GRAVIS,1
AF,OROPHARYNGEAL PAIN,1
AF,PAIN,1
AF,PANIC ATTACK,1
AF,PARANOIA,1
AF,PERIPHERAL SWELLING,1
AF,PHYSICAL ASSAULT,1
AF,PNEUMONIA,1
AF,PRODUCT SUBSTITUTION ISSUE,1
AF,PSEUDOMONAL SEPSIS,1
AF,PSYCHOTIC BEHAVIOUR,1
AF,RASH GENERALISED,1
AF,RASH PRURITIC,1
AF,RHABDOMYOLYSIS,1
AF,SEROTONIN SYNDROME,1
AF,SMALL INTESTINAL OBSTRUCTION,1
AF,SUICIDAL BEHAVIOUR,1
AF,SUICIDAL IDEATION,1
AF,SWELLING FACE,1
AF,SWOLLEN TONGUE,1
AF,VOMITING,1
AF,WHITE BLOOD CELL COUNT INCREASED,1
AX,PRODUCT SUBSTITUTION ISSUE,2
AX,ANGINA PECTORIS,1
AX,APATHY,1
AX,ARTHRALGIA,1
AX,BLOOD PRESSURE INCREASED,1
AX,COGNITIVE DISORDER,1
AX,CONSTIPATION,1
AX,DEPRESSION,1
AX,FATIGUE,1
AX,FEELING ABNORMAL,1
AX,HAEMORRHAGE,1
AX,HEART RATE INCREASED,1
AX,INSURANCE ISSUE,1
AX,OXYGEN SATURATION DECREASED,1
AX,POOR QUALITY SLEEP,1
AX,SOCIAL PROBLEM,1
AX,SOMNOLENCE,1
AL,DEATH,14
AL,DYSPNOEA,9
AL,URTICARIA,7
AL,DRUG HYPERSENSITIVITY,6
AL,MULTI-ORGAN FAILURE,6
AL,COUGH,5
AL,DRUG INEFFECTIVE,5
AL,ERYTHEMA,5
AL,HYPOTENSION,5
AL,LACTIC ACIDOSIS,5
AL,PRURITUS,5
AL,ANGIOEDEMA,4
AL,LIP OEDEMA,4
AL,VOMITING,4
AL,ACUTE MYOCARDIAL INFARCTION,3
AL,ANAPHYLACTIC REACTION,3
AL,CHEST DISCOMFORT,3
AL,CHOKING,3
AL,OVERDOSE,3
AL,PANCREATITIS ACUTE,3
AL,PYREXIA,3
AL,SOMNOLENCE,3
AL,STEVENS-JOHNSON SYNDROME,3
AL,TOXICITY TO VARIOUS AGENTS,3
AL,WEIGHT DECREASED,3
AL,ABDOMINAL PAIN,2
AL,ACCIDENTAL OVERDOSE,2
AL,ACUTE HEPATIC FAILURE,2
AL,ARTHRALGIA,2
AL,ASTHENIA,2
AL,BLINDNESS,2
AL,BONE LESION,2
AL,CILIARY HYPERAEMIA,2
AL,CIRCULATORY COLLAPSE,2
AL,DUODENAL OBSTRUCTION,2
AL,FALL,2
AL,GENERAL PHYSICAL HEALTH DETERIORATION,2
AL,HEADACHE,2
AL,HYPERTRANSAMINASAEMIA,2
AL,HYPOAESTHESIA ORAL,2
AL,INTESTINAL HAEMATOMA,2
AL,MALAISE,2
AL,MALIGNANT NEOPLASM PROGRESSION,2
AL,METASTASES TO CENTRAL NERVOUS SYSTEM,2
AL,NAUSEA,2
AL,RENAL IMPAIRMENT,2
AL,RHINORRHOEA,2
AL,SNEEZING,2
AL,TRANSIENT ISCHAEMIC ATTACK,2
AL,ABDOMINAL PAIN UPPER,1
AL,ABNORMAL WITHDRAWAL BLEEDING,1
AL,ABORTION SPONTANEOUS,1
AL,AGEUSIA,1
AL,AGITATION,1
AL,AGRANULOCYTOSIS,1
AL,ANAEMIA,1
AL,ANAL INCONTINENCE,1
AL,ANOSMIA,1
AL,ANURIA,1
AL,ANXIETY,1
AL,APHASIA,1
AL,ARTHRITIS,1
AL,ASTHMA,1
AL,AZOTAEMIA,1
AL,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
AL,BLOOD CREATINE INCREASED,1
AL,BLOOD GLUCOSE DECREASED,1
AL,BLOOD GLUCOSE INCREASED,1
AL,BLOOD PRESSURE FLUCTUATION,1
AL,BREAST CANCER,1
AL,BREAST CANCER METASTATIC,1
AL,BRONCHOSPASM,1
AL,CARDIAC FAILURE,1
AL,CEREBELLAR DYSPLASIA,1
AL,CEREBRAL HAEMATOMA,1
AL,CEREBROVASCULAR ACCIDENT,1
AL,CHEST PAIN,1
AL,COAGULOPATHY,1
AL,COMA,1
AL,CONDITION AGGRAVATED,1
AL,CONFUSIONAL STATE,1
AL,CONJUNCTIVAL HYPERAEMIA,1
AL,CONSTIPATION,1
AL,DECREASED INTEREST,1
AL,DEHYDRATION,1
AL,DELUSION,1
AL,DEPRESSED MOOD,1
AL,DEPRESSION,1
AL,DERMATITIS BULLOUS,1
AL,DIARRHOEA,1
AL,DIPLOPIA,1
AL,DISEASE PROGRESSION,1
AL,DISTURBANCE IN ATTENTION,1
AL,DIZZINESS,1
AL,DROOLING,1
AL,DRUG DOSE OMISSION,1
AL,DYSPHAGIA,1
AL,EATING DISORDER,1
AL,ENCEPHALOPATHY,1
AL,EYE PAIN,1
AL,EYE PRURITUS,1
AL,FATIGUE,1
AL,FEBRILE NEUTROPENIA,1
AL,FEELING HOT,1
AL,GAIT INABILITY,1
AL,GANGRENE,1
AL,GASTROINTESTINAL MOTILITY DISORDER,1
AL,HAEMATEMESIS,1
AL,HAEMATOMA,1
AL,HALLUCINATION_ AUDITORY,1
AL,HALLUCINATION_ VISUAL,1
AL,HEMIPARESIS,1
AL,HEPATIC FAILURE,1
AL,HEPATOMEGALY,1
AL,HEPATOTOXICITY,1
AL,HYPERCALCAEMIA,1
AL,HYPERHIDROSIS,1
AL,HYPERNATRAEMIA,1
AL,HYPERSPLENISM,1
AL,HYPOKALAEMIA,1
AL,IMMUNE SYSTEM DISORDER,1
AL,INFECTION,1
AL,INFECTIOUS PLEURAL EFFUSION,1
AL,INSOMNIA,1
AL,INTERSTITIAL LUNG DISEASE,1
AL,INTESTINAL MASS,1
AL,INTRAOCULAR PRESSURE INCREASED,1
AL,ISCHAEMIC STROKE,1
AL,JAUNDICE,1
AL,JOINT EFFUSION,1
AL,KLEBSIELLA INFECTION,1
AL,LARGE INTESTINE PERFORATION,1
AL,LARYNGOSPASM,1
AL,LETHARGY,1
AL,LIBIDO DECREASED,1
AL,LYMPH NODE TUBERCULOSIS,1
AL,MATERNAL EXPOSURE BEFORE PREGNANCY,1
AL,MATERNAL EXPOSURE DURING PREGNANCY,1
AL,MELAENA,1
AL,MEMORY IMPAIRMENT,1
AL,MENOPAUSE,1
AL,METASTASES TO BONE,1
AL,MICTURITION URGENCY,1
AL,MIDDLE INSOMNIA,1
AL,MUSCULOSKELETAL PAIN,1
AL,MYDRIASIS,1
AL,MYOCARDIAL INFARCTION,1
AL,NIGHTMARE,1
AL,NOCTURIA,1
AL,OBSESSIVE-COMPULSIVE DISORDER,1
AL,OEDEMA,1
AL,ORBITAL OEDEMA,1
AL,OROPHARYNGEAL PAIN,1
AL,OSTEONECROSIS,1
AL,PAIN,1
AL,PAIN IN EXTREMITY,1
AL,PALPITATIONS,1
AL,PANIC ATTACK,1
AL,PARAESTHESIA,1
AL,PARAPARESIS,1
AL,PERIPHERAL SWELLING,1
AL,PLEURAL EFFUSION,1
AL,PNEUMONIA BACTERIAL,1
AL,POLYNEUROPATHY,1
AL,PORTAL VEIN THROMBOSIS,1
AL,PRODUCT USE ISSUE,1
AL,PSORIATIC ARTHROPATHY,1
AL,PULMONARY THROMBOSIS,1
AL,PULMONARY TUBERCULOSIS,1
AL,RALES,1
AL,RASH,1
AL,RENAL VASCULAR THROMBOSIS,1
AL,SENSORY DISTURBANCE,1
AL,SEPTIC SHOCK,1
AL,SEXUAL DYSFUNCTION,1
AL,SKIN LESION,1
AL,SLEEP TALKING,1
AL,STREPTOCOCCAL URINARY TRACT INFECTION,1
AL,SUPERINFECTION,1
AL,TACHYCARDIA,1
AL,THERAPY CESSATION,1
AL,THROMBOCYTOPENIA,1
AL,THROMBOPHLEBITIS,1
AL,TUMOUR MARKER INCREASED,1
AL,UNEVALUABLE EVENT,1
AL,VASCULITIS,1
AL,VISCERAL LEISHMANIASIS,1
AL,VISUAL ACUITY REDUCED,1
AL,WEIGHT ABNORMAL,1
DZ,DEATH,68
DZ,VOMITING,51
DZ,ASTHENIA,47
DZ,ANAEMIA,41
DZ,DIARRHOEA,40
DZ,DISEASE PROGRESSION,36
DZ,THROMBOCYTOPENIA,36
DZ,NAUSEA,34
DZ,DYSPNOEA,30
DZ,LEUKOPENIA,25
DZ,HYPERTENSION,24
DZ,NEUTROPENIA,24
DZ,PYREXIA,23
DZ,GENERAL PHYSICAL HEALTH DETERIORATION,21
DZ,HEADACHE,21
DZ,MUCOSAL INFLAMMATION,19
DZ,RESPIRATORY DISTRESS,19
DZ,CONSTIPATION,18
DZ,PRURITUS,18
DZ,URTICARIA,18
DZ,GASTROINTESTINAL DISORDER,16
DZ,RENAL FAILURE,16
DZ,EJECTION FRACTION DECREASED,15
DZ,ABDOMINAL PAIN,14
DZ,LUNG DISORDER,14
DZ,CHEST PAIN,13
DZ,DECREASED APPETITE,12
DZ,FATIGUE,12
DZ,HYPERSENSITIVITY,12
DZ,INFLUENZA LIKE ILLNESS,12
DZ,LOSS OF CONSCIOUSNESS,12
DZ,NEUROPATHY PERIPHERAL,12
DZ,PARAESTHESIA,12
DZ,APLASIA,11
DZ,ASCITES,11
DZ,CEREBROVASCULAR ACCIDENT,11
DZ,COUGH,11
DZ,GENERAL PHYSICAL CONDITION ABNORMAL,11
DZ,OEDEMA PERIPHERAL,11
DZ,VERTIGO,11
DZ,WEIGHT DECREASED,11
DZ,ARTHRALGIA,10
DZ,HAEMOGLOBIN DECREASED,10
DZ,HEPATOCELLULAR INJURY,10
DZ,HYPERGLYCAEMIA,10
DZ,MYOCARDIAL INFARCTION,10
DZ,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,10
DZ,PULMONARY EMBOLISM,10
DZ,TUBERCULOSIS,10
DZ,URINARY TRACT INFECTION,10
DZ,ABDOMINAL PAIN UPPER,9
DZ,ANGIOEDEMA,9
DZ,CARDIAC FAILURE,9
DZ,INFECTION,9
DZ,INSOMNIA,9
DZ,MYALGIA,9
DZ,NEURALGIA,9
DZ,RASH,9
DZ,ADENOCARCINOMA PANCREAS,8
DZ,DEPRESSION,8
DZ,DRUG INEFFECTIVE,8
DZ,ERYTHEMA,8
DZ,HYPOTENSION,8
DZ,LYMPHADENOPATHY,8
DZ,MENTAL DISORDER,8
DZ,OEDEMA,8
DZ,RESPIRATORY DISORDER,8
DZ,RESPIRATORY FAILURE,8
DZ,SEIZURE,8
DZ,TACHYCARDIA,8
DZ,ANGINA PECTORIS,7
DZ,ASTHMA,7
DZ,BONE PAIN,7
DZ,CARDIAC ARREST,7
DZ,CHILLS,7
DZ,EPISTAXIS,7
DZ,HAEMATEMESIS,7
DZ,HEPATIC FAILURE,7
DZ,HYPOTHYROIDISM,7
DZ,INTESTINAL INFARCTION,7
DZ,MALAISE,7
DZ,OVERDOSE,7
DZ,PLATELET COUNT DECREASED,7
DZ,PRODUCT USE ISSUE,7
DZ,RASH GENERALISED,7
DZ,VISUAL IMPAIRMENT,7
DZ,ABORTION SPONTANEOUS,6
DZ,CARDIAC DISORDER,6
DZ,CELL DEATH,6
DZ,CHOLANGITIS SCLEROSING,6
DZ,COMA,6
DZ,CONFUSIONAL STATE,6
DZ,DEHYDRATION,6
DZ,EMBOLISM,6
DZ,FACE OEDEMA,6
DZ,GAIT DISTURBANCE,6
DZ,HAEMORRHAGE,6
DZ,INFUSION RELATED REACTION,6
DZ,ISCHAEMIC STROKE,6
DZ,LUNG INFECTION,6
DZ,PALPITATIONS,6
DZ,PLASMA CELL MYELOMA,6
DZ,PLEURAL EFFUSION,6
DZ,PULMONARY TUBERCULOSIS,6
DZ,SKIN LESION,6
DZ,SUICIDE ATTEMPT,6
DZ,THERMAL BURN,6
DZ,TRANSAMINASES INCREASED,6
DZ,TREATMENT FAILURE,6
DZ,VISION BLURRED,6
DZ,ABDOMINAL DISTENSION,5
DZ,AGITATION,5
DZ,ALOPECIA,5
DZ,ANAPHYLACTIC SHOCK,5
DZ,ANXIETY,5
DZ,APHASIA,5
DZ,BRADYCARDIA,5
DZ,C-REACTIVE PROTEIN INCREASED,5
DZ,CARDIO-RESPIRATORY ARREST,5
DZ,CONVULSION,5
DZ,DEEP VEIN THROMBOSIS,5
DZ,DERMATITIS ALLERGIC,5
DZ,DYSPHAGIA,5
DZ,FOETAL EXPOSURE DURING PREGNANCY,5
DZ,HEPATOCELLULAR CARCINOMA,5
DZ,HEPATOTOXICITY,5
DZ,HYPOVOLAEMIC SHOCK,5
DZ,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
DZ,INTESTINAL OBSTRUCTION,5
DZ,INVESTIGATION,5
DZ,JAUNDICE,5
DZ,MYOCARDIAL ISCHAEMIA,5
DZ,PRODUCTIVE COUGH,5
DZ,PULMONARY FIBROSIS,5
DZ,SEPSIS,5
DZ,SHOCK,5
DZ,SKIN DISCOLOURATION,5
DZ,SKIN DISORDER,5
DZ,THROMBOPHLEBITIS,5
DZ,TOXIC SKIN ERUPTION,5
DZ,TREMOR,5
DZ,WHITE BLOOD CELL COUNT INCREASED,5
DZ,ACUTE KIDNEY INJURY,4
DZ,ALTERED STATE OF CONSCIOUSNESS,4
DZ,ASPHYXIA,4
DZ,DISEASE COMPLICATION,4
DZ,ENCEPHALITIS,4
DZ,EPILEPSY,4
DZ,EXPOSURE DURING PREGNANCY,4
DZ,EYELID OEDEMA,4
DZ,FALL,4
DZ,FEBRILE NEUTROPENIA,4
DZ,HAEMATOTOXICITY,4
DZ,HAEMORRHAGIC DISORDER,4
DZ,HAEMORRHAGIC STROKE,4
DZ,HEPATIC CIRRHOSIS,4
DZ,HYPOKALAEMIA,4
DZ,HYPONATRAEMIA,4
DZ,INTERSTITIAL LUNG DISEASE,4
DZ,MALIGNANT NEOPLASM PROGRESSION,4
DZ,METASTASES TO LUNG,4
DZ,ORTHOSTATIC HYPOTENSION,4
DZ,PAIN,4
DZ,PAIN IN EXTREMITY,4
DZ,PANCYTOPENIA,4
DZ,PERICARDITIS,4
DZ,PERITONEAL HAEMORRHAGE,4
DZ,PROSTATIC SPECIFIC ANTIGEN INCREASED,4
DZ,PURPURA,4
DZ,RED BLOOD CELL SEDIMENTATION RATE INCREASED,4
DZ,SEPTIC SHOCK,4
DZ,VENTRICULAR EXTRASYSTOLES,4
DZ,ARRHYTHMIA,3
DZ,ARTHRITIS,3
DZ,BALANCE DISORDER,3
DZ,BLOOD PRESSURE DECREASED,3
DZ,BRONCHOSPASM,3
DZ,BURNS SECOND DEGREE,3
DZ,CHOKING,3
DZ,CHOLESTASIS,3
DZ,CONDITION AGGRAVATED,3
DZ,CYANOSIS,3
DZ,DIZZINESS,3
DZ,DYSPNOEA AT REST,3
DZ,DYSPNOEA EXERTIONAL,3
DZ,EXOPHTHALMOS,3
DZ,FEMORAL NECK FRACTURE,3
DZ,FISTULA,3
DZ,FUNGAL INFECTION,3
DZ,GASTROINTESTINAL TOXICITY,3
DZ,GENERALISED OEDEMA,3
DZ,GENITAL HAEMORRHAGE,3
DZ,HAEMATURIA,3
DZ,HAEMOPTYSIS,3
DZ,HAIR COLOUR CHANGES,3
DZ,HEART DISEASE CONGENITAL,3
DZ,HEMIPLEGIA,3
DZ,HERPES ZOSTER,3
DZ,HYPERKALAEMIA,3
DZ,HYPOXIA,3
DZ,INJECTION SITE PAIN,3
DZ,LIVER DISORDER,3
DZ,METASTASES TO BONE,3
DZ,METRORRHAGIA,3
DZ,MITRAL VALVE INCOMPETENCE,3
DZ,MOTOR DYSFUNCTION,3
DZ,MULTIPLE SCLEROSIS RELAPSE,3
DZ,NEPHROLITHIASIS,3
DZ,NEPHROTIC SYNDROME,3
DZ,ORAL HERPES,3
DZ,PULMONARY MASS,3
DZ,PURULENT DISCHARGE,3
DZ,RENAL DISORDER,3
DZ,SOMNOLENCE,3
DZ,SPEECH DISORDER,3
DZ,SPLENOMEGALY,3
DZ,SUICIDAL IDEATION,3
DZ,SUPRAVENTRICULAR TACHYCARDIA,3
DZ,SWELLING,3
DZ,SWELLING FACE,3
DZ,SYNCOPE,3
DZ,THROMBOSIS,3
DZ,VASCULITIS,3
DZ,VIITH NERVE PARALYSIS,3
DZ,VISUAL ACUITY REDUCED,3
DZ,WEIGHT INCREASED,3
DZ,WHEELCHAIR USER,3
DZ,WHITE BLOOD CELL COUNT DECREASED,3
DZ,YELLOW SKIN,3
DZ,ABASIA,2
DZ,ABDOMINAL PAIN LOWER,2
DZ,ABORTION,2
DZ,ACUTE MYELOID LEUKAEMIA,2
DZ,ACUTE PULMONARY OEDEMA,2
DZ,AGGRESSION,2
DZ,AMNESIA,2
DZ,ANURIA,2
DZ,ASPARTATE AMINOTRANSFERASE INCREASED,2
DZ,ATRIAL FIBRILLATION,2
DZ,BACK PAIN,2
DZ,BICYTOPENIA,2
DZ,BLINDNESS,2
DZ,BLISTER,2
DZ,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
DZ,BLOOD CREATININE INCREASED,2
DZ,BLOOD DISORDER,2
DZ,BLOOD GLUCOSE INCREASED,2
DZ,BLOOD PRESSURE INCREASED,2
DZ,BREAST CANCER,2
DZ,BREAST MASS,2
DZ,BRONCHITIS,2
DZ,CANDIDA INFECTION,2
DZ,CARDIOTOXICITY,2
DZ,CAUDA EQUINA SYNDROME,2
DZ,CHEST DISCOMFORT,2
DZ,CHRONIC KIDNEY DISEASE,2
DZ,COAGULOPATHY,2
DZ,COLECTOMY,2
DZ,CONGENITAL ANOMALY,2
DZ,CRYING,2
DZ,DEPRESSED LEVEL OF CONSCIOUSNESS,2
DZ,DEPRESSED MOOD,2
DZ,DERMATITIS BULLOUS,2
DZ,DERMATOMYOSITIS,2
DZ,DIABETES MELLITUS,2
DZ,DILATATION VENTRICULAR,2
DZ,DIPLOPIA,2
DZ,DISCOMFORT,2
DZ,DISEASE RECURRENCE,2
DZ,DISORIENTATION,2
DZ,DISSEMINATED INTRAVASCULAR COAGULATION,2
DZ,DISSEMINATED TUBERCULOSIS,2
DZ,DRUG HYPERSENSITIVITY,2
DZ,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
DZ,DYSLIPIDAEMIA,2
DZ,DYSPEPSIA,2
DZ,ENCEPHALOPATHY,2
DZ,ERECTILE DYSFUNCTION,2
DZ,EYE DISORDER,2
DZ,EYE PAIN,2
DZ,FACIAL PARALYSIS,2
DZ,FINGER AMPUTATION,2
DZ,FORMICATION,2
DZ,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
DZ,GASTROINTESTINAL HAEMORRHAGE,2
DZ,GENERALISED ERYTHEMA,2
DZ,GENERALISED TONIC-CLONIC SEIZURE,2
DZ,GINGIVAL BLEEDING,2
DZ,HAEMATOCRIT DECREASED,2
DZ,HAEMATOMA,2
DZ,HAEMORRHOIDS,2
DZ,HALLUCINATION,2
DZ,HEPATIC ENCEPHALOPATHY,2
DZ,HEPATITIS C,2
DZ,HEPATOMEGALY,2
DZ,HERPES VIRUS INFECTION,2
DZ,HIRSUTISM,2
DZ,HISTIOCYTOSIS HAEMATOPHAGIC,2
DZ,HOT FLUSH,2
DZ,HYPERHIDROSIS,2
DZ,HYPERTHYROIDISM,2
DZ,HYPOGLYCAEMIA,2
DZ,HYPOREFLEXIA,2
DZ,HYPOTHERMIA,2
DZ,HYPOTONIA,2
DZ,IMMUNODEFICIENCY,2
DZ,INTENTIONAL OVERDOSE,2
DZ,INTENTIONAL PRODUCT MISUSE,2
DZ,INTRACRANIAL PRESSURE INCREASED,2
DZ,IRRITABILITY,2
DZ,ISCHAEMIA,2
DZ,JOINT SWELLING,2
DZ,LARYNGOSPASM,2
DZ,LIP OEDEMA,2
DZ,LOCALISED INFECTION,2
DZ,LYMPHADENOPATHY MEDIASTINAL,2
DZ,MACULOPATHY,2
DZ,MATERNAL EXPOSURE DURING PREGNANCY,2
DZ,MELAENA,2
DZ,METASTASES TO CENTRAL NERVOUS SYSTEM,2
DZ,METASTASES TO LIVER,2
DZ,MOOD ALTERED,2
DZ,MUSCLE SPASMS,2
DZ,MUSCULAR WEAKNESS,2
DZ,MYELODYSPLASTIC SYNDROME,2
DZ,NEUROTOXICITY,2
DZ,NIGHT SWEATS,2
DZ,OPTIC NEUROPATHY,2
DZ,PALLOR,2
DZ,PAPILLOEDEMA,2
DZ,PARAESTHESIA ORAL,2
DZ,PARAPLEGIA,2
DZ,PERITONEAL CLOUDY EFFLUENT,2
DZ,PERITONITIS,2
DZ,PETECHIAE,2
DZ,PHLEBITIS,2
DZ,PLASMA CELL LEUKAEMIA,2
DZ,PNEUMONIA,2
DZ,POST PROCEDURAL COMPLICATION,2
DZ,PREGNANCY WITH IMPLANT CONTRACEPTIVE,2
DZ,PROTEINURIA,2
DZ,PROTHROMBIN LEVEL DECREASED,2
DZ,PRURITUS GENERALISED,2
DZ,PSORIASIS,2
DZ,PULMONARY OEDEMA,2
DZ,RASH ERYTHEMATOUS,2
DZ,RASH PRURITIC,2
DZ,RECTAL HAEMORRHAGE,2
DZ,RED BLOOD CELL COUNT DECREASED,2
DZ,RENAL FAILURE ACUTE,2
DZ,RENAL FUNCTION TEST ABNORMAL,2
DZ,RENAL IMPAIRMENT,2
DZ,RETINAL HAEMORRHAGE,2
DZ,RETINOPATHY,2
DZ,SKIN EXFOLIATION,2
DZ,SKIN PLAQUE,2
DZ,SKIN TOXICITY,2
DZ,SPINAL CORD COMPRESSION,2
DZ,STUPOR,2
DZ,SUBILEUS,2
DZ,TACHYPNOEA,2
DZ,TOOTH ABSCESS,2
DZ,TOXICITY TO VARIOUS AGENTS,2
DZ,TRANSIENT ISCHAEMIC ATTACK,2
DZ,UNEVALUABLE EVENT,2
DZ,UNINTENDED PREGNANCY,2
DZ,URINARY RETENTION,2
DZ,UVEITIS,2
DZ,VASCULAR PURPURA,2
DZ,VENTRICULAR FIBRILLATION,2
DZ,VENTRICULAR HYPOKINESIA,2
DZ,ABDOMINAL CAVITY DRAINAGE,1
DZ,ABDOMINAL DISCOMFORT,1
DZ,ABDOMINAL LYMPHADENOPATHY,1
DZ,ABNORMAL BEHAVIOUR,1
DZ,ABSCESS LIMB,1
DZ,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
DZ,ACCIDENTAL OVERDOSE,1
DZ,ACTIVITIES OF DAILY LIVING IMPAIRED,1
DZ,ACUTE ABDOMEN,1
DZ,ACUTE GRAFT VERSUS HOST DISEASE,1
DZ,ACUTE RESPIRATORY DISTRESS SYNDROME,1
DZ,ADENOCARCINOMA,1
DZ,ADVERSE EVENT,1
DZ,ALLERGIC GASTROENTERITIS,1
DZ,ALLERGIC GRANULOMATOUS ANGIITIS,1
DZ,ALPHA 1 FOETOPROTEIN INCREASED,1
DZ,AMENORRHOEA,1
DZ,AMOEBIASIS,1
DZ,AMYOTROPHY,1
DZ,ANAL ABSCESS,1
DZ,ANAL FISTULA,1
DZ,ANAPHYLACTIC REACTION,1
DZ,ANGIOPATHY,1
DZ,ANOREXIA NERVOSA,1
DZ,ANTI FACTOR VII ANTIBODY POSITIVE,1
DZ,ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE,1
DZ,ANXIETY DISORDER,1
DZ,AORTIC VALVE INCOMPETENCE,1
DZ,APHAGIA,1
DZ,APPLICATION SITE ERYTHEMA,1
DZ,ARACHNOIDITIS,1
DZ,ARTERIAL DISORDER,1
DZ,ARTERIOSCLEROSIS,1
DZ,ARTHROPATHY,1
DZ,ASTHENOPIA,1
DZ,ATRIAL THROMBOSIS,1
DZ,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
DZ,AUTOIMMUNE THYROIDITIS,1
DZ,AZOOSPERMIA,1
DZ,BACTERASCITES,1
DZ,BACTERIAL SEPSIS,1
DZ,BASEDOW^S DISEASE,1
DZ,BENIGN PROSTATIC HYPERPLASIA,1
DZ,BIOPSY LYMPH GLAND ABNORMAL,1
DZ,BLOOD CREATININE ABNORMAL,1
DZ,BLOOD CREATININE DECREASED,1
DZ,BLOOD IRON INCREASED,1
DZ,BLOOD POTASSIUM DECREASED,1
DZ,BLOOD PROLACTIN INCREASED,1
DZ,BLOOD THYROID STIMULATING HORMONE INCREASED,1
DZ,BLOOD TRIGLYCERIDES INCREASED,1
DZ,BLOOD UREA ABNORMAL,1
DZ,BLOOD URIC ACID INCREASED,1
DZ,BONE MARROW FAILURE,1
DZ,BRAIN ABSCESS,1
DZ,BRAIN MALFORMATION,1
DZ,BREAST ABSCESS,1
DZ,BREAST CANCER METASTATIC,1
DZ,BREAST CANCER RECURRENT,1
DZ,BREAST CYST,1
DZ,BREAST DISCHARGE,1
DZ,BREAST NEOPLASM,1
DZ,BRONCHIAL HYPERREACTIVITY,1
DZ,BUNDLE BRANCH BLOCK,1
DZ,BUNDLE BRANCH BLOCK RIGHT,1
DZ,CACHEXIA,1
DZ,CANCER SURGERY,1
DZ,CANDIDA SEPSIS,1
DZ,CARCINOID SYNDROME,1
DZ,CARDIAC DEATH,1
DZ,CARDIAC VENTRICULAR DISORDER,1
DZ,CARDIAC VENTRICULAR THROMBOSIS,1
DZ,CARDIO-RESPIRATORY DISTRESS,1
DZ,CARDIOMEGALY,1
DZ,CARDIOMYOPATHY,1
DZ,CARDIOPULMONARY FAILURE,1
DZ,CELLULITIS,1
DZ,CEREBRAL HAEMATOMA,1
DZ,CEREBRAL HAEMORRHAGE,1
DZ,CEREBRAL THROMBOSIS,1
DZ,CHEST X-RAY ABNORMAL,1
DZ,CHOLECYSTITIS,1
DZ,CHOLELITHIASIS,1
DZ,CHOLELITHIASIS MIGRATION,1
DZ,CHRONIC MYELOID LEUKAEMIA,1
DZ,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
DZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
DZ,CIRCADIAN RHYTHM SLEEP DISORDER,1
DZ,CIRCULATING ANTICOAGULANT,1
DZ,CLONIC CONVULSION,1
DZ,COGNITIVE DISORDER,1
DZ,COLON CANCER,1
DZ,COMA ACIDOTIC,1
DZ,CONGESTIVE CARDIOMYOPATHY,1
DZ,CONJUNCTIVAL HYPERAEMIA,1
DZ,CONJUNCTIVAL NEOPLASM,1
DZ,CONTUSION,1
DZ,CRANIAL NERVE PALSIES MULTIPLE,1
DZ,CRANIOPHARYNGIOMA,1
DZ,CREATININE RENAL CLEARANCE DECREASED,1
DZ,CROHN^S DISEASE,1
DZ,CYSTITIS,1
DZ,CYTOMEGALOVIRUS CHORIORETINITIS,1
DZ,CYTOMEGALOVIRUS INFECTION,1
DZ,CYTOPENIA,1
DZ,DECUBITUS ULCER,1
DZ,DELAYED GRAFT FUNCTION,1
DZ,DELIRIUM,1
DZ,DEPRESSIVE SYMPTOM,1
DZ,DERMATITIS CONTACT,1
DZ,DERMATITIS EXFOLIATIVE,1
DZ,DERMATITIS PSORIASIFORM,1
DZ,DERMATOSIS,1
DZ,DIABETES MELLITUS INADEQUATE CONTROL,1
DZ,DIABETES MELLITUS MANAGEMENT,1
DZ,DIABETIC COMA,1
DZ,DIABETIC FOOT,1
DZ,DIABETIC KETOACIDOSIS,1
DZ,DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA,1
DZ,DIABETIC RETINOPATHY,1
DZ,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,1
DZ,DISSEMINATED CRYPTOCOCCOSIS,1
DZ,DISTURBANCE IN ATTENTION,1
DZ,DROOLING,1
DZ,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
DZ,DRUG ADMINISTRATION ERROR,1
DZ,DRUG DOSE OMISSION,1
DZ,DRUG ERUPTION,1
DZ,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
DZ,DRUG INTOLERANCE,1
DZ,DRUG TITRATION ERROR,1
DZ,DRUG-INDUCED LIVER INJURY,1
DZ,DRY MOUTH,1
DZ,DRY SKIN,1
DZ,DYSAESTHESIA,1
DZ,DYSPHONIA,1
DZ,DYSURIA,1
DZ,EATING DISORDER,1
DZ,ECCHYMOSIS,1
DZ,ELECTRIC SHOCK,1
DZ,ELECTROCARDIOGRAM HIGH VOLTAGE,1
DZ,EMOTIONAL DISTRESS,1
DZ,ENDOCARDITIS,1
DZ,ENDOMETRIAL ADENOCARCINOMA,1
DZ,ENTEROCUTANEOUS FISTULA,1
DZ,ERYSIPELAS,1
DZ,ERYTHEMA MULTIFORME,1
DZ,ERYTHEMA NODOSUM,1
DZ,ESCHAR,1
DZ,EXTRA DOSE ADMINISTERED,1
DZ,EXTRAPYRAMIDAL DISORDER,1
DZ,EYE IRRITATION,1
DZ,EYE OEDEMA,1
DZ,FACIAL BONES FRACTURE,1
DZ,FEBRILE BONE MARROW APLASIA,1
DZ,FEELING ABNORMAL,1
DZ,FEMALE GENITAL TRACT FISTULA,1
DZ,FEMUR FRACTURE,1
DZ,FISTULA DISCHARGE,1
DZ,FLATULENCE,1
DZ,FLUSHING,1
DZ,FRACTURE,1
DZ,FURUNCLE,1
DZ,GALACTORRHOEA,1
DZ,GALLBLADDER DISORDER,1
DZ,GASTRIC DISORDER,1
DZ,GASTROENTERITIS,1
DZ,GASTROINTESTINAL NEOPLASM,1
DZ,GASTROINTESTINAL STROMAL TUMOUR,1
DZ,GASTROINTESTINAL WALL THICKENING,1
DZ,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,1
DZ,GOUT,1
DZ,GRAFT VERSUS HOST DISEASE,1
DZ,GROWTH RETARDATION,1
DZ,GYNAECOMASTIA,1
DZ,HAEMOLYTIC ANAEMIA,1
DZ,HAEMORRHAGE INTRACRANIAL,1
DZ,HAEMORRHAGE SUBCUTANEOUS,1
DZ,HELICOBACTER GASTRITIS,1
DZ,HEPATIC CANCER,1
DZ,HEPATIC ENZYME INCREASED,1
DZ,HEPATIC FUNCTION ABNORMAL,1
DZ,HEPATIC NEOPLASM,1
DZ,HEPATITIS B REACTIVATION,1
DZ,HEPATITIS FULMINANT,1
DZ,HIGH DENSITY LIPOPROTEIN DECREASED,1
DZ,HUMAN CHORIONIC GONADOTROPIN INCREASED,1
DZ,HUNGER,1
DZ,HYDROCEPHALUS,1
DZ,HYDRONEPHROSIS,1
DZ,HYPERBILIRUBINAEMIA,1
DZ,HYPERKERATOSIS,1
DZ,HYPERLEUKOCYTOSIS,1
DZ,HYPERPHAGIA,1
DZ,HYPERPLASIA,1
DZ,HYPERSENSITIVITY VASCULITIS,1
DZ,HYPERSEXUALITY,1
DZ,HYPERSOMNIA,1
DZ,HYPERTENSIVE CRISIS,1
DZ,HYPERTONIC BLADDER,1
DZ,HYPOAESTHESIA,1
DZ,HYPOALBUMINAEMIA,1
DZ,HYPOCALCAEMIA,1
DZ,HYPOCALCAEMIC SEIZURE,1
DZ,HYPOKINESIA,1
DZ,HYPOPHAGIA,1
DZ,ILEOSTOMY,1
DZ,ILL-DEFINED DISORDER,1
DZ,IMMUNOGLOBULINS DECREASED,1
DZ,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
DZ,INCOHERENT,1
DZ,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
DZ,INCREASED APPETITE,1
DZ,INFLUENZA,1
DZ,INJECTION SITE INFECTION,1
DZ,INJECTION SITE INFLAMMATION,1
DZ,INJECTION SITE NECROSIS,1
DZ,INJECTION SITE PRURITUS,1
DZ,INJECTION SITE SWELLING,1
DZ,INJECTION SITE ULCER,1
DZ,INJECTION SITE URTICARIA,1
DZ,INJECTION SITE WARMTH,1
DZ,INSTILLATION SITE ERYTHEMA,1
DZ,INTENTIONAL DRUG MISUSE,1
DZ,INTENTIONAL PRODUCT USE ISSUE,1
DZ,INTERNATIONAL NORMALISED RATIO,1
DZ,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
DZ,INTERTRIGO,1
DZ,INTERVERTEBRAL DISC PROTRUSION,1
DZ,INTESTINAL FISTULA,1
DZ,INTESTINAL TRANSIT TIME ABNORMAL,1
DZ,IRIDOCYCLITIS,1
DZ,IRON DEFICIENCY ANAEMIA,1
DZ,ISCHAEMIC CARDIOMYOPATHY,1
DZ,ISCHAEMIC CEREBRAL INFARCTION,1
DZ,JOINT WARMTH,1
DZ,KETOACIDOSIS,1
DZ,KETOSIS,1
DZ,KIDNEY MALFORMATION,1
DZ,LARGE INTESTINE PERFORATION,1
DZ,LARYNGEAL DISCOMFORT,1
DZ,LARYNX IRRITATION,1
DZ,LEFT VENTRICULAR HYPERTROPHY,1
DZ,LEG AMPUTATION,1
DZ,LEUKOCYTOSIS,1
DZ,LEUKOSTASIS SYNDROME,1
DZ,LIBIDO INCREASED,1
DZ,LICHENIFICATION,1
DZ,LIMB DISCOMFORT,1
DZ,LIMB INJURY,1
DZ,LIP DISCOLOURATION,1
DZ,LIP SWELLING,1
DZ,LIPOMA,1
DZ,LIVER FUNCTION TEST ABNORMAL,1
DZ,LIVER TRANSPLANT,1
DZ,LOCAL SWELLING,1
DZ,LUNG INFILTRATION,1
DZ,LUNG NEOPLASM MALIGNANT,1
DZ,LYMPH NODE TUBERCULOSIS,1
DZ,LYMPHOCYTE COUNT DECREASED,1
DZ,LYMPHOEDEMA,1
DZ,MACULAR OEDEMA,1
DZ,MALIGNANT PERITONEAL NEOPLASM,1
DZ,MALNUTRITION,1
DZ,MEAN CELL HAEMOGLOBIN INCREASED,1
DZ,MEAN CELL VOLUME INCREASED,1
DZ,MEMORY IMPAIRMENT,1
DZ,MENINGIOMA,1
DZ,MENINGORRHAGIA,1
DZ,MENOMETRORRHAGIA,1
DZ,MENTAL RETARDATION,1
DZ,METABOLIC DISORDER,1
DZ,METASTASES TO ADRENALS,1
DZ,METASTASES TO LARGE INTESTINE,1
DZ,METASTASES TO LYMPH NODES,1
DZ,METASTASES TO UTERUS,1
DZ,METASTATIC GASTRIC CANCER,1
DZ,METASTATIC RENAL CELL CARCINOMA,1
DZ,MICROLITHIASIS,1
DZ,MIGRAINE,1
DZ,MITRAL VALVE DISEASE,1
DZ,MOBILITY DECREASED,1
DZ,MONOPARESIS,1
DZ,MONOPLEGIA,1
DZ,MOUTH ULCERATION,1
DZ,MUCOSAL INFECTION,1
DZ,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
DZ,MULTIPLE SCLEROSIS,1
DZ,MUSCLE DISORDER,1
DZ,MUSCLE FATIGUE,1
DZ,MUSCULOSKELETAL DISORDER,1
DZ,MYASTHENIA GRAVIS,1
DZ,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST,1
DZ,MYOCARDITIS SEPTIC,1
DZ,MYOCLONIC EPILEPSY,1
DZ,NARCOLEPSY,1
DZ,NASOPHARYNGEAL CANCER,1
DZ,NASOPHARYNGITIS,1
DZ,NECK DEFORMITY,1
DZ,NECK PAIN,1
DZ,NECROSIS,1
DZ,NECROTISING FASCIITIS,1
DZ,NEOPLASM MALIGNANT,1
DZ,NEPHROPATHY,1
DZ,NEPHROPATHY TOXIC,1
DZ,NERVE COMPRESSION,1
DZ,NERVOUS SYSTEM DISORDER,1
DZ,NEUROGENIC SHOCK,1
DZ,NEUTROPHIL COUNT DECREASED,1
DZ,NEUTROPHILIC DERMATOSIS,1
DZ,NODULE,1
DZ,NON-HODGKIN^S LYMPHOMA RECURRENT,1
DZ,NYSTAGMUS,1
DZ,OBESITY,1
DZ,OBSTRUCTION,1
DZ,OEDEMA DUE TO HEPATIC DISEASE,1
DZ,OESOPHAGEAL VARICES HAEMORRHAGE,1
DZ,ORAL CANDIDIASIS,1
DZ,ORAL FUNGAL INFECTION,1
DZ,ORAL MUCOSA EROSION,1
DZ,ORAL MUCOSAL ERUPTION,1
DZ,OROPHARYNGEAL PAIN,1
DZ,ORTHOPNOEA,1
DZ,OSTEONECROSIS,1
DZ,OTITIS MEDIA,1
DZ,OVULATION DISORDER,1
DZ,PAIN OF SKIN,1
DZ,PALPATORY FINDING ABNORMAL,1
DZ,PANCREATIC CARCINOMA,1
DZ,PANCREATIC CARCINOMA METASTATIC,1
DZ,PANCREATITIS,1
DZ,PANCREATITIS ACUTE,1
DZ,PANIC ATTACK,1
DZ,PARALYSIS,1
DZ,PARANEOPLASTIC SYNDROME,1
DZ,PARAPARESIS,1
DZ,PARKINSON^S DISEASE,1
DZ,PATERNAL DRUGS AFFECTING FOETUS,1
DZ,PATHOLOGICAL FRACTURE,1
DZ,PERICARDIAL EFFUSION,1
DZ,PERIORBITAL OEDEMA,1
DZ,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
DZ,PERIPHERAL PARALYSIS,1
DZ,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
DZ,PERITONEAL DIALYSIS COMPLICATION,1
DZ,PERITONEAL TUBERCULOSIS,1
DZ,PHARYNGEAL OEDEMA,1
DZ,PHARYNGITIS,1
DZ,PHARYNGITIS BACTERIAL,1
DZ,PIGMENTATION DISORDER,1
DZ,PLASMACYTOMA,1
DZ,PLEURISY,1
DZ,PNEUMOBILIA,1
DZ,POLLAKIURIA,1
DZ,POLYDIPSIA,1
DZ,POLYMYOSITIS,1
DZ,POLYNEUROPATHY,1
DZ,POLYURIA,1
DZ,POOR PERSONAL HYGIENE,1
DZ,POST PROCEDURAL SEPSIS,1
DZ,POST TRANSPLANT DISTAL LIMB SYNDROME,1
DZ,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
DZ,POSTOPERATIVE HERNIA,1
DZ,PRE-ECLAMPSIA,1
DZ,PRECANCEROUS CELLS PRESENT,1
DZ,PRERENAL FAILURE,1
DZ,PRESCRIBED UNDERDOSE,1
DZ,PRIAPISM,1
DZ,PROCEDURAL COMPLICATION,1
DZ,PRODUCT STORAGE ERROR,1
DZ,PRODUCT USE IN UNAPPROVED INDICATION,1
DZ,PROLACTINOMA,1
DZ,PROTHROMBIN TIME ABNORMAL,1
DZ,PSYCHOTIC DISORDER,1
DZ,PSYCHOTIC SYMPTOM,1
DZ,PULMONARY ARTERIAL HYPERTENSION,1
DZ,PULMONARY FUNCTION TEST ABNORMAL,1
DZ,PULMONARY HAEMORRHAGE,1
DZ,PULMONARY VENO-OCCLUSIVE DISEASE,1
DZ,PUPILLARY DEFORMITY,1
DZ,PURPURA NON-THROMBOCYTOPENIC,1
DZ,PYRAMIDAL TRACT SYNDROME,1
DZ,RADIATION SKIN INJURY,1
DZ,RALES,1
DZ,RASH MACULO-PAPULAR,1
DZ,RAYNAUD^S PHENOMENON,1
DZ,RED CELL DISTRIBUTION WIDTH INCREASED,1
DZ,RENAL ATROPHY,1
DZ,RENAL FAILURE CHRONIC,1
DZ,RENAL TRANSPLANT,1
DZ,RENAL TUBULAR ACIDOSIS,1
DZ,RENAL TUBULAR NECROSIS,1
DZ,RENAL VASCULITIS,1
DZ,RESPIRATION ABNORMAL,1
DZ,RESPIRATORY ARREST,1
DZ,RESTLESSNESS,1
DZ,RETINAL DETACHMENT,1
DZ,RHABDOMYOLYSIS,1
DZ,RHEUMATOID ARTHRITIS,1
DZ,RHINORRHOEA,1
DZ,SECONDARY HYPERTENSION,1
DZ,SENSE OF OPPRESSION,1
DZ,SENSORY DISTURBANCE,1
DZ,SENSORY LOSS,1
DZ,SINUS TACHYCARDIA,1
DZ,SINUSITIS,1
DZ,SKIN NECROSIS,1
DZ,SKIN REACTION,1
DZ,SLEEP DISORDER,1
DZ,SOCIAL AVOIDANT BEHAVIOUR,1
DZ,SOCIAL FEAR,1
DZ,SODIUM RETENTION,1
DZ,SPUTUM PURULENT,1
DZ,STEVENS-JOHNSON SYNDROME,1
DZ,STILLBIRTH,1
DZ,STOMATITIS,1
DZ,STRANGULATED UMBILICAL HERNIA,1
DZ,STRESS,1
DZ,SUBARACHNOID HAEMORRHAGE,1
DZ,SUBDURAL HAEMATOMA,1
DZ,SUPERINFECTION,1
DZ,SWOLLEN TONGUE,1
DZ,SYSTEMIC CANDIDA,1
DZ,TACHYCARDIA PAROXYSMAL,1
DZ,TENDONITIS,1
DZ,THERAPY NON-RESPONDER,1
DZ,THINKING ABNORMAL,1
DZ,THROMBOCYTOPENIC PURPURA,1
DZ,THYROIDITIS,1
DZ,THYROIDITIS ACUTE,1
DZ,TORSADE DE POINTES,1
DZ,TOXIC ENCEPHALOPATHY,1
DZ,TOXIC EPIDERMAL NECROLYSIS,1
DZ,TROPONIN INCREASED,1
DZ,TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM,1
DZ,TUBULOINTERSTITIAL NEPHRITIS,1
DZ,TYPE 1 DIABETES MELLITUS,1
DZ,ULCER,1
DZ,ULTRASOUND SCAN ABNORMAL,1
DZ,UMBILICAL HERNIA,1
DZ,UNDERDOSE,1
DZ,UPPER LIMB FRACTURE,1
DZ,UPPER RESPIRATORY TRACT INFECTION,1
DZ,URINARY TRACT INFECTION BACTERIAL,1
DZ,URINOMA,1
DZ,URTICARIA PAPULAR,1
DZ,UTERINE HAEMORRHAGE,1
DZ,UTERINE PROLAPSE,1
DZ,VARICELLA,1
DZ,VENOUS THROMBOSIS,1
DZ,VERTEBRAL COLUMN MASS,1
DZ,VIRAL INFECTION,1
DZ,VITILIGO,1
DZ,WHIPPLE^S DISEASE,1
DZ,WOUND,1
DZ,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
AS,DIZZINESS,3
AS,CONFUSIONAL STATE,2
AS,GASTROINTESTINAL HAEMORRHAGE,2
AS,HAEMORRHAGE INTRACRANIAL,2
AS,HYPERKALAEMIA,2
AS,ABDOMINAL PAIN,1
AS,ANGIOEDEMA,1
AS,APNOEA,1
AS,ASTHENIA,1
AS,BRADYCARDIA,1
AS,BRAIN MIDLINE SHIFT,1
AS,CEREBROVASCULAR ACCIDENT,1
AS,CYANOSIS,1
AS,DRUG DOSE OMISSION,1
AS,ELECTROCARDIOGRAM T WAVE PEAKED,1
AS,EPISTAXIS,1
AS,FAECES DISCOLOURED,1
AS,FATIGUE,1
AS,GASTRIC HAEMORRHAGE,1
AS,GASTROINTESTINAL ARTERIOVENOUS MALFORMATION,1
AS,GASTROINTESTINAL DISORDER,1
AS,HAEMATOCRIT DECREASED,1
AS,HAEMOGLOBIN DECREASED,1
AS,HEADACHE,1
AS,HYPONATRAEMIA,1
AS,INCISION SITE HAEMORRHAGE,1
AS,MELAENA,1
AS,MUSCLE HAEMORRHAGE,1
AS,NAUSEA,1
AS,NODAL RHYTHM,1
AS,OCCULT BLOOD POSITIVE,1
AS,RENAL IMPAIRMENT,1
AS,SUBDURAL HAEMATOMA,1
AS,SYNCOPE,1
AS,THERAPY CHANGE,1
AS,TRANSIENT ISCHAEMIC ATTACK,1
AS,UNRESPONSIVE TO STIMULI,1
AS,VOMITING,1
AD,ERYTHEMA,4
AD,DYSPNOEA,3
AD,DISCOMFORT,2
AD,INFUSION RELATED REACTION,2
AD,RASH,2
AD,ABDOMINAL DISTENSION,1
AD,ANION GAP ABNORMAL,1
AD,APPLICATION SITE CELLULITIS,1
AD,APPLICATION SITE PRURITUS,1
AD,ARTHROPATHY,1
AD,ASTHENIA,1
AD,BACK PAIN,1
AD,BLOOD CREATININE ABNORMAL,1
AD,BLOOD ELECTROLYTES ABNORMAL,1
AD,BLOOD UREA ABNORMAL,1
AD,BRONCHITIS,1
AD,BRONCHOSPASM,1
AD,CHEST DISCOMFORT,1
AD,CROHN^S DISEASE,1
AD,DRUG EFFECT INCOMPLETE,1
AD,EPIGASTRIC DISCOMFORT,1
AD,FALL,1
AD,FEELING HOT,1
AD,HAEMATOCRIT ABNORMAL,1
AD,HYPERBILIRUBINAEMIA,1
AD,HYPERHIDROSIS,1
AD,HYPOTENSION,1
AD,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
AD,INSULIN RESISTANCE,1
AD,INTESTINAL STENOSIS,1
AD,JAUNDICE CHOLESTATIC,1
AD,KIDNEY INFECTION,1
AD,LYMPHOCYTE COUNT ABNORMAL,1
AD,MATERNAL EXPOSURE BEFORE PREGNANCY,1
AD,MELANOCYTIC NAEVUS,1
AD,NEUTROPHIL COUNT ABNORMAL,1
AD,PLACENTA PRAEVIA,1
AD,PLATELET DISORDER,1
AD,PSORIASIS,1
AD,PYREXIA,1
AD,TRANSAMINASES INCREASED,1
AD,UROSEPSIS,1
AD,VOMITING,1
AD,WEIGHT INCREASED,1
AO,GENOTYPE DRUG RESISTANCE TEST POSITIVE,14
AO,TREATMENT FAILURE,14
AO,VIROLOGIC FAILURE,14
AO,HEADACHE,2
AO,PYREXIA,2
AO,DEATH,1
AO,FATIGUE,1
AO,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
AO,MALARIA,1
AO,MUSCLE SPASMS,1
AO,PAIN,1
AO,PRODUCT QUALITY ISSUE,1
AO,VASCULITIS,1
AI,DEATH,1
AG,INJURY,1
AG,SUBARACHNOID HAEMATOMA,1
AG,SUBDURAL HAEMATOMA,1
AG,URINARY RETENTION,1
AR,DEATH,1870
AR,PAIN,880
AR,FALL,802
AR,PNEUMONIA,763
AR,MALAISE,738
AR,PYREXIA,606
AR,DRUG INEFFECTIVE,555
AR,DYSPNOEA,481
AR,PAIN IN EXTREMITY,458
AR,GAIT DISTURBANCE,449
AR,ANAEMIA,428
AR,ARTHRALGIA,428
AR,RHEUMATOID ARTHRITIS,420
AR,BLOOD PRESSURE INCREASED,393
AR,ABASIA,383
AR,DIABETES MELLITUS,376
AR,CONDITION AGGRAVATED,358
AR,VOMITING,338
AR,CEREBROVASCULAR ACCIDENT,335
AR,GENERAL PHYSICAL HEALTH DETERIORATION,327
AR,ARTHROPATHY,326
AR,FATIGUE,318
AR,HYPERTENSION,316
AR,URINARY TRACT INFECTION,315
AR,ASTHENIA,288
AR,CARDIO-RESPIRATORY ARREST,285
AR,DIARRHOEA,281
AR,HEADACHE,279
AR,DIZZINESS,277
AR,CATARACT,267
AR,COUGH,267
AR,DISEASE PROGRESSION,250
AR,NERVOUSNESS,244
AR,WEIGHT DECREASED,243
AR,INFECTION,239
AR,CARDIAC DISORDER,238
AR,BRONCHITIS,232
AR,FEELING ABNORMAL,231
AR,MOBILITY DECREASED,228
AR,VISUAL IMPAIRMENT,227
AR,INFLUENZA,219
AR,DECREASED IMMUNE RESPONSIVENESS,209
AR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,205
AR,LUNG DISORDER,199
AR,VISUAL ACUITY REDUCED,196
AR,MEMORY IMPAIRMENT,195
AR,ARRHYTHMIA,194
AR,MYOCARDIAL INFARCTION,190
AR,CARDIAC FAILURE,189
AR,OSTEOARTHRITIS,189
AR,PERIPHERAL SWELLING,189
AR,DEHYDRATION,181
AR,PRODUCT USE ISSUE,178
AR,HIP FRACTURE,172
AR,CARDIAC ARREST,171
AR,ARTHRITIS,170
AR,HYPOTENSION,169
AR,SYNCOPE,168
AR,HAEMORRHAGE,167
AR,HYPERSENSITIVITY,167
AR,BACK PAIN,166
AR,RENAL FAILURE,166
AR,DEPRESSION,161
AR,PULMONARY OEDEMA,155
AR,AGITATION,152
AR,SEIZURE,151
AR,BRONCHOSPASM,145
AR,THROMBOSIS,145
AR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,145
AR,ANXIETY,136
AR,BLOOD PRESSURE DECREASED,135
AR,BLINDNESS,134
AR,LIVER DISORDER,132
AR,SEPSIS,131
AR,CHOLELITHIASIS,130
AR,ABDOMINAL PAIN,129
AR,JOINT SWELLING,129
AR,NASOPHARYNGITIS,128
AR,NAUSEA,128
AR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,127
AR,LOSS OF CONSCIOUSNESS,125
AR,RENAL DISORDER,125
AR,RASH,124
AR,DECREASED APPETITE,122
AR,CHEST PAIN,120
AR,FOETAL EXPOSURE DURING PREGNANCY,119
AR,BLOOD GLUCOSE INCREASED,118
AR,PLEURAL EFFUSION,118
AR,MACULOPATHY,117
AR,SWELLING,117
AR,ABDOMINAL PAIN UPPER,115
AR,PSORIASIS,114
AR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,114
AR,NEUTROPENIA,112
AR,INFLAMMATION,110
AR,OEDEMA PERIPHERAL,110
AR,INFARCTION,108
AR,GASTROINTESTINAL DISORDER,107
AR,STRESS,107
AR,BONE PAIN,105
AR,FOOT DEFORMITY,104
AR,TACHYCARDIA,104
AR,THROMBOCYTOPENIA,104
AR,UPPER LIMB FRACTURE,103
AR,VISION BLURRED,101
AR,GAIT INABILITY,100
AR,RESPIRATORY FAILURE,100
AR,ABDOMINAL DISCOMFORT,99
AR,LOCALISED INFECTION,98
AR,MALIGNANT NEOPLASM PROGRESSION,97
AR,LIMB INJURY,94
AR,RESPIRATORY DISORDER,94
AR,PRURITUS,93
AR,BREAST CANCER,92
AR,CONVULSION,92
AR,ARTERIAL OCCLUSIVE DISEASE,90
AR,MATERNAL EXPOSURE DURING PREGNANCY,90
AR,MUSCULOSKELETAL DISORDER,90
AR,ACCIDENT,88
AR,HYPOKINESIA,88
AR,PLATELET COUNT DECREASED,88
AR,AMNESIA,87
AR,ABORTION SPONTANEOUS,86
AR,DEPRESSED MOOD,86
AR,FLUID RETENTION,86
AR,LOCAL SWELLING,86
AR,NEOPLASM MALIGNANT,83
AR,DEAFNESS,82
AR,WHITE BLOOD CELL COUNT DECREASED,82
AR,ASTHMA,81
AR,MUSCULAR WEAKNESS,81
AR,COMA,80
AR,DRUG INTOLERANCE,80
AR,SOMNOLENCE,80
AR,WEIGHT INCREASED,80
AR,FEMUR FRACTURE,79
AR,HYPOAESTHESIA,79
AR,SPEECH DISORDER,78
AR,BONE DISORDER,76
AR,LUNG NEOPLASM MALIGNANT,76
AR,OSTEOPOROSIS,76
AR,RENAL IMPAIRMENT,76
AR,SPINAL DISORDER,76
AR,CELLULITIS,75
AR,HEAD INJURY,74
AR,ROAD TRAFFIC ACCIDENT,73
AR,EXPOSURE DURING PREGNANCY,72
AR,MUSCULOSKELETAL STIFFNESS,72
AR,INSOMNIA,71
AR,INTERVERTEBRAL DISC PROTRUSION,71
AR,TREMOR,71
AR,INJECTION SITE PAIN,70
AR,JOINT DISLOCATION,70
AR,NEOPLASM PROGRESSION,70
AR,BLINDNESS UNILATERAL,69
AR,ERYTHEMA,67
AR,NEOPLASM,67
AR,GASTRITIS,66
AR,LIMB DISCOMFORT,66
AR,SPINAL FRACTURE,66
AR,EPISTAXIS,65
AR,EYE DISORDER,65
AR,FEAR,65
AR,HAEMATOMA,65
AR,INJURY,65
AR,LUNG INFECTION,65
AR,SKIN ULCER,65
AR,TUBERCULOSIS,64
AR,DEEP VEIN THROMBOSIS,63
AR,DYSPHAGIA,63
AR,GASTROINTESTINAL HAEMORRHAGE,63
AR,LOWER LIMB FRACTURE,63
AR,MOVEMENT DISORDER,63
AR,PSORIATIC ARTHROPATHY,63
AR,DYSPHONIA,62
AR,HEPATITIS,62
AR,STOMATITIS,62
AR,CONFUSIONAL STATE,61
AR,FEBRILE NEUTROPENIA,61
AR,JOINT INJURY,61
AR,LEUKOPENIA,61
AR,MUSCLE SPASMS,61
AR,PULMONARY MASS,61
AR,CHOKING,60
AR,EYE HAEMORRHAGE,60
AR,GASTRIC DISORDER,60
AR,GASTROENTERITIS,60
AR,MUSCULOSKELETAL PAIN,60
AR,PULMONARY FIBROSIS,60
AR,COLITIS,59
AR,GALLBLADDER DISORDER,59
AR,MYALGIA,59
AR,URTICARIA,59
AR,VIRAL INFECTION,59
AR,LYMPHADENOPATHY,58
AR,PARAESTHESIA,58
AR,BLISTER,57
AR,IMMUNODEFICIENCY,57
AR,NEPHROLITHIASIS,57
AR,PNEUMONITIS,57
AR,WRIST FRACTURE,57
AR,BLOOD PRESSURE ABNORMAL,56
AR,DISCOMFORT,56
AR,RED BLOOD CELL COUNT DECREASED,56
AR,DEVICE RELATED INFECTION,55
AR,FRACTURE,54
AR,MULTIPLE SCLEROSIS RELAPSE,54
AR,SKIN DISCOLOURATION,54
AR,DISORIENTATION,53
AR,HERPES ZOSTER,53
AR,INCORRECT DOSE ADMINISTERED,53
AR,ALOPECIA,52
AR,GLAUCOMA,52
AR,LABORATORY TEST ABNORMAL,52
AR,PERITONITIS,52
AR,TOXICITY TO VARIOUS AGENTS,52
AR,DRUG DOSE OMISSION,51
AR,EATING DISORDER,51
AR,PARKINSON^S DISEASE,51
AR,THYROID DISORDER,51
AR,DRUG DEPENDENCE,50
AR,IMPAIRED HEALING,50
AR,SURGERY,50
AR,BLOOD PRESSURE FLUCTUATION,49
AR,HYPERGLYCAEMIA,49
AR,INTESTINAL OBSTRUCTION,49
AR,MENISCUS INJURY,49
AR,OEDEMA,49
AR,PALPITATIONS,49
AR,DYSSTASIA,48
AR,ERYSIPELAS,48
AR,PERICARDIAL EFFUSION,48
AR,SPINAL PAIN,48
AR,SUDDEN DEATH,48
AR,ASCITES,47
AR,BRONCHIAL DISORDER,47
AR,ISCHAEMIC STROKE,47
AR,MENTAL DISORDER,47
AR,NERVOUS SYSTEM DISORDER,47
AR,NODULE,47
AR,OROPHARYNGEAL PAIN,47
AR,PRODUCT USE IN UNAPPROVED INDICATION,47
AR,SEPTIC SHOCK,47
AR,APHONIA,46
AR,METASTATIC RENAL CELL CARCINOMA,46
AR,PHARYNGITIS,46
AR,ATRIAL FIBRILLATION,45
AR,CENTRAL NERVOUS SYSTEM LESION,45
AR,COLON CANCER,45
AR,EPILEPSY,45
AR,HAND DEFORMITY,45
AR,NOSOCOMIAL INFECTION,45
AR,ABDOMINAL DISTENSION,44
AR,BLOOD CHOLESTEROL INCREASED,44
AR,CYST,44
AR,DRUG PRESCRIBING ERROR,44
AR,EMPHYSEMA,44
AR,HYPERHIDROSIS,44
AR,PREMATURE BABY,44
AR,WHITE BLOOD CELL COUNT INCREASED,44
AR,BALANCE DISORDER,43
AR,CONSTIPATION,43
AR,RENAL CANCER,43
AR,RENAL TUBULAR NECROSIS,43
AR,VERTIGO,43
AR,BACTERIAL INFECTION,42
AR,HAEMATOCHEZIA,42
AR,NECK PAIN,42
AR,ANGINA PECTORIS,41
AR,BLOOD POTASSIUM DECREASED,41
AR,EYE PAIN,41
AR,OSTEOMYELITIS,41
AR,RIB FRACTURE,41
AR,SYSTEMIC LUPUS ERYTHEMATOSUS,41
AR,TONSILLITIS,41
AR,VARICOSE VEIN,41
AR,ACUTE MYOCARDIAL INFARCTION,40
AR,ASTHMATIC CRISIS,40
AR,BLOOD PRESSURE SYSTOLIC INCREASED,40
AR,CONTUSION,40
AR,CORONARY ARTERY OCCLUSION,40
AR,HERNIA,40
AR,RENAL FAILURE ACUTE,40
AR,THERAPEUTIC RESPONSE DECREASED,40
AR,CONCOMITANT DISEASE AGGRAVATED,39
AR,EMOTIONAL DISORDER,39
AR,FOOT FRACTURE,39
AR,HAEMATOCRIT DECREASED,39
AR,INGUINAL HERNIA,39
AR,PULMONARY EMBOLISM,39
AR,SECOND PRIMARY MALIGNANCY,39
AR,ULCER,39
AR,ACTIVITIES OF DAILY LIVING IMPAIRED,38
AR,HYPOACUSIS,38
AR,LOW BIRTH WEIGHT BABY,38
AR,MUSCULOSKELETAL DISCOMFORT,38
AR,RESPIRATORY TRACT INFECTION,38
AR,TIBIA FRACTURE,38
AR,UVEITIS,38
AR,ARTHRITIS INFECTIVE,37
AR,BLOOD CREATININE INCREASED,37
AR,BRAIN NEOPLASM,37
AR,HYPOTHYROIDISM,37
AR,JOINT EFFUSION,37
AR,SKIN LESION,37
AR,BURNING SENSATION,36
AR,CHILLS,36
AR,DEVICE DISLOCATION,36
AR,FIBULA FRACTURE,36
AR,NEUROPATHY PERIPHERAL,36
AR,PANCREATITIS,36
AR,PARALYSIS,36
AR,SWELLING FACE,36
AR,ACUTE KIDNEY INJURY,35
AR,HEPATIC ENZYME INCREASED,35
AR,HYPOGLYCAEMIA,35
AR,POISONING,35
AR,TENDON RUPTURE,35
AR,THROAT IRRITATION,35
AR,BEDRIDDEN,34
AR,COELIAC DISEASE,34
AR,DEMENTIA ALZHEIMER^S TYPE,34
AR,DRY SKIN,34
AR,METASTASES TO LIVER,34
AR,RESPIRATORY ARREST,34
AR,CONJUNCTIVITIS,33
AR,FINGER DEFORMITY,33
AR,LIGAMENT SPRAIN,33
AR,TOOTH DISORDER,33
AR,TYPE 2 DIABETES MELLITUS,33
AR,URINARY INCONTINENCE,33
AR,URINARY RETENTION,33
AR,VIITH NERVE PARALYSIS,33
AR,BLOOD SODIUM DECREASED,32
AR,CHEST DISCOMFORT,32
AR,DISEASE RECURRENCE,32
AR,DRY EYE,32
AR,HEPATOTOXICITY,32
AR,INFUSION RELATED REACTION,32
AR,KIDNEY INFECTION,32
AR,POST PROCEDURAL COMPLICATION,32
AR,PRODUCTIVE COUGH,32
AR,SYNOVIAL CYST,32
AR,ACNE,31
AR,CATARRH,31
AR,HAEMORRHOIDS,31
AR,HOSPITALISATION,31
AR,HYPOPHAGIA,31
AR,IMMUNOSUPPRESSION,31
AR,METASTASES TO LUNG,31
AR,OVERDOSE,31
AR,RETINAL DETACHMENT,31
AR,SKIN DISORDER,31
AR,SKIN EXFOLIATION,31
AR,ANKLE FRACTURE,30
AR,APHASIA,30
AR,BRADYCARDIA,30
AR,COGNITIVE DISORDER,30
AR,CRYING,30
AR,DRUG-INDUCED LIVER INJURY,30
AR,HAEMATURIA,30
AR,HEMIPLEGIA,30
AR,HYPOXIA,30
AR,OVARIAN CYST,30
AR,APPENDICITIS,29
AR,ASPHYXIA,29
AR,BLOOD PRESSURE INADEQUATELY CONTROLLED,29
AR,CARDIOMEGALY,29
AR,CHONDROPATHY,29
AR,DYSPEPSIA,29
AR,FEELING HOT,29
AR,HEPATIC CIRRHOSIS,29
AR,MULTIPLE SCLEROSIS,29
AR,PALLOR,29
AR,POLYP,29
AR,PROSTATE CANCER,29
AR,SINUSITIS,29
AR,UMBILICAL HERNIA,29
AR,UTERINE LEIOMYOMA,29
AR,WOUND,29
AR,AGGRESSION,28
AR,ANGINA UNSTABLE,28
AR,GASTRIC ULCER,28
AR,INTESTINAL PERFORATION,28
AR,OESOPHAGEAL ATRESIA,28
AR,TRANSAMINASES INCREASED,28
AR,VAGINAL HAEMORRHAGE,28
AR,BONE MARROW FAILURE,27
AR,EAR INFECTION,27
AR,HAEMOPTYSIS,27
AR,HEPATIC FAILURE,27
AR,INTESTINAL HAEMORRHAGE,27
AR,LARYNGEAL OEDEMA,27
AR,METASTASES TO CENTRAL NERVOUS SYSTEM,27
AR,MOTOR DYSFUNCTION,27
AR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,27
AR,OCULAR HYPERAEMIA,27
AR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,27
AR,PELVIC FRACTURE,27
AR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,27
AR,CYANOSIS,26
AR,DRUG HYPERSENSITIVITY,26
AR,DYSURIA,26
AR,HEPATITIS TOXIC,26
AR,PROCEDURAL PAIN,26
AR,RENAL NEOPLASM,26
AR,SCIATICA,26
AR,TOOTH INFECTION,26
AR,ANGIOEDEMA,25
AR,BONE EROSION,25
AR,BREAST MASS,25
AR,CARDIOVASCULAR DISORDER,25
AR,CEREBRAL ISCHAEMIA,25
AR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,25
AR,FUNGAL INFECTION,25
AR,HIATUS HERNIA,25
AR,OVERWEIGHT,25
AR,RESPIRATORY DISTRESS,25
AR,SECRETION DISCHARGE,25
AR,BLOOD URINE PRESENT,24
AR,COAGULOPATHY,24
AR,DELIRIUM,24
AR,DIVERTICULUM,24
AR,GASTRIC HAEMORRHAGE,24
AR,GASTROINTESTINAL INFECTION,24
AR,HAEMOGLOBIN DECREASED,24
AR,HAND FRACTURE,24
AR,INFLUENZA LIKE ILLNESS,24
AR,LACRIMATION INCREASED,24
AR,LEUKOCYTOSIS,24
AR,LYMPHOMA,24
AR,ORAL DISORDER,24
AR,OXYGEN SATURATION DECREASED,24
AR,PULMONARY HYPERTENSION,24
AR,SENSITIVITY TO WEATHER CHANGE,24
AR,VASCULITIS,24
AR,FEELING OF DESPAIR,23
AR,FISTULA,23
AR,HAEMATEMESIS,23
AR,HEPATIC STEATOSIS,23
AR,HYPERKERATOSIS,23
AR,INJECTION SITE ERYTHEMA,23
AR,METASTASES TO BONE,23
AR,MULTI-ORGAN FAILURE,23
AR,ORAL PAIN,23
AR,OSTEONECROSIS,23
AR,PANCREATIC CARCINOMA,23
AR,PANCYTOPENIA,23
AR,ANGER,22
AR,ANGIOPATHY,22
AR,BLOOD BILIRUBIN INCREASED,22
AR,BLOOD CHOLESTEROL ABNORMAL,22
AR,FACE INJURY,22
AR,FACE OEDEMA,22
AR,FACIAL PARALYSIS,22
AR,FEELING COLD,22
AR,FURUNCLE,22
AR,HEART RATE DECREASED,22
AR,HEPATIC CANCER,22
AR,MOOD ALTERED,22
AR,MUCOSAL INFLAMMATION,22
AR,PANIC ATTACK,22
AR,PETIT MAL EPILEPSY,22
AR,PLATELET COUNT INCREASED,22
AR,CARDIOPULMONARY FAILURE,21
AR,CAROTID ARTERY OCCLUSION,21
AR,CYSTITIS,21
AR,DIABETES MELLITUS INADEQUATE CONTROL,21
AR,DRUG ADMINISTRATION ERROR,21
AR,ENCEPHALOPATHY,21
AR,EYE SWELLING,21
AR,HYPOKALAEMIA,21
AR,HYPONATRAEMIA,21
AR,KNEE DEFORMITY,21
AR,MIGRAINE,21
AR,NASAL CONGESTION,21
AR,POSTOPERATIVE WOUND INFECTION,21
AR,AORTIC ANEURYSM,20
AR,BLOOD GLUCOSE DECREASED,20
AR,BONE FISSURE,20
AR,CARDIAC FAILURE CONGESTIVE,20
AR,CARDIAC VALVE DISEASE,20
AR,CHOLANGITIS,20
AR,EYE IRRITATION,20
AR,HAEMORRHAGIC STROKE,20
AR,HERPES VIRUS INFECTION,20
AR,HUMERUS FRACTURE,20
AR,JOINT STIFFNESS,20
AR,LIGAMENT RUPTURE,20
AR,LISTLESS,20
AR,ORAL INFECTION,20
AR,ORAL MUCOSAL BLISTERING,20
AR,PRODUCT QUALITY ISSUE,20
AR,SUICIDAL IDEATION,20
AR,TENDON DISORDER,20
AR,TINNITUS,20
AR,TRANSIENT ISCHAEMIC ATTACK,20
AR,ADVERSE EVENT,19
AR,ALANINE AMINOTRANSFERASE INCREASED,19
AR,ASPARTATE AMINOTRANSFERASE INCREASED,19
AR,BLOOD CALCIUM DECREASED,19
AR,CORONARY ARTERY DISEASE,19
AR,DEPRESSED LEVEL OF CONSCIOUSNESS,19
AR,DIVERTICULITIS,19
AR,EAR PAIN,19
AR,HYPERTHYROIDISM,19
AR,INJECTION SITE HAEMATOMA,19
AR,INTRAOCULAR PRESSURE INCREASED,19
AR,JAUNDICE,19
AR,MUSCLE ATROPHY,19
AR,MUSCLE CONTRACTURE,19
AR,MUSCLE RIGIDITY,19
AR,PROTEINURIA,19
AR,PSYCHOTIC DISORDER,19
AR,PULMONARY THROMBOSIS,19
AR,RED BLOOD CELL COUNT INCREASED,19
AR,SENILE DEMENTIA,19
AR,SKIN INFECTION,19
AR,SPINAL COLUMN INJURY,19
AR,YELLOW SKIN,19
AR,ANEURYSM,18
AR,BLOOD TRIGLYCERIDES INCREASED,18
AR,BRONCHIECTASIS,18
AR,CAESAREAN SECTION,18
AR,CARPAL TUNNEL SYNDROME,18
AR,CEREBRAL HAEMORRHAGE,18
AR,COLITIS ULCERATIVE,18
AR,DIPLOPIA,18
AR,DRUG EFFECT INCOMPLETE,18
AR,DRUG RESISTANCE,18
AR,DRY MOUTH,18
AR,EMOTIONAL DISTRESS,18
AR,ERYTHEMA MULTIFORME,18
AR,EXOSTOSIS,18
AR,EXPOSURE DURING BREAST FEEDING,18
AR,FIBROMYALGIA,18
AR,GASTROOESOPHAGEAL REFLUX DISEASE,18
AR,HYPERTENSIVE CRISIS,18
AR,INCREASED UPPER AIRWAY SECRETION,18
AR,LARGE INTESTINE POLYP,18
AR,MALNUTRITION,18
AR,OCULAR DISCOMFORT,18
AR,PARATHYROID DISORDER,18
AR,POST PROCEDURAL INFECTION,18
AR,RASH MACULAR,18
AR,RENAL CELL CARCINOMA,18
AR,SKIN CANCER,18
AR,SUICIDE ATTEMPT,18
AR,UNDERDOSE,18
AR,WOUND INFECTION,18
AR,ABNORMAL BEHAVIOUR,17
AR,ANAPHYLACTIC REACTION,17
AR,ANKYLOSING SPONDYLITIS,17
AR,APPARENT DEATH,17
AR,CROHN^S DISEASE,17
AR,EOSINOPHILIA,17
AR,FOETAL DEATH,17
AR,GENERALISED OEDEMA,17
AR,HEARING IMPAIRED,17
AR,HEPATITIS C,17
AR,HYPOTHERMIA,17
AR,IMMUNE SYSTEM DISORDER,17
AR,LIMB DEFORMITY,17
AR,LUNG NEOPLASM,17
AR,MONOPLEGIA,17
AR,MOUTH HAEMORRHAGE,17
AR,PORTAL HYPERTENSIVE GASTROPATHY,17
AR,PROSTATIC DISORDER,17
AR,SENSORY DISTURBANCE,17
AR,SHOCK,17
AR,SPINAL COMPRESSION FRACTURE,17
AR,TENDON INJURY,17
AR,TENDONITIS,17
AR,THROMBOTIC MICROANGIOPATHY,17
AR,BILE DUCT STONE,16
AR,BLOOD ALKALINE PHOSPHATASE INCREASED,16
AR,BLOOD DISORDER,16
AR,CARTILAGE INJURY,16
AR,CHOLECYSTITIS,16
AR,CHRONIC KIDNEY DISEASE,16
AR,DEFORMITY,16
AR,DRUG EFFECT DECREASED,16
AR,FEEDING DISORDER,16
AR,GASTROINTESTINAL PAIN,16
AR,GENERALISED TONIC-CLONIC SEIZURE,16
AR,HEART RATE INCREASED,16
AR,HEPATIC PAIN,16
AR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,16
AR,LUNG INFILTRATION,16
AR,MUSCULOSKELETAL CHEST PAIN,16
AR,NERVE COMPRESSION,16
AR,NORMAL NEWBORN,16
AR,POLLAKIURIA,16
AR,POST TRANSPLANT DISTAL LIMB SYNDROME,16
AR,RECTAL HAEMORRHAGE,16
AR,RENAL CYST,16
AR,SENSORY LOSS,16
AR,SPINAL DEFORMITY,16
AR,THYROID NEOPLASM,16
AR,TOOTH FRACTURE,16
AR,UNEVALUABLE EVENT,16
AR,WALKING DISABILITY,16
AR,APHAGIA,15
AR,APPLICATION SITE PAIN,15
AR,ARTHRITIS BACTERIAL,15
AR,AUTOIMMUNE HEPATITIS,15
AR,BACTERAEMIA,15
AR,BASAL CELL CARCINOMA,15
AR,BLOOD GLUCOSE ABNORMAL,15
AR,BUNION,15
AR,CARDIOGENIC SHOCK,15
AR,DECUBITUS ULCER,15
AR,DISLOCATION OF VERTEBRA,15
AR,HAEMARTHROSIS,15
AR,HALLUCINATION,15
AR,HERNIAL EVENTRATION,15
AR,HYPOTONIA,15
AR,INTENTIONAL PRODUCT MISUSE,15
AR,ISCHAEMIA,15
AR,LACERATION,15
AR,NO THERAPEUTIC RESPONSE,15
AR,OSTEOPENIA,15
AR,PERIPHERAL VASCULAR DISORDER,15
AR,PERITONITIS BACTERIAL,15
AR,PHLEBITIS,15
AR,SPINAL CORD COMPRESSION,15
AR,TREATMENT FAILURE,15
AR,VARICES OESOPHAGEAL,15
AR,VEIN DISORDER,15
AR,ACUTE RESPIRATORY FAILURE,14
AR,ANAL FISTULA,14
AR,ARTERIAL DISORDER,14
AR,BLOOD UREA INCREASED,14
AR,BRAIN OEDEMA,14
AR,BREAST CANCER FEMALE,14
AR,BREAST NEOPLASM,14
AR,CARDIOMYOPATHY,14
AR,CYTOMEGALOVIRUS INFECTION,14
AR,DEVICE OCCLUSION,14
AR,DYSGEUSIA,14
AR,ELECTROCARDIOGRAM QT PROLONGED,14
AR,ENTEROCOLITIS,14
AR,EYE INFECTION,14
AR,EYE INJURY,14
AR,GASTROINTESTINAL INFLAMMATION,14
AR,HEMIVERTEBRA,14
AR,HEPATOMEGALY,14
AR,HYPERSOMNIA,14
AR,ILL-DEFINED DISORDER,14
AR,INJECTION SITE PRURITUS,14
AR,INTERSTITIAL LUNG DISEASE,14
AR,IRRITABILITY,14
AR,KIDNEY TRANSPLANT REJECTION,14
AR,LIVER INJURY,14
AR,MASS,14
AR,MICROTIA,14
AR,PATELLA FRACTURE,14
AR,PATENT DUCTUS ARTERIOSUS,14
AR,PNEUMONIA ASPIRATION,14
AR,PRESCRIBED UNDERDOSE,14
AR,RASH ERYTHEMATOUS,14
AR,RASH GENERALISED,14
AR,RETINAL VASCULAR THROMBOSIS,14
AR,SKIN REACTION,14
AR,SPLENOMEGALY,14
AR,TOTAL LUNG CAPACITY DECREASED,14
AR,UNDERWEIGHT,14
AR,UPPER GASTROINTESTINAL HAEMORRHAGE,14
AR,UTERINE CANCER,14
AR,ACUTE PULMONARY OEDEMA,13
AR,APNOEA,13
AR,ARTERIOVENOUS FISTULA OCCLUSION,13
AR,ATRIOVENTRICULAR BLOCK FIRST DEGREE,13
AR,CEREBRAL DISORDER,13
AR,CEREBRAL INFARCTION,13
AR,CHEST INJURY,13
AR,CHOKING SENSATION,13
AR,CHOLECYSTITIS ACUTE,13
AR,CLEFT LIP AND PALATE,13
AR,DERMATITIS,13
AR,DEVICE MALFUNCTION,13
AR,DIABETIC FOOT,13
AR,DIVERTICULUM INTESTINAL,13
AR,DYSARTHRIA,13
AR,GROIN PAIN,13
AR,HAEMODYNAMIC INSTABILITY,13
AR,INJECTION SITE URTICARIA,13
AR,INTESTINAL POLYP,13
AR,INTRACRANIAL PRESSURE INCREASED,13
AR,IRRITABLE BOWEL SYNDROME,13
AR,JOINT RANGE OF MOTION DECREASED,13
AR,KERATITIS,13
AR,LEUKAEMIA,13
AR,NO ADVERSE EVENT,13
AR,OBESITY,13
AR,OSTEONECROSIS OF JAW,13
AR,PETECHIAE,13
AR,PREMATURE DELIVERY,13
AR,PRURITUS GENERALISED,13
AR,PULMONARY HAEMORRHAGE,13
AR,PURPURA,13
AR,SJOGREN^S SYNDROME,13
AR,SKIN FISSURES,13
AR,SKIN INJURY,13
AR,TOOTH LOSS,13
AR,TUBERCULIN TEST POSITIVE,13
AR,VEIN RUPTURE,13
AR,ABDOMINAL HERNIA,12
AR,ABSCESS,12
AR,ACUTE ABDOMEN,12
AR,AGEUSIA,12
AR,BLADDER CANCER,12
AR,BLOOD IMMUNOGLOBULIN E INCREASED,12
AR,BLOOD LACTATE DEHYDROGENASE INCREASED,12
AR,BONE DECALCIFICATION,12
AR,BONE MARROW DISORDER,12
AR,BRONCHIAL OBSTRUCTION,12
AR,BRONCHIOLITIS,12
AR,CARDIAC MURMUR,12
AR,DENTAL CARIES,12
AR,DERMATITIS ALLERGIC,12
AR,GASTROINTESTINAL OEDEMA,12
AR,GINGIVAL BLEEDING,12
AR,GRANULOMA,12
AR,HEMIPARESIS,12
AR,INCONTINENCE,12
AR,INJECTION SITE HAEMORRHAGE,12
AR,MENTAL IMPAIRMENT,12
AR,OVARIAN CANCER,12
AR,PANCREATIC DISORDER,12
AR,PANCREATIC NEOPLASM,12
AR,PERICARDITIS,12
AR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,12
AR,PROCEDURAL COMPLICATION,12
AR,RENAL COLIC,12
AR,RENAL PAIN,12
AR,RHINORRHOEA,12
AR,SCRATCH,12
AR,SKIN PAPILLOMA,12
AR,SNEEZING,12
AR,SPINAL CORD DISORDER,12
AR,TERMINAL STATE,12
AR,THROAT TIGHTNESS,12
AR,THYROID CANCER,12
AR,ADRENAL INSUFFICIENCY,11
AR,ANOSMIA,11
AR,ARTHROPOD BITE,11
AR,ATRIAL SEPTAL DEFECT,11
AR,ATRIOVENTRICULAR BLOCK,11
AR,BLOOD PRESSURE DIASTOLIC DECREASED,11
AR,BONE DEFORMITY,11
AR,BREAST DISORDER,11
AR,CARDIAC FIBRILLATION,11
AR,CARDIOTOXICITY,11
AR,CATARACT OPERATION,11
AR,CONGESTIVE CARDIOMYOPATHY,11
AR,DEAFNESS UNILATERAL,11
AR,DEMYELINATION,11
AR,DRUG DISPENSING ERROR,11
AR,DYSKINESIA,11
AR,EAR DISORDER,11
AR,EYE DISCHARGE,11
AR,EYE OEDEMA,11
AR,FOETAL GROWTH RESTRICTION,11
AR,FOOD INTOLERANCE,11
AR,GASTRIC CANCER,11
AR,HAEMOLYTIC ANAEMIA,11
AR,HEAT STROKE,11
AR,HIP SURGERY,11
AR,HYDROCEPHALUS,11
AR,IMMOBILE,11
AR,INJECTION SITE REACTION,11
AR,INTERNAL HAEMORRHAGE,11
AR,INTRACRANIAL ANEURYSM,11
AR,LARYNGITIS,11
AR,OPTIC NEURITIS,11
AR,ORAL CANDIDIASIS,11
AR,PHARYNGEAL OEDEMA,11
AR,PIGMENTATION DISORDER,11
AR,PNEUMOTHORAX,11
AR,PREGNANCY ON CONTRACEPTIVE,11
AR,PROCEDURAL HAEMORRHAGE,11
AR,RHINITIS,11
AR,SLEEP DISORDER,11
AR,SPINAL OPERATION,11
AR,TRAUMATIC LUNG INJURY,11
AR,URINARY BLADDER POLYP,11
AR,VENTRICULAR SEPTAL DEFECT,11
AR,WHEEZING,11
AR,ACUTE HEPATIC FAILURE,10
AR,APPLICATION SITE PRURITUS,10
AR,ASPIRATION,10
AR,AZOTAEMIA,10
AR,BILE DUCT OBSTRUCTION,10
AR,BLADDER DISORDER,10
AR,CALCULUS BLADDER,10
AR,CANDIDA INFECTION,10
AR,CHOLESTASIS,10
AR,CLAVICLE FRACTURE,10
AR,COLOBOMA,10
AR,DEMENTIA,10
AR,DERMATITIS EXFOLIATIVE,10
AR,DIARRHOEA HAEMORRHAGIC,10
AR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,10
AR,EXTREMITY NECROSIS,10
AR,EYELID PTOSIS,10
AR,GASTROINTESTINAL NEOPLASM,10
AR,GLYCOSYLATED HAEMOGLOBIN INCREASED,10
AR,H1N1 INFLUENZA,10
AR,HEAD DISCOMFORT,10
AR,HEPATIC LESION,10
AR,HEPATIC NEOPLASM,10
AR,HERPES OPHTHALMIC,10
AR,HORMONE LEVEL ABNORMAL,10
AR,HYPERAESTHESIA,10
AR,INCORRECT DRUG ADMINISTRATION DURATION,10
AR,INJECTION SITE SWELLING,10
AR,INTENTIONAL PRODUCT USE ISSUE,10
AR,LIPOMA,10
AR,MELAENA,10
AR,MENINGIOMA,10
AR,MOUTH ULCERATION,10
AR,MUSCLE SPASTICITY,10
AR,NAIL DISORDER,10
AR,NEPHROCALCINOSIS,10
AR,NEUTROPHIL COUNT INCREASED,10
AR,OBSTRUCTIVE AIRWAYS DISORDER,10
AR,ORAL DISCOMFORT,10
AR,PANCREATITIS ACUTE,10
AR,PARTIAL SEIZURES,10
AR,PATHOLOGICAL FRACTURE,10
AR,PHOTOSENSITIVITY REACTION,10
AR,PLASMA CELL MYELOMA,10
AR,POLYNEUROPATHY,10
AR,POOR PERIPHERAL CIRCULATION,10
AR,POSTOPERATIVE WOUND COMPLICATION,10
AR,PULMONARY FUNCTION TEST DECREASED,10
AR,PURULENT DISCHARGE,10
AR,PYELONEPHRITIS,10
AR,SCAB,10
AR,SCAR,10
AR,SERUM FERRITIN INCREASED,10
AR,SKIN HAEMORRHAGE,10
AR,STEVENS-JOHNSON SYNDROME,10
AR,STILLBIRTH,10
AR,ULCERATIVE KERATITIS,10
AR,UTERINE HAEMORRHAGE,10
AR,VENOUS THROMBOSIS,10
AR,VISUAL FIELD DEFECT,10
AR,ANAL HAEMORRHAGE,9
AR,ANAPHYLACTIC SHOCK,9
AR,ANOMALY OF EXTERNAL EAR CONGENITAL,9
AR,ANURIA,9
AR,BACK INJURY,9
AR,BLINDNESS TRANSIENT,9
AR,BLOOD TEST ABNORMAL,9
AR,BODY TEMPERATURE INCREASED,9
AR,BREAST CYST,9
AR,BURSITIS,9
AR,C-REACTIVE PROTEIN INCREASED,9
AR,CARDIAC PACEMAKER INSERTION,9
AR,DERMAL CYST,9
AR,DEVICE FAILURE,9
AR,DIABETIC COMPLICATION,9
AR,DRUG WITHDRAWAL SYNDROME,9
AR,EJECTION FRACTION DECREASED,9
AR,ERGOT POISONING,9
AR,EYELID OEDEMA,9
AR,FAECES DISCOLOURED,9
AR,FLUID OVERLOAD,9
AR,GANGRENE,9
AR,GENERAL PHYSICAL CONDITION ABNORMAL,9
AR,HAEMATOTOXICITY,9
AR,HEPATIC FUNCTION ABNORMAL,9
AR,HEPATOCELLULAR CARCINOMA,9
AR,HIP ARTHROPLASTY,9
AR,HOT FLUSH,9
AR,HYPERSENSITIVITY VASCULITIS,9
AR,IMMUNE THROMBOCYTOPENIC PURPURA,9
AR,INFECTED SKIN ULCER,9
AR,INJECTION SITE ABSCESS,9
AR,INTERVERTEBRAL DISC DISORDER,9
AR,INTERVERTEBRAL DISC DISPLACEMENT,9
AR,LUNG CYST,9
AR,METABOLIC DISORDER,9
AR,MUSCLE RUPTURE,9
AR,MYOCLONUS,9
AR,MYOPIA,9
AR,NECROSIS,9
AR,OLIGURIA,9
AR,ORGAN FAILURE,9
AR,PULMONARY PAIN,9
AR,QUADRIPLEGIA,9
AR,RESTLESSNESS,9
AR,ROTATOR CUFF SYNDROME,9
AR,SKELETAL INJURY,9
AR,SKIN BURNING SENSATION,9
AR,SKIN IRRITATION,9
AR,SKIN NECROSIS,9
AR,SLEEP APNOEA SYNDROME,9
AR,STATUS EPILEPTICUS,9
AR,SUBDURAL HAEMATOMA,9
AR,SWOLLEN TONGUE,9
AR,THYROID MASS,9
AR,TREATMENT NONCOMPLIANCE,9
AR,TYPE 1 DIABETES MELLITUS,9
AR,URINARY TRACT DISORDER,9
AR,URINARY TRACT OBSTRUCTION,9
AR,WITHDRAWAL SYNDROME,9
AR,ABORTION INDUCED,8
AR,ACCIDENT AT HOME,8
AR,ACCIDENT AT WORK,8
AR,ADENOCARCINOMA,8
AR,APATHY,8
AR,ATAXIA,8
AR,ATRIOVENTRICULAR SEPTAL DEFECT,8
AR,BILIARY TRACT DISORDER,8
AR,BIPOLAR DISORDER,8
AR,BLOOD COUNT ABNORMAL,8
AR,BLOOD PARATHYROID HORMONE INCREASED,8
AR,BLOOD POTASSIUM INCREASED,8
AR,BLOOD URIC ACID INCREASED,8
AR,BREAST CALCIFICATIONS,8
AR,BREAST CANCER METASTATIC,8
AR,COLON NEOPLASM,8
AR,COMPLETED SUICIDE,8
AR,CONCOMITANT DISEASE PROGRESSION,8
AR,COORDINATION ABNORMAL,8
AR,CYTOPENIA,8
AR,DENGUE FEVER,8
AR,DIABETIC COMA,8
AR,DIABETIC METABOLIC DECOMPENSATION,8
AR,DRY THROAT,8
AR,DYSPNOEA EXERTIONAL,8
AR,EMBOLISM,8
AR,ENCEPHALITIS,8
AR,ESCHERICHIA INFECTION,8
AR,EYE ULCER,8
AR,FLUID INTAKE REDUCED,8
AR,GASTRIC POLYPS,8
AR,GOUT,8
AR,HEPATIC CYST,8
AR,HEPATIC ENZYME ABNORMAL,8
AR,HYPOCALCAEMIA,8
AR,HYPOVOLAEMIC SHOCK,8
AR,INCORRECT ROUTE OF DRUG ADMINISTRATION,8
AR,INJECTION SITE WARMTH,8
AR,KETOACIDOSIS,8
AR,LIGAMENT INJURY,8
AR,LIVER FUNCTION TEST ABNORMAL,8
AR,LOWER GASTROINTESTINAL HAEMORRHAGE,8
AR,MEDICATION ERROR,8
AR,METASTASIS,8
AR,MOUTH SWELLING,8
AR,MYASTHENIA GRAVIS,8
AR,NASAL POLYPS,8
AR,NEURALGIA,8
AR,NEUROLOGICAL DECOMPENSATION,8
AR,NON-SMALL CELL LUNG CANCER METASTATIC,8
AR,PATIENT-DEVICE INCOMPATIBILITY,8
AR,PHOTOPHOBIA,8
AR,POST PROCEDURAL HAEMORRHAGE,8
AR,PSEUDOMONAS INFECTION,8
AR,PSYCHOMOTOR HYPERACTIVITY,8
AR,PULMONARY ARTERIAL HYPERTENSION,8
AR,RASH PUSTULAR,8
AR,RESPIRATORY TRACT CONGESTION,8
AR,SEDATION,8
AR,SNORING,8
AR,STENT PLACEMENT,8
AR,SUBARACHNOID HAEMORRHAGE,8
AR,SYNOVITIS,8
AR,THERMAL BURN,8
AR,TRANSFUSION,8
AR,TRANSPLANT REJECTION,8
AR,TRISOMY 21,8
AR,TUBULOINTERSTITIAL NEPHRITIS,8
AR,TUMOUR MARKER INCREASED,8
AR,TYMPANIC MEMBRANE PERFORATION,8
AR,VENOUS OCCLUSION,8
AR,VENTRICULAR ARRHYTHMIA,8
AR,VIRAL UPPER RESPIRATORY TRACT INFECTION,8
AR,VIROLOGIC FAILURE,8
AR,ABDOMINAL ADHESIONS,7
AR,ABDOMINAL PAIN LOWER,7
AR,ABSCESS LIMB,7
AR,ADVERSE DRUG REACTION,7
AR,ANAL FISSURE,7
AR,ANKLE DEFORMITY,7
AR,AORTIC VALVE DISEASE,7
AR,APPLICATION SITE ERYTHEMA,7
AR,ASPERGILLUS INFECTION,7
AR,ASPIRATION BRONCHIAL,7
AR,ASTHENOPIA,7
AR,ATRIOVENTRICULAR BLOCK COMPLETE,7
AR,BLOOD CREATINE PHOSPHOKINASE INCREASED,7
AR,BLOOD GLUCOSE FLUCTUATION,7
AR,BONE CANCER,7
AM,DEATH,30
AM,ASTHENIA,8
AM,MYOCARDIAL INFARCTION,7
AM,CARDIAC FAILURE,6
AM,DRUG INEFFECTIVE,6
AM,NAUSEA,6
AM,CHRONIC MYELOID LEUKAEMIA,5
AM,DEPRESSION,5
AM,MALIGNANT NEOPLASM PROGRESSION,5
AM,VOMITING,5
AM,ANAEMIA,4
AM,COUGH,4
AM,DIARRHOEA,4
AM,DISEASE PROGRESSION,4
AM,DYSPNOEA,4
AM,PANCYTOPENIA,4
AM,PULMONARY EMBOLISM,4
AM,THROMBOCYTOPENIA,4
AM,TUMOUR MARKER INCREASED,4
AM,ACUTE KIDNEY INJURY,3
AM,ANGIOEDEMA,3
AM,ANXIETY,3
AM,ARRHYTHMIA,3
AM,CUSHINGOID,3
AM,HEPATIC ENCEPHALOPATHY,3
AM,HYPERKINESIA,3
AM,METASTASES TO CENTRAL NERVOUS SYSTEM,3
AM,MYALGIA,3
AM,PRURITUS,3
AM,PYREXIA,3
AM,TUBERCULOSIS,3
AM,ARTHRALGIA,2
AM,BLOOD CREATININE INCREASED,2
AM,BRONCHOSPASM,2
AM,CATARACT,2
AM,CEREBROVASCULAR ACCIDENT,2
AM,CHEST PAIN,2
AM,CONDITION AGGRAVATED,2
AM,DEEP VEIN THROMBOSIS,2
AM,DYSKINESIA,2
AM,ENCEPHALOPATHY,2
AM,HEADACHE,2
AM,HEPATIC CIRRHOSIS,2
AM,HEPATORENAL SYNDROME,2
AM,HYPERSENSITIVITY,2
AM,HYPERTENSION,2
AM,HYPOTENSION,2
AM,INFECTION,2
AM,INFLAMMATION,2
AM,INSOMNIA,2
AM,LEUKOPENIA,2
AM,METASTASES TO LIVER,2
AM,METASTASES TO LUNG,2
AM,NEUROPATHY PERIPHERAL,2
AM,NEUTROPENIA,2
AM,PANCOAST^S TUMOUR,2
AM,PNEUMONIA,2
AM,PULMONARY TUBERCULOSIS,2
AM,RENAL IMPAIRMENT,2
AM,RESPIRATORY FAILURE,2
AM,SKIN EXFOLIATION,2
AM,TORTICOLLIS,2
AM,ABDOMINAL PAIN UPPER,1
AM,ABORTION SPONTANEOUS,1
AM,ACCIDENT,1
AM,ACQUIRED IMMUNODEFICIENCY SYNDROME,1
AM,ALANINE AMINOTRANSFERASE ABNORMAL,1
AM,ALANINE AMINOTRANSFERASE INCREASED,1
AM,AMYLOIDOSIS,1
AM,ANAL INCONTINENCE,1
AM,ANAPHYLACTIC SHOCK,1
AM,ARTERIOSCLEROSIS,1
AM,ARTHRITIS,1
AM,ASCITES,1
AM,ASPARTATE AMINOTRANSFERASE INCREASED,1
AM,ASTHMA,1
AM,ATAXIA,1
AM,BACK PAIN,1
AM,BLINDNESS,1
AM,BLOOD BILIRUBIN INCREASED,1
AM,BLOOD CALCIUM DECREASED,1
AM,BLOOD DISORDER,1
AM,BLOOD POTASSIUM INCREASED,1
AM,BLOOD PRESSURE DECREASED,1
AM,BODY TEMPERATURE INCREASED,1
AM,BREAST CANCER,1
AM,BREAST CANCER RECURRENT,1
AM,BREATH SOUNDS ABNORMAL,1
AM,BREATH SOUNDS ABSENT,1
AM,CALCULUS URINARY,1
AM,CARCINOGENICITY,1
AM,CARDIAC FAILURE CONGESTIVE,1
AM,CARDIOPULMONARY FAILURE,1
AM,CARPAL TUNNEL SYNDROME,1
AM,CATHETER SITE HAEMATOMA,1
AM,CEREBROVASCULAR DISORDER,1
AM,COLD SWEAT,1
AM,COMPLEMENT FACTOR C3 DECREASED,1
AM,COMPLEMENT FACTOR C4 DECREASED,1
AM,CONDUCTION DISORDER,1
AM,CONTRAINDICATED PRODUCT ADMINISTERED,1
AM,COR PULMONALE,1
AM,COR PULMONALE CHRONIC,1
AM,CORONARY ARTERY DISSECTION,1
AM,DEAFNESS,1
AM,DECREASED APPETITE,1
AM,DEPRESSED LEVEL OF CONSCIOUSNESS,1
AM,DEVICE MALFUNCTION,1
AM,DISCOMFORT,1
AM,DIZZINESS,1
AM,DRUG INTOLERANCE,1
AM,DYSPNOEA AT REST,1
AM,ELECTROCARDIOGRAM QT PROLONGED,1
AM,ELECTROLYTE IMBALANCE,1
AM,EMBOLISM,1
AM,ENTERITIS,1
AM,EUPHORIC MOOD,1
AM,FACE OEDEMA,1
AM,FATIGUE,1
AM,FEELING COLD,1
AM,GASTROINTESTINAL CARCINOMA,1
AM,GASTROINTESTINAL DISORDER,1
AM,GLAUCOMA,1
AM,GRIMACING,1
AM,HAEMATURIA,1
AM,HAEMODIALYSIS COMPLICATION,1
AM,HAEMOPTYSIS,1
AM,HAEMORRHOIDS THROMBOSED,1
AM,HALLUCINATION,1
AM,HEAD AND NECK CANCER METASTATIC,1
AM,HEART SOUNDS ABNORMAL,1
AM,HEPATIC CANCER,1
AM,HEPATIC ENZYME INCREASED,1
AM,HEPATIC FAILURE,1
AM,HEPATIC PAIN,1
AM,HERPES ZOSTER DISSEMINATED,1
AM,HIP FRACTURE,1
AM,HIV INFECTION,1
AM,HYPERGLYCAEMIA,1
AM,HYPERTENSIVE CRISIS,1
AM,HYPERTONIA,1
AM,HYPOACUSIS,1
AM,HYPOALBUMINAEMIA,1
AM,HYPOTONIA,1
AM,INCORRECT DRUG ADMINISTRATION DURATION,1
AM,INJECTION SITE RASH,1
AM,INTENTIONAL PRODUCT USE ISSUE,1
AM,INTESTINAL HAEMORRHAGE,1
AM,INTESTINAL OBSTRUCTION,1
AM,IRRITABILITY,1
AM,ISCHAEMIC STROKE,1
AM,JAUNDICE,1
AM,JOINT SWELLING,1
AM,LOSS OF CONSCIOUSNESS,1
AM,LYMPHADENOPATHY,1
AM,MEDICATION ERROR,1
AM,METASTASES TO ABDOMINAL CAVITY,1
AM,METASTASES TO PELVIS,1
AM,MOVEMENT DISORDER,1
AM,MUCOSAL INFLAMMATION,1
AM,MUSCULAR WEAKNESS,1
AM,MYOCARDIAL ISCHAEMIA,1
AM,NEPHROTIC SYNDROME,1
AM,NERVOUS SYSTEM DISORDER,1
AM,NIGHTMARE,1
AM,NO THERAPEUTIC RESPONSE,1
AM,NON-SMALL CELL LUNG CANCER,1
AM,OEDEMA PERIPHERAL,1
AM,OPTIC NEURITIS,1
AM,OVARIAN CANCER RECURRENT,1
AM,PAIN,1
AM,PAIN OF SKIN,1
AM,PANIC ATTACK,1
AM,PARKINSONISM,1
AM,PATERNAL EXPOSURE DURING PREGNANCY,1
AM,PATHOLOGICAL FRACTURE,1
AM,PHARYNGEAL OEDEMA,1
AM,PLEURAL EFFUSION,1
AM,PRE-EXISTING CONDITION IMPROVED,1
AM,PROSTATIC ADENOMA,1
AM,PULMONARY ARTERY THROMBOSIS,1
AM,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
AM,RENAL FAILURE,1
AM,RENAL VEIN THROMBOSIS,1
AM,RHEUMATOID ARTHRITIS,1
AM,RIGHT VENTRICULAR FAILURE,1
AM,SECOND PRIMARY MALIGNANCY,1
AM,SEPSIS,1
AM,SINUS NODE DYSFUNCTION,1
AM,SKIN DISCOLOURATION,1
AM,SOFT TISSUE NECROSIS,1
AM,SPINAL PAIN,1
AM,SPLENOMEGALY,1
AM,STOMATITIS,1
AM,STRABISMUS,1
AM,SUFFOCATION FEELING,1
AM,SUICIDAL IDEATION,1
AM,SYNCOPE,1
AM,TETANY,1
AM,THERAPY NON-RESPONDER,1
AM,TRANSAMINASES INCREASED,1
AM,TREATMENT FAILURE,1
AM,TREATMENT NONCOMPLIANCE,1
AM,TREMOR,1
AM,TUMOUR NECROSIS,1
AM,UNDERDOSE,1
AM,URINARY INCONTINENCE,1
AM,VENOUS THROMBOSIS,1
AM,VERTIGO,1
AM,WEIGHT DECREASED,1
AM,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
AW,ABASIA,1
AW,ABNORMAL BEHAVIOUR,1
AW,ACUTE MYELOID LEUKAEMIA,1
AW,ADVERSE EVENT,1
AW,AGGRESSION,1
AW,AGITATION,1
AW,ANAEMIA,1
AW,APPARENT DEATH,1
AW,ARTHRALGIA,1
AW,BLOOD COUNT ABNORMAL,1
AW,BLOOD UREA INCREASED,1
AW,COLITIS ULCERATIVE,1
AW,CONDITION AGGRAVATED,1
AW,CONVULSION,1
AW,DECREASED APPETITE,1
AW,DEPRESSION,1
AW,DIABETIC KETOACIDOSIS,1
AW,DIARRHOEA,1
AW,DIZZINESS,1
AW,DRUG DOSE OMISSION,1
AW,DYSPNOEA,1
AW,EAR INFECTION,1
AW,ENCEPHALITIS,1
AW,FEELING ABNORMAL,1
AW,GASTRIC PERFORATION,1
AW,GASTRIC ULCER,1
AW,GENERAL PHYSICAL HEALTH DETERIORATION,1
AW,GUN SHOT WOUND,1
AW,HAEMATEMESIS,1
AW,HAEMOGLOBIN DECREASED,1
AW,HAEMORRHAGE INTRACRANIAL,1
AW,HEAD INJURY,1
AW,HEADACHE,1
AW,HYPERTENSION,1
AW,HYPOTENSION,1
AW,INFECTION,1
AW,INFUSION RELATED REACTION,1
AW,INSOMNIA,1
AW,LIVER FUNCTION TEST ABNORMAL,1
AW,LOSS OF CONSCIOUSNESS,1
AW,MALAISE,1
AW,MALIGNANT MELANOMA,1
AW,MYALGIA,1
AW,OROPHARYNGEAL PAIN,1
AW,PALPITATIONS,1
AW,PANCYTOPENIA,1
AW,PERIPHERAL MOTOR NEUROPATHY,1
AW,PERITONEAL DIALYSIS COMPLICATION,1
AW,PLATELET COUNT INCREASED,1
AW,POLYMERASE CHAIN REACTION,1
AW,PRURITUS,1
AW,RASH,1
AW,TOOTH LOSS,1
AW,UPPER GASTROINTESTINAL HAEMORRHAGE,1
AW,VENTRICULAR TACHYCARDIA,1
AW,VOMITING,1
AU,DEATH,3762
AU,MALAISE,1450
AU,DRUG INEFFECTIVE,1374
AU,NAUSEA,1359
AU,DYSPNOEA,1247
AU,FALL,1216
AU,FATIGUE,1216
AU,DIARRHOEA,1112
AU,DISEASE PROGRESSION,1112
AU,PYREXIA,1020
AU,VOMITING,1001
AU,HEADACHE,935
AU,PAIN,915
AU,TOXICITY TO VARIOUS AGENTS,889
AU,DIZZINESS,870
AU,OVERDOSE,809
AU,PNEUMONIA,770
AU,MALIGNANT NEOPLASM PROGRESSION,723
AU,HYPOTENSION,713
AU,RASH,697
AU,ARTHRALGIA,657
AU,CEREBROVASCULAR ACCIDENT,611
AU,CHEST PAIN,597
AU,WEIGHT DECREASED,584
AU,NEUTROPENIA,561
AU,RENAL IMPAIRMENT,541
AU,DEPRESSION,532
AU,LOWER RESPIRATORY TRACT INFECTION,530
AU,ANXIETY,522
AU,WHITE BLOOD CELL COUNT INCREASED,512
AU,SEPSIS,506
AU,CONFUSIONAL STATE,493
AU,ABDOMINAL PAIN,489
AU,ASTHENIA,475
AU,MYOCARDIAL INFARCTION,474
AU,SUICIDAL IDEATION,473
AU,BACK PAIN,471
AU,HYPERTENSION,471
AU,PAIN IN EXTREMITY,460
AU,ANAEMIA,450
AU,FEELING ABNORMAL,433
AU,CONDITION AGGRAVATED,431
AU,INSOMNIA,423
AU,PRURITUS,419
AU,ACUTE KIDNEY INJURY,415
AU,FOETAL EXPOSURE DURING PREGNANCY,409
AU,TACHYCARDIA,404
AU,COUGH,401
AU,INFECTION,398
AU,LETHARGY,398
AU,DECREASED APPETITE,397
AU,DEHYDRATION,378
AU,HAEMOGLOBIN DECREASED,372
AU,CONSTIPATION,371
AU,URINARY TRACT INFECTION,370
AU,LOSS OF CONSCIOUSNESS,367
AU,PSYCHOTIC DISORDER,364
AU,WEIGHT INCREASED,361
AU,THROMBOCYTOPENIA,360
AU,SYNCOPE,358
AU,PULMONARY EMBOLISM,357
AU,PRODUCT USE ISSUE,356
AU,ATRIAL FIBRILLATION,347
AU,PARAESTHESIA,344
AU,SEIZURE,337
AU,TREMOR,337
AU,VISION BLURRED,334
AU,VISUAL IMPAIRMENT,334
AU,HYPERHIDROSIS,332
AU,MYALGIA,331
AU,HAEMORRHAGE,329
AU,PRODUCT QUALITY ISSUE,329
AU,CHILLS,328
AU,FEBRILE NEUTROPENIA,321
AU,CARDIAC ARREST,320
AU,SOMNOLENCE,318
AU,EXPOSURE DURING PREGNANCY,313
AU,LIVER FUNCTION TEST ABNORMAL,313
AU,GAIT DISTURBANCE,312
AU,ANAPHYLACTIC REACTION,305
AU,INTENTIONAL OVERDOSE,302
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,296
AU,OEDEMA PERIPHERAL,295
AU,GENERAL PHYSICAL HEALTH DETERIORATION,293
AU,AGITATION,290
AU,PALPITATIONS,290
AU,CARDIAC FAILURE,289
AU,RENAL FAILURE,289
AU,AGGRESSION,284
AU,CELLULITIS,279
AU,MUSCULAR WEAKNESS,279
AU,MUSCLE SPASMS,270
AU,NEUTROPHIL COUNT INCREASED,270
AU,CARDIAC DISORDER,268
AU,BLOOD GLUCOSE INCREASED,263
AU,RESPIRATORY FAILURE,259
AU,BLOOD CREATININE INCREASED,255
AU,DEEP VEIN THROMBOSIS,255
AU,SCHIZOPHRENIA,255
AU,URTICARIA,255
AU,DELIRIUM,254
AU,ABDOMINAL PAIN UPPER,251
AU,CHEST DISCOMFORT,251
AU,BLOOD PRESSURE INCREASED,250
AU,ELECTROCARDIOGRAM QT PROLONGED,249
AU,DRUG DOSE OMISSION,245
AU,ERYTHEMA,244
AU,CROHN^S DISEASE,242
AU,PANCYTOPENIA,240
AU,DYSPHAGIA,237
AU,HYPOCALCAEMIA,236
AU,MOBILITY DECREASED,235
AU,ASTHMA,234
AU,CONVULSION,234
AU,MATERNAL EXPOSURE DURING PREGNANCY,228
AU,INFLUENZA LIKE ILLNESS,227
AU,HYPOAESTHESIA,225
AU,PLEURAL EFFUSION,225
AU,HYPERSENSITIVITY,222
AU,MENTAL IMPAIRMENT,222
AU,PLATELET COUNT DECREASED,222
AU,DIABETIC KETOACIDOSIS,220
AU,WHITE BLOOD CELL COUNT DECREASED,219
AU,RENAL FAILURE ACUTE,216
AU,OSTEONECROSIS OF JAW,214
AU,FLUSHING,213
AU,ALANINE AMINOTRANSFERASE INCREASED,210
AU,BRADYCARDIA,206
AU,CONTUSION,206
AU,INFLUENZA,206
AU,RHABDOMYOLYSIS,206
AU,ABDOMINAL DISTENSION,202
AU,HEART RATE INCREASED,200
AU,MYOCARDITIS,200
AU,ACCIDENTAL OVERDOSE,197
AU,SUICIDE ATTEMPT,196
AU,ABNORMAL BEHAVIOUR,195
AU,DRUG-INDUCED LIVER INJURY,194
AU,GASTROINTESTINAL HAEMORRHAGE,194
AU,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,193
AU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,193
AU,HOSPITALISATION,188
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,187
AU,HYPONATRAEMIA,186
AU,MENTAL DISORDER,186
AU,INCORRECT DOSE ADMINISTERED,185
AU,WRONG TECHNIQUE IN DRUG USAGE PROCESS,184
AU,HOT FLUSH,183
AU,HYPOGLYCAEMIA,183
AU,C-REACTIVE PROTEIN INCREASED,181
AU,BREAST CANCER,180
AU,VISUAL ACUITY REDUCED,180
AU,PERIPHERAL SWELLING,179
AU,PANCREATITIS,178
AU,NEOPLASM MALIGNANT,176
AU,ACUTE MYOCARDIAL INFARCTION,174
AU,ALOPECIA,174
AU,RHEUMATOID ARTHRITIS,174
AU,BALANCE DISORDER,173
AU,DEPRESSED LEVEL OF CONSCIOUSNESS,173
AU,HALLUCINATION,171
AU,HEPATIC FAILURE,171
AU,LACTIC ACIDOSIS,171
AU,INJECTION SITE PAIN,170
AU,HIP FRACTURE,169
AU,CATARACT,168
AU,MEMORY IMPAIRMENT,168
AU,NEUROPATHY PERIPHERAL,168
AU,SEROTONIN SYNDROME,168
AU,ABDOMINAL DISCOMFORT,165
AU,COMPLETED SUICIDE,165
AU,EYE PAIN,165
AU,MOUTH ULCERATION,165
AU,NASOPHARYNGITIS,164
AU,ABORTION SPONTANEOUS,163
AU,BASAL CELL CARCINOMA,163
AU,DRUG ABUSE,163
AU,VIRAL INFECTION,163
AU,INTESTINAL OBSTRUCTION,162
AU,SEDATION,162
AU,DIABETES MELLITUS,161
AU,PLASMA CELL MYELOMA,157
AU,CIRCULATORY COLLAPSE,156
AU,DISEASE RECURRENCE,156
AU,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,156
AU,BLINDNESS,155
AU,JOINT SWELLING,154
AU,MUSCULOSKELETAL PAIN,153
AU,PULMONARY OEDEMA,153
AU,RECTAL HAEMORRHAGE,153
AU,HERPES ZOSTER,152
AU,DEPRESSED MOOD,151
AU,SINUS TACHYCARDIA,151
AU,SKIN CANCER,151
AU,BLOOD ALKALINE PHOSPHATASE INCREASED,149
AU,DRUG EFFECT INCOMPLETE,149
AU,DRUG DEPENDENCE,148
AU,DRUG WITHDRAWAL SYNDROME,147
AU,OROPHARYNGEAL PAIN,147
AU,TREATMENT FAILURE,147
AU,RIB FRACTURE,146
AU,SWELLING FACE,146
AU,TRANSIENT ISCHAEMIC ATTACK,146
AU,PARANOIA,145
AU,THROMBOSIS,145
AU,ARTHRITIS,144
AU,HALLUCINATION_ AUDITORY,144
AU,PSORIASIS,144
AU,DYSARTHRIA,143
AU,URINARY RETENTION,143
AU,MIGRAINE,140
AU,ASPARTATE AMINOTRANSFERASE INCREASED,138
AU,NEUTROPHIL COUNT DECREASED,137
AU,LYMPHOCYTE COUNT DECREASED,135
AU,PULMONARY ARTERIAL HYPERTENSION,135
AU,AMNESIA,134
AU,DEMENTIA,134
AU,MUSCULOSKELETAL STIFFNESS,134
AU,SQUAMOUS CELL CARCINOMA OF SKIN,134
AU,ASCITES,133
AU,DRY MOUTH,133
AU,IRRITABILITY,133
AU,COGNITIVE DISORDER,132
AU,COLITIS,132
AU,GLOMERULAR FILTRATION RATE DECREASED,132
AU,EJECTION FRACTION DECREASED,131
AU,EYE HAEMORRHAGE,131
AU,SKIN ULCER,131
AU,MULTIPLE SCLEROSIS RELAPSE,130
AU,SLEEP DISORDER,130
AU,CARDIOMYOPATHY,129
AU,BLOOD LACTATE DEHYDROGENASE INCREASED,128
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,128
AU,HAEMATURIA,128
AU,OSTEOPOROSIS,128
AU,ACUTE MYELOID LEUKAEMIA,126
AU,DYSKINESIA,125
AU,GASTROINTESTINAL DISORDER,125
AU,GASTROOESOPHAGEAL REFLUX DISEASE,125
AU,DELUSION,124
AU,HYPOKALAEMIA,124
AU,MALIGNANT MELANOMA,124
AU,WITHDRAWAL SYNDROME,123
AU,HYPERKALAEMIA,122
AU,METASTASES TO LIVER,122
AU,PNEUMONIA ASPIRATION,122
AU,SPEECH DISORDER,122
AU,BLOOD PRESSURE DECREASED,121
AU,CARDIAC FAILURE CONGESTIVE,121
AU,EPISTAXIS,121
AU,STRESS,121
AU,BONE PAIN,120
AU,METASTASES TO CENTRAL NERVOUS SYSTEM,120
AU,TREATMENT NONCOMPLIANCE,120
AU,ANTIPSYCHOTIC DRUG LEVEL INCREASED,119
AU,INFUSION RELATED REACTION,118
AU,SURGERY,118
AU,FEMUR FRACTURE,117
AU,VERTIGO,117
AU,ATAXIA,116
AU,HYPOXIA,116
AU,PNEUMOCYSTIS JIROVECII PNEUMONIA,116
AU,ANGINA PECTORIS,115
AU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,115
AU,PRODUCT USE IN UNAPPROVED INDICATION,115
AU,PNEUMONITIS,114
AU,UPPER RESPIRATORY TRACT INFECTION,114
AU,THERAPEUTIC RESPONSE DECREASED,113
AU,ANGIOEDEMA,112
AU,DRUG INTOLERANCE,112
AU,JAUNDICE,112
AU,NECK PAIN,112
AU,PREMATURE BABY,112
AU,RASH PRURITIC,112
AU,BLOOD BILIRUBIN INCREASED,111
AU,COMA SCALE ABNORMAL,110
AU,DISTURBANCE IN ATTENTION,110
AU,SQUAMOUS CELL CARCINOMA,110
AU,TROPONIN INCREASED,110
AU,INTENTIONAL PRODUCT MISUSE,109
AU,LEFT VENTRICULAR DYSFUNCTION,108
AU,PULMONARY HYPERTENSION,108
AU,ABASIA,107
AU,BONE MARROW FAILURE,107
AU,HAEMORRHAGE INTRACRANIAL,107
AU,INCORRECT ROUTE OF DRUG ADMINISTRATION,107
AU,PERICARDIAL EFFUSION,107
AU,FEELING HOT,106
AU,MANIA,106
AU,OSTEONECROSIS,106
AU,WHEEZING,106
AU,HEPATIC FUNCTION ABNORMAL,105
AU,STAPHYLOCOCCAL INFECTION,105
AU,SWOLLEN TONGUE,105
AU,THINKING ABNORMAL,105
AU,DRUG HYPERSENSITIVITY,104
AU,NEPHROLITHIASIS,104
AU,URINARY INCONTINENCE,104
AU,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,103
AU,TUBULOINTERSTITIAL NEPHRITIS,103
AU,ADVERSE DRUG REACTION,102
AU,INTENTIONAL SELF-INJURY,102
AU,LEUKOPENIA,102
AU,OEDEMA,102
AU,OXYGEN SATURATION DECREASED,102
AU,ARTHROPATHY,101
AU,LYMPHADENOPATHY,101
AU,METABOLIC ACIDOSIS,101
AU,RASH ERYTHEMATOUS,101
AU,CEREBRAL HAEMORRHAGE,100
AU,HEAD INJURY,100
AU,MITRAL VALVE INCOMPETENCE,100
AU,ROAD TRAFFIC ACCIDENT,100
AU,ADVERSE EVENT,99
AU,MULTI-ORGAN FAILURE,99
AU,SYSTEMIC LUPUS ERYTHEMATOSUS,99
AU,APHASIA,98
AU,BLOOD CHOLESTEROL INCREASED,98
AU,COMA,98
AU,EMOTIONAL DISTRESS,98
AU,SWELLING,98
AU,DYSGEUSIA,97
AU,RESPIRATORY DISTRESS,97
AU,OSTEOARTHRITIS,96
AU,IMPAIRED HEALING,95
AU,PROSTATE CANCER,95
AU,LIVER DISORDER,94
AU,LUNG NEOPLASM MALIGNANT,94
AU,TINNITUS,94
AU,ARRHYTHMIA,93
AU,DIVERTICULITIS,93
AU,LUNG INFECTION,93
AU,METASTASES TO BONE,93
AU,RENAL DISORDER,93
AU,SPINAL FRACTURE,93
AU,UPPER LIMB FRACTURE,93
AU,DRUG EFFECT DECREASED,91
AU,HYPOTHERMIA,91
AU,MELAENA,91
AU,RED BLOOD CELL COUNT DECREASED,91
AU,BLISTER,90
AU,HEPATOTOXICITY,90
AU,SINUSITIS,90
AU,ENCEPHALOPATHY,89
AU,ORTHOSTATIC HYPOTENSION,89
AU,HAEMATEMESIS,88
AU,PANCREATIC CARCINOMA,88
AU,DISORIENTATION,87
AU,CHOLELITHIASIS,85
AU,HEPATITIS,85
AU,HYPOPHAGIA,85
AU,MULTIPLE SCLEROSIS,85
AU,PALLOR,85
AU,PRODUCTIVE COUGH,85
AU,RESPIRATORY TRACT INFECTION,85
AU,UNEVALUABLE EVENT,85
AU,DEAFNESS,84
AU,LOCALISED INFECTION,84
AU,LUNG DISORDER,84
AU,OCULAR HYPERAEMIA,84
AU,PANIC ATTACK,84
AU,BURNING SENSATION,83
AU,EYE SWELLING,83
AU,HYPOMAGNESAEMIA,83
AU,LIP SWELLING,83
AU,RASH GENERALISED,83
AU,BLOOD TRIGLYCERIDES INCREASED,82
AU,DRUG PRESCRIBING ERROR,82
AU,DYSPEPSIA,82
AU,MOOD ALTERED,82
AU,PRODUCT ADHESION ISSUE,81
AU,THROAT TIGHTNESS,81
AU,DYSPNOEA EXERTIONAL,80
AU,FLUID RETENTION,80
AU,GENERALISED TONIC-CLONIC SEIZURE,80
AU,MYOCARDIAL ISCHAEMIA,80
AU,OSTEOMYELITIS,80
AU,ANGER,79
AU,GASTROINTESTINAL CARCINOMA,79
AU,SKIN LESION,79
AU,UNDERDOSE,79
AU,HAEMATOCHEZIA,78
AU,HEPATIC CIRRHOSIS,78
AU,PERICARDITIS,78
AU,SEPTIC SHOCK,78
AU,WRIST FRACTURE,78
AU,EYE DISORDER,77
AU,MYOPATHY,77
AU,TOXIC EPIDERMAL NECROLYSIS,77
AU,FLUID OVERLOAD,76
AU,FRACTURE,76
AU,VAGINAL HAEMORRHAGE,76
AU,ANKLE FRACTURE,75
AU,CATARACT OPERATION,75
AU,DRUG RESISTANCE,75
AU,GLAUCOMA,75
AU,INTESTINAL PERFORATION,75
AU,SMALL INTESTINAL OBSTRUCTION,75
AU,TYPE 2 DIABETES MELLITUS,75
AU,BRONCHITIS,74
AU,DEVICE DISLOCATION,74
AU,HAEMATOCRIT DECREASED,74
AU,LOCAL SWELLING,74
AU,METASTASES TO LUNG,74
AU,MUCOSAL INFLAMMATION,74
AU,MYOSITIS,74
AU,NEURALGIA,74
AU,NIGHT SWEATS,74
AU,RESTLESSNESS,74
AU,DRY EYE,73
AU,LUPUS-LIKE SYNDROME,73
AU,MUSCLE TWITCHING,73
AU,NO ADVERSE EVENT,73
AU,UNRESPONSIVE TO STIMULI,73
AU,BLOOD SODIUM DECREASED,72
AU,DRUG ADMINISTRATION ERROR,72
AU,HALLUCINATION_ VISUAL,72
AU,HEPATITIS C,72
AU,INFLAMMATION,72
AU,LACERATION,72
AU,MOOD SWINGS,72
AU,HERNIA,71
AU,INTENTIONAL PRODUCT USE ISSUE,71
AU,BONE DENSITY DECREASED,70
AU,CRYING,70
AU,DYSTONIA,70
AU,HEART RATE IRREGULAR,70
AU,ISCHAEMIC STROKE,70
AU,PAIN IN JAW,70
AU,PRESYNCOPE,70
AU,BODY TEMPERATURE INCREASED,69
AU,INJECTION SITE ERYTHEMA,69
AU,NERVOUS SYSTEM DISORDER,69
AU,NIGHTMARE,69
AU,SKIN EXFOLIATION,69
AU,EPILEPSY,68
AU,HAEMATOMA,68
AU,PHARYNGEAL OEDEMA,68
AU,PNEUMOTHORAX,68
AU,TRICUSPID VALVE INCOMPETENCE,68
AU,HYPERGLYCAEMIA,67
AU,INTERSTITIAL LUNG DISEASE,67
AU,NEUROLEPTIC MALIGNANT SYNDROME,67
AU,WOUND INFECTION,67
AU,COAGULOPATHY,66
AU,DISCOMFORT,66
AU,DYSURIA,66
AU,MYELODYSPLASTIC SYNDROME,66
AU,PARKINSON^S DISEASE,66
AU,SPLENOMEGALY,66
AU,UROSEPSIS,66
AU,BLOOD ALBUMIN DECREASED,65
AU,BLOOD UREA INCREASED,65
AU,BREAST CANCER METASTATIC,65
AU,CENTRAL NERVOUS SYSTEM LESION,65
AU,DYSPHONIA,65
AU,FEMORAL NECK FRACTURE,65
AU,INTERNATIONAL NORMALISED RATIO INCREASED,65
AU,LIVER FUNCTION TEST INCREASED,65
AU,MEDICATION ERROR,65
AU,MUSCULOSKELETAL CHEST PAIN,65
AU,POLLAKIURIA,65
AU,SHOCK,65
AU,ACTIVITIES OF DAILY LIVING IMPAIRED,64
AU,AGE-RELATED MACULAR DEGENERATION,64
AU,ALTERED STATE OF CONSCIOUSNESS,64
AU,DRY SKIN,64
AU,RASH MACULO-PAPULAR,64
AU,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,63
AU,POOR QUALITY SLEEP,63
AU,RESPIRATORY DEPRESSION,63
AU,RIGHT VENTRICULAR FAILURE,63
AU,AKATHISIA,62
AU,HYPERTHYROIDISM,62
AU,INTRAOCULAR PRESSURE INCREASED,62
AU,LOWER LIMB FRACTURE,62
AU,LYMPHOPENIA,62
AU,PARAESTHESIA ORAL,62
AU,SUBDURAL HAEMATOMA,62
AU,GASTROENTERITIS,61
AU,IRON DEFICIENCY ANAEMIA,61
AU,NEPHROPATHY TOXIC,61
AU,OBSTRUCTIVE AIRWAYS DISORDER,61
AU,ACUTE HEPATIC FAILURE,60
AU,ATYPICAL FEMUR FRACTURE,60
AU,CHROMATURIA,60
AU,DEVICE RELATED INFECTION,60
AU,DRUG LEVEL INCREASED,60
AU,HAEMOPTYSIS,60
AU,HEMIPARESIS,60
AU,HOMICIDAL IDEATION,60
AU,CORONARY ARTERY DISEASE,59
AU,DIPLOPIA,59
AU,NEOPLASM,59
AU,PARALYSIS,59
AU,PERSECUTORY DELUSION,59
AU,ANTIPSYCHOTIC DRUG LEVEL DECREASED,58
AU,CONGESTIVE CARDIOMYOPATHY,58
AU,COORDINATION ABNORMAL,58
AU,EXERCISE TOLERANCE DECREASED,58
AU,FOOT FRACTURE,58
AU,INTENTIONAL DRUG MISUSE,58
AU,KIDNEY TRANSPLANT REJECTION,58
AU,NERVOUSNESS,58
AU,SECOND PRIMARY MALIGNANCY,58
AU,CANDIDA INFECTION,57
AU,CYSTITIS,57
AU,DRUG LEVEL DECREASED,57
AU,HEPATIC STEATOSIS,57
AU,INCORRECT DRUG ADMINISTRATION DURATION,57
AU,LACRIMATION INCREASED,57
AU,NO THERAPEUTIC RESPONSE,57
AU,PHOTOPHOBIA,57
AU,PHOTOSENSITIVITY REACTION,57
AU,POST PROCEDURAL HAEMORRHAGE,57
AU,RESPIRATORY DISORDER,57
AU,SKIN DISCOLOURATION,57
AU,TOOTH DISORDER,57
AU,CEREBRAL INFARCTION,56
AU,GASTRIC ULCER,56
AU,HEPATIC ENZYME INCREASED,56
AU,HYPERCALCAEMIA,56
AU,PERITONITIS,56
AU,THROMBOTIC MICROANGIOPATHY,56
AU,VITAMIN D DECREASED,56
AU,CHOLECYSTITIS,55
AU,EXTRAPYRAMIDAL DISORDER,55
AU,GASTRITIS,55
AU,PULMONARY FIBROSIS,55
AU,VENTRICULAR HYPOKINESIA,55
AU,COLITIS ULCERATIVE,54
AU,CONCOMITANT DISEASE AGGRAVATED,54
AU,FEELING COLD,54
AU,FUNGAL INFECTION,54
AU,HYPOPHOSPHATAEMIA,54
AU,INJECTION SITE BRUISING,54
AU,POST PROCEDURAL COMPLICATION,54
AU,PREMATURE DELIVERY,54
AU,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,53
AU,ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC,53
AU,BLOOD POTASSIUM DECREASED,53
AU,CARDIOMEGALY,53
AU,KIDNEY INFECTION,53
AU,LIMB INJURY,53
AU,SKIN DISORDER,53
AU,CYTOMEGALOVIRUS INFECTION,52
AU,HYPOTHYROIDISM,52
AU,INJECTION SITE REACTION,52
AU,INTERVERTEBRAL DISC PROTRUSION,52
AU,KNEE ARTHROPLASTY,52
AU,LYMPHOMA,52
AU,MENORRHAGIA,52
AU,RHINORRHOEA,52
AU,UVEITIS,52
AU,VITAMIN D DEFICIENCY,52
AU,BLINDNESS UNILATERAL,51
AU,BODY MASS INDEX INCREASED,51
AU,EOSINOPHILIA,51
AU,HIP ARTHROPLASTY,51
AU,ILL-DEFINED DISORDER,51
AU,RETINAL HAEMORRHAGE,51
AU,SOMNAMBULISM,51
AU,CHRONIC KIDNEY DISEASE,50
AU,COELIAC DISEASE,50
AU,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,50
AU,EMPHYSEMA,50
AU,HEART RATE DECREASED,50
AU,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,50
AU,INCONTINENCE,50
AU,LIMB DISCOMFORT,50
AU,METASTASIS,50
AU,PRODUCT SUBSTITUTION ISSUE,50
AU,PROTEINURIA,50
AU,PULMONARY MASS,50
AU,AGRANULOCYTOSIS,49
AU,CYANOSIS,49
AU,EOSINOPHIL COUNT INCREASED,49
AU,HYPERTHERMIA,49
AU,INJURY,49
AU,JOINT DISLOCATION,49
AU,MOVEMENT DISORDER,49
AU,PYODERMA GANGRENOSUM,49
AU,SALIVARY HYPERSECRETION,49
AU,STEVENS-JOHNSON SYNDROME,49
AU,STOMATITIS,49
AU,TRANSFUSION,49
AU,VASCULITIS,49
AU,WRONG DRUG ADMINISTERED,49
AU,ACIDOSIS,48
AU,BLOOD CALCIUM DECREASED,48
AU,BLOOD GLUCOSE DECREASED,48
AU,DEAFNESS NEUROSENSORY,48
AU,INTESTINAL RESECTION,48
AU,MACULAR DEGENERATION,48
AU,NEUTROPENIC SEPSIS,48
AU,PROSTATE CANCER METASTATIC,48
AU,BLOOD IRON DECREASED,47
AU,BRAIN INJURY,47
AU,CARDIOGENIC SHOCK,47
AU,FOETAL DEATH,47
AU,HEPATIC ENCEPHALOPATHY,47
AU,MONOCYTE COUNT INCREASED,47
AU,RENAL TUBULAR NECROSIS,47
AU,TRANSAMINASES INCREASED,47
AU,ACUTE MYELOID LEUKAEMIA RECURRENT,46
AU,CHOKING,46
AU,CYTOPENIA,46
AU,ELECTROCARDIOGRAM ABNORMAL,46
AU,HYPOKINESIA,46
AU,IMMUNODEFICIENCY,46
AU,NEOPLASM PROGRESSION,46
AU,PREGNANCY,46
AU,PROTEIN TOTAL DECREASED,46
AU,RASH MACULAR,46
AU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,46
AU,VITREOUS FLOATERS,46
AU,ABORTION INDUCED,45
AU,BOWEN^S DISEASE,45
AU,EYE IRRITATION,45
AU,FLATULENCE,45
AU,HAEMORRHOIDS,45
AU,OBESITY,45
AU,PELVIC FRACTURE,45
AU,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,45
AU,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,45
AU,THROAT IRRITATION,45
AU,AUTOIMMUNE HEPATITIS,44
AU,DISSEMINATED INTRAVASCULAR COAGULATION,44
AU,GOUT,44
AU,MYOCLONUS,44
AU,PLATELET COUNT INCREASED,44
AU,SLEEP APNOEA SYNDROME,44
AU,WOUND,44
AU,ACCIDENTAL EXPOSURE TO PRODUCT,43
AU,DYSSTASIA,43
AU,EAR INFECTION,43
AU,FISTULA,43
AU,GASTRIC DISORDER,43
AU,HAEMOLYSIS,43
AU,MUSCLE RIGIDITY,43
AU,OLIGURIA,43
AU,POISONING DELIBERATE,43
AU,RENAL TUBULAR ACIDOSIS,43
AU,SKIN INFECTION,43
AU,URINE OUTPUT DECREASED,43
AU,ACCIDENT,42
AU,ACNE,42
AU,ASPIRATION,42
AU,BLOOD UREA DECREASED,42
AU,CUSHING^S SYNDROME,42
AU,INTESTINAL ISCHAEMIA,42
AU,RESPIRATORY ARREST,42
AU,SUPRAVENTRICULAR TACHYCARDIA,42
AU,ACUTE PULMONARY OEDEMA,41
AU,BACTERIAL INFECTION,41
AU,BONE DISORDER,41
AU,DRUG WITHDRAWAL SYNDROME NEONATAL,41
AU,ECZEMA,41
AU,JOINT STIFFNESS,41
AU,POST PROCEDURAL INFECTION,41
AU,ATELECTASIS,40
AU,COLD SWEAT,40
AU,DRUG DISPENSING ERROR,40
AU,DRUG LEVEL BELOW THERAPEUTIC,40
AU,HUMERUS FRACTURE,40
AU,MALNUTRITION,40
AU,MASS,40
AU,NASAL CONGESTION,40
AU,PSORIATIC ARTHROPATHY,40
AU,ATRIAL FLUTTER,39
AU,BEDRIDDEN,39
AU,BEZOAR,39
AU,BREAKTHROUGH PAIN,39
AU,DRUG DIVERSION,39
AU,HYPOAESTHESIA ORAL,39
AU,LEFT VENTRICULAR HYPERTROPHY,39
AU,METASTATIC NEOPLASM,39
AU,NEUTROPHILIA,39
AU,STRESS CARDIOMYOPATHY,39
AU,SUBDURAL HAEMORRHAGE,39
AU,TOOTHACHE,39
AU,ULCER,39
AU,ADRENAL INSUFFICIENCY,38
AU,BLADDER CANCER,38
AU,BRONCHOSPASM,38
AU,CARDIOVASCULAR DISORDER,38
AU,DEVICE DIFFICULT TO USE,38
AU,EATING DISORDER,38
AU,HEPATOCELLULAR CARCINOMA,38
AU,HYPERCHOLESTEROLAEMIA,38
AU,HYPERSOMNIA,38
AU,MUSCLE ATROPHY,38
AU,NEUROTOXICITY,38
AU,PROSTATIC SPECIFIC ANTIGEN INCREASED,38
AU,RESTLESS LEGS SYNDROME,38
AU,SKIN REACTION,38
AU,SUICIDAL BEHAVIOUR,38
AU,TERMINAL STATE,38
AU,BLOOD CHLORIDE DECREASED,37
AU,BRONCHIECTASIS,37
AU,BUNDLE BRANCH BLOCK LEFT,37
AU,CAESAREAN SECTION,37
AU,CARDIO-RESPIRATORY ARREST,37
AU,COLECTOMY,37
AU,EXPOSURE DURING BREAST FEEDING,37
AU,FEAR,37
AU,FOREIGN BODY SENSATION IN EYES,37
AU,HEAD DISCOMFORT,37
AU,JOINT INJURY,37
AU,OCULAR DISCOMFORT,37
AU,ORAL PAIN,37
AU,SCHIZOAFFECTIVE DISORDER,37
AU,SENSORY DISTURBANCE,37
AU,ABDOMINAL PAIN LOWER,36
AU,ACTINIC KERATOSIS,36
AU,BLINDNESS TRANSIENT,36
AU,BLOOD PRESSURE SYSTOLIC INCREASED,36
AU,BLOOD TEST ABNORMAL,36
AU,DEVICE BREAKAGE,36
AU,DEVICE MALFUNCTION,36
AU,EMOTIONAL DISORDER,36
AU,ERECTILE DYSFUNCTION,36
AU,HYPERBILIRUBINAEMIA,36
AU,LIVER INJURY,36
AU,RETINAL DETACHMENT,36
AU,THIRST,36
AU,VENTRICULAR TACHYCARDIA,36
AU,VISUAL FIELD DEFECT,36
AU,BRAIN NEOPLASM,35
AU,DIASTOLIC DYSFUNCTION,35
AU,DISTRIBUTIVE SHOCK,35
AU,GRAFT VERSUS HOST DISEASE,35
AU,INJECTION SITE HAEMORRHAGE,35
AU,PERSONALITY CHANGE,35
AU,SUBARACHNOID HAEMORRHAGE,35
AU,SUDDEN DEATH,35
AU,TENDON RUPTURE,35
AU,THERAPEUTIC RESPONSE UNEXPECTED,35
AU,BLOOD POTASSIUM INCREASED,34
AU,BREAST CANCER RECURRENT,34
AU,FAECES DISCOLOURED,34
AU,GRAND MAL CONVULSION,34
AU,HEPATOMEGALY,34
AU,HISTIOCYTOSIS HAEMATOPHAGIC,34
AU,HYPERSENSITIVITY VASCULITIS,34
AU,IMMUNE THROMBOCYTOPENIC PURPURA,34
AU,INJECTION SITE MASS,34
AU,LEUKOCYTOSIS,34
AU,MULTIPLE FRACTURES,34
AU,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,34
AU,NON-HODGKIN^S LYMPHOMA,34
AU,PRESCRIBED OVERDOSE,34
AU,RENAL CELL CARCINOMA,34
AU,SYSTEMIC MYCOSIS,34
AU,TACHYPNOEA,34
AU,UPPER GASTROINTESTINAL HAEMORRHAGE,34
AU,VIITH NERVE PARALYSIS,34
AU,WAIST CIRCUMFERENCE INCREASED,34
AU,COLON CANCER,33
AU,DIABETES MELLITUS INADEQUATE CONTROL,33
AU,ENDOPHTHALMITIS,33
AU,EPSTEIN-BARR VIRUS INFECTION,33
AU,FREQUENT BOWEL MOVEMENTS,33
AU,GLOBULINS DECREASED,33
AU,IMMUNOSUPPRESSION,33
AU,LYMPHOEDEMA,33
AU,RED CELL DISTRIBUTION WIDTH INCREASED,33
AU,SINUS BRADYCARDIA,33
AU,STAPHYLOCOCCAL SEPSIS,33
AU,TOOTH INFECTION,33
AU,UNINTENDED PREGNANCY,33
AU,ABSCESS,32
AU,BACK DISORDER,32
AU,BLOOD CALCIUM INCREASED,32
AU,BODY TEMPERATURE DECREASED,32
AU,DEVICE ISSUE,32
AU,EMBOLISM,32
AU,EYE INFECTION,32
AU,FAECALOMA,32
AU,FOETAL GROWTH RESTRICTION,32
AU,GLYCOSYLATED HAEMOGLOBIN INCREASED,32
AU,HAEMORRHAGIC STROKE,32
AU,HEMIPLEGIA,32
AU,HIATUS HERNIA,32
AU,LEFT ATRIAL DILATATION,32
AU,MAJOR DEPRESSION,32
AU,METASTASES TO SPINE,32
AU,ORAL HERPES,32
AU,TOOTH ABSCESS,32
AU,ABNORMAL DREAMS,31
AU,ACUTE RESPIRATORY DISTRESS SYNDROME,31
AU,ANION GAP INCREASED,31
AU,APATHY,31
AU,BLOOD BICARBONATE DECREASED,31
AU,BRONCHOPULMONARY ASPERGILLOSIS,31
AU,BURSITIS,31
AU,CORONARY ARTERY OCCLUSION,31
AU,DEVICE DEPLOYMENT ISSUE,31
AU,DEVICE OCCLUSION,31
AU,DIVERTICULUM,31
AU,FACE OEDEMA,31
AU,FLANK PAIN,31
AU,FOETAL DISTRESS SYNDROME,31
AU,HEPATIC LESION,31
AU,IMMUNE SYSTEM DISORDER,31
AU,IRON DEFICIENCY,31
AU,NYSTAGMUS,31
AU,PARKINSONISM,31
AU,PHARYNGITIS,31
AU,PSYCHIATRIC SYMPTOM,31
AU,SERUM FERRITIN INCREASED,31
AU,SPINAL COMPRESSION FRACTURE,31
AU,STILLBIRTH,31
AU,SYSTOLIC DYSFUNCTION,31
AU,TENDERNESS,31
AU,TRANSPLANT REJECTION,31
AU,VENTRICULAR EXTRASYSTOLES,31
AU,VIRAL UPPER RESPIRATORY TRACT INFECTION,31
AU,ACUTE PSYCHOSIS,30
AU,AFFECT LABILITY,30
AU,APLASIA PURE RED CELL,30
AU,BLOOD GLUCOSE ABNORMAL,30
AU,CATATONIA,30
AU,CHOLANGITIS,30
AU,CONJUNCTIVITIS,30
AU,DEVICE FAILURE,30
AU,DILATATION VENTRICULAR,30
AU,EAR PAIN,30
AU,HAEMOLYTIC URAEMIC SYNDROME,30
AU,LOW BIRTH WEIGHT BABY,30
AU,LYMPHOCYTE COUNT INCREASED,30
AU,METASTATIC MALIGNANT MELANOMA,30
AU,OESOPHAGITIS,30
AU,PERIORBITAL OEDEMA,30
AU,POLYP,30
AU,POLYURIA,30
AU,PRURITUS GENERALISED,30
AU,PSEUDOMONAS INFECTION,30
AU,PULMONARY HAEMORRHAGE,30
AU,SENSORY LOSS,30
AU,TETANY,30
AU,THERAPY NON-RESPONDER,30
AU,VENTRICULAR FIBRILLATION,30
AU,APLASTIC ANAEMIA,29
AU,ARTERIOSCLEROSIS CORONARY ARTERY,29
AU,BLOOD LACTIC ACID INCREASED,29
AU,BLOOD PHOSPHORUS INCREASED,29
AU,BLOOD PRESSURE ABNORMAL,29
AU,BRAIN OEDEMA,29
AU,BRUXISM,29
AU,CARPAL TUNNEL SYNDROME,29
AU,DIFFUSE LARGE B-CELL LYMPHOMA,29
AU,FEELING JITTERY,29
AU,HAEMOGLOBIN ABNORMAL,29
AU,HAEMOLYTIC ANAEMIA,29
AU,HEPATIC CANCER,29
AU,HYPERLACTACIDAEMIA,29
AU,ILEUS,29
AU,INTESTINAL HAEMORRHAGE,29
AU,JOINT EFFUSION,29
AU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,29
AU,LUMBAR VERTEBRAL FRACTURE,29
AU,LUNG INFILTRATION,29
AU,OPTIC NEURITIS,29
AU,PATHOLOGICAL FRACTURE,29
AU,POLYARTHRITIS,29
AU,PSYCHOMOTOR HYPERACTIVITY,29
AU,RENAL CYST,29
AU,RENAL FAILURE CHRONIC,29
AU,SCIATICA,29
AU,SKIN BURNING SENSATION,29
AU,ACUTE CORONARY SYNDROME,28
AU,ANAL ABSCESS,28
AU,ANGINA UNSTABLE,28
AU,BLOOD PRESSURE FLUCTUATION,28
AU,BLOOD URIC ACID INCREASED,28
AU,BLOOD URINE PRESENT,28
AU,CARDIAC PACEMAKER INSERTION,28
AU,CUSHINGOID,28
AU,DEVELOPMENTAL DELAY,28
AU,DISTURBANCE IN SOCIAL BEHAVIOUR,28
AU,GESTATIONAL DIABETES,28
AU,GROIN PAIN,28
AU,HYPOALBUMINAEMIA,28
AU,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,28
AU,MACULOPATHY,28
AU,NOCTURIA,28
AU,OPTIC NEUROPATHY,28
AU,PAPILLOEDEMA,28
AU,PERONEAL NERVE PALSY,28
AU,PLEURITIC PAIN,28
AU,PULMONARY THROMBOSIS,28
AU,SCAR,28
AU,TOOTH EXTRACTION,28
AU,TOOTH LOSS,28
AU,AFFECTIVE DISORDER,27
AU,AORTIC ANEURYSM,27
AU,APPENDICITIS,27
AU,BIPOLAR DISORDER,27
AU,CARDIAC MURMUR,27
AU,CREATININE RENAL CLEARANCE DECREASED,27
AU,DEMENTIA ALZHEIMER^S TYPE,27
AU,GASTRIC HAEMORRHAGE,27
AU,IMPAIRED WORK ABILITY,27
AU,INFLAMMATORY MARKER INCREASED,27
AU,INJECTION SITE PRURITUS,27
AU,INJECTION SITE SWELLING,27
AU,INTESTINAL STENOSIS,27
AU,MENTAL STATUS CHANGES,27
AU,METRORRHAGIA,27
AU,MUSCULOSKELETAL DISORDER,27
AU,NEONATAL RESPIRATORY DISTRESS SYNDROME,27
AU,NERVE INJURY,27
AU,OSTEOPENIA,27
AU,PLEURISY,27
AU,POSTPARTUM HAEMORRHAGE,27
AU,QUALITY OF LIFE DECREASED,27
AU,SNEEZING,27
AU,STRESS FRACTURE,27
AU,STRIDOR,27
AU,TOOTH FRACTURE,27
AU,ABDOMINAL ADHESIONS,26
AU,ABDOMINAL TENDERNESS,26
AU,ANGLE CLOSURE GLAUCOMA,26
AU,BLOOD CREATININE DECREASED,26
AU,BLOOD PRESSURE SYSTOLIC DECREASED,26
AU,BONE CANCER,26
AU,CLOSTRIDIUM DIFFICILE COLITIS,26
AU,DEMYELINATION,26
AU,DRUG ADMINISTERED AT INAPPROPRIATE SITE,26
AU,DUODENAL ULCER,26
AU,FAECAL INCONTINENCE,26
AU,FANCONI SYNDROME,26
AU,HERPES SIMPLEX,26
AU,HYPERTONIA,26
AU,PERIPHERAL COLDNESS,26
AU,POSTOPERATIVE WOUND INFECTION,26
AU,PREMATURE LABOUR,26
AU,PROCOAGULANT THERAPY,26
AU,PULSELESS ELECTRICAL ACTIVITY,26
AU,RETCHING,26
AU,SPINAL PAIN,26
AU,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,26
AU,TUBERCULOSIS,26
AU,TYPE 1 DIABETES MELLITUS,26
AU,ANKYLOSING SPONDYLITIS,25
AU,APPLICATION SITE ERYTHEMA,25
AU,ASPERGILLUS INFECTION,25
AU,BLOOD COUNT ABNORMAL,25
AU,BLOOD DISORDER,25
AU,BLOOD PARATHYROID HORMONE INCREASED,25
AU,BLOOD PHOSPHORUS DECREASED,25
AU,CYST,25
AU,DIALYSIS,25
AU,DYSMORPHISM,25
AU,ENCEPHALITIS,25
AU,EOSINOPHIL COUNT DECREASED,25
AU,ESCHERICHIA SEPSIS,25
AU,EYE PRURITUS,25
AU,EYELID PTOSIS,25
AU,FEELING OF BODY TEMPERATURE CHANGE,25
AU,GAIT INABILITY,25
AU,GALLBLADDER DISORDER,25
AU,GASTRIC PERFORATION,25
AU,GASTROENTERITIS VIRAL,25
AU,GINGIVAL BLEEDING,25
AU,INJECTION SITE DISCOMFORT,25
AU,MUSCLE TIGHTNESS,25
AU,NEEDLE ISSUE,25
AU,NEONATAL BEHAVIOURAL SYNDROME,25
AU,NEPHROPATHY,25
AU,NEPHROTIC SYNDROME,25
AU,PARTIAL SEIZURES,25
AU,PERIPHERAL VASCULAR DISORDER,25
AU,PERITONITIS BACTERIAL,25
AU,PRESCRIBED UNDERDOSE,25
AU,PROCEDURAL PAIN,25
AU,SEXUAL DYSFUNCTION,25
AU,SOCIAL AVOIDANT BEHAVIOUR,25
AU,AORTIC VALVE INCOMPETENCE,24
AU,ATRIOVENTRICULAR SEPTAL DEFECT,24
AU,BLOOD PROLACTIN INCREASED,24
AU,CARDIOTOXICITY,24
AU,CHOLESTASIS,24
AU,CLOSTRIDIUM DIFFICILE INFECTION,24
AU,DEPENDENCE,24
AU,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,24
AU,HOMICIDE,24
AU,HYDROCEPHALUS,24
AU,HYPOACUSIS,24
AU,INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS,24
AU,LYMPHADENOPATHY MEDIASTINAL,24
AU,MACULAR OEDEMA,24
AU,NERVE COMPRESSION,24
AU,ORAL CANDIDIASIS,24
AU,PERIPHERAL SENSORY NEUROPATHY,24
AU,PLATELET COUNT ABNORMAL,24
AU,POLYDIPSIA,24
AT,DEATH,650
AT,DIARRHOEA,331
AT,PNEUMONIA,323
AT,NAUSEA,322
AT,FATIGUE,281
AT,DRUG INEFFECTIVE,275
AT,DYSPNOEA,259
AT,GENERAL PHYSICAL HEALTH DETERIORATION,255
AT,PYREXIA,247
AT,VOMITING,216
AT,ANAEMIA,215
AT,THROMBOCYTOPENIA,198
AT,CEREBROVASCULAR ACCIDENT,187
AT,MALIGNANT NEOPLASM PROGRESSION,177
AT,FALL,174
AT,PULMONARY EMBOLISM,165
AT,CARDIAC FAILURE,164
AT,INFECTION,161
AT,HEADACHE,159
AT,SEPSIS,155
AT,WEIGHT DECREASED,154
AT,DIZZINESS,149
AT,NEUTROPENIA,141
AT,LEUKOPENIA,138
AT,RASH,138
AT,URINARY TRACT INFECTION,128
AT,RENAL FAILURE,125
AT,SYNCOPE,121
AT,OSTEONECROSIS OF JAW,118
AT,OEDEMA PERIPHERAL,115
AT,PAIN,113
AT,VERTIGO,113
AT,DISEASE PROGRESSION,112
AT,ABDOMINAL PAIN,111
AT,ASTHENIA,111
AT,PRURITUS,107
AT,ARTHRALGIA,106
AT,C-REACTIVE PROTEIN INCREASED,103
AT,HYPERTENSION,102
AT,DEPRESSION,99
AT,PLEURAL EFFUSION,99
AT,ATRIAL FIBRILLATION,98
AT,ACUTE KIDNEY INJURY,97
AT,DECREASED APPETITE,97
AT,MYOCARDIAL INFARCTION,97
AT,CEREBRAL HAEMORRHAGE,92
AT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,92
AT,TACHYCARDIA,92
AT,HAEMORRHAGE,91
AT,HYPOTENSION,91
AT,SOMNOLENCE,90
AT,CIRCULATORY COLLAPSE,89
AT,TOXICITY TO VARIOUS AGENTS,87
AT,FEBRILE NEUTROPENIA,86
AT,RENAL IMPAIRMENT,86
AT,PAIN IN EXTREMITY,85
AT,DELIRIUM,84
AT,COUGH,81
AT,OVERDOSE,81
AT,WEIGHT INCREASED,81
AT,HYPONATRAEMIA,80
AT,MATERNAL EXPOSURE DURING PREGNANCY,80
AT,DEEP VEIN THROMBOSIS,78
AT,PANCYTOPENIA,78
AT,ERYTHEMA,77
AT,MUSCLE SPASMS,77
AT,HAEMOGLOBIN DECREASED,75
AT,MALAISE,75
AT,MYALGIA,75
AT,CONDITION AGGRAVATED,74
AT,BLOOD CREATININE INCREASED,73
AT,ABDOMINAL PAIN UPPER,71
AT,PRODUCT USE ISSUE,71
AT,ABORTION SPONTANEOUS,69
AT,CHILLS,69
AT,GASTROINTESTINAL HAEMORRHAGE,69
AT,RHABDOMYOLYSIS,68
AT,FOETAL EXPOSURE DURING PREGNANCY,67
AT,ASCITES,65
AT,ASPARTATE AMINOTRANSFERASE INCREASED,64
AT,HEPATIC ENZYME INCREASED,64
AT,STOMATITIS,64
AT,ALANINE AMINOTRANSFERASE INCREASED,63
AT,BLOOD PRESSURE INCREASED,63
AT,GAIT DISTURBANCE,63
AT,RESPIRATORY FAILURE,63
AT,EPILEPSY,62
AT,HAEMATOMA,62
AT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,62
AT,PARAESTHESIA,62
AT,SUICIDAL IDEATION,62
AT,CONFUSIONAL STATE,61
AT,RESTLESSNESS,61
AT,SLEEP DISORDER,61
AT,KETOACIDOSIS,60
AT,URINARY RETENTION,60
AT,AGITATION,59
AT,HYPERHIDROSIS,59
AT,VISUAL IMPAIRMENT,59
AT,HYPOKALAEMIA,58
AT,TREMOR,58
AT,CARDIAC ARREST,57
AT,ERYSIPELAS,57
AT,HYPERSENSITIVITY,57
AT,PANCREATITIS,56
AT,PRODUCT USE IN UNAPPROVED INDICATION,56
AT,BLOOD GLUCOSE INCREASED,55
AT,CONSTIPATION,55
AT,INSOMNIA,54
AT,RESPIRATORY TRACT INFECTION,54
AT,SEIZURE,54
AT,DEHYDRATION,53
AT,NEUROPATHY PERIPHERAL,53
AT,INTENTIONAL OVERDOSE,52
AT,URTICARIA,52
AT,CHEST PAIN,51
AT,DYSPHAGIA,51
AT,POLYNEUROPATHY,51
AT,ALOPECIA,50
AT,HEPATOCELLULAR CARCINOMA,50
AT,ISCHAEMIC STROKE,50
AT,LOSS OF CONSCIOUSNESS,50
AT,ANXIETY,49
AT,METASTASES TO LIVER,49
AT,BLOOD CREATINE PHOSPHOKINASE INCREASED,48
AT,BRONCHITIS,48
AT,ELECTROCARDIOGRAM QT PROLONGED,48
AT,EPISTAXIS,48
AT,MUSCULAR WEAKNESS,48
AT,LIVER DISORDER,47
AT,COLITIS,46
AT,EXPOSURE DURING PREGNANCY,46
AT,PLATELET COUNT DECREASED,46
AT,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,46
AT,SUICIDE ATTEMPT,46
AT,MULTI-ORGAN FAILURE,45
AT,PNEUMONITIS,45
AT,PSYCHOTIC DISORDER,45
AT,SEDATION,45
AT,BACK PAIN,44
AT,ILEUS,44
AT,MUCOSAL INFLAMMATION,44
AT,BLOOD ALKALINE PHOSPHATASE INCREASED,43
AT,BLOOD LACTATE DEHYDROGENASE INCREASED,43
AT,NASOPHARYNGITIS,43
AT,ACUTE MYELOID LEUKAEMIA,42
AT,ACUTE MYOCARDIAL INFARCTION,42
AT,COMA,42
AT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,42
AT,OEDEMA,42
AT,ANGINA PECTORIS,41
AT,DRUG INTOLERANCE,41
AT,LACTIC ACIDOSIS,41
AT,BLOOD CHOLESTEROL INCREASED,40
AT,DYSGEUSIA,40
AT,HERPES ZOSTER,40
AT,PALPITATIONS,40
AT,TRANSAMINASES INCREASED,40
AT,BREAST CANCER,39
AT,ENTEROCOLITIS,39
AT,HYPERTENSIVE CRISIS,39
AT,LIVER FUNCTION TEST INCREASED,39
AT,METASTASES TO BONE,39
AT,DRUG ABUSE,38
AT,HEPATOTOXICITY,38
AT,INFLUENZA,38
AT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,38
AT,RENAL FAILURE ACUTE,38
AT,ANGIOEDEMA,37
AT,BLOOD PRESSURE DECREASED,37
AT,INFLUENZA LIKE ILLNESS,37
AT,SEPTIC SHOCK,37
AT,THROMBOSIS,37
AT,WHITE BLOOD CELL COUNT INCREASED,37
AT,CARDIAC DISORDER,36
AT,TRANSIENT ISCHAEMIC ATTACK,36
AT,ANAPHYLACTIC REACTION,35
AT,APHASIA,35
AT,CORONARY ARTERY DISEASE,35
AT,FLUSHING,35
AT,GASTROINTESTINAL DISORDER,35
AT,HEMIPARESIS,35
AT,RESTLESS LEGS SYNDROME,35
AT,ARRHYTHMIA,34
AT,CARDIOMYOPATHY,34
AT,CYTOMEGALOVIRUS INFECTION,34
AT,DIVERTICULITIS,34
AT,MULTIPLE SCLEROSIS RELAPSE,34
AT,ACUTE HEPATIC FAILURE,33
AT,BONE PAIN,33
AT,BRADYCARDIA,33
AT,CARDIOVASCULAR DISORDER,33
AT,DEVICE DISLOCATION,33
AT,DIPLOPIA,33
AT,DISORIENTATION,33
AT,EXTRAPYRAMIDAL DISORDER,33
AT,IMPAIRED HEALING,33
AT,LEUKOCYTOSIS,33
AT,MELAENA,33
AT,PREMATURE BABY,33
AT,DIABETIC KETOACIDOSIS,32
AT,DRUG-INDUCED LIVER INJURY,32
AT,DRY MOUTH,32
AT,GASTRITIS,32
AT,HEPATIC FAILURE,32
AT,WHITE BLOOD CELL COUNT DECREASED,32
AT,AGGRESSION,31
AT,B-CELL LYMPHOMA RECURRENT,31
AT,EMBOLISM VENOUS,31
AT,FEELING ABNORMAL,31
AT,METASTASES TO CENTRAL NERVOUS SYSTEM,31
AT,RASH GENERALISED,31
AT,VISION BLURRED,31
AT,ADVERSE EVENT,30
AT,AKATHISIA,30
AT,CROHN^S DISEASE,30
AT,DISTURBANCE IN ATTENTION,30
AT,DRUG ERUPTION,30
AT,EMBOLISM,30
AT,GASTROENTERITIS,30
AT,GASTROOESOPHAGEAL REFLUX DISEASE,30
AT,HYPOTHYROIDISM,30
AT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,30
AT,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,30
AT,BLOOD BILIRUBIN INCREASED,29
AT,DIABETES MELLITUS,29
AT,HYPOCALCAEMIA,29
AT,LARGE INTESTINE PERFORATION,29
AT,NEOPLASM PROGRESSION,29
AT,PERICARDIAL EFFUSION,29
AT,PERIPHERAL SWELLING,29
AT,ATAXIA,28
AT,CHOLELITHIASIS,28
AT,DYSKINESIA,28
AT,LIVER FUNCTION TEST ABNORMAL,28
AT,METASTASES TO LUNG,28
AT,PNEUMONIA ASPIRATION,28
AT,SALIVARY HYPERSECRETION,28
AT,SECOND PRIMARY MALIGNANCY,28
AT,ACUTE RESPIRATORY DISTRESS SYNDROME,27
AT,HYPOAESTHESIA,27
AT,INTERVERTEBRAL DISC PROTRUSION,27
AT,PANIC ATTACK,27
AT,PULMONARY ARTERIAL HYPERTENSION,27
AT,RESPIRATORY DISTRESS,27
AT,STATUS EPILEPTICUS,27
AT,BLOOD TRIGLYCERIDES INCREASED,26
AT,CHEST DISCOMFORT,26
AT,GLOMERULAR FILTRATION RATE DECREASED,26
AT,HOSPITALISATION,26
AT,JAUNDICE,26
AT,LUNG DISORDER,26
AT,NO THERAPEUTIC RESPONSE,26
AT,OSTEOARTHRITIS,26
AT,PROTEINURIA,26
AT,PSORIASIS,26
AT,SPLENOMEGALY,26
AT,DRUG WITHDRAWAL SYNDROME,25
AT,DYSPNOEA EXERTIONAL,25
AT,HYPERGLYCAEMIA,25
AT,INFLAMMATION,25
AT,LYMPHOPENIA,25
AT,MUSCULOSKELETAL PAIN,25
AT,PULMONARY OEDEMA,25
AT,CARDIOTOXICITY,24
AT,DIVERTICULAR PERFORATION,24
AT,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,24
AT,INCORRECT ROUTE OF DRUG ADMINISTRATION,24
AT,INFUSION RELATED REACTION,24
AT,PANCREATIC CARCINOMA,24
AT,BRAIN OEDEMA,23
AT,DEPRESSED MOOD,23
AT,FEMORAL NECK FRACTURE,23
AT,HAEMATOCHEZIA,23
AT,HAEMATURIA,23
AT,METASTASES TO LYMPH NODES,23
AT,MOVEMENT DISORDER,23
AT,REFEEDING SYNDROME,23
AT,STAPHYLOCOCCAL INFECTION,23
AT,TINNITUS,23
AT,BASAL CELL CARCINOMA,22
AT,CHOLESTASIS,22
AT,COMPLETED SUICIDE,22
AT,DRUG LEVEL INCREASED,22
AT,RENAL DISORDER,22
AT,RIB FRACTURE,22
AT,SUBDURAL HAEMATOMA,22
AT,TREATMENT NONCOMPLIANCE,22
AT,VISUAL ACUITY REDUCED,22
AT,ANAPHYLACTIC SHOCK,21
AT,CEREBRAL INFARCTION,21
AT,COLD SWEAT,21
AT,CONVULSION,21
AT,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,21
AT,FEBRILE INFECTION,21
AT,HEART RATE INCREASED,21
AT,LYMPHADENOPATHY,21
AT,MENTAL DISORDER,21
AT,NEUTROPHIL COUNT DECREASED,21
AT,PARKINSONISM,21
AT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,21
AT,PERITONITIS,21
AT,SINUS TACHYCARDIA,21
AT,SKIN REACTION,21
AT,ABDOMINAL PAIN LOWER,20
AT,ABSCESS,20
AT,ACUTE CORONARY SYNDROME,20
AT,AGRANULOCYTOSIS,20
AT,COGNITIVE DISORDER,20
AT,DRUG RESISTANCE,20
AT,DRY SKIN,20
AT,DYSARTHRIA,20
AT,DYSPHONIA,20
AT,ELECTROLYTE IMBALANCE,20
AT,HAEMATOCRIT DECREASED,20
AT,INCORRECT DOSE ADMINISTERED,20
AT,INFLAMMATORY MARKER INCREASED,20
AT,INJECTION SITE ERYTHEMA,20
AT,INTERSTITIAL LUNG DISEASE,20
AT,JOINT SWELLING,20
AT,MITRAL VALVE INCOMPETENCE,20
AT,NEPHROLITHIASIS,20
AT,NERVOUSNESS,20
AT,ORAL HERPES,20
AT,PLASMA CELL MYELOMA,20
AT,RIGHT VENTRICULAR FAILURE,20
AT,ABDOMINAL DISCOMFORT,19
AT,ALTERED STATE OF CONSCIOUSNESS,19
AT,BONE MARROW FAILURE,19
AT,CHRONIC KIDNEY DISEASE,19
AT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,19
AT,DEAFNESS,19
AT,DEMENTIA,19
AT,EJECTION FRACTION DECREASED,19
AT,EYELID OEDEMA,19
AT,HEPATIC FUNCTION ABNORMAL,19
AT,MALIGNANT MELANOMA,19
AT,MYELODYSPLASTIC SYNDROME,19
AT,NIGHT SWEATS,19
AT,PERICARDIAL HAEMORRHAGE,19
AT,PRURITUS GENERALISED,19
AT,SKIN ULCER,19
AT,SPEECH DISORDER,19
AT,SWELLING FACE,19
AT,APATHY,18
AT,BLINDNESS,18
AT,CENTRAL NERVOUS SYSTEM LESION,18
AT,DERMATITIS ALLERGIC,18
AT,DISEASE RECURRENCE,18
AT,ENCEPHALOPATHY,18
AT,FLATULENCE,18
AT,HAEMORRHAGE INTRACRANIAL,18
AT,HYPERTHYROIDISM,18
AT,INTESTINAL HAEMORRHAGE,18
AT,METASTASIS,18
AT,OSTEOPOROSIS,18
AT,SKIN DISORDER,18
AT,SPINAL PAIN,18
AT,ARTHRITIS,17
AT,CARDIOGENIC SHOCK,17
AT,CHOLECYSTITIS,17
AT,COLITIS ULCERATIVE,17
AT,DEPRESSED LEVEL OF CONSCIOUSNESS,17
AT,ENDOCARDITIS,17
AT,FOETAL DEATH,17
AT,GENERALISED TONIC-CLONIC SEIZURE,17
AT,HALLUCINATION,17
AT,HEPATIC CIRRHOSIS,17
AT,HEPATITIS C,17
AT,HISTIOCYTOSIS HAEMATOPHAGIC,17
AT,HYPERPROLACTINAEMIA,17
AT,HYPOGLYCAEMIA,17
AT,LUNG INFILTRATION,17
AT,LYMPHOCYTE COUNT DECREASED,17
AT,MANIA,17
AT,MEMORY IMPAIRMENT,17
AT,MYELOFIBROSIS,17
AT,NERVOUS SYSTEM DISORDER,17
AT,RASH MACULO-PAPULAR,17
AT,SUBARACHNOID HAEMORRHAGE,17
AT,SWELLING,17
AT,THROMBOTIC MICROANGIOPATHY,17
AT,ASPIRATION,16
AT,BRONCHOSPASM,16
AT,CATATONIA,16
AT,DIARRHOEA HAEMORRHAGIC,16
AT,EOSINOPHILIA,16
AT,EPSTEIN-BARR VIRUS INFECTION,16
AT,HAEMATEMESIS,16
AT,HYPOPHOSPHATAEMIA,16
AT,LIPASE INCREASED,16
AT,LUNG INFECTION,16
AT,MIGRAINE,16
AT,PRESCRIBED OVERDOSE,16
AT,ROAD TRAFFIC ACCIDENT,16
AT,SKIN LESION,16
AT,STAPHYLOCOCCAL SEPSIS,16
AT,THERAPEUTIC RESPONSE DECREASED,16
AT,VENTRICULAR TACHYCARDIA,16
AT,ACCIDENT,15
AT,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,15
AT,BODY TEMPERATURE INCREASED,15
AT,CHOLANGITIS,15
AT,DEVICE RELATED INFECTION,15
AT,DYSPEPSIA,15
AT,DYSURIA,15
AT,HAEMATOTOXICITY,15
AT,HEAD INJURY,15
AT,HYDRONEPHROSIS,15
AT,HYPERKALAEMIA,15
AT,HYPERTONIA,15
AT,LOW BIRTH WEIGHT BABY,15
AT,PLATELET COUNT INCREASED,15
AT,SINUS BRADYCARDIA,15
AT,TUBERCULOSIS,15
AT,VAGINAL HAEMORRHAGE,15
AT,VASCULITIS,15
AT,VENTRICULAR FIBRILLATION,15
AT,VISUAL FIELD DEFECT,15
AT,BLISTER,14
AT,CARDIAC FAILURE ACUTE,14
AT,CARDIOPULMONARY FAILURE,14
AT,COAGULOPATHY,14
AT,CYTOPENIA,14
AT,DEVICE ISSUE,14
AT,DIFFUSE LARGE B-CELL LYMPHOMA,14
AT,DRUG EFFECT DECREASED,14
AT,DRUG EFFECT INCOMPLETE,14
AT,ERECTILE DYSFUNCTION,14
AT,FEAR,14
AT,INJURY,14
AT,INTESTINAL STENOSIS,14
AT,MULTIPLE SCLEROSIS,14
AT,MYOCARDIAL ISCHAEMIA,14
AT,MYOCARDITIS,14
AT,PSYCHOTIC SYMPTOM,14
AT,RED BLOOD CELL COUNT DECREASED,14
AT,SENSORY DISTURBANCE,14
AT,SUBILEUS,14
AT,SWOLLEN TONGUE,14
AT,UVEITIS,14
AT,ABDOMINAL DISTENSION,13
AT,ASTHMA,13
AT,BENIGN PROSTATIC HYPERPLASIA,13
AT,CONJUNCTIVITIS,13
AT,CONTUSION,13
AT,ECZEMA,13
AT,EXTRASYSTOLES,13
AT,GASTRIC ULCER,13
AT,GASTROINTESTINAL INFECTION,13
AT,HEPATITIS,13
AT,HYPERBILIRUBINAEMIA,13
AT,HYPERVENTILATION,13
AT,INCREASED APPETITE,13
AT,INTENTIONAL PRODUCT MISUSE,13
AT,LUNG NEOPLASM MALIGNANT,13
AT,NEOPLASM MALIGNANT,13
AT,OROPHARYNGEAL PAIN,13
AT,POST PROCEDURAL HAEMORRHAGE,13
AT,PREMATURE DELIVERY,13
AT,PRESCRIBED UNDERDOSE,13
AT,PROSTATE CANCER,13
AT,PULMONARY HAEMORRHAGE,13
AT,RENAL CELL CARCINOMA,13
AT,RENAL FUNCTION TEST ABNORMAL,13
AT,SHOCK,13
AT,SINUSITIS,13
AT,SPINAL FRACTURE,13
AT,STRESS,13
AT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,12
AT,ASPHYXIA,12
AT,BLOOD PRESSURE FLUCTUATION,12
AT,BLOOD PROLACTIN INCREASED,12
AT,BLOOD UREA INCREASED,12
AT,BREAST CANCER METASTATIC,12
AT,BURSITIS,12
AT,CANDIDA INFECTION,12
AT,CATARACT,12
AT,COLITIS ISCHAEMIC,12
AT,DERMATITIS,12
AT,DRUG HYPERSENSITIVITY,12
AT,FISTULA,12
AT,HAEMOLYSIS,12
AT,HEPATIC STEATOSIS,12
AT,HEPATOMEGALY,12
AT,HYPERCHOLESTEROLAEMIA,12
AT,HYPOTONIA,12
AT,INJECTION SITE PAIN,12
AT,INTESTINAL PERFORATION,12
AT,OPTIC NEURITIS,12
AT,OSTEONECROSIS,12
AT,OXYGEN SATURATION DECREASED,12
AT,POLLAKIURIA,12
AT,PSYCHOMOTOR HYPERACTIVITY,12
AT,PULMONARY FIBROSIS,12
AT,RETINAL HAEMORRHAGE,12
AT,SKIN DISCOLOURATION,12
AT,SUDDEN CARDIAC DEATH,12
AT,THROMBOPHLEBITIS,12
AT,THYROIDITIS,12
AT,TOOTH DISORDER,12
AT,TRANSPLANT REJECTION,12
AT,UNDERDOSE,12
AT,VENOOCCLUSIVE LIVER DISEASE,12
AT,ACNE,11
AT,AMYLASE INCREASED,11
AT,ANKLE FRACTURE,11
AT,ARTHROPATHY,11
AT,ATELECTASIS,11
AT,BLOOD PRESSURE SYSTOLIC INCREASED,11
AT,BLOOD SODIUM DECREASED,11
AT,CAESAREAN SECTION,11
AT,CARDIAC TAMPONADE,11
AT,CAROTID ARTERY STENOSIS,11
AT,CEREBRAL ISCHAEMIA,11
AT,COLITIS MICROSCOPIC,11
AT,CYANOSIS,11
AT,CYSTITIS,11
AT,DISCOMFORT,11
AT,DISSEMINATED INTRAVASCULAR COAGULATION,11
AT,DRUG ADMINISTRATION ERROR,11
AT,DRUG DEPENDENCE,11
AT,DRUG DOSE OMISSION,11
AT,DRUG PRESCRIBING ERROR,11
AT,FACE OEDEMA,11
AT,FEELING COLD,11
AT,FEELING HOT,11
AT,FEMUR FRACTURE,11
AT,FRACTURE,11
AT,GASTRITIS EROSIVE,11
AT,HAEMOPTYSIS,11
AT,HEMIPLEGIA,11
AT,HYPERKINESIA,11
AT,HYPERLIPIDAEMIA,11
AT,HYPERTHERMIA,11
AT,INTENTIONAL DRUG MISUSE,11
AT,LIP SWELLING,11
AT,LOCAL SWELLING,11
AT,LYMPHOEDEMA,11
AT,MOBILITY DECREASED,11
AT,MOOD ALTERED,11
AT,MUSCLE ATROPHY,11
AT,MUSCLE CONTRACTIONS INVOLUNTARY,11
AT,PAIN IN JAW,11
AT,PARALYSIS,11
AT,PARANOIA,11
AT,PERIPHERAL SENSORY NEUROPATHY,11
AT,PNEUMOTHORAX,11
AT,PULMONARY HYPERTENSION,11
AT,RESPIRATORY DISORDER,11
AT,RHEUMATOID ARTHRITIS,11
AT,SEROTONIN SYNDROME,11
AT,SKIN EXFOLIATION,11
AT,SKIN NECROSIS,11
AT,SKIN TOXICITY,11
AT,TACHYPNOEA,11
AT,TARDIVE DYSKINESIA,11
AT,TONSILLITIS,11
AT,TROPONIN T INCREASED,11
AT,TYPE 2 DIABETES MELLITUS,11
AT,UPPER RESPIRATORY TRACT INFECTION,11
AT,WITHDRAWAL SYNDROME,11
AT,AMENORRHOEA,10
AT,ANURIA,10
AT,AORTIC ARTERIOSCLEROSIS,10
AT,ATRIOVENTRICULAR BLOCK COMPLETE,10
AT,BLOOD POTASSIUM DECREASED,10
AT,BLOOD URIC ACID INCREASED,10
AT,CELLULITIS,10
AT,CEREBRAL ATROPHY,10
AT,CHRONIC LYMPHOCYTIC LEUKAEMIA,10
AT,COLON CANCER,10
AT,EMPHYSEMA,10
AT,ENTERITIS,10
AT,FUNGAL INFECTION,10
AT,HEPATOBILIARY DISEASE,10
AT,INCORRECT DRUG ADMINISTRATION DURATION,10
AT,INJECTION SITE REACTION,10
AT,INTENSIVE CARE,10
AT,ISCHAEMIA,10
AT,LYMPHOCYTE COUNT INCREASED,10
AT,MEDICATION ERROR,10
AT,METABOLIC ACIDOSIS,10
AT,MULTIMORBIDITY,10
AT,MUSCULOSKELETAL STIFFNESS,10
AT,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,10
AT,NEOPLASM,10
AT,OBESITY,10
AT,ON AND OFF PHENOMENON,10
AT,PANNICULITIS,10
AT,PRODUCT QUALITY ISSUE,10
AT,PROSTATIC SPECIFIC ANTIGEN INCREASED,10
AT,RASH PRURITIC,10
AT,RASH PUSTULAR,10
AT,RENAL CYST,10
AT,RHINITIS,10
AT,SENSATION OF FOREIGN BODY,10
AT,SUDDEN HEARING LOSS,10
AT,SURGERY,10
AT,TENDON PAIN,10
AT,THROMBOCYTOSIS,10
AT,THROMBOSIS IN DEVICE,10
AT,TOOTH EXTRACTION,10
AT,UROSEPSIS,10
AT,ABORTION INDUCED,9
AT,ACCIDENTAL OVERDOSE,9
AT,ACIDOSIS,9
AT,ANAL FISTULA,9
AT,ATRIAL THROMBOSIS,9
AT,AUTOIMMUNE HEPATITIS,9
AT,BLOOD CALCIUM DECREASED,9
AT,BLOOD URINE PRESENT,9
AT,BRONCHIOLITIS,9
AT,BURNING SENSATION,9
AT,CARDIOMEGALY,9
AT,CUSHING^S SYNDROME,9
AT,DEMYELINATION,9
AT,EYE PAIN,9
AT,FOETAL GROWTH RESTRICTION,9
AT,GENERALISED ERYTHEMA,9
AT,HEPATIC ENCEPHALOPATHY,9
AT,HOT FLUSH,9
AT,HYPOPHAGIA,9
AT,HYPOXIA,9
AT,INGUINAL HERNIA,9
AT,INTESTINAL FISTULA,9
AT,ISCHAEMIC CEREBRAL INFARCTION,9
AT,KIDNEY TRANSPLANT REJECTION,9
AT,LEFT VENTRICULAR DYSFUNCTION,9
AT,LETHARGY,9
AT,LISTLESS,9
AT,LUMBAR VERTEBRAL FRACTURE,9
AT,LYMPHOMA,9
AT,METASTASES TO PERITONEUM,9
AT,METASTASES TO SPINE,9
AT,NECROSIS,9
AT,NEUROTOXICITY,9
AT,NEUTROPHIL COUNT INCREASED,9
AT,NYSTAGMUS,9
AT,OSTEOLYSIS,9
AT,PARONYCHIA,9
AT,PATHOGEN RESISTANCE,9
AT,PHARYNGITIS,9
AT,PLEURISY,9
AT,PNEUMOCYSTIS JIROVECII PNEUMONIA,9
AT,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,9
AT,PREGNANCY,9
AT,PROCEDURAL PAIN,9
AT,PRODUCTIVE COUGH,9
AT,PROTEIN TOTAL DECREASED,9
AT,PULMONARY CONGESTION,9
AT,PYELONEPHRITIS,9
AT,SCHIZOPHRENIA,9
AT,SERUM FERRITIN INCREASED,9
AT,SPINAL OSTEOARTHRITIS,9
AT,STOMA SITE HYPERGRANULATION,9
AT,SUDDEN DEATH,9
AT,SUPRAVENTRICULAR TACHYCARDIA,9
AT,SYRINGE ISSUE,9
AT,TENDON RUPTURE,9
AT,TREATMENT FAILURE,9
AT,UNINTENDED PREGNANCY,9
AT,UPPER GASTROINTESTINAL HAEMORRHAGE,9
AT,URINARY INCONTINENCE,9
AT,ABORTION,8
AT,AKINESIA,8
AT,AORTIC ANEURYSM,8
AT,AORTIC STENOSIS,8
AT,APPENDICITIS,8
AT,AUTONOMIC NERVOUS SYSTEM IMBALANCE,8
AT,BALANCE DISORDER,8
AT,BILIARY COLIC,8
AT,BRONCHIAL CARCINOMA,8
AT,CACHEXIA,8
AT,CEREBRAL DISORDER,8
AT,COAGULATION TIME PROLONGED,8
AT,CONCUSSION,8
AT,CRANIOCEREBRAL INJURY,8
AT,DECUBITUS ULCER,8
AT,DELUSION,8
AT,DEPRESSIVE SYMPTOM,8
AT,DERMATITIS BULLOUS,8
AT,DEVICE OCCLUSION,8
AT,DIALYSIS,8
AT,ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE,8
AT,ENCEPHALITIS,8
AT,FLUID RETENTION,8
AT,GALACTORRHOEA,8
AT,GASTRITIS HAEMORRHAGIC,8
AT,GASTROINTESTINAL INFLAMMATION,8
AT,GASTROINTESTINAL PAIN,8
AT,GENERAL PHYSICAL CONDITION ABNORMAL,8
AT,GENERALISED OEDEMA,8
AT,GYNAECOMASTIA,8
AT,HAEMODYNAMIC INSTABILITY,8
AT,HALLUCINATION_ AUDITORY,8
AT,HERPES SIMPLEX,8
AT,HYPERAMMONAEMIA,8
AT,HYPERSENSITIVITY VASCULITIS,8
AT,HYPERURICAEMIA,8
AT,HYPOMANIA,8
AT,INVASIVE DUCTAL BREAST CARCINOMA,8
AT,IRIDOCYCLITIS,8
AT,IRON DEFICIENCY,8
AT,IRRITABILITY,8
AT,LACERATION,8
AT,LARYNGOSPASM,8
AT,LEUKOENCEPHALOPATHY,8
AT,METASTASES TO MENINGES,8
AT,MOOD SWINGS,8
AT,MOTOR DYSFUNCTION,8
AT,MYOCLONUS,8
AT,NEPHROPATHY TOXIC,8
AT,NEURALGIA,8
AT,NEUROLOGICAL SYMPTOM,8
AT,NIGHTMARE,8
AT,ORGANISING PNEUMONIA,8
AT,OVARIAN CYST,8
AT,PALLOR,8
AT,PARESIS,8
AT,PARTIAL SEIZURES,8
AT,PERFORMANCE STATUS DECREASED,8
AT,PERIPHERAL COLDNESS,8
AT,PERSONALITY CHANGE,8
AT,PETECHIAE,8
AT,PHOTOSENSITIVITY REACTION,8
AT,PROCEDURAL HAEMORRHAGE,8
AT,PYODERMA GANGRENOSUM,8
AT,RESPIRATORY ARREST,8
AT,RETCHING,8
AT,RETINAL DETACHMENT,8
AT,SENSORY LOSS,8
AT,SKIN CANCER,8
AT,SKIN HAEMORRHAGE,8
AT,SLEEP APNOEA SYNDROME,8
AT,SQUAMOUS CELL CARCINOMA,8
AT,STOMA SITE DISCHARGE,8
AT,THERAPY NON-RESPONDER,8
AT,THROMBIN TIME PROLONGED,8
AT,VASCULAR STENT THROMBOSIS,8
AT,VENOUS THROMBOSIS,8
AT,VENTRICULAR HYPOKINESIA,8
AT,VIRAL INFECTION,8
AT,VIRAL LOAD INCREASED,8
AT,VITAMIN D DEFICIENCY,8
AT,WOUND,8
AT,WRONG TECHNIQUE IN DRUG USAGE PROCESS,8
AT,ABSCESS LIMB,7
AT,ACUTE ABDOMEN,7
AT,AGEUSIA,7
AT,AMAUROSIS,7
AT,AMNESIA,7
AT,ANXIETY DISORDER,7
AT,APPENDICITIS PERFORATED,7
AT,ARTERIOSCLEROSIS,7
AT,ATRIOVENTRICULAR BLOCK,7
AT,B-CELL LYMPHOMA,7
AT,BASAL GANGLIA HAEMORRHAGE,7
AT,BLOOD GLUCOSE FLUCTUATION,7
AT,BLOOD HIV RNA INCREASED,7
AT,BLOOD PHOSPHORUS DECREASED,7
AT,BONE MARROW OEDEMA,7
AT,BRADYPHRENIA,7
AT,BRONCHOPULMONARY ASPERGILLOSIS,7
AT,BUNDLE BRANCH BLOCK LEFT,7
AT,CARDIAC DEATH,7
AT,CARDIAC FAILURE CHRONIC,7
AT,CARPAL TUNNEL SYNDROME,7
AT,CEREBELLAR INFARCTION,7
AT,CEREBRAL MICROANGIOPATHY,7
AT,CHRONIC GASTRITIS,7
AT,CHRONIC MYELOMONOCYTIC LEUKAEMIA,7
AT,CLOSTRIDIUM DIFFICILE COLITIS,7
AT,CLOSTRIDIUM DIFFICILE INFECTION,7
AT,CONCOMITANT DISEASE AGGRAVATED,7
AT,CONCOMITANT DISEASE PROGRESSION,7
AT,CONGENITAL ANOMALY,7
AT,CONGESTIVE CARDIOMYOPATHY,7
AT,CORONARY ARTERY STENOSIS,7
AT,DEVICE CONNECTION ISSUE,7
AT,EMBOLISM ARTERIAL,7
AT,ERYTHEMA NODOSUM,7
AT,EYE HAEMORRHAGE,7
AT,EYELID PTOSIS,7
AT,FAECALOMA,7
AT,FAECES DISCOLOURED,7
AT,FIBRIN D DIMER INCREASED,7
AT,FOOT DEFORMITY,7
AT,FOOT FRACTURE,7
AT,GALLBLADDER DISORDER,7
AT,GASTRIC CANCER,7
AT,GASTROENTERITIS SAPOVIRUS,7
AT,GINGIVITIS,7
AT,GOITRE,7
AT,GRAFT VERSUS HOST DISEASE,7
AT,HELICOBACTER GASTRITIS,7
AT,HEPATIC LESION,7
AT,HEPATITIS TOXIC,7
AT,HIP FRACTURE,7
AT,HUNGER,7
AT,HYPERCALCAEMIA,7
AT,HYPOKINESIA,7
AT,ILEUS PARALYTIC,7
AT,IMMUNE THROMBOCYTOPENIC PURPURA,7
AT,INTERMITTENT CLAUDICATION,7
AT,INTRACARDIAC THROMBUS,7
AT,JC VIRUS TEST POSITIVE,7
AT,JOINT DISLOCATION,7
AT,JOINT INJURY,7
AT,KNEE ARTHROPLASTY,7
AT,LARYNGEAL OEDEMA,7
AT,LEFT VENTRICULAR FAILURE,7
AT,LEUKAEMIA RECURRENT,7
AT,LOSS OF LIBIDO,7
AT,LOWER LIMB FRACTURE,7
AT,LUPUS-LIKE SYNDROME,7
AT,LYMPHOCYTE PERCENTAGE DECREASED,7
AT,MENTAL IMPAIRMENT,7
AT,METABOLIC DISORDER,7
AT,METASTATIC MALIGNANT MELANOMA,7
AT,MICROEMBOLISM,7
AT,MUSCULOSKELETAL DISORDER,7
AT,MYOPATHY,7
AT,MYOSITIS,7
AT,NECK PAIN,7
AT,NEPHROTIC SYNDROME,7
AT,NO ADVERSE EVENT,7
AT,OESOPHAGITIS,7
AT,OPHTHALMIC HERPES ZOSTER,7
AT,OSTEOCHONDROSIS,7
AT,OSTEOMYELITIS,7
AT,PAPILLARY THYROID CANCER,7
AT,PARKINSON^S DISEASE,7
AT,PERIPHERAL NERVE SHEATH TUMOUR MALIGNANT,7
AT,PHARYNGEAL OEDEMA,7
AT,PHLEBITIS,7
AT,PLEUROTHOTONUS,7
AT,POISONING,7
AT,POST PROCEDURAL COMPLICATION,7
AT,PRERENAL FAILURE,7
AT,PULMONARY INFARCTION,7
AT,RASH PAPULAR,7
AT,REDUCED FACIAL EXPRESSION,7
AT,RENAL CANCER,7
AT,RENAL COLIC,7
AT,RESPIRATORY SYNCYTIAL VIRUS INFECTION,7
AT,SARCOIDOSIS,7
AT,SJOGREN^S SYNDROME,7
AT,SOCIAL AVOIDANT BEHAVIOUR,7
AT,SQUAMOUS CELL CARCINOMA OF SKIN,7
AT,STRESS CARDIOMYOPATHY,7
AT,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,7
AT,TRICUSPID VALVE INCOMPETENCE,7
AT,TUMOUR FLARE,7
AT,TUMOUR MARKER INCREASED,7
AT,UNEVALUABLE EVENT,7
AT,UTERINE LEIOMYOMA,7
AT,VENTRICULAR EXTRASYSTOLES,7
AT,WATER INTOXICATION,7
AT,ABDOMINAL ADHESIONS,6
AT,ABNORMAL BEHAVIOUR,6
AT,ACTINIC KERATOSIS,6
AT,ACTIVITIES OF DAILY LIVING IMPAIRED,6
AT,ADENOCARCINOMA OF COLON,6
AT,ADVERSE DRUG REACTION,6
AT,ANAEMIA MACROCYTIC,6
AT,ANTICONVULSANT DRUG LEVEL INCREASED,6
AT,AORTIC VALVE INCOMPETENCE,6
AT,ARTERIOSCLEROSIS CORONARY ARTERY,6
AT,ATRIAL TACHYCARDIA,6
AT,AUTOIMMUNE HAEMOLYTIC ANAEMIA,6
AT,BILE DUCT STONE,6
AT,BLADDER CANCER,6
AT,BLAST CELL COUNT INCREASED,6
AT,BLOOD CHLORIDE DECREASED,6
AT,BLOOD COUNT ABNORMAL,6
AT,BLOOD POTASSIUM INCREASED,6
AT,BLOOD TEST ABNORMAL,6
AT,BLOOD THYROID STIMULATING HORMONE INCREASED,6
AT,BONE DISORDER,6
AT,BONE LESION,6
AT,BONE MARROW TOXICITY,6
AT,BREAST PAIN,6
AT,CARDIO-RESPIRATORY ARREST,6
AT,CAROTID ARTERY THROMBOSIS,6
AT,CEREBELLAR ATROPHY,6
AT,CHOLECYSTECTOMY,6
AT,COLON CANCER METASTATIC,6
AT,CONJUNCTIVAL HAEMORRHAGE,6
AT,CORONARY ARTERY OCCLUSION,6
AT,DRY EYE,6
AT,ECTOPIC PREGNANCY,6
AT,ELECTROCARDIOGRAM CHANGE,6
AT,ENTEROCOCCAL INFECTION,6
AT,ENTEROCOLITIS HAEMORRHAGIC,6
AT,EPIDIDYMITIS,6
AT,FAECAL INCONTINENCE,6
AT,FOLLICULITIS,6
AT,FOOD AVERSION,6
AT,FOOD CRAVING,6
AT,FURUNCLE,6
AT,GASTRIC DISORDER,6
AT,GASTRIC HAEMORRHAGE,6
AT,GRAFT LOSS,6
AT,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,6
AT,GRAFT VERSUS HOST DISEASE IN SKIN,6
AT,GRAND MAL CONVULSION,6
AT,GRANULOMA,6
AT,HAEMOLYTIC ANAEMIA,6
AT,HAEMORRHAGIC ANAEMIA,6
AT,HAEMORRHOIDS,6
AT,HALLUCINATION_ VISUAL,6
AT,HALLUCINATIONS_ MIXED,6
AT,HEAD DISCOMFORT,6
AT,HIATUS HERNIA,6
AT,HICCUPS,6
AT,HYPERPARATHYROIDISM,6
AT,HYPERTRIGLYCERIDAEMIA,6
AT,HYPOACUSIS,6
AT,HYPOAESTHESIA ORAL,6
AT,HYPOALBUMINAEMIA,6
AT,HYPOCHLORAEMIA,6
AT,HYPONATRAEMIC ENCEPHALOPATHY,6
AT,HYPOPHYSITIS,6
AT,INJECTION SITE PRURITUS,6
AT,INTENTIONAL PRODUCT USE ISSUE,6
AT,INTERNATIONAL NORMALISED RATIO INCREASED,6
AT,INTERVERTEBRAL DISC DEGENERATION,6
AT,INTRAOCULAR PRESSURE INCREASED,6
AT,LACRIMATION INCREASED,6
AT,LARGE INTESTINAL STENOSIS,6
AT,LEFT VENTRICULAR HYPERTROPHY,6
AT,LIVER INJURY,6
AT,LOCALISED OEDEMA,6
AT,LUNG ADENOCARCINOMA,6
AT,MAJOR DEPRESSION,6
AT,METABOLIC ALKALOSIS,6
AT,MITOCHONDRIAL TOXICITY,6
AT,MONOPARESIS,6
AT,MUSCLE HAEMORRHAGE,6
AT,MUSCLE TIGHTNESS,6
AT,MUSCLE TWITCHING,6
AT,MUSCULOSKELETAL DISCOMFORT,6
AT,NEPHROPATHY,6
AT,NOCTURIA,6
AT,NON-ALCOHOLIC STEATOHEPATITIS,6
AT,OPTIC ATROPHY,6
AT,ORAL DISORDER,6
AT,OSTEITIS,6
AT,PANCREATIC ENZYMES INCREASED,6
AT,PANCREATITIS ACUTE,6
AT,PANCREATITIS NECROTISING,6
AT,PARAESTHESIA ORAL,6
AT,PARAPARESIS,6
AT,PARAPLEGIA,6
AT,PERIORBITAL OEDEMA,6
AT,PERIPHERAL ISCHAEMIA,6
AT,PREGNANCY WITH CONTRACEPTIVE DEVICE,6
AT,PREMATURE LABOUR,6
AT,PRESYNCOPE,6
AT,PSORIATIC ARTHROPATHY,6
AT,PULMONARY MASS,6
AT,RECTAL ADENOCARCINOMA,6
AT,RED CELL DISTRIBUTION WIDTH INCREASED,6
AT,RENAL TRANSPLANT FAILURE,6
AT,SENSE OF OPPRESSION,6
AT,STEVENS-JOHNSON SYNDROME,6
AT,SYSTEMIC LUPUS ERYTHEMATOSUS,6
AT,TETANY,6
AT,TOOTH LOSS,6
AT,UPPER LIMB FRACTURE,6
AT,VAGINAL DISCHARGE,6
AT,VENOUS THROMBOSIS LIMB,6
AT,WOUND INFECTION,6
AT,ABASIA,5
AT,ABDOMINAL ABSCESS,5
AT,ACUTE PSYCHOSIS,5
AT,ADENOCARCINOMA,5
AT,ADRENAL INSUFFICIENCY,5
AT,AFFECT LABILITY,5
AT,AMMONIA INCREASED,5
AT,ANAL ABSCESS,5
AT,ANORGASMIA,5
AT,ANOSMIA,5
AT,ANTICHOLINERGIC SYNDROME,5
AT,AORTIC VALVE STENOSIS,5
AT,APHTHOUS STOMATITIS,5
AT,APLASIA PURE RED CELL,5
AT,APLASTIC ANAEMIA,5
AT,ARTERIAL OCCLUSIVE DISEASE,5
AT,ATRIAL FLUTTER,5
AT,ATRIOVENTRICULAR BLOCK SECOND DEGREE,5
AT,ATROPHIC VULVOVAGINITIS,5
AT,ATYPICAL PNEUMONIA,5
AT,AUTOIMMUNE DISORDER,5
AT,AUTOIMMUNE THYROIDITIS,5
AT,BACTERAEMIA,5
AT,BACTERIAL VAGINOSIS,5
AZ,DEATH,36
AZ,EXPOSURE DURING PREGNANCY,18
AZ,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,9
AZ,FOETAL EXPOSURE DURING PREGNANCY,9
AZ,CHRONIC MYELOID LEUKAEMIA,6
AZ,CARDIAC FAILURE,5
AZ,BLOOD GLUCOSE INCREASED,4
AZ,CARDIAC FAILURE ACUTE,4
AZ,SECOND PRIMARY MALIGNANCY,4
AZ,ABORTION SPONTANEOUS,3
AZ,ASTHENIA,3
AZ,CEREBRAL HAEMORRHAGE,3
AZ,CONDITION AGGRAVATED,3
AZ,DRUG INEFFECTIVE,3
AZ,DRUG RESISTANCE,3
AZ,GENERAL PHYSICAL HEALTH DETERIORATION,3
AZ,HYPERTENSION,3
AZ,LUNG NEOPLASM MALIGNANT,3
AZ,PREMATURE BABY,3
AZ,THROMBOCYTOSIS,3
AZ,CARDIOVASCULAR INSUFFICIENCY,2
AZ,CEREBROVASCULAR ACCIDENT,2
AZ,CHOLELITHIASIS,2
AZ,CHRONIC KIDNEY DISEASE,2
AZ,COMA,2
AZ,DRUG EFFECT INCOMPLETE,2
AZ,HALLUCINATION_ VISUAL,2
AZ,HEADACHE,2
AZ,HEPATOSPLENOMEGALY,2
AZ,ISCHAEMIC STROKE,2
AZ,LEUKOCYTOSIS,2
AZ,LOSS OF CONSCIOUSNESS,2
AZ,METASTASES TO LIVER,2
AZ,NEONATAL HYPOXIA,2
AZ,OXYGEN SATURATION DECREASED,2
AZ,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
AZ,SEIZURE,2
AZ,TACHYCARDIA,2
AZ,TERMINAL STATE,2
AZ,THERAPEUTIC RESPONSE DECREASED,2
AZ,VENTRICULAR FIBRILLATION,2
AZ,ABORTION INDUCED,1
AZ,ACUTE ABDOMEN,1
AZ,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
AZ,ANAEMIA,1
AZ,ARRHYTHMIA,1
AZ,ASPHYXIA,1
AZ,ATRIAL THROMBOSIS,1
AZ,BLOOD PRESSURE INCREASED,1
AZ,BRONCHOPNEUMONIA,1
AZ,CANDIDA INFECTION,1
AZ,CEREBRAL ISCHAEMIA,1
AZ,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
AZ,CIRCULATORY COLLAPSE,1
AZ,CORONARY ARTERY THROMBOSIS,1
AZ,CYST,1
AZ,DEEP VEIN THROMBOSIS,1
AZ,DIABETIC FOETOPATHY,1
AZ,DIABETIC NEPHROPATHY,1
AZ,DIARRHOEA,1
AZ,DISEASE COMPLICATION,1
AZ,DYSPNOEA,1
AZ,EXOPHTHALMOS,1
AZ,FEMUR FRACTURE,1
AZ,FINGER DEFORMITY,1
AZ,FOETAL CYSTIC HYGROMA,1
AZ,FOETAL DEATH,1
AZ,FULL BLOOD COUNT ABNORMAL,1
AZ,FURUNCLE,1
AZ,GASTROINTESTINAL HAEMORRHAGE,1
AZ,GASTROINTESTINAL PERFORATION,1
AZ,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
AZ,HAEMORRHAGE,1
AZ,HAEMORRHOIDAL HAEMORRHAGE,1
AZ,HEART RATE INCREASED,1
AZ,HEPATIC STEATOSIS,1
AZ,HEPATOMEGALY,1
AZ,HYPERSENSITIVITY,1
AZ,HYPOGLYCAEMIA,1
AZ,ILEUS,1
AZ,INFLUENZA,1
AZ,INTESTINAL HAEMORRHAGE,1
AZ,INTRACRANIAL PRESSURE INCREASED,1
AZ,JAUNDICE NEONATAL,1
AZ,LOW BIRTH WEIGHT BABY,1
AZ,MALIGNANT NEOPLASM PROGRESSION,1
AZ,MENIERE^S DISEASE,1
AZ,METASTASIS,1
AZ,NEPHROLITHIASIS,1
AZ,NEUROPATHY PERIPHERAL,1
AZ,NEUROSIS,1
AZ,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
AZ,ONCOLOGIC COMPLICATION,1
AZ,OVARIAN CANCER,1
AZ,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
AZ,PANCREATITIS NECROTISING,1
AZ,PANCYTOPENIA,1
AZ,PERITONITIS,1
AZ,PLACENTAL INFARCTION,1
AZ,PLEURISY,1
AZ,PNEUMONIA,1
AZ,PRE-ECLAMPSIA,1
AZ,PREMATURE DELIVERY,1
AZ,PROTEINURIA,1
AZ,PRURITUS,1
AZ,RASH,1
AZ,RENAL FAILURE,1
AZ,RENAL FAILURE CHRONIC,1
AZ,RESPIRATORY FAILURE,1
AZ,RESPIRATORY TRACT INFECTION,1
AZ,SEPTIC SHOCK,1
AZ,SMALL INTESTINAL HAEMORRHAGE,1
AZ,SPLENIC VEIN THROMBOSIS,1
AZ,SPLENOMEGALY,1
AZ,STAPHYLOCOCCAL INFECTION,1
AZ,STILLBIRTH,1
AZ,SWELLING,1
AZ,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
AZ,THROMBOCYTOPENIA,1
AZ,THROMBOSIS,1
AZ,THYROID NEOPLASM,1
AZ,TRANSIENT ISCHAEMIC ATTACK,1
AZ,TREATMENT FAILURE,1
AZ,TREMOR,1
AZ,TUBULOINTERSTITIAL NEPHRITIS,1
BS,DEATH,4
BS,DRUG INEFFECTIVE,3
BS,INTRACARDIAC THROMBUS,2
BS,THROMBOSIS,2
BS,ANAPHYLACTIC REACTION,1
BS,BLISTER,1
BS,BLOOD CREATININE INCREASED,1
BS,BLOOD UREA INCREASED,1
BS,CONDITION AGGRAVATED,1
BS,CROHN^S DISEASE,1
BS,DEEP VEIN THROMBOSIS,1
BS,DIABETES MELLITUS,1
BS,DISEASE PROGRESSION,1
BS,GINGIVAL BLEEDING,1
BS,HAEMATOCHEZIA,1
BS,INFECTION,1
BS,LOSS OF CONSCIOUSNESS,1
BS,MITRAL VALVE INCOMPETENCE,1
BS,NEOPLASM MALIGNANT,1
BS,NEPHROLITHIASIS,1
BS,PANCREATIC CARCINOMA,1
BS,PRODUCT USE ISSUE,1
BS,RENAL IMPAIRMENT,1
BH,METABOLIC ACIDOSIS,14
BH,RHABDOMYOLYSIS,14
BH,OVERDOSE,13
BH,DRUG INEFFECTIVE,6
BH,FOETAL EXPOSURE DURING PREGNANCY,6
BH,PNEUMONIA SALMONELLA,6
BH,EMPYEMA,5
BH,PAIN,5
BH,DEATH,4
BH,DYSPNOEA,4
BH,PRODUCT QUALITY ISSUE,4
BH,PRURITUS,4
BH,RASH,4
BH,ACUTE KIDNEY INJURY,3
BH,ANAEMIA,3
BH,ANGIOEDEMA,3
BH,HYPERLACTACIDAEMIA,3
BH,NEUTROPENIA,3
BH,PSORIASIS,3
BH,PYREXIA,3
BH,THROMBOSIS IN DEVICE,3
BH,TOXICITY TO VARIOUS AGENTS,3
BH,VOMITING,3
BH,ABDOMINAL PAIN UPPER,2
BH,ACUTE MYOCARDIAL INFARCTION,2
BH,CARDIOPULMONARY FAILURE,2
BH,CHRONIC KIDNEY DISEASE,2
BH,CLEFT LIP,2
BH,CLEFT PALATE,2
BH,CONDITION AGGRAVATED,2
BH,DIARRHOEA,2
BH,ERYTHEMA,2
BH,EXPOSURE DURING PREGNANCY,2
BH,FEBRILE NEUTROPENIA,2
BH,HYPERTENSION,2
BH,INJECTION SITE MASS,2
BH,MATERNAL EXPOSURE DURING PREGNANCY,2
BH,MOUTH ULCERATION,2
BH,OROPHARYNGEAL PAIN,2
BH,PALPITATIONS,2
BH,PANCYTOPENIA,2
BH,PREMATURE BABY,2
BH,PREMATURE DELIVERY,2
BH,RESPIRATORY TRACT INFECTION,2
BH,SUPRAVENTRICULAR TACHYCARDIA,2
BH,UPPER RESPIRATORY TRACT INFECTION,2
BH,UROSEPSIS,2
BH,ABASIA,1
BH,ABDOMINAL PAIN,1
BH,ABDOMINAL SEPSIS,1
BH,ABORTION SPONTANEOUS,1
BH,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
BH,ACCIDENTAL OVERDOSE,1
BH,ACNE,1
BH,ACTIVITIES OF DAILY LIVING IMPAIRED,1
BH,ALANINE AMINOTRANSFERASE INCREASED,1
BH,ALOPECIA,1
BH,ANAPHYLACTIC REACTION,1
BH,APGAR SCORE LOW,1
BH,ARTHRALGIA,1
BH,ASCITES,1
BH,ATELECTASIS,1
BH,BACK PAIN,1
BH,BLOOD PARATHYROID HORMONE INCREASED,1
BH,BRADYCARDIA,1
BH,BRAIN OEDEMA,1
BH,BREAST CANCER FEMALE,1
BH,BURNING SENSATION,1
BH,CARDIAC ARREST,1
BH,CARDIOACTIVE DRUG LEVEL INCREASED,1
BH,CEREBRAL HAEMORRHAGE,1
BH,CEREBROVASCULAR ACCIDENT,1
BH,CHEST PAIN,1
BH,CHILDHOOD DISINTEGRATIVE DISORDER,1
BH,CHOKING,1
BH,CHOLECYSTITIS ACUTE,1
BH,CIRCULATORY COLLAPSE,1
BH,CLOSTRIDIUM DIFFICILE INFECTION,1
BH,COMA,1
BH,COMPLICATION OF PREGNANCY,1
BH,CONFUSIONAL STATE,1
BH,CONGESTIVE CARDIOMYOPATHY,1
BH,CONJUNCTIVAL HAEMORRHAGE,1
BH,CONSTIPATION,1
BH,CONVULSION,1
BH,CORONARY ARTERY RESTENOSIS,1
BH,COUGH,1
BH,DEATH NEONATAL,1
BH,DEPRESSED LEVEL OF CONSCIOUSNESS,1
BH,DIABETIC KETOACIDOSIS,1
BH,DIZZINESS,1
BH,DRUG DOSE OMISSION,1
BH,DRUG EFFECT DECREASED,1
BH,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
BH,DRUG-INDUCED LIVER INJURY,1
BH,DRY SKIN,1
BH,EAR CANAL INJURY,1
BH,ECCHYMOSIS,1
BH,EMPHYSEMA,1
BH,EPISTAXIS,1
BH,FACE OEDEMA,1
BH,FAILED INDUCTION OF LABOUR,1
BH,FALL,1
BH,FATIGUE,1
BH,FOETAL GROWTH RESTRICTION,1
BH,GALLBLADDER DISORDER,1
BH,GASTROENTERITIS SALMONELLA,1
BH,GENERAL PHYSICAL HEALTH DETERIORATION,1
BH,GUILLAIN-BARRE SYNDROME,1
BH,HAEMATEMESIS,1
BH,HAEMODIALYSIS,1
BH,HAEMOGLOBIN DECREASED,1
BH,HAEMORRHAGE,1
BH,HAEMORRHAGIC DIATHESIS,1
BH,HAEMORRHAGIC STROKE,1
BH,HEADACHE,1
BH,HEPATIC ENZYME INCREASED,1
BH,HEPATITIS C,1
BH,HEPATITIS TOXIC,1
BH,HERNIA,1
BH,HILAR LYMPHADENOPATHY,1
BH,HYPERGLYCAEMIA,1
BH,HYPERSENSITIVITY,1
BH,HYPOTENSION,1
BH,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
BH,IMMUNOSUPPRESSION,1
BH,IMPAIRED WORK ABILITY,1
BH,INFLUENZA,1
BH,INFUSION RELATED REACTION,1
BH,INJECTION SITE CELLULITIS,1
BH,INJECTION SITE ERYTHEMA,1
BH,INJECTION SITE INDURATION,1
BH,INJECTION SITE INFLAMMATION,1
BH,INJECTION SITE RASH,1
BH,INJECTION SITE SWELLING,1
BH,INSOMNIA,1
BH,INTENTIONAL OVERDOSE,1
BH,INTERVERTEBRAL DISC PROTRUSION,1
BH,ISCHAEMIC STROKE,1
BH,JAUNDICE,1
BH,LEUKOCYTOSIS,1
BH,LEUKOPENIA,1
BH,LOSS OF CONSCIOUSNESS,1
BH,LOW BIRTH WEIGHT BABY,1
BH,LUNG CONSOLIDATION,1
BH,LUNG DISORDER,1
BH,LUNG INFECTION,1
BH,LYMPHADENOPATHY,1
BH,LYMPHADENOPATHY MEDIASTINAL,1
BH,MALAISE,1
BH,MEDIASTINAL DISORDER,1
BH,MENTAL IMPAIRMENT,1
BH,METASTASES TO LIVER,1
BH,MILIARIA,1
BH,MONOCYTE COUNT INCREASED,1
BH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
BH,MUSCLE RIGIDITY,1
BH,MUSCULOSKELETAL PAIN,1
BH,MYDRIASIS,1
BH,NAIL BED BLEEDING,1
BH,NAIL INFECTION,1
BH,NAUSEA,1
BH,NEUROMYELITIS OPTICA,1
BH,NEUROPATHY PERIPHERAL,1
BH,OCULAR ROSACEA,1
BH,OVARIAN CYST,1
BH,PAPILLARY THYROID CANCER,1
BH,PIGMENTATION DISORDER,1
BH,PLATELET COUNT DECREASED,1
BH,PLEURAL EFFUSION,1
BH,PNEUMONIA,1
BH,PNEUMONITIS,1
BH,POLYMERASE CHAIN REACTION POSITIVE,1
BH,PROCEDURAL PAIN,1
BH,PRODUCT USE IN UNAPPROVED INDICATION,1
BH,PRURITUS GENERALISED,1
BH,PULMONARY EMBOLISM,1
BH,PULMONARY OEDEMA,1
BH,PUPILLARY REFLEX IMPAIRED,1
BH,PYOGENIC GRANULOMA,1
BH,RASH ERYTHEMATOUS,1
BH,RASH GENERALISED,1
BH,ROSACEA,1
BH,SEPSIS,1
BH,SHOCK,1
BH,SKIN ANGIOSARCOMA,1
BH,SKIN DISORDER,1
BH,SKIN HAEMORRHAGE,1
BH,SKIN PAPILLOMA,1
BH,SKIN SENSITISATION,1
BH,SPLENIC CYST,1
BH,SUBCUTANEOUS ABSCESS,1
BH,TACHYCARDIA,1
BH,TACHYCARDIA FOETAL,1
BH,THERMAL BURN,1
BH,TOOTH DISCOLOURATION,1
BH,TOXIC ENCEPHALOPATHY,1
BH,TREATMENT NONCOMPLIANCE,1
BH,URINARY INCONTINENCE,1
BH,VAGINAL HAEMORRHAGE,1
BH,VASCULAR NEOPLASM,1
BH,WRONG DRUG ADMINISTERED,1
BD,DEATH,198
BD,CEREBROVASCULAR ACCIDENT,107
BD,EXPOSURE DURING PREGNANCY,73
BD,ABORTION,34
BD,PYREXIA,31
BD,DYSPNOEA,30
BD,FOETAL EXPOSURE DURING PREGNANCY,27
BD,ASTHENIA,26
BD,ABORTION SPONTANEOUS,24
BD,DIABETES MELLITUS,24
BD,STILLBIRTH,24
BD,RENAL DISORDER,23
BD,HYPERTENSION,22
BD,MYOCARDIAL INFARCTION,22
BD,DEMENTIA,20
BD,GENERAL PHYSICAL HEALTH DETERIORATION,18
BD,CARDIAC DISORDER,16
BD,ELECTROLYTE IMBALANCE,16
BD,INFECTION,16
BD,MALAISE,16
BD,DIARRHOEA,14
BD,PAIN,14
BD,TOXIC EPIDERMAL NECROLYSIS,14
BD,DRUG INEFFECTIVE,13
BD,PNEUMONIA,13
BD,VOMITING,13
BD,COUGH,12
BD,DEHYDRATION,12
BD,OSTEOPOROSIS,12
BD,ARTHRALGIA,11
BD,SEPSIS,11
BD,ALOPECIA,10
BD,CORNEAL OPACITY,10
BD,TACHYCARDIA,10
BD,BODY TEMPERATURE INCREASED,9
BD,HYPOTENSION,9
BD,LOSS OF CONSCIOUSNESS,9
BD,LUNG DISORDER,9
BD,RENAL FAILURE,9
BD,RESTLESSNESS,9
BD,SUDDEN DEATH,9
BD,ABDOMINAL PAIN,8
BD,BLISTER,8
BD,ERYTHEMA,8
BD,FALL,8
BD,HAEMOGLOBIN DECREASED,8
BD,HYPOPROTEINAEMIA,8
BD,MATERNAL EXPOSURE DURING PREGNANCY,8
BD,NASOPHARYNGITIS,8
BD,NERVOUS SYSTEM DISORDER,8
BD,RESPIRATORY DISTRESS,8
BD,APHASIA,7
BD,ASTHMA,7
BD,EYELID OEDEMA,7
BD,GAIT DISTURBANCE,7
BD,HEADACHE,7
BD,HYPOPHAGIA,7
BD,MOVEMENT DISORDER,7
BD,MUCOSAL EROSION,7
BD,APHAGIA,6
BD,CARDIAC FAILURE,6
BD,CEREBRAL HAEMORRHAGE,6
BD,CONJUNCTIVITIS,6
BD,DECREASED APPETITE,6
BD,EATING DISORDER,6
BD,HEPATIC CIRRHOSIS,6
BD,HYPERSENSITIVITY,6
BD,MYALGIA,6
BD,RASH,6
BD,RESPIRATORY DISORDER,6
BD,RESPIRATORY FAILURE,6
BD,RHABDOMYOLYSIS,6
BD,URINARY TRACT INFECTION,6
BD,CARDIAC ARREST,5
BD,CARDIAC TAMPONADE,5
BD,HYPERHIDROSIS,5
BD,INTENTIONAL PRODUCT USE ISSUE,5
BD,OEDEMA,5
BD,PARALYSIS,5
BD,PRODUCT USE IN UNAPPROVED INDICATION,5
BD,ACARODERMATITIS,4
BD,ALTERED STATE OF CONSCIOUSNESS,4
BD,AMNESIA,4
BD,BLOOD PRESSURE INCREASED,4
BD,BONE CANCER,4
BD,CHEST PAIN,4
BD,CONFUSIONAL STATE,4
BD,DISORIENTATION,4
BD,FEELING ABNORMAL,4
BD,FRACTURE,4
BD,HEPATITIS B,4
BD,HYPOKALAEMIA,4
BD,HYPOKINESIA,4
BD,LUNG INFECTION,4
BD,MENINGOMYELOCELE,4
BD,NAUSEA,4
BD,PIGMENTATION DISORDER,4
BD,PLATELET COUNT DECREASED,4
BD,PLEURAL EFFUSION,4
BD,SEIZURE,4
BD,SWELLING FACE,4
BD,TYPE 2 LEPRA REACTION,4
BD,WEIGHT DECREASED,4
BD,ACUTE PULMONARY OEDEMA,3
BD,BALANCE DISORDER,3
BD,BLIGHTED OVUM,3
BD,BLOOD PRESSURE DECREASED,3
BD,CONSTIPATION,3
BD,CONVULSION,3
BD,DEMENTIA ALZHEIMER^S TYPE,3
BD,DISEASE RECURRENCE,3
BD,DIZZINESS,3
BD,DRUG RESISTANCE,3
BD,HAEMATEMESIS,3
BD,HEPATIC CANCER,3
BD,INTENTIONAL OVERDOSE,3
BD,JAUNDICE,3
BD,OEDEMA PERIPHERAL,3
BD,PAIN IN EXTREMITY,3
BD,PATHOGEN RESISTANCE,3
BD,PERICARDIAL EFFUSION,3
BD,PRURITUS,3
BD,PULMONARY OEDEMA,3
BD,RHEUMATIC FEVER,3
BD,ROAD TRAFFIC ACCIDENT,3
BD,SKIN STRIAE,3
BD,SOMNOLENCE,3
BD,VENTRICULAR TACHYCARDIA,3
BD,WEIGHT INCREASED,3
BD,ABASIA,2
BD,ABDOMINAL NEOPLASM,2
BD,ABDOMINAL PAIN UPPER,2
BD,ANAPHYLACTIC SHOCK,2
BD,ANURIA,2
BD,ASCITES,2
BD,BACK PAIN,2
BD,BLOOD GLUCOSE DECREASED,2
BD,BLOOD PRESSURE ABNORMAL,2
BD,BONE PAIN,2
BD,BONE TUBERCULOSIS,2
BD,BRAIN NEOPLASM,2
BD,BREAST CANCER,2
BD,BURNING SENSATION,2
BD,CHEST DISCOMFORT,2
BD,CHOLELITHIASIS,2
BD,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
BD,CONCOMITANT DISEASE PROGRESSION,2
BD,COORDINATION ABNORMAL,2
BD,CSF TEST ABNORMAL,2
BD,DECUBITUS ULCER,2
BD,DENGUE FEVER,2
BD,DIABETES MELLITUS INADEQUATE CONTROL,2
BD,DRUG ERUPTION,2
BD,ECTOPIC PREGNANCY,2
BD,ELECTROCARDIOGRAM QT PROLONGED,2
BD,GANGRENE,2
BD,GASTRIC CANCER,2
BD,GENERAL PHYSICAL CONDITION ABNORMAL,2
BD,GENERALISED OEDEMA,2
BD,HAEMATOCHEZIA,2
BD,HAEMATOPOIETIC NEOPLASM,2
BD,HAEMOPTYSIS,2
BD,HAEMORRHAGE,2
BD,HAEMORRHAGIC STROKE,2
BD,HAEMOTHORAX,2
BD,HEMIPLEGIA,2
BD,HEPATITIS C,2
BD,HYPOCALCAEMIA,2
BD,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
BD,INCORRECT DRUG ADMINISTRATION DURATION,2
BD,INFLUENZA LIKE ILLNESS,2
BD,LIVER DISORDER,2
BD,LOWER LIMB FRACTURE,2
BD,MALNUTRITION,2
BD,MENTAL DISORDER,2
BD,METASTASES TO BONE,2
BD,METASTASES TO CENTRAL NERVOUS SYSTEM,2
BD,METASTASES TO LUNG,2
BD,MOBILITY DECREASED,2
BD,MULTI-ORGAN FAILURE,2
BD,MUSCULOSKELETAL STIFFNESS,2
BD,OCULAR HYPERAEMIA,2
BD,OESOPHAGEAL CARCINOMA,2
BD,OSTEONECROSIS,2
BD,OVARIAN CANCER,2
BD,PARAESTHESIA,2
BD,PARKINSON^S DISEASE,2
BD,PERFORMANCE STATUS DECREASED,2
BD,PERICARDIAL HAEMORRHAGE,2
BD,SKIN DISCOLOURATION,2
BD,SKIN IRRITATION,2
BD,THYROID CANCER,2
BD,TRANSIENT ISCHAEMIC ATTACK,2
BD,UTERINE RUPTURE,2
BD,VISION BLURRED,2
BD,WHITE BLOOD CELL COUNT INCREASED,2
BD,WRONG DRUG ADMINISTERED,2
BD,ABDOMINAL DISCOMFORT,1
BD,ABDOMINAL DISTENSION,1
BD,ABNORMAL BEHAVIOUR,1
BD,ACCIDENTAL DEATH,1
BD,ACCIDENTAL OVERDOSE,1
BD,ADVERSE EVENT,1
BD,AGEUSIA,1
BD,ALANINE AMINOTRANSFERASE INCREASED,1
BD,ANAEMIA OF CHRONIC DISEASE,1
BD,ANAPHYLACTIC REACTION,1
BD,ANISOCYTOSIS,1
BD,ANXIETY,1
BD,APNOEA,1
BD,ARTHRITIS,1
BD,ASPIRATION,1
BD,BEDRIDDEN,1
BD,BLADDER DILATATION,1
BD,BLOOD ALBUMIN DECREASED,1
BD,BLOOD CALCIUM DECREASED,1
BD,BLOOD CREATININE ABNORMAL,1
BD,BLOOD CREATININE INCREASED,1
BD,BLOOD DISORDER,1
BD,BLOOD GLUCOSE INCREASED,1
BD,BLOOD INSULIN INCREASED,1
BD,BLOOD THYROID STIMULATING HORMONE INCREASED,1
BD,BLOOD UREA INCREASED,1
BD,BLOOD URINE PRESENT,1
BD,BONE DISORDER,1
BD,BONE EROSION,1
BD,BROAD LIGAMENT HAEMATOMA,1
BD,BRONCHIAL SECRETION RETENTION,1
BD,BRONCHITIS,1
BD,CARDIOPULMONARY FAILURE,1
BD,CELL DEATH,1
BD,CEREBRAL VENTRICLE DILATATION,1
BD,CHANGE OF BOWEL HABIT,1
BD,CHILLS,1
BD,CHOKING,1
BD,CIRCULATORY COLLAPSE,1
BD,COMA,1
BD,COMPLETED SUICIDE,1
BD,CONCOMITANT DISEASE AGGRAVATED,1
BD,CONDITION AGGRAVATED,1
BD,CRANIAL NERVE DISORDER,1
BD,CREATININE RENAL CLEARANCE DECREASED,1
BD,DEAFNESS,1
BD,DEPRESSION,1
BD,DIABETIC COMPLICATION,1
BD,DISCOMFORT,1
BD,DRUG HYPERSENSITIVITY,1
BD,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
BD,DRUG PRESCRIBING ERROR,1
BD,DYSARTHRIA,1
BD,DYSENTERY,1
BD,DYSGEUSIA,1
BD,DYSKINESIA,1
BD,DYSPEPSIA,1
BD,DYSPHAGIA,1
BD,DYSPNOEA EXERTIONAL,1
BD,EJECTION FRACTION DECREASED,1
BD,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,1
BD,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
BD,EPILEPSY,1
BD,EYE PAIN,1
BD,EYE PRURITUS,1
BD,FEAR,1
BD,FEEDING TUBE COMPLICATION,1
BD,FEMORAL NECK FRACTURE,1
BD,FLUID OVERLOAD,1
BD,FLUID RETENTION,1
BD,FOAMING AT MOUTH,1
BD,GASTRIC DISORDER,1
BD,GASTROINTESTINAL CARCINOMA,1
BD,GASTROINTESTINAL DISORDER,1
BD,GASTROINTESTINAL INFECTION,1
BD,GASTROINTESTINAL TRACT IRRITATION,1
BD,GINGIVAL BLEEDING,1
BD,GLIOBLASTOMA,1
BD,HAEMATOLOGICAL MALIGNANCY,1
BD,HAND FRACTURE,1
BD,HEAD INJURY,1
BD,HEART RATE INCREASED,1
BD,HEMIPARESIS,1
BD,HEPATIC FAILURE,1
BD,HEPATIC FUNCTION ABNORMAL,1
BD,HEPATIC NEOPLASM,1
BD,HEPATITIS B VIRUS TEST POSITIVE,1
BD,HEPATOCELLULAR CARCINOMA,1
BD,HIP FRACTURE,1
BD,HYDRONEPHROSIS,1
BD,HYPERCHOLESTEROLAEMIA,1
BD,HYPOACUSIS,1
BD,HYPOAESTHESIA,1
BD,HYPOGLYCAEMIA,1
BD,HYPOVOLAEMIC SHOCK,1
BD,ILEUS,1
BD,IMPAIRED HEALING,1
BD,INCONTINENCE,1
BD,INFREQUENT BOWEL MOVEMENTS,1
BD,INJECTION SITE EXTRAVASATION,1
BD,INJECTION SITE INDURATION,1
BD,INJECTION SITE INFECTION,1
BD,INJECTION SITE PAIN,1
BD,INSOMNIA,1
BD,INSULIN RESISTANCE,1
BD,INTENTIONAL PRODUCT MISUSE,1
BD,INTRACRANIAL PRESSURE INCREASED,1
BD,IRRITABILITY,1
BD,JUGULAR VEIN DISTENSION,1
BD,KIDNEY INFECTION,1
BD,KNEE DEFORMITY,1
BD,KWASHIORKOR,1
BD,LACRIMATION INCREASED,1
BD,LETHARGY,1
BD,LEUKAEMIA,1
BD,LEUKOCYTOSIS,1
BD,LIBIDO DECREASED,1
BD,LIP INFECTION,1
BD,LIVER INJURY,1
BD,LOCAL SWELLING,1
BD,LOCALISED INFECTION,1
BD,LOGORRHOEA,1
BD,LOW BIRTH WEIGHT BABY,1
BD,LUNG NEOPLASM MALIGNANT,1
BD,MALIGNANT NEOPLASM PROGRESSION,1
BD,MATERNAL DRUGS AFFECTING FOETUS,1
BD,MELANODERMA,1
BD,MENINGITIS,1
BD,MENINGITIS TUBERCULOUS,1
BD,MENTAL IMPAIRMENT,1
BD,METASTASES TO LIVER,1
BD,MICROCYTOSIS,1
BD,MOTOR DYSFUNCTION,1
BD,MOUTH ULCERATION,1
BD,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
BD,MUSCLE DISORDER,1
BD,MUSCULAR WEAKNESS,1
BD,MUSCULOSKELETAL PAIN,1
BD,MYCOBACTERIUM TEST POSITIVE,1
BD,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
BD,MYOCARDIAL ISCHAEMIA,1
BD,MYOPATHY,1
BD,NECK PAIN,1
BD,NECROSIS,1
BD,NEONATAL ASPHYXIA,1
BD,NEOPLASM MALIGNANT,1
BD,NEUROPATHY PERIPHERAL,1
BD,NEUTROPENIC SEPSIS,1
BD,NOSOCOMIAL INFECTION,1
BD,OBESITY,1
BD,OBSTRUCTIVE AIRWAYS DISORDER,1
BD,OESOPHAGEAL INFECTION,1
BD,OPTIC NERVE DISORDER,1
BD,ORAL INFECTION,1
BD,OSTEOMYELITIS,1
BD,OSTEONECROSIS OF JAW,1
BD,OVERDOSE,1
BD,OXYGEN SATURATION DECREASED,1
BD,PAINFUL DEFAECATION,1
BD,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
BD,PANCREATIC CARCINOMA,1
BD,PANCREATITIS,1
BD,PAPULE,1
BD,PARAPLEGIA,1
BD,PARKINSONISM,1
BD,PEPTIC ULCER,1
BD,PERICARDIAL RUB,1
BD,PERIPHERAL EMBOLISM,1
BD,PHARYNGITIS,1
BD,PHOTOPHOBIA,1
BD,PLASMA CELL MYELOMA,1
BD,PNEUMOTHORAX,1
BD,POLLAKIURIA,1
BD,POLYARTERITIS NODOSA,1
BD,POST PROCEDURAL COMPLICATION,1
BD,POSTOPERATIVE WOUND INFECTION,1
BD,PREMATURE DELIVERY,1
BD,PRODUCT USE ISSUE,1
BD,PROSTATIC DISORDER,1
BD,PSYCHIATRIC SYMPTOM,1
BD,PULMONARY CAVITATION,1
BD,PULMONARY HAEMORRHAGE,1
BD,PULSE ABNORMAL,1
BD,PURPURA,1
BD,RALES,1
BD,RASH MACULAR,1
BD,RASH PRURITIC,1
BD,RENAL FAILURE ACUTE,1
BD,RENAL IMPAIRMENT,1
BD,RENAL INJURY,1
BD,RESPIRATORY TRACT INFECTION,1
BD,RICKETTSIOSIS,1
BD,ROTAVIRUS INFECTION,1
BD,SEDATION,1
BD,SENSORY LOSS,1
BD,SEPTIC SHOCK,1
BD,SHOCK,1
BD,SHOCK HAEMORRHAGIC,1
BD,SKIN EXFOLIATION,1
BD,SKIN INFECTION,1
BD,SKIN LESION,1
BD,SKIN REACTION,1
BD,SPEECH DISORDER,1
BD,SPINAL COLUMN INJURY,1
BD,SPINAL CORD INJURY,1
BD,SPINAL PAIN,1
BD,SPUTUM ABNORMAL,1
BD,STEVENS-JOHNSON SYNDROME,1
BD,STOMATITIS,1
BD,STRONGYLOIDIASIS,1
BD,SWELLING,1
BD,SYNCOPE,1
BD,THROAT CANCER,1
BD,THROMBOCYTOPENIA,1
BD,THROMBOCYTOSIS,1
BD,TINNITUS,1
BD,TONGUE PARALYSIS,1
BD,TOOTH LOSS,1
BD,TUBERCULOSIS,1
BD,TUMOUR HAEMORRHAGE,1
BD,UNDERDOSE,1
BD,URINARY HESITATION,1
BD,URINARY RETENTION,1
BD,VARICELLA,1
BD,VENOUS OCCLUSION,1
BD,VERTIGO,1
BD,VICTIM OF HOMICIDE,1
BD,VIRAL INFECTION,1
BD,VISCERAL LEISHMANIASIS,1
BD,VOLUME BLOOD DECREASED,1
BD,WHITE BLOOD CELL COUNT DECREASED,1
BD,X-RAY ABNORMAL,1
BB,DEATH,8
BB,ASTHMA,5
BB,HEART RATE INCREASED,4
BB,HYPOTENSION,4
BB,CEREBROVASCULAR ACCIDENT,3
BB,DYSPNOEA,3
BB,MATERNAL EXPOSURE DURING PREGNANCY,3
BB,PARAPSORIASIS,3
BB,PULMONARY EMBOLISM,3
BB,WHEEZING,3
BB,ANGIOEDEMA,2
BB,ARTHRALGIA,2
BB,DRY SKIN,2
BB,DYSPHAGIA,2
BB,EATING DISORDER,2
BB,ISCHAEMIC STROKE,2
BB,JAUNDICE,2
BB,LIP SWELLING,2
BB,NORMAL NEWBORN,2
BB,RASH PAPULAR,2
BB,WEIGHT DECREASED,2
BB,ACCIDENT,1
BB,ACUTE MYOCARDIAL INFARCTION,1
BB,AMNESIA,1
BB,APPLICATION SITE PAPULES,1
BB,APPLICATION SITE RASH,1
BB,ASTHENIA,1
BB,BACK PAIN,1
BB,BLOOD CALCIUM DECREASED,1
BB,BLOOD PRESSURE DECREASED,1
BB,BODY TEMPERATURE INCREASED,1
BB,BURNING SENSATION,1
BB,CARDIAC FAILURE,1
BB,CARDIAC TAMPONADE,1
BB,CHEST DISCOMFORT,1
BB,CONFUSIONAL STATE,1
BB,CORONARY ARTERY DISEASE,1
BB,DEEP VEIN THROMBOSIS,1
BB,DIABETES MELLITUS,1
BB,DISCOMFORT,1
BB,DRUG DOSE OMISSION,1
BB,DYSPEPSIA,1
BB,ECZEMA,1
BB,ELECTROCARDIOGRAM QT PROLONGED,1
BB,EMBOLIC STROKE,1
BB,EXPOSURE DURING PREGNANCY,1
BB,FALL,1
BB,FEELING ABNORMAL,1
BB,FORCEPS DELIVERY,1
BB,GASTROINTESTINAL DISORDER,1
BB,GASTROINTESTINAL HAEMORRHAGE,1
BB,GENERAL PHYSICAL HEALTH DETERIORATION,1
BB,HAEMATEMESIS,1
BB,HAEMOGLOBIN DECREASED,1
BB,HAEMORRHAGE INTRACRANIAL,1
BB,HEADACHE,1
BB,HEPATIC HAEMATOMA,1
BB,HYPERTENSION,1
BB,HYPOGLYCAEMIA,1
BB,JOINT RANGE OF MOTION DECREASED,1
BB,LIVER FUNCTION TEST ABNORMAL,1
BB,MALAISE,1
BB,MUSCLE ATROPHY,1
BB,MUSCULAR WEAKNESS,1
BB,MUSCULOSKELETAL STIFFNESS,1
BB,MYOCARDIAL INFARCTION,1
BB,MYOCARDIAL ISCHAEMIA,1
BB,NAUSEA,1
BB,PANCREATIC CARCINOMA,1
BB,PHARYNGEAL OEDEMA,1
BB,PNEUMONIA,1
BB,PROTHROMBIN TIME PROLONGED,1
BB,PRURITUS GENERALISED,1
BB,PYREXIA,1
BB,RASH ERYTHEMATOUS,1
BB,RASH MACULO-PAPULAR,1
BB,SKIN HYPERPIGMENTATION,1
BB,SLEEP DISORDER,1
BB,SPEECH DISORDER,1
BB,STEVENS-JOHNSON SYNDROME,1
BB,STILLBIRTH,1
BB,SWELLING FACE,1
BB,SWOLLEN TONGUE,1
BB,THROAT TIGHTNESS,1
BB,TINEA VERSICOLOUR,1
BB,UPPER GASTROINTESTINAL HAEMORRHAGE,1
BB,UROSEPSIS,1
BB,VOMITING,1
BY,NEPHROPATHY,14
BY,DEATH,10
BY,DIZZINESS,9
BY,HEADACHE,8
BY,SEPSIS,8
BY,ASTHENIA,7
BY,PNEUMONIA,7
BY,ANAEMIA,6
BY,DYSPNOEA,6
BY,ISCHAEMIC STROKE,6
BY,LEUKOPENIA,6
BY,PULMONARY EMBOLISM,6
BY,THROMBOCYTOPENIA,6
BY,CREATININE RENAL CLEARANCE DECREASED,5
BY,INTENTIONAL PRODUCT USE ISSUE,5
BY,RASH,5
BY,ASCITES,4
BY,CONDITION AGGRAVATED,4
BY,CYANOSIS,4
BY,DRUG INEFFECTIVE,4
BY,LOSS OF CONSCIOUSNESS,4
BY,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
BY,PRODUCT USE ISSUE,4
BY,VOMITING,4
BY,BLOOD BILIRUBIN INCREASED,3
BY,CHILLS,3
BY,EPSTEIN-BARR VIRUS INFECTION,3
BY,FATIGUE,3
BY,GASTROINTESTINAL DISORDER,3
BY,GENERAL PHYSICAL HEALTH DETERIORATION,3
BY,HAEMOGLOBIN DECREASED,3
BY,HEPATOMEGALY,3
BY,HYPOTENSION,3
BY,MALIGNANT NEOPLASM PROGRESSION,3
BY,NAUSEA,3
BY,NEUTROPENIA,3
BY,OEDEMA,3
BY,PANCYTOPENIA,3
BY,PERICARDIAL EFFUSION,3
BY,PLATELET COUNT DECREASED,3
BY,PULMONARY ARTERIAL HYPERTENSION,3
BY,PYREXIA,3
BY,TOXIC SKIN ERUPTION,3
BY,TREATMENT NONCOMPLIANCE,3
BY,ABDOMINAL PAIN,2
BY,ABORTION THREATENED,2
BY,ACUTE KIDNEY INJURY,2
BY,ADVERSE EVENT,2
BY,ALANINE AMINOTRANSFERASE INCREASED,2
BY,ANGINA PECTORIS,2
BY,ANXIETY,2
BY,ARTHRALGIA,2
BY,ASPARTATE AMINOTRANSFERASE INCREASED,2
BY,ASPHYXIA,2
BY,ATRIAL FIBRILLATION,2
BY,ATRIAL THROMBOSIS,2
BY,BILIRUBIN CONJUGATED INCREASED,2
BY,BLOOD ALKALINE PHOSPHATASE INCREASED,2
BY,BLOOD DISORDER,2
BY,BLOOD PRESSURE DECREASED,2
BY,BRADYCARDIA,2
BY,BRONCHITIS,2
BY,CARDIAC TAMPONADE,2
BY,CHOKING,2
BY,CIRCULATORY COLLAPSE,2
BY,CONSTIPATION,2
BY,COUGH,2
BY,DECREASED APPETITE,2
BY,DEEP VEIN THROMBOSIS,2
BY,DERMATITIS BULLOUS,2
BY,DEVICE RELATED INFECTION,2
BY,DISORIENTATION,2
BY,DYSPHAGIA,2
BY,ELECTROCARDIOGRAM QT PROLONGED,2
BY,EPISTAXIS,2
BY,EXPOSURE DURING PREGNANCY,2
BY,EYELID OEDEMA,2
BY,FEELING ABNORMAL,2
BY,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
BY,GASTROINTESTINAL HAEMORRHAGE,2
BY,HAEMATURIA,2
BY,HAEMOPTYSIS,2
BY,HYPERTENSION,2
BY,HYPOMAGNESAEMIA,2
BY,INFECTION,2
BY,INFUSION RELATED REACTION,2
BY,INSOMNIA,2
BY,LYMPHADENOPATHY,2
BY,MALAISE,2
BY,MULTI-ORGAN FAILURE,2
BY,MYOCARDIAL INFARCTION,2
BY,NEPHROLITHIASIS,2
BY,OEDEMA PERIPHERAL,2
BY,OSTEONECROSIS,2
BY,PAIN,2
BY,PALPITATIONS,2
BY,PRODUCT ADHESION ISSUE,2
BY,PRODUCT QUALITY ISSUE,2
BY,PRURITUS,2
BY,PULMONARY TUBERCULOSIS,2
BY,PYELONEPHRITIS ACUTE,2
BY,RESPIRATORY FAILURE,2
BY,SEIZURE,2
BY,SEPTIC SHOCK,2
BY,SUBARACHNOID HAEMORRHAGE,2
BY,SYMPATHETIC POSTERIOR CERVICAL SYNDROME,2
BY,SYNCOPE,2
BY,TINNITUS,2
BY,UTERINE HAEMORRHAGE,2
BY,VENOUS THROMBOSIS,2
BY,WEIGHT DECREASED,2
BY,WHITE BLOOD CELL COUNT INCREASED,2
BY,ABDOMINAL PAIN UPPER,1
BY,ABORTION MISSED,1
BY,ACCIDENT,1
BY,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
BY,ACINETOBACTER INFECTION,1
BY,ACUTE HEPATIC FAILURE,1
BY,ACUTE LEUKAEMIA,1
BY,ADENOCARCINOMA GASTRIC,1
BY,AGRANULOCYTOSIS,1
BY,ALOPECIA,1
BY,AMYLASE INCREASED,1
BY,ANAPHYLACTIC SHOCK,1
BY,ANASTOMOTIC STENOSIS,1
BY,ARRHYTHMIA,1
BY,ASPERGILLUS TEST POSITIVE,1
BY,ASTHMATIC CRISIS,1
BY,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
BY,BACK PAIN,1
BY,BLADDER CANCER,1
BY,BLINDNESS TRANSIENT,1
BY,BLISTER,1
BY,BLOOD CREATININE INCREASED,1
BY,BLOOD GLUCOSE ABNORMAL,1
BY,BLOOD PRESSURE FLUCTUATION,1
BY,BODY TEMPERATURE INCREASED,1
BY,BONE PAIN,1
BY,BONE TUBERCULOSIS,1
BY,BRONCHOPULMONARY ASPERGILLOSIS,1
BY,CALCULUS URINARY,1
BY,CANDIDA INFECTION,1
BY,CANDIDA TEST POSITIVE,1
BY,CARDIAC ARREST,1
BY,CARDIAC DISORDER,1
BY,CARDIAC FAILURE,1
BY,CARDIOPULMONARY FAILURE,1
BY,CELL DEATH,1
BY,CEREBRAL HAEMORRHAGE,1
BY,CEREBRAL ISCHAEMIA,1
BY,CHILD-PUGH-TURCOTTE SCORE INCREASED,1
BY,COLD SWEAT,1
BY,COLON NEOPLASM,1
BY,COMA,1
BY,CYTOKINE RELEASE SYNDROME,1
BY,CYTOMEGALOVIRUS CHORIORETINITIS,1
BY,CYTOMEGALOVIRUS TEST POSITIVE,1
BY,CYTOPENIA,1
BY,DEAFNESS,1
BY,DELIRIUM,1
BY,DEPRESSED LEVEL OF CONSCIOUSNESS,1
BY,DEPRESSION,1
BY,DIARRHOEA HAEMORRHAGIC,1
BY,DISSEMINATED INTRAVASCULAR COAGULATION,1
BY,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
BY,DRUG EFFECT INCOMPLETE,1
BY,DRUG RESISTANCE,1
BY,DRY MOUTH,1
BY,DUODENAL ULCER,1
BY,DYSGEUSIA,1
BY,DYSPNOEA EXERTIONAL,1
BY,ELECTROCARDIOGRAM ABNORMAL,1
BY,ELECTROLYTE IMBALANCE,1
BY,ENCEPHALOMYELITIS,1
BY,ENTEROCOCCAL INFECTION,1
BY,ERYTHEMA,1
BY,ERYTHEMA NODOSUM,1
BY,EXTRASYSTOLES,1
BY,EXTRAVASATION BLOOD,1
BY,FEAR,1
BY,FEBRILE NEUTROPENIA,1
BY,FEELING COLD,1
BY,GAIT DISTURBANCE,1
BY,GASTRIC CANCER,1
BY,GASTROINTESTINAL INFECTION,1
BY,GENERALISED TONIC-CLONIC SEIZURE,1
BY,GLAUCOMA,1
BY,GLUCOSE TOLERANCE IMPAIRED,1
BY,HAEMORRHAGIC ARTERIOVENOUS MALFORMATION,1
BY,HAEMORRHOIDS,1
BY,HAEMOSTASIS,1
BY,HALLUCINATION,1
BY,HEART RATE INCREASED,1
BY,HEART SOUNDS ABNORMAL,1
BY,HEPATIC CIRRHOSIS,1
BY,HEPATIC CONGESTION,1
BY,HEPATIC FUNCTION ABNORMAL,1
BY,HEPATIC NECROSIS,1
BY,HEPATITIS C,1
BY,HEPATOBILIARY DISEASE,1
BY,HEPATORENAL FAILURE,1
BY,HEPATOTOXICITY,1
BY,HERPES ZOSTER,1
BY,HISTIOCYTOSIS HAEMATOPHAGIC,1
BY,HOSPITALISATION,1
BY,HYDROTHORAX,1
BY,HYPERKALAEMIA,1
BY,HYPERSENSITIVITY,1
BY,HYPERTHERMIA,1
BY,HYPERURICAEMIA,1
BY,HYPOACUSIS,1
BY,HYPOAESTHESIA ORAL,1
BY,HYPOPNOEA,1
BY,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
BY,ILEUS,1
BY,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
BY,IMMUNE THROMBOCYTOPENIC PURPURA,1
BY,INCORRECT DOSAGE ADMINISTERED,1
BY,INFERIOR VENA CAVA STENOSIS,1
BY,INFESTATION,1
BY,INGUINAL HERNIA,1
BY,INNER EAR DISORDER,1
BY,INTENTIONAL PRODUCT MISUSE,1
BY,INTENTIONAL SELF-INJURY,1
BY,JAUNDICE,1
BY,KLEBSIELLA TEST POSITIVE,1
BY,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
BY,LIP SWELLING,1
BY,LOWER LIMB FRACTURE,1
BY,LUNG CANCER METASTATIC,1
BY,LUNG DISORDER,1
BY,MEDIASTINITIS,1
BY,MEDICATION ERROR,1
BY,MELAENA,1
BY,MENTAL DISORDER,1
BY,METABOLIC DISORDER,1
BY,METASTASES TO BONE,1
BY,METASTASES TO CENTRAL NERVOUS SYSTEM,1
BY,METASTASES TO LIVER,1
BY,MOOD SWINGS,1
BY,MULTIPLE SCLEROSIS RELAPSE,1
BY,MUSCLE SPASMS,1
BY,MYALGIA,1
BY,MYASTHENIA GRAVIS,1
BY,MYCETOMA MYCOTIC,1
BY,NERVOUS SYSTEM DISORDER,1
BY,ORAL MUCOSA EROSION,1
BY,PAIN IN EXTREMITY,1
BY,PANIC ATTACK,1
BY,PANIC DISORDER,1
BY,PARAESTHESIA,1
BY,PERICARDIAL HAEMORRHAGE,1
BY,PERIPHERAL SENSORY NEUROPATHY,1
BY,PHARYNGEAL HAEMORRHAGE,1
BY,PLEURISY,1
BY,PNEUMONECTOMY,1
BY,PNEUMOTHORAX,1
BY,POLLAKIURIA,1
BY,PORTAL HYPERTENSION,1
BY,POST CARDIAC ARREST SYNDROME,1
BY,PROCEDURAL HAEMORRHAGE,1
BY,PRODUCT PRESCRIBING ISSUE,1
BY,PROTHROMBIN LEVEL DECREASED,1
BY,PRURITUS GENITAL,1
BY,PULMONARY HAEMORRHAGE,1
BY,PULMONARY MASS,1
BY,PULMONARY OEDEMA,1
BY,PULMONARY THROMBOSIS,1
BY,PURULENT DISCHARGE,1
BY,PYELOCALIECTASIS,1
BY,RALES,1
BY,RASH ERYTHEMATOUS,1
BY,RASH GENERALISED,1
BY,RECTAL CANCER,1
BY,RENAL DISORDER,1
BY,RENAL FAILURE,1
BY,RENAL FAILURE ACUTE,1
BY,RESPIRATORY DISORDER,1
BY,RESPIRATORY DISTRESS,1
BY,RIGHT VENTRICULAR FAILURE,1
BY,SINUSITIS,1
BY,SKIN DISORDER,1
BY,SLEEP DISORDER,1
BY,SOMNOLENCE,1
BY,SPLENIC RUPTURE,1
BY,SPLENOMEGALY,1
BY,SPUTUM CULTURE POSITIVE,1
BY,STAPHYLOCOCCAL SEPSIS,1
BY,STAPHYLOCOCCUS TEST POSITIVE,1
BY,SUBCLAVIAN VEIN THROMBOSIS,1
BY,SUPRAVENTRICULAR EXTRASYSTOLES,1
BY,TACHYCARDIA,1
BY,THERAPY CESSATION,1
BY,THERAPY NON-RESPONDER,1
BY,THIRST,1
BY,THROMBOCYTOSIS,1
BY,THROMBOSIS,1
BY,THYROID DISORDER,1
BY,TONGUE OEDEMA,1
BY,TONSILLITIS,1
BY,TOXIC ENCEPHALOPATHY,1
BY,TOXIC EPIDERMAL NECROLYSIS,1
BY,TRANSIENT ISCHAEMIC ATTACK,1
BY,TREMOR,1
BY,TUBERCULOSIS,1
BY,UPPER RESPIRATORY TRACT INFECTION,1
BY,URINARY RETENTION,1
BY,URTICARIA,1
BY,UTERINE INFLAMMATION,1
BY,VAGINAL HAEMORRHAGE,1
BY,VAGINAL INFECTION,1
BY,VENTRICULAR FIBRILLATION,1
BY,VISUAL ACUITY REDUCED,1
BY,VISUAL FIELD DEFECT,1
BY,WEIGHT INCREASED,1
BY,XEROSIS,1
BE,DEATH,798
BE,FATIGUE,548
BE,DIARRHOEA,487
BE,PYREXIA,448
BE,NAUSEA,419
BE,DECREASED APPETITE,388
BE,DYSPNOEA,376
BE,DRUG INEFFECTIVE,373
BE,OSTEONECROSIS OF JAW,373
BE,GENERAL PHYSICAL HEALTH DETERIORATION,361
BE,VOMITING,334
BE,FALL,317
BE,WEIGHT DECREASED,316
BE,PNEUMONIA,315
BE,ANAEMIA,311
BE,MALAISE,289
BE,HEADACHE,274
BE,ASTHENIA,273
BE,CONFUSIONAL STATE,256
BE,NEUTROPENIA,255
BE,ABDOMINAL PAIN,212
BE,MALIGNANT NEOPLASM PROGRESSION,209
BE,HYPERTENSION,208
BE,ACUTE KIDNEY INJURY,205
BE,TOXICITY TO VARIOUS AGENTS,204
BE,THROMBOCYTOPENIA,200
BE,RENAL FAILURE,197
BE,CEREBROVASCULAR ACCIDENT,193
BE,HYPOTENSION,192
BE,DISEASE PROGRESSION,189
BE,RASH,189
BE,PAIN,188
BE,CARDIAC FAILURE,181
BE,PULMONARY EMBOLISM,172
BE,ARTHRALGIA,168
BE,FEBRILE NEUTROPENIA,166
BE,BACK PAIN,159
BE,DIZZINESS,154
BE,GAIT DISTURBANCE,147
BE,DYSKINESIA,144
BE,PRURITUS,142
BE,SEPSIS,141
BE,URINARY TRACT INFECTION,138
BE,PAIN IN EXTREMITY,136
BE,CONSTIPATION,134
BE,DEHYDRATION,134
BE,MYALGIA,134
BE,DEPRESSION,133
BE,OEDEMA PERIPHERAL,132
BE,SOMNOLENCE,131
BE,PANCYTOPENIA,130
BE,ATRIAL FIBRILLATION,124
BE,RENAL IMPAIRMENT,124
BE,EPILEPSY,120
BE,BREAST CANCER,119
BE,SEPTIC SHOCK,117
BE,ANXIETY,116
BE,OVERDOSE,114
BE,PARAESTHESIA,113
BE,HAEMORRHAGE,112
BE,LOSS OF CONSCIOUSNESS,107
BE,MYOCARDIAL INFARCTION,107
BE,DEEP VEIN THROMBOSIS,106
BE,CARDIAC ARREST,105
BE,RESPIRATORY FAILURE,104
BE,AGITATION,103
BE,COUGH,103
BE,PRODUCT USE ISSUE,102
BE,ERYTHEMA,101
BE,CHEST PAIN,100
BE,EPISTAXIS,99
BE,PLEURAL EFFUSION,99
BE,TACHYCARDIA,95
BE,FOETAL EXPOSURE DURING PREGNANCY,94
BE,INFECTION,94
BE,ALOPECIA,93
BE,DYSPHAGIA,92
BE,RENAL FAILURE ACUTE,92
BE,HYPERSENSITIVITY,91
BE,CHILLS,89
BE,COMA,89
BE,SYNCOPE,89
BE,FREEZING PHENOMENON,87
BE,INSOMNIA,87
BE,HEPATIC FAILURE,86
BE,HYPOKALAEMIA,86
BE,ABDOMINAL PAIN UPPER,85
BE,HYPONATRAEMIA,85
BE,C-REACTIVE PROTEIN INCREASED,84
BE,CONDITION AGGRAVATED,84
BE,MUSCLE SPASMS,84
BE,TREMOR,84
BE,WEIGHT INCREASED,83
BE,STOMATITIS,82
BE,INFLUENZA LIKE ILLNESS,78
BE,LUNG INFECTION,78
BE,CEREBRAL HAEMORRHAGE,75
BE,HAEMOGLOBIN DECREASED,74
BE,HYPERHIDROSIS,74
BE,COGNITIVE DISORDER,73
BE,HYPOCALCAEMIA,73
BE,LEUKOPENIA,73
BE,ELECTROCARDIOGRAM QT PROLONGED,72
BE,ABORTION SPONTANEOUS,71
BE,DYSGEUSIA,71
BE,INCORRECT ROUTE OF DRUG ADMINISTRATION,71
BE,BALANCE DISORDER,70
BE,DRY MOUTH,70
BE,RESPIRATORY TRACT INFECTION,70
BE,TRANSIENT ISCHAEMIC ATTACK,70
BE,VERTIGO,70
BE,DEVICE DISLOCATION,69
BE,EXPOSURE DURING PREGNANCY,69
BE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,69
BE,MUSCULAR WEAKNESS,69
BE,BRADYCARDIA,68
BE,HOSPITALISATION,68
BE,METABOLIC ACIDOSIS,68
BE,PALPITATIONS,67
BE,HYPERGLYCAEMIA,66
BE,BRONCHITIS,65
BE,RHABDOMYOLYSIS,65
BE,MOBILITY DECREASED,64
BE,HYPOGLYCAEMIA,63
BE,MATERNAL EXPOSURE DURING PREGNANCY,63
BE,AGGRESSION,62
BE,CROHN^S DISEASE,62
BE,DYSPEPSIA,62
BE,FEELING ABNORMAL,62
BE,ON AND OFF PHENOMENON,62
BE,PSORIASIS,62
BE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,61
BE,GASTROINTESTINAL HAEMORRHAGE,60
BE,HAEMATOMA,60
BE,HIP FRACTURE,60
BE,ISCHAEMIC STROKE,60
BE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,60
BE,VISUAL IMPAIRMENT,60
BE,ALANINE AMINOTRANSFERASE INCREASED,59
BE,CYTOMEGALOVIRUS INFECTION,59
BE,HALLUCINATION,59
BE,INFLAMMATION,59
BE,POLYNEUROPATHY,59
BE,DISORIENTATION,58
BE,INTESTINAL OBSTRUCTION,58
BE,METASTASES TO LIVER,58
BE,PULMONARY OEDEMA,58
BE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,57
BE,GASTROINTESTINAL DISORDER,57
BE,METASTASES TO BONE,57
BE,ARRHYTHMIA,56
BE,INTERSTITIAL LUNG DISEASE,56
BE,LIVER FUNCTION TEST ABNORMAL,56
BE,CARDIAC DISORDER,55
BE,ENCEPHALOPATHY,55
BE,MULTIPLE SCLEROSIS RELAPSE,55
BE,ABDOMINAL DISTENSION,54
BE,DYSPHONIA,54
BE,HYPERKALAEMIA,54
BE,MUSCULOSKELETAL PAIN,54
BE,OEDEMA,54
BE,PANCREATITIS,54
BE,ASCITES,53
BE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,53
BE,SPEECH DISORDER,53
BE,STRESS,53
BE,VISUAL ACUITY REDUCED,53
BE,ASPARTATE AMINOTRANSFERASE INCREASED,52
BE,INTENTIONAL OVERDOSE,52
BE,DELIRIUM,51
BE,INCORRECT DOSE ADMINISTERED,51
BE,MUCOSAL INFLAMMATION,51
BE,ACUTE MYOCARDIAL INFARCTION,50
BE,ANGIOEDEMA,50
BE,DIABETES MELLITUS,50
BE,ANAPHYLACTIC SHOCK,48
BE,LUNG DISORDER,48
BE,PSYCHOTIC DISORDER,48
BE,SUDDEN DEATH,48
BE,ECZEMA,47
BE,HAEMATURIA,47
BE,HERPES ZOSTER,47
BE,NEUROPATHY PERIPHERAL,47
BE,MUSCULOSKELETAL STIFFNESS,46
BE,PERIPHERAL SWELLING,46
BE,PRODUCT USE IN UNAPPROVED INDICATION,46
BE,SHOCK,46
BE,HEPATITIS,45
BE,VISION BLURRED,45
BE,ACUTE RESPIRATORY DISTRESS SYNDROME,44
BE,BLOOD PRESSURE DECREASED,44
BE,PLATELET COUNT DECREASED,44
BE,SEDATION,44
BE,STAPHYLOCOCCAL INFECTION,44
BE,DEVICE OCCLUSION,43
BE,BLINDNESS,42
BE,CARDIOGENIC SHOCK,42
BE,CHEST DISCOMFORT,42
BE,COLITIS,42
BE,DRUG EFFECT INCOMPLETE,42
BE,MUSCLE RIGIDITY,42
BE,NASOPHARYNGITIS,42
BE,OROPHARYNGEAL PAIN,42
BE,PNEUMONITIS,42
BE,PROTEINURIA,42
BE,URTICARIA,42
BE,CATARACT,41
BE,DEPRESSED MOOD,41
BE,DRUG INTOLERANCE,41
BE,DRUG-INDUCED LIVER INJURY,41
BE,DYSPNOEA EXERTIONAL,41
BE,HYPOAESTHESIA,41
BE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,41
BE,MEMORY IMPAIRMENT,41
BE,MULTI-ORGAN FAILURE,41
BE,SUICIDE ATTEMPT,41
BE,THROMBOSIS,41
BE,TUBULOINTERSTITIAL NEPHRITIS,41
BE,URINARY RETENTION,41
BE,BRONCHOPULMONARY ASPERGILLOSIS,40
BE,ERYSIPELAS,40
BE,HYPOXIA,40
BE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,40
BE,AMNESIA,39
BE,CHOLESTASIS,39
BE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,39
BE,JAUNDICE,39
BE,OXYGEN SATURATION DECREASED,39
BE,STAPHYLOCOCCAL SEPSIS,39
BE,ANGINA PECTORIS,38
BE,APHASIA,38
BE,BLOOD CREATINE PHOSPHOKINASE INCREASED,38
BE,SINUSITIS,38
BE,ASPERGILLUS INFECTION,37
BE,BLOOD CREATININE INCREASED,37
BE,DISTURBANCE IN ATTENTION,37
BE,MENTAL DISORDER,37
BE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,37
BE,PLASMA CELL MYELOMA,37
BE,RESPIRATORY DISORDER,37
BE,SUICIDAL IDEATION,37
BE,TRANSAMINASES INCREASED,37
BE,WHITE BLOOD CELL COUNT DECREASED,37
BE,ASTHMA,36
BE,LYMPHADENOPATHY,36
BE,PALLOR,36
BE,ARTHRITIS,35
BE,BLOOD LACTATE DEHYDROGENASE INCREASED,35
BE,CELLULITIS,35
BE,CYSTITIS,35
BE,LUNG NEOPLASM MALIGNANT,35
BE,PANCREATIC CARCINOMA,35
BE,PULMONARY HYPERTENSION,35
BE,SLEEP DISORDER,35
BE,CENTRAL NERVOUS SYSTEM LESION,34
BE,CHOLELITHIASIS,34
BE,COMPLETED SUICIDE,34
BE,DRY SKIN,34
BE,DYSARTHRIA,34
BE,GASTROENTERITIS,34
BE,HEMIPLEGIA,34
BE,HEPATIC CIRRHOSIS,34
BE,HEPATIC ENZYME INCREASED,34
BE,LYMPHOCYTE COUNT DECREASED,34
BE,METASTASES TO LUNG,34
BE,NEPHROLITHIASIS,34
BE,OSTEONECROSIS,34
BE,PREMATURE BABY,34
BE,RECTAL HAEMORRHAGE,34
BE,RESPIRATORY DISTRESS,34
BE,BRONCHOSPASM,33
BE,HEPATOCELLULAR INJURY,33
BE,INJECTION SITE ERYTHEMA,33
BE,LACTIC ACIDOSIS,33
BE,MIGRAINE,33
BE,NECK PAIN,33
BE,NERVOUSNESS,33
BE,NEUROTOXICITY,33
BE,PERITONITIS,33
BE,PNEUMONIA ASPIRATION,33
BE,HEPATOTOXICITY,32
BE,HYPERTHYROIDISM,32
BE,LIMB DISCOMFORT,32
BE,NEOPLASM MALIGNANT,32
BE,STATUS EPILEPTICUS,32
BE,ABSCESS,31
BE,BLOOD BILIRUBIN INCREASED,31
BE,DEVICE RELATED INFECTION,31
BE,DIVERTICULITIS,31
BE,FEMUR FRACTURE,31
BE,HEPATITIS TOXIC,31
BE,INTENTIONAL PRODUCT USE ISSUE,31
BE,NEUTROPENIC SEPSIS,31
BE,RESTLESSNESS,31
BE,SEIZURE,31
BE,ABDOMINAL DISCOMFORT,30
BE,ATAXIA,30
BE,DRUG DOSE OMISSION,30
BE,ABNORMAL BEHAVIOUR,29
BE,BLISTER,29
BE,CARDIOVASCULAR DISORDER,29
BE,DISSEMINATED INTRAVASCULAR COAGULATION,29
BE,DRUG RESISTANCE,29
BE,HAEMATOCHEZIA,29
BE,HAEMORRHAGE INTRACRANIAL,29
BE,HEMIPARESIS,29
BE,HYPOTHERMIA,29
BE,LIVER DISORDER,29
BE,MALIGNANT MELANOMA,29
BE,POISONING,29
BE,PROSTATE CANCER,29
BE,RENAL CELL CARCINOMA,29
BE,SKIN LESION,29
BE,STOMA SITE DISCHARGE,29
BE,ANAPHYLACTIC REACTION,28
BE,APATHY,28
BE,BASAL CELL CARCINOMA,28
BE,BRONCHOPNEUMONIA,28
BE,EOSINOPHILIA,28
BE,INJECTION SITE PAIN,28
BE,JOINT SWELLING,28
BE,PERIPHERAL SENSORY NEUROPATHY,28
BE,THERAPEUTIC RESPONSE DECREASED,28
BE,UNDERDOSE,28
BE,UPPER RESPIRATORY TRACT INFECTION,28
BE,VENTRICULAR TACHYCARDIA,28
BE,ABORTION INDUCED,27
BE,ADVERSE EVENT,27
BE,BRAIN OEDEMA,27
BE,CONTUSION,27
BE,DEPRESSED LEVEL OF CONSCIOUSNESS,27
BE,DEVICE ISSUE,27
BE,DYSTONIA,27
BE,FEELING HOT,27
BE,HYPOMAGNESAEMIA,27
BE,LUNG INFILTRATION,27
BE,METASTASES TO CENTRAL NERVOUS SYSTEM,27
BE,PERICARDITIS,27
BE,PREGNANCY,27
BE,PRODUCTIVE COUGH,27
BE,STOMA SITE HYPERGRANULATION,27
BE,WOUND,27
BE,BLOOD ALKALINE PHOSPHATASE INCREASED,26
BE,COLITIS ULCERATIVE,26
BE,DEMENTIA,26
BE,DISEASE RECURRENCE,26
BE,DRUG HYPERSENSITIVITY,26
BE,EYE PAIN,26
BE,GASTROOESOPHAGEAL REFLUX DISEASE,26
BE,HEPATIC FUNCTION ABNORMAL,26
BE,HYPERVENTILATION,26
BE,INFLUENZA,26
BE,INFUSION RELATED REACTION,26
BE,MYDRIASIS,26
BE,NEURALGIA,26
BE,PERICARDIAL EFFUSION,26
BE,PRODUCT QUALITY ISSUE,26
BE,TINNITUS,26
BE,UNINTENDED PREGNANCY,26
BE,APHTHOUS ULCER,25
BE,BLOOD GLUCOSE INCREASED,25
BE,BONE PAIN,25
BE,DEAFNESS,25
BE,DISCOMFORT,25
BE,ESCHERICHIA URINARY TRACT INFECTION,25
BE,HEPATOCELLULAR CARCINOMA,25
BE,PAIN IN JAW,25
BE,UROSEPSIS,25
BE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,25
BE,ALTERED STATE OF CONSCIOUSNESS,24
BE,BONE MARROW FAILURE,24
BE,CACHEXIA,24
BE,CONVULSION,24
BE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,24
BE,EPSTEIN-BARR VIRUS INFECTION,24
BE,FACE OEDEMA,24
BE,HEART RATE INCREASED,24
BE,HYPERCALCAEMIA,24
BE,HYPOPHAGIA,24
BE,NO ADVERSE EVENT,24
BE,ORTHOSTATIC HYPOTENSION,24
BE,OSTEOARTHRITIS,24
BE,SALIVARY HYPERSECRETION,24
BE,SYSTEMIC LUPUS ERYTHEMATOSUS,24
BE,URINARY INCONTINENCE,24
BE,ACCIDENTAL OVERDOSE,23
BE,BLOOD PRESSURE INCREASED,23
BE,BURNING SENSATION,23
BE,CYTOPENIA,23
BE,DIFFUSE LARGE B-CELL LYMPHOMA,23
BE,FLUID RETENTION,23
BE,INFARCTION,23
BE,IRON DEFICIENCY ANAEMIA,23
BE,LYMPHOPENIA,23
BE,NERVOUS SYSTEM DISORDER,23
BE,NEUTROPHIL COUNT DECREASED,23
BE,PARALYSIS,23
BE,PARKINSON^S DISEASE,23
BE,SHOCK HAEMORRHAGIC,23
BE,SKIN REACTION,23
BE,SMALL INTESTINAL OBSTRUCTION,23
BE,TREATMENT FAILURE,23
BE,UVEITIS,23
BE,VIRAL INFECTION,23
BE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,23
BE,ACUTE MYELOID LEUKAEMIA,22
BE,COLON CANCER,22
BE,DRUG ADMINISTRATION ERROR,22
BE,DYSSTASIA,22
BE,EJECTION FRACTION DECREASED,22
BE,GASTRIC ULCER,22
BE,GASTRITIS,22
BE,MELAENA,22
BE,MYELODYSPLASTIC SYNDROME,22
BE,NEPHROPATHY TOXIC,22
BE,OESOPHAGITIS,22
BE,ROAD TRAFFIC ACCIDENT,22
BE,STOMA SITE ERYTHEMA,22
BE,STOMA SITE INFECTION,22
BE,TOOTHACHE,22
BE,TORSADE DE POINTES,22
BE,TRANSPLANT REJECTION,22
BE,CARDIO-RESPIRATORY ARREST,21
BE,CUSHING^S SYNDROME,21
BE,DEVICE ALARM ISSUE,21
BE,GENERALISED OEDEMA,21
BE,HYPOKINESIA,21
BE,KAPOSI^S SARCOMA,21
BE,LARGE INTESTINE PERFORATION,21
BE,MENTAL IMPAIRMENT,21
BE,MULTIPLE SCLEROSIS,21
BE,NEOPLASM PROGRESSION,21
BE,OSTEITIS,21
BE,POOR QUALITY SLEEP,21
BE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,21
BE,RENAL DISORDER,21
BE,RESPIRATORY DEPRESSION,21
BE,STUPOR,21
BE,SURGERY,21
BE,UPPER LIMB FRACTURE,21
BE,VENOOCCLUSIVE LIVER DISEASE,21
BE,ACUTE HEPATIC FAILURE,20
BE,CARDIOMYOPATHY,20
BE,ENTERITIS,20
BE,FLUSHING,20
BE,GASTRIC DISORDER,20
BE,HAEMATEMESIS,20
BE,HOT FLUSH,20
BE,IRRITABILITY,20
BE,LACRIMATION INCREASED,20
BE,MYOCLONUS,20
BE,NEPHROTIC SYNDROME,20
BE,OTOTOXICITY,20
BE,SPINAL FRACTURE,20
BE,SWELLING FACE,20
BE,TOOTH EXTRACTION,20
BE,VASCULITIS,20
BE,ABASIA,19
BE,ACUTE CORONARY SYNDROME,19
BE,CARDIOTOXICITY,19
BE,CHOLANGITIS,19
BE,CHRONIC KIDNEY DISEASE,19
BE,END STAGE RENAL DISEASE,19
BE,GASTROINTESTINAL INFLAMMATION,19
BE,GENERALISED TONIC-CLONIC SEIZURE,19
BE,HAEMOLYTIC ANAEMIA,19
BE,HEPATIC NECROSIS,19
BE,HEPATITIS C,19
BE,HEPATOMEGALY,19
BE,HYPERTHERMIA,19
BE,INTESTINAL PERFORATION,19
BE,LEUKOCYTOSIS,19
BE,MOUTH ULCERATION,19
BE,ORAL CANDIDIASIS,19
BE,PRURITUS GENERALISED,19
BE,RENAL TUBULAR NECROSIS,19
BE,RHINORRHOEA,19
BE,SEROTONIN SYNDROME,19
BE,SKIN ULCER,19
BE,SUBDURAL HAEMATOMA,19
BE,THROMBOTIC MICROANGIOPATHY,19
BE,ANURIA,18
BE,ARTHROPATHY,18
BE,BREAST CANCER METASTATIC,18
BE,CHOLECYSTITIS,18
BE,COAGULOPATHY,18
BE,DIPLOPIA,18
BE,DRY EYE,18
BE,EMBOLISM,18
BE,EYELID OEDEMA,18
BE,FAECALOMA,18
BE,FISTULA,18
BE,GASTROINTESTINAL INFECTION,18
BE,GLOMERULAR FILTRATION RATE DECREASED,18
BE,HALLUCINATION_ VISUAL,18
BE,HEPATIC STEATOSIS,18
BE,HYPERLACTACIDAEMIA,18
BE,HYPOTHYROIDISM,18
BE,INTESTINAL ISCHAEMIA,18
BE,MOVEMENT DISORDER,18
BE,NIGHT SWEATS,18
BE,PANCREATITIS ACUTE,18
BE,PARANOIA,18
BE,PHOTOPHOBIA,18
BE,PNEUMOCYSTIS JIROVECII PNEUMONIA,18
BE,PREMATURE DELIVERY,18
BE,PULMONARY FIBROSIS,18
BE,RETINAL DETACHMENT,18
BE,SKIN TOXICITY,18
BE,SWELLING,18
BE,VAGINAL HAEMORRHAGE,18
BE,WOUND INFECTION,18
BE,ACUTE PULMONARY OEDEMA,17
BE,DECUBITUS ULCER,17
BE,DYSURIA,17
BE,EMOTIONAL DISORDER,17
BE,ENDOCARDITIS,17
BE,GASTRIC HAEMORRHAGE,17
BE,GASTROINTESTINAL PAIN,17
BE,HAEMARTHROSIS,17
BE,KERATITIS,17
BE,LEFT VENTRICULAR DYSFUNCTION,17
BE,LOCAL SWELLING,17
BE,LYMPHOMA,17
BE,MITRAL VALVE INCOMPETENCE,17
BE,NASAL CONGESTION,17
BE,PLEURISY,17
BE,PREGNANCY WITH CONTRACEPTIVE DEVICE,17
BE,PRESCRIBED UNDERDOSE,17
BE,RASH ERYTHEMATOUS,17
BE,RASH MACULO-PAPULAR,17
BE,RHEUMATOID ARTHRITIS,17
BE,SINUS BRADYCARDIA,17
BE,SPLENOMEGALY,17
BE,SQUAMOUS CELL CARCINOMA OF SKIN,17
BE,TOOTH DISORDER,17
BE,TOXIC EPIDERMAL NECROLYSIS,17
BE,UNEVALUABLE EVENT,17
BE,WITHDRAWAL SYNDROME,17
BE,ANAL FISSURE,16
BE,BODY TEMPERATURE INCREASED,16
BE,CARDIOPULMONARY FAILURE,16
BE,CHROMATURIA,16
BE,DERMATITIS,16
BE,DERMATITIS ALLERGIC,16
BE,DRUG EFFECT DECREASED,16
BE,EXTRAPYRAMIDAL DISORDER,16
BE,HEPATIC ENCEPHALOPATHY,16
BE,HYPERBILIRUBINAEMIA,16
BE,HYPOVOLAEMIC SHOCK,16
BE,ILEUS PARALYTIC,16
BE,INCREASED APPETITE,16
BE,LUPUS-LIKE SYNDROME,16
BE,MALNUTRITION,16
BE,NON-HODGKIN^S LYMPHOMA,16
BE,OPTIC NEURITIS,16
BE,OSTEOPOROSIS,16
BE,PHARYNGITIS,16
BE,PRESCRIBED OVERDOSE,16
BE,PRESYNCOPE,16
BE,PSEUDOMONAS INFECTION,16
BE,TOXIC SKIN ERUPTION,16
BE,TREATMENT NONCOMPLIANCE,16
BE,TUBERCULOSIS,16
BE,WHITE BLOOD CELL COUNT INCREASED,16
BE,ACTIVITIES OF DAILY LIVING IMPAIRED,15
BE,AGEUSIA,15
BE,ANAL ABSCESS,15
BE,APPENDICITIS,15
BE,ASPHYXIA,15
BE,BEDRIDDEN,15
BE,BLOOD CHOLESTEROL INCREASED,15
BE,BONE MARROW TOXICITY,15
BE,BREAST PAIN,15
BE,CANDIDA INFECTION,15
BE,DISTRIBUTIVE SHOCK,15
BE,FEELING COLD,15
BE,FEMORAL NECK FRACTURE,15
BE,HAEMORRHOIDS,15
BE,HYDRONEPHROSIS,15
BE,HYPERNATRAEMIA,15
BE,HYPERSOMNIA,15
BE,HYPOALBUMINAEMIA,15
BE,INTERVERTEBRAL DISC PROTRUSION,15
BE,NECROSIS,15
BE,NEUROLEPTIC MALIGNANT SYNDROME,15
BE,PNEUMOTHORAX,15
BE,PORTAL HYPERTENSION,15
BE,PULMONARY HAEMORRHAGE,15
BE,RASH GENERALISED,15
BE,RASH PRURITIC,15
BE,RED BLOOD CELL COUNT DECREASED,15
BE,RIB FRACTURE,15
BE,SINUS TACHYCARDIA,15
BE,STOMA SITE PAIN,15
BE,SWOLLEN TONGUE,15
BE,TOOTH ABSCESS,15
BE,ACNE,14
BE,ATRIOVENTRICULAR BLOCK,14
BE,BURSITIS,14
BE,CARDIAC FAILURE ACUTE,14
BE,CIRCULATORY COLLAPSE,14
BE,COMPLICATION OF DEVICE INSERTION,14
BE,DELUSION,14
BE,DRUG ABUSE,14
BE,ENCEPHALITIS,14
BE,FEAR,14
BE,FUNGAL INFECTION,14
BE,GUILLAIN-BARRE SYNDROME,14
BE,HAEMOPTYSIS,14
BE,HEART RATE DECREASED,14
BE,HYDROCEPHALUS,14
BE,HYPERCHOLESTEROLAEMIA,14
BE,IMPAIRED HEALING,14
BE,INTERNATIONAL NORMALISED RATIO INCREASED,14
BE,LIPASE INCREASED,14
BE,LYMPHANGITIS,14
BE,MACULAR DEGENERATION,14
BE,MEDICATION ERROR,14
BE,MENTAL STATUS CHANGES,14
BE,MOOD SWINGS,14
BE,MOTOR DYSFUNCTION,14
BE,MYOCARDIAL ISCHAEMIA,14
BE,NODULAR REGENERATIVE HYPERPLASIA,14
BE,OCULAR HYPERAEMIA,14
BE,PANIC ATTACK,14
BE,PREGNANCY ON CONTRACEPTIVE,14
BE,PROSTATIC SPECIFIC ANTIGEN INCREASED,14
BE,SCIATICA,14
BE,SENSORY DISTURBANCE,14
BE,SERUM FERRITIN INCREASED,14
BE,SUBCLAVIAN VEIN THROMBOSIS,14
BE,SUBCUTANEOUS ABSCESS,14
BE,TENDONITIS,14
BE,TERMINAL STATE,14
BE,ABDOMINAL PAIN LOWER,13
BE,ADENOCARCINOMA OF COLON,13
BE,AKATHISIA,13
BE,APHTHOUS STOMATITIS,13
BE,ATRIAL THROMBOSIS,13
BE,AUTISM,13
BE,BLOOD LACTIC ACID INCREASED,13
BE,COLITIS ISCHAEMIC,13
BE,CYTOKINE RELEASE SYNDROME,13
BE,DEVICE CONNECTION ISSUE,13
BE,ECCHYMOSIS,13
BE,ERYTHEMA MULTIFORME,13
BE,ESCHERICHIA SEPSIS,13
BE,EYE DISORDER,13
BE,FOOD ALLERGY,13
BE,IMMUNE THROMBOCYTOPENIC PURPURA,13
BE,INTENTIONAL PRODUCT MISUSE,13
BE,INTERVERTEBRAL DISCITIS,13
BE,LIMB INJURY,13
BE,LOSS OF LIBIDO,13
BE,METASTASES TO LYMPH NODES,13
BE,MUSCLE HAEMORRHAGE,13
BE,NEPHROPATHY,13
BE,NYSTAGMUS,13
BE,OESOPHAGEAL CARCINOMA,13
BE,OESOPHAGEAL ULCER,13
BE,POLYARTHRITIS,13
BE,POLYURIA,13
BE,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,13
BE,PSYCHIATRIC DECOMPENSATION,13
BE,PULMONARY MASS,13
BE,PYELONEPHRITIS,13
BE,RENAL COLIC,13
BE,SKIN DISCOLOURATION,13
BE,SUBARACHNOID HAEMORRHAGE,13
BE,THERAPEUTIC REACTION TIME DECREASED,13
BE,THORACIC VERTEBRAL FRACTURE,13
BE,TRANSFUSION,13
BE,TYPE 2 DIABETES MELLITUS,13
BE,VENTRICULAR EXTRASYSTOLES,13
BE,VENTRICULAR FIBRILLATION,13
BE,ACCIDENTAL EXPOSURE TO PRODUCT,12
BE,ACUTE RESPIRATORY FAILURE,12
BE,ADENOVIRAL HEPATITIS,12
BE,AMENORRHOEA,12
BE,CONCOMITANT DISEASE PROGRESSION,12
BE,CONJUNCTIVITIS,12
BE,DERMATITIS BULLOUS,12
BE,DEVICE DIFFICULT TO USE,12
BE,DIABETES MELLITUS INADEQUATE CONTROL,12
BE,DRUG LEVEL INCREASED,12
BE,DRUG WITHDRAWAL SYNDROME,12
BE,EATING DISORDER,12
BE,ESCHERICHIA INFECTION,12
BE,EYE HAEMORRHAGE,12
BE,FAECES DISCOLOURED,12
BE,FRACTURE,12
BE,HAEMOTHORAX,12
BE,HEPATITIS FULMINANT,12
BE,HISTIOCYTOSIS HAEMATOPHAGIC,12
BE,INCORRECT DRUG ADMINISTRATION DURATION,12
BE,JOINT DISLOCATION,12
BE,LUNG ADENOCARCINOMA,12
BE,METASTASIS,12
BE,MOOD ALTERED,12
BE,MUSCLE SPASTICITY,12
BE,MYOCARDITIS,12
BE,NORMOCHROMIC NORMOCYTIC ANAEMIA,12
BE,OLIGURIA,12
BE,ORAL PAIN,12
BE,OSTEOMYELITIS,12
BE,PAIN OF SKIN,12
BE,PETIT MAL EPILEPSY,12
BE,POLLAKIURIA,12
BE,PROCEDURAL PAIN,12
BE,PURPURA,12
BE,PURULENT DISCHARGE,12
BE,SECOND PRIMARY MALIGNANCY,12
BE,SKIN DISORDER,12
BE,SLEEP APNOEA SYNDROME,12
BE,STEVENS-JOHNSON SYNDROME,12
BE,TENDON RUPTURE,12
BE,THROMBOSIS IN DEVICE,12
BE,UNRESPONSIVE TO STIMULI,12
BE,WHEEZING,12
BE,ACCIDENTAL POISONING,11
BE,ADRENAL INSUFFICIENCY,11
BE,AORTIC DISSECTION,11
BE,ARTERIOSCLEROSIS,11
BE,BLADDER DISORDER,11
BE,BLOOD ALBUMIN DECREASED,11
BE,BLOOD URINE PRESENT,11
BE,BRUGADA SYNDROME,11
BE,CARDIOMEGALY,11
BE,CARPAL TUNNEL SYNDROME,11
BE,CLOSTRIDIUM DIFFICILE INFECTION,11
BE,CONTRAINDICATED PRODUCT ADMINISTERED,11
BE,DEVICE EXPULSION,11
BE,DYSAESTHESIA,11
BE,EXCESSIVE GRANULATION TISSUE,11
BE,EYE SWELLING,11
BE,FIBRIN D DIMER INCREASED,11
BE,GINGIVAL BLEEDING,11
BE,GLOSSODYNIA,11
BE,GRAFT VERSUS HOST DISEASE,11
BE,HAEMATOTOXICITY,11
BE,HAEMODYNAMIC INSTABILITY,11
BE,HAEMOLYTIC URAEMIC SYNDROME,11
BE,HEAD INJURY,11
BE,HICCUPS,11
BE,HYPOPHOSPHATAEMIA,11
BE,ILL-DEFINED DISORDER,11
BE,INJECTION SITE INDURATION,11
BE,INVASIVE DUCTAL BREAST CARCINOMA,11
BE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,11
BE,LETHARGY,11
BE,LIP SWELLING,11
BE,LIVER FUNCTION TEST INCREASED,11
BE,MENINGIOMA,11
BE,MENINGITIS,11
BE,MENORRHAGIA,11
BE,METASTASES TO PERITONEUM,11
BE,METRORRHAGIA,11
BE,MYCOBACTERIUM AVIUM COMPLEX INFECTION,11
BE,NEOPLASM,11
BE,NEPHROGENIC DIABETES INSIPIDUS,11
BE,NEUROLOGICAL DECOMPENSATION,11
BE,OCULAR ICTERUS,11
BE,PHARYNGEAL OEDEMA,11
BE,POST PROCEDURAL HAEMORRHAGE,11
BE,PYURIA,11
BE,SKIN EXFOLIATION,11
BE,SKIN INFECTION,11
BE,SKIN IRRITATION,11
BE,TRICUSPID VALVE INCOMPETENCE,11
BE,TUMOUR LYSIS SYNDROME,11
BE,TUMOUR NECROSIS,11
BE,VASOPLEGIA SYNDROME,11
BE,VITAMIN D DEFICIENCY,11
BE,ABNORMAL FAECES,10
BE,ABSCESS JAW,10
BE,ADENOCARCINOMA PANCREAS,10
BE,ANKYLOSING SPONDYLITIS,10
BE,ATELECTASIS,10
BE,ATRIAL FLUTTER,10
BE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,10
BE,AUTONOMIC NEUROPATHY,10
BE,BLOOD TEST ABNORMAL,10
BE,BONE DISORDER,10
BE,BUNDLE BRANCH BLOCK LEFT,10
BE,CALCULUS URINARY,10
BE,CEREBRAL INFARCTION,10
BE,CHOLECYSTITIS ACUTE,10
BE,CORONARY ARTERY DISEASE,10
BE,CORONARY ARTERY STENOSIS,10
BE,CREATININE RENAL CLEARANCE DECREASED,10
BE,DEVICE DEPLOYMENT ISSUE,10
BE,DEVICE RELATED SEPSIS,10
BE,DIARRHOEA HAEMORRHAGIC,10
BE,DRUG PRESCRIBING ERROR,10
BE,DUODENAL ULCER,10
BE,ENTEROCOCCAL INFECTION,10
BE,GASTROINTESTINAL TOXICITY,10
BE,GINGIVITIS,10
BE,GOUT,10
BE,GRANULOMA,10
BE,HIATUS HERNIA,10
BE,HUMERUS FRACTURE,10
BE,HYPERAMMONAEMIC ENCEPHALOPATHY,10
BE,HYPERSENSITIVITY VASCULITIS,10
BE,INJECTION SITE REACTION,10
BE,INJECTION SITE SWELLING,10
BE,INJURY,10
BE,INTESTINAL HAEMORRHAGE,10
BE,IRIS TRANSILLUMINATION DEFECT,10
BE,KETOACIDOSIS,10
BE,MALABSORPTION,10
BE,MONOPARESIS,10
BE,MUSCLE RUPTURE,10
BE,MYOPATHY,10
BE,NAIL DISORDER,10
BE,PHOTOSENSITIVITY REACTION,10
BE,PLATELET COUNT INCREASED,10
BE,PNEUMONIA PSEUDOMONAL,10
BE,POST PROCEDURAL COMPLICATION,10
BE,PULMONARY TOXICITY,10
BE,RHINITIS,10
BE,RIGHT VENTRICULAR FAILURE,10
BE,SENSORY LOSS,10
BE,SKIN NECROSIS,10
BE,SPINAL COMPRESSION FRACTURE,10
BE,SPLENIC RUPTURE,10
BE,SQUAMOUS CELL CARCINOMA,10
BE,STOMA SITE EXTRAVASATION,10
BE,STRESS CARDIOMYOPATHY,10
BE,SUPRAVENTRICULAR TACHYCARDIA,10
BE,THERAPY NON-RESPONDER,10
BE,THROMBOTIC THROMBOCYTOPENIC PURPURA,10
BE,TOXIC ENCEPHALOPATHY,10
BE,VAGINAL INFECTION,10
BE,VIITH NERVE PARALYSIS,10
BE,YELLOW SKIN,10
BE,AMYLOIDOSIS,9
BE,ANGINA UNSTABLE,9
BE,ANKLE FRACTURE,9
BE,AUTOIMMUNE HAEMOLYTIC ANAEMIA,9
BE,AUTOIMMUNE HEPATITIS,9
BE,BACK DISORDER,9
BE,BACTERIAL SEPSIS,9
BE,BLINDNESS UNILATERAL,9
BE,BLOOD POTASSIUM INCREASED,9
BE,CAPILLARY LEAK SYNDROME,9
BE,CERVICAL DYSPLASIA,9
BE,CHOLANGIOCARCINOMA,9
BE,DERMATITIS EXFOLIATIVE,9
BE,DEVICE FAILURE,9
BE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,9
BE,DRUG DEPENDENCE,9
BE,EMPHYSEMA,9
BE,ERECTILE DYSFUNCTION,9
BE,EYE IRRITATION,9
BE,FOETAL ANTICONVULSANT SYNDROME,9
BE,GASTROINTESTINAL STROMAL TUMOUR,9
BE,GINGIVAL PAIN,9
BE,GLIOBLASTOMA,9
BE,HAEMORRHAGIC STROKE,9
BE,HERPES VIRUS INFECTION,9
BE,HIP ARTHROPLASTY,9
BE,HYPERAMMONAEMIA,9
BE,HYPERTONIA,9
BE,HYPOGLYCAEMIC COMA,9
BE,HYPOTONIA,9
BE,ILEUS,9
BE,IMMUNE-MEDIATED NECROTISING MYOPATHY,9
BE,INGUINAL HERNIA,9
BE,INTENTIONAL DRUG MISUSE,9
BE,INTRAOCULAR PRESSURE INCREASED,9
BE,KERATOPATHY,9
BE,KNEE ARTHROPLASTY,9
BE,LOCALISED INFECTION,9
BE,MANIA,9
BE,MICROCYTIC ANAEMIA,9
BE,MONOCYTE COUNT INCREASED,9
BE,MULTIPLE FRACTURES,9
BE,MYOSITIS,9
BE,ORAL HERPES,9
BE,ORTHOPNOEA,9
BE,OSTEOPENIA,9
BE,PAPILLOEDEMA,9
BE,PATHOGEN RESISTANCE,9
BE,PEMPHIGOID,9
BE,PERIODONTITIS,9
BE,PERITONEAL HAEMORRHAGE,9
BE,PHLEBITIS,9
BE,POST-INJECTION DELIRIUM SEDATION SYNDROME,9
BE,PSEUDOMONAL SEPSIS,9
BE,PSYCHOMOTOR HYPERACTIVITY,9
BE,RASH MACULAR,9
BE,RENAL INFARCT,9
BE,RENAL PAIN,9
BE,RESTLESS LEGS SYNDROME,9
BE,RETINAL DEGENERATION,9
BE,ROTATOR CUFF SYNDROME,9
BE,SARCOIDOSIS,9
BE,SKIN ATROPHY,9
BE,SOMATIC DELUSION,9
BE,SUPERIOR VENA CAVA SYNDROME,9
BE,SYSTEMIC CANDIDA,9
BE,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,9
BE,TENOSYNOVITIS,9
BE,THERAPEUTIC RESPONSE UNEXPECTED,9
BE,THIRST,9
BE,UNINTENTIONAL MEDICAL DEVICE REMOVAL,9
BE,VARICOSE VEIN,9
BE,WOUND SECRETION,9
BE,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,8
BE,ANAL HAEMORRHAGE,8
BE,ANGER,8
BE,APNOEA,8
BE,ARTHRITIS BACTERIAL,8
BE,ATRIOVENTRICULAR BLOCK COMPLETE,8
BE,BLOOD UREA INCREASED,8
BE,BRAIN NEOPLASM,8
BE,CEREBRAL HAEMATOMA,8
BE,CERVIX CARCINOMA RECURRENT,8
BE,CHRONIC LYMPHOCYTIC LEUKAEMIA,8
BE,CONCOMITANT DISEASE AGGRAVATED,8
BE,CONGESTIVE CARDIOMYOPATHY,8
BE,DERMATITIS ACNEIFORM,8
BE,DISINHIBITION,8
BE,DIVERTICULUM,8
BE,DRUG DISPENSING ERROR,8
BE,DRUG SPECIFIC ANTIBODY PRESENT,8
BE,DYSMORPHISM,8
BE,EAR MALFORMATION,8
BE,EAR PAIN,8
BE,EXPOSED BONE IN JAW,8
BE,EXTRASYSTOLES,8
BE,FOLLICULITIS,8
BE,FOOT FRACTURE,8
BE,FUNGAEMIA,8
BE,GASTROINTESTINAL NECROSIS,8
BE,HEART RATE IRREGULAR,8
BE,HEPATIC ENZYME ABNORMAL,8
BE,HEPATIC LESION,8
BE,HYPERKERATOSIS,8
BE,HYPERPARATHYROIDISM SECONDARY,8
BE,HYPOVOLAEMIA,8
BE,IMMUNODEFICIENCY,8
BE,IMPAIRED GASTRIC EMPTYING,8
BE,INCONTINENCE,8
BE,INJECTION SITE HAEMATOMA,8
BE,INJECTION SITE NODULE,8
BE,INJECTION SITE PRURITUS,8
BE,KIDNEY TRANSPLANT REJECTION,8
BE,LEUKAEMIA,8
BE,LOCALISED OEDEMA,8
BE,LONG QT SYNDROME,8
BE,LOWER GASTROINTESTINAL HAEMORRHAGE,8
BE,LUNG ABSCESS,8
BE,MACULAR OEDEMA,8
BE,METASTASES TO MENINGES,8
BE,MOUTH HAEMORRHAGE,8
BE,MUSCLE TIGHTNESS,8
BE,MYELOFIBROSIS,8
BE,OBESITY,8
BE,ODYNOPHAGIA,8
BE,OVARIAN CANCER,8
BE,PARESIS,8
BE,PREMATURE LABOUR,8
BE,PROCTALGIA,8
BE,PROSTATITIS,8
BE,PULMONARY ALVEOLAR HAEMORRHAGE,8
BE,PYODERMA GANGRENOSUM,8
BE,RALES,8
BE,RASH PAPULAR,8
BE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,8
BE,RESPIRATORY ARREST,8
BE,RHEUMATIC DISORDER,8
BE,SCAR,8
BE,SINUSITIS BACTERIAL,8
BE,SKIN FISSURES,8
BE,SPEECH DISORDER DEVELOPMENTAL,8
BE,SPINAL PAIN,8
BE,SYNOVITIS,8
BE,TACHYPNOEA,8
BE,THERAPY CESSATION,8
BE,TONSILLITIS,8
BE,TOOTH FRACTURE,8
BE,TOOTH INFECTION,8
BE,TRISOMY 18,8
BE,ULCERATIVE KERATITIS,8
BE,VARICES OESOPHAGEAL,8
BE,VASCULAR PSEUDOANEURYSM,8
BE,WHITE BLOOD CELL DISORDER,8
BE,WOUND DEHISCENCE,8
BE,ABDOMINAL ABSCESS,7
BE,ACUTE ABDOMEN,7
BE,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,7
BE,ADENOCARCINOMA,7
BE,AGRANULOCYTOSIS,7
BE,ANAL FISTULA,7
BE,ANGLE CLOSURE GLAUCOMA,7
BZ,BLOOD CALCIUM INCREASED,1
BZ,BLOOD POTASSIUM DECREASED,1
BZ,DEHYDRATION,1
BZ,DEVICE KINK,1
BZ,DISABILITY,1
BZ,DIZZINESS,1
BZ,DRY EYE,1
BZ,ELECTROLYTE IMBALANCE,1
BZ,FACIAL PARALYSIS,1
BZ,FEELING ABNORMAL,1
BZ,HYPERNATRAEMIA,1
BZ,HYPERTENSION,1
BZ,LACRIMATION INCREASED,1
BZ,MIGRAINE,1
BZ,PAIN IN EXTREMITY,1
BZ,PARAESTHESIA,1
BZ,PREGNANCY,1
BZ,PRURITUS GENERALISED,1
BZ,SEPSIS,1
BZ,STATUS EPILEPTICUS,1
BZ,TOOTHACHE,1
BZ,URTICARIA,1
BJ,DEATH,11
BJ,EXPOSURE DURING PREGNANCY,4
BJ,DIARRHOEA,3
BJ,DIZZINESS,3
BJ,FATIGUE,3
BJ,INSOMNIA,3
BJ,NAUSEA,3
BJ,NIGHTMARE,3
BJ,PAIN,3
BJ,SOMNOLENCE,3
BJ,VOMITING,3
BJ,ABORTION,2
BJ,DRUG RESISTANCE,2
BJ,STILLBIRTH,2
BJ,AGRANULOCYTOSIS,1
BJ,ASTHENIA,1
BJ,CARDIAC ARREST,1
BJ,CEREBRAL HAEMORRHAGE,1
BJ,CYTOPENIA,1
BJ,DRUG INEFFECTIVE,1
BJ,GENERAL PHYSICAL HEALTH DETERIORATION,1
BJ,HAEMOGLOBIN DECREASED,1
BJ,HEADACHE,1
BJ,HIV TEST POSITIVE,1
BJ,MALARIA,1
BJ,MATERNAL EXPOSURE DURING PREGNANCY,1
BJ,MENINGITIS,1
BJ,MENINGORRHAGIA,1
BJ,OSTEOARTHRITIS,1
BJ,PANCYTOPENIA,1
BJ,PNEUMONIA,1
BJ,PYREXIA,1
BJ,RESPIRATORY DISTRESS,1
BJ,STEVENS-JOHNSON SYNDROME,1
BJ,THERAPY NON-RESPONDER,1
BJ,THROMBOCYTOPENIA,1
BJ,TONSILLITIS,1
BJ,TREATMENT FAILURE,1
BJ,WHITE BLOOD CELL COUNT INCREASED,1
BM,DEEP VEIN THROMBOSIS,2
BM,ACUTE KIDNEY INJURY,1
BM,AGITATION,1
BM,ATAXIA,1
BM,BACTERIAL INFECTION,1
BM,BLOOD PRESSURE INCREASED,1
BM,CEREBROVASCULAR ACCIDENT,1
BM,DEATH,1
BM,DRUG DOSE OMISSION,1
BM,DRUG INEFFECTIVE,1
BM,DRUG RESISTANCE,1
BM,EPISTAXIS,1
BM,FALL,1
BM,FOETAL HEART RATE DECELERATION ABNORMALITY,1
BM,HAEMOPTYSIS,1
BM,HAEMORRHAGIC STROKE,1
BM,HEART RATE INCREASED,1
BM,HEMIPLEGIA,1
BM,INCORRECT DOSE ADMINISTERED,1
BM,INJECTION SITE ABSCESS,1
BM,INJECTION SITE ERYTHEMA,1
BM,INJECTION SITE SCAR,1
BM,INJECTION SITE SWELLING,1
BM,LOSS OF CONSCIOUSNESS,1
BM,MUSCLE TWITCHING,1
BM,NASAL DRYNESS,1
BM,NEPHROLITHIASIS,1
BM,ORAL DISORDER,1
BM,PATHOGEN RESISTANCE,1
BM,RESTLESSNESS,1
BM,TOOTH DISORDER,1
BM,TREATMENT FAILURE,1
BM,VOMITING,1
BT,DEATH,3
BT,GENERAL PHYSICAL HEALTH DETERIORATION,1
BO,DEATH,34
BO,GENERAL PHYSICAL HEALTH DETERIORATION,12
BO,MALIGNANT NEOPLASM PROGRESSION,10
BO,LEUKOCYTOSIS,9
BO,ANAEMIA,8
BO,CHRONIC MYELOID LEUKAEMIA,8
BO,THROMBOCYTOPENIA,8
BO,WHITE BLOOD CELL COUNT INCREASED,8
BO,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,6
BO,HAEMOGLOBIN DECREASED,6
BO,PYREXIA,6
BO,SEPSIS,6
BO,ASTHENIA,5
BO,CEREBRAL HAEMORRHAGE,5
BO,DIARRHOEA,5
BO,INFECTION,5
BO,PLATELET COUNT INCREASED,5
BO,DRUG INTOLERANCE,4
BO,HAEMORRHAGE,4
BO,HEADACHE,4
BO,MALAISE,4
BO,NEUTROPENIA,4
BO,PLATELET COUNT DECREASED,4
BO,VOMITING,4
BO,ABASIA,3
BO,BONE PAIN,3
BO,CHEST PAIN,3
BO,DRUG RESISTANCE,3
BO,GASTROINTESTINAL STROMAL TUMOUR,3
BO,LOSS OF CONSCIOUSNESS,3
BO,METASTASES TO LIVER,3
BO,PAIN,3
BO,PANCYTOPENIA,3
BO,RESPIRATORY FAILURE,3
BO,SECOND PRIMARY MALIGNANCY,3
BO,ACUTE LYMPHOCYTIC LEUKAEMIA,2
BO,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,2
BO,ARTHRALGIA,2
BO,BLINDNESS,2
BO,CARDIAC FAILURE,2
BO,CARDIO-RESPIRATORY ARREST,2
BO,CENTRAL NERVOUS SYSTEM LEUKAEMIA,2
BO,DISEASE COMPLICATION,2
BO,DIZZINESS,2
BO,DRUG INEFFECTIVE,2
BO,FALL,2
BO,FATIGUE,2
BO,FEELING ABNORMAL,2
BO,GASTROINTESTINAL INFECTION,2
BO,HYPOAESTHESIA,2
BO,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
BO,INJURY,2
BO,LEUKAEMIA RECURRENT,2
BO,LEUKOPENIA,2
BO,MATERNAL EXPOSURE DURING PREGNANCY,2
BO,NAUSEA,2
BO,PAIN IN EXTREMITY,2
BO,PANCREATIC CARCINOMA,2
BO,PLEURAL EFFUSION,2
BO,PNEUMONIA,2
BO,PULMONARY FIBROSIS,2
BO,PULMONARY OEDEMA,2
BO,ROAD TRAFFIC ACCIDENT,2
BO,SPLENOMEGALY,2
BO,SYNCOPE,2
BO,TUBERCULOSIS,2
BO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
BO,ABDOMINAL DISCOMFORT,1
BO,ABDOMINAL NEOPLASM,1
BO,ABDOMINAL PAIN UPPER,1
BO,ABORTION SPONTANEOUS,1
BO,ABSCESS LIMB,1
BO,ACCIDENTAL DEATH,1
BO,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
BO,ACUTE KIDNEY INJURY,1
BO,ACUTE MYOCARDIAL INFARCTION,1
BO,ACUTE RESPIRATORY FAILURE,1
BO,ADENOMYOSIS,1
BO,AGGRESSION,1
BO,ALOPECIA,1
BO,AMERICAN TRYPANOSOMIASIS,1
BO,ANXIETY,1
BO,APHASIA,1
BO,APLASIA,1
BO,APLASTIC ANAEMIA,1
BO,APPENDICITIS,1
BO,ARRHYTHMIA,1
BO,ATRIAL FIBRILLATION,1
BO,BACK PAIN,1
BO,BLAST CELL CRISIS,1
BO,BLOOD CHOLESTEROL INCREASED,1
BO,BLOOD DISORDER,1
BO,BLOOD GLUCOSE INCREASED,1
BO,BLOOD LACTATE DEHYDROGENASE INCREASED,1
BO,BLOOD TRIGLYCERIDES INCREASED,1
BO,BONE DENSITY DECREASED,1
BO,BONE MARROW FAILURE,1
BO,BRAIN NEOPLASM BENIGN,1
BO,BREAST CANCER METASTATIC,1
BO,CACHEXIA,1
BO,CALCINOSIS,1
BO,CARDIAC DISORDER,1
BO,CARDIOMEGALY,1
BO,CARTILAGE ATROPHY,1
BO,CELLULITIS,1
BO,CHILLS,1
BO,CHLOROMA,1
BO,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
BO,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
BO,COMA,1
BO,COMPLETED SUICIDE,1
BO,CONDITION AGGRAVATED,1
BO,DECREASED IMMUNE RESPONSIVENESS,1
BO,DEEP VEIN THROMBOSIS,1
BO,DEHYDRATION,1
BO,DEVELOPMENTAL HIP DYSPLASIA,1
BO,DIABETES MELLITUS,1
BO,DIABETES MELLITUS INADEQUATE CONTROL,1
BO,DIABETIC COMPLICATION,1
BO,DISSEMINATED INTRAVASCULAR COAGULATION,1
BO,DOLICHOCOLON,1
BO,EPSTEIN-BARR VIRUS INFECTION,1
BO,EXPOSURE DURING PREGNANCY,1
BO,FAECALOMA,1
BO,FAECES DISCOLOURED,1
BO,FEBRILE NEUTROPENIA,1
BO,FOETAL EXPOSURE DURING PREGNANCY,1
BO,FOOD INTOLERANCE,1
BO,FULL BLOOD COUNT INCREASED,1
BO,FUNGAL INFECTION,1
BO,GASTROINTESTINAL DISORDER,1
BO,GASTROINTESTINAL HAEMORRHAGE,1
BO,GASTROINTESTINAL VIRAL INFECTION,1
BO,GINGIVAL BLEEDING,1
BO,HAEMATOCHEZIA,1
BO,HAEMATOCRIT DECREASED,1
BO,HAEMATOLOGY TEST ABNORMAL,1
BO,HAEMATURIA,1
BO,HAEMOGLOBINURIA,1
BO,HAEMORRHAGE INTRACRANIAL,1
BO,HEAD INJURY,1
BO,HEPATIC FAILURE,1
BO,HEPATIC STEATOSIS,1
BO,HEPATOBILIARY DISEASE,1
BO,HERNIA,1
BO,HYPERLEUKOCYTOSIS,1
BO,HYPERTENSION,1
BO,HYPERTENSIVE CRISIS,1
BO,HYPERTHYROIDISM,1
BO,HYPOFIBRINOGENAEMIA,1
BO,HYPOPHAGIA,1
BO,HYPOPROTEINAEMIA,1
BO,HYPOVOLAEMIC SHOCK,1
BO,HYPOXIA,1
BO,IMMUNOSUPPRESSION,1
BO,INFARCTION,1
BO,INSOMNIA,1
BO,INTERMITTENT CLAUDICATION,1
BO,INTERSTITIAL LUNG DISEASE,1
BO,INTESTINAL OBSTRUCTION,1
BO,INTESTINAL PERFORATION,1
BO,IRRITABLE BOWEL SYNDROME,1
BO,LARYNGEAL NEOPLASM,1
BO,LIVER DISORDER,1
BO,LOWER LIMB FRACTURE,1
BO,LUNG NEOPLASM MALIGNANT,1
BO,MEMORY IMPAIRMENT,1
BO,METASTASES TO LUNG,1
BO,METASTASES TO LYMPH NODES,1
BO,METASTASES TO STOMACH,1
BO,MUSCLE SPASMS,1
BO,MYALGIA,1
BO,MYELOBLAST COUNT INCREASED,1
BO,MYOCARDIAL INFARCTION,1
BO,NEOPLASM MALIGNANT,1
BO,NEUROLOGICAL DECOMPENSATION,1
BO,NEUTROPHIL COUNT DECREASED,1
BO,NO THERAPEUTIC RESPONSE,1
BO,NOCARDIOSIS,1
BO,ORAL HERPES,1
BO,OSTEOMYELITIS,1
BO,OSTEOPOROSIS,1
BO,PARAPLEGIA,1
BO,PATHOLOGICAL FRACTURE,1
BO,PITUITARY TUMOUR,1
BO,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
BO,POISONING,1
BO,POLYNEUROPATHY,1
BO,POST PROCEDURAL COMPLICATION,1
BO,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
BO,PREMATURE BABY,1
BO,PREMATURE DELIVERY,1
BO,PROCEDURAL PAIN,1
BO,PRODUCT COUNTERFEIT,1
BO,PRODUCT QUALITY ISSUE,1
BO,PROTHROMBIN TIME PROLONGED,1
BO,PSEUDOMONAS INFECTION,1
BO,PULMONARY EMBOLISM,1
BO,PULMONARY SEPSIS,1
BO,PULMONARY TUBERCULOSIS,1
BO,RECTAL ABSCESS,1
BO,RECURRENT CANCER,1
BO,RED BLOOD CELL COUNT DECREASED,1
BO,RENAL DISORDER,1
BO,RENAL FAILURE,1
BO,RENAL FAILURE CHRONIC,1
BO,RESPIRATORY DISORDER,1
BO,RESTLESSNESS,1
BO,RETICULOCYTE COUNT INCREASED,1
BO,RETINAL HAEMORRHAGE,1
BO,RIB FRACTURE,1
BO,SALMONELLOSIS,1
BO,SEPTIC SHOCK,1
BO,SKIN HYPOPIGMENTATION,1
BO,STRESS,1
BO,SUBARACHNOID HAEMORRHAGE,1
BO,SUBMANDIBULAR MASS,1
BO,SWELLING,1
BO,TACHYCARDIA,1
BO,TOOTH ABSCESS,1
BO,TRANSAMINASES INCREASED,1
BO,TRANSIENT ISCHAEMIC ATTACK,1
BO,TREATMENT FAILURE,1
BO,TREATMENT NONCOMPLIANCE,1
BO,TREMOR,1
BO,TUMOUR LYSIS SYNDROME,1
BO,UNDERDOSE,1
BO,URINARY TRACT INFECTION,1
BO,UTERINE LEIOMYOMA,1
BO,VAGINAL HAEMORRHAGE,1
BO,VISION BLURRED,1
BO,WEIGHT DECREASED,1
BO,WHITE BLOOD CELL COUNT DECREASED,1
BA,PULMONARY EMBOLISM,19
BA,HYPERPROLACTINAEMIA,16
BA,DEATH,10
BA,URTICARIA,9
BA,THROMBOCYTOPENIA,8
BA,VOMITING,8
BA,CEREBRAL ARTERY EMBOLISM,7
BA,ERYTHEMA,7
BA,FATIGUE,7
BA,HEADACHE,7
BA,NAUSEA,7
BA,PYREXIA,7
BA,ASTHENIA,6
BA,BLOOD PRESSURE INCREASED,6
BA,EXTRAPYRAMIDAL DISORDER,6
BA,FOETAL EXPOSURE DURING PREGNANCY,6
BA,PRURITUS,6
BA,RASH,6
BA,SINUS TACHYCARDIA,6
BA,CEREBROVASCULAR ACCIDENT,5
BA,DIARRHOEA,5
BA,DISEASE PROGRESSION,5
BA,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,5
BA,DIZZINESS,4
BA,HYPERKALAEMIA,4
BA,HYPERTENSION,4
BA,HYPONATRAEMIA,4
BA,RHINORRHOEA,4
BA,WATER INTOXICATION,4
BA,ABDOMINAL PAIN UPPER,3
BA,BLOOD PRESSURE DECREASED,3
BA,C-REACTIVE PROTEIN INCREASED,3
BA,CHEST PAIN,3
BA,COMPLETED SUICIDE,3
BA,COUGH,3
BA,DECREASED APPETITE,3
BA,DYSPNOEA,3
BA,EXPOSURE DURING BREAST FEEDING,3
BA,GENERAL PHYSICAL HEALTH DETERIORATION,3
BA,HAEMATOCHEZIA,3
BA,HEPATIC FAILURE,3
BA,HYPERSENSITIVITY,3
BA,ILEUS,3
BA,INCORRECT DOSE ADMINISTERED,3
BA,MYOCARDIAL INFARCTION,3
BA,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,3
BA,RASH MACULO-PAPULAR,3
BA,WEIGHT DECREASED,3
BA,ABDOMINAL ABSCESS,2
BA,ABDOMINAL PAIN,2
BA,ABORTION SPONTANEOUS,2
BA,ANAEMIA,2
BA,ANXIETY,2
BA,APHTHOUS ULCER,2
BA,ASPHYXIA,2
BA,ATRIAL FIBRILLATION,2
BA,BLOOD BILIRUBIN INCREASED,2
BA,BLOOD GLUCOSE INCREASED,2
BA,BLOOD LACTATE DEHYDROGENASE INCREASED,2
BA,BRADYCARDIA,2
BA,BRAIN OEDEMA,2
BA,BRONCHIOLITIS,2
BA,CARDIAC FAILURE,2
BA,CEREBRAL INFARCTION,2
BA,CEREBRAL ISCHAEMIA,2
BA,CHEST DISCOMFORT,2
BA,CHOKING,2
BA,CONDITION AGGRAVATED,2
BA,CROHN^S DISEASE,2
BA,CYANOSIS,2
BA,DEEP VEIN THROMBOSIS,2
BA,DRUG INEFFECTIVE,2
BA,DYSKINESIA,2
BA,ELECTROCARDIOGRAM QT PROLONGED,2
BA,EOSINOPHILIA,2
BA,EPISTAXIS,2
BA,EXPOSURE DURING PREGNANCY,2
BA,EXPOSURE VIA FATHER,2
BA,FACE OEDEMA,2
BA,FACIAL PARESIS,2
BA,FEELING HOT,2
BA,FREQUENT BOWEL MOVEMENTS,2
BA,GASTROINTESTINAL HAEMORRHAGE,2
BA,GINGIVAL BLEEDING,2
BA,GLAUCOMA,2
BA,HAEMATURIA,2
BA,HEART RATE DECREASED,2
BA,HEMIANAESTHESIA,2
BA,HOSPITALISATION,2
BA,HYPOAESTHESIA ORAL,2
BA,LOSS OF CONSCIOUSNESS,2
BA,MELAENA,2
BA,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,2
BA,NASAL CONGESTION,2
BA,NEOPLASM PROGRESSION,2
BA,NEUTROPENIA,2
BA,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
BA,PARAESTHESIA,2
BA,PERIPHERAL SWELLING,2
BA,PLASMA CELL MYELOMA,2
BA,PLEURAL EFFUSION,2
BA,PRODUCT USE ISSUE,2
BA,RECTAL HAEMORRHAGE,2
BA,RESPIRATORY ARREST,2
BA,RESPIRATORY TRACT INFECTION BACTERIAL,2
BA,SPEECH DISORDER,2
BA,SPLENOMEGALY,2
BA,SUDDEN DEATH,2
BA,SWELLING FACE,2
BA,SWOLLEN TONGUE,2
BA,TONGUE OEDEMA,2
BA,TREMOR,2
BA,TUBERCULOSIS,2
BA,URINARY INCONTINENCE,2
BA,URINARY TRACT INFECTION,2
BA,ABNORMAL BEHAVIOUR,1
BA,ABSCESS,1
BA,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
BA,ACUTE KIDNEY INJURY,1
BA,AGITATION,1
BA,ALANINE AMINOTRANSFERASE INCREASED,1
BA,ALLERGIC OEDEMA,1
BA,ALOPECIA,1
BA,AMENORRHOEA,1
BA,AMNESIA,1
BA,AMYOTROPHIC LATERAL SCLEROSIS,1
BA,ANAL FISTULA,1
BA,ANASTOMOTIC ULCER,1
BA,ANGINA PECTORIS,1
BA,APATHY,1
BA,APHASIA,1
BA,APNOEA,1
BA,APPLICATION SITE PAIN,1
BA,ARRHYTHMIA SUPRAVENTRICULAR,1
BA,ARTERIOSCLEROSIS,1
BA,ARTHRALGIA,1
BA,ARTHROPOD BITE,1
BA,ASCITES,1
BA,ASPARTATE AMINOTRANSFERASE INCREASED,1
BA,ATAXIA,1
BA,ATRIAL SEPTAL DEFECT,1
BA,ATRIAL THROMBOSIS,1
BA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
BA,BACTERIAL TEST POSITIVE,1
BA,BLINDNESS UNILATERAL,1
BA,BLOOD COUNT ABNORMAL,1
BA,BLOOD PRESSURE DIASTOLIC DECREASED,1
BA,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
BA,BLOOD PROLACTIN INCREASED,1
BA,BLOOD URIC ACID INCREASED,1
BA,BLOOD URINE PRESENT,1
BA,BONE MARROW FAILURE,1
BA,BURNING SENSATION,1
BA,CARDIAC ARREST,1
BA,CARDIAC MURMUR,1
BA,CARDIOMYOPATHY,1
BA,CEREBRAL THROMBOSIS,1
BA,CHILLS,1
BA,CHOKING SENSATION,1
BA,CHRONIC GASTRITIS,1
BA,COGNITIVE DISORDER,1
BA,COLITIS,1
BA,COLITIS ULCERATIVE,1
BA,COMA,1
BA,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
BA,COMPULSIONS,1
BA,CONCOMITANT DISEASE PROGRESSION,1
BA,CONGENITAL CARDIOVASCULAR ANOMALY,1
BA,CONSTIPATION,1
BA,CONVULSION,1
BA,DEPRESSED LEVEL OF CONSCIOUSNESS,1
BA,DEPRESSIVE SYMPTOM,1
BA,DERMATITIS ALLERGIC,1
BA,DERMATOMYOSITIS,1
BA,DIABETES MELLITUS,1
BA,DIPLOPIA,1
BA,DISEASE RECURRENCE,1
BA,DISORIENTATION,1
BA,DIVERTICULUM GASTRIC,1
BA,DRUG HYPERSENSITIVITY,1
BA,DRUG INTOLERANCE,1
BA,DRUG WITHDRAWAL SYNDROME,1
BA,DYSARTHRIA,1
BA,DYSGEUSIA,1
BA,DYSLIPIDAEMIA,1
BA,ECTOPIC PREGNANCY,1
BA,ELECTROCARDIOGRAM ABNORMAL,1
BA,ENTERITIS,1
BA,ERYTHEMA NODOSUM,1
BA,EXTENSOR PLANTAR RESPONSE,1
BA,EYELID OEDEMA,1
BA,EYELID RASH,1
BA,FALLOT^S TETRALOGY,1
BA,FEBRILE NEUTROPENIA,1
BA,FIBRIN DEGRADATION PRODUCTS INCREASED,1
BA,FLUSHING,1
BA,GAIT DISTURBANCE,1
BA,GAIT SPASTIC,1
BA,GALACTORRHOEA,1
BA,GASTRIC CANCER,1
BA,GASTRIC ULCER,1
BA,GASTROOESOPHAGEAL REFLUX DISEASE,1
BA,GENERALISED TONIC-CLONIC SEIZURE,1
BA,GLIOBLASTOMA MULTIFORME,1
BA,HAEMATOMA,1
BA,HAEMOGLOBIN ABNORMAL,1
BA,HAEMOGLOBIN DECREASED,1
BA,HAEMORRHAGE,1
BA,HAEMORRHAGE SUBCUTANEOUS,1
BA,HALLUCINATION,1
BA,HALLUCINATION_ AUDITORY,1
BA,HEMIPARESIS,1
BA,HEMIPLEGIA,1
BA,HEPATIC FUNCTION ABNORMAL,1
BA,HEPATITIS TOXIC,1
BA,HEPATOCELLULAR CARCINOMA,1
BA,HERPES ZOSTER,1
BA,HIGH RISK PREGNANCY,1
BA,HOSTILITY,1
BA,HYDROCEPHALUS,1
BA,HYDRONEPHROSIS,1
BA,HYPERGLYCAEMIA,1
BA,HYPERHIDROSIS,1
BA,HYPERPLASIA,1
BA,HYPERPROTEINAEMIA,1
BA,HYPERTENSIVE CARDIOMYOPATHY,1
BA,HYPERTONIA,1
BA,HYPERVENTILATION,1
BA,HYPOGLYCAEMIA,1
BA,HYPOTENSION,1
BA,HYPOTHYROIDISM,1
BA,IMMUNOSUPPRESSION,1
BA,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
BA,INTENTIONAL DRUG MISUSE,1
BA,INTESTINAL FISTULA,1
BA,INTESTINAL POLYP,1
BA,INTRA-ABDOMINAL FLUID COLLECTION,1
BA,IRON DEFICIENCY,1
BA,JAUNDICE,1
BA,JAUNDICE NEONATAL,1
BA,JUVENILE IDIOPATHIC ARTHRITIS,1
BA,KETOACIDOSIS,1
BA,LEUKOCYTOSIS,1
BA,LEUKOPENIA,1
BA,LOCAL SWELLING,1
BA,LOCALISED OEDEMA,1
BA,LOW BIRTH WEIGHT BABY,1
BA,LUNG INFILTRATION,1
BA,LUNG NEOPLASM MALIGNANT,1
BA,LYMPH NODES SCAN ABNORMAL,1
BA,LYMPHOCYTE MORPHOLOGY ABNORMAL,1
BA,MALAISE,1
BA,MATERNAL EXPOSURE DURING PREGNANCY,1
BA,MITRAL VALVE INCOMPETENCE,1
BA,MUCOSAL HYPERAEMIA,1
BA,MUCOSAL INFLAMMATION,1
BA,MULTI-ORGAN FAILURE,1
BA,MUSCLE SPASMS,1
BA,MUSCULAR WEAKNESS,1
BA,MUSCULOSKELETAL STIFFNESS,1
BA,MYOSITIS,1
BA,NASAL INFLAMMATION,1
BA,NASAL OEDEMA,1
BA,NECROSIS,1
BA,NEPHROTIC SYNDROME,1
BA,NERVOUS SYSTEM DISORDER,1
BA,NIGHT SWEATS,1
BA,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
BA,NYSTAGMUS,1
BA,OBSTRUCTIVE AIRWAYS DISORDER,1
BA,OEDEMA,1
BA,OPTIC ATROPHY,1
BA,OPTIC NEUROPATHY,1
BA,OVERDOSE,1
BA,PAIN IN EXTREMITY,1
BA,PAIN OF SKIN,1
BA,PALLOR,1
BA,PALPITATIONS,1
BA,PERIORBITAL OEDEMA,1
BA,PERIPHERAL ARTERY THROMBOSIS,1
BA,PHARYNGEAL OEDEMA,1
BA,PHYSICAL ASSAULT,1
BA,PNEUMONIA,1
BA,PNEUMONITIS,1
BA,POOR PERIPHERAL CIRCULATION,1
BA,PORTAL VEIN THROMBOSIS,1
BA,PREMATURE BABY,1
BA,PREMATURE DELIVERY,1
BA,PRODUCT CONTAMINATION,1
BA,PROSTATE CANCER METASTATIC,1
BA,PROTEINURIA,1
BA,PSYCHOMOTOR SKILLS IMPAIRED,1
BA,PSYCHOTIC DISORDER,1
BA,PSYCHOTIC DISORDER DUE TO A GENERAL MEDICAL CONDITION,1
BA,PULSE ABNORMAL,1
BA,PURPURA,1
BA,PYOGENIC STERILE ARTHRITIS PYODERMA GANGRENOSUM AND ACNE SYNDROME,1
BA,PYURIA,1
BA,RADIAL PULSE ABNORMAL,1
BA,RASH ERYTHEMATOUS,1
BA,RASH PRURITIC,1
BA,RED BLOOD CELL ABNORMALITY,1
BA,RED BLOOD CELL COUNT DECREASED,1
BA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
BA,RED BLOOD CELLS URINE POSITIVE,1
BA,REFLEXES ABNORMAL,1
BA,RENAL DISORDER,1
BA,RENAL IMPAIRMENT,1
BA,RESPIRATORY FAILURE,1
BA,RETINAL HAEMORRHAGE,1
BA,ROMBERG TEST POSITIVE,1
BA,SALIVARY HYPERSECRETION,1
BA,SARCOIDOSIS,1
BA,SCREAMING,1
BA,SECONDARY CEREBELLAR DEGENERATION,1
BA,SEIZURE,1
BA,SKIN ATROPHY,1
BA,SKIN DISORDER,1
BA,SKIN SWELLING,1
BA,SLEEP DISORDER,1
BA,SOMNOLENCE,1
BA,STATUS EPILEPTICUS,1
BA,SUBARACHNOID HAEMORRHAGE,1
BA,SUBDURAL HAEMATOMA,1
BA,SUBILEUS,1
BA,THEFT,1
BA,THERAPY NON-RESPONDER,1
BA,THROMBOSIS,1
BA,TINNITUS,1
BA,TONGUE DRY,1
BA,TONGUE SPASM,1
BA,TUBERCULIN TEST POSITIVE,1
BA,TUNNEL VISION,1
BA,ULCER,1
BA,ULTRASOUND DOPPLER ABNORMAL,1
BA,UMBILICAL CORD AROUND NECK,1
BA,UNDERDOSE,1
BA,URINARY TRACT INFLAMMATION,1
BA,URTICARIA CHRONIC,1
BA,VAGINAL HAEMORRHAGE,1
BA,VARICES OESOPHAGEAL,1
BA,VEIN COLLAPSE,1
BA,VISUAL FIELD DEFECT,1
BA,VISUAL IMPAIRMENT,1
BA,WEIGHT INCREASED,1
BA,WHITE BLOOD CELL COUNT INCREASED,1
BA,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
BA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
BW,FOETAL EXPOSURE DURING PREGNANCY,311
BW,SMALL FOR DATES BABY,240
BW,STILLBIRTH,77
BW,EXPOSURE DURING PREGNANCY,60
BW,MATERNAL EXPOSURE DURING PREGNANCY,59
BW,PREMATURE BABY,46
BW,PREMATURE DELIVERY,41
BW,DEATH NEONATAL,24
BW,ABORTION SPONTANEOUS,14
BW,DRUG INEFFECTIVE,6
BW,VOMITING,6
BW,ANAEMIA,5
BW,BLOOD CREATININE INCREASED,5
BW,INTRACRANIAL PRESSURE INCREASED,5
BW,PREGNANCY,5
BW,ACUTE KIDNEY INJURY,4
BW,HEADACHE,4
BW,HYPERLACTACIDAEMIA,4
BW,SEPSIS,4
BW,COUGH,3
BW,DEATH,3
BW,FOETAL DEATH,3
BW,RENAL IMPAIRMENT,3
BW,ADVERSE EVENT,2
BW,ALANINE AMINOTRANSFERASE ABNORMAL,2
BW,ALANINE AMINOTRANSFERASE INCREASED,2
BW,CONFUSIONAL STATE,2
BW,CONGENITAL ANOMALY,2
BW,DIARRHOEA,2
BW,DIZZINESS,2
BW,DYSPNOEA,2
BW,FALL,2
BW,FOETAL MALFORMATION,2
BW,HAEMATEMESIS,2
BW,HEPATIC FAILURE,2
BW,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
BW,INTRACRANIAL VENOUS SINUS THROMBOSIS,2
BW,MALAISE,2
BW,MENORRHAGIA,2
BW,NEUTROPENIA,2
BW,OEDEMA PERIPHERAL,2
BW,PHOTOPHOBIA,2
BW,PNEUMONIA,2
BW,PULMONARY TUBERCULOSIS,2
BW,UTERINE DILATION AND CURETTAGE,2
BW,ABDOMINAL PAIN UPPER,1
BW,ABORTION INCOMPLETE,1
BW,ACUTE HEPATIC FAILURE,1
BW,ACUTE PSYCHOSIS,1
BW,ACUTE RESPIRATORY DISTRESS SYNDROME,1
BW,AMYLASE INCREASED,1
BW,ANGIOEDEMA,1
BW,ASTHMA,1
BW,ATRIAL THROMBOSIS,1
BW,BLOOD BICARBONATE DECREASED,1
BW,BREECH PRESENTATION,1
BW,BRONCHOSPASM,1
BW,BUNDLE BRANCH BLOCK RIGHT,1
BW,CAESAREAN SECTION,1
BW,CARDIAC FAILURE CONGESTIVE,1
BW,CARDIOMEGALY,1
BW,CARDIOMYOPATHY,1
BW,CHEST DISCOMFORT,1
BW,CONCUSSION,1
BW,CONVULSION,1
BW,DEPRESSED MOOD,1
BW,DEPRESSION,1
BW,DIPLOPIA,1
BW,DRUG DEPENDENCE,1
BW,DYSURIA,1
BW,EYE PAIN,1
BW,FEEDING DISORDER,1
BW,FEELING ABNORMAL,1
BW,FLUID INTAKE REDUCED,1
BW,FOETAL EXPOSURE DURING DELIVERY,1
BW,GENITAL INFECTION,1
BW,GESTATIONAL HYPERTENSION,1
BW,HAEMOPTYSIS,1
BW,HYPERCOAGULATION,1
BW,HYPERTENSION,1
BW,HYPOMAGNESAEMIA,1
BW,HYPONATRAEMIA,1
BW,HYPOTENSION,1
BW,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
BW,INSOMNIA,1
BW,INTENTIONAL OVERDOSE,1
BW,INTESTINAL OBSTRUCTION,1
BW,JAUNDICE,1
BW,JUGULAR VEIN DISTENSION,1
BW,LACTIC ACIDOSIS,1
BW,LIPASE INCREASED,1
BW,LIVE BIRTH,1
BW,LIVER DISORDER,1
BW,LOW BIRTH WEIGHT BABY,1
BW,MENINGITIS CRYPTOCOCCAL,1
BW,MICTURITION URGENCY,1
BW,NECK PAIN,1
BW,NEGATIVE THOUGHTS,1
BW,OROPHARYNGEAL PAIN,1
BW,PAPILLOEDEMA,1
BW,PARTIAL SEIZURES,1
BW,PELVIC VENOUS THROMBOSIS,1
BW,PNEUMOCYSTIS JIROVECI PNEUMONIA,1
BW,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
BW,POLLAKIURIA,1
BW,POLYDIPSIA,1
BW,POLYURIA,1
BW,POOR QUALITY SLEEP,1
BW,POSTMATURE BABY,1
BW,PREGNANCY ON ORAL CONTRACEPTIVE,1
BW,PRODUCT QUALITY ISSUE,1
BW,PULMONARY EMBOLISM,1
BW,PYREXIA,1
BW,RASH ERYTHEMATOUS,1
BW,RESPIRATORY DISTRESS,1
BW,RIGHT VENTRICULAR FAILURE,1
BW,SEIZURE,1
BW,SEPSIS NEONATAL,1
BW,SKELETAL DYSPLASIA,1
BW,STEVENS-JOHNSON SYNDROME,1
BW,SUBDURAL HAEMATOMA,1
BW,SUDDEN DEATH,1
BW,SUICIDAL IDEATION,1
BW,THINKING ABNORMAL,1
BW,TOXOPLASMOSIS,1
BW,TRANSAMINASES INCREASED,1
BW,UMBILICAL HERNIA,1
BW,UPPER RESPIRATORY TRACT INFECTION,1
BW,UTERINE LEIOMYOMA,1
BW,VAGINAL DISCHARGE,1
BW,VIITH NERVE PARALYSIS,1
BW,VISION BLURRED,1
BW,VITH NERVE PARALYSIS,1
BW,VITILIGO,1
BR,DRUG INEFFECTIVE,5414
BR,MALAISE,4904
BR,PAIN,4725
BR,DEATH,4019
BR,DYSPNOEA,3531
BR,WEIGHT DECREASED,3281
BR,PNEUMONIA,3246
BR,HEADACHE,3165
BR,ASTHENIA,2918
BR,PAIN IN EXTREMITY,2790
BR,FATIGUE,2718
BR,FALL,2690
BR,ARTHRALGIA,2680
BR,PYREXIA,2522
BR,DIZZINESS,2474
BR,NAUSEA,2403
BR,HYPERTENSION,2387
BR,VOMITING,2325
BR,GAIT DISTURBANCE,2225
BR,DIARRHOEA,2174
BR,URINARY TRACT INFECTION,2145
BR,CEREBROVASCULAR ACCIDENT,1869
BR,BLOOD PRESSURE INCREASED,1828
BR,INFLUENZA,1753
BR,DIABETES MELLITUS,1695
BR,FEELING ABNORMAL,1660
BR,DEPRESSION,1619
BR,COUGH,1602
BR,WEIGHT INCREASED,1591
BR,ANAEMIA,1499
BR,ABDOMINAL PAIN,1488
BR,INSOMNIA,1477
BR,MEMORY IMPAIRMENT,1420
BR,HYPERSENSITIVITY,1401
BR,PRODUCT USE ISSUE,1361
BR,DECREASED APPETITE,1354
BR,CATARACT,1334
BR,TREMOR,1292
BR,BACK PAIN,1279
BR,PRURITUS,1260
BR,SOMNOLENCE,1256
BR,PERIPHERAL SWELLING,1250
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1230
BR,SYNCOPE,1192
BR,VISUAL IMPAIRMENT,1180
BR,BLOOD GLUCOSE INCREASED,1174
BR,SWELLING,1146
BR,CARDIAC DISORDER,1144
BR,ANXIETY,1143
BR,DRUG DOSE OMISSION,1092
BR,INFECTION,1077
BR,ERYTHEMA,1074
BR,NERVOUSNESS,1063
BR,MYOCARDIAL INFARCTION,1029
BR,CHEST PAIN,1026
BR,ABDOMINAL PAIN UPPER,1025
BR,ABASIA,1015
BR,ARRHYTHMIA,980
BR,CONDITION AGGRAVATED,979
BR,INFARCTION,959
BR,INJECTION SITE PAIN,945
BR,SEIZURE,919
BR,OSTEOARTHRITIS,874
BR,HYPOAESTHESIA,840
BR,IMMUNODEFICIENCY,834
BR,HAEMORRHAGE,830
BR,DISEASE PROGRESSION,829
BR,RHEUMATOID ARTHRITIS,822
BR,THROMBOSIS,821
BR,HYPOTENSION,811
BR,BLOOD CHOLESTEROL INCREASED,802
BR,VISION BLURRED,763
BR,MUSCULAR WEAKNESS,753
BR,EXPOSURE DURING PREGNANCY,746
BR,SPEECH DISORDER,717
BR,TACHYCARDIA,717
BR,LUNG DISORDER,715
BR,FEMUR FRACTURE,707
BR,CONFUSIONAL STATE,703
BR,DEMENTIA ALZHEIMER^S TYPE,683
BR,BLOOD PRESSURE DECREASED,668
BR,ABDOMINAL DISTENSION,659
BR,JOINT SWELLING,659
BR,ASTHMA,649
BR,ARTHROPATHY,643
BR,MULTIPLE SCLEROSIS RELAPSE,643
BR,CARDIAC ARREST,640
BR,INCORRECT DOSE ADMINISTERED,638
BR,SPINAL PAIN,630
BR,HYPERGLYCAEMIA,623
BR,SINUSITIS,610
BR,RENAL DISORDER,605
BR,SEPSIS,604
BR,ALOPECIA,603
BR,HYPERHIDROSIS,601
BR,RENAL FAILURE,598
BR,RESPIRATORY FAILURE,593
BR,FOETAL EXPOSURE DURING PREGNANCY,589
BR,PARAESTHESIA,574
BR,RASH,568
BR,DENGUE FEVER,566
BR,AGITATION,555
BR,CONSTIPATION,550
BR,DYSPHAGIA,548
BR,GLAUCOMA,548
BR,MUSCLE SPASMS,537
BR,PSORIASIS,537
BR,CORONARY ARTERY OCCLUSION,535
BR,MOBILITY DECREASED,535
BR,SKIN DISCOLOURATION,530
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,529
BR,PULMONARY EMBOLISM,526
BR,WOUND,526
BR,BLINDNESS,520
BR,PLATELET COUNT DECREASED,519
BR,CROHN^S DISEASE,518
BR,NASOPHARYNGITIS,515
BR,CHILLS,504
BR,ARTHRITIS,503
BR,OSTEOPOROSIS,503
BR,NEPHROLITHIASIS,499
BR,HYPOGLYCAEMIA,486
BR,ASTHMATIC CRISIS,482
BR,INTENTIONAL PRODUCT MISUSE,482
BR,INTERVERTEBRAL DISC PROTRUSION,481
BR,DYSSTASIA,479
BR,INJECTION SITE ERYTHEMA,479
BR,LIVER DISORDER,479
BR,LOSS OF CONSCIOUSNESS,476
BR,BEDRIDDEN,473
BR,DYSPHONIA,466
BR,INFLAMMATION,466
BR,VISUAL ACUITY REDUCED,465
BR,CHOLELITHIASIS,463
BR,GENERAL PHYSICAL HEALTH DETERIORATION,463
BR,DRUG DEPENDENCE,459
BR,GASTRITIS,455
BR,BLOOD PRESSURE FLUCTUATION,454
BR,SPINAL DISORDER,451
BR,RENAL IMPAIRMENT,447
BR,DRY MOUTH,445
BR,HEART RATE INCREASED,445
BR,MYALGIA,445
BR,EATING DISORDER,433
BR,MUSCULOSKELETAL STIFFNESS,430
BR,PRODUCT USE IN UNAPPROVED INDICATION,428
BR,GASTROINTESTINAL DISORDER,426
BR,COMA,425
BR,CONVULSION,425
BR,STRESS,425
BR,BALANCE DISORDER,423
BR,PRODUCT QUALITY ISSUE,420
BR,DEPRESSED MOOD,419
BR,OROPHARYNGEAL PAIN,419
BR,BONE PAIN,416
BR,OEDEMA PERIPHERAL,412
BR,BLISTER,408
BR,HOSPITALISATION,406
BR,LUNG INFECTION,406
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,406
BR,ACUTE KIDNEY INJURY,405
BR,FEELING HOT,403
BR,SEPTIC SHOCK,403
BR,MOVEMENT DISORDER,401
BR,PLEURAL EFFUSION,400
BR,HAEMOGLOBIN DECREASED,399
BR,CRYING,398
BR,EMPHYSEMA,394
BR,LABYRINTHITIS,391
BR,NECK PAIN,391
BR,BRONCHITIS,389
BR,DRUG ADMINISTRATION ERROR,389
BR,TUBERCULOSIS,388
BR,BURNING SENSATION,385
BR,BREAST CANCER,382
BR,CARDIAC FAILURE,381
BR,MATERNAL EXPOSURE DURING PREGNANCY,380
BR,DECREASED IMMUNE RESPONSIVENESS,379
BR,NEOPLASM MALIGNANT,379
BR,AMNESIA,378
BR,MUSCULOSKELETAL PAIN,376
BR,EYE PAIN,375
BR,IRRITABILITY,371
BR,RETCHING,370
BR,ABDOMINAL DISCOMFORT,369
BR,PULMONARY OEDEMA,366
BR,INFUSION RELATED REACTION,365
BR,GASTROOESOPHAGEAL REFLUX DISEASE,364
BR,ROAD TRAFFIC ACCIDENT,359
BR,DEHYDRATION,358
BR,SKIN EXFOLIATION,358
BR,DYSGEUSIA,351
BR,DRUG HYPERSENSITIVITY,349
BR,HAEMATOCHEZIA,342
BR,LOCAL SWELLING,341
BR,SWELLING FACE,341
BR,CARDIO-RESPIRATORY ARREST,339
BR,DEAFNESS,338
BR,RESPIRATORY DISORDER,336
BR,DYSPEPSIA,335
BR,AGGRESSION,333
BR,DRY SKIN,333
BR,LIMB INJURY,331
BR,ARTERIAL OCCLUSIVE DISEASE,330
BR,BODY HEIGHT DECREASED,328
BR,MALIGNANT NEOPLASM PROGRESSION,327
BR,FEAR,325
BR,THROMBOCYTOPENIA,325
BR,ABORTION SPONTANEOUS,324
BR,UPPER LIMB FRACTURE,323
BR,SURGERY,322
BR,BLOOD PRESSURE ABNORMAL,320
BR,PALPITATIONS,319
BR,VIRAL INFECTION,317
BR,OVERDOSE,315
BR,HYPOPHAGIA,314
BR,DRUG INTOLERANCE,309
BR,FEEDING DISORDER,309
BR,THYROID DISORDER,308
BR,PHARYNGITIS,304
BR,SPINAL FRACTURE,303
BR,VENOUS OCCLUSION,303
BR,GASTRIC DISORDER,298
BR,HEAD INJURY,291
BR,EYE DISORDER,289
BR,PRURITUS GENERALISED,289
BR,DYSURIA,288
BR,OCULAR HYPERAEMIA,285
BR,EPISTAXIS,284
BR,APHASIA,283
BR,RHINITIS,283
BR,DIABETES MELLITUS INADEQUATE CONTROL,280
BR,HYPOKINESIA,280
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,278
BR,URTICARIA,277
BR,ANGINA PECTORIS,276
BR,INJECTION SITE PRURITUS,273
BR,BONE DISORDER,270
BR,DRUG PRESCRIBING ERROR,270
BR,LIMB DISCOMFORT,270
BR,URINARY INCONTINENCE,270
BR,EMOTIONAL DISORDER,269
BR,GAIT INABILITY,268
BR,HALLUCINATION,268
BR,PARKINSON^S DISEASE,267
BR,ISCHAEMIC STROKE,264
BR,HEAD DISCOMFORT,263
BR,FLATULENCE,262
BR,DEVICE MALFUNCTION,261
BR,DRUG EFFECT INCOMPLETE,261
BR,HYPOACUSIS,261
BR,THROAT IRRITATION,258
BR,HYPOTHYROIDISM,257
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,254
BR,VARICOSE VEIN,254
BR,WHEEZING,254
BR,HEPATIC STEATOSIS,253
BR,DRUG-INDUCED LIVER INJURY,250
BR,UNEVALUABLE EVENT,250
BR,BLOOD TRIGLYCERIDES INCREASED,248
BR,MIGRAINE,248
BR,EYE IRRITATION,246
BR,PALLOR,245
BR,EPILEPSY,243
BR,LOWER LIMB FRACTURE,243
BR,RASH MACULAR,243
BR,APPARENT DEATH,241
BR,MULTI-ORGAN FAILURE,238
BR,PREMATURE BABY,235
BR,FLUID RETENTION,234
BR,LUNG NEOPLASM MALIGNANT,234
BR,GASTROINTESTINAL INFECTION,233
BR,BLOOD CHOLESTEROL ABNORMAL,232
BR,FOOT FRACTURE,232
BR,NODULE,231
BR,PANIC DISORDER,230
BR,DYSENTERY,227
BR,BACTERIAL INFECTION,225
BR,SLEEP DISORDER,225
BR,DIVERTICULITIS,224
BR,THERAPEUTIC RESPONSE DECREASED,224
BR,BLINDNESS UNILATERAL,223
BR,CHEST DISCOMFORT,223
BR,BLOOD GLUCOSE ABNORMAL,221
BR,OXYGEN SATURATION DECREASED,221
BR,BLOOD CREATININE INCREASED,220
BR,FIBROMYALGIA,220
BR,MEDICATION ERROR,219
BR,ADVERSE EVENT,218
BR,SUICIDAL IDEATION,218
BR,DEEP VEIN THROMBOSIS,217
BR,DISCOMFORT,217
BR,FEELING COLD,217
BR,HERPES ZOSTER,217
BR,NEUTROPENIA,217
BR,CAESAREAN SECTION,216
BR,MASS,215
BR,ACUTE MYOCARDIAL INFARCTION,211
BR,ERYSIPELAS,211
BR,MENTAL DISORDER,211
BR,BLOOD GLUCOSE DECREASED,210
BR,CENTRAL NERVOUS SYSTEM LESION,210
BR,SUICIDE ATTEMPT,210
BR,HAEMATOMA,209
BR,ABNORMAL BEHAVIOUR,208
BR,FOOT DEFORMITY,208
BR,EYE SWELLING,206
BR,NOSOCOMIAL INFECTION,206
BR,TINNITUS,205
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,204
BR,NEOPLASM,204
BR,PULMONARY MASS,204
BR,URINARY RETENTION,204
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,203
BR,BLOOD GLUCOSE FLUCTUATION,202
BR,FEBRILE NEUTROPENIA,202
BR,ILL-DEFINED DISORDER,202
BR,CHOKING,201
BR,JOINT INJURY,201
BR,ACCIDENT,200
BR,NERVOUS SYSTEM DISORDER,200
BR,NEUROPATHY PERIPHERAL,198
BR,SERUM FERRITIN INCREASED,198
BR,DISTURBANCE IN ATTENTION,196
BR,PANCREATITIS,196
BR,CONCOMITANT DISEASE AGGRAVATED,195
BR,CARDIOMEGALY,193
BR,MULTIPLE SCLEROSIS,192
BR,TOXICITY TO VARIOUS AGENTS,192
BR,INTRAOCULAR PRESSURE INCREASED,191
BR,POST PROCEDURAL COMPLICATION,190
BR,EYE HAEMORRHAGE,189
BR,SKIN LESION,188
BR,PARALYSIS,187
BR,INTESTINAL OBSTRUCTION,186
BR,LARYNGEAL OEDEMA,186
BR,DRUG EFFECT DECREASED,185
BR,HEART RATE DECREASED,185
BR,INJECTION SITE SWELLING,185
BR,PRODUCTIVE COUGH,185
BR,SKIN DISORDER,184
BR,IMPAIRED HEALING,183
BR,INJECTION SITE MASS,183
BR,HEPATIC CIRRHOSIS,182
BR,LOCALISED INFECTION,182
BR,HEPATITIS C,181
BR,YELLOW SKIN,180
BR,HERPES VIRUS INFECTION,179
BR,SECRETION DISCHARGE,179
BR,DISORIENTATION,178
BR,HAEMOLYSIS,178
BR,CHROMATURIA,177
BR,CARDIOVASCULAR DISORDER,176
BR,KIDNEY INFECTION,175
BR,LEUKOPENIA,175
BR,PROSTATE CANCER,175
BR,SLUGGISHNESS,175
BR,RESPIRATORY TRACT INFECTION,174
BR,GASTROINTESTINAL HAEMORRHAGE,172
BR,POLLAKIURIA,172
BR,UNDERDOSE,172
BR,HYPERTENSIVE CRISIS,171
BR,INCORRECT PRODUCT STORAGE,170
BR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,170
BR,RESPIRATORY ARREST,170
BR,RHEUMATIC DISORDER,170
BR,THROAT TIGHTNESS,170
BR,STOMATITIS,168
BR,TOOTH DISORDER,168
BR,TENDON RUPTURE,167
BR,RIB FRACTURE,166
BR,VAGINAL HAEMORRHAGE,166
BR,INJURY,165
BR,OEDEMA,165
BR,APATHY,163
BR,DELIRIUM,162
BR,THERAPEUTIC RESPONSE UNEXPECTED,162
BR,ACNE,161
BR,DRY EYE,161
BR,COLITIS,160
BR,HYPERAEMIA,159
BR,INCORRECT ROUTE OF DRUG ADMINISTRATION,159
BR,RETINAL DETACHMENT,159
BR,FISTULA,158
BR,HAEMATURIA,158
BR,TENDONITIS,156
BR,ANKYLOSING SPONDYLITIS,154
BR,BRONCHOSPASM,153
BR,INFLUENZA LIKE ILLNESS,153
BR,MUSCULOSKELETAL DISORDER,153
BR,VERTIGO,153
BR,ASCITES,152
BR,HYPERSOMNIA,152
BR,INJECTION SITE DISCOLOURATION,152
BR,HAEMATEMESIS,151
BR,INCORRECT DRUG ADMINISTRATION DURATION,151
BR,PROCEDURAL PAIN,151
BR,INJECTION SITE HAEMATOMA,150
BR,HEPATIC CANCER,149
BR,ISCHAEMIA,149
BR,DEMENTIA,148
BR,GALLBLADDER DISORDER,147
BR,ATRIAL FIBRILLATION,144
BR,CONTUSION,144
BR,CYANOSIS,144
BR,GASTROINTESTINAL INFLAMMATION,143
BR,WHITE BLOOD CELL COUNT DECREASED,143
BR,MENORRHAGIA,140
BR,RENAL PAIN,140
BR,DERMATITIS ALLERGIC,139
BR,HAND DEFORMITY,139
BR,BIPOLAR DISORDER,138
BR,EXOSTOSIS,138
BR,FORMICATION,138
BR,HEPATOMEGALY,138
BR,IMMUNE SYSTEM DISORDER,138
BR,AGEUSIA,137
BR,GASTROINTESTINAL CARCINOMA,137
BR,HEPATIC NEOPLASM,137
BR,HAEMORRHOIDS,136
BR,BREAST MASS,135
BR,DEVICE RELATED INFECTION,135
BR,DRUG DISPENSING ERROR,135
BR,HERNIA,135
BR,MOOD ALTERED,135
BR,ORAL PAIN,135
BR,HEMIPLEGIA,134
BR,HEPATITIS,134
BR,RHINORRHOEA,134
BR,SHOCK,134
BR,BRADYCARDIA,133
BR,INJECTION SITE BRUISING,133
BR,INTESTINAL HAEMORRHAGE,133
BR,PULMONARY FIBROSIS,133
BR,COLD SWEAT,132
BR,HIATUS HERNIA,132
BR,OBESITY,132
BR,NASAL CONGESTION,131
BR,EAR INFECTION,130
BR,ANAPHYLACTIC SHOCK,129
BR,CATARRH,129
BR,INJECTION SITE HAEMORRHAGE,129
BR,JOINT DISLOCATION,129
BR,OSTEOPENIA,129
BR,PANCYTOPENIA,129
BR,EAR PAIN,128
BR,VITAMIN D DEFICIENCY,128
BR,FEELING OF DESPAIR,127
BR,CHIKUNGUNYA VIRUS INFECTION,126
BR,MATERNAL EXPOSURE BEFORE PREGNANCY,125
BR,THYROID NEOPLASM,125
BR,CHONDROPATHY,124
BR,FLUSHING,124
BR,HEPATIC FAILURE,124
BR,MOUTH INJURY,124
BR,CELLULITIS,123
BR,CYST,123
BR,HAEMORRHAGIC STROKE,122
BR,AMENORRHOEA,121
BR,ASPHYXIA,121
BR,CANDIDA INFECTION,121
BR,UVEITIS,121
BR,ABORTION,120
BR,APHONIA,120
BR,TREATMENT NONCOMPLIANCE,120
BR,UTERINE LEIOMYOMA,120
BR,CYSTITIS,119
BR,BLOOD LACTATE DEHYDROGENASE INCREASED,118
BR,DIPLOPIA,118
BR,EXPIRED PRODUCT ADMINISTERED,118
BR,METASTASES TO LIVER,118
BR,PSORIATIC ARTHROPATHY,118
BR,SNEEZING,118
BR,DUCTUS ARTERIOSUS STENOSIS FOETAL,117
BR,APPLICATION SITE ERYTHEMA,116
BR,GENERALISED OEDEMA,116
BR,ANGIOPATHY,115
BR,LYMPHADENOPATHY,115
BR,LACRIMATION INCREASED,114
BR,NEOPLASM PROGRESSION,114
BR,VEIN DISORDER,114
BR,ALANINE AMINOTRANSFERASE INCREASED,113
BR,COORDINATION ABNORMAL,113
BR,JOINT STIFFNESS,113
BR,MUSCLE ATROPHY,113
BR,UMBILICAL HERNIA,113
BR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,112
BR,EYE PRURITUS,112
BR,GLUCOSE TOLERANCE IMPAIRED,112
BR,BLOOD URINE PRESENT,111
BR,RESPIRATORY DISTRESS,111
BR,TYPE 2 DIABETES MELLITUS,111
BR,ANAPHYLACTIC REACTION,110
BR,COGNITIVE DISORDER,110
BR,SKIN FISSURES,110
BR,ASPARTATE AMINOTRANSFERASE INCREASED,109
BR,MUCOSAL INFLAMMATION,109
BR,SENSORY LOSS,109
BR,APHTHOUS ULCER,108
BR,DISEASE RECURRENCE,108
BR,METRORRHAGIA,108
BR,ORAL DISCOMFORT,108
BR,PSYCHOTIC DISORDER,108
BR,HEARING IMPAIRED,107
BR,INGUINAL HERNIA,107
BR,JOINT RANGE OF MOTION DECREASED,107
BR,LABORATORY TEST ABNORMAL,107
BR,MUSCLE RIGIDITY,107
BR,CAROTID ARTERY OCCLUSION,106
BR,GASTROINTESTINAL PAIN,106
BR,LIGAMENT SPRAIN,106
BR,RESTLESSNESS,106
BR,SCIATICA,106
BR,VITAMIN D DECREASED,106
BR,FURUNCLE,105
BR,INTESTINAL PERFORATION,105
BR,JAUNDICE,105
BR,BLOOD TEST ABNORMAL,104
BR,DRUG RESISTANCE,104
BR,PETIT MAL EPILEPSY,104
BR,THYROID CANCER,104
BR,WRONG DRUG ADMINISTERED,104
BR,BRAIN NEOPLASM,103
BR,INTENTIONAL DRUG MISUSE,103
BR,MALNUTRITION,103
BR,MOTOR DYSFUNCTION,103
BR,MUSCULOSKELETAL CHEST PAIN,103
BR,INJECTION SITE INDURATION,102
BR,SENSORY DISTURBANCE,102
BR,DEVICE DISLOCATION,101
BR,FINGER DEFORMITY,101
BR,OESOPHAGITIS,101
BR,OSTEONECROSIS,101
BR,SKIN CANCER,101
BR,THYROID MASS,101
BR,PREMATURE DELIVERY,100
BR,PRODUCT AVAILABILITY ISSUE,100
BR,ACUTE RESPIRATORY FAILURE,99
BR,ANKLE FRACTURE,99
BR,APPENDICITIS,99
BR,ATROPHY,99
BR,DYSARTHRIA,99
BR,HIP FRACTURE,99
BR,INJECTION SITE WARMTH,99
BR,BURSITIS,98
BR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,98
BR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,98
BR,HYPOAESTHESIA ORAL,98
BR,ULCER,98
BR,EMOTIONAL DISTRESS,97
BR,FRACTURE,97
BR,LYMPHOMA,97
BR,METASTASES TO LUNG,97
BR,OSTEOMYELITIS,97
BR,OVARIAN CYST,97
BR,POISONING,97
BR,BLOOD POTASSIUM DECREASED,96
BR,CONJUNCTIVITIS,96
BR,LEIOMYOMA,96
BR,SKIN ULCER,96
BR,APPLICATION SITE PAIN,95
BR,CYTOMEGALOVIRUS INFECTION,95
BR,GASTRIC ULCER,95
BR,INTENTIONAL PRODUCT USE ISSUE,95
BR,METASTASES TO BONE,95
BR,SKIN WOUND,95
BR,TOOTH FRACTURE,95
BR,TOOTH INFECTION,95
BR,DEPRESSED LEVEL OF CONSCIOUSNESS,94
BR,SPINAL OSTEOARTHRITIS,94
BR,SICKLE CELL ANAEMIA WITH CRISIS,93
BR,TONGUE DISORDER,93
BR,TRANSIENT ISCHAEMIC ATTACK,93
BR,CARPAL TUNNEL SYNDROME,92
BR,DYSKINESIA,92
BR,SEDATION,92
BR,TOOTHACHE,92
BR,WRIST FRACTURE,92
BR,FACE OEDEMA,91
BR,PNEUMONITIS,91
BR,WEIGHT FLUCTUATION,91
BR,CEREBRAL ISCHAEMIA,90
BR,FOETAL DEATH,90
BR,HAEMATOCRIT DECREASED,90
BR,JOINT EFFUSION,90
BR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,90
BR,PHARYNGEAL OEDEMA,90
BR,PRESYNCOPE,90
BR,PROTEINURIA,90
BR,PSYCHIATRIC SYMPTOM,90
BR,UNINTENDED PREGNANCY,90
BR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,89
BR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,89
BR,HORMONE LEVEL ABNORMAL,89
BR,OSTEONECROSIS OF JAW,89
BR,PERIPHERAL COLDNESS,89
BR,PHLEBITIS,89
BR,THIRST,89
BR,TRICUSPID VALVE INCOMPETENCE,89
BR,HAEMOPTYSIS,88
BR,SKIN REACTION,88
BR,GENERALISED ERYTHEMA,87
BR,ADVERSE DRUG REACTION,86
BR,ENDOMETRIOSIS,86
BR,GASTRIC HAEMORRHAGE,86
BR,OVERWEIGHT,86
BR,APPLICATION SITE PRURITUS,85
BR,CATARACT OPERATION,85
BR,RASH ERYTHEMATOUS,85
BR,ACCIDENTAL EXPOSURE TO PRODUCT,84
BR,APHAGIA,84
BR,BLOOD DISORDER,84
BR,BLOOD SODIUM DECREASED,84
BR,COAGULOPATHY,84
BR,CORONARY ARTERY DISEASE,84
BR,EYELID OEDEMA,84
BR,PERICARDIAL EFFUSION,84
BR,SKIN IRRITATION,84
BR,LIMB DEFORMITY,83
BR,SCHIZOPHRENIA,83
BR,ANAL FISTULA,82
BR,APNOEA,82
BR,BLOOD UREA INCREASED,82
BR,GLYCOSYLATED HAEMOGLOBIN INCREASED,82
BR,HYPERTHYROIDISM,82
BR,INTESTINAL STENOSIS,82
BR,METASTASIS,82
BR,PNEUMONIA ASPIRATION,82
BR,POSTOPERATIVE WOUND INFECTION,82
BR,PROSTATIC DISORDER,82
BR,THERAPY CESSATION,82
BR,ABSCESS,81
BR,COLITIS ULCERATIVE,81
BR,DIARRHOEA HAEMORRHAGIC,81
BR,INJECTION SITE REACTION,81
BR,MENISCUS INJURY,81
BR,MOUTH HAEMORRHAGE,81
BR,NECROSIS,81
BR,POST PROCEDURAL INFECTION,81
BR,TOOTH LOSS,81
BR,CHRONIC KIDNEY DISEASE,80
BR,DILATATION VENTRICULAR,80
BR,INCREASED BRONCHIAL SECRETION,80
BR,POOR PERIPHERAL CIRCULATION,80
BR,PRODUCT ADHESION ISSUE,80
BR,EYE INFLAMMATION,79
BR,FUNGAL INFECTION,79
BR,IMMUNOSUPPRESSION,79
BR,INJECTION SITE NODULE,79
BR,MENSTRUAL DISORDER,79
BR,NEURALGIA,79
BR,NO ADVERSE EVENT,79
BR,PREGNANCY,79
BR,PRODUCT PHYSICAL ISSUE,79
BR,WHITE BLOOD CELL COUNT INCREASED,79
BR,GASTROENTERITIS,78
BR,HYPOTHERMIA,78
BR,INCREASED APPETITE,78
BR,KETOACIDOSIS,78
BR,OBSTRUCTIVE AIRWAYS DISORDER,78
BR,ANEURYSM,77
BR,AORTIC ANEURYSM,77
BR,BRONCHOPNEUMONIA,77
BR,KNEE ARTHROPLASTY,77
BR,METASTATIC RENAL CELL CARCINOMA,77
BR,MONOPLEGIA,77
BR,NAIL DISORDER,77
BR,PULMONARY HYPERTENSION,77
BR,ANAL HAEMORRHAGE,76
BR,DERMATITIS,76
BR,FREQUENT BOWEL MOVEMENTS,76
BR,HEMIPARESIS,76
BR,KNEE OPERATION,76
BR,LEUKAEMIA,76
BR,PETECHIAE,76
BR,SKIN BURNING SENSATION,76
BR,SKIN HAEMORRHAGE,76
BR,BLOOD URIC ACID INCREASED,75
BR,DIABETIC RETINOPATHY,75
BR,GINGIVAL BLEEDING,75
BR,HEPATIC ENZYME INCREASED,75
BR,HYPERKERATOSIS,75
BR,PIGMENTATION DISORDER,75
BR,SPLENOMEGALY,75
BR,THERAPY NON-RESPONDER,75
BR,ABDOMINAL HERNIA,74
BR,DEAFNESS UNILATERAL,74
BR,HEPATIC PAIN,74
BR,NIGHTMARE,74
BR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,74
BR,RENAL CANCER,74
BR,VASCULITIS,74
BR,BONE EROSION,73
BR,CARDIAC FAILURE CONGESTIVE,73
BR,DRUG WITHDRAWAL SYNDROME,73
BR,HYPONATRAEMIA,73
BR,LEUKOCYTOSIS,73
BR,PSYCHOMOTOR HYPERACTIVITY,73
BR,SKIN ATROPHY,73
BR,SPINAL COLUMN INJURY,73
BR,SWOLLEN TONGUE,73
BR,EXPOSURE DURING BREAST FEEDING,72
BR,HYDROCEPHALUS,72
BR,UTERINE DISORDER,72
BR,CARTILAGE INJURY,71
BR,INTENTIONAL OVERDOSE,71
BR,LACERATION,71
BR,BLOOD IRON INCREASED,70
BR,HAND FRACTURE,70
BR,ORAL DISORDER,70
BR,PAIN IN JAW,70
BR,PAPULE,70
BR,RENAL CELL CARCINOMA,70
BR,SUFFOCATION FEELING,70
BR,ANURIA,69
BR,BONE MARROW FAILURE,69
BR,DEVICE BREAKAGE,69
BR,FAECES DISCOLOURED,69
BR,FLAVIVIRUS INFECTION,69
BR,LETHARGY,69
BR,ORAL CANDIDIASIS,69
BR,PANCREATITIS ACUTE,69
BR,SALIVARY HYPERSECRETION,69
BR,ANGIOEDEMA,68
BR,DRY THROAT,68
BR,GLOSSODYNIA,68
BR,PANIC ATTACK,68
BR,PYELONEPHRITIS,68
BR,VIITH NERVE PARALYSIS,68
BR,ANGER,67
BR,BREAST PAIN,67
BR,PULMONARY TUBERCULOSIS,67
BR,SPINAL CORD COMPRESSION,67
BR,CEREBRAL HAEMORRHAGE,66
BR,CEREBRAL THROMBOSIS,66
BR,DEPENDENCE,66
BR,DYSPNOEA EXERTIONAL,66
BR,HELICOBACTER INFECTION,66
BR,HYPOXIA,66
BR,LOW BIRTH WEIGHT BABY,66
BR,MENTAL IMPAIRMENT,66
BR,PANCREATIC CARCINOMA,66
BR,PELVIC FRACTURE,66
BR,RHINITIS ALLERGIC,66
BR,SKIN HYPERTROPHY,66
BR,ARTHRITIS INFECTIVE,65
BR,C-REACTIVE PROTEIN INCREASED,65
BR,HOT FLUSH,65
BR,NEEDLE ISSUE,65
BR,PREGNANCY ON ORAL CONTRACEPTIVE,65
BR,RED BLOOD CELL COUNT DECREASED,65
BR,RENAL COLIC,65
BR,RETINAL DISORDER,65
BR,SCREAMING,65
BR,SKIN MASS,65
BR,DIABETIC NEUROPATHY,64
BR,HEPATOTOXICITY,64
BR,PULMONARY HAEMORRHAGE,64
BR,BLOOD PRESSURE SYSTOLIC INCREASED,63
BR,CEREBRAL DISORDER,63
BR,MYOCARDIAL ISCHAEMIA,63
BR,PRESCRIBED UNDERDOSE,63
BR,URINE OUTPUT DECREASED,63
BR,ARTERIOSCLEROSIS,62
BR,ASPIRATION,62
BR,GENERAL PHYSICAL CONDITION ABNORMAL,62
BR,HAEMOGLOBINURIA,62
BR,INJECTION SITE HYPERSENSITIVITY,62
BR,LACTOSE INTOLERANCE,62
BR,LIVER INJURY,62
BR,PROSTATOMEGALY,62
BR,SKIN INFECTION,62
BR,TONSILLITIS,62
BR,TREATMENT FAILURE,62
BR,UTERINE HAEMORRHAGE,62
BR,APPLICATION SITE HYPERSENSITIVITY,61
BR,FACE INJURY,61
BR,HEART RATE IRREGULAR,61
BR,HIP ARTHROPLASTY,61
BR,GROIN PAIN,60
BR,HYPOTONIA,60
BR,MOUTH ULCERATION,60
BR,ORAL HERPES,60
BR,POOR QUALITY SLEEP,60
BR,CARDIAC OPERATION,59
BR,CHOLECYSTECTOMY,59
BR,CHOLECYSTITIS,59
BR,DEVICE ISSUE,59
BR,EAR DISCOMFORT,59
BR,HYPERAESTHESIA,59
BR,METASTASES TO CENTRAL NERVOUS SYSTEM,59
BR,POLYURIA,59
BR,PROCEDURAL COMPLICATION,59
BR,PURULENT DISCHARGE,59
BR,SKIN PLAQUE,59
BR,TIBIA FRACTURE,59
BR,ACUTE PULMONARY OEDEMA,58
BR,BREAST CANCER FEMALE,58
BR,H1N1 INFLUENZA,58
BR,MUSCULOSKELETAL DISCOMFORT,58
BR,RECTAL HAEMORRHAGE,58
BR,VIRAL LOAD INCREASED,58
BR,BRAIN OEDEMA,57
BR,DIABETIC KETOACIDOSIS,57
BR,EMBOLISM,57
BR,HUNGER,57
BR,HYPOKALAEMIA,57
BR,INTESTINAL POLYP,57
BR,PATIENT-DEVICE INCOMPATIBILITY,57
BR,PERIPHERAL VASCULAR DISORDER,57
BR,STAPHYLOCOCCAL INFECTION,57
BR,APHTHOUS STOMATITIS,56
BR,BLINDNESS TRANSIENT,56
BR,ENCEPHALOPATHY,56
BR,PHOTOPHOBIA,56
BR,POOR QUALITY DRUG ADMINISTERED,56
BR,BLOOD GROWTH HORMONE INCREASED,55
BR,MENINGITIS,55
BR,OCULAR DISCOMFORT,55
BR,OPTIC NEURITIS,55
BR,PANIC REACTION,55
BR,RENAL CYST,55
BR,SPINAL DEFORMITY,55
BR,CARDIOGENIC SHOCK,54
BR,DEVICE OCCLUSION,54
BR,GASTRIC CANCER,54
BR,HALLUCINATION_ VISUAL,54
BR,INTRACRANIAL PRESSURE INCREASED,54
BR,MENSTRUATION IRREGULAR,54
BR,PREMATURE SEPARATION OF PLACENTA,54
BR,PULMONARY SEPSIS,54
BR,BACK DISORDER,53
BR,DERMATITIS BULLOUS,53
BR,DRUG ABUSE,53
BR,EAR DISORDER,53
BR,FUNCTIONAL GASTROINTESTINAL DISORDER,53
BR,GASTROINTESTINAL NEOPLASM,53
BR,PLASMA CELL MYELOMA,53
BR,PRODUCT STORAGE ERROR,53
BR,STEVENS-JOHNSON SYNDROME,53
BR,TACHYPNOEA,53
BR,TENSION,53
BR,UNDERWEIGHT,53
BR,BLADDER DISORDER,52
BR,DEFORMITY,52
BR,HEPATIC ENZYME ABNORMAL,52
BR,KNEE DEFORMITY,52
BR,LYMPHOCYTE COUNT DECREASED,52
BR,NO THERAPEUTIC RESPONSE,52
BR,PANCREATIC DISORDER,52
BR,SCOLIOSIS,52
BR,TRANSFUSION,52
BR,BLOOD TRIGLYCERIDES ABNORMAL,51
BR,DYSLIPIDAEMIA,51
BR,DYSMENORRHOEA,51
BR,HAEMODIALYSIS,51
BR,INTESTINAL FISTULA,51
BR,LIP SWELLING,51
BR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,51
BR,THROMBOTIC MICROANGIOPATHY,51
BR,TOOTH EXTRACTION,51
BR,UNRESPONSIVE TO STIMULI,51
BR,WALKING DISABILITY,51
BR,WOUND INFECTION,51
BR,CARDIAC MURMUR,50
BR,DECUBITUS ULCER,50
BR,EYE INFECTION,50
BR,FACIAL PAIN,50
BR,HEPATIC FUNCTION ABNORMAL,50
BR,HYSTERECTOMY,50
BR,IMPAIRED WORK ABILITY,50
BR,LIMB OPERATION,50
BR,MOUTH SWELLING,50
BR,PELVIC PAIN,50
BR,PNEUMONIA BACTERIAL,50
BR,PURULENCE,50
BR,RASH PUSTULAR,50
BR,SKIN INJURY,50
BR,WOUND COMPLICATION,50
BR,BONE MARROW DISORDER,49
BR,CARDIOMYOPATHY,49
BR,DAYDREAMING,49
BR,ERECTILE DYSFUNCTION,49
BR,JOINT LOCK,49
BR,SENSITIVITY TO WEATHER CHANGE,49
BR,SKIN PAPILLOMA,49
BR,BLOOD CALCIUM DECREASED,48
BR,BONE DENSITY DECREASED,48
BR,EYE MOVEMENT DISORDER,48
BR,HALLUCINATION_ AUDITORY,48
BR,MUSCLE TWITCHING,48
BR,MYOPIA,48
BR,ONYCHOCLASIS,48
BR,PLATELET COUNT INCREASED,48
BR,PULPITIS DENTAL,48
BR,SLEEP APNOEA SYNDROME,48
BR,VAGINAL DISCHARGE,48
BR,VENOUS THROMBOSIS,48
BR,BLOOD CREATININE ABNORMAL,47
BR,BLOOD PROLACTIN INCREASED,47
BR,FACIAL PARALYSIS,47
BR,INTESTINAL RESECTION,47
BR,PHARYNGEAL INFLAMMATION,47
BR,PULMONARY PAIN,47
BR,RENAL FAILURE ACUTE,47
BR,SJOGREN^S SYNDROME,47
BR,WITHDRAWAL SYNDROME,47
BR,ABNORMAL FAECES,46
BR,ANGIOPLASTY,46
BR,BONE LOSS,46
BR,INTRACRANIAL ANEURYSM,46
BR,LIGAMENT RUPTURE,46
BR,LUMBAR VERTEBRAL FRACTURE,46
BR,MEDICATION RESIDUE PRESENT,46
BR,OCULAR ICTERUS,46
BR,PRODUCT TASTE ABNORMAL,46
BR,RASH PAPULAR,46
BR,VARICELLA,46
BR,WOUND HAEMORRHAGE,46
BR,ANGINA UNSTABLE,45
BR,ASPIRATION BRONCHIAL,45
BR,BRONCHIOLITIS,45
BR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,45
BR,ENTERITIS INFECTIOUS,45
BR,GOITRE,45
BR,HYPOVITAMINOSIS,45
BR,MALIGNANT MELANOMA,45
BR,MITRAL VALVE DISEASE,45
BR,MYELODYSPLASTIC SYNDROME,45
BR,POLYNEUROPATHY,45
BR,PROCTALGIA,45
BR,THINKING ABNORMAL,45
BR,TRANSAMINASES INCREASED,45
BR,URINARY TRACT INFECTION BACTERIAL,45
BR,ACCIDENTAL OVERDOSE,44
BR,CACHEXIA,44
BR,CARDIAC VALVE DISEASE,44
BR,PARAESTHESIA ORAL,44
BR,PHARYNGEAL DISORDER,44
BR,PRE-EXISTING CONDITION IMPROVED,44
BR,PRODUCT DROPPER ISSUE,44
BR,RETINAL HAEMORRHAGE,44
BR,SYNOVIAL CYST,44
BR,TENDON DISORDER,44
BR,ALLERGIC COUGH,43
BR,CHOKING SENSATION,43
BR,EXTRA DOSE ADMINISTERED,43
BR,HAEMORRHAGE IN PREGNANCY,43
BR,MICTURITION URGENCY,43
BR,NORMAL NEWBORN,43
BR,PERITONITIS,43
BR,PRE-ECLAMPSIA,43
BR,SCAR,43
BR,SPINAL OPERATION,43
BR,VISUAL FIELD DEFECT,43
BR,BONE CANCER,42
BR,BRONCHIECTASIS,42
BR,COMPLETED SUICIDE,42
BR,NASAL DISCOMFORT,42
BR,PROSTATIC SPECIFIC ANTIGEN INCREASED,42
BR,PULMONARY CONGESTION,42
BR,PULMONARY THROMBOSIS,42
BR,RASH GENERALISED,42
BR,RETINOPATHY,42
BR,BLOOD THYROID STIMULATING HORMONE INCREASED,41
BR,DECREASED ACTIVITY,41
BR,DIABETIC METABOLIC DECOMPENSATION,41
BR,FIBROSIS,41
BR,GRIP STRENGTH DECREASED,41
BR,INCREASED UPPER AIRWAY SECRETION,41
BR,INTERSTITIAL LUNG DISEASE,41
BR,OLIGURIA,41
BR,POOR VENOUS ACCESS,41
BR,RENAL FAILURE CHRONIC,41
BR,SENSATION OF HEAVINESS,41
BR,TRIGEMINAL NEURALGIA,41
BR,UTERINE CANCER,41
BR,BLOOD POTASSIUM INCREASED,40
BR,BODY TEMPERATURE DECREASED,40
BR,DIABETIC COMPLICATION,40
BR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,40
BR,INJECTION SITE OEDEMA,40
BR,LIBIDO DECREASED,40
BR,LIVE BIRTH,40
BR,MENSTRUATION DELAYED,40
BR,METABOLIC DISORDER,40
BR,PANCREATIC NEOPLASM,40
BR,PITUITARY TUMOUR,40
BR,TERMINAL STATE,40
BR,TONGUE DISCOLOURATION,40
BR,ABNORMAL WITHDRAWAL BLEEDING,39
BR,BRAIN DEATH,39
BR,CARDIAC PACEMAKER INSERTION,39
BR,CLAVICLE FRACTURE,39
BR,COMPLICATION ASSOCIATED WITH DEVICE,39
BR,HYPERCHOLESTEROLAEMIA,39
BR,HYPOVOLAEMIC SHOCK,39
BR,INVESTIGATION,39
IO,DRUG DOSE OMISSION,1
IO,DRUG-INDUCED LIVER INJURY,1
BN,DEATH,6
BN,FEMUR FRACTURE,4
BN,HAEMOGLOBIN DECREASED,3
BN,NEUTROPENIA,3
BN,ACUTE MYELOID LEUKAEMIA,2
BN,ARTHRALGIA,2
BN,DRUG INEFFECTIVE,2
BN,FATIGUE,2
BN,PATHOLOGICAL FRACTURE,2
BN,SEPSIS,2
BN,THROMBOCYTOPENIA,2
BN,ABSCESS,1
BN,ASTHENIA,1
BN,BLOOD GLUCOSE DECREASED,1
BN,BLOOD GLUCOSE INCREASED,1
BN,BLOOD LACTATE DEHYDROGENASE INCREASED,1
BN,BLOOD POTASSIUM DECREASED,1
BN,BONE MARROW MYELOGRAM ABNORMAL,1
BN,BRADYCARDIA,1
BN,BURKHOLDERIA PSEUDOMALLEI INFECTION,1
BN,CENTRAL NERVOUS SYSTEM LESION,1
BN,CEREBRAL HAEMORRHAGE,1
BN,CONSTIPATION,1
BN,DECREASED APPETITE,1
BN,DIARRHOEA,1
BN,DISEASE PROGRESSION,1
BN,DIZZINESS,1
BN,DYSPNOEA,1
BN,EATING DISORDER,1
BN,ELECTROCARDIOGRAM QT PROLONGED,1
BN,HAEMATOCHEZIA,1
BN,HAEMORRHAGE,1
BN,HEADACHE,1
BN,HEPATIC ENZYME INCREASED,1
BN,HEPATIC LESION,1
BN,HYPOCALCAEMIA,1
BN,HYPOTENSION,1
BN,LETHARGY,1
BN,MALAISE,1
BN,MOUTH ULCERATION,1
BN,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
BN,NAUSEA,1
BN,OESOPHAGEAL ULCER,1
BN,PAIN,1
BN,PLASMA CELL MYELOMA,1
BN,PRODUCT USE ISSUE,1
BN,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
BN,PULMONARY EMBOLISM,1
BN,PYELONEPHRITIS,1
BN,PYREXIA,1
BN,RENAL CYST,1
BN,RENAL HAEMATOMA,1
BN,RENAL IMPAIRMENT,1
BN,TUMOUR MARKER INCREASED,1
BN,VASCULAR PSEUDOANEURYSM,1
BN,VENTRICULAR ASSIST DEVICE INSERTION,1
BN,VOMITING,1
BN,WEIGHT DECREASED,1
BN,WEIGHT INCREASED,1
BG,DEATH,83
BG,DYSPNOEA,55
BG,ANAEMIA,50
BG,ASTHENIA,48
BG,FATIGUE,42
BG,GENERAL PHYSICAL HEALTH DETERIORATION,40
BG,PYREXIA,39
BG,RASH,36
BG,DRUG INEFFECTIVE,35
BG,TOXICITY TO VARIOUS AGENTS,34
BG,CARDIAC FAILURE,33
BG,HYPOTENSION,32
BG,COMA,31
BG,CONDITION AGGRAVATED,31
BG,DIARRHOEA,31
BG,VOMITING,30
BG,ATRIAL FIBRILLATION,27
BG,DRUG LEVEL INCREASED,25
BG,LACTIC ACIDOSIS,25
BG,ISCHAEMIC STROKE,24
BG,NAUSEA,24
BG,OEDEMA PERIPHERAL,24
BG,PNEUMONIA,24
BG,HEADACHE,23
BG,PULMONARY EMBOLISM,23
BG,ARTHRALGIA,22
BG,OVERDOSE,22
BG,RESPIRATORY FAILURE,22
BG,HAEMOGLOBIN DECREASED,21
BG,MALIGNANT NEOPLASM PROGRESSION,21
BG,SOMNOLENCE,21
BG,ACUTE KIDNEY INJURY,20
BG,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,20
BG,HYPERSENSITIVITY,20
BG,PRURITUS,20
BG,THROMBOCYTOPENIA,20
BG,ABDOMINAL PAIN,19
BG,ANGINA UNSTABLE,19
BG,COUGH,19
BG,INTENTIONAL OVERDOSE,19
BG,ANGINA PECTORIS,18
BG,DECREASED APPETITE,18
BG,TACHYCARDIA,18
BG,ACUTE MYOCARDIAL INFARCTION,17
BG,ASTHMA,17
BG,NEUTROPENIA,17
BG,PALPITATIONS,17
BG,WEIGHT DECREASED,17
BG,PAIN,16
BG,RASH GENERALISED,16
BG,VERTIGO,16
BG,LEUKOPENIA,15
BG,MALAISE,15
BG,ALANINE AMINOTRANSFERASE INCREASED,14
BG,CEREBROVASCULAR ACCIDENT,14
BG,CYANOSIS,14
BG,DIZZINESS,14
BG,HYPERTENSION,14
BG,METASTASES TO BONE,14
BG,PALLOR,14
BG,SUICIDE ATTEMPT,14
BG,BRONCHOSPASM,13
BG,CHEST DISCOMFORT,13
BG,CHEST PAIN,13
BG,CIRCULATORY COLLAPSE,13
BG,GAIT DISTURBANCE,13
BG,HYPERHIDROSIS,13
BG,HYPOTONIA,13
BG,LOSS OF CONSCIOUSNESS,13
BG,PAIN IN EXTREMITY,13
BG,PERIPHERAL SWELLING,13
BG,BLOOD CREATININE INCREASED,12
BG,CARDIOGENIC SHOCK,12
BG,HAEMATEMESIS,12
BG,HAEMATURIA,12
BG,HAEMORRHAGIC STROKE,12
BG,HEPATOCELLULAR CARCINOMA,12
BG,HYPERBILIRUBINAEMIA,12
BG,MYOCARDIAL INFARCTION,12
BG,PLEURAL EFFUSION,12
BG,URTICARIA,12
BG,CEREBRAL HAEMORRHAGE,11
BG,DEEP VEIN THROMBOSIS,11
BG,FLUSHING,11
BG,GASTROINTESTINAL HAEMORRHAGE,11
BG,LYMPHADENOPATHY,11
BG,MELAENA,11
BG,PRODUCT USE ISSUE,11
BG,THROMBOSIS IN DEVICE,11
BG,ANXIETY,10
BG,ASPARTATE AMINOTRANSFERASE INCREASED,10
BG,BACK PAIN,10
BG,DISEASE PROGRESSION,10
BG,DRUG DOSE OMISSION,10
BG,ERYTHEMA,10
BG,HEPATITIS TOXIC,10
BG,INFARCTION,10
BG,INSOMNIA,10
BG,METASTASES TO LIVER,10
BG,MYALGIA,10
BG,OSTEONECROSIS OF JAW,10
BG,PANCYTOPENIA,10
BG,STAPHYLOCOCCAL INFECTION,10
BG,ABDOMINAL PAIN UPPER,9
BG,ACUTE RESPIRATORY FAILURE,9
BG,ARRHYTHMIA,9
BG,BLOOD PRESSURE DECREASED,9
BG,BONE MARROW FAILURE,9
BG,DEPRESSED LEVEL OF CONSCIOUSNESS,9
BG,DIABETIC KETOACIDOSIS,9
BG,DYSARTHRIA,9
BG,HEART RATE INCREASED,9
BG,POISONING,9
BG,PROSTATE CANCER,9
BG,SEIZURE,9
BG,VASCULAR STENT THROMBOSIS,9
BG,ACUTE CORONARY SYNDROME,8
BG,BLOOD PRESSURE INCREASED,8
BG,BODY TEMPERATURE INCREASED,8
BG,CARDIAC FAILURE CONGESTIVE,8
BG,COMPLETED SUICIDE,8
BG,EPISTAXIS,8
BG,EXPOSURE DURING PREGNANCY,8
BG,FALL,8
BG,MUSCLE SPASMS,8
BG,MYOCARDIAL ISCHAEMIA,8
BG,RASH MACULO-PAPULAR,8
BG,RASH PRURITIC,8
BG,RECTAL HAEMORRHAGE,8
BG,RENAL FAILURE,8
BG,SWELLING FACE,8
BG,APNOEA,7
BG,ASCITES,7
BG,ASPHYXIA,7
BG,BRADYCARDIA,7
BG,CARDIAC FAILURE ACUTE,7
BG,CHROMATURIA,7
BG,CONFUSIONAL STATE,7
BG,CONVULSION,7
BG,DYSPHAGIA,7
BG,HEPATIC ENZYME INCREASED,7
BG,HEPATIC FAILURE,7
BG,HYPOALBUMINAEMIA,7
BG,METHAEMOGLOBINAEMIA,7
BG,MUSCULAR WEAKNESS,7
BG,PARAESTHESIA,7
BG,PNEUMONITIS,7
BG,POISONING DELIBERATE,7
BG,PREMATURE BABY,7
BG,SECOND PRIMARY MALIGNANCY,7
BG,SYNCOPE,7
BG,TACHYPNOEA,7
BG,THERAPY CESSATION,7
BG,THROMBOSIS,7
BG,TREMOR,7
BG,TUBERCULOSIS,7
BG,VIRAL INFECTION,7
BG,ABNORMAL BEHAVIOUR,6
BG,AGITATION,6
BG,APHASIA,6
BG,BRAIN OEDEMA,6
BG,CARDIAC ARREST,6
BG,CARDIAC FAILURE CHRONIC,6
BG,CORONARY ARTERY STENOSIS,6
BG,DERMATITIS ALLERGIC,6
BG,DYSPEPSIA,6
BG,EYELID OEDEMA,6
BG,FOETAL EXPOSURE DURING PREGNANCY,6
BG,GASTRITIS EROSIVE,6
BG,HAEMATOCHEZIA,6
BG,HAEMORRHAGE,6
BG,HEMIPARESIS,6
BG,HYDRONEPHROSIS,6
BG,HYPOGLYCAEMIA,6
BG,HYPOTHERMIA,6
BG,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,6
BG,INFECTION,6
BG,INTENTIONAL PRODUCT USE ISSUE,6
BG,JOINT SWELLING,6
BG,MATERNAL EXPOSURE DURING PREGNANCY,6
BG,METASTASES TO LUNG,6
BG,NEUROTOXICITY,6
BG,PETECHIAE,6
BG,PROTEINURIA,6
BG,PULMONARY FIBROSIS,6
BG,RENAL CELL CARCINOMA,6
BG,RHABDOMYOLYSIS,6
BG,SHOCK HAEMORRHAGIC,6
BG,SWELLING,6
BG,TOXIC EPIDERMAL NECROLYSIS,6
BG,TRANSAMINASES INCREASED,6
BG,VISION BLURRED,6
BG,WHEEZING,6
BG,ALOPECIA,5
BG,ANAPHYLACTIC SHOCK,5
BG,ANGIOEDEMA,5
BG,ANURIA,5
BG,APHTHOUS ULCER,5
BG,ATAXIA,5
BG,BLOOD UREA INCREASED,5
BG,BREAST CANCER,5
BG,CARDIOPULMONARY FAILURE,5
BG,DEPRESSION,5
BG,DISORIENTATION,5
BG,DRUG HYPERSENSITIVITY,5
BG,DRY SKIN,5
BG,DUODENAL ULCER,5
BG,DYSURIA,5
BG,GASTRITIS,5
BG,HAEMORRHOIDS,5
BG,HYPERTENSIVE CRISIS,5
BG,INFLUENZA,5
BG,JAUNDICE,5
BG,LETHARGY,5
BG,LIP SWELLING,5
BG,MEDICATION ERROR,5
BG,METABOLIC ACIDOSIS,5
BG,MULTIPLE ORGAN DYSFUNCTION SYNDROME,5
BG,MULTIPLE SCLEROSIS RELAPSE,5
BG,MUSCULOSKELETAL STIFFNESS,5
BG,NECROSIS,5
BG,OEDEMA,5
BG,ORAL PAIN,5
BG,OROPHARYNGEAL PAIN,5
BG,OSTEOPOROSIS,5
BG,PULMONARY OEDEMA,5
BG,PYELONEPHRITIS,5
BG,RASH PUSTULAR,5
BG,RENAL CANCER,5
BG,RESPIRATORY ARREST,5
BG,STEVENS-JOHNSON SYNDROME,5
BG,STOMATITIS,5
BG,SWOLLEN TONGUE,5
BG,URINARY TRACT INFECTION,5
BG,VISUAL IMPAIRMENT,5
BG,ABDOMINAL DISCOMFORT,4
BG,ABDOMINAL DISTENSION,4
BG,ACIDOSIS,4
BG,AGGRESSION,4
BG,ANAPHYLACTIC REACTION,4
BG,APLASTIC ANAEMIA,4
BG,BALANCE DISORDER,4
BG,BICYTOPENIA,4
BG,BLINDNESS,4
BG,BLISTER,4
BG,BLOOD GLUCOSE INCREASED,4
BG,BLOOD POTASSIUM INCREASED,4
BG,BONE PAIN,4
BG,BREATH SOUNDS ABNORMAL,4
BG,BRONCHIAL OBSTRUCTION,4
BG,CARDIAC DISORDER,4
BG,CARDIOVASCULAR DISORDER,4
BG,CHOLELITHIASIS,4
BG,CORONARY ARTERY DISEASE,4
BG,DERMATITIS,4
BG,DISCOMFORT,4
BG,DRUG-INDUCED LIVER INJURY,4
BG,DRY MOUTH,4
BG,DYSGEUSIA,4
BG,FAECES DISCOLOURED,4
BG,GASTRIC ULCER HAEMORRHAGE,4
BG,GASTRODUODENITIS,4
BG,GASTROINTESTINAL DISORDER,4
BG,GENERALISED OEDEMA,4
BG,GENERALISED TONIC-CLONIC SEIZURE,4
BG,GENITAL HAEMORRHAGE,4
BG,HAEMATOCRIT DECREASED,4
BG,HAEMATOMA,4
BG,HAEMODYNAMIC INSTABILITY,4
BG,HAEMOPTYSIS,4
BG,HAEMORRHAGE SUBCUTANEOUS,4
BG,HEMIPLEGIA,4
BG,HEPATOMEGALY,4
BG,HIATUS HERNIA,4
BG,HYPERKALAEMIA,4
BG,HYPOAESTHESIA,4
BG,HYPOREFLEXIA,4
BG,HYPOTHYROIDISM,4
BG,IMPAIRED HEALING,4
BG,LYMPHADENOPATHY MEDIASTINAL,4
BG,METASTASES TO LYMPH NODES,4
BG,MITRAL VALVE INCOMPETENCE,4
BG,MOBILITY DECREASED,4
BG,MONOPARESIS,4
BG,MOUTH ULCERATION,4
BG,MULTI-ORGAN FAILURE,4
BG,NECK PAIN,4
BG,NEPHROLITHIASIS,4
BG,NEUROPATHY PERIPHERAL,4
BG,NON-HODGKIN^S LYMPHOMA,4
BG,OESOPHAGITIS,4
BG,OSTEITIS,4
BG,PHARYNGITIS,4
BG,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,4
BG,PRODUCT USE IN UNAPPROVED INDICATION,4
BG,PULMONARY TUBERCULOSIS,4
BG,RENAL FAILURE ACUTE,4
BG,RHINITIS,4
BG,SINUS BRADYCARDIA,4
BG,SKIN DISCOLOURATION,4
BG,SKIN EROSION,4
BG,TRICUSPID VALVE INCOMPETENCE,4
BG,TRIGEMINO-CARDIAC REFLEX,4
BG,TYPE 2 DIABETES MELLITUS,4
BG,ABORTION INDUCED,3
BG,ABORTION SPONTANEOUS,3
BG,ACUTE HEPATIC FAILURE,3
BG,ALCOHOL INTERACTION,3
BG,ALCOHOL INTOLERANCE,3
BG,ANGER,3
BG,AORTIC VALVE SCLEROSIS,3
BG,APATHY,3
BG,APNOEIC ATTACK,3
BG,ARTERIAL THROMBOSIS,3
BG,ATRIAL FLUTTER,3
BG,ATRIAL THROMBOSIS,3
BG,ATRIOVENTRICULAR BLOCK FIRST DEGREE,3
BG,BLADDER CANCER,3
BG,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
BG,BLOOD LACTIC ACID INCREASED,3
BG,CHEMICAL POISONING,3
BG,CHILLS,3
BG,CHRONIC KIDNEY DISEASE,3
BG,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,3
BG,COLD SWEAT,3
BG,COLON CANCER,3
BG,COLORECTAL CANCER METASTATIC,3
BG,CONJUNCTIVITIS,3
BG,CONSTIPATION,3
BG,CYSTITIS,3
BG,DEMENTIA,3
BG,DERMATITIS ACNEIFORM,3
BG,DIABETIC METABOLIC DECOMPENSATION,3
BG,DIARRHOEA HAEMORRHAGIC,3
BG,DISEASE RECURRENCE,3
BG,DISSEMINATED TUBERCULOSIS,3
BG,DRUG CLEARANCE DECREASED,3
BG,DRUG INTOLERANCE,3
BG,DUODENAL ULCER HAEMORRHAGE,3
BG,DYSSTASIA,3
BG,ECCHYMOSIS,3
BG,EJECTION FRACTION DECREASED,3
BG,ELECTROCARDIOGRAM QT PROLONGED,3
BG,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,3
BG,ELECTROCARDIOGRAM T WAVE INVERSION,3
BG,ENCEPHALOPATHY,3
BG,EOSINOPHILIA,3
BG,EROSIVE OESOPHAGITIS,3
BG,EXPOSED BONE IN JAW,3
BG,FOETAL DEATH,3
BG,GASTRIC HAEMORRHAGE,3
BG,GASTRIC ULCER,3
BG,GASTROOESOPHAGEAL REFLUX DISEASE,3
BG,GENERAL PHYSICAL CONDITION ABNORMAL,3
BG,GILBERT^S SYNDROME,3
BG,GOUT,3
BG,HAEMORRHAGE INTRACRANIAL,3
BG,HEAD INJURY,3
BG,HEART RATE DECREASED,3
BG,HEPATIC ENCEPHALOPATHY,3
BG,HEPATITIS,3
BG,HEPATITIS C,3
BG,HEPATOSPLENOMEGALY,3
BG,HYPERGLYCAEMIA,3
BG,HYPERTHYROIDISM,3
BG,HYPOACUSIS,3
BG,HYPOKINESIA,3
BG,HYPOXIA,3
BG,ILEUS,3
BG,INCORRECT DOSE ADMINISTERED,3
BG,INCORRECT DRUG ADMINISTRATION RATE,3
BG,INJURY,3
BG,INTENTIONAL PRODUCT MISUSE,3
BG,INTERMITTENT CLAUDICATION,3
BG,IRIDOCYCLITIS,3
BG,KETOACIDOSIS,3
BG,LATENT TUBERCULOSIS,3
BG,LEUKOCYTOSIS,3
BG,LOW BIRTH WEIGHT BABY,3
BG,LUNG INFECTION,3
BG,LUNG NEOPLASM MALIGNANT,3
BG,MALNUTRITION,3
BG,MEMORY IMPAIRMENT,3
BG,METASTASES TO CENTRAL NERVOUS SYSTEM,3
BG,METASTASES TO SPLEEN,3
BG,MYELODYSPLASTIC SYNDROME,3
BG,NAIL DISCOLOURATION,3
BG,NODAL RHYTHM,3
BG,ORTHOPNOEA,3
BG,PAIN IN JAW,3
BG,PAIN OF SKIN,3
BG,PERICARDIAL EFFUSION,3
BG,PLASMA CELL MYELOMA,3
BG,PLATELET COUNT DECREASED,3
BG,PLATELET COUNT INCREASED,3
BG,PLEURISY,3
BG,PRESCRIBED OVERDOSE,3
BG,PROTHROMBIN TIME PROLONGED,3
BG,PSYCHOTIC DISORDER,3
BG,PULMONARY CONGESTION,3
BG,PULMONARY HYPERTENSION,3
BG,PULSE ABSENT,3
BG,PUSTULAR PSORIASIS,3
BG,PYODERMA,3
BG,RALES,3
BG,RASH ERYTHEMATOUS,3
BG,RESPIRATORY TRACT INFECTION,3
BG,RETINAL DETACHMENT,3
BG,RHINORRHOEA,3
BG,SCHIZOPHRENIA,3
BG,SINUS TACHYCARDIA,3
BG,SKIN DISORDER,3
BG,SKIN FISSURES,3
BG,SKIN TOXICITY,3
BG,SPEECH DISORDER,3
BG,SUBARACHNOID HAEMORRHAGE,3
BG,SUBDURAL HAEMATOMA,3
BG,ULCER,3
BG,URINARY INCONTINENCE,3
BG,URINE OUTPUT DECREASED,3
BG,UROSEPSIS,3
BG,VASCULITIS NECROTISING,3
BG,VENTRICULAR EXTRASYSTOLES,3
BG,WEIGHT INCREASED,3
BG,WHITE BLOOD CELL COUNT DECREASED,3
BG,WHITE BLOOD CELL COUNT INCREASED,3
BG,WOUND HAEMORRHAGE,3
BG,ACCIDENTAL OVERDOSE,2
BG,ACUTE LEFT VENTRICULAR FAILURE,2
BG,AGRANULOCYTOSIS,2
BG,ALTERED STATE OF CONSCIOUSNESS,2
BG,ANAL FISTULA,2
BG,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY INCREASED,2
BG,AORTIC VALVE INCOMPETENCE,2
BG,APHTHOUS STOMATITIS,2
BG,ARTHROPATHY,2
BG,ATRIOVENTRICULAR BLOCK,2
BG,ATRIOVENTRICULAR BLOCK COMPLETE,2
BG,AUTOIMMUNE HAEMOLYTIC ANAEMIA,2
BG,BASAL CELL CARCINOMA,2
BG,BLADDER DIVERTICULUM,2
BG,BLINDNESS UNILATERAL,2
BG,BLOOD ALKALINE PHOSPHATASE INCREASED,2
BG,BLOOD BILIRUBIN INCREASED,2
BG,BLOOD THYROID STIMULATING HORMONE DECREASED,2
BG,BLOOD URIC ACID INCREASED,2
BG,BONE LESION,2
BG,BRADYARRHYTHMIA,2
BG,BRADYPNOEA,2
BG,BRONCHIOLITIS,2
BG,BUNDLE BRANCH BLOCK RIGHT,2
BG,BURSITIS,2
BG,C-REACTIVE PROTEIN INCREASED,2
BG,CACHEXIA,2
BG,CARDIOVASCULAR SYMPTOM,2
BG,CAROTID ARTERY THROMBOSIS,2
BG,CATARACT,2
BG,CEREBRAL INFARCTION,2
BG,CERVICAL RADICULOPATHY,2
BG,CERVIX CARCINOMA,2
BG,CHROMATOPSIA,2
BG,CHRONIC GASTRITIS,2
BG,COAGULATION TIME PROLONGED,2
BG,COGNITIVE DISORDER,2
BG,COLITIS ULCERATIVE,2
BG,COLORECTAL CANCER,2
BG,CONCOMITANT DISEASE AGGRAVATED,2
BG,CONJUNCTIVAL HYPERAEMIA,2
BG,CONTUSION,2
BG,CORONARY ARTERY ANEURYSM,2
BG,CORONARY ARTERY OCCLUSION,2
BG,CORONARY ARTERY RESTENOSIS,2
BG,CRYING,2
BG,CYTOPENIA,2
BG,DEHYDRATION,2
BG,DELIRIUM,2
BG,DERMATITIS BULLOUS,2
BG,DERMATITIS EXFOLIATIVE,2
BG,DIABETES MELLITUS,2
BG,DIABETES MELLITUS INADEQUATE CONTROL,2
BG,DIABETIC NEUROPATHY,2
BG,DIASTOLIC DYSFUNCTION,2
BG,DISSEMINATED INTRAVASCULAR COAGULATION,2
BG,DRUG ABUSE,2
BG,DRUG ADMINISTRATION ERROR,2
BG,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
BG,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
BG,DUODENAL ULCER PERFORATION,2
BG,DYSKINESIA,2
BG,DYSLIPIDAEMIA,2
BG,EAR INFECTION,2
BG,EPILEPSY,2
BG,ERECTILE DYSFUNCTION,2
BG,EXTRAVASATION,2
BG,EXTRAVASATION BLOOD,2
BG,EYE HAEMORRHAGE,2
BG,EYE INFECTION,2
BG,EYE SWELLING,2
BG,EYELID PTOSIS,2
BG,FACE OEDEMA,2
BG,FEBRILE NEUTROPENIA,2
BG,FEELING ABNORMAL,2
BG,FEELING HOT,2
BG,FEMORAL NECK FRACTURE,2
BG,FLUID RETENTION,2
BG,FOAMING AT MOUTH,2
BG,FORMICATION,2
BG,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
BG,GASTROENTERITIS,2
BG,GASTROINTESTINAL MOTILITY DISORDER,2
BG,GINGIVAL BLEEDING,2
BG,GINGIVAL PAIN,2
BG,GOITRE,2
BG,HAEMOGLOBIN ABNORMAL,2
BG,HAEMORRHAGIC ANAEMIA,2
BG,HAEMORRHAGIC DIATHESIS,2
BG,HAEMORRHAGIC EROSIVE GASTRITIS,2
BG,HALLUCINATION,2
BG,HEAD DISCOMFORT,2
BG,HENOCH-SCHONLEIN PURPURA,2
BG,HEPATIC CANCER METASTATIC,2
BG,HEPATIC PAIN,2
BG,HEPATITIS A,2
BG,HEPATOTOXICITY,2
BG,HERPES SIMPLEX,2
BG,HERPES ZOSTER,2
BG,HIRSUTISM,2
BG,HOT FLUSH,2
BG,HYDROURETER,2
BG,HYPOKALAEMIA,2
BG,HYPONATRAEMIA,2
BG,HYPOPNOEA,2
BG,HYPORESPONSIVE TO STIMULI,2
BG,IMPETIGO,2
BG,INCORRECT PRODUCT STORAGE,2
BG,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
BG,INFUSION RELATED REACTION,2
BG,INTERNATIONAL NORMALISED RATIO INCREASED,2
BG,INTRAOCULAR PRESSURE INCREASED,2
BG,INVASIVE DUCTAL BREAST CARCINOMA,2
BG,IRON DEFICIENCY ANAEMIA,2
BG,IRREGULAR BREATHING,2
BG,IRRITABLE BOWEL SYNDROME,2
BG,JOINT DESTRUCTION,2
BG,LARYNGEAL CANCER,2
BG,LEFT ATRIAL DILATATION,2
BG,LEFT VENTRICULAR DYSFUNCTION,2
BG,LIVER INJURY,2
BG,LOCALISED OEDEMA,2
BG,LUNG DISORDER,2
BG,LUPUS-LIKE SYNDROME,2
BG,LYMPHOCYTE COUNT DECREASED,2
BG,LYMPHOMA,2
BG,MACULAR OEDEMA,2
BG,MACULE,2
BG,MATERNAL EXPOSURE BEFORE PREGNANCY,2
BG,MENINGITIS,2
BG,MENSTRUATION IRREGULAR,2
BG,METABOLIC ENCEPHALOPATHY,2
BG,METASTASES TO ABDOMINAL WALL,2
BG,METASTASES TO HEART,2
BG,METASTASES TO SPINE,2
BG,MIOSIS,2
BG,MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY,2
BG,MITRAL VALVE SCLEROSIS,2
BG,MUCOSAL DRYNESS,2
BG,MUCOSAL INFLAMMATION,2
BG,MUSCLE ATROPHY,2
BG,MUSCLE RIGIDITY,2
BG,MYDRIASIS,2
BG,NEOPLASM,2
BG,NEOPLASM MALIGNANT,2
BG,NERVOUSNESS,2
BG,NEUROLOGICAL SYMPTOM,2
BG,NIH STROKE SCALE ABNORMAL,2
BG,NYSTAGMUS,2
BG,OBSTRUCTIVE AIRWAYS DISORDER,2
BG,OCULAR HYPERAEMIA,2
BG,ONYCHOCLASIS,2
BG,ORAL MUCOSAL BLISTERING,2
BG,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
BG,PANCREATITIS,2
BG,PAPILLOEDEMA,2
BG,PAPULE,2
BG,PARONYCHIA,2
BG,PAROTITIS,2
BG,PATHOGEN RESISTANCE,2
BG,PATHOLOGICAL FRACTURE,2
BG,PELVIC PAIN,2
BG,PERICARDIAL HAEMORRHAGE,2
BG,PERICARDITIS,2
BG,PERIODONTITIS,2
BG,PERIORBITAL OEDEMA,2
BG,PERIPHERAL COLDNESS,2
BG,POLLAKIURIA,2
BG,POLYURIA,2
BG,PREMATURE DELIVERY,2
BG,PRESCRIBED UNDERDOSE,2
BG,PRODUCTIVE COUGH,2
BG,PROSTATIC SPECIFIC ANTIGEN INCREASED,2
BG,PRURITUS GENERALISED,2
BG,PULMONARY ARTERIAL HYPERTENSION,2
BG,PURULENT DISCHARGE,2
BG,RASH PAPULAR,2
BG,RECTAL ADENOCARCINOMA,2
BG,RECTAL CANCER,2
BG,RED BLOOD CELL COUNT DECREASED,2
BG,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
BG,RENAL CYST,2
BG,RENAL IMPAIRMENT,2
BG,RESPIRATORY DEPRESSION,2
BG,RESTLESSNESS,2
BG,RHEUMATOID ARTHRITIS,2
BG,SALIVARY HYPERSECRETION,2
BG,SEPSIS,2
BG,SEPTIC SHOCK,2
BG,SIMPLE PARTIAL SEIZURES,2
BG,SKIN EXFOLIATION,2
BG,SKIN HAEMORRHAGE,2
BG,SKIN LESION,2
BG,SKIN ULCER,2
BG,SPINAL OSTEOARTHRITIS,2
BG,SPINAL PAIN,2
BG,SPLENOMEGALY,2
BG,STAPHYLOCOCCAL SEPSIS,2
BG,STAPHYLOCOCCAL SKIN INFECTION,2
BG,STUPOR,2
BG,SUDDEN DEATH,2
BG,SUSPECTED COUNTERFEIT PRODUCT,2
BG,TACHYARRHYTHMIA,2
BG,TINNITUS,2
BG,TOOTH DISORDER,2
BG,TOOTHACHE,2
BG,TRAUMATIC INTRACRANIAL HAEMORRHAGE,2
BG,TREATMENT NONCOMPLIANCE,2
BG,TRICUSPID VALVE SCLEROSIS,2
BG,TROPONIN INCREASED,2
BG,TUBULOINTERSTITIAL NEPHRITIS,2
BG,UNDERDOSE,2
BG,UNEVALUABLE EVENT,2
BG,UPPER RESPIRATORY TRACT INFECTION,2
BG,URINARY BLADDER HAEMORRHAGE,2
BG,URINARY RETENTION,2
BG,UTERINE CANCER,2
BG,UTERINE LEIOMYOMA,2
BG,UVEITIS,2
BG,VASCULAR STENT RESTENOSIS,2
BG,VENOUS THROMBOSIS,2
BG,VISUAL ACUITY REDUCED,2
BG,VISUAL FIELD DEFECT,2
BG,WEIGHT ABNORMAL,2
BG,WOUND,2
BG,WOUND INFECTION,2
BG,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
BG,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
BG,YELLOW SKIN,2
BG,ABASIA,1
BG,ABDOMINAL HERNIA REPAIR,1
BG,ABDOMINAL NEOPLASM,1
BG,ABDOMINAL RIGIDITY,1
BG,ABDOMINAL WALL HAEMATOMA,1
BG,ABNORMAL FAECES,1
BG,ABORTION,1
BG,ABORTION MISSED,1
BG,ABSCESS DRAINAGE,1
BG,ABSCESS OF SALIVARY GLAND,1
BG,ACCIDENT,1
BG,ACCIDENTAL EXPOSURE TO PRODUCT,1
BG,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
BG,ACQUIRED GENE MUTATION,1
BG,ACUTE ABDOMEN,1
BG,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
BG,ACUTE HAEMORRHAGIC ULCERATIVE COLITIS,1
BG,ACUTE LEUKAEMIA,1
BG,ACUTE LYMPHOCYTIC LEUKAEMIA,1
BG,ACUTE MYELOID LEUKAEMIA,1
BG,ACUTE PSYCHOSIS,1
BG,ACUTE RESPIRATORY DISTRESS SYNDROME,1
BG,ACUTE SINUSITIS,1
BG,ADENOCARCINOMA GASTRIC,1
BG,ADRENAL ADENOMA,1
BG,ADRENAL INSUFFICIENCY,1
BG,ADRENAL MASS,1
BG,ADVERSE EVENT,1
BG,AFFECTIVE DISORDER,1
BG,AKATHISIA,1
BG,ALBUMINURIA,1
BG,ALDOLASE ABNORMAL,1
BG,ALLERGIC GRANULOMATOUS ANGIITIS,1
BG,ALPHA 1 FOETOPROTEIN INCREASED,1
BG,AMMONIA INCREASED,1
BG,AMNESIA,1
BG,AMNIORRHOEA,1
BG,AMYLASE INCREASED,1
BG,ANAEMIA HAEMOLYTIC AUTOIMMUNE,1
BG,ANAEMIA MACROCYTIC,1
BG,ANAL ABSCESS,1
BG,ANAL FISSURE,1
BG,ANAL INCONTINENCE,1
BG,ANAL PRURITUS,1
BG,ANASTOMOTIC COMPLICATION,1
BG,ANTI-THYROID ANTIBODY POSITIVE,1
BG,ANTINUCLEAR ANTIBODY POSITIVE,1
BG,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,1
BG,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
BG,AORTIC DILATATION,1
BG,AORTIC DISSECTION,1
BG,AORTIC THROMBOSIS,1
BG,AREFLEXIA,1
BG,ARTERIAL INSUFFICIENCY,1
BG,ARTERIOSCLEROTIC RETINOPATHY,1
BG,ARTHRITIS,1
BG,ASPIRATION,1
BG,ASTIGMATISM,1
BG,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
BG,AUTOIMMUNE THYROIDITIS,1
BG,AUTOIMMUNE UVEITIS,1
BG,BACTERIAL SEPSIS,1
BG,BASE EXCESS DECREASED,1
BG,BASEDOW^S DISEASE,1
BG,BILE DUCT STONE,1
BG,BILIARY CIRRHOSIS,1
BG,BLADDER TAMPONADE,1
BG,BLADDER TRANSITIONAL CELL CARCINOMA,1
BG,BLEPHAROSPASM,1
BG,BLINDNESS TRANSIENT,1
BG,BLOOD ALBUMIN ABNORMAL,1
BG,BLOOD ALBUMIN DECREASED,1
BG,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
BG,BLOOD CALCIUM DECREASED,1
BG,BLOOD CHOLESTEROL INCREASED,1
BG,BLOOD CHOLINESTERASE INCREASED,1
BG,BLOOD CREATINE INCREASED,1
BG,BLOOD CREATINE PHOSPHOKINASE ABNORMAL,1
BG,BLOOD CREATINE PHOSPHOKINASE MB,1
BG,BLOOD CREATININE ABNORMAL,1
BG,BLOOD FIBRINOGEN DECREASED,1
BG,BLOOD GLUCOSE ABNORMAL,1
BG,BLOOD HIV RNA INCREASED,1
BG,BLOOD HOMOCYSTEINE INCREASED,1
BG,BLOOD IRON DECREASED,1
BG,BLOOD PARATHYROID HORMONE INCREASED,1
BG,BLOOD PH DECREASED,1
BG,BLOOD POTASSIUM DECREASED,1
BG,BLOOD PRESSURE ABNORMAL,1
BG,BLOOD PRESSURE DIASTOLIC ABNORMAL,1
BG,BLOOD PRESSURE FLUCTUATION,1
BG,BLOOD PRESSURE SYSTOLIC DECREASED,1
BG,BLOOD SODIUM DECREASED,1
BG,BLOOD TESTOSTERONE DECREASED,1
BG,BLOOD TESTOSTERONE INCREASED,1
BG,BLOOD TRIGLYCERIDES INCREASED,1
BG,BODY MASS INDEX DECREASED,1
BG,BODY TEMPERATURE ABNORMAL,1
BG,BONE GIANT CELL TUMOUR,1
BG,BRADYPHRENIA,1
BG,BRAIN COMPRESSION,1
BG,BRAIN DEATH,1
BG,BRAIN NEOPLASM,1
BG,BREECH PRESENTATION,1
BG,BRONCHIECTASIS,1
BG,BRONCHITIS CHRONIC,1
BG,BRONCHOPNEUMONIA,1
BG,BUNDLE BRANCH BLOCK LEFT,1
BG,CALCULUS BLADDER,1
BG,CANDIDA SEPSIS,1
BG,CARBOHYDRATE ANTIGEN 19-9 INCREASED,1
BG,CARCINOEMBRYONIC ANTIGEN INCREASED,1
BG,CARDIAC ANEURYSM,1
BG,CARDIAC ASTHMA,1
BG,CARDIAC CIRRHOSIS,1
BG,CARDIAC TAMPONADE,1
BG,CARDIAC VALVE DISEASE,1
BG,CARDIAC VALVE VEGETATION,1
BG,CARDIORENAL SYNDROME,1
BG,CARDIOTOXICITY,1
BG,CARDIOVASCULAR INSUFFICIENCY,1
BG,CAROTID ARTERY OCCLUSION,1
BG,CATARACT CORTICAL,1
BG,CAUDA EQUINA SYNDROME,1
BG,CELLULITIS,1
BG,CEREBELLAR ATROPHY,1
BG,CEREBRAL HAEMATOMA,1
BG,CEREBRAL HYGROMA,1
BG,CEREBRAL ISCHAEMIA,1
BG,CERVIX CARCINOMA STAGE 0,1
BG,CHANGE OF BOWEL HABIT,1
BG,CHEMICAL BURN OF GASTROINTESTINAL TRACT,1
BG,CHEMICAL PERITONITIS,1
BG,CHOKING,1
BG,CHOLANGITIS,1
BG,CHOLANGITIS ACUTE,1
BG,CHOLECYSTITIS ACUTE,1
BG,CHOLECYSTITIS CHRONIC,1
BG,CHOLECYSTITIS INFECTIVE,1
BG,CHOREA,1
BG,CHORIORETINAL ATROPHY,1
BG,CHRONIC ALLOGRAFT NEPHROPATHY,1
BG,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
BG,CHRONIC LYMPHOCYTIC LEUKAEMIA (IN REMISSION),1
BG,CHRONIC MYELOID LEUKAEMIA,1
BG,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
BG,CHRONIC RESPIRATORY FAILURE,1
BG,CITROBACTER INFECTION,1
BG,CLEAR CELL RENAL CELL CARCINOMA,1
BG,CLOSTRIDIUM DIFFICILE COLITIS,1
BG,COAGULATION TIME SHORTENED,1
BG,COAGULOPATHY,1
BG,COLLAGEN DISORDER,1
BG,COLON ADENOMA,1
BG,COMA HEPATIC,1
BG,COMMUNICATION DISORDER,1
BG,CONGENITAL NEUROLOGICAL DISORDER,1
BG,CONGESTIVE CARDIOMYOPATHY,1
BG,CONJUNCTIVAL HAEMORRHAGE,1
BG,CORNEAL EROSION,1
BG,CORNEAL LESION,1
BG,CORONARY ARTERY BYPASS,1
BG,CORONARY ARTERY DISSECTION,1
BG,CORONARY ARTERY THROMBOSIS,1
BG,CRANIAL NERVE DISORDER,1
BG,CRANIOCEREBRAL INJURY,1
BG,CREATININE RENAL CLEARANCE ABNORMAL,1
BG,CREATININE RENAL CLEARANCE DECREASED,1
BG,CREPITATIONS,1
BG,CROHN^S DISEASE,1
BG,CSF PROTEIN INCREASED,1
BG,CUSHING^S SYNDROME,1
BG,CYANOPSIA,1
BG,CYANOSIS CENTRAL,1
BG,CYSTIC FIBROSIS PANCREATIC,1
BG,CYTOMEGALOVIRUS INFECTION,1
BG,DARK CIRCLES UNDER EYES,1
BG,DEAFNESS BILATERAL,1
BG,DECUBITUS ULCER,1
BG,DELAYED PUBERTY,1
BG,DELUSION,1
BG,DEMYELINATING POLYNEUROPATHY,1
BG,DENTAL OPERATION,1
BG,DENTAL RESTORATION FAILURE,1
BG,DEREALISATION,1
BG,DERMATOMYOSITIS,1
BG,DEVICE ISSUE,1
BG,DEVICE OCCLUSION,1
BG,DIABETES INSIPIDUS,1
BG,DIABETIC FOETOPATHY,1
BG,DILATATION ATRIAL,1
BG,DIPLOPIA,1
BG,DNA ANTIBODY POSITIVE,1
BG,DROWNING,1
BG,DRUG DISPENSING ERROR,1
BG,DRUG EFFECT DECREASED,1
BG,DRUG EFFECT INCOMPLETE,1
BG,DRUG ERUPTION,1
BG,DRUG LEVEL DECREASED,1
BG,DRUG PRESCRIBING ERROR,1
BG,DRUG RESISTANCE,1
BG,DRUG SPECIFIC ANTIBODY PRESENT,1
BG,DRY EYE,1
BG,DUODENITIS,1
BG,DUODENITIS HAEMORRHAGIC,1
BG,DYSHIDROTIC ECZEMA,1
BG,DYSPNOEA AT REST,1
BG,DYSPNOEA EXERTIONAL,1
BG,DYSPRAXIA,1
BG,ECTOPIC PREGNANCY,1
BG,ECZEMA IMPETIGINOUS,1
BG,ELECTROCARDIOGRAM ABNORMAL,1
BG,ELECTROCARDIOGRAM PR PROLONGATION,1
BG,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
BG,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
BG,EMBOLISM,1
BG,EMPHYSEMA,1
BG,ENCEPHALITIS,1
BG,ENCEPHALITIS VIRAL,1
BG,ENDOCARDITIS,1
BG,ENDOMETRIAL ADENOCARCINOMA,1
BG,ENDOMETRIAL ATROPHY,1
BG,ENDOMETRIAL CANCER,1
BG,ENDOMETRIAL HYPERPLASIA,1
BG,ENDOTRACHEAL INTUBATION COMPLICATION,1
BG,ENTEROBACTER SEPSIS,1
BG,ENTEROCUTANEOUS FISTULA,1
BG,ENTEROSTOMY,1
BG,EPIDERMOLYSIS,1
BG,EPIPHYSES DELAYED FUSION,1
BG,EPISCLERITIS,1
BG,EROSIVE DUODENITIS,1
BG,ERYTHEMA NODOSUM,1
BG,ESCHERICHIA URINARY TRACT INFECTION,1
BG,ESSENTIAL THROMBOCYTHAEMIA,1
BG,EXOPHTHALMOS,1
BG,EXPIRED DRUG ADMINISTERED,1
BG,EXPOSURE VIA PARTNER,1
BG,EXTRAPYRAMIDAL DISORDER,1
BG,EXTRASYSTOLES,1
BG,EYE IRRITATION,1
BG,EYE MOVEMENT DISORDER,1
BG,EYE PAIN,1
BG,EYELID RASH,1
BG,FACIAL PAIN,1
BG,FAECES PALE,1
BG,FASCIITIS,1
BG,FEEDING DISORDER,1
BG,FEMUR FRACTURE,1
BG,FIBRIN D DIMER INCREASED,1
BG,FIBROADENOMA OF BREAST,1
BG,FISTULA,1
BG,FLOPPY IRIS SYNDROME,1
BG,FLUID INTAKE REDUCED,1
BG,FLUID OVERLOAD,1
BG,FOETAL EXPOSURE DURING DELIVERY,1
BG,FOOD INTERACTION,1
BG,FRACTURE,1
BG,FREQUENT BOWEL MOVEMENTS,1
BG,FURUNCLE,1
BG,GAIT INABILITY,1
BG,GAMMA-GLUTAMYLTRANSFERASE,1
BG,GASTRITIS HAEMORRHAGIC,1
BG,GASTRODUODENITIS HAEMORRHAGIC,1
BG,GASTROINTESTINAL BACTERIAL INFECTION,1
BG,GASTROINTESTINAL TOXICITY,1
BG,GASTROINTESTINAL ULCER,1
BG,GASTROINTESTINAL ULCER HAEMORRHAGE,1
BG,GELATINOUS TRANSFORMATION OF THE BONE MARROW,1
BG,GENITAL BURNING SENSATION,1
BG,GENITAL HYPOAESTHESIA,1
BG,GENITAL INFECTION,1
BG,GENITAL PAIN,1
BG,GENITAL ULCERATION,1
BG,GINGIVAL DISORDER,1
BG,GINGIVAL INFECTION,1
BG,GLIOBLASTOMA,1
BG,GLIOMA,1
BG,GLOMERULONEPHRITIS CHRONIC,1
BG,GLOMERULONEPHRITIS MEMBRANOUS,1
BG,GLOSSITIS,1
BG,GLOSSODYNIA,1
BG,GLUCOSE TOLERANCE IMPAIRED,1
BG,GRAFT LOSS,1
BG,GRANULOCYTE COUNT DECREASED,1
BG,GRANULOCYTOPENIA,1
BG,GRANULOMATOSIS WITH POLYANGIITIS,1
BG,GROIN PAIN,1
BG,GROWTH OF EYELASHES,1
BG,GUILLAIN-BARRE SYNDROME,1
BG,GYNAECOMASTIA,1
BG,HAEMANGIOMA,1
BG,HAEMATOTOXICITY,1
BG,HAEMOGLOBIN URINE PRESENT,1
BG,HAEMOLYTIC ANAEMIA,1
BG,HAEMORRHAGE IN PREGNANCY,1
BG,HAEMORRHAGIC CEREBRAL INFARCTION,1
BG,HAEMORRHAGIC INFARCTION,1
BG,HAEMORRHOIDAL HAEMORRHAGE,1
BG,HAEMOSIDEROSIS,1
BG,HAIR COLOUR CHANGES,1
BG,HAIR GROWTH ABNORMAL,1
BG,HEART RATE ABNORMAL,1
BG,HEART SOUNDS ABNORMAL,1
BG,HEART VALVE INCOMPETENCE,1
BG,HEPATIC CIRRHOSIS,1
BG,HEPATIC CYST,1
BG,HEPATIC FUNCTION ABNORMAL,1
BG,HEPATIC LESION,1
BG,HEPATIC MASS,1
BG,HEPATIC NEOPLASM,1
BG,HEPATIC STEATOSIS,1
BG,HEPATITIS ACUTE,1
BG,HEPATITIS B,1
BG,HEPATITIS B VIRUS TEST POSITIVE,1
BG,HEPATITIS C VIRUS TEST POSITIVE,1
BG,HEPATITIS E,1
BG,HEPATOBILIARY DISEASE,1
BG,HEPATOCELLULAR INJURY,1
BG,HEPATORENAL SYNDROME,1
BG,HICCUPS,1
BG,HIGH DENSITY LIPOPROTEIN DECREASED,1
BG,HIP FRACTURE,1
BG,HODGKIN^S DISEASE,1
BG,HOSPITALISATION,1
BG,HYPERAEMIA,1
BG,HYPERCALCAEMIA,1
BG,HYPERCALCIURIA,1
BG,HYPERCHOLESTEROLAEMIA,1
BG,HYPERCORTICOIDISM,1
BG,HYPERINSULINAEMIA,1
BG,HYPERPROLACTINAEMIA,1
BG,HYPERPYREXIA,1
BG,HYPERREFLEXIA,1
BG,HYPERSENSITIVITY VASCULITIS,1
BG,HYPERTONIA,1
BG,HYPERTRICHOSIS,1
BG,HYPERVENTILATION,1
BG,HYPOCALCAEMIA,1
BG,HYPOCHROMIC ANAEMIA,1
BG,HYPOGLYCAEMIA NEONATAL,1
BG,HYPOGLYCAEMIC COMA,1
BF,VIROLOGIC FAILURE,33
BF,FOETAL EXPOSURE DURING PREGNANCY,14
BF,VIRAL MUTATION IDENTIFIED,13
BF,DRUG RESISTANCE,12
BF,EXPOSURE DURING BREAST FEEDING,8
BF,DEATH,5
BF,ABORTION SPONTANEOUS,4
BF,DYSPNOEA,3
BF,EXPOSURE DURING PREGNANCY,3
BF,PYREXIA,3
BF,TREATMENT FAILURE,3
BF,ANAEMIA,2
BF,ANXIETY,2
BF,BLISTER,2
BF,CHEST DISCOMFORT,2
BF,DISCOMFORT,2
BF,DIZZINESS,2
BF,PALPITATIONS,2
BF,PELVIC FLUID COLLECTION,2
BF,PLACENTA PRAEVIA,2
BF,PREMATURE BABY,2
BF,PRESYNCOPE,2
BF,SKIN EXFOLIATION,2
BF,TOXIC EPIDERMAL NECROLYSIS,2
BF,VENTRICULAR TACHYCARDIA,2
BF,ACUTE MYELOID LEUKAEMIA,1
BF,BLINDNESS,1
BF,BRAIN ABSCESS,1
BF,CARDIAC ARREST,1
BF,CHRONIC KIDNEY DISEASE,1
BF,CHRONIC MYELOID LEUKAEMIA,1
BF,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
BF,DRUG INEFFECTIVE,1
BF,ECTOPIC PREGNANCY,1
BF,ELECTROCARDIOGRAM QT PROLONGED,1
BF,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
BF,EPISTAXIS,1
BF,FOETAL DISTRESS SYNDROME,1
BF,GENERAL PHYSICAL HEALTH DETERIORATION,1
BF,HIV INFECTION,1
BF,HYPERALDOSTERONISM,1
BF,HYPERCHOLESTEROLAEMIA,1
BF,LEUKOCYTOSIS,1
BF,LEUKOPENIA,1
BF,LONG QT SYNDROME,1
BF,LYMPHADENOPATHY,1
BF,MALARIA,1
BF,MATERNAL EXPOSURE DURING PREGNANCY,1
BF,MENINGEAL DISORDER,1
BF,MYELOCYTOSIS,1
BF,NEUTROPENIA,1
BF,NODULE,1
BF,PREMATURE DELIVERY,1
BF,RASH GENERALISED,1
BF,RASH MACULAR,1
BF,RENAL FAILURE,1
BF,RESPIRATORY DISTRESS,1
BF,RETINAL HAEMORRHAGE,1
BF,SEPSIS,1
BF,SHOCK HAEMORRHAGIC,1
BF,SKIN LESION,1
BF,SPLENOMEGALY,1
BF,THROMBOCYTOPENIA,1
BF,TOXICITY TO VARIOUS AGENTS,1
BF,TUBERCULOSIS,1
BF,VISION BLURRED,1
BI,VIROLOGIC FAILURE,11
BI,DRUG RESISTANCE,10
BI,DRUG INEFFECTIVE,2
BI,PREGNANCY WITH IMPLANT CONTRACEPTIVE,2
BI,TREATMENT NONCOMPLIANCE,2
BI,DRUG LEVEL DECREASED,1
BI,VIRAL LOAD INCREASED,1
KH,PYREXIA,8
KH,ASTHENIA,7
KH,FATIGUE,7
KH,DEATH,6
KH,ANAEMIA,5
KH,MUSCULAR WEAKNESS,5
KH,THROMBOCYTOPENIA,5
KH,VOMITING,5
KH,DIZZINESS,4
KH,EXPOSURE DURING PREGNANCY,4
KH,GENERAL PHYSICAL HEALTH DETERIORATION,4
KH,HAEMOGLOBIN DECREASED,4
KH,MALIGNANT NEOPLASM PROGRESSION,4
KH,PLATELET COUNT DECREASED,4
KH,WHITE BLOOD CELL COUNT INCREASED,4
KH,ABORTION SPONTANEOUS,3
KH,AKATHISIA,3
KH,ANXIETY,3
KH,BONE MARROW FAILURE,3
KH,CEREBRAL HAEMORRHAGE,3
KH,DEPRESSION,3
KH,DIARRHOEA,3
KH,DRUG INEFFECTIVE,3
KH,FEELING ABNORMAL,3
KH,GASTRITIS,3
KH,IMPAIRED WORK ABILITY,3
KH,LOSS OF CONSCIOUSNESS,3
KH,MALAISE,3
KH,MEMORY IMPAIRMENT,3
KH,MIGRAINE,3
KH,NAUSEA,3
KH,RESPIRATORY DEPRESSION,3
KH,TREMOR,3
KH,VISUAL IMPAIRMENT,3
KH,WHITE BLOOD CELL COUNT DECREASED,3
KH,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,2
KH,CHRONIC MYELOID LEUKAEMIA,2
KH,DUODENOGASTRIC REFLUX,2
KH,ERYTHEMA NODOSUM,2
KH,GASTROINTESTINAL STROMAL TUMOUR,2
KH,HAEMORRHAGE,2
KH,INSOMNIA,2
KH,INTESTINAL OBSTRUCTION,2
KH,LEUKOCYTOSIS,2
KH,LYMPHADENOPATHY,2
KH,MICROCYTIC ANAEMIA,2
KH,MUSCULOSKELETAL PAIN,2
KH,MYALGIA,2
KH,NEUTROPHIL COUNT DECREASED,2
KH,PAIN,2
KH,PARALYSIS,2
KH,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
KH,ROAD TRAFFIC ACCIDENT,2
KH,SEIZURE,2
KH,THROMBOCYTOSIS,2
KH,ABDOMINAL DISCOMFORT,1
KH,ABDOMINAL MASS,1
KH,ABORTION INDUCED,1
KH,ABSCESS NECK,1
KH,ACUTE LYMPHOCYTIC LEUKAEMIA,1
KH,ACUTE MYELOID LEUKAEMIA,1
KH,ALANINE AMINOTRANSFERASE DECREASED,1
KH,ALANINE AMINOTRANSFERASE INCREASED,1
KH,ARTHRALGIA,1
KH,ASCITES,1
KH,ASPARTATE AMINOTRANSFERASE DECREASED,1
KH,ASPARTATE AMINOTRANSFERASE INCREASED,1
KH,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
KH,BACK PAIN,1
KH,BALANCE DISORDER,1
KH,BICYTOPENIA,1
KH,BLOOD ALBUMIN DECREASED,1
KH,BONE MARROW RETICULIN FIBROSIS,1
KH,BRONCHIOLITIS,1
KH,CARDIAC FAILURE,1
KH,CEREBRAL DISORDER,1
KH,CEREBROVASCULAR ACCIDENT,1
KH,CHILLS,1
KH,CHRONIC GASTROINTESTINAL BLEEDING,1
KH,CHRONIC KIDNEY DISEASE,1
KH,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
KH,COGNITIVE DISORDER,1
KH,COMA,1
KH,CONJUNCTIVAL HAEMORRHAGE,1
KH,CONTUSION,1
KH,DECEREBRATION,1
KH,DECREASED APPETITE,1
KH,DELIRIUM,1
KH,DIABETIC HYPEROSMOLAR COMA,1
KH,DRUG INTOLERANCE,1
KH,DRUG RESISTANCE,1
KH,DRUG-INDUCED LIVER INJURY,1
KH,DYSENTERY,1
KH,DYSPNOEA,1
KH,ECLAMPSIA,1
KH,ELECTROCARDIOGRAM ABNORMAL,1
KH,ESCHAR,1
KH,FEELING HOT,1
KH,FOETAL DEATH,1
KH,GAIT DISTURBANCE,1
KH,GASTROENTERITIS,1
KH,GASTROINTESTINAL HAEMORRHAGE,1
KH,GASTROINTESTINAL PERFORATION,1
KH,GASTROOESOPHAGEAL REFLUX DISEASE,1
KH,GINGIVAL BLEEDING,1
KH,HAEMATOCHEZIA,1
KH,HAEMOGLOBIN INCREASED,1
KH,HEADACHE,1
KH,HEART RATE INCREASED,1
KH,HEMIPLEGIA,1
KH,HEPATIC LESION,1
KH,HOSPITALISATION,1
KH,HYPERPLASIA,1
KH,HYPOAESTHESIA,1
KH,HYPOPHAGIA,1
KH,HYPOTENSION,1
KH,INCREASED TENDENCY TO BRUISE,1
KH,INJECTION SITE HAEMORRHAGE,1
KH,INJECTION SITE NECROSIS,1
KH,INJECTION SITE SWELLING,1
KH,JAUNDICE,1
KH,KELOID SCAR,1
KH,LEUKOPENIA,1
KH,LIVER INJURY,1
KH,LUNG ADENOCARCINOMA,1
KH,MATERNAL EXPOSURE DURING PREGNANCY,1
KH,MENORRHAGIA,1
KH,METASTASES TO ABDOMINAL CAVITY,1
KH,METASTASES TO LIVER,1
KH,METASTASES TO LUNG,1
KH,METASTASES TO PELVIS,1
KH,METASTATIC NEOPLASM,1
KH,MULTI-ORGAN FAILURE,1
KH,MUSCLE TWITCHING,1
KH,NERVE ROOT COMPRESSION,1
KH,NEURALGIA,1
KH,NEUTROPENIA,1
KH,NIGHT SWEATS,1
KH,NO THERAPEUTIC RESPONSE,1
KH,ORAL DISCOMFORT,1
KH,PERITONITIS,1
KH,PHLEBITIS,1
KH,PLASMA CELL MYELOMA,1
KH,PNEUMONIA,1
KH,PNEUMONIA ASPIRATION,1
KH,PNEUMONIA KLEBSIELLA,1
KH,PRESCRIBED OVERDOSE,1
KH,RED BLOOD CELL COUNT DECREASED,1
KH,RENAL TRANSPLANT,1
KH,RESPIRATORY FAILURE,1
KH,SECOND PRIMARY MALIGNANCY,1
KH,SEPSIS,1
KH,SEPTIC SHOCK,1
KH,SEROTONIN SYNDROME,1
KH,SKIN DISORDER,1
KH,SKIN MASS,1
KH,SPEECH DISORDER,1
KH,SPLENOMEGALY,1
KH,TACHYCARDIA,1
KH,TENDERNESS,1
KH,THERAPY CHANGE,1
KH,UNEVALUABLE EVENT,1
KH,VAGINAL HAEMORRHAGE,1
KH,VERTIGO,1
KH,WEIGHT DECREASED,1
CM,DEATH,43
CM,ASTHENIA,27
CM,PYREXIA,18
CM,HEADACHE,15
CM,COMA,11
CM,CONDITION AGGRAVATED,11
CM,ENCEPHALOPATHY,9
CM,MENINGITIS BACTERIAL,9
CM,PARADOXICAL DRUG REACTION,9
CM,ANAEMIA,8
CM,OEDEMA PERIPHERAL,8
CM,SKIN ULCER,8
CM,TOXIC EPIDERMAL NECROLYSIS,8
CM,ABASIA,7
CM,CONJUNCTIVAL HAEMORRHAGE,7
CM,DYSPNOEA,7
CM,PRURITUS,7
CM,GENERALISED OEDEMA,6
CM,ARTHRALGIA,5
CM,DEAFNESS,5
CM,DECREASED APPETITE,5
CM,DERMATITIS BULLOUS,5
CM,DRUG INEFFECTIVE,5
CM,HYPERTENSION,5
CM,MALARIA,5
CM,MYALGIA,5
CM,OCULAR HYPERAEMIA,5
CM,PAIN,5
CM,SKIN LESION,5
CM,STEVENS-JOHNSON SYNDROME,5
CM,VISION BLURRED,5
CM,DEPRESSED LEVEL OF CONSCIOUSNESS,4
CM,DRUG RESISTANCE,4
CM,GAIT DISTURBANCE,4
CM,HAEMORRHAGE,4
CM,HYPERSENSITIVITY,4
CM,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,4
CM,NEUROPATHY PERIPHERAL,4
CM,OEDEMA,4
CM,PRODUCT USE IN UNAPPROVED INDICATION,4
CM,PRURITUS GENERALISED,4
CM,RAYNAUD^S PHENOMENON,4
CM,SKIN EXFOLIATION,4
CM,VERTIGO,4
CM,VITILIGO,4
CM,VOMITING,4
CM,ABDOMINAL PAIN UPPER,3
CM,ABORTION INDUCED,3
CM,ADVERSE EVENT,3
CM,BLINDNESS,3
CM,DIARRHOEA,3
CM,EXPOSURE DURING PREGNANCY,3
CM,FACE OEDEMA,3
CM,FOETAL EXPOSURE DURING PREGNANCY,3
CM,GRANULOMA,3
CM,HYPERTHERMIA,3
CM,INFECTION,3
CM,INFLAMMATION,3
CM,NAUSEA,3
CM,NECROSIS,3
CM,PAIN IN EXTREMITY,3
CM,PALPITATIONS,3
CM,SEIZURE,3
CM,TONSILLAR INFLAMMATION,3
CM,UTERINE HAEMORRHAGE,3
CM,ABDOMINAL DISTENSION,2
CM,ABDOMINAL PAIN,2
CM,ABNORMAL BEHAVIOUR,2
CM,ACTIVITIES OF DAILY LIVING IMPAIRED,2
CM,AGITATION,2
CM,ALCOHOL POISONING,2
CM,ALTERED STATE OF CONSCIOUSNESS,2
CM,APHASIA,2
CM,CEREBRAL PALSY,2
CM,CHILLS,2
CM,CONFUSIONAL STATE,2
CM,DEAFNESS UNILATERAL,2
CM,DERMATITIS EXFOLIATIVE,2
CM,DIZZINESS,2
CM,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
CM,ECCHYMOSIS,2
CM,EYE OEDEMA,2
CM,EYE PAIN,2
CM,FASTING,2
CM,FATIGUE,2
CM,FEELING COLD,2
CM,FINGER AMPUTATION,2
CM,INCOHERENT,2
CM,KAPOSI^S SARCOMA,2
CM,MENINGITIS,2
CM,NASOPHARYNGITIS,2
CM,NEONATAL ASPHYXIA,2
CM,ODYNOPHAGIA,2
CM,PETECHIAE,2
CM,PLACENTA PRAEVIA,2
CM,POSTPARTUM HAEMORRHAGE,2
CM,RASH,2
CM,RASH PUSTULAR,2
CM,SKIN HYPOPIGMENTATION,2
CM,SKIN NECROSIS,2
CM,STILLBIRTH,2
CM,THROMBOCYTOPENIA,2
CM,URTICARIA,2
CM,VIROLOGIC FAILURE,2
CM,VISUAL IMPAIRMENT,2
CM,ABDOMINAL DISCOMFORT,1
CM,ABORTION SPONTANEOUS,1
CM,ACUTE KIDNEY INJURY,1
CM,ALANINE AMINOTRANSFERASE INCREASED,1
CM,AMNESIA,1
CM,ANENCEPHALY,1
CM,ANGINA PECTORIS,1
CM,ANGIOEDEMA,1
CM,ANKYLOGLOSSIA CONGENITAL,1
CM,ARTERIAL RUPTURE,1
CM,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
CM,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
CM,BODY TEMPERATURE INCREASED,1
CM,BONE MARROW FAILURE,1
CM,CEREBELLAR SYNDROME,1
CM,CHOLESTASIS,1
CM,CHRONIC MYELOID LEUKAEMIA,1
CM,COELIAC DISEASE,1
CM,COLITIS ULCERATIVE,1
CM,CONJUNCTIVAL HYPERAEMIA,1
CM,CONTUSION,1
CM,CYTOGENETIC ANALYSIS ABNORMAL,1
CM,CYTOMEGALOVIRUS INFECTION,1
CM,DERMATITIS,1
CM,DERMATOSIS,1
CM,DISEASE PROGRESSION,1
CM,DISORIENTATION,1
CM,DRUG DISPENSING ERROR,1
CM,DRY GANGRENE,1
CM,DYSARTHRIA,1
CM,DYSPHAGIA,1
CM,DYSTONIA,1
CM,ENCEPHALITIS,1
CM,EOSINOPHILIA,1
CM,EOSINOPHILIC PUSTULAR FOLLICULITIS,1
CM,ERECTILE DYSFUNCTION,1
CM,EXTRAPYRAMIDAL DISORDER,1
CM,EYE IRRITATION,1
CM,EYE MOVEMENT DISORDER,1
CM,FACIAL PARALYSIS,1
CM,FALL,1
CM,FILARIASIS,1
CM,GANGRENE,1
CM,GASTRITIS,1
CM,GASTROINTESTINAL DISORDER,1
CM,GENERAL PHYSICAL HEALTH DETERIORATION,1
CM,GENOTYPE DRUG RESISTANCE TEST POSITIVE,1
CM,GRIP STRENGTH DECREASED,1
CM,HAEMATOCHEZIA,1
CM,HAEMATOTOXICITY,1
CM,HAEMOGLOBIN ABNORMAL,1
CM,HEPATIC FAILURE,1
CM,HEPATIC STEATOSIS,1
CM,HEPATITIS,1
CM,HICCUPS,1
CM,HIV INFECTION,1
CM,HOT FLUSH,1
CM,HYPERTENSIVE CRISIS,1
CM,HYPERTONIA,1
CM,HYPOTENSION,1
CM,HYPOTONIA,1
CM,HYPOVOLAEMIC SHOCK,1
CM,INCORRECT DOSE ADMINISTERED,1
CM,INCORRECT DRUG DOSAGE FORM ADMINISTERED,1
CM,INJECTION SITE NECROSIS,1
CM,INJECTION SITE REACTION,1
CM,ISCHAEMIA,1
CM,LIBIDO DISORDER,1
CM,LIMB DISCOMFORT,1
CM,LIP SWELLING,1
CM,LIP ULCERATION,1
CM,LOCALISED OEDEMA,1
CM,LOSS OF CONSCIOUSNESS,1
CM,MACULE,1
CM,MALAISE,1
CM,MATERNAL EXPOSURE DURING PREGNANCY,1
CM,MENTAL DISORDER,1
CM,MOBILITY DECREASED,1
CM,MOUTH ULCERATION,1
CM,MUSCULAR WEAKNESS,1
CM,MUSCULOSKELETAL DISORDER,1
CM,MYCOBACTERIAL INFECTION,1
CM,MYOCARDIAL STUNNING,1
CM,NAIL DISORDER,1
CM,NERVE COMPRESSION,1
CM,NEUTROPENIA,1
CM,NO THERAPEUTIC RESPONSE,1
CM,NORMAL NEWBORN,1
CM,ONYCHOMADESIS,1
CM,ONYCHOMYCOSIS,1
CM,PARESIS,1
CM,PERITONEAL HAEMORRHAGE,1
CM,PNEUMONIA,1
CM,PNEUMOTHORAX,1
CM,POISONING,1
CM,PREGNANCY,1
CM,PULMONARY EMBOLISM,1
CM,PURULENT DISCHARGE,1
CM,RASH PRURITIC,1
CM,RASH VESICULAR,1
CM,RECTAL HAEMORRHAGE,1
CM,RENAL FAILURE,1
CM,RESPIRATORY ARREST,1
CM,RESPIRATORY DISTRESS,1
CM,SEPSIS,1
CM,SKIN GRAFT,1
CM,SPEECH DISORDER,1
CM,SPINAL FRACTURE,1
CM,SPINAL PAIN,1
CM,SUSPECTED COUNTERFEIT PRODUCT,1
CM,TACHYCARDIA,1
CM,TONGUE ULCERATION,1
CM,TRANSAMINASES INCREASED,1
CM,TREATMENT NONCOMPLIANCE,1
CM,ULCER,1
CM,UPPER LIMB FRACTURE,1
CM,UROSEPSIS,1
CM,UTERINE RUPTURE,1
CM,VIRAL MUTATION IDENTIFIED,1
CM,WEIGHT DECREASED,1
CM,WOUND NECROSIS,1
CA,DRUG INEFFECTIVE,13845
CA,DEATH,12093
CA,FATIGUE,9354
CA,NAUSEA,7786
CA,PAIN,7405
CA,DYSPNOEA,7016
CA,MALAISE,6681
CA,DIARRHOEA,6665
CA,ARTHRALGIA,6301
CA,HEADACHE,5996
CA,RHEUMATOID ARTHRITIS,5940
CA,PNEUMONIA,5708
CA,FALL,5034
CA,VOMITING,5007
CA,WEIGHT DECREASED,4858
CA,ASTHENIA,4844
CA,DIZZINESS,4688
CA,COUGH,4321
CA,PAIN IN EXTREMITY,4269
CA,ABDOMINAL PAIN,4205
CA,BLOOD PRESSURE INCREASED,4056
CA,NASOPHARYNGITIS,4034
CA,PYREXIA,3946
CA,PRODUCT USE ISSUE,3188
CA,CONDITION AGGRAVATED,3166
CA,RASH,3165
CA,BACK PAIN,3124
CA,JOINT SWELLING,3114
CA,PERIPHERAL SWELLING,2771
CA,DRUG INTOLERANCE,2674
CA,WEIGHT INCREASED,2671
CA,INFECTION,2663
CA,DECREASED APPETITE,2586
CA,GAIT DISTURBANCE,2583
CA,ASTHMA,2559
CA,PRURITUS,2522
CA,INFLUENZA,2521
CA,INSOMNIA,2491
CA,HYPERTENSION,2434
CA,CROHN^S DISEASE,2423
CA,HYPOTENSION,2277
CA,HAEMOGLOBIN DECREASED,2201
CA,CHEST PAIN,2195
CA,HEART RATE INCREASED,2188
CA,INFUSION RELATED REACTION,2180
CA,URINARY TRACT INFECTION,2166
CA,ANXIETY,2162
CA,ABDOMINAL DISCOMFORT,2161
CA,MYOCARDIAL INFARCTION,2089
CA,ABDOMINAL PAIN UPPER,2051
CA,GENERAL PHYSICAL HEALTH DETERIORATION,2002
CA,DEPRESSION,1935
CA,HYPOAESTHESIA,1910
CA,HYPERSENSITIVITY,1870
CA,CEREBROVASCULAR ACCIDENT,1847
CA,HOSPITALISATION,1828
CA,LOWER RESPIRATORY TRACT INFECTION,1811
CA,FEELING ABNORMAL,1808
CA,SINUSITIS,1806
CA,ERYTHEMA,1803
CA,CONSTIPATION,1748
CA,OROPHARYNGEAL PAIN,1746
CA,BLOOD PRESSURE SYSTOLIC INCREASED,1719
CA,MUSCLE SPASMS,1717
CA,LOSS OF CONSCIOUSNESS,1708
CA,DRUG HYPERSENSITIVITY,1700
CA,BRONCHITIS,1696
CA,CHEST DISCOMFORT,1627
CA,DRUG EFFECT DECREASED,1601
CA,ALOPECIA,1600
CA,MYALGIA,1589
CA,MUSCULOSKELETAL STIFFNESS,1584
CA,DEHYDRATION,1583
CA,INTESTINAL OBSTRUCTION,1570
CA,ARTHROPATHY,1549
CA,CHILLS,1532
CA,ARTHRITIS,1531
CA,TREATMENT FAILURE,1493
CA,PARAESTHESIA,1485
CA,SWELLING,1485
CA,MALIGNANT NEOPLASM PROGRESSION,1484
CA,PRODUCTIVE COUGH,1474
CA,URTICARIA,1463
CA,HAEMATOCHEZIA,1462
CA,CONTUSION,1451
CA,MOBILITY DECREASED,1444
CA,DISEASE PROGRESSION,1443
CA,MUSCULOSKELETAL PAIN,1385
CA,ANAEMIA,1382
CA,INJECTION SITE PAIN,1379
CA,CONFUSIONAL STATE,1376
CA,SOMNOLENCE,1370
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1361
CA,ABDOMINAL DISTENSION,1338
CA,LUNG INFECTION,1324
CA,TREMOR,1311
CA,HYPERHIDROSIS,1286
CA,WHEEZING,1255
CA,OEDEMA PERIPHERAL,1252
CA,DRUG EFFECT INCOMPLETE,1247
CA,PALPITATIONS,1241
CA,HERPES ZOSTER,1210
CA,NEPHROLITHIASIS,1192
CA,HAEMORRHAGE,1183
CA,BLOOD PRESSURE DECREASED,1182
CA,EXPOSURE DURING PREGNANCY,1181
CA,RENAL FAILURE,1181
CA,STRESS,1175
CA,PSORIASIS,1170
CA,SEPSIS,1160
CA,HEART RATE DECREASED,1154
CA,MUSCULAR WEAKNESS,1124
CA,OXYGEN SATURATION DECREASED,1119
CA,SYNOVITIS,1098
CA,WHITE BLOOD CELL COUNT DECREASED,1087
CA,BODY TEMPERATURE DECREASED,1077
CA,HEPATIC ENZYME INCREASED,1074
CA,GASTROINTESTINAL DISORDER,1073
CA,NEOPLASM MALIGNANT,1062
CA,SYNCOPE,1054
CA,CARDIAC DISORDER,1053
CA,OSTEOARTHRITIS,1048
CA,PLATELET COUNT DECREASED,1048
CA,TOXICITY TO VARIOUS AGENTS,1035
CA,DRUG DOSE OMISSION,1028
CA,VISION BLURRED,1026
CA,DIABETES MELLITUS,1023
CA,NASAL CONGESTION,1022
CA,DYSPEPSIA,1017
CA,CELLULITIS,1004
CA,FREQUENT BOWEL MOVEMENTS,993
CA,CYSTITIS,983
CA,LUNG DISORDER,969
CA,DYSPHAGIA,967
CA,SEIZURE,964
CA,PULMONARY EMBOLISM,962
CA,INFLUENZA LIKE ILLNESS,956
CA,OVERDOSE,954
CA,RHINORRHOEA,952
CA,CATARACT,948
CA,BREAST CANCER,946
CA,FLUSHING,928
CA,THROMBOSIS,917
CA,COLITIS ULCERATIVE,907
CA,MIGRAINE,893
CA,SUICIDAL IDEATION,888
CA,VISUAL IMPAIRMENT,885
CA,THERAPEUTIC RESPONSE DECREASED,863
CA,BALANCE DISORDER,848
CA,BLOOD GLUCOSE INCREASED,841
CA,RENAL IMPAIRMENT,836
CA,ATRIAL FIBRILLATION,831
CA,NECK PAIN,831
CA,MEMORY IMPAIRMENT,828
CA,INFLAMMATION,827
CA,HOT FLUSH,801
CA,EPISTAXIS,800
CA,PULMONARY OEDEMA,796
CA,SURGERY,794
CA,BLOOD CREATININE INCREASED,784
CA,LOCALISED INFECTION,776
CA,TACHYCARDIA,765
CA,DIVERTICULITIS,751
CA,CLOSTRIDIUM DIFFICILE INFECTION,748
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,740
CA,ABORTION SPONTANEOUS,738
CA,FOETAL EXPOSURE DURING PREGNANCY,732
CA,PLEURAL EFFUSION,726
CA,SLEEP DISORDER,725
CA,BURNING SENSATION,723
CA,HIP FRACTURE,714
CA,INTESTINAL RESECTION,711
CA,GASTROOESOPHAGEAL REFLUX DISEASE,710
CA,RECTAL HAEMORRHAGE,702
CA,BONE PAIN,700
CA,NEUTROPENIA,699
CA,AMNESIA,691
CA,SWELLING FACE,691
CA,EAR INFECTION,689
CA,GASTROINTESTINAL HAEMORRHAGE,687
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,685
CA,DYSPHONIA,676
CA,CARDIAC FAILURE CONGESTIVE,667
CA,DRY MOUTH,661
CA,FEELING HOT,660
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,647
CA,BLOOD PRESSURE DIASTOLIC DECREASED,646
CA,DYSPNOEA EXERTIONAL,636
CA,ABASIA,627
CA,IMPAIRED HEALING,619
CA,BLOOD PRESSURE FLUCTUATION,608
CA,ACNE,607
CA,FISTULA,607
CA,LUNG NEOPLASM MALIGNANT,602
CA,VIRAL INFECTION,602
CA,DRY SKIN,598
CA,INCORRECT DOSE ADMINISTERED,598
CA,ACUTE KIDNEY INJURY,592
CA,WHITE BLOOD CELL COUNT INCREASED,585
CA,C-REACTIVE PROTEIN INCREASED,582
CA,FEBRILE NEUTROPENIA,582
CA,FLATULENCE,578
CA,PANCREATITIS,575
CA,LOCAL SWELLING,574
CA,OSTEOPOROSIS,571
CA,VERTIGO,569
CA,WOUND,562
CA,CHOLELITHIASIS,558
CA,RENAL DISORDER,558
CA,SPUTUM DISCOLOURED,558
CA,KNEE ARTHROPLASTY,557
CA,ANAPHYLACTIC REACTION,555
CA,RESPIRATORY DISORDER,555
CA,DISCOMFORT,554
CA,DEEP VEIN THROMBOSIS,546
CA,THROAT IRRITATION,545
CA,ADVERSE EVENT,544
CA,ROAD TRAFFIC ACCIDENT,544
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,542
CA,ALANINE AMINOTRANSFERASE INCREASED,539
CA,CARDIAC FAILURE,539
CA,ADVERSE DRUG REACTION,538
CA,PRODUCT SUBSTITUTION ISSUE,537
CA,LIVER DISORDER,536
CA,CARDIAC ARREST,529
CA,RIB FRACTURE,526
CA,KIDNEY INFECTION,522
CA,UPPER RESPIRATORY TRACT INFECTION,519
CA,HERNIA,517
CA,DEPRESSED MOOD,516
CA,RESPIRATORY RATE INCREASED,516
CA,UPPER LIMB FRACTURE,516
CA,LYMPHADENOPATHY,512
CA,STOMATITIS,512
CA,NEUROPATHY PERIPHERAL,510
CA,AGITATION,507
CA,SPEECH DISORDER,507
CA,C-REACTIVE PROTEIN ABNORMAL,499
CA,HEART RATE IRREGULAR,495
CA,PALLOR,492
CA,HYPOPHAGIA,490
CA,RASH PRURITIC,489
CA,ABSCESS,485
CA,ARRHYTHMIA,484
CA,FORCED EXPIRATORY VOLUME DECREASED,483
CA,DRUG DEPENDENCE,480
CA,SKIN DISCOLOURATION,480
CA,RESPIRATORY TRACT INFECTION,479
CA,PRODUCT USE IN UNAPPROVED INDICATION,476
CA,FIBROMYALGIA,475
CA,LIMB INJURY,473
CA,JOINT STIFFNESS,469
CA,SKIN ULCER,467
CA,OEDEMA,466
CA,FLUID RETENTION,463
CA,LIMB DISCOMFORT,463
CA,INJECTION SITE ERYTHEMA,459
CA,MATERNAL EXPOSURE DURING PREGNANCY,456
CA,DELIRIUM,455
CA,RESPIRATORY TRACT CONGESTION,453
CA,PHARYNGITIS,450
CA,BASAL CELL CARCINOMA,448
CA,EYE PAIN,448
CA,THROMBOCYTOPENIA,448
CA,FUNGAL INFECTION,447
CA,LETHARGY,445
CA,BLOOD CHOLESTEROL INCREASED,444
CA,BLISTER,442
CA,POST PROCEDURAL COMPLICATION,440
CA,UNEVALUABLE EVENT,438
CA,INJECTION SITE REACTION,437
CA,DYSGEUSIA,436
CA,MULTIPLE SCLEROSIS RELAPSE,436
CA,FEMUR FRACTURE,434
CA,AGGRESSION,431
CA,RESPIRATORY FAILURE,430
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,430
CA,GASTRIC DISORDER,429
CA,EYE DISORDER,427
CA,ANGINA PECTORIS,426
CA,INTERSTITIAL LUNG DISEASE,425
CA,ASPARTATE AMINOTRANSFERASE INCREASED,423
CA,RED BLOOD CELL COUNT DECREASED,422
CA,INTESTINAL STENOSIS,415
CA,TRANSIENT ISCHAEMIC ATTACK,415
CA,ILL-DEFINED DISORDER,414
CA,TOOTH ABSCESS,414
CA,COLITIS,413
CA,PULMONARY MASS,411
CA,BODY TEMPERATURE INCREASED,408
CA,CONVULSION,408
CA,DYSURIA,407
CA,HALLUCINATION,407
CA,RASH GENERALISED,406
CA,PAIN IN JAW,404
CA,SUICIDE ATTEMPT,404
CA,RASH ERYTHEMATOUS,403
CA,DISTURBANCE IN ATTENTION,401
CA,SKIN EXFOLIATION,401
CA,HEPATIC FAILURE,400
CA,JOINT INJURY,400
CA,SWOLLEN TONGUE,400
CA,PSORIATIC ARTHROPATHY,399
CA,POLLAKIURIA,398
CA,DIABETIC KETOACIDOSIS,397
CA,EYE SWELLING,397
CA,IMPAIRED WORK ABILITY,394
CA,IRRITABILITY,393
CA,LYMPHOMA,393
CA,PHARYNGEAL OEDEMA,393
CA,PRODUCT QUALITY ISSUE,393
CA,SPINAL FRACTURE,393
CA,POST PROCEDURAL INFECTION,392
CA,ASCITES,389
CA,BLINDNESS,387
CA,BLOOD POTASSIUM DECREASED,387
CA,TOOTH DISORDER,387
CA,BLOOD URINE PRESENT,384
CA,NEUTROPHIL COUNT DECREASED,384
CA,OBSTRUCTIVE AIRWAYS DISORDER,383
CA,FOOT FRACTURE,382
CA,COMA,381
CA,PROSTATE CANCER,381
CA,MASS,380
CA,FOOT DEFORMITY,379
CA,NERVOUSNESS,379
CA,ECZEMA,378
CA,NIGHT SWEATS,377
CA,SKIN CANCER,377
CA,MUSCULOSKELETAL DISORDER,376
CA,SINUS CONGESTION,374
CA,SMALL INTESTINAL OBSTRUCTION,373
CA,PSYCHOTIC DISORDER,372
CA,FEELING COLD,371
CA,PULMONARY FIBROSIS,370
CA,SKIN LESION,369
CA,COGNITIVE DISORDER,368
CA,HYPOGLYCAEMIA,368
CA,THROAT TIGHTNESS,367
CA,HEPATIC CIRRHOSIS,364
CA,HIP ARTHROPLASTY,364
CA,HEAD INJURY,360
CA,INJECTION SITE BRUISING,360
CA,SEPTIC SHOCK,360
CA,ORAL HERPES,356
CA,BRADYCARDIA,347
CA,EAR PAIN,347
CA,CYST,345
CA,LACERATION,345
CA,HAND DEFORMITY,344
CA,JAUNDICE,344
CA,MOVEMENT DISORDER,342
CA,TINNITUS,342
CA,EATING DISORDER,339
CA,MIDDLE INSOMNIA,339
CA,COLECTOMY,336
CA,STAPHYLOCOCCAL INFECTION,336
CA,INJECTION SITE SWELLING,335
CA,LIVER FUNCTION TEST ABNORMAL,335
CA,LYMPHOCYTE COUNT DECREASED,335
CA,PULMONARY CONGESTION,335
CA,MOUTH ULCERATION,333
CA,CARPAL TUNNEL SYNDROME,332
CA,OVARIAN CYST,331
CA,GASTROENTERITIS VIRAL,330
CA,LOWER LIMB FRACTURE,330
CA,CHOKING,329
CA,CRYING,329
CA,NEOPLASM,328
CA,ANKLE FRACTURE,326
CA,PANCYTOPENIA,326
CA,GLAUCOMA,325
CA,HAEMOPTYSIS,325
CA,OCULAR HYPERAEMIA,325
CA,SECRETION DISCHARGE,325
CA,ANGIOEDEMA,324
CA,DEAFNESS,324
CA,LIP SWELLING,323
CA,VISUAL ACUITY REDUCED,322
CA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,321
CA,SCIATICA,321
CA,BLOOD TEST ABNORMAL,320
CA,TYPE 2 DIABETES MELLITUS,320
CA,HYPERSOMNIA,319
CA,PROCEDURAL PAIN,319
CA,BLOOD IRON DECREASED,318
CA,OSTEOMYELITIS,318
CA,PRURITUS GENERALISED,318
CA,MENTAL DISORDER,317
CA,PEMPHIGUS,314
CA,DISORIENTATION,313
CA,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,312
CA,WOUND INFECTION,312
CA,DRY EYE,311
CA,METASTASES TO LIVER,311
CA,UNDERDOSE,311
CA,URINARY RETENTION,310
CA,TOOTH INFECTION,308
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,306
CA,DYSSTASIA,306
CA,NEOPLASM PROGRESSION,305
CA,NODULE,305
CA,PLASMA CELL MYELOMA,304
CA,HYPERGLYCAEMIA,302
CA,BACTERIAL INFECTION,301
CA,HEPATITIS,301
CA,FAECES DISCOLOURED,300
CA,MULTIPLE SCLEROSIS,300
CA,SKIN DISORDER,297
CA,ABDOMINAL PAIN LOWER,295
CA,GLOSSODYNIA,295
CA,GASTROENTERITIS,294
CA,NEEDLE ISSUE,294
CA,WRIST FRACTURE,294
CA,BLOOD PRESSURE DIASTOLIC INCREASED,293
CA,DEMENTIA,293
CA,BONE EROSION,292
CA,INTERNATIONAL NORMALISED RATIO INCREASED,292
CA,MALIGNANT MELANOMA,292
CA,PNEUMONITIS,291
CA,APHONIA,290
CA,GASTROINTESTINAL INFLAMMATION,290
CA,FEEDING DISORDER,289
CA,JOINT RANGE OF MOTION DECREASED,289
CA,PANIC ATTACK,289
CA,INTENTIONAL OVERDOSE,288
CA,SLEEP APNOEA SYNDROME,288
CA,INJECTION SITE HAEMORRHAGE,287
CA,INTESTINAL PERFORATION,287
CA,POOR VENOUS ACCESS,286
CA,TREATMENT NONCOMPLIANCE,286
CA,ABNORMAL BEHAVIOUR,285
CA,DYSARTHRIA,284
CA,POOR QUALITY SLEEP,284
CA,MUSCULOSKELETAL CHEST PAIN,283
CA,URINARY INCONTINENCE,283
CA,CORONARY ARTERY DISEASE,281
CA,INTERVERTEBRAL DISC PROTRUSION,280
CA,CONTRAINDICATED PRODUCT ADMINISTERED,279
CA,DRUG WITHDRAWAL SYNDROME,279
CA,LACRIMATION INCREASED,277
CA,DISABILITY,276
CA,INJECTION SITE MASS,276
CA,SENSITIVITY TO WEATHER CHANGE,276
CA,LEUKOPENIA,275
CA,MUSCULOSKELETAL DISCOMFORT,274
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,274
CA,EYE HAEMORRHAGE,273
CA,DRUG ABUSE,272
CA,APHASIA,271
CA,RESPIRATORY DISTRESS,271
CA,BONE DISORDER,270
CA,HYPOTHYROIDISM,270
CA,SUBSTANCE ABUSE,269
CA,VAGINAL HAEMORRHAGE,269
CA,HAEMATEMESIS,263
CA,GASTROINTESTINAL PAIN,262
CA,NEURALGIA,262
CA,UNRESPONSIVE TO STIMULI,262
CA,CHROMATURIA,261
CA,TERMINAL STATE,261
CA,BLOOD GLUCOSE DECREASED,260
CA,INTENTIONAL PRODUCT MISUSE,260
CA,MOOD SWINGS,258
CA,GOUT,257
CA,LIVER FUNCTION TEST INCREASED,257
CA,MOOD ALTERED,256
CA,HAEMATURIA,255
CA,PNEUMOTHORAX,255
CA,ELECTROCARDIOGRAM QT PROLONGED,254
CA,PERITONITIS,254
CA,HEPATIC STEATOSIS,253
CA,GALLBLADDER DISORDER,250
CA,PRESYNCOPE,249
CA,BLOOD PRESSURE ABNORMAL,248
CA,HYPONATRAEMIA,248
CA,PNEUMONIA ASPIRATION,247
CA,HAEMORRHOIDS,246
CA,HYPOACUSIS,246
CA,DEVICE RELATED INFECTION,245
CA,DIPLOPIA,244
CA,EYE INFECTION,244
CA,TOOTHACHE,244
CA,HAEMATOCRIT DECREASED,242
CA,HAEMATOMA,242
CA,ANKYLOSING SPONDYLITIS,240
CA,CORONARY ARTERY OCCLUSION,240
CA,DRUG ADMINISTRATION ERROR,240
CA,SCAR,240
CA,ULCER,240
CA,HEPATITIS C,237
CA,RHEUMATOID FACTOR POSITIVE,237
CA,GASTRIC ULCER,236
CA,SNEEZING,236
CA,HEPATOTOXICITY,235
CA,HYPOKINESIA,235
CA,LUPUS-LIKE SYNDROME,235
CA,METASTASES TO BONE,234
CA,PREMATURE BABY,234
CA,GAIT INABILITY,233
CA,RALES,233
CA,ANGER,232
CA,CEREBRAL HAEMORRHAGE,231
CA,COLON CANCER,231
CA,HYPOXIA,231
CA,FRACTURE,229
CA,OSTEONECROSIS OF JAW,228
CA,SKIN INFECTION,228
CA,COMPLETED SUICIDE,227
CA,DIARRHOEA HAEMORRHAGIC,227
CA,PELVIC FRACTURE,226
CA,POSTOPERATIVE WOUND INFECTION,226
CA,SEASONAL ALLERGY,226
CA,EMOTIONAL DISORDER,225
CA,ACUTE MYOCARDIAL INFARCTION,224
CA,EYE PRURITUS,224
CA,INJURY,224
CA,BREATH SOUNDS ABNORMAL,220
CA,BLOOD BILIRUBIN INCREASED,219
CA,BLOOD COUNT ABNORMAL,219
CA,GASTROINTESTINAL INFECTION,218
CA,INJECTION SITE PRURITUS,218
CA,ABDOMINAL ADHESIONS,217
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,217
CA,ORAL PAIN,217
CA,PERICARDITIS,217
CA,IMMUNE SYSTEM DISORDER,216
CA,RENAL FAILURE ACUTE,216
CA,TENDERNESS,216
CA,CANDIDA INFECTION,215
CA,PERICARDIAL EFFUSION,214
CA,POLYP,213
CA,BLOOD CREATINE PHOSPHOKINASE INCREASED,212
CA,BURSITIS,212
CA,TOOTH FRACTURE,212
CA,ANAL ABSCESS,211
CA,THYROID DISORDER,211
CA,JOINT DISLOCATION,210
CA,BRONCHOSPASM,209
CA,RASH MACULAR,208
CA,IMMUNODEFICIENCY,207
CA,COELIAC DISEASE,206
CA,SPINAL COLUMN STENOSIS,206
CA,LIGAMENT SPRAIN,205
CA,MENTAL IMPAIRMENT,205
CA,NERVOUS SYSTEM DISORDER,205
CA,HYSTERECTOMY,203
CA,PHARYNGITIS STREPTOCOCCAL,203
CA,PHOTOPHOBIA,202
CA,PULMONARY FUNCTION TEST DECREASED,201
CA,SECOND PRIMARY MALIGNANCY,199
CA,GLOMERULAR FILTRATION RATE DECREASED,198
CA,HYPOKALAEMIA,198
CA,SINUS DISORDER,198
CA,BLOOD MAGNESIUM DECREASED,197
CA,ANAL FISTULA,196
CA,EYE IRRITATION,195
CA,NIGHTMARE,195
CA,NO THERAPEUTIC RESPONSE,195
CA,PARALYSIS,195
CA,THERAPY NON-RESPONDER,195
CA,ACCIDENTAL OVERDOSE,194
CA,BEDRIDDEN,194
CA,UVEITIS,194
CA,RESTLESSNESS,193
CA,MANIA,192
CA,PHOTOSENSITIVITY REACTION,192
CA,RENAL PAIN,192
CA,RED CELL DISTRIBUTION WIDTH INCREASED,191
CA,DISEASE RECURRENCE,190
CA,HEAD DISCOMFORT,190
CA,EMOTIONAL DISTRESS,189
CA,GRIP STRENGTH DECREASED,189
CA,NERVE INJURY,189
CA,GROIN PAIN,188
CA,HYPOVENTILATION,188
CA,CENTRAL NERVOUS SYSTEM LESION,187
CA,TENDONITIS,187
CA,ACUTE HEPATIC FAILURE,186
CA,ANAPHYLACTIC SHOCK,186
CA,FLANK PAIN,186
CA,NEUTROPHIL COUNT INCREASED,186
CA,PARKINSON^S DISEASE,186
CA,SPLENOMEGALY,186
CA,TRANSFUSION,185
CA,BRAIN NEOPLASM,184
CA,ENCEPHALOPATHY,183
CA,ISCHAEMIC STROKE,183
CA,PROSTATE CANCER METASTATIC,183
CA,ORAL CANDIDIASIS,182
CA,BACK INJURY,181
CA,MENORRHAGIA,181
CA,ADRENAL INSUFFICIENCY,180
CA,JOINT EFFUSION,180
CA,PROSTATIC SPECIFIC ANTIGEN INCREASED,180
CA,DENTAL CARIES,178
CA,GENERALISED TONIC-CLONIC SEIZURE,178
CA,INCORRECT ROUTE OF DRUG ADMINISTRATION,178
CA,BREAST MASS,177
CA,DRUG RESISTANCE,177
CA,BLOOD POTASSIUM INCREASED,176
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,175
CA,FINGER DEFORMITY,175
CA,INCREASED APPETITE,174
CA,LARYNGITIS,174
CA,DYSKINESIA,173
CA,HEMIPARESIS,173
CA,HEPATIC CANCER,173
CA,METASTASES TO CENTRAL NERVOUS SYSTEM,172
CA,RHABDOMYOLYSIS,172
CA,SEDATION,172
CA,SPINAL PAIN,172
CA,ACCIDENT,171
CA,BACK DISORDER,171
CA,CONCUSSION,171
CA,DRUG-INDUCED LIVER INJURY,171
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,171
CA,ILEOSTOMY,171
CA,MUSCLE TWITCHING,171
CA,HYPOAESTHESIA ORAL,170
CA,ABDOMINAL HERNIA,169
CA,PARANOIA,169
CA,SHOCK,169
CA,SYNOVIAL CYST,169
CA,APPENDICITIS,167
CA,METABOLIC ACIDOSIS,166
CA,SQUAMOUS CELL CARCINOMA,166
CA,WEIGHT FLUCTUATION,166
CA,BRONCHIECTASIS,165
CA,QUALITY OF LIFE DECREASED,165
CA,TOOTH EXTRACTION,165
CA,TRANSPLANT REJECTION,165
CA,VASCULITIS,165
CA,BONE DENSITY DECREASED,164
CA,MEDICATION ERROR,164
CA,ABDOMINAL ABSCESS,163
CA,CAESAREAN SECTION,163
CA,IRRITABLE BOWEL SYNDROME,163
CA,BLOOD SODIUM DECREASED,162
CA,GASTROINTESTINAL OBSTRUCTION,162
CA,EMPHYSEMA,161
CA,DRY THROAT,160
CA,HAEMORRHAGE INTRACRANIAL,160
CA,BLADDER CANCER,159
CA,LIVER INJURY,159
CA,MULTI-ORGAN FAILURE,159
CA,MUSCLE STRAIN,159
CA,DIABETES MELLITUS INADEQUATE CONTROL,156
CA,ROTATOR CUFF SYNDROME,156
CA,THERAPEUTIC RESPONSE UNEXPECTED,156
CA,HYPERAESTHESIA,155
CA,LABORATORY TEST ABNORMAL,155
CA,MUSCLE ATROPHY,155
CA,NAIL DISORDER,155
CA,BLOOD CALCIUM DECREASED,154
CA,GASTRITIS,154
CA,HEPATIC NEOPLASM,154
CA,MUSCLE TIGHTNESS,154
CA,ARTERIAL OCCLUSIVE DISEASE,153
CA,SENSORY LOSS,153
CA,TRANSPLANT DYSFUNCTION,153
CA,ARTHRITIS INFECTIVE,152
CA,BRAIN INJURY,152
CA,RESPIRATORY ARREST,152
CA,SEROTONIN SYNDROME,152
CA,EPILEPSY,151
CA,PERITONEAL DIALYSIS COMPLICATION,151
CA,RHEUMATOID NODULE,151
CA,FEAR,150
CA,PANCREATIC CARCINOMA,150
CA,HEPATIC FUNCTION ABNORMAL,149
CA,TUBERCULOSIS,149
CA,UROSEPSIS,149
CA,BREAST PAIN,147
CA,CYANOSIS,147
CA,METASTASES TO LUNG,147
CA,ORTHOSTATIC HYPOTENSION,147
CA,TENDON RUPTURE,147
CA,COLD SWEAT,146
CA,FULL BLOOD COUNT DECREASED,146
CA,HIATUS HERNIA,146
CA,THINKING ABNORMAL,146
CA,CARDIOVASCULAR DISORDER,145
CA,HAND FRACTURE,145
CA,MELAENA,145
CA,NON-HODGKIN^S LYMPHOMA,145
CA,PERIPHERAL COLDNESS,145
CA,BONE MARROW FAILURE,144
CA,DRUG ERUPTION,144
CA,IMMOBILE,144
CA,PLATELET COUNT INCREASED,144
CA,PULMONARY HYPERTENSION,144
CA,BLINDNESS UNILATERAL,143
CA,FAECES SOFT,143
CA,PARAESTHESIA ORAL,143
CA,APPARENT DEATH,142
CA,BREAST CANCER METASTATIC,142
CA,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,142
CA,EAR DISCOMFORT,142
CA,FOOT OPERATION,142
CA,HEPATIC PAIN,142
CA,PANCREATITIS ACUTE,142
CA,DEMENTIA ALZHEIMER^S TYPE,141
CA,PULMONARY THROMBOSIS,141
CA,RETINAL DETACHMENT,141
CA,SKIN BURNING SENSATION,141
CA,BRAIN OEDEMA,140
CA,NERVE COMPRESSION,140
CA,PYELONEPHRITIS,140
CA,SKIN PLAQUE,140
CA,SKIN REACTION,140
CA,EXPOSURE DURING BREAST FEEDING,139
CA,INCREASED UPPER AIRWAY SECRETION,139
CA,BACTERAEMIA,138
CA,GENERALISED OEDEMA,138
CA,HYPERCALCAEMIA,138
CA,OBESITY,138
CA,HYPERKALAEMIA,137
CA,INCORRECT DRUG ADMINISTRATION DURATION,137
CA,INTENTIONAL PRODUCT USE ISSUE,137
CA,POST PROCEDURAL HAEMORRHAGE,137
CA,STEVENS-JOHNSON SYNDROME,137
CA,UPPER GASTROINTESTINAL HAEMORRHAGE,137
CA,FACE OEDEMA,136
CA,SCAB,135
CA,BLOOD GLUCOSE ABNORMAL,134
CA,CARDIOMYOPATHY,134
CA,MUCOSAL INFLAMMATION,134
CA,RESTLESS LEGS SYNDROME,134
CA,SPINAL COMPRESSION FRACTURE,134
CA,UTERINE LEIOMYOMA,134
CA,ATELECTASIS,133
CA,BLADDER DISORDER,133
CA,INTERVERTEBRAL DISC DEGENERATION,133
CA,CONJUNCTIVITIS,132
CA,METASTASIS,132
CA,SKIN IRRITATION,132
CA,SUBCUTANEOUS ABSCESS,132
CA,THIRST,132
CA,CLOSTRIDIUM DIFFICILE COLITIS,131
CA,FINE MOTOR SKILL DYSFUNCTION,131
CA,MICTURITION URGENCY,131
CA,PAIN OF SKIN,131
CA,ADVERSE REACTION,130
CA,CONCOMITANT DISEASE AGGRAVATED,130
CA,RHINITIS,130
CA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,129
CA,ELECTROLYTE IMBALANCE,129
CA,FOETAL DEATH,129
CA,SPINAL DISORDER,129
CA,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,128
CA,AGEUSIA,127
CA,BOWEL MOVEMENT IRREGULARITY,127
CA,DERMATITIS ALLERGIC,127
CA,EUPHORIC MOOD,127
CA,LOWER RESPIRATORY TRACT CONGESTION,127
CA,MACULAR DEGENERATION,127
CA,SKIN FISSURES,127
CA,BLOOD IMMUNOGLOBULIN E INCREASED,126
CA,GINGIVAL BLEEDING,126
CA,BIPOLAR DISORDER,125
CA,PREMATURE DELIVERY,125
CA,CHOLECYSTITIS,124
CA,SHOULDER ARTHROPLASTY,124
CA,SINUS TACHYCARDIA,124
CA,TOOTH LOSS,124
CA,LACTIC ACIDOSIS,123
CA,LEUKAEMIA,123
CA,PROCEDURAL COMPLICATION,123
CA,PROCTALGIA,123
CA,RASH PAPULAR,123
CA,CREPITATIONS,122
CA,DERMATITIS,122
CA,INGUINAL HERNIA,122
CA,WITHDRAWAL SYNDROME,122
CA,CHRONIC KIDNEY DISEASE,121
CA,HALLUCINATION_ AUDITORY,121
CA,HEPATIC LESION,121
CA,MUCOUS STOOLS,121
CA,RETCHING,121
CA,WALKING AID USER,121
CA,BLOOD PRESSURE SYSTOLIC DECREASED,120
CA,HEPATIC ENCEPHALOPATHY,120
CA,SCRATCH,120
CA,CARDIOMEGALY,119
CA,DECREASED ACTIVITY,119
CA,BLOOD ALBUMIN DECREASED,118
CA,HYPOCALCAEMIA,118
CA,INTRAOCULAR PRESSURE INCREASED,118
CA,NO ADVERSE EVENT,118
CA,SKIN HAEMORRHAGE,118
CA,VAGINAL INFECTION,118
CA,WRONG TECHNIQUE IN DRUG USAGE PROCESS,118
CA,FOOD ALLERGY,116
CA,ORAL DISCOMFORT,116
CA,CATARACT OPERATION,115
CA,CHOLECYSTECTOMY,115
CA,DRUG LEVEL DECREASED,115
CA,HEPATOMEGALY,115
CA,KNEE OPERATION,115
CA,RENAL CANCER,115
CA,THYROID CANCER,115
CA,BLOOD CALCIUM INCREASED,114
CA,DRUG LEVEL INCREASED,114
CA,ENTERITIS,114
CA,ONYCHOMYCOSIS,114
CA,APHTHOUS ULCER,113
CA,BLOOD DISORDER,113
CA,MYELODYSPLASTIC SYNDROME,113
CA,PREGNANCY,113
CA,UMBILICAL HERNIA,113
CA,AORTIC ANEURYSM,112
CA,PYODERMA GANGRENOSUM,112
CA,CYTOMEGALOVIRUS INFECTION,111
CA,FACIAL PARALYSIS,111
CA,FURUNCLE,111
CA,INTESTINAL OPERATION,111
CA,PALLIATIVE CARE,111
CA,PELVIC PAIN,111
CA,PULMONARY FUNCTION TEST ABNORMAL,111
CA,ARTHROPOD BITE,110
CA,EXOSTOSIS,110
CA,HYPOMAGNESAEMIA,110
CA,MULTIPLE FRACTURES,110
CA,PETECHIAE,110
CA,SERUM FERRITIN INCREASED,110
CA,HALLUCINATION_ VISUAL,109
CA,INCISION SITE INFECTION,109
CA,INCREASED TENDENCY TO BRUISE,109
CA,CIRCULATORY COLLAPSE,108
CA,INVESTIGATION,108
CA,RASH MACULO-PAPULAR,108
CA,RENAL CYST,108
CA,ABNORMAL DREAMS,107
CA,ABSCESS INTESTINAL,107
CA,HAEMOGLOBIN ABNORMAL,107
CA,TONGUE DISORDER,107
CA,DEFAECATION URGENCY,106
CA,INTESTINAL ISCHAEMIA,106
CA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,106
CA,COLITIS MICROSCOPIC,105
CA,EOSINOPHIL COUNT INCREASED,105
CA,ESCHERICHIA INFECTION,105
CA,GASTRIC HAEMORRHAGE,105
CA,GINGIVAL PAIN,105
CA,HAEMOLYSIS,105
CA,IMMUNE THROMBOCYTOPENIC PURPURA,105
CA,INTERNAL HAEMORRHAGE,105
CA,PROTEINURIA,105
CA,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,105
CA,UPPER-AIRWAY COUGH SYNDROME,105
CA,CARDIAC VALVE DISEASE,104
CA,COORDINATION ABNORMAL,104
CA,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,104
CA,OSTEOPENIA,104
CA,URINE ABNORMALITY,104
CA,ACUTE CORONARY SYNDROME,103
CA,ATAXIA,103
CA,CARDIAC FLUTTER,103
CA,DEVICE DISLOCATION,103
CA,DRUG PRESCRIBING ERROR,103
CA,EJECTION FRACTION DECREASED,103
CA,EYELID OEDEMA,103
CA,PHLEBITIS,103
CA,ANEURYSM,102
CA,ILEAL STENOSIS,102
CA,MALNUTRITION,102
CA,MENISCUS INJURY,102
CA,PNEUMONIA VIRAL,102
CA,FOOD POISONING,101
CA,GASTRIC INFECTION,101
CA,HUMERUS FRACTURE,101
CA,IMMUNOSUPPRESSION,101
CA,INJECTION SITE DISCOMFORT,101
CA,IRITIS,101
CA,MYOCARDIAL ISCHAEMIA,101
CA,NASAL POLYPS,101
CA,ANAL INCONTINENCE,100
CA,MYOCARDITIS,100
CA,SCOLIOSIS,100
CA,WOUND SECRETION,100
CA,APHAGIA,99
CA,COAGULOPATHY,99
CA,MOTOR DYSFUNCTION,99
CA,POOR PERIPHERAL CIRCULATION,99
CA,BLINDNESS TRANSIENT,98
CA,DRUG SPECIFIC ANTIBODY PRESENT,98
CA,EYELID PTOSIS,98
CA,GASTROINTESTINAL CARCINOMA,98
CA,HIP SURGERY,98
CA,INFARCTION,98
CA,MELANOCYTIC NAEVUS,98
CA,OSTEONECROSIS,98
CA,RASH PUSTULAR,98
CA,GANGRENE,97
CA,MENINGITIS,97
CA,PRESCRIBED UNDERDOSE,97
CA,TENDON DISORDER,97
CA,TRANSAMINASES INCREASED,97
CA,HEPATIC ENZYME ABNORMAL,96
CA,MYOCLONUS,96
CA,SCHIZOPHRENIA,96
CA,STREPTOCOCCAL INFECTION,96
CA,EYE INFLAMMATION,95
CA,FACIAL PAIN,95
CA,NEUROTOXICITY,95
CA,SENSORY DISTURBANCE,95
CA,STAPHYLOCOCCAL BACTERAEMIA,95
CA,TACHYPNOEA,95
CA,THYROID NEOPLASM,95
CA,URINE OUTPUT DECREASED,95
CA,ACUTE RESPIRATORY DISTRESS SYNDROME,94
CA,ASPIRATION,94
CA,DEVICE FAILURE,94
CA,EXERCISE TOLERANCE DECREASED,94
CA,FORCED VITAL CAPACITY DECREASED,94
CA,HEART RATE ABNORMAL,94
CA,PLEURISY,94
CA,POLYARTHRITIS,94
CA,RECTAL ABSCESS,94
CA,SPINAL OSTEOARTHRITIS,94
CA,APATHY,93
CA,ARTERIOSCLEROSIS CORONARY ARTERY,93
CA,EYE DISCHARGE,93
CA,GINGIVITIS,93
CA,HELICOBACTER INFECTION,93
CA,INCONTINENCE,93
CA,INCREASED BRONCHIAL SECRETION,93
CA,MAJOR DEPRESSION,93
CA,OBSTRUCTION,93
CA,SKIN MASS,93
CA,SUBDURAL HAEMATOMA,93
CA,CARDIO-RESPIRATORY ARREST,92
CA,CREATININE RENAL CLEARANCE DECREASED,92
CA,HEMIPLEGIA,92
CA,NECK MASS,92
CA,PANCREATIC DISORDER,92
CA,ABNORMAL FAECES,91
CA,CARDIAC MURMUR,91
CA,DEFORMITY,91
CA,ECCHYMOSIS,91
CA,ENCEPHALITIS,91
CA,INJECTION SITE RASH,91
CA,OPTIC NEURITIS,91
CA,PERITONITIS BACTERIAL,91
CA,PRESCRIBED OVERDOSE,91
CA,SKIN ABRASION,91
CA,SKIN ATROPHY,91
CA,AFFECT LABILITY,90
CA,DECUBITUS ULCER,90
CA,GENERALISED ERYTHEMA,90
CA,INTESTINAL HAEMORRHAGE,90
CA,LIGAMENT RUPTURE,90
CA,OVARIAN CANCER,90
CA,STRESS FRACTURE,90
CA,ANAL FISSURE,89
CA,ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE,89
CA,DELUSION,89
CA,DEVICE OCCLUSION,89
CA,EPIGASTRIC DISCOMFORT,89
CA,INTESTINAL POLYP,89
CA,PRECANCEROUS CELLS PRESENT,89
CA,PSYCHOMOTOR HYPERACTIVITY,89
CA,SQUAMOUS CELL CARCINOMA OF SKIN,89
CA,ERECTILE DYSFUNCTION,88
CA,INJECTION SITE WARMTH,88
CA,MONOCYTE COUNT INCREASED,88
CA,ORAL DISORDER,88
CA,THERAPY CESSATION,88
CA,ALTERED STATE OF CONSCIOUSNESS,87
CA,BONE CANCER,87
CA,BREAST CANCER FEMALE,87
CA,EOSINOPHILIA,87
CA,FLUID OVERLOAD,87
CA,INCOHERENT,87
CA,LEUKOCYTOSIS,87
CA,LOSS OF LIBIDO,87
CA,PSEUDOMONAS INFECTION,87
CA,ACUTE MYELOID LEUKAEMIA,86
CA,BILE DUCT OBSTRUCTION,86
CA,EMBOLISM,86
CA,ERUCTATION,86
CA,HEPATITIS B,86
CA,HEPATOCELLULAR CARCINOMA,86
CA,INJECTION SITE INDURATION,86
CA,LUNG NEOPLASM,86
CA,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,86
CA,TEMPERATURE INTOLERANCE,86
CA,VEIN DISORDER,86
CA,ABDOMINAL MASS,85
CA,HYPERTHYROIDISM,85
CA,JUVENILE IDIOPATHIC ARTHRITIS,85
CA,LYMPHOEDEMA,85
CA,RESPIRATORY DEPRESSION,85
CA,SKIN NECROSIS,85
CA,UTERINE CANCER,85
CA,VIITH NERVE PARALYSIS,85
CA,FEAR OF INJECTION,84
CV,ABDOMINAL PAIN,1
CV,ACTIVITIES OF DAILY LIVING IMPAIRED,1
CV,ANAL FISSURE,1
CV,ANAL FISTULA,1
CV,DIARRHOEA,1
CV,FREQUENT BOWEL MOVEMENTS,1
CV,GASTROINTESTINAL OBSTRUCTION,1
KY,DIZZINESS,2
KY,FALL,2
KY,ABDOMINAL DISCOMFORT,1
KY,ABDOMINAL INJURY,1
KY,BENIGN NEOPLASM OF THYROID GLAND,1
KY,CHEST INJURY,1
KY,DEATH,1
KY,DRUG ABUSE,1
KY,DRUG DISPENSING ERROR,1
KY,FURUNCLE,1
KY,GLIOMA,1
KY,HAEMORRHAGE INTRACRANIAL,1
KY,HEAD INJURY,1
KY,HYPERSENSITIVITY,1
KY,PAIN,1
KY,PALPITATIONS,1
KY,PANCREATIC CARCINOMA STAGE IV,1
KY,RASH,1
KY,SKIN BURNING SENSATION,1
KY,SPLENOMEGALY,1
KY,SUBDURAL HAEMATOMA,1
KY,TREATMENT NONCOMPLIANCE,1
CF,DEATH,2
CF,MATERNAL EXPOSURE DURING PREGNANCY,2
CF,DEATH NEONATAL,1
CF,DRUG INEFFECTIVE,1
CF,FOETAL DEATH,1
CF,SLUGGISHNESS,1
CF,SOPOR,1
CF,VARICELLA,1
TD,VIROLOGIC FAILURE,14
CL,DEATH,418
CL,VOMITING,193
CL,NAUSEA,174
CL,DRUG INEFFECTIVE,171
CL,DIARRHOEA,167
CL,HEADACHE,163
CL,PAIN,144
CL,PYREXIA,134
CL,FATIGUE,120
CL,DIZZINESS,117
CL,MALAISE,114
CL,PNEUMONIA,99
CL,DYSPNOEA,94
CL,ABDOMINAL PAIN UPPER,90
CL,FALL,89
CL,CATARACT,87
CL,DECREASED APPETITE,87
CL,NASOPHARYNGITIS,86
CL,ABDOMINAL PAIN,84
CL,ANAEMIA,81
CL,WEIGHT DECREASED,78
CL,ASTHENIA,69
CL,IMMUNE SYSTEM DISORDER,68
CL,DISEASE PROGRESSION,67
CL,GENERAL PHYSICAL HEALTH DETERIORATION,66
CL,HYPOTENSION,66
CL,BACK PAIN,65
CL,HYPOAESTHESIA,64
CL,ARTHRALGIA,63
CL,PAIN IN EXTREMITY,60
CL,MUSCULAR WEAKNESS,59
CL,PARAESTHESIA,59
CL,SWELLING,58
CL,TACHYCARDIA,58
CL,HYPERTENSION,57
CL,PLATELET COUNT DECREASED,55
CL,CEREBROVASCULAR ACCIDENT,54
CL,ERYTHEMA,54
CL,DEPRESSED MOOD,53
CL,CARDIO-RESPIRATORY ARREST,52
CL,DEPRESSION,52
CL,SYNCOPE,51
CL,COUGH,50
CL,RESPIRATORY FAILURE,49
CL,SKIN DISCOLOURATION,47
CL,DEHYDRATION,46
CL,PRURITUS,46
CL,URINARY TRACT INFECTION,46
CL,GAIT DISTURBANCE,45
CL,BRONCHITIS,44
CL,HYPERSENSITIVITY,44
CL,VISUAL ACUITY REDUCED,44
CL,BONE PAIN,43
CL,CHEST PAIN,42
CL,SEPSIS,42
CL,DEAFNESS,41
CL,INSOMNIA,41
CL,DRUG DOSE OMISSION,40
CL,WHITE BLOOD CELL COUNT DECREASED,40
CL,ARRHYTHMIA,39
CL,CARDIAC DISORDER,39
CL,MYALGIA,38
CL,RASH,38
CL,THROMBOSIS,38
CL,WOUND,38
CL,INFLAMMATION,35
CL,SOMNOLENCE,35
CL,ABDOMINAL DISTENSION,34
CL,FEELING ABNORMAL,34
CL,LOSS OF CONSCIOUSNESS,34
CL,SEIZURE,34
CL,CHILLS,33
CL,DISORIENTATION,33
CL,INFECTION,33
CL,RENAL FAILURE,33
CL,SEPTIC SHOCK,33
CL,ACUTE MYOCARDIAL INFARCTION,32
CL,CARDIAC FAILURE,32
CL,MATERNAL EXPOSURE DURING PREGNANCY,32
CL,DRY SKIN,31
CL,NEOPLASM,31
CL,HYPOGLYCAEMIA,30
CL,INFLUENZA,30
CL,ANXIETY,29
CL,DIABETES MELLITUS,29
CL,EYE DISORDER,29
CL,MYOCARDIAL INFARCTION,29
CL,OVERDOSE,29
CL,DISCOMFORT,28
CL,HAEMORRHAGE,28
CL,MEMORY IMPAIRMENT,28
CL,PRODUCT USE ISSUE,28
CL,SKIN EXFOLIATION,28
CL,WEIGHT INCREASED,28
CL,ABORTION SPONTANEOUS,27
CL,METASTASIS,27
CL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,27
CL,OSTEOARTHRITIS,27
CL,VISUAL IMPAIRMENT,27
CL,CONSTIPATION,26
CL,RESPIRATORY DISORDER,26
CL,ARTHRITIS,25
CL,DEEP VEIN THROMBOSIS,25
CL,GASTRITIS,25
CL,MUSCLE SPASMS,25
CL,PERIPHERAL SWELLING,25
CL,FOETAL EXPOSURE DURING PREGNANCY,24
CL,INTESTINAL OBSTRUCTION,24
CL,LACTIC ACIDOSIS,24
CL,MALIGNANT NEOPLASM PROGRESSION,24
CL,PRODUCT QUALITY ISSUE,24
CL,BLINDNESS,23
CL,BLOOD GLUCOSE INCREASED,23
CL,BLOOD PRESSURE INCREASED,23
CL,HYPERHIDROSIS,23
CL,NEOPLASM MALIGNANT,23
CL,NEUTROPENIA,23
CL,ALOPECIA,22
CL,AMNESIA,22
CL,ARTHROPATHY,22
CL,BURNING SENSATION,22
CL,DYSPEPSIA,22
CL,GLAUCOMA,22
CL,HAEMATOCRIT DECREASED,22
CL,HYPERKALAEMIA,22
CL,OEDEMA PERIPHERAL,22
CL,PLEURAL EFFUSION,22
CL,BLOOD PRESSURE DECREASED,21
CL,HEARING IMPAIRED,21
CL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,21
CL,METASTASES TO LIVER,21
CL,MOOD ALTERED,21
CL,PULMONARY EMBOLISM,21
CL,PULMONARY HYPERTENSION,21
CL,EXPOSURE DURING PREGNANCY,20
CL,HYPERGLYCAEMIA,20
CL,PANCREATITIS,20
CL,TRANSAMINASES INCREASED,20
CL,VERTIGO,20
CL,BLISTER,19
CL,BLOOD CREATININE INCREASED,19
CL,COLITIS,19
CL,CONDITION AGGRAVATED,19
CL,METASTASES TO CENTRAL NERVOUS SYSTEM,19
CL,MULTI-ORGAN FAILURE,19
CL,MULTIPLE SCLEROSIS RELAPSE,19
CL,PULMONARY MASS,19
CL,ABDOMINAL DISCOMFORT,18
CL,ACUTE KIDNEY INJURY,18
CL,CARCINOEMBRYONIC ANTIGEN INCREASED,18
CL,DYSGEUSIA,18
CL,DYSPHAGIA,18
CL,HIP FRACTURE,18
CL,INCORRECT DRUG ADMINISTRATION DURATION,18
CL,LUNG DISORDER,18
CL,OROPHARYNGEAL PAIN,18
CL,PNEUMONITIS,18
CL,SPEECH DISORDER,18
CL,ANAPHYLACTIC REACTION,17
CL,BREAST CANCER,17
CL,HYPOACUSIS,17
CL,MUCOSAL INFLAMMATION,17
CL,PERITONITIS,17
CL,PRODUCT USE IN UNAPPROVED INDICATION,17
CL,PULMONARY OEDEMA,17
CL,RENAL DISORDER,17
CL,RESPIRATORY DISTRESS,17
CL,VISION BLURRED,17
CL,ABASIA,16
CL,ANAPHYLACTIC SHOCK,16
CL,BEDRIDDEN,16
CL,DEVICE DEPLOYMENT ISSUE,16
CL,FEBRILE NEUTROPENIA,16
CL,JOINT SWELLING,16
CL,METASTASES TO LUNG,16
CL,NERVOUSNESS,16
CL,STRESS,16
CL,CHOLELITHIASIS,15
CL,COMPLICATION ASSOCIATED WITH DEVICE,15
CL,CONTUSION,15
CL,DEMENTIA ALZHEIMER^S TYPE,15
CL,DYSURIA,15
CL,ECHOCARDIOGRAM ABNORMAL,15
CL,ENDOPHTHALMITIS,15
CL,EYE PAIN,15
CL,FEELING HOT,15
CL,METASTASES TO BONE,15
CL,NEUROPATHY PERIPHERAL,15
CL,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,15
CL,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,15
CL,BRONCHIAL OBSTRUCTION,14
CL,DRY MOUTH,14
CL,EPISTAXIS,14
CL,GASTROINTESTINAL DISORDER,14
CL,GASTROOESOPHAGEAL REFLUX DISEASE,14
CL,IMMUNODEFICIENCY,14
CL,LIMB DISCOMFORT,14
CL,PREMATURE BABY,14
CL,RENAL IMPAIRMENT,14
CL,SINUSITIS,14
CL,THROMBOCYTOPENIA,14
CL,TOXICITY TO VARIOUS AGENTS,14
CL,TREMOR,14
CL,WRONG TECHNIQUE IN DRUG USAGE PROCESS,14
CL,ANGIOPATHY,13
CL,BLINDNESS UNILATERAL,13
CL,BLOOD CHOLESTEROL INCREASED,13
CL,BRADYCARDIA,13
CL,GASTROENTERITIS,13
CL,GASTROINTESTINAL HAEMORRHAGE,13
CL,HYPOTHYROIDISM,13
CL,INTRAOCULAR PRESSURE INCREASED,13
CL,MUSCULOSKELETAL STIFFNESS,13
CL,AZOTAEMIA,12
CL,BONE DISORDER,12
CL,CONFUSIONAL STATE,12
CL,DRUG-INDUCED LIVER INJURY,12
CL,EPILEPSY,12
CL,HAEMATOCHEZIA,12
CL,HEART RATE DECREASED,12
CL,ILL-DEFINED DISORDER,12
CL,INCORRECT DOSE ADMINISTERED,12
CL,JAUNDICE,12
CL,LYMPHADENOPATHY,12
CL,MUSCULOSKELETAL PAIN,12
CL,OBSTRUCTIVE AIRWAYS DISORDER,12
CL,OPTIC NEURITIS,12
CL,OXYGEN SATURATION DECREASED,12
CL,SENILE DEMENTIA,12
CL,SYSTEMIC LUPUS ERYTHEMATOSUS,12
CL,UPPER LIMB FRACTURE,12
CL,ADVERSE EVENT,11
CL,ALTERED STATE OF CONSCIOUSNESS,11
CL,BLOOD TRIGLYCERIDES INCREASED,11
CL,BRAIN NEOPLASM,11
CL,BREAST MASS,11
CL,CATATONIA,11
CL,DEVICE DISLOCATION,11
CL,FEELING COLD,11
CL,GASTROINTESTINAL STROMAL TUMOUR,11
CL,GENERALISED TONIC-CLONIC SEIZURE,11
CL,HEPATOMEGALY,11
CL,HERPES ZOSTER,11
CL,INCORRECT ROUTE OF DRUG ADMINISTRATION,11
CL,LEUKOPENIA,11
CL,LIVER DISORDER,11
CL,METRORRHAGIA,11
CL,NEPHROLITHIASIS,11
CL,NODULE,11
CL,PALPITATIONS,11
CL,PANCYTOPENIA,11
CL,PERITONITIS BACTERIAL,11
CL,PYELONEPHRITIS,11
CL,SKIN LESION,11
CL,STATUS EPILEPTICUS,11
CL,BALANCE DISORDER,10
CL,BLOOD BILIRUBIN INCREASED,10
CL,BLOOD CREATINE PHOSPHOKINASE INCREASED,10
CL,CELLULITIS,10
CL,CHROMATURIA,10
CL,COLITIS ULCERATIVE,10
CL,COLON CANCER,10
CL,COMA,10
CL,CONVULSION,10
CL,DEVICE DIFFICULT TO USE,10
CL,DEVICE RELATED INFECTION,10
CL,HEART RATE INCREASED,10
CL,HEPATIC FAILURE,10
CL,HEPATIC NEOPLASM,10
CL,LIGAMENT SPRAIN,10
CL,MOVEMENT DISORDER,10
CL,PHARYNGITIS,10
CL,PRESYNCOPE,10
CL,PULMONARY FIBROSIS,10
CL,RED BLOOD CELL COUNT DECREASED,10
CL,SECOND PRIMARY MALIGNANCY,10
CL,SURGERY,10
CL,SWELLING FACE,10
CL,UNINTENDED PREGNANCY,10
CL,URTICARIA,10
CL,VIRAL INFECTION,10
CL,YELLOW SKIN,10
CL,ACNE,9
CL,ANXIETY DISORDER,9
CL,APHASIA,9
CL,ASCITES,9
CL,BLOOD TEST ABNORMAL,9
CL,CARDIOMEGALY,9
CL,CENTRAL NERVOUS SYSTEM LESION,9
CL,CEREBRAL INFARCTION,9
CL,DERMATITIS ALLERGIC,9
CL,DIVERTICULITIS,9
CL,DYSARTHRIA,9
CL,DYSPHONIA,9
CL,EAR PAIN,9
CL,FRACTURE,9
CL,HAEMOGLOBIN DECREASED,9
CL,HEPATITIS,9
CL,HERNIA,9
CL,INFUSION RELATED REACTION,9
CL,LIMB INJURY,9
CL,LOCAL SWELLING,9
CL,MENSTRUATION IRREGULAR,9
CL,NERVOUS SYSTEM DISORDER,9
CL,OCULAR HYPERAEMIA,9
CL,PARKINSON^S DISEASE,9
CL,PERIPHERAL ISCHAEMIA,9
CL,PNEUMONIA ASPIRATION,9
CL,PSYCHIATRIC DECOMPENSATION,9
CL,RESPIRATORY SYMPTOM,9
CL,RESTLESSNESS,9
CL,SKIN DISORDER,9
CL,SKIN FISSURES,9
CL,SPINAL DISORDER,9
CL,TONSILLITIS,9
CL,VAGINAL HAEMORRHAGE,9
CL,VARICELLA ZOSTER VIRUS INFECTION,9
CL,ACUTE MYELOID LEUKAEMIA,8
CL,AGITATION,8
CL,ALANINE AMINOTRANSFERASE INCREASED,8
CL,APPENDICITIS,8
CL,ASPARTATE AMINOTRANSFERASE INCREASED,8
CL,ASPHYXIA,8
CL,ASTHMA,8
CL,ASTHMATIC CRISIS,8
CL,ATRIOVENTRICULAR BLOCK,8
CL,BONE MARROW FAILURE,8
CL,BREAST PAIN,8
CL,CYANOSIS,8
CL,DIABETIC KETOACIDOSIS,8
CL,DISEASE RECURRENCE,8
CL,DRUG ADMINISTRATION ERROR,8
CL,DRUG HYPERSENSITIVITY,8
CL,EUPHORIC MOOD,8
CL,FLATULENCE,8
CL,FLUID RETENTION,8
CL,GALLBLADDER DISORDER,8
CL,GASTRIC INFECTION,8
CL,GASTRIC ULCER,8
CL,HAEMATOMA,8
CL,HEMIPLEGIA,8
CL,HEPATIC ENZYME INCREASED,8
CL,HYPERSOMNIA,8
CL,HYPERTENSIVE CRISIS,8
CL,HYPOKINESIA,8
CL,INJECTION SITE PAIN,8
CL,ISCHAEMIC STROKE,8
CL,JOINT INJURY,8
CL,LINEAR IGA DISEASE,8
CL,LIVER FUNCTION TEST ABNORMAL,8
CL,MEDICATION ERROR,8
CL,MENORRHAGIA,8
CL,MENTAL DISORDER,8
CL,METABOLIC ACIDOSIS,8
CL,MOBILITY DECREASED,8
CL,NAIL DISORDER,8
CL,NASAL CONGESTION,8
CL,PERICARDIAL EFFUSION,8
CL,POSTOPERATIVE WOUND INFECTION,8
CL,PRODUCTIVE COUGH,8
CL,RESPIRATORY TRACT INFECTION,8
CL,RESTLESS LEGS SYNDROME,8
CL,ROAD TRAFFIC ACCIDENT,8
CL,SENSORY DISTURBANCE,8
CL,SINUS BRADYCARDIA,8
CL,STOMATITIS,8
CL,SUDDEN DEATH,8
CL,SUICIDE ATTEMPT,8
CL,TUBERCULOSIS,8
CL,UPPER RESPIRATORY TRACT INFECTION,8
CL,ABNORMAL BEHAVIOUR,7
CL,ACCIDENT,7
CL,ACCIDENTAL OVERDOSE,7
CL,AGGRESSION,7
CL,AMENORRHOEA,7
CL,BLOOD POTASSIUM DECREASED,7
CL,BRAIN OEDEMA,7
CL,CARDIAC ARREST,7
CL,CEREBRAL HAEMORRHAGE,7
CL,CHEST DISCOMFORT,7
CL,CHOLESTASIS,7
CL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,7
CL,CLOSTRIDIUM DIFFICILE INFECTION,7
CL,CROHN^S DISEASE,7
CL,DIABETIC FOOT,7
CL,DISEASE COMPLICATION,7
CL,DRUG EFFECT INCOMPLETE,7
CL,DRUG INTOLERANCE,7
CL,EXTREMITY NECROSIS,7
CL,EYE IRRITATION,7
CL,EYELID OEDEMA,7
CL,GASTRIC CANCER,7
CL,GASTRIC DISORDER,7
CL,HEPATIC STEATOSIS,7
CL,HYPERAESTHESIA,7
CL,INFLUENZA LIKE ILLNESS,7
CL,INJURY,7
CL,INTERVERTEBRAL DISC PROTRUSION,7
CL,LABORATORY TEST ABNORMAL,7
CL,LIVER INJURY,7
CL,LOCALISED INFECTION,7
CL,LUNG NEOPLASM MALIGNANT,7
CL,PALLOR,7
CL,PANCREATIC CARCINOMA,7
CL,PERITONEAL DIALYSIS COMPLICATION,7
CL,PSORIASIS,7
CL,PSYCHOTIC DISORDER,7
CL,PYELONEPHRITIS ACUTE,7
CL,ROTAVIRUS INFECTION,7
CL,SJOGREN^S SYNDROME,7
CL,SKIN ULCER,7
CL,SLEEP DISORDER,7
CL,STAPHYLOCOCCAL INFECTION,7
CL,SUICIDAL IDEATION,7
CL,TENDON RUPTURE,7
CL,THERAPEUTIC RESPONSE DECREASED,7
CL,TOOTH INFECTION,7
CL,UPPER GASTROINTESTINAL HAEMORRHAGE,7
CL,URINARY INCONTINENCE,7
CL,VIRAL LOAD INCREASED,7
CL,WHITE BLOOD CELL COUNT INCREASED,7
CL,ABDOMINAL MASS,6
CL,ABNORMAL FAECES,6
CL,ABORTION INDUCED,6
CL,ACUTE PULMONARY OEDEMA,6
CL,ANAL ABSCESS,6
CL,ANAL HAEMORRHAGE,6
CL,ANGIOEDEMA,6
CL,APATHY,6
CL,BACTERIAL INFECTION,6
CL,BLOOD GLUCOSE ABNORMAL,6
CL,BLOOD UREA INCREASED,6
CL,BRONCHOSPASM,6
CL,CHOKING,6
CL,COGNITIVE DISORDER,6
CL,CONJUNCTIVITIS,6
CL,CORONARY ARTERY DISEASE,6
CL,ENCEPHALITIS,6
CL,EYE HAEMORRHAGE,6
CL,EYE SWELLING,6
CL,FEAR,6
CL,FEEDING DISORDER,6
CL,FLUSHING,6
CL,FOOT DEFORMITY,6
CL,FREQUENT BOWEL MOVEMENTS,6
CL,GASTROINTESTINAL OEDEMA,6
CL,HAEMORRHOIDS,6
CL,HEAD INJURY,6
CL,HEPATIC NECROSIS,6
CL,HEPATITIS ACUTE,6
CL,HERPES VIRUS INFECTION,6
CL,HIP SURGERY,6
CL,HYPERTHYROIDISM,6
CL,IMPAIRED HEALING,6
CL,INFARCTION,6
CL,INTERSTITIAL LUNG DISEASE,6
CL,INTESTINAL PERFORATION,6
CL,INTRACRANIAL PRESSURE INCREASED,6
CL,IRRITABILITY,6
CL,LEUKOCYTOSIS,6
CL,LYMPHOPENIA,6
CL,MALNUTRITION,6
CL,MITRAL VALVE INCOMPETENCE,6
CL,MOTOR DYSFUNCTION,6
CL,NECK PAIN,6
CL,NO THERAPEUTIC RESPONSE,6
CL,NOSOCOMIAL INFECTION,6
CL,OEDEMA,6
CL,ONYCHOCLASIS,6
CL,PLASMA CELL MYELOMA,6
CL,POLLAKIURIA,6
CL,PORTAL VEIN THROMBOSIS,6
CL,POST PROCEDURAL COMPLICATION,6
CL,POST PROCEDURAL HAEMORRHAGE,6
CL,PREMATURE DELIVERY,6
CL,PROSTATE CANCER,6
CL,PULMONARY THROMBOSIS,6
CL,RECTAL HAEMORRHAGE,6
CL,RESPIRATORY SYNCYTIAL VIRUS INFECTION,6
CL,SENSORY LOSS,6
CL,TENDONITIS,6
CL,THYROID CANCER,6
CL,THYROID DISORDER,6
CL,TOOTH DISORDER,6
CL,UMBILICAL HERNIA,6
CL,URINE ODOUR ABNORMAL,6
CL,UVEITIS,6
CL,ABDOMINAL PAIN LOWER,5
CL,ABDOMINAL SEPSIS,5
CL,ACUTE HEPATIC FAILURE,5
CL,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,5
CL,ACUTE RESPIRATORY FAILURE,5
CL,AFFECTIVE DISORDER,5
CL,ATRIAL FIBRILLATION,5
CL,BIPOLAR DISORDER,5
CL,BLOOD URINE PRESENT,5
CL,BRADYARRHYTHMIA,5
CL,CALCIPHYLAXIS,5
CL,CATHETER SITE INFECTION,5
CL,CEREBRAL THROMBOSIS,5
CL,CHOKING SENSATION,5
CL,CONTRAINDICATED PRODUCT ADMINISTERED,5
CL,CRYING,5
CL,CYTOMEGALOVIRUS INFECTION,5
CL,DELIRIUM,5
CL,DIABETIC METABOLIC DECOMPENSATION,5
CL,DRUG DISPENSING ERROR,5
CL,DRUG PRESCRIBING ERROR,5
CL,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,5
CL,DYSKINESIA,5
CL,EAR INFECTION,5
CL,EATING DISORDER,5
CL,ELECTROCARDIOGRAM ABNORMAL,5
CL,EXTRAPYRAMIDAL DISORDER,5
CL,EYELID DISORDER,5
CL,FLUID OVERLOAD,5
CL,FOOD AVERSION,5
CL,FOOT FRACTURE,5
CL,FOOT OPERATION,5
CL,GLUCOSE TOLERANCE IMPAIRED,5
CL,HAEMATURIA,5
CL,HAEMODYNAMIC INSTABILITY,5
CL,HALLUCINATION,5
CL,HEAD DISCOMFORT,5
CL,HEPATIC CANCER,5
CL,HEPATIC ENCEPHALOPATHY,5
CL,HISTIOCYTOSIS HAEMATOPHAGIC,5
CL,INTENTIONAL PRODUCT MISUSE,5
CL,KIDNEY INFECTION,5
CL,LACRIMATION INCREASED,5
CL,LARYNGITIS,5
CL,LISTLESS,5
CL,LYMPHOCYTE COUNT DECREASED,5
CL,LYMPHOMA,5
CL,MASS,5
CL,MENTAL IMPAIRMENT,5
CL,MYOSITIS,5
CL,NAIL DISCOLOURATION,5
CL,NEOPLASM PROGRESSION,5
CL,ORAL DISORDER,5
CL,ORAL HERPES,5
CL,OVERWEIGHT,5
CL,PANIC ATTACK,5
CL,PELVIC PAIN,5
CL,PNEUMOTHORAX,5
CL,POLYNEUROPATHY,5
CL,POLYURIA,5
CL,PROTEINURIA,5
CL,PRURITUS GENERALISED,5
CL,RASH ERYTHEMATOUS,5
CL,RENAL CYST,5
CL,RENAL FAILURE ACUTE,5
CL,RENAL TUBULAR NECROSIS,5
CL,RESPIRATORY ARREST,5
CL,RHEUMATOID ARTHRITIS,5
CL,SALIVARY HYPERSECRETION,5
CL,SKIN INFECTION,5
CL,SLEEP APNOEA SYNDROME,5
CL,STEVENS-JOHNSON SYNDROME,5
CL,TERMINAL STATE,5
CL,THERAPY NON-RESPONDER,5
CL,THIRST,5
CL,TINNITUS,5
CL,ULTRAFILTRATION FAILURE,5
CL,UROSEPSIS,5
CL,UTERINE LEIOMYOMA,5
CL,VARICES OESOPHAGEAL,5
CL,VASCULITIS,5
CL,VIRAL TEST POSITIVE,5
CL,ACTIVITIES OF DAILY LIVING IMPAIRED,4
CL,AMYLASE INCREASED,4
CL,ANGINA UNSTABLE,4
CL,ANKLE FRACTURE,4
CL,APHONIA,4
CL,APLASTIC ANAEMIA,4
CL,ARTHRITIS BACTERIAL,4
CL,ASPIRATION,4
CL,BACTERIAL TRANSLOCATION,4
CL,BILE DUCT STONE,4
CL,BILIARY COLIC,4
CL,BRAIN INJURY,4
CL,BREAST NEOPLASM,4
CL,BRONCHOPNEUMONIA,4
CL,BRONCHOPULMONARY ASPERGILLOSIS,4
CL,CARDIOVASCULAR DISORDER,4
CL,CEREBELLAR SYNDROME,4
CL,CHOLECYSTITIS ACUTE,4
CL,COAGULOPATHY,4
CL,COELIAC DISEASE,4
CL,CUSHING^S SYNDROME,4
CL,CYST,4
CL,DEAFNESS UNILATERAL,4
CL,DECREASED IMMUNE RESPONSIVENESS,4
CL,DIABETIC COMA,4
CL,DIPLOPIA,4
CL,DIVERTICULUM,4
CL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,4
CL,DRUG WITHDRAWAL SYNDROME,4
CL,EAR DISCOMFORT,4
CL,ELECTROCARDIOGRAM QT PROLONGED,4
CL,EMBOLIC STROKE,4
CL,EMOTIONAL DISTRESS,4
CL,EYE INJURY,4
CL,FACE OEDEMA,4
CL,FOETAL DEATH,4
CL,FOETAL GROWTH RESTRICTION,4
CL,FOOD ALLERGY,4
CL,FRACTURED COCCYX,4
CL,FUNGAL PERITONITIS,4
CL,GAIT INABILITY,4
CL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
CL,GASTRIC HAEMORRHAGE,4
CL,GASTRITIS EROSIVE,4
CL,GASTROINTESTINAL INFECTION,4
CL,GASTROINTESTINAL SOUNDS ABNORMAL,4
CL,GENERALISED OEDEMA,4
CL,HAEMATEMESIS,4
CL,HEPATIC CYST,4
CL,HEPATOTOXICITY,4
CL,HIATUS HERNIA,4
CL,HICCUPS,4
CL,HORMONE LEVEL ABNORMAL,4
CL,HOSPITALISATION,4
CL,HUMERUS FRACTURE,4
CL,HYDROCEPHALUS,4
CL,HYPOKALAEMIA,4
CL,HYPONATRAEMIA,4
CL,HYPOXIA,4
CL,IMMUNE-MEDIATED NECROTISING MYOPATHY,4
CL,INCOHERENT,4
CL,INCREASED BRONCHIAL SECRETION,4
CL,INTENTIONAL PRODUCT USE ISSUE,4
CL,JOINT DISLOCATION,4
CL,JOINT EFFUSION,4
CL,KETOACIDOSIS,4
CL,MACULE,4
CL,MACULOPATHY,4
CL,MENINGITIS,4
CL,METABOLIC DISORDER,4
CL,METASTASES TO PERITONEUM,4
CL,MOUTH HAEMORRHAGE,4
CL,MUCOSAL DRYNESS,4
CL,MUSCLE RIGIDITY,4
CL,MUSCULOSKELETAL DISORDER,4
CL,MYOCARDITIS,4
CL,NEUTROPHIL COUNT DECREASED,4
CL,OCULAR DISCOMFORT,4
CL,OCULAR VASCULAR DISORDER,4
CL,OSTEOMYELITIS,4
CL,OSTEOPOROSIS,4
CL,PAIN IN JAW,4
CL,PANCREATITIS ACUTE,4
CL,PARALYSIS,4
CL,PARAPARESIS,4
CL,PAROSMIA,4
CL,PLASMABLASTIC LYMPHOMA,4
CL,PNEUMOCYSTIS JIROVECII PNEUMONIA,4
CL,PORTAL HYPERTENSION,4
CL,PREGNANCY WITH IMPLANT CONTRACEPTIVE,4
CL,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,4
CL,PSYCHIATRIC SYMPTOM,4
CL,PULMONARY PAIN,4
CL,PULMONARY TUBERCULOSIS,4
CL,RASH GENERALISED,4
CL,RASH PRURITIC,4
CL,RENAL INJURY,4
CL,RETINAL DETACHMENT,4
CL,RETINAL INJURY,4
CL,RHINITIS,4
CL,RIB FRACTURE,4
CL,SCAR,4
CL,SKIN HYPERPIGMENTATION,4
CL,SKIN IRRITATION,4
CL,SPHINCTER OF ODDI DYSFUNCTION,4
CL,SPINAL FRACTURE,4
CL,THROAT TIGHTNESS,4
CL,TIBIA FRACTURE,4
CL,TOOTHACHE,4
CL,TREATMENT FAILURE,4
CL,UNEVALUABLE EVENT,4
CL,VARICOSE VEIN,4
CL,VASCULAR CALCIFICATION,4
CL,WITHDRAWAL BLEED,4
CL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,4
CL,ABDOMINAL HERNIA,3
CL,ABSCESS NECK,3
CL,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,3
CL,ACUTE LYMPHOCYTIC LEUKAEMIA,3
CL,AGEUSIA,3
CL,ANAL FISTULA,3
CL,ANGINA PECTORIS,3
CL,APPETITE DISORDER,3
CL,ARTERIAL OCCLUSIVE DISEASE,3
CL,ARTERIOSCLEROSIS,3
CL,AUTOIMMUNE DISORDER,3
CL,AXILLARY PAIN,3
CL,BENIGN PROSTATIC HYPERPLASIA,3
CL,BLADDER CANCER,3
CL,BLINDNESS TRANSIENT,3
CL,BLOOD ALKALINE PHOSPHATASE INCREASED,3
CL,BLOOD PRESSURE ABNORMAL,3
CL,BLOOD THYROID STIMULATING HORMONE INCREASED,3
CL,BLOOD URIC ACID INCREASED,3
CL,BONE CANCER,3
CL,BONE SCAN ABNORMAL,3
CL,BRAIN NATRIURETIC PEPTIDE INCREASED,3
CL,BREAST DISCOMFORT,3
CL,BREAST DISORDER,3
CL,C-REACTIVE PROTEIN INCREASED,3
CL,CARDIOGENIC SHOCK,3
CL,CARDIOPULMONARY FAILURE,3
CL,CARTILAGE INJURY,3
CL,CATHETER SITE EXTRAVASATION,3
CL,CERVICAL DYSPLASIA,3
CL,CERVICAL SPINAL STENOSIS,3
CL,CIRCULATORY COLLAPSE,3
CL,CONCOMITANT DISEASE AGGRAVATED,3
CL,COTARD^S SYNDROME,3
CL,CRANIOCEREBRAL INJURY,3
CL,DERMATITIS,3
CL,DIABETIC NEUROPATHY,3
CL,DRUG LEVEL DECREASED,3
CL,DRUG LEVEL INCREASED,3
CL,DRY EYE,3
CL,DYSSTASIA,3
CL,EAR DISORDER,3
CL,ECCHYMOSIS,3
CL,EMBOLISM,3
CL,EMOTIONAL DISORDER,3
CL,ERYTHEMA MULTIFORME,3
CL,EYE INFECTION,3
CL,EYE PRURITUS,3
CL,FAECALOMA,3
CL,FAECES DISCOLOURED,3
CL,FEELING OF DESPAIR,3
CL,FEMUR FRACTURE,3
CL,FIBROMYALGIA,3
CL,FIBULA FRACTURE,3
CL,FLANK PAIN,3
CL,FUNGAL INFECTION,3
CL,GASTROINTESTINAL NECROSIS,3
CL,GASTROINTESTINAL PAIN,3
CL,GENITAL HAEMORRHAGE,3
CL,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,3
CL,HAEMOLYTIC URAEMIC SYNDROME,3
CL,HAEMORRHAGIC STROKE,3
CL,HAIR GROWTH ABNORMAL,3
CL,HALLUCINATION_ VISUAL,3
CL,HAND FRACTURE,3
CL,HEPATIC CIRRHOSIS,3
CL,HEPATIC FUNCTION ABNORMAL,3
CL,HEPATIC PAIN,3
CL,HEPATIC VEIN THROMBOSIS,3
CL,HOT FLUSH,3
CL,HYDRONEPHROSIS,3
CL,HYPERBILIRUBINAEMIA,3
CL,HYPOALBUMINAEMIA,3
CL,HYPOGAMMAGLOBULINAEMIA,3
CL,HYPOPERFUSION,3
CL,HYPOPHAGIA,3
CL,IIIRD NERVE PARESIS,3
CL,IMMOBILE,3
CL,IMMUNOSUPPRESSION,3
CL,IMPAIRED GASTRIC EMPTYING,3
CL,INFERTILITY FEMALE,3
CL,INGUINAL HERNIA,3
CL,INJECTION SITE ERYTHEMA,3
CL,INJECTION SITE NECROSIS,3
CL,INSULIN RESISTANCE,3
CL,INTELLECTUAL DISABILITY,3
CL,INTERNATIONAL NORMALISED RATIO INCREASED,3
CL,INTERVERTEBRAL DISC DISORDER,3
CL,INTRACRANIAL ANEURYSM,3
CL,LACRIMAL DISORDER,3
CL,LETHARGY,3
CL,LEUKAEMIA RECURRENT,3
CL,LIBIDO DECREASED,3
CL,LIGAMENT RUPTURE,3
CL,LIMB OPERATION,3
CL,LIPASE INCREASED,3
CL,LIVE BIRTH,3
CL,LOW BIRTH WEIGHT BABY,3
CL,LOWER LIMB FRACTURE,3
CL,LUMBAR HERNIA,3
CL,LUNG INFECTION,3
CL,LUNG NEOPLASM,3
CL,MACULAR DEGENERATION,3
CL,MACULAR OEDEMA,3
CL,MELAENA,3
CL,METASTASES TO KIDNEY,3
CL,MICTURITION URGENCY,3
CL,MIGRAINE,3
CL,MIGRATION OF IMPLANTED DRUG,3
CL,MOUTH ULCERATION,3
CL,MULTIPLE GATED ACQUISITION SCAN ABNORMAL,3
CL,MUSCLE ATROPHY,3
CL,MUSCLE FATIGUE,3
CL,MUSCULOSKELETAL DISCOMFORT,3
CL,MYCOBACTERIUM ABSCESSUS INFECTION,3
CL,MYOCARDIAL NECROSIS,3
CL,MYOPATHY,3
CL,NECROSIS,3
CL,NEPHRITIS,3
CL,NEPHROTIC SYNDROME,3
CL,NEURALGIA,3
CL,NEUROLEPTIC MALIGNANT SYNDROME,3
CL,NEUROTOXICITY,3
CL,NOCTURIA,3
CL,NODULAR REGENERATIVE HYPERPLASIA,3
CL,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,3
CL,OCULAR ICTERUS,3
CL,OESOPHAGEAL ULCER,3
CL,ORAL CANDIDIASIS,3
CL,ORAL INFECTION,3
CL,ORAL MUCOSAL BLISTERING,3
CL,ORGANISING PNEUMONIA,3
CL,OSTEONECROSIS OF JAW,3
CL,OVARIAN CANCER,3
CL,PANCREATIC DISORDER,3
CL,PARESIS,3
CL,PEMPHIGUS,3
CL,PERIPHERAL EMBOLISM,3
CL,PERITONEAL HAEMORRHAGE,3
CL,PERITONEAL TUBERCULOSIS,3
CL,PETIT MAL EPILEPSY,3
CL,PHARYNGEAL OEDEMA,3
CL,PHYSICAL DISABILITY,3
CL,PLATELET COUNT ABNORMAL,3
CL,PLEURAL DISORDER,3
CL,PNEUMONIA BACTERIAL,3
CL,POLYDIPSIA,3
CL,POOR QUALITY SLEEP,3
CL,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,3
CL,PRE-ECLAMPSIA,3
CL,PROCEDURAL COMPLICATION,3
CL,PROSTATIC DISORDER,3
CL,PROTEIN TOTAL DECREASED,3
CL,PULMONARY SEPSIS,3
CL,PULMONARY TOXICITY,3
CL,PURPURA,3
CL,RASH MACULAR,3
CL,RASH PAPULAR,3
CL,RECURRENT CANCER,3
CL,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
CL,RENAL NEOPLASM,3
CL,RENAL PAIN,3
CL,RESPIRATORY DEPRESSION,3
CL,RHINORRHOEA,3
CL,RIGHT VENTRICULAR FAILURE,3
CL,SKELETAL INJURY,3
CL,SKIN CANCER,3
CL,SKIN WRINKLING,3
CL,SPINAL OPERATION,3
CL,SPLENOMEGALY,3
CL,STRESS CARDIOMYOPATHY,3
CL,STUPOR,3
CL,SUFFOCATION FEELING,3
CL,TACHYPNOEA,3
CL,TEMPERATURE INTOLERANCE,3
CL,THROAT IRRITATION,3
CL,THROMBOPHLEBITIS,3
CL,THYROID FUNCTION TEST ABNORMAL,3
CL,THYROID MASS,3
CL,TOOTH FRACTURE,3
CL,TRANSIENT ISCHAEMIC ATTACK,3
CL,TUBERCULIN TEST POSITIVE,3
CL,TUBULOINTERSTITIAL NEPHRITIS,3
CL,TUMOUR MARKER INCREASED,3
CL,UNDERDOSE,3
CL,UNDERWEIGHT,3
CL,URINE ANALYSIS ABNORMAL,3
CL,URINE OUTPUT DECREASED,3
CL,UTERINE PAIN,3
CL,VASODILATATION,3
CL,VENOUS OCCLUSION,3
CL,VIITH NERVE PARALYSIS,3
CL,VIRAL UPPER RESPIRATORY TRACT INFECTION,3
CL,VISUAL FIELD DEFECT,3
CL,VULVOVAGINAL BURNING SENSATION,3
CL,VULVOVAGINAL SWELLING,3
CL,WOUND INFECTION,3
CL,ABDOMINAL INJURY,2
CL,ABNORMAL WITHDRAWAL BLEEDING,2
CL,ABORTION THREATENED,2
CL,ACUTE ABDOMEN,2
CL,ACUTE LEUKAEMIA,2
CL,ADENOIDAL DISORDER,2
CL,ADENOIDAL HYPERTROPHY,2
CL,ADENOVIRUS INFECTION,2
CL,ADMINISTRATION SITE PAIN,2
CL,ADNEXA UTERI PAIN,2
CL,AFFECT LABILITY,2
CL,ALANINE AMINOTRANSFERASE ABNORMAL,2
CL,AMIMIA,2
CL,ANGER,2
CL,ANKYLOSING SPONDYLITIS,2
CL,ANORECTAL DISORDER,2
CL,ANURIA,2
CL,AORTIC ANEURYSM,2
CL,AORTIC VALVE INCOMPETENCE,2
CL,APGAR SCORE LOW,2
CL,APHAGIA,2
CL,APHTHOUS STOMATITIS,2
CL,APLASIA,2
CL,APNOEA,2
CL,APPLICATION SITE ERYTHEMA,2
CL,ARTERIAL DISORDER,2
CL,ASPARTATE AMINOTRANSFERASE ABNORMAL,2
CL,ASTIGMATISM,2
CL,ATELECTASIS,2
CL,ATRIAL FLUTTER,2
CL,AUTOIMMUNE HEPATITIS,2
CL,AUTONOMIC NERVOUS SYSTEM IMBALANCE,2
CL,AVERSION,2
CL,BACTERAEMIA,2
CL,BENIGN NEOPLASM OF THYROID GLAND,2
CL,BILE DUCT STENOSIS,2
CL,BILIARY TRACT DISORDER,2
CL,BLAST CELLS PRESENT,2
CL,BLEPHARITIS,2
CL,BLOOD CHOLESTEROL ABNORMAL,2
CL,BLOOD CREATININE ABNORMAL,2
CL,BLOOD CREATININE DECREASED,2
CL,BLOOD POTASSIUM INCREASED,2
CL,BLOOD THYROID STIMULATING HORMONE DECREASED,2
CL,BLOOD URINE,2
CL,BODY TEMPERATURE DECREASED,2
CL,BODY TEMPERATURE INCREASED,2
CL,BREAST CYST,2
CL,BREAST SWELLING,2
CL,BREAST ULCERATION,2
CL,BREATH ODOUR,2
CL,BREECH PRESENTATION,2
CL,BRONCHIECTASIS,2
CL,BRONCHIOLITIS,2
CL,BURSITIS,2
CL,CAESAREAN SECTION,2
CL,CANDIDA INFECTION,2
CL,CARDIAC FAILURE CHRONIC,2
CL,CARDIAC FAILURE CONGESTIVE,2
CL,CARDIAC FUNCTION TEST ABNORMAL,2
CL,CARDIAC OPERATION,2
CL,CARDIAC PACEMAKER INSERTION,2
CL,CARDIOMYOPATHY,2
CL,CARDIORENAL SYNDROME,2
CL,CAROTID ARTERY STENOSIS,2
CL,CARPAL TUNNEL SYNDROME,2
CL,CATARACT OPERATION,2
CL,CATARACT OPERATION COMPLICATION,2
CL,CD4 LYMPHOCYTES DECREASED,2
CL,CENTRAL NERVOUS SYSTEM LEUKAEMIA,2
CL,CERVIX CARCINOMA,2
CL,CHEMICAL PERITONITIS,2
CL,CHOLECYSTITIS,2
CL,CHONDROPATHY,2
CL,CLOSTRIDIUM DIFFICILE COLITIS,2
CL,COITAL BLEEDING,2
CL,COLD SWEAT,2
CL,COLECTOMY,2
CL,COLON ADENOMA,2
CL,CONGENITAL RENAL DISORDER,2
CL,CONJUNCTIVAL HAEMORRHAGE,2
CL,CORONARY ARTERY OCCLUSION,2
CL,CRANIOPHARYNGIOMA,2
CL,CUTANEOUS VASCULITIS,2
CL,CYTOMEGALOVIRUS CHORIORETINITIS,2
CL,CYTOPENIA,2
CL,DECREASED ACTIVITY,2
CL,DECUBITUS ULCER,2
CL,DEMYELINATION,2
CL,DEPENDENCE,2
CL,DEPRESSIVE SYMPTOM,2
CL,DERMATITIS BULLOUS,2
CL,DEVELOPMENTAL HIP DYSPLASIA,2
CL,DEVICE BREAKAGE,2
CL,DIARRHOEA INFECTIOUS,2
CL,DISINHIBITION,2
CL,DISTRACTIBILITY,2
CL,DRUG EFFECT DELAYED,2
CL,DYSPHEMIA,2
CL,DYSPNOEA EXERTIONAL,2
CL,DYSTONIA,2
CL,ECTOPIC PREGNANCY,2
CL,EJECTION FRACTION DECREASED,2
CL,ELECTRIC SHOCK,2
CL,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,2
CL,ENCEPHALOPATHY,2
CL,ENDOMETRIAL HYPERPLASIA,2
CL,ENDOMETRITIS,2
CL,ENTEROCOLITIS,2
CL,EOSINOPHILIA,2
CL,EPIDERMOLYSIS,2
CL,ERGOT POISONING,2
CL,ESCHAR,2
CL,ESCHERICHIA INFECTION,2
CL,EXTRASYSTOLES,2
CL,EYE CONTUSION,2
CL,EYE INFLAMMATION,2
CN,DEATH,4675
CN,PYREXIA,1388
CN,VOMITING,1330
CN,NAUSEA,1258
CN,DRUG INEFFECTIVE,1177
CN,RASH,1029
CN,DYSPNOEA,1023
CN,DIZZINESS,985
CN,WHITE BLOOD CELL COUNT DECREASED,957
CN,DIARRHOEA,924
CN,BONE MARROW FAILURE,921
CN,ASTHENIA,853
CN,HEPATIC FUNCTION ABNORMAL,848
CN,CHEST DISCOMFORT,840
CN,PRURITUS,731
CN,LUNG INFECTION,676
CN,DECREASED APPETITE,670
CN,PLATELET COUNT DECREASED,632
CN,DISEASE PROGRESSION,625
CN,FATIGUE,610
CN,RENAL IMPAIRMENT,559
CN,PALPITATIONS,544
CN,INFECTION,543
CN,BLOOD GLUCOSE INCREASED,542
CN,EPILEPSY,530
CN,ALANINE AMINOTRANSFERASE INCREASED,515
CN,PNEUMONIA,502
CN,THROMBOCYTOPENIA,489
CN,CHILLS,487
CN,RESPIRATORY FAILURE,485
CN,COUGH,461
CN,ANAEMIA,450
CN,DRUG RESISTANCE,450
CN,HEADACHE,428
CN,LEUKOPENIA,421
CN,CARDIAC FAILURE,417
CN,GASTROINTESTINAL HAEMORRHAGE,414
CN,LOSS OF CONSCIOUSNESS,409
CN,CONDITION AGGRAVATED,406
CN,ABDOMINAL PAIN,379
CN,ASPARTATE AMINOTRANSFERASE INCREASED,378
CN,NEUTROPENIA,377
CN,COMA,375
CN,HAEMORRHAGE,374
CN,HYPERTENSION,374
CN,LIVER INJURY,371
CN,PAIN,356
CN,CEREBRAL INFARCTION,352
CN,ERYTHEMA,350
CN,PRODUCT USE ISSUE,345
CN,MALIGNANT NEOPLASM PROGRESSION,338
CN,DRUG-INDUCED LIVER INJURY,337
CN,FOETAL EXPOSURE DURING PREGNANCY,333
CN,SOMNOLENCE,331
CN,HYPERHIDROSIS,325
CN,BLOOD PRESSURE INCREASED,323
CN,NASOPHARYNGITIS,314
CN,ANAPHYLACTIC SHOCK,310
CN,BLOOD CREATININE INCREASED,310
CN,ABDOMINAL DISTENSION,303
CN,HAEMOGLOBIN DECREASED,299
CN,MUSCULAR WEAKNESS,294
CN,ARRHYTHMIA,290
CN,OEDEMA PERIPHERAL,277
CN,HYPOAESTHESIA,276
CN,HYPERSENSITIVITY,272
CN,ASTHMA,269
CN,OVERDOSE,269
CN,CONSTIPATION,267
CN,TREMOR,264
CN,GASTROINTESTINAL DISORDER,257
CN,BLOOD CREATINE PHOSPHOKINASE INCREASED,256
CN,HYPOTENSION,255
CN,MYALGIA,254
CN,BLOOD PRESSURE DECREASED,246
CN,ARTHRALGIA,242
CN,HAEMARTHROSIS,242
CN,DISCOMFORT,239
CN,FALL,238
CN,INSOMNIA,237
CN,WEIGHT DECREASED,234
CN,BLOOD BILIRUBIN INCREASED,231
CN,ABDOMINAL DISCOMFORT,228
CN,GAIT DISTURBANCE,228
CN,PAIN IN EXTREMITY,228
CN,INTESTINAL OBSTRUCTION,227
CN,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,227
CN,TOXICITY TO VARIOUS AGENTS,227
CN,MATERNAL EXPOSURE DURING PREGNANCY,226
CN,VISION BLURRED,226
CN,DELIRIUM,225
CN,NEUTROPHIL COUNT DECREASED,223
CN,CEREBRAL HAEMORRHAGE,220
CN,FLUSHING,215
CN,PRODUCT USE IN UNAPPROVED INDICATION,215
CN,ASCITES,214
CN,HAEMATOCHEZIA,212
CN,PLEURAL EFFUSION,212
CN,EXPOSURE DURING PREGNANCY,211
CN,SYNCOPE,209
CN,HEPATITIS B,206
CN,CYANOSIS,203
CN,HEART RATE INCREASED,203
CN,OSTEOMALACIA,203
CN,CHEST PAIN,202
CN,HYPOGLYCAEMIA,201
CN,MULTI-ORGAN FAILURE,200
CN,SEIZURE,198
CN,TRANSAMINASES INCREASED,198
CN,HYPOKALAEMIA,196
CN,RENAL FAILURE,196
CN,SHOCK,195
CN,ACUTE KIDNEY INJURY,194
CN,MOUTH ULCERATION,193
CN,DIABETES MELLITUS,192
CN,PRODUCT QUALITY ISSUE,191
CN,OSTEOPOROSIS,190
CN,MENTAL DISORDER,186
CN,OEDEMA,185
CN,DRUG DOSE OMISSION,184
CN,SUSPECTED COUNTERFEIT PRODUCT,184
CN,MYOCARDIAL INFARCTION,183
CN,JAUNDICE,180
CN,HAEMATURIA,178
CN,RHABDOMYOLYSIS,175
CN,URTICARIA,175
CN,BACK PAIN,174
CN,NEUROTOXICITY,173
CN,LIVER FUNCTION TEST ABNORMAL,171
CN,WHITE BLOOD CELL COUNT INCREASED,171
CN,ALOPECIA,170
CN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,166
CN,DISEASE RECURRENCE,165
CN,INTERSTITIAL LUNG DISEASE,165
CN,DRUG ERUPTION,164
CN,TACHYPNOEA,163
CN,HYPERPYREXIA,161
CN,TACHYCARDIA,161
CN,HEPATOCELLULAR INJURY,160
CN,BLOOD UREA INCREASED,159
CN,NEUROPATHY PERIPHERAL,159
CN,HAEMOPTYSIS,158
CN,DRUG HYPERSENSITIVITY,157
CN,RASH GENERALISED,156
CN,DYSPHORIA,155
CN,ABDOMINAL PAIN UPPER,154
CN,HEPATIC FAILURE,153
CN,BONE PAIN,152
CN,CONFUSIONAL STATE,150
CN,CARDIAC ARREST,149
CN,CONVULSION,149
CN,PRODUCTIVE COUGH,148
CN,BLISTER,146
CN,LIVER DISORDER,146
CN,RENAL CELL CARCINOMA,146
CN,UPPER GASTROINTESTINAL HAEMORRHAGE,144
CN,FEBRILE NEUTROPENIA,142
CN,ATRIAL FIBRILLATION,141
CN,SKIN EXFOLIATION,141
CN,CARDIAC DISORDER,140
CN,RASH ERYTHEMATOUS,139
CN,HYPOPHOSPHATAEMIA,136
CN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,134
CN,CORONARY ARTERY DISEASE,133
CN,AGRANULOCYTOSIS,131
CN,PALLOR,131
CN,PROTEINURIA,131
CN,HYPERTHYROIDISM,130
CN,INFUSION RELATED REACTION,127
CN,MALAISE,127
CN,AGITATION,126
CN,SEPSIS,126
CN,URINARY RETENTION,125
CN,RASH MACULO-PAPULAR,124
CN,ANAPHYLACTOID REACTION,122
CN,DEPRESSED LEVEL OF CONSCIOUSNESS,122
CN,DYSURIA,122
CN,ALTERED STATE OF CONSCIOUSNESS,121
CN,HALLUCINATION,121
CN,URINARY TRACT INFECTION,121
CN,WEIGHT INCREASED,121
CN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,120
CN,LYMPHOCYTE COUNT DECREASED,120
CN,RENAL FAILURE ACUTE,120
CN,HAEMATEMESIS,114
CN,HAEMATOTOXICITY,114
CN,GASTROINTESTINAL STROMAL TUMOUR,113
CN,DERMATITIS EXFOLIATIVE,112
CN,HEPATIC ENZYME INCREASED,112
CN,TIC,112
CN,PROTEIN URINE PRESENT,111
CN,ANAPHYLACTIC REACTION,110
CN,EYELID OEDEMA,110
CN,URINARY INCONTINENCE,110
CN,HAEMORRHAGE INTRACRANIAL,109
CN,ANXIETY,108
CN,HEPATITIS B DNA INCREASED,108
CN,GASTRIC HAEMORRHAGE,107
CN,ANGINA PECTORIS,106
CN,LARYNGEAL OEDEMA,106
CN,FACE OEDEMA,105
CN,RENAL INJURY,104
CN,HEPATIC CIRRHOSIS,103
CN,NEUTROPHIL COUNT INCREASED,103
CN,RESTLESSNESS,103
CN,DRY MOUTH,102
CN,PERIPHERAL SWELLING,102
CN,EPISTAXIS,101
CN,PRURITUS GENERALISED,101
CN,ACUTE GRAFT VERSUS HOST DISEASE,99
CN,HYPERGLYCAEMIA,99
CN,INTENTIONAL PRODUCT MISUSE,99
CN,COAGULOPATHY,98
CN,HERPES ZOSTER,98
CN,SEPTIC SHOCK,98
CN,DYSPHAGIA,97
CN,GAMMA-GLUTAMYLTRANSFERASE INCREASED,97
CN,HEPATOCELLULAR CARCINOMA,97
CN,LUNG NEOPLASM MALIGNANT,96
CN,BLOOD GLUCOSE ABNORMAL,95
CN,FOAMING AT MOUTH,95
CN,GASTRIC ULCER,95
CN,EXTRAPYRAMIDAL DISORDER,94
CN,GRANULOCYTOPENIA,93
CN,CARDIOPULMONARY FAILURE,92
CN,NEOPLASM MALIGNANT,92
CN,NEPHROPATHY TOXIC,92
CN,SWELLING,92
CN,WHEEZING,92
CN,ABASIA,91
CN,DIABETES MELLITUS INADEQUATE CONTROL,91
CN,SPEECH DISORDER,91
CN,TREATMENT FAILURE,91
CN,VIRAL LOAD INCREASED,91
CN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,91
CN,LUNG DISORDER,90
CN,DRUG ADMINISTRATION ERROR,89
CN,DYSPHONIA,89
CN,OROPHARYNGEAL PAIN,89
CN,SWELLING FACE,89
CN,VISUAL IMPAIRMENT,89
CN,ABORTION SPONTANEOUS,88
CN,DEPRESSION,88
CN,GENERAL PHYSICAL HEALTH DETERIORATION,88
CN,OXYGEN SATURATION DECREASED,88
CN,PRODUCT COUNTERFEIT,88
CN,TEMPERATURE INTOLERANCE,88
CN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,87
CN,INCORRECT DOSE ADMINISTERED,87
CN,GINGIVAL BLEEDING,86
CN,VIRAL MUTATION IDENTIFIED,86
CN,ANURIA,85
CN,MUSCLE TWITCHING,85
CN,THERAPEUTIC RESPONSE DECREASED,85
CN,BLOOD PHOSPHORUS DECREASED,84
CN,IRRITABILITY,84
CN,ASPHYXIA,83
CN,CHROMATURIA,83
CN,HYPOGLYCAEMIC COMA,83
CN,TREATMENT NONCOMPLIANCE,83
CN,UPPER RESPIRATORY TRACT INFECTION,83
CN,ELECTROLYTE IMBALANCE,82
CN,HEPATIC CANCER,82
CN,OLIGURIA,82
CN,PATHOGEN RESISTANCE,82
CN,MELAENA,81
CN,FUNGAL INFECTION,80
CN,HYPERBILIRUBINAEMIA,80
CN,LACTIC ACIDOSIS,80
CN,SINUS TACHYCARDIA,80
CN,METABOLIC ACIDOSIS,79
CN,MYOCARDIAL NECROSIS MARKER INCREASED,79
CN,ORGAN FAILURE,79
CN,FANCONI SYNDROME ACQUIRED,78
CN,METASTASES TO LUNG,78
CN,SUICIDE ATTEMPT,78
CN,HYDRONEPHROSIS,77
CN,RASH PRURITIC,77
CN,RED BLOOD CELL COUNT DECREASED,77
CN,MOVEMENT DISORDER,76
CN,THROMBOSIS,76
CN,BLOOD POTASSIUM DECREASED,75
CN,ERYTHEMA MULTIFORME,75
CN,HAEMORRHAGE SUBCUTANEOUS,75
CN,HOSPITALISATION,75
CN,HYPONATRAEMIA,75
CN,PERICARDIAL EFFUSION,75
CN,ABORTION INDUCED,74
CN,CACHEXIA,74
CN,COLD SWEAT,74
CN,MUSCLE SPASMS,74
CN,BLINDNESS,73
CN,BLOOD ALBUMIN DECREASED,73
CN,COGNITIVE DISORDER,73
CN,DYSKINESIA,73
CN,FAECES DISCOLOURED,73
CN,FEELING ABNORMAL,73
CN,MEMORY IMPAIRMENT,73
CN,OSTEONECROSIS,73
CN,OSTEONECROSIS OF JAW,73
CN,PULMONARY EMBOLISM,73
CN,TRAUMATIC LUNG INJURY,73
CN,METASTASES TO CENTRAL NERVOUS SYSTEM,72
CN,PULMONARY ARTERIAL HYPERTENSION,72
CN,HEART RATE DECREASED,71
CN,MUCOSAL INFLAMMATION,71
CN,TINNITUS,71
CN,VISUAL ACUITY REDUCED,71
CN,DERMATITIS ALLERGIC,70
CN,METASTASES TO LIVER,70
CN,POLLAKIURIA,70
CN,PULMONARY TUBERCULOSIS,70
CN,ACUTE MYOCARDIAL INFARCTION,69
CN,ELECTROCARDIOGRAM QT PROLONGED,69
CN,EYE DISORDER,69
CN,POOR QUALITY SLEEP,69
CN,APHASIA,68
CN,BLOOD LACTATE DEHYDROGENASE INCREASED,68
CN,DYSPEPSIA,68
CN,MUSCULOSKELETAL STIFFNESS,68
CN,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,68
CN,SINUS BRADYCARDIA,68
CN,BLOOD URIC ACID INCREASED,67
CN,INTENTIONAL OVERDOSE,67
CN,TRANSPLANT REJECTION,67
CN,TUBERCULOSIS,67
CN,CHRONIC MYELOID LEUKAEMIA,66
CN,DEAFNESS,66
CN,HYPOXIA,66
CN,MANIA,66
CN,PERITONITIS,66
CN,SUDDEN DEATH,66
CN,ACUTE HEPATIC FAILURE,65
CN,CHOLELITHIASIS,65
CN,HEPATOTOXICITY,65
CN,POSTRENAL FAILURE,65
CN,TOXIC EPIDERMAL NECROLYSIS,65
CN,CARDIAC FAILURE CONGESTIVE,64
CN,CONJUNCTIVAL HYPERAEMIA,64
CN,CYTOMEGALOVIRUS INFECTION,64
CN,FRACTURE,64
CN,PAPULE,64
CN,PARALYSIS,64
CN,TRISMUS,64
CN,METASTASIS,63
CN,STOMATITIS,63
CN,CARDIAC DISCOMFORT,62
CN,PLASMA CELL MYELOMA,62
CN,PREMATURE BABY,62
CN,SKIN DISCOLOURATION,62
CN,STEVENS-JOHNSON SYNDROME,62
CN,SUICIDAL IDEATION,62
CN,ABDOMINAL INFECTION,61
CN,DEEP VEIN THROMBOSIS,61
CN,HYPOTHYROIDISM,61
CN,UNRESPONSIVE TO STIMULI,61
CN,BILIRUBIN CONJUGATED INCREASED,60
CN,C-REACTIVE PROTEIN INCREASED,60
CN,EYE MOVEMENT DISORDER,60
CN,SCHIZOPHRENIA,60
CN,BLOOD ALKALINE PHOSPHATASE INCREASED,59
CN,BRADYCARDIA,59
CN,VERTIGO,59
CN,CEREBROVASCULAR ACCIDENT,58
CN,GRAFT VERSUS HOST DISEASE,58
CN,METASTASES TO BONE,58
CN,NEPHROLITHIASIS,58
CN,RETINAL DETACHMENT,58
CN,WRONG TECHNIQUE IN DRUG USAGE PROCESS,58
CN,NEOPLASM PROGRESSION,57
CN,BODY TEMPERATURE INCREASED,56
CN,CIRCULATORY COLLAPSE,56
CN,CRYING,56
CN,GENERALISED TONIC-CLONIC SEIZURE,56
CN,RESPIRATORY DEPRESSION,56
CN,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,55
CN,DRUG DEPENDENCE,55
CN,GASTROOESOPHAGEAL REFLUX DISEASE,55
CN,LYMPHADENOPATHY,55
CN,MYOCARDIAL ISCHAEMIA,55
CN,DERMATITIS,54
CN,PANCYTOPENIA,54
CN,RENAL DISORDER,54
CN,ANGIOEDEMA,53
CN,BLOOD GLUCOSE DECREASED,53
CN,HEPATITIS,53
CN,HYPERKALAEMIA,53
CN,HYPERLIPIDAEMIA,53
CN,INJECTION SITE PAIN,53
CN,INTERVERTEBRAL DISC PROTRUSION,53
CN,JOINT SWELLING,53
CN,PNEUMOCYSTIS JIROVECII PNEUMONIA,53
CN,PURPURA,53
CN,ADVERSE EVENT,52
CN,ANGINA UNSTABLE,52
CN,CHOLECYSTITIS,52
CN,HEPATIC ENCEPHALOPATHY,52
CN,HEPATIC STEATOSIS,52
CN,INCISION SITE PAIN,52
CN,INCORRECT ROUTE OF DRUG ADMINISTRATION,52
CN,INTENTIONAL PRODUCT USE ISSUE,52
CN,PULMONARY OEDEMA,52
CN,RED BLOOD CELLS URINE POSITIVE,52
CN,ABNORMAL BEHAVIOUR,51
CN,HYPOCALCAEMIA,51
CN,MALNUTRITION,51
CN,MEDICATION ERROR,51
CN,NEOPLASM,51
CN,ACUTE RESPIRATORY DISTRESS SYNDROME,50
CN,ARTERIOSCLEROSIS,50
CN,BLOOD TRIGLYCERIDES INCREASED,50
CN,BRAIN OEDEMA,50
CN,CYSTITIS HAEMORRHAGIC,50
CN,DISSEMINATED INTRAVASCULAR COAGULATION,50
CN,GENERALISED OEDEMA,50
CN,HYDROTHORAX,50
CN,PNEUMONITIS,50
CN,VENTRICULAR EXTRASYSTOLES,50
CN,YELLOW SKIN,50
CN,CATARACT,49
CN,FEELING COLD,49
CN,GENERALISED ERYTHEMA,49
CN,HENOCH-SCHONLEIN PURPURA,49
CN,LETHARGY,49
CN,RETINAL HAEMORRHAGE,49
CN,URINE OUTPUT DECREASED,49
CN,VENTRICULAR FIBRILLATION,49
CN,CHRONIC KIDNEY DISEASE,48
CN,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,48
CN,PANCREATITIS ACUTE,48
CN,RETINOPATHY,48
CN,SKIN ULCER,48
CN,TUBULOINTERSTITIAL NEPHRITIS,48
CN,BLOOD PRESSURE INADEQUATELY CONTROLLED,47
CN,COMPLICATIONS OF TRANSPLANTED KIDNEY,47
CN,VASCULAR STENT THROMBOSIS,47
CN,BRONCHITIS,46
CN,EYE SWELLING,46
CN,HYPOAESTHESIA ORAL,46
CN,MUSCULOSKELETAL PAIN,46
CN,NERVOUS SYSTEM DISORDER,46
CN,OCULAR HYPERAEMIA,46
CN,PERIPHERAL COLDNESS,46
CN,SPLENOMEGALY,46
CN,DRUG INTOLERANCE,45
CN,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,44
CN,ECCHYMOSIS,44
CN,GASTROINTESTINAL TOXICITY,44
CN,LOCAL SWELLING,44
CN,LYMPHOPENIA,44
CN,NEPHROTIC SYNDROME,44
CN,RESPIRATORY ARREST,44
CN,SLEEP DISORDER,44
CN,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,43
CN,SURGERY,43
CN,BLOOD PRESSURE SYSTOLIC INCREASED,42
CN,EYE PAIN,42
CN,HYPOPROTEINAEMIA,42
CN,LANGUAGE DISORDER,42
CN,MUSCULOSKELETAL DISORDER,42
CN,RALES,42
CN,CHRONIC GASTRITIS,41
CN,DEPRESSED MOOD,41
CN,HEPATITIS C,41
CN,INFLAMMATION,41
CN,INTESTINAL PERFORATION,41
CN,MIOSIS,41
CN,PSYCHOTIC DISORDER,41
CN,SHOCK HAEMORRHAGIC,41
CN,VAGINAL HAEMORRHAGE,41
CN,ACUTE MYELOID LEUKAEMIA,40
CN,CANDIDA INFECTION,40
CN,DRY SKIN,40
CN,GASTRITIS,40
CN,HYPERURICAEMIA,40
CN,RESPIRATORY TRACT INFECTION,40
CN,AMNESIA,39
CN,CARDIOVASCULAR DISORDER,39
CN,COMPLICATIONS OF BONE MARROW TRANSPLANT,39
CN,HICCUPS,39
CN,HYPOMAGNESAEMIA,39
CN,LACUNAR INFARCTION,39
CN,LIVE BIRTH,39
CN,MENTAL IMPAIRMENT,39
CN,METASTASES TO LYMPH NODES,39
CN,MYOPATHY,39
CN,PULMONARY ALVEOLAR HAEMORRHAGE,39
CN,SALIVARY HYPERSECRETION,39
CN,SECOND PRIMARY MALIGNANCY,39
CN,BACTERIAL INFECTION,38
CN,DRUG LEVEL INCREASED,38
CN,GRANULOCYTE COUNT DECREASED,38
CN,HYPOACUSIS,38
CN,LIP SWELLING,38
CN,RHINORRHOEA,38
CN,SKIN LESION,38
CN,SUPRAVENTRICULAR EXTRASYSTOLES,38
CN,VENTRICULAR TACHYCARDIA,38
CN,HALLUCINATION_ AUDITORY,37
CN,HYPOALBUMINAEMIA,37
CN,IATROGENIC INJURY,37
CN,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,37
CN,MULTIPLE-DRUG RESISTANCE,37
CN,MYOGLOBIN BLOOD INCREASED,37
CN,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,36
CN,AMAUROSIS,36
CN,CARDIOMYOPATHY,36
CN,DIABETIC KETOACIDOSIS,36
CN,RASH PAPULAR,36
CN,RENAL TUBULAR ACIDOSIS,36
CN,RESPIRATORY RATE INCREASED,36
CN,ACUTE LYMPHOCYTIC LEUKAEMIA,35
CN,BLOOD PRESSURE FLUCTUATION,35
CN,BREATH SOUNDS ABNORMAL,35
CN,EATING DISORDER,35
CN,ENCEPHALOPATHY,35
CN,FLANK PAIN,35
CN,HAEMOLYSIS,35
CN,PARAESTHESIA,35
CN,UNEVALUABLE EVENT,35
CN,DRUG ABUSE,34
CN,ELECTROCARDIOGRAM ABNORMAL,34
CN,FLATULENCE,34
CN,KIDNEY TRANSPLANT REJECTION,34
CN,LOW BIRTH WEIGHT BABY,34
CN,MENSTRUAL DISORDER,34
CN,MUSCLE HAEMORRHAGE,34
CN,AZOTAEMIA,33
CN,BLOOD GLUCOSE FLUCTUATION,33
CN,CARDIO-RESPIRATORY ARREST,33
CN,CARDIOTOXICITY,33
CN,DEHYDRATION,33
CN,DRUG EFFECT INCOMPLETE,33
CN,DYSSTASIA,33
CN,FEEDING DISORDER,33
CN,FEELING HOT,33
CN,GOUT,33
CN,HYPOPHAGIA,33
CN,MUSCLE ATROPHY,33
CN,OCULAR ICTERUS,33
CN,PROTHROMBIN TIME PROLONGED,33
CN,SKIN DISORDER,33
CN,SLOW RESPONSE TO STIMULI,33
CN,THROAT IRRITATION,33
CN,UNDERDOSE,33
CN,ABNORMAL FAECES,32
CN,ASPERGILLUS INFECTION,32
CN,DYSARTHRIA,32
CN,EMBOLISM,32
CN,EPSTEIN-BARR VIRUS INFECTION,32
CN,EXTRASYSTOLES,32
CN,KLEBSIELLA INFECTION,32
CN,PANCREATITIS,32
CN,PULMONARY FIBROSIS,32
CN,TENDERNESS,32
CN,VIRAL INFECTION,32
CN,ACCIDENTAL OVERDOSE,31
CN,ACUTE RESPIRATORY FAILURE,31
CN,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,31
CN,BLOOD CHOLESTEROL INCREASED,31
CN,BRAIN HERNIATION,31
CN,CALCULUS URETERIC,31
CN,CEREBRAL THROMBOSIS,31
CN,COMPLETED SUICIDE,31
CN,HEAD DISCOMFORT,31
CN,KAPOSI^S SARCOMA,31
CN,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,31
CN,LEUKOCYTOSIS,31
CN,MACULAR OEDEMA,31
CN,MOUTH HAEMORRHAGE,31
CN,MUSCLE RIGIDITY,31
CN,NEPHROPATHY,31
CN,PETECHIAE,31
CN,PETIT MAL EPILEPSY,31
CN,PREMATURE DELIVERY,31
CN,PULMONARY MASS,31
CN,RESPIRATORY DISTRESS,31
CN,AKATHISIA,30
CN,ARTERIOSCLEROSIS CORONARY ARTERY,30
CN,BLOOD SODIUM DECREASED,30
CN,CARDIAC FAILURE ACUTE,30
CN,CHRONIC GRAFT VERSUS HOST DISEASE,30
CN,EMPHYSEMA,30
CN,FULL BLOOD COUNT DECREASED,30
CN,HAEMOLYTIC ANAEMIA,30
CN,HALLUCINATION_ VISUAL,30
CN,HEART DISEASE CONGENITAL,30
CN,INTERNATIONAL NORMALISED RATIO INCREASED,30
CN,MUSCLE TIGHTNESS,30
CN,PIGMENTATION DISORDER,30
CN,ROAD TRAFFIC ACCIDENT,30
CN,UNWANTED AWARENESS DURING ANAESTHESIA,30
CN,BENIGN PROSTATIC HYPERPLASIA,29
CN,DRUG PRESCRIBING ERROR,29
CN,FOETAL DEATH,29
CN,GENE MUTATION,29
CN,HYPOKINESIA,29
CN,LACRIMATION INCREASED,29
CN,REGURGITATION,29
CN,SUPRAVENTRICULAR TACHYCARDIA,29
CN,ACNE,28
CN,BLOOD URINE PRESENT,28
CN,CEREBROVASCULAR DISORDER,28
CN,ENTERITIS,28
CN,HEPATIC CYST,28
CN,HEPATIC LESION,28
CN,ILEUS,28
CN,ORTHOSTATIC HYPOTENSION,28
CN,PLATELET AGGREGATION INCREASED,28
CN,PULMONARY TOXICITY,28
CN,SKIN INFECTION,28
CN,THERAPEUTIC RESPONSE UNEXPECTED,28
CN,TYPE 2 DIABETES MELLITUS,28
CN,APPENDICITIS,27
CN,ATRIOVENTRICULAR BLOCK,27
CN,CARDIAC DEATH,27
CN,CEREBRAL ATROPHY,27
CN,DYSGEUSIA,27
CN,GASTRIC PERFORATION,27
CN,GASTROENTERITIS,27
CN,GLAUCOMA,27
CN,ILL-DEFINED DISORDER,27
CN,MICTURITION URGENCY,27
CN,OESOPHAGEAL CANDIDIASIS,27
CN,RHEUMATOID ARTHRITIS,27
CN,TUMOUR LYSIS SYNDROME,27
CN,VIRAL UPPER RESPIRATORY TRACT INFECTION,27
CN,ADVERSE DRUG REACTION,26
CN,ANGLE CLOSURE GLAUCOMA,26
CN,BLOOD PRESSURE IMMEASURABLE,26
CN,BLOOD TEST ABNORMAL,26
CN,CAESAREAN SECTION,26
CN,CHOLESTASIS,26
CN,CONCOMITANT DISEASE AGGRAVATED,26
CN,DIABETIC NEPHROPATHY,26
CN,GAZE PALSY,26
CN,GLOMERULAR FILTRATION RATE DECREASED,26
CN,HEPATITIS B REACTIVATION,26
CN,HERPES VIRUS INFECTION,26
CN,IMPAIRED HEALING,26
CN,INTENTIONAL DRUG MISUSE,26
CN,INTRAOCULAR PRESSURE INCREASED,26
CN,LIMB DISCOMFORT,26
CN,MOBILITY DECREASED,26
CN,OROPHARYNGEAL DISCOMFORT,26
CN,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,26
CN,RASH MACULAR,26
CN,RIB FRACTURE,26
CN,SKIN REACTION,26
CN,SUBARACHNOID HAEMORRHAGE,26
CN,TORSADE DE POINTES,26
CN,ACINETOBACTER INFECTION,25
CN,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,25
CN,ALPHA 1 FOETOPROTEIN INCREASED,25
CN,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,25
CN,APPETITE DISORDER,25
CN,BREAST CANCER,25
CN,CHOLECYSTITIS ACUTE,25
CN,FOETAL GROWTH RESTRICTION,25
CN,HEPATIC PAIN,25
CN,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,25
CN,LEFT VENTRICULAR FAILURE,25
CN,NEOPLASM RECURRENCE,25
CN,PLATELET COUNT INCREASED,25
CN,PNEUMONIA CYTOMEGALOVIRAL,25
CN,PNEUMOTHORAX,25
CN,SUDDEN CARDIAC DEATH,25
CN,UTERINE HAEMORRHAGE,25
CN,AGGRESSION,24
CN,APHAGIA,24
CN,BRONCHOSPASM,24
CN,DUODENAL ULCER,24
CN,EPIDERMOLYSIS BULLOSA,24
CN,EYE HAEMORRHAGE,24
CN,FEAR,24
CN,GASTROINTESTINAL INFECTION,24
CN,HEMIPLEGIA,24
CN,HEPATIC NEOPLASM,24
CN,ILEUS PARALYTIC,24
CN,LOWER LIMB FRACTURE,24
CN,MOOD ALTERED,24
CN,OCCULT BLOOD POSITIVE,24
CN,OSTEOMYELITIS,24
CN,PARONYCHIA,24
CN,PREGNANCY,24
CN,PULMONARY HAEMORRHAGE,24
CN,URINE ANALYSIS ABNORMAL,24
CN,ACUTE CORONARY SYNDROME,23
CN,BLOOD CALCIUM DECREASED,23
CN,CHOKING,23
CN,CONTUSION,23
CN,ERUCTATION,23
CN,FREQUENT BOWEL MOVEMENTS,23
CN,GASTRIC CANCER,23
CN,HEPATOMEGALY,23
CN,MEASLES,23
CN,MENTAL STATUS CHANGES,23
CN,PSORIASIS,23
CN,PULMONARY HYPERTENSION,23
CN,PULMONARY MYCOSIS,23
CN,SKIN EROSION,23
CN,TOOTHACHE,23
CN,TRANSIENT ISCHAEMIC ATTACK,23
CN,ULCER,23
CN,BLOOD POTASSIUM INCREASED,22
CN,BLOOD THYROID STIMULATING HORMONE INCREASED,22
CN,BONE DENSITY DECREASED,22
CN,CARDIAC FAILURE CHRONIC,22
CN,CORONARY ARTERY STENOSIS,22
CN,CROHN^S DISEASE,22
CN,CUSHING^S SYNDROME,22
CN,DELUSION,22
CN,DIABETIC COMPLICATION,22
CN,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,22
CN,DRUG EFFECT DECREASED,22
CN,ECZEMA,22
CN,EMOTIONAL DISORDER,22
CN,FAECAL INCONTINENCE,22
CN,HAEMORRHAGIC TRANSFORMATION STROKE,22
CN,INJECTION SITE ERYTHEMA,22
CN,KETOACIDOSIS,22
CN,LOW DENSITY LIPOPROTEIN INCREASED,22
CN,METRORRHAGIA,22
CN,MUSCULOSKELETAL CHEST PAIN,22
CN,MYELODYSPLASTIC SYNDROME,22
CN,NERVOUSNESS,22
CN,NEUROLEPTIC MALIGNANT SYNDROME,22
CN,NEUTROPENIC INFECTION,22
CN,PHARYNGEAL OEDEMA,22
CN,PURULENT DISCHARGE,22
CN,RED BLOOD CELL SEDIMENTATION RATE INCREASED,22
CN,SCAB,22
CN,ANAL ABSCESS,21
CN,APATHY,21
CN,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,21
CN,DIPLOPIA,21
CN,FANCONI SYNDROME,21
CN,GAIT INABILITY,21
CN,GLYCOSYLATED HAEMOGLOBIN INCREASED,21
CN,HAEMORRHOIDS,21
CN,HYPERTHERMIA MALIGNANT,21
CN,HYPOTONIA,21
CN,IMMUNODEFICIENCY,21
CN,INFLUENZA LIKE ILLNESS,21
CN,KOUNIS SYNDROME,21
CN,MENORRHAGIA,21
CN,MITRAL VALVE INCOMPETENCE,21
CN,MYOSITIS,21
CN,NERVE INJURY,21
CN,NIGHT SWEATS,21
CN,NO THERAPEUTIC RESPONSE,21
CN,POLYURIA,21
CN,RASH PUSTULAR,21
CN,STAPHYLOCOCCAL INFECTION,21
CN,STATUS EPILEPTICUS,21
CN,ABDOMINAL PAIN LOWER,20
CN,ACUTE PULMONARY OEDEMA,20
CN,AMMONIA INCREASED,20
CN,BLADDER CANCER,20
CN,BLOOD PROLACTIN INCREASED,20
CN,BURNING SENSATION,20
CN,CONJUNCTIVAL HAEMORRHAGE,20
CN,EXPOSURE VIA BODY FLUID,20
CN,EXPOSURE VIA FATHER,20
CN,FEMORAL NECK FRACTURE,20
CN,HEPATORENAL SYNDROME,20
CN,IMMUNE THROMBOCYTOPENIC PURPURA,20
CN,INCONTINENCE,20
CN,ISCHAEMIC STROKE,20
CN,LIGAMENT SPRAIN,20
CN,LISTLESS,20
CN,LYMPHOMA,20
CN,MYDRIASIS,20
CN,ORAL MUCOSA EROSION,20
CN,PERITONEAL DIALYSIS COMPLICATION,20
CN,PROCEDURAL PAIN,20
CN,PULSE ABSENT,20
CN,RETCHING,20
CN,SELF-MEDICATION,20
CN,THERAPY NON-RESPONDER,20
CN,THIRST,20
CN,THYROID NEOPLASM,20
CN,VENOOCCLUSIVE LIVER DISEASE,20
CN,ACIDOSIS,19
CN,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,19
CN,ANGER,19
CN,BEDRIDDEN,19
CN,BLOOD LACTIC ACID INCREASED,19
CN,CALCULUS URINARY,19
CN,CENTRAL NERVOUS SYSTEM LESION,19
CN,CEREBRAL ISCHAEMIA,19
CN,CONJUNCTIVITIS,19
CN,CYTOMEGALOVIRUS VIRAEMIA,19
CN,DEAFNESS NEUROSENSORY,19
CN,DISORIENTATION,19
CN,EXOPHTHALMOS,19
CN,EXPIRED PRODUCT ADMINISTERED,19
CN,EYE DISCHARGE,19
CN,GASTRITIS EROSIVE,19
CN,GENOTYPE DRUG RESISTANCE TEST POSITIVE,19
CN,GROWTH RETARDATION,19
CN,HAEMATOMA,19
CN,HEART INJURY,19
CN,HYPERSOMNIA,19
CN,INJECTION SITE PRURITUS,19
CN,LIPIDS INCREASED,19
CN,LIVER TRANSPLANT REJECTION,19
CN,PAIN OF SKIN,19
CN,PUPILLARY REFLEX IMPAIRED,19
CN,RASH VESICULAR,19
CN,SKIN SWELLING,19
CN,THYROID FUNCTION TEST ABNORMAL,19
CN,URETERIC STENOSIS,19
CN,VENOUS THROMBOSIS LIMB,19
CN,VENTRICULAR ARRHYTHMIA,19
CN,ANAL INCONTINENCE,18
CN,APNOEA,18
CN,ARTHRITIS,18
CN,BACTERAEMIA,18
CN,BLINDNESS TRANSIENT,18
CN,BLOOD BILIRUBIN UNCONJUGATED INCREASED,18
CN,BODY TEMPERATURE DECREASED,18
CN,BRONCHOPULMONARY ASPERGILLOSIS,18
CN,DEMENTIA ALZHEIMER^S TYPE,18
CN,EJECTION FRACTION DECREASED,18
CN,ESCHERICHIA INFECTION,18
CN,GASTRIC DISORDER,18
CN,HISTIOCYTOSIS HAEMATOPHAGIC,18
CN,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,18
CN,LEFT VENTRICULAR DYSFUNCTION,18
CN,LOGORRHOEA,18
CN,MATERNAL EXPOSURE BEFORE PREGNANCY,18
CN,MYASTHENIA GRAVIS,18
CN,NASAL CONGESTION,18
CN,NON-SMALL CELL LUNG CANCER,18
CN,OSTEOARTHRITIS,18
CN,OUT OF SPECIFICATION TEST RESULTS,18
CN,PNEUMONIA ASPIRATION,18
CN,QUADRIPLEGIA,18
CN,RENAL CYST,18
CN,RENAL TUBULAR DISORDER,18
CN,SINUS ARRHYTHMIA,18
CN,SYSTEMIC LUPUS ERYTHEMATOSUS,18
CN,VASCULITIS,18
CN,ABDOMINAL TENDERNESS,17
CN,ABORTION,17
CN,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,17
CN,ARTERIAL RUPTURE,17
CN,BREAST CANCER RECURRENT,17
CN,BRUXISM,17
CN,CARCINOEMBRYONIC ANTIGEN INCREASED,17
CN,CARDIOGENIC SHOCK,17
CN,CEREBRAL DISORDER,17
CN,CHRONIC HEPATITIS B,17
CN,COAGULATION TIME PROLONGED,17
CN,DRY THROAT,17
CN,EFFUSION,17
CN,ELECTROCARDIOGRAM ST-T CHANGE,17
CN,HIGH DENSITY LIPOPROTEIN DECREASED,17
CN,HYPERTONIA,17
CN,ILEAL ULCER,17
CN,ILLUSION,17
CN,INCORRECT DRUG ADMINISTRATION DURATION,17
CN,INTESTINAL HAEMORRHAGE,17
CN,INTRACRANIAL PRESSURE INCREASED,17
CN,INTRAVENTRICULAR HAEMORRHAGE,17
CN,JAUNDICE CHOLESTATIC,17
CN,LOWER URINARY TRACT SYMPTOMS,17
CN,LUNG ADENOCARCINOMA,17
CN,MENSTRUATION IRREGULAR,17
CN,MUCORMYCOSIS,17
CN,NO ADVERSE EVENT,17
CN,OESOPHAGEAL HAEMORRHAGE,17
CN,ORAL PAIN,17
CN,PARKINSON^S DISEASE,17
CN,PHARYNGITIS,17
CN,PULSE ABNORMAL,17
CN,RIGHT VENTRICULAR FAILURE,17
CN,TRICUSPID VALVE INCOMPETENCE,17
CN,ACUTE MYELOID LEUKAEMIA RECURRENT,16
CN,ACUTE PROMYELOCYTIC LEUKAEMIA,16
CN,CANDIDIASIS,16
CN,CEREBRAL HAEMATOMA,16
CN,COMA HEPATIC,16
CN,CYTOMEGALOVIRUS CHORIORETINITIS,16
CN,DERMATITIS BULLOUS,16
CN,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,16
CN,ELECTROCARDIOGRAM T WAVE ABNORMAL,16
CN,ENCEPHALITIS,16
CN,EOSINOPHILIA,16
CN,EPSTEIN-BARR VIRAEMIA,16
CN,ERECTILE DYSFUNCTION,16
CN,FUNGAL OESOPHAGITIS,16
CN,GASTRIC POLYPS,16
CN,GASTROINTESTINAL PERFORATION,16
CN,GRAND MAL CONVULSION,16
CN,HEPATITIS B SURFACE ANTIGEN POSITIVE,16
CN,HYPERAMMONAEMIA,16
CN,HYPERCALCAEMIA,16
CN,HYPOVOLAEMIC SHOCK,16
CN,IDIOPATHIC PNEUMONIA SYNDROME,16
CN,INADEQUATE ANALGESIA,16
CN,INTESTINAL FISTULA,16
CN,LUNG NEOPLASM,16
CN,LYMPHOCYTE COUNT INCREASED,16
CN,MARASMUS,16
CN,METASTASES TO MENINGES,16
CN,MULTIPLE FRACTURES,16
CN,NASAL OBSTRUCTION,16
CN,NEPHRITIS,16
CN,NEURALGIA,16
CN,PAIN IN JAW,16
CN,PHLEBITIS,16
CN,PHOTOPHOBIA,16
CN,PNEUMONIA KLEBSIELLA,16
CN,PORTAL HYPERTENSION,16
CN,POSTPARTUM HAEMORRHAGE,16
CN,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,16
CN,RADIATION SKIN INJURY,16
CN,RENAL PAIN,16
CN,RETINOPATHY OF PREMATURITY,16
CN,SKIN FISSURES,16
CN,SKIN NECROSIS,16
CN,SPINAL OSTEOARTHRITIS,16
CN,THROAT TIGHTNESS,16
CN,TRANSPLANT FAILURE,16
CN,WOUND COMPLICATION,16
CN,ALCOHOL INTOLERANCE,15
CN,AMENORRHOEA,15
CN,ATAXIA,15
CN,ATRIOVENTRICULAR BLOCK COMPLETE,15
CN,BLOOD CREATININE DECREASED,15
CN,BLOOD PRESSURE ABNORMAL,15
CN,BRAIN STEM HAEMORRHAGE,15
CN,CARDIOMEGALY,15
CN,COLORECTAL CANCER,15
CN,CONVULSIONS LOCAL,15
CN,CYSTITIS,15
CN,DEAFNESS UNILATERAL,15
CN,DRY EYE,15
CN,DYSCHEZIA,15
CN,FIBRIN D DIMER INCREASED,15
CN,GINGIVAL HYPERPLASIA,15
CN,HEAD INJURY,15
CN,HEART RATE ABNORMAL,15
CN,HEMIPARESIS,15
CN,HEPATIC FIBROSIS,15
CN,HYPERTRIGLYCERIDAEMIA,15
CN,HYPOFIBRINOGENAEMIA,15
CN,INJECTION SITE SWELLING,15
CN,LUPUS-LIKE SYNDROME,15
CN,MUCOSAL ULCERATION,15
CN,MUSCULOSKELETAL DISCOMFORT,15
CN,MYOCARDITIS,15
CN,NOCTURIA,15
CN,OBLITERATIVE BRONCHIOLITIS,15
CN,OBSTRUCTIVE AIRWAYS DISORDER,15
CN,PANCREATIC CARCINOMA,15
CN,PREMATURE LABOUR,15
CN,PRESCRIBED OVERDOSE,15
CN,PRIMARY SEQUESTRUM,15
CN,RESPIRATORY ACIDOSIS,15
CN,RESPIRATORY DISORDER,15
CN,SINUS ARREST,15
CN,SINUSITIS,15
CN,SKIN HAEMORRHAGE,15
CN,SNEEZING,15
CN,SPUTUM DISCOLOURED,15
CN,STARING,15
CN,SUFFOCATION FEELING,15
CN,THYROID DISORDER,15
CN,URINE PHOSPHORUS INCREASED,15
CN,UTERINE LEIOMYOMA,15
CN,VANISHING BILE DUCT SYNDROME,15
CN,VENOUS THROMBOSIS,15
CN,ATRIOVENTRICULAR BLOCK FIRST DEGREE,14
CN,AUTOIMMUNE HAEMOLYTIC ANAEMIA,14
CN,AUTOIMMUNE HEPATITIS,14
CN,BIPOLAR DISORDER,14
CN,BLOOD COUNT ABNORMAL,14
CN,BREAST MASS,14
CN,BUNDLE BRANCH BLOCK RIGHT,14
CN,CEREBROVASCULAR INSUFFICIENCY,14
CN,COMPLICATION OF PREGNANCY,14
CN,CONCOMITANT DISEASE PROGRESSION,14
CN,CONJUNCTIVAL OEDEMA,14
CN,COR PULMONALE,14
CN,CREATININE RENAL CLEARANCE DECREASED,14
CN,DEMYELINATION,14
CN,DISORGANISED SPEECH,14
CN,DISTURBANCE IN ATTENTION,14
CN,DRUG LEVEL DECREASED,14
CN,DRUG WITHDRAWAL SYNDROME,14
CN,DYSBACTERIOSIS,14
CN,DYSTONIA,14
CN,ECTOPIC PREGNANCY,14
CN,EPIGASTRIC DISCOMFORT,14
CN,FACTOR VIII INHIBITION,14
CO,DEATH,2200
CO,HEADACHE,1115
CO,PYREXIA,1030
CO,VOMITING,848
CO,MALAISE,807
CO,ARTHRALGIA,791
CO,DIZZINESS,738
CO,DIARRHOEA,723
CO,CARDIO-RESPIRATORY ARREST,703
CO,PAIN,702
CO,PAIN IN EXTREMITY,702
CO,PNEUMONIA,699
CO,URINARY TRACT INFECTION,689
CO,ASTHENIA,681
CO,DYSPNOEA,678
CO,DRUG INEFFECTIVE,653
CO,ABDOMINAL PAIN,599
CO,COUGH,503
CO,INFLUENZA,501
CO,FALL,499
CO,FATIGUE,486
CO,DECREASED APPETITE,466
CO,CHEST PAIN,443
CO,NAUSEA,430
CO,WEIGHT DECREASED,400
CO,ACUTE MYOCARDIAL INFARCTION,399
CO,GENERAL PHYSICAL HEALTH DETERIORATION,399
CO,INFLAMMATION,397
CO,GAIT DISTURBANCE,396
CO,HAEMOGLOBIN DECREASED,394
CO,ANAEMIA,387
CO,PLATELET COUNT DECREASED,348
CO,RASH,342
CO,HYPERTENSION,337
CO,MYOCARDIAL INFARCTION,335
CO,BACK PAIN,320
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,308
CO,ABDOMINAL PAIN UPPER,297
CO,AGGRESSION,289
CO,HYPOTENSION,282
CO,DEPRESSION,278
CO,INSOMNIA,267
CO,RESPIRATORY DISTRESS,266
CO,SEIZURE,260
CO,PRURITUS,249
CO,THROMBOCYTOPENIA,249
CO,SYNCOPE,248
CO,CEREBROVASCULAR ACCIDENT,247
CO,TACHYCARDIA,243
CO,ERYTHEMA,240
CO,ANXIETY,233
CO,PRODUCT USE ISSUE,231
CO,CARDIAC FAILURE,228
CO,OEDEMA PERIPHERAL,216
CO,PERIPHERAL SWELLING,212
CO,CHILLS,211
CO,PULMONARY OEDEMA,209
CO,CONDITION AGGRAVATED,207
CO,CARDIAC ARREST,205
CO,FEELING ABNORMAL,198
CO,INFARCTION,197
CO,LOSS OF CONSCIOUSNESS,196
CO,CARDIAC DISORDER,193
CO,SOMNOLENCE,192
CO,RESPIRATORY ARREST,189
CO,RESPIRATORY FAILURE,188
CO,VISION BLURRED,186
CO,GASTRITIS,185
CO,ASPHYXIA,184
CO,DEPRESSED MOOD,181
CO,SEPSIS,179
CO,BLINDNESS,177
CO,LEUKOPENIA,177
CO,CATARACT,176
CO,RENAL FAILURE,175
CO,DISCOMFORT,172
CO,HYPERSENSITIVITY,168
CO,THROMBOSIS,167
CO,MOBILITY DECREASED,166
CO,ABDOMINAL DISTENSION,165
CO,BLOOD GLUCOSE INCREASED,165
CO,HYPERHIDROSIS,163
CO,MALIGNANT NEOPLASM PROGRESSION,163
CO,BRONCHITIS,158
CO,HYPERGLYCAEMIA,158
CO,HYPOAESTHESIA,158
CO,BONE PAIN,157
CO,DISEASE PROGRESSION,155
CO,DRUG DOSE OMISSION,153
CO,EPISTAXIS,150
CO,PLEURAL EFFUSION,149
CO,FLUID RETENTION,147
CO,CHOLELITHIASIS,146
CO,OSTEOARTHRITIS,146
CO,CELLULITIS,144
CO,ARTHROPATHY,139
CO,INFECTION,139
CO,BLOOD PRESSURE INCREASED,137
CO,HAEMORRHAGE,137
CO,JOINT SWELLING,136
CO,ARTHRITIS,131
CO,LUNG DISORDER,131
CO,BLOOD CREATININE INCREASED,130
CO,DYSURIA,129
CO,DIABETES MELLITUS,128
CO,MUSCULAR WEAKNESS,128
CO,PSORIASIS,128
CO,DECREASED IMMUNE RESPONSIVENESS,127
CO,HOSPITALISATION,127
CO,VISUAL IMPAIRMENT,124
CO,DEHYDRATION,123
CO,ARRHYTHMIA,122
CO,MYALGIA,121
CO,SWELLING,121
CO,PERITONITIS,118
CO,HYPERTENSIVE CRISIS,117
CO,ROAD TRAFFIC ACCIDENT,117
CO,TUBERCULOSIS,115
CO,RENAL DISORDER,114
CO,TREMOR,113
CO,INFUSION RELATED REACTION,112
CO,CONSTIPATION,109
CO,DIABETIC FOOT,109
CO,VIRAL INFECTION,109
CO,ABASIA,104
CO,CHOKING,103
CO,CONTUSION,103
CO,VERTIGO,103
CO,AMNESIA,102
CO,SPEECH DISORDER,101
CO,HYPOGLYCAEMIA,100
CO,PARAESTHESIA,100
CO,INCORRECT DOSE ADMINISTERED,99
CO,NEPHROLITHIASIS,99
CO,HAEMATOMA,98
CO,OXYGEN SATURATION DECREASED,98
CO,MUSCLE SPASMS,97
CO,EYE PAIN,96
CO,INTESTINAL OBSTRUCTION,96
CO,RASH GENERALISED,96
CO,VAGINAL HAEMORRHAGE,96
CO,HIP FRACTURE,94
CO,LIMB INJURY,94
CO,MUSCULOSKELETAL PAIN,94
CO,GASTROINTESTINAL HAEMORRHAGE,93
CO,ALOPECIA,92
CO,DRY SKIN,92
CO,OROPHARYNGEAL PAIN,92
CO,RHEUMATOID ARTHRITIS,91
CO,WEIGHT INCREASED,90
CO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,89
CO,VISUAL ACUITY REDUCED,89
CO,HAEMATURIA,87
CO,LUNG INFECTION,87
CO,FOOT DEFORMITY,86
CO,NASAL CONGESTION,85
CO,PRODUCTIVE COUGH,85
CO,TUBERCULIN TEST POSITIVE,85
CO,ABDOMINAL DISCOMFORT,84
CO,RESPIRATORY DISORDER,84
CO,BLISTER,83
CO,HAEMATEMESIS,83
CO,SPINAL PAIN,83
CO,HAEMATOCHEZIA,82
CO,PALLOR,82
CO,KIDNEY TRANSPLANT REJECTION,81
CO,GLAUCOMA,80
CO,HEPATITIS,80
CO,PULMONARY EMBOLISM,80
CO,RECTAL HAEMORRHAGE,80
CO,EATING DISORDER,79
CO,IMMUNODEFICIENCY,79
CO,INTENTIONAL PRODUCT MISUSE,79
CO,STOMATITIS,79
CO,THROMBOCYTOSIS,78
CO,DISORIENTATION,76
CO,DRUG INTOLERANCE,76
CO,FEELING HOT,76
CO,INJECTION SITE PAIN,76
CO,EYE HAEMORRHAGE,75
CO,BLINDNESS UNILATERAL,74
CO,CONVULSION,74
CO,DYSPHAGIA,74
CO,GENERALISED OEDEMA,74
CO,JAUNDICE,74
CO,SKIN DISCOLOURATION,74
CO,TRANSAMINASES INCREASED,73
CO,ASTHMATIC CRISIS,72
CO,BURNING SENSATION,72
CO,OEDEMA,72
CO,PRURITUS GENERALISED,72
CO,GAIT INABILITY,71
CO,LIVER DISORDER,71
CO,CHIKUNGUNYA VIRUS INFECTION,70
CO,JOINT INJURY,70
CO,PULMONARY HYPERTENSION,70
CO,CYANOSIS,69
CO,DISEASE COMPLICATION,69
CO,EXPOSURE DURING PREGNANCY,69
CO,FEELING OF DESPAIR,69
CO,MOUTH HAEMORRHAGE,69
CO,WOUND,69
CO,HERPES ZOSTER,68
CO,MULTIPLE SCLEROSIS RELAPSE,68
CO,MUSCULOSKELETAL STIFFNESS,68
CO,PETECHIAE,67
CO,URTICARIA,67
CO,APPENDICITIS,66
CO,BACTERAEMIA,66
CO,INGUINAL HERNIA,66
CO,NECK PAIN,66
CO,PULMONARY MASS,66
CO,DEVICE RELATED INFECTION,65
CO,NEUTROPENIA,65
CO,OSTEOPOROSIS,65
CO,TREATMENT FAILURE,65
CO,GASTROINTESTINAL INFECTION,64
CO,POSTOPERATIVE WOUND INFECTION,64
CO,TONSILLITIS,64
CO,DYSPHONIA,63
CO,LYMPHOPENIA,63
CO,SWELLING FACE,63
CO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,63
CO,BLOOD PRESSURE DECREASED,62
CO,FEMUR FRACTURE,62
CO,LOCALISED INFECTION,62
CO,PLATELET COUNT INCREASED,62
CO,TREATMENT NONCOMPLIANCE,62
CO,CHOKING SENSATION,61
CO,OVERDOSE,61
CO,SKIN ULCER,61
CO,EYE DISORDER,60
CO,GASTROENTERITIS,60
CO,GASTROINTESTINAL DISORDER,60
CO,MIGRAINE,60
CO,RENAL TRANSPLANT,59
CO,SINUSITIS,59
CO,DEEP VEIN THROMBOSIS,58
CO,ABNORMAL BEHAVIOUR,57
CO,BACTERIAL INFECTION,57
CO,BRADYCARDIA,57
CO,COMA,57
CO,HAEMORRHOIDS,57
CO,INFLUENZA LIKE ILLNESS,57
CO,HEAD INJURY,56
CO,IRRITABILITY,56
CO,NASOPHARYNGITIS,56
CO,SPLENOMEGALY,56
CO,TRANSPLANT REJECTION,56
CO,ASCITES,55
CO,DISEASE RECURRENCE,55
CO,MASS,55
CO,RESPIRATORY TRACT INFECTION,55
CO,TOXICITY TO VARIOUS AGENTS,55
CO,UNEVALUABLE EVENT,55
CO,CARDIOMEGALY,54
CO,CHEST DISCOMFORT,54
CO,IMMUNOSUPPRESSION,54
CO,KIDNEY INFECTION,54
CO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,54
CO,NEOPLASM,54
CO,NEOPLASM MALIGNANT,54
CO,SKIN LESION,54
CO,ANGINA UNSTABLE,53
CO,DIARRHOEA HAEMORRHAGIC,53
CO,MALNUTRITION,53
CO,MEMORY IMPAIRMENT,53
CO,METASTASES TO LUNG,53
CO,PRODUCT USE IN UNAPPROVED INDICATION,53
CO,SKIN EXFOLIATION,53
CO,SYSTEMIC LUPUS ERYTHEMATOSUS,53
CO,WHITE BLOOD CELL COUNT INCREASED,53
CO,BLOOD CHOLESTEROL INCREASED,52
CO,DEAFNESS,52
CO,HEPATIC CIRRHOSIS,52
CO,PSYCHIATRIC SYMPTOM,52
CO,UMBILICAL HERNIA,52
CO,ANGINA PECTORIS,51
CO,CEREBRAL ISCHAEMIA,51
CO,HEPATIC STEATOSIS,51
CO,INCOHERENT,51
CO,NERVOUS SYSTEM DISORDER,51
CO,CRYING,50
CO,DRUG HYPERSENSITIVITY,50
CO,MOVEMENT DISORDER,50
CO,ACNE,49
CO,ADVERSE EVENT,49
CO,DENGUE FEVER,49
CO,MULTI-ORGAN FAILURE,49
CO,PANCREATITIS,49
CO,PERITONITIS BACTERIAL,49
CO,CORONARY ARTERY DISEASE,48
CO,DRUG PRESCRIBING ERROR,48
CO,EYE IRRITATION,48
CO,HALLUCINATION_ AUDITORY,48
CO,THYROID DISORDER,48
CO,WHITE BLOOD CELL COUNT DECREASED,48
CO,BREAST CANCER,47
CO,COLITIS ULCERATIVE,47
CO,DYSPEPSIA,47
CO,GASTRIC ULCER,47
CO,GINGIVAL BLEEDING,47
CO,RENAL IMPAIRMENT,47
CO,UPPER LIMB FRACTURE,47
CO,EAR PAIN,46
CO,FACE OEDEMA,46
CO,HYPERCREATINAEMIA,46
CO,MELAENA,46
CO,METASTASES TO BONE,46
CO,BLOOD POTASSIUM DECREASED,45
CO,HEPATIC FAILURE,45
CO,NERVOUSNESS,45
CO,CEREBRAL HAEMORRHAGE,44
CO,HAEMOPTYSIS,44
CO,IMMUNE SYSTEM DISORDER,44
CO,JOINT DISLOCATION,44
CO,RETINAL DETACHMENT,44
CO,BALANCE DISORDER,43
CO,LIMB DISCOMFORT,43
CO,LOCAL SWELLING,43
CO,METASTASES TO LIVER,43
CO,OCULAR HYPERAEMIA,43
CO,SEPTIC SHOCK,43
CO,AGITATION,42
CO,ASTHMA,42
CO,COLITIS,42
CO,FOETAL EXPOSURE DURING PREGNANCY,42
CO,HALLUCINATION,42
CO,HEMIPARESIS,42
CO,PELVIC PAIN,42
CO,PHARYNGITIS,42
CO,POST PROCEDURAL COMPLICATION,42
CO,CARDIOVASCULAR DISORDER,41
CO,DELIRIUM,41
CO,DYSSTASIA,41
CO,HEPATOMEGALY,41
CO,LYMPHADENOPATHY,41
CO,BLOOD GLUCOSE DECREASED,40
CO,BLOOD URINE PRESENT,40
CO,HEPATOTOXICITY,40
CO,HYPOTHYROIDISM,40
CO,INTERVERTEBRAL DISC PROTRUSION,40
CO,ISCHAEMIC STROKE,40
CO,TOOTHACHE,40
CO,WOUND INFECTION,40
CO,BLOOD TRIGLYCERIDES INCREASED,39
CO,CYSTITIS,39
CO,INJECTION SITE ERYTHEMA,39
CO,LOWER LIMB FRACTURE,39
CO,PARALYSIS,39
CO,SLEEP DISORDER,39
CO,URINARY RETENTION,39
CO,YELLOW SKIN,39
CO,EAR INFECTION,38
CO,EYE INFECTION,38
CO,EYE INFLAMMATION,38
CO,GASTROOESOPHAGEAL REFLUX DISEASE,38
CO,PRODUCT QUALITY ISSUE,38
CO,SURGERY,38
CO,UNWANTED AWARENESS DURING ANAESTHESIA,38
CO,APHASIA,37
CO,BRAIN NEOPLASM,37
CO,CHOLECYSTITIS,37
CO,DRUG ADMINISTRATION ERROR,37
CO,DRY MOUTH,37
CO,ECCHYMOSIS,37
CO,MULTIPLE SCLEROSIS,37
CO,OVARIAN CYST,37
CO,PANCYTOPENIA,37
CO,UVEITIS,37
CO,APHONIA,36
CO,CHRONIC MYELOID LEUKAEMIA,36
CO,HERPES VIRUS INFECTION,36
CO,HYPOKALAEMIA,36
CO,HYPOKINESIA,36
CO,PERITONEAL DIALYSIS COMPLICATION,36
CO,SUBCUTANEOUS ABSCESS,36
CO,UTERINE LEIOMYOMA,36
CO,DYSARTHRIA,35
CO,DYSKINESIA,35
CO,FEEDING DISORDER,35
CO,GENITAL HAEMORRHAGE,35
CO,PLATELET COUNT ABNORMAL,35
CO,PREGNANCY WITH IMPLANT CONTRACEPTIVE,35
CO,PTERYGIUM,35
CO,RESTLESSNESS,35
CO,URINARY INCONTINENCE,35
CO,ABSCESS,34
CO,ACCIDENT,34
CO,ACUTE KIDNEY INJURY,34
CO,BONE DISORDER,34
CO,BRONCHIOLITIS,34
CO,DRY EYE,34
CO,FOOT FRACTURE,34
CO,HYPOACUSIS,34
CO,LACRIMATION INCREASED,34
CO,MATERNAL EXPOSURE DURING PREGNANCY,34
CO,MENORRHAGIA,34
CO,PROCEDURAL PAIN,34
CO,PURULENT DISCHARGE,34
CO,SPINAL FRACTURE,34
CO,STRESS,34
CO,ARTERIAL OCCLUSIVE DISEASE,33
CO,BLOOD GLUCOSE ABNORMAL,33
CO,CHROMATURIA,33
CO,COAGULOPATHY,33
CO,HAEMOLYSIS,33
CO,JOINT RANGE OF MOTION DECREASED,33
CO,LABORATORY TEST ABNORMAL,33
CO,MENTAL DISORDER,33
CO,PROCEDURAL COMPLICATION,33
CO,UNDERDOSE,33
CO,VARICOSE VEIN,33
CO,FURUNCLE,32
CO,INCORRECT ROUTE OF DRUG ADMINISTRATION,32
CO,METASTASIS,32
CO,MOOD ALTERED,32
CO,MUCOSAL INFLAMMATION,32
CO,RHINORRHOEA,32
CO,SOFT TISSUE INFECTION,32
CO,ANAESTHETIC COMPLICATION,31
CO,DERMATITIS,31
CO,DRUG DISPENSING ERROR,31
CO,ELECTROLYTE IMBALANCE,31
CO,FEELING COLD,31
CO,FIBROMYALGIA,31
CO,FINGER DEFORMITY,31
CO,LACERATION,31
CO,MOUTH ULCERATION,31
CO,OSTEOMYELITIS,31
CO,PROSTATIC DISORDER,31
CO,CONJUNCTIVITIS,30
CO,EOSINOPHILIA,30
CO,EYELID OEDEMA,30
CO,PNEUMONIA BACTERIAL,30
CO,SUDDEN DEATH,30
CO,CORONARY ARTERY OCCLUSION,29
CO,CROHN^S DISEASE,29
CO,DERMATITIS ALLERGIC,29
CO,ENCEPHALOPATHY,29
CO,HAEMOGLOBIN ABNORMAL,29
CO,HALLUCINATION_ VISUAL,29
CO,LARYNGITIS,29
CO,LIVER INJURY,29
CO,NOSOCOMIAL INFECTION,29
CO,PALPITATIONS,29
CO,PHLEBITIS,29
CO,SUICIDAL IDEATION,29
CO,VIITH NERVE PARALYSIS,29
CO,ANKYLOSING SPONDYLITIS,28
CO,BREAST PAIN,28
CO,CATARACT OPERATION,28
CO,CHRONIC GASTRITIS,28
CO,FACIAL PAIN,28
CO,GALLBLADDER DISORDER,28
CO,HAEMORRHAGIC STROKE,28
CO,INJURY,28
CO,PROSTATE CANCER,28
CO,RENAL PAIN,28
CO,SKIN INFECTION,28
CO,SPINAL DISORDER,28
CO,THROMBOPHLEBITIS,28
CO,TINNITUS,28
CO,UPPER GASTROINTESTINAL HAEMORRHAGE,28
CO,ALTERED STATE OF CONSCIOUSNESS,27
CO,DEVICE DISLOCATION,27
CO,FLAVIVIRUS INFECTION,27
CO,HEMIPLEGIA,27
CO,HUMERUS FRACTURE,27
CO,LYMPHOMA,27
CO,MUSCULOSKELETAL CHEST PAIN,27
CO,PNEUMONITIS,27
CO,SUICIDE ATTEMPT,27
CO,TIBIA FRACTURE,27
CO,TOOTH ABSCESS,27
CO,TOOTH DISORDER,27
CO,ACTIVITIES OF DAILY LIVING IMPAIRED,26
CO,ATRIAL FIBRILLATION,26
CO,CARPAL TUNNEL SYNDROME,26
CO,CENTRAL NERVOUS SYSTEM LESION,26
CO,DIABETIC COMA,26
CO,FISTULA,26
CO,FLATULENCE,26
CO,HAND DEFORMITY,26
CO,HEPATIC CANCER,26
CO,HIATUS HERNIA,26
CO,INJECTION SITE PRURITUS,26
CO,LUNG NEOPLASM MALIGNANT,26
CO,MENINGITIS,26
CO,PLASMA CELL MYELOMA,26
CO,PSYCHOTIC DISORDER,26
CO,RHINITIS,26
CO,THROAT IRRITATION,26
CO,ABDOMINAL PAIN LOWER,25
CO,BRAIN DEATH,25
CO,CONTRAINDICATED PRODUCT ADMINISTERED,25
CO,EPILEPSY,25
CO,FEBRILE NEUTROPENIA,25
CO,GASTROINTESTINAL INFLAMMATION,25
CO,GROIN PAIN,25
CO,MENISCUS INJURY,25
CO,ODYNOPHAGIA,25
CO,PANCREATIC CARCINOMA,25
CO,PERICARDIAL EFFUSION,25
CO,POISONING,25
CO,POST PROCEDURAL INFECTION,25
CO,SPLENITIS,25
CO,TOOTH EXTRACTION,25
CO,ABORTION SPONTANEOUS,24
CO,APNOEA,24
CO,BLOOD BILIRUBIN INCREASED,24
CO,BLOOD PARATHYROID HORMONE INCREASED,24
CO,ERYSIPELAS,24
CO,HEART RATE INCREASED,24
CO,LEUKOCYTOSIS,24
CO,NEOPLASM PROGRESSION,24
CO,NEUROPATHY PERIPHERAL,24
CO,POLLAKIURIA,24
CO,RED BLOOD CELL COUNT DECREASED,24
CO,ROTATOR CUFF SYNDROME,24
CO,SLEEP APNOEA SYNDROME,24
CO,UROSEPSIS,24
CO,VARICELLA,24
CO,ABSCESS LIMB,23
CO,BENIGN PROSTATIC HYPERPLASIA,23
CO,BLOOD IRON INCREASED,23
CO,BONE MARROW FAILURE,23
CO,CARDIAC FAILURE CONGESTIVE,23
CO,CHRONIC MYELOID LEUKAEMIA RECURRENT,23
CO,EYE PRURITUS,23
CO,FREQUENT BOWEL MOVEMENTS,23
CO,HAEMATOCRIT DECREASED,23
CO,HYPERKERATOSIS,23
CO,HYPOPHAGIA,23
CO,ORAL HERPES,23
CO,PROCTALGIA,23
CO,RENAL CANCER,23
CO,SECOND PRIMARY MALIGNANCY,23
CO,SERUM FERRITIN INCREASED,23
CO,SKIN BURNING SENSATION,23
CO,UTERINE HAEMORRHAGE,23
CO,ANKLE FRACTURE,22
CO,CEREBRAL INFARCTION,22
CO,CEREBRAL THROMBOSIS,22
CO,CHRONIC KIDNEY DISEASE,22
CO,CONFUSIONAL STATE,22
CO,DENTAL CARIES,22
CO,DIABETES MELLITUS INADEQUATE CONTROL,22
CO,DYSGEUSIA,22
CO,EXTREMITY NECROSIS,22
CO,GASTRIC DISORDER,22
CO,HAND FRACTURE,22
CO,HYPOXIA,22
CO,INCORRECT DRUG ADMINISTRATION DURATION,22
CO,INTRACRANIAL ANEURYSM,22
CO,NECK MASS,22
CO,NODULE,22
CO,ORAL DISORDER,22
CO,ORAL PAIN,22
CO,PAIN IN JAW,22
CO,POST PROCEDURAL HAEMORRHAGE,22
CO,RASH PRURITIC,22
CO,TERMINAL STATE,22
CO,VENOUS OCCLUSION,22
CO,APATHY,21
CO,BLOOD THYROID STIMULATING HORMONE INCREASED,21
CO,DECUBITUS ULCER,21
CO,DRUG DEPENDENCE,21
CO,EMBOLISM,21
CO,HYPERTHERMIA,21
CO,HYPONATRAEMIA,21
CO,JOINT STIFFNESS,21
CO,MEDICATION ERROR,21
CO,ORAL MUCOSAL BLISTERING,21
CO,PROSTATITIS,21
CO,PSORIATIC ARTHROPATHY,21
CO,PULMONARY TUBERCULOSIS,21
CO,RASH ERYTHEMATOUS,21
CO,RETINAL HAEMORRHAGE,21
CO,SECRETION DISCHARGE,21
CO,SENSORY LOSS,21
CO,TOOTH FRACTURE,21
CO,BLOOD COUNT ABNORMAL,20
CO,BLOOD DISORDER,20
CO,BRONCHOPNEUMONIA,20
CO,CARDIAC OPERATION,20
CO,COLON CANCER,20
CO,CYST,20
CO,FACIAL PARALYSIS,20
CO,GASTRIC CANCER,20
CO,HAEMOGLOBIN INCREASED,20
CO,HEPATIC ENZYME INCREASED,20
CO,INJECTION SITE SWELLING,20
CO,ISCHAEMIA,20
CO,LOCALISED OEDEMA,20
CO,MUSCULOSKELETAL DISORDER,20
CO,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,20
CO,PARATHYROIDECTOMY,20
CO,PRESCRIBED UNDERDOSE,20
CO,PULMONARY THROMBOSIS,20
CO,SKIN DISORDER,20
CO,SOLILOQUY,20
CO,TACHYPNOEA,20
CO,TOXIC SKIN ERUPTION,20
CO,VASCULITIS,20
CO,ABDOMINAL MASS,19
CO,ANAL FISTULA,19
CO,CLAVICLE FRACTURE,19
CO,CRANIOCEREBRAL INJURY,19
CO,DELUSION,19
CO,DIVERTICULITIS,19
CO,EJECTION FRACTION DECREASED,19
CO,EYE SWELLING,19
CO,HAEMARTHROSIS,19
CO,HYPOTHERMIA,19
CO,INTERNAL HAEMORRHAGE,19
CO,JOINT EFFUSION,19
CO,MYOCARDIAL ISCHAEMIA,19
CO,PERIPHERAL COLDNESS,19
CO,PROSTATIC SPECIFIC ANTIGEN INCREASED,19
CO,PULMONARY ARTERIAL HYPERTENSION,19
CO,RADIUS FRACTURE,19
CO,SJOGREN^S SYNDROME,19
CO,SKIN CANCER,19
CO,STRESS CARDIOMYOPATHY,19
CO,URINE ANALYSIS ABNORMAL,19
CO,VARICOSE ULCERATION,19
CO,ANAPHYLACTIC REACTION,18
CO,BLOOD CREATININE ABNORMAL,18
CO,BLOOD LACTATE DEHYDROGENASE INCREASED,18
CO,BLOOD POTASSIUM INCREASED,18
CO,BLOOD PRESSURE ABNORMAL,18
CO,BLOOD TEST ABNORMAL,18
CO,BRONCHOSPASM,18
CO,CEREBROVASCULAR DISORDER,18
CO,DEAFNESS UNILATERAL,18
CO,DRUG-INDUCED LIVER INJURY,18
CO,FIBULA FRACTURE,18
CO,HEART RATE DECREASED,18
CO,HYPOAESTHESIA ORAL,18
CO,IMPAIRED HEALING,18
CO,METASTASES TO CENTRAL NERVOUS SYSTEM,18
CO,NEPHROPATHY,18
CO,ORAL MUCOSAL EXFOLIATION,18
CO,PULMONARY CONGESTION,18
CO,PULMONARY FIBROSIS,18
CO,RASH PUSTULAR,18
CO,THERAPEUTIC RESPONSE DECREASED,18
CO,THYROID CANCER,18
CO,ABDOMINAL HERNIA,17
CO,ADVERSE DRUG REACTION,17
CO,ARTHRITIS INFECTIVE,17
CO,ASPARTATE AMINOTRANSFERASE INCREASED,17
CO,AZOTAEMIA,17
CO,BEDRIDDEN,17
CO,BLOOD SODIUM DECREASED,17
CO,BLOOD UREA INCREASED,17
CO,CARDIAC VALVE DISEASE,17
CO,FLUSHING,17
CO,HAEMOGLOBINURIA,17
CO,HAEMORRHAGE INTRACRANIAL,17
CO,HEPATIC LESION,17
CO,HYPERSOMNIA,17
CO,HYPERTHYROIDISM,17
CO,HYPOCALCAEMIA,17
CO,HYPOTONIA,17
CO,INTESTINAL PERFORATION,17
CO,LEUKAEMIA,17
CO,LIVER FUNCTION TEST ABNORMAL,17
CO,METABOLIC ACIDOSIS,17
CO,MUSCLE RIGIDITY,17
CO,PEAU D^ORANGE,17
CO,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,17
CO,PSYCHOMOTOR HYPERACTIVITY,17
CO,PULMONARY SEPSIS,17
CO,RENAL CYST,17
CO,SCOLIOSIS,17
CO,SKIN PAPILLOMA,17
CO,SYNOVIAL CYST,17
CO,THIRST,17
CO,UNDERWEIGHT,17
CO,URINE ODOUR ABNORMAL,17
CO,WHEEZING,17
CO,AMENORRHOEA,16
CO,ARTHRITIS BACTERIAL,16
CO,ASPIRATION BRONCHIAL,16
CO,BILE DUCT OBSTRUCTION,16
CO,CARDIOGENIC SHOCK,16
CO,EMOTIONAL DISORDER,16
CO,EYE DISCHARGE,16
CO,FRACTURE,16
CO,FUNGAL INFECTION,16
CO,GANGRENE,16
CO,HELICOBACTER INFECTION,16
CO,HERNIA,16
CO,HYPERKALAEMIA,16
CO,INTRAOCULAR LENS IMPLANT,16
CO,LYMPHOCYTE COUNT DECREASED,16
CO,METASTASES TO SPINE,16
CO,PAIN OF SKIN,16
CO,PRODUCT SUPPLY ISSUE,16
CO,PROTEINURIA,16
CO,PULMONARY HAEMORRHAGE,16
CO,RASH MACULAR,16
CO,RENAL FAILURE ACUTE,16
CO,SALIVARY HYPERSECRETION,16
CO,SENSORY DISTURBANCE,16
CO,SUBDURAL HAEMATOMA,16
CO,THERMAL BURN,16
CO,TOOTH LOSS,16
CO,ULCER,16
CO,WOUND COMPLICATION,16
CO,ALANINE AMINOTRANSFERASE INCREASED,15
CO,ANGIOPATHY,15
CO,ANORECTAL DISORDER,15
CO,BACTERIURIA,15
CO,BILE DUCT STONE,15
CO,BRAIN OEDEMA,15
CO,CARDIOPULMONARY FAILURE,15
CO,CATHETER SITE INFECTION,15
CO,COGNITIVE DISORDER,15
CO,CYSTOCELE,15
CO,CYTOMEGALOVIRUS INFECTION,15
CO,DISTURBANCE IN ATTENTION,15
CO,DRUG EFFECT INCOMPLETE,15
CO,DRUG RESISTANCE,15
CO,FACE INJURY,15
CO,HYDROCEPHALUS,15
CO,HYPOVOLAEMIC SHOCK,15
CO,ILL-DEFINED DISORDER,15
CO,INJECTION SITE BRUISING,15
CO,INJECTION SITE HAEMORRHAGE,15
CO,INTENTIONAL PRODUCT USE ISSUE,15
CO,LOGORRHOEA,15
CO,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,15
CO,LYMPHADENITIS,15
CO,MUSCULOSKELETAL DISCOMFORT,15
CO,NEURALGIA,15
CO,NEUTROPHIL COUNT INCREASED,15
CO,NIGHT SWEATS,15
CO,OESOPHAGITIS,15
CO,PAPULE,15
CO,RHABDOMYOLYSIS,15
CO,SPINAL OSTEOARTHRITIS,15
CO,SUBSTANCE ABUSE,15
CO,ANAL HAEMORRHAGE,14
CO,ANEURYSM,14
CO,ANURIA,14
CO,BASAL CELL CARCINOMA,14
CO,BONE CANCER,14
CO,CACHEXIA,14
CO,DIABETIC COMPLICATION,14
CO,DIABETIC KETOACIDOSIS,14
CO,DIPLOPIA,14
CO,ENDOMETRIOSIS,14
CO,ERYTHROPENIA,14
CO,ESCHERICHIA URINARY TRACT INFECTION,14
CO,FAECES DISCOLOURED,14
CO,GENERALISED ERYTHEMA,14
CO,GINGIVAL PAIN,14
CO,HEAD DISCOMFORT,14
CO,HEPATIC NEOPLASM,14
CO,INJECTION SITE HAEMATOMA,14
CO,INJECTION SITE URTICARIA,14
CO,KNEE ARTHROPLASTY,14
CO,MONOPLEGIA,14
CO,NEUTROPHIL COUNT DECREASED,14
CO,OPTIC NEURITIS,14
CO,PARKINSON^S DISEASE,14
CO,PHOTOPHOBIA,14
CO,PULMONARY INFARCTION,14
CO,PYELONEPHRITIS,14
CO,RIB FRACTURE,14
CO,SKIN HAEMORRHAGE,14
CO,SPINAL CORD COMPRESSION,14
CO,STEVENS-JOHNSON SYNDROME,14
CO,THERAPY CESSATION,14
CO,THERAPY NON-RESPONDER,14
CO,THYROID MASS,14
CO,TOOTH INFECTION,14
CO,TRANSIENT ISCHAEMIC ATTACK,14
CO,URINARY TRACT OBSTRUCTION,14
CO,AORTIC ANEURYSM,13
CO,APHTHOUS ULCER,13
CO,BIPOLAR DISORDER,13
CO,BLOOD PROLACTIN INCREASED,13
CO,CALCULUS URINARY,13
CO,CANDIDA INFECTION,13
CO,COLORECTAL CANCER METASTATIC,13
CO,COMPLETED SUICIDE,13
CO,DEMENTIA ALZHEIMER^S TYPE,13
CO,DERMATITIS EXFOLIATIVE,13
CO,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,13
CO,DRY THROAT,13
CO,GENERAL PHYSICAL CONDITION ABNORMAL,13
CO,HIP ARTHROPLASTY,13
CO,INCREASED UPPER AIRWAY SECRETION,13
CO,LARGE INTESTINE POLYP,13
CO,LIGAMENT SPRAIN,13
CO,LIVER TRANSPLANT REJECTION,13
CO,LOWER GASTROINTESTINAL HAEMORRHAGE,13
CO,MELANOCYTIC NAEVUS,13
CO,METRORRHAGIA,13
CO,MYELOFIBROSIS,13
CO,OCULAR ICTERUS,13
CO,ORAL DISCOMFORT,13
CO,PERIPHERAL VASCULAR DISORDER,13
CO,PERSECUTORY DELUSION,13
CO,PNEUMOTHORAX,13
CO,POSTOPERATIVE WOUND COMPLICATION,13
CO,PREMATURE BABY,13
CO,PULMONARY PAIN,13
CO,PURULENCE,13
CO,RENAL FAILURE CHRONIC,13
CO,RESPIRATORY TRACT CONGESTION,13
CO,SCHIZOPHRENIA,13
CO,STAPHYLOCOCCAL INFECTION,13
CO,SUBARACHNOID HAEMORRHAGE,13
CO,SUSPECTED COUNTERFEIT PRODUCT,13
CO,VAGINAL DISCHARGE,13
CO,VEIN DISORDER,13
CO,VENOUS THROMBOSIS,13
CO,ACUTE RESPIRATORY FAILURE,12
CO,ANAPHYLACTIC SHOCK,12
CO,ATAXIA,12
CO,BACTERIAL TEST POSITIVE,12
CO,BLINDNESS TRANSIENT,12
CO,BLOOD CALCIUM DECREASED,12
CO,BLOOD URIC ACID INCREASED,12
CO,CARDIAC MURMUR,12
CO,CARDIOTOXICITY,12
CO,CEREBRAL HAEMATOMA,12
CO,CONCOMITANT DISEASE AGGRAVATED,12
CO,CUSHING^S SYNDROME,12
CO,DEVICE BREAKAGE,12
CO,DEVICE ISSUE,12
CO,DIABETIC RETINOPATHY,12
CO,EAR DISORDER,12
CO,ESCHERICHIA INFECTION,12
CO,FEAR,12
CO,GASTRIC HAEMORRHAGE,12
CO,GOITRE,12
CO,HAEMODYNAMIC INSTABILITY,12
CO,HALLUCINATIONS_ MIXED,12
CO,HEPATIC PAIN,12
CO,HYDRONEPHROSIS,12
CO,INCONTINENCE,12
CO,INTERNATIONAL NORMALISED RATIO INCREASED,12
CO,IRIDOCYCLITIS,12
CO,IRRITABLE BOWEL SYNDROME,12
CO,LEIOMYOMA,12
CO,MITRAL VALVE INCOMPETENCE,12
CO,MONOCYTE COUNT INCREASED,12
CO,MONOCYTE PERCENTAGE INCREASED,12
CO,MOUTH INJURY,12
CO,NECROSIS,12
CO,NEUROLOGICAL DECOMPENSATION,12
CO,NO ADVERSE EVENT,12
CO,OSTEOPENIA,12
CO,PELVIC FRACTURE,12
CO,PRE-ECLAMPSIA,12
CO,RECURRENT CANCER,12
CO,SICKLE CELL ANAEMIA WITH CRISIS,12
CO,SPINAL COLUMN INJURY,12
CO,SPINAL OPERATION,12
CO,SPLEEN DISORDER,12
CO,THROMBOCYTOPENIC PURPURA,12
CO,TRANSFUSION,12
CO,TRICUSPID VALVE INCOMPETENCE,12
CO,ULCERATIVE KERATITIS,12
CO,VARICES OESOPHAGEAL,12
CO,WRIST FRACTURE,12
CO,WRONG DRUG ADMINISTERED,12
CO,WRONG TECHNIQUE IN DRUG USAGE PROCESS,12
CO,ABDOMINAL SEPSIS,11
CO,ANGIOEDEMA,11
CO,ANORECTAL DISCOMFORT,11
CO,APLASTIC ANAEMIA,11
CO,BREAST MASS,11
CO,CARDIAC PACEMAKER INSERTION,11
CO,CHOLANGITIS,11
CO,COMPLICATIONS OF TRANSPLANTED KIDNEY,11
CO,COORDINATION ABNORMAL,11
CO,DEVICE MALFUNCTION,11
CO,DIALYSIS,11
CO,DISTURBANCE IN SOCIAL BEHAVIOUR,11
CO,DRUG ABUSE,11
CO,ENDOCARDITIS,11
CO,EYE MOVEMENT DISORDER,11
CO,FOOD INTOLERANCE,11
CO,FUNGAL PERITONITIS,11
CO,GLYCOSYLATED HAEMOGLOBIN INCREASED,11
CO,HEPATIC FUNCTION ABNORMAL,11
CO,HEPATIC MASS,11
CO,HYPERAMMONAEMIC ENCEPHALOPATHY,11
CO,HYSTERECTOMY,11
CO,INCORRECT PRODUCT STORAGE,11
CO,INTERVERTEBRAL DISC DISORDER,11
CO,INTESTINAL HAEMORRHAGE,11
CO,INTRACRANIAL PRESSURE INCREASED,11
CO,LATENT TUBERCULOSIS,11
CO,LEUKOCYTURIA,11
CO,LIMB DEFORMITY,11
CO,LIPOMA,11
CO,MENSTRUATION IRREGULAR,11
CO,ONCOLOGIC COMPLICATION,11
CO,ONYCHOCLASIS,11
CO,OSTEONECROSIS OF JAW,11
CO,PLATELET DISORDER,11
CO,POLYURIA,11
CO,PREGNANCY,11
CO,PULMONARY GRANULOMA,11
CO,REFLUX GASTRITIS,11
CO,RENAL CANCER METASTATIC,11
CO,SKIN MASS,11
CO,SKIN PLAQUE,11
CO,STOMACH MASS,11
CO,SUFFOCATION FEELING,11
CO,SYNOVITIS,11
CO,TENSION,11
CO,UNRESPONSIVE TO STIMULI,11
CO,VAGINAL INFECTION,11
CO,VITREOUS HAEMORRHAGE,11
CO,WOUND SECRETION,11
CO,ACUTE CORONARY SYNDROME,10
CO,ACUTE RESPIRATORY DISTRESS SYNDROME,10
CO,AFFECTIVE DISORDER,10
CO,ARTERIOSCLEROSIS,10
CO,ASPIRATION,10
CO,ATELECTASIS,10
CO,BODY TEMPERATURE INCREASED,10
CO,BONE DEFORMITY,10
CO,BONE MARROW DISORDER,10
CO,C-REACTIVE PROTEIN INCREASED,10
CO,CARDIAC TAMPONADE,10
CO,CATHETERISATION CARDIAC,10
CO,CEREBRAL DISORDER,10
CO,COLD SWEAT,10
CO,CONGESTIVE CARDIOMYOPATHY,10
CO,DIABETIC NEUROPATHY,10
CO,DRUG EFFECT DECREASED,10
CO,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,10
CO,ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE,10
CO,ECZEMA,10
CO,FUNGAL SKIN INFECTION,10
CO,GASTROENTERITIS VIRAL,10
CO,GLOSSODYNIA,10
CO,HEPATITIS C,10
CO,HISTOPLASMOSIS,10
CO,HORMONE LEVEL ABNORMAL,10
CO,INGROWING NAIL,10
CO,INJECTION SITE HYPERSENSITIVITY,10
CO,INJECTION SITE RASH,10
CO,INVESTIGATION,10
CO,LUMBAR VERTEBRAL FRACTURE,10
CO,MANIA,10
CO,METASTATIC NEOPLASM,10
CO,MULTIMORBIDITY,10
CO,NO THERAPEUTIC RESPONSE,10
CO,NONINFECTIVE GINGIVITIS,10
CO,OBESITY,10
CO,OBSTRUCTIVE AIRWAYS DISORDER,10
CO,OCULAR DISCOMFORT,10
CO,ONYCHOMADESIS,10
CO,OSTEONECROSIS,10
CO,PARAESTHESIA ORAL,10
CO,PIGMENTATION DISORDER,10
CO,PITUITARY TUMOUR BENIGN,10
CO,PNEUMONIA ASPIRATION,10
CO,POLYCYTHAEMIA,10
CO,POLYNEUROPATHY,10
CO,PRODUCT AVAILABILITY ISSUE,10
CO,QUADRIPLEGIA,10
CO,RECTAL CANCER,10
CO,RENAL INJURY,10
CO,SELF INJURIOUS BEHAVIOUR,10
CO,SHOCK,10
CO,SKIN TOXICITY,10
CO,SUPERINFECTION,10
CO,TENDON RUPTURE,10
CO,THORACIC VERTEBRAL FRACTURE,10
CO,TRACHEOSTOMY,10
CO,URINARY TRACT INFECTION BACTERIAL,10
CO,URINE ABNORMALITY,10
CO,URINE OUTPUT DECREASED,10
CO,WALKING DISABILITY,10
CO,AFFECT LABILITY,9
CO,AMOEBIASIS,9
CO,ASYMPTOMATIC BACTERIURIA,9
CO,ATRIOVENTRICULAR BLOCK,9
CO,BENIGN BREAST NEOPLASM,9
CO,BLOOD CHOLESTEROL ABNORMAL,9
CO,BLOOD ELECTROLYTES DECREASED,9
CO,BLOOD GLUCOSE FLUCTUATION,9
CO,BLOOD GROWTH HORMONE INCREASED,9
CO,BONE DECALCIFICATION,9
CO,BRAIN NEOPLASM MALIGNANT,9
CO,CARDIOMYOPATHY,9
KM,FOOT DEFORMITY,1
CG,ASTHENIA,18
CG,PYREXIA,17
CG,GAIT DISTURBANCE,12
CG,HYPOTENSION,10
CG,HEADACHE,9
CG,DEPRESSED LEVEL OF CONSCIOUSNESS,8
CG,TOXIC ENCEPHALOPATHY,8
CG,COMA,7
CG,BACK PAIN,6
CG,DIARRHOEA,5
CG,ENCEPHALOPATHY,5
CG,MALARIA,5
CG,MYALGIA,5
CG,SPEECH DISORDER,5
CG,URINARY INCONTINENCE,5
CG,CONJUNCTIVAL HAEMORRHAGE,4
CG,NERVOUS SYSTEM DISORDER,4
CG,DEATH,3
CG,DISORIENTATION,3
CG,HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION,3
CG,ABNORMAL BEHAVIOUR,2
CG,APHASIA,2
CG,ARTHRALGIA,2
CG,BLOOD PRESSURE ABNORMAL,2
CG,COMA SCALE ABNORMAL,2
CG,DRUG RESISTANCE,2
CG,ISCHAEMIC CEREBRAL INFARCTION,2
CG,OCULAR HYPERAEMIA,2
CG,SEPSIS,2
CG,TREATMENT NONCOMPLIANCE,2
CG,VOMITING,2
CG,WOUND,2
CG,ABASIA,1
CG,ABDOMINAL PAIN UPPER,1
CG,ACUTE LEUKAEMIA,1
CG,ADVERSE EVENT,1
CG,AGITATION,1
CG,APATHY,1
CG,ATROPHY OF GLOBE,1
CG,BLADDER CATHETERISATION,1
CG,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
CG,BLINDNESS,1
CG,BODY TEMPERATURE,1
CG,BODY TEMPERATURE ABNORMAL,1
CG,CHRONIC MYELOID LEUKAEMIA,1
CG,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
CG,CONJUNCTIVAL HYPERAEMIA,1
CG,COUNTERFEIT DRUG ADMINISTERED,1
CG,CYSTITIS BACTERIAL,1
CG,CYSTOSTOMY,1
CG,DEAFNESS,1
CG,DECUBITUS ULCER,1
CG,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
CG,DYSPHAGIA,1
CG,DYSSTASIA,1
CG,DYSTONIA,1
CG,FACE OEDEMA,1
CG,FAECAL INCONTINENCE,1
CG,HEMIPLEGIA,1
CG,HEPATOMEGALY,1
CG,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
CG,INCONTINENCE,1
CG,INFECTED SKIN ULCER,1
CG,LOGORRHOEA,1
CG,LOSS OF CONSCIOUSNESS,1
CG,LOW BIRTH WEIGHT BABY,1
CG,LYMPHADENOPATHY,1
CG,MALIGNANT NEOPLASM PROGRESSION,1
CG,MANIA,1
CG,MATERNAL EXPOSURE DURING DELIVERY,1
CG,PREMATURE BABY,1
CG,PSYCHOTIC BEHAVIOUR,1
CG,PYURIA,1
CG,RASH,1
CG,SCHISTOSOMIASIS,1
CG,SEPTIC SHOCK,1
CG,SKIN DISCOLOURATION,1
CG,SKIN INFECTION,1
CG,SKIN REACTION,1
CG,SOMNOLENCE,1
CG,SPINAL PAIN,1
CG,THERAPY NON-RESPONDER,1
CG,TUBERCULOSIS,1
CG,VARICELLA,1
CG,VERTIGO,1
CG,WOUND INFECTION,1
CD,ASTHENIA,34
CD,PYREXIA,25
CD,COMA,19
CD,HEADACHE,14
CD,DIARRHOEA,12
CD,MALARIA,12
CD,URINARY INCONTINENCE,12
CD,VOMITING,11
CD,ANAEMIA,9
CD,ENCEPHALOPATHY,9
CD,HYPOTENSION,7
CD,NERVOUS SYSTEM DISORDER,7
CD,VERTIGO,7
CD,AGITATION,6
CD,DYSSTASIA,6
CD,GAIT DISTURBANCE,6
CD,DEATH,5
CD,SOMNOLENCE,5
CD,TOXIC ENCEPHALOPATHY,5
CD,CHRONIC MYELOID LEUKAEMIA,4
CD,CONJUNCTIVAL HAEMORRHAGE,4
CD,DRUG RESISTANCE,4
CD,LOSS OF CONSCIOUSNESS,4
CD,PRURITUS,4
CD,SEPSIS,4
CD,ABASIA,3
CD,ABDOMINAL DISTENSION,3
CD,ABDOMINAL PAIN,3
CD,BACK PAIN,3
CD,BLOOD PRESSURE ABNORMAL,3
CD,DISORIENTATION,3
CD,MALIGNANT NEOPLASM PROGRESSION,3
CD,PERIPHERAL SWELLING,3
CD,SPLENOMEGALY,3
CD,ABNORMAL BEHAVIOUR,2
CD,ADVERSE EVENT,2
CD,ALTERED STATE OF CONSCIOUSNESS,2
CD,ARTHRALGIA,2
CD,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,2
CD,BODY TEMPERATURE ABNORMAL,2
CD,CEREBROVASCULAR ACCIDENT,2
CD,DECREASED APPETITE,2
CD,DIZZINESS,2
CD,ELECTROLYTE IMBALANCE,2
CD,EYELID OEDEMA,2
CD,LOGORRHOEA,2
CD,NAUSEA,2
CD,NEUROPATHY PERIPHERAL,2
CD,OEDEMA PERIPHERAL,2
CD,PLATELET COUNT DECREASED,2
CD,PRURITUS GENERALISED,2
CD,PULMONARY EMBOLISM,2
CD,RASH,2
CD,SEIZURE,2
CD,SEPTIC SHOCK,2
CD,WHITE BLOOD CELL COUNT DECREASED,2
CD,ABDOMINAL PAIN UPPER,1
CD,ACUTE KIDNEY INJURY,1
CD,ANAL SPHINCTER ATONY,1
CD,APATHY,1
CD,APHONIA,1
CD,AREFLEXIA,1
CD,ASCITES,1
CD,ATELECTASIS,1
CD,BLINDNESS,1
CD,BLOOD PRESSURE DECREASED,1
CD,BONE PAIN,1
CD,BURNING SENSATION,1
CD,CANDIDA INFECTION,1
CD,CARDIAC FAILURE,1
CD,CARDIO-RESPIRATORY ARREST,1
CD,CARDIO-RESPIRATORY DISTRESS,1
CD,CARDIOGENIC SHOCK,1
CD,CHEST PAIN,1
CD,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
CD,CHRONIC RESPIRATORY FAILURE,1
CD,COMA SCALE ABNORMAL,1
CD,CONJUNCTIVAL HYPERAEMIA,1
CD,CONSTIPATION,1
CD,DECREASED ACTIVITY,1
CD,DEHYDRATION,1
CD,DEPRESSED LEVEL OF CONSCIOUSNESS,1
CD,DEPRESSION,1
CD,DIET REFUSAL,1
CD,DRUG INEFFECTIVE,1
CD,DYSARTHRIA,1
CD,DYSPHAGIA,1
CD,DYSPNOEA,1
CD,EATING DISORDER,1
CD,ELEPHANTIASIS,1
CD,ENTERITIS,1
CD,EYE HAEMORRHAGE,1
CD,EYE PAIN,1
CD,FAECAL INCONTINENCE,1
CD,FEELING COLD,1
CD,GAIT SPASTIC,1
CD,GASTROINTESTINAL HAEMORRHAGE,1
CD,GENERAL PHYSICAL HEALTH DETERIORATION,1
CD,GENERALISED OEDEMA,1
CD,GENITAL ULCERATION,1
CD,HAEMORRHAGE,1
CD,HAEMORRHAGIC DIATHESIS,1
CD,HIV INFECTION,1
CD,HOT FLUSH,1
CD,HYPERHIDROSIS,1
CD,HYPOACUSIS,1
CD,HYPOVOLAEMIA,1
CD,HYPOVOLAEMIC SHOCK,1
CD,INCOHERENT,1
CD,INCONTINENCE,1
CD,INCREASED BRONCHIAL SECRETION,1
CD,LACRIMATION INCREASED,1
CD,LETHARGY,1
CD,LEUKOPENIA,1
CD,LIMB DEFORMITY,1
CD,LIP SWELLING,1
CD,MAJOR DEPRESSION,1
CD,MALNUTRITION,1
CD,MELAENA,1
CD,MOUTH ULCERATION,1
CD,MUSCLE SPASMS,1
CD,MUTISM,1
CD,MYALGIA,1
CD,NO THERAPEUTIC RESPONSE,1
CD,NUCHAL RIGIDITY,1
CD,OEDEMA,1
CD,ORAL CANDIDIASIS,1
CD,ORAL HERPES,1
CD,OVERWEIGHT,1
CD,PAIN,1
CD,PALLOR,1
CD,PANCYTOPENIA,1
CD,PLEURAL EFFUSION,1
CD,PREGNANCY,1
CD,PSYCHOTIC DISORDER,1
CD,PULMONARY ARTERIAL HYPERTENSION,1
CD,PULMONARY TUBERCULOSIS,1
CD,RASH PRURITIC,1
CD,RESPIRATORY DISORDER,1
CD,RESPIRATORY FAILURE,1
CD,RESPIRATORY TRACT INFECTION,1
CD,SCREAMING,1
CD,SHOCK HAEMORRHAGIC,1
CD,SKIN EXFOLIATION,1
CD,SPEECH DISORDER,1
CD,SUDDEN DEATH,1
CD,SUICIDAL IDEATION,1
CD,SUPRAVENTRICULAR EXTRASYSTOLES,1
CD,SWELLING,1
CD,SWELLING FACE,1
CD,SYNCOPE,1
CD,THROMBOCYTOPENIA,1
CD,TINNITUS,1
CD,TREATMENT FAILURE,1
CD,URINARY RETENTION,1
CD,VENTRICULAR EXTRASYSTOLES,1
CD,VISION BLURRED,1
CD,WHITE BLOOD CELL COUNT INCREASED,1
CR,DEATH,146
CR,MALAISE,59
CR,DRUG INEFFECTIVE,50
CR,FATIGUE,48
CR,HEADACHE,45
CR,DYSPNOEA,43
CR,DIZZINESS,40
CR,BLOOD PRESSURE INCREASED,36
CR,NAUSEA,34
CR,MYOCARDIAL INFARCTION,32
CR,CEREBROVASCULAR ACCIDENT,29
CR,DIARRHOEA,29
CR,VOMITING,29
CR,WEIGHT DECREASED,29
CR,PAIN,28
CR,FALL,27
CR,PAIN IN EXTREMITY,26
CR,FEELING ABNORMAL,25
CR,HYPOACUSIS,25
CR,MEMORY IMPAIRMENT,24
CR,PNEUMONIA,24
CR,GAIT DISTURBANCE,22
CR,ASTHENIA,21
CR,HYPERSENSITIVITY,21
CR,PYREXIA,21
CR,ARTHRALGIA,20
CR,ANXIETY,19
CR,HYPERTENSION,19
CR,PERIPHERAL SWELLING,19
CR,DEAFNESS,18
CR,DEPRESSION,18
CR,DIABETES MELLITUS,18
CR,HYPOAESTHESIA,18
CR,INSOMNIA,18
CR,SOMNOLENCE,18
CR,VISUAL IMPAIRMENT,18
CR,ABDOMINAL PAIN,17
CR,GENERAL PHYSICAL HEALTH DETERIORATION,17
CR,CHEST PAIN,16
CR,DECREASED APPETITE,16
CR,INFARCTION,16
CR,PRODUCT USE ISSUE,16
CR,VISION BLURRED,16
CR,COUGH,15
CR,EXPOSURE DURING PREGNANCY,15
CR,HAEMOGLOBIN DECREASED,15
CR,PRODUCT USE IN UNAPPROVED INDICATION,15
CR,PRURITUS,15
CR,RASH,15
CR,ARRHYTHMIA,14
CR,ASTHMATIC CRISIS,14
CR,ATRIAL FIBRILLATION,13
CR,DISCOMFORT,13
CR,HYPERHIDROSIS,13
CR,SEIZURE,13
CR,ANAEMIA,12
CR,MUSCULAR WEAKNESS,12
CR,NASOPHARYNGITIS,12
CR,RENAL FAILURE,12
CR,TACHYCARDIA,12
CR,BACK PAIN,11
CR,BLOOD PRESSURE DECREASED,11
CR,CARDIAC FAILURE,11
CR,HIP FRACTURE,11
CR,INFLUENZA,11
CR,MUSCLE SPASMS,11
CR,OEDEMA PERIPHERAL,11
CR,PARAESTHESIA,11
CR,SYNCOPE,11
CR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,11
CR,BONE PAIN,10
CR,CARDIAC DISORDER,10
CR,CARDIOMEGALY,10
CR,CHOLELITHIASIS,10
CR,ERYTHEMA,10
CR,GASTRITIS,10
CR,LOSS OF CONSCIOUSNESS,10
CR,MOBILITY DECREASED,10
CR,THROMBOSIS,10
CR,ABDOMINAL DISCOMFORT,9
CR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,9
CR,CONSTIPATION,9
CR,DRUG INTOLERANCE,9
CR,DYSPHONIA,9
CR,HEPATIC CANCER,9
CR,HYPOTENSION,9
CR,MOVEMENT DISORDER,9
CR,OBSTRUCTIVE AIRWAYS DISORDER,9
CR,SPEECH DISORDER,9
CR,URINARY TRACT INFECTION,9
CR,ABDOMINAL PAIN UPPER,8
CR,BLOOD GLUCOSE INCREASED,8
CR,BLOOD PRESSURE INADEQUATELY CONTROLLED,8
CR,BURNING SENSATION,8
CR,COGNITIVE DISORDER,8
CR,COLITIS ULCERATIVE,8
CR,CONDITION AGGRAVATED,8
CR,DEMENTIA ALZHEIMER^S TYPE,8
CR,DISEASE PROGRESSION,8
CR,DYSLIPIDAEMIA,8
CR,DYSPHAGIA,8
CR,FEELING HOT,8
CR,MULTIPLE SCLEROSIS RELAPSE,8
CR,POLLAKIURIA,8
CR,SENILE DEMENTIA,8
CR,SEPSIS,8
CR,TREMOR,8
CR,URINARY INCONTINENCE,8
CR,URINARY RETENTION,8
CR,UVEITIS,8
CR,AGITATION,7
CR,AMNESIA,7
CR,BLOOD CHOLESTEROL INCREASED,7
CR,CATARACT,7
CR,CHEST DISCOMFORT,7
CR,EJECTION FRACTION DECREASED,7
CR,GOITRE,7
CR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,7
CR,INFLAMMATION,7
CR,MALIGNANT NEOPLASM PROGRESSION,7
CR,MYALGIA,7
CR,OVERDOSE,7
CR,PALPITATIONS,7
CR,PREMATURE BABY,7
CR,PREMATURE DELIVERY,7
CR,RENAL IMPAIRMENT,7
CR,STRESS,7
CR,SWELLING FACE,7
CR,THROMBOCYTOPENIA,7
CR,URTICARIA,7
CR,ABORTION SPONTANEOUS,6
CR,AORTIC ANEURYSM,6
CR,ARTHROPATHY,6
CR,BLINDNESS,6
CR,BLOOD POTASSIUM DECREASED,6
CR,BLOOD THYROID STIMULATING HORMONE ABNORMAL,6
CR,BRAIN NATRIURETIC PEPTIDE ABNORMAL,6
CR,BUNDLE BRANCH BLOCK LEFT,6
CR,BUNDLE BRANCH BLOCK RIGHT,6
CR,C-REACTIVE PROTEIN ABNORMAL,6
CR,CARDIAC FAILURE CHRONIC,6
CR,CONDUCTION DISORDER,6
CR,CONTUSION,6
CR,DELIRIUM,6
CR,DEPRESSED MOOD,6
CR,EPISTAXIS,6
CR,FEMUR FRACTURE,6
CR,FLUID RETENTION,6
CR,FOETAL EXPOSURE DURING PREGNANCY,6
CR,FRACTURED COCCYX,6
CR,GASTRIC CANCER,6
CR,GASTRITIS EROSIVE,6
CR,HAEMORRHAGE,6
CR,INFECTION,6
CR,LEFT VENTRICULAR DILATATION,6
CR,LIMB DISCOMFORT,6
CR,LUNG DISORDER,6
CR,MATERNAL EXPOSURE DURING PREGNANCY,6
CR,MIGRAINE,6
CR,MITRAL VALVE INCOMPETENCE,6
CR,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE ABNORMAL,6
CR,NEOPLASM MALIGNANT,6
CR,PANCREATITIS,6
CR,POST PROCEDURAL COMPLICATION,6
CR,PULMONARY EMBOLISM,6
CR,PULMONARY OEDEMA,6
CR,RENAL DISORDER,6
CR,SEPTIC SHOCK,6
CR,THYROIDITIS,6
CR,TRICUSPID VALVE INCOMPETENCE,6
CR,TYPE 2 DIABETES MELLITUS,6
CR,VENTRICULAR HYPOKINESIA,6
CR,VERTIGO,6
CR,ABASIA,5
CR,ABDOMINAL DISTENSION,5
CR,ACUTE MYOCARDIAL INFARCTION,5
CR,ASPHYXIA,5
CR,BALANCE DISORDER,5
CR,BLOOD PRESSURE ABNORMAL,5
CR,BRADYCARDIA,5
CR,CEREBRAL INFARCTION,5
CR,COLITIS,5
CR,DEHYDRATION,5
CR,DEMENTIA,5
CR,DERMATITIS ALLERGIC,5
CR,DISORIENTATION,5
CR,DYSSTASIA,5
CR,EAR PAIN,5
CR,ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL,5
CR,FEAR,5
CR,GAIT INABILITY,5
CR,GASTRIC DISORDER,5
CR,GASTRIC ULCER,5
CR,HAEMATOCHEZIA,5
CR,HEMIPARESIS,5
CR,INTENTIONAL OVERDOSE,5
CR,JAUNDICE,5
CR,LEUKAEMIA,5
CR,MULTIPLE SCLEROSIS,5
CR,MUSCULOSKELETAL PAIN,5
CR,NASAL CONGESTION,5
CR,NECK PAIN,5
CR,NEOPLASM,5
CR,NEOPLASM PROGRESSION,5
CR,NEUTROPENIA,5
CR,OEDEMA,5
CR,OROPHARYNGEAL PAIN,5
CR,OXYGEN SATURATION INCREASED,5
CR,PLATELET COUNT DECREASED,5
CR,PROCEDURAL PAIN,5
CR,PRODUCTIVE COUGH,5
CR,PULMONARY ARTERIAL PRESSURE ABNORMAL,5
CR,RENAL TRANSPLANT,5
CR,SKIN LESION,5
CR,SKIN ULCER,5
CR,THROAT IRRITATION,5
CR,WEIGHT INCREASED,5
CR,APHONIA,4
CR,ARTERIAL DISORDER,4
CR,ASTHMA,4
CR,BASAL CELL CARCINOMA,4
CR,BLINDNESS UNILATERAL,4
CR,BLOOD BILIRUBIN INCREASED,4
CR,BLOOD GLUCOSE ABNORMAL,4
CR,BLOOD GROWTH HORMONE INCREASED,4
CR,BLOOD PRESSURE FLUCTUATION,4
CR,BLOOD SODIUM DECREASED,4
CR,BLOOD TRIGLYCERIDES INCREASED,4
CR,CARDIAC ARREST,4
CR,CARDIO-RESPIRATORY ARREST,4
CR,CELLULITIS,4
CR,CENTRAL NERVOUS SYSTEM LESION,4
CR,CHOKING,4
CR,COMA,4
CR,CONCOMITANT DISEASE AGGRAVATED,4
CR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,4
CR,DYSARTHRIA,4
CR,DYSPEPSIA,4
CR,DYSURIA,4
CR,EAR DISORDER,4
CR,EATING DISORDER,4
CR,EMOTIONAL DISORDER,4
CR,EYE DISORDER,4
CR,GASTROINTESTINAL DISORDER,4
CR,GASTROINTESTINAL INFLAMMATION,4
CR,GASTROOESOPHAGEAL REFLUX DISEASE,4
CR,GLAUCOMA,4
CR,HAEMATOMA,4
CR,HAEMORRHAGIC STROKE,4
CR,HALLUCINATION,4
CR,HEART RATE DECREASED,4
CR,HEPATIC STEATOSIS,4
CR,INCORRECT DOSE ADMINISTERED,4
CR,INTENTIONAL PRODUCT MISUSE,4
CR,INTESTINAL OBSTRUCTION,4
CR,ISCHAEMIC STROKE,4
CR,KIDNEY INFECTION,4
CR,LIMB INJURY,4
CR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
CR,NEUROPATHY PERIPHERAL,4
CR,OSTEOARTHRITIS,4
CR,OSTEOPOROSIS,4
CR,PALLOR,4
CR,PARALYSIS,4
CR,PERIPHERAL ISCHAEMIA,4
CR,POSTOPERATIVE WOUND COMPLICATION,4
CR,PSYCHOTIC DISORDER,4
CR,SCAR,4
CR,SKIN DISCOLOURATION,4
CR,SLEEP APNOEA SYNDROME,4
CR,STEVENS-JOHNSON SYNDROME,4
CR,SWELLING,4
CR,UPPER LIMB FRACTURE,4
CR,VAGINAL HAEMORRHAGE,4
CR,VISUAL ACUITY REDUCED,4
CR,WHITE BLOOD CELL COUNT DECREASED,4
CR,ACCIDENT,3
CR,ACNE,3
CR,ANAPHYLACTIC REACTION,3
CR,ANGINA PECTORIS,3
CR,ARTHRITIS,3
CR,ASCITES,3
CR,BLOOD ALKALINE PHOSPHATASE INCREASED,3
CR,BLOOD CREATININE INCREASED,3
CR,BONE DISORDER,3
CR,BONE MARROW FAILURE,3
CR,BRAIN NEOPLASM,3
CR,BRONCHIOLITIS,3
CR,BRONCHITIS,3
CR,CEREBRAL PALSY,3
CR,CHILLS,3
CR,CHOKING SENSATION,3
CR,CONFUSIONAL STATE,3
CR,CONVULSION,3
CR,CRYING,3
CR,CYANOSIS,3
CR,DEVICE EXPULSION,3
CR,DISTURBANCE IN ATTENTION,3
CR,DRUG HYPERSENSITIVITY,3
CR,DRUG LEVEL BELOW THERAPEUTIC,3
CR,DRUG PRESCRIBING ERROR,3
CR,DRY SKIN,3
CR,DYSGEUSIA,3
CR,ECZEMA,3
CR,EMBOLISM,3
CR,EYE PAIN,3
CR,FACIAL PAIN,3
CR,FEELING COLD,3
CR,FOOT FRACTURE,3
CR,FRACTURE,3
CR,GASTROINTESTINAL HAEMORRHAGE,3
CR,GENERALISED OEDEMA,3
CR,HAEMATEMESIS,3
CR,HAEMATURIA,3
CR,HAEMORRHOIDS,3
CR,HEPATIC NEOPLASM,3
CR,HEPATITIS,3
CR,HIATUS HERNIA,3
CR,HORMONE LEVEL ABNORMAL,3
CR,HYPERTENSIVE CRISIS,3
CR,HYPERTROPHIC CARDIOMYOPATHY,3
CR,HYPOAESTHESIA ORAL,3
CR,HYPOCALCAEMIA,3
CR,HYPOGLYCAEMIA,3
CR,HYPOKALAEMIA,3
CR,HYPOTHYROIDISM,3
CR,INCORRECT DRUG ADMINISTRATION DURATION,3
CR,INJECTION SITE ERYTHEMA,3
CR,INTERVERTEBRAL DISC PROTRUSION,3
CR,INTRAOCULAR PRESSURE INCREASED,3
CR,ISCHAEMIA,3
CR,JOINT INJURY,3
CR,JOINT SWELLING,3
CR,LOW BIRTH WEIGHT BABY,3
CR,LUNG INFECTION,3
CR,LUNG NEOPLASM MALIGNANT,3
CR,LYMPHOCYTE COUNT DECREASED,3
CR,MALNUTRITION,3
CR,METASTASES TO LIVER,3
CR,METASTASES TO LUNG,3
CR,MUSCLE ATROPHY,3
CR,MYELOFIBROSIS,3
CR,NERVOUSNESS,3
CR,NEURALGIA,3
CR,NO ADVERSE EVENT,3
CR,OBESITY,3
CR,OCULAR HYPERAEMIA,3
CR,OLIGOHYDRAMNIOS,3
CR,OPTIC NEURITIS,3
CR,PANCYTOPENIA,3
CR,PARKINSON^S DISEASE,3
CR,PERICARDIAL EFFUSION,3
CR,PLATELET COUNT INCREASED,3
CR,PSORIASIS,3
CR,PULMONARY HYPERTENSION,3
CR,PULMONARY THROMBOSIS,3
CR,RASH PAPULAR,3
CR,RESPIRATORY ARREST,3
CR,RETINAL DETACHMENT,3
CR,RHINITIS,3
CR,RIB FRACTURE,3
CR,SINUSITIS,3
CR,SLUGGISHNESS,3
CR,SUBCUTANEOUS ABSCESS,3
CR,SUICIDE ATTEMPT,3
CR,THIRST,3
CR,THROAT TIGHTNESS,3
CR,THYROID CANCER,3
CR,THYROID DISORDER,3
CR,TOXICITY TO VARIOUS AGENTS,3
CR,TRANSAMINASES INCREASED,3
CR,TREATMENT FAILURE,3
CR,TRIGEMINAL NEURALGIA,3
CR,WHITE BLOOD CELL COUNT INCREASED,3
CR,WRIST FRACTURE,3
CR,ABDOMINAL HERNIA,2
CR,ABSCESS LIMB,2
CR,ACCIDENTAL OVERDOSE,2
CR,ACUTE ABDOMEN,2
CR,ACUTE CORONARY SYNDROME,2
CR,ACUTE HEPATIC FAILURE,2
CR,ACUTE KIDNEY INJURY,2
CR,ADVERSE EVENT,2
CR,AGGRESSION,2
CR,AGNOSIA,2
CR,ALOPECIA,2
CR,ALPHA 1 FOETOPROTEIN INCREASED,2
CR,ALTERED STATE OF CONSCIOUSNESS,2
CR,AMNIOTIC FLUID VOLUME DECREASED,2
CR,ANAL FISTULA,2
CR,ANOGENITAL WARTS,2
CR,APLASIA,2
CR,APNOEA,2
CR,APPARENT DEATH,2
CR,BACTERIAL INFECTION,2
CR,BENIGN PROSTATIC HYPERPLASIA,2
CR,BLAST CELL COUNT INCREASED,2
CR,BLEEDING TIME PROLONGED,2
CR,BLISTER,2
CR,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
CR,BLOOD GLUCOSE DECREASED,2
CR,BLOOD THYROID STIMULATING HORMONE INCREASED,2
CR,BLOOD TRIGLYCERIDES ABNORMAL,2
CR,BLOOD UREA INCREASED,2
CR,BODY TEMPERATURE INCREASED,2
CR,BRADYPHRENIA,2
CR,BREAST ABSCESS,2
CR,BREAST CANCER,2
CR,BREAST PAIN,2
CR,BRONCHOSPASM,2
CR,CANDIDA INFECTION,2
CR,CARDIAC FAILURE CONGESTIVE,2
CR,CARDIOMYOPATHY,2
CR,CARDIOTOXICITY,2
CR,CARDIOVASCULAR DISORDER,2
CR,CENTRAL NERVOUS SYSTEM LUPUS,2
CR,CEREBRAL ATROPHY,2
CR,CEREBRAL DISORDER,2
CR,CEREBRAL HAEMORRHAGE,2
CR,CEREBROSPINAL FLUID LEAKAGE,2
CR,CHROMATURIA,2
CR,CHRONIC GASTRITIS,2
CR,COLON CANCER,2
CR,CONJUNCTIVITIS,2
CR,CORONARY ARTERY DISEASE,2
CR,DEAFNESS UNILATERAL,2
CR,DECREASED INTEREST,2
CR,DEEP VEIN THROMBOSIS,2
CR,DEFORMITY,2
CR,DENGUE FEVER,2
CR,DERMATITIS,2
CR,DERMATITIS EXFOLIATIVE,2
CR,DEVICE RELATED INFECTION,2
CR,DIPLEGIA,2
CR,DISEASE COMPLICATION,2
CR,DISSEMINATED INTRAVASCULAR COAGULATION,2
CR,DISTRACTIBILITY,2
CR,DRUG DOSE OMISSION,2
CR,DRUG EFFECT INCOMPLETE,2
CR,DRY EYE,2
CR,DRY MOUTH,2
CR,DUCTUS ARTERIOSUS STENOSIS FOETAL,2
CR,DYSKINESIA,2
CR,DYSPHORIA,2
CR,DYSPNOEA EXERTIONAL,2
CR,ECCHYMOSIS,2
CR,EYE DISCHARGE,2
CR,EYE HAEMORRHAGE,2
CR,EYE IRRITATION,2
CR,EYELID OEDEMA,2
CR,FACIAL PARALYSIS,2
CR,FAECES DISCOLOURED,2
CR,FISTULA,2
CR,FLUSHING,2
CR,FOETAL EXPOSURE TIMING UNSPECIFIED,2
CR,FOOD INTERACTION,2
CR,GALLBLADDER OPERATION,2
CR,GASTRIC ADENOMA,2
CR,GASTROINTESTINAL PAIN,2
CR,GENITAL HAEMORRHAGE,2
CR,GLUCOSE TOLERANCE IMPAIRED,2
CR,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
CR,GUILLAIN-BARRE SYNDROME,2
CR,HAEMARTHROSIS,2
CR,HAEMORRHAGE INTRACRANIAL,2
CR,HEAD INJURY,2
CR,HEPATIC FAILURE,2
CR,HOLOPROSENCEPHALY,2
CR,HOSPITALISATION,2
CR,HYPERAEMIA,2
CR,HYPERCHLORHYDRIA,2
CR,HYPERGLYCAEMIA,2
CR,HYPERKALAEMIA,2
CR,HYPERTELORISM OF ORBIT,2
CR,HYPOALBUMINAEMIA,2
CR,HYPOKINESIA,2
CR,HYPOTONIA,2
CR,ILEOSTOMY,2
CR,IMMUNODEFICIENCY,2
CR,INCISION SITE HAEMATOMA,2
CR,INFLUENZA LIKE ILLNESS,2
CR,INJECTION SITE HAEMORRHAGE,2
CR,INJECTION SITE PAIN,2
CR,INJURY,2
CR,INNER EAR DISORDER,2
CR,INTESTINAL PERFORATION,2
CR,INTRACRANIAL VENOUS SINUS THROMBOSIS,2
CR,IRRITABLE BOWEL SYNDROME,2
CR,JOINT EFFUSION,2
CR,KETOACIDOSIS,2
CR,LABORATORY TEST ABNORMAL,2
CR,LEUKOENCEPHALOPATHY,2
CR,LEUKOPENIA,2
CR,LIP DISORDER,2
CR,LIPASE INCREASED,2
CR,LIPIDS INCREASED,2
CR,LIVE BIRTH,2
CR,LIVER DISORDER,2
CR,LYMPHOMA,2
CR,MENINGITIS,2
CR,MENORRHAGIA,2
CR,MENTAL DISORDER,2
CR,METASTASES TO BONE,2
CR,METASTASES TO CENTRAL NERVOUS SYSTEM,2
CR,MICTURITION URGENCY,2
CR,MOTOR DYSFUNCTION,2
CR,MOUTH HAEMORRHAGE,2
CR,MUCOSAL INFLAMMATION,2
CR,MUSCLE RUPTURE,2
CR,MUSCULOSKELETAL STIFFNESS,2
CR,MYOCARDIAL ISCHAEMIA,2
CR,MYOPATHY,2
CR,NECROSIS,2
CR,NEUROGENIC BLADDER,2
CR,NODULE,2
CR,NOSOCOMIAL INFECTION,2
CR,OCCULT BLOOD POSITIVE,2
CR,OCULAR DISCOMFORT,2
CR,ORAL MUCOSAL BLISTERING,2
CR,OSTEONECROSIS,2
CR,OSTEOSARCOMA,2
CR,OTITIS MEDIA,2
CR,PANCREATIC CARCINOMA,2
CR,PANIC ATTACK,2
CR,PELVIC PAIN,2
CR,PERIPHERAL VENOUS DISEASE,2
CR,PHARYNGITIS,2
CR,PHLEBITIS,2
CR,PHOTOPHOBIA,2
CR,PLEURAL EFFUSION,2
CR,PNEUMONITIS,2
CR,POLYP,2
CR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
CR,PRESCRIBED OVERDOSE,2
CR,PRODUCT ADHESION ISSUE,2
CR,PRODUCT QUALITY ISSUE,2
CR,PROSTATE CANCER,2
CR,RASH ERYTHEMATOUS,2
CR,RASH GENERALISED,2
CR,RASH MACULAR,2
CR,RASH PRURITIC,2
CR,RASH VESICULAR,2
CR,RED BLOOD CELL COUNT INCREASED,2
CR,RENAL CANCER,2
CR,RENAL FAILURE ACUTE,2
CR,RESPIRATORY FAILURE,2
CR,RESPIRATORY TRACT INFECTION,2
CR,RHABDOMYOLYSIS,2
CR,RHEUMATOID ARTHRITIS,2
CR,RHINORRHOEA,2
CR,ROAD TRAFFIC ACCIDENT,2
CR,SECOND PRIMARY MALIGNANCY,2
CR,SENSITIVITY TO WEATHER CHANGE,2
CR,SKIN EXFOLIATION,2
CR,SKIN INFECTION,2
CR,SKIN NECROSIS,2
CR,SKIN REACTION,2
CR,SOMNAMBULISM,2
CR,SPINAL CORD NEOPLASM,2
CR,SPINAL PAIN,2
CR,STOMATITIS,2
CR,STRABISMUS,2
CR,SUICIDAL IDEATION,2
CR,SURGERY,2
CR,TEMPERATURE INTOLERANCE,2
CR,TENSION,2
CR,TERMINAL STATE,2
CR,THERAPEUTIC RESPONSE DECREASED,2
CR,THERAPEUTIC RESPONSE UNEXPECTED,2
CR,THERAPY NON-RESPONDER,2
CR,THYROTOXIC CRISIS,2
CR,TINNITUS,2
CR,TONGUE BLISTERING,2
CR,TONGUE DISORDER,2
CR,TONIC CONVULSION,2
CR,TRISOMY 13,2
CR,TUBULOINTERSTITIAL NEPHRITIS,2
CR,UNINTENDED PREGNANCY,2
CR,VARICOSE VEIN,2
CR,VASCULITIS,2
CR,VEIN DISORDER,2
CR,VENTRICULAR ARRHYTHMIA,2
CR,VISUAL FIELD DEFECT,2
CR,WITHDRAWAL BLEED,2
CR,WITHDRAWAL SYNDROME,2
CR,YAWNING,2
CR,ABDOMINAL ABSCESS,1
CR,ABDOMINAL ADHESIONS,1
CR,ABDOMINAL MASS,1
CR,ABDOMINAL NEOPLASM,1
CR,ABDOMINAL PAIN LOWER,1
CR,ABDOMINAL RIGIDITY,1
CR,ABDOMINAL WOUND DEHISCENCE,1
CR,ABNORMAL BEHAVIOUR,1
CR,ABNORMAL FAECES,1
CR,ABORTION,1
CR,ABSCESS,1
CR,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
CR,ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL,1
CR,ACTIVITIES OF DAILY LIVING IMPAIRED,1
CR,ACUTE MYELOID LEUKAEMIA,1
CR,ACUTE PULMONARY OEDEMA,1
CR,ACUTE RESPIRATORY FAILURE,1
CR,ADENOCARCINOMA OF COLON,1
CR,ADMINISTRATION SITE HAEMATOMA,1
CR,ADNEXA UTERI PAIN,1
CR,ADRENAL CYST,1
CR,AFFECTIVE DISORDER,1
CR,AGEUSIA,1
CR,AMENORRHOEA,1
CR,AMPUTATION,1
CR,AMYLASE INCREASED,1
CR,AMYOTROPHIC LATERAL SCLEROSIS,1
CR,ANAESTHETIC COMPLICATION,1
CR,ANAL CANDIDIASIS,1
CR,ANAPHYLACTIC SHOCK,1
CR,ANEMBRYONIC GESTATION,1
CR,ANEURYSM,1
CR,ANGER,1
CR,ANGINA UNSTABLE,1
CR,ANGIOEDEMA,1
CR,ANGIOMYOLIPOMA,1
CR,ANGIOPATHY,1
CR,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,1
CR,AORTIC CALCIFICATION,1
CR,APHASIA,1
CR,APPENDICITIS PERFORATED,1
CR,APPLICATION SITE BURN,1
CR,APPLICATION SITE ERYTHEMA,1
CR,APPLICATION SITE INJURY,1
CR,APPLICATION SITE PAIN,1
CR,ARTERIAL HAEMORRHAGE,1
CR,ARTERIAL INSUFFICIENCY,1
CR,ARTERIOSCLEROSIS,1
CR,ARTHRITIS BACTERIAL,1
CR,ASPARTATE AMINOTRANSFERASE INCREASED,1
CR,ASPIRATION BRONCHIAL,1
CR,ATRIAL THROMBOSIS,1
CR,ATRIOVENTRICULAR BLOCK,1
CR,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
CR,BACK DISORDER,1
CR,BACTERIAL SEPSIS,1
CR,BACTERIAL TEST POSITIVE,1
CR,BAND NEUTROPHIL COUNT INCREASED,1
CR,BEDRIDDEN,1
CR,BENIGN BONE NEOPLASM,1
CR,BENIGN NEOPLASM OF THYROID GLAND,1
CR,BILE DUCT OBSTRUCTION,1
CR,BILE DUCT STONE,1
CR,BILIRUBIN CONJUGATED INCREASED,1
CR,BIPOLAR DISORDER,1
CR,BIPOLAR I DISORDER,1
CR,BLADDER CATHETERISATION,1
CR,BLADDER DISORDER,1
CR,BLEPHAROSPASM,1
CR,BLINDNESS TRANSIENT,1
CR,BLOOD CALCIUM ABNORMAL,1
CR,BLOOD CALCIUM DECREASED,1
CR,BLOOD CANNABINOIDS,1
CR,BLOOD CHLORIDE DECREASED,1
CR,BLOOD CHOLESTEROL ABNORMAL,1
CR,BLOOD CREATININE DECREASED,1
CR,BLOOD DISORDER,1
CR,BLOOD ELECTROLYTES ABNORMAL,1
CR,BLOOD LACTATE DEHYDROGENASE ABNORMAL,1
CR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CR,BLOOD MAGNESIUM DECREASED,1
CR,BLOOD PHOSPHORUS INCREASED,1
CR,BLOOD POTASSIUM ABNORMAL,1
CR,BLOOD PRESSURE DIASTOLIC DECREASED,1
CR,BLOOD PRESSURE DIFFERENCE OF EXTREMITIES,1
CR,BLOOD SODIUM ABNORMAL,1
CR,BLOOD SODIUM INCREASED,1
CR,BLOOD TEST ABNORMAL,1
CR,BLOOD TESTOSTERONE DECREASED,1
CR,BODY HEIGHT DECREASED,1
CR,BONE DEFORMITY,1
CR,BONE FISSURE,1
CR,BRAIN OEDEMA,1
CR,BRAIN STEM HAEMORRHAGE,1
CR,BREAST CANCER IN SITU,1
CR,BREAST CANCER METASTATIC,1
CR,BREAST DISCHARGE,1
CR,BREAST DISORDER,1
CR,BREAST INFLAMMATION,1
CR,BREAST OPERATION,1
CR,BRONCHIAL DISORDER,1
CR,BRONCHIAL OEDEMA,1
CR,BRONCHOPNEUMONIA,1
CR,CAESAREAN SECTION,1
CR,CARBON DIOXIDE ABNORMAL,1
CR,CARDIAC ANEURYSM,1
CR,CARDIAC INDEX ABNORMAL,1
CR,CARDIAC NEOPLASM UNSPECIFIED,1
CR,CARDIAC OUTPUT DECREASED,1
CR,CARDIAC TAMPONADE,1
CR,CARDIAC VALVE DISEASE,1
CR,CARDIOGENIC SHOCK,1
CR,CAVERNOUS SINUS THROMBOSIS,1
CR,CENTRAL NERVOUS SYSTEM HAEMORRHAGE,1
CR,CEREBELLAR ISCHAEMIA,1
CR,CEREBRAL ISCHAEMIA,1
CR,CEREBROSPINAL FISTULA,1
CR,CEREBROSPINAL FLUID CIRCULATION DISORDER,1
CR,CEREBROVASCULAR DISORDER,1
CR,CERVIX CARCINOMA,1
CR,CERVIX NEOPLASM,1
CR,CHEILITIS,1
CR,CHEST INJURY,1
CR,CHIKUNGUNYA VIRUS INFECTION,1
CR,CHOLANGITIS,1
CR,CHOLESTASIS,1
CR,CHOLURIA,1
CR,CHONDROMALACIA,1
CR,CHROMOSOME ANALYSIS ABNORMAL,1
CR,CHRONIC HEPATIC FAILURE,1
CR,CHRONIC KIDNEY DISEASE,1
CR,CHRONIC MYELOID LEUKAEMIA,1
CR,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
CR,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
CR,CLAUSTROPHOBIA,1
CR,CLOSTRIDIUM DIFFICILE INFECTION,1
CR,CLOSTRIDIUM TEST POSITIVE,1
CR,COAGULATION TEST ABNORMAL,1
CR,COAGULOPATHY,1
CR,COLD SWEAT,1
CR,COLECTOMY TOTAL,1
CR,COLON DYSPLASIA,1
CR,COLON INJURY,1
CR,COLORECTAL CANCER METASTATIC,1
CR,COLOSTOMY,1
CR,COMPLETED SUICIDE,1
CR,COMPLICATION OF DEVICE INSERTION,1
CR,CONGENITAL ARTERIAL MALFORMATION,1
CR,CONTRAST MEDIA ALLERGY,1
CR,CORNEAL DEPOSITS,1
CR,CORONARY ARTERY INSUFFICIENCY,1
CR,CORONARY ARTERY OCCLUSION,1
CR,CYST,1
CR,CYST RUPTURE,1
CR,CYSTITIS,1
CR,DANDRUFF,1
CR,DAYDREAMING,1
CR,DELIVERY,1
CR,DELUSION,1
CR,DEPENDENCE,1
CR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
CR,DEPRESSION SUICIDAL,1
CR,DERMATITIS ATOPIC,1
CR,DERMATITIS BULLOUS,1
CR,DEVICE DISLOCATION,1
CR,DEVICE USE ISSUE,1
CR,DIABETES MELLITUS INADEQUATE CONTROL,1
CR,DIABETIC KETOACIDOSIS,1
CR,DIABETIC RETINAL OEDEMA,1
CR,DIARRHOEA HAEMORRHAGIC,1
CR,DIPLOPIA,1
CR,DISEASE RECURRENCE,1
CR,DISSOCIATION,1
CR,DISTRIBUTIVE SHOCK,1
CR,DIVERTICULITIS,1
CR,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
CR,DNA ANTIBODY POSITIVE,1
CR,DROOLING,1
CR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
CR,DRUG ADMINISTRATION ERROR,1
CR,DRUG DEPENDENCE,1
CR,DRUG DIVERSION,1
CR,DRUG EFFECT DECREASED,1
CR,DRUG EFFECTIVE FOR UNAPPROVED INDICATION,1
CR,DRUG WITHDRAWAL SYNDROME,1
CR,DRUG-INDUCED LIVER INJURY,1
CR,DRY THROAT,1
CR,DUODENAL ULCER PERFORATION,1
CR,DYSAESTHESIA,1
CR,DYSBACTERIOSIS,1
CR,DYSPLASIA,1
CR,EAR DISCOMFORT,1
CR,EAR INFECTION,1
CR,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
CR,ELECTROCARDIOGRAM QT PROLONGED,1
CR,EMBOLISM VENOUS,1
CR,EMPHYSEMA,1
CR,ENCEPHALITIS,1
CR,ENCEPHALOPATHY,1
CR,ENDOMETRIOSIS,1
CR,ENZYME LEVEL ABNORMAL,1
CR,EPIGASTRIC DISCOMFORT,1
CR,EPILEPSY,1
CR,ERECTILE DYSFUNCTION,1
CR,EXPIRED PRODUCT ADMINISTERED,1
CR,EXPOSURE TO TOXIC AGENT,1
CR,EXTRAPYRAMIDAL DISORDER,1
CR,EXTRASYSTOLES,1
CR,EYE INFECTION TOXOPLASMAL,1
CR,EYE INJURY,1
CR,EYE PRURITUS,1
CR,EYE SWELLING,1
CR,EYELID INJURY,1
CR,FACE OEDEMA,1
CR,FAECES PALE,1
CR,FAILED IN VITRO FERTILISATION,1
CR,FAT INTOLERANCE,1
CR,FAT NECROSIS,1
CR,FEAR OF DISEASE,1
CR,FEBRILE NEUTROPENIA,1
CR,FEEDING DISORDER,1
CR,FIBROSIS,1
CR,FINE MOTOR SKILL DYSFUNCTION,1
CR,FLATULENCE,1
CR,FOCAL DYSCOGNITIVE SEIZURES,1
CR,FOETAL GROWTH RESTRICTION,1
CR,FOOD ALLERGY,1
CR,FREQUENT BOWEL MOVEMENTS,1
CR,FRUSTRATION TOLERANCE DECREASED,1
CR,FUNGAEMIA,1
CR,FUNGAL SKIN INFECTION,1
CR,FURUNCLE,1
CR,FUSARIUM INFECTION,1
CR,GALLBLADDER ENLARGEMENT,1
CR,GALLBLADDER OBSTRUCTION,1
CR,GALLBLADDER POLYP,1
CR,GASTRIC DYSPLASIA,1
CR,GASTRIC MUCOSAL LESION,1
CR,GASTRIC ULCER HAEMORRHAGE,1
CR,GASTRIC ULCER PERFORATION,1
CR,GASTROINTESTINAL BACTERIAL OVERGROWTH,1
CR,GASTROINTESTINAL DYSPLASIA,1
CR,GASTROINTESTINAL INJURY,1
CR,GASTROINTESTINAL LYMPHOMA,1
CR,GASTROINTESTINAL NEOPLASM,1
CR,GASTROINTESTINAL SOUNDS ABNORMAL,1
CR,GENITAL HERPES,1
CR,GINGIVAL BLEEDING,1
CR,GINGIVAL DISORDER,1
CR,GINGIVITIS,1
CR,GLOSSODYNIA,1
CR,GRANULOMATOSIS WITH POLYANGIITIS,1
CR,GRIP STRENGTH DECREASED,1
CR,GROIN PAIN,1
CR,HAEMATOCRIT ABNORMAL,1
CR,HAEMATOCRIT DECREASED,1
CR,HAEMATOLOGICAL MALIGNANCY,1
CR,HAEMOPTYSIS,1
CR,HAEMORRHAGIC CYST,1
CR,HEART RATE IRREGULAR,1
CR,HEART VALVE INCOMPETENCE,1
CR,HEAT ILLNESS,1
CR,HEAT STROKE,1
CR,HELICOBACTER INFECTION,1
CR,HELICOBACTER TEST POSITIVE,1
CR,HEMIANAESTHESIA,1
CR,HEMIPLEGIA,1
CR,HEPATIC ADENOMA,1
CR,HEPATIC CIRRHOSIS,1
CR,HEPATITIS ACUTE,1
CR,HEPATITIS TOXIC,1
CR,HEPATOBILIARY CANCER,1
CR,HEPATOCELLULAR CARCINOMA,1
CR,HEPATOMEGALY,1
CR,HIGH DENSITY LIPOPROTEIN DECREASED,1
CR,HODGKIN^S DISEASE,1
CR,HOT FLUSH,1
CR,HYDROCEPHALUS,1
CR,HYPERAMMONAEMIA,1
CR,HYPEREMESIS GRAVIDARUM,1
CR,HYPERSOMNIA,1
CR,HYPERTENSIVE CARDIOMYOPATHY,1
CR,HYPERTHERMIA,1
CR,HYPERTHYROIDISM,1
CR,HYPOMENORRHOEA,1
CR,HYPONATRAEMIA,1
CR,HYPOVITAMINOSIS,1
CR,HYPOXIA,1
CR,ILEUS PARALYTIC,1
CR,IMMATURE RESPIRATORY SYSTEM,1
CR,IMMOBILE,1
CR,IMMUNE SYSTEM DISORDER,1
CR,IMPAIRED HEALING,1
CR,IMPAIRED REASONING,1
CR,IMPATIENCE,1
CR,IMPLANT SITE ABSCESS,1
CR,INCARCERATED HERNIA,1
CR,INCISION SITE SWELLING,1
CR,INCISIONAL DRAINAGE,1
CR,INCOHERENT,1
CR,INCORRECT DOSAGE ADMINISTERED,1
CR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CR,INFECTION SUSCEPTIBILITY INCREASED,1
CR,INFERIORITY COMPLEX,1
CR,INHIBITORY DRUG INTERACTION,1
CR,INJECTION SITE CELLULITIS,1
CR,INJECTION SITE DISCOLOURATION,1
CR,INJECTION SITE DISCOMFORT,1
CR,INJECTION SITE PARAESTHESIA,1
CR,INJECTION SITE REACTION,1
CR,INSULIN-LIKE GROWTH FACTOR INCREASED,1
CR,INTENTIONAL PRODUCT USE ISSUE,1
CR,INTENTIONAL SELF-INJURY,1
CR,INTENTIONAL UNDERDOSE,1
CR,INTERMITTENT CLAUDICATION,1
CR,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
CR,INTERNATIONAL NORMALISED RATIO INCREASED,1
CR,INTESTINAL HAEMORRHAGE,1
CR,INTESTINAL ISCHAEMIA,1
CR,INTESTINAL MASS,1
CR,INTESTINAL POLYP,1
CR,INTESTINAL STENOSIS,1
CR,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
CR,INTRUSIVE THOUGHTS,1
CR,INVASIVE DUCTAL BREAST CARCINOMA,1
CR,IRON DEFICIENCY,1
CR,IRON DEFICIENCY ANAEMIA,1
CR,IRRITABILITY,1
CR,ISCHAEMIC CARDIOMYOPATHY,1
CR,JUGULAR VEIN THROMBOSIS,1
CR,KETOSIS,1
CR,KNEE ARTHROPLASTY,1
CR,KNEE DEFORMITY,1
CR,KNEE OPERATION,1
CR,LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR,1
CR,LACERATION,1
CR,LACRIMATION INCREASED,1
CR,LACTIC ACIDOSIS,1
CR,LACTOSE INTOLERANCE,1
CR,LANGUAGE DISORDER,1
CR,LARGE INTESTINE PERFORATION,1
CR,LARGE INTESTINE POLYP,1
CR,LARYNGEAL STENOSIS,1
CR,LAZINESS,1
CR,LEFT VENTRICULAR DYSFUNCTION,1
CR,LEG AMPUTATION,1
CR,LENTIGO MALIGNA,1
CR,LETHARGY,1
CR,LIGAMENT DISORDER,1
CR,LIGAMENT SPRAIN,1
CR,LIMB OPERATION,1
CR,LIP DRY,1
CR,LIP OEDEMA,1
CR,LIPOINJECTION,1
CR,LIPOMA,1
CR,LIVER INJURY,1
CR,LOWER GASTROINTESTINAL HAEMORRHAGE,1
CR,LOWER RESPIRATORY TRACT INFECTION,1
CR,LUNG CANCER METASTATIC,1
CR,LYME DISEASE,1
CR,LYMPHADENOPATHY MEDIASTINAL,1
CR,LYMPHOCYTE PERCENTAGE INCREASED,1
CR,LYMPHOCYTOSIS,1
CR,LYMPHOEDEMA,1
CR,LYMPHOPENIA,1
CR,MACROGLOSSIA,1
CR,MACULAR OEDEMA,1
CR,MALIGNANT MELANOMA,1
CR,MALIGNANT NEOPLASM OF AMPULLA OF VATER,1
CR,MASS,1
CR,MEAN CELL VOLUME DECREASED,1
CR,MEAN PLATELET VOLUME INCREASED,1
CR,MELANOCYTIC NAEVUS,1
CR,MENINGITIS BACTERIAL,1
CR,MENSTRUATION DELAYED,1
CR,MENTAL IMPAIRMENT,1
CR,MESENTERIC ARTERY THROMBOSIS,1
CR,METABOLIC SYNDROME,1
CR,METAMYELOCYTE COUNT INCREASED,1
CR,METASTASES TO SPINE,1
CR,METASTASES TO TRACHEA,1
CR,MIDDLE INSOMNIA,1
CR,MONOCLONAL GAMMOPATHY,1
CR,MONOCYTE COUNT INCREASED,1
CR,MONOCYTE PERCENTAGE INCREASED,1
CR,MONOCYTOSIS,1
CR,MONOPLEGIA,1
CR,MOOD ALTERED,1
CR,MOUTH INJURY,1
CR,MUSCLE CONTRACTURE,1
CR,MUSCLE DISORDER,1
CR,MUSCLE RIGIDITY,1
CR,MUSCLE SPASTICITY,1
CR,MUSCULOSKELETAL DISCOMFORT,1
CR,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
CR,MYELITIS,1
CR,MYELOPROLIFERATIVE NEOPLASM,1
CR,MYOCARDIAL NECROSIS,1
CR,MYOCARDITIS,1
CR,NASAL PRURITUS,1
CR,NECROTISING FASCIITIS,1
CR,NEPHROLITHIASIS,1
CR,NERVE COMPRESSION,1
CR,NERVOUS SYSTEM DISORDER,1
CR,NERVOUS SYSTEM NEOPLASM,1
CR,NEURITIS,1
CR,NEUTROPHIL COUNT INCREASED,1
CR,NEUTROPHILIA,1
CR,NIGHT SWEATS,1
CR,NIGHTMARE,1
CR,NORMAL NEWBORN,1
CR,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
CI,ABORTION SPONTANEOUS,31
CI,DEATH,17
CI,STILLBIRTH,13
CI,ABORTION INDUCED,11
CI,MATERNAL EXPOSURE DURING PREGNANCY,8
CI,BLINDNESS,5
CI,HEADACHE,5
CI,FOETAL EXPOSURE DURING PREGNANCY,4
CI,ASTHENIA,3
CI,DEATH NEONATAL,3
CI,DIZZINESS,3
CI,DRUG RESISTANCE,3
CI,HEPATOCELLULAR INJURY,3
CI,LIPOMA,3
CI,MALARIA,3
CI,MUCORMYCOSIS,3
CI,MYALGIA,3
CI,PYREXIA,3
CI,SWELLING FACE,3
CI,TENDONITIS,3
CI,ANGINA PECTORIS,2
CI,CHYLOTHORAX,2
CI,DECREASED APPETITE,2
CI,DELIRIUM,2
CI,DRUG INEFFECTIVE,2
CI,EXOMPHALOS,2
CI,GASTROINTESTINAL HAEMORRHAGE,2
CI,HICCUPS,2
CI,INTENTIONAL PRODUCT MISUSE,2
CI,METASTATIC NEOPLASM,2
CI,OVERDOSE,2
CI,RENAL FAILURE,2
CI,TUBERCULOSIS,2
CI,ULCER,2
CI,ABDOMINAL PAIN,1
CI,ABORTION THREATENED,1
CI,ANGIOEDEMA,1
CI,APATHY,1
CI,APPARENT DEATH,1
CI,BONE NEOPLASM,1
CI,BRAIN NEOPLASM,1
CI,CARDIAC ARREST,1
CI,CHOLECYSTITIS ACUTE,1
CI,CHOLESTASIS,1
CI,CHRONIC RESPIRATORY FAILURE,1
CI,COAGULOPATHY,1
CI,COMA,1
CI,CONFUSIONAL STATE,1
CI,CONJUNCTIVAL HYPERAEMIA,1
CI,COR PULMONALE CHRONIC,1
CI,DERMATITIS ALLERGIC,1
CI,DIASTOLIC DYSFUNCTION,1
CI,DISCOMFORT,1
CI,DYSPNOEA,1
CI,ENCEPHALOPATHY,1
CI,EYE BURNS,1
CI,EYE IRRITATION,1
CI,EYELID OEDEMA,1
CI,EYELID PTOSIS,1
CI,GASTROINTESTINAL DISORDER,1
CI,GENERAL PHYSICAL CONDITION ABNORMAL,1
CI,GINGIVAL EROSION,1
CI,GINGIVAL HYPERPLASIA,1
CI,GINGIVAL PAIN,1
CI,GINGIVITIS,1
CI,HAEMORRHAGE,1
CI,HAEMORRHAGIC DIATHESIS,1
CI,HALLUCINATION,1
CI,HEPATIC ENZYME INCREASED,1
CI,HEPATIC NEOPLASM,1
CI,HYPERCREATINAEMIA,1
CI,HYPERCREATININAEMIA,1
CI,HYPERGLYCAEMIA,1
CI,HYPERSOMNIA,1
CI,HYPERTENSION,1
CI,INCORRECT DOSE ADMINISTERED,1
CI,INFLUENZA LIKE ILLNESS,1
CI,INSOMNIA,1
CI,INVASIVE LOBULAR BREAST CARCINOMA,1
CI,JAUNDICE,1
CI,LACRIMATION INCREASED,1
CI,LEFT ATRIAL DILATATION,1
CI,LEUKOPENIA,1
CI,LIMB DEFORMITY,1
CI,LIMB DISCOMFORT,1
CI,LOCAL SWELLING,1
CI,LOSS OF CONSCIOUSNESS,1
CI,LOW BIRTH WEIGHT BABY,1
CI,LYMPHOPENIA,1
CI,MUCOSAL INFLAMMATION,1
CI,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CI,MULTIPLE-DRUG RESISTANCE,1
CI,MUSCULOSKELETAL DISCOMFORT,1
CI,NAUSEA,1
CI,NEONATAL DISORDER,1
CI,NEPHROTIC SYNDROME,1
CI,NEUTROPENIA,1
CI,NIGHTMARE,1
CI,NONINFECTIVE GINGIVITIS,1
CI,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
CI,OCULAR DISCOMFORT,1
CI,OCULAR HYPERAEMIA,1
CI,ORAL DISCOMFORT,1
CI,PAIN,1
CI,PATHOGEN RESISTANCE,1
CI,PHOTOPHOBIA,1
CI,PNEUMONIA,1
CI,PNEUMONITIS,1
CI,PNEUMOTHORAX,1
CI,PREGNANCY,1
CI,PREMATURE BABY,1
CI,PRURITUS,1
CI,RENAL TUBERCULOSIS,1
CI,SEIZURE,1
CI,SKIN EXFOLIATION,1
CI,TOXOPLASMOSIS,1
CI,TREATMENT FAILURE,1
CI,VISUAL ACUITY REDUCED,1
CI,VISUAL FIELD DEFECT,1
CI,VOMITING,1
CI,WEIGHT INCREASED,1
HR,SUICIDE ATTEMPT,452
HR,INTENTIONAL OVERDOSE,354
HR,SOMNOLENCE,242
HR,DYSPNOEA,163
HR,HYPOTENSION,121
HR,PYREXIA,120
HR,ASTHENIA,119
HR,ERYTHEMA,119
HR,LOSS OF CONSCIOUSNESS,119
HR,DIARRHOEA,114
HR,NAUSEA,111
HR,DEATH,104
HR,FATIGUE,99
HR,VOMITING,91
HR,MALIGNANT NEOPLASM PROGRESSION,89
HR,FEBRILE NEUTROPENIA,88
HR,DRUG INEFFECTIVE,87
HR,PRURITUS,85
HR,HEADACHE,79
HR,TACHYCARDIA,79
HR,COMA,70
HR,THROMBOCYTOPENIA,66
HR,DIZZINESS,65
HR,ANAEMIA,64
HR,ABDOMINAL PAIN,62
HR,NEUTROPENIA,58
HR,CONFUSIONAL STATE,57
HR,RASH,57
HR,CHEST DISCOMFORT,56
HR,HYPERSENSITIVITY,54
HR,CHOKING,51
HR,COUGH,51
HR,RHABDOMYOLYSIS,49
HR,MUSCLE SPASMS,48
HR,OEDEMA PERIPHERAL,48
HR,RESPIRATORY FAILURE,48
HR,NO ADVERSE EVENT,47
HR,TOXICITY TO VARIOUS AGENTS,47
HR,CHEST PAIN,46
HR,MALAISE,46
HR,PNEUMONIA,45
HR,URTICARIA,45
HR,GAIT DISTURBANCE,43
HR,HYPERTENSION,43
HR,LEUKOPENIA,43
HR,CHILLS,41
HR,DECREASED APPETITE,41
HR,PLEURAL EFFUSION,41
HR,SYNCOPE,41
HR,METASTASES TO BONE,40
HR,INSOMNIA,38
HR,RENAL FAILURE,38
HR,BLOOD PRESSURE DECREASED,37
HR,BLOOD PRESSURE INCREASED,37
HR,CARDIAC FAILURE,37
HR,HYPERHIDROSIS,37
HR,OVERDOSE,37
HR,RESTLESSNESS,37
HR,AGITATION,36
HR,DISEASE PROGRESSION,36
HR,MYALGIA,36
HR,ACUTE KIDNEY INJURY,35
HR,ARTHRALGIA,35
HR,HAEMATOCHEZIA,35
HR,PAIN IN EXTREMITY,35
HR,BRADYCARDIA,34
HR,METASTASES TO LIVER,34
HR,EXTRAPYRAMIDAL DISORDER,33
HR,MUSCULAR WEAKNESS,33
HR,PARAESTHESIA,33
HR,SEPSIS,33
HR,PAIN,32
HR,PSYCHOTIC DISORDER,32
HR,ATRIAL FIBRILLATION,31
HR,DISORIENTATION,31
HR,DYSPHAGIA,31
HR,GENERAL PHYSICAL HEALTH DETERIORATION,31
HR,MELAENA,31
HR,PALPITATIONS,31
HR,WEIGHT DECREASED,31
HR,ALTERED STATE OF CONSCIOUSNESS,30
HR,BODY TEMPERATURE INCREASED,30
HR,TREMOR,30
HR,VERTIGO,30
HR,C-REACTIVE PROTEIN INCREASED,29
HR,JOINT SWELLING,29
HR,TREATMENT NONCOMPLIANCE,29
HR,BACK PAIN,28
HR,HEPATIC ENZYME INCREASED,28
HR,AGGRESSION,27
HR,ANAPHYLACTIC REACTION,27
HR,ANXIETY,27
HR,BREAST CANCER METASTATIC,27
HR,CONSTIPATION,27
HR,DRY MOUTH,27
HR,EYELID OEDEMA,27
HR,FOETAL EXPOSURE DURING PREGNANCY,27
HR,HAEMATOMA,27
HR,ASPARTATE AMINOTRANSFERASE INCREASED,26
HR,PANCYTOPENIA,26
HR,VISION BLURRED,26
HR,ALANINE AMINOTRANSFERASE INCREASED,25
HR,ANGIOEDEMA,25
HR,DYSARTHRIA,25
HR,HAEMATURIA,25
HR,URINARY RETENTION,25
HR,URINARY TRACT INFECTION,25
HR,ABDOMINAL PAIN UPPER,24
HR,BREAST CANCER,24
HR,DEPRESSION,24
HR,FACE OEDEMA,24
HR,HYPOAESTHESIA,24
HR,PALLOR,24
HR,SEIZURE,24
HR,CARDIO-RESPIRATORY ARREST,23
HR,FALL,23
HR,MYOCARDIAL INFARCTION,23
HR,PULMONARY EMBOLISM,23
HR,RASH MACULO-PAPULAR,23
HR,SCHIZOPHRENIA,23
HR,ARRHYTHMIA,22
HR,CEREBROVASCULAR ACCIDENT,22
HR,EPISTAXIS,22
HR,FEELING HOT,22
HR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,22
HR,PANCREATITIS ACUTE,22
HR,RECTAL HAEMORRHAGE,22
HR,ANGINA PECTORIS,21
HR,BLOOD CREATININE INCREASED,21
HR,DEHYDRATION,21
HR,SEDATION,21
HR,SEPTIC SHOCK,21
HR,TOXIC EPIDERMAL NECROLYSIS,21
HR,ASPHYXIA,20
HR,CONDITION AGGRAVATED,20
HR,HAEMOGLOBIN DECREASED,20
HR,HEART RATE INCREASED,20
HR,HYPOGLYCAEMIA,20
HR,LEUKOCYTOSIS,20
HR,PERIPHERAL SWELLING,20
HR,SPEECH DISORDER,20
HR,SWELLING FACE,20
HR,BRONCHOSPASM,19
HR,NEUROLEPTIC MALIGNANT SYNDROME,19
HR,OEDEMA,19
HR,SUICIDAL IDEATION,19
HR,DIABETIC KETOACIDOSIS,18
HR,DYSKINESIA,18
HR,EPILEPSY,18
HR,INTERNATIONAL NORMALISED RATIO INCREASED,18
HR,RASH GENERALISED,18
HR,DEEP VEIN THROMBOSIS,17
HR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,17
HR,LIP SWELLING,17
HR,ALOPECIA,16
HR,CEREBRAL HAEMORRHAGE,16
HR,LACTIC ACIDOSIS,16
HR,MULTI-ORGAN FAILURE,16
HR,MUSCULOSKELETAL STIFFNESS,16
HR,OXYGEN SATURATION DECREASED,16
HR,WEIGHT INCREASED,16
HR,ACUTE MYOCARDIAL INFARCTION,15
HR,DRUG ABUSE,15
HR,DRY SKIN,15
HR,EXPOSURE DURING PREGNANCY,15
HR,FEELING ABNORMAL,15
HR,FLATULENCE,15
HR,HAEMOPTYSIS,15
HR,LIP OEDEMA,15
HR,METASTASES TO LUNG,15
HR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,15
HR,NEUROPATHY PERIPHERAL,15
HR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,15
HR,RESPIRATORY DEPRESSION,15
HR,RHEUMATOID ARTHRITIS,15
HR,ASCITES,14
HR,ATAXIA,14
HR,BLOOD CREATINE PHOSPHOKINASE INCREASED,14
HR,BLOOD GLUCOSE INCREASED,14
HR,CHOKING SENSATION,14
HR,DIABETES MELLITUS,14
HR,GASTROINTESTINAL HAEMORRHAGE,14
HR,HAEMORRHAGE,14
HR,HEPATOTOXICITY,14
HR,HYPERGLYCAEMIA,14
HR,LIVER INJURY,14
HR,MIOSIS,14
HR,OROPHARYNGEAL PAIN,14
HR,POLYNEUROPATHY,14
HR,PRODUCT USE ISSUE,14
HR,SOPOR,14
HR,SWOLLEN TONGUE,14
HR,TINNITUS,14
HR,TRANSAMINASES INCREASED,14
HR,ANAPHYLACTIC SHOCK,13
HR,APHTHOUS STOMATITIS,13
HR,BONE PAIN,13
HR,BURNING SENSATION,13
HR,CANDIDA INFECTION,13
HR,CHRONIC KIDNEY DISEASE,13
HR,CONTUSION,13
HR,DRUG HYPERSENSITIVITY,13
HR,GASTROINTESTINAL DISORDER,13
HR,HEMIPARESIS,13
HR,INTERSTITIAL LUNG DISEASE,13
HR,MOBILITY DECREASED,13
HR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,13
HR,POISONING,13
HR,ABDOMINAL DISTENSION,12
HR,ABORTION SPONTANEOUS,12
HR,BLISTER,12
HR,BLOOD BILIRUBIN INCREASED,12
HR,GENERALISED ERYTHEMA,12
HR,HEPATIC LESION,12
HR,INFLAMMATION,12
HR,INFUSION RELATED REACTION,12
HR,MATERNAL EXPOSURE DURING PREGNANCY,12
HR,METASTASES TO LYMPH NODES,12
HR,NIGHTMARE,12
HR,OCULAR HYPERAEMIA,12
HR,OLIGURIA,12
HR,PLATELET COUNT DECREASED,12
HR,AMNESIA,11
HR,AMYLASE INCREASED,11
HR,APATHY,11
HR,APHASIA,11
HR,BLOOD CHOLESTEROL INCREASED,11
HR,BLOOD UREA INCREASED,11
HR,CARDIAC ARREST,11
HR,CLOSTRIDIUM DIFFICILE INFECTION,11
HR,COLD SWEAT,11
HR,DELIRIUM,11
HR,EYE SWELLING,11
HR,HYPERTENSIVE CRISIS,11
HR,HYPONATRAEMIA,11
HR,HYPOTHERMIA,11
HR,HYPOTONIA,11
HR,ISCHAEMIC STROKE,11
HR,LYMPHADENOPATHY,11
HR,MALIGNANT MELANOMA,11
HR,MICROCYTIC ANAEMIA,11
HR,NECROTISING OESOPHAGITIS,11
HR,PRURITUS GENERALISED,11
HR,PULMONARY OEDEMA,11
HR,RASH MACULAR,11
HR,RENAL FAILURE ACUTE,11
HR,STOMATITIS,11
HR,WHITE BLOOD CELL COUNT DECREASED,11
HR,ACCIDENTAL OVERDOSE,10
HR,ANURIA,10
HR,BRAIN OEDEMA,10
HR,COGNITIVE DISORDER,10
HR,DERMATITIS,10
HR,DRUG PRESCRIBING ERROR,10
HR,DYSGEUSIA,10
HR,DYSTONIA,10
HR,HYPERKALAEMIA,10
HR,LOCAL SWELLING,10
HR,MENTAL DISORDER,10
HR,MUSCLE RIGIDITY,10
HR,PERICARDIAL EFFUSION,10
HR,RED BLOOD CELL COUNT DECREASED,10
HR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,10
HR,RENAL IMPAIRMENT,10
HR,STEVENS-JOHNSON SYNDROME,10
HR,THROAT IRRITATION,10
HR,VISUAL IMPAIRMENT,10
HR,ACUTE RESPIRATORY FAILURE,9
HR,CELLULITIS,9
HR,DEPRESSED LEVEL OF CONSCIOUSNESS,9
HR,DIPLOPIA,9
HR,DRUG DOSE OMISSION,9
HR,DRUG-INDUCED LIVER INJURY,9
HR,DYSPEPSIA,9
HR,DYSPNOEA EXERTIONAL,9
HR,ENTEROCOLITIS,9
HR,ERYTHEMA MULTIFORME,9
HR,EYE PRURITUS,9
HR,HAEMOTHORAX,9
HR,HALLUCINATION,9
HR,HERPES ZOSTER,9
HR,HYPERBILIRUBINAEMIA,9
HR,MEDICATION ERROR,9
HR,MYDRIASIS,9
HR,PELVIC PAIN,9
HR,PHARYNGEAL OEDEMA,9
HR,PRODUCT USE IN UNAPPROVED INDICATION,9
HR,RESPIRATORY TRACT INFECTION,9
HR,STAPHYLOCOCCAL SEPSIS,9
HR,STUPOR,9
HR,SWELLING,9
HR,TENSION,9
HR,TRANSIENT ISCHAEMIC ATTACK,9
HR,AKATHISIA,8
HR,APHTHOUS ULCER,8
HR,BALANCE DISORDER,8
HR,BLOOD ALKALINE PHOSPHATASE INCREASED,8
HR,BLOOD URIC ACID INCREASED,8
HR,BLOOD URINE PRESENT,8
HR,CONJUNCTIVAL HYPERAEMIA,8
HR,COPPER DEFICIENCY,8
HR,CYANOSIS,8
HR,DELUSION,8
HR,DERMATITIS BULLOUS,8
HR,DRUG EFFECT INCOMPLETE,8
HR,DRUG INTOLERANCE,8
HR,DYSPHONIA,8
HR,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,8
HR,ERECTILE DYSFUNCTION,8
HR,EYE IRRITATION,8
HR,FEAR,8
HR,GANGRENE,8
HR,HAEMATEMESIS,8
HR,HEAD DISCOMFORT,8
HR,HEART RATE IRREGULAR,8
HR,HYPOAESTHESIA ORAL,8
HR,INFECTION,8
HR,LACRIMATION INCREASED,8
HR,NEUROTOXICITY,8
HR,NORMOCHROMIC NORMOCYTIC ANAEMIA,8
HR,ORAL HERPES,8
HR,PARAESTHESIA ORAL,8
HR,PETECHIAE,8
HR,POLYARTHRITIS,8
HR,POST-INJECTION DELIRIUM SEDATION SYNDROME,8
HR,PROTEINURIA,8
HR,PSYCHOMOTOR SKILLS IMPAIRED,8
HR,RASH PUSTULAR,8
HR,SINUS TACHYCARDIA,8
HR,SKIN EXFOLIATION,8
HR,SUFFOCATION FEELING,8
HR,TONGUE OEDEMA,8
HR,TRANSPLANT REJECTION,8
HR,WHEEZING,8
HR,ACUTE PROMYELOCYTIC LEUKAEMIA,7
HR,ANKYLOSING SPONDYLITIS,7
HR,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,7
HR,AZOTAEMIA,7
HR,BLINDNESS,7
HR,CEREBRAL ISCHAEMIA,7
HR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,7
HR,COMPLICATIONS OF TRANSPLANTED KIDNEY,7
HR,DISTURBANCE IN ATTENTION,7
HR,DRUG EFFECT DECREASED,7
HR,DUODENAL ULCER,7
HR,ELECTROCARDIOGRAM QT PROLONGED,7
HR,EOSINOPHILIA,7
HR,FOOT FRACTURE,7
HR,GASTRIC ULCER,7
HR,HAEMATOCRIT DECREASED,7
HR,HYPERCALCAEMIA,7
HR,HYPOXIA,7
HR,ILEUS,7
HR,INFLAMMATORY MARKER INCREASED,7
HR,INFLUENZA LIKE ILLNESS,7
HR,JOINT DISLOCATION,7
HR,LUNG INFILTRATION,7
HR,MEMORY IMPAIRMENT,7
HR,MITRAL VALVE INCOMPETENCE,7
HR,PATHOLOGICAL FRACTURE,7
HR,PRODUCTIVE COUGH,7
HR,RHINORRHOEA,7
HR,SEROTONIN SYNDROME,7
HR,SINUSITIS,7
HR,UPPER GASTROINTESTINAL HAEMORRHAGE,7
HR,ABASIA,6
HR,ABDOMINAL DISCOMFORT,6
HR,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,6
HR,ACCIDENTAL POISONING,6
HR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,6
HR,AGEUSIA,6
HR,ALCOHOL ABUSE,6
HR,ARTHRITIS,6
HR,BASAL CELL CARCINOMA,6
HR,BLOOD LACTATE DEHYDROGENASE INCREASED,6
HR,BRONCHITIS,6
HR,CARDIOMYOPATHY,6
HR,CATARACT,6
HR,CEREBRAL INFARCTION,6
HR,COAGULOPATHY,6
HR,COMPLETED SUICIDE,6
HR,CONCOMITANT DISEASE AGGRAVATED,6
HR,COORDINATION ABNORMAL,6
HR,CRYING,6
HR,DYSMORPHISM,6
HR,DYSURIA,6
HR,EMBOLISM,6
HR,ENDOCARDITIS,6
HR,ERYTHEMA OF EYELID,6
HR,FAECES DISCOLOURED,6
HR,FOETAL GROWTH RESTRICTION,6
HR,GASTRITIS,6
HR,GASTRITIS EROSIVE,6
HR,GASTROOESOPHAGEAL REFLUX DISEASE,6
HR,GENITAL ULCERATION,6
HR,GINGIVITIS,6
HR,HAEMODYNAMIC INSTABILITY,6
HR,HALLUCINATIONS_ MIXED,6
HR,HEAD INJURY,6
HR,HEMIPLEGIA,6
HR,HEPATIC FAILURE,6
HR,HYPOTHYROIDISM,6
HR,IGA NEPHROPATHY,6
HR,ILEUS PARALYTIC,6
HR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,6
HR,INCORRECT DOSE ADMINISTERED,6
HR,INCORRECT ROUTE OF DRUG ADMINISTRATION,6
HR,INTESTINAL HAEMORRHAGE,6
HR,INVASIVE LOBULAR BREAST CARCINOMA,6
HR,IRRITABILITY,6
HR,KLEBSIELLA INFECTION,6
HR,MENTAL STATUS CHANGES,6
HR,MUSCLE ATROPHY,6
HR,MUSCULOSKELETAL PAIN,6
HR,MYELODYSPLASTIC SYNDROME,6
HR,MYOPATHY,6
HR,NASAL CONGESTION,6
HR,NEPHROLITHIASIS,6
HR,NERVOUS SYSTEM DISORDER,6
HR,ODYNOPHAGIA,6
HR,OSTEONECROSIS OF JAW,6
HR,OSTEOPOROSIS,6
HR,PARESIS,6
HR,PERITONITIS,6
HR,PLEUROTHOTONUS,6
HR,PNEUMONITIS,6
HR,POOR QUALITY SLEEP,6
HR,PSEUDOMONAS INFECTION,6
HR,PSORIASIS,6
HR,PSYCHOMOTOR HYPERACTIVITY,6
HR,PULMONARY HYPERTENSION,6
HR,PUPILS UNEQUAL,6
HR,RESPIRATORY ACIDOSIS,6
HR,SALIVARY HYPERSECRETION,6
HR,SECRETION DISCHARGE,6
HR,SLUGGISHNESS,6
HR,SUBDURAL HAEMATOMA,6
HR,SUPRAVENTRICULAR TACHYCARDIA,6
HR,TACHYPNOEA,6
HR,UROSEPSIS,6
HR,VENOUS THROMBOSIS,6
HR,ABNORMAL BEHAVIOUR,5
HR,ACCIDENTAL EXPOSURE TO PRODUCT,5
HR,ACIDOSIS,5
HR,ACTIVITIES OF DAILY LIVING IMPAIRED,5
HR,ACUTE RESPIRATORY DISTRESS SYNDROME,5
HR,AGRANULOCYTOSIS,5
HR,ANAL INCONTINENCE,5
HR,ASTHMA,5
HR,ATRIAL SEPTAL DEFECT,5
HR,BLOOD POTASSIUM INCREASED,5
HR,BLOOD TRIGLYCERIDES INCREASED,5
HR,BONE EROSION,5
HR,CARDIAC DISORDER,5
HR,COLITIS,5
HR,COLITIS ULCERATIVE,5
HR,COMMUNICATION DISORDER,5
HR,CONJUNCTIVITIS,5
HR,DIARRHOEA HAEMORRHAGIC,5
HR,DIFFUSE LARGE B-CELL LYMPHOMA,5
HR,DISCOMFORT,5
HR,DRUG DEPENDENCE,5
HR,EOSINOPHIL PERCENTAGE INCREASED,5
HR,ESCHERICHIA INFECTION,5
HR,FOETAL DEATH,5
HR,GENERALISED OEDEMA,5
HR,GENERALISED TONIC-CLONIC SEIZURE,5
HR,GLOMERULAR FILTRATION RATE DECREASED,5
HR,HAEMORRHAGIC ANAEMIA,5
HR,HAEMORRHAGIC DIATHESIS,5
HR,HAEMORRHOIDS,5
HR,HEPATOCELLULAR CARCINOMA,5
HR,HISTIOCYTOSIS HAEMATOPHAGIC,5
HR,HYPERLIPIDAEMIA,5
HR,HYPERPYREXIA,5
HR,HYPERTHYROIDISM,5
HR,HYPERTRIGLYCERIDAEMIA,5
HR,HYPOKALAEMIA,5
HR,HYPOPNOEA,5
HR,INCREASED APPETITE,5
HR,INFARCTION,5
HR,KIDNEY TRANSPLANT REJECTION,5
HR,LARYNGEAL OEDEMA,5
HR,LOCALISED OEDEMA,5
HR,MENTAL IMPAIRMENT,5
HR,METABOLIC ACIDOSIS,5
HR,METASTASES TO CENTRAL NERVOUS SYSTEM,5
HR,METASTASES TO THE MEDIASTINUM,5
HR,METASTASIS,5
HR,MOOD ALTERED,5
HR,MUSCLE TWITCHING,5
HR,MYCOBACTERIAL INFECTION,5
HR,NAIL DISCOLOURATION,5
HR,NASOPHARYNGITIS,5
HR,OEDEMA MUCOSAL,5
HR,PARAPARESIS,5
HR,PARKINSONISM,5
HR,PARKINSON^S DISEASE,5
HR,PERIORBITAL OEDEMA,5
HR,PERIPHERAL SENSORY NEUROPATHY,5
HR,PLASMA CELL MYELOMA,5
HR,PNEUMOTHORAX,5
HR,POLLAKIURIA,5
HR,POLYDIPSIA,5
HR,PREGNANCY ON ORAL CONTRACEPTIVE,5
HR,PSYCHOMOTOR RETARDATION,5
HR,PTERYGIUM,5
HR,RASH PAPULAR,5
HR,RASH PRURITIC,5
HR,RENAL TUBULAR NECROSIS,5
HR,RESPIRATORY ARREST,5
HR,SHOCK HAEMORRHAGIC,5
HR,SKIN LESION,5
HR,SKIN REACTION,5
HR,SKIN TURGOR DECREASED,5
HR,SKIN ULCER,5
HR,SKULL FRACTURE,5
HR,SMALL INTESTINAL PERFORATION,5
HR,SPINAL PAIN,5
HR,STAPHYLOCOCCAL INFECTION,5
HR,STOMA SITE ERYTHEMA,5
HR,THERAPEUTIC RESPONSE DECREASED,5
HR,THROAT TIGHTNESS,5
HR,URINARY INCONTINENCE,5
HR,UVEITIS,5
HR,VAGINAL HAEMORRHAGE,5
HR,VENTRICULAR TACHYCARDIA,5
HR,ABDOMINAL PAIN LOWER,4
HR,ACNE,4
HR,APNOEA,4
HR,APPENDICECTOMY,4
HR,APPLICATION SITE ERYTHEMA,4
HR,APPLICATION SITE SWELLING,4
HR,APTYALISM,4
HR,BLOOD CHLORIDE DECREASED,4
HR,BLOOD PH DECREASED,4
HR,BLOOD POTASSIUM DECREASED,4
HR,BODY HEIGHT BELOW NORMAL,4
HR,BODY TEMPERATURE DECREASED,4
HR,BRAIN STEM HAEMORRHAGE,4
HR,BUNDLE BRANCH BLOCK RIGHT,4
HR,BURSITIS,4
HR,CARDIOGENIC SHOCK,4
HR,CHOLANGITIS ACUTE,4
HR,CHOLELITHIASIS,4
HR,CLOSTRIDIUM TEST POSITIVE,4
HR,COLORECTAL CANCER METASTATIC,4
HR,COMPRESSION FRACTURE,4
HR,CONGESTIVE CARDIOMYOPATHY,4
HR,CORONARY ARTERY OCCLUSION,4
HR,CROHN^S DISEASE,4
HR,CYTOMEGALOVIRUS TEST POSITIVE,4
HR,CYTOPENIA,4
HR,DERMATITIS ACNEIFORM,4
HR,DRUG ADMINISTRATION ERROR,4
HR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,4
HR,DRUG RESISTANCE,4
HR,DRY EYE,4
HR,EAR PAIN,4
HR,ECTOPIC PREGNANCY,4
HR,ECZEMA,4
HR,ENTEROCOCCAL INFECTION,4
HR,ESCHERICHIA TEST POSITIVE,4
HR,EXERCISE TOLERANCE DECREASED,4
HR,EYE HAEMORRHAGE,4
HR,EYE PAIN,4
HR,EYELID IRRITATION,4
HR,FEELING COLD,4
HR,HAEMARTHROSIS,4
HR,HALLUCINATION_ AUDITORY,4
HR,HEPATITIS TOXIC,4
HR,HEPATOMEGALY,4
HR,HYPERPROLACTINAEMIA,4
HR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,4
HR,ISCHAEMIC CARDIOMYOPATHY,4
HR,JAUNDICE,4
HR,KLEBSIELLA TEST POSITIVE,4
HR,LIMB DISCOMFORT,4
HR,LIVER DISORDER,4
HR,LUNG NEOPLASM MALIGNANT,4
HR,LYMPHOMA,4
HR,METASTASES TO NECK,4
HR,METASTASES TO PERITONEUM,4
HR,METASTASES TO PLEURA,4
HR,METASTASES TO THORAX,4
HR,MICTURITION DISORDER,4
HR,MOUTH ULCERATION,4
HR,MUCOUS STOOLS,4
HR,MUSCLE TIGHTNESS,4
HR,MUSCULOSKELETAL CHEST PAIN,4
HR,MUTISM,4
HR,MYASTHENIA GRAVIS,4
HR,NEOPLASM MALIGNANT,4
HR,NEPHROPATHY TOXIC,4
HR,NERVOUSNESS,4
HR,NEUROLOGICAL SYMPTOM,4
HR,NEUROMYOPATHY,4
HR,ORAL DISCOMFORT,4
HR,ORAL DISORDER,4
HR,PALMAR ERYTHEMA,4
HR,PARANOIA,4
HR,PCO2 DECREASED,4
HR,PENILE ULCERATION,4
HR,PERIPHERAL COLDNESS,4
HR,PERIPHERAL ISCHAEMIA,4
HR,PERIPHERAL SENSORIMOTOR NEUROPATHY,4
HR,PHOSPHOLIPIDOSIS,4
HR,PNEUMONIA KLEBSIELLA,4
HR,PO2 INCREASED,4
HR,POISONING DELIBERATE,4
HR,POLYURIA,4
HR,POST PROCEDURAL OEDEMA,4
HR,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,4
HR,PROSTATE CANCER,4
HR,PSEUDOMEMBRANOUS COLITIS,4
HR,PSORIATIC ARTHROPATHY,4
HR,QUADRIPLEGIA,4
HR,RASH ERYTHEMATOUS,4
HR,RENAL INJURY,4
HR,RENAL PAIN,4
HR,SARCOIDOSIS,4
HR,SCAB,4
HR,SCROTAL ULCER,4
HR,SKIN DISORDER,4
HR,SKIN INFECTION,4
HR,SLEEP DISORDER,4
HR,STOMA SITE DISCHARGE,4
HR,SUPRAVENTRICULAR EXTRASYSTOLES,4
HR,THIRST,4
HR,THROMBOPHLEBITIS,4
HR,TRICUSPID VALVE INCOMPETENCE,4
HR,UNDERDOSE,4
HR,UNEVALUABLE EVENT,4
HR,URINE OUTPUT DECREASED,4
HR,VENTRICULAR HYPOKINESIA,4
HR,VISCERAL LEISHMANIASIS,4
HR,VISUAL ACUITY REDUCED,4
HR,WALKING DISABILITY,4
HR,WITHDRAWAL SYNDROME,4
HR,WOUND INFECTION,4
HR,ACINETOBACTER INFECTION,3
HR,ACUTE ABDOMEN,3
HR,ACUTE CORONARY SYNDROME,3
HR,ACUTE HEPATIC FAILURE,3
HR,ACUTE MYELOID LEUKAEMIA,3
HR,ADENOCARCINOMA OF COLON,3
HR,ANGINA UNSTABLE,3
HR,ANGIODYSPLASIA,3
HR,ANTINUCLEAR ANTIBODY POSITIVE,3
HR,APPENDICITIS,3
HR,ARRHYTHMIA SUPRAVENTRICULAR,3
HR,ARTERIAL STENOSIS,3
HR,ATRIOVENTRICULAR BLOCK COMPLETE,3
HR,AUTOIMMUNE HEPATITIS,3
HR,BACTERAEMIA,3
HR,BASAL GANGLIA HAEMORRHAGE,3
HR,BASEDOW^S DISEASE,3
HR,BENIGN PROSTATIC HYPERPLASIA,3
HR,BLINDNESS TRANSIENT,3
HR,BLOOD CALCIUM DECREASED,3
HR,BLOOD MAGNESIUM DECREASED,3
HR,BLOOD PRESSURE FLUCTUATION,3
HR,BLOOD PRESSURE SYSTOLIC INCREASED,3
HR,BRAIN INJURY,3
HR,BREAST PAIN,3
HR,BREAST SWELLING,3
HR,BRONCHOPULMONARY ASPERGILLOSIS,3
HR,CARDIAC VALVE VEGETATION,3
HR,CARDIOVASCULAR DISORDER,3
HR,CAROTID ARTERY OCCLUSION,3
HR,CAROTID ARTERY STENOSIS,3
HR,CENTRAL NERVOUS SYSTEM LESION,3
HR,CHOLESTASIS,3
HR,CIRCULATORY COLLAPSE,3
HR,COLONIC PSEUDO-OBSTRUCTION,3
HR,COMPLEMENT FACTOR C3 DECREASED,3
HR,CONVULSION,3
HR,CORONARY ARTERY DISEASE,3
HR,CORONARY ARTERY STENOSIS,3
HR,CYSTITIS,3
HR,CYSTITIS HAEMORRHAGIC,3
HR,CYTOGENETIC ANALYSIS ABNORMAL,3
HR,CYTOMEGALOVIRUS INFECTION,3
HR,DELAYED GRAFT FUNCTION,3
HR,DENERVATION ATROPHY,3
HR,DEPRESSED MOOD,3
HR,DERMATITIS EXFOLIATIVE,3
HR,DIABETES MELLITUS INADEQUATE CONTROL,3
HR,DISSEMINATED INTRAVASCULAR COAGULATION,3
HR,DISSEMINATED TUBERCULOSIS,3
HR,DRUG WITHDRAWAL SYNDROME,3
HR,DRY THROAT,3
HR,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,3
HR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,3
HR,EPIDERMOLYSIS,3
HR,ERYSIPELAS,3
HR,ESCHERICHIA URINARY TRACT INFECTION,3
HR,EXOPHTHALMOS,3
HR,EYE MOVEMENT DISORDER,3
HR,EYE OEDEMA,3
HR,EYELIDS PRURITUS,3
HR,FACIAL PARESIS,3
HR,FASCIITIS,3
HR,FEBRILE CONVULSION,3
HR,FEELING DRUNK,3
HR,FLUID RETENTION,3
HR,FLUSHING,3
HR,FUNGAL INFECTION,3
HR,GAIT DEVIATION,3
HR,GASTROENTERITIS,3
HR,GASTROINTESTINAL INFLAMMATION,3
HR,GAZE PALSY,3
HR,GINGIVAL BLEEDING,3
HR,GINGIVAL SWELLING,3
HR,HAEMOCHROMATOSIS,3
HR,HAEMOGLOBIN ABNORMAL,3
HR,HAEMORRHAGE INTRACRANIAL,3
HR,HAEMORRHAGE URINARY TRACT,3
HR,HALLUCINATION_ VISUAL,3
HR,HEARING IMPAIRED,3
HR,HEART RATE DECREASED,3
HR,HEPATIC STEATOSIS,3
HR,HEPATITIS C,3
HR,HICCUPS,3
HR,HYDRONEPHROSIS,3
HR,HYPERCHOLESTEROLAEMIA,3
HR,HYPERTROPHIC CARDIOMYOPATHY,3
HR,HYPOCALCAEMIA,3
HR,HYPOGAMMAGLOBULINAEMIA,3
HR,HYPOVOLAEMIC SHOCK,3
HR,INJECTION SITE ABSCESS,3
HR,INTRAOCULAR PRESSURE INCREASED,3
HR,JOINT EFFUSION,3
HR,KETOACIDOSIS,3
HR,KLEBSIELLA SEPSIS,3
HR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
HR,LARGE INTESTINAL HAEMORRHAGE,3
HR,LARYNGITIS,3
HR,LETHARGY,3
HR,LOWER GASTROINTESTINAL HAEMORRHAGE,3
HR,LUNG DISORDER,3
HR,LUPUS-LIKE SYNDROME,3
HR,MACULE,3
HR,MENINGITIS,3
HR,MENINGITIS ASEPTIC,3
HR,MENINGITIS CHEMICAL,3
HR,MENSTRUATION IRREGULAR,3
HR,MITRAL VALVE CALCIFICATION,3
HR,MITRAL VALVE PROLAPSE,3
HR,MONOPARESIS,3
HR,MOTOR DYSFUNCTION,3
HR,MOUTH HAEMORRHAGE,3
HR,MULTIPLE SCLEROSIS RELAPSE,3
HR,MUSCLE CONTRACTIONS INVOLUNTARY,3
HR,MUSCLE ENZYME INCREASED,3
HR,MUSCLE INJURY,3
HR,MYCOBACTERIUM ABSCESSUS INFECTION,3
HR,MYCOBACTERIUM AVIUM COMPLEX INFECTION,3
HR,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,3
HR,MYCOSIS FUNGOIDES,3
HR,NECK PAIN,3
HR,NEGATIVISM,3
HR,NEPHROPATHY,3
HR,NEUROENDOCRINE TUMOUR,3
HR,NEUROLOGICAL DECOMPENSATION,3
HR,NEUTROPENIC COLITIS,3
HR,NITRITE URINE PRESENT,3
HR,NODULE,3
HR,NON-HODGKIN^S LYMPHOMA REFRACTORY,3
HR,OBESITY,3
HR,OBSTRUCTIVE AIRWAYS DISORDER,3
HR,OOPHORECTOMY BILATERAL,3
HR,ORAL PAIN,3
HR,OSTEOPENIA,3
HR,PANCREATIC CARCINOMA,3
HR,PARALYSIS,3
HR,PARONYCHIA,3
HR,PERFORMANCE STATUS DECREASED,3
HR,PERIPHERAL NERVE PARESIS,3
HR,PERITONITIS BACTERIAL,3
HR,PIGMENTATION DISORDER,3
HR,PNEUMONIA PSEUDOMONAL,3
HR,PRODUCT QUALITY ISSUE,3
HR,PROSTATIC SPECIFIC ANTIGEN INCREASED,3
HR,PROTEUS TEST POSITIVE,3
HR,PULMONARY FIBROSIS,3
HR,PULMONARY HAEMORRHAGE,3
HR,RENAL CANCER,3
HR,RENAL CYST,3
HR,RENAL FAILURE CHRONIC,3
HR,RESPIRATORY DISORDER,3
HR,RESPIRATORY DISTRESS,3
HR,RHEUMATIC DISORDER,3
HR,ROSACEA,3
HR,SEBORRHOEIC DERMATITIS,3
HR,SECOND PRIMARY MALIGNANCY,3
HR,SEVERE MYOCLONIC EPILEPSY OF INFANCY,3
HR,SHOCK,3
HR,SKIN ATROPHY,3
HR,SKIN BURNING SENSATION,3
HR,SKIN HYPERPIGMENTATION,3
HR,SKIN TIGHTNESS,3
HR,SNEEZING,3
HR,SPEECH DISORDER DEVELOPMENTAL,3
HR,SPLENOMEGALY,3
HR,SUDDEN CARDIAC DEATH,3
HR,SUDDEN ONSET OF SLEEP,3
HR,SUPRAPUBIC PAIN,3
HR,SYNOVIAL RUPTURE,3
HR,SYSTEMIC LUPUS ERYTHEMATOSUS,3
HR,TARDIVE DYSKINESIA,3
HR,THERMAL BURN,3
HR,THINKING ABNORMAL,3
HR,THYROIDITIS,3
HR,TOXIC NEUROPATHY,3
HR,TREATMENT FAILURE,3
HR,TYPE 2 DIABETES MELLITUS,3
HR,TYPE IV HYPERSENSITIVITY REACTION,3
HR,ULTRASOUND ABDOMEN ABNORMAL,3
HR,UNRESPONSIVE TO STIMULI,3
HR,VENOUS THROMBOSIS LIMB,3
HR,VISUAL FIELD DEFECT,3
HR,WHITE BLOOD CELL COUNT INCREASED,3
HR,WRONG PATIENT RECEIVED MEDICATION,3
HR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
HR,ABORTION THREATENED,2
HR,ACARODERMATITIS,2
HR,ACUTE PSYCHOSIS,2
HR,ADJUSTMENT DISORDER WITH DEPRESSED MOOD,2
HR,ADRENAL DISORDER,2
HR,ALCOHOL INTERACTION,2
HR,AMENORRHOEA,2
HR,ANAEMIA MEGALOBLASTIC,2
HR,ANAL ABSCESS,2
HR,ANGER,2
HR,ANORECTAL DISCOMFORT,2
HR,ANOSMIA,2
HR,ANTIPSYCHOTIC DRUG LEVEL INCREASED,2
HR,AORTIC DILATATION,2
HR,ARTERIOSCLEROSIS,2
HR,ARTHROPATHY,2
HR,ASPERGILLUS INFECTION,2
HR,ATRIAL FLUTTER,2
HR,AUTOIMMUNE DISORDER,2
HR,BILE DUCT STONE,2
HR,BILIARY SEPSIS,2
HR,BIPOLAR DISORDER,2
HR,BK VIRUS INFECTION,2
HR,BLADDER DIVERTICULITIS,2
HR,BLOOD BICARBONATE DECREASED,2
HR,BLOOD BICARBONATE INCREASED,2
HR,BLOOD CREATINE PHOSPHOKINASE BB INCREASED,2
HR,BLOOD FIBRINOGEN INCREASED,2
HR,BLOOD PARATHYROID HORMONE INCREASED,2
HR,BLOOD PRESSURE ABNORMAL,2
HR,BLOOD PRESSURE IMMEASURABLE,2
HR,BLOOD SELENIUM DECREASED,2
HR,BLOOD THYROID STIMULATING HORMONE DECREASED,2
HR,BONE MARROW TOXICITY,2
HR,BRAIN HERNIATION,2
HR,BREAST ENLARGEMENT,2
HR,BREATH SOUNDS ABNORMAL,2
HR,BRONCHIAL OBSTRUCTION,2
HR,BRONCHOPNEUMONIA,2
HR,BRONCHOSPASM PARADOXICAL,2
HR,CACHEXIA,2
HR,CALCULUS BLADDER,2
HR,CAPILLARY DISORDER,2
HR,CARDIAC FAILURE CONGESTIVE,2
HR,CARDIOPULMONARY FAILURE,2
HR,CENTRAL NERVOUS SYSTEM HAEMORRHAGE,2
HR,CHEST X-RAY ABNORMAL,2
HR,CHOLECYSTITIS,2
HR,CHOLECYSTITIS ACUTE,2
HR,CHROMATURIA,2
HR,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
HR,CLOSTRIDIUM DIFFICILE COLITIS,2
HR,CONJUNCTIVAL HAEMORRHAGE,2
HR,CONJUNCTIVAL OEDEMA,2
HR,CONVERSION DISORDER,2
HR,CORYNEBACTERIUM BACTERAEMIA,2
HR,CUSHINGOID,2
HR,CUSHING^S SYNDROME,2
HR,CYTOGENETIC ABNORMALITY,2
HR,CYTOTOXIC OEDEMA,2
HR,DACTYLITIS,2
HR,DARK CIRCLES UNDER EYES,2
HR,DEAFNESS,2
HR,DELUSIONAL DISORDER_ UNSPECIFIED TYPE,2
HR,DEMENTIA,2
HR,DERMATITIS ALLERGIC,2
HR,DEVICE DISLOCATION,2
HR,DEVICE EXPULSION,2
HR,DISABILITY,2
HR,DISSOCIATION,2
HR,DIVERTICULITIS,2
HR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,2
HR,DRUG LEVEL INCREASED,2
HR,DRUG USE DISORDER,2
HR,DUODENAL STENOSIS,2
HR,DUODENAL ULCER HAEMORRHAGE,2
HR,DUPUYTREN^S CONTRACTURE,2
HR,DYSPHEMIA,2
HR,DYSSTASIA,2
HR,EAR SWELLING,2
HR,EJECTION FRACTION DECREASED,2
HR,ELECTROCARDIOGRAM ABNORMAL,2
HR,ENANTHEMA,2
HR,ENCEPHALITIS AUTOIMMUNE,2
HR,ENERGY INCREASED,2
HR,EPIGASTRIC DISCOMFORT,2
HR,EROSIVE OESOPHAGITIS,2
HR,ESCHERICHIA SEPSIS,2
HR,EXPOSED BONE IN JAW,2
HR,EXTENSOR PLANTAR RESPONSE,2
HR,EYE INFLAMMATION,2
HR,FACIAL PARALYSIS,2
HR,FAMILY STRESS,2
HR,FEEDING DISORDER,2
HR,FEMUR FRACTURE,2
HR,FIBRIN D DIMER INCREASED,2
HR,FOAMING AT MOUTH,2
HR,FOETAL ANTICONVULSANT SYNDROME,2
HR,FORMICATION,2
HR,FREQUENT BOWEL MOVEMENTS,2
HR,GASTRIC HAEMORRHAGE,2
HR,GASTROINTESTINAL MOTILITY DISORDER,2
HR,GASTROINTESTINAL SOUNDS ABNORMAL,2
HR,GASTROINTESTINAL STROMAL TUMOUR,2
HR,GINGIVAL HYPERPLASIA,2
HR,GINGIVAL PAIN,2
HR,GLOMERULONEPHRITIS MEMBRANOUS,2
HR,GLOSSODYNIA,2
HR,GLUCOSE TOLERANCE IMPAIRED,2
HR,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
HR,GOUT,2
HR,GRAFT LOSS,2
HR,GRAND MAL CONVULSION,2
HR,GRANULOCYTOPENIA,2
HR,GYNAECOMASTIA,2
HR,HAEMANGIOMA OF LIVER,2
HR,HAEMOLYSIS,2
HR,HAEMOLYTIC ANAEMIA,2
HR,HAEMORRHAGE SUBCUTANEOUS,2
HR,HAEMORRHOIDAL HAEMORRHAGE,2
HR,HAIR COLOUR CHANGES,2
HR,HANGOVER,2
HR,HEPATIC ARTERY THROMBOSIS,2
HR,HEPATIC CONGESTION,2
HR,HEPATIC CYST,2
HR,HEPATIC FUNCTION ABNORMAL,2
HR,HEPATIC HAEMATOMA,2
HR,HEPATIC NEOPLASM,2
HR,HEPATITIS ACUTE,2
HR,HEPATITIS B,2
HR,HEPATOBILIARY DISEASE,2
HR,HEPATOCELLULAR INJURY,2
HR,HIP ARTHROPLASTY,2
HR,HIP FRACTURE,2
HR,HOSTILITY,2
HR,HOT FLUSH,2
HR,HYDROCEPHALUS,2
HR,HYDROTHORAX,2
HR,HYPERCOAGULATION,2
HR,HYPERPHAGIA,2
HR,HYPERSENSITIVITY VASCULITIS,2
HR,HYPERTONIA,2
HR,HYPERVIGILANCE,2
HR,HYPOKINESIA,2
HR,HYPOMAGNESAEMIA,2
HR,HYPOPROTEINAEMIA,2
HR,HYPOSMIA,2
HR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
HR,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,2
HR,IMMUNOSUPPRESSION,2
HR,IMPAIRED SELF-CARE,2
HR,INAPPROPRIATE AFFECT,2
HR,INCARCERATED HERNIA,2
HR,INCOHERENT,2
HR,INCONTINENCE,2
HR,INCREASED BRONCHIAL SECRETION,2
HR,INFLUENZA,2
HR,INJECTION SITE DISCOLOURATION,2
HR,INJECTION SITE PAIN,2
HR,INJURY,2
HR,INTENTIONAL PRODUCT USE ISSUE,2
HR,INTENTIONAL SELF-INJURY,2
HR,INTERCEPTED DRUG DISPENSING ERROR,2
HR,INTESTINAL PERFORATION,2
HR,INTESTINAL PSEUDO-OBSTRUCTION,2
HR,INTESTINAL STENOSIS,2
HR,IRON BINDING CAPACITY TOTAL DECREASED,2
HR,IRON DEFICIENCY ANAEMIA,2
HR,ISCHAEMIC CEREBRAL INFARCTION,2
HR,JAUNDICE CHOLESTATIC,2
HR,JOINT ANKYLOSIS,2
HR,JOINT RANGE OF MOTION DECREASED,2
HR,JOINT STIFFNESS,2
CU,DEVICE FAILURE,5
CU,DIABETIC KETOACIDOSIS,5
CU,HYPERGLYCAEMIA,5
CU,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,5
CU,ARTHRALGIA,3
CU,DIARRHOEA,3
CU,HAEMORRHAGE,3
CU,ANAPHYLACTIC SHOCK,2
CU,CONJUNCTIVAL HAEMORRHAGE,2
CU,GASTROINTESTINAL HAEMORRHAGE,2
CU,HAEMOLYTIC ANAEMIA,2
CU,HEADACHE,2
CU,INFLAMMATION,2
CU,PRODUCT USE ISSUE,2
CU,PYREXIA,2
CU,ABDOMINAL DISTENSION,1
CU,ABDOMINAL PAIN,1
CU,ABDOMINAL PAIN UPPER,1
CU,ACUTE MYELOID LEUKAEMIA,1
CU,ADMINISTRATION SITE INFLAMMATION,1
CU,ADMINISTRATION SITE REACTION,1
CU,ADVERSE EVENT,1
CU,ALOPECIA,1
CU,ANAEMIA,1
CU,ARTHRITIS,1
CU,ASTHENIA,1
CU,ASTHMATIC CRISIS,1
CU,BACTERAEMIA,1
CU,BONE PAIN,1
CU,CARCINOEMBRYONIC ANTIGEN INCREASED,1
CU,CHOLANGITIS,1
CU,CHOLELITHIASIS,1
CU,CHOLESTASIS,1
CU,CRYPTOCOCCOSIS,1
CU,CYSTITIS,1
CU,DECREASED APPETITE,1
CU,DISORIENTATION,1
CU,DISSEMINATED INTRAVASCULAR COAGULATION,1
CU,DRUG EFFECT INCOMPLETE,1
CU,DRUG INEFFECTIVE,1
CU,DRY EYE,1
CU,DYSPEPSIA,1
CU,DYSPNOEA,1
CU,ENCEPHALITIS,1
CU,EPILEPSY,1
CU,EYE OEDEMA,1
CU,EYE PAIN,1
CU,EYE SWELLING,1
CU,FATIGUE,1
CU,FEBRILE NEUTROPENIA,1
CU,FIBROSIS,1
CU,FLATULENCE,1
CU,FOOT OPERATION,1
CU,FUNGAL SEPSIS,1
CU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
CU,GASTRITIS,1
CU,GASTROINTESTINAL DISORDER,1
CU,HAEMATOCHEZIA,1
CU,HAEMATURIA,1
CU,HEPATITIS,1
CU,HEPATOCELLULAR INJURY,1
CU,HEPATOMEGALY,1
CU,HIATUS HERNIA,1
CU,HOT FLUSH,1
CU,HYPERSENSITIVITY,1
CU,HYPERTENSION,1
CU,HYPOCALCAEMIA,1
CU,HYPOKALAEMIA,1
CU,INSOMNIA,1
CU,INTERSTITIAL LUNG DISEASE,1
CU,IRRITABILITY,1
CU,LIVER INJURY,1
CU,LYMPHATIC DISORDER,1
CU,MACULAR OEDEMA,1
CU,MENORRHAGIA,1
CU,MULTI-ORGAN FAILURE,1
CU,MUSCLE SPASMS,1
CU,MYALGIA,1
CU,NAUSEA,1
CU,NECK PAIN,1
CU,NEUROPATHY PERIPHERAL,1
CU,NON-CARDIAC CHEST PAIN,1
CU,OCULAR HYPERTENSION,1
CU,OESOPHAGITIS,1
CU,OSTEITIS,1
CU,PANCREATITIS,1
CU,PARAESTHESIA,1
CU,PATHOGEN RESISTANCE,1
CU,PHOTOPHOBIA,1
CU,PNEUMONIA,1
CU,PRURITUS,1
CU,PSYCHOMOTOR HYPERACTIVITY,1
CU,PULMONARY HAEMORRHAGE,1
CU,PULMONARY SEPSIS,1
CU,REMOVAL OF INERT MATTER FROM SKIN OR SUBCUTANEOUS TISSUE,1
CU,RENAL TUBULAR NECROSIS,1
CU,RESPIRATORY DISTRESS,1
CU,RESPIRATORY FAILURE,1
CU,RESPIRATORY TRACT IRRITATION,1
CU,RHEUMATOID FACTOR INCREASED,1
CU,SALMONELLOSIS,1
CU,SENSORY DISTURBANCE,1
CU,SJOGREN^S SYNDROME,1
CU,SKIN HYPERPIGMENTATION,1
CU,SPLENITIS,1
CU,STRESS ULCER,1
CU,SUICIDAL IDEATION,1
CU,SWELLING FACE,1
CU,THROMBOCYTOPENIA,1
CU,THROMBOSIS,1
CU,THROMBOSIS IN DEVICE,1
CU,TONIC CONVULSION,1
CU,TOXICITY TO VARIOUS AGENTS,1
CU,URINARY TRACT INFECTION,1
CU,VOMITING,1
CU,WEIGHT DECREASED,1
CW,ANAPHYLACTIC REACTION,1
CW,BACK PAIN,1
CW,BASAL CELL CARCINOMA,1
CW,BONE MARROW FAILURE,1
CW,CHEST PAIN,1
CW,DYSPNOEA,1
CW,EPISTAXIS,1
CW,HAEMATOMA,1
CW,HYPERSENSITIVITY,1
CW,INFLAMMATION,1
CW,INFUSION SITE DISCOLOURATION,1
CW,INFUSION SITE VASCULITIS,1
CW,INJECTION SITE PRURITUS,1
CW,PRURITUS,1
CW,PULMONARY EMBOLISM,1
CW,PYREXIA,1
CW,RESPIRATORY DISORDER,1
CW,RESTLESSNESS,1
CW,SKIN DISORDER,1
CW,STEVENS-JOHNSON SYNDROME,1
CY,LOSS OF CONSCIOUSNESS,15
CY,MYOCARDIAL INFARCTION,15
CY,PYREXIA,12
CY,RASH,12
CY,DRUG INEFFECTIVE,11
CY,HEART RATE INCREASED,11
CY,OSTEONECROSIS OF JAW,10
CY,DYSPNOEA,9
CY,FATIGUE,9
CY,NEPHROLITHIASIS,9
CY,TOXICITY TO VARIOUS AGENTS,9
CY,HEPATIC ENZYME INCREASED,8
CY,ACUTE CORONARY SYNDROME,7
CY,ASTHENIA,7
CY,DEATH,7
CY,ERYTHEMA,7
CY,OEDEMA PERIPHERAL,7
CY,SYNCOPE,7
CY,ACUTE KIDNEY INJURY,6
CY,ARTHRALGIA,6
CY,FALL,6
CY,NAUSEA,6
CY,PAIN,6
CY,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,6
CY,VOMITING,6
CY,ABASIA,5
CY,BONE LESION,5
CY,BRADYCARDIA,5
CY,DIARRHOEA,5
CY,FEMUR FRACTURE,5
CY,FOETAL EXPOSURE DURING PREGNANCY,5
CY,NEUTROPENIA,5
CY,PAIN IN JAW,5
CY,PERIPHERAL SWELLING,5
CY,PROTEINURIA,5
CY,THROMBOCYTOPENIA,5
CY,ANAEMIA,4
CY,BLOOD ALKALINE PHOSPHATASE INCREASED,4
CY,BLOOD CREATININE INCREASED,4
CY,BLOOD GLUCOSE INCREASED,4
CY,BLOOD UREA INCREASED,4
CY,BREAST CANCER,4
CY,CARDIAC ARREST,4
CY,CHOLECYSTITIS ACUTE,4
CY,DECREASED APPETITE,4
CY,DEPRESSED MOOD,4
CY,DIZZINESS,4
CY,EXPOSED BONE IN JAW,4
CY,GENERALISED OEDEMA,4
CY,HAEMOGLOBIN DECREASED,4
CY,MALIGNANT NEOPLASM PROGRESSION,4
CY,MATERNAL EXPOSURE DURING PREGNANCY,4
CY,NIGHTMARE,4
CY,PAIN IN EXTREMITY,4
CY,PREMATURE BABY,4
CY,PRODUCT USE IN UNAPPROVED INDICATION,4
CY,RENAL FAILURE,4
CY,SPINAL FRACTURE,4
CY,STATUS EPILEPTICUS,4
CY,SWELLING,4
CY,TACHYCARDIA,4
CY,ABDOMINAL PAIN,3
CY,ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED,3
CY,ANAPHYLACTIC REACTION,3
CY,ANAPHYLACTIC SHOCK,3
CY,APHAGIA,3
CY,ATRIAL FIBRILLATION,3
CY,BLOOD BILIRUBIN INCREASED,3
CY,BLOOD CALCIUM INCREASED,3
CY,BLOOD IRON DECREASED,3
CY,BRAIN OEDEMA,3
CY,CEREBROVASCULAR ACCIDENT,3
CY,CHOLELITHIASIS,3
CY,CIRCULATORY COLLAPSE,3
CY,DEEP VEIN THROMBOSIS,3
CY,DEPRESSION,3
CY,DRUG PRESCRIBING ERROR,3
CY,DYSPHAGIA,3
CY,EMBOLISM,3
CY,GAIT DISTURBANCE,3
CY,GASTRIC HAEMORRHAGE,3
CY,HEADACHE,3
CY,HIP FRACTURE,3
CY,HYPERSENSITIVITY,3
CY,HYPOAESTHESIA,3
CY,ILLUSION,3
CY,INCORRECT DOSE ADMINISTERED,3
CY,JOINT SWELLING,3
CY,KIDNEY CONGESTION,3
CY,LUMBAR VERTEBRAL FRACTURE,3
CY,MUCOSAL INFLAMMATION,3
CY,OVERDOSE,3
CY,PANIC ATTACK,3
CY,PREGNANCY,3
CY,PROSTATE CANCER,3
CY,PRURITUS,3
CY,PULMONARY OEDEMA,3
CY,RESPIRATORY FAILURE,3
CY,RESPIRATORY TRACT INFECTION,3
CY,SPLEEN CONGESTION,3
CY,VENTRICULAR EXTRASYSTOLES,3
CY,WHITE BLOOD CELL COUNT DECREASED,3
CY,ABDOMINAL PAIN UPPER,2
CY,ALANINE AMINOTRANSFERASE INCREASED,2
CY,ANGIOEDEMA,2
CY,ARRHYTHMIA,2
CY,ARTERIOSCLEROSIS CORONARY ARTERY,2
CY,ASPARTATE AMINOTRANSFERASE INCREASED,2
CY,BACK PAIN,2
CY,BENIGN INTRACRANIAL HYPERTENSION,2
CY,BLINDNESS UNILATERAL,2
CY,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
CY,BONE MARROW DISORDER,2
CY,CARDIAC FAILURE,2
CY,CARDIAC VENTRICULAR THROMBOSIS,2
CY,CARDIOMEGALY,2
CY,CEREBRAL HAEMORRHAGE,2
CY,CHOLECYSTITIS,2
CY,CONDITION AGGRAVATED,2
CY,CONFUSIONAL STATE,2
CY,CONVULSION,2
CY,DEAFNESS,2
CY,DEHYDRATION,2
CY,DEPRESSED LEVEL OF CONSCIOUSNESS,2
CY,DIABETIC KETOACIDOSIS,2
CY,DRY MOUTH,2
CY,DYSLIPIDAEMIA,2
CY,DYSSTASIA,2
CY,ELECTROCARDIOGRAM QT PROLONGED,2
CY,EXPOSURE DURING PREGNANCY,2
CY,EYE HAEMORRHAGE,2
CY,FACE OEDEMA,2
CY,GANGRENE,2
CY,GASTROINTESTINAL HAEMORRHAGE,2
CY,HALLUCINATION,2
CY,HEAD INJURY,2
CY,HEMIPARESIS,2
CY,HEPATIC STEATOSIS,2
CY,HYPERCALCAEMIA,2
CY,HYPERTENSION,2
CY,HYPONATRAEMIA,2
CY,HYPOTENSION,2
CY,INFECTION,2
CY,INSOMNIA,2
CY,INTRADUCTAL PROLIFERATIVE BREAST LESION,2
CY,LARYNGEAL OEDEMA,2
CY,LEUKOPENIA,2
CY,LOWER RESPIRATORY TRACT INFECTION,2
CY,LYMPHOCYTE COUNT DECREASED,2
CY,MEMORY IMPAIRMENT,2
CY,MENORRHAGIA,2
CY,MUSCLE SPASMS,2
CY,MUSCLE TIGHTNESS,2
CY,MYALGIA,2
CY,MYASTHENIA GRAVIS,2
CY,MYOCARDIAL ISCHAEMIA,2
CY,NECK PAIN,2
CY,OCULAR HYPERAEMIA,2
CY,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
CY,PALPITATIONS,2
CY,PANCREATITIS,2
CY,PANCYTOPENIA,2
CY,PANIC REACTION,2
CY,PLASMA CELL MYELOMA,2
CY,PLATELET COUNT DECREASED,2
CY,PNEUMONIA,2
CY,PREMATURE DELIVERY,2
CY,PRODUCT USE ISSUE,2
CY,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
CY,PROSTATE CANCER METASTATIC,2
CY,PRURITUS ALLERGIC,2
CY,PULMONARY EMBOLISM,2
CY,PULMONARY HYPERTENSION,2
CY,RECTAL HAEMORRHAGE,2
CY,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
CY,RESPIRATORY DISTRESS,2
CY,ROAD TRAFFIC ACCIDENT,2
CY,SERUM FERRITIN INCREASED,2
CY,SINUS TACHYCARDIA,2
CY,STOMATITIS,2
CY,SUBDURAL HAEMATOMA,2
CY,THROMBOSIS,2
CY,THYROID CANCER,2
CY,TOOTH ABSCESS,2
CY,TOOTH INFECTION,2
CY,TOOTHACHE,2
CY,TRANSIENT ISCHAEMIC ATTACK,2
CY,TRIGEMINAL NEURALGIA,2
CY,TYPE I HYPERSENSITIVITY,2
CY,UNRESPONSIVE TO STIMULI,2
CY,VENTRICULAR FIBRILLATION,2
CY,VIRAL INFECTION,2
CY,WEIGHT DECREASED,2
CY,ABDOMINAL TENDERNESS,1
CY,ABNORMAL BEHAVIOUR,1
CY,ABNORMAL SENSATION IN EYE,1
CY,ABORTION INDUCED,1
CY,ABORTION SPONTANEOUS,1
CY,ACINETOBACTER TEST POSITIVE,1
CY,ACNE,1
CY,ACUTE ABDOMEN,1
CY,ACUTE DISSEMINATED ENCEPHALOMYELITIS,1
CY,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
CY,ACUTE HEPATIC FAILURE,1
CY,ACUTE MYELOID LEUKAEMIA,1
CY,ACUTE MYOCARDIAL INFARCTION,1
CY,ACUTE PULMONARY OEDEMA,1
CY,ACUTE RESPIRATORY DISTRESS SYNDROME,1
CY,ADENOCARCINOMA,1
CY,ADRENAL DISORDER,1
CY,ADVERSE DRUG REACTION,1
CY,ADVERSE EVENT,1
CY,AGEUSIA,1
CY,AGITATION,1
CY,AGRANULOCYTOSIS,1
CY,ALOPECIA,1
CY,ALVEOLITIS ALLERGIC,1
CY,AMNESIA,1
CY,AMYLASE INCREASED,1
CY,ANAL POLYP,1
CY,AORTIC VALVE DISEASE,1
CY,ARTERIOSCLEROSIS,1
CY,ATRIAL THROMBOSIS,1
CY,ATROPHY,1
CY,ATYPICAL FEMUR FRACTURE,1
CY,BALANCE DISORDER,1
CY,BLADDER DIVERTICULUM,1
CY,BLADDER PAPILLOMA,1
CY,BLISTER,1
CY,BLISTER INFECTED,1
CY,BLOOD BICARBONATE INCREASED,1
CY,BLOOD CALCIUM DECREASED,1
CY,BLOOD CHOLESTEROL INCREASED,1
CY,BLOOD GLUCOSE DECREASED,1
CY,BLOOD PHOSPHORUS DECREASED,1
CY,BLOOD PHOSPHORUS INCREASED,1
CY,BLOOD POTASSIUM DECREASED,1
CY,BLOOD PRESSURE FLUCTUATION,1
CY,BLOOD PRESSURE INCREASED,1
CY,BODY TEMPERATURE INCREASED,1
CY,BONE DENSITY ABNORMAL,1
CY,BONE MARROW OEDEMA,1
CY,BONE MARROW TOXICITY,1
CY,BRADYARRHYTHMIA,1
CY,BREAST CANCER IN SITU,1
CY,BREAST CANCER STAGE II,1
CY,BREECH PRESENTATION,1
CY,BRONCHOSPASM,1
CY,CAESAREAN SECTION,1
CY,CANDIDIASIS,1
CY,CARDIAC DISORDER,1
CY,CARDIAC FAILURE CHRONIC,1
CY,CARDIAC HYPERTROPHY,1
CY,CARDIAC PACEMAKER INSERTION,1
CY,CARDIAC PACEMAKER REPLACEMENT,1
CY,CARDIOGENIC SHOCK,1
CY,CENTRAL NERVOUS SYSTEM LESION,1
CY,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
CY,CEREBELLAR ATAXIA,1
CY,CEREBRAL ARTERY EMBOLISM,1
CY,CEREBRAL CONGESTION,1
CY,CHOKING SENSATION,1
CY,CLEFT LIP AND PALATE,1
CY,COAGULOPATHY,1
CY,COGNITIVE DISORDER,1
CY,COLECTOMY,1
CY,COMA,1
CY,COMPLETED SUICIDE,1
CY,CONSTIPATION,1
CY,CONTRAINDICATED PRODUCT ADMINISTERED,1
CY,CONTUSION,1
CY,COORDINATION ABNORMAL,1
CY,CORNEAL SCAR,1
CY,CORONARY ARTERY OCCLUSION,1
CY,COUGH,1
CY,CREATININE RENAL CLEARANCE DECREASED,1
CY,DARK CIRCLES UNDER EYES,1
CY,DELIRIUM,1
CY,DEMYELINATION,1
CY,DENTAL IMPLANTATION,1
CY,DERMATITIS ALLERGIC,1
CY,DERMATITIS BULLOUS,1
CY,DERMATOMYOSITIS,1
CY,DEVICE DEFECTIVE,1
CY,DEVICE DISLOCATION,1
CY,DEVICE RELATED INFECTION,1
CY,DIPLEGIA,1
CY,DISORIENTATION,1
CY,DISSEMINATED INTRAVASCULAR COAGULATION,1
CY,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
CY,DRUG LEVEL INCREASED,1
CY,DRUG WITHDRAWAL SYNDROME,1
CY,DRUG-INDUCED LIVER INJURY,1
CY,DRY EYE,1
CY,DYSARTHRIA,1
CY,DYSGEUSIA,1
CY,DYSKINESIA,1
CY,DYSURIA,1
CY,EATING DISORDER,1
CY,ECCHYMOSIS,1
CY,ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE,1
CY,ECZEMA,1
CY,EJACULATION DISORDER,1
CY,EMBOLISM VENOUS,1
CY,ENCEPHALITIS,1
CY,ENDOCARDITIS,1
CY,ENDOTRACHEAL INTUBATION,1
CY,ENTEROCOCCUS TEST POSITIVE,1
CY,ENZYME LEVEL INCREASED,1
CY,EPISTAXIS,1
CY,ERECTILE DYSFUNCTION,1
CY,EXCESSIVE EYE BLINKING,1
CY,EXCORIATION,1
CY,EXPOSURE DURING BREAST FEEDING,1
CY,EXPOSURE VIA FATHER,1
CY,EYE MOVEMENT DISORDER,1
CY,EYE SWELLING,1
CY,FAECES DISCOLOURED,1
CY,FEEDING DISORDER,1
CY,FEELING ABNORMAL,1
CY,FEELING OF BODY TEMPERATURE CHANGE,1
CY,FLATULENCE,1
CY,FOOD INTERACTION,1
CY,FRACTURE,1
CY,FULL BLOOD COUNT DECREASED,1
CY,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
CY,GASTRIC DILATATION,1
CY,GASTRITIS,1
CY,GASTROINTESTINAL DISORDER,1
CY,GENERAL PHYSICAL HEALTH DETERIORATION,1
CY,GENERALISED ERYTHEMA,1
CY,GENERALISED TONIC-CLONIC SEIZURE,1
CY,GENITAL HAEMORRHAGE,1
CY,GENITAL INFECTION,1
CY,GINGIVAL BLEEDING,1
CY,GINGIVITIS,1
CY,GLAUCOMA,1
CY,GLOMERULONEPHRITIS,1
CY,GOITRE,1
CY,GRANULOCYTOPENIA,1
CY,GRANULOMATOSIS WITH POLYANGIITIS,1
CY,GROWTH RETARDATION,1
CY,GUILLAIN-BARRE SYNDROME,1
CY,HAEMATEMESIS,1
CY,HAEMATURIA,1
CY,HAEMODYNAMIC INSTABILITY,1
CY,HAEMOPTYSIS,1
CY,HAEMORRHAGE,1
CY,HAEMORRHAGE URINARY TRACT,1
CY,HAEMORRHAGIC STROKE,1
CY,HAEMORRHAGIC TRANSFORMATION STROKE,1
CY,HELICOBACTER INFECTION,1
CY,HEPATIC ENCEPHALOPATHY,1
CY,HEPATIC NECROSIS,1
CY,HEPATITIS ACUTE,1
CY,HEPATITIS C,1
CY,HEPATOCELLULAR CARCINOMA,1
CY,HEPATOMEGALY,1
CY,HERPES ZOSTER INFECTION NEUROLOGICAL,1
CY,HOSPITALISATION,1
CY,HYDROCEPHALUS,1
CY,HYPERCHLORHYDRIA,1
CY,HYPERTENSIVE CRISIS,1
CY,HYPERTHYROIDISM,1
CY,HYPOACUSIS,1
CY,HYPOPYON,1
CY,HYPOTHYROIDISM,1
CY,HYSTERECTOMY,1
CY,IDIOPATHIC ANGIOEDEMA,1
CY,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
CY,IMMUNE THROMBOCYTOPENIC PURPURA,1
CY,IMMUNE-MEDIATED NECROTISING MYOPATHY,1
CY,IMPAIRED DRIVING ABILITY,1
CY,IMPAIRED HEALING,1
CY,IMPAIRED QUALITY OF LIFE,1
CY,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CY,INCORRECT DOSE ADMINISTERED BY DEVICE,1
CY,INCORRECT DRUG ADMINISTRATION RATE,1
CY,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CY,INFUSION RELATED REACTION,1
CY,INTELLECTUAL DISABILITY,1
CY,INTENTIONAL DRUG MISUSE,1
CY,INTENTIONAL PRODUCT MISUSE,1
CY,INTENTIONAL PRODUCT USE ISSUE,1
CY,INTENTIONAL UNDERDOSE,1
CY,INTERNATIONAL NORMALISED RATIO INCREASED,1
CY,INTESTINAL ANASTOMOSIS,1
CY,INTESTINAL POLYP,1
CY,INTRA-ABDOMINAL HAEMORRHAGE,1
CY,INTRACRANIAL PRESSURE INCREASED,1
CY,IRIS NEOVASCULARISATION,1
CY,ISCHAEMIA,1
CY,ISCHAEMIC STROKE,1
CY,JAUNDICE,1
CY,JAW CYST,1
CY,JAW DISORDER,1
CY,JOINT ANKYLOSIS,1
CY,KLEBSIELLA TEST POSITIVE,1
CY,KNEE OPERATION,1
CY,LACTIC ACIDOSIS,1
CY,LARGE INTESTINE POLYP,1
CY,LEFT VENTRICULAR FAILURE,1
CY,LEG AMPUTATION,1
CY,LIMB DISCOMFORT,1
CY,LIP SWELLING,1
CY,LOCALISED OEDEMA,1
CY,LOW DENSITY LIPOPROTEIN INCREASED,1
CY,LYMPHADENOPATHY,1
CY,LYMPHATIC DISORDER,1
CY,LYMPHOID TISSUE HYPERPLASIA,1
CY,MACULAR DEGENERATION,1
CY,MALAISE,1
CY,MEDICATION ERROR,1
CY,MELAENA,1
CY,MENSTRUATION IRREGULAR,1
CY,MENTAL DISORDER,1
CY,METASTASES TO LIVER,1
CY,METASTASES TO LUNG,1
CY,METASTASIS,1
CY,MITRAL VALVE REPAIR,1
CY,MONOCYTE COUNT ABNORMAL,1
CY,MOUTH ULCERATION,1
CY,MOVEMENT DISORDER,1
CY,MUCOUS STOOLS,1
CY,MULTI-ORGAN FAILURE,1
CY,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CY,MULTIPLE SCLEROSIS RELAPSE,1
CY,MUSCULAR DYSTROPHY,1
CY,MUSCULOSKELETAL PAIN,1
CY,MUSCULOSKELETAL STIFFNESS,1
CY,MYDRIASIS,1
CY,MYOSITIS,1
CY,NASAL POLYPS,1
CY,NEPHROTIC SYNDROME,1
CY,NERVOUS SYSTEM DISORDER,1
CY,NEUROLOGICAL SYMPTOM,1
CY,NEUROPATHY PERIPHERAL,1
CY,NEUTROPHIL COUNT DECREASED,1
CY,NEUTROPHIL COUNT INCREASED,1
CY,NON-SMALL CELL LUNG CANCER,1
CY,NYSTAGMUS,1
CY,OBSTRUCTION GASTRIC,1
CY,OCULAR VASCULAR DISORDER,1
CY,OEDEMA,1
CY,OESOPHAGEAL ADENOCARCINOMA,1
CY,ON AND OFF PHENOMENON,1
CY,ONYCHOMYCOSIS,1
CY,OSCILLOPSIA,1
CY,OSTEITIS,1
CY,OSTEOLYSIS,1
CY,OSTEOMYELITIS,1
CY,OSTEONECROSIS,1
CY,PANCREATIC CARCINOMA,1
CY,PANCREATIC DISORDER,1
CY,PANCREATITIS ACUTE,1
CY,PARAPROTEINAEMIA,1
CY,PARATHYROID DISORDER,1
CY,PATHOLOGICAL FRACTURE,1
CY,PEMPHIGOID,1
CY,PENILE OEDEMA,1
CY,PENILE SQUAMOUS CELL CARCINOMA,1
CY,PENILE ULCERATION,1
CY,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CY,PERIPHERAL EMBOLISM,1
CY,PETECHIAE,1
CY,PEYRONIE^S DISEASE,1
CY,PHARYNGITIS,1
CY,PHOBIA,1
CY,PHOTOSENSITIVITY REACTION,1
CY,PLEURAL EFFUSION,1
CY,PNEUMATOSIS INTESTINALIS,1
CY,PNEUMONIA ASPIRATION,1
CY,PNEUMONITIS,1
CY,POLYDACTYLY,1
CY,POLYNEUROPATHY,1
CY,POLYPECTOMY,1
CY,POLYURIA,1
CY,POSTPARTUM HAEMORRHAGE,1
CY,PREGNANCY ON CONTRACEPTIVE,1
CY,PREGNANCY WITH CONTRACEPTIVE DEVICE,1
CY,PRESCRIBED UNDERDOSE,1
CY,PROCEDURAL COMPLICATION,1
CY,PROSTATIC HAEMORRHAGE,1
CY,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
CY,PROTEIN URINE PRESENT,1
CY,PSEUDOCYST,1
CY,PSEUDOMONAS INFECTION,1
CY,PSYCHIATRIC SYMPTOM,1
CY,PULMONARY ALVEOLAR HAEMORRHAGE,1
CY,PULMONARY CONGESTION,1
CY,PULMONARY FIBROSIS,1
CY,PULMONARY MASS,1
CY,PURPURA,1
CY,RADIATION SKIN INJURY,1
CY,RASH ERYTHEMATOUS,1
CY,RENAL COLIC,1
CY,RENAL IMPAIRMENT,1
CY,RESORPTION BONE INCREASED,1
CY,RESPIRATORY DISORDER,1
CY,RESPIRATORY RATE INCREASED,1
CY,RETINAL ISCHAEMIA,1
CY,RETINAL VEIN OCCLUSION,1
CY,RHABDOMYOLYSIS,1
CY,RHEUMATOID ARTHRITIS,1
CY,RUPTURED ECTOPIC PREGNANCY,1
CY,SCHIZOPHRENIA,1
CY,SCIATICA,1
CY,SENSITIVITY OF TEETH,1
CY,SENSORY DISTURBANCE,1
CY,SENSORY LOSS,1
CY,SEPTAL PANNICULITIS,1
CY,SEPTIC SHOCK,1
CY,SEROTONIN SYNDROME,1
CY,SKELETAL DYSPLASIA,1
CY,SKULL MALFORMATION,1
CY,SMALL INTESTINAL OBSTRUCTION,1
CY,SOFT TISSUE INFECTION,1
CY,SPEECH DISORDER,1
CY,SPINA BIFIDA,1
CY,SPINAL CORD DISORDER,1
CY,SPINAL DISORDER,1
CY,SPINAL OPERATION,1
CY,STAPHYLOCOCCAL INFECTION,1
CY,STOMA SITE DISCHARGE,1
CY,STOMA SITE HAEMORRHAGE,1
CY,STOMA SITE HYPERGRANULATION,1
CY,STREPTOCOCCUS TEST POSITIVE,1
CY,SUDDEN DEATH,1
CY,SUDDEN UNEXPLAINED DEATH IN EPILEPSY,1
CY,SUICIDE ATTEMPT,1
CY,SYNOVITIS,1
CY,TACHYARRHYTHMIA,1
CY,TACHYPNOEA,1
CY,TENSION,1
CY,TESTIS CANCER,1
CY,THORACIC HAEMORRHAGE,1
CY,THROAT TIGHTNESS,1
CY,THROMBOCYTOPENIC PURPURA,1
CY,TIC,1
CY,TOOTH DISORDER,1
CY,TREMOR,1
CY,TWIN PREGNANCY,1
CY,TYPE 1 DIABETES MELLITUS,1
CY,ULCERATIVE KERATITIS,1
CY,UNWANTED AWARENESS DURING ANAESTHESIA,1
CY,URINARY TRACT INFECTION,1
CY,URINE OUTPUT DECREASED,1
CY,URTICARIA,1
CY,UTERINE CANCER,1
CY,UTERINE POLYP,1
CY,VASCULITIS,1
CY,VEIN DISORDER,1
CY,VENTRICULAR TACHYCARDIA,1
CY,VERTEBRAL OSTEOPHYTE,1
CY,VIITH NERVE PARALYSIS,1
CY,VOCAL CORD PARALYSIS,1
CY,WHEELCHAIR USER,1
CY,WOUND INFECTION,1
CZ,DIARRHOEA,219
CZ,DYSPNOEA,210
CZ,DEATH,203
CZ,DRUG INEFFECTIVE,188
CZ,NAUSEA,182
CZ,FATIGUE,180
CZ,VOMITING,179
CZ,PNEUMONIA,161
CZ,ANAEMIA,157
CZ,TOXICITY TO VARIOUS AGENTS,148
CZ,NEUTROPENIA,147
CZ,PYREXIA,147
CZ,SEPSIS,145
CZ,THROMBOCYTOPENIA,143
CZ,ACUTE KIDNEY INJURY,139
CZ,CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT,123
CZ,ASTHENIA,120
CZ,MALIGNANT NEOPLASM PROGRESSION,120
CZ,FEBRILE NEUTROPENIA,111
CZ,RENAL FAILURE,108
CZ,INFECTION,104
CZ,DISEASE PROGRESSION,103
CZ,DECREASED APPETITE,95
CZ,LACTIC ACIDOSIS,94
CZ,CARDIAC FAILURE,93
CZ,ABORTION SPONTANEOUS,91
CZ,HEADACHE,90
CZ,PULMONARY EMBOLISM,90
CZ,FALL,88
CZ,HYPERTENSION,84
CZ,GASTROINTESTINAL DISORDER,83
CZ,HYPOTENSION,79
CZ,RASH,79
CZ,OVERDOSE,78
CZ,HYPERSENSITIVITY,77
CZ,ABDOMINAL PAIN,76
CZ,WEIGHT DECREASED,74
CZ,METABOLIC ACIDOSIS,72
CZ,DEHYDRATION,69
CZ,LOSS OF CONSCIOUSNESS,69
CZ,CONDITION AGGRAVATED,68
CZ,GENERAL PHYSICAL HEALTH DETERIORATION,68
CZ,DEEP VEIN THROMBOSIS,67
CZ,LEUKOPENIA,67
CZ,DYSPEPSIA,65
CZ,ERYTHEMA,65
CZ,PANCYTOPENIA,65
CZ,CIRCULATORY COLLAPSE,63
CZ,WEIGHT INCREASED,60
CZ,ARTHRALGIA,57
CZ,C-REACTIVE PROTEIN INCREASED,57
CZ,CARDIAC ARREST,57
CZ,LIVER DISORDER,57
CZ,ATRIAL FIBRILLATION,55
CZ,OEDEMA PERIPHERAL,55
CZ,BLOOD CREATININE INCREASED,54
CZ,MATERNAL EXPOSURE DURING PREGNANCY,54
CZ,ISCHAEMIC STROKE,52
CZ,URINARY TRACT INFECTION,51
CZ,SEPTIC SHOCK,50
CZ,SYNCOPE,50
CZ,MULTIPLE ORGAN DYSFUNCTION SYNDROME,49
CZ,NEUROPATHY PERIPHERAL,48
CZ,HAEMATOTOXICITY,47
CZ,HYPERHIDROSIS,47
CZ,VERTIGO,47
CZ,DIABETES MELLITUS,46
CZ,MALAISE,46
CZ,PARAESTHESIA,46
CZ,MYALGIA,45
CZ,SKIN TOXICITY,45
CZ,CHILLS,44
CZ,SUICIDE ATTEMPT,44
CZ,COUGH,43
CZ,DIZZINESS,43
CZ,HYPOGLYCAEMIA,43
CZ,OSTEONECROSIS OF JAW,43
CZ,RESPIRATORY FAILURE,43
CZ,SOMNOLENCE,43
CZ,HYPOKALAEMIA,42
CZ,MYOCARDIAL INFARCTION,42
CZ,CEREBROVASCULAR ACCIDENT,41
CZ,BACK PAIN,40
CZ,PRURITUS,40
CZ,URTICARIA,40
CZ,HYPERLACTACIDAEMIA,39
CZ,TREMOR,39
CZ,CHEST PAIN,38
CZ,HYPOVOLAEMIA,38
CZ,BREAST CANCER,37
CZ,SEIZURE,37
CZ,HERPES ZOSTER,36
CZ,HYPONATRAEMIA,36
CZ,MUSCULAR WEAKNESS,36
CZ,PRODUCT QUALITY ISSUE,36
CZ,ABDOMINAL PAIN LOWER,35
CZ,ALTERED STATE OF CONSCIOUSNESS,35
CZ,CONFUSIONAL STATE,35
CZ,DRUG LEVEL INCREASED,35
CZ,EPISTAXIS,35
CZ,MULTIPLE SCLEROSIS RELAPSE,35
CZ,TACHYCARDIA,35
CZ,INTENTIONAL OVERDOSE,34
CZ,NEUROTOXICITY,34
CZ,PALPITATIONS,34
CZ,RENAL IMPAIRMENT,34
CZ,RESPIRATORY TRACT INFECTION,34
CZ,SYSTEMIC INFECTION,34
CZ,COMA,33
CZ,EPILEPSY,33
CZ,INSOMNIA,33
CZ,SEDATION,33
CZ,CONSTIPATION,32
CZ,DRUG ABUSE,32
CZ,HEPATIC ENZYME INCREASED,32
CZ,IMMUNE-MEDIATED NECROTISING MYOPATHY,32
CZ,RASH GENERALISED,32
CZ,ALANINE AMINOTRANSFERASE INCREASED,31
CZ,FOETAL EXPOSURE DURING PREGNANCY,31
CZ,HYPERGLYCAEMIA,31
CZ,OSTEOPOROSIS,31
CZ,PAIN IN EXTREMITY,31
CZ,PLEURAL EFFUSION,31
CZ,SWELLING FACE,31
CZ,DEPRESSION,30
CZ,EXPOSURE DURING PREGNANCY,30
CZ,HAEMATURIA,30
CZ,ANION GAP INCREASED,29
CZ,ANXIETY,29
CZ,BLOOD BICARBONATE DECREASED,29
CZ,INTENTIONAL PRODUCT MISUSE,29
CZ,MUSCLE SPASMS,29
CZ,PAIN,29
CZ,POLYNEUROPATHY,29
CZ,STOMATITIS,29
CZ,THROMBOSIS,29
CZ,BLOOD PH DECREASED,28
CZ,COLITIS,28
CZ,CREATININE RENAL CLEARANCE DECREASED,28
CZ,DERMATITIS ALLERGIC,28
CZ,HEPATOTOXICITY,28
CZ,PCO2 DECREASED,28
CZ,SHOCK,28
CZ,BASE EXCESS DECREASED,27
CZ,EMBOLISM,27
CZ,HYPERKALAEMIA,27
CZ,HYPOCAPNIA,27
CZ,ILEUS,27
CZ,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,27
CZ,VAGINAL HAEMORRHAGE,27
CZ,ACUTE MYOCARDIAL INFARCTION,26
CZ,DYSARTHRIA,26
CZ,ENCEPHALOPATHY,26
CZ,GASTROINTESTINAL TOXICITY,26
CZ,GENE MUTATION,26
CZ,INFUSION RELATED REACTION,26
CZ,STEVENS-JOHNSON SYNDROME,26
CZ,ALOPECIA,25
CZ,ANAPHYLACTIC REACTION,25
CZ,BLOOD CHLORIDE DECREASED,25
CZ,CHEST DISCOMFORT,25
CZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,25
CZ,OSTEONECROSIS,25
CZ,PRODUCT USE IN UNAPPROVED INDICATION,25
CZ,PRODUCT USE ISSUE,25
CZ,ACUTE MYELOID LEUKAEMIA,24
CZ,CARDIOPULMONARY FAILURE,24
CZ,COMPLETED SUICIDE,24
CZ,DRUG DEPENDENCE,24
CZ,GASTROENTERITIS,24
CZ,HEMIPARESIS,24
CZ,HOT FLUSH,24
CZ,MUCOSAL TOXICITY,24
CZ,PULMONARY OEDEMA,24
CZ,SEROTONIN SYNDROME,24
CZ,VISUAL IMPAIRMENT,24
CZ,ARRHYTHMIA,23
CZ,BONE MARROW FAILURE,23
CZ,CEREBRAL HAEMORRHAGE,23
CZ,COAGULOPATHY,23
CZ,DRUG ERUPTION,23
CZ,GAIT DISTURBANCE,23
CZ,MUCOSAL INFLAMMATION,23
CZ,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,23
CZ,RESTLESSNESS,23
CZ,SUBILEUS,23
CZ,CYTOMEGALOVIRUS INFECTION,22
CZ,DRUG INTOLERANCE,22
CZ,DYSPHAGIA,22
CZ,FLUID RETENTION,22
CZ,LEUKAEMIA RECURRENT,22
CZ,METASTASES TO LIVER,22
CZ,PERIPHERAL SENSORY NEUROPATHY,22
CZ,ASPARTATE AMINOTRANSFERASE INCREASED,21
CZ,BRADYCARDIA,21
CZ,BRONCHOPNEUMONIA,21
CZ,DEVICE EXPULSION,21
CZ,HEPATIC FAILURE,21
CZ,MULTIPLE SCLEROSIS,21
CZ,OEDEMA,21
CZ,SPINAL PAIN,21
CZ,TREATMENT FAILURE,21
CZ,BLOOD PHOSPHORUS INCREASED,20
CZ,BRAIN OEDEMA,20
CZ,BRONCHITIS,20
CZ,LUNG NEOPLASM MALIGNANT,20
CZ,MYELODYSPLASTIC SYNDROME,20
CZ,PERITONITIS,20
CZ,ABDOMINAL DISCOMFORT,19
CZ,BLOOD POTASSIUM INCREASED,19
CZ,DIABETES MELLITUS INADEQUATE CONTROL,19
CZ,DRUG EFFECT INCOMPLETE,19
CZ,DRUG RESISTANCE,19
CZ,FEMUR FRACTURE,19
CZ,HAEMORRHAGE,19
CZ,LIP SWELLING,19
CZ,LYMPHOCYTE COUNT DECREASED,19
CZ,PERIPHERAL SWELLING,19
CZ,PNEUMONITIS,19
CZ,POLYMYOSITIS,19
CZ,SPINAL FRACTURE,19
CZ,SUDDEN DEATH,19
CZ,TONGUE OEDEMA,19
CZ,ABDOMINAL PAIN UPPER,18
CZ,ACUTE HEPATIC FAILURE,18
CZ,ANGIOEDEMA,18
CZ,BLOOD SODIUM DECREASED,18
CZ,CHOLELITHIASIS,18
CZ,DIABETIC METABOLIC DECOMPENSATION,18
CZ,DISORIENTATION,18
CZ,ERYSIPELAS,18
CZ,HAEMODYNAMIC INSTABILITY,18
CZ,INTESTINAL HAEMORRHAGE,18
CZ,JAUNDICE,18
CZ,OXYGEN SATURATION DECREASED,18
CZ,PRESYNCOPE,18
CZ,PROSTATE CANCER,18
CZ,PSYCHOMOTOR HYPERACTIVITY,18
CZ,TOXIC EPIDERMAL NECROLYSIS,18
CZ,TUMOUR LYSIS SYNDROME,18
CZ,UROSEPSIS,18
CZ,BLOOD PRESSURE INCREASED,17
CZ,DEVICE DISLOCATION,17
CZ,LYMPHADENOPATHY,17
CZ,PANCREATITIS ACUTE,17
CZ,PARAPARESIS,17
CZ,SINUSITIS,17
CZ,SKIN DISORDER,17
CZ,SUICIDAL IDEATION,17
CZ,BODY TEMPERATURE INCREASED,16
CZ,GENITAL HAEMORRHAGE,16
CZ,HYPOTHYROIDISM,16
CZ,LEUKOCYTOSIS,16
CZ,LIVER FUNCTION TEST ABNORMAL,16
CZ,MULTI-ORGAN FAILURE,16
CZ,PSORIASIS,16
CZ,VENTRICULAR FIBRILLATION,16
CZ,ASCITES,15
CZ,CELLULITIS,15
CZ,CYSTITIS,15
CZ,DERMATITIS,15
CZ,DERMATITIS ACNEIFORM,15
CZ,DRUG-INDUCED LIVER INJURY,15
CZ,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,15
CZ,GASTROINTESTINAL HAEMORRHAGE,15
CZ,METASTASES TO LUNG,15
CZ,NEPHROTIC SYNDROME,15
CZ,OSTEOARTHRITIS,15
CZ,PELVIC PAIN,15
CZ,PLASMA CELL MYELOMA,15
CZ,RASH MACULO-PAPULAR,15
CZ,RHABDOMYOLYSIS,15
CZ,VISUAL ACUITY REDUCED,15
CZ,CARDIOGENIC SHOCK,14
CZ,CARDIOTOXICITY,14
CZ,CONJUNCTIVITIS,14
CZ,DRY MOUTH,14
CZ,DYSGEUSIA,14
CZ,GAMMA-GLUTAMYLTRANSFERASE INCREASED,14
CZ,GASTRITIS,14
CZ,LIVER FUNCTION TEST INCREASED,14
CZ,PATHOLOGICAL FRACTURE,14
CZ,PERIPHERAL ISCHAEMIA,14
CZ,PO2 INCREASED,14
CZ,RENAL CELL CARCINOMA,14
CZ,RHINITIS,14
CZ,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,14
CZ,ANGINA PECTORIS,13
CZ,CANDIDA INFECTION,13
CZ,CHRONIC KIDNEY DISEASE,13
CZ,DISSEMINATED INTRAVASCULAR COAGULATION,13
CZ,FLUSHING,13
CZ,HAEMATOMA,13
CZ,HALLUCINATION,13
CZ,HYDROTHORAX,13
CZ,HYPERTHYROIDISM,13
CZ,HYPOCALCAEMIA,13
CZ,INFLUENZA LIKE ILLNESS,13
CZ,INTERSTITIAL LUNG DISEASE,13
CZ,MALNUTRITION,13
CZ,MEDICATION ERROR,13
CZ,MELAENA,13
CZ,MENTAL DISORDER,13
CZ,MYOCARDIAL ISCHAEMIA,13
CZ,PERFORMANCE STATUS DECREASED,13
CZ,PERITONEAL HAEMORRHAGE,13
CZ,PLATELET COUNT DECREASED,13
CZ,PNEUMOCYSTIS JIROVECII PNEUMONIA,13
CZ,PREGNANCY,13
CZ,RENAL CANCER,13
CZ,VENOUS THROMBOSIS,13
CZ,VENOUS THROMBOSIS LIMB,13
CZ,ACUTE RESPIRATORY FAILURE,12
CZ,AGITATION,12
CZ,COMPLICATIONS OF TRANSPLANT SURGERY,12
CZ,DEPRESSED LEVEL OF CONSCIOUSNESS,12
CZ,DIPLOPIA,12
CZ,EXTRAPYRAMIDAL DISORDER,12
CZ,GASTROINTESTINAL STROMAL TUMOUR,12
CZ,HEPATITIS B,12
CZ,METASTASES TO BONE,12
CZ,METASTASES TO CENTRAL NERVOUS SYSTEM,12
CZ,MULTIPLE-DRUG RESISTANCE,12
CZ,MUSCULOSKELETAL STIFFNESS,12
CZ,PARAESTHESIA ORAL,12
CZ,PROTEINURIA,12
CZ,PULMONARY FIBROSIS,12
CZ,PYELONEPHRITIS,12
CZ,SECOND PRIMARY MALIGNANCY,12
CZ,SKIN EXFOLIATION,12
CZ,SKIN REACTION,12
CZ,THERAPEUTIC RESPONSE DECREASED,12
CZ,UTERINE LEIOMYOMA,12
CZ,ACCIDENTAL OVERDOSE,11
CZ,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,11
CZ,BLOOD PRESSURE DECREASED,11
CZ,CARDIOVASCULAR DISORDER,11
CZ,DELIRIUM,11
CZ,DYSKINESIA,11
CZ,DYSPHEMIA,11
CZ,DYSPNOEA EXERTIONAL,11
CZ,FACE OEDEMA,11
CZ,FLATULENCE,11
CZ,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,11
CZ,INVASIVE DUCTAL BREAST CARCINOMA,11
CZ,IRON DEFICIENCY ANAEMIA,11
CZ,LYMPHOPENIA,11
CZ,MALIGNANT MELANOMA,11
CZ,METRORRHAGIA,11
CZ,NEPHROLITHIASIS,11
CZ,OLIGURIA,11
CZ,OPTIC NEURITIS,11
CZ,PHOTOSENSITIVITY REACTION,11
CZ,SINUS TACHYCARDIA,11
CZ,VASOPLEGIA SYNDROME,11
CZ,AGGRESSION,10
CZ,AMENORRHOEA,10
CZ,BASAL CELL CARCINOMA,10
CZ,BRONCHOPULMONARY ASPERGILLOSIS,10
CZ,BRONCHOSPASM,10
CZ,CAESAREAN SECTION,10
CZ,CATARACT,10
CZ,CHOLESTASIS,10
CZ,CROHN^S DISEASE,10
CZ,CYANOSIS,10
CZ,DRUG HYPERSENSITIVITY,10
CZ,DRUG WITHDRAWAL SYNDROME,10
CZ,DRY SKIN,10
CZ,DYSURIA,10
CZ,EJECTION FRACTION DECREASED,10
CZ,ELECTROLYTE IMBALANCE,10
CZ,ESCHERICHIA INFECTION,10
CZ,EYELID OEDEMA,10
CZ,FEELING HOT,10
CZ,GENERALISED TONIC-CLONIC SEIZURE,10
CZ,GOITRE,10
CZ,HAEMOGLOBIN DECREASED,10
CZ,HEPATIC STEATOSIS,10
CZ,HEPATORENAL FAILURE,10
CZ,HYPOAESTHESIA,10
CZ,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,10
CZ,INCORRECT ROUTE OF DRUG ADMINISTRATION,10
CZ,LOW BIRTH WEIGHT BABY,10
CZ,MENSTRUATION IRREGULAR,10
CZ,METASTATIC RENAL CELL CARCINOMA,10
CZ,MYOPATHY,10
CZ,NEOPLASM PROGRESSION,10
CZ,NON-SMALL CELL LUNG CANCER,10
CZ,PARONYCHIA,10
CZ,PREMATURE BABY,10
CZ,PRURITUS GENERALISED,10
CZ,PSYCHOTIC DISORDER,10
CZ,RHEUMATOID ARTHRITIS,10
CZ,TRANSIENT ISCHAEMIC ATTACK,10
CZ,UPPER RESPIRATORY TRACT INFECTION,10
CZ,VISION BLURRED,10
CZ,ABDOMINAL DISTENSION,9
CZ,ABORTION INDUCED,9
CZ,ACNE,9
CZ,ACUTE RESPIRATORY DISTRESS SYNDROME,9
CZ,ANAPHYLACTIC SHOCK,9
CZ,APHTHOUS STOMATITIS,9
CZ,APHTHOUS ULCER,9
CZ,ASTHMA,9
CZ,BLISTER,9
CZ,BLOOD GLUCOSE INCREASED,9
CZ,BLOOD MAGNESIUM INCREASED,9
CZ,BURNING SENSATION,9
CZ,CACHEXIA,9
CZ,CARDIAC DISORDER,9
CZ,CLOSTRIDIUM DIFFICILE COLITIS,9
CZ,COGNITIVE DISORDER,9
CZ,CONVULSION,9
CZ,DISTURBANCE IN ATTENTION,9
CZ,DIVERTICULITIS,9
CZ,ENTERITIS,9
CZ,INFLAMMATION,9
CZ,INTERVERTEBRAL DISCITIS,9
CZ,JOINT SWELLING,9
CZ,LATENT TUBERCULOSIS,9
CZ,LUNG DISORDER,9
CZ,LUNG INFILTRATION,9
CZ,LUNG NEOPLASM,9
CZ,METASTASES TO LYMPH NODES,9
CZ,MYDRIASIS,9
CZ,NEPHROPATHY TOXIC,9
CZ,NERVOUS SYSTEM DISORDER,9
CZ,OSTEOMYELITIS,9
CZ,OVARIAN CYST,9
CZ,PETECHIAE,9
CZ,SPEECH DISORDER,9
CZ,TUBERCULOSIS,9
CZ,ACUTE CORONARY SYNDROME,8
CZ,ACUTE MONOCYTIC LEUKAEMIA,8
CZ,APATHY,8
CZ,ASPERGILLUS INFECTION,8
CZ,ATYPICAL PNEUMONIA,8
CZ,BLOOD BILIRUBIN INCREASED,8
CZ,BONE PAIN,8
CZ,CUSHINGOID,8
CZ,DIABETIC RETINOPATHY,8
CZ,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,8
CZ,ECZEMA,8
CZ,FOREARM FRACTURE,8
CZ,HAEMATOCRIT DECREASED,8
CZ,HAEMOPTYSIS,8
CZ,HALLUCINATION_ VISUAL,8
CZ,HERPES VIRUS INFECTION,8
CZ,HICCUPS,8
CZ,HUMERUS FRACTURE,8
CZ,HYPOMAGNESAEMIA,8
CZ,ILEUS PARALYTIC,8
CZ,IMMEDIATE POST-INJECTION REACTION,8
CZ,INFLAMMATORY MARKER INCREASED,8
CZ,INFLUENZA,8
CZ,LIPASE INCREASED,8
CZ,LIVER INJURY,8
CZ,NEOPLASM MALIGNANT,8
CZ,NEURALGIA,8
CZ,NEUTROPHIL COUNT DECREASED,8
CZ,ONYCHOLYSIS,8
CZ,PNEUMOTHORAX,8
CZ,POST PROCEDURAL COMPLICATION,8
CZ,PRODUCTIVE COUGH,8
CZ,PURPURA,8
CZ,RASH PRURITIC,8
CZ,RESPIRATORY ARREST,8
CZ,SKIN FISSURES,8
CZ,SPINAL CORD COMPRESSION,8
CZ,STAPHYLOCOCCAL INFECTION,8
CZ,STATUS EPILEPTICUS,8
CZ,TACHYPNOEA,8
CZ,TONSILLITIS,8
CZ,TRANSPLANT REJECTION,8
CZ,VIRAL INFECTION,8
CZ,WHITE BLOOD CELL COUNT DECREASED,8
CZ,ABORTION,7
CZ,ABSCESS LIMB,7
CZ,ADENOCARCINOMA OF COLON,7
CZ,ALCOHOL ABUSE,7
CZ,AMNESIA,7
CZ,AMYLASE INCREASED,7
CZ,ANURIA,7
CZ,APPENDICITIS,7
CZ,ATAXIA,7
CZ,BALANCE DISORDER,7
CZ,BLOOD ALKALINE PHOSPHATASE INCREASED,7
CZ,BLOOD MAGNESIUM DECREASED,7
CZ,BLOOD POTASSIUM DECREASED,7
CZ,CARDIAC FAILURE ACUTE,7
CZ,CENTRAL NERVOUS SYSTEM LESION,7
CZ,CEREBRAL ISCHAEMIA,7
CZ,DECUBITUS ULCER,7
CZ,DIABETIC NEUROPATHY,7
CZ,DUODENAL ULCER HAEMORRHAGE,7
CZ,DYSPNOEA AT REST,7
CZ,DYSTONIA,7
CZ,ELECTROCARDIOGRAM QT PROLONGED,7
CZ,ENDOCARDITIS,7
CZ,ENTEROCOLITIS,7
CZ,EYE SWELLING,7
CZ,FACIAL PARESIS,7
CZ,FEEDING DISORDER,7
CZ,FEELING COLD,7
CZ,GASTROOESOPHAGEAL REFLUX DISEASE,7
CZ,GRAFT VERSUS HOST DISEASE,7
CZ,HEART RATE INCREASED,7
CZ,HEPATIC CIRRHOSIS,7
CZ,HYPERBILIRUBINAEMIA,7
CZ,HYPOCHLORAEMIA,7
CZ,IMMUNOSUPPRESSION,7
CZ,INGUINAL HERNIA,7
CZ,INTESTINAL OBSTRUCTION,7
CZ,LEFT VENTRICULAR DYSFUNCTION,7
CZ,LOCALISED OEDEMA,7
CZ,LOWER RESPIRATORY TRACT INFECTION,7
CZ,LUMBAR VERTEBRAL FRACTURE,7
CZ,LUNG ADENOCARCINOMA,7
CZ,MENINGITIS ASEPTIC,7
CZ,METASTASES TO PERITONEUM,7
CZ,MOBILITY DECREASED,7
CZ,MULTIPLE USE OF SINGLE-USE PRODUCT,7
CZ,MYOCLONUS,7
CZ,MYOGLOBIN BLOOD INCREASED,7
CZ,PALLOR,7
CZ,PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA,7
CZ,PHARYNGEAL OEDEMA,7
CZ,PREMATURE DELIVERY,7
CZ,RENAL FAILURE ACUTE,7
CZ,RESPIRATORY DISTRESS,7
CZ,RIB FRACTURE,7
CZ,ROAD TRAFFIC ACCIDENT,7
CZ,SALMONELLA SEPSIS,7
CZ,SARCOPENIA,7
CZ,SCHIZOPHRENIA,7
CZ,SHOCK HAEMORRHAGIC,7
CZ,SKIN LESION,7
CZ,SKIN ULCER,7
CZ,SPINAL COMPRESSION FRACTURE,7
CZ,SPLENOMEGALY,7
CZ,VENTRICULAR TACHYCARDIA,7
CZ,YELLOW SKIN,7
CZ,ABSCESS,6
CZ,ACUTE GRAFT VERSUS HOST DISEASE,6
CZ,ASPIRATION,6
CZ,BLOOD PRESSURE FLUCTUATION,6
CZ,BODY HEIGHT DECREASED,6
CZ,BREAST CANCER METASTATIC,6
CZ,CARDIOMYOPATHY,6
CZ,CHEILITIS,6
CZ,CHOLECYSTITIS,6
CZ,CHRONIC GRAFT VERSUS HOST DISEASE,6
CZ,CLOSTRIDIUM COLITIS,6
CZ,COLITIS ULCERATIVE,6
CZ,CONCOMITANT DISEASE PROGRESSION,6
CZ,CONTUSION,6
CZ,CYTOPENIA,6
CZ,DIABETIC KETOACIDOSIS,6
CZ,DISINHIBITION,6
CZ,DYSPHONIA,6
CZ,EATING DISORDER,6
CZ,ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE,6
CZ,EMBOLISM VENOUS,6
CZ,ENDOPHTHALMITIS,6
CZ,EYE HAEMORRHAGE,6
CZ,FIBRIN D DIMER INCREASED,6
CZ,FISTULA,6
CZ,FOETAL DEATH,6
CZ,GLYCOSYLATED HAEMOGLOBIN INCREASED,6
CZ,HAEMATEMESIS,6
CZ,HAEMORRHAGE INTRACRANIAL,6
CZ,HEAD DISCOMFORT,6
CZ,HEAD INJURY,6
CZ,HEPATIC ENCEPHALOPATHY,6
CZ,HEPATIC FUNCTION ABNORMAL,6
CZ,HEPATITIS E,6
CZ,HODGKIN^S DISEASE,6
CZ,HYPERKERATOSIS,6
CZ,HYPOPROTEINAEMIA,6
CZ,INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT,6
CZ,INTERNATIONAL NORMALISED RATIO INCREASED,6
CZ,KLEBSIELLA INFECTION,6
CZ,LACRIMATION INCREASED,6
CZ,MENORRHAGIA,6
CZ,METASTASIS,6
CZ,MOOD ALTERED,6
CZ,MOTOR DYSFUNCTION,6
CZ,MOVEMENT DISORDER,6
CZ,MULTIPLE FRACTURES,6
CZ,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,6
CZ,NASOPHARYNGITIS,6
CZ,ONCOLOGIC COMPLICATION,6
CZ,ORAL CANDIDIASIS,6
CZ,OROPHARYNGEAL PAIN,6
CZ,PANCREATIC CARCINOMA,6
CZ,PANCREATITIS,6
CZ,PARESIS,6
CZ,PERICARDIAL EFFUSION,6
CZ,PERINEAL PAIN,6
CZ,PLEURISY,6
CZ,PSYCHOMOTOR RETARDATION,6
CZ,PULMONARY TOXICITY,6
CZ,PYELONEPHRITIS ACUTE,6
CZ,RENAL COLIC,6
CZ,RENAL FUNCTION TEST ABNORMAL,6
CZ,RESPIRATORY DISORDER,6
CZ,SALPINGO-OOPHORITIS,6
CZ,SLEEP DISORDER,6
CZ,STAPHYLOCOCCAL SEPSIS,6
CZ,SWELLING,6
CZ,TENDON RUPTURE,6
CZ,TENSION,6
CZ,THERAPY NON-RESPONDER,6
CZ,THIRST,6
CZ,THROAT IRRITATION,6
CZ,TICK-BORNE VIRAL ENCEPHALITIS,6
CZ,TINNITUS,6
CZ,TRANSAMINASES INCREASED,6
CZ,URINARY RETENTION,6
CZ,URTICARIAL VASCULITIS,6
CZ,UTERINE HAEMORRHAGE,6
CZ,UVEITIS,6
CZ,VENA CAVA THROMBOSIS,6
CZ,VENTRICULAR EXTRASYSTOLES,6
CZ,ABASIA,5
CZ,ABNORMAL BEHAVIOUR,5
CZ,ADENOCARCINOMA,5
CZ,AGRANULOCYTOSIS,5
CZ,APHASIA,5
CZ,ARTERIOSCLEROSIS CORONARY ARTERY,5
CZ,ARTHROPATHY,5
CZ,ATRIAL FLUTTER,5
CZ,AZOTAEMIA,5
CZ,B-CELL LYMPHOMA,5
CZ,BACTERIAL INFECTION,5
CZ,BLOOD CREATINE PHOSPHOKINASE INCREASED,5
CZ,BONE MARROW TOXICITY,5
CZ,BUNDLE BRANCH BLOCK RIGHT,5
CZ,CARDIAC TAMPONADE,5
CZ,CEREBRAL HAEMATOMA,5
CZ,CHLAMYDIAL INFECTION,5
CZ,CHOLANGITIS,5
CZ,CHOLECYSTITIS ACUTE,5
CZ,COMPLICATIONS OF TRANSPLANTED KIDNEY,5
CZ,CONJUNCTIVAL HYPERAEMIA,5
CZ,CORONARY ARTERY STENOSIS,5
CZ,CUSHING^S SYNDROME,5
CZ,DIABETIC NEPHROPATHY,5
CZ,DIARRHOEA HAEMORRHAGIC,5
CZ,DISEASE RECURRENCE,5
CZ,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,5
CZ,DRUG PRESCRIBING ERROR,5
CZ,DYSPAREUNIA,5
CZ,EXPIRED PRODUCT ADMINISTERED,5
CZ,EXPOSURE DURING BREAST FEEDING,5
CZ,EYE IRRITATION,5
CZ,FEELING ABNORMAL,5
CZ,FLUID INTAKE REDUCED,5
CZ,FOLLICULITIS,5
CZ,GANGRENE,5
CZ,GASTRIC DISORDER,5
CZ,GASTRIC ULCER,5
CZ,GENERALISED ERYTHEMA,5
CZ,HAEMATOSPERMIA,5
CZ,HAEMORRHAGIC ANAEMIA,5
CZ,HAEMORRHOIDS,5
CZ,HEPATIC LESION,5
CZ,HEPATITIS C,5
CZ,HEPATOCELLULAR CARCINOMA,5
CZ,HISTIOCYTOSIS HAEMATOPHAGIC,5
CZ,HYPERCALCAEMIA,5
CZ,HYPERPROLACTINAEMIA,5
CZ,HYPOGAMMAGLOBULINAEMIA,5
CZ,HYPOTONIA,5
CZ,HYPOXIA,5
CZ,IGA NEPHROPATHY,5
CZ,ILEAL STENOSIS,5
CZ,INJECTION SITE ERYTHEMA,5
CZ,IRRITABILITY,5
CZ,LABORATORY TEST ABNORMAL,5
CZ,LACERATION,5
CZ,LISTERIA SEPSIS,5
CZ,LYMPHOEDEMA,5
CZ,LYMPHOMA,5
CZ,MEMORY IMPAIRMENT,5
CZ,MENINGIOMA,5
CZ,METABOLIC DISORDER,5
CZ,METASTATIC NEOPLASM,5
CZ,MIGRAINE,5
CZ,MOUTH HAEMORRHAGE,5
CZ,MUSCLE NECROSIS,5
CZ,NON-CARDIAC CHEST PAIN,5
CZ,NORMOCHROMIC NORMOCYTIC ANAEMIA,5
CZ,OBSTRUCTIVE AIRWAYS DISORDER,5
CZ,PARKINSONISM,5
CZ,PERICARDITIS,5
CZ,PERITONSILLAR ABSCESS,5
CZ,PHARYNGITIS,5
CZ,PNEUMONIA FUNGAL,5
CZ,PO2 DECREASED,5
CZ,PRODUCT SOLUBILITY ABNORMAL,5
CZ,PSYCHOMOTOR SKILLS IMPAIRED,5
CZ,PULMONARY CONGESTION,5
CZ,PULMONARY HYPERTENSION,5
CZ,PULMONARY MYCOSIS,5
CZ,PULMONARY TUBERCULOSIS,5
CZ,RECTAL HAEMORRHAGE,5
CZ,RED BLOOD CELL COUNT DECREASED,5
CZ,RED BLOOD CELL SEDIMENTATION RATE INCREASED,5
CZ,RESPIRATION ABNORMAL,5
CZ,SENSATION OF FOREIGN BODY,5
CZ,SINUS BRADYCARDIA,5
CZ,SQUAMOUS CELL CARCINOMA OF SKIN,5
CZ,SUBDIAPHRAGMATIC ABSCESS,5
CZ,SUPRAVENTRICULAR TACHYCARDIA,5
CZ,THROMBOPHLEBITIS,5
CZ,THYROID CANCER,5
CZ,TOOTH DISORDER,5
CZ,TORSADE DE POINTES,5
CZ,TROPONIN I INCREASED,5
CZ,TUBULOINTERSTITIAL NEPHRITIS,5
CZ,URINARY INCONTINENCE,5
CZ,UTERINE INFLAMMATION,5
CZ,VAGINAL DISCHARGE,5
CZ,VENTRICULAR HYPOKINESIA,5
CZ,WHEEZING,5
CZ,WOUND,5
CZ,ABNORMAL DREAMS,4
CZ,ABNORMAL LOSS OF WEIGHT,4
CZ,ACTIVITIES OF DAILY LIVING IMPAIRED,4
CZ,ACUTE MOTOR AXONAL NEUROPATHY,4
CZ,ADENOCARCINOMA GASTRIC,4
CZ,ADVERSE EVENT,4
CZ,ALCOHOL POISONING,4
CZ,ANGINA UNSTABLE,4
CZ,ANGIOPATHY,4
CZ,ANKYLOSING SPONDYLITIS,4
CZ,APLASTIC ANAEMIA,4
CZ,ARTERIOSCLEROSIS,4
CZ,ARTERIOSPASM CORONARY,4
CZ,ARTHRITIS,4
CZ,ASPHYXIA,4
CZ,ATRIOVENTRICULAR BLOCK COMPLETE,4
CZ,AUTOIMMUNE HEPATITIS,4
CZ,BASILAR ARTERY OCCLUSION,4
CZ,BLADDER CANCER,4
CZ,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,4
CZ,BLOOD GLUCOSE FLUCTUATION,4
CZ,BLOOD PRESSURE IMMEASURABLE,4
CZ,BLOOD UREA INCREASED,4
CZ,BONE DISORDER,4
CZ,BRONCHIAL CARCINOMA,4
CZ,CALCULUS URINARY,4
CZ,CARDIAC AMYLOIDOSIS,4
CZ,CARDIAC FAILURE CONGESTIVE,4
CZ,CARDIO-RESPIRATORY ARREST,4
CZ,CAROTID ARTERY STENOSIS,4
CZ,CHOLANGIOCARCINOMA,4
CZ,CHOLANGITIS ACUTE,4
CZ,CHROMATURIA,4
CZ,COLON CANCER,4
CZ,COMPRESSION FRACTURE,4
CZ,CONGENITAL SYPHILIS,4
CZ,CONJUNCTIVAL HAEMORRHAGE,4
CZ,CONTRAINDICATED PRODUCT ADMINISTERED,4
CZ,CORONARY ARTERY DISEASE,4
CZ,CYTOMEGALOVIRUS COLITIS,4
CZ,CYTOMEGALOVIRUS SYNDROME,4
CZ,DERMATITIS BULLOUS,4
CZ,DEVICE FAILURE,4
CZ,DEVICE USE ISSUE,4
CZ,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,4
CZ,EAR INFECTION,4
CZ,EMBOLIC STROKE,4
CZ,EMOTIONAL DISORDER,4
CZ,ENDOMETRIOSIS,4
CZ,ESCHERICHIA SEPSIS,4
CZ,EYE PAIN,4
CZ,FAECES DISCOLOURED,4
CZ,FEMORAL NECK FRACTURE,4
CZ,FLUID OVERLOAD,4
CZ,FUNGAL INFECTION,4
CZ,GASTRIC HAEMORRHAGE,4
CZ,GASTROINTESTINAL WALL THICKENING,4
CZ,GINGIVAL BLEEDING,4
CZ,GRANULOMATOUS LIVER DISEASE,4
CZ,GROWTH RETARDATION,4
CZ,HAEMATOCHEZIA,4
CZ,HAEMOTHORAX,4
CZ,HEMIANOPIA,4
CZ,HEMIPLEGIA,4
CZ,HIP FRACTURE,4
CZ,HYPERCALCIURIA,4
CZ,HYPERPYREXIA,4
CZ,HYPERTONIA,4
CZ,HYPERURICAEMIA,4
CZ,HYPONATRAEMIC ENCEPHALOPATHY,4
CZ,HYPOPHYSITIS,4
CZ,IMMUNE THROMBOCYTOPENIC PURPURA,4
CZ,IMMUNOGLOBULINS INCREASED,4
CZ,IMPAIRED HEALING,4
CZ,INCORRECT DOSE ADMINISTERED,4
CZ,INJURY,4
CZ,INTENTIONAL DRUG MISUSE,4
CZ,INTRAOCULAR PRESSURE INCREASED,4
CZ,IRIDOCYCLITIS,4
CZ,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,4
CZ,LACTOSE INTOLERANCE,4
CZ,LYMPHADENOPATHY MEDIASTINAL,4
CZ,LYMPHOCYTIC INFILTRATION,4
CZ,MENINGITIS,4
CZ,MENINGITIS LISTERIA,4
CZ,MENOMETRORRHAGIA,4
CZ,MINERAL DEFICIENCY,4
CZ,MOUTH SWELLING,4
CZ,MUSCLE CONTRACTIONS INVOLUNTARY,4
CZ,MUSCLE RIGIDITY,4
CZ,NAIL DISCOLOURATION,4
CZ,NECK PAIN,4
CZ,NECROSIS,4
CZ,NEPHRITIS,4
CZ,NEPHROPATHY,4
CZ,NUTRITIONAL CONDITION ABNORMAL,4
CZ,ODYNOPHAGIA,4
CZ,ORAL DISORDER,4
CZ,ORTHOSTATIC HYPOTENSION,4
CZ,OSTEOPOROTIC FRACTURE,4
CZ,OVARIAN CANCER,4
CZ,PANCREATIC DISORDER,4
CZ,PANCREATITIS CHRONIC,4
CZ,PERIPHERAL VASCULAR DISORDER,4
CZ,PHOTOPHOBIA,4
CZ,PITUITARY TUMOUR BENIGN,4
CZ,PNEUMONIA BACTERIAL,4
CZ,POOR QUALITY SLEEP,4
CZ,POST PROCEDURAL HAEMORRHAGE,4
CZ,PSEUDOMONAS INFECTION,4
CZ,PSYCHIATRIC DECOMPENSATION,4
CZ,PULMONARY HAEMORRHAGE,4
CZ,PULMONARY INFARCTION,4
CZ,PULSELESS ELECTRICAL ACTIVITY,4
CZ,RADIUS FRACTURE,4
CZ,RASH MACULAR,4
CZ,RASH PAPULAR,4
CZ,RAYNAUD^S PHENOMENON,4
CZ,RENAL CANCER METASTATIC,4
CZ,RENAL FAILURE CHRONIC,4
CZ,RETINAL DEPIGMENTATION,4
CZ,RETINAL PIGMENT EPITHELIAL TEAR,4
CZ,RHINORRHOEA,4
CZ,SOPOR,4
CZ,SPINAL COLUMN STENOSIS,4
CZ,STRESS,4
CZ,STRESS CARDIOMYOPATHY,4
CZ,SUBRETINAL FIBROSIS,4
CZ,SWOLLEN TONGUE,4
CZ,SYPHILIS,4
CZ,SYSTOLIC DYSFUNCTION,4
CZ,THYROID DISORDER,4
CZ,TOBACCO ABUSE,4
CZ,TOOTHACHE,4
CZ,TRANSPLANT FAILURE,4
CZ,UTERINE PERFORATION,4
CZ,VARICOSE ULCERATION,4
CZ,VERTEBRAL ARTERY OCCLUSION,4
CZ,VIITH NERVE PARALYSIS,4
CZ,VITREOUS HAEMORRHAGE,4
CZ,WHITE BLOOD CELL COUNT INCREASED,4
CZ,WITHDRAWAL SYNDROME,4
CZ,WOUND INFECTION,4
CZ,ABDOMINAL ABSCESS,3
CZ,ACCELERATED HYPERTENSION,3
CZ,ACIDOSIS,3
CZ,ACUTE ABDOMEN,3
CZ,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,3
CZ,ALCOHOL INTERACTION,3
CZ,ALPHA 1 FOETOPROTEIN INCREASED,3
CZ,AMYLOIDOSIS,3
CZ,ANKLE FRACTURE,3
CZ,ANTIPSYCHOTIC DRUG LEVEL INCREASED,3
CZ,AORTIC STENOSIS,3
CZ,ARACHNOIDITIS,3
CZ,ARTHRITIS INFECTIVE,3
CZ,ATRIAL SEPTAL DEFECT,3
CZ,ATRIAL TACHYCARDIA,3
CZ,ATRIAL THROMBOSIS,3
CZ,AUTOIMMUNE DISORDER,3
CZ,AUTOIMMUNE HAEMOLYTIC ANAEMIA,3
CZ,BLADDER TRANSITIONAL CELL CARCINOMA,3
CZ,BLIGHTED OVUM,3
CZ,BLOOD COUNT ABNORMAL,3
CZ,BLOOD LACTIC ACID INCREASED,3
CZ,BLOOD PHOSPHORUS DECREASED,3
CZ,BONE LESION,3
CZ,BRADYPHRENIA,3
CZ,BRAIN ABSCESS,3
CZ,BRAIN NEOPLASM,3
CZ,BREAST CANCER FEMALE,3
CZ,BREAST PAIN,3
CZ,BRONCHOPULMONARY DYSPLASIA,3
CZ,BURSITIS,3
CZ,CANCER PAIN,3
CZ,CARDIAC FAILURE CHRONIC,3
CZ,CARDIAC HYPERTROPHY,3
CZ,CATHETER SITE ERYTHEMA,3
CZ,CATHETER SITE PAIN,3
CZ,CEREBRAL VENOUS THROMBOSIS,3
CZ,CEREBROSPINAL FLUID LEAKAGE,3
CZ,CERVIX CARCINOMA,3
CZ,CHEST WALL HAEMATOMA,3
CZ,CHRONIC MYELOID LEUKAEMIA,3
CZ,CLOSTRIDIUM DIFFICILE INFECTION,3
CZ,CLOSTRIDIUM TEST POSITIVE,3
CZ,COLITIS MICROSCOPIC,3
CZ,COLORECTAL CANCER,3
CZ,COMPARTMENT SYNDROME,3
CZ,CREPITATIONS,3
CZ,CYST,3
CZ,DEFAECATION URGENCY,3
CZ,DEMYELINATION,3
CZ,DERMATITIS EXFOLIATIVE,3
CZ,DEVICE RELATED SEPSIS,3
CZ,DIALYSIS,3
CZ,DIFFUSE LARGE B-CELL LYMPHOMA,3
CZ,DOPAMINE DYSREGULATION SYNDROME,3
CZ,DROWNING,3
CZ,DRUG DOSE OMISSION,3
CZ,DRUG EFFECT DECREASED,3
CZ,DUODENITIS,3
CZ,DYSMENORRHOEA,3
CZ,ECTOPIC PREGNANCY,3
CZ,ELECTROCARDIOGRAM ABNORMAL,3
CZ,EMPYEMA,3
CZ,ENCEPHALITIS VIRAL,3
CZ,ENDOMETRIAL ADENOCARCINOMA,3
CZ,ENDOMETRIAL CANCER,3
CZ,ENTEROCOCCAL INFECTION,3
CZ,ENURESIS,3
CZ,EOSINOPHILIA,3
CZ,EOSINOPHILIC COLITIS,3
CZ,EPIGLOTTITIS,3
CZ,EPSTEIN-BARR VIRUS INFECTION,3
CZ,ERYTHEMA NODOSUM,3
CZ,EYE INFLAMMATION,3
CZ,FINE MOTOR SKILL DYSFUNCTION,3
CZ,FOAMING AT MOUTH,3
CZ,FOOT FRACTURE,3
CZ,FRACTURE,3
CZ,FUNGAL SEPSIS,3
CZ,FUNGAL SKIN INFECTION,3
CZ,GASTRIC ULCER HAEMORRHAGE,3
CZ,GASTROENTERITIS ROTAVIRUS,3
CZ,GASTROENTERITIS SALMONELLA,3
CZ,GASTROINTESTINAL INFLAMMATION,3
CZ,GASTROINTESTINAL NECROSIS,3
CZ,GENERALISED OEDEMA,3
CZ,GINGIVAL SWELLING,3
CZ,GINGIVITIS,3
CZ,GLOMERULONEPHRITIS MINIMAL LESION,3
CZ,GRANULOMA,3
CZ,GUILLAIN-BARRE SYNDROME,3
CZ,HAEMODIALYSIS,3
CZ,HAEMOLYSIS,3
CZ,HAEMOLYTIC ANAEMIA,3
CZ,HAEMORRHAGE IN PREGNANCY,3
CZ,HAEMORRHAGIC STROKE,3
CZ,HAIR COLOUR CHANGES,3
CZ,HALLUCINATION_ AUDITORY,3
CZ,HEART RATE DECREASED,3
CZ,HEART RATE IRREGULAR,3
CZ,HENOCH-SCHONLEIN PURPURA,3
CZ,HEPATIC NECROSIS,3
CZ,HEPATOMEGALY,3
CZ,HEPATOSPLENOMEGALY,3
CZ,HYDROCEPHALUS,3
CZ,HYPERAMMONAEMIA,3
CZ,HYPERPARATHYROIDISM SECONDARY,3
CZ,HYPERREFLEXIA,3
CZ,HYPERSOMNIA,3
CZ,HYPERTENSIVE CRISIS,3
CZ,HYPERTRIGLYCERIDAEMIA,3
CZ,HYPOACUSIS,3
CZ,HYPOALBUMINAEMIA,3
CZ,HYPOGLYCAEMIC COMA,3
CZ,HYPOKINESIA,3
CZ,HYPOPHAGIA,3
CZ,HYSTERECTOMY,3
CZ,IDIOSYNCRATIC DRUG REACTION,3
CZ,IMMOBILE,3
CZ,IMPAIRED GASTRIC EMPTYING,3
CZ,IMPETIGO,3
CZ,INCONTINENCE,3
CZ,INFARCTION,3
CZ,INJECTION SITE PAIN,3
CZ,INJECTION SITE REACTION,3
CZ,INTENTIONAL PRODUCT USE ISSUE,3
CZ,INTERVERTEBRAL DISC COMPRESSION,3
CZ,INTERVERTEBRAL DISC PROTRUSION,3
DK,FATIGUE,562
DK,DYSPNOEA,560
DK,DIZZINESS,520
DK,OSTEONECROSIS OF JAW,507
DK,FOETAL EXPOSURE DURING PREGNANCY,497
DK,NAUSEA,433
DK,PYREXIA,349
DK,VOMITING,339
DK,HEADACHE,337
DK,MALAISE,322
DK,ABORTION SPONTANEOUS,303
DK,TOXICITY TO VARIOUS AGENTS,288
DK,DIARRHOEA,286
DK,SUICIDE ATTEMPT,274
DK,PAIN,271
DK,PAIN IN EXTREMITY,253
DK,ARTHRALGIA,240
DK,INTENTIONAL OVERDOSE,233
DK,DEATH,221
DK,MYALGIA,221
DK,DRUG INEFFECTIVE,215
DK,PARAESTHESIA,211
DK,CARDIAC ARREST,207
DK,MEMORY IMPAIRMENT,207
DK,ABDOMINAL PAIN,204
DK,WEIGHT DECREASED,203
DK,PNEUMONIA,196
DK,DRUG DEPENDENCE,184
DK,FALL,182
DK,MUSCLE SPASMS,178
DK,INFECTION,175
DK,GAIT DISTURBANCE,174
DK,RASH,174
DK,MUSCULAR WEAKNESS,170
DK,VISUAL IMPAIRMENT,168
DK,ANXIETY,167
DK,OVERDOSE,164
DK,PRURITUS,161
DK,CONFUSIONAL STATE,159
DK,SENSORY DISTURBANCE,159
DK,CONGENITAL ANOMALY,155
DK,HYPERSENSITIVITY,155
DK,ANAEMIA,154
DK,SUICIDAL IDEATION,153
DK,TREMOR,153
DK,DISEASE PROGRESSION,151
DK,EXPOSED BONE IN JAW,150
DK,DISTURBANCE IN ATTENTION,147
DK,ASTHENIA,145
DK,HYPOTENSION,145
DK,VENOOCCLUSIVE LIVER DISEASE,145
DK,RESTLESSNESS,142
DK,BACK PAIN,136
DK,CHEST PAIN,135
DK,INCORRECT DRUG ADMINISTRATION DURATION,134
DK,RENAL IMPAIRMENT,133
DK,PALPITATIONS,132
DK,DEPRESSION,130
DK,CARDIAC FAILURE,128
DK,INSOMNIA,126
DK,LOSS OF CONSCIOUSNESS,124
DK,ABDOMINAL PAIN UPPER,121
DK,GENERAL PHYSICAL HEALTH DETERIORATION,121
DK,SYNCOPE,120
DK,COUGH,117
DK,DEHYDRATION,116
DK,WEIGHT INCREASED,115
DK,SEPSIS,113
DK,PULMONARY EMBOLISM,111
DK,CONSTIPATION,110
DK,HYPERTENSION,108
DK,ATRIAL FIBRILLATION,107
DK,EXPOSURE DURING PREGNANCY,107
DK,DECREASED APPETITE,106
DK,ERYTHEMA,106
DK,HYPERHIDROSIS,105
DK,SOMNOLENCE,104
DK,FEBRILE NEUTROPENIA,101
DK,OEDEMA PERIPHERAL,101
DK,SPEECH DISORDER,101
DK,BALANCE DISORDER,99
DK,CEREBRAL HAEMORRHAGE,98
DK,COGNITIVE DISORDER,97
DK,RENAL FAILURE,95
DK,NEUTROPENIA,94
DK,RHABDOMYOLYSIS,94
DK,RESPIRATORY FAILURE,89
DK,CHEST DISCOMFORT,86
DK,HYPOAESTHESIA,86
DK,URTICARIA,86
DK,DEPRESSED LEVEL OF CONSCIOUSNESS,85
DK,PRODUCT USE ISSUE,85
DK,PSYCHOTIC DISORDER,85
DK,SEIZURE,85
DK,THROMBOSIS,85
DK,VISION BLURRED,85
DK,AGGRESSION,84
DK,ANGIOEDEMA,84
DK,DRY MOUTH,84
DK,SLEEP DISORDER,82
DK,MATERNAL EXPOSURE DURING PREGNANCY,81
DK,ALANINE AMINOTRANSFERASE INCREASED,80
DK,JAW OPERATION,80
DK,HYPONATRAEMIA,79
DK,LEUKOPENIA,78
DK,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,78
DK,PERIPHERAL SWELLING,77
DK,AUTISM SPECTRUM DISORDER,75
DK,BLOOD CREATININE INCREASED,75
DK,THROMBOCYTOPENIA,74
DK,SEQUESTRECTOMY,73
DK,ALOPECIA,72
DK,PAIN IN JAW,72
DK,DISCOMFORT,71
DK,DEEP VEIN THROMBOSIS,70
DK,ANAPHYLACTIC REACTION,69
DK,HAEMOGLOBIN DECREASED,69
DK,INTERSTITIAL LUNG DISEASE,67
DK,HALLUCINATION,66
DK,MUSCULOSKELETAL STIFFNESS,66
DK,NEUROPATHY PERIPHERAL,65
DK,HEPATIC ENZYME INCREASED,64
DK,STOMATITIS,64
DK,ELECTROCARDIOGRAM QT PROLONGED,63
DK,NEPHROGENIC SYSTEMIC FIBROSIS,63
DK,CONDITION AGGRAVATED,62
DK,FEELING ABNORMAL,62
DK,ACUTE KIDNEY INJURY,61
DK,HAEMORRHAGE,61
DK,SWELLING,61
DK,INFLUENZA LIKE ILLNESS,60
DK,MUSCULOSKELETAL PAIN,60
DK,PREGNANCY,60
DK,ACUTE MYOCARDIAL INFARCTION,59
DK,HEMIPARESIS,59
DK,TINNITUS,59
DK,APHASIA,58
DK,C-REACTIVE PROTEIN INCREASED,58
DK,CEREBRAL INFARCTION,58
DK,HEART RATE INCREASED,58
DK,ABDOMINAL DISCOMFORT,56
DK,ANGINA PECTORIS,56
DK,ARRHYTHMIA,56
DK,CEREBRAL THROMBOSIS,56
DK,COMPLETED SUICIDE,56
DK,DEPRESSED MOOD,56
DK,DIPLOPIA,56
DK,DYSPHAGIA,56
DK,PULMONARY FIBROSIS,56
DK,LACTIC ACIDOSIS,55
DK,PLEURAL EFFUSION,55
DK,PRODUCT USE IN UNAPPROVED INDICATION,55
DK,BREAST CANCER,53
DK,HEPATIC FAILURE,53
DK,INTERNATIONAL NORMALISED RATIO INCREASED,53
DK,METASTASIS,53
DK,OEDEMA,53
DK,SWELLING FACE,52
DK,VISUAL ACUITY REDUCED,52
DK,AMNESIA,51
DK,DYSGEUSIA,51
DK,JAUNDICE,51
DK,POLYNEUROPATHY,51
DK,SEDATION,51
DK,TACHYCARDIA,51
DK,URINARY TRACT INFECTION,51
DK,HYPOKALAEMIA,50
DK,SWOLLEN TONGUE,50
DK,ALTERED STATE OF CONSCIOUSNESS,49
DK,DYSKINESIA,49
DK,LIVER DISORDER,49
DK,OSTEOPOROSIS,49
DK,PHARYNGEAL OEDEMA,49
DK,WITHDRAWAL SYNDROME,49
DK,METASTASES TO LIVER,48
DK,MYOCARDIAL INFARCTION,48
DK,NERVOUS SYSTEM DISORDER,48
DK,CARDIAC DISORDER,47
DK,SKIN DISCOLOURATION,47
DK,EPISTAXIS,46
DK,NEURALGIA,46
DK,IMPAIRED HEALING,45
DK,IMPAIRED WORK ABILITY,45
DK,NIGHTMARE,45
DK,STRESS,45
DK,BRADYCARDIA,44
DK,BRAIN INJURY,44
DK,GASTROINTESTINAL DISORDER,44
DK,MALIGNANT NEOPLASM PROGRESSION,44
DK,TOOTH DISORDER,44
DK,CEREBROVASCULAR ACCIDENT,43
DK,LUNG NEOPLASM MALIGNANT,43
DK,TORSADE DE POINTES,43
DK,BLOOD PRESSURE DECREASED,42
DK,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,42
DK,DRUG ABUSE,42
DK,EPILEPSY,42
DK,EJECTION FRACTION DECREASED,41
DK,HAEMATEMESIS,41
DK,TOOTH EXTRACTION,41
DK,BLISTER,40
DK,BONE MARROW FAILURE,40
DK,DYSPEPSIA,40
DK,LETHARGY,40
DK,LIP SWELLING,40
DK,LOCAL SWELLING,40
DK,LUNG INFILTRATION,40
DK,MOTOR DYSFUNCTION,40
DK,PRESCRIBED OVERDOSE,40
DK,ERECTILE DYSFUNCTION,39
DK,EYE PAIN,39
DK,HYPERKALAEMIA,39
DK,MOBILITY DECREASED,39
DK,PNEUMONITIS,39
DK,ABDOMINAL DISTENSION,38
DK,ANAPHYLACTIC SHOCK,38
DK,CONVULSION,38
DK,SUBDURAL HAEMATOMA,38
DK,BLOOD CREATINE PHOSPHOKINASE INCREASED,37
DK,CHILLS,37
DK,HEMIPLEGIA,37
DK,NEUROTOXICITY,37
DK,PREMATURE BABY,37
DK,PRODUCT SUBSTITUTION ISSUE,37
DK,URINARY RETENTION,37
DK,BURNING SENSATION,36
DK,DRUG WITHDRAWAL SYNDROME,36
DK,HOT FLUSH,36
DK,LYMPHADENOPATHY,36
DK,PANCYTOPENIA,36
DK,SEROTONIN SYNDROME,36
DK,GASTROINTESTINAL HAEMORRHAGE,35
DK,HAEMATURIA,35
DK,HYPERSOMNIA,35
DK,JOINT SWELLING,35
DK,MENTAL DISORDER,35
DK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,35
DK,OSTEONECROSIS,35
DK,PANCREATITIS ACUTE,35
DK,PULMONARY OEDEMA,35
DK,URINARY INCONTINENCE,35
DK,ACCIDENTAL OVERDOSE,34
DK,ASCITES,34
DK,DIABETIC KETOACIDOSIS,34
DK,HAEMATOMA,34
DK,MUSCLE TIGHTNESS,34
DK,OROPHARYNGEAL PAIN,34
DK,SKIN EXFOLIATION,34
DK,COLITIS ULCERATIVE,33
DK,DYSPNOEA EXERTIONAL,33
DK,GASTRIC ULCER,33
DK,MULTI-ORGAN FAILURE,33
DK,MUSCLE ATROPHY,33
DK,MYELODYSPLASTIC SYNDROME,33
DK,RASH PRURITIC,33
DK,DENTAL CARIES,32
DK,LIMB DISCOMFORT,32
DK,LUNG INFECTION,32
DK,MENTAL IMPAIRMENT,32
DK,SURGERY,32
DK,COORDINATION ABNORMAL,31
DK,DRUG-INDUCED LIVER INJURY,31
DK,DYSARTHRIA,31
DK,EOSINOPHILIC MYOCARDITIS,31
DK,HEART RATE DECREASED,31
DK,ORAL PAIN,31
DK,VENTRICULAR FIBRILLATION,31
DK,AGITATION,30
DK,BLOOD PRESSURE INCREASED,30
DK,CHROMATURIA,30
DK,METASTASES TO BONE,30
DK,NASOPHARYNGITIS,30
DK,RESPIRATORY DISORDER,30
DK,WALKING DISABILITY,30
DK,CATARACT,29
DK,DELIRIUM,29
DK,DIABETES MELLITUS,29
DK,DISORIENTATION,29
DK,DRY EYE,29
DK,FRACTURE,29
DK,INFUSION RELATED REACTION,29
DK,LOOSE TOOTH,29
DK,PANCREATITIS,29
DK,PULMONARY FUNCTION TEST DECREASED,29
DK,WOUND,29
DK,CYANOSIS,28
DK,DRUG RESISTANCE,28
DK,IRRITABILITY,28
DK,MATERNAL DRUGS AFFECTING FOETUS,28
DK,NECK PAIN,28
DK,NEUROLEPTIC MALIGNANT SYNDROME,28
DK,PHOTOPHOBIA,28
DK,PNEUMONIA ASPIRATION,28
DK,RESPIRATORY ARREST,28
DK,SEPTIC SHOCK,28
DK,THROAT TIGHTNESS,28
DK,TOOTH LOSS,28
DK,VISUAL FIELD DEFECT,28
DK,BASAL CELL CARCINOMA,27
DK,CARDIOVASCULAR DISORDER,27
DK,COMA,27
DK,DRUG HYPERSENSITIVITY,27
DK,DRUG LEVEL INCREASED,27
DK,GASTRIC ULCER HAEMORRHAGE,27
DK,GASTROOESOPHAGEAL REFLUX DISEASE,27
DK,MULTIPLE SCLEROSIS,27
DK,PERICARDITIS,27
DK,PERIPHERAL SENSORY NEUROPATHY,27
DK,PRURITUS GENERALISED,27
DK,ERYSIPELAS,26
DK,FEELING HOT,26
DK,HALLUCINATION_ VISUAL,26
DK,MELAENA,26
DK,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,26
DK,POISONING,26
DK,BLINDNESS,25
DK,COLITIS,25
DK,CYSTITIS,25
DK,CYTOPENIA,25
DK,DYSURIA,25
DK,ENDOTRACHEAL INTUBATION,25
DK,FEELING COLD,25
DK,GLOMERULAR FILTRATION RATE DECREASED,25
DK,MALIGNANT MELANOMA,25
DK,MOUTH SWELLING,25
DK,NERVE INJURY,25
DK,PALLOR,25
DK,ABNORMAL BEHAVIOUR,24
DK,ARTHRITIS,24
DK,BLOOD ALKALINE PHOSPHATASE INCREASED,24
DK,ECZEMA,24
DK,FACIAL PARESIS,24
DK,FAECES DISCOLOURED,24
DK,HAEMOPTYSIS,24
DK,HYPOACUSIS,24
DK,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,24
DK,NEPHROPATHY TOXIC,24
DK,POLLAKIURIA,24
DK,PREMATURE MENOPAUSE,24
DK,PRESYNCOPE,24
DK,RASH GENERALISED,24
DK,SCHIZOPHRENIA,24
DK,SKIN BURNING SENSATION,24
DK,VENTRICULAR TACHYCARDIA,24
DK,ANGER,23
DK,ASTHMA,23
DK,BLOOD CHOLESTEROL INCREASED,23
DK,BODY TEMPERATURE INCREASED,23
DK,CONTUSION,23
DK,DRY SKIN,23
DK,ENCEPHALOPATHY,23
DK,GINGIVITIS,23
DK,HEAD DISCOMFORT,23
DK,HYPOGLYCAEMIA,23
DK,INTRACRANIAL PRESSURE INCREASED,23
DK,MUSCLE TWITCHING,23
DK,PARAESTHESIA ORAL,23
DK,PSORIASIS,23
DK,SPLENOMEGALY,23
DK,ACTIVITIES OF DAILY LIVING IMPAIRED,22
DK,AKATHISIA,22
DK,BLOOD GLUCOSE INCREASED,22
DK,BRONCHOPULMONARY ASPERGILLOSIS,22
DK,CRYING,22
DK,EXPOSURE DURING BREAST FEEDING,22
DK,EYE HAEMORRHAGE,22
DK,HAEMODIALYSIS,22
DK,HALLUCINATION_ AUDITORY,22
DK,HYPERTHYROIDISM,22
DK,INCORRECT ROUTE OF DRUG ADMINISTRATION,22
DK,INTENTIONAL PRODUCT MISUSE,22
DK,JOINT STIFFNESS,22
DK,LINEAR IGA DISEASE,22
DK,MUSCLE RIGIDITY,22
DK,OCULAR HYPERAEMIA,22
DK,ORAL CANDIDIASIS,22
DK,ORAL FUNGAL INFECTION,22
DK,OXYGEN SATURATION DECREASED,22
DK,PARALYSIS,22
DK,PERIPHERAL COLDNESS,22
DK,THROAT IRRITATION,22
DK,TOOTH FRACTURE,22
DK,ASPARTATE AMINOTRANSFERASE INCREASED,21
DK,BRAIN OEDEMA,21
DK,CARDIOMYOPATHY,21
DK,CHORIORETINOPATHY,21
DK,DIALYSIS,21
DK,EATING DISORDER,21
DK,HEART DISEASE CONGENITAL,21
DK,HEPATITIS TOXIC,21
DK,HEPATOTOXICITY,21
DK,LUNG DISORDER,21
DK,PROSTATE CANCER,21
DK,QUALITY OF LIFE DECREASED,21
DK,STEVENS-JOHNSON SYNDROME,21
DK,VAGINAL HAEMORRHAGE,21
DK,WHITE BLOOD CELL COUNT DECREASED,21
DK,ALVEOLITIS ALLERGIC,20
DK,BLOOD BILIRUBIN INCREASED,20
DK,HAEMORRHAGIC DIATHESIS,20
DK,HEPATIC FUNCTION ABNORMAL,20
DK,HYPERACUSIS,20
DK,HYPERAESTHESIA,20
DK,HYPERAMMONAEMIC ENCEPHALOPATHY,20
DK,MANIA,20
DK,MIGRAINE,20
DK,MYOPATHY,20
DK,PLATELET COUNT DECREASED,20
DK,PRODUCT QUALITY ISSUE,20
DK,RECTAL HAEMORRHAGE,20
DK,THIRST,20
DK,ABORTION INDUCED,19
DK,ANURIA,19
DK,BONE PAIN,19
DK,CHOLELITHIASIS,19
DK,DEPENDENCE,19
DK,DEREALISATION,19
DK,DERMATITIS,19
DK,DRUG PRESCRIBING ERROR,19
DK,EYE SWELLING,19
DK,FUNGAL INFECTION,19
DK,HAEMATOCHEZIA,19
DK,INCORRECT DOSE ADMINISTERED,19
DK,MEDICATION ERROR,19
DK,MOOD SWINGS,19
DK,MUCOSAL INFLAMMATION,19
DK,NIGHT SWEATS,19
DK,ORTHOSTATIC HYPOTENSION,19
DK,RESTLESS LEGS SYNDROME,19
DK,SKIN INFECTION,19
DK,VASCULITIS,19
DK,VERTIGO,19
DK,ADVERSE EVENT,18
DK,AZOTAEMIA,18
DK,BONE DISORDER,18
DK,CROHN^S DISEASE,18
DK,DELUSION,18
DK,DYSSTASIA,18
DK,DYSTONIA,18
DK,EYE DISORDER,18
DK,FOOD AVERSION,18
DK,GENERALISED TONIC-CLONIC SEIZURE,18
DK,HEPATIC CIRRHOSIS,18
DK,HEPATIC STEATOSIS,18
DK,HYPOXIA,18
DK,ILEUS,18
DK,INTENTIONAL DRUG MISUSE,18
DK,MOVEMENT DISORDER,18
DK,MYOCLONUS,18
DK,NICOTINE DEPENDENCE,18
DK,OESOPHAGEAL OBSTRUCTION,18
DK,PARKINSON^S DISEASE,18
DK,PERIODONTITIS,18
DK,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,18
DK,PULMONARY HYPERTENSION,18
DK,PULMONARY TOXICITY,18
DK,RESPIRATORY SYMPTOM,18
DK,SINUS BRADYCARDIA,18
DK,SUDDEN DEATH,18
DK,TENDERNESS,18
DK,TENDON RUPTURE,18
DK,TIC,18
DK,TOXIC EPIDERMAL NECROLYSIS,18
DK,WHEELCHAIR USER,18
DK,BEZOAR,17
DK,DIARRHOEA HAEMORRHAGIC,17
DK,DRUG DOSE OMISSION,17
DK,DYSAESTHESIA,17
DK,DYSPHONIA,17
DK,FISTULA,17
DK,FOOT FRACTURE,17
DK,HEART RATE IRREGULAR,17
DK,HYPERCALCAEMIA,17
DK,INVASIVE DUCTAL BREAST CARCINOMA,17
DK,KETOACIDOSIS,17
DK,LUPUS-LIKE SYNDROME,17
DK,LYMPHOEDEMA,17
DK,MYOCARDITIS,17
DK,NEOPLASM MALIGNANT,17
DK,PLASMA CELL MYELOMA,17
DK,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,17
DK,SKIN CANCER,17
DK,TRANSIENT ISCHAEMIC ATTACK,17
DK,AGEUSIA,16
DK,DEVELOPMENTAL GLAUCOMA,16
DK,FLATULENCE,16
DK,HERPES ZOSTER,16
DK,HYPERGLYCAEMIA,16
DK,HYPOKINESIA,16
DK,INFLUENZA,16
DK,LIVER FUNCTION TEST ABNORMAL,16
DK,METASTASES TO CENTRAL NERVOUS SYSTEM,16
DK,MUSCLE FATIGUE,16
DK,MUSCULOSKELETAL DISCOMFORT,16
DK,NEUROLOGICAL SYMPTOM,16
DK,NEUTROPHIL COUNT DECREASED,16
DK,PNEUMOTHORAX,16
DK,PULMONARY THROMBOSIS,16
DK,RESPIRATORY DISTRESS,16
DK,SKIN DISORDER,16
DK,TOOTHACHE,16
DK,WHITE BLOOD CELL COUNT INCREASED,16
DK,ADENOCARCINOMA OF COLON,15
DK,ANOSMIA,15
DK,APATHY,15
DK,ASPHYXIA,15
DK,ATRIAL SEPTAL DEFECT,15
DK,CAESAREAN SECTION,15
DK,DEMENTIA,15
DK,DEVICE DISLOCATION,15
DK,DIABETES MELLITUS INADEQUATE CONTROL,15
DK,DRUG EFFECT DECREASED,15
DK,DRUG EFFECT INCOMPLETE,15
DK,EMBOLISM,15
DK,FEMUR FRACTURE,15
DK,FLUID RETENTION,15
DK,FLUSHING,15
DK,FOETAL DEATH,15
DK,HOSPITALISATION,15
DK,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,15
DK,LOW BIRTH WEIGHT BABY,15
DK,PAIN OF SKIN,15
DK,PARKINSONISM,15
DK,PERITONITIS,15
DK,PETIT MAL EPILEPSY,15
DK,RESPIRATORY DEPRESSION,15
DK,SALIVARY HYPERSECRETION,15
DK,SECOND PRIMARY MALIGNANCY,15
DK,TREATMENT FAILURE,15
DK,TREATMENT NONCOMPLIANCE,15
DK,ULCER,15
DK,ABDOMINAL PAIN LOWER,14
DK,ACUTE MYELOID LEUKAEMIA,14
DK,BLOOD URINE PRESENT,14
DK,CEREBRAL DISORDER,14
DK,CHOLESTASIS,14
DK,COLD SWEAT,14
DK,DECREASED IMMUNE RESPONSIVENESS,14
DK,DISSEMINATED INTRAVASCULAR COAGULATION,14
DK,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,14
DK,DRUG ADMINISTRATION ERROR,14
DK,EOSINOPHILIA,14
DK,GASTRITIS,14
DK,HAEMORRHAGE INTRACRANIAL,14
DK,HYPOTONIA,14
DK,INJECTION SITE PAIN,14
DK,LEUKOCYTOSIS,14
DK,METABOLIC ACIDOSIS,14
DK,METASTASES TO LYMPH NODES,14
DK,NEURITIS,14
DK,OSTEOPOROTIC FRACTURE,14
DK,PANCREATIC CARCINOMA,14
DK,PAPILLOEDEMA,14
DK,PERONEAL NERVE PALSY,14
DK,POST PROCEDURAL HAEMORRHAGE,14
DK,RESPIRATORY TRACT INFECTION,14
DK,SKIN HYPERTROPHY,14
DK,SOCIAL AVOIDANT BEHAVIOUR,14
DK,SYNOVITIS,14
DK,THINKING ABNORMAL,14
DK,TYPE 2 DIABETES MELLITUS,14
DK,UNRESPONSIVE TO STIMULI,14
DK,ABDOMINAL ABSCESS,13
DK,ACUTE RESPIRATORY DISTRESS SYNDROME,13
DK,BLINDNESS UNILATERAL,13
DK,CARDIAC FAILURE CHRONIC,13
DK,COLON CANCER,13
DK,DRUG INTOLERANCE,13
DK,GINGIVAL BLEEDING,13
DK,GROWTH RETARDATION,13
DK,HEPATOMEGALY,13
DK,HIP ARTHROPLASTY,13
DK,HYPERVENTILATION,13
DK,INTENTIONAL PRODUCT USE ISSUE,13
DK,LUNG ADENOCARCINOMA,13
DK,MENTAL STATUS CHANGES,13
DK,MUSCULOSKELETAL DISORDER,13
DK,MYOCARDIAL ISCHAEMIA,13
DK,NEPHROPATHY,13
DK,NYSTAGMUS,13
DK,ORAL CAVITY FISTULA,13
DK,PERIPHERAL MOTOR NEUROPATHY,13
DK,PERSONALITY CHANGE,13
DK,RENAL CANCER,13
DK,RENAL FAILURE ACUTE,13
DK,SINUS TACHYCARDIA,13
DK,SKIN ULCER,13
DK,SUBARACHNOID HAEMORRHAGE,13
DK,SYSTEMIC LUPUS ERYTHEMATOSUS,13
DK,UROSEPSIS,13
DK,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,13
DK,ADRENAL INSUFFICIENCY,12
DK,ATAXIA,12
DK,BLOOD LACTATE DEHYDROGENASE INCREASED,12
DK,CEREBRAL ISCHAEMIA,12
DK,CIRCULATORY COLLAPSE,12
DK,COLECTOMY,12
DK,DERMATITIS ALLERGIC,12
DK,ENCEPHALITIS,12
DK,EXERCISE TOLERANCE DECREASED,12
DK,EXTRAPYRAMIDAL DISORDER,12
DK,EYE MOVEMENT DISORDER,12
DK,FLUID OVERLOAD,12
DK,GASTRIC HAEMORRHAGE,12
DK,GROIN PAIN,12
DK,HEPATIC ENCEPHALOPATHY,12
DK,HEPATITIS,12
DK,HYPOGLYCAEMIA NEONATAL,12
DK,IDIOPATHIC INTRACRANIAL HYPERTENSION,12
DK,INTRACRANIAL VENOUS SINUS THROMBOSIS,12
DK,LYMPHOPENIA,12
DK,MUSCLE DISORDER,12
DK,MYOSITIS,12
DK,OSTEOARTHRITIS,12
DK,OSTEOMYELITIS,12
DK,PARANOIA,12
DK,PHOTOPSIA,12
DK,POLYMYOSITIS,12
DK,PRE-ECLAMPSIA,12
DK,PSYCHOMOTOR HYPERACTIVITY,12
DK,RASH ERYTHEMATOUS,12
DK,SCAR,12
DK,SINUSITIS,12
DK,SLOW SPEECH,12
DK,UPPER RESPIRATORY TRACT INFECTION,12
DK,ABASIA,11
DK,ANKLE FRACTURE,11
DK,ARTHROPATHY,11
DK,ATYPICAL FEMUR FRACTURE,11
DK,BODY TEMPERATURE FLUCTUATION,11
DK,BRONCHOSPASM,11
DK,CANDIDA INFECTION,11
DK,CARDIOVASCULAR INSUFFICIENCY,11
DK,CYTOMEGALOVIRUS INFECTION,11
DK,DENTAL FISTULA,11
DK,DRUG CLEARANCE DECREASED,11
DK,DRUG WITHDRAWAL SYNDROME NEONATAL,11
DK,EAR PAIN,11
DK,ENDOPHTHALMITIS,11
DK,FACE OEDEMA,11
DK,FAECAL INCONTINENCE,11
DK,GLAUCOMA,11
DK,HAEMATOTOXICITY,11
DK,HEPATITIS C,11
DK,HYPERTRIGLYCERIDAEMIA,11
DK,HYPOPHOSPHATAEMIA,11
DK,INFLAMMATION,11
DK,INJURY,11
DK,IRRITABLE BOWEL SYNDROME,11
DK,MALIGNANT RESPIRATORY TRACT NEOPLASM,11
DK,MASTICATION DISORDER,11
DK,MONOPARESIS,11
DK,MOUTH ULCERATION,11
DK,MUCOSAL DRYNESS,11
DK,NEPHROLITHIASIS,11
DK,OESOPHAGEAL HAEMORRHAGE,11
DK,PAROSMIA,11
DK,PREMATURE DELIVERY,11
DK,PREMATURE LABOUR,11
DK,PRODUCTIVE COUGH,11
DK,PROTEINURIA,11
DK,PSEUDOPORPHYRIA,11
DK,SENSORY LOSS,11
DK,SKIN LESION,11
DK,STILLBIRTH,11
DK,SUPRAVENTRICULAR TACHYCARDIA,11
DK,TENDON PAIN,11
DK,TRANSFUSION,11
DK,VARICES OESOPHAGEAL,11
DK,VENTRICULAR SEPTAL DEFECT,11
DK,YELLOW SKIN,11
DK,ABSCESS,10
DK,ACUTE HEPATIC FAILURE,10
DK,ACUTE RESPIRATORY FAILURE,10
DK,AFFECT LABILITY,10
DK,AGRANULOCYTOSIS,10
DK,AMENORRHOEA,10
DK,ASPIRATION,10
DK,ATRIOVENTRICULAR BLOCK COMPLETE,10
DK,BLOOD GLUCOSE DECREASED,10
DK,BRAIN HERNIATION,10
DK,CARDIAC FAILURE ACUTE,10
DK,CARTILAGE ATROPHY,10
DK,DEMYELINATION,10
DK,DISABILITY,10
DK,DRUG USE DISORDER,10
DK,EMOTIONAL DISORDER,10
DK,EMOTIONAL DISTRESS,10
DK,EMPHYSEMA,10
DK,EYE PRURITUS,10
DK,FACIAL PAIN,10
DK,FINE MOTOR SKILL DYSFUNCTION,10
DK,GASTROINTESTINAL NECROSIS,10
DK,HODGKIN^S DISEASE,10
DK,HYPOMAGNESAEMIA,10
DK,IMMUNE SYSTEM DISORDER,10
DK,IRON DEFICIENCY ANAEMIA,10
DK,JOINT RANGE OF MOTION DECREASED,10
DK,LIBIDO DECREASED,10
DK,LUMBAR VERTEBRAL FRACTURE,10
DK,MOOD ALTERED,10
DK,MULTIPLE SCLEROSIS RELAPSE,10
DK,MYOGLOBIN BLOOD INCREASED,10
DK,NECROSIS,10
DK,NECROTISING COLITIS,10
DK,OESOPHAGEAL CARCINOMA,10
DK,ORBITAL APEX SYNDROME,10
DK,OTITIS MEDIA,10
DK,PERICARDIAL EFFUSION,10
DK,PHARYNGITIS,10
DK,PHOTOSENSITIVITY REACTION,10
DK,POLYURIA,10
DK,SECONDARY ADRENOCORTICAL INSUFFICIENCY,10
DK,SKIN IRRITATION,10
DK,SPINAL COMPRESSION FRACTURE,10
DK,STAPHYLOCOCCAL INFECTION,10
DK,STATUS EPILEPTICUS,10
DK,STRESS CARDIOMYOPATHY,10
DK,SUICIDAL BEHAVIOUR,10
DK,SUPERIOR VENA CAVA SYNDROME,10
DK,TACHYPHRENIA,10
DK,TENDONITIS,10
DK,TRISMUS,10
DK,TUBULOINTERSTITIAL NEPHRITIS,10
DK,UPPER LIMB FRACTURE,10
DK,VARICELLA ZOSTER VIRUS INFECTION,10
DK,VIOLENCE-RELATED SYMPTOM,10
DK,ABNORMAL DREAMS,9
DK,ABORTION MISSED,9
DK,ANAL INCONTINENCE,9
DK,ANGINA UNSTABLE,9
DK,AUTOIMMUNE DISORDER,9
DK,BLOOD SODIUM DECREASED,9
DK,BRAIN MIDLINE SHIFT,9
DK,BRONCHITIS,9
DK,BUNDLE BRANCH BLOCK RIGHT,9
DK,CENTRAL NERVOUS SYSTEM LESION,9
DK,CEREBELLAR HAEMORRHAGE,9
DK,CHOLECYSTITIS,9
DK,CORONARY ARTERY RESTENOSIS,9
DK,CRANIOSYNOSTOSIS,9
DK,CUTANEOUS LUPUS ERYTHEMATOSUS,9
DK,DEAFNESS,9
DK,DIFFUSE LARGE B-CELL LYMPHOMA,9
DK,DYSPHEMIA,9
DK,ELECTROENCEPHALOGRAM ABNORMAL,9
DK,EPSTEIN-BARR VIRUS INFECTION,9
DK,EXTRASYSTOLES,9
DK,GAMMA-GLUTAMYLTRANSFERASE INCREASED,9
DK,GASTROENTERITIS,9
DK,GENERALISED OEDEMA,9
DK,GINGIVAL PAIN,9
DK,HIP FRACTURE,9
DK,HISTIOCYTOSIS HAEMATOPHAGIC,9
DK,HYPERCHOLESTEROLAEMIA,9
DK,HYPERLIPIDAEMIA,9
DK,HYPERPROLACTINAEMIA,9
DK,IMMUNE-MEDIATED NECROTISING MYOPATHY,9
DK,IMPAIRED DRIVING ABILITY,9
DK,IMPULSIVE BEHAVIOUR,9
DK,INCREASED TENDENCY TO BRUISE,9
DK,INTESTINAL ISCHAEMIA,9
DK,KNEE OPERATION,9
DK,LACRIMATION INCREASED,9
DK,LEARNING DISORDER,9
DK,LIFE SUPPORT,9
DK,LIMB INJURY,9
DK,MATERNAL EXPOSURE TIMING UNSPECIFIED,9
DK,METASTASES TO LUNG,9
DK,MOUTH HAEMORRHAGE,9
DK,MUSCLE CONTRACTIONS INVOLUNTARY,9
DK,NASAL CONGESTION,9
DK,NERVOUSNESS,9
DK,OCULAR DISCOMFORT,9
DK,ONYCHOMYCOSIS,9
DK,ORAL MUCOSAL ERYTHEMA,9
DK,PARTIAL SEIZURES,9
DK,PELVIC PAIN,9
DK,PHYSICAL DISABILITY,9
DK,PNEUMOCYSTIS JIROVECII PNEUMONIA,9
DK,POLYDIPSIA,9
DK,PREGNANCY ON ORAL CONTRACEPTIVE,9
DK,PRIAPISM,9
DK,PSYCHOMOTOR SKILLS IMPAIRED,9
DK,PURULENT DISCHARGE,9
DK,RENAL DISORDER,9
DK,RESPIRATION ABNORMAL,9
DK,RETINAL DETACHMENT,9
DK,RHEUMATOID ARTHRITIS,9
DK,SHOCK,9
DK,SKIN FISSURES,9
DK,SKIN HAEMORRHAGE,9
DK,SNEEZING,9
DK,SQUAMOUS CELL CARCINOMA,9
DK,SUBCUTANEOUS ABSCESS,9
DK,SUDDEN CARDIAC DEATH,9
DK,TENDON INJURY,9
DK,THERAPEUTIC RESPONSE DECREASED,9
DK,VITREOUS DETACHMENT,9
DK,WOUND SECRETION,9
DK,ABNORMAL FAECES,8
DK,ACIDOSIS,8
DK,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,8
DK,ADVERSE DRUG REACTION,8
DK,AMYLASE INCREASED,8
DK,ANTIPSYCHOTIC DRUG LEVEL INCREASED,8
DK,ARTERIOSCLEROSIS,8
DK,ATRIAL FLUTTER,8
DK,BILIARY DILATATION,8
DK,BLADDER PAIN,8
DK,BLOOD CALCIUM INCREASED,8
DK,BLOOD POTASSIUM DECREASED,8
DK,BLOOD THYROID STIMULATING HORMONE INCREASED,8
DK,BONE ATROPHY,8
DK,BONE LESION,8
DK,BRAIN NEOPLASM,8
DK,CARDIAC DEATH,8
DK,CARDIAC FIBRILLATION,8
DK,CARDIOMEGALY,8
DK,CATARACT OPERATION,8
DK,COAGULOPATHY,8
DK,COARCTATION OF THE AORTA,8
DK,COMA HEPATIC,8
DK,CONNECTIVE TISSUE DISORDER,8
DK,CONTRAINDICATED PRODUCT ADMINISTERED,8
DK,DEPRESSIVE SYMPTOM,8
DK,DILATATION VENTRICULAR,8
DK,DIZZINESS POSTURAL,8
DK,DROOLING,8
DK,DRUG DISPENSING ERROR,8
DK,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,8
DK,DRUG SPECIFIC ANTIBODY PRESENT,8
DK,EJECTION FRACTION ABNORMAL,8
DK,ENDOMETRIAL CANCER,8
DK,EYE IRRITATION,8
DK,FAECES PALE,8
DK,FEELING OF BODY TEMPERATURE CHANGE,8
DK,GAIT INABILITY,8
DK,GASTROINTESTINAL INFLAMMATION,8
DK,GENERALISED ERYTHEMA,8
DK,HEPATOCELLULAR CARCINOMA,8
DK,HERNIA,8
DK,HYDROCEPHALUS,8
DK,HYDRONEPHROSIS,8
DK,HYPERTONIA,8
DK,HYPOCALCAEMIA,8
DK,HYPOGAMMAGLOBULINAEMIA,8
DK,HYPOTHYROIDISM,8
DK,HYSTERECTOMY,8
DK,ILL-DEFINED DISORDER,8
DK,IMMUNOSUPPRESSION,8
DK,INCONTINENCE,8
DK,INJECTION SITE ERYTHEMA,8
DK,INJECTION SITE NECROSIS,8
DK,JOINT DISLOCATION,8
DK,JOINT INJURY,8
DK,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,8
DK,LANGUAGE DISORDER,8
DK,LOCALISED INFECTION,8
DK,LOWER LIMB FRACTURE,8
DK,MALIGNANT NERVOUS SYSTEM NEOPLASM,8
DK,MENTAL RETARDATION,8
DK,METASTASES TO SPINE,8
DK,METASTATIC NEOPLASM,8
DK,MITRAL VALVE INCOMPETENCE,8
DK,MONOPLEGIA,8
DK,MUSCLE INJURY,8
DK,MUSCLE RUPTURE,8
DK,MUSCULOSKELETAL CHEST PAIN,8
DK,MYDRIASIS,8
DK,NAIL DISORDER,8
DK,NEUROLOGIC NEGLECT SYNDROME,8
DK,NO ADVERSE EVENT,8
DK,OBSESSIVE THOUGHTS,8
DK,ORAL MUCOSAL BLISTERING,8
DK,PAINFUL RESPIRATION,8
DK,PARESIS,8
DK,PERSECUTORY DELUSION,8
DK,POOR QUALITY SLEEP,8
DK,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,8
DK,PUPILS UNEQUAL,8
DK,PURPURA,8
DK,QUADRIPLEGIA,8
DK,RASH PUSTULAR,8
DK,SENSATION OF FOREIGN BODY,8
DK,SENSITISATION,8
DK,SKIN ATROPHY,8
DK,SLUGGISHNESS,8
DK,SPINAL COLUMN INJURY,8
DK,SQUAMOUS CELL CARCINOMA OF SKIN,8
DK,TACHYPNOEA,8
DK,TENSION,8
DK,TROPONIN T INCREASED,8
DK,TYPE 1 DIABETES MELLITUS,8
DK,VENOUS THROMBOSIS,8
DK,WRONG DRUG ADMINISTERED,8
DK,ACUTE PSYCHOSIS,7
DK,ALCOHOL INTERACTION,7
DK,ANOMALY OF EXTERNAL EAR CONGENITAL,7
DK,ANORGASMIA,7
DK,AORTIC DISSECTION,7
DK,APGAR SCORE LOW,7
DK,APNOEA,7
DK,ARTERIOSCLEROSIS CORONARY ARTERY,7
DK,ATRIOVENTRICULAR BLOCK FIRST DEGREE,7
DK,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,7
DK,BLADDER TRANSITIONAL CELL CARCINOMA STAGE II,7
DK,BLOOD LACTIC ACID INCREASED,7
DK,BODY TEMPERATURE DECREASED,7
DK,BONE MARROW TOXICITY,7
DK,BRONCHIECTASIS,7
DK,CARDIAC FAILURE CONGESTIVE,7
DK,CARDIAC HYPERTROPHY,7
DK,CARDIAC MASSAGE,7
DK,CARDIAC PACEMAKER INSERTION,7
DK,CARDIOGENIC SHOCK,7
DK,CLOSTRIDIUM DIFFICILE COLITIS,7
DK,CONCOMITANT DISEASE PROGRESSION,7
DK,CONGENITAL HAND MALFORMATION,7
DK,CONGENITAL MEGACOLON,7
DK,CONGESTIVE CARDIOMYOPATHY,7
DK,CORONARY ARTERY THROMBOSIS,7
DK,COTARD^S SYNDROME,7
DK,CROSS SENSITIVITY REACTION,7
DK,DEVICE FAILURE,7
DK,DIVERTICULITIS,7
DK,DRUG ERUPTION,7
DK,DRUG LEVEL DECREASED,7
DK,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,7
DK,DUODENAL ULCER,7
DK,DYSPNOEA AT REST,7
DK,ELECTROLYTE IMBALANCE,7
DK,EPIGASTRIC DISCOMFORT,7
DK,FACIAL BONES FRACTURE,7
DK,FEAR OF DEATH,7
DK,FINE MOTOR DELAY,7
DK,FUNCTIONAL GASTROINTESTINAL DISORDER,7
DK,GAZE PALSY,7
DK,GOUT,7
DK,GYNAECOMASTIA,7
DK,HAEMOLYTIC ANAEMIA,7
DK,HAEMORRHOIDS,7
DK,HEAD INJURY,7
DK,HEARING IMPAIRED,7
DK,HEMIANOPIA,7
DK,HEMIANOPIA HOMONYMOUS,7
DK,HEPATIC PAIN,7
DK,HYPERSENSITIVITY VASCULITIS,7
DK,HYPOREFLEXIA,7
DK,HYPOSPADIAS,7
DK,ILEOSTOMY,7
DK,IMMUNODEFICIENCY,7
DK,INJECTION SITE REACTION,7
DK,INTESTINAL PERFORATION,7
DK,INTRACARDIAC THROMBUS,7
DK,IRIDOCYCLITIS,7
DK,JAW DISORDER,7
DK,JOINT ANKYLOSIS,7
DK,JOINT LOCK,7
DK,LARGE INTESTINE PERFORATION,7
DK,LARYNGEAL OEDEMA,7
DK,LEARNING DISABILITY,7
DK,LEFT VENTRICULAR DYSFUNCTION,7
DK,LYMPHOCYTIC INFILTRATION,7
DK,LYMPHOMA,7
DK,MALABSORPTION,7
DK,MICTURITION URGENCY,7
DK,MIDDLE INSOMNIA,7
DK,NEUTROPENIC COLITIS,7
DK,NOCTURIA,7
DK,NON-CARDIAC CHEST PAIN,7
DK,OCCUPATIONAL EXPOSURE TO PRODUCT,7
DK,OCULAR ICTERUS,7
DK,OEDEMA MOUTH,7
DK,ONYCHOMADESIS,7
DK,OPTIC NEURITIS,7
DK,OVERWEIGHT,7
DK,PAINFUL ERECTION,7
DK,PANCREATIC CARCINOMA METASTATIC,7
DK,PANCREATITIS CHRONIC,7
DK,PARAPLEGIA,7
DK,PEMPHIGOID,7
DK,PREGNANCY WITH CONTRACEPTIVE DEVICE,7
DK,PSEUDOMEMBRANOUS COLITIS,7
DK,PULMONARY CONGESTION,7
DK,PUSTULAR PSORIASIS,7
DK,RASH MACULO-PAPULAR,7
DK,RESUSCITATION,7
DK,RETINAL VASCULAR THROMBOSIS,7
DK,RHINORRHOEA,7
DK,RIGHT VENTRICULAR FAILURE,7
DK,SELF-MEDICATION,7
DK,SERUM FERRITIN INCREASED,7
DK,SKIN NECROSIS,7
DK,SKIN SENSITISATION,7
DK,SMALL CELL LUNG CANCER,7
DK,SMALL FIBRE NEUROPATHY,7
DK,SPEECH DISORDER DEVELOPMENTAL,7
DM,CARDIAC DISORDER,1
DM,DRUG DOSE OMISSION,1
DM,DYSPHAGIA,1
DM,ERYTHEMA,1
DM,GENERAL PHYSICAL HEALTH DETERIORATION,1
DM,KOUNIS SYNDROME,1
DM,LOCAL SWELLING,1
DM,MUSCLE ATROPHY,1
DM,MUSCLE SPASMS,1
DM,MUSCULAR WEAKNESS,1
DM,PYODERMA GANGRENOSUM,1
DM,WALKING DISABILITY,1
DO,DEATH,63
DO,PYREXIA,31
DO,VOMITING,18
DO,ASTHENIA,17
DO,DIZZINESS,17
DO,MALAISE,17
DO,PAIN,17
DO,ARTHRALGIA,16
DO,FATIGUE,16
DO,PNEUMONIA,16
DO,NAUSEA,14
DO,DRUG INEFFECTIVE,13
DO,ANAEMIA,12
DO,DIARRHOEA,12
DO,GAIT DISTURBANCE,12
DO,HEADACHE,11
DO,ABDOMINAL PAIN,10
DO,HYPERTENSION,10
DO,TACHYCARDIA,10
DO,WEIGHT DECREASED,10
DO,CHEST PAIN,9
DO,DEHYDRATION,9
DO,INFLUENZA,9
DO,PAIN IN EXTREMITY,9
DO,DECREASED APPETITE,8
DO,FALL,8
DO,HYPERSENSITIVITY,8
DO,CEREBROVASCULAR ACCIDENT,7
DO,CHIKUNGUNYA VIRUS INFECTION,7
DO,DIABETES MELLITUS,7
DO,EXPOSURE DURING PREGNANCY,7
DO,SEIZURE,7
DO,THROMBOSIS,7
DO,URINARY TRACT INFECTION,7
DO,VISION BLURRED,7
DO,ABORTION SPONTANEOUS,6
DO,AMOEBIASIS,6
DO,BLOOD GLUCOSE INCREASED,6
DO,CONSTIPATION,6
DO,DEPRESSION,6
DO,HAEMOGLOBIN DECREASED,6
DO,HYPOTENSION,6
DO,INFECTION,6
DO,INSOMNIA,6
DO,ARRHYTHMIA,5
DO,BLOOD PRESSURE INCREASED,5
DO,DISCOMFORT,5
DO,ENDOPHTHALMITIS,5
DO,HIP FRACTURE,5
DO,LIVER DISORDER,5
DO,MALNUTRITION,5
DO,MEMORY IMPAIRMENT,5
DO,MYOCARDIAL INFARCTION,5
DO,PARAESTHESIA,5
DO,PRODUCT USE ISSUE,5
DO,SWELLING,5
DO,SYNCOPE,5
DO,TREMOR,5
DO,TUBERCULIN TEST POSITIVE,5
DO,VERTIGO,5
DO,ABDOMINAL DISTENSION,4
DO,ANXIETY,4
DO,BLOOD CHOLESTEROL INCREASED,4
DO,CATARACT,4
DO,COLITIS ULCERATIVE,4
DO,COUGH,4
DO,DEAFNESS,4
DO,DYSPHAGIA,4
DO,DYSPNOEA,4
DO,FEELING ABNORMAL,4
DO,FEELING HOT,4
DO,FOETAL DEATH,4
DO,GASTROINTESTINAL HAEMORRHAGE,4
DO,GENERAL PHYSICAL HEALTH DETERIORATION,4
DO,GLAUCOMA,4
DO,HYDROCHOLECYSTIS,4
DO,HYPERHIDROSIS,4
DO,JOINT SWELLING,4
DO,LEUKOPENIA,4
DO,MOBILITY DECREASED,4
DO,NEUTROPENIA,4
DO,OSTEOARTHRITIS,4
DO,PARKINSON^S DISEASE,4
DO,PERIPHERAL SWELLING,4
DO,PRURITUS,4
DO,PULMONARY OEDEMA,4
DO,RECTAL HAEMORRHAGE,4
DO,RESPIRATORY FAILURE,4
DO,SEPTIC SHOCK,4
DO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,4
DO,ABDOMINAL PAIN UPPER,3
DO,ANGINA PECTORIS,3
DO,ASCITES,3
DO,BACK PAIN,3
DO,BALANCE DISORDER,3
DO,BRONCHITIS,3
DO,CARDIAC ARREST,3
DO,CARDIAC DISORDER,3
DO,CARDIOMEGALY,3
DO,CEREBRAL ISCHAEMIA,3
DO,CHEST DISCOMFORT,3
DO,CHOLECYSTITIS ACUTE,3
DO,CHOLELITHIASIS,3
DO,CORONARY ARTERY OCCLUSION,3
DO,CROHN^S DISEASE,3
DO,DYSURIA,3
DO,EPISTAXIS,3
DO,ERYTHEMA,3
DO,FLATULENCE,3
DO,FOETAL EXPOSURE DURING PREGNANCY,3
DO,FREQUENT BOWEL MOVEMENTS,3
DO,GAIT INABILITY,3
DO,GASTRITIS,3
DO,HAEMATOCHEZIA,3
DO,HAEMATOCRIT DECREASED,3
DO,HAEMORRHAGE,3
DO,HYPERTHYROIDISM,3
DO,HYPOACUSIS,3
DO,HYPOTHYROIDISM,3
DO,INCORRECT DOSE ADMINISTERED,3
DO,INTESTINAL OBSTRUCTION,3
DO,LIMB DISCOMFORT,3
DO,LOSS OF CONSCIOUSNESS,3
DO,MATERNAL EXPOSURE DURING PREGNANCY,3
DO,MYALGIA,3
DO,NEPHROLITHIASIS,3
DO,OCULAR HYPERAEMIA,3
DO,OEDEMA PERIPHERAL,3
DO,OVERDOSE,3
DO,PREMATURE BABY,3
DO,PRODUCT QUALITY ISSUE,3
DO,PRODUCT USE IN UNAPPROVED INDICATION,3
DO,PSYCHIATRIC SYMPTOM,3
DO,RASH ERYTHEMATOUS,3
DO,RENAL DISORDER,3
DO,RENAL FAILURE,3
DO,RESPIRATORY ARREST,3
DO,RHINITIS,3
DO,SKIN LESION,3
DO,SPEECH DISORDER,3
DO,STRESS,3
DO,THROAT IRRITATION,3
DO,THYROID MASS,3
DO,TRANSAMINASES INCREASED,3
DO,TREATMENT FAILURE,3
DO,TREATMENT NONCOMPLIANCE,3
DO,VAGINAL HAEMORRHAGE,3
DO,VIRAL INFECTION,3
DO,VISUAL IMPAIRMENT,3
DO,YELLOW SKIN,3
DO,ABASIA,2
DO,ABDOMINAL DISCOMFORT,2
DO,ABDOMINAL HERNIA,2
DO,ACCIDENT,2
DO,ACUTE ABDOMEN,2
DO,ADVERSE EVENT,2
DO,AGGRESSION,2
DO,ALOPECIA,2
DO,ANAL FISTULA,2
DO,APPENDICITIS,2
DO,ARTERIAL OCCLUSIVE DISEASE,2
DO,ARTHRITIS,2
DO,ASPHYXIA,2
DO,ASTHMATIC CRISIS,2
DO,ATRIAL FIBRILLATION,2
DO,BACTERIAL TEST POSITIVE,2
DO,BEDRIDDEN,2
DO,BLINDNESS,2
DO,BLOOD PRESSURE ABNORMAL,2
DO,BONE MARROW FAILURE,2
DO,BRAIN HYPOXIA,2
DO,BRONCHOSPASM,2
DO,BURNING SENSATION,2
DO,CACHEXIA,2
DO,CARDIAC FAILURE,2
DO,CARDIO-RESPIRATORY ARREST,2
DO,CARDIOGENIC SHOCK,2
DO,CELLULITIS,2
DO,CHROMATURIA,2
DO,CONVULSION,2
DO,DEAFNESS UNILATERAL,2
DO,DEEP VEIN THROMBOSIS,2
DO,DEMENTIA,2
DO,DEMENTIA ALZHEIMER^S TYPE,2
DO,DERMAL CYST,2
DO,DISEASE PROGRESSION,2
DO,DRUG HYPERSENSITIVITY,2
DO,DYSLIPIDAEMIA,2
DO,DYSPEPSIA,2
DO,DYSSTASIA,2
DO,ESCHERICHIA URINARY TRACT INFECTION,2
DO,EXPOSURE VIA BODY FLUID,2
DO,EYE INFECTION,2
DO,EYE PAIN,2
DO,FEMUR FRACTURE,2
DO,FLAVIVIRUS INFECTION,2
DO,FOOD POISONING,2
DO,GASTROINTESTINAL DISORDER,2
DO,GASTROINTESTINAL INFLAMMATION,2
DO,GASTROINTESTINAL STROMAL TUMOUR,2
DO,GENERALISED OEDEMA,2
DO,GOITRE,2
DO,HAEMATURIA,2
DO,HAEMORRHAGIC OVARIAN CYST,2
DO,HEPATIC FAILURE,2
DO,HEPATIC STEATOSIS,2
DO,HERNIA,2
DO,HIGH DENSITY LIPOPROTEIN DECREASED,2
DO,HYPERAESTHESIA,2
DO,HYPERGLYCAEMIA,2
DO,HYPOAESTHESIA,2
DO,HYPOAESTHESIA ORAL,2
DO,HYPOGLYCAEMIA,2
DO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
DO,INCISION SITE PAIN,2
DO,INFLAMMATION,2
DO,INJECTION SITE ABSCESS,2
DO,INJECTION SITE PAIN,2
DO,INTERSTITIAL LUNG DISEASE,2
DO,ISCHAEMIC CARDIOMYOPATHY,2
DO,ISCHAEMIC STROKE,2
DO,JOINT RANGE OF MOTION DECREASED,2
DO,KNEE ARTHROPLASTY,2
DO,LIMB INJURY,2
DO,LOWER LIMB FRACTURE,2
DO,MENORRHAGIA,2
DO,MENSTRUAL DISORDER,2
DO,MOOD ALTERED,2
DO,MUCOUS STOOLS,2
DO,MULTIPLE SCLEROSIS,2
DO,MUSCLE SPASMS,2
DO,NASOPHARYNGITIS,2
DO,NECK PAIN,2
DO,NEOPLASM,2
DO,OEDEMATOUS KIDNEY,2
DO,OVARIAN CYST,2
DO,PALLOR,2
DO,PANCREATIC CARCINOMA,2
DO,PLATELET COUNT DECREASED,2
DO,PLEURAL EFFUSION,2
DO,POST PROCEDURAL COMPLICATION,2
DO,POST PROCEDURAL HAEMORRHAGE,2
DO,PROCEDURAL COMPLICATION,2
DO,PROCEDURAL PAIN,2
DO,PROCTALGIA,2
DO,PROGRESSIVE MULTIPLE SCLEROSIS,2
DO,PULMONARY EMBOLISM,2
DO,PULMONARY TUBERCULOSIS,2
DO,RASH,2
DO,RECTAL TENESMUS,2
DO,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
DO,RENAL CYST,2
DO,RENAL NEOPLASM,2
DO,RESPIRATORY TRACT CONGESTION,2
DO,RESPIRATORY TRACT INFECTION,2
DO,SEPSIS,2
DO,STAPHYLOCOCCAL INFECTION,2
DO,THROMBOCYTOPENIA,2
DO,THYROID DISORDER,2
DO,TRANSIENT ISCHAEMIC ATTACK,2
DO,TWIN PREGNANCY,2
DO,UMBILICAL HERNIA,2
DO,UNDERWEIGHT,2
DO,UPPER LIMB FRACTURE,2
DO,URINARY SEDIMENT PRESENT,2
DO,URINE ABNORMALITY,2
DO,UTERINE LEIOMYOMA,2
DO,VISUAL ACUITY REDUCED,2
DO,VITAMIN D DECREASED,2
DO,WHITE BLOOD CELLS URINE POSITIVE,2
DO,ABDOMINAL PAIN LOWER,1
DO,ABORTION INCOMPLETE,1
DO,ABSCESS INTESTINAL,1
DO,ABSCESS JAW,1
DO,ACQUIRED EPIDERMOLYSIS BULLOSA,1
DO,ACTINIC KERATOSIS,1
DO,ACUTE CORONARY SYNDROME,1
DO,ACUTE KIDNEY INJURY,1
DO,ACUTE MYOCARDIAL INFARCTION,1
DO,ADMINISTRATION SITE PAIN,1
DO,ADVERSE DRUG REACTION,1
DO,ALBUMIN GLOBULIN RATIO DECREASED,1
DO,ALTERED STATE OF CONSCIOUSNESS,1
DO,AMENORRHOEA,1
DO,AMNESIA,1
DO,AMNIOTIC FLUID VOLUME DECREASED,1
DO,ANAL FISSURE,1
DO,ANAL FISTULA INFECTION,1
DO,ANAL HAEMORRHAGE,1
DO,ANAL INFECTION,1
DO,ANEURYSM,1
DO,ANGER,1
DO,ANKYLOSING SPONDYLITIS,1
DO,ANOGENITAL WARTS,1
DO,ANOSMIA,1
DO,ANTI-THYROID ANTIBODY POSITIVE,1
DO,ANTI-VIMENTIN ANTIBODY POSITIVE,1
DO,APHAGIA,1
DO,APHASIA,1
DO,APHONIA,1
DO,APLASIA,1
DO,ARTERIOVENOUS FISTULA SITE INFECTION,1
DO,ASPIRATION,1
DO,ASTHMA,1
DO,ATELECTASIS,1
DO,AUTOIMMUNE DISORDER,1
DO,AXILLARY MASS,1
DO,BACTERAEMIA,1
DO,BASAL CELL CARCINOMA,1
DO,BENIGN LUNG NEOPLASM,1
DO,BLADDER DISORDER,1
DO,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
DO,BLEEDING VARICOSE VEIN,1
DO,BLEPHARITIS,1
DO,BLINDNESS UNILATERAL,1
DO,BLOOD ALBUMIN DECREASED,1
DO,BLOOD CREATININE DECREASED,1
DO,BLOOD CREATININE INCREASED,1
DO,BLOOD GLUCOSE DECREASED,1
DO,BLOOD GLUCOSE FLUCTUATION,1
DO,BLOOD PRESSURE DIASTOLIC INCREASED,1
DO,BLOOD THYROID STIMULATING HORMONE ABNORMAL,1
DO,BLOOD THYROID STIMULATING HORMONE DECREASED,1
DO,BLOOD TRIGLYCERIDES INCREASED,1
DO,BLOOD UREA INCREASED,1
DO,BONE ATROPHY,1
DO,BONE DEFORMITY,1
DO,BONE DENSITY DECREASED,1
DO,BONE DISORDER,1
DO,BONE MARROW TOXICITY,1
DO,BREAST CANCER FEMALE,1
DO,BREAST CYST,1
DO,BREAST DISCOMFORT,1
DO,BREATH SOUNDS ABNORMAL,1
DO,BURNS FIRST DEGREE,1
DO,BURSITIS,1
DO,C-REACTIVE PROTEIN INCREASED,1
DO,CAESAREAN SECTION,1
DO,CANDIDIASIS,1
DO,CARCINOMA IN SITU OF SKIN,1
DO,CARDIAC FIBRILLATION,1
DO,CARDIAC MURMUR,1
DO,CARDIAC STRESS TEST ABNORMAL,1
DO,CATHETER SITE ERYTHEMA,1
DO,CATHETER SITE INFECTION,1
DO,CATHETER SITE PAIN,1
DO,CATHETER SITE SWELLING,1
DO,CELLULITIS ORBITAL,1
DO,CEREBRAL INFARCTION,1
DO,CEREBRAL TOXOPLASMOSIS,1
DO,CERVIX CARCINOMA,1
DO,CHOLANGIOCARCINOMA,1
DO,CHOLECYSTITIS,1
DO,COMA,1
DO,COMMUNICATION DISORDER,1
DO,CONCOMITANT DISEASE AGGRAVATED,1
DO,CONDITION AGGRAVATED,1
DO,CONGESTIVE CARDIOMYOPATHY,1
DO,CONJUNCTIVITIS,1
DO,CONJUNCTIVITIS VIRAL,1
DO,CORNEAL PERFORATION,1
DO,CRITICAL ILLNESS,1
DO,CRYPTORCHISM,1
DO,CYANOSIS,1
DO,CYCLITIC MEMBRANE,1
DO,CYST,1
DO,DENTAL NECROSIS,1
DO,DEPRESSED MOOD,1
DO,DERMATITIS ALLERGIC,1
DO,DERMATITIS EXFOLIATIVE,1
DO,DEVICE FAILURE,1
DO,DIABETES MELLITUS INADEQUATE CONTROL,1
DO,DIAPHRAGM NEOPLASM,1
DO,DIAPHRAGMATIC DISORDER,1
DO,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,1
DO,DIPLEGIA,1
DO,DISEASE COMPLICATION,1
DO,DISEASE RECURRENCE,1
DO,DISORIENTATION,1
DO,DRUG ADMINISTRATION ERROR,1
DO,DRUG DEPENDENCE,1
DO,DRUG DOSE OMISSION,1
DO,DRUG EFFECT DECREASED,1
DO,DRUG EFFECT INCOMPLETE,1
DO,DRUG PRESCRIBING ERROR,1
DO,DRUG TOLERANCE,1
DO,DRY SKIN,1
DO,DUODENAL ULCER,1
DO,DYSARTHRIA,1
DO,DYSCHEZIA,1
DO,DYSMENORRHOEA,1
DO,DYSPHONIA,1
DO,DYSPLASTIC NAEVUS,1
DO,EAR PAIN,1
DO,ECZEMA,1
DO,EJECTION FRACTION DECREASED,1
DO,ELECTROPHORESIS PROTEIN ABNORMAL,1
DO,ENCEPHALITIS,1
DO,ENDOMETRIOSIS,1
DO,ERYSIPELAS,1
DO,ERYTHEMA NODOSUM,1
DO,ESCHERICHIA INFECTION,1
DO,EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE),1
DO,EXTRASYSTOLES,1
DO,EYE OEDEMA,1
DO,FACE OEDEMA,1
DO,FACIAL NERVE DISORDER,1
DO,FAECAL CALPROTECTIN INCREASED,1
DO,FALLOPIAN TUBE DISORDER,1
DO,FEELING COLD,1
DO,FEMALE GENITAL TRACT FISTULA,1
DO,FIBROADENOMA OF BREAST,1
DO,FISTULA,1
DO,FLUID OVERLOAD,1
DO,FLUID RETENTION,1
DO,FUNGAL INFECTION,1
DO,GALLBLADDER NECROSIS,1
DO,GALLBLADDER OEDEMA,1
DO,GASTRIC CANCER,1
DO,GASTRIC DISORDER,1
DO,GASTRIC INFECTION,1
DO,GASTROENTERITIS,1
DO,GASTROINTESTINAL HYPOMOTILITY,1
DO,GASTROINTESTINAL OBSTRUCTION,1
DO,GASTROINTESTINAL OEDEMA,1
DO,GASTROINTESTINAL PAIN,1
DO,GASTROINTESTINAL PERFORATION,1
DO,GASTROINTESTINAL STENOSIS,1
DO,GASTROOESOPHAGEAL REFLUX DISEASE,1
DO,GLOMERULONEPHRITIS,1
DO,GLOSSOPHARYNGEAL NERVE PARALYSIS,1
DO,GLUCOSE TOLERANCE IMPAIRED,1
DO,HAEMATEMESIS,1
DO,HAEMODIALYSIS-INDUCED SYMPTOM,1
DO,HAEMODYNAMIC INSTABILITY,1
DO,HAEMOGLOBIN ABNORMAL,1
DO,HAEMOPTYSIS,1
DO,HAEMORRHAGIC STROKE,1
DO,HAEMORRHOIDS,1
DO,HAND DEFORMITY,1
DO,HEAD DISCOMFORT,1
DO,HEART RATE DECREASED,1
DO,HELICOBACTER INFECTION,1
DO,HEMIPARESIS,1
DO,HEPATIC CANCER,1
DO,HEPATIC HAEMORRHAGE,1
DO,HEPATIC NECROSIS,1
DO,HEPATITIS C,1
DO,HEPATOMEGALY,1
DO,HEPATORENAL SYNDROME,1
DO,HERPES SIMPLEX TEST POSITIVE,1
DO,HERPES VIRUS INFECTION,1
DO,HIDRADENITIS,1
DO,HOSPITALISATION,1
DO,HYPERBILIRUBINAEMIA NEONATAL,1
DO,HYPERKERATOSIS,1
DO,HYPERPHOSPHATAEMIA,1
DO,HYPERTENSIVE CRISIS,1
DO,HYPERTHERMIA,1
DO,HYPERTRANSAMINASAEMIA,1
DO,HYPOCALCAEMIA,1
DO,HYPOKALAEMIA,1
DO,HYPOKINESIA,1
DO,HYPOPHAGIA,1
DO,HYPOTHERMIA NEONATAL,1
DO,HYPOVOLAEMIC SHOCK,1
DO,ILEAL STENOSIS,1
DO,ILL-DEFINED DISORDER,1
DO,ILLUSION,1
DO,IMMUNOSUPPRESSION,1
DO,IN VITRO FERTILISATION,1
DO,INCISION SITE OEDEMA,1
DO,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
DO,INDURATION,1
DO,INFARCTION,1
DO,INFLAMMATORY BOWEL DISEASE,1
DO,INFLUENZA LIKE ILLNESS,1
DO,INGUINAL HERNIA,1
DO,INITIAL INSOMNIA,1
DO,INJECTION SITE BRUISING,1
DO,INJECTION SITE ERYTHEMA,1
DO,INJECTION SITE NECROSIS,1
DO,INJECTION SITE PRURITUS,1
DO,INJECTION SITE PUSTULE,1
DO,INJECTION SITE REACTION,1
DO,INJECTION SITE SWELLING,1
DO,INJURY,1
DO,INTENTIONAL OVERDOSE,1
DO,INTESTINAL FISTULA,1
DO,INTESTINAL HAEMORRHAGE,1
DO,INTESTINAL PERFORATION,1
DO,INTRACARDIAC THROMBUS,1
DO,INTRAOCULAR PRESSURE INCREASED,1
DO,INVESTIGATION,1
DO,JAW DISORDER,1
DO,JOINT WARMTH,1
DO,KIDNEY ENLARGEMENT,1
DO,KIDNEY SMALL,1
DO,KNEE DEFORMITY,1
DO,LACERATION,1
DO,LACRIMATION INCREASED,1
DO,LARGE INTESTINE POLYP,1
DO,LARYNGEAL OEDEMA,1
DO,LIGAMENT INJURY,1
DO,LIGAMENT RUPTURE,1
DO,LIGAMENT SPRAIN,1
DO,LIMB MASS,1
DO,LIP OEDEMA,1
DO,LIPASE INCREASED,1
DO,LIPOMA,1
DO,LOCAL SWELLING,1
DO,LUNG DISORDER,1
DO,LUNG NEOPLASM,1
DO,LUNG NEOPLASM MALIGNANT,1
DO,LYMPHADENOPATHY,1
DO,LYMPHOCYTE COUNT INCREASED,1
DO,LYMPHOMA,1
DO,MALIGNANT NEOPLASM PROGRESSION,1
DO,MASTICATION DISORDER,1
DO,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
DO,MEAN CELL HAEMOGLOBIN DECREASED,1
DO,MEGACOLON,1
DO,MELAENA,1
DO,MENIERE^S DISEASE,1
DO,MENISCUS INJURY,1
DO,METASTASES TO LARGE INTESTINE,1
DO,METASTASES TO LIVER,1
DO,METRORRHAGIA,1
DO,MICTURITION URGENCY,1
DO,MOTOR DYSFUNCTION,1
DO,MOUTH HAEMORRHAGE,1
DO,MOVEMENT DISORDER,1
DO,MUCOSAL INFLAMMATION,1
DO,MULTI-ORGAN DISORDER,1
DO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
DO,MULTIPLE SCLEROSIS RELAPSE,1
DO,MUSCLE SPASTICITY,1
DO,MYCOBACTERIUM AVIUM COMPLEX INFECTION,1
DO,MYCOBACTERIUM FORTUITUM INFECTION,1
DO,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
DO,MYOCLONIC EPILEPSY,1
DO,MYOSITIS,1
DO,NAIL INFECTION,1
DO,NECK INJURY,1
DO,NEPHROCALCINOSIS,1
DO,NERVOUS SYSTEM DISORDER,1
DO,NERVOUSNESS,1
DO,NEUROGENIC BLADDER,1
DO,NEUROPATHY PERIPHERAL,1
DO,NEUTROPHIL COUNT DECREASED,1
DO,NIKOLSKY^S SIGN,1
DO,NO ADVERSE EVENT,1
DO,NODULE,1
DO,NORMAL NEWBORN,1
DO,NYSTAGMUS,1
DO,OCCULT BLOOD POSITIVE,1
DO,OEDEMA,1
DO,OEDEMA MUCOSAL,1
DO,OESOPHAGEAL CARCINOMA,1
DO,OMPHALITIS,1
DO,OPTIC NEURITIS,1
DO,OROPHARYNGEAL PAIN,1
DO,OSTEITIS,1
DO,OSTEOMYELITIS,1
DO,OSTEONECROSIS OF JAW,1
DO,OSTEOPOROSIS,1
DO,OVERWEIGHT,1
DO,PAINFUL DEFAECATION,1
DO,PANCREATITIS,1
DO,PANCREATITIS ACUTE,1
DO,PANCYTOPENIA,1
DO,PARAESTHESIA ORAL,1
DO,PARAPLEGIA,1
DO,PATERNAL DRUGS AFFECTING FOETUS,1
DO,PATHOGEN RESISTANCE,1
DO,PELVIC PAIN,1
DO,PERIPHERAL ARTERY OCCLUSION,1
DO,PERIPHERAL COLDNESS,1
DO,PERIPHERAL VENOUS DISEASE,1
DO,PETECHIAE,1
DO,PHARYNGEAL ABSCESS,1
DO,PHARYNGITIS STREPTOCOCCAL,1
DO,PHARYNGOTONSILLITIS,1
DO,PHOTOSENSITIVITY REACTION,1
DO,PLASMACYTOMA,1
DO,PLATELET COUNT INCREASED,1
DO,PNEUMONIA VIRAL,1
DO,POLLAKIURIA,1
DO,POLYDIPSIA,1
DO,POLYMERASE CHAIN REACTION POSITIVE,1
DO,POLYP,1
DO,POLYURIA,1
DO,POST PROCEDURAL DISCOMFORT,1
DO,POST-TRAUMATIC PAIN,1
DO,POSTOPERATIVE WOUND INFECTION,1
DO,PREGNANCY ON CONTRACEPTIVE,1
DO,PREMATURE DELIVERY,1
DO,PRESCRIBED UNDERDOSE,1
DO,PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS,1
DO,PRODUCTIVE COUGH,1
DO,PROSTATE CANCER,1
DO,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
DO,PROTEIN URINE PRESENT,1
DO,PROTRUSION TONGUE,1
DO,PSEUDO-BARTTER SYNDROME,1
DO,PSEUDOMONAS INFECTION,1
DO,PSEUDOPOLYPOSIS,1
DO,PSORIASIS,1
DO,PULMONARY CONGESTION,1
DO,PULMONARY HYPERTENSION,1
DO,PULMONARY THROMBOSIS,1
DO,PURULENT DISCHARGE,1
DO,PUSTULAR PSORIASIS,1
DO,PYELONEPHRITIS,1
DO,PYODERMA GANGRENOSUM,1
DO,RASH MACULAR,1
DO,RASH PUSTULAR,1
DO,RASH VESICULAR,1
DO,RECTAL ABSCESS,1
DO,RECTAL CANCER,1
DO,RECTAL NEOPLASM,1
DO,RECTAL POLYP,1
DO,RECTAL PROLAPSE,1
DO,RED BLOOD CELL COUNT DECREASED,1
DO,RED BLOOD CELLS URINE,1
DO,RED BLOOD CELLS URINE POSITIVE,1
DO,RED CELL DISTRIBUTION WIDTH INCREASED,1
DO,RENAL PAIN,1
DO,RENAL TRANSPLANT,1
DO,RESPIRATION ABNORMAL,1
DO,RESPIRATORY DISORDER,1
DO,RESPIRATORY DISORDER NEONATAL,1
DO,RESPIRATORY DISTRESS,1
DO,RHABDOMYOLYSIS,1
DO,SALIVARY HYPERSECRETION,1
DO,SALMONELLOSIS,1
DO,SCAR,1
DO,SCHWANNOMA,1
DO,SCLERAL OEDEMA,1
DO,SEBORRHOEIC KERATOSIS,1
DO,SECOND PRIMARY MALIGNANCY,1
DO,SENSATION OF FOREIGN BODY,1
DO,SENSITIVITY TO WEATHER CHANGE,1
DO,SENSORY LOSS,1
DO,SERUM FERRITIN INCREASED,1
DO,SKIN ATROPHY,1
DO,SKIN EXFOLIATION,1
DO,SKIN HYPERPIGMENTATION,1
DO,SKIN INJURY,1
DO,SKIN IRRITATION,1
DO,SKIN REACTION,1
DO,SOLAR LENTIGO,1
DO,SPINAL FRACTURE,1
DO,SPINAL OSTEOARTHRITIS,1
DO,STATUS EPILEPTICUS,1
DO,STILLBIRTH,1
DO,STRIDOR,1
DO,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,1
DO,SUDDEN DEATH,1
DO,SUFFOCATION FEELING,1
DO,SUICIDAL IDEATION,1
DO,SUNBURN,1
DO,SURGICAL FAILURE,1
DO,SUTURE RUPTURE,1
DO,SYSTEMIC LUPUS ERYTHEMATOSUS,1
DO,T-CELL LYMPHOMA,1
DO,TELANGIECTASIA,1
DO,TENDONITIS,1
DO,THALAMIC INFARCTION,1
DO,THINKING ABNORMAL,1
DO,THROAT TIGHTNESS,1
DO,THYROXINE FREE DECREASED,1
DO,TINNITUS,1
DO,TONSILLITIS STREPTOCOCCAL,1
DO,TOXIC EPIDERMAL NECROLYSIS,1
DO,TOXICITY TO VARIOUS AGENTS,1
DO,TOXOPLASMA SEROLOGY POSITIVE,1
DO,TRANSFUSION REACTION,1
DO,TRAUMATIC INTRACRANIAL HAEMORRHAGE,1
DO,TYMPANIC MEMBRANE PERFORATION,1
DO,TYPE 1 DIABETES MELLITUS,1
DO,TYPE IV HYPERSENSITIVITY REACTION,1
DO,ULCER,1
DO,UNDERDOSE,1
DO,UNEVALUABLE EVENT,1
DO,URINARY INCONTINENCE,1
DO,URINE ANALYSIS ABNORMAL,1
DO,URTICARIA,1
DO,UTERINE DILATION AND CURETTAGE,1
DO,UTERINE DISORDER,1
DO,VARICELLA,1
DO,VARICOSE VEIN,1
DO,VASODILATATION,1
DO,VERTIGO POSITIONAL,1
DO,VESTIBULAR NEURONITIS,1
DO,VIITH NERVE PARALYSIS,1
DO,VITH NERVE PARALYSIS,1
DO,WALKING DISABILITY,1
DO,WEIGHT INCREASED,1
DO,WHITE BLOOD CELL COUNT INCREASED,1
DO,WHITE BLOOD CELLS STOOL POSITIVE,1
DO,WRONG DRUG ADMINISTERED,1
DO,ZIKA VIRUS INFECTION,1
EC,DEATH,163
EC,CARDIO-RESPIRATORY ARREST,83
EC,PYREXIA,59
EC,PNEUMONIA,56
EC,DRUG INEFFECTIVE,53
EC,HEADACHE,53
EC,FALL,48
EC,PAIN,46
EC,MYOCARDIAL INFARCTION,44
EC,DYSPNOEA,42
EC,DIZZINESS,41
EC,CEREBROVASCULAR ACCIDENT,40
EC,VOMITING,40
EC,ABDOMINAL PAIN,39
EC,MALAISE,38
EC,DECREASED IMMUNE RESPONSIVENESS,35
EC,PAIN IN EXTREMITY,35
EC,ARTHRALGIA,33
EC,ASTHENIA,31
EC,RENAL FAILURE,30
EC,DISEASE PROGRESSION,28
EC,FATIGUE,27
EC,INFARCTION,27
EC,PERITONITIS,27
EC,RESPIRATORY ARREST,27
EC,HYPERTENSION,26
EC,ANAEMIA,25
EC,CARDIAC DISORDER,25
EC,DIARRHOEA,25
EC,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,25
EC,NAUSEA,25
EC,ABDOMINAL PAIN UPPER,24
EC,BACK PAIN,23
EC,CARDIAC ARREST,23
EC,DECREASED APPETITE,22
EC,GAIT DISTURBANCE,22
EC,TACHYCARDIA,22
EC,URINARY TRACT INFECTION,22
EC,CHEST PAIN,21
EC,INFLUENZA,21
EC,BONE PAIN,20
EC,GENERAL PHYSICAL HEALTH DETERIORATION,20
EC,HAEMORRHAGE,20
EC,HYPOTENSION,20
EC,SYNCOPE,20
EC,INFECTION,19
EC,PLATELET COUNT DECREASED,19
EC,COUGH,18
EC,EPISTAXIS,18
EC,FEELING ABNORMAL,18
EC,ACUTE MYOCARDIAL INFARCTION,17
EC,BLOOD PRESSURE INCREASED,17
EC,MALIGNANT NEOPLASM PROGRESSION,17
EC,SEPSIS,17
EC,THROMBOCYTOPENIA,17
EC,CHILLS,16
EC,OEDEMA PERIPHERAL,16
EC,SEIZURE,16
EC,GASTROINTESTINAL DISORDER,15
EC,LUNG DISORDER,15
EC,PALLOR,15
EC,ABASIA,14
EC,RENAL DISORDER,14
EC,DEEP VEIN THROMBOSIS,13
EC,HEPATIC CIRRHOSIS,13
EC,HYPERSENSITIVITY,13
EC,PERIPHERAL SWELLING,13
EC,RESPIRATORY FAILURE,13
EC,ABDOMINAL DISTENSION,12
EC,CARDIAC FAILURE,12
EC,CONVULSION,12
EC,GASTRITIS,12
EC,HIP FRACTURE,12
EC,PULMONARY OEDEMA,12
EC,WEIGHT DECREASED,12
EC,ANXIETY,11
EC,BREAST CANCER,11
EC,CONSTIPATION,11
EC,DIABETES MELLITUS,11
EC,HYPERTENSIVE CRISIS,11
EC,THROMBOSIS,11
EC,URTICARIA,11
EC,BRAIN NEOPLASM,10
EC,DEPRESSION,10
EC,INSOMNIA,10
EC,NEUTROPENIA,10
EC,PERFORMANCE STATUS DECREASED,10
EC,PLEURAL EFFUSION,10
EC,RASH,10
EC,RED BLOOD CELL COUNT DECREASED,10
EC,RENAL TRANSPLANT,10
EC,SPINAL DISORDER,10
EC,SWELLING,10
EC,BLINDNESS,9
EC,CATARACT,9
EC,CHOLELITHIASIS,9
EC,CHRONIC MYELOID LEUKAEMIA,9
EC,DISCOMFORT,9
EC,FLUID RETENTION,9
EC,HAEMATOCRIT DECREASED,9
EC,HYPOAESTHESIA,9
EC,NEOPLASM MALIGNANT,9
EC,PULMONARY EMBOLISM,9
EC,RESPIRATORY DISORDER,9
EC,UPPER LIMB FRACTURE,9
EC,VISION BLURRED,9
EC,DYSPHAGIA,8
EC,EXPOSURE DURING PREGNANCY,8
EC,GENERALISED OEDEMA,8
EC,INFUSION RELATED REACTION,8
EC,LOSS OF CONSCIOUSNESS,8
EC,MYALGIA,8
EC,PRODUCT USE ISSUE,8
EC,ARTHROPATHY,7
EC,ASPHYXIA,7
EC,BLISTER,7
EC,BLOOD GLUCOSE INCREASED,7
EC,BONE MARROW FAILURE,7
EC,DRUG DOSE OMISSION,7
EC,FEBRILE NEUTROPENIA,7
EC,GASTROINTESTINAL HAEMORRHAGE,7
EC,HAEMATURIA,7
EC,HEAD INJURY,7
EC,HYPERHIDROSIS,7
EC,INTERVERTEBRAL DISC PROTRUSION,7
EC,ISCHAEMIC STROKE,7
EC,MUSCULOSKELETAL PAIN,7
EC,OROPHARYNGEAL PAIN,7
EC,SPINAL PAIN,7
EC,VISUAL IMPAIRMENT,7
EC,ACNE,6
EC,CEREBRAL HAEMORRHAGE,6
EC,CEREBRAL INFARCTION,6
EC,COMA,6
EC,CONJUNCTIVITIS,6
EC,DEHYDRATION,6
EC,DYSGEUSIA,6
EC,ERYTHEMA,6
EC,GASTROINTESTINAL INFECTION,6
EC,HAEMORRHAGE INTRACRANIAL,6
EC,HERPES VIRUS INFECTION,6
EC,LOWER LIMB FRACTURE,6
EC,MOBILITY DECREASED,6
EC,MUSCLE SPASMS,6
EC,NO THERAPEUTIC RESPONSE,6
EC,PANCREATITIS,6
EC,PARATHYROIDECTOMY,6
EC,PROSTATE CANCER,6
EC,RECTAL HAEMORRHAGE,6
EC,ROAD TRAFFIC ACCIDENT,6
EC,SOMNOLENCE,6
EC,SWELLING FACE,6
EC,TREMOR,6
EC,WEIGHT INCREASED,6
EC,WHITE BLOOD CELL COUNT INCREASED,6
EC,ACCIDENT,5
EC,AMNESIA,5
EC,ANAPHYLACTIC REACTION,5
EC,ANAPHYLACTIC SHOCK,5
EC,ANGIOEDEMA,5
EC,APHASIA,5
EC,APNOEA,5
EC,APPENDICITIS,5
EC,ARRHYTHMIA,5
EC,BLOOD CREATININE INCREASED,5
EC,BRADYCARDIA,5
EC,BRONCHOPNEUMONIA,5
EC,CHIKUNGUNYA VIRUS INFECTION,5
EC,CHOKING SENSATION,5
EC,DENGUE FEVER,5
EC,DEPRESSED MOOD,5
EC,DISORIENTATION,5
EC,DRY MOUTH,5
EC,DYSPEPSIA,5
EC,FACE OEDEMA,5
EC,GAIT INABILITY,5
EC,GALLBLADDER DISORDER,5
EC,GASTRIC CANCER,5
EC,HAEMATEMESIS,5
EC,HAEMATOCHEZIA,5
EC,HAEMOPTYSIS,5
EC,HEPATIC FAILURE,5
EC,HERNIA,5
EC,HYPERGLYCAEMIA,5
EC,INCORRECT DRUG ADMINISTRATION DURATION,5
EC,INFLAMMATION,5
EC,INTESTINAL OBSTRUCTION,5
EC,LIVER DISORDER,5
EC,MULTI-ORGAN FAILURE,5
EC,NEOPLASM,5
EC,OCULAR HYPERAEMIA,5
EC,PANCYTOPENIA,5
EC,PARAESTHESIA,5
EC,PARATHYROID GLAND OPERATION,5
EC,PROSTATIC DISORDER,5
EC,PRURITUS GENERALISED,5
EC,RASH GENERALISED,5
EC,RESPIRATORY TRACT INFECTION,5
EC,SEPTIC SHOCK,5
EC,SPEECH DISORDER,5
EC,WOUND,5
EC,WRIST FRACTURE,5
EC,ABORTION SPONTANEOUS,4
EC,ADVERSE EVENT,4
EC,ANGINA PECTORIS,4
EC,ANKLE FRACTURE,4
EC,BALANCE DISORDER,4
EC,BRONCHOSPASM,4
EC,CONDITION AGGRAVATED,4
EC,DERMATITIS ALLERGIC,4
EC,DIABETIC COMPLICATION,4
EC,DYSURIA,4
EC,EYE HAEMORRHAGE,4
EC,FOOT FRACTURE,4
EC,GINGIVAL BLEEDING,4
EC,HERPES ZOSTER,4
EC,HYPOTHYROIDISM,4
EC,IMMOBILE,4
EC,INCORRECT DOSE ADMINISTERED,4
EC,LEUKAEMIA,4
EC,LUNG NEOPLASM MALIGNANT,4
EC,MATERNAL EXPOSURE DURING PREGNANCY,4
EC,METABOLIC DISORDER,4
EC,MOOD ALTERED,4
EC,MOVEMENT DISORDER,4
EC,MUSCULOSKELETAL STIFFNESS,4
EC,MYELOFIBROSIS,4
EC,NECK PAIN,4
EC,NEOPLASM PROGRESSION,4
EC,NEPHROLITHIASIS,4
EC,OSMOTIC DEMYELINATION SYNDROME,4
EC,OVERDOSE,4
EC,PROCEDURAL PAIN,4
EC,PRURITUS,4
EC,RENAL IMPAIRMENT,4
EC,RENAL PAIN,4
EC,SERUM FERRITIN INCREASED,4
EC,SICKLE CELL ANAEMIA WITH CRISIS,4
EC,THROMBOCYTOSIS,4
EC,TOXICITY TO VARIOUS AGENTS,4
EC,ULCER,4
EC,WHITE BLOOD CELL COUNT DECREASED,4
EC,AGITATION,3
EC,ANGINA UNSTABLE,3
EC,APHONIA,3
EC,ARTHRITIS,3
EC,BACTERIAL INFECTION,3
EC,BLOOD GLUCOSE DECREASED,3
EC,BLOOD IRON INCREASED,3
EC,BLOOD POTASSIUM INCREASED,3
EC,BLOOD PRESSURE DECREASED,3
EC,BLOOD UREA INCREASED,3
EC,BONE CANCER,3
EC,BRONCHITIS,3
EC,BURNING SENSATION,3
EC,CARDIOMEGALY,3
EC,CHEST DISCOMFORT,3
EC,CHOKING,3
EC,CHONDROPATHY,3
EC,COAGULOPATHY,3
EC,COGNITIVE DISORDER,3
EC,COLITIS,3
EC,COLON CANCER,3
EC,COMPLETED SUICIDE,3
EC,CYANOSIS,3
EC,DERMATITIS,3
EC,DIABETIC COMA,3
EC,DIABETIC FOOT,3
EC,DIABETIC KETOACIDOSIS,3
EC,DISEASE RECURRENCE,3
EC,DRUG HYPERSENSITIVITY,3
EC,DRY SKIN,3
EC,DYSKINESIA,3
EC,DYSPHONIA,3
EC,DYSSTASIA,3
EC,EATING DISORDER,3
EC,EMOTIONAL DISTRESS,3
EC,EYE INFLAMMATION,3
EC,EYE IRRITATION,3
EC,EYE PAIN,3
EC,EYELID OEDEMA,3
EC,FLATULENCE,3
EC,FULL BLOOD COUNT DECREASED,3
EC,GASTRIC INFECTION,3
EC,GLAUCOMA,3
EC,HAEMOGLOBIN DECREASED,3
EC,HEMIPLEGIA,3
EC,HEPATIC CANCER,3
EC,HEPATIC ENZYME INCREASED,3
EC,HYPERTHYROIDISM,3
EC,HYPOACUSIS,3
EC,ILL-DEFINED DISORDER,3
EC,IMMUNODEFICIENCY,3
EC,IMPAIRED HEALING,3
EC,INFLUENZA LIKE ILLNESS,3
EC,INGUINAL HERNIA,3
EC,INJECTION SITE PAIN,3
EC,JAUNDICE,3
EC,JOINT INJURY,3
EC,LEUKOCYTOSIS,3
EC,LIMB INJURY,3
EC,LUNG INFECTION,3
EC,LYMPHOMA,3
EC,MEDICAL DEVICE COMPLICATION,3
EC,MELAENA,3
EC,MENINGITIS,3
EC,METASTATIC NEOPLASM,3
EC,MONOPLEGIA,3
EC,NERVOUS SYSTEM DISORDER,3
EC,NEURALGIA,3
EC,NODULE,3
EC,OSTEOARTHRITIS,3
EC,OVERWEIGHT,3
EC,PAIN IN JAW,3
EC,PANCREATIC CARCINOMA,3
EC,PANCREATIC DISORDER,3
EC,PARALYSIS,3
EC,PARKINSONISM,3
EC,PARKINSON^S DISEASE,3
EC,PERITONEAL CLOUDY EFFLUENT,3
EC,PETECHIAE,3
EC,PHLEBITIS,3
EC,PITUITARY TUMOUR,3
EC,PNEUMONITIS,3
EC,POISONING,3
EC,POST PROCEDURAL COMPLICATION,3
EC,PRODUCT PACKAGING ISSUE,3
EC,PSORIASIS,3
EC,RENAL CANCER,3
EC,RETINAL DETACHMENT,3
EC,RHEUMATOID ARTHRITIS,3
EC,SKIN EXFOLIATION,3
EC,SKIN LESION,3
EC,SKIN ULCER,3
EC,STRESS,3
EC,SYNOVIAL CYST,3
EC,THYROID MASS,3
EC,TIBIA FRACTURE,3
EC,TOOTH DISORDER,3
EC,VIITH NERVE PARALYSIS,3
EC,VISUAL ACUITY REDUCED,3
EC,WHITE BLOOD CELL DISORDER,3
EC,ABDOMINAL DISCOMFORT,2
EC,ABDOMINAL SEPSIS,2
EC,ABORTION,2
EC,ACUTE ABDOMEN,2
EC,ACUTE KIDNEY INJURY,2
EC,ACUTE PULMONARY OEDEMA,2
EC,ALANINE AMINOTRANSFERASE INCREASED,2
EC,ALOPECIA,2
EC,ANAEMIA MEGALOBLASTIC,2
EC,ANEURYSM,2
EC,ANGER,2
EC,ANTIBODY TEST ABNORMAL,2
EC,ARTERIAL OCCLUSIVE DISEASE,2
EC,ARTERIAL THROMBOSIS,2
EC,ARTERIOVENOUS FISTULA OPERATION,2
EC,ASCITES,2
EC,ASPARTATE AMINOTRANSFERASE INCREASED,2
EC,ATRIAL FIBRILLATION,2
EC,BEDRIDDEN,2
EC,BLADDER PROLAPSE,2
EC,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,2
EC,BLINDNESS TRANSIENT,2
EC,BLINDNESS UNILATERAL,2
EC,BLOOD PRESSURE SYSTOLIC INCREASED,2
EC,BLOOD URINE PRESENT,2
EC,BODY TEMPERATURE INCREASED,2
EC,BRAIN ABSCESS,2
EC,BRAIN INJURY,2
EC,BREAST MASS,2
EC,BRONCHIAL DISORDER,2
EC,CARDIAC FAILURE CONGESTIVE,2
EC,CARDIOPULMONARY FAILURE,2
EC,CARDIOTOXICITY,2
EC,CARDIOVASCULAR DISORDER,2
EC,CATHETER PLACEMENT,2
EC,CEREBRAL CALCIFICATION,2
EC,CEREBRAL DISORDER,2
EC,CHOLECYSTITIS,2
EC,CHROMATURIA,2
EC,COAGULATION TIME PROLONGED,2
EC,COLORECTAL CANCER,2
EC,COLOSTOMY,2
EC,CONFUSIONAL STATE,2
EC,COORDINATION ABNORMAL,2
EC,CRANIOCEREBRAL INJURY,2
EC,DEAFNESS,2
EC,DECUBITUS ULCER,2
EC,DEPRESSED LEVEL OF CONSCIOUSNESS,2
EC,DEVICE ISSUE,2
EC,DEVICE MALFUNCTION,2
EC,DEVICE OCCLUSION,2
EC,DIARRHOEA HAEMORRHAGIC,2
EC,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
EC,DYSARTHRIA,2
EC,EAR NEOPLASM,2
EC,EAR PAIN,2
EC,ELECTROLYTE IMBALANCE,2
EC,EXPIRED PRODUCT ADMINISTERED,2
EC,EYE DISORDER,2
EC,EYE PRURITUS,2
EC,EYE SWELLING,2
EC,FAECES DISCOLOURED,2
EC,FEAR,2
EC,FEMUR FRACTURE,2
EC,FLUID OVERLOAD,2
EC,FOETAL DEATH,2
EC,FOETAL EXPOSURE DURING PREGNANCY,2
EC,FRACTURE,2
EC,GASTRIC DISORDER,2
EC,GASTRIC HAEMORRHAGE,2
EC,GASTRIC ULCER HAEMORRHAGE,2
EC,GASTROINTESTINAL PAIN,2
EC,GENERAL PHYSICAL CONDITION ABNORMAL,2
EC,GENERALISED TONIC-CLONIC SEIZURE,2
EC,GINGIVITIS,2
EC,GOITRE,2
EC,H1N1 INFLUENZA,2
EC,HAEMATOMA,2
EC,HAEMORRHOIDS,2
EC,HAND FRACTURE,2
EC,HEART RATE DECREASED,2
EC,HEMIPARESIS,2
EC,HEPATIC STEATOSIS,2
EC,HEPATITIS A,2
EC,HOSPITALISATION,2
EC,HUNGER,2
EC,HYPERTHERMIA,2
EC,HYPOGLYCAEMIA,2
EC,HYPONATRAEMIA,2
EC,HYPOVOLAEMIC SHOCK,2
EC,HYPOXIA,2
EC,HYSTERECTOMY,2
EC,IDIOPATHIC PULMONARY FIBROSIS,2
EC,IMMUNE SYSTEM DISORDER,2
EC,IMPLANT SITE HAEMATOMA,2
EC,INFECTION PARASITIC,2
EC,INTRAOCULAR PRESSURE INCREASED,2
EC,IRRITABILITY,2
EC,IRRITABLE BOWEL SYNDROME,2
EC,JOINT DISLOCATION,2
EC,JOINT SWELLING,2
EC,KIDNEY INFECTION,2
EC,LABORATORY TEST ABNORMAL,2
EC,LARGE INTESTINAL OBSTRUCTION,2
EC,LARYNGEAL OEDEMA,2
EC,LOOSE TOOTH,2
EC,LUNG NEOPLASM,2
EC,MASTITIS,2
EC,MEMORY IMPAIRMENT,2
EC,MENTAL STATUS CHANGES,2
EC,MONOPARESIS,2
EC,MOUTH HAEMORRHAGE,2
EC,MULTIPLE SCLEROSIS RELAPSE,2
EC,MUSCULAR WEAKNESS,2
EC,MUSCULOSKELETAL DISCOMFORT,2
EC,NASAL CONGESTION,2
EC,NASOPHARYNGITIS,2
EC,NOCTURIA,2
EC,NONINFECTIOUS PERITONITIS,2
EC,NONINFECTIVE GINGIVITIS,2
EC,OCULAR DISCOMFORT,2
EC,OCULAR ICTERUS,2
EC,OEDEMA,2
EC,ORAL CANDIDIASIS,2
EC,ORAL HERPES,2
EC,OSTEONECROSIS OF JAW,2
EC,PALPITATIONS,2
EC,PELVIC FRACTURE,2
EC,PERIORBITAL OEDEMA,2
EC,PHOTOPHOBIA,2
EC,PLATELET COUNT INCREASED,2
EC,PNEUMONIA STAPHYLOCOCCAL,2
EC,PNEUMOTHORAX,2
EC,POLLAKIURIA,2
EC,POSTOPERATIVE WOUND INFECTION,2
EC,PRESCRIBED OVERDOSE,2
EC,PRESYNCOPE,2
EC,PRODUCT QUALITY ISSUE,2
EC,PRODUCTIVE COUGH,2
EC,PULMONARY FIBROSIS,2
EC,PULMONARY MASS,2
EC,PULMONARY PAIN,2
EC,PURULENT DISCHARGE,2
EC,PYELONEPHRITIS,2
EC,RENAL INJURY,2
EC,RESPIRATORY DISTRESS,2
EC,RIB FRACTURE,2
EC,SICKLE CELL ANAEMIA,2
EC,SKIN DISCOLOURATION,2
EC,SKIN DISORDER,2
EC,SPLEEN DISORDER,2
EC,STOMATITIS,2
EC,SUICIDAL IDEATION,2
EC,SYSTEMIC LUPUS ERYTHEMATOSUS,2
EC,TENSION,2
EC,THERAPY NON-RESPONDER,2
EC,THERMAL BURN,2
EC,THYROID CANCER,2
EC,THYROID DISORDER,2
EC,THYROID OPERATION,2
EC,TOOTH LOSS,2
EC,TRANSIENT ISCHAEMIC ATTACK,2
EC,TRAUMATIC LUNG INJURY,2
EC,TREATMENT NONCOMPLIANCE,2
EC,TUBERCULOSIS,2
EC,TYPHOID FEVER,2
EC,UNDERWEIGHT,2
EC,UNEVALUABLE EVENT,2
EC,UNWANTED AWARENESS DURING ANAESTHESIA,2
EC,UPPER GASTROINTESTINAL HAEMORRHAGE,2
EC,URINARY TRACT DISORDER,2
EC,UTERINE CANCER,2
EC,UVEITIS,2
EC,VASCULAR RUPTURE,2
EC,VASCULAR STENT THROMBOSIS,2
EC,VENOUS THROMBOSIS LIMB,2
EC,VIRAL INFECTION,2
EC,VULVOVAGINAL BURNING SENSATION,2
EC,WOUND INFECTION,2
EC,WRONG DRUG ADMINISTERED,2
EC,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
EC,YELLOW SKIN,2
EC,ABDOMINAL ADHESIONS,1
EC,ABDOMINAL HERNIA,1
EC,ABDOMINAL MASS,1
EC,ABDOMINAL NEOPLASM,1
EC,ABDOMINAL WALL CYST,1
EC,ABNORMAL SLEEP-RELATED EVENT,1
EC,ABORTION INDUCED,1
EC,ABSCESS LIMB,1
EC,ACANTHOSIS NIGRICANS,1
EC,ACCIDENT AT HOME,1
EC,ACCIDENTAL OVERDOSE,1
EC,ACINETOBACTER TEST POSITIVE,1
EC,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
EC,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
EC,ACUTE MYELOID LEUKAEMIA,1
EC,ADENOCARCINOMA PANCREAS,1
EC,ADMINISTRATION SITE PRURITUS,1
EC,ADMINISTRATION SITE REACTION,1
EC,ADVERSE REACTION,1
EC,AFFECT LABILITY,1
EC,ALVEOLAR OSTEITIS,1
EC,AMENORRHOEA,1
EC,ANAESTHETIC COMPLICATION,1
EC,ANAL FISTULA,1
EC,ANAL ULCER,1
EC,ANGIOPATHY,1
EC,ANTHRAX,1
EC,ANURIA,1
EC,AORTIC ANEURYSM,1
EC,AORTIC OCCLUSION,1
EC,AORTIC VALVE STENOSIS,1
EC,APATHY,1
EC,APPARENT DEATH,1
EC,APPENDIX DISORDER,1
EC,ARTERIOVENOUS FISTULA OCCLUSION,1
EC,ARTHROPOD BITE,1
EC,ASPIRATION,1
EC,ASPIRATION BRONCHIAL,1
EC,ASTHMA,1
EC,ASTHMATIC CRISIS,1
EC,ATRIAL THROMBOSIS,1
EC,BACILLUS INFECTION,1
EC,BALLISMUS,1
EC,BILIARY COLIC,1
EC,BIPOLAR DISORDER,1
EC,BLADDER CANCER,1
EC,BLADDER NEOPLASM,1
EC,BLADDER OBSTRUCTION,1
EC,BLAST CELL COUNT INCREASED,1
EC,BLEPHARITIS,1
EC,BLOOD BLISTER,1
EC,BLOOD DISORDER,1
EC,BLOOD GROWTH HORMONE INCREASED,1
EC,BLOOD INSULIN INCREASED,1
EC,BLOOD PARATHYROID HORMONE ABNORMAL,1
EC,BLOOD PHOSPHORUS ABNORMAL,1
EC,BLOOD PRESSURE FLUCTUATION,1
EC,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
EC,BLOOD TRIGLYCERIDES INCREASED,1
EC,BLOOD URIC ACID INCREASED,1
EC,BONE DEFORMITY,1
EC,BONE DISORDER,1
EC,BONE MARROW NECROSIS,1
EC,BONE NEOPLASM,1
EC,BRAIN CANCER METASTATIC,1
EC,BRAIN HYPOXIA,1
EC,BRAIN MASS,1
EC,BREAST ABSCESS,1
EC,BREAST CANCER FEMALE,1
EC,BREAST INJURY,1
EC,BREAST OEDEMA,1
EC,BREAST PAIN,1
EC,BRONCHIECTASIS,1
EC,BURNING FEET SYNDROME,1
EC,BURNS THIRD DEGREE,1
EC,C-REACTIVE PROTEIN INCREASED,1
EC,CACHEXIA,1
EC,CAESAREAN SECTION,1
EC,CANDIDA PNEUMONIA,1
EC,CARCINOID TUMOUR,1
EC,CARDIAC FIBRILLATION,1
EC,CARDIAC TAMPONADE,1
EC,CARDIAC VALVE DISEASE,1
EC,CARDIAC VALVE REPLACEMENT COMPLICATION,1
EC,CARDIAC VENTRICULAR DISORDER,1
EC,CARDIOGENIC SHOCK,1
EC,CATHETER SITE HAEMORRHAGE,1
EC,CATHETER SITE INFECTION,1
EC,CELLULITIS,1
EC,CENTRAL VENOUS CATHETERISATION,1
EC,CEREBRAL HYPOPERFUSION,1
EC,CEREBRAL ISCHAEMIA,1
EC,CEREBRAL THROMBOSIS,1
EC,CEREBROSPINAL FLUID LEAKAGE,1
EC,CERVICAL SPINAL STENOSIS,1
EC,CERVICOBRACHIAL SYNDROME,1
EC,CERVIX CARCINOMA,1
EC,CHOLANGITIS,1
EC,CHOLECYSTECTOMY,1
EC,CHOREA,1
EC,CHROMOSOME ANALYSIS ABNORMAL,1
EC,CHRONIC KIDNEY DISEASE,1
EC,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
EC,CLOSTRIDIUM DIFFICILE COLITIS,1
EC,COAGULATION TIME SHORTENED,1
EC,COLITIS ISCHAEMIC,1
EC,COLITIS ULCERATIVE,1
EC,COLON NEOPLASM,1
EC,COMPLICATION ASSOCIATED WITH DEVICE,1
EC,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
EC,CONCOMITANT DISEASE PROGRESSION,1
EC,CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY,1
EC,CONJUNCTIVAL HYPERAEMIA,1
EC,CONTRAINDICATED PRODUCT ADMINISTERED,1
EC,CONTUSION,1
EC,CORNEAL OPACITY,1
EC,CORONARY ARTERY OCCLUSION,1
EC,CORONARY ARTERY STENOSIS,1
EC,CRANIAL NERVE DISORDER,1
EC,CRANIOCERVICAL SYNDROME,1
EC,CRITICAL ILLNESS,1
EC,CRYING,1
EC,CUSHING^S SYNDROME,1
EC,CUTANEOUS ANTHRAX,1
EC,CYST,1
EC,CYTOMEGALOVIRUS INFECTION,1
EC,DEAFNESS UNILATERAL,1
EC,DECREASED INTEREST,1
EC,DELIRIUM,1
EC,DELUSION OF GRANDEUR,1
EC,DEMENTIA,1
EC,DERMATITIS ATOPIC,1
EC,DEVICE DEPOSIT ISSUE,1
EC,DEVICE DISLOCATION,1
EC,DEVICE RELATED INFECTION,1
EC,DIABETES INSIPIDUS,1
EC,DIABETES MELLITUS INADEQUATE CONTROL,1
EC,DIABETIC METABOLIC DECOMPENSATION,1
EC,DIALYSIS RELATED COMPLICATION,1
EC,DIPLEGIA,1
EC,DIPLOPIA,1
EC,DISEASE COMPLICATION,1
EC,DISLOCATION OF VERTEBRA,1
EC,DISSEMINATED TUBERCULOSIS,1
EC,DISTURBANCE IN ATTENTION,1
EC,DIVERTICULUM INTESTINAL,1
EC,DROWNING,1
EC,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
EC,DRUG ADMINISTRATION ERROR,1
EC,DRUG DISPENSING ERROR,1
EC,DRUG EFFECT DECREASED,1
EC,DRUG EFFECT INCOMPLETE,1
EC,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
EC,DRUG INTOLERANCE,1
EC,DRUG PRESCRIBING ERROR,1
EC,DRUG RESISTANCE,1
EC,DRUG-INDUCED LIVER INJURY,1
EC,DRY THROAT,1
EC,DUODENAL ULCER,1
EC,DYSPLASIA,1
EC,EAR DISCOMFORT,1
EC,EAR DISORDER,1
EC,EAR HAEMORRHAGE,1
EC,EAR INFECTION,1
EC,EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED,1
EC,ECCHYMOSIS,1
EC,ECHINOCOCCIASIS,1
EC,ECZEMA INFECTED,1
EC,ELDERLY,1
EC,EMBOLIC STROKE,1
EC,EMBOLISM,1
EC,EMPHYSEMA,1
EC,ENCEPHALITIS,1
EC,ENDOMETRIAL CANCER,1
EC,EPIGLOTTITIS,1
EC,EPILEPSY,1
EC,EPIPHYSES PREMATURE FUSION,1
EC,ERYTHRODERMIC PSORIASIS,1
EC,ESCHERICHIA INFECTION,1
EC,EXPOSED BONE IN JAW,1
EC,EXPOSURE VIA BODY FLUID,1
EC,EXTRASYSTOLES,1
EC,EXTREMITY NECROSIS,1
EC,EYE DISCHARGE,1
EC,EYE OEDEMA,1
EC,EYE OPERATION,1
EC,EYELID THICKENING,1
EC,FACIAL ASYMMETRY,1
EC,FACIAL PAIN,1
EC,FACIAL SPASM,1
EC,FAECAL INCONTINENCE,1
EC,FEEDING DISORDER,1
EC,FEELING HOT,1
EC,FEELING JITTERY,1
EC,FEELING OF DESPAIR,1
EC,FIBROMYALGIA,1
EC,FIBULA FRACTURE,1
EC,FLANK PAIN,1
EC,FLAVIVIRUS INFECTION,1
EC,FOLLICULITIS,1
EC,FOOD INTERACTION,1
EC,FOOT AMPUTATION,1
EC,FOOT DEFORMITY,1
EC,FOOT OPERATION,1
EC,FREQUENT BOWEL MOVEMENTS,1
EC,FRUCTOSAMINE INCREASED,1
EC,FUNGAL INFECTION,1
EC,GALLBLADDER OPERATION,1
EC,GALLBLADDER PERFORATION,1
EC,GANGRENE,1
EC,GASTRIC PERFORATION,1
EC,GASTRIC ULCER,1
EC,GASTRITIS ATROPHIC,1
EC,GASTROENTERITIS,1
EC,GASTROENTERITIS BACILLUS,1
EC,GASTROINTESTINAL INFLAMMATION,1
EC,GASTROINTESTINAL MOTILITY DISORDER,1
EC,GASTROINTESTINAL OBSTRUCTION,1
EC,GASTROINTESTINAL POLYP,1
EC,GASTROOESOPHAGEAL REFLUX DISEASE,1
EC,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
EC,GENITAL INFECTION,1
EC,GENITAL ULCERATION,1
EC,GINGIVAL DISORDER,1
EC,GINGIVAL PAIN,1
EC,GINGIVAL SWELLING,1
EC,GLOMERULAR FILTRATION RATE DECREASED,1
EC,GLOSSODYNIA,1
EC,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
EC,GROIN ABSCESS,1
EC,GROWTH RETARDATION,1
EC,GUILLAIN-BARRE SYNDROME,1
EC,GUN SHOT WOUND,1
EC,HAEMATOLOGICAL MALIGNANCY,1
EC,HAEMATOTOXICITY,1
EC,HAEMODIALYSIS,1
EC,HAEMODIALYSIS COMPLICATION,1
EC,HAEMODYNAMIC INSTABILITY,1
EC,HAEMOGLOBIN INCREASED,1
EC,HAEMOLYTIC ANAEMIA,1
EC,HAEMORRHAGIC STROKE,1
EC,HALLUCINATION,1
EC,HEAD DISCOMFORT,1
EC,HEARING IMPAIRED,1
EC,HEART RATE INCREASED,1
EC,HEART VALVE STENOSIS,1
EC,HELICOBACTER GASTRITIS,1
EC,HEPATIC ENZYME ABNORMAL,1
EC,HEPATIC INFECTION,1
EC,HEPATIC LESION,1
EC,HEPATIC NEOPLASM,1
EC,HEPATITIS,1
EC,HEPATITIS TOXIC,1
EC,HERNIA REPAIR,1
EC,HIP ARTHROPLASTY,1
EC,HODGKIN^S DISEASE,1
EC,HOMICIDAL IDEATION,1
EC,HORMONE LEVEL ABNORMAL,1
EC,HUMERUS FRACTURE,1
EC,HYDROCEPHALUS,1
EC,HYDRONEPHROSIS,1
EC,HYPERCALCAEMIA,1
EC,HYPERCHLORHYDRIA,1
EC,HYPERCHOLESTEROLAEMIA,1
EC,HYPERNATRAEMIA,1
EC,HYPEROSMOLAR STATE,1
EC,HYPOAESTHESIA ORAL,1
EC,HYPOALBUMINAEMIA,1
EC,HYPOBARISM,1
EC,HYPOCALCAEMIA,1
EC,HYPOKALAEMIC SYNDROME,1
EC,HYPOKINESIA,1
EC,HYPONATRAEMIC SYNDROME,1
EC,HYPOPHAGIA,1
EC,ILEUS PARALYTIC,1
EC,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
EC,IMMUNOSUPPRESSION,1
EC,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
EC,INCISIONAL HERNIA,1
EC,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
EC,INCREASED UPPER AIRWAY SECRETION,1
EC,INFANTILE SPASMS,1
EC,INFECTED VARICOSE VEIN,1
EC,INFECTIOUS PLEURAL EFFUSION,1
EC,INFECTIOUS THYROIDITIS,1
EC,INGUINAL HERNIA REPAIR,1
EC,INJECTION SITE ABSCESS,1
EC,INSULIN RESISTANCE SYNDROME,1
EC,INTENTIONAL PRODUCT MISUSE,1
EC,INTERNAL HAEMORRHAGE,1
EC,INTERVERTEBRAL DISC DISORDER,1
EC,INTERVERTEBRAL DISC DISPLACEMENT,1
EC,INTESTINAL DILATATION,1
EC,INTESTINAL FISTULA,1
EC,INTESTINAL HAEMORRHAGE,1
EC,INTESTINAL PSEUDO-OBSTRUCTION,1
EC,INTESTINAL ULCER,1
EC,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
EC,INTRAOCULAR LENS IMPLANT,1
EC,INVESTIGATION,1
EC,ISCHAEMIA,1
EC,JAW DISORDER,1
EC,JUDGEMENT IMPAIRED,1
EC,JUVENILE IDIOPATHIC ARTHRITIS,1
EC,KAPOSI^S SARCOMA,1
EC,KERATITIS,1
EC,KETOACIDOSIS,1
EC,KETONURIA,1
EC,LARGE FOR DATES BABY,1
EC,LARGE INTESTINAL ULCER HAEMORRHAGE,1
EC,LARGE INTESTINE POLYP,1
EC,LARYNGEAL CANCER,1
EC,LARYNGEAL DISCOMFORT,1
EC,LARYNGOSPASM,1
EC,LETHARGY,1
EC,LEUKOPENIA,1
EC,LIBIDO DECREASED,1
EC,LIGAMENT INJURY,1
EC,LIMB DISCOMFORT,1
EC,LIMB OPERATION,1
EC,LIP AND/OR ORAL CAVITY CANCER,1
EC,LIP DISCOLOURATION,1
EC,LIP HAEMORRHAGE,1
EC,LIP PAIN,1
EC,LIPODYSTROPHY ACQUIRED,1
EC,LIVER FUNCTION TEST ABNORMAL,1
EC,LIVER INJURY,1
EC,LIVER TRANSPLANT,1
EC,LIVER TRANSPLANT REJECTION,1
EC,LOCAL SWELLING,1
EC,LOCALISED INFECTION,1
EC,LOGORRHOEA,1
EC,LOOSE BODY IN JOINT,1
EC,LOWER RESPIRATORY TRACT INFECTION,1
EC,LYMPH NODE TUBERCULOSIS,1
EC,LYMPHADENITIS,1
EC,LYMPHADENOPATHY,1
EC,LYMPHOEDEMA,1
EC,MACULAR DEGENERATION,1
EC,MALABSORPTION,1
EC,MALIGNANT PERITONEAL NEOPLASM,1
EC,MALNUTRITION,1
EC,MASS,1
EC,MASTICATION DISORDER,1
EC,MENSTRUAL DISORDER,1
EC,MENSTRUATION IRREGULAR,1
EC,MENTAL DISORDER,1
EC,METAL POISONING,1
EC,METASTASES TO BONE,1
EC,METASTASES TO CENTRAL NERVOUS SYSTEM,1
EC,METASTASES TO LIVER,1
EC,METASTASES TO LUNG,1
EC,METASTASES TO SPINE,1
EC,METASTASIS,1
EC,METASTATIC GASTRIC CANCER,1
EC,METRORRHAGIA,1
EC,MICTURITION DISORDER,1
EC,MITRAL VALVE CALCIFICATION,1
EC,MITRAL VALVE STENOSIS,1
EC,MOOD SWINGS,1
EC,MOUTH SWELLING,1
EC,MOUTH ULCERATION,1
EC,MUCOSAL INFLAMMATION,1
EC,MUCOUS MEMBRANE DISORDER,1
EC,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
EC,MULTIPLE SCLEROSIS,1
EC,MUSCLE ATROPHY,1
EC,MUSCLE CONTRACTURE,1
EC,MUSCLE RIGIDITY,1
EC,MUSCULOSKELETAL CHEST PAIN,1
EC,MYASTHENIC SYNDROME,1
EC,MYOCARDIAL ISCHAEMIA,1
EC,MYOCARDITIS,1
EC,MYOPIA,1
EC,NAIL BED BLEEDING,1
EC,NASAL DISCOMFORT,1
EC,NASAL NEOPLASM,1
EC,NEAR DROWNING,1
EC,NECK MASS,1
EC,NEOPLASM PROSTATE,1
EC,NEOPLASM RECURRENCE,1
EC,NEURITIS,1
EC,NEURODEGENERATIVE DISORDER,1
EC,NEUTROPHIL COUNT DECREASED,1
EC,NEUTROPHILIA,1
EC,NO ADVERSE EVENT,1
EC,NOCTURNAL DYSPNOEA,1
EC,NONINFECTIVE SIALOADENITIS,1
EC,NORMAL NEWBORN,1
EC,NOSOCOMIAL INFECTION,1
EC,OCULAR HYPERTENSION,1
EC,OEDEMA DUE TO HEPATIC DISEASE,1
EC,OESOPHAGITIS,1
EC,OLIGURIA,1
EC,ONCOLOGIC COMPLICATION,1
EC,ORAL FUNGAL INFECTION,1
EC,ORAL MUCOSAL BLISTERING,1
EC,ORAL PAIN,1
EC,OSTEOPOROSIS,1
EC,OVARIAN CYST,1
EC,OVARIAN CYST RUPTURED,1
EC,OVARIAN NEOPLASM,1
EC,OXYGEN SATURATION DECREASED,1
EC,PANCREATIC NEOPLASM,1
EC,PANCREATITIS ACUTE,1
EC,PANCREATITIS HAEMORRHAGIC,1
EC,PANNICULITIS,1
EC,PAPILLOEDEMA,1
EC,PARAESTHESIA ORAL,1
EC,PARANOIA,1
EC,PARATHYROID REIMPLANTATION,1
EC,PATELLA FRACTURE,1
EC,PATHOLOGICAL FRACTURE,1
EC,PELVIC NEOPLASM,1
EC,PELVIC ORGAN INJURY,1
EC,PELVIC PAIN,1
EC,PEMPHIGOID,1
EC,PERICARDIAL EFFUSION,1
EC,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
EC,PERIPHERAL ARTERY THROMBOSIS,1
EC,PERIPHERAL COLDNESS,1
EC,PERIPHERAL VASCULAR DISORDER,1
EC,PERIPHERAL VENOUS DISEASE,1
EC,PERITONEAL DISORDER,1
EC,PERITONEAL EFFLUENT ABNORMAL,1
EC,PERITONEAL FLUID ANALYSIS ABNORMAL,1
EC,PHARYNGEAL INFLAMMATION,1
EC,PHARYNGEAL MASS,1
EC,PHARYNGEAL ULCERATION,1
EC,PHARYNGITIS,1
EC,PHARYNGOTONSILLITIS,1
EC,PHOTOSENSITIVITY REACTION,1
EC,PIGMENTATION DISORDER,1
EC,PITUITARY TUMOUR BENIGN,1
EC,PLASMACYTOMA,1
EC,PLATELET COUNT ABNORMAL,1
EC,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
EC,PNEUMONIA INFLUENZAL,1
EC,PNEUMONIA VIRAL,1
EC,POLYCYSTIC OVARIES,1
EC,POST PROCEDURAL HAEMATURIA,1
EC,POST PROCEDURAL INFECTION,1
EC,POSTICTAL HEADACHE,1
EC,PREGNANCY,1
EC,PREGNANCY ON CONTRACEPTIVE,1
EC,PREGNANCY WITH CONTRACEPTIVE PATCH,1
EC,PREGNANCY WITH IMPLANT CONTRACEPTIVE,1
EC,PREMATURE BABY,1
EC,PREMATURE DELIVERY,1
EC,PREMATURE SEPARATION OF PLACENTA,1
EC,PROCEDURAL COMPLICATION,1
EC,PRODUCT USE IN UNAPPROVED INDICATION,1
EC,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
EC,PROSTATECTOMY,1
EC,PROTEINURIA,1
EC,PSYCHOTIC DISORDER,1
EC,PTERYGIUM,1
EC,PULMONARY ARTERIAL HYPERTENSION,1
EC,PULMONARY HAEMORRHAGE,1
EC,PULMONARY HYPERTENSION,1
EC,PULMONARY THROMBOSIS,1
EC,PULMONARY VALVE INCOMPETENCE,1
EC,PULSE ABSENT,1
EC,PYODERMA,1
EC,QUADRIPLEGIA,1
EC,RADIATION HEPATITIS,1
EC,RASH MACULAR,1
EC,RED BLOOD CELL COUNT INCREASED,1
EC,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,1
EC,RENAL COLIC,1
EC,RENAL CYST,1
EC,RENAL FAILURE ACUTE,1
EC,RENAL FAILURE CHRONIC,1
EC,RENAL HAEMORRHAGE,1
EG,DEATH,197
EG,HEPATIC FAILURE,194
EG,ANAEMIA,119
EG,VOMITING,76
EG,HYPERGLYCAEMIA,69
EG,DYSPNOEA,67
EG,CONDITION AGGRAVATED,64
EG,TOXICITY TO VARIOUS AGENTS,56
EG,PYREXIA,55
EG,FATIGUE,54
EG,DRUG INEFFECTIVE,52
EG,RASH,52
EG,HYPOTENSION,51
EG,HYPERSENSITIVITY,47
EG,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,46
EG,DIARRHOEA,46
EG,CEREBROVASCULAR ACCIDENT,45
EG,THROMBOCYTOPENIA,40
EG,CARDIAC DISORDER,38
EG,NEUTROPENIA,38
EG,RENAL IMPAIRMENT,38
EG,DIZZINESS,35
EG,HEPATITIS C,35
EG,LIVER DISORDER,35
EG,BLOOD GLUCOSE INCREASED,34
EG,COMA,32
EG,RENAL FAILURE,32
EG,PNEUMONIA,30
EG,DEEP VEIN THROMBOSIS,29
EG,NAUSEA,29
EG,CARDIAC ARREST,28
EG,FLUSHING,28
EG,MUCOSAL INFLAMMATION,27
EG,EXPOSURE DURING PREGNANCY,26
EG,HEADACHE,26
EG,HYPERTENSION,26
EG,SEPSIS,26
EG,ASCITES,25
EG,BLINDNESS,25
EG,CHILLS,24
EG,COUGH,24
EG,SEIZURE,24
EG,FEBRILE NEUTROPENIA,23
EG,HAEMORRHAGE,23
EG,PRURITUS,23
EG,CHEST PAIN,22
EG,HEPATIC ENZYME INCREASED,22
EG,LOSS OF CONSCIOUSNESS,22
EG,WEIGHT DECREASED,22
EG,SKIN BURNING SENSATION,21
EG,ULCER,21
EG,ANAPHYLACTIC SHOCK,20
EG,MYOCARDIAL INFARCTION,20
EG,TACHYCARDIA,20
EG,THROMBOPHLEBITIS,20
EG,WHITE BLOOD CELL COUNT DECREASED,20
EG,DECREASED APPETITE,19
EG,MEDICATION ERROR,19
EG,RENAL DISORDER,19
EG,CARDIAC FAILURE,18
EG,HYPOGLYCAEMIA,18
EG,LEUKOPENIA,18
EG,THROMBOSIS,18
EG,CHEST DISCOMFORT,17
EG,DEHYDRATION,17
EG,HEPATOCELLULAR CARCINOMA,17
EG,DIABETIC HYPERGLYCAEMIC COMA,16
EG,KETOACIDOSIS,16
EG,PRODUCT USE ISSUE,16
EG,ALOPECIA,15
EG,HYPOAESTHESIA,15
EG,PULMONARY EMBOLISM,15
EG,ANGINA PECTORIS,14
EG,FOETAL EXPOSURE DURING PREGNANCY,14
EG,HAEMOGLOBIN DECREASED,14
EG,HEPATIC CANCER,14
EG,INCORRECT ROUTE OF DRUG ADMINISTRATION,14
EG,LOWER RESPIRATORY TRACT INFECTION,14
EG,PAIN,14
EG,RESPIRATORY FAILURE,14
EG,SOMNOLENCE,14
EG,BONE MARROW FAILURE,13
EG,BREAST CANCER,13
EG,COMA HEPATIC,13
EG,JAUNDICE,13
EG,NEPHROLITHIASIS,13
EG,NEUROPATHY PERIPHERAL,13
EG,PLATELET COUNT DECREASED,13
EG,ABDOMINAL PAIN,12
EG,ACUTE KIDNEY INJURY,12
EG,BONE PAIN,12
EG,DEPRESSION,12
EG,DISEASE PROGRESSION,12
EG,ERYTHEMA,12
EG,HAEMATEMESIS,12
EG,OEDEMA PERIPHERAL,12
EG,OVARIAN EPITHELIAL CANCER RECURRENT,12
EG,OVERDOSE,12
EG,PAIN IN EXTREMITY,12
EG,PRODUCT USE IN UNAPPROVED INDICATION,12
EG,ARRHYTHMIA,11
EG,BLADDER DISORDER,11
EG,BLOOD BILIRUBIN INCREASED,11
EG,DIABETES MELLITUS,11
EG,DIABETIC KETOACIDOSIS,11
EG,EYE INFECTION,11
EG,HYPERHIDROSIS,11
EG,INFLUENZA LIKE ILLNESS,11
EG,MELAENA,11
EG,PALPITATIONS,11
EG,PULMONARY OEDEMA,11
EG,SYNCOPE,11
EG,TOXIC EPIDERMAL NECROLYSIS,11
EG,VISUAL ACUITY REDUCED,11
EG,ALTERED STATE OF CONSCIOUSNESS,10
EG,ANAPHYLACTIC REACTION,10
EG,ASTHENIA,10
EG,BLOOD PRESSURE INCREASED,10
EG,CEREBRAL HAEMORRHAGE,10
EG,EYE HAEMORRHAGE,10
EG,FALL,10
EG,GANGRENE,10
EG,HEPATIC FIBROSIS,10
EG,HEPATOTOXICITY,10
EG,INFECTION,10
EG,MYALGIA,10
EG,NEOPLASM MALIGNANT,10
EG,PANCYTOPENIA,10
EG,PERIPHERAL SWELLING,10
EG,PNEUMONITIS,10
EG,TREMOR,10
EG,ABDOMINAL PAIN UPPER,9
EG,BACK PAIN,9
EG,BLOOD CREATININE INCREASED,9
EG,CIRCULATORY COLLAPSE,9
EG,CONFUSIONAL STATE,9
EG,ENDOPHTHALMITIS,9
EG,EPILEPSY,9
EG,GENERALISED OEDEMA,9
EG,HEPATIC FUNCTION ABNORMAL,9
EG,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,9
EG,INSOMNIA,9
EG,INTRAOCULAR PRESSURE INCREASED,9
EG,RESPIRATORY DISTRESS,9
EG,STEVENS-JOHNSON SYNDROME,9
EG,SUDDEN DEATH,9
EG,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,9
EG,ABDOMINAL DISTENSION,8
EG,ATRIAL FIBRILLATION,8
EG,BLOOD GLUCOSE ABNORMAL,8
EG,BLOOD GLUCOSE FLUCTUATION,8
EG,BRADYCARDIA,8
EG,CYANOSIS,8
EG,DIABETIC FOOT,8
EG,EYE IRRITATION,8
EG,FACE OEDEMA,8
EG,HAEMOLYTIC ANAEMIA,8
EG,HALLUCINATION,8
EG,HEPATIC CIRRHOSIS,8
EG,HEPATIC ENCEPHALOPATHY,8
EG,HYPOGLYCAEMIC COMA,8
EG,MALIGNANT NEOPLASM PROGRESSION,8
EG,MYOCARDIAL ISCHAEMIA,8
EG,PANCREATIC CARCINOMA,8
EG,PREMATURE BABY,8
EG,SKIN DISCOLOURATION,8
EG,SKIN REACTION,8
EG,SPEECH DISORDER,8
EG,STOMATITIS,8
EG,URTICARIA,8
EG,VISION BLURRED,8
EG,ABDOMINAL DISCOMFORT,7
EG,ABORTION,7
EG,ASTHMA,7
EG,CARDIOGENIC SHOCK,7
EG,CEREBRAL INFARCTION,7
EG,CONSTIPATION,7
EG,DEPRESSED LEVEL OF CONSCIOUSNESS,7
EG,DIABETIC COMA,7
EG,DRUG DOSE OMISSION,7
EG,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,7
EG,HEPATITIS,7
EG,HERPES ZOSTER,7
EG,HYPERBILIRUBINAEMIA,7
EG,INFLAMMATION,7
EG,METASTASES TO LUNG,7
EG,MUSCLE SPASMS,7
EG,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,7
EG,RECTAL TENESMUS,7
EG,SHOCK,7
EG,STATUS EPILEPTICUS,7
EG,TREATMENT FAILURE,7
EG,ABORTION SPONTANEOUS,6
EG,ACUTE RESPIRATORY DISTRESS SYNDROME,6
EG,ADVERSE EVENT,6
EG,ANAL HAEMORRHAGE,6
EG,BRAIN OEDEMA,6
EG,BRONCHOSPASM,6
EG,DRUG DEPENDENCE,6
EG,EYE PAIN,6
EG,EYELID OEDEMA,6
EG,GASTROINTESTINAL DISORDER,6
EG,GENERAL PHYSICAL HEALTH DETERIORATION,6
EG,HEART RATE INCREASED,6
EG,HEMIPLEGIA,6
EG,HOSPITALISATION,6
EG,HYPOALBUMINAEMIA,6
EG,INJECTION SITE PAIN,6
EG,INTERNATIONAL NORMALISED RATIO INCREASED,6
EG,LEUKOCYTOSIS,6
EG,MATERNAL EXPOSURE DURING PREGNANCY,6
EG,METABOLIC ACIDOSIS,6
EG,MULTI-ORGAN DISORDER,6
EG,NO THERAPEUTIC RESPONSE,6
EG,SEPTIC SHOCK,6
EG,SUICIDE ATTEMPT,6
EG,VISUAL IMPAIRMENT,6
EG,ACIDOSIS,5
EG,ACUTE MYOCARDIAL INFARCTION,5
EG,ARTHRALGIA,5
EG,ASPHYXIA,5
EG,BLOOD GLUCOSE DECREASED,5
EG,BLOOD URINE PRESENT,5
EG,CARDIAC OPERATION,5
EG,CATARACT,5
EG,CONVULSION,5
EG,COUNTERFEIT DRUG ADMINISTERED,5
EG,CYSTITIS,5
EG,DIABETES MELLITUS INADEQUATE CONTROL,5
EG,DYSPHAGIA,5
EG,EPISTAXIS,5
EG,GASTROENTERITIS,5
EG,GASTROINTESTINAL HAEMORRHAGE,5
EG,HAEMATURIA,5
EG,HEPATITIS TOXIC,5
EG,HYPOKALAEMIA,5
EG,HYPOXIA,5
EG,INCORRECT DOSE ADMINISTERED,5
EG,IRRITABILITY,5
EG,JOINT DISLOCATION,5
EG,LEG AMPUTATION,5
EG,LEUKAEMIA,5
EG,LUNG DISORDER,5
EG,LUNG NEOPLASM MALIGNANT,5
EG,NEPHROPATHY TOXIC,5
EG,NEUROTOXICITY,5
EG,OEDEMA,5
EG,OROPHARYNGEAL PAIN,5
EG,OVARIAN CYST,5
EG,OXYGEN SATURATION DECREASED,5
EG,PALLOR,5
EG,PNEUMATOSIS INTESTINALIS,5
EG,PRODUCT QUALITY ISSUE,5
EG,RASH GENERALISED,5
EG,RHEUMATOID ARTHRITIS,5
EG,SWELLING,5
EG,TACHYPNOEA,5
EG,ULCERATIVE KERATITIS,5
EG,VIRAL INFECTION,5
EG,WOUND INFECTION,5
EG,ANGINA UNSTABLE,4
EG,ANURIA,4
EG,ANXIETY,4
EG,ASPARTATE AMINOTRANSFERASE INCREASED,4
EG,ATRIAL THROMBOSIS,4
EG,BLOOD DISORDER,4
EG,BRAIN NEOPLASM MALIGNANT,4
EG,CARDIO-RESPIRATORY ARREST,4
EG,CARDIOVASCULAR DISORDER,4
EG,CHOKING,4
EG,COLITIS,4
EG,DEMYELINATION,4
EG,DRUG HYPERSENSITIVITY,4
EG,DYSURIA,4
EG,EYE INFLAMMATION,4
EG,FOETAL DEATH,4
EG,GASTROINTESTINAL PERFORATION,4
EG,GENERALISED TONIC-CLONIC SEIZURE,4
EG,HAEMATOMA,4
EG,HAEMOPTYSIS,4
EG,HYPOPYON,4
EG,INFLUENZA,4
EG,INJECTION SITE HAEMORRHAGE,4
EG,INTENTIONAL OVERDOSE,4
EG,INTESTINAL OBSTRUCTION,4
EG,INTRACARDIAC THROMBUS,4
EG,JAUNDICE NEONATAL,4
EG,JC VIRUS TEST POSITIVE,4
EG,KIDNEY TRANSPLANT REJECTION,4
EG,LIMB DISCOMFORT,4
EG,LOWER LIMB FRACTURE,4
EG,MATERNAL DRUGS AFFECTING FOETUS,4
EG,MATERNAL EXPOSURE BEFORE PREGNANCY,4
EG,NEPHROPATHY,4
EG,NO ADVERSE EVENT,4
EG,OCULAR HYPERAEMIA,4
EG,PARALYSIS,4
EG,PERITONITIS,4
EG,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,4
EG,PREMATURE DELIVERY,4
EG,RENAL FAILURE ACUTE,4
EG,RENAL PAIN,4
EG,ROAD TRAFFIC ACCIDENT,4
EG,SERUM FERRITIN INCREASED,4
EG,SUSPECTED COUNTERFEIT PRODUCT,4
EG,TRANSAMINASES INCREASED,4
EG,TREATMENT NONCOMPLIANCE,4
EG,UNDERDOSE,4
EG,URINE OUTPUT DECREASED,4
EG,WEIGHT INCREASED,4
EG,WRONG DRUG ADMINISTERED,4
EG,ABASIA,3
EG,ABORTION INDUCED,3
EG,ALANINE AMINOTRANSFERASE INCREASED,3
EG,ANGIOEDEMA,3
EG,BILE DUCT OBSTRUCTION,3
EG,BLOOD CHOLESTEROL INCREASED,3
EG,BRONCHITIS,3
EG,BURNING SENSATION,3
EG,CARDIOMYOPATHY,3
EG,CARDIOTOXICITY,3
EG,CELLULITIS,3
EG,CEREBRAL THROMBOSIS,3
EG,CHOLELITHIASIS,3
EG,CONCOMITANT DISEASE PROGRESSION,3
EG,CORNEAL INFILTRATES,3
EG,DEATH NEONATAL,3
EG,DELIRIUM,3
EG,DERMATITIS,3
EG,DEVICE ISSUE,3
EG,DIABETIC COMPLICATION,3
EG,DISCOMFORT,3
EG,DRUG ABUSE,3
EG,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,3
EG,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
EG,DRUG RESISTANCE,3
EG,DRUG-INDUCED LIVER INJURY,3
EG,DRY EYE,3
EG,ELECTROLYTE IMBALANCE,3
EG,ERYTHEMA OF EYELID,3
EG,EYE DISCHARGE,3
EG,EYE SWELLING,3
EG,GAIT DISTURBANCE,3
EG,GASTROOESOPHAGEAL REFLUX DISEASE,3
EG,HAEMORRHAGE INTRACRANIAL,3
EG,HEPATOMEGALY,3
EG,HYPOCALCAEMIA,3
EG,HYPONATRAEMIA,3
EG,ILL-DEFINED DISORDER,3
EG,INCORRECT PRODUCT STORAGE,3
EG,LIVER FUNCTION TEST INCREASED,3
EG,LOW BIRTH WEIGHT BABY,3
EG,LYMPHOMA,3
EG,METASTASES TO BONE,3
EG,METASTASES TO LIVER,3
EG,MOVEMENT DISORDER,3
EG,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
EG,MULTIPLE SCLEROSIS RELAPSE,3
EG,MUSCLE ATROPHY,3
EG,MUSCULAR WEAKNESS,3
EG,MUSCULOSKELETAL PAIN,3
EG,MYOCARDITIS,3
EG,NEOPLASM,3
EG,NERVOUS SYSTEM DISORDER,3
EG,OSTEONECROSIS,3
EG,OVARIAN CANCER RECURRENT,3
EG,PHOTOSENSITIVITY REACTION,3
EG,POTENTIATING DRUG INTERACTION,3
EG,PRODUCTIVE COUGH,3
EG,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
EG,PSORIASIS,3
EG,PULMONARY FIBROSIS,3
EG,PULMONARY MASS,3
EG,PULSE ABSENT,3
EG,PURPURA,3
EG,RESTLESSNESS,3
EG,RETINAL DETACHMENT,3
EG,SACROILIITIS,3
EG,SCHIZOPHRENIA,3
EG,SKIN ULCER,3
EG,SNEEZING,3
EG,SPLENOMEGALY,3
EG,STAPHYLOCOCCAL INFECTION,3
EG,STRESS,3
EG,SUICIDAL IDEATION,3
EG,SWELLING FACE,3
EG,THERAPEUTIC RESPONSE UNEXPECTED,3
EG,TRANSPLANT REJECTION,3
EG,TUMOUR LYSIS SYNDROME,3
EG,UNRESPONSIVE TO STIMULI,3
EG,URINARY INCONTINENCE,3
EG,URINARY RETENTION,3
EG,VENTRICULAR SEPTAL DEFECT,3
EG,VENTRICULAR TACHYCARDIA,3
EG,VITRITIS,3
EG,WHEEZING,3
EG,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
EG,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
EG,ACCIDENT,2
EG,ACCIDENTAL OVERDOSE,2
EG,ACNE,2
EG,ACUTE CHEST SYNDROME,2
EG,ACUTE HEPATIC FAILURE,2
EG,AGRANULOCYTOSIS,2
EG,ALLERGIC BRONCHITIS,2
EG,AMENORRHOEA,2
EG,ANTERIOR CHAMBER DISORDER,2
EG,AORTIC STENOSIS,2
EG,AORTIC VALVE STENOSIS,2
EG,AREFLEXIA,2
EG,ARTERIOSCLEROSIS,2
EG,ARTHRITIS,2
EG,ATRIAL FLUTTER,2
EG,BACTERIAL INFECTION,2
EG,BALANCE DISORDER,2
EG,BLOOD ALBUMIN DECREASED,2
EG,BLOOD ALKALINE PHOSPHATASE INCREASED,2
EG,BLOOD CALCIUM DECREASED,2
EG,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
EG,BLOOD IMMUNOGLOBULIN E INCREASED,2
EG,BLOOD PRESSURE DECREASED,2
EG,BLOOD PRESSURE FLUCTUATION,2
EG,BLOOD TRIGLYCERIDES INCREASED,2
EG,BODY TEMPERATURE INCREASED,2
EG,BONE CANCER,2
EG,BRAIN NEOPLASM,2
EG,BRAIN STEM STROKE,2
EG,BREAST MASS,2
EG,C-REACTIVE PROTEIN INCREASED,2
EG,CARDIAC VALVE REPLACEMENT COMPLICATION,2
EG,CEREBRAL ISCHAEMIA,2
EG,CHOLESTASIS,2
EG,CHROMATURIA,2
EG,CHRONIC ALLOGRAFT NEPHROPATHY,2
EG,CHRONIC HEPATITIS,2
EG,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
EG,CLEFT LIP,2
EG,CLEFT PALATE,2
EG,COMPLEX REGIONAL PAIN SYNDROME,2
EG,CONJUNCTIVAL HAEMORRHAGE,2
EG,CONJUNCTIVITIS,2
EG,CORONARY ARTERY INSUFFICIENCY,2
EG,DEAFNESS,2
EG,DEAFNESS BILATERAL,2
EG,DEAFNESS NEUROSENSORY,2
EG,DELAYED RECOVERY FROM ANAESTHESIA,2
EG,DERMATITIS ALLERGIC,2
EG,DEVICE USE ERROR,2
EG,DISEASE RECURRENCE,2
EG,DISSEMINATED INTRAVASCULAR COAGULATION,2
EG,DISTURBANCE IN ATTENTION,2
EG,DRUG EFFECT INCOMPLETE,2
EG,DRUG USE DISORDER,2
EG,DRY SKIN,2
EG,DYSKINESIA,2
EG,EAR PAIN,2
EG,EATING DISORDER,2
EG,ECCHYMOSIS,2
EG,EMBOLISM,2
EG,EOSINOPHILIA,2
EG,EYE DISORDER,2
EG,FAECES DISCOLOURED,2
EG,FEELING ABNORMAL,2
EG,FEELING COLD,2
EG,FEELING HOT,2
EG,FOAMING AT MOUTH,2
EG,FOETAL HEART RATE ABNORMAL,2
EG,FOREIGN BODY SENSATION IN EYES,2
EG,FRACTURE,2
EG,GASTRIC CANCER,2
EG,GASTRIC PERFORATION,2
EG,GASTRIC ULCER,2
EG,GINGIVAL BLEEDING,2
EG,GLAUCOMA,2
EG,GLUCOSE TOLERANCE IMPAIRED,2
EG,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
EG,HAEMATOTOXICITY,2
EG,HAEMORRHOIDS,2
EG,HAEMOTHORAX,2
EG,HEAD TITUBATION,2
EG,HEART RATE IRREGULAR,2
EG,HEPATIC HAEMORRHAGE,2
EG,HEPATIC STEATOSIS,2
EG,HEPATITIS A,2
EG,HEPATITIS B REACTIVATION,2
EG,HEPATOSPLENOMEGALY,2
EG,HERPES VIRUS INFECTION,2
EG,HYPERAESTHESIA,2
EG,HYPERGLYCAEMIC UNCONSCIOUSNESS,2
EG,HYPERSOMNIA,2
EG,HYPERTHERMIA,2
EG,HYPERTHYROIDISM,2
EG,HYPOACUSIS,2
EG,HYPOMAGNESAEMIA,2
EG,HYPOPHAGIA,2
EG,HYPOTHERMIA,2
EG,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
EG,INJECTION SITE DISCOLOURATION,2
EG,INJECTION SITE HAEMATOMA,2
EG,INJECTION SITE INDURATION,2
EG,INJECTION SITE MASS,2
EG,INJECTION SITE REACTION,2
EG,INJURY,2
EG,INTERSTITIAL LUNG DISEASE,2
EG,ISCHAEMIA,2
EG,LIP SWELLING,2
EG,LIVER FUNCTION TEST ABNORMAL,2
EG,LIVER INJURY,2
EG,LYMPHOEDEMA,2
EG,MALAISE,2
EG,MARGINAL ZONE LYMPHOMA,2
EG,MATERNAL EXPOSURE DURING DELIVERY,2
EG,MENORRHAGIA,2
EG,METASTASES TO CENTRAL NERVOUS SYSTEM,2
EG,METASTASIS,2
EG,MIDDLE EAR EFFUSION,2
EG,MOOD ALTERED,2
EG,MOUTH ULCERATION,2
EG,MULTIPLE CONGENITAL ABNORMALITIES,2
EG,MULTIPLE SCLEROSIS,2
EG,MYOPATHY TOXIC,2
EG,NERVOUSNESS,2
EG,OESOPHAGEAL DISORDER,2
EG,OESOPHAGEAL VARICES HAEMORRHAGE,2
EG,ORTHOPNOEA,2
EG,OSTEOARTHRITIS,2
EG,OSTEONECROSIS OF JAW,2
EG,OTITIS MEDIA,2
EG,PAPULE,2
EG,PARAPLEGIA,2
EG,PARTIAL SEIZURES,2
EG,PELVIC FRACTURE,2
EG,PEPTIC ULCER,2
EG,PERICARDIAL EFFUSION,2
EG,PERICARDITIS,2
EG,PERIPHERAL COLDNESS,2
EG,PERIPHERAL ISCHAEMIA,2
EG,PHOTOPHOBIA,2
EG,PITYRIASIS LICHENOIDES ET VARIOLIFORMIS ACUTA,2
EG,PLASMA CELL MYELOMA,2
EG,PLATELET COUNT INCREASED,2
EG,PNEUMONIA ASPIRATION,2
EG,PNEUMONIA FUNGAL,2
EG,PNEUMOTHORAX,2
EG,PORTAL VEIN THROMBOSIS,2
EG,POST PROCEDURAL HAEMORRHAGE,2
EG,PRESCRIBED OVERDOSE,2
EG,PROCTITIS,2
EG,PRODUCT COUNTERFEIT,2
EG,PROTEINURIA,2
EG,PRURITUS GENERALISED,2
EG,PSEUDOMONAL SEPSIS,2
EG,PSYCHIATRIC SYMPTOM,2
EG,PULMONARY HAEMORRHAGE,2
EG,RASH ERYTHEMATOUS,2
EG,RASH PRURITIC,2
EG,RED BLOOD CELL COUNT DECREASED,2
EG,RESPIRATORY ARREST,2
EG,RESPIRATORY RATE INCREASED,2
EG,RETINAL ARTERY OCCLUSION,2
EG,RETINAL VASCULAR DISORDER,2
EG,RETINOPATHY,2
EG,RIGHT VENTRICULAR FAILURE,2
EG,SARCOIDOSIS,2
EG,SCREAMING,2
EG,SICKLE CELL ANAEMIA WITH CRISIS,2
EG,SKIN EXFOLIATION,2
EG,SKIN IRRITATION,2
EG,SKIN OEDEMA,2
EG,SKIN SWELLING,2
EG,SPINA BIFIDA,2
EG,SPLEEN DISORDER,2
EG,SUPRAVENTRICULAR TACHYCARDIA,2
EG,SURGERY,2
EG,SYNOVITIS,2
EG,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
EG,SYSTEMIC LUPUS ERYTHEMATOSUS,2
EG,THERAPEUTIC PRODUCT INEFFECTIVE,2
EG,THERAPY NON-RESPONDER,2
EG,THERMAL BURN,2
EG,THIRST,2
EG,THROMBOCYTOSIS,2
EG,TINNITUS,2
EG,TOOTH LOSS,2
EG,TRANSIENT ISCHAEMIC ATTACK,2
EG,UPPER GASTROINTESTINAL HAEMORRHAGE,2
EG,UPPER LIMB FRACTURE,2
EG,UTERINE CANCER,2
EG,UVEITIS,2
EG,VAGINAL HAEMORRHAGE,2
EG,VASCULITIS,2
EG,VENOOCCLUSIVE LIVER DISEASE,2
EG,VENTRICULAR EXTRASYSTOLES,2
EG,VENTRICULAR FIBRILLATION,2
EG,VERTIGO,2
EG,VITREOUS ABSCESS,2
EG,VITREOUS HAEMORRHAGE,2
EG,ABDOMINAL ABSCESS,1
EG,ABDOMINAL HERNIA REPAIR,1
EG,ABNORMAL BEHAVIOUR,1
EG,ABNORMAL FAECES,1
EG,ABORTION EARLY,1
EG,ABSCESS LIMB,1
EG,ACCIDENTAL EXPOSURE TO PRODUCT,1
EG,ACNE FULMINANS,1
EG,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
EG,ACUTE ABDOMEN,1
EG,ACUTE CORONARY SYNDROME,1
EG,ACUTE GRAFT VERSUS HOST DISEASE,1
EG,ACUTE LEUKAEMIA,1
EG,ACUTE POST ASTHMATIC AMYOTROPHY,1
EG,ADMINISTRATION SITE ERYTHEMA,1
EG,AGEUSIA,1
EG,AGGRESSION,1
EG,AGORAPHOBIA,1
EG,AKATHISIA,1
EG,AKINESIA,1
EG,ALLERGIC OEDEMA,1
EG,ALLODYNIA,1
EG,AMNESIA,1
EG,AMNIOTIC FLUID VOLUME DECREASED,1
EG,AMPUTATION,1
EG,AMYLASE INCREASED,1
EG,ANAL INCONTINENCE,1
EG,ANAL INFECTION,1
EG,ANAPHYLACTOID REACTION,1
EG,ANAPHYLACTOID SYNDROME OF PREGNANCY,1
EG,ANGIOPATHY,1
EG,ANGLE CLOSURE GLAUCOMA,1
EG,ANTINUCLEAR ANTIBODY INCREASED,1
EG,ANTISOCIAL PERSONALITY DISORDER,1
EG,AORTIC ARTERIOSCLEROSIS,1
EG,APGAR SCORE LOW,1
EG,APHAGIA,1
EG,APLASIA PURE RED CELL,1
EG,APNOEA,1
EG,APPENDICITIS,1
EG,APPETITE DISORDER,1
EG,AQUEOUS HUMOUR LEAKAGE,1
EG,ARTERIAL OCCLUSIVE DISEASE,1
EG,ARTERIAL RUPTURE,1
EG,ARTERIAL THROMBOSIS,1
EG,ARTHROPATHY,1
EG,ARTHROPOD BITE,1
EG,ASPIRATION,1
EG,ASPIRATION PLEURAL CAVITY ABNORMAL,1
EG,ASTHENOSPERMIA,1
EG,ATRIAL SEPTAL DEFECT,1
EG,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
EG,ATROPHIC GLOSSITIS,1
EG,AUTOIMMUNE DISORDER,1
EG,AZOOSPERMIA,1
EG,BACK DISORDER,1
EG,BALLOON ATRIAL SEPTOSTOMY,1
EG,BENIGN PROSTATIC HYPERPLASIA,1
EG,BENIGN SOFT TISSUE NEOPLASM,1
EG,BIOPSY BONE MARROW,1
EG,BIPOLAR DISORDER,1
EG,BLADDER MASS,1
EG,BLISTER,1
EG,BLOOD CREATININE ABNORMAL,1
EG,BLOOD GASES ABNORMAL,1
EG,BLOOD KETONE BODY INCREASED,1
EG,BLOOD LACTATE DEHYDROGENASE INCREASED,1
EG,BLOOD PRESSURE NORMAL,1
EG,BLOOD PROLACTIN INCREASED,1
EG,BLOOD SODIUM DECREASED,1
EG,BONE DENSITY DECREASED,1
EG,BONE GIANT CELL TUMOUR BENIGN,1
EG,BONE INFARCTION,1
EG,BONE MARROW DISORDER,1
EG,BONE MARROW INFILTRATION,1
EG,BONE NEOPLASM,1
EG,BORDERLINE PERSONALITY DISORDER,1
EG,BRAIN DEATH,1
EG,BRAIN INJURY,1
EG,BREAST CANCER FEMALE,1
EG,BREAST CANCER METASTATIC,1
EG,BREAST ENLARGEMENT,1
EG,BREAST OEDEMA,1
EG,BREATH SOUNDS ABNORMAL,1
EG,BRONCHIAL DISORDER,1
EG,BRONCHOPNEUMONIA,1
EG,CALCINOSIS,1
EG,CALCULUS URETERIC,1
EG,CALCULUS URINARY,1
EG,CAPILLARY FRAGILITY,1
EG,CAPILLARY LEAK SYNDROME,1
EG,CARDIAC FAILURE ACUTE,1
EG,CARDIAC FAILURE CHRONIC,1
EG,CARDIAC FAILURE CONGESTIVE,1
EG,CARDIAC SEPTAL DEFECT,1
EG,CARDIAC VALVE DISEASE,1
EG,CARDIAC VENTRICULAR THROMBOSIS,1
EG,CARDIOMEGALY,1
EG,CARDIOPULMONARY FAILURE,1
EG,CATHETER SITE HAEMORRHAGE,1
EG,CATHETER SITE PAIN,1
EG,CELLULITIS ORBITAL,1
EG,CENTRAL NERVOUS SYSTEM INFLAMMATION,1
EG,CENTRAL NERVOUS SYSTEM LESION,1
EG,CEREBRAL ATROPHY,1
EG,CEREBRAL DISORDER,1
EG,CHEST X-RAY ABNORMAL,1
EG,CHOLANGITIS ACUTE,1
EG,CHOLECYSTITIS,1
EG,CHOLECYSTITIS ACUTE,1
EG,CHOREOATHETOSIS,1
EG,CHOROIDAL NEOVASCULARISATION,1
EG,CHRONIC GASTRITIS,1
EG,CHRONIC HEPATITIS C,1
EG,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
EG,COAGULOPATHY,1
EG,COLON CANCER,1
EG,COMMUNICATION DISORDER,1
EG,COMPLICATIONS OF TRANSPLANT SURGERY,1
EG,CONCUSSION,1
EG,CONDUCTIVE DEAFNESS,1
EG,CONGENITAL ANOMALY,1
EG,CONGENITAL CORONARY ARTERY MALFORMATION,1
EG,CONGENITAL HEART VALVE DISORDER,1
EG,CONJUNCTIVAL HYPERAEMIA,1
EG,CONJUNCTIVAL OEDEMA,1
EG,CONTUSION,1
EG,COR PULMONALE,1
EG,CORNEAL DISORDER,1
EG,CORNEAL EPITHELIUM DEFECT,1
EG,CORNEAL NEOVASCULARISATION,1
EG,CORNEAL OEDEMA,1
EG,CORNEAL OPACITY,1
EG,CORONARY ARTERY BYPASS,1
EG,CORONARY ARTERY EMBOLISM,1
EG,CORONARY ARTERY OCCLUSION,1
EG,CORONARY ARTERY STENOSIS,1
EG,CORONARY ARTERY THROMBOSIS,1
EG,COUNTERFEIT PRODUCT ADMINISTERED,1
EG,CREATININE RENAL CLEARANCE DECREASED,1
EG,CROUP NONINFECTIOUS,1
EG,CUSHINGOID,1
EG,CUTANEOUS LEISHMANIASIS,1
EG,CUTANEOUS VASCULITIS,1
EG,CYST,1
EG,CYST RUPTURE,1
EG,CYSTITIS HAEMORRHAGIC,1
EG,CYSTITIS NONINFECTIVE,1
EG,CYTOMEGALOVIRUS INFECTION,1
EG,DANDRUFF,1
EG,DEAFNESS UNILATERAL,1
EG,DECREASED ACTIVITY,1
EG,DECREASED IMMUNE RESPONSIVENESS,1
EG,DEMENTIA,1
EG,DEMENTIA ALZHEIMER^S TYPE,1
EG,DENTAL CARIES,1
EG,DEPENDENCE,1
EG,DERMAL CYST,1
EG,DERMATITIS ACNEIFORM,1
EG,DEVICE BREAKAGE,1
EG,DEVICE MALFUNCTION,1
EG,DIABETIC RETINAL OEDEMA,1
EG,DIABETIC RETINOPATHY,1
EG,DIALYSIS,1
EG,DIFFUSE LAMELLAR KERATITIS,1
EG,DIPLOPIA,1
EG,DROP ATTACKS,1
EG,DRUG ADMINISTRATION ERROR,1
EG,DRUG DIVERSION,1
EG,DRUG EFFECT PROLONGED,1
EG,DRUG LEVEL BELOW THERAPEUTIC,1
EG,DRUG LEVEL DECREASED,1
EG,DRUG LEVEL INCREASED,1
EG,DRUG PRESCRIBING ERROR,1
EG,DRUG WITHDRAWAL SYNDROME,1
EG,DRY MOUTH,1
EG,DYSPHONIA,1
EG,DYSTONIA,1
EG,EAR SWELLING,1
EG,ECTHYMA,1
EG,ECTOPIC PREGNANCY,1
EG,EJECTION FRACTION DECREASED,1
EG,EMBOLIC CEREBRAL INFARCTION,1
EG,EMBOLIC STROKE,1
EG,EMPHYSEMA,1
EG,ENCEPHALITIS,1
EG,ENCEPHALOPATHY,1
EG,END STAGE RENAL DISEASE,1
EG,END-TIDAL CO2 DECREASED,1
EG,ENDOCRINE NEOPLASM,1
EG,ENDOMETRIAL CANCER STAGE III,1
EG,ENURESIS,1
EG,ERECTILE DYSFUNCTION,1
EG,ERUCTATION,1
EG,ERYTHEMA MULTIFORME,1
EG,EXCESSIVE GRANULATION TISSUE,1
EG,EXOPHTHALMOS,1
EG,EXPOSURE DURING BREAST FEEDING,1
EG,EXTRAPYRAMIDAL DISORDER,1
EG,EXTRAVASATION,1
EG,EYE OEDEMA,1
EG,EYE OPERATION,1
EG,FACIAL PARALYSIS,1
EG,FACTOR VIII INHIBITION,1
EG,FAECAL INCONTINENCE,1
EG,FALLOPIAN TUBE CYST,1
EG,FEMUR FRACTURE,1
EG,FINGER AMPUTATION,1
EG,FLAT ANTERIOR CHAMBER OF EYE,1
EG,FLATULENCE,1
EG,FLUID INTAKE REDUCED,1
EG,FLUID RETENTION,1
EG,FOCAL DYSCOGNITIVE SEIZURES,1
EG,FOETAL DISORDER,1
EG,FOETAL GROWTH RESTRICTION,1
EG,FOOT AMPUTATION,1
EG,FOOT FRACTURE,1
EG,FOREARM FRACTURE,1
EG,FOREIGN BODY IN EYE,1
EG,FULL BLOOD COUNT ABNORMAL,1
EG,FUNCTIONAL GASTROINTESTINAL DISORDER,1
EG,FUNGAL INFECTION,1
EG,FURUNCLE,1
EG,GALACTORRHOEA,1
EG,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
EG,GASTRIC VARICES,1
EG,GASTRIC VARICES HAEMORRHAGE,1
EG,GASTRITIS,1
EG,GASTROENTERITIS VIRAL,1
EG,GASTROINTESTINAL FUNGAL INFECTION,1
EG,GASTROINTESTINAL MOTILITY DISORDER,1
EG,GASTROINTESTINAL PAIN,1
EG,GASTROINTESTINAL STOMA COMPLICATION,1
EG,GASTROINTESTINAL TOXICITY,1
EG,GENERALISED ANXIETY DISORDER,1
EG,GIARDIASIS,1
EG,GLOMERULAR FILTRATION RATE DECREASED,1
EG,GLOSSODYNIA,1
EG,GRAND MAL CONVULSION,1
EG,GROWTH RETARDATION,1
EG,GYNAECOMASTIA,1
EG,HAEMARTHROSIS,1
EG,HAEMATOCHEZIA,1
EG,HAEMATOLOGY TEST ABNORMAL,1
EG,HAEMOCONCENTRATION,1
EG,HAEMODYNAMIC INSTABILITY,1
EG,HAEMOGLOBIN INCREASED,1
EG,HAEMOPHILIA,1
EG,HAEMORRHAGIC STROKE,1
EG,HAIR GROWTH ABNORMAL,1
EG,HAND DEFORMITY,1
EG,HEAD DISCOMFORT,1
EG,HEAD INJURY,1
EG,HEART RATE ABNORMAL,1
EG,HEART RATE DECREASED,1
EG,HEART RATE NORMAL,1
EG,HEART SOUNDS ABNORMAL,1
EG,HELICOBACTER TEST POSITIVE,1
EG,HELPLESSNESS,1
EG,HEMIPARESIS,1
EG,HEPATIC CANCER STAGE IV,1
EG,HEPATIC LESION,1
EG,HEPATIC VEIN THROMBOSIS,1
EG,HEPATITIS B DNA ASSAY POSITIVE,1
EG,HEPATITIS C VIRUS TEST POSITIVE,1
EG,HEPATITIS FULMINANT,1
EG,HEPATOPULMONARY SYNDROME,1
EG,HIP FRACTURE,1
EG,HISTIOCYTOSIS HAEMATOPHAGIC,1
EG,HISTOLOGY ABNORMAL,1
EG,HUNGER,1
EG,HYDRONEPHROSIS,1
EG,HYPERCALCAEMIA,1
EG,HYPERCAPNIA,1
EG,HYPERCHLORHYDRIA,1
EG,HYPERKALAEMIA,1
EG,HYPERPHAGIA,1
EG,HYPERPROLACTINAEMIA,1
EG,HYPERPROTEINAEMIA,1
EG,HYPERVENTILATION,1
EG,HYPOCAPNIA,1
EG,HYPOKINESIA,1
EG,HYPOPROTEINAEMIA,1
EG,HYPOSMIA,1
EG,HYPOTHALAMO-PITUITARY DISORDER,1
EG,HYPOTHYROIDISM,1
EG,HYPOTONIA,1
EG,HYPOVOLAEMIA,1
EG,HYSTERECTOMY,1
EG,IDIOPATHIC PULMONARY FIBROSIS,1
EG,ILEUS,1
EG,IMMATURE RESPIRATORY SYSTEM,1
EG,IMMUNODEFICIENCY,1
EG,INCISIONAL HERNIA,1
EG,INCONTINENCE,1
EG,INCORRECT DOSE ADMINISTERED BY DEVICE,1
EG,INCORRECT DRUG ADMINISTRATION DURATION,1
EG,INDURATION,1
EG,INFECTIOUS PLEURAL EFFUSION,1
EG,INFECTIVE TENOSYNOVITIS,1
EG,INJECTION SITE ERYTHEMA,1
EG,INJECTION SITE EXTRAVASATION,1
EG,INJECTION SITE FIBROSIS,1
EG,INJECTION SITE HYPOAESTHESIA,1
EG,INJECTION SITE INFECTION,1
EG,INJECTION SITE OEDEMA,1
EG,INJECTION SITE RASH,1
EG,INJECTION SITE SWELLING,1
EG,INTENTIONAL PRODUCT MISUSE,1
EG,INTENTIONAL PRODUCT USE ISSUE,1
EG,INTENTIONAL SELF-INJURY,1
EG,INTERNAL HAEMORRHAGE,1
EG,INTERVERTEBRAL DISC PROTRUSION,1
EG,INTRA-ABDOMINAL HAEMORRHAGE,1
EG,INTUSSUSCEPTION,1
EG,IRIDOCYCLITIS,1
EG,ISCHAEMIC STROKE,1
EG,JAW DISORDER,1
EG,JOINT ABSCESS,1
EG,JOINT STIFFNESS,1
EG,JOINT SWELLING,1
EG,JUVENILE IDIOPATHIC ARTHRITIS,1
EG,KAPOSI^S SARCOMA,1
EG,KIDNEY FIBROSIS,1
EG,LACRIMAL GLAND ENLARGEMENT,1
EG,LACTIC ACIDOSIS,1
EG,LARYNGEAL OEDEMA,1
EG,LARYNGITIS,1
EG,LAZINESS,1
EG,LEFT ATRIAL DILATATION,1
EG,LEFT VENTRICULAR DYSFUNCTION,1
EG,LETHARGY,1
EG,LIBIDO DECREASED,1
EG,LID LAG,1
EG,LIGAMENT INJURY,1
EG,LIGAMENT SPRAIN,1
EG,LIPASE INCREASED,1
EG,LIPID METABOLISM DISORDER,1
EG,LIPOMA,1
EG,LIQUID PRODUCT PHYSICAL ISSUE,1
EG,LIVER TRANSPLANT,1
EG,LIVER TRANSPLANT REJECTION,1
EG,LOCAL SWELLING,1
EG,LOCALISED OEDEMA,1
EG,LOWER GASTROINTESTINAL HAEMORRHAGE,1
EG,LUDWIG ANGINA,1
EG,LUMBAR VERTEBRAL FRACTURE,1
EG,LUNG ABSCESS,1
EG,LYMPH GLAND INFECTION,1
EG,LYMPH NODE TUBERCULOSIS,1
EG,LYMPHOPENIA,1
EG,MALNUTRITION,1
EG,MARROW HYPERPLASIA,1
EG,MASS,1
EG,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
EG,MEDICAL DEVICE COMPLICATION,1
EG,MEDICATION RESIDUE PRESENT,1
EG,MEGAKARYOCYTE DESTRUCTION INCREASED,1
EG,MEMORY IMPAIRMENT,1
EG,MENINGITIS,1
EG,MENINGOENCEPHALITIS HERPETIC,1
EG,MENSTRUAL DISORDER,1
EG,MENSTRUATION IRREGULAR,1
EG,MESENTERIC VEIN THROMBOSIS,1
EG,METABOLIC SYNDROME,1
EG,METASTATIC NEOPLASM,1
EG,MICTURITION URGENCY,1
EG,MITRAL VALVE INCOMPETENCE,1
EG,MITRAL VALVE REPLACEMENT,1
EG,MOBILITY DECREASED,1
EG,MOUTH HAEMORRHAGE,1
EG,MUCOSAL INFECTION,1
EG,MUCOSAL PAIN,1
EG,MULTI-ORGAN FAILURE,1
EG,MULTIPLE USE OF SINGLE-USE PRODUCT,1
EG,MUSCLE ABSCESS,1
EG,MUSCLE DISORDER,1
EG,MUSCLE SPASTICITY,1
EG,MUSCULOSKELETAL STIFFNESS,1
EG,MYASTHENIA GRAVIS,1
EG,MYOCARDIAL DEPRESSION,1
EG,MYOCLONIC EPILEPSY,1
EG,MYOCLONUS,1
EG,MYOPATHY,1
EG,MYOSITIS,1
EG,NAIL DISORDER,1
EG,NAIL GROWTH ABNORMAL,1
EG,NAIL PIGMENTATION,1
EG,NASAL PRURITUS,1
EG,NECK PAIN,1
EG,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
EG,NEOPLASM PROGRESSION,1
EG,NEPHRITIS,1
EG,NEURALGIA,1
EG,NEURITIS,1
EG,NEUROGENIC SHOCK,1
EG,NEUROMUSCULAR BLOCK PROLONGED,1
EG,NEUTROPHIL COUNT DECREASED,1
EG,NIPPLE SWELLING,1
EG,NON-HODGKIN^S LYMPHOMA,1
EG,NON-IMMUNE HEPARIN ASSOCIATED THROMBOCYTOPENIA,1
SV,DEATH,31
SV,HAEMOGLOBIN DECREASED,12
SV,PLATELET COUNT DECREASED,9
SV,DIARRHOEA,7
SV,SEPTIC SHOCK,7
SV,WHITE BLOOD CELL COUNT DECREASED,7
SV,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,6
SV,PNEUMONIA,6
SV,WHITE BLOOD CELL COUNT INCREASED,6
SV,BLOOD CREATININE INCREASED,5
SV,HYPOTENSION,5
SV,INFECTION,5
SV,MALIGNANT NEOPLASM PROGRESSION,5
SV,SEPSIS,5
SV,ASTHMATIC CRISIS,4
SV,BONE MARROW FAILURE,4
SV,CEREBRAL HAEMORRHAGE,4
SV,CEREBROVASCULAR ACCIDENT,4
SV,CHRONIC MYELOID LEUKAEMIA,4
SV,COUGH,4
SV,INFLAMMATION,4
SV,MALAISE,4
SV,MYOCARDIAL INFARCTION,4
SV,TACHYCARDIA,4
SV,THROMBOCYTOPENIA,4
SV,VOMITING,4
SV,ACUTE KIDNEY INJURY,3
SV,ASPARTATE AMINOTRANSFERASE INCREASED,3
SV,BLAST CELL COUNT INCREASED,3
SV,BLOOD LACTATE DEHYDROGENASE INCREASED,3
SV,CARDIO-RESPIRATORY ARREST,3
SV,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,3
SV,DEHYDRATION,3
SV,GENERAL PHYSICAL HEALTH DETERIORATION,3
SV,HAEMORRHAGE,3
SV,HYPERGLYCAEMIA,3
SV,NEUTROPENIA,3
SV,NEUTROPHIL COUNT DECREASED,3
SV,NEUTROPHIL COUNT INCREASED,3
SV,PERITONITIS,3
SV,PYREXIA,3
SV,URTICARIA,3
SV,ACUTE LYMPHOCYTIC LEUKAEMIA,2
SV,ALANINE AMINOTRANSFERASE INCREASED,2
SV,ANAPHYLACTIC REACTION,2
SV,ASCITES,2
SV,BLOOD BILIRUBIN INCREASED,2
SV,BLOOD CREATININE ABNORMAL,2
SV,BLOOD CREATININE DECREASED,2
SV,BLOOD GLUCOSE INCREASED,2
SV,BRONCHOPNEUMONIA,2
SV,CARDIAC DISORDER,2
SV,CRYING,2
SV,DECREASED APPETITE,2
SV,DRUG INEFFECTIVE,2
SV,DRUG RESISTANCE,2
SV,EXPOSURE DURING PREGNANCY,2
SV,FALL,2
SV,FLUID OVERLOAD,2
SV,GASTROINTESTINAL STROMAL TUMOUR,2
SV,HEPATIC CIRRHOSIS,2
SV,HYPOGLYCAEMIA,2
SV,HYPONATRAEMIA,2
SV,INFARCTION,2
SV,INSOMNIA,2
SV,LIVER INJURY,2
SV,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
SV,NAUSEA,2
SV,PLATELET COUNT INCREASED,2
SV,RASH,2
SV,RESPIRATORY FAILURE,2
SV,SEIZURE,2
SV,SOMNOLENCE,2
SV,TOXICITY TO VARIOUS AGENTS,2
SV,TRANSAMINASES INCREASED,2
SV,VISUAL IMPAIRMENT,2
SV,ABDOMINAL PAIN,1
SV,ABDOMINAL PAIN UPPER,1
SV,ABDOMINAL WALL ABSCESS,1
SV,ABORTION,1
SV,ABORTION SPONTANEOUS,1
SV,ABSCESS INTESTINAL,1
SV,ACCIDENT,1
SV,ACUTE CORONARY SYNDROME,1
SV,ACUTE LEUKAEMIA,1
SV,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
SV,ADENOCARCINOMA,1
SV,AGITATION,1
SV,APPENDICITIS,1
SV,ARRHYTHMIA,1
SV,ASTHMA,1
SV,ATRIOVENTRICULAR BLOCK COMPLETE,1
SV,BASOPHIL COUNT INCREASED,1
SV,BENIGN PROSTATIC HYPERPLASIA,1
SV,BILIRUBIN CONJUGATED INCREASED,1
SV,BIPOLAR I DISORDER,1
SV,BLADDER DISORDER,1
SV,BLAST CELLS PRESENT,1
SV,BLINDNESS,1
SV,BLOOD ALBUMIN DECREASED,1
SV,BLOOD ALBUMIN INCREASED,1
SV,BLOOD ALKALINE PHOSPHATASE INCREASED,1
SV,BLOOD BICARBONATE DECREASED,1
SV,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
SV,BLOOD FIBRINOGEN DECREASED,1
SV,BLOOD IRON DECREASED,1
SV,BLOOD PHOSPHORUS ABNORMAL,1
SV,BLOOD POTASSIUM DECREASED,1
SV,BLOOD PRESSURE INCREASED,1
SV,BLOOD SODIUM ABNORMAL,1
SV,BONE FISSURE,1
SV,BONE LESION,1
SV,BRAIN DEATH,1
SV,BRONCHOSPASM,1
SV,BUNDLE BRANCH BLOCK LEFT,1
SV,CARDIAC ARREST,1
SV,CARDIAC FAILURE CONGESTIVE,1
SV,CARDIOMEGALY,1
SV,CARDIOMYOPATHY,1
SV,CARDIOVASCULAR DISORDER,1
SV,CAROTID ARTERY OCCLUSION,1
SV,CEREBELLAR HAEMORRHAGE,1
SV,CEREBRAL VENOUS THROMBOSIS,1
SV,CERVIX CARCINOMA RECURRENT,1
SV,CHIKUNGUNYA VIRUS INFECTION,1
SV,CHOLELITHIASIS,1
SV,CHROMOSOME ANALYSIS ABNORMAL,1
SV,CHRONIC HEPATITIS,1
SV,COAGULOPATHY,1
SV,COLD SWEAT,1
SV,CONGESTIVE CARDIOMYOPATHY,1
SV,CONSTIPATION,1
SV,CREATININE RENAL CLEARANCE DECREASED,1
SV,CROHN^S DISEASE,1
SV,DECREASED ACTIVITY,1
SV,DELIRIUM,1
SV,DEMYELINATING POLYNEUROPATHY,1
SV,DERMATITIS ALLERGIC,1
SV,DIABETIC FOOT,1
SV,DIABETIC FOOT INFECTION,1
SV,DISCOMFORT,1
SV,DISEASE PROGRESSION,1
SV,DIVERTICULUM,1
SV,DIZZINESS,1
SV,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
SV,DYSPNOEA,1
SV,DYSSTASIA,1
SV,DYSURIA,1
SV,ECCHYMOSIS,1
SV,ELECTROENCEPHALOGRAM ABNORMAL,1
SV,EMBOLISM,1
SV,END STAGE RENAL DISEASE,1
SV,EPISTAXIS,1
SV,ERYTHEMA,1
SV,EYELID OEDEMA,1
SV,FACIAL PARESIS,1
SV,FEBRILE NEUTROPENIA,1
SV,FEELING OF DESPAIR,1
SV,FOETAL EXPOSURE TIMING UNSPECIFIED,1
SV,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SV,GASTRIC HAEMORRHAGE,1
SV,GASTROENTERITIS,1
SV,HAEMATOMA,1
SV,HAEMATOTOXICITY,1
SV,HAEMATURIA,1
SV,HAEMODYNAMIC INSTABILITY,1
SV,HAEMOGLOBIN ABNORMAL,1
SV,HEART RATE DECREASED,1
SV,HEPATIC CANCER STAGE IV,1
SV,HEPATIC ENCEPHALOPATHY,1
SV,HEPATIC FAILURE,1
SV,HEPATIC STEATOSIS,1
SV,HIP FRACTURE,1
SV,HYDRONEPHROSIS,1
SV,HYPERKALAEMIA,1
SV,HYPERNATRAEMIA,1
SV,HYPERPROLACTINAEMIA,1
SV,HYPERTENSION,1
SV,HYPOKINESIA,1
SV,HYPOREFLEXIA,1
SV,HYPOVOLAEMIC SHOCK,1
SV,INFECTED SKIN ULCER,1
SV,INTENTIONAL DRUG MISUSE,1
SV,INTERNATIONAL NORMALISED RATIO DECREASED,1
SV,INTERSTITIAL LUNG DISEASE,1
SV,INTESTINAL OBSTRUCTION,1
SV,LARGE INTESTINAL ULCER HAEMORRHAGE,1
SV,LEUKAEMIC INFILTRATION,1
SV,LIVEDO RETICULARIS,1
SV,LOSS OF CONSCIOUSNESS,1
SV,LUNG CANCER METASTATIC,1
SV,LYMPHOCYTE COUNT DECREASED,1
SV,LYMPHOCYTE COUNT INCREASED,1
SV,MATERNAL EXPOSURE DURING PREGNANCY,1
SV,METABOLIC ACIDOSIS,1
SV,METASTASES TO CENTRAL NERVOUS SYSTEM,1
SV,METASTASES TO LIVER,1
SV,MOBILITY DECREASED,1
SV,MULTIPLE SCLEROSIS RELAPSE,1
SV,MUSCLE TIGHTNESS,1
SV,MYOCARDIAC ABSCESS,1
SV,MYOCLONUS,1
SV,NEONATAL DISORDER,1
SV,NEOPLASM RECURRENCE,1
SV,NEUROLOGICAL DECOMPENSATION,1
SV,OBSTRUCTIVE AIRWAYS DISORDER,1
SV,OEDEMA,1
SV,OPTIC NEURITIS,1
SV,OXYGEN SATURATION DECREASED,1
SV,PANCYTOPENIA,1
SV,PERITONEAL FLUID ANALYSIS ABNORMAL,1
SV,PITUITARY TUMOUR BENIGN,1
SV,PLATELET COUNT ABNORMAL,1
SV,PLEURAL EFFUSION,1
SV,PORTAL HYPERTENSION,1
SV,PREMATURE BABY,1
SV,PRESCRIBED UNDERDOSE,1
SV,PRODUCT ADMINISTERED AT INAPPROPRIATE SITE,1
SV,PRODUCT USE IN UNAPPROVED INDICATION,1
SV,PROTEIN TOTAL DECREASED,1
SV,PROTHROMBIN TIME PROLONGED,1
SV,PULMONARY HAEMORRHAGE,1
SV,PULMONARY OEDEMA,1
SV,PUPILLARY REFLEX IMPAIRED,1
SV,RASH GENERALISED,1
SV,RASH VESICULAR,1
SV,RECTAL HAEMORRHAGE,1
SV,RED BLOOD CELL COUNT DECREASED,1
SV,RENAL DISORDER,1
SV,RENAL INJURY,1
SV,RESPIRATORY DISORDER,1
SV,RESPIRATORY RATE,1
SV,RETINAL PIGMENT EPITHELIOPATHY,1
SV,RHABDOMYOLYSIS,1
SV,ROAD TRAFFIC ACCIDENT,1
SV,SKIN DISORDER,1
SV,SKIN HAEMORRHAGE,1
SV,SKIN LESION,1
SV,SKIN ULCER,1
SV,SLOW SPEECH,1
SV,SPINAL OPERATION,1
SV,SPLEEN DISORDER,1
SV,STEVENS-JOHNSON SYNDROME,1
SV,SWELLING,1
SV,SYSTEMIC LUPUS ERYTHEMATOSUS,1
SV,TACHYPNOEA,1
SV,TESTIS CANCER,1
SV,THERAPEUTIC RESPONSE DECREASED,1
SV,THERAPY CESSATION,1
SV,THERAPY NON-RESPONDER,1
SV,TRANSFUSION,1
SV,URINARY TRACT INFECTION,1
SV,VASCULITIS CEREBRAL,1
SV,VENTRICULAR FIBRILLATION,1
SV,VISION BLURRED,1
SV,WERNICKE^S ENCEPHALOPATHY,1
SV,WHEEZING,1
SV,WHITE BLOOD CELL COUNT ABNORMAL,1
SV,WRONG DRUG ADMINISTERED,1
ER,HAEMOGLOBIN DECREASED,1
ER,OVERDOSE,1
ER,VAGINAL HAEMORRHAGE,1
EE,NAUSEA,19
EE,CEREBROVASCULAR ACCIDENT,16
EE,PYREXIA,16
EE,ASTHENIA,15
EE,DRUG INEFFECTIVE,14
EE,DYSPNOEA,12
EE,DIZZINESS,11
EE,HEADACHE,11
EE,RENAL FAILURE,11
EE,SEPSIS,11
EE,CEREBRAL HAEMORRHAGE,10
EE,MALAISE,10
EE,PNEUMONIA,10
EE,THROMBOSIS,10
EE,CEREBRAL INFARCTION,9
EE,PULMONARY EMBOLISM,9
EE,VOMITING,9
EE,FATIGUE,8
EE,ISCHAEMIC STROKE,8
EE,LUMBAR VERTEBRAL FRACTURE,8
EE,MUSCULAR WEAKNESS,8
EE,ALANINE AMINOTRANSFERASE INCREASED,7
EE,CARDIAC FAILURE,7
EE,COUGH,7
EE,DIARRHOEA,7
EE,GASTROINTESTINAL HAEMORRHAGE,7
EE,MYOCARDIAL INFARCTION,7
EE,TOXICITY TO VARIOUS AGENTS,7
EE,URINARY TRACT INFECTION,7
EE,EXPOSURE DURING PREGNANCY,6
EE,GENERAL PHYSICAL HEALTH DETERIORATION,6
EE,HAEMORRHAGE,6
EE,HYPONATRAEMIA,6
EE,LEUKOPENIA,6
EE,PAIN,6
EE,PRURITUS,6
EE,ABDOMINAL PAIN,5
EE,ANAEMIA,5
EE,ASPARTATE AMINOTRANSFERASE INCREASED,5
EE,C-REACTIVE PROTEIN INCREASED,5
EE,DEATH,5
EE,DIVERTICULITIS,5
EE,ERYTHEMA,5
EE,HAEMATOMA,5
EE,HEPATIC ENZYME INCREASED,5
EE,PANCYTOPENIA,5
EE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,5
EE,PROSTATE CANCER,5
EE,THORACIC VERTEBRAL FRACTURE,5
EE,THROMBOCYTOPENIA,5
EE,WEIGHT DECREASED,5
EE,WOUND,5
EE,ABDOMINAL PAIN UPPER,4
EE,ABORTION SPONTANEOUS,4
EE,ARTHRALGIA,4
EE,ATRIAL FIBRILLATION,4
EE,BALANCE DISORDER,4
EE,BLOOD CREATININE INCREASED,4
EE,BLOOD PRESSURE INCREASED,4
EE,BRADYCARDIA,4
EE,CARDIAC ARREST,4
EE,CHILLS,4
EE,CONDITION AGGRAVATED,4
EE,CONFUSIONAL STATE,4
EE,ENTEROBACTER SEPSIS,4
EE,EPISTAXIS,4
EE,FALL,4
EE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
EE,MALIGNANT NEOPLASM PROGRESSION,4
EE,PANNICULITIS,4
EE,PELVIC FRACTURE,4
EE,PERITONITIS,4
EE,SOMNOLENCE,4
EE,ABDOMINAL PAIN LOWER,3
EE,ACUTE RESPIRATORY FAILURE,3
EE,ANGINA PECTORIS,3
EE,ANXIETY,3
EE,BLISTER,3
EE,BRAIN OEDEMA,3
EE,CANDIDA INFECTION,3
EE,CHEST PAIN,3
EE,CHOLECYSTITIS ACUTE,3
EE,CHRONIC MYELOID LEUKAEMIA,3
EE,COMA,3
EE,CYANOSIS,3
EE,DECREASED APPETITE,3
EE,DEPRESSION,3
EE,DEVICE OCCLUSION,3
EE,DIABETIC KETOACIDOSIS,3
EE,DIVERTICULAR PERFORATION,3
EE,DRY MOUTH,3
EE,EPILEPSY,3
EE,FLATULENCE,3
EE,FOETAL EXPOSURE DURING PREGNANCY,3
EE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
EE,HAEMATOCHEZIA,3
EE,HYDRONEPHROSIS,3
EE,HYPERHIDROSIS,3
EE,HYPERSENSITIVITY,3
EE,HYPERTENSION,3
EE,HYPOAESTHESIA,3
EE,INFECTION,3
EE,INFUSION RELATED REACTION,3
EE,LOSS OF CONSCIOUSNESS,3
EE,LUPUS-LIKE SYNDROME,3
EE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
EE,OEDEMA,3
EE,ORAL CANDIDIASIS,3
EE,PALPITATIONS,3
EE,PARAESTHESIA,3
EE,PHOTOSENSITIVITY REACTION,3
EE,RASH,3
EE,RASH GENERALISED,3
EE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
EE,RENAL IMPAIRMENT,3
EE,SINUSITIS,3
EE,SKIN PLAQUE,3
EE,SKIN ULCER,3
EE,STAPHYLOCOCCAL INFECTION,3
EE,SUDDEN DEATH,3
EE,SYNCOPE,3
EE,URINARY BLADDER HAEMORRHAGE,3
EE,WALKING AID USER,3
EE,WOUND DRAINAGE,3
EE,ABSCESS INTESTINAL,2
EE,ACUTE MYOCARDIAL INFARCTION,2
EE,AGITATION,2
EE,ALLERGIC RESPIRATORY SYMPTOM,2
EE,ALOPECIA,2
EE,AMYLASE INCREASED,2
EE,ANGER,2
EE,APHASIA,2
EE,APTYALISM,2
EE,ASTHMA,2
EE,AUTOIMMUNE DISORDER,2
EE,BACK PAIN,2
EE,BASAL CELL CARCINOMA,2
EE,BLOOD ALKALINE PHOSPHATASE INCREASED,2
EE,BLOOD UREA INCREASED,2
EE,BODY TEMPERATURE INCREASED,2
EE,BRONCHOSPASM,2
EE,BURNING SENSATION,2
EE,CAESAREAN SECTION,2
EE,CANDIDA PNEUMONIA,2
EE,CARDIAC FAILURE ACUTE,2
EE,CATARACT,2
EE,CENTRAL NERVOUS SYSTEM LESION,2
EE,CHEST DISCOMFORT,2
EE,CHOLECYSTITIS,2
EE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
EE,COAGULOPATHY,2
EE,COMPLETED SUICIDE,2
EE,DISEASE PROGRESSION,2
EE,DIVERTICULUM,2
EE,DRUG PRESCRIBING ERROR,2
EE,DYSARTHRIA,2
EE,DYSGEUSIA,2
EE,DYSPEPSIA,2
EE,DYSPHAGIA,2
EE,EAR INFECTION,2
EE,ECZEMA,2
EE,ENTEROCOCCAL INFECTION,2
EE,ENTEROCOCCAL SEPSIS,2
EE,EYE HAEMORRHAGE,2
EE,EYE PRURITUS,2
EE,EYE SWELLING,2
EE,FEMUR FRACTURE,2
EE,FOETAL DISTRESS SYNDROME,2
EE,GASTRITIS EROSIVE,2
EE,GASTROINTESTINAL NECROSIS,2
EE,GROIN PAIN,2
EE,HAEMATEMESIS,2
EE,HAEMORRHAGE INTRACRANIAL,2
EE,HAEMORRHAGIC STROKE,2
EE,HALLUCINATION_ VISUAL,2
EE,HEAD DISCOMFORT,2
EE,HEPATIC CIRRHOSIS,2
EE,HERPES ZOSTER,2
EE,HYDROCEPHALUS,2
EE,HYPERKERATOSIS,2
EE,HYPERTENSIVE CRISIS,2
EE,HYPOKALAEMIA,2
EE,HYPOTHYROIDISM,2
EE,HYPOVOLAEMIC SHOCK,2
EE,INFLUENZA,2
EE,INTENTIONAL PRODUCT MISUSE,2
EE,INTERNAL FIXATION OF FRACTURE,2
EE,INTERSTITIAL LUNG DISEASE,2
EE,LARYNGEAL OEDEMA,2
EE,LOCALISED OEDEMA,2
EE,LUNG ADENOCARCINOMA,2
EE,LUNG INFILTRATION,2
EE,MATERNAL EXPOSURE DURING PREGNANCY,2
EE,MUCOSAL INFLAMMATION,2
EE,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,2
EE,NEUROLOGICAL SYMPTOM,2
EE,NEUTROPENIA,2
EE,ORAL MUCOSAL ERYTHEMA,2
EE,ORAL PAIN,2
EE,OROPHARYNGEAL PAIN,2
EE,OVERDOSE,2
EE,PANCREATITIS,2
EE,PEMPHIGOID,2
EE,PERIPHERAL ARTERY THROMBOSIS,2
EE,PERIPHERAL SWELLING,2
EE,PIGMENTATION DISORDER,2
EE,PLASMA CELL MYELOMA,2
EE,PREGNANCY WITH CONTRACEPTIVE DEVICE,2
EE,PRODUCT USE ISSUE,2
EE,PRURITUS GENERALISED,2
EE,RASH ERYTHEMATOUS,2
EE,RECTAL HAEMORRHAGE,2
EE,RENAL DISORDER,2
EE,RENAL FAILURE ACUTE,2
EE,RESPIRATORY FAILURE,2
EE,RICHTER^S SYNDROME,2
EE,SCHIZOPHRENIA,2
EE,SEIZURE,2
EE,SINUS TACHYCARDIA,2
EE,SKIN EROSION,2
EE,SUBDURAL HAEMATOMA,2
EE,TACHYCARDIA,2
EE,TONSILLITIS,2
EE,TREATMENT NONCOMPLIANCE,2
EE,TREMOR,2
EE,TYPE 1 DIABETES MELLITUS,2
EE,ULCERATIVE KERATITIS,2
EE,URTICARIA,2
EE,VAGINAL HAEMORRHAGE,2
EE,VIRAL INFECTION,2
EE,VISUAL IMPAIRMENT,2
EE,WHEEZING,2
EE,ABDOMINAL DISTENSION,1
EE,ABDOMINAL RIGIDITY,1
EE,ABDOMINAL TENDERNESS,1
EE,ABSCESS JAW,1
EE,ACCIDENTAL OVERDOSE,1
EE,ACUTE HEPATIC FAILURE,1
EE,AFFECTIVE DISORDER,1
EE,AMNESIA,1
EE,AMNIOCENTESIS ABNORMAL,1
EE,AMNIOTIC CAVITY INFECTION,1
EE,ANTERIOR CHAMBER DISORDER,1
EE,ANTI FACTOR VIII ANTIBODY INCREASED,1
EE,ANTIPHOSPHOLIPID SYNDROME,1
EE,ANURIA,1
EE,ANXIETY DISORDER,1
EE,APGAR SCORE LOW,1
EE,APHTHOUS ULCER,1
EE,APPLICATION SITE ERYTHEMA,1
EE,APPLICATION SITE OEDEMA,1
EE,APPLICATION SITE PAIN,1
EE,APPLICATION SITE PRURITUS,1
EE,APPLICATION SITE VESICLES,1
EE,ARRHYTHMIA,1
EE,ASCITES,1
EE,ATRIAL FLUTTER,1
EE,B-CELL LYMPHOMA,1
EE,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
EE,BLOOD ALBUMIN DECREASED,1
EE,BLOOD IMMUNOGLOBULIN A DECREASED,1
EE,BLOOD POTASSIUM INCREASED,1
EE,BLOOD PRESSURE DECREASED,1
EE,BLOOD PRESSURE ORTHOSTATIC ABNORMAL,1
EE,BLOOD PRESSURE SYSTOLIC INCREASED,1
EE,BLOOD PRODUCT TRANSFUSION,1
EE,BLOOD URIC ACID INCREASED,1
EE,BLOODY DISCHARGE,1
EE,BODY TEMPERATURE DECREASED,1
EE,BONE PAIN,1
EE,BRAIN NATRIURETIC PEPTIDE INCREASED,1
EE,BRAIN NEOPLASM MALIGNANT,1
EE,BREAST CANCER,1
EE,BRONCHIAL CARCINOMA,1
EE,BRONCHITIS BACTERIAL,1
EE,CARDIAC DISORDER,1
EE,CARDIOACTIVE DRUG LEVEL INCREASED,1
EE,CARDIOMYOPATHY,1
EE,CARDIOPULMONARY FAILURE,1
EE,CARPAL TUNNEL SYNDROME,1
EE,CERVIX CARCINOMA STAGE 0,1
EE,CERVIX NEOPLASM,1
EE,CHOLESTASIS,1
EE,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
EE,CIRCULATORY COLLAPSE,1
EE,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
EE,CLAVICLE FRACTURE,1
EE,CLOSTRIDIUM DIFFICILE COLITIS,1
EE,CLUSTER HEADACHE,1
EE,CNS VENTRICULITIS,1
EE,COAGULATION FACTOR IX LEVEL DECREASED,1
EE,COAGULATION FACTOR XI LEVEL DECREASED,1
EE,COLD SWEAT,1
EE,COMPLICATION OF DEVICE REMOVAL,1
EE,CONGESTIVE CARDIOMYOPATHY,1
EE,CONSTIPATION,1
EE,CONTRAST MEDIA ALLERGY,1
EE,CONTUSION,1
EE,CONVULSION,1
EE,CORNEAL DEPOSITS,1
EE,CORNEAL PERFORATION,1
EE,CRYING,1
EE,CRYOGLOBULINAEMIA,1
EE,CUTANEOUS LUPUS ERYTHEMATOSUS,1
EE,CYTOMEGALOVIRUS INFECTION,1
EE,DEEP VEIN THROMBOSIS,1
EE,DEHYDRATION,1
EE,DELUSION,1
EE,DEMYELINATION,1
EE,DEPRESSED MOOD,1
EE,DERMATITIS BULLOUS,1
EE,DEVICE DIFFICULT TO USE,1
EE,DEVICE DISLOCATION,1
EE,DEVICE ISSUE,1
EE,DIABETES MELLITUS INADEQUATE CONTROL,1
EE,DIAPHRAGMATIC HERNIA,1
EE,DIARRHOEA HAEMORRHAGIC,1
EE,DIFFICULTY REMOVING DRUG IMPLANT,1
EE,DIPLOPIA,1
EE,DISCOMFORT,1
EE,DISORIENTATION,1
EE,DISTURBANCE IN ATTENTION,1
EE,DRUG CLEARANCE DECREASED,1
EE,DRUG DISPENSING ERROR,1
EE,DRUG EFFECT DECREASED,1
EE,DRUG INTOLERANCE,1
EE,DRUG RESISTANCE,1
EE,DRY SKIN,1
EE,DUODENAL ULCER,1
EE,DUODENITIS,1
EE,DYSPHORIA,1
EE,EAR DISCOMFORT,1
EE,EAR HAEMORRHAGE,1
EE,ECTOPIC PREGNANCY,1
EE,ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE,1
EE,ELECTROCARDIOGRAM QT PROLONGED,1
EE,ENCEPHALITIS,1
EE,ENCEPHALOPATHY,1
EE,ENTEROCOLITIS INFECTIOUS,1
EE,ERECTILE DYSFUNCTION,1
EE,EROSIVE DUODENITIS,1
EE,EXFOLIATIVE RASH,1
EE,EXPOSURE DURING BREAST FEEDING,1
EE,EXTRAPYRAMIDAL DISORDER,1
EE,EYE PAIN,1
EE,EYELID OEDEMA,1
EE,FAECES DISCOLOURED,1
EE,FEBRILE NEUTROPENIA,1
EE,FEELING ABNORMAL,1
EE,FLUID RETENTION,1
EE,FLUSHING,1
EE,FOETAL DEATH,1
EE,FOETAL GROWTH RESTRICTION,1
EE,FOETAL HYPOKINESIA,1
EE,FOETAL MACROSOMIA,1
EE,FRUSTRATION TOLERANCE DECREASED,1
EE,FUNGAL OESOPHAGITIS,1
EE,GAIT DISTURBANCE,1
EE,GASTRIC ULCER,1
EE,GASTRITIS HAEMORRHAGIC,1
EE,GASTROINTESTINAL DISORDER,1
EE,GASTROINTESTINAL MUCOSAL DISORDER,1
EE,GASTROINTESTINAL ULCER,1
EE,GASTROINTESTINAL WALL THICKENING,1
EE,GASTROOESOPHAGEAL REFLUX DISEASE,1
EE,GESTATIONAL DIABETES,1
EE,GLOMERULONEPHRITIS,1
EE,GLOSSITIS,1
EE,GROWTH RETARDATION,1
EE,HAEMATOSALPINX,1
EE,HAEMODYNAMIC INSTABILITY,1
EE,HAEMOGLOBIN ABNORMAL,1
EE,HAEMORRHAGE IN PREGNANCY,1
EE,HAEMORRHAGIC ANAEMIA,1
EE,HAEMORRHAGIC EROSIVE GASTRITIS,1
EE,HAEMOTHORAX,1
EE,HALLUCINATION_ AUDITORY,1
EE,HEART RATE ABNORMAL,1
EE,HEART RATE INCREASED,1
EE,HEMIANOPIA HOMONYMOUS,1
EE,HEMIPARESIS,1
EE,HEMIPLEGIA,1
EE,HEPATIC FAILURE,1
EE,HEPATIC RUPTURE,1
EE,HEPATITIS TOXIC,1
EE,HEPATOCELLULAR CARCINOMA,1
EE,HERNIA,1
EE,HERPES VIRUS INFECTION,1
EE,HISTIOCYTOSIS HAEMATOPHAGIC,1
EE,HODGKIN^S DISEASE,1
EE,HYPERACUSIS,1
EE,HYPERAEMIA,1
EE,HYPERAESTHESIA,1
EE,HYPERBILIRUBINAEMIA,1
EE,HYPERNATRAEMIA,1
EE,HYPERTONIA,1
EE,HYPERTRANSAMINASAEMIA,1
EE,HYPOFIBRINOGENAEMIA,1
EE,HYPOGLYCAEMIA,1
EE,HYPOGLYCAEMIA NEONATAL,1
EE,HYPOPHAGIA,1
EE,HYPOPHYSITIS,1
EE,HYPOPITUITARISM,1
EE,HYPOTENSION,1
EE,HYPOTHERMIA,1
EE,HYPOTONIA,1
EE,ILEAL STENOSIS,1
EE,ILL-DEFINED DISORDER,1
EE,IMMUNOSUPPRESSION,1
EE,INCORRECT DOSE ADMINISTERED,1
EE,INFECTIOUS MONONUCLEOSIS,1
EE,INITIAL INSOMNIA,1
EE,INJECTION SITE ERYTHEMA,1
EE,INJECTION SITE EXTRAVASATION,1
EE,INJECTION SITE OEDEMA,1
EE,INJECTION SITE PAIN,1
EE,INJECTION SITE PRURITUS,1
EE,INJECTION SITE REACTION,1
EE,INTENTIONAL OVERDOSE,1
EE,INTENTIONAL PRODUCT USE ISSUE,1
EE,INTERNATIONAL NORMALISED RATIO INCREASED,1
EE,INTERVERTEBRAL DISC COMPRESSION,1
EE,INTERVERTEBRAL DISC PROTRUSION,1
EE,INVASIVE DUCTAL BREAST CARCINOMA,1
EE,IRIDOCYCLITIS,1
EE,IRRITABILITY,1
EE,ISCHAEMIC CEREBRAL INFARCTION,1
EE,JAUNDICE,1
EE,JOINT SWELLING,1
EE,KERATITIS,1
EE,KETOACIDOSIS,1
EE,KIDNEY ENLARGEMENT,1
EE,KYPHOSIS,1
EE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
EE,LABYRINTHITIS,1
EE,LACRIMATION INCREASED,1
EE,LARGE INTESTINAL HAEMORRHAGE,1
EE,LARGE INTESTINE PERFORATION,1
EE,LARGE INTESTINE POLYP,1
EE,LARYNGOSPASM,1
EE,LETHARGY,1
EE,LEUKOCYTOSIS,1
EE,LIBIDO DISORDER,1
EE,LIMB MALFORMATION,1
EE,LIP OEDEMA,1
EE,LIPASE INCREASED,1
EE,LIPODYSTROPHY ACQUIRED,1
EE,LISTERIA SEPSIS,1
EE,LIVE BIRTH,1
EE,LIVER DISORDER,1
EE,LOCAL REACTION,1
EE,LOOSE TOOTH,1
EE,LOW BIRTH WEIGHT BABY,1
EE,LUNG CANCER METASTATIC,1
EE,LUNG DISORDER,1
EE,LUNG NEOPLASM MALIGNANT,1
EE,LYMPHADENITIS,1
EE,LYMPHADENOPATHY,1
EE,LYMPHATIC DUCT INJURY,1
EE,LYMPHOCYTE COUNT INCREASED,1
EE,MADAROSIS,1
EE,MALIGNANT MELANOMA IN SITU,1
EE,MARROW HYPERPLASIA,1
EE,MASTOIDITIS,1
EE,MATERNAL DRUGS AFFECTING FOETUS,1
EE,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
EE,MECONIUM ASPIRATION SYNDROME,1
EE,MELAENA,1
EE,MENINGITIS,1
EE,MENSTRUAL DISORDER,1
EE,MENSTRUATION DELAYED,1
EE,MESENTERIC ARTERIAL OCCLUSION,1
EE,METABOLIC ACIDOSIS,1
EE,METASTASES TO CENTRAL NERVOUS SYSTEM,1
EE,METASTASES TO PERINEUM,1
EE,MIGRAINE,1
EE,MOVEMENT DISORDER,1
EE,MULTIPLE SCLEROSIS,1
EE,MULTIPLE SCLEROSIS RELAPSE,1
EE,MUSCLE TWITCHING,1
EE,MUSCULOSKELETAL STIFFNESS,1
EE,MYALGIA,1
EE,MYELOPROLIFERATIVE NEOPLASM,1
EE,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE,1
EE,NAIL DISORDER,1
EE,NECROSIS,1
EE,NEEDLE ISSUE,1
EE,NEPHROPATHY TOXIC,1
EE,NEPHROSTOMY,1
EE,NERVOUS SYSTEM DISORDER,1
EE,NEUTROPENIC INFECTION,1
EE,NEUTROPHIL COUNT DECREASED,1
EE,NIGHTMARE,1
EE,NO THERAPEUTIC RESPONSE,1
EE,NUCHAL RIGIDITY,1
EE,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
EE,NYSTAGMUS,1
EE,OBSTRUCTED LABOUR,1
EE,OBSTRUCTIVE SHOCK,1
EE,OCULAR HYPERAEMIA,1
EE,OEDEMA PERIPHERAL,1
EE,OESOPHAGEAL ULCER,1
EE,OESOPHAGITIS,1
EE,OLIGOHYDRAMNIOS,1
EE,ON AND OFF PHENOMENON,1
EE,OSTEOARTHRITIS,1
EE,OSTEOMYELITIS,1
EE,OSTEONECROSIS OF JAW,1
EE,PAIN IN EXTREMITY,1
EE,PALLOR,1
EE,PARAPARESIS,1
EE,PERFORMANCE STATUS DECREASED,1
EE,PERIORBITAL OEDEMA,1
EE,PERIPHERAL COLDNESS,1
EE,PERITONEAL HAEMORRHAGE,1
EE,PERITONITIS BACTERIAL,1
EE,PETECHIAE,1
EE,PHARYNGEAL OEDEMA,1
EE,PHOTODERMATOSIS,1
EE,PHOTOPHOBIA,1
EE,PLEURAL EFFUSION,1
EE,PNEUMONIA BACTERIAL,1
EE,PNEUMONIA STREPTOCOCCAL,1
EE,PNEUMONITIS,1
EE,PNEUMOTHORAX,1
EE,PNEUMOTHORAX SPONTANEOUS,1
EE,POISONING,1
EE,PREGNANCY,1
EE,PREGNANCY ON CONTRACEPTIVE,1
EE,PREMATURE SEPARATION OF PLACENTA,1
EE,PRESCRIBED OVERDOSE,1
EE,PRESCRIBED UNDERDOSE,1
EE,PROCEDURAL PAIN,1
EE,PRODUCT USE IN UNAPPROVED INDICATION,1
EE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
EE,PROSTATIC HAEMORRHAGE,1
EE,PRURITUS GENITAL,1
EE,PSEUDOMEMBRANOUS COLITIS,1
EE,PSEUDOMONAL SEPSIS,1
EE,PSEUDOMONAS TEST POSITIVE,1
EE,PULMONARY ARTERY THROMBOSIS,1
EE,PULMONARY FIBROSIS,1
EE,PULMONARY HYPOPLASIA,1
EE,PULMONARY OEDEMA,1
EE,PURPURA,1
EE,RADIATION MUCOSITIS,1
EE,RADIATION SKIN INJURY,1
EE,RALES,1
EE,RASH MACULO-PAPULAR,1
EE,RASH PRURITIC,1
EE,RECTAL ADENOCARCINOMA,1
EE,RENAL TUBULAR NECROSIS,1
EE,RESPIRATION ABNORMAL,1
EE,RESPIRATORY TRACT INFECTION,1
EE,RESTLESSNESS,1
EE,RETINAL HAEMORRHAGE,1
EE,RETROPERITONEAL HAEMORRHAGE,1
EE,RETROPLACENTAL HAEMATOMA,1
EE,ROSACEA,1
EE,SALIVARY GLAND CANCER,1
EE,SALPINGECTOMY,1
EE,SCLERAL HYPERAEMIA,1
EE,SENSORY LOSS,1
EE,SKIN DISORDER,1
EE,SKIN EXFOLIATION,1
EE,SKIN HYPOPIGMENTATION,1
EE,SKULL MALFORMATION,1
EE,SLEEP DISORDER,1
EE,SMALL INTESTINAL PERFORATION,1
EE,SOMATISATION DISORDER,1
EE,SPEECH DISORDER,1
EE,SPLENOMEGALY,1
EE,STOMATITIS,1
EE,SUICIDAL IDEATION,1
EE,SWELLING FACE,1
EE,SWOLLEN TONGUE,1
EE,THERAPEUTIC RESPONSE DECREASED,1
EE,THORACOSTOMY,1
EE,THROMBOCYTOSIS,1
EE,THROMBOEMBOLECTOMY,1
EE,THROMBOLYSIS,1
EE,THROMBOPHLEBITIS,1
EE,TINNITUS,1
EE,TOOTH DISORDER,1
EE,TOOTH FRACTURE,1
EE,TOOTH LOSS,1
EE,TRANSIENT GLOBAL AMNESIA,1
EE,TRANSIENT ISCHAEMIC ATTACK,1
EE,TRANSPLANT REJECTION,1
EE,TREATMENT FAILURE,1
EE,TUBERCULOSIS,1
EE,TUBULOINTERSTITIAL NEPHRITIS,1
EE,TUMOUR HAEMORRHAGE,1
EE,TYPE I HYPERSENSITIVITY,1
EE,ULTRASOUND ABDOMEN ABNORMAL,1
EE,UNDERDOSE,1
EE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
EE,URINARY RETENTION,1
EE,UROGENITAL HAEMORRHAGE,1
EE,UTERINE CANCER,1
EE,UTERINE CARCINOMA IN SITU,1
EE,UTERINE HYPOTONUS,1
EE,UTERINE LEIOMYOSARCOMA,1
EE,UTERINE PERFORATION,1
EE,VAGINAL CANCER,1
EE,VAGINAL DYSPLASIA,1
EE,VASCULAR STENT THROMBOSIS,1
EE,VENTRICULAR EXTRASYSTOLES,1
EE,VERTIGO,1
EE,VISION BLURRED,1
EE,VISUAL ACUITY REDUCED TRANSIENTLY,1
EE,VOLVULUS,1
EE,VULVOVAGINAL CANDIDIASIS,1
EE,WEIGHT INCREASED,1
EE,WHITE BLOOD CELL COUNT INCREASED,1
EE,WOUND INFECTION,1
EE,WRONG DRUG ADMINISTERED,1
ET,DEATH,312
ET,VIROLOGIC FAILURE,115
ET,DRUG RESISTANCE,96
ET,DRUG-INDUCED LIVER INJURY,62
ET,ACQUIRED GENE MUTATION,53
ET,VIRAL MUTATION IDENTIFIED,44
ET,DIABETES MELLITUS,27
ET,CHOLESTATIC LIVER INJURY,14
ET,HIV INFECTION,11
ET,FOETAL EXPOSURE DURING DELIVERY,8
ET,MALAISE,8
ET,ANAEMIA,5
ET,EPISTAXIS,5
ET,HEPATOTOXICITY,5
ET,TREATMENT FAILURE,5
ET,TUBERCULOSIS,5
ET,DRUG INEFFECTIVE,4
ET,MIXED LIVER INJURY,4
ET,COUGH,3
ET,DIABETIC KETOACIDOSIS,3
ET,DYSPNOEA,3
ET,HAEMORRHAGE,3
ET,MULTI-ORGAN FAILURE,3
ET,ABDOMINAL PAIN UPPER,2
ET,ACUTE HEPATITIS B,2
ET,ANAESTHETIC COMPLICATION,2
ET,APNOEA,2
ET,ASPIRATION,2
ET,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,2
ET,BRADYCARDIA,2
ET,CARDIO-RESPIRATORY ARREST,2
ET,CHOKING,2
ET,DIARRHOEA,2
ET,ENCEPHALOCELE,2
ET,HALLUCINATION,2
ET,HEADACHE,2
ET,HEPATOSPLENOMEGALY,2
ET,HERPES ZOSTER,2
ET,HYPOTENSION,2
ET,INTERNATIONAL NORMALISED RATIO INCREASED,2
ET,LOSS OF CONSCIOUSNESS,2
ET,MUSCULOSKELETAL DISORDER,2
ET,NIGHT SWEATS,2
ET,OTOTOXICITY,2
ET,PLEURISY,2
ET,PNEUMONIA,2
ET,PULMONARY TUBERCULOSIS,2
ET,PYREXIA,2
ET,SEPSIS,2
ET,SEPTIC SHOCK,2
ET,STILLBIRTH,2
ET,SUDDEN DEATH,2
ET,THERAPY NON-RESPONDER,2
ET,THROMBOCYTOPENIA,2
ET,VOMITING,2
ET,WEIGHT DECREASED,2
ET,ABDOMINAL DISTENSION,1
ET,ABDOMINAL PAIN,1
ET,ADVERSE DRUG REACTION,1
ET,AGITATION,1
ET,ALTERED STATE OF CONSCIOUSNESS,1
ET,AMENORRHOEA,1
ET,ANAPHYLACTIC SHOCK,1
ET,ANTICONVULSANT DRUG LEVEL DECREASED,1
ET,BRAIN STEM SYNDROME,1
ET,CARDIAC FAILURE,1
ET,CERVIX CARCINOMA STAGE III,1
ET,DEAFNESS,1
ET,DECREASED APPETITE,1
ET,DEEP VEIN THROMBOSIS,1
ET,DERMATITIS ALLERGIC,1
ET,DEVICE DISLOCATION,1
ET,DIASTOLIC DYSFUNCTION,1
ET,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
ET,DRUG ADMINISTRATION ERROR,1
ET,DRUG INTOLERANCE,1
ET,DRUG LEVEL BELOW THERAPEUTIC,1
ET,DRUG PRESCRIBING ERROR,1
ET,DYSPEPSIA,1
ET,ELECTROCARDIOGRAM QT PROLONGED,1
ET,EMPYEMA,1
ET,ERYTHEMA MULTIFORME,1
ET,EXTRAVASATION,1
ET,FATIGUE,1
ET,FOETAL DEATH,1
ET,FOETAL EXPOSURE DURING PREGNANCY,1
ET,FOETAL HEART RATE ABNORMAL,1
ET,GASTRITIS,1
ET,GENERAL ANAESTHESIA,1
ET,GENERALISED OEDEMA,1
ET,GINGIVAL BLEEDING,1
ET,GLAUCOMA,1
ET,HAEMATEMESIS,1
ET,HAEMATOTOXICITY,1
ET,HEART RATE INCREASED,1
ET,HEPATIC ENZYME INCREASED,1
ET,HEPATITIS,1
ET,HYPERSENSITIVITY,1
ET,HYPERTENSION,1
ET,HYPOACUSIS,1
ET,HYPOAESTHESIA,1
ET,IMPLANT SITE PAIN,1
ET,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
ET,INDUCED LABOUR,1
ET,INFLUENZA,1
ET,INTENTIONAL OVERDOSE,1
ET,IRRITABILITY,1
ET,MALIGNANT NEOPLASM PROGRESSION,1
ET,MATERNAL EXPOSURE DURING PREGNANCY,1
ET,MEDICAL DEVICE COMPLICATION,1
ET,MEDICATION RESIDUE PRESENT,1
ET,MEMORY IMPAIRMENT,1
ET,MOUTH HAEMORRHAGE,1
ET,MULTIPLE-DRUG RESISTANCE,1
ET,MUSCULOSKELETAL PAIN,1
ET,MYCOBACTERIUM TEST POSITIVE,1
ET,NECROSIS,1
ET,NECROTISING FASCIITIS,1
ET,NEOPLASM PROGRESSION,1
ET,NEUROPATHY PERIPHERAL,1
ET,OCULAR RETROBULBAR HAEMORRHAGE,1
ET,OSTEOMYELITIS,1
ET,OVERDOSE,1
ET,PAIN,1
ET,PAIN IN EXTREMITY,1
ET,PALLOR,1
ET,PLATELET COUNT DECREASED,1
ET,PROCEDURAL COMPLICATION,1
ET,PSYCHIATRIC SYMPTOM,1
ET,PSYCHOTIC DISORDER,1
ET,RESPIRATORY ARREST,1
ET,SCAR,1
ET,SECOND PRIMARY MALIGNANCY,1
ET,SEDATION COMPLICATION,1
ET,SEIZURE,1
ET,SPLENOMEGALY,1
ET,SUICIDE ATTEMPT,1
ET,SURGERY,1
ET,TINNITUS,1
ET,TONIC CONVULSION,1
ET,TREATMENT NONCOMPLIANCE,1
ET,TUBO-OVARIAN ABSCESS,1
ET,UNRESPONSIVE TO STIMULI,1
ET,URINARY TRACT INFECTION,1
ET,VENTRICULAR EXTRASYSTOLES,1
ET,VESTIBULAR DISORDER,1
ET,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
FO,RHABDOMYOLYSIS,7
FO,BACK PAIN,1
FO,BEDRIDDEN,1
FO,BLOOD ALKALINE PHOSPHATASE INCREASED,1
FO,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
FO,BLOOD LACTATE DEHYDROGENASE INCREASED,1
FO,BRAIN NATRIURETIC PEPTIDE INCREASED,1
FO,DIARRHOEA,1
FO,DIFFUSE ALOPECIA,1
FO,DIZZINESS,1
FO,DRY SKIN,1
FO,FALL,1
FO,FATIGUE,1
FO,HYPOTENSION,1
FO,IMMOBILE,1
FO,LACERATION,1
FO,LIVER FUNCTION TEST INCREASED,1
FO,LOSS OF CONSCIOUSNESS,1
FO,LUNG NEOPLASM MALIGNANT,1
FO,MUSCLE SPASMS,1
FO,MUSCULAR WEAKNESS,1
FO,MYALGIA,1
FO,MYOGLOBIN BLOOD INCREASED,1
FO,RASH,1
FJ,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,2
FJ,DEATH,2
FJ,BLAST CELLS PRESENT,1
FJ,CELLULITIS,1
FJ,CEREBROVASCULAR ACCIDENT,1
FJ,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
FJ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
FJ,COUGH,1
FJ,DYSPNOEA,1
FJ,HEPATOSPLENOMEGALY,1
FJ,HEPATOTOXICITY,1
FJ,HYPOCHROMIC ANAEMIA,1
FJ,PNEUMONIA,1
FJ,PYREXIA,1
FJ,SEPSIS,1
FJ,SPLENOMEGALY,1
FJ,THROMBOCYTOSIS,1
FJ,WHITE BLOOD CELL COUNT INCREASED,1
FI,FATIGUE,336
FI,PYREXIA,327
FI,DYSPNOEA,304
FI,NAUSEA,262
FI,DRUG INEFFECTIVE,238
FI,DEATH,223
FI,TOXICITY TO VARIOUS AGENTS,222
FI,DIZZINESS,213
FI,DIARRHOEA,188
FI,NEUTROPENIA,184
FI,PNEUMONIA,183
FI,C-REACTIVE PROTEIN INCREASED,169
FI,MALAISE,165
FI,OSTEONECROSIS OF JAW,165
FI,HEADACHE,163
FI,FOETAL EXPOSURE DURING PREGNANCY,148
FI,VOMITING,147
FI,FALL,141
FI,ERYTHEMA,139
FI,PAIN,138
FI,LOSS OF CONSCIOUSNESS,137
FI,INFECTION,135
FI,ASTHENIA,134
FI,PAIN IN EXTREMITY,123
FI,CONFUSIONAL STATE,121
FI,GENERAL PHYSICAL HEALTH DETERIORATION,121
FI,ANXIETY,120
FI,ARTHRALGIA,116
FI,INTENTIONAL PRODUCT MISUSE,113
FI,RASH,113
FI,COUGH,107
FI,ARRHYTHMIA,106
FI,INSOMNIA,103
FI,GAIT DISTURBANCE,100
FI,HAEMOGLOBIN DECREASED,98
FI,WEIGHT INCREASED,97
FI,HYPOTENSION,95
FI,PULMONARY EMBOLISM,95
FI,BLOOD PRESSURE INCREASED,91
FI,FEELING ABNORMAL,91
FI,ANAEMIA,90
FI,ABDOMINAL PAIN,89
FI,MUSCULAR WEAKNESS,89
FI,PRURITUS,89
FI,HYPERSENSITIVITY,88
FI,URTICARIA,87
FI,WEIGHT DECREASED,84
FI,ABDOMINAL PAIN UPPER,83
FI,TREMOR,83
FI,CARDIAC FAILURE,81
FI,HYPOAESTHESIA,81
FI,CEREBRAL INFARCTION,79
FI,BACK PAIN,76
FI,SEPSIS,76
FI,MYALGIA,75
FI,MUSCULOSKELETAL STIFFNESS,74
FI,PALPITATIONS,74
FI,ALANINE AMINOTRANSFERASE INCREASED,72
FI,CONDITION AGGRAVATED,72
FI,WHITE BLOOD CELL COUNT DECREASED,71
FI,DYSARTHRIA,68
FI,MEMORY IMPAIRMENT,68
FI,MUSCLE SPASMS,67
FI,OVERDOSE,66
FI,THROMBOCYTOPENIA,65
FI,RESTLESSNESS,64
FI,NEUTROPHIL COUNT DECREASED,63
FI,SOMNOLENCE,63
FI,VISUAL IMPAIRMENT,63
FI,BLOOD CREATININE INCREASED,62
FI,DYSPHAGIA,61
FI,HEART RATE INCREASED,61
FI,HYPERTENSION,61
FI,ATRIAL FIBRILLATION,60
FI,HEPATIC ENZYME INCREASED,59
FI,MYOCARDIAL INFARCTION,58
FI,DECREASED APPETITE,57
FI,EPILEPSY,57
FI,EXPOSURE DURING PREGNANCY,57
FI,INFLUENZA,57
FI,PARAESTHESIA,57
FI,PRODUCT QUALITY ISSUE,57
FI,CEREBRAL HAEMORRHAGE,56
FI,CHEST PAIN,56
FI,AGGRESSION,55
FI,PRODUCT USE ISSUE,55
FI,SEIZURE,55
FI,URINARY TRACT INFECTION,55
FI,BLOOD PRESSURE DECREASED,54
FI,CONSTIPATION,54
FI,DEEP VEIN THROMBOSIS,54
FI,HYPERHIDROSIS,54
FI,RENAL FAILURE,54
FI,SYNCOPE,54
FI,ALOPECIA,53
FI,DEPRESSION,52
FI,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,52
FI,HYPOGLYCAEMIA,50
FI,OROPHARYNGEAL PAIN,50
FI,ABORTION SPONTANEOUS,49
FI,DISEASE PROGRESSION,47
FI,HALLUCINATION,47
FI,PERIPHERAL SWELLING,47
FI,LEUKOPENIA,46
FI,SPEECH DISORDER,46
FI,THROMBOSIS,46
FI,BLOOD GLUCOSE INCREASED,45
FI,PSYCHOTIC DISORDER,45
FI,SLEEP DISORDER,45
FI,VISION BLURRED,45
FI,ABDOMINAL DISCOMFORT,44
FI,DEPRESSED MOOD,44
FI,DEPRESSED LEVEL OF CONSCIOUSNESS,42
FI,DRUG DEPENDENCE,42
FI,CEREBROVASCULAR ACCIDENT,41
FI,HEPATITIS C,41
FI,BALANCE DISORDER,40
FI,CHEST DISCOMFORT,40
FI,DRUG ABUSE,40
FI,TACHYCARDIA,40
FI,UNINTENDED PREGNANCY,39
FI,BLOOD ALKALINE PHOSPHATASE INCREASED,38
FI,ERYSIPELAS,38
FI,HYPOTHERMIA,38
FI,OEDEMA PERIPHERAL,38
FI,SUBSTANCE ABUSE,38
FI,DYSKINESIA,37
FI,PLEURAL EFFUSION,37
FI,ANAPHYLACTIC REACTION,36
FI,CARDIAC DISORDER,36
FI,RHABDOMYOLYSIS,36
FI,SINUSITIS,36
FI,SUICIDAL IDEATION,36
FI,EPISTAXIS,35
FI,MANIA,35
FI,NERVOUSNESS,35
FI,SWELLING,35
FI,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,35
FI,HAEMORRHAGE,34
FI,PANCREATITIS,34
FI,BRADYCARDIA,33
FI,EOSINOPHILIA,33
FI,NASOPHARYNGITIS,33
FI,OXYGEN SATURATION DECREASED,33
FI,PRODUCT USE IN UNAPPROVED INDICATION,33
FI,VERTIGO,33
FI,CARDIAC ARREST,32
FI,DRY MOUTH,32
FI,DRY SKIN,32
FI,IRRITABILITY,32
FI,NEUROPATHY PERIPHERAL,32
FI,ORAL PAIN,32
FI,PYELONEPHRITIS,32
FI,BREAST CANCER,31
FI,CHILLS,31
FI,DISORIENTATION,31
FI,JOINT SWELLING,31
FI,KETOACIDOSIS,31
FI,MIDDLE INSOMNIA,31
FI,PLATELET COUNT DECREASED,31
FI,SWELLING FACE,31
FI,ABNORMAL BEHAVIOUR,30
FI,BLISTER,30
FI,CONTUSION,30
FI,ELECTROCARDIOGRAM QT PROLONGED,30
FI,LUNG DISORDER,30
FI,MATERNAL EXPOSURE DURING PREGNANCY,30
FI,MENTAL IMPAIRMENT,30
FI,PREMATURE BABY,30
FI,DEVICE DISLOCATION,29
FI,HEART RATE DECREASED,29
FI,HEPATIC FAILURE,29
FI,MUSCLE TWITCHING,29
FI,NEUTROPENIC INFECTION,29
FI,TRANSIENT ISCHAEMIC ATTACK,29
FI,ABDOMINAL DISTENSION,28
FI,ASTHMA,28
FI,INTRAOCULAR PRESSURE INCREASED,28
FI,MALIGNANT NEOPLASM PROGRESSION,28
FI,THROAT IRRITATION,28
FI,WHITE BLOOD CELL COUNT INCREASED,28
FI,WOUND,28
FI,CLOSTRIDIUM DIFFICILE INFECTION,27
FI,COMPLETED SUICIDE,27
FI,DRUG DOSE OMISSION,27
FI,INCORRECT DOSE ADMINISTERED,27
FI,MENTAL DISORDER,27
FI,RESPIRATORY TRACT INFECTION,27
FI,SLEEP APNOEA SYNDROME,27
FI,TINNITUS,27
FI,UPPER RESPIRATORY TRACT INFECTION,27
FI,APHASIA,26
FI,DEHYDRATION,26
FI,DELIRIUM,26
FI,DYSPEPSIA,26
FI,ECZEMA,26
FI,HALLUCINATION_ VISUAL,26
FI,METASTASES TO BONE,26
FI,PHARYNGEAL OEDEMA,26
FI,URINARY RETENTION,26
FI,AGITATION,25
FI,ARTHROPATHY,25
FI,GAMMA-GLUTAMYLTRANSFERASE INCREASED,25
FI,GASTROINTESTINAL DISORDER,25
FI,LACTIC ACIDOSIS,25
FI,MEDICATION ERROR,25
FI,WRONG TECHNIQUE IN DRUG USAGE PROCESS,25
FI,ASCITES,24
FI,BRONCHITIS,24
FI,DIABETES MELLITUS,24
FI,DRUG EFFECT INCOMPLETE,24
FI,DYSGEUSIA,24
FI,DYSPHONIA,24
FI,FEELING HOT,24
FI,HYPONATRAEMIA,24
FI,INFUSION RELATED REACTION,24
FI,LEUKOCYTOSIS,24
FI,PSORIASIS,24
FI,AMNESIA,23
FI,BURNING SENSATION,23
FI,CALCIPHYLAXIS,23
FI,COLITIS,23
FI,HAEMATOMA,23
FI,HYPERTHYROIDISM,23
FI,INTERNATIONAL NORMALISED RATIO INCREASED,23
FI,LOCAL SWELLING,23
FI,LUNG INFECTION,23
FI,MOBILITY DECREASED,23
FI,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,23
FI,TERMINAL INSOMNIA,23
FI,THERAPEUTIC RESPONSE DECREASED,23
FI,ANGIOEDEMA,22
FI,BLOOD BILIRUBIN INCREASED,22
FI,DELUSION,22
FI,DEVICE ISSUE,22
FI,DIPLOPIA,22
FI,DRUG EFFECT DECREASED,22
FI,FEBRILE NEUTROPENIA,22
FI,GASTROINTESTINAL HAEMORRHAGE,22
FI,HYPOTHYROIDISM,22
FI,INCORRECT DRUG ADMINISTRATION DURATION,22
FI,LYMPHOPENIA,22
FI,MIGRAINE,22
FI,PALLOR,22
FI,PRESCRIBED OVERDOSE,22
FI,SKIN EXFOLIATION,22
FI,SWOLLEN TONGUE,22
FI,VAGINAL HAEMORRHAGE,22
FI,ABORTION INDUCED,21
FI,FLUSHING,21
FI,IMPAIRED HEALING,21
FI,INTENTIONAL OVERDOSE,21
FI,INTERSTITIAL LUNG DISEASE,21
FI,LIMB DISCOMFORT,21
FI,METASTASES TO LIVER,21
FI,PARKINSON^S DISEASE,21
FI,POISONING,21
FI,SKIN DISCOLOURATION,21
FI,UNRESPONSIVE TO STIMULI,21
FI,ANGER,20
FI,FACE OEDEMA,20
FI,GASTROENTERITIS,20
FI,HEPATIC STEATOSIS,20
FI,HERPES ZOSTER,20
FI,HIP FRACTURE,20
FI,INTENTIONAL PRODUCT USE ISSUE,20
FI,MULTIPLE SCLEROSIS RELAPSE,20
FI,MUSCULOSKELETAL PAIN,20
FI,NIGHTMARE,20
FI,PERIPHERAL COLDNESS,20
FI,PNEUMONIA ASPIRATION,20
FI,SCHIZOPHRENIA,20
FI,SKIN DISORDER,20
FI,SUICIDE ATTEMPT,20
FI,ADVERSE EVENT,19
FI,BODY TEMPERATURE INCREASED,19
FI,COAGULATION TIME PROLONGED,19
FI,COGNITIVE DISORDER,19
FI,CONVULSION,19
FI,DEVICE FAILURE,19
FI,DYSURIA,19
FI,EYE PAIN,19
FI,FEMUR FRACTURE,19
FI,HERPES OPHTHALMIC,19
FI,INCREASED APPETITE,19
FI,LYMPHADENOPATHY,19
FI,MELAENA,19
FI,NEURALGIA,19
FI,PRODUCT USED FOR UNKNOWN INDICATION,19
FI,TRANSAMINASES INCREASED,19
FI,ABASIA,18
FI,ACNE,18
FI,BONE PAIN,18
FI,CERVICAL MYELOPATHY,18
FI,HAEMATOCHEZIA,18
FI,HAEMATURIA,18
FI,HEAD INJURY,18
FI,HEMIPLEGIA,18
FI,HEPATOCELLULAR CARCINOMA,18
FI,HOSPITALISATION,18
FI,HYPOCALCAEMIA,18
FI,HYPOKALAEMIA,18
FI,JOINT STIFFNESS,18
FI,LIP SWELLING,18
FI,STOMATITIS,18
FI,AGRANULOCYTOSIS,17
FI,BLINDNESS,17
FI,BLOOD CHOLESTEROL INCREASED,17
FI,BONE MARROW FAILURE,17
FI,BRAIN OEDEMA,17
FI,CYTOPENIA,17
FI,DEVICE DIFFICULT TO USE,17
FI,DISTURBANCE IN ATTENTION,17
FI,DYSSTASIA,17
FI,FEELING COLD,17
FI,HALLUCINATION_ AUDITORY,17
FI,HYPOTONIA,17
FI,ILEUS,17
FI,IRITIS,17
FI,JAUNDICE,17
FI,LIVER FUNCTION TEST INCREASED,17
FI,MOVEMENT DISORDER,17
FI,PLASMA CELL MYELOMA,17
FI,POOR QUALITY SLEEP,17
FI,PROTEINURIA,17
FI,RASH ERYTHEMATOUS,17
FI,UPPER AIRWAY OBSTRUCTION,17
FI,URINARY INCONTINENCE,17
FI,VISUAL ACUITY REDUCED,17
FI,ACTIVITIES OF DAILY LIVING IMPAIRED,16
FI,ASPARTATE AMINOTRANSFERASE INCREASED,16
FI,BACTERIAL INFECTION,16
FI,BLOOD LACTIC ACID INCREASED,16
FI,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,16
FI,CORONARY ARTERY DISEASE,16
FI,DRY EYE,16
FI,FEAR,16
FI,GASTRIC DISORDER,16
FI,NASAL CONGESTION,16
FI,OBSTRUCTIVE AIRWAYS DISORDER,16
FI,PETIT MAL EPILEPSY,16
FI,PNEUMONITIS,16
FI,POLLAKIURIA,16
FI,PREMATURE DELIVERY,16
FI,PROSTATE CANCER,16
FI,RENAL IMPAIRMENT,16
FI,SEMEN VOLUME DECREASED,16
FI,SKIN REACTION,16
FI,VIRAL INFECTION,16
FI,VISUAL FIELD DEFECT,16
FI,WITHDRAWAL SYNDROME,16
FI,ACUTE MYOCARDIAL INFARCTION,15
FI,BLOOD CREATINE PHOSPHOKINASE INCREASED,15
FI,CATARACT,15
FI,COMPARTMENT SYNDROME,15
FI,DRUG SPECIFIC ANTIBODY PRESENT,15
FI,EYE SWELLING,15
FI,EYELID OEDEMA,15
FI,FAECES DISCOLOURED,15
FI,HYPERGLYCAEMIA,15
FI,INCORRECT ROUTE OF DRUG ADMINISTRATION,15
FI,INTERVERTEBRAL DISC PROTRUSION,15
FI,OEDEMA,15
FI,POISONING DELIBERATE,15
FI,PREGNANCY WITH CONTRACEPTIVE DEVICE,15
FI,SENSATION OF FOREIGN BODY,15
FI,SKIN ULCER,15
FI,SPERMATOZOA PROGRESSIVE MOTILITY DECREASED,15
FI,VENTRICULAR FIBRILLATION,15
FI,VENTRICULAR SEPTAL DEFECT,15
FI,WOUND INFECTION,15
FI,ANGINA PECTORIS,14
FI,BLOOD GLUCOSE FLUCTUATION,14
FI,CYANOSIS,14
FI,DRUG PRESCRIBING ERROR,14
FI,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,14
FI,DRUG SCREEN POSITIVE,14
FI,GASTROINTESTINAL NECROSIS,14
FI,HEPATOTOXICITY,14
FI,HOT FLUSH,14
FI,HYDRONEPHROSIS,14
FI,HYPOKINESIA,14
FI,INCOHERENT,14
FI,MUCOSAL INFLAMMATION,14
FI,NECK PAIN,14
FI,OSTEOPOROSIS,14
FI,RASH PRURITIC,14
FI,STATUS EPILEPTICUS,14
FI,TOOTH DISORDER,14
FI,ABDOMINAL PAIN LOWER,13
FI,ACCIDENTAL OVERDOSE,13
FI,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,13
FI,ACUTE KIDNEY INJURY,13
FI,BLOOD PRESSURE FLUCTUATION,13
FI,COLITIS ULCERATIVE,13
FI,CROHN^S DISEASE,13
FI,DEVICE OCCLUSION,13
FI,FEELING DRUNK,13
FI,FLATULENCE,13
FI,FLUID RETENTION,13
FI,FRACTURE,13
FI,INTESTINAL OBSTRUCTION,13
FI,IRREGULAR SLEEP PHASE,13
FI,ISCHAEMIC STROKE,13
FI,LIVER FUNCTION TEST ABNORMAL,13
FI,MENORRHAGIA,13
FI,METASTASES TO CENTRAL NERVOUS SYSTEM,13
FI,MOOD ALTERED,13
FI,MOUTH ULCERATION,13
FI,NEOPLASM MALIGNANT,13
FI,ORAL CANDIDIASIS,13
FI,OSTEONECROSIS,13
FI,PAIN IN JAW,13
FI,RECTAL HAEMORRHAGE,13
FI,RESPIRATORY FAILURE,13
FI,RHEUMATOID ARTHRITIS,13
FI,SEDATION,13
FI,SELF-INJURIOUS IDEATION,13
FI,SENSORY LOSS,13
FI,SNORING,13
FI,STRESS,13
FI,SUFFOCATION FEELING,13
FI,TOOTH INFECTION,13
FI,ATAXIA,12
FI,BLOOD POTASSIUM DECREASED,12
FI,CAESAREAN SECTION,12
FI,COLD SWEAT,12
FI,DEAFNESS UNILATERAL,12
FI,DEATH NEONATAL,12
FI,DRUG RESISTANCE,12
FI,GINGIVITIS,12
FI,HAEMOPTYSIS,12
FI,HEMIPARESIS,12
FI,INFLAMMATION,12
FI,LETHARGY,12
FI,LYMPHOCYTE COUNT DECREASED,12
FI,MOOD SWINGS,12
FI,OCULAR HYPERAEMIA,12
FI,ORGANISING PNEUMONIA,12
FI,OSTEOARTHRITIS,12
FI,OSTEOMYELITIS,12
FI,PANIC DISORDER,12
FI,SENSORY DISTURBANCE,12
FI,SUBDURAL HAEMATOMA,12
FI,SURGERY,12
FI,ALTERED STATE OF CONSCIOUSNESS,11
FI,AMENORRHOEA,11
FI,ARTHRITIS,11
FI,BONE DISORDER,11
FI,CELLULITIS,11
FI,COMA HEPATIC,11
FI,CYTOMEGALOVIRUS INFECTION,11
FI,DIVERTICULITIS,11
FI,DRUG ADMINISTRATION ERROR,11
FI,DRUG HYPERSENSITIVITY,11
FI,DRUG LEVEL INCREASED,11
FI,EAR INFECTION,11
FI,ELECTROCARDIOGRAM ABNORMAL,11
FI,FISTULA,11
FI,FOETAL DEATH,11
FI,HYPERCALCAEMIA,11
FI,HYPERKALAEMIA,11
FI,JOINT RANGE OF MOTION DECREASED,11
FI,LIVER TRANSPLANT,11
FI,LOW BIRTH WEIGHT BABY,11
FI,LUNG INFILTRATION,11
FI,METASTASES TO LUNG,11
FI,MYOPATHY,11
FI,NEOPLASM PROGRESSION,11
FI,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,11
FI,PAPULE,11
FI,PARANOIA,11
FI,PREGNANCY,11
FI,PSYCHOMOTOR HYPERACTIVITY,11
FI,PULMONARY HAEMORRHAGE,11
FI,SEPTIC SHOCK,11
FI,SINUS TACHYCARDIA,11
FI,STAPHYLOCOCCAL SEPSIS,11
FI,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,11
FI,TENDERNESS,11
FI,THERAPY CESSATION,11
FI,TOXIC EPIDERMAL NECROLYSIS,11
FI,UROSEPSIS,11
FI,VASCULITIS,11
FI,ACIDOSIS,10
FI,ANAPHYLACTIC SHOCK,10
FI,APATHY,10
FI,ARTERIOSCLEROSIS,10
FI,ATYPICAL FEMUR FRACTURE,10
FI,CENTRAL NERVOUS SYSTEM LESION,10
FI,CHOLELITHIASIS,10
FI,CRYING,10
FI,DEMYELINATION,10
FI,DERMATITIS,10
FI,DEVICE USE ISSUE,10
FI,EMOTIONAL DISTRESS,10
FI,EXPOSED BONE IN JAW,10
FI,EYE MOVEMENT DISORDER,10
FI,GENERALISED TONIC-CLONIC SEIZURE,10
FI,HAEMOLYSIS,10
FI,HEAD DISCOMFORT,10
FI,HEPATIC CIRRHOSIS,10
FI,INFLAMMATORY BOWEL DISEASE,10
FI,INJECTION SITE PAIN,10
FI,INTENTIONAL DRUG MISUSE,10
FI,IRON DEFICIENCY ANAEMIA,10
FI,LIVER DISORDER,10
FI,MALIGNANT MELANOMA,10
FI,MUSCLE ATROPHY,10
FI,NIGHT SWEATS,10
FI,OLIGOSPERMIA,10
FI,OPTIC NEURITIS,10
FI,PANCYTOPENIA,10
FI,PARALYSIS,10
FI,PEMPHIGOID,10
FI,POLYNEUROPATHY,10
FI,PULMONARY OEDEMA,10
FI,RASH GENERALISED,10
FI,RASH PUSTULAR,10
FI,RED BLOOD CELL SEDIMENTATION RATE INCREASED,10
FI,RESPIRATORY DEPRESSION,10
FI,RESTLESS LEGS SYNDROME,10
FI,SARCOIDOSIS,10
FI,STRIDOR,10
FI,TENDON PAIN,10
FI,THINKING ABNORMAL,10
FI,THROMBOCYTOSIS,10
FI,TIBIA FRACTURE,10
FI,TONIC CLONIC MOVEMENTS,10
FI,TOOTH EXTRACTION,10
FI,TUBULOINTERSTITIAL NEPHRITIS,10
FI,UVEITIS,10
FI,ACUTE HEPATIC FAILURE,9
FI,AUTOIMMUNE HEPATITIS,9
FI,BLOOD GLUCOSE DECREASED,9
FI,BLOOD SODIUM DECREASED,9
FI,BODY TEMPERATURE DECREASED,9
FI,BREAST CANCER METASTATIC,9
FI,BRONCHOSPASM,9
FI,CHRONIC GRAFT VERSUS HOST DISEASE,9
FI,CIRCULATORY COLLAPSE,9
FI,DEREALISATION,9
FI,DERMATITIS EXFOLIATIVE,9
FI,DEVICE ALARM ISSUE,9
FI,EATING DISORDER,9
FI,ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE,9
FI,ELECTROCARDIOGRAM T WAVE INVERSION,9
FI,EMBOLISM,9
FI,ENCEPHALOPATHY,9
FI,EUPHORIC MOOD,9
FI,EYE IRRITATION,9
FI,FACIAL PARALYSIS,9
FI,FUNGAL INFECTION,9
FI,GASTROOESOPHAGEAL REFLUX DISEASE,9
FI,HAEMATEMESIS,9
FI,HAEMORRHAGE IN PREGNANCY,9
FI,HYPOXIA,9
FI,INJECTION SITE ERYTHEMA,9
FI,LARYNGEAL OEDEMA,9
FI,METASTASIS,9
FI,MICTURITION URGENCY,9
FI,MOUTH SWELLING,9
FI,MUCOUS MEMBRANE DISORDER,9
FI,MUSCLE RIGIDITY,9
FI,MUSCLE TIGHTNESS,9
FI,MYOCARDIAL ISCHAEMIA,9
FI,MYOCARDITIS,9
FI,NEUROLEPTIC MALIGNANT SYNDROME,9
FI,NEUTROPENIC SEPSIS,9
FI,NICOTINE DEPENDENCE,9
FI,NO ADVERSE EVENT,9
FI,PANIC ATTACK,9
FI,PANIC REACTION,9
FI,PARAESTHESIA ORAL,9
FI,PERITONITIS,9
FI,PERSONALITY CHANGE,9
FI,PHOTOPHOBIA,9
FI,PLATELET COUNT INCREASED,9
FI,PROCTITIS,9
FI,PRODUCTIVE COUGH,9
FI,PULMONARY FIBROSIS,9
FI,RASH MACULAR,9
FI,RASH VESICULAR,9
FI,RENAL DISORDER,9
FI,RHINORRHOEA,9
FI,ROAD TRAFFIC ACCIDENT,9
FI,SECRETION DISCHARGE,9
FI,SKIN INFECTION,9
FI,STOMA SITE DISCHARGE,9
FI,SUBARACHNOID HAEMORRHAGE,9
FI,TEARFULNESS,9
FI,THROAT TIGHTNESS,9
FI,TOOTH LOSS,9
FI,UNDERDOSE,9
FI,ABSCESS,8
FI,ACUTE GRAFT VERSUS HOST DISEASE,8
FI,ACUTE MYELOID LEUKAEMIA,8
FI,ACUTE RESPIRATORY DISTRESS SYNDROME,8
FI,ADRENAL INSUFFICIENCY,8
FI,ADVERSE DRUG REACTION,8
FI,AMMONIA INCREASED,8
FI,ANURIA,8
FI,APPENDICITIS,8
FI,BILIRUBIN CONJUGATED INCREASED,8
FI,BLOOD GLUCOSE ABNORMAL,8
FI,BLOOD LACTATE DEHYDROGENASE INCREASED,8
FI,CARDIOVASCULAR DISORDER,8
FI,CLUMSINESS,8
FI,COMPLICATION ASSOCIATED WITH DEVICE,8
FI,COMPLICATION OF DEVICE REMOVAL,8
FI,CONJUNCTIVITIS,8
FI,DERMATITIS PSORIASIFORM,8
FI,DIARRHOEA HAEMORRHAGIC,8
FI,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,8
FI,DRUG ERUPTION,8
FI,DRUG WITHDRAWAL SYNDROME,8
FI,DYSPNOEA EXERTIONAL,8
FI,EJECTION FRACTION DECREASED,8
FI,ENDOPHTHALMITIS,8
FI,FACIAL PARESIS,8
FI,GLYCOSYLATED HAEMOGLOBIN INCREASED,8
FI,HYPERVENTILATION,8
FI,IMMUNE THROMBOCYTOPENIC PURPURA,8
FI,IMPAIRED WORK ABILITY,8
FI,INFLAMMATORY MARKER INCREASED,8
FI,INFLUENZA LIKE ILLNESS,8
FI,INHIBIN B,8
FI,INJECTION SITE HAEMORRHAGE,8
FI,INTENTIONAL SELF-INJURY,8
FI,INTERCEPTED DRUG PRESCRIBING ERROR,8
FI,INTESTINAL HAEMORRHAGE,8
FI,INVASIVE DUCTAL BREAST CARCINOMA,8
FI,METABOLIC ACIDOSIS,8
FI,MIOSIS,8
FI,MULTIPLE SCLEROSIS,8
FI,MUSCULOSKELETAL DISCOMFORT,8
FI,MYDRIASIS,8
FI,NAIL DISORDER,8
FI,NEUROTOXICITY,8
FI,ORAL DISORDER,8
FI,OVERWEIGHT,8
FI,PANCREATIC CARCINOMA METASTATIC,8
FI,PHARYNGITIS,8
FI,PHOTOSENSITIVITY REACTION,8
FI,PREGNANCY ON ORAL CONTRACEPTIVE,8
FI,PROCEDURAL PAIN,8
FI,PRURITUS GENERALISED,8
FI,PSORIATIC ARTHROPATHY,8
FI,PURPURA,8
FI,RENAL CANCER,8
FI,RETINAL DETACHMENT,8
FI,SMALL FOR DATES BABY,8
FI,STOMA SITE INFLAMMATION,8
FI,SUBCUTANEOUS ABSCESS,8
FI,TENDONITIS,8
FI,THERAPEUTIC RESPONSE CHANGED,8
FI,TONSILLITIS,8
FI,TOOTHACHE,8
FI,TYPE 2 DIABETES MELLITUS,8
FI,VENTRICULAR TACHYCARDIA,8
FI,WRONG PATIENT RECEIVED MEDICATION,8
FI,ACUTE SINUSITIS,7
FI,AGEUSIA,7
FI,ASPHYXIA,7
FI,BASAL CELL CARCINOMA,7
FI,BLOOD ALBUMIN DECREASED,7
FI,BLOOD PROLACTIN INCREASED,7
FI,BLOOD URIC ACID INCREASED,7
FI,BRAIN INJURY,7
FI,BRUXISM,7
FI,CARDIOMEGALY,7
FI,CHROMATURIA,7
FI,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,7
FI,CLOSTRIDIUM DIFFICILE COLITIS,7
FI,COMPUTERISED TOMOGRAM ABNORMAL,7
FI,DEAFNESS,7
FI,DERMATITIS ALLERGIC,7
FI,DEVICE BREAKAGE,7
FI,DEVICE EXPULSION,7
FI,DIABETIC KETOACIDOSIS,7
FI,DIFFUSE ALVEOLAR DAMAGE,7
FI,DISCOMFORT,7
FI,DISEASE RECURRENCE,7
FI,DISSEMINATED INTRAVASCULAR COAGULATION,7
FI,DRUG SPECIFIC ANTIBODY,7
FI,ELECTROENCEPHALOGRAM ABNORMAL,7
FI,EXPOSURE DURING BREAST FEEDING,7
FI,EXTREMITY NECROSIS,7
FI,EYELID PTOSIS,7
FI,FUNCTIONAL GASTROINTESTINAL DISORDER,7
FI,GAZE PALSY,7
FI,GESTATIONAL DIABETES,7
FI,HEART RATE IRREGULAR,7
FI,HEPATIC NECROSIS,7
FI,HYPOAESTHESIA ORAL,7
FI,HYPOGAMMAGLOBULINAEMIA,7
FI,INTRA-ABDOMINAL HAEMORRHAGE,7
FI,JOINT INJURY,7
FI,KETOSIS,7
FI,LABORATORY TEST ABNORMAL,7
FI,LACRIMATION INCREASED,7
FI,LIVER INJURY,7
FI,LOCALISED OEDEMA,7
FI,LYMPHOMA,7
FI,MASS,7
FI,MATERNAL EXPOSURE BEFORE PREGNANCY,7
FI,MUSCLE SPASTICITY,7
FI,MYELITIS,7
FI,NEUTROPHIL COUNT INCREASED,7
FI,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,7
FI,PAIN OF SKIN,7
FI,PANCREATIC CARCINOMA,7
FI,PANCREATITIS ACUTE,7
FI,PERIPHERAL SENSORY NEUROPATHY,7
FI,PHOTOPSIA,7
FI,PLATELET COUNT ABNORMAL,7
FI,POSTOPERATIVE WOUND INFECTION,7
FI,PRE-ECLAMPSIA,7
FI,PROCEDURAL COMPLICATION,7
FI,PSYCHIATRIC SYMPTOM,7
FI,PYODERMA GANGRENOSUM,7
FI,QUALITY OF LIFE DECREASED,7
FI,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,7
FI,RENAL FAILURE ACUTE,7
FI,RESPIRATORY ARREST,7
FI,RESPIRATORY DISORDER,7
FI,SELF INJURIOUS BEHAVIOUR,7
FI,SEROTONIN SYNDROME,7
FI,SKIN LESION,7
FI,SOCIAL AVOIDANT BEHAVIOUR,7
FI,SPINAL FRACTURE,7
FI,STAPHYLOCOCCAL INFECTION,7
FI,STRESS CARDIOMYOPATHY,7
FI,STRESS FRACTURE,7
FI,STUPOR,7
FI,SUICIDAL BEHAVIOUR,7
FI,THERAPY NON-RESPONDER,7
FI,TOOTH FRACTURE,7
FI,TUBERCULOSIS,7
FI,ACCIDENTAL POISONING,6
FI,AFFECTIVE DISORDER,6
FI,AKATHISIA,6
FI,ANOSMIA,6
FI,ANTIPSYCHOTIC DRUG LEVEL INCREASED,6
FI,APNOEA,6
FI,ARTHRITIS BACTERIAL,6
FI,AUTOIMMUNE HAEMOLYTIC ANAEMIA,6
FI,AZOOSPERMIA,6
FI,BIPOLAR DISORDER,6
FI,BLADDER CANCER,6
FI,BLINDNESS UNILATERAL,6
FI,BLOOD PRESSURE ABNORMAL,6
FI,BRAIN STEM INFARCTION,6
FI,CANDIDA INFECTION,6
FI,CARDIAC DISCOMFORT,6
FI,CARDIAC FIBRILLATION,6
FI,CARDIOMYOPATHY,6
FI,CEREBRAL PALSY,6
FI,COLON CANCER,6
FI,CONGESTIVE CARDIOMYOPATHY,6
FI,DENTAL CARIES,6
FI,DEVELOPMENTAL DELAY,6
FI,DIABETES MELLITUS INADEQUATE CONTROL,6
FI,DRUG LEVEL DECREASED,6
FI,EAR PAIN,6
FI,ENDOCARDITIS,6
FI,ERECTILE DYSFUNCTION,6
FI,ESCHERICHIA SEPSIS,6
FI,EXTRASYSTOLES,6
FI,EYE DISORDER,6
FI,FAECAL CALPROTECTIN INCREASED,6
FI,FEBRILE INFECTION,6
FI,FLANK PAIN,6
FI,FOETAL GROWTH RESTRICTION,6
FI,FREQUENT BOWEL MOVEMENTS,6
FI,GASTROENTERITIS VIRAL,6
FI,GASTROINTESTINAL INFLAMMATION,6
FI,GENERAL PHYSICAL CONDITION ABNORMAL,6
FI,GINGIVAL PAIN,6
FI,GLOMERULAR FILTRATION RATE DECREASED,6
FI,GLOSSODYNIA,6
FI,GOUT,6
FI,HAEMANGIOMA,6
FI,HAEMORRHAGE INTRACRANIAL,6
FI,HEPATIC FUNCTION ABNORMAL,6
FI,HEPATITIS,6
FI,HERPES VIRUS INFECTION,6
FI,HORMONE-REFRACTORY PROSTATE CANCER,6
FI,HYPERNATRAEMIA,6
FI,HYPERSOMNIA,6
FI,ILEUS PARALYTIC,6
FI,IMPAIRED GASTRIC EMPTYING,6
FI,INJURY,6
FI,JOINT EFFUSION,6
FI,JUVENILE IDIOPATHIC ARTHRITIS,6
FI,LIMB INJURY,6
FI,LOWER RESPIRATORY TRACT INFECTION,6
FI,LUNG NEOPLASM MALIGNANT,6
FI,MENINGITIS,6
FI,METASTASES TO LYMPH NODES,6
FI,METRORRHAGIA,6
FI,MUSCLE DISORDER,6
FI,MUSCLE NECROSIS,6
FI,MUSCULOSKELETAL DISORDER,6
FI,MYOSITIS,6
FI,NERVE INJURY,6
FI,NODULE,6
FI,NORMAL NEWBORN,6
FI,NYSTAGMUS,6
FI,OBESITY,6
FI,OESOPHAGITIS,6
FI,ORAL HERPES,6
FI,PERICARDIAL EFFUSION,6
FI,PERIPHERAL ISCHAEMIA,6
FI,PETECHIAE,6
FI,PNEUMOCYSTIS JIROVECII INFECTION,6
FI,PNEUMONIA BACTERIAL,6
FI,PORTAL VEIN THROMBOSIS,6
FI,POSTURE ABNORMAL,6
FI,PREGNANCY WITH IMPLANT CONTRACEPTIVE,6
FI,PRODUCT ADHESION ISSUE,6
FI,PULMONARY HYPERTENSION,6
FI,PURULENT DISCHARGE,6
FI,QUADRIPARESIS,6
FI,REFUSAL OF TREATMENT BY PATIENT,6
FI,RETINAL DISORDER,6
FI,RHINITIS,6
FI,SALIVARY HYPERSECRETION,6
FI,SCIATICA,6
FI,SECOND PRIMARY MALIGNANCY,6
FI,SERUM FERRITIN INCREASED,6
FI,SKIN NECROSIS,6
FI,SPINAL COLUMN STENOSIS,6
FI,STILLBIRTH,6
FI,SYNOVITIS,6
FI,SYSTEMIC LUPUS ERYTHEMATOSUS,6
FI,TENDON RUPTURE,6
FI,THERAPEUTIC RESPONSE UNEXPECTED,6
FI,TOE AMPUTATION,6
FI,TROPONIN T INCREASED,6
FI,ULCER,6
FI,UNEVALUABLE EVENT,6
FI,VAGINAL INFECTION,6
FI,VASODILATATION,6
FI,VERTIGO POSITIONAL,6
FI,WRIST FRACTURE,6
FI,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,5
FI,ACUTE RESPIRATORY FAILURE,5
FI,ALCOHOL INTERACTION,5
FI,ALCOHOL POISONING,5
FI,ANDROGEN DEFICIENCY,5
FI,APPLICATION SITE ERYTHEMA,5
FI,ARTERIOSPASM CORONARY,5
FI,ATRIAL FLUTTER,5
FI,B-CELL LYMPHOMA,5
FI,BLOOD CALCIUM DECREASED,5
FI,BLOOD THYROID STIMULATING HORMONE INCREASED,5
FI,BONE EROSION,5
FI,BONE LOSS,5
FI,BREAST CANCER FEMALE,5
FI,BURSITIS,5
FI,C-REACTIVE PROTEIN ABNORMAL,5
FI,CATATONIA,5
FI,CEREBRAL ARTERY EMBOLISM,5
FI,CEREBRAL DISORDER,5
FI,CHOLESTASIS,5
FI,CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE,5
FI,CHRONIC LYMPHOCYTIC LEUKAEMIA,5
FI,COMA,5
FI,COMPUTERISED TOMOGRAM THORAX ABNORMAL,5
FI,CONJUNCTIVITIS BACTERIAL,5
FI,DECREASED INTEREST,5
FI,DECUBITUS ULCER,5
FI,DEMENTIA,5
FI,DEVICE KINK,5
FI,DEVICE MALFUNCTION,5
FI,DEVICE RELATED INFECTION,5
FI,DIAPHRAGMATIC HERNIA,5
FI,DROOLING,5
FI,DRUG INTOLERANCE,5
FI,DRUG LEVEL CHANGED,5
FI,DYSGRAPHIA,5
FI,DYSLIPIDAEMIA,5
FI,DYSPHEMIA,5
FI,ERUCTATION,5
FI,EXPOSURE VIA FATHER,5
FI,EYE DISCHARGE,5
FI,EYE HAEMORRHAGE,5
FI,EYE INFLAMMATION,5
FI,FREEZING PHENOMENON,5
FI,GAIT INABILITY,5
FI,GASTRIC ULCER,5
FI,GASTROINTESTINAL TOXICITY,5
FI,GENERALISED ERYTHEMA,5
FI,GENITAL HAEMORRHAGE,5
FI,GLAUCOMA,5
FI,GROWTH RETARDATION,5
FI,HAEMORRHOIDS,5
FI,HEARING IMPAIRED,5
FI,HERPES SIMPLEX,5
FI,HYPERCAPNIA,5
FI,HYPOACUSIS,5
FI,HYPOMAGNESAEMIA,5
FI,HYPOREFLEXIA,5
FI,IMMUNE SYSTEM DISORDER,5
FI,IMPAIRED DRIVING ABILITY,5
FI,IMPULSIVE BEHAVIOUR,5
FI,INCONTINENCE,5
FI,INJECTION SITE BRUISING,5
FI,INJECTION SITE INJURY,5
FI,INJECTION SITE MASS,5
FI,INJECTION SITE REACTION,5
FI,INJECTION SITE SWELLING,5
FI,INTERNATIONAL NORMALISED RATIO DECREASED,5
FI,INTERVERTEBRAL DISCITIS,5
FI,INTESTINAL PERFORATION,5
FI,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,5
FI,LIBIDO DECREASED,5
FI,LOCALISED INFECTION,5
FI,LOSS OF CONTROL OF LEGS,5
FI,LUNG ADENOCARCINOMA,5
FI,LUPUS-LIKE SYNDROME,5
FI,MACULAR OEDEMA,5
FI,MENSTRUAL DISORDER,5
FI,MITRAL VALVE INCOMPETENCE,5
FI,MUSCLE CONTRACTIONS INVOLUNTARY,5
FI,MUTISM,5
FI,MYELODYSPLASTIC SYNDROME,5
FI,NEPHROPATHY TOXIC,5
FI,NERVOUS SYSTEM DISORDER,5
FI,NEUROLOGICAL SYMPTOM,5
FI,OCCUPATIONAL EXPOSURE TO PRODUCT,5
FI,OEDEMA MOUTH,5
FI,OEDEMA MUCOSAL,5
FI,ONYCHALGIA,5
FI,ORAL MUCOSAL BLISTERING,5
FI,OXYGEN SATURATION ABNORMAL,5
FI,PELVIC FRACTURE,5
FI,PERIODONTITIS,5
FI,PITUITARY TUMOUR BENIGN,5
FI,PNEUMOTHORAX,5
FI,POLYMYALGIA RHEUMATICA,5
FI,POST PROCEDURAL HAEMORRHAGE,5
FI,POST-INJECTION DELIRIUM SEDATION SYNDROME,5
FI,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,5
FI,PREMATURE LABOUR,5
FI,PROSTATIC SPECIFIC ANTIGEN INCREASED,5
FI,PSYCHOTIC SYMPTOM,5
FI,PULMONARY CONGESTION,5
FI,PULSE ABNORMAL,5
FI,PUSTULAR PSORIASIS,5
FI,RED BLOOD CELL COUNT DECREASED,5
FI,RENAL TUBULAR INJURY,5
FI,RESPIRATORY RATE DECREASED,5
FI,RETCHING,5
FI,RIB FRACTURE,5
FI,SENSE OF OPPRESSION,5
FI,SEXUALLY TRANSMITTED DISEASE,5
FI,SKIN ATROPHY,5
FI,SKIN BURNING SENSATION,5
FI,SKIN MASS,5
FI,SKIN PAPILLOMA,5
FI,SNEEZING,5
FI,SPINA BIFIDA,5
FI,SPINAL COMPRESSION FRACTURE,5
FI,SPLENOMEGALY,5
FI,SUDDEN ONSET OF SLEEP,5
FI,TENDON DISORDER,5
FI,THROMBOPHLEBITIS SUPERFICIAL,5
FI,THYROIDITIS,5
FI,TONGUE DISORDER,5
FI,TOOTH ABSCESS,5
FI,TREATMENT NONCOMPLIANCE,5
FI,UMBILICAL CORD AROUND NECK,5
FI,UNINTENTIONAL MEDICAL DEVICE REMOVAL,5
FI,VENOUS THROMBOSIS,5
FI,VIITH NERVE PARALYSIS,5
FI,VITREOUS DETACHMENT,5
FI,WHEEZING,5
FI,WRONG DRUG ADMINISTERED,5
FI,ABDOMINAL TENDERNESS,4
FI,ACCIDENTAL EXPOSURE TO PRODUCT,4
FI,ADENOCARCINOMA,4
FI,ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD,4
FI,ADRENOCORTICAL INSUFFICIENCY ACUTE,4
FI,AMYLOIDOSIS,4
FI,AMYOTROPHIC LATERAL SCLEROSIS,4
FI,ANAL ABSCESS,4
FI,ANKLE FRACTURE,4
FI,ANKYLOSING SPONDYLITIS,4
FI,ANTINUCLEAR ANTIBODY INCREASED,4
FI,APHONIA,4
FI,APNOEIC ATTACK,4
FI,AREFLEXIA,4
FI,ARTHRITIS INFECTIVE,4
FI,ASPERGILLUS INFECTION,4
FI,ASPIRATION,4
FI,ATRIAL SEPTAL DEFECT,4
FR,FATIGUE,7136
FR,HEADACHE,5201
FR,DIARRHOEA,4697
FR,ASTHENIA,4617
FR,ACUTE KIDNEY INJURY,4175
FR,NAUSEA,4077
FR,PYREXIA,3906
FR,VOMITING,3838
FR,ANAEMIA,3800
FR,DYSPNOEA,3605
FR,FALL,3586
FR,THROMBOCYTOPENIA,3337
FR,HEPATOCELLULAR INJURY,3323
FR,VERTIGO,3309
FR,MALAISE,3260
FR,WEIGHT INCREASED,3051
FR,INSOMNIA,3004
FR,DRUG INEFFECTIVE,2931
FR,DEPRESSION,2926
FR,DEATH,2846
FR,ABDOMINAL PAIN,2813
FR,HYPOTENSION,2804
FR,CONFUSIONAL STATE,2728
FR,NEUTROPENIA,2647
FR,ARTHRALGIA,2642
FR,RENAL FAILURE,2637
FR,GENERAL PHYSICAL HEALTH DETERIORATION,2547
FR,MYALGIA,2519
FR,SOMNOLENCE,2471
FR,FOETAL EXPOSURE DURING PREGNANCY,2428
FR,PRURITUS,2346
FR,WEIGHT DECREASED,2333
FR,DIZZINESS,2294
FR,MUSCLE SPASMS,2197
FR,OVERDOSE,2133
FR,COMA,2123
FR,ANXIETY,2119
FR,TACHYCARDIA,2103
FR,CHOLESTASIS,2002
FR,RASH,1972
FR,TOXICITY TO VARIOUS AGENTS,1934
FR,ALOPECIA,1862
FR,HYPONATRAEMIA,1853
FR,DECREASED APPETITE,1764
FR,CARDIAC FAILURE,1723
FR,PULMONARY EMBOLISM,1720
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1699
FR,ERYTHEMA,1688
FR,HYPERTENSION,1666
FR,CONDITION AGGRAVATED,1613
FR,LUNG DISORDER,1610
FR,RENAL FAILURE ACUTE,1599
FR,PAIN,1586
FR,PALPITATIONS,1568
FR,IRRITABILITY,1553
FR,SEPTIC SHOCK,1521
FR,PANCYTOPENIA,1492
FR,TREMOR,1415
FR,HYPERHIDROSIS,1408
FR,OEDEMA PERIPHERAL,1404
FR,LOSS OF CONSCIOUSNESS,1377
FR,BACK PAIN,1348
FR,PARAESTHESIA,1343
FR,BLOOD THYROID STIMULATING HORMONE INCREASED,1315
FR,EOSINOPHILIA,1311
FR,DISTURBANCE IN ATTENTION,1309
FR,RASH MACULO-PAPULAR,1257
FR,DEHYDRATION,1241
FR,PAIN IN EXTREMITY,1228
FR,PRODUCT USE ISSUE,1197
FR,MIGRAINE,1194
FR,HEPATITIS,1184
FR,AGRANULOCYTOSIS,1181
FR,SEPSIS,1175
FR,HYPOKALAEMIA,1168
FR,CHEST PAIN,1167
FR,BRADYCARDIA,1156
FR,CONSTIPATION,1143
FR,INTERSTITIAL LUNG DISEASE,1134
FR,HOT FLUSH,1114
FR,TOXIC SKIN ERUPTION,1113
FR,DIFFUSE ALOPECIA,1110
FR,HAEMATOMA,1102
FR,ISCHAEMIC STROKE,1101
FR,AMNESIA,1096
FR,URTICARIA,1089
FR,DISEASE PROGRESSION,1072
FR,GASTROINTESTINAL DISORDER,1070
FR,HYPERKALAEMIA,1060
FR,RESPIRATORY DISTRESS,1057
FR,FEBRILE BONE MARROW APLASIA,1047
FR,COUGH,1043
FR,ABDOMINAL PAIN UPPER,1039
FR,SUICIDE ATTEMPT,1034
FR,GAIT DISTURBANCE,1010
FR,RHABDOMYOLYSIS,1003
FR,MALIGNANT NEOPLASM PROGRESSION,1002
FR,AGITATION,993
FR,LEUKOPENIA,986
FR,SLEEP DISORDER,983
FR,EXPOSURE DURING PREGNANCY,980
FR,LOSS OF LIBIDO,977
FR,INTERNATIONAL NORMALISED RATIO INCREASED,972
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,949
FR,ATRIAL FIBRILLATION,927
FR,VISION BLURRED,899
FR,CHILLS,896
FR,INTENTIONAL OVERDOSE,884
FR,CEREBROVASCULAR ACCIDENT,883
FR,PNEUMONIA,872
FR,VISUAL IMPAIRMENT,869
FR,PANCREATITIS ACUTE,866
FR,CARDIO-RESPIRATORY ARREST,846
FR,DYSPHAGIA,840
FR,HYPERTHERMIA,838
FR,CARDIAC ARREST,829
FR,ENCEPHALOPATHY,828
FR,BALANCE DISORDER,827
FR,PLEURAL EFFUSION,818
FR,HYPERSENSITIVITY,816
FR,AGGRESSION,815
FR,DEEP VEIN THROMBOSIS,813
FR,RECTAL HAEMORRHAGE,813
FR,ANGIOEDEMA,812
FR,INFECTION,803
FR,TRANSAMINASES INCREASED,784
FR,MATERNAL EXPOSURE DURING PREGNANCY,783
FR,SEIZURE,769
FR,FEBRILE NEUTROPENIA,764
FR,HALLUCINATION,762
FR,MEMORY IMPAIRMENT,762
FR,FACE OEDEMA,747
FR,BLOOD THYROID STIMULATING HORMONE DECREASED,735
FR,HYPOGLYCAEMIA,732
FR,EPILEPSY,726
FR,MUCOSAL INFLAMMATION,726
FR,MELAENA,722
FR,PRODUCT USE IN UNAPPROVED INDICATION,721
FR,LACTIC ACIDOSIS,719
FR,URINARY TRACT INFECTION,716
FR,SUICIDAL IDEATION,710
FR,ANAPHYLACTIC SHOCK,708
FR,OSTEONECROSIS OF JAW,708
FR,HYPERTHYROIDISM,707
FR,MYOCARDIAL INFARCTION,707
FR,DISORIENTATION,706
FR,ALANINE AMINOTRANSFERASE INCREASED,704
FR,ABDOMINAL DISTENSION,703
FR,INFLAMMATION,702
FR,ABNORMAL BEHAVIOUR,699
FR,ELECTROCARDIOGRAM QT PROLONGED,699
FR,ARRHYTHMIA,687
FR,BONE MARROW FAILURE,679
FR,EPISTAXIS,679
FR,BLOOD THYROID STIMULATING HORMONE NORMAL,677
FR,LYMPHOPENIA,669
FR,GASTROINTESTINAL HAEMORRHAGE,653
FR,HAEMATURIA,622
FR,ASPARTATE AMINOTRANSFERASE INCREASED,621
FR,HAEMORRHAGE,610
FR,PRODUCT FORMULATION ISSUE,608
FR,SYNCOPE,604
FR,OEDEMA,598
FR,BRONCHITIS,595
FR,OXYGEN SATURATION DECREASED,593
FR,NEUROPATHY PERIPHERAL,587
FR,ABORTION SPONTANEOUS,585
FR,PNEUMONIA ASPIRATION,585
FR,BLOOD CREATININE INCREASED,576
FR,JAUNDICE,574
FR,MUSCULAR WEAKNESS,562
FR,LUNG INFECTION,561
FR,SUBDURAL HAEMATOMA,559
FR,HAEMOGLOBIN DECREASED,557
FR,INCORRECT DOSE ADMINISTERED,556
FR,ALTERED STATE OF CONSCIOUSNESS,552
FR,VISUAL ACUITY REDUCED,552
FR,CEREBRAL HAEMORRHAGE,549
FR,SHOCK HAEMORRHAGIC,548
FR,ASCITES,547
FR,ECZEMA,545
FR,CARDIOGENIC SHOCK,544
FR,RENAL IMPAIRMENT,543
FR,INFUSION RELATED REACTION,541
FR,METABOLIC ACIDOSIS,540
FR,MEDICATION ERROR,537
FR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,535
FR,COLITIS,535
FR,PURPURA,535
FR,PREMATURE BABY,533
FR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,531
FR,SPEECH DISORDER,529
FR,DELIRIUM,525
FR,ACUTE PULMONARY OEDEMA,522
FR,SHOCK,522
FR,URINARY RETENTION,513
FR,CHEST DISCOMFORT,508
FR,ACNE,505
FR,APHASIA,505
FR,BLOOD CREATINE PHOSPHOKINASE INCREASED,504
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,503
FR,DYSPEPSIA,499
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,494
FR,MULTI-ORGAN FAILURE,491
FR,TINNITUS,490
FR,DEPRESSED MOOD,489
FR,DRUG PRESCRIBING ERROR,489
FR,DIABETES MELLITUS,480
FR,INTENTIONAL PRODUCT MISUSE,479
FR,RASH ERYTHEMATOUS,479
FR,DERMATITIS EXFOLIATIVE,474
FR,CEREBRAL HAEMATOMA,471
FR,ORTHOSTATIC HYPOTENSION,471
FR,PSORIASIS,470
FR,EXTRAPYRAMIDAL DISORDER,466
FR,NERVOUSNESS,465
FR,BREAST CANCER,460
FR,BREAST PAIN,459
FR,RESPIRATORY FAILURE,457
FR,HYPOTHERMIA,452
FR,PANCREATITIS,448
FR,DRY MOUTH,447
FR,HEPATIC FAILURE,439
FR,ACUTE CORONARY SYNDROME,431
FR,FEELING ABNORMAL,431
FR,DRUG ABUSE,426
FR,DRUG DEPENDENCE,426
FR,HYPOTHYROIDISM,426
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,425
FR,PULMONARY ARTERIAL HYPERTENSION,424
FR,COGNITIVE DISORDER,422
FR,AFFECTIVE DISORDER,416
FR,DYSARTHRIA,413
FR,C-REACTIVE PROTEIN INCREASED,406
FR,PLASMA CELL MYELOMA,402
FR,STATUS EPILEPTICUS,402
FR,PATHOGEN RESISTANCE,400
FR,RENAL TUBULAR NECROSIS,398
FR,BRONCHOSPASM,396
FR,HAEMATEMESIS,394
FR,DYSKINESIA,389
FR,LYMPHADENOPATHY,387
FR,ABORTION INDUCED,380
FR,CELL DEATH,377
FR,HYPOTONIA,377
FR,DRUG-INDUCED LIVER INJURY,375
FR,CARDIAC DISORDER,374
FR,ACUTE MYELOID LEUKAEMIA,372
FR,RESPIRATORY DISORDER,372
FR,HYPOCALCAEMIA,371
FR,HYPOXIA,368
FR,LIBIDO DECREASED,368
FR,CONVULSION,364
FR,HEPATITIS CHOLESTATIC,364
FR,POISONING DELIBERATE,361
FR,TRANSIENT ISCHAEMIC ATTACK,359
FR,INTESTINAL OBSTRUCTION,358
FR,HYPOAESTHESIA,357
FR,BLOOD THYROID STIMULATING HORMONE,356
FR,NERVOUS SYSTEM DISORDER,355
FR,FOETAL GROWTH RESTRICTION,351
FR,HALLUCINATION_ VISUAL,345
FR,TREATMENT FAILURE,345
FR,MIOSIS,342
FR,BLOOD PRESSURE INCREASED,341
FR,DRUG INTOLERANCE,341
FR,HAEMOPTYSIS,340
FR,LIPASE INCREASED,340
FR,HAEMOLYTIC ANAEMIA,339
FR,DERMATITIS BULLOUS,338
FR,COMPLETED SUICIDE,337
FR,BLOOD PRESSURE DECREASED,336
FR,SKIN EXFOLIATION,334
FR,HEAD INJURY,333
FR,OSTEONECROSIS,330
FR,TENDONITIS,330
FR,MOOD SWINGS,329
FR,SKIN LESION,328
FR,PEMPHIGOID,327
FR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,326
FR,PYELONEPHRITIS,324
FR,ACUTE RESPIRATORY FAILURE,323
FR,DYSPNOEA EXERTIONAL,323
FR,PHLEBITIS,321
FR,BLOOD BILIRUBIN INCREASED,320
FR,PLATELET COUNT DECREASED,319
FR,HYPERGLYCAEMIA,316
FR,ACCIDENTAL OVERDOSE,312
FR,MOOD ALTERED,312
FR,PULMONARY OEDEMA,312
FR,EJECTION FRACTION DECREASED,310
FR,MYOCLONUS,307
FR,DRY SKIN,306
FR,NECK PAIN,305
FR,PERITONITIS,304
FR,THROMBOTIC MICROANGIOPATHY,304
FR,PERICARDIAL EFFUSION,303
FR,HEPATIC ENZYME INCREASED,302
FR,HISTIOCYTOSIS HAEMATOPHAGIC,301
FR,CYTOMEGALOVIRUS INFECTION,299
FR,ASTHMA,297
FR,MUSCULOSKELETAL STIFFNESS,296
FR,HYPERTRIGLYCERIDAEMIA,295
FR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,293
FR,ANGINA PECTORIS,289
FR,MUSCLE HAEMORRHAGE,289
FR,MUSCULOSKELETAL PAIN,289
FR,ERYSIPELAS,288
FR,MYDRIASIS,288
FR,PRESYNCOPE,288
FR,ADVERSE EVENT,287
FR,BURNING SENSATION,287
FR,FEELING HOT,287
FR,HAEMORRHAGIC STROKE,286
FR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,286
FR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,283
FR,DIPLOPIA,282
FR,TOXIC EPIDERMAL NECROLYSIS,282
FR,DYSPHONIA,281
FR,MALNUTRITION,281
FR,STRESS,280
FR,DEPRESSED LEVEL OF CONSCIOUSNESS,278
FR,LEUKOCYTOSIS,278
FR,HEPATOCELLULAR CARCINOMA,277
FR,ANAPHYLACTIC REACTION,275
FR,EYE PAIN,275
FR,STOMATITIS,274
FR,DRUG LEVEL INCREASED,273
FR,HEPATITIS ACUTE,273
FR,PERICARDITIS,270
FR,PROTEINURIA,270
FR,ANURIA,269
FR,BASAL CELL CARCINOMA,268
FR,DRUG RESISTANCE,267
FR,MYELODYSPLASTIC SYNDROME,267
FR,INTENTIONAL PRODUCT USE ISSUE,266
FR,PHOTOSENSITIVITY REACTION,266
FR,HEMIPLEGIA,265
FR,BONE PAIN,264
FR,HOSPITALISATION,264
FR,CYANOSIS,262
FR,THROMBOSIS,261
FR,PNEUMOCYSTIS JIROVECII PNEUMONIA,257
FR,APLASIA,255
FR,RENAL TUBULAR DISORDER,255
FR,CIRCULATORY COLLAPSE,252
FR,TUBULOINTERSTITIAL NEPHRITIS,252
FR,DRUG HYPERSENSITIVITY,251
FR,HYPERTRICHOSIS,251
FR,DIABETES MELLITUS INADEQUATE CONTROL,250
FR,EYELID OEDEMA,250
FR,INFLUENZA,250
FR,LIVER DISORDER,248
FR,INCORRECT ROUTE OF DRUG ADMINISTRATION,247
FR,CHRONIC KIDNEY DISEASE,246
FR,CRYING,245
FR,PALLOR,245
FR,TREATMENT NONCOMPLIANCE,245
FR,INJECTION SITE PAIN,244
FR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,244
FR,HYPERBILIRUBINAEMIA,243
FR,PRODUCT QUALITY ISSUE,242
FR,DRUG ADMINISTRATION ERROR,241
FR,HEPATIC ENCEPHALOPATHY,241
FR,SUDDEN DEATH,241
FR,BLINDNESS,240
FR,GENERALISED TONIC-CLONIC SEIZURE,240
FR,WITHDRAWAL SYNDROME,240
FR,HEMIPARESIS,239
FR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,239
FR,PULMONARY FIBROSIS,239
FR,FORMICATION,238
FR,CROHN^S DISEASE,236
FR,GENERALISED OEDEMA,236
FR,MULTIPLE SCLEROSIS RELAPSE,236
FR,GASTROOESOPHAGEAL REFLUX DISEASE,234
FR,PSYCHOMOTOR RETARDATION,234
FR,PREGNANCY,233
FR,SKIN ULCER,233
FR,DYSGEUSIA,232
FR,HYPERCALCAEMIA,232
FR,RASH PUSTULAR,232
FR,STAPHYLOCOCCAL INFECTION,232
FR,HERPES ZOSTER,228
FR,VASCULAR PURPURA,228
FR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,228
FR,PSYCHOTIC DISORDER,227
FR,DISEASE RECURRENCE,226
FR,DYSURIA,226
FR,RASH PRURITIC,226
FR,SINUS BRADYCARDIA,225
FR,CHOLELITHIASIS,223
FR,DRUG WITHDRAWAL SYNDROME,223
FR,NIGHT SWEATS,223
FR,RASH MACULAR,222
FR,MENTAL DISORDER,221
FR,OVARIAN HYPERSTIMULATION SYNDROME,221
FR,SQUAMOUS CELL CARCINOMA,221
FR,CONJUNCTIVITIS,220
FR,HEPATIC STEATOSIS,219
FR,LIVER INJURY,219
FR,CEREBELLAR SYNDROME,217
FR,PREMATURE DELIVERY,216
FR,SYSTEMIC LUPUS ERYTHEMATOSUS,216
FR,PELVIC PAIN,215
FR,RASH GENERALISED,215
FR,BLISTER,214
FR,PSYCHOMOTOR SKILLS IMPAIRED,214
FR,NEUROLEPTIC MALIGNANT SYNDROME,213
FR,OVARIAN CYST,213
FR,CONGESTIVE CARDIOMYOPATHY,212
FR,INFLUENZA LIKE ILLNESS,212
FR,HEART RATE INCREASED,211
FR,APATHY,209
FR,STEVENS-JOHNSON SYNDROME,209
FR,HYPOMAGNESAEMIA,207
FR,METRORRHAGIA,207
FR,SKIN NECROSIS,207
FR,GASTROENTERITIS,206
FR,NEPHROPATHY TOXIC,205
FR,COLITIS ISCHAEMIC,204
FR,FEELING COLD,203
FR,INCORRECT DRUG ADMINISTRATION DURATION,203
FR,TRANSFUSION,203
FR,CATARACT,201
FR,URINARY INCONTINENCE,200
FR,DYSMORPHISM,199
FR,HYPERTENSIVE CRISIS,199
FR,CAESAREAN SECTION,198
FR,GENERAL PHYSICAL CONDITION ABNORMAL,198
FR,NIGHTMARE,198
FR,WRONG DRUG ADMINISTERED,198
FR,GENERALISED ERYTHEMA,196
FR,HEPATITIS FULMINANT,195
FR,DRUG DOSE OMISSION,194
FR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,194
FR,RASH MORBILLIFORM,194
FR,SINUSITIS,194
FR,MYOCARDITIS,193
FR,POLYNEUROPATHY,193
FR,SINUS TACHYCARDIA,193
FR,FOETAL DEATH,192
FR,PRURITUS GENERALISED,192
FR,UVEITIS,191
FR,DRUG ERUPTION,190
FR,HAEMORRHAGIC ANAEMIA,190
FR,NEPHROLITHIASIS,189
FR,MOTOR DYSFUNCTION,188
FR,DEVICE RELATED INFECTION,187
FR,SUBARACHNOID HAEMORRHAGE,187
FR,VENOUS THROMBOSIS,187
FR,FUNGAL INFECTION,186
FR,SEDATION,186
FR,MIXED LIVER INJURY,185
FR,BLOOD THYROID STIMULATING HORMONE ABNORMAL,184
FR,DRY EYE,184
FR,HAEMODYNAMIC INSTABILITY,184
FR,ARTHRITIS,183
FR,DISSEMINATED INTRAVASCULAR COAGULATION,183
FR,HYPOVOLAEMIC SHOCK,182
FR,NEOPLASM MALIGNANT,182
FR,OSTEOARTHRITIS,182
FR,TACHYPNOEA,182
FR,CELLULITIS,180
FR,PERIPHERAL SWELLING,179
FR,MALIGNANT MELANOMA,178
FR,NO ADVERSE EVENT,177
FR,PRESCRIBED OVERDOSE,177
FR,SKIN REACTION,176
FR,AMENORRHOEA,175
FR,HYPERSENSITIVITY VASCULITIS,174
FR,SCIATICA,174
FR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,174
FR,UNINTENDED PREGNANCY,174
FR,PERIPHERAL ISCHAEMIA,173
FR,GASTRIC ULCER,171
FR,GASTRITIS,171
FR,NEURALGIA,171
FR,CREATININE RENAL CLEARANCE DECREASED,170
FR,HAEMATOTOXICITY,170
FR,HEPATOMEGALY,170
FR,MAJOR DEPRESSION,170
FR,MANIA,170
FR,HEPATIC CIRRHOSIS,169
FR,OESOPHAGITIS,169
FR,RHEUMATOID ARTHRITIS,169
FR,ASPHYXIA,168
FR,DEAFNESS,167
FR,LIVER FUNCTION TEST ABNORMAL,167
FR,PACKED RED BLOOD CELL TRANSFUSION,167
FR,RENAL COLIC,167
FR,RHINITIS,167
FR,PHOTOPHOBIA,166
FR,PROSTATE CANCER,166
FR,PSYCHOMOTOR HYPERACTIVITY,166
FR,GASTROINTESTINAL MOTILITY DISORDER,165
FR,ATRIOVENTRICULAR BLOCK,164
FR,MOUTH ULCERATION,164
FR,RASH PAPULAR,164
FR,WHITE BLOOD CELL COUNT DECREASED,164
FR,ATAXIA,163
FR,SECOND PRIMARY MALIGNANCY,163
FR,STAPHYLOCOCCAL SEPSIS,163
FR,SWELLING FACE,163
FR,EPSTEIN-BARR VIRUS INFECTION,162
FR,SEROTONIN SYNDROME,162
FR,SUBILEUS,161
FR,HALLUCINATION_ AUDITORY,160
FR,LIP OEDEMA,160
FR,OLIGURIA,160
FR,CARDIOMYOPATHY,159
FR,ECCHYMOSIS,159
FR,HYPOGAMMAGLOBULINAEMIA,159
FR,BRADYPNOEA,158
FR,PANIC ATTACK,158
FR,FAECALOMA,157
FR,HEPATOTOXICITY,157
FR,HYPOALBUMINAEMIA,157
FR,LIVE BIRTH,157
FR,SKIN DISORDER,157
FR,HYPERTONIA,156
FR,NASOPHARYNGITIS,156
FR,OSTEOPOROSIS,154
FR,FLATULENCE,153
FR,PRODUCTIVE COUGH,153
FR,SKIN TOXICITY,153
FR,FLUSHING,152
FR,LIMB DISCOMFORT,152
FR,MATERNAL EXPOSURE BEFORE PREGNANCY,152
FR,HYPERLACTACIDAEMIA,151
FR,OROPHARYNGEAL PAIN,151
FR,PERITONEAL HAEMORRHAGE,151
FR,POLLAKIURIA,151
FR,VIITH NERVE PARALYSIS,151
FR,SOCIAL AVOIDANT BEHAVIOUR,150
FR,TRANSPLANT REJECTION,150
FR,IRON DEFICIENCY ANAEMIA,149
FR,SLEEP APNOEA SYNDROME,149
FR,WHITE BLOOD CELL COUNT INCREASED,149
FR,CEREBRAL VENOUS THROMBOSIS,148
FR,CLOSTRIDIUM DIFFICILE COLITIS,148
FR,NEOPLASM PROGRESSION,148
FR,PLEURISY,148
FR,TONGUE OEDEMA,148
FR,NEPHROPATHY,146
FR,NEUTROPHIL COUNT DECREASED,146
FR,VENTRICULAR TACHYCARDIA,146
FR,FLUID RETENTION,145
FR,GINGIVAL BLEEDING,145
FR,PNEUMOTHORAX,145
FR,HYPERAMMONAEMIA,144
FR,INTENTIONAL DRUG MISUSE,143
FR,TENDON RUPTURE,143
FR,HYPOACUSIS,142
FR,PETECHIAE,142
FR,ACUTE PRERENAL FAILURE,141
FR,CEREBRAL INFARCTION,141
FR,ENCEPHALITIS,141
FR,CRANIOCEREBRAL INJURY,140
FR,DELUSION,140
FR,DYSSTASIA,140
FR,GESTATIONAL DIABETES,139
FR,NORMOCHROMIC NORMOCYTIC ANAEMIA,139
FR,ATRIOVENTRICULAR BLOCK COMPLETE,138
FR,BRONCHOPULMONARY ASPERGILLOSIS,138
FR,EXTRAVASATION,138
FR,IMMUNE THROMBOCYTOPENIC PURPURA,138
FR,PRODUCT SUBSTITUTION ISSUE,138
FR,SURGERY,138
FR,VIROLOGIC FAILURE,138
FR,ARTHROPATHY,137
FR,PANCREATIC CARCINOMA,137
FR,SKIN DISCOLOURATION,137
FR,ABSCESS,136
FR,ERECTILE DYSFUNCTION,136
FR,INJECTION SITE ERYTHEMA,136
FR,DRUG DISPENSING ERROR,135
FR,PULMONARY HYPERTENSION,135
FR,PULMONARY MASS,135
FR,SWELLING,135
FR,COLITIS MICROSCOPIC,134
FR,FEMUR FRACTURE,134
FR,RETINAL DETACHMENT,134
FR,VAGINAL DISCHARGE,134
FR,VASCULITIS,134
FR,CANDIDA INFECTION,133
FR,INTESTINAL ISCHAEMIA,133
FR,NEPHROTIC SYNDROME,133
FR,COLITIS ULCERATIVE,132
FR,FACIAL PARALYSIS,132
FR,HYPOPHOSPHATAEMIA,132
FR,PROTHROMBIN TIME SHORTENED,132
FR,VENTRICULAR FIBRILLATION,132
FR,DISCOMFORT,131
FR,HYPOKINESIA,131
FR,BLOOD LACTIC ACID INCREASED,130
FR,METASTASES TO LIVER,130
FR,MITRAL VALVE INCOMPETENCE,130
FR,EYE DISORDER,129
FR,JAUNDICE CHOLESTATIC,129
FR,PERIPHERAL SENSORY NEUROPATHY,129
FR,ERYTHEMA MULTIFORME,128
FR,HYPOFIBRINOGENAEMIA,128
FR,OPTIC NEURITIS,128
FR,PYELONEPHRITIS ACUTE,128
FR,TUBERCULOSIS,128
FR,CHEILITIS,127
FR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,127
FR,PARALYSIS,127
FR,ABDOMINAL PAIN LOWER,126
FR,THROMBOPHLEBITIS,126
FR,ABNORMAL WEIGHT GAIN,125
FR,GRAFT VERSUS HOST DISEASE,125
FR,HAEMORRHAGE INTRACRANIAL,125
FR,HYPERCHOLESTEROLAEMIA,125
FR,NEONATAL RESPIRATORY DISTRESS SYNDROME,125
FR,PARKINSONISM,125
FR,THERAPEUTIC RESPONSE DECREASED,125
FR,TORSADE DE POINTES,125
FR,DYSAESTHESIA,124
FR,INTRACRANIAL PRESSURE INCREASED,124
FR,LUNG NEOPLASM MALIGNANT,124
FR,PERSECUTORY DELUSION,124
FR,ADRENAL INSUFFICIENCY,123
FR,BLOOD LACTATE DEHYDROGENASE INCREASED,123
FR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,123
FR,HAEMATOCHEZIA,123
FR,HYPERNATRAEMIA,123
FR,TOOTH ABSCESS,123
FR,ANGER,122
FR,APHTHOUS ULCER,122
FR,EYE IRRITATION,122
FR,LOW BIRTH WEIGHT BABY,121
FR,MENORRHAGIA,121
FR,PRURIGO,121
FR,EAR INFECTION,120
FR,HEPATITIS C,120
FR,IMPAIRED HEALING,120
FR,MIDDLE INSOMNIA,119
FR,SENSE OF OPPRESSION,119
FR,APLASTIC ANAEMIA,118
FR,ENDOCARDITIS,118
FR,FOLLICULITIS,118
FR,FRACTURE,118
FR,GASTROINTESTINAL PAIN,118
FR,LIVEDO RETICULARIS,118
FR,POOR QUALITY SLEEP,118
FR,PSYCHIATRIC DECOMPENSATION,118
FR,DRUG USE DISORDER,117
FR,MOBILITY DECREASED,117
FR,RIB FRACTURE,117
FR,THROMBOPHLEBITIS SUPERFICIAL,117
FR,BLOOD GLUCOSE INCREASED,116
FR,BRAIN OEDEMA,116
FR,CARDIOTOXICITY,116
FR,JOINT SWELLING,116
FR,RED BLOOD CELL COUNT DECREASED,116
FR,VISUAL FIELD DEFECT,116
FR,ACUTE HEPATIC FAILURE,115
FR,BUNDLE BRANCH BLOCK RIGHT,115
FR,CARDIAC MURMUR,115
FR,HEPATIC FUNCTION ABNORMAL,115
FR,POLYURIA,115
FR,ASPERGILLUS INFECTION,114
FR,ASTHMATIC CRISIS,114
FR,B-CELL LYMPHOMA,114
FR,EXTRASYSTOLES,114
FR,HYPOGLYCAEMIC COMA,114
FR,LOCALISED OEDEMA,114
FR,NEUROTOXICITY,114
FR,ORGANISING PNEUMONIA,114
FR,PSEUDOMONAS INFECTION,114
FR,CARDIAC FAILURE ACUTE,113
FR,CHOLANGITIS,113
FR,INJECTION SITE REACTION,113
FR,PARTIAL SEIZURES,113
FR,ANAEMIA MACROCYTIC,112
FR,DIVERTICULITIS,112
FR,EATING DISORDER,112
FR,ESCHERICHIA SEPSIS,112
FR,FEMORAL NECK FRACTURE,112
FR,PHARYNGEAL OEDEMA,112
FR,PRESCRIBED UNDERDOSE,112
FR,RESPIRATORY ARREST,112
FR,ROAD TRAFFIC ACCIDENT,112
FR,TYPE 2 DIABETES MELLITUS,112
FR,VENTRICULAR EXTRASYSTOLES,112
FR,BICYTOPENIA,111
FR,UNEVALUABLE EVENT,111
FR,BACTERAEMIA,110
FR,LARGE INTESTINE PERFORATION,110
FR,NECROSIS,110
FR,SALIVARY HYPERSECRETION,110
FR,ADENOCARCINOMA OF COLON,109
FR,FAECES DISCOLOURED,109
FR,HIRSUTISM,108
FR,KAPOSI^S SARCOMA,108
FR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,108
FR,NYSTAGMUS,108
FR,PNEUMONITIS,108
FR,SARCOIDOSIS,108
FR,TROPONIN INCREASED,108
FR,TUMOUR LYSIS SYNDROME,108
FR,CHOLECYSTITIS,107
FR,DEVICE DISLOCATION,107
FR,MENINGITIS ASEPTIC,107
FR,OLIGOHYDRAMNIOS,107
FR,RALES,107
FR,THROMBOCYTOSIS,107
FR,AUTOIMMUNE HAEMOLYTIC ANAEMIA,106
FR,EMBOLISM,106
FR,ESCHERICHIA INFECTION,106
FR,LEUKOENCEPHALOPATHY,106
FR,PAIN IN JAW,106
FR,RESPIRATORY DEPRESSION,106
FR,DIARRHOEA HAEMORRHAGIC,105
FR,LANGUAGE DISORDER,105
FR,PULMONARY ALVEOLAR HAEMORRHAGE,105
FR,SPEECH DISORDER DEVELOPMENTAL,105
FR,INCOHERENT,104
FR,LARYNGEAL OEDEMA,104
FR,THERAPY CESSATION,104
FR,CLOSTRIDIUM DIFFICILE INFECTION,103
FR,RENAL DISORDER,103
FR,CORONARY ARTERY STENOSIS,102
FR,DEVELOPMENTAL DELAY,102
FR,HODGKIN^S DISEASE,102
FR,BRONCHOPNEUMONIA,101
FR,CARDIAC TAMPONADE,101
FR,CENTRAL NERVOUS SYSTEM LESION,101
FR,HAEMARTHROSIS,101
FR,HEPARIN-INDUCED THROMBOCYTOPENIA,101
FR,INVASIVE DUCTAL BREAST CARCINOMA,101
FR,METASTASES TO BONE,101
FR,MOVEMENT DISORDER,101
FR,ODYNOPHAGIA,101
FR,SPLENOMEGALY,101
FR,WOUND,101
FR,RENAL FAILURE CHRONIC,100
FR,TALIPES,100
FR,UNDERDOSE,100
FR,EMOTIONAL DISORDER,99
FR,GLAUCOMA,99
FR,VAGINAL HAEMORRHAGE,99
FR,VIRAL INFECTION,99
FR,BACTERIAL SEPSIS,98
FR,DRUG EFFECT DECREASED,98
FR,ENTERITIS,98
FR,FOETAL ANTICONVULSANT SYNDROME,98
FR,LUPUS-LIKE SYNDROME,98
FR,MYOCARDIAL ISCHAEMIA,98
FR,NEUROLOGICAL DECOMPENSATION,98
FR,THROAT IRRITATION,98
FR,THROMBOCYTOPENIC PURPURA,98
FR,TOXIC ENCEPHALOPATHY,98
FR,COAGULOPATHY,97
FR,KERATITIS,97
FR,LACRIMATION INCREASED,97
FR,METASTASES TO CENTRAL NERVOUS SYSTEM,97
FR,RESTLESS LEGS SYNDROME,97
FR,SERUM SICKNESS,97
FR,AGEUSIA,96
FR,BUNDLE BRANCH BLOCK LEFT,96
FR,CYSTITIS,96
FR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,96
FR,FEELING DRUNK,96
FR,HAEMOLYTIC URAEMIC SYNDROME,96
FR,HAEMORRHOIDS,96
FR,ILL-DEFINED DISORDER,96
FR,POLYARTHRITIS,96
FR,SKIN INFECTION,96
FR,SKIN PLAQUE,96
FR,CHOKING,95
FR,CHROMATURIA,95
FR,LEFT VENTRICULAR DYSFUNCTION,95
FR,LEFT VENTRICULAR FAILURE,95
FR,MYOSITIS,95
FR,PROSTATITIS,95
FR,RAYNAUD^S PHENOMENON,95
FR,STRESS CARDIOMYOPATHY,95
FR,THIRST,95
FR,ABASIA,94
FR,CLONUS,94
FR,LYMPHOMA,94
FR,MACULAR OEDEMA,94
FR,PRERENAL FAILURE,94
FR,SENSORY LOSS,94
FR,ALCOHOL ABUSE,93
FR,BRONCHIOLITIS,93
FR,COMPLICATION ASSOCIATED WITH DEVICE,93
FR,CONTUSION,93
FR,CUTANEOUS LUPUS ERYTHEMATOSUS,93
FR,ESCHERICHIA URINARY TRACT INFECTION,93
FR,OSTEITIS,93
FR,PAPILLOEDEMA,93
FR,SUPRAVENTRICULAR TACHYCARDIA,93
FR,CARDIOVASCULAR DISORDER,92
FR,CATATONIA,92
FR,HEART DISEASE CONGENITAL,92
FR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,92
FR,PSYCHIATRIC SYMPTOM,92
FR,TENDON DISORDER,92
FR,TYPE I HYPERSENSITIVITY,92
FR,DERMATITIS,91
FR,DYSPAREUNIA,91
FR,MICROCYTIC ANAEMIA,91
FR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,90
FR,INJURY,90
FR,LUNG ADENOCARCINOMA,90
FR,POISONING,90
FR,RHINORRHOEA,90
FR,ATRIOVENTRICULAR BLOCK FIRST DEGREE,89
FR,BLOOD TRIGLYCERIDES INCREASED,89
FR,BLOOD UREA INCREASED,89
FR,CACHEXIA,89
FR,EOSINOPHIL COUNT INCREASED,89
FR,GRAND MAL CONVULSION,89
FR,HYDROCEPHALUS,89
FR,OCULAR HYPERAEMIA,89
FR,ACIDOSIS,88
FR,AUTOIMMUNE HEPATITIS,88
FR,DRUG EFFECT INCOMPLETE,88
FR,DUODENAL ULCER,88
FR,MUSCLE RIGIDITY,88
FR,COMA SCALE ABNORMAL,87
FR,LYMPHOCYTE COUNT DECREASED,87
FR,VENTRICULAR SEPTAL DEFECT,87
FR,ABDOMINAL WALL HAEMATOMA,86
FR,AXONAL NEUROPATHY,86
FR,DERMO-HYPODERMITIS,86
FR,ELECTROCARDIOGRAM ABNORMAL,86
FR,GROWTH RETARDATION,86
FR,MULTIPLE SCLEROSIS,86
FR,PHARYNGITIS,86
FR,PORTAL HYPERTENSION,86
FR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,85
FR,APNOEA,85
FR,BRONCHOPNEUMOPATHY,85
FR,RETINAL VEIN OCCLUSION,85
FR,SPINAL FRACTURE,85
FR,SQUAMOUS CELL CARCINOMA OF SKIN,85
FR,CEREBRAL ISCHAEMIA,84
FR,DERMATITIS ALLERGIC,84
FR,EXPOSURE DURING BREAST FEEDING,84
FR,HAEMOTHORAX,84
FR,HIATUS HERNIA,84
FR,LEARNING DISORDER,84
FR,LIPODYSTROPHY ACQUIRED,84
FR,NEUTROPHIL COUNT INCREASED,84
FR,PRE-ECLAMPSIA,84
FR,SPINAL PAIN,84
FR,WHEEZING,84
FR,CONTRAINDICATED PRODUCT ADMINISTERED,83
FR,DRUG WITHDRAWAL SYNDROME NEONATAL,83
FR,HAEMOLYSIS,83
FR,ATRIAL FLUTTER,82
FR,FOOT DEFORMITY,82
FR,HYPOTONIA NEONATAL,82
FR,INGUINAL HERNIA,82
FR,LICHENOID KERATOSIS,82
FR,MENINGORRHAGIA,82
FR,ABDOMINAL DISCOMFORT,81
FR,BLOOD PRESSURE ABNORMAL,81
FR,GOUT,81
FR,KIDNEY TRANSPLANT REJECTION,81
FR,MUSCULOSKELETAL CHEST PAIN,81
FR,SUPERINFECTION,81
FR,ACCIDENTAL EXPOSURE TO PRODUCT,80
FR,GASTRIC DISORDER,80
FR,ORAL CANDIDIASIS,80
FR,RESPIRATORY ACIDOSIS,80
FR,RESPIRATORY TRACT INFECTION,80
FR,SJOGREN^S SYNDROME,80
FR,DYSTONIA,79
FR,PROTHROMBIN LEVEL DECREASED,79
FR,TONSILLITIS,79
FR,BACTERIAL INFECTION,78
FR,CARDIOMEGALY,78
FR,CONGENITAL ANOMALY,78
FR,ELECTROENCEPHALOGRAM ABNORMAL,78
FR,FEEDING DISORDER,78
FR,GRAFT LOSS,78
FR,LYMPHOCYTOSIS,78
FR,PARADOXICAL DRUG REACTION,78
FR,RIGHT VENTRICULAR FAILURE,78
FR,SINOATRIAL BLOCK,78
FR,VULVOVAGINAL MYCOTIC INFECTION,78
FR,DEMENTIA,77
FR,DIABETIC KETOACIDOSIS,77
FR,DIVERTICULUM INTESTINAL,77
FR,EYELID PTOSIS,77
FR,GLOMERULAR FILTRATION RATE DECREASED,77
FR,HYPERSOMNIA,77
FR,IMPAIRED WORK ABILITY,77
FR,LARYNGEAL DISCOMFORT,77
FR,PNEUMOPERITONEUM,77
FR,SUBCUTANEOUS ABSCESS,77
FR,ADNEXA UTERI PAIN,76
FR,ARTHRITIS BACTERIAL,76
FR,INJECTION SITE INDURATION,76
FR,MONOPLEGIA,76
FR,PERIPHERAL COLDNESS,76
FR,RETROPERITONEAL HAEMATOMA,76
FR,THYROID DISORDER,76
FR,UPPER RESPIRATORY TRACT INFECTION,76
FR,CYTOPENIA,75
FR,FEELING JITTERY,75
FR,GYNAECOMASTIA,75
FR,METASTASES TO LUNG,75
FR,NEOPLASM,75
FR,TENDON PAIN,75
FR,TONIC CLONIC MOVEMENTS,75
FR,VASOPLEGIA SYNDROME,75
FR,ACUTE LYMPHOCYTIC LEUKAEMIA,74
FR,ASPIRATION,74
FR,CARDIAC FAILURE CONGESTIVE,74
FR,EYE MOVEMENT DISORDER,74
FR,INTELLECTUAL DISABILITY,74
FR,KLEBSIELLA INFECTION,74
FR,PARKINSON^S DISEASE,74
FR,PLATELET COUNT INCREASED,74
FR,PROTHROMBIN TIME RATIO DECREASED,74
FR,RENAL PAIN,74
FR,RESTLESSNESS,74
FR,ATRIAL SEPTAL DEFECT,73
FR,DEAFNESS UNILATERAL,73
FR,GASTROINTESTINAL TOXICITY,73
FR,HERPES VIRUS INFECTION,73
FR,HIDRADENITIS,73
FR,HYPERAESTHESIA,73
FR,ORAL HERPES,73
FR,PETIT MAL EPILEPSY,73
FR,SCHIZOPHRENIA,73
FR,CHOLECYSTITIS ACUTE,72
FR,ENURESIS,72
FR,EYE HAEMORRHAGE,72
FR,HEART RATE DECREASED,72
FR,NECROTISING FASCIITIS,72
FR,OBSESSIVE-COMPULSIVE DISORDER,72
FR,ORAL FUNGAL INFECTION,72
FR,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,72
FR,CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY,71
FR,CORONARY ARTERY DISEASE,71
FR,MOUTH HAEMORRHAGE,71
FR,POTENTIATING DRUG INTERACTION,71
FR,SMALL INTESTINAL OBSTRUCTION,71
FR,APHTHOUS STOMATITIS,70
FR,AUTISM SPECTRUM DISORDER,70
FR,DERMATITIS PSORIASIFORM,70
FR,DRUG LEVEL ABOVE THERAPEUTIC,70
FR,HYPERKERATOSIS,70
FR,HYPERLIPASAEMIA,70
FR,HYPOCHLORAEMIA,70
FR,MENINGITIS,70
FR,MIGRAINE WITH AURA,70
FR,TOOTH DISORDER,70
FR,CONDUCTION DISORDER,69
FR,GUILLAIN-BARRE SYNDROME,69
FR,IMPULSE-CONTROL DISORDER,69
FR,INTRAVENTRICULAR HAEMORRHAGE,69
FR,PORTAL VEIN THROMBOSIS,69
FR,PREMATURE LABOUR,69
FR,SPINAL COMPRESSION FRACTURE,69
FR,VARICES OESOPHAGEAL,69
FR,VENOOCCLUSIVE LIVER DISEASE,69
FR,VENTRICULAR HYPOKINESIA,69
FR,ANAL ABSCESS,68
FR,ANAPHYLACTOID REACTION,68
FR,COLON CANCER,68
FR,COORDINATION ABNORMAL,68
FR,FOETAL DISTRESS SYNDROME,68
FR,GENITAL HAEMORRHAGE,68
FR,IMPAIRED DRIVING ABILITY,68
FR,INFARCTION,68
FR,INTESTINAL PERFORATION,68
FR,LIP SWELLING,68
FR,SUBCUTANEOUS HAEMATOMA,68
FR,THROAT TIGHTNESS,68
FR,VENOOCCLUSIVE DISEASE,68
FR,ANKYLOSING SPONDYLITIS,67
FR,BREAST CYST,67
FR,EXPOSURE VIA FATHER,67
FR,HEAD DISCOMFORT,67
FR,IMPATIENCE,67
FR,LYMPHOEDEMA,67
FR,MULTIPLE CONGENITAL ABNORMALITIES,67
FR,POST PROCEDURAL HAEMORRHAGE,67
FR,PULMONARY TUBERCULOSIS,67
FR,AUTISM,66
FR,CYST,66
FR,DEPRESSIVE SYMPTOM,66
FR,DISINHIBITION,66
FR,DYSGRAPHIA,66
FR,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,66
FR,GASTROINTESTINAL NECROSIS,66
FR,HYPERCAPNIA,66
FR,INTERVERTEBRAL DISC PROTRUSION,66
FR,MENINGIOMA,66
GF,PARADOXICAL DRUG REACTION,7
GF,CONDITION AGGRAVATED,4
GF,EXPOSURE DURING PREGNANCY,3
GF,HAEMORRHAGIC TRANSFORMATION STROKE,3
GF,CARDIAC FAILURE ACUTE,2
GF,OLIGURIA,2
GF,BRADYCARDIA FOETAL,1
GF,CIRCULATORY COLLAPSE,1
GF,MYCOBACTERIUM ULCERANS INFECTION,1
GF,SUICIDE ATTEMPT,1
PF,DERMATOPHYTOSIS,1
PF,HEPATITIS E,1
GA,DRUG RESISTANCE,10
GA,VIRAL MUTATION IDENTIFIED,10
GA,DEATH,5
GA,ALVEOLITIS,3
GA,ASTHENIA,2
GA,BLOOD HIV RNA INCREASED,2
GA,DRUG INEFFECTIVE,2
GA,NERVOUS SYSTEM DISORDER,2
GA,NEUROLOGICAL SYMPTOM,2
GA,PNEUMONIA,2
GA,SHOCK,2
GA,ABORTION,1
GA,AMNESIA,1
GA,ANAEMIA,1
GA,BLINDNESS,1
GA,CHOLESTASIS,1
GA,COAGULOPATHY,1
GA,COUGH,1
GA,DIZZINESS,1
GA,DYSPNOEA,1
GA,ENCEPHALOPATHY,1
GA,GENERAL PHYSICAL HEALTH DETERIORATION,1
GA,HAEMATEMESIS,1
GA,HEADACHE,1
GA,HEPATIC ENCEPHALOPATHY,1
GA,HEPATITIS TOXIC,1
GA,HYPERSENSITIVITY,1
GA,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
GA,INDUCED ABORTION HAEMORRHAGE,1
GA,INTERSTITIAL LUNG DISEASE,1
GA,LUNG DISORDER,1
GA,MALARIA,1
GA,MATERNAL EXPOSURE DURING PREGNANCY,1
GA,PRODUCT USE ISSUE,1
GA,RALES,1
GA,RENAL FAILURE,1
GA,RESPIRATORY FAILURE,1
GA,ROAD TRAFFIC ACCIDENT,1
GA,SEIZURE,1
GM,FOETAL EXPOSURE DURING PREGNANCY,4
GM,LOW BIRTH WEIGHT BABY,4
GM,PAIN,3
GM,ABASIA,2
GM,ASTHENIA,2
GM,GAIT DISTURBANCE,2
GM,JOINT SWELLING,2
GM,MUSCULAR WEAKNESS,2
GM,TENDON DISORDER,2
GM,ABORTION SPONTANEOUS,1
GM,DRUG DOSE OMISSION,1
GM,MATERNAL EXPOSURE DURING PREGNANCY,1
GM,PSORIATIC ARTHROPATHY,1
GM,VAGINAL HAEMORRHAGE,1
GE,DEATH,64
GE,HEPATIC CIRRHOSIS,38
GE,PULMONARY TUBERCULOSIS,11
GE,HEPATITIS,9
GE,PNEUMONIA,9
GE,VOMITING,9
GE,ASTHENIA,8
GE,DRUG INEFFECTIVE,8
GE,FOETAL EXPOSURE DURING PREGNANCY,8
GE,RESPIRATORY FAILURE,8
GE,ANAEMIA,7
GE,ASCITES,7
GE,ENCEPHALOPATHY,7
GE,HEPATIC FAILURE,7
GE,ABORTION SPONTANEOUS,6
GE,CARDIAC FAILURE,6
GE,ELECTROCARDIOGRAM QT PROLONGED,6
GE,HEPATITIS C,6
GE,NAUSEA,6
GE,OESOPHAGEAL VARICES HAEMORRHAGE,6
GE,OVERDOSE,6
GE,THROMBOCYTOPENIA,6
GE,TREMOR,6
GE,ACUTE HEPATIC FAILURE,5
GE,DYSPNOEA,5
GE,HYPERBILIRUBINAEMIA,5
GE,MATERNAL EXPOSURE DURING PREGNANCY,5
GE,RENAL FAILURE,5
GE,HEADACHE,4
GE,HEPATOTOXICITY,4
GE,HYPERSENSITIVITY,4
GE,NEONATAL LUPUS ERYTHEMATOSUS,4
GE,PULMONARY EMBOLISM,4
GE,PYREXIA,4
GE,THROMBOCYTOSIS,4
GE,TREATMENT FAILURE,4
GE,ACUTE KIDNEY INJURY,3
GE,ANXIETY,3
GE,CHOLELITHIASIS,3
GE,COLITIS,3
GE,COMPLETED SUICIDE,3
GE,DISEASE PROGRESSION,3
GE,EXPOSURE DURING PREGNANCY,3
GE,INFLUENZA LIKE ILLNESS,3
GE,LACTIC ACIDOSIS,3
GE,LEUKOPENIA,3
GE,LUNG NEOPLASM MALIGNANT,3
GE,MYOCARDIAL INFARCTION,3
GE,PANCYTOPENIA,3
GE,TOXICITY TO VARIOUS AGENTS,3
GE,TREATMENT NONCOMPLIANCE,3
GE,ABDOMINAL PAIN,2
GE,ABORTION SPONTANEOUS INCOMPLETE,2
GE,AGITATION,2
GE,ANGINA UNSTABLE,2
GE,APPENDICITIS,2
GE,ATRIAL FIBRILLATION,2
GE,BACK PAIN,2
GE,BACTERIAL INFECTION,2
GE,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,2
GE,BLEEDING VARICOSE VEIN,2
GE,CARDIOPULMONARY FAILURE,2
GE,CEREBROVASCULAR ACCIDENT,2
GE,COMA,2
GE,CONSTIPATION,2
GE,CORONARY ARTERY RESTENOSIS,2
GE,DECREASED APPETITE,2
GE,DEPRESSION,2
GE,DIARRHOEA,2
GE,DIZZINESS,2
GE,DRUG ABUSE,2
GE,DRUG EFFECT INCOMPLETE,2
GE,FATIGUE,2
GE,GASTRODUODENAL HAEMORRHAGE,2
GE,GENERAL PHYSICAL HEALTH DETERIORATION,2
GE,HAEMORRHAGE,2
GE,HYPERTENSION,2
GE,INFECTIOUS PLEURAL EFFUSION,2
GE,INSOMNIA,2
GE,INTENTIONAL DRUG MISUSE,2
GE,INTENTIONAL PRODUCT USE ISSUE,2
GE,LIVER TRANSPLANT,2
GE,LYMPH NODE TUBERCULOSIS,2
GE,MUSCLE SPASMS,2
GE,NEOPLASM PROGRESSION,2
GE,NEPHROPATHY TOXIC,2
GE,NERVOUS SYSTEM DISORDER,2
GE,NEUROPATHY PERIPHERAL,2
GE,OESOPHAGEAL HAEMORRHAGE,2
GE,PORTAL VEIN THROMBOSIS,2
GE,PRURITUS,2
GE,PULMONARY RESECTION,2
GE,RASH,2
GE,RASH GENERALISED,2
GE,SEPSIS,2
GE,SPEECH DISORDER DEVELOPMENTAL,2
GE,STILLBIRTH,2
GE,TRANSAMINASES INCREASED,2
GE,UNEVALUABLE EVENT,2
GE,UPPER RESPIRATORY TRACT INFECTION,2
GE,WEIGHT DECREASED,2
GE,ABDOMINAL DISTENSION,1
GE,ACCIDENT,1
GE,ACUTE CORONARY SYNDROME,1
GE,ADENOCARCINOMA OF COLON,1
GE,ALANINE AMINOTRANSFERASE INCREASED,1
GE,AMYLASE INCREASED,1
GE,ANAPHYLACTIC SHOCK,1
GE,ANGINA PECTORIS,1
GE,APPENDICECTOMY,1
GE,ARTHRALGIA,1
GE,ASPARTATE AMINOTRANSFERASE INCREASED,1
GE,ASPHYXIA,1
GE,ATRIAL FLUTTER,1
GE,BALANCE DISORDER,1
GE,BLOOD BILIRUBIN INCREASED,1
GE,BLOOD LACTATE DEHYDROGENASE INCREASED,1
GE,BLOOD PRESSURE INCREASED,1
GE,BLOOD SODIUM DECREASED,1
GE,BLOOD URINE PRESENT,1
GE,BONE PAIN,1
GE,BRONCHOSPASM,1
GE,BURN INFECTION,1
GE,CARDIAC ARREST,1
GE,CARDIAC DISORDER,1
GE,CARDIAC FAILURE CHRONIC,1
GE,CARDIOGENIC SHOCK,1
GE,CELLULITIS,1
GE,CEREBRAL CIRCULATORY FAILURE,1
GE,CEREBRAL HAEMORRHAGE,1
GE,CERVICAL DILATATION,1
GE,CHOLECYSTITIS ACUTE,1
GE,CHRONIC HEPATITIS,1
GE,CHRONIC HEPATITIS C,1
GE,CHRONIC KIDNEY DISEASE,1
GE,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
GE,CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 1,1
GE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
GE,COLON CANCER,1
GE,COMA HEPATIC,1
GE,CONCUSSION,1
GE,CONDITION AGGRAVATED,1
GE,CONGENITAL ANOMALY,1
GE,COUGH,1
GE,CYANOSIS,1
GE,DEATH NEONATAL,1
GE,DEEP VEIN THROMBOSIS,1
GE,DELIRIUM,1
GE,DERMATITIS ALLERGIC,1
GE,DIABETES MELLITUS INADEQUATE CONTROL,1
GE,DIFFUSE LARGE B-CELL LYMPHOMA,1
GE,DISORIENTATION,1
GE,DRUG ADMINISTRATION ERROR,1
GE,DRUG DOSE OMISSION,1
GE,DRUG INTOLERANCE,1
GE,DRUG RESISTANCE,1
GE,DRUG-INDUCED LIVER INJURY,1
GE,DRY SKIN,1
GE,DYSARTHRIA,1
GE,DYSHIDROTIC ECZEMA,1
GE,DYSMENORRHOEA,1
GE,EATING DISORDER,1
GE,ENTEROCOLITIS,1
GE,ENURESIS,1
GE,EPIGASTRIC DISCOMFORT,1
GE,EYE PAIN,1
GE,FACE OEDEMA,1
GE,FAECALOMA,1
GE,FEBRILE NEUTROPENIA,1
GE,FEMUR FRACTURE,1
GE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
GE,GASTRIC ULCER HAEMORRHAGE,1
GE,GASTRIC ULCER HELICOBACTER,1
GE,GASTRITIS,1
GE,GASTRITIS EROSIVE,1
GE,GASTROINTESTINAL DISORDER,1
GE,GASTROINTESTINAL HAEMORRHAGE,1
GE,GASTROINTESTINAL STROMAL TUMOUR,1
GE,GASTROOESOPHAGEAL REFLUX DISEASE,1
GE,GENERAL PHYSICAL CONDITION ABNORMAL,1
GE,GENERALISED OEDEMA,1
GE,GENOTYPE DRUG RESISTANCE TEST POSITIVE,1
GE,HAEMATEMESIS,1
GE,HAEMATURIA,1
GE,HAEMOGLOBIN DECREASED,1
GE,HAEMORRHAGE IN PREGNANCY,1
GE,HALLUCINATION,1
GE,HALLUCINATION_ VISUAL,1
GE,HEAD DISCOMFORT,1
GE,HEART RATE INCREASED,1
GE,HEPATIC ENCEPHALOPATHY,1
GE,HEPATIC ENZYME INCREASED,1
GE,HEPATITIS TOXIC,1
GE,HEPATOCELLULAR CARCINOMA,1
GE,HERPES ZOSTER,1
GE,HOSPITALISATION,1
GE,HOT FLUSH,1
GE,HYPERTENSIVE CRISIS,1
GE,HYPOAESTHESIA,1
GE,HYPOALBUMINAEMIA,1
GE,HYPOKALAEMIA,1
GE,HYPOKINESIA,1
GE,HYPOPROTEINAEMIA,1
GE,INCORRECT DOSE ADMINISTERED,1
GE,INFECTION,1
GE,INFUSION RELATED REACTION,1
GE,INSURANCE ISSUE,1
GE,INTENTIONAL OVERDOSE,1
GE,JOINT SWELLING,1
GE,LARGE INTESTINAL HAEMORRHAGE,1
GE,LERICHE SYNDROME,1
GE,LEUKOCYTOSIS,1
GE,LIPASE INCREASED,1
GE,LIPIDS ABNORMAL,1
GE,LOSS OF CONSCIOUSNESS,1
GE,LUPUS-LIKE SYNDROME,1
GE,MELAENA,1
GE,MEMORY IMPAIRMENT,1
GE,MENINGIOMA,1
GE,MENTAL STATUS CHANGES,1
GE,MIDDLE INSOMNIA,1
GE,MOOD ALTERED,1
GE,MUSCULAR WEAKNESS,1
GE,NEPHROPATHY,1
GE,NEPHROTIC SYNDROME,1
GE,NERVOUSNESS,1
GE,NEUTROPENIA,1
GE,OEDEMA,1
GE,OEDEMA PERIPHERAL,1
GE,ONCOLOGIC COMPLICATION,1
GE,ORAL MUCOSAL ERUPTION,1
GE,OSTEOARTHRITIS,1
GE,OSTEOMYELITIS,1
GE,PAIN,1
GE,PAIN IN EXTREMITY,1
GE,PANCREATITIS ACUTE,1
GE,PANCREATITIS HAEMORRHAGIC,1
GE,PARAESTHESIA,1
GE,PARALYSIS,1
GE,PARESIS,1
GE,PATERNAL EXPOSURE DURING PREGNANCY,1
GE,PERIPHERAL SENSORY NEUROPATHY,1
GE,PERIPHERAL SWELLING,1
GE,PETIT MAL EPILEPSY,1
GE,PLATELET COUNT DECREASED,1
GE,PLEURISY,1
GE,PNEUMONITIS,1
GE,PNEUMOTHORAX,1
GE,POLYNEUROPATHY,1
GE,PORTAL HYPERTENSION,1
GE,POST ABORTION HAEMORRHAGE,1
GE,PREGNANCY,1
GE,PREGNANCY ON ORAL CONTRACEPTIVE,1
GE,PROSTATE CANCER,1
GE,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
GE,PROTEINURIA,1
GE,PSYCHOTIC DISORDER,1
GE,PUPILLARY REFLEX IMPAIRED,1
GE,RECTAL HAEMORRHAGE,1
GE,REFUSAL OF TREATMENT BY PATIENT,1
GE,RENAL COLIC,1
GE,RENAL DISORDER,1
GE,RETAINED PRODUCTS OF CONCEPTION,1
GE,RETINOPATHY,1
GE,ROAD TRAFFIC ACCIDENT,1
GE,SECOND PRIMARY MALIGNANCY,1
GE,SELF-MEDICATION,1
GE,SEPTIC SHOCK,1
GE,SLOW RESPONSE TO STIMULI,1
GE,SMALL INTESTINE CARCINOMA,1
GE,SOMNOLENCE,1
GE,SPEECH DISORDER,1
GE,SQUAMOUS CELL CARCINOMA OF SKIN,1
GE,SUBARACHNOID HAEMORRHAGE,1
GE,SUBCUTANEOUS ABSCESS,1
GE,SUBSTANCE ABUSE,1
GE,SYNOVITIS,1
GE,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
GE,THERAPY CESSATION,1
GE,THROAT TIGHTNESS,1
GE,TONGUE HAEMORRHAGE,1
GE,TOXIC SHOCK SYNDROME,1
GE,TRANSAMINASES DECREASED,1
GE,TRAUMATIC HAEMORRHAGE,1
GE,TUBERCULOSIS,1
GE,URTICARIA,1
GE,UTERINE HAEMORRHAGE,1
GE,VAGINAL DISCHARGE,1
GE,VAGINAL HAEMORRHAGE,1
GE,VENTRICULAR TACHYCARDIA,1
GE,VISION BLURRED,1
GE,WEIGHT INCREASED,1
GE,WHITE BLOOD CELLS URINE POSITIVE,1
DE,DEATH,3667
DE,NAUSEA,3662
DE,DYSPNOEA,3557
DE,FATIGUE,3328
DE,DIARRHOEA,3174
DE,GENERAL PHYSICAL HEALTH DETERIORATION,3126
DE,FOETAL EXPOSURE DURING PREGNANCY,3089
DE,PNEUMONIA,3076
DE,DIZZINESS,2748
DE,PYREXIA,2608
DE,DRUG INEFFECTIVE,2438
DE,FALL,2388
DE,VOMITING,2351
DE,HEADACHE,2156
DE,ANAEMIA,1896
DE,ASTHENIA,1705
DE,THROMBOCYTOPENIA,1691
DE,ARTHRALGIA,1687
DE,PAIN,1618
DE,EXPOSURE DURING PREGNANCY,1588
DE,SEPSIS,1573
DE,WEIGHT DECREASED,1509
DE,CEREBROVASCULAR ACCIDENT,1472
DE,RENAL FAILURE,1465
DE,CARDIAC FAILURE,1432
DE,HYPERTENSION,1408
DE,RASH,1400
DE,LEUKOPENIA,1395
DE,PULMONARY EMBOLISM,1376
DE,DEPRESSION,1359
DE,PAIN IN EXTREMITY,1345
DE,MYALGIA,1342
DE,ABDOMINAL PAIN,1341
DE,PRURITUS,1311
DE,ATRIAL FIBRILLATION,1298
DE,INFECTION,1298
DE,ACUTE KIDNEY INJURY,1275
DE,GAIT DISTURBANCE,1247
DE,SYNCOPE,1152
DE,MULTIPLE SCLEROSIS RELAPSE,1127
DE,DECREASED APPETITE,1110
DE,MALIGNANT NEOPLASM PROGRESSION,1095
DE,COUGH,1080
DE,TOXICITY TO VARIOUS AGENTS,1057
DE,URINARY TRACT INFECTION,1052
DE,VISUAL IMPAIRMENT,1037
DE,ATRIAL SEPTAL DEFECT,1036
DE,MATERNAL EXPOSURE DURING PREGNANCY,1024
DE,TACHYCARDIA,1019
DE,SOMNOLENCE,992
DE,PARAESTHESIA,988
DE,MYOCARDIAL INFARCTION,986
DE,HAEMOGLOBIN DECREASED,977
DE,HYPOTENSION,969
DE,BACK PAIN,958
DE,OVERDOSE,958
DE,ERYTHEMA,935
DE,CIRCULATORY COLLAPSE,932
DE,ABDOMINAL PAIN UPPER,926
DE,RESTLESSNESS,918
DE,CONDITION AGGRAVATED,917
DE,PLEURAL EFFUSION,915
DE,HAEMORRHAGE,913
DE,HYPOAESTHESIA,910
DE,CHILLS,906
DE,ARRHYTHMIA,890
DE,DYSPHAGIA,887
DE,OSTEONECROSIS OF JAW,884
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,864
DE,NEUTROPENIA,863
DE,MALAISE,861
DE,OEDEMA PERIPHERAL,846
DE,SLEEP DISORDER,836
DE,PANCYTOPENIA,829
DE,HYPERHIDROSIS,828
DE,LOSS OF CONSCIOUSNESS,828
DE,ALOPECIA,814
DE,DEHYDRATION,808
DE,SEIZURE,804
DE,C-REACTIVE PROTEIN INCREASED,803
DE,BLOOD CREATININE INCREASED,797
DE,MUSCLE SPASMS,797
DE,ALANINE AMINOTRANSFERASE INCREASED,796
DE,CONSTIPATION,796
DE,SMALL FOR DATES BABY,790
DE,SUICIDE ATTEMPT,786
DE,TREMOR,786
DE,RESPIRATORY FAILURE,763
DE,ANXIETY,745
DE,HYPERSENSITIVITY,743
DE,EPILEPSY,741
DE,WEIGHT INCREASED,737
DE,DISTURBANCE IN ATTENTION,726
DE,PREMATURE BABY,722
DE,BLOOD PRESSURE INCREASED,710
DE,BRONCHITIS,703
DE,POLYNEUROPATHY,701
DE,HYPONATRAEMIA,695
DE,PALPITATIONS,691
DE,PRODUCT USE ISSUE,691
DE,CEREBRAL HAEMORRHAGE,687
DE,NASOPHARYNGITIS,687
DE,CHEST PAIN,685
DE,ASPARTATE AMINOTRANSFERASE INCREASED,673
DE,CONFUSIONAL STATE,672
DE,MUSCULAR WEAKNESS,667
DE,HAEMATOMA,661
DE,HEPATIC ENZYME INCREASED,648
DE,EPISTAXIS,645
DE,VERTIGO,643
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,636
DE,GASTROINTESTINAL HAEMORRHAGE,629
DE,DEEP VEIN THROMBOSIS,622
DE,THROMBOSIS,613
DE,GESTATIONAL DIABETES,609
DE,CEREBRAL INFARCTION,607
DE,SUICIDAL IDEATION,599
DE,CARDIOVASCULAR DISORDER,598
DE,DISEASE PROGRESSION,597
DE,HYPOKALAEMIA,590
DE,ABORTION SPONTANEOUS,586
DE,HYPERTENSIVE CRISIS,586
DE,IMPAIRED HEALING,579
DE,RENAL FAILURE ACUTE,578
DE,TRANSAMINASES INCREASED,577
DE,FEBRILE NEUTROPENIA,561
DE,LACTIC ACIDOSIS,556
DE,RHEUMATOID ARTHRITIS,551
DE,INSOMNIA,548
DE,CARDIAC ARREST,539
DE,MUCOSAL INFLAMMATION,538
DE,ANGINA PECTORIS,531
DE,HEPATIC FAILURE,513
DE,OSTEOARTHRITIS,508
DE,GASTROINTESTINAL DISORDER,502
DE,INTENTIONAL OVERDOSE,499
DE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,497
DE,RHABDOMYOLYSIS,497
DE,CROHN^S DISEASE,487
DE,RENAL IMPAIRMENT,487
DE,OEDEMA,486
DE,PERIPHERAL SWELLING,479
DE,URTICARIA,476
DE,BLOOD GLUCOSE INCREASED,473
DE,CHEST DISCOMFORT,469
DE,NEONATAL RESPIRATORY DISTRESS SYNDROME,467
DE,GASTRITIS,466
DE,STOMATITIS,465
DE,DRUG INTOLERANCE,464
DE,DIABETES MELLITUS,458
DE,BREAST CANCER,456
DE,INFLAMMATION,456
DE,HEMIPARESIS,455
DE,ASCITES,451
DE,MULTI-ORGAN FAILURE,448
DE,PSYCHOTIC DISORDER,447
DE,APHASIA,446
DE,ILEUS,446
DE,AGGRESSION,443
DE,CARDIAC DISORDER,443
DE,PANCREATITIS,442
DE,INTERVERTEBRAL DISC PROTRUSION,439
DE,COMA,435
DE,FLUSHING,435
DE,VENTRICULAR SEPTAL DEFECT,435
DE,DISORIENTATION,434
DE,MEMORY IMPAIRMENT,432
DE,VISUAL ACUITY REDUCED,432
DE,LIVER FUNCTION TEST ABNORMAL,429
DE,ACUTE MYOCARDIAL INFARCTION,426
DE,ABDOMINAL DISCOMFORT,422
DE,VISION BLURRED,421
DE,INFLUENZA LIKE ILLNESS,418
DE,DELIRIUM,417
DE,HERPES ZOSTER,417
DE,RESPIRATORY DISORDER NEONATAL,416
DE,PSORIASIS,414
DE,AGITATION,407
DE,ISCHAEMIC STROKE,406
DE,PRODUCT USE IN UNAPPROVED INDICATION,404
DE,WHITE BLOOD CELL COUNT DECREASED,404
DE,COMPLETED SUICIDE,403
DE,JAUNDICE,403
DE,COLITIS,402
DE,BLOOD BILIRUBIN INCREASED,400
DE,ARTHROPATHY,398
DE,RESPIRATORY DISTRESS,397
DE,CORONARY ARTERY DISEASE,396
DE,PULMONARY OEDEMA,396
DE,SEPTIC SHOCK,396
DE,BASAL CELL CARCINOMA,395
DE,ELECTROCARDIOGRAM QT PROLONGED,394
DE,PANIC ATTACK,393
DE,ANGIOEDEMA,392
DE,DRUG-INDUCED LIVER INJURY,390
DE,PNEUMONITIS,390
DE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,386
DE,MULTIPLE SCLEROSIS,383
DE,PATENT DUCTUS ARTERIOSUS,383
DE,BLOOD PRESSURE DECREASED,382
DE,DRY MOUTH,378
DE,MOBILITY DECREASED,378
DE,DYSARTHRIA,375
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,374
DE,SPEECH DISORDER,372
DE,CYSTITIS,370
DE,PLATELET COUNT DECREASED,368
DE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,367
DE,HAEMATOCHEZIA,362
DE,ACUTE HEPATIC FAILURE,361
DE,HALLUCINATION,361
DE,HOSPITALISATION,359
DE,BRADYCARDIA,358
DE,TINNITUS,356
DE,CHOLELITHIASIS,355
DE,DRUG EFFECT DECREASED,355
DE,URINARY RETENTION,351
DE,HYPOGLYCAEMIA,350
DE,CAESAREAN SECTION,349
DE,CONVULSION,349
DE,SKIN DISORDER,347
DE,HEART RATE INCREASED,342
DE,FEELING ABNORMAL,341
DE,JOINT SWELLING,341
DE,DYSPNOEA EXERTIONAL,337
DE,TRANSIENT ISCHAEMIC ATTACK,336
DE,SWELLING FACE,333
DE,DYSGEUSIA,331
DE,BONE PAIN,328
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,327
DE,BALANCE DISORDER,320
DE,DYSPEPSIA,316
DE,HAEMATURIA,315
DE,MENTAL DISORDER,312
DE,ABSCESS,308
DE,METASTASES TO LIVER,308
DE,MUSCULOSKELETAL STIFFNESS,308
DE,CATARACT,303
DE,COGNITIVE DISORDER,302
DE,CONTUSION,302
DE,ERYSIPELAS,300
DE,ANAPHYLACTIC SHOCK,299
DE,GASTROENTERITIS,298
DE,MUSCULOSKELETAL PAIN,297
DE,DEPRESSED MOOD,295
DE,PRESCRIBED UNDERDOSE,293
DE,WHITE BLOOD CELL COUNT INCREASED,289
DE,INTESTINAL STENOSIS,288
DE,LYMPHADENOPATHY,288
DE,DIVERTICULITIS,286
DE,DRUG ABUSE,286
DE,ANAPHYLACTIC REACTION,284
DE,ABDOMINAL DISTENSION,282
DE,GENERALISED TONIC-CLONIC SEIZURE,281
DE,APATHY,277
DE,DRY SKIN,275
DE,UROSEPSIS,275
DE,DERMATITIS ALLERGIC,274
DE,PNEUMONIA ASPIRATION,273
DE,COLITIS ULCERATIVE,272
DE,RESPIRATORY TRACT INFECTION,272
DE,ASTHMA,271
DE,ADVERSE EVENT,270
DE,HYPERKALAEMIA,270
DE,PERICARDIAL EFFUSION,270
DE,ARTHRITIS,267
DE,BLOOD ALKALINE PHOSPHATASE INCREASED,266
DE,INFLUENZA,263
DE,TENDON RUPTURE,261
DE,AGRANULOCYTOSIS,259
DE,DRUG DEPENDENCE,259
DE,GASTROINTESTINAL INFLAMMATION,256
DE,INCORRECT DOSE ADMINISTERED,256
DE,OROPHARYNGEAL PAIN,256
DE,FEEDING DISORDER NEONATAL,255
DE,POST PROCEDURAL HAEMORRHAGE,251
DE,METABOLIC ACIDOSIS,250
DE,URINARY INCONTINENCE,249
DE,HEPATOTOXICITY,248
DE,TENDON PAIN,248
DE,AGITATION NEONATAL,247
DE,CEREBRAL ISCHAEMIA,246
DE,DRUG WITHDRAWAL SYNDROME NEONATAL,246
DE,HEPATIC CIRRHOSIS,245
DE,ROAD TRAFFIC ACCIDENT,245
DE,MELAENA,244
DE,PROSTATE CANCER,244
DE,DRUG WITHDRAWAL SYNDROME,243
DE,LEUKOCYTOSIS,243
DE,NEUROPATHY PERIPHERAL,242
DE,PERITONITIS,242
DE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,242
DE,PULMONARY FIBROSIS,241
DE,OXYGEN SATURATION DECREASED,240
DE,LIVER DISORDER,239
DE,BRADYCARDIA NEONATAL,238
DE,PREGNANCY,238
DE,HYPOTHYROIDISM,236
DE,DEVICE DISLOCATION,235
DE,INFLAMMATORY MARKER INCREASED,235
DE,HYPOSPADIAS,234
DE,CYTOMEGALOVIRUS INFECTION,232
DE,HOT FLUSH,231
DE,PULMONARY HYPERTENSION,231
DE,SPINAL FRACTURE,231
DE,SURGERY,231
DE,HYPERGLYCAEMIA,230
DE,ACUTE MYELOID LEUKAEMIA,228
DE,FISTULA,226
DE,GASTRIC ULCER,226
DE,HYPOTONIA,225
DE,STAPHYLOCOCCAL INFECTION,225
DE,ECZEMA,224
DE,NEOPLASM MALIGNANT,224
DE,PARKINSON^S DISEASE,224
DE,ATAXIA,222
DE,SUBDURAL HAEMATOMA,221
DE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,220
DE,INTERSTITIAL LUNG DISEASE,220
DE,MYELODYSPLASTIC SYNDROME,219
DE,RASH GENERALISED,219
DE,SWOLLEN TONGUE,219
DE,FOOT DEFORMITY,218
DE,LOW BIRTH WEIGHT BABY,216
DE,BLISTER,215
DE,CHOLESTASIS,215
DE,RASH PUSTULAR,215
DE,ABDOMINAL PAIN LOWER,214
DE,SKIN ULCER,214
DE,FEMORAL NECK FRACTURE,213
DE,GASTROOESOPHAGEAL REFLUX DISEASE,213
DE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,213
DE,METASTASES TO BONE,211
DE,HAEMORRHAGE INTRACRANIAL,210
DE,SKIN REACTION,210
DE,GLOMERULAR FILTRATION RATE DECREASED,209
DE,PRURITUS GENERALISED,209
DE,FEELING HOT,208
DE,FLATULENCE,208
DE,NIGHT SWEATS,208
DE,PREMATURE RUPTURE OF MEMBRANES,208
DE,PRODUCT QUALITY ISSUE,208
DE,SYSTEMIC LUPUS ERYTHEMATOSUS,208
DE,LUNG DISORDER,207
DE,LYMPHOPENIA,207
DE,TOOTH DISORDER,207
DE,DYSURIA,206
DE,INTESTINAL HAEMORRHAGE,206
DE,HYPOGLYCAEMIA NEONATAL,205
DE,HYPERKINESIA,204
DE,DEMENTIA,203
DE,LIPASE INCREASED,203
DE,LIVER FUNCTION TEST INCREASED,203
DE,ABORTION INDUCED,202
DE,HAEMATOTOXICITY,202
DE,NO ADVERSE EVENT,201
DE,SKIN EXFOLIATION,201
DE,UNDERDOSE,201
DE,NEPHROLITHIASIS,200
DE,CARDIOGENIC SHOCK,199
DE,DIPLOPIA,199
DE,INJECTION SITE ERYTHEMA,199
DE,SWELLING,199
DE,TYPE 2 DIABETES MELLITUS,199
DE,BRAIN OEDEMA,198
DE,VENTRICULAR TACHYCARDIA,198
DE,EMBOLISM,197
DE,FEELING COLD,197
DE,INGUINAL HERNIA,197
DE,PLASMA CELL MYELOMA,197
DE,SENSORY DISTURBANCE,197
DE,STRESS,197
DE,HAEMOPTYSIS,196
DE,HEPATIC STEATOSIS,196
DE,DYSPHONIA,195
DE,LYMPHOCYTE COUNT DECREASED,195
DE,RASH MACULO-PAPULAR,195
DE,OSTEONECROSIS,193
DE,BODY TEMPERATURE INCREASED,192
DE,METASTASES TO CENTRAL NERVOUS SYSTEM,192
DE,OSTEOPOROSIS,192
DE,HEPATITIS,191
DE,COAGULOPATHY,190
DE,HYPERTHYROIDISM,189
DE,OLIGOHYDRAMNIOS,189
DE,DEVICE RELATED INFECTION,188
DE,HYPOTONIA NEONATAL,188
DE,NERVOUS SYSTEM DISORDER,188
DE,UPPER GASTROINTESTINAL HAEMORRHAGE,188
DE,LIMB DISCOMFORT,187
DE,PREMATURE DELIVERY,187
DE,SINUSITIS,187
DE,GLAUCOMA,186
DE,KETOACIDOSIS,186
DE,RIB FRACTURE,186
DE,CARDIOMYOPATHY,185
DE,DYSKINESIA,185
DE,LACERATION,185
DE,MYOCLONUS,184
DE,MOVEMENT DISORDER,183
DE,ATYPICAL PNEUMONIA,182
DE,DRUG LEVEL INCREASED,182
DE,UPPER RESPIRATORY TRACT INFECTION,182
DE,ANAL FISTULA,181
DE,EXPOSURE DURING BREAST FEEDING,181
DE,INJECTION SITE PAIN,181
DE,VAGINAL HAEMORRHAGE,181
DE,VENTRICULAR FIBRILLATION,181
DE,DRUG EFFECT INCOMPLETE,180
DE,DEPRESSED LEVEL OF CONSCIOUSNESS,179
DE,MYOPATHY,179
DE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,179
DE,CHOLECYSTITIS,178
DE,DISEASE RECURRENCE,178
DE,PETECHIAE,176
DE,ALTERED STATE OF CONSCIOUSNESS,175
DE,FLUID RETENTION,175
DE,BURNING SENSATION,174
DE,FOETAL GROWTH RESTRICTION,174
DE,AKINESIA,173
DE,DEAFNESS,173
DE,LUNG INFILTRATION,173
DE,ABASIA,172
DE,ACTINIC KERATOSIS,172
DE,DRUG DOSE OMISSION,172
DE,FOETAL DEATH,171
DE,PROTEINURIA,171
DE,DRUG HYPERSENSITIVITY,170
DE,HYPOCALCAEMIA,170
DE,INFUSION RELATED REACTION,170
DE,SPLENOMEGALY,170
DE,HAEMANGIOMA CONGENITAL,169
DE,INCORRECT ROUTE OF DRUG ADMINISTRATION,169
DE,SUBILEUS,169
DE,VASCULITIS,169
DE,HYPOKINESIA,168
DE,MUSCLE TWITCHING,168
DE,BLOOD CHOLESTEROL INCREASED,167
DE,CARDIOVASCULAR INSUFFICIENCY,167
DE,MITRAL VALVE INCOMPETENCE,167
DE,NEOPLASM PROGRESSION,167
DE,ALVEOLITIS,166
DE,LARGE FOR DATES BABY,166
DE,CENTRAL NERVOUS SYSTEM LESION,165
DE,HAEMATEMESIS,165
DE,MALIGNANT MELANOMA,165
DE,MIGRAINE,165
DE,PARKINSONISM,165
DE,SPINAL PAIN,165
DE,OPTIC NEURITIS,164
DE,RESPIRATORY DISORDER,164
DE,SKIN DISCOLOURATION,164
DE,IRRITABILITY,163
DE,LONG QT SYNDROME,163
DE,RHINITIS,163
DE,ACCIDENTAL EXPOSURE TO PRODUCT,162
DE,CHROMATURIA,162
DE,RESTLESS LEGS SYNDROME,162
DE,ENCEPHALOPATHY,161
DE,NECK PAIN,161
DE,SECOND PRIMARY MALIGNANCY,161
DE,SQUAMOUS CELL CARCINOMA,161
DE,STATUS EPILEPTICUS,161
DE,DRUG ERUPTION,160
DE,GASTROINTESTINAL PAIN,160
DE,PRE-ECLAMPSIA,159
DE,INTESTINAL PERFORATION,158
DE,FEBRILE INFECTION,157
DE,GASTRIC HAEMORRHAGE,157
DE,LIP SWELLING,157
DE,MYOCARDITIS,157
DE,BONE MARROW FAILURE,156
DE,ENTERITIS,156
DE,HAEMOLYSIS,155
DE,HYPOXIA,155
DE,LOCAL SWELLING,155
DE,PALLOR,155
DE,WITHDRAWAL SYNDROME,155
DE,WOUND,155
DE,NIGHTMARE,154
DE,TENDONITIS,154
DE,BLINDNESS,153
DE,BLOOD TEST ABNORMAL,153
DE,CYANOSIS,153
DE,PNEUMOTHORAX,153
DE,RENAL DISORDER,152
DE,UNEVALUABLE EVENT,152
DE,EYELID OEDEMA,151
DE,METASTASES TO LUNG,151
DE,CONJUNCTIVITIS,150
DE,DRUG RESISTANCE,150
DE,UPPER LIMB FRACTURE,150
DE,HEPATIC ENCEPHALOPATHY,149
DE,RHEUMATIC DISORDER,149
DE,LUNG INFECTION,148
DE,RED BLOOD CELL COUNT DECREASED,148
DE,SINUS TACHYCARDIA,148
DE,RENAL FUNCTION TEST ABNORMAL,147
DE,INTENTIONAL PRODUCT MISUSE,146
DE,PANCREATITIS ACUTE,146
DE,PERSONALITY CHANGE,146
DE,PHARYNGEAL OEDEMA,146
DE,SUDDEN HEARING LOSS,146
DE,MOOD SWINGS,145
DE,SKIN HAEMORRHAGE,145
DE,ACUTE RESPIRATORY DISTRESS SYNDROME,144
DE,FOOT FRACTURE,144
DE,FUNGAL INFECTION,144
DE,ILEUS PARALYTIC,144
DE,PREMATURE LABOUR,144
DE,TACHYARRHYTHMIA,144
DE,AMNESIA,143
DE,INTRAOCULAR PRESSURE INCREASED,143
DE,PARALYSIS,143
DE,TALIPES,143
DE,VENTRICULAR EXTRASYSTOLES,143
DE,DIARRHOEA HAEMORRHAGIC,142
DE,FEMUR FRACTURE,142
DE,RETINAL DETACHMENT,142
DE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,142
DE,ACNE,141
DE,HYPOACUSIS,141
DE,MENORRHAGIA,141
DE,TEMPERATURE REGULATION DISORDER,141
DE,DERMATITIS,140
DE,PRODUCTIVE COUGH,140
DE,HAEMOLYTIC ANAEMIA,139
DE,ASPIRATION,138
DE,VISUAL FIELD DEFECT,138
DE,BLOOD PRESSURE FLUCTUATION,137
DE,HAEMORRHAGIC ANAEMIA,137
DE,NERVOUSNESS,137
DE,NEURALGIA,137
DE,RASH PRURITIC,137
DE,SUBARACHNOID HAEMORRHAGE,137
DE,VIRAL INFECTION,137
DE,COORDINATION ABNORMAL,136
DE,INTERNATIONAL NORMALISED RATIO INCREASED,136
DE,MEDICATION ERROR,136
DE,PHOTOSENSITIVITY REACTION,136
DE,RIGHT VENTRICULAR FAILURE,136
DE,SELECTIVE EATING DISORDER,135
DE,SHOCK,135
DE,DYSMORPHISM,134
DE,NEOPLASM,134
DE,EYE HAEMORRHAGE,133
DE,REHABILITATION THERAPY,133
DE,SKIN CANCER,133
DE,EYE SWELLING,132
DE,SEDATION,132
DE,ERECTILE DYSFUNCTION,131
DE,EXTRASYSTOLES,131
DE,MUSCULOSKELETAL DISCOMFORT,131
DE,PARTIAL SEIZURES,131
DE,ANAL ABSCESS,130
DE,BACTERIAL INFECTION,130
DE,PERIPHERAL SENSORY NEUROPATHY,130
DE,SHOCK HAEMORRHAGIC,130
DE,BLOOD URINE PRESENT,129
DE,OVARIAN CYST,129
DE,PANCREATIC CARCINOMA,129
DE,PYELONEPHRITIS,129
DE,TREATMENT NONCOMPLIANCE,129
DE,ACCIDENT,128
DE,CACHEXIA,128
DE,CONGESTIVE CARDIOMYOPATHY,128
DE,HEPATIC FUNCTION ABNORMAL,128
DE,LUMBAR VERTEBRAL FRACTURE,128
DE,DRUG ADMINISTRATION ERROR,127
DE,EJECTION FRACTION DECREASED,127
DE,FAECES DISCOLOURED,127
DE,HYPERSENSITIVITY VASCULITIS,127
DE,LIVE BIRTH,127
DE,TORSADE DE POINTES,127
DE,EYE PAIN,126
DE,FACIAL PARESIS,126
DE,AUTOIMMUNE THYROIDITIS,125
DE,CHRONIC KIDNEY DISEASE,125
DE,RESUSCITATION,125
DE,SUDDEN DEATH,125
DE,THERAPEUTIC RESPONSE DECREASED,125
DE,TONSILLITIS,125
DE,ABDOMINAL ADHESIONS,124
DE,GLYCOSYLATED HAEMOGLOBIN INCREASED,124
DE,HYPERBILIRUBINAEMIA,124
DE,NECROSIS,124
DE,AUTOIMMUNE HEPATITIS,123
DE,INJECTION SITE REACTION,123
DE,PLATELET COUNT INCREASED,123
DE,POST PROCEDURAL COMPLICATION,123
DE,ATRIAL FLUTTER,122
DE,CELLULITIS,122
DE,ACCIDENTAL OVERDOSE,121
DE,MICTURITION URGENCY,121
DE,PSORIATIC ARTHROPATHY,121
DE,TACHYPNOEA,121
DE,ABNORMAL BEHAVIOUR,120
DE,AGEUSIA,120
DE,DISCOMFORT,120
DE,HYPOPHAGIA,120
DE,MUSCLE SPASTICITY,120
DE,ACUTE CORONARY SYNDROME,119
DE,BRONCHOSPASM,119
DE,GASTROINTESTINAL INFECTION,119
DE,HEMIPLEGIA,119
DE,RENAL CYST,119
DE,RHINORRHOEA,119
DE,TREATMENT FAILURE,119
DE,BURSITIS,118
DE,CORONARY ARTERY STENOSIS,118
DE,DELUSION,118
DE,MATERNAL DRUGS AFFECTING FOETUS,118
DE,APPENDICITIS,117
DE,FRACTURE,117
DE,HYPERBILIRUBINAEMIA NEONATAL,117
DE,HYPOTHERMIA,117
DE,MENISCUS INJURY,117
DE,METASTASIS,117
DE,SKIN BURNING SENSATION,117
DE,SPINAL OSTEOARTHRITIS,117
DE,DRUG PRESCRIBING ERROR,116
DE,DUODENAL ULCER,116
DE,INCONTINENCE,116
DE,LIVER INJURY,116
DE,SKIN TOXICITY,116
DE,ANURIA,115
DE,CHOLANGITIS,115
DE,EYE DISORDER,115
DE,IRON DEFICIENCY ANAEMIA,115
DE,METASTASES TO LYMPH NODES,115
DE,MUSCLE ATROPHY,115
DE,NEUTROPHIL COUNT DECREASED,115
DE,SCIATICA,115
DE,FAECALOMA,114
DE,HEPATOCELLULAR CARCINOMA,114
DE,OCULAR HYPERAEMIA,114
DE,SALIVARY HYPERSECRETION,114
DE,SUBCUTANEOUS ABSCESS,114
DE,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,114
DE,BLOOD GLUCOSE ABNORMAL,113
DE,COLON CANCER,113
DE,HALLUCINATION_ VISUAL,113
DE,HEART RATE DECREASED,113
DE,LISTLESS,113
DE,SEROTONIN SYNDROME,113
DE,BREAST CANCER METASTATIC,112
DE,MOTOR DYSFUNCTION,112
DE,POISONING,112
DE,RESPIRATORY ARREST,112
DE,TUBULOINTERSTITIAL NEPHRITIS,112
DE,ATRIAL THROMBOSIS,111
DE,COLD SWEAT,111
DE,HEPATITIS C,111
DE,PROTHROMBIN TIME PROLONGED,111
DE,TOOTH EXTRACTION,111
DE,ADVERSE DRUG REACTION,110
DE,CRYPTORCHISM,110
DE,INTRAVENTRICULAR HAEMORRHAGE,110
DE,PROSTATIC SPECIFIC ANTIGEN INCREASED,110
DE,THROMBOPHLEBITIS,110
DE,TRICUSPID VALVE INCOMPETENCE,110
DE,BOWEN^S DISEASE,109
DE,POLLAKIURIA,109
DE,RECTAL HAEMORRHAGE,109
DE,DRY EYE,108
DE,EYE IRRITATION,108
DE,GASTRIC DISORDER,108
DE,GINGIVAL BLEEDING,108
DE,INJURY,108
DE,MENTAL IMPAIRMENT,108
DE,PNEUMOCYSTIS JIROVECII PNEUMONIA,108
DE,PRESYNCOPE,108
DE,RETINAL HAEMORRHAGE,108
DE,BRONCHIAL CARCINOMA,107
DE,EXTRAPYRAMIDAL DISORDER,107
DE,HAEMATOCRIT DECREASED,107
DE,HEAD DISCOMFORT,107
DE,PERIPHERAL COLDNESS,107
DE,TOXIC EPIDERMAL NECROLYSIS,107
DE,ANKLE FRACTURE,106
DE,CONTRAINDICATED PRODUCT ADMINISTERED,106
DE,INCORRECT DRUG ADMINISTRATION DURATION,106
DE,MATERNAL EXPOSURE BEFORE PREGNANCY,106
DE,PARESIS,106
DE,GENERALISED OEDEMA,105
DE,PULMONARY HAEMORRHAGE,105
DE,IMMUNE THROMBOCYTOPENIC PURPURA,104
DE,LEFT VENTRICULAR DYSFUNCTION,104
DE,THROAT IRRITATION,104
DE,APNOEA,103
DE,PROCEDURAL PAIN,103
DE,CARPAL TUNNEL SYNDROME,102
DE,HAEMORRHOIDS,102
DE,MYOSITIS,102
DE,ORAL CANDIDIASIS,102
DE,PRESCRIBED OVERDOSE,102
DE,SUDDEN CARDIAC DEATH,102
DE,SUPRAVENTRICULAR TACHYCARDIA,102
DE,TOOTHACHE,102
DE,UNRESPONSIVE TO STIMULI,102
DE,BLOOD UREA INCREASED,101
DE,BRAIN INJURY,101
DE,FEAR,101
DE,HAEMANGIOMA,101
DE,HAEMORRHAGIC DIATHESIS,101
DE,HERPES SIMPLEX,101
DE,LYMPHOMA,101
DE,ORAL HERPES,101
DE,VENOUS THROMBOSIS,101
DE,VENOUS THROMBOSIS LIMB,101
DE,ABORTION MISSED,100
DE,ENCEPHALITIS,100
DE,EOSINOPHILIA,100
DE,INTESTINAL OBSTRUCTION,100
DE,CARDIOMEGALY,99
DE,DYSSTASIA,99
DE,HYPERCALCAEMIA,99
DE,MICROCEPHALY,99
DE,OESOPHAGITIS,99
DE,SKIN LESION,99
DE,APNOEA NEONATAL,98
DE,BRONCHOPNEUMONIA,98
DE,GOITRE,98
DE,GRAND MAL CONVULSION,98
DE,HYPERVENTILATION,98
DE,SKIN NECROSIS,98
DE,CAROTID ARTERY STENOSIS,97
DE,CYST,97
DE,HYDROCEPHALUS,97
DE,LYMPHOEDEMA,97
DE,NASAL CONGESTION,97
DE,RENAL PAIN,97
DE,EXPOSURE VIA FATHER,96
DE,LABORATORY TEST ABNORMAL,96
DE,LOWER GASTROINTESTINAL HAEMORRHAGE,96
DE,LUNG NEOPLASM MALIGNANT,96
DE,MACULAR OEDEMA,96
DE,PHARYNGITIS,96
DE,POLYHYDRAMNIOS,96
DE,RASH MACULAR,96
DE,ACIDOSIS,95
DE,CRYING,95
DE,DISSEMINATED INTRAVASCULAR COAGULATION,95
DE,PELVIC FRACTURE,95
DE,SPINAL COLUMN STENOSIS,95
DE,THROAT TIGHTNESS,95
DE,ATRIOVENTRICULAR BLOCK COMPLETE,94
DE,GASTRITIS EROSIVE,94
DE,HYDRONEPHROSIS,94
DE,IRON DEFICIENCY,94
DE,JOINT STIFFNESS,94
DE,MANIA,94
DE,PHOTOPHOBIA,94
DE,AKATHISIA,93
DE,BENIGN PROSTATIC HYPERPLASIA,93
DE,BLOOD TRIGLYCERIDES INCREASED,93
DE,CLOSTRIDIUM DIFFICILE COLITIS,93
DE,ILEAL STENOSIS,93
DE,NEUTROPENIC SEPSIS,93
DE,OSTEOMYELITIS,93
DE,PERFORMANCE STATUS DECREASED,93
DE,PLACENTAL INSUFFICIENCY,93
DE,UTERINE LEIOMYOMA,93
DE,VITAMIN D DEFICIENCY,93
DE,DYSAESTHESIA,92
DE,LARGE INTESTINE PERFORATION,92
DE,LOSS OF LIBIDO,92
DE,NEUTROPENIC INFECTION,92
DE,NORMAL NEWBORN,92
DE,PAIN IN JAW,92
DE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,92
DE,JOINT DISLOCATION,90
DE,THORACIC VERTEBRAL FRACTURE,90
DE,ANXIETY DISORDER,89
DE,BLADDER CANCER,89
DE,GENERAL PHYSICAL CONDITION ABNORMAL,89
DE,HEART RATE IRREGULAR,89
DE,HYPERAESTHESIA,89
DE,INTENTIONAL PRODUCT USE ISSUE,89
DE,SLEEP APNOEA SYNDROME,89
DE,DIABETIC KETOACIDOSIS,88
DE,FACE OEDEMA,88
DE,HEPATIC CYST,88
DE,HYPERTONIA NEONATAL,88
DE,INTRACRANIAL PRESSURE INCREASED,88
DE,KIDNEY TRANSPLANT REJECTION,88
DE,KNEE ARTHROPLASTY,88
DE,THROMBOCYTOSIS,88
DE,ACUTE RESPIRATORY FAILURE,87
DE,ARTERIAL OCCLUSIVE DISEASE,87
DE,CANDIDA INFECTION,87
DE,INFECTION SUSCEPTIBILITY INCREASED,87
DE,WOUND INFECTION,87
DE,CONGENITAL HYDRONEPHROSIS,86
DE,FREQUENT BOWEL MOVEMENTS,86
DE,GRAFT VERSUS HOST DISEASE,86
DE,SENSATION OF FOREIGN BODY,86
DE,SPINAL DISORDER,86
DE,URINARY HESITATION,86
DE,ARTERIOSCLEROSIS,85
DE,BASAL GANGLIA HAEMORRHAGE,85
DE,MONOPARESIS,85
DE,OESOPHAGEAL CANDIDIASIS,85
DE,PLEURISY,85
DE,TYPE IV HYPERSENSITIVITY REACTION,85
DE,VARICOSE VEIN,85
DE,BRAIN STEM INFARCTION,84
DE,DERMATITIS EXFOLIATIVE,84
DE,ENDOCARDITIS,84
DE,IMPAIRED WORK ABILITY,84
DE,LACRIMATION INCREASED,84
DE,MUSCLE RUPTURE,84
DE,CRANIOCEREBRAL INJURY,83
DE,LOWER LIMB FRACTURE,83
DE,SCAR,83
DE,AMENORRHOEA,82
DE,AORTIC VALVE STENOSIS,82
DE,BLOOD SODIUM DECREASED,82
DE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,82
DE,RETCHING,82
DE,SCHIZOPHRENIA,82
DE,CARDIAC FAILURE CONGESTIVE,81
DE,GOUT,81
DE,HIATUS HERNIA,81
DE,HUMERUS FRACTURE,81
DE,JOINT RANGE OF MOTION DECREASED,81
DE,LARGE INTESTINAL STENOSIS,81
DE,ACUTE ABDOMEN,80
DE,BLOOD POTASSIUM INCREASED,79
DE,BREAST PAIN,79
DE,DRUG USE DISORDER,79
DE,JOINT INJURY,79
DE,MUSCULOSKELETAL DISORDER,79
DE,PERIPHERAL VASCULAR DISORDER,79
DE,SERUM FERRITIN INCREASED,79
DE,UNINTENDED PREGNANCY,79
DE,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,78
DE,BREECH PRESENTATION,78
DE,JOINT EFFUSION,78
DE,RENAL CELL CARCINOMA,78
DE,STRESS CARDIOMYOPATHY,78
DE,BLOOD POTASSIUM DECREASED,77
DE,COMPARTMENT SYNDROME,77
DE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,77
DE,MUSCLE HAEMORRHAGE,77
DE,NO THERAPEUTIC RESPONSE,77
DE,OSTEITIS,77
DE,RENAL INJURY,77
DE,RESPIRATORY SYNCYTIAL VIRUS INFECTION,77
DE,CLEFT LIP AND PALATE,76
DE,FLANK PAIN,76
DE,HEPATOMEGALY,76
DE,NEPHROPATHY TOXIC,76
DE,PULMONARY SEPSIS,76
DE,ROTATOR CUFF SYNDROME,76
DE,STAPHYLOCOCCAL SEPSIS,76
DE,CONCOMITANT DISEASE AGGRAVATED,75
DE,DRUG LEVEL DECREASED,75
DE,EYE INFLAMMATION,75
DE,FEEDING DISORDER,75
DE,GASTROENTERITIS NOROVIRUS,75
DE,INFANTILE APNOEA,75
DE,LIGAMENT RUPTURE,75
DE,MACULAR DEGENERATION,75
DE,OSTEOCHONDROSIS,75
DE,SQUAMOUS CELL CARCINOMA OF SKIN,75
DE,TRANSFUSION,75
DE,TRANSPLANT REJECTION,75
DE,UMBILICAL HERNIA,75
DE,BLINDNESS UNILATERAL,74
DE,CREATININE RENAL CLEARANCE DECREASED,74
DE,FACIAL PARALYSIS,74
DE,INCISIONAL HERNIA,74
DE,MUSCLE TIGHTNESS,74
DE,POLYURIA,74
DE,PULMONARY CONGESTION,74
DE,SYNOVIAL CYST,74
DE,DIABETES MELLITUS INADEQUATE CONTROL,73
DE,DIVERTICULAR PERFORATION,73
DE,ERYTHEMA MULTIFORME,73
DE,GROIN PAIN,73
DE,HAEMARTHROSIS,73
DE,LIMB INJURY,73
DE,PRODUCT SUBSTITUTION ISSUE,73
DE,RESPIRATORY DEPRESSION,73
DE,RHEUMATOID NODULE,73
DE,STILLBIRTH,73
DE,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,72
DE,BLOOD CALCIUM DECREASED,72
DE,BRONCHIOLITIS,72
DE,BUNDLE BRANCH BLOCK RIGHT,72
DE,CEREBRAL ARTERY OCCLUSION,72
DE,EAR PAIN,72
DE,HIP ARTHROPLASTY,72
DE,INJECTION SITE INDURATION,72
DE,LEUKOENCEPHALOPATHY,72
DE,PHOTOPSIA,72
DE,BLOOD PRESSURE ABNORMAL,71
DE,DYSPNOEA AT REST,71
DE,ELECTROLYTE IMBALANCE,71
DE,EMPHYSEMA,71
DE,ISCHAEMIA,71
DE,JARISCH-HERXHEIMER REACTION,71
DE,NEPHROTIC SYNDROME,71
DE,NOCTURIA,71
DE,NON-HODGKIN^S LYMPHOMA,71
DE,PATHOLOGICAL FRACTURE,71
DE,PRERENAL FAILURE,71
DE,THIRST,71
DE,ABORTION,70
DE,ABSCESS LIMB,70
DE,ACUTE PSYCHOSIS,70
DE,AMYLASE INCREASED,70
DE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,70
DE,FACIAL BONES FRACTURE,70
DE,GINGIVITIS,70
DE,HEAD INJURY,70
DE,INFARCTION,70
DE,INTENTIONAL DRUG MISUSE,70
DE,MOOD ALTERED,70
DE,PARAPARESIS,70
DE,POLYDACTYLY,70
DE,PREGNANCY WITH CONTRACEPTIVE DEVICE,70
DE,TOOTH LOSS,70
DE,TYPE 1 DIABETES MELLITUS,70
DE,UVEITIS,70
DE,VIITH NERVE PARALYSIS,70
DE,ANAL HAEMORRHAGE,69
DE,CARDIOTOXICITY,69
DE,EPSTEIN-BARR VIRUS INFECTION,69
DE,EXERCISE TOLERANCE DECREASED,69
DE,INTESTINAL ISCHAEMIA,69
DE,LARYNGEAL OEDEMA,69
DE,LUPUS-LIKE SYNDROME,69
DE,METRORRHAGIA,69
DE,PULMONARY VALVE STENOSIS CONGENITAL,69
DE,BILE DUCT STONE,68
DE,BLOOD URIC ACID INCREASED,68
DE,CHRONIC LYMPHOCYTIC LEUKAEMIA,68
DE,CONCUSSION,68
DE,DIALYSIS,68
DE,EMBOLIC STROKE,68
DE,ESCHERICHIA URINARY TRACT INFECTION,68
DE,GENERALISED ERYTHEMA,68
DE,MICTURITION DISORDER,68
DE,MOUTH HAEMORRHAGE,68
DE,OTITIS MEDIA,68
DE,PANCREATITIS NECROTISING,68
DE,PATHOGEN RESISTANCE,68
DE,PYLORIC STENOSIS,68
DE,STEVENS-JOHNSON SYNDROME,68
DE,ACTIVITIES OF DAILY LIVING IMPAIRED,67
DE,BLOOD COUNT ABNORMAL,67
DE,BLOOD PRESSURE SYSTOLIC INCREASED,67
DE,DIVERTICULUM INTESTINAL,67
DE,HALLUCINATION_ AUDITORY,67
DE,HERPES VIRUS INFECTION,67
DE,ILL-DEFINED DISORDER,67
DE,INTESTINAL FISTULA,67
DE,MONOPLEGIA,67
DE,NEUROLEPTIC MALIGNANT SYNDROME,67
DE,OBESITY,67
DE,PAPILLOEDEMA,67
DE,PRECANCEROUS SKIN LESION,67
DE,PULPITIS DENTAL,67
DE,STOMA SITE INFLAMMATION,67
DE,TUMOUR LYSIS SYNDROME,67
DE,ANKYLOSING SPONDYLITIS,66
DE,DEVICE OCCLUSION,66
DE,EMBOLIC CEREBRAL INFARCTION,66
DE,HYPERCHOLESTEROLAEMIA,66
DE,MYOCARDIAL ISCHAEMIA,66
DE,PURULENT DISCHARGE,66
DE,STUPOR,66
DE,DUODENITIS,65
DE,ERYTHEMA NODOSUM,65
DE,HAND FRACTURE,65
DE,HISTIOCYTOSIS HAEMATOPHAGIC,65
DE,HYPERURICAEMIA,65
DE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,65
DE,MENINGITIS,65
DE,MUSCLE RIGIDITY,65
DE,NEPHRITIS,65
DE,POLYARTHRITIS,65
DE,RADIUS FRACTURE,65
DE,SENSORY LOSS,65
DE,AORTIC VALVE INCOMPETENCE,64
DE,BONE MARROW TOXICITY,64
DE,HAEMOTHORAX,64
DE,HEPATORENAL SYNDROME,64
DE,LEUKAEMIA,64
DE,MAJOR DEPRESSION,64
DE,NAIL DISORDER,64
DE,PARAESTHESIA ORAL,64
DE,RENAL COLIC,64
DE,SKIN FISSURES,64
DE,STENT PLACEMENT,64
DE,THROMBOTIC MICROANGIOPATHY,64
GH,DEATH,26
GH,NEUROPATHY PERIPHERAL,15
GH,PATHOGEN RESISTANCE,13
GH,RED BLOOD CELL ABNORMALITY,11
GH,MENTAL DISORDER,10
GH,MALNUTRITION,9
GH,METABOLIC DISORDER,9
GH,ASTHENIA,8
GH,GASTROINTESTINAL DISORDER,8
GH,VIRAL MUTATION IDENTIFIED,8
GH,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,7
GH,DRUG INEFFECTIVE,7
GH,DYSPNOEA,6
GH,JAUNDICE,6
GH,NERVOUS SYSTEM DISORDER,6
GH,PYREXIA,6
GH,RASH,6
GH,HYPERTENSION,5
GH,PLATELET COUNT DECREASED,5
GH,RASH PRURITIC,5
GH,WHITE BLOOD CELL COUNT DECREASED,5
GH,BLINDNESS,4
GH,CARDIOVASCULAR DISORDER,4
GH,DEHYDRATION,4
GH,DIARRHOEA,4
GH,DISEASE PROGRESSION,4
GH,DRUG HYPERSENSITIVITY,4
GH,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,4
GH,LOSS OF CONSCIOUSNESS,4
GH,MALARIA,4
GH,MUCOSAL ULCERATION,4
GH,OPTIC ATROPHY,4
GH,PALPITATIONS,4
GH,RASH MACULO-PAPULAR,4
GH,RESTLESSNESS,4
GH,SEIZURE,4
GH,SUSPECTED COUNTERFEIT PRODUCT,4
GH,TREATMENT FAILURE,4
GH,WEIGHT DECREASED,4
GH,AGGRESSION,3
GH,ANAEMIA,3
GH,CHEST PAIN,3
GH,DRUG RESISTANCE,3
GH,FATIGUE,3
GH,HAEMOGLOBIN DECREASED,3
GH,HEADACHE,3
GH,HYPERHIDROSIS,3
GH,INSOMNIA,3
GH,MUSCULOSKELETAL DISORDER,3
GH,STEVENS-JOHNSON SYNDROME,3
GH,VENTRICULAR TACHYCARDIA,3
GH,VOMITING,3
GH,ACIDOSIS,2
GH,ADVERSE EVENT,2
GH,BLINDNESS UNILATERAL,2
GH,CHRONIC MYELOID LEUKAEMIA,2
GH,CONVERSION DISORDER,2
GH,COUGH,2
GH,DECREASED APPETITE,2
GH,DEPRESSED LEVEL OF CONSCIOUSNESS,2
GH,DIZZINESS,2
GH,DRUG INTOLERANCE,2
GH,DYSPHAGIA,2
GH,FALL,2
GH,GASTROINTESTINAL STROMAL TUMOUR,2
GH,GENERAL PHYSICAL HEALTH DETERIORATION,2
GH,GINGIVAL BLEEDING,2
GH,HAEMORRHAGE,2
GH,HEPATOBILIARY DISEASE,2
GH,HEPATOCELLULAR CARCINOMA,2
GH,HEPATOTOXICITY,2
GH,HYPOAESTHESIA,2
GH,HYPOGLYCAEMIA,2
GH,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
GH,INFECTION,2
GH,LYMPHOMA,2
GH,MYOCLONUS,2
GH,NASOPHARYNGITIS,2
GH,NAUSEA,2
GH,NO THERAPEUTIC RESPONSE,2
GH,PANCREATITIS,2
GH,PLEURAL EFFUSION,2
GH,POLYURIA,2
GH,POSTOPERATIVE WOUND INFECTION,2
GH,PSYCHOTIC DISORDER,2
GH,PUPILLARY REFLEX IMPAIRED,2
GH,SKIN SWELLING,2
GH,STATUS EPILEPTICUS,2
GH,SWELLING FACE,2
GH,TACHYCARDIA,2
GH,ULCER,2
GH,WRONG DRUG ADMINISTERED,2
GH,ABDOMINAL DISTENSION,1
GH,ABDOMINAL MASS,1
GH,ABDOMINAL PAIN,1
GH,ABDOMINAL PAIN UPPER,1
GH,ABDOMINAL WALL ABSCESS,1
GH,ABORTION SPONTANEOUS,1
GH,ACUTE ABDOMEN,1
GH,ACUTE KIDNEY INJURY,1
GH,ADVERSE DRUG REACTION,1
GH,ANAL FISSURE,1
GH,ANXIETY,1
GH,APPARENT DEATH,1
GH,ARTERIOSPASM CORONARY,1
GH,BACK PAIN,1
GH,BLOOD GLUCOSE INCREASED,1
GH,BLOOD PRESSURE DECREASED,1
GH,BLOOD TEST ABNORMAL,1
GH,BODY TEMPERATURE INCREASED,1
GH,BONE DISORDER,1
GH,CACHEXIA,1
GH,CARBOHYDRATE ANTIGEN 125 INCREASED,1
GH,CARDIAC ARREST,1
GH,CARDIAC FAILURE,1
GH,CARDIO-RESPIRATORY ARREST,1
GH,CERVIX CARCINOMA,1
GH,CHEST DISCOMFORT,1
GH,CHILLS,1
GH,CHROMOSOME ANALYSIS ABNORMAL,1
GH,CHRONIC HEPATIC FAILURE,1
GH,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
GH,COLOUR BLINDNESS ACQUIRED,1
GH,COMA,1
GH,COMA SCALE ABNORMAL,1
GH,CONJUNCTIVAL HYPERAEMIA,1
GH,CONSTIPATION,1
GH,CONTUSION,1
GH,DELIRIUM,1
GH,DIABETES MELLITUS,1
GH,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,1
GH,DRUG ABUSE,1
GH,DRUG DOSE OMISSION,1
GH,DRUG THERAPEUTIC INCOMPATIBILITY,1
GH,EARLY SATIETY,1
GH,EXCESSIVE GRANULATION TISSUE,1
GH,EXPOSURE DURING PREGNANCY,1
GH,EYE PAIN,1
GH,FEBRILE NEUTROPENIA,1
GH,FEEDING DISORDER,1
GH,FEELING ABNORMAL,1
GH,FLATULENCE,1
GH,FLUID OVERLOAD,1
GH,GANGRENE,1
GH,GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY,1
GH,HAEMATOLOGICAL MALIGNANCY,1
GH,HAEMODYNAMIC INSTABILITY,1
GH,HEARING DISABILITY,1
GH,HEART RATE INCREASED,1
GH,HEPATIC AMOEBIASIS,1
GH,HEPATITIS B,1
GH,HERPES OESOPHAGITIS,1
GH,HYPERINSULINAEMIC HYPOGLYCAEMIA,1
GH,HYPEROSMOLAR HYPERGLYCAEMIC STATE,1
GH,HYPERPYREXIA,1
GH,HYPERSENSITIVITY,1
GH,HYPERTENSIVE CRISIS,1
GH,HYPOTENSION,1
GH,HYPOXIA,1
GH,ILL-DEFINED DISORDER,1
GH,INCORRECT DRUG ADMINISTRATION RATE,1
GH,INCREASED TENDENCY TO BRUISE,1
GH,INDURATION,1
GH,INTESTINAL TUBERCULOSIS,1
GH,KAPOSI^S SARCOMA,1
GH,LEFT VENTRICULAR HYPERTROPHY,1
GH,LETHARGY,1
GH,LEUKAEMIA RECURRENT,1
GH,LEUKOSTASIS,1
GH,LICHENOID KERATOSIS,1
GH,LUNG DISORDER,1
GH,MACULAR PIGMENTATION,1
GH,MACULAR SCAR,1
GH,MALAISE,1
GH,MALIGNANT NEOPLASM PROGRESSION,1
GH,MEDICATION RESIDUE PRESENT,1
GH,MENINGITIS CRYPTOCOCCAL,1
GH,METASTASES TO BONE,1
GH,METASTASES TO CENTRAL NERVOUS SYSTEM,1
GH,METASTASES TO PELVIS,1
GH,MIGRAINE,1
GH,MUMPS,1
GH,MUSCLE SPASMS,1
GH,MYALGIA,1
GH,MYDRIASIS,1
GH,MYELOBLAST PERCENTAGE INCREASED,1
GH,NEOPLASM,1
GH,NEOPLASM RECURRENCE,1
GH,NEUTROPENIA,1
GH,NOCTURNAL DYSPNOEA,1
GH,NON-HODGKIN^S LYMPHOMA,1
GH,OESOPHAGEAL CARCINOMA,1
GH,ORAL DISORDER,1
GH,OTITIS MEDIA,1
GH,OVARIAN CANCER,1
GH,OVERDOSE,1
GH,OXYGEN SATURATION DECREASED,1
GH,PAIN,1
GH,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
GH,PAPILLOEDEMA,1
GH,PARTIAL SEIZURES,1
GH,PERICARDIAL EFFUSION,1
GH,PERIPHERAL SWELLING,1
GH,PIGMENTATION DISORDER,1
GH,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
GH,PNEUMONIA,1
GH,POLLAKIURIA,1
GH,POST PROCEDURAL DISCHARGE,1
GH,POST PROCEDURAL HAEMORRHAGE,1
GH,PRODUCT PACKAGING CONFUSION,1
GH,PRURITUS,1
GH,PSYCHOMOTOR RETARDATION,1
GH,RASH ERYTHEMATOUS,1
GH,RASH GENERALISED,1
GH,RECURRENT CANCER,1
GH,RENAL FAILURE,1
GH,RESPIRATORY DISTRESS,1
GH,RETINAL INFARCTION,1
GH,RETROPERITONEAL MASS,1
GH,SCREAMING,1
GH,SECOND PRIMARY MALIGNANCY,1
GH,SECRETION DISCHARGE,1
GH,SEPSIS,1
GH,SKIN LESION,1
GH,SKIN NECROSIS,1
GH,SKIN STRIAE,1
GH,SOMNOLENCE,1
GH,STOMATITIS,1
GH,STRANGULATED HERNIA,1
GH,SUBCUTANEOUS ABSCESS,1
GH,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,1
GH,SUDDEN DEATH,1
GH,SUDDEN VISUAL LOSS,1
GH,SWOLLEN TONGUE,1
GH,SYSTEMIC CANDIDA,1
GH,TACHYARRHYTHMIA,1
GH,TACHYPHYLAXIS,1
GH,TETANY,1
GH,THERAPEUTIC RESPONSE DECREASED,1
GH,TREMOR,1
GH,TUBULOINTERSTITIAL NEPHRITIS,1
GH,TUMOUR MARKER INCREASED,1
GH,TYPHOID FEVER,1
GH,URTICARIA,1
GH,VASCULITIS,1
GH,VENTRICULAR FIBRILLATION,1
GH,VESTIBULAR DISORDER,1
GH,VIRAL LOAD INCREASED,1
GH,VISION BLURRED,1
GH,VISUAL ACUITY REDUCED,1
GH,WEIGHT INCREASED,1
GH,WHEEZING,1
GH,WOUND HAEMATOMA,1
GH,WOUND HAEMORRHAGE,1
GH,WOUND SEPSIS,1
GI,PRODUCT LEAKAGE,2
GI,BLOOD GLUCOSE INCREASED,1
GI,BLOOD KETONE BODY PRESENT,1
GI,COMA,1
GI,DIABETIC KETOACIDOSIS,1
GI,PROSTATE CANCER,1
GR,DEATH,550
GR,PYREXIA,433
GR,DRUG INEFFECTIVE,417
GR,DYSPNOEA,286
GR,DIARRHOEA,270
GR,FATIGUE,232
GR,RASH,219
GR,DIZZINESS,214
GR,ANAEMIA,200
GR,THROMBOCYTOPENIA,199
GR,VOMITING,188
GR,ASTHENIA,187
GR,HAEMATOCRIT DECREASED,175
GR,DISEASE RECURRENCE,173
GR,NEUTROPENIA,173
GR,RESPIRATORY TRACT INFECTION,172
GR,OSTEONECROSIS OF JAW,168
GR,MALIGNANT NEOPLASM PROGRESSION,164
GR,HEADACHE,155
GR,HYPOTENSION,137
GR,FALL,129
GR,ABDOMINAL PAIN,127
GR,DISEASE PROGRESSION,125
GR,OEDEMA PERIPHERAL,124
GR,PNEUMONIA,124
GR,CARDIAC ARREST,123
GR,MYOCARDIAL INFARCTION,122
GR,PRURITUS,121
GR,SYNCOPE,121
GR,CEREBROVASCULAR ACCIDENT,118
GR,CONDITION AGGRAVATED,118
GR,ATRIAL FIBRILLATION,117
GR,FEBRILE NEUTROPENIA,117
GR,SEPTIC SHOCK,117
GR,PAIN,116
GR,INFECTION,112
GR,HYPERSENSITIVITY,111
GR,RENAL IMPAIRMENT,111
GR,HYPOAESTHESIA,109
GR,SEPSIS,107
GR,TACHYCARDIA,107
GR,ACUTE KIDNEY INJURY,105
GR,URINARY TRACT INFECTION,105
GR,DECREASED APPETITE,104
GR,HYPERTENSION,103
GR,NAUSEA,102
GR,MYALGIA,101
GR,ERYTHEMA,100
GR,LEUKOPENIA,100
GR,GAIT DISTURBANCE,99
GR,ARTHRALGIA,97
GR,BLOOD CREATININE INCREASED,95
GR,COUGH,95
GR,OVERDOSE,94
GR,NEPHROPATHY TOXIC,93
GR,FOETAL EXPOSURE DURING PREGNANCY,92
GR,WEIGHT DECREASED,91
GR,ARRHYTHMIA,88
GR,PRODUCT USE ISSUE,86
GR,RESPIRATORY FAILURE,85
GR,RENAL FAILURE,84
GR,TOXICITY TO VARIOUS AGENTS,84
GR,BLOOD PRESSURE INCREASED,82
GR,MUSCULAR WEAKNESS,80
GR,BACK PAIN,77
GR,CARDIAC FAILURE,74
GR,EXPOSURE DURING PREGNANCY,74
GR,MULTIPLE SCLEROSIS RELAPSE,74
GR,PLEURAL EFFUSION,74
GR,PULMONARY OEDEMA,74
GR,LOSS OF CONSCIOUSNESS,73
GR,PAIN IN EXTREMITY,73
GR,CHEST PAIN,72
GR,EPILEPSY,72
GR,GASTROINTESTINAL DISORDER,71
GR,TREMOR,70
GR,WHITE BLOOD CELL COUNT DECREASED,70
GR,PULMONARY EMBOLISM,69
GR,PLATELET COUNT DECREASED,68
GR,VISION BLURRED,68
GR,BREAST CANCER,67
GR,HAEMORRHAGE,67
GR,HEPATIC ENZYME INCREASED,67
GR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,67
GR,PRODUCT USE IN UNAPPROVED INDICATION,67
GR,ISCHAEMIC STROKE,66
GR,TRANSAMINASES INCREASED,66
GR,CONSTIPATION,65
GR,POST PROCEDURAL COMPLICATION,65
GR,ABDOMINAL PAIN UPPER,64
GR,MALAISE,64
GR,SOMNOLENCE,63
GR,DYSPHAGIA,62
GR,PLASMA CELL MYELOMA,62
GR,GENERAL PHYSICAL HEALTH DETERIORATION,61
GR,CONFUSIONAL STATE,60
GR,HYPERHIDROSIS,60
GR,METASTASES TO LIVER,60
GR,ALOPECIA,59
GR,STOMATITIS,58
GR,BLOOD GLUCOSE INCREASED,57
GR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,57
GR,HYPONATRAEMIA,57
GR,PREMATURE BABY,57
GR,PSORIASIS,57
GR,INSOMNIA,55
GR,HYPOKALAEMIA,54
GR,C-REACTIVE PROTEIN INCREASED,53
GR,ASPARTATE AMINOTRANSFERASE INCREASED,52
GR,MATERNAL EXPOSURE DURING PREGNANCY,52
GR,ALANINE AMINOTRANSFERASE INCREASED,51
GR,CARDIAC DISORDER,51
GR,HAEMATURIA,51
GR,PANCYTOPENIA,51
GR,EPISTAXIS,50
GR,HAEMOPTYSIS,50
GR,RHABDOMYOLYSIS,50
GR,COMA,49
GR,GASTROINTESTINAL HAEMORRHAGE,48
GR,MUSCLE SPASMS,48
GR,WHITE BLOOD CELL COUNT INCREASED,48
GR,ACUTE MYOCARDIAL INFARCTION,47
GR,LUNG NEOPLASM MALIGNANT,47
GR,LYMPHADENOPATHY,47
GR,THROMBOSIS,47
GR,CHILLS,46
GR,DEEP VEIN THROMBOSIS,46
GR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,46
GR,METASTASES TO BONE,46
GR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,45
GR,HAEMATOCHEZIA,44
GR,HEPATIC FAILURE,44
GR,HYPOGLYCAEMIA,44
GR,DEHYDRATION,43
GR,DEPRESSION,43
GR,FEMUR FRACTURE,43
GR,BLOOD CREATINE PHOSPHOKINASE INCREASED,42
GR,BLOOD UREA INCREASED,42
GR,LOWER RESPIRATORY TRACT INFECTION,42
GR,ANAPHYLACTIC SHOCK,41
GR,ASCITES,41
GR,PALPITATIONS,41
GR,BRADYCARDIA,40
GR,NEUROTOXICITY,40
GR,PNEUMONITIS,40
GR,RASH GENERALISED,40
GR,VISUAL IMPAIRMENT,40
GR,ANAPHYLACTIC REACTION,39
GR,BLOOD BILIRUBIN INCREASED,39
GR,DISCOMFORT,39
GR,DRUG INTOLERANCE,39
GR,HYPERKALAEMIA,39
GR,LUNG INFECTION,39
GR,RHEUMATOID ARTHRITIS,39
GR,THERAPEUTIC RESPONSE DECREASED,39
GR,VERTIGO,39
GR,AGITATION,38
GR,BONE PAIN,38
GR,CEREBRAL HAEMORRHAGE,38
GR,ANGIOEDEMA,37
GR,ANXIETY,37
GR,BLINDNESS,37
GR,BLOOD PRESSURE DECREASED,37
GR,DRY MOUTH,37
GR,HYPERGLYCAEMIA,37
GR,OEDEMA,37
GR,RENAL FAILURE ACUTE,37
GR,URINARY RETENTION,37
GR,AMNESIA,36
GR,CATARACT,36
GR,PERIPHERAL SWELLING,36
GR,VISUAL ACUITY REDUCED,36
GR,CENTRAL NERVOUS SYSTEM LESION,35
GR,HAEMOGLOBIN DECREASED,35
GR,HEPATOTOXICITY,35
GR,HYPOCALCAEMIA,35
GR,NEUROPATHY PERIPHERAL,35
GR,SUICIDE ATTEMPT,35
GR,DIABETES MELLITUS,34
GR,DYSARTHRIA,34
GR,INTESTINAL PERFORATION,34
GR,PSORIATIC ARTHROPATHY,34
GR,SEIZURE,34
GR,ABORTION SPONTANEOUS,33
GR,CROHN^S DISEASE,33
GR,DISORIENTATION,33
GR,HYPOXIA,33
GR,JAUNDICE,33
GR,PEMPHIGOID,33
GR,URTICARIA,33
GR,ARTHRITIS,32
GR,BURNING SENSATION,32
GR,INTENTIONAL PRODUCT MISUSE,32
GR,LEUKOCYTOSIS,32
GR,MYELODYSPLASTIC SYNDROME,32
GR,NEOPLASM MALIGNANT,32
GR,ACUTE MYELOID LEUKAEMIA,31
GR,ACUTE RESPIRATORY DISTRESS SYNDROME,31
GR,CARDIO-RESPIRATORY ARREST,31
GR,DRUG ADMINISTRATION ERROR,31
GR,TUBERCULOSIS,31
GR,VIRAL INFECTION,31
GR,BRONCHOSPASM,30
GR,CONTUSION,30
GR,LYMPHOPENIA,30
GR,MULTI-ORGAN FAILURE,30
GR,OSTEOPOROSIS,30
GR,PNEUMONIA ASPIRATION,30
GR,PROTEINURIA,30
GR,BREAST CANCER METASTATIC,29
GR,HYPOFIBRINOGENAEMIA,29
GR,INCORRECT DOSE ADMINISTERED,29
GR,MOBILITY DECREASED,29
GR,EYE PAIN,28
GR,HERPES ZOSTER,28
GR,ILEUS,28
GR,MUCOSAL INFLAMMATION,28
GR,PANCREATITIS,28
GR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,28
GR,ANGINA PECTORIS,27
GR,ATAXIA,27
GR,DERMATITIS ALLERGIC,27
GR,FOETAL GROWTH RESTRICTION,27
GR,HAEMODYNAMIC INSTABILITY,27
GR,INFUSION RELATED REACTION,27
GR,KAPOSI^S SARCOMA,27
GR,PREMATURE DELIVERY,27
GR,WEIGHT INCREASED,27
GR,ABDOMINAL DISTENSION,26
GR,ASPIRATION,26
GR,BONE MARROW FAILURE,26
GR,DELIRIUM,26
GR,FLATULENCE,26
GR,INFLAMMATION,26
GR,MUSCULOSKELETAL STIFFNESS,26
GR,MYOCARDIAL ISCHAEMIA,26
GR,NEUROLEPTIC MALIGNANT SYNDROME,26
GR,SEROTONIN SYNDROME,26
GR,SPLENOMEGALY,26
GR,ASTHMA,25
GR,DRUG RESISTANCE,25
GR,FACE OEDEMA,25
GR,GASTRIC HAEMORRHAGE,25
GR,HYPOMAGNESAEMIA,25
GR,MOVEMENT DISORDER,25
GR,NEPHROLITHIASIS,25
GR,OCULAR HYPERAEMIA,25
GR,OSTEONECROSIS,25
GR,PULMONARY MASS,25
GR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,25
GR,STATUS EPILEPTICUS,25
GR,SUICIDAL IDEATION,25
GR,CHOLELITHIASIS,24
GR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,24
GR,DYSPHONIA,24
GR,HIP FRACTURE,24
GR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,24
GR,LOW BIRTH WEIGHT BABY,24
GR,SECOND PRIMARY MALIGNANCY,24
GR,SHOCK,24
GR,TOOTH DISORDER,24
GR,UPPER RESPIRATORY TRACT INFECTION,24
GR,DEPRESSED LEVEL OF CONSCIOUSNESS,23
GR,DRUG HYPERSENSITIVITY,23
GR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,23
GR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,23
GR,DRY SKIN,23
GR,DYSURIA,23
GR,EOSINOPHILIA,23
GR,EYE DISORDER,23
GR,HEART RATE INCREASED,23
GR,MEMORY IMPAIRMENT,23
GR,PERICARDIAL EFFUSION,23
GR,PERICARDITIS,23
GR,ABASIA,22
GR,ACNE,22
GR,CHEST DISCOMFORT,22
GR,CHOLECYSTITIS,22
GR,DIABETIC KETOACIDOSIS,22
GR,EJECTION FRACTION DECREASED,22
GR,FEELING ABNORMAL,22
GR,FLUSHING,22
GR,HAEMATOMA,22
GR,INFLUENZA LIKE ILLNESS,22
GR,LETHARGY,22
GR,LUNG DISORDER,22
GR,METABOLIC ACIDOSIS,22
GR,METASTASES TO LUNG,22
GR,PANCREATIC CARCINOMA,22
GR,RASH MACULO-PAPULAR,22
GR,SKIN LESION,22
GR,SPEECH DISORDER,22
GR,SPINAL FRACTURE,22
GR,SUDDEN DEATH,22
GR,SWELLING,22
GR,TINNITUS,22
GR,ACUTE RESPIRATORY FAILURE,21
GR,BACTERAEMIA,21
GR,BLOOD ALKALINE PHOSPHATASE INCREASED,21
GR,COLITIS ULCERATIVE,21
GR,EYE OEDEMA,21
GR,HALLUCINATION,21
GR,INCORRECT ROUTE OF DRUG ADMINISTRATION,21
GR,IRIDOCYCLITIS,21
GR,MELAENA,21
GR,METASTASES TO LYMPH NODES,21
GR,OPTIC NEURITIS,21
GR,OXYGEN SATURATION DECREASED,21
GR,RESPIRATORY DISTRESS,21
GR,STRESS,21
GR,SWELLING FACE,21
GR,TRANSIENT ISCHAEMIC ATTACK,21
GR,ABDOMINAL DISCOMFORT,20
GR,ABORTION INDUCED,20
GR,ADVERSE EVENT,20
GR,ANURIA,20
GR,ARTHROPATHY,20
GR,BALANCE DISORDER,20
GR,DEAFNESS,20
GR,HAEMORRHAGIC STROKE,20
GR,HEMIPARESIS,20
GR,HYPERCALCAEMIA,20
GR,LUPUS-LIKE SYNDROME,20
GR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,20
GR,PROSTATE CANCER,20
GR,PSYCHOTIC DISORDER,20
GR,SYSTEMIC LUPUS ERYTHEMATOSUS,20
GR,APHASIA,19
GR,BRONCHOPULMONARY ASPERGILLOSIS,19
GR,CARDIOMYOPATHY,19
GR,DIPLOPIA,19
GR,DRUG-INDUCED LIVER INJURY,19
GR,GENERALISED OEDEMA,19
GR,HYPOTHYROIDISM,19
GR,LIVER DISORDER,19
GR,MENTAL DISORDER,19
GR,METASTASES TO CENTRAL NERVOUS SYSTEM,19
GR,OROPHARYNGEAL PAIN,19
GR,PRURITUS GENERALISED,19
GR,PULMONARY HYPERTENSION,19
GR,PYELONEPHRITIS,19
GR,SKIN EXFOLIATION,19
GR,VAGINAL HAEMORRHAGE,19
GR,VISCERAL LEISHMANIASIS,19
GR,AGGRESSION,18
GR,BASAL CELL CARCINOMA,18
GR,CORONARY ARTERY DISEASE,18
GR,DERMATITIS EXFOLIATIVE,18
GR,DRUG DOSE OMISSION,18
GR,ENTERITIS,18
GR,EYELID OEDEMA,18
GR,GLAUCOMA,18
GR,HAEMATOTOXICITY,18
GR,HEPATITIS B,18
GR,HISTIOCYTOSIS HAEMATOPHAGIC,18
GR,INTENTIONAL OVERDOSE,18
GR,MUSCULOSKELETAL PAIN,18
GR,NO THERAPEUTIC RESPONSE,18
GR,PLATELET COUNT INCREASED,18
GR,PNEUMOCYSTIS JIROVECII PNEUMONIA,18
GR,PULMONARY HAEMORRHAGE,18
GR,RECTAL HAEMORRHAGE,18
GR,RETINAL HAEMORRHAGE,18
GR,TACHYPNOEA,18
GR,THYROID CANCER,18
GR,ABNORMAL BEHAVIOUR,17
GR,BLISTER,17
GR,BLOOD CHOLESTEROL INCREASED,17
GR,CARDIOTOXICITY,17
GR,DEMENTIA,17
GR,DIVERTICULITIS,17
GR,HYPERKINESIA,17
GR,LYMPHOMA,17
GR,MEDICATION ERROR,17
GR,MULTIPLE SCLEROSIS,17
GR,MYDRIASIS,17
GR,MYOCARDITIS,17
GR,MYOCLONUS,17
GR,NERVOUS SYSTEM DISORDER,17
GR,PNEUMOTHORAX,17
GR,PULMONARY TOXICITY,17
GR,RESPIRATORY DISORDER,17
GR,RESTLESSNESS,17
GR,RETINAL DETACHMENT,17
GR,SKIN ULCER,17
GR,TREATMENT FAILURE,17
GR,BLOOD LACTATE DEHYDROGENASE INCREASED,16
GR,BRONCHITIS,16
GR,CHOLESTASIS,16
GR,CONVULSION,16
GR,DRUG DEPENDENCE,16
GR,DYSKINESIA,16
GR,DYSPEPSIA,16
GR,ELECTROCARDIOGRAM QT PROLONGED,16
GR,ERECTILE DYSFUNCTION,16
GR,EXTRAPYRAMIDAL DISORDER,16
GR,EYE SWELLING,16
GR,GENERALISED ERYTHEMA,16
GR,HEPATITIS B REACTIVATION,16
GR,INFLUENZA,16
GR,INTERSTITIAL LUNG DISEASE,16
GR,NASOPHARYNGITIS,16
GR,PALLOR,16
GR,PANCREATITIS ACUTE,16
GR,PARAESTHESIA,16
GR,PERITONITIS,16
GR,PHOTOSENSITIVITY REACTION,16
GR,RASH PRURITIC,16
GR,URINARY INCONTINENCE,16
GR,VASCULITIS,16
GR,ACCIDENTAL OVERDOSE,15
GR,ALBUMINURIA,15
GR,BRAIN OEDEMA,15
GR,COLITIS,15
GR,COMPLETED SUICIDE,15
GR,DEPRESSED MOOD,15
GR,DERMATITIS,15
GR,DRUG ABUSE,15
GR,DYSGEUSIA,15
GR,EYE IRRITATION,15
GR,HAEMATEMESIS,15
GR,HAEMOLYTIC ANAEMIA,15
GR,HEPATIC STEATOSIS,15
GR,HYPERTENSIVE CRISIS,15
GR,IRRITABILITY,15
GR,LACRIMATION INCREASED,15
GR,LOCAL SWELLING,15
GR,NEOPLASM PROGRESSION,15
GR,OLIGOHYDRAMNIOS,15
GR,SARCOIDOSIS,15
GR,STAPHYLOCOCCAL INFECTION,15
GR,TREATMENT NONCOMPLIANCE,15
GR,BONE MARROW TOXICITY,14
GR,BREAST CANCER RECURRENT,14
GR,CARDIOGENIC SHOCK,14
GR,CELLULITIS,14
GR,DIARRHOEA HAEMORRHAGIC,14
GR,DISSEMINATED INTRAVASCULAR COAGULATION,14
GR,ENDOTHELIAL DYSFUNCTION,14
GR,INFARCTION,14
GR,INTRAOCULAR PRESSURE INCREASED,14
GR,ISCHAEMIA,14
GR,JOINT SWELLING,14
GR,KOUNIS SYNDROME,14
GR,MYOPATHY,14
GR,NO ADVERSE EVENT,14
GR,ORTHOSTATIC HYPOTENSION,14
GR,PATHOGEN RESISTANCE,14
GR,PRODUCT QUALITY ISSUE,14
GR,PRODUCTIVE COUGH,14
GR,PROSTATITIS,14
GR,PULMONARY FIBROSIS,14
GR,RENAL DISORDER,14
GR,SEDATION,14
GR,SURGERY,14
GR,TENDONITIS,14
GR,TUMOUR MARKER INCREASED,14
GR,UPPER GASTROINTESTINAL HAEMORRHAGE,14
GR,ACUTE PULMONARY OEDEMA,13
GR,AGEUSIA,13
GR,AGRANULOCYTOSIS,13
GR,ANGLE CLOSURE GLAUCOMA,13
GR,BEDRIDDEN,13
GR,BLOOD SODIUM DECREASED,13
GR,CHOLECYSTITIS ACUTE,13
GR,CIRCULATORY COLLAPSE,13
GR,CONJUNCTIVITIS,13
GR,CYTOMEGALOVIRUS INFECTION,13
GR,DRUG EFFECT DECREASED,13
GR,ELECTROLYTE IMBALANCE,13
GR,EMBOLISM,13
GR,ENCEPHALOPATHY,13
GR,EPSTEIN-BARR VIRUS INFECTION,13
GR,FAECES DISCOLOURED,13
GR,GASTRIC ULCER,13
GR,GASTROENTERITIS,13
GR,HAEMOLYSIS,13
GR,HEAD INJURY,13
GR,HEMIPLEGIA,13
GR,HYPOTONIA,13
GR,INJECTION SITE ERYTHEMA,13
GR,INTESTINAL HAEMORRHAGE,13
GR,LACTIC ACIDOSIS,13
GR,LARGE INTESTINE PERFORATION,13
GR,LUNG INFILTRATION,13
GR,LYMPHOCYTE COUNT DECREASED,13
GR,MACULAR OEDEMA,13
GR,MITRAL VALVE INCOMPETENCE,13
GR,MUSCLE RIGIDITY,13
GR,NEPHROTIC SYNDROME,13
GR,PARALYSIS,13
GR,POLLAKIURIA,13
GR,PSEUDOMONAS INFECTION,13
GR,ROAD TRAFFIC ACCIDENT,13
GR,SENSORY LOSS,13
GR,SKIN DISCOLOURATION,13
GR,SQUAMOUS CELL CARCINOMA,13
GR,SUBDURAL HAEMATOMA,13
GR,THERAPY NON-RESPONDER,13
GR,TROPONIN INCREASED,13
GR,VISUAL FIELD DEFECT,13
GR,ACUTE CORONARY SYNDROME,12
GR,ACUTE LYMPHOCYTIC LEUKAEMIA,12
GR,BEZOAR,12
GR,BLADDER CANCER,12
GR,BLOOD PRESSURE ABNORMAL,12
GR,BLOOD TRIGLYCERIDES INCREASED,12
GR,BLOOD URIC ACID INCREASED,12
GR,CAESAREAN SECTION,12
GR,CHORIORETINOPATHY,12
GR,CHROMATURIA,12
GR,COGNITIVE DISORDER,12
GR,DELUSION,12
GR,DEMYELINATION,12
GR,DEVICE DISLOCATION,12
GR,DIABETES MELLITUS INADEQUATE CONTROL,12
GR,DYSSTASIA,12
GR,ECZEMA,12
GR,ENDOPHTHALMITIS,12
GR,EYE HAEMORRHAGE,12
GR,FEAR,12
GR,GINGIVAL BLEEDING,12
GR,HEPATITIS,12
GR,HEPATOCELLULAR CARCINOMA,12
GR,HEPATOMEGALY,12
GR,HOSPITALISATION,12
GR,IMPAIRED HEALING,12
GR,KLEBSIELLA INFECTION,12
GR,LIMB INJURY,12
GR,LIVER FUNCTION TEST ABNORMAL,12
GR,LOWER LIMB FRACTURE,12
GR,MOUTH ULCERATION,12
GR,NECK PAIN,12
GR,NEURALGIA,12
GR,OESOPHAGITIS,12
GR,OLIGURIA,12
GR,OSTEOPOROTIC FRACTURE,12
GR,PAIN IN JAW,12
GR,PARKINSON^S DISEASE,12
GR,POLYP,12
GR,RASH PUSTULAR,12
GR,RIGHT VENTRICULAR FAILURE,12
GR,SLEEP DISORDER,12
GR,TOOTH EXTRACTION,12
GR,WOUND,12
GR,ABSCESS,11
GR,ALTERED STATE OF CONSCIOUSNESS,11
GR,BACTERIAL SEPSIS,11
GR,CANDIDA INFECTION,11
GR,CARDIOPULMONARY FAILURE,11
GR,COAGULOPATHY,11
GR,COLON CANCER,11
GR,DERMATITIS ACNEIFORM,11
GR,EXPOSED BONE IN JAW,11
GR,GASTROOESOPHAGEAL REFLUX DISEASE,11
GR,H1N1 INFLUENZA,11
GR,HEPATIC LESION,11
GR,HYPOPHOSPHATAEMIA,11
GR,HYPOPYON,11
GR,HYPOTHERMIA,11
GR,ILEUS PARALYTIC,11
GR,IMMUNOSUPPRESSION,11
GR,JOINT EFFUSION,11
GR,LARYNGEAL OEDEMA,11
GR,NEUTROPHIL COUNT DECREASED,11
GR,ORAL PAIN,11
GR,PANIC ATTACK,11
GR,PLATELET COUNT ABNORMAL,11
GR,PROCTITIS,11
GR,PSEUDOMEMBRANOUS COLITIS,11
GR,PSYCHOMOTOR HYPERACTIVITY,11
GR,PURPURA,11
GR,SERUM FERRITIN INCREASED,11
GR,TUMOUR LYSIS SYNDROME,11
GR,URINE OUTPUT DECREASED,11
GR,UVEITIS,11
GR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,11
GR,ACTIVITIES OF DAILY LIVING IMPAIRED,10
GR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,10
GR,ADRENAL INSUFFICIENCY,10
GR,ATYPICAL FEMUR FRACTURE,10
GR,AUTOIMMUNE HAEMOLYTIC ANAEMIA,10
GR,BLINDNESS UNILATERAL,10
GR,COMMUNICATION DISORDER,10
GR,CONCOMITANT DISEASE AGGRAVATED,10
GR,DECUBITUS ULCER,10
GR,DRUG LEVEL INCREASED,10
GR,DYSPNOEA EXERTIONAL,10
GR,ENCEPHALITIS,10
GR,EYE INFLAMMATION,10
GR,FISTULA,10
GR,HAEMORRHAGE INTRACRANIAL,10
GR,HAEMORRHOIDS,10
GR,HEART RATE DECREASED,10
GR,HODGKIN^S DISEASE,10
GR,HYPERBILIRUBINAEMIA,10
GR,HYPERLIPIDAEMIA,10
GR,HYPERTHYROIDISM,10
GR,HYPOAESTHESIA ORAL,10
GR,HYPOPHAGIA,10
GR,INJURY,10
GR,LIP SWELLING,10
GR,LUNG CANCER METASTATIC,10
GR,MACULAR DEGENERATION,10
GR,MACULOPATHY,10
GR,MAJOR DEPRESSION,10
GR,MENTAL STATUS CHANGES,10
GR,MYOSITIS,10
GR,NIGHTMARE,10
GR,NON-HODGKIN^S LYMPHOMA,10
GR,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,10
GR,OSTEOMYELITIS,10
GR,OVARIAN CYST,10
GR,PARESIS,10
GR,PLEURISY,10
GR,PULMONARY ARTERIAL HYPERTENSION,10
GR,SCHIZOPHRENIA,10
GR,SKIN DISORDER,10
GR,SKIN REACTION,10
GR,SKIN TOXICITY,10
GR,SOFT TISSUE INFECTION,10
GR,SPINAL PAIN,10
GR,STEVENS-JOHNSON SYNDROME,10
GR,TRANSPLANT REJECTION,10
GR,TUBERCULIN TEST POSITIVE,10
GR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,10
GR,ANGIOPATHY,9
GR,APNOEA,9
GR,ASPERGILLUS INFECTION,9
GR,BLOOD DISORDER,9
GR,BLOOD URINE PRESENT,9
GR,BONE MARROW OEDEMA,9
GR,CARDIAC FAILURE ACUTE,9
GR,CARDIOVASCULAR DISORDER,9
GR,CATABOLIC STATE,9
GR,CHRONIC LYMPHOCYTIC LEUKAEMIA,9
GR,COLITIS ISCHAEMIC,9
GR,COORDINATION ABNORMAL,9
GR,CORONARY ARTERY OCCLUSION,9
GR,DIPLEGIA,9
GR,DRUG ERUPTION,9
GR,DYSAESTHESIA,9
GR,EAR INFECTION,9
GR,ERYTHEMA MULTIFORME,9
GR,FACIAL PARESIS,9
GR,FEELING HOT,9
GR,FRACTURE,9
GR,HEPATIC CANCER,9
GR,HEPATIC CIRRHOSIS,9
GR,HEPATIC ENCEPHALOPATHY,9
GR,HERPES VIRUS INFECTION,9
GR,HYPERKERATOSIS,9
GR,HYPERSENSITIVITY VASCULITIS,9
GR,INCORRECT DRUG ADMINISTRATION DURATION,9
GR,INFLAMMATORY MARKER INCREASED,9
GR,INGUINAL HERNIA,9
GR,INJECTION SITE PAIN,9
GR,METASTASIS,9
GR,MOTOR DYSFUNCTION,9
GR,MYELOFIBROSIS,9
GR,NOCARDIOSIS,9
GR,PETECHIAE,9
GR,POLYNEUROPATHY,9
GR,PORTAL VEIN THROMBOSIS,9
GR,PRESCRIBED OVERDOSE,9
GR,PRESCRIBED UNDERDOSE,9
GR,RASH ERYTHEMATOUS,9
GR,RENAL PAIN,9
GR,SINUSITIS,9
GR,TACHYARRHYTHMIA,9
GR,THROAT IRRITATION,9
GR,THYROID DISORDER,9
GR,TONSILLITIS,9
GR,TOOTH ABSCESS,9
GR,TOOTH LOSS,9
GR,TUBULOINTERSTITIAL NEPHRITIS,9
GR,ULCER,9
GR,UNDERDOSE,9
GR,VIRAL MUTATION IDENTIFIED,9
GR,ABDOMINAL ADHESIONS,8
GR,ACUTE LEUKAEMIA,8
GR,ANTINUCLEAR ANTIBODY POSITIVE,8
GR,ASTHENOPIA,8
GR,ATRIOVENTRICULAR BLOCK COMPLETE,8
GR,AUTOIMMUNE DISORDER,8
GR,AUTOIMMUNE HEPATITIS,8
GR,BLADDER PAPILLOMA,8
GR,BONE LESION,8
GR,CHRONIC KIDNEY DISEASE,8
GR,CYANOSIS,8
GR,ERYSIPELAS,8
GR,ERYTHEMA NODOSUM,8
GR,ESCHERICHIA URINARY TRACT INFECTION,8
GR,EXTRAVASATION,8
GR,FIBRIN D DIMER INCREASED,8
GR,GASTRIC CANCER,8
GR,GASTRITIS,8
GR,GASTROINTESTINAL TOXICITY,8
GR,GLOMERULAR FILTRATION RATE DECREASED,8
GR,GLYCOSYLATED HAEMOGLOBIN INCREASED,8
GR,GRANULOMA,8
GR,GUILLAIN-BARRE SYNDROME,8
GR,HEPATOSPLENOMEGALY,8
GR,HERNIA,8
GR,HYPERPYREXIA,8
GR,HYPERTRIGLYCERIDAEMIA,8
GR,ILLUSION,8
GR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,8
GR,INCONTINENCE,8
GR,INJECTION SITE OEDEMA,8
GR,INTERNATIONAL NORMALISED RATIO INCREASED,8
GR,INTERVERTEBRAL DISC PROTRUSION,8
GR,INTESTINAL STENOSIS,8
GR,INVASIVE DUCTAL BREAST CARCINOMA,8
GR,JUGULAR VEIN DISTENSION,8
GR,LEUKOENCEPHALOPATHY,8
GR,LOCALISED OEDEMA,8
GR,LUNG ABSCESS,8
GR,MALIGNANT MELANOMA,8
GR,MENINGIOMA,8
GR,MENINGITIS,8
GR,MENTAL IMPAIRMENT,8
GR,MUSCLE SPASTICITY,8
GR,MUSCULOSKELETAL DISORDER,8
GR,NEOPLASM,8
GR,NERVOUSNESS,8
GR,NEUTROPENIC INFECTION,8
GR,PANCREATITIS NECROTISING,8
GR,PARAPARESIS,8
GR,PATHOLOGICAL FRACTURE,8
GR,PERIPHERAL SENSORY NEUROPATHY,8
GR,PERIPHERAL VENOUS DISEASE,8
GR,PHOTOPHOBIA,8
GR,POLYURIA,8
GR,QUADRIPARESIS,8
GR,RED BLOOD CELL COUNT DECREASED,8
GR,RENAL ARTERY STENOSIS,8
GR,RESTLESS LEGS SYNDROME,8
GR,RETCHING,8
GR,RHINORRHOEA,8
GR,SACROILIITIS,8
GR,STUPOR,8
GR,THERAPEUTIC RESPONSE UNEXPECTED,8
GR,THERAPY RESPONDER,8
GR,THROMBOPHLEBITIS,8
GR,TOOTHACHE,8
GR,WALKING DISABILITY,8
GR,WHITE BLOOD CELL COUNT ABNORMAL,8
GR,ACCIDENT,7
GR,ACUTE HEPATIC FAILURE,7
GR,AMYLASE INCREASED,7
GR,ANEURYSM,7
GR,APHTHOUS STOMATITIS,7
GR,APLASTIC ANAEMIA,7
GR,ARTERIOSCLEROSIS,7
GR,BACK DISORDER,7
GR,BILIARY TRACT DISORDER,7
GR,BLINDNESS TRANSIENT,7
GR,BLOOD POTASSIUM INCREASED,7
GR,BREATH SOUNDS ABNORMAL,7
GR,CARDIAC DYSFUNCTION,7
GR,CARDIAC FAILURE CHRONIC,7
GR,CARDIAC FAILURE CONGESTIVE,7
GR,CHOKING,7
GR,CHOKING SENSATION,7
GR,CHRONIC MYELOID LEUKAEMIA,7
GR,CLOSTRIDIUM DIFFICILE INFECTION,7
GR,CORONARY ARTERY STENOSIS,7
GR,CRYING,7
GR,CYSTITIS HAEMORRHAGIC,7
GR,CYSTOID MACULAR OEDEMA,7
GR,DIASTOLIC DYSFUNCTION,7
GR,DISTURBANCE IN ATTENTION,7
GR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,7
GR,DYSPHORIA,7
GR,ENDOMETRIAL CANCER,7
GR,EOSINOPHILIC PNEUMONIA ACUTE,7
GR,EYE PRURITUS,7
GR,FLUID RETENTION,7
GR,FOETAL DEATH,7
GR,GAIT INABILITY,7
GR,GASTROINTESTINAL CARCINOMA,7
GR,GASTROINTESTINAL PAIN,7
GR,GENERALISED TONIC-CLONIC SEIZURE,7
GR,GINGIVAL HYPERPLASIA,7
GR,GLOMERULONEPHRITIS,7
GR,HEPATIC FUNCTION ABNORMAL,7
GR,HYPOACUSIS,7
GR,JOINT DISLOCATION,7
GR,LABORATORY TEST ABNORMAL,7
GR,LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION,7
GR,LEUKAEMIA,7
GR,LIPOMA,7
GR,LOWER GASTROINTESTINAL HAEMORRHAGE,7
GR,LYMPHOCYTOSIS,7
GR,MACULAR HOLE,7
GR,MASS,7
GR,MENORRHAGIA,7
GR,MIGRAINE,7
GR,MONOPLEGIA,7
GR,MOOD ALTERED,7
GR,MULTIPLE-DRUG RESISTANCE,7
GR,MYASTHENIA GRAVIS,7
GR,MYCOSIS FUNGOIDES,7
GR,NODULE,7
GR,NYSTAGMUS,7
GR,ORGANISING PNEUMONIA,7
GR,PELVIC FRACTURE,7
GR,PHARYNGITIS,7
GR,PNEUMOCYSTIS JIROVECII INFECTION,7
GR,POISONING,7
GR,PROSTATIC SPECIFIC ANTIGEN INCREASED,7
GR,PUSTULAR PSORIASIS,7
GR,RENAL COLIC,7
GR,RENAL FAILURE CHRONIC,7
GR,RETINAL VEIN THROMBOSIS,7
GR,SALIVARY HYPERSECRETION,7
GR,SCLERODERMA,7
GR,SKIN INFECTION,7
GR,SKIN IRRITATION,7
GR,SKIN NECROSIS,7
GR,SMALL INTESTINAL OBSTRUCTION,7
GR,SWOLLEN TONGUE,7
GR,THERAPY CESSATION,7
GR,THROAT TIGHTNESS,7
GR,THROMBOPHLEBITIS SUPERFICIAL,7
GR,TONGUE ULCERATION,7
GR,TRICUSPID VALVE INCOMPETENCE,7
GR,TYPE 1 DIABETES MELLITUS,7
GR,TYPE I HYPERSENSITIVITY,7
GR,UNEVALUABLE EVENT,7
GR,VENTRICULAR TACHYCARDIA,7
GR,WHEEZING,7
GR,ABDOMINAL MASS,6
GR,ABDOMINAL PAIN LOWER,6
GR,ABNORMAL DREAMS,6
GR,ALBUMIN URINE PRESENT,6
GR,ANGIOPLASTY,6
GR,ANOSMIA,6
GR,APPENDICITIS,6
GR,ATRIOVENTRICULAR BLOCK,6
GR,B-CELL LYMPHOMA,6
GR,BILE DUCT OBSTRUCTION,6
GR,BLOOD PRESSURE FLUCTUATION,6
GR,BLOOD THYROID STIMULATING HORMONE INCREASED,6
GR,BONE DENSITY DECREASED,6
GR,BONE DISORDER,6
GR,CARDIAC MURMUR,6
GR,CARDIAC TAMPONADE,6
GR,CEREBRAL HAEMATOMA,6
GR,CEREBRAL INFARCTION,6
GR,CEREBRAL ISCHAEMIA,6
GR,COLD SWEAT,6
GR,CORNEAL DISORDER,6
GR,CORYNEBACTERIUM INFECTION,6
GR,CYTOPENIA,6
GR,DEAFNESS NEUROSENSORY,6
GR,DEVICE MALFUNCTION,6
GR,DRUG WITHDRAWAL SYNDROME,6
GR,DUODENAL ULCER,6
GR,DYSLIPIDAEMIA,6
GR,DYSTONIA,6
GR,ECCHYMOSIS,6
GR,ELECTROCARDIOGRAM ABNORMAL,6
GR,EMBOLIC STROKE,6
GR,ESCHERICHIA INFECTION,6
GR,EYELID PTOSIS,6
GR,FORCED EXPIRATORY VOLUME DECREASED,6
GR,FUNGAL INFECTION,6
GR,GASTRIC DISORDER,6
GR,GASTRITIS EROSIVE,6
GR,GINGIVAL PAIN,6
GR,HEPATITIS C,6
GR,HYPERNATRAEMIA,6
GR,HYPERREFLEXIA,6
GR,HYPERTRANSAMINASAEMIA,6
GR,HYPOALBUMINAEMIA,6
GR,IMMOBILE,6
GR,IMMUNE-MEDIATED ADVERSE REACTION,6
GR,IMPAIRED GASTRIC EMPTYING,6
GR,INJECTION SITE REACTION,6
GR,INTENTIONAL PRODUCT USE ISSUE,6
GR,IRIS ATROPHY,6
GR,KERATOACANTHOMA,6
GR,LARYNGITIS,6
GR,LEFT VENTRICULAR DYSFUNCTION,6
GR,LEUKAEMIA RECURRENT,6
GR,LIBIDO DECREASED,6
GR,LIP OEDEMA,6
GR,LIVER FUNCTION TEST INCREASED,6
GR,LUMBAR VERTEBRAL FRACTURE,6
GR,LUNG ADENOCARCINOMA,6
GR,LYMPHADENITIS,6
GR,MEGACOLON,6
GR,MIOSIS,6
GR,MOUTH HAEMORRHAGE,6
GR,MUSCLE HAEMORRHAGE,6
GR,NORMOCHROMIC NORMOCYTIC ANAEMIA,6
GR,ORAL DISORDER,6
GR,ORAL FUNGAL INFECTION,6
GR,OSTEOPENIA,6
GR,PERFORMANCE STATUS DECREASED,6
GR,PERIORBITAL OEDEMA,6
GR,PERIPHERAL EMBOLISM,6
GR,PHARYNGEAL OEDEMA,6
GR,PLASMA CELL LEUKAEMIA,6
GR,PLEUROTHOTONUS,6
GR,POLYARTHRITIS,6
GR,POLYDIPSIA,6
GR,PREMATURE LABOUR,6
GR,PURULENCE,6
GR,PYODERMA GANGRENOSUM,6
GR,REBOUND EFFECT,6
GR,RECTAL CANCER,6
GR,RECURRENT CANCER,6
GR,RENAL TUBULAR NECROSIS,6
GR,RETINAL VASCULITIS,6
GR,RETINOPATHY,6
GR,SCIATICA,6
GR,SHOCK HAEMORRHAGIC,6
GR,SKIN CANCER,6
GR,SQUAMOUS CELL CARCINOMA OF SKIN,6
GR,STEATOHEPATITIS,6
GR,STRESS CARDIOMYOPATHY,6
GR,SUDDEN CARDIAC DEATH,6
GR,TENSION,6
GR,THERMAL BURN,6
GR,TOXIC EPIDERMAL NECROLYSIS,6
GR,TRANSFUSION,6
GR,URINARY TRACT INFECTION BACTERIAL,6
GR,YELLOW SKIN,6
GR,ABORTION,5
GR,ACCIDENTAL EXPOSURE TO PRODUCT,5
GR,ACUTE HEPATITIS B,5
GR,ANTINUCLEAR ANTIBODY INCREASED,5
GR,ANTIPHOSPHOLIPID SYNDROME,5
GR,AORTIC VALVE INCOMPETENCE,5
GR,ATELECTASIS,5
GR,ATRIAL FLUTTER,5
GR,ATRIAL THROMBOSIS,5
GR,AUTOIMMUNE THYROIDITIS,5
GR,BACTERIAL INFECTION,5
GR,BLEPHARITIS,5
GR,BLOOD CALCIUM DECREASED,5
GR,BLOOD GLUCOSE DECREASED,5
GR,BLOOD IRON DECREASED,5
GR,BLOOD POTASSIUM DECREASED,5
GR,BONE MARROW DISORDER,5
GR,BRADYKINESIA,5
GR,BREAST MASS,5
GR,CARDIAC FIBRILLATION,5
GR,CEREBRAL ATROPHY,5
GR,CEREBRAL VENOUS THROMBOSIS,5
GR,CLONUS,5
GR,COLECTOMY,5
GR,COMPLICATIONS OF TRANSPLANTED KIDNEY,5
GR,CONJUNCTIVAL OEDEMA,5
GR,COOMBS POSITIVE HAEMOLYTIC ANAEMIA,5
GR,DACRYOSTENOSIS ACQUIRED,5
GR,DECREASED IMMUNE RESPONSIVENESS,5
GR,DERMATITIS BULLOUS,5
GR,DEVICE ISSUE,5
GR,DEVICE KINK,5
GR,DEVICE RELATED INFECTION,5
GR,DIFFUSE LARGE B-CELL LYMPHOMA,5
GR,DRUG EFFECT INCOMPLETE,5
GR,DRUG LEVEL BELOW THERAPEUTIC,5
GR,DRY EYE,5
GR,DYSPNOEA AT REST,5
GR,EATING DISORDER,5
GR,EMPHYSEMA,5
GR,ENTEROCOLITIS,5
GR,FAMILIAL MEDITERRANEAN FEVER,5
GR,FLOPPY IRIS SYNDROME,5
GR,FOREIGN BODY SENSATION IN EYES,5
GR,GASTROINTESTINAL INFLAMMATION,5
GR,GINGIVAL DISORDER,5
GR,GINGIVITIS,5
GR,GLOSSODYNIA,5
GR,GRANULOMATOSIS WITH POLYANGIITIS,5
GR,GUTTATE PSORIASIS,5
GR,HAEMORRHOIDAL HAEMORRHAGE,5
GR,HAEMOTHORAX,5
GR,HALLUCINATION_ AUDITORY,5
GR,HEAD DISCOMFORT,5
GR,HEPATIC ENZYME ABNORMAL,5
GR,HEPATOCELLULAR INJURY,5
GR,HEPATORENAL SYNDROME,5
GR,HYPERAMMONAEMIC ENCEPHALOPATHY,5
GR,HYPOKINESIA,5
GR,HYPOVOLAEMIC SHOCK,5
GR,ILL-DEFINED DISORDER,5
GR,IMMUNE SYSTEM DISORDER,5
GR,IMMUNE THROMBOCYTOPENIC PURPURA,5
GR,INFECTIOUS MONONUCLEOSIS,5
GR,INJECTION SITE PRURITUS,5
GR,INTESTINAL OBSTRUCTION,5
GR,INTESTINAL POLYP,5
GL,DRUG INEFFECTIVE,1
GL,HEADACHE,1
GL,MENINGIOMA,1
GL,MENINGIOMA BENIGN,1
GL,PROTEINURIA,1
GL,RENAL FAILURE,1
GL,RENAL IMPAIRMENT,1
GD,PNEUMOCEPHALUS,4
GD,MATERNAL EXPOSURE DURING PREGNANCY,3
GD,DRUG INEFFECTIVE,2
GD,INTESTINAL OBSTRUCTION,2
GD,ANAEMIA,1
GD,ANGULAR CHEILITIS,1
GD,BONE MARROW INFILTRATION,1
GD,CELLULITIS,1
GD,CONSTIPATION,1
GD,DEPRESSION,1
GD,DIARRHOEA,1
GD,DYSARTHRIA,1
GD,EXPOSURE DURING PREGNANCY,1
GD,FAILURE TO THRIVE,1
GD,FATIGUE,1
GD,GLUCAGONOMA,1
GD,HYPOTENSION,1
GD,INTENTIONAL OVERDOSE,1
GD,METABOLIC ACIDOSIS,1
GD,OEDEMA PERIPHERAL,1
GD,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
GD,PERIPHERAL VENOUS DISEASE,1
GD,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
GD,RASH,1
GD,RASH ERYTHEMATOUS,1
GD,RENAL IMPAIRMENT,1
GD,RETROPERITONEAL LYMPHADENOPATHY,1
GD,SKIN EXFOLIATION,1
GD,THROMBOCYTOPENIA,1
GD,VOLVULUS,1
GD,WEIGHT DECREASED,1
GP,CORNEAL DISORDER,1
GP,DEATH,1
GP,GASTRODUODENAL ULCER,1
GP,GASTROINTESTINAL HAEMORRHAGE,1
GP,GASTROINTESTINAL NEOPLASM,1
GP,HYPOTHALAMO-PITUITARY DISORDER,1
GP,IRIDOCELE,1
GP,METASTASES TO CENTRAL NERVOUS SYSTEM,1
GP,PULMONARY EMBOLISM,1
GP,ULCERATIVE KERATITIS,1
GU,DEATH,3
GU,ANAEMIA,1
GU,ASTHENIA,1
GU,DEHYDRATION,1
GU,DEMENTIA,1
GU,DERMATITIS,1
GU,DERMATITIS ACNEIFORM,1
GU,DIARRHOEA,1
GU,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
GU,DRUG DOSE OMISSION,1
GU,DYSPEPSIA,1
GU,EXPOSURE DURING PREGNANCY,1
GU,FATIGUE,1
GU,HYPERCALCAEMIA,1
GU,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
GU,INSOMNIA,1
GU,MALAISE,1
GU,MIGRAINE,1
GU,MUCOSAL INFLAMMATION,1
GU,MYOCARDIAL INFARCTION,1
GU,NAUSEA,1
GU,NO THERAPEUTIC RESPONSE,1
GU,OVERDOSE,1
GU,PARAESTHESIA,1
GU,PRODUCT EXPIRATION DATE ISSUE,1
GU,PRODUCT LOT NUMBER ISSUE,1
GU,PRODUCT USE ISSUE,1
GU,PRURITUS,1
GU,RASH,1
GU,SKIN IRRITATION,1
GU,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
GU,VOMITING,1
GU,WEIGHT DECREASED,1
GT,DEATH,148
GT,MALAISE,76
GT,PAIN,32
GT,PAIN IN EXTREMITY,29
GT,DYSPNOEA,27
GT,PNEUMONIA,26
GT,PYREXIA,24
GT,HEADACHE,22
GT,FATIGUE,21
GT,SERRATIA BACTERAEMIA,21
GT,VOMITING,21
GT,DIARRHOEA,19
GT,DIZZINESS,19
GT,MYOCARDIAL INFARCTION,18
GT,WEIGHT DECREASED,18
GT,ARTHRALGIA,17
GT,GAIT DISTURBANCE,17
GT,MULTIPLE SCLEROSIS RELAPSE,17
GT,URINARY TRACT INFECTION,17
GT,DRUG INEFFECTIVE,16
GT,FEELING ABNORMAL,16
GT,ABDOMINAL PAIN,15
GT,ABDOMINAL PAIN UPPER,15
GT,ASTHENIA,15
GT,DIABETES MELLITUS,15
GT,HAEMOGLOBIN DECREASED,15
GT,NAUSEA,15
GT,RENAL FAILURE,15
GT,GENERAL PHYSICAL HEALTH DETERIORATION,14
GT,ANAEMIA,13
GT,FALL,13
GT,MOBILITY DECREASED,13
GT,CEREBROVASCULAR ACCIDENT,12
GT,COUGH,12
GT,DEPRESSION,12
GT,HYPOTENSION,12
GT,PRODUCT USE ISSUE,12
GT,BLOOD PRESSURE INCREASED,11
GT,PERIPHERAL SWELLING,11
GT,RASH,10
GT,SPEECH DISORDER,10
GT,CARDIAC DISORDER,9
GT,CHEST PAIN,9
GT,HYPERSENSITIVITY,9
GT,HYPERTENSION,9
GT,MUSCULAR WEAKNESS,9
GT,SEIZURE,9
GT,VISUAL IMPAIRMENT,9
GT,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,9
GT,ANXIETY,8
GT,CARDIAC ARREST,8
GT,DECREASED APPETITE,8
GT,MEMORY IMPAIRMENT,8
GT,SOMNOLENCE,8
GT,ABDOMINAL DISCOMFORT,7
GT,ARRHYTHMIA,7
GT,BACK PAIN,7
GT,CARDIAC FAILURE,7
GT,DYSPHAGIA,7
GT,HIP FRACTURE,7
GT,INFECTION,7
GT,SEROTONIN SYNDROME,7
GT,SYNCOPE,7
GT,BLOOD GLUCOSE INCREASED,6
GT,BLOOD PRESSURE DECREASED,6
GT,BONE PAIN,6
GT,CARDIO-RESPIRATORY ARREST,6
GT,GASTRITIS,6
GT,HYPOAESTHESIA,6
GT,INFLUENZA,6
GT,LIMB DISCOMFORT,6
GT,MALIGNANT NEOPLASM PROGRESSION,6
GT,MUSCLE SPASMS,6
GT,PULMONARY EMBOLISM,6
GT,SWELLING,6
GT,TACHYCARDIA,6
GT,TREMOR,6
GT,ABASIA,5
GT,APHASIA,5
GT,CENTRAL NERVOUS SYSTEM LESION,5
GT,DEHYDRATION,5
GT,DENGUE FEVER,5
GT,DEVICE RELATED INFECTION,5
GT,DYSURIA,5
GT,EYE PAIN,5
GT,FLUID RETENTION,5
GT,GASTROINTESTINAL DISORDER,5
GT,HAEMORRHAGE,5
GT,HEART RATE DECREASED,5
GT,LIVER DISORDER,5
GT,LOSS OF CONSCIOUSNESS,5
GT,MUSCULOSKELETAL PAIN,5
GT,PLATELET COUNT DECREASED,5
GT,PRURITUS,5
GT,RESPIRATORY DISORDER,5
GT,TINNITUS,5
GT,TRANSAMINASES INCREASED,5
GT,URINARY INCONTINENCE,5
GT,VISION BLURRED,5
GT,VISUAL ACUITY REDUCED,5
GT,WHITE BLOOD CELL COUNT DECREASED,5
GT,ANAPHYLACTIC REACTION,4
GT,BLINDNESS,4
GT,BLOOD CREATININE INCREASED,4
GT,BRONCHITIS,4
GT,CARDIOMEGALY,4
GT,CHIKUNGUNYA VIRUS INFECTION,4
GT,CHOLELITHIASIS,4
GT,CONSTIPATION,4
GT,DEEP VEIN THROMBOSIS,4
GT,DEMENTIA ALZHEIMER^S TYPE,4
GT,DISCOMFORT,4
GT,DYSPHONIA,4
GT,EXPOSURE DURING PREGNANCY,4
GT,EYE HAEMORRHAGE,4
GT,FEELING COLD,4
GT,GASTROOESOPHAGEAL REFLUX DISEASE,4
GT,HEAD DISCOMFORT,4
GT,HEPATIC STEATOSIS,4
GT,HERNIA,4
GT,HYPOGLYCAEMIA,4
GT,INSOMNIA,4
GT,JAUNDICE,4
GT,LUNG DISORDER,4
GT,MATERNAL EXPOSURE DURING PREGNANCY,4
GT,MULTIPLE SCLEROSIS,4
GT,NEOPLASM,4
GT,NEPHROLITHIASIS,4
GT,NEPHROPATHY,4
GT,OCULAR HYPERAEMIA,4
GT,OEDEMA PERIPHERAL,4
GT,OROPHARYNGEAL PAIN,4
GT,PARAESTHESIA,4
GT,PLEURAL EFFUSION,4
GT,PRODUCTIVE COUGH,4
GT,RENAL DISORDER,4
GT,RENAL FAILURE ACUTE,4
GT,SERRATIA INFECTION,4
GT,TOXICITY TO VARIOUS AGENTS,4
GT,WOUND,4
GT,ABDOMINAL DISTENSION,3
GT,ACCIDENT,3
GT,ACUTE KIDNEY INJURY,3
GT,AGGRESSION,3
GT,ALOPECIA,3
GT,ANAL INCONTINENCE,3
GT,APHONIA,3
GT,ARTHROPATHY,3
GT,ASTHMATIC CRISIS,3
GT,BALANCE DISORDER,3
GT,BLOOD GLUCOSE DECREASED,3
GT,BLOOD PRESSURE ABNORMAL,3
GT,BONE DISORDER,3
GT,BURNING SENSATION,3
GT,CHILLS,3
GT,CHOKING,3
GT,CLUMSINESS,3
GT,CONDITION AGGRAVATED,3
GT,CRYING,3
GT,CYANOSIS,3
GT,CYST,3
GT,DEAFNESS,3
GT,DECREASED IMMUNE RESPONSIVENESS,3
GT,DISEASE RECURRENCE,3
GT,DRUG INTOLERANCE,3
GT,EATING DISORDER,3
GT,EPISTAXIS,3
GT,FAECES DISCOLOURED,3
GT,FEMUR FRACTURE,3
GT,FOETAL EXPOSURE DURING PREGNANCY,3
GT,GASTRIC ULCER,3
GT,GASTROINTESTINAL INFECTION,3
GT,HAEMATOCHEZIA,3
GT,HAEMATURIA,3
GT,HEAD INJURY,3
GT,HEART RATE INCREASED,3
GT,HEPATIC FAILURE,3
GT,HEPATITIS,3
GT,HYPERTHYROIDISM,3
GT,HYPOKINESIA,3
GT,HYPOVOLAEMIC SHOCK,3
GT,INCONTINENCE,3
GT,INFARCTION,3
GT,INFLAMMATION,3
GT,LOWER GASTROINTESTINAL HAEMORRHAGE,3
GT,LYMPHOCYTE COUNT DECREASED,3
GT,MOVEMENT DISORDER,3
GT,MYALGIA,3
GT,NASAL CONGESTION,3
GT,NASOPHARYNGITIS,3
GT,NECK PAIN,3
GT,NEOPLASM PROGRESSION,3
GT,NERVOUS SYSTEM DISORDER,3
GT,NERVOUSNESS,3
GT,NEUROPATHY PERIPHERAL,3
GT,OPTIC NEURITIS,3
GT,OSTEOARTHRITIS,3
GT,OSTEOPOROSIS,3
GT,PALLOR,3
GT,PERICARDIAL EFFUSION,3
GT,PNEUMOTHORAX,3
GT,POLLAKIURIA,3
GT,PRESCRIBED UNDERDOSE,3
GT,PRODUCT USE IN UNAPPROVED INDICATION,3
GT,PULMONARY HAEMORRHAGE,3
GT,SEPTIC SHOCK,3
GT,SERUM FERRITIN INCREASED,3
GT,SPLENOMEGALY,3
GT,STEVENS-JOHNSON SYNDROME,3
GT,STOMATITIS,3
GT,SUDDEN DEATH,3
GT,THROMBOCYTOPENIA,3
GT,UPPER GASTROINTESTINAL HAEMORRHAGE,3
GT,UPPER LIMB FRACTURE,3
GT,URTICARIA,3
GT,VERTIGO,3
GT,ABDOMINAL HERNIA,2
GT,ABNORMAL BEHAVIOUR,2
GT,ABORTION SPONTANEOUS,2
GT,ACUTE LYMPHOCYTIC LEUKAEMIA,2
GT,ADVERSE DRUG REACTION,2
GT,ADVERSE EVENT,2
GT,AGITATION,2
GT,ALANINE AMINOTRANSFERASE INCREASED,2
GT,ANGIOPATHY,2
GT,APHTHOUS STOMATITIS,2
GT,ARTERIOVENOUS FISTULA OCCLUSION,2
GT,ARTERIOVENOUS FISTULA SITE COMPLICATION,2
GT,ARTHRITIS,2
GT,ASPARTATE AMINOTRANSFERASE INCREASED,2
GT,ASPHYXIA,2
GT,ASTHMA,2
GT,ATRIAL FIBRILLATION,2
GT,AUTONOMIC NERVOUS SYSTEM IMBALANCE,2
GT,BACK INJURY,2
GT,BACTERAEMIA,2
GT,BLOOD BILIRUBIN INCREASED,2
GT,BLOOD GLUCOSE ABNORMAL,2
GT,BLOOD PARATHYROID HORMONE DECREASED,2
GT,BLOOD PARATHYROID HORMONE INCREASED,2
GT,BLOOD PRESSURE SYSTOLIC INCREASED,2
GT,BLOOD SODIUM DECREASED,2
GT,BRONCHIAL HYPERREACTIVITY,2
GT,CARTILAGE INJURY,2
GT,CATHETER SITE INFECTION,2
GT,CEREBRAL HAEMORRHAGE,2
GT,CEREBRAL THROMBOSIS,2
GT,CHEST DISCOMFORT,2
GT,COGNITIVE DISORDER,2
GT,COLON CANCER,2
GT,COMPLICATION ASSOCIATED WITH DEVICE,2
GT,CONCOMITANT DISEASE AGGRAVATED,2
GT,CONJUNCTIVITIS ALLERGIC,2
GT,DELIRIUM,2
GT,DEMENTIA,2
GT,DEPRESSED MOOD,2
GT,DIABETES MELLITUS INADEQUATE CONTROL,2
GT,DIARRHOEA HAEMORRHAGIC,2
GT,DIPLOPIA,2
GT,DISEASE PROGRESSION,2
GT,DISORIENTATION,2
GT,DYSPNOEA EXERTIONAL,2
GT,EJECTION FRACTION DECREASED,2
GT,EMPHYSEMA,2
GT,ERYTHEMA,2
GT,EYE IRRITATION,2
GT,FLATULENCE,2
GT,FOETAL DEATH,2
GT,FOETAL DISTRESS SYNDROME,2
GT,FOETAL GROWTH RESTRICTION,2
GT,GAIT INABILITY,2
GT,GASTRIC DISORDER,2
GT,GASTROINTESTINAL HAEMORRHAGE,2
GT,GASTROINTESTINAL PAIN,2
GT,GENERALISED OEDEMA,2
GT,GENITAL HAEMORRHAGE,2
GT,GLAUCOMA,2
GT,GOITRE,2
GT,HAEMATEMESIS,2
GT,HAEMOGLOBIN INCREASED,2
GT,HAEMOLYSIS,2
GT,HAEMORRHOIDS,2
GT,HALLUCINATION,2
GT,HEPATIC CIRRHOSIS,2
GT,HEPATIC ENZYME INCREASED,2
GT,HYDROCEPHALUS,2
GT,HYPERGLYCAEMIA,2
GT,HYPERHIDROSIS,2
GT,HYPOACUSIS,2
GT,HYPOPHAGIA,2
GT,HYPOTHERMIA,2
GT,INFECTED SKIN ULCER,2
GT,INJECTION SITE PAIN,2
GT,IRRITABLE BOWEL SYNDROME,2
GT,LEUKOCYTOSIS,2
GT,LIVER FUNCTION TEST INCREASED,2
GT,LOOSE TOOTH,2
GT,MENTAL DISORDER,2
GT,MENTAL IMPAIRMENT,2
GT,MICTURITION URGENCY,2
GT,MIGRAINE,2
GT,NECK MASS,2
GT,NEUTROPHIL COUNT DECREASED,2
GT,NORMAL NEWBORN,2
GT,OCULAR DISCOMFORT,2
GT,OROPHARYNGEAL DISCOMFORT,2
GT,OVARIAN CYST,2
GT,PANCREATITIS,2
GT,PRESCRIBED OVERDOSE,2
GT,PULMONARY OEDEMA,2
GT,PURULENT DISCHARGE,2
GT,RENAL TRANSPLANT,2
GT,RESPIRATORY ARREST,2
GT,SENSORY DISTURBANCE,2
GT,SEPSIS,2
GT,SHOCK,2
GT,SKIN DISCOLOURATION,2
GT,SKIN ULCER,2
GT,SLEEP DISORDER,2
GT,SUICIDAL IDEATION,2
GT,SWELLING FACE,2
GT,SYSTEMIC LUPUS ERYTHEMATOSUS,2
GT,THROMBOSIS,2
GT,TUMOUR MARKER INCREASED,2
GT,ULCER,2
GT,URINE OUTPUT DECREASED,2
GT,VAGINAL HAEMORRHAGE,2
GT,WEIGHT INCREASED,2
GT,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
GT,ABDOMINAL ADHESIONS,1
GT,ABDOMINAL MASS,1
GT,ABDOMINAL PAIN LOWER,1
GT,ABNORMAL SENSATION IN EYE,1
GT,ABORTION,1
GT,ABSCESS,1
GT,ABSCESS LIMB,1
GT,ABSCESS NECK,1
GT,ACCIDENTAL OVERDOSE,1
GT,ACCIDENTAL UNDERDOSE,1
GT,ACNE,1
GT,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
GT,ACUTE MYOCARDIAL INFARCTION,1
GT,ACUTE PULMONARY OEDEMA,1
GT,ACUTE RESPIRATORY FAILURE,1
GT,ADENOCARCINOMA,1
GT,ADENOMYOSIS,1
GT,AGEUSIA,1
GT,AMNESIA,1
GT,ANAL ULCER,1
GT,ANAPHYLACTIC SHOCK,1
GT,ANGER,1
GT,ANGINA PECTORIS,1
GT,ANIMAL BITE,1
GT,ANORECTAL DISORDER,1
GT,ANTI-JC VIRUS ANTIBODY INDEX,1
GT,ANURIA,1
GT,AORTIC ANEURYSM,1
GT,APHAGIA,1
GT,APHTHOUS ULCER,1
GT,APLASIA,1
GT,APPARENT DEATH,1
GT,APPENDICITIS,1
GT,APPENDIX DISORDER,1
GT,APPLICATION SITE HAEMATOMA,1
GT,ARTERIAL INJURY,1
GT,ARTERIAL INSUFFICIENCY,1
GT,ARTERIAL OCCLUSIVE DISEASE,1
GT,ARTERIOVENOUS FISTULA SITE INFECTION,1
GT,ARTERIOVENOUS FISTULA THROMBOSIS,1
GT,ASPIRATION,1
GT,ASTIGMATISM,1
GT,ATAXIA,1
GT,ATRIAL TACHYCARDIA,1
GT,ATRIOVENTRICULAR BLOCK,1
GT,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
GT,BACTERIAL TEST POSITIVE,1
GT,BASOPHIL PERCENTAGE INCREASED,1
GT,BEDRIDDEN,1
GT,BENIGN NEOPLASM,1
GT,BENIGN PROSTATIC HYPERPLASIA,1
GT,BENIGN TUMOUR EXCISION,1
GT,BILIRUBIN CONJUGATED INCREASED,1
GT,BIPOLAR I DISORDER,1
GT,BLADDER DISCOMFORT,1
GT,BLADDER PROLAPSE,1
GT,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
GT,BLINDNESS UNILATERAL,1
GT,BLOOD ALKALINE PHOSPHATASE INCREASED,1
GT,BLOOD CREATININE ABNORMAL,1
GT,BLOOD CREATININE DECREASED,1
GT,BLOOD GLUCOSE FLUCTUATION,1
GT,BLOOD GROWTH HORMONE INCREASED,1
GT,BLOOD IRON INCREASED,1
GT,BLOOD PHOSPHORUS ABNORMAL,1
GT,BLOOD POTASSIUM DECREASED,1
GT,BLOOD PRESSURE FLUCTUATION,1
GT,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
GT,BLOOD URINE PRESENT,1
GT,BODY MASS INDEX DECREASED,1
GT,BODY TEMPERATURE FLUCTUATION,1
GT,BONE LESION,1
GT,BRADYCARDIA,1
GT,BRAIN NATRIURETIC PEPTIDE INCREASED,1
GT,BRAIN NEOPLASM,1
GT,BREAST CANCER,1
GT,BREAST ULCERATION,1
GT,BUNDLE BRANCH BLOCK,1
GT,BURKHOLDERIA INFECTION,1
GT,CAESAREAN SECTION,1
GT,CALCIUM METABOLISM DISORDER,1
GT,CALCULUS URINARY,1
GT,CANDIDA INFECTION,1
GT,CARDIAC FAILURE CONGESTIVE,1
GT,CARDIAC FIBRILLATION,1
GT,CARDIAC INFECTION,1
GT,CARDIAC TAMPONADE,1
GT,CARDIOGENIC SHOCK,1
GT,CARDIOVASCULAR DISORDER,1
GT,CATHETER REMOVAL,1
GT,CATHETER SITE PAIN,1
GT,CEREBELLAR SYNDROME,1
GT,CEREBRAL ATROPHY,1
GT,CEREBRAL INFARCTION,1
GT,CEREBRAL ISCHAEMIA,1
GT,CEREBROVASCULAR DISORDER,1
GT,CHAPPED LIPS,1
GT,CHEST INJURY,1
GT,CHOLECYSTITIS,1
GT,CHOLECYSTITIS INFECTIVE,1
GT,CHROMATURIA,1
GT,CHRONIC MYELOID LEUKAEMIA,1
GT,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
GT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
GT,CHRONIC SINUSITIS,1
GT,CLOSTRIDIAL INFECTION,1
GT,COELIAC DISEASE,1
GT,COLD SWEAT,1
GT,COLITIS,1
GT,COLITIS ULCERATIVE,1
GT,COMA,1
GT,COMMUNICATION DISORDER,1
GT,CONCOMITANT DISEASE PROGRESSION,1
GT,CONFUSIONAL STATE,1
GT,CONGESTIVE CARDIOMYOPATHY,1
GT,CONJUNCTIVITIS,1
GT,CONTRAINDICATED PRODUCT ADMINISTERED,1
GT,CONTUSION,1
GT,COORDINATION ABNORMAL,1
GT,CORONARY ARTERY OCCLUSION,1
GT,CYSTITIS,1
GT,DEAFNESS UNILATERAL,1
GT,DECUBITUS ULCER,1
GT,DENTAL NECROSIS,1
GT,DEVICE EXPULSION,1
GT,DEVICE INFUSION ISSUE,1
GT,DEVICE ISSUE,1
GT,DEVICE OCCLUSION,1
GT,DEVICE USE ISSUE,1
GT,DIABETIC FOOT INFECTION,1
GT,DISEASE COMPLICATION,1
GT,DIVERTICULUM INTESTINAL,1
GT,DRUG EFFECT INCOMPLETE,1
GT,DRUG LEVEL INCREASED,1
GT,DRUG PRESCRIBING ERROR,1
GT,DRUG RESISTANCE,1
GT,DRUG WITHDRAWAL SYNDROME,1
GT,DRUG-INDUCED LIVER INJURY,1
GT,DRY EYE,1
GT,DRY SKIN,1
GT,DUODENITIS,1
GT,DYSCHEZIA,1
GT,DYSGRAPHIA,1
GT,DYSPEPSIA,1
GT,DYSSTASIA,1
GT,EAR DISORDER,1
GT,EAR INFECTION,1
GT,EAR NEOPLASM,1
GT,EAR PAIN,1
GT,ECCHYMOSIS,1
GT,ECLAMPSIA,1
GT,EFFUSION,1
GT,ELECTROLYTE IMBALANCE,1
GT,EMOTIONAL DISORDER,1
GT,EOSINOPHIL COUNT INCREASED,1
GT,EPHELIDES,1
GT,EPIGASTRIC DISCOMFORT,1
GT,ERYTHEMA OF EYELID,1
GT,ERYTHRODERMIC PSORIASIS,1
GT,ESCHERICHIA INFECTION,1
GT,ESCHERICHIA URINARY TRACT INFECTION,1
GT,EXPIRED PRODUCT ADMINISTERED,1
GT,EYE INFECTION,1
GT,EYE PRURITUS,1
GT,EYE SWELLING,1
GT,EYELID OEDEMA,1
GT,FAECES SOFT,1
GT,FASCIAL RUPTURE,1
GT,FAT EMBOLISM,1
GT,FEBRILE NEUTROPENIA,1
GT,FEEDING DISORDER,1
GT,FEELING DRUNK,1
GT,FEELING HOT,1
GT,FEELING OF DESPAIR,1
GT,FEMORAL HERNIA,1
GT,FOOD INTOLERANCE,1
GT,FOOD POISONING,1
GT,FOOT DEFORMITY,1
GT,FRACTURE,1
GT,GALLBLADDER DISORDER,1
GT,GALLBLADDER OPERATION,1
GT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
GT,GANGRENE,1
GT,GASTRIC CANCER,1
GT,GASTRIC HAEMORRHAGE,1
GT,GASTRIC INFECTION,1
GT,GASTRODUODENITIS,1
GT,GASTROINTESTINAL STROMAL TUMOUR,1
GT,GASTROINTESTINAL SURGERY,1
GT,GESTATIONAL HYPERTENSION,1
GT,GINGIVAL BLEEDING,1
GT,GINGIVAL DISORDER,1
GT,GLOMERULONEPHRITIS,1
GT,GLUTEN SENSITIVITY,1
GT,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
GT,GRIP STRENGTH DECREASED,1
GT,GROIN PAIN,1
GT,HAEMARTHROSIS,1
GT,HAEMATOCOLPOS,1
GT,HAEMATOCRIT DECREASED,1
GT,HAEMATOCRIT INCREASED,1
GT,HAEMATOMA,1
GT,HAEMODIALYSIS-INDUCED SYMPTOM,1
GT,HAEMOGLOBIN ABNORMAL,1
GT,HAEMOPTYSIS,1
GT,HAND FRACTURE,1
GT,HEARING IMPAIRED,1
GT,HEMIPLEGIA,1
GT,HEPATIC CANCER,1
GT,HEPATIC FIBROSIS,1
GT,HEPATIC LESION,1
GT,HEPATIC MASS,1
GT,HEPATIC NEOPLASM,1
GT,HEPATITIS CHOLESTATIC,1
GT,HEPATOMEGALY,1
GT,HERPES VIRUS INFECTION,1
GT,HERPES ZOSTER,1
GT,HORMONE LEVEL ABNORMAL,1
GT,HUMERUS FRACTURE,1
GT,HYPERAMMONAEMIA,1
GT,HYPERCREATINAEMIA,1
GT,HYPERTENSIVE CRISIS,1
GT,HYPOKALAEMIA,1
GT,HYPOTHYROIDISM,1
GT,HYPOTONIA,1
GT,HYPOXIA,1
GT,IGA NEPHROPATHY,1
GT,IMMUNODEFICIENCY,1
GT,IMMUNOSUPPRESSION,1
GT,IMPAIRED GASTRIC EMPTYING,1
GT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
GT,INCISION SITE HAEMORRHAGE,1
GT,INCISION SITE PAIN,1
GT,INCOHERENT,1
GT,INCORRECT DOSE ADMINISTERED,1
GT,INCORRECT DRUG ADMINISTRATION DURATION,1
GT,INFECTIOUS COLITIS,1
GT,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
GT,INFUSION RELATED REACTION,1
GT,INFUSION SITE DISCOLOURATION,1
GT,INGUINAL HERNIA,1
GT,INJECTION SITE ERYTHEMA,1
GT,INJECTION SITE INJURY,1
GT,INJECTION SITE ULCER,1
GT,INNER EAR DISORDER,1
GT,INTELLECTUAL DISABILITY,1
GT,INTENTIONAL OVERDOSE,1
GT,INTENTIONAL PRODUCT USE ISSUE,1
GT,INTERMITTENT CLAUDICATION,1
GT,INTERNAL HAEMORRHAGE,1
GT,INTERVERTEBRAL DISC DISORDER,1
GT,INTESTINAL HAEMORRHAGE,1
GT,INTESTINAL OBSTRUCTION,1
GT,INTESTINAL PERFORATION,1
GT,INTRACARDIAC THROMBUS,1
GT,INTRAOCULAR HAEMATOMA,1
GT,INTRAOCULAR PRESSURE INCREASED,1
GT,IRIDOTOMY,1
GT,IRREGULAR SLEEP PHASE,1
GT,ISCHAEMIA,1
GT,ISCHAEMIC STROKE,1
GT,JOINT DISLOCATION,1
GT,JOINT INJURY,1
GT,JOINT NEOPLASM,1
GT,JOINT RANGE OF MOTION DECREASED,1
GT,JOINT STIFFNESS,1
GT,JUGULAR VEIN DISTENSION,1
GT,KERATITIS,1
GT,KIDNEY INFECTION,1
GT,KIDNEY TRANSPLANT REJECTION,1
GT,LABOUR PAIN,1
GT,LEUKAEMIA,1
GT,LEUKOPENIA,1
GT,LIMB DEFORMITY,1
GT,LIMB INJURY,1
GT,LIP SWELLING,1
GT,LIVE BIRTH,1
GT,LIVER FUNCTION TEST ABNORMAL,1
GT,LIVER INJURY,1
GT,LOW BIRTH WEIGHT BABY,1
GT,LUNG INFECTION,1
GT,LUNG NEOPLASM MALIGNANT,1
GT,LUPUS NEPHRITIS,1
GT,MACULAR DETACHMENT,1
GT,MASS,1
GT,MATERNAL EXPOSURE DURING DELIVERY,1
GT,MEAN PLATELET VOLUME DECREASED,1
GT,MENISCUS INJURY,1
GT,MESENTERIC VEIN THROMBOSIS,1
GT,METASTASES TO BONE,1
GT,METASTASES TO CENTRAL NERVOUS SYSTEM,1
GT,METASTASES TO LUNG,1
GT,METASTASES TO THE MEDIASTINUM,1
GT,METASTASIS,1
GT,MIGRATION OF IMPLANTED DRUG,1
GT,MITRAL VALVE DISEASE,1
GT,MONOCYTE COUNT INCREASED,1
GT,MONOCYTE PERCENTAGE INCREASED,1
GT,MONOPLEGIA,1
GT,MOUTH SWELLING,1
GT,MOUTH ULCERATION,1
GT,MULTI-ORGAN FAILURE,1
GT,MUSCLE CONTRACTURE,1
GT,MUSCLE RIGIDITY,1
GT,MUSCULOSKELETAL DISORDER,1
GT,MUSCULOSKELETAL STIFFNESS,1
GT,MYELOFIBROSIS,1
GT,MYOCARDIAL ISCHAEMIA,1
GT,MYOCARDIAL RUPTURE,1
GT,MYOCLONUS,1
GT,MYOPIA,1
GT,NAIL DISORDER,1
GT,NECROSIS ISCHAEMIC,1
GT,NEOPLASM MALIGNANT,1
GT,NERVE COMPRESSION,1
GT,NEURODEGENERATIVE DISORDER,1
GT,NEUROLOGICAL SYMPTOM,1
GT,NEUTROPENIA,1
GT,NEUTROPHIL COUNT INCREASED,1
GT,NEUTROPHIL PERCENTAGE INCREASED,1
GT,NIGHT SWEATS,1
GT,NO ADVERSE EVENT,1
GT,NOCTURIA,1
GT,NON-HODGKIN^S LYMPHOMA,1
GT,NONINFECTIVE ENCEPHALITIS,1
GT,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
GT,OBSTRUCTIVE AIRWAYS DISORDER,1
GT,OEDEMA,1
GT,OESOPHAGEAL CANDIDIASIS,1
GT,OLIGOHYDRAMNIOS,1
GT,OPHTHALMOPLEGIA,1
GT,ORAL DISCOMFORT,1
GT,ORAL PAIN,1
GT,OROPHARYNGEAL CANDIDIASIS,1
GT,ORTHOSTATIC INTOLERANCE,1
GT,OSTEONECROSIS OF JAW,1
GT,OVERWEIGHT,1
GT,OXYGEN SATURATION DECREASED,1
GT,PALATAL OEDEMA,1
GT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
GT,PALPITATIONS,1
GT,PANCREATIC CARCINOMA,1
GT,PANCREATITIS HAEMORRHAGIC,1
GT,PARALYSIS,1
GT,PARAPARESIS,1
GT,PARAPLEGIA,1
GT,PARKINSON^S DISEASE,1
GT,PATHOGEN RESISTANCE,1
GT,PELVIC PAIN,1
GT,PERINEAL PAIN,1
GT,PERIPHERAL ARTERY ANEURYSM,1
GT,PERIPHERAL ISCHAEMIA,1
GT,PHARYNGEAL ULCERATION,1
GT,PLASMA CELL MYELOMA,1
GT,PLATELET COUNT ABNORMAL,1
GT,PLEUROCUTANEOUS FISTULA,1
GT,PNEUMONITIS,1
GT,POLYMENORRHOEA,1
GT,POST ABORTION HAEMORRHAGE,1
GT,POSTOPERATIVE ABSCESS,1
GT,POSTOPERATIVE THROMBOSIS,1
GT,POVERTY OF SPEECH,1
GT,PRE-ECLAMPSIA,1
GT,PREGNANCY WITH CONTRACEPTIVE DEVICE,1
GT,PREMATURE BABY,1
GT,PREMATURE DELIVERY,1
GT,PROCEDURAL HAEMORRHAGE,1
GT,PROCTALGIA,1
GT,PRODUCT USE COMPLAINT,1
GT,PROSTATE CANCER,1
GT,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
GT,PROTEINURIA,1
GT,PROTHROMBIN TIME PROLONGED,1
GT,PSYCHIATRIC SYMPTOM,1
GT,PSYCHOTIC DISORDER,1
GT,PULMONARY CONGESTION,1
GT,PULMONARY HYPERTENSION,1
GT,PULMONARY MASS,1
GT,PULMONARY THROMBOSIS,1
GT,PYELONEPHRITIS,1
GT,RASH GENERALISED,1
GT,RASH PAPULAR,1
GT,RED BLOOD CELL COUNT DECREASED,1
GT,RED BLOOD CELL COUNT INCREASED,1
GT,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
GT,RENAL CYST,1
GT,RENAL FAILURE CHRONIC,1
GT,RENAL IMPAIRMENT,1
GT,RENAL MASS,1
GT,RENAL PAIN,1
GT,RENAL TRANSPLANT FAILURE,1
GT,RENAL TUBULAR NECROSIS,1
GT,RESPIRATORY FAILURE,1
GT,RESPIRATORY TRACT INFECTION,1
GT,RESPIRATORY TRACT INFECTION BACTERIAL,1
GT,RETINAL DETACHMENT,1
GT,RHEUMATOID ARTHRITIS,1
GT,RIB FRACTURE,1
GT,ROAD TRAFFIC ACCIDENT,1
GT,ROMBERG TEST POSITIVE,1
GT,SCREAMING,1
GT,SECOND PRIMARY MALIGNANCY,1
GT,SECRETION DISCHARGE,1
GT,SELF INJURIOUS BEHAVIOUR,1
GT,SENSORY LOSS,1
GT,SERUM FERRITIN DECREASED,1
GT,SHOCK HYPOGLYCAEMIC,1
GT,SINUS NODE DYSFUNCTION,1
GT,SINUSITIS,1
GT,SJOGREN^S SYNDROME,1
GT,SKIN BACTERIAL INFECTION,1
GT,SKIN BURNING SENSATION,1
GT,SKIN DEPIGMENTATION,1
GT,SKIN FISSURES,1
GT,SKIN INFECTION,1
GT,SKIN LESION,1
GT,SKIN REACTION,1
GT,SKIN TOXICITY,1
GT,SKIN WARM,1
GT,SPINAL COLUMN INJURY,1
GT,SPINAL CORD HERNIATION,1
GT,SPINAL DEFORMITY,1
GT,SPINAL DISORDER,1
GT,SPINAL PAIN,1
GT,SPLEEN DISORDER,1
GT,STARING,1
GT,STEM CELL TRANSPLANT,1
GT,STRESS,1
GT,STRIDOR,1
GT,SUBDURAL HAEMATOMA,1
GT,SURGERY,1
GT,SUSPECTED COUNTERFEIT PRODUCT,1
GT,TEMPERATURE REGULATION DISORDER,1
GT,TENDON DISORDER,1
GT,TENDON INJURY,1
GT,THERAPEUTIC RESPONSE DELAYED,1
GT,THERAPY CESSATION,1
GT,THERAPY NON-RESPONDER,1
GT,THROAT CANCER,1
GT,THROAT IRRITATION,1
GT,THROAT TIGHTNESS,1
GT,THROMBOCYTOSIS,1
GT,THROMBOSIS IN DEVICE,1
GT,TICK PARALYSIS,1
GT,TONGUE DISCOMFORT,1
GT,TONGUE DISORDER,1
GT,TONGUE GEOGRAPHIC,1
GT,TONSILLAR EXUDATE,1
GT,TONSILLITIS,1
GT,TONSILLITIS BACTERIAL,1
GT,TOOTH LOSS,1
GT,TOOTH SOCKET HAEMORRHAGE,1
GT,TOOTHACHE,1
GT,TOTAL LUNG CAPACITY DECREASED,1
GT,TOXIC ENCEPHALOPATHY,1
GT,TRANSFUSION,1
GT,TRANSFUSION RELATED COMPLICATION,1
GT,TUBERCULOSIS,1
GT,TWIN PREGNANCY,1
GT,TYMPANOPLASTY,1
GT,UMBILICAL HERNIA,1
GT,URINARY RETENTION,1
GT,URINARY TRACT DISORDER,1
GT,URINE ANALYSIS ABNORMAL,1
GT,UTERINE ENLARGEMENT,1
GT,UTERINE LEIOMYOMA,1
GT,UVEITIS,1
GT,VAGINAL ULCERATION,1
GT,VARICOSE VEIN,1
GT,VASCULAR ACCESS COMPLICATION,1
GT,VASCULITIS,1
GT,VASOSPASM,1
GT,VEIN DISORDER,1
GT,VENOUS HAEMORRHAGE,1
GT,VENOUS THROMBOSIS LIMB,1
GT,VENOUS VALVE RUPTURED,1
GT,VENTRICULAR DYSFUNCTION,1
GT,VENTRICULAR EXTRASYSTOLES,1
GT,VENTRICULAR TACHYCARDIA,1
GT,VIRAL INFECTION,1
GT,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
GT,WEIGHT LOSS POOR,1
GT,WERNER^S SYNDROME,1
GT,WHEEZING,1
GT,WRONG DRUG ADMINISTERED,1
GG,HAEMORRHAGE,1
GN,EXPOSURE DURING PREGNANCY,2
GN,INTENTIONAL PRODUCT USE ISSUE,2
GN,NIKOLSKY^S SIGN,2
GN,RESPIRATORY DISTRESS,2
GN,SKIN EROSION,2
GN,SKIN EXFOLIATION,2
GN,TOXIC EPIDERMAL NECROLYSIS,2
GN,WOUND SECRETION,2
GN,ANAEMIA,1
GN,ASPHYXIA,1
GN,BASOPHILIA,1
GN,BLISTER,1
GN,CARDIO-RESPIRATORY ARREST,1
GN,CEREBROVASCULAR ACCIDENT,1
GN,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
GN,CONJUNCTIVAL DISORDER,1
GN,CONJUNCTIVAL EROSION,1
GN,DECREASED APPETITE,1
GN,DERMATITIS BULLOUS,1
GN,DIPLEGIA,1
GN,EBOLA DISEASE,1
GN,FOETAL DEATH,1
GN,FOETAL EXPOSURE DURING PREGNANCY,1
GN,GENERAL PHYSICAL HEALTH DETERIORATION,1
GN,GENITAL EROSION,1
GN,GENITAL LESION,1
GN,HEADACHE,1
GN,HEMIPARESIS,1
GN,HEMIPLEGIA,1
GN,HYPERTENSIVE CRISIS,1
GN,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
GN,LOW BIRTH WEIGHT BABY,1
GN,MATERNAL EXPOSURE DURING PREGNANCY,1
GN,MUCOSAL EROSION,1
GN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
GN,ORAL DISORDER,1
GN,ORAL MUCOSA EROSION,1
GN,OVERDOSE,1
GN,PREMATURE BABY,1
GN,PREMATURE DELIVERY,1
GN,PYREXIA,1
GN,RASH,1
GN,SPEECH DISORDER,1
GN,SPLENOMEGALY,1
GN,STILLBIRTH,1
GN,VIITH NERVE PARALYSIS,1
GN,VOMITING,1
GN,WHITE BLOOD CELL COUNT INCREASED,1
GW,DEATH,6
GW,DIARRHOEA,3
GW,PYREXIA,3
GW,UNEVALUABLE EVENT,3
GW,VOMITING,3
GW,ABDOMINAL PAIN UPPER,2
GW,ABORTION SPONTANEOUS,2
GW,ANAEMIA,2
GW,NAUSEA,2
GW,CEREBRAL TOXOPLASMOSIS,1
GW,COUGH,1
GW,CRYPTOCOCCOSIS,1
GW,DYSURIA,1
GW,HEADACHE,1
GW,INSOMNIA,1
GW,MOUTH ULCERATION,1
GW,MULTI-ORGAN FAILURE,1
GW,MYALGIA,1
GW,NEUROPATHY PERIPHERAL,1
GW,OEDEMA,1
GW,ORAL CANDIDIASIS,1
GW,PARALYSIS,1
GW,RESPIRATORY DISORDER,1
GW,TOXOPLASMOSIS,1
GW,VIITH NERVE PARALYSIS,1
GY,RENAL IMPAIRMENT,1
HT,ANAEMIA,7
HT,SEPSIS,5
HT,MATERNAL EXPOSURE DURING PREGNANCY,3
HT,STILLBIRTH,3
HT,ABORTION SPONTANEOUS,2
HT,CEREBRAL CALCIFICATION,2
HT,DEATH,2
HT,DIARRHOEA,2
HT,GASTROINTESTINAL STROMAL TUMOUR,2
HT,MALIGNANT NEOPLASM PROGRESSION,2
HT,RESPIRATORY DISTRESS,2
HT,RESPIRATORY TRACT INFECTION,2
HT,ABDOMINAL DISTENSION,1
HT,ABDOMINAL PAIN,1
HT,ACUTE KIDNEY INJURY,1
HT,AGITATION,1
HT,AIDS RELATED COMPLICATION,1
HT,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,1
HT,ASPARTATE AMINOTRANSFERASE INCREASED,1
HT,ATRIAL FIBRILLATION,1
HT,BENIGN PROSTATIC HYPERPLASIA,1
HT,BLOOD GLUCOSE INCREASED,1
HT,BLOOD SODIUM DECREASED,1
HT,CACHEXIA,1
HT,CONFUSIONAL STATE,1
HT,CONGESTIVE CARDIOMYOPATHY,1
HT,DECREASED APPETITE,1
HT,DEHYDRATION,1
HT,DEPRESSED LEVEL OF CONSCIOUSNESS,1
HT,DIABETIC KETOACIDOSIS,1
HT,DISCOMFORT,1
HT,DRUG DOSE OMISSION,1
HT,ENCEPHALOMALACIA,1
HT,EXPOSURE DURING PREGNANCY,1
HT,FOETAL EXPOSURE DURING PREGNANCY,1
HT,GASTROENTERITIS,1
HT,GASTROINTESTINAL DISORDER,1
HT,GENITOURINARY TRACT INFECTION,1
HT,HEAT EXHAUSTION,1
HT,HELICOBACTER INFECTION,1
HT,HEPATOTOXICITY,1
HT,HERBAL INTERACTION,1
HT,HYPOGLYCAEMIA,1
HT,IDIOPATHIC INTERSTITIAL PNEUMONIA,1
HT,INTERNATIONAL NORMALISED RATIO INCREASED,1
HT,LIVE BIRTH,1
HT,MALNUTRITION,1
HT,NEOPLASM RECURRENCE,1
HT,PERFORMANCE STATUS DECREASED,1
HT,PNEUMONIA,1
HT,PRODUCT USE ISSUE,1
HT,RENAL FAILURE ACUTE,1
HT,SEIZURE,1
HT,SEPSIS SYNDROME,1
HT,TREATMENT FAILURE,1
HT,TUBERCULOSIS,1
HT,URINARY TRACT INFECTION,1
HT,WRONG PATIENT RECEIVED MEDICATION,1
HN,DEATH,136
HN,CEREBROVASCULAR ACCIDENT,20
HN,MALAISE,18
HN,PYREXIA,18
HN,GAIT DISTURBANCE,14
HN,DYSPNOEA,13
HN,ASTHENIA,11
HN,DIARRHOEA,11
HN,FATIGUE,11
HN,HEADACHE,11
HN,HAEMOGLOBIN DECREASED,10
HN,MYOCARDIAL INFARCTION,10
HN,THROMBOCYTOPENIA,10
HN,VOMITING,10
HN,DEAFNESS,9
HN,THERAPEUTIC RESPONSE DECREASED,9
HN,DIABETES MELLITUS,8
HN,FALL,8
HN,FEELING ABNORMAL,8
HN,NAUSEA,8
HN,PNEUMONIA,8
HN,SPLENOMEGALY,8
HN,ABASIA,7
HN,ABDOMINAL PAIN,7
HN,ANAEMIA,7
HN,ARTHRALGIA,7
HN,BLOOD PRESSURE INCREASED,7
HN,DECREASED APPETITE,7
HN,DRUG INEFFECTIVE,7
HN,PLATELET COUNT DECREASED,7
HN,RENAL FAILURE,7
HN,BLOOD GLUCOSE INCREASED,6
HN,CARDIAC DISORDER,6
HN,CARDIO-RESPIRATORY ARREST,6
HN,CHEST PAIN,6
HN,DIZZINESS,6
HN,EXPOSURE DURING PREGNANCY,6
HN,GENERAL PHYSICAL HEALTH DETERIORATION,6
HN,HYPERTENSION,6
HN,HYPOACUSIS,6
HN,HYPOTENSION,6
HN,PALLOR,6
HN,PANCYTOPENIA,6
HN,CONDITION AGGRAVATED,5
HN,COUGH,5
HN,DRUG INTOLERANCE,5
HN,EPISTAXIS,5
HN,HYPERSENSITIVITY,5
HN,INFARCTION,5
HN,INSOMNIA,5
HN,LEUKOCYTOSIS,5
HN,MEMORY IMPAIRMENT,5
HN,OEDEMA PERIPHERAL,5
HN,PAIN IN EXTREMITY,5
HN,SOMNOLENCE,5
HN,TACHYCARDIA,5
HN,TREMOR,5
HN,ABDOMINAL PAIN UPPER,4
HN,ARRHYTHMIA,4
HN,BONE PAIN,4
HN,CEREBRAL HAEMORRHAGE,4
HN,DEHYDRATION,4
HN,DRUG RESISTANCE,4
HN,DYSPHAGIA,4
HN,GAIT INABILITY,4
HN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
HN,INFLUENZA,4
HN,MALIGNANT NEOPLASM PROGRESSION,4
HN,PLATELET COUNT INCREASED,4
HN,SEIZURE,4
HN,SPEECH DISORDER,4
HN,THROMBOSIS,4
HN,WHITE BLOOD CELL COUNT INCREASED,4
HN,ACCIDENT,3
HN,ALTERED STATE OF CONSCIOUSNESS,3
HN,BACK PAIN,3
HN,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,3
HN,BLINDNESS,3
HN,BLOOD PRESSURE DECREASED,3
HN,CARDIAC ARREST,3
HN,CARDIAC FAILURE,3
HN,CHOKING,3
HN,CHRONIC MYELOID LEUKAEMIA,3
HN,CONSTIPATION,3
HN,DEPRESSED MOOD,3
HN,DEPRESSION,3
HN,DISORIENTATION,3
HN,DRUG PRESCRIBING ERROR,3
HN,EATING DISORDER,3
HN,FEELING HOT,3
HN,FLUID RETENTION,3
HN,FOETAL EXPOSURE DURING PREGNANCY,3
HN,GASTROINTESTINAL STROMAL TUMOUR,3
HN,HAEMORRHAGE INTRACRANIAL,3
HN,HYPERAESTHESIA,3
HN,HYPERHIDROSIS,3
HN,HYPERTHYROIDISM,3
HN,INTRACRANIAL PRESSURE INCREASED,3
HN,LIVER DISORDER,3
HN,LOSS OF CONSCIOUSNESS,3
HN,MATERNAL EXPOSURE DURING PREGNANCY,3
HN,METASTASES TO LIVER,3
HN,MOBILITY DECREASED,3
HN,MYDRIASIS,3
HN,PAIN,3
HN,PALPITATIONS,3
HN,RENAL IMPAIRMENT,3
HN,RESPIRATORY ARREST,3
HN,SEPSIS,3
HN,SUBARACHNOID HAEMORRHAGE,3
HN,SYNCOPE,3
HN,VAGINAL HAEMORRHAGE,3
HN,WEIGHT INCREASED,3
HN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
HN,ABORTION SPONTANEOUS,2
HN,ANURIA,2
HN,ANXIETY,2
HN,APPENDICITIS,2
HN,ARTHROPATHY,2
HN,ASTHMA,2
HN,ASTHMATIC CRISIS,2
HN,BALANCE DISORDER,2
HN,BLOOD BILIRUBIN INCREASED,2
HN,BLOOD CHOLESTEROL INCREASED,2
HN,BLOOD CREATININE INCREASED,2
HN,BLOOD GLUCOSE DECREASED,2
HN,BLOOD SODIUM DECREASED,2
HN,BRAIN HERNIATION,2
HN,BRONCHITIS,2
HN,BURNING SENSATION,2
HN,CENTRAL NERVOUS SYSTEM LESION,2
HN,CHOLECYSTITIS,2
HN,CHOLELITHIASIS,2
HN,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,2
HN,COGNITIVE DISORDER,2
HN,COMPLICATION OF PREGNANCY,2
HN,CONFUSIONAL STATE,2
HN,CONVULSION,2
HN,CYANOSIS,2
HN,DECEREBRATE POSTURE,2
HN,DEEP VEIN THROMBOSIS,2
HN,DEMENTIA ALZHEIMER^S TYPE,2
HN,DEMYELINATION,2
HN,DIABETES MELLITUS INADEQUATE CONTROL,2
HN,DRUG ADMINISTRATION ERROR,2
HN,DRY SKIN,2
HN,DYSGEUSIA,2
HN,DYSPHONIA,2
HN,DYSSTASIA,2
HN,EYE PRURITUS,2
HN,FACIAL PARALYSIS,2
HN,FEMUR FRACTURE,2
HN,GASTROINTESTINAL HAEMORRHAGE,2
HN,GASTROOESOPHAGEAL REFLUX DISEASE,2
HN,GENERALISED TONIC-CLONIC SEIZURE,2
HN,GINGIVAL BLEEDING,2
HN,GOITRE,2
HN,HALLUCINATION,2
HN,HEART RATE INCREASED,2
HN,HEPATIC NEOPLASM,2
HN,HYPERGLYCAEMIA,2
HN,HYPERTENSIVE CRISIS,2
HN,HYPERURICAEMIA,2
HN,HYPOAESTHESIA,2
HN,IMMUNE THROMBOCYTOPENIC PURPURA,2
HN,INFLAMMATION,2
HN,KETOACIDOSIS,2
HN,LEUKOPENIA,2
HN,LIGAMENT SPRAIN,2
HN,LIMB INJURY,2
HN,LUNG INFECTION,2
HN,MENORRHAGIA,2
HN,MENTAL DISORDER,2
HN,METASTASES TO PELVIS,2
HN,MOUTH HAEMORRHAGE,2
HN,MOVEMENT DISORDER,2
HN,MUSCULAR WEAKNESS,2
HN,MUSCULOSKELETAL STIFFNESS,2
HN,NEOPLASM PROGRESSION,2
HN,OCCUPATIONAL EXPOSURE TO PRODUCT,2
HN,PARAESTHESIA,2
HN,PARANOIA,2
HN,PERIPHERAL SWELLING,2
HN,PREMATURE BABY,2
HN,PRODUCT USE ISSUE,2
HN,RASH,2
HN,RECURRENT CANCER,2
HN,RESPIRATORY DISORDER,2
HN,RESPIRATORY DISTRESS,2
HN,RETINAL DETACHMENT,2
HN,SCOLIOSIS,2
HN,SEPTIC SHOCK,2
HN,SKIN EXFOLIATION,2
HN,SPINAL CORD DISORDER,2
HN,STILLBIRTH,2
HN,THYROID MASS,2
HN,TOXICITY TO VARIOUS AGENTS,2
HN,VERTIGO,2
HN,WEIGHT DECREASED,2
HN,WHITE BLOOD CELL COUNT DECREASED,2
HN,ABDOMINAL DISCOMFORT,1
HN,ABDOMINAL DISTENSION,1
HN,ABNORMAL BEHAVIOUR,1
HN,ACCIDENT AT WORK,1
HN,ACUTE KIDNEY INJURY,1
HN,ACUTE RESPIRATORY DISTRESS SYNDROME,1
HN,ADVERSE DRUG REACTION,1
HN,ADVERSE EVENT,1
HN,AGITATION,1
HN,AKATHISIA,1
HN,ALLERGIC COUGH,1
HN,ALLERGY TO METALS,1
HN,ALOPECIA,1
HN,ALPHA 1 FOETOPROTEIN INCREASED,1
HN,AMAUROSIS,1
HN,AMNESIA,1
HN,ANAL ULCER,1
HN,ANAPHYLACTIC SHOCK,1
HN,ANEMBRYONIC GESTATION,1
HN,ANEURYSM,1
HN,ANEURYSM RUPTURED,1
HN,ANGIOEDEMA,1
HN,AREFLEXIA,1
HN,ARTHRITIS,1
HN,ARTHRITIS INFECTIVE,1
HN,ASCITES,1
HN,ASPHYXIA,1
HN,ATRIAL THROMBOSIS,1
HN,AZOTAEMIA,1
HN,BLADDER PROLAPSE,1
HN,BLISTER,1
HN,BLOOD CALCIUM ABNORMAL,1
HN,BLOOD CHOLESTEROL DECREASED,1
HN,BLOOD DISORDER,1
HN,BLOOD GLUCOSE ABNORMAL,1
HN,BLOOD GLUCOSE FLUCTUATION,1
HN,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
HN,BLOOD PRESSURE SYSTOLIC INCREASED,1
HN,BLOOD TRIGLYCERIDES INCREASED,1
HN,BLOOD URINE PRESENT,1
HN,BONE DISORDER,1
HN,BRAIN HYPOXIA,1
HN,BRAIN STEM STROKE,1
HN,BREAST INJURY,1
HN,BRONCHITIS CHRONIC,1
HN,BRONCHOSPASM,1
HN,CARDIAC FAILURE CHRONIC,1
HN,CARDIAC FAILURE CONGESTIVE,1
HN,CARDIAC MURMUR,1
HN,CARDIOMEGALY,1
HN,CARDITIS,1
HN,CAROTID ARTERY CALCIFICATION,1
HN,CATARACT,1
HN,CELLULITIS,1
HN,CENTRAL NERVOUS SYSTEM HAEMORRHAGE,1
HN,CHEST DISCOMFORT,1
HN,CHIKUNGUNYA VIRUS INFECTION,1
HN,CHILLS,1
HN,CHOKING SENSATION,1
HN,CHRONIC KIDNEY DISEASE,1
HN,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
HN,CINCHONISM,1
HN,COITAL BLEEDING,1
HN,COLITIS,1
HN,CONGESTIVE CARDIOMYOPATHY,1
HN,CONJUNCTIVAL HAEMORRHAGE,1
HN,CORONARY ARTERY OCCLUSION,1
HN,CRYING,1
HN,CYST,1
HN,CYSTITIS,1
HN,DENGUE FEVER,1
HN,DEPENDENCE ON OXYGEN THERAPY,1
HN,DIABETIC COMPLICATION,1
HN,DIABETIC FOOT INFECTION,1
HN,DIABETIC METABOLIC DECOMPENSATION,1
HN,DIABETIC RETINOPATHY,1
HN,DIALYSIS,1
HN,DISSEMINATED INTRAVASCULAR COAGULATION,1
HN,DIVERTICULUM,1
HN,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
HN,DRY MOUTH,1
HN,DUST ALLERGY,1
HN,DYSARTHRIA,1
HN,DYSGRAPHIA,1
HN,DYSPAREUNIA,1
HN,DYSPNOEA EXERTIONAL,1
HN,DYSURIA,1
HN,EAR DISCOMFORT,1
HN,ECCHYMOSIS,1
HN,ELECTROENCEPHALOGRAM ABNORMAL,1
HN,ELECTROLYTE IMBALANCE,1
HN,EPIDERMAL NECROSIS,1
HN,ERYTHEMA,1
HN,EXCESSIVE CERUMEN PRODUCTION,1
HN,EXPOSURE DURING BREAST FEEDING,1
HN,EYE HAEMORRHAGE,1
HN,EYE SWELLING,1
HN,FEAR,1
HN,FEBRILE NEUTROPENIA,1
HN,FEELING COLD,1
HN,FEELING OF BODY TEMPERATURE CHANGE,1
HN,FEELING OF DESPAIR,1
HN,FEMALE GENITAL TRACT FISTULA,1
HN,FISTULA,1
HN,FLATULENCE,1
HN,FOETAL DEATH,1
HN,FRACTURE NONUNION,1
HN,FUNGAL INFECTION,1
HN,GALLBLADDER DISORDER,1
HN,GALLBLADDER OPERATION,1
HN,GASTRIC ADENOMA,1
HN,GASTRIC DISORDER,1
HN,GASTRIC HAEMORRHAGE,1
HN,GASTRITIS EROSIVE,1
HN,GASTROENTERITIS,1
HN,GENE MUTATION,1
HN,GENERALISED OEDEMA,1
HN,GENITAL HYPERAESTHESIA,1
HN,GLAUCOMA,1
HN,GLUCOSE TOLERANCE IMPAIRED,1
HN,HAEMANGIOMA,1
HN,HAEMATOCRIT DECREASED,1
HN,HAEMATOMA,1
HN,HAEMATURIA,1
HN,HAEMODYNAMIC INSTABILITY,1
HN,HAEMORRHAGE IN PREGNANCY,1
HN,HAEMORRHAGIC STROKE,1
HN,HAEMORRHOIDAL HAEMORRHAGE,1
HN,HAEMORRHOIDS,1
HN,HAIR DISORDER,1
HN,HEAD DISCOMFORT,1
HN,HEART RATE DECREASED,1
HN,HEART VALVE INCOMPETENCE,1
HN,HEMIPARESIS,1
HN,HEMIPLEGIA,1
HN,HEPATIC ENCEPHALOPATHY,1
HN,HEPATITIS,1
HN,HEPATOCELLULAR CARCINOMA,1
HN,HEPATOSPLENOMEGALY,1
HN,HERPES SIMPLEX HEPATITIS,1
HN,HIP FRACTURE,1
HN,HOSPITALISATION,1
HN,HUMERUS FRACTURE,1
HN,HYDRONEPHROSIS,1
HN,HYPERCALCAEMIA,1
HN,HYPOGLYCAEMIA,1
HN,HYPOPHAGIA,1
HN,HYPOTHYROIDISM,1
HN,HYPOVOLAEMIC SHOCK,1
HN,HYPOXIA,1
HN,IMPLANT SITE ERYTHEMA,1
HN,INJECTION SITE ERYTHEMA,1
HN,INJECTION SITE REACTION,1
HN,INTERNAL HAEMORRHAGE,1
HN,INTESTINAL OBSTRUCTION,1
HN,INTESTINAL PERFORATION,1
HN,INTRACRANIAL ANEURYSM,1
HN,INTRAOCULAR PRESSURE INCREASED,1
HN,IRRITABLE BOWEL SYNDROME,1
HN,ISCHAEMIC CEREBRAL INFARCTION,1
HN,ISCHAEMIC STROKE,1
HN,JOINT DISLOCATION,1
HN,JOINT SWELLING,1
HN,KIDNEY INFECTION,1
HN,KNEE OPERATION,1
HN,LETHARGY,1
HN,LIMB DISCOMFORT,1
HN,LIP SWELLING,1
HN,LIVE BIRTH,1
HN,LOCAL SWELLING,1
HN,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
HN,LOW DENSITY LIPOPROTEIN INCREASED,1
HN,LOWER LIMB FRACTURE,1
HN,LOWER RESPIRATORY TRACT INFECTION,1
HN,LUMBAR VERTEBRAL FRACTURE,1
HN,LUNG CANCER METASTATIC,1
HN,LUNG DISORDER,1
HN,LYMPHADENOPATHY,1
HN,LYMPHOCYTE COUNT INCREASED,1
HN,MASTICATION DISORDER,1
HN,MASTITIS,1
HN,MELAENA,1
HN,MENSTRUATION DELAYED,1
HN,METABOLIC ACIDOSIS,1
HN,METASTASES TO ABDOMINAL CAVITY,1
HN,METASTASES TO ABDOMINAL WALL,1
HN,METASTASES TO SPINE,1
HN,METASTASIS,1
HN,MIGRAINE,1
HN,MOOD ALTERED,1
HN,MOTOR DYSFUNCTION,1
HN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
HN,MUSCLE SPASMS,1
HN,MYALGIA,1
HN,NASAL DRYNESS,1
HN,NASOPHARYNGITIS,1
HN,NECK PAIN,1
HN,NEOPLASM,1
HN,NEPHROPATHY,1
HN,NERVOUS SYSTEM DISORDER,1
HN,NERVOUSNESS,1
HN,NEUROLOGICAL SYMPTOM,1
HN,NO ADVERSE EVENT,1
HN,NO THERAPEUTIC RESPONSE,1
HN,NONSPECIFIC REACTION,1
HN,OEDEMA,1
HN,ORAL DISCOMFORT,1
HN,ORAL DISORDER,1
HN,ORAL MUCOSAL DISCOLOURATION,1
HN,ORAL PAIN,1
HN,OROPHARYNGEAL PAIN,1
HN,ORTHOPNOEA,1
HN,OSTEOARTHRITIS,1
HN,OSTEOPOROSIS,1
HN,OVERDOSE,1
HN,OVERWEIGHT,1
HN,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
HN,PAPULE,1
HN,PARKINSON^S DISEASE,1
HN,PENICILLIUM INFECTION,1
HN,PERICARDIAL EFFUSION,1
HN,PERIPHERAL COLDNESS,1
HN,PETIT MAL EPILEPSY,1
HN,PHOTOSENSITIVITY REACTION,1
HN,PIGMENTATION DISORDER,1
HN,PLEURAL EFFUSION,1
HN,POISONING,1
HN,POLYURIA,1
HN,PORTAL VEIN DILATATION,1
HN,PREGNANCY,1
HN,PREGNANCY ON ORAL CONTRACEPTIVE,1
HN,PREGNANCY WITH INJECTABLE CONTRACEPTIVE,1
HN,PREMATURE DELIVERY,1
HN,PRODUCT USE IN UNAPPROVED INDICATION,1
HN,PRODUCTIVE COUGH,1
HN,PROSTATIC DISORDER,1
HN,PROSTATIC OBSTRUCTION,1
HN,PROTEIN TOTAL DECREASED,1
HN,PROTEINURIA,1
HN,PRURITUS GENERALISED,1
HN,PSYCHOTIC DISORDER,1
HN,PULMONARY SEPSIS,1
HN,PULMONARY TUBERCULOSIS,1
HN,RECTAL HAEMORRHAGE,1
HN,RED CELL DISTRIBUTION WIDTH INCREASED,1
HN,RENAL CANCER,1
HN,RENAL CYST,1
HN,RENAL DISORDER,1
HN,RENAL FAILURE ACUTE,1
HN,RENAL INJURY,1
HN,RENAL NEOPLASM,1
HN,RESPIRATORY TRACT INFECTION,1
HN,RESPIRATORY TRACT INFECTION FUNGAL,1
HN,RESTLESSNESS,1
HN,RESUSCITATION,1
HN,RETINAL HAEMORRHAGE,1
HN,RETINAL VASCULAR OCCLUSION,1
HN,RETINAL VASCULAR THROMBOSIS,1
HN,RHINORRHOEA,1
HN,RIB FRACTURE,1
HN,ROAD TRAFFIC ACCIDENT,1
HN,ROSACEA,1
HN,SCIATICA,1
HN,SENILE DEMENTIA,1
HN,SEPTIC ENCEPHALOPATHY,1
HN,SKIN CANCER,1
HN,SKIN HYPERPIGMENTATION,1
HN,SKIN NECROSIS,1
HN,SKIN PLAQUE,1
HN,SPINAL COMPRESSION FRACTURE,1
HN,SPINAL CORD HERNIATION,1
HN,SPINAL DISORDER,1
HN,SPINAL FRACTURE,1
HN,STEVENS-JOHNSON SYNDROME,1
HN,SUDDEN DEATH,1
HN,TACHYPNOEA,1
HN,TERMINAL STATE,1
HN,THROMBOCYTOSIS,1
HN,THYROGLOSSAL CYST,1
HN,THYROID CANCER,1
HN,THYROID DISORDER,1
HN,TINNITUS,1
HN,TONGUE DISCOLOURATION,1
HN,TOXIC ENCEPHALOPATHY,1
HN,TOXIC EPIDERMAL NECROLYSIS,1
HN,TRANSFUSION,1
HN,TREATMENT FAILURE,1
HN,TUBERCULIN TEST POSITIVE,1
HN,ULTRASOUND KIDNEY ABNORMAL,1
HN,URINARY TRACT INFECTION,1
HN,URINARY TRACT INFECTION BACTERIAL,1
HN,UTERINE LEIOMYOMA,1
HN,UTERINE OPERATION,1
HN,VARICELLA,1
HN,VARICES OESOPHAGEAL,1
HN,VASCULAR RUPTURE,1
HN,VENTRICULAR ARRHYTHMIA,1
HN,VIRAL INFECTION,1
HN,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
HN,VISION BLURRED,1
HN,VISUAL IMPAIRMENT,1
HN,VULVITIS,1
HN,VULVOVAGINAL PAIN,1
HK,DEATH,1057
HK,DRUG INEFFECTIVE,66
HK,OVERDOSE,55
HK,RENAL IMPAIRMENT,54
HK,TOXICITY TO VARIOUS AGENTS,52
HK,PNEUMONIA,44
HK,PYREXIA,38
HK,DYSPNOEA,35
HK,SHOCK,34
HK,DISEASE PROGRESSION,33
HK,VOMITING,33
HK,HYPOTENSION,31
HK,THROMBOCYTOPENIA,31
HK,DRUG ABUSE,28
HK,HEPATITIS B,28
HK,LACTIC ACIDOSIS,28
HK,RESPIRATORY FAILURE,27
HK,DIARRHOEA,25
HK,ANAEMIA,24
HK,FEBRILE NEUTROPENIA,24
HK,RASH,23
HK,MALIGNANT NEOPLASM PROGRESSION,22
HK,ACUTE KIDNEY INJURY,20
HK,CARDIAC ARREST,20
HK,DIZZINESS,20
HK,HAEMOGLOBIN DECREASED,20
HK,PANCREATITIS ACUTE,20
HK,HEPATOCELLULAR CARCINOMA,19
HK,LIVER FUNCTION TEST ABNORMAL,19
HK,SEPSIS,19
HK,CEREBROVASCULAR ACCIDENT,18
HK,NEUROTOXICITY,18
HK,PRODUCT USE IN UNAPPROVED INDICATION,18
HK,HEADACHE,17
HK,INJURY,17
HK,NAUSEA,17
HK,FOETAL EXPOSURE DURING PREGNANCY,16
HK,GENERAL PHYSICAL HEALTH DETERIORATION,16
HK,INCORRECT ROUTE OF DRUG ADMINISTRATION,16
HK,BILIARY TRACT DISORDER,15
HK,DRUG SCREEN POSITIVE,15
HK,INFECTION,15
HK,PRODUCT USE ISSUE,15
HK,ROAD TRAFFIC ACCIDENT,15
HK,VISION BLURRED,15
HK,HYPONATRAEMIA,14
HK,NEUTROPENIA,14
HK,PERITONITIS,14
HK,PLEURAL EFFUSION,14
HK,THERAPEUTIC RESPONSE DECREASED,14
HK,ABDOMINAL PAIN,13
HK,CONDITION AGGRAVATED,13
HK,DECREASED APPETITE,13
HK,DELIRIUM,13
HK,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,13
HK,INTENTIONAL OVERDOSE,13
HK,PANCYTOPENIA,13
HK,PNEUMOCYSTIS JIROVECII PNEUMONIA,13
HK,ARTHRALGIA,12
HK,CELLULITIS,12
HK,DISEASE RECURRENCE,12
HK,FATIGUE,12
HK,ABDOMINAL DISCOMFORT,11
HK,APLASIA PURE RED CELL,11
HK,BLOOD CREATININE INCREASED,11
HK,CARDIOTOXICITY,11
HK,FALL,11
HK,HYPERSENSITIVITY,11
HK,HYPOGLYCAEMIA,11
HK,HYPOKALAEMIA,11
HK,LOWER RESPIRATORY TRACT INFECTION,11
HK,OEDEMA PERIPHERAL,11
HK,PLATELET COUNT DECREASED,11
HK,APPENDICITIS,10
HK,ASCITES,10
HK,DEHYDRATION,10
HK,DEPRESSED LEVEL OF CONSCIOUSNESS,10
HK,MALAISE,10
HK,METABOLIC ACIDOSIS,10
HK,NON-INFECTIOUS ENDOPHTHALMITIS,10
HK,SOMNOLENCE,10
HK,URINARY TRACT INFECTION,10
HK,ABDOMINAL WALL HAEMATOMA,9
HK,BACK PAIN,9
HK,CANDIDA INFECTION,9
HK,CHEST PAIN,9
HK,COMA SCALE ABNORMAL,9
HK,COUGH,9
HK,EXPOSURE DURING PREGNANCY,9
HK,GASTROINTESTINAL HAEMORRHAGE,9
HK,HYPERTENSION,9
HK,HYPOAESTHESIA,9
HK,INSOMNIA,9
HK,NEOPLASM,9
HK,NEUROPATHY PERIPHERAL,9
HK,PAIN IN EXTREMITY,9
HK,PANCREATITIS NECROTISING,9
HK,SUICIDE ATTEMPT,9
HK,ABDOMINAL DISTENSION,8
HK,ALANINE AMINOTRANSFERASE INCREASED,8
HK,ATRIAL FIBRILLATION,8
HK,CARCINOEMBRYONIC ANTIGEN INCREASED,8
HK,CARDIAC FAILURE CONGESTIVE,8
HK,CONFUSIONAL STATE,8
HK,CONSTIPATION,8
HK,DEPRESSION,8
HK,METASTASES TO CENTRAL NERVOUS SYSTEM,8
HK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,8
HK,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,8
HK,PRURITUS,8
HK,RENAL FAILURE,8
HK,STAPHYLOCOCCAL INFECTION,8
HK,TREATMENT FAILURE,8
HK,URINARY TRACT DISORDER,8
HK,VISUAL FIELD DEFECT,8
HK,WEIGHT DECREASED,8
HK,ABDOMINAL PAIN UPPER,7
HK,CARDIAC DISORDER,7
HK,DRUG EFFECT INCOMPLETE,7
HK,DYSPHAGIA,7
HK,ECZEMA,7
HK,GAIT DISTURBANCE,7
HK,HAEMOPTYSIS,7
HK,HEPATITIS,7
HK,HYPERAMMONAEMIC ENCEPHALOPATHY,7
HK,LIVER INJURY,7
HK,MATERNAL EXPOSURE DURING PREGNANCY,7
HK,MENTAL DISORDER,7
HK,MUCOSAL INFLAMMATION,7
HK,MUSCULAR WEAKNESS,7
HK,PEPTIC ULCER,7
HK,PNEUMONITIS,7
HK,SECONDARY ADRENOCORTICAL INSUFFICIENCY,7
HK,SINUS TACHYCARDIA,7
HK,STEVENS-JOHNSON SYNDROME,7
HK,SYNCOPE,7
HK,TACHYCARDIA,7
HK,VIRAL INFECTION,7
HK,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,6
HK,AGRANULOCYTOSIS,6
HK,ARRHYTHMIA,6
HK,BACTERIAL SEPSIS,6
HK,BILIARY DILATATION,6
HK,BLINDNESS,6
HK,BLOOD ALKALINE PHOSPHATASE INCREASED,6
HK,BLOOD CREATINE PHOSPHOKINASE INCREASED,6
HK,BLOOD UREA INCREASED,6
HK,CARDIAC FAILURE,6
HK,CHOLESTATIC LIVER INJURY,6
HK,COMA,6
HK,DEEP VEIN THROMBOSIS,6
HK,DRUG INTOLERANCE,6
HK,DYSPHONIA,6
HK,EPISTAXIS,6
HK,FUNGAL INFECTION,6
HK,HEPATIC ENZYME INCREASED,6
HK,HEPATIC FAILURE,6
HK,HEPATOTOXICITY,6
HK,HERPES ZOSTER,6
HK,INFLUENZA,6
HK,INTERSTITIAL LUNG DISEASE,6
HK,LOSS OF CONSCIOUSNESS,6
HK,METASTASES TO BONE,6
HK,METASTASES TO LIVER,6
HK,MULTIPLE SCLEROSIS RELAPSE,6
HK,MYCOBACTERIUM ABSCESSUS INFECTION,6
HK,NEPHROPATHY TOXIC,6
HK,OXYGEN SATURATION DECREASED,6
HK,PALPITATIONS,6
HK,PERIPHERAL SWELLING,6
HK,PERITONEAL DIALYSIS COMPLICATION,6
HK,PERITONEAL HAEMORRHAGE,6
HK,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,6
HK,PROTEINURIA,6
HK,PSEUDOMONAS INFECTION,6
HK,PULMONARY TUBERCULOSIS,6
HK,RENAL FAILURE ACUTE,6
HK,RETINITIS PIGMENTOSA,6
HK,RETINOPATHY,6
HK,SEIZURE,6
HK,SEPTIC SHOCK,6
HK,SIRENOMELIA,6
HK,SKIN EXFOLIATION,6
HK,SPLENIC RUPTURE,6
HK,STOMATITIS,6
HK,ABORTION INDUCED,5
HK,ADVERSE EVENT,5
HK,AMYLASE INCREASED,5
HK,ATYPICAL FEMUR FRACTURE,5
HK,CEREBRAL HAEMORRHAGE,5
HK,CHILLS,5
HK,CHOLECYSTITIS,5
HK,CONTRAINDICATION TO MEDICAL TREATMENT,5
HK,CYTOMEGALOVIRUS INFECTION,5
HK,GASTROENTERITIS,5
HK,HAEMATURIA,5
HK,HAEMOLYSIS,5
HK,HAEMORRHAGE,5
HK,INFLAMMATION,5
HK,INJECTION SITE PAIN,5
HK,INTESTINAL OBSTRUCTION,5
HK,METASTASES TO LUNG,5
HK,MUSCLE TWITCHING,5
HK,MYALGIA,5
HK,MYOCARDIAL INFARCTION,5
HK,MYOCLONUS,5
HK,NEPHROTIC SYNDROME,5
HK,OCULAR TOXICITY,5
HK,PANCREATITIS,5
HK,PELVIC ABSCESS,5
HK,PLASMA CELL MYELOMA,5
HK,PNEUMOPERITONEUM,5
HK,PNEUMOTHORAX,5
HK,PREMATURE BABY,5
HK,PULMONARY EMBOLISM,5
HK,RENAL DISORDER,5
HK,RETROPERITONEAL HAEMATOMA,5
HK,SWELLING,5
HK,URINARY RETENTION,5
HK,VASCULAR PSEUDOANEURYSM,5
HK,ZYGOMYCOSIS,5
HK,ABNORMAL BEHAVIOUR,4
HK,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,4
HK,ACUTE MYOCARDIAL INFARCTION,4
HK,ADENOCARCINOMA,4
HK,ARTHRITIS,4
HK,ASTHMA,4
HK,BLOOD BILIRUBIN INCREASED,4
HK,BLOOD LACTATE DEHYDROGENASE INCREASED,4
HK,BLOOD PRESSURE INCREASED,4
HK,BONE MARROW FAILURE,4
HK,CACHEXIA,4
HK,CHEST DISCOMFORT,4
HK,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
HK,COLITIS,4
HK,COMPUTERISED TOMOGRAM THORAX ABNORMAL,4
HK,CRYPTOCOCCOSIS,4
HK,CYANOSIS,4
HK,DIABETES MELLITUS,4
HK,DIARRHOEA HAEMORRHAGIC,4
HK,DRUG-INDUCED LIVER INJURY,4
HK,DRY SKIN,4
HK,ELECTROCARDIOGRAM QT PROLONGED,4
HK,ENCEPHALITIS,4
HK,ENTERITIS,4
HK,ERYTHEMA,4
HK,ESCHERICHIA SEPSIS,4
HK,GESTATIONAL TROPHOBLASTIC TUMOUR,4
HK,GLAUCOMA,4
HK,HAEMOGLOBINURIA,4
HK,HAEMORRHAGE INTRACRANIAL,4
HK,HALLUCINATION,4
HK,HEPATIC FUNCTION ABNORMAL,4
HK,HYDRONEPHROSIS,4
HK,HYPERBILIRUBINAEMIA,4
HK,HYPOPHOSPHATAEMIA,4
HK,INTRAOCULAR PRESSURE INCREASED,4
HK,IRITIS,4
HK,IRRITABILITY,4
HK,LETHARGY,4
HK,LEUKOCYTOSIS,4
HK,LOWER GASTROINTESTINAL HAEMORRHAGE,4
HK,LOWER URINARY TRACT SYMPTOMS,4
HK,LUNG INFILTRATION,4
HK,LYMPHOCYTE COUNT ABNORMAL,4
HK,LYMPHOPENIA,4
HK,MULTI-ORGAN FAILURE,4
HK,NOROVIRUS TEST POSITIVE,4
HK,OBSTRUCTIVE AIRWAYS DISORDER,4
HK,OBSTRUCTIVE UROPATHY,4
HK,OROPHARYNGEAL PAIN,4
HK,PATHOGEN RESISTANCE,4
HK,PNEUMONIA ASPIRATION,4
HK,POISONING,4
HK,POST PROCEDURAL HAEMORRHAGE,4
HK,PRODUCT QUALITY ISSUE,4
HK,PROSTATE CANCER METASTATIC,4
HK,PROSTATIC SPECIFIC ANTIGEN INCREASED,4
HK,PULMONARY HYPERTENSION,4
HK,PULMONARY MASS,4
HK,RECTAL HAEMORRHAGE,4
HK,TOXIC ENCEPHALOPATHY,4
HK,TRANSIENT ISCHAEMIC ATTACK,4
HK,TREMOR,4
HK,TUBERCULOSIS,4
HK,TUMOUR RUPTURE,4
HK,VERTIGO,4
HK,WRONG TECHNIQUE IN DRUG USAGE PROCESS,4
HK,ABASIA,3
HK,ABDOMINAL PAIN LOWER,3
HK,ABDOMINAL TENDERNESS,3
HK,ABSCESS,3
HK,ACINETOBACTER INFECTION,3
HK,ACUTE ABDOMEN,3
HK,ACUTE GRAFT VERSUS HOST DISEASE,3
HK,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,3
HK,ACUTE HEPATIC FAILURE,3
HK,ALANINE AMINOTRANSFERASE ABNORMAL,3
HK,ANGINA PECTORIS,3
HK,ANGIOEDEMA,3
HK,ANGIOPATHY,3
HK,ANURIA,3
HK,APLASTIC ANAEMIA,3
HK,APPENDICITIS PERFORATED,3
HK,ASPARTATE AMINOTRANSFERASE INCREASED,3
HK,ASPERGILLUS INFECTION,3
HK,ASTHENIA,3
HK,BLISTER,3
HK,BLOOD PRESSURE DECREASED,3
HK,BONE PAIN,3
HK,BRADYCARDIA FOETAL,3
HK,BRAIN OEDEMA,3
HK,CARDIAC VALVE DISEASE,3
HK,CARDIOGENIC SHOCK,3
HK,CHOLECYSTITIS ACUTE,3
HK,CIRCULATORY COLLAPSE,3
HK,COAGULOPATHY,3
HK,COLON CANCER,3
HK,COLORECTAL CANCER METASTATIC,3
HK,CONGENITAL NOSE MALFORMATION,3
HK,CUSHING^S SYNDROME,3
HK,CYTOKINE STORM,3
HK,CYTOMEGALOVIRUS CHORIORETINITIS,3
HK,DEAFNESS,3
HK,DIABETES MELLITUS INADEQUATE CONTROL,3
HK,DIABETIC KETOACIDOSIS,3
HK,DIFFUSE LARGE B-CELL LYMPHOMA,3
HK,DISCOMFORT,3
HK,DISSEMINATED INTRAVASCULAR COAGULATION,3
HK,DRUG DOSE OMISSION,3
HK,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
HK,DYSARTHRIA,3
HK,DYSURIA,3
HK,ENCEPHALOPATHY,3
HK,ENTEROCOCCAL INFECTION,3
HK,EYE MOVEMENT DISORDER,3
HK,EYE PAIN,3
HK,GASTRITIS,3
HK,GASTROINTESTINAL PERFORATION,3
HK,HAEMATEMESIS,3
HK,HALLUCINATION_ VISUAL,3
HK,HEMIPLEGIA,3
HK,HUMERUS FRACTURE,3
HK,HYPERGLYCAEMIA,3
HK,HYPERHIDROSIS,3
HK,HYPERKALAEMIA,3
HK,HYPERTELORISM OF ORBIT,3
HK,HYPERTHYROIDISM,3
HK,HYPOCALCAEMIA,3
HK,HYPOVENTILATION,3
HK,IMPAIRED HEALING,3
HK,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
HK,INCORRECT DRUG ADMINISTRATION DURATION,3
HK,INJECTION SITE BRUISING,3
HK,INJECTION SITE ERYTHEMA,3
HK,INJECTION SITE SWELLING,3
HK,INTERNATIONAL NORMALISED RATIO INCREASED,3
HK,ISCHAEMIC STROKE,3
HK,JAUNDICE,3
HK,LARYNGEAL OEDEMA,3
HK,LIVER DISORDER,3
HK,LIVER TRANSPLANT REJECTION,3
HK,LUNG INFECTION,3
HK,LUNG NEOPLASM MALIGNANT,3
HK,LYMPHADENOPATHY,3
HK,MATERNAL EXPOSURE TIMING UNSPECIFIED,3
HK,MENORRHAGIA,3
HK,METASTASES TO LYMPH NODES,3
HK,MYCOBACTERIAL PERITONITIS,3
HK,NEOPLASM MALIGNANT,3
HK,NEUTROPHIL COUNT DECREASED,3
HK,OSTEONECROSIS OF JAW,3
HK,OSTEOPOROTIC FRACTURE,3
HK,PANCREATIC CARCINOMA,3
HK,PEPTIC ULCER PERFORATION,3
HK,POOR QUALITY SLEEP,3
HK,PREGNANCY,3
HK,PULMONARY FIBROSIS,3
HK,PULMONARY HAEMORRHAGE,3
HK,REBOUND EFFECT,3
HK,RED BLOOD CELL COUNT DECREASED,3
HK,RENAL FAILURE CHRONIC,3
HK,RESPIRATORY DISTRESS,3
HK,RESPIRATORY TRACT OEDEMA,3
HK,RETINAL HAEMORRHAGE,3
HK,RHABDOMYOLYSIS,3
HK,SPEECH DISORDER,3
HK,SUBCUTANEOUS ABSCESS,3
HK,SUBCUTANEOUS EMPHYSEMA,3
HK,SWELLING FACE,3
HK,SYSTEMIC LUPUS ERYTHEMATOSUS,3
HK,TARDIVE DYSKINESIA,3
HK,THROMBOSIS,3
HK,THYROID FUNCTION TEST ABNORMAL,3
HK,TRANSFUSION,3
HK,TUMOUR LYSIS SYNDROME,3
HK,UNDERDOSE,3
HK,VAGINAL HAEMORRHAGE,3
HK,VISUAL ACUITY REDUCED,3
HK,WHITE BLOOD CELL COUNT INCREASED,3
HK,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
HK,ABORTION MISSED,2
HK,ABORTION SPONTANEOUS,2
HK,ACCIDENTAL EXPOSURE TO PRODUCT,2
HK,ACTIVITIES OF DAILY LIVING IMPAIRED,2
HK,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,2
HK,ACUTE LYMPHOCYTIC LEUKAEMIA,2
HK,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,2
HK,ACUTE PHOSPHATE NEPHROPATHY,2
HK,ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION,2
HK,ALTERED STATE OF CONSCIOUSNESS,2
HK,AMMONIA INCREASED,2
HK,AMNESIA,2
HK,APPLICATION SITE PRURITUS,2
HK,ARTHROPATHY,2
HK,ATRIOVENTRICULAR BLOCK,2
HK,ATYPICAL MYCOBACTERIAL INFECTION,2
HK,BILE DUCT OBSTRUCTION,2
HK,BLOOD ALKALINE PHOSPHATASE DECREASED,2
HK,BLOOD TRIGLYCERIDES INCREASED,2
HK,BRAIN CANCER METASTATIC,2
HK,BREAST CANCER,2
HK,CALCIPHYLAXIS,2
HK,CARDIOVASCULAR DISORDER,2
HK,CEREBRAL ARTERY THROMBOSIS,2
HK,CEREBROVASCULAR DISORDER,2
HK,CHEST X-RAY ABNORMAL,2
HK,CHROMATURIA,2
HK,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,2
HK,CLOSTRIDIUM DIFFICILE INFECTION,2
HK,COMPLICATIONS OF TRANSPLANTED KIDNEY,2
HK,CONTUSION,2
HK,CONVULSION,2
HK,CYSTITIS,2
HK,CYSTITIS NONINFECTIVE,2
HK,DECREASED IMMUNE RESPONSIVENESS,2
HK,DEPOSIT EYE,2
HK,DEVICE BREAKAGE,2
HK,DIAPHRAGMATIC RUPTURE,2
HK,DISORIENTATION,2
HK,DISSEMINATED TUBERCULOSIS,2
HK,DIVERTICULITIS,2
HK,DRUG DEPENDENCE,2
HK,DRUG DISPENSING ERROR,2
HK,DRUG EFFECT DECREASED,2
HK,DRUG HYPERSENSITIVITY,2
HK,DRUG LEVEL INCREASED,2
HK,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
HK,DRUG WITHDRAWAL CONVULSIONS,2
HK,DYSPEPSIA,2
HK,DYSPNOEA EXERTIONAL,2
HK,DYSTONIA,2
HK,ELECTROCARDIOGRAM ABNORMAL,2
HK,ELECTROLYTE IMBALANCE,2
HK,ENTEROBACTER INFECTION,2
HK,EPILEPSY,2
HK,EPSTEIN-BARR VIRUS INFECTION,2
HK,ERYTHEMA MULTIFORME,2
HK,ESCHERICHIA INFECTION,2
HK,EXTRAPYRAMIDAL DISORDER,2
HK,EYE HAEMORRHAGE,2
HK,FACIAL PARALYSIS,2
HK,FEELING ABNORMAL,2
HK,FEMUR FRACTURE,2
HK,FLIGHT OF IDEAS,2
HK,FLOPPY IRIS SYNDROME,2
HK,FOETAL DEATH,2
HK,FRACTURE NONUNION,2
HK,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
HK,GASTROINTESTINAL STROMAL TUMOUR,2
HK,GENERALISED ERYTHEMA,2
HK,GENERALISED TONIC-CLONIC SEIZURE,2
HK,GRAFT VERSUS HOST DISEASE,2
HK,GRAFT VERSUS HOST DISEASE IN LUNG,2
HK,HAEMATOCHEZIA,2
HK,HAEMATOCRIT DECREASED,2
HK,HAEMATOTOXICITY,2
HK,HAEMODYNAMIC INSTABILITY,2
HK,HAEMOLYTIC ANAEMIA,2
HK,HAEMORRHAGIC STROKE,2
HK,HEAD INJURY,2
HK,HEPARIN-INDUCED THROMBOCYTOPENIA,2
HK,HEPATIC ENCEPHALOPATHY,2
HK,HEPATIC PAIN,2
HK,HEPATITIS B REACTIVATION,2
HK,HEPATITIS C,2
HK,HEPATOMEGALY,2
HK,HISTIOCYTOSIS HAEMATOPHAGIC,2
HK,HYPERCALCAEMIA,2
HK,HYPERLIPIDAEMIA,2
HK,HYPERTRIGLYCERIDAEMIA,2
HK,HYPERVENTILATION,2
HK,HYPOALBUMINAEMIA,2
HK,HYPOTONIA,2
HK,HYPOVOLAEMIA,2
HK,ILEUS PARALYTIC,2
HK,IMMUNE SYSTEM DISORDER,2
HK,INCORRECT DOSE ADMINISTERED,2
HK,INFLUENZA LIKE ILLNESS,2
HK,INJECTION SITE HAEMORRHAGE,2
HK,INJECTION SITE PRURITUS,2
HK,INJECTION SITE REACTION,2
HK,INTENTIONAL PRODUCT MISUSE,2
HK,INTERNATIONAL NORMALISED RATIO DECREASED,2
HK,INTESTINAL PERFORATION,2
HK,JOINT STIFFNESS,2
HK,JOINT SWELLING,2
HK,LACERATION,2
HK,LEFT VENTRICULAR DYSFUNCTION,2
HK,LEUKOPENIA,2
HK,LIPODYSTROPHY ACQUIRED,2
HK,LOWER LIMB FRACTURE,2
HK,LUPUS NEPHRITIS,2
HK,LYMPHOCYTE COUNT DECREASED,2
HK,LYMPHOMA,2
HK,MANIA,2
HK,MASS,2
HK,MEAN PLATELET VOLUME INCREASED,2
HK,MEDICATION ERROR,2
HK,MEMORY IMPAIRMENT,2
HK,MENIERE^S DISEASE,2
HK,MENTAL STATUS CHANGES,2
HK,METASTASES TO LARGE INTESTINE,2
HK,METASTASIS,2
HK,MICTURITION URGENCY,2
HK,MIOSIS,2
HK,MUSCLE DISORDER,2
HK,MUSCLE HAEMORRHAGE,2
HK,MUSCLE SPASMS,2
HK,MUSCULOSKELETAL STIFFNESS,2
HK,MYCOBACTERIUM CHELONAE INFECTION,2
HK,MYOPATHY,2
HK,NEEDLE ISSUE,2
HK,NEOPLASM PROGRESSION,2
HK,NERVOUS SYSTEM DISORDER,2
HK,NEUROLOGICAL DECOMPENSATION,2
HK,NEUTROPENIC SEPSIS,2
HK,NEUTROPHIL COUNT INCREASED,2
HK,OEDEMA,2
HK,OESOPHAGEAL STENOSIS,2
HK,OESOPHAGITIS,2
HK,OSTEOPOROSIS,2
HK,PAIN,2
HK,PALLOR,2
HK,PARALYSIS,2
HK,PARONYCHIA,2
HK,PERFORMANCE STATUS DECREASED,2
HK,PERICARDIAL EFFUSION,2
HK,PERINEAL PAIN,2
HK,PERIORBITAL OEDEMA,2
HK,PNEUMOMEDIASTINUM,2
HK,POLLAKIURIA,2
HK,POLYMYOSITIS,2
HK,POOR VENOUS ACCESS,2
HK,PORTAL HYPERTENSION,2
HK,PRODUCT CONTAMINATION,2
HK,PROSTATITIS,2
HK,PROTHROMBIN TIME PROLONGED,2
HK,PSEUDOCYST,2
HK,PYODERMA GANGRENOSUM,2
HK,RASH GENERALISED,2
HK,RECTAL CANCER,2
HK,RED CELL DISTRIBUTION WIDTH INCREASED,2
HK,REMISSION NOT ACHIEVED,2
HK,RENAL ISCHAEMIA,2
HK,RENAL PAIN,2
HK,RIGHT VENTRICULAR FAILURE,2
HK,SINUS BRADYCARDIA,2
HK,SKIN REACTION,2
HK,SKIN TOXICITY,2
HK,SKIN ULCER,2
HK,SOCIAL AVOIDANT BEHAVIOUR,2
HK,SPINAL COLUMN INJURY,2
HK,SPINAL OSTEOARTHRITIS,2
HK,SPLENOMEGALY,2
HK,STAPHYLOCOCCAL SEPSIS,2
HK,STREPTOCOCCAL SEPSIS,2
HK,SUDDEN DEATH,2
HK,SULPHAEMOGLOBINAEMIA,2
HK,SUPERINFECTION,2
HK,SUPRAVENTRICULAR TACHYCARDIA,2
HK,SURGERY,2
HK,TACHYPNOEA,2
HK,THERAPY PARTIAL RESPONDER,2
HK,THYROID CANCER,2
HK,TINNITUS,2
HK,TOOTH EXTRACTION,2
HK,TOOTHACHE,2
HK,TOXIC EPIDERMAL NECROLYSIS,2
HK,TRANSPLANT ABSCESS,2
HK,TREATMENT NONCOMPLIANCE,2
HK,UNEVALUABLE EVENT,2
HK,UNINTENTIONAL USE FOR UNAPPROVED INDICATION,2
HK,UPPER GASTROINTESTINAL HAEMORRHAGE,2
HK,UPPER RESPIRATORY TRACT INFECTION,2
HK,URETERIC STENOSIS,2
HK,URINARY TRACT INFECTION BACTERIAL,2
HK,URTICARIA,2
HK,VASOCONSTRICTION,2
HK,VIRAEMIA,2
HK,VIRAL LOAD INCREASED,2
HK,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
HK,VISUAL IMPAIRMENT,2
HK,VOCAL CORD PARALYSIS,2
HK,WEIGHT INCREASED,2
HK,WHITE BLOOD CELL COUNT DECREASED,2
HK,ABDOMINAL ABSCESS,1
HK,ABDOMINAL INFECTION,1
HK,ABORTION,1
HK,ABORTION INDUCED COMPLETE,1
HK,ABSCESS BACTERIAL,1
HK,ABSCESS DRAINAGE,1
HK,ABSCESS JAW,1
HK,ACCIDENTAL OVERDOSE,1
HK,ACOUSTIC NEUROMA,1
HK,ACQUIRED PIGMENTED RETINOPATHY,1
HK,ACUTE CORONARY SYNDROME,1
HK,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,1
HK,ACUTE MYELOID LEUKAEMIA,1
HK,ADENOCARCINOMA GASTRIC,1
HK,ADENOCARCINOMA OF THE CERVIX,1
HK,AGITATION,1
HK,AGNOSIA,1
HK,ANAPHYLACTIC REACTION,1
HK,ANAPHYLACTIC SHOCK,1
HK,ANAPLASTIC THYROID CANCER,1
HK,ANTICONVULSANT DRUG LEVEL DECREASED,1
HK,ANXIETY,1
HK,AORTIC RUPTURE,1
HK,AORTITIS SALMONELLA,1
HK,APGAR SCORE LOW,1
HK,APHASIA,1
HK,APPLICATION SITE ERYTHEMA,1
HK,APPLICATION SITE PAIN,1
HK,ARTHRITIS BACTERIAL,1
HK,ASPERGILLOSIS,1
HK,ASYMPTOMATIC VIRAL HEPATITIS,1
HK,ATAXIA,1
HK,ATROPHY,1
HK,ATYPICAL FRACTURE,1
HK,AUTOIMMUNE NEUROPATHY,1
HK,BACILLUS INFECTION,1
HK,BACTERAEMIA,1
HK,BACTERIAL INFECTION,1
HK,BALANOPOSTHITIS,1
HK,BEDRIDDEN,1
HK,BILE DUCT STENOSIS,1
HK,BILIARY TRACT INFECTION,1
HK,BILIRUBIN CONJUGATED ABNORMAL,1
HK,BLADDER CANCER,1
HK,BLADDER DISORDER,1
HK,BLADDER OBSTRUCTION,1
HK,BLADDER STENOSIS,1
HK,BLEEDING TIME SHORTENED,1
HK,BLINDNESS UNILATERAL,1
HK,BLOOD ALBUMIN DECREASED,1
HK,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
HK,BLOOD CHLORIDE DECREASED,1
HK,BLOOD CHOLESTEROL INCREASED,1
HK,BLOOD CREATININE ABNORMAL,1
HK,BLOOD DISORDER,1
HK,BLOOD FIBRINOGEN INCREASED,1
HK,BLOOD FOLLICLE STIMULATING HORMONE DECREASED,1
HK,BLOOD GLUCOSE DECREASED,1
HK,BLOOD GLUCOSE INCREASED,1
HK,BLOOD LACTIC ACID INCREASED,1
HK,BLOOD LUTEINISING HORMONE DECREASED,1
HK,BLOOD POTASSIUM INCREASED,1
HK,BLOOD PROLACTIN DECREASED,1
HK,BLOOD SODIUM DECREASED,1
HK,BLOOD SODIUM INCREASED,1
HK,BLOOD STEM CELL TRANSPLANT FAILURE,1
HK,BLOOD THYROID STIMULATING HORMONE DECREASED,1
HK,BONE DISORDER,1
HK,BONE MARROW TOXICITY,1
HK,BONE SWELLING,1
HK,BONE TUBERCULOSIS,1
HK,BRAIN ABSCESS,1
HK,BRAIN DEATH,1
HK,BRAIN HYPOXIA,1
HK,BRAIN SCAN ABNORMAL,1
HK,BRAIN STEM STROKE,1
HK,BREAST CANCER METASTATIC,1
HK,BREAST CONSERVING SURGERY,1
HK,BREAST NEOPLASM,1
HK,BRONCHITIS,1
HK,BURKHOLDERIA CEPACIA COMPLEX INFECTION,1
HK,CANDIDIASIS,1
HK,CARBOHYDRATE ANTIGEN 19-9,1
HK,CARBOHYDRATE ANTIGEN 19-9 INCREASED,1
HK,CARDIAC NEOPLASM UNSPECIFIED,1
HK,CARDIAC TAMPONADE,1
HK,CARDIOMEGALY,1
HK,CARDIOPULMONARY FAILURE,1
HK,CARDIOVASCULAR SYMPTOM,1
HK,CARPAL TUNNEL SYNDROME,1
HK,CATARACT,1
HK,CATARACT SUBCAPSULAR,1
HK,CENTRAL NERVOUS SYSTEM NECROSIS,1
HK,CENTRAL VENOUS CATHETERISATION,1
HK,CEREBRAL INFARCTION,1
HK,CERVICAL CORD COMPRESSION,1
HK,CERVICAL MYELOPATHY,1
HK,CERVIX CARCINOMA,1
HK,CHEILITIS,1
HK,CHILD ABUSE,1
HK,CHOLANGIOCARCINOMA,1
HK,CHOLANGITIS,1
HK,CHOLANGITIS ACUTE,1
HK,CHOROIDAL DETACHMENT,1
HK,CHRONIC GRAFT VERSUS HOST DISEASE,1
HK,CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE,1
HK,CHRONIC HEPATITIS B,1
HK,CHRONIC KIDNEY DISEASE,1
HK,CLOSTRIDIUM TEST POSITIVE,1
HK,COGWHEEL RIGIDITY,1
HK,COLD SWEAT,1
HK,COLONIC FISTULA,1
HK,COLORECTAL CANCER STAGE IV,1
HK,CONGENITAL ANOMALY,1
HK,CONJUNCTIVAL HAEMORRHAGE,1
HK,CONTRAST MEDIA ALLERGY,1
HK,COORDINATION ABNORMAL,1
HK,COR PULMONALE,1
HK,CORTISOL DECREASED,1
HK,CORYNEBACTERIUM INFECTION,1
HK,CRANIOCEREBRAL INJURY,1
HK,CREATININE RENAL CLEARANCE DECREASED,1
HK,CROHN^S DISEASE,1
HK,CRYPTOCOCCAL CUTANEOUS INFECTION,1
HK,CUTANEOUS LUPUS ERYTHEMATOSUS,1
HK,CYCLOTHYMIC DISORDER,1
HK,CYTOKINE RELEASE SYNDROME,1
HK,CYTOPENIA,1
HK,DECUBITUS ULCER,1
HK,DELIVERY,1
HK,DELUSION,1
HK,DELUSIONAL DISORDER_ UNSPECIFIED TYPE,1
HK,DEMENTIA,1
HK,DEMENTIA WITH LEWY BODIES,1
HK,DEMYELINATION,1
HK,DENTAL CARE,1
HK,DEPRESSED MOOD,1
HK,DERMATITIS,1
HK,DERMATITIS ACNEIFORM,1
HK,DERMATITIS ALLERGIC,1
HK,DERMATITIS BULLOUS,1
HK,DEVICE DIFFICULT TO USE,1
HK,DEVICE MALFUNCTION,1
HK,DEVICE RELATED INFECTION,1
HK,DEVICE USE ISSUE,1
HK,DIABETES INSIPIDUS,1
HK,DIABETIC COMPLICATION,1
HK,DIAPHRAGMATIC DISORDER,1
HK,DIPLEGIA,1
HK,DIPLOPIA,1
HK,DISORGANISED SPEECH,1
HK,DIVERTICULUM,1
HK,DIZZINESS EXERTIONAL,1
HK,DONOR SPECIFIC ANTIBODY PRESENT,1
HK,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
HK,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
HK,DRUG ADMINISTRATION ERROR,1
HK,DRUG EFFECT DELAYED,1
HK,DRUG ERUPTION,1
HK,DRUG RESISTANCE,1
HK,DRY MOUTH,1
HK,DRY THROAT,1
HK,DYSGEUSIA,1
HK,DYSGRAPHIA,1
HK,DYSKINESIA,1
HK,DYSMENORRHOEA,1
HK,EAR DISCOMFORT,1
HK,ECCHYMOSIS,1
HK,EJECTION FRACTION DECREASED,1
HK,EMBOLISM,1
HK,EMPHYSEMA,1
HK,EMPYEMA,1
HK,ENCEPHALITIS CYTOMEGALOVIRUS,1
HK,ENCEPHALITIS INFLUENZAL,1
HK,ENCEPHALITIS JAPANESE B,1
HK,ENDOMETRIAL HYPERPLASIA,1
HK,ENDOPHTHALMITIS,1
HK,EOSINOPHIL COUNT DECREASED,1
HK,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,1
HK,EROSIVE DUODENITIS,1
HK,EROSIVE OESOPHAGITIS,1
HK,ERUCTATION,1
HK,EXERCISE TOLERANCE DECREASED,1
HK,EXFOLIATIVE RASH,1
HK,EYE SWELLING,1
HK,EYELID FUNCTION DISORDER,1
HK,EYELID PTOSIS,1
HK,FACIAL PAIN,1
HK,FACTOR V INHIBITION,1
HK,FAECAL INCONTINENCE,1
HK,FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT,1
HK,FEAR,1
HK,FEELING COLD,1
HK,FEELING HOT,1
HK,FIBRIN D DIMER INCREASED,1
HK,FIBRIN INCREASED,1
HK,FLUID RETENTION,1
HK,FLUSHING,1
HK,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
HK,FOLATE DEFICIENCY,1
HK,FOLLICULITIS,1
HK,FOREIGN BODY,1
HK,FUSARIUM INFECTION,1
HK,GALLBLADDER OPERATION,1
HK,GANGRENE,1
HK,GASTRIC HAEMORRHAGE,1
HK,GASTRIC OPERATION,1
HK,GASTRIC VARICES,1
HK,GASTRITIS EROSIVE,1
HK,GASTRODUODENITIS,1
HK,GASTROINTESTINAL DISORDER,1
HK,GASTROINTESTINAL FUNGAL INFECTION,1
HK,GASTROINTESTINAL HYPOMOTILITY,1
HK,GASTROINTESTINAL OBSTRUCTION,1
HK,GASTROINTESTINAL TOXICITY,1
HK,GASTROINTESTINAL TRACT ADENOMA,1
HK,GASTROINTESTINAL WALL THICKENING,1
HK,GASTROOESOPHAGEAL REFLUX DISEASE,1
HK,GENERALISED OEDEMA,1
HK,GINGIVAL BLEEDING,1
HK,GINGIVITIS,1
HK,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
HK,GOUT,1
HK,GOUTY ARTHRITIS,1
HK,GRAFT VERSUS HOST DISEASE IN SKIN,1
HK,GRANULOCYTOPENIA,1
HK,GRIP STRENGTH DECREASED,1
HK,GYNAECOMASTIA,1
HK,HAEMARTHROSIS,1
HK,HAEMATOSPERMIA,1
HK,HAEMORRHAGE URINARY TRACT,1
HK,HAEMORRHOIDAL HAEMORRHAGE,1
HK,HAEMORRHOIDS,1
HK,HAND DEFORMITY,1
HK,HAND FRACTURE,1
HK,HEART RATE DECREASED,1
HK,HEART RATE INCREASED,1
HK,HEART RATE IRREGULAR,1
HK,HEMIPARESIS,1
HK,HEPATIC CIRRHOSIS,1
HK,HEPATITIS ACUTE,1
HK,HEPATITIS C VIRUS TEST POSITIVE,1
HK,HEPATITIS VIRAL,1
HK,HEPATOSPLENOMEGALY,1
HK,HERBAL INTERACTION,1
HK,HERNIA,1
HK,HERPES SIMPLEX,1
HK,HERPES ZOSTER DISSEMINATED,1
HK,HICCUPS,1
HK,HIP FRACTURE,1
HK,HODGKIN^S DISEASE STAGE III,1
HK,HORMONE-REFRACTORY PROSTATE CANCER,1
HK,HOSPITALISATION,1
HK,HUMAN HERPESVIRUS 6 INFECTION,1
HK,HYPERKERATOSIS,1
HK,HYPERMETROPIA,1
HK,HYPERNATRAEMIA,1
HK,HYPERSENSITIVITY VASCULITIS,1
HK,HYPERSPLENISM,1
HK,HYPERTHERMIA,1
HK,HYPERTONIC BLADDER,1
HK,HYPOAESTHESIA ORAL,1
HK,HYPOCHROMIC ANAEMIA,1
HK,HYPORESPONSIVE TO STIMULI,1
HK,HYPOTHERMIA,1
HK,HYPOTONY OF EYE,1
HK,HYPOVOLAEMIC SHOCK,1
HK,HYPOXIA,1
HK,IDIOPATHIC PNEUMONIA SYNDROME,1
HK,IGA NEPHROPATHY,1
HK,ILEUS,1
HK,IMMUNOSUPPRESSION,1
HK,IMPAIRED GASTRIC EMPTYING,1
HK,INABILITY TO AFFORD MEDICATION,1
HK,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
HK,INFECTIVE ANEURYSM,1
HK,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
HK,INFLAMMATORY BOWEL DISEASE,1
HK,INFUSION RELATED REACTION,1
HK,INFUSION SITE CELLULITIS,1
HK,INFUSION SITE GRANULOMA,1
HK,INJECTION SITE ATROPHY,1
HK,INJECTION SITE INDURATION,1
HK,INJECTION SITE INFECTION,1
HK,INJURY CORNEAL,1
HK,INTENTIONAL PRODUCT USE ISSUE,1
HK,INTERNAL HAEMORRHAGE,1
HK,INTESTINAL HAEMORRHAGE,1
HK,INTESTINAL ISCHAEMIA,1
HK,INTRACRANIAL PRESSURE INCREASED,1
HK,INVASIVE DUCTAL BREAST CARCINOMA,1
HK,JAUNDICE CHOLESTATIC,1
HK,JOINT DESTRUCTION,1
HK,JOINT INJURY,1
HK,JUGULAR VEIN THROMBOSIS,1
HK,KIDNEY TRANSPLANT REJECTION,1
HK,KLEBSIELLA TEST POSITIVE,1
HK,LACK OF INJECTION SITE ROTATION,1
HK,LACRIMAL DISORDER,1
HK,LARGE GRANULAR LYMPHOCYTOSIS,1
HK,LARGE INTESTINAL STENOSIS,1
HK,LARGE INTESTINE PERFORATION,1
HK,LARYNGITIS,1
HK,LEFT VENTRICULAR FAILURE,1
HK,LENTICULAR PIGMENTATION,1
HK,LEUKAEMIA,1
HK,LEUKOENCEPHALOPATHY,1
HK,LIGHT CHAIN ANALYSIS DECREASED,1
HK,LIMB DISCOMFORT,1
HK,LIP SWELLING,1
HK,LIPOATROPHY,1
HK,LIQUID PRODUCT PHYSICAL ISSUE,1
HK,LIVE BIRTH,1
HK,LOCALISED OEDEMA,1
HK,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
HK,LOW DENSITY LIPOPROTEIN INCREASED,1
HK,LOWER RESPIRATORY TRACT INFECTION BACTERIAL,1
HK,LUNG ABSCESS,1
HK,LUNG CONSOLIDATION,1
HK,LUNG DISORDER,1
HK,LUNG NEOPLASM,1
HK,LYMPHANGIOSIS CARCINOMATOSA,1
HK,LYMPHOCYTIC INFILTRATION,1
HK,MACROCEPHALY,1
HK,MACULAR DEGENERATION,1
HK,MACULAR OEDEMA,1
HK,MALABSORPTION,1
HK,MALIGNANT PERITONEAL NEOPLASM,1
HK,MALIGNANT PLEURAL EFFUSION,1
HK,MANTLE CELL LYMPHOMA RECURRENT,1
HK,MECONIUM PERITONITIS,1
HK,MEDICATION RESIDUE PRESENT,1
HK,MELAENA,1
HK,MENINGITIS ASEPTIC,1
HK,MENSTRUATION IRREGULAR,1
HK,METABOLIC ENCEPHALOPATHY,1
HK,METASTASES TO ADRENALS,1
HK,METASTASES TO BREAST,1
HK,METASTASES TO MENINGES,1
HK,METASTASES TO PELVIS,1
HK,METASTASES TO PERITONEUM,1
HK,METASTASES TO PLEURA,1
HK,METASTASES TO SKIN,1
HK,METASTATIC NEOPLASM,1
HK,MICROPHTHALMOS,1
HK,MOBILITY DECREASED,1
HK,MOOD ALTERED,1
HK,MOUTH ULCERATION,1
HK,MUCOSAL ULCERATION,1
HK,MUCOUS MEMBRANE DISORDER,1
HK,MULTI-ORGAN DISORDER,1
HK,MULTIPLE FRACTURES,1
HK,MULTIPLE SCLEROSIS,1
HK,MUSCLE HYPERTROPHY,1
HK,MUSCULOSKELETAL DISCOMFORT,1
HK,MUSCULOSKELETAL DISORDER,1
HK,MUSCULOSKELETAL PAIN,1
HK,MYCOBACTERIUM FORTUITUM INFECTION,1
HK,MYELITIS,1
HK,MYELOPATHY,1
HK,MYELOPROLIFERATIVE DISORDER,1
HK,MYOCARDIAL ISCHAEMIA,1
HK,MYOCARDITIS,1
HK,MYOSITIS,1
HK,MYXOID LIPOSARCOMA,1
HK,NASAL DISCOMFORT,1
HK,NASAL OEDEMA,1
HK,NASOPHARYNGEAL CANCER,1
HK,NASOPHARYNGITIS,1
HK,NECK MASS,1
HK,NECROTISING COLITIS,1
HK,NEPHROGENIC DIABETES INSIPIDUS,1
HK,NEPHROLITHIASIS,1
HK,NEPHROPATHY,1
HK,NEURALGIA,1
HK,NEURITIS CRANIAL,1
HK,NEUROLEPTIC MALIGNANT SYNDROME,1
HK,NO THERAPEUTIC RESPONSE,1
HK,NON-SMALL CELL LUNG CANCER,1
HK,NON-SMALL CELL LUNG CANCER STAGE IV,1
HK,NONINFECTIVE ENCEPHALITIS,1
HK,NORMAL NEWBORN,1
HK,NYSTAGMUS,1
HK,OCULAR HYPERAEMIA,1
HK,OEDEMA MUCOSAL,1
HK,OESOPHAGEAL CANDIDIASIS,1
HK,OESOPHAGEAL VARICES HAEMORRHAGE,1
HK,OESOPHAGITIS HAEMORRHAGIC,1
HK,OLIGOHYDRAMNIOS,1
HK,OLIGURIA,1
HK,ORAL DISCOMFORT,1
HK,ORAL HERPES,1
HU,DEATH,407
HU,DIARRHOEA,288
HU,DYSPNOEA,249
HU,ASTHENIA,242
HU,NAUSEA,219
HU,ANAEMIA,216
HU,DRUG INEFFECTIVE,199
HU,PYREXIA,198
HU,PNEUMONIA,182
HU,VOMITING,177
HU,FATIGUE,176
HU,DECREASED APPETITE,155
HU,DIZZINESS,129
HU,COUGH,125
HU,MALAISE,121
HU,DISEASE PROGRESSION,119
HU,WEIGHT DECREASED,118
HU,HYPERTENSION,114
HU,MODIFIED RANKIN SCORE INCREASED,107
HU,THROMBOCYTOPENIA,105
HU,CARDIAC FAILURE,104
HU,SEPSIS,96
HU,NEUTROPENIA,89
HU,ABDOMINAL PAIN,88
HU,HEADACHE,86
HU,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,85
HU,MALIGNANT NEOPLASM PROGRESSION,83
HU,RENAL IMPAIRMENT,82
HU,FALL,81
HU,RASH,80
HU,CONDITION AGGRAVATED,78
HU,ARTHRALGIA,76
HU,PULMONARY EMBOLISM,72
HU,BLOOD PRESSURE INCREASED,71
HU,GENERAL PHYSICAL HEALTH DETERIORATION,71
HU,PAIN IN EXTREMITY,71
HU,CEREBROVASCULAR ACCIDENT,70
HU,DEEP VEIN THROMBOSIS,70
HU,ATRIAL FIBRILLATION,68
HU,SOMNOLENCE,66
HU,RESPIRATORY FAILURE,65
HU,METASTASES TO LIVER,64
HU,HYPOTENSION,59
HU,DEHYDRATION,58
HU,HYPOAESTHESIA,57
HU,LOSS OF CONSCIOUSNESS,57
HU,OEDEMA PERIPHERAL,57
HU,RENAL FAILURE,57
HU,PERIPHERAL SWELLING,56
HU,HEPATIC ENZYME INCREASED,55
HU,PRURITUS,54
HU,GAIT DISTURBANCE,52
HU,ABDOMINAL PAIN UPPER,50
HU,BACK PAIN,50
HU,ERYTHEMA,50
HU,FEBRILE NEUTROPENIA,49
HU,HYPERSENSITIVITY,49
HU,TREATMENT FAILURE,49
HU,ARRHYTHMIA,48
HU,CONSTIPATION,48
HU,HAEMORRHAGE,48
HU,HYPERHIDROSIS,48
HU,BLOOD GLUCOSE INCREASED,47
HU,VISUAL IMPAIRMENT,47
HU,ALOPECIA,45
HU,CHEST PAIN,44
HU,JAUNDICE,44
HU,BRONCHITIS,43
HU,STOMATITIS,43
HU,CHILLS,42
HU,HYPONATRAEMIA,42
HU,MUSCLE SPASMS,42
HU,MYOCARDIAL INFARCTION,42
HU,CIRCULATORY COLLAPSE,41
HU,CONFUSIONAL STATE,41
HU,LEUKOPENIA,41
HU,METASTASES TO BONE,41
HU,COMPUTERISED TOMOGRAM ABNORMAL,40
HU,DYSGEUSIA,40
HU,PAIN,40
HU,CARDIOPULMONARY FAILURE,39
HU,DEPRESSION,39
HU,MUSCULAR WEAKNESS,39
HU,ASCITES,37
HU,COMA SCALE ABNORMAL,37
HU,HAEMATOCHEZIA,37
HU,MATERNAL EXPOSURE DURING PREGNANCY,37
HU,ASPARTATE AMINOTRANSFERASE INCREASED,36
HU,ISCHAEMIC STROKE,36
HU,METASTASES TO LUNG,36
HU,URTICARIA,36
HU,C-REACTIVE PROTEIN INCREASED,35
HU,NASOPHARYNGITIS,35
HU,NEOPLASM PROGRESSION,35
HU,OVERDOSE,35
HU,URINARY TRACT INFECTION,35
HU,WEIGHT INCREASED,35
HU,EPISTAXIS,34
HU,EXPOSURE DURING PREGNANCY,34
HU,MYALGIA,34
HU,RIGHT VENTRICULAR FAILURE,34
HU,ALANINE AMINOTRANSFERASE INCREASED,33
HU,CHEST DISCOMFORT,33
HU,FOETAL EXPOSURE DURING PREGNANCY,33
HU,SKIN REACTION,33
HU,BLOOD CREATININE INCREASED,32
HU,HAEMOGLOBIN DECREASED,32
HU,INSOMNIA,32
HU,PLATELET COUNT DECREASED,32
HU,THROMBOSIS,32
HU,ABDOMINAL DISTENSION,31
HU,ASPHYXIA,31
HU,HEART RATE INCREASED,31
HU,HYPOKALAEMIA,31
HU,MUCOSAL INFLAMMATION,31
HU,PULMONARY OEDEMA,31
HU,SYNCOPE,31
HU,WHITE BLOOD CELL COUNT DECREASED,31
HU,DYSPNOEA EXERTIONAL,30
HU,HYPOGLYCAEMIA,30
HU,PANCYTOPENIA,30
HU,TACHYCARDIA,30
HU,TREMOR,30
HU,ANGINA PECTORIS,29
HU,CARDIAC ARREST,29
HU,DYSPHAGIA,29
HU,DYSPHONIA,29
HU,INFARCTION,28
HU,LYMPHADENOPATHY,28
HU,BLOOD CREATINE PHOSPHOKINASE INCREASED,27
HU,CATARACT,27
HU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,27
HU,GASTROINTESTINAL HAEMORRHAGE,27
HU,PLEURAL EFFUSION,27
HU,CHOLELITHIASIS,26
HU,PRODUCT USE IN UNAPPROVED INDICATION,26
HU,SEIZURE,26
HU,ACUTE MYOCARDIAL INFARCTION,25
HU,BLOOD ALKALINE PHOSPHATASE INCREASED,25
HU,BREAST CANCER,25
HU,EPILEPSY,25
HU,LUNG NEOPLASM MALIGNANT,25
HU,PALPITATIONS,25
HU,BLOOD LACTATE DEHYDROGENASE INCREASED,24
HU,BLOOD PRESSURE DECREASED,24
HU,FLUSHING,24
HU,HAEMOPTYSIS,24
HU,METASTASES TO CENTRAL NERVOUS SYSTEM,24
HU,SEPTIC SHOCK,24
HU,ACUTE KIDNEY INJURY,23
HU,BONE MARROW FAILURE,23
HU,BONE PAIN,23
HU,CARDIAC DISORDER,23
HU,CEREBRAL HAEMORRHAGE,23
HU,COMA,23
HU,DRY SKIN,23
HU,HEPATIC FAILURE,23
HU,INFECTION,23
HU,NEOPLASM,23
HU,PRODUCT USE ISSUE,23
HU,TOXIC SKIN ERUPTION,23
HU,CEREBRAL INFARCTION,22
HU,CHOKING,22
HU,DYSARTHRIA,22
HU,GLOMERULAR FILTRATION RATE DECREASED,22
HU,HAEMORRHAGIC TRANSFORMATION STROKE,22
HU,METASTASES TO LYMPH NODES,22
HU,MULTIPLE SCLEROSIS RELAPSE,22
HU,OROPHARYNGEAL PAIN,22
HU,OSTEONECROSIS OF JAW,22
HU,SUICIDE ATTEMPT,22
HU,VIRAL INFECTION,22
HU,ABORTION SPONTANEOUS,21
HU,GASTROINTESTINAL DISORDER,21
HU,VISION BLURRED,21
HU,WHITE BLOOD CELL COUNT INCREASED,21
HU,DISORIENTATION,20
HU,DRY MOUTH,20
HU,ERYSIPELAS,20
HU,HAEMATURIA,20
HU,HEPATOCELLULAR CARCINOMA,20
HU,HYDROTHORAX,20
HU,INFLAMMATION,20
HU,NEUROPATHY PERIPHERAL,20
HU,RHINORRHOEA,20
HU,BLOOD BILIRUBIN INCREASED,19
HU,BLOOD PRESSURE FLUCTUATION,19
HU,DRUG INTOLERANCE,19
HU,MOBILITY DECREASED,19
HU,MUSCULOSKELETAL PAIN,19
HU,PARAESTHESIA,19
HU,PULMONARY FIBROSIS,19
HU,ANXIETY,18
HU,APHASIA,18
HU,BLISTER,18
HU,HALLUCINATION,18
HU,HEAD INJURY,18
HU,HEMIPARESIS,18
HU,HERPES ZOSTER,18
HU,HYPERGLYCAEMIA,18
HU,OEDEMA,18
HU,PULMONARY ARTERIAL HYPERTENSION,18
HU,RASH PRURITIC,18
HU,SWELLING FACE,18
HU,TOXICITY TO VARIOUS AGENTS,18
HU,VERTIGO,18
HU,ARTHRITIS,17
HU,BODY TEMPERATURE INCREASED,17
HU,CONTUSION,17
HU,DEVICE DISLOCATION,17
HU,FEMUR FRACTURE,17
HU,GASTROOESOPHAGEAL REFLUX DISEASE,17
HU,GENERALISED OEDEMA,17
HU,HAEMATEMESIS,17
HU,HAEMORRHAGE INTRACRANIAL,17
HU,HEPATOMEGALY,17
HU,HOT FLUSH,17
HU,ILL-DEFINED DISORDER,17
HU,LIVER DISORDER,17
HU,PANCREATITIS,17
HU,ABDOMINAL DISCOMFORT,16
HU,AGRANULOCYTOSIS,16
HU,BRAIN OEDEMA,16
HU,DIPLOPIA,16
HU,ELECTROCARDIOGRAM QT PROLONGED,16
HU,ILEUS,16
HU,METASTASIS,16
HU,PERITONITIS,16
HU,PNEUMONITIS,16
HU,RASH GENERALISED,16
HU,RECTAL HAEMORRHAGE,16
HU,SPEECH DISORDER,16
HU,STOMA SITE DISCHARGE,16
HU,SURGERY,16
HU,TRANSIENT ISCHAEMIC ATTACK,16
HU,VISUAL ACUITY REDUCED,16
HU,ARTERIOSCLEROSIS,15
HU,BALANCE DISORDER,15
HU,CLOSTRIDIUM DIFFICILE COLITIS,15
HU,COLON CANCER,15
HU,DERMATITIS,15
HU,FEELING ABNORMAL,15
HU,HYPOTONIA,15
HU,INTERNATIONAL NORMALISED RATIO INCREASED,15
HU,SUDDEN DEATH,15
HU,URINARY RETENTION,15
HU,ANGIOPATHY,14
HU,BLOOD THYROID STIMULATING HORMONE INCREASED,14
HU,BRADYCARDIA,14
HU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,14
HU,COLORECTAL CANCER METASTATIC,14
HU,DYSPEPSIA,14
HU,EYE PAIN,14
HU,FACE OEDEMA,14
HU,GASTRIC HAEMORRHAGE,14
HU,HAEMATOCRIT DECREASED,14
HU,HAEMATOMA,14
HU,HEPATIC FUNCTION ABNORMAL,14
HU,LEUKOCYTOSIS,14
HU,MALIGNANT MELANOMA,14
HU,POLYNEUROPATHY,14
HU,PSORIASIS,14
HU,SKIN EXFOLIATION,14
HU,VENTRICULAR FIBRILLATION,14
HU,ABNORMAL BEHAVIOUR,13
HU,COLITIS ULCERATIVE,13
HU,CROHN^S DISEASE,13
HU,DYSURIA,13
HU,LUNG DISORDER,13
HU,LUNG NEOPLASM,13
HU,MENTAL DISORDER,13
HU,MYOCARDIAL ISCHAEMIA,13
HU,PERICARDIAL EFFUSION,13
HU,PHOTOSENSITIVITY REACTION,13
HU,PREGNANCY,13
HU,RENAL DISORDER,13
HU,RHEUMATOID ARTHRITIS,13
HU,ROAD TRAFFIC ACCIDENT,13
HU,SINUSITIS,13
HU,SLEEP DISORDER,13
HU,THERAPY NON-RESPONDER,13
HU,TINNITUS,13
HU,TREATMENT NONCOMPLIANCE,13
HU,TUMOUR MARKER INCREASED,13
HU,UPPER RESPIRATORY TRACT INFECTION,13
HU,VASCULITIS,13
HU,WOUND,13
HU,ABORTION INDUCED,12
HU,DRUG EFFECT DECREASED,12
HU,EYELID OEDEMA,12
HU,GLYCOSYLATED HAEMOGLOBIN INCREASED,12
HU,HYPERKERATOSIS,12
HU,HYPOAESTHESIA ORAL,12
HU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,12
HU,INFUSION RELATED REACTION,12
HU,INTENTIONAL OVERDOSE,12
HU,INTENTIONAL PRODUCT MISUSE,12
HU,IRON DEFICIENCY ANAEMIA,12
HU,JOINT SWELLING,12
HU,MELAENA,12
HU,MENTAL IMPAIRMENT,12
HU,NEOPLASM MALIGNANT,12
HU,ORTHOSTATIC HYPOTENSION,12
HU,OSTEOPOROSIS,12
HU,PREMATURE BABY,12
HU,PRODUCTIVE COUGH,12
HU,RED BLOOD CELL COUNT DECREASED,12
HU,RENAL CANCER METASTATIC,12
HU,RESTLESSNESS,12
HU,STATUS EPILEPTICUS,12
HU,SUBILEUS,12
HU,SWOLLEN TONGUE,12
HU,ABDOMINAL PAIN LOWER,11
HU,ANAPHYLACTIC REACTION,11
HU,ARTHROPATHY,11
HU,ASPERGILLUS INFECTION,11
HU,ASTHMA,11
HU,CACHEXIA,11
HU,CARDIOMYOPATHY,11
HU,CARDIOVASCULAR DISORDER,11
HU,COLITIS,11
HU,DERMATITIS ALLERGIC,11
HU,DIABETES MELLITUS,11
HU,EYE DISORDER,11
HU,FAECES DISCOLOURED,11
HU,FLATULENCE,11
HU,GASTROENTERITIS,11
HU,GRANULOMATOSIS WITH POLYANGIITIS,11
HU,HEPATIC CIRRHOSIS,11
HU,HYPOTHYROIDISM,11
HU,INVASIVE DUCTAL BREAST CARCINOMA,11
HU,LIVER FUNCTION TEST INCREASED,11
HU,MENORRHAGIA,11
HU,NEPHROLITHIASIS,11
HU,ORAL PAIN,11
HU,PARKINSON^S DISEASE,11
HU,PULMONARY HAEMORRHAGE,11
HU,RENAL CYST,11
HU,SKIN ULCER,11
HU,SUICIDAL IDEATION,11
HU,TUBERCULOSIS,11
HU,ANAL ABSCESS,10
HU,APHTHOUS ULCER,10
HU,BLOOD CHOLESTEROL INCREASED,10
HU,BLOOD GLUCOSE ABNORMAL,10
HU,BLOOD GLUCOSE DECREASED,10
HU,CLOSTRIDIUM DIFFICILE INFECTION,10
HU,CUTANEOUS SYMPTOM,10
HU,DELIRIUM,10
HU,ENDOCARDITIS,10
HU,FEELING HOT,10
HU,GENERALISED TONIC-CLONIC SEIZURE,10
HU,GRANULOCYTOPENIA,10
HU,HAEMORRHAGIC ANAEMIA,10
HU,HOSPITALISATION,10
HU,HYPERAMMONAEMIA,10
HU,INFLAMMATORY MARKER INCREASED,10
HU,LACRIMATION INCREASED,10
HU,LIVER FUNCTION TEST ABNORMAL,10
HU,LOCAL SWELLING,10
HU,LUNG ADENOCARCINOMA,10
HU,METRORRHAGIA,10
HU,NASAL CONGESTION,10
HU,PALLOR,10
HU,PERIORBITAL OEDEMA,10
HU,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,10
HU,PSYCHOTIC DISORDER,10
HU,RASH MACULO-PAPULAR,10
HU,RASH PUSTULAR,10
HU,SHOCK,10
HU,STAPHYLOCOCCAL INFECTION,10
HU,SYSTEMIC LUPUS ERYTHEMATOSUS,10
HU,THERAPEUTIC RESPONSE DECREASED,10
HU,THERAPEUTIC RESPONSE UNEXPECTED,10
HU,TOOTH LOSS,10
HU,TUMOUR LYSIS SYNDROME,10
HU,URINARY INCONTINENCE,10
HU,UTERINE HAEMORRHAGE,10
HU,VAGINAL HAEMORRHAGE,10
HU,YELLOW SKIN,10
HU,ABDOMINAL HERNIA,9
HU,ACUTE CORONARY SYNDROME,9
HU,BLOOD PRESSURE INADEQUATELY CONTROLLED,9
HU,BLOOD UREA INCREASED,9
HU,BRAIN NEOPLASM,9
HU,BURNING SENSATION,9
HU,CARDIAC FAILURE CONGESTIVE,9
HU,CHOROIDAL DETACHMENT,9
HU,CLEAR CELL RENAL CELL CARCINOMA,9
HU,DRUG ADMINISTRATION ERROR,9
HU,DRUG HYPERSENSITIVITY,9
HU,EATING DISORDER,9
HU,ECZEMA,9
HU,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,9
HU,GANGRENE,9
HU,GASTRITIS EROSIVE,9
HU,GINGIVAL BLEEDING,9
HU,HEPATIC STEATOSIS,9
HU,HYPERNATRAEMIA,9
HU,HYPOACUSIS,9
HU,LYMPHOCYTE COUNT DECREASED,9
HU,MEDICATION ERROR,9
HU,MOOD ALTERED,9
HU,MOVEMENT DISORDER,9
HU,MULTI-ORGAN FAILURE,9
HU,PANCREATITIS ACUTE,9
HU,PHARYNGITIS,9
HU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,9
HU,RESPIRATORY DISORDER,9
HU,RHABDOMYOLYSIS,9
HU,SKIN DISCOLOURATION,9
HU,SKIN DISORDER,9
HU,SPINAL COMPRESSION FRACTURE,9
HU,STRESS CARDIOMYOPATHY,9
HU,TOOTH DISORDER,9
HU,TOXIC EPIDERMAL NECROLYSIS,9
HU,TRANSFUSION,9
HU,ABASIA,8
HU,ABSCESS,8
HU,ACNE,8
HU,ACUTE RESPIRATORY DISTRESS SYNDROME,8
HU,AGITATION,8
HU,AZOTAEMIA,8
HU,BASAL CELL CARCINOMA,8
HU,BLOOD TRIGLYCERIDES INCREASED,8
HU,BRAIN INJURY,8
HU,BREAST CANCER METASTATIC,8
HU,BRONCHOPNEUMONIA,8
HU,CHRONIC KIDNEY DISEASE,8
HU,COMPLETED SUICIDE,8
HU,CYANOSIS,8
HU,CYTOMEGALOVIRUS INFECTION,8
HU,DISSEMINATED INTRAVASCULAR COAGULATION,8
HU,DIVERTICULITIS,8
HU,DRUG EFFECT INCOMPLETE,8
HU,EJECTION FRACTION DECREASED,8
HU,ENCEPHALOPATHY,8
HU,FOETAL DEATH,8
HU,GASTRIC ULCER,8
HU,GLAUCOMA,8
HU,HEPATITIS C,8
HU,HERNIA,8
HU,HYPERKALAEMIA,8
HU,INFLUENZA LIKE ILLNESS,8
HU,INTRACRANIAL PRESSURE INCREASED,8
HU,ISCHAEMIA,8
HU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,8
HU,LIP SWELLING,8
HU,NERVOUSNESS,8
HU,OCULAR HYPERAEMIA,8
HU,PANCREATIC CARCINOMA,8
HU,PETECHIAE,8
HU,PLASMA CELL MYELOMA,8
HU,PLEURISY,8
HU,PREMATURE DELIVERY,8
HU,PURPURA,8
HU,PURULENT DISCHARGE,8
HU,RASH ERYTHEMATOUS,8
HU,RESPIRATORY ARREST,8
HU,SCHIZOPHRENIA,8
HU,SECOND PRIMARY MALIGNANCY,8
HU,SKIN LESION,8
HU,SUNBURN,8
HU,UNEVALUABLE EVENT,8
HU,UPPER LIMB FRACTURE,8
HU,ABDOMINAL ABSCESS,7
HU,ACUTE LEUKAEMIA,7
HU,ALVEOLITIS,7
HU,ANAL INCONTINENCE,7
HU,ANGINA UNSTABLE,7
HU,ANGIOEDEMA,7
HU,APPENDICITIS,7
HU,ATRIAL FLUTTER,7
HU,ATRIAL THROMBOSIS,7
HU,ATRIOVENTRICULAR BLOCK COMPLETE,7
HU,BACTERIAL INFECTION,7
HU,BASEDOW^S DISEASE,7
HU,BENIGN PROSTATIC HYPERPLASIA,7
HU,BLOOD POTASSIUM INCREASED,7
HU,BLOOD URINE PRESENT,7
HU,CANDIDA INFECTION,7
HU,CARDIOGENIC SHOCK,7
HU,CATATONIA,7
HU,CONCOMITANT DISEASE AGGRAVATED,7
HU,CONCOMITANT DISEASE PROGRESSION,7
HU,CONJUNCTIVITIS,7
HU,DEMENTIA,7
HU,DERMATITIS ACNEIFORM,7
HU,DISCOMFORT,7
HU,DISEASE RECURRENCE,7
HU,DRUG DOSE OMISSION,7
HU,DRUG RESISTANCE,7
HU,DRUG WITHDRAWAL SYNDROME,7
HU,DUODENITIS,7
HU,DYSSTASIA,7
HU,EAR INFECTION,7
HU,EYE INFLAMMATION,7
HU,FEAR OF DEATH,7
HU,FULL BLOOD COUNT ABNORMAL,7
HU,GASTRIC DISORDER,7
HU,GASTROINTESTINAL INFLAMMATION,7
HU,GENITAL HAEMORRHAGE,7
HU,GINGIVAL SWELLING,7
HU,GINGIVITIS,7
HU,HAEMORRHOIDAL HAEMORRHAGE,7
HU,HEPATITIS B,7
HU,HYPERAESTHESIA,7
HU,HYPOCALCAEMIA,7
HU,HYPOXIA,7
HU,IDIOPATHIC PULMONARY FIBROSIS,7
HU,INCORRECT DOSE ADMINISTERED,7
HU,INFLUENZA,7
HU,INJURY,7
HU,INTERVERTEBRAL DISC PROTRUSION,7
HU,LEFT VENTRICULAR DYSFUNCTION,7
HU,MUSCULOSKELETAL CHEST PAIN,7
HU,MUSCULOSKELETAL STIFFNESS,7
HU,MYOSITIS,7
HU,NERVOUS SYSTEM DISORDER,7
HU,NEUTROPHIL COUNT DECREASED,7
HU,NEUTROPHIL COUNT INCREASED,7
HU,OESOPHAGEAL VARICES HAEMORRHAGE,7
HU,OTITIS MEDIA,7
HU,PAIN OF SKIN,7
HU,PARAPARESIS,7
HU,PATHOGEN RESISTANCE,7
HU,PRESYNCOPE,7
HU,PROTEINURIA,7
HU,PULMONARY MASS,7
HU,PYELONEPHRITIS,7
HU,RENAL NEOPLASM,7
HU,SINUS BRADYCARDIA,7
HU,SQUAMOUS CELL CARCINOMA,7
HU,SUBDURAL HAEMATOMA,7
HU,THROAT IRRITATION,7
HU,VASCULAR ENCEPHALOPATHY,7
HU,VISUAL FIELD DEFECT,7
HU,WHEEZING,7
HU,ABORTION,6
HU,ACUTE MYELOID LEUKAEMIA,6
HU,ADENOCARCINOMA OF COLON,6
HU,AGEUSIA,6
HU,AGGRESSION,6
HU,ANAL FISTULA,6
HU,ANURIA,6
HU,AORTIC STENOSIS,6
HU,ASPIRATION,6
HU,BLADDER CANCER,6
HU,BLINDNESS,6
HU,BLOOD COUNT ABNORMAL,6
HU,BLOOD POTASSIUM DECREASED,6
HU,BLOOD PRESSURE SYSTOLIC INCREASED,6
HU,BREATH SOUNDS ABNORMAL,6
HU,CAESAREAN SECTION,6
HU,CARDIOMEGALY,6
HU,CAROTID ARTERY OCCLUSION,6
HU,CENTRAL NERVOUS SYSTEM LESION,6
HU,CEREBROVASCULAR DISORDER,6
HU,CHOLECYSTITIS,6
HU,CHRONIC LYMPHOCYTIC LEUKAEMIA,6
HU,DEVICE EXPULSION,6
HU,DEVICE ISSUE,6
HU,DRUG-INDUCED LIVER INJURY,6
HU,DUODENAL ULCER,6
HU,DYSKINESIA,6
HU,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,6
HU,ELECTROCARDIOGRAM T WAVE INVERSION,6
HU,EXTRAVASATION,6
HU,EYE HAEMORRHAGE,6
HU,EYE SWELLING,6
HU,FACTOR VIII INHIBITION,6
HU,FEEDING DISORDER,6
HU,FEMORAL NECK FRACTURE,6
HU,FLUID RETENTION,6
HU,GASTRIC CANCER,6
HU,GLOSSODYNIA,6
HU,HAEMORRHAGIC STROKE,6
HU,HAEMORRHOIDS,6
HU,HEPATIC ENZYME ABNORMAL,6
HU,HEPATIC LESION,6
HU,HEPATOSPLENOMEGALY,6
HU,HEPATOTOXICITY,6
HU,HICCUPS,6
HU,HYPERTENSIVE CRISIS,6
HU,HYPOALBUMINAEMIA,6
HU,HYPOKINESIA,6
HU,INFECTIOUS MONONUCLEOSIS,6
HU,INFLAMMATORY BOWEL DISEASE,6
HU,KETOACIDOSIS,6
HU,LARYNGEAL OEDEMA,6
HU,LEFT VENTRICULAR FAILURE,6
HU,LIPASE INCREASED,6
HU,LIPIDS ABNORMAL,6
HU,LIVER INJURY,6
HU,LOW BIRTH WEIGHT BABY,6
HU,LOWER LIMB FRACTURE,6
HU,MALNUTRITION,6
HU,MEMORY IMPAIRMENT,6
HU,MENSTRUAL DISORDER,6
HU,METABOLIC ACIDOSIS,6
HU,MOOD SWINGS,6
HU,MYELODYSPLASTIC SYNDROME,6
HU,NECK PAIN,6
HU,NEOPLASM RECURRENCE,6
HU,NEURALGIA,6
HU,NORMAL NEWBORN,6
HU,ORAL INFECTION,6
HU,OSTEOARTHRITIS,6
HU,OXYGEN SATURATION DECREASED,6
HU,PAROTID GLAND ENLARGEMENT,6
HU,PERITONITIS BACTERIAL,6
HU,PHOTOPHOBIA,6
HU,POLLAKIURIA,6
HU,PREMATURE RUPTURE OF MEMBRANES,6
HU,PRESCRIBED OVERDOSE,6
HU,PRURITUS GENERALISED,6
HU,PULMONARY TUBERCULOSIS,6
HU,PYOGENIC GRANULOMA,6
HU,RENAL CANCER,6
HU,RESPIRATORY TRACT INFECTION,6
HU,SHOCK HAEMORRHAGIC,6
HU,SINUS TACHYCARDIA,6
HU,SPLENOMEGALY,6
HU,STENOSIS,6
HU,STEVENS-JOHNSON SYNDROME,6
HU,STOMA SITE INFLAMMATION,6
HU,STRESS,6
HU,SUFFOCATION FEELING,6
HU,TOXIC ENCEPHALOPATHY,6
HU,TROPONIN T INCREASED,6
HU,UVEITIS,6
HU,WRIST FRACTURE,6
HU,ACUTE ABDOMEN,5
HU,ALTERED STATE OF CONSCIOUSNESS,5
HU,AMNESIA,5
HU,ANKYLOSING SPONDYLITIS,5
HU,AUTOIMMUNE HAEMOLYTIC ANAEMIA,5
HU,BILIRUBIN CONJUGATED INCREASED,5
HU,BLOOD SODIUM DECREASED,5
HU,BODY TEMPERATURE DECREASED,5
HU,BONE LESION,5
HU,CARDIAC FAILURE ACUTE,5
HU,CARDIOTOXICITY,5
HU,CELLULITIS,5
HU,CEREBRAL DISORDER,5
HU,COLECTOMY,5
HU,CONVULSION,5
HU,CORONARY ARTERY OCCLUSION,5
HU,CORONARY ARTERY STENOSIS,5
HU,CYSTITIS,5
HU,CYSTITIS HAEMORRHAGIC,5
HU,DECUBITUS ULCER,5
HU,DERMATITIS BULLOUS,5
HU,DERMATITIS EXFOLIATIVE,5
HU,DIABETES MELLITUS INADEQUATE CONTROL,5
HU,DIABETIC KETOACIDOSIS,5
HU,DISSEMINATED TUBERCULOSIS,5
HU,DISTURBANCE IN ATTENTION,5
HU,DIVERTICULUM,5
HU,DIZZINESS POSTURAL,5
HU,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,5
HU,DRUG LEVEL INCREASED,5
HU,ENCEPHALOMALACIA,5
HU,ENDOPHTHALMITIS,5
HU,ERYTHEMA MULTIFORME,5
HU,EXPOSURE DURING BREAST FEEDING,5
HU,EYE OEDEMA,5
HU,FACIAL PARESIS,5
HU,GASTRITIS,5
HU,GASTROINTESTINAL NECROSIS,5
HU,GINGIVAL PAIN,5
HU,HAEMANGIOMA OF LIVER,5
HU,HAEMARTHROSIS,5
HU,HAEMOLYSIS,5
HU,HEARING IMPAIRED,5
HU,HEPATIC NEOPLASM,5
HU,HEPATORENAL FAILURE,5
HU,HEPATORENAL SYNDROME,5
HU,HIATUS HERNIA,5
HU,HISTIOCYTOSIS HAEMATOPHAGIC,5
HU,HUNGER,5
HU,HYPERBILIRUBINAEMIA,5
HU,HYPERKINESIA,5
HU,HYPERTHYROIDISM,5
HU,HYPERTONIA,5
HU,ILEUS PARALYTIC,5
HU,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,5
HU,INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT,5
HU,INTENTIONAL PRODUCT USE ISSUE,5
HU,INTERSTITIAL LUNG DISEASE,5
HU,INTESTINAL OBSTRUCTION,5
HU,INTRACARDIAC THROMBUS,5
HU,IRIDOCYCLITIS,5
HU,LABORATORY TEST ABNORMAL,5
HU,LETHARGY,5
HU,LIVE BIRTH,5
HU,LUPUS-LIKE SYNDROME,5
HU,LYMPHANGIOSIS CARCINOMATOSA,5
HU,LYMPHOCYTOSIS,5
HU,LYMPHOPENIA,5
HU,MEGACOLON,5
HU,METASTASES TO SPINE,5
HU,METASTASES TO THE MEDIASTINUM,5
HU,METASTASES TO THORAX,5
HU,MONOPARESIS,5
HU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,5
HU,NEUTROPENIC SEPSIS,5
HU,NIGHT SWEATS,5
HU,NODULE,5
HU,NON-HODGKIN^S LYMPHOMA,5
HU,OBESITY,5
HU,OSTEOMYELITIS,5
HU,OSTEONECROSIS,5
HU,OVARIAN CYST,5
HU,PARESIS,5
HU,PEMPHIGOID,5
HU,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,5
HU,PERIPHERAL COLDNESS,5
HU,PERIPHERAL ISCHAEMIA,5
HU,PHARYNGEAL OEDEMA,5
HU,PNEUMOTHORAX,5
HU,POST PROCEDURAL HAEMORRHAGE,5
HU,PROSTATITIS,5
HU,PSEUDOPHAEOCHROMOCYTOMA,5
HU,PULMONARY HYPERTENSION,5
HU,RECTAL ADENOCARCINOMA,5
HU,RENAL FAILURE ACUTE,5
HU,RENAL PAIN,5
HU,RETINAL HAEMORRHAGE,5
HU,RIB FRACTURE,5
HU,ROTAVIRUS INFECTION,5
HU,SENSATION OF FOREIGN BODY,5
HU,SKIN HAEMORRHAGE,5
HU,SKIN NECROSIS,5
HU,SNEEZING,5
HU,SPINAL PAIN,5
HU,STENT PLACEMENT,5
HU,SUBCUTANEOUS HAEMATOMA,5
HU,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,5
HU,SWELLING,5
HU,TESTICULAR ATROPHY,5
HU,THROMBOPHLEBITIS,5
HU,TOOTHACHE,5
HU,TRANSAMINASES INCREASED,5
HU,VASCULAR INJURY,5
HU,ACTIVITIES OF DAILY LIVING IMPAIRED,4
HU,ACUTE PRERENAL FAILURE,4
HU,ACUTE PSYCHOSIS,4
HU,ACUTE RESPIRATORY FAILURE,4
HU,ADVERSE DRUG REACTION,4
HU,ADVERSE EVENT,4
HU,AKATHISIA,4
HU,ANAPHYLACTIC SHOCK,4
HU,ANOSMIA,4
HU,APATHY,4
HU,APHTHOUS STOMATITIS,4
HU,APNOEA,4
HU,ARTERIOSCLEROSIS CORONARY ARTERY,4
HU,ARTERIOSPASM CORONARY,4
HU,ATAXIA,4
HU,AUTOIMMUNE DISORDER,4
HU,AUTOIMMUNE HEPATITIS,4
HU,B-CELL LYMPHOMA,4
HU,BACTERIAL TOXAEMIA,4
HU,BLADDER NEOPLASM,4
HU,BLOOD DISORDER,4
HU,BLOOD URIC ACID INCREASED,4
HU,BREAST ABSCESS,4
HU,BREAST SWELLING,4
HU,BRONCHITIS CHRONIC,4
HU,BRONCHOPULMONARY ASPERGILLOSIS,4
HU,CARCINOEMBRYONIC ANTIGEN INCREASED,4
HU,CARDIAC TAMPONADE,4
HU,CARDIO-RESPIRATORY ARREST,4
HU,CAROTID ARTERY STENOSIS,4
HU,CEREBRAL ARTERY EMBOLISM,4
HU,CEREBRAL ATROPHY,4
HU,CEREBRAL ISCHAEMIA,4
HU,CHEILITIS,4
HU,CHOLECYSTITIS ACUTE,4
HU,CHROMATURIA,4
HU,COAGULOPATHY,4
HU,COGNITIVE DISORDER,4
HU,COLD SWEAT,4
HU,COLON NEOPLASM,4
HU,CONGESTIVE CARDIOMYOPATHY,4
HU,CONTRAINDICATED PRODUCT ADMINISTERED,4
HU,COORDINATION ABNORMAL,4
HU,DERMATOMYOSITIS,4
HU,DEVICE RELATED INFECTION,4
HU,DIARRHOEA HAEMORRHAGIC,4
HU,DIVERTICULAR PERFORATION,4
HU,DRUG DEPENDENCE,4
HU,DRUG ERUPTION,4
HU,DRUG PRESCRIBING ERROR,4
HU,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
HU,DUODENAL ULCER HAEMORRHAGE,4
HU,DYSPNOEA AT REST,4
HU,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,4
HU,EMBOLISM,4
HU,ENTEROCOCCAL INFECTION,4
HU,EPISCLERITIS,4
HU,ERUCTATION,4
HU,ESCHERICHIA SEPSIS,4
HU,EXTRAPYRAMIDAL DISORDER,4
HU,EXTRAVASATION BLOOD,4
HU,FACIAL PARALYSIS,4
HU,FLUID INTAKE REDUCED,4
HU,FREQUENT BOWEL MOVEMENTS,4
HU,GENERAL PHYSICAL CONDITION ABNORMAL,4
HU,GLIOBLASTOMA,4
HU,HAIR COLOUR CHANGES,4
HU,HALLUCINATION_ VISUAL,4
HU,HAND FRACTURE,4
HU,HEART RATE DECREASED,4
HU,HELICOBACTER INFECTION,4
HU,HEPATIC CANCER,4
HU,HEPATIC CYST,4
HU,HERPES VIRUS INFECTION,4
HU,HYPOPHYSITIS,4
HU,HYPOVOLAEMIC SHOCK,4
HU,IMMUNE SYSTEM DISORDER,4
HU,IMMUNOSUPPRESSION,4
HU,IMPAIRED HEALING,4
HU,INCONTINENCE,4
HU,INCREASED APPETITE,4
HU,INJECTION SITE ERYTHEMA,4
HU,INJECTION SITE INFLAMMATION,4
HU,INJECTION SITE NODULE,4
HU,INJECTION SITE REACTION,4
HU,INJECTION SITE SWELLING,4
HU,INTESTINAL HAEMORRHAGE,4
HU,INTESTINAL PERFORATION,4
HU,JOINT RANGE OF MOTION DECREASED,4
HU,LARGE INTESTINE POLYP,4
HU,LICHEN PLANUS,4
HU,LIMB INJURY,4
HU,LOOSE TOOTH,4
HU,LOWER GASTROINTESTINAL HAEMORRHAGE,4
HU,LUNG CANCER METASTATIC,4
HU,LUNG INFILTRATION,4
HU,LUPUS NEPHRITIS,4
HU,LYMPHOMA,4
HU,MALABSORPTION,4
HU,MEAN CELL VOLUME DECREASED,4
HU,METASTASES TO MENINGES,4
HU,METASTASES TO SKIN,4
HU,MOUTH HAEMORRHAGE,4
HU,MUSCLE TWITCHING,4
HU,MUSCULOSKELETAL DISORDER,4
HU,MYDRIASIS,4
HU,MYOCARDIAL NECROSIS,4
HU,MYOPATHY,4
HU,NEUROLOGICAL DECOMPENSATION,4
HU,NIGHTMARE,4
HU,NO ADVERSE EVENT,4
HU,NORMOCHROMIC NORMOCYTIC ANAEMIA,4
HU,NYSTAGMUS,4
HU,ODYNOPHAGIA,4
HU,OPTIC NEURITIS,4
HU,ORAL FUNGAL INFECTION,4
HU,ORAL HERPES,4
HU,ORAL MUCOSAL BLISTERING,4
HU,PANCREATIC CARCINOMA METASTATIC,4
HU,PANCREATIC NEOPLASM,4
HU,PANCREATIC NEUROENDOCRINE TUMOUR,4
HU,PANIC REACTION,4
HU,PARALYSIS,4
HU,PARTIAL SEIZURES,4
HU,PERIPHERAL ARTERY OCCLUSION,4
HU,PHLEBITIS,4
HU,PLEURAL THICKENING,4
HU,PNEUMONIA ASPIRATION,4
HU,POLYP,4
HU,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,4
HU,PRE-ECLAMPSIA,4
HU,PRODUCT CONTAINER ISSUE,4
HU,PROSTATE CANCER,4
HU,PROSTATE CANCER METASTATIC,4
HU,PSEUDOMEMBRANOUS COLITIS,4
HU,PUPILS UNEQUAL,4
HU,PYELONEPHRITIS ACUTE,4
HU,RASH VESICULAR,4
HU,RESPIRATORY SYNCYTIAL VIRUS INFECTION,4
HU,RETINITIS PIGMENTOSA,4
HU,SINUS ARREST,4
HU,SINUS ARRHYTHMIA,4
HU,SKIN BURNING SENSATION,4
HU,SKIN HYPERTROPHY,4
HU,SPINAL DISORDER,4
HU,SPINAL FRACTURE,4
HU,SPUTUM DISCOLOURED,4
HU,STAPHYLOCOCCAL SEPSIS,4
HU,STOMA SITE ERYTHEMA,4
HU,TACHYARRHYTHMIA,4
HU,TENSION,4
HU,THROAT TIGHTNESS,4
HU,THROMBOCYTOPENIC PURPURA,4
HU,TONGUE BLISTERING,4
HU,TONGUE DISORDER,4
HU,TORSADE DE POINTES,4
HU,TRACHEITIS,4
HU,TRANSPLANT,4
HU,TRICUSPID VALVE INCOMPETENCE,4
HU,TUBULOINTERSTITIAL NEPHRITIS,4
HU,UPPER RESPIRATORY TRACT INFLAMMATION,4
HU,URINARY TRACT INFECTION BACTERIAL,4
HU,URINE OUTPUT DECREASED,4
HU,VENOUS THROMBOSIS LIMB,4
HU,VENTRICULAR EXTRASYSTOLES,4
HU,VENTRICULAR TACHYCARDIA,4
HU,WITHDRAWAL SYNDROME,4
HU,ABDOMINAL SYMPTOM,3
HU,ACIDOSIS,3
HU,ACUTE HEPATIC FAILURE,3
HU,ADRENAL INSUFFICIENCY,3
HU,AMYLASE INCREASED,3
HU,ANKLE FRACTURE,3
HU,APHONIA,3
HU,ARTHRITIS BACTERIAL,3
HU,ATELECTASIS,3
HU,ATRIAL TACHYCARDIA,3
HU,ATROPHY,3
HU,ATYPICAL PNEUMONIA,3
HU,BILE DUCT STONE,3
HU,BLEPHARITIS,3
HU,BLOOD IRON DECREASED,3
HU,BONE DISORDER,3
HU,BONE MARROW TOXICITY,3
HU,BRADYARRHYTHMIA,3
HU,BREAST NEOPLASM,3
HU,BREAST PAIN,3
HU,BRONCHOSPASM,3
HU,BUNDLE BRANCH BLOCK LEFT,3
HU,BUNDLE BRANCH BLOCK RIGHT,3
HU,CARDIAC OPERATION,3
HU,CARDIAC VALVE DISEASE,3
HU,CARDIOVASCULAR INSUFFICIENCY,3
HU,CATARRH,3
HU,CHLAMYDIAL INFECTION,3
HU,CHOKING SENSATION,3
HU,CHORIORETINOPATHY,3
HU,CLONIC CONVULSION,3
HU,COLON CANCER METASTATIC,3
HU,CONCUSSION,3
HU,CORNEAL NEOVASCULARISATION,3
HU,CORNEAL PERFORATION,3
HU,CORONARY ARTERY DISEASE,3
HU,CORONARY ARTERY EMBOLISM,3
HU,CORONARY ARTERY THROMBOSIS,3
HU,CRYING,3
HU,CYSTOID MACULAR OEDEMA,3
HU,CYTOPENIA,3
HU,DEPRESSED MOOD,3
HU,DIABETIC NEPHROPATHY,3
HU,DIABETIC NEUROPATHY,3
HU,DIVERTICULUM INTESTINAL,3
HU,DRY EYE,3
HU,DYSTHYMIC DISORDER,3
HU,ECHOCARDIOGRAM ABNORMAL,3
HU,ELECTROLYTE IMBALANCE,3
HU,EMOTIONAL POVERTY,3
HU,EMPHYSEMA,3
HU,ENTERITIS,3
HU,EOSINOPHILIA,3
HU,ERECTILE DYSFUNCTION,3
HU,EXPOSURE VIA FATHER,3
HU,FACE INJURY,3
HU,FEAR,3
HU,FEELING COLD,3
HU,FIBRIN D DIMER INCREASED,3
HU,FIBROSIS,3
HU,FISTULA,3
HU,FOOT DEFORMITY,3
HU,FRACTURE,3
HU,GALLBLADDER DISORDER,3
HU,GASTROINTESTINAL INFECTION,3
HU,GASTROINTESTINAL MOTILITY DISORDER,3
HU,GLOMERULAR FILTRATION RATE ABNORMAL,3
HU,GLOMERULAR FILTRATION RATE INCREASED,3
HU,GRANULOCYTE COUNT DECREASED,3
HU,GROIN PAIN,3
HU,HAEMOGLOBIN ABNORMAL,3
HU,HAEMORRHAGE SUBCUTANEOUS,3
HU,HEAD DISCOMFORT,3
HU,HEART VALVE INCOMPETENCE,3
HU,HEMIPLEGIA,3
HU,HEPATITIS,3
HU,HEPATITIS E,3
HU,HERPES SIMPLEX,3
HU,HYPERCALCAEMIA,3
HU,HYPOGEUSIA,3
HU,HYPOMAGNESAEMIA,3
HU,HYPOPNOEA,3
HU,HYPOVENTILATION,3
HU,ILLUSION,3
HU,IMMUNE THROMBOCYTOPENIC PURPURA,3
HU,INAPPROPRIATE AFFECT,3
IS,DRUG-INDUCED LIVER INJURY,19
IS,VOMITING,11
IS,CHOLANGITIS SCLEROSING,10
IS,HEPATOTOXICITY,10
IS,DRUG ABUSE,9
IS,JAUNDICE,9
IS,NAUSEA,9
IS,OVERDOSE,9
IS,ASTHENIA,8
IS,DRUG INEFFECTIVE,8
IS,DYSPNOEA,8
IS,BLOOD CREATININE INCREASED,7
IS,FATIGUE,7
IS,INTENTIONAL PRODUCT MISUSE,7
IS,PROTHROMBIN TIME PROLONGED,7
IS,PYREXIA,7
IS,WEIGHT DECREASED,7
IS,ACUTE HEPATIC FAILURE,6
IS,ALANINE AMINOTRANSFERASE INCREASED,6
IS,ASPARTATE AMINOTRANSFERASE INCREASED,6
IS,DIARRHOEA,6
IS,ENCEPHALOPATHY,6
IS,FEELING ABNORMAL,6
IS,INCORRECT ROUTE OF DRUG ADMINISTRATION,6
IS,PREMATURE BABY,6
IS,RASH,6
IS,ABDOMINAL PAIN,5
IS,ACCIDENTAL OVERDOSE,5
IS,ANXIETY,5
IS,DEATH,5
IS,DIZZINESS,5
IS,FOETAL GROWTH RESTRICTION,5
IS,GASTROINTESTINAL HAEMORRHAGE,5
IS,HEADACHE,5
IS,INTENTIONAL OVERDOSE,5
IS,LOW BIRTH WEIGHT BABY,5
IS,PAIN,5
IS,PRURITUS,5
IS,TREMOR,5
IS,VENTRICULAR TACHYCARDIA,5
IS,VIRAL INFECTION,5
IS,CARDIAC ARREST,4
IS,COMPLETED SUICIDE,4
IS,DELIRIUM,4
IS,DEPRESSION,4
IS,DRUG DEPENDENCE,4
IS,HAEMOGLOBIN DECREASED,4
IS,HYPERHIDROSIS,4
IS,HYPOAESTHESIA,4
IS,LEUKOPENIA,4
IS,LOSS OF CONSCIOUSNESS,4
IS,MALAISE,4
IS,MATERNAL EXPOSURE DURING PREGNANCY,4
IS,MYOCARDIAL INFARCTION,4
IS,NEUTROPENIA,4
IS,PAIN IN EXTREMITY,4
IS,PNEUMONIA,4
IS,SYNCOPE,4
IS,THERAPY CESSATION,4
IS,TYPE 2 DIABETES MELLITUS,4
IS,ABORTION SPONTANEOUS,3
IS,ARRHYTHMIA,3
IS,CEREBRAL HAEMORRHAGE,3
IS,CHILLS,3
IS,CHOLESTATIC LIVER INJURY,3
IS,COUGH,3
IS,FOETAL EXPOSURE DURING PREGNANCY,3
IS,FOETAL EXPOSURE TIMING UNSPECIFIED,3
IS,HYPERSENSITIVITY,3
IS,HYPOTENSION,3
IS,JOINT SWELLING,3
IS,LIVER INJURY,3
IS,LUPUS-LIKE SYNDROME,3
IS,MYALGIA,3
IS,NICOTINE DEPENDENCE,3
IS,PLEURAL EFFUSION,3
IS,PULMONARY EMBOLISM,3
IS,RENAL FAILURE,3
IS,SUICIDE ATTEMPT,3
IS,ABDOMINAL COMPARTMENT SYNDROME,2
IS,ABDOMINAL DISCOMFORT,2
IS,ABDOMINAL PAIN UPPER,2
IS,ACTIVITIES OF DAILY LIVING IMPAIRED,2
IS,ALOPECIA,2
IS,ANAEMIA,2
IS,ARTHRALGIA,2
IS,ATRIAL FIBRILLATION,2
IS,BLOOD GLUCOSE INCREASED,2
IS,CARDIAC FAILURE CHRONIC,2
IS,CHEST PAIN,2
IS,CONFUSIONAL STATE,2
IS,CONSTIPATION,2
IS,DECREASED APPETITE,2
IS,DEEP VEIN THROMBOSIS,2
IS,DISCOMFORT,2
IS,DRY MOUTH,2
IS,DYSPHORIA,2
IS,EATING DISORDER,2
IS,ERYTHEMA,2
IS,EXERCISE TOLERANCE DECREASED,2
IS,EXPOSURE DURING BREAST FEEDING,2
IS,EXPOSURE DURING PREGNANCY,2
IS,FACIAL PARALYSIS,2
IS,FALL,2
IS,GAIT DISTURBANCE,2
IS,GASTRIC ULCER HAEMORRHAGE,2
IS,GASTROINTESTINAL INJURY,2
IS,GENERALISED TONIC-CLONIC SEIZURE,2
IS,HAEMOPTYSIS,2
IS,HEART RATE DECREASED,2
IS,HEART RATE INCREASED,2
IS,HEPATITIS ACUTE,2
IS,HYPERKALAEMIA,2
IS,HYPOACUSIS,2
IS,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
IS,INCARCERATED HERNIA,2
IS,INCORRECT DOSE ADMINISTERED,2
IS,INCORRECT DRUG ADMINISTRATION DURATION,2
IS,INSOMNIA,2
IS,INTENTIONAL PRODUCT USE ISSUE,2
IS,INTESTINAL ISCHAEMIA,2
IS,INTRA-ABDOMINAL FLUID COLLECTION,2
IS,INTRA-ABDOMINAL HAEMORRHAGE,2
IS,ISCHAEMIC STROKE,2
IS,KETOACIDOSIS,2
IS,LIVER FUNCTION TEST INCREASED,2
IS,LYMPHOPENIA,2
IS,MANIA,2
IS,MONOPLEGIA,2
IS,MUCOSAL INFLAMMATION,2
IS,MUSCLE SPASMS,2
IS,MUSCULAR WEAKNESS,2
IS,OEDEMA PERIPHERAL,2
IS,OESOPHAGEAL INJURY,2
IS,PERICARDIAL EFFUSION,2
IS,PREMATURE LABOUR,2
IS,PRODUCT QUALITY ISSUE,2
IS,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
IS,PSYCHOTIC DISORDER,2
IS,PULMONARY OEDEMA,2
IS,RESPIRATORY TRACT INFECTION,2
IS,ROAD TRAFFIC ACCIDENT,2
IS,SHRINKING LUNG SYNDROME,2
IS,SINUS BRADYCARDIA,2
IS,SOMNOLENCE,2
IS,STUPOR,2
IS,THROMBOCYTOPENIA,2
IS,TONGUE COATED,2
IS,URINARY RETENTION,2
IS,VASCULITIS,2
IS,VERTIGO,2
IS,VISION BLURRED,2
IS,ABDOMINAL DISTENSION,1
IS,ABDOMINAL WALL HAEMATOMA,1
IS,ABNORMAL BEHAVIOUR,1
IS,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
IS,ACNE,1
IS,ACUTE KIDNEY INJURY,1
IS,ACUTE MYOCARDIAL INFARCTION,1
IS,ACUTE RESPIRATORY DISTRESS SYNDROME,1
IS,ADRENOMEGALY,1
IS,ADVERSE EVENT,1
IS,AGGRESSION,1
IS,AKATHISIA,1
IS,ALCOHOLISM,1
IS,AMAUROSIS FUGAX,1
IS,AMNESIA,1
IS,ANAPHYLACTIC SHOCK,1
IS,ANEURYSM RUPTURED,1
IS,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
IS,ANURIA,1
IS,ANXIETY DISORDER,1
IS,AORTIC VALVE INCOMPETENCE,1
IS,APHONIA,1
IS,APNOEA,1
IS,APPLICATION SITE HYPERSENSITIVITY,1
IS,APPLICATION SITE PAIN,1
IS,APPLICATION SITE REACTION,1
IS,APPLICATION SITE VESICLES,1
IS,ARRHYTHMIA SUPRAVENTRICULAR,1
IS,ARTHRITIS,1
IS,ASTHMA,1
IS,ATELECTASIS,1
IS,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
IS,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
IS,BACK PAIN,1
IS,BACTERIAL INFECTION,1
IS,BILE DUCT STONE,1
IS,BILIARY TRACT DISORDER,1
IS,BLOOD BICARBONATE DECREASED,1
IS,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
IS,BLOOD PRESSURE ABNORMAL,1
IS,BLOOD PRESSURE DECREASED,1
IS,BLOOD PRESSURE INCREASED,1
IS,BONE MARROW FAILURE,1
IS,BRADYCARDIA,1
IS,BRAIN INJURY,1
IS,BRONCHIAL WALL THICKENING,1
IS,BRONCHITIS,1
IS,CARDIAC DISORDER,1
IS,CARDIAC FAILURE CONGESTIVE,1
IS,CARDIAC FIBRILLATION,1
IS,CARDIOMEGALY,1
IS,CHEST DISCOMFORT,1
IS,CHOLECYSTECTOMY,1
IS,CHOLECYSTITIS,1
IS,CHROMATURIA,1
IS,CHRONIC KIDNEY DISEASE,1
IS,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
IS,COLITIS,1
IS,COLITIS ISCHAEMIC,1
IS,COMA,1
IS,CONCUSSION,1
IS,CONDITION AGGRAVATED,1
IS,CONDUCTION DISORDER,1
IS,CONTUSION,1
IS,COORDINATION ABNORMAL,1
IS,CORONARY ARTERY THROMBOSIS,1
IS,CRIME,1
IS,CYANOSIS,1
IS,DEAFNESS,1
IS,DECREASED INTEREST,1
IS,DELUSION,1
IS,DEPENDENCE,1
IS,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IS,DEVELOPMENTAL HIP DYSPLASIA,1
IS,DEVICE DIFFICULT TO USE,1
IS,DEVICE EXPULSION,1
IS,DIARRHOEA HAEMORRHAGIC,1
IS,DISABILITY,1
IS,DISEASE PROGRESSION,1
IS,DISORIENTATION,1
IS,DRUG DIVERSION,1
IS,DRUG EFFECT DECREASED,1
IS,DRUG EFFECT INCOMPLETE,1
IS,DRUG INTOLERANCE,1
IS,DRUG PRESCRIBING ERROR,1
IS,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
IS,DRUG SCREEN POSITIVE,1
IS,DRUG USE DISORDER,1
IS,DRUG WITHDRAWAL SYNDROME,1
IS,DYSARTHRIA,1
IS,DYSKINESIA,1
IS,DYSPEPSIA,1
IS,DYSURIA,1
IS,ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE,1
IS,ECZEMA INFECTED,1
IS,ELECTROCARDIOGRAM QT PROLONGED,1
IS,EMOTIONAL DISTRESS,1
IS,EPENDYMOMA,1
IS,EPILEPSY,1
IS,EYELID OEDEMA,1
IS,FACE OEDEMA,1
IS,FACIAL PAIN,1
IS,FAECES DISCOLOURED,1
IS,FEAR,1
IS,FEELING COLD,1
IS,FOOD INTOLERANCE,1
IS,FORCED EXPIRATORY VOLUME DECREASED,1
IS,FRUSTRATION,1
IS,GALLBLADDER OEDEMA,1
IS,GASTRITIS,1
IS,GASTROINTESTINAL DISORDER,1
IS,GENERAL PHYSICAL HEALTH DETERIORATION,1
IS,GENERALISED ERYTHEMA,1
IS,GENERALISED OEDEMA,1
IS,GESTATIONAL DIABETES,1
IS,GINGIVAL DISORDER,1
IS,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
IS,HAEMATEMESIS,1
IS,HAEMATOCHEZIA,1
IS,HAEMATURIA,1
IS,HAEMOGLOBIN ABNORMAL,1
IS,HAEMORRHAGE,1
IS,HAEMORRHAGE IN PREGNANCY,1
IS,HAEMORRHAGE INTRACRANIAL,1
IS,HAEMOTHORAX,1
IS,HALLUCINATION_ AUDITORY,1
IS,HALLUCINATION_ VISUAL,1
IS,HEAD DISCOMFORT,1
IS,HEAD INJURY,1
IS,HEART RATE IRREGULAR,1
IS,HEMIPARESIS,1
IS,HEPATIC ENZYME INCREASED,1
IS,HEPATIC FAILURE,1
IS,HEPATITIS,1
IS,HEPATOCELLULAR CARCINOMA,1
IS,HIV INFECTION,1
IS,HOMICIDE,1
IS,HYPERGLYCAEMIA,1
IS,HYPERSEXUALITY,1
IS,HYPERTROPHIC CARDIOMYOPATHY,1
IS,HYPOAESTHESIA ORAL,1
IS,HYPOKALAEMIA,1
IS,HYPONATRAEMIA,1
IS,HYPOTHERMIA,1
IS,HYPOTONIA,1
IS,HYPOXIA,1
IS,IMPAIRED DRIVING ABILITY,1
IS,IMPETIGO,1
IS,IMPLANT SITE NECROSIS,1
IS,IMPLANT SITE PAIN,1
IS,INFECTION,1
IS,INFLAMMATION,1
IS,INFLUENZA LIKE ILLNESS,1
IS,INJURY,1
IS,INTENTIONAL DRUG MISUSE,1
IS,INTESTINAL PERFORATION,1
IS,INTRACRANIAL ANEURYSM,1
IS,INTRAOCULAR MELANOMA,1
IS,IRON DEFICIENCY ANAEMIA,1
IS,IRRITABILITY,1
IS,JC POLYOMAVIRUS TEST POSITIVE,1
IS,JC VIRUS INFECTION,1
IS,JOINT STIFFNESS,1
IS,LACTIC ACIDOSIS,1
IS,LARGE INTESTINAL STENOSIS,1
IS,LARGE INTESTINAL ULCER,1
IS,LARYNGEAL OEDEMA,1
IS,LIP OEDEMA,1
IS,LIVER FUNCTION TEST ABNORMAL,1
IS,LOCAL SWELLING,1
IS,LUNG ABSCESS,1
IS,LUNG ADENOCARCINOMA,1
IS,LUNG NEOPLASM MALIGNANT,1
IS,LYMPHOCYTE COUNT DECREASED,1
IS,MALIGNANT MELANOMA,1
IS,MEDICAL DEVICE COMPLICATION,1
IS,MEDICATION ERROR,1
IS,MEMORY IMPAIRMENT,1
IS,MENINGITIS,1
IS,MENORRHAGIA,1
IS,MENTAL DISORDER,1
IS,METASTASES TO ABDOMINAL WALL,1
IS,METASTASES TO LIVER,1
IS,METASTASES TO PANCREAS,1
IS,MIXED LIVER INJURY,1
IS,MOOD ALTERED,1
IS,MOOD SWINGS,1
IS,MULTIPLE SCLEROSIS RELAPSE,1
IS,MUSCULOSKELETAL STIFFNESS,1
IS,NASAL DRYNESS,1
IS,NASOPHARYNGITIS,1
IS,NEPHROLITHIASIS,1
IS,NERVOUSNESS,1
IS,NEUROPATHY PERIPHERAL,1
IS,NEUTROPHIL COUNT DECREASED,1
IS,NODULE,1
IS,NON-CARDIAC CHEST PAIN,1
IS,OBSESSIVE THOUGHTS,1
IS,OEDEMA GENITAL,1
IS,OLIGURIA,1
IS,OROPHARYNGEAL PAIN,1
IS,ORTHOSTATIC HYPOTENSION,1
IS,OSTEONECROSIS,1
IS,PALLOR,1
IS,PALPITATIONS,1
IS,PANCREATIC CARCINOMA,1
IS,PANCREATITIS ACUTE,1
IS,PANIC ATTACK,1
IS,PERIPHERAL COLDNESS,1
IS,PERIPHERAL SWELLING,1
IS,PHARYNGEAL OEDEMA,1
IS,PHOTOPSIA,1
IS,PHOTOSENSITIVITY REACTION,1
IS,PLACENTAL INSUFFICIENCY,1
IS,POISONING,1
IS,PRE-ECLAMPSIA,1
IS,PREGNANCY WITH CONTRACEPTIVE DEVICE,1
IS,PRODUCT SUBSTITUTION ISSUE,1
IS,PROLONGED LABOUR,1
IS,PROSTATE CANCER,1
IS,PSYCHIATRIC SYMPTOM,1
IS,PULMONARY EOSINOPHILIA,1
IS,PULMONARY HAEMORRHAGE,1
IS,PULMONARY NECROSIS,1
IS,RASH GENERALISED,1
IS,RECTAL HAEMORRHAGE,1
IS,RENAL FAILURE CHRONIC,1
IS,RESPIRATORY FAILURE,1
IS,RESTLESSNESS,1
IS,SARCOMA,1
IS,SEDATION,1
IS,SEROTONIN SYNDROME,1
IS,SKIN BURNING SENSATION,1
IS,SKIN NECROSIS,1
IS,SKIN SENSITISATION,1
IS,SLEEP DISORDER,1
IS,SLEEP PHASE RHYTHM DISTURBANCE,1
IS,SNEEZING,1
IS,SPEECH DISORDER,1
IS,SPINAL DISORDER,1
IS,SPINAL FRACTURE,1
IS,SPLENOMEGALY,1
IS,STRIDOR,1
IS,SUBARACHNOID HAEMORRHAGE,1
IS,SUBSTANCE ABUSE,1
IS,SWELLING FACE,1
IS,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
IS,SYSTEMIC LUPUS ERYTHEMATOSUS,1
IS,TELANGIECTASIA,1
IS,TENSION,1
IS,THEFT,1
IS,THERAPEUTIC RESPONSE DECREASED,1
IS,THERAPY NON-RESPONDER,1
IS,THINKING ABNORMAL,1
IS,THROMBIN TIME PROLONGED,1
IS,TINNITUS,1
IS,TOOTH DISORDER,1
IS,TOURETTE^S DISORDER,1
IS,TOXICITY TO VARIOUS AGENTS,1
IS,TREATMENT NONCOMPLIANCE,1
IS,TUBULOINTERSTITIAL NEPHRITIS,1
IS,TYMPANIC MEMBRANE DISORDER,1
IS,UNDERSENSING,1
IS,UNINTENDED PREGNANCY,1
IS,URINARY TRACT INFECTION,1
IS,URTICARIA,1
IS,UTERINE DILATION AND CURETTAGE,1
IS,VIOLENCE-RELATED SYMPTOM,1
IS,WEIGHT INCREASED,1
IS,WHITE BLOOD CELL COUNT DECREASED,1
IS,WRONG PATIENT RECEIVED MEDICATION,1
IS,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
IN,DEATH,5641
IN,INFECTION,917
IN,MYOCARDIAL INFARCTION,861
IN,PYREXIA,646
IN,DRUG INEFFECTIVE,625
IN,CARDIAC FAILURE CONGESTIVE,622
IN,VOMITING,621
IN,DYSPNOEA,615
IN,PERITONITIS,601
IN,ASTHENIA,507
IN,SEPSIS,481
IN,TOXICITY TO VARIOUS AGENTS,406
IN,HYPOTENSION,389
IN,DIARRHOEA,324
IN,CARDIAC ARREST,322
IN,MALIGNANT NEOPLASM PROGRESSION,320
IN,DECREASED APPETITE,290
IN,FOETAL EXPOSURE DURING PREGNANCY,284
IN,HAEMOGLOBIN DECREASED,283
IN,DISEASE PROGRESSION,241
IN,HEADACHE,235
IN,NAUSEA,213
IN,COUGH,210
IN,PAIN,208
IN,PNEUMONIA,208
IN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,200
IN,OVERDOSE,199
IN,HYPERTENSION,195
IN,PLATELET COUNT DECREASED,195
IN,ANAEMIA,188
IN,LOSS OF CONSCIOUSNESS,188
IN,THROMBOCYTOPENIA,188
IN,DIZZINESS,184
IN,CEREBROVASCULAR ACCIDENT,182
IN,DEVICE RELATED INFECTION,178
IN,SEIZURE,178
IN,CONDITION AGGRAVATED,174
IN,RASH,173
IN,BLOOD GLUCOSE INCREASED,167
IN,CARDIAC DISORDER,165
IN,SWELLING,165
IN,ABDOMINAL PAIN,164
IN,PRURITUS,158
IN,FALL,157
IN,FATIGUE,157
IN,DRUG RESISTANCE,151
IN,PULMONARY OEDEMA,149
IN,BLOOD CREATININE INCREASED,147
IN,METABOLIC ACIDOSIS,147
IN,PRODUCT USE ISSUE,146
IN,TUBERCULOSIS,146
IN,CHRONIC MYELOID LEUKAEMIA,144
IN,RENAL FAILURE,143
IN,MATERNAL EXPOSURE DURING PREGNANCY,142
IN,SOMNOLENCE,142
IN,PAIN IN EXTREMITY,139
IN,SHOCK,139
IN,TACHYCARDIA,139
IN,CHEST PAIN,137
IN,INTENTIONAL OVERDOSE,136
IN,ABDOMINAL PAIN UPPER,135
IN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,132
IN,JAUNDICE,132
IN,SEROTONIN SYNDROME,132
IN,PLEURAL EFFUSION,130
IN,STEVENS-JOHNSON SYNDROME,129
IN,PANCYTOPENIA,128
IN,FEBRILE NEUTROPENIA,125
IN,HYPONATRAEMIA,125
IN,PERITONEAL DIALYSIS COMPLICATION,125
IN,CHILLS,124
IN,DRUG DEPENDENCE,122
IN,ACUTE KIDNEY INJURY,121
IN,NEUTROPENIA,120
IN,URINARY TRACT INFECTION,120
IN,EXPOSURE DURING PREGNANCY,116
IN,BRADYCARDIA,115
IN,PERIPHERAL SWELLING,114
IN,TREMOR,113
IN,MALAISE,112
IN,THERAPEUTIC RESPONSE DECREASED,112
IN,GAIT DISTURBANCE,111
IN,TOXIC EPIDERMAL NECROLYSIS,111
IN,TREATMENT FAILURE,111
IN,BACK PAIN,110
IN,HYPOGLYCAEMIA,110
IN,DIABETES MELLITUS,109
IN,GENERAL PHYSICAL HEALTH DETERIORATION,108
IN,HEPATIC FAILURE,107
IN,RESPIRATORY DISORDER,103
IN,PARALYSIS,102
IN,HAEMORRHAGE,100
IN,MOUTH ULCERATION,100
IN,COMA,99
IN,ERYTHEMA,98
IN,WEIGHT DECREASED,98
IN,INSOMNIA,97
IN,SUICIDE ATTEMPT,95
IN,DRUG-INDUCED LIVER INJURY,94
IN,PRODUCT USE IN UNAPPROVED INDICATION,93
IN,FULL BLOOD COUNT DECREASED,92
IN,ARTHRALGIA,90
IN,DRUG WITHDRAWAL SYNDROME,90
IN,MUCOSAL INFLAMMATION,90
IN,PREMATURE BABY,89
IN,RESTLESSNESS,89
IN,LOWER LIMB FRACTURE,88
IN,CONSTIPATION,87
IN,BLINDNESS,85
IN,DRUG ABUSE,85
IN,DELIRIUM,84
IN,ENCEPHALOPATHY,84
IN,ANXIETY,83
IN,ACCIDENT,82
IN,RESPIRATORY FAILURE,81
IN,WHITE BLOOD CELL COUNT DECREASED,81
IN,HYPERSENSITIVITY,80
IN,NO THERAPEUTIC RESPONSE,80
IN,WEIGHT INCREASED,80
IN,UNEVALUABLE EVENT,79
IN,GENERALISED TONIC-CLONIC SEIZURE,78
IN,HEPATITIS B,78
IN,OEDEMA PERIPHERAL,78
IN,BLOOD PRESSURE DECREASED,77
IN,EXTRAPYRAMIDAL DISORDER,77
IN,NEUROLEPTIC MALIGNANT SYNDROME,77
IN,ABASIA,76
IN,DEPRESSED LEVEL OF CONSCIOUSNESS,76
IN,TOXIC ENCEPHALOPATHY,76
IN,DRUG INTOLERANCE,75
IN,ELECTROCARDIOGRAM QT PROLONGED,75
IN,HYPERHIDROSIS,75
IN,LOWER RESPIRATORY TRACT INFECTION,75
IN,RENAL IMPAIRMENT,75
IN,VISUAL ACUITY REDUCED,75
IN,BLOOD PRESSURE INCREASED,74
IN,CEREBRAL HAEMORRHAGE,74
IN,ENDOPHTHALMITIS,74
IN,LEUKOPENIA,74
IN,ASCITES,73
IN,CARDIAC FAILURE,73
IN,RESPIRATORY DISTRESS,73
IN,ABDOMINAL DISTENSION,72
IN,MUSCULAR WEAKNESS,72
IN,WHITE BLOOD CELL COUNT INCREASED,72
IN,HAEMATEMESIS,71
IN,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,71
IN,STATUS EPILEPTICUS,70
IN,DYSTONIA,69
IN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,69
IN,ANAPHYLACTIC REACTION,68
IN,BLISTER,68
IN,NEOPLASM MALIGNANT,68
IN,NEUROTOXICITY,68
IN,VISION BLURRED,68
IN,CYTOMEGALOVIRUS INFECTION,67
IN,DYSPHAGIA,67
IN,SEPTIC SHOCK,67
IN,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,66
IN,LOW BIRTH WEIGHT BABY,66
IN,METASTATIC RENAL CELL CARCINOMA,66
IN,CONFUSIONAL STATE,65
IN,GASTROINTESTINAL DISORDER,65
IN,IRRITABILITY,65
IN,EYE PAIN,63
IN,HYPERGLYCAEMIA,63
IN,HYPERKALAEMIA,63
IN,LUNG INFECTION,63
IN,PSYCHOTIC DISORDER,63
IN,SUICIDAL IDEATION,63
IN,AGITATION,62
IN,DYSARTHRIA,62
IN,RASH MACULO-PAPULAR,61
IN,VISUAL IMPAIRMENT,61
IN,KIDNEY TRANSPLANT REJECTION,60
IN,RHABDOMYOLYSIS,60
IN,SKIN LESION,60
IN,ACUTE HEPATIC FAILURE,59
IN,LACTIC ACIDOSIS,59
IN,MULTI-ORGAN FAILURE,59
IN,ABORTION SPONTANEOUS,58
IN,SWELLING FACE,58
IN,BONE MARROW FAILURE,57
IN,CONVULSION,57
IN,NEOPLASM PROGRESSION,57
IN,RENAL FAILURE ACUTE,57
IN,DISORIENTATION,56
IN,MUSCLE RIGIDITY,56
IN,OCULAR HYPERAEMIA,56
IN,DEEP VEIN THROMBOSIS,55
IN,NERVOUS SYSTEM DISORDER,55
IN,NEUROPATHY PERIPHERAL,55
IN,SYNCOPE,55
IN,ACUTE RESPIRATORY DISTRESS SYNDROME,54
IN,ATAXIA,54
IN,DYSPEPSIA,54
IN,HEART RATE DECREASED,54
IN,PULMONARY EMBOLISM,54
IN,SKIN EXFOLIATION,54
IN,PARKINSONISM,53
IN,RENAL DISORDER,53
IN,SPEECH DISORDER,53
IN,GANGRENE,52
IN,LIVER DISORDER,52
IN,TACHYPNOEA,52
IN,THERAPY NON-RESPONDER,52
IN,ABNORMAL BEHAVIOUR,51
IN,DEHYDRATION,51
IN,FEEDING DISORDER,51
IN,HYPOTHYROIDISM,51
IN,MUCORMYCOSIS,50
IN,SECOND PRIMARY MALIGNANCY,50
IN,HEPATOMEGALY,49
IN,HYPERAMMONAEMIA,49
IN,HYPOPHAGIA,49
IN,PRURITUS GENERALISED,49
IN,PULMONARY TUBERCULOSIS,49
IN,ALTERED STATE OF CONSCIOUSNESS,48
IN,MOBILITY DECREASED,48
IN,SLEEP DISORDER,48
IN,DEPRESSION,47
IN,DYSKINESIA,47
IN,OCULOGYRIC CRISIS,47
IN,CARDIO-RESPIRATORY ARREST,46
IN,HAEMATURIA,46
IN,HEART RATE INCREASED,46
IN,POST PROCEDURAL COMPLICATION,46
IN,RASH GENERALISED,46
IN,BLOOD SODIUM DECREASED,45
IN,BURNING SENSATION,45
IN,EYE SWELLING,45
IN,GASTRITIS,45
IN,HEPATITIS,45
IN,HYPERSENSITIVITY VASCULITIS,45
IN,LEUKOCYTOSIS,45
IN,PRODUCT QUALITY ISSUE,45
IN,STOMATITIS,45
IN,TUBULOINTERSTITIAL NEPHRITIS,45
IN,ABDOMINAL DISCOMFORT,44
IN,GASTRIC DISORDER,44
IN,HEPATIC ENCEPHALOPATHY,44
IN,HYPOKINESIA,44
IN,LUNG DISORDER,44
IN,MANIA,44
IN,GASTROINTESTINAL STROMAL TUMOUR,43
IN,GASTROINTESTINAL TOXICITY,43
IN,HYPOAESTHESIA,43
IN,INCORRECT DOSE ADMINISTERED,43
IN,ULTRAFILTRATION FAILURE,43
IN,ALANINE AMINOTRANSFERASE INCREASED,42
IN,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,42
IN,INTESTINAL OBSTRUCTION,42
IN,LETHARGY,42
IN,NASOPHARYNGITIS,42
IN,OXYGEN SATURATION DECREASED,42
IN,PANCREATITIS ACUTE,42
IN,URINARY RETENTION,42
IN,URTICARIA,42
IN,HAEMATOCHEZIA,41
IN,HEPATIC CIRRHOSIS,41
IN,HYPOXIA,41
IN,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,41
IN,LIVER FUNCTION TEST ABNORMAL,41
IN,MYOCLONUS,41
IN,PERITONEAL CLOUDY EFFLUENT,41
IN,THROMBOSIS,41
IN,ANURIA,40
IN,ATELECTASIS,40
IN,BEDRIDDEN,40
IN,BLOOD GLUCOSE DECREASED,40
IN,CARDIOTOXICITY,40
IN,DRUG ERUPTION,40
IN,PARAESTHESIA,40
IN,SKIN DISCOLOURATION,40
IN,ACUTE MYOCARDIAL INFARCTION,39
IN,CATATONIA,39
IN,HEPATIC CANCER,39
IN,HYPOKALAEMIA,39
IN,LOCAL SWELLING,39
IN,PANCREATITIS,39
IN,SEDATION,39
IN,ACUTE MYELOID LEUKAEMIA,38
IN,ALOPECIA,38
IN,HEPATIC FUNCTION ABNORMAL,38
IN,RASH ERYTHEMATOUS,38
IN,TRANSPLANT REJECTION,38
IN,URINE OUTPUT DECREASED,38
IN,ANAPHYLACTIC SHOCK,37
IN,ANGIOEDEMA,37
IN,DENGUE FEVER,37
IN,DISEASE RECURRENCE,37
IN,HAEMORRHAGE INTRACRANIAL,37
IN,HEPATIC ENZYME INCREASED,37
IN,LYMPHADENOPATHY,37
IN,OEDEMA,37
IN,PNEUMONITIS,37
IN,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,37
IN,AMNESIA,36
IN,BLOOD UREA INCREASED,36
IN,BLOODY PERITONEAL EFFLUENT,36
IN,EPISTAXIS,36
IN,GASTROINTESTINAL HAEMORRHAGE,36
IN,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,36
IN,LACRIMATION INCREASED,36
IN,PLATELET COUNT INCREASED,36
IN,PREMATURE DELIVERY,36
IN,URINARY INCONTINENCE,36
IN,ASPARTATE AMINOTRANSFERASE INCREASED,35
IN,DYSURIA,35
IN,HISTIOCYTOSIS HAEMATOPHAGIC,35
IN,INTERSTITIAL LUNG DISEASE,35
IN,MOVEMENT DISORDER,35
IN,NEPHROLITHIASIS,35
IN,CATARACT,34
IN,CELLULITIS,34
IN,DRUG HYPERSENSITIVITY,34
IN,DYSMORPHISM,34
IN,EOSINOPHILIA,34
IN,TARDIVE DYSKINESIA,34
IN,BLOOD BILIRUBIN INCREASED,33
IN,HYPERTENSIVE CRISIS,33
IN,SELF-MEDICATION,33
IN,AGGRESSION,32
IN,BLOOD COUNT ABNORMAL,32
IN,CEREBRAL THROMBOSIS,32
IN,DRUG PRESCRIBING ERROR,32
IN,FEELING ABNORMAL,32
IN,MUSCULOSKELETAL STIFFNESS,32
IN,MYALGIA,32
IN,PERITONITIS BACTERIAL,32
IN,PSORIASIS,32
IN,SPLENOMEGALY,32
IN,TYPHOID FEVER,32
IN,UNRESPONSIVE TO STIMULI,32
IN,BLOOD GLUCOSE ABNORMAL,31
IN,CARDIOGENIC SHOCK,31
IN,CHORIORETINOPATHY,31
IN,COMPLICATIONS OF TRANSPLANTED KIDNEY,31
IN,CYANOSIS,31
IN,HEMIPARESIS,31
IN,METASTASES TO CENTRAL NERVOUS SYSTEM,31
IN,PALLOR,31
IN,PALPITATIONS,31
IN,PERITONEAL EFFLUENT ABNORMAL,31
IN,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,31
IN,PULMONARY HAEMORRHAGE,31
IN,STRONGYLOIDIASIS,31
IN,TRANSAMINASES INCREASED,31
IN,ASTHMA,30
IN,DERMATITIS BULLOUS,30
IN,EJECTION FRACTION DECREASED,30
IN,FEMUR FRACTURE,30
IN,LEFT VENTRICULAR DYSFUNCTION,30
IN,LIVER INJURY,30
IN,MYOPATHY,30
IN,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,30
IN,THROMBOTIC MICROANGIOPATHY,30
IN,TOXIC ANTERIOR SEGMENT SYNDROME,30
IN,WITHDRAWAL SYNDROME,30
IN,CHOLELITHIASIS,29
IN,CHRONIC KIDNEY DISEASE,29
IN,DISCOMFORT,29
IN,DISSEMINATED TUBERCULOSIS,29
IN,FLUID RETENTION,29
IN,MEMORY IMPAIRMENT,29
IN,NYSTAGMUS,29
IN,SINUS TACHYCARDIA,29
IN,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,29
IN,VENTRICULAR TACHYCARDIA,29
IN,APHASIA,28
IN,CHROMATURIA,28
IN,DRUG ADMINISTRATION ERROR,28
IN,FUNGAL INFECTION,28
IN,INTENTIONAL PRODUCT MISUSE,28
IN,MUSCLE SPASMS,28
IN,MYCOBACTERIAL PERITONITIS,28
IN,PERICARDIAL EFFUSION,28
IN,RENAL TUBULAR NECROSIS,28
IN,RESPIRATORY TRACT INFECTION,28
IN,ROAD TRAFFIC ACCIDENT,28
IN,SKIN HYPERPIGMENTATION,28
IN,SKIN ULCER,28
IN,BACTERIAL INFECTION,27
IN,BLOOD CREATINE PHOSPHOKINASE INCREASED,27
IN,COLITIS,27
IN,EPILEPSY,27
IN,EYE IRRITATION,27
IN,GINGIVAL HYPERTROPHY,27
IN,HEPATOTOXICITY,27
IN,HYPERCHLORHYDRIA,27
IN,MENINGITIS CRYPTOCOCCAL,27
IN,MENTAL DISORDER,27
IN,METASTASES TO LIVER,27
IN,FLUID OVERLOAD,26
IN,HAEMATOMA,26
IN,METASTASES TO LUNG,26
IN,PNEUMONIA ASPIRATION,26
IN,ACCIDENTAL OVERDOSE,25
IN,APHAGIA,25
IN,BLOOD PRESSURE FLUCTUATION,25
IN,BREAST CANCER,25
IN,CAESAREAN SECTION,25
IN,CARDIOVASCULAR DISORDER,25
IN,CEREBELLAR ATROPHY,25
IN,CYTOGENETIC ANALYSIS ABNORMAL,25
IN,DRUG DOSE OMISSION,25
IN,FURUNCLE,25
IN,GASTRIC INFECTION,25
IN,HYPERAMMONAEMIC ENCEPHALOPATHY,25
IN,JOINT SWELLING,25
IN,NO ADVERSE EVENT,25
IN,PRIAPISM,25
IN,RESPIRATORY RATE INCREASED,25
IN,VENTRICULAR FIBRILLATION,25
IN,AKATHISIA,24
IN,COAGULOPATHY,24
IN,COMPARTMENT SYNDROME,24
IN,GINGIVAL HYPERPLASIA,24
IN,HAEMOGLOBIN ABNORMAL,24
IN,HICCUPS,24
IN,HYPERREFLEXIA,24
IN,HYPOCALCAEMIA,24
IN,INCORRECT ROUTE OF DRUG ADMINISTRATION,24
IN,PARADOXICAL DRUG REACTION,24
IN,SUPRAVENTRICULAR TACHYCARDIA,24
IN,SYSTEMIC CANDIDA,24
IN,TERATOGENICITY,24
IN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,24
IN,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,23
IN,AREFLEXIA,23
IN,CIRCULATORY COLLAPSE,23
IN,DEPRESSED MOOD,23
IN,DIABETIC KETOACIDOSIS,23
IN,ERYTHEMA MULTIFORME,23
IN,FACE OEDEMA,23
IN,FLATULENCE,23
IN,FRACTURE,23
IN,GASTROINTESTINAL INFECTION,23
IN,GINGIVAL BLEEDING,23
IN,HYPERPROLACTINAEMIA,23
IN,LUNG NEOPLASM MALIGNANT,23
IN,MEDICATION ERROR,23
IN,MYCOBACTERIAL INFECTION,23
IN,MYELOFIBROSIS,23
IN,ORAL CANDIDIASIS,23
IN,PRODUCTIVE COUGH,23
IN,BLOOD POTASSIUM DECREASED,22
IN,BONE PAIN,22
IN,CEREBRAL INFARCTION,22
IN,CHEST DISCOMFORT,22
IN,DIABETES MELLITUS INADEQUATE CONTROL,22
IN,DISEASE COMPLICATION,22
IN,DRUG LEVEL INCREASED,22
IN,FULL BLOOD COUNT INCREASED,22
IN,GAIT INABILITY,22
IN,GENERALISED OEDEMA,22
IN,HAEMATOTOXICITY,22
IN,HALLUCINATION,22
IN,HEPATIC INFECTION,22
IN,MYELODYSPLASTIC SYNDROME,22
IN,OLIGURIA,22
IN,SENSORY LOSS,22
IN,SUBARACHNOID HAEMORRHAGE,22
IN,SUDDEN DEATH,22
IN,TALIPES,22
IN,THROMBOSIS IN DEVICE,22
IN,BLOOD ALKALINE PHOSPHATASE INCREASED,21
IN,BLOOD POTASSIUM INCREASED,21
IN,BRONCHOSPASM,21
IN,CREPITATIONS,21
IN,DYSENTERY,21
IN,DYSPHONIA,21
IN,ELECTROLYTE IMBALANCE,21
IN,GASTROENTERITIS,21
IN,HAEMOPTYSIS,21
IN,HAND FRACTURE,21
IN,HEAD INJURY,21
IN,HIP FRACTURE,21
IN,HYPOMANIA,21
IN,KLEBSIELLA INFECTION,21
IN,MELAENA,21
IN,RASH PRURITIC,21
IN,VERTIGO,21
IN,VIROLOGIC FAILURE,21
IN,WHEEZING,21
IN,WOUND,21
IN,ABORTION INDUCED,20
IN,ACUTE CORONARY SYNDROME,20
IN,ANGINA PECTORIS,20
IN,ARRHYTHMIA,20
IN,BLINDNESS UNILATERAL,20
IN,BRADYKINESIA,20
IN,CARDIOMEGALY,20
IN,EYE DISORDER,20
IN,EYELID OEDEMA,20
IN,HALLUCINATION_ VISUAL,20
IN,INTERNATIONAL NORMALISED RATIO INCREASED,20
IN,IRIDOCYCLITIS,20
IN,MULTIPLE SCLEROSIS RELAPSE,20
IN,NEPHROPATHY TOXIC,20
IN,OSTEONECROSIS,20
IN,PULMONARY HYPERTENSION,20
IN,RED BLOOD CELL COUNT DECREASED,20
IN,SCAB,20
IN,SUBDURAL HAEMATOMA,20
IN,TENDERNESS,20
IN,TREATMENT NONCOMPLIANCE,20
IN,ABORTION,19
IN,ADVERSE EVENT,19
IN,BLOOD ALBUMIN DECREASED,19
IN,BLOOD CREATININE ABNORMAL,19
IN,BRAIN ABSCESS,19
IN,CANDIDA INFECTION,19
IN,CENTRAL NERVOUS SYSTEM LESION,19
IN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,19
IN,CLONUS,19
IN,CUSHINGOID,19
IN,CYTOPENIA,19
IN,DRY MOUTH,19
IN,EATING DISORDER,19
IN,EYE INFECTION,19
IN,FOETAL ANTICONVULSANT SYNDROME,19
IN,HYPOTONIA,19
IN,ISCHAEMIC STROKE,19
IN,JOINT DISLOCATION,19
IN,LIP SWELLING,19
IN,MALARIA,19
IN,MUTISM,19
IN,PROTEINURIA,19
IN,RESPIRATORY ALKALOSIS,19
IN,RESTLESS LEGS SYNDROME,19
IN,SINUS BRADYCARDIA,19
IN,TORSADE DE POINTES,19
IN,TRANSPLANT DYSFUNCTION,19
IN,UNDERDOSE,19
IN,VENOOCCLUSIVE LIVER DISEASE,19
IN,ATRIAL FIBRILLATION,18
IN,BLOOD CALCIUM DECREASED,18
IN,BRAIN NEOPLASM,18
IN,CATHETER SITE INFECTION,18
IN,CORNEAL OEDEMA,18
IN,DYSPNOEA EXERTIONAL,18
IN,FOETAL WARFARIN SYNDROME,18
IN,FUNGAL PERITONITIS,18
IN,HEMIPLEGIA,18
IN,MUSCULOSKELETAL PAIN,18
IN,MYOCARDITIS,18
IN,NEONATAL RESPIRATORY DISTRESS SYNDROME,18
IN,NEUTROPENIC SEPSIS,18
IN,OPTIC NEUROPATHY,18
IN,PARTIAL SEIZURES,18
IN,SALIVARY HYPERSECRETION,18
IN,SKIN PLAQUE,18
IN,TUBERCULOMA OF CENTRAL NERVOUS SYSTEM,18
IN,VAGINAL HAEMORRHAGE,18
IN,VASCULAR STENT THROMBOSIS,18
IN,ANGLE CLOSURE GLAUCOMA,17
IN,BLOOD URINE PRESENT,17
IN,CARDIOMYOPATHY,17
IN,COMPLETED SUICIDE,17
IN,DEAFNESS,17
IN,DELUSION,17
IN,DRY SKIN,17
IN,DYSGEUSIA,17
IN,FEMORAL NECK FRACTURE,17
IN,HYPERTHERMIA,17
IN,LIMB INJURY,17
IN,METASTASIS,17
IN,MYXOEDEMA COMA,17
IN,OROMANDIBULAR DYSTONIA,17
IN,POLLAKIURIA,17
IN,RED BLOOD CELL SEDIMENTATION RATE INCREASED,17
IN,RESPIRATORY DEPRESSION,17
IN,RETINAL ARTERY OCCLUSION,17
IN,RETINAL HAEMORRHAGE,17
IN,AMENORRHOEA,16
IN,ANENCEPHALY,16
IN,APLASIA PURE RED CELL,16
IN,ASPERGILLUS INFECTION,16
IN,ASPIRATION,16
IN,CORNEAL DEPOSITS,16
IN,DYSSTASIA,16
IN,EMBOLIA CUTIS MEDICAMENTOSA,16
IN,EUPHORIC MOOD,16
IN,EYE INFLAMMATION,16
IN,EYE MOVEMENT DISORDER,16
IN,FOETAL DEATH,16
IN,GASTRIC ULCER,16
IN,HAEMORRHOIDS,16
IN,HALLUCINATION_ AUDITORY,16
IN,HERNIA,16
IN,HERPES ZOSTER,16
IN,HOSPITALISATION,16
IN,HYDROCEPHALUS,16
IN,HYPERBILIRUBINAEMIA,16
IN,HYPOGLYCAEMIC COMA,16
IN,KOUNIS SYNDROME,16
IN,LEUKOENCEPHALOPATHY,16
IN,MENTAL STATUS CHANGES,16
IN,METASTASES TO BONE,16
IN,OLIGOHYDRAMNIOS,16
IN,OPTIC ATROPHY,16
IN,PATHOGEN RESISTANCE,16
IN,POTENTIATING DRUG INTERACTION,16
IN,RESPIRATORY ACIDOSIS,16
IN,YELLOW SKIN,16
IN,ARTHRITIS,15
IN,ATRIOVENTRICULAR BLOCK,15
IN,BLOOD LACTATE DEHYDROGENASE INCREASED,15
IN,BLOOD PRESSURE ABNORMAL,15
IN,CEREBELLAR ATAXIA,15
IN,CUSHING^S SYNDROME,15
IN,DEAFNESS NEUROSENSORY,15
IN,DERMATITIS EXFOLIATIVE,15
IN,DUODENAL ATRESIA,15
IN,ENCEPHALITIS,15
IN,FAILURE TO THRIVE,15
IN,GALACTORRHOEA,15
IN,HEPATOSPLENOMEGALY,15
IN,HYPERTONIA,15
IN,HYPERTRIGLYCERIDAEMIA,15
IN,INFLAMMATION,15
IN,INJECTION SITE ABSCESS,15
IN,LIMB DEFORMITY,15
IN,LYMPHOCYTE COUNT DECREASED,15
IN,MOUTH HAEMORRHAGE,15
IN,OBSESSIVE-COMPULSIVE DISORDER,15
IN,OROPHARYNGEAL PAIN,15
IN,OSTEOPOROSIS,15
IN,PIGMENTATION DISORDER,15
IN,PRIMARY MYELOFIBROSIS,15
IN,PURPLE GLOVE SYNDROME,15
IN,SKIN DISORDER,15
IN,SKIN EROSION,15
IN,SURGERY,15
IN,ULCER,15
IN,VARICELLA,15
IN,VASCULITIS,15
IN,VIRAL INFECTION,15
IN,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,14
IN,AGEUSIA,14
IN,BODY TEMPERATURE INCREASED,14
IN,BRAIN OEDEMA,14
IN,COGNITIVE DISORDER,14
IN,CONGESTIVE CARDIOMYOPATHY,14
IN,DISSEMINATED INTRAVASCULAR COAGULATION,14
IN,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,14
IN,DRUG EFFECT INCOMPLETE,14
IN,DRUG TOLERANCE,14
IN,FOETAL GROWTH RESTRICTION,14
IN,GRAND MAL CONVULSION,14
IN,HEPATITIS C,14
IN,HYDRONEPHROSIS,14
IN,HYPERCHOLESTEROLAEMIA,14
IN,HYPERVENTILATION,14
IN,HYPOPYON,14
IN,HYPOTHERMIA,14
IN,INCORRECT DRUG ADMINISTRATION DURATION,14
IN,MULTIPLE-DRUG RESISTANCE,14
IN,MYDRIASIS,14
IN,NECK DEFORMITY,14
IN,NECK PAIN,14
IN,PAPULE,14
IN,PHYSICAL EXAMINATION ABNORMAL,14
IN,PNEUMOTHORAX,14
IN,PSEUDOPORPHYRIA,14
IN,SCEDOSPORIUM INFECTION,14
IN,SENSORY DISTURBANCE,14
IN,SPLENIC INFARCTION,14
IN,TESTIS CANCER,14
IN,UPPER LIMB FRACTURE,14
IN,VENTRICULAR EXTRASYSTOLES,14
IN,VITREOUS HAEMORRHAGE,14
IN,WRIST DEFORMITY,14
IN,ACCIDENTAL EXPOSURE TO PRODUCT,13
IN,ADVERSE DRUG REACTION,13
IN,AUTOIMMUNE HAEMOLYTIC ANAEMIA,13
IN,BIPOLAR DISORDER,13
IN,BONE DISORDER,13
IN,C-REACTIVE PROTEIN INCREASED,13
IN,CHOROIDAL DETACHMENT,13
IN,CONGENITAL CHOROID PLEXUS CYST,13
IN,DIFFUSE LARGE B-CELL LYMPHOMA,13
IN,FLUSHING,13
IN,GRANULOMA,13
IN,HEPATIC STEATOSIS,13
IN,HEPATOCELLULAR CARCINOMA,13
IN,ILEUS PARALYTIC,13
IN,INCORRECT DOSAGE ADMINISTERED,13
IN,INJURY,13
IN,INTERNAL HAEMORRHAGE,13
IN,LIVER ABSCESS,13
IN,LOGORRHOEA,13
IN,MATERNAL DRUGS AFFECTING FOETUS,13
IN,MICROGNATHIA,13
IN,MULTIMORBIDITY,13
IN,NON-CARDIOGENIC PULMONARY OEDEMA,13
IN,OCULAR TOXICITY,13
IN,ORAL MUCOSAL BLISTERING,13
IN,PEMPHIGUS,13
IN,PHARYNGITIS,13
IN,PROTEIN TOTAL DECREASED,13
IN,PSYCHOMOTOR HYPERACTIVITY,13
IN,SCAR,13
IN,SPINAL FRACTURE,13
IN,TETANY,13
IN,THROMBOPHLEBITIS,13
IN,TRANSFUSION,13
IN,TRISMUS,13
IN,WRONG DRUG ADMINISTERED,13
IN,BLADDER CANCER,12
IN,BLOOD GLUCOSE FLUCTUATION,12
IN,COGWHEEL RIGIDITY,12
IN,CORNEAL INFILTRATES,12
IN,CORONARY ARTERY DISEASE,12
IN,DEATH NEONATAL,12
IN,DISTURBANCE IN ATTENTION,12
IN,DRUG DISPENSING ERROR,12
IN,ECCHYMOSIS,12
IN,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,12
IN,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,12
IN,ERECTILE DYSFUNCTION,12
IN,FIXED DRUG ERUPTION,12
IN,HIV INFECTION,12
IN,HYPOACUSIS,12
IN,INFUSION RELATED REACTION,12
IN,INTENTIONAL PRODUCT USE ISSUE,12
IN,INTRACRANIAL PRESSURE INCREASED,12
IN,LOCALISED INFECTION,12
IN,MACULE,12
IN,MACULOPATHY,12
IN,METABOLIC ENCEPHALOPATHY,12
IN,METABOLIC SYNDROME,12
IN,NODULE,12
IN,OPTIC NEURITIS,12
IN,PERIORBITAL OEDEMA,12
IN,PETECHIAE,12
IN,PHAEHYPHOMYCOSIS,12
IN,PLEOCYTOSIS,12
IN,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,12
IN,PRIMARY HYPOGONADISM,12
IN,PULMONARY TOXICITY,12
IN,RALES,12
IN,RENAL FAILURE CHRONIC,12
IN,RENAL FUNCTION TEST ABNORMAL,12
IN,RENAL TUBULAR ACIDOSIS,12
IN,SINGLE UMBILICAL ARTERY,12
IN,TRICUSPID VALVE INCOMPETENCE,12
IN,UROSEPSIS,12
IN,VIITH NERVE PARALYSIS,12
IN,ABDOMINAL PAIN LOWER,11
IN,ACNE,11
IN,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,11
IN,AMMONIA INCREASED,11
IN,ARTERIOSPASM CORONARY,11
IN,ASPHYXIA,11
IN,ATRIOVENTRICULAR BLOCK FIRST DEGREE,11
IN,BALANCE DISORDER,11
IN,BLINDNESS TRANSIENT,11
IN,BRADYARRHYTHMIA,11
IN,BREAST CANCER METASTATIC,11
IN,BRONCHITIS,11
IN,BRONCHOPULMONARY ASPERGILLOSIS,11
IN,CATARACT SUBCAPSULAR,11
IN,CATHETER SITE EXTRAVASATION,11
IN,CEREBELLAR SYNDROME,11
IN,CEREBRAL VENOUS THROMBOSIS,11
IN,CYTOMEGALOVIRUS CHORIORETINITIS,11
IN,DECUBITUS ULCER,11
IN,DIPLOPIA,11
IN,EXTENSOR PLANTAR RESPONSE,11
IN,FINGER DEFORMITY,11
IN,FOOT FRACTURE,11
IN,FUNGAEMIA,11
IN,GLAUCOMA,11
IN,HAEMATOCRIT DECREASED,11
IN,HAEMODIALYSIS,11
IN,HAEMOLYTIC ANAEMIA,11
IN,HAND DEFORMITY,11
IN,HIRSUTISM,11
IN,HYPERSOMNIA,11
IN,HYPOREFLEXIA,11
IN,IRIS ADHESIONS,11
IN,LIVE BIRTH,11
IN,MENINGITIS,11
IN,MYOGLOBINURIA,11
IN,MYOSITIS,11
IN,NEPHROPATHY,11
IN,NIKOLSKY^S SIGN,11
IN,ODYNOPHAGIA,11
IN,ORAL DISORDER,11
IN,ORTHOSTATIC HYPOTENSION,11
IN,PERIPHERAL COLDNESS,11
IN,PERONEAL NERVE PALSY,11
IN,RENAL INJURY,11
IN,RESPIRATORY ARREST,11
IN,RETINOPATHY,11
IN,SPINAL DISORDER,11
IN,STUPOR,11
IN,SUBGALEAL HAEMATOMA,11
IN,TUMOUR LYSIS SYNDROME,11
IN,UVEITIS,11
IN,VITAMIN D DEFICIENCY,11
IN,ACUTE GRAFT VERSUS HOST DISEASE,10
IN,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,10
IN,ALVEOLITIS ALLERGIC,10
IN,ANAL INCONTINENCE,10
IN,APLASTIC ANAEMIA,10
IN,ARTHROPATHY,10
IN,ATRIOVENTRICULAR BLOCK COMPLETE,10
IN,ATRIOVENTRICULAR BLOCK SECOND DEGREE,10
IN,AUTOIMMUNE HEPATITIS,10
IN,BLOOD CREATINE INCREASED,10
IN,BLOOD URIC ACID INCREASED,10
IN,BRAIN INJURY,10
IN,BUNDLE BRANCH BLOCK RIGHT,10
IN,CHIKUNGUNYA VIRUS INFECTION,10
IN,CHOREA,10
IN,CHRONIC MYELOID LEUKAEMIA RECURRENT,10
IN,CONJUNCTIVAL HYPERAEMIA,10
IN,DERMATITIS,10
IN,DIALYSIS,10
IN,EYE HAEMORRHAGE,10
IN,FAECES DISCOLOURED,10
IN,FEELING COLD,10
IN,GENERALISED ERYTHEMA,10
IN,GYNAECOMASTIA,10
IN,HEAD DISCOMFORT,10
IN,HEPATITIS C VIRUS TEST POSITIVE,10
IN,HYPERCALCAEMIA,10
IN,HYPERLIPIDAEMIA,10
IN,HYPERNATRAEMIA,10
IN,HYPERTHYROIDISM,10
IN,HYPOPERFUSION,10
IN,INFLUENZA LIKE ILLNESS,10
IN,INJECTION SITE PAIN,10
IN,INTENTIONAL SELF-INJURY,10
IN,IRIS ATROPHY,10
IN,KIDNEY INFECTION,10
IN,LARGE INTESTINE PERFORATION,10
IN,LEFT VENTRICULAR HYPERTROPHY,10
IN,LIMB MALFORMATION,10
IN,LUNG INFILTRATION,10
IN,MACULAR OEDEMA,10
IN,MAJOR DEPRESSION,10
IN,METHAEMOGLOBINAEMIA,10
IN,MUSCLE CONTRACTURE,10
IN,NEOPLASM,10
IN,ORAL MUCOSA EROSION,10
IN,ORAL PAIN,10
IN,PARKINSON^S DISEASE,10
IN,PLASMA CELL MYELOMA,10
IN,POLYHYDRAMNIOS,10
IN,POLYURIA,10
IN,PORPHYRIA ACUTE,10
IN,PORTAL VEIN THROMBOSIS,10
IN,PROCEDURAL HYPOTENSION,10
IN,PULMONARY MASS,10
IN,PUSTULAR PSORIASIS,10
IN,RECTAL HAEMORRHAGE,10
IN,SEPTIC ENCEPHALOPATHY,10
IN,SKIN TOXICITY,10
IN,SOMNAMBULISM,10
IN,STAPHYLOCOCCAL INFECTION,10
IN,STRESS CARDIOMYOPATHY,10
IN,TYPE 2 LEPRA REACTION,10
IN,UPPER RESPIRATORY TRACT INFECTION,10
IN,VENTRICULAR ARRHYTHMIA,10
IN,WRONG TECHNIQUE IN DRUG USAGE PROCESS,10
IN,ABDOMINAL TENDERNESS,9
IN,ACCIDENTAL POISONING,9
IN,ACUTE PSYCHOSIS,9
IN,ADRENOCORTICAL INSUFFICIENCY ACUTE,9
IN,ANAESTHETIC COMPLICATION NEUROLOGICAL,9
IN,APNOEA,9
IN,ARTERIAL OCCLUSIVE DISEASE,9
IN,BENIGN INTRACRANIAL HYPERTENSION,9
IN,BLOOD PHOSPHORUS INCREASED,9
IN,CARDIAC OPERATION,9
IN,CONJUNCTIVAL HAEMORRHAGE,9
IN,DELAYED RECOVERY FROM ANAESTHESIA,9
IN,DERMATITIS ALLERGIC,9
IN,DYSPHORIA,9
IN,EAR MALFORMATION,9
IN,EMOTIONAL DISTRESS,9
IN,EXTRAPULMONARY TUBERCULOSIS,9
IN,EXTRAVASATION,9
IN,EYELID PTOSIS,9
IN,FACIAL PARALYSIS,9
IN,FEAR,9
IN,FEELING HOT,9
IN,FISTULA,9
IN,FIXED ERUPTION,9
IN,FOETAL EXPOSURE DURING DELIVERY,9
IN,HAEMODYNAMIC INSTABILITY,9
IN,HEPATITIS B REACTIVATION,9
IN,HYPERLACTACIDAEMIA,9
IN,INCREASED APPETITE,9
IN,INTRAVENTRICULAR HAEMORRHAGE,9
IN,ISCHAEMIA,9
IN,LIP ULCERATION,9
IN,MIOSIS,9
IN,MOOD ALTERED,9
IN,MUCOSAL EROSION,9
IN,MYOPIA,9
IN,NOCARDIOSIS,9
IN,NODAL RHYTHM,9
IN,OBSESSIVE-COMPULSIVE SYMPTOM,9
IN,OCULAR ICTERUS,9
IN,OPSOCLONUS MYOCLONUS,9
IN,OSTEOARTHRITIS,9
IN,PEMPHIGOID,9
IN,PHOTOPHOBIA,9
IN,PNEUMONIA CYTOMEGALOVIRAL,9
IN,PNEUMONIA FUNGAL,9
IN,POSTURAL TREMOR,9
IN,PULMONARY ARTERIAL HYPERTENSION,9
IN,PUPILLARY REFLEX IMPAIRED,9
IN,RECURRENT CANCER,9
IN,REDUCED FACIAL EXPRESSION,9
IN,RENAL INFARCT,9
IN,ROTAVIRUS INFECTION,9
IN,SINUS ARREST,9
IN,SINUSITIS,9
IN,SKIN INFECTION,9
IN,STRABISMUS,9
IN,TINNITUS,9
IN,VASCULAR PSEUDOANEURYSM,9
IN,VIRAL LOAD INCREASED,9
IN,VITAMIN D DECREASED,9
IN,ACID-BASE BALANCE DISORDER MIXED,8
IN,ACIDOSIS,8
IN,ACTIVITIES OF DAILY LIVING IMPAIRED,8
IN,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,8
IN,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,8
IN,ADENOVIRUS INFECTION,8
IN,ADRENAL INSUFFICIENCY,8
IN,BLOOD PRESSURE SYSTOLIC INCREASED,8
IN,BLOOD TEST ABNORMAL,8
IN,BRADYCARDIA FOETAL,8
IN,CATHETER SITE PAIN,8
IN,CELLULITIS ORBITAL,8
IN,CEREBRAL ATROPHY,8
IN,CHOKING,8
IN,COMA SCALE ABNORMAL,8
IN,CONCOMITANT DISEASE PROGRESSION,8
IN,CONGENITAL NAIL DISORDER,8
IN,CONJUNCTIVITIS,8
IN,CONTUSION,8
IN,COORDINATION ABNORMAL,8
IN,CRYING,8
IN,DECREASED ACTIVITY,8
IN,DEMYELINATION,8
IN,DEVELOPMENTAL DELAY,8
IN,DRUG CROSS-REACTIVITY,8
IN,DRUG LEVEL DECREASED,8
IN,DRY GANGRENE,8
IN,ENURESIS,8
IN,EYE OEDEMA,8
IN,FIBROSIS,8
IN,GAZE PALSY,8
IN,GINGIVAL SWELLING,8
IN,GOUTY ARTHRITIS,8
IN,GRAFT VERSUS HOST DISEASE,8
IN,GUILLAIN-BARRE SYNDROME,8
IN,HAEMOLYSIS,8
IN,HEPATITIS ACUTE,8
IN,HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION,8
IN,HYPOVOLAEMIA,8
IN,IDIOPATHIC INTRACRANIAL HYPERTENSION,8
IN,ILL-DEFINED DISORDER,8
IN,IMMUNE SYSTEM DISORDER,8
IN,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,8
IN,INTERVERTEBRAL DISC PROTRUSION,8
IN,LEFT VENTRICULAR FAILURE,8
IN,LEPROMATOUS LEPROSY,8
IN,LYMPHADENOPATHY MEDIASTINAL,8
IN,MALNUTRITION,8
IN,MASTITIS,8
IN,MENORRHAGIA,8
IN,MENTAL IMPAIRMENT,8
IN,MITRAL VALVE INCOMPETENCE,8
IN,MUCOSAL ULCERATION,8
IN,MULTI-ORGAN DISORDER,8
IN,MUSCLE ATROPHY,8
IN,MUSCULOSKELETAL DISORDER,8
IN,OPHTHALMOPLEGIA,8
IN,OROPHARYNGEAL CANDIDIASIS,8
IN,ORTHOPNOEA,8
IN,PANCREATIC CARCINOMA,8
IN,PATENT DUCTUS ARTERIOSUS,8
IN,PERIODONTITIS,8
IN,PHOTOSENSITIVITY REACTION,8
IN,POLYDIPSIA,8
IN,PRESCRIBED UNDERDOSE,8
IN,PROTHROMBIN TIME PROLONGED,8
IN,PSEUDOMONAS INFECTION,8
IN,PSYCHIATRIC SYMPTOM,8
ID,DEATH,960
ID,DYSPNOEA,136
ID,GENERAL PHYSICAL HEALTH DETERIORATION,135
ID,DIARRHOEA,90
ID,PYREXIA,86
ID,NAUSEA,78
ID,VOMITING,66
ID,DECREASED APPETITE,65
ID,ASTHENIA,62
ID,LOSS OF CONSCIOUSNESS,59
ID,FATIGUE,56
ID,SEPSIS,55
ID,ANAEMIA,54
ID,DRUG INEFFECTIVE,43
ID,HAEMOGLOBIN DECREASED,43
ID,THROMBOCYTOPENIA,40
ID,LEUKOPENIA,37
ID,WEIGHT DECREASED,33
ID,ABDOMINAL PAIN,31
ID,DIZZINESS,29
ID,MALIGNANT NEOPLASM PROGRESSION,29
ID,PAIN,29
ID,RASH,29
ID,ABDOMINAL PAIN UPPER,27
ID,HYPERTENSION,27
ID,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,27
ID,CARDIOVASCULAR DISORDER,26
ID,CEREBROVASCULAR ACCIDENT,26
ID,OEDEMA PERIPHERAL,26
ID,MYALGIA,25
ID,ABDOMINAL DISTENSION,24
ID,DISEASE PROGRESSION,24
ID,PERITONITIS,24
ID,PLATELET COUNT DECREASED,24
ID,HEPATOCELLULAR CARCINOMA,23
ID,COUGH,22
ID,HAEMATEMESIS,22
ID,HEADACHE,21
ID,PLEURAL EFFUSION,21
ID,PNEUMONIA,21
ID,WHITE BLOOD CELL COUNT DECREASED,21
ID,CHILLS,20
ID,CONDITION AGGRAVATED,20
ID,HYPOTENSION,20
ID,GAIT DISTURBANCE,19
ID,METASTASES TO LUNG,18
ID,SEIZURE,18
ID,CHEST PAIN,17
ID,HAEMATOCHEZIA,17
ID,ASPARTATE AMINOTRANSFERASE INCREASED,16
ID,BACK PAIN,16
ID,PAIN IN EXTREMITY,16
ID,PNEUMOTHORAX SPONTANEOUS,16
ID,PULMONARY OEDEMA,16
ID,ACUTE HEPATIC FAILURE,15
ID,ALANINE AMINOTRANSFERASE INCREASED,15
ID,DEPRESSED LEVEL OF CONSCIOUSNESS,15
ID,MELAENA,15
ID,OEDEMA,15
ID,PERITONEAL DIALYSIS COMPLICATION,15
ID,ALOPECIA,14
ID,BLOOD PRESSURE DECREASED,14
ID,CONSTIPATION,14
ID,DRUG RESISTANCE,14
ID,HAEMATURIA,14
ID,RESPIRATORY FAILURE,14
ID,ULTRAFILTRATION FAILURE,14
ID,ARTHRALGIA,13
ID,CARDIAC DISORDER,13
ID,DRY SKIN,13
ID,HAEMORRHAGE,13
ID,HYPOALBUMINAEMIA,13
ID,HYPOPHAGIA,13
ID,PRURITUS,13
ID,ASCITES,12
ID,BONE PAIN,12
ID,GASTROINTESTINAL HAEMORRHAGE,12
ID,INFECTION,12
ID,MALAISE,12
ID,STEVENS-JOHNSON SYNDROME,12
ID,WHITE BLOOD CELL COUNT INCREASED,12
ID,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,11
ID,BLOOD ALBUMIN DECREASED,11
ID,BLOOD CREATININE INCREASED,11
ID,CARDIAC FAILURE,11
ID,DISEASE RECURRENCE,11
ID,DYSPHAGIA,11
ID,HYPONATRAEMIA,11
ID,LEUKOCYTOSIS,11
ID,METASTASES TO BONE,11
ID,METASTASES TO CENTRAL NERVOUS SYSTEM,11
ID,PERIPHERAL SWELLING,11
ID,SOMNOLENCE,11
ID,BLISTER,10
ID,CARCINOEMBRYONIC ANTIGEN INCREASED,10
ID,DEHYDRATION,10
ID,ERYTHEMA,10
ID,FEBRILE NEUTROPENIA,10
ID,FEELING HOT,10
ID,INSOMNIA,10
ID,JAUNDICE,10
ID,MOUTH ULCERATION,10
ID,MUSCULOSKELETAL STIFFNESS,10
ID,PRODUCT USE ISSUE,10
ID,TYPHOID FEVER,10
ID,BLOOD BILIRUBIN INCREASED,9
ID,BLOOD PRESSURE INCREASED,9
ID,DEEP VEIN THROMBOSIS,9
ID,ELECTROCARDIOGRAM QT PROLONGED,9
ID,LUNG INFECTION,9
ID,METASTASIS,9
ID,MUSCLE SPASMS,9
ID,MYOCARDIAL INFARCTION,9
ID,NEUTROPENIA,9
ID,SPLENOMEGALY,9
ID,VISION BLURRED,9
ID,ABASIA,8
ID,BLOOD GLUCOSE INCREASED,8
ID,EATING DISORDER,8
ID,HAEMORRHAGIC STROKE,8
ID,HYPOKALAEMIA,8
ID,METASTASES TO LIVER,8
ID,PARAESTHESIA,8
ID,RENAL FAILURE,8
ID,SEPTIC SHOCK,8
ID,SKIN EXFOLIATION,8
ID,STOMATITIS,8
ID,SYNCOPE,8
ID,ABDOMINAL DISCOMFORT,7
ID,ANAPHYLACTIC SHOCK,7
ID,CARDIAC ARREST,7
ID,COMA,7
ID,DEAFNESS,7
ID,DENGUE FEVER,7
ID,DRY THROAT,7
ID,FALL,7
ID,FEEDING DISORDER,7
ID,FREQUENT BOWEL MOVEMENTS,7
ID,HAEMORRHAGE INTRACRANIAL,7
ID,HEPATITIS B,7
ID,HEPATOMEGALY,7
ID,HYPOAESTHESIA,7
ID,LABORATORY TEST ABNORMAL,7
ID,MALNUTRITION,7
ID,NEUROLEPTIC MALIGNANT SYNDROME,7
ID,OCULAR ICTERUS,7
ID,PARALYSIS,7
ID,PRURITUS GENERALISED,7
ID,TACHYCARDIA,7
ID,TORSADE DE POINTES,7
ID,TREMOR,7
ID,ACUTE MYOCARDIAL INFARCTION,6
ID,CEREBROVASCULAR DISORDER,6
ID,CONVULSION,6
ID,DIET REFUSAL,6
ID,DYSPHONIA,6
ID,EPISTAXIS,6
ID,FOETAL EXPOSURE DURING PREGNANCY,6
ID,GINGIVAL BLEEDING,6
ID,HEART RATE INCREASED,6
ID,HEPATIC FUNCTION ABNORMAL,6
ID,HERPES VIRUS INFECTION,6
ID,HOSPITALISATION,6
ID,INCORRECT DOSE ADMINISTERED,6
ID,PANCYTOPENIA,6
ID,PLATELET COUNT INCREASED,6
ID,PRODUCT USE IN UNAPPROVED INDICATION,6
ID,SKIN DISCOLOURATION,6
ID,SPEECH DISORDER,6
ID,ACUTE RESPIRATORY DISTRESS SYNDROME,5
ID,ALPHA 1 FOETOPROTEIN INCREASED,5
ID,ANOGENITAL WARTS,5
ID,CARDIOGENIC SHOCK,5
ID,CEREBRAL HAEMORRHAGE,5
ID,DEPRESSION,5
ID,DRUG DOSE OMISSION,5
ID,DRY MOUTH,5
ID,FIBRIN D DIMER INCREASED,5
ID,FLATULENCE,5
ID,GASTRIC DISORDER,5
ID,GASTRITIS,5
ID,GASTRITIS EROSIVE,5
ID,GASTROINTESTINAL STROMAL TUMOUR,5
ID,HEPATIC ENCEPHALOPATHY,5
ID,HEPATIC FAILURE,5
ID,HYPERBILIRUBINAEMIA,5
ID,HYPERHIDROSIS,5
ID,HYPERKERATOSIS,5
ID,INFLUENZA,5
ID,LOCAL SWELLING,5
ID,LUNG DISORDER,5
ID,LUNG NEOPLASM MALIGNANT,5
ID,METASTATIC NEOPLASM,5
ID,NEOPLASM,5
ID,RENAL DISORDER,5
ID,RENAL IMPAIRMENT,5
ID,SHOCK,5
ID,SUBARACHNOID HAEMORRHAGE,5
ID,SUICIDE ATTEMPT,5
ID,SWELLING,5
ID,TACHYPNOEA,5
ID,THROMBOSIS,5
ID,URINARY RETENTION,5
ID,APATHY,4
ID,APHONIA,4
ID,ARRHYTHMIA,4
ID,ASTHMA,4
ID,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
ID,BLOOD ELECTROLYTES DECREASED,4
ID,BLOOD SODIUM DECREASED,4
ID,BRAIN OEDEMA,4
ID,CARDIOMEGALY,4
ID,COLD SWEAT,4
ID,CYANOSIS,4
ID,DIABETES MELLITUS,4
ID,DISCOMFORT,4
ID,DYSURIA,4
ID,FEELING ABNORMAL,4
ID,HAEMATOMA,4
ID,HALLUCINATION,4
ID,HICCUPS,4
ID,HYPERGLYCAEMIA,4
ID,INFLUENZA LIKE ILLNESS,4
ID,ISCHAEMIC STROKE,4
ID,METASTASES TO GASTROINTESTINAL TRACT,4
ID,MOBILITY DECREASED,4
ID,MUSCULOSKELETAL PAIN,4
ID,NO THERAPEUTIC RESPONSE,4
ID,OROPHARYNGEAL PAIN,4
ID,PAIN OF SKIN,4
ID,PALMOPLANTAR KERATODERMA,4
ID,PALPITATIONS,4
ID,PAPILLOMA VIRAL INFECTION,4
ID,PERITONEAL CLOUDY EFFLUENT,4
ID,PNEUMOTHORAX,4
ID,PROSTATIC SPECIFIC ANTIGEN INCREASED,4
ID,RASH PUSTULAR,4
ID,SCHIZOPHRENIA,4
ID,URTICARIA,4
ID,VERTIGO,4
ID,ABDOMINAL RIGIDITY,3
ID,ACUTE CORONARY SYNDROME,3
ID,AMMONIA INCREASED,3
ID,ANURIA,3
ID,APHASIA,3
ID,APLASTIC ANAEMIA,3
ID,BLOOD GLUCOSE DECREASED,3
ID,BLOOD TRIGLYCERIDES INCREASED,3
ID,BRADYCARDIA,3
ID,BREAST CANCER,3
ID,BURNING SENSATION,3
ID,CARBOHYDRATE ANTIGEN 125 INCREASED,3
ID,CARDIAC FAILURE CONGESTIVE,3
ID,CHEST DISCOMFORT,3
ID,CHROMATURIA,3
ID,CHRONIC MYELOID LEUKAEMIA,3
ID,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
ID,COAGULOPATHY,3
ID,COLON CANCER,3
ID,COLORECTAL CANCER METASTATIC,3
ID,CYST,3
ID,DELIRIUM,3
ID,DIABETES MELLITUS INADEQUATE CONTROL,3
ID,DYSSTASIA,3
ID,ENCEPHALITIS,3
ID,EXPOSURE DURING PREGNANCY,3
ID,EYE HAEMORRHAGE,3
ID,FACE OEDEMA,3
ID,FAECES DISCOLOURED,3
ID,FLUID INTAKE REDUCED,3
ID,FLUID OVERLOAD,3
ID,FRACTURE,3
ID,GASTRIC HAEMORRHAGE,3
ID,GASTROENTERITIS,3
ID,GASTROINTESTINAL DISORDER,3
ID,GINGIVITIS,3
ID,HAEMATOCRIT DECREASED,3
ID,HEPATIC CIRRHOSIS,3
ID,HEPATIC ENZYME INCREASED,3
ID,HYPERCHOLESTEROLAEMIA,3
ID,HYPERTHERMIA,3
ID,HYPOGLYCAEMIA,3
ID,HYPOKINESIA,3
ID,HYPOVOLAEMIC SHOCK,3
ID,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
ID,LETHARGY,3
ID,LIVER DISORDER,3
ID,MATERNAL EXPOSURE DURING PREGNANCY,3
ID,MENORRHAGIA,3
ID,MUSCULAR WEAKNESS,3
ID,NECK MASS,3
ID,NEOPLASM PROGRESSION,3
ID,NEUROPATHY PERIPHERAL,3
ID,OSTEOPOROSIS,3
ID,PLASMA CELL MYELOMA,3
ID,PLATELET COUNT ABNORMAL,3
ID,PNEUMONIA ASPIRATION,3
ID,PRODUCTIVE COUGH,3
ID,PROSTATE CANCER METASTATIC,3
ID,RETINAL DETACHMENT,3
ID,RHABDOMYOLYSIS,3
ID,SWELLING FACE,3
ID,THROAT IRRITATION,3
ID,TREATMENT NONCOMPLIANCE,3
ID,TUBERCULOSIS,3
ID,ULCER,3
ID,UTERINE LEIOMYOMA,3
ID,VASCULAR STENT THROMBOSIS,3
ID,VENTRICULAR TACHYCARDIA,3
ID,VISUAL ACUITY REDUCED,3
ID,WOUND,3
ID,YELLOW SKIN,3
ID,ABDOMINAL PAIN LOWER,2
ID,ACCIDENT,2
ID,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
ID,ACTIVITIES OF DAILY LIVING IMPAIRED,2
ID,ADVERSE DRUG REACTION,2
ID,ANAPHYLACTIC REACTION,2
ID,ANGIOEDEMA,2
ID,ANGIOPATHY,2
ID,ANXIETY,2
ID,APHTHOUS STOMATITIS,2
ID,APNOEA,2
ID,ATELECTASIS,2
ID,BALANCE DISORDER,2
ID,BEDRIDDEN,2
ID,BILE DUCT STONE,2
ID,BLOOD CHOLESTEROL INCREASED,2
ID,BLOOD IMMUNOGLOBULIN E INCREASED,2
ID,BLOOD LACTATE DEHYDROGENASE INCREASED,2
ID,BLOOD POTASSIUM DECREASED,2
ID,BLOOD PRESSURE SYSTOLIC DECREASED,2
ID,BLOOD SODIUM INCREASED,2
ID,BLOOD TEST ABNORMAL,2
ID,BLOOD UREA ABNORMAL,2
ID,BLOOD UREA INCREASED,2
ID,BLOOD URIC ACID INCREASED,2
ID,BONE CANCER METASTATIC,2
ID,BRAIN NEOPLASM,2
ID,BREAST HAEMORRHAGE,2
ID,BREAST MASS,2
ID,BRONCHITIS,2
ID,BRONCHOPNEUMONIA,2
ID,C-REACTIVE PROTEIN INCREASED,2
ID,CANDIDA INFECTION,2
ID,CEREBRAL ARTERY OCCLUSION,2
ID,CHAPPED LIPS,2
ID,COLORECTAL CANCER,2
ID,CONGENITAL ANOMALY,2
ID,CONJUNCTIVAL HAEMORRHAGE,2
ID,CREATININE RENAL CLEARANCE DECREASED,2
ID,DEVICE DISLOCATION,2
ID,DIABETIC KETOACIDOSIS,2
ID,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,2
ID,DISORIENTATION,2
ID,DISSEMINATED INTRAVASCULAR COAGULATION,2
ID,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,2
ID,DRUG HYPERSENSITIVITY,2
ID,DYSARTHRIA,2
ID,DYSCHEZIA,2
ID,DYSPEPSIA,2
ID,EAR INJURY,2
ID,ELECTROLYTE IMBALANCE,2
ID,EMBOLIC STROKE,2
ID,ENCEPHALOPATHY,2
ID,EPILEPSY,2
ID,EXTRAPYRAMIDAL DISORDER,2
ID,EYE DISORDER,2
ID,EYE SWELLING,2
ID,EYELID OEDEMA,2
ID,FEELING COLD,2
ID,GAIT INABILITY,2
ID,GALLBLADDER ENLARGEMENT,2
ID,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
ID,GASTRIC INFECTION,2
ID,GASTRIC ULCER,2
ID,GENERALISED ERYTHEMA,2
ID,GINGIVAL PAIN,2
ID,GINGIVAL SWELLING,2
ID,HAEMOPTYSIS,2
ID,HEAD INJURY,2
ID,HEART DISEASE CONGENITAL,2
ID,HEART RATE DECREASED,2
ID,HEART RATE IRREGULAR,2
ID,HEPARIN-INDUCED THROMBOCYTOPENIA,2
ID,HEPATIC NEOPLASM,2
ID,HEPATITIS B DNA INCREASED,2
ID,HEPATITIS C,2
ID,HOMICIDE,2
ID,HYDRONEPHROSIS,2
ID,HYPERKALAEMIA,2
ID,HYPERNATRAEMIA,2
ID,HYPOXIA,2
ID,IMMUNE THROMBOCYTOPENIC PURPURA,2
ID,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
ID,INFLAMMATION,2
ID,INFUSION RELATED REACTION,2
ID,INJECTION SITE NECROSIS,2
ID,INTENTIONAL PRODUCT MISUSE,2
ID,INTENTIONAL PRODUCT USE ISSUE,2
ID,INTERNATIONAL NORMALISED RATIO INCREASED,2
ID,INTESTINAL PERFORATION,2
ID,JOINT SWELLING,2
ID,LIMB DISCOMFORT,2
ID,LIMB INJURY,2
ID,LIP DRY,2
ID,LIVER FUNCTION TEST ABNORMAL,2
ID,LIVER INJURY,2
ID,LOCALISED INFECTION,2
ID,LOOSE TOOTH,2
ID,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
ID,LUNG INFILTRATION,2
ID,LUPUS NEPHRITIS,2
ID,LYMPHADENOPATHY,2
ID,LYMPHOMA,2
ID,MALIGNANT HYPERTENSION,2
ID,MASS,2
ID,MEDICATION ERROR,2
ID,MEMORY IMPAIRMENT,2
ID,MENTAL STATUS CHANGES,2
ID,MUCOSAL INFLAMMATION,2
ID,MULTI-ORGAN DISORDER,2
ID,MULTI-ORGAN FAILURE,2
ID,MYOPIA,2
ID,NECK PAIN,2
ID,NECROSIS,2
ID,NERVOUS SYSTEM DISORDER,2
ID,NUTRITIONAL CONDITION ABNORMAL,2
ID,OCULAR HYPERAEMIA,2
ID,ODYNOPHAGIA,2
ID,OROPHARYNGEAL DISCOMFORT,2
ID,OVARIAN CYST,2
ID,PAPULE,2
ID,PARONYCHIA,2
ID,PERICARDIAL EFFUSION,2
ID,PERIPHERAL ARTERY THROMBOSIS,2
ID,PERIPHERAL COLDNESS,2
ID,PERITONEAL DISORDER,2
ID,PERITONITIS BACTERIAL,2
ID,PHLEBITIS,2
ID,POLLAKIURIA,2
ID,POLYNEUROPATHY,2
ID,POST PROCEDURAL HAEMORRHAGE,2
ID,PRECANCEROUS CELLS PRESENT,2
ID,PREGNANCY ON ORAL CONTRACEPTIVE,2
ID,PRESCRIBED UNDERDOSE,2
ID,PRODUCT COLOUR ISSUE,2
ID,PRODUCT COUNTERFEIT,2
ID,PRODUCT PHYSICAL ISSUE,2
ID,PROSTATE CANCER,2
ID,PROTHROMBIN TIME PROLONGED,2
ID,PULMONARY EMBOLISM,2
ID,PULMONARY MASS,2
ID,PULSE ABNORMAL,2
ID,PULSE ABSENT,2
ID,PURPURA,2
ID,RASH ERYTHEMATOUS,2
ID,RASH MACULAR,2
ID,RASH MACULO-PAPULAR,2
ID,RASH PRURITIC,2
ID,SECOND PRIMARY MALIGNANCY,2
ID,SKIN BURNING SENSATION,2
ID,SKIN HYPERPIGMENTATION,2
ID,SPINAL DISORDER,2
ID,STUPOR,2
ID,SUDDEN DEATH,2
ID,SUSPECTED COUNTERFEIT PRODUCT,2
ID,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
ID,THERAPEUTIC PRODUCT INEFFECTIVE,2
ID,THERAPY CESSATION,2
ID,THROMBOCYTOSIS,2
ID,TOOTHACHE,2
ID,TOXIC EPIDERMAL NECROLYSIS,2
ID,TUMOUR MARKER INCREASED,2
ID,TUMOUR RUPTURE,2
ID,URINARY TRACT DISORDER,2
ID,URINE OUTPUT DECREASED,2
ID,UTERINE HAEMORRHAGE,2
ID,VASCULAR RUPTURE,2
ID,VITAMIN C DEFICIENCY,2
ID,WEIGHT INCREASED,2
ID,WHEEZING,2
ID,ABDOMINAL ADHESIONS,1
ID,ABDOMINAL WALL CYST,1
ID,ABNORMAL BEHAVIOUR,1
ID,ABORTION,1
ID,ABORTION MISSED,1
ID,ABORTION SPONTANEOUS,1
ID,ABSCESS,1
ID,ABSCESS LIMB,1
ID,ABSCESS RUPTURE,1
ID,ACNE,1
ID,ACQUIRED IMMUNODEFICIENCY SYNDROME,1
ID,ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL,1
ID,ACUTE ABDOMEN,1
ID,ACUTE KIDNEY INJURY,1
ID,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
ID,ACUTE RESPIRATORY FAILURE,1
ID,ADRENAL SUPPRESSION,1
ID,AGEUSIA,1
ID,AGGRESSION,1
ID,AGITATION,1
ID,AKATHISIA,1
ID,ALANINE AMINOTRANSFERASE ABNORMAL,1
ID,ALANINE AMINOTRANSFERASE DECREASED,1
ID,ALTERED STATE OF CONSCIOUSNESS,1
ID,AMAUROSIS FUGAX,1
ID,AMENORRHOEA,1
ID,AMNESIA,1
ID,AMNIOTIC CAVITY DISORDER,1
ID,AMOEBIC DYSENTERY,1
ID,ANAL HAEMORRHAGE,1
ID,ANAL INCONTINENCE,1
ID,ANAL INJURY,1
ID,ANXIETY DISORDER,1
ID,APHAGIA,1
ID,APHTHOUS ULCER,1
ID,APPETITE DISORDER,1
ID,ARTERIOSPASM CORONARY,1
ID,ARTHROPATHY,1
ID,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
ID,ASPARTATE AMINOTRANSFERASE DECREASED,1
ID,ASPHYXIA,1
ID,ASPIRATION,1
ID,ATAXIA,1
ID,ATRIAL FIBRILLATION,1
ID,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
ID,AUTOIMMUNE HEPATITIS,1
ID,AUTOPHOBIA,1
ID,AXILLARY MASS,1
ID,BASAL CELL CARCINOMA,1
ID,BILE DUCT OBSTRUCTION,1
ID,BLINDNESS UNILATERAL,1
ID,BLISTER INFECTED,1
ID,BLOOD BILIRUBIN,1
ID,BLOOD BILIRUBIN ABNORMAL,1
ID,BLOOD CALCIUM DECREASED,1
ID,BLOOD CORTISOL DECREASED,1
ID,BLOOD CREATININE ABNORMAL,1
ID,BLOOD CREATININE DECREASED,1
ID,BLOOD GLUCOSE ABNORMAL,1
ID,BLOOD PRESSURE ABNORMAL,1
ID,BLOOD PRESSURE MEASUREMENT,1
ID,BLOOD PRESSURE SYSTOLIC INCREASED,1
ID,BLOOD TESTOSTERONE DECREASED,1
ID,BLOODY PERITONEAL EFFLUENT,1
ID,BONE MARROW FAILURE,1
ID,BONE MARROW MYELOGRAM ABNORMAL,1
ID,BONE NEOPLASM,1
ID,BRAIN HERNIATION,1
ID,BREAST DISCHARGE,1
ID,BREAST ENLARGEMENT,1
ID,BRONCHIECTASIS,1
ID,BRONCHOSPASM,1
ID,BRONCHOSTENOSIS,1
ID,BRUXISM,1
ID,BURSITIS,1
ID,CANCER PAIN,1
ID,CARBOHYDRATE ANTIGEN 15-3 INCREASED,1
ID,CARDIOMYOPATHY,1
ID,CATARACT,1
ID,CENTRAL NERVOUS SYSTEM LESION,1
ID,CEREBRAL INFARCTION,1
ID,CEREBRAL THROMBOSIS,1
ID,CERVIX WARTS,1
ID,CHOKING SENSATION,1
ID,CHOLANGITIS SCLEROSING,1
ID,CHOLELITHIASIS,1
ID,CHOLESTATIC LIVER INJURY,1
ID,CHOROIDAL HAEMORRHAGE,1
ID,CLEFT LIP,1
ID,CLEFT PALATE,1
ID,COGNITIVE DISORDER,1
ID,COLOSTOMY,1
ID,COMA SCALE ABNORMAL,1
ID,COMMUNICATION DISORDER,1
ID,COMPLETED SUICIDE,1
ID,COMPLICATION OF DEVICE REMOVAL,1
ID,COMPUTERISED TOMOGRAM ABNORMAL,1
ID,CONFUSIONAL STATE,1
ID,CONJUNCTIVAL HYPERAEMIA,1
ID,CONJUNCTIVAL PALLOR,1
ID,CONTRAINDICATED PRODUCT ADMINISTERED,1
ID,CONTRAST MEDIA ALLERGY,1
ID,COORDINATION ABNORMAL,1
ID,CORONARY ARTERY DISEASE,1
ID,CORONARY ARTERY OCCLUSION,1
ID,CORONARY ARTERY RESTENOSIS,1
ID,CORONARY VASCULAR GRAFT OCCLUSION,1
ID,CREATININE RENAL CLEARANCE INCREASED,1
ID,CROHN^S DISEASE,1
ID,CUSHINGOID,1
ID,CUSHING^S SYNDROME,1
ID,CYSTITIS HAEMORRHAGIC,1
ID,DEAFNESS TRANSITORY,1
ID,DECREASED IMMUNE RESPONSIVENESS,1
ID,DECUBITUS ULCER,1
ID,DEFAECATION URGENCY,1
ID,DELIVERY,1
ID,DELUSION,1
ID,DEMENTIA,1
ID,DERMATITIS,1
ID,DERMATITIS ALLERGIC,1
ID,DERMATITIS BULLOUS,1
ID,DERMATITIS EXFOLIATIVE,1
ID,DEVICE BREAKAGE,1
ID,DEVICE ISSUE,1
ID,DEVICE OCCLUSION,1
ID,DEVICE RELATED INFECTION,1
ID,DIARRHOEA HAEMORRHAGIC,1
ID,DIASTOLIC DYSFUNCTION,1
ID,DIFFUSE LARGE B-CELL LYMPHOMA,1
ID,DIPLOPIA,1
ID,DISABILITY,1
ID,DISEASE COMPLICATION,1
ID,DRUG DEPENDENCE,1
ID,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
ID,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
ID,DRUG TOLERANCE INCREASED,1
ID,DRY GANGRENE,1
ID,DYSGEUSIA,1
ID,DYSPAREUNIA,1
ID,DYSPNOEA EXERTIONAL,1
ID,EAR HAEMORRHAGE,1
ID,EJECTION FRACTION DECREASED,1
ID,ELECTROLYTE DEPLETION,1
ID,EMBOLISM,1
ID,EMBOLISM VENOUS,1
ID,EMOTIONAL DISORDER,1
ID,ENDOTRACHEAL INTUBATION,1
ID,ENTERITIS,1
ID,ENURESIS,1
ID,EOSINOPHIL COUNT INCREASED,1
ID,ERECTILE DYSFUNCTION,1
ID,ERYTHEMA MULTIFORME,1
ID,EXTRA DOSE ADMINISTERED,1
ID,EYE IRRITATION,1
ID,EYE PAIN,1
ID,FACIAL PAIN,1
ID,FACIAL PARALYSIS,1
ID,FAECAL INCONTINENCE,1
ID,FIBROSIS,1
ID,FIXED ERUPTION,1
ID,FLUID RETENTION,1
ID,FOAMING AT MOUTH,1
ID,FOETAL DISTRESS SYNDROME,1
ID,FOETAL GROWTH RESTRICTION,1
ID,FOOD AVERSION,1
ID,FOOD POISONING,1
ID,FOOD REFUSAL,1
ID,FOOT AMPUTATION,1
ID,FRAGILE X SYNDROME,1
ID,FULL BLOOD COUNT ABNORMAL,1
ID,FUNGAL INFECTION,1
ID,FURUNCLE,1
ID,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
ID,GANGRENE,1
ID,GASTRIC DILATATION,1
ID,GASTRIC PH DECREASED,1
ID,GASTROENTERITIS BACTERIAL,1
ID,GASTROINTESTINAL INFECTION,1
ID,GASTROINTESTINAL MOTILITY DISORDER,1
ID,GASTROINTESTINAL MUCOSAL EXFOLIATION,1
ID,GASTROINTESTINAL OBSTRUCTION,1
ID,GASTROINTESTINAL OEDEMA,1
ID,GASTROINTESTINAL PERFORATION,1
ID,GASTROINTESTINAL STROMAL CANCER,1
ID,GASTROOESOPHAGEAL REFLUX DISEASE,1
ID,GENERAL PHYSICAL CONDITION ABNORMAL,1
ID,GENERALISED OEDEMA,1
ID,GINGIVAL HYPERTROPHY,1
ID,GLAUCOMA,1
ID,GLOMERULAR FILTRATION RATE DECREASED,1
ID,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
ID,GROIN PAIN,1
ID,HAEMATOCRIT ABNORMAL,1
ID,HAEMATOCRIT INCREASED,1
ID,HAEMATOLOGICAL MALIGNANCY,1
ID,HAEMOGLOBIN INCREASED,1
ID,HAEMORRHAGE IN PREGNANCY,1
ID,HAEMORRHAGE SUBCUTANEOUS,1
ID,HAEMORRHAGE URINARY TRACT,1
ID,HAEMORRHAGIC ANAEMIA,1
ID,HAEMORRHAGIC ASCITES,1
ID,HAIR GROWTH ABNORMAL,1
ID,HALLUCINATION_ AUDITORY,1
ID,HAND FRACTURE,1
ID,HEART RATE ABNORMAL,1
ID,HEMIPARESIS,1
ID,HEPATIC CANCER,1
ID,HEPATIC INFECTION,1
ID,HEPATIC NECROSIS,1
ID,HEPATITIS B SURFACE ANTIGEN POSITIVE,1
ID,HEPATITIS FULMINANT,1
ID,HEPATOTOXICITY,1
ID,HISTIOCYTOSIS HAEMATOPHAGIC,1
ID,HIV INFECTION,1
ID,HORMONE LEVEL ABNORMAL,1
ID,HOT FLUSH,1
ID,HYPERPHAGIA,1
ID,HYPERSENSITIVITY,1
ID,HYPERSOMNIA,1
ID,HYPHAEMA,1
ID,HYPOCALCAEMIA,1
ID,HYPOMENORRHOEA,1
ID,HYPOSPADIAS,1
ID,ILL-DEFINED DISORDER,1
ID,IMMUNODEFICIENCY,1
ID,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
ID,IMPAIRED HEALING,1
ID,INCISION SITE HAEMORRHAGE,1
ID,INCREASED TENDENCY TO BRUISE,1
ID,INCREASED UPPER AIRWAY SECRETION,1
ID,INFARCTION,1
ID,INFECTION SUSCEPTIBILITY INCREASED,1
ID,INFUSION SITE EXTRAVASATION,1
ID,INFUSION SITE PAIN,1
ID,INFUSION SITE PHLEBITIS,1
ID,INJECTION SITE DISCOMFORT,1
ID,INJECTION SITE EXTRAVASATION,1
ID,INJECTION SITE INFLAMMATION,1
ID,INJECTION SITE OEDEMA,1
ID,INJECTION SITE REACTION,1
ID,INSTILLATION SITE VESICLES,1
ID,INTENSIVE CARE,1
ID,INTENTIONAL DRUG MISUSE,1
ID,INTERNAL HAEMORRHAGE,1
ID,INTESTINAL HAEMORRHAGE,1
ID,INTESTINAL OBSTRUCTION,1
ID,INTRA-ABDOMINAL FLUID COLLECTION,1
ID,INTRA-ABDOMINAL HAEMORRHAGE,1
ID,INTRACRANIAL HAEMATOMA,1
ID,IRIS ADHESIONS,1
ID,ISCHAEMIA,1
ID,JOINT DESTRUCTION,1
ID,KARNOFSKY SCALE WORSENED,1
ID,LABILE BLOOD PRESSURE,1
ID,LACRIMATION INCREASED,1
ID,LARYNGITIS,1
ID,LEFT VENTRICULAR DYSFUNCTION,1
ID,LEFT VENTRICULAR HYPERTROPHY,1
ID,LENTICULAR OPACITIES,1
ID,LEUKAEMIA,1
ID,LEUKOCYTURIA,1
ID,LICHENOID KERATOSIS,1
ID,LIP HAEMORRHAGE,1
ID,LIP SWELLING,1
ID,LIVER FUNCTION TEST INCREASED,1
ID,LOCALISED OEDEMA,1
ID,LOGORRHOEA,1
ID,LOWER GASTROINTESTINAL HAEMORRHAGE,1
ID,LUNG OPERATION,1
ID,LYMPHOCYTE COUNT INCREASED,1
ID,LYMPHOPENIA,1
ID,MACULE,1
ID,MACULOPATHY,1
ID,MADAROSIS,1
ID,MALIGNANT PLEURAL EFFUSION,1
ID,MASTOIDITIS,1
ID,MECHANICAL VENTILATION,1
ID,MEDICAL DEVICE DISCOMFORT,1
ID,MEGACOLON,1
ID,MENINGITIS BACTERIAL,1
ID,MENSTRUATION IRREGULAR,1
ID,MENTAL DISORDER,1
ID,MENTAL IMPAIRMENT,1
ID,METASTASES TO BREAST,1
ID,METASTASES TO LARGE INTESTINE,1
ID,METASTASES TO LYMPH NODES,1
ID,METASTASES TO MENINGES,1
ID,METASTASES TO NECK,1
ID,METASTASES TO PHARYNX,1
ID,METASTASES TO SPINE,1
ID,METASTASES TO STOMACH,1
ID,METASTATIC RENAL CELL CARCINOMA,1
ID,METASTATIC SQUAMOUS CELL CARCINOMA,1
ID,MICROANGIOPATHY,1
ID,MIGRAINE,1
ID,MONOCYTE COUNT INCREASED,1
ID,MOUTH HAEMORRHAGE,1
ID,MOVEMENT DISORDER,1
ID,MUCOSAL ULCERATION,1
ID,MULTIMORBIDITY,1
ID,MUSCLE FATIGUE,1
ID,MUSCLE RIGIDITY,1
ID,MUSCLE STRAIN,1
ID,MYELODYSPLASTIC SYNDROME,1
ID,MYOCARDIAL ISCHAEMIA,1
ID,MYOPATHY,1
ID,NAIL DISCOLOURATION,1
ID,NASAL DISCOMFORT,1
ID,NASOPHARYNGEAL CANCER,1
ID,NASOPHARYNGITIS,1
ID,NEEDLE ISSUE,1
ID,NEOPLASM MALIGNANT,1
ID,NEOPLASM RECURRENCE,1
ID,NEPHROLITHIASIS,1
ID,NEPHROPATHY TOXIC,1
ID,NEUROMYOPATHY,1
ID,NEUTROPHIL COUNT DECREASED,1
ID,NON-HODGKIN^S LYMPHOMA,1
ID,NON-HODGKIN^S LYMPHOMA RECURRENT,1
ID,NORMAL NEWBORN,1
ID,OBSTRUCTION,1
ID,OBSTRUCTIVE AIRWAYS DISORDER,1
ID,OESOPHAGEAL CANDIDIASIS,1
ID,OESOPHAGEAL HAEMORRHAGE,1
ID,OESOPHAGEAL VARICES HAEMORRHAGE,1
ID,OLIGURIA,1
ID,ONCOLOGIC COMPLICATION,1
ID,ONYCHALGIA,1
ID,OPEN ANGLE GLAUCOMA,1
ID,ORAL DISCOMFORT,1
ID,ORAL FUNGAL INFECTION,1
ID,ORAL INFECTION,1
ID,ORAL MUCOSAL ERUPTION,1
ID,ORAL MUCOSAL EXFOLIATION,1
ID,ORAL NEOPLASM,1
ID,ORAL PAIN,1
ID,ORAL SURGERY,1
ID,OSMOTIC DEMYELINATION SYNDROME,1
ID,OSTEOARTHRITIS,1
ID,OSTEONECROSIS OF JAW,1
ID,OTITIS EXTERNA,1
ID,OTITIS MEDIA,1
ID,OVERDOSE,1
ID,OXYGEN SATURATION DECREASED,1
ID,OXYGEN SATURATION INCREASED,1
ID,PALLOR,1
ID,PANCREATIC HAEMORRHAGE,1
ID,PANCREATITIS,1
ID,PANCREATITIS ACUTE,1
ID,PARAPSORIASIS,1
ID,PATHOGEN RESISTANCE,1
ID,PERFORATION,1
ID,PERFORMANCE STATUS DECREASED,1
ID,PERIPHERAL VENOUS DISEASE,1
ID,PERITONEAL EFFLUENT ABNORMAL,1
ID,PERSONALITY DISORDER,1
ID,PETECHIAE,1
ID,PHARYNGEAL HAEMORRHAGE,1
ID,PHARYNGITIS,1
ID,PLANTAR ERYTHEMA,1
ID,PLATELET AGGREGATION INHIBITION,1
ID,PLEURAL HAEMORRHAGE,1
ID,POLYDIPSIA,1
ID,POLYURIA,1
ID,PORTAL VEIN THROMBOSIS,1
ID,POST PROCEDURAL COMPLICATION,1
ID,POST PROCEDURAL HAEMATURIA,1
ID,POST PROCEDURAL PERSISTENT DRAIN FLUID,1
ID,POST STREPTOCOCCAL GLOMERULONEPHRITIS,1
ID,PREGNANCY,1
ID,PREMATURE DELIVERY,1
ID,PROCEDURAL HAEMORRHAGE,1
ID,PROCEDURAL NAUSEA,1
ID,PROCEDURAL PAIN,1
ID,PRODUCT ODOUR ABNORMAL,1
ID,PRODUCT PACKAGING ISSUE,1
ID,PRODUCT SIZE ISSUE,1
ID,PRODUCT TAMPERING,1
ID,PROLONGED EXPIRATION,1
ID,PROTEINURIA,1
ID,PROTHROMBIN TIME ABNORMAL,1
ID,PROTRUSION TONGUE,1
ID,PSEUDOMONAS INFECTION,1
ID,PSYCHOTIC DISORDER,1
ID,PULMONARY HAEMORRHAGE,1
ID,PULMONARY HYPERTENSION,1
ID,PULMONARY TUBERCULOSIS,1
ID,PULMONARY VASCULAR DISORDER,1
ID,PULMONARY VENO-OCCLUSIVE DISEASE,1
ID,PURULENT DISCHARGE,1
ID,PUSTULAR PSORIASIS,1
ID,PYOPNEUMOTHORAX,1
ID,QUADRIPLEGIA,1
ID,RAPID CORRECTION OF HYPONATRAEMIA,1
ID,RASH PAPULAR,1
ID,REBOUND EFFECT,1
ID,RECTAL HAEMORRHAGE,1
ID,RECURRENT CANCER,1
ID,RED BLOOD CELL COUNT ABNORMAL,1
ID,RED BLOOD CELL COUNT DECREASED,1
ID,RED BLOOD CELL COUNT INCREASED,1
ID,RENAL CELL CARCINOMA,1
ID,RENAL COLIC,1
ID,RENAL FAILURE ACUTE,1
ID,RESPIRATORY ARREST,1
ID,RESPIRATORY DEPRESSION,1
ID,RESPIRATORY DISORDER,1
ID,RESPIRATORY TRACT CONGESTION,1
ID,RESPIRATORY TRACT INFECTION,1
ID,RESTLESSNESS,1
ID,RETINAL FIBROSIS,1
ID,RETINAL THICKENING,1
ID,RHEUMATOID FACTOR INCREASED,1
ID,RHINALGIA,1
ID,RHINITIS,1
ID,ROAD TRAFFIC ACCIDENT,1
ID,SALIVARY HYPERSECRETION,1
ID,SCAB,1
ID,SCAR,1
ID,SCROTAL OEDEMA,1
ID,SCROTAL SWELLING,1
ID,SENSORY LOSS,1
ID,SEXUAL DYSFUNCTION,1
ID,SHOCK HAEMORRHAGIC,1
ID,SHORT-BOWEL SYNDROME,1
ID,SKIN EROSION,1
ID,SKIN HYPERTROPHY,1
ID,SKIN INFECTION,1
ID,SKIN LESION,1
ID,SKIN MASS,1
ID,SKIN PLAQUE,1
ID,SKIN REACTION,1
ID,SKIN ULCER,1
ID,SLEEP DISORDER,1
ID,SMALL INTESTINAL OBSTRUCTION,1
ID,SNORING,1
ID,SPINAL COMPRESSION FRACTURE,1
ID,SPINAL CORD COMPRESSION,1
ID,SPINAL PAIN,1
ID,SPUTUM DISCOLOURED,1
ID,STRESS ULCER,1
ID,STRIDOR,1
ID,SUBCUTANEOUS HAEMATOMA,1
ID,SUDDEN CARDIAC DEATH,1
ID,SUICIDAL IDEATION,1
ID,SURGERY,1
ID,TACHYARRHYTHMIA,1
ID,TENDERNESS,1
ID,THERAPEUTIC RESPONSE DECREASED,1
ID,THERAPEUTIC RESPONSE UNEXPECTED,1
ID,THROMBOSIS IN DEVICE,1
ID,TIBIA FRACTURE,1
ID,TONGUE DISCOMFORT,1
ID,TOXICOLOGIC TEST ABNORMAL,1
ID,TRANSAMINASES INCREASED,1
ID,TRANSFUSION,1
ID,TRANSIENT ISCHAEMIC ATTACK,1
ID,TRANSPLANT REJECTION,1
ID,TRICHOMEGALY,1
ID,TRISMUS,1
ID,TUBO-OVARIAN ABSCESS,1
ID,TUMOUR COMPRESSION,1
ID,ULCERATIVE KERATITIS,1
ID,UNEVALUABLE EVENT,1
ID,UNRESPONSIVE TO STIMULI,1
ID,UPPER GASTROINTESTINAL HAEMORRHAGE,1
ID,UPPER RESPIRATORY TRACT INFECTION,1
ID,UREA RENAL CLEARANCE INCREASED,1
ID,URINARY BLADDER HAEMORRHAGE,1
ID,URINARY TRACT INFECTION,1
ID,URINARY TRACT OPERATION,1
ID,URINE ANALYSIS ABNORMAL,1
ID,URINE OUTPUT INCREASED,1
ID,USE OF ACCESSORY RESPIRATORY MUSCLES,1
ID,VAGINAL HAEMORRHAGE,1
ID,VARICELLA,1
ID,VARICES OESOPHAGEAL,1
ID,VASCULAR GRAFT OCCLUSION,1
ID,VASCULAR INJURY,1
ID,VASCULITIS,1
ID,VEIN DISORDER,1
ID,VENA CAVA FILTER INSERTION,1
ID,VENOUS OCCLUSION,1
ID,VENTRICULAR EXTRASYSTOLES,1
ID,VIRAL INFECTION,1
ID,VISUAL IMPAIRMENT,1
ID,VITREOUS HAEMORRHAGE,1
ID,VULVOVAGINAL DRYNESS,1
ID,WALKING DISABILITY,1
ID,WEIGHT FLUCTUATION,1
ID,WHITE BLOOD CELL COUNT ABNORMAL,1
ID,WHITE BLOOD CELL DISORDER,1
ID,WOUND COMPLICATION,1
ID,WRONG DRUG ADMINISTERED,1
ID,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
ID,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
IR,TOXICITY TO VARIOUS AGENTS,263
IR,OVERDOSE,106
IR,APNOEA,99
IR,VOMITING,85
IR,DRUG INEFFECTIVE,78
IR,INTENTIONAL OVERDOSE,76
IR,DRUG ABUSE,63
IR,SOMNOLENCE,63
IR,AGITATION,59
IR,ABDOMINAL PAIN,49
IR,ACCIDENTAL OVERDOSE,48
IR,CYANOSIS,48
IR,ASTHENIA,47
IR,LOSS OF CONSCIOUSNESS,47
IR,PYREXIA,46
IR,DYSPNOEA,44
IR,NAUSEA,44
IR,RHABDOMYOLYSIS,44
IR,HEADACHE,43
IR,ANAEMIA,42
IR,DEATH,41
IR,COMA,40
IR,METABOLIC ACIDOSIS,40
IR,TACHYCARDIA,40
IR,THROMBOCYTOPENIA,39
IR,FOETAL EXPOSURE DURING PREGNANCY,38
IR,HYPOTENSION,36
IR,CARDIAC ARREST,34
IR,SUICIDE ATTEMPT,33
IR,SEPSIS,32
IR,GENERALISED TONIC-CLONIC SEIZURE,31
IR,MATERNAL EXPOSURE DURING PREGNANCY,31
IR,RESPIRATORY DEPRESSION,31
IR,ACIDOSIS,30
IR,FATIGUE,30
IR,CONVULSION,29
IR,DIZZINESS,29
IR,DRUG DEPENDENCE,29
IR,RESPIRATORY ALKALOSIS,29
IR,CONDITION AGGRAVATED,27
IR,DIARRHOEA,27
IR,SEIZURE,27
IR,ABORTION,26
IR,IRRITABILITY,25
IR,RESPIRATORY ACIDOSIS,25
IR,ANXIETY,24
IR,ATAXIA,24
IR,DEEP VEIN THROMBOSIS,24
IR,EXPOSURE DURING PREGNANCY,24
IR,CARDIO-RESPIRATORY ARREST,23
IR,DEPRESSED LEVEL OF CONSCIOUSNESS,23
IR,CHRONIC MYELOID LEUKAEMIA,22
IR,RESTLESSNESS,22
IR,DECREASED APPETITE,21
IR,HYPERHIDROSIS,21
IR,PRODUCT USE ISSUE,21
IR,CONSTIPATION,20
IR,ELECTROCARDIOGRAM QT PROLONGED,20
IR,NEUTROPENIA,20
IR,POISONING DELIBERATE,20
IR,RESPIRATORY DISTRESS,20
IR,SUICIDAL IDEATION,20
IR,CONFUSIONAL STATE,19
IR,INSOMNIA,19
IR,STEVENS-JOHNSON SYNDROME,19
IR,COMPLETED SUICIDE,18
IR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,18
IR,HYPOGLYCAEMIA,18
IR,INFECTION,18
IR,PNEUMONIA,18
IR,PRURITUS,18
IR,DRUG RESISTANCE,17
IR,PATHOGEN RESISTANCE,17
IR,BLOOD CREATININE INCREASED,16
IR,BRADYCARDIA,16
IR,HYPERTENSION,16
IR,LIVER FUNCTION TEST ABNORMAL,16
IR,MIOSIS,16
IR,TREMOR,16
IR,CARDIAC FAILURE,15
IR,CEREBRAL HAEMORRHAGE,15
IR,DELIRIUM,15
IR,LETHARGY,15
IR,RESPIRATORY FAILURE,15
IR,SEROTONIN SYNDROME,15
IR,DRUG WITHDRAWAL SYNDROME,14
IR,HAEMOGLOBIN DECREASED,14
IR,HEPATIC ENZYME INCREASED,14
IR,MYOCARDIAL INFARCTION,14
IR,PALPITATIONS,14
IR,PULMONARY OEDEMA,14
IR,TACHYPNOEA,14
IR,VERTIGO,14
IR,DEPRESSION,13
IR,ENCEPHALOPATHY,13
IR,MUSCULAR WEAKNESS,13
IR,MYALGIA,13
IR,PAIN IN EXTREMITY,13
IR,PULMONARY HAEMORRHAGE,13
IR,RENAL FAILURE,13
IR,SCIATIC NERVE PALSY,13
IR,SLEEP DISORDER,13
IR,AGGRESSION,12
IR,COUGH,12
IR,HEPATORENAL SYNDROME,12
IR,KAPOSI^S SARCOMA,12
IR,LEUKOPENIA,12
IR,POISONING,12
IR,ACUTE KIDNEY INJURY,11
IR,ACUTE RESPIRATORY DISTRESS SYNDROME,11
IR,BLINDNESS,11
IR,DEHYDRATION,11
IR,DIPLOPIA,11
IR,MENORRHAGIA,11
IR,OPTIC NEURITIS,11
IR,OSTEONECROSIS,11
IR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,11
IR,STRONGYLOIDIASIS,11
IR,URTICARIA,11
IR,VISION BLURRED,11
IR,ATROPHY OF GLOBE,10
IR,CATARACT,10
IR,CHILLS,10
IR,CYTOMEGALOVIRUS INFECTION,10
IR,EMBOLISM VENOUS,10
IR,ERYTHEMA,10
IR,FEBRILE NEUTROPENIA,10
IR,PANCYTOPENIA,10
IR,PULMONARY EMBOLISM,10
IR,RASH,10
IR,RENAL IMPAIRMENT,10
IR,RETINAL HAEMORRHAGE,10
IR,DYSARTHRIA,9
IR,GAIT DISTURBANCE,9
IR,HAEMORRHAGE,9
IR,HYPERTONIA,9
IR,HYPOKALAEMIA,9
IR,IRIS ADHESIONS,9
IR,JAUNDICE,9
IR,JOINT DISLOCATION,9
IR,MUSCLE SPASMS,9
IR,NYSTAGMUS,9
IR,SINUS TACHYCARDIA,9
IR,SUBSTANCE ABUSE,9
IR,VASCULAR PSEUDOANEURYSM,9
IR,ALANINE AMINOTRANSFERASE INCREASED,8
IR,ANGIOEDEMA,8
IR,BLISTER,8
IR,BRONCHOPULMONARY ASPERGILLOSIS,8
IR,CARDIOMYOPATHY,8
IR,CHEST PAIN,8
IR,CHORIORETINOPATHY,8
IR,COLITIS ULCERATIVE,8
IR,DISEASE PROGRESSION,8
IR,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,8
IR,FLUSHING,8
IR,GRAND MAL CONVULSION,8
IR,OEDEMA PERIPHERAL,8
IR,PLEURAL EFFUSION,8
IR,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,8
IR,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,8
IR,RETAINED PLACENTA OR MEMBRANES,8
IR,RETINAL DETACHMENT,8
IR,SCIATIC NERVE INJURY,8
IR,SHOCK,8
IR,VISUAL ACUITY REDUCED,8
IR,VITREOUS HAEMORRHAGE,8
IR,WRONG DRUG ADMINISTERED,8
IR,ABDOMINAL TENDERNESS,7
IR,ARRHYTHMIA,7
IR,ARTHRALGIA,7
IR,ASPARTATE AMINOTRANSFERASE INCREASED,7
IR,BRAIN OEDEMA,7
IR,DECUBITUS ULCER,7
IR,DRUG-INDUCED LIVER INJURY,7
IR,GASTROINTESTINAL HAEMORRHAGE,7
IR,HAEMATURIA,7
IR,HAEMOPTYSIS,7
IR,HYPERSENSITIVITY,7
IR,HYPOXIA,7
IR,INTENTIONAL PRODUCT MISUSE,7
IR,LEUKOCYTOSIS,7
IR,MATERNAL EXPOSURE BEFORE PREGNANCY,7
IR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,7
IR,NEUROTOXICITY,7
IR,OEDEMA,7
IR,PAIN,7
IR,PALLOR,7
IR,PANIC ATTACK,7
IR,PRODUCT USE IN UNAPPROVED INDICATION,7
IR,RHINORRHOEA,7
IR,TOXIC ENCEPHALOPATHY,7
IR,ABDOMINAL DISTENSION,6
IR,ACUTE MYOCARDIAL INFARCTION,6
IR,AKATHISIA,6
IR,ATRIAL FIBRILLATION,6
IR,BACK PAIN,6
IR,BLOOD PRESSURE DECREASED,6
IR,CEREBROVASCULAR ACCIDENT,6
IR,CONJUNCTIVITIS,6
IR,CORNEAL EPITHELIUM DEFECT,6
IR,DISSEMINATED INTRAVASCULAR COAGULATION,6
IR,DRUG HYPERSENSITIVITY,6
IR,DYSTONIA,6
IR,ECTOPIC PREGNANCY,6
IR,HAEMOLYTIC ANAEMIA,6
IR,HAEMORRHAGE INTRACRANIAL,6
IR,HALLUCINATION_ VISUAL,6
IR,HEMIPLEGIA,6
IR,HEPATOTOXICITY,6
IR,HYPONATRAEMIA,6
IR,HYPOPYON,6
IR,HYPOREFLEXIA,6
IR,HYPOTONIA,6
IR,INCREASED APPETITE,6
IR,LOW BIRTH WEIGHT BABY,6
IR,MALAISE,6
IR,NEUROPATHY PERIPHERAL,6
IR,OESOPHAGEAL PERFORATION,6
IR,PANCREATITIS,6
IR,PERONEAL NERVE PALSY,6
IR,PREGNANCY,6
IR,PREMATURE DELIVERY,6
IR,PRODUCTIVE COUGH,6
IR,RESPIRATORY DISORDER,6
IR,SPEECH DISORDER,6
IR,URINARY INCONTINENCE,6
IR,VISUAL IMPAIRMENT,6
IR,ABDOMINAL DISCOMFORT,5
IR,ACCIDENTAL EXPOSURE TO PRODUCT,5
IR,ASCITES,5
IR,BLOOD LACTATE DEHYDROGENASE INCREASED,5
IR,CARDIOPULMONARY FAILURE,5
IR,CONGENITAL ANOMALY,5
IR,CRYING,5
IR,CUSHING^S SYNDROME,5
IR,DEAFNESS BILATERAL,5
IR,DEVICE MALFUNCTION,5
IR,DISTURBANCE IN ATTENTION,5
IR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,5
IR,DRUG WITHDRAWAL SYNDROME NEONATAL,5
IR,DYSKINESIA,5
IR,DYSPHAGIA,5
IR,EUPHORIC MOOD,5
IR,FOETAL HEART RATE DECREASED,5
IR,HEART RATE INCREASED,5
IR,HEPATIC FAILURE,5
IR,HEPATITIS,5
IR,HOT FLUSH,5
IR,HYPERAMMONAEMIA,5
IR,HYPERHOMOCYSTEINAEMIA,5
IR,HYPERSENSITIVITY VASCULITIS,5
IR,HYPERTENSIVE CRISIS,5
IR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,5
IR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,5
IR,INTENTIONAL PRODUCT USE ISSUE,5
IR,IRIDOCYCLITIS,5
IR,METABOLIC ALKALOSIS,5
IR,MUCOSAL INFLAMMATION,5
IR,MULTIPLE SCLEROSIS RELAPSE,5
IR,MYOCARDITIS,5
IR,NON-ALCOHOLIC STEATOHEPATITIS,5
IR,OVARIAN ADENOMA,5
IR,OXYGEN SATURATION DECREASED,5
IR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,5
IR,PLATELET COUNT DECREASED,5
IR,PREMATURE BABY,5
IR,PRIAPISM,5
IR,PUPIL FIXED,5
IR,RESPIRATORY ARREST,5
IR,RESPIRATORY TRACT INFECTION,5
IR,RETROPERITONEAL FIBROSIS,5
IR,SEPTIC SHOCK,5
IR,SINUS BRADYCARDIA,5
IR,SKIN LESION,5
IR,STAPHYLOCOCCAL INFECTION,5
IR,STRESS CARDIOMYOPATHY,5
IR,THERAPY NON-RESPONDER,5
IR,THROMBOSIS,5
IR,UNRESPONSIVE TO STIMULI,5
IR,VAGINAL HAEMORRHAGE,5
IR,WEIGHT DECREASED,5
IR,WITHDRAWAL SYNDROME,5
IR,ABDOMINAL PAIN UPPER,4
IR,ALOPECIA,4
IR,AMNESIA,4
IR,ANAPHYLACTIC REACTION,4
IR,ANGLE CLOSURE GLAUCOMA,4
IR,AREFLEXIA,4
IR,ASPERGILLUS INFECTION,4
IR,ASTHMA,4
IR,BLOOD ALKALINE PHOSPHATASE INCREASED,4
IR,BLOOD UREA INCREASED,4
IR,BUNDLE BRANCH BLOCK RIGHT,4
IR,CARDIAC DISORDER,4
IR,CARDIAC VALVE REPLACEMENT COMPLICATION,4
IR,CARDIOGENIC SHOCK,4
IR,CARDIOTOXICITY,4
IR,CHEST DISCOMFORT,4
IR,CHOROIDAL DETACHMENT,4
IR,DEAFNESS NEUROSENSORY,4
IR,DISORIENTATION,4
IR,DRUG EFFECT INCOMPLETE,4
IR,DRUG INTOLERANCE,4
IR,DYSGEUSIA,4
IR,DYSPEPSIA,4
IR,ECCHYMOSIS,4
IR,ENDOCARDITIS BACTERIAL,4
IR,ERYTHEMA MULTIFORME,4
IR,FOETAL DEATH,4
IR,FOETAL DISTRESS SYNDROME,4
IR,HAEMOLYTIC URAEMIC SYNDROME,4
IR,HALLUCINATION,4
IR,HEPATIC ENCEPHALOPATHY,4
IR,HEPATITIS C,4
IR,HEPATITIS CHOLESTATIC,4
IR,HEPATORENAL FAILURE,4
IR,HYPERKALAEMIA,4
IR,HYPERREFLEXIA,4
IR,HYPOMANIA,4
IR,HYPOTONY OF EYE,4
IR,INTESTINAL PERFORATION,4
IR,LOGORRHOEA,4
IR,MACULAR DEGENERATION,4
IR,MALIGNANT NEOPLASM PROGRESSION,4
IR,MEDICATION ERROR,4
IR,MENINGITIS BACTERIAL,4
IR,MENINGITIS CRYPTOCOCCAL,4
IR,MYDRIASIS,4
IR,NEPHROLITHIASIS,4
IR,NERVOUS SYSTEM DISORDER,4
IR,NO THERAPEUTIC RESPONSE,4
IR,NON-INFECTIOUS ENDOPHTHALMITIS,4
IR,OPTIC ATROPHY,4
IR,OSTEONECROSIS OF JAW,4
IR,OVARIAN CANCER,4
IR,OVARIAN HYPERSTIMULATION SYNDROME,4
IR,PARAESTHESIA,4
IR,PERICARDIAL EFFUSION,4
IR,PERIORBITAL OEDEMA,4
IR,PNEUMOCYSTIS JIROVECII PNEUMONIA,4
IR,PNEUMOTHORAX,4
IR,PROTEINURIA,4
IR,PSYCHOMOTOR HYPERACTIVITY,4
IR,PSYCHOTIC DISORDER,4
IR,RALES,4
IR,RASH MACULO-PAPULAR,4
IR,RECTAL HAEMORRHAGE,4
IR,RENAL FAILURE ACUTE,4
IR,RENAL FUNCTION TEST ABNORMAL,4
IR,SKIN DISCOLOURATION,4
IR,SKIN EXFOLIATION,4
IR,SUBARACHNOID HAEMORRHAGE,4
IR,SWELLING FACE,4
IR,SYSTEMIC LUPUS ERYTHEMATOSUS,4
IR,TUBERCULOSIS,4
IR,VENTRICULAR TACHYCARDIA,4
IR,VON WILLEBRAND^S FACTOR INHIBITION,4
IR,ZYGOMYCOSIS,4
IR,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,3
IR,ACCIDENTAL POISONING,3
IR,ACNE,3
IR,ACUTE MYELOID LEUKAEMIA,3
IR,ACUTE PHOSPHATE NEPHROPATHY,3
IR,ALTERED STATE OF CONSCIOUSNESS,3
IR,ANAL ATRESIA,3
IR,ANAPHYLACTIC SHOCK,3
IR,ANOPHTHALMOS,3
IR,ANOTIA,3
IR,ANURIA,3
IR,ARTERIAL THROMBOSIS,3
IR,ARTHRITIS,3
IR,AZOTAEMIA,3
IR,BALANCE DISORDER,3
IR,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,3
IR,BLINDNESS TRANSIENT,3
IR,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
IR,BLOOD GLUCOSE INCREASED,3
IR,BLOOD PRESSURE INCREASED,3
IR,BODY TEMPERATURE INCREASED,3
IR,BONE MARROW FAILURE,3
IR,BRAIN ABSCESS,3
IR,BRAIN DEATH,3
IR,C-REACTIVE PROTEIN INCREASED,3
IR,CAESAREAN SECTION,3
IR,CHROMATURIA,3
IR,CLEFT PALATE,3
IR,COAGULATION TIME SHORTENED,3
IR,CONJUNCTIVAL TELANGIECTASIA,3
IR,CUSHINGOID,3
IR,CYTOMEGALOVIRUS CHORIORETINITIS,3
IR,DEAFNESS,3
IR,DERMATITIS BULLOUS,3
IR,DERMATITIS EXFOLIATIVE,3
IR,DIABETIC KETOACIDOSIS,3
IR,DISEASE RECURRENCE,3
IR,DRUG ADMINISTRATION ERROR,3
IR,DRUG SCREEN POSITIVE,3
IR,ELECTROCARDIOGRAM PR PROLONGATION,3
IR,ENURESIS,3
IR,EYE PAIN,3
IR,FALL,3
IR,FINGERPRINT LOSS,3
IR,FUNGAL INFECTION,3
IR,FUSARIUM INFECTION,3
IR,GANGRENE,3
IR,GENE MUTATION,3
IR,HAEMATEMESIS,3
IR,HAEMATOCRIT DECREASED,3
IR,HAEMOLYSIS NEONATAL,3
IR,HALLUCINATIONS_ MIXED,3
IR,HEPARIN-INDUCED THROMBOCYTOPENIA,3
IR,HEPATITIS B REACTIVATION,3
IR,HEPATOCELLULAR INJURY,3
IR,HERPES ZOSTER,3
IR,HYPERGLYCAEMIA,3
IR,HYPERNATRAEMIA,3
IR,HYPERVENTILATION,3
IR,HYPOAESTHESIA,3
IR,HYPOVOLAEMIC SHOCK,3
IR,IMPATIENCE,3
IR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
IR,INCORRECT DOSE ADMINISTERED,3
IR,INFECTION MASKED,3
IR,INFUSION RELATED REACTION,3
IR,INJECTION SITE INJURY,3
IR,INJURY,3
IR,LEUKOENCEPHALOPATHY,3
IR,LINEAR IGA DISEASE,3
IR,LIVER DISORDER,3
IR,LOCAL SWELLING,3
IR,LYMPHADENOPATHY,3
IR,MENTAL DISORDER,3
IR,MICROTIA,3
IR,MULTIPLE SCLEROSIS,3
IR,MUSCLE SPASTICITY,3
IR,MUSCULOSKELETAL PAIN,3
IR,MYOCLONUS,3
IR,NASOPHARYNGITIS,3
IR,NIGHTMARE,3
IR,NON-CARDIOGENIC PULMONARY OEDEMA,3
IR,OCULAR RETROBULBAR HAEMORRHAGE,3
IR,OLIGURIA,3
IR,OROPHARYNGEAL PAIN,3
IR,PAIN IN JAW,3
IR,PARADOXICAL EMBOLISM,3
IR,PERIPHERAL SWELLING,3
IR,PERITONITIS,3
IR,PLATELET COUNT INCREASED,3
IR,PULMONARY ALVEOLAR HAEMORRHAGE,3
IR,PULMONARY MASS,3
IR,PUPILLARY REFLEX IMPAIRED,3
IR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
IR,RENAL TRANSPLANT,3
IR,RETINAL DEGENERATION,3
IR,SEDATION,3
IR,SIALOADENITIS,3
IR,SKIN EROSION,3
IR,SKIN MASS,3
IR,SKIN REACTION,3
IR,SKIN ULCER,3
IR,SPLENOMEGALY,3
IR,STATUS EPILEPTICUS,3
IR,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,3
IR,SUDDEN VISUAL LOSS,3
IR,THROMBOTIC THROMBOCYTOPENIC PURPURA,3
IR,TRANSPLANT DYSFUNCTION,3
IR,TUBULOINTERSTITIAL NEPHRITIS,3
IR,URINARY RETENTION,3
IR,VENTRICULAR EXTRASYSTOLES,3
IR,WHEEZING,3
IR,WHITE BLOOD CELL COUNT DECREASED,3
IR,WHITE BLOOD CELL COUNT INCREASED,3
IR,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,2
IR,ACUTE HEPATIC FAILURE,2
IR,ADRENAL INSUFFICIENCY,2
IR,ALTERNARIA INFECTION,2
IR,AMYLASE INCREASED,2
IR,ANTERIOR CHAMBER DISORDER,2
IR,APATHY,2
IR,APPENDICITIS PERFORATED,2
IR,ASTERIXIS,2
IR,AUTOIMMUNE UVEITIS,2
IR,BACTERIAL INFECTION,2
IR,BACTERIAL SEPSIS,2
IR,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,2
IR,BLINDNESS UNILATERAL,2
IR,BONE PAIN,2
IR,BRADYCARDIA FOETAL,2
IR,BRADYPNOEA,2
IR,BREATH SOUNDS ABNORMAL,2
IR,BRONCHOSPASM,2
IR,BRUCELLOSIS,2
IR,BUNDLE BRANCH BLOCK LEFT,2
IR,BURNING SENSATION,2
IR,CALCIPHYLAXIS,2
IR,CARDIAC VALVE DISEASE,2
IR,CARDIOMEGALY,2
IR,CARDIOVASCULAR DISORDER,2
IR,CEREBRAL INFARCTION,2
IR,CHEMICAL POISONING,2
IR,CHRONIC GASTRITIS,2
IR,CIRCULATORY COLLAPSE,2
IR,CLONUS,2
IR,COELIAC DISEASE,2
IR,COGNITIVE DISORDER,2
IR,COLON CANCER,2
IR,COMPARTMENT SYNDROME,2
IR,COMPLICATIONS OF TRANSPLANTED KIDNEY,2
IR,CONGENITAL CEREBELLAR AGENESIS,2
IR,CONJUNCTIVAL ULCER,2
IR,CORNEAL OEDEMA,2
IR,DEAFNESS UNILATERAL,2
IR,DEMYELINATION,2
IR,DERMATITIS,2
IR,DERMATITIS ALLERGIC,2
IR,DIABETES MELLITUS INADEQUATE CONTROL,2
IR,DRUG TOLERANCE,2
IR,DRUG USE DISORDER,2
IR,DRY MOUTH,2
IR,DYSPNOEA EXERTIONAL,2
IR,EAR PAIN,2
IR,ELECTROCARDIOGRAM ABNORMAL,2
IR,ELECTROCARDIOGRAM CHANGE,2
IR,ELECTROCARDIOGRAM QT SHORTENED,2
IR,EMBOLIA CUTIS MEDICAMENTOSA,2
IR,EMBOLISM,2
IR,EOSINOPHILIA,2
IR,EPISTAXIS,2
IR,ESCHERICHIA INFECTION,2
IR,EYE DISORDER,2
IR,EYELID PTOSIS,2
IR,FACE OEDEMA,2
IR,FACTOR VIII INHIBITION,2
IR,FEAR OF DEATH,2
IR,FOETAL GROWTH RESTRICTION,2
IR,FUNGAL SKIN INFECTION,2
IR,GASTRITIS EROSIVE,2
IR,GASTROINTESTINAL DISORDER,2
IR,GASTROINTESTINAL NECROSIS,2
IR,GASTROINTESTINAL TOXICITY,2
IR,GENERAL PHYSICAL HEALTH DETERIORATION,2
IR,GENERALISED OEDEMA,2
IR,GESTATIONAL HYPERTENSION,2
IR,GINGIVAL HYPERPLASIA,2
IR,HAEMATOCHEZIA,2
IR,HAEMATOMA,2
IR,HANGOVER,2
IR,HEMIPARESIS,2
IR,HEPATIC ENZYME ABNORMAL,2
IR,HEPATIC NEOPLASM,2
IR,HERPES OPHTHALMIC,2
IR,HERPES VIRUS INFECTION,2
IR,HYPERAESTHESIA,2
IR,HYPERBILIRUBINAEMIA,2
IR,HYPERCALCAEMIA,2
IR,HYPERTENSIVE ENCEPHALOPATHY,2
IR,HYPOACUSIS,2
IR,HYPOTHYROIDISM,2
IR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,2
IR,INFECTIVE ANEURYSM,2
IR,INFECTIVE SCLERITIS,2
IR,INHIBITORY DRUG INTERACTION,2
IR,INTENTIONAL DRUG MISUSE,2
IR,INTRACRANIAL VENOUS SINUS THROMBOSIS,2
IR,INTRAOCULAR PRESSURE INCREASED,2
IR,INTRAVENTRICULAR HAEMORRHAGE,2
IR,JAUNDICE CHOLESTATIC,2
IR,JAUNDICE NEONATAL,2
IR,JUGULAR VEIN THROMBOSIS,2
IR,LACRIMATION INCREASED,2
IR,LIBIDO DECREASED,2
IR,LIBIDO INCREASED,2
IR,LIPASE INCREASED,2
IR,LIVER FUNCTION TEST INCREASED,2
IR,LIVER INJURY,2
IR,LUNG ABSCESS,2
IR,LUNG DISORDER,2
IR,LUNG INFECTION,2
IR,LUNG INFILTRATION,2
IR,MANIA,2
IR,MASS,2
IR,MEDIASTINITIS,2
IR,MELAENA,2
IR,METAPLASIA,2
IR,METASTASES TO BONE,2
IR,MIXED LIVER INJURY,2
IR,MOUTH ULCERATION,2
IR,MUCOSAL HAEMORRHAGE,2
IR,MUSCLE RIGIDITY,2
IR,MYASTHENIA GRAVIS CRISIS,2
IR,MYOKYMIA,2
IR,MYOPIA,2
IR,NAIL DISCOLOURATION,2
IR,NECROTISING FASCIITIS,2
IR,NECROTISING RETINITIS,2
IR,NECROTISING SCLERITIS,2
IR,NEONATAL RESPIRATORY DISTRESS SYNDROME,2
IR,NEURALGIA,2
IR,NEUROLOGICAL SYMPTOM,2
IR,NEUTROPENIC SEPSIS,2
IR,NO ADVERSE EVENT,2
IR,NOCARDIOSIS,2
IR,NODAL RHYTHM,2
IR,NORMAL NEWBORN,2
IR,ORAL CANDIDIASIS,2
IR,OVERLAP SYNDROME,2
IR,PERIORBITAL HAEMORRHAGE,2
IR,PERSECUTORY DELUSION,2
IR,PETECHIAE,2
IR,PHARYNGEAL HAEMORRHAGE,2
IR,POSTERIOR CAPSULE RUPTURE,2
IR,PROCTITIS,2
IR,PRODUCT ADHESION ISSUE,2
IR,PSEUDOMONAL SEPSIS,2
IR,PSYCHOGENIC SEIZURE,2
IR,PULMONARY HYPERTENSION,2
IR,PULMONARY TUBERCULOSIS,2
IR,QRS AXIS ABNORMAL,2
IR,RASH GENERALISED,2
IR,RECTAL PERFORATION,2
IR,RESPIRATORY RATE DECREASED,2
IR,RETROPERITONEAL HAEMATOMA,2
IR,RIB FRACTURE,2
IR,SCLERAL DISCOLOURATION,2
IR,SECOND PRIMARY MALIGNANCY,2
IR,SELF-MEDICATION,2
IR,SEROUS CYSTADENOCARCINOMA OVARY,2
IR,SKIN ODOUR ABNORMAL,2
IR,SKIN PLAQUE,2
IR,SKIN STRIAE,2
IR,STOMATITIS,2
IR,STRIDOR,2
IR,SUDDEN DEATH,2
IR,SWELLING,2
IR,SYNCOPE,2
IR,TENDERNESS,2
IR,TESTICULAR GERM CELL CANCER,2
IR,TESTICULAR GERM CELL TUMOUR MIXED,2
IR,THERMAL BURN,2
IR,THROAT TIGHTNESS,2
IR,TIC,2
IR,TONGUE INJURY,2
IR,TONSILLAR INFLAMMATION,2
IR,TRACHEOBRONCHITIS,2
IR,TRANSAMINASES INCREASED,2
IR,TRISMUS,2
IR,TUMOUR LYSIS SYNDROME,2
IR,TYPE I HYPERSENSITIVITY,2
IR,ULCER,2
IR,UPPER GASTROINTESTINAL HAEMORRHAGE,2
IR,URINE OUTPUT DECREASED,2
IR,UTERINE FISTULA,2
IR,UTERINE NECROSIS,2
IR,VASCULITIS,2
IR,VERTIGO POSITIONAL,2
IR,VISUAL FIELD DEFECT,2
IR,VITILIGO,2
IR,WOUND,2
IR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
IR,ABASIA,1
IR,ABDOMINAL ABSCESS,1
IR,ABNORMAL BEHAVIOUR,1
IR,ABNORMAL DREAMS,1
IR,ABNORMAL FAECES,1
IR,ABORTED PREGNANCY,1
IR,ABORTION EARLY,1
IR,ABORTION LATE,1
IR,ABORTION SPONTANEOUS,1
IR,ACCIDENT,1
IR,ACINETOBACTER INFECTION,1
IR,ACINETOBACTER TEST POSITIVE,1
IR,ACOUSTIC NEUROMA,1
IR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
IR,ACTIVITIES OF DAILY LIVING IMPAIRED,1
IR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
IR,ACUTE GRAFT VERSUS HOST DISEASE,1
IR,ACUTE LYMPHOCYTIC LEUKAEMIA,1
IR,ADENOCARCINOMA,1
IR,ADRENOCORTICOTROPIC HORMONE DEFICIENCY,1
IR,ADVERSE EVENT,1
IR,AGEUSIA,1
IR,ALANINE AMINOTRANSFERASE ABNORMAL,1
IR,ALCOHOL POISONING,1
IR,ALLERGIC OEDEMA,1
IR,AMENORRHOEA,1
IR,AMMONIA INCREASED,1
IR,ANAESTHETIC COMPLICATION,1
IR,ANAPHYLACTOID SHOCK,1
IR,ANEURYSM RUPTURED,1
IR,ANORGASMIA,1
IR,APGAR SCORE ABNORMAL,1
IR,APGAR SCORE LOW,1
IR,APHASIA,1
IR,APHTHOUS ULCER,1
IR,APLASIA PURE RED CELL,1
IR,APPLICATION SITE PAIN,1
IR,APRAXIA,1
IR,ARTERIAL INJURY,1
IR,ARTERIAL RUPTURE,1
IR,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
IR,ASPIRATION,1
IR,ASPIRATION BONE MARROW,1
IR,ATRIAL THROMBOSIS,1
IR,ATRIOVENTRICULAR BLOCK,1
IR,ATRIOVENTRICULAR BLOCK COMPLETE,1
IR,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
IR,AUTOIMMUNE DISORDER,1
IR,AUTOIMMUNE HEPATITIS,1
IR,AUTONOMIC DYSREFLEXIA,1
IR,AZOOSPERMIA,1
IR,BILIRUBIN CONJUGATED INCREASED,1
IR,BLAST CELL PROLIFERATION,1
IR,BLOOD ALBUMIN DECREASED,1
IR,BLOOD BILIRUBIN INCREASED,1
IR,BLOOD CALCIUM INCREASED,1
IR,BLOOD CORTISOL INCREASED,1
IR,BLOOD CREATINE INCREASED,1
IR,BLOOD CREATININE DECREASED,1
IR,BLOOD ELECTROLYTES ABNORMAL,1
IR,BLOOD GASES ABNORMAL,1
IR,BLOOD GLUCOSE DECREASED,1
IR,BLOOD IMMUNOGLOBULIN G INCREASED,1
IR,BLOOD POTASSIUM DECREASED,1
IR,BLOOD PRESSURE FLUCTUATION,1
IR,BLOOD PRESSURE SYSTOLIC DECREASED,1
IR,BLOOD SODIUM DECREASED,1
IR,BLOOD URIC ACID INCREASED,1
IR,BONE DEFORMITY,1
IR,BONE MARROW TRANSPLANT,1
IR,BOTULISM,1
IR,BRADYARRHYTHMIA,1
IR,BREAST INFLAMMATION,1
IR,BRUGADA SYNDROME,1
IR,CARDIAC ARREST NEONATAL,1
IR,CARDIAC DYSFUNCTION,1
IR,CARDIAC FAILURE ACUTE,1
IR,CARDIAC FAILURE CHRONIC,1
IR,CARDIAC FAILURE CONGESTIVE,1
IR,CATARACT OPERATION,1
IR,CAUDA EQUINA SYNDROME,1
IR,CAVERNOUS SINUS THROMBOSIS,1
IR,CELLULITIS ORBITAL,1
IR,CENTRAL OBESITY,1
IR,CEREBELLAR SYNDROME,1
IR,CEREBRAL DISORDER,1
IR,CEREBRAL HAEMANGIOMA,1
IR,CEREBRAL SALT-WASTING SYNDROME,1
IR,CEREBRAL THROMBOSIS,1
IR,CHEILOSIS,1
IR,CHEST WALL MASS,1
IR,CHLOROMA,1
IR,CHOLESTASIS,1
IR,CHOREA,1
IR,CHOROIDAL EFFUSION,1
IR,CHOROIDAL HAEMORRHAGE,1
IR,CHRONIC GRAFT VERSUS HOST DISEASE,1
IR,CHRONIC KIDNEY DISEASE,1
IR,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
IR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IR,COLITIS,1
IR,COLON CANCER METASTATIC,1
IR,COMA SCALE ABNORMAL,1
IR,CONCOMITANT DISEASE PROGRESSION,1
IR,CONGENITAL NOSE MALFORMATION,1
IR,CONJUNCTIVAL BLEB,1
IR,CONJUNCTIVAL HYPERAEMIA,1
IR,CONJUNCTIVAL VASCULAR DISORDER,1
IR,COOMBS NEGATIVE HAEMOLYTIC ANAEMIA,1
IR,CORNEAL DECOMPENSATION,1
IR,CORNEAL INFILTRATES,1
IR,CORNEAL SCAR,1
IR,CORONARY ARTERY ANEURYSM,1
IR,CORONARY ARTERY STENOSIS,1
IR,CRANIAL NERVE DISORDER,1
IR,CREPITATIONS,1
IR,CSF CELL COUNT INCREASED,1
IR,CSF GLUCOSE DECREASED,1
IR,CSF LYMPHOCYTE COUNT ABNORMAL,1
IR,CSF PROTEIN INCREASED,1
IR,CSF WHITE BLOOD CELL COUNT INCREASED,1
IR,CUTANEOUS TUBERCULOSIS,1
IR,CYTOKINE RELEASE SYNDROME,1
IR,CYTOPENIA,1
IR,DELAYED GRAFT FUNCTION,1
IR,DELAYED PUBERTY,1
IR,DELIVERY,1
IR,DELUSION,1
IR,DEPENDENCE,1
IR,DEPRESSED MOOD,1
IR,DIAPHRAGMATIC PARALYSIS,1
IR,DIASTOLIC DYSFUNCTION,1
IR,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,1
IR,DIFFUSE LARGE B-CELL LYMPHOMA,1
IR,DISABILITY,1
IR,DISCOMFORT,1
IR,DISORGANISED SPEECH,1
IR,DISSEMINATED TUBERCULOSIS,1
IR,DOUBLE STRANDED DNA ANTIBODY POSITIVE,1
IR,DRUG DISPENSING ERROR,1
IR,DRUG LEVEL DECREASED,1
IR,DRUG LEVEL INCREASED,1
IR,DRUG TOLERANCE DECREASED,1
IR,DRY SKIN,1
IR,DYSAESTHESIA,1
IR,DYSTONIC TREMOR,1
IR,DYSURIA,1
IR,EATING DISORDER,1
IR,ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL,1
IR,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
IR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
IR,ELECTROCARDIOGRAM T WAVE INVERSION,1
IR,ELECTROLYTE IMBALANCE,1
IR,ELEVATED MOOD,1
IR,EMOTIONAL DISTRESS,1
IR,EMPHYSEMATOUS PYELONEPHRITIS,1
IR,ENDOCARDITIS,1
IR,ENDOMETRIAL DISORDER,1
IR,ENDOMETRIOSIS,1
IR,ENDOPHTHALMITIS,1
IR,ENDOTRACHEAL INTUBATION,1
IR,ENERGY INCREASED,1
IR,EPIDERMAL NECROSIS,1
IR,EPILEPSY,1
IR,ERECTILE DYSFUNCTION,1
IR,ERYTHEMA NODOSUM,1
IR,EXCORIATION,1
IR,EXOPHTHALMOS,1
IR,EXPOSED BONE IN JAW,1
IR,EXTRADURAL ABSCESS,1
IR,EXTRADURAL HAEMATOMA,1
IR,EXTRADURAL NEOPLASM,1
IR,EXTRAOCULAR MUSCLE DISORDER,1
IR,EXTRAPYRAMIDAL DISORDER,1
IR,EXTRAVASATION,1
IR,EYE DISCHARGE,1
IR,EYE HAEMORRHAGE,1
IR,EYE IRRITATION,1
IR,EYE OEDEMA,1
IR,EYELID FUNCTION DISORDER,1
IR,EYELID OEDEMA,1
IR,FACIAL PARALYSIS,1
IR,FAECALOMA,1
IR,FEAR OF DISEASE,1
IR,FEEDING DISORDER,1
IR,FEEDING DISORDER NEONATAL,1
IR,FEELING ABNORMAL,1
IR,FEMUR FRACTURE,1
IR,FLUID INTAKE REDUCED,1
IR,FOETAL HEART RATE ABNORMAL,1
IR,FOETAL HEART RATE DECELERATION ABNORMALITY,1
IR,FOREIGN BODY,1
IR,GASTRIC CANCER,1
IR,GASTRIC MUCOSA ERYTHEMA,1
IR,GASTRIC ULCER,1
IR,GASTRITIS,1
IR,GAZE PALSY,1
IR,GENERAL PHYSICAL CONDITION ABNORMAL,1
IR,GENERALISED ERYTHEMA,1
IR,GENITAL HYPOAESTHESIA,1
IR,GINGIVITIS,1
IR,GLAUCOMA,1
IR,GLOMERULONEPHRITIS PROLIFERATIVE,1
IR,GLYCOSURIA,1
IR,GRANULOCYTOSIS,1
IR,GROIN ABSCESS,1
IR,GUILLAIN-BARRE SYNDROME,1
IR,HAEMOLYSIS,1
IR,HAEMORRHAGE IN PREGNANCY,1
IR,HAEMORRHAGIC ASCITES,1
IR,HAEMOTHORAX,1
IR,HAIR DISORDER,1
IR,HAIR TEXTURE ABNORMAL,1
IR,HALLUCINATION_ AUDITORY,1
IR,HALLUCINATION_ TACTILE,1
IR,HEAD INJURY,1
IR,HEART RATE ABNORMAL,1
IR,HEART RATE DECREASED,1
IR,HEMIANAESTHESIA,1
IR,HEMIANOPIA HOMONYMOUS,1
IR,HEPATIC CIRRHOSIS,1
IR,HEPATIC FIBROSIS,1
IR,HEPATIC FUNCTION ABNORMAL,1
IR,HEPATITIS ACUTE,1
IR,HEPATITIS B,1
IR,HEPATITIS B CORE ANTIBODY,1
IR,HEPATITIS B SURFACE ANTIGEN POSITIVE,1
IR,HEPATOCELLULAR CARCINOMA,1
IR,HEPATOMEGALY,1
IR,HEPATOSPLENOMEGALY,1
IR,HERPES SIMPLEX MENINGOENCEPHALITIS,1
IR,HICCUPS,1
IR,HIP FRACTURE,1
IR,HISTIOCYTOSIS HAEMATOPHAGIC,1
IR,HODGKIN^S DISEASE RECURRENT,1
IR,HOSPITALISATION,1
IR,HYDRONEPHROSIS,1
IR,HYPERCAPNIA,1
IR,HYPERCORTICOIDISM,1
IR,HYPERKERATOSIS,1
IR,HYPERPROLACTINAEMIA,1
IR,HYPERTHERMIA,1
IR,HYPERTHERMIA MALIGNANT,1
IR,HYPERTHYROIDISM,1
IR,HYPERTRICHOSIS,1
IR,HYPERURICAEMIA,1
IR,HYPOAESTHESIA EYE,1
IR,HYPOCALCAEMIA,1
IR,HYPOGLYCAEMIA NEONATAL,1
IR,HYPOKINESIA,1
IR,HYPOPHAGIA,1
IR,HYPORESPONSIVE TO STIMULI,1
IR,HYPOTHERMIA,1
IR,HYPOVENTILATION,1
IR,ILLUSION,1
IR,IMMATURE RESPIRATORY SYSTEM,1
IR,IMMUNE THROMBOCYTOPENIC PURPURA,1
IR,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
IR,IMPAIRED SELF-CARE,1
IR,INAPPROPRIATE AFFECT,1
IR,INCISION SITE COMPLICATION,1
IR,INFECTED SKIN ULCER,1
IR,INFECTION PROTOZOAL,1
IR,INFERTILITY,1
IR,INFLUENZA LIKE ILLNESS,1
IR,INJECTION SITE CELLULITIS,1
IR,INJECTION SITE ERYTHEMA,1
IR,INJECTION SITE INFLAMMATION,1
IR,INJECTION SITE NECROSIS,1
IR,INJECTION SITE OEDEMA,1
IR,INJECTION SITE PAIN,1
IR,INJECTION SITE REACTION,1
IR,INJECTION SITE SWELLING,1
IR,INJECTION SITE ULCER,1
IR,INJECTION SITE VESICLES,1
IR,INSULIN C-PEPTIDE INCREASED,1
IR,INTENTION TREMOR,1
IR,INTENTIONAL SELF-INJURY,1
IR,INTENTIONAL UNDERDOSE,1
IR,INTERCEPTED MEDICATION ERROR,1
IR,INTERCEPTED PRODUCT SELECTION ERROR,1
IR,INTERNATIONAL NORMALISED RATIO INCREASED,1
IR,INTERSTITIAL LUNG DISEASE,1
IR,INTERVERTEBRAL DISCITIS,1
IR,INTESTINAL INFARCTION,1
IR,INTESTINAL ISCHAEMIA,1
IR,INTRA-ABDOMINAL HAEMORRHAGE,1
IR,INTRACARDIAC THROMBUS,1
IR,INVASIVE PAPILLARY BREAST CARCINOMA,1
IR,ISCHAEMIA,1
IR,ISCHAEMIC STROKE,1
IR,JEALOUS DELUSION,1
IR,JOINT SWELLING,1
IR,KIDNEY ENLARGEMENT,1
IR,KIDNEY INFECTION,1
IR,KIDNEY PERFORATION,1
IR,KIDNEY TRANSPLANT REJECTION,1
IR,KLEBSIELLA INFECTION,1
IR,LACERATION,1
IR,LACTIC ACIDOSIS,1
IR,LANGUAGE DISORDER,1
IR,LARYNGOSPASM,1
IR,LEISHMANIASIS,1
IR,LICHENOID KERATOSIS,1
IR,LIPOHYPERTROPHY,1
IR,LIVE BIRTH,1
IR,LIVER ABSCESS,1
IR,LIVER FUNCTION TEST,1
IR,LIVER TENDERNESS,1
IR,LIVER TRANSPLANT,1
IR,LOCALISED INFECTION,1
IR,LOCALISED OEDEMA,1
IR,LUNG CONSOLIDATION,1
IR,LUPUS NEPHRITIS,1
IR,LUPUS-LIKE SYNDROME,1
IR,LYMPH NODE PAIN,1
IR,LYMPHOCELE,1
IR,LYMPHOCYTE COUNT INCREASED,1
IR,LYMPHOCYTIC INFILTRATION,1
IR,LYMPHOCYTOSIS,1
IR,LYMPHOEDEMA,1
IR,LYMPHOMA,1
IR,LYMPHOPENIA,1
IR,LYMPHOPROLIFERATIVE DISORDER,1
IR,MACULAR DETACHMENT,1
IR,MACULAR OEDEMA,1
IR,MACULAR PIGMENTATION,1
IR,MACULOPATHY,1
IR,MAJOR DEPRESSION,1
IR,MARROW HYPERPLASIA,1
IR,MEDICATION RESIDUE PRESENT,1
IR,MEMORY IMPAIRMENT,1
IR,MENINGITIS,1
IR,MENINGITIS TUBERCULOUS,1
IR,MENTAL IMPAIRMENT,1
IR,MESENTERIC HAEMORRHAGE,1
IR,MESENTERIC VEIN THROMBOSIS,1
IR,METASTASES TO BREAST,1
IQ,FATIGUE,39
IQ,PYREXIA,34
IQ,HEADACHE,28
IQ,INFLUENZA,28
IQ,ARTHRALGIA,27
IQ,VOMITING,25
IQ,ANAEMIA,21
IQ,ANXIETY,21
IQ,DYSPNOEA,21
IQ,NAUSEA,21
IQ,NEPHROLITHIASIS,21
IQ,ABDOMINAL PAIN,20
IQ,DIZZINESS,19
IQ,ABDOMINAL PAIN UPPER,18
IQ,HYPERGLYCAEMIA,18
IQ,RASH,18
IQ,COUGH,17
IQ,ABDOMINAL DISTENSION,15
IQ,DECREASED APPETITE,14
IQ,HYPERTENSION,14
IQ,HYPOTENSION,14
IQ,WEIGHT INCREASED,14
IQ,CHEST PAIN,13
IQ,DEATH,13
IQ,HYPERSENSITIVITY,13
IQ,OEDEMA PERIPHERAL,13
IQ,DIARRHOEA,12
IQ,FLANK PAIN,12
IQ,PAIN,12
IQ,WEIGHT DECREASED,12
IQ,BACK PAIN,11
IQ,LEUKOCYTOSIS,11
IQ,URINARY TRACT INFECTION,11
IQ,BONE PAIN,10
IQ,HOT FLUSH,10
IQ,INSOMNIA,10
IQ,OROPHARYNGEAL PAIN,10
IQ,THROMBOCYTOPENIA,10
IQ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,9
IQ,GRANULOMA SKIN,9
IQ,PRURITUS,9
IQ,TACHYCARDIA,9
IQ,DRUG INEFFECTIVE,8
IQ,INCORRECT DRUG ADMINISTRATION DURATION,8
IQ,MENSTRUAL DISORDER,8
IQ,NERVOUSNESS,8
IQ,PAIN IN EXTREMITY,8
IQ,PANCYTOPENIA,8
IQ,RENAL PAIN,8
IQ,CYTOGENETIC ANALYSIS ABNORMAL,7
IQ,DYSURIA,7
IQ,ERYTHEMA,7
IQ,HAEMOGLOBIN DECREASED,7
IQ,MALAISE,7
IQ,SPLENOMEGALY,7
IQ,ALOPECIA,6
IQ,BLOOD CREATININE INCREASED,6
IQ,BLOOD UREA INCREASED,6
IQ,CHROMATURIA,6
IQ,CONSTIPATION,6
IQ,EYELID OEDEMA,6
IQ,FEBRILE NEUTROPENIA,6
IQ,GENERALISED OEDEMA,6
IQ,HEPATIC ENZYME INCREASED,6
IQ,LEUKOPENIA,6
IQ,LOSS OF CONSCIOUSNESS,6
IQ,MEMORY IMPAIRMENT,6
IQ,MYALGIA,6
IQ,OVARIAN CYST,6
IQ,RASH GENERALISED,6
IQ,SKIN DISCOLOURATION,6
IQ,ANGINA PECTORIS,5
IQ,CEREBROVASCULAR ACCIDENT,5
IQ,CHILLS,5
IQ,CYANOSIS,5
IQ,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
IQ,KAPOSI^S SARCOMA,5
IQ,KIDNEY INFECTION,5
IQ,PARAESTHESIA,5
IQ,PNEUMONIA,5
IQ,RENAL TUBULAR NECROSIS,5
IQ,SKIN DISORDER,5
IQ,STEVENS-JOHNSON SYNDROME,5
IQ,SWELLING,5
IQ,TOOTH DISORDER,5
IQ,APHASIA,4
IQ,ARTHRITIS BACTERIAL,4
IQ,ASTHENIA,4
IQ,BLADDER PAIN,4
IQ,CARDIAC DISORDER,4
IQ,CHOLELITHIASIS,4
IQ,DRUG ABUSE,4
IQ,DYSPHAGIA,4
IQ,EXPOSURE VIA FATHER,4
IQ,EYE PAIN,4
IQ,FACE OEDEMA,4
IQ,FALL,4
IQ,FOOD INTERACTION,4
IQ,GASTROINTESTINAL DISORDER,4
IQ,HAEMATURIA,4
IQ,HAEMORRHAGE,4
IQ,HYPERHIDROSIS,4
IQ,JAUNDICE,4
IQ,LACRIMATION INCREASED,4
IQ,LYMPHADENOPATHY,4
IQ,MATERNAL EXPOSURE DURING PREGNANCY,4
IQ,MUSCLE SPASMS,4
IQ,OEDEMA,4
IQ,PALPITATIONS,4
IQ,PIGMENTATION DISORDER,4
IQ,PNEUMONITIS,4
IQ,RENAL COLIC,4
IQ,THALAMUS HAEMORRHAGE,4
IQ,TREMOR,4
IQ,VISION BLURRED,4
IQ,ANAPHYLACTIC SHOCK,3
IQ,ASCITES,3
IQ,BLOOD CALCIUM DECREASED,3
IQ,BLOOD URIC ACID INCREASED,3
IQ,CEREBRAL HAEMORRHAGE,3
IQ,CONJUNCTIVAL HAEMORRHAGE,3
IQ,DEPRESSED LEVEL OF CONSCIOUSNESS,3
IQ,DIABETIC KETOACIDOSIS,3
IQ,EATING DISORDER,3
IQ,EPISTAXIS,3
IQ,EXPOSURE DURING PREGNANCY,3
IQ,EYE OEDEMA,3
IQ,FLUSHING,3
IQ,FURUNCLE,3
IQ,GAIT DISTURBANCE,3
IQ,HYPOAESTHESIA,3
IQ,INCORRECT DOSE ADMINISTERED,3
IQ,INCREASED APPETITE,3
IQ,INFECTION,3
IQ,LYMPHADENITIS,3
IQ,MENORRHAGIA,3
IQ,MENSTRUATION DELAYED,3
IQ,MOOD ALTERED,3
IQ,MUSCULAR WEAKNESS,3
IQ,NECK PAIN,3
IQ,NEUTROPENIA,3
IQ,NORMAL NEWBORN,3
IQ,OCULAR HYPERAEMIA,3
IQ,OVERWEIGHT,3
IQ,PALLOR,3
IQ,PANCREATITIS ACUTE,3
IQ,PRODUCTIVE COUGH,3
IQ,QUADRIPLEGIA,3
IQ,SEIZURE,3
IQ,SEPSIS,3
IQ,SJOGREN^S SYNDROME,3
IQ,TACHYPNOEA,3
IQ,TUBERCULOSIS,3
IQ,URTICARIA,3
IQ,WHITE BLOOD CELL COUNT INCREASED,3
IQ,ALOPECIA AREATA,2
IQ,ANGIOEDEMA,2
IQ,ARRHYTHMIA,2
IQ,ARTHRITIS,2
IQ,BLOOD BILIRUBIN INCREASED,2
IQ,BRADYCARDIA,2
IQ,BREAST PAIN,2
IQ,CALCULUS URINARY,2
IQ,CARDIAC ARREST,2
IQ,CARDIAC FAILURE,2
IQ,CHEST DISCOMFORT,2
IQ,CHEST X-RAY ABNORMAL,2
IQ,CHOLECYSTITIS,2
IQ,DECREASED IMMUNE RESPONSIVENESS,2
IQ,DELIVERY,2
IQ,DERMATITIS ALLERGIC,2
IQ,DIABETES MELLITUS,2
IQ,DRY SKIN,2
IQ,EAR INFECTION,2
IQ,EAR PAIN,2
IQ,EJECTION FRACTION DECREASED,2
IQ,ERYTHRODERMIC PSORIASIS,2
IQ,EXTENSOR PLANTAR RESPONSE,2
IQ,FAECES DISCOLOURED,2
IQ,FEAR,2
IQ,FEEDING DISORDER,2
IQ,FEELING HOT,2
IQ,FLATULENCE,2
IQ,FOETAL EXPOSURE DURING PREGNANCY,2
IQ,FUNGAL INFECTION,2
IQ,HAEMORRHAGIC STROKE,2
IQ,HEMIPARESIS,2
IQ,HEPATIC FAILURE,2
IQ,HEPATIC STEATOSIS,2
IQ,HEPATOSPLENOMEGALY,2
IQ,HYPERREFLEXIA,2
IQ,HYPOGLYCAEMIA,2
IQ,INFLAMMATION,2
IQ,INFLUENZA LIKE ILLNESS,2
IQ,INFUSION RELATED REACTION,2
IQ,INJECTION SITE PAIN,2
IQ,INTERSTITIAL LUNG DISEASE,2
IQ,IRRITABLE BOWEL SYNDROME,2
IQ,JOINT EFFUSION,2
IQ,LIVE BIRTH,2
IQ,LOCALISED OEDEMA,2
IQ,LOWER RESPIRATORY TRACT INFECTION,2
IQ,LUNG INFECTION,2
IQ,LUPUS-LIKE SYNDROME,2
IQ,LYMPHOCYTOSIS,2
IQ,MENTAL DISORDER,2
IQ,MENTAL IMPAIRMENT,2
IQ,MOUTH ULCERATION,2
IQ,MOVEMENT DISORDER,2
IQ,MUCOSAL INFLAMMATION,2
IQ,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
IQ,NIGHT SWEATS,2
IQ,OESOPHAGEAL CANDIDIASIS,2
IQ,OLIGOHYDRAMNIOS,2
IQ,OLIGURIA,2
IQ,OSTEOPOROSIS,2
IQ,PERIPHERAL COLDNESS,2
IQ,PLASMA CELL MYELOMA,2
IQ,PLEURAL EFFUSION,2
IQ,POLLAKIURIA,2
IQ,POLYMERASE CHAIN REACTION POSITIVE,2
IQ,PRESCRIBED UNDERDOSE,2
IQ,PRODUCT USE IN UNAPPROVED INDICATION,2
IQ,PRODUCT USE ISSUE,2
IQ,PULMONARY EMBOLISM,2
IQ,PULMONARY TUBERCULOSIS,2
IQ,QUADRIPARESIS,2
IQ,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
IQ,RENAL DISORDER,2
IQ,RESPIRATORY DISTRESS,2
IQ,RHINORRHOEA,2
IQ,SHOCK,2
IQ,SKIN LESION,2
IQ,SKIN NECROSIS,2
IQ,SLEEP DISORDER,2
IQ,SOMNOLENCE,2
IQ,SPEECH DISORDER,2
IQ,SPINAL PAIN,2
IQ,SYNCOPE,2
IQ,VITAMIN D DECREASED,2
IQ,WHEEZING,2
IQ,YELLOW SKIN,2
IQ,ABASIA,1
IQ,ABDOMINAL DISCOMFORT,1
IQ,ABORTION,1
IQ,ABSCESS LIMB,1
IQ,ACARODERMATITIS,1
IQ,ACUTE KIDNEY INJURY,1
IQ,ACUTE MYELOID LEUKAEMIA,1
IQ,ADENOIDAL HYPERTROPHY,1
IQ,ADENOMA BENIGN,1
IQ,ADRENAL INSUFFICIENCY,1
IQ,ADVERSE DRUG REACTION,1
IQ,ADVERSE EVENT,1
IQ,ALANINE AMINOTRANSFERASE INCREASED,1
IQ,AMENORRHOEA,1
IQ,AMNESIA,1
IQ,ANAL ABSCESS,1
IQ,ANGLE CLOSURE GLAUCOMA,1
IQ,ANKYLOSING SPONDYLITIS,1
IQ,ANORECTAL DISCOMFORT,1
IQ,ANOVULATORY CYCLE,1
IQ,ANTINUCLEAR ANTIBODY POSITIVE,1
IQ,ANURIA,1
IQ,APHONIA,1
IQ,APHTHOUS STOMATITIS,1
IQ,APNOEA,1
IQ,APNOEIC ATTACK,1
IQ,APPENDICECTOMY,1
IQ,APPETITE DISORDER,1
IQ,ARTHROPOD STING,1
IQ,ASPARTATE AMINOTRANSFERASE INCREASED,1
IQ,ASPHYXIA,1
IQ,ASTHENOPIA,1
IQ,ATELECTASIS,1
IQ,ATRIAL FIBRILLATION,1
IQ,AZOTAEMIA,1
IQ,BENIGN PROSTATIC HYPERPLASIA,1
IQ,BICYTOPENIA,1
IQ,BLAST CELL CRISIS,1
IQ,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
IQ,BLINDNESS,1
IQ,BLOOD CHOLESTEROL INCREASED,1
IQ,BLOOD CREATINE INCREASED,1
IQ,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IQ,BLOOD GLUCOSE ABNORMAL,1
IQ,BLOOD GLUCOSE INCREASED,1
IQ,BLOOD IRON DECREASED,1
IQ,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IQ,BLOOD PRESSURE ABNORMAL,1
IQ,BLOOD PRESSURE IMMEASURABLE,1
IQ,BLOOD PRESSURE INCREASED,1
IQ,BLOOD PROLACTIN INCREASED,1
IQ,BLOOD TEST ABNORMAL,1
IQ,BLOOD URINE PRESENT,1
IQ,BONE LESION,1
IQ,BOREDOM,1
IQ,BRADYCARDIA FOETAL,1
IQ,BRAIN NEOPLASM,1
IQ,BREAST CANCER METASTATIC,1
IQ,BREAST FIBROMA,1
IQ,BREAST HAEMORRHAGE,1
IQ,BREAST MASS,1
IQ,BREATH SOUNDS ABNORMAL,1
IQ,BURNING SENSATION,1
IQ,CALCULUS URETHRAL,1
IQ,CANDIDA INFECTION,1
IQ,CARDIAC DYSFUNCTION,1
IQ,CARDIAC OPERATION,1
IQ,CARDIOVASCULAR DISORDER,1
IQ,CHOKING SENSATION,1
IQ,CHOLECYSTITIS ACUTE,1
IQ,CHOLECYSTITIS INFECTIVE,1
IQ,CHRONIC KIDNEY DISEASE,1
IQ,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
IQ,CHRONIC TONSILLITIS,1
IQ,CIRCULATORY COLLAPSE,1
IQ,CLONUS,1
IQ,CLOSTRIDIUM DIFFICILE INFECTION,1
IQ,CONDITION AGGRAVATED,1
IQ,CONFUSIONAL STATE,1
IQ,CONTUSION,1
IQ,CONVULSION,1
IQ,CORONARY ARTERY EMBOLISM,1
IQ,CORONARY ARTERY STENOSIS,1
IQ,CORONARY REVASCULARISATION,1
IQ,CORTISOL FREE URINE DECREASED,1
IQ,CREPITATIONS,1
IQ,CUSHING^S SYNDROME,1
IQ,CYANOSIS CENTRAL,1
IQ,CYSTITIS,1
IQ,DANDRUFF,1
IQ,DEATH NEONATAL,1
IQ,DECUBITUS ULCER,1
IQ,DEEP VEIN THROMBOSIS,1
IQ,DEHYDRATION,1
IQ,DEPRESSED MOOD,1
IQ,DEPRESSION,1
IQ,DERMATOFIBROSARCOMA PROTUBERANS,1
IQ,DIARRHOEA HAEMORRHAGIC,1
IQ,DIPLOPIA,1
IQ,DISEASE PROGRESSION,1
IQ,DISTURBANCE IN ATTENTION,1
IQ,DRUG PRESCRIBING ERROR,1
IQ,DYSCHEZIA,1
IQ,DYSGEUSIA,1
IQ,DYSKINESIA,1
IQ,DYSLIPIDAEMIA,1
IQ,DYSMENORRHOEA,1
IQ,DYSPEPSIA,1
IQ,DYSPHONIA,1
IQ,DYSPHORIA,1
IQ,DYSPNOEA EXERTIONAL,1
IQ,DYSSTASIA,1
IQ,ECZEMA,1
IQ,EJECTION FRACTION ABNORMAL,1
IQ,EMBOLISM,1
IQ,EPILEPSY,1
IQ,ERECTILE DYSFUNCTION,1
IQ,ERYTHEMA OF EYELID,1
IQ,ERYTHROBLASTOSIS,1
IQ,EXCESSIVE GRANULATION TISSUE,1
IQ,EXPOSED BONE IN JAW,1
IQ,EYE COLOUR CHANGE,1
IQ,EYE HAEMORRHAGE,1
IQ,FEELING ABNORMAL,1
IQ,FLUID INTAKE REDUCED,1
IQ,FOETAL DEATH,1
IQ,FOETAL HYPOKINESIA,1
IQ,FOOD POISONING,1
IQ,GALLBLADDER DISORDER,1
IQ,GASTRIC DISORDER,1
IQ,GASTRIC ULCER,1
IQ,GASTRITIS EROSIVE,1
IQ,GASTROENTERITIS,1
IQ,GASTROINTESTINAL HAEMORRHAGE,1
IQ,GASTROINTESTINAL INFECTION,1
IQ,GASTROINTESTINAL PAIN,1
IQ,GASTROOESOPHAGEAL REFLUX DISEASE,1
IQ,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,1
IQ,GENE MUTATION,1
IQ,GENERAL PHYSICAL HEALTH DETERIORATION,1
IQ,GINGIVAL BLEEDING,1
IQ,GINGIVAL DISCOMFORT,1
IQ,GINGIVITIS,1
IQ,GUILLAIN-BARRE SYNDROME,1
IQ,HAEMATOCHEZIA,1
IQ,HAEMOLYTIC URAEMIC SYNDROME,1
IQ,HAEMOPTYSIS,1
IQ,HAEMORRHOIDS,1
IQ,HAIR GROWTH ABNORMAL,1
IQ,HEART RATE DECREASED,1
IQ,HEART RATE INCREASED,1
IQ,HELMINTHIC INFECTION,1
IQ,HEMIPLEGIA,1
IQ,HEPATIC INFECTION,1
IQ,HEPATIC MASS,1
IQ,HEPATIC PAIN,1
IQ,HEPATITIS B,1
IQ,HEPATOCELLULAR CARCINOMA,1
IQ,HERPES ZOSTER,1
IQ,HIP FRACTURE,1
IQ,HISTOLOGY ABNORMAL,1
IQ,HIV INFECTION,1
IQ,HORMONE LEVEL ABNORMAL,1
IQ,HYDRONEPHROSIS,1
IQ,HYPERCHOLESTEROLAEMIA,1
IQ,HYPERLIPIDAEMIA,1
IQ,HYPERTENSIVE CRISIS,1
IQ,HYPERTONIA,1
IQ,HYPOCALCAEMIA,1
IQ,HYPOKALAEMIA,1
IQ,HYPOPHAGIA,1
IQ,HYPOREFLEXIA,1
IQ,HYPOTHYROIDISM,1
IQ,HYPOXIA,1
IQ,IMMUNODEFICIENCY,1
IQ,INFERTILITY,1
IQ,INJECTION SITE RASH,1
IQ,INJECTION SITE REACTION,1
IQ,INTENTIONAL DRUG MISUSE,1
IQ,INTERVERTEBRAL DISC PROTRUSION,1
IQ,INVASIVE DUCTAL BREAST CARCINOMA,1
IQ,INVESTIGATION ABNORMAL,1
IQ,JOINT SWELLING,1
IQ,LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR,1
IQ,LAZINESS,1
IQ,LEFT VENTRICULAR HYPERTROPHY,1
IQ,LIBIDO DECREASED,1
IQ,LIP DRY,1
IQ,LIP ERYTHEMA,1
IQ,LIVER FUNCTION TEST INCREASED,1
IQ,LOCAL SWELLING,1
IQ,LOSS OF LIBIDO,1
IQ,LUMBAR VERTEBRAL FRACTURE,1
IQ,LYMPHOCYTE COUNT INCREASED,1
IQ,MALIGNANT NEOPLASM PROGRESSION,1
IQ,MALOCCLUSION,1
IQ,MARROW HYPERPLASIA,1
IQ,MEDICATION ERROR,1
IQ,MEIBOMIAN GLAND DYSFUNCTION,1
IQ,MENINGITIS,1
IQ,MENSTRUATION IRREGULAR,1
IQ,METABOLIC ACIDOSIS,1
IQ,METASTASES TO BONE MARROW,1
IQ,METRORRHAGIA,1
IQ,MIDDLE EAR EFFUSION,1
IQ,MIGRAINE,1
IQ,MOTOR DYSFUNCTION,1
IQ,MOUTH BREATHING,1
IQ,MUSCULOSKELETAL PAIN,1
IQ,MUSCULOSKELETAL STIFFNESS,1
IQ,MYCOSIS FUNGOIDES,1
IQ,MYOCARDIAL INFARCTION,1
IQ,MYOCARDITIS,1
IQ,NAIL GROWTH ABNORMAL,1
IQ,NASAL SEPTUM DEVIATION,1
IQ,NEOPLASM,1
IQ,NEURALGIA,1
IQ,NEUROPATHY PERIPHERAL,1
IQ,NEUTROPHILIA,1
IQ,NO THERAPEUTIC RESPONSE,1
IQ,OCULAR DISCOMFORT,1
IQ,OESOPHAGEAL INFECTION,1
IQ,ONCOLOGIC COMPLICATION,1
IQ,ORAL CANDIDIASIS,1
IQ,ORTHOPNOEA,1
IQ,OSTEONECROSIS OF JAW,1
IQ,OVERDOSE,1
IQ,PAIN IN JAW,1
IQ,PANCREATITIS,1
IQ,PAPULE,1
IQ,PELVIC INFECTION,1
IQ,PELVIC PAIN,1
IQ,PETECHIAE,1
IQ,PHARYNGITIS,1
IQ,PHOBIA,1
IQ,PHYSICAL DISABILITY,1
IQ,PLATELET COUNT DECREASED,1
IQ,PLATELET COUNT INCREASED,1
IQ,POIKILOCYTOSIS,1
IQ,POLYURIA,1
IQ,POSTPARTUM HAEMORRHAGE,1
IQ,PROCEDURAL PAIN,1
IQ,PRODUCT ADHESION ISSUE,1
IQ,PRODUCT COUNTERFEIT,1
IQ,PRODUCT STORAGE ERROR,1
IQ,PRODUCT SUBSTITUTION ISSUE,1
IQ,PROSTATIC SPECIFIC ANTIGEN DECREASED,1
IQ,PROTEIN DEFICIENCY,1
IQ,PROTEIN TOTAL DECREASED,1
IQ,PRURITUS GENERALISED,1
IQ,PSORIATIC ARTHROPATHY,1
IQ,PSYCHOLOGICAL FACTOR AFFECTING MEDICAL CONDITION,1
IQ,PULMONARY FIBROSIS,1
IQ,PULMONARY HAEMORRHAGE,1
IQ,PULMONARY HYPERTENSION,1
IQ,PULMONARY MASS,1
IQ,PULSE ABSENT,1
IQ,RASH ERYTHEMATOUS,1
IQ,RASH PAPULAR,1
IQ,RECTAL HAEMORRHAGE,1
IQ,RENAL FAILURE,1
IQ,RENAL FAILURE ACUTE,1
IQ,RENAL IMPAIRMENT,1
IQ,RESPIRATION ABNORMAL,1
IQ,RESPIRATORY ACIDOSIS,1
IQ,RESPIRATORY FAILURE,1
IQ,RESPIRATORY TRACT INFECTION,1
IQ,RETINOPATHY HAEMORRHAGIC,1
IQ,SELECTIVE EATING DISORDER,1
IQ,SENSORY LOSS,1
IQ,SEPTIC SHOCK,1
IQ,SINUSITIS,1
IQ,SKIN EXFOLIATION,1
IQ,SKIN FIBROSIS,1
IQ,SKIN MASS,1
IQ,SKIN ULCER,1
IQ,SPINAL CORD DISORDER,1
IQ,SPINAL DISORDER,1
IQ,STAPHYLOCOCCUS TEST POSITIVE,1
IQ,STENOSIS,1
IQ,STRESS AT WORK,1
IQ,SUICIDE THREAT,1
IQ,SUSPECTED COUNTERFEIT PRODUCT,1
IQ,SWELLING FACE,1
IQ,SYSTEMIC LUPUS ERYTHEMATOSUS,1
IQ,THROAT IRRITATION,1
IQ,THROMBOCYTOSIS,1
IQ,THROMBOPHLEBITIS,1
IQ,THYROID DISORDER,1
IQ,TINNITUS,1
IQ,TONSILLAR DISORDER,1
IQ,TONSILLITIS,1
IQ,TOOTH FRACTURE,1
IQ,TOXICITY TO VARIOUS AGENTS,1
IQ,TRACHEAL DISORDER,1
IQ,TRANSPLANT REJECTION,1
IQ,TUBERCULOSIS GASTROINTESTINAL,1
IQ,TUMOUR MARKER INCREASED,1
IQ,TYPHOID FEVER,1
IQ,ULTRASOUND SCAN ABNORMAL,1
IQ,UNDERDOSE,1
IQ,UNEVALUABLE EVENT,1
IQ,UPPER GASTROINTESTINAL HAEMORRHAGE,1
IQ,UPPER LIMB FRACTURE,1
IQ,UPPER MOTOR NEURONE LESION,1
IQ,URINARY RETENTION,1
IQ,URINARY TRACT DISORDER,1
IQ,URINE ABNORMALITY,1
IQ,URINE OUTPUT DECREASED,1
IQ,UTERINE ENLARGEMENT,1
IQ,UTERINE LEIOMYOMA,1
IQ,UTERINE PAIN,1
IQ,UVEITIS,1
IQ,VAGINAL HAEMORRHAGE,1
IQ,VAGINAL INFECTION,1
IQ,VERTIGO,1
IQ,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
IQ,VISUAL ACUITY REDUCED,1
IQ,VISUAL IMPAIRMENT,1
IQ,VITAMIN D DEFICIENCY,1
IQ,VOCAL CORD PARALYSIS,1
IQ,WEIGHT ABNORMAL,1
IE,DEATH,1055
IE,LOWER RESPIRATORY TRACT INFECTION,465
IE,MALAISE,421
IE,FATIGUE,332
IE,NAUSEA,317
IE,DYSPNOEA,302
IE,VOMITING,287
IE,DIARRHOEA,286
IE,DRUG INEFFECTIVE,267
IE,FALL,254
IE,PYREXIA,253
IE,COUGH,246
IE,HEADACHE,221
IE,HAEMOGLOBIN DECREASED,216
IE,DIZZINESS,207
IE,HOSPITALISATION,200
IE,PAIN,182
IE,RASH,174
IE,WHITE BLOOD CELL COUNT INCREASED,158
IE,ABDOMINAL PAIN,156
IE,ASTHENIA,156
IE,PNEUMONIA,152
IE,URINARY TRACT INFECTION,147
IE,FOETAL EXPOSURE DURING PREGNANCY,146
IE,HYPOTENSION,142
IE,PAIN IN EXTREMITY,142
IE,PRODUCT USE ISSUE,135
IE,ARTHRALGIA,130
IE,CONFUSIONAL STATE,129
IE,BACK PAIN,124
IE,NEUTROPHIL COUNT INCREASED,124
IE,HYPERTENSION,121
IE,CHEST PAIN,118
IE,PARAESTHESIA,118
IE,INFECTION,115
IE,DECREASED APPETITE,114
IE,SEPSIS,112
IE,CEREBROVASCULAR ACCIDENT,108
IE,CONSTIPATION,106
IE,DYSPHAGIA,104
IE,PULMONARY EMBOLISM,103
IE,WHEEZING,103
IE,WEIGHT DECREASED,101
IE,PRURITUS,100
IE,ANXIETY,99
IE,NEUTROPENIA,99
IE,WHITE BLOOD CELL COUNT DECREASED,99
IE,SEIZURE,98
IE,CHEST DISCOMFORT,97
IE,ACUTE KIDNEY INJURY,95
IE,PLATELET COUNT DECREASED,92
IE,DEHYDRATION,91
IE,GAIT DISTURBANCE,91
IE,BRONCHIOLITIS,86
IE,CELLULITIS,86
IE,TACHYCARDIA,86
IE,RESPIRATORY TRACT INFECTION,85
IE,HYPOAESTHESIA,84
IE,KIDNEY INFECTION,84
IE,RENAL IMPAIRMENT,84
IE,INSOMNIA,83
IE,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,81
IE,EXPOSURE DURING PREGNANCY,81
IE,MUSCULAR WEAKNESS,78
IE,VISION BLURRED,77
IE,TOXICITY TO VARIOUS AGENTS,76
IE,ANAEMIA,75
IE,FLUSHING,75
IE,HYPERHIDROSIS,74
IE,PALPITATIONS,74
IE,DISEASE PROGRESSION,73
IE,SYNCOPE,73
IE,CONDITION AGGRAVATED,72
IE,NEUTROPHIL COUNT DECREASED,71
IE,HAEMORRHAGE,70
IE,MATERNAL EXPOSURE DURING PREGNANCY,70
IE,MYALGIA,70
IE,OROPHARYNGEAL PAIN,70
IE,SOMNOLENCE,70
IE,INFLUENZA LIKE ILLNESS,69
IE,HYPONATRAEMIA,67
IE,TREMOR,67
IE,DRUG DOSE OMISSION,65
IE,HYPERSENSITIVITY,65
IE,MUSCLE SPASMS,65
IE,ABDOMINAL DISTENSION,64
IE,ABDOMINAL PAIN UPPER,64
IE,DIABETIC KETOACIDOSIS,64
IE,ERYTHEMA,64
IE,OVERDOSE,64
IE,ATRIAL FIBRILLATION,61
IE,BLOOD PRESSURE INCREASED,61
IE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,61
IE,DEPRESSION,61
IE,LETHARGY,61
IE,NASOPHARYNGITIS,61
IE,CHILLS,60
IE,FEELING ABNORMAL,60
IE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,60
IE,NEOPLASM MALIGNANT,60
IE,CAESAREAN SECTION,59
IE,ABORTION SPONTANEOUS,58
IE,DEPRESSED MOOD,58
IE,LOSS OF CONSCIOUSNESS,58
IE,AGITATION,57
IE,MYOCARDIAL INFARCTION,57
IE,VIRAL INFECTION,57
IE,ASCITES,56
IE,BODY TEMPERATURE INCREASED,56
IE,CARDIAC ARREST,56
IE,GASTROINTESTINAL HAEMORRHAGE,56
IE,LIVER FUNCTION TEST ABNORMAL,56
IE,MALIGNANT NEOPLASM PROGRESSION,56
IE,RESPIRATORY FAILURE,56
IE,SCHIZOPHRENIA,56
IE,ABDOMINAL DISCOMFORT,55
IE,BLOOD CREATININE INCREASED,55
IE,PRODUCT USE IN UNAPPROVED INDICATION,54
IE,C-REACTIVE PROTEIN INCREASED,53
IE,MOBILITY DECREASED,53
IE,URTICARIA,53
IE,HEART RATE INCREASED,52
IE,CENTRAL NERVOUS SYSTEM LESION,51
IE,THROMBOCYTOPENIA,51
IE,INFUSION RELATED REACTION,49
IE,MULTIPLE SCLEROSIS RELAPSE,49
IE,CONTUSION,48
IE,GENERAL PHYSICAL HEALTH DETERIORATION,48
IE,MUSCULOSKELETAL PAIN,47
IE,MUSCULOSKELETAL STIFFNESS,46
IE,TREATMENT NONCOMPLIANCE,46
IE,BONE PAIN,45
IE,RENAL FAILURE,45
IE,SUICIDAL IDEATION,45
IE,PALLOR,44
IE,PSYCHOTIC DISORDER,44
IE,DEEP VEIN THROMBOSIS,43
IE,INFLUENZA,43
IE,JOINT SWELLING,43
IE,OEDEMA PERIPHERAL,43
IE,PLEURAL EFFUSION,43
IE,AGGRESSION,42
IE,SWELLING FACE,41
IE,VISUAL IMPAIRMENT,41
IE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,41
IE,ASTHMA,40
IE,CONVULSION,40
IE,HEAD INJURY,40
IE,INCORRECT DOSE ADMINISTERED,40
IE,PRODUCTIVE COUGH,40
IE,SINUSITIS,40
IE,WEIGHT INCREASED,40
IE,BRADYCARDIA,39
IE,BREAST CANCER,39
IE,EPISTAXIS,39
IE,TRANSIENT ISCHAEMIC ATTACK,39
IE,CARDIAC FAILURE,38
IE,DYSKINESIA,38
IE,PREMATURE BABY,38
IE,UPPER RESPIRATORY TRACT INFECTION,38
IE,COMPLETED SUICIDE,37
IE,LUNG NEOPLASM MALIGNANT,37
IE,NEUTROPENIC SEPSIS,37
IE,PERIPHERAL SWELLING,37
IE,PRODUCT QUALITY ISSUE,37
IE,COLITIS,36
IE,EYE PAIN,36
IE,FEELING HOT,36
IE,INTESTINAL OBSTRUCTION,36
IE,PLATELET COUNT INCREASED,36
IE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,36
IE,RHINORRHOEA,36
IE,BALANCE DISORDER,35
IE,CYANOSIS,35
IE,DYSPEPSIA,35
IE,HALLUCINATION,35
IE,RECTAL HAEMORRHAGE,35
IE,ALOPECIA,34
IE,ANAPHYLACTIC REACTION,34
IE,BLOOD GLUCOSE INCREASED,34
IE,BLOOD PRESSURE DECREASED,34
IE,DYSARTHRIA,34
IE,HAEMATURIA,34
IE,IRRITABILITY,34
IE,NECK PAIN,34
IE,OXYGEN SATURATION DECREASED,34
IE,RASH GENERALISED,34
IE,DRUG WITHDRAWAL SYNDROME NEONATAL,33
IE,GASTRITIS,33
IE,INCORRECT ROUTE OF DRUG ADMINISTRATION,33
IE,OSTEONECROSIS OF JAW,33
IE,STOMATITIS,33
IE,ALANINE AMINOTRANSFERASE INCREASED,32
IE,HERPES ZOSTER,32
IE,HYPOGLYCAEMIA,32
IE,LYMPHOCYTE COUNT DECREASED,32
IE,MEMORY IMPAIRMENT,32
IE,NEUROPATHY PERIPHERAL,32
IE,PNEUMONIA ASPIRATION,32
IE,RASH ERYTHEMATOUS,32
IE,RASH PRURITIC,32
IE,UNRESPONSIVE TO STIMULI,32
IE,ADVERSE EVENT,31
IE,CARDIAC DISORDER,31
IE,CROHN^S DISEASE,31
IE,EYE SWELLING,31
IE,LIP SWELLING,31
IE,PSORIASIS,31
IE,TINNITUS,31
IE,AMNESIA,30
IE,CEREBRAL HAEMORRHAGE,30
IE,CIRCULATORY COLLAPSE,30
IE,EPILEPSY,30
IE,MENTAL IMPAIRMENT,30
IE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,30
IE,SURGERY,30
IE,BLISTER,29
IE,CRYING,29
IE,DISORIENTATION,29
IE,DYSGEUSIA,29
IE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,29
IE,LYMPHADENOPATHY,29
IE,MENTAL DISORDER,29
IE,THROAT TIGHTNESS,29
IE,DRUG WITHDRAWAL SYNDROME,28
IE,HEPATIC FAILURE,28
IE,HYPOPHAGIA,28
IE,JAUNDICE,28
IE,MULTIPLE SCLEROSIS,28
IE,OVARIAN HYPERSTIMULATION SYNDROME,28
IE,SWELLING,28
IE,BRONCHITIS,27
IE,CARDIAC FAILURE CONGESTIVE,27
IE,CHOLELITHIASIS,27
IE,DRUG ABUSE,27
IE,DRUG-INDUCED LIVER INJURY,27
IE,EMOTIONAL DISTRESS,27
IE,ENCEPHALOPATHY,27
IE,HAEMOGLOBIN ABNORMAL,27
IE,HIP FRACTURE,27
IE,IMPAIRED HEALING,27
IE,PHARYNGITIS,27
IE,PLASMA CELL MYELOMA,27
IE,RHEUMATOID ARTHRITIS,27
IE,ELECTROCARDIOGRAM QT PROLONGED,26
IE,FEMUR FRACTURE,26
IE,GASTROOESOPHAGEAL REFLUX DISEASE,26
IE,LUNG DISORDER,26
IE,PANCYTOPENIA,26
IE,PULMONARY OEDEMA,26
IE,SLEEP DISORDER,26
IE,UNEVALUABLE EVENT,26
IE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,26
IE,ADVERSE DRUG REACTION,25
IE,DEVICE RELATED INFECTION,25
IE,GASTROINTESTINAL DISORDER,25
IE,INTENTIONAL OVERDOSE,25
IE,LIVER FUNCTION TEST INCREASED,25
IE,PROSTATE CANCER,25
IE,RENAL FAILURE ACUTE,25
IE,SKIN DISCOLOURATION,25
IE,VERTIGO,25
IE,BLOOD ALKALINE PHOSPHATASE INCREASED,24
IE,BURNING SENSATION,24
IE,DISTURBANCE IN ATTENTION,24
IE,HEART RATE IRREGULAR,24
IE,MOUTH ULCERATION,24
IE,ABNORMAL BEHAVIOUR,23
IE,COGNITIVE DISORDER,23
IE,DRUG EFFECT INCOMPLETE,23
IE,DRUG HYPERSENSITIVITY,23
IE,DRY SKIN,23
IE,ECZEMA,23
IE,INTERNATIONAL NORMALISED RATIO INCREASED,23
IE,LEUKOPENIA,23
IE,PARKINSON^S DISEASE,23
IE,RENAL DISORDER,23
IE,RESPIRATORY RATE INCREASED,23
IE,SEDATION,23
IE,STRESS,23
IE,VISUAL ACUITY REDUCED,23
IE,ACUTE HEPATIC FAILURE,22
IE,ARTHRITIS,22
IE,INJECTION SITE PAIN,22
IE,MEDICATION ERROR,22
IE,MUCOSAL INFLAMMATION,22
IE,PANIC ATTACK,22
IE,RESPIRATORY DISORDER,22
IE,ROAD TRAFFIC ACCIDENT,22
IE,STAPHYLOCOCCAL INFECTION,22
IE,URINARY RETENTION,22
IE,ACUTE MYOCARDIAL INFARCTION,21
IE,ANGIOEDEMA,21
IE,COLITIS ULCERATIVE,21
IE,DISCOMFORT,21
IE,EAR INFECTION,21
IE,LOCAL SWELLING,21
IE,SECONDARY ADRENOCORTICAL INSUFFICIENCY,21
IE,SWOLLEN TONGUE,21
IE,THROMBOSIS,21
IE,BRAIN OEDEMA,20
IE,COLD SWEAT,20
IE,CORONARY ARTERY DISEASE,20
IE,DELIRIUM,20
IE,DRY MOUTH,20
IE,DYSURIA,20
IE,EOSINOPHIL COUNT INCREASED,20
IE,FEBRILE NEUTROPENIA,20
IE,GASTROENTERITIS,20
IE,HAEMOPTYSIS,20
IE,HEPATIC CIRRHOSIS,20
IE,HERNIA,20
IE,LUNG INFECTION,20
IE,MALIGNANT MELANOMA,20
IE,NIGHT SWEATS,20
IE,NIGHTMARE,20
IE,PARAESTHESIA ORAL,20
IE,PNEUMOCYSTIS JIROVECII PNEUMONIA,20
IE,PRESYNCOPE,20
IE,SKIN LESION,20
IE,SKIN ULCER,20
IE,TERMINAL STATE,20
IE,THERAPY CESSATION,20
IE,TUMOUR PAIN,20
IE,ARTHROPATHY,19
IE,BRONCHOSPASM,19
IE,CEREBRAL INFARCTION,19
IE,DRUG INTOLERANCE,19
IE,DYSPHONIA,19
IE,EXTRAPYRAMIDAL DISORDER,19
IE,HAEMATEMESIS,19
IE,HAEMATOMA,19
IE,HAEMORRHAGE INTRACRANIAL,19
IE,LACERATION,19
IE,LYMPHOPENIA,19
IE,NASAL CONGESTION,19
IE,ORTHOSTATIC HYPOTENSION,19
IE,POLLAKIURIA,19
IE,PRODUCT SUBSTITUTION ISSUE,19
IE,SPEECH DISORDER,19
IE,SUDDEN DEATH,19
IE,TONSILLITIS,19
IE,ANTIPSYCHOTIC DRUG LEVEL INCREASED,18
IE,ASPARTATE AMINOTRANSFERASE INCREASED,18
IE,BLOOD CREATINE PHOSPHOKINASE INCREASED,18
IE,CHEMOTHERAPY,18
IE,DRUG RESISTANCE,18
IE,FEELING COLD,18
IE,FOETAL ANTICONVULSANT SYNDROME,18
IE,HEMIPARESIS,18
IE,HYPOXIA,18
IE,INJECTION SITE ERYTHEMA,18
IE,LIVE BIRTH,18
IE,LYMPHOMA,18
IE,NEOPLASM PROGRESSION,18
IE,RED BLOOD CELL COUNT DECREASED,18
IE,RHABDOMYOLYSIS,18
IE,SUBDURAL HAEMATOMA,18
IE,TUBULOINTERSTITIAL NEPHRITIS,18
IE,TYPE 2 DIABETES MELLITUS,18
IE,ABASIA,17
IE,ACCIDENTAL OVERDOSE,17
IE,BLOOD CHOLESTEROL INCREASED,17
IE,BLOOD UREA INCREASED,17
IE,GENERALISED TONIC-CLONIC SEIZURE,17
IE,HYPOKALAEMIA,17
IE,MELAENA,17
IE,MYOCARDIAL ISCHAEMIA,17
IE,OCULAR HYPERAEMIA,17
IE,ORAL PAIN,17
IE,PAIN IN JAW,17
IE,PANCREATITIS,17
IE,PERIPHERAL COLDNESS,17
IE,RASH MACULAR,17
IE,SUICIDE ATTEMPT,17
IE,TACHYPNOEA,17
IE,TOOTH ABSCESS,17
IE,TOOTH DISORDER,17
IE,URINARY INCONTINENCE,17
IE,ARRHYTHMIA,16
IE,ATAXIA,16
IE,CANDIDA INFECTION,16
IE,CONJUNCTIVITIS,16
IE,DIVERTICULITIS,16
IE,EAR PAIN,16
IE,FACIAL PARALYSIS,16
IE,INCORRECT DRUG ADMINISTRATION DURATION,16
IE,LIVER DISORDER,16
IE,METASTASES TO CENTRAL NERVOUS SYSTEM,16
IE,MUSCLE TWITCHING,16
IE,NEURALGIA,16
IE,PARANOIA,16
IE,POOR FEEDING INFANT,16
IE,RESPIRATORY DISTRESS,16
IE,RESTLESSNESS,16
IE,SKIN EXFOLIATION,16
IE,SPINAL CORD COMPRESSION,16
IE,UPPER GASTROINTESTINAL HAEMORRHAGE,16
IE,VAGINAL HAEMORRHAGE,16
IE,ABDOMINAL PAIN LOWER,15
IE,ASPIRATION,15
IE,BLOOD SODIUM DECREASED,15
IE,BLOOD TEST ABNORMAL,15
IE,DIABETES MELLITUS INADEQUATE CONTROL,15
IE,EYE INFECTION,15
IE,HAEMATOCHEZIA,15
IE,HEPATITIS,15
IE,HYPERTHYROIDISM,15
IE,INFLAMMATION,15
IE,MANIA,15
IE,METASTATIC RENAL CELL CARCINOMA,15
IE,MOOD ALTERED,15
IE,NEPHROLITHIASIS,15
IE,PULMONARY MASS,15
IE,RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE,15
IE,RESPIRATORY TRACT CONGESTION,15
IE,SINUS TACHYCARDIA,15
IE,SYSTEMIC LUPUS ERYTHEMATOSUS,15
IE,UPPER LIMB FRACTURE,15
IE,ABSCESS,14
IE,APHASIA,14
IE,BLOOD BILIRUBIN INCREASED,14
IE,BLOOD GLUCOSE DECREASED,14
IE,BLOOD URINE PRESENT,14
IE,CHOKING,14
IE,COAGULOPATHY,14
IE,DEMENTIA,14
IE,DEPRESSED LEVEL OF CONSCIOUSNESS,14
IE,DEVICE DISLOCATION,14
IE,DEVICE FAILURE,14
IE,DRUG ADMINISTRATION ERROR,14
IE,DRUG DEPENDENCE,14
IE,DRUG EFFECT DECREASED,14
IE,DRUG PRESCRIBING ERROR,14
IE,HYPERKALAEMIA,14
IE,HYPOTHYROIDISM,14
IE,IRON DEFICIENCY ANAEMIA,14
IE,LACTIC ACIDOSIS,14
IE,LEUKOCYTOSIS,14
IE,LIMB DISCOMFORT,14
IE,METASTASES TO LUNG,14
IE,MULTI-ORGAN FAILURE,14
IE,ORAL CANDIDIASIS,14
IE,OVARIAN CYST,14
IE,PULMONARY CONGESTION,14
IE,PULMONARY FIBROSIS,14
IE,PULMONARY HYPERTENSION,14
IE,RESPIRATORY SYNCYTIAL VIRUS INFECTION,14
IE,SENSORY DISTURBANCE,14
IE,THROAT IRRITATION,14
IE,VENTRICULAR TACHYCARDIA,14
IE,WITHDRAWAL SYNDROME,14
IE,BLINDNESS,13
IE,BLOOD IRON DECREASED,13
IE,BLOOD POTASSIUM DECREASED,13
IE,CARDIOMYOPATHY,13
IE,CATARACT,13
IE,DIPLOPIA,13
IE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,13
IE,FLATULENCE,13
IE,FREQUENT BOWEL MOVEMENTS,13
IE,GENERAL PHYSICAL CONDITION ABNORMAL,13
IE,GLOMERULAR FILTRATION RATE DECREASED,13
IE,GOUT,13
IE,GROIN PAIN,13
IE,HEPATIC FUNCTION ABNORMAL,13
IE,HEPATITIS C,13
IE,HYPOTONIA,13
IE,INFLAMMATORY BOWEL DISEASE,13
IE,INTESTINAL PERFORATION,13
IE,INTESTINAL RESECTION,13
IE,LOCALISED INFECTION,13
IE,MASS,13
IE,METABOLIC ACIDOSIS,13
IE,METASTASES TO BONE,13
IE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,13
IE,PREMATURE DELIVERY,13
IE,RESPIRATORY ARREST,13
IE,AUTISM SPECTRUM DISORDER,12
IE,COELIAC DISEASE,12
IE,DEAFNESS,12
IE,DEVICE ISSUE,12
IE,DRUG DISPENSING ERROR,12
IE,DYSTONIA,12
IE,FAECALOMA,12
IE,FLUID RETENTION,12
IE,GASTROINTESTINAL CARCINOMA,12
IE,GASTROINTESTINAL INFECTION,12
IE,HALLUCINATION_ AUDITORY,12
IE,HYPOCALCAEMIA,12
IE,ILL-DEFINED DISORDER,12
IE,INJECTION SITE SWELLING,12
IE,JOINT DISLOCATION,12
IE,METASTASES TO LIVER,12
IE,MULTI-ORGAN DISORDER,12
IE,MYOCARDITIS,12
IE,NEOPLASM,12
IE,NORMAL NEWBORN,12
IE,OEDEMA,12
IE,OPTIC NEURITIS,12
IE,PERICARDIAL EFFUSION,12
IE,PNEUMOTHORAX,12
IE,SINUS DISORDER,12
IE,SKIN DISORDER,12
IE,TREATMENT FAILURE,12
IE,TUBERCULOSIS,12
IE,WOUND INFECTION,12
IE,ACCIDENTAL EXPOSURE TO PRODUCT,11
IE,ANKLE FRACTURE,11
IE,BLOOD CALCIUM DECREASED,11
IE,BLOOD PRESSURE ABNORMAL,11
IE,BONE MARROW FAILURE,11
IE,BRAIN NEOPLASM,11
IE,COLECTOMY,11
IE,COORDINATION ABNORMAL,11
IE,DIABETES MELLITUS,11
IE,DUODENAL ULCER PERFORATION,11
IE,EJECTION FRACTION DECREASED,11
IE,ENTEROCOCCAL INFECTION,11
IE,ERECTILE DYSFUNCTION,11
IE,EYE DISORDER,11
IE,GALACTORRHOEA,11
IE,HEART RATE DECREASED,11
IE,HIP ARTHROPLASTY,11
IE,HYPERGLYCAEMIA,11
IE,HYPERPARATHYROIDISM,11
IE,HYPOMAGNESAEMIA,11
IE,HYPOMANIA,11
IE,INCONTINENCE,11
IE,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,11
IE,INJECTION SITE REACTION,11
IE,INTENTIONAL PRODUCT MISUSE,11
IE,LACRIMATION INCREASED,11
IE,LIMB INJURY,11
IE,LIVER INJURY,11
IE,LUNG CONSOLIDATION,11
IE,MOOD SWINGS,11
IE,MUSCLE ATROPHY,11
IE,MUSCLE RIGIDITY,11
IE,MUSCULOSKELETAL CHEST PAIN,11
IE,MYOPATHY,11
IE,ON AND OFF PHENOMENON,11
IE,ORAL HERPES,11
IE,OSTEONECROSIS,11
IE,PHOTOPHOBIA,11
IE,PRESCRIBED UNDERDOSE,11
IE,PSYCHOMOTOR HYPERACTIVITY,11
IE,REBOUND EFFECT,11
IE,RESPIRATORY DEPRESSION,11
IE,SALIVARY HYPERSECRETION,11
IE,SEPTIC SHOCK,11
IE,SKIN BURNING SENSATION,11
IE,SKIN FISSURES,11
IE,SNEEZING,11
IE,SPINAL FRACTURE,11
IE,TROPONIN INCREASED,11
IE,UVEITIS,11
IE,VIITH NERVE PARALYSIS,11
IE,VIRAL UPPER RESPIRATORY TRACT INFECTION,11
IE,BODY TEMPERATURE DECREASED,10
IE,CATATONIA,10
IE,COMA,10
IE,CUTANEOUS LUPUS ERYTHEMATOSUS,10
IE,CYST,10
IE,CYSTITIS,10
IE,DEVELOPMENTAL DELAY,10
IE,DIABETES INSIPIDUS,10
IE,DISEASE RECURRENCE,10
IE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,10
IE,EXPOSURE DURING BREAST FEEDING,10
IE,EYE PRURITUS,10
IE,FEEDING DISORDER,10
IE,GESTATIONAL DIABETES,10
IE,HEPATOTOXICITY,10
IE,HYPERCALCAEMIA,10
IE,ISCHAEMIC STROKE,10
IE,JOINT STIFFNESS,10
IE,LYMPHOEDEMA,10
IE,MENINGITIS,10
IE,MENORRHAGIA,10
IE,METASTATIC NEOPLASM,10
IE,MYELODYSPLASTIC SYNDROME,10
IE,NO THERAPEUTIC RESPONSE,10
IE,OESOPHAGEAL CARCINOMA,10
IE,PANCREATIC CARCINOMA,10
IE,POST PROCEDURAL COMPLICATION,10
IE,PREGNANCY,10
IE,RHINITIS,10
IE,SECOND PRIMARY MALIGNANCY,10
IE,SENSATION OF FOREIGN BODY,10
IE,STOMA SITE DISCHARGE,10
IE,UNDERDOSE,10
IE,ABDOMINAL TENDERNESS,9
IE,ABNORMAL DREAMS,9
IE,ACUTE MYELOID LEUKAEMIA,9
IE,ADVERSE REACTION,9
IE,B-CELL LYMPHOMA,9
IE,BLOOD COUNT ABNORMAL,9
IE,BLOOD PROLACTIN INCREASED,9
IE,BONE DISORDER,9
IE,BRONCHOPNEUMONIA,9
IE,CARDIAC FLUTTER,9
IE,CARPAL TUNNEL SYNDROME,9
IE,DEVICE DIFFICULT TO USE,9
IE,DEVICE MALFUNCTION,9
IE,DROOLING,9
IE,DUODENITIS,9
IE,DYSSTASIA,9
IE,EOSINOPHILIA,9
IE,ERYTHEMA MULTIFORME,9
IE,EYELID OEDEMA,9
IE,FAECES DISCOLOURED,9
IE,FEAR,9
IE,FORMICATION,9
IE,GASTROINTESTINAL TUBE INSERTION,9
IE,GYNAECOMASTIA,9
IE,HAEMOGLOBIN INCREASED,9
IE,HEPATIC NECROSIS,9
IE,IMMUNE THROMBOCYTOPENIC PURPURA,9
IE,INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS,9
IE,INTENTIONAL SELF-INJURY,9
IE,INVESTIGATION,9
IE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,9
IE,LEFT VENTRICULAR HYPERTROPHY,9
IE,MIGRAINE,9
IE,NECROTISING FASCIITIS,9
IE,NERVOUS SYSTEM DISORDER,9
IE,NEUROLEPTIC MALIGNANT SYNDROME,9
IE,NEUROMYOPATHY,9
IE,NO ADVERSE EVENT,9
IE,PELVIC PAIN,9
IE,PNEUMONIA KLEBSIELLA,9
IE,PORTAL HYPERTENSION,9
IE,PROSTATIC SPECIFIC ANTIGEN INCREASED,9
IE,PULMONARY SEPSIS,9
IE,RASH MACULO-PAPULAR,9
IE,RETCHING,9
IE,SEXUAL DYSFUNCTION,9
IE,SKIN REACTION,9
IE,SQUAMOUS CELL CARCINOMA,9
IE,SUBARACHNOID HAEMORRHAGE,9
IE,TENDON RUPTURE,9
IE,THERAPEUTIC RESPONSE DECREASED,9
IE,TRANSAMINASES INCREASED,9
IE,ULCER,9
IE,UROSEPSIS,9
IE,VISUAL FIELD DEFECT,9
IE,ACCIDENT,8
IE,ACNE,8
IE,ACTIVITIES OF DAILY LIVING IMPAIRED,8
IE,ACUTE PSYCHOSIS,8
IE,ADRENAL SUPPRESSION,8
IE,AGEUSIA,8
IE,AGRANULOCYTOSIS,8
IE,ALTERED STATE OF CONSCIOUSNESS,8
IE,AMENORRHOEA,8
IE,ANGER,8
IE,ANGLE CLOSURE GLAUCOMA,8
IE,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,8
IE,ANTIPSYCHOTIC DRUG LEVEL DECREASED,8
IE,APATHY,8
IE,APNOEA,8
IE,BASAL CELL CARCINOMA,8
IE,BIPOLAR DISORDER,8
IE,BLINDNESS UNILATERAL,8
IE,BLOOD CALCIUM INCREASED,8
IE,BLOOD MAGNESIUM DECREASED,8
IE,BLOOD PARATHYROID HORMONE INCREASED,8
IE,BLOOD POTASSIUM INCREASED,8
IE,BODY TEMPERATURE ABNORMAL,8
IE,BREAST PAIN,8
IE,BUNDLE BRANCH BLOCK LEFT,8
IE,CARDIOMEGALY,8
IE,CHOLECYSTITIS ACUTE,8
IE,CHOLESTASIS,8
IE,DECUBITUS ULCER,8
IE,DERMATITIS,8
IE,DEVICE OCCLUSION,8
IE,DRY EYE,8
IE,DYSMORPHISM,8
IE,DYSPRAXIA,8
IE,ENDOTHELIAL DYSFUNCTION,8
IE,ESCHERICHIA INFECTION,8
IE,EYE MOVEMENT DISORDER,8
IE,FACE OEDEMA,8
IE,FISTULA,8
IE,FUNGAL INFECTION,8
IE,GASTROSTOMY,8
IE,GINGIVAL PAIN,8
IE,H1N1 INFLUENZA,8
IE,HAEMATOCRIT DECREASED,8
IE,HALLUCINATION_ VISUAL,8
IE,HEPATIC STEATOSIS,8
IE,HIATUS HERNIA,8
IE,HIDRADENITIS,8
IE,HYDROCEPHALUS,8
IE,HYPOKINESIA,8
IE,INGUINAL HERNIA,8
IE,INTENTIONAL PRODUCT USE ISSUE,8
IE,INTERVERTEBRAL DISC PROTRUSION,8
IE,INTESTINAL ISCHAEMIA,8
IE,JC VIRUS INFECTION,8
IE,LARYNGOSPASM,8
IE,LOW BIRTH WEIGHT BABY,8
IE,LYMPHOCYTE COUNT INCREASED,8
IE,METASTASIS,8
IE,MOVEMENT DISORDER,8
IE,NEPHROTIC SYNDROME,8
IE,NERVE COMPRESSION,8
IE,OCULOGYRIC CRISIS,8
IE,OESOPHAGITIS,8
IE,PANCREATITIS ACUTE,8
IE,PANIC REACTION,8
IE,PARKINSONISM,8
IE,PERICARDITIS,8
IE,PERIPHERAL ISCHAEMIA,8
IE,PERSONALITY CHANGE,8
IE,PLEURITIC PAIN,8
IE,POOR VENOUS ACCESS,8
IE,POST PROCEDURAL HAEMORRHAGE,8
IE,PROTEINURIA,8
IE,PRURITUS GENERALISED,8
IE,PSORIATIC ARTHROPATHY,8
IE,RIB FRACTURE,8
IE,SMALL INTESTINAL OBSTRUCTION,8
IE,STOMA SITE ERYTHEMA,8
IE,THERAPEUTIC RESPONSE UNEXPECTED,8
IE,THIRST,8
IE,UNINTENDED PREGNANCY,8
IE,VITAMIN B12 DEFICIENCY,8
IE,WOUND SECRETION,8
IE,ADRENAL INSUFFICIENCY,7
IE,AKATHISIA,7
IE,ANAL ABSCESS,7
IE,ANAPHYLACTOID REACTION,7
IE,ANKYLOGLOSSIA CONGENITAL,7
IE,ATRIAL FLUTTER,7
IE,BLOOD PRESSURE FLUCTUATION,7
IE,BLOOD PRESSURE SYSTOLIC INCREASED,7
IE,BRAIN INJURY,7
IE,CALCIPHYLAXIS,7
IE,CARBOHYDRATE ANTIGEN 15-3 INCREASED,7
IE,CARDIAC FAILURE ACUTE,7
IE,CARDIAC PACEMAKER INSERTION,7
IE,CARDIOGENIC SHOCK,7
IE,CHOREOATHETOSIS,7
IE,CHROMATURIA,7
IE,COLON CANCER,7
IE,COMA SCALE ABNORMAL,7
IE,COMPLICATION ASSOCIATED WITH DEVICE,7
IE,CONGESTIVE CARDIOMYOPATHY,7
IE,CONTRAINDICATED PRODUCT ADMINISTERED,7
IE,CYTOMEGALOVIRUS INFECTION,7
IE,DELUSION,7
IE,DEMYELINATION,7
IE,DEVICE BREAKAGE,7
IE,DIALYSIS,7
IE,DYSPNOEA EXERTIONAL,7
IE,EMOTIONAL DISORDER,7
IE,EOSINOPHILIC MYOCARDITIS,7
IE,EYE INFLAMMATION,7
IE,EYELID PTOSIS,7
IE,FAECAL INCONTINENCE,7
IE,FOETAL DEATH,7
IE,FOETAL DISTRESS SYNDROME,7
IE,FOOT DEFORMITY,7
IE,GASTRIC ULCER,7
IE,GASTROENTERITIS VIRAL,7
IE,GINGIVAL ABSCESS,7
IE,GOITRE,7
IE,GRAND MAL CONVULSION,7
IE,HAEMORRHOIDS,7
IE,HEARING IMPAIRED,7
IE,HOT FLUSH,7
IE,HYDRONEPHROSIS,7
IE,HYPERSOMNIA,7
IE,HYPOACUSIS,7
IE,HYPOAESTHESIA ORAL,7
IE,ILEAL STENOSIS,7
IE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,7
IE,IMMUNODEFICIENCY,7
IE,INJECTION SITE HAEMORRHAGE,7
IE,INJURY,7
IE,INTENTIONAL DRUG MISUSE,7
IE,INTERNAL HAEMORRHAGE,7
IE,INTERSTITIAL LUNG DISEASE,7
IE,INTESTINAL OPERATION,7
IE,IRRITABLE BOWEL SYNDROME,7
IE,LIMB MASS,7
IE,LIP OEDEMA,7
IE,LOWER LIMB FRACTURE,7
IE,MACULAR OEDEMA,7
IE,MATERNAL DRUGS AFFECTING FOETUS,7
IE,MEDICAL DEVICE COMPLICATION,7
IE,METASTATIC MALIGNANT MELANOMA,7
IE,MONOCYTE COUNT INCREASED,7
IE,MOTOR DYSFUNCTION,7
IE,MYDRIASIS,7
IE,MYOCLONUS,7
IE,MYOSITIS,7
IE,NASAL OBSTRUCTION,7
IE,NEONATAL RESPIRATORY DISTRESS SYNDROME,7
IE,NON-HODGKIN^S LYMPHOMA,7
IE,OSTEOARTHRITIS,7
IE,PAIN OF SKIN,7
IE,PARADOXICAL DRUG REACTION,7
IE,PELVIC FRACTURE,7
IE,PERIORBITAL OEDEMA,7
IE,PERITONITIS,7
IE,PHARYNGEAL OEDEMA,7
IE,PHOTOSENSITIVITY REACTION,7
IE,PNEUMONITIS,7
IE,POSTOPERATIVE WOUND INFECTION,7
IE,PULSE ABNORMAL,7
IE,RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS,7
IE,RETINAL TOXICITY,7
IE,RETROPERITONEAL FIBROSIS,7
IE,SKIN INFECTION,7
IE,SPINAL PAIN,7
IE,SPUTUM DISCOLOURED,7
IE,STEVENS-JOHNSON SYNDROME,7
IE,STILLBIRTH,7
IE,STOMA SITE INFECTION,7
IE,STOMA SITE PAIN,7
IE,SYNDACTYLY,7
IE,THINKING ABNORMAL,7
IE,TOOTHACHE,7
IE,TOXIC EPIDERMAL NECROLYSIS,7
IE,TYPE 1 DIABETES MELLITUS,7
IE,VASCULITIS,7
IE,WOUND,7
IE,WRIST FRACTURE,7
IE,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,6
IE,ACUTE RESPIRATORY DISTRESS SYNDROME,6
IE,ADRENOCORTICAL INSUFFICIENCY ACUTE,6
IE,ANAPHYLACTIC SHOCK,6
IE,ANGINA PECTORIS,6
IE,ANGIOPATHY,6
IE,ANKYLOSING SPONDYLITIS,6
IE,ARTERIOSCLEROSIS CORONARY ARTERY,6
IE,ATYPICAL FEMUR FRACTURE,6
IE,BLADDER CANCER,6
IE,BLOOD ALBUMIN DECREASED,6
IE,BLOOD LACTATE DEHYDROGENASE INCREASED,6
IE,BREAST MASS,6
IE,BRONCHIECTASIS,6
IE,CARCINOID CRISIS,6
IE,CENTRAL VENOUS CATHETERISATION,6
IE,CHOLECYSTITIS,6
IE,CHRONIC LYMPHOCYTIC LEUKAEMIA,6
IE,COMPLICATION OF DEVICE REMOVAL,6
IE,COMPULSIVE SHOPPING,6
IE,CONGENITAL CORONARY ARTERY MALFORMATION,6
IE,CREATININE RENAL CLEARANCE DECREASED,6
IE,CUSHINGOID,6
IE,DEAFNESS UNILATERAL,6
IE,DELAYED RECOVERY FROM ANAESTHESIA,6
IE,DEVICE LEAKAGE,6
IE,DIAPHRAGMATIC DISORDER,6
IE,DRUG LEVEL INCREASED,6
IE,EAR DISCOMFORT,6
IE,ELECTROCARDIOGRAM ABNORMAL,6
IE,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,6
IE,EMBOLISM,6
IE,ERUCTATION,6
IE,EXTRA DOSE ADMINISTERED,6
IE,FLANK PAIN,6
IE,FRACTURE,6
IE,GASTRIC INFECTION,6
IE,GASTROENTERITIS NOROVIRUS,6
IE,HAEMOLYSIS,6
IE,HAEMORRHAGE IN PREGNANCY,6
IE,HAND FRACTURE,6
IE,HEPATIC ENZYME ABNORMAL,6
IE,HEPATOCELLULAR CARCINOMA,6
IE,HICCUPS,6
IE,HYPERSEXUALITY,6
IE,HYPOGLYCAEMIA NEONATAL,6
IE,IMPAIRED QUALITY OF LIFE,6
IE,IMPULSE-CONTROL DISORDER,6
IE,IMPULSIVE BEHAVIOUR,6
IE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,6
IE,INJECTION SITE BRUISING,6
IE,INVASIVE DUCTAL BREAST CARCINOMA,6
IE,JOINT ANKYLOSIS,6
IE,KNEE ARTHROPLASTY,6
IE,LUPUS-LIKE SYNDROME,6
IE,MEAN CELL HAEMOGLOBIN INCREASED,6
IE,MENINGITIS ASEPTIC,6
IE,MULTIPLE FRACTURES,6
IE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,6
IE,NERVOUSNESS,6
IE,NEUTROPHILIA,6
IE,OESOPHAGEAL CANDIDIASIS,6
IE,ORAL MUCOSAL BLISTERING,6
IE,OVARIAN CYST RUPTURED,6
IE,PARALYSIS,6
IE,PETIT MAL EPILEPSY,6
IE,PHARYNGEAL ERYTHEMA,6
IE,POOR QUALITY SLEEP,6
IE,POSTPARTUM HAEMORRHAGE,6
IE,PROSTATOMEGALY,6
IE,PSYCHIATRIC SYMPTOM,6
IE,PULMONARY TUBERCULOSIS,6
IE,PURPURA,6
IE,RESPIRATORY TRACT INFECTION VIRAL,6
IE,RESTLESS LEGS SYNDROME,6
IE,RETINAL HAEMORRHAGE,6
IE,SCAR,6
IE,SENSORY LOSS,6
IE,SERUM FERRITIN INCREASED,6
IE,SKIN HYPERPIGMENTATION,6
IE,SKIN IRRITATION,6
IE,SKIN PLAQUE,6
IE,STATUS EPILEPTICUS,6
IE,SUBDURAL HAEMORRHAGE,6
IE,TEARFULNESS,6
IE,THERAPY NON-RESPONDER,6
IE,TRANSFUSION,6
IE,ULCERATIVE KERATITIS,6
IE,VEIN DISORDER,6
IE,WRONG DRUG ADMINISTERED,6
IE,ABSCESS LIMB,5
IE,ANAEMIA MACROCYTIC,5
IE,ANAEMIA MEGALOBLASTIC,5
IE,ASPERGILLUS INFECTION,5
IE,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,5
IE,ASTERIXIS,5
IE,AUTOIMMUNE HEPATITIS,5
IE,AXILLARY MASS,5
IE,BEDRIDDEN,5
IE,BLOOD CREATINE INCREASED,5
IE,BLOOD DISORDER,5
IE,BLOOD GLUCOSE ABNORMAL,5
IE,BODY MASS INDEX INCREASED,5
IE,BREAST CANCER FEMALE,5
IE,BREATH SOUNDS ABNORMAL,5
IE,CACHEXIA,5
IE,CEREBRAL PALSY,5
IE,CHRONIC KIDNEY DISEASE,5
IE,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,5
IE,CLOSTRIDIUM DIFFICILE INFECTION,5
IE,COLORECTAL CANCER METASTATIC,5
IE,COMPLICATIONS OF TRANSPLANTED LIVER,5
IE,CUSHING^S SYNDROME,5
IE,DEMENTIA ALZHEIMER^S TYPE,5
IE,DEPENDENCE,5
IE,DERMATITIS ACNEIFORM,5
IE,DERMATITIS ALLERGIC,5
IE,DERMATITIS BULLOUS,5
IE,DERMATITIS CONTACT,5
IE,DEVICE KINK,5
IE,DIARRHOEA HAEMORRHAGIC,5
IE,DIVERTICULUM,5
IE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,5
IE,DRUG SPECIFIC ANTIBODY PRESENT,5
IE,DUODENAL ULCER,5
IE,ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE,5
IE,ELECTROCARDIOGRAM T WAVE INVERSION,5
IE,ENCEPHALITIS,5
IE,EOSINOPHILIC PNEUMONIA,5
IE,EUPHORIC MOOD,5
IE,EXERCISE TOLERANCE DECREASED,5
IE,EYE IRRITATION,5
IE,FEAR OF DEATH,5
IE,FEAR OF INJECTION,5
IE,FIBRIN D DIMER INCREASED,5
IE,FOCAL DYSCOGNITIVE SEIZURES,5
IE,FOOT FRACTURE,5
IE,GALLBLADDER DISORDER,5
IE,GASTROINTESTINAL NECROSIS,5
IE,GENITAL HAEMORRHAGE,5
IE,GINGIVAL BLEEDING,5
IE,GLAUCOMA,5
IE,HAEMATOTOXICITY,5
IE,HEPATIC CONGESTION,5
IE,HYPERNATRAEMIA,5
IE,HYPOTHALAMO-PITUITARY DISORDER,5
IE,HYPOTHERMIA,5
IE,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,5
IE,IMMUNE SYSTEM DISORDER,5
IE,IMMUNE-MEDIATED NECROTISING MYOPATHY,5
IE,IMMUNOSUPPRESSION,5
IE,IMPAIRED DRIVING ABILITY,5
IE,INCREASED APPETITE,5
IE,INCREASED TENDENCY TO BRUISE,5
IE,INJECTION SITE CELLULITIS,5
IE,INJECTION SITE INDURATION,5
IE,INJECTION SITE PRURITUS,5
IE,INTERVERTEBRAL DISC DISORDER,5
IE,ISCHAEMIA,5
IE,JAUNDICE CHOLESTATIC,5
IE,JOINT INJURY,5
IE,LARGE INTESTINE PERFORATION,5
IE,LARYNGITIS,5
IE,LATENT TUBERCULOSIS,5
IE,LEARNING DISORDER,5
IE,LEFT VENTRICULAR DYSFUNCTION,5
IM,ABORTION SPONTANEOUS,1
IM,BACK PAIN,1
IM,CHEST PAIN,1
IM,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IM,DIZZINESS,1
IM,DYSPNOEA,1
IM,ERYTHEMA,1
IM,HYPERSENSITIVITY,1
IM,MUSCULOSKELETAL DISORDER,1
IM,NAUSEA,1
IM,NEUROPATHY PERIPHERAL,1
IL,ASTHENIA,595
IL,PYREXIA,557
IL,DEATH,510
IL,DYSPNOEA,447
IL,DIARRHOEA,377
IL,DRUG INEFFECTIVE,370
IL,FALL,339
IL,VOMITING,328
IL,NAUSEA,325
IL,ABDOMINAL PAIN,313
IL,PNEUMONIA,311
IL,FATIGUE,287
IL,DIZZINESS,265
IL,HAEMOGLOBIN DECREASED,263
IL,PAIN,241
IL,HEADACHE,231
IL,DISEASE PROGRESSION,211
IL,DECREASED APPETITE,204
IL,ANAEMIA,196
IL,PAIN IN EXTREMITY,195
IL,WEIGHT DECREASED,192
IL,MALIGNANT NEOPLASM PROGRESSION,188
IL,RASH,178
IL,CEREBROVASCULAR ACCIDENT,175
IL,RENAL FAILURE,172
IL,THROMBOCYTOPENIA,171
IL,ARTHRALGIA,170
IL,SEPSIS,162
IL,GENERAL PHYSICAL HEALTH DETERIORATION,160
IL,NEUTROPENIA,160
IL,MALAISE,157
IL,GAIT DISTURBANCE,156
IL,FOETAL EXPOSURE DURING PREGNANCY,155
IL,CONDITION AGGRAVATED,150
IL,BACK PAIN,149
IL,FEELING ABNORMAL,144
IL,HYPERTENSION,144
IL,PRURITUS,144
IL,CHEST PAIN,140
IL,URINARY TRACT INFECTION,140
IL,COUGH,135
IL,SYNCOPE,135
IL,PANCYTOPENIA,128
IL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,125
IL,LOSS OF CONSCIOUSNESS,124
IL,INFECTION,115
IL,TOXICITY TO VARIOUS AGENTS,115
IL,EXPOSURE DURING PREGNANCY,113
IL,ERYTHEMA,111
IL,HEPATIC ENZYME INCREASED,106
IL,CHILLS,104
IL,CONFUSIONAL STATE,104
IL,OEDEMA PERIPHERAL,104
IL,CONSTIPATION,103
IL,MUSCULAR WEAKNESS,101
IL,RENAL IMPAIRMENT,97
IL,ABDOMINAL PAIN UPPER,96
IL,MYOCARDIAL INFARCTION,96
IL,FEBRILE NEUTROPENIA,95
IL,OSTEONECROSIS OF JAW,93
IL,CROHN^S DISEASE,91
IL,BLOOD GLUCOSE INCREASED,89
IL,HAEMORRHAGE,89
IL,ACUTE KIDNEY INJURY,88
IL,MYALGIA,88
IL,PULMONARY EMBOLISM,88
IL,INTESTINAL OBSTRUCTION,87
IL,MATERNAL EXPOSURE DURING PREGNANCY,87
IL,BLOOD CREATININE INCREASED,84
IL,PRODUCT USE ISSUE,83
IL,PSORIASIS,83
IL,ATRIAL FIBRILLATION,82
IL,CARDIAC FAILURE,81
IL,HYPERSENSITIVITY,81
IL,GASTROINTESTINAL HAEMORRHAGE,80
IL,PULMONARY OEDEMA,77
IL,DEPRESSION,76
IL,DEEP VEIN THROMBOSIS,75
IL,PERIPHERAL SWELLING,75
IL,ASCITES,74
IL,INFUSION RELATED REACTION,74
IL,PARAESTHESIA,74
IL,SEIZURE,74
IL,HYPOTENSION,73
IL,DIABETIC KETOACIDOSIS,71
IL,DYSPHAGIA,70
IL,VISION BLURRED,70
IL,ABORTION SPONTANEOUS,68
IL,ARRHYTHMIA,68
IL,LUNG INFILTRATION,68
IL,MUCOSAL INFLAMMATION,68
IL,EPISTAXIS,67
IL,WEIGHT INCREASED,67
IL,LEUKOPENIA,64
IL,MULTIPLE SCLEROSIS RELAPSE,63
IL,SEPTIC SHOCK,63
IL,HYPONATRAEMIA,61
IL,PLATELET COUNT DECREASED,61
IL,TREMOR,61
IL,BLOOD PRESSURE INCREASED,60
IL,CHEST DISCOMFORT,60
IL,BALANCE DISORDER,59
IL,DEHYDRATION,59
IL,CARDIAC ARREST,58
IL,URINARY RETENTION,58
IL,INJECTION SITE PAIN,57
IL,PLEURAL EFFUSION,56
IL,PNEUMONITIS,56
IL,RESPIRATORY FAILURE,56
IL,ABDOMINAL DISTENSION,55
IL,BONE PAIN,55
IL,HYPOAESTHESIA,55
IL,INSOMNIA,54
IL,PLASMA CELL MYELOMA,54
IL,RENAL FAILURE ACUTE,54
IL,SPEECH DISORDER,54
IL,CARDIAC FAILURE CONGESTIVE,53
IL,JOINT SWELLING,53
IL,BREAST CANCER,51
IL,HEAD INJURY,51
IL,OEDEMA,51
IL,PALPITATIONS,51
IL,PRODUCT USE IN UNAPPROVED INDICATION,51
IL,HAEMATOMA,50
IL,OROPHARYNGEAL PAIN,50
IL,CEREBRAL HAEMORRHAGE,49
IL,DRY MOUTH,49
IL,SOMNOLENCE,49
IL,MUSCULOSKELETAL PAIN,48
IL,OXYGEN SATURATION DECREASED,48
IL,WHITE BLOOD CELL COUNT DECREASED,48
IL,BLOOD BILIRUBIN INCREASED,47
IL,CELLULITIS,47
IL,DYSGEUSIA,47
IL,SWELLING FACE,47
IL,ARTHRITIS,46
IL,HIP FRACTURE,46
IL,MUSCLE SPASMS,46
IL,PANCREATIC CARCINOMA,46
IL,HYPOGLYCAEMIA,45
IL,ACUTE MYELOID LEUKAEMIA,44
IL,BLOOD PRESSURE DECREASED,44
IL,CARDIAC DISORDER,44
IL,DRY SKIN,44
IL,LYMPHADENOPATHY,44
IL,PANCREATITIS,44
IL,ANXIETY,43
IL,INFLUENZA,43
IL,JAUNDICE,43
IL,MULTI-ORGAN FAILURE,43
IL,RASH GENERALISED,43
IL,VISUAL IMPAIRMENT,43
IL,OVERDOSE,42
IL,RECTAL HAEMORRHAGE,42
IL,SKIN LESION,42
IL,ALOPECIA,41
IL,ENCEPHALOPATHY,41
IL,HYPERHIDROSIS,41
IL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,41
IL,NEUROPATHY PERIPHERAL,41
IL,BURNING SENSATION,39
IL,HEART RATE INCREASED,39
IL,HEPATIC FUNCTION ABNORMAL,39
IL,STOMATITIS,39
IL,CENTRAL NERVOUS SYSTEM LESION,38
IL,DYSPEPSIA,38
IL,HEPATIC FAILURE,38
IL,MEMORY IMPAIRMENT,38
IL,TACHYCARDIA,38
IL,DEPRESSED MOOD,37
IL,DRUG DOSE OMISSION,37
IL,EPILEPSY,37
IL,HAEMATURIA,37
IL,INTERNATIONAL NORMALISED RATIO INCREASED,37
IL,INTERSTITIAL LUNG DISEASE,37
IL,NASOPHARYNGITIS,37
IL,PRURITUS GENERALISED,37
IL,RESPIRATORY DISORDER,37
IL,DRUG EFFECT DECREASED,36
IL,PSYCHOTIC DISORDER,36
IL,COGNITIVE DISORDER,35
IL,DYSURIA,35
IL,GASTROINTESTINAL INFLAMMATION,35
IL,HAEMATOCHEZIA,35
IL,TRANSIENT ISCHAEMIC ATTACK,35
IL,ASPARTATE AMINOTRANSFERASE INCREASED,34
IL,SPLENOMEGALY,34
IL,CONTUSION,33
IL,DRUG HYPERSENSITIVITY,33
IL,HAEMORRHAGE INTRACRANIAL,33
IL,HEPATOTOXICITY,33
IL,INCORRECT DOSE ADMINISTERED,33
IL,ISCHAEMIC STROKE,33
IL,ORAL PAIN,33
IL,SWELLING,33
IL,VIRAL INFECTION,33
IL,WOUND,33
IL,ACUTE MYOCARDIAL INFARCTION,32
IL,CHOLELITHIASIS,32
IL,HEPATIC CIRRHOSIS,32
IL,HOSPITALISATION,32
IL,MOBILITY DECREASED,32
IL,NEPHROPATHY TOXIC,32
IL,PREMATURE BABY,32
IL,SECOND PRIMARY MALIGNANCY,32
IL,BLOOD LACTATE DEHYDROGENASE INCREASED,31
IL,DYSSTASIA,31
IL,INFLAMMATION,31
IL,INFLUENZA LIKE ILLNESS,31
IL,MELAENA,31
IL,PROTEINURIA,31
IL,THROMBOSIS,31
IL,WHITE BLOOD CELL COUNT INCREASED,31
IL,ABDOMINAL PAIN LOWER,30
IL,ALANINE AMINOTRANSFERASE INCREASED,30
IL,C-REACTIVE PROTEIN INCREASED,30
IL,DIABETES MELLITUS,30
IL,HAEMOPTYSIS,30
IL,METABOLIC ACIDOSIS,30
IL,METASTASES TO LIVER,30
IL,SKIN DISCOLOURATION,30
IL,ABDOMINAL DISCOMFORT,29
IL,BRADYCARDIA,29
IL,COLITIS,29
IL,LYMPHOPENIA,29
IL,MUSCULOSKELETAL STIFFNESS,29
IL,PERICARDIAL EFFUSION,29
IL,PULMONARY HYPERTENSION,29
IL,RENAL CELL CARCINOMA,29
IL,SUICIDE ATTEMPT,29
IL,CATARACT,28
IL,FREQUENT BOWEL MOVEMENTS,28
IL,GASTROENTERITIS,28
IL,HAEMATEMESIS,28
IL,LYMPHOMA,28
IL,PRESCRIBED UNDERDOSE,28
IL,PSORIATIC ARTHROPATHY,28
IL,RHEUMATOID ARTHRITIS,28
IL,URTICARIA,28
IL,UVEITIS,28
IL,BRONCHITIS,27
IL,DYSPHONIA,27
IL,FACE OEDEMA,27
IL,LEUKOCYTOSIS,27
IL,NEUTROPHIL COUNT DECREASED,27
IL,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,27
IL,PARKINSON^S DISEASE,27
IL,SKIN EXFOLIATION,27
IL,VISUAL ACUITY REDUCED,27
IL,AMNESIA,26
IL,BACTERAEMIA,26
IL,BLOOD CREATINE PHOSPHOKINASE INCREASED,26
IL,DYSKINESIA,26
IL,FLUSHING,26
IL,HYPERAMMONAEMIA,26
IL,HYPOTHYROIDISM,26
IL,MENTAL DISORDER,26
IL,PRODUCTIVE COUGH,26
IL,SLEEP DISORDER,26
IL,ABORTION INDUCED,25
IL,ANAPHYLACTIC SHOCK,25
IL,BLINDNESS,25
IL,BLOOD ALBUMIN DECREASED,25
IL,HEMIPARESIS,25
IL,HEPATITIS,25
IL,HYPERGLYCAEMIA,25
IL,LIMB INJURY,25
IL,NEOPLASM PROGRESSION,25
IL,PROSTATE CANCER,25
IL,TREATMENT FAILURE,25
IL,ACTIVITIES OF DAILY LIVING IMPAIRED,24
IL,ATRIAL SEPTAL DEFECT,24
IL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,24
IL,COLITIS ULCERATIVE,24
IL,COMA,24
IL,CONCOMITANT DISEASE AGGRAVATED,24
IL,DRUG EFFECT INCOMPLETE,24
IL,FLATULENCE,24
IL,GASTROINTESTINAL DISORDER,24
IL,HERPES ZOSTER,24
IL,INJECTION SITE ERYTHEMA,24
IL,INTENTIONAL PRODUCT MISUSE,24
IL,NEOPLASM MALIGNANT,24
IL,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,24
IL,PULMONARY CONGESTION,24
IL,RESPIRATORY DISTRESS,24
IL,ASPHYXIA,23
IL,BLOOD COUNT ABNORMAL,23
IL,CONVULSION,23
IL,DRUG-INDUCED LIVER INJURY,23
IL,EYE PAIN,23
IL,LYMPHOCYTE COUNT DECREASED,23
IL,MALIGNANT MELANOMA,23
IL,NEPHROLITHIASIS,23
IL,RESTLESSNESS,23
IL,RHABDOMYOLYSIS,23
IL,RHINORRHOEA,23
IL,VENTRICULAR SEPTAL DEFECT,23
IL,VERTIGO,23
IL,ABASIA,22
IL,ANGINA PECTORIS,22
IL,EYE INFECTION,22
IL,FEMUR FRACTURE,22
IL,HEART RATE DECREASED,22
IL,MULTIPLE SCLEROSIS,22
IL,NERVOUSNESS,22
IL,PARALYSIS,22
IL,SUFFOCATION FEELING,22
IL,TUMOUR LYSIS SYNDROME,22
IL,ABORTION,21
IL,APHASIA,21
IL,BLOOD CHOLESTEROL INCREASED,21
IL,BLOOD THYROID STIMULATING HORMONE INCREASED,21
IL,FULL BLOOD COUNT DECREASED,21
IL,LARYNGEAL OEDEMA,21
IL,LIVER DISORDER,21
IL,LIVER FUNCTION TEST ABNORMAL,21
IL,LOCAL SWELLING,21
IL,LUNG DISORDER,21
IL,PELVIC PAIN,21
IL,ROAD TRAFFIC ACCIDENT,21
IL,SUICIDAL IDEATION,21
IL,SURGERY,21
IL,THERAPEUTIC RESPONSE DECREASED,21
IL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,21
IL,ABNORMAL BEHAVIOUR,20
IL,ANGLE CLOSURE GLAUCOMA,20
IL,BACTERIAL INFECTION,20
IL,DEPRESSED LEVEL OF CONSCIOUSNESS,20
IL,DISTURBANCE IN ATTENTION,20
IL,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,20
IL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,20
IL,HAEMOLYTIC ANAEMIA,20
IL,HAEMORRHOIDS,20
IL,HERPES VIRUS INFECTION,20
IL,HYPOKALAEMIA,20
IL,INTERVERTEBRAL DISC PROTRUSION,20
IL,INTESTINAL PERFORATION,20
IL,LUNG INFECTION,20
IL,MOVEMENT DISORDER,20
IL,OVARIAN FAILURE,20
IL,RESPIRATORY TRACT INFECTION,20
IL,STEVENS-JOHNSON SYNDROME,20
IL,SYSTEMIC LUPUS ERYTHEMATOSUS,20
IL,TOXIC EPIDERMAL NECROLYSIS,20
IL,ASTHMA,19
IL,AUTOIMMUNE DISORDER,19
IL,BLOOD ALKALINE PHOSPHATASE INCREASED,19
IL,BLOOD URINE PRESENT,19
IL,CHRONIC KIDNEY DISEASE,19
IL,FEELING COLD,19
IL,HEAD DISCOMFORT,19
IL,HYPERKALAEMIA,19
IL,LOWER LIMB FRACTURE,19
IL,TREATMENT NONCOMPLIANCE,19
IL,UPPER LIMB FRACTURE,19
IL,ANAPHYLACTIC REACTION,18
IL,DIPLOPIA,18
IL,EYE HAEMORRHAGE,18
IL,HAEMOLYSIS,18
IL,HAND FRACTURE,18
IL,KLEBSIELLA INFECTION,18
IL,LEUKAEMIA,18
IL,LIMB DISCOMFORT,18
IL,LUNG NEOPLASM MALIGNANT,18
IL,METASTASES TO BONE,18
IL,PANCREATITIS ACUTE,18
IL,RASH MACULO-PAPULAR,18
IL,RASH PRURITIC,18
IL,RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE,18
IL,SPINAL FRACTURE,18
IL,UNDERDOSE,18
IL,ACUTE HEPATIC FAILURE,17
IL,ANGIOEDEMA,17
IL,APATHY,17
IL,APNOEA,17
IL,CARDIAC FIBRILLATION,17
IL,COAGULOPATHY,17
IL,DECUBITUS ULCER,17
IL,DIARRHOEA HAEMORRHAGIC,17
IL,DISORIENTATION,17
IL,DRUG ADMINISTRATION ERROR,17
IL,FISTULA,17
IL,GENERALISED OEDEMA,17
IL,HYPOCALCAEMIA,17
IL,HYPOPHAGIA,17
IL,HYPOTHERMIA,17
IL,INFLAMMATORY MARKER INCREASED,17
IL,INJECTION SITE SWELLING,17
IL,LIVER FUNCTION TEST INCREASED,17
IL,LUPUS-LIKE SYNDROME,17
IL,OCULAR HYPERAEMIA,17
IL,PERICARDITIS,17
IL,POLYMYALGIA RHEUMATICA,17
IL,PRESYNCOPE,17
IL,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,17
IL,RIB FRACTURE,17
IL,VAGINAL HAEMORRHAGE,17
IL,ABSCESS,16
IL,AGITATION,16
IL,BLOOD GLUCOSE ABNORMAL,16
IL,BLOOD GLUCOSE DECREASED,16
IL,COLON CANCER,16
IL,DISEASE RECURRENCE,16
IL,HALLUCINATION,16
IL,HALLUCINATION_ VISUAL,16
IL,HEPATITIS C,16
IL,HEPATOMEGALY,16
IL,HYPOALBUMINAEMIA,16
IL,INTESTINAL RESECTION,16
IL,KETOACIDOSIS,16
IL,NECK PAIN,16
IL,OSTEOPOROSIS,16
IL,PERITONITIS,16
IL,PLATELET COUNT ABNORMAL,16
IL,PNEUMOCYSTIS JIROVECII PNEUMONIA,16
IL,PROCEDURAL PAIN,16
IL,RENAL DISORDER,16
IL,SENSORY DISTURBANCE,16
IL,URINARY INCONTINENCE,16
IL,VASCULITIS,16
IL,ANKYLOSING SPONDYLITIS,15
IL,APPENDICITIS,15
IL,ATAXIA,15
IL,BLOOD SODIUM DECREASED,15
IL,DEAFNESS,15
IL,ERECTILE DYSFUNCTION,15
IL,FEELING HOT,15
IL,GLOSSODYNIA,15
IL,HYPERCALCAEMIA,15
IL,HYPOKINESIA,15
IL,INGUINAL HERNIA,15
IL,MYOCARDIAL ISCHAEMIA,15
IL,MYOCARDITIS,15
IL,NERVOUS SYSTEM DISORDER,15
IL,OPTIC NEURITIS,15
IL,PLASMACYTOMA,15
IL,PULMONARY MASS,15
IL,SENSORY LOSS,15
IL,SINUSITIS,15
IL,SQUAMOUS CELL CARCINOMA,15
IL,STAPHYLOCOCCAL BACTERAEMIA,15
IL,STRESS,15
IL,TALIPES,15
IL,WRONG TECHNIQUE IN DRUG USAGE PROCESS,15
IL,AGGRESSION,14
IL,ANKLE FRACTURE,14
IL,ARTHROPATHY,14
IL,ASPIRATION,14
IL,ATRIAL FLUTTER,14
IL,BLISTER,14
IL,BLOOD IRON DECREASED,14
IL,BLOOD TEST ABNORMAL,14
IL,BONE MARROW FAILURE,14
IL,BRONCHIOLITIS,14
IL,CHOKING,14
IL,CHROMATURIA,14
IL,DEVICE DISLOCATION,14
IL,DEVICE RELATED INFECTION,14
IL,DIABETES MELLITUS INADEQUATE CONTROL,14
IL,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,14
IL,EAR INFECTION,14
IL,EATING DISORDER,14
IL,EXPOSURE VIA FATHER,14
IL,FEMORAL NECK FRACTURE,14
IL,FUNGAL INFECTION,14
IL,GASTRIC ULCER,14
IL,GASTRITIS,14
IL,INTENTIONAL OVERDOSE,14
IL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,14
IL,METASTASES TO CENTRAL NERVOUS SYSTEM,14
IL,MYOPATHY,14
IL,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,14
IL,PELVIC FRACTURE,14
IL,POSTOPERATIVE WOUND INFECTION,14
IL,RICHTER^S SYNDROME,14
IL,TACHYPNOEA,14
IL,THROMBOSIS IN DEVICE,14
IL,TUBERCULOSIS,14
IL,TUBULOINTERSTITIAL NEPHRITIS,14
IL,VASCULAR INJURY,14
IL,WHEEZING,14
IL,ADVERSE EVENT,13
IL,CARDIAC TAMPONADE,13
IL,CYANOSIS,13
IL,DEMENTIA,13
IL,DISCOMFORT,13
IL,ELECTROLYTE IMBALANCE,13
IL,ENCEPHALITIS,13
IL,HEPATOCELLULAR CARCINOMA,13
IL,IMMUNE THROMBOCYTOPENIC PURPURA,13
IL,INCORRECT ROUTE OF DRUG ADMINISTRATION,13
IL,INJECTION SITE HAEMORRHAGE,13
IL,INTENTIONAL DRUG MISUSE,13
IL,LOCALISED OEDEMA,13
IL,MUSCULOSKELETAL CHEST PAIN,13
IL,MYCOSIS FUNGOIDES,13
IL,MYELODYSPLASTIC SYNDROME,13
IL,ON AND OFF PHENOMENON,13
IL,SEXUAL DYSFUNCTION,13
IL,SHOCK,13
IL,SUBDURAL HAEMORRHAGE,13
IL,WOUND INFECTION,13
IL,AGEUSIA,12
IL,BLOOD UREA INCREASED,12
IL,BRAIN OEDEMA,12
IL,CATHETERISATION CARDIAC,12
IL,CYTOMEGALOVIRUS INFECTION,12
IL,DERMATITIS,12
IL,DERMATITIS ALLERGIC,12
IL,DRUG INTOLERANCE,12
IL,DRUG LEVEL DECREASED,12
IL,DRUG RESISTANCE,12
IL,DUODENAL ULCER,12
IL,DYSARTHRIA,12
IL,EAR PAIN,12
IL,EYE SWELLING,12
IL,FLUID RETENTION,12
IL,HAEMORRHAGIC STROKE,12
IL,HYDRONEPHROSIS,12
IL,HYPOACUSIS,12
IL,HYPOMAGNESAEMIA,12
IL,HYPOXIA,12
IL,INCORRECT DRUG ADMINISTRATION DURATION,12
IL,INJECTION SITE REACTION,12
IL,INTENTIONAL PRODUCT USE ISSUE,12
IL,LACTIC ACIDOSIS,12
IL,LIP SWELLING,12
IL,METASTATIC RENAL CELL CARCINOMA,12
IL,MUSCLE SPASTICITY,12
IL,NEPHROTIC SYNDROME,12
IL,NORMAL NEWBORN,12
IL,PANCREATIC CARCINOMA METASTATIC,12
IL,PIGMENTATION DISORDER,12
IL,PNEUMONIA ASPIRATION,12
IL,POLLAKIURIA,12
IL,PREMATURE DELIVERY,12
IL,RESPIRATORY SYNCYTIAL VIRUS INFECTION,12
IL,RETINAL DETACHMENT,12
IL,SKIN HAEMORRHAGE,12
IL,SKIN ULCER,12
IL,SUBARACHNOID HAEMORRHAGE,12
IL,SUBDURAL HAEMATOMA,12
IL,TINNITUS,12
IL,TOOTHACHE,12
IL,TRANSFUSION,12
IL,UPPER GASTROINTESTINAL HAEMORRHAGE,12
IL,UPPER RESPIRATORY TRACT INFECTION,12
IL,UROSEPSIS,12
IL,VASCULAR STENT THROMBOSIS,12
IL,VENTRICULAR FIBRILLATION,12
IL,YELLOW SKIN,12
IL,ABDOMINAL ABSCESS,11
IL,ACNE,11
IL,ATELECTASIS,11
IL,ATRIOVENTRICULAR BLOCK COMPLETE,11
IL,BASAL CELL CARCINOMA,11
IL,BLADDER CANCER,11
IL,BLOOD CALCIUM DECREASED,11
IL,BLOOD PRESSURE ABNORMAL,11
IL,BREAST CANCER FEMALE,11
IL,COMPLETED SUICIDE,11
IL,DECREASED ACTIVITY,11
IL,DELIRIUM,11
IL,DISSEMINATED INTRAVASCULAR COAGULATION,11
IL,ELECTROCARDIOGRAM QT PROLONGED,11
IL,FLUID INTAKE REDUCED,11
IL,FOETAL DEATH,11
IL,GINGIVAL PAIN,11
IL,GRAFT VERSUS HOST DISEASE,11
IL,H1N1 INFLUENZA,11
IL,HERNIA,11
IL,HOT FLUSH,11
IL,INCONTINENCE,11
IL,JUVENILE IDIOPATHIC ARTHRITIS,11
IL,LACRIMATION INCREASED,11
IL,LIVER INJURY,11
IL,LOCALISED INFECTION,11
IL,MECHANICAL VENTILATION,11
IL,MICTURITION URGENCY,11
IL,MIGRAINE,11
IL,MONOPLEGIA,11
IL,PALLOR,11
IL,PHARYNGITIS,11
IL,RED BLOOD CELL COUNT DECREASED,11
IL,SKIN DISORDER,11
IL,SPINAL CORD COMPRESSION,11
IL,SUDDEN DEATH,11
IL,TROPONIN INCREASED,11
IL,VENTRICULAR TACHYCARDIA,11
IL,ACCIDENTAL OVERDOSE,10
IL,ACUTE RESPIRATORY DISTRESS SYNDROME,10
IL,ACUTE RESPIRATORY FAILURE,10
IL,ARTHRITIS INFECTIVE,10
IL,BLOOD POTASSIUM INCREASED,10
IL,BODY TEMPERATURE INCREASED,10
IL,CARDIOVASCULAR DISORDER,10
IL,CHOKING SENSATION,10
IL,CHOLECYSTITIS ACUTE,10
IL,CONJUNCTIVITIS,10
IL,CYST,10
IL,DEVICE OCCLUSION,10
IL,EYE DISORDER,10
IL,FAECES DISCOLOURED,10
IL,GASTROOESOPHAGEAL REFLUX DISEASE,10
IL,GINGIVAL SWELLING,10
IL,GLYCOSYLATED HAEMOGLOBIN INCREASED,10
IL,HAEMORRHOIDAL HAEMORRHAGE,10
IL,HEART RATE IRREGULAR,10
IL,HELICOBACTER INFECTION,10
IL,HEPATIC LESION,10
IL,HEPATIC STEATOSIS,10
IL,HYPERAESTHESIA,10
IL,INCREASED APPETITE,10
IL,INJECTION SITE HAEMATOMA,10
IL,INJURY,10
IL,INTRACRANIAL ANEURYSM,10
IL,MASS,10
IL,MEDICATION ERROR,10
IL,MENINGITIS,10
IL,MOOD ALTERED,10
IL,NEUROLEPTIC MALIGNANT SYNDROME,10
IL,OESOPHAGITIS,10
IL,OVARIAN CYST,10
IL,PATHOLOGICAL FRACTURE,10
IL,PHARYNGEAL OEDEMA,10
IL,PLATELET COUNT INCREASED,10
IL,POST PROCEDURAL HAEMORRHAGE,10
IL,PROCTALGIA,10
IL,PULMONARY HAEMORRHAGE,10
IL,SUBCUTANEOUS ABSCESS,10
IL,THROMBOTIC MICROANGIOPATHY,10
IL,THYROID DISORDER,10
IL,UNEVALUABLE EVENT,10
IL,VENOOCCLUSIVE DISEASE,10
IL,VENOUS THROMBOSIS,10
IL,ABDOMINAL TENDERNESS,9
IL,ABSCESS LIMB,9
IL,ACUTE CORONARY SYNDROME,9
IL,AMYLASE INCREASED,9
IL,ANGINA UNSTABLE,9
IL,BACK INJURY,9
IL,BEDRIDDEN,9
IL,BLADDER NEOPLASM,9
IL,BLINDNESS UNILATERAL,9
IL,BLOOD CALCIUM INCREASED,9
IL,BLOOD LACTIC ACID INCREASED,9
IL,CARDIOGENIC SHOCK,9
IL,CENTRAL NERVOUS SYSTEM ENTEROVIRAL INFECTION,9
IL,CEREBRAL INFARCTION,9
IL,CHOLANGITIS,9
IL,CIRCULATORY COLLAPSE,9
IL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,9
IL,ENDOPHTHALMITIS,9
IL,EYE IRRITATION,9
IL,EYE OEDEMA,9
IL,FOOD INTERACTION,9
IL,GASTROINTESTINAL OBSTRUCTION,9
IL,GENERALISED ERYTHEMA,9
IL,GENITAL HAEMORRHAGE,9
IL,GINGIVAL BLEEDING,9
IL,HAEMATOCRIT DECREASED,9
IL,HEPATIC CANCER,9
IL,HEPATIC NEOPLASM,9
IL,HEPATIC PAIN,9
IL,HYPERTHYROIDISM,9
IL,HYPERTRIGLYCERIDAEMIA,9
IL,HYPOPHOSPHATAEMIA,9
IL,IRRITABILITY,9
IL,MENINGIOMA,9
IL,MENTAL IMPAIRMENT,9
IL,NEOPLASM,9
IL,NEUROLOGICAL SYMPTOM,9
IL,NIGHT SWEATS,9
IL,ORAL DISCOMFORT,9
IL,ORGAN FAILURE,9
IL,POST PROCEDURAL INFECTION,9
IL,PRE-ECLAMPSIA,9
IL,PREMATURE LABOUR,9
IL,PROCEDURAL HAEMORRHAGE,9
IL,PRODUCT QUALITY ISSUE,9
IL,PULMONARY ARTERIAL HYPERTENSION,9
IL,PULMONARY TOXICITY,9
IL,RESPIRATORY ACIDOSIS,9
IL,SKIN INFECTION,9
IL,SKIN IRRITATION,9
IL,SKIN REACTION,9
IL,STATUS EPILEPTICUS,9
IL,STUPOR,9
IL,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,9
IL,SUBCUTANEOUS HAEMATOMA,9
IL,SWOLLEN TONGUE,9
IL,TENDERNESS,9
IL,THERAPY NON-RESPONDER,9
IL,THROAT IRRITATION,9
IL,TRICUSPID VALVE INCOMPETENCE,9
IL,UNRESPONSIVE TO STIMULI,9
IL,WITHDRAWAL SYNDROME,9
IL,ANAL INCONTINENCE,8
IL,ANGER,8
IL,ANGIOPATHY,8
IL,ASTERIXIS,8
IL,BLOOD TRIGLYCERIDES INCREASED,8
IL,BLOOD URIC ACID INCREASED,8
IL,BONE DISORDER,8
IL,BREAST CANCER METASTATIC,8
IL,BRONCHOSPASM,8
IL,BRUGADA SYNDROME,8
IL,CANDIDA INFECTION,8
IL,CHOLECYSTITIS,8
IL,CHRONIC LYMPHOCYTIC LEUKAEMIA,8
IL,CRYING,8
IL,CYTOPENIA,8
IL,DELUSION,8
IL,DEVELOPMENTAL DELAY,8
IL,DIVERTICULITIS,8
IL,DRUG ERUPTION,8
IL,DRUG LEVEL INCREASED,8
IL,DRUG SPECIFIC ANTIBODY PRESENT,8
IL,EJECTION FRACTION DECREASED,8
IL,ELECTROCARDIOGRAM PR PROLONGATION,8
IL,EYE PRURITUS,8
IL,FACIAL PARALYSIS,8
IL,FEEDING DISORDER,8
IL,FOOT FRACTURE,8
IL,GASTRITIS EROSIVE,8
IL,GINGIVITIS,8
IL,GLAUCOMA,8
IL,HEART DISEASE CONGENITAL,8
IL,HUMAN HERPESVIRUS 6 INFECTION,8
IL,HYPERSENSITIVITY VASCULITIS,8
IL,HYPERSOMNIA,8
IL,HYPOGAMMAGLOBULINAEMIA,8
IL,INJECTION SITE NODULE,8
IL,INJECTION SITE PRURITUS,8
IL,INTESTINAL STENOSIS,8
IL,INTRAOCULAR PRESSURE INCREASED,8
IL,LEFT VENTRICULAR DYSFUNCTION,8
IL,LEG AMPUTATION,8
IL,LOW DENSITY LIPOPROTEIN INCREASED,8
IL,MATERNAL EXPOSURE BEFORE PREGNANCY,8
IL,METASTASES TO LUNG,8
IL,MITRAL VALVE INCOMPETENCE,8
IL,MOUTH HAEMORRHAGE,8
IL,MYELITIS,8
IL,NEUTROPHIL COUNT INCREASED,8
IL,OBESITY,8
IL,ORAL HERPES,8
IL,OSTEOARTHRITIS,8
IL,PAIN IN JAW,8
IL,PARANOIA,8
IL,PATENT DUCTUS ARTERIOSUS,8
IL,PELVIC INFLAMMATORY DISEASE,8
IL,PERIPHERAL SENSORY NEUROPATHY,8
IL,PNEUMOPERITONEUM,8
IL,PORTAL VEIN THROMBOSIS,8
IL,PREGNANCY,8
IL,PROSTATIC SPECIFIC ANTIGEN INCREASED,8
IL,PROSTATOMEGALY,8
IL,PROTEIN TOTAL DECREASED,8
IL,PROTEIN URINE PRESENT,8
IL,SHOCK HAEMORRHAGIC,8
IL,SKIN MASS,8
IL,SMALL INTESTINAL OBSTRUCTION,8
IL,SPINAL PAIN,8
IL,SQUAMOUS CELL CARCINOMA OF SKIN,8
IL,STILLBIRTH,8
IL,SUPRAVENTRICULAR TACHYCARDIA,8
IL,TOOTH DISORDER,8
IL,TRANSAMINASES INCREASED,8
IL,TRIGEMINAL NEURALGIA,8
IL,UNINTENDED PREGNANCY,8
IL,VENTRICULAR ARRHYTHMIA,8
IL,VITAMIN D DECREASED,8
IL,ADVERSE DRUG REACTION,7
IL,ANAL ABSCESS,7
IL,ANAL FISSURE,7
IL,APLASTIC ANAEMIA,7
IL,ATRIOVENTRICULAR BLOCK SECOND DEGREE,7
IL,AUTOIMMUNE HEPATITIS,7
IL,B-CELL LYMPHOMA,7
IL,BLOOD POTASSIUM DECREASED,7
IL,BLOOD PRESSURE FLUCTUATION,7
IL,BLOOD PRESSURE SYSTOLIC INCREASED,7
IL,BREAST MASS,7
IL,CAESAREAN SECTION,7
IL,CHRONIC MYELOID LEUKAEMIA,7
IL,COMMUNICATION DISORDER,7
IL,COOMBS TEST POSITIVE,7
IL,CORONARY ARTERY DISEASE,7
IL,CORONARY ARTERY OCCLUSION,7
IL,DERMATOPHYTOSIS,7
IL,DIPLEGIA,7
IL,DRUG DEPENDENCE,7
IL,DYSPNOEA EXERTIONAL,7
IL,ELECTROCARDIOGRAM ABNORMAL,7
IL,EMBOLISM VENOUS,7
IL,ERYSIPELAS,7
IL,EXTRAPYRAMIDAL DISORDER,7
IL,EYE MOVEMENT DISORDER,7
IL,FACIAL PAIN,7
IL,FOETAL GROWTH RESTRICTION,7
IL,GASTROINTESTINAL INFECTION,7
IL,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,7
IL,HAEMORRHAGE IN PREGNANCY,7
IL,HEPATIC ENCEPHALOPATHY,7
IL,HEPATITIS B,7
IL,HEPATITIS TOXIC,7
IL,HYPERBILIRUBINAEMIA,7
IL,HYPERCHOLESTEROLAEMIA,7
IL,HYPERCOAGULATION,7
IL,HYPOTONIA,7
IL,INTESTINAL HAEMORRHAGE,7
IL,INTRACARDIAC THROMBUS,7
IL,JAUNDICE CHOLESTATIC,7
IL,LETHARGY,7
IL,LIGAMENT SPRAIN,7
IL,LIPASE INCREASED,7
IL,LIVER ABSCESS,7
IL,LIVER TRANSPLANT,7
IL,MANTLE CELL LYMPHOMA,7
IL,METASTASES TO MENINGES,7
IL,METASTASIS,7
IL,MYASTHENIA GRAVIS,7
IL,MYELOFIBROSIS,7
IL,MYOCLONUS,7
IL,NECROSIS,7
IL,OESOPHAGITIS ULCERATIVE,7
IL,ONYCHOMYCOSIS,7
IL,ORAL CANDIDIASIS,7
IL,PAIN OF SKIN,7
IL,PERICARDIAL HAEMORRHAGE,7
IL,POST PROCEDURAL COMPLICATION,7
IL,PROTHROMBIN TIME PROLONGED,7
IL,QUALITY OF LIFE DECREASED,7
IL,RASH ERYTHEMATOUS,7
IL,RASH PUSTULAR,7
IL,RENAL INJURY,7
IL,RENAL PAIN,7
IL,RETINAL HAEMORRHAGE,7
IL,RIGHT VENTRICULAR FAILURE,7
IL,STAPHYLOCOCCAL INFECTION,7
IL,STOMA SITE DISCHARGE,7
IL,TOOTH INFECTION,7
IL,TRISMUS,7
IL,TUMOUR MARKER INCREASED,7
IL,ULCER,7
IL,UMBILICAL HERNIA,7
IL,URINE OUTPUT DECREASED,7
IL,ACCIDENTAL EXPOSURE TO PRODUCT,6
IL,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,6
IL,ACQUIRED HAEMOPHILIA,6
IL,ADENOCARCINOMA GASTRIC,6
IL,ALCOHOL INTERACTION,6
IL,ALTERED STATE OF CONSCIOUSNESS,6
IL,ANURIA,6
IL,AUTOINFLAMMATORY DISEASE,6
IL,BLOOD DISORDER,6
IL,BONE DENSITY DECREASED,6
IL,BONE LESION,6
IL,BRAIN NEOPLASM,6
IL,CACHEXIA,6
IL,CARDIAC VALVE DISEASE,6
IL,CARDIO-RESPIRATORY ARREST,6
IL,CEREBRAL ISCHAEMIA,6
IL,CHOLESTASIS,6
IL,CHRONIC GRAFT VERSUS HOST DISEASE,6
IL,CHYLOTHORAX,6
IL,COMPLICATION OF DEVICE INSERTION,6
IL,CREATININE RENAL CLEARANCE DECREASED,6
IL,CUSHING^S SYNDROME,6
IL,DEPRESSION SUICIDAL,6
IL,DEVELOPMENTAL HIP DYSPLASIA,6
IL,DEVICE DIFFICULT TO USE,6
IL,DEVICE EXPULSION,6
IL,DIALYSIS,6
IL,DRY EYE,6
IL,DYSMORPHISM,6
IL,EAR DISORDER,6
IL,EMOTIONAL DISTRESS,6
IL,ENTERITIS,6
IL,ESCHERICHIA SEPSIS,6
IL,EXTRA DOSE ADMINISTERED,6
IL,FAECAL INCONTINENCE,6
IL,FOCAL NODULAR HYPERPLASIA,6
IL,GAIT INABILITY,6
IL,GASTRIC HAEMORRHAGE,6
IL,GASTROINTESTINAL TOXICITY,6
IL,GENERALISED TONIC-CLONIC SEIZURE,6
IL,GOUT,6
IL,GRAFT VERSUS HOST DISEASE IN LIVER,6
IL,HEPATITIS ACUTE,6
IL,HEREDITARY ANGIOEDEMA,6
IL,HUMERUS FRACTURE,6
IL,HYDROCEPHALUS,6
IL,HYPERKERATOSIS,6
IL,IMMUNE SYSTEM DISORDER,6
IL,IMMUNODEFICIENCY,6
IL,IMPATIENCE,6
IL,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,6
IL,INJECTION SITE ABSCESS,6
IL,INVASIVE DUCTAL BREAST CARCINOMA,6
IL,JOINT EFFUSION,6
IL,MAJOR DEPRESSION,6
IL,MOTOR DYSFUNCTION,6
IL,MUCORMYCOSIS,6
IL,MUSCLE RIGIDITY,6
IL,MUSCULOSKELETAL DISCOMFORT,6
IL,MYELITIS TRANSVERSE,6
IL,MYOSITIS,6
IL,NEPHRITIS,6
IL,NOCARDIOSIS,6
IL,OCULAR DISCOMFORT,6
IL,ODYNOPHAGIA,6
IL,OLIGURIA,6
IL,OSTEOPOROTIC FRACTURE,6
IL,PANCREATIC NEOPLASM,6
IL,PAPILLARY THYROID CANCER,6
IL,PERIPHERAL COLDNESS,6
IL,PERIPHERAL ISCHAEMIA,6
IL,PNEUMATOSIS INTESTINALIS,6
IL,PNEUMOTHORAX,6
IL,POLYARTHRITIS,6
IL,POLYURIA,6
IL,PORTAL HYPERTENSION,6
IL,PREGNANCY WITH CONTRACEPTIVE DEVICE,6
IL,PROSTATE CANCER METASTATIC,6
IL,PURULENCE,6
IL,PYODERMA GANGRENOSUM,6
IL,RASH MACULAR,6
IL,RENAL CYST,6
IL,RESPIRATORY ARREST,6
IL,RETINAL VEIN OCCLUSION,6
IL,SARCOIDOSIS,6
IL,SCHIZOPHRENIA,6
IL,SERUM FERRITIN INCREASED,6
IL,SINUS BRADYCARDIA,6
IL,SINUS TACHYCARDIA,6
IL,SKIN BURNING SENSATION,6
IL,SKIN PAPILLOMA,6
IL,STRIDOR,6
IL,TERMINAL STATE,6
IL,THERAPEUTIC RESPONSE UNEXPECTED,6
IL,THERMAL BURN,6
IL,THROMBOTIC THROMBOCYTOPENIC PURPURA,6
IL,THYROIDITIS,6
IL,TRANSPLANT REJECTION,6
IL,VASCULAR GRAFT,6
IL,VIRAL UPPER RESPIRATORY TRACT INFECTION,6
IL,VULVOVAGINAL MYCOTIC INFECTION,6
IL,ABDOMINAL HERNIA,5
IL,ABSCESS INTESTINAL,5
IL,ACCIDENT,5
IL,ACIDOSIS,5
IL,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,5
IL,ACUTE GRAFT VERSUS HOST DISEASE,5
IL,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,5
IL,ACUTE LEUKAEMIA,5
IL,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,5
IL,ADENOCARCINOMA OF COLON,5
IL,ADENOVIRUS INFECTION,5
IL,ANAL FISTULA,5
IL,ANAL HAEMORRHAGE,5
IL,ANKYLOGLOSSIA CONGENITAL,5
IL,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY INCREASED,5
IL,ANTINUCLEAR ANTIBODY POSITIVE,5
IL,ARTERIAL THROMBOSIS,5
IL,ARTERIOSPASM CORONARY,5
IL,ATRIAL THROMBOSIS,5
IL,ATRIOVENTRICULAR BLOCK,5
IL,AZOOSPERMIA,5
IL,BLINDNESS TRANSIENT,5
IL,BLOOD CREATININE DECREASED,5
IL,BLOOD FIBRINOGEN DECREASED,5
IL,BRADYPHRENIA,5
IL,BRAIN ABSCESS,5
IL,BRAIN MALFORMATION,5
IL,BRONCHIECTASIS,5
IL,BURSITIS,5
IL,C-REACTIVE PROTEIN ABNORMAL,5
IL,CAPILLARY LEAK SYNDROME,5
IL,CARDIAC OPERATION,5
IL,CARDIOMYOPATHY,5
IL,CEREBROSPINAL FLUID LEAKAGE,5
IL,COLECTOMY,5
IL,CONGENITAL HYDRONEPHROSIS,5
IL,CONGENITAL HYPOTHYROIDISM,5
IL,CONJUNCTIVAL HAEMORRHAGE,5
IL,COORDINATION ABNORMAL,5
IL,CORONARY ARTERY STENOSIS,5
IL,CYSTITIS,5
IL,DEVICE ISSUE,5
IL,DEVICE RELATED SEPSIS,5
IL,DIAPHRAGMATIC HERNIA,5
IL,DIFFUSE LARGE B-CELL LYMPHOMA,5
IL,DUODENITIS,5
IL,EBSTEIN^S ANOMALY,5
IL,ECZEMA,5
IT,DRUG ABUSE,5449
IT,SOPOR,4487
IT,ASTHENIA,3421
IT,VOMITING,3103
IT,DYSPNOEA,3071
IT,ANAEMIA,2967
IT,NAUSEA,2495
IT,HYPOTENSION,2426
IT,DIARRHOEA,2375
IT,ERYTHEMA,2200
IT,INTENTIONAL SELF-INJURY,2177
IT,DRUG INEFFECTIVE,2139
IT,CONFUSIONAL STATE,2022
IT,PYREXIA,1968
IT,NEUTROPENIA,1965
IT,OVERDOSE,1894
IT,SYNCOPE,1875
IT,TOXICITY TO VARIOUS AGENTS,1874
IT,HYPOGLYCAEMIA,1799
IT,THROMBOCYTOPENIA,1797
IT,PRURITUS,1640
IT,DEATH,1599
IT,LOSS OF CONSCIOUSNESS,1543
IT,ABDOMINAL PAIN,1486
IT,INTENTIONAL OVERDOSE,1473
IT,HEADACHE,1426
IT,RASH,1401
IT,MALAISE,1357
IT,URTICARIA,1333
IT,ACUTE KIDNEY INJURY,1331
IT,PRESYNCOPE,1264
IT,ABDOMINAL PAIN UPPER,1180
IT,SOMNOLENCE,1129
IT,SUICIDE ATTEMPT,1118
IT,HYPERHIDROSIS,1101
IT,VERTIGO,1037
IT,TREMOR,1020
IT,DISEASE PROGRESSION,996
IT,OSTEONECROSIS OF JAW,990
IT,HYPERTENSION,970
IT,TACHYCARDIA,944
IT,HYPONATRAEMIA,924
IT,BRADYCARDIA,918
IT,LEUKOPENIA,894
IT,PARAESTHESIA,893
IT,COMA,890
IT,PNEUMONIA,887
IT,AGITATION,885
IT,FALL,883
IT,HYPOKALAEMIA,839
IT,FATIGUE,805
IT,HYPERSENSITIVITY,784
IT,RESPIRATORY FAILURE,783
IT,LACTIC ACIDOSIS,770
IT,MELAENA,770
IT,CHEST PAIN,754
IT,DECREASED APPETITE,749
IT,RENAL FAILURE,726
IT,FEBRILE NEUTROPENIA,712
IT,HYPERTENSIVE CRISIS,709
IT,BRADYPHRENIA,702
IT,ATRIAL FIBRILLATION,698
IT,MEDICATION ERROR,698
IT,INTERNATIONAL NORMALISED RATIO INCREASED,678
IT,SELF INJURIOUS BEHAVIOUR,678
IT,ELECTROCARDIOGRAM QT PROLONGED,665
IT,DIZZINESS,654
IT,COUGH,652
IT,CARDIAC FAILURE,641
IT,CONDITION AGGRAVATED,597
IT,METABOLIC ACIDOSIS,589
IT,RHABDOMYOLYSIS,579
IT,RECTAL HAEMORRHAGE,575
IT,SEPSIS,567
IT,DEHYDRATION,565
IT,ANGIOEDEMA,561
IT,PRODUCT USE ISSUE,560
IT,OEDEMA PERIPHERAL,557
IT,CARDIAC ARREST,554
IT,CEREBRAL HAEMORRHAGE,553
IT,PSYCHOMOTOR HYPERACTIVITY,552
IT,HEAD INJURY,548
IT,ARTHRALGIA,546
IT,FOETAL EXPOSURE DURING PREGNANCY,543
IT,HYPERKALAEMIA,542
IT,DYSARTHRIA,537
IT,RENAL FAILURE ACUTE,536
IT,PANCYTOPENIA,535
IT,HYPERPYREXIA,529
IT,EPISTAXIS,527
IT,TRANSAMINASES INCREASED,523
IT,MUCOSAL INFLAMMATION,505
IT,HAEMATURIA,493
IT,BRADYKINESIA,489
IT,HYPERTRANSAMINASAEMIA,484
IT,EPILEPSY,482
IT,CONSTIPATION,478
IT,PAIN,478
IT,MALIGNANT NEOPLASM PROGRESSION,473
IT,INTENTIONAL PRODUCT MISUSE,471
IT,DISORIENTATION,466
IT,INSOMNIA,464
IT,WEIGHT DECREASED,464
IT,PRURITUS GENERALISED,463
IT,SEPTIC SHOCK,453
IT,LIP OEDEMA,449
IT,BLOOD CREATININE INCREASED,444
IT,ALOPECIA,443
IT,STOMATITIS,439
IT,DYSPHAGIA,437
IT,ANXIETY,427
IT,MYALGIA,426
IT,PAIN IN EXTREMITY,420
IT,PULMONARY EMBOLISM,420
IT,BRONCHOSPASM,418
IT,MATERNAL EXPOSURE DURING PREGNANCY,416
IT,FACE OEDEMA,409
IT,HAEMATEMESIS,401
IT,THROAT TIGHTNESS,401
IT,GAIT DISTURBANCE,396
IT,APHASIA,388
IT,INFUSION RELATED REACTION,381
IT,PLEURAL EFFUSION,380
IT,ALANINE AMINOTRANSFERASE INCREASED,379
IT,SEIZURE,379
IT,FLUSHING,376
IT,PRODUCT USE IN UNAPPROVED INDICATION,372
IT,HYPERBILIRUBINAEMIA,370
IT,HYPERGLYCAEMIA,368
IT,BACK PAIN,362
IT,BLOOD PRESSURE INCREASED,360
IT,DRUG USE DISORDER,357
IT,JAUNDICE,357
IT,CHEST DISCOMFORT,352
IT,HEPATOTOXICITY,351
IT,PALPITATIONS,349
IT,OEDEMA,347
IT,PLASMA CELL MYELOMA,344
IT,BALANCE DISORDER,338
IT,RENAL IMPAIRMENT,335
IT,EXPOSURE DURING PREGNANCY,334
IT,HALLUCINATION,331
IT,MYOCARDIAL INFARCTION,329
IT,GENERAL PHYSICAL HEALTH DETERIORATION,327
IT,ASCITES,326
IT,PNEUMONITIS,322
IT,SPEECH DISORDER,322
IT,HAEMATOMA,319
IT,INFECTION,317
IT,OXYGEN SATURATION DECREASED,315
IT,CHILLS,313
IT,HAEMORRHAGE,313
IT,GASTROINTESTINAL HAEMORRHAGE,304
IT,HEPATIC FAILURE,303
IT,TONGUE OEDEMA,303
IT,ACUTE MYOCARDIAL INFARCTION,301
IT,DEEP VEIN THROMBOSIS,301
IT,ORTHOSTATIC HYPOTENSION,300
IT,FEELING HOT,299
IT,ASPARTATE AMINOTRANSFERASE INCREASED,297
IT,DYSPEPSIA,295
IT,DRUG RESISTANCE,294
IT,DEPRESSION,291
IT,BLOOD CREATINE PHOSPHOKINASE INCREASED,289
IT,HAEMOGLOBIN DECREASED,283
IT,ABORTION SPONTANEOUS,281
IT,NEUROPATHY PERIPHERAL,280
IT,DRUG HYPERSENSITIVITY,275
IT,ANAPHYLACTIC SHOCK,273
IT,INJURY,273
IT,DEPRESSED LEVEL OF CONSCIOUSNESS,270
IT,DISEASE RECURRENCE,269
IT,DYSPHONIA,267
IT,HYPOGLYCAEMIC COMA,267
IT,LARYNGEAL OEDEMA,263
IT,HYPOTHERMIA,257
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,254
IT,SINUS BRADYCARDIA,252
IT,VISION BLURRED,252
IT,ANURIA,250
IT,CEREBROVASCULAR ACCIDENT,250
IT,HEPATOCELLULAR CARCINOMA,250
IT,POISONING,250
IT,DRUG DEPENDENCE,249
IT,RASH GENERALISED,248
IT,NEUROTOXICITY,242
IT,DYSKINESIA,237
IT,SUBDURAL HAEMATOMA,235
IT,INCORRECT DOSE ADMINISTERED,234
IT,EYELID OEDEMA,233
IT,INTERSTITIAL LUNG DISEASE,233
IT,HYPOCALCAEMIA,230
IT,PALLOR,230
IT,AGGRESSION,229
IT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,228
IT,MUSCLE SPASMS,225
IT,ACUTE RESPIRATORY FAILURE,224
IT,ISCHAEMIC STROKE,224
IT,RETCHING,224
IT,PSYCHOMOTOR RETARDATION,223
IT,LARYNGOSPASM,222
IT,ARRHYTHMIA,218
IT,OSTEONECROSIS,215
IT,HEPATITIS ACUTE,213
IT,ACCIDENTAL OVERDOSE,212
IT,CYANOSIS,212
IT,OSTEOPOROSIS,211
IT,PULMONARY OEDEMA,208
IT,SKIN EXFOLIATION,207
IT,VISUAL IMPAIRMENT,207
IT,PRODUCT SUBSTITUTION ISSUE,206
IT,WEIGHT INCREASED,206
IT,HEPATITIS C,205
IT,MIOSIS,203
IT,MUSCLE RIGIDITY,203
IT,TRANSIENT ISCHAEMIC ATTACK,203
IT,COLD SWEAT,202
IT,DERMATITIS BULLOUS,201
IT,SEDATION,200
IT,SLUGGISHNESS,200
IT,NEPHROPATHY TOXIC,198
IT,SKIN TOXICITY,198
IT,GASTROINTESTINAL DISORDER,196
IT,URINARY TRACT INFECTION,196
IT,HAEMATOTOXICITY,195
IT,SUICIDAL IDEATION,195
IT,BLOOD BILIRUBIN INCREASED,194
IT,COGNITIVE DISORDER,194
IT,PANCREATITIS ACUTE,192
IT,DRUG-INDUCED LIVER INJURY,191
IT,HYPOMAGNESAEMIA,191
IT,HYPOKINESIA,190
IT,PROTEINURIA,190
IT,MYELODYSPLASTIC SYNDROME,189
IT,RASH ERYTHEMATOUS,189
IT,ALTERED STATE OF CONSCIOUSNESS,188
IT,DYSENTERY,187
IT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,187
IT,RASH MACULO-PAPULAR,187
IT,ANAPHYLACTIC REACTION,186
IT,CHRONIC KIDNEY DISEASE,184
IT,LEUKOCYTOSIS,184
IT,ABDOMINAL DISTENSION,183
IT,ATAXIA,183
IT,PREMATURE BABY,181
IT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,180
IT,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,180
IT,PSYCHOMOTOR SKILLS IMPAIRED,179
IT,MUSCULAR WEAKNESS,178
IT,DRUG INTOLERANCE,177
IT,IRRITABILITY,177
IT,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,177
IT,CEREBRAL ISCHAEMIA,176
IT,HAEMOPTYSIS,176
IT,URINARY RETENTION,175
IT,DRY MOUTH,173
IT,SKIN LESION,173
IT,BONE MARROW FAILURE,172
IT,CONJUNCTIVITIS,171
IT,MULTI-ORGAN FAILURE,171
IT,SHOCK,171
IT,GENERALISED ERYTHEMA,170
IT,NO THERAPEUTIC RESPONSE,170
IT,CYTOMEGALOVIRUS INFECTION,169
IT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,166
IT,TREATMENT FAILURE,166
IT,CARDIOTOXICITY,165
IT,DROP ATTACKS,165
IT,MYDRIASIS,165
IT,TOXIC EPIDERMAL NECROLYSIS,165
IT,PLATELET COUNT DECREASED,164
IT,THERAPEUTIC RESPONSE DECREASED,164
IT,LIVER DISORDER,162
IT,EXTRAPYRAMIDAL DISORDER,159
IT,PSYCHOTIC DISORDER,159
IT,PALATAL OEDEMA,158
IT,RESTLESSNESS,158
IT,BRONCHITIS,157
IT,SUBARACHNOID HAEMORRHAGE,156
IT,PETECHIAE,155
IT,INTESTINAL OBSTRUCTION,154
IT,STEVENS-JOHNSON SYNDROME,153
IT,DELIRIUM,152
IT,HEPATIC ENZYME INCREASED,152
IT,GASTRIC ULCER,151
IT,ACUTE MYELOID LEUKAEMIA,150
IT,HERPES ZOSTER,150
IT,HALLUCINATION_ VISUAL,148
IT,DIABETES MELLITUS,147
IT,MUSCULOSKELETAL PAIN,147
IT,SINUS TACHYCARDIA,147
IT,DRUG ADMINISTRATION ERROR,146
IT,DYSTONIA,146
IT,GASTRITIS EROSIVE,146
IT,HYPOCOAGULABLE STATE,146
IT,HYPOXIA,146
IT,ELECTROLYTE IMBALANCE,145
IT,VISUAL ACUITY REDUCED,145
IT,ACUTE CORONARY SYNDROME,144
IT,TACHYPNOEA,144
IT,CHOLESTASIS,142
IT,GASTRITIS,142
IT,TRANSFUSION,142
IT,DIPLOPIA,141
IT,ANGINA PECTORIS,140
IT,DYSGEUSIA,140
IT,HEMIPARESIS,140
IT,BLOOD PRESSURE DECREASED,139
IT,DUODENAL ULCER,139
IT,CARDIO-RESPIRATORY ARREST,138
IT,LYMPHADENOPATHY,136
IT,PARAESTHESIA ORAL,136
IT,PERICARDIAL EFFUSION,136
IT,EJECTION FRACTION DECREASED,134
IT,SKIN REACTION,134
IT,TOXIC SKIN ERUPTION,134
IT,GENERALISED TONIC-CLONIC SEIZURE,133
IT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,133
IT,PARKINSONISM,133
IT,SWELLING,133
IT,RESPIRATORY DISTRESS,132
IT,BLISTER,131
IT,LIVER INJURY,131
IT,DYSPNOEA EXERTIONAL,130
IT,VIROLOGIC FAILURE,130
IT,BREAST CANCER,129
IT,DERMATITIS EXFOLIATIVE,129
IT,GASTROINTESTINAL TOXICITY,128
IT,HYPOAESTHESIA,128
IT,MYOCARDIAL ISCHAEMIA,128
IT,HOT FLUSH,127
IT,URINARY INCONTINENCE,127
IT,DERMATITIS,126
IT,HYPOTHYROIDISM,126
IT,SUDDEN DEATH,126
IT,NERVOUS SYSTEM DISORDER,125
IT,ADVERSE EVENT,124
IT,DRUG LEVEL INCREASED,124
IT,HAEMATOCHEZIA,124
IT,DEPRESSED MOOD,123
IT,INFLUENZA,123
IT,PANCREATITIS,123
IT,LYMPHOPENIA,122
IT,MOVEMENT DISORDER,122
IT,PATHOGEN RESISTANCE,122
IT,DYSURIA,121
IT,BONE PAIN,120
IT,CONTUSION,118
IT,CONVULSION,118
IT,EXPOSED BONE IN JAW,118
IT,OLIGURIA,118
IT,BLOOD GLUCOSE INCREASED,117
IT,INTESTINAL PERFORATION,117
IT,PURPURA,117
IT,SLOW SPEECH,117
IT,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,115
IT,PHARYNGEAL OEDEMA,115
IT,BLOOD LACTATE DEHYDROGENASE INCREASED,113
IT,ERYTHEMA MULTIFORME,113
IT,FEMUR FRACTURE,113
IT,TREATMENT NONCOMPLIANCE,113
IT,ACUTE HEPATIC FAILURE,112
IT,CARDIAC DISORDER,112
IT,IRON DEFICIENCY ANAEMIA,111
IT,MULTIPLE SCLEROSIS RELAPSE,111
IT,SWELLING FACE,111
IT,COMPLETED SUICIDE,110
IT,DIABETES MELLITUS INADEQUATE CONTROL,110
IT,HEMIPLEGIA,110
IT,DYSSTASIA,109
IT,RESPIRATORY ARREST,109
IT,VIRAL MUTATION IDENTIFIED,108
IT,CHOKING SENSATION,107
IT,DISTURBANCE IN ATTENTION,107
IT,SALIVARY HYPERSECRETION,107
IT,SHOCK HAEMORRHAGIC,107
IT,UNRESPONSIVE TO STIMULI,107
IT,ACUTE PULMONARY OEDEMA,106
IT,CHOLELITHIASIS,106
IT,LIPASE INCREASED,106
IT,MYOPATHY,106
IT,AMNESIA,104
IT,FORMICATION,104
IT,PREMATURE DELIVERY,104
IT,SECOND PRIMARY MALIGNANCY,104
IT,C-REACTIVE PROTEIN INCREASED,103
IT,ENCEPHALOPATHY,103
IT,HEART RATE INCREASED,103
IT,OROPHARYNGEAL PAIN,103
IT,BRONCHOPNEUMONIA,102
IT,BASAL CELL CARCINOMA,101
IT,CRYING,101
IT,HYPERAEMIA,101
IT,HYPERAMMONAEMIA,101
IT,ACCIDENTAL EXPOSURE TO PRODUCT,100
IT,GRAVITATIONAL OEDEMA,100
IT,PERIORBITAL OEDEMA,100
IT,PERIPHERAL SWELLING,100
IT,ECCHYMOSIS,99
IT,EOSINOPHILIA,99
IT,GASTRIC HAEMORRHAGE,99
IT,HYPERTHERMIA,99
IT,KAPOSI^S SARCOMA,99
IT,RESPIRATORY DISORDER,99
IT,HEPATIC ENCEPHALOPATHY,98
IT,HEPATOCELLULAR INJURY,98
IT,HEPATITIS,97
IT,ALCOHOL INTERACTION,96
IT,DELUSION,96
IT,STATUS EPILEPTICUS,96
IT,STILLBIRTH,96
IT,WHITE BLOOD CELL COUNT DECREASED,96
IT,ABDOMINAL DISCOMFORT,95
IT,HAEMORRHAGE INTRACRANIAL,95
IT,HYPONATRAEMIC SYNDROME,95
IT,SELF-MEDICATION,95
IT,ALCOHOL ABUSE,94
IT,GASTROENTERITIS,94
IT,HEPATIC FUNCTION ABNORMAL,94
IT,ABNORMAL BEHAVIOUR,93
IT,HYPERTHYROIDISM,93
IT,LETHARGY,92
IT,PERICARDITIS,92
IT,THROMBOSIS,92
IT,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,91
IT,AMYLASE INCREASED,91
IT,CARDIOVASCULAR DISORDER,91
IT,COLITIS,91
IT,DRUG EFFECT DECREASED,91
IT,EMBOLISM,91
IT,INCORRECT DRUG ADMINISTRATION DURATION,91
IT,INCORRECT ROUTE OF DRUG ADMINISTRATION,91
IT,LOCALISED OEDEMA,91
IT,LUNG DISORDER,91
IT,NEPHROLITHIASIS,91
IT,BLOOD ALKALINE PHOSPHATASE INCREASED,90
IT,NEUROLEPTIC MALIGNANT SYNDROME,90
IT,PSORIASIS,90
IT,GENERALISED OEDEMA,89
IT,RASH PRURITIC,89
IT,AUTOIMMUNE HAEMOLYTIC ANAEMIA,88
IT,DERMATITIS ALLERGIC,88
IT,ERECTILE DYSFUNCTION,88
IT,HYPOTONIA,88
IT,THERAPY NON-RESPONDER,88
IT,FISTULA,87
IT,PERITONITIS,87
IT,SEROTONIN SYNDROME,87
IT,SKIN ULCER,87
IT,THROMBOCYTOSIS,87
IT,ACUTE GRAFT VERSUS HOST DISEASE,86
IT,ARTHRITIS,86
IT,HEPATIC CIRRHOSIS,86
IT,LUNG INFECTION,86
IT,MOTOR DYSFUNCTION,85
IT,PULMONARY HYPERTENSION,85
IT,TORSADE DE POINTES,85
IT,APRAXIA,84
IT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,84
IT,ENTERITIS,84
IT,PANIC ATTACK,84
IT,ATRIAL FLUTTER,83
IT,DRUG EFFECT INCOMPLETE,83
IT,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,83
IT,HEPATITIS B,83
IT,HYPERCHOLESTEROLAEMIA,83
IT,TINNITUS,83
IT,BUNDLE BRANCH BLOCK RIGHT,82
IT,CARDIAC FAILURE ACUTE,82
IT,DRY SKIN,82
IT,ECZEMA,82
IT,MYOCLONUS,82
IT,PNEUMONIA ASPIRATION,82
IT,TRISMUS,82
IT,MOOD ALTERED,81
IT,MUSCULOSKELETAL STIFFNESS,81
IT,SUPRAVENTRICULAR TACHYCARDIA,81
IT,SYSTEMIC LUPUS ERYTHEMATOSUS,81
IT,ASTHMA,80
IT,CARDIOGENIC SHOCK,80
IT,HYPOVOLAEMIC SHOCK,80
IT,ILEUS PARALYTIC,80
IT,METASTASES TO LIVER,80
IT,CONJUNCTIVAL HAEMORRHAGE,79
IT,HYPERTONIA,79
IT,LOW BIRTH WEIGHT BABY,79
IT,RASH PUSTULAR,79
IT,ROAD TRAFFIC ACCIDENT,79
IT,BONE MARROW TOXICITY,78
IT,CARDIAC FAILURE CONGESTIVE,78
IT,FEELING ABNORMAL,78
IT,HAEMOLYTIC ANAEMIA,77
IT,INTESTINAL HAEMORRHAGE,77
IT,PHOTOSENSITIVITY REACTION,77
IT,POLYURIA,77
IT,PROSTATE CANCER,77
IT,VENTRICULAR EXTRASYSTOLES,77
IT,CLOSTRIDIUM DIFFICILE COLITIS,76
IT,CYSTITIS,76
IT,DISSEMINATED INTRAVASCULAR COAGULATION,76
IT,DIVERTICULITIS,76
IT,FLATULENCE,76
IT,GINGIVAL BLEEDING,76
IT,RASH PAPULAR,76
IT,SLEEP DISORDER,76
IT,VASCULITIS,76
IT,BLINDNESS,75
IT,DIABETIC METABOLIC DECOMPENSATION,75
IT,ELECTROCARDIOGRAM ABNORMAL,75
IT,FOLLICULITIS,75
IT,HEPATITIS CHOLESTATIC,75
IT,TACHYARRHYTHMIA,75
IT,TENDONITIS,75
IT,VENOUS THROMBOSIS,75
IT,WOUND,75
IT,DRUG WITHDRAWAL SYNDROME,74
IT,FAECALOMA,74
IT,HYPOACUSIS,74
IT,LUNG NEOPLASM MALIGNANT,74
IT,MEMORY IMPAIRMENT,74
IT,STUPOR,74
IT,BRADYARRHYTHMIA,73
IT,CACHEXIA,73
IT,CHROMATURIA,73
IT,RASH MACULAR,73
IT,CHOLECYSTITIS ACUTE,72
IT,COLITIS ULCERATIVE,72
IT,FAECES DISCOLOURED,72
IT,FUNGAL INFECTION,72
IT,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,72
IT,RESPIRATORY DEPRESSION,72
IT,ADVERSE DRUG REACTION,71
IT,BRONCHOSTENOSIS,71
IT,INTENTIONAL DRUG MISUSE,71
IT,MICROCYTIC ANAEMIA,71
IT,DYSAESTHESIA,70
IT,HAEMORRHAGIC ANAEMIA,70
IT,HEPATIC CANCER,70
IT,MITRAL VALVE INCOMPETENCE,70
IT,AKATHISIA,69
IT,HAEMORRHOIDS,69
IT,MIGRAINE,69
IT,WITHDRAWAL SYNDROME,69
IT,WRONG DRUG ADMINISTERED,69
IT,BURNING SENSATION,68
IT,DYSPHORIA,68
IT,NECK PAIN,68
IT,NEOPLASM PROGRESSION,68
IT,NO ADVERSE EVENT,68
IT,RHEUMATOID ARTHRITIS,68
IT,STRESS CARDIOMYOPATHY,68
IT,BLOOD SODIUM DECREASED,67
IT,BRONCHOPULMONARY ASPERGILLOSIS,67
IT,CIRCULATORY COLLAPSE,67
IT,THROAT IRRITATION,67
IT,ATRIOVENTRICULAR BLOCK COMPLETE,66
IT,CENTRAL NERVOUS SYSTEM LESION,66
IT,CLONUS,66
IT,DRUG PRESCRIBING ERROR,66
IT,HYPERCREATININAEMIA,66
IT,JOINT SWELLING,66
IT,BLOOD POTASSIUM DECREASED,65
IT,CONJUNCTIVAL HYPERAEMIA,65
IT,EXTRASYSTOLES,65
IT,JAUNDICE CHOLESTATIC,65
IT,PRODUCT MEASURED POTENCY ISSUE,65
IT,TUBULOINTERSTITIAL NEPHRITIS,65
IT,VENTRICULAR FIBRILLATION,65
IT,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,64
IT,HEAT STROKE,64
IT,MALIGNANT MELANOMA,64
IT,PRESCRIBED UNDERDOSE,64
IT,SPINAL FRACTURE,64
IT,FLUID RETENTION,63
IT,PRESCRIBED OVERDOSE,63
IT,ABORTION INDUCED,62
IT,APATHY,62
IT,ASPERGILLUS INFECTION,62
IT,BLOOD UREA INCREASED,62
IT,CYSTITIS HAEMORRHAGIC,62
IT,LIP SWELLING,62
IT,METASTASES TO BONE,62
IT,PREGNANCY,62
IT,THROMBOTIC MICROANGIOPATHY,62
IT,VENTRICULAR HYPOKINESIA,62
IT,AGRANULOCYTOSIS,61
IT,APNOEA,61
IT,ATRIOVENTRICULAR BLOCK FIRST DEGREE,61
IT,LACRIMATION INCREASED,61
IT,SWOLLEN TONGUE,61
IT,THROMBOPHLEBITIS,61
IT,DISCOMFORT,60
IT,FEELING COLD,60
IT,GRAFT VERSUS HOST DISEASE,60
IT,ISCHAEMIA,60
IT,METABOLIC DISORDER,60
IT,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,60
IT,DRUG WITHDRAWAL CONVULSIONS,59
IT,HYPERSENSITIVITY VASCULITIS,59
IT,VENOOCCLUSIVE LIVER DISEASE,59
IT,VENTRICULAR TACHYCARDIA,59
IT,CATATONIA,58
IT,LANGUAGE DISORDER,58
IT,MANIA,58
IT,WHEEZING,58
IT,CELLULITIS,57
IT,MALABSORPTION,57
IT,PEMPHIGOID,57
IT,SENSATION OF FOREIGN BODY,57
IT,TRANSPLANT REJECTION,57
IT,ATRIOVENTRICULAR BLOCK,56
IT,CAESAREAN SECTION,56
IT,CHRONIC GRAFT VERSUS HOST DISEASE,56
IT,HAEMOLYSIS,56
IT,HEPATIC STEATOSIS,56
IT,NEUROLOGICAL SYMPTOM,56
IT,NODAL ARRHYTHMIA,56
IT,NORMOCHROMIC NORMOCYTIC ANAEMIA,56
IT,ODYNOPHAGIA,56
IT,POLLAKIURIA,56
IT,POLYNEUROPATHY,56
IT,RENAL FAILURE CHRONIC,56
IT,RESPIRATORY ACIDOSIS,56
IT,HALLUCINATION_ AUDITORY,55
IT,HEPATOMEGALY,55
IT,INFLAMMATION,55
IT,MENTAL DISORDER,55
IT,PERIPHERAL SENSORY NEUROPATHY,55
IT,SKIN DISCOLOURATION,55
IT,TROPONIN INCREASED,55
IT,WHITE BLOOD CELL COUNT INCREASED,55
IT,ACUTE RESPIRATORY DISTRESS SYNDROME,54
IT,DISORGANISED SPEECH,54
IT,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,54
IT,GASTROOESOPHAGEAL REFLUX DISEASE,54
IT,KOUNIS SYNDROME,54
IT,NEPHROTIC SYNDROME,54
IT,PERIPHERAL ISCHAEMIA,54
IT,SENSORY DISTURBANCE,54
IT,STRANGURY,54
IT,BRAIN OEDEMA,53
IT,CEREBRAL HAEMATOMA,53
IT,HEPATIC LESION,53
IT,LONG QT SYNDROME,53
IT,MACROGLOSSIA,53
IT,METASTASIS,53
IT,NYSTAGMUS,53
IT,PARTIAL SEIZURES,53
IT,RETINAL DETACHMENT,53
IT,THERAPY RESPONDER,53
IT,TUBERCULOSIS,53
IT,DUODENAL ULCER HAEMORRHAGE,52
IT,ERYSIPELAS,52
IT,HYPERTRIGLYCERIDAEMIA,52
IT,OCULAR HYPERAEMIA,52
IT,PHOTOPHOBIA,52
IT,PORTAL VEIN THROMBOSIS,52
IT,SPONTANEOUS HAEMATOMA,52
IT,SURGERY,52
IT,ACIDOSIS,51
IT,COAGULOPATHY,51
IT,HAEMOLYTIC URAEMIC SYNDROME,51
IT,HYPERCHLORHYDRIA,51
IT,IMMUNE THROMBOCYTOPENIC PURPURA,51
IT,MUSCLE HAEMORRHAGE,51
IT,NEONATAL BEHAVIOURAL SYNDROME,51
IT,NON-HODGKIN^S LYMPHOMA,51
IT,PRODUCTIVE COUGH,51
IT,SKIN BURNING SENSATION,51
IT,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,50
IT,DIABETIC KETOACIDOSIS,50
IT,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,50
IT,FACIAL BONES FRACTURE,50
IT,FRACTURE,50
IT,GASTRIC DISORDER,50
IT,GLYCOSYLATED HAEMOGLOBIN INCREASED,50
IT,HEPATITIS B REACTIVATION,50
IT,LEFT VENTRICULAR DYSFUNCTION,50
IT,PAIN IN JAW,50
IT,AUTOIMMUNE HEPATITIS,49
IT,DRUG ERUPTION,49
IT,FACE INJURY,49
IT,HYPERCALCAEMIA,49
IT,NEUTROPHILIA,49
IT,OESOPHAGITIS,49
IT,STAPHYLOCOCCAL SEPSIS,49
IT,SUFFOCATION FEELING,49
IT,ASTHMATIC CRISIS,48
IT,ATRIOVENTRICULAR BLOCK SECOND DEGREE,48
IT,EYE PAIN,48
IT,HYPERCAPNIA,48
IT,KLEBSIELLA INFECTION,48
IT,MYOGLOBIN BLOOD INCREASED,48
IT,NEOPLASM MALIGNANT,48
IT,PETIT MAL EPILEPSY,48
IT,THROMBOTIC THROMBOCYTOPENIC PURPURA,48
IT,TROPONIN I INCREASED,48
IT,AZOTAEMIA,47
IT,CHOLANGITIS,47
IT,DERMATITIS ACNEIFORM,47
IT,NEONATAL RESPIRATORY DISTRESS SYNDROME,47
IT,NEURALGIA,47
IT,OCULOGYRIC CRISIS,47
IT,PANCREATIC CARCINOMA METASTATIC,47
IT,ABDOMINAL PAIN LOWER,46
IT,CONGESTIVE CARDIOMYOPATHY,46
IT,CONTRAINDICATED PRODUCT ADMINISTERED,46
IT,CRANIOCEREBRAL INJURY,46
IT,EMBOLIC STROKE,46
IT,HYPERLACTACIDAEMIA,46
IT,INVASIVE DUCTAL BREAST CARCINOMA,46
IT,LYMPHOCYTE COUNT DECREASED,46
IT,NERVOUSNESS,46
IT,NIGHTMARE,46
IT,SELF-INJURIOUS IDEATION,46
IT,SLOW RESPONSE TO STIMULI,46
IT,SPINAL PAIN,46
IT,SUPRAVENTRICULAR EXTRASYSTOLES,46
IT,ABSCESS,45
IT,CATARACT,45
IT,MYOCARDITIS,45
IT,OSTEOPENIA,45
IT,PARADOXICAL DRUG REACTION,45
IT,POVERTY OF SPEECH,45
IT,SECONDARY IMMUNODEFICIENCY,45
IT,SPLENOMEGALY,45
IT,BILIARY COLIC,44
IT,BLOOD LACTIC ACID INCREASED,44
IT,CROHN^S DISEASE,44
IT,GASTRIC ULCER HAEMORRHAGE,44
IT,HYPOMANIA,44
IT,HYPOPHOSPHATAEMIA,44
IT,HYPORESPONSIVE TO STIMULI,44
IT,INFLUENZA LIKE ILLNESS,44
IT,INJECTION SITE PAIN,44
IT,METASTASES TO LUNG,44
IT,PAPULE,44
IT,PNEUMOTHORAX,44
IT,ABASIA,43
IT,ANGINA UNSTABLE,43
IT,APHTHOUS ULCER,43
IT,CARDIOMYOPATHY,43
IT,CORONARY ARTERY DISEASE,43
IT,EYE MOVEMENT DISORDER,43
IT,GLOMERULAR FILTRATION RATE DECREASED,43
IT,HOSPITALISATION,43
IT,HYPERAMYLASAEMIA,43
IT,LOCAL SWELLING,43
IT,MOOD SWINGS,43
IT,NASOPHARYNGITIS,43
IT,PULMONARY MASS,43
IT,RALES,43
IT,RED BLOOD CELL COUNT DECREASED,43
IT,RHINITIS,43
IT,ANHEDONIA,42
IT,BUNDLE BRANCH BLOCK LEFT,42
IT,CANDIDA INFECTION,42
IT,DIARRHOEA HAEMORRHAGIC,42
IT,EROSIVE DUODENITIS,42
IT,ESCHERICHIA URINARY TRACT INFECTION,42
IT,JOINT STIFFNESS,42
IT,LIVER FUNCTION TEST ABNORMAL,42
IT,METABOLIC ALKALOSIS,42
IT,SALIVARY GLAND CANCER,42
IT,SQUAMOUS CELL CARCINOMA OF SKIN,42
IT,BLOOD POTASSIUM INCREASED,41
IT,CHOLECYSTITIS,41
IT,CYTOPENIA,41
IT,DOPAMINE DYSREGULATION SYNDROME,41
IT,HAEMATOCRIT DECREASED,41
IT,HYPERNATRAEMIA,41
IT,HYPOGLYCAEMIC UNCONSCIOUSNESS,41
IT,HYPOSIDERAEMIA,41
IT,INTERNATIONAL NORMALISED RATIO ABNORMAL,41
IT,MUSCLE CONTRACTIONS INVOLUNTARY,41
IT,OESOPHAGEAL VARICES HAEMORRHAGE,41
IT,POISONING DELIBERATE,41
IT,RESPIRATORY TRACT INFECTION,41
IT,SUBCUTANEOUS HAEMATOMA,41
IT,BLOOD CHOLESTEROL INCREASED,40
IT,CONDUCT DISORDER,40
IT,CONDUCTION DISORDER,40
IT,CRYOGLOBULINAEMIA,40
IT,EYE IRRITATION,40
IT,EYE OEDEMA,40
IT,EYE SWELLING,40
IT,FEELING JITTERY,40
IT,HAEMODYNAMIC INSTABILITY,40
IT,HERPES SIMPLEX,40
IT,HYPERLIPASAEMIA,40
IT,JOINT INJURY,40
IT,PACKED RED BLOOD CELL TRANSFUSION,40
IT,PHARYNGITIS,40
IT,PSORIATIC ARTHROPATHY,40
IT,RENAL TUBULAR DISORDER,40
IT,RETINAL HAEMORRHAGE,40
IT,RIB FRACTURE,40
IT,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,39
IT,ELECTROCARDIOGRAM T WAVE INVERSION,39
IT,EROSIVE OESOPHAGITIS,39
IT,GLYCOSURIA,39
IT,HEPATORENAL SYNDROME,39
IT,HICCUPS,39
IT,HYPOALBUMINAEMIA,39
IT,INCONTINENCE,39
IT,INJECTION SITE ERYTHEMA,39
IT,MAJOR DEPRESSION,39
IT,METASTASES TO CENTRAL NERVOUS SYSTEM,39
IT,METRORRHAGIA,39
IT,NEUROLOGICAL DECOMPENSATION,39
IT,NEUTROPHIL COUNT DECREASED,39
IT,PHLEBITIS,39
IT,ULCER,39
IT,UPPER RESPIRATORY TRACT INFECTION,39
IT,VISUAL FIELD DEFECT,39
IT,AFFECTIVE DISORDER,38
IT,DIFFUSE LARGE B-CELL LYMPHOMA,38
IT,HYDRONEPHROSIS,38
IT,MIXED LIVER INJURY,38
IT,ORAL CANDIDIASIS,38
IT,PARKINSON^S DISEASE,38
IT,SENSE OF OPPRESSION,38
IT,SQUAMOUS CELL CARCINOMA,38
IT,UNDERDOSE,38
IT,UVEITIS,38
IT,CEREBELLAR HAEMORRHAGE,37
IT,DIZZINESS POSTURAL,37
IT,EYE HAEMORRHAGE,37
IT,INFARCTION,37
IT,LICHENOID KERATOSIS,37
IT,OBSTRUCTIVE AIRWAYS DISORDER,37
IT,OSTEITIS,37
IT,POSTURE ABNORMAL,37
IT,STAPHYLOCOCCAL INFECTION,37
IT,ACUTE LYMPHOCYTIC LEUKAEMIA,36
IT,ARTHROPATHY,36
IT,BLOOD TRIGLYCERIDES INCREASED,36
IT,COLON CANCER,36
IT,DRUG DIVERSION,36
IT,DYSLIPIDAEMIA,36
IT,EPSTEIN-BARR VIRUS INFECTION,36
IT,ESCHERICHIA SEPSIS,36
IT,FOETAL GROWTH RESTRICTION,36
IT,LUPUS-LIKE SYNDROME,36
IT,MULTIPLE SCLEROSIS,36
IT,NEOPLASM,36
IT,OEDEMA MOUTH,36
IT,RETROPERITONEAL HAEMATOMA,36
IT,COMA SCALE ABNORMAL,35
IT,EPIGASTRIC DISCOMFORT,35
IT,GAZE PALSY,35
IT,HYPERPHOSPHATAEMIA,35
IT,HYPOREFLEXIA,35
IT,LOCALISED INFECTION,35
IT,MENINGIOMA,35
IT,METASTASES TO LYMPH NODES,35
IT,NAIL DISORDER,35
IT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,35
IT,PLEUROTHOTONUS,35
IT,RASH MORBILLIFORM,35
IT,RENAL PAIN,35
IT,SINUSITIS,35
IT,SUBSTANCE ABUSE,35
IT,TOOTH ABSCESS,35
IT,DEAFNESS,34
IT,ENTEROCOCCAL INFECTION,34
IT,EYELID PTOSIS,34
IT,FOETAL DEATH,34
IT,HEART RATE DECREASED,34
IT,HYPERKERATOSIS,34
IT,LARGE INTESTINE PERFORATION,34
IT,PERITONITIS BACTERIAL,34
IT,PULMONARY INFARCTION,34
IT,PULMONARY TOXICITY,34
IT,PURULENT DISCHARGE,34
IT,SJOGREN^S SYNDROME,34
IT,SKIN DISORDER,34
IT,SMALL FOR DATES BABY,34
IT,SYSTEMIC CANDIDA,34
IT,ACTINIC KERATOSIS,33
IT,ACTIVITIES OF DAILY LIVING IMPAIRED,33
IT,BREATH SOUNDS ABNORMAL,33
IT,GASTRIC CANCER,33
IT,HIATUS HERNIA,33
IT,HODGKIN^S DISEASE,33
IT,HYPOCHLORAEMIA,33
IT,LABORATORY TEST ABNORMAL,33
IT,LIPODYSTROPHY ACQUIRED,33
IT,PARALYSIS,33
IT,PLEURISY,33
IT,PORTAL HYPERTENSION,33
IT,PRODUCT QUALITY ISSUE,33
IT,PULMONARY FIBROSIS,33
IT,RECURRENT CANCER,33
IT,RENAL COLIC,33
IT,TETANY,33
IT,THIRST,33
IT,TRICUSPID VALVE INCOMPETENCE,33
IT,VITAMIN D DEFICIENCY,33
IT,ABDOMINAL WALL HAEMATOMA,32
IT,ANGER,32
IT,BACTERIAL INFECTION,32
IT,BACTERIAL SEPSIS,32
IT,BODY TEMPERATURE INCREASED,32
IT,CYTOKINE RELEASE SYNDROME,32
IT,DRUG DOSE OMISSION,32
IT,HAEMORRHAGIC STROKE,32
IT,HYPERCREATINAEMIA,32
IT,INCREASED APPETITE,32
IT,INTENTIONAL PRODUCT USE ISSUE,32
IT,LYMPHOMA,32
IT,MENTAL IMPAIRMENT,32
IT,OPTIC NEURITIS,32
IT,PARONYCHIA,32
IT,PATHOLOGICAL FRACTURE,32
IT,POST-INJECTION DELIRIUM SEDATION SYNDROME,32
IT,POTENTIATING DRUG INTERACTION,32
IT,PROTHROMBIN TIME PROLONGED,32
IT,SUBDURAL HAEMORRHAGE,32
IT,TONIC CLONIC MOVEMENTS,32
IT,VIRAL INFECTION,32
IT,ADRENAL INSUFFICIENCY,31
IT,ANAEMIA MACROCYTIC,31
IT,ANAL INCONTINENCE,31
IT,B-CELL LYMPHOMA,31
IT,CARDIOPULMONARY FAILURE,31
IT,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,31
IT,EYE PRURITUS,31
IT,GASTROINTESTINAL HYPOMOTILITY,31
IT,GRAND MAL CONVULSION,31
IT,HEPATIC NEOPLASM,31
IT,HEPATITIS C RNA INCREASED,31
IT,HYPERPHAGIA,31
IT,HYPOPARATHYROIDISM,31
IT,LIVER TRANSPLANT REJECTION,31
IT,LUNG ADENOCARCINOMA,31
IT,MYOSITIS,31
IT,ORAL DISCOMFORT,31
IT,PANCREATIC CARCINOMA,31
IT,PELVIC PAIN,31
IT,RHINORRHOEA,31
IT,SUBILEUS,31
IT,SUDDEN CARDIAC DEATH,31
IT,UNEVALUABLE EVENT,31
IT,WOUND DEHISCENCE,31
IT,ABNORMAL WEIGHT GAIN,30
IT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,30
IT,ACUTE ABDOMEN,30
IT,ANGULAR CHEILITIS,30
IT,APPENDICITIS,30
IT,CEREBROVASCULAR DISORDER,30
IT,CORONARY ARTERY OCCLUSION,30
IT,DEVICE RELATED INFECTION,30
IT,DRY EYE,30
IT,DYSPNOEA AT REST,30
IT,FAECAL INCONTINENCE,30
IT,GASTRITIS HAEMORRHAGIC,30
IT,GRAFT VERSUS HOST DISEASE IN SKIN,30
IT,GROWTH RETARDATION,30
IT,LEUKOENCEPHALOPATHY,30
IT,LUNG CONSOLIDATION,30
IT,MOBILITY DECREASED,30
IT,NEUTROPHIL COUNT INCREASED,30
IT,ORAL DISORDER,30
IT,PARAPARESIS,30
IT,PERITONEAL HAEMORRHAGE,30
IT,PROCTITIS,30
IT,SKIN FISSURES,30
IT,SLE ARTHRITIS,30
IT,BLADDER CANCER,29
IT,BLOOD PRESSURE FLUCTUATION,29
IT,BRAIN INJURY,29
IT,CARDIAC VENTRICULAR THROMBOSIS,29
IT,CEREBELLAR SYNDROME,29
IT,CLOSTRIDIUM DIFFICILE INFECTION,29
IT,COLITIS ISCHAEMIC,29
IT,ENCEPHALITIS,29
IT,ENTEROCOLITIS,29
IT,EXOPHTHALMOS,29
IT,FLANK PAIN,29
IT,HAEMARTHROSIS,29
IT,HEPATITIS TOXIC,29
IT,LEFT VENTRICULAR HYPERTROPHY,29
IT,MUSCULOSKELETAL CHEST PAIN,29
IT,NEPHRITIS,29
IT,NON-HODGKIN^S LYMPHOMA RECURRENT,29
IT,OSTEOARTHRITIS,29
IT,PARAPLEGIA,29
IT,PNEUMONIA BACTERIAL,29
IT,RENAL DISORDER,29
IT,RENAL TUBULAR NECROSIS,29
IT,STEREOTYPY,29
IT,TUMOUR LYSIS SYNDROME,29
IT,VENTRICULAR ARRHYTHMIA,29
IT,VIRAL LOAD INCREASED,29
IT,ABDOMINAL TENDERNESS,28
IT,BIPOLAR DISORDER,28
IT,BRADYPNOEA,28
JM,ANAESTHETIC COMPLICATION NEUROLOGICAL,56
JM,DEATH,45
JM,CEREBROVASCULAR ACCIDENT,9
JM,CHRONIC MYELOID LEUKAEMIA,7
JM,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,7
JM,DRUG INEFFECTIVE,7
JM,MYOCARDIAL INFARCTION,7
JM,THROMBOCYTOPENIA,7
JM,ANAEMIA,6
JM,DIARRHOEA,6
JM,MALIGNANT NEOPLASM PROGRESSION,6
JM,PROCEDURAL HAEMORRHAGE,6
JM,PSEUDOMEMBRANOUS COLITIS,6
JM,PULMONARY EMBOLISM,6
JM,VOMITING,6
JM,CLOSTRIDIUM DIFFICILE INFECTION,5
JM,DYSPNOEA,5
JM,GASTROINTESTINAL HAEMORRHAGE,5
JM,HAEMORRHAGE,5
JM,INTESTINAL PERFORATION,5
JM,MEGACOLON,5
JM,PATHOLOGICAL FRACTURE,5
JM,PNEUMONIA,5
JM,PYREXIA,5
JM,CARDIAC FAILURE,4
JM,DRUG RESISTANCE,4
JM,HYPERSENSITIVITY,4
JM,KLEBSIELLA SEPSIS,4
JM,LEUKOPENIA,4
JM,PULMONARY OEDEMA,4
JM,SEIZURE,4
JM,STEVENS-JOHNSON SYNDROME,4
JM,URINARY RETENTION,4
JM,ABDOMINAL PAIN,3
JM,ACUTE KIDNEY INJURY,3
JM,ACUTE RESPIRATORY DISTRESS SYNDROME,3
JM,ASTHENIA,3
JM,DEEP VEIN THROMBOSIS,3
JM,DEHYDRATION,3
JM,HYPOTENSION,3
JM,ISCHAEMIC STROKE,3
JM,MALAISE,3
JM,NAUSEA,3
JM,RENAL FAILURE,3
JM,RESPIRATORY FAILURE,3
JM,SKIN EXFOLIATION,3
JM,TACHYCARDIA,3
JM,THROMBOSIS,3
JM,UPPER GASTROINTESTINAL HAEMORRHAGE,3
JM,ATRIAL FIBRILLATION,2
JM,BLADDER CATHETERISATION,2
JM,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,2
JM,BONE PAIN,2
JM,CARDIO-RESPIRATORY DISTRESS,2
JM,CHEST PAIN,2
JM,CHIKUNGUNYA VIRUS INFECTION,2
JM,CONSTIPATION,2
JM,CONVULSION,2
JM,COUGH,2
JM,DECREASED APPETITE,2
JM,DRUG DELIVERY DEVICE REMOVAL,2
JM,FATIGUE,2
JM,GASTRITIS,2
JM,HAEMATEMESIS,2
JM,HAEMATURIA,2
JM,HEADACHE,2
JM,HEMIPARESIS,2
JM,HEPATOMEGALY,2
JM,HYPOAESTHESIA,2
JM,KLEBSIELLA INFECTION,2
JM,LOWER RESPIRATORY TRACT INFECTION,2
JM,MYALGIA,2
JM,NO THERAPEUTIC RESPONSE,2
JM,PAIN IN EXTREMITY,2
JM,PERIPHERAL SWELLING,2
JM,PROSTATOMEGALY,2
JM,PRURITUS,2
JM,RASH ERYTHEMATOUS,2
JM,RASH PUSTULAR,2
JM,RECTAL HAEMORRHAGE,2
JM,RENAL IMPAIRMENT,2
JM,SECOND PRIMARY MALIGNANCY,2
JM,SEIZURE LIKE PHENOMENA,2
JM,SEPTIC SHOCK,2
JM,SINUSITIS,2
JM,SPLENOMEGALY,2
JM,SUICIDAL IDEATION,2
JM,SYNCOPE,2
JM,UNEVALUABLE EVENT,2
JM,URTICARIA,2
JM,WHITE BLOOD CELL COUNT INCREASED,2
JM,ABDOMINAL DISTENSION,1
JM,ACCIDENT,1
JM,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
JM,ADENOCARCINOMA GASTRIC,1
JM,AGITATION,1
JM,ANAEMIA OF MALIGNANT DISEASE,1
JM,ANAESTHETIC COMPLICATION,1
JM,ANGER,1
JM,ANGINA PECTORIS,1
JM,ANXIETY,1
JM,APNOEIC ATTACK,1
JM,ARRHYTHMIA,1
JM,ASCITES,1
JM,ASPARTATE AMINOTRANSFERASE INCREASED,1
JM,ASTHMA,1
JM,BACK PAIN,1
JM,BACTERAEMIA,1
JM,BACTERIAL INFECTION,1
JM,BLOOD ALBUMIN DECREASED,1
JM,BLOOD ALKALINE PHOSPHATASE INCREASED,1
JM,BLOOD CREATININE INCREASED,1
JM,BLOOD PRESSURE INCREASED,1
JM,BLOOD UREA INCREASED,1
JM,BLOOD URIC ACID INCREASED,1
JM,BODY TEMPERATURE INCREASED,1
JM,BONE MARROW RETICULIN FIBROSIS,1
JM,BRAIN HERNIATION,1
JM,CARDIAC ARREST,1
JM,CARDIAC DISORDER,1
JM,CARDIAC FAILURE CONGESTIVE,1
JM,CARDIOMYOPATHY,1
JM,CARDIOVASCULAR DISORDER,1
JM,CELLULITIS,1
JM,CEREBRAL HAEMORRHAGE,1
JM,CEREBRAL ISCHAEMIA,1
JM,CHEST DISCOMFORT,1
JM,CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION,1
JM,CLEFT LIP,1
JM,COAGULOPATHY,1
JM,COGNITIVE DISORDER,1
JM,CONCOMITANT DISEASE AGGRAVATED,1
JM,CONFUSIONAL STATE,1
JM,CONVERSION DISORDER,1
JM,CRYING,1
JM,DECUBITUS ULCER,1
JM,DEPRESSED LEVEL OF CONSCIOUSNESS,1
JM,DEPRESSION,1
JM,DEVICE DISLOCATION,1
JM,DEVICE FAILURE,1
JM,DISEASE COMPLICATION,1
JM,DISEASE PROGRESSION,1
JM,DISORIENTATION,1
JM,DIZZINESS,1
JM,DRUG EFFECT DECREASED,1
JM,DRUG EFFECT DELAYED,1
JM,DRUG PRESCRIBING ERROR,1
JM,DUODENAL ULCER,1
JM,DYSBACTERIOSIS,1
JM,DYSSTASIA,1
JM,EMBOLISM VENOUS,1
JM,EMOTIONAL DISTRESS,1
JM,EMPHYSEMA,1
JM,EMPTY SELLA SYNDROME,1
JM,ENDOMETRIAL CANCER,1
JM,ERYTHEMA MULTIFORME,1
JM,ERYTHEMA NODOSUM,1
JM,EXPIRED PRODUCT ADMINISTERED,1
JM,EXPOSURE DURING PREGNANCY,1
JM,EXTRAPULMONARY TUBERCULOSIS,1
JM,FALL,1
JM,FEAR,1
JM,FEELING ABNORMAL,1
JM,FISTULA,1
JM,FLATULENCE,1
JM,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
JM,GASTROINTESTINAL SOUNDS ABNORMAL,1
JM,GASTROINTESTINAL STROMAL TUMOUR,1
JM,GENERAL PHYSICAL HEALTH DETERIORATION,1
JM,HAEMATOMA,1
JM,HAEMOGLOBIN DECREASED,1
JM,HAEMORRHAGE INTRACRANIAL,1
JM,HAEMOTHORAX,1
JM,HALLUCINATION_ VISUAL,1
JM,HEPATIC CANCER,1
JM,HEPATIC FAILURE,1
JM,HEPATIC FUNCTION ABNORMAL,1
JM,HIV TEST POSITIVE,1
JM,HOSPITALISATION,1
JM,HYPERKALAEMIA,1
JM,HYPERSPLENISM,1
JM,HYPERTENSION,1
JM,HYPERTENSIVE HEART DISEASE,1
JM,HYPOACUSIS,1
JM,HYPOAESTHESIA ORAL,1
JM,HYPOXIA,1
JM,IDIOPATHIC PULMONARY FIBROSIS,1
JM,INFECTED FISTULA,1
JM,INSOMNIA,1
JM,INTERNATIONAL NORMALISED RATIO INCREASED,1
JM,INTESTINAL OBSTRUCTION,1
JM,LARGE INTESTINE PERFORATION,1
JM,LEFT VENTRICULAR FAILURE,1
JM,LEUKAEMIA,1
JM,LEUKOCYTOSIS,1
JM,LEUKOSTASIS SYNDROME,1
JM,LIBIDO DECREASED,1
JM,LIVER FUNCTION TEST ABNORMAL,1
JM,LOCAL SWELLING,1
JM,LOSS OF CONSCIOUSNESS,1
JM,LOWER GASTROINTESTINAL HAEMORRHAGE,1
JM,LUNG DISORDER,1
JM,LUNG NEOPLASM MALIGNANT,1
JM,LYMPHADENOPATHY,1
JM,LYMPHOMA,1
JM,MENORRHAGIA,1
JM,MENTAL STATUS CHANGES,1
JM,METABOLIC ACIDOSIS,1
JM,METASTASES TO LIVER,1
JM,MUCOSAL DISCOLOURATION,1
JM,MUSCLE SPASMS,1
JM,MYELOFIBROSIS,1
JM,MYOCARDIAL ISCHAEMIA,1
JM,NEOPLASM MALIGNANT,1
JM,NEOPLASM PROGRESSION,1
JM,NERVOUSNESS,1
JM,NEUTROPHIL PERCENTAGE INCREASED,1
JM,NOCTURNAL DYSPNOEA,1
JM,NON-CARDIAC CHEST PAIN,1
JM,OEDEMA PERIPHERAL,1
JM,ONYCHOLYSIS,1
JM,OROPHARYNGEAL PAIN,1
JM,OSTEONECROSIS OF JAW,1
JM,OVERDOSE,1
JM,PARONYCHIA,1
JM,PERITONITIS,1
JM,PLASMA CELL MYELOMA,1
JM,PLASMACYTOMA,1
JM,PLATELET COUNT DECREASED,1
JM,PLEURAL EFFUSION,1
JM,PNEUMONIA ASPIRATION,1
JM,POLYP,1
JM,POSTOPERATIVE WOUND INFECTION,1
JM,PRESYNCOPE,1
JM,PROSTATE CANCER,1
JM,PROTEIN TOTAL DECREASED,1
JM,PSORIATIC ARTHROPATHY,1
JM,PULMONARY HYPERTENSION,1
JM,RASH,1
JM,RASH GENERALISED,1
JM,RASH VESICULAR,1
JM,RECTAL CANCER,1
JM,RENAL TUBULAR NECROSIS,1
JM,RESPIRATORY DISTRESS,1
JM,RESTLESSNESS,1
JM,RETINAL DETACHMENT,1
JM,RETROPERITONEAL MASS,1
JM,RHABDOMYOLYSIS,1
JM,SCREAMING,1
JM,SHOCK,1
JM,SOMNOLENCE,1
JM,SPLENIC INFARCTION,1
JM,SPLENIC RUPTURE,1
JM,STARING,1
JM,SUBDURAL HAEMATOMA,1
JM,SUDDEN DEATH,1
JM,SWOLLEN TONGUE,1
JM,THERAPEUTIC RESPONSE UNEXPECTED,1
JM,THROAT IRRITATION,1
JM,TONGUE INJURY,1
JM,TUBULOINTERSTITIAL NEPHRITIS,1
JM,URINARY TRACT DISORDER,1
JM,URINARY TRACT INFECTION,1
JM,URINE OUTPUT DECREASED,1
JM,UTERINE LEIOMYOMA,1
JM,VAGINAL HAEMORRHAGE,1
JM,VENTRICULAR EXTRASYSTOLES,1
JM,VESSEL PUNCTURE SITE HAEMORRHAGE,1
JM,VISUAL IMPAIRMENT,1
JM,WEIGHT DECREASED,1
JM,WHEEZING,1
JM,WITHDRAWAL SYNDROME,1
JP,PYREXIA,7498
JP,INTERSTITIAL LUNG DISEASE,5936
JP,ANAEMIA,5638
JP,PLATELET COUNT DECREASED,5638
JP,PNEUMONIA,5387
JP,DECREASED APPETITE,5239
JP,DIARRHOEA,4622
JP,HEPATIC FUNCTION ABNORMAL,4621
JP,RENAL IMPAIRMENT,4446
JP,NAUSEA,4386
JP,DEATH,4206
JP,MALAISE,3908
JP,RASH,3820
JP,WHITE BLOOD CELL COUNT DECREASED,3730
JP,CEREBRAL INFARCTION,3726
JP,MALIGNANT NEOPLASM PROGRESSION,3696
JP,DRUG INEFFECTIVE,3251
JP,CARDIAC FAILURE,3075
JP,VOMITING,3029
JP,FALL,2947
JP,NEUTROPHIL COUNT DECREASED,2882
JP,FEBRILE NEUTROPENIA,2456
JP,ALTERED STATE OF CONSCIOUSNESS,2384
JP,LIVER DISORDER,2327
JP,HAEMOGLOBIN DECREASED,2287
JP,NEUTROPENIA,2247
JP,DYSPNOEA,2136
JP,SEPSIS,2101
JP,DIZZINESS,2079
JP,CONDITION AGGRAVATED,2040
JP,LOSS OF CONSCIOUSNESS,1998
JP,OSTEONECROSIS OF JAW,1994
JP,ALANINE AMINOTRANSFERASE INCREASED,1940
JP,DISEASE PROGRESSION,1915
JP,ASPARTATE AMINOTRANSFERASE INCREASED,1902
JP,STOMATITIS,1890
JP,HYPERTENSION,1887
JP,DRUG ERUPTION,1775
JP,DISSEMINATED INTRAVASCULAR COAGULATION,1767
JP,BLOOD CREATININE INCREASED,1732
JP,PLEURAL EFFUSION,1704
JP,SOMNOLENCE,1691
JP,PNEUMONIA ASPIRATION,1680
JP,THROMBOCYTOPENIA,1658
JP,CONSTIPATION,1652
JP,HEADACHE,1600
JP,DEHYDRATION,1598
JP,PLASMA CELL MYELOMA,1568
JP,ERYTHEMA,1510
JP,C-REACTIVE PROTEIN INCREASED,1489
JP,BLOOD PRESSURE DECREASED,1479
JP,BONE MARROW FAILURE,1463
JP,PANCYTOPENIA,1460
JP,CEREBRAL HAEMORRHAGE,1413
JP,DELIRIUM,1370
JP,RHABDOMYOLYSIS,1366
JP,HOSPITALISATION,1349
JP,PRURITUS,1328
JP,RESPIRATORY FAILURE,1314
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,1288
JP,FRACTURE,1287
JP,RENAL DISORDER,1272
JP,ACUTE KIDNEY INJURY,1271
JP,BLOOD CREATINE PHOSPHOKINASE INCREASED,1269
JP,ABDOMINAL PAIN,1235
JP,HYPONATRAEMIA,1225
JP,OVERDOSE,1215
JP,OEDEMA PERIPHERAL,1211
JP,GASTROINTESTINAL HAEMORRHAGE,1203
JP,HYPOGLYCAEMIA,1201
JP,DRUG-INDUCED LIVER INJURY,1193
JP,OEDEMA,1175
JP,INFECTION,1156
JP,FATIGUE,1142
JP,BLOOD BILIRUBIN INCREASED,1121
JP,INSOMNIA,1107
JP,SEIZURE,1100
JP,ARTHRALGIA,1065
JP,LEUKOPENIA,1055
JP,DIABETES MELLITUS,1049
JP,ASCITES,1040
JP,COUGH,1040
JP,DYSPHAGIA,1038
JP,HYPOKALAEMIA,1031
JP,ASTHENIA,1030
JP,HYPOAESTHESIA,1028
JP,WHITE BLOOD CELL COUNT INCREASED,1025
JP,PAIN,1017
JP,RENAL FAILURE,1012
JP,ILEUS,1010
JP,ERYTHEMA MULTIFORME,1005
JP,BACK PAIN,967
JP,ELECTROCARDIOGRAM QT PROLONGED,956
JP,MATERNAL EXPOSURE DURING PREGNANCY,946
JP,BLOOD ALKALINE PHOSPHATASE INCREASED,932
JP,PRODUCT USE ISSUE,932
JP,HEPATOCELLULAR CARCINOMA,929
JP,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,923
JP,GAMMA-GLUTAMYLTRANSFERASE INCREASED,920
JP,MELAENA,920
JP,GAIT DISTURBANCE,915
JP,SEPTIC SHOCK,913
JP,HYPERKALAEMIA,904
JP,ATRIAL FIBRILLATION,866
JP,NASOPHARYNGITIS,855
JP,NEUROPATHY PERIPHERAL,855
JP,BLOOD PRESSURE INCREASED,850
JP,SUICIDE ATTEMPT,844
JP,FOETAL EXPOSURE DURING PREGNANCY,833
JP,PNEUMOCYSTIS JIROVECII PNEUMONIA,832
JP,URINARY TRACT INFECTION,826
JP,BRADYCARDIA,825
JP,HERPES ZOSTER,823
JP,COLON CANCER,820
JP,TOXICITY TO VARIOUS AGENTS,806
JP,HAEMORRHAGE,805
JP,EPILEPSY,803
JP,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,803
JP,WEIGHT DECREASED,791
JP,BLOOD LACTATE DEHYDROGENASE INCREASED,784
JP,SHOCK,781
JP,BLOOD UREA INCREASED,780
JP,CELLULITIS,764
JP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,759
JP,INTENTIONAL OVERDOSE,758
JP,URINARY RETENTION,758
JP,MYOCARDIAL INFARCTION,757
JP,FEMUR FRACTURE,749
JP,MUSCULAR WEAKNESS,749
JP,HEPATIC FAILURE,747
JP,HYPERGLYCAEMIA,733
JP,GENERAL PHYSICAL HEALTH DETERIORATION,721
JP,MYELODYSPLASTIC SYNDROME,717
JP,HYPOTENSION,710
JP,BLOOD GLUCOSE INCREASED,700
JP,CARDIO-RESPIRATORY ARREST,696
JP,GASTRIC CANCER,695
JP,LUNG NEOPLASM MALIGNANT,686
JP,CYTOMEGALOVIRUS INFECTION,684
JP,ASTHMA,682
JP,STEVENS-JOHNSON SYNDROME,676
JP,LUNG DISORDER,669
JP,DRUG PRESCRIBING ERROR,667
JP,PROTEINURIA,659
JP,VISUAL ACUITY REDUCED,653
JP,HYPERURICAEMIA,651
JP,DRUG EFFECT INCOMPLETE,649
JP,LYMPHOCYTE COUNT DECREASED,646
JP,TREMOR,646
JP,FEELING ABNORMAL,645
JP,PALPITATIONS,644
JP,ARRHYTHMIA,641
JP,PULMONARY EMBOLISM,641
JP,JAUNDICE,640
JP,PAIN IN EXTREMITY,640
JP,ANAPHYLACTIC SHOCK,632
JP,CARDIAC ARREST,629
JP,PERITONITIS,629
JP,HAEMATURIA,628
JP,PNEUMONIA BACTERIAL,626
JP,URTICARIA,619
JP,EXPOSURE DURING PREGNANCY,616
JP,GASTRIC ULCER,615
JP,CARDIAC FAILURE CONGESTIVE,613
JP,PNEUMOTHORAX,606
JP,DEEP VEIN THROMBOSIS,593
JP,CATARACT,591
JP,ANGINA PECTORIS,589
JP,DYSGEUSIA,582
JP,ENTEROCOLITIS,577
JP,DEMENTIA,574
JP,DEPRESSION,574
JP,MYALGIA,574
JP,HYPOCALCAEMIA,571
JP,HYPOTHYROIDISM,570
JP,WEIGHT INCREASED,562
JP,PRODUCT USE IN UNAPPROVED INDICATION,559
JP,RENAL FAILURE ACUTE,557
JP,EPISTAXIS,550
JP,HAEMORRHAGE SUBCUTANEOUS,547
JP,NEUROLEPTIC MALIGNANT SYNDROME,539
JP,RED BLOOD CELL COUNT DECREASED,538
JP,SUBDURAL HAEMATOMA,534
JP,ACUTE MYOCARDIAL INFARCTION,531
JP,BREAST CANCER,527
JP,ABDOMINAL PAIN UPPER,511
JP,INTESTINAL OBSTRUCTION,508
JP,RASH GENERALISED,508
JP,CHEST PAIN,507
JP,HALLUCINATION,503
JP,HYPOALBUMINAEMIA,501
JP,ABNORMAL BEHAVIOUR,497
JP,ECZEMA,495
JP,PROSTATE CANCER,495
JP,ACUTE RESPIRATORY DISTRESS SYNDROME,490
JP,OSTEOMYELITIS,489
JP,PANCREATITIS ACUTE,488
JP,WRONG TECHNIQUE IN DRUG USAGE PROCESS,486
JP,PULMONARY OEDEMA,484
JP,CONVULSION,482
JP,METASTASES TO LIVER,482
JP,MULTI-ORGAN FAILURE,480
JP,RESTLESSNESS,479
JP,BRONCHITIS,472
JP,ANAPHYLACTIC REACTION,470
JP,ABDOMINAL DISTENSION,463
JP,ALOPECIA,463
JP,HYPOXIA,463
JP,NEOPLASM MALIGNANT,461
JP,ROAD TRAFFIC ACCIDENT,461
JP,SURGERY,461
JP,HAEMATOCHEZIA,460
JP,SECOND PRIMARY MALIGNANCY,458
JP,SUBARACHNOID HAEMORRHAGE,456
JP,GASTROINTESTINAL PERFORATION,454
JP,HAEMOPTYSIS,454
JP,SPINAL COMPRESSION FRACTURE,452
JP,MULTIPLE ORGAN DYSFUNCTION SYNDROME,450
JP,HEPATITIS B,449
JP,DRUG RESISTANCE,448
JP,TACHYCARDIA,448
JP,LYMPHOMA,447
JP,NEPHROTIC SYNDROME,447
JP,ABDOMINAL DISCOMFORT,444
JP,PANCREATIC CARCINOMA,442
JP,TUMOUR LYSIS SYNDROME,437
JP,HAEMATEMESIS,435
JP,RETINAL HAEMORRHAGE,435
JP,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,433
JP,THROMBOTIC MICROANGIOPATHY,432
JP,GENERALISED ERYTHEMA,430
JP,EOSINOPHIL COUNT INCREASED,428
JP,LYMPHADENOPATHY,428
JP,AGRANULOCYTOSIS,426
JP,HEPATIC ENZYME INCREASED,423
JP,EMBOLIC STROKE,420
JP,FACE OEDEMA,419
JP,PARONYCHIA,417
JP,TUBULOINTERSTITIAL NEPHRITIS,417
JP,SKIN DISORDER,416
JP,CHOLECYSTITIS,415
JP,INFLUENZA,412
JP,DERMATITIS ACNEIFORM,411
JP,THERAPEUTIC RESPONSE DECREASED,408
JP,PYELONEPHRITIS,403
JP,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,402
JP,METASTASES TO BONE,401
JP,SUDDEN DEATH,400
JP,ACUTE MYELOID LEUKAEMIA,398
JP,GASTROENTERITIS,397
JP,INFUSION RELATED REACTION,395
JP,HEPATIC ENCEPHALOPATHY,394
JP,DYSKINESIA,388
JP,SYNCOPE,388
JP,TOXIC EPIDERMAL NECROLYSIS,388
JP,DYSARTHRIA,386
JP,ORGANISING PNEUMONIA,386
JP,TOXIC SKIN ERUPTION,383
JP,CARDIAC FAILURE ACUTE,381
JP,OXYGEN SATURATION DECREASED,375
JP,PULMONARY ALVEOLAR HAEMORRHAGE,368
JP,RHEUMATOID ARTHRITIS,368
JP,INTENTIONAL PRODUCT MISUSE,366
JP,LIVER FUNCTION TEST ABNORMAL,366
JP,SHOCK HAEMORRHAGIC,366
JP,CHOLANGITIS,365
JP,CHILLS,362
JP,THIRST,360
JP,UPPER RESPIRATORY TRACT INFLAMMATION,360
JP,ACUTE GRAFT VERSUS HOST DISEASE,358
JP,CHEST DISCOMFORT,358
JP,COMPLETED SUICIDE,358
JP,OROPHARYNGEAL PAIN,358
JP,HISTIOCYTOSIS HAEMATOPHAGIC,357
JP,MUSCULOSKELETAL STIFFNESS,357
JP,PERICARDIAL EFFUSION,356
JP,NEOPLASM PROGRESSION,351
JP,CHOLELITHIASIS,347
JP,CONTUSION,347
JP,HYPERSENSITIVITY,347
JP,HYPOPHAGIA,346
JP,TOXIC ENCEPHALOPATHY,344
JP,ADVERSE EVENT,341
JP,PRESCRIBED UNDERDOSE,341
JP,FEMORAL NECK FRACTURE,337
JP,INFLAMMATION,336
JP,VENTRICULAR FIBRILLATION,336
JP,PREMATURE BABY,335
JP,LYMPHOPROLIFERATIVE DISORDER,332
JP,MUSCLE SPASMS,330
JP,DYSPHONIA,328
JP,GENERALISED OEDEMA,328
JP,DELUSION,327
JP,GASTROINTESTINAL DISORDER,327
JP,VISION BLURRED,326
JP,ENCEPHALOPATHY,325
JP,PNEUMONITIS,320
JP,METASTASES TO LUNG,319
JP,TREATMENT NONCOMPLIANCE,319
JP,VENTRICULAR TACHYCARDIA,318
JP,CONCOMITANT DISEASE AGGRAVATED,317
JP,INTERNATIONAL NORMALISED RATIO INCREASED,317
JP,HYPERCALCAEMIA,315
JP,HYPERHIDROSIS,315
JP,SKIN ULCER,315
JP,DEVICE RELATED INFECTION,314
JP,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,314
JP,RESPIRATORY DISORDER,314
JP,HYPERBILIRUBINAEMIA,313
JP,ANXIETY,310
JP,ATYPICAL FEMUR FRACTURE,309
JP,LOW BIRTH WEIGHT BABY,309
JP,BLOOD URIC ACID INCREASED,307
JP,COLITIS ISCHAEMIC,307
JP,DISEASE RECURRENCE,306
JP,HAEMATOCRIT DECREASED,306
JP,NO ADVERSE EVENT,306
JP,BLISTER,304
JP,BLOOD POTASSIUM INCREASED,304
JP,BRONCHOPULMONARY ASPERGILLOSIS,304
JP,PULMONARY HYPERTENSION,304
JP,RENAL CELL CARCINOMA,304
JP,COMA,302
JP,HEPATITIS C,298
JP,MARASMUS,298
JP,HYPERAMMONAEMIA,292
JP,HYPERTHYROIDISM,292
JP,ABORTION SPONTANEOUS,291
JP,DRUG LEVEL INCREASED,291
JP,HYPOPHOSPHATAEMIA,291
JP,PANCREATITIS,290
JP,SUICIDAL IDEATION,290
JP,VISUAL IMPAIRMENT,290
JP,GASTRIC ULCER HAEMORRHAGE,289
JP,PEMPHIGOID,289
JP,PSYCHIATRIC SYMPTOM,288
JP,ILEUS PARALYTIC,287
JP,BLADDER CANCER,286
JP,GLYCOSYLATED HAEMOGLOBIN INCREASED,286
JP,COMPRESSION FRACTURE,285
JP,DIABETES MELLITUS INADEQUATE CONTROL,285
JP,DYSURIA,278
JP,THROMBOSIS,278
JP,BLOOD ALBUMIN DECREASED,277
JP,HEPATIC CIRRHOSIS,277
JP,HAEMOLYTIC ANAEMIA,276
JP,AMYLASE INCREASED,275
JP,METABOLIC ACIDOSIS,273
JP,PERIPHERAL SENSORY NEUROPATHY,273
JP,LARGE INTESTINE PERFORATION,271
JP,AGITATION,270
JP,OSTEONECROSIS,270
JP,LACTIC ACIDOSIS,269
JP,PHARYNGITIS,269
JP,DIABETIC KETOACIDOSIS,267
JP,DIFFUSE LARGE B-CELL LYMPHOMA,264
JP,METASTASES TO CENTRAL NERVOUS SYSTEM,264
JP,CIRCULATORY COLLAPSE,262
JP,HYPERNATRAEMIA,262
JP,SKIN EXFOLIATION,261
JP,HEPATIC CANCER,259
JP,IRON DEFICIENCY ANAEMIA,259
JP,STATUS EPILEPTICUS,259
JP,PARKINSON^S DISEASE,258
JP,AGGRESSION,257
JP,DRY SKIN,257
JP,HEMIPLEGIA,256
JP,AORTIC DISSECTION,254
JP,STAPHYLOCOCCAL INFECTION,254
JP,CHRONIC KIDNEY DISEASE,253
JP,DEAFNESS,253
JP,ADRENAL INSUFFICIENCY,252
JP,DUODENAL ULCER,252
JP,IRRITABILITY,252
JP,SWELLING,251
JP,BLOOD POTASSIUM DECREASED,250
JP,EXPOSED BONE IN JAW,250
JP,OCULAR HYPERAEMIA,250
JP,RESPIRATORY DEPRESSION,250
JP,APLASIA PURE RED CELL,249
JP,GASTROOESOPHAGEAL REFLUX DISEASE,249
JP,CYSTITIS,248
JP,PNEUMATOSIS INTESTINALIS,248
JP,COLITIS ULCERATIVE,246
JP,INTESTINAL PERFORATION,246
JP,RECTAL CANCER,246
JP,URINE OUTPUT DECREASED,244
JP,COLITIS,243
JP,PURPURA,243
JP,CYSTITIS HAEMORRHAGIC,242
JP,TRANSIENT ISCHAEMIC ATTACK,242
JP,CHOLECYSTITIS ACUTE,240
JP,GLAUCOMA,239
JP,PARKINSONISM,238
JP,GASTRITIS,237
JP,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,235
JP,ASPIRATION,232
JP,OSTEOPOROSIS,232
JP,SCHIZOPHRENIA,232
JP,CARDIAC DISORDER,231
JP,EPSTEIN-BARR VIRUS INFECTION,230
JP,HEPATITIS FULMINANT,230
JP,FAECES DISCOLOURED,229
JP,HALLUCINATION_ AUDITORY,229
JP,PULMONARY HAEMORRHAGE,228
JP,APPENDICITIS,227
JP,HYPERTHERMIA,227
JP,BONE PAIN,226
JP,RESPIRATORY ARREST,226
JP,DISORIENTATION,225
JP,MEMORY IMPAIRMENT,225
JP,DERMATITIS,223
JP,HYPOMAGNESAEMIA,223
JP,TUMOUR HAEMORRHAGE,223
JP,ACUTE RESPIRATORY FAILURE,222
JP,COGNITIVE DISORDER,222
JP,RETINAL DETACHMENT,221
JP,EYELID OEDEMA,220
JP,BLOOD SODIUM DECREASED,219
JP,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,218
JP,HEART RATE INCREASED,218
JP,HYPOTHERMIA,218
JP,TUBERCULOSIS,217
JP,BACTERAEMIA,216
JP,CYTOPENIA,216
JP,RETINOPATHY,215
JP,GRAFT VERSUS HOST DISEASE,213
JP,PLEURISY,211
JP,NEUTROPHIL COUNT INCREASED,210
JP,CARDIAC TAMPONADE,208
JP,IMMUNE THROMBOCYTOPENIC PURPURA,208
JP,LUNG INFECTION,208
JP,TRANSFUSION,208
JP,ARTERIOVENOUS FISTULA SITE COMPLICATION,206
JP,CYTOMEGALOVIRUS TEST POSITIVE,205
JP,CARDIAC FAILURE CHRONIC,204
JP,MUCOSAL INFLAMMATION,204
JP,UPPER GASTROINTESTINAL HAEMORRHAGE,204
JP,IMPAIRED HEALING,203
JP,METASTASES TO LYMPH NODES,203
JP,PERIPHERAL SWELLING,203
JP,PRODUCTIVE COUGH,203
JP,CAESAREAN SECTION,202
JP,CELL MARKER INCREASED,202
JP,PULMONARY TUBERCULOSIS,201
JP,INJECTION SITE ERYTHEMA,200
JP,MYELOFIBROSIS,200
JP,POLLAKIURIA,199
JP,PREMATURE DELIVERY,199
JP,BRAIN OEDEMA,198
JP,LYMPHOPENIA,198
JP,PRURITUS GENERALISED,198
JP,SALIVARY HYPERSECRETION,198
JP,DRUG HYPERSENSITIVITY,196
JP,FEEDING DISORDER,196
JP,SPEECH DISORDER,196
JP,MUSCULOSKELETAL PAIN,193
JP,WHEEZING,193
JP,LARGE INTESTINE POLYP,192
JP,VISUAL FIELD DEFECT,192
JP,DYSPNOEA EXERTIONAL,191
JP,INJURY,191
JP,DRUG ADMINISTRATION ERROR,190
JP,HYDRONEPHROSIS,190
JP,INTENTIONAL PRODUCT USE ISSUE,190
JP,HAEMATOTOXICITY,189
JP,BILE DUCT STONE,188
JP,EOSINOPHILIA,188
JP,LEUKOENCEPHALOPATHY,187
JP,SKIN EROSION,187
JP,FANCONI SYNDROME ACQUIRED,186
JP,BLOOD TRIGLYCERIDES INCREASED,185
JP,CARDIOMYOPATHY,185
JP,EATING DISORDER,185
JP,EOSINOPHILIC PNEUMONIA,185
JP,PSEUDOMEMBRANOUS COLITIS,185
JP,VENTRICULAR EXTRASYSTOLES,185
JP,ATRIOVENTRICULAR BLOCK COMPLETE,184
JP,INCORRECT DOSE ADMINISTERED,184
JP,HALLUCINATION_ VISUAL,183
JP,INTRAOCULAR PRESSURE INCREASED,182
JP,ORAL MUCOSA EROSION,182
JP,FLUSHING,181
JP,STRESS CARDIOMYOPATHY,181
JP,ARTHRITIS,180
JP,HYPERLIPIDAEMIA,180
JP,INTENTIONAL DRUG MISUSE,180
JP,MANIA,179
JP,MENTAL DISORDER,178
JP,PARALYSIS,178
JP,RIB FRACTURE,178
JP,RIGHT VENTRICULAR FAILURE,178
JP,PLATELET COUNT INCREASED,177
JP,BACTERIAL INFECTION,176
JP,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,176
JP,INJECTION SITE PAIN,176
JP,CHRONIC GRAFT VERSUS HOST DISEASE,175
JP,DRUG DOSE OMISSION,175
JP,HEPATIC STEATOSIS,175
JP,INTENTIONAL UNDERDOSE,175
JP,FUNGAL INFECTION,174
JP,MEDICATION ERROR,174
JP,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,172
JP,HOT FLUSH,172
JP,PULMONARY ARTERIAL HYPERTENSION,172
JP,CEREBROVASCULAR ACCIDENT,171
JP,ENTERITIS INFECTIOUS,171
JP,SUDDEN HEARING LOSS,171
JP,TREATMENT FAILURE,171
JP,PIGMENTATION DISORDER,168
JP,PULMONARY CONGESTION,168
JP,URINARY INCONTINENCE,168
JP,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,167
JP,DIVERTICULITIS,167
JP,CHROMATURIA,166
JP,DECUBITUS ULCER,166
JP,SWELLING FACE,166
JP,ANURIA,165
JP,CYTOMEGALOVIRUS VIRAEMIA,165
JP,DEPRESSIVE SYMPTOM,165
JP,DYSSTASIA,165
JP,LEUKAEMIA,164
JP,LIP EROSION,164
JP,NERVOUS SYSTEM DISORDER,164
JP,RASH MACULO-PAPULAR,164
JP,ATYPICAL MYCOBACTERIAL INFECTION,163
JP,CANCER PAIN,163
JP,DYSLALIA,163
JP,HAEMATOMA,163
JP,INCORRECT ROUTE OF DRUG ADMINISTRATION,163
JP,HAEMORRHAGE INTRACRANIAL,161
JP,INCORRECT DRUG ADMINISTRATION DURATION,161
JP,ASPHYXIA,160
JP,HAEMORRHAGIC DIATHESIS,160
JP,ENTEROCOLITIS HAEMORRHAGIC,159
JP,ABORTION,158
JP,CARDIOMEGALY,158
JP,FLUID RETENTION,158
JP,CONJUNCTIVAL HYPERAEMIA,157
JP,ACCIDENTAL OVERDOSE,156
JP,DYSPEPSIA,156
JP,GASTROINTESTINAL NECROSIS,156
JP,NON-SMALL CELL LUNG CANCER,156
JP,OSTEOMALACIA,156
JP,SYSTEMIC LUPUS ERYTHEMATOSUS,156
JP,EXTRAPYRAMIDAL DISORDER,155
JP,STAPHYLOCOCCAL SEPSIS,155
JP,APLASTIC ANAEMIA,154
JP,BRAIN NATRIURETIC PEPTIDE INCREASED,154
JP,LOWER GASTROINTESTINAL HAEMORRHAGE,154
JP,MALNUTRITION,154
JP,ORTHOSTATIC HYPOTENSION,154
JP,SEROTONIN SYNDROME,154
JP,SMALL INTESTINAL PERFORATION,154
JP,SPLENOMEGALY,154
JP,VASCULITIS,154
JP,CONFUSIONAL STATE,153
JP,PROTEIN URINE PRESENT,153
JP,RENAL TUBULAR DISORDER,153
JP,INJECTION SITE BRUISING,151
JP,TINNITUS,151
JP,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,150
JP,LACUNAR INFARCTION,150
JP,GLOMERULAR FILTRATION RATE DECREASED,149
JP,LIVER ABSCESS,149
JP,ORAL CANDIDIASIS,149
JP,ASPERGILLUS INFECTION,148
JP,FOETAL GROWTH RESTRICTION,148
JP,HEPATITIS ACUTE,148
JP,PERIODONTITIS,148
JP,SINUSITIS,148
JP,COAGULOPATHY,147
JP,DRUG WITHDRAWAL SYNDROME,147
JP,EYE PAIN,147
JP,GINGIVITIS,146
JP,OLIGURIA,146
JP,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,146
JP,DRY MOUTH,145
JP,COLITIS MICROSCOPIC,143
JP,IDIOPATHIC PULMONARY FIBROSIS,143
JP,MOVEMENT DISORDER,143
JP,THALAMUS HAEMORRHAGE,143
JP,PALLOR,142
JP,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,142
JP,DIPLOPIA,141
JP,INTERNAL HAEMORRHAGE,141
JP,MONOPLEGIA,141
JP,APHASIA,140
JP,EMBOLISM,140
JP,ABASIA,139
JP,ABORTION INDUCED,139
JP,FEELING HOT,139
JP,PROTHROMBIN TIME PROLONGED,139
JP,CEREBELLAR INFARCTION,138
JP,HEPATITIS,138
JP,HEPATITIS B REACTIVATION,138
JP,JAUNDICE CHOLESTATIC,138
JP,LYMPHANGIOSIS CARCINOMATOSA,138
JP,OESOPHAGEAL CARCINOMA,138
JP,OESOPHAGEAL VARICES HAEMORRHAGE,138
JP,MENTAL IMPAIRMENT,137
JP,COLD SWEAT,136
JP,CYTOMEGALOVIRUS ENTEROCOLITIS,136
JP,MACULAR OEDEMA,136
JP,RHINORRHOEA,136
JP,UPPER RESPIRATORY TRACT INFECTION,136
JP,WITHDRAWAL SYNDROME,136
JP,AKATHISIA,135
JP,FACIAL PARALYSIS,135
JP,GASTROINTESTINAL STROMAL TUMOUR,135
JP,LIVER FUNCTION TEST INCREASED,135
JP,MYOCLONUS,135
JP,PAIN IN JAW,135
JP,PRINZMETAL ANGINA,134
JP,PYELONEPHRITIS ACUTE,134
JP,SEDATION,134
JP,SMALL INTESTINAL HAEMORRHAGE,134
JP,VITREOUS HAEMORRHAGE,134
JP,MUSCLE RIGIDITY,133
JP,SERUM FERRITIN INCREASED,133
JP,DERMATITIS EXFOLIATIVE,132
JP,GASTRIC HAEMORRHAGE,132
JP,INFECTIOUS PLEURAL EFFUSION,132
JP,LIVER INJURY,132
JP,MUSCLE HAEMORRHAGE,132
JP,NEPHROLITHIASIS,132
JP,HYPERTRIGLYCERIDAEMIA,131
JP,MUCOUS MEMBRANE DISORDER,131
JP,ABDOMINAL PAIN LOWER,130
JP,AMNESIA,130
JP,AZOTAEMIA,130
JP,CONJUNCTIVITIS,130
JP,DRUG INTOLERANCE,130
JP,JOINT SWELLING,130
JP,METASTATIC RENAL CELL CARCINOMA,130
JP,MYOCARDIAL ISCHAEMIA,130
JP,NECROTISING FASCIITIS,130
JP,AUTOIMMUNE HEPATITIS,129
JP,HEAD INJURY,129
JP,MENINGITIS,129
JP,UNEVALUABLE EVENT,129
JP,DRUG EFFECT DECREASED,127
JP,HAEMORRHOIDS,127
JP,HYDROCEPHALUS,127
JP,TRANSAMINASES INCREASED,127
JP,HEART RATE DECREASED,126
JP,PREMATURE LABOUR,126
JP,RETINAL VEIN OCCLUSION,126
JP,UTERINE CANCER,126
JP,CORONARY ARTERY STENOSIS,125
JP,GASTRIC PERFORATION,124
JP,OESOPHAGEAL CANDIDIASIS,124
JP,AGE-RELATED MACULAR DEGENERATION,123
JP,ELECTROLYTE IMBALANCE,123
JP,MULTIPLE SCLEROSIS RELAPSE,123
JP,RASH ERYTHEMATOUS,123
JP,RASH PRURITIC,123
JP,VENOOCCLUSIVE LIVER DISEASE,123
JP,BRAIN NEOPLASM,122
JP,CHRONIC MYELOID LEUKAEMIA,122
JP,ISCHAEMIC STROKE,122
JP,LIPASE INCREASED,122
JP,LUMBAR VERTEBRAL FRACTURE,122
JP,MALIGNANT PLEURAL EFFUSION,121
JP,PSORIASIS,121
JP,TORSADE DE POINTES,121
JP,VERTIGO,121
JP,GENITAL HAEMORRHAGE,120
JP,RENAL CANCER,120
JP,ACUTE HEPATIC FAILURE,119
JP,PARAESTHESIA,119
JP,ARTHRITIS BACTERIAL,118
JP,DIVERTICULUM INTESTINAL HAEMORRHAGIC,118
JP,ENTERITIS,118
JP,HELICOBACTER INFECTION,118
JP,INTESTINAL ISCHAEMIA,118
JP,METASTASIS,118
JP,AORTIC ANEURYSM,117
JP,CEREBRAL ARTERY EMBOLISM,117
JP,FANCONI SYNDROME,117
JP,GENERALISED TONIC-CLONIC SEIZURE,117
JP,OESOPHAGITIS,117
JP,RADIATION PNEUMONITIS,117
JP,CARDIOVASCULAR DISORDER,116
JP,CHEST X-RAY ABNORMAL,116
JP,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,116
JP,HICCUPS,116
JP,MOUTH HAEMORRHAGE,116
JP,NECK PAIN,116
JP,OSTEOARTHRITIS,116
JP,RESPIRATORY TRACT INFECTION,116
JP,HYPOGAMMAGLOBULINAEMIA,115
JP,OCULOMUCOCUTANEOUS SYNDROME,115
JP,OESOPHAGEAL ULCER,115
JP,PREGNANCY,115
JP,SINUS NODE DYSFUNCTION,115
JP,ANGINA UNSTABLE,114
JP,BLOOD GLUCOSE DECREASED,114
JP,CONJUNCTIVAL HAEMORRHAGE,114
JP,FIBRIN D DIMER INCREASED,114
JP,PRESCRIBED OVERDOSE,114
JP,PURULENT DISCHARGE,114
JP,BLOOD CALCIUM DECREASED,113
JP,BONE DISORDER,113
JP,EXPOSURE DURING BREAST FEEDING,113
JP,VENOUS THROMBOSIS LIMB,113
JP,BLOOD PHOSPHORUS DECREASED,112
JP,CYANOSIS,112
JP,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,112
JP,LIP SWELLING,112
JP,LIVE BIRTH,112
JP,ATELECTASIS,111
JP,BILE DUCT CANCER,111
JP,CEREBELLAR HAEMORRHAGE,111
JP,DUODENAL ULCER HAEMORRHAGE,111
JP,GINGIVAL SWELLING,111
JP,HYPOGLYCAEMIC COMA,111
JP,INJECTION SITE INDURATION,111
JP,INTRA-ABDOMINAL HAEMORRHAGE,111
JP,LARYNGEAL OEDEMA,111
JP,LUNG ADENOCARCINOMA,111
JP,CANDIDA INFECTION,110
JP,HUMAN HERPESVIRUS 6 INFECTION,110
JP,GINGIVAL BLEEDING,109
JP,HYPOPROTEINAEMIA,109
JP,PNEUMONIA CYTOMEGALOVIRAL,109
JP,POST PROCEDURAL HAEMORRHAGE,109
JP,THREATENED LABOUR,109
JP,CENTRAL NERVOUS SYSTEM LESION,108
JP,COLORECTAL CANCER,108
JP,HEAT ILLNESS,108
JP,NO THERAPEUTIC RESPONSE,108
JP,PULMONARY FIBROSIS,108
JP,TYPE 1 DIABETES MELLITUS,108
JP,UVEITIS,108
JP,DYSLIPIDAEMIA,107
JP,FISTULA,107
JP,GLUCOSE TOLERANCE IMPAIRED,107
JP,HEPATIC ATROPHY,107
JP,VIITH NERVE PARALYSIS,107
JP,VIRAL INFECTION,107
JP,ANGER,106
JP,CROHN^S DISEASE,106
JP,SINUS BRADYCARDIA,106
JP,SPINAL COLUMN STENOSIS,106
JP,DYSTONIA,105
JP,ENDOCARDITIS,105
JP,ERYTHEMA OF EYELID,105
JP,EYE DISCHARGE,105
JP,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,105
JP,OROPHARYNGEAL DISCOMFORT,105
JP,PERICARDITIS,105
JP,ACNE,104
JP,BLOOD PRESSURE SYSTOLIC INCREASED,104
JP,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,104
JP,NEOPLASM,104
JP,RENAL FAILURE CHRONIC,104
JP,ABDOMINAL ABSCESS,103
JP,ANGIOEDEMA,103
JP,ARTHROPATHY,103
JP,HYPOACUSIS,103
JP,PROTEIN TOTAL DECREASED,103
JP,UNDERDOSE,103
JP,CHOLESTASIS,102
JP,EMBOLIC CEREBRAL INFARCTION,102
JP,HAEMORRHAGIC CEREBRAL INFARCTION,102
JP,METASTASES TO PERITONEUM,102
JP,MYOCARDITIS,102
JP,OVARIAN CANCER,102
JP,SUPRAVENTRICULAR TACHYCARDIA,102
JP,ACUTE CORONARY SYNDROME,101
JP,ADULT T-CELL LYMPHOMA/LEUKAEMIA,101
JP,DIABETES INSIPIDUS,101
JP,DRUG DEPENDENCE,101
JP,MALIGNANT ASCITES,101
JP,MYASTHENIA GRAVIS,101
JP,PHOTOSENSITIVITY REACTION,101
JP,SENSORY DISTURBANCE,101
JP,ANAPHYLACTOID REACTION,100
JP,CHEMOTHERAPY,100
JP,EMPHYSEMA,100
JP,ENCEPHALITIS,100
JP,PAPULE,100
JP,PORTAL VEIN THROMBOSIS,100
JP,PRODUCT QUALITY ISSUE,100
JP,TOOTHACHE,100
JP,ABSCESS,99
JP,CYTOMEGALOVIRUS CHORIORETINITIS,99
JP,DISSEMINATED TUBERCULOSIS,99
JP,DIZZINESS POSTURAL,99
JP,HUMERUS FRACTURE,99
JP,LARGE INTESTINAL ULCER,99
JP,MYOSITIS,99
JP,PATHOLOGICAL FRACTURE,99
JP,PERFORMANCE STATUS DECREASED,99
JP,RASH PUSTULAR,99
JP,RESPIRATORY DISTRESS,99
JP,SUBCUTANEOUS ABSCESS,99
JP,THYROIDITIS,99
JP,ATRIOVENTRICULAR BLOCK,98
JP,HENOCH-SCHONLEIN PURPURA,98
JP,EYELID PTOSIS,97
JP,HEPATIC CANCER RECURRENT,97
JP,TENDERNESS,97
JP,VARICES OESOPHAGEAL,97
JP,ACIDOSIS,96
JP,BASEDOW^S DISEASE,96
JP,BRAIN STEM HAEMORRHAGE,96
JP,CHOLANGITIS ACUTE,96
JP,DERMATITIS CONTACT,96
JP,POLYPOIDAL CHOROIDAL VASCULOPATHY,96
JP,SPINAL FRACTURE,96
JP,THROMBOTIC CEREBRAL INFARCTION,96
JP,CHEILITIS,95
JP,NEUROTOXICITY,95
JP,INGUINAL HERNIA,94
JP,PERSECUTORY DELUSION,94
JP,STUPOR,94
JP,FOOT FRACTURE,93
JP,GASTRITIS EROSIVE,92
JP,HYPERCAPNIA,92
JP,NEPHROPATHY TOXIC,92
JP,PNEUMOMEDIASTINUM,92
JP,PSEUDOMONAS INFECTION,92
JP,THROMBOTIC THROMBOCYTOPENIC PURPURA,92
JP,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,91
JP,APHAGIA,91
JP,BLOOD CHOLESTEROL INCREASED,91
JP,BRAIN HERNIATION,91
JP,DEVICE MALFUNCTION,91
JP,HYPERVENTILATION,91
JP,INJECTION SITE SWELLING,91
JP,METASTASES TO MENINGES,91
JP,NEPHROPATHY,91
JP,PHARYNGEAL OEDEMA,91
JP,PULMONARY ARTERY THROMBOSIS,91
JP,PUTAMEN HAEMORRHAGE,91
JP,CALCULUS URINARY,90
JP,CYSTOID MACULAR OEDEMA,90
JP,FAECES SOFT,90
JP,FEELING COLD,90
JP,GASTRIC ANTRAL VASCULAR ECTASIA,90
JP,HAEMOLYSIS,90
JP,HEPATOTOXICITY,90
JP,INADEQUATE ANALGESIA,90
JP,PRERENAL FAILURE,90
JP,BENIGN PROSTATIC HYPERPLASIA,89
JP,CERVIX CARCINOMA,89
JP,DERMATOMYOSITIS,89
JP,GASTROINTESTINAL OEDEMA,89
JP,ORAL HERPES,89
JP,PROSTATIC SPECIFIC ANTIGEN INCREASED,89
JP,RENAL TUBULAR NECROSIS,89
JP,MOUTH ULCERATION,88
JP,POLYURIA,88
JP,SYSTEMIC CANDIDA,88
JP,ATRIAL THROMBOSIS,87
JP,GRANULOCYTOPENIA,87
JP,PNEUMONIA STAPHYLOCOCCAL,87
JP,RADIATION SKIN INJURY,87
JP,TRANSPLANT REJECTION,87
JP,AKINESIA,86
JP,BRAIN CONTUSION,86
JP,CHRONIC GASTRITIS,86
JP,DROWNING,86
JP,NEPHROGENIC ANAEMIA,86
JP,NEUROGENIC BLADDER,86
JP,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,86
JP,BLOOD THYROID STIMULATING HORMONE INCREASED,85
JP,BLOOD URINE PRESENT,85
JP,CONCOMITANT DISEASE PROGRESSION,85
JP,INJECTION SITE PRURITUS,85
JP,MOBILITY DECREASED,85
JP,PERIPHERAL COLDNESS,85
JP,SINUS TACHYCARDIA,85
JP,SKIN DISCOLOURATION,85
JP,SLEEP DISORDER,85
JP,ATAXIA,84
JP,ATRIOVENTRICULAR BLOCK SECOND DEGREE,84
JP,BLAST CELL COUNT INCREASED,84
JP,HEPATITIS B DNA INCREASED,84
JP,INTENTIONAL SELF-INJURY,84
JP,LUNG INFILTRATION,84
JP,NORMAL NEWBORN,84
JP,CORNEAL DISORDER,83
JP,HAEMOTHORAX,83
JP,HYPERCHOLESTEROLAEMIA,83
JP,HYPOAESTHESIA ORAL,83
JP,MALLORY-WEISS SYNDROME,83
JP,MEDICATION RESIDUE PRESENT,83
JP,PRIMARY SEQUESTRUM,83
JP,RASH PAPULAR,83
JP,SCAB,83
JP,CHOKING,82
JP,CREATININE RENAL CLEARANCE DECREASED,82
JP,DIABETIC NEPHROPATHY,82
JP,EJECTION FRACTION DECREASED,82
JP,HODGKIN^S DISEASE,82
JP,INTERVERTEBRAL DISC PROTRUSION,82
JP,NEURALGIA,82
JP,PORTAL HYPERTENSION,82
JP,SUBCUTANEOUS HAEMATOMA,82
JP,AORTIC ANEURYSM RUPTURE,81
JP,APPLICATION SITE PRURITUS,81
JP,BRAIN STEM INFARCTION,81
JP,CLOSTRIDIUM DIFFICILE COLITIS,81
JP,DEMENTIA ALZHEIMER^S TYPE,81
JP,HYPOGLYCAEMIC ENCEPHALOPATHY,81
JP,LOCAL SWELLING,81
JP,RETINAL EXUDATES,81
JP,CORONARY ARTERY DISEASE,80
JP,FULMINANT TYPE 1 DIABETES MELLITUS,80
JP,KIDNEY TRANSPLANT REJECTION,80
JP,NOCARDIOSIS,80
JP,PSYCHOTIC DISORDER,80
JP,RHINITIS ALLERGIC,80
JP,FOETAL DEATH,79
JP,HEMIPARESIS,79
JP,LARGE INTESTINAL HAEMORRHAGE,79
JP,ORAL PAIN,79
JP,ACTIVITIES OF DAILY LIVING IMPAIRED,78
JP,ARTERIOSPASM CORONARY,78
JP,BONE DENSITY DECREASED,78
JP,COLONY STIMULATING FACTOR THERAPY,78
JP,DEPRESSED MOOD,78
JP,IGA NEPHROPATHY,78
JP,NASAL CONGESTION,78
JP,SMALL CELL LUNG CANCER,78
JP,TUMOUR NECROSIS,78
JP,BEHCET^S SYNDROME,77
JP,LUMBAR SPINAL STENOSIS,77
JP,METRORRHAGIA,77
JP,QUADRIPLEGIA,77
JP,SKIN LESION,77
JP,WATER INTOXICATION,77
JP,HAEMARTHROSIS,76
JP,HYPOPITUITARISM,76
JP,LUNG ABSCESS,76
JP,NEUTROPHIL PERCENTAGE INCREASED,76
JP,UNRESPONSIVE TO STIMULI,76
JP,UPPER LIMB FRACTURE,76
JP,BLINDNESS,75
JP,DECREASED ACTIVITY,75
JP,EXTRADURAL HAEMATOMA,75
JP,EYE DISORDER,75
JP,GANGRENE,75
JP,HERPES VIRUS INFECTION,75
JP,HYPERAMMONAEMIC ENCEPHALOPATHY,75
JP,MYCOBACTERIUM AVIUM COMPLEX INFECTION,75
JP,TACHYPNOEA,75
JP,ULCER,75
JP,VASCULAR PSEUDOANEURYSM,75
JP,VIRAL MUTATION IDENTIFIED,75
JP,CARDIOGENIC SHOCK,74
JP,INJECTION SITE HAEMORRHAGE,74
JP,OCCULT BLOOD POSITIVE,74
JP,PORTAL VENOUS GAS,74
JP,DISCOMFORT,73
JP,HAEMORRHAGIC ANAEMIA,73
JP,OTITIS MEDIA,73
JP,PUSTULAR PSORIASIS,73
JP,SUDDEN ONSET OF SLEEP,73
JP,ACCIDENTAL EXPOSURE TO PRODUCT,72
JP,AUTOIMMUNE HAEMOLYTIC ANAEMIA,72
JP,BILIRUBIN CONJUGATED INCREASED,72
JP,BODY TEMPERATURE INCREASED,72
JP,CARDIAC VALVE DISEASE,72
JP,DRUG LEVEL DECREASED,72
JP,ELECTROCARDIOGRAM ABNORMAL,72
JP,EMBOLISM VENOUS,72
JP,FACTOR VIII INHIBITION,72
JP,HYPOURICAEMIA,72
JP,LONG QT SYNDROME,72
JP,ORAL DISORDER,72
JP,SKIN NECROSIS,72
JP,SMALL INTESTINE ULCER,72
JP,SUPRAVENTRICULAR EXTRASYSTOLES,72
JP,ADVERSE REACTION,71
JP,LUPUS-LIKE SYNDROME,71
JP,NAIL DISORDER,71
JP,OBSTRUCTIVE AIRWAYS DISORDER,71
JP,PULMONARY MASS,71
JP,VIROLOGIC FAILURE,71
JP,ACUTE LYMPHOCYTIC LEUKAEMIA,70
JP,ANAL ABSCESS,70
JP,BLOOD BETA-D-GLUCAN INCREASED,70
JP,BLOOD PRESSURE SYSTOLIC DECREASED,70
JP,BRAIN ABSCESS,70
JP,HYPOKINESIA,70
JP,IMMUNODEFICIENCY,70
JP,IMMUNOSUPPRESSION,70
JP,MACULAR HOLE,70
JP,PETECHIAE,70
JP,POLYDIPSIA,70
JP,PROTEIN URINE,70
JP,RENAL INFARCT,70
JP,TYPE 2 DIABETES MELLITUS,70
JP,CACHEXIA,69
JE,CEREBROVASCULAR ACCIDENT,2
JE,BURNING SENSATION,1
JE,CONDITION AGGRAVATED,1
JE,DEPRESSION,1
JE,ERYTHEMA,1
JE,FALL,1
JE,FATIGUE,1
JE,HAEMORRHAGE,1
JE,IMPAIRED WORK ABILITY,1
JE,INSOMNIA,1
JE,JOINT INJURY,1
JE,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
JE,MALAISE,1
JE,PAIN,1
JE,PERIPHERAL SWELLING,1
JE,PERITONEAL PERFORATION,1
JE,PRURITUS,1
JE,QUALITY OF LIFE DECREASED,1
JE,SKIN DISORDER,1
JE,SKIN EXFOLIATION,1
JE,STEROID WITHDRAWAL SYNDROME,1
JE,SUICIDAL IDEATION,1
JE,SWELLING FACE,1
JE,VIRAL INFECTION,1
JE,VISION BLURRED,1
JE,WEIGHT DECREASED,1
JO,DRUG ABUSE,19
JO,DEATH,17
JO,SEPSIS,17
JO,SEPSIS NEONATAL,13
JO,DISEASE PROGRESSION,12
JO,DYSPNOEA,12
JO,FATIGUE,9
JO,DRUG INEFFECTIVE,8
JO,PYREXIA,8
JO,HYPOTENSION,7
JO,PSOAS ABSCESS,7
JO,ASTHENIA,6
JO,DIABETIC KETOACIDOSIS,6
JO,DIARRHOEA,6
JO,ARTHRALGIA,5
JO,FEBRILE NEUTROPENIA,5
JO,HAEMORRHAGE,5
JO,LOSS OF CONSCIOUSNESS,5
JO,NEUTROPENIA,5
JO,OSTEONECROSIS OF JAW,5
JO,PLASMA CELL MYELOMA,5
JO,RASH,5
JO,STAPHYLOCOCCAL INFECTION,5
JO,VOMITING,5
JO,ACUTE MYELOID LEUKAEMIA,4
JO,ANAEMIA,4
JO,CHEST PAIN,4
JO,CHILLS,4
JO,DIZZINESS,4
JO,HEADACHE,4
JO,HYPERSENSITIVITY,4
JO,MYOCARDIAL INFARCTION,4
JO,PRODUCT USE ISSUE,4
JO,SEROTONIN SYNDROME,4
JO,ABDOMINAL PAIN UPPER,3
JO,ACUTE KIDNEY INJURY,3
JO,BLOOD PRESSURE INCREASED,3
JO,CARDIAC ARREST,3
JO,DEAFNESS NEUROSENSORY,3
JO,DECREASED APPETITE,3
JO,DISSEMINATED INTRAVASCULAR COAGULATION,3
JO,DISTURBANCE IN ATTENTION,3
JO,ERYTHEMA,3
JO,FOETAL EXPOSURE DURING PREGNANCY,3
JO,GENERALISED TONIC-CLONIC SEIZURE,3
JO,HAEMATURIA,3
JO,HAEMOGLOBIN DECREASED,3
JO,HEART RATE INCREASED,3
JO,HYPERHIDROSIS,3
JO,HYPONATRAEMIA,3
JO,KOUNIS SYNDROME,3
JO,LIVER INJURY,3
JO,MUCOSAL INFLAMMATION,3
JO,MULTI-ORGAN FAILURE,3
JO,NAUSEA,3
JO,NEUTROPHIL COUNT INCREASED,3
JO,PLATELET COUNT DECREASED,3
JO,RENAL FAILURE,3
JO,RENAL TUBULAR DISORDER,3
JO,SOMNOLENCE,3
JO,TACHYCARDIA,3
JO,TREMOR,3
JO,ABDOMINAL PAIN LOWER,2
JO,ANXIETY,2
JO,BLOOD ALBUMIN DECREASED,2
JO,BLOOD BILIRUBIN INCREASED,2
JO,BONE MARROW FAILURE,2
JO,CEREBROVASCULAR ACCIDENT,2
JO,CHOLECYSTITIS,2
JO,CIRCULATORY COLLAPSE,2
JO,COMPLICATIONS OF TRANSPLANTED KIDNEY,2
JO,COUGH,2
JO,CRIGLER-NAJJAR SYNDROME,2
JO,DEEP VEIN THROMBOSIS,2
JO,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
JO,ECZEMA,2
JO,GAIT DISTURBANCE,2
JO,HAEMOPTYSIS,2
JO,HEMIPARESIS,2
JO,HEMIPLEGIA,2
JO,HEPATIC FAILURE,2
JO,HEPATITIS,2
JO,HYPOAESTHESIA ORAL,2
JO,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
JO,INFECTION,2
JO,INFUSION RELATED REACTION,2
JO,INTERNATIONAL NORMALISED RATIO INCREASED,2
JO,JAW FRACTURE,2
JO,MALAISE,2
JO,MASS,2
JO,MATERNAL EXPOSURE DURING PREGNANCY,2
JO,MUSCLE SPASTICITY,2
JO,MYALGIA,2
JO,NEONATAL HYPOTENSION,2
JO,NEONATAL RESPIRATORY FAILURE,2
JO,OEDEMA PERIPHERAL,2
JO,OVARIAN GERM CELL TERATOMA,2
JO,PAIN,2
JO,PALPITATIONS,2
JO,PANCREATITIS,2
JO,PANCREATITIS ACUTE,2
JO,PANCREATITIS RELAPSING,2
JO,PHARYNGITIS,2
JO,PNEUMONITIS,2
JO,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,2
JO,PREMATURE BABY,2
JO,PRURITUS,2
JO,PULMONARY EMBOLISM,2
JO,RENAL IMPAIRMENT,2
JO,RESPIRATORY FAILURE,2
JO,SEIZURE,2
JO,SEPTIC SHOCK,2
JO,SKIN EXFOLIATION,2
JO,SUICIDE ATTEMPT,2
JO,ULCER,2
JO,UNRESPONSIVE TO STIMULI,2
JO,URINARY TRACT INFECTION,2
JO,WEIGHT INCREASED,2
JO,ABASIA,1
JO,ABDOMINAL DISCOMFORT,1
JO,ABDOMINAL DISTENSION,1
JO,ABDOMINAL PAIN,1
JO,ABDOMINAL TENDERNESS,1
JO,ABORTION SPONTANEOUS,1
JO,ACNE,1
JO,ACUTE MYOCARDIAL INFARCTION,1
JO,ACUTE RESPIRATORY DISTRESS SYNDROME,1
JO,AFFECT LABILITY,1
JO,AGRANULOCYTOSIS,1
JO,ANAPHYLACTIC REACTION,1
JO,ANGINA PECTORIS,1
JO,ANGIOEDEMA,1
JO,APNOEA,1
JO,APPETITE DISORDER,1
JO,ARTERIOSPASM CORONARY,1
JO,ASPERGILLUS TEST POSITIVE,1
JO,ATRIAL PRESSURE INCREASED,1
JO,ATRIAL SEPTAL DEFECT,1
JO,ATRIOVENTRICULAR BLOCK,1
JO,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
JO,AVERSION,1
JO,BACK PAIN,1
JO,BILIRUBIN CONJUGATED INCREASED,1
JO,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
JO,BLINDNESS,1
JO,BLISTER,1
JO,BLOOD CALCIUM DECREASED,1
JO,BLOOD CREATININE INCREASED,1
JO,BLOOD DISORDER,1
JO,BLOOD GLUCOSE DECREASED,1
JO,BLOOD THYROID STIMULATING HORMONE INCREASED,1
JO,BODY TEMPERATURE INCREASED,1
JO,BRIEF PSYCHOTIC DISORDER_ WITH POSTPARTUM ONSET,1
JO,BURNS FIRST DEGREE,1
JO,CAESAREAN SECTION,1
JO,CANDIDA TEST POSITIVE,1
JO,CARDIAC FAILURE,1
JO,CAUDAL REGRESSION SYNDROME,1
JO,CELLULITIS ORBITAL,1
JO,CERVICAL DISCHARGE,1
JO,CHEST DISCOMFORT,1
JO,CHOKING,1
JO,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
JO,COELIAC DISEASE,1
JO,COMA SCALE ABNORMAL,1
JO,CONFUSIONAL STATE,1
JO,CONGENITAL JAW MALFORMATION,1
JO,CONTUSION,1
JO,CONVULSION,1
JO,CRANIOPHARYNGIOMA,1
JO,CREATININE RENAL CLEARANCE INCREASED,1
JO,CROHN^S DISEASE,1
JO,CROSSMATCH INCOMPATIBLE,1
JO,DEHYDRATION,1
JO,DEMYELINATION,1
JO,DEPENDENCE,1
JO,DEPRESSED LEVEL OF CONSCIOUSNESS,1
JO,DEPRESSION,1
JO,DERMATITIS BULLOUS,1
JO,DERMATITIS EXFOLIATIVE,1
JO,DIABETES MELLITUS,1
JO,DISEASE RECURRENCE,1
JO,DISORGANISED SPEECH,1
JO,DISSEMINATED TUBERCULOSIS,1
JO,DRUG ADMINISTRATION ERROR,1
JO,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
JO,DRUG INTOLERANCE,1
JO,DRUG SPECIFIC ANTIBODY PRESENT,1
JO,DRY AGE-RELATED MACULAR DEGENERATION,1
JO,DRY MOUTH,1
JO,DUODENITIS HAEMORRHAGIC,1
JO,DYSARTHRIA,1
JO,DYSSTASIA,1
JO,ECTOPIC PREGNANCY UNDER HORMONAL CONTRACEPTION,1
JO,ELECTROCARDIOGRAM QT PROLONGED,1
JO,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
JO,EMOTIONAL DISTRESS,1
JO,ENTEROCOCCUS TEST POSITIVE,1
JO,EXPOSURE DURING PREGNANCY,1
JO,EYE PAIN,1
JO,EYE SWELLING,1
JO,FACIAL PARALYSIS,1
JO,FAECES SOFT,1
JO,FEEDING DISORDER,1
JO,FEELING ABNORMAL,1
JO,FEELING HOT,1
JO,FIBRIN DEPOSITION ON LENS POSTOPERATIVE,1
JO,FLUID RETENTION,1
JO,FLUSHING,1
JO,FRACTURE,1
JO,FREQUENT BOWEL MOVEMENTS,1
JO,FUNGAL INFECTION,1
JO,GAIT INABILITY,1
JO,GASTRIC VARICES HAEMORRHAGE,1
JO,GASTROINTESTINAL TRACT ADENOMA,1
JO,GENERAL PHYSICAL HEALTH DETERIORATION,1
JO,GINGIVAL INJURY,1
JO,GLYCOSYLATED HAEMOGLOBIN DECREASED,1
JO,GRIP STRENGTH DECREASED,1
JO,HAEMATEMESIS,1
JO,HAEMORRHAGIC STROKE,1
JO,HALLUCINATION,1
JO,HALLUCINATION_ AUDITORY,1
JO,HALLUCINATIONS_ MIXED,1
JO,HELICOBACTER GASTRITIS,1
JO,HEPATIC ENZYME INCREASED,1
JO,HEPATIC HYDROTHORAX,1
JO,HEPATIC NECROSIS,1
JO,HEPATIC PAIN,1
JO,HEPATIC STEATOSIS,1
JO,HERPES SIMPLEX HEPATITIS,1
JO,HERPES VIRUS INFECTION,1
JO,HOSPITALISATION,1
JO,HYDROCEPHALUS,1
JO,HYPERCALCAEMIA,1
JO,HYPERINSULINAEMIA,1
JO,HYPERNATRAEMIA,1
JO,HYPERPARATHYROIDISM,1
JO,HYPERPYREXIA,1
JO,HYPERSENSITIVITY VASCULITIS,1
JO,HYPERTENSION,1
JO,HYPERTHERMIA MALIGNANT,1
JO,HYPOAESTHESIA,1
JO,HYPOCALCAEMIA,1
JO,HYPOGLYCAEMIA,1
JO,HYPONATRAEMIC SEIZURE,1
JO,HYPOVOLAEMIA,1
JO,HYPOXIA,1
JO,IMMUNOSUPPRESSION,1
JO,IMPAIRED HEALING,1
JO,INFECTIOUS PLEURAL EFFUSION,1
JO,INFLUENZA LIKE ILLNESS,1
JO,INFUSION SITE DISCOLOURATION,1
JO,INFUSION SITE ERYTHEMA,1
JO,INFUSION SITE EXTRAVASATION,1
JO,INFUSION SITE IRRITATION,1
JO,INFUSION SITE PAIN,1
JO,INFUSION SITE SWELLING,1
JO,INJECTION SITE PAIN,1
JO,INTENTIONAL DEVICE MISUSE,1
JO,INTENTIONAL OVERDOSE,1
JO,INTESTINAL VARICES HAEMORRHAGE,1
JO,INTRACARDIAC MASS,1
JO,INTRAOCULAR PRESSURE INCREASED,1
JO,INVASIVE DUCTAL BREAST CARCINOMA,1
JO,IRRITABILITY,1
JO,JAUNDICE,1
JO,JOINT EFFUSION,1
JO,LABORATORY TEST ABNORMAL,1
JO,LACTIC ACIDOSIS,1
JO,LEGIONELLA INFECTION,1
JO,LIP SWELLING,1
JO,LIVER ABSCESS,1
JO,LIVER FUNCTION TEST ABNORMAL,1
JO,LOCAL SWELLING,1
JO,LOCALISED INFECTION,1
JO,LOWER RESPIRATORY TRACT INFECTION,1
JO,LUNG CANCER METASTATIC,1
JO,MALIGNANT NEOPLASM PROGRESSION,1
JO,MATERNAL EXPOSURE DURING DELIVERY,1
JO,MENTAL STATUS CHANGES,1
JO,METASTASES TO LUNG,1
JO,MICROALBUMINURIA,1
JO,MIGRAINE,1
JO,MUCOUS STOOLS,1
JO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
JO,MUSCLE ABSCESS,1
JO,MUSCLE RIGIDITY,1
JO,MUSCLE RUPTURE,1
JO,MUSCLE SPASMS,1
JO,MUSCULOSKELETAL PAIN,1
JO,NAIL DISCOLOURATION,1
JO,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
JO,NERVOUS SYSTEM DISORDER,1
JO,NEUTROPHIL COUNT DECREASED,1
JO,NIGHT SWEATS,1
JO,NON-HODGKIN^S LYMPHOMA,1
JO,NON-SMALL CELL LUNG CANCER,1
JO,OBESITY,1
JO,OBSTRUCTIVE AIRWAYS DISORDER,1
JO,OEDEMA,1
JO,ORAL CANDIDIASIS,1
JO,OSTEOPOROSIS,1
JO,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
JO,PANCREATIC MASS,1
JO,PANCYTOPENIA,1
JO,PARALYSIS,1
JO,PELVIC PAIN,1
JO,PERFORATION,1
JO,PERICARDIAL EFFUSION,1
JO,PERICARDIAL HAEMORRHAGE,1
JO,PERICARDITIS URAEMIC,1
JO,PERIPHERAL SWELLING,1
JO,PLASMACYTOMA,1
JO,PLATELET COUNT ABNORMAL,1
JO,PNEUMONIA,1
JO,PNEUMONIA LEGIONELLA,1
JO,POSTICTAL PARALYSIS,1
JO,PRODUCT BLISTER PACKAGING ISSUE,1
JO,PRODUCT TASTE ABNORMAL,1
JO,PRODUCT USE IN UNAPPROVED INDICATION,1
JO,PSORIASIS,1
JO,RASH GENERALISED,1
JO,RECURRENCE OF NEUROMUSCULAR BLOCKADE,1
JO,RENAL COLIC,1
JO,RENAL FAILURE ACUTE,1
JO,RENAL INJURY,1
JO,RESPIRATORY ARREST,1
JO,RESPIRATORY DISTRESS,1
JO,RESPIRATORY MONILIASIS,1
JO,RETINOPATHY OF PREMATURITY,1
JO,ROAD TRAFFIC ACCIDENT,1
JO,SALIVARY HYPERSECRETION,1
JO,SINUSITIS,1
JO,SKIN DISCOLOURATION,1
JO,SKIN HYPERPIGMENTATION,1
JO,SKIN HYPERTROPHY,1
JO,SKIN LESION,1
JO,SKIN ODOUR ABNORMAL,1
JO,SKIN STRIAE,1
JO,SPEECH DISORDER,1
JO,STRESS,1
JO,SUPRAVENTRICULAR TACHYCARDIA,1
JO,SUSPECTED COUNTERFEIT PRODUCT,1
JO,SWELLING FACE,1
JO,SWOLLEN TONGUE,1
JO,TALIPES,1
JO,TENDERNESS,1
JO,TENDON PAIN,1
JO,TENDON RUPTURE,1
JO,THROMBOCYTOPENIA,1
JO,TOXICITY TO VARIOUS AGENTS,1
JO,TRANSPLANT REJECTION,1
JO,TUBERCULOSIS,1
JO,TUMOUR HAEMORRHAGE,1
JO,URINARY RETENTION,1
JO,URTICARIA,1
JO,VARICELLA,1
JO,VASCULAR PSEUDOANEURYSM,1
JO,VASCULAR STENT THROMBOSIS,1
JO,VASCULITIS,1
JO,VENA CAVA THROMBOSIS,1
JO,VENTRICULAR TACHYCARDIA,1
JO,VERTIGO,1
JO,VIITH NERVE PARALYSIS,1
JO,VISION BLURRED,1
JO,VITREOUS HAEMORRHAGE,1
JO,WATER INTOXICATION,1
JO,WEIGHT DECREASED,1
JO,WHITE BLOOD CELL COUNT DECREASED,1
JO,YELLOW SKIN,1
KZ,DRUG INEFFECTIVE,26
KZ,DEATH,21
KZ,ASTHENIA,18
KZ,DYSPNOEA,17
KZ,NAUSEA,14
KZ,BODY TEMPERATURE INCREASED,13
KZ,VOMITING,12
KZ,THROMBOCYTOPENIA,10
KZ,DEEP VEIN THROMBOSIS,9
KZ,HEADACHE,9
KZ,PULMONARY EMBOLISM,9
KZ,PULMONARY TUBERCULOSIS,9
KZ,PYREXIA,9
KZ,ANAEMIA,8
KZ,EPISTAXIS,8
KZ,PNEUMONIA,8
KZ,SEIZURE,8
KZ,CARDIAC FAILURE,7
KZ,COUGH,7
KZ,FATIGUE,7
KZ,HYPERTENSION,7
KZ,LEUKOPENIA,7
KZ,WEIGHT DECREASED,7
KZ,ANGIOEDEMA,6
KZ,BLOOD PRESSURE INCREASED,6
KZ,CONDITION AGGRAVATED,6
KZ,ELECTROCARDIOGRAM QT PROLONGED,6
KZ,HAEMOGLOBIN DECREASED,6
KZ,PANCYTOPENIA,6
KZ,PRURITUS,6
KZ,RASH,6
KZ,TACHYCARDIA,6
KZ,VASCULAR STENT THROMBOSIS,6
KZ,ANGINA PECTORIS,5
KZ,ARTHRALGIA,5
KZ,ASCITES,5
KZ,CHILLS,5
KZ,DISEASE PROGRESSION,5
KZ,ERYTHEMA,5
KZ,INTENTIONAL PRODUCT USE ISSUE,5
KZ,LOSS OF CONSCIOUSNESS,5
KZ,MYOCARDIAL INFARCTION,5
KZ,ACUTE KIDNEY INJURY,4
KZ,ALANINE AMINOTRANSFERASE INCREASED,4
KZ,ASPARTATE AMINOTRANSFERASE INCREASED,4
KZ,BLOOD PRESSURE DECREASED,4
KZ,CARDIOPULMONARY FAILURE,4
KZ,DECREASED APPETITE,4
KZ,DIZZINESS,4
KZ,EPILEPSY,4
KZ,GASTROINTESTINAL HAEMORRHAGE,4
KZ,HAEMORRHAGE,4
KZ,HEPATIC CIRRHOSIS,4
KZ,HEPATITIS TOXIC,4
KZ,HYPERSENSITIVITY,4
KZ,HYPOAESTHESIA,4
KZ,HYPOTENSION,4
KZ,LEUKOCYTOSIS,4
KZ,OEDEMA PERIPHERAL,4
KZ,PULMONARY ARTERIAL HYPERTENSION,4
KZ,RHEUMATOID ARTHRITIS,4
KZ,THROMBOSIS,4
KZ,URTICARIA,4
KZ,ALCOHOL POISONING,3
KZ,ATRIAL THROMBOSIS,3
KZ,BLOOD CREATININE INCREASED,3
KZ,CHEST PAIN,3
KZ,COLD SWEAT,3
KZ,DIARRHOEA,3
KZ,DRUG RESISTANCE,3
KZ,EXPOSURE DURING PREGNANCY,3
KZ,FOETAL EXPOSURE DURING PREGNANCY,3
KZ,GASTRITIS EROSIVE,3
KZ,GENERAL PHYSICAL HEALTH DETERIORATION,3
KZ,HEPATITIS C,3
KZ,HYPOVOLAEMIC SHOCK,3
KZ,INFUSION RELATED REACTION,3
KZ,ISCHAEMIC STROKE,3
KZ,JOINT SWELLING,3
KZ,NEUTROPENIA,3
KZ,PAIN IN EXTREMITY,3
KZ,PALPITATIONS,3
KZ,PRODUCT QUALITY ISSUE,3
KZ,PRODUCT USE IN UNAPPROVED INDICATION,3
KZ,RASH GENERALISED,3
KZ,RESPIRATORY FAILURE,3
KZ,SEPSIS,3
KZ,STRIDOR,3
KZ,TREATMENT NONCOMPLIANCE,3
KZ,TREMOR,3
KZ,TUBERCULOSIS,3
KZ,WHEEZING,3
KZ,ABDOMINAL DISCOMFORT,2
KZ,ABDOMINAL PAIN UPPER,2
KZ,ADENOCARCINOMA GASTRIC,2
KZ,ADVERSE EVENT,2
KZ,AGRANULOCYTOSIS,2
KZ,ANAL PRURITUS,2
KZ,ANXIETY,2
KZ,APLASTIC ANAEMIA,2
KZ,ARRHYTHMIA,2
KZ,ARTHRITIS,2
KZ,BLOOD GLUCOSE INCREASED,2
KZ,BLOOD POTASSIUM DECREASED,2
KZ,BONE PAIN,2
KZ,BRAIN OEDEMA,2
KZ,BRONCHITIS,2
KZ,BRONCHOPNEUMONIA,2
KZ,CARDIAC ARREST,2
KZ,CARDIOVASCULAR INSUFFICIENCY,2
KZ,CEREBRAL ISCHAEMIA,2
KZ,CHOLECYSTITIS,2
KZ,CHOLECYSTITIS CHRONIC,2
KZ,CHOLESTASIS,2
KZ,COLON CANCER,2
KZ,COMPLETED SUICIDE,2
KZ,CROHN^S DISEASE,2
KZ,DEAFNESS,2
KZ,DISSEMINATED INTRAVASCULAR COAGULATION,2
KZ,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,2
KZ,DRUG DOSE OMISSION,2
KZ,DRUG EFFECT DECREASED,2
KZ,DRUG INTOLERANCE,2
KZ,DUODENAL ULCER,2
KZ,DYSPEPSIA,2
KZ,ENCEPHALOPATHY,2
KZ,EYE SWELLING,2
KZ,FAECES DISCOLOURED,2
KZ,GAIT DISTURBANCE,2
KZ,GASTRIC HAEMORRHAGE,2
KZ,HAEMATOCHEZIA,2
KZ,HAEMATOMA,2
KZ,HAEMORRHAGIC STROKE,2
KZ,HEPATIC PAIN,2
KZ,HEPATOCELLULAR CARCINOMA,2
KZ,HEPATOTOXICITY,2
KZ,HERPES VIRUS INFECTION,2
KZ,HYPERAEMIA,2
KZ,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
KZ,LIVER INJURY,2
KZ,MALAISE,2
KZ,MENTAL DISORDER,2
KZ,MUSCLE SPASMS,2
KZ,NEPHRITIS,2
KZ,NEPHROPATHY TOXIC,2
KZ,ODYNOPHAGIA,2
KZ,OEDEMA,2
KZ,ORAL HERPES,2
KZ,OROPHARYNGEAL CANDIDIASIS,2
KZ,OVERDOSE,2
KZ,PALLOR,2
KZ,PREMATURE BABY,2
KZ,PRODUCT USE ISSUE,2
KZ,PROSTATE CANCER,2
KZ,PRURITUS GENITAL,2
KZ,PSYCHOTIC DISORDER,2
KZ,PULMONARY HAEMORRHAGE,2
KZ,PULMONARY OEDEMA,2
KZ,RED BLOOD CELL COUNT DECREASED,2
KZ,RENAL FAILURE ACUTE,2
KZ,RESPIRATORY DISTRESS,2
KZ,RESPIRATORY TRACT INFECTION VIRAL,2
KZ,SKIN EXFOLIATION,2
KZ,SMALL INTESTINAL HAEMORRHAGE,2
KZ,SOMNOLENCE,2
KZ,SPINAL PAIN,2
KZ,STATUS EPILEPTICUS,2
KZ,SUSPECTED COUNTERFEIT PRODUCT,2
KZ,SWELLING FACE,2
KZ,SWOLLEN TONGUE,2
KZ,UTERINE HAEMORRHAGE,2
KZ,VISION BLURRED,2
KZ,WHITE BLOOD CELL COUNT INCREASED,2
KZ,ABASIA,1
KZ,ABDOMINAL DISTENSION,1
KZ,ABDOMINAL PAIN,1
KZ,ABDOMINAL PAIN LOWER,1
KZ,ABNORMAL DREAMS,1
KZ,ABORTION INDUCED,1
KZ,ABORTION SPONTANEOUS,1
KZ,ACNE,1
KZ,ACUTE HEPATIC FAILURE,1
KZ,ACUTE LYMPHOCYTIC LEUKAEMIA,1
KZ,ACUTE RESPIRATORY DISTRESS SYNDROME,1
KZ,ADRENAL ADENOMA,1
KZ,AFFECT LABILITY,1
KZ,AGGRESSION,1
KZ,AGITATION,1
KZ,ALCOHOL USE,1
KZ,ALCOHOLIC PSYCHOSIS,1
KZ,ALPHA 1 FOETOPROTEIN INCREASED,1
KZ,ALTERED STATE OF CONSCIOUSNESS,1
KZ,AMENORRHOEA,1
KZ,ANORECTAL DISCOMFORT,1
KZ,APHASIA,1
KZ,ARTERIAL RESTENOSIS,1
KZ,ASPERGILLUS INFECTION,1
KZ,ASPHYXIA,1
KZ,ASTHMA,1
KZ,ATRIAL FIBRILLATION,1
KZ,AUDITORY DISORDER,1
KZ,AZOTAEMIA,1
KZ,BACK PAIN,1
KZ,BILIARY CIRRHOSIS,1
KZ,BILIRUBIN CONJUGATED INCREASED,1
KZ,BLADDER CANCER,1
KZ,BLAST CELL CRISIS,1
KZ,BLAST CELLS,1
KZ,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
KZ,BLISTER,1
KZ,BLOOD BILIRUBIN INCREASED,1
KZ,BLOOD ERYTHROPOIETIN ABNORMAL,1
KZ,BLOOD GLUCOSE ABNORMAL,1
KZ,BLOOD GLUCOSE DECREASED,1
KZ,BLOOD GLUCOSE FLUCTUATION,1
KZ,BLOOD IMMUNOGLOBULIN E INCREASED,1
KZ,BLOOD KETONE BODY INCREASED,1
KZ,BLOOD LACTATE DEHYDROGENASE INCREASED,1
KZ,BLOOD PRESSURE DIASTOLIC INCREASED,1
KZ,BLOOD PRESSURE SYSTOLIC INCREASED,1
KZ,BODY TEMPERATURE DECREASED,1
KZ,BONE MARROW FAILURE,1
KZ,BRADYARRHYTHMIA,1
KZ,BRAIN NEOPLASM,1
KZ,BREAST CANCER,1
KZ,BREATH SOUNDS,1
KZ,BRONCHIAL OBSTRUCTION,1
KZ,BRONCHOSPASM,1
KZ,BURN ORAL CAVITY,1
KZ,CALCULUS URINARY,1
KZ,CARDIAC FAILURE ACUTE,1
KZ,CARDIAC FAILURE CHRONIC,1
KZ,CARDIOGENIC SHOCK,1
KZ,CARDIOMYOPATHY ALCOHOLIC,1
KZ,CATARACT,1
KZ,CEREBRAL ARTERY THROMBOSIS,1
KZ,CEREBRAL HAEMORRHAGE,1
KZ,CEREBRAL INFARCTION,1
KZ,CEREBROVASCULAR DISORDER,1
KZ,CERVIX CARCINOMA,1
KZ,CHEST DISCOMFORT,1
KZ,CHOLANGIOCARCINOMA,1
KZ,CHROMATURIA,1
KZ,CHRONIC HEPATITIS C,1
KZ,CHRONIC KIDNEY DISEASE,1
KZ,CHRONIC MYELOID LEUKAEMIA,1
KZ,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
KZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
KZ,CIRRHOSIS ALCOHOLIC,1
KZ,COAGULOPATHY,1
KZ,COLITIS ULCERATIVE,1
KZ,CONSTIPATION,1
KZ,CONVULSION,1
KZ,CORONARY ARTERY INSUFFICIENCY,1
KZ,CORONARY ARTERY OCCLUSION,1
KZ,CREATININE URINE ABNORMAL,1
KZ,CUSHINGOID,1
KZ,CYANOSIS,1
KZ,CYSTIC LYMPHANGIOMA,1
KZ,CYSTITIS,1
KZ,DEAFNESS NEUROSENSORY,1
KZ,DEPRESSED MOOD,1
KZ,DEPRESSIVE SYMPTOM,1
KZ,DERMATITIS ALLERGIC,1
KZ,DERMATITIS ATOPIC,1
KZ,DEVELOPMENTAL DELAY,1
KZ,DEVICE EXPULSION,1
KZ,DEVICE RELATED INFECTION,1
KZ,DIABETIC KETOACIDOSIS,1
KZ,DIABETIC VASCULAR DISORDER,1
KZ,DIARRHOEA HAEMORRHAGIC,1
KZ,DIFFUSE ALOPECIA,1
KZ,DISEASE RECURRENCE,1
KZ,DISSEMINATED TUBERCULOSIS,1
KZ,DRY SKIN,1
KZ,DYSCHEZIA,1
KZ,DYSPHAGIA,1
KZ,DYSPHONIA,1
KZ,DYSPNOEA EXERTIONAL,1
KZ,DYSURIA,1
KZ,EAR DISCOMFORT,1
KZ,EAR HAEMORRHAGE,1
KZ,EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY WITH BURST-SUPPRESSION,1
KZ,ELECTROCARDIOGRAM ABNORMAL,1
KZ,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
KZ,EMBOLISM VENOUS,1
KZ,EMOTIONAL DISTRESS,1
KZ,EPIDIDYMITIS,1
KZ,ERUCTATION,1
KZ,EXTRA DOSE ADMINISTERED,1
KZ,EYELID PTOSIS,1
KZ,FACE OEDEMA,1
KZ,FACIAL PARESIS,1
KZ,FALL,1
KZ,FEMALE GENITAL TRACT FISTULA,1
KZ,FIBROADENOMA OF BREAST,1
KZ,FISTULA,1
KZ,FOETAL DEATH,1
KZ,FOOT FRACTURE,1
KZ,FORCED EXPIRATORY VOLUME DECREASED,1
KZ,GALLBLADDER DISORDER,1
KZ,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
KZ,GASTRIC ULCER,1
KZ,GENERALISED ERYTHEMA,1
KZ,GENITAL HAEMORRHAGE,1
KZ,GIARDIASIS,1
KZ,GLOMERULONEPHRITIS,1
KZ,GLOMERULONEPHRITIS CHRONIC,1
KZ,HAEMATEMESIS,1
KZ,HAEMODIALYSIS,1
KZ,HAEMOPTYSIS,1
KZ,HAEMORRHAGE SUBCUTANEOUS,1
KZ,HAEMORRHAGIC EROSIVE GASTRITIS,1
KZ,HAEMORRHAGIC VASCULITIS,1
KZ,HAEMORRHOIDAL HAEMORRHAGE,1
KZ,HAEMORRHOIDS,1
KZ,HAEMOTHORAX,1
KZ,HEART DISEASE CONGENITAL,1
KZ,HEART RATE,1
KZ,HEART RATE DECREASED,1
KZ,HEART RATE INCREASED,1
KZ,HEPATIC ECHINOCOCCIASIS,1
KZ,HEPATIC ENZYME INCREASED,1
KZ,HEPATIC HAEMATOMA,1
KZ,HEPATITIS,1
KZ,HEPATOSPLENOMEGALY,1
KZ,HERPES OPHTHALMIC,1
KZ,HOMICIDE,1
KZ,HYPERGLYCAEMIA,1
KZ,HYPERHIDROSIS,1
KZ,HYPERKALAEMIA,1
KZ,HYPERTENSIVE CRISIS,1
KZ,HYPOACUSIS,1
KZ,HYPOAESTHESIA ORAL,1
KZ,HYPOALBUMINAEMIA,1
KZ,HYPOCALCAEMIA,1
KZ,HYPOCHROMIC ANAEMIA,1
KZ,HYPOGLYCAEMIA NEONATAL,1
KZ,HYPOGLYCAEMIC COMA,1
KZ,HYPOTHERMIA,1
KZ,ILL-DEFINED DISORDER,1
KZ,INCORRECT DOSE ADMINISTERED,1
KZ,INFECTION,1
KZ,INFLUENZA,1
KZ,INFLUENZA LIKE ILLNESS,1
KZ,INGUINAL HERNIA,1
KZ,INJECTION SITE HYPERSENSITIVITY,1
KZ,INJECTION SITE PAIN,1
KZ,INTENTION TREMOR,1
KZ,INTENTIONAL DEVICE MISUSE,1
KZ,INTENTIONAL OVERDOSE,1
KZ,INTENTIONAL PRODUCT MISUSE,1
KZ,IRON DEFICIENCY ANAEMIA,1
KZ,IRRITABILITY,1
KZ,ISCHAEMIA,1
KZ,JOINT STIFFNESS,1
KZ,KETOACIDOSIS,1
KZ,KIDNEY TRANSPLANT REJECTION,1
KZ,LARGE INTESTINAL STENOSIS,1
KZ,LEFT VENTRICULAR FAILURE,1
KZ,LIVER DISORDER,1
KZ,LOCALISED INFECTION,1
KZ,LUNG ABSCESS,1
KZ,LUNG NEOPLASM,1
KZ,LYMPH NODE TUBERCULOSIS,1
KZ,LYMPHADENOPATHY,1
KZ,LYMPHOSTASIS,1
KZ,MACULAR OEDEMA,1
KZ,MALIGNANT NEOPLASM PROGRESSION,1
KZ,MEASLES,1
KZ,MELAENA,1
KZ,MEMORY IMPAIRMENT,1
KZ,MENINGITIS,1
KZ,MERYCISM,1
KZ,METASTASIS,1
KZ,MICTURITION FREQUENCY DECREASED,1
KZ,MOBILITY DECREASED,1
KZ,MONOCYTE COUNT INCREASED,1
KZ,MOVEMENT DISORDER,1
KZ,MUCOSAL INFLAMMATION,1
KZ,MULTI-ORGAN DISORDER,1
KZ,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
KZ,MULTIPLE SCLEROSIS,1
KZ,MUSCLE ATROPHY,1
KZ,MUSCLE CONTRACTURE,1
KZ,MUSCULAR WEAKNESS,1
KZ,MUSCULOSKELETAL CHEST PAIN,1
KZ,MYALGIA,1
KZ,MYELODYSPLASTIC SYNDROME,1
KZ,MYOCARDIAL ISCHAEMIA,1
KZ,MYOSITIS,1
KZ,NASAL TURBINATE HYPERTROPHY,1
KZ,NASOPHARYNGITIS,1
KZ,NEONATAL HYPOXIA,1
KZ,NEPHROLITHIASIS,1
KZ,NEUROPATHY PERIPHERAL,1
KZ,NEUROTOXICITY,1
KZ,NEUTROPHIL COUNT DECREASED,1
KZ,NIEMANN-PICK DISEASE,1
KZ,NIGHTMARE,1
KZ,NYSTAGMUS,1
KZ,OBESITY,1
KZ,OBSTRUCTIVE AIRWAYS DISORDER,1
KZ,OCCULT BLOOD POSITIVE,1
KZ,OESOPHAGEAL CARCINOMA,1
KZ,OESOPHAGEAL VARICES HAEMORRHAGE,1
KZ,OPTIC ISCHAEMIC NEUROPATHY,1
KZ,ORAL PAIN,1
KZ,OSTEOARTHRITIS,1
KZ,OVARIAN CANCER,1
KZ,OVARIAN CYST,1
KZ,PAIN,1
KZ,PALMAR ERYTHEMA,1
KZ,PANCREATITIS ACUTE,1
KZ,PAPULE,1
KZ,PARASPINAL ABSCESS,1
KZ,PARKINSON^S DISEASE,1
KZ,PERICARDIAL EFFUSION,1
KZ,PERIPHERAL COLDNESS,1
KZ,PERIPHERAL SWELLING,1
KZ,PERITONSILLAR ABSCESS,1
KZ,PETIT MAL EPILEPSY,1
KZ,PHARYNGITIS BACTERIAL,1
KZ,PLATELET AGGREGATION ABNORMAL,1
KZ,PLATELET COUNT DECREASED,1
KZ,PLEURISY,1
KZ,PNEUMOTHORAX,1
KZ,PNEUMOTHORAX SPONTANEOUS,1
KZ,POISONING,1
KZ,POLLAKIURIA,1
KZ,PORTAL HYPERTENSION,1
KZ,PRESCRIBED UNDERDOSE,1
KZ,PROCTALGIA,1
KZ,PRODUCT PREPARATION ERROR,1
KZ,PROSTATITIS,1
KZ,PRURITUS GENERALISED,1
KZ,PSEUDOPOLYPOSIS,1
KZ,PSORIASIS,1
KZ,PULSE ABNORMAL,1
KZ,PURULENT DISCHARGE,1
KZ,PUS IN STOOL,1
KZ,PYELONEPHRITIS,1
KZ,PYELONEPHRITIS ACUTE,1
KZ,RADIATION SICKNESS SYNDROME,1
KZ,RADICULITIS,1
KZ,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
KZ,RENAL ABSCESS,1
KZ,RENAL CELL CARCINOMA,1
KZ,RENAL CYST,1
KZ,RENAL FAILURE CHRONIC,1
KZ,RENAL NECROSIS,1
KZ,RESPIRATORY DISORDER,1
KZ,RESPIRATORY TRACT INFECTION,1
KZ,RETINAL DETACHMENT,1
KZ,RETINAL VASCULAR DISORDER,1
KZ,RHEUMATOID NODULE,1
KZ,RHINORRHOEA,1
KZ,SCLERAL HAEMORRHAGE,1
KZ,SECOND PRIMARY MALIGNANCY,1
KZ,SECONDARY IMMUNODEFICIENCY,1
KZ,SENSATION OF FOREIGN BODY,1
KZ,SHOCK,1
KZ,SINUS BRADYCARDIA,1
KZ,SKIN DISORDER,1
KZ,SKIN LESION,1
KZ,SKIN ULCER,1
KZ,SLEEP DISORDER,1
KZ,SMALL FOR DATES BABY,1
KZ,SPLENOMEGALY,1
KZ,STRANGURY,1
KZ,STRESS,1
KZ,SUBARACHNOID HAEMORRHAGE,1
KZ,SUBCUTANEOUS HAEMATOMA,1
KZ,SUDDEN DEATH,1
KZ,SUFFOCATION FEELING,1
KZ,SURGERY,1
KZ,SWELLING,1
KZ,SYNCOPE,1
KZ,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
KZ,THROMBOPHLEBITIS,1
KZ,THROMBOPHLEBITIS SUPERFICIAL,1
KZ,TONGUE OEDEMA,1
KZ,TOXIC NEUROPATHY,1
KZ,TOXICITY TO VARIOUS AGENTS,1
KZ,TRACHEITIS,1
KZ,TRANSFUSION,1
KZ,TREATMENT FAILURE,1
KZ,TUNNEL VISION,1
KZ,TYPE 2 DIABETES MELLITUS,1
KZ,UNDERDOSE,1
KZ,UNINTENTIONAL USE FOR UNAPPROVED INDICATION,1
KZ,URINARY RETENTION,1
KZ,URINARY TRACT PAIN,1
KZ,URINE KETONE BODY PRESENT,1
KZ,UTERINE CANCER,1
KZ,UTERINE LEIOMYOMA,1
KZ,VAGINAL DISCHARGE,1
KZ,VAGINAL HAEMORRHAGE,1
KZ,VENTRICULAR FIBRILLATION,1
KZ,VENTRICULAR HYPERTROPHY,1
KZ,VERTIGO,1
KZ,VIRAL INFECTION,1
KZ,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
KZ,VISUAL ACUITY REDUCED,1
KZ,VITILIGO,1
KZ,WHITE BLOOD CELL COUNT DECREASED,1
KZ,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
KZ,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
KE,DEATH,168
KE,ABORTION SPONTANEOUS,65
KE,FOETAL EXPOSURE DURING PREGNANCY,49
KE,EXPOSURE DURING PREGNANCY,46
KE,ANAEMIA,31
KE,DRUG RESISTANCE,27
KE,HIV INFECTION,27
KE,EXPOSURE DURING BREAST FEEDING,26
KE,MATERNAL EXPOSURE DURING PREGNANCY,25
KE,DEEP VEIN THROMBOSIS,23
KE,TUBERCULOSIS,18
KE,DRUG INEFFECTIVE,17
KE,FOETAL DEATH,16
KE,PULMONARY EMBOLISM,16
KE,PULMONARY TUBERCULOSIS,16
KE,RENAL FAILURE ACUTE,15
KE,HEADACHE,13
KE,PYREXIA,13
KE,SEPSIS,13
KE,VIROLOGIC FAILURE,13
KE,VOMITING,13
KE,WHITE BLOOD CELL COUNT INCREASED,13
KE,CHRONIC MYELOID LEUKAEMIA,12
KE,DIARRHOEA,12
KE,HAEMOGLOBIN DECREASED,11
KE,ORAL CANDIDIASIS,11
KE,MALAISE,10
KE,MALARIA,10
KE,MALNUTRITION,10
KE,THROMBOCYTOPENIA,10
KE,TREATMENT FAILURE,10
KE,ACUTE KIDNEY INJURY,9
KE,JAUNDICE,9
KE,MALIGNANT NEOPLASM PROGRESSION,9
KE,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,8
KE,DRUG EFFECT INCREASED,8
KE,DYSPNOEA,8
KE,GASTROENTERITIS,8
KE,INTERNATIONAL NORMALISED RATIO FLUCTUATION,8
KE,OVERDOSE,8
KE,CACHEXIA,7
KE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,7
KE,NEUTROPENIA,7
KE,PNEUMONIA,7
KE,ASTHENIA,6
KE,FATIGUE,6
KE,HYPERKALAEMIA,6
KE,INTERNATIONAL NORMALISED RATIO ABNORMAL,6
KE,MENINGITIS,6
KE,MENINGITIS CRYPTOCOCCAL,6
KE,NAUSEA,6
KE,PANCYTOPENIA,6
KE,PRURITUS,6
KE,UMBILICAL HERNIA,6
KE,ABDOMINAL PAIN,5
KE,ASCITES,5
KE,CEREBRAL TOXOPLASMOSIS,5
KE,DIZZINESS,5
KE,DRUG EFFECT DECREASED,5
KE,EXTRAPULMONARY TUBERCULOSIS,5
KE,GASTROINTESTINAL STROMAL TUMOUR,5
KE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS,5
KE,OESOPHAGEAL CANDIDIASIS,5
KE,PAIN,5
KE,STEVENS-JOHNSON SYNDROME,5
KE,STILLBIRTH,5
KE,VIRAL MUTATION IDENTIFIED,5
KE,ALANINE AMINOTRANSFERASE INCREASED,4
KE,ANGIOEDEMA,4
KE,CHEST PAIN,4
KE,CHILLS,4
KE,CONDITION AGGRAVATED,4
KE,COUGH,4
KE,DEHYDRATION,4
KE,DRUG-INDUCED LIVER INJURY,4
KE,ENCEPHALITIS,4
KE,GASTROINTESTINAL HAEMORRHAGE,4
KE,INTESTINAL OBSTRUCTION,4
KE,MENINGITIS TUBERCULOUS,4
KE,MUSCULAR WEAKNESS,4
KE,PALPITATIONS,4
KE,PLATELET COUNT DECREASED,4
KE,PRODUCT QUALITY ISSUE,4
KE,PRODUCT USE ISSUE,4
KE,RASH GENERALISED,4
KE,SEIZURE,4
KE,SPLENOMEGALY,4
KE,THROMBOSIS,4
KE,ACUTE RESPIRATORY DISTRESS SYNDROME,3
KE,ANKYLOGLOSSIA CONGENITAL,3
KE,ARTHRALGIA,3
KE,BLOOD CREATININE INCREASED,3
KE,CEREBELLAR INFARCTION,3
KE,CIRCULATORY COLLAPSE,3
KE,DECREASED APPETITE,3
KE,EMBOLISM,3
KE,ERYTHEMA,3
KE,GASTRITIS,3
KE,GENERAL PHYSICAL HEALTH DETERIORATION,3
KE,HAEMATEMESIS,3
KE,HAEMORRHAGE,3
KE,HAEMORRHAGE INTRACRANIAL,3
KE,HEPATITIS B,3
KE,INFECTION,3
KE,LOCAL SWELLING,3
KE,MELAENA,3
KE,MYALGIA,3
KE,PERIPHERAL SWELLING,3
KE,PLATELET COUNT INCREASED,3
KE,PLEURAL EFFUSION,3
KE,PREGNANCY,3
KE,PREMATURE BABY,3
KE,RENAL FAILURE,3
KE,SKIN DISCOLOURATION,3
KE,SKIN ULCER,3
KE,TACHYCARDIA,3
KE,THERAPEUTIC RESPONSE DECREASED,3
KE,TINNITUS,3
KE,WHITE BLOOD CELL COUNT DECREASED,3
KE,ABDOMINAL DISTENSION,2
KE,ABNORMAL DREAMS,2
KE,ABORTION INCOMPLETE,2
KE,ACUTE PSYCHOSIS,2
KE,ASPARTATE AMINOTRANSFERASE INCREASED,2
KE,BEDRIDDEN,2
KE,BLOOD BILIRUBIN INCREASED,2
KE,CARDIAC ARREST,2
KE,CEREBROVASCULAR ACCIDENT,2
KE,CHOLECYSTITIS,2
KE,CHROMATURIA,2
KE,CONFUSIONAL STATE,2
KE,CONSTIPATION,2
KE,DEATH NEONATAL,2
KE,DECREASED IMMUNE RESPONSIVENESS,2
KE,DEPRESSION,2
KE,DERMATITIS BULLOUS,2
KE,DISSEMINATED TUBERCULOSIS,2
KE,DISTURBANCE IN ATTENTION,2
KE,DRUG HYPERSENSITIVITY,2
KE,DYSSTASIA,2
KE,ENCEPHALITIS VIRAL,2
KE,EPISTAXIS,2
KE,FALL,2
KE,FEELING ABNORMAL,2
KE,GASTRIC ULCER,2
KE,GRAND MAL CONVULSION,2
KE,HAEMATOCHEZIA,2
KE,HEART RATE INCREASED,2
KE,HEPATOCELLULAR CARCINOMA,2
KE,HYPERHIDROSIS,2
KE,HYPERSENSITIVITY,2
KE,HYPOGLYCAEMIA,2
KE,INTERNATIONAL NORMALISED RATIO INCREASED,2
KE,LEUKAEMIA CUTIS,2
KE,LIVER DISORDER,2
KE,LOSS OF CONSCIOUSNESS,2
KE,LOWER RESPIRATORY TRACT INFECTION,2
KE,LYMPHOPENIA,2
KE,MATERNAL DRUGS AFFECTING FOETUS,2
KE,NEPHROPATHY TOXIC,2
KE,NEUTROPHIL COUNT INCREASED,2
KE,NO THERAPEUTIC RESPONSE,2
KE,NON-HODGKIN^S LYMPHOMA,2
KE,OCULAR HYPERAEMIA,2
KE,ODYNOPHAGIA,2
KE,OEDEMA PERIPHERAL,2
KE,PAIN IN EXTREMITY,2
KE,PAIN OF SKIN,2
KE,PALLOR,2
KE,PANCREATITIS ACUTE,2
KE,PARAESTHESIA,2
KE,PARALYSIS,2
KE,POTENTIATING DRUG INTERACTION,2
KE,PREMATURE LABOUR,2
KE,PROCEDURAL HAEMORRHAGE,2
KE,PURULENT DISCHARGE,2
KE,PYELONEPHRITIS,2
KE,RASH,2
KE,RASH PRURITIC,2
KE,RENAL FAILURE CHRONIC,2
KE,RESPIRATORY DISTRESS,2
KE,RESTLESSNESS,2
KE,SKIN EXFOLIATION,2
KE,SLEEP DISORDER,2
KE,SUICIDE ATTEMPT,2
KE,SWELLING FACE,2
KE,TALIPES,2
KE,TRANSVERSE SINUS THROMBOSIS,2
KE,TRISOMY 21,2
KE,URINE OUTPUT DECREASED,2
KE,VERTIGO,2
KE,VISUAL IMPAIRMENT,2
KE,WEIGHT INCREASED,2
KE,ABASIA,1
KE,ABDOMINAL ABSCESS,1
KE,ABDOMINAL DISCOMFORT,1
KE,ABORTION INDUCED,1
KE,ABORTION SPONTANEOUS INCOMPLETE,1
KE,ABSCESS ORAL,1
KE,ACUTE CHEST SYNDROME,1
KE,ACUTE MYOCARDIAL INFARCTION,1
KE,ACUTE RESPIRATORY FAILURE,1
KE,ACUTE SINUSITIS,1
KE,AFFECTIVE DISORDER,1
KE,AGITATION,1
KE,AGORAPHOBIA,1
KE,ALCOHOL INTOLERANCE,1
KE,ALOPECIA,1
KE,ANAL SPHINCTER HYPERTONIA,1
KE,ANAL STENOSIS,1
KE,ANAPHYLACTIC SHOCK,1
KE,ANKLE FRACTURE,1
KE,ANURIA,1
KE,ANXIETY,1
KE,ANXIETY DISORDER,1
KE,APHASIA,1
KE,APLASIA PURE RED CELL,1
KE,ASPHYXIA,1
KE,ATAXIA,1
KE,ATRIAL THROMBOSIS,1
KE,ATRIOVENTRICULAR BLOCK,1
KE,BALANCE DISORDER,1
KE,BENIGN INTRACRANIAL HYPERTENSION,1
KE,BLINDNESS,1
KE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
KE,BLOOD GLUCOSE FLUCTUATION,1
KE,BLOOD POTASSIUM DECREASED,1
KE,BLOOD PRESSURE DECREASED,1
KE,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
KE,BLOOD PRESSURE INCREASED,1
KE,BLOOD SODIUM DECREASED,1
KE,BLOOD URINE PRESENT,1
KE,BODY TEMPERATURE DECREASED,1
KE,BONE DENSITY ABNORMAL,1
KE,BONE DISORDER,1
KE,BONE PAIN,1
KE,BRADYARRHYTHMIA,1
KE,BRADYCARDIA,1
KE,BRAIN INJURY,1
KE,BREAST CANCER,1
KE,BREAST MASS,1
KE,BREAST NEOPLASM,1
KE,BREAST SWELLING,1
KE,C-REACTIVE PROTEIN INCREASED,1
KE,CARDIAC DISORDER,1
KE,CARDIAC FAILURE CONGESTIVE,1
KE,CARDIO-RESPIRATORY ARREST,1
KE,CARDIOMEGALY,1
KE,CARDIOVASCULAR DISORDER,1
KE,CAVERNOUS SINUS THROMBOSIS,1
KE,CEREBRAL ARTERY EMBOLISM,1
KE,CHAPPED LIPS,1
KE,CLAUSTROPHOBIA,1
KE,CLEFT LIP AND PALATE,1
KE,COGNITIVE DISORDER,1
KE,COLON CANCER,1
KE,COMA,1
KE,COMPLETED SUICIDE,1
KE,CONGENITAL ANOMALY,1
KE,CONGENITAL UMBILICAL HERNIA,1
KE,CONJUNCTIVITIS INFECTIVE,1
KE,CONVULSIVE THRESHOLD LOWERED,1
KE,COORDINATION ABNORMAL,1
KE,CORONARY ARTERY INSUFFICIENCY,1
KE,CORONARY ARTERY OCCLUSION,1
KE,CRANIOCEREBRAL INJURY,1
KE,CREATININE RENAL CLEARANCE DECREASED,1
KE,DECREASED ACTIVITY,1
KE,DECUBITUS ULCER,1
KE,DENGUE FEVER,1
KE,DEPENDENCE,1
KE,DEPERSONALISATION,1
KE,DEREALISATION,1
KE,DERMATITIS ALLERGIC,1
KE,DEVICE DIFFICULT TO USE,1
KE,DEVICE DISLOCATION,1
KE,DIABETIC COMPLICATION,1
KE,DIET REFUSAL,1
KE,DISEASE PROGRESSION,1
KE,DISSOCIATION,1
KE,DRUG ABUSE,1
KE,DRUG ABUSER,1
KE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
KE,DRUG DOSE OMISSION,1
KE,DRUG INTOLERANCE,1
KE,DRY SKIN,1
KE,DRY THROAT,1
KE,DUODENAL ULCER,1
KE,DYSGEUSIA,1
KE,DYSKINESIA,1
KE,DYSPEPSIA,1
KE,DYSPHAGIA,1
KE,DYSPHONIA,1
KE,EAR HAEMORRHAGE,1
KE,ECCHYMOSIS,1
KE,ECZEMA,1
KE,ENTERITIS,1
KE,EOSINOPHILIA,1
KE,ERECTILE DYSFUNCTION,1
KE,EXOMPHALOS,1
KE,EXSANGUINATION,1
KE,EYE DISCHARGE,1
KE,EYE DISORDER,1
KE,EYELID OEDEMA,1
KE,FEELING JITTERY,1
KE,FLATULENCE,1
KE,FOETAL DISTRESS SYNDROME,1
KE,FOOD ALLERGY,1
KE,FORMICATION,1
KE,FULL BLOOD COUNT DECREASED,1
KE,GAIT DISTURBANCE,1
KE,GASTROINTESTINAL INFECTION,1
KE,GASTROINTESTINAL NEOPLASM,1
KE,GENERALISED ANXIETY DISORDER,1
KE,GENITAL ABSCESS,1
KE,GINGIVAL BLEEDING,1
KE,GLOMERULONEPHROPATHY,1
KE,GLUCOSE TOLERANCE IMPAIRED IN PREGNANCY,1
KE,GOITRE,1
KE,HAEMANGIOMA,1
KE,HAEMATURIA,1
KE,HAEMOGLOBIN INCREASED,1
KE,HAEMORRHAGIC DIATHESIS,1
KE,HAEMORRHOIDS,1
KE,HEARING IMPAIRED,1
KE,HEART RATE ABNORMAL,1
KE,HEPATIC ENCEPHALOPATHY,1
KE,HEPATIC ENZYME INCREASED,1
KE,HEPATITIS ACUTE,1
KE,HEPATOSPLENOMEGALY,1
KE,HIV TEST POSITIVE,1
KE,HIV WASTING SYNDROME,1
KE,HYPERCHLORHYDRIA,1
KE,HYPERSOMNIA,1
KE,HYPERTENSION,1
KE,HYPERTENSIVE HEART DISEASE,1
KE,HYPOKALAEMIA,1
KE,HYPONATRAEMIA,1
KE,HYPOSPADIAS,1
KE,HYPOTENSION,1
KE,HYPOVOLAEMIC SHOCK,1
KE,ILL-DEFINED DISORDER,1
KE,IMMUNOSUPPRESSION,1
KE,IMPAIRED DRIVING ABILITY,1
KE,INCORRECT DOSE ADMINISTERED,1
KE,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
KE,INSOMNIA,1
KE,INTERNATIONAL NORMALISED RATIO DECREASED,1
KE,INTESTINAL MASS,1
KE,ISCHAEMIC STROKE,1
KE,LEFT VENTRICULAR DYSFUNCTION,1
KE,LETHARGY,1
KE,LEUKAEMIA,1
KE,LEUKOPENIA,1
KE,LIBIDO DECREASED,1
KE,LIP OEDEMA,1
KE,LIP SWELLING,1
KE,LIPASE INCREASED,1
KE,LIVE BIRTH,1
KE,LIVER ABSCESS,1
KE,LOW BIRTH WEIGHT BABY,1
KE,LOWER GASTROINTESTINAL HAEMORRHAGE,1
KE,LOWER RESPIRATORY TRACT CONGESTION,1
KE,LUNG DISORDER,1
KE,LYMPH NODE TUBERCULOSIS,1
KE,LYMPHADENOPATHY,1
KE,LYMPHOEDEMA,1
KE,MATERNAL EXPOSURE BEFORE PREGNANCY,1
KE,MECHANICAL VENTILATION,1
KE,MECONIUM ASPIRATION SYNDROME,1
KE,MEMORY IMPAIRMENT,1
KE,MENINGITIS BACTERIAL,1
KE,MENTAL DISORDER,1
KE,MENTAL RETARDATION,1
KE,MESENTERIC ABSCESS,1
KE,METASTASES TO LIVER,1
KE,METASTASES TO SPINE,1
KE,MOUTH ULCERATION,1
KE,MUCOSAL TOXICITY,1
KE,MULTIPLE-DRUG RESISTANCE,1
KE,MUSCLE SPASMS,1
KE,MUSCLE TWITCHING,1
KE,MYCOBACTERIUM AVIUM COMPLEX INFECTION,1
KE,MYELITIS TRANSVERSE,1
KE,MYELOFIBROSIS,1
KE,MYOCARDIAL INFARCTION,1
KE,MYOCLONUS,1
KE,MYOPATHY,1
KE,NAIL PIGMENTATION,1
KE,NEOPLASM PROGRESSION,1
KE,NEOPLASM RECURRENCE,1
KE,NERVOUS SYSTEM DISORDER,1
KE,NEUROPATHY PERIPHERAL,1
KE,NEUROSYPHILIS,1
KE,NEUTROPHIL COUNT DECREASED,1
KE,NEUTROPHILIA,1
KE,NIGHT SWEATS,1
KE,NIGHTMARE,1
KE,NONSPECIFIC REACTION,1
KE,OEDEMA,1
KE,OEDEMA MOUTH,1
KE,OESOPHAGEAL IRRITATION,1
KE,ORAL PAIN,1
KE,OROPHARYNGEAL PAIN,1
KE,OXYGEN SATURATION ABNORMAL,1
KE,PANIC ATTACK,1
KE,PARTIAL SEIZURES,1
KE,PENILE HAEMORRHAGE,1
KE,PERIPHERAL COLDNESS,1
KE,PERITONEAL TUBERCULOSIS,1
KE,PHOTOPHOBIA,1
KE,PHOTOSENSITIVITY REACTION,1
KE,PIGMENTATION DISORDER,1
KE,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
KE,POLYDACTYLY,1
KE,POSTICTAL STATE,1
KE,POSTPARTUM HAEMORRHAGE,1
KE,PRE-ECLAMPSIA,1
KE,PREMATURE DELIVERY,1
KE,PREMATURE RUPTURE OF MEMBRANES,1
KE,PRODUCT LABEL ISSUE,1
KE,PRODUCT PREPARATION ERROR,1
KE,PSYCHIATRIC SYMPTOM,1
KE,PSYCHOMOTOR HYPERACTIVITY,1
KE,PULSE ABNORMAL,1
KE,PURPURA,1
KE,RADIATION PROCTITIS,1
KE,RASH ERYTHEMATOUS,1
KE,RASH MACULO-PAPULAR,1
KE,RASH PUSTULAR,1
KE,RECTAL HAEMORRHAGE,1
KE,RED BLOOD CELL COUNT INCREASED,1
KE,RELAPSING FEVER,1
KE,RENAL IMPAIRMENT,1
KE,RESPIRATORY ARREST,1
KE,RESPIRATORY TRACT CONGESTION,1
KE,RESPIRATORY TRACT INFECTION,1
KE,RETINAL HAEMORRHAGE,1
KE,ROAD TRAFFIC ACCIDENT,1
KE,SCAB,1
KE,SCRATCH,1
KE,SEPSIS NEONATAL,1
KE,SEPTIC SHOCK,1
KE,SHOCK,1
KE,SICKLE CELL ANAEMIA WITH CRISIS,1
KE,SINUS TACHYCARDIA,1
KE,SKIN DISORDER,1
KE,SKIN HAEMORRHAGE,1
KE,SKIN HYPOPIGMENTATION,1
KE,SKIN LESION,1
KE,SKIN MASS,1
KE,SKIN TOXICITY,1
KE,SOCIAL AVOIDANT BEHAVIOUR,1
KE,SPEECH DISORDER,1
KE,SPLENIC THROMBOSIS,1
KE,SUFFOCATION FEELING,1
KE,SUICIDAL IDEATION,1
KE,SUNBURN,1
KE,SWELLING,1
KE,SYNDACTYLY,1
KE,SYSTEMIC LUPUS ERYTHEMATOSUS,1
KE,TACHYPNOEA,1
KE,TEARFULNESS,1
KE,THERAPY NON-RESPONDER,1
KE,THERMAL BURN,1
KE,THROMBOSIS MESENTERIC VESSEL,1
KE,TONSILLAR DISORDER,1
KE,TONSILLAR HYPERTROPHY,1
KE,TONSILLAR INFLAMMATION,1
KE,TONSILLITIS,1
KE,TONSILLITIS BACTERIAL,1
KE,TOOTH DEVELOPMENT DISORDER,1
KE,TOXIC EPIDERMAL NECROLYSIS,1
KE,TOXICITY TO VARIOUS AGENTS,1
KE,TOXOPLASMOSIS,1
KE,TREATMENT NONCOMPLIANCE,1
KE,UNDERDOSE,1
KE,UNEVALUABLE EVENT,1
KE,UPPER RESPIRATORY TRACT INFECTION,1
KE,URINARY TRACT INFECTION,1
KE,URINE ODOUR ABNORMAL,1
KE,URTICARIA,1
KE,UTERINE HAEMORRHAGE,1
KE,UVEITIS,1
KE,VAGINAL DISCHARGE,1
KE,VAGINAL HAEMORRHAGE,1
KE,VENTRICULAR EXTRASYSTOLES,1
KE,VENTRICULAR FIBRILLATION,1
KE,VENTRICULAR SEPTAL DEFECT,1
KE,VENTRICULAR TACHYCARDIA,1
KE,VESTIBULAR DISORDER,1
KE,VESTIBULAR NEURONITIS,1
KE,VIITH NERVE PARALYSIS,1
KE,VIRAL LOAD INCREASED,1
KE,VISION BLURRED,1
KE,VULVOVAGINAL PRURITUS,1
KE,WEIGHT DECREASED,1
KE,WHEEZING,1
KE,WRONG DRUG ADMINISTERED,1
KE,YELLOW SKIN,1
KI,CENTRAL NERVOUS SYSTEM LESION,1
KI,INSOMNIA,1
KP,DISEASE PROGRESSION,19
KP,PNEUMONIA,13
KP,TOXICITY TO VARIOUS AGENTS,12
KP,INFECTION,11
KP,DEATH,10
KP,PANCREATIC CARCINOMA,9
KP,DIARRHOEA,8
KP,DRUG RESISTANCE,8
KP,MALIGNANT NEOPLASM PROGRESSION,8
KP,DRUG INEFFECTIVE,7
KP,NEUROPATHY PERIPHERAL,7
KP,NEUTROPENIA,7
KP,SEPSIS,7
KP,WEIGHT DECREASED,7
KP,NAUSEA,6
KP,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,6
KP,PYREXIA,6
KP,VOMITING,6
KP,ABDOMINAL PAIN,5
KP,CARDIAC ARREST,5
KP,RASH,5
KP,CARDIAC FAILURE,4
KP,DYSPNOEA,4
KP,FEBRILE NEUTROPENIA,4
KP,HERPES ZOSTER,4
KP,HYPERTENSION,4
KP,ORAL CANDIDIASIS,4
KP,PNEUMONIA ASPIRATION,4
KP,SEPTIC SHOCK,4
KP,THROMBOCYTOPENIA,4
KP,TOXIC EPIDERMAL NECROLYSIS,4
KP,TREATMENT FAILURE,4
KP,VENOOCCLUSIVE LIVER DISEASE,4
KP,ALANINE AMINOTRANSFERASE INCREASED,3
KP,ANAEMIA,3
KP,ASTHENIA,3
KP,BLOOD PRESSURE DECREASED,3
KP,CEREBRAL SALT-WASTING SYNDROME,3
KP,COAGULOPATHY,3
KP,CONDITION AGGRAVATED,3
KP,FOETAL EXPOSURE DURING PREGNANCY,3
KP,HAEMATOMA,3
KP,HAEMATURIA,3
KP,HYPERSENSITIVITY VASCULITIS,3
KP,MOOD ALTERED,3
KP,NEOPLASM PROGRESSION,3
KP,NEUROTOXICITY,3
KP,REOCCLUSION,3
KP,UROSEPSIS,3
KP,VISUAL ACUITY REDUCED,3
KP,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,2
KP,ACUTE KIDNEY INJURY,2
KP,ASPHYXIA,2
KP,ATYPICAL FRACTURE,2
KP,BLOOD BRAIN BARRIER DEFECT,2
KP,BLOOD CREATININE INCREASED,2
KP,BRONCHOSPASM,2
KP,C-REACTIVE PROTEIN INCREASED,2
KP,CEREBRAL INFARCTION,2
KP,COMA SCALE ABNORMAL,2
KP,COUGH,2
KP,CUTANEOUS VASCULITIS,2
KP,DECREASED APPETITE,2
KP,DEHYDRATION,2
KP,DIZZINESS,2
KP,ELECTROLYTE IMBALANCE,2
KP,EMBOLISM ARTERIAL,2
KP,GASTROINTESTINAL DISORDER,2
KP,GINGIVAL BLEEDING,2
KP,GRANULOMATOUS PNEUMONITIS,2
KP,HAEMATOTOXICITY,2
KP,HAEMORRHAGE,2
KP,HEART RATE INCREASED,2
KP,HEMIPARESIS,2
KP,HEPATOCELLULAR CARCINOMA,2
KP,HEPATOTOXICITY,2
KP,HYPERAESTHESIA,2
KP,HYPONATRAEMIA,2
KP,HYPOTENSION,2
KP,HYPOVOLAEMIC SHOCK,2
KP,LEUKOENCEPHALOPATHY,2
KP,LIVER INJURY,2
KP,LOSS OF CONSCIOUSNESS,2
KP,METASTASES TO CENTRAL NERVOUS SYSTEM,2
KP,MUSCLE SPASMS,2
KP,MYALGIA,2
KP,NEPHROPATHY TOXIC,2
KP,OCCUPATIONAL EXPOSURE TO TOXIC AGENT,2
KP,PAIN,2
KP,PANCREATIC CARCINOMA METASTATIC,2
KP,PLEUROTHOTONUS,2
KP,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
KP,PNEUMONITIS,2
KP,PRODUCT USE ISSUE,2
KP,PULMONARY MASS,2
KP,PUNCTURE SITE HAEMORRHAGE,2
KP,RENAL INJURY,2
KP,SCROTAL SWELLING,2
KP,SEROTONIN SYNDROME,2
KP,SPLENOMEGALY,2
KP,URTICARIA,2
KP,ABDOMINAL PAIN UPPER,1
KP,ACCIDENTAL OVERDOSE,1
KP,ACQUIRED HAEMOPHILIA,1
KP,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
KP,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
KP,ACUTE PROMYELOCYTIC LEUKAEMIA,1
KP,ACUTE RESPIRATORY FAILURE,1
KP,AMPUTATION,1
KP,ANAPHYLACTIC REACTION,1
KP,ANAPHYLACTIC SHOCK,1
KP,ANGIOEDEMA,1
KP,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE,1
KP,ARTERIOSCLEROSIS,1
KP,ARTERIOSPASM CORONARY,1
KP,ARTHRALGIA,1
KP,ARTHRITIS HELMINTHIC,1
KP,ARTHRITIS INFECTIVE,1
KP,ASCITES,1
KP,ASPARTATE AMINOTRANSFERASE INCREASED,1
KP,ATAXIA,1
KP,ATELECTASIS,1
KP,BACK PAIN,1
KP,BACTERAEMIA,1
KP,BASAL GANGLIA HAEMORRHAGE,1
KP,BILIARY TRACT INFECTION,1
KP,BK VIRUS INFECTION,1
KP,BLINDNESS,1
KP,BLOOD BILIRUBIN INCREASED,1
KP,BLOOD GLUCOSE INCREASED,1
KP,BONE MARROW FAILURE,1
KP,BRONCHIECTASIS,1
KP,BRONCHOPULMONARY DYSPLASIA,1
KP,CALCIPHYLAXIS,1
KP,CAROTID ARTERY ANEURYSM,1
KP,CATARACT,1
KP,CEREBRAL ASPERGILLOSIS,1
KP,CEREBRAL HAEMORRHAGE,1
KP,CHEST DISCOMFORT,1
KP,CHEST PAIN,1
KP,CHOLELITHIASIS,1
KP,COLITIS,1
KP,COLOUR BLINDNESS ACQUIRED,1
KP,COMA,1
KP,COMPLETED SUICIDE,1
KP,COMPLEX REGIONAL PAIN SYNDROME,1
KP,CONFUSIONAL STATE,1
KP,CONGENITAL GASTRIC ANOMALY,1
KP,CONJUNCTIVITIS,1
KP,CONSTIPATION,1
KP,CORONARY ARTERY OCCLUSION,1
KP,CORONARY ARTERY STENOSIS,1
KP,CROHN^S DISEASE,1
KP,CYANOSIS,1
KP,CYTOMEGALOVIRUS CHORIORETINITIS,1
KP,CYTOMEGALOVIRUS INFECTION,1
KP,CYTOMEGALOVIRUS VIRAEMIA,1
KP,CYTOPENIA,1
KP,DEPRESSED LEVEL OF CONSCIOUSNESS,1
KP,DEPRESSION,1
KP,DERMATITIS ALLERGIC,1
KP,DERMATITIS BULLOUS,1
KP,DIABETES MELLITUS,1
KP,DIARRHOEA INFECTIOUS,1
KP,DRUG DOSE OMISSION,1
KP,DRUG HYPERSENSITIVITY,1
KP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
KP,DRUG-INDUCED LIVER INJURY,1
KP,DUODENAL OBSTRUCTION,1
KP,DYSARTHRIA,1
KP,DYSPHAGIA,1
KP,DYSTONIA,1
KP,DYSURIA,1
KP,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
KP,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
KP,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
KP,EMPHYSEMA,1
KP,ENCEPHALITIS VIRAL,1
KP,ENDOCARDITIS,1
KP,ENTERITIS,1
KP,ENTEROCOLITIS,1
KP,EPIDERMAL NECROSIS,1
KP,ERYTHEMA MULTIFORME,1
KP,EXTRADURAL HAEMATOMA,1
KP,FEMORAL NECK FRACTURE,1
KP,FEMUR FRACTURE,1
KP,FISTULA OF SMALL INTESTINE,1
KP,GASTRIC PERFORATION,1
KP,GASTRIC ULCER HAEMORRHAGE,1
KP,GASTROENTERITIS,1
KP,GASTROENTERITIS BACTERIAL,1
KP,GENITAL HERPES ZOSTER,1
KP,HAEMORRHAGE INTRACRANIAL,1
KP,HEPATIC CIRRHOSIS,1
KP,HEPATIC ENCEPHALOPATHY,1
KP,HEPATIC ENZYME INCREASED,1
KP,HEPATIC FAILURE,1
KP,HEPATIC FUNCTION ABNORMAL,1
KP,HEPATIC INFARCTION,1
KP,HEPATIC STEATOSIS,1
KP,HEPATOMEGALY,1
KP,HEPATOPULMONARY SYNDROME,1
KP,HISTIOCYTOSIS HAEMATOPHAGIC,1
KP,HYPERSENSITIVITY,1
KP,HYPERTRIGLYCERIDAEMIA,1
KP,HYPOVOLAEMIA,1
KP,ILEUS,1
KP,ILEUS PARALYTIC,1
KP,INJECTION SITE REACTION,1
KP,INTRAVENTRICULAR HAEMORRHAGE NEONATAL,1
KP,JAUNDICE,1
KP,JOINT ARTHROPLASTY,1
KP,JOINT SWELLING,1
KP,KLEBSIELLA INFECTION,1
KP,KOUNIS SYNDROME,1
KP,LOW BIRTH WEIGHT BABY,1
KP,LYMPH NODE TUBERCULOSIS,1
KP,LYMPHOCELE,1
KP,LYMPHOMA,1
KP,MATERNAL EXPOSURE DURING PREGNANCY,1
KP,MENINGITIS ASEPTIC,1
KP,MENTAL DISORDER,1
KP,MENTAL IMPAIRMENT,1
KP,MENTAL STATUS CHANGES,1
KP,METABOLIC ACIDOSIS,1
KP,METABOLIC ENCEPHALOPATHY,1
KP,METASTASES TO LUNG,1
KP,METASTASES TO LYMPH NODES,1
KP,METASTASES TO OVARY,1
KP,METASTASIS,1
KP,MUCORMYCOSIS,1
KP,MULTI-ORGAN FAILURE,1
KP,MUSCULAR WEAKNESS,1
KP,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
KP,NEUROLEPTIC MALIGNANT SYNDROME,1
KP,OEDEMA MUCOSAL,1
KP,OESOPHAGEAL ULCER,1
KP,OPTIC ISCHAEMIC NEUROPATHY,1
KP,OSTEOARTHRITIS,1
KP,OTOTOXICITY,1
KP,OVERDOSE,1
KP,PALMAR ERYTHEMA,1
KP,PALPITATIONS,1
KP,PANCREATITIS ACUTE,1
KP,PANCYTOPENIA,1
KP,PARADOXICAL DRUG REACTION,1
KP,PARKINSONISM,1
KP,PARKINSON^S DISEASE,1
KP,PEMPHIGOID,1
KP,PERIPHERAL ARTERY OCCLUSION,1
KP,PNEUMONIA BACTERIAL,1
KP,PNEUMONIA FUNGAL,1
KP,POLYNEUROPATHY,1
KP,PORTAL VEIN THROMBOSIS,1
KP,POST-TUSSIVE VOMITING,1
KP,PREMATURE BABY,1
KP,PREMATURE MENOPAUSE,1
KP,PRINZMETAL ANGINA,1
KP,PROSTATIC OPERATION,1
KP,PROTHROMBIN TIME PROLONGED,1
KP,PULMONARY FIBROSIS,1
KP,PULMONARY HAEMORRHAGE,1
KP,PYELONEPHRITIS,1
KP,PYELONEPHRITIS ACUTE,1
KP,PYODERMA GANGRENOSUM,1
KP,RADIATION PNEUMONITIS,1
KP,RASH GENERALISED,1
KP,RECALL PHENOMENON,1
KP,RENAL FAILURE,1
KP,RENAL HAEMORRHAGE,1
KP,RESPIRATORY DISTRESS,1
KP,RETINAL PIGMENT EPITHELIAL TEAR,1
KP,RETINAL VEIN OCCLUSION,1
KP,RETROPERITONEAL HAEMATOMA,1
KP,SEIZURE,1
KP,SEPSIS NEONATAL,1
KP,SINUSITIS,1
KP,SKIN EXFOLIATION,1
KP,SKIN LESION,1
KP,SLEEP-RELATED EATING DISORDER,1
KP,SPINAL CORD INFARCTION,1
KP,STEVENS-JOHNSON SYNDROME,1
KP,STILLBIRTH,1
KP,STRESS CARDIOMYOPATHY,1
KP,STUPOR,1
KP,SUDDEN DEATH,1
KP,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
KP,TOXIC SKIN ERUPTION,1
KP,TREATMENT NONCOMPLIANCE,1
KP,TREMOR,1
KP,TUBERCULOSIS,1
KP,TUBULOINTERSTITIAL NEPHRITIS,1
KP,URTICARIA CHOLINERGIC,1
KP,UTERINE RUPTURE,1
KP,VANISHING BILE DUCT SYNDROME,1
KP,VASCULAR STENT THROMBOSIS,1
KP,VENTRICULAR FIBRILLATION,1
KP,VENTRICULAR HYPOKINESIA,1
KP,VIRAL LOAD INCREASED,1
KP,VIROLOGIC FAILURE,1
KR,NEUTROPENIA,763
KR,DEATH,759
KR,PNEUMONIA,585
KR,PYREXIA,547
KR,NAUSEA,518
KR,DYSPNOEA,418
KR,DIARRHOEA,414
KR,ASTHENIA,410
KR,DRUG INEFFECTIVE,398
KR,VOMITING,386
KR,FEBRILE NEUTROPENIA,360
KR,DIZZINESS,325
KR,DECREASED APPETITE,293
KR,HEADACHE,250
KR,DISEASE PROGRESSION,241
KR,RASH,231
KR,ANAEMIA,228
KR,ABDOMINAL PAIN,219
KR,THROMBOCYTOPENIA,208
KR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,206
KR,CONSTIPATION,195
KR,SEPSIS,190
KR,COUGH,169
KR,PAIN,166
KR,ALANINE AMINOTRANSFERASE INCREASED,161
KR,SEPTIC SHOCK,161
KR,ACUTE KIDNEY INJURY,158
KR,TREATMENT FAILURE,158
KR,PRURITUS,157
KR,MALIGNANT NEOPLASM PROGRESSION,154
KR,BLOOD GLUCOSE INCREASED,149
KR,TOXICITY TO VARIOUS AGENTS,149
KR,CONDITION AGGRAVATED,145
KR,ASPARTATE AMINOTRANSFERASE INCREASED,142
KR,DELIRIUM,139
KR,HAEMORRHAGE,139
KR,FATIGUE,133
KR,DRUG RESISTANCE,132
KR,INSOMNIA,129
KR,HYPOTENSION,127
KR,CEREBRAL INFARCTION,120
KR,DYSPEPSIA,119
KR,FALL,117
KR,PAIN IN EXTREMITY,115
KR,PLEURAL EFFUSION,113
KR,BACK PAIN,112
KR,MYALGIA,112
KR,CARDIAC ARREST,111
KR,PRODUCT USE ISSUE,111
KR,TUBERCULOSIS,110
KR,STOMATITIS,109
KR,FOETAL EXPOSURE DURING PREGNANCY,102
KR,HYPOPHAGIA,98
KR,HYPERGLYCAEMIA,97
KR,NASOPHARYNGITIS,97
KR,HEPATITIS B,93
KR,HYPOGLYCAEMIA,93
KR,SOMNOLENCE,92
KR,URTICARIA,92
KR,CHEST PAIN,89
KR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,89
KR,PRODUCT USE IN UNAPPROVED INDICATION,89
KR,ANAPHYLACTIC REACTION,88
KR,SEIZURE,88
KR,VISUAL ACUITY REDUCED,87
KR,ARTHRALGIA,86
KR,LOSS OF CONSCIOUSNESS,86
KR,LEUKOPENIA,85
KR,CHEST DISCOMFORT,84
KR,HAEMATOCHEZIA,84
KR,HYPOAESTHESIA,83
KR,PLATELET COUNT DECREASED,83
KR,INFECTION,81
KR,LOW BIRTH WEIGHT BABY,81
KR,HYPONATRAEMIA,80
KR,PULMONARY EMBOLISM,80
KR,HAEMOGLOBIN DECREASED,79
KR,PANCYTOPENIA,79
KR,MUSCULAR WEAKNESS,78
KR,SYNCOPE,78
KR,OVERDOSE,77
KR,MYOCLONUS,76
KR,NEUTROPHIL COUNT DECREASED,76
KR,BLOOD CREATININE INCREASED,74
KR,NEUROPATHY PERIPHERAL,74
KR,PREGNANCY,74
KR,OEDEMA,73
KR,PULMONARY TUBERCULOSIS,73
KR,TREMOR,73
KR,UPPER RESPIRATORY TRACT INFECTION,73
KR,ABDOMINAL PAIN UPPER,72
KR,CARDIAC FAILURE,72
KR,HERPES ZOSTER,72
KR,GAIT DISTURBANCE,71
KR,HYPERTENSION,71
KR,DEPRESSION,70
KR,GENERAL PHYSICAL HEALTH DETERIORATION,70
KR,HYPOKALAEMIA,70
KR,OEDEMA PERIPHERAL,70
KR,PULMONARY OEDEMA,70
KR,TOXIC EPIDERMAL NECROLYSIS,70
KR,PALPITATIONS,68
KR,PARAESTHESIA,67
KR,URINARY TRACT INFECTION,67
KR,WEIGHT INCREASED,67
KR,HEPATIC FAILURE,66
KR,WEIGHT DECREASED,66
KR,ALOPECIA,65
KR,RENAL IMPAIRMENT,65
KR,RESPIRATORY FAILURE,65
KR,STEVENS-JOHNSON SYNDROME,65
KR,ABDOMINAL DISTENSION,63
KR,HAEMOPTYSIS,62
KR,INTERSTITIAL LUNG DISEASE,62
KR,ASCITES,61
KR,CHILLS,61
KR,DIABETES MELLITUS,61
KR,HEPATOCELLULAR CARCINOMA,61
KR,ERYTHEMA,60
KR,EXPOSURE DURING PREGNANCY,59
KR,CEREBRAL HAEMORRHAGE,58
KR,PERITONITIS,57
KR,RENAL FAILURE ACUTE,57
KR,CEREBROVASCULAR ACCIDENT,56
KR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,56
KR,ABDOMINAL DISCOMFORT,55
KR,ADVERSE EVENT,55
KR,GASTROINTESTINAL HAEMORRHAGE,55
KR,HEPATIC ENZYME INCREASED,55
KR,MYOCARDIAL INFARCTION,55
KR,PRODUCTIVE COUGH,55
KR,SHOCK,55
KR,HYPERHIDROSIS,54
KR,LACTIC ACIDOSIS,54
KR,OSTEONECROSIS OF JAW,53
KR,BLOOD PRESSURE DECREASED,52
KR,HEPATITIS,52
KR,PNEUMONITIS,52
KR,VISION BLURRED,52
KR,BLOOD BILIRUBIN INCREASED,51
KR,BLOOD PRESSURE INCREASED,51
KR,C-REACTIVE PROTEIN INCREASED,50
KR,DRUG-INDUCED LIVER INJURY,50
KR,ANXIETY,49
KR,COLITIS,49
KR,DRY MOUTH,49
KR,VISUAL IMPAIRMENT,49
KR,CELLULITIS,48
KR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,48
KR,ATRIAL FIBRILLATION,47
KR,BRADYCARDIA,47
KR,DEPRESSED LEVEL OF CONSCIOUSNESS,47
KR,HYPERKALAEMIA,47
KR,PARKINSONISM,47
KR,RHABDOMYOLYSIS,47
KR,ARRHYTHMIA,46
KR,CONVULSION,45
KR,PLASMA CELL MYELOMA,45
KR,SEROTONIN SYNDROME,45
KR,WHITE BLOOD CELL COUNT DECREASED,44
KR,AZOTAEMIA,43
KR,GASTRITIS,43
KR,ROAD TRAFFIC ACCIDENT,42
KR,DEHYDRATION,41
KR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,41
KR,PANCREATITIS ACUTE,41
KR,BLISTER,40
KR,JAUNDICE,40
KR,URINARY RETENTION,40
KR,VENOOCCLUSIVE LIVER DISEASE,40
KR,DYSURIA,39
KR,LUNG NEOPLASM MALIGNANT,39
KR,PNEUMONIA ASPIRATION,39
KR,PULMONARY ARTERIAL HYPERTENSION,39
KR,VENOUS THROMBOSIS,39
KR,BONE MARROW FAILURE,38
KR,CATARACT,38
KR,EPISTAXIS,38
KR,HAEMATURIA,38
KR,LIVER FUNCTION TEST ABNORMAL,38
KR,MUCOSAL INFLAMMATION,38
KR,TACHYCARDIA,38
KR,CYTOMEGALOVIRUS INFECTION,37
KR,GASTRIC ULCER,37
KR,INCORRECT DOSE ADMINISTERED,37
KR,RASH GENERALISED,37
KR,ACUTE MYELOID LEUKAEMIA,36
KR,CONFUSIONAL STATE,36
KR,DRUG ADMINISTRATION ERROR,36
KR,ILEUS,36
KR,OROPHARYNGEAL PAIN,36
KR,PNEUMOCYSTIS JIROVECII PNEUMONIA,36
KR,RENAL FAILURE,36
KR,CYTOPENIA,35
KR,DISEASE RECURRENCE,35
KR,HYPERBILIRUBINAEMIA,35
KR,INFLAMMATION,35
KR,MATERNAL EXPOSURE DURING PREGNANCY,35
KR,MEDICATION ERROR,35
KR,PANCREATITIS,35
KR,BONE PAIN,34
KR,DRUG DEPENDENCE,34
KR,MUSCULOSKELETAL PAIN,34
KR,RASH MACULO-PAPULAR,34
KR,SURGERY,34
KR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,33
KR,DEEP VEIN THROMBOSIS,33
KR,GASTROINTESTINAL DISORDER,33
KR,HYPERSENSITIVITY,33
KR,OXYGEN SATURATION DECREASED,33
KR,SUICIDE ATTEMPT,33
KR,TOXIC ENCEPHALOPATHY,33
KR,TREATMENT NONCOMPLIANCE,33
KR,AORTIC THROMBOSIS,32
KR,GASTROOESOPHAGEAL REFLUX DISEASE,32
KR,HOSPITALISATION,32
KR,METASTASES TO LUNG,32
KR,RETINAL HAEMORRHAGE,32
KR,SUICIDAL IDEATION,32
KR,COMA,31
KR,EXPOSED BONE IN JAW,31
KR,HEPATIC ENCEPHALOPATHY,31
KR,HEPATOTOXICITY,31
KR,PERICARDIAL EFFUSION,31
KR,ACUTE MYOCARDIAL INFARCTION,30
KR,CHRONIC KIDNEY DISEASE,30
KR,COMPLETED SUICIDE,30
KR,DIABETIC KETOACIDOSIS,30
KR,HAEMORRHAGE INTRACRANIAL,30
KR,INFUSION RELATED REACTION,30
KR,PERIPHERAL SWELLING,30
KR,PROTEINURIA,30
KR,PYELONEPHRITIS ACUTE,30
KR,BREAST CANCER RECURRENT,29
KR,DYSARTHRIA,29
KR,DYSPHAGIA,29
KR,ELECTROCARDIOGRAM QT PROLONGED,29
KR,FEMUR FRACTURE,29
KR,METABOLIC ACIDOSIS,29
KR,ABNORMAL BEHAVIOUR,28
KR,CAESAREAN SECTION,28
KR,CHOLELITHIASIS,28
KR,EXTRAPYRAMIDAL DISORDER,28
KR,EYE PAIN,28
KR,FACE OEDEMA,28
KR,FEELING ABNORMAL,28
KR,GENERALISED OEDEMA,28
KR,HYPOXIA,28
KR,INFLUENZA,28
KR,MUSCULOSKELETAL STIFFNESS,28
KR,PANCREATIC CARCINOMA,28
KR,SWELLING,28
KR,CARDIAC DISORDER,27
KR,DYSTONIA,27
KR,HYPOPHOSPHATAEMIA,27
KR,INTERVERTEBRAL DISC PROTRUSION,27
KR,MELAENA,27
KR,NEUROTOXICITY,27
KR,THERAPEUTIC RESPONSE DECREASED,27
KR,TUMOUR LYSIS SYNDROME,27
KR,BLINDNESS,26
KR,BLOOD CREATINE PHOSPHOKINASE INCREASED,26
KR,CENTRAL NERVOUS SYSTEM LESION,26
KR,DIABETES MELLITUS INADEQUATE CONTROL,26
KR,ENTERITIS,26
KR,GASTRIC CANCER,26
KR,LIVER DISORDER,26
KR,MULTI-ORGAN FAILURE,26
KR,OSTEOPOROSIS,26
KR,PSYCHOTIC DISORDER,26
KR,SKIN EXFOLIATION,26
KR,VENOOCCLUSIVE DISEASE,26
KR,ABORTION SPONTANEOUS,25
KR,ACUTE HEPATIC FAILURE,25
KR,AMNESIA,25
KR,CHOLECYSTITIS ACUTE,25
KR,DEPRESSED MOOD,25
KR,DRUG ERUPTION,25
KR,ENCEPHALOPATHY,25
KR,HYPERLIPIDAEMIA,25
KR,LETHARGY,25
KR,LIVER FUNCTION TEST INCREASED,25
KR,LYMPHADENOPATHY,25
KR,PARALYSIS,25
KR,RETINAL PIGMENT EPITHELIAL TEAR,25
KR,SCHIZOPHRENIA,25
KR,STUPOR,25
KR,VAGINAL HAEMORRHAGE,25
KR,VIRAL INFECTION,25
KR,ANGINA PECTORIS,24
KR,APPENDICITIS,24
KR,BLOOD ALKALINE PHOSPHATASE INCREASED,24
KR,BRONCHITIS,24
KR,ORAL CANDIDIASIS,24
KR,PRODUCT QUALITY ISSUE,24
KR,RENAL TUBULAR DISORDER,24
KR,RETINAL DETACHMENT,24
KR,BRONCHOPULMONARY ASPERGILLOSIS,23
KR,COLD SWEAT,23
KR,DRUG ABUSE,23
KR,EPILEPSY,23
KR,GASTROENTERITIS,23
KR,HEPATIC CANCER,23
KR,INCORRECT ROUTE OF DRUG ADMINISTRATION,23
KR,LEUKOCYTOSIS,23
KR,METASTASES TO LIVER,23
KR,NEOPLASM MALIGNANT,23
KR,NEUROLEPTIC MALIGNANT SYNDROME,23
KR,OSTEONECROSIS,23
KR,POLLAKIURIA,23
KR,PREMATURE BABY,23
KR,RHINORRHOEA,23
KR,SKIN LESION,23
KR,SLEEP DISORDER,23
KR,TINNITUS,23
KR,ANAPHYLACTIC SHOCK,22
KR,BACTERIAL INFECTION,22
KR,COGNITIVE DISORDER,22
KR,HEPATIC FUNCTION ABNORMAL,22
KR,MENTAL STATUS CHANGES,22
KR,METASTASES TO CENTRAL NERVOUS SYSTEM,22
KR,PURULENT DISCHARGE,22
KR,TARDIVE DYSKINESIA,22
KR,WHITE BLOOD CELL COUNT INCREASED,22
KR,ACUTE RESPIRATORY FAILURE,21
KR,CONTUSION,21
KR,EOSINOPHILIA,21
KR,GLAUCOMA,21
KR,HEMIPARESIS,21
KR,INJECTION SITE PAIN,21
KR,MALAISE,21
KR,SECOND PRIMARY MALIGNANCY,21
KR,SUDDEN DEATH,21
KR,SWELLING FACE,21
KR,ACUTE RESPIRATORY DISTRESS SYNDROME,20
KR,ANGIOEDEMA,20
KR,BLOOD LACTATE DEHYDROGENASE INCREASED,20
KR,CARDIOVASCULAR DISORDER,20
KR,DISORIENTATION,20
KR,DRUG DOSE OMISSION,20
KR,DYSKINESIA,20
KR,DYSPHONIA,20
KR,DYSPNOEA EXERTIONAL,20
KR,ELECTROLYTE IMBALANCE,20
KR,FACIAL PARALYSIS,20
KR,HAEMATEMESIS,20
KR,HALLUCINATION,20
KR,HICCUPS,20
KR,HYPOALBUMINAEMIA,20
KR,HYPOTHYROIDISM,20
KR,OSTEOMALACIA,20
KR,PNEUMOTHORAX,20
KR,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,20
KR,RENAL DISORDER,20
KR,SLEEP APNOEA SYNDROME,20
KR,ACTIVITIES OF DAILY LIVING IMPAIRED,19
KR,AGITATION,19
KR,BLOOD GLUCOSE ABNORMAL,19
KR,BREAST CANCER,19
KR,CHOLECYSTITIS,19
KR,CROHN^S DISEASE,19
KR,DUODENAL ULCER,19
KR,FLANK PAIN,19
KR,FRACTURE,19
KR,HAEMORRHAGIC TRANSFORMATION STROKE,19
KR,HIP FRACTURE,19
KR,INTENTIONAL OVERDOSE,19
KR,MYOSITIS,19
KR,OCULOGYRIC CRISIS,19
KR,PERIPHERAL SENSORY NEUROPATHY,19
KR,RASH ERYTHEMATOUS,19
KR,THYROID CANCER,19
KR,ATAXIA,18
KR,CYSTITIS HAEMORRHAGIC,18
KR,DRUG EFFECT INCOMPLETE,18
KR,ENTEROCOLITIS,18
KR,EPSTEIN-BARR VIRUS INFECTION,18
KR,EXTRAPULMONARY TUBERCULOSIS,18
KR,GASTRIC HAEMORRHAGE,18
KR,GENOTYPE DRUG RESISTANCE TEST,18
KR,HEART RATE INCREASED,18
KR,HEPATIC CIRRHOSIS,18
KR,INCORRECT DRUG ADMINISTRATION DURATION,18
KR,INTENTIONAL DRUG MISUSE,18
KR,LIMB INJURY,18
KR,MEMORY IMPAIRMENT,18
KR,METASTASES TO BONE,18
KR,MOUTH ULCERATION,18
KR,MUSCLE SPASMS,18
KR,NORMAL NEWBORN,18
KR,OCULAR HYPERAEMIA,18
KR,RESPIRATORY DEPRESSION,18
KR,ABASIA,17
KR,ALTERED STATE OF CONSCIOUSNESS,17
KR,BACTERAEMIA,17
KR,CONJUNCTIVAL HYPERAEMIA,17
KR,DISCOMFORT,17
KR,DRUG PRESCRIBING ERROR,17
KR,EMBOLISM,17
KR,ERYTHEMA MULTIFORME,17
KR,HAEMATOMA,17
KR,HYPERTHERMIA,17
KR,LIVER INJURY,17
KR,LYMPHOMA,17
KR,NO THERAPEUTIC RESPONSE,17
KR,PRURITUS GENERALISED,17
KR,SPINAL COLUMN STENOSIS,17
KR,SPINAL COMPRESSION FRACTURE,17
KR,THROMBOSIS,17
KR,URINE OUTPUT DECREASED,17
KR,APHASIA,16
KR,CARDIAC FAILURE CONGESTIVE,16
KR,CARDIOGENIC SHOCK,16
KR,CIRCULATORY COLLAPSE,16
KR,COLON CANCER,16
KR,DEMENTIA,16
KR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,16
KR,DRUG HYPERSENSITIVITY,16
KR,EYE HAEMORRHAGE,16
KR,HYPOTHERMIA,16
KR,ISCHAEMIC STROKE,16
KR,LUNG INFECTION,16
KR,NECK PAIN,16
KR,NERVOUS SYSTEM DISORDER,16
KR,OESOPHAGITIS,16
KR,PARADOXICAL DRUG REACTION,16
KR,PULMONARY ALVEOLAR HAEMORRHAGE,16
KR,SUBARACHNOID HAEMORRHAGE,16
KR,VIRAL MUTATION IDENTIFIED,16
KR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,16
KR,ABORTION INDUCED,15
KR,ACNE,15
KR,ASPERGILLUS INFECTION,15
KR,BLINDNESS UNILATERAL,15
KR,BRAIN INJURY,15
KR,CHOLANGITIS,15
KR,COAGULOPATHY,15
KR,CONCOMITANT DISEASE AGGRAVATED,15
KR,DERMATITIS,15
KR,ECZEMA,15
KR,HAEMOLYTIC ANAEMIA,15
KR,HAEMORRHOIDS,15
KR,HYPOCALCAEMIA,15
KR,ILEUS PARALYTIC,15
KR,INFLUENZA LIKE ILLNESS,15
KR,IRRITABILITY,15
KR,KAPOSI^S SARCOMA,15
KR,LUMBAR VERTEBRAL FRACTURE,15
KR,NYSTAGMUS,15
KR,ORAL PAIN,15
KR,ORGANISING PNEUMONIA,15
KR,PARKINSON^S DISEASE,15
KR,PULMONARY HAEMORRHAGE,15
KR,RIB FRACTURE,15
KR,SPINAL FRACTURE,15
KR,VIITH NERVE PARALYSIS,15
KR,VIRAL LOAD INCREASED,15
KR,VISUAL FIELD DEFECT,15
KR,ADRENAL INSUFFICIENCY,14
KR,ADVERSE DRUG REACTION,14
KR,ARTHRITIS,14
KR,BIPOLAR DISORDER,14
KR,BURNING SENSATION,14
KR,CYSTITIS,14
KR,DEVICE DISLOCATION,14
KR,DIABETIC FOOT,14
KR,DISSEMINATED INTRAVASCULAR COAGULATION,14
KR,DRY EYE,14
KR,EPIGASTRIC DISCOMFORT,14
KR,FEEDING DISORDER,14
KR,GINGIVAL BLEEDING,14
KR,GRAFT VERSUS HOST DISEASE,14
KR,HALLUCINATION_ AUDITORY,14
KR,HEMIPLEGIA,14
KR,INTENTIONAL PRODUCT MISUSE,14
KR,INTESTINAL PERFORATION,14
KR,MENTAL DISORDER,14
KR,MENTAL IMPAIRMENT,14
KR,NECROSIS,14
KR,PARAPLEGIA,14
KR,PATHOGEN RESISTANCE,14
KR,PRESCRIBED UNDERDOSE,14
KR,PURPURA,14
KR,SKIN NECROSIS,14
KR,SPEECH DISORDER,14
KR,SPLENOMEGALY,14
KR,STRESS CARDIOMYOPATHY,14
KR,THROMBOTIC MICROANGIOPATHY,14
KR,TRANSAMINASES INCREASED,14
KR,TRANSPLANT REJECTION,14
KR,TUBULOINTERSTITIAL NEPHRITIS,14
KR,UTERINE LEIOMYOMA,14
KR,VENTRICULAR TACHYCARDIA,14
KR,WERNICKE^S ENCEPHALOPATHY,14
KR,AGGRESSION,13
KR,ANGINA UNSTABLE,13
KR,ARTERIOSPASM CORONARY,13
KR,ASTHMA,13
KR,BLOOD PRESSURE SYSTOLIC INCREASED,13
KR,CHRONIC GASTRITIS,13
KR,CYTOMEGALOVIRUS COLITIS,13
KR,DEVICE RELATED INFECTION,13
KR,DYSSTASIA,13
KR,EOSINOPHIL COUNT INCREASED,13
KR,FEELING HOT,13
KR,FLUSHING,13
KR,GENERALISED TONIC-CLONIC SEIZURE,13
KR,HISTIOCYTOSIS HAEMATOPHAGIC,13
KR,INTESTINAL OBSTRUCTION,13
KR,KIDNEY TRANSPLANT REJECTION,13
KR,LEUKOENCEPHALOPATHY,13
KR,MYELODYSPLASTIC SYNDROME,13
KR,NEOPLASM PROGRESSION,13
KR,PNEUMONIA FUNGAL,13
KR,POLYNEUROPATHY,13
KR,PROSTATE CANCER,13
KR,PULMONARY FIBROSIS,13
KR,RASH MACULAR,13
KR,STAPHYLOCOCCAL INFECTION,13
KR,STATUS EPILEPTICUS,13
KR,SUBDURAL HAEMORRHAGE,13
KR,SYSTEMIC LUPUS ERYTHEMATOSUS,13
KR,TRANSIENT ISCHAEMIC ATTACK,13
KR,UPPER LIMB FRACTURE,13
KR,VANISHING BILE DUCT SYNDROME,13
KR,VENTRICULAR FIBRILLATION,13
KR,VITREOUS HAEMORRHAGE,13
KR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,13
KR,ARTERIAL THROMBOSIS,12
KR,ARTHRITIS BACTERIAL,12
KR,ATELECTASIS,12
KR,BLOOD CALCIUM DECREASED,12
KR,BLOOD UREA INCREASED,12
KR,BRAIN OEDEMA,12
KR,COLITIS ISCHAEMIC,12
KR,CONJUNCTIVITIS,12
KR,CORONARY ARTERY DISEASE,12
KR,CYANOSIS,12
KR,DETACHMENT OF RETINAL PIGMENT EPITHELIUM,12
KR,DRY SKIN,12
KR,EATING DISORDER,12
KR,EXPOSURE VIA BODY FLUID,12
KR,EYE DISORDER,12
KR,GLYCOSYLATED HAEMOGLOBIN INCREASED,12
KR,HAEMATOTOXICITY,12
KR,HEPATITIS B DNA INCREASED,12
KR,HYDRONEPHROSIS,12
KR,HYPERAMMONAEMIA,12
KR,HYPERCALCAEMIA,12
KR,HYPERSENSITIVITY VASCULITIS,12
KR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,12
KR,INFARCTION,12
KR,JOINT SWELLING,12
KR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,12
KR,LIVER ABSCESS,12
KR,LOWER LIMB FRACTURE,12
KR,LUNG INFILTRATION,12
KR,MASS,12
KR,METHAEMOGLOBINAEMIA,12
KR,MONOPLEGIA,12
KR,MUSCLE RIGIDITY,12
KR,NEURALGIA,12
KR,NEUROLOGICAL DECOMPENSATION,12
KR,NEUTROPENIC SEPSIS,12
KR,OTITIS MEDIA,12
KR,PAIN IN JAW,12
KR,PALLOR,12
KR,PAPILLARY THYROID CANCER,12
KR,PARONYCHIA,12
KR,PNEUMATOSIS INTESTINALIS,12
KR,POOR QUALITY SLEEP,12
KR,POST PROCEDURAL COMPLICATION,12
KR,RESPIRATORY DISTRESS,12
KR,RETINAL OEDEMA,12
KR,SKIN DISCOLOURATION,12
KR,THERAPY NON-RESPONDER,12
KR,URINARY INCONTINENCE,12
KR,ABSCESS,11
KR,ACUTE GRAFT VERSUS HOST DISEASE,11
KR,AKATHISIA,11
KR,ANKLE FRACTURE,11
KR,BK VIRUS INFECTION,11
KR,BRONCHIOLITIS,11
KR,CHRONIC GRAFT VERSUS HOST DISEASE,11
KR,DELUSION,11
KR,DRUG INTOLERANCE,11
KR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,11
KR,HAEMODIALYSIS,11
KR,HALLUCINATION_ VISUAL,11
KR,HEPATITIS B REACTIVATION,11
KR,HYPOACUSIS,11
KR,ILEAL PERFORATION,11
KR,INJURY,11
KR,INTESTINAL STENOSIS,11
KR,KOUNIS SYNDROME,11
KR,LARGE INTESTINE POLYP,11
KR,LOWER RESPIRATORY TRACT INFECTION,11
KR,LYMPHOEDEMA,11
KR,METASTASIS,11
KR,MYOPATHY,11
KR,NEPHROTIC SYNDROME,11
KR,NIGHTMARE,11
KR,PNEUMONIA BACTERIAL,11
KR,PROTHROMBIN TIME PROLONGED,11
KR,PULMONARY MASS,11
KR,RAOULTELLA ORNITHINOLYTICA INFECTION,11
KR,RED BLOOD CELL COUNT DECREASED,11
KR,RENAL INJURY,11
KR,RHINITIS,11
KR,SPUTUM INCREASED,11
KR,TACHYPNOEA,11
KR,TORSADE DE POINTES,11
KR,TUMOUR HAEMORRHAGE,11
KR,UTERINE HAEMORRHAGE,11
KR,UVEITIS,11
KR,VASCULAR STENT THROMBOSIS,11
KR,ABDOMINAL PAIN LOWER,10
KR,ABDOMINAL TENDERNESS,10
KR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,10
KR,ATYPICAL PNEUMONIA,10
KR,BENIGN PROSTATIC HYPERPLASIA,10
KR,BLOOD POTASSIUM INCREASED,10
KR,BLOOD URIC ACID INCREASED,10
KR,BONE LESION,10
KR,CYSTOID MACULAR OEDEMA,10
KR,DECREASED IMMUNE RESPONSIVENESS,10
KR,DIABETIC COMPLICATION,10
KR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,10
KR,ENTEROCOCCAL INFECTION,10
KR,FEMORAL NECK FRACTURE,10
KR,GASTRIC ULCER HAEMORRHAGE,10
KR,GASTROINTESTINAL PERFORATION,10
KR,HEART RATE DECREASED,10
KR,HERPES VIRUS INFECTION,10
KR,HYPERAMMONAEMIC ENCEPHALOPATHY,10
KR,HYPOVOLAEMIC SHOCK,10
KR,INJECTION SITE ERYTHEMA,10
KR,LUNG DISORDER,10
KR,MENSTRUATION IRREGULAR,10
KR,METASTASES TO LYMPH NODES,10
KR,METASTASES TO PERITONEUM,10
KR,MUCORMYCOSIS,10
KR,NEPHROPATHY TOXIC,10
KR,NO ADVERSE EVENT,10
KR,NOCTURIA,10
KR,OVARIAN GERM CELL TERATOMA,10
KR,PELVIC PAIN,10
KR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,10
KR,PHARYNGITIS,10
KR,PHLEBITIS,10
KR,POST PROCEDURAL HAEMORRHAGE,10
KR,PRESCRIBED OVERDOSE,10
KR,PULMONARY CONGESTION,10
KR,PULMONARY HYPERTENSION,10
KR,RAYNAUD^S PHENOMENON,10
KR,RECTAL HAEMORRHAGE,10
KR,RETINAL DEPIGMENTATION,10
KR,RETINOPATHY,10
KR,RHEUMATOID ARTHRITIS,10
KR,SINUSITIS,10
KR,SKIN DISORDER,10
KR,SMALL INTESTINAL OBSTRUCTION,10
KR,SUBDURAL HAEMATOMA,10
KR,SUBRETINAL FLUID,10
KR,T-CELL LYMPHOMA RECURRENT,10
KR,TENDERNESS,10
KR,UNEVALUABLE EVENT,10
KR,UPPER GASTROINTESTINAL HAEMORRHAGE,10
KR,VESTIBULAR DISORDER,10
KR,ANAL ABSCESS,9
KR,APNOEA,9
KR,ASPIRATION,9
KR,ATRIOVENTRICULAR BLOCK COMPLETE,9
KR,BLOOD CHOLESTEROL INCREASED,9
KR,BLOOD GLUCOSE DECREASED,9
KR,BLOOD POTASSIUM DECREASED,9
KR,BONE DENSITY DECREASED,9
KR,BRAIN DEATH,9
KR,CANDIDA INFECTION,9
KR,CARDIAC DEATH,9
KR,CARDIOMEGALY,9
KR,CLOSTRIDIUM DIFFICILE COLITIS,9
KR,DEAFNESS,9
KR,DERMATITIS BULLOUS,9
KR,DEVICE DIFFICULT TO USE,9
KR,DIFFUSE LARGE B-CELL LYMPHOMA,9
KR,DIPLOPIA,9
KR,DISSEMINATED TUBERCULOSIS,9
KR,DRUG CROSS-REACTIVITY,9
KR,ENCEPHALITIS,9
KR,ENDOMETRIAL DISORDER,9
KR,FANCONI SYNDROME,9
KR,GASTRIC PERFORATION,9
KR,GUILLAIN-BARRE SYNDROME,9
KR,HEARING IMPAIRED,9
KR,HEPATIC STEATOSIS,9
KR,HEPATITIS TOXIC,9
KR,HYPEROSMOLAR HYPERGLYCAEMIC STATE,9
KR,IMMUNODEFICIENCY,9
KR,INFECTIOUS COLITIS,9
KR,INFLAMMATORY MARKER INCREASED,9
KR,INTENTIONAL PRODUCT USE ISSUE,9
KR,INTRACRANIAL ANEURYSM,9
KR,ISCHAEMIA,9
KR,LATENT TUBERCULOSIS,9
KR,LIGAMENT RUPTURE,9
KR,LUMBAR SPINAL STENOSIS,9
KR,MACULAR OEDEMA,9
KR,MACULOPATHY,9
KR,MENORRHAGIA,9
KR,MYASTHENIA GRAVIS,9
KR,NEPHROLITHIASIS,9
KR,OLIGURIA,9
KR,OSTEOARTHRITIS,9
KR,PAIN OF SKIN,9
KR,PAPULE,9
KR,PERITONITIS BACTERIAL,9
KR,PETECHIAE,9
KR,POLYURIA,9
KR,PRESYNCOPE,9
KR,PSORIASIS,9
KR,PULMONARY TOXICITY,9
KR,PYELONEPHRITIS,9
KR,RENAL INFARCT,9
KR,RENAL TUBULAR NECROSIS,9
KR,RESPIRATORY ARREST,9
KR,RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED,9
KR,SEDATION,9
KR,SKIN ULCER,9
KR,SLEEP-RELATED EATING DISORDER,9
KR,THIRST,9
KR,TOXIC ANTERIOR SEGMENT SYNDROME,9
KR,TUBERCULOUS PLEURISY,9
KR,UNINTENDED PREGNANCY,9
KR,WHEEZING,9
KR,ABORTION,8
KR,ABULIA,8
KR,ACCIDENTAL OVERDOSE,8
KR,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,8
KR,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,8
KR,AMENORRHOEA,8
KR,BALANCE DISORDER,8
KR,BILE DUCT STONE,8
KR,BILIRUBIN CONJUGATED INCREASED,8
KR,BLINDNESS TRANSIENT,8
KR,BLOOD PRESSURE INADEQUATELY CONTROLLED,8
KR,BODY TEMPERATURE INCREASED,8
KR,BRAIN ABSCESS,8
KR,CALCULUS URINARY,8
KR,CAUDA EQUINA SYNDROME,8
KR,CEREBELLAR INFARCTION,8
KR,CEREBRAL ATROPHY,8
KR,COLITIS ULCERATIVE,8
KR,COMA HEPATIC,8
KR,CORONARY ARTERY STENOSIS,8
KR,DERMATITIS CONTACT,8
KR,DIPLEGIA,8
KR,DRUG SPECIFIC ANTIBODY PRESENT,8
KR,ENDOPHTHALMITIS,8
KR,EYE MOVEMENT DISORDER,8
KR,EYE SWELLING,8
KR,FANCONI SYNDROME ACQUIRED,8
KR,FEELING COLD,8
KR,FLATULENCE,8
KR,FLUID RETENTION,8
KR,GASTRIC DISORDER,8
KR,GINGIVITIS,8
KR,GLOMERULAR FILTRATION RATE DECREASED,8
KR,GLYCOSURIA,8
KR,GRAND MAL CONVULSION,8
KR,HEPATITIS ACUTE,8
KR,HEPATITIS C,8
KR,HYPERAESTHESIA,8
KR,HYPERTENSIVE CRISIS,8
KR,HYPERTHYROIDISM,8
KR,HYPERTRIGLYCERIDAEMIA,8
KR,HYPOVOLAEMIA,8
KR,INTESTINAL HAEMORRHAGE,8
KR,LARGE INTESTINE PERFORATION,8
KR,LISTLESS,8
KR,MITRAL VALVE INCOMPETENCE,8
KR,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,8
KR,OPTIC ISCHAEMIC NEUROPATHY,8
KR,OSTEOSARCOMA,8
KR,PERITONEAL DIALYSIS COMPLICATION,8
KR,PSEUDOMEMBRANOUS COLITIS,8
KR,PSEUDOMONAS INFECTION,8
KR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,8
KR,RESPIRATORY RATE INCREASED,8
KR,RESTLESS LEGS SYNDROME,8
KR,RETINOPATHY OF PREMATURITY,8
KR,SINUS NODE DYSFUNCTION,8
KR,SPIROMETRY ABNORMAL,8
KR,SPUTUM DISCOLOURED,8
KR,TENDON RUPTURE,8
KR,THERAPEUTIC RESPONSE UNEXPECTED,8
KR,TONSILLITIS,8
KR,TORTICOLLIS,8
KR,TYPE 2 DIABETES MELLITUS,8
KR,ULCERATIVE KERATITIS,8
KR,URINARY TRACT DISORDER,8
KR,VERTIGO,8
KR,ACCIDENTAL EXPOSURE TO PRODUCT,7
KR,ACIDOSIS,7
KR,AGE-RELATED MACULAR DEGENERATION,7
KR,ALVEOLITIS ALLERGIC,7
KR,ARTERIAL RUPTURE,7
KR,ARTHROPATHY,7
KR,ATYPICAL FEMUR FRACTURE,7
KR,AUTOIMMUNE HEPATITIS,7
KR,BACTERIAL SEPSIS,7
KR,BLOOD PRESSURE SYSTOLIC DECREASED,7
KR,BLOOD SODIUM DECREASED,7
KR,BRADYKINESIA,7
KR,BRONCHIECTASIS,7
KR,CARDIOMYOPATHY,7
KR,CHROMATURIA,7
KR,CHRONIC MYELOID LEUKAEMIA,7
KR,CORNEAL OEDEMA,7
KR,DECUBITUS ULCER,7
KR,DERMATITIS ALLERGIC,7
KR,DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY,7
KR,DISTURBANCE IN ATTENTION,7
KR,DRUG LEVEL INCREASED,7
KR,EJECTION FRACTION DECREASED,7
KR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,7
KR,EXTRADURAL HAEMATOMA,7
KR,EXTREMITY NECROSIS,7
KR,GASTROINTESTINAL STROMAL TUMOUR,7
KR,GINGIVAL SWELLING,7
KR,GOUT,7
KR,GYNAECOMASTIA,7
KR,HAEMOLYSIS,7
KR,HEPATIC FIBROSIS,7
KR,HEPATOCELLULAR INJURY,7
KR,HEPATORENAL SYNDROME,7
KR,HERPES SIMPLEX,7
KR,HYPERKERATOSIS,7
KR,HYPOMAGNESAEMIA,7
KR,IDIOPATHIC PULMONARY FIBROSIS,7
KR,IGA NEPHROPATHY,7
KR,IMPAIRED HEALING,7
KR,INGUINAL HERNIA,7
KR,INTERNATIONAL NORMALISED RATIO INCREASED,7
KR,INTRAOCULAR PRESSURE INCREASED,7
KR,KNEE ARTHROPLASTY,7
KR,LEUKAEMIA RECURRENT,7
KR,LIMB DISCOMFORT,7
KR,LOCAL SWELLING,7
KR,MACULE,7
KR,MANIA,7
KR,METASTASES TO SPINE,7
KR,MOBILITY DECREASED,7
KR,MUSCULOSKELETAL CHEST PAIN,7
KR,MUSCULOSKELETAL DISCOMFORT,7
KR,MYOPIA,7
KR,NEOPLASM,7
KR,NEUTROPHIL COUNT INCREASED,7
KR,OESOPHAGEAL VARICES HAEMORRHAGE,7
KR,ORBITAL OEDEMA,7
KR,OSTEOMYELITIS,7
KR,PERICARDITIS,7
KR,PERIODONTITIS,7
KR,PERITONEAL HAEMORRHAGE,7
KR,PERSECUTORY DELUSION,7
KR,PERSISTENT FOETAL CIRCULATION,7
KR,PLEURITIC PAIN,7
KR,PNEUMONIA CYTOMEGALOVIRAL,7
KR,PNEUMONIA NECROTISING,7
KR,PORTAL SHUNT,7
KR,PREMATURE LABOUR,7
KR,PROCEDURAL PAIN,7
KR,PROGRESSIVE SUPRANUCLEAR PALSY,7
KR,QUADRIPLEGIA,7
KR,RALES,7
KR,RASH PAPULAR,7
KR,RASH PRURITIC,7
KR,RECTAL CANCER,7
KR,RETINAL ARTERY OCCLUSION,7
KR,RETINAL DEGENERATION,7
KR,RETINAL VEIN OCCLUSION,7
KR,SARCOIDOSIS,7
KR,SCIATIC NERVE INJURY,7
KR,SCIATIC NERVE NEUROPATHY,7
KR,SINUS BRADYCARDIA,7
KR,SKIN PLAQUE,7
KR,SMALL INTESTINAL HAEMORRHAGE,7
KR,SPINAL PAIN,7
KR,TONGUE PARALYSIS,7
KR,TRANSITIONAL CELL CARCINOMA,7
KR,UROSEPSIS,7
KR,ABSCESS INTESTINAL,6
KR,ACUTE LYMPHOCYTIC LEUKAEMIA,6
KR,AIRWAY PEAK PRESSURE INCREASED,6
KR,AMYLASE INCREASED,6
KR,ANAL FISTULA,6
KR,ANGLE CLOSURE GLAUCOMA,6
KR,ANTIPSYCHOTIC DRUG LEVEL INCREASED,6
KR,BLEPHARITIS,6
KR,BONE DISORDER,6
KR,BRONCHOPULMONARY DYSPLASIA,6
KR,BRONCHOSPASM,6
KR,CACHEXIA,6
KR,CANCER PAIN,6
KR,CARPAL TUNNEL SYNDROME,6
KR,CATHETER SITE INFECTION,6
KR,CEREBRAL VASOCONSTRICTION,6
KR,CHORIORETINOPATHY,6
KR,COLORECTAL CANCER,6
KR,CONGESTIVE CARDIOMYOPATHY,6
KR,CORONARY ARTERY OCCLUSION,6
KR,CYTOKINE RELEASE SYNDROME,6
KR,CYTOMEGALOVIRUS CHORIORETINITIS,6
KR,DEAFNESS NEUROSENSORY,6
KR,DEVICE LEAKAGE,6
KR,DIABETES INSIPIDUS,6
KR,DIABETIC RETINOPATHY,6
KR,EAR PAIN,6
KR,EMBOLIA CUTIS MEDICAMENTOSA,6
KR,EMPHYSEMA,6
KR,ENDOMETRIAL ATROPHY,6
KR,ENDOMETRIOSIS,6
KR,EYE INFLAMMATION,6
KR,EYELID PTOSIS,6
KR,FIBROMYALGIA,6
KR,FISTULA,6
KR,FOOT FRACTURE,6
KR,FUNGAL INFECTION,6
KR,FURUNCLE,6
KR,GASTROINTESTINAL INJURY,6
KR,GENITAL HAEMORRHAGE,6
KR,HEPATIC INFARCTION,6
KR,HIP ARTHROPLASTY,6
KR,HIP SURGERY,6
KR,HOT FLUSH,6
KR,HUMAN HERPESVIRUS 8 INFECTION,6
KR,HYDROCEPHALUS,6
KR,ILL-DEFINED DISORDER,6
KR,INJECTION SITE REACTION,6
KR,IRON DEFICIENCY ANAEMIA,6
KR,JOINT RANGE OF MOTION DECREASED,6
KR,JUVENILE IDIOPATHIC ARTHRITIS,6
KR,LACERATION,6
KR,LARYNGITIS,6
KR,LIGAMENT SPRAIN,6
KR,LIPASE INCREASED,6
KR,MEDICAL DEVICE COMPLICATION,6
KR,MEGACOLON,6
KR,MENINGITIS,6
KR,METABOLIC ENCEPHALOPATHY,6
KR,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,6
KR,MOVEMENT DISORDER,6
KR,MULTIPLE SCLEROSIS,6
KR,MULTIPLE SCLEROSIS RELAPSE,6
KR,MUSCLE HAEMORRHAGE,6
KR,MYELOPATHY,6
KR,NEPHROPATHY,6
KR,NERVOUSNESS,6
KR,NEUTROPENIC INFECTION,6
KR,OBSTRUCTION GASTRIC,6
KR,OCULAR DISCOMFORT,6
KR,OCULAR ICTERUS,6
KR,ORAL HERPES,6
KR,ORTHOSTATIC HYPOTENSION,6
KR,OVARIAN CYST,6
KR,PANCREATITIS NECROTISING,6
KR,PANIC DISORDER,6
KR,PELVIC FRACTURE,6
KR,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,6
KR,PHARYNGEAL OEDEMA,6
KR,POLYDIPSIA,6
KR,PROSTATIC SPECIFIC ANTIGEN INCREASED,6
KR,PULMONARY INFARCTION,6
KR,PYODERMA GANGRENOSUM,6
KR,RECALL PHENOMENON,6
KR,RECTAL PERFORATION,6
KR,RENAL CELL CARCINOMA,6
KR,RENAL FAILURE CHRONIC,6
KR,RENAL FUNCTION TEST ABNORMAL,6
KR,RESPIRATORY SYNCYTIAL VIRUS INFECTION,6
KR,RETCHING,6
KR,REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME,6
KR,SHOCK HYPOGLYCAEMIC,6
KR,SINUS TACHYCARDIA,6
KR,SPINAL CORD COMPRESSION,6
KR,STRIDOR,6
KR,SUBCUTANEOUS ABSCESS,6
KR,SYSTEMIC CANDIDA,6
KR,THERMAL BURN,6
KR,TRAUMATIC LUNG INJURY,6
KR,UNDERDOSE,6
KR,URETEROLITHIASIS,6
KR,VASCULITIS,6
KR,YELLOW SKIN,6
KR,ABDOMINAL ADHESIONS,5
KR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,5
KR,AFFECT LABILITY,5
KR,AGRANULOCYTOSIS,5
KW,DRUG INEFFECTIVE,27
KW,DEATH,15
KW,DYSPNOEA,13
KW,ANAEMIA,11
KW,FATIGUE,10
KW,MYASTHENIA GRAVIS,10
KW,NEUTROPENIA,9
KW,STRESS CARDIOMYOPATHY,9
KW,TREMOR,8
KW,URTICARIA,8
KW,CARDIAC ARREST,7
KW,PREMATURE BABY,7
KW,PYREXIA,7
KW,RENAL IMPAIRMENT,7
KW,SEPSIS,7
KW,SEPTIC SHOCK,7
KW,WEIGHT INCREASED,7
KW,ANGIOEDEMA,6
KW,ASTHENIA,6
KW,COMA,6
KW,DRUG RESISTANCE,6
KW,LOWER RESPIRATORY TRACT INFECTION,6
KW,MATERNAL EXPOSURE DURING PREGNANCY,6
KW,MULTIPLE SCLEROSIS RELAPSE,6
KW,PNEUMONIA,6
KW,PRODUCT USE ISSUE,6
KW,THROMBOCYTOPENIA,6
KW,URINARY TRACT INFECTION,6
KW,VOMITING,6
KW,ABDOMINAL PAIN,5
KW,ACUTE KIDNEY INJURY,5
KW,BLOOD PROLACTIN INCREASED,5
KW,CHEST PAIN,5
KW,COMPLICATIONS OF TRANSPLANTED KIDNEY,5
KW,DRUG HYPERSENSITIVITY,5
KW,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,5
KW,FOETAL EXPOSURE DURING PREGNANCY,5
KW,LOW BIRTH WEIGHT BABY,5
KW,NAUSEA,5
KW,PANCYTOPENIA,5
KW,PREMATURE DELIVERY,5
KW,PRODUCT SUBSTITUTION ISSUE,5
KW,ABDOMINAL DISTENSION,4
KW,ANAPHYLACTIC REACTION,4
KW,BLOOD CREATININE INCREASED,4
KW,BRADYCARDIA,4
KW,CEREBRAL HAEMORRHAGE,4
KW,DEPRESSION,4
KW,DIABETIC KETOACIDOSIS,4
KW,DISEASE PROGRESSION,4
KW,EXPOSURE DURING PREGNANCY,4
KW,FOETAL GROWTH RESTRICTION,4
KW,GASTROINTESTINAL HAEMORRHAGE,4
KW,HEPATIC ENZYME INCREASED,4
KW,HYPOTENSION,4
KW,LIVER FUNCTION TEST INCREASED,4
KW,MUSCLE RIGIDITY,4
KW,MYOCARDIAL ISCHAEMIA,4
KW,PALPITATIONS,4
KW,PANCREATITIS ACUTE,4
KW,RASH,4
KW,RHABDOMYOLYSIS,4
KW,SALIVARY HYPERSECRETION,4
KW,SEIZURE,4
KW,TOXICITY TO VARIOUS AGENTS,4
KW,5Q MINUS SYNDROME,3
KW,ACUTE RESPIRATORY DISTRESS SYNDROME,3
KW,ATRIAL FIBRILLATION,3
KW,BLADDER PERFORATION,3
KW,CENTRAL NERVOUS SYSTEM LESION,3
KW,CEREBROVASCULAR ACCIDENT,3
KW,CHEST DISCOMFORT,3
KW,DIZZINESS,3
KW,DRUG DOSE OMISSION,3
KW,HAEMOLYTIC ANAEMIA,3
KW,HAEMOPTYSIS,3
KW,HYPERKALAEMIA,3
KW,HYPOXIA,3
KW,INTENTIONAL PRODUCT MISUSE,3
KW,JAUNDICE NEONATAL,3
KW,LUNG INFECTION,3
KW,METASTASES TO LIVER,3
KW,METASTATIC NEOPLASM,3
KW,MYOCARDIAL INFARCTION,3
KW,NASAL CONGESTION,3
KW,NEONATAL RESPIRATORY DISTRESS SYNDROME,3
KW,NEPHROLITHIASIS,3
KW,NODAL ARRHYTHMIA,3
KW,OXYGEN SATURATION DECREASED,3
KW,PAIN,3
KW,PRURITUS,3
KW,PSYCHOTIC DISORDER,3
KW,RENAL TUBULAR NECROSIS,3
KW,SUICIDAL IDEATION,3
KW,ABASIA,2
KW,ABNORMAL BEHAVIOUR,2
KW,ABORTION SPONTANEOUS,2
KW,ACUTE MYELOID LEUKAEMIA,2
KW,ACUTE MYOCARDIAL INFARCTION,2
KW,ADVERSE EVENT,2
KW,ANAPHYLACTIC SHOCK,2
KW,ANURIA,2
KW,ARTHRALGIA,2
KW,BLOOD BILIRUBIN INCREASED,2
KW,CARDIAC DISORDER,2
KW,CARDIO-RESPIRATORY ARREST,2
KW,CARDIOVASCULAR DISORDER,2
KW,COUGH,2
KW,DECREASED APPETITE,2
KW,DEHYDRATION,2
KW,DIARRHOEA,2
KW,DISTURBANCE IN ATTENTION,2
KW,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,2
KW,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
KW,DYSURIA,2
KW,EYE PRURITUS,2
KW,GAIT DISTURBANCE,2
KW,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,2
KW,HAEMOGLOBIN DECREASED,2
KW,HEADACHE,2
KW,HEPATIC FUNCTION ABNORMAL,2
KW,HEPATITIS C,2
KW,HORMONE LEVEL ABNORMAL,2
KW,HOSPITALISATION,2
KW,HYPERHIDROSIS,2
KW,HYPERPROLACTINAEMIA,2
KW,HYPERSENSITIVITY,2
KW,HYPERTENSION,2
KW,HYPOVENTILATION,2
KW,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
KW,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
KW,KIDNEY FIBROSIS,2
KW,LEUKOPENIA,2
KW,LYMPHOCYTE COUNT DECREASED,2
KW,LYMPHOPENIA,2
KW,METASTASES TO BONE,2
KW,MULTIPLE SCLEROSIS,2
KW,MYASTHENIA GRAVIS CRISIS,2
KW,MYOPATHY,2
KW,NEPHROPATHY,2
KW,NON-INFECTIOUS ENDOPHTHALMITIS,2
KW,OSTEOMALACIA,2
KW,OVERDOSE,2
KW,PANCREATITIS,2
KW,PERICARDIAL EFFUSION,2
KW,PERIPHERAL COLDNESS,2
KW,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
KW,PNEUMONIA ASPIRATION,2
KW,PREMATURE LABOUR,2
KW,PRODUCT USE IN UNAPPROVED INDICATION,2
KW,PROSTATOMEGALY,2
KW,PULMONARY HAEMORRHAGE,2
KW,RENAL FAILURE,2
KW,RESPIRATORY DISTRESS,2
KW,SEDATION,2
KW,SINUS TACHYCARDIA,2
KW,SKIN EXFOLIATION,2
KW,SOMNOLENCE,2
KW,SPINAL CORD COMPRESSION,2
KW,SPLEEN PALPABLE,2
KW,STEVENS-JOHNSON SYNDROME,2
KW,TACHYCARDIA,2
KW,URINARY INCONTINENCE,2
KW,ABDOMINAL PAIN UPPER,1
KW,ABDOMINAL TENDERNESS,1
KW,ACCIDENT,1
KW,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
KW,ADDISON^S DISEASE,1
KW,ADENOMA BENIGN,1
KW,ADVERSE REACTION,1
KW,AGGRESSION,1
KW,AGITATION,1
KW,AKATHISIA,1
KW,AKINESIA,1
KW,ALANINE AMINOTRANSFERASE INCREASED,1
KW,AMENORRHOEA,1
KW,ANAL FISTULA,1
KW,ANGER,1
KW,ANGINA UNSTABLE,1
KW,ANOVULATORY CYCLE,1
KW,ANTINUCLEAR ANTIBODY INCREASED,1
KW,ARRHYTHMIA,1
KW,ARTERIOSCLEROSIS CORONARY ARTERY,1
KW,ARTERIOVENOUS FISTULA SITE HAEMORRHAGE,1
KW,ASCITES,1
KW,ASPARTATE AMINOTRANSFERASE DECREASED,1
KW,ASPARTATE AMINOTRANSFERASE INCREASED,1
KW,ASTHMA,1
KW,ATRIOVENTRICULAR BLOCK,1
KW,ATRIOVENTRICULAR BLOCK COMPLETE,1
KW,BACK PAIN,1
KW,BACTERAEMIA,1
KW,BALANCE DISORDER,1
KW,BENIGN HYDATIDIFORM MOLE,1
KW,BILIARY DILATATION,1
KW,BLADDER DISORDER,1
KW,BLAST CELLS PRESENT,1
KW,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
KW,BLINDNESS TRANSIENT,1
KW,BLOOD ALBUMIN INCREASED,1
KW,BLOOD BICARBONATE DECREASED,1
KW,BLOOD CHOLESTEROL ABNORMAL,1
KW,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
KW,BLOOD DISORDER,1
KW,BLOOD GLUCOSE ABNORMAL,1
KW,BLOOD POTASSIUM INCREASED,1
KW,BLOOD PRESSURE ABNORMAL,1
KW,BLOOD PRESSURE DECREASED,1
KW,BLOOD PRESSURE INCREASED,1
KW,BLOOD SODIUM INCREASED,1
KW,BLOOD TRIGLYCERIDES INCREASED,1
KW,BLOOD UREA INCREASED,1
KW,BLUNTED AFFECT,1
KW,BONE DISORDER,1
KW,BONE MARROW FAILURE,1
KW,BREAST CANCER,1
KW,BREAST CANCER METASTATIC,1
KW,BREAST MASS,1
KW,BREECH PRESENTATION,1
KW,CANDIDA INFECTION,1
KW,CARDIAC FAILURE,1
KW,CARDIAC MYXOMA,1
KW,CARDIAC OUTPUT DECREASED,1
KW,CARDIOMYOPATHY,1
KW,CATARACT,1
KW,CEREBRAL INFARCTION,1
KW,CEREBRAL ISCHAEMIA,1
KW,CHOLELITHIASIS,1
KW,CHOLESTASIS OF PREGNANCY,1
KW,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,1
KW,CHYLOTHORAX,1
KW,CIRCULATORY COLLAPSE,1
KW,CLEAR CELL RENAL CELL CARCINOMA,1
KW,COGNITIVE DISORDER,1
KW,COLECTOMY,1
KW,COLITIS ULCERATIVE,1
KW,CONDITION AGGRAVATED,1
KW,CONFUSIONAL STATE,1
KW,CONJUNCTIVITIS,1
KW,CONJUNCTIVITIS ALLERGIC,1
KW,CONVULSION,1
KW,COOMBS POSITIVE HAEMOLYTIC ANAEMIA,1
KW,CORNEAL LIGHT REFLEX TEST ABNORMAL,1
KW,CRITICAL ILLNESS POLYNEUROPATHY,1
KW,CYANOSIS,1
KW,DELAYED GRAFT FUNCTION,1
KW,DEPRESSED MOOD,1
KW,DERMATITIS EXFOLIATIVE,1
KW,DEVELOPMENTAL HIP DYSPLASIA,1
KW,DEVICE MALFUNCTION,1
KW,DIABETES MELLITUS,1
KW,DIABETIC NEPHROPATHY,1
KW,DIFFUSE ALOPECIA,1
KW,DISEASE RECURRENCE,1
KW,DISORIENTATION,1
KW,DISSEMINATED INTRAVASCULAR COAGULATION,1
KW,DRUG ABUSE,1
KW,DRUG ADMINISTRATION ERROR,1
KW,DRUG EFFECT DECREASED,1
KW,DRUG LEVEL INCREASED,1
KW,DRY AGE-RELATED MACULAR DEGENERATION,1
KW,DRY MOUTH,1
KW,DUODENAL ULCER PERFORATION,1
KW,DYSARTHRIA,1
KW,DYSHIDROTIC ECZEMA,1
KW,EAR CONGESTION,1
KW,ECCHYMOSIS,1
KW,ECZEMA,1
KW,EMBOLIC STROKE,1
KW,EMOTIONAL DISTRESS,1
KW,ENCEPHALITIS,1
KW,END STAGE RENAL DISEASE,1
KW,ENTEROBACTER SEPSIS,1
KW,ERYTHRODERMIC PSORIASIS,1
KW,ESCHERICHIA INFECTION,1
KW,EUGLYCAEMIC DIABETIC KETOACIDOSIS,1
KW,FALL,1
KW,FEMUR FRACTURE,1
KW,FLANK PAIN,1
KW,FOETAL EXPOSURE TIMING UNSPECIFIED,1
KW,FULL BLOOD COUNT ABNORMAL,1
KW,GALLBLADDER ENLARGEMENT,1
KW,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
KW,GANGRENE,1
KW,GASTRIC ULCER,1
KW,GASTROENTERITIS ESCHERICHIA COLI,1
KW,GASTROINTESTINAL PERFORATION,1
KW,GASTROINTESTINAL SOUNDS ABNORMAL,1
KW,GAZE PALSY,1
KW,GINGIVAL PAIN,1
KW,GLYCOSURIA,1
KW,GRAFT VERSUS HOST DISEASE IN LIVER,1
KW,GRAFT VERSUS HOST DISEASE IN SKIN,1
KW,GYNAECOMASTIA,1
KW,HAEMOGLOBINURIA,1
KW,HAEMORRHAGE,1
KW,HAEMORRHAGE IN PREGNANCY,1
KW,HAEMORRHAGE INTRACRANIAL,1
KW,HAEMORRHAGIC STROKE,1
KW,HAEMORRHOIDS,1
KW,HALLUCINATION,1
KW,HALLUCINATIONS_ MIXED,1
KW,HEART RATE DECREASED,1
KW,HEART RATE INCREASED,1
KW,HEART RATE IRREGULAR,1
KW,HEMIPARESIS,1
KW,HEMIPLEGIA,1
KW,HEPATIC CIRRHOSIS,1
KW,HEPATIC ENZYME ABNORMAL,1
KW,HEPATIC FAILURE,1
KW,HEPATIC LESION,1
KW,HEPATIC STEATOSIS,1
KW,HEPATITIS C RNA INCREASED,1
KW,HEPATITIS FULMINANT,1
KW,HEPATOMEGALY,1
KW,HEPATOPULMONARY SYNDROME,1
KW,HERPES SIMPLEX SEROLOGY POSITIVE,1
KW,HERPES ZOSTER,1
KW,HYDRONEPHROSIS,1
KW,HYPERAMMONAEMIC CRISIS,1
KW,HYPERCHLORHYDRIA,1
KW,HYPERKINESIA,1
KW,HYPERTRICHOSIS,1
KW,HYPOCALCAEMIA,1
KW,HYPOKINESIA,1
KW,HYPONATRAEMIA,1
KW,IMMOBILE,1
KW,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
KW,IMPULSIVE BEHAVIOUR,1
KW,INCOHERENT,1
KW,INCORRECT DRUG ADMINISTRATION RATE,1
KW,INFECTION,1
KW,INFERTILITY FEMALE,1
KW,INFLAMMATION,1
KW,INFLUENZA LIKE ILLNESS,1
KW,INFUSION RELATED REACTION,1
KW,INJECTION SITE REACTION,1
KW,INSOMNIA,1
KW,INTENTIONAL OVERDOSE,1
KW,INTESTINAL PERFORATION,1
KW,INTRA-ABDOMINAL PRESSURE INCREASED,1
KW,INTRACARDIAC THROMBUS,1
KW,INTRACRANIAL PRESSURE INCREASED,1
KW,JAUNDICE,1
KW,JC VIRUS TEST POSITIVE,1
KW,JOINT STIFFNESS,1
KW,JOINT SWELLING,1
KW,KLEBSIELLA TEST POSITIVE,1
KW,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
KW,LACTIC ACIDOSIS,1
KW,LARYNGEAL OEDEMA,1
KW,LEFT VENTRICULAR DYSFUNCTION,1
KW,LETHARGY,1
KW,LEUKAEMIA,1
KW,LEUKOCYTOSIS,1
KW,LICHEN PLANUS,1
KW,LIVE BIRTH,1
KW,LIVER PALPABLE SUBCOSTAL,1
KW,LOCALISED INTRAABDOMINAL FLUID COLLECTION,1
KW,LOGORRHOEA,1
KW,LOSS OF CONSCIOUSNESS,1
KW,LUNG CONSOLIDATION,1
KW,LUNG INFILTRATION,1
KW,LUPUS-LIKE SYNDROME,1
KW,LYMPHADENOPATHY,1
KW,LYMPHOCELE,1
KW,MALIGNANT NEOPLASM PROGRESSION,1
KW,MANIA,1
KW,MARITAL PROBLEM,1
KW,MASTITIS,1
KW,MEMORY IMPAIRMENT,1
KW,MENTAL DISORDER,1
KW,METABOLIC ACIDOSIS,1
KW,METASTASES TO BONE MARROW,1
KW,METASTASES TO BREAST,1
KW,METASTATIC RENAL CELL CARCINOMA,1
KW,MOTOR DYSFUNCTION,1
KW,MOUTH ULCERATION,1
KW,MULTI-ORGAN FAILURE,1
KW,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
KW,MUSCULOSKELETAL STIFFNESS,1
KW,MYALGIA,1
KW,MYELODYSPLASTIC SYNDROME,1
KW,MYELOFIBROSIS,1
KW,NECROSIS,1
KW,NECROTISING ENTEROCOLITIS NEONATAL,1
KW,NEPHROSCLEROSIS,1
KW,NEUROLOGICAL SYMPTOM,1
KW,NIGHTMARE,1
KW,NO THERAPEUTIC RESPONSE,1
KW,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
KW,OCULAR HYPERAEMIA,1
KW,OEDEMA,1
KW,OESOPHAGEAL VARICES HAEMORRHAGE,1
KW,ONYCHOMYCOSIS,1
KW,ORAL FUNGAL INFECTION,1
KW,ORAL INFECTION,1
KW,ORAL MUCOSAL ERYTHEMA,1
KW,ORTHOSTATIC HYPOTENSION,1
KW,OVARIAN HYPERSTIMULATION SYNDROME,1
KW,PAIN IN JAW,1
KW,PALLOR,1
KW,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
KW,PANCREATIC PSEUDOCYST,1
KW,PANCREATITIS NECROTISING,1
KW,PARALYSIS,1
KW,PARONYCHIA,1
KW,PERITONITIS,1
KW,PERSONALITY CHANGE,1
KW,PHARYNGITIS,1
KW,PLACENTA PRAEVIA,1
KW,PLEURAL EFFUSION,1
KW,PNEUMONIA INFLUENZAL,1
KW,POST HERPETIC NEURALGIA,1
KW,POST PROCEDURAL HAEMATOMA,1
KW,PREGNANCY,1
KW,PRODUCT DEPOSIT,1
KW,PROGESTERONE DECREASED,1
KW,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
KW,PROSTATE CANCER,1
KW,PROSTATIC DISORDER,1
KW,PROSTATIC PAIN,1
KW,PROTEINURIA,1
KW,PSEUDOLYMPHOMA,1
KW,PSORIATIC ARTHROPATHY,1
KW,PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME,1
KW,PULSE PRESSURE DECREASED,1
KW,REBOUND EFFECT,1
KW,RECTAL HAEMORRHAGE,1
KW,RENAL ABSCESS,1
KW,RENAL ARTERY STENOSIS,1
KW,RENAL CYST,1
KW,RENAL INFARCT,1
KW,RENAL INJURY,1
KW,RENAL TUBULAR ATROPHY,1
KW,RESTLESSNESS,1
KW,RETINAL DETACHMENT,1
KW,RHINORRHOEA,1
KW,ROAD TRAFFIC ACCIDENT,1
KW,SCHISTOSOMIASIS,1
KW,SCHIZOPHRENIA,1
KW,SCLERITIS,1
KW,SCLERODERMA-LIKE REACTION,1
KW,SEMINAL VESICULAR DISORDER,1
KW,SEPSIS NEONATAL,1
KW,SHOCK,1
KW,SKIN DISCOLOURATION,1
KW,SKIN REACTION,1
KW,SLEEP APNOEA SYNDROME,1
KW,SLEEP DISORDER,1
KW,SPINAL CORD HAEMATOMA,1
KW,SPONDYLOLYSIS,1
KW,STAPHYLOCOCCAL SEPSIS,1
KW,STILLBIRTH,1
KW,STOMA SITE DISCHARGE,1
KW,STOMA SITE ERYTHEMA,1
KW,STOMA SITE HAEMORRHAGE,1
KW,SUBCUTANEOUS ABSCESS,1
KW,SYNCOPE,1
KW,TACHYPNOEA,1
KW,TERATOGENICITY,1
KW,THALAMIC INFARCTION,1
KW,THERAPEUTIC RESPONSE DECREASED,1
KW,THROMBOTIC MICROANGIOPATHY,1
KW,TONGUE DISCOLOURATION,1
KW,TOTAL LUNG CAPACITY DECREASED,1
KW,TOURETTE^S DISORDER,1
KW,TRANSFUSION-RELATED ACUTE LUNG INJURY,1
KW,TRANSIENT ISCHAEMIC ATTACK,1
KW,TRANSPLANT DYSFUNCTION,1
KW,TRANSPLANT REJECTION,1
KW,TREATMENT FAILURE,1
KW,TREATMENT NONCOMPLIANCE,1
KW,TRICHOGLOSSIA,1
KW,TUBERCULOSIS,1
KW,UNINTENTIONAL USE FOR UNAPPROVED INDICATION,1
KW,UNRESPONSIVE TO STIMULI,1
KW,UPPER RESPIRATORY TRACT INFECTION,1
KW,URINARY RETENTION,1
KW,URINE FLOW DECREASED,1
KW,URINE KETONE BODY PRESENT,1
KW,UROSEPSIS,1
KW,UTERINE HAEMORRHAGE,1
KW,VAGINAL HAEMORRHAGE,1
KW,VENTRICULAR TACHYCARDIA,1
KW,VISION BLURRED,1
KW,VISUAL IMPAIRMENT,1
KW,VITAMIN D DECREASED,1
KW,VULVOVAGINAL DISCOMFORT,1
KW,VULVOVAGINAL PRURITUS,1
KW,WEIGHT DECREASED,1
KW,WHITE BLOOD CELL COUNT INCREASED,1
KW,WHITE BLOOD CELL DISORDER,1
KW,WOUND DEHISCENCE,1
KG,DEATH,11
KG,TUBERCULOSIS,5
KG,CHEST PAIN,4
KG,LOSS OF CONSCIOUSNESS,4
KG,FEELING ABNORMAL,3
KG,FEELING COLD,3
KG,NAUSEA,3
KG,PALPITATIONS,3
KG,PERICARDIAL EFFUSION,3
KG,PRODUCT USE ISSUE,3
KG,VOMITING,3
KG,ANXIETY,2
KG,CEREBROVASCULAR ACCIDENT,2
KG,ELECTROCARDIOGRAM QT PROLONGED,2
KG,SKIN DISCOLOURATION,2
KG,AGGRESSION,1
KG,ALANINE AMINOTRANSFERASE INCREASED,1
KG,ANGIOEDEMA,1
KG,ASPARTATE AMINOTRANSFERASE INCREASED,1
KG,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
KG,BLOOD CALCIUM DECREASED,1
KG,BLOOD MAGNESIUM DECREASED,1
KG,BLOOD POTASSIUM DECREASED,1
KG,BLOOD TESTOSTERONE INCREASED,1
KG,BRAIN NEOPLASM,1
KG,BRUCELLOSIS,1
KG,CARDIAC FAILURE,1
KG,CHRONIC MYELOID LEUKAEMIA,1
KG,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
KG,CONFUSIONAL STATE,1
KG,CONJUNCTIVITIS,1
KG,DISCOMFORT,1
KG,DRUG RESISTANCE,1
KG,ENLARGED CLITORIS,1
KG,EUPHORIC MOOD,1
KG,EXPOSURE DURING PREGNANCY,1
KG,FOETAL EXPOSURE DURING PREGNANCY,1
KG,HAEMOGLOBIN DECREASED,1
KG,HEPATITIS D,1
KG,HYPOKALAEMIA,1
KG,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
KG,LABIA ENLARGED,1
KG,LEUKOCYTOSIS,1
KG,LIVE BIRTH,1
KG,MALIGNANT NEOPLASM PROGRESSION,1
KG,MYALGIA,1
KG,OESOPHAGEAL CARCINOMA,1
KG,PLATELET COUNT DECREASED,1
KG,PRURITUS,1
KG,PRURITUS GENERALISED,1
KG,PSEUDOHERMAPHRODITISM FEMALE,1
KG,PSYCHOTIC BEHAVIOUR,1
KG,PYREXIA,1
KG,RASH,1
KG,RASH GENERALISED,1
KG,RASH PUSTULAR,1
KG,SEIZURE,1
KG,SWELLING FACE,1
KG,TACHYCARDIA,1
KG,TERMINAL STATE,1
KG,TOXIC EPIDERMAL NECROLYSIS,1
KG,TREATMENT NONCOMPLIANCE,1
KG,URTICARIA,1
KG,VISION BLURRED,1
LA,DYSPNOEA,4
LA,GASTRIC ULCER HAEMORRHAGE,4
LA,HYPOKALAEMIA,4
LA,TOXIC EPIDERMAL NECROLYSIS,2
LA,ACCIDENTAL OVERDOSE,1
LA,APPENDICITIS,1
LA,DIARRHOEA,1
LA,DRUG DEPENDENCE,1
LA,DUODENAL ULCER HAEMORRHAGE,1
LA,HEPATITIS,1
LA,JAUNDICE,1
LA,ULCER,1
LV,DYSPNOEA,25
LV,PNEUMONIA,21
LV,DRUG INEFFECTIVE,19
LV,DIARRHOEA,18
LV,PYREXIA,16
LV,NAUSEA,15
LV,VOMITING,15
LV,DEATH,14
LV,THROMBOCYTOPENIA,14
LV,ASTHENIA,12
LV,HYPERTENSION,11
LV,LEUKOPENIA,11
LV,ABDOMINAL PAIN,10
LV,OEDEMA PERIPHERAL,10
LV,DIZZINESS,9
LV,FACE OEDEMA,9
LV,HEADACHE,9
LV,PANCYTOPENIA,9
LV,PRURITUS,9
LV,RESPIRATORY FAILURE,9
LV,LOSS OF CONSCIOUSNESS,8
LV,SOMNOLENCE,8
LV,ABSCESS,7
LV,AGITATION,7
LV,ARTHRALGIA,7
LV,DECREASED APPETITE,7
LV,ERYTHEMA,7
LV,FATIGUE,7
LV,HYPERHIDROSIS,7
LV,HYPONATRAEMIA,7
LV,HYPOTENSION,7
LV,PAIN,7
LV,POLYNEUROPATHY,7
LV,PRODUCT USE IN UNAPPROVED INDICATION,7
LV,RESPIRATORY DISTRESS,7
LV,ACUTE KIDNEY INJURY,6
LV,ANXIETY,6
LV,BODY TEMPERATURE INCREASED,6
LV,CHEST DISCOMFORT,6
LV,URINARY TRACT INFECTION,6
LV,ABDOMINAL PAIN UPPER,5
LV,ANGIOEDEMA,5
LV,BLOOD CREATININE INCREASED,5
LV,BLOOD PRESSURE INCREASED,5
LV,CEREBROVASCULAR ACCIDENT,5
LV,COUGH,5
LV,EXPOSURE DURING PREGNANCY,5
LV,GASTROINTESTINAL HAEMORRHAGE,5
LV,HAEMORRHAGIC ANAEMIA,5
LV,JAUNDICE,5
LV,PALPITATIONS,5
LV,RASH,5
LV,THIRST,5
LV,ANAEMIA,4
LV,ANGINA PECTORIS,4
LV,CHILLS,4
LV,CONDITION AGGRAVATED,4
LV,DISORIENTATION,4
LV,DRUG-INDUCED LIVER INJURY,4
LV,FALL,4
LV,FEELING ABNORMAL,4
LV,GASTRIC ULCER HAEMORRHAGE,4
LV,HYPERSENSITIVITY,4
LV,MALAISE,4
LV,MYALGIA,4
LV,OVERDOSE,4
LV,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,4
LV,PAPILLOMA VIRAL INFECTION,4
LV,STOMATITIS,4
LV,TREMOR,4
LV,URINARY RETENTION,4
LV,URTICARIA,4
LV,WEIGHT DECREASED,4
LV,ABDOMINAL DISTENSION,3
LV,ABORTION SPONTANEOUS,3
LV,ALANINE AMINOTRANSFERASE INCREASED,3
LV,APATHY,3
LV,ASPARTATE AMINOTRANSFERASE INCREASED,3
LV,ASTHMA,3
LV,ATRIAL FIBRILLATION,3
LV,BLOOD PRESSURE DECREASED,3
LV,BURNING SENSATION,3
LV,CARDIAC FAILURE,3
LV,CHOLELITHIASIS,3
LV,COAGULOPATHY,3
LV,DYSGEUSIA,3
LV,ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE,3
LV,EPILEPSY,3
LV,HEPATIC FAILURE,3
LV,HEPATOMEGALY,3
LV,MALIGNANT NEOPLASM PROGRESSION,3
LV,NEOPLASM PROGRESSION,3
LV,NEUTROPENIA,3
LV,PAIN IN EXTREMITY,3
LV,PETECHIAE,3
LV,PULMONARY EMBOLISM,3
LV,PULMONARY OEDEMA,3
LV,RASH GENERALISED,3
LV,RUPTURED ECTOPIC PREGNANCY,3
LV,SKIN DISORDER,3
LV,SUBCUTANEOUS HAEMATOMA,3
LV,VISION BLURRED,3
LV,WEIGHT INCREASED,3
LV,ALOPECIA TOTALIS,2
LV,ANURIA,2
LV,ASCITES,2
LV,ATYPICAL PNEUMONIA,2
LV,BLINDNESS TRANSIENT,2
LV,BLOOD BILIRUBIN INCREASED,2
LV,BLOOD CHOLESTEROL INCREASED,2
LV,BLOOD TRIGLYCERIDES INCREASED,2
LV,BLOOD UREA INCREASED,2
LV,BONE MARROW FAILURE,2
LV,BONE PAIN,2
LV,BRADYCARDIA,2
LV,BREAST PAIN,2
LV,CARDIAC ARREST,2
LV,CARDIAC DISCOMFORT,2
LV,CHEST PAIN,2
LV,CHRONIC GASTRITIS,2
LV,CHRONIC HEPATITIS C,2
LV,COMA,2
LV,CONVULSION,2
LV,CRYOGLOBULINAEMIA,2
LV,CYANOSIS,2
LV,DERMATITIS,2
LV,DEVICE RELATED INFECTION,2
LV,DIABETIC KETOACIDOSIS,2
LV,DIPLOPIA,2
LV,DISSEMINATED INTRAVASCULAR COAGULATION,2
LV,DNA ANTIBODY POSITIVE,2
LV,DRUG DISPENSING ERROR,2
LV,DRUG EFFECT INCOMPLETE,2
LV,DRY MOUTH,2
LV,EATING DISORDER,2
LV,EMBOLIC STROKE,2
LV,EMOTIONAL DISORDER,2
LV,ENTEROCOLITIS,2
LV,EPISTAXIS,2
LV,FAECAL INCONTINENCE,2
LV,FEBRILE NEUTROPENIA,2
LV,FLUID RETENTION,2
LV,FLUSHING,2
LV,GASTRIC NEOPLASM,2
LV,GENERAL PHYSICAL HEALTH DETERIORATION,2
LV,GINGIVITIS,2
LV,GLOMERULAR FILTRATION RATE DECREASED,2
LV,HAEMATURIA,2
LV,HAEMORRHAGIC TRANSFORMATION STROKE,2
LV,HALLUCINATION_ VISUAL,2
LV,HEART RATE INCREASED,2
LV,HEPATIC CIRRHOSIS,2
LV,HEPATIC ENCEPHALOPATHY,2
LV,HEPATIC PAIN,2
LV,HEPATITIS TOXIC,2
LV,HOSPITALISATION,2
LV,HYPERTENSIVE CRISIS,2
LV,ILEUS,2
LV,INFARCTION,2
LV,INFLAMMATORY MARKER INCREASED,2
LV,INFLUENZA,2
LV,INSOMNIA,2
LV,INTERSTITIAL LUNG DISEASE,2
LV,ISCHAEMIC STROKE,2
LV,JOINT SWELLING,2
LV,LIMB INJURY,2
LV,LYMPHADENOPATHY,2
LV,LYMPHOPENIA,2
LV,MATERNAL EXPOSURE DURING PREGNANCY,2
LV,MENTAL DISORDER,2
LV,MITRAL VALVE INCOMPETENCE,2
LV,MUCOSAL INFLAMMATION,2
LV,MULTI-ORGAN FAILURE,2
LV,MUSCLE SPASMS,2
LV,NERVOUS SYSTEM DISORDER,2
LV,OEDEMA,2
LV,OEDEMA MOUTH,2
LV,ORAL DISCOMFORT,2
LV,OSTEOCHONDROSIS,2
LV,PALMAR ERYTHEMA,2
LV,PARAESTHESIA,2
LV,PERIORBITAL OEDEMA,2
LV,PERITONEAL HAEMORRHAGE,2
LV,PHOTOPSIA,2
LV,PLEURISY,2
LV,PNEUMONIA CHLAMYDIAL,2
LV,POLYSEROSITIS,2
LV,POST PROCEDURAL HAEMORRHAGE,2
LV,PREGNANCY WITH CONTRACEPTIVE DEVICE,2
LV,PREMATURE BABY,2
LV,PRODUCT USE ISSUE,2
LV,PROSTATE CANCER,2
LV,PROTHROMBIN TIME SHORTENED,2
LV,PULMONARY VALVE INCOMPETENCE,2
LV,PURPURA,2
LV,RASH PRURITIC,2
LV,RECTAL HAEMORRHAGE,2
LV,RENAL FAILURE ACUTE,2
LV,SEIZURE,2
LV,SEPSIS,2
LV,SHOCK,2
LV,SINUS TACHYCARDIA,2
LV,SKIN DISCOLOURATION,2
LV,SPLENOMEGALY,2
LV,SUDDEN DEATH,2
LV,SWELLING,2
LV,SYSTEMIC LUPUS ERYTHEMATOSUS,2
LV,TACHYCARDIA,2
LV,THORACIC VERTEBRAL FRACTURE,2
LV,THROMBOSIS,2
LV,TONGUE OEDEMA,2
LV,TRICUSPID VALVE INCOMPETENCE,2
LV,VASCULITIS,2
LV,VISUAL ACUITY REDUCED,2
LV,VISUAL FIELD DEFECT,2
LV,ABDOMINAL INFECTION,1
LV,ABDOMINAL PAIN LOWER,1
LV,ABDOMINAL RIGIDITY,1
LV,ABDOMINAL SYMPTOM,1
LV,ABORTION MISSED,1
LV,ABSCESS LIMB,1
LV,ACUTE PSYCHOSIS,1
LV,ACUTE RESPIRATORY FAILURE,1
LV,AGGRESSION,1
LV,ALOPECIA,1
LV,ALTERED STATE OF CONSCIOUSNESS,1
LV,ALVEOLITIS ALLERGIC,1
LV,ANAPHYLACTIC REACTION,1
LV,APLASTIC ANAEMIA,1
LV,APPENDICITIS,1
LV,APPETITE DISORDER,1
LV,APPLICATION SITE BRUISE,1
LV,ASPERGILLUS INFECTION,1
LV,ASPHYXIA,1
LV,ASPIRATION,1
LV,AURA,1
LV,AUTOIMMUNE THYROIDITIS,1
LV,BACK PAIN,1
LV,BALANCE DISORDER,1
LV,BLADDER DYSFUNCTION,1
LV,BLAST CELL CRISIS,1
LV,BLOOD GLUCOSE ABNORMAL,1
LV,BLOOD PARATHYROID HORMONE INCREASED,1
LV,BLOOD POTASSIUM INCREASED,1
LV,BLOOD PRESSURE ABNORMAL,1
LV,BLOOD PRODUCT TRANSFUSION DEPENDENT,1
LV,BLOOD THYROID STIMULATING HORMONE INCREASED,1
LV,BONE CANCER,1
LV,BONE DISORDER,1
LV,BRAIN HYPOXIA,1
LV,BRAIN INJURY,1
LV,BRAIN NATRIURETIC PEPTIDE INCREASED,1
LV,BRAIN NEOPLASM,1
LV,BREAST CANCER,1
LV,BREAST DISCOMFORT,1
LV,BREAST DISORDER,1
LV,BRONCHIECTASIS,1
LV,BRONCHOPULMONARY ASPERGILLOSIS,1
LV,BRONCHOSPASM,1
LV,C-REACTIVE PROTEIN INCREASED,1
LV,CAESAREAN SECTION,1
LV,CARDIAC FAILURE ACUTE,1
LV,CARDIAC FAILURE CONGESTIVE,1
LV,CARDIOTOXICITY,1
LV,CARDIOVASCULAR DISORDER,1
LV,CATHETER SITE INFLAMMATION,1
LV,CAUDA EQUINA SYNDROME,1
LV,CELLULITIS,1
LV,CEREBRAL HAEMATOMA,1
LV,CEREBRAL INFARCTION,1
LV,CEREBRAL ISCHAEMIA,1
LV,CEREBROVASCULAR DISORDER,1
LV,CHEST INJURY,1
LV,CHOKING SENSATION,1
LV,CHOLANGIOCARCINOMA,1
LV,CHOLECYSTITIS ACUTE,1
LV,CHRONIC KIDNEY DISEASE,1
LV,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
LV,CIRCULATORY COLLAPSE,1
LV,COLD SWEAT,1
LV,COLITIS ULCERATIVE,1
LV,COMPLETED SUICIDE,1
LV,CONJUNCTIVITIS,1
LV,CONSTIPATION,1
LV,CONTRAINDICATED PRODUCT ADMINISTERED,1
LV,CRYING,1
LV,CRYPTOCOCCOSIS,1
LV,CYTOMEGALOVIRUS INFECTION,1
LV,DEAFNESS,1
LV,DECREASED ACTIVITY,1
LV,DEMENTIA,1
LV,DERMATITIS BULLOUS,1
LV,DEVICE DIFFICULT TO USE,1
LV,DEVICE EXPULSION,1
LV,DIABETES MELLITUS,1
LV,DIARRHOEA HAEMORRHAGIC,1
LV,DISCOMFORT,1
LV,DISEASE COMPLICATION,1
LV,DISEASE PROGRESSION,1
LV,DISEASE RECURRENCE,1
LV,DISTURBANCE IN ATTENTION,1
LV,DIVERTICULITIS,1
LV,DRUG ADMINISTRATION ERROR,1
LV,DRUG HYPERSENSITIVITY,1
LV,DRY SKIN,1
LV,DUODENAL ULCER,1
LV,DYSMENORRHOEA,1
LV,DYSPHONIA,1
LV,DYSURIA,1
LV,ECCHYMOSIS,1
LV,ELECTROCARDIOGRAM ST-T CHANGE,1
LV,ELECTROLYTE IMBALANCE,1
LV,EMBEDDED DEVICE,1
LV,EMBOLIC CEREBRAL INFARCTION,1
LV,ENCEPHALITIS,1
LV,END STAGE RENAL DISEASE,1
LV,ENTEROBACTER SEPSIS,1
LV,EOSINOPHILIA,1
LV,ERECTILE DYSFUNCTION,1
LV,EXERCISE TOLERANCE DECREASED,1
LV,EYE IRRITATION,1
LV,EYE PAIN,1
LV,EYE PRURITUS,1
LV,EYE SWELLING,1
LV,FACIAL PAIN,1
LV,FAILURE TO THRIVE,1
LV,FEELING HOT,1
LV,FISTULA,1
LV,FOAMING AT MOUTH,1
LV,FOETAL EXPOSURE TIMING UNSPECIFIED,1
LV,FOREIGN BODY SENSATION IN EYES,1
LV,FRACTURE,1
LV,FUNGAL PHARYNGITIS,1
LV,GAIT DISTURBANCE,1
LV,GAIT INABILITY,1
LV,GASTRIC DISORDER,1
LV,GASTRIC HAEMORRHAGE,1
LV,GASTRIC ULCER,1
LV,GASTRITIS,1
LV,GASTRITIS EROSIVE,1
LV,GASTROENTERITIS,1
LV,GASTROENTERITIS NOROVIRUS,1
LV,GASTROINTESTINAL NECROSIS,1
LV,GASTROINTESTINAL PERFORATION,1
LV,GASTROOESOPHAGEAL REFLUX DISEASE,1
LV,GENITAL EROSION,1
LV,GENITAL ERYTHEMA,1
LV,GLOMERULAR FILTRATION RATE INCREASED,1
LV,GLOSSODYNIA,1
LV,GOUT,1
LV,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
LV,GRAFT VERSUS HOST DISEASE IN LIVER,1
LV,GYNAECOMASTIA,1
LV,HAEMATOMA,1
LV,HAEMATOMA EVACUATION,1
LV,HAEMORRHAGE SUBCUTANEOUS,1
LV,HEART RATE DECREASED,1
LV,HEMIANAESTHESIA,1
LV,HEMIPARESIS,1
LV,HEPATIC ENZYME INCREASED,1
LV,HEPATIC STEATOSIS,1
LV,HEPATITIS,1
LV,HEPATORENAL SYNDROME,1
LV,HIP FRACTURE,1
LV,HIV INFECTION WHO CLINICAL STAGE III,1
LV,HYDROCEPHALUS,1
LV,HYDROTHORAX,1
LV,HYPERAEMIA,1
LV,HYPERAESTHESIA,1
LV,HYPERBILIRUBINAEMIA,1
LV,HYPERKALAEMIA,1
LV,HYPERSENSITIVITY VASCULITIS,1
LV,HYPOAESTHESIA,1
LV,HYPOALBUMINAEMIA,1
LV,HYPOCHLORAEMIA,1
LV,HYPOGLYCAEMIA,1
LV,HYPOKINESIA,1
LV,HYPOPHOSPHATAEMIA,1
LV,HYPOPROTEINAEMIA,1
LV,HYPOVOLAEMIA,1
LV,HYPOVOLAEMIC SHOCK,1
LV,IDIOPATHIC PULMONARY FIBROSIS,1
LV,ILEAL ULCER,1
LV,ILEUS PARALYTIC,1
LV,ILLUSION,1
LV,IMPAIRED QUALITY OF LIFE,1
LV,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
LV,INCOHERENT,1
LV,INFUSION SITE PAIN,1
LV,INJECTION SITE ERYTHEMA,1
LV,INJECTION SITE PAIN,1
LV,INJECTION SITE PRURITUS,1
LV,INTENTIONAL OVERDOSE,1
LV,INTENTIONAL PRODUCT MISUSE,1
LV,INTENTIONAL UNDERDOSE,1
LV,INTESTINAL PERFORATION,1
LV,INTRA-ABDOMINAL HAEMORRHAGE,1
LV,INTRACRANIAL HAEMATOMA,1
LV,IRON DEFICIENCY ANAEMIA,1
LV,IRRITABILITY,1
LV,JOINT INJURY,1
LV,JOINT STIFFNESS,1
LV,KETOACIDOSIS,1
LV,KIDNEY ENLARGEMENT,1
LV,KIDNEY TRANSPLANT REJECTION,1
LV,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
LV,LACRIMATION INCREASED,1
LV,LACTIC ACIDOSIS,1
LV,LATENT TUBERCULOSIS,1
LV,LIGAMENT RUPTURE,1
LV,LIGAMENT SPRAIN,1
LV,LIP OEDEMA,1
LV,LIP PRURITUS,1
LV,LIPASE INCREASED,1
LV,LIVER DISORDER,1
LV,LIVER FUNCTION TEST ABNORMAL,1
LV,LOCALISED OEDEMA,1
LV,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
LV,LOWER LIMB FRACTURE,1
LV,LYMPHADENITIS,1
LV,MACULE,1
LV,MASTECTOMY,1
LV,MATERNAL DRUGS AFFECTING FOETUS,1
LV,MELAENA,1
LV,MENORRHAGIA,1
LV,MESENTERIC VEIN THROMBOSIS,1
LV,METASTASES TO LUNG,1
LV,MONOPARESIS,1
LV,MOUTH ULCERATION,1
LV,MUCORMYCOSIS,1
LV,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
LV,MUSCLE TWITCHING,1
LV,MUSCULAR WEAKNESS,1
LV,MUSCULOSKELETAL STIFFNESS,1
LV,MYOCARDIAL INFARCTION,1
LV,NASAL INFLAMMATION,1
LV,NASOPHARYNGITIS,1
LV,NECK PAIN,1
LV,NECROTISING FASCIITIS,1
LV,NECROTISING OESOPHAGITIS,1
LV,NERVOUSNESS,1
LV,OCCULT BLOOD POSITIVE,1
LV,OCULAR HYPERAEMIA,1
LV,OESOPHAGITIS,1
LV,ORAL PAIN,1
LV,OROPHARYNGEAL CANDIDIASIS,1
LV,OROPHARYNGEAL PAIN,1
LV,ORTHOPNOEA,1
LV,OSTEOARTHRITIS,1
LV,OSTEOMYELITIS,1
LV,OSTEONECROSIS OF JAW,1
LV,OSTEOPENIA,1
LV,PALLOR,1
LV,PANCREATITIS,1
LV,PANCREATITIS ACUTE,1
LV,PAPILLARY THYROID CANCER,1
LV,PAPULE,1
LV,PAROSMIA,1
LV,PERFORMANCE STATUS DECREASED,1
LV,PERIPHERAL CIRCULATORY FAILURE,1
LV,PERIPHERAL COLDNESS,1
LV,PERITONEAL DIALYSIS COMPLICATION,1
LV,PERITONITIS,1
LV,PERITONITIS BACTERIAL,1
LV,PHOTOPHOBIA,1
LV,PHOTOSENSITIVITY REACTION,1
LV,PIGMENTATION DISORDER,1
LV,PNEUMONIA ASPIRATION,1
LV,PNEUMONIA FUNGAL,1
LV,PNEUMONIA LEGIONELLA,1
LV,PNEUMONITIS,1
LV,POISONING,1
LV,POLLAKIURIA,1
LV,POLYURIA,1
LV,POST PROCEDURAL FISTULA,1
LV,PRESCRIBED UNDERDOSE,1
LV,PRODUCT CONTAINER ISSUE,1
LV,PROSTATE CANCER METASTATIC,1
LV,PROTEINURIA,1
LV,PRURITUS GENERALISED,1
LV,PSEUDOMONAS INFECTION,1
LV,PSORIASIS,1
LV,PSYCHOMOTOR HYPERACTIVITY,1
LV,PSYCHOTIC DISORDER,1
LV,PULMONARY ARTERY THROMBOSIS,1
LV,PULMONARY FIBROSIS,1
LV,PULMONARY HYPERTENSION,1
LV,PULMONARY TUBERCULOSIS,1
LV,PURULENT DISCHARGE,1
LV,PYELONEPHRITIS CHRONIC,1
LV,PYODERMA,1
LV,RECTAL PERFORATION,1
LV,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
LV,RENAL ABSCESS,1
LV,RENAL ATROPHY,1
LV,RENAL CANCER,1
LV,RENAL PAIN,1
LV,RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE,1
LV,RESPIRATORY TRACT INFECTION VIRAL,1
LV,RHABDOMYOLYSIS,1
LV,RIGHT VENTRICULAR FAILURE,1
LV,SACROILIITIS,1
LV,SCHIZOPHRENIA,1
LV,SENSORY LOSS,1
LV,SKIN BURNING SENSATION,1
LV,SKIN HAEMORRHAGE,1
LV,SKIN REACTION,1
LV,SKIN ULCER,1
LV,SMALL FIBRE NEUROPATHY,1
LV,SPEECH DISORDER,1
LV,SPINAL OSTEOARTHRITIS,1
LV,SPINAL PAIN,1
LV,SPINAL SUBDURAL HAEMATOMA,1
LV,SPONDYLOARTHROPATHY,1
LV,SPUTUM CULTURE POSITIVE,1
LV,STREPTOCOCCAL SEPSIS,1
LV,SUDDEN ONSET OF SLEEP,1
LV,SUICIDAL IDEATION,1
LV,SUICIDE ATTEMPT,1
LV,SUPRAVENTRICULAR EXTRASYSTOLES,1
LV,SYNCOPE,1
LV,SYNOVITIS,1
LV,TEARFULNESS,1
LV,TELANGIECTASIA,1
LV,THERAPEUTIC RESPONSE UNEXPECTED,1
LV,THROMBOSIS IN DEVICE,1
LV,THROMBOTIC MICROANGIOPATHY,1
LV,THYROID DISORDER,1
LV,TICK-BORNE VIRAL ENCEPHALITIS,1
LV,TINNITUS,1
LV,TONSILLECTOMY,1
LV,TOXIC SKIN ERUPTION,1
LV,TRANSAMINASES INCREASED,1
LV,TRANSFUSION,1
LV,TRANSFUSION MICROCHIMERISM,1
LV,TRANSFUSION RELATED COMPLICATION,1
LV,TRANSIENT ISCHAEMIC ATTACK,1
LV,TRANSPLANT REJECTION,1
LV,TRAUMATIC HAEMORRHAGE,1
LV,TUBERCULOSIS OF INTRATHORACIC LYMPH NODES,1
LV,TUBULOINTERSTITIAL NEPHRITIS,1
LV,ULCER,1
LV,URINARY INCONTINENCE,1
LV,URODYNAMICS MEASUREMENT ABNORMAL,1
LV,UTERINE HAEMORRHAGE,1
LV,UVEITIS,1
LV,VAGINAL DISORDER,1
LV,VAGINAL HAEMORRHAGE,1
LV,VENOUS THROMBOSIS,1
LV,VENOUS THROMBOSIS LIMB,1
LV,VENTRICULAR HYPERTROPHY,1
LV,VENTRICULAR SEPTAL DEFECT,1
LV,VIRAL INFECTION,1
LV,WRONG DRUG ADMINISTERED,1
LV,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
LV,XEROPHTHALMIA,1
LB,DEATH,196
LB,PYREXIA,154
LB,FATIGUE,130
LB,DYSPNOEA,116
LB,DIARRHOEA,95
LB,VOMITING,91
LB,NAUSEA,80
LB,INFLUENZA,79
LB,ANAEMIA,71
LB,ABDOMINAL PAIN,69
LB,DRUG INEFFECTIVE,68
LB,MYOCARDIAL INFARCTION,63
LB,HEADACHE,61
LB,HYPOTENSION,60
LB,BLOOD CREATININE INCREASED,57
LB,COUGH,52
LB,DIZZINESS,52
LB,RASH,52
LB,HYPERGLYCAEMIA,51
LB,PNEUMONIA,49
LB,SEPTIC SHOCK,48
LB,CARDIAC ARREST,47
LB,CHEST PAIN,47
LB,PULMONARY OEDEMA,47
LB,RENAL FAILURE,46
LB,ABDOMINAL PAIN UPPER,45
LB,DISEASE PROGRESSION,45
LB,HYPERTENSION,45
LB,URINARY TRACT INFECTION,44
LB,INFECTION,43
LB,OEDEMA PERIPHERAL,43
LB,PAIN IN EXTREMITY,43
LB,BACK PAIN,41
LB,FALL,41
LB,PAIN,40
LB,WEIGHT DECREASED,39
LB,GENERAL PHYSICAL HEALTH DETERIORATION,38
LB,DECREASED APPETITE,37
LB,ASTHENIA,36
LB,OEDEMA,34
LB,TACHYCARDIA,33
LB,ARTHRALGIA,32
LB,CEREBROVASCULAR ACCIDENT,32
LB,MALIGNANT NEOPLASM PROGRESSION,32
LB,CARDIAC DISORDER,31
LB,LOSS OF CONSCIOUSNESS,30
LB,CHILLS,29
LB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,29
LB,LUNG INFECTION,29
LB,NEUTROPENIA,28
LB,CARDIAC FAILURE,27
LB,ABDOMINAL DISTENSION,26
LB,HYPERSENSITIVITY,26
LB,INSOMNIA,26
LB,PLASMA CELL MYELOMA,26
LB,ANXIETY,25
LB,ERYTHEMA,25
LB,MYALGIA,25
LB,PRODUCT USE ISSUE,25
LB,VISION BLURRED,25
LB,INTESTINAL OBSTRUCTION,23
LB,MUSCLE SPASMS,23
LB,SEPSIS,23
LB,TOXICITY TO VARIOUS AGENTS,22
LB,WEIGHT INCREASED,22
LB,CONDITION AGGRAVATED,21
LB,DEHYDRATION,21
LB,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,21
LB,BONE PAIN,20
LB,HYPERHIDROSIS,20
LB,THROMBOCYTOPENIA,20
LB,COLECTOMY,19
LB,DRUG RESISTANCE,19
LB,LEUKOCYTOSIS,19
LB,NEPHROLITHIASIS,19
LB,CONFUSIONAL STATE,18
LB,CROHN^S DISEASE,18
LB,EXPOSURE DURING PREGNANCY,18
LB,SOMNOLENCE,18
LB,ALOPECIA,17
LB,HAEMATURIA,17
LB,HAEMOGLOBIN DECREASED,17
LB,HYPOGLYCAEMIA,17
LB,PERIPHERAL SWELLING,17
LB,PULMONARY EMBOLISM,17
LB,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,17
LB,ACUTE KIDNEY INJURY,16
LB,CYTOGENETIC ANALYSIS ABNORMAL,16
LB,DEPRESSION,16
LB,GASTROENTERITIS,16
LB,GASTROINTESTINAL INFLAMMATION,16
LB,HIP FRACTURE,16
LB,C-REACTIVE PROTEIN INCREASED,15
LB,GAIT DISTURBANCE,15
LB,GASTROINTESTINAL INFECTION,15
LB,HAEMATOCRIT DECREASED,15
LB,HAEMORRHAGE,15
LB,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,15
LB,MUSCULAR WEAKNESS,15
LB,PALPITATIONS,15
LB,PANCYTOPENIA,15
LB,BRONCHITIS,14
LB,CONSTIPATION,14
LB,HAEMATOCHEZIA,14
LB,HYPERAMMONAEMIA,14
LB,FLUID RETENTION,13
LB,HOT FLUSH,13
LB,HUMAN HERPESVIRUS 6 INFECTION,13
LB,MALAISE,13
LB,PRESCRIBED UNDERDOSE,13
LB,PRURITUS,13
LB,SWELLING,13
LB,TREMOR,13
LB,VERTIGO,13
LB,COMA,12
LB,DRUG PRESCRIBING ERROR,12
LB,DRY SKIN,12
LB,GRAFT VERSUS HOST DISEASE IN SKIN,12
LB,HAEMORRHOIDS,12
LB,HYPONATRAEMIA,12
LB,LYMPHOMA,12
LB,NEUROPATHY PERIPHERAL,12
LB,PRODUCT USE IN UNAPPROVED INDICATION,12
LB,BLOOD GLUCOSE INCREASED,11
LB,BLOOD UREA INCREASED,11
LB,CONJUNCTIVAL HAEMORRHAGE,11
LB,DYSPHAGIA,11
LB,EJECTION FRACTION DECREASED,11
LB,EMBOLISM,11
LB,HEPATIC FAILURE,11
LB,HYPOAESTHESIA,11
LB,LUNG NEOPLASM MALIGNANT,11
LB,LYMPHADENOPATHY,11
LB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,11
LB,NECK PAIN,11
LB,PANCREATITIS,11
LB,PARAESTHESIA,11
LB,PLATELET COUNT DECREASED,11
LB,RENAL IMPAIRMENT,11
LB,ABORTION SPONTANEOUS,10
LB,ACUTE PULMONARY OEDEMA,10
LB,ANGINA PECTORIS,10
LB,BRADYCARDIA,10
LB,CHEST DISCOMFORT,10
LB,CHRONIC GRAFT VERSUS HOST DISEASE,10
LB,EPILEPSY,10
LB,FOETAL EXPOSURE DURING PREGNANCY,10
LB,FURUNCLE,10
LB,LYMPHOPENIA,10
LB,OVARIAN CYST,10
LB,OVERDOSE,10
LB,OXYGEN SATURATION DECREASED,10
LB,RECTAL HAEMORRHAGE,10
LB,SEIZURE,10
LB,SPLENOMEGALY,10
LB,SYNCOPE,10
LB,ACUTE GRAFT VERSUS HOST DISEASE,9
LB,ANAL FISTULA,9
LB,APHASIA,9
LB,ARRHYTHMIA,9
LB,ASCITES,9
LB,BLOOD PRESSURE INCREASED,9
LB,CARDIAC OPERATION,9
LB,CEREBRAL HAEMORRHAGE,9
LB,COGNITIVE DISORDER,9
LB,DYSLIPIDAEMIA,9
LB,ELECTROENCEPHALOGRAM ABNORMAL,9
LB,FISTULA,9
LB,GASTROINTESTINAL HAEMORRHAGE,9
LB,GLYCOSYLATED HAEMOGLOBIN INCREASED,9
LB,HEPATOTOXICITY,9
LB,HYPERKALAEMIA,9
LB,LEUKOPENIA,9
LB,MUSCULOSKELETAL PAIN,9
LB,OCULAR HYPERAEMIA,9
LB,OLIGURIA,9
LB,OROPHARYNGEAL PAIN,9
LB,PSORIASIS,9
LB,SKIN EXFOLIATION,9
LB,THROMBOSIS,9
LB,URINE OUTPUT DECREASED,9
LB,ABASIA,8
LB,ACUTE MYELOID LEUKAEMIA,8
LB,BLOOD IRON DECREASED,8
LB,CATARACT,8
LB,CENTRAL NERVOUS SYSTEM LESION,8
LB,CORONARY ARTERY STENOSIS,8
LB,DISCOMFORT,8
LB,DYSURIA,8
LB,FACE OEDEMA,8
LB,GRANULOMA SKIN,8
LB,HEPATIC CIRRHOSIS,8
LB,JAUNDICE,8
LB,LETHARGY,8
LB,LIVER DISORDER,8
LB,MULTI-ORGAN FAILURE,8
LB,PANCREATIC CARCINOMA,8
LB,PLEURAL EFFUSION,8
LB,RENAL DISORDER,8
LB,RENAL PAIN,8
LB,RESPIRATORY ARREST,8
LB,SKIN LESION,8
LB,URTICARIA,8
LB,WHITE BLOOD CELL COUNT DECREASED,8
LB,ACUTE RESPIRATORY DISTRESS SYNDROME,7
LB,ANAL ABSCESS,7
LB,ATRIAL FIBRILLATION,7
LB,BLINDNESS,7
LB,CANDIDA INFECTION,7
LB,CYTOMEGALOVIRUS INFECTION,7
LB,DEEP VEIN THROMBOSIS,7
LB,GENERALISED OEDEMA,7
LB,HEPATIC ENZYME INCREASED,7
LB,HEPATITIS,7
LB,HYPOXIA,7
LB,INCORRECT DOSE ADMINISTERED,7
LB,INTERVERTEBRAL DISC PROTRUSION,7
LB,MEMORY IMPAIRMENT,7
LB,NON-HODGKIN^S LYMPHOMA,7
LB,OSTEOPOROSIS,7
LB,PATHOGEN RESISTANCE,7
LB,PELVIC PAIN,7
LB,POLYURIA,7
LB,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,7
LB,RESPIRATORY FAILURE,7
LB,SECOND PRIMARY MALIGNANCY,7
LB,SERUM FERRITIN INCREASED,7
LB,SPEECH DISORDER,7
LB,STEVENS-JOHNSON SYNDROME,7
LB,TOOTH ABSCESS,7
LB,TOOTHACHE,7
LB,VISUAL IMPAIRMENT,7
LB,VITAMIN D DECREASED,7
LB,ANAPHYLACTIC SHOCK,6
LB,ASTHMA,6
LB,BREAST CANCER,6
LB,CARDIO-RESPIRATORY ARREST,6
LB,CYANOSIS,6
LB,DERMATITIS ALLERGIC,6
LB,DISEASE RECURRENCE,6
LB,DRUG DOSE OMISSION,6
LB,EPISTAXIS,6
LB,EXPOSURE VIA FATHER,6
LB,FEBRILE NEUTROPENIA,6
LB,FOETAL DEATH,6
LB,GAIT INABILITY,6
LB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,6
LB,HYPOTHYROIDISM,6
LB,INFLUENZA LIKE ILLNESS,6
LB,INFUSION RELATED REACTION,6
LB,ISCHAEMIC STROKE,6
LB,LEUKAEMIA,6
LB,MATERNAL EXPOSURE DURING PREGNANCY,6
LB,MENSTRUAL DISORDER,6
LB,MOUTH ULCERATION,6
LB,MULTIPLE SCLEROSIS RELAPSE,6
LB,NEOPLASM MALIGNANT,6
LB,NORMAL NEWBORN,6
LB,PALLOR,6
LB,PANCREATITIS ACUTE,6
LB,PRODUCTIVE COUGH,6
LB,RED BLOOD CELL COUNT DECREASED,6
LB,RED BLOOD CELL SEDIMENTATION RATE INCREASED,6
LB,RESPIRATORY TRACT INFECTION,6
LB,SALIVARY HYPERSECRETION,6
LB,SKIN DISCOLOURATION,6
LB,SKIN DISORDER,6
LB,STOMATITIS,6
LB,THYROID DISORDER,6
LB,UNDERDOSE,6
LB,VAGINAL HAEMORRHAGE,6
LB,VITAMIN D DEFICIENCY,6
LB,WHITE BLOOD CELL COUNT INCREASED,6
LB,ABSCESS,5
LB,ABSCESS INTESTINAL,5
LB,ACUTE CORONARY SYNDROME,5
LB,ATONIC SEIZURES,5
LB,BLINDNESS UNILATERAL,5
LB,BLISTER,5
LB,BLOOD POTASSIUM INCREASED,5
LB,BONE MARROW FAILURE,5
LB,CELLULITIS,5
LB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
LB,COLITIS,5
LB,COLITIS ULCERATIVE,5
LB,DEPRESSED MOOD,5
LB,DIABETES MELLITUS,5
LB,DRUG INTOLERANCE,5
LB,DRY MOUTH,5
LB,EAR INFECTION,5
LB,EAR PAIN,5
LB,ENTEROVESICAL FISTULA,5
LB,FEEDING DISORDER,5
LB,FUNGAL INFECTION,5
LB,GASTROOESOPHAGEAL REFLUX DISEASE,5
LB,HAEMATOTOXICITY,5
LB,HAEMOPTYSIS,5
LB,HALLUCINATION,5
LB,HERNIA,5
LB,HYPERSOMNIA,5
LB,HYPOCALCAEMIA,5
LB,INGUINAL HERNIA,5
LB,INTERNAL HAEMORRHAGE,5
LB,IRRITABILITY,5
LB,JOINT SWELLING,5
LB,LOCALISED INFECTION,5
LB,LUNG DISORDER,5
LB,MYELODYSPLASTIC SYNDROME,5
LB,MYELOFIBROSIS,5
LB,NEOPLASM PROGRESSION,5
LB,NIGHT SWEATS,5
LB,RASH GENERALISED,5
LB,RASH PRURITIC,5
LB,RESPIRATORY DISTRESS,5
LB,ROAD TRAFFIC ACCIDENT,5
LB,SINUSITIS,5
LB,SKIN INFECTION,5
LB,SPINAL FRACTURE,5
LB,ULCER,5
LB,ACCIDENTAL EXPOSURE TO PRODUCT,4
LB,AGGRESSION,4
LB,AGITATION,4
LB,ALANINE AMINOTRANSFERASE INCREASED,4
LB,ANGINA UNSTABLE,4
LB,ANGIOEDEMA,4
LB,ANGIOPLASTY,4
LB,ANURIA,4
LB,ARTHRITIS BACTERIAL,4
LB,BLOOD ALBUMIN DECREASED,4
LB,BLOOD BILIRUBIN INCREASED,4
LB,BLOOD CHOLESTEROL INCREASED,4
LB,BLOOD LACTATE DEHYDROGENASE INCREASED,4
LB,BLOOD PRESSURE DECREASED,4
LB,BLOOD URIC ACID INCREASED,4
LB,BURNING SENSATION,4
LB,CARDIAC FAILURE CONGESTIVE,4
LB,CARDIOMYOPATHY,4
LB,CEREBRAL ISCHAEMIA,4
LB,CHOLECYSTECTOMY,4
LB,CORONARY ARTERY DISEASE,4
LB,CYSTITIS HAEMORRHAGIC,4
LB,DECUBITUS ULCER,4
LB,DERMATITIS BULLOUS,4
LB,DISORIENTATION,4
LB,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,4
LB,DRUG-INDUCED LIVER INJURY,4
LB,DYSARTHRIA,4
LB,DYSGEUSIA,4
LB,DYSPEPSIA,4
LB,DYSPHONIA,4
LB,FEELING COLD,4
LB,FLANK PAIN,4
LB,FLUSHING,4
LB,FOOD INTERACTION,4
LB,GASTRITIS,4
LB,GASTROINTESTINAL DISORDER,4
LB,GINGIVAL BLEEDING,4
LB,GINGIVITIS,4
LB,GLAUCOMA,4
LB,GROWTH RETARDATION,4
LB,HAEMORRHAGE INTRACRANIAL,4
LB,HEPATIC CANCER,4
LB,HEPATITIS FULMINANT,4
LB,HERPES ZOSTER,4
LB,HERPES ZOSTER INFECTION NEUROLOGICAL,4
LB,HYPOKINESIA,4
LB,IMMUNE SYSTEM DISORDER,4
LB,INTENTIONAL PRODUCT MISUSE,4
LB,INTERSTITIAL LUNG DISEASE,4
LB,INTRAOCULAR PRESSURE INCREASED,4
LB,IRON DEFICIENCY,4
LB,KIDNEY INFECTION,4
LB,LACTIC ACIDOSIS,4
LB,LIVER FUNCTION TEST ABNORMAL,4
LB,LOWER LIMB FRACTURE,4
LB,MUCORMYCOSIS,4
LB,MULTIPLE SCLEROSIS,4
LB,MUSCULOSKELETAL CHEST PAIN,4
LB,MYOCLONIC EPILEPSY,4
LB,MYOSITIS,4
LB,NERVOUSNESS,4
LB,NEUTROPHIL COUNT INCREASED,4
LB,NODULE,4
LB,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,4
LB,POLYMERASE CHAIN REACTION POSITIVE,4
LB,PREMATURE BABY,4
LB,PROCEDURAL PAIN,4
LB,PROTEINURIA,4
LB,PULMONARY FIBROSIS,4
LB,PULMONARY SARCOIDOSIS,4
LB,RENAL ISCHAEMIA,4
LB,RENAL PAPILLARY NECROSIS,4
LB,RESPIRATORY DISORDER,4
LB,RHABDOMYOLYSIS,4
LB,SALMONELLA BACTERAEMIA,4
LB,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,4
LB,SECRETION DISCHARGE,4
LB,SKIN ULCER,4
LB,STAPHYLOCOCCAL INFECTION,4
LB,STENOSIS,4
LB,STRESS CARDIOMYOPATHY,4
LB,SUBDURAL HAEMATOMA,4
LB,SUICIDAL IDEATION,4
LB,SUICIDE ATTEMPT,4
LB,SWELLING FACE,4
LB,TENDON RUPTURE,4
LB,TENDONITIS,4
LB,TESTIS CANCER,4
LB,THROMBOCYTOSIS,4
LB,THROMBOPHLEBITIS,4
LB,THROMBOTIC THROMBOCYTOPENIC PURPURA,4
LB,TONSILLITIS,4
LB,TOOTH INFECTION,4
LB,TREATMENT NONCOMPLIANCE,4
LB,UMBILICAL HERNIA,4
LB,URINARY INCONTINENCE,4
LB,UROSEPSIS,4
LB,UTERINE LEIOMYOMA,4
LB,VIRAL INFECTION,4
LB,VISUAL ACUITY REDUCED,4
LB,WEIGHT FLUCTUATION,4
LB,WOUND,4
LB,ABDOMINAL ABSCESS,3
LB,ABDOMINAL MASS,3
LB,ABDOMINAL RIGIDITY,3
LB,ABNORMAL BEHAVIOUR,3
LB,ACNE,3
LB,ALTERED STATE OF CONSCIOUSNESS,3
LB,APNOEA,3
LB,ASPARTATE AMINOTRANSFERASE INCREASED,3
LB,BALANCE DISORDER,3
LB,BIPOLAR DISORDER,3
LB,BLADDER CANCER,3
LB,BLOOD CREATINE INCREASED,3
LB,BLOOD POTASSIUM DECREASED,3
LB,BLOOD PRESSURE ABNORMAL,3
LB,BLOOD PRESSURE FLUCTUATION,3
LB,BREAST PAIN,3
LB,BRONCHOSPASM,3
LB,C-REACTIVE PROTEIN ABNORMAL,3
LB,CACHEXIA,3
LB,CARDIOGENIC SHOCK,3
LB,CARDIOMEGALY,3
LB,CHROMATURIA,3
LB,COLON CANCER,3
LB,COLONIC ABSCESS,3
LB,COMPLICATIONS OF TRANSPLANTED KIDNEY,3
LB,CONVULSION,3
LB,DEAFNESS,3
LB,DEPRESSED LEVEL OF CONSCIOUSNESS,3
LB,DIARRHOEA HAEMORRHAGIC,3
LB,DRUG ABUSE,3
LB,DRUG DEPENDENCE,3
LB,DRUG EFFECT INCOMPLETE,3
LB,DYSPNOEA AT REST,3
LB,EAR DISORDER,3
LB,ELECTROLYTE IMBALANCE,3
LB,ENCEPHALITIS,3
LB,EPSTEIN-BARR VIRUS INFECTION,3
LB,ESCHERICHIA INFECTION,3
LB,ESCHERICHIA URINARY TRACT INFECTION,3
LB,EXTREMITY NECROSIS,3
LB,EYE PAIN,3
LB,FEELING ABNORMAL,3
LB,GALLBLADDER DISORDER,3
LB,GANGRENE,3
LB,GASTRIC DISORDER,3
LB,GASTRIC HAEMORRHAGE,3
LB,GASTRIC ULCER,3
LB,GASTROINTESTINAL CARCINOMA,3
LB,GASTROINTESTINAL NECROSIS,3
LB,GASTROINTESTINAL STROMAL TUMOUR,3
LB,GRAFT VERSUS HOST DISEASE,3
LB,GRANULOMA,3
LB,HAEMATEMESIS,3
LB,HAEMOLYTIC ANAEMIA,3
LB,HEAD INJURY,3
LB,HEART RATE DECREASED,3
LB,HEPATIC ENCEPHALOPATHY,3
LB,HEPATIC INFECTION,3
LB,HEPATITIS C,3
LB,HEPATOCELLULAR CARCINOMA,3
LB,HYPEROXALURIA,3
LB,HYPERTHYROIDISM,3
LB,HYPOALBUMINAEMIA,3
LB,HYPOKALAEMIA,3
LB,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
LB,INCREASED APPETITE,3
LB,INFLAMMATION,3
LB,INJURY,3
LB,INTENTIONAL OVERDOSE,3
LB,INTERVERTEBRAL DISC DISORDER,3
LB,INTESTINAL STENOSIS,3
LB,INTESTINAL ULCER,3
LB,IRON DEFICIENCY ANAEMIA,3
LB,ISCHAEMIC NEUROPATHY,3
LB,JOINT DISLOCATION,3
LB,LARYNGEAL OEDEMA,3
LB,LIBIDO DECREASED,3
LB,LIP OEDEMA,3
LB,LOCALISED OEDEMA,3
LB,LYMPHOCYTOSIS,3
LB,MALNUTRITION,3
LB,MENINGITIS LISTERIA,3
LB,METASTASES TO CENTRAL NERVOUS SYSTEM,3
LB,METASTASES TO LIVER,3
LB,METASTASES TO LUNG,3
LB,METASTASES TO LYMPH NODES,3
LB,MITOCHONDRIAL CYTOPATHY,3
LB,MOBILITY DECREASED,3
LB,MOUTH HAEMORRHAGE,3
LB,MOVEMENT DISORDER,3
LB,MUCOCUTANEOUS ULCERATION,3
LB,MUCOSAL INFLAMMATION,3
LB,MYCOSIS FUNGOIDES,3
LB,MYOCLONUS,3
LB,NECROSIS,3
LB,NEOPLASM,3
LB,NEPHROPATHY,3
LB,NEURALGIA,3
LB,OCULAR HYPERTENSION,3
LB,ORGAN FAILURE,3
LB,OSTEOMYELITIS,3
LB,OSTEONECROSIS OF JAW,3
LB,PANCREATIC CARCINOMA METASTATIC,3
LB,PANCREATIC DISORDER,3
LB,PEMPHIGOID,3
LB,PHLEBITIS,3
LB,POST PROCEDURAL COMPLICATION,3
LB,POST PROCEDURAL INFECTION,3
LB,POSTPARTUM HAEMORRHAGE,3
LB,PREMATURE DELIVERY,3
LB,PRODUCT QUALITY ISSUE,3
LB,PROSTATE CANCER METASTATIC,3
LB,PROSTATIC SPECIFIC ANTIGEN INCREASED,3
LB,PULMONARY HAEMORRHAGE,3
LB,PURULENCE,3
LB,RASH MACULAR,3
LB,RASH MORBILLIFORM,3
LB,RENAL COLIC,3
LB,ROTAVIRUS INFECTION,3
LB,SKIN PLAQUE,3
LB,SNEEZING,3
LB,STATUS EPILEPTICUS,3
LB,SUBCUTANEOUS ABSCESS,3
LB,SUDDEN DEATH,3
LB,TERMINAL STATE,3
LB,THERAPEUTIC RESPONSE DECREASED,3
LB,TOE AMPUTATION,3
LB,TOOTH DISORDER,3
LB,TREATMENT FAILURE,3
LB,TUBULOINTERSTITIAL NEPHRITIS,3
LB,VASCULITIS,3
LB,VIROLOGIC FAILURE,3
LB,WHEEZING,3
LB,WOUND INFECTION,3
LB,ABDOMINAL DISCOMFORT,2
LB,ABDOMINAL HERNIA,2
LB,ABDOMINAL INFECTION,2
LB,ABDOMINAL PAIN LOWER,2
LB,ABORTION,2
LB,ABORTION INDUCED,2
LB,ACCIDENTAL OVERDOSE,2
LB,ACIDOSIS,2
LB,ACINETOBACTER BACTERAEMIA,2
LB,ACQUIRED MITOCHONDRIAL DNA MUTATION,2
LB,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
LB,ADENOCARCINOMA GASTRIC,2
LB,ALLERGIC COUGH,2
LB,AMMONIA INCREASED,2
LB,AMNESIA,2
LB,ANAL HAEMORRHAGE,2
LB,ANAPHYLACTIC REACTION,2
LB,ANHEDONIA,2
LB,AORTIC CALCIFICATION,2
LB,APHAGIA,2
LB,APHONIA,2
LB,APHTHOUS ULCER,2
LB,APPENDICECTOMY,2
LB,APPENDICITIS,2
LB,ARTERIAL STENOSIS,2
LB,ATRIOVENTRICULAR BLOCK,2
LB,BACTERIAL INFECTION,2
LB,BETA 2 MICROGLOBULIN INCREASED,2
LB,BILE DUCT STONE,2
LB,BLEPHARITIS,2
LB,BLOOD ALKALINE PHOSPHATASE INCREASED,2
LB,BLOOD DISORDER,2
LB,BLOOD POTASSIUM ABNORMAL,2
LB,BLOOD URINE PRESENT,2
LB,BONE DISORDER,2
LB,BONE LESION,2
LB,BRAIN INJURY,2
LB,BRAIN NEOPLASM,2
LB,BREATH ODOUR,2
LB,BRONCHOPULMONARY ASPERGILLOSIS,2
LB,CAESAREAN SECTION,2
LB,CALCIFICATION OF MUSCLE,2
LB,CALCULUS URINARY,2
LB,CARDIAC HYPERTROPHY,2
LB,CARDIAC VALVE DISEASE,2
LB,CARDIOPULMONARY FAILURE,2
LB,CARDIOVASCULAR DISORDER,2
LB,CENTRAL NERVOUS SYSTEM NECROSIS,2
LB,CEREBRAL ARTERY EMBOLISM,2
LB,CERVICAL RADICULOPATHY,2
LB,CHOLECYSTITIS,2
LB,CHOLELITHIASIS,2
LB,CHRONIC KIDNEY DISEASE,2
LB,CHRONIC MYELOID LEUKAEMIA,2
LB,COLON CANCER METASTATIC,2
LB,COLONIC FISTULA,2
LB,COMPLETED SUICIDE,2
LB,CONTUSION,2
LB,CORONARY ARTERY BYPASS,2
LB,CYST,2
LB,DECREASED ACTIVITY,2
LB,DECREASED IMMUNE RESPONSIVENESS,2
LB,DEVICE RELATED INFECTION,2
LB,DIABETIC KETOACIDOSIS,2
LB,DIFFUSE LARGE B-CELL LYMPHOMA,2
LB,DISTURBANCE IN ATTENTION,2
LB,DRUG HYPERSENSITIVITY,2
LB,DRUG WITHDRAWAL SYNDROME,2
LB,DYSPNOEA EXERTIONAL,2
LB,DYSSTASIA,2
LB,EATING DISORDER,2
LB,ECZEMA,2
LB,ENCEPHALOPATHY,2
LB,ENDOCARDITIS,2
LB,EOSINOPHILIA,2
LB,EPHELIDES,2
LB,ERECTILE DYSFUNCTION,2
LB,EYE ALLERGY,2
LB,EYE HAEMORRHAGE,2
LB,EYE INFECTION FUNGAL,2
LB,EYE SWELLING,2
LB,EYELID OEDEMA,2
LB,FACIAL PARALYSIS,2
LB,FASCIITIS,2
LB,FEELING HOT,2
LB,FIBULA FRACTURE,2
LB,FOLLICULITIS,2
LB,GASTRECTOMY,2
LB,GASTROINTESTINAL FUNGAL INFECTION,2
LB,GLOMERULONEPHRITIS MEMBRANOUS,2
LB,GYNAECOMASTIA,2
LB,HAEMORRHAGE SUBCUTANEOUS,2
LB,HAEMORRHOIDAL HAEMORRHAGE,2
LB,HEART INJURY,2
LB,HEMIPARESIS,2
LB,HEMIPLEGIA,2
LB,HEPARIN-INDUCED THROMBOCYTOPENIA,2
LB,HEPATIC STEATOSIS,2
LB,HISTIOCYTOSIS HAEMATOPHAGIC,2
LB,HOSPITALISATION,2
LB,HUNGER,2
LB,HYPERBILIRUBINAEMIA,2
LB,HYPERKERATOSIS,2
LB,HYPERTRIGLYCERIDAEMIA,2
LB,HYPOACUSIS,2
LB,HYPOMANIA,2
LB,HYPOPHAGIA,2
LB,HYPOTHERMIA,2
LB,IMMUNOSUPPRESSION,2
LB,INCORRECT DRUG ADMINISTRATION DURATION,2
LB,INFLAMMATORY BOWEL DISEASE,2
LB,INJECTION SITE PAIN,2
LB,INTERNATIONAL NORMALISED RATIO INCREASED,2
LB,INTESTINAL FISTULA,2
LB,INTESTINAL PERFORATION,2
LB,IRRITABLE BOWEL SYNDROME,2
LB,JC VIRUS INFECTION,2
LB,KETOACIDOSIS,2
LB,KLEBSIELLA INFECTION,2
LB,LACRIMATION INCREASED,2
LB,LARGE INTESTINAL OBSTRUCTION,2
LB,LARGE INTESTINE POLYP,2
LB,LIMB INJURY,2
LB,LINEAR IGA DISEASE,2
LB,LOCAL SWELLING,2
LB,LUNG INFILTRATION,2
LB,LYMPHADENITIS,2
LB,LYMPHOCYTE COUNT DECREASED,2
LB,MACULAR HOLE,2
LB,MALARIA,2
LB,MANIA,2
LB,MATERNAL EXPOSURE BEFORE PREGNANCY,2
LB,MEDICATION ERROR,2
LB,MENINGITIS,2
LB,METASTASES TO ABDOMINAL CAVITY,2
LB,METASTASES TO BONE,2
LB,METASTATIC RENAL CELL CARCINOMA,2
LB,MITRAL VALVE INCOMPETENCE,2
LB,MOTOR DYSFUNCTION,2
LB,MUSCULOSKELETAL STIFFNESS,2
LB,MYASTHENIA GRAVIS,2
LB,MYOCARDITIS,2
LB,NASOPHARYNGITIS,2
LB,NEPHROTIC SYNDROME,2
LB,NEUROMYELITIS OPTICA SPECTRUM DISORDER,2
LB,NIGHTMARE,2
LB,NOSOCOMIAL INFECTION,2
LB,OCULAR ICTERUS,2
LB,ONYCHOCLASIS,2
LB,OPHTHALMOPLEGIA,2
LB,ORAL DISORDER,2
LB,ORCHITIS,2
LB,ORTHOPNOEA,2
LB,ORTHOSTATIC HYPOTENSION,2
LB,OSTEONECROSIS,2
LB,OVARIAN CANCER,2
LB,OVARIAN GERM CELL TERATOMA,2
LB,PANIC ATTACK,2
LB,PARADOXICAL DRUG REACTION,2
LB,PARALYSIS,2
LB,PARKINSON^S DISEASE,2
LB,PCO2 DECREASED,2
LB,PELVIC FLUID COLLECTION,2
LB,PELVIC MASS,2
LB,PERICARDIAL EFFUSION,2
LB,PERIORBITAL OEDEMA,2
LB,PERIPHERAL EMBOLISM,2
LB,PERIPHERAL NERVE INJURY,2
LB,PIGMENTATION DISORDER,2
LB,PITYRIASIS ROSEA,2
LB,PLASMA CELL MYELOMA RECURRENT,2
LB,PLATELET DISORDER,2
LB,PNEUMONITIS,2
LB,PNEUMOTHORAX,2
LB,POLLAKIURIA,2
LB,POST PROCEDURAL HAEMORRHAGE,2
LB,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
LB,POSTOPERATIVE WOUND INFECTION,2
LB,PROSTATE CANCER,2
LB,PROSTATIC DISORDER,2
LB,PROTEIN TOTAL DECREASED,2
LB,PSEUDOLYMPHOMA,2
LB,PULMONARY CONGESTION,2
LB,PYELONEPHRITIS,2
LB,PYODERMA GANGRENOSUM,2
LB,RASH ERYTHEMATOUS,2
LB,RASH PUSTULAR,2
LB,RECTAL OBSTRUCTION,2
LB,RENAL CELL CARCINOMA,2
LB,RENAL FAILURE ACUTE,2
LB,RENAL HAEMORRHAGE,2
LB,RENAL TUBULAR NECROSIS,2
LB,RETROPERITONEAL HAEMORRHAGE,2
LB,RIB FRACTURE,2
LB,SEDATION,2
LB,SENSORY LOSS,2
LB,SHOCK HAEMORRHAGIC,2
LB,SJOGREN^S SYNDROME,2
LB,SKIN BURNING SENSATION,2
LB,SKIN IRRITATION,2
LB,SPUTUM DISCOLOURED,2
LB,SQUAMOUS CELL CARCINOMA OF SKIN,2
LB,SYNOVIAL CYST,2
LB,THIRST,2
LB,THROMBOSIS IN DEVICE,2
LB,THROMBOTIC MICROANGIOPATHY,2
LB,THROMBOTIC STROKE,2
LB,THYROID CANCER,2
LB,TIBIA FRACTURE,2
LB,TOXIC ANTERIOR SEGMENT SYNDROME,2
LB,TRANSAMINASES INCREASED,2
LB,TRANSPLANT,2
LB,TUBERCULOSIS,2
LB,TUMOUR MARKER INCREASED,2
LB,TYPE 2 DIABETES MELLITUS,2
LB,TYPHOID FEVER,2
LB,UNINTENTIONAL USE FOR UNAPPROVED INDICATION,2
LB,UPPER LIMB FRACTURE,2
LB,UPPER RESPIRATORY TRACT INFECTION,2
LB,URINARY BLADDER HAEMORRHAGE,2
LB,URINARY RETENTION,2
LB,VAGINAL INFECTION,2
LB,VARICOSE VEIN,2
LB,VASOSPASM,2
LB,VITAMIN B12 DECREASED,2
LB,WOUND COMPLICATION,2
LB,WOUND SECRETION,2
LB,YELLOW SKIN,2
LB,ABDOMINAL LYMPHADENOPATHY,1
LB,ABDOMINAL NEOPLASM,1
LB,ABDOMINAL OPERATION,1
LB,ABDOMINAL STRANGULATED HERNIA,1
LB,ABDOMINAL WALL HAEMORRHAGE,1
LB,ABSCESS BACTERIAL,1
LB,ABSCESS DRAINAGE,1
LB,ABSCESS LIMB,1
LB,ABSCESS NECK,1
LB,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
LB,ACUTE HEPATIC FAILURE,1
LB,ACUTE LYMPHOCYTIC LEUKAEMIA,1
LB,ADENOIDAL HYPERTROPHY,1
LB,ADENOVIRUS INFECTION,1
LB,ADNEXAL TORSION,1
LB,ADVERSE DRUG REACTION,1
LB,ADVERSE REACTION,1
LB,AFFECTIVE DISORDER,1
LB,AGEUSIA,1
LB,ALBUMIN URINE PRESENT,1
LB,ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
LB,AMPUTATION,1
LB,AMYLOIDOSIS,1
LB,ANAEMIA HAEMOLYTIC AUTOIMMUNE,1
LB,ANAL INCONTINENCE,1
LB,ANAL PRURITUS,1
LB,ANGIOGRAM,1
LB,ANKLE FRACTURE,1
LB,ANKYLOSING SPONDYLITIS,1
LB,ANOGENITAL WARTS,1
LB,ANORECTAL DISCOMFORT,1
LB,ANTIMICROBIAL SUSCEPTIBILITY TEST,1
LB,ANTINUCLEAR ANTIBODY,1
LB,AORTIC ANEURYSM,1
LB,AORTIC DISSECTION,1
LB,AORTIC STENOSIS,1
LB,AORTIC THROMBOSIS,1
LB,AORTIC VALVE INCOMPETENCE,1
LB,AORTIC VALVE STENOSIS,1
LB,APLASTIC ANAEMIA,1
LB,APPLICATION SITE ERYTHEMA,1
LB,APRAXIA,1
LB,ARRESTED LABOUR,1
LB,ARTERIAL OCCLUSIVE DISEASE,1
LB,ARTERIAL RUPTURE,1
LB,ARTERIAL THERAPEUTIC PROCEDURE,1
LB,ARTERIOGRAM CORONARY,1
LB,ARTHRITIS,1
LB,ARTHROPOD STING,1
LB,ASPERGILLOMA,1
LB,ASPERGILLUS INFECTION,1
LB,ASTHMATIC CRISIS,1
LB,ATAXIA,1
LB,ATRIAL FLUTTER,1
LB,ATRIAL SEPTAL DEFECT,1
LB,ATRIAL TACHYCARDIA,1
LB,ATRIOVENTRICULAR BLOCK COMPLETE,1
LB,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
LB,AUTOIMMUNE DISORDER,1
LB,AUTOIMMUNE HEPATITIS,1
LB,AZOTAEMIA,1
LB,BACTERAEMIA,1
LB,BARRETT^S OESOPHAGUS,1
LB,BASOPHIL COUNT INCREASED,1
LB,BEDRIDDEN,1
LB,BENIGN NEOPLASM OF THYROID GLAND,1
LB,BILE DUCT OBSTRUCTION,1
LB,BIOCHEMICAL PREGNANCY,1
LB,BK VIRUS INFECTION,1
LB,BLADDER DISORDER,1
LB,BLADDER NEOPLASM SURGERY,1
LB,BLADDER PERFORATION,1
LB,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
LB,BLINDNESS TRANSIENT,1
LB,BLOOD CALCITONIN INCREASED,1
LB,BLOOD CALCIUM DECREASED,1
LB,BLOOD CORTICOTROPHIN ABNORMAL,1
LB,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
LB,BLOOD GLUCOSE ABNORMAL,1
LB,BLOOD OSMOLARITY DECREASED,1
LB,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
LB,BLOOD PRESSURE MEASUREMENT,1
LB,BLOOD PRESSURE ORTHOSTATIC ABNORMAL,1
LB,BLOOD PRESSURE SYSTOLIC INCREASED,1
LB,BLOOD SODIUM DECREASED,1
LB,BLOOD TESTOSTERONE INCREASED,1
LB,BLOOD TRIGLYCERIDES INCREASED,1
LB,BLOOD URIC ACID ABNORMAL,1
LB,BLOOD URIC ACID DECREASED,1
LB,BLOOD URINE,1
LB,BONE MARROW RETICULIN FIBROSIS,1
LB,BOTULISM,1
LB,BRAIN DEATH,1
LB,BRAIN NEOPLASM BENIGN,1
LB,BRAIN STEM STROKE,1
LB,BREAST CANCER FEMALE,1
LB,BREAST CANCER METASTATIC,1
LB,BREAST CANCER STAGE IV,1
LB,BREAST DISORDER FEMALE,1
LB,BREAST ENGORGEMENT,1
LB,BREAST FIBROMA,1
LB,BREAST ULCERATION,1
LB,BRONCHIAL WALL THICKENING,1
LB,BRONCHITIS VIRAL,1
LB,CALCULUS URETHRAL,1
LB,CARBON DIOXIDE INCREASED,1
LB,CARCINOEMBRYONIC ANTIGEN INCREASED,1
LB,CARDIAC AMYLOIDOSIS,1
LB,CARDIAC ARREST NEONATAL,1
LB,CARDIAC CONTUSION,1
LB,CARDIAC DISCOMFORT,1
LB,CARDIAC MURMUR,1
LB,CARDIAC OUTPUT DECREASED,1
LB,CARDIAC PACEMAKER REPLACEMENT,1
LB,CARDIAC PERFORATION,1
LB,CARDIOTOXICITY,1
LB,CARDIOVASCULAR INSUFFICIENCY,1
LB,CAROTID ARTERY STENOSIS,1
LB,CAROTID ARTERY THROMBOSIS,1
LB,CARTILAGE INJURY,1
LB,CATARACT TRAUMATIC,1
LB,CATHETER SITE THROMBOSIS,1
LB,CATHETERISATION CARDIAC ABNORMAL,1
LB,CD30 EXPRESSION,1
LB,CENTRAL NERVOUS SYSTEM INFECTION,1
LB,CEREBRAL ATROPHY,1
LB,CEREBRAL INFARCTION,1
LB,CEREBRAL THROMBOSIS,1
LB,CEREBRAL VENOUS THROMBOSIS,1
LB,CHALAZION,1
LB,CHEST INJURY,1
LB,CHOKING SENSATION,1
LB,CHOLECYSTITIS INFECTIVE,1
LB,CHOLESTASIS,1
LB,CHOLESTATIC LIVER INJURY,1
LB,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
LB,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
LB,CHRONIC SINUSITIS,1
LB,CIRCULATORY COLLAPSE,1
LB,CLONUS,1
LB,COLD SWEAT,1
LB,COLECTOMY TOTAL,1
LB,COLON CANCER STAGE IV,1
LB,COLOSTOMY,1
LB,COMPLEMENT FACTOR C3 DECREASED,1
LB,COMPLICATION OF PREGNANCY,1
LB,COMPUTERISED TOMOGRAM ABDOMEN ABNORMAL,1
LB,CONCOMITANT DISEASE AGGRAVATED,1
LB,CONGENITAL PULMONARY ARTERY ANOMALY,1
LB,CONGESTIVE CARDIOMYOPATHY,1
LB,CONJUNCTIVITIS,1
LB,CONTRAINDICATED PRODUCT ADMINISTERED,1
LB,COOMBS INDIRECT TEST POSITIVE,1
LB,CORNEAL CYST,1
LB,CORNEAL DISORDER,1
LB,CORNEAL OEDEMA,1
LB,CORONARY ARTERY OCCLUSION,1
LB,CORONARY ARTERY RESTENOSIS,1
LB,CRANIAL NERVE INFECTION,1
LB,CREATININE RENAL CLEARANCE DECREASED,1
LB,CRYSTAL NEPHROPATHY,1
LB,CSF GLUCOSE DECREASED,1
LB,CULTURE URINE POSITIVE,1
LB,CYSTITIS INTERSTITIAL,1
LB,CYTOKINE RELEASE SYNDROME,1
LB,CYTOMEGALOVIRUS PANCREATITIS,1
LB,DEAFNESS UNILATERAL,1
LB,DEBRIDEMENT,1
LB,DELIRIUM,1
LB,DELIVERY,1
LB,DELUSION,1
LB,DEMENTIA,1
LB,DEMENTIA ALZHEIMER^S TYPE,1
LB,DENTAL CARIES,1
LB,DENTAL RESTORATION FAILURE,1
LB,DEPENDENCE,1
LB,DERMATITIS,1
LB,DERMATITIS CONTACT,1
LB,DERMATITIS EXFOLIATIVE,1
LB,DEVICE EXPULSION,1
LB,DEVICE FAILURE,1
LB,DIABETES MELLITUS INADEQUATE CONTROL,1
LB,DIABETIC COMPLICATION,1
LB,DIABETIC HYPERGLYCAEMIC COMA,1
LB,DIABETIC MICROANGIOPATHY,1
LB,DIALYSIS DEVICE INSERTION,1
LB,DIAPHRAGMATIC DISORDER,1
LB,DIASTOLIC DYSFUNCTION,1
LB,DIASTOLIC HYPERTENSION,1
LB,DIPLOPIA,1
LB,DISEASE COMPLICATION,1
LB,DISSEMINATED INTRAVASCULAR COAGULATION,1
LB,DIVERTICULAR PERFORATION,1
LB,DIVERTICULITIS,1
LB,DIVERTICULUM,1
LB,DIVERTICULUM INTESTINAL,1
LB,DROP ATTACKS,1
LB,DRUG ADMINISTRATION ERROR,1
LB,DRUG LEVEL ABOVE THERAPEUTIC,1
LB,DRUG LEVEL DECREASED,1
LB,DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED,1
LB,DRUG SPECIFIC ANTIBODY PRESENT,1
LB,DRY EYE,1
LB,DYSAESTHESIA,1
LB,DYSENTERY,1
LB,DYSMENORRHOEA,1
LB,EAR HAEMORRHAGE,1
LB,EAR INFECTION FUNGAL,1
LB,EAR PRURITUS,1
LB,EATING DISORDER SYMPTOM,1
LB,ECG SIGNS OF MYOCARDIAL ISCHAEMIA,1
LB,ECTHYMA,1
LB,EJECTION FRACTION ABNORMAL,1
LB,ELECTROCARDIOGRAM DELTA WAVES ABNORMAL,1
LS,DRUG RESISTANCE,11
LS,ANAEMIA,9
LS,RESPIRATORY FAILURE,8
LS,DEATH,7
LS,VIRAL MUTATION IDENTIFIED,7
LS,VOMITING,7
LS,ELECTROCARDIOGRAM QT PROLONGED,5
LS,PYREXIA,5
LS,RESPIRATORY DISTRESS,5
LS,HYPOKALAEMIA,4
LS,WEIGHT DECREASED,4
LS,ACUTE KIDNEY INJURY,3
LS,CONDITION AGGRAVATED,3
LS,COUGH,3
LS,FAILURE TO THRIVE,3
LS,HAEMOGLOBIN DECREASED,3
LS,LARYNGITIS,3
LS,PULMONARY TUBERCULOSIS,3
LS,THROMBOCYTOPENIA,3
LS,TUBERCULOSIS,3
LS,ASTHENIA,2
LS,CD4 LYMPHOCYTES DECREASED,2
LS,DEEP VEIN THROMBOSIS,2
LS,HEPATIC ENZYME INCREASED,2
LS,HYPOVOLAEMIC SHOCK,2
LS,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
LS,PANCYTOPENIA,2
LS,PLATELET COUNT DECREASED,2
LS,PNEUMONIA,2
LS,PULMONARY EMBOLISM,2
LS,WHITE BLOOD CELL COUNT INCREASED,2
LS,AIDS RELATED COMPLICATION,1
LS,ARTHRALGIA,1
LS,ASCITES,1
LS,BACK PAIN,1
LS,BUNDLE BRANCH BLOCK LEFT,1
LS,BURNING SENSATION,1
LS,CARDIAC FAILURE CONGESTIVE,1
LS,CARDIO-RESPIRATORY ARREST,1
LS,COGNITIVE DISORDER,1
LS,DEAFNESS,1
LS,DERMATITIS ALLERGIC,1
LS,DISEASE PROGRESSION,1
LS,DRUG INEFFECTIVE,1
LS,DRUG-INDUCED LIVER INJURY,1
LS,DYSPNOEA,1
LS,GASTROENTERITIS,1
LS,GASTROINTESTINAL HAEMORRHAGE,1
LS,HALLUCINATION_ AUDITORY,1
LS,HEPATIC ENZYME ABNORMAL,1
LS,HEPATORENAL SYNDROME,1
LS,HEPATOTOXICITY,1
LS,HYPOTHYROIDISM,1
LS,INTENTIONAL PRODUCT USE ISSUE,1
LS,JAUNDICE,1
LS,LEFT VENTRICULAR FAILURE,1
LS,LIVER FUNCTION TEST INCREASED,1
LS,LOSS OF CONSCIOUSNESS,1
LS,LUNG DISORDER,1
LS,MENINGITIS TUBERCULOUS,1
LS,NEUROPATHY PERIPHERAL,1
LS,ODYNOPHAGIA,1
LS,OEDEMA,1
LS,OPPORTUNISTIC INFECTION,1
LS,PANCREATITIS ACUTE,1
LS,PELVIC INFLAMMATORY DISEASE,1
LS,PLEURAL EFFUSION,1
LS,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
LS,PRODUCTIVE COUGH,1
LS,PSYCHOTIC DISORDER,1
LS,PULMONARY OEDEMA,1
LS,RENAL FAILURE,1
LS,RESPIRATORY ARREST,1
LS,SEPSIS,1
LS,SUDDEN DEATH,1
LS,SUPRAVENTRICULAR TACHYCARDIA,1
LS,TUBERCULOMA OF CENTRAL NERVOUS SYSTEM,1
LS,TUMOUR HAEMORRHAGE,1
LR,DEATH,2
LY,PULMONARY HAEMORRHAGE,11
LY,DRUG INEFFECTIVE,7
LY,DEATH,3
LY,RESPIRATORY ACIDOSIS,3
LY,UPPER RESPIRATORY TRACT CONGESTION,3
LY,CHEST PAIN,2
LY,CHILLS,2
LY,COUGH,2
LY,DYSPNOEA,2
LY,HYPOTENSION,2
LY,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
LY,PAIN,2
LY,RASH,2
LY,ACUTE RESPIRATORY DISTRESS SYNDROME,1
LY,AMMONIA INCREASED,1
LY,ANAEMIA,1
LY,ANGIOEDEMA,1
LY,APHASIA,1
LY,ARTHROPATHY,1
LY,BREAST ATROPHY,1
LY,BREATH SOUNDS ABNORMAL,1
LY,CARDIOTOXICITY,1
LY,CONDITION AGGRAVATED,1
LY,CONTUSION,1
LY,CYANOSIS,1
LY,DECREASED APPETITE,1
LY,DEHYDRATION,1
LY,DEPENDENCE,1
LY,DIARRHOEA,1
LY,DIZZINESS,1
LY,DRUG ABUSE,1
LY,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
LY,DRUG INTOLERANCE,1
LY,ECCHYMOSIS,1
LY,ENERGY INCREASED,1
LY,ERYTHEMA,1
LY,EXPOSURE DURING PREGNANCY,1
LY,FEELING ABNORMAL,1
LY,FLUSHING,1
LY,GAIT DISTURBANCE,1
LY,HEADACHE,1
LY,HEART RATE INCREASED,1
LY,HYPERCAPNIA,1
LY,HYPOCALCAEMIA,1
LY,HYPONATRAEMIA,1
LY,INFECTION,1
LY,JUVENILE IDIOPATHIC ARTHRITIS,1
LY,LEUKOPENIA,1
LY,LIPIDS INCREASED,1
LY,LOCAL SWELLING,1
LY,LOW BIRTH WEIGHT BABY,1
LY,LOWER RESPIRATORY TRACT INFECTION,1
LY,LYMPHOPENIA,1
LY,MOOD SWINGS,1
LY,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
LY,NERVOUS SYSTEM DISORDER,1
LY,NIGHT SWEATS,1
LY,PAPILLARY THYROID CANCER,1
LY,PARAPLEGIA,1
LY,PLEURAL EFFUSION,1
LY,PNEUMONIA ASPIRATION,1
LY,PRODUCT USE ISSUE,1
LY,PROTEIN URINE PRESENT,1
LY,RESPIRATORY DISTRESS,1
LY,RESPIRATORY TRACT INFECTION,1
LY,SCHIZOPHRENIA,1
LY,SEPSIS,1
LY,SINUSITIS,1
LY,SUDDEN DEATH,1
LY,SWELLING,1
LY,TACHYCARDIA,1
LY,THROAT IRRITATION,1
LY,THROMBOCYTOPENIA,1
LY,TUBERCULOSIS,1
LY,UNDERDOSE,1
LY,UNEVALUABLE EVENT,1
LY,VAGINAL HAEMORRHAGE,1
LI,DIZZINESS,2
LI,PULMONARY EMBOLISM,2
LI,DEATH,1
LI,DRUG INEFFECTIVE,1
LI,DYSPNOEA,1
LI,FEELING HOT,1
LI,HEART RATE INCREASED,1
LI,HIP FRACTURE,1
LI,MULTIPLE SCLEROSIS,1
LI,PANCREATITIS,1
LI,PNEUMONIA,1
LI,VERTIGO,1
LT,SUICIDE ATTEMPT,51
LT,PYREXIA,39
LT,INTENTIONAL OVERDOSE,35
LT,DRUG INEFFECTIVE,33
LT,ASTHENIA,32
LT,DYSPNOEA,28
LT,NAUSEA,28
LT,DIZZINESS,20
LT,SOMNOLENCE,18
LT,FOETAL EXPOSURE DURING PREGNANCY,17
LT,VOMITING,17
LT,HYPOTENSION,16
LT,OVERDOSE,16
LT,MATERNAL EXPOSURE DURING PREGNANCY,15
LT,PNEUMONIA,15
LT,ANAPHYLACTIC REACTION,14
LT,HYPOCALCAEMIA,14
LT,THROMBOCYTOPENIA,14
LT,PREMATURE BABY,13
LT,ANAEMIA,12
LT,BLOOD PRESSURE DECREASED,12
LT,ERYTHEMA,12
LT,FATIGUE,12
LT,HEADACHE,12
LT,RASH,12
LT,DIARRHOEA,11
LT,TACHYCARDIA,11
LT,BONE PAIN,10
LT,COMA,10
LT,CONDITION AGGRAVATED,10
LT,DEATH,10
LT,HYPERSENSITIVITY,10
LT,PREMATURE DELIVERY,10
LT,PRURITUS,10
LT,VITAMIN D DEFICIENCY,10
LT,BRADYCARDIA,9
LT,DRUG RESISTANCE,9
LT,DRUG-INDUCED LIVER INJURY,9
LT,FEBRILE NEUTROPENIA,9
LT,ISCHAEMIC STROKE,9
LT,NEUTROPENIA,9
LT,ARTHRALGIA,8
LT,GAIT DISTURBANCE,8
LT,NEUROENDOCRINE CARCINOMA OF THE SKIN,8
LT,WEIGHT DECREASED,8
LT,ABDOMINAL PAIN,7
LT,ABDOMINAL PAIN UPPER,7
LT,ANXIETY,7
LT,ARRHYTHMIA,7
LT,CIRCULATORY COLLAPSE,7
LT,DIABETES MELLITUS,7
LT,DISORIENTATION,7
LT,EPILEPSY,7
LT,HAEMODYNAMIC INSTABILITY,7
LT,HYDRONEPHROSIS,7
LT,MALAISE,7
LT,PAIN IN EXTREMITY,7
LT,TOXICITY TO VARIOUS AGENTS,7
LT,URINARY TRACT OBSTRUCTION,7
LT,BLISTER,6
LT,CARDIAC ARREST,6
LT,CARDIAC FAILURE,6
LT,CARDIO-RESPIRATORY ARREST,6
LT,CEREBROVASCULAR ACCIDENT,6
LT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,6
LT,EPISTAXIS,6
LT,EXPOSURE DURING PREGNANCY,6
LT,HAEMOGLOBIN DECREASED,6
LT,HYPERTENSION,6
LT,HYPOTHYROIDISM,6
LT,INSOMNIA,6
LT,RASH MACULO-PAPULAR,6
LT,RENAL INJURY,6
LT,SEPSIS,6
LT,URINARY TRACT INFECTION,6
LT,ALANINE AMINOTRANSFERASE INCREASED,5
LT,ASPARTATE AMINOTRANSFERASE INCREASED,5
LT,BLOOD BILIRUBIN INCREASED,5
LT,BLOOD PRESSURE INCREASED,5
LT,CARDIAC FAILURE ACUTE,5
LT,CARDIOTOXICITY,5
LT,CHEST PAIN,5
LT,CONVULSION,5
LT,COUGH,5
LT,DECREASED APPETITE,5
LT,GENERAL PHYSICAL HEALTH DETERIORATION,5
LT,HEPATIC ENZYME INCREASED,5
LT,HYPOMAGNESAEMIA,5
LT,LEUKOCYTOSIS,5
LT,MYOCARDIAL INFARCTION,5
LT,OVARIAN CYST,5
LT,RESPIRATORY FAILURE,5
LT,SPEECH DISORDER,5
LT,TUBERCULOSIS,5
LT,VISUAL IMPAIRMENT,5
LT,AGITATION,4
LT,ANGIOEDEMA,4
LT,ARTHRITIS,4
LT,BLOOD ALKALINE PHOSPHATASE INCREASED,4
LT,BLOOD CREATININE INCREASED,4
LT,BODY TEMPERATURE INCREASED,4
LT,BRONCHOSPASM,4
LT,CARDIOVASCULAR INSUFFICIENCY,4
LT,CHEST DISCOMFORT,4
LT,DISEASE PROGRESSION,4
LT,ERYSIPELAS,4
LT,FEELING ABNORMAL,4
LT,HAEMORRHAGE,4
LT,HEART RATE INCREASED,4
LT,LYMPHADENOPATHY,4
LT,METASTASES TO CENTRAL NERVOUS SYSTEM,4
LT,MUSCULAR WEAKNESS,4
LT,MYALGIA,4
LT,PAIN,4
LT,PERIPHERAL SWELLING,4
LT,PLASMA CELL MYELOMA,4
LT,POISONING,4
LT,PRODUCT QUALITY ISSUE,4
LT,PULMONARY EMBOLISM,4
LT,PULMONARY OEDEMA,4
LT,RASH MACULAR,4
LT,RENAL IMPAIRMENT,4
LT,SEIZURE,4
LT,SEPTIC SHOCK,4
LT,SWELLING,4
LT,TREMOR,4
LT,URINARY RETENTION,4
LT,ACUTE RESPIRATORY FAILURE,3
LT,AGGRESSION,3
LT,ANGINA PECTORIS,3
LT,ANGINA UNSTABLE,3
LT,APATHY,3
LT,ATRIAL FIBRILLATION,3
LT,BLOOD LACTATE DEHYDROGENASE INCREASED,3
LT,BLOOD PRESSURE FLUCTUATION,3
LT,BRAIN OEDEMA,3
LT,BRONCHITIS,3
LT,C-REACTIVE PROTEIN INCREASED,3
LT,CHROMATURIA,3
LT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
LT,CONSTIPATION,3
LT,DRUG DISPENSING ERROR,3
LT,DYSPHAGIA,3
LT,DYSURIA,3
LT,ELECTROCARDIOGRAM QT PROLONGED,3
LT,EOSINOPHILIA,3
LT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
LT,HAEMOPTYSIS,3
LT,HYPOAESTHESIA,3
LT,INJECTION SITE EXTRAVASATION,3
LT,LIVER DISORDER,3
LT,LOSS OF CONSCIOUSNESS,3
LT,MALIGNANT NEOPLASM PROGRESSION,3
LT,MULTIPLE SCLEROSIS RELAPSE,3
LT,MUSCULOSKELETAL PAIN,3
LT,NORMAL NEWBORN,3
LT,OEDEMA PERIPHERAL,3
LT,PANCREATITIS,3
LT,PERICARDIAL EFFUSION,3
LT,PREMATURE LABOUR,3
LT,PRODUCTIVE COUGH,3
LT,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
LT,PSEUDOLYMPHOMA,3
LT,PULMONARY TUBERCULOSIS,3
LT,RENAL FAILURE,3
LT,RESPIRATORY DISORDER,3
LT,RHINORRHOEA,3
LT,SCHIZOPHRENIA,3
LT,SKIN DISCOLOURATION,3
LT,SKIN ULCER,3
LT,SUDDEN CARDIAC DEATH,3
LT,SUICIDAL IDEATION,3
LT,SYNCOPE,3
LT,THROMBOSIS,3
LT,TINNITUS,3
LT,TRANSIENT ISCHAEMIC ATTACK,3
LT,WHITE BLOOD CELL COUNT DECREASED,3
LT,WRONG DRUG ADMINISTERED,3
LT,YELLOW SKIN,3
LT,ABDOMINAL ABSCESS,2
LT,ABDOMINAL DISTENSION,2
LT,ABORTION SPONTANEOUS,2
LT,ACUTE MYOCARDIAL INFARCTION,2
LT,ADENOCARCINOMA OF COLON,2
LT,AMNESIA,2
LT,ANEURYSM,2
LT,ANGER,2
LT,ARTERIAL INJURY,2
LT,ASCITES,2
LT,ASPERGILLOMA,2
LT,ASPHYXIA,2
LT,ASTHMA,2
LT,BACK PAIN,2
LT,BENIGN OVARIAN TUMOUR,2
LT,BLINDNESS TRANSIENT,2
LT,BLOOD CALCIUM DECREASED,2
LT,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
LT,BLOOD URINE PRESENT,2
LT,BONE MARROW TOXICITY,2
LT,BREAST CANCER,2
LT,BREAST PAIN,2
LT,CAESAREAN SECTION,2
LT,CARDIAC DISORDER,2
LT,CATARACT,2
LT,CELLULITIS,2
LT,CEREBRAL HAEMORRHAGE,2
LT,CERVICAL SPINAL STENOSIS,2
LT,CHILLS,2
LT,CHOLECYSTITIS ACUTE,2
LT,CHRONIC KIDNEY DISEASE,2
LT,COLITIS,2
LT,COLON CANCER,2
LT,CORONARY ARTERY THROMBOSIS,2
LT,CROHN^S DISEASE,2
LT,CYANOSIS,2
LT,CYTOKINE RELEASE SYNDROME,2
LT,DEEP VEIN THROMBOSIS,2
LT,DEHYDRATION,2
LT,DEPRESSION,2
LT,DERMATITIS,2
LT,DEVICE RELATED INFECTION,2
LT,DIFFUSE LARGE B-CELL LYMPHOMA,2
LT,DRUG ABUSE,2
LT,DYSPEPSIA,2
LT,DYSPNOEA EXERTIONAL,2
LT,DYSTONIA,2
LT,EPSTEIN-BARR VIRUS TEST POSITIVE,2
LT,EYE SWELLING,2
LT,EYELID PTOSIS,2
LT,FACE OEDEMA,2
LT,FACIAL PARESIS,2
LT,FALL,2
LT,GASTRIC HAEMORRHAGE,2
LT,GASTRITIS EROSIVE,2
LT,GASTROENTERITIS,2
LT,GENERALISED OEDEMA,2
LT,GENITAL HAEMORRHAGE,2
LT,GINGIVAL BLEEDING,2
LT,GLAUCOMA,2
LT,GYNAECOMASTIA,2
LT,HAEMATOMA,2
LT,HEART RATE ABNORMAL,2
LT,HEART RATE DECREASED,2
LT,HEPATITIS ACUTE,2
LT,HEPATOTOXICITY,2
LT,HERPES VIRUS INFECTION,2
LT,HIDRADENITIS,2
LT,HIV INFECTION,2
LT,HYPERTHYROIDISM,2
LT,HYPOGLYCAEMIA,2
LT,INFECTION,2
LT,INJECTION SITE INDURATION,2
LT,INJECTION SITE NODULE,2
LT,IRRITABILITY,2
LT,KAPOSI^S SARCOMA,2
LT,LARYNGEAL OEDEMA,2
LT,LARYNGOSPASM,2
LT,LOW BIRTH WEIGHT BABY,2
LT,LYMPHOCYTE COUNT INCREASED,2
LT,METASTASES TO LUNG,2
LT,METASTASES TO PANCREAS,2
LT,METASTASIS,2
LT,METRORRHAGIA,2
LT,MOVEMENT DISORDER,2
LT,MUSCLE SPASMS,2
LT,NEUROPATHY PERIPHERAL,2
LT,OBSESSIVE THOUGHTS,2
LT,OEDEMA,2
LT,ORAL PAIN,2
LT,OSTEOMYELITIS,2
LT,PARAESTHESIA,2
LT,PHARYNGEAL OEDEMA,2
LT,PLEURAL EFFUSION,2
LT,PRESYNCOPE,2
LT,PRODUCT USE IN UNAPPROVED INDICATION,2
LT,PROTEIN URINE PRESENT,2
LT,RASH GENERALISED,2
LT,RENAL CYST,2
LT,RENAL VEIN THROMBOSIS,2
LT,RESPIRATORY RATE INCREASED,2
LT,RESTLESSNESS,2
LT,RETINAL HAEMORRHAGE,2
LT,RETROVIRAL REBOUND SYNDROME,2
LT,RHABDOMYOLYSIS,2
LT,SEXUAL DYSFUNCTION,2
LT,SKIN LESION,2
LT,SLUGGISHNESS,2
LT,STILLBIRTH,2
LT,STOMATITIS,2
LT,TENSION HEADACHE,2
LT,THINKING ABNORMAL,2
LT,THROMBOTIC MICROANGIOPATHY,2
LT,TRANSAMINASES INCREASED,2
LT,TRANSPLANT FAILURE,2
LT,TREATMENT NONCOMPLIANCE,2
LT,UTERINE HAEMORRHAGE,2
LT,UVEITIS,2
LT,WEIGHT INCREASED,2
LT,ABDOMINAL WALL CYST,1
LT,ABNORMAL BEHAVIOUR,1
LT,ABSCESS,1
LT,ABSCESS JAW,1
LT,ABSCESS LIMB,1
LT,ACCIDENTAL OVERDOSE,1
LT,ACNE,1
LT,ACUTE KIDNEY INJURY,1
LT,ACUTE LEUKAEMIA,1
LT,ACUTE PSYCHOSIS,1
LT,ACUTE RESPIRATORY DISTRESS SYNDROME,1
LT,ADACTYLY,1
LT,ADVERSE EVENT,1
LT,AGRANULOCYTOSIS,1
LT,ALCOHOLISM,1
LT,ALOPECIA,1
LT,AMENORRHOEA,1
LT,AMYOTROPHIC LATERAL SCLEROSIS,1
LT,ANAEMIA OF CHRONIC DISEASE,1
LT,ANAL ABSCESS,1
LT,ANAL FISTULA,1
LT,ANTI FACTOR VIII ANTIBODY POSITIVE,1
LT,AORTIC ANEURYSM RUPTURE,1
LT,AORTIC INTRAMURAL HAEMATOMA,1
LT,APLASTIC ANAEMIA,1
LT,ARTERIAL THROMBOSIS,1
LT,ARTHRITIS BACTERIAL,1
LT,ATRIOVENTRICULAR BLOCK,1
LT,ATTENTION-SEEKING BEHAVIOUR,1
LT,BALANCE DISORDER,1
LT,BENIGN NEOPLASM,1
LT,BLINDNESS,1
LT,BLOOD BICARBONATE DECREASED,1
LT,BLOOD CORTICOTROPHIN DECREASED,1
LT,BLOOD CREATININE DECREASED,1
LT,BLOOD GLUCOSE ABNORMAL,1
LT,BLOOD GLUCOSE FLUCTUATION,1
LT,BLOOD IRON DECREASED,1
LT,BLOOD LACTIC ACID INCREASED,1
LT,BLOOD PH DECREASED,1
LT,BLOOD PRESSURE SYSTOLIC INCREASED,1
LT,BLOOD SODIUM DECREASED,1
LT,BONE DENSITY DECREASED,1
LT,BONE LOSS,1
LT,BONE MARROW FAILURE,1
LT,BONE MARROW INFILTRATION,1
LT,BRAIN DEATH,1
LT,BRAIN OPERATION,1
LT,BREAST CANCER METASTATIC,1
LT,BRONCHOSPASM PARADOXICAL,1
LT,BRUGADA SYNDROME,1
LT,BURNING SENSATION,1
LT,BURSITIS,1
LT,CARDIAC FAILURE CONGESTIVE,1
LT,CARDIAC TAMPONADE,1
LT,CARDIAC VALVE REPLACEMENT COMPLICATION,1
LT,CARDIOGENIC SHOCK,1
LT,CARDIOMYOPATHY,1
LT,CARDIOVASCULAR DISORDER,1
LT,CEREBRAL ARTERY STENOSIS,1
LT,CEREBRAL CYST,1
LT,CEREBRAL ISCHAEMIA,1
LT,CERVIX CARCINOMA,1
LT,CHAPPED LIPS,1
LT,CHEST X-RAY ABNORMAL,1
LT,CHOKING,1
LT,CHOKING SENSATION,1
LT,CHOLANGITIS ACUTE,1
LT,CHROMATOPSIA,1
LT,CLOSTRIDIUM DIFFICILE COLITIS,1
LT,CLOSTRIDIUM DIFFICILE INFECTION,1
LT,COAGULOPATHY,1
LT,COLD SWEAT,1
LT,COLORECTAL CANCER,1
LT,COMMUNICATION DISORDER,1
LT,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
LT,CONCOMITANT DISEASE AGGRAVATED,1
LT,CONDUCTION DISORDER,1
LT,CONFUSIONAL STATE,1
LT,CONGENITAL CYTOMEGALOVIRUS INFECTION,1
LT,CONGENITAL JOINT MALFORMATION,1
LT,CONJUNCTIVITIS BACTERIAL,1
LT,CONTRAINDICATED PRODUCT ADMINISTERED,1
LT,CONTUSION,1
LT,COORDINATION ABNORMAL,1
LT,CORNEA VERTICILLATA,1
LT,CORONARY ARTERY ANEURYSM,1
LT,CORONARY ARTERY STENOSIS,1
LT,CRYING,1
LT,CUTANEOUS SYMPTOM,1
LT,CYST,1
LT,CYSTITIS,1
LT,CYSTITIS BACTERIAL,1
LT,DEAFNESS,1
LT,DEFORMITY,1
LT,DELUSION,1
LT,DEPENDENCE,1
LT,DEPOSIT EYE,1
LT,DEPRESSED LEVEL OF CONSCIOUSNESS,1
LT,DEPRESSED MOOD,1
LT,DERMATITIS ACNEIFORM,1
LT,DERMATITIS ALLERGIC,1
LT,DEVICE DEFECTIVE,1
LT,DEVICE DISLOCATION,1
LT,DEVICE ISSUE,1
LT,DIEULAFOY^S VASCULAR MALFORMATION,1
LT,DIPLOPIA,1
LT,DISCOMFORT,1
LT,DISEASE COMPLICATION,1
LT,DISTURBANCE IN ATTENTION,1
LT,DIVERTICULUM INTESTINAL,1
LT,DRUG ADMINISTRATION ERROR,1
LT,DRUG DEPENDENCE,1
LT,DRUG DOSE OMISSION,1
LT,DRUG EFFECT INCOMPLETE,1
LT,DRUG PROVOCATION TEST,1
LT,DRY MOUTH,1
LT,DYSARTHRIA,1
LT,DYSGEUSIA,1
LT,DYSLIPIDAEMIA,1
LT,DYSSTASIA,1
LT,ECZEMA HERPETICUM,1
LT,ELECTROCARDIOGRAM ABNORMAL,1
LT,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
LT,ELECTROLYTE IMBALANCE,1
LT,EMOTIONAL DISORDER,1
LT,ENDOMETRIOSIS,1
LT,ENTEROVIRUS INFECTION,1
LT,EPSTEIN-BARR VIRUS INFECTION,1
LT,ERECTILE DYSFUNCTION,1
LT,ERECTION INCREASED,1
LT,EROSIVE DUODENITIS,1
LT,ERYTHEMA MULTIFORME,1
LT,ESCHERICHIA SEPSIS,1
LT,EUPHORIC MOOD,1
LT,EXOSTOSIS,1
LT,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,1
LT,EXPIRED PRODUCT ADMINISTERED,1
LT,EXTRAPYRAMIDAL DISORDER,1
LT,EXTRASYSTOLES,1
LT,EYE ALLERGY,1
LT,EYE HAEMORRHAGE,1
LT,EYE PAIN,1
LT,FAECES DISCOLOURED,1
LT,FEAR,1
LT,FEELING COLD,1
LT,FEELING JITTERY,1
LT,FINGER DEFORMITY,1
LT,FISTULA DISCHARGE,1
LT,FLANK PAIN,1
LT,FLATULENCE,1
LT,FLUID RETENTION,1
LT,FLUSHING,1
LT,FOAMING AT MOUTH,1
LT,FOETAL DISTRESS SYNDROME,1
LT,FOETAL MONITORING ABNORMAL,1
LT,FRUSTRATION,1
LT,FUNGAL SEPSIS,1
LT,FUNGAL SKIN INFECTION,1
LT,GAIT INABILITY,1
LT,GASTRIC CANCER,1
LT,GASTRIC DISORDER,1
LT,GASTRIC ULCER HAEMORRHAGE,1
LT,GASTRITIS,1
LT,GASTROENTERITIS ROTAVIRUS,1
LT,GASTROINTESTINAL DISORDER,1
LT,GASTROINTESTINAL HAEMORRHAGE,1
LT,GASTROINTESTINAL PERFORATION,1
LT,GASTROINTESTINAL WALL THICKENING,1
LT,GASTROOESOPHAGEAL CANCER,1
LT,GENITOURINARY TRACT INFECTION,1
LT,GERM CELL CANCER,1
LT,GLAUCOMA SURGERY,1
LT,GLIOBLASTOMA,1
LT,GLOMERULONEPHRITIS,1
LT,GLOSSODYNIA,1
LT,GLUCOCORTICOID DEFICIENCY,1
LT,GRAFT VERSUS HOST DISEASE,1
LT,HAEMATOTOXICITY,1
LT,HAEMATURIA,1
LT,HAEMODIALYSIS,1
LT,HAEMOLYTIC URAEMIC SYNDROME,1
LT,HAEMORRHAGIC ANAEMIA,1
LT,HAEMORRHAGIC DISORDER,1
LT,HAEMORRHAGIC STROKE,1
LT,HALLUCINATION_ AUDITORY,1
LT,HEART DISEASE CONGENITAL,1
LT,HEMIPARESIS,1
LT,HEPATIC FAILURE,1
LT,HEPATIC FUNCTION ABNORMAL,1
LT,HEPATITIS B,1
LT,HEPATITIS TOXIC,1
LT,HEPATOSPLENOMEGALY,1
LT,HERNIA,1
LT,HERPES ZOSTER DISSEMINATED,1
LT,HERPES ZOSTER INFECTION NEUROLOGICAL,1
LT,HOLT-ORAM SYNDROME,1
LT,HOMICIDE,1
LT,HOSPITALISATION,1
LT,HUMAN HERPESVIRUS 8 INFECTION,1
LT,HYDROTHORAX,1
LT,HYPERAEMIA,1
LT,HYPERAESTHESIA,1
LT,HYPERCALCAEMIA,1
LT,HYPERHIDROSIS,1
LT,HYPERPARATHYROIDISM SECONDARY,1
LT,HYPERPYREXIA,1
LT,HYPERREFLEXIA,1
LT,HYPERSENSITIVITY VASCULITIS,1
LT,HYPERTENSIVE CRISIS,1
LT,HYPERTONIA,1
LT,HYPERTROPHY,1
LT,HYPOAESTHESIA ORAL,1
LT,HYPOCALCAEMIC SEIZURE,1
LT,HYPOKINESIA,1
LT,HYPONATRAEMIA,1
LT,HYPOPROTEINAEMIA,1
LT,HYPOTONIA,1
LT,IDIOPATHIC PULMONARY FIBROSIS,1
LT,ILL-DEFINED DISORDER,1
LT,IMMUNOSUPPRESSION,1
LT,IMPATIENCE,1
LT,INCOHERENT,1
LT,INCORRECT DOSE ADMINISTERED,1
LT,INFLAMMATION,1
LT,INFLAMMATORY MARKER INCREASED,1
LT,INFLUENZA,1
LT,INFREQUENT BOWEL MOVEMENTS,1
LT,INFUSION RELATED REACTION,1
LT,INJECTION SITE ERYTHEMA,1
LT,INJECTION SITE HAEMORRHAGE,1
LT,INJECTION SITE NECROSIS,1
LT,INJECTION SITE PRURITUS,1
LT,INJECTION SITE SWELLING,1
LT,INJURY,1
LT,INTENTIONAL PRODUCT MISUSE,1
LT,INTESTINAL OBSTRUCTION,1
LT,INTESTINAL STENOSIS,1
LT,INTESTINAL ULCER,1
LT,INTRACRANIAL VENOUS SINUS THROMBOSIS,1
LT,INTRAOCULAR PRESSURE INCREASED,1
LT,INTRAVENTRICULAR HAEMORRHAGE,1
LT,IRON DEFICIENCY ANAEMIA,1
LT,JAUNDICE,1
LT,JOINT SWELLING,1
LT,KERATOACANTHOMA,1
LT,LACTIC ACIDOSIS,1
LT,LARGE INTESTINE POLYP,1
LT,LATENT TUBERCULOSIS,1
LT,LEFT VENTRICULAR HYPERTROPHY,1
LT,LEIOMYOMA,1
LT,LEUKOPENIA,1
LT,LIBIDO DISORDER,1
LT,LICHEN PLANUS,1
LT,LIMB MASS,1
LT,LIP HAEMORRHAGE,1
LT,LISTERIA SEPSIS,1
LT,LIVE BIRTH,1
LT,LIVER INJURY,1
LT,LOCAL SWELLING,1
LT,LUMBAR VERTEBRAL FRACTURE,1
LT,LUNG ABSCESS,1
LT,LUNG ADENOCARCINOMA,1
LT,LUNG INFILTRATION,1
LT,LUNG NEOPLASM,1
LT,LUNG NEOPLASM MALIGNANT,1
LT,LUNG TRANSPLANT REJECTION,1
LT,LYMPHOCYTE COUNT DECREASED,1
LT,LYMPHOCYTIC LEUKAEMIA,1
LT,LYMPHOCYTOSIS,1
LT,LYMPHOMA,1
LT,LYMPHOPENIA,1
LT,MACULAR OEDEMA,1
LT,MALIGNANT MELANOMA,1
LT,MANIA,1
LT,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
LT,MEDICATION ERROR,1
LT,MELAENA,1
LT,MENSTRUATION IRREGULAR,1
LT,MENTAL DISORDER,1
LT,METASTASES TO KIDNEY,1
LT,METASTASES TO LIVER,1
LT,METASTASES TO SOFT TISSUE,1
LT,METASTASES TO THORAX,1
LT,METASTATIC LYMPHOMA,1
LT,METASTATIC MALIGNANT MELANOMA,1
LT,MICROEMBOLISM,1
LT,MICTURITION FREQUENCY DECREASED,1
LT,MONOCYTE COUNT DECREASED,1
LT,MOOD ALTERED,1
LT,MOOD SWINGS,1
LT,MOTOR NEURONE DISEASE,1
LT,MUCINOUS CYSTADENOCARCINOMA OVARY,1
LT,MUCOSAL INFLAMMATION,1
LT,MUCOUS STOOLS,1
LT,MULTI-ORGAN FAILURE,1
LT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
LT,MULTIPLE SCLEROSIS,1
LT,MYDRIASIS,1
LT,MYOCARDITIS,1
LT,NASOPHARYNGITIS,1
LT,NECK PAIN,1
LT,NEGATIVE THOUGHTS,1
LT,NEOPLASM,1
LT,NEOPLASM PROGRESSION,1
LT,NEPHRITIS,1
LT,NERVOUS SYSTEM DISORDER,1
LT,NEUROENDOCRINE CARCINOMA METASTATIC,1
LT,NEUROLEPTIC MALIGNANT SYNDROME,1
LT,NEUROLOGICAL DECOMPENSATION,1
LT,NEUTROPHIL COUNT DECREASED,1
LT,NIGHT SWEATS,1
LT,NO THERAPEUTIC RESPONSE,1
LT,OBLITERATIVE BRONCHIOLITIS,1
LT,OCULAR HYPERAEMIA,1
LT,ODYNOPHAGIA,1
LT,OESOPHAGEAL OBSTRUCTION,1
LT,OESOPHAGEAL PROSTHESIS INSERTION,1
LT,OLIGURIA,1
LT,ONYCHOMYCOSIS,1
LT,OPEN ANGLE GLAUCOMA,1
LT,OPHTHALMIC HERPES ZOSTER,1
LT,OPTIC DISC HAEMORRHAGE,1
LT,OPTIC DISC VASCULAR DISORDER,1
LT,OPTIC DISCS BLURRED,1
LT,OPTIC ISCHAEMIC NEUROPATHY,1
LT,OROPHARYNGEAL PAIN,1
LT,ORTHOPNOEA,1
LT,ORTHOSTATIC INTOLERANCE,1
LT,OSTEOARTHRITIS,1
LT,OSTEOMYELITIS CHRONIC,1
LT,OSTEONECROSIS,1
LT,OSTEONECROSIS OF JAW,1
LT,PALLOR,1
LT,PANCREATIC CARCINOMA METASTATIC,1
LT,PANCREATITIS CHRONIC,1
LT,PANCREATOLITHIASIS,1
LT,PANCYTOPENIA,1
LT,PANIC ATTACK,1
LT,PAPILLOEDEMA,1
LT,PARANEOPLASTIC SYNDROME,1
LT,PARKINSON^S DISEASE,1
LT,PARTIAL SEIZURES,1
LT,PATENT DUCTUS ARTERIOSUS,1
LT,PCO2 DECREASED,1
LT,PELVIC FLUID COLLECTION,1
LT,PELVIC PAIN,1
LT,PELVIC VENOUS THROMBOSIS,1
LT,PEPTIC ULCER PERFORATION,1
LT,PERICARDIAL HAEMORRHAGE,1
LT,PERITONITIS,1
LT,PERITONSILLAR ABSCESS,1
LT,PERSONALITY DISORDER,1
LT,PITUITARY HAEMORRHAGE,1
LT,PLASMA CELL MYELOMA RECURRENT,1
LT,PLATELET COUNT DECREASED,1
LT,PLEOMORPHIC ADENOMA,1
LT,POLLAKIURIA,1
LT,POLYARTHRITIS,1
LT,POLYCYTHAEMIA VERA,1
LT,POLYHYDRAMNIOS,1
LT,PREMATURE RUPTURE OF MEMBRANES,1
LT,PROCALCITONIN DECREASED,1
LT,PROCTITIS,1
LT,PROCTITIS INFECTIOUS,1
LT,PRODUCT CONTAMINATION MICROBIAL,1
LT,PRODUCT SOLUBILITY ABNORMAL,1
LT,PRODUCT SUBSTITUTION ISSUE,1
LT,PRODUCT USE ISSUE,1
LT,PSORIASIS,1
LT,PSYCHOMOTOR HYPERACTIVITY,1
LT,PULMONARY TOXICITY,1
LT,PURULENT DISCHARGE,1
LT,PYELONEPHRITIS,1
LT,RADIATION INJURY,1
LT,RASH ERYTHEMATOUS,1
LT,RASH PAPULAR,1
LT,RASH PUSTULAR,1
LT,RECTAL TENESMUS,1
LT,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
LT,RENAL ABSCESS,1
LT,RESPIRATORY ARREST,1
LT,RESPIRATORY DISTRESS,1
LT,RESPIRATORY TRACT INFECTION,1
LT,RETINAL EXUDATES,1
LT,RETINAL VEIN THROMBOSIS,1
LT,REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME,1
LT,RHABDOMYOMA,1
LT,SALIVARY HYPERSECRETION,1
LT,SCHIZOAFFECTIVE DISORDER,1
LT,SCLERODERMA,1
LT,SECONDARY HYPERTENSION,1
LT,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,1
LT,SECRETION DISCHARGE,1
LT,SEDATION,1
LT,SENILE DEMENTIA,1
LT,SEROTONIN SYNDROME,1
LT,SERUM SICKNESS,1
LT,SINUS BRADYCARDIA,1
LT,SINUS TACHYCARDIA,1
LT,SKIN BURNING SENSATION,1
LT,SKIN INFECTION,1
LT,SKIN IRRITATION,1
LT,SKIN MASS,1
LT,SNEEZING,1
LT,SPINAL PAIN,1
LT,SPONTANEOUS PENILE ERECTION,1
LT,SQUAMOUS CELL CARCINOMA OF SKIN,1
LT,STAPHYLOCOCCAL INFECTION,1
LT,STAPHYLOCOCCUS TEST,1
LT,STATUS EPILEPTICUS,1
LT,STOMA SITE ERYTHEMA,1
LT,STOMA SITE OEDEMA,1
LT,STOMA SITE PAIN,1
LT,STRESS,1
LT,STUPOR,1
LT,SUBCUTANEOUS ABSCESS,1
LT,SUDDEN VISUAL LOSS,1
LT,SUPRAVENTRICULAR EXTRASYSTOLES,1
LT,SUPRAVENTRICULAR TACHYCARDIA,1
LT,SURGERY,1
LT,SUSPICIOUSNESS,1
LT,SWELLING FACE,1
LT,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
LT,SYSTEMIC LUPUS ERYTHEMATOSUS,1
LT,TACHYPNOEA,1
LT,TENSION,1
LT,TESTICULAR GERM CELL CANCER METASTATIC,1
LT,TESTICULAR HYPERTROPHY,1
LT,TESTIS CANCER,1
LT,THERAPEUTIC RESPONSE DECREASED,1
LT,THERAPY NON-RESPONDER,1
LT,THIRST,1
LT,THIRST DECREASED,1
LT,THROAT IRRITATION,1
LT,THYROID DISORDER,1
LT,THYROID NEOPLASM,1
LT,TONSILLITIS,1
LT,TOOTH INFECTION,1
LT,TRAUMATIC FRACTURE,1
LT,TRISOMY 18,1
LT,TROPONIN INCREASED,1
LT,TUBULOINTERSTITIAL NEPHRITIS,1
LT,TUMOUR EXCISION,1
LT,UNDERDOSE,1
LT,UNEVALUABLE EVENT,1
LT,UNRESPONSIVE TO STIMULI,1
LT,UPPER LIMB FRACTURE,1
LT,UPPER RESPIRATORY TRACT INFECTION,1
LT,URINARY HESITATION,1
LT,URINE FLOW DECREASED,1
LT,URINE KETONE BODY PRESENT,1
LT,URINE OUTPUT DECREASED,1
LT,UROSEPSIS,1
LT,URTICARIA,1
LT,UTERINE LEIOMYOMA,1
LT,VASOSPASM,1
LT,VENOUS THROMBOSIS,1
LT,VENTRICULAR EXTRASYSTOLES,1
LT,VENTRICULAR HYPOKINESIA,1
LT,VENTRICULAR SEPTAL DEFECT,1
LT,VENTRICULAR TACHYCARDIA,1
LT,VESTIBULAR ATAXIA,1
LT,VIRAL INFECTION,1
LT,VIROLOGIC FAILURE,1
LT,VISION BLURRED,1
LT,VISUAL PATHWAY DISORDER,1
LT,VITAMIN D DECREASED,1
LT,WHEEZING,1
LT,WHITE BLOOD CELL COUNT INCREASED,1
LT,WHITE BLOOD CELLS URINE,1
LT,WRIST DEFORMITY,1
LT,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
LU,DEATH,11
LU,DYSPNOEA,11
LU,PNEUMONIA,11
LU,CEREBRAL HAEMORRHAGE,10
LU,OSTEONECROSIS OF JAW,10
LU,ANAPHYLACTIC REACTION,9
LU,FALL,9
LU,FATIGUE,9
LU,ASTHENIA,8
LU,GENERAL PHYSICAL HEALTH DETERIORATION,8
LU,NAUSEA,8
LU,CEREBROVASCULAR ACCIDENT,7
LU,COMA,7
LU,DIARRHOEA,7
LU,DYSBACTERIOSIS,7
LU,ABDOMINAL PAIN,6
LU,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,6
LU,COUGH,6
LU,DEPRESSION,6
LU,ERYTHEMA,6
LU,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,6
LU,PRURITUS,6
LU,PULMONARY EMBOLISM,6
LU,RENAL FAILURE,6
LU,DEHYDRATION,5
LU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,5
LU,HEPATOCELLULAR INJURY,5
LU,HYPOTENSION,5
LU,MALAISE,5
LU,PYREXIA,5
LU,RENAL IMPAIRMENT,5
LU,VERTIGO,5
LU,ABORTION SPONTANEOUS,4
LU,ANAPHYLACTIC SHOCK,4
LU,ANXIETY,4
LU,BLOOD LACTATE DEHYDROGENASE INCREASED,4
LU,DECREASED APPETITE,4
LU,DYSPHAGIA,4
LU,HEADACHE,4
LU,HEPATOTOXICITY,4
LU,LUNG DISORDER,4
LU,NEUTROPENIA,4
LU,OEDEMA PERIPHERAL,4
LU,PARAESTHESIA,4
LU,RHABDOMYOLYSIS,4
LU,SPINAL COMPRESSION FRACTURE,4
LU,SYNCOPE,4
LU,THROMBOSIS,4
LU,TOOTH DISORDER,4
LU,VOMITING,4
LU,WEIGHT DECREASED,4
LU,WHITE BLOOD CELL COUNT DECREASED,4
LU,ABASIA,3
LU,ABNORMAL BEHAVIOUR,3
LU,ACUTE KIDNEY INJURY,3
LU,ALANINE AMINOTRANSFERASE INCREASED,3
LU,AORTIC THROMBOSIS,3
LU,ASPARTATE AMINOTRANSFERASE INCREASED,3
LU,BRADYCARDIA,3
LU,CARDIAC FAILURE,3
LU,CHEST PAIN,3
LU,CHOLESTASIS,3
LU,DEEP VEIN THROMBOSIS,3
LU,DIVERTICULITIS,3
LU,DRUG DEPENDENCE,3
LU,DRUG DOSE OMISSION,3
LU,DRUG INEFFECTIVE,3
LU,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,3
LU,HYPERKALAEMIA,3
LU,HYPERNATRAEMIA,3
LU,HYPERTENSIVE CRISIS,3
LU,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,3
LU,INFECTION,3
LU,INJECTION SITE PAIN,3
LU,MANIA,3
LU,MUSCULAR WEAKNESS,3
LU,MYOCARDIAL INFARCTION,3
LU,PANCREATITIS,3
LU,PARAPLEGIA,3
LU,PLATELET COUNT DECREASED,3
LU,PRODUCT USE ISSUE,3
LU,RASH,3
LU,RENAL TRANSPLANT FAILURE,3
LU,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,3
LU,URTICARIA,3
LU,AFFECT LABILITY,2
LU,ALTERED STATE OF CONSCIOUSNESS,2
LU,ANAEMIA,2
LU,APHASIA,2
LU,ARRHYTHMIA,2
LU,ARTERITIS,2
LU,ATRIAL FIBRILLATION,2
LU,BACK PAIN,2
LU,BLOOD CREATININE INCREASED,2
LU,BORRELIA INFECTION,2
LU,BRONCHOPNEUMOPATHY,2
LU,C-REACTIVE PROTEIN INCREASED,2
LU,CARDIAC DISORDER,2
LU,CHEST DISCOMFORT,2
LU,CIRCULATORY COLLAPSE,2
LU,COGNITIVE DISORDER,2
LU,COMPLEX PARTIAL SEIZURES,2
LU,CROHN^S DISEASE,2
LU,DERMATITIS BULLOUS,2
LU,DISEASE PROGRESSION,2
LU,DISTURBANCE IN ATTENTION,2
LU,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
LU,DRUG-INDUCED LIVER INJURY,2
LU,DYSKINESIA,2
LU,ENCEPHALOPATHY,2
LU,ENTERAL NUTRITION,2
LU,EOSINOPHILIA,2
LU,EPILEPSY,2
LU,EYELID OEDEMA,2
LU,FEELING ABNORMAL,2
LU,FOETAL EXPOSURE DURING PREGNANCY,2
LU,HAEMANGIOMA OF LIVER,2
LU,HAEMOGLOBIN DECREASED,2
LU,HAEMORRHAGE,2
LU,HAEMORRHAGE INTRACRANIAL,2
LU,HEPATIC ENZYME INCREASED,2
LU,HEPATIC FAILURE,2
LU,HEPATIC FUNCTION ABNORMAL,2
LU,HERPES ZOSTER,2
LU,HYPERHIDROSIS,2
LU,HYPERTENSION,2
LU,HYPOAESTHESIA,2
LU,HYPONATRAEMIA,2
LU,HYPOPHAGIA,2
LU,HYPOXIA,2
LU,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
LU,INFARCTION,2
LU,INFECTIVE UVEITIS,2
LU,INFLAMMATION,2
LU,LEUKAEMIA,2
LU,LICHEN PLANUS,2
LU,LOSS OF CONSCIOUSNESS,2
LU,LYME DISEASE,2
LU,METASTASES TO BONE,2
LU,MOBILITY DECREASED,2
LU,MUCOSAL INFLAMMATION,2
LU,MYALGIA,2
LU,NEOPLASM MALIGNANT,2
LU,NEPHROTIC SYNDROME,2
LU,OSTEONECROSIS,2
LU,OVERDOSE,2
LU,PAIN,2
LU,PAIN IN EXTREMITY,2
LU,PARALYSIS,2
LU,PNEUMONIA BACTERIAL,2
LU,POSTPARTUM HAEMORRHAGE,2
LU,PROSTATE CANCER,2
LU,PSYCHOTIC DISORDER,2
LU,PULMONARY VALVE STENOSIS,2
LU,RASH ERYTHEMATOUS,2
LU,RESPIRATORY DISORDER,2
LU,SARCOIDOSIS,2
LU,SEPSIS,2
LU,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,2
LU,TOXIC SKIN ERUPTION,2
LU,TRANSIENT ISCHAEMIC ATTACK,2
LU,URINARY TRACT INFECTION,2
LU,VENTRICULAR SEPTAL DEFECT,2
LU,VISION BLURRED,2
LU,WEIGHT INCREASED,2
LU,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
LU,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
LU,ACUTE MYELOID LEUKAEMIA,1
LU,ADENOCARCINOMA,1
LU,AFFECTIVE DISORDER,1
LU,AGGRESSION,1
LU,AMNESIA,1
LU,ANAPHYLACTOID REACTION,1
LU,ANGIOEDEMA,1
LU,ANTIPHOSPHOLIPID SYNDROME,1
LU,AORTIC ANEURYSM,1
LU,APATHY,1
LU,APLASIA,1
LU,APRAXIA,1
LU,ARTERIAL OCCLUSIVE DISEASE,1
LU,ARTERIAL STENOSIS,1
LU,ARTERIOSCLEROSIS,1
LU,ARTERIOVENOUS SHUNT OPERATION,1
LU,ARTHRALGIA,1
LU,ARTHRITIS,1
LU,ARTHROPOD BITE,1
LU,ASCITES,1
LU,ASTHMA,1
LU,B-LYMPHOCYTE COUNT DECREASED,1
LU,BACTERIAL SEPSIS,1
LU,BALANCE DISORDER,1
LU,BETA 2 MICROGLOBULIN INCREASED,1
LU,BETA-2 GLYCOPROTEIN ANTIBODY POSITIVE,1
LU,BLEPHAROSPASM,1
LU,BLINDNESS,1
LU,BLOOD ALKALINE PHOSPHATASE INCREASED,1
LU,BLOOD BILIRUBIN INCREASED,1
LU,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
LU,BLOOD GLUCOSE INCREASED,1
LU,BLOOD POTASSIUM DECREASED,1
LU,BLOOD PRESSURE DECREASED,1
LU,BONE PAIN,1
LU,BRAIN INJURY,1
LU,BREAST CANCER,1
LU,BREAST NEOPLASM,1
LU,BREAST OPERATION,1
LU,BRONCHIAL DISORDER,1
LU,BRONCHITIS,1
LU,BRONCHITIS CHRONIC,1
LU,BRONCHOSPASM,1
LU,BURNING SENSATION,1
LU,CARCINOEMBRYONIC ANTIGEN INCREASED,1
LU,CARCINOID TUMOUR PULMONARY,1
LU,CARDIAC FAILURE CONGESTIVE,1
LU,CARDIAC PERFORATION,1
LU,CARDIAC PROCEDURE COMPLICATION,1
LU,CARDIO-RESPIRATORY ARREST,1
LU,CAROTID ARTERY THROMBOSIS,1
LU,CELL DEATH,1
LU,CEREBRAL HAEMATOMA,1
LU,CERVICAL DYSPLASIA,1
LU,CHEMOTHERAPY,1
LU,CHILLS,1
LU,CHOLECYSTITIS,1
LU,CIRRHOSIS ALCOHOLIC,1
LU,COAGULOPATHY,1
LU,COLONIC ABSCESS,1
LU,COLORECTAL CANCER,1
LU,COLORECTAL CANCER METASTATIC,1
LU,COMMUNICATION DISORDER,1
LU,COMPLETED SUICIDE,1
LU,COMPLICATION ASSOCIATED WITH DEVICE,1
LU,CONFUSIONAL STATE,1
LU,CONSCIOUSNESS FLUCTUATING,1
LU,CONTUSION,1
LU,CORNEAL DEPOSITS,1
LU,CORNEAL DISORDER,1
LU,CORNEAL OPACITY,1
LU,CREATININE RENAL CLEARANCE DECREASED,1
LU,CREPITATIONS,1
LU,CYANOSIS,1
LU,CYTOMEGALOVIRUS TEST POSITIVE,1
LU,DAYDREAMING,1
LU,DEMENTIA,1
LU,DEMYELINATING POLYNEUROPATHY,1
LU,DEPERSONALISATION/DEREALISATION DISORDER,1
LU,DEPRESSED LEVEL OF CONSCIOUSNESS,1
LU,DERMATITIS EXFOLIATIVE,1
LU,DETACHMENT OF RETINAL PIGMENT EPITHELIUM,1
LU,DEVICE USE ERROR,1
LU,DEVICE USE ISSUE,1
LU,DIABETES MELLITUS,1
LU,DIABETIC FOOT,1
LU,DIARRHOEA HAEMORRHAGIC,1
LU,DIPLOPIA,1
LU,DOPAMINE DYSREGULATION SYNDROME,1
LU,DRUG ADMINISTRATION ERROR,1
LU,DRUG HYPERSENSITIVITY,1
LU,DRUG INTOLERANCE,1
LU,DYSPNOEA EXERTIONAL,1
LU,DYSSTASIA,1
LU,EAR INFECTION,1
LU,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
LU,EMBEDDED DEVICE,1
LU,EMBOLISM,1
LU,ENCEPHALITIS,1
LU,ENDOMETRIAL CANCER,1
LU,ENDOTHELIAL DYSFUNCTION,1
LU,ENTEROCUTANEOUS FISTULA,1
LU,EOSINOPHIL COUNT DECREASED,1
LU,ERYTHEMA MIGRANS,1
LU,ERYTHEMA MULTIFORME,1
LU,ESCHERICHIA INFECTION,1
LU,EXPOSURE DURING PREGNANCY,1
LU,EXPOSURE VIA FATHER,1
LU,EYE DISORDER,1
LU,FACIAL PARALYSIS,1
LU,FEAR,1
LU,FEMORAL NECK FRACTURE,1
LU,FOOD POISONING,1
LU,FUNGAL INFECTION,1
LU,GASTRIC DISORDER,1
LU,GASTRIC HAEMORRHAGE,1
LU,GASTRITIS VIRAL,1
LU,GASTROINTESTINAL HAEMORRHAGE,1
LU,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
LU,GOUT,1
LU,GRAFT VERSUS HOST DISEASE IN SKIN,1
LU,GRANULOMA,1
LU,GUILLAIN-BARRE SYNDROME,1
LU,HAEMATEMESIS,1
LU,HAEMATOCHEZIA,1
LU,HAEMATOMA,1
LU,HAEMATURIA,1
LU,HAEMOLYTIC URAEMIC SYNDROME,1
LU,HALLUCINATION_ VISUAL,1
LU,HEART RATE INCREASED,1
LU,HEART VALVE INCOMPETENCE,1
LU,HEMIPLEGIA,1
LU,HENOCH-SCHONLEIN PURPURA,1
LU,HEPATIC NECROSIS,1
LU,HEPATITIS ACUTE,1
LU,HEPATITIS FULMINANT,1
LU,HEPATOCELLULAR CARCINOMA,1
LU,HEPATOMEGALY,1
LU,HEREDITARY ANGIOEDEMA,1
LU,HERPES SIMPLEX SEROLOGY POSITIVE,1
LU,HIP FRACTURE,1
LU,HOMICIDAL IDEATION,1
LU,HOT FLUSH,1
LU,HUMORAL IMMUNE DEFECT,1
LU,HYPERAESTHESIA,1
LU,HYPERCOAGULATION,1
LU,HYPERGLYCAEMIA,1
LU,HYPERSENSITIVITY,1
LU,HYPERSENSITIVITY VASCULITIS,1
LU,HYPOGAMMAGLOBULINAEMIA,1
LU,HYPOTHERMIA,1
LU,HYPOTHYROIDISM,1
LU,HYPOVOLAEMIA,1
LU,ILL-DEFINED DISORDER,1
LU,IMMOBILE,1
LU,IMMUNODEFICIENCY,1
LU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
LU,INFERTILITY FEMALE,1
LU,INJECTION SITE NODULE,1
LU,INSOMNIA,1
LU,INTENTIONAL PRODUCT MISUSE,1
LU,INTENTIONAL PRODUCT USE ISSUE,1
LU,INTERNAL HAEMORRHAGE,1
LU,INTERSTITIAL LUNG DISEASE,1
LU,INTERVERTEBRAL DISC PROTRUSION,1
LU,INTESTINAL PERFORATION,1
LU,INTRACRANIAL HAEMATOMA,1
LU,INTRAOCULAR PRESSURE INCREASED,1
LU,ISCHAEMIC STROKE,1
LU,JAW DISORDER,1
LU,JOINT SWELLING,1
LU,KETOACIDOSIS,1
LU,KETOSIS,1
LU,LACUNAR INFARCTION,1
LU,LARGE INTESTINAL HAEMORRHAGE,1
LU,LARGE INTESTINE POLYP,1
LU,LATENT TUBERCULOSIS,1
LU,LENTICULAR OPACITIES,1
LU,LEUKOPENIA,1
LU,LIPASE INCREASED,1
LU,LIVER FUNCTION TEST ABNORMAL,1
LU,LIVER INJURY,1
LU,LOSS OF LIBIDO,1
LU,LOW DENSITY LIPOPROTEIN INCREASED,1
LU,LOWER LIMB FRACTURE,1
LU,LUNG INFECTION,1
LU,LUNG INFILTRATION,1
LU,LUNG NEOPLASM,1
LU,LYMPHADENOPATHY,1
LU,LYMPHOCYTE COUNT DECREASED,1
LU,LYMPHOPENIA,1
LU,MACULAR DETACHMENT,1
LU,MACULAR OEDEMA,1
LU,MACULOPATHY,1
LU,MALIGNANT NEOPLASM OF PLEURA,1
LU,MASTOIDITIS,1
LU,MEAN CELL VOLUME INCREASED,1
LU,MELAENA,1
LU,MESENTERIC VEIN THROMBOSIS,1
LU,METASTASES TO CENTRAL NERVOUS SYSTEM,1
LU,METASTASES TO LUNG,1
LU,METASTASES TO SPINE,1
LU,MIGRAINE,1
LU,MIGRAINE WITH AURA,1
LU,MONOCYTE COUNT DECREASED,1
LU,MONOPARESIS,1
LU,MOOD SWINGS,1
LU,MUCOUS MEMBRANE DISORDER,1
LU,MULTIPLE SCLEROSIS,1
LU,MULTIPLE SCLEROSIS RELAPSE,1
LU,MULTIPLE-DRUG RESISTANCE,1
LU,MUSCLE RIGIDITY,1
LU,MUSCLE SPASMS,1
LU,MUSCULOSKELETAL PAIN,1
LU,MYELITIS TRANSVERSE,1
LU,MYOCARDITIS,1
LU,NASAL CAVITY CANCER,1
LU,NEOPLASM,1
LU,NEOPLASM PROGRESSION,1
LU,NERVOUS SYSTEM DISORDER,1
LU,NERVOUSNESS,1
LU,NEUROBORRELIOSIS,1
LU,NEURODEGENERATIVE DISORDER,1
LU,NEUROPATHY PERIPHERAL,1
LU,NEUTROPENIC SEPSIS,1
LU,NO ADVERSE EVENT,1
LU,NODULE,1
LU,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
LU,NOSOCOMIAL INFECTION,1
LU,NOSOPHOBIA,1
LU,NYSTAGMUS,1
LU,OBSTRUCTION,1
LU,OCULAR ICTERUS,1
LU,OEDEMA,1
LU,ORAL HERPES,1
LU,ORTHOSTATIC INTOLERANCE,1
LU,OTITIS MEDIA,1
LU,PALLOR,1
LU,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
LU,PANCREATIC CARCINOMA,1
LU,PANCREATITIS ACUTE,1
LU,PANCYTOPENIA,1
LU,PANIC ATTACK,1
LU,PARANASAL SINUS MUCOSAL HYPERTROPHY,1
LU,PARASPINAL ABSCESS,1
LU,PEMPHIGOID,1
LU,PERIORBITAL OEDEMA,1
LU,PERIPHERAL SWELLING,1
LU,PERSECUTORY DELUSION,1
LU,PHARYNGITIS,1
LU,PHOTOPSIA,1
LU,PITUITARY TUMOUR BENIGN,1
LU,PLASMA CELL MYELOMA,1
LU,PLATELET COUNT ABNORMAL,1
LU,PLEURAL EFFUSION,1
LU,PNEUMONITIS,1
LU,PNEUMOTHORAX,1
LU,POOR PERSONAL HYGIENE,1
LU,PORTAL VEIN THROMBOSIS,1
LU,PREGNANCY,1
LU,PREMATURE BABY,1
LU,PREMATURE DELIVERY,1
LU,PRESCRIBED UNDERDOSE,1
LU,PRESYNCOPE,1
LU,PROSTATIC OBSTRUCTION,1
LU,PROSTATITIS,1
LU,PRURIGO,1
LU,PULMONARY CONGESTION,1
LU,PULMONARY MASS,1
LU,PULMONARY TUBERCULOSIS,1
LU,PULMONARY VALVE INCOMPETENCE,1
LU,RADICULOPATHY,1
LU,RADIOTHERAPY,1
LU,RASH PUSTULAR,1
LU,RENAL FAILURE ACUTE,1
LU,RENAL VEIN COMPRESSION,1
LU,RESPIRATORY ARREST,1
LU,RESPIRATORY DEPRESSION,1
LU,RETINAL DETACHMENT,1
LU,RHEUMATOID ARTHRITIS,1
LU,SERUM FERRITIN DECREASED,1
LU,SERUM FERRITIN INCREASED,1
LU,SHOCK,1
LU,SINUS ARREST,1
LU,SINUS DISORDER,1
LU,SKIN DISCOLOURATION,1
LU,SKIN EXFOLIATION,1
LU,SKIN LESION,1
LU,SMALL INTESTINAL OBSTRUCTION,1
LU,SOMNOLENCE,1
LU,SPEECH DISORDER,1
LU,SPINAL CORD COMPRESSION,1
LU,SPINAL FRACTURE,1
LU,SPLENIC INFARCTION,1
LU,STEVENS-JOHNSON SYNDROME,1
LU,STOMA SITE ERYTHEMA,1
LU,STOMA SITE IRRITATION,1
LU,STRESS,1
LU,SUBCUTANEOUS HAEMATOMA,1
LU,SUBMANDIBULAR MASS,1
LU,SUICIDAL IDEATION,1
LU,SWELLING,1
LU,TACHYCARDIA,1
LU,TESTICULAR PAIN,1
LU,THIRST,1
LU,THROAT IRRITATION,1
LU,THROMBOCYTOPENIA,1
LU,THYMECTOMY,1
LU,THYROID HAEMORRHAGE,1
LU,THYROID MASS,1
LU,THYROXINE FREE DECREASED,1
LU,TOBACCO USER,1
LU,TOXIC EPIDERMAL NECROLYSIS,1
LU,TOXOPLASMA SEROLOGY POSITIVE,1
LU,TRANSAMINASES INCREASED,1
LU,TREMOR,1
LU,TRIGEMINAL NEURALGIA,1
LU,TUBERCULOSIS,1
LU,UPPER RESPIRATORY TRACT INFECTION,1
LU,URETHRITIS,1
LU,URINARY RETENTION,1
LU,URINE ABNORMALITY,1
LU,UTERINE CANCER,1
LU,UTERINE HAEMATOMA,1
LU,VARICELLA VIRUS TEST POSITIVE,1
LU,VASCULAR CALCIFICATION,1
LU,VASCULAR STENT THROMBOSIS,1
LU,VASCULITIS,1
LU,VEIN DISORDER,1
LU,VIOLENCE-RELATED SYMPTOM,1
LU,VIRAL INFECTION,1
LU,VISUAL FIELD DEFECT,1
LU,VITH NERVE PARALYSIS,1
LU,WHEEZING,1
MO,DEATH,4
MO,ANAEMIA,2
MO,ANTIBODY TEST ABNORMAL,2
MO,APLASIA PURE RED CELL,2
MO,COMPLETED SUICIDE,2
MO,HEPATITIS B E ANTIBODY POSITIVE,2
MO,LIVER FUNCTION TEST ABNORMAL,2
MO,ACUTE RESPIRATORY FAILURE,1
MO,ADENOVIRUS INFECTION,1
MO,ANAPHYLACTIC SHOCK,1
MO,ANGIOEDEMA,1
MO,ATRIOVENTRICULAR BLOCK,1
MO,ATYPICAL FEMUR FRACTURE,1
MO,BIPOLAR DISORDER,1
MO,BLINDNESS,1
MO,BONE MARROW FAILURE,1
MO,BRADYCARDIA,1
MO,CARDIAC FAILURE,1
MO,CEREBROVASCULAR ACCIDENT,1
MO,DELIRIUM,1
MO,DIARRHOEA,1
MO,DISEASE PROGRESSION,1
MO,ENCEPHALOPATHY,1
MO,HAEMORRHAGIC ASCITES,1
MO,HAEMORRHOIDAL HAEMORRHAGE,1
MO,HEADACHE,1
MO,HEPATIC FAILURE,1
MO,LICHENOID KERATOSIS,1
MO,LOSS OF CONSCIOUSNESS,1
MO,LYMPHOMA,1
MO,NAUSEA,1
MO,NEPHRITIS,1
MO,PERICARDIAL EFFUSION,1
MO,PLASMA CELL MYELOMA,1
MO,PULMONARY OEDEMA,1
MO,PYREXIA,1
MO,REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA,1
MO,RETINAL DETACHMENT,1
MO,SEBORRHOEIC KERATOSIS,1
MO,STOMATITIS,1
MO,TONGUE PARALYSIS,1
MO,TOXICITY TO VARIOUS AGENTS,1
MO,TRANSFUSION,1
MO,VISUAL ACUITY REDUCED,1
MO,VITREOUS HAEMORRHAGE,1
MK,ABORTION SPONTANEOUS,15
MK,EXPOSURE DURING PREGNANCY,10
MK,FOETAL EXPOSURE DURING PREGNANCY,9
MK,MATERNAL EXPOSURE DURING PREGNANCY,9
MK,DYSPNOEA,8
MK,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,7
MK,FATIGUE,7
MK,ONYCHOMADESIS,6
MK,GENERALISED TONIC-CLONIC SEIZURE,5
MK,HYPERSENSITIVITY VASCULITIS,5
MK,HYPOTENSION,5
MK,OEDEMA PERIPHERAL,5
MK,PULMONARY EMBOLISM,5
MK,SOMNOLENCE,5
MK,SUICIDE ATTEMPT,5
MK,TOXICITY TO VARIOUS AGENTS,5
MK,CUTANEOUS VASCULITIS,4
MK,DIZZINESS,4
MK,OVERDOSE,4
MK,PAIN IN EXTREMITY,4
MK,ABDOMINAL PAIN,3
MK,ATRIAL FIBRILLATION,3
MK,CHEST PAIN,3
MK,DEEP VEIN THROMBOSIS,3
MK,DRUG INEFFECTIVE,3
MK,HYPERTENSION,3
MK,NAIL RIDGING,3
MK,NAUSEA,3
MK,PALPITATIONS,3
MK,VOMITING,3
MK,ABORTION,2
MK,ANAEMIA,2
MK,ARRHYTHMIA,2
MK,ASPHYXIA,2
MK,BLOOD PRESSURE INCREASED,2
MK,CARDIAC FAILURE CHRONIC,2
MK,CARDIOMYOPATHY,2
MK,CEREBROVASCULAR ACCIDENT,2
MK,DIARRHOEA,2
MK,DRUG ABUSE,2
MK,ENDOPHTHALMITIS,2
MK,EXPOSURE DURING BREAST FEEDING,2
MK,HEPATITIS TOXIC,2
MK,HYPERKALAEMIA,2
MK,HYPOPYON,2
MK,IMMUNE THROMBOCYTOPENIC PURPURA,2
MK,JOINT SWELLING,2
MK,MALAISE,2
MK,MUSCULAR WEAKNESS,2
MK,PERIPHERAL SWELLING,2
MK,SEIZURE,2
MK,THROMBOPHLEBITIS,2
MK,TREMOR,2
MK,VERTIGO,2
MK,ABDOMINAL DISCOMFORT,1
MK,ABDOMINAL PAIN LOWER,1
MK,ABDOMINAL PAIN UPPER,1
MK,ANGINA PECTORIS,1
MK,ANGIOEDEMA,1
MK,ANXIETY,1
MK,AORTIC VALVE INCOMPETENCE,1
MK,APHASIA,1
MK,ARTERIOSCLEROSIS,1
MK,ASTHENIA,1
MK,ASTHMA,1
MK,ATRIAL FLUTTER,1
MK,ATRIAL SEPTAL DEFECT,1
MK,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
MK,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
MK,BLADDER CANCER,1
MK,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
MK,BLOOD PRESSURE DIASTOLIC INCREASED,1
MK,BLOOD PRESSURE FLUCTUATION,1
MK,BONE PAIN,1
MK,BREATH SOUNDS ABNORMAL,1
MK,CARDIAC ANEURYSM,1
MK,CARDIAC ARREST,1
MK,CARDIAC MURMUR,1
MK,CHEST DISCOMFORT,1
MK,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
MK,CONSTIPATION,1
MK,CYANOSIS,1
MK,DEATH,1
MK,DEMENTIA,1
MK,DEPRESSION,1
MK,DIABETES MELLITUS INADEQUATE CONTROL,1
MK,DISSEMINATED INTRAVASCULAR COAGULATION,1
MK,DRUG DOSE OMISSION,1
MK,DRUG INTOLERANCE,1
MK,DYSLEXIA,1
MK,DYSLIPIDAEMIA,1
MK,DYSPHONIA,1
MK,DYSPNOEA EXERTIONAL,1
MK,EAR DISCOMFORT,1
MK,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
MK,ENDOTOXAEMIA,1
MK,EPILEPSY,1
MK,ERYTHEMA,1
MK,FALL,1
MK,FOETAL CARDIAC DISORDER,1
MK,FOETAL EXPOSURE TIMING UNSPECIFIED,1
MK,FOETAL GROWTH RESTRICTION,1
MK,GINGIVITIS ULCERATIVE,1
MK,GRAND MAL CONVULSION,1
MK,HAEMATURIA,1
MK,HAEMOGLOBIN INCREASED,1
MK,HAEMORRHAGE INTRACRANIAL,1
MK,HAEMORRHAGE URINARY TRACT,1
MK,HAEMORRHAGIC FEVER,1
MK,HAEMORRHAGIC OVARIAN CYST,1
MK,HEADACHE,1
MK,HEART RATE IRREGULAR,1
MK,HEART VALVE CALCIFICATION,1
MK,HEPATITIS B,1
MK,HERPES VIRUS INFECTION,1
MK,HOT FLUSH,1
MK,HYPERCOAGULATION,1
MK,HYPERGLYCAEMIA,1
MK,HYPERSENSITIVITY,1
MK,IIIRD NERVE PARESIS,1
MK,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
MK,INFECTION,1
MK,INFERIOR VENA CAVA DILATATION,1
MK,INJECTION SITE ERYTHEMA,1
MK,INJECTION SITE THROMBOSIS,1
MK,KETOACIDOSIS,1
MK,LEUKOCYTOSIS,1
MK,LIPIDS ABNORMAL,1
MK,LOSS OF CONSCIOUSNESS,1
MK,LOW BIRTH WEIGHT BABY,1
MK,MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED,1
MK,MENINGOMYELOCELE,1
MK,MIDDLE EAR INFLAMMATION,1
MK,MITRAL VALVE DISEASE,1
MK,MITRAL VALVE INCOMPETENCE,1
MK,MULTI-ORGAN FAILURE,1
MK,MUSCLE SPASMS,1
MK,MYOCARDIAL INFARCTION,1
MK,NAIL BED DISORDER,1
MK,NEPHROPATHY TOXIC,1
MK,NEPHROTIC SYNDROME,1
MK,NEUROPATHY PERIPHERAL,1
MK,NO ADVERSE EVENT,1
MK,NOCTURIA,1
MK,OESOPHAGITIS HAEMORRHAGIC,1
MK,OVARIAN NEOPLASM,1
MK,PAIN,1
MK,PAIN IN JAW,1
MK,PANCYTOPENIA,1
MK,PARAESTHESIA,1
MK,PECTUS CARINATUM,1
MK,PERIPHERAL ARTERY DISSECTION,1
MK,PLATELET COUNT INCREASED,1
MK,PLEURAL EFFUSION,1
MK,POLYARTHRITIS,1
MK,POLYCYTHAEMIA VERA,1
MK,POLYDACTYLY,1
MK,POLYURIA,1
MK,PREGNANCY,1
MK,PREMATURE BABY,1
MK,PREMATURE DELIVERY,1
MK,PRODUCT QUALITY ISSUE,1
MK,PRODUCT USE ISSUE,1
MK,PRURITUS,1
MK,PSYCHOMOTOR HYPERACTIVITY,1
MK,PULMONARY HYPERTENSION,1
MK,PUSTULAR PSORIASIS,1
MK,RASH MACULO-PAPULAR,1
MK,RED BLOOD CELL COUNT INCREASED,1
MK,RENAL FAILURE,1
MK,RENAL IMPAIRMENT,1
MK,RESPIRATORY DISTRESS,1
MK,SEPSIS,1
MK,SINUS TACHYCARDIA,1
MK,SKIN NECROSIS,1
MK,SOMATIC SYMPTOM DISORDER,1
MK,SPINAL OSTEOARTHRITIS,1
MK,SPINAL PAIN,1
MK,STILLBIRTH,1
MK,SUBDURAL HAEMATOMA,1
MK,SUPERIOR SAGITTAL SINUS THROMBOSIS,1
MK,SUSPECTED COUNTERFEIT PRODUCT,1
MK,TACHYARRHYTHMIA,1
MK,TACHYCARDIA,1
MK,TACHYPNOEA,1
MK,THINKING ABNORMAL,1
MK,THIRST,1
MK,THROMBOCYTOPENIA,1
MK,THROMBOSIS,1
MK,TRANSPLANT REJECTION,1
MK,TREATMENT NONCOMPLIANCE,1
MK,TRICUSPID VALVE INCOMPETENCE,1
MK,TRISOMY 21,1
MK,URINARY TRACT INFECTION,1
MK,URTICARIA,1
MK,VASCULITIS,1
MK,VASODILATATION,1
MK,VENOUS THROMBOSIS,1
MK,VIITH NERVE PARALYSIS,1
MK,VISUAL IMPAIRMENT,1
MK,VITH NERVE PARESIS,1
MK,WHEEZING,1
MK,WHITE BLOOD CELL COUNT INCREASED,1
MK,WITHDRAWAL SYNDROME,1
MG,DEATH,6
MG,PYREXIA,4
MG,MALIGNANT NEOPLASM PROGRESSION,3
MG,ASTHENIA,2
MG,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,2
MG,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,2
MG,COUGH,2
MG,DRUG INEFFECTIVE,2
MG,GENERAL PHYSICAL HEALTH DETERIORATION,2
MG,PATHOGEN RESISTANCE,2
MG,ABDOMINAL PAIN UPPER,1
MG,ACUTE LYMPHOCYTIC LEUKAEMIA,1
MG,AGRANULOCYTOSIS,1
MG,ANAEMIA,1
MG,ANTI FACTOR VIII ANTIBODY POSITIVE,1
MG,BLOOD LACTATE DEHYDROGENASE INCREASED,1
MG,CHRONIC MYELOID LEUKAEMIA,1
MG,COMA,1
MG,CONDITION AGGRAVATED,1
MG,DECREASED APPETITE,1
MG,DEPRESSION,1
MG,DERMATOPHYTOSIS,1
MG,DRUG RESISTANCE,1
MG,DYSPHONIA,1
MG,ELECTROLYTE IMBALANCE,1
MG,EOSINOPHILIA,1
MG,EPILEPSY,1
MG,EYE OEDEMA,1
MG,FACTOR VIII INHIBITION,1
MG,FATIGUE,1
MG,FULL BLOOD COUNT DECREASED,1
MG,GASTROINTESTINAL STROMAL TUMOUR,1
MG,HAEMORRHAGE,1
MG,HAEMORRHAGIC DISORDER,1
MG,HELICOBACTER INFECTION,1
MG,HEPATIC FAILURE,1
MG,HIDRADENITIS,1
MG,HYPERKALAEMIA,1
MG,HYPOCHROMIC ANAEMIA,1
MG,HYPOTENSION,1
MG,IMMUNOSUPPRESSION,1
MG,INFLAMMATION,1
MG,INTENTIONAL PRODUCT MISUSE,1
MG,LEUKOCYTOSIS,1
MG,LEUKOSTASIS SYNDROME,1
MG,LUNG INFECTION,1
MG,LYMPHADENOPATHY,1
MG,LYMPHOCYTOSIS,1
MG,MALAISE,1
MG,METASTASES TO LIVER,1
MG,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
MG,NAUSEA,1
MG,NEOPLASM PROGRESSION,1
MG,NO THERAPEUTIC RESPONSE,1
MG,OEDEMA PERIPHERAL,1
MG,POST PROCEDURAL COMPLICATION,1
MG,PRODUCT USE IN UNAPPROVED INDICATION,1
MG,PSYCHOMOTOR HYPERACTIVITY,1
MG,PSYCHOTIC DISORDER,1
MG,PULMONARY OEDEMA,1
MG,PULMONARY TUBERCULOSIS,1
MG,RESPIRATORY FAILURE,1
MG,SCHISTOSOMIASIS,1
MG,SEPSIS,1
MG,SEPTIC SHOCK,1
MG,SPEECH DISORDER,1
MG,SPLENOMEGALY,1
MG,STRABISMUS,1
MG,SYNCOPE,1
MG,TACHYCARDIA,1
MG,THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION,1
MG,THERAPY NON-RESPONDER,1
MG,THROAT IRRITATION,1
MG,THROMBOCYTOSIS,1
MG,TOXIC EPIDERMAL NECROLYSIS,1
MG,TREATMENT FAILURE,1
MG,VERTIGO,1
MG,VISUAL IMPAIRMENT,1
MG,WHITE BLOOD CELL COUNT INCREASED,1
MW,FOETAL EXPOSURE DURING DELIVERY,88
MW,EXPOSURE DURING BREAST FEEDING,72
MW,DEATH,58
MW,EXPOSURE DURING PREGNANCY,41
MW,FOETAL EXPOSURE DURING PREGNANCY,39
MW,HIV INFECTION,38
MW,ANAEMIA,35
MW,PNEUMONIA,23
MW,DRUG RESISTANCE,21
MW,VIROLOGIC FAILURE,19
MW,SEPSIS,17
MW,NEUROPATHY PERIPHERAL,13
MW,PREMATURE BABY,12
MW,MALARIA,10
MW,BACTERIAL SEPSIS,8
MW,DISSEMINATED TUBERCULOSIS,8
MW,HEPATOTOXICITY,8
MW,KAPOSI^S SARCOMA,8
MW,MATERNAL EXPOSURE DURING PREGNANCY,8
MW,NEUTROPENIA,8
MW,SEPSIS NEONATAL,8
MW,STILLBIRTH,8
MW,ALANINE AMINOTRANSFERASE INCREASED,7
MW,DIARRHOEA,7
MW,HEPATITIS B,7
MW,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,7
MW,MENINGITIS CRYPTOCOCCAL,7
MW,PNEUMONIA BACTERIAL,7
MW,LIVE BIRTH,6
MW,MENINGITIS,6
MW,OSTEOPENIA,6
MW,PULMONARY TUBERCULOSIS,6
MW,PYREXIA,6
MW,RENAL FAILURE,6
MW,ABDOMINAL PAIN,5
MW,ABORTION SPONTANEOUS,5
MW,HEPATITIS,5
MW,MATERNAL EXPOSURE DURING DELIVERY,5
MW,OSTEONECROSIS,5
MW,OSTEOSCLEROSIS,5
MW,PAIN IN EXTREMITY,5
MW,THROMBOCYTOPENIA,5
MW,BLINDNESS,4
MW,EPIPHYSES DELAYED FUSION,4
MW,FOETAL DEATH,4
MW,HAEMATOCHEZIA,4
MW,HYPERSENSITIVITY,4
MW,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS,4
MW,LOWER RESPIRATORY TRACT INFECTION,4
MW,NEUTROPHIL COUNT DECREASED,4
MW,PANCREATITIS,4
MW,STEVENS-JOHNSON SYNDROME,4
MW,TREATMENT FAILURE,4
MW,VOMITING,4
MW,ABORTION INDUCED,3
MW,CONFUSIONAL STATE,3
MW,CONJUNCTIVAL OEDEMA,3
MW,CONJUNCTIVITIS,3
MW,DEHYDRATION,3
MW,DIABETES MELLITUS,3
MW,EYE INFLAMMATION,3
MW,GASTROINTESTINAL DISORDER,3
MW,GENERALISED OEDEMA,3
MW,HEART RATE INCREASED,3
MW,HYPONATRAEMIA,3
MW,MALNUTRITION,3
MW,MONOPLEGIA,3
MW,PLASMODIUM FALCIPARUM INFECTION,3
MW,PLEURAL EFFUSION,3
MW,RESPIRATORY DISTRESS,3
MW,SYMBLEPHARON,3
MW,TOXICITY TO VARIOUS AGENTS,3
MW,UPPER RESPIRATORY TRACT INFECTION,3
MW,ABDOMINAL DISCOMFORT,2
MW,ABORTION INCOMPLETE,2
MW,ACCESSORY AURICLE,2
MW,ACROCHORDON,2
MW,ACUTE KIDNEY INJURY,2
MW,ANURIA,2
MW,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,2
MW,BLOOD ALBUMIN DECREASED,2
MW,BLOOD PHOSPHORUS DECREASED,2
MW,BONE DISORDER,2
MW,CONGENITAL ACROCHORDON,2
MW,CONGENITAL SYPHILIS,2
MW,CORNEAL THINNING,2
MW,COUGH,2
MW,DEPRESSION,2
MW,DIABETIC KETOACIDOSIS,2
MW,DIZZINESS,2
MW,DRUG LEVEL INCREASED,2
MW,DRUG-INDUCED LIVER INJURY,2
MW,DYSPNOEA,2
MW,ELECTROLYTE IMBALANCE,2
MW,ENDOPHTHALMITIS,2
MW,EYE DISORDER,2
MW,EYELID OEDEMA,2
MW,FOREIGN BODY SENSATION IN EYES,2
MW,GASTROENTERITIS,2
MW,GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY,2
MW,HAEMATURIA,2
MW,HAEMOGLOBIN DECREASED,2
MW,HAEMORRHAGE,2
MW,HYPERHIDROSIS,2
MW,HYPOAESTHESIA,2
MW,HYPOGLYCAEMIA,2
MW,INSOMNIA,2
MW,KIDNEY ENLARGEMENT,2
MW,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
MW,LOW BIRTH WEIGHT BABY,2
MW,LYMPH NODE TUBERCULOSIS,2
MW,MENINGITIS BACTERIAL,2
MW,OEDEMATOUS KIDNEY,2
MW,PLASMODIUM MALARIAE INFECTION,2
MW,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
MW,POLYDACTYLY,2
MW,PROTEINURIA,2
MW,PYURIA,2
MW,RASH,2
MW,SALMONELLA SEPSIS,2
MW,STAPHYLOCOCCAL SEPSIS,2
MW,TOXIC EPIDERMAL NECROLYSIS,2
MW,UTERINE DILATION AND CURETTAGE,2
MW,VISUAL ACUITY REDUCED,2
MW,WEIGHT DECREASED,2
MW,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
MW,ABDOMINAL PAIN UPPER,1
MW,ABDOMINAL SEPSIS,1
MW,ABNORMAL LOSS OF WEIGHT,1
MW,ABORTION MISSED,1
MW,ACIDOSIS,1
MW,ACUTE ABDOMEN,1
MW,ARTHRALGIA,1
MW,ARTHROPATHY,1
MW,ASCITES,1
MW,ASTHENIA,1
MW,BACTERIAL INFECTION,1
MW,BLEPHARITIS,1
MW,BLOOD DISORDER,1
MW,BLOOD PRESSURE DIASTOLIC INCREASED,1
MW,BONE FRAGMENTATION,1
MW,BRAIN OEDEMA,1
MW,CANDIDA INFECTION,1
MW,CELLULITIS,1
MW,CENTRAL NERVOUS SYSTEM INFECTION,1
MW,CEREBROVASCULAR ACCIDENT,1
MW,CHEMICAL POISONING,1
MW,CHILLS,1
MW,CONVULSION,1
MW,CORNEAL DISORDER,1
MW,DIABETES INSIPIDUS,1
MW,DROWNING,1
MW,DRUG HYPERSENSITIVITY,1
MW,ECTOPIC PREGNANCY,1
MW,EPIPHYSES PREMATURE FUSION,1
MW,EXTRAPULMONARY TUBERCULOSIS,1
MW,FAILURE TO THRIVE,1
MW,FLAT ANTERIOR CHAMBER OF EYE,1
MW,FOAMING AT MOUTH,1
MW,GAIT DISTURBANCE,1
MW,GASTROINTESTINAL HAEMORRHAGE,1
MW,GASTROINTESTINAL STROMAL TUMOUR,1
MW,HAEMATEMESIS,1
MW,HAEMOGLOBIN ABNORMAL,1
MW,HEPATIC FUNCTION ABNORMAL,1
MW,HEPATITIS ACUTE,1
MW,HEPATOMEGALY,1
MW,HICCUPS,1
MW,HOSPITALISATION,1
MW,INFECTION REACTIVATION,1
MW,JAUNDICE,1
MW,LEUKOPENIA,1
MW,LOSS OF CONSCIOUSNESS,1
MW,MALIGNANT NEOPLASM PROGRESSION,1
MW,MEASLES,1
MW,MENINGITIS TUBERCULOUS,1
MW,MICTURITION FREQUENCY DECREASED,1
MW,NEOPLASM MALIGNANT,1
MW,NON-HODGKIN^S LYMPHOMA,1
MW,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
MW,OEDEMA,1
MW,OSTEOARTHRITIS,1
MW,OTITIS MEDIA,1
MW,PATHOGEN RESISTANCE,1
MW,PERICARDIAL EFFUSION,1
MW,PERITONITIS,1
MW,PLATELET COUNT DECREASED,1
MW,POLLAKIURIA,1
MW,PREGNANCY ON CONTRACEPTIVE,1
MW,PREMATURE DELIVERY,1
MW,PRODUCT TASTE ABNORMAL,1
MW,PRODUCT USE IN UNAPPROVED INDICATION,1
MW,PRODUCT USE ISSUE,1
MW,RECTAL HAEMORRHAGE,1
MW,RIGHT VENTRICULAR FAILURE,1
MW,ROAD TRAFFIC ACCIDENT,1
MW,SEIZURE,1
MW,SENSATION OF FOREIGN BODY,1
MW,SKIN INFECTION,1
MW,SMALL INTESTINAL OBSTRUCTION,1
MW,SPLENOMEGALY,1
MW,STAPHYLOCOCCAL BACTERAEMIA,1
MW,SYSTEMIC LUPUS ERYTHEMATOSUS,1
MW,URINARY TRACT INFECTION,1
MW,WHITE BLOOD CELL COUNT DECREASED,1
MY,DEATH,448
MY,DYSPNOEA,111
MY,PYREXIA,76
MY,PNEUMONIA,75
MY,DRUG INEFFECTIVE,70
MY,PRURITUS,70
MY,SEPSIS,68
MY,VOMITING,64
MY,DIZZINESS,60
MY,ANGIOEDEMA,48
MY,MALIGNANT NEOPLASM PROGRESSION,48
MY,RASH MACULO-PAPULAR,48
MY,DIARRHOEA,47
MY,NAUSEA,46
MY,ORBITAL OEDEMA,44
MY,RASH,44
MY,ACUTE KIDNEY INJURY,43
MY,DISEASE PROGRESSION,40
MY,ANAEMIA,37
MY,HYPOTENSION,36
MY,NEUTROPENIC SEPSIS,36
MY,CONDITION AGGRAVATED,35
MY,URTICARIA,35
MY,ASTHENIA,34
MY,STEVENS-JOHNSON SYNDROME,34
MY,ANAPHYLACTIC SHOCK,33
MY,THROMBOCYTOPENIA,33
MY,HEADACHE,31
MY,FATIGUE,30
MY,COUGH,29
MY,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,29
MY,PANCYTOPENIA,29
MY,CEREBROVASCULAR ACCIDENT,28
MY,FACE OEDEMA,28
MY,GASTROINTESTINAL STROMAL TUMOUR,28
MY,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,27
MY,DRUG RESISTANCE,27
MY,LETHARGY,27
MY,SEIZURE,27
MY,SEPTIC SHOCK,27
MY,ABDOMINAL PAIN,26
MY,ALANINE AMINOTRANSFERASE INCREASED,26
MY,PLEURAL EFFUSION,26
MY,OEDEMA PERIPHERAL,25
MY,HAEMOGLOBIN DECREASED,24
MY,NEUTROPENIA,24
MY,FALL,23
MY,DECREASED APPETITE,22
MY,MATERNAL EXPOSURE DURING PREGNANCY,22
MY,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,22
MY,SOMNOLENCE,22
MY,ARTHRALGIA,21
MY,BLOOD CREATININE INCREASED,21
MY,PERIORBITAL OEDEMA,21
MY,CARDIAC ARREST,20
MY,ERYTHEMA,20
MY,GENERAL PHYSICAL HEALTH DETERIORATION,20
MY,HYPERTENSION,20
MY,HYPOGLYCAEMIA,20
MY,WEIGHT DECREASED,20
MY,HAEMORRHAGE INTRACRANIAL,19
MY,HYPONATRAEMIA,19
MY,LOSS OF CONSCIOUSNESS,19
MY,MYALGIA,19
MY,OVERDOSE,19
MY,RHABDOMYOLYSIS,19
MY,SYNCOPE,19
MY,TOXICITY TO VARIOUS AGENTS,19
MY,FOETAL EXPOSURE DURING PREGNANCY,18
MY,HEPATIC ENZYME INCREASED,18
MY,PALPITATIONS,18
MY,PULMONARY HAEMORRHAGE,18
MY,UPPER GASTROINTESTINAL HAEMORRHAGE,18
MY,METABOLIC ACIDOSIS,17
MY,DEEP VEIN THROMBOSIS,16
MY,FEBRILE NEUTROPENIA,16
MY,GASTROINTESTINAL HAEMORRHAGE,16
MY,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,16
MY,MYOCARDIAL INFARCTION,16
MY,PAIN,16
MY,TOXIC EPIDERMAL NECROLYSIS,16
MY,CARDIAC FAILURE,15
MY,CHRONIC MYELOID LEUKAEMIA,15
MY,INFECTION,15
MY,LIP SWELLING,15
MY,MOUTH ULCERATION,15
MY,PLATELET COUNT DECREASED,15
MY,ABORTION SPONTANEOUS,14
MY,ACUTE MYELOID LEUKAEMIA,14
MY,BLOOD PRESSURE INCREASED,14
MY,CHILLS,14
MY,ELECTROCARDIOGRAM QT PROLONGED,14
MY,EXPOSURE DURING PREGNANCY,14
MY,HYPERSENSITIVITY,14
MY,JAUNDICE,14
MY,RENAL IMPAIRMENT,14
MY,VISION BLURRED,14
MY,WHITE BLOOD CELL COUNT INCREASED,14
MY,CHEST DISCOMFORT,13
MY,EPILEPSY,13
MY,EYE SWELLING,13
MY,HAEMORRHAGE,13
MY,INSOMNIA,13
MY,INTERNATIONAL NORMALISED RATIO INCREASED,13
MY,MALAISE,13
MY,MELAENA,13
MY,OXYGEN SATURATION DECREASED,13
MY,RASH GENERALISED,13
MY,SCHIZOPHRENIA,13
MY,TREATMENT FAILURE,13
MY,BLOOD ALKALINE PHOSPHATASE INCREASED,12
MY,BOWEN^S DISEASE,12
MY,BRADYCARDIA,12
MY,DEHYDRATION,12
MY,DRUG INTOLERANCE,12
MY,PERIPHERAL SWELLING,12
MY,TACHYCARDIA,12
MY,TINNITUS,12
MY,TREMOR,12
MY,TUBERCULOSIS,12
MY,ABDOMINAL DISCOMFORT,11
MY,APNOEA,11
MY,CHEST PAIN,11
MY,CONFUSIONAL STATE,11
MY,HEPATIC FAILURE,11
MY,LEUKOPENIA,11
MY,OCULOGYRIC CRISIS,11
MY,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,11
MY,PRODUCT USE ISSUE,11
MY,THERAPEUTIC RESPONSE DECREASED,11
MY,ACTINIC KERATOSIS,10
MY,ACUTE RESPIRATORY DISTRESS SYNDROME,10
MY,BACK PAIN,10
MY,BLOOD PRESSURE DECREASED,10
MY,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,10
MY,CONSTIPATION,10
MY,DELIRIUM,10
MY,FEMUR FRACTURE,10
MY,HAEMATEMESIS,10
MY,HALLUCINATION,10
MY,HEPATITIS,10
MY,HYPERHIDROSIS,10
MY,HYPOKALAEMIA,10
MY,MULTI-ORGAN FAILURE,10
MY,NEUROPATHY PERIPHERAL,10
MY,PAIN IN EXTREMITY,10
MY,PRODUCT QUALITY ISSUE,10
MY,RENAL FAILURE,10
MY,RESPIRATORY FAILURE,10
MY,URINARY TRACT INFECTION,10
MY,ABDOMINAL PAIN UPPER,9
MY,ATRIAL FIBRILLATION,9
MY,BASAL CELL CARCINOMA,9
MY,BRONCHOSPASM,9
MY,CELLULITIS,9
MY,CONVULSION,9
MY,DIABETES MELLITUS INADEQUATE CONTROL,9
MY,DRUG ABUSE,9
MY,HYPERKALAEMIA,9
MY,LOW BIRTH WEIGHT BABY,9
MY,LUNG INFECTION,9
MY,MUSCULAR WEAKNESS,9
MY,NO THERAPEUTIC RESPONSE,9
MY,PNEUMONITIS,9
MY,PRODUCT USE IN UNAPPROVED INDICATION,9
MY,PSYCHOTIC DISORDER,9
MY,PULMONARY EMBOLISM,9
MY,SQUAMOUS CELL CARCINOMA,9
MY,SUICIDAL IDEATION,9
MY,THROMBOSIS,9
MY,VISUAL ACUITY REDUCED,9
MY,WEIGHT INCREASED,9
MY,ABDOMINAL DISTENSION,8
MY,ABNORMAL BEHAVIOUR,8
MY,ACUTE MYOCARDIAL INFARCTION,8
MY,ASPARTATE AMINOTRANSFERASE INCREASED,8
MY,ASTHMA,8
MY,BLISTER,8
MY,BLOOD BILIRUBIN INCREASED,8
MY,COMA,8
MY,CONTUSION,8
MY,CYANOSIS,8
MY,DEAFNESS,8
MY,DEAFNESS NEUROSENSORY,8
MY,DIABETIC KETOACIDOSIS,8
MY,DRUG DOSE OMISSION,8
MY,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,8
MY,EPISTAXIS,8
MY,GASTROENTERITIS,8
MY,HEAT STROKE,8
MY,HYPOAESTHESIA,8
MY,INTENTIONAL OVERDOSE,8
MY,LIVER FUNCTION TEST ABNORMAL,8
MY,MULTIPLE ORGAN DYSFUNCTION SYNDROME,8
MY,MUSCLE SPASMS,8
MY,NEUROLEPTIC MALIGNANT SYNDROME,8
MY,OCULAR HYPERAEMIA,8
MY,PRURITUS GENERALISED,8
MY,PULMONARY TUBERCULOSIS,8
MY,RENAL FAILURE ACUTE,8
MY,RESPIRATORY DEPRESSION,8
MY,SKIN REACTION,8
MY,STOMATITIS,8
MY,URINARY RETENTION,8
MY,ABASIA,7
MY,ARRHYTHMIA,7
MY,ASCITES,7
MY,BLINDNESS,7
MY,CARDIAC FAILURE CONGESTIVE,7
MY,CATATONIA,7
MY,CEREBRAL INFARCTION,7
MY,CHOKING,7
MY,DIABETES MELLITUS,7
MY,DISSEMINATED INTRAVASCULAR COAGULATION,7
MY,DRUG-INDUCED LIVER INJURY,7
MY,DYSPHAGIA,7
MY,ENDOPHTHALMITIS,7
MY,ERYTHEMA MULTIFORME,7
MY,EYE PRURITUS,7
MY,HAEMOPTYSIS,7
MY,HEPATITIS ACUTE,7
MY,HERPES ZOSTER,7
MY,HYPOPHAGIA,7
MY,LACRIMATION INCREASED,7
MY,NEOPLASM PROGRESSION,7
MY,NEUROTOXICITY,7
MY,OTOTOXICITY,7
MY,PHOTOSENSITIVITY REACTION,7
MY,PREMATURE BABY,7
MY,RASH ERYTHEMATOUS,7
MY,STAPHYLOCOCCAL SEPSIS,7
MY,SWELLING,7
MY,UNRESPONSIVE TO STIMULI,7
MY,WHITE BLOOD CELL COUNT DECREASED,7
MY,ANAPHYLACTIC REACTION,6
MY,COLONIC PSEUDO-OBSTRUCTION,6
MY,CONJUNCTIVITIS,6
MY,DEPRESSION,6
MY,DISSEMINATED TUBERCULOSIS,6
MY,DRUG DEPENDENCE,6
MY,DRY SKIN,6
MY,DYSKINESIA,6
MY,GAIT DISTURBANCE,6
MY,GASTRITIS,6
MY,GENERALISED OEDEMA,6
MY,HAEMATURIA,6
MY,HEAD INJURY,6
MY,HEART RATE DECREASED,6
MY,HENOCH-SCHONLEIN PURPURA NEPHRITIS,6
MY,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,6
MY,INCORRECT DOSE ADMINISTERED,6
MY,MUSCULOSKELETAL STIFFNESS,6
MY,OEDEMA,6
MY,OPHTHALMOPLEGIA,6
MY,PARONYCHIA,6
MY,SWELLING FACE,6
MY,WHEEZING,6
MY,ABSCESS,5
MY,ABSCESS LIMB,5
MY,ACUTE PULMONARY OEDEMA,5
MY,AGGRESSION,5
MY,ANXIETY,5
MY,APHASIA,5
MY,BLOOD CREATINE PHOSPHOKINASE INCREASED,5
MY,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,5
MY,COAGULOPATHY,5
MY,COLON CANCER,5
MY,CONJUNCTIVAL ULCER,5
MY,DELUSION,5
MY,DENGUE FEVER,5
MY,DEPRESSED LEVEL OF CONSCIOUSNESS,5
MY,DERMATITIS BULLOUS,5
MY,DERMATITIS EXFOLIATIVE,5
MY,DISCOMFORT,5
MY,DRUG ADMINISTRATION ERROR,5
MY,EXTRAPYRAMIDAL DISORDER,5
MY,GENERALISED TONIC-CLONIC SEIZURE,5
MY,HAEMATOMA,5
MY,HEPATIC ENCEPHALOPATHY,5
MY,HEPATIC ENZYME ABNORMAL,5
MY,HYDRONEPHROSIS,5
MY,HYPERGLYCAEMIA,5
MY,IMMUNE THROMBOCYTOPENIC PURPURA,5
MY,INTESTINAL OBSTRUCTION,5
MY,LIVER DISORDER,5
MY,LOWER RESPIRATORY TRACT INFECTION,5
MY,METASTASES TO LIVER,5
MY,MYASTHENIA GRAVIS,5
MY,NERVOUS SYSTEM DISORDER,5
MY,OROPHARYNGEAL PAIN,5
MY,PALLOR,5
MY,PNEUMONIA ASPIRATION,5
MY,PNEUMONIA KLEBSIELLA,5
MY,PRODUCT ODOUR ABNORMAL,5
MY,PRODUCT SUBSTITUTION ISSUE,5
MY,PULMONARY OEDEMA,5
MY,RASH PRURITIC,5
MY,RESPIRATORY DISTRESS,5
MY,SKIN DISCOLOURATION,5
MY,SKIN EXFOLIATION,5
MY,SKIN LESION,5
MY,SKIN ULCER,5
MY,SPEECH DISORDER,5
MY,SPLENOMEGALY,5
MY,THROMBOPHLEBITIS,5
MY,TORSADE DE POINTES,5
MY,TRANSAMINASES INCREASED,5
MY,TUMOUR LYSIS SYNDROME,5
MY,UROSEPSIS,5
MY,VENTRICULAR EXTRASYSTOLES,5
MY,VISUAL IMPAIRMENT,5
MY,ACUTE CORONARY SYNDROME,4
MY,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,4
MY,ACUTE HEPATIC FAILURE,4
MY,ADVERSE EVENT,4
MY,AGEUSIA,4
MY,ALTERED STATE OF CONSCIOUSNESS,4
MY,ANGER,4
MY,BLOOD GLUCOSE INCREASED,4
MY,BLOOD SODIUM DECREASED,4
MY,CARDIAC DISORDER,4
MY,CEREBRAL HAEMORRHAGE,4
MY,CHOLESTASIS,4
MY,CHRONIC KIDNEY DISEASE,4
MY,COAGULATION TIME PROLONGED,4
MY,COMA SCALE ABNORMAL,4
MY,CONJUNCTIVAL HAEMORRHAGE,4
MY,CORNEAL OPACITY,4
MY,CYTOPENIA,4
MY,DEMYELINATION,4
MY,DERMATITIS ACNEIFORM,4
MY,DRUG HYPERSENSITIVITY,4
MY,DRUG WITHDRAWAL CONVULSIONS,4
MY,DRUG WITHDRAWAL SYNDROME,4
MY,DRY MOUTH,4
MY,DYSARTHRIA,4
MY,ELECTROCARDIOGRAM T WAVE INVERSION,4
MY,ENCEPHALITIS,4
MY,EYE MOVEMENT DISORDER,4
MY,EYE PAIN,4
MY,FLUSHING,4
MY,FOETAL DEATH,4
MY,HAEMATOCHEZIA,4
MY,HAEMORRHAGIC DIATHESIS,4
MY,HEMIPARESIS,4
MY,HEPATIC CIRRHOSIS,4
MY,HODGKIN^S DISEASE,4
MY,HOT FLUSH,4
MY,HYPERTONIA,4
MY,HYPOVOLAEMIC SHOCK,4
MY,ILEUS PARALYTIC,4
MY,IMMUNE-MEDIATED NECROTISING MYOPATHY,4
MY,INFLUENZA,4
MY,INJECTION SITE PAIN,4
MY,KETOSIS,4
MY,LIVER INJURY,4
MY,LYMPHOPENIA,4
MY,MACULOPATHY,4
MY,MEDICATION ERROR,4
MY,MEDICATION OVERUSE HEADACHE,4
MY,MUCOSAL INFLAMMATION,4
MY,MULTIPLE SCLEROSIS RELAPSE,4
MY,MYELODYSPLASTIC SYNDROME,4
MY,MYOCARDIAL ISCHAEMIA,4
MY,NEOPLASM MALIGNANT,4
MY,NORMAL NEWBORN,4
MY,NOSOCOMIAL INFECTION,4
MY,PATHOGEN RESISTANCE,4
MY,PERITONITIS BACTERIAL,4
MY,PHARYNGEAL OEDEMA,4
MY,PREMATURE DELIVERY,4
MY,PROTHROMBIN TIME PROLONGED,4
MY,PUSTULAR PSORIASIS,4
MY,RESTLESSNESS,4
MY,RHINORRHOEA,4
MY,SECOND PRIMARY MALIGNANCY,4
MY,STILLBIRTH,4
MY,STRONGYLOIDIASIS,4
MY,SUBDURAL HAEMATOMA,4
MY,SUBSTANCE USE,4
MY,SUPRAVENTRICULAR TACHYCARDIA,4
MY,TACHYPNOEA,4
MY,URINE OUTPUT DECREASED,4
MY,VASCULITIS,4
MY,VENTRICULAR TACHYCARDIA,4
MY,WITHDRAWAL SYNDROME,4
MY,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,4
MY,ABORTION INDUCED,3
MY,ACUTE PSYCHOSIS,3
MY,ATAXIA,3
MY,BLOOD CALCIUM DECREASED,3
MY,BODY TEMPERATURE INCREASED,3
MY,BONE PAIN,3
MY,BRAIN DEATH,3
MY,BRAIN OEDEMA,3
MY,BURNING SENSATION,3
MY,CAESAREAN SECTION,3
MY,CARDIOGENIC SHOCK,3
MY,CENTRAL NERVOUS SYSTEM LEUKAEMIA,3
MY,CEREBELLAR ATAXIA,3
MY,CHANGE OF BOWEL HABIT,3
MY,CHOLECYSTITIS,3
MY,CHROMATURIA,3
MY,CHRONIC MYELOID LEUKAEMIA RECURRENT,3
MY,CIRCULATORY COLLAPSE,3
MY,COGNITIVE DISORDER,3
MY,COLD SWEAT,3
MY,CONJUNCTIVAL FILTERING BLEB LEAK,3
MY,CORNEAL OEDEMA,3
MY,CREPITATIONS,3
MY,CRYING,3
MY,CYSTITIS,3
MY,CYTOMEGALOVIRUS INFECTION,3
MY,DEVICE RELATED INFECTION,3
MY,DISEASE COMPLICATION,3
MY,DISEASE RECURRENCE,3
MY,DISORIENTATION,3
MY,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,3
MY,DRUG CROSS-REACTIVITY,3
MY,DRUG DISPENSING ERROR,3
MY,DUODENAL ULCER HAEMORRHAGE,3
MY,DYSPEPSIA,3
MY,DYSURIA,3
MY,ECZEMA,3
MY,END STAGE RENAL DISEASE,3
MY,EYE IRRITATION,3
MY,EYELID OEDEMA,3
MY,FEEDING DISORDER,3
MY,FLUID OVERLOAD,3
MY,FLUID RETENTION,3
MY,GASTROINTESTINAL DISORDER,3
MY,GAZE PALSY,3
MY,GINGIVAL BLEEDING,3
MY,GLAUCOMA,3
MY,GRAFT VERSUS HOST DISEASE,3
MY,GRAND MAL CONVULSION,3
MY,HAEMODIALYSIS,3
MY,HAEMODYNAMIC INSTABILITY,3
MY,HALLUCINATION_ AUDITORY,3
MY,HEART RATE INCREASED,3
MY,HEPATIC FIBROSIS,3
MY,HEPATIC LESION,3
MY,HEPATOMEGALY,3
MY,HOSPITALISATION,3
MY,HYDROCEPHALUS,3
MY,HYPERREFLEXIA,3
MY,HYPOCALCAEMIA,3
MY,HYPOPNOEA,3
MY,INFLUENZA LIKE ILLNESS,3
MY,INFUSION RELATED REACTION,3
MY,INJECTION SITE RASH,3
MY,INJECTION SITE SWELLING,3
MY,INTENTIONAL PRODUCT MISUSE,3
MY,INTENTIONAL PRODUCT USE ISSUE,3
MY,INTENTIONAL SELF-INJURY,3
MY,IRRITABILITY,3
MY,ISCHAEMIC STROKE,3
MY,JOINT SWELLING,3
MY,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
MY,LIP PAIN,3
MY,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,3
MY,LYMPHADENOPATHY,3
MY,LYMPHOCYTE COUNT DECREASED,3
MY,MANIA,3
MY,MEMORY IMPAIRMENT,3
MY,METASTASES TO BONE,3
MY,METASTASES TO CENTRAL NERVOUS SYSTEM,3
MY,METASTASIS,3
MY,MIOSIS,3
MY,MOVEMENT DISORDER,3
MY,MUSCLE TWITCHING,3
MY,MYELOPROLIFERATIVE NEOPLASM,3
MY,NECROSIS,3
MY,NEPHROPATHY TOXIC,3
MY,NEUTROPHIL COUNT DECREASED,3
MY,NON-HODGKIN^S LYMPHOMA,3
MY,ORAL PAIN,3
MY,OROMANDIBULAR DYSTONIA,3
MY,ORTHOPNOEA,3
MY,OSTEONECROSIS OF JAW,3
MY,OVARIAN CYST RUPTURED,3
MY,PARAESTHESIA,3
MY,PARKINSONISM,3
MY,PERITONEAL HAEMORRHAGE,3
MY,PLASMA CELL MYELOMA,3
MY,PNEUMONIA FUNGAL,3
MY,PNEUMOTHORAX,3
MY,POLLAKIURIA,3
MY,POSTPARTUM HAEMORRHAGE,3
MY,PREGNANCY,3
MY,PRODUCTIVE COUGH,3
MY,PROSTATIC SPECIFIC ANTIGEN INCREASED,3
MY,PURPURA,3
MY,RASH MACULAR,3
MY,RECTAL HAEMORRHAGE,3
MY,RECURRENT CANCER,3
MY,REITER^S SYNDROME,3
MY,RENAL CELL CARCINOMA,3
MY,RESPIRATORY TRACT INFECTION,3
MY,ROAD TRAFFIC ACCIDENT,3
MY,SCREAMING,3
MY,SCROTAL ULCER,3
MY,SHOCK HAEMORRHAGIC,3
MY,SKIN INFECTION,3
MY,SQUAMOUS CELL CARCINOMA OF SKIN,3
MY,STAPHYLOCOCCAL INFECTION,3
MY,SUBDURAL HAEMORRHAGE,3
MY,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,3
MY,SWOLLEN TONGUE,3
MY,SYSTEMIC LUPUS ERYTHEMATOSUS,3
MY,THROAT IRRITATION,3
MY,TONGUE ULCERATION,3
MY,TREATMENT NONCOMPLIANCE,3
MY,TUBULOINTERSTITIAL NEPHRITIS,3
MY,UNINTENDED PREGNANCY,3
MY,UPPER RESPIRATORY TRACT INFECTION,3
MY,VENTRICULAR FIBRILLATION,3
MY,VIRAL MUTATION IDENTIFIED,3
MY,VITAMIN D DEFICIENCY,3
MY,WOUND,3
MY,ABDOMINAL RIGIDITY,2
MY,ABORTION,2
MY,ACTIVITIES OF DAILY LIVING IMPAIRED,2
MY,ACUTE ABDOMEN,2
MY,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,2
MY,AGRANULOCYTOSIS,2
MY,ALOPECIA,2
MY,ALPHA 1 FOETOPROTEIN INCREASED,2
MY,AMENORRHOEA,2
MY,ANAEMIA VITAMIN B12 DEFICIENCY,2
MY,ANURIA,2
MY,APHAGIA,2
MY,ATRIOVENTRICULAR BLOCK FIRST DEGREE,2
MY,ATYPICAL FEMUR FRACTURE,2
MY,AURA,2
MY,BACTERAEMIA,2
MY,BACTERIAL SEPSIS,2
MY,BALANCE DISORDER,2
MY,BEDRIDDEN,2
MY,BICYTOPENIA,2
MY,BIPOLAR I DISORDER,2
MY,BLEBITIS,2
MY,BLOOD ELECTROLYTES ABNORMAL,2
MY,BLOOD GLUCOSE DECREASED,2
MY,BLOOD MAGNESIUM DECREASED,2
MY,BLOOD PHOSPHORUS DECREASED,2
MY,BLOOD POTASSIUM DECREASED,2
MY,BLOOD POTASSIUM INCREASED,2
MY,BLOOD PRESSURE INADEQUATELY CONTROLLED,2
MY,BLOOD PRESSURE SYSTOLIC INCREASED,2
MY,BONE DENSITY DECREASED,2
MY,BREAST CANCER,2
MY,BRONCHOPNEUMONIA,2
MY,BRONCHOPULMONARY ASPERGILLOSIS,2
MY,CANDIDA INFECTION,2
MY,CARCINOEMBRYONIC ANTIGEN INCREASED,2
MY,CARDIO-RESPIRATORY ARREST,2
MY,CARDIOMEGALY,2
MY,CARDIOMYOPATHY,2
MY,CENTRAL NERVOUS SYSTEM LESION,2
MY,CEREBRAL DISORDER,2
MY,CEREBRAL HAEMATOMA,2
MY,CEREBRAL THROMBOSIS,2
MY,CHAPPED LIPS,2
MY,CHEMICAL PERITONITIS,2
MY,CHLOROMA,2
MY,CHOKING SENSATION,2
MY,CHOLANGITIS,2
MY,COAGULATION TEST ABNORMAL,2
MY,COMPLICATIONS OF TRANSPLANTED KIDNEY,2
MY,CONTRAINDICATED DRUG PRESCRIBED,2
MY,CORONARY ARTERY DISEASE,2
MY,CYSTITIS HAEMORRHAGIC,2
MY,CYTOMEGALOVIRUS COLITIS,2
MY,DEPRESSED MOOD,2
MY,DIPLOPIA,2
MY,DROOLING,2
MY,DRUG CLEARANCE DECREASED,2
MY,DRUG ERUPTION,2
MY,DRUG LEVEL INCREASED,2
MY,DYSPAREUNIA,2
MY,DYSPHONIA,2
MY,DYSTONIA,2
MY,EATING DISORDER,2
MY,EGFR GENE MUTATION,2
MY,EJECTION FRACTION DECREASED,2
MY,ELECTROLYTE IMBALANCE,2
MY,ENDOCARDITIS,2
MY,ERECTILE DYSFUNCTION,2
MY,EXOPHTHALMOS,2
MY,EXPOSURE VIA FATHER,2
MY,EYE DISORDER,2
MY,EYE HAEMORRHAGE,2
MY,FACIAL PARALYSIS,2
MY,FAECES DISCOLOURED,2
MY,FEAR,2
MY,FEELING ABNORMAL,2
MY,FEELING HOT,2
MY,FIBROSIS,2
MY,FLATULENCE,2
MY,FOETAL DISTRESS SYNDROME,2
MY,FOETAL GROWTH RESTRICTION,2
MY,FRACTURE,2
MY,FREQUENT BOWEL MOVEMENTS,2
MY,GANGRENE,2
MY,GASTRIC DISORDER,2
MY,GINGIVAL ULCERATION,2
MY,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
MY,HAEMOLYSIS,2
MY,HAEMOLYTIC ANAEMIA,2
MY,HAEMOTHORAX,2
MY,HALLUCINATIONS_ MIXED,2
MY,HEART RATE ABNORMAL,2
MY,HEPARIN RESISTANCE,2
MY,HEPATIC CANCER,2
MY,HEPATIC CYST,2
MY,HEPATIC FUNCTION ABNORMAL,2
MY,HEPATOCELLULAR CARCINOMA,2
MY,HEPATOSPLENOMEGALY,2
MY,HEPATOTOXICITY,2
MY,HYPERBILIRUBINAEMIA,2
MY,HYPERCALCAEMIA,2
MY,HYPERSOMNIA,2
MY,HYPERTENSIVE CRISIS,2
MY,HYPOACUSIS,2
MY,HYPOMAGNESAEMIA,2
MY,HYPOMANIA,2
MY,HYPOTHYROIDISM,2
MY,IMPAIRED HEALING,2
MY,INFUSION SITE ERYTHEMA,2
MY,INJECTION SITE INDURATION,2
MY,INJECTION SITE PRURITUS,2
MY,INJURY,2
MY,INTERNATIONAL NORMALISED RATIO FLUCTUATION,2
MY,INTRAOCULAR PRESSURE INCREASED,2
MY,INTRAVENTRICULAR HAEMORRHAGE,2
MY,IRIDOCYCLITIS,2
MY,IRON DEFICIENCY ANAEMIA,2
MY,JAUNDICE CHOLESTATIC,2
MY,JOINT STIFFNESS,2
MY,KERATOPATHY,2
MY,KETONURIA,2
MY,LIP ULCERATION,2
MY,LIVER ABSCESS,2
MY,LOCAL SWELLING,2
MY,LOCALISED OEDEMA,2
MY,LUNG ABSCESS,2
MY,LUNG CONSOLIDATION,2
MY,LUNG DISORDER,2
MY,LUNG NEOPLASM MALIGNANT,2
MY,LYMPHADENITIS,2
MY,MALABSORPTION,2
MY,MASKED FACIES,2
MY,MEDICATION RESIDUE PRESENT,2
MY,MENINGITIS,2
MY,METASTASES TO LUNG,2
MY,METASTATIC RENAL CELL CARCINOMA,2
MY,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,2
MY,MITRAL VALVE INCOMPETENCE,2
MY,MOBILITY DECREASED,2
MY,MOOD ALTERED,2
MY,MUCOSAL DRYNESS,2
MY,MUSCLE RIGIDITY,2
MY,MUSCULOSKELETAL CHEST PAIN,2
MY,MUSCULOSKELETAL PAIN,2
MY,MYELOFIBROSIS,2
MY,MYOCLONUS,2
MY,MYOSITIS,2
MY,NASAL CONGESTION,2
MY,NECROTISING FASCIITIS,2
MY,NEONATAL RESPIRATORY DISTRESS SYNDROME,2
MY,NEOPLASM RECURRENCE,2
MY,NEPHROLITHIASIS,2
MY,NEUTROPHIL COUNT INCREASED,2
MY,NEUTROPHILIA,2
MY,NO ADVERSE EVENT,2
MY,NODULE,2
MY,OBSTRUCTION GASTRIC,2
MY,ODYNOPHAGIA,2
MY,OEDEMA MOUTH,2
MY,OSTEOMALACIA,2
MY,OVARIAN CYST,2
MY,PAIN IN JAW,2
MY,PALLIATIVE CARE,2
MY,PANIC ATTACK,2
MY,PAPILLOEDEMA,2
MY,PARANEOPLASTIC SYNDROME,2
MY,PARAPLEGIA,2
MY,PEPTIC ULCER,2
MY,PERIPHERAL COLDNESS,2
MY,PERIPHERAL VASCULAR DISORDER,2
MY,PERITONEAL DIALYSIS COMPLICATION,2
MY,PERSONALITY CHANGE,2
MY,PETECHIAE,2
MY,PHOTOPHOBIA,2
MY,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
MY,PNEUMONIA CYTOMEGALOVIRAL,2
MY,PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL,2
MY,POST PROCEDURAL COMPLICATION,2
MY,POST PROCEDURAL HAEMORRHAGE,2
MY,PREMATURE LABOUR,2
MY,PRESCRIBED OVERDOSE,2
MY,PSORIASIS,2
MY,PULMONARY ARTERIAL HYPERTENSION,2
MY,PULMONARY FIBROSIS,2
MY,PULMONARY MASS,2
MY,PULSE ABNORMAL,2
MY,PYELONEPHRITIS,2
MY,QUALITY OF LIFE DECREASED,2
MY,RED BLOOD CELL COUNT DECREASED,2
MY,RENAL CANCER METASTATIC,2
MY,RETROPERITONEAL HAEMORRHAGE,2
MY,RHEUMATOID ARTHRITIS,2
MY,RIGHT VENTRICULAR FAILURE,2
MY,SCLERAL DISCOLOURATION,2
MY,SERUM FERRITIN INCREASED,2
MY,SERUM SICKNESS-LIKE REACTION,2
MY,SEXUAL DYSFUNCTION,2
MY,SHOCK,2
MY,SINUS TACHYCARDIA,2
MY,SKIN DISORDER,2
MY,SKIN FISSURES,2
MY,SKIN TOXICITY,2
MY,SKULL FRACTURE,2
MY,SPINAL EPIDURAL HAEMATOMA,2
MY,STUPOR,2
MY,SUBARACHNOID HAEMORRHAGE,2
MY,SUDDEN DEATH,2
MY,SUICIDAL BEHAVIOUR,2
MY,SURGERY,2
MY,SYSTEMIC CANDIDA,2
MY,TENDON RUPTURE,2
MY,THINKING ABNORMAL,2
MY,THROAT TIGHTNESS,2
MY,TONGUE DISORDER,2
MY,TONGUE MOVEMENT DISTURBANCE,2
MY,TONGUE PARALYSIS,2
MY,TONSILLITIS,2
MY,TOOTHACHE,2
MY,TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA,2
MY,TRANSIENT ISCHAEMIC ATTACK,2
MY,TUBERCULOMA OF CENTRAL NERVOUS SYSTEM,2
MY,TUBERCULOSIS GASTROINTESTINAL,2
MY,TUBERCULOUS PLEURISY,2
MY,URETERIC OBSTRUCTION,2
MY,URETHRAL DISCHARGE,2
MY,VAGINAL HAEMORRHAGE,2
MY,VENTRICULAR ARRHYTHMIA,2
MY,VENTRICULAR HYPOKINESIA,2
MY,VIITH NERVE PARALYSIS,2
MY,VITAMIN B12 DEFICIENCY,2
MY,WOUND INFECTION,2
MY,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
MY,ABDOMINAL PAIN LOWER,1
MY,ABNORMAL DREAMS,1
MY,ABNORMAL FAECES,1
MY,ABORTION THREATENED,1
MY,ACCIDENT,1
MY,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
MY,ACETONAEMIA,1
MY,ACIDOSIS,1
MY,ACINETOBACTER INFECTION,1
MY,ACNE,1
MY,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
MY,ACUTE GRAFT VERSUS HOST DISEASE,1
MY,ACUTE HAEMORRHAGIC CONJUNCTIVITIS,1
MY,ACUTE LUNG INJURY,1
MY,ACUTE LYMPHOCYTIC LEUKAEMIA,1
MY,ACUTE TONSILLITIS,1
MY,ADDISON^S DISEASE,1
MY,ADENOCARCINOMA,1
MY,ADENOCARCINOMA OF COLON,1
MY,ADJUSTMENT DISORDER,1
MY,ADNEXA UTERI MASS,1
MY,ADRENAL INSUFFICIENCY,1
MY,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
MY,ADRENOLEUKODYSTROPHY,1
MY,ADVERSE REACTION,1
MY,AFFECT LABILITY,1
MY,AGITATION,1
MY,ALCOHOL POISONING,1
MY,ALCOHOL WITHDRAWAL SYNDROME,1
MY,ANAEMIA MACROCYTIC,1
MY,ANAL ABSCESS,1
MY,ANAL FISSURE,1
MY,ANAPHYLACTOID SHOCK,1
MY,ANEURYSM,1
MY,ANGINA PECTORIS,1
MY,ANGINA UNSTABLE,1
MY,ANGLE CLOSURE GLAUCOMA,1
MY,ANTERIOR CHAMBER FLARE,1
MY,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,1
MY,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,1
MY,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
MY,AORTIC ANEURYSM,1
MY,AORTIC ARTERIOSCLEROSIS,1
MY,APGAR SCORE LOW,1
MY,APHTHOUS ULCER,1
MY,APLASIA PURE RED CELL,1
MY,APPENDICITIS,1
MY,ARTERIAL THROMBOSIS,1
MY,ARTERIOVENOUS FISTULA SITE COMPLICATION,1
MY,ARTERIOVENOUS FISTULA SITE HAEMORRHAGE,1
MY,ARTERIOVENOUS MALFORMATION,1
MY,ARTHRITIS BACTERIAL,1
MY,ARTHROPATHY,1
MY,ASPERGILLUS INFECTION,1
MY,ASPIRATION,1
MY,ASPIRATION JOINT,1
MY,ASSISTED DELIVERY,1
MY,ATRIAL THROMBOSIS,1
MY,ATYPICAL FRACTURE,1
MY,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
MY,AUTONOMIC NEUROPATHY,1
MY,BASAL GANGLIA HAEMATOMA,1
MY,BILE DUCT STONE,1
MY,BIPOLAR DISORDER,1
MY,BLADDER DYSFUNCTION,1
MY,BLADDER OBSTRUCTION,1
MY,BLAST CELL CRISIS,1
MY,BLAST CELLS PRESENT,1
MY,BLEPHARITIS,1
MY,BLINDNESS CORTICAL,1
MY,BLINDNESS TRANSIENT,1
MY,BLOOD ALBUMIN ABNORMAL,1
MY,BLOOD ALBUMIN DECREASED,1
MY,BLOOD BILIRUBIN ABNORMAL,1
MY,BLOOD BLISTER,1
MY,BLOOD CALCIUM INCREASED,1
MY,BLOOD CORTISOL DECREASED,1
MY,BLOOD COUNT ABNORMAL,1
MY,BLOOD CREATININE ABNORMAL,1
MY,BLOOD ELECTROLYTES DECREASED,1
MY,BLOOD GLUCOSE ABNORMAL,1
MY,BLOOD IRON DECREASED,1
MY,BLOOD IRON INCREASED,1
MY,BLOOD LACTATE DEHYDROGENASE INCREASED,1
MY,BLOOD LACTIC ACID INCREASED,1
MY,BLOOD PARATHYROID HORMONE ABNORMAL,1
MY,BLOOD PRESSURE ABNORMAL,1
MY,BLOOD PRESSURE FLUCTUATION,1
MY,BLOOD PRESSURE SYSTOLIC DECREASED,1
MY,BLOOD PRODUCT TRANSFUSION,1
MY,BLOOD THYROID STIMULATING HORMONE DECREASED,1
MY,BLOOD UREA ABNORMAL,1
MY,BLOOD UREA INCREASED,1
MY,BLOOD URINE PRESENT,1
MY,BODY SURFACE AREA INCREASED,1
MY,BONE DISORDER,1
MY,BONE FORMATION INCREASED,1
MY,BONE MARROW FAILURE,1
MY,BONE MARROW TRANSPLANT REJECTION,1
MY,BOWEL MOVEMENT IRREGULARITY,1
MY,BRADYCARDIA FOETAL,1
MY,BRAIN INJURY,1
MY,BRAIN MIDLINE SHIFT,1
MY,BRAIN STEM EMBOLISM,1
MY,BRAIN STEM HAEMORRHAGE,1
MY,BRAIN STEM STROKE,1
MY,BREAST CANCER METASTATIC,1
MY,BREAST CANCER STAGE III,1
MY,BREAST DISORDER,1
MY,BREAST HYPERPLASIA,1
MY,BRONCHIAL HYPERREACTIVITY,1
MY,BRONCHITIS,1
MY,BULBAR PALSY,1
MY,BUNDLE BRANCH BLOCK LEFT,1
MY,BUNDLE BRANCH BLOCK RIGHT,1
MY,BURKHOLDERIA PSEUDOMALLEI INFECTION,1
MY,CANCER SURGERY,1
MY,CARDIAC AMYLOIDOSIS,1
MY,CARDIAC FAILURE CHRONIC,1
MY,CARDIAC FLUTTER,1
MY,CARDIAC MURMUR,1
MY,CARDIAC PROCEDURE COMPLICATION,1
MY,CARDIAC TAMPONADE,1
MY,CARDIO-RESPIRATORY DISTRESS,1
MY,CARDIOTOXICITY,1
MY,CARDIOVASCULAR INSUFFICIENCY,1
MY,CAROTID BODY TUMOUR,1
MY,CATAPLEXY,1
MY,CATHETER SITE ABSCESS,1
MY,CATHETER SITE HAEMATOMA,1
MY,CATHETER SITE HAEMORRHAGE,1
MY,CATHETER SITE RELATED REACTION,1
MY,CAUDA EQUINA SYNDROME,1
MY,CELLULITIS GANGRENOUS,1
MY,CENTRAL NERVOUS SYSTEM HAEMORRHAGE,1
MY,CENTRAL NERVOUS SYSTEM INFECTION,1
MY,CEREBRAL ATROPHY,1
MY,CEREBRAL TOXOPLASMOSIS,1
MY,CHEILITIS,1
MY,CHEMICAL POISONING,1
MY,CHOLANGIOCARCINOMA,1
MY,CHOLECYSTITIS CHRONIC,1
MY,CHOLECYSTITIS INFECTIVE,1
MY,CHOLELITHIASIS,1
MY,CHRONIC GASTRITIS,1
MY,CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER,1
MY,CIRCUMORAL OEDEMA,1
MY,CLAVICLE FRACTURE,1
MY,CLONIC CONVULSION,1
MY,CLONUS,1
MY,CLUSTER HEADACHE,1
MY,COGWHEEL RIGIDITY,1
MY,COLORECTAL CANCER,1
MY,COMPLICATION ASSOCIATED WITH DEVICE,1
MY,COMPRESSION FRACTURE,1
MY,CONGENITAL DIAPHRAGMATIC HERNIA,1
MY,CONGENITAL SMALL INTESTINAL ATRESIA,1
MY,CONJUNCTIVAL HYPERAEMIA,1
MY,CORNEAL PERFORATION,1
MY,CORONARY ARTERY OCCLUSION,1
MY,CROHN^S DISEASE,1
MY,CUTANEOUS VASCULITIS,1
MY,CYANOSIS CENTRAL,1
MY,CYST RUPTURE,1
MY,CYSTITIS RADIATION,1
MY,CYTOTOXIC OEDEMA,1
MY,DECUBITUS ULCER,1
MY,DELIVERY,1
MY,DELUSION OF REFERENCE,1
MY,DEMENTIA ALZHEIMER^S TYPE,1
MY,DERMATITIS,1
MY,DERMATITIS ALLERGIC,1
MY,DEVELOPMENTAL DELAY,1
MY,DEVICE OCCLUSION,1
MY,DEVICE RELATED SEPSIS,1
MY,DIABETIC BLINDNESS,1
MY,DIABETIC FOOT,1
MY,DIARRHOEA HAEMORRHAGIC,1
MY,DISTURBANCE IN ATTENTION,1
MY,DIVERTICULAR PERFORATION,1
MY,DROWNING,1
MY,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
MY,DRUG EFFECT INCOMPLETE,1
MY,DRUG PRESCRIBING ERROR,1
MY,DRUG TOLERANCE,1
MY,DUODENAL ULCER,1
MY,DYSAESTHESIA,1
MY,DYSGEUSIA,1
MY,DYSPHEMIA,1
MY,DYSPNOEA EXERTIONAL,1
MY,EAR DISCOMFORT,1
MY,EAR INFECTION,1
MY,EAR INFECTION BACTERIAL,1
MY,EGFR STATUS ASSAY,1
MY,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
MY,ELECTROCARDIOGRAM T WAVE PEAKED,1
MY,ELEVATED MOOD,1
MY,EMPYEMA,1
MY,ENCEPHALOPATHY,1
MY,ENCEPHALOPATHY NEONATAL,1
MY,ENDOMETRIAL CANCER,1
MY,ENDOMETRIOSIS,1
MY,ENDOMETRITIS,1
MY,ENTEROVESICAL FISTULA,1
MY,EOSINOPHIL COUNT DECREASED,1
MY,EOSINOPHIL COUNT INCREASED,1
MY,EOSINOPHILIA,1
MY,ERYTHEMA OF EYELID,1
MY,EXCESSIVE EYE BLINKING,1
MY,EXERCISE TOLERANCE DECREASED,1
MY,EXFOLIATIVE RASH,1
MY,EXOMPHALOS,1
MY,EXPOSURE VIA BODY FLUID,1
MY,EXTRA DOSE ADMINISTERED,1
MY,EXTRASYSTOLES,1
MY,EYE DISCHARGE,1
MY,EYE INFECTION,1
MY,EYELID FUNCTION DISORDER,1
MY,EYELID PTOSIS,1
MY,FACIAL SPASM,1
MY,FACTOR VIII INHIBITION,1
MY,FEELING GUILTY,1
MY,FIBROADENOMA OF BREAST,1
MY,FISTULA,1
MY,FLANK PAIN,1
MY,FOAMING AT MOUTH,1
MY,FOLATE DEFICIENCY,1
MY,FOOD POISONING,1
MY,FOREIGN BODY ASPIRATION,1
MY,FULL BLOOD COUNT DECREASED,1
MY,FUNGAL PERITONITIS,1
MY,FUNGAL SEPSIS,1
MY,FURUNCLE,1
MY,GALACTORRHOEA,1
MY,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
MY,GASTRECTOMY,1
MY,GASTRIC ULCER,1
MY,GASTRIC ULCER HAEMORRHAGE,1
MY,GASTRITIS HAEMORRHAGIC,1
MY,GASTROINTESTINAL CANCER METASTATIC,1
MY,GASTROINTESTINAL MOTILITY DISORDER,1
MY,GASTROINTESTINAL ULCER,1
MY,GASTROINTESTINAL ULCER HAEMORRHAGE,1
MY,GASTROINTESTINAL WALL THICKENING,1
MY,GASTROOESOPHAGEAL REFLUX DISEASE,1
MV,DEATH,5
ML,HAEMOGLOBIN DECREASED,4
ML,MALARIA,4
ML,DRUG INEFFECTIVE,3
ML,WHITE BLOOD CELL COUNT INCREASED,3
ML,ACUTE MYELOID LEUKAEMIA,2
ML,COUGH,2
ML,DEATH,2
ML,DECREASED APPETITE,2
ML,DEHYDRATION,2
ML,GASTRITIS EROSIVE,2
ML,HEADACHE,2
ML,LUNG INFECTION,2
ML,ORAL CANDIDIASIS,2
ML,PLATELET COUNT INCREASED,2
ML,PYREXIA,2
ML,VOMITING,2
ML,ACQUIRED IMMUNODEFICIENCY SYNDROME,1
ML,BLOOD CREATINE INCREASED,1
ML,BODY TEMPERATURE INCREASED,1
ML,BREAST SWELLING,1
ML,CEREBROVASCULAR ACCIDENT,1
ML,CHRONIC MYELOID LEUKAEMIA,1
ML,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
ML,CONJUNCTIVAL HAEMORRHAGE,1
ML,CONTRAINDICATED PRODUCT ADMINISTERED,1
ML,DERMATITIS ALLERGIC,1
ML,DRUG ERUPTION,1
ML,DRUG INTOLERANCE,1
ML,DYSPNOEA,1
ML,DYSPNOEA EXERTIONAL,1
ML,ECTOPIC PREGNANCY UNDER HORMONAL CONTRACEPTION,1
ML,ERYTHEMA MULTIFORME,1
ML,EYE DISORDER,1
ML,FUNGAL INFECTION,1
ML,GENERAL PHYSICAL CONDITION ABNORMAL,1
ML,GENERAL PHYSICAL HEALTH DETERIORATION,1
ML,HAEMORRHAGE,1
ML,HELICOBACTER GASTRITIS,1
ML,HYPOALBUMINAEMIA,1
ML,INCREASED BRONCHIAL SECRETION,1
ML,INFECTION,1
ML,MONOCYTE COUNT INCREASED,1
ML,NAUSEA,1
ML,OEDEMA PERIPHERAL,1
ML,PALPITATIONS,1
ML,PLATELET COUNT DECREASED,1
ML,PRURITUS,1
ML,RUPTURED ECTOPIC PREGNANCY,1
ML,SWELLING FACE,1
ML,ULCER,1
ML,WHITE BLOOD CELL COUNT DECREASED,1
MT,DEATH,16
MT,NEUROLEPTIC MALIGNANT SYNDROME,16
MT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,15
MT,DYSPNOEA,14
MT,ASTHMA,12
MT,NAUSEA,9
MT,PYREXIA,9
MT,LOWER RESPIRATORY TRACT INFECTION,8
MT,MALIGNANT HYPERTENSION,8
MT,COUGH,7
MT,SYNCOPE,7
MT,VOMITING,7
MT,DRUG WITHDRAWAL SYNDROME,6
MT,NEUTROPENIC SEPSIS,6
MT,PRURITUS,6
MT,TOXICITY TO VARIOUS AGENTS,6
MT,ASTHENIA,5
MT,ATRIAL FIBRILLATION,5
MT,DISEASE PROGRESSION,5
MT,FLUID RETENTION,5
MT,FOOD INTERACTION,5
MT,LOSS OF CONSCIOUSNESS,5
MT,MALAISE,5
MT,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,5
MT,PANCYTOPENIA,5
MT,PNEUMONIA,5
MT,AMYLASE INCREASED,4
MT,CONFUSIONAL STATE,4
MT,DIARRHOEA,4
MT,DRUG INEFFECTIVE,4
MT,ERYTHEMA,4
MT,FALL,4
MT,HAEMOLYSIS,4
MT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
MT,INSOMNIA,4
MT,MOBILITY DECREASED,4
MT,MYOCARDIAL INFARCTION,4
MT,OCULAR HYPERAEMIA,4
MT,PAIN,4
MT,PERIPHERAL SWELLING,4
MT,RESPIRATORY FAILURE,4
MT,SWELLING FACE,4
MT,ABDOMINAL PAIN,3
MT,ACCELERATED HYPERTENSION,3
MT,ACUTE KIDNEY INJURY,3
MT,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,3
MT,BLOOD PRESSURE INCREASED,3
MT,CARDIAC ARREST,3
MT,CARDIAC FAILURE,3
MT,CHEST PAIN,3
MT,DELIRIUM,3
MT,DRUG DOSE OMISSION,3
MT,GASTRIC ULCER,3
MT,HAEMATEMESIS,3
MT,HEADACHE,3
MT,HIP FRACTURE,3
MT,INTESTINAL ANGINA,3
MT,PARAESTHESIA ORAL,3
MT,PRODUCTIVE COUGH,3
MT,RECTAL HAEMORRHAGE,3
MT,RENAL FAILURE,3
MT,RETINAL HAEMORRHAGE,3
MT,SEIZURE,3
MT,URINARY TRACT INFECTION,3
MT,WEIGHT INCREASED,3
MT,WHEEZING,3
MT,ACCIDENTAL OVERDOSE,2
MT,AGITATION,2
MT,ALOPECIA,2
MT,ANXIETY,2
MT,BACK PAIN,2
MT,BALANCE DISORDER,2
MT,BLOOD PRESSURE DECREASED,2
MT,CAROTID ARTERY THROMBOSIS,2
MT,CHEST DISCOMFORT,2
MT,CHILLS,2
MT,COAGULOPATHY,2
MT,CONJUNCTIVITIS,2
MT,CONTUSION,2
MT,CONVULSION,2
MT,DECREASED APPETITE,2
MT,DEPRESSED MOOD,2
MT,DERMATITIS BULLOUS,2
MT,DISEASE RECURRENCE,2
MT,DISTURBANCE IN ATTENTION,2
MT,DIZZINESS,2
MT,DYSPNOEA AT REST,2
MT,EMBOLISM,2
MT,EPISTAXIS,2
MT,EYE IRRITATION,2
MT,FATIGUE,2
MT,FOETAL EXPOSURE DURING PREGNANCY,2
MT,GINGIVAL BLEEDING,2
MT,HAEMOGLOBINURIA,2
MT,HEPATIC ENCEPHALOPATHY,2
MT,HYPERGLYCAEMIA,2
MT,HYPERHIDROSIS,2
MT,HYPERPYREXIA,2
MT,HYPERSENSITIVITY,2
MT,HYPOXIA,2
MT,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
MT,INFECTION,2
MT,INJECTION SITE PAIN,2
MT,INTENTIONAL PRODUCT MISUSE,2
MT,INTERNATIONAL NORMALISED RATIO INCREASED,2
MT,INTESTINAL HAEMATOMA,2
MT,JAUNDICE NEONATAL,2
MT,LICHEN PLANUS,2
MT,LIP HAEMATOMA,2
MT,LOCAL SWELLING,2
MT,MACULOPATHY,2
MT,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,2
MT,NASAL CONGESTION,2
MT,NEPHROPATHY,2
MT,NEUTROPENIA,2
MT,NIGHT SWEATS,2
MT,OEDEMA,2
MT,OESOPHAGEAL VARICES HAEMORRHAGE,2
MT,ORAL CANDIDIASIS,2
MT,OSTEOPOROSIS,2
MT,PAIN IN EXTREMITY,2
MT,PNEUMONIA ASPIRATION,2
MT,PRODUCT USE IN UNAPPROVED INDICATION,2
MT,PROTHROMBIN TIME PROLONGED,2
MT,PSORIASIS,2
MT,PULMONARY EMBOLISM,2
MT,PULMONARY OEDEMA,2
MT,PULMONARY SENSITISATION,2
MT,RASH,2
MT,RASH GENERALISED,2
MT,RENAL CANCER,2
MT,SALIVARY HYPERSECRETION,2
MT,SEPSIS,2
MT,SMALL INTESTINAL OBSTRUCTION,2
MT,STRESS CARDIOMYOPATHY,2
MT,TACHYPNOEA,2
MT,TREMOR,2
MT,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
MT,ABDOMINAL DISCOMFORT,1
MT,ABDOMINAL DISTENSION,1
MT,ABDOMINAL PAIN UPPER,1
MT,ABDOMINAL TENDERNESS,1
MT,ABDOMINAL WALL ABSCESS,1
MT,ABNORMAL BEHAVIOUR,1
MT,ABSCESS RUPTURE,1
MT,ACUTE MYELOID LEUKAEMIA,1
MT,ADRENAL INSUFFICIENCY,1
MT,AGEUSIA,1
MT,AGGRESSION,1
MT,ALLERGIC GRANULOMATOUS ANGIITIS,1
MT,ANAEMIA,1
MT,ANAL ATRESIA,1
MT,ANALGESIC DRUG LEVEL INCREASED,1
MT,ANAPHYLACTIC SHOCK,1
MT,ANGIOEDEMA,1
MT,ANOSMIA,1
MT,ANTINUCLEAR ANTIBODY INCREASED,1
MT,APPLICATION SITE OEDEMA,1
MT,ARRHYTHMIA,1
MT,ARTHRALGIA,1
MT,ASCITES,1
MT,ASPIRATION,1
MT,ATAXIA,1
MT,ATYPICAL FRACTURE,1
MT,BACTERIAL INFECTION,1
MT,BASAL CELL CARCINOMA,1
MT,BASOSQUAMOUS CARCINOMA OF SKIN,1
MT,BLADDER TRANSITIONAL CELL CARCINOMA STAGE II,1
MT,BLINDNESS,1
MT,BLISTER,1
MT,BLOOD CHLORIDE DECREASED,1
MT,BLOOD CHOLESTEROL INCREASED,1
MT,BLOOD CREATININE INCREASED,1
MT,BLOOD DISORDER,1
MT,BLOOD GLUCOSE INCREASED,1
MT,BLOOD LACTATE DEHYDROGENASE INCREASED,1
MT,BLOOD POTASSIUM INCREASED,1
MT,BLOOD PRESSURE ORTHOSTATIC DECREASED,1
MT,BLOOD TESTOSTERONE INCREASED,1
MT,BLOOD UREA INCREASED,1
MT,BLOOD URIC ACID INCREASED,1
MT,BLOOD URINE PRESENT,1
MT,BRADYCARDIA,1
MT,BRAIN OEDEMA,1
MT,BRONCHITIS,1
MT,C-REACTIVE PROTEIN INCREASED,1
MT,CACHEXIA,1
MT,CAMPYLOBACTER TEST POSITIVE,1
MT,CARDIAC FAILURE CHRONIC,1
MT,CARDIAC FAILURE CONGESTIVE,1
MT,CARDIOVASCULAR DISORDER,1
MT,CASTLEMAN^S DISEASE,1
MT,CHOKING,1
MT,CHROMATURIA,1
MT,CHRONIC KIDNEY DISEASE,1
MT,CHVOSTEK^S SIGN,1
MT,CLOSTRIDIAL INFECTION,1
MT,COGNITIVE DISORDER,1
MT,COLITIS,1
MT,COLITIS ULCERATIVE,1
MT,COLON CANCER,1
MT,CONSTIPATION,1
MT,COORDINATION ABNORMAL,1
MT,CROHN^S DISEASE,1
MT,DECREASED INTEREST,1
MT,DEEP VEIN THROMBOSIS,1
MT,DEHYDRATION,1
MT,DEMENTIA,1
MT,DEPRESSED LEVEL OF CONSCIOUSNESS,1
MT,DEPRESSION,1
MT,DIPLOPIA,1
MT,DIZZINESS POSTURAL,1
MT,DRUG ADMINISTRATION ERROR,1
MT,DRUG EFFECT DELAYED,1
MT,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
MT,DRUG LEVEL DECREASED,1
MT,DRUG SPECIFIC ANTIBODY PRESENT,1
MT,DRY SKIN,1
MT,DUODENAL ULCER,1
MT,DYSARTHRIA,1
MT,DYSGEUSIA,1
MT,DYSPEPSIA,1
MT,DYSPHAGIA,1
MT,DYSPHONIA,1
MT,DYSSTASIA,1
MT,ENDOCARDITIS,1
MT,EXPOSED BONE IN JAW,1
MT,EXPOSURE TO ALLERGEN,1
MT,EYE INFECTION INTRAOCULAR,1
MT,EYE INFLAMMATION,1
MT,EYE MOVEMENT DISORDER,1
MT,EYE PRURITUS,1
MT,EYE SWELLING,1
MT,EYELID INJURY,1
MT,EYELID SKIN DRYNESS,1
MT,FACE OEDEMA,1
MT,FACIAL PARALYSIS,1
MT,FAECAL CALPROTECTIN INCREASED,1
MT,FAECES DISCOLOURED,1
MT,FEELING ABNORMAL,1
MT,FEELING OF DESPAIR,1
MT,FLUID IMBALANCE,1
MT,FLUSHING,1
MT,FOLLICULITIS,1
MT,FRACTURE,1
MT,FULL BLOOD COUNT DECREASED,1
MT,GAIT DISTURBANCE,1
MT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
MT,GANGRENE,1
MT,GASTROINTESTINAL DISORDER,1
MT,GASTROINTESTINAL HAEMORRHAGE,1
MT,GASTROINTESTINAL MOTILITY DISORDER,1
MT,GASTROINTESTINAL PAIN,1
MT,GENERAL PHYSICAL HEALTH DETERIORATION,1
MT,GENERALISED TONIC-CLONIC SEIZURE,1
MT,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
MT,GOUT,1
MT,GRAND MAL CONVULSION,1
MT,GYNAECOMASTIA,1
MT,HAEMATURIA,1
MT,HAEMOGLOBIN DECREASED,1
MT,HAEMOPTYSIS,1
MT,HAEMORRHAGE IN PREGNANCY,1
MT,HALLUCINATION,1
MT,HALLUCINATION_ VISUAL,1
MT,HEAD INJURY,1
MT,HEPATIC CIRRHOSIS,1
MT,HEPATIC FUNCTION ABNORMAL,1
MT,HEPATITIS,1
MT,HEPATITIS CHOLESTATIC,1
MT,HEPATORENAL FAILURE,1
MT,HEPATOTOXICITY,1
MT,HERPES ZOSTER,1
MT,HIGH DENSITY LIPOPROTEIN DECREASED,1
MT,HIV INFECTION,1
MT,HYPERBILIRUBINAEMIA,1
MT,HYPERKALAEMIA,1
MT,HYPERTENSION,1
MT,HYPERTONIA,1
MT,HYPOAESTHESIA ORAL,1
MT,HYPOALBUMINAEMIA,1
MT,HYPOCALCAEMIA,1
MT,HYPOMAGNESAEMIA,1
MT,HYPOTENSION,1
MT,HYPOTHERMIA,1
MT,ILEUS PARALYTIC,1
MT,IMMUNE SYSTEM DISORDER,1
MT,IMPAIRED HEALING,1
MT,INCOHERENT,1
MT,INCORRECT DOSE ADMINISTERED,1
MT,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
MT,INFLUENZA,1
MT,INFLUENZA LIKE ILLNESS,1
MT,INJECTION SITE EXTRAVASATION,1
MT,INJECTION SITE REACTION,1
MT,INTENTIONAL DRUG MISUSE,1
MT,INTENTIONAL OVERDOSE,1
MT,INTESTINAL ISCHAEMIA,1
MT,INTESTINAL MASS,1
MT,INTESTINAL OBSTRUCTION,1
MT,INTESTINAL STENOSIS,1
MT,INTRAVASCULAR HAEMOLYSIS,1
MT,JOINT SWELLING,1
MT,LABORATORY TEST ABNORMAL,1
MT,LARGE INTESTINE POLYP,1
MT,LETHARGY,1
MT,LIVER ABSCESS,1
MT,LIVER DISORDER,1
MT,LIVER FUNCTION TEST ABNORMAL,1
MT,LOCALISED OEDEMA,1
MT,LOW DENSITY LIPOPROTEIN INCREASED,1
MT,LUNG ADENOCARCINOMA METASTATIC,1
MT,LUNG NEOPLASM MALIGNANT,1
MT,LYMPHADENOPATHY,1
MT,MALIGNANT NEOPLASM PROGRESSION,1
MT,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
MT,MEMORY IMPAIRMENT,1
MT,MESENTERIC VEIN THROMBOSIS,1
MT,METABOLIC ENCEPHALOPATHY,1
MT,METASTASES TO ADRENALS,1
MT,METASTASES TO SPINE,1
MT,MICTURITION URGENCY,1
MT,MIGRAINE,1
MT,MOUTH ULCERATION,1
MT,MULTIPLE SCLEROSIS,1
MT,MULTIPLE SCLEROSIS RELAPSE,1
MT,MUSCLE RIGIDITY,1
MT,MUSCLE SPASMS,1
MT,MUSCLE TWITCHING,1
MT,MUSCULAR WEAKNESS,1
MT,MUSCULOSKELETAL STIFFNESS,1
MT,NAIL DISORDER,1
MT,NASOPHARYNGITIS,1
MT,NECK PAIN,1
MT,NEOPLASM,1
MT,NEOPLASM MALIGNANT,1
MT,NERVOUS SYSTEM DISORDER,1
MT,NEURODERMATITIS,1
MT,NEUTROPHIL COUNT DECREASED,1
MT,NIGHTMARE,1
MT,NO THERAPEUTIC RESPONSE,1
MT,OEDEMA PERIPHERAL,1
MT,OESOPHAGITIS,1
MT,ONYCHOLYSIS,1
MT,OPSOCLONUS MYOCLONUS,1
MT,ORBITAL OEDEMA,1
MT,OSTEOARTHRITIS,1
MT,OSTEOMYELITIS,1
MT,OSTEONECROSIS OF JAW,1
MT,OSTEOPENIA,1
MT,OVERDOSE,1
MT,OXYGEN SATURATION DECREASED,1
MT,PANIC ATTACK,1
MT,PARAESTHESIA,1
MT,PARKINSON^S DISEASE,1
MT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
MT,PETECHIAE,1
MT,PHOTOPHOBIA,1
MT,PHOTOSENSITIVITY REACTION,1
MT,PLATELET COUNT INCREASED,1
MT,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
MT,POLYP,1
MT,PORTAL VEIN THROMBOSIS,1
MT,POST PROCEDURAL COMPLICATION,1
MT,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
MT,PRODUCT ADHESION ISSUE,1
MT,PRODUCT QUALITY ISSUE,1
MT,PRODUCT SUBSTITUTION ERROR,1
MT,PRODUCT SUBSTITUTION ISSUE,1
MT,PRODUCT USE ISSUE,1
MT,PROSTATE CANCER,1
MT,PROSTATE CANCER STAGE III,1
MT,PRURITUS GENERALISED,1
MT,PSORIATIC ARTHROPATHY,1
MT,PSYCHOMOTOR HYPERACTIVITY,1
MT,PULMONARY FIBROSIS,1
MT,PURULENT DISCHARGE,1
MT,QUALITY OF LIFE DECREASED,1
MT,RADIATION SKIN INJURY,1
MT,RASH ERYTHEMATOUS,1
MT,RASH MACULAR,1
MT,RASH PRURITIC,1
MT,RECTAL ADENOCARCINOMA,1
MT,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
MT,RENAL DISORDER,1
MT,RENAL FAILURE ACUTE,1
MT,RENAL IMPAIRMENT,1
MT,RESTLESSNESS,1
MT,RHABDOMYOLYSIS,1
MT,RHEUMATOID ARTHRITIS,1
MT,RHINORRHOEA,1
MT,RIGHT ATRIAL DILATATION,1
MT,RIGHT VENTRICULAR DILATATION,1
MT,RIGHT VENTRICULAR DYSFUNCTION,1
MT,RIGHT VENTRICULAR FAILURE,1
MT,SCRATCH,1
MT,SENSATION OF FOREIGN BODY,1
MT,SENSORY LOSS,1
MT,SEXUAL DYSFUNCTION,1
MT,SKIN EXFOLIATION,1
MT,SKIN FISSURES,1
MT,SKIN NECROSIS,1
MT,SKIN ULCER,1
MT,SLEEP TALKING,1
MT,SMALL INTESTINAL HAEMORRHAGE,1
MT,SOFT TISSUE INFECTION,1
MT,SOMNOLENCE,1
MT,SPEECH DISORDER,1
MT,SPINAL DISORDER,1
MT,SPINAL FRACTURE,1
MT,SPINAL OSTEOARTHRITIS,1
MT,STAPHYLOCOCCAL INFECTION,1
MT,STAPHYLOCOCCUS TEST POSITIVE,1
MT,STRESS,1
MT,SUBILEUS,1
MT,SUDDEN DEATH,1
MT,SWELLING,1
MT,TACHYCARDIA,1
MT,TESTICULAR PAIN,1
MT,TETANY,1
MT,THERAPY RESPONDER,1
MT,THROMBOPHLEBITIS SUPERFICIAL,1
MT,TOTAL CHOLESTEROL/HDL RATIO INCREASED,1
MT,TRANSIENT GLOBAL AMNESIA,1
MT,TRANSIENT ISCHAEMIC ATTACK,1
MT,TRANSITIONAL CELL CARCINOMA,1
MT,TRISOMY 21,1
MT,TROUSSEAU^S SIGN,1
MT,TUBERCULOSIS,1
MT,TUMEFACTIVE MULTIPLE SCLEROSIS,1
MT,UNEVALUABLE EVENT,1
MT,UPPER GASTROINTESTINAL HAEMORRHAGE,1
MT,UPPER LIMB FRACTURE,1
MT,URINARY RETENTION,1
MT,UTERINE LEIOMYOMA,1
MT,UVEITIS,1
MT,VEIN RUPTURE,1
MT,VIITH NERVE PARALYSIS,1
MT,VIRAL INFECTION,1
MT,VISION BLURRED,1
MT,VITAMIN D DECREASED,1
MT,WALKING DISABILITY,1
MT,WEIGHT DECREASED,1
MT,WHITE BLOOD CELL COUNT DECREASED,1
MT,WHITE BLOOD CELL COUNT INCREASED,1
MQ,ACUTE MYELOID LEUKAEMIA,1
MQ,ANOMALY OF EXTERNAL EAR CONGENITAL,1
MQ,APGAR SCORE LOW,1
MQ,ASPERGILLUS INFECTION,1
MQ,B-CELL LYMPHOMA,1
MQ,BLOOD LACTATE DEHYDROGENASE INCREASED,1
MQ,BREECH PRESENTATION,1
MQ,CARDIAC MURMUR,1
MQ,CARDIAC VALVE DISEASE,1
MQ,CONGENITAL ANOMALY,1
MQ,CONGENITAL HAND MALFORMATION,1
MQ,CONGENITAL NOSE MALFORMATION,1
MQ,DISEASE PROGRESSION,1
MQ,DISTURBANCE IN ATTENTION,1
MQ,DRUG INEFFECTIVE,1
MQ,DYSMORPHISM,1
MQ,FEBRILE NEUTROPENIA,1
MQ,FOETAL ANTICONVULSANT SYNDROME,1
MQ,FOETAL EXPOSURE DURING PREGNANCY,1
MQ,FUNGAL INFECTION,1
MQ,HAEMOGLOBIN DECREASED,1
MQ,HEADACHE,1
MQ,HYPERGLYCAEMIA,1
MQ,HYPERTELORISM OF ORBIT,1
MQ,HYPERTONIA,1
MQ,HYPERTRICHOSIS,1
MQ,HYPOTONIA,1
MQ,IMMUNODEFICIENCY,1
MQ,INTESTINAL STENOSIS,1
MQ,INTRACARDIAC THROMBUS,1
MQ,MALAISE,1
MQ,MUSCLE DISORDER,1
MQ,NECK DEFORMITY,1
MQ,PLATELET COUNT DECREASED,1
MQ,RENAL FAILURE,1
MQ,RETROGNATHIA,1
MQ,SEPSIS,1
MQ,SEPTIC SHOCK,1
MQ,SKIN DISCOLOURATION,1
MQ,SKIN HAEMORRHAGE,1
MQ,SKIN LESION,1
MQ,SKIN ULCER,1
MQ,SYNCOPE,1
MQ,VOMITING,1
MQ,WHITE BLOOD CELL COUNT INCREASED,1
MR,HEPATIC ENCEPHALOPATHY,1
MR,JAUNDICE,1
MR,MELANODERMA,1
MR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
MR,SKIN DISORDER,1
MU,DEATH,5
MU,BLINDNESS,4
MU,INFECTION,4
MU,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,4
MU,CHRONIC MYELOID LEUKAEMIA,3
MU,INTENTIONAL OVERDOSE,3
MU,PULMONARY EMBOLISM,3
MU,VERTIGO,3
MU,ACUTE KIDNEY INJURY,2
MU,CEREBROVASCULAR ACCIDENT,2
MU,GASTROINTESTINAL DISORDER,2
MU,GASTROINTESTINAL STROMAL TUMOUR,2
MU,PYREXIA,2
MU,SUICIDE ATTEMPT,2
MU,THROMBOSIS IN DEVICE,2
MU,ABASIA,1
MU,ABDOMINAL MASS,1
MU,ACUTE HEPATITIS B,1
MU,ANAL PRURITUS,1
MU,ANAPHYLACTIC REACTION,1
MU,ANORECTAL DISORDER,1
MU,APLASIA PURE RED CELL,1
MU,BALANCE DISORDER,1
MU,BONE MARROW DISORDER,1
MU,BRONCHOSPASM,1
MU,CELLULITIS,1
MU,CHOLESTATIC LIVER INJURY,1
MU,CIRCULATORY COLLAPSE,1
MU,COMPLETED SUICIDE,1
MU,COORDINATION ABNORMAL,1
MU,CORONARY ARTERY DISEASE,1
MU,DEEP VEIN THROMBOSIS,1
MU,DERMATITIS BULLOUS,1
MU,DIABETIC KETOACIDOSIS,1
MU,DIABETIC NEPHROPATHY,1
MU,DISORIENTATION,1
MU,DRUG INEFFECTIVE,1
MU,DRUG RESISTANCE,1
MU,DYSPNOEA,1
MU,ELECTROLYTE IMBALANCE,1
MU,FATIGUE,1
MU,FOETAL EXPOSURE DURING PREGNANCY,1
MU,GASTRITIS,1
MU,GASTROINTESTINAL NECROSIS,1
MU,HEPATIC FAILURE,1
MU,HEPATITIS ACUTE,1
MU,HYPERSENSITIVITY,1
MU,HYPERVISCOSITY SYNDROME,1
MU,HYPOMANIA,1
MU,INTERMITTENT CLAUDICATION,1
MU,INTRACRANIAL HAEMATOMA,1
MU,LOGORRHOEA,1
MU,LOSS OF CONSCIOUSNESS,1
MU,LOWER RESPIRATORY TRACT INFECTION,1
MU,MALIGNANT NEOPLASM PROGRESSION,1
MU,MANIA,1
MU,MUSCLE CONTRACTIONS INVOLUNTARY,1
MU,MUSCLE RIGIDITY,1
MU,MUSCULAR WEAKNESS,1
MU,MYOCARDIAL INFARCTION,1
MU,NEOPLASM RECURRENCE,1
MU,NEUTROPENIA,1
MU,PALPITATIONS,1
MU,PARESIS,1
MU,PARONYCHIA,1
MU,PEMPHIGUS,1
MU,PLATELET COUNT DECREASED,1
MU,PREMATURE BABY,1
MU,PRODUCT USE IN UNAPPROVED INDICATION,1
MU,PYOGENIC GRANULOMA,1
MU,RECTAL DISCHARGE,1
MU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
MU,SEIZURE,1
MU,SKIN EXFOLIATION,1
MU,SKIN LESION,1
MU,SOMNOLENCE,1
MU,THERAPEUTIC RESPONSE DECREASED,1
MU,THERAPY NON-RESPONDER,1
MU,WHITE BLOOD CELL COUNT DECREASED,1
MU,WHITE BLOOD CELL COUNT INCREASED,1
MX,DEATH,2086
MX,FALL,526
MX,HEADACHE,512
MX,MALAISE,497
MX,FATIGUE,454
MX,PNEUMONIA,450
MX,DRUG INEFFECTIVE,440
MX,HYPERTENSION,417
MX,DIARRHOEA,402
MX,DIZZINESS,392
MX,PYREXIA,384
MX,BLOOD PRESSURE INCREASED,369
MX,DYSPNOEA,366
MX,VOMITING,365
MX,PAIN,363
MX,NAUSEA,340
MX,ASTHENIA,324
MX,PAIN IN EXTREMITY,316
MX,DISEASE PROGRESSION,301
MX,FEELING ABNORMAL,300
MX,PRODUCT USE ISSUE,296
MX,WEIGHT DECREASED,280
MX,ARTHRALGIA,268
MX,GAIT DISTURBANCE,265
MX,BLOOD GLUCOSE INCREASED,264
MX,COUGH,259
MX,DIABETES MELLITUS,253
MX,WRONG TECHNIQUE IN DRUG USAGE PROCESS,244
MX,ANXIETY,227
MX,INFARCTION,224
MX,MYOCARDIAL INFARCTION,214
MX,DECREASED APPETITE,212
MX,URINARY TRACT INFECTION,207
MX,DEPRESSION,205
MX,ANAEMIA,196
MX,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,195
MX,INSOMNIA,191
MX,GENERAL PHYSICAL HEALTH DETERIORATION,182
MX,INFLUENZA,181
MX,SOMNOLENCE,180
MX,HYPERGLYCAEMIA,176
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,176
MX,MEMORY IMPAIRMENT,175
MX,CEREBROVASCULAR ACCIDENT,173
MX,RENAL FAILURE,173
MX,ABASIA,169
MX,DRUG PRESCRIBING ERROR,166
MX,SPEECH DISORDER,162
MX,RESPIRATORY FAILURE,160
MX,SEIZURE,156
MX,TACHYCARDIA,153
MX,ABDOMINAL PAIN,152
MX,BLOOD PRESSURE DECREASED,148
MX,FEBRILE NEUTROPENIA,147
MX,RASH,144
MX,ABDOMINAL PAIN UPPER,142
MX,BACK PAIN,142
MX,DEHYDRATION,140
MX,GASTRITIS,139
MX,ARRHYTHMIA,137
MX,CARDIAC DISORDER,137
MX,BONE PAIN,136
MX,CATARACT,133
MX,HYPOTENSION,133
MX,VISUAL IMPAIRMENT,132
MX,CARDIAC FAILURE,128
MX,SYNCOPE,128
MX,CHEST PAIN,125
MX,PRODUCT USE IN UNAPPROVED INDICATION,125
MX,RESPIRATORY ARREST,125
MX,CONSTIPATION,122
MX,MALIGNANT NEOPLASM PROGRESSION,121
MX,BLINDNESS,120
MX,DEAFNESS,116
MX,WEIGHT INCREASED,115
MX,CARDIAC ARREST,113
MX,TOXICITY TO VARIOUS AGENTS,113
MX,CARDIO-RESPIRATORY ARREST,112
MX,HAEMORRHAGE,112
MX,PERIPHERAL SWELLING,109
MX,INFECTION,106
MX,OEDEMA PERIPHERAL,104
MX,PRURITUS,103
MX,CONVULSION,101
MX,INFLAMMATION,100
MX,NEUTROPENIA,100
MX,THROMBOSIS,100
MX,EMBOLISM,99
MX,TREMOR,99
MX,VISION BLURRED,99
MX,DEPRESSED MOOD,98
MX,LOSS OF CONSCIOUSNESS,98
MX,SEPTIC SHOCK,98
MX,MOBILITY DECREASED,97
MX,RENAL DISORDER,95
MX,STRESS,95
MX,THROMBOCYTOPENIA,95
MX,CEREBRAL INFARCTION,90
MX,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,90
MX,MUSCLE SPASMS,88
MX,HIP FRACTURE,87
MX,HYPOAESTHESIA,86
MX,ERYTHEMA,85
MX,EXPOSURE DURING PREGNANCY,85
MX,FLUID RETENTION,85
MX,HAEMOGLOBIN DECREASED,85
MX,PLATELET COUNT DECREASED,85
MX,HYPOGLYCAEMIA,84
MX,SEPSIS,84
MX,MUSCULAR WEAKNESS,83
MX,ASPHYXIA,82
MX,INCORRECT DOSE ADMINISTERED,82
MX,NEOPLASM MALIGNANT,82
MX,PARAESTHESIA,80
MX,CONDITION AGGRAVATED,79
MX,LUNG DISORDER,78
MX,BLOOD CHOLESTEROL INCREASED,77
MX,GASTROINTESTINAL HAEMORRHAGE,76
MX,EPISTAXIS,75
MX,DRY SKIN,74
MX,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,72
MX,DISCOMFORT,72
MX,BRONCHITIS,71
MX,BLOOD PRESSURE INADEQUATELY CONTROLLED,70
MX,DRUG INTOLERANCE,69
MX,HYPERHIDROSIS,69
MX,FOETAL EXPOSURE DURING PREGNANCY,68
MX,MOVEMENT DISORDER,68
MX,VISUAL ACUITY REDUCED,68
MX,APHASIA,66
MX,RESPIRATORY DISORDER,66
MX,BLOOD TRIGLYCERIDES INCREASED,65
MX,BREAST CANCER,65
MX,HYPOACUSIS,65
MX,ABDOMINAL DISCOMFORT,64
MX,AMNESIA,64
MX,COLITIS,64
MX,PARKINSON^S DISEASE,64
MX,ABDOMINAL DISTENSION,63
MX,ALOPECIA,63
MX,HOSPITALISATION,63
MX,HYPERSENSITIVITY,63
MX,URTICARIA,63
MX,BLOOD GLUCOSE DECREASED,62
MX,CHILLS,62
MX,NERVOUSNESS,62
MX,BURNING SENSATION,61
MX,LIMB DISCOMFORT,61
MX,MUSCULOSKELETAL PAIN,61
MX,MYALGIA,61
MX,OSTEOPOROSIS,61
MX,VERTIGO,60
MX,ARTHROPATHY,59
MX,PRODUCTIVE COUGH,59
MX,SWELLING,59
MX,MATERNAL EXPOSURE DURING PREGNANCY,58
MX,PULMONARY OEDEMA,58
MX,DEMENTIA ALZHEIMER^S TYPE,57
MX,SURGERY,57
MX,DYSSTASIA,56
MX,GASTROINTESTINAL DISORDER,56
MX,PULMONARY FIBROSIS,56
MX,DYSPEPSIA,55
MX,DYSPHAGIA,55
MX,GLAUCOMA,55
MX,JOINT INJURY,55
MX,LOWER LIMB FRACTURE,55
MX,DISORIENTATION,54
MX,PHARYNGITIS,54
MX,SKIN DISCOLOURATION,54
MX,IRRITABILITY,53
MX,ACUTE KIDNEY INJURY,52
MX,CHOLELITHIASIS,52
MX,EYE PAIN,52
MX,INTESTINAL OBSTRUCTION,52
MX,NERVOUS SYSTEM DISORDER,52
MX,UPPER LIMB FRACTURE,52
MX,ACCIDENT,51
MX,CARDIOMEGALY,51
MX,ARTHRITIS,50
MX,PLEURAL EFFUSION,50
MX,ROAD TRAFFIC ACCIDENT,50
MX,ACUTE MYOCARDIAL INFARCTION,49
MX,BLOOD PRESSURE FLUCTUATION,49
MX,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,49
MX,DYSPHONIA,49
MX,HYPERTENSIVE CRISIS,49
MX,PULMONARY EMBOLISM,49
MX,EPILEPSY,48
MX,KIDNEY INFECTION,48
MX,SENILE DEMENTIA,48
MX,ABNORMAL BEHAVIOUR,47
MX,HEAD INJURY,47
MX,RENAL CANCER,47
MX,CONFUSIONAL STATE,46
MX,DRUG DOSE OMISSION,46
MX,EATING DISORDER,46
MX,EYE DISORDER,46
MX,FEMUR FRACTURE,46
MX,GASTROOESOPHAGEAL REFLUX DISEASE,46
MX,INFUSION RELATED REACTION,46
MX,NEUROPATHY PERIPHERAL,46
MX,AGITATION,45
MX,LOCAL SWELLING,45
MX,MULTIPLE SCLEROSIS RELAPSE,45
MX,BALANCE DISORDER,44
MX,CEREBRAL HAEMORRHAGE,44
MX,CONTUSION,44
MX,MUSCULOSKELETAL STIFFNESS,44
MX,ASTHMA,43
MX,CARDIOVASCULAR DISORDER,43
MX,HALLUCINATION,43
MX,INTENTIONAL PRODUCT MISUSE,43
MX,ANGINA PECTORIS,42
MX,AGGRESSION,41
MX,JOINT SWELLING,41
MX,OROPHARYNGEAL PAIN,41
MX,OVERDOSE,41
MX,PALLOR,41
MX,TYPE 2 DIABETES MELLITUS,41
MX,ABORTION SPONTANEOUS,40
MX,BLOOD CREATININE INCREASED,40
MX,CHEST DISCOMFORT,40
MX,LACTIC ACIDOSIS,40
MX,MUCOSAL INFLAMMATION,40
MX,NECK PAIN,40
MX,PANCREATITIS,40
MX,PROSTATE CANCER,40
MX,SPINAL DISORDER,40
MX,THYROID DISORDER,40
MX,BACTERAEMIA,39
MX,FEAR,39
MX,HEPATIC CANCER,39
MX,SKIN EXFOLIATION,39
MX,SPINAL PAIN,39
MX,STOMATITIS,39
MX,NASOPHARYNGITIS,38
MX,POISONING,38
MX,ARTERIAL OCCLUSIVE DISEASE,37
MX,DRY MOUTH,37
MX,EYE HAEMORRHAGE,37
MX,HYPOTHYROIDISM,37
MX,MULTIPLE ORGAN DYSFUNCTION SYNDROME,37
MX,NEPHROLITHIASIS,37
MX,SLEEP DISORDER,37
MX,BLISTER,36
MX,BLOOD PRESSURE ABNORMAL,36
MX,BONE DISORDER,36
MX,CRYING,36
MX,HAEMATURIA,36
MX,HEMIPLEGIA,36
MX,HYPOKINESIA,36
MX,HYPOPHAGIA,36
MX,PREMATURE BABY,36
MX,RENAL IMPAIRMENT,36
MX,RESPIRATORY DISTRESS,36
MX,SUSPECTED COUNTERFEIT PRODUCT,36
MX,TOXIC EPIDERMAL NECROLYSIS,36
MX,TUBERCULOSIS,36
MX,CONCOMITANT DISEASE AGGRAVATED,35
MX,DRUG DEPENDENCE,35
MX,DRUG HYPERSENSITIVITY,35
MX,DYSURIA,35
MX,FEELING OF DESPAIR,35
MX,INCORRECT ROUTE OF DRUG ADMINISTRATION,35
MX,LEUKOCYTOSIS,35
MX,LIMB INJURY,35
MX,MUSCLE RIGIDITY,35
MX,SWELLING FACE,35
MX,TINNITUS,35
MX,ANGER,34
MX,CHRONIC KIDNEY DISEASE,34
MX,IMMUNODEFICIENCY,34
MX,LEUKOPENIA,34
MX,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,34
MX,EMOTIONAL DISORDER,33
MX,FEELING HOT,33
MX,GASTRIC ULCER,33
MX,HEPATIC FAILURE,33
MX,LUNG INFECTION,33
MX,MEDICATION ERROR,33
MX,PALPITATIONS,33
MX,PARALYSIS,33
MX,RASH GENERALISED,33
MX,RESPIRATORY TRACT INFECTION,33
MX,SUICIDE ATTEMPT,33
MX,SYSTEMIC LUPUS ERYTHEMATOSUS,33
MX,UNEVALUABLE EVENT,33
MX,BODY TEMPERATURE INCREASED,32
MX,HAEMATEMESIS,32
MX,HEARING IMPAIRED,32
MX,HERNIA,32
MX,INTERVERTEBRAL DISC PROTRUSION,32
MX,MOOD ALTERED,32
MX,PANCYTOPENIA,32
MX,FEELING COLD,31
MX,INTENTIONAL OVERDOSE,31
MX,LIVER DISORDER,31
MX,MULTI-ORGAN FAILURE,31
MX,PERITONITIS,31
MX,RESTLESSNESS,31
MX,RHEUMATOID ARTHRITIS,31
MX,SUICIDAL IDEATION,31
MX,ACNE,30
MX,ADVERSE EVENT,30
MX,GASTRIC DISORDER,30
MX,HAEMATOMA,30
MX,HEPATIC CIRRHOSIS,30
MX,INJURY,30
MX,LUNG NEOPLASM MALIGNANT,30
MX,METASTASES TO BONE,30
MX,CYANOSIS,29
MX,DYSGEUSIA,29
MX,GASTROENTERITIS,29
MX,HYPOXIA,29
MX,OEDEMA,29
MX,OSTEOARTHRITIS,29
MX,OVERWEIGHT,29
MX,POLLAKIURIA,29
MX,PRODUCT QUALITY ISSUE,29
MX,RETINAL DETACHMENT,29
MX,THROAT TIGHTNESS,29
MX,BRONCHOSPASM,28
MX,CEREBROVASCULAR DISORDER,28
MX,GALLBLADDER DISORDER,28
MX,HEART RATE INCREASED,28
MX,HYPONATRAEMIA,28
MX,MALNUTRITION,28
MX,MENTAL DISORDER,28
MX,PETIT MAL EPILEPSY,28
MX,SPINAL FRACTURE,28
MX,ANAPHYLACTIC SHOCK,27
MX,COMA,27
MX,DRUG ADMINISTRATION ERROR,27
MX,ENDOPHTHALMITIS,27
MX,INJECTION SITE PAIN,27
MX,LIVER INJURY,27
MX,METABOLIC ACIDOSIS,27
MX,METASTASES TO LIVER,27
MX,OCULAR HYPERAEMIA,27
MX,PRESCRIBED UNDERDOSE,27
MX,SKIN ULCER,27
MX,VAGINAL HAEMORRHAGE,27
MX,VARICOSE VEIN,27
MX,BLOOD URIC ACID INCREASED,26
MX,BONE MARROW FAILURE,26
MX,COGNITIVE DISORDER,26
MX,DECREASED IMMUNE RESPONSIVENESS,26
MX,DIABETES MELLITUS INADEQUATE CONTROL,26
MX,DIABETIC COMPLICATION,26
MX,GASTRIC INFECTION,26
MX,PULMONARY HAEMORRHAGE,26
MX,THERAPEUTIC RESPONSE DECREASED,26
MX,ULCER,26
MX,ASCITES,25
MX,BLOOD SODIUM DECREASED,25
MX,BRADYCARDIA,25
MX,EMPHYSEMA,25
MX,GENERALISED OEDEMA,25
MX,HIATUS HERNIA,25
MX,MOUTH ULCERATION,25
MX,NEOPLASM,25
MX,NEOPLASM PROGRESSION,25
MX,NO ADVERSE EVENT,25
MX,OXYGEN SATURATION DECREASED,25
MX,PROSTATIC DISORDER,25
MX,RENAL PAIN,25
MX,ANGINA UNSTABLE,24
MX,ANGIOEDEMA,24
MX,ASPARTATE AMINOTRANSFERASE INCREASED,24
MX,BLOOD CHOLESTEROL ABNORMAL,24
MX,BRAIN INJURY,24
MX,DELIRIUM,24
MX,DRUG RESISTANCE,24
MX,DYSKINESIA,24
MX,ELECTROLYTE IMBALANCE,24
MX,GAIT INABILITY,24
MX,HAEMORRHOIDS,24
MX,HERPES ZOSTER,24
MX,HYPOVOLAEMIC SHOCK,24
MX,METASTASES TO LUNG,24
MX,PULMONARY ARTERIAL HYPERTENSION,24
MX,THROAT IRRITATION,24
MX,TRANSAMINASES INCREASED,24
MX,APPENDICITIS,23
MX,ASPIRATION BRONCHIAL,23
MX,BLOOD UREA INCREASED,23
MX,BRAIN NEOPLASM,23
MX,DEMENTIA,23
MX,DEVICE RELATED INFECTION,23
MX,DISEASE COMPLICATION,23
MX,FAECES DISCOLOURED,23
MX,HAND FRACTURE,23
MX,HEPATIC STEATOSIS,23
MX,JAUNDICE,23
MX,METASTASIS,23
MX,SPINAL COLUMN INJURY,23
MX,ANAPHYLACTIC REACTION,22
MX,ATRIAL FIBRILLATION,22
MX,BLINDNESS UNILATERAL,22
MX,BRONCHIAL DISORDER,22
MX,CHONDROPATHY,22
MX,DEEP VEIN THROMBOSIS,22
MX,DIABETIC KETOACIDOSIS,22
MX,FRACTURE,22
MX,HEPATITIS,22
MX,POST PROCEDURAL COMPLICATION,22
MX,SKIN LESION,22
MX,WHITE BLOOD CELL COUNT DECREASED,22
MX,APATHY,21
MX,CEREBRAL THROMBOSIS,21
MX,CONCOMITANT DISEASE PROGRESSION,21
MX,ENCEPHALOPATHY,21
MX,FACE INJURY,21
MX,FACIAL PARALYSIS,21
MX,GASTROINTESTINAL INFECTION,21
MX,IMMUNE SYSTEM DISORDER,21
MX,KETOACIDOSIS,21
MX,LIGAMENT SPRAIN,21
MX,LOW BIRTH WEIGHT BABY,21
MX,LYMPHOMA,21
MX,MULTIPLE SCLEROSIS,21
MX,MUSCULOSKELETAL DISORDER,21
MX,PANCREATIC CARCINOMA,21
MX,PERICARDIAL EFFUSION,21
MX,PRURITUS GENERALISED,21
MX,TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,21
MX,TREATMENT NONCOMPLIANCE,21
MX,WRIST FRACTURE,21
MX,BLOOD BILIRUBIN INCREASED,20
MX,BURKHOLDERIA CEPACIA COMPLEX INFECTION,20
MX,CHOKING,20
MX,CHRONIC MYELOID LEUKAEMIA,20
MX,DISEASE RECURRENCE,20
MX,DISTURBANCE IN ATTENTION,20
MX,FLATULENCE,20
MX,FOOT FRACTURE,20
MX,HYPERSOMNIA,20
MX,HYPERTHYROIDISM,20
MX,INTESTINAL PERFORATION,20
MX,METASTASES TO CENTRAL NERVOUS SYSTEM,20
MX,ORAL DISCOMFORT,20
MX,OSTEOPENIA,20
MX,RHINORRHOEA,20
MX,ABORTION,19
MX,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,19
MX,CARTILAGE INJURY,19
MX,CEREBRAL ISCHAEMIA,19
MX,FACE OEDEMA,19
MX,LARGE INTESTINE PERFORATION,19
MX,LYMPHADENOPATHY,19
MX,MELAENA,19
MX,MUSCULOSKELETAL DISCOMFORT,19
MX,PROCEDURAL PAIN,19
MX,PULMONARY HYPERTENSION,19
MX,RIB FRACTURE,19
MX,SKIN BURNING SENSATION,19
MX,VEIN DISORDER,19
MX,VIROLOGIC FAILURE,19
MX,ALANINE AMINOTRANSFERASE INCREASED,18
MX,ASTHMATIC CRISIS,18
MX,BLOOD DISORDER,18
MX,DIPLOPIA,18
MX,EYE IRRITATION,18
MX,FEEDING DISORDER,18
MX,HAEMATOCHEZIA,18
MX,HEAD DISCOMFORT,18
MX,HERPES VIRUS INFECTION,18
MX,HYPERKERATOSIS,18
MX,INTENTIONAL PRODUCT USE ISSUE,18
MX,JOINT DISLOCATION,18
MX,OSTEONECROSIS OF JAW,18
MX,PREMATURE DELIVERY,18
MX,RECTAL HAEMORRHAGE,18
MX,ANKLE FRACTURE,17
MX,BACTERIAL INFECTION,17
MX,BEDRIDDEN,17
MX,BLOOD GLUCOSE ABNORMAL,17
MX,BLOOD POTASSIUM DECREASED,17
MX,CEREBRAL ARTERY EMBOLISM,17
MX,DIABETIC NEUROPATHY,17
MX,DRY THROAT,17
MX,DYSARTHRIA,17
MX,HEMIPARESIS,17
MX,IMPAIRED HEALING,17
MX,INCREASED UPPER AIRWAY SECRETION,17
MX,INGUINAL HERNIA,17
MX,LACRIMATION INCREASED,17
MX,PHLEBITIS,17
MX,RENAL INJURY,17
MX,SKIN DISORDER,17
MX,ACUTE PULMONARY OEDEMA,16
MX,CARDIOGENIC SHOCK,16
MX,COORDINATION ABNORMAL,16
MX,CORONARY ARTERY OCCLUSION,16
MX,DENGUE FEVER,16
MX,DEPRESSED LEVEL OF CONSCIOUSNESS,16
MX,DERMATITIS,16
MX,DIVERTICULUM,16
MX,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,16
MX,DRY EYE,16
MX,EAR PAIN,16
MX,GINGIVAL BLEEDING,16
MX,HAEMATOTOXICITY,16
MX,HAEMOPTYSIS,16
MX,ILL-DEFINED DISORDER,16
MX,INCOHERENT,16
MX,ORAL CANDIDIASIS,16
MX,RENAL FAILURE ACUTE,16
MX,SPINAL DEFORMITY,16
MX,TENDON RUPTURE,16
MX,THERAPY CESSATION,16
MX,THIRST,16
MX,UPPER RESPIRATORY TRACT INFECTION,16
MX,URINARY INCONTINENCE,16
MX,VIITH NERVE PARALYSIS,16
MX,APHAGIA,15
MX,BENIGN PROSTATIC HYPERPLASIA,15
MX,BLOOD GLUCOSE FLUCTUATION,15
MX,CONGESTIVE CARDIOMYOPATHY,15
MX,DRUG EFFECT INCOMPLETE,15
MX,EAR DISCOMFORT,15
MX,GENERAL PHYSICAL CONDITION ABNORMAL,15
MX,HYPERCHOLESTEROLAEMIA,15
MX,LEUKAEMIA,15
MX,LIVER ABSCESS,15
MX,MENTAL IMPAIRMENT,15
MX,NO THERAPEUTIC RESPONSE,15
MX,ORAL PAIN,15
MX,PRODUCT COUNTERFEIT,15
MX,PROSTATIC SPECIFIC ANTIGEN INCREASED,15
MX,RENAL FAILURE CHRONIC,15
MX,SALIVARY HYPERSECRETION,15
MX,SKIN IRRITATION,15
MX,SUFFOCATION FEELING,15
MX,TACHYPNOEA,15
MX,TOOTHACHE,15
MX,VIRAL INFECTION,15
MX,YELLOW SKIN,15
MX,ACUTE RESPIRATORY FAILURE,14
MX,ARTERIOSCLEROSIS,14
MX,BLOOD LACTATE DEHYDROGENASE INCREASED,14
MX,BRAIN OEDEMA,14
MX,COLON CANCER,14
MX,DECREASED ACTIVITY,14
MX,EYE SWELLING,14
MX,FOOD INTOLERANCE,14
MX,HAEMODYNAMIC INSTABILITY,14
MX,HEPATIC FUNCTION ABNORMAL,14
MX,HEPATOCELLULAR CARCINOMA,14
MX,HEPATOMEGALY,14
MX,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,14
MX,INTRAOCULAR PRESSURE INCREASED,14
MX,ISCHAEMIC STROKE,14
MX,LETHARGY,14
MX,NASAL CONGESTION,14
MX,PAIN OF SKIN,14
MX,PSORIASIS,14
MX,PULMONARY THROMBOSIS,14
MX,SALMONELLOSIS,14
MX,SKIN FISSURES,14
MX,STEVENS-JOHNSON SYNDROME,14
MX,SUDDEN DEATH,14
MX,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,14
MX,TOOTH DISORDER,14
MX,UPPER GASTROINTESTINAL HAEMORRHAGE,14
MX,WOUND,14
MX,ALTERED STATE OF CONSCIOUSNESS,13
MX,APPARENT DEATH,13
MX,BLOOD POTASSIUM INCREASED,13
MX,BONE DECALCIFICATION,13
MX,BRAIN HYPOXIA,13
MX,CHOLECYSTITIS,13
MX,CYST,13
MX,DERMATOSIS,13
MX,DIABETIC RETINOPATHY,13
MX,DISTRACTIBILITY,13
MX,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,13
MX,DRUG-INDUCED LIVER INJURY,13
MX,EXPIRED PRODUCT ADMINISTERED,13
MX,EXPOSURE DURING BREAST FEEDING,13
MX,FOOT DEFORMITY,13
MX,GASTRIC HAEMORRHAGE,13
MX,HEART RATE DECREASED,13
MX,HEPATIC ENCEPHALOPATHY,13
MX,HEPATIC PAIN,13
MX,HEPATOTOXICITY,13
MX,HYDROCEPHALUS,13
MX,HYPERBILIRUBINAEMIA,13
MX,HYPERTRIGLYCERIDAEMIA,13
MX,INJECTION SITE ERYTHEMA,13
MX,LOCALISED INFECTION,13
MX,LYMPHOEDEMA,13
MX,MENINGITIS,13
MX,OESOPHAGITIS,13
MX,PROCEDURAL COMPLICATION,13
MX,PSYCHOTIC DISORDER,13
MX,RASH MACULAR,13
MX,TERMINAL STATE,13
MX,TYPHOID FEVER,13
MX,APNOEA,12
MX,BLOOD ALKALINE PHOSPHATASE INCREASED,12
MX,BLOOD PRESSURE SYSTOLIC INCREASED,12
MX,BLOOD URINE PRESENT,12
MX,CARDIOMYOPATHY,12
MX,CHROMATURIA,12
MX,DYSPNOEA EXERTIONAL,12
MX,EAR DISORDER,12
MX,FEELING DRUNK,12
MX,GASTROINTESTINAL INFLAMMATION,12
MX,GENERALISED ERYTHEMA,12
MX,ILEUS PARALYTIC,12
MX,IMMUNOSUPPRESSION,12
MX,MASTICATION DISORDER,12
MX,MEDICAL DEVICE COMPLICATION,12
MX,MICTURITION URGENCY,12
MX,MIGRAINE,12
MX,MUSCLE CONTRACTURE,12
MX,NERVE COMPRESSION,12
MX,OLIGURIA,12
MX,PERIPHERAL VASCULAR DISORDER,12
MX,PHARYNGEAL OEDEMA,12
MX,PHOTOPHOBIA,12
MX,PSEUDOMEMBRANOUS COLITIS,12
MX,PULMONARY TUBERCULOSIS,12
MX,RETINOIC ACID SYNDROME,12
MX,SHOCK,12
MX,SINUSITIS,12
MX,SPLENOMEGALY,12
MX,THYROID CANCER,12
MX,TONGUE DISCOMFORT,12
MX,TOOTH LOSS,12
MX,UMBILICAL HERNIA,12
MX,UNINTENDED PREGNANCY,12
MX,URINARY RETENTION,12
MX,VASCULITIS,12
MX,VENOUS OCCLUSION,12
MX,BONE CANCER,11
MX,BREAST PAIN,11
MX,CEREBRAL DISORDER,11
MX,COAGULOPATHY,11
MX,COLITIS ULCERATIVE,11
MX,CYTOMEGALOVIRUS INFECTION,11
MX,DIARRHOEA HAEMORRHAGIC,11
MX,EFFUSION,11
MX,EXTRAPULMONARY TUBERCULOSIS,11
MX,EYE INFLAMMATION,11
MX,EYELID OEDEMA,11
MX,FIBROMYALGIA,11
MX,FOETAL DEATH,11
MX,HALLUCINATION_ VISUAL,11
MX,HEPATITIS C,11
MX,HUNGER,11
MX,HYPOTHERMIA,11
MX,HYPOTONIA,11
MX,INCORRECT DRUG ADMINISTRATION DURATION,11
MX,INFLUENZA LIKE ILLNESS,11
MX,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,11
MX,MASS,11
MX,MITRAL VALVE INCOMPETENCE,11
MX,MUSCULOSKELETAL CHEST PAIN,11
MX,MYOCARDIAL ISCHAEMIA,11
MX,NORMAL NEWBORN,11
MX,PEMPHIGUS,11
MX,PNEUMONITIS,11
MX,POLYURIA,11
MX,PRE-ECLAMPSIA,11
MX,PRESCRIBED OVERDOSE,11
MX,PRODUCT CONTAMINATION MICROBIAL,11
MX,RETINAL HAEMORRHAGE,11
MX,SJOGREN^S SYNDROME,11
MX,SKIN CANCER,11
MX,SPINAL OPERATION,11
MX,TENSION,11
MX,THERAPEUTIC RESPONSE UNEXPECTED,11
MX,TRANSFUSION,11
MX,TRANSIENT ISCHAEMIC ATTACK,11
MX,VAGINAL INFECTION,11
MX,VENOUS THROMBOSIS,11
MX,WHITE BLOOD CELL COUNT INCREASED,11
MX,ABDOMINAL HERNIA,10
MX,ABDOMINAL SEPSIS,10
MX,ACUTE RESPIRATORY DISTRESS SYNDROME,10
MX,AMENORRHOEA,10
MX,APHONIA,10
MX,APHTHOUS ULCER,10
MX,APPLICATION SITE PAIN,10
MX,ASPIRATION,10
MX,ASTHENOPIA,10
MX,AUTOIMMUNE HAEMOLYTIC ANAEMIA,10
MX,BLOOD CREATINE PHOSPHOKINASE INCREASED,10
MX,BONE MARROW DISORDER,10
MX,CERVIX CARCINOMA,10
MX,CONJUNCTIVAL HAEMORRHAGE,10
MX,CYSTITIS,10
MX,DEVICE DIFFICULT TO USE,10
MX,DRUG ABUSE,10
MX,EYE INFECTION,10
MX,HEPATIC ENZYME INCREASED,10
MX,HOT FLUSH,10
MX,HYPERAESTHESIA,10
MX,HYPERKALAEMIA,10
MX,HYPERLIPIDAEMIA,10
MX,IMMOBILE,10
MX,KNEE OPERATION,10
MX,LUNG INFILTRATION,10
MX,MONOPLEGIA,10
MX,MOUTH HAEMORRHAGE,10
MX,NASAL DRYNESS,10
MX,NEUROLOGICAL DECOMPENSATION,10
MX,OROPHARYNGEAL DISCOMFORT,10
MX,PANIC ATTACK,10
MX,PETECHIAE,10
MX,PREGNANCY,10
MX,PROSTATITIS,10
MX,PSEUDOMONAS INFECTION,10
MX,RASH ERYTHEMATOUS,10
MX,RIGHT VENTRICULAR FAILURE,10
MX,SCAR,10
MX,SCIATICA,10
MX,SENSATION OF FOREIGN BODY,10
MX,SKELETAL INJURY,10
MX,STATUS EPILEPTICUS,10
MX,THERAPY NON-RESPONDER,10
MX,UNDERDOSE,10
MX,UVEITIS,10
MX,ACTIVITIES OF DAILY LIVING IMPAIRED,9
MX,ACUTE HEPATIC FAILURE,9
MX,ADVERSE DRUG REACTION,9
MX,AGEUSIA,9
MX,BIPOLAR DISORDER,9
MX,BLOOD CALCIUM DECREASED,9
MX,BONE FISSURE,9
MX,CANDIDA INFECTION,9
MX,CARDIAC MURMUR,9
MX,CARDIOTOXICITY,9
MX,CELLULITIS,9
MX,CENTRAL NERVOUS SYSTEM LESION,9
MX,CHIKUNGUNYA VIRUS INFECTION,9
MX,CYTOPENIA,9
MX,DAYDREAMING,9
MX,DECUBITUS ULCER,9
MX,DERMATITIS ALLERGIC,9
MX,DISABILITY,9
MX,DRUG EFFECT DECREASED,9
MX,ESCHERICHIA INFECTION,9
MX,EYE OPERATION,9
MX,GANGRENE,9
MX,HAEMOLYTIC ANAEMIA,9
MX,HAEMORRHAGIC STROKE,9
MX,HALLUCINATION_ AUDITORY,9
MX,HUMERUS FRACTURE,9
MX,HYPOAESTHESIA ORAL,9
MX,INTENTIONAL DRUG MISUSE,9
MX,JOINT STIFFNESS,9
MX,LARYNGEAL OEDEMA,9
MX,LYMPHOCYTE COUNT DECREASED,9
MX,MYELODYSPLASTIC SYNDROME,9
MX,NEURALGIA,9
MX,NIGHTMARE,9
MX,ORAL DISORDER,9
MX,PAIN IN JAW,9
MX,PERIPHERAL VENOUS DISEASE,9
MX,PLASMA CELL MYELOMA,9
MX,PLATELET COUNT INCREASED,9
MX,PNEUMOTHORAX,9
MX,POOR QUALITY SLEEP,9
MX,POSTOPERATIVE WOUND INFECTION,9
MX,PULMONARY CONGESTION,9
MX,RASH MACULO-PAPULAR,9
MX,RHINITIS,9
MX,SEDATION,9
MX,SYSTEMIC CANDIDA,9
MX,TREATMENT FAILURE,9
MX,UNRESPONSIVE TO STIMULI,9
MX,UTERINE DISORDER,9
MX,VARICELLA,9
MX,WHEEZING,9
MX,ABORTION INDUCED,8
MX,ABSCESS,8
MX,ANTEROGRADE AMNESIA,8
MX,APPLICATION SITE ERYTHEMA,8
MX,APPLICATION SITE PRURITUS,8
MX,ARTERIAL DISORDER,8
MX,BLADDER DISORDER,8
MX,CARDIAC FAILURE CONGESTIVE,8
MX,CARDIAC PACEMAKER INSERTION,8
MX,CARDIOPULMONARY FAILURE,8
MX,CAROTID ARTERY OCCLUSION,8
MX,CLAVICLE FRACTURE,8
MX,COLD SWEAT,8
MX,COLONIC PSEUDO-OBSTRUCTION,8
MX,COMMUNICATION DISORDER,8
MX,COMPLETED SUICIDE,8
MX,CONJUNCTIVAL HYPERAEMIA,8
MX,CONJUNCTIVITIS,8
MX,DENTAL CARIES,8
MX,DIABETIC FOOT,8
MX,DRUG DISPENSING ERROR,8
MX,ECZEMA,8
MX,EMOTIONAL DISTRESS,8
MX,EOSINOPHILIA,8
MX,EYE DISCHARGE,8
MX,FOETAL GROWTH RESTRICTION,8
MX,FOOT OPERATION,8
MX,FUNGAL INFECTION,8
MX,GASTRIC CANCER,8
MX,GASTRITIS EROSIVE,8
MX,GASTROINTESTINAL PAIN,8
MX,GASTROINTESTINAL STROMAL TUMOUR,8
MX,HYPOCALCAEMIA,8
MX,INCREASED APPETITE,8
MX,LABORATORY TEST ABNORMAL,8
MX,LEUKAEMIA RECURRENT,8
MX,MAJOR DEPRESSION,8
MX,MELANOCYTIC NAEVUS,8
MX,MENINGIOMA,8
MX,MOTOR DYSFUNCTION,8
MX,MUCORMYCOSIS,8
MX,MYDRIASIS,8
MX,NEUROTOXICITY,8
MX,NEUTROPENIC COLITIS,8
MX,NEUTROPHIL COUNT DECREASED,8
MX,OBSTRUCTIVE AIRWAYS DISORDER,8
MX,OSTEOMYELITIS,8
MX,OVARIAN CANCER,8
MX,PIGMENTATION DISORDER,8
MX,PREGNANCY ON CONTRACEPTIVE,8
MX,PULMONARY MASS,8
MX,RASH PAPULAR,8
MX,RENAL NEOPLASM,8
MX,SCAB,8
MX,SKIN HAEMORRHAGE,8
MX,SLEEP APNOEA SYNDROME,8
MX,SPINAL CORD DISORDER,8
MX,TOOTH INFECTION,8
MX,TUBERCULIN TEST POSITIVE,8
MX,UTERINE LEIOMYOMA,8
MX,ANURIA,7
MX,ATELECTASIS,7
MX,AUTOIMMUNE HYPOTHYROIDISM,7
MX,AZOTAEMIA,7
MX,BLEPHAROSPASM,7
MX,BLOOD POTASSIUM ABNORMAL,7
MX,BRAIN DEATH,7
MX,BREAST MASS,7
MX,BRONCHOPNEUMONIA,7
MX,CEREBRAL ATROPHY,7
MX,CHEILITIS,7
MX,COMPLICATION ASSOCIATED WITH DEVICE,7
MX,CROHN^S DISEASE,7
MX,DEMYELINATION,7
MX,DEVICE DISLOCATION,7
MX,DIET REFUSAL,7
MX,DIVERTICULITIS,7
MX,DUODENAL ULCER,7
MX,EAR INFECTION,7
MX,EPIGASTRIC DISCOMFORT,7
MX,ERECTILE DYSFUNCTION,7
MX,EYE MOVEMENT DISORDER,7
MX,EYE OEDEMA,7
MX,FOOD ALLERGY,7
MX,GASTROINTESTINAL TOXICITY,7
MX,GESTATIONAL DIABETES,7
MX,GLOSSITIS,7
MX,GLOSSODYNIA,7
MX,GLUCOSE TOLERANCE IMPAIRED,7
MX,HAEMOTHORAX,7
MX,HICCUPS,7
MX,HYPERLACTACIDAEMIA,7
MX,HYPERTONIA,7
MX,HYPOKALAEMIA,7
MX,INVESTIGATION,7
MX,IRRITABLE BOWEL SYNDROME,7
MX,JOINT RANGE OF MOTION DECREASED,7
MX,LACERATION,7
MX,LIGAMENT RUPTURE,7
MX,LOOSE TOOTH,7
MX,LOWER RESPIRATORY TRACT INFECTION,7
MX,MENISCUS INJURY,7
MX,METASTATIC NEOPLASM,7
MX,MYCOBACTERIAL INFECTION,7
MX,NEPHROPATHY,7
MX,NEPHROPATHY TOXIC,7
MX,NODULE,7
MX,OCULAR HYPERTENSION,7
MX,OCULAR ICTERUS,7
MX,ODYNOPHAGIA,7
MX,OESOPHAGEAL ULCER,7
MX,ORAL HERPES,7
MX,OVARIAN CYST,7
MX,PAPULE,7
MX,PARAPLEGIA,7
MX,PATHOGEN RESISTANCE,7
MX,PELVIC FRACTURE,7
MX,PERITONEAL TUBERCULOSIS,7
MX,PHILADELPHIA CHROMOSOME POSITIVE,7
MX,PNEUMONIA BACTERIAL,7
MX,POOR PERIPHERAL CIRCULATION,7
MX,PROCTALGIA,7
MX,PRODUCT AVAILABILITY ISSUE,7
MX,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,7
MX,PROTEINURIA,7
MX,PSYCHOMOTOR HYPERACTIVITY,7
MX,RENAL CYST,7
MX,RHABDOMYOLYSIS,7
MX,SECOND PRIMARY MALIGNANCY,7
MX,SECRETION DISCHARGE,7
MX,SKIN HYPERPIGMENTATION,7
MX,SKIN PAPILLOMA,7
MX,SLOW SPEECH,7
MX,SNEEZING,7
MX,SPINAL COMPRESSION FRACTURE,7
MX,STILLBIRTH,7
MX,TIBIA FRACTURE,7
MX,TONSILLITIS,7
MX,TOOTH FRACTURE,7
MX,TOXIC SKIN ERUPTION,7
MX,ULCERATIVE KERATITIS,7
MX,VASCULAR RUPTURE,7
MX,VENTRICULAR FIBRILLATION,7
MX,WALKING DISABILITY,7
MX,WRONG DRUG ADMINISTERED,7
MX,ABORTION THREATENED,6
MX,ABSCESS LIMB,6
MX,ACCIDENTAL OVERDOSE,6
MX,ANAL FISTULA,6
MX,ANGIOPATHY,6
MX,ANORECTAL DISCOMFORT,6
MX,AORTIC ANEURYSM,6
MX,APRAXIA,6
MX,ARTHROPOD BITE,6
MX,ATRIAL SEPTAL DEFECT,6
MX,ATROPHY,6
MX,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,6
MX,BACK INJURY,6
MX,BILIRUBIN CONJUGATED INCREASED,6
MX,BRADYPHRENIA,6
MX,BREAST CYST,6
MX,BRONCHIAL OBSTRUCTION,6
MX,BRONCHIECTASIS,6
MX,CARDIAC OPERATION,6
MX,CLUMSINESS,6
MX,COUNTERFEIT DRUG ADMINISTERED,6
MX,CRANIOCEREBRAL INJURY,6
MX,CREATININE RENAL CLEARANCE DECREASED,6
MX,DEAFNESS UNILATERAL,6
MX,DECREASED INTEREST,6
MX,DERMATITIS ATOPIC,6
MX,DISLOCATION OF VERTEBRA,6
MX,DYSAESTHESIA,6
MX,DYSGRAPHIA,6
MX,DYSPHEMIA,6
MX,ECCHYMOSIS,6
MX,ENTERITIS,6
MX,ESCHERICHIA URINARY TRACT INFECTION,6
MX,EXPIRED DRUG ADMINISTERED,6
MX,EXTRASYSTOLES,6
MX,EXTREMITY NECROSIS,6
MX,FACIAL BONES FRACTURE,6
MX,FACIAL PAIN,6
MX,FIBROSIS,6
MX,FIBULA FRACTURE,6
MX,FLANK PAIN,6
MX,FLAVIVIRUS INFECTION,6
MX,FLUSHING,6
MX,FOOD POISONING,6
MX,FRUSTRATION TOLERANCE DECREASED,6
MX,GASTRIC ULCER PERFORATION,6
MX,GLYCOSYLATED HAEMOGLOBIN INCREASED,6
MX,GROIN PAIN,6
MX,HAEMATOCRIT DECREASED,6
MX,HAEMOGLOBIN INCREASED,6
MX,HAEMORRHAGE INTRACRANIAL,6
MX,HAEMORRHAGE URINARY TRACT,6
MX,HEAD TITUBATION,6
MX,HEPATOCELLULAR INJURY,6
MX,HIP SURGERY,6
MX,HORMONE LEVEL ABNORMAL,6
MX,INJECTION SITE HAEMORRHAGE,6
MX,INJECTION SITE PRURITUS,6
MX,INTENTIONAL SELF-INJURY,6
MX,INTERNAL HAEMORRHAGE,6
MX,INTERSTITIAL LUNG DISEASE,6
MX,INTESTINAL HAEMORRHAGE,6
MX,INTRACRANIAL PRESSURE INCREASED,6
MX,LAZINESS,6
MX,LIP DRY,6
MX,LOSS OF CONTROL OF LEGS,6
MX,LUMBAR VERTEBRAL FRACTURE,6
MX,LYMPHADENITIS,6
MX,LYMPHOPENIA,6
MX,MACULOPATHY,6
MX,METABOLIC DISORDER,6
MX,MICTURITION DISORDER,6
MX,MUSCLE TIGHTNESS,6
MX,MYELOFIBROSIS,6
MX,MYOCARDITIS,6
FM,DRUG INEFFECTIVE,2
FM,UNINTENDED PREGNANCY,2
FM,ANAL ATRESIA,1
FM,BACK PAIN,1
FM,BREECH PRESENTATION,1
FM,CLEFT PALATE,1
FM,FEMALE GENITAL TRACT FISTULA,1
FM,MATERNAL EXPOSURE DURING PREGNANCY,1
FM,OLIGOHYDRAMNIOS,1
MD,TREMOR,7
MD,HYPERTHERMIA,5
MD,HYPOTENSION,5
MD,NAUSEA,4
MD,BODY TEMPERATURE INCREASED,3
MD,DEEP VEIN THROMBOSIS,3
MD,HEADACHE,3
MD,HYPERHIDROSIS,3
MD,VOMITING,3
MD,ASTHENIA,2
MD,CYANOSIS,2
MD,DEATH,2
MD,DISCOMFORT,2
MD,DRUG INEFFECTIVE,2
MD,DRY GANGRENE,2
MD,LOSS OF CONSCIOUSNESS,2
MD,MALIGNANT NEOPLASM PROGRESSION,2
MD,PULSE ABNORMAL,2
MD,TOXICITY TO VARIOUS AGENTS,2
MD,AGITATION,1
MD,ALANINE AMINOTRANSFERASE INCREASED,1
MD,ARRHYTHMIA,1
MD,ASPARTATE AMINOTRANSFERASE INCREASED,1
MD,BLOOD PRESSURE DECREASED,1
MD,BLOOD PRESSURE INCREASED,1
MD,BLOOD PRESSURE SYSTOLIC INCREASED,1
MD,CEREBROVASCULAR ACCIDENT,1
MD,CHILLS,1
MD,CHRONIC KIDNEY DISEASE,1
MD,COLD SWEAT,1
MD,COMPLETED SUICIDE,1
MD,DISSEMINATED TUBERCULOSIS,1
MD,DIZZINESS,1
MD,DYSARTHRIA,1
MD,FACE OEDEMA,1
MD,FEELING ABNORMAL,1
MD,FEELING COLD,1
MD,FEMUR FRACTURE,1
MD,FOETAL GROWTH RESTRICTION,1
MD,FOOT AMPUTATION,1
MD,GANGRENE,1
MD,HEMIPARESIS,1
MD,HYPERAEMIA,1
MD,HYPERTENSION,1
MD,HYPERTENSIVE CRISIS,1
MD,HYPOPNOEA,1
MD,INFECTION,1
MD,INTENTIONAL DRUG MISUSE,1
MD,LEUKOCYTOSIS,1
MD,LIVEDO RETICULARIS,1
MD,MATERNAL EXPOSURE BEFORE PREGNANCY,1
MD,MELAENA,1
MD,MUSCLE RIGIDITY,1
MD,MUSCULOSKELETAL CHEST PAIN,1
MD,MYDRIASIS,1
MD,OEDEMA PERIPHERAL,1
MD,OSTEONECROSIS,1
MD,OSTEOPOROSIS,1
MD,PALLOR,1
MD,PANCREATITIS ACUTE,1
MD,PERICARDITIS,1
MD,POST THROMBOTIC SYNDROME,1
MD,PRURITUS,1
MD,PSYCHOMOTOR HYPERACTIVITY,1
MD,PULMONARY EMBOLISM,1
MD,PYREXIA,1
MD,SCHIZOPHRENIA_ CATATONIC TYPE,1
MD,SEIZURE,1
MD,TACHYCARDIA,1
MD,TACHYPNOEA,1
MD,THROMBECTOMY,1
MD,THROMBOCYTOPENIA,1
MD,THYROID DISORDER,1
MD,URTICARIA,1
MC,ATRIAL FIBRILLATION,2
MC,SEPTIC SHOCK,2
MC,THROMBOCYTOPENIA,2
MC,VERTIGO,2
MC,ABDOMINAL PAIN UPPER,1
MC,ACCIDENT,1
MC,AGITATION,1
MC,ALANINE AMINOTRANSFERASE INCREASED,1
MC,ARRHYTHMIA,1
MC,ASPARTATE AMINOTRANSFERASE INCREASED,1
MC,BLOOD LACTATE DEHYDROGENASE INCREASED,1
MC,BLOOD PRESSURE INCREASED,1
MC,CARDIAC FAILURE,1
MC,CARDIAC TAMPONADE,1
MC,CATARACT,1
MC,CHOLESTASIS,1
MC,COLITIS,1
MC,COMA,1
MC,CONJUNCTIVAL HYPERAEMIA,1
MC,CORNEAL ABSCESS,1
MC,CORNEAL PERFORATION,1
MC,DEATH,1
MC,DECREASED APPETITE,1
MC,DEFAECATION URGENCY,1
MC,DIARRHOEA,1
MC,DISEASE PROGRESSION,1
MC,DIVERTICULUM,1
MC,DIVERTICULUM INTESTINAL,1
MC,DRY MOUTH,1
MC,DYSPNOEA,1
MC,ELECTROCARDIOGRAM QT PROLONGED,1
MC,EPILEPSY,1
MC,EPISTAXIS,1
MC,ERYSIPELAS,1
MC,ESCHERICHIA INFECTION,1
MC,EYELID BLEEDING,1
MC,FATIGUE,1
MC,FEBRILE BONE MARROW APLASIA,1
MC,GASTRITIS,1
MC,GASTROENTERITIS,1
MC,HAEMOGLOBIN DECREASED,1
MC,HEADACHE,1
MC,HEART RATE DECREASED,1
MC,HEPATOCELLULAR INJURY,1
MC,HYPERNATRAEMIA,1
MC,HYPERTHERMIA,1
MC,INFLUENZA,1
MC,INFLUENZA LIKE ILLNESS,1
MC,INFUSION RELATED REACTION,1
MC,INTESTINAL PERFORATION,1
MC,INTRAOCULAR PRESSURE INCREASED,1
MC,LUNG INFECTION,1
MC,LYMPHOCYTE COUNT INCREASED,1
MC,MICTURITION URGENCY,1
MC,MULTI-ORGAN FAILURE,1
MC,NAUSEA,1
MC,NEUTROPENIC COLITIS,1
MC,OCULAR HYPERTENSION,1
MC,OROPHARYNGEAL PAIN,1
MC,PANCYTOPENIA,1
MC,PERICARDIAL HAEMORRHAGE,1
MC,PHARYNGITIS,1
MC,PROCTITIS,1
MC,PSORIASIS,1
MC,PULMONARY FIBROSIS,1
MC,RECTAL HAEMORRHAGE,1
MC,RED BLOOD CELL COUNT DECREASED,1
MC,RENAL FAILURE,1
MC,RESPIRATORY ARREST,1
MC,SHOCK,1
MC,SINUSITIS,1
MC,STAPHYLOCOCCAL INFECTION,1
MC,STOMATITIS,1
MC,SUBDURAL HAEMATOMA,1
MC,TOXIC SKIN ERUPTION,1
MC,ULCER HAEMORRHAGE,1
MC,ULCERATIVE KERATITIS,1
MC,URINARY TRACT INFECTION,1
MC,VENOOCCLUSIVE LIVER DISEASE,1
MC,VISUAL ACUITY REDUCED,1
MC,WHITE BLOOD CELL COUNT INCREASED,1
MN,ENDOPHTHALMITIS,6
MN,INTENTIONAL PRODUCT USE ISSUE,6
MN,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,6
MN,HAEMOLYSIS,4
MN,HYPERBILIRUBINAEMIA,4
MN,TOXIC ANTERIOR SEGMENT SYNDROME,4
MN,HEADACHE,3
MN,DEPRESSION,2
MN,DIARRHOEA,2
MN,DRUG INEFFECTIVE,2
MN,INSOMNIA,2
MN,PYREXIA,2
MN,ACUTE LYMPHOCYTIC LEUKAEMIA,1
MN,ANAPHYLACTIC REACTION,1
MN,ASTHENIA,1
MN,BLOOD GLUCOSE INCREASED,1
MN,CARDIOVASCULAR DISORDER,1
MN,CHEILITIS,1
MN,COMA,1
MN,COUGH,1
MN,DEAFNESS,1
MN,DEATH,1
MN,DIZZINESS,1
MN,DYSPNOEA,1
MN,EPILEPSY,1
MN,FACE OEDEMA,1
MN,FALL,1
MN,FATIGUE,1
MN,FOETAL EXPOSURE DURING PREGNANCY,1
MN,GENERALISED OEDEMA,1
MN,GLOSSITIS,1
MN,HAEMORRHAGE,1
MN,HEAD INJURY,1
MN,HEPATITIS TOXIC,1
MN,HYPERTENSION,1
MN,HYPOTHERMIA,1
MN,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
MN,MALIGNANT NEOPLASM PROGRESSION,1
MN,MICROCOCCUS TEST POSITIVE,1
MN,MUSCULOSKELETAL STIFFNESS,1
MN,NAUSEA,1
MN,PLEURAL EFFUSION,1
MN,POLYDACTYLY,1
MN,PRODUCT QUALITY ISSUE,1
MN,PSYCHOMOTOR RETARDATION,1
MN,ROAD TRAFFIC ACCIDENT,1
MN,RUPTURED ECTOPIC PREGNANCY,1
MN,SKIN HYPOPIGMENTATION,1
MN,SKIN IRRITATION,1
MN,SOMNOLENCE,1
MN,SPEECH DISORDER,1
MN,SUSPECTED COUNTERFEIT PRODUCT,1
MN,TACHYCARDIA,1
MN,TONGUE OEDEMA,1
MN,TOXIC ENCEPHALOPATHY,1
MN,VOMITING,1
ME,RASH,11
ME,DIARRHOEA,9
ME,GASTROINTESTINAL DISORDER,8
ME,FATIGUE,6
ME,DISEASE PROGRESSION,5
ME,HEADACHE,5
ME,NAUSEA,5
ME,PYREXIA,5
ME,ABDOMINAL PAIN,4
ME,BLOOD PRESSURE INCREASED,4
ME,COLITIS MICROSCOPIC,4
ME,COUGH,4
ME,DEATH,4
ME,GENERAL PHYSICAL HEALTH DETERIORATION,4
ME,HEPATOTOXICITY,4
ME,HYPERTENSION,4
ME,TACHYCARDIA,4
ME,VOMITING,4
ME,ANAEMIA MACROCYTIC,3
ME,ASPHYXIA,3
ME,ASTHENIA,3
ME,BODY TEMPERATURE INCREASED,3
ME,BREAST CANCER,3
ME,DIZZINESS,3
ME,DRUG ABUSE,3
ME,ERYTHEMA,3
ME,HAEMOLYTIC ANAEMIA,3
ME,HYPOTENSION,3
ME,LEUKOPENIA,3
ME,LIVER INJURY,3
ME,PERIPHERAL SWELLING,3
ME,PNEUMONIA,3
ME,SEPSIS,3
ME,TACHYPNOEA,3
ME,TREMOR,3
ME,VERTIGO,3
ME,ABDOMINAL PAIN UPPER,2
ME,ACUTE KIDNEY INJURY,2
ME,AGRANULOCYTOSIS,2
ME,ALANINE AMINOTRANSFERASE INCREASED,2
ME,ALOPECIA,2
ME,ALPHA 1 FOETOPROTEIN INCREASED,2
ME,ANAEMIA,2
ME,ASPARTATE AMINOTRANSFERASE INCREASED,2
ME,BLOOD ALKALINE PHOSPHATASE INCREASED,2
ME,DISORIENTATION,2
ME,DRUG INEFFECTIVE,2
ME,DYSPNOEA,2
ME,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
ME,HEPATIC LESION,2
ME,HEPATOCELLULAR CARCINOMA,2
ME,INTESTINAL STENOSIS,2
ME,JAUNDICE,2
ME,LOSS OF CONSCIOUSNESS,2
ME,OLIGURIA,2
ME,OVERDOSE,2
ME,PALPITATIONS,2
ME,PRODUCTIVE COUGH,2
ME,PRURITUS GENERALISED,2
ME,PULMONARY EMBOLISM,2
ME,PULMONARY TUBERCULOSIS,2
ME,PYOGENIC GRANULOMA,2
ME,RENAL IMPAIRMENT,2
ME,THROMBOCYTOPENIA,2
ME,TRANSPLANT REJECTION,2
ME,WHITE BLOOD CELL COUNT INCREASED,2
ME,ABORTION SPONTANEOUS,1
ME,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
ME,ACUTE HEPATIC FAILURE,1
ME,ACUTE HEPATITIS B,1
ME,ACUTE MYOCARDIAL INFARCTION,1
ME,ADRENAL GLAND INJURY,1
ME,AMNESIA,1
ME,ANGINA PECTORIS,1
ME,ANURIA,1
ME,APHTHOUS ULCER,1
ME,ATRIAL FIBRILLATION,1
ME,BACTERIAL INFECTION,1
ME,BACTERIAL TEST POSITIVE,1
ME,BILIRUBIN CONJUGATED INCREASED,1
ME,BIRTH TRAUMA,1
ME,BLOOD BILIRUBIN INCREASED,1
ME,BLOOD CREATININE INCREASED,1
ME,BLOOD DISORDER,1
ME,BLOOD LACTATE DEHYDROGENASE INCREASED,1
ME,BLOOD UREA INCREASED,1
ME,BONE PAIN,1
ME,BRADYCARDIA,1
ME,BREATH SOUNDS ABNORMAL,1
ME,BRONCHIECTASIS,1
ME,BRONCHITIS,1
ME,BRONCHOSPASM,1
ME,C-REACTIVE PROTEIN INCREASED,1
ME,CARDIAC ARREST,1
ME,CEREBRAL ISCHAEMIA,1
ME,CEREBROVASCULAR ACCIDENT,1
ME,CHEST PAIN,1
ME,CHOKING,1
ME,CIRRHOSIS ALCOHOLIC,1
ME,CLOSTRIDIAL INFECTION,1
ME,COAGULOPATHY,1
ME,COELIAC DISEASE,1
ME,COMA,1
ME,COMPLICATION OF DEVICE INSERTION,1
ME,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
ME,CONFUSIONAL STATE,1
ME,CONTUSION,1
ME,CROHN^S DISEASE,1
ME,DERMATITIS BULLOUS,1
ME,DIABETES MELLITUS,1
ME,DIABETIC COMA,1
ME,DIABETIC NEPHROPATHY,1
ME,DISSEMINATED TUBERCULOSIS,1
ME,DIZZINESS POSTURAL,1
ME,DRUG DOSE OMISSION,1
ME,DRUG INTOLERANCE,1
ME,DRUG LEVEL DECREASED,1
ME,DRUG-INDUCED LIVER INJURY,1
ME,DYSPLASTIC NAEVUS,1
ME,ECTOPIC PREGNANCY,1
ME,ELECTROLYTE IMBALANCE,1
ME,EMPHYSEMA,1
ME,END STAGE RENAL DISEASE,1
ME,ENTEROCOLITIS,1
ME,EPILEPSY,1
ME,FACE OEDEMA,1
ME,FACIAL PARESIS,1
ME,FEMUR FRACTURE,1
ME,FLUSHING,1
ME,FOETAL EXPOSURE DURING PREGNANCY,1
ME,GASTROINTESTINAL HAEMORRHAGE,1
ME,GASTROINTESTINAL TOXICITY,1
ME,GRAFT COMPLICATION,1
ME,GRANULOMATOSIS WITH POLYANGIITIS,1
ME,GROIN PAIN,1
ME,HAEMATEMESIS,1
ME,HAEMATOCHEZIA,1
ME,HAEMATOMA,1
ME,HAEMORRHAGIC DISORDER,1
ME,HAIR COLOUR CHANGES,1
ME,HEPATIC FAILURE,1
ME,HEPATORENAL SYNDROME,1
ME,HYPERSENSITIVITY,1
ME,HYPOKALAEMIA,1
ME,IMPLANT SITE INFECTION,1
ME,IMPLANT SITE INFLAMMATION,1
ME,IMPLANT SITE REACTION,1
ME,INFECTIOUS PLEURAL EFFUSION,1
ME,INFLAMMATION,1
ME,INFUSION RELATED REACTION,1
ME,INTERNATIONAL NORMALISED RATIO INCREASED,1
ME,ISCHAEMIA,1
ME,KIDNEY TRANSPLANT REJECTION,1
ME,LIVER DISORDER,1
ME,LUPUS-LIKE SYNDROME,1
ME,LYMPH NODE TUBERCULOSIS,1
ME,LYMPHADENOPATHY,1
ME,MALAISE,1
ME,MALIGNANT NEOPLASM PROGRESSION,1
ME,MATERNAL EXPOSURE DURING PREGNANCY,1
ME,MELANOSIS,1
ME,METASTASES TO BONE,1
ME,METASTASES TO LUNG,1
ME,METASTASES TO LYMPH NODES,1
ME,METASTATIC RENAL CELL CARCINOMA,1
ME,MICTURITION DISORDER,1
ME,MOUTH ULCERATION,1
ME,MUSCULOSKELETAL PAIN,1
ME,MUSCULOSKELETAL STIFFNESS,1
ME,MYALGIA,1
ME,NEPHROTIC SYNDROME,1
ME,NEUTROPHIL COUNT DECREASED,1
ME,OCCULT BLOOD POSITIVE,1
ME,OCULAR HYPERAEMIA,1
ME,OEDEMA,1
ME,OEDEMA PERIPHERAL,1
ME,OESOPHAGEAL VARICES HAEMORRHAGE,1
ME,OPTIC NERVE DISORDER,1
ME,PAIN IN EXTREMITY,1
ME,PALLOR,1
ME,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
ME,PALMOPLANTAR KERATODERMA,1
ME,PARESIS,1
ME,POSTPARTUM VENOUS THROMBOSIS,1
ME,POTENTIATING DRUG INTERACTION,1
ME,PRODUCT USE ISSUE,1
ME,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
ME,PRURITUS,1
ME,PULMONARY OEDEMA,1
ME,RENAL ARTERY THROMBOSIS,1
ME,RENAL FAILURE,1
ME,SEBORRHOEIC DERMATITIS,1
ME,SEIZURE,1
ME,SELF-MEDICATION,1
ME,SEPTIC SHOCK,1
ME,SKIN DEPIGMENTATION,1
ME,SKIN DISORDER,1
ME,SKIN EXFOLIATION,1
ME,SOPOR,1
ME,SPEECH DISORDER,1
ME,SPINAL PAIN,1
ME,SPLENOMEGALY,1
ME,STENT PLACEMENT,1
ME,SUDDEN DEATH,1
ME,SUFFOCATION FEELING,1
ME,SWELLING,1
ME,THROMBOSIS,1
ME,TONGUE DISORDER,1
ME,TONGUE OEDEMA,1
ME,TUBERCULIN TEST POSITIVE,1
ME,URINARY INCONTINENCE,1
ME,URINE ABNORMALITY,1
ME,URINE OUTPUT DECREASED,1
ME,UROGENITAL INFECTION BACTERIAL,1
ME,URTICARIA,1
ME,URTICARIAL VASCULITIS,1
ME,UTERINE HAEMORRHAGE,1
ME,WHITE BLOOD CELL COUNT DECREASED,1
MA,DEATH,73
MA,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,33
MA,PYREXIA,28
MA,TOXICITY TO VARIOUS AGENTS,27
MA,DRUG INEFFECTIVE,26
MA,VOMITING,25
MA,SEPTIC SHOCK,24
MA,DISEASE PROGRESSION,23
MA,ANAEMIA,20
MA,TOXIC EPIDERMAL NECROLYSIS,16
MA,GENERAL PHYSICAL HEALTH DETERIORATION,15
MA,THROMBOCYTOPENIA,15
MA,TOXIC SKIN ERUPTION,15
MA,ASTHENIA,14
MA,MALIGNANT NEOPLASM PROGRESSION,14
MA,ACUTE KIDNEY INJURY,13
MA,NEUROLEPTIC MALIGNANT SYNDROME,13
MA,NEUROPATHY PERIPHERAL,13
MA,RENAL FAILURE,13
MA,DYSPNOEA,12
MA,FATIGUE,12
MA,MATERNAL EXPOSURE DURING PREGNANCY,12
MA,RASH,12
MA,TACHYCARDIA,12
MA,EOSINOPHILIA,11
MA,FOETAL EXPOSURE DURING PREGNANCY,11
MA,HYPOKALAEMIA,11
MA,HYPONATRAEMIA,11
MA,HYPOTENSION,11
MA,NEUTROPENIA,11
MA,CARDIAC FAILURE,10
MA,CONDITION AGGRAVATED,10
MA,DIARRHOEA,10
MA,FACE OEDEMA,10
MA,HYPERTENSION,10
MA,SEIZURE,10
MA,DERMATITIS BULLOUS,9
MA,NAUSEA,9
MA,OEDEMA,9
MA,PRURITUS,9
MA,BLOOD CREATINE PHOSPHOKINASE INCREASED,8
MA,CHILLS,8
MA,ISCHAEMIC STROKE,8
MA,PRODUCT USE IN UNAPPROVED INDICATION,8
MA,RASH MACULO-PAPULAR,8
MA,RESPIRATORY DISTRESS,8
MA,RHABDOMYOLYSIS,8
MA,ABORTION SPONTANEOUS,7
MA,COUGH,7
MA,DECREASED APPETITE,7
MA,DEHYDRATION,7
MA,DERMATITIS PSORIASIFORM,7
MA,DRUG ERUPTION,7
MA,FEBRILE NEUTROPENIA,7
MA,HAEMORRHAGE,7
MA,HALLUCINATION,7
MA,HEPATOCELLULAR INJURY,7
MA,LOSS OF CONSCIOUSNESS,7
MA,MYOCARDIAL INFARCTION,7
MA,PRODUCT USE ISSUE,7
MA,SUICIDE ATTEMPT,7
MA,TUBERCULOSIS,7
MA,WEIGHT DECREASED,7
MA,ARTHRALGIA,6
MA,BRADYCARDIA,6
MA,CARDIAC ARREST,6
MA,CATATONIA,6
MA,CHRONIC MYELOID LEUKAEMIA,6
MA,HEADACHE,6
MA,HYPERHIDROSIS,6
MA,HYPOTHYROIDISM,6
MA,LEUKOPENIA,6
MA,METABOLIC ALKALOSIS,6
MA,MUCOSAL INFLAMMATION,6
MA,MYALGIA,6
MA,PANCYTOPENIA,6
MA,PREMATURE BABY,6
MA,SARCOIDOSIS,6
MA,SKIN LESION,6
MA,SOMNOLENCE,6
MA,ALTERED STATE OF CONSCIOUSNESS,5
MA,BONE MARROW FAILURE,5
MA,CARDIOTOXICITY,5
MA,COLITIS,5
MA,COMA,5
MA,CORNEAL OPACITY,5
MA,DIABETES MELLITUS,5
MA,ERYTHEMA,5
MA,GENERALISED OEDEMA,5
MA,HAEMATOTOXICITY,5
MA,INFLUENZA LIKE ILLNESS,5
MA,INTERSTITIAL LUNG DISEASE,5
MA,NEUROMUSCULAR BLOCK PROLONGED,5
MA,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,5
MA,PSORIASIS,5
MA,PULMONARY EMBOLISM,5
MA,RASH ERYTHEMATOUS,5
MA,RENAL TUBULAR NECROSIS,5
MA,ABDOMINAL PAIN,4
MA,ASCITES,4
MA,BLISTER,4
MA,BODY TEMPERATURE INCREASED,4
MA,C-REACTIVE PROTEIN INCREASED,4
MA,CEREBRAL HAEMORRHAGE,4
MA,CEREBROVASCULAR ACCIDENT,4
MA,CHEILITIS,4
MA,CIRCULATORY COLLAPSE,4
MA,CONFUSIONAL STATE,4
MA,CONJUNCTIVITIS,4
MA,DIZZINESS,4
MA,DRUG INTOLERANCE,4
MA,DYSPHAGIA,4
MA,EMBOLISM,4
MA,EXPOSURE DURING PREGNANCY,4
MA,GASTROINTESTINAL HAEMORRHAGE,4
MA,GENERALISED TONIC-CLONIC SEIZURE,4
MA,HEMIPLEGIA,4
MA,HEPATIC CIRRHOSIS,4
MA,HEPATITIS C,4
MA,INFECTION,4
MA,INTENTIONAL OVERDOSE,4
MA,KIDNEY FIBROSIS,4
MA,LEUKOCYTOSIS,4
MA,LYMPH NODE TUBERCULOSIS,4
MA,MUSCULOSKELETAL STIFFNESS,4
MA,MYOCARDITIS,4
MA,NEOPLASM PROGRESSION,4
MA,NEUROTOXICITY,4
MA,OVERDOSE,4
MA,PLEURAL EFFUSION,4
MA,PROTEINURIA,4
MA,PULMONARY ALVEOLAR HAEMORRHAGE,4
MA,RASH MACULAR,4
MA,RENAL IMPAIRMENT,4
MA,SEPSIS,4
MA,SHOCK,4
MA,TREATMENT FAILURE,4
MA,TREMOR,4
MA,VISUAL ACUITY REDUCED,4
MA,WRONG DRUG ADMINISTERED,4
MA,ABDOMINAL PAIN UPPER,3
MA,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,3
MA,ACUTE MYELOID LEUKAEMIA,3
MA,AGITATION,3
MA,ANAPHYLACTIC SHOCK,3
MA,APHASIA,3
MA,APLASIA,3
MA,APLASTIC ANAEMIA,3
MA,BLINDNESS,3
MA,CARDIO-RESPIRATORY ARREST,3
MA,CARDIOMYOPATHY,3
MA,CEREBRAL VENOUS THROMBOSIS,3
MA,COLITIS ISCHAEMIC,3
MA,CORNEAL DEPOSITS,3
MA,DEPRESSED LEVEL OF CONSCIOUSNESS,3
MA,DERMATITIS EXFOLIATIVE,3
MA,DISSEMINATED TUBERCULOSIS,3
MA,DRUG ABUSE,3
MA,DRUG ADMINISTRATION ERROR,3
MA,DRUG DISPENSING ERROR,3
MA,DRUG EFFECT INCOMPLETE,3
MA,ELECTROLYTE IMBALANCE,3
MA,FAECALOMA,3
MA,FIBROSIS,3
MA,FOETAL DISTRESS SYNDROME,3
MA,HAEMATEMESIS,3
MA,HAEMOPTYSIS,3
MA,HAEMORRHAGIC STROKE,3
MA,HEPATOSPLENOMEGALY,3
MA,HYPERSENSITIVITY,3
MA,HYPERTHERMIA,3
MA,HYPOAESTHESIA,3
MA,HYPOGLYCAEMIA,3
MA,HYPOTHERMIA,3
MA,JOINT DESTRUCTION,3
MA,KOUNIS SYNDROME,3
MA,LEUKOENCEPHALOPATHY,3
MA,LUNG DISORDER,3
MA,LYMPHADENOPATHY,3
MA,LYMPHOPENIA,3
MA,MALAISE,3
MA,MEDICATION ERROR,3
MA,METASTASES TO LUNG,3
MA,MUCOSAL TOXICITY,3
MA,MUSCULAR WEAKNESS,3
MA,NEONATAL RESPIRATORY DISTRESS SYNDROME,3
MA,NERVOUS SYSTEM DISORDER,3
MA,NEURALGIA,3
MA,OEDEMA PERIPHERAL,3
MA,OPTIC ISCHAEMIC NEUROPATHY,3
MA,ORAL DISORDER,3
MA,OSTEONECROSIS OF JAW,3
MA,PAIN,3
MA,PHLEBITIS,3
MA,PLASMA CELL MYELOMA,3
MA,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,3
MA,PROSTATIC SPECIFIC ANTIGEN INCREASED,3
MA,RASH PUSTULAR,3
MA,SKIN EXFOLIATION,3
MA,SLEEP DISORDER,3
MA,STEVENS-JOHNSON SYNDROME,3
MA,SYSTEMIC LUPUS ERYTHEMATOSUS,3
MA,TREATMENT NONCOMPLIANCE,3
MA,URTICARIA,3
MA,VISUAL IMPAIRMENT,3
MA,ABNORMAL BEHAVIOUR,2
MA,ABSCESS LIMB,2
MA,ADVERSE EVENT,2
MA,ALANINE AMINOTRANSFERASE INCREASED,2
MA,ANAPHYLACTIC REACTION,2
MA,ASPARTATE AMINOTRANSFERASE INCREASED,2
MA,BLOOD GLUCOSE ABNORMAL,2
MA,BLOOD PRESSURE DECREASED,2
MA,BLOOD PRESSURE INCREASED,2
MA,BODY HEIGHT BELOW NORMAL,2
MA,BREAST CANCER,2
MA,BUTTERFLY RASH,2
MA,CARDIOGENIC SHOCK,2
MA,CARDIOVASCULAR DISORDER,2
MA,CHOLESTASIS,2
MA,CONGENITAL ANOMALY,2
MA,CONJUNCTIVAL ADHESION,2
MA,CONJUNCTIVAL HYPERAEMIA,2
MA,CROHN^S DISEASE,2
MA,CUSHINGOID,2
MA,CYTOMEGALOVIRUS INFECTION,2
MA,DEPRESSION,2
MA,DISORIENTATION,2
MA,DISSEMINATED INTRAVASCULAR COAGULATION,2
MA,DRUG DOSE OMISSION,2
MA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
MA,DRUG RESISTANCE,2
MA,DRY MOUTH,2
MA,DYSPNOEA EXERTIONAL,2
MA,EPIDERMAL NECROSIS,2
MA,EPISTAXIS,2
MA,ESCHERICHIA BACTERAEMIA,2
MA,FEBRILE BONE MARROW APLASIA,2
MA,FEMUR FRACTURE,2
MA,FISTULA,2
MA,FOETAL ARRHYTHMIA,2
MA,FOETAL DEATH,2
MA,GASTROENTERITIS VIRAL,2
MA,GASTROINTESTINAL DISORDER,2
MA,GASTROINTESTINAL PERFORATION,2
MA,GINGIVAL BLEEDING,2
MA,GRANULOMA,2
MA,HAEMOGLOBIN DECREASED,2
MA,HAEMOLYSIS,2
MA,HAEMORRHAGIC DISORDER,2
MA,HALLUCINATION_ VISUAL,2
MA,HEART RATE INCREASED,2
MA,HEMIPARESIS,2
MA,HEPATIC ENCEPHALOPATHY,2
MA,HEPATIC FAILURE,2
MA,HEPATITIS FULMINANT,2
MA,HEPATOCELLULAR CARCINOMA,2
MA,HISTIOCYTOSIS HAEMATOPHAGIC,2
MA,HYPERGLYCAEMIA,2
MA,HYPOALBUMINAEMIA,2
MA,INCORRECT DRUG ADMINISTRATION DURATION,2
MA,INFLAMMATION,2
MA,INFLAMMATORY MARKER INCREASED,2
MA,INTENTIONAL PRODUCT MISUSE,2
MA,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
MA,LARYNGOSPASM,2
MA,LOW BIRTH WEIGHT BABY,2
MA,LUPUS-LIKE SYNDROME,2
MA,MACULE,2
MA,MELANODERMA,2
MA,MEMORY IMPAIRMENT,2
MA,MENINGITIS,2
MA,MULTI-ORGAN FAILURE,2
MA,MUSCLE SPASMS,2
MA,MYELOPATHY,2
MA,NEGATIVISM,2
MA,NEPHROPATHY TOXIC,2
MA,NIGHTMARE,2
MA,NIKOLSKY^S SIGN,2
MA,NO THERAPEUTIC RESPONSE,2
MA,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
MA,NOSOCOMIAL INFECTION,2
MA,ORAL MUCOSA EROSION,2
MA,OSTEOARTHRITIS,2
MA,OSTEOPOROSIS,2
MA,PANCREATITIS ACUTE,2
MA,PANIC ATTACK,2
MA,PAPILLOEDEMA,2
MA,PARAESTHESIA,2
MA,PATHOGEN RESISTANCE,2
MA,PELVIC PAIN,2
MA,PERCUTANEOUS CORONARY INTERVENTION,2
MA,PERFORMANCE STATUS DECREASED,2
MA,PERIPHERAL COLDNESS,2
MA,PLATELET COUNT DECREASED,2
MA,PRESYNCOPE,2
MA,PRIAPISM,2
MA,RALES,2
MA,RASH GENERALISED,2
MA,RECTAL HAEMORRHAGE,2
MA,RENAL FAILURE ACUTE,2
MA,RESPIRATORY DISORDER,2
MA,RESPIRATORY FAILURE,2
MA,RETINAL HAEMORRHAGE,2
MA,RHINORRHOEA,2
MA,SINUS TACHYCARDIA,2
MA,SKIN DISCOLOURATION,2
MA,SKIN NECROSIS,2
MA,SODIUM RETENTION,2
MA,STILLBIRTH,2
MA,STUPOR,2
MA,SUICIDAL IDEATION,2
MA,SWELLING FACE,2
MA,SYNCOPE,2
MA,TACHYPNOEA,2
MA,THROMBOSIS,2
MA,TRANSAMINASES INCREASED,2
MA,TRANSIENT ISCHAEMIC ATTACK,2
MA,ULCERATIVE KERATITIS,2
MA,URINARY INCONTINENCE,2
MA,WHITE BLOOD CELL COUNT INCREASED,2
MA,WITHDRAWAL SYNDROME,2
MA,ABDOMINAL DISTENSION,1
MA,ABDOMINAL MASS,1
MA,ABORTION,1
MA,ACCIDENTAL EXPOSURE TO PRODUCT,1
MA,ACINETOBACTER INFECTION,1
MA,ACNE,1
MA,ACUTE ABDOMEN,1
MA,ACUTE CORONARY SYNDROME,1
MA,ACUTE DISSEMINATED ENCEPHALOMYELITIS,1
MA,ACUTE HEPATIC FAILURE,1
MA,ACUTE MYOCARDIAL INFARCTION,1
MA,ACUTE PULMONARY OEDEMA,1
MA,ACUTE RESPIRATORY DISTRESS SYNDROME,1
MA,ACUTE TONSILLITIS,1
MA,ADHESION,1
MA,ADRENAL INSUFFICIENCY,1
MA,AIR EMBOLISM,1
MA,ALOPECIA,1
MA,AMENORRHOEA,1
MA,AMNESIA,1
MA,AMYLOIDOSIS,1
MA,ANAL ABSCESS,1
MA,ANAL INFLAMMATION,1
MA,ANGINA PECTORIS,1
MA,ANGIOEDEMA,1
MA,ANGIOPATHY,1
MA,ANGULAR CHEILITIS,1
MA,ANTINUCLEAR ANTIBODY POSITIVE,1
MA,APATHY,1
MA,APHAGIA,1
MA,APHONIA,1
MA,APPENDICITIS,1
MA,APRAXIA,1
MA,ARTERIAL STENOSIS,1
MA,ARTERIAL THROMBOSIS,1
MA,ARTERIOGRAM CORONARY,1
MA,ARTHRITIS BACTERIAL,1
MA,ARTHROPOD BITE,1
MA,ASPHYXIA,1
MA,ASTHMA,1
MA,ATAXIA,1
MA,ATRIAL FIBRILLATION,1
MA,ATRIAL FLUTTER,1
MA,ATRIOVENTRICULAR BLOCK COMPLETE,1
MA,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
MA,B-CELL LYMPHOMA,1
MA,BACK PAIN,1
MA,BACTERIAL INFECTION,1
MA,BACTERIAL SEPSIS,1
MA,BALANCE DISORDER,1
MA,BLAST CELL CRISIS,1
MA,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
MA,BLINDNESS TRANSIENT,1
MA,BLOOD IMMUNOGLOBULIN G INCREASED,1
MA,BLOOD PRESSURE,1
MA,BLOOD PRESSURE ABNORMAL,1
MA,BLOOD PRESSURE FLUCTUATION,1
MA,BONE DISORDER,1
MA,BONE PAIN,1
MA,BRAIN INJURY,1
MA,BRAIN MALFORMATION,1
MA,BRAIN STEM STROKE,1
MA,BREAST ABSCESS,1
MA,BREAST CANCER METASTATIC,1
MA,BREAST NECROSIS,1
MA,BREAST NEOPLASM,1
MA,BRONCHOSPASM,1
MA,BRONCHOSPASM PARADOXICAL,1
MA,BULIMIA NERVOSA,1
MA,CARDIAC DISCOMFORT,1
MA,CARDIAC FAILURE CONGESTIVE,1
MA,CARPAL TUNNEL SYNDROME,1
MA,CATARACT,1
MA,CELLULITIS,1
MA,CEREBELLAR ATROPHY,1
MA,CEREBRAL INFARCTION,1
MA,CERVIX DISORDER,1
MA,CHEST DISCOMFORT,1
MA,CHEST PAIN,1
MA,CHEST X-RAY ABNORMAL,1
MA,CHOKING,1
MA,CHOROIDAL NEOVASCULARISATION,1
MA,CHRONIC KIDNEY DISEASE,1
MA,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
MA,COGNITIVE DISORDER,1
MA,COLON CANCER METASTATIC,1
MA,COMPLETED SUICIDE,1
MA,COMPLEX REGIONAL PAIN SYNDROME,1
MA,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
MA,CONJUNCTIVAL DISORDER,1
MA,CONJUNCTIVAL EROSION,1
MA,CONSTIPATION,1
MA,CONTRAINDICATED PRODUCT ADMINISTERED,1
MA,CONVULSION,1
MA,CORNEAL ABSCESS,1
MA,CORNEAL DEFECT,1
MA,CORONARY ARTERY DISEASE,1
MA,CRANIAL NERVE PARALYSIS,1
MA,CRYPTOCOCCOSIS,1
MA,CYST,1
MA,CYSTITIS,1
MA,CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION,1
MA,CYTOPENIA,1
MA,DEAFNESS,1
MA,DEAFNESS TRANSITORY,1
MA,DEATH NEONATAL,1
MA,DELAYED CLOSURE OF CRANIAL SUTURES,1
MA,DELIRIUM,1
MA,DELUSION,1
MA,DELUSION OF GRANDEUR,1
MA,DELUSION OF REFERENCE,1
MA,DEMENTIA,1
MA,DEMYELINATING POLYNEUROPATHY,1
MA,DEMYELINATION,1
MA,DERMATITIS ALLERGIC,1
MA,DERMATOMYOSITIS,1
MA,DERMATOSIS,1
MA,DEVICE RELATED INFECTION,1
MA,DIABETIC HYPEROSMOLAR COMA,1
MA,DIABETIC KETOACIDOSIS,1
MA,DIARRHOEA HAEMORRHAGIC,1
MA,DISCOMFORT,1
MA,DISEASE RECURRENCE,1
MA,DISSEMINATED CRYPTOCOCCOSIS,1
MA,DISTURBANCE IN ATTENTION,1
MA,DRUG LEVEL ABOVE THERAPEUTIC,1
MA,DRUG PRESCRIBING ERROR,1
MA,DRUG WITHDRAWAL SYNDROME,1
MA,DRUG-INDUCED LIVER INJURY,1
MA,DRY SKIN,1
MA,DYSARTHRIA,1
MA,DYSLIPIDAEMIA,1
MA,DYSMORPHISM,1
MA,DYSPEPSIA,1
MA,DYSPNOEA AT REST,1
MA,DYSPNOEA PAROXYSMAL NOCTURNAL,1
MA,DYSSTASIA,1
MA,ECCHYMOSIS,1
MA,EJECTION FRACTION DECREASED,1
MA,ELECTROCARDIOGRAM PR PROLONGATION,1
MA,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,1
MA,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
MA,EMBOLIA CUTIS MEDICAMENTOSA,1
MA,ENANTHEMA,1
MA,ENCEPHALITIS,1
MA,ENTEROCOLITIS HAEMORRHAGIC,1
MA,EPIDERMOLYSIS,1
MA,ERECTILE DYSFUNCTION,1
MA,ERYTHEMA MULTIFORME,1
MA,EXPOSED BONE IN JAW,1
MA,EXTENSOR PLANTAR RESPONSE,1
MA,EYE DISORDER,1
MA,EYE OEDEMA,1
MA,EYE PAIN,1
MA,FAECAL INCONTINENCE,1
MA,FALL,1
MA,FLUID OVERLOAD,1
MA,FLUID RETENTION,1
MA,FLUSHING,1
MA,FOETAL HEART RATE DECREASED,1
MA,FOETAL MALFORMATION,1
MA,FRACTURE,1
MA,FRACTURE INFECTION,1
MA,FUNCTIONAL GASTROINTESTINAL DISORDER,1
MA,GAIT DISTURBANCE,1
MA,GASTRIC NEOPLASM,1
MA,GASTRIC ULCER,1
MA,GASTROINTESTINAL INFECTION,1
MA,GASTROINTESTINAL STROMAL TUMOUR,1
MA,GENITAL EROSION,1
MA,GENITAL LABIAL ADHESIONS,1
MA,GLOMERULAR FILTRATION RATE DECREASED,1
MA,GLOMERULAR VASCULAR DISORDER,1
MA,GOITRE,1
MA,GUILLAIN-BARRE SYNDROME,1
MA,HAEMATOMA,1
MA,HAEMATURIA,1
MA,HAEMOBILIA,1
MA,HAEMORRHAGE INTRACRANIAL,1
MA,HAEMORRHAGIC CYST,1
MA,HAEMORRHAGIC INFARCTION,1
MA,HAIR COLOUR CHANGES,1
MA,HALLUCINATION_ AUDITORY,1
MA,HEART RATE DECREASED,1
MA,HEAT EXHAUSTION,1
MA,HEPATIC FIBROSIS,1
MA,HEPATIC NEOPLASM,1
MA,HEPATIC SIDEROSIS,1
MA,HEPATITIS ACUTE,1
MA,HEPATITIS TOXIC,1
MA,HEPATOTOXICITY,1
MA,HIDRADENITIS,1
MA,HORMONE LEVEL ABNORMAL,1
MA,HUMAN HERPES VIRUS 6 SEROLOGY POSITIVE,1
MA,HYPERFERRITINAEMIA,1
MA,HYPERKALAEMIA,1
MA,HYPERLEUKOCYTOSIS,1
MA,HYPERREFLEXIA,1
MA,HYPERSENSITIVITY VASCULITIS,1
MA,HYPERTONIA,1
MA,HYPERTRIGLYCERIDAEMIA,1
MA,HYPOAESTHESIA ORAL,1
MA,HYPOCALCAEMIA,1
MA,HYPOCOAGULABLE STATE,1
MA,HYPOGAMMAGLOBULINAEMIA,1
MA,HYPOSIDERAEMIA,1
MA,HYPOTONIA,1
MA,IMMUNE SYSTEM DISORDER,1
MA,IMMUNE THROMBOCYTOPENIC PURPURA,1
MA,IMPAIRED HEALING,1
MA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
MA,INCORRECT PRODUCT STORAGE,1
MA,INDURATION,1
MA,INFUSION RELATED REACTION,1
MA,INJECTION SITE ABSCESS,1
MA,INJECTION SITE HAEMATOMA,1
MA,INSOMNIA,1
MA,INTENTIONAL PRODUCT USE ISSUE,1
MA,INTERVERTEBRAL DISC DEGENERATION,1
MA,INTERVERTEBRAL DISC DISORDER,1
MA,INTESTINAL INFARCTION,1
MA,INTESTINAL PERFORATION,1
MA,INTRAOCULAR HAEMATOMA,1
MA,ISCHAEMIA,1
MA,JAUNDICE,1
MA,JAUNDICE CHOLESTATIC,1
MA,KAPOSI^S SARCOMA,1
MA,LARGE INTESTINAL ULCER,1
MA,LARYNGEAL OEDEMA,1
MA,LETHARGY,1
MA,LEUKAEMIA,1
MA,LICHENIFICATION,1
MA,LIP INJURY,1
MA,LIVER INJURY,1
MA,LIVER TRANSPLANT,1
MA,LUNG CONSOLIDATION,1
MA,LUNG INFECTION,1
MA,LUNG NEOPLASM MALIGNANT,1
MA,LUPUS NEPHRITIS,1
MA,LYMPHOCYTIC INFILTRATION,1
MA,MAJOR DEPRESSION,1
MA,MANIA,1
MA,MATERNAL DRUGS AFFECTING FOETUS,1
MA,MATERNAL EXPOSURE DURING DELIVERY,1
MA,MELAENA,1
MA,MENINGITIS ASEPTIC,1
MA,MENINGITIS BACTERIAL,1
MA,MENTAL DISORDER,1
MA,MESENTERIC VEIN THROMBOSIS,1
MA,METABOLIC ACIDOSIS,1
MA,METABOLIC DISORDER,1
MA,METASTASES TO PITUITARY GLAND,1
MA,METASTASES TO SMALL INTESTINE,1
MA,METASTASIS,1
MA,MITRAL VALVE INCOMPETENCE,1
MA,MONOCLONAL IMMUNOGLOBULIN PRESENT,1
MA,MOTOR DYSFUNCTION,1
MA,MOUTH ULCERATION,1
MA,MULTIPLE SCLEROSIS RELAPSE,1
MA,MUSCLE ATROPHY,1
MA,MUSCLE CONTRACTURE,1
MA,MUSCLE RIGIDITY,1
MA,MUSCULOSKELETAL DISORDER,1
MA,MUTISM,1
MA,MYELOFIBROSIS,1
MA,MYOCLONUS,1
MA,NAIL DISORDER,1
MA,NAIL PIGMENTATION,1
MA,NEONATAL CARDIAC FAILURE,1
MA,NEOPLASM,1
MA,NEOPLASM MALIGNANT,1
MA,NEOPLASM RECURRENCE,1
MA,NEPHROCALCINOSIS,1
MA,NEPHROTIC SYNDROME,1
MA,NEURITIS,1
MA,NEUROLOGICAL DECOMPENSATION,1
MA,NEUROLOGICAL SYMPTOM,1
MA,NEUTRALISING ANTIBODIES POSITIVE,1
MA,NODULE,1
MA,NONINFECTIVE GINGIVITIS,1
MA,NORMAL NEWBORN,1
MA,ONYCHOCLASIS,1
MA,ONYCHOLYSIS,1
MA,ONYCHOMYCOSIS,1
MA,OPHTHALMIC HERPES SIMPLEX,1
MA,OPTIC ATROPHY,1
MA,OPTIC NEUROPATHY,1
MA,ORAL HERPES,1
MA,ORAL PAIN,1
MA,OVARIAN CYST,1
MA,OVERLAP SYNDROME,1
MA,PAIN IN EXTREMITY,1
MA,PAIN OF SKIN,1
MA,PALLOR,1
MA,PALMOPLANTAR KERATODERMA,1
MA,PALPITATIONS,1
MA,PANCREATIC CARCINOMA METASTATIC,1
MA,PANCREATITIS,1
MA,PANOPHTHALMITIS,1
MA,PAPULE,1
MA,PARALYSIS FLACCID,1
MA,PARAPARESIS,1
MA,PARAPLEGIA,1
MA,PERICARDITIS,1
MA,PERINEAL INJURY,1
MA,PERIPHERAL SENSORY NEUROPATHY,1
MA,PERIRENAL HAEMATOMA,1
MA,PERITONITIS,1
MA,PERNICIOUS ANAEMIA,1
MA,PERSECUTORY DELUSION,1
MA,PETIT MAL EPILEPSY,1
MA,PHOTOSENSITIVITY REACTION,1
MA,PIGMENTATION DISORDER,1
MA,PITUITARY TUMOUR,1
MA,PNEUMONIA,1
MA,POISONING,1
MA,POLYARTHRITIS,1
MA,POLYNEUROPATHY,1
MA,PRESCRIBED UNDERDOSE,1
MA,PRODUCT DEPOSIT,1
MA,PRODUCT STORAGE ERROR,1
MA,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
MA,PSEUDOENDOPHTHALMITIS,1
MA,PSYCHOMOTOR RETARDATION,1
MA,PSYCHOTIC DISORDER,1
MA,PULMONARY ARTERIAL HYPERTENSION,1
MA,PULMONARY HAEMORRHAGE,1
MA,PULMONARY MASS,1
MA,PULMONARY OEDEMA,1
MA,PYELONEPHRITIS ACUTE,1
MA,PYRAMIDAL TRACT SYNDROME,1
MA,RECTAL ADENOCARCINOMA,1
MA,RECTAL PERFORATION,1
MA,RED BLOOD CELL COUNT DECREASED,1
MA,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,1
MA,RENAL CANCER,1
MA,RESTING TREMOR,1
MA,RETINAL ARTERY OCCLUSION,1
MA,RETINAL EXUDATES,1
MA,RETINAL VEIN OCCLUSION,1
MA,RETINOPATHY,1
MA,RHABDOMYOSARCOMA,1
MA,RHEUMATOID ARTHRITIS,1
MA,SALMONELLA SEPSIS,1
MA,SARCOMA,1
MA,SCIATICA,1
MA,SCLERODERMA RENAL CRISIS,1
MA,SENSE OF OPPRESSION,1
MA,SENSORY DISTURBANCE,1
MA,SENSORY LOSS,1
MA,SKIN PLAQUE,1
MA,SKIN REACTION,1
MA,SKIN SWELLING,1
MA,SKIN TOXICITY,1
MA,SMALL INTESTINAL HAEMORRHAGE,1
MA,SMALL INTESTINAL PERFORATION,1
MA,SOCIAL AVOIDANT BEHAVIOUR,1
MA,SOFT TISSUE SARCOMA,1
MA,SPEECH DISORDER,1
MA,SPEECH DISORDER DEVELOPMENTAL,1
MA,SPIROMETRY ABNORMAL,1
MA,SPLENIC ABSCESS,1
MA,STAPHYLOCOCCAL INFECTION,1
MA,STOMATITIS,1
MA,STRAWBERRY TONGUE,1
MA,SUBARACHNOID HAEMORRHAGE,1
MA,SUDDEN DEATH,1
MA,SUPERINFECTION,1
MA,SYSTOLIC DYSFUNCTION,1
MA,TENDERNESS,1
MA,THERAPY NON-RESPONDER,1
MA,THROMBOTIC MICROANGIOPATHY,1
MA,TINNITUS,1
MA,TONGUE PARALYSIS,1
MA,TONSILLAR NEOPLASM,1
MA,TORSADE DE POINTES,1
MA,TOXIC OPTIC NEUROPATHY,1
MA,TRANSPLANT,1
MA,TRANSPLANT REJECTION,1
MA,TRICUSPID VALVE INCOMPETENCE,1
MA,TRISMUS,1
MA,TUBERCULOUS PLEURISY,1
MA,TUBULOINTERSTITIAL NEPHRITIS,1
MA,TUMOUR COMPRESSION,1
MA,TUMOUR LYSIS SYNDROME,1
MA,UMBILICAL HERNIA_ OBSTRUCTIVE,1
MA,UNILATERAL BRONCHOSPASM,1
MA,URINARY BLADDER TOXICITY,1
MA,URINARY RETENTION,1
MA,URINARY TRACT DISORDER,1
MA,URINARY TRACT INFECTION,1
MA,VAGINAL PERFORATION,1
MA,VASCULITIS,1
MA,VENOUS THROMBOSIS,1
MA,VENTRICULAR EXTRASYSTOLES,1
MA,VENTRICULAR FIBRILLATION,1
MA,VERTIGO,1
MA,VIITH NERVE PARALYSIS,1
MA,VIRAEMIA,1
MA,VIRAL INFECTION,1
MA,VISUAL FIELD DEFECT,1
MA,VITAMIN B12 DEFICIENCY,1
MA,VITAMIN D DECREASED,1
MA,VITREOUS HAEMORRHAGE,1
MA,VULVAR EROSION,1
MA,WAXY FLEXIBILITY,1
MA,WEIGHT INCREASED,1
MA,WHITE BLOOD CELL COUNT DECREASED,1
MZ,ANAEMIA,4
MZ,APLASIA CUTIS CONGENITA,4
MZ,FOETAL EXPOSURE DURING PREGNANCY,4
MZ,DEATH,3
MZ,FISTULA,3
MZ,MALARIA,3
MZ,ABDOMINAL DISTENSION,2
MZ,ACUTE KIDNEY INJURY,2
MZ,CONDITION AGGRAVATED,2
MZ,CONTRAINDICATION TO MEDICAL TREATMENT,2
MZ,IRRITABILITY,2
MZ,LACERATION,2
MZ,LOW BIRTH WEIGHT BABY,2
MZ,NECROSIS,2
MZ,NEUROPATHY PERIPHERAL,2
MZ,PAIN,2
MZ,PRODUCT USE ISSUE,2
MZ,SELECTIVE EATING DISORDER,2
MZ,SKIN DISORDER,2
MZ,SKIN EXFOLIATION,2
MZ,SKIN LESION,2
MZ,SKIN NECROSIS,2
MZ,STILLBIRTH,2
MZ,TRANSAMINASES INCREASED,2
MZ,TREATMENT FAILURE,2
MZ,WEIGHT DECREASED,2
MZ,ABORTION INDUCED,1
MZ,ACUTE RESPIRATORY FAILURE,1
MZ,ASPIRATION BRONCHIAL,1
MZ,BACK PAIN,1
MZ,COUGH,1
MZ,DIARRHOEA,1
MZ,DRUG ERUPTION,1
MZ,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
MZ,FACE OEDEMA,1
MZ,FACIAL PARALYSIS,1
MZ,GASTROENTERITIS,1
MZ,HAEMOPTYSIS,1
MZ,LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR,1
MZ,PLASMODIUM FALCIPARUM INFECTION,1
MZ,PNEUMONIA BACTERIAL,1
MZ,PREGNANCY WITH IMPLANT CONTRACEPTIVE,1
MZ,PURULENT DISCHARGE,1
MZ,RESPIRATORY FAILURE,1
MZ,SPINA BIFIDA,1
MZ,UNINTENDED PREGNANCY,1
MZ,URINARY TRACT INFECTION,1
MZ,VOMITING,1
MM,ELECTROCARDIOGRAM QT PROLONGED,5
MM,ABDOMINAL DISTENSION,3
MM,MUSCLE SPASMS,3
MM,ANAEMIA,2
MM,ASCITES,2
MM,CHILLS,2
MM,DIARRHOEA,2
MM,DRUG INEFFECTIVE,2
MM,DYSPNOEA,2
MM,EYE MOVEMENT DISORDER,2
MM,LOSS OF CONSCIOUSNESS,2
MM,MUCOSAL INFLAMMATION,2
MM,PALPITATIONS,2
MM,PYREXIA,2
MM,RASH,2
MM,RECTAL HAEMORRHAGE,2
MM,RESPIRATORY FAILURE,2
MM,VOMITING,2
MM,ABDOMINAL DISCOMFORT,1
MM,ABORTION,1
MM,ANAPHYLACTIC SHOCK,1
MM,BLOOD GLUCOSE DECREASED,1
MM,BLOOD PRESSURE DECREASED,1
MM,BLOOD PRESSURE INCREASED,1
MM,CARDIAC ARREST,1
MM,CARDIAC FAILURE,1
MM,CHEST DISCOMFORT,1
MM,CHOKING,1
MM,COMA,1
MM,CONDITION AGGRAVATED,1
MM,CONFUSIONAL STATE,1
MM,CONSTIPATION,1
MM,CYANOSIS,1
MM,DEATH,1
MM,DEPRESSED LEVEL OF CONSCIOUSNESS,1
MM,DIABETES MELLITUS,1
MM,DIARRHOEA HAEMORRHAGIC,1
MM,DISEASE PROGRESSION,1
MM,DISSEMINATED TUBERCULOSIS,1
MM,DIZZINESS,1
MM,DRUG RESISTANCE,1
MM,DRUG-INDUCED LIVER INJURY,1
MM,ENLARGED UVULA,1
MM,FALL,1
MM,GASTROINTESTINAL HAEMORRHAGE,1
MM,HAEMATOCHEZIA,1
MM,HYPERHIDROSIS,1
MM,HYPERSENSITIVITY,1
MM,HYPOAESTHESIA,1
MM,INFECTIOUS PLEURAL EFFUSION,1
MM,INFLUENZA,1
MM,JAUNDICE,1
MM,LUNG DISORDER,1
MM,LUPUS NEPHRITIS,1
MM,MATERNAL EXPOSURE DURING PREGNANCY,1
MM,MUCOUS STOOLS,1
MM,NAUSEA,1
MM,NEUTROPENIA,1
MM,OEDEMA PERIPHERAL,1
MM,ONYCHOLYSIS,1
MM,PERITONITIS BACTERIAL,1
MM,PNEUMONIA,1
MM,PREGNANCY WITH IMPLANT CONTRACEPTIVE,1
MM,PRODUCT USE ISSUE,1
MM,PRURITUS GENERALISED,1
MM,PULSE ABSENT,1
MM,RIGHT VENTRICULAR FAILURE,1
MM,SWELLING FACE,1
MM,VARICES OESOPHAGEAL,1
NA,DEATH,10
NA,DIARRHOEA,2
NA,HAEMOGLOBIN DECREASED,2
NA,NEUTROPENIA,2
NA,PALPITATIONS,2
NA,PRODUCT QUALITY ISSUE,2
NA,PYREXIA,2
NA,RASH,2
NA,SEPSIS,2
NA,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
NA,ALPHA 1 FOETOPROTEIN INCREASED,1
NA,ANAEMIA,1
NA,ANXIETY,1
NA,APPLICATION SITE DRYNESS,1
NA,APPLICATION SITE EXFOLIATION,1
NA,CHEST PAIN,1
NA,CONDITION AGGRAVATED,1
NA,CONVULSION,1
NA,DEPRESSION,1
NA,DISSEMINATED INTRAVASCULAR COAGULATION,1
NA,DISSEMINATED TUBERCULOSIS,1
NA,DIZZINESS,1
NA,DRUG EFFECT INCOMPLETE,1
NA,DRUG INEFFECTIVE,1
NA,DYSPNOEA,1
NA,DYSTONIA,1
NA,ENCEPHALITIS,1
NA,EPILEPSY,1
NA,FATIGUE,1
NA,FOETAL EXPOSURE DURING PREGNANCY,1
NA,HAEMATOCRIT DECREASED,1
NA,HEADACHE,1
NA,HYPOKALAEMIA,1
NA,HYPOPHAGIA,1
NA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
NA,INCONTINENCE,1
NA,INSOMNIA,1
NA,LARYNGOSPASM,1
NA,LETHARGY,1
NA,LEUKOPENIA,1
NA,LIP SWELLING,1
NA,MUSCULAR WEAKNESS,1
NA,MYALGIA,1
NA,MYELOFIBROSIS,1
NA,NEURAL TUBE DEFECT,1
NA,OSTEONECROSIS OF JAW,1
NA,OVERDOSE,1
NA,PLATELET COUNT DECREASED,1
NA,PLATELET DISORDER,1
NA,POSTPARTUM HAEMORRHAGE,1
NA,POUCHITIS,1
NA,PROCTITIS,1
NA,PRODUCT ADHESION ISSUE,1
NA,PRURITUS GENERALISED,1
NA,PULMONARY EMBOLISM,1
NA,RECTAL CANCER,1
NA,RED BLOOD CELL COUNT DECREASED,1
NA,RED CELL DISTRIBUTION WIDTH INCREASED,1
NA,RETINAL DETACHMENT,1
NA,RETINAL TEAR,1
NA,SOMNOLENCE,1
NA,SWEAT GLAND DISORDER,1
NA,THIRST,1
NA,THROMBOCYTOPENIA,1
NA,VOMITING,1
NA,WEIGHT DECREASED,1
NR,ANXIETY,1
NR,CROHN^S DISEASE,1
NR,DEVICE DIFFICULT TO USE,1
NR,FEAR OF INJECTION,1
NR,GASTROINTESTINAL OBSTRUCTION,1
NR,INCORRECT PRODUCT STORAGE,1
NR,INJECTION SITE PAIN,1
NR,PAIN,1
NP,DEATH,169
NP,HYPOTENSION,14
NP,NONINFECTIOUS PERITONITIS,12
NP,VOMITING,11
NP,RESPIRATORY ALKALOSIS,9
NP,INTENTIONAL OVERDOSE,8
NP,OVERDOSE,8
NP,SEPSIS,8
NP,SWELLING FACE,8
NP,DYSPNOEA,7
NP,NON-CARDIOGENIC PULMONARY OEDEMA,7
NP,TYPE IV HYPERSENSITIVITY REACTION,7
NP,DIZZINESS,6
NP,MYOCARDIAL DEPRESSION,6
NP,PNEUMONIA,6
NP,DRUG INTOLERANCE,5
NP,HAEMORRHAGE INTRACRANIAL,5
NP,TOXICITY TO VARIOUS AGENTS,5
NP,ANAEMIA,4
NP,CYSTITIS,4
NP,HYPOXIA,4
NP,PARADOXICAL DRUG REACTION,4
NP,PNEUMONIA FUNGAL,4
NP,PULMONARY OEDEMA,4
NP,SEPTIC SHOCK,4
NP,SUICIDE ATTEMPT,4
NP,ACUTE RESPIRATORY DISTRESS SYNDROME,3
NP,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,3
NP,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,3
NP,NEUTROPENIA,3
NP,PAIN IN EXTREMITY,3
NP,PERICARDIAL EFFUSION,3
NP,PLEURAL EFFUSION,3
NP,PYREXIA,3
NP,RETINAL ARTERY OCCLUSION,3
NP,SOMNOLENCE,3
NP,THROMBOCYTOPENIA,3
NP,ACCIDENTAL OVERDOSE,2
NP,APLASIA PURE RED CELL,2
NP,ARTHRALGIA,2
NP,CHRONIC MYELOID LEUKAEMIA RECURRENT,2
NP,DEPRESSION,2
NP,DERMATITIS ALLERGIC,2
NP,DRUG LEVEL INCREASED,2
NP,ELECTROCARDIOGRAM QT PROLONGED,2
NP,FATIGUE,2
NP,GASTROINTESTINAL HAEMORRHAGE,2
NP,HYPONATRAEMIA,2
NP,JAUNDICE,2
NP,LEMIERRE SYNDROME,2
NP,LUNG CONSOLIDATION,2
NP,LUNG INFILTRATION,2
NP,MUSCLE DISORDER,2
NP,MYELOFIBROSIS,2
NP,NAUSEA,2
NP,NEPHROTIC SYNDROME,2
NP,OROPHARYNGEAL PAIN,2
NP,PAIN,2
NP,PANCYTOPENIA,2
NP,PANIC ATTACK,2
NP,PARTIAL SEIZURES,2
NP,PERITONEAL CLOUDY EFFLUENT,2
NP,PRODUCT USE ISSUE,2
NP,RASH,2
NP,RENAL FAILURE,2
NP,RESPIRATORY DISTRESS,2
NP,SINUS TACHYCARDIA,2
NP,SUICIDAL IDEATION,2
NP,THERAPY NON-RESPONDER,2
NP,TREATMENT FAILURE,2
NP,TUBERCULOMA OF CENTRAL NERVOUS SYSTEM,2
NP,TYPHOID FEVER,2
NP,URTICARIA,2
NP,WHITE BLOOD CELL COUNT DECREASED,2
NP,ABDOMINAL PAIN,1
NP,ABDOMINAL PAIN UPPER,1
NP,ABNORMAL BEHAVIOUR,1
NP,ABORTION,1
NP,ACUTE HEPATIC FAILURE,1
NP,ACUTE LEUKAEMIA,1
NP,ADVERSE EVENT,1
NP,AKINESIA,1
NP,ANXIETY,1
NP,ASTHENIA,1
NP,ASTHMA,1
NP,BACK PAIN,1
NP,BLINDNESS,1
NP,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
NP,BRAIN OEDEMA,1
NP,BRONCHOPNEUMONIA,1
NP,BRONCHOSPASM,1
NP,BURNING SENSATION,1
NP,C-REACTIVE PROTEIN INCREASED,1
NP,CARDIAC FAILURE,1
NP,CARDIAC FAILURE CONGESTIVE,1
NP,CARDIOMYOPATHY,1
NP,CEREBRAL ATROPHY,1
NP,CEREBROVASCULAR ACCIDENT,1
NP,CHEST DISCOMFORT,1
NP,CHEST PAIN,1
NP,CHILLS,1
NP,CHOLELITHIASIS,1
NP,CHRONIC MYELOID LEUKAEMIA,1
NP,COMA,1
NP,COMA SCALE ABNORMAL,1
NP,CONDITION AGGRAVATED,1
NP,CONFUSIONAL STATE,1
NP,CONSCIOUSNESS FLUCTUATING,1
NP,CONSTIPATION,1
NP,CONVULSION NEONATAL,1
NP,COUGH,1
NP,CUSHINGOID,1
NP,CYSTITIS NONINFECTIVE,1
NP,DERMATITIS,1
NP,DIABETES MELLITUS,1
NP,DIABETIC COMPLICATION,1
NP,DIABETIC NEPHROPATHY,1
NP,DIARRHOEA,1
NP,DISEASE PROGRESSION,1
NP,DISEASE RECURRENCE,1
NP,DRUG ABUSE,1
NP,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
NP,DRUG EFFECTIVE FOR UNAPPROVED INDICATION,1
NP,DRUG ERUPTION,1
NP,DRUG HYPERSENSITIVITY,1
NP,DRUG INEFFECTIVE,1
NP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
NP,DRUG RESISTANCE,1
NP,DYSENTERY,1
NP,EYE SWELLING,1
NP,GAIT DISTURBANCE,1
NP,GASTROINTESTINAL STROMAL TUMOUR,1
NP,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
NP,HAEMOGLOBIN DECREASED,1
NP,HAEMOLYTIC URAEMIC SYNDROME,1
NP,HALLUCINATION,1
NP,HALLUCINATION_ AUDITORY,1
NP,HELMINTHIC INFECTION,1
NP,HEPATIC ENCEPHALOPATHY,1
NP,HERPES ZOSTER,1
NP,HYPERHIDROSIS,1
NP,HYPERVISCOSITY SYNDROME,1
NP,HYPOGLYCAEMIA,1
NP,HYPOKINESIA,1
NP,INCOHERENT,1
NP,INSOMNIA,1
NP,INSULIN AUTOIMMUNE SYNDROME,1
NP,IRRITABLE BOWEL SYNDROME,1
NP,LEUKOCYTOSIS,1
NP,LEUKOSTASIS SYNDROME,1
NP,LIP SWELLING,1
NP,LOSS OF CONSCIOUSNESS,1
NP,LOWER RESPIRATORY TRACT INFECTION,1
NP,LUNG INFECTION,1
NP,MALAISE,1
NP,MALIGNANT NEOPLASM PROGRESSION,1
NP,MARROW HYPERPLASIA,1
NP,MATERNAL EXPOSURE DURING PREGNANCY,1
NP,MUSCLE CONTRACTIONS INVOLUNTARY,1
NP,MUSCLE INJURY,1
NP,MUSCLE SPASMS,1
NP,MYASTHENIA GRAVIS,1
NP,NEPHROLITHIASIS,1
NP,NEUROPATHY PERIPHERAL,1
NP,NO THERAPEUTIC RESPONSE,1
NP,OEDEMA PERIPHERAL,1
NP,OSTEONECROSIS,1
NP,PANCREATIC CARCINOMA,1
NP,PARAESTHESIA,1
NP,PARALYSIS,1
NP,PERIPHERAL SWELLING,1
NP,PETECHIAE,1
NP,POLLAKIURIA,1
NP,POLYARTHRITIS,1
NP,POST-TRAUMATIC STRESS DISORDER,1
NP,PRESYNCOPE,1
NP,PSEUDOMONAS INFECTION,1
NP,PULMONARY VALVE STENOSIS,1
NP,RALES,1
NP,RECURRENT CANCER,1
NP,RENAL FAILURE ACUTE,1
NP,RHEUMATIC HEART DISEASE,1
NP,SECOND PRIMARY MALIGNANCY,1
NP,SEIZURE,1
NP,SPLENOMEGALY,1
NP,STAPHYLOCOCCAL INFECTION,1
NP,STARING,1
NP,STEVENS-JOHNSON SYNDROME,1
NP,STRESS ULCER,1
NP,STUPOR,1
NP,SWOLLEN TONGUE,1
NP,SYMPTOM MASKED,1
NP,TACHYCARDIA,1
NP,TACHYPNOEA,1
NP,TENDON PAIN,1
NP,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
NP,TOXIC EPIDERMAL NECROLYSIS,1
NP,TUBERCULOSIS,1
NP,UPPER GASTROINTESTINAL HAEMORRHAGE,1
NP,VAGINAL HAEMORRHAGE,1
NP,WEIGHT DECREASED,1
NL,DEATH,12188
NL,HOSPITALISATION,2258
NL,TERMINAL STATE,1212
NL,INVESTIGATION,1004
NL,PYREXIA,968
NL,PNEUMONIA,949
NL,FATIGUE,910
NL,DYSPNOEA,850
NL,MALAISE,850
NL,NAUSEA,810
NL,DIARRHOEA,664
NL,TOXICITY TO VARIOUS AGENTS,653
NL,VOMITING,582
NL,DIZZINESS,561
NL,DRUG INEFFECTIVE,554
NL,FALL,551
NL,HEADACHE,550
NL,PAIN,415
NL,DISEASE PROGRESSION,397
NL,GENERAL PHYSICAL HEALTH DETERIORATION,389
NL,PULMONARY EMBOLISM,373
NL,ABDOMINAL PAIN,363
NL,WEIGHT DECREASED,362
NL,HYPERTENSION,351
NL,CONFUSIONAL STATE,347
NL,CARDIAC FAILURE,341
NL,MALIGNANT NEOPLASM PROGRESSION,339
NL,DEHYDRATION,313
NL,FOETAL EXPOSURE DURING PREGNANCY,311
NL,ASTHENIA,306
NL,RENAL IMPAIRMENT,305
NL,GAIT DISTURBANCE,303
NL,MYALGIA,300
NL,HYPOTENSION,280
NL,RENAL FAILURE,274
NL,BACK PAIN,266
NL,DECREASED APPETITE,266
NL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,265
NL,ANAEMIA,264
NL,ARTHRALGIA,263
NL,SEPSIS,263
NL,CHEST PAIN,261
NL,PAIN IN EXTREMITY,261
NL,URINARY TRACT INFECTION,261
NL,SYNCOPE,259
NL,MYOCARDIAL INFARCTION,257
NL,TREMOR,257
NL,CONSTIPATION,256
NL,RESPIRATORY FAILURE,253
NL,SUICIDAL IDEATION,246
NL,HAEMOGLOBIN DECREASED,244
NL,EPILEPSY,242
NL,LOSS OF CONSCIOUSNESS,239
NL,CEREBROVASCULAR ACCIDENT,237
NL,SOMNOLENCE,237
NL,PRODUCT USE ISSUE,234
NL,HOT FLUSH,230
NL,AGITATION,223
NL,INFECTION,220
NL,MUSCLE SPASMS,218
NL,PRURITUS,218
NL,TACHYCARDIA,218
NL,CONDITION AGGRAVATED,216
NL,PALPITATIONS,215
NL,INSOMNIA,213
NL,ARRHYTHMIA,210
NL,PROSTATE CANCER METASTATIC,201
NL,COUGH,200
NL,WEIGHT INCREASED,198
NL,HYPOTHYROIDISM,197
NL,ANXIETY,195
NL,INTENTIONAL PRODUCT MISUSE,195
NL,HYPERHIDROSIS,194
NL,TRANSIENT ISCHAEMIC ATTACK,194
NL,CARDIAC DISORDER,193
NL,PARAESTHESIA,193
NL,DYSKINESIA,190
NL,DEPRESSION,189
NL,THROMBOCYTOPENIA,189
NL,CARDIAC ARREST,186
NL,ERYTHEMA,186
NL,PROSTATE CANCER,186
NL,METASTASES TO BONE,183
NL,RESPIRATORY TRACT INFECTION,183
NL,HALLUCINATION,180
NL,BONE PAIN,179
NL,FEBRILE NEUTROPENIA,178
NL,ACUTE KIDNEY INJURY,177
NL,PROSTATIC SPECIFIC ANTIGEN INCREASED,177
NL,FEELING ABNORMAL,176
NL,MUSCULAR WEAKNESS,176
NL,RASH,173
NL,HYPERSENSITIVITY,172
NL,DELIRIUM,171
NL,OVERDOSE,170
NL,PLEURAL EFFUSION,166
NL,RESTLESSNESS,163
NL,ABDOMINAL PAIN UPPER,159
NL,EXPOSURE DURING PREGNANCY,158
NL,CEREBRAL HAEMORRHAGE,156
NL,HYPOKALAEMIA,155
NL,PSYCHOTIC DISORDER,155
NL,THROMBOSIS,152
NL,ADVERSE EVENT,151
NL,ON AND OFF PHENOMENON,151
NL,SUICIDE ATTEMPT,151
NL,ABORTION SPONTANEOUS,148
NL,GASTROINTESTINAL DISORDER,148
NL,ATRIAL FIBRILLATION,147
NL,MATERNAL EXPOSURE DURING PREGNANCY,146
NL,HAEMORRHAGE,145
NL,INFLUENZA LIKE ILLNESS,144
NL,NEUTROPENIA,144
NL,HYPONATRAEMIA,143
NL,HIP FRACTURE,142
NL,SEIZURE,140
NL,DEPRESSED MOOD,138
NL,BREAST CANCER,135
NL,FLUID RETENTION,135
NL,AGGRESSION,133
NL,DEPRESSED LEVEL OF CONSCIOUSNESS,132
NL,DYSPHAGIA,131
NL,SHOCK,131
NL,INFLUENZA,130
NL,MUSCULOSKELETAL STIFFNESS,130
NL,SPEECH DISORDER,130
NL,CHEST DISCOMFORT,128
NL,OEDEMA PERIPHERAL,128
NL,COGNITIVE DISORDER,127
NL,CEREBRAL INFARCTION,125
NL,PRODUCT USE IN UNAPPROVED INDICATION,124
NL,VISION BLURRED,124
NL,NEOPLASM MALIGNANT,122
NL,ANGIOEDEMA,121
NL,LEUKOPENIA,121
NL,MUCOSAL INFLAMMATION,121
NL,MUSCLE RUPTURE,119
NL,MEMORY IMPAIRMENT,118
NL,CHILLS,117
NL,DRUG EFFECT INCOMPLETE,117
NL,OSTEONECROSIS OF JAW,117
NL,BREAST CANCER METASTATIC,116
NL,METASTASIS,114
NL,OEDEMA,114
NL,LACTIC ACIDOSIS,113
NL,METABOLIC ACIDOSIS,111
NL,VISUAL IMPAIRMENT,110
NL,ABDOMINAL DISCOMFORT,108
NL,INTENTIONAL OVERDOSE,107
NL,MOBILITY DECREASED,105
NL,COMA,103
NL,CYSTITIS,103
NL,LUNG DISORDER,103
NL,INJECTION SITE PAIN,102
NL,BRADYCARDIA,101
NL,LIVER DISORDER,101
NL,METASTASES TO LIVER,101
NL,ALOPECIA,100
NL,NASOPHARYNGITIS,100
NL,PANCYTOPENIA,99
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,98
NL,HYPOGLYCAEMIA,98
NL,HYPOAESTHESIA,97
NL,PARKINSON^S DISEASE,97
NL,BALANCE DISORDER,96
NL,DIALYSIS,96
NL,HEART RATE INCREASED,96
NL,NEOPLASM PROGRESSION,96
NL,URINARY RETENTION,96
NL,ASCITES,95
NL,MULTIPLE SCLEROSIS RELAPSE,95
NL,UNEVALUABLE EVENT,94
NL,URTICARIA,94
NL,APHASIA,91
NL,DRUG RESISTANCE,91
NL,INFLAMMATION,90
NL,MUSCLE RIGIDITY,89
NL,MYDRIASIS,89
NL,SURGERY,89
NL,DRY MOUTH,88
NL,HEPATIC FAILURE,87
NL,APATHY,86
NL,HEPATIC FUNCTION ABNORMAL,85
NL,MUSCULOSKELETAL PAIN,85
NL,ABNORMAL BEHAVIOUR,84
NL,NEUROPATHY PERIPHERAL,84
NL,EPISTAXIS,83
NL,HEPATIC ENZYME INCREASED,82
NL,PANCREATITIS,82
NL,SLEEP DISORDER,82
NL,THERAPEUTIC RESPONSE UNEXPECTED,82
NL,ADVERSE DRUG REACTION,81
NL,BODY TEMPERATURE INCREASED,81
NL,STOMA SITE DISCHARGE,81
NL,VISUAL ACUITY REDUCED,81
NL,ARTHROPATHY,80
NL,DIABETES MELLITUS,80
NL,HYPOCALCAEMIA,80
NL,HAEMATOCHEZIA,79
NL,POLYNEUROPATHY,79
NL,SEROTONIN SYNDROME,79
NL,OXYGEN SATURATION DECREASED,77
NL,BLISTER,76
NL,HAEMATOMA,76
NL,DEAFNESS,75
NL,ILEUS,75
NL,HYPERKINESIA,74
NL,INJECTION SITE REACTION,73
NL,ALANINE AMINOTRANSFERASE INCREASED,72
NL,ANAPHYLACTIC SHOCK,72
NL,ASPARTATE AMINOTRANSFERASE INCREASED,72
NL,DISTURBANCE IN ATTENTION,72
NL,ERYSIPELAS,72
NL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,72
NL,TACHYPNOEA,72
NL,TINNITUS,72
NL,BLOOD CREATINE PHOSPHOKINASE INCREASED,71
NL,DRUG LEVEL INCREASED,71
NL,PNEUMONITIS,71
NL,RHEUMATOID ARTHRITIS,71
NL,TRANSFUSION,71
NL,GASTROINTESTINAL HAEMORRHAGE,70
NL,PAIN IN JAW,70
NL,SENSE OF OPPRESSION,70
NL,WOUND,70
NL,ABASIA,68
NL,ABDOMINAL DISTENSION,68
NL,BLOOD PRESSURE INCREASED,68
NL,CATARACT,68
NL,HYPOPHAGIA,68
NL,LIVER FUNCTION TEST ABNORMAL,68
NL,LUNG INFECTION,68
NL,LUNG NEOPLASM MALIGNANT,68
NL,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,68
NL,PULMONARY ARTERIAL HYPERTENSION,68
NL,HYPOMAGNESAEMIA,67
NL,MOOD SWINGS,67
NL,MULTI-ORGAN FAILURE,67
NL,CIRCULATORY COLLAPSE,66
NL,INCORRECT DOSE ADMINISTERED,66
NL,LIMB DISCOMFORT,66
NL,MENTAL DISORDER,66
NL,PALLOR,66
NL,STOMA SITE ERYTHEMA,66
NL,TREATMENT FAILURE,66
NL,ANGINA PECTORIS,65
NL,ELECTROCARDIOGRAM QT PROLONGED,65
NL,LIVER INJURY,65
NL,COMPLETED SUICIDE,64
NL,PRODUCT QUALITY ISSUE,64
NL,RHABDOMYOLYSIS,64
NL,DEEP VEIN THROMBOSIS,63
NL,METASTASES TO CENTRAL NERVOUS SYSTEM,63
NL,PERIPHERAL SWELLING,63
NL,PULMONARY OEDEMA,63
NL,RECTAL HAEMORRHAGE,63
NL,SWOLLEN TONGUE,63
NL,CONTUSION,62
NL,DEVICE DISLOCATION,62
NL,CHOLELITHIASIS,61
NL,FREEZING PHENOMENON,61
NL,HYPERCALCAEMIA,61
NL,WHITE BLOOD CELL COUNT DECREASED,61
NL,DEMENTIA,60
NL,ASTHMA,59
NL,HAEMATURIA,59
NL,INJECTION SITE ERYTHEMA,59
NL,BACTERIAL INFECTION,58
NL,DYSSTASIA,58
NL,EYE DISORDER,58
NL,OSTEOARTHRITIS,58
NL,SWELLING FACE,58
NL,ACUTE CORONARY SYNDROME,57
NL,AMNESIA,57
NL,BLOOD CREATININE INCREASED,57
NL,CARDIOMYOPATHY,57
NL,CONVULSION,57
NL,GASTROENTERITIS,57
NL,HEMIPARESIS,57
NL,HYPERGLYCAEMIA,57
NL,MULTIPLE SCLEROSIS,57
NL,POOR QUALITY SLEEP,57
NL,STRESS,57
NL,UROSEPSIS,57
NL,ABNORMAL DREAMS,56
NL,HOSPICE CARE,56
NL,INCORRECT ROUTE OF DRUG ADMINISTRATION,56
NL,PREGNANCY,56
NL,THERAPEUTIC RESPONSE DECREASED,56
NL,FIBROMA,55
NL,GASTRIC HAEMORRHAGE,55
NL,MANIA,55
NL,PREMATURE BABY,55
NL,VENTRICULAR FIBRILLATION,55
NL,BLOOD GLUCOSE INCREASED,54
NL,BRADYKINESIA,54
NL,C-REACTIVE PROTEIN INCREASED,54
NL,COLITIS,54
NL,CYSTITIS NONINFECTIVE,54
NL,DRUG EFFECT DECREASED,54
NL,NIGHT SWEATS,54
NL,PLASMA CELL MYELOMA,54
NL,ACUTE MYOCARDIAL INFARCTION,53
NL,DELUSION,53
NL,HYPERKALAEMIA,53
NL,SWELLING,53
NL,ANAPHYLACTIC REACTION,52
NL,DRUG WITHDRAWAL SYNDROME,52
NL,EMOTIONAL DISORDER,52
NL,PLATELET COUNT DECREASED,52
NL,RENAL DISORDER,52
NL,RENAL FAILURE ACUTE,52
NL,SEPTIC SHOCK,52
NL,WITHDRAWAL SYNDROME,52
NL,BASAL CELL CARCINOMA,51
NL,DERMATITIS BULLOUS,51
NL,DYSGEUSIA,51
NL,SKIN DISCOLOURATION,51
NL,ABNORMAL FAECES,50
NL,CHRONIC KIDNEY DISEASE,50
NL,DYSARTHRIA,50
NL,ECZEMA,50
NL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,50
NL,REHABILITATION THERAPY,50
NL,CHOLECYSTITIS,49
NL,EUTHANASIA,49
NL,HAEMODYNAMIC INSTABILITY,49
NL,HYPOPHOSPHATAEMIA,49
NL,INTERSTITIAL LUNG DISEASE,49
NL,JAW DISORDER,49
NL,METASTASES TO LUNG,49
NL,PANIC ATTACK,49
NL,STOMATITIS,49
NL,VIRAL INFECTION,49
NL,DIPLOPIA,48
NL,DIVERTICULITIS,48
NL,LIVING IN RESIDENTIAL INSTITUTION,48
NL,PERITONITIS,48
NL,PRODUCT SUBSTITUTION ISSUE,48
NL,DYSTONIA,47
NL,HEPATOTOXICITY,47
NL,MENTAL IMPAIRMENT,47
NL,NEPHROLITHIASIS,47
NL,HEPATITIS,46
NL,ILL-DEFINED DISORDER,46
NL,LYMPHADENOPATHY,46
NL,NIGHTMARE,46
NL,OROPHARYNGEAL PAIN,46
NL,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,45
NL,TENDON RUPTURE,45
NL,UNDERDOSE,45
NL,UPPER RESPIRATORY TRACT INFECTION,45
NL,BLINDNESS,44
NL,BLOOD URINE PRESENT,44
NL,DYSURIA,44
NL,INTERNATIONAL NORMALISED RATIO INCREASED,44
NL,ORTHOSTATIC HYPOTENSION,44
NL,OSTEONECROSIS,44
NL,ARTERIOSPASM CORONARY,43
NL,BONE MARROW FAILURE,43
NL,CROHN^S DISEASE,43
NL,DRUG DEPENDENCE,43
NL,FEELING COLD,43
NL,FRACTURE,43
NL,MALIGNANT MELANOMA,43
NL,NASAL CONGESTION,43
NL,NECK PAIN,43
NL,POLLAKIURIA,43
NL,URINARY INCONTINENCE,43
NL,ABSCESS JAW,42
NL,HERPES ZOSTER,42
NL,HYPOXIA,42
NL,INTESTINAL PERFORATION,42
NL,NEURALGIA,42
NL,PHOTOSENSITIVITY REACTION,42
NL,PULMONARY HAEMORRHAGE,42
NL,SKIN DISORDER,42
NL,SKIN EXFOLIATION,42
NL,TENSION,42
NL,VENTRICULAR TACHYCARDIA,42
NL,DRUG ADMINISTRATION ERROR,41
NL,DYSPHONIA,41
NL,FLUSHING,41
NL,GASTRIC DISORDER,41
NL,NEOPLASM,41
NL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,41
NL,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,40
NL,BLOOD PRESSURE DECREASED,40
NL,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,40
NL,HAEMOPTYSIS,40
NL,METASTASES TO LYMPH NODES,40
NL,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,40
NL,BEDRIDDEN,39
NL,DRUG DOSE OMISSION,39
NL,FLUID INTAKE REDUCED,39
NL,HYPERVENTILATION,39
NL,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,39
NL,LOCALISED INFECTION,39
NL,OSTEOPOROSIS,39
NL,PNEUMOTHORAX,39
NL,PYELONEPHRITIS,39
NL,TOXIC SKIN ERUPTION,39
NL,TUBULOINTERSTITIAL NEPHRITIS,39
NL,JAUNDICE,38
NL,PARKINSONISM,38
NL,PERICARDIAL EFFUSION,38
NL,SPINAL COMPRESSION FRACTURE,38
NL,ACUTE MYELOID LEUKAEMIA,37
NL,ACUTE RESPIRATORY DISTRESS SYNDROME,37
NL,BLOOD ALKALINE PHOSPHATASE INCREASED,37
NL,DRUG HYPERSENSITIVITY,37
NL,DRUG LEVEL DECREASED,37
NL,HAEMOLYTIC ANAEMIA,37
NL,HEART RATE DECREASED,37
NL,IMPAIRED HEALING,37
NL,PALLIATIVE CARE,37
NL,PANCREATIC CARCINOMA,37
NL,PSORIASIS,37
NL,RIB FRACTURE,37
NL,SEDATION,37
NL,SPINAL FRACTURE,37
NL,UPPER LIMB FRACTURE,37
NL,VAGINAL HAEMORRHAGE,37
NL,ANGIOPATHY,36
NL,ARTHRITIS,36
NL,CYTOMEGALOVIRUS INFECTION,36
NL,DISORIENTATION,36
NL,HAEMATEMESIS,36
NL,MUSCLE CONTRACTURE,36
NL,PULMONARY HYPERTENSION,36
NL,RASH ERYTHEMATOUS,36
NL,RESTLESS LEGS SYNDROME,36
NL,SECOND PRIMARY MALIGNANCY,36
NL,STOMA SITE PAIN,36
NL,ACIDOSIS,35
NL,CRYING,35
NL,DISEASE RECURRENCE,35
NL,EJECTION FRACTION DECREASED,35
NL,RETINAL DETACHMENT,35
NL,AGRANULOCYTOSIS,34
NL,APNOEA,34
NL,ARTERIAL OCCLUSIVE DISEASE,34
NL,BLOOD TEST ABNORMAL,34
NL,COLON CANCER,34
NL,DRUG INTOLERANCE,34
NL,EYE PAIN,34
NL,LOWER LIMB FRACTURE,34
NL,PHARYNGEAL OEDEMA,34
NL,AKATHISIA,33
NL,BRONCHITIS,33
NL,BURNING SENSATION,33
NL,HALLUCINATION_ VISUAL,33
NL,INJECTION SITE MASS,33
NL,LEUKOCYTOSIS,33
NL,NERVOUS SYSTEM DISORDER,33
NL,OBESITY,33
NL,PERIPHERAL COLDNESS,33
NL,WOUND INFECTION,33
NL,AGEUSIA,32
NL,ANGER,32
NL,ERECTILE DYSFUNCTION,32
NL,INTRAOCULAR PRESSURE INCREASED,32
NL,IRRITABILITY,32
NL,ISCHAEMIC STROKE,32
NL,MIGRAINE,32
NL,MUSCULOSKELETAL DISCOMFORT,32
NL,MUSCULOSKELETAL DISORDER,32
NL,OOPHORECTOMY,32
NL,PERICARDITIS,32
NL,PREMATURE DELIVERY,32
NL,PRURITUS GENERALISED,32
NL,SENSORY DISTURBANCE,32
NL,ABDOMINAL ABSCESS,31
NL,ATAXIA,31
NL,BLOOD BILIRUBIN INCREASED,31
NL,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,31
NL,FEMUR FRACTURE,31
NL,HEPATIC STEATOSIS,31
NL,HYPERSOMNIA,31
NL,HYPOKINESIA,31
NL,MEDICATION ERROR,31
NL,NEUROTOXICITY,31
NL,NOCTURIA,31
NL,OSTEOMYELITIS,31
NL,PNEUMOCYSTIS JIROVECII PNEUMONIA,31
NL,PROTEINURIA,31
NL,RESPIRATORY DISORDER,31
NL,RIGHT VENTRICULAR FAILURE,31
NL,ACTIVITIES OF DAILY LIVING IMPAIRED,30
NL,BACTERAEMIA,30
NL,DEVICE ISSUE,30
NL,DRY EYE,30
NL,EMBOLISM,30
NL,ENCEPHALOPATHY,30
NL,FUNGAL INFECTION,30
NL,HYPOTHERMIA,30
NL,INJECTION SITE SWELLING,30
NL,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,30
NL,ROAD TRAFFIC ACCIDENT,30
NL,SKIN CANCER,30
NL,DRY SKIN,29
NL,FEAR,29
NL,FEELING HOT,29
NL,FLATULENCE,29
NL,HERNIA,29
NL,INJECTION SITE INDURATION,29
NL,LIP SWELLING,29
NL,LOW BIRTH WEIGHT BABY,29
NL,MENINGITIS,29
NL,METASTASES TO SPINE,29
NL,NERVOUSNESS,29
NL,PARALYSIS,29
NL,PARAPLEGIA,29
NL,POISONING,29
NL,RESPIRATORY DEPRESSION,29
NL,SALIVARY HYPERSECRETION,29
NL,SUBARACHNOID HAEMORRHAGE,29
NL,SUDDEN DEATH,29
NL,ABSCESS,28
NL,DRUG-INDUCED LIVER INJURY,28
NL,EATING DISORDER,28
NL,GOUT,28
NL,LOCAL SWELLING,28
NL,MOTOR DYSFUNCTION,28
NL,PRESYNCOPE,28
NL,TOOTH DISORDER,28
NL,TRISMUS,28
NL,VERTIGO,28
NL,VIROLOGIC FAILURE,28
NL,BRONCHOPULMONARY ASPERGILLOSIS,27
NL,CELLULITIS,27
NL,CUTANEOUS LUPUS ERYTHEMATOSUS,27
NL,CYANOSIS,27
NL,FOETAL DEATH,27
NL,GASTRIC PERFORATION,27
NL,HEAD DISCOMFORT,27
NL,MELAENA,27
NL,MOVEMENT DISORDER,27
NL,MUSCULOSKELETAL CHEST PAIN,27
NL,MYELODYSPLASTIC SYNDROME,27
NL,MYOCLONUS,27
NL,NEUROLEPTIC MALIGNANT SYNDROME,27
NL,PATHOLOGICAL FRACTURE,27
NL,PNEUMONIA ASPIRATION,27
NL,SINUSITIS,27
NL,STOMA SITE REACTION,27
NL,TREATMENT NONCOMPLIANCE,27
NL,ABDOMINAL PAIN LOWER,26
NL,ABORTION INDUCED,26
NL,ALTERED STATE OF CONSCIOUSNESS,26
NL,ANKLE FRACTURE,26
NL,BLADDER CANCER,26
NL,BRAIN NEOPLASM,26
NL,BRONCHOSPASM,26
NL,CEREBRAL VENOUS THROMBOSIS,26
NL,DECUBITUS ULCER,26
NL,DISCOMFORT,26
NL,GASTROENTERITIS VIRAL,26
NL,GASTROOESOPHAGEAL REFLUX DISEASE,26
NL,HEART RATE IRREGULAR,26
NL,INCONTINENCE,26
NL,LABORATORY TEST ABNORMAL,26
NL,RESPIRATORY SYNCYTIAL VIRUS INFECTION,26
NL,RHINOVIRUS INFECTION,26
NL,SKIN REACTION,26
NL,SKIN TOXICITY,26
NL,STAPHYLOCOCCAL INFECTION,26
NL,STOMA SITE INFLAMMATION,26
NL,VASCULITIS,26
NL,WRIST FRACTURE,26
NL,ACUTE HEPATIC FAILURE,25
NL,CHEILITIS,25
NL,CHOLESTASIS,25
NL,DRUG ABUSE,25
NL,DRUG ERUPTION,25
NL,DYSPNOEA EXERTIONAL,25
NL,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,25
NL,FAECES DISCOLOURED,25
NL,LARGE INTESTINE PERFORATION,25
NL,MENORRHAGIA,25
NL,MOUTH ULCERATION,25
NL,NO ADVERSE EVENT,25
NL,OSTEITIS,25
NL,PSYCHIATRIC SYMPTOM,25
NL,STOMA SITE IRRITATION,25
NL,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,25
NL,SUPRAVENTRICULAR TACHYCARDIA,25
NL,CARDIOGENIC SHOCK,24
NL,DEVICE DIFFICULT TO USE,24
NL,DEVICE OCCLUSION,24
NL,DEVICE RELATED INFECTION,24
NL,GAIT INABILITY,24
NL,HISTOPLASMOSIS DISSEMINATED,24
NL,JOINT SWELLING,24
NL,LUNG TRANSPLANT,24
NL,POST PROCEDURAL COMPLICATION,24
NL,POST PROCEDURAL HAEMORRHAGE,24
NL,RASH MACULAR,24
NL,ADRENAL INSUFFICIENCY,23
NL,ASPERGILLUS INFECTION,23
NL,BRAIN OEDEMA,23
NL,CANDIDA INFECTION,23
NL,CONGENITAL ANOMALY,23
NL,GASTROINTESTINAL PAIN,23
NL,GENE MUTATION,23
NL,GYNAECOMASTIA,23
NL,HAEMATOTOXICITY,23
NL,HYPERNATRAEMIA,23
NL,HYPERTHYROIDISM,23
NL,INFUSION RELATED REACTION,23
NL,INTENTIONAL PRODUCT USE ISSUE,23
NL,INTENTIONAL SELF-INJURY,23
NL,INTESTINAL ISCHAEMIA,23
NL,MALNUTRITION,23
NL,PANCREATITIS ACUTE,23
NL,PELVIC FRACTURE,23
NL,PORTAL HYPERTENSION,23
NL,RASH PRURITIC,23
NL,RESPIRATORY DISTRESS,23
NL,RHINORRHOEA,23
NL,TYPE 2 DIABETES MELLITUS,23
NL,BACK DISORDER,22
NL,BLOOD CHOLESTEROL INCREASED,22
NL,BLOOD LACTATE DEHYDROGENASE INCREASED,22
NL,COORDINATION ABNORMAL,22
NL,DYSPEPSIA,22
NL,EPSTEIN-BARR VIRUS INFECTION,22
NL,HEPATITIS E,22
NL,IMMUNE THROMBOCYTOPENIC PURPURA,22
NL,INCORRECT DRUG ADMINISTRATION DURATION,22
NL,LISTLESS,22
NL,LIVER TRANSPLANT,22
NL,PATHOGEN RESISTANCE,22
NL,RASH GENERALISED,22
NL,RESPIRATORY ARREST,22
NL,TENDONITIS,22
NL,WHITE BLOOD CELL COUNT INCREASED,22
NL,ATYPICAL FEMUR FRACTURE,21
NL,BURSITIS,21
NL,CAESAREAN SECTION,21
NL,CARDIAC VALVE DISEASE,21
NL,CENTRAL NERVOUS SYSTEM LESION,21
NL,CHROMATURIA,21
NL,COAGULOPATHY,21
NL,CORONARY ARTERY STENOSIS,21
NL,DIABETES MELLITUS INADEQUATE CONTROL,21
NL,HEAD INJURY,21
NL,HYPOVOLAEMIA,21
NL,INGUINAL HERNIA,21
NL,INITIAL INSOMNIA,21
NL,INTESTINAL HAEMORRHAGE,21
NL,LETHARGY,21
NL,NEPHROPATHY TOXIC,21
NL,NON-HODGKIN^S LYMPHOMA,21
NL,PANIC REACTION,21
NL,PSORIATIC ARTHROPATHY,21
NL,PSYCHIATRIC DECOMPENSATION,21
NL,RENAL TUBULAR NECROSIS,21
NL,SECRETION DISCHARGE,21
NL,SINUS TACHYCARDIA,21
NL,SQUAMOUS CELL CARCINOMA,21
NL,THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION,21
NL,TOOTHACHE,21
NL,UNRESPONSIVE TO STIMULI,21
NL,ANAL ABSCESS,20
NL,ANOSMIA,20
NL,BRAIN INJURY,20
NL,CATATONIA,20
NL,CHEMOTHERAPY,20
NL,CHOKING,20
NL,CHOLANGITIS,20
NL,DERMATITIS,20
NL,DEVICE DEPLOYMENT ISSUE,20
NL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,20
NL,FLANK PAIN,20
NL,GASTROINTESTINAL TOXICITY,20
NL,GLAUCOMA,20
NL,HAEMOLYSIS,20
NL,HALLUCINATION_ AUDITORY,20
NL,HYPERTONIA,20
NL,ISCHAEMIA,20
NL,LUNG CANCER METASTATIC,20
NL,OESOPHAGEAL CARCINOMA,20
NL,OVARIAN CYST,20
NL,PHOTOPHOBIA,20
NL,SPLENOMEGALY,20
NL,STEROID WITHDRAWAL SYNDROME,20
NL,TARDIVE DYSKINESIA,20
NL,BLINDNESS UNILATERAL,19
NL,BLOOD PRESSURE SYSTOLIC INCREASED,19
NL,BREAST RECONSTRUCTION,19
NL,CARDIOVASCULAR DISORDER,19
NL,DIABETIC KETOACIDOSIS,19
NL,DRUG EFFECT VARIABLE,19
NL,DRUG PRESCRIBING ERROR,19
NL,ESCHERICHIA SEPSIS,19
NL,EUPHORIC MOOD,19
NL,GENERAL PHYSICAL CONDITION ABNORMAL,19
NL,HAEMORRHAGE INTRACRANIAL,19
NL,HAEMORRHAGIC STROKE,19
NL,HEPATIC CIRRHOSIS,19
NL,HEPATIC ENZYME ABNORMAL,19
NL,HYPERBILIRUBINAEMIA,19
NL,HYPERTHERMIA,19
NL,HYPOSPADIAS,19
NL,LIBIDO DECREASED,19
NL,LYMPHOMA,19
NL,METRORRHAGIA,19
NL,ORAL MUCOSAL BLISTERING,19
NL,ORGAN FAILURE,19
NL,PERIPHERAL ARTERY THROMBOSIS,19
NL,POTENTIATING DRUG INTERACTION,19
NL,PROCEDURAL HAEMORRHAGE,19
NL,PSYCHOMOTOR HYPERACTIVITY,19
NL,SENSORY LOSS,19
NL,WRONG TECHNIQUE IN DRUG USAGE PROCESS,19
NL,ASPIRATION,18
NL,BLOOD CALCIUM DECREASED,18
NL,BLOOD CALCIUM INCREASED,18
NL,BLOOD GLUCOSE ABNORMAL,18
NL,BLOOD PRESSURE FLUCTUATION,18
NL,BREAST CANCER FEMALE,18
NL,CARDIAC ASTHMA,18
NL,DIARRHOEA HAEMORRHAGIC,18
NL,ELECTROCARDIOGRAM ABNORMAL,18
NL,ENTERITIS,18
NL,FEEDING DISORDER,18
NL,FISTULA,18
NL,FOOT DEFORMITY,18
NL,GASTROINTESTINAL INFECTION,18
NL,GLOMERULAR FILTRATION RATE DECREASED,18
NL,GRAFT VERSUS HOST DISEASE,18
NL,HAEMOGLOBIN ABNORMAL,18
NL,HERPES SIMPLEX,18
NL,HICCUPS,18
NL,HUMERUS FRACTURE,18
NL,INTRACRANIAL PRESSURE INCREASED,18
NL,JOINT STIFFNESS,18
NL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,18
NL,LYMPHOCYTE COUNT DECREASED,18
NL,MICTURITION DISORDER,18
NL,MUSCLE DISORDER,18
NL,MYASTHENIA GRAVIS,18
NL,NEONATAL BEHAVIOURAL SYNDROME,18
NL,NEOPLASM RECURRENCE,18
NL,NEPHROBLASTOMA,18
NL,NEUROLOGICAL SYMPTOM,18
NL,OBSTRUCTIVE AIRWAYS DISORDER,18
NL,OCULAR HYPERAEMIA,18
NL,OESOPHAGITIS,18
NL,OSTEOPENIA,18
NL,PETECHIAE,18
NL,PETIT MAL EPILEPSY,18
NL,PLEURISY,18
NL,POLYARTHRITIS,18
NL,POLYURIA,18
NL,PRESCRIBED OVERDOSE,18
NL,RETINAL DRUSEN,18
NL,SKIN ULCER,18
NL,STATUS EPILEPTICUS,18
NL,STEVENS-JOHNSON SYNDROME,18
NL,STRIDOR,18
NL,THERAPY CESSATION,18
NL,TOOTH EXTRACTION,18
NL,ADVERSE REACTION,17
NL,AFFECT LABILITY,17
NL,ATRIOVENTRICULAR BLOCK,17
NL,ATRIOVENTRICULAR BLOCK COMPLETE,17
NL,BLOOD UREA INCREASED,17
NL,CACHEXIA,17
NL,CUSHING^S SYNDROME,17
NL,DEVICE RELATED SEPSIS,17
NL,DISEASE COMPLICATION,17
NL,ELECTROLYTE IMBALANCE,17
NL,EYE HAEMORRHAGE,17
NL,EYE INFLAMMATION,17
NL,FACIAL PARALYSIS,17
NL,GASTRIC ULCER,17
NL,GENERALISED ERYTHEMA,17
NL,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,17
NL,HEART VALVE INCOMPETENCE,17
NL,HYPOTONIA,17
NL,HYSTERECTOMY,17
NL,INJECTION SITE DISCOLOURATION,17
NL,INJECTION SITE PRURITUS,17
NL,INTESTINAL OBSTRUCTION,17
NL,MACULAR FIBROSIS,17
NL,NEPHROTIC SYNDROME,17
NL,NEUTROPHIL COUNT DECREASED,17
NL,PARANOIA,17
NL,PSEUDOMONAS INFECTION,17
NL,RETINAL DISORDER,17
NL,SKIN BURNING SENSATION,17
NL,SKIN LESION,17
NL,SYSTEMIC LUPUS ERYTHEMATOSUS,17
NL,WHEEZING,17
NL,ACNE,16
NL,ADRENOCORTICAL INSUFFICIENCY ACUTE,16
NL,APPENDICITIS,16
NL,ATRIAL FLUTTER,16
NL,BK VIRUS INFECTION,16
NL,BLOOD COUNT ABNORMAL,16
NL,BLOOD GLUCOSE FLUCTUATION,16
NL,BONE DISORDER,16
NL,COLECTOMY,16
NL,DEVELOPMENTAL DELAY,16
NL,EAR PAIN,16
NL,ENDOMETRIOSIS,16
NL,EOSINOPHILIA,16
NL,ESCHERICHIA INFECTION,16
NL,FOETAL GROWTH RESTRICTION,16
NL,GALLBLADDER DISORDER,16
NL,GASTROINTESTINAL INFLAMMATION,16
NL,GROWTH RETARDATION,16
NL,HYPERREFLEXIA,16
NL,HYPERSENSITIVITY VASCULITIS,16
NL,HYPOACUSIS,16
NL,INJECTION SITE BRUISING,16
NL,LEUKAEMIA,16
NL,LUNG INFILTRATION,16
NL,LYMPHOPROLIFERATIVE DISORDER,16
NL,MACULAR DEGENERATION,16
NL,MUSCLE TIGHTNESS,16
NL,NYSTAGMUS,16
NL,OESOPHAGEAL STENOSIS,16
NL,PRIAPISM,16
NL,PRODUCTIVE COUGH,16
NL,RESPIRATORY RATE INCREASED,16
NL,SEXUAL DYSFUNCTION,16
NL,SKIN INFECTION,16
NL,STOMA SITE EXTRAVASATION,16
NL,SUBDURAL HAEMATOMA,16
NL,THROAT IRRITATION,16
NL,TUMOUR MARKER INCREASED,16
NL,VENTRICULAR ARRHYTHMIA,16
NL,ACCIDENTAL OVERDOSE,15
NL,BLINDNESS TRANSIENT,15
NL,BLOOD POTASSIUM DECREASED,15
NL,BLOOD POTASSIUM INCREASED,15
NL,BONE MARROW DISORDER,15
NL,BREAST PAIN,15
NL,CARDIAC FAILURE CONGESTIVE,15
NL,CARDIAC OPERATION,15
NL,CARPAL TUNNEL SYNDROME,15
NL,CEREBRAL ISCHAEMIA,15
NL,COMPLICATION ASSOCIATED WITH DEVICE,15
NL,CONCUSSION,15
NL,CYST,15
NL,DEAFNESS UNILATERAL,15
NL,DEVICE BREAKAGE,15
NL,DRUG WITHDRAWAL SYNDROME NEONATAL,15
NL,EYELID OEDEMA,15
NL,FACE OEDEMA,15
NL,GASTRITIS,15
NL,GASTROINTESTINAL CARCINOMA,15
NL,GENERALISED TONIC-CLONIC SEIZURE,15
NL,HAEMORRHOIDS,15
NL,HEMIPLEGIA,15
NL,HYDRONEPHROSIS,15
NL,INTERVERTEBRAL DISC PROTRUSION,15
NL,IRON DEFICIENCY ANAEMIA,15
NL,IRRITABLE BOWEL SYNDROME,15
NL,JARISCH-HERXHEIMER REACTION,15
NL,JOINT INJURY,15
NL,LUPUS-LIKE SYNDROME,15
NL,MATERNAL DRUGS AFFECTING FOETUS,15
NL,MENSTRUAL DISORDER,15
NL,MENTAL STATUS CHANGES,15
NL,MIDDLE INSOMNIA,15
NL,MUSCLE ATROPHY,15
NL,MYOCARDIAL ISCHAEMIA,15
NL,PHOTOPSIA,15
NL,PULMONARY TOXICITY,15
NL,RED BLOOD CELL COUNT DECREASED,15
NL,SPINAL CORD INJURY,15
NL,STILLBIRTH,15
NL,SUBCUTANEOUS ABSCESS,15
NL,THINKING ABNORMAL,15
NL,THYROID DISORDER,15
NL,TRANSPLANT,15
NL,URINARY BLADDER HAEMORRHAGE,15
NL,ARTERIAL THROMBOSIS,14
NL,ATELECTASIS,14
NL,BRADYPHRENIA,14
NL,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,14
NL,EAR INFECTION,14
NL,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,14
NL,ERUCTATION,14
NL,ESCHERICHIA URINARY TRACT INFECTION,14
NL,EXTREMITY NECROSIS,14
NL,EYE IRRITATION,14
NL,FREQUENT BOWEL MOVEMENTS,14
NL,GROIN PAIN,14
NL,HAEMOLYTIC URAEMIC SYNDROME,14
NL,HEPATIC NECROSIS,14
NL,HEPATIC NEOPLASM,14
NL,HYPERTENSIVE CRISIS,14
NL,INCREASED APPETITE,14
NL,LEFT VENTRICULAR DYSFUNCTION,14
NL,LIVER FUNCTION TEST INCREASED,14
NL,LOSS OF LIBIDO,14
NL,MEDICAL DEVICE COMPLICATION,14
NL,METASTATIC NEOPLASM,14
NL,MICTURITION URGENCY,14
NL,MOOD ALTERED,14
NL,MUSCLE CONTRACTIONS INVOLUNTARY,14
NL,MYOCARDITIS,14
NL,OBSESSIVE-COMPULSIVE DISORDER,14
NL,OESOPHAGEAL VARICES HAEMORRHAGE,14
NL,OLIGURIA,14
NL,PROCEDURAL COMPLICATION,14
NL,RENAL CELL CARCINOMA,14
NL,RENAL TUBULAR DISORDER,14
NL,RESPIRATORY ACIDOSIS,14
NL,RHEUMATIC DISORDER,14
NL,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,14
NL,SLEEP APNOEA SYNDROME,14
NL,STOMA SITE HAEMORRHAGE,14
NL,SUSPICIOUSNESS,14
NL,THIRST,14
NL,THROMBOSIS IN DEVICE,14
NL,THROMBOTIC THROMBOCYTOPENIC PURPURA,14
NL,TONGUE DISORDER,14
NL,TOXIC EPIDERMAL NECROLYSIS,14
NL,TRANSAMINASES INCREASED,14
NL,WAIST CIRCUMFERENCE INCREASED,14
NL,ANGIOPLASTY,13
NL,ANTICHOLINERGIC SYNDROME,13
NL,ANURIA,13
NL,BOWEL MOVEMENT IRREGULARITY,13
NL,CANCER PAIN,13
NL,DELAYED PUBERTY,13
NL,DEVELOPMENTAL HIP DYSPLASIA,13
NL,DEVICE FAILURE,13
NL,DYSAESTHESIA,13
NL,ECG SIGNS OF MYOCARDIAL ISCHAEMIA,13
NL,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,13
NL,EMOTIONAL DISTRESS,13
NL,ENTEROCOCCAL INFECTION,13
NL,FIBROMYALGIA,13
NL,FOOT FRACTURE,13
NL,FUNCTIONAL GASTROINTESTINAL DISORDER,13
NL,GASTROENTERITIS NOROVIRUS,13
NL,HYPERAMMONAEMIA,13
NL,INJECTION SITE EXTRAVASATION,13
NL,ISCHAEMIC CEREBRAL INFARCTION,13
NL,LACERATION,13
NL,LARYNGITIS,13
NL,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,13
NL,MACULAR OEDEMA,13
NL,NEPHRITIS,13
NL,NEUROLOGICAL DECOMPENSATION,13
NL,NODULAR REGENERATIVE HYPERPLASIA,13
NL,PELVIC PAIN,13
NL,PERITONITIS BACTERIAL,13
NL,PHARYNGITIS,13
NL,POST-TRAUMATIC STRESS DISORDER,13
NL,PRESCRIBED UNDERDOSE,13
NL,RASH PAPULAR,13
NL,RENAL CANCER,13
NL,RENAL TRANSPLANT,13
NL,RETINAL HAEMORRHAGE,13
NL,SQUAMOUS CELL CARCINOMA OF SKIN,13
NL,STAPHYLOCOCCAL SEPSIS,13
NL,STENT PLACEMENT,13
NL,STRESS CARDIOMYOPATHY,13
NL,SUICIDAL BEHAVIOUR,13
NL,UNINTENDED PREGNANCY,13
NL,UVEITIS,13
NL,VITAMIN D DEFICIENCY,13
NL,ANGINA UNSTABLE,12
NL,ANKYLOSING SPONDYLITIS,12
NL,AORTIC ANEURYSM,12
NL,AUTISM SPECTRUM DISORDER,12
NL,BILE DUCT STONE,12
NL,BLOOD GLUCOSE DECREASED,12
NL,BLOOD LACTIC ACID INCREASED,12
NL,BLOOD SODIUM DECREASED,12
NL,BRADYPNOEA,12
NL,CLOSTRIDIUM DIFFICILE INFECTION,12
NL,CORONARY ARTERY OCCLUSION,12
NL,CUSHINGOID,12
NL,DECREASED IMMUNE RESPONSIVENESS,12
NL,DRUG DISPENSING ERROR,12
NL,DRUG LEVEL BELOW THERAPEUTIC,12
NL,EAR DISORDER,12
NL,EXERCISE TOLERANCE DECREASED,12
NL,EYE MOVEMENT DISORDER,12
NL,FOETAL DISTRESS SYNDROME,12
NL,GASTROINTESTINAL NEOPLASM,12
NL,HYPERCHOLESTEROLAEMIA,12
NL,HYPOVOLAEMIC SHOCK,12
NL,INCORRECT PRODUCT STORAGE,12
NL,INFECTION SUSCEPTIBILITY INCREASED,12
NL,INJECTION SITE HAEMORRHAGE,12
NL,JAW OPERATION,12
NL,LEG AMPUTATION,12
NL,LIVER ABSCESS,12
NC,DEVICE DEPLOYMENT ISSUE,2
NC,PARAESTHESIA,2
NC,PERIPHERAL NERVE LESION,2
NC,SCAR,2
NC,ULNAR NERVE PALSY,2
NC,ARRHYTHMIA,1
NC,CARDIAC FAILURE,1
NC,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NC,COMPLICATION ASSOCIATED WITH DEVICE,1
NC,DEVICE DIFFICULT TO USE,1
NC,DEVICE DISLOCATION,1
NC,DIABETES MELLITUS,1
NC,ERYTHEMA,1
NC,GENERALISED ERYTHEMA,1
NC,HEPATITIS,1
NC,HEPATOCELLULAR INJURY,1
NC,HEPATOTOXICITY,1
NC,HYPOAESTHESIA,1
NC,ILL-DEFINED DISORDER,1
NC,INCORRECT DRUG ADMINISTRATION DURATION,1
NC,LABORATORY TEST ABNORMAL,1
NC,MEDICAL DEVICE REMOVAL,1
NC,NAUSEA,1
NC,NERVE GRAFT,1
NC,NEUROMA,1
NC,RASH,1
NC,SKIN REACTION,1
NC,SKIN SWELLING,1
NC,TENDON RUPTURE,1
NC,THERMAL BURN,1
NC,TRANSAMINASES INCREASED,1
NC,VASCULITIS,1
NZ,DEATH,372
NZ,MALAISE,199
NZ,DYSPNOEA,170
NZ,DRUG INEFFECTIVE,168
NZ,FATIGUE,148
NZ,NAUSEA,135
NZ,PYREXIA,110
NZ,VOMITING,108
NZ,HEADACHE,100
NZ,ANXIETY,99
NZ,FALL,97
NZ,PAIN,97
NZ,DIARRHOEA,88
NZ,DIZZINESS,86
NZ,CEREBROVASCULAR ACCIDENT,85
NZ,CONFUSIONAL STATE,85
NZ,FOETAL EXPOSURE DURING PREGNANCY,81
NZ,ACUTE KIDNEY INJURY,76
NZ,PNEUMONIA,75
NZ,ARTHRALGIA,73
NZ,HYPOTENSION,70
NZ,MYOCARDIAL INFARCTION,69
NZ,RASH,67
NZ,NEUTROPENIA,65
NZ,OVERDOSE,64
NZ,FEELING ABNORMAL,63
NZ,DEPRESSION,62
NZ,PAIN IN EXTREMITY,61
NZ,WEIGHT DECREASED,60
NZ,CHEST PAIN,59
NZ,PSYCHOTIC DISORDER,59
NZ,SOMNOLENCE,59
NZ,SEPSIS,58
NZ,TACHYCARDIA,58
NZ,ABDOMINAL PAIN,57
NZ,GAIT DISTURBANCE,57
NZ,HAEMORRHAGE,56
NZ,INSOMNIA,56
NZ,TOXICITY TO VARIOUS AGENTS,56
NZ,WHITE BLOOD CELL COUNT INCREASED,56
NZ,SUICIDAL IDEATION,54
NZ,SYNCOPE,54
NZ,ANAEMIA,53
NZ,GASTROINTESTINAL HAEMORRHAGE,52
NZ,NEUTROPHIL COUNT INCREASED,52
NZ,PRURITUS,52
NZ,SEDATION,51
NZ,CROHN^S DISEASE,49
NZ,LOWER RESPIRATORY TRACT INFECTION,48
NZ,AGITATION,46
NZ,CONSTIPATION,46
NZ,DISEASE PROGRESSION,46
NZ,GENERAL PHYSICAL HEALTH DETERIORATION,46
NZ,RESPIRATORY FAILURE,46
NZ,BACK PAIN,45
NZ,COUGH,45
NZ,INFECTION,45
NZ,ANAPHYLACTIC REACTION,44
NZ,DYSARTHRIA,44
NZ,MENTAL IMPAIRMENT,44
NZ,HAEMOGLOBIN DECREASED,43
NZ,LOSS OF CONSCIOUSNESS,43
NZ,PULMONARY EMBOLISM,43
NZ,ACUTE HEPATIC FAILURE,41
NZ,RENAL FAILURE,41
NZ,ASTHENIA,40
NZ,MYALGIA,39
NZ,C-REACTIVE PROTEIN INCREASED,38
NZ,INTENTIONAL OVERDOSE,38
NZ,PARAESTHESIA,38
NZ,URTICARIA,38
NZ,CARDIAC FAILURE,36
NZ,CONDITION AGGRAVATED,36
NZ,DEPRESSED LEVEL OF CONSCIOUSNESS,36
NZ,MALIGNANT NEOPLASM PROGRESSION,36
NZ,RENAL IMPAIRMENT,36
NZ,INCORRECT DOSE ADMINISTERED,35
NZ,CARDIAC DISORDER,34
NZ,WEIGHT INCREASED,34
NZ,HYPERTENSION,33
NZ,WHITE BLOOD CELL COUNT DECREASED,32
NZ,DEEP VEIN THROMBOSIS,31
NZ,PALPITATIONS,31
NZ,SEIZURE,31
NZ,CHILLS,30
NZ,CIRCULATORY COLLAPSE,30
NZ,HAEMORRHAGE INTRACRANIAL,30
NZ,HYPERHIDROSIS,30
NZ,RECTAL HAEMORRHAGE,30
NZ,VISUAL IMPAIRMENT,30
NZ,DECREASED APPETITE,29
NZ,HYPOAESTHESIA,29
NZ,LIVER FUNCTION TEST ABNORMAL,29
NZ,MEDICATION ERROR,29
NZ,TREMOR,29
NZ,URINARY TRACT INFECTION,29
NZ,ABDOMINAL PAIN UPPER,28
NZ,EXPOSURE DURING PREGNANCY,28
NZ,FLUSHING,28
NZ,HEPATIC FAILURE,28
NZ,MELAENA,28
NZ,NEUTROPHIL COUNT DECREASED,28
NZ,PRODUCT USE ISSUE,28
NZ,ABNORMAL BEHAVIOUR,27
NZ,AGGRESSION,27
NZ,DEHYDRATION,27
NZ,ALANINE AMINOTRANSFERASE INCREASED,26
NZ,DIABETES MELLITUS,26
NZ,FOETAL ANTICONVULSANT SYNDROME,26
NZ,ACUTE MYOCARDIAL INFARCTION,25
NZ,COMPLETED SUICIDE,25
NZ,DYSPHAGIA,25
NZ,ELECTROCARDIOGRAM QT PROLONGED,25
NZ,HYPONATRAEMIA,25
NZ,INTESTINAL OBSTRUCTION,25
NZ,LETHARGY,25
NZ,NEOPLASM MALIGNANT,25
NZ,ATRIAL FIBRILLATION,24
NZ,CARDIAC ARREST,24
NZ,COAGULOPATHY,24
NZ,INFLUENZA LIKE ILLNESS,24
NZ,INJECTION SITE PAIN,24
NZ,MYOCARDITIS,24
NZ,RHEUMATOID ARTHRITIS,24
NZ,SCHIZOPHRENIA,24
NZ,BODY TEMPERATURE INCREASED,23
NZ,CEREBRAL HAEMORRHAGE,23
NZ,CHEST DISCOMFORT,23
NZ,DELIRIUM,23
NZ,ERYTHEMA,23
NZ,FEBRILE NEUTROPENIA,23
NZ,HEPATIC ENZYME INCREASED,23
NZ,IRRITABILITY,23
NZ,LACTIC ACIDOSIS,23
NZ,MUSCULAR WEAKNESS,23
NZ,NECROTISING MYOSITIS,23
NZ,OEDEMA PERIPHERAL,23
NZ,PSORIASIS,23
NZ,THROMBOCYTOPENIA,23
NZ,ARTHROPATHY,22
NZ,CELLULITIS,22
NZ,HYPERSENSITIVITY,22
NZ,MENTAL DISORDER,22
NZ,PREMATURE BABY,22
NZ,SUICIDE ATTEMPT,22
NZ,VISION BLURRED,22
NZ,BLOOD PRESSURE INCREASED,21
NZ,CONTUSION,21
NZ,DEPRESSED MOOD,21
NZ,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,21
NZ,ISCHAEMIC STROKE,21
NZ,MUSCULOSKELETAL PAIN,21
NZ,PNEUMONITIS,21
NZ,RENAL FAILURE ACUTE,21
NZ,SALIVARY HYPERSECRETION,21
NZ,STRESS,21
NZ,ANGIOEDEMA,20
NZ,ARRHYTHMIA,20
NZ,BALANCE DISORDER,20
NZ,BLOOD CREATININE INCREASED,20
NZ,GASTROOESOPHAGEAL REFLUX DISEASE,20
NZ,HEPATIC ENCEPHALOPATHY,20
NZ,MEMORY IMPAIRMENT,20
NZ,MOBILITY DECREASED,20
NZ,NON-SMALL CELL LUNG CANCER,20
NZ,PLATELET COUNT DECREASED,20
NZ,TRANSIENT ISCHAEMIC ATTACK,20
NZ,VIRAL INFECTION,20
NZ,ARTHRITIS,19
NZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,19
NZ,DRUG EFFECT DECREASED,19
NZ,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,19
NZ,HALLUCINATION,19
NZ,INFLUENZA,19
NZ,INTERSTITIAL LUNG DISEASE,19
NZ,MUSCULOSKELETAL STIFFNESS,19
NZ,PERIPHERAL SWELLING,19
NZ,PLASMA CELL MYELOMA,19
NZ,PNEUMONIA ASPIRATION,19
NZ,PRESCRIBED OVERDOSE,19
NZ,ABDOMINAL DISCOMFORT,18
NZ,CHOKING,18
NZ,DRUG DOSE OMISSION,18
NZ,GAMMA-GLUTAMYLTRANSFERASE INCREASED,18
NZ,JAUNDICE,18
NZ,RESTLESSNESS,18
NZ,SLEEP DISORDER,18
NZ,DISEASE RECURRENCE,17
NZ,DISORIENTATION,17
NZ,DRUG EFFECT INCOMPLETE,17
NZ,GASTROINTESTINAL DISORDER,17
NZ,HAEMOPTYSIS,17
NZ,SPEECH DISORDER,17
NZ,ABDOMINAL DISTENSION,16
NZ,BILIARY DILATATION,16
NZ,HAEMATOCRIT DECREASED,16
NZ,HEART RATE INCREASED,16
NZ,HOSPITALISATION,16
NZ,HYPOKALAEMIA,16
NZ,JOINT SWELLING,16
NZ,MATERNAL EXPOSURE DURING PREGNANCY,16
NZ,OSTEOARTHRITIS,16
NZ,OSTEONECROSIS,16
NZ,RESPIRATORY DISTRESS,16
NZ,RHABDOMYOLYSIS,16
NZ,UNEVALUABLE EVENT,16
NZ,UNRESPONSIVE TO STIMULI,16
NZ,AMNESIA,15
NZ,ANGINA PECTORIS,15
NZ,BASAL CELL CARCINOMA,15
NZ,EMOTIONAL DISTRESS,15
NZ,FEELING HOT,15
NZ,HAEMATEMESIS,15
NZ,HALLUCINATION_ AUDITORY,15
NZ,INFUSION RELATED REACTION,15
NZ,MALIGNANT MELANOMA,15
NZ,MUSCLE SPASMS,15
NZ,PARANOIA,15
NZ,PLATELET COUNT INCREASED,15
NZ,PRODUCT QUALITY ISSUE,15
NZ,PRODUCTIVE COUGH,15
NZ,RESPIRATORY DISORDER,15
NZ,ABORTION SPONTANEOUS,14
NZ,ACTIVITIES OF DAILY LIVING IMPAIRED,14
NZ,ADVERSE DRUG REACTION,14
NZ,ALOPECIA,14
NZ,ATAXIA,14
NZ,BLOOD BILIRUBIN INCREASED,14
NZ,CARDIAC FAILURE CONGESTIVE,14
NZ,DRUG DEPENDENCE,14
NZ,GOUT,14
NZ,HYPERTHYROIDISM,14
NZ,HYPOPHAGIA,14
NZ,IMPAIRED HEALING,14
NZ,MIGRAINE,14
NZ,MONOCYTE COUNT INCREASED,14
NZ,NEUROPATHY PERIPHERAL,14
NZ,PALLOR,14
NZ,PANCYTOPENIA,14
NZ,PERICARDIAL EFFUSION,14
NZ,PLEURAL EFFUSION,14
NZ,SWELLING FACE,14
NZ,ASTHMA,13
NZ,BLADDER CANCER RECURRENT,13
NZ,BONE PAIN,13
NZ,CONVULSION,13
NZ,DEMENTIA,13
NZ,DRY MOUTH,13
NZ,DYSGEUSIA,13
NZ,DYSPEPSIA,13
NZ,EMOTIONAL DISORDER,13
NZ,FOETAL GROWTH RESTRICTION,13
NZ,HYPERSEXUALITY,13
NZ,HYPERTHERMIA MALIGNANT,13
NZ,HYPOXIA,13
NZ,LYMPHOCYTE COUNT DECREASED,13
NZ,METABOLIC ACIDOSIS,13
NZ,NECK PAIN,13
NZ,OROPHARYNGEAL PAIN,13
NZ,ORTHOSTATIC HYPOTENSION,13
NZ,PANCREATITIS,13
NZ,RASH ERYTHEMATOUS,13
NZ,SUDDEN DEATH,13
NZ,SURGERY,13
NZ,SWELLING,13
NZ,WHEEZING,13
NZ,WRONG TECHNIQUE IN DRUG USAGE PROCESS,13
NZ,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,13
NZ,BLOOD ALKALINE PHOSPHATASE INCREASED,12
NZ,BLOOD CREATINE PHOSPHOKINASE INCREASED,12
NZ,BLOOD PRESSURE DECREASED,12
NZ,CARDIOTOXICITY,12
NZ,CHOLECYSTITIS,12
NZ,COGNITIVE DISORDER,12
NZ,COLD SWEAT,12
NZ,COLITIS,12
NZ,COMA,12
NZ,DISTURBANCE IN ATTENTION,12
NZ,EJECTION FRACTION DECREASED,12
NZ,HEPATIC CIRRHOSIS,12
NZ,HYPERGLYCAEMIA,12
NZ,HYPOTHERMIA,12
NZ,INTESTINAL PERFORATION,12
NZ,MANIA,12
NZ,NERVOUSNESS,12
NZ,PHOTOPHOBIA,12
NZ,STAPHYLOCOCCAL INFECTION,12
NZ,URINARY INCONTINENCE,12
NZ,UVEITIS,12
NZ,ABASIA,11
NZ,ANGER,11
NZ,ANTIPSYCHOTIC DRUG LEVEL INCREASED,11
NZ,APHASIA,11
NZ,ASPARTATE AMINOTRANSFERASE INCREASED,11
NZ,BLOOD GLUCOSE INCREASED,11
NZ,DELUSION,11
NZ,ENCEPHALOPATHY,11
NZ,HAEMATURIA,11
NZ,HEPATITIS C,11
NZ,HERNIA,11
NZ,INTENTIONAL PRODUCT MISUSE,11
NZ,INTERNATIONAL NORMALISED RATIO INCREASED,11
NZ,LUPUS-LIKE SYNDROME,11
NZ,LYMPHADENOPATHY,11
NZ,MULTI-ORGAN FAILURE,11
NZ,OSTEONECROSIS OF JAW,11
NZ,PARKINSON^S DISEASE,11
NZ,PULMONARY MASS,11
NZ,PULMONARY OEDEMA,11
NZ,RASH PRURITIC,11
NZ,RESPIRATORY TRACT INFECTION,11
NZ,SINUSITIS,11
NZ,SYSTEMIC LUPUS ERYTHEMATOSUS,11
NZ,THROMBOSIS,11
NZ,TROPONIN INCREASED,11
NZ,TUBULOINTERSTITIAL NEPHRITIS,11
NZ,TYPE 2 DIABETES MELLITUS,11
NZ,BLADDER CANCER,10
NZ,BREAST CANCER,10
NZ,BRONCHOSPASM,10
NZ,BURNING SENSATION,10
NZ,CARCINOMA IN SITU,10
NZ,CARDIOMYOPATHY,10
NZ,CEREBRAL INFARCTION,10
NZ,COLON CANCER,10
NZ,DRUG INTOLERANCE,10
NZ,EPISTAXIS,10
NZ,FEAR,10
NZ,GLOMERULAR FILTRATION RATE DECREASED,10
NZ,HEART RATE IRREGULAR,10
NZ,HEPATIC FUNCTION ABNORMAL,10
NZ,HEPATOCELLULAR CARCINOMA,10
NZ,HERPES ZOSTER,10
NZ,HOT FLUSH,10
NZ,HYPOCALCAEMIA,10
NZ,HYPOGLYCAEMIA,10
NZ,HYPOMAGNESAEMIA,10
NZ,INTESTINAL RESECTION,10
NZ,LOW BIRTH WEIGHT BABY,10
NZ,MENORRHAGIA,10
NZ,METASTASES TO BONE,10
NZ,METASTASES TO CENTRAL NERVOUS SYSTEM,10
NZ,METASTASES TO LIVER,10
NZ,METASTASES TO LUNG,10
NZ,MULTIPLE FRACTURES,10
NZ,MYOCARDIAL ISCHAEMIA,10
NZ,NASOPHARYNGITIS,10
NZ,NIGHT SWEATS,10
NZ,POST-INJECTION DELIRIUM SEDATION SYNDROME,10
NZ,TREATMENT FAILURE,10
NZ,ANAL FISTULA,9
NZ,ANKYLOSING SPONDYLITIS,9
NZ,ANTIPSYCHOTIC DRUG LEVEL DECREASED,9
NZ,BONE MARROW FAILURE,9
NZ,CHOLELITHIASIS,9
NZ,DEVICE DISLOCATION,9
NZ,DIABETES MELLITUS INADEQUATE CONTROL,9
NZ,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,9
NZ,DRUG LEVEL INCREASED,9
NZ,DYSKINESIA,9
NZ,EOSINOPHILIA,9
NZ,GENERAL PHYSICAL CONDITION ABNORMAL,9
NZ,GENERALISED TONIC-CLONIC SEIZURE,9
NZ,HAEMATOCHEZIA,9
NZ,HEAD INJURY,9
NZ,HEART RATE DECREASED,9
NZ,HEPATIC STEATOSIS,9
NZ,HYPERCALCAEMIA,9
NZ,IMMUNE-MEDIATED NECROTISING MYOPATHY,9
NZ,INCORRECT DRUG ADMINISTRATION DURATION,9
NZ,INFLAMMATION,9
NZ,INJURY,9
NZ,LACERATION,9
NZ,MYELODYSPLASTIC SYNDROME,9
NZ,NECROTISING FASCIITIS,9
NZ,OEDEMA,9
NZ,OXYGEN SATURATION DECREASED,9
NZ,POST PROCEDURAL COMPLICATION,9
NZ,PRODUCT SUBSTITUTION ISSUE,9
NZ,PRODUCT USE IN UNAPPROVED INDICATION,9
NZ,RED BLOOD CELL COUNT DECREASED,9
NZ,ROAD TRAFFIC ACCIDENT,9
NZ,SKIN ULCER,9
NZ,SQUAMOUS CELL CARCINOMA,9
NZ,SQUAMOUS CELL CARCINOMA OF SKIN,9
NZ,SUBDURAL HAEMORRHAGE,9
NZ,TALIPES,9
NZ,VERTIGO,9
NZ,WRONG DRUG ADMINISTERED,9
NZ,ACCIDENTAL OVERDOSE,8
NZ,BLOOD ALBUMIN DECREASED,8
NZ,CHRONIC KIDNEY DISEASE,8
NZ,COMA SCALE ABNORMAL,8
NZ,DEVICE FAILURE,8
NZ,DRUG ADMINISTRATION ERROR,8
NZ,DRUG LEVEL DECREASED,8
NZ,DYSPHONIA,8
NZ,DYSURIA,8
NZ,ELECTROCARDIOGRAM ABNORMAL,8
NZ,EOSINOPHIL COUNT INCREASED,8
NZ,EXPOSURE DURING BREAST FEEDING,8
NZ,FEMORAL NECK FRACTURE,8
NZ,FISTULA,8
NZ,GASTROINTESTINAL STOMA COMPLICATION,8
NZ,GLYCOSYLATED HAEMOGLOBIN INCREASED,8
NZ,HAEMATOMA,8
NZ,HEPATIC CANCER,8
NZ,HYPERREFLEXIA,8
NZ,INJECTION SITE BRUISING,8
NZ,INTRAOCULAR PRESSURE INCREASED,8
NZ,LUNG DISORDER,8
NZ,LUNG NEOPLASM MALIGNANT,8
NZ,LYMPHOPENIA,8
NZ,MEAN CELL HAEMOGLOBIN DECREASED,8
NZ,METASTATIC MALIGNANT MELANOMA,8
NZ,MOOD ALTERED,8
NZ,MYASTHENIA GRAVIS,8
NZ,OSTEOMALACIA,8
NZ,PERIORBITAL OEDEMA,8
NZ,POST PROCEDURAL INFECTION,8
NZ,PSEUDOLYMPHOMA,8
NZ,PSYCHIATRIC DECOMPENSATION,8
NZ,PSYCHIATRIC SYMPTOM,8
NZ,RESPIRATORY RATE INCREASED,8
NZ,RHINORRHOEA,8
NZ,RIB FRACTURE,8
NZ,SEPTIC SHOCK,8
NZ,SINUS TACHYCARDIA,8
NZ,SKIN DISORDER,8
NZ,SMALL INTESTINAL OBSTRUCTION,8
NZ,SWOLLEN TONGUE,8
NZ,TEARFULNESS,8
NZ,THERAPEUTIC RESPONSE DECREASED,8
NZ,THINKING ABNORMAL,8
NZ,THROAT TIGHTNESS,8
NZ,URINARY RETENTION,8
NZ,VAGINAL HAEMORRHAGE,8
NZ,VISUAL ACUITY REDUCED,8
NZ,ACUTE MYELOID LEUKAEMIA,7
NZ,ADENOCARCINOMA OF COLON,7
NZ,AFFECT LABILITY,7
NZ,AKATHISIA,7
NZ,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,7
NZ,ASCITES,7
NZ,AUTISM,7
NZ,BIPOLAR DISORDER,7
NZ,BLINDNESS,7
NZ,BLOOD GLUCOSE ABNORMAL,7
NZ,BLOOD SODIUM DECREASED,7
NZ,BRADYCARDIA,7
NZ,CANDIDA SEPSIS,7
NZ,DRUG HYPERSENSITIVITY,7
NZ,DUODENAL ULCER,7
NZ,ECZEMA,7
NZ,EXTRAPYRAMIDAL DISORDER,7
NZ,FEMUR FRACTURE,7
NZ,FLATULENCE,7
NZ,FLUID OVERLOAD,7
NZ,FREQUENT BOWEL MOVEMENTS,7
NZ,GASTROINTESTINAL INFLAMMATION,7
NZ,HEMIPARESIS,7
NZ,HEMIPLEGIA,7
NZ,HYPERBILIRUBINAEMIA,7
NZ,HYPERSENSITIVITY VASCULITIS,7
NZ,IMMUNODEFICIENCY,7
NZ,INCORRECT ROUTE OF DRUG ADMINISTRATION,7
NZ,INJECTION SITE ERYTHEMA,7
NZ,INJECTION SITE HAEMORRHAGE,7
NZ,INJECTION SITE REACTION,7
NZ,JOINT STIFFNESS,7
NZ,LEUKOPENIA,7
NZ,LIMB DISCOMFORT,7
NZ,LIVER DISORDER,7
NZ,LOCALISED INFECTION,7
NZ,LYMPHOCYTE COUNT INCREASED,7
NZ,MENSTRUATION IRREGULAR,7
NZ,MOUTH ULCERATION,7
NZ,MULTIPLE ORGAN DYSFUNCTION SYNDROME,7
NZ,NEPHROLITHIASIS,7
NZ,OSTEOPOROSIS,7
NZ,PANIC ATTACK,7
NZ,PATHOLOGICAL FRACTURE,7
NZ,PERICARDITIS,7
NZ,PERITONITIS,7
NZ,PHARYNGITIS,7
NZ,POOR QUALITY SLEEP,7
NZ,RASH GENERALISED,7
NZ,RASH MACULAR,7
NZ,RESPIRATORY ARREST,7
NZ,SHOCK,7
NZ,SKIN CANCER,7
NZ,SKIN NECROSIS,7
NZ,STREPTOCOCCAL INFECTION,7
NZ,SUBDURAL HAEMATOMA,7
NZ,SUPRAVENTRICULAR TACHYCARDIA,7
NZ,TORSADE DE POINTES,7
NZ,TROPONIN T INCREASED,7
NZ,TYPE I HYPERSENSITIVITY,7
NZ,UPPER GASTROINTESTINAL HAEMORRHAGE,7
NZ,ABDOMINAL ADHESIONS,6
NZ,ACUTE RESPIRATORY DISTRESS SYNDROME,6
NZ,ANAL ABSCESS,6
NZ,ANKLE FRACTURE,6
NZ,ANOSOGNOSIA,6
NZ,AORTIC DISSECTION,6
NZ,APATHY,6
NZ,ATRIAL FLUTTER,6
NZ,BLISTER,6
NZ,BRAIN NEOPLASM,6
NZ,BREAST MASS,6
NZ,COLITIS ULCERATIVE,6
NZ,CYANOSIS,6
NZ,DIPLOPIA,6
NZ,DISCOMFORT,6
NZ,DRUG ABUSE,6
NZ,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,6
NZ,ENDOPHTHALMITIS,6
NZ,ERECTILE DYSFUNCTION,6
NZ,EYE PAIN,6
NZ,FACE OEDEMA,6
NZ,FISTULA DISCHARGE,6
NZ,FOOT DEFORMITY,6
NZ,FRACTURE,6
NZ,GASTRIC ULCER HAEMORRHAGE,6
NZ,GASTROINTESTINAL CARCINOMA,6
NZ,GENITAL HAEMORRHAGE,6
NZ,HAEMOGLOBIN ABNORMAL,6
NZ,HEPATITIS,6
NZ,HYPOGAMMAGLOBULINAEMIA,6
NZ,HYPOTONIA,6
NZ,IMPAIRED WORK ABILITY,6
NZ,INTERVERTEBRAL DISC PROTRUSION,6
NZ,INTESTINAL ISCHAEMIA,6
NZ,JOINT EFFUSION,6
NZ,LEUKOCYTOSIS,6
NZ,LIMB INJURY,6
NZ,LOCAL SWELLING,6
NZ,LYMPHOMA,6
NZ,MASS,6
NZ,METASTASES TO LYMPH NODES,6
NZ,MOOD SWINGS,6
NZ,NEPHROTIC SYNDROME,6
NZ,NERVE COMPRESSION,6
NZ,NERVOUS SYSTEM DISORDER,6
NZ,NEURALGIA,6
NZ,NEUROLEPTIC MALIGNANT SYNDROME,6
NZ,NEUTROPENIC SEPSIS,6
NZ,NEUTROPHILIA,6
NZ,NIGHTMARE,6
NZ,NYSTAGMUS,6
NZ,OBSTRUCTIVE AIRWAYS DISORDER,6
NZ,OLIGOHYDRAMNIOS,6
NZ,PLEURITIC PAIN,6
NZ,PRESYNCOPE,6
NZ,PROCEDURAL PAIN,6
NZ,PROTEIN TOTAL DECREASED,6
NZ,PSORIATIC ARTHROPATHY,6
NZ,PULMONARY HYPERTENSION,6
NZ,RASH MACULO-PAPULAR,6
NZ,SCAR,6
NZ,SELF INJURIOUS BEHAVIOUR,6
NZ,SEPSIS SYNDROME,6
NZ,SEROTONIN SYNDROME,6
NZ,SKIN DISCOLOURATION,6
NZ,SLEEP APNOEA SYNDROME,6
NZ,SPINAL FRACTURE,6
NZ,STOMATITIS,6
NZ,TACHYPNOEA,6
NZ,TREATMENT NONCOMPLIANCE,6
NZ,UNDERDOSE,6
NZ,UROSEPSIS,6
NZ,VENTRICULAR FIBRILLATION,6
NZ,WITHDRAWAL SYNDROME,6
NZ,ABNORMAL DREAMS,5
NZ,ABSCESS,5
NZ,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,5
NZ,ADRENAL SUPPRESSION,5
NZ,ADVERSE EVENT,5
NZ,AFFECTIVE DISORDER,5
NZ,ALCOHOL INTERACTION,5
NZ,ALCOHOL POISONING,5
NZ,ANGINA UNSTABLE,5
NZ,ARTHRITIS BACTERIAL,5
NZ,ASPHYXIA,5
NZ,ATELECTASIS,5
NZ,B-CELL LYMPHOMA,5
NZ,BACK DISORDER,5
NZ,BLOOD TEST ABNORMAL,5
NZ,BLOOD UREA DECREASED,5
NZ,BRAIN NATRIURETIC PEPTIDE INCREASED,5
NZ,BRONCHITIS,5
NZ,CARDIAC MURMUR,5
NZ,CARPAL TUNNEL SYNDROME,5
NZ,CATARACT,5
NZ,CHRONIC LYMPHOCYTIC LEUKAEMIA,5
NZ,COMPLICATION OF DEVICE REMOVAL,5
NZ,CONGESTIVE CARDIOMYOPATHY,5
NZ,CYST,5
NZ,DERMATITIS BULLOUS,5
NZ,DEVELOPMENTAL DELAY,5
NZ,DRUG DISPENSING ERROR,5
NZ,DRUG PRESCRIBING ERROR,5
NZ,DRUG WITHDRAWAL SYNDROME,5
NZ,DRUG-INDUCED LIVER INJURY,5
NZ,DRY SKIN,5
NZ,DYSENTERY,5
NZ,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,5
NZ,ESCHERICHIA SEPSIS,5
NZ,ESCHERICHIA URINARY TRACT INFECTION,5
NZ,EXPIRED PRODUCT ADMINISTERED,5
NZ,FEAR OF INJECTION,5
NZ,FUNCTIONAL GASTROINTESTINAL DISORDER,5
NZ,GASTRIC ULCER,5
NZ,GASTRITIS,5
NZ,GRAFT COMPLICATION,5
NZ,HIP FRACTURE,5
NZ,HYPERKALAEMIA,5
NZ,HYPOACUSIS,5
NZ,HYPOKINESIA,5
NZ,HYPOMANIA,5
NZ,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,5
NZ,INJECTION SITE MASS,5
NZ,INTENTIONAL SELF-INJURY,5
NZ,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,5
NZ,LARGE INTESTINE POLYP,5
NZ,LEFT VENTRICULAR DYSFUNCTION,5
NZ,LIP SWELLING,5
NZ,LUMBAR VERTEBRAL FRACTURE,5
NZ,LUNG INFILTRATION,5
NZ,LYMPHOEDEMA,5
NZ,MALNUTRITION,5
NZ,MUSCLE ATROPHY,5
NZ,MUSCLE TWITCHING,5
NZ,NECK MASS,5
NZ,NO ADVERSE EVENT,5
NZ,PANCREATIC CARCINOMA,5
NZ,PERIPHERAL ISCHAEMIA,5
NZ,PHARYNGEAL OEDEMA,5
NZ,PNEUMOTHORAX,5
NZ,POST PROCEDURAL HAEMORRHAGE,5
NZ,PROSTATE CANCER,5
NZ,PROSTATOMEGALY,5
NZ,RASH MORBILLIFORM,5
NZ,RED CELL DISTRIBUTION WIDTH INCREASED,5
NZ,RESPIRATORY DEPRESSION,5
NZ,SCIATICA,5
NZ,SECOND PRIMARY MALIGNANCY,5
NZ,SKIN INFECTION,5
NZ,SKIN LESION,5
NZ,THIRST,5
NZ,UPPER RESPIRATORY TRACT INFECTION,5
NZ,VASCULITIS,5
NZ,ABDOMINAL TENDERNESS,4
NZ,ACCIDENT,4
NZ,ACCIDENTAL EXPOSURE TO PRODUCT,4
NZ,ACUTE CORONARY SYNDROME,4
NZ,ADVERSE REACTION,4
NZ,ALTERED STATE OF CONSCIOUSNESS,4
NZ,ANAPHYLACTIC SHOCK,4
NZ,APPENDICITIS,4
NZ,ASPIRATION,4
NZ,AUTISM SPECTRUM DISORDER,4
NZ,BEDRIDDEN,4
NZ,BENIGN INTRACRANIAL HYPERTENSION,4
NZ,BLOOD POTASSIUM DECREASED,4
NZ,BLOOD PRESSURE ABNORMAL,4
NZ,BLOOD URINE PRESENT,4
NZ,BONE DENSITY DECREASED,4
NZ,BRONCHIECTASIS,4
NZ,CALCIPHYLAXIS,4
NZ,CARDIOGENIC SHOCK,4
NZ,CERVICAL DYSPLASIA,4
NZ,COLITIS ISCHAEMIC,4
NZ,CONJUNCTIVITIS,4
NZ,CONTRAST MEDIA REACTION,4
NZ,CORONARY ARTERY DISEASE,4
NZ,CRYING,4
NZ,DEAFNESS,4
NZ,DECREASED INTEREST,4
NZ,DERMATITIS,4
NZ,DEVICE RELATED INFECTION,4
NZ,DISINHIBITION,4
NZ,DROOLING,4
NZ,DRUG EFFECT DELAYED,4
NZ,DUODENAL ULCER PERFORATION,4
NZ,DYSMORPHISM,4
NZ,DYSPNOEA EXERTIONAL,4
NZ,DYSSTASIA,4
NZ,ELEVATED MOOD,4
NZ,EMBOLISM VENOUS,4
NZ,ENCEPHALITIS,4
NZ,EPILEPSY,4
NZ,EYE HAEMORRHAGE,4
NZ,EYE PRURITUS,4
NZ,EYELID OEDEMA,4
NZ,FAECALOMA,4
NZ,FAECES DISCOLOURED,4
NZ,FAT NECROSIS,4
NZ,FIBROMYALGIA,4
NZ,FLAT AFFECT,4
NZ,FLUID RETENTION,4
NZ,GANGRENE,4
NZ,GASTRIC DISORDER,4
NZ,GASTROINTESTINAL HYPOMOTILITY,4
NZ,GASTROINTESTINAL PAIN,4
NZ,GRANULOMA,4
NZ,GRIP STRENGTH DECREASED,4
NZ,GROIN PAIN,4
NZ,GROWTH RETARDATION,4
NZ,HAEMARTHROSIS,4
NZ,HAEMODYNAMIC INSTABILITY,4
NZ,HAEMOLYSIS,4
NZ,HAEMORRHAGIC STROKE,4
NZ,HEPATIC FIBROSIS,4
NZ,HEPATITIS B,4
NZ,HEPATITIS CHOLESTATIC,4
NZ,HYPERLIPIDAEMIA,4
NZ,HYPERVENTILATION,4
NZ,HYPOPHOSPHATASIA,4
NZ,IIIRD NERVE PARALYSIS,4
NZ,ILEOSTOMY,4
NZ,ILEUS PARALYTIC,4
NZ,INCONTINENCE,4
NZ,INCORRECT DRUG ADMINISTRATION RATE,4
NZ,INFLAMMATORY MARKER INCREASED,4
NZ,INJECTION SITE SWELLING,4
NZ,INJURY ASSOCIATED WITH DEVICE,4
NZ,INTENTIONAL DRUG MISUSE,4
NZ,INTESTINAL FISTULA,4
NZ,INTESTINAL STENOSIS,4
NZ,INVASIVE DUCTAL BREAST CARCINOMA,4
NZ,IRITIS,4
NZ,ISCHAEMIA,4
NZ,JOINT INJURY,4
NZ,JOINT RANGE OF MOTION DECREASED,4
NZ,KERATITIS,4
NZ,KERATOACANTHOMA,4
NZ,LIVER FUNCTION TEST INCREASED,4
NZ,LIVER INJURY,4
NZ,LUNG INFECTION,4
NZ,MAJOR DEPRESSION,4
NZ,MALIGNANT MELANOMA IN SITU,4
NZ,MEAN CELL VOLUME DECREASED,4
NZ,MENTAL STATUS CHANGES,4
NZ,MOTOR DEVELOPMENTAL DELAY,4
NZ,MUSCLE CONTRACTIONS INVOLUNTARY,4
NZ,MUSCULOSKELETAL CHEST PAIN,4
NZ,MYDRIASIS,4
NZ,MYELOFIBROSIS,4
NZ,MYOCLONUS,4
NZ,MYOPATHY,4
NZ,NEOPLASM,4
NZ,NEPHROPATHY TOXIC,4
NZ,NODULE,4
NZ,OBESITY,4
NZ,ORGAN FAILURE,4
NZ,OTORRHOEA,4
NZ,PAIN IN JAW,4
NZ,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,4
NZ,PARALYSIS,4
NZ,PELVIC PAIN,4
NZ,PELVIC VENOUS THROMBOSIS,4
NZ,PNEUMOCYSTIS JIROVECII PNEUMONIA,4
NZ,PNEUMOMEDIASTINUM,4
NZ,POLYARTHRITIS,4
NZ,PROCEDURAL COMPLICATION,4
NZ,PSYCHOTIC BEHAVIOUR,4
NZ,PULMONARY HAEMORRHAGE,4
NZ,RED BLOOD CELL SEDIMENTATION RATE INCREASED,4
NZ,RESPIRATION ABNORMAL,4
NZ,RETINAL INJURY,4
NZ,SENSORY LOSS,4
NZ,SKIN BURNING SENSATION,4
NZ,SKIN EXFOLIATION,4
NZ,SPINAL COMPRESSION FRACTURE,4
NZ,SPINAL DISORDER,4
NZ,SPINAL FUSION SURGERY,4
NZ,SPUTUM DISCOLOURED,4
NZ,SUBARACHNOID HAEMORRHAGE,4
NZ,SUICIDAL BEHAVIOUR,4
NZ,SYNOVITIS,4
NZ,TACHYARRHYTHMIA,4
NZ,TENDONITIS,4
NZ,TERMINAL STATE,4
NZ,THERAPEUTIC RESPONSE UNEXPECTED,4
NZ,THROMBOSIS IN DEVICE,4
NZ,TOOTH INFECTION,4
NZ,UPPER LIMB FRACTURE,4
NZ,URINE ODOUR ABNORMAL,4
NZ,VASCULAR STENT THROMBOSIS,4
NZ,VASCULITIS CEREBRAL,4
NZ,VENTRICULAR TACHYCARDIA,4
NZ,WOUND,4
NZ,ABDOMINAL MASS,3
NZ,ABDOMINAL PAIN LOWER,3
NZ,ADENOCARCINOMA,3
NZ,ADRENAL INSUFFICIENCY,3
NZ,AGEUSIA,3
NZ,ALCOHOL WITHDRAWAL SYNDROME,3
NZ,ANAL HAEMORRHAGE,3
NZ,ANAPHYLACTOID REACTION,3
NZ,ANGIOPATHY,3
NZ,ANORECTAL DISORDER,3
NZ,ANTIBIOTIC LEVEL ABOVE THERAPEUTIC,3
NZ,ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC,3
NZ,ANURIA,3
NZ,APNOEA,3
NZ,ARACHNOIDITIS,3
NZ,ARTERIAL HAEMORRHAGE,3
NZ,ARTHRITIS INFECTIVE,3
NZ,BILE DUCT OBSTRUCTION,3
NZ,BLINDNESS UNILATERAL,3
NZ,BLOOD PARATHYROID HORMONE DECREASED,3
NZ,BRADYPHRENIA,3
NZ,BRAIN OEDEMA,3
NZ,BREAST CANCER METASTATIC,3
NZ,BRONCHIAL WALL THICKENING,3
NZ,BURSITIS,3
NZ,C-REACTIVE PROTEIN ABNORMAL,3
NZ,CAESAREAN SECTION,3
NZ,CANDIDA INFECTION,3
NZ,CARDIAC TAMPONADE,3
NZ,CARDIO-RESPIRATORY ARREST,3
NZ,CATATONIA,3
NZ,CAUDA EQUINA SYNDROME,3
NZ,CEREBROVASCULAR DISORDER,3
NZ,CHOLANGITIS,3
NZ,CHONDROCALCINOSIS PYROPHOSPHATE,3
NZ,CLAVICLE FRACTURE,3
NZ,CLEFT PALATE,3
NZ,CLOSTRIDIUM DIFFICILE INFECTION,3
NZ,COLOSTOMY,3
NZ,COORDINATION ABNORMAL,3
NZ,CORNEAL SCAR,3
NZ,CORONARY ARTERY BYPASS,3
NZ,CREPITATIONS,3
NZ,DEAFNESS NEUROSENSORY,3
NZ,DEAFNESS UNILATERAL,3
NZ,DEMENTIA ALZHEIMER^S TYPE,3
NZ,DEMYELINATION,3
NZ,DENTAL CARIES,3
NZ,DERMATITIS ALLERGIC,3
NZ,DEVICE ISSUE,3
NZ,DEVICE MALFUNCTION,3
NZ,DEVICE USE ISSUE,3
NZ,DIARRHOEA HAEMORRHAGIC,3
NZ,DIVERTICULITIS,3
NZ,DIVERTICULUM,3
NZ,DRUG LEVEL ABOVE THERAPEUTIC,3
NZ,DRUG WITHDRAWAL SYNDROME NEONATAL,3
NZ,DUODENAL ULCER HAEMORRHAGE,3
NZ,DYSTONIA,3
NZ,EAR INFECTION,3
NZ,EATING DISORDER,3
NZ,ECTOPIC PREGNANCY,3
NZ,EMPHYSEMA,3
NZ,EXPOSURE TO CONTAMINATED DEVICE,3
NZ,EXTRASYSTOLES,3
NZ,EYE DISORDER,3
NZ,EYE IRRITATION,3
NZ,EYELID PTOSIS,3
NZ,FACTOR VIII INHIBITION,3
NZ,FAECAL CALPROTECTIN INCREASED,3
NZ,FAILURE TO THRIVE,3
NZ,FEELING COLD,3
NZ,FEELING DRUNK,3
NZ,FEELING OF BODY TEMPERATURE CHANGE,3
NZ,FEELING OF DESPAIR,3
NZ,FRUSTRATION,3
NZ,FURUNCLE,3
NZ,GASTRIC CANCER,3
NZ,GASTRIC INFECTION,3
NZ,GASTROENTERITIS,3
NZ,GASTROINTESTINAL INFECTION,3
NZ,GASTROINTESTINAL STENOSIS,3
NZ,GESTATIONAL DIABETES,3
NZ,GLUCOSE TOLERANCE IMPAIRED,3
NZ,GOITRE,3
NZ,GRAND MAL CONVULSION,3
NZ,HAEMATOMA INFECTION,3
NZ,HAEMOLYTIC ANAEMIA,3
NZ,HAEMORRHAGE URINARY TRACT,3
NZ,HAND DEFORMITY,3
NZ,HEARING IMPAIRED,3
NZ,HEPATOTOXICITY,3
NZ,HIP ARTHROPLASTY,3
NZ,HOMICIDE,3
NZ,HYDRONEPHROSIS,3
NZ,HYPERKERATOSIS,3
NZ,HYPERSOMNIA,3
NZ,HYPERTONIA,3
NZ,HYPOPITUITARISM,3
NZ,HYPOVOLAEMIC SHOCK,3
NZ,ILL-DEFINED DISORDER,3
NZ,IMMUNOSUPPRESSION,3
NZ,IMPULSE-CONTROL DISORDER,3
NZ,INCOHERENT,3
NZ,INCREASED APPETITE,3
NZ,INJECTION SITE PRURITUS,3
NZ,INTERNAL HAEMORRHAGE,3
NZ,IRON DEFICIENCY,3
NZ,IRRITABLE BOWEL SYNDROME,3
NZ,KIDNEY TRANSPLANT REJECTION,3
NZ,KNEE ARTHROPLASTY,3
NZ,LEARNING DISORDER,3
NZ,LEFT VENTRICULAR FAILURE,3
NZ,LISTERIOSIS,3
NZ,LIVER ABSCESS,3
NZ,LOGORRHOEA,3
NZ,LUNG CANCER METASTATIC,3
NZ,LUNG CONSOLIDATION,3
NZ,LYMPH NODE PAIN,3
NZ,MALABSORPTION,3
NZ,MEAN PLATELET VOLUME INCREASED,3
NZ,MENSTRUAL DISORDER,3
NZ,MIDDLE INSOMNIA,3
NZ,MIGRATION OF IMPLANTED DRUG,3
NZ,MITRAL VALVE INCOMPETENCE,3
NZ,MONOCYTE COUNT DECREASED,3
NZ,MUCORMYCOSIS,3
NZ,MULTIPLE SCLEROSIS,3
NZ,MULTIPLE SCLEROSIS RELAPSE,3
NZ,MUSCLE DISORDER,3
NZ,MUSCLE RIGIDITY,3
NZ,MUSCLE TIGHTNESS,3
NZ,MYOSITIS,3
NZ,NERVE INJURY,3
NZ,NOCTURNAL DYSPNOEA,3
NZ,NON-CARDIAC CHEST PAIN,3
NZ,OESOPHAGITIS,3
NZ,OPTIC NEUROPATHY,3
NZ,ORAL CANDIDIASIS,3
NZ,OTITIS MEDIA,3
NZ,OVARIAN CYST,3
NZ,PANCREATITIS NECROTISING,3
NZ,PERICARDIAL HAEMORRHAGE,3
NZ,PERIPHERAL SENSORY NEUROPATHY,3
NZ,PHOTOSENSITIVITY REACTION,3
NZ,PHYSICAL DISABILITY,3
NZ,PNEUMOCYSTIS JIROVECII INFECTION,3
NZ,POLLAKIURIA,3
NZ,POLYDIPSIA,3
NZ,POLYMYOSITIS,3
NZ,POLYP,3
NZ,POSTPARTUM HAEMORRHAGE,3
NZ,PRESCRIBED UNDERDOSE,3
NZ,PROCOAGULANT THERAPY,3
NZ,PROCTALGIA,3
NZ,PRODUCT ADHESION ISSUE,3
NZ,PROSTATE CANCER METASTATIC,3
NZ,PROSTATISM,3
NZ,PROTEINURIA,3
NZ,PULMONARY THROMBOSIS,3
NZ,PURPURA,3
NZ,PYODERMA GANGRENOSUM,3
NZ,QUALITY OF LIFE DECREASED,3
NZ,RADIUS FRACTURE,3
NZ,RASH PUSTULAR,3
NZ,RENAL DISORDER,3
NZ,RENAL FAILURE CHRONIC,3
NZ,RENAL TUBULAR NECROSIS,3
NZ,RESTLESS LEGS SYNDROME,3
NZ,RHEUMATIC DISORDER,3
NZ,RHINITIS,3
NZ,ROTATOR CUFF SYNDROME,3
NZ,SCHIZOPHRENIA_ PARANOID TYPE,3
NZ,SENSATION OF FOREIGN BODY,3
NZ,SEXUAL ABUSE,3
NZ,SJOGREN^S SYNDROME,3
NZ,SNEEZING,3
NZ,SOCIAL PROBLEM,3
NZ,SOFT TISSUE INJURY,3
NZ,SPEECH DISORDER DEVELOPMENTAL,3
NZ,SPINAL COLUMN STENOSIS,3
NZ,SPINAL CORD COMPRESSION,3
NZ,SPINAL SUBDURAL HAEMATOMA,3
NZ,SPLENOMEGALY,3
NZ,STEVENS-JOHNSON SYNDROME,3
NZ,STRESS FRACTURE,3
NZ,STRIDOR,3
NZ,SURGICAL FAILURE,3
NZ,TEMPORAL ARTERITIS,3
NZ,TENDON RUPTURE,3
NZ,THERAPY NON-RESPONDER,3
NZ,THROAT IRRITATION,3
NZ,THROMBIN TIME PROLONGED,3
NZ,THYROID DISORDER,3
NZ,TINNITUS,3
NZ,TONGUE ULCERATION,3
NZ,TOXIC EPIDERMAL NECROLYSIS,3
NZ,TRANSPLANT REJECTION,3
NZ,TYMPANIC MEMBRANE PERFORATION,3
NZ,VENTRICULAR ARRHYTHMIA,3
NZ,VENTRICULAR EXTRASYSTOLES,3
NZ,VIRAL UPPER RESPIRATORY TRACT INFECTION,3
NZ,VIROLOGIC FAILURE,3
NZ,WEIGHT BEARING DIFFICULTY,3
NZ,WOUND INFECTION,3
NI,UNWANTED AWARENESS DURING ANAESTHESIA,28
NI,PRODUCT QUALITY ISSUE,26
NI,ANAESTHETIC COMPLICATION,24
NI,DEATH,24
NI,PRODUCT ODOUR ABNORMAL,24
NI,PRODUCT TAMPERING,24
NI,INCORRECT STORAGE OF DRUG,3
NI,MALAISE,3
NI,PNEUMONIA,3
NI,PULMONARY HAEMORRHAGE,3
NI,SECOND PRIMARY MALIGNANCY,3
NI,ANURIA,2
NI,CHRONIC MYELOID LEUKAEMIA,2
NI,CONVULSION,2
NI,DRUG RESISTANCE,2
NI,EPISTAXIS,2
NI,GENERAL PHYSICAL HEALTH DETERIORATION,2
NI,HYPEROSMOLAR STATE,2
NI,MULTIPLE SCLEROSIS RELAPSE,2
NI,NAUSEA,2
NI,PLATELET COUNT DECREASED,2
NI,PRODUCT COLOUR ISSUE,2
NI,URETHRAL DILATATION,2
NI,URINARY RETENTION,2
NI,VOMITING,2
NI,AKATHISIA,1
NI,ALOPECIA,1
NI,ANAEMIA,1
NI,ASCITES,1
NI,ASPIRATION BRONCHIAL,1
NI,ASTHENIA,1
NI,ASTHMA,1
NI,ATRIAL FIBRILLATION,1
NI,BIOCHEMICAL PREGNANCY,1
NI,BLADDER MASS,1
NI,BLAST CELL COUNT INCREASED,1
NI,BLOOD CREATININE INCREASED,1
NI,BLOOD PRESSURE INCREASED,1
NI,BONE PAIN,1
NI,BRAIN NEOPLASM MALIGNANT,1
NI,BRONCHOSPASM,1
NI,BUNDLE BRANCH BLOCK RIGHT,1
NI,BURNING SENSATION,1
NI,CARDIAC FIBRILLATION,1
NI,CARDIO-RESPIRATORY ARREST,1
NI,CARDIOGENIC SHOCK,1
NI,CEREBRAL HAEMORRHAGE,1
NI,CEREBROVASCULAR ACCIDENT,1
NI,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NI,COLON CANCER,1
NI,CONDITION AGGRAVATED,1
NI,CONSTIPATION,1
NI,DECREASED APPETITE,1
NI,DEPRESSION,1
NI,DISCOMFORT,1
NI,DIZZINESS,1
NI,DRUG INEFFECTIVE,1
NI,DYSGEUSIA,1
NI,DYSPNOEA,1
NI,DYSPNOEA EXERTIONAL,1
NI,ELECTROCARDIOGRAM QT PROLONGED,1
NI,ENDOMETRIOSIS,1
NI,GASTRIC CANCER,1
NI,GASTROINTESTINAL HAEMORRHAGE,1
NI,GASTROINTESTINAL PAIN,1
NI,GASTROINTESTINAL STROMAL TUMOUR,1
NI,GENERAL ANAESTHESIA,1
NI,GINGIVITIS,1
NI,HAEMOGLOBIN DECREASED,1
NI,HEPATIC CIRRHOSIS,1
NI,HEPATIC ENCEPHALOPATHY,1
NI,HEPATIC MASS,1
NI,HEPATIC STEATOSIS,1
NI,HEPATOCELLULAR CARCINOMA,1
NI,HYPERGLYCAEMIA,1
NI,HYPERVOLAEMIA,1
NI,HYPOAESTHESIA,1
NI,HYPOKALAEMIA,1
NI,HYPONATRAEMIA,1
NI,HYPOTENSION,1
NI,HYPOXIA,1
NI,INCOHERENT,1
NI,INFERTILITY FEMALE,1
NI,INSOMNIA,1
NI,INTESTINAL MASS,1
NI,JOINT SWELLING,1
NI,KIDNEY INFECTION,1
NI,LEUKAEMIC INFILTRATION PULMONARY,1
NI,LIMB DISCOMFORT,1
NI,LOSS OF CONSCIOUSNESS,1
NI,LUNG NEOPLASM MALIGNANT,1
NI,MALIGNANT NEOPLASM PROGRESSION,1
NI,METABOLIC ACIDOSIS,1
NI,MOVEMENT DISORDER,1
NI,MUSCLE SPASMS,1
NI,MUSCULOSKELETAL STIFFNESS,1
NI,MYOCARDIAL INFARCTION,1
NI,NEUTROPHILIA,1
NI,ONYCHOLYSIS,1
NI,OSTEOCHONDROSIS,1
NI,PAIN,1
NI,PALPITATIONS,1
NI,PANCREATIC MASS,1
NI,PARAESTHESIA,1
NI,PELVIC NEOPLASM,1
NI,PLATELET COUNT INCREASED,1
NI,PRODUCT USE IN UNAPPROVED INDICATION,1
NI,PRODUCT USE ISSUE,1
NI,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
NI,PRURITUS,1
NI,PULMONARY FIBROSIS,1
NI,PYREXIA,1
NI,RASH,1
NI,RECURRENT CANCER,1
NI,RED BLOOD CELL COUNT DECREASED,1
NI,RENAL FAILURE,1
NI,RESPIRATORY FAILURE,1
NI,SEIZURE,1
NI,SENSORY LOSS,1
NI,SEPTIC SHOCK,1
NI,SHOCK,1
NI,SHOCK HAEMORRHAGIC,1
NI,SPLENITIS,1
NI,STRESS AT WORK,1
NI,THERAPY NON-RESPONDER,1
NI,THROAT CANCER,1
NI,THROMBOCYTOPENIA,1
NI,TOOTH LOSS,1
NI,TOXICITY TO VARIOUS AGENTS,1
NI,TREMOR,1
NI,TROPONIN INCREASED,1
NI,URINARY BLADDER HAEMORRHAGE,1
NI,URTICARIA,1
NI,VARICELLA,1
NI,WHITE BLOOD CELL COUNT DECREASED,1
NI,WHITE BLOOD CELL COUNT INCREASED,1
NE,DRUG DEPENDENCE,17
NE,DRUG ABUSE,16
NE,FOOD INTERACTION,13
NE,EPILEPSY,10
NE,CONVULSION,7
NE,DEATH,7
NE,TOBACCO INTERACTION,7
NE,TOXIC EPIDERMAL NECROLYSIS,4
NE,PYREXIA,3
NE,ANAEMIA,2
NE,CHRONIC MYELOID LEUKAEMIA,2
NE,COMA,2
NE,PANCYTOPENIA,2
NE,PNEUMONIA,2
NE,TREATMENT FAILURE,2
NE,ASTHENIA,1
NE,BACTERIAL INFECTION,1
NE,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
NE,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
NE,CLONAL EVOLUTION,1
NE,CONFUSIONAL STATE,1
NE,CYTOGENETIC ABNORMALITY,1
NE,DEHYDRATION,1
NE,HEPATIC FAILURE,1
NE,HYPOGLYCAEMIA,1
NE,HYPOVOLAEMIC SHOCK,1
NE,INFECTION PARASITIC,1
NE,INTENTIONAL DRUG MISUSE,1
NE,MALIGNANT NEOPLASM PROGRESSION,1
NE,NEUTROPHIL COUNT DECREASED,1
NE,PULMONARY MASS,1
NE,THERAPY NON-RESPONDER,1
NG,DEATH,118
NG,DRUG INTOLERANCE,25
NG,HEADACHE,25
NG,DRUG INEFFECTIVE,22
NG,ASTHENIA,17
NG,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,15
NG,DYSPNOEA,14
NG,FOETAL EXPOSURE DURING PREGNANCY,14
NG,DIZZINESS,13
NG,PALPITATIONS,12
NG,DIABETES MELLITUS,11
NG,MALAISE,11
NG,PYREXIA,11
NG,PAIN,10
NG,ANAEMIA,9
NG,JEALOUS DELUSION,9
NG,THROMBOCYTOPENIA,9
NG,CEREBROVASCULAR ACCIDENT,8
NG,CLEFT PALATE,8
NG,DRUG RESISTANCE,8
NG,GENERALISED TONIC-CLONIC SEIZURE,8
NG,INSOMNIA,8
NG,LOSS OF CONSCIOUSNESS,8
NG,SEIZURE,8
NG,SPINA BIFIDA,8
NG,VIROLOGIC FAILURE,8
NG,ADVERSE DRUG REACTION,7
NG,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,7
NG,DRUG ABUSE,7
NG,EXPOSURE DURING PREGNANCY,7
NG,MALIGNANT NEOPLASM PROGRESSION,7
NG,SEPSIS,7
NG,SOMNOLENCE,7
NG,TOXICITY TO VARIOUS AGENTS,7
NG,VIRAL LOAD INCREASED,7
NG,AGGRESSION,6
NG,CHRONIC MYELOID LEUKAEMIA,6
NG,DEPRESSION,6
NG,DISEASE PROGRESSION,6
NG,HAEMATOCRIT DECREASED,6
NG,HYPERHIDROSIS,6
NG,HYPOTENSION,6
NG,NEUTROPENIA,6
NG,PULMONARY EMBOLISM,6
NG,TREATMENT FAILURE,6
NG,ABDOMINAL PAIN,5
NG,CHEST DISCOMFORT,5
NG,CHEST PAIN,5
NG,COUGH,5
NG,DRUG DEPENDENCE,5
NG,DYSPEPSIA,5
NG,HEPATOMEGALY,5
NG,HYPERTENSION,5
NG,ILL-DEFINED DISORDER,5
NG,MICROSPORIDIA INFECTION,5
NG,PNEUMONIA,5
NG,PREMATURE BABY,5
NG,PRURITUS,5
NG,RESPIRATORY DISTRESS,5
NG,TACHYCARDIA,5
NG,THERAPY NON-RESPONDER,5
NG,VOMITING,5
NG,ABDOMINAL DISCOMFORT,4
NG,ABDOMINAL PAIN UPPER,4
NG,ACUTE KIDNEY INJURY,4
NG,ANXIETY,4
NG,CONVULSION,4
NG,DEEP VEIN THROMBOSIS,4
NG,FACTOR VIII INHIBITION,4
NG,HAEMOPTYSIS,4
NG,HEPATITIS B SURFACE ANTIGEN POSITIVE,4
NG,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,4
NG,LIVE BIRTH,4
NG,MEMORY IMPAIRMENT,4
NG,MUSCLE SPASMS,4
NG,NAUSEA,4
NG,NO THERAPEUTIC RESPONSE,4
NG,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,4
NG,PANCYTOPENIA,4
NG,PERIPHERAL SWELLING,4
NG,RASH,4
NG,SPLENOMEGALY,4
NG,SUDDEN DEATH,4
NG,URINARY RETENTION,4
NG,ACCIDENTAL OVERDOSE,3
NG,ANAPHYLACTIC SHOCK,3
NG,ANGIOEDEMA,3
NG,BACK PAIN,3
NG,BLINDNESS,3
NG,BLISTER,3
NG,BODY TEMPERATURE INCREASED,3
NG,BONE MARROW FAILURE,3
NG,CYTOMEGALOVIRUS INFECTION,3
NG,DECREASED APPETITE,3
NG,DIARRHOEA,3
NG,DISORIENTATION,3
NG,DIVERTICULUM,3
NG,FALL,3
NG,GAIT DISTURBANCE,3
NG,HAEMATEMESIS,3
NG,HAEMORRHAGE,3
NG,HEARING IMPAIRED,3
NG,HISTIOCYTOSIS HAEMATOPHAGIC,3
NG,HYPOGLYCAEMIA,3
NG,HYPOXIA,3
NG,INCORRECT DRUG ADMINISTRATION DURATION,3
NG,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
NG,JAUNDICE,3
NG,LOCAL SWELLING,3
NG,MUSCLE RIGIDITY,3
NG,MYELOPATHY,3
NG,OEDEMA PERIPHERAL,3
NG,OTOTOXICITY,3
NG,PAIN IN EXTREMITY,3
NG,PLATELET COUNT DECREASED,3
NG,PREMATURE DELIVERY,3
NG,PRODUCT USE ISSUE,3
NG,RESTLESSNESS,3
NG,SOMATIC SYMPTOM DISORDER,3
NG,SPEECH DISORDER,3
NG,SWELLING,3
NG,VISION BLURRED,3
NG,VITILIGO,3
NG,WEIGHT DECREASED,3
NG,WEIGHT INCREASED,3
NG,ABASIA,2
NG,ABDOMINAL MASS,2
NG,ABORTION SPONTANEOUS,2
NG,ALANINE AMINOTRANSFERASE INCREASED,2
NG,ALTERED STATE OF CONSCIOUSNESS,2
NG,ANGER,2
NG,ARTHRALGIA,2
NG,ASCITES,2
NG,ASTHMA,2
NG,AZOTAEMIA,2
NG,BACTERIAL INFECTION,2
NG,BLOOD BILIRUBIN INCREASED,2
NG,BLOOD COUNT ABNORMAL,2
NG,BLOOD CREATININE INCREASED,2
NG,BREAST MASS,2
NG,CARDIAC ANEURYSM,2
NG,CARDIAC ARREST,2
NG,CARDIAC VENTRICULAR THROMBOSIS,2
NG,CARDIO-RESPIRATORY ARREST,2
NG,CARDIOMEGALY,2
NG,CATARRH,2
NG,COMA,2
NG,CONDITION AGGRAVATED,2
NG,CONFUSIONAL STATE,2
NG,CYANOSIS,2
NG,CYTOPENIA,2
NG,DEAFNESS,2
NG,DEAFNESS BILATERAL,2
NG,DEHYDRATION,2
NG,DIPLOPIA,2
NG,DISCOMFORT,2
NG,DRUG-INDUCED LIVER INJURY,2
NG,DYSGEUSIA,2
NG,DYSKINESIA,2
NG,DYSPHAGIA,2
NG,DYSTONIA,2
NG,ENDOPHTHALMITIS,2
NG,EUPHORIC MOOD,2
NG,FATIGUE,2
NG,FEELING ABNORMAL,2
NG,FORMICATION,2
NG,GAIT INABILITY,2
NG,GENERALISED OEDEMA,2
NG,HAEMATURIA,2
NG,HEAD DISCOMFORT,2
NG,HEART RATE INCREASED,2
NG,HEPATIC ENZYME ABNORMAL,2
NG,HYPERSENSITIVITY,2
NG,HYPERTENSIVE HEART DISEASE,2
NG,HYPOACUSIS,2
NG,HYPONATRAEMIA,2
NG,INCOHERENT,2
NG,INFLAMMATION,2
NG,INTESTINAL OBSTRUCTION,2
NG,KERATITIS,2
NG,KIDNEY TRANSPLANT REJECTION,2
NG,LEFT VENTRICULAR DYSFUNCTION,2
NG,LOSS OF LIBIDO,2
NG,METABOLIC ACIDOSIS,2
NG,MOUTH HAEMORRHAGE,2
NG,MUSCULAR WEAKNESS,2
NG,MYOCARDIAL INFARCTION,2
NG,OLIGURIA,2
NG,OROPHARYNGEAL PAIN,2
NG,PEPTIC ULCER,2
NG,PLEURAL EFFUSION,2
NG,PNEUMONITIS,2
NG,PREGNANCY WITH IMPLANT CONTRACEPTIVE,2
NG,PREMATURE LABOUR,2
NG,PRURITUS GENERALISED,2
NG,PULMONARY FIBROSIS,2
NG,PULMONARY TUBERCULOSIS,2
NG,RASH MACULO-PAPULAR,2
NG,RENAL FAILURE,2
NG,RENAL FAILURE ACUTE,2
NG,STATUS EPILEPTICUS,2
NG,SUBCUTANEOUS EMPHYSEMA,2
NG,SUICIDE ATTEMPT,2
NG,TALIPES,2
NG,TARDIVE DYSKINESIA,2
NG,THROAT IRRITATION,2
NG,TONGUE DISORDER,2
NG,TONGUE MOVEMENT DISTURBANCE,2
NG,TORTICOLLIS,2
NG,TRISOMY 21,2
NG,TUBERCULOSIS,2
NG,UNEVALUABLE EVENT,2
NG,UPPER GASTROINTESTINAL HAEMORRHAGE,2
NG,URINARY TRACT INFECTION BACTERIAL,2
NG,VERTIGO,2
NG,VISUAL IMPAIRMENT,2
NG,WHEEZING,2
NG,ABDOMINAL ABSCESS,1
NG,ABDOMINAL DISTENSION,1
NG,ABNORMAL BEHAVIOUR,1
NG,ACCIDENT AT HOME,1
NG,ACQUIRED IMMUNODEFICIENCY SYNDROME,1
NG,ACUTE GRAFT VERSUS HOST DISEASE,1
NG,ACUTE HEPATIC FAILURE,1
NG,ACUTE LYMPHOCYTIC LEUKAEMIA,1
NG,ACUTE PSYCHOSIS,1
NG,ALANINE AMINOTRANSFERASE ABNORMAL,1
NG,ALOPECIA,1
NG,AMNESIA,1
NG,ANAL INCONTINENCE,1
NG,ANAPHYLACTIC REACTION,1
NG,ANORECTAL DISCOMFORT,1
NG,APLASTIC ANAEMIA,1
NG,ARACHNODACTYLY,1
NG,ARTERIAL INJURY,1
NG,ARTHROPATHY,1
NG,ASTERIXIS,1
NG,ASTHENOPIA,1
NG,ASTHMATIC CRISIS,1
NG,ATRIOVENTRICULAR BLOCK COMPLETE,1
NG,AURA,1
NG,AXONAL NEUROPATHY,1
NG,BLEPHARITIS,1
NG,BLINDNESS CORTICAL,1
NG,BLOOD ALBUMIN INCREASED,1
NG,BLOOD CHOLESTEROL INCREASED,1
NG,BLOOD DISORDER,1
NG,BLOOD GLUCOSE INCREASED,1
NG,BLOOD PRESSURE DECREASED,1
NG,BLOOD PRESSURE INCREASED,1
NG,BLOOD THYROID STIMULATING HORMONE DECREASED,1
NG,BLOOD TRIGLYCERIDES INCREASED,1
NG,BLOOD UREA INCREASED,1
NG,BLOOD URINE PRESENT,1
NG,BRAIN DEATH,1
NG,BREAST CANCER,1
NG,BREAST PAIN,1
NG,BRIEF PSYCHOTIC DISORDER_ WITH POSTPARTUM ONSET,1
NG,BRONCHIECTASIS,1
NG,BURNING SENSATION,1
NG,CARDIAC FAILURE,1
NG,CARDIAC FAILURE ACUTE,1
NG,CARDIAC FAILURE CHRONIC,1
NG,CARDIOPULMONARY FAILURE,1
NG,CEREBRAL ATROPHY,1
NG,CEREBRAL DISORDER,1
NG,CEREBRAL HAEMORRHAGE,1
NG,CEREBRAL INFARCTION,1
NG,CEREBRAL TOXOPLASMOSIS,1
NG,CHEILITIS,1
NG,CHILLS,1
NG,CHOKING,1
NG,CHOROIDAL HAEMORRHAGE,1
NG,CHRONIC RESPIRATORY DISEASE,1
NG,CIRCULATORY COLLAPSE,1
NG,COAGULOPATHY,1
NG,COGNITIVE DISORDER,1
NG,COGWHEEL RIGIDITY,1
NG,COMMUNICATION DISORDER,1
NG,COMPLEX PARTIAL SEIZURES,1
NG,CONGENITAL EYE DISORDER,1
NG,CONGENITAL HAND MALFORMATION,1
NG,CONGENITAL HEPATOMEGALY,1
NG,CONTRAST MEDIA ALLERGY,1
NG,CONVERSION DISORDER,1
NG,CREPITATIONS,1
NG,CYSTITIS HAEMORRHAGIC,1
NG,DEAFNESS NEUROSENSORY,1
NG,DEATH NEONATAL,1
NG,DELUSION,1
NG,DEPRESSED MOOD,1
NG,DERMATOMYOSITIS,1
NG,DEVICE DIFFICULT TO USE,1
NG,DEVICE DISLOCATION,1
NG,DIASTOLIC DYSFUNCTION,1
NG,DILATATION VENTRICULAR,1
NG,DISEASE RECURRENCE,1
NG,DISSEMINATED CYTOMEGALOVIRAL INFECTION,1
NG,DISSEMINATED INTRAVASCULAR COAGULATION,1
NG,DRUG ERUPTION,1
NG,DRUG HYPERSENSITIVITY,1
NG,DRUG WITHDRAWAL CONVULSIONS,1
NG,DRY MOUTH,1
NG,DRY SKIN,1
NG,DYSARTHRIA,1
NG,DYSGRAPHIA,1
NG,DYSMORPHISM,1
NG,DYSPNOEA PAROXYSMAL NOCTURNAL,1
NG,ECTOPIC PREGNANCY,1
NG,EJACULATION DELAYED,1
NG,EMBOLISM,1
NG,EMBOLISM VENOUS,1
NG,END STAGE RENAL DISEASE,1
NG,ENTEROCOCCUS TEST POSITIVE,1
NG,ERECTILE DYSFUNCTION,1
NG,ERYTHEMA MULTIFORME,1
NG,EXCORIATION,1
NG,EXECUTIVE DYSFUNCTION,1
NG,EXPOSURE DURING BREAST FEEDING,1
NG,EYE DISORDER,1
NG,EYE IRRITATION,1
NG,EYE PAIN,1
NG,FACE OEDEMA,1
NG,FAECAL INCONTINENCE,1
NG,FALSE LABOUR,1
NG,FIBROADENOMA OF BREAST,1
NG,FIBROCYSTIC BREAST DISEASE,1
NG,FLUID RETENTION,1
NG,FOETAL DISTRESS SYNDROME,1
NG,FOLLICULITIS,1
NG,FULL BLOOD COUNT DECREASED,1
NG,FUNGAL INFECTION,1
NG,FURUNCLE,1
NG,GASTROENTERITIS,1
NG,GASTROINTESTINAL DISORDER,1
NG,GASTROINTESTINAL PAIN,1
NG,GASTROINTESTINAL STROMAL TUMOUR,1
NG,GENERAL PHYSICAL HEALTH DETERIORATION,1
NG,GLOMERULAR FILTRATION RATE DECREASED,1
NG,GRAFT DYSFUNCTION,1
NG,GRAND MAL CONVULSION,1
NG,GYNAECOMASTIA,1
NG,HAEMATOTOXICITY,1
NG,HAEMODIALYSIS COMPLICATION,1
NG,HAEMOLYSIS,1
NG,HAEMORRHAGE IN PREGNANCY,1
NG,HAEMOTHORAX,1
NG,HEAD INJURY,1
NG,HELLP SYNDROME,1
NG,HEMIPARESIS,1
NG,HEPATIC ENZYME INCREASED,1
NG,HEPATIC FAILURE,1
NG,HEPATIC NEOPLASM,1
NG,HEPATITIS B DNA INCREASED,1
NG,HEPATOCELLULAR CARCINOMA,1
NG,HEPATOTOXICITY,1
NG,HIGH DENSITY LIPOPROTEIN DECREASED,1
NG,HYPERKALAEMIA,1
NG,HYPERTONIA,1
NG,HYPHAEMA,1
NG,HYPOALBUMINAEMIA,1
NG,HYPOPROTEINAEMIA,1
NG,IDIOSYNCRATIC DRUG REACTION,1
NG,IMPAIRED WORK ABILITY,1
NG,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
NG,INFECTION,1
NG,INTENTIONAL OVERDOSE,1
NG,INTESTINAL ULCER,1
NG,INTRACRANIAL PRESSURE INCREASED,1
NG,INTRAVENTRICULAR HAEMORRHAGE,1
NG,INVASIVE DUCTAL BREAST CARCINOMA,1
NG,ISCHAEMIC STROKE,1
NG,JAUNDICE HEPATOCELLULAR,1
NG,JOINT SWELLING,1
NG,KERATIC PRECIPITATES,1
NG,KLEBSIELLA INFECTION,1
NG,LACRIMATION INCREASED,1
NG,LACTIC ACIDOSIS,1
NG,LEFT ATRIAL HYPERTROPHY,1
NG,LEFT VENTRICULAR HYPERTROPHY,1
NG,LEUKAEMIA,1
NG,LEUKAEMIA RECURRENT,1
NG,LEUKOPENIA,1
NG,LIBIDO DECREASED,1
NG,LIP SWELLING,1
NG,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
NG,LOW DENSITY LIPOPROTEIN INCREASED,1
NG,LOWER GASTROINTESTINAL HAEMORRHAGE,1
NG,LUNG DISORDER,1
NG,LYMPHADENITIS,1
NG,LYMPHADENOPATHY,1
NG,MALARIA,1
NG,MASKED FACIES,1
NG,MATERNAL DEATH DURING CHILDBIRTH,1
NG,MATERNAL EXPOSURE DURING PREGNANCY,1
NG,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
NG,MEDICAL DEVICE COMPLICATION,1
NG,MEDICATION ERROR,1
NG,MELAENA,1
NG,MENINGITIS,1
NG,MENORRHAGIA,1
NG,MENSTRUAL DISORDER,1
NG,METASTASES TO LIVER,1
NG,METASTASES TO LYMPH NODES,1
NG,MULTI-ORGAN FAILURE,1
NG,MYALGIA,1
NG,NAIL BED DISORDER,1
NG,NASAL DISCOMFORT,1
NG,NASAL DISORDER,1
NG,NASOPHARYNGITIS,1
NG,NECROTISING FASCIITIS,1
NG,NEGATIVISM,1
NG,NEOPLASM PROGRESSION,1
NG,NEPHROTIC SYNDROME,1
NG,NEURITIS,1
NG,NEUROLOGICAL SYMPTOM,1
NG,NEUROPATHY PERIPHERAL,1
NG,NEUTROPHILIA,1
NG,NIPPLE EXUDATE BLOODY,1
NG,NODULE,1
NG,OCULAR HYPERAEMIA,1
NG,OCULAR ICTERUS,1
NG,OEDEMA MOUTH,1
NG,OPISTHOTONUS,1
NG,ORAL CANDIDIASIS,1
NG,ORAL PAIN,1
NG,ORTHOPNOEA,1
NG,ORTHOSTATIC HYPOTENSION,1
NG,OSTEOPENIA,1
NG,OVARIAN CYST,1
NG,PALLOR,1
NG,PALMOMENTAL REFLEX,1
NG,PARAPARESIS,1
NG,PARTIAL SEIZURES,1
NG,PERICARDIAL EFFUSION,1
NG,PERINEAL INJURY,1
NG,PETECHIAE,1
NG,PNEUMONIA ASPIRATION,1
NG,PNEUMONIA ESCHERICHIA,1
NG,PNEUMONIA PNEUMOCOCCAL,1
NG,POLYURIA,1
NG,POST PROCEDURAL HAEMORRHAGE,1
NG,POSTERIOR CAPSULE OPACIFICATION,1
NG,POSTPARTUM HAEMORRHAGE,1
NG,PREGNANCY,1
NG,PREGNANCY TEST URINE POSITIVE,1
NG,PREMATURE SEPARATION OF PLACENTA,1
NG,PROCEDURAL COMPLICATION,1
NG,PROCEDURAL HAEMORRHAGE,1
NG,PROCEDURAL HYPOTENSION,1
NG,PRODUCT AVAILABILITY ISSUE,1
NG,PRODUCT CONTAMINATION,1
NG,PRODUCT USE IN UNAPPROVED INDICATION,1
NG,PRODUCTIVE COUGH,1
NG,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
NG,PROTEIN TOTAL INCREASED,1
NG,PROTEINURIA,1
NG,PSYCHOTIC DISORDER,1
NG,PULMONARY HAEMORRHAGE,1
NG,PULMONARY HYPERTENSION,1
NG,PULMONARY OEDEMA,1
NG,QUADRIPARESIS,1
NG,RASH PAPULAR,1
NG,READING DISORDER,1
NG,RECTAL HAEMORRHAGE,1
NG,RECURRENT CANCER,1
NG,RENAL DISORDER,1
NG,RENAL IMPAIRMENT,1
NG,RESPIRATORY DEPRESSION,1
NG,RESPIRATORY FAILURE,1
NG,RESTING TREMOR,1
NG,ROAD TRAFFIC ACCIDENT,1
NG,RUPTURED CEREBRAL ANEURYSM,1
NG,SALIVARY HYPERSECRETION,1
NG,SALMONELLA SEPSIS,1
NG,SEDATION,1
NG,SELF-MEDICATION,1
NG,SEPTIC SHOCK,1
NG,SICKLE CELL ANAEMIA WITH CRISIS,1
NG,SKIN DISCOLOURATION,1
NG,SKIN SWELLING,1
NG,SLEEP APNOEA SYNDROME,1
NG,SLEEP DISORDER,1
NG,SNORING,1
NG,SPERM CONCENTRATION INCREASED,1
NG,SPUTUM INCREASED,1
NG,STAPHYLOCOCCAL INFECTION,1
NG,STAPHYLOCOCCUS TEST POSITIVE,1
NG,STATUS ASTHMATICUS,1
NG,STEM CELL TRANSPLANT,1
NG,STILL^S DISEASE ADULT ONSET,1
NG,STOMATITIS,1
NG,SUBARACHNOID HAEMORRHAGE,1
NG,SUBSTANCE ABUSE,1
NG,SURGERY,1
NG,SWELLING FACE,1
NG,SWOLLEN TONGUE,1
NG,SYNCOPE,1
NG,TACHYPNOEA,1
NG,THERAPY CESSATION,1
NG,THROMBOPHLEBITIS,1
NG,TINNITUS,1
NG,TOXIC EPIDERMAL NECROLYSIS,1
NG,TRANSPLANT REJECTION,1
NG,TRICUSPID VALVE INCOMPETENCE,1
NG,TYPHOID FEVER,1
NG,ULTRASOUND ABDOMEN,1
NG,URINARY INCONTINENCE,1
NG,URINARY TRACT INFECTION,1
NG,URINARY TRACT INFECTION ENTEROCOCCAL,1
NG,URINE OUTPUT DECREASED,1
NG,UROGENITAL FISTULA,1
NG,UROSEPSIS,1
NG,UTERINE ATONY,1
NG,UTERINE LEIOMYOMA,1
NG,VERY LOW DENSITY LIPOPROTEIN INCREASED,1
NG,VISUAL ACUITY REDUCED,1
NG,VITREOUS FLOATERS,1
NG,VITRITIS,1
NG,VOMITING PROJECTILE,1
NG,VULVOVAGINAL BURNING SENSATION,1
NG,WHITE BLOOD CELL COUNT DECREASED,1
NG,WHITE BLOOD CELL COUNT INCREASED,1
NG,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
NO,TOXICITY TO VARIOUS AGENTS,342
NO,DYSPNOEA,321
NO,NAUSEA,306
NO,FATIGUE,289
NO,PYREXIA,289
NO,DIZZINESS,260
NO,DRUG INEFFECTIVE,250
NO,DIARRHOEA,249
NO,HEADACHE,232
NO,DEATH,223
NO,FEBRILE NEUTROPENIA,214
NO,EXPOSURE VIA FATHER,190
NO,SMALL FOR DATES BABY,188
NO,ABORTION SPONTANEOUS,180
NO,FOETAL EXPOSURE DURING PREGNANCY,173
NO,OSTEONECROSIS OF JAW,170
NO,MALAISE,165
NO,VOMITING,161
NO,HAEMATOTOXICITY,159
NO,RENAL FAILURE,156
NO,PNEUMONIA,155
NO,DEPRESSION,150
NO,GENERAL PHYSICAL HEALTH DETERIORATION,149
NO,RASH,147
NO,ANXIETY,145
NO,MYALGIA,141
NO,PAIN,139
NO,OVERDOSE,133
NO,SEPSIS,132
NO,ARTHRALGIA,126
NO,ABDOMINAL PAIN UPPER,122
NO,INFECTION,119
NO,CONFUSIONAL STATE,116
NO,THROMBOCYTOPENIA,115
NO,ABDOMINAL PAIN,113
NO,ACUTE KIDNEY INJURY,110
NO,HYPOTENSION,110
NO,MATERNAL EXPOSURE DURING PREGNANCY,110
NO,ASTHENIA,109
NO,NEUTROPENIA,108
NO,SUICIDAL IDEATION,108
NO,ANAEMIA,103
NO,WEIGHT DECREASED,103
NO,OSTEITIS,101
NO,RESTLESSNESS,100
NO,CEREBRAL HAEMORRHAGE,98
NO,DECREASED APPETITE,96
NO,PARAESTHESIA,96
NO,SOMNOLENCE,96
NO,WEIGHT INCREASED,96
NO,PAIN IN EXTREMITY,95
NO,PREGNANCY,95
NO,PRURITUS,94
NO,FALL,92
NO,MEMORY IMPAIRMENT,90
NO,CARDIAC FAILURE,89
NO,DRUG ABUSE,89
NO,EXPOSURE DURING PREGNANCY,88
NO,INSOMNIA,88
NO,CHILLS,87
NO,CHEST PAIN,85
NO,LOSS OF CONSCIOUSNESS,85
NO,TREMOR,85
NO,LACTIC ACIDOSIS,82
NO,OSTEONECROSIS,82
NO,PALPITATIONS,82
NO,HYPERTENSION,79
NO,MUSCULOSKELETAL STIFFNESS,79
NO,BACK PAIN,78
NO,DISTURBANCE IN ATTENTION,78
NO,DISEASE PROGRESSION,77
NO,GAIT DISTURBANCE,77
NO,HYPERHIDROSIS,77
NO,MUSCLE SPASMS,77
NO,ATRIAL FIBRILLATION,76
NO,DEHYDRATION,75
NO,PULMONARY EMBOLISM,75
NO,VISUAL IMPAIRMENT,75
NO,CARDIAC ARREST,74
NO,DRUG DEPENDENCE,74
NO,TACHYCARDIA,73
NO,DYSARTHRIA,72
NO,CONDITION AGGRAVATED,71
NO,SYNCOPE,69
NO,COUGH,68
NO,MUSCULAR WEAKNESS,68
NO,RESPIRATORY FAILURE,67
NO,ERYTHEMA,66
NO,HYPERSENSITIVITY,66
NO,ANAPHYLACTIC REACTION,65
NO,HYPOAESTHESIA,65
NO,SEIZURE,65
NO,CEREBRAL INFARCTION,63
NO,URINARY TRACT INFECTION,62
NO,BONE MARROW FAILURE,60
NO,CONSTIPATION,60
NO,POLYNEUROPATHY,60
NO,TINNITUS,60
NO,MYOCARDIAL INFARCTION,59
NO,FEELING ABNORMAL,58
NO,URTICARIA,58
NO,BLOOD CREATININE INCREASED,56
NO,BALANCE DISORDER,53
NO,ALANINE AMINOTRANSFERASE INCREASED,52
NO,AGGRESSION,51
NO,LEUKOPENIA,51
NO,NEUROPATHY PERIPHERAL,51
NO,PRODUCT USE ISSUE,51
NO,INTERSTITIAL LUNG DISEASE,50
NO,RHABDOMYOLYSIS,49
NO,AMNESIA,48
NO,C-REACTIVE PROTEIN INCREASED,48
NO,COGNITIVE DISORDER,48
NO,COLD SWEAT,47
NO,DRY MOUTH,47
NO,DYSPHAGIA,47
NO,EPISTAXIS,46
NO,PRODUCT USE IN UNAPPROVED INDICATION,46
NO,CEREBROVASCULAR ACCIDENT,45
NO,VISION BLURRED,45
NO,BLOOD CREATINE PHOSPHOKINASE INCREASED,44
NO,COLITIS,44
NO,LISTLESS,44
NO,RENAL IMPAIRMENT,44
NO,EPILEPSY,43
NO,TRANSAMINASES INCREASED,43
NO,BRADYCARDIA,42
NO,HEPATIC FAILURE,42
NO,MEDICATION ERROR,42
NO,AGITATION,41
NO,HAEMOGLOBIN DECREASED,41
NO,HAEMORRHAGE,41
NO,HEPATIC ENZYME INCREASED,41
NO,IRRITABILITY,41
NO,PANCYTOPENIA,41
NO,PSYCHOTIC DISORDER,41
NO,ALOPECIA,40
NO,HEART RATE INCREASED,39
NO,HYPOGLYCAEMIA,39
NO,CHEST DISCOMFORT,38
NO,HALLUCINATION,38
NO,MALIGNANT NEOPLASM PROGRESSION,38
NO,SLEEP DISORDER,38
NO,VENOOCCLUSIVE DISEASE,38
NO,ASPARTATE AMINOTRANSFERASE INCREASED,37
NO,BLOOD PRESSURE INCREASED,37
NO,GASTROINTESTINAL HAEMORRHAGE,37
NO,HYPONATRAEMIA,37
NO,MANIA,37
NO,OROPHARYNGEAL PAIN,37
NO,ANGIOEDEMA,36
NO,DEEP VEIN THROMBOSIS,36
NO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,36
NO,MUSCLE TWITCHING,36
NO,OEDEMA PERIPHERAL,36
NO,RASH GENERALISED,36
NO,ASTHMA,35
NO,BONE PAIN,35
NO,DYSKINESIA,35
NO,MENTAL DISORDER,35
NO,OBLITERATIVE BRONCHIOLITIS,35
NO,DYSPEPSIA,34
NO,HYPOKALAEMIA,34
NO,INCORRECT DOSE ADMINISTERED,34
NO,NEUROLEPTIC MALIGNANT SYNDROME,34
NO,QUALITY OF LIFE DECREASED,34
NO,THROAT TIGHTNESS,34
NO,FEMUR FRACTURE,33
NO,PNEUMOCYSTIS JIROVECII PNEUMONIA,33
NO,PNEUMONITIS,33
NO,SPEECH DISORDER,33
NO,CIRCULATORY COLLAPSE,32
NO,COMPLETED SUICIDE,32
NO,CONGENITAL ANOMALY,32
NO,FLATULENCE,32
NO,HEPATITIS,32
NO,SWELLING,32
NO,AGRANULOCYTOSIS,31
NO,CYTOMEGALOVIRUS INFECTION,31
NO,DRUG EFFECT DECREASED,31
NO,INFUSION RELATED REACTION,31
NO,LETHARGY,31
NO,PLEURAL EFFUSION,31
NO,PSORIASIS,31
NO,SEDATION,31
NO,ARRHYTHMIA,30
NO,BLOOD BILIRUBIN INCREASED,30
NO,DRUG DIVERSION,30
NO,HYPOMAGNESAEMIA,30
NO,INFLUENZA LIKE ILLNESS,30
NO,URINARY RETENTION,30
NO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,29
NO,CYANOSIS,29
NO,DEAFNESS,29
NO,HYPERKALAEMIA,29
NO,IMPAIRED WORK ABILITY,29
NO,INCORRECT ROUTE OF DRUG ADMINISTRATION,29
NO,INTERNATIONAL NORMALISED RATIO INCREASED,29
NO,PERSONALITY CHANGE,29
NO,RECTAL HAEMORRHAGE,29
NO,RESPIRATORY ARREST,29
NO,BLOOD PRESSURE DECREASED,28
NO,EXPOSURE DURING BREAST FEEDING,28
NO,FEELING HOT,28
NO,ILEUS,28
NO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,28
NO,INTENTIONAL PRODUCT MISUSE,28
NO,SUDDEN DEATH,28
NO,SUICIDE ATTEMPT,28
NO,ASCITES,27
NO,CHRONIC GRAFT VERSUS HOST DISEASE,27
NO,DISCOMFORT,27
NO,MENTAL IMPAIRMENT,27
NO,MULTI-ORGAN FAILURE,27
NO,NECK PAIN,27
NO,WHITE BLOOD CELL COUNT DECREASED,27
NO,ABDOMINAL DISCOMFORT,26
NO,ACUTE MYOCARDIAL INFARCTION,26
NO,ANAPHYLACTIC SHOCK,26
NO,DEPRESSED LEVEL OF CONSCIOUSNESS,26
NO,DRUG WITHDRAWAL SYNDROME NEONATAL,26
NO,HYPOXIA,26
NO,INCORRECT DRUG ADMINISTRATION DURATION,26
NO,MOUTH ULCERATION,26
NO,PARALYSIS,26
NO,RASH PRURITIC,26
NO,THROMBOSIS,26
NO,ABNORMAL BEHAVIOUR,25
NO,ACCIDENTAL OVERDOSE,25
NO,DELIRIUM,25
NO,DRUG EFFECT INCOMPLETE,25
NO,EYE PAIN,25
NO,HERPES ZOSTER,25
NO,HOT FLUSH,25
NO,JOINT SWELLING,25
NO,PERIPHERAL SWELLING,25
NO,PHOTOPHOBIA,25
NO,STOMATITIS,25
NO,SUDDEN UNEXPLAINED DEATH IN EPILEPSY,25
NO,APHASIA,24
NO,BRONCHOSPASM,24
NO,DELUSION,24
NO,INTRACRANIAL VENOUS SINUS THROMBOSIS,24
NO,NIGHTMARE,24
NO,PNEUMOCYSTIS JIROVECII INFECTION,24
NO,SEROTONIN SYNDROME,24
NO,SWELLING FACE,24
NO,VISUAL ACUITY REDUCED,24
NO,ACUTE RESPIRATORY DISTRESS SYNDROME,23
NO,APATHY,23
NO,ATAXIA,23
NO,DEPRESSED MOOD,23
NO,DYSGEUSIA,23
NO,ECZEMA,23
NO,MIGRAINE,23
NO,PREMATURE BABY,23
NO,PRODUCT SUBSTITUTION ISSUE,23
NO,TRANSIENT ISCHAEMIC ATTACK,23
NO,WRONG DRUG ADMINISTERED,23
NO,COMA,22
NO,DIABETIC KETOACIDOSIS,22
NO,DRUG LEVEL INCREASED,22
NO,DUODENAL ULCER,22
NO,GENERALISED TONIC-CLONIC SEIZURE,22
NO,JAUNDICE,22
NO,MOTOR DYSFUNCTION,22
NO,MUSCLE RIGIDITY,22
NO,OEDEMA,22
NO,OXYGEN SATURATION DECREASED,22
NO,PARKINSON^S DISEASE,22
NO,RENAL FAILURE ACUTE,22
NO,ANGINA PECTORIS,21
NO,CLEFT LIP AND PALATE,21
NO,DEVICE DIFFICULT TO USE,21
NO,DEVICE DISLOCATION,21
NO,HEAD DISCOMFORT,21
NO,HYPOTHERMIA,21
NO,KETOACIDOSIS,21
NO,LEUKOCYTOSIS,21
NO,NASOPHARYNGITIS,21
NO,PLATELET COUNT DECREASED,21
NO,TORSADE DE POINTES,21
NO,ACTIVITIES OF DAILY LIVING IMPAIRED,20
NO,CONTUSION,20
NO,CONVULSION,20
NO,DIPLOPIA,20
NO,FLUSHING,20
NO,MUSCULOSKELETAL PAIN,20
NO,OSTEOPOROSIS,20
NO,SEPTIC SHOCK,20
NO,SWOLLEN TONGUE,20
NO,WITHDRAWAL SYNDROME,20
NO,WOUND,20
NO,BLINDNESS,19
NO,BLOOD GLUCOSE INCREASED,19
NO,DRUG-INDUCED LIVER INJURY,19
NO,GAMMA-GLUTAMYLTRANSFERASE INCREASED,19
NO,HAEMATEMESIS,19
NO,HAEMATURIA,19
NO,HYPERAESTHESIA,19
NO,HYPOGAMMAGLOBULINAEMIA,19
NO,NERVOUS SYSTEM DISORDER,19
NO,PULMONARY FIBROSIS,19
NO,RHEUMATOID ARTHRITIS,19
NO,TARDIVE DYSKINESIA,19
NO,BIPOLAR DISORDER,18
NO,BURNING SENSATION,18
NO,CONGESTIVE CARDIOMYOPATHY,18
NO,DRUG WITHDRAWAL SYNDROME,18
NO,FACE OEDEMA,18
NO,HEPATIC STEATOSIS,18
NO,HYPERVENTILATION,18
NO,LUNG DISORDER,18
NO,LUNG INFILTRATION,18
NO,PRESCRIBED OVERDOSE,18
NO,PROCEDURAL PAIN,18
NO,SINUSITIS,18
NO,ABORTION INDUCED,17
NO,ACUTE HEPATIC FAILURE,17
NO,CARDIOMYOPATHY,17
NO,DEPRESSIVE SYMPTOM,17
NO,DISSEMINATED INTRAVASCULAR COAGULATION,17
NO,EXPOSED BONE IN JAW,17
NO,HYPOTHYROIDISM,17
NO,INFLAMMATION,17
NO,INTENTIONAL SELF-INJURY,17
NO,LUNG INFECTION,17
NO,METABOLIC ACIDOSIS,17
NO,MUCOSAL INFLAMMATION,17
NO,OCULAR HYPERAEMIA,17
NO,STRESS,17
NO,SUBDURAL HAEMATOMA,17
NO,THERAPEUTIC RESPONSE DECREASED,17
NO,THROAT IRRITATION,17
NO,ACIDOSIS,16
NO,ADVERSE EVENT,16
NO,BLISTER,16
NO,BRAIN INJURY,16
NO,BREAST CANCER,16
NO,CRYING,16
NO,DRUG RESISTANCE,16
NO,DUODENAL ULCER HAEMORRHAGE,16
NO,ERECTILE DYSFUNCTION,16
NO,HEPATOTOXICITY,16
NO,HYPOACUSIS,16
NO,LIVER FUNCTION TEST ABNORMAL,16
NO,LYMPHADENOPATHY,16
NO,MELAENA,16
NO,MULTIPLE SCLEROSIS,16
NO,MYOCARDITIS,16
NO,MYOCLONUS,16
NO,NEOPLASM RECURRENCE,16
NO,PAIN IN JAW,16
NO,PERICARDIAL EFFUSION,16
NO,PERICARDITIS,16
NO,PULMONARY OEDEMA,16
NO,RASH MACULO-PAPULAR,16
NO,SKIN DISORDER,16
NO,SLEEP APNOEA SYNDROME,16
NO,STATUS EPILEPTICUS,16
NO,UPPER RESPIRATORY TRACT INFECTION,16
NO,URINARY INCONTINENCE,16
NO,VAGINAL HAEMORRHAGE,16
NO,ABDOMINAL DISTENSION,15
NO,ABSCESS,15
NO,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,15
NO,CLOSTRIDIUM DIFFICILE INFECTION,15
NO,COLITIS ULCERATIVE,15
NO,DISORIENTATION,15
NO,DRUG INTOLERANCE,15
NO,DYSTONIA,15
NO,ENDOPHTHALMITIS,15
NO,FEELING COLD,15
NO,GASTRIC ULCER,15
NO,GASTROINTESTINAL DISORDER,15
NO,GRAND MAL CONVULSION,15
NO,HEPATITIS C,15
NO,HYPERSOMNIA,15
NO,IMMUNOSUPPRESSION,15
NO,IMPAIRED GASTRIC EMPTYING,15
NO,INTENTIONAL DRUG MISUSE,15
NO,INTENTIONAL OVERDOSE,15
NO,LIMB DISCOMFORT,15
NO,NEUTROPHIL COUNT DECREASED,15
NO,OSTEOMYELITIS,15
NO,PHOTOSENSITIVITY REACTION,15
NO,POISONING,15
NO,POOR QUALITY SLEEP,15
NO,PREMATURE DELIVERY,15
NO,SKIN EXFOLIATION,15
NO,SUBARACHNOID HAEMORRHAGE,15
NO,ACNE,14
NO,ANAPHYLACTOID REACTION,14
NO,BODY TEMPERATURE INCREASED,14
NO,CARCINOID TUMOUR OF THE STOMACH,14
NO,CROHN^S DISEASE,14
NO,DISTURBANCE IN SOCIAL BEHAVIOUR,14
NO,DRY EYE,14
NO,EMBOLISM,14
NO,FACIAL PARESIS,14
NO,GENERALISED OEDEMA,14
NO,HAEMATOMA,14
NO,HEAD TITUBATION,14
NO,HEART RATE DECREASED,14
NO,HYPOMANIA,14
NO,INFLUENZA,14
NO,IRIDOCYCLITIS,14
NO,METASTASES TO LUNG,14
NO,NASAL CONGESTION,14
NO,PANCREATITIS,14
NO,PANIC ATTACK,14
NO,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,14
NO,PULMONARY CONGESTION,14
NO,PULMONARY HYPERTENSION,14
NO,RESPIRATORY TRACT INFECTION,14
NO,VENTRICULAR TACHYCARDIA,14
NO,ADVERSE DRUG REACTION,13
NO,BREATH ODOUR,13
NO,CARDIOVASCULAR DISORDER,13
NO,CATARACT,13
NO,CHOLECYSTITIS,13
NO,DEREALISATION,13
NO,DIABETES MELLITUS,13
NO,DRUG ADMINISTRATION ERROR,13
NO,DRY SKIN,13
NO,DYSPHONIA,13
NO,DYSSTASIA,13
NO,DYSURIA,13
NO,GINGIVITIS,13
NO,HEART RATE IRREGULAR,13
NO,HEMIPARESIS,13
NO,HOSPITALISATION,13
NO,JUDGEMENT IMPAIRED,13
NO,LOGORRHOEA,13
NO,MALIGNANT MELANOMA,13
NO,MUCOUS MEMBRANE DISORDER,13
NO,MYELODYSPLASTIC SYNDROME,13
NO,MYOPATHY,13
NO,NEOPLASM MALIGNANT,13
NO,NEUROENDOCRINE TUMOUR,13
NO,OPTIC NEURITIS,13
NO,PARKINSONISM,13
NO,PERSONALITY DISORDER,13
NO,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,13
NO,PULMONARY TOXICITY,13
NO,SENSORY LOSS,13
NO,SINUS TACHYCARDIA,13
NO,TENSION,13
NO,UROSEPSIS,13
NO,WRONG TECHNIQUE IN DRUG USAGE PROCESS,13
NO,ADENOCARCINOMA OF COLON,12
NO,ALCOHOL ABUSE,12
NO,AMMONIA INCREASED,12
NO,BASAL CELL CARCINOMA,12
NO,COMPLICATION OF DEVICE INSERTION,12
NO,CONTRAST MEDIA REACTION,12
NO,DEAFNESS UNILATERAL,12
NO,DERMATITIS ALLERGIC,12
NO,DEVICE EXPULSION,12
NO,DISEASE RECURRENCE,12
NO,DRUG LEVEL DECREASED,12
NO,EATING DISORDER,12
NO,FACIAL ASYMMETRY,12
NO,FEMORAL NECK FRACTURE,12
NO,HAEMORRHAGIC ANAEMIA,12
NO,HEPATIC FIBROSIS,12
NO,HYPERGASTRINAEMIA,12
NO,HYPOAESTHESIA ORAL,12
NO,HYPOCALCAEMIA,12
NO,HYPOTONIA,12
NO,IMMUNE-MEDIATED NECROTISING MYOPATHY,12
NO,INCREASED APPETITE,12
NO,INTERCEPTED MEDICATION ERROR,12
NO,LIVER DISORDER,12
NO,MATERNAL EXPOSURE TIMING UNSPECIFIED,12
NO,MOBILITY DECREASED,12
NO,MULTIPLE SCLEROSIS RELAPSE,12
NO,MYELOPATHY,12
NO,NEUTROPHILIA,12
NO,PERIPHERAL COLDNESS,12
NO,PIGMENTATION DISORDER,12
NO,RASH ERYTHEMATOUS,12
NO,RENAL DISORDER,12
NO,RESPIRATORY DEPRESSION,12
NO,SENSORY DISTURBANCE,12
NO,SKIN REACTION,12
NO,STEVENS-JOHNSON SYNDROME,12
NO,TOOTHACHE,12
NO,TRICUSPID VALVE INCOMPETENCE,12
NO,TUMOUR HAEMORRHAGE,12
NO,UNEVALUABLE EVENT,12
NO,ACUTE MYELOID LEUKAEMIA,11
NO,AMENORRHOEA,11
NO,ANGER,11
NO,APLASTIC ANAEMIA,11
NO,ARTHRITIS,11
NO,ATRIOVENTRICULAR BLOCK,11
NO,BASEDOW^S DISEASE,11
NO,BLOOD ALKALINE PHOSPHATASE INCREASED,11
NO,CERVICAL DYSPLASIA,11
NO,CHROMATURIA,11
NO,CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY,11
NO,DERMATITIS,11
NO,DRUG EFFECT PROLONGED,11
NO,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,11
NO,DYSPNOEA EXERTIONAL,11
NO,ENTEROCHROMAFFIN CELL HYPERPLASIA,11
NO,ENTEROCOCCAL INFECTION,11
NO,ERYSIPELAS,11
NO,GASTROOESOPHAGEAL REFLUX DISEASE,11
NO,HAEMATOCHEZIA,11
NO,HEPATIC CIRRHOSIS,11
NO,HEPATIC ENCEPHALOPATHY,11
NO,HYPERACUSIS,11
NO,HYPERGLYCAEMIA,11
NO,INTENTIONAL PRODUCT USE ISSUE,11
NO,LYMPHOCYTE COUNT DECREASED,11
NO,METASTASIS,11
NO,MUSCLE TIGHTNESS,11
NO,MYOCARDIAL ISCHAEMIA,11
NO,NEOPLASM,11
NO,NIGHT SWEATS,11
NO,OBSTRUCTIVE AIRWAYS DISORDER,11
NO,OCULOGYRIC CRISIS,11
NO,OESOPHAGITIS,11
NO,PELVIC PAIN,11
NO,PHARYNGEAL OEDEMA,11
NO,PROSTATE CANCER,11
NO,RASH PUSTULAR,11
NO,REBOUND EFFECT,11
NO,RESPIRATORY DISTRESS,11
NO,STRONGYLOIDIASIS,11
NO,SUBSTANCE ABUSE,11
NO,SURGERY,11
NO,TACHYPNOEA,11
NO,TOOTH DISORDER,11
NO,ALTERED STATE OF CONSCIOUSNESS,10
NO,ATRIOVENTRICULAR BLOCK COMPLETE,10
NO,BLOOD LACTATE DEHYDROGENASE INCREASED,10
NO,BODY TEMPERATURE DECREASED,10
NO,CARDIAC FAILURE ACUTE,10
NO,COELIAC DISEASE,10
NO,COLON CANCER,10
NO,CONGENITAL PULMONARY HYPERTENSION,10
NO,CYTOPENIA,10
NO,DECREASED INTEREST,10
NO,DIARRHOEA HAEMORRHAGIC,10
NO,DRUG HYPERSENSITIVITY,10
NO,EOSINOPHILIA,10
NO,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,10
NO,FAECES DISCOLOURED,10
NO,FEAR,10
NO,FOOD CRAVING,10
NO,GASTRIC DISORDER,10
NO,GASTRITIS,10
NO,GENE MUTATION,10
NO,HALLUCINATION_ VISUAL,10
NO,HYPOSPADIAS,10
NO,LACRIMATION INCREASED,10
NO,LARGE INTESTINE PERFORATION,10
NO,LIVER FUNCTION TEST INCREASED,10
NO,LOW BIRTH WEIGHT BABY,10
NO,LUNG NEOPLASM MALIGNANT,10
NO,MENORRHAGIA,10
NO,METASTASES TO LIVER,10
NO,MOOD ALTERED,10
NO,MOVEMENT DISORDER,10
NO,MYOSITIS,10
NO,NASAL SEPTUM PERFORATION,10
NO,NERVOUSNESS,10
NO,NEUTROPENIC SEPSIS,10
NO,ORAL PAIN,10
NO,OSTEOARTHRITIS,10
NO,PANIC DISORDER,10
NO,PARAESTHESIA ORAL,10
NO,PARESIS,10
NO,PERITONITIS,10
NO,PNEUMONIA ASPIRATION,10
NO,PNEUMOTHORAX,10
NO,PNEUMOTHORAX SPONTANEOUS,10
NO,POLLAKIURIA,10
NO,POST PROCEDURAL HAEMORRHAGE,10
NO,PRESYNCOPE,10
NO,PRODUCT QUALITY ISSUE,10
NO,RESPIRATORY RATE INCREASED,10
NO,RHEUMATIC DISORDER,10
NO,SERUM FERRITIN INCREASED,10
NO,SHOULDER DEFORMITY,10
NO,SKIN INFECTION,10
NO,STILLBIRTH,10
NO,SUICIDAL BEHAVIOUR,10
NO,TENDONITIS,10
NO,TIC,10
NO,TOXIC EPIDERMAL NECROLYSIS,10
NO,TREATMENT FAILURE,10
NO,ULCER,10
NO,UNRESPONSIVE TO STIMULI,10
NO,VENTRICULAR SEPTAL DEFECT,10
NO,ACCIDENTAL EXPOSURE TO PRODUCT,9
NO,ACUTE RESPIRATORY FAILURE,9
NO,AKATHISIA,9
NO,BLOOD CHOLESTEROL INCREASED,9
NO,BURSITIS,9
NO,CARDIAC DISORDER,9
NO,CHOLELITHIASIS,9
NO,CLOSTRIDIUM COLITIS,9
NO,COMA SCALE ABNORMAL,9
NO,DEATH NEONATAL,9
NO,DEVELOPMENTAL HIP DYSPLASIA,9
NO,DYSPHORIA,9
NO,EMBOLISM VENOUS,9
NO,ENTEROCOLITIS,9
NO,ESCHERICHIA SEPSIS,9
NO,EYE HAEMORRHAGE,9
NO,EYELID PTOSIS,9
NO,FEELING DRUNK,9
NO,FLUID RETENTION,9
NO,GASTROENTERITIS,9
NO,GENERALISED ERYTHEMA,9
NO,GENITAL HAEMORRHAGE,9
NO,HAEMOLYSIS,9
NO,HEAD INJURY,9
NO,HYPERCALCAEMIA,9
NO,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,9
NO,IMPULSE-CONTROL DISORDER,9
NO,INFECTION REACTIVATION,9
NO,INTESTINAL PERFORATION,9
NO,INTRA-ABDOMINAL HAEMORRHAGE,9
NO,LARGE INTESTINE POLYP,9
NO,LISTERIOSIS,9
NO,LIVE BIRTH,9
NO,LOSS OF LIBIDO,9
NO,METABOLIC DISORDER,9
NO,MOOD SWINGS,9
NO,MUCOSAL HAEMORRHAGE,9
NO,MYELOMALACIA,9
NO,ORAL PRURITUS,9
NO,PALLOR,9
NO,PAROSMIA,9
NO,PATHOGEN RESISTANCE,9
NO,PULMONARY HAEMORRHAGE,9
NO,RASH MACULAR,9
NO,RESPIRATORY DISORDER,9
NO,RIGHT VENTRICULAR FAILURE,9
NO,ROAD TRAFFIC ACCIDENT,9
NO,SALIVARY HYPERSECRETION,9
NO,SINUS BRADYCARDIA,9
NO,SKIN DISCOLOURATION,9
NO,SKIN HAEMORRHAGE,9
NO,SMALL INTESTINAL HAEMORRHAGE,9
NO,SPINAL CORD INFARCTION,9
NO,TENSION HEADACHE,9
NO,THINKING ABNORMAL,9
NO,UVEITIS,9
NO,VASCULITIS,9
NO,VERTIGO,9
NO,VOLVULUS,9
NO,WALKING DISABILITY,9
NO,WHEEZING,9
NO,WHITE BLOOD CELL COUNT INCREASED,9
NO,ABDOMINAL PAIN LOWER,8
NO,ACUTE PSYCHOSIS,8
NO,ANAL SPHINCTER ATONY,8
NO,BLOOD URINE PRESENT,8
NO,BODY TEMPERATURE FLUCTUATION,8
NO,BONE LESION,8
NO,BRONCHITIS,8
NO,CAESAREAN SECTION,8
NO,CARDIAC FIBRILLATION,8
NO,CARDIOMYOPATHY ACUTE,8
NO,CENTRAL NERVOUS SYSTEM LESION,8
NO,DEVICE RELATED INFECTION,8
NO,DRUG ERUPTION,8
NO,DUCTUS ARTERIOSUS PREMATURE CLOSURE,8
NO,ENCEPHALOPATHY,8
NO,ENDOCARDITIS,8
NO,GASTROINTESTINAL PAIN,8
NO,HAEMORRHAGE INTRACRANIAL,8
NO,HEARING IMPAIRED,8
NO,HERPES VIRUS INFECTION,8
NO,HYPERPLASIA,8
NO,HYPERTONIA,8
NO,INFLAMMATORY BOWEL DISEASE,8
NO,INTERVERTEBRAL DISC PROTRUSION,8
NO,JOINT STIFFNESS,8
NO,LIP BLISTER,8
NO,LIP SWELLING,8
NO,MAJOR DEPRESSION,8
NO,MONOPLEGIA,8
NO,MUSCLE ATROPHY,8
NO,MYDRIASIS,8
NO,NEGATIVE THOUGHTS,8
NO,NEOPLASM PROGRESSION,8
NO,NEPHROLITHIASIS,8
NO,NEUROGENIC BLADDER,8
NO,NEUROLOGICAL SYMPTOM,8
NO,OBSESSIVE THOUGHTS,8
NO,ONYCHOCLASIS,8
NO,OPHTHALMIC HERPES ZOSTER,8
NO,ORAL CANDIDIASIS,8
NO,PLEURISY,8
NO,PRODUCTIVE COUGH,8
NO,PROTEINURIA,8
NO,PRURITUS GENERALISED,8
NO,PULMONARY FUNCTION TEST DECREASED,8
NO,RADIATION PNEUMONITIS,8
NO,RENAL CANCER,8
NO,ROSACEA,8
NO,SELF INJURIOUS BEHAVIOUR,8
NO,SNEEZING,8
NO,SUBDURAL HAEMORRHAGE,8
NO,SUDDEN CARDIAC DEATH,8
NO,SUPRAVENTRICULAR TACHYCARDIA,8
NO,TENDERNESS,8
NO,TONGUE BLISTERING,8
NO,TONIC CONVULSION,8
NO,TROPONIN INCREASED,8
NO,URINE OUTPUT DECREASED,8
NO,VENTRICULAR ARRHYTHMIA,8
NO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,8
NO,APPENDICITIS,7
NO,BACTERIAL INFECTION,7
NO,BENIGN PROSTATIC HYPERPLASIA,7
NO,CHOLANGITIS,7
NO,CLONUS,7
NO,CYTOMEGALOVIRUS TEST POSITIVE,7
NO,DEMYELINATION,7
NO,DIVERTICULITIS,7
NO,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,7
NO,DRUG LEVEL BELOW THERAPEUTIC,7
NO,ENCEPHALITIS,7
NO,ERYTHEMA MULTIFORME,7
NO,EXTRAPYRAMIDAL DISORDER,7
NO,EYE MOVEMENT DISORDER,7
NO,EYE SWELLING,7
NO,FACIAL PAIN,7
NO,FEELING OF DESPAIR,7
NO,FOETAL HEART RATE ABNORMAL,7
NO,FORMICATION,7
NO,GENERAL PHYSICAL CONDITION ABNORMAL,7
NO,HAEMORRHAGE SUBCUTANEOUS,7
NO,HAEMORRHOIDS,7
NO,HEPATIC ENZYME ABNORMAL,7
NO,HEPATITIS TOXIC,7
NO,HIP DEFORMITY,7
NO,HYPERSENSITIVITY VASCULITIS,7
NO,HYPOGEUSIA,7
NO,HYPOKINESIA,7
NO,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,7
NO,INTRAOCULAR PRESSURE INCREASED,7
NO,LEFT VENTRICULAR HYPERTROPHY,7
NO,LOCAL SWELLING,7
NO,MENINGITIS,7
NO,MESENTERIC VASCULAR INSUFFICIENCY,7
NO,METASTASES TO CENTRAL NERVOUS SYSTEM,7
NO,MOTOR DEVELOPMENTAL DELAY,7
NO,MOUTH INJURY,7
NO,MOUTH SWELLING,7
NO,MYASTHENIA GRAVIS,7
NO,NAIL PSORIASIS,7
NO,NERVE INJURY,7
NO,OBESITY,7
NO,OSTEOPENIA,7
NO,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,7
NO,PETECHIAE,7
NO,PNEUMOMEDIASTINUM,7
NO,POLYDACTYLY,7
NO,POST PROCEDURAL COMPLICATION,7
NO,POST VIRAL FATIGUE SYNDROME,7
NO,PREMATURE LABOUR,7
NO,PRIAPISM,7
NO,PROCEDURAL HAEMORRHAGE,7
NO,PSYCHOMOTOR HYPERACTIVITY,7
NO,PUSTULAR PSORIASIS,7
NO,RESPIRATION ABNORMAL,7
NO,RETINAL DETACHMENT,7
NO,SECOND PRIMARY MALIGNANCY,7
NO,SELF-INJURIOUS IDEATION,7
NO,SINUS ARREST,7
NO,SPINAL CORD PARALYSIS,7
NO,THERAPEUTIC RESPONSE UNEXPECTED,7
NO,THROMBOPHLEBITIS,7
NO,TUBULOINTERSTITIAL NEPHRITIS,7
NO,VENOUS INJURY,7
NO,VIRAL INFECTION,7
NO,VISUAL FIELD DEFECT,7
NO,ABASIA,6
NO,ABNORMAL DREAMS,6
NO,AFFECT LABILITY,6
NO,ANHEDONIA,6
NO,ANORGASMIA,6
NO,ANOSMIA,6
NO,APLASIA,6
NO,APNOEA,6
NO,APRAXIA,6
NO,ARTHROPATHY,6
NO,ASPIRATION,6
NO,ATHETOSIS,6
NO,ATRIAL FLUTTER,6
NO,ATYPICAL FEMUR FRACTURE,6
NO,AUTOIMMUNE HEPATITIS,6
NO,BLOOD LACTIC ACID INCREASED,6
NO,BLOOD TEST ABNORMAL,6
NO,BODY FAT DISORDER,6
NO,BRAIN HERNIATION,6
NO,BRUXISM,6
NO,CAPILLARY LEAK SYNDROME,6
NO,CARDIAC SARCOIDOSIS,6
NO,CEREBRAL DISORDER,6
NO,CLAUSTROPHOBIA,6
NO,COITAL BLEEDING,6
NO,CORONARY ARTERY STENOSIS,6
NO,DEPENDENCE,6
NO,DIFFUSE LARGE B-CELL LYMPHOMA,6
NO,DIPLEGIA,6
NO,DISSOCIATION,6
NO,DROOLING,6
NO,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,6
NO,DRUG PRESCRIBING ERROR,6
NO,DRY THROAT,6
NO,EAR DISCOMFORT,6
NO,ECONOMIC PROBLEM,6
NO,ELECTROCARDIOGRAM T WAVE INVERSION,6
NO,ELECTROLYTE IMBALANCE,6
NO,ESCHERICHIA URINARY TRACT INFECTION,6
NO,EWING^S SARCOMA,6
NO,EYE INFECTION,6
NO,FINE MOTOR DELAY,6
NO,FISTULA,6
NO,FOETAL DEATH,6
NO,FOETAL DISTRESS SYNDROME,6
NO,GENITAL ULCERATION,6
NO,GLOMERULAR FILTRATION RATE DECREASED,6
NO,GRAFT VERSUS HOST DISEASE,6
NO,HAEMOGLOBIN INCREASED,6
NO,HAEMOPTYSIS,6
NO,HEPATITIS ACUTE,6
NO,HOSTILITY,6
NO,HYPERNATRAEMIA,6
NO,HYPERPHAGIA,6
NO,HYPERTHYROIDISM,6
NO,HYPOPHOSPHATAEMIA,6
NO,HYPOVENTILATION,6
NO,ILL-DEFINED DISORDER,6
NO,IMMUNE THROMBOCYTOPENIC PURPURA,6
NO,IMPAIRED DRIVING ABILITY,6
NO,IMPAIRED QUALITY OF LIFE,6
NO,IMPULSIVE BEHAVIOUR,6
NO,INJURY,6
NO,INVESTIGATION,6
NO,ISCHAEMIC STROKE,6
NO,KAPOSI^S SARCOMA,6
NO,LARYNGOSPASM,6
NO,LID SULCUS DEEPENED,6
NO,LUNG TRANSPLANT REJECTION,6
NO,MALNUTRITION,6
NO,MATERNAL EXPOSURE BEFORE PREGNANCY,6
NO,MENSTRUATION IRREGULAR,6
NO,MIXED DEAFNESS,6
NO,MUSCLE CONTRACTIONS INVOLUNTARY,6
NO,MUSCLE HAEMORRHAGE,6
NO,MUTISM,6
NO,MYELITIS TRANSVERSE,6
NO,MYOCLONIC EPILEPSY,6
NO,MYOGLOBIN BLOOD INCREASED,6
NO,NECROSIS,6
NO,NEONATAL RESPIRATORY DEPRESSION,6
NO,NEUROTOXICITY,6
NO,NEUTROPENIC INFECTION,6
NO,OESOPHAGEAL CANDIDIASIS,6
NO,OESOPHAGEAL ULCER,6
NO,OVARIAN CYST,6
NO,PANCREATIC CARCINOMA,6
NO,PANCREATITIS ACUTE,6
NO,PANIC REACTION,6
NO,PARANOIA,6
NO,PARTIAL SEIZURES,6
NO,PERIODONTITIS,6
NO,PERONEAL NERVE PALSY,6
NO,PHYSICAL ABUSE,6
NO,PLASMA CELL MYELOMA,6
NO,PLATELET COUNT INCREASED,6
NO,POLYDIPSIA,6
NO,PRE-ECLAMPSIA,6
NO,PREMATURE SEPARATION OF PLACENTA,6
NO,PRESCRIBED UNDERDOSE,6
NO,PYELONEPHRITIS,6
NO,RECTAL ABSCESS,6
NO,RECTAL ADENOCARCINOMA,6
NO,SENSORIMOTOR DISORDER,6
NO,SEXUAL ABUSE,6
NO,SHOCK,6
NO,SKIN CANCER,6
NO,SKIN PAPILLOMA,6
NO,SPEECH DISORDER DEVELOPMENTAL,6
NO,SPLENIC HAEMORRHAGE,6
NO,SYNOVITIS,6
NO,TALIPES,6
NO,TRISOMY 21,6
NO,TROPONIN T INCREASED,6
NO,TUBERCULOSIS,6
NO,TUMOUR LYSIS SYNDROME,6
NO,TYPE 2 DIABETES MELLITUS,6
NO,ULCERATIVE KERATITIS,6
NO,URINARY BLADDER HAEMORRHAGE,6
NO,VIITH NERVE PARALYSIS,6
NO,WRONG PATIENT RECEIVED MEDICATION,6
NO,ACCIDENTAL POISONING,5
NO,ACUTE GRAFT VERSUS HOST DISEASE,5
NO,ALVEOLITIS ALLERGIC,5
NO,ANAL ABSCESS,5
NO,ANTIBODY TEST POSITIVE,5
NO,ARACHNOIDITIS,5
NO,ATRIAL SEPTAL DEFECT,5
NO,ATYPICAL PNEUMONIA,5
NO,AUTISM SPECTRUM DISORDER,5
NO,AUTOIMMUNE HAEMOLYTIC ANAEMIA,5
NO,AXILLARY MASS,5
NO,B-CELL LYMPHOMA,5
NO,BLADDER CANCER,5
NO,BLINDNESS TRANSIENT,5
NO,BLOOD POTASSIUM INCREASED,5
NO,BLOOD PRESSURE FLUCTUATION,5
NO,BLOOD PRESSURE SYSTOLIC INCREASED,5
NO,BRAIN NEOPLASM,5
NO,CANDIDA INFECTION,5
NO,CHOLESTASIS,5
NO,CLOSTRIDIUM DIFFICILE COLITIS,5
NO,COMMUNICATION DISORDER,5
NO,CONGENITAL CARDIOVASCULAR ANOMALY,5
NO,CONGENITAL EYE DISORDER,5
NO,CONGENITAL MONORCHIDISM,5
NO,CONJUNCTIVAL HAEMORRHAGE,5
NO,CONNECTIVE TISSUE DISORDER,5
NO,COORDINATION ABNORMAL,5
NO,COR PULMONALE,5
NO,DEAFNESS BILATERAL,5
NO,DEAFNESS NEUROSENSORY,5
NO,DERMATITIS EXFOLIATIVE,5
NO,DEVICE DEPLOYMENT ISSUE,5
NO,DROP ATTACKS,5
NO,DRUG DOSE OMISSION,5
NO,DUCTUS ARTERIOSUS STENOSIS FOETAL,5
NO,EAR PAIN,5
NO,EJACULATION DISORDER,5
NO,ELECTROCARDIOGRAM QT PROLONGED,5
NO,EMPHYSEMA,5
NO,EOSINOPHIL COUNT INCREASED,5
NO,EXTRADURAL HAEMATOMA,5
NO,EXTRASYSTOLES,5
NO,EYE DISORDER,5
NO,EYELID OEDEMA,5
NO,FAECAL INCONTINENCE,5
NO,FALLOT^S TETRALOGY,5
NO,FEEDING DISORDER,5
NO,FIBRIN D DIMER INCREASED,5
NO,FOETAL GROWTH RESTRICTION,5
NO,FREQUENT BOWEL MOVEMENTS,5
NO,GASTRODUODENITIS,5
NO,GASTROINTESTINAL OEDEMA,5
NO,GENOTYPE DRUG RESISTANCE TEST POSITIVE,5
NO,GINGIVAL BLEEDING,5
NO,GLYCOSYLATED HAEMOGLOBIN INCREASED,5
NO,GRIP STRENGTH DECREASED,5
NO,HAEMOGLOBIN ABNORMAL,5
NO,HEPATOMEGALY,5
NO,HISTIOCYTOSIS HAEMATOPHAGIC,5
NO,HOMICIDE,5
NO,HYPEREMESIS GRAVIDARUM,5
NO,HYPERTRIGLYCERIDAEMIA,5
NO,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,5
NO,IMPAIRED HEALING,5
NO,INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT,5
NO,INAPPROPRIATE AFFECT,5
NO,INDIFFERENCE,5
NO,INFARCTION,5
NO,INFECTION SUSCEPTIBILITY INCREASED,5
NO,INFUSION SITE PAIN,5
NO,INJECTION SITE PAIN,5
NO,INTRAVENTRICULAR HAEMORRHAGE,5
NO,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,5
NO,LACERATION,5
NO,LANGUAGE DISORDER,5
NO,LARYNGEAL OEDEMA,5
NO,LATENT AUTOIMMUNE DIABETES IN ADULTS,5
NO,LEFT VENTRICULAR FAILURE,5
NO,LIBIDO DECREASED,5
NO,LIMB CRUSHING INJURY,5
NO,LYMPHOMA,5
NO,MEDIASTINAL ABSCESS,5
NO,MEDICAL DEVICE COMPLICATION,5
NO,MENINGITIS ASEPTIC,5
NO,MENISCUS INJURY,5
NO,MENSTRUAL DISORDER,5
NO,METASTASES TO BLADDER,5
NO,METASTASES TO BONE,5
NO,MICROCEPHALY,5
NO,MITRAL VALVE INCOMPETENCE,5
OM,GENERALISED OEDEMA,49
OM,ASCITES,32
OM,HYPERTENSION,22
OM,PLEURAL EFFUSION,21
OM,WEIGHT INCREASED,14
OM,GASTROINTESTINAL HAEMORRHAGE,12
OM,DEATH,11
OM,DRUG INEFFECTIVE,11
OM,HYPERALDOSTERONISM,9
OM,AUTONOMIC NEUROPATHY,8
OM,DYSPNOEA,8
OM,GASTRITIS,8
OM,RENAL IMPAIRMENT,8
OM,PYREXIA,7
OM,CARDIAC ARREST,6
OM,OEDEMA PERIPHERAL,6
OM,OSTEONECROSIS,6
OM,PERIORBITAL OEDEMA,6
OM,VOMITING,6
OM,ACUTE KIDNEY INJURY,5
OM,ANGIOEDEMA,5
OM,EPILEPSY,5
OM,HYPERGLYCAEMIA,5
OM,HYPERTROPHIC CARDIOMYOPATHY,5
OM,HYPOTENSION,5
OM,TOXICITY TO VARIOUS AGENTS,5
OM,ARRHYTHMIA,4
OM,ASTHENIA,4
OM,DIZZINESS,4
OM,ENCEPHALOPATHY,4
OM,EXPOSURE DURING PREGNANCY,4
OM,HAEMATURIA,4
OM,HYPOKALAEMIA,4
OM,HYPOMAGNESAEMIA,4
OM,ISCHAEMIC STROKE,4
OM,MATERNAL EXPOSURE DURING PREGNANCY,4
OM,MELAENA,4
OM,PRURITUS,4
OM,SECONDARY HYPERTENSION,4
OM,SEIZURE,4
OM,SEPSIS,4
OM,TACHYPNOEA,4
OM,ABDOMINAL PAIN,3
OM,ADRENAL INSUFFICIENCY,3
OM,ANAEMIA,3
OM,ATRIAL TACHYCARDIA,3
OM,BRADYCARDIA,3
OM,CHEST PAIN,3
OM,DIABETES MELLITUS,3
OM,ELECTROLYTE IMBALANCE,3
OM,FATIGUE,3
OM,FOETAL EXPOSURE DURING PREGNANCY,3
OM,HAEMOPTYSIS,3
OM,HAEMORRHAGE,3
OM,HEADACHE,3
OM,HEPATIC ENZYME INCREASED,3
OM,HYPERBILIRUBINAEMIA,3
OM,HYPERKALAEMIA,3
OM,LEUKOCYTOSIS,3
OM,LEUKOPENIA,3
OM,MITRAL VALVE INCOMPETENCE,3
OM,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
OM,NEPHROPATHY TOXIC,3
OM,NEUTROPENIA,3
OM,PALPITATIONS,3
OM,PSEUDOMONAL SEPSIS,3
OM,PULMONARY HAEMORRHAGE,3
OM,RASH,3
OM,SEPTIC SHOCK,3
OM,STATUS EPILEPTICUS,3
OM,SUPRAVENTRICULAR TACHYCARDIA,3
OM,SYSTOLIC ANTERIOR MOTION OF MITRAL VALVE,3
OM,TACHYCARDIA,3
OM,THROMBOCYTOPENIA,3
OM,URTICARIA,3
OM,ABORTION SPONTANEOUS,2
OM,ACUTE RESPIRATORY DISTRESS SYNDROME,2
OM,AGRANULOCYTOSIS,2
OM,ANAPHYLACTIC REACTION,2
OM,ANAPHYLACTIC SHOCK,2
OM,ANTERIOR CHAMBER DISORDER,2
OM,BLOOD CREATININE INCREASED,2
OM,BRONCHOSPASM,2
OM,CARDIAC FAILURE,2
OM,CHEST DISCOMFORT,2
OM,CONDITION AGGRAVATED,2
OM,CONJUNCTIVITIS,2
OM,CORNEAL OPACITY,2
OM,CRANIAL NERVE DISORDER,2
OM,DEAFNESS,2
OM,DEPRESSED LEVEL OF CONSCIOUSNESS,2
OM,DIARRHOEA,2
OM,DISEASE RECURRENCE,2
OM,DISORIENTATION,2
OM,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,2
OM,DRUG RESISTANCE,2
OM,DRY GANGRENE,2
OM,EPISTAXIS,2
OM,ERYTHEMA,2
OM,EXTRAPYRAMIDAL DISORDER,2
OM,FLUSHING,2
OM,FOETAL GROWTH RESTRICTION,2
OM,GANGRENE,2
OM,HYPERADRENOCORTICISM,2
OM,HYPERHIDROSIS,2
OM,HYPERSENSITIVITY,2
OM,HYPERSENSITIVITY VASCULITIS,2
OM,HYPOGLYCAEMIA,2
OM,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
OM,JAUNDICE,2
OM,KAPOSI^S SARCOMA,2
OM,LARYNGEAL OEDEMA,2
OM,LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION,2
OM,LOSS OF CONSCIOUSNESS,2
OM,LYMPHOCYTE COUNT DECREASED,2
OM,MALAISE,2
OM,MYOCARDIAL INFARCTION,2
OM,NORMAL NEWBORN,2
OM,PHOTOONYCHOLYSIS,2
OM,PNEUMONIA,2
OM,POLYHYDRAMNIOS,2
OM,PREMATURE DELIVERY,2
OM,RENAL TUBULAR DYSFUNCTION,2
OM,STEVENS-JOHNSON SYNDROME,2
OM,TREATMENT FAILURE,2
OM,UTERINE MALPOSITION,2
OM,VAGINAL DISCHARGE,2
OM,VENTRICULAR EXTRASYSTOLES,2
OM,VENTRICULAR TACHYCARDIA,2
OM,WHEEZING,2
OM,ZYGOMYCOSIS,2
OM,ABASIA,1
OM,ABDOMINAL DISCOMFORT,1
OM,ABSCESS,1
OM,ACNE,1
OM,ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME,1
OM,AFFECTIVE DISORDER,1
OM,ALANINE AMINOTRANSFERASE INCREASED,1
OM,ALCOHOL WITHDRAWAL SYNDROME,1
OM,ANEURYSM,1
OM,ANGINA PECTORIS,1
OM,ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC,1
OM,ANXIETY,1
OM,ARTERIAL RUPTURE,1
OM,ARTHRITIS BACTERIAL,1
OM,ARTHRITIS INFECTIVE,1
OM,ASPARTATE AMINOTRANSFERASE INCREASED,1
OM,ATAXIA,1
OM,ATRIAL FIBRILLATION,1
OM,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
OM,B-CELL LYMPHOMA,1
OM,BLINDNESS,1
OM,BLOOD IRON INCREASED,1
OM,BLOOD LACTATE DEHYDROGENASE INCREASED,1
OM,BLOOD PRESSURE IMMEASURABLE,1
OM,BLOOD PRESSURE INCREASED,1
OM,BREAST ULCERATION,1
OM,BURNING SENSATION,1
OM,CAESAREAN SECTION,1
OM,CARDIAC FAILURE ACUTE,1
OM,CARDIAC MURMUR,1
OM,CARDIOMYOPATHY,1
OM,CARDIOTOXICITY,1
OM,CELLULITIS,1
OM,CHOLECYSTITIS,1
OM,CHOLELITHIASIS,1
OM,CHROMATURIA,1
OM,CHRONIC KIDNEY DISEASE,1
OM,CIRCULATORY COLLAPSE,1
OM,CIRCUMORAL OEDEMA,1
OM,CLONUS,1
OM,COLOUR BLINDNESS,1
OM,COMA,1
OM,CONFUSIONAL STATE,1
OM,CROHN^S DISEASE,1
OM,CUSHING^S SYNDROME,1
OM,CYTOMEGALOVIRUS INFECTION,1
OM,CYTOPENIA,1
OM,DEATH NEONATAL,1
OM,DEEP VEIN THROMBOSIS,1
OM,DEPRESSION,1
OM,DERMATITIS CONTACT,1
OM,DIABETIC KETOACIDOSIS,1
OM,DIAPHRAGMATIC HERNIA,1
OM,DISEASE PROGRESSION,1
OM,DRUG EFFECT INCOMPLETE,1
OM,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
OM,DRUG INTOLERANCE,1
OM,DRUG LEVEL INCREASED,1
OM,DYSSTASIA,1
OM,EAR HAEMORRHAGE,1
OM,ECLAMPSIA,1
OM,EJECTION FRACTION DECREASED,1
OM,ELECTROCARDIOGRAM QT INTERVAL ABNORMAL,1
OM,ERECTILE DYSFUNCTION,1
OM,EYE MOVEMENT DISORDER,1
OM,EYELID PTOSIS,1
OM,FEBRILE NEUTROPENIA,1
OM,FEELING ABNORMAL,1
OM,FLANK PAIN,1
OM,FOETAL DISTRESS SYNDROME,1
OM,FOETAL MALPRESENTATION,1
OM,GASTRIC ULCER,1
OM,GASTRIC VARICES,1
OM,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
OM,GRANULOMATOSIS WITH POLYANGIITIS,1
OM,HAEMATOMA,1
OM,HAEMOGLOBIN DECREASED,1
OM,HAEMOLYSIS,1
OM,HELLP SYNDROME,1
OM,HEPARIN-INDUCED THROMBOCYTOPENIA,1
OM,HEPATIC CIRRHOSIS,1
OM,HEPATIC NEOPLASM,1
OM,HEPATOCELLULAR CARCINOMA,1
OM,HEPATOTOXICITY,1
OM,HICCUPS,1
OM,HYPERURICAEMIA,1
OM,HYPOAESTHESIA ORAL,1
OM,HYPOXIA,1
OM,IDIOPATHIC PULMONARY FIBROSIS,1
OM,ILEUS PARALYTIC,1
OM,IMPAIRED DRIVING ABILITY,1
OM,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
OM,INHIBITORY DRUG INTERACTION,1
OM,INTERVERTEBRAL DISC DISORDER,1
OM,INTESTINAL FISTULA,1
OM,INTESTINAL OBSTRUCTION,1
OM,IRRITABLE BOWEL SYNDROME,1
OM,JUGULAR VEIN THROMBOSIS,1
OM,KIDNEY ENLARGEMENT,1
OM,LEFT VENTRICULAR DYSFUNCTION,1
OM,LEFT VENTRICULAR HYPERTROPHY,1
OM,LETHARGY,1
OM,LIBIDO DECREASED,1
OM,LIVE BIRTH,1
OM,LIVER FUNCTION TEST ABNORMAL,1
OM,LIVER FUNCTION TEST INCREASED,1
OM,LOCAL SWELLING,1
OM,LOWER RESPIRATORY TRACT INFECTION,1
OM,LUNG INFILTRATION,1
OM,LYMPHADENOPATHY,1
OM,LYMPHOHISTIOCYTOSIS,1
OM,LYMPHOPENIA,1
OM,MALIGNANT NEOPLASM PROGRESSION,1
OM,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
OM,MENINGITIS BACTERIAL,1
OM,MENORRHAGIA,1
OM,METASTASES TO LUNG,1
OM,MICROANGIOPATHY,1
OM,MOUTH ULCERATION,1
OM,MUCOSAL HAEMORRHAGE,1
OM,MULTI-ORGAN FAILURE,1
OM,MULTIPLE-DRUG RESISTANCE,1
OM,MUSCLE ATROPHY,1
OM,MYASTHENIC SYNDROME,1
OM,MYOCARDIAL ISCHAEMIA,1
OM,MYOCARDIAL NECROSIS MARKER INCREASED,1
OM,MYOPATHY,1
OM,MYOSITIS,1
OM,NASAL CONGESTION,1
OM,NAUSEA,1
OM,NEUTROPHILIA,1
OM,NO THERAPEUTIC RESPONSE,1
OM,NYSTAGMUS,1
OM,OCULAR TOXICITY,1
OM,OTORRHOEA,1
OM,OXYGEN SATURATION ABNORMAL,1
OM,PAIN,1
OM,PAIN IN EXTREMITY,1
OM,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
OM,PANCYTOPENIA,1
OM,PARTIAL SEIZURES,1
OM,PARVOVIRUS B19 INFECTION,1
OM,PELVIC PAIN,1
OM,PERFORMANCE STATUS DECREASED,1
OM,PERICARDIAL EFFUSION,1
OM,PERIPHERAL ISCHAEMIA,1
OM,PLATELET COUNT DECREASED,1
OM,PNEUMONIA ASPIRATION,1
OM,POLYCHROMASIA,1
OM,POLYURIA,1
OM,PORTAL VEIN THROMBOSIS,1
OM,POST PROCEDURAL HAEMORRHAGE,1
OM,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
OM,PREMATURE BABY,1
OM,PRODUCT USE IN UNAPPROVED INDICATION,1
OM,PRODUCT USED FOR UNKNOWN INDICATION,1
OM,PRODUCTIVE COUGH,1
OM,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
OM,PSEUDOSEPSIS,1
OM,PSORIASIS,1
OM,PULMONARY ARTERY THROMBOSIS,1
OM,PULMONARY EMBOLISM,1
OM,PURULENT DISCHARGE,1
OM,RASH PAPULAR,1
OM,RED MAN SYNDROME,1
OM,RESPIRATORY FAILURE,1
OM,RETINAL TOXICITY,1
OM,RETINAL VEIN OCCLUSION,1
OM,RETINOIC ACID SYNDROME,1
OM,SACROILIITIS,1
OM,SCAR,1
OM,SCLERAL PIGMENTATION,1
OM,SCROTAL ULCER,1
OM,SECONDARY ADRENOCORTICAL INSUFFICIENCY,1
OM,SELF-MEDICATION,1
OM,SENSATION OF FOREIGN BODY,1
OM,SERUM FERRITIN INCREASED,1
OM,SHARED PSYCHOTIC DISORDER,1
OM,SHOCK,1
OM,SINUS ARRHYTHMIA,1
OM,SKIN DISCOLOURATION,1
OM,SKIN MASS,1
OM,SKIN OEDEMA,1
OM,SKIN REACTION,1
OM,SKIN ULCER,1
OM,SOFT TISSUE NECROSIS,1
OM,SPINAL FRACTURE,1
OM,SPLENOMEGALY,1
OM,STAPHYLOCOCCAL INFECTION,1
OM,STILLBIRTH,1
OM,SUICIDAL IDEATION,1
OM,SWELLING,1
OM,SYNOVITIS,1
OM,SYSTEMIC LUPUS ERYTHEMATOSUS RASH,1
OM,THROMBOSIS,1
OM,TORSADE DE POINTES,1
OM,TRANSPLANT REJECTION,1
OM,TREATMENT NONCOMPLIANCE,1
OM,TUMOUR NECROSIS,1
OM,TYPE I HYPERSENSITIVITY,1
OM,ULCER,1
OM,UNSTABLE FOETAL LIE,1
OM,UPPER GASTROINTESTINAL HAEMORRHAGE,1
OM,URINARY TRACT INFECTION,1
OM,VAGINAL HAEMORRHAGE,1
OM,VENA CAVA THROMBOSIS,1
OM,VENTRICULAR DYSFUNCTION,1
OM,VISION BLURRED,1
OM,XANTHOPSIA,1
PK,DEATH,769
PK,PYREXIA,77
PK,DYSPNOEA,72
PK,VOMITING,61
PK,HAEMOGLOBIN DECREASED,55
PK,MYOCARDIAL INFARCTION,52
PK,CARDIO-RESPIRATORY ARREST,46
PK,PAIN,43
PK,DIARRHOEA,39
PK,LOSS OF CONSCIOUSNESS,38
PK,CARDIOPULMONARY FAILURE,36
PK,ASTHENIA,35
PK,HYPOTENSION,34
PK,COUGH,30
PK,HYPERGLYCAEMIA,30
PK,PLATELET COUNT DECREASED,28
PK,CHEST PAIN,27
PK,DRUG INEFFECTIVE,27
PK,ANAEMIA,26
PK,BLOOD GLUCOSE INCREASED,26
PK,FATIGUE,25
PK,CARDIAC ARREST,24
PK,FALL,23
PK,MALIGNANT NEOPLASM PROGRESSION,23
PK,PNEUMONIA,23
PK,WHITE BLOOD CELL COUNT INCREASED,23
PK,THROMBOCYTOPENIA,22
PK,HEADACHE,21
PK,PRURITUS,21
PK,DECREASED APPETITE,20
PK,RENAL FAILURE,19
PK,BLOOD CREATINE PHOSPHOKINASE INCREASED,18
PK,DIZZINESS,18
PK,TOXICITY TO VARIOUS AGENTS,18
PK,ABDOMINAL PAIN,17
PK,SEPSIS,17
PK,ASCITES,16
PK,CHEST DISCOMFORT,16
PK,NAUSEA,16
PK,PANCYTOPENIA,16
PK,ARTHRALGIA,15
PK,BONE MARROW FAILURE,15
PK,CHRONIC MYELOID LEUKAEMIA,15
PK,PLATELET COUNT INCREASED,15
PK,PULMONARY OEDEMA,15
PK,RASH,15
PK,SWELLING,15
PK,WHITE BLOOD CELL COUNT DECREASED,15
PK,APHASIA,14
PK,ACUTE PSYCHOSIS,13
PK,BLOOD PRESSURE INCREASED,13
PK,CARDIAC DISORDER,13
PK,DISEASE PROGRESSION,13
PK,EXPOSURE DURING PREGNANCY,13
PK,FOETAL EXPOSURE DURING PREGNANCY,13
PK,BLOOD CREATININE INCREASED,12
PK,DRUG INTOLERANCE,12
PK,HAEMOPTYSIS,12
PK,HEPATITIS C,12
PK,PAIN IN EXTREMITY,12
PK,PRIMARY MYELOFIBROSIS,12
PK,SEIZURE,12
PK,ANGINA PECTORIS,11
PK,CARDIAC FAILURE,11
PK,CEREBRAL HAEMORRHAGE,11
PK,CEREBROVASCULAR ACCIDENT,11
PK,DIABETIC KETOACIDOSIS,11
PK,GAIT DISTURBANCE,11
PK,HYPERTENSION,11
PK,MATERNAL EXPOSURE DURING PREGNANCY,11
PK,PARALYSIS,11
PK,PRODUCT QUALITY ISSUE,11
PK,SHOCK,11
PK,ACUTE KIDNEY INJURY,10
PK,ANAPHYLACTIC REACTION,10
PK,GLYCOSYLATED HAEMOGLOBIN INCREASED,10
PK,HAEMATEMESIS,10
PK,HAEMORRHAGE,10
PK,HYPOAESTHESIA,10
PK,JAUNDICE,10
PK,LOWER RESPIRATORY TRACT INFECTION,10
PK,POLYURIA,10
PK,PREMATURE BABY,10
PK,RESPIRATORY DISTRESS,10
PK,RESPIRATORY FAILURE,10
PK,SPLENOMEGALY,10
PK,STRESS CARDIOMYOPATHY,10
PK,BACK PAIN,9
PK,COMA,9
PK,DIABETES MELLITUS,9
PK,HEPATIC ENCEPHALOPATHY,9
PK,HYPOGLYCAEMIA,9
PK,INFECTION,9
PK,LEUKOPENIA,9
PK,MALAISE,9
PK,MYOCARDIAL ISCHAEMIA,9
PK,SOMNOLENCE,9
PK,STOMATITIS,9
PK,TACHYCARDIA,9
PK,TOXIC EPIDERMAL NECROLYSIS,9
PK,WEIGHT DECREASED,9
PK,ASTHMA,8
PK,CONSTIPATION,8
PK,DIABETES MELLITUS INADEQUATE CONTROL,8
PK,ERYTHEMA,8
PK,GASTROINTESTINAL DISORDER,8
PK,LETHARGY,8
PK,LOW BIRTH WEIGHT BABY,8
PK,PARAESTHESIA,8
PK,PRODUCT USE ISSUE,8
PK,RENAL IMPAIRMENT,8
PK,TUBERCULOSIS,8
PK,WHEEZING,8
PK,ABDOMINAL PAIN UPPER,7
PK,BLOOD PRESSURE DECREASED,7
PK,BLOOD UREA INCREASED,7
PK,DRUG RESISTANCE,7
PK,GENERAL PHYSICAL HEALTH DETERIORATION,7
PK,HAEMATURIA,7
PK,HEPATIC CIRRHOSIS,7
PK,HYPERSENSITIVITY,7
PK,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,7
PK,INFUSION SITE INFECTION,7
PK,INSOMNIA,7
PK,MOTOR DYSFUNCTION,7
PK,PALPITATIONS,7
PK,PERIPHERAL SWELLING,7
PK,PRODUCT CONTAMINATION,7
PK,RESTLESSNESS,7
PK,VERTIGO,7
PK,ABORTION SPONTANEOUS,6
PK,ACUTE MYOCARDIAL INFARCTION,6
PK,BLOOD GLUCOSE DECREASED,6
PK,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,6
PK,DYSPEPSIA,6
PK,EPISTAXIS,6
PK,HEPATIC FAILURE,6
PK,HYPOTHYROIDISM,6
PK,INCORRECT DOSE ADMINISTERED,6
PK,IRRITABILITY,6
PK,LOWER LIMB FRACTURE,6
PK,METASTATIC RENAL CELL CARCINOMA,6
PK,MYELODYSPLASTIC SYNDROME,6
PK,NECROSIS,6
PK,NEUROPATHY PERIPHERAL,6
PK,OVERDOSE,6
PK,STILLBIRTH,6
PK,SWELLING FACE,6
PK,VISION BLURRED,6
PK,WEIGHT INCREASED,6
PK,ABDOMINAL DISCOMFORT,5
PK,ALTERED STATE OF CONSCIOUSNESS,5
PK,ARRHYTHMIA,5
PK,ASPIRATION,5
PK,BLINDNESS,5
PK,BLISTER,5
PK,BLOOD GLUCOSE ABNORMAL,5
PK,CONFUSIONAL STATE,5
PK,DEPRESSION,5
PK,DYSURIA,5
PK,EPILEPSY,5
PK,FACIAL PARALYSIS,5
PK,FEMUR FRACTURE,5
PK,HEMIPLEGIA,5
PK,HYPERHIDROSIS,5
PK,HYPOPHAGIA,5
PK,LIVER INJURY,5
PK,LUNG DISORDER,5
PK,MOUTH HAEMORRHAGE,5
PK,MUCOSAL INFLAMMATION,5
PK,MULTI-ORGAN FAILURE,5
PK,MYALGIA,5
PK,MYOPATHY,5
PK,NEPHROLITHIASIS,5
PK,NEUTROPENIA,5
PK,PAIN IN JAW,5
PK,PLEURAL EFFUSION,5
PK,PRURITUS GENERALISED,5
PK,PULMONARY CONGESTION,5
PK,RASH GENERALISED,5
PK,ROAD TRAFFIC ACCIDENT,5
PK,SKIN EXFOLIATION,5
PK,URINARY TRACT INFECTION,5
PK,URINE OUTPUT DECREASED,5
PK,URTICARIA,5
PK,ABNORMAL BEHAVIOUR,4
PK,ACCIDENTAL EXPOSURE TO PRODUCT,4
PK,ACUTE CORONARY SYNDROME,4
PK,AGGRESSION,4
PK,ALOPECIA,4
PK,AMNESIA,4
PK,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,4
PK,BLOOD PRESSURE INADEQUATELY CONTROLLED,4
PK,BREAST CANCER,4
PK,BURNING SENSATION,4
PK,CEREBRAL INFARCTION,4
PK,CONDITION AGGRAVATED,4
PK,CREPITATIONS,4
PK,DEMYELINATION,4
PK,DISORIENTATION,4
PK,DRUG HYPERSENSITIVITY,4
PK,DYSPHAGIA,4
PK,EXPOSURE VIA FATHER,4
PK,FLUSHING,4
PK,FOETAL GROWTH RESTRICTION,4
PK,GENERALISED TONIC-CLONIC SEIZURE,4
PK,HEPATOCELLULAR CARCINOMA,4
PK,HYPONATRAEMIA,4
PK,LEFT VENTRICULAR DYSFUNCTION,4
PK,LEUKOENCEPHALOPATHY,4
PK,LIVER DISORDER,4
PK,METASTASES TO LUNG,4
PK,MOUTH ULCERATION,4
PK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
PK,MUSCLE SPASMS,4
PK,MYELOFIBROSIS,4
PK,NECK PAIN,4
PK,NERVOUS SYSTEM DISORDER,4
PK,OCULAR HYPERAEMIA,4
PK,ODYNOPHAGIA,4
PK,OEDEMA PERIPHERAL,4
PK,OSTEONECROSIS OF JAW,4
PK,OSTEOPOROSIS,4
PK,PALLOR,4
PK,PANCREATITIS ACUTE,4
PK,PATHOGEN RESISTANCE,4
PK,POLYDIPSIA,4
PK,PRODUCT USE IN UNAPPROVED INDICATION,4
PK,PULMONARY EMBOLISM,4
PK,RASH ERYTHEMATOUS,4
PK,RED BLOOD CELL COUNT DECREASED,4
PK,RESPIRATORY ARREST,4
PK,SYNCOPE,4
PK,THROMBOSIS IN DEVICE,4
PK,UPPER LIMB FRACTURE,4
PK,ACUTE MOTOR AXONAL NEUROPATHY,3
PK,ACUTE MYELOID LEUKAEMIA,3
PK,ANGIOEDEMA,3
PK,ANGIOPLASTY,3
PK,ARTERIOSPASM CORONARY,3
PK,ASPHYXIA,3
PK,AUTOIMMUNE THYROIDITIS,3
PK,BLAST CELL COUNT INCREASED,3
PK,BLOOD PRESSURE ABNORMAL,3
PK,CARDIOMYOPATHY,3
PK,CELLULITIS,3
PK,CHILLS,3
PK,CHOKING,3
PK,CHROMATURIA,3
PK,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
PK,CIRCULATORY COLLAPSE,3
PK,CORONARY ARTERY DISEASE,3
PK,CYANOSIS,3
PK,DEMENTIA,3
PK,DEMENTIA ALZHEIMER^S TYPE,3
PK,DENGUE FEVER,3
PK,DERMATITIS EXFOLIATIVE,3
PK,DISCOMFORT,3
PK,DRUG PRESCRIBING ERROR,3
PK,DRUG-INDUCED LIVER INJURY,3
PK,DYSGEUSIA,3
PK,ELECTROCARDIOGRAM ABNORMAL,3
PK,EYE HAEMORRHAGE,3
PK,EYELID OEDEMA,3
PK,FEBRILE NEUTROPENIA,3
PK,GINGIVAL BLEEDING,3
PK,HAEMATOCHEZIA,3
PK,HEART RATE DECREASED,3
PK,HEART RATE INCREASED,3
PK,HEPATIC ENZYME INCREASED,3
PK,HEPATITIS B,3
PK,HEPATOTOXICITY,3
PK,HYPERBILIRUBINAEMIA,3
PK,HYPERVENTILATION,3
PK,HYPOXIA,3
PK,INFUSION SITE ERYTHEMA,3
PK,INJECTION SITE HAEMORRHAGE,3
PK,INTENTIONAL PRODUCT USE ISSUE,3
PK,INTESTINAL OBSTRUCTION,3
PK,LEUKAEMIA RECURRENT,3
PK,LEUKOCYTOSIS,3
PK,LUNG NEOPLASM MALIGNANT,3
PK,LYMPHOCYTE COUNT DECREASED,3
PK,MEMORY IMPAIRMENT,3
PK,METABOLIC ACIDOSIS,3
PK,MUSCULOSKELETAL PAIN,3
PK,NEOPLASM MALIGNANT,3
PK,NEUROBLASTOMA,3
PK,NEUTROPENIC SEPSIS,3
PK,OEDEMA,3
PK,OROPHARYNGEAL PAIN,3
PK,PERIPHERAL ISCHAEMIA,3
PK,PERITONEAL HAEMORRHAGE,3
PK,PNEUMONIA ASPIRATION,3
PK,PRODUCTIVE COUGH,3
PK,QUADRIPARESIS,3
PK,RALES,3
PK,RENAL DISORDER,3
PK,RENAL PAIN,3
PK,RESPIRATORY ACIDOSIS,3
PK,SNEEZING,3
PK,SPEECH DISORDER,3
PK,SPINAL FRACTURE,3
PK,SUDDEN DEATH,3
PK,THROMBOCYTOSIS,3
PK,TREATMENT NONCOMPLIANCE,3
PK,VASCULITIS,3
PK,VISUAL IMPAIRMENT,3
PK,WRIST FRACTURE,3
PK,ABASIA,2
PK,ABDOMINAL DISTENSION,2
PK,ABDOMINAL PAIN LOWER,2
PK,ABORTION INDUCED,2
PK,ABORTION MISSED,2
PK,ACNE,2
PK,ACUTE HEPATIC FAILURE,2
PK,AGEUSIA,2
PK,AMMONIA INCREASED,2
PK,ANKLE FRACTURE,2
PK,ANXIETY,2
PK,APLASIA PURE RED CELL,2
PK,APLASTIC ANAEMIA,2
PK,ARRHYTHMIA SUPRAVENTRICULAR,2
PK,BICYTOPENIA,2
PK,BLOOD CHOLESTEROL INCREASED,2
PK,BLOOD IMMUNOGLOBULIN E INCREASED,2
PK,BLOOD PRESSURE SYSTOLIC INCREASED,2
PK,BLOOD SODIUM INCREASED,2
PK,BLOOD URINE PRESENT,2
PK,BONE CANCER,2
PK,BONE PAIN,2
PK,BRADYCARDIA,2
PK,BRAIN NEOPLASM,2
PK,BRONCHOSPASM,2
PK,CARDIOVASCULAR DISORDER,2
PK,COMA SCALE ABNORMAL,2
PK,CONGENITAL ANOMALY,2
PK,CONJUNCTIVAL HAEMORRHAGE,2
PK,CREATININE URINE INCREASED,2
PK,DEEP VEIN THROMBOSIS,2
PK,DEHYDRATION,2
PK,DEPRESSED LEVEL OF CONSCIOUSNESS,2
PK,DERMATITIS ALLERGIC,2
PK,DIABETIC FOOT,2
PK,DRUG DOSE OMISSION,2
PK,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
PK,DRY MOUTH,2
PK,DYSARTHRIA,2
PK,EATING DISORDER,2
PK,ELECTROCARDIOGRAM QT PROLONGED,2
PK,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
PK,ELECTROCARDIOGRAM T WAVE INVERSION,2
PK,ELECTROLYTE IMBALANCE,2
PK,EPIGASTRIC DISCOMFORT,2
PK,EYE DISORDER,2
PK,EYE INJURY,2
PK,EYE IRRITATION,2
PK,FIXED DRUG ERUPTION,2
PK,FLATULENCE,2
PK,FOAMING AT MOUTH,2
PK,FOETAL DEATH,2
PK,FOETAL DISTRESS SYNDROME,2
PK,FONTANELLE BULGING,2
PK,GANGRENE,2
PK,GASTRIC DISORDER,2
PK,GASTROENTERITIS,2
PK,GASTROINTESTINAL HAEMORRHAGE,2
PK,GENE MUTATION,2
PK,GENERALISED OEDEMA,2
PK,GESTATIONAL DIABETES,2
PK,HAEMORRHAGE INTRACRANIAL,2
PK,HAEMORRHOIDS,2
PK,HEAD INJURY,2
PK,HEMIANOPIA,2
PK,HEMIPARESIS,2
PK,HEPATIC CONGESTION,2
PK,HEPATITIS,2
PK,HEPATOMEGALY,2
PK,HIP FRACTURE,2
PK,HYPERCHLORHYDRIA,2
PK,HYPERKINESIA,2
PK,HYPERPHAGIA,2
PK,HYPERREFLEXIA,2
PK,HYPERTHYROIDISM,2
PK,HYPOACUSIS,2
PK,HYPOKALAEMIA,2
PK,INFUSION SITE EXFOLIATION,2
PK,INFUSION SITE RASH,2
PK,INTRACRANIAL PRESSURE INCREASED,2
PK,KIDNEY CONGESTION,2
PK,KOEBNER PHENOMENON,2
PK,LACRIMATION INCREASED,2
PK,LARGE INTESTINE PERFORATION,2
PK,LINEAR IGA DISEASE,2
PK,LIVER FUNCTION TEST INCREASED,2
PK,LUNG INFECTION,2
PK,MEAN CELL VOLUME DECREASED,2
PK,MELAENA,2
PK,MENTAL STATUS CHANGES,2
PK,METASTASES TO CENTRAL NERVOUS SYSTEM,2
PK,MONOPLEGIA,2
PK,MOVEMENT DISORDER,2
PK,MULTIPLE SCLEROSIS,2
PK,MUSCLE RIGIDITY,2
PK,MUSCULOSKELETAL STIFFNESS,2
PK,NEOPLASM PROGRESSION,2
PK,NEUROENDOCRINE TUMOUR,2
PK,NEUTROPHIL COUNT INCREASED,2
PK,NOCARDIOSIS,2
PK,OESOPHAGEAL VARICES HAEMORRHAGE,2
PK,ORAL MUCOSAL BLISTERING,2
PK,ORAL PAIN,2
PK,ORTHOPNOEA,2
PK,PARAPLEGIA,2
PK,PARESIS,2
PK,PERICARDIAL EFFUSION,2
PK,PIGMENTATION DISORDER,2
PK,PNEUMONITIS,2
PK,POLYCYTHAEMIA VERA,2
PK,PRESYNCOPE,2
PK,PSYCHOTIC DISORDER,2
PK,PULMONARY TUBERCULOSIS,2
PK,PULSE ABSENT,2
PK,PURPURA,2
PK,RASH MACULO-PAPULAR,2
PK,RED MAN SYNDROME,2
PK,RENAL FAILURE ACUTE,2
PK,RESPIRATORY DEPRESSION,2
PK,RESPIRATORY DISORDER,2
PK,RESPIRATORY RATE INCREASED,2
PK,RESPIRATORY TRACT INFECTION,2
PK,RETINOPATHY,2
PK,SEDATION,2
PK,SENSATION OF FOREIGN BODY,2
PK,SENSORY LOSS,2
PK,SEPTIC SHOCK,2
PK,SHOCK HAEMORRHAGIC,2
PK,SPINAL CORD COMPRESSION,2
PK,SPLEEN CONGESTION,2
PK,STEVENS-JOHNSON SYNDROME,2
PK,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,2
PK,SUPRAVENTRICULAR TACHYCARDIA,2
PK,SUSPECTED COUNTERFEIT PRODUCT,2
PK,THROMBOSIS,2
PK,THYROID DISORDER,2
PK,TRANSPLANT DYSFUNCTION,2
PK,TRANSPLANT REJECTION,2
PK,TREATMENT FAILURE,2
PK,TREMOR,2
PK,TUMOUR LYSIS SYNDROME,2
PK,UPPER AIRWAY OBSTRUCTION,2
PK,VEIN COLLAPSE,2
PK,VENTRICULAR FIBRILLATION,2
PK,VENTRICULAR TACHYCARDIA,2
PK,VIITH NERVE PARALYSIS,2
PK,VOMITING PROJECTILE,2
PK,ABDOMINAL RIGIDITY,1
PK,ABDOMINAL TENDERNESS,1
PK,ABDOMINAL WALL HAEMORRHAGE,1
PK,ABSCESS,1
PK,ACIDOSIS,1
PK,ACINETOBACTER BACTERAEMIA,1
PK,ACINETOBACTER INFECTION,1
PK,ACTIVITIES OF DAILY LIVING IMPAIRED,1
PK,ACUTE ABDOMEN,1
PK,ACUTE LEUKAEMIA,1
PK,ACUTE LYMPHOCYTIC LEUKAEMIA,1
PK,ACUTE MYELOID LEUKAEMIA RECURRENT,1
PK,ACUTE POSTOPERATIVE SIALADENITIS,1
PK,ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME,1
PK,ADRENAL MASS,1
PK,ADVERSE DRUG REACTION,1
PK,ADVERSE EVENT,1
PK,AKINESIA,1
PK,ALANINE AMINOTRANSFERASE INCREASED,1
PK,ALVEOLAR SOFT PART SARCOMA METASTATIC,1
PK,AMENORRHOEA,1
PK,AMYLASE INCREASED,1
PK,ANAEMIA MEGALOBLASTIC,1
PK,ANAEMIA POSTOPERATIVE,1
PK,ANAL FISSURE,1
PK,ANGER,1
PK,ANGINA UNSTABLE,1
PK,ANGIOMYOLIPOMA,1
PK,ANTI FACTOR VII ANTIBODY POSITIVE,1
PK,AORTIC ARTERIOSCLEROSIS,1
PK,AORTIC STENOSIS,1
PK,APALLIC SYNDROME,1
PK,APHAGIA,1
PK,APNOEA,1
PK,APPENDICITIS,1
PK,APPLICATION SITE HYPERSENSITIVITY,1
PK,ARTERIOSCLEROSIS,1
PK,ARTERIOSCLEROSIS CORONARY ARTERY,1
PK,ARTERIOVENOUS FISTULA SITE HAEMORRHAGE,1
PK,ARTHROPATHY,1
PK,ASPARTATE AMINOTRANSFERASE INCREASED,1
PK,ASTERIXIS,1
PK,ATAXIA,1
PK,ATRIAL FIBRILLATION,1
PK,ATYPICAL PNEUMONIA,1
PK,AXONAL NEUROPATHY,1
PK,AZOTAEMIA,1
PK,BACK INJURY,1
PK,BACTERIAL SEPSIS,1
PK,BALANCE DISORDER,1
PK,BLADDER HYPERTROPHY,1
PK,BLADDER NEOPLASM,1
PK,BLEEDING VARICOSE VEIN,1
PK,BLEPHARITIS,1
PK,BLINDNESS TRANSIENT,1
PK,BLINDNESS UNILATERAL,1
PK,BLOOD ALBUMIN DECREASED,1
PK,BLOOD CALCIUM DECREASED,1
PK,BLOOD CALCIUM INCREASED,1
PK,BLOOD CREATINE ABNORMAL,1
PK,BLOOD CREATINE PHOSPHOKINASE BB INCREASED,1
PK,BLOOD CREATININE ABNORMAL,1
PK,BLOOD FIBRINOGEN DECREASED,1
PK,BLOOD MAGNESIUM DECREASED,1
PK,BLOOD POTASSIUM DECREASED,1
PK,BLOOD PRESSURE DIASTOLIC INCREASED,1
PK,BLOOD PRESSURE SYSTOLIC DECREASED,1
PK,BLOOD SODIUM DECREASED,1
PK,BLOOD THYROID STIMULATING HORMONE INCREASED,1
PK,BODY TEMPERATURE INCREASED,1
PK,BONE SWELLING,1
PK,BRADYARRHYTHMIA,1
PK,BRADYKINESIA,1
PK,BRAIN INJURY,1
PK,BREAST CANCER METASTATIC,1
PK,BREAST CANCER STAGE III,1
PK,BREAST MASS,1
PK,BREATH SOUNDS ABNORMAL,1
PK,BRONCHIECTASIS,1
PK,CAMPYLOBACTER SEPSIS,1
PK,CANDIDA INFECTION,1
PK,CARDIAC DEATH,1
PK,CARDIAC OUTPUT DECREASED,1
PK,CARDIAC TAMPONADE,1
PK,CARDIAC VALVE REPLACEMENT COMPLICATION,1
PK,CARDIOTOXICITY,1
PK,CATARACT,1
PK,CENTRAL NERVOUS SYSTEM DERMOID TUMOUR,1
PK,CENTRAL NERVOUS SYSTEM LESION,1
PK,CENTRAL NERVOUS SYSTEM VIRAL INFECTION,1
PK,CEREBRAL ATROPHY,1
PK,CEREBRAL ISCHAEMIA,1
PK,CHIKUNGUNYA VIRUS INFECTION,1
PK,CHLOROMA,1
PK,CHOLELITHIASIS,1
PK,CHRONIC KIDNEY DISEASE,1
PK,CLEFT PALATE,1
PK,CLONUS,1
PK,COAGULATION TEST ABNORMAL,1
PK,COGNITIVE DISORDER,1
PK,COLD SWEAT,1
PK,COLON CANCER,1
PK,COMPUTERISED TOMOGRAM ABDOMEN ABNORMAL,1
PK,CONGENITAL HYDROCEPHALUS,1
PK,CONGENITAL MUSCULOSKELETAL ANOMALY,1
PK,CONJUNCTIVAL OEDEMA,1
PK,CONVULSION,1
PK,COORDINATION ABNORMAL,1
PK,COR PULMONALE,1
PK,CORNEAL ABRASION,1
PK,CORNEAL OEDEMA,1
PK,CORONARY ARTERY OCCLUSION,1
PK,CSF PRESSURE INCREASED,1
PK,CYCLOPLEGIA,1
PK,CYST REMOVAL,1
PK,CYSTIC FIBROSIS,1
PK,CYSTOID MACULAR OEDEMA,1
PK,CYTOGENETIC ABNORMALITY,1
PK,CYTOMEGALOVIRUS INFECTION,1
PK,DEAFNESS,1
PK,DEAFNESS NEUROSENSORY,1
PK,DELIRIUM,1
PK,DENTAL CARIES,1
PK,DEPRESSED MOOD,1
PK,DERMATITIS ATOPIC,1
PK,DEVICE DISLOCATION,1
PK,DEVICE ISSUE,1
PK,DEVICE RELATED INFECTION,1
PK,DIABETIC COMPLICATION,1
PK,DIABETIC NEPHROPATHY,1
PK,DIARRHOEA HAEMORRHAGIC,1
PK,DIASTOLIC DYSFUNCTION,1
PK,DIPLOPIA,1
PK,DISCOLOURED VOMIT,1
PK,DISEASE COMPLICATION,1
PK,DISLOCATION OF VERTEBRA,1
PK,DISSEMINATED INTRAVASCULAR COAGULATION,1
PK,DISSEMINATED TUBERCULOSIS,1
PK,DISTURBANCE IN ATTENTION,1
PK,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
PK,DRUG DEPENDENCE,1
PK,DRUG EFFECT INCREASED,1
PK,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
PK,DRUG WITHDRAWAL CONVULSIONS,1
PK,DRY SKIN,1
PK,DYSAESTHESIA,1
PK,DYSLIPIDAEMIA,1
PK,DYSPNOEA AT REST,1
PK,EAR HAEMORRHAGE,1
PK,EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED,1
PK,ECCHYMOSIS,1
PK,ECZEMA,1
PK,EJECTION FRACTION DECREASED,1
PK,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
PK,EMBOLIC STROKE,1
PK,EMBOLISM VENOUS,1
PK,ENCEPHALOPATHY,1
PK,ENDOPHTHALMITIS,1
PK,ENTEROCUTANEOUS FISTULA,1
PK,EOSINOPHIL COUNT INCREASED,1
PK,ESCHERICHIA SEPSIS,1
PK,ESCHERICHIA URINARY TRACT INFECTION,1
PK,EXERCISE TOLERANCE DECREASED,1
PK,EXOSTOSIS,1
PK,EXPIRED DRUG ADMINISTERED,1
PK,EXPOSURE DURING BREAST FEEDING,1
PK,EXTENSOR PLANTAR RESPONSE,1
PK,EYE INFLAMMATION,1
PK,EYE MOVEMENT DISORDER,1
PK,EYE OEDEMA,1
PK,EYE PAIN,1
PK,EYE SWELLING,1
PK,EYELID PTOSIS,1
PK,FACE OEDEMA,1
PK,FAECAL INCONTINENCE,1
PK,FAILED INDUCTION OF LABOUR,1
PK,FALSE NEGATIVE INVESTIGATION RESULT,1
PK,FEEDING DISORDER,1
PK,FEEDING DISORDER NEONATAL,1
PK,FEELING HOT,1
PK,FIBROSIS,1
PK,FISTULA,1
PK,FLUID RETENTION,1
PK,FOETAL EXPOSURE DURING DELIVERY,1
PK,FRACTURE,1
PK,FULL BLOOD COUNT DECREASED,1
PK,GASTRITIS,1
PK,GASTRITIS EROSIVE,1
PK,GASTROINTESTINAL ANASTOMOTIC COMPLICATION,1
PK,GASTROINTESTINAL STROMAL TUMOUR,1
PK,GASTROINTESTINAL WALL THICKENING,1
PK,GAZE PALSY,1
PK,GENITALIA EXTERNAL AMBIGUOUS,1
PK,GLOSSITIS,1
PK,GLYCOSYLATED HAEMOGLOBIN DECREASED,1
PK,GOITRE,1
PK,GRAFT DYSFUNCTION,1
PK,GRAFT THROMBOSIS,1
PK,GRAFT VERSUS HOST DISEASE,1
PK,GRAFT VERSUS HOST DISEASE IN INTESTINE,1
PK,GRAFT VERSUS HOST DISEASE IN LIVER,1
PK,GRAFT VERSUS HOST DISEASE IN SKIN,1
PK,GROWTH RETARDATION,1
PK,HAEMARTHROSIS,1
PK,HAEMATOCRIT DECREASED,1
PK,HAEMATOLOGICAL MALIGNANCY,1
PK,HAEMATOMA,1
PK,HAEMODYNAMIC INSTABILITY,1
PK,HAEMOGLOBIN INCREASED,1
PK,HAEMOLYSIS,1
PK,HAEMOLYTIC ANAEMIA,1
PK,HAEMORRHAGIC DIATHESIS,1
PK,HAEMORRHAGIC STROKE,1
PK,HAIR COLOUR CHANGES,1
PK,HEART RATE ABNORMAL,1
PK,HEART RATE IRREGULAR,1
PK,HEPATIC CANCER,1
PK,HEPATIC HYDROTHORAX,1
PK,HEPATIC LESION,1
PK,HEPATIC NECROSIS,1
PK,HEPATITIS C VIRUS TEST POSITIVE,1
PK,HEPATITIS D,1
PK,HEPATITIS E,1
PK,HEPATITIS FULMINANT,1
PK,HEPATOCELLULAR INJURY,1
PK,HEPATORENAL FAILURE,1
PK,HEPATOSPLENOMEGALY,1
PK,HERNIA,1
PK,HERPES ZOSTER,1
PK,HICCUPS,1
PK,HIGH DENSITY LIPOPROTEIN DECREASED,1
PK,HISTOLOGY ABNORMAL,1
PK,HOSPITALISATION,1
PK,HYDRONEPHROSIS,1
PK,HYPERKALAEMIA,1
PK,HYPEROSMOLAR HYPERGLYCAEMIC STATE,1
PK,HYPERTENSIVE CRISIS,1
PK,HYPERTONIA,1
PK,HYPOKINESIA,1
PK,HYPOVOLAEMIA,1
PK,HYPOVOLAEMIC SHOCK,1
PK,ILL-DEFINED DISORDER,1
PK,IMMUNODEFICIENCY,1
PK,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
PK,IMMUNOSUPPRESSION,1
PK,INCONTINENCE,1
PK,INCORRECT DRUG ADMINISTRATION DURATION,1
PK,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
PK,INCREASED APPETITE,1
PK,INDUCED LABOUR,1
PK,INFESTATION,1
PK,INFLUENZA LIKE ILLNESS,1
PK,INFUSION SITE NECROSIS,1
PK,INFUSION SITE REACTION,1
PK,INFUSION SITE SWELLING,1
PK,INJECTION SITE EXFOLIATION,1
PK,INJECTION SITE HYPERSENSITIVITY,1
PK,INJECTION SITE INFECTION,1
PK,INJECTION SITE NECROSIS,1
PK,INJECTION SITE PAIN,1
PK,INJECTION SITE PRURITUS,1
PK,INJECTION SITE RASH,1
PK,INJECTION SITE REACTION,1
PK,INJECTION SITE SWELLING,1
PK,INJECTION SITE VESICLES,1
PK,INTENTIONAL OVERDOSE,1
PK,INTENTIONAL PRODUCT MISUSE,1
PK,INTERNAL HAEMORRHAGE,1
PK,INTERSTITIAL LUNG DISEASE,1
PK,INTRACRANIAL VENOUS SINUS THROMBOSIS,1
PK,INTRADUCTAL PAPILLARY-MUCINOUS CARCINOMA OF PANCREAS,1
PK,IRIDOCYCLITIS,1
PK,ISCHAEMIC STROKE,1
PK,JAUNDICE CHOLESTATIC,1
PK,JAUNDICE NEONATAL,1
PK,JOINT DISLOCATION,1
PK,JOINT INJURY,1
PK,JOINT SWELLING,1
PK,LABORATORY TEST ABNORMAL,1
PK,LACTIC ACIDOSIS,1
PK,LEFT VENTRICULAR FAILURE,1
PK,LEG AMPUTATION,1
PK,LIMB INJURY,1
PK,LIP AND/OR ORAL CAVITY CANCER,1
PK,LIP SWELLING,1
PK,LIPASE INCREASED,1
PK,LIPIDS INCREASED,1
PK,LIPOMA EXCISION,1
PK,LIVEDO RETICULARIS,1
PK,LIVER FUNCTION TEST ABNORMAL,1
PK,LOCALISED INFECTION,1
PK,LOCALISED OEDEMA,1
PK,LUNG ABSCESS,1
PK,LYMPHADENOPATHY,1
PK,LYMPHOCYTE COUNT INCREASED,1
PK,LYMPHOCYTIC INFILTRATION,1
PK,LYMPHOMA,1
PK,MASS,1
PK,MATERNAL DEATH DURING CHILDBIRTH,1
PK,MATERNAL EXPOSURE DURING DELIVERY,1
PK,MEAN CELL VOLUME INCREASED,1
PK,MEAN PLATELET VOLUME INCREASED,1
PK,MEDICAL DEVICE COMPLICATION,1
PK,MEDICATION ERROR,1
PK,MELANOCYTIC HYPERPLASIA,1
PK,MENINGITIS TUBERCULOUS,1
PK,MENORRHAGIA,1
PK,MENSTRUAL DISORDER,1
PK,MENSTRUATION IRREGULAR,1
PK,MENTAL DISORDER,1
PK,MENTAL IMPAIRMENT,1
PK,METASTASES TO BONE,1
PK,METASTASES TO LIVER,1
PK,METASTASES TO THE MEDIASTINUM,1
PK,METASTASIS,1
PK,METASTATIC NEOPLASM,1
PK,MICROALBUMINURIA,1
PK,MICTURITION DISORDER,1
PK,MICTURITION URGENCY,1
PK,MIOSIS,1
PK,MITRAL VALVE INCOMPETENCE,1
PK,MOBILITY DECREASED,1
PK,MONOCYTE COUNT INCREASED,1
PK,MOTION SICKNESS,1
PK,MUCOSAL EROSION,1
PK,MUSCLE ATROPHY,1
PK,MUSCLE CONTRACTIONS INVOLUNTARY,1
PK,MUSCLE TIGHTNESS,1
PK,MUSCULAR WEAKNESS,1
PK,MYCETOMA MYCOTIC,1
PK,MYELOPROLIFERATIVE NEOPLASM,1
PK,NASAL CONGESTION,1
PK,NASAL NECROSIS,1
PK,NECROTISING COLITIS,1
PK,NEONATAL ASPHYXIA,1
PK,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
PK,NEOPLASM,1
PK,NEPHROTIC SYNDROME,1
PK,NEUROLEPTIC MALIGNANT SYNDROME,1
PK,NEUROTOXICITY,1
PK,NEUTROPHIL COUNT DECREASED,1
PK,NIKOLSKY^S SIGN,1
PK,NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED,1
PK,NYSTAGMUS,1
PK,OBSTRUCTIVE AIRWAYS DISORDER,1
PK,OCULAR TOXICITY,1
PK,OESOPHAGEAL CANDIDIASIS,1
PK,OESOPHAGEAL ULCER,1
PK,OPHTHALMOPLEGIA,1
PK,OPTIC ATROPHY,1
PK,OPTIC PATHWAY INJURY,1
PK,ORAL CANDIDIASIS,1
PK,ORAL MUCOSAL ERUPTION,1
PK,ORAL MUCOSAL EXFOLIATION,1
PK,OROPHARYNGEAL SWELLING,1
PK,OXYGEN SATURATION DECREASED,1
PK,PAIN OF SKIN,1
PK,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
PK,PAPULE,1
PK,PARONYCHIA,1
PK,PARVOVIRUS B19 INFECTION,1
PK,PATHOLOGICAL FRACTURE,1
PK,PEPTIC ULCER,1
PK,PERICARDIAL HAEMORRHAGE,1
PK,PERIORBITAL HAEMATOMA,1
PK,PERIPHERAL MOTOR NEUROPATHY,1
PK,PERIPHERAL SENSORY NEUROPATHY,1
PK,PERITONITIS,1
PK,PETECHIAE,1
PK,PHARYNGEAL DISORDER,1
PK,PHARYNGEAL FISTULA,1
PK,PHOTOPHOBIA,1
PK,PITUITARY TUMOUR BENIGN,1
PK,PLASMA CELL MYELOMA,1
PK,PLASMABLASTIC LYMPHOMA,1
PK,PNEUMOBILIA,1
PK,PNEUMONIA PNEUMOCOCCAL,1
PK,PNEUMOTHORAX,1
PK,POLLAKIURIA,1
PK,POLYDACTYLY,1
PK,POLYNEUROPATHY,1
PK,POOR PERSONAL HYGIENE,1
PK,PORTAL HYPERTENSION,1
PK,POSTOPERATIVE ADHESION,1
PK,POSTPARTUM HAEMORRHAGE,1
PK,PRE-ECLAMPSIA,1
PK,PRESCRIBED OVERDOSE,1
PK,PRODUCT COLOUR ISSUE,1
PK,PRODUCT NAME CONFUSION,1
PK,PRODUCT STORAGE ERROR,1
PK,PROSTATIC DISORDER,1
PK,PROTEINURIA,1
PK,PROTHROMBIN TIME PROLONGED,1
PK,PSEUDOMEMBRANOUS COLITIS,1
PK,PULMONARY ARTERIOPATHY,1
PK,PULMONARY HAEMORRHAGE,1
PK,PULMONARY HYPERTENSIVE CRISIS,1
PK,PULMONARY TOXICITY,1
PK,PULSE ABNORMAL,1
PK,PULSELESS ELECTRICAL ACTIVITY,1
PK,PURULENCE,1
PK,RADIUS FRACTURE,1
PK,RASH PRURITIC,1
PK,RASH PUSTULAR,1
PK,REACTIVE PERFORATING COLLAGENOSIS,1
PK,RECTAL ABSCESS,1
PK,RECTAL HAEMORRHAGE,1
PK,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PK,REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA,1
PK,RENAL ATROPHY,1
PK,RENAL CANCER,1
PK,RENAL CELL CARCINOMA,1
PK,RENAL FAILURE CHRONIC,1
PK,RENAL FUNCTION TEST ABNORMAL,1
PK,RENAL TRANSPLANT FAILURE,1
PK,RENAL TUBULAR NECROSIS,1
PK,RENAL VEIN THROMBOSIS,1
PK,RESPIRATORY TRACT CONGESTION,1
PK,RETINAL VEIN THROMBOSIS,1
PK,RHABDOMYOLYSIS,1
PK,SALIVARY HYPERSECRETION,1
PK,SCAR,1
PK,SCHIZOPHRENIA,1
PK,SCRATCH,1
PK,SECOND PRIMARY MALIGNANCY,1
PK,SERUM FERRITIN INCREASED,1
PK,SINGLE FUNCTIONAL KIDNEY,1
PK,SKIN ATROPHY,1
PK,SKIN DISCOLOURATION,1
PK,SKIN DISORDER,1
PK,SKIN HYPERPIGMENTATION,1
PK,SKIN IRRITATION,1
PK,SKIN OEDEMA,1
PK,SKIN PAPILLOMA,1
PK,SKIN TOXICITY,1
PK,SKULL FRACTURE,1
PK,SLEEP DISORDER,1
PK,SNAKE BITE,1
PK,SPINAL ANAESTHESIA,1
PK,SPINAL COMPRESSION FRACTURE,1
PK,SPINAL CORD DISORDER,1
PK,SPINAL CORD NEOPLASM,1
PK,SPLENECTOMY,1
PK,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,1
PK,STRIDOR,1
PK,SUICIDAL IDEATION,1
PK,SURGERY,1
PK,SURGICAL FAILURE,1
PK,SWOLLEN TONGUE,1
PK,SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA,1
PK,SYSTOLIC DYSFUNCTION,1
PK,TACHYARRHYTHMIA,1
PK,THERAPY NON-RESPONDER,1
PK,THIRST,1
PK,THROAT IRRITATION,1
PK,TINNITUS,1
PK,TONGUE DRY,1
PK,TOTAL LUNG CAPACITY DECREASED,1
PK,TOTAL LUNG CAPACITY INCREASED,1
PK,TOXIC ENCEPHALOPATHY,1
PK,TRANSAMINASES INCREASED,1
PK,TRANSFUSION,1
PK,TRANSIENT PSYCHOSIS,1
PK,TRISMUS,1
PK,TUBEROUS SCLEROSIS,1
PK,TYPE I HYPERSENSITIVITY,1
PK,TYPHOID FEVER,1
PK,UNRESPONSIVE TO STIMULI,1
PK,UPPER GASTROINTESTINAL HAEMORRHAGE,1
PK,UPPER RESPIRATORY TRACT INFECTION,1
PK,URINARY HESITATION,1
PK,URINARY INCONTINENCE,1
PK,URINARY TRACT DISORDER,1
PK,UROSEPSIS,1
PK,UVEITIS,1
PK,VAGINAL HAEMORRHAGE,1
PK,VAGINAL INFECTION,1
PK,VASCULAR GRAFT,1
PK,VASCULAR STENT THROMBOSIS,1
PK,VEIN DISORDER,1
PK,VENOOCCLUSIVE DISEASE,1
PK,VENOUS THROMBOSIS LIMB,1
PK,VENTRICULAR DYSFUNCTION,1
PK,VENTRICULAR HYPOKINESIA,1
PK,VIRAL MUTATION IDENTIFIED,1
PK,VITAMIN B12 DEFICIENCY,1
PK,VITH NERVE PARALYSIS,1
PK,VITREOUS HAEMORRHAGE,1
PK,VULVOVAGINAL BURNING SENSATION,1
PK,WALDENSTROM^S MACROGLOBULINAEMIA,1
PK,WITHDRAWAL SYNDROME,1
PK,WOUND,1
PK,WOUND INFECTION,1
PK,WRONG DRUG ADMINISTERED,1
PK,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
PK,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
PK,XEROSIS,1
PK,YELLOW SKIN,1
PW,ANGINA UNSTABLE,1
PS,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,3
PS,FATIGUE,3
PS,ABDOMINAL PAIN UPPER,2
PS,ANAEMIA,2
PS,DRUG INEFFECTIVE,2
PS,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
PS,INTENTIONAL PRODUCT MISUSE,2
PS,LEUKOPENIA,2
PS,MYALGIA,2
PS,NEUTROPENIA,2
PS,PANCYTOPENIA,2
PS,PNEUMONIA,2
PS,RESPIRATORY FAILURE,2
PS,SPLENOMEGALY,2
PS,THROMBOCYTOPENIA,2
PS,TREATMENT FAILURE,2
PS,ABORTION,1
PS,ACUTE LEUKAEMIA,1
PS,ANAL ABSCESS,1
PS,ANXIETY,1
PS,ASTHENIA,1
PS,AUTOIMMUNE HEPATITIS,1
PS,BACK PAIN,1
PS,BLINDNESS UNILATERAL,1
PS,BLOOD CHOLESTEROL INCREASED,1
PS,BLOOD GLUCOSE INCREASED,1
PS,BLOOD PARATHYROID HORMONE INCREASED,1
PS,BLOOD TRIGLYCERIDES INCREASED,1
PS,BONE MARROW FAILURE,1
PS,BONE PAIN,1
PS,BRONCHOSPASM,1
PS,CHEST DISCOMFORT,1
PS,CHEST PAIN,1
PS,CHLOROMA,1
PS,CHRONIC MYELOID LEUKAEMIA,1
PS,COMA,1
PS,CONSTIPATION,1
PS,COUGH,1
PS,CYTOGENETIC ANALYSIS ABNORMAL,1
PS,DEATH,1
PS,DECREASED APPETITE,1
PS,DIABETES MELLITUS,1
PS,DIABETES MELLITUS INADEQUATE CONTROL,1
PS,DIARRHOEA,1
PS,DIPLEGIA,1
PS,DISCOMFORT,1
PS,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
PS,ELECTROLYTE IMBALANCE,1
PS,ENDOPHTHALMITIS,1
PS,FEEDING DISORDER,1
PS,FEELING COLD,1
PS,GAIT DISTURBANCE,1
PS,GASTRIC CANCER,1
PS,GASTROINTESTINAL HAEMORRHAGE,1
PS,HAEMATEMESIS,1
PS,HAEMOGLOBIN DECREASED,1
PS,HAEMOLYSIS,1
PS,HAEMOLYTIC ANAEMIA,1
PS,HAEMORRHAGE,1
PS,HEART RATE DECREASED,1
PS,HYPERTHERMIA,1
PS,HYPOAESTHESIA,1
PS,HYPOTENSION,1
PS,HYPOTONIA,1
PS,HYPOXIA,1
PS,INFECTION,1
PS,INFECTIOUS MONONUCLEOSIS,1
PS,INFUSION RELATED REACTION,1
PS,INTERMITTENT CLAUDICATION,1
PS,INTERVERTEBRAL DISC DEGENERATION,1
PS,LOWER RESPIRATORY TRACT INFECTION,1
PS,MALAISE,1
PS,MALIGNANT NEOPLASM PROGRESSION,1
PS,MASS,1
PS,MATERNAL EXPOSURE DURING PREGNANCY,1
PS,MUSCLE SPASMS,1
PS,MYOCARDIAL INFARCTION,1
PS,NAUSEA,1
PS,PAIN,1
PS,PARALYSIS,1
PS,PLATELET COUNT DECREASED,1
PS,PRODUCT USE ISSUE,1
PS,PYREXIA,1
PS,SEIZURE,1
PS,SENSORY LOSS,1
PS,SEPSIS,1
PS,SINUS TACHYCARDIA,1
PS,SPINAL CORD COMPRESSION,1
PS,THROMBOCYTOSIS,1
PS,TREMOR,1
PS,VOMITING,1
PS,WALKING DISABILITY,1
PS,WEIGHT INCREASED,1
PS,WHITE BLOOD CELL COUNT DECREASED,1
PA,DEATH,68
PA,HEADACHE,52
PA,ASTHENIA,51
PA,MALAISE,51
PA,PYREXIA,37
PA,HAEMOGLOBIN DECREASED,36
PA,PAIN,36
PA,FATIGUE,34
PA,DIZZINESS,33
PA,DIARRHOEA,28
PA,NAUSEA,28
PA,PAIN IN EXTREMITY,28
PA,SERUM FERRITIN INCREASED,27
PA,DYSPNOEA,26
PA,VOMITING,26
PA,ARTHRALGIA,25
PA,BACK PAIN,23
PA,GAIT DISTURBANCE,22
PA,NASOPHARYNGITIS,21
PA,ABDOMINAL DISCOMFORT,20
PA,MULTIPLE SCLEROSIS RELAPSE,20
PA,FALL,19
PA,HYPERTENSION,18
PA,ABDOMINAL PAIN UPPER,17
PA,CHEST PAIN,17
PA,WEIGHT DECREASED,17
PA,HYPOAESTHESIA,16
PA,SEIZURE,16
PA,SYNCOPE,16
PA,COUGH,15
PA,FEELING ABNORMAL,15
PA,INSOMNIA,15
PA,ABDOMINAL PAIN,14
PA,DRUG INEFFECTIVE,14
PA,OEDEMA PERIPHERAL,14
PA,VISUAL IMPAIRMENT,14
PA,DECREASED APPETITE,13
PA,MEMORY IMPAIRMENT,13
PA,PERIPHERAL SWELLING,13
PA,PNEUMONIA,13
PA,ANXIETY,12
PA,BLOOD PRESSURE INCREASED,12
PA,ERYTHEMA,12
PA,TACHYCARDIA,12
PA,TOXICITY TO VARIOUS AGENTS,12
PA,VISION BLURRED,12
PA,AGITATION,11
PA,CEREBROVASCULAR ACCIDENT,11
PA,PRURITUS,11
PA,SOMNOLENCE,11
PA,BLOOD GLUCOSE INCREASED,10
PA,CENTRAL NERVOUS SYSTEM LESION,10
PA,CHILLS,10
PA,EYE PAIN,10
PA,GENERAL PHYSICAL HEALTH DETERIORATION,10
PA,MUSCULAR WEAKNESS,10
PA,RASH,10
PA,SICKLE CELL ANAEMIA WITH CRISIS,10
PA,ABASIA,9
PA,HYPOTENSION,9
PA,SPEECH DISORDER,9
PA,URINARY TRACT INFECTION,9
PA,ABDOMINAL DISTENSION,8
PA,ACNE,8
PA,ALOPECIA,8
PA,BONE PAIN,8
PA,CONSTIPATION,8
PA,DIABETES MELLITUS,8
PA,GASTRITIS,8
PA,HIP FRACTURE,8
PA,HYPERHIDROSIS,8
PA,LOSS OF CONSCIOUSNESS,8
PA,STRESS,8
PA,SWELLING,8
PA,THROMBOSIS,8
PA,TREMOR,8
PA,AGGRESSION,7
PA,ANAEMIA,7
PA,BURNING SENSATION,7
PA,CATARACT,7
PA,DEPRESSED MOOD,7
PA,DISCOMFORT,7
PA,DISORIENTATION,7
PA,MALIGNANT NEOPLASM PROGRESSION,7
PA,MOYAMOYA DISEASE,7
PA,MYOCARDIAL INFARCTION,7
PA,OBESITY,7
PA,PLATELET COUNT DECREASED,7
PA,SKIN ULCER,7
PA,SPINAL PAIN,7
PA,STOMATITIS,7
PA,ASTHMATIC CRISIS,6
PA,BALANCE DISORDER,6
PA,BLOOD CHOLESTEROL INCREASED,6
PA,BODY MASS INDEX INCREASED,6
PA,CHEST DISCOMFORT,6
PA,CONTUSION,6
PA,DEMENTIA ALZHEIMER^S TYPE,6
PA,DYSSTASIA,6
PA,DYSURIA,6
PA,EXPOSURE DURING PREGNANCY,6
PA,FLATULENCE,6
PA,HAEMORRHAGE,6
PA,HEART RATE DECREASED,6
PA,HORMONE LEVEL ABNORMAL,6
PA,HYPERGLYCAEMIA,6
PA,HYPERSENSITIVITY,6
PA,LIMB DISCOMFORT,6
PA,MOBILITY DECREASED,6
PA,MUSCULOSKELETAL STIFFNESS,6
PA,PARAESTHESIA,6
PA,PULMONARY OEDEMA,6
PA,TRANSIENT ISCHAEMIC ATTACK,6
PA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,6
PA,BLOOD GROWTH HORMONE INCREASED,5
PA,BLOOD IRON INCREASED,5
PA,CARDIAC ARREST,5
PA,CARDIAC DISORDER,5
PA,CHOLELITHIASIS,5
PA,CRYING,5
PA,DISEASE PROGRESSION,5
PA,DISEASE RECURRENCE,5
PA,HYPOKINESIA,5
PA,HYPOPHAGIA,5
PA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
PA,INFECTION,5
PA,INFLUENZA,5
PA,JAUNDICE,5
PA,MULTIPLE SCLEROSIS,5
PA,MUSCULOSKELETAL PAIN,5
PA,MYALGIA,5
PA,NECK PAIN,5
PA,NEOPLASM,5
PA,NEOPLASM PROGRESSION,5
PA,ORAL PAIN,5
PA,PALLOR,5
PA,PRODUCT USE ISSUE,5
PA,PRURITUS GENERALISED,5
PA,RENAL FAILURE,5
PA,THROMBOCYTOPENIA,5
PA,ARRHYTHMIA,4
PA,BLISTER,4
PA,BLOOD CREATININE INCREASED,4
PA,BLOOD GLUCOSE DECREASED,4
PA,BRADYCARDIA,4
PA,COORDINATION ABNORMAL,4
PA,DEHYDRATION,4
PA,DEPRESSION,4
PA,DEVICE OCCLUSION,4
PA,DISEASE COMPLICATION,4
PA,DRUG INTOLERANCE,4
PA,DRY SKIN,4
PA,ECCHYMOSIS,4
PA,EPISTAXIS,4
PA,FACIAL PARALYSIS,4
PA,FLUID RETENTION,4
PA,GLOSSODYNIA,4
PA,HEMIPARESIS,4
PA,HYPOACUSIS,4
PA,IMPAIRED HEALING,4
PA,ISCHAEMIA,4
PA,LIVER DISORDER,4
PA,MACULAR DEGENERATION,4
PA,METASTASES TO LUNG,4
PA,MUSCLE SPASMS,4
PA,NERVOUS SYSTEM DISORDER,4
PA,ORAL DISORDER,4
PA,PALPITATIONS,4
PA,PRODUCTIVE COUGH,4
PA,RENAL CANCER,4
PA,RESTLESSNESS,4
PA,SKIN DISORDER,4
PA,SKIN EXFOLIATION,4
PA,THERAPEUTIC RESPONSE DECREASED,4
PA,URINARY RETENTION,4
PA,VAGINAL HAEMORRHAGE,4
PA,WHITE BLOOD CELL COUNT DECREASED,4
PA,ABDOMINAL HERNIA,3
PA,AMNESIA,3
PA,APHASIA,3
PA,APPARENT DEATH,3
PA,APPLICATION SITE PAIN,3
PA,ASTHMA,3
PA,BLINDNESS,3
PA,BLOOD POTASSIUM DECREASED,3
PA,BRAIN NEOPLASM,3
PA,BRAIN OEDEMA,3
PA,BREAST CANCER,3
PA,BRONCHITIS,3
PA,BRONCHOSPASM,3
PA,CARCINOID CRISIS,3
PA,CARDIAC FAILURE,3
PA,CEREBRAL ATROPHY,3
PA,CEREBRAL ISCHAEMIA,3
PA,CHOKING,3
PA,CHOKING SENSATION,3
PA,CONCOMITANT DISEASE AGGRAVATED,3
PA,CROHN^S DISEASE,3
PA,DECREASED IMMUNE RESPONSIVENESS,3
PA,DEEP VEIN THROMBOSIS,3
PA,DEVICE RELATED INFECTION,3
PA,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,3
PA,DRUG-INDUCED LIVER INJURY,3
PA,DRY MOUTH,3
PA,DYSARTHRIA,3
PA,DYSGEUSIA,3
PA,DYSKINESIA,3
PA,DYSPEPSIA,3
PA,EATING DISORDER,3
PA,EMOTIONAL DISORDER,3
PA,EXTREMITY NECROSIS,3
PA,EYE PRURITUS,3
PA,FACE OEDEMA,3
PA,FACIAL PAIN,3
PA,FEELING HOT,3
PA,FOETAL EXPOSURE DURING PREGNANCY,3
PA,GENERALISED OEDEMA,3
PA,GLAUCOMA,3
PA,GLOSSITIS,3
PA,HAEMATOMA,3
PA,HAEMOGLOBIN ABNORMAL,3
PA,HEMIPLEGIA,3
PA,HEPATIC SIDEROSIS,3
PA,HEPATOMEGALY,3
PA,HYPERTENSIVE CRISIS,3
PA,HYPOGLYCAEMIA,3
PA,INCORRECT DOSE ADMINISTERED,3
PA,INFARCTION,3
PA,INFUSION RELATED REACTION,3
PA,INTRAOCULAR PRESSURE INCREASED,3
PA,ISCHAEMIC STROKE,3
PA,LEG AMPUTATION,3
PA,MENTAL DISORDER,3
PA,METASTASES TO BONE,3
PA,METASTASES TO LIVER,3
PA,MOOD ALTERED,3
PA,MOUTH HAEMORRHAGE,3
PA,MUSCULOSKELETAL DISCOMFORT,3
PA,NASAL CONGESTION,3
PA,OCULAR HYPERAEMIA,3
PA,OEDEMA,3
PA,OPTIC NEURITIS,3
PA,OSTEOARTHRITIS,3
PA,PANCREATITIS,3
PA,PARALYSIS,3
PA,PERITONITIS,3
PA,POST PROCEDURAL COMPLICATION,3
PA,RENAL IMPAIRMENT,3
PA,RESPIRATORY FAILURE,3
PA,RHINORRHOEA,3
PA,SICKLE CELL ANAEMIA,3
PA,SKIN LESION,3
PA,TOOTHACHE,3
PA,VIRAL UPPER RESPIRATORY TRACT INFECTION,3
PA,VISUAL ACUITY REDUCED,3
PA,WEIGHT INCREASED,3
PA,WHITE BLOOD CELL COUNT INCREASED,3
PA,WOUND,3
PA,WOUND SECRETION,3
PA,ABDOMINAL MASS,2
PA,ABNORMAL SENSATION IN EYE,2
PA,ABSCESS,2
PA,ANAPHYLACTIC REACTION,2
PA,ANURIA,2
PA,APHTHOUS ULCER,2
PA,APPLICATION SITE ERYTHEMA,2
PA,ARTHRITIS,2
PA,ASPHYXIA,2
PA,BLINDNESS UNILATERAL,2
PA,BLOOD GLUCOSE FLUCTUATION,2
PA,BLOOD PRESSURE DECREASED,2
PA,BLOOD PRESSURE INADEQUATELY CONTROLLED,2
PA,BLOOD SODIUM DECREASED,2
PA,BONE CANCER METASTATIC,2
PA,BONE DISORDER,2
PA,BONE LOSS,2
PA,BRUXISM,2
PA,CARDIO-RESPIRATORY ARREST,2
PA,CARDIOMEGALY,2
PA,CATHETER SITE ABSCESS,2
PA,CELLULITIS,2
PA,CEREBRAL DISORDER,2
PA,CEREBRAL INFARCTION,2
PA,CEREBROVASCULAR DISORDER,2
PA,CHEILITIS,2
PA,CHOLECYSTECTOMY,2
PA,CHOLECYSTITIS ACUTE,2
PA,COMPLICATION ASSOCIATED WITH DEVICE,2
PA,CONDITION AGGRAVATED,2
PA,CONFUSIONAL STATE,2
PA,CYANOSIS,2
PA,CYST,2
PA,CYTOGENETIC ANALYSIS ABNORMAL,2
PA,DECUBITUS ULCER,2
PA,DERMATITIS CONTACT,2
PA,DEVICE ISSUE,2
PA,DIPLEGIA,2
PA,DISABILITY,2
PA,DRUG MONITORING PROCEDURE NOT PERFORMED,2
PA,DYSPHAGIA,2
PA,ELECTROCARDIOGRAM QT PROLONGED,2
PA,ELECTROENCEPHALOGRAM ABNORMAL,2
PA,ENCEPHALOPATHY,2
PA,EPILEPSY,2
PA,EXOPHTHALMOS,2
PA,EYE HAEMORRHAGE,2
PA,EYE INFECTION,2
PA,EYELID PTOSIS,2
PA,FEEDING DISORDER,2
PA,FREQUENT BOWEL MOVEMENTS,2
PA,GAIT INABILITY,2
PA,GASTROINTESTINAL HAEMORRHAGE,2
PA,HAEMATOCHEZIA,2
PA,HALLUCINATION,2
PA,HEAD DISCOMFORT,2
PA,HEAD INJURY,2
PA,HEART RATE INCREASED,2
PA,HEPATIC CANCER METASTATIC,2
PA,HERPES SIMPLEX,2
PA,HYDROCEPHALUS,2
PA,HYPOAESTHESIA ORAL,2
PA,INADEQUATE HAEMODIALYSIS,2
PA,INJECTION SITE PAIN,2
PA,INTERVERTEBRAL DISC PROTRUSION,2
PA,IRRITABILITY,2
PA,LEUKOENCEPHALOPATHY,2
PA,LUNG CANCER METASTATIC,2
PA,LYMPHADENOPATHY,2
PA,LYMPHOCYTE COUNT DECREASED,2
PA,MALNUTRITION,2
PA,MATERNAL EXPOSURE DURING PREGNANCY,2
PA,MELAENA,2
PA,MELANOCYTIC NAEVUS,2
PA,MENINGIOMA,2
PA,METASTASES TO CENTRAL NERVOUS SYSTEM,2
PA,MOUTH SWELLING,2
PA,MOVEMENT DISORDER,2
PA,MUSCLE CONTRACTIONS INVOLUNTARY,2
PA,MUSCLE RIGIDITY,2
PA,MUSCULOSKELETAL CHEST PAIN,2
PA,MYELOFIBROSIS,2
PA,NAIL DISORDER,2
PA,NEPHROLITHIASIS,2
PA,NERVOUSNESS,2
PA,NEURALGIA,2
PA,OCULAR ICTERUS,2
PA,ONYCHOCLASIS,2
PA,ORAL DISCOMFORT,2
PA,OROPHARYNGEAL PAIN,2
PA,OVERDOSE,2
PA,PARAPLEGIA,2
PA,PERIORBITAL OEDEMA,2
PA,PHLEBITIS,2
PA,PLEURAL EFFUSION,2
PA,POLLAKIURIA,2
PA,POOR QUALITY SLEEP,2
PA,POST-TRAUMATIC PAIN,2
PA,PRESCRIBED UNDERDOSE,2
PA,PROCEDURAL PAIN,2
PA,PRODUCT USE IN UNAPPROVED INDICATION,2
PA,PROSTATE CANCER,2
PA,PROTEIN TOTAL DECREASED,2
PA,PSORIASIS,2
PA,PSORIATIC ARTHROPATHY,2
PA,PTERYGIUM,2
PA,PULMONARY EMBOLISM,2
PA,RASH ERYTHEMATOUS,2
PA,RASH GENERALISED,2
PA,RASH PRURITIC,2
PA,RASH PUSTULAR,2
PA,RECTAL HAEMORRHAGE,2
PA,RESPIRATORY ARREST,2
PA,RESPIRATORY DISTRESS,2
PA,SALIVARY HYPERSECRETION,2
PA,SEPSIS,2
PA,SINGLE FUNCTIONAL KIDNEY,2
PA,SINUSITIS,2
PA,SKIN INFECTION,2
PA,SKIN IRRITATION,2
PA,SNEEZING,2
PA,SPINAL FRACTURE,2
PA,SPINAL OSTEOARTHRITIS,2
PA,SPLENOMEGALY,2
PA,STEVENS-JOHNSON SYNDROME,2
PA,SUBCUTANEOUS ABSCESS,2
PA,SWELLING FACE,2
PA,THYROID DISORDER,2
PA,TUBERCULOSIS,2
PA,UNEVALUABLE EVENT,2
PA,UPPER GASTROINTESTINAL HAEMORRHAGE,2
PA,URINARY INCONTINENCE,2
PA,URTICARIA,2
PA,UVEITIS,2
PA,VARICOSE VEIN,2
PA,VERTIGO,2
PA,VIRAL INFECTION,2
PA,WAIST CIRCUMFERENCE INCREASED,2
PA,ABDOMINAL PAIN LOWER,1
PA,ABDOMINAL TENDERNESS,1
PA,ABSCESS JAW,1
PA,ABSCESS LIMB,1
PA,ABSCESS RUPTURE,1
PA,ACROMEGALY,1
PA,ACTIVITIES OF DAILY LIVING IMPAIRED,1
PA,ACUTE CHEST SYNDROME,1
PA,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
PA,ACUTE HEPATIC FAILURE,1
PA,ACUTE MYOCARDIAL INFARCTION,1
PA,ACUTE PULMONARY OEDEMA,1
PA,ADENOMA BENIGN,1
PA,ADVERSE EVENT,1
PA,AGEUSIA,1
PA,ALANINE AMINOTRANSFERASE INCREASED,1
PA,ALBUMIN URINE PRESENT,1
PA,AMAUROSIS,1
PA,AMNIOTIC FLUID VOLUME DECREASED,1
PA,ANAEMIA MEGALOBLASTIC,1
PA,ANAESTHETIC COMPLICATION,1
PA,ANAL ABSCESS,1
PA,ANAL INCONTINENCE,1
PA,ANAL PRURITUS,1
PA,ANEURYSM RUPTURED,1
PA,ANGER,1
PA,ANGIOEDEMA,1
PA,ANGIOPATHY,1
PA,ANKLE DEFORMITY,1
PA,ANORECTAL DISCOMFORT,1
PA,ANTINUCLEAR ANTIBODY POSITIVE,1
PA,APATHY,1
PA,APHONIA,1
PA,APPLICATION SITE HYPERSENSITIVITY,1
PA,ARTERIAL DISORDER,1
PA,ARTERIAL OCCLUSIVE DISEASE,1
PA,ARTERIOVENOUS FISTULA OCCLUSION,1
PA,ARTERIOVENOUS FISTULA OPERATION,1
PA,ARTHROPATHY,1
PA,ARTHROPOD BITE,1
PA,ASCITES,1
PA,ASTHENOPIA,1
PA,ASTIGMATISM,1
PA,ATYPICAL PNEUMONIA,1
PA,AUTOIMMUNE DISORDER,1
PA,AXILLARY VEIN THROMBOSIS,1
PA,BACTERAEMIA,1
PA,BACTERIAL INFECTION,1
PA,BASAL CELL CARCINOMA,1
PA,BENIGN BREAST NEOPLASM,1
PA,BENIGN HEPATIC NEOPLASM,1
PA,BENIGN NEOPLASM,1
PA,BENIGN SPLEEN TUMOUR,1
PA,BICYTOPENIA,1
PA,BK VIRUS INFECTION,1
PA,BLADDER SPHINCTER ATONY,1
PA,BLAST CELLS,1
PA,BLEPHARITIS,1
PA,BLINDNESS TRANSIENT,1
PA,BLOOD ALBUMIN DECREASED,1
PA,BLOOD ALKALINE PHOSPHATASE INCREASED,1
PA,BLOOD COUNT ABNORMAL,1
PA,BLOOD CREATINE INCREASED,1
PA,BLOOD CREATININE ABNORMAL,1
PA,BLOOD DISORDER,1
PA,BLOOD FOLATE INCREASED,1
PA,BLOOD IRON DECREASED,1
PA,BLOOD LACTATE DEHYDROGENASE INCREASED,1
PA,BLOOD PARATHYROID HORMONE ABNORMAL,1
PA,BLOOD PHOSPHORUS INCREASED,1
PA,BLOOD PRESSURE ABNORMAL,1
PA,BLOOD PRESSURE FLUCTUATION,1
PA,BLOOD PRESSURE SYSTOLIC INCREASED,1
PA,BLOOD PROLACTIN INCREASED,1
PA,BLOOD SODIUM INCREASED,1
PA,BLOOD TRIGLYCERIDES INCREASED,1
PA,BLOOD UREA INCREASED,1
PA,BLOOD URIC ACID ABNORMAL,1
PA,BLOOD URINE,1
PA,BLOOD URINE PRESENT,1
PA,BONE DECALCIFICATION,1
PA,BONE MARROW FAILURE,1
PA,BRADYARRHYTHMIA,1
PA,BRAIN HYPOXIA,1
PA,BRAIN INJURY,1
PA,BREAST INFLAMMATION,1
PA,BRONCHIOLITIS,1
PA,CALCULUS URINARY,1
PA,CARDIAC FAILURE CONGESTIVE,1
PA,CARDIAC INFECTION,1
PA,CARDIAC PROCEDURE COMPLICATION,1
PA,CARDIOGENIC SHOCK,1
PA,CARDIOVASCULAR DISORDER,1
PA,CAROTID ARTERY OCCLUSION,1
PA,CATARRH,1
PA,CATHETER SITE DISCHARGE,1
PA,CATHETER SITE PAIN,1
PA,CEREBELLAR ATROPHY,1
PA,CEREBRAL HAEMORRHAGE,1
PA,CHLOROMA,1
PA,CHRONIC MYELOID LEUKAEMIA,1
PA,CLOSTRIDIUM DIFFICILE INFECTION,1
PA,COGNITIVE DISORDER,1
PA,COLITIS,1
PA,COMA,1
PA,COMPLETED SUICIDE,1
PA,CONGENITAL NEUROLOGICAL DISORDER,1
PA,CONJUNCTIVAL HAEMORRHAGE,1
PA,CONJUNCTIVITIS,1
PA,CONTRAINDICATED PRODUCT ADMINISTERED,1
PA,CONVULSION,1
PA,CONVULSION NEONATAL,1
PA,CORNEAL INFECTION,1
PA,CORONARY ARTERY OCCLUSION,1
PA,CORTISOL DECREASED,1
PA,CRANIOCEREBRAL INJURY,1
PA,CUTANEOUS VASCULITIS,1
PA,CYTOKINE RELEASE SYNDROME,1
PA,CYTOKINE STORM,1
PA,DEAFNESS,1
PA,DECREASED ACTIVITY,1
PA,DECREASED INTEREST,1
PA,DEFAECATION URGENCY,1
PA,DELIVERY,1
PA,DENGUE FEVER,1
PA,DENTAL CARIES,1
PA,DEPRESSED LEVEL OF CONSCIOUSNESS,1
PA,DERMATITIS ALLERGIC,1
PA,DIABETES MELLITUS INADEQUATE CONTROL,1
PA,DIABETIC FOOT,1
PA,DIALYSIS,1
PA,DISTRACTIBILITY,1
PA,DISTURBANCE IN ATTENTION,1
PA,DIVERTICULAR PERFORATION,1
PA,DIVERTICULITIS,1
PA,DIVERTICULUM,1
PA,DIZZINESS POSTURAL,1
PA,DRUG EFFECT INCOMPLETE,1
PA,DRUG EFFECT VARIABLE,1
PA,DRUG HYPERSENSITIVITY,1
PA,DRUG RESISTANCE,1
PA,DRY EYE,1
PA,DYSAESTHESIA,1
PA,DYSGRAPHIA,1
PA,EAR DISCOMFORT,1
PA,ELECTRIC SHOCK,1
PA,ELECTROLYTE IMBALANCE,1
PA,EMOTIONAL DISTRESS,1
PA,END STAGE RENAL DISEASE,1
PA,ENDOCARDITIS,1
PA,ENDOCRINE DISORDER,1
PA,EOSINOPHILIA,1
PA,EPIGASTRIC DISCOMFORT,1
PA,ERYTHEMA OF EYELID,1
PA,ESCHERICHIA URINARY TRACT INFECTION,1
PA,EXERCISE TEST ABNORMAL,1
PA,EXTRA DOSE ADMINISTERED,1
PA,EYE ABSCESS,1
PA,EYE DISORDER,1
PA,EYE INJURY,1
PA,EYE IRRITATION,1
PA,EYE SWELLING,1
PA,FAECES HARD,1
PA,FEAR,1
PA,FEBRILE NEUTROPENIA,1
PA,FEELING DRUNK,1
PA,FEMUR FRACTURE,1
PA,FIBROMYALGIA,1
PA,FIBULA FRACTURE,1
PA,FLUSHING,1
PA,FOAMING AT MOUTH,1
PA,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
PA,FOOD INTERACTION,1
PA,FOOD INTOLERANCE,1
PA,FOOT DEFORMITY,1
PA,FOOT FRACTURE,1
PA,FOREARM FRACTURE,1
PA,FRACTURE,1
PA,FURUNCLE,1
PA,GALLBLADDER DISORDER,1
PA,GASTRIC ULCER,1
PA,GASTRITIS BACTERIAL,1
PA,GASTROENTERITIS,1
PA,GASTROINTESTINAL INFECTION,1
PA,GASTROINTESTINAL INFLAMMATION,1
PA,GASTROINTESTINAL OEDEMA,1
PA,GASTROOESOPHAGEAL REFLUX DISEASE,1
PA,GAZE PALSY,1
PA,GENERAL PHYSICAL CONDITION ABNORMAL,1
PA,GENITAL LESION,1
PA,GINGIVAL ABSCESS,1
PA,GINGIVAL PAIN,1
PA,GLOMERULAR FILTRATION RATE DECREASED,1
PA,GOITRE,1
PA,GRAFT COMPLICATION,1
PA,GRAFT VERSUS HOST DISEASE,1
PA,GRIP STRENGTH DECREASED,1
PA,HAEMATEMESIS,1
PA,HAEMATOTOXICITY,1
PA,HAEMOCHROMATOSIS,1
PA,HAEMORRHAGE IN PREGNANCY,1
PA,HAEMORRHAGIC DISORDER,1
PA,HAEMORRHAGIC STROKE,1
PA,HAEMORRHOIDS,1
PA,HALLUCINATION_ VISUAL,1
PA,HAND DEFORMITY,1
PA,HAND FRACTURE,1
PA,HEAD TITUBATION,1
PA,HEART RATE IRREGULAR,1
PA,HELICOBACTER GASTRITIS,1
PA,HEPATIC CANCER,1
PA,HEPATIC ENZYME INCREASED,1
PA,HEPATIC LESION,1
PA,HEPATIC STEATOSIS,1
PA,HEPATITIS,1
PA,HEPATITIS B,1
PA,HEPATOTOXICITY,1
PA,HERPES ZOSTER,1
PA,HICCUPS,1
PA,HIP ARTHROPLASTY,1
PA,HIV INFECTION,1
PA,HOSPITALISATION,1
PA,HUMAN BITE,1
PA,HUNGER,1
PA,HYPERAESTHESIA,1
PA,HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME,1
PA,HYPERSPLENISM,1
PA,HYPERTHYROIDISM,1
PA,HYPOCALCAEMIA,1
PA,HYPOKALAEMIA,1
PA,HYPONATRAEMIA,1
PA,HYPOPHYSITIS,1
PA,HYPOPLASTIC RIGHT HEART SYNDROME,1
PA,HYPOTHALAMO-PITUITARY DISORDER,1
PA,HYPOTHYROIDISM,1
PA,HYPOXIA,1
PA,IDIOPATHIC PULMONARY FIBROSIS,1
PA,ILEUS,1
PA,IMMUNODEFICIENCY,1
PA,INAPPROPRIATE AFFECT,1
PA,INCOHERENT,1
PA,INCONTINENCE,1
PA,INCORRECT DRUG ADMINISTRATION DURATION,1
PA,INCREASED UPPER AIRWAY SECRETION,1
PA,INFLAMMATION,1
PA,INJECTION SITE DISCOLOURATION,1
PA,INJECTION SITE ERYTHEMA,1
PA,INJECTION SITE HAEMATOMA,1
PA,INJECTION SITE PRURITUS,1
PA,INJECTION SITE RASH,1
PA,INNER EAR DISORDER,1
PA,INSULIN-LIKE GROWTH FACTOR DECREASED,1
PA,INSULIN-LIKE GROWTH FACTOR INCREASED,1
PA,INTENTIONAL PRODUCT USE ISSUE,1
PA,INTENTIONAL SELF-INJURY,1
PA,INTERVERTEBRAL DISC DEGENERATION,1
PA,INTERVERTEBRAL DISC DISORDER,1
PA,INTESTINAL FISTULA,1
PA,INTESTINAL HAEMORRHAGE,1
PA,INTESTINAL MASS,1
PA,INTESTINAL OBSTRUCTION,1
PA,INTESTINAL PERFORATION,1
PA,INTESTINAL STENOSIS,1
PA,INTRACARDIAC MASS,1
PA,INVESTIGATION ABNORMAL,1
PA,IODINE UPTAKE ABNORMAL,1
PA,IRRITABLE BOWEL SYNDROME,1
PA,JOINT NEOPLASM,1
PA,KERATITIS,1
PA,KETOACIDOSIS,1
PA,KIDNEY SMALL,1
PA,KIDNEY TRANSPLANT REJECTION,1
PA,KLEBSIELLA INFECTION,1
PA,LABORATORY TEST ABNORMAL,1
PA,LETHARGY,1
PA,LEUKAEMIA,1
PA,LEUKOCYTOSIS,1
PA,LEUKOPENIA,1
PA,LIMB DEFORMITY,1
PA,LIMB MALFORMATION,1
PA,LIMB MASS,1
PA,LIP BLISTER,1
PA,LIP DISORDER,1
PA,LIP DRY,1
PA,LIP SWELLING,1
PA,LIP ULCERATION,1
PA,LIVER ABSCESS,1
PA,LIVER FUNCTION TEST ABNORMAL,1
PA,LIVER INJURY,1
PA,LOCAL SWELLING,1
PA,LOOSE TOOTH,1
PA,LORDOSIS,1
PA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
PA,LOW BIRTH WEIGHT BABY,1
PA,LOW DENSITY LIPOPROTEIN INCREASED,1
PA,LOWER EXTREMITY MASS,1
PA,LOWER RESPIRATORY TRACT INFECTION,1
PA,LUNG DISORDER,1
PA,LUNG INFECTION,1
PA,LUPUS NEPHRITIS,1
PA,LYMPHOCYTE COUNT ABNORMAL,1
PA,LYMPHOCYTE PERCENTAGE DECREASED,1
PA,LYMPHOMA,1
PA,LYMPHOPENIA,1
PA,MASS,1
PA,MEIGE^S SYNDROME,1
PA,MENIERE^S DISEASE,1
PA,MENINGITIS BACTERIAL,1
PA,MENINGITIS CRYPTOCOCCAL,1
PA,MENSTRUAL DISORDER,1
PA,MENSTRUATION NORMAL,1
PA,MENTAL IMPAIRMENT,1
PA,MENTAL STATUS CHANGES,1
PA,METABOLIC ACIDOSIS,1
PA,METABOLIC DISORDER,1
PA,METASTASES TO KIDNEY,1
PA,METASTASES TO LARGE INTESTINE,1
PA,METASTASES TO PHARYNX,1
PA,METASTASES TO THORAX,1
PA,MIDDLE INSOMNIA,1
PA,MIGRAINE,1
PA,MONOCLONAL GAMMOPATHY,1
PA,MONONEURITIS,1
PA,MONOPARESIS,1
PA,MONOPLEGIA,1
PA,MOOD SWINGS,1
PA,MOTOR DEVELOPMENTAL DELAY,1
PA,MOUTH ULCERATION,1
PA,MUCOUS MEMBRANE DISORDER,1
PA,MULTI-ORGAN FAILURE,1
PA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
PA,MUSCLE CONTRACTURE,1
PA,MUSCLE FATIGUE,1
PA,MUSCLE RUPTURE,1
PA,MUSCLE SPASTICITY,1
PA,MUSCLE STRAIN,1
PA,MUSCLE SWELLING,1
PA,MUSCLE TWITCHING,1
PA,MUSCULOSKELETAL DISORDER,1
PA,MYCOBACTERIUM ABSCESSUS INFECTION,1
PA,MYCOBACTERIUM TEST POSITIVE,1
PA,MYDRIASIS,1
PA,MYELODYSPLASTIC SYNDROME TRANSFORMATION,1
PA,MYOCLONUS,1
PA,MYOPIA,1
PA,NASAL DRYNESS,1
PA,NEOPLASM MALIGNANT,1
PA,NEOPLASM SKIN,1
PA,NEUROENDOCRINE TUMOUR,1
PA,NEUTROPHIL COUNT INCREASED,1
PA,NO ADVERSE EVENT,1
PA,NONINFECTIVE GINGIVITIS,1
PA,NORMAL NEWBORN,1
PA,NUCHAL RIGIDITY,1
PA,OEDEMA GENITAL,1
PA,OLIGURIA,1
PA,OPHTHALMOPLEGIA,1
PA,OPTIC NERVE DISORDER,1
PA,OPTIC NERVE INJURY,1
PA,OSTEOLYSIS,1
PA,OSTEOPOROSIS,1
PA,OTITIS MEDIA,1
PA,OTORRHOEA,1
PA,PAIN IN JAW,1
PA,PAIN OF SKIN,1
PA,PALATAL DISORDER,1
PA,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
PA,PANCREATIC DISORDER,1
PA,PANCREATIC NEUROENDOCRINE TUMOUR,1
PA,PAPILLOEDEMA,1
PA,PARANOIA,1
PA,PARASITIC GASTROENTERITIS,1
PA,PARKINSON^S DISEASE,1
PA,PELVIC PAIN,1
PA,PEPTIC ULCER,1
PA,PERICARDIAL EFFUSION,1
PA,PERIPHERAL VENOUS DISEASE,1
PA,PERISTALSIS VISIBLE,1
PA,PETECHIAE,1
PA,PHARYNGEAL OEDEMA,1
PA,PHOTOPSIA,1
PA,PITUITARY CYST,1
PA,PITUITARY TUMOUR RECURRENT,1
PA,PLAGUE,1
PA,PLASMA CELL MYELOMA,1
PA,PLATELET COUNT ABNORMAL,1
PA,PLATELET COUNT INCREASED,1
PA,PLEURISY,1
PA,PNEUMONITIS,1
PA,POISONING,1
PA,POLYARTHRITIS,1
PA,POOR VENOUS ACCESS,1
PA,POST PROCEDURAL DISCHARGE,1
PA,POSTICTAL STATE,1
PA,POSTOPERATIVE ADHESION,1
PA,POSTOPERATIVE WOUND INFECTION,1
PA,PREGNANCY WITH CONTRACEPTIVE DEVICE,1
PA,PREMATURE BABY,1
PA,PREMATURE DELIVERY,1
PA,PREMATURE LABOUR,1
PA,PRESBYOPIA,1
PA,PRESYNCOPE,1
PA,PRIAPISM,1
PA,PROCEDURAL COMPLICATION,1
PA,PRODUCT COLOUR ISSUE,1
PA,PROSTATIC DISORDER,1
PA,PROTEINURIA,1
PA,PSEUDARTHROSIS,1
PA,PSYCHIATRIC SYMPTOM,1
PA,PSYCHOGENIC MOVEMENT DISORDER,1
PA,PSYCHOMOTOR HYPERACTIVITY,1
PA,PULMONARY MASS,1
PA,PULMONARY OEDEMA NEONATAL,1
PA,PULMONARY VASCULITIS,1
PA,PULPITIS DENTAL,1
PA,PULSE ABNORMAL,1
PA,RADICULAR PAIN,1
PA,RASH PAPULAR,1
PA,RECTAL PROLAPSE,1
PA,RED BLOOD CELL COUNT INCREASED,1
PA,RENAL ARTERY STENOSIS,1
PA,RENAL CYST,1
PA,RENAL PAIN,1
PA,RENAL VASCULITIS,1
PA,RESPIRATORY DISORDER,1
PA,RESPIRATORY TRACT INFECTION,1
PA,RETINAL DEGENERATION,1
PA,RETINAL DETACHMENT,1
PA,RETINAL INJURY,1
PA,RETINAL THICKENING,1
PA,RETINITIS PIGMENTOSA,1
PA,RETRO-ORBITAL NEOPLASM,1
PA,RHEUMATOID ARTHRITIS,1
PA,RHINALGIA,1
PA,RHINITIS,1
PA,RHINITIS ALLERGIC,1
PA,RIB FRACTURE,1
PA,ROAD TRAFFIC ACCIDENT,1
PA,ROCKY MOUNTAIN SPOTTED FEVER,1
PA,SALIVA ALTERED,1
PA,SCAB,1
PA,SCHOOL REFUSAL,1
PA,SCRATCH,1
PA,SEBORRHOEA,1
PA,SEBORRHOEIC DERMATITIS,1
PA,SENILE DEMENTIA,1
PA,SENSATION OF HEAVINESS,1
PA,SENSITIVITY TO WEATHER CHANGE,1
PA,SEPTIC SHOCK,1
PA,SERUM SEROTONIN INCREASED,1
PA,SHOCK,1
PA,SHORT-BOWEL SYNDROME,1
PA,SJOGREN^S SYNDROME,1
PA,SKELETAL DYSPLASIA,1
PA,SKIN ABRASION,1
PA,SKIN ATROPHY,1
PA,SKIN BURNING SENSATION,1
PA,SKIN DISCOLOURATION,1
PA,SKIN NECROSIS,1
PA,SKIN PLAQUE,1
PA,SOFT TISSUE INFECTION,1
PA,SPLEEN DISORDER,1
PA,STUPOR,1
PA,SUICIDAL IDEATION,1
PA,SURGERY,1
PA,SWOLLEN TONGUE,1
PA,TACHYPNOEA,1
PA,TEMPERATURE INTOLERANCE,1
PA,TEMPOROMANDIBULAR JOINT SYNDROME,1
PA,TENSION HEADACHE,1
PA,THIRST,1
PA,THORACIC OUTLET SYNDROME,1
PA,THROAT TIGHTNESS,1
PA,THROMBOPHLEBITIS SUPERFICIAL,1
PA,THYROIDITIS,1
PA,TIBIA FRACTURE,1
PA,TINNITUS,1
PA,TOE AMPUTATION,1
PA,TONGUE DISCOLOURATION,1
PA,TONGUE DISCOMFORT,1
PA,TONGUE ERYTHEMA,1
PA,TONSILLAR HYPERTROPHY,1
PA,TOOTH ABSCESS,1
PA,TOOTH FRACTURE,1
PA,TOOTH LOSS,1
PA,TOXIC SKIN ERUPTION,1
PA,TOXOPLASMOSIS,1
PA,TRANCE,1
PA,TRANSFUSION,1
PA,TRIGEMINAL NEURALGIA,1
PA,TUMOUR MARKER INCREASED,1
PA,TUMOUR PAIN,1
PA,TUNNEL VISION,1
PA,TYMPANIC MEMBRANE PERFORATION,1
PA,ULCER,1
PA,ULCERATIVE KERATITIS,1
PA,ULTRASOUND DOPPLER ABNORMAL,1
PA,UMBILICAL HERNIA,1
PA,UNDERDOSE,1
PA,UNDERWEIGHT,1
PA,UNINTENDED PREGNANCY,1
PA,UPPER LIMB FRACTURE,1
PA,URINE ODOUR ABNORMAL,1
PA,UTERINE ABSCESS,1
PA,UTERINE HAEMORRHAGE,1
PA,UTERINE LEIOMYOMA,1
PA,VARICELLA,1
PA,VARICOPHLEBITIS,1
PA,VASCULAR GRAFT,1
PA,VASCULITIS,1
PA,VASODILATATION,1
PA,VENA CAVA THROMBOSIS,1
PA,VENOUS OCCLUSION,1
PA,VERTEBRAL OSTEOPHYTE,1
PA,VIITH NERVE PARALYSIS,1
PA,VIRAL PHARYNGITIS,1
PA,VISCERAL PAIN,1
PA,VITAMIN B COMPLEX DEFICIENCY,1
PA,VOCAL CORD DISORDER,1
PA,VULVOVAGINAL PAIN,1
PA,WALDENSTROM^S MACROGLOBULINAEMIA,1
PA,WEIGHT ABNORMAL,1
PA,WHITE BLOOD CELL COUNT ABNORMAL,1
PA,WOUND COMPLICATION,1
PA,WOUND HAEMORRHAGE,1
PA,XEROPHTHALMIA,1
PA,YELLOW SKIN,1
PA,ZIKA VIRUS INFECTION,1
PG,DEATH,8
PG,INTENTIONAL PRODUCT USE ISSUE,7
PG,PNEUMONIA,2
PG,ABNORMAL BEHAVIOUR,1
PG,ANAEMIA,1
PG,BREAST FEEDING,1
PG,CEREBROVASCULAR ACCIDENT,1
PG,CHOKING,1
PG,CHRONIC MYELOID LEUKAEMIA,1
PG,DEATH NEONATAL,1
PG,DIARRHOEA,1
PG,DYSPNOEA,1
PG,EXPOSURE DURING BREAST FEEDING,1
PG,EXPOSURE DURING PREGNANCY,1
PG,FOETAL EXPOSURE DURING PREGNANCY,1
PG,FOETAL MEGACYSTIS,1
PG,HEPATITIS,1
PG,HYPOGLYCAEMIA,1
PG,LOW BIRTH WEIGHT BABY,1
PG,NEUTROPENIA,1
PG,OLIGOHYDRAMNIOS,1
PG,OVARIAN CYST,1
PG,PRECOCIOUS PUBERTY,1
PG,PREMATURE BABY,1
PG,PREMATURE LABOUR,1
PG,RENAL IMPAIRMENT,1
PG,RESPIRATORY FAILURE,1
PG,SEPSIS,1
PG,SHOCK,1
PG,STAPHYLOCOCCAL SKIN INFECTION,1
PG,STATUS EPILEPTICUS,1
PG,TREATMENT NONCOMPLIANCE,1
PY,DEATH,16
PY,PYREXIA,10
PY,FOETAL EXPOSURE DURING PREGNANCY,7
PY,SEPSIS,7
PY,WHITE BLOOD CELL COUNT INCREASED,7
PY,ANAEMIA,6
PY,PNEUMONIA,6
PY,SEPTIC SHOCK,6
PY,SPLENOMEGALY,6
PY,CHRONIC MYELOID LEUKAEMIA,5
PY,MALIGNANT NEOPLASM PROGRESSION,5
PY,NO THERAPEUTIC RESPONSE,5
PY,CARDIAC FAILURE,4
PY,DENGUE FEVER,4
PY,DRUG INEFFECTIVE,4
PY,GENERAL PHYSICAL HEALTH DETERIORATION,4
PY,MATERNAL EXPOSURE DURING PREGNANCY,4
PY,MYELOCYTOSIS,4
PY,NAUSEA,4
PY,PREMATURE BABY,4
PY,ABDOMINAL PAIN,3
PY,ACUTE MYOCARDIAL INFARCTION,3
PY,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,3
PY,DYSPNOEA,3
PY,HAEMOGLOBIN DECREASED,3
PY,SECOND PRIMARY MALIGNANCY,3
PY,VOMITING,3
PY,ASTHENIA,2
PY,CARDIAC DISORDER,2
PY,CARDIAC MURMUR,2
PY,CARDIO-RESPIRATORY ARREST,2
PY,CHEST PAIN,2
PY,DYSURIA,2
PY,NEONATAL RESPIRATORY DISTRESS SYNDROME,2
PY,NORMAL NEWBORN,2
PY,PLATELET COUNT INCREASED,2
PY,PNEUMONIA KLEBSIELLA,2
PY,RESPIRATORY ARREST,2
PY,THROMBOCYTOPENIA,2
PY,URINARY TRACT INFECTION,2
PY,ABDOMINAL PAIN UPPER,1
PY,ACIDOSIS,1
PY,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
PY,ACUTE KIDNEY INJURY,1
PY,AGGRESSION,1
PY,AKATHISIA,1
PY,AMERICAN TRYPANOSOMIASIS,1
PY,ANGER,1
PY,ANURIA,1
PY,APHASIA,1
PY,APLASIA,1
PY,APLASIA PURE RED CELL,1
PY,ARRHYTHMIA,1
PY,ASCITES,1
PY,ATELECTASIS,1
PY,ATRIOVENTRICULAR BLOCK COMPLETE,1
PY,BACK PAIN,1
PY,BASOPHIL PERCENTAGE INCREASED,1
PY,BLAST CELL COUNT INCREASED,1
PY,BLOOD CALCIUM INCREASED,1
PY,BLOOD CREATININE DECREASED,1
PY,BLOOD DISORDER,1
PY,BLOOD GLUCOSE DECREASED,1
PY,BLOOD GLUCOSE INCREASED,1
PY,BONE MARROW DISORDER,1
PY,BONE MARROW FAILURE,1
PY,BONE PAIN,1
PY,BREAST CANCER,1
PY,BREAST DISORDER,1
PY,BREAST PAIN,1
PY,BREAST SWELLING,1
PY,CARDIO-RESPIRATORY DISTRESS,1
PY,CARDIOGENIC SHOCK,1
PY,CATARRH,1
PY,CEREBRAL HAEMORRHAGE,1
PY,CERVIX CARCINOMA,1
PY,CHROMOSOME ANALYSIS ABNORMAL,1
PY,CHRONIC HEPATITIS,1
PY,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
PY,COMPLETED SUICIDE,1
PY,CONGESTIVE CARDIOMYOPATHY,1
PY,COUGH,1
PY,DECREASED APPETITE,1
PY,DEHYDRATION,1
PY,DEVICE RELATED INFECTION,1
PY,DIABETES MELLITUS,1
PY,DIABETIC COMPLICATION,1
PY,DIARRHOEA,1
PY,DISEASE PROGRESSION,1
PY,DRUG INTOLERANCE,1
PY,ELECTROCARDIOGRAM QT PROLONGED,1
PY,ELECTROLYTE IMBALANCE,1
PY,ERYTHROBLAST COUNT INCREASED,1
PY,FOETAL DISORDER,1
PY,FOETAL EXPOSURE TIMING UNSPECIFIED,1
PY,GASTROINTESTINAL DISORDER,1
PY,GASTROINTESTINAL HAEMORRHAGE,1
PY,GASTROINTESTINAL INFECTION,1
PY,HAEMATOCRIT DECREASED,1
PY,HAEMORRHAGE,1
PY,HAEMORRHAGE INTRACRANIAL,1
PY,HAEMORRHAGE URINARY TRACT,1
PY,HALLUCINATION,1
PY,HEADACHE,1
PY,HEPATIC ENZYME ABNORMAL,1
PY,HEPATIC FIBROSIS,1
PY,HEPATOMEGALY,1
PY,HERNIA,1
PY,HOMICIDE,1
PY,HOSPITALISATION,1
PY,HYPERCAPNIA,1
PY,HYPERSPLENISM,1
PY,HYPERTENSION,1
PY,HYPERURICAEMIA,1
PY,HYPOTENSION,1
PY,HYPOVOLAEMIA,1
PY,IMMATURE RESPIRATORY SYSTEM,1
PY,IMMOBILE,1
PY,INFARCTION,1
PY,INFECTION,1
PY,INTERNATIONAL NORMALISED RATIO INCREASED,1
PY,INTRACRANIAL PRESSURE INCREASED,1
PY,JAUNDICE,1
PY,LEUKOCYTOSIS,1
PY,LEUKOPENIA,1
PY,LUNG DISORDER,1
PY,LYMPHOCYTE COUNT DECREASED,1
PY,MENSTRUATION DELAYED,1
PY,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
PY,MYALGIA,1
PY,MYOCARDIAL INFARCTION,1
PY,NASOPHARYNGITIS,1
PY,NEOPLASM RECURRENCE,1
PY,OEDEMA,1
PY,OLIGODENDROGLIOMA,1
PY,ORAL HERPES,1
PY,OSTEOMYELITIS,1
PY,OVERDOSE,1
PY,PALLOR,1
PY,PANCREATITIS,1
PY,PANCYTOPENIA,1
PY,PERFORATION,1
PY,PHARYNGEAL DISORDER,1
PY,PLATELET COUNT DECREASED,1
PY,PNEUMONIA PNEUMOCOCCAL,1
PY,PREGNANCY ON CONTRACEPTIVE,1
PY,PREGNANCY ON ORAL CONTRACEPTIVE,1
PY,PREGNANCY WITH INJECTABLE CONTRACEPTIVE,1
PY,PREMATURE LABOUR,1
PY,PRODUCT USE ISSUE,1
PY,PROTHROMBIN LEVEL INCREASED,1
PY,PULMONARY SEPSIS,1
PY,PYELONEPHRITIS,1
PY,RASH,1
PY,RED BLOOD CELL COUNT INCREASED,1
PY,RENAL CANCER,1
PY,RESPIRATORY ACIDOSIS,1
PY,RESPIRATORY DISTRESS,1
PY,RESPIRATORY FAILURE,1
PY,SHOCK,1
PY,SPLENIC INFARCTION,1
PY,STILLBIRTH,1
PY,SYSTEMIC LUPUS ERYTHEMATOSUS,1
PY,THERAPEUTIC RESPONSE DECREASED,1
PY,THERAPY NON-RESPONDER,1
PY,TORSADE DE POINTES,1
PY,TRACHEAL DISORDER,1
PY,TREATMENT FAILURE,1
PY,UREAPLASMA INFECTION,1
PY,UTERINE CANCER,1
PY,VENTRICULAR TACHYARRHYTHMIA,1
PY,VIRAL INFECTION,1
PE,DEATH,778
PE,PNEUMONIA,209
PE,PULMONARY FIBROSIS,140
PE,FALL,136
PE,CATARACT,119
PE,MALAISE,99
PE,CEREBROVASCULAR ACCIDENT,97
PE,PYREXIA,89
PE,DRUG INEFFECTIVE,82
PE,MYOCARDIAL INFARCTION,71
PE,HEADACHE,66
PE,PAIN,66
PE,CONDITION AGGRAVATED,62
PE,DIARRHOEA,60
PE,DYSPNOEA,60
PE,GLAUCOMA,59
PE,VOMITING,58
PE,DIABETES MELLITUS,55
PE,URINARY TRACT INFECTION,55
PE,ABASIA,53
PE,NEOPLASM MALIGNANT,51
PE,CARDIAC DISORDER,50
PE,DIZZINESS,50
PE,ASTHMATIC CRISIS,49
PE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,47
PE,EYE DISORDER,46
PE,NAUSEA,46
PE,GAIT DISTURBANCE,45
PE,GENERAL PHYSICAL HEALTH DETERIORATION,45
PE,COUGH,44
PE,INFECTION,43
PE,RESPIRATORY FAILURE,43
PE,ANAEMIA,41
PE,PAIN IN EXTREMITY,39
PE,VISUAL ACUITY REDUCED,37
PE,DISEASE PROGRESSION,36
PE,PRODUCT USE ISSUE,36
PE,HYPERTENSION,35
PE,BLINDNESS,34
PE,INFLUENZA,34
PE,SEPSIS,34
PE,ARTHRALGIA,33
PE,CARDIAC ARREST,33
PE,HAEMOGLOBIN DECREASED,33
PE,ACCIDENT,32
PE,HIP FRACTURE,32
PE,ASTHENIA,31
PE,ASTHMA,31
PE,FATIGUE,31
PE,GASTRITIS,30
PE,LUNG NEOPLASM MALIGNANT,29
PE,WEIGHT DECREASED,29
PE,INFARCTION,28
PE,RENAL FAILURE,28
PE,VISUAL IMPAIRMENT,28
PE,ABDOMINAL PAIN,27
PE,DISCOMFORT,27
PE,INTRAOCULAR PRESSURE INCREASED,27
PE,HYPERSENSITIVITY,26
PE,LUNG DISORDER,26
PE,RENAL DISORDER,25
PE,SURGERY,25
PE,BLOOD GLUCOSE INCREASED,24
PE,CARDIO-RESPIRATORY ARREST,24
PE,EXPOSURE DURING PREGNANCY,24
PE,OSTEOARTHRITIS,24
PE,CARDIAC FAILURE,23
PE,DECREASED APPETITE,23
PE,GASTRIC INFECTION,23
PE,HEPATIC CIRRHOSIS,23
PE,RASH,23
PE,ANXIETY,22
PE,FEELING ABNORMAL,22
PE,INTESTINAL OBSTRUCTION,22
PE,PSEUDOMONAS INFECTION,22
PE,ARRHYTHMIA,21
PE,BLINDNESS UNILATERAL,21
PE,BREAST CANCER,21
PE,CEREBRAL INFARCTION,21
PE,DEPRESSION,21
PE,BRONCHIAL DISORDER,20
PE,BRONCHITIS,20
PE,HYPOTENSION,20
PE,INTENTIONAL PRODUCT MISUSE,20
PE,MALIGNANT NEOPLASM PROGRESSION,20
PE,RESPIRATORY TRACT INFECTION,20
PE,SEIZURE,20
PE,SOMNOLENCE,20
PE,CONSTIPATION,19
PE,EYE PAIN,19
PE,NASOPHARYNGITIS,19
PE,PERIPHERAL SWELLING,19
PE,BLOOD PRESSURE INCREASED,18
PE,DEAFNESS,18
PE,HYPOACUSIS,18
PE,INCORRECT DOSE ADMINISTERED,18
PE,LIVER DISORDER,18
PE,LUNG INFECTION,18
PE,ROAD TRAFFIC ACCIDENT,18
PE,BACK PAIN,17
PE,CELLULITIS,17
PE,DEHYDRATION,17
PE,GALLBLADDER OPERATION,17
PE,MATERNAL EXPOSURE DURING PREGNANCY,17
PE,PRODUCTIVE COUGH,17
PE,PULMONARY OEDEMA,17
PE,SYNCOPE,17
PE,THROMBOCYTOPENIA,17
PE,TUBERCULOSIS,17
PE,ABORTION SPONTANEOUS,16
PE,CHILLS,16
PE,HYPERGLYCAEMIA,16
PE,LOWER LIMB FRACTURE,16
PE,PRURITUS,16
PE,SPINAL DISORDER,16
PE,THROMBOSIS,16
PE,ABDOMINAL DISCOMFORT,15
PE,AGITATION,15
PE,ANGINA UNSTABLE,15
PE,BEDRIDDEN,15
PE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,15
PE,DRUG DOSE OMISSION,15
PE,FOETAL EXPOSURE DURING PREGNANCY,15
PE,GASTRIC CANCER,15
PE,HAEMORRHAGE,15
PE,INSOMNIA,15
PE,LIMB INJURY,15
PE,PROSTATIC DISORDER,15
PE,RESPIRATORY DISORDER,15
PE,TACHYCARDIA,15
PE,UPPER LIMB FRACTURE,15
PE,VISION BLURRED,15
PE,ARTHROPATHY,14
PE,CHEST PAIN,14
PE,GALLBLADDER DISORDER,14
PE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,14
PE,LIMB DISCOMFORT,14
PE,RESPIRATORY ARREST,14
PE,INFUSION RELATED REACTION,13
PE,NEUROPATHY PERIPHERAL,13
PE,PANCREATIC CARCINOMA,13
PE,PARKINSON^S DISEASE,13
PE,PHARYNGITIS,13
PE,PLEURAL EFFUSION,13
PE,PRODUCT USE IN UNAPPROVED INDICATION,13
PE,RESPIRATORY DISTRESS,13
PE,SEPTIC SHOCK,13
PE,URTICARIA,13
PE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,13
PE,BLOOD PRESSURE DECREASED,12
PE,BRAIN NEOPLASM,12
PE,DYSPEPSIA,12
PE,ERYTHEMA,12
PE,FEBRILE NEUTROPENIA,12
PE,GASTRIC DISORDER,12
PE,HYPOAESTHESIA,12
PE,MOBILITY DECREASED,12
PE,MOVEMENT DISORDER,12
PE,NEOPLASM,12
PE,NO ADVERSE EVENT,12
PE,PLATELET COUNT DECREASED,12
PE,TREMOR,12
PE,ARTHRITIS,11
PE,BONE PAIN,11
PE,BRONCHIECTASIS,11
PE,DISEASE RECURRENCE,11
PE,FEMUR FRACTURE,11
PE,GASTRIC ULCER,11
PE,JOINT INJURY,11
PE,KIDNEY INFECTION,11
PE,LEUKOPENIA,11
PE,LOSS OF CONSCIOUSNESS,11
PE,MUSCULAR WEAKNESS,11
PE,NEUTROPENIA,11
PE,OVERDOSE,11
PE,PANCYTOPENIA,11
PE,THYROID DISORDER,11
PE,APHASIA,10
PE,CHOLELITHIASIS,10
PE,COMA,10
PE,CONTUSION,10
PE,DYSURIA,10
PE,EYE INFECTION,10
PE,GASTROINTESTINAL HAEMORRHAGE,10
PE,HYPOGLYCAEMIA,10
PE,INFLAMMATION,10
PE,JOINT SWELLING,10
PE,METASTASES TO CENTRAL NERVOUS SYSTEM,10
PE,METASTASIS,10
PE,MULTI-ORGAN FAILURE,10
PE,MYALGIA,10
PE,NEPHROLITHIASIS,10
PE,PARAESTHESIA,10
PE,PERITONITIS,10
PE,POISONING,10
PE,PREMATURE BABY,10
PE,SPEECH DISORDER,10
PE,ABDOMINAL PAIN UPPER,9
PE,ACUTE KIDNEY INJURY,9
PE,ANGINA PECTORIS,9
PE,APPENDICITIS,9
PE,ASCITES,9
PE,ATRIAL FIBRILLATION,9
PE,CHEST DISCOMFORT,9
PE,DIABETIC FOOT,9
PE,ENDOCARDITIS,9
PE,EPISTAXIS,9
PE,EYE HAEMORRHAGE,9
PE,EYE IRRITATION,9
PE,FOOT FRACTURE,9
PE,HAEMATOCHEZIA,9
PE,HEMIPLEGIA,9
PE,HEPATIC FAILURE,9
PE,HERPES VIRUS INFECTION,9
PE,HOSPITALISATION,9
PE,IMMUNODEFICIENCY,9
PE,ISCHAEMIC STROKE,9
PE,MEMORY IMPAIRMENT,9
PE,MENISCUS INJURY,9
PE,MUSCLE SPASMS,9
PE,NERVOUSNESS,9
PE,OEDEMA PERIPHERAL,9
PE,TREATMENT NONCOMPLIANCE,9
PE,WRIST FRACTURE,9
PE,ABDOMINAL DISTENSION,8
PE,ACUTE MYOCARDIAL INFARCTION,8
PE,ASPHYXIA,8
PE,BLOOD PRESSURE ABNORMAL,8
PE,CONVULSION,8
PE,DEVICE RELATED INFECTION,8
PE,DRUG DEPENDENCE,8
PE,FIBROMYALGIA,8
PE,HAEMOPTYSIS,8
PE,HEPATITIS,8
PE,IRRITABILITY,8
PE,LIGAMENT SPRAIN,8
PE,MACULAR DEGENERATION,8
PE,OROPHARYNGEAL PAIN,8
PE,OSTEOPOROSIS,8
PE,PALPITATIONS,8
PE,PANCREATITIS,8
PE,PATHOGEN RESISTANCE,8
PE,STAPHYLOCOCCAL INFECTION,8
PE,SYSTEMIC LUPUS ERYTHEMATOSUS,8
PE,UPPER GASTROINTESTINAL HAEMORRHAGE,8
PE,URINARY TRACT OBSTRUCTION,8
PE,WOUND,8
PE,ACUTE RESPIRATORY FAILURE,7
PE,ANKLE FRACTURE,7
PE,CANDIDA INFECTION,7
PE,CHOKING,7
PE,DEMENTIA ALZHEIMER^S TYPE,7
PE,DEPRESSED MOOD,7
PE,DRUG PRESCRIBING ERROR,7
PE,DRY EYE,7
PE,DRY MOUTH,7
PE,DYSPHAGIA,7
PE,EMPHYSEMA,7
PE,FIBULA FRACTURE,7
PE,FRACTURE,7
PE,HAEMATEMESIS,7
PE,HERNIA,7
PE,HERPES ZOSTER,7
PE,HYPERHIDROSIS,7
PE,INTENTIONAL PRODUCT USE ISSUE,7
PE,INTERVERTEBRAL DISC PROTRUSION,7
PE,LYMPHADENOPATHY,7
PE,METASTASES TO LIVER,7
PE,METASTASES TO LUNG,7
PE,MUSCULOSKELETAL DISORDER,7
PE,NEOPLASM PROGRESSION,7
PE,OCULAR HYPERAEMIA,7
PE,PNEUMONITIS,7
PE,PRESCRIBED OVERDOSE,7
PE,PROSTATE CANCER,7
PE,PROSTATIC OPERATION,7
PE,PULMONARY EMBOLISM,7
PE,RIB FRACTURE,7
PE,SKIN DISCOLOURATION,7
PE,THYROID CANCER,7
PE,ULCER,7
PE,URINARY RETENTION,7
PE,UTERINE CANCER,7
PE,VAGINAL HAEMORRHAGE,7
PE,ALANINE AMINOTRANSFERASE INCREASED,6
PE,ALOPECIA,6
PE,AMNESIA,6
PE,BENIGN PROSTATIC HYPERPLASIA,6
PE,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,6
PE,BLISTER,6
PE,BRADYCARDIA,6
PE,BRONCHOSPASM,6
PE,CHRONIC MYELOID LEUKAEMIA,6
PE,CONJUNCTIVITIS,6
PE,CYST,6
PE,DEEP VEIN THROMBOSIS,6
PE,DENGUE FEVER,6
PE,DIABETIC COMPLICATION,6
PE,DIABETIC METABOLIC DECOMPENSATION,6
PE,DRUG EFFECT INCOMPLETE,6
PE,DRUG-INDUCED LIVER INJURY,6
PE,DYSSTASIA,6
PE,ENTEROCOLITIS,6
PE,FEELING OF DESPAIR,6
PE,GASTROINTESTINAL DISORDER,6
PE,HAEMATURIA,6
PE,HEPATIC CANCER,6
PE,HYPERTENSIVE CRISIS,6
PE,HYPOKINESIA,6
PE,LABYRINTHITIS,6
PE,LACTIC ACIDOSIS,6
PE,LEUKOCYTOSIS,6
PE,LYMPHOMA,6
PE,MENTAL DISORDER,6
PE,NEONATAL RESPIRATORY DISTRESS SYNDROME,6
PE,RENAL TRANSPLANT,6
PE,RHEUMATOID ARTHRITIS,6
PE,SKIN LESION,6
PE,SPINAL CORD HERNIATION,6
PE,SPINAL FRACTURE,6
PE,TOXICITY TO VARIOUS AGENTS,6
PE,TRANSAMINASES INCREASED,6
PE,VARICOSE VEIN,6
PE,VASCULITIS,6
PE,VIRAL INFECTION,6
PE,ANEURYSM,5
PE,BLOOD CHOLESTEROL INCREASED,5
PE,BLOOD CREATININE INCREASED,5
PE,BLOOD URINE PRESENT,5
PE,CARDIOVASCULAR DISORDER,5
PE,CEREBRAL HAEMORRHAGE,5
PE,CEREBRAL ISCHAEMIA,5
PE,CHRONIC GASTRITIS,5
PE,CRYING,5
PE,CYANOSIS,5
PE,DELIRIUM,5
PE,DISEASE COMPLICATION,5
PE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,5
PE,DRUG INTOLERANCE,5
PE,DYSARTHRIA,5
PE,EAR PAIN,5
PE,END STAGE RENAL DISEASE,5
PE,ENDOCARDITIS CANDIDA,5
PE,EYE INFLAMMATION,5
PE,GASTROINTESTINAL INFECTION,5
PE,HEPATIC ENZYME INCREASED,5
PE,HIP SURGERY,5
PE,HUMERUS FRACTURE,5
PE,IMMOBILE,5
PE,ISOSPORIASIS,5
PE,JAUNDICE,5
PE,LARYNGEAL OEDEMA,5
PE,LEUKAEMIA,5
PE,LIVER INJURY,5
PE,MYELODYSPLASTIC SYNDROME,5
PE,NEPHROPATHY,5
PE,NERVOUS SYSTEM DISORDER,5
PE,NO THERAPEUTIC RESPONSE,5
PE,OSTEONECROSIS,5
PE,OVARIAN CYST,5
PE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,5
PE,RENAL CANCER,5
PE,RENAL IMPAIRMENT,5
PE,SENILE DEMENTIA,5
PE,SHOCK,5
PE,SLEEP DISORDER,5
PE,SPINAL PAIN,5
PE,SUDDEN DEATH,5
PE,SWELLING,5
PE,TONSILLITIS,5
PE,UNDERWEIGHT,5
PE,WALKING DISABILITY,5
PE,ADVERSE EVENT,4
PE,AGGRESSION,4
PE,ANGIOPATHY,4
PE,ASPARTATE AMINOTRANSFERASE INCREASED,4
PE,BILE DUCT STONE,4
PE,BLOOD GLUCOSE ABNORMAL,4
PE,BLOOD PRESSURE FLUCTUATION,4
PE,BONE DISORDER,4
PE,BONE FISSURE,4
PE,BRONCHOPNEUMONIA,4
PE,BURNING SENSATION,4
PE,CARDIAC FAILURE CONGESTIVE,4
PE,CARDIAC MURMUR,4
PE,CARDIOMEGALY,4
PE,CATARACT OPERATION,4
PE,CHOKING SENSATION,4
PE,CHRONIC KIDNEY DISEASE,4
PE,COLON CANCER,4
PE,DECREASED IMMUNE RESPONSIVENESS,4
PE,DIABETIC COMA,4
PE,DISORIENTATION,4
PE,DYSGEUSIA,4
PE,EATING DISORDER,4
PE,FLUID RETENTION,4
PE,GANGRENE,4
PE,GASTROENTERITIS,4
PE,HALLUCINATION,4
PE,HEAD INJURY,4
PE,HEPATIC ENCEPHALOPATHY,4
PE,HERNIA REPAIR,4
PE,HYPOTHYROIDISM,4
PE,IDIOPATHIC PULMONARY FIBROSIS,4
PE,INTERNAL HAEMORRHAGE,4
PE,IRON DEFICIENCY ANAEMIA,4
PE,JOINT DISLOCATION,4
PE,KNEE OPERATION,4
PE,LOCALISED INFECTION,4
PE,MACULOPATHY,4
PE,MUSCULOSKELETAL PAIN,4
PE,MUSCULOSKELETAL STIFFNESS,4
PE,NASAL CONGESTION,4
PE,NASAL DISCOMFORT,4
PE,OVERWEIGHT,4
PE,OXYGEN SATURATION DECREASED,4
PE,PALLOR,4
PE,PANCREATIC NEOPLASM,4
PE,PANCREATITIS ACUTE,4
PE,PARALYSIS,4
PE,PERICARDIAL EFFUSION,4
PE,PNEUMOTHORAX,4
PE,PREGNANCY WITH IMPLANT CONTRACEPTIVE,4
PE,PRODUCT QUALITY ISSUE,4
PE,PROSTATITIS,4
PE,PRURITUS GENERALISED,4
PE,PTERYGIUM,4
PE,PULMONARY TUBERCULOSIS,4
PE,RASH ERYTHEMATOUS,4
PE,RENAL CYST,4
PE,SENSORY LOSS,4
PE,SINUSITIS,4
PE,SKIN DISORDER,4
PE,STRESS,4
PE,SUICIDAL IDEATION,4
PE,SWELLING FACE,4
PE,TIBIA FRACTURE,4
PE,URINARY INCONTINENCE,4
PE,UTERINE DISORDER,4
PE,VAGINAL PROLAPSE,4
PE,VARICELLA,4
PE,VARICES OESOPHAGEAL,4
PE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,4
PE,ABORTION,3
PE,ABSCESS,3
PE,ACROMEGALY,3
PE,ANAPHYLACTIC SHOCK,3
PE,APHONIA,3
PE,BACTERIAL INFECTION,3
PE,BALANCE DISORDER,3
PE,BIPOLAR DISORDER,3
PE,BLOOD BILIRUBIN INCREASED,3
PE,BLOOD CHOLESTEROL ABNORMAL,3
PE,BLOOD TRIGLYCERIDES INCREASED,3
PE,BODY TEMPERATURE INCREASED,3
PE,BRAIN OEDEMA,3
PE,BREAST MASS,3
PE,BRONCHOPULMONARY ASPERGILLOSIS,3
PE,BRUCELLOSIS,3
PE,BURSITIS,3
PE,CAESAREAN SECTION,3
PE,CARDIAC FIBRILLATION,3
PE,CARDIAC OPERATION,3
PE,CAT SCRATCH DISEASE,3
PE,CEREBROVASCULAR DISORDER,3
PE,CLAVICLE FRACTURE,3
PE,COLITIS,3
PE,CONJUNCTIVAL HAEMORRHAGE,3
PE,CORNEAL LESION,3
PE,CROHN^S DISEASE,3
PE,DECUBITUS ULCER,3
PE,DIVERTICULITIS,3
PE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
PE,DRY THROAT,3
PE,DYSPHONIA,3
PE,ELECTROCARDIOGRAM QT PROLONGED,3
PE,ENCEPHALITIS,3
PE,ENTERITIS,3
PE,ESCHERICHIA INFECTION,3
PE,ESCHERICHIA URINARY TRACT INFECTION,3
PE,EYE PRURITUS,3
PE,EYE SWELLING,3
PE,FACE OEDEMA,3
PE,FACIAL PARALYSIS,3
PE,FAECES DISCOLOURED,3
PE,FEAR,3
PE,FLATULENCE,3
PE,FOOT DEFORMITY,3
PE,GALLBLADDER CANCER,3
PE,GASTRIC HAEMORRHAGE,3
PE,GASTRITIS EROSIVE,3
PE,GASTROOESOPHAGEAL REFLUX DISEASE,3
PE,GENERALISED TONIC-CLONIC SEIZURE,3
PE,GINGIVAL BLEEDING,3
PE,HAEMATOMA,3
PE,HAEMORRHOIDS,3
PE,HEART RATE INCREASED,3
PE,HELICOBACTER GASTRITIS,3
PE,HEMIPARESIS,3
PE,HEPATIC CYST,3
PE,HEPATIC FIBROSIS,3
PE,HEPATIC STEATOSIS,3
PE,HEPATOMEGALY,3
PE,HERPES OPHTHALMIC,3
PE,HYSTERECTOMY,3
PE,IMMUNE SYSTEM DISORDER,3
PE,IMMUNE THROMBOCYTOPENIC PURPURA,3
PE,INCREASED BRONCHIAL SECRETION,3
PE,INGUINAL HERNIA,3
PE,INTENTIONAL OVERDOSE,3
PE,INTERNATIONAL NORMALISED RATIO INCREASED,3
PE,INTRACRANIAL ANEURYSM,3
PE,JAUNDICE NEONATAL,3
PE,KERATITIS,3
PE,LEG AMPUTATION,3
PE,LIP AND/OR ORAL CAVITY CANCER,3
PE,LIVE BIRTH,3
PE,LUNG OPERATION,3
PE,MALIGNANT MELANOMA,3
PE,MEDICATION ERROR,3
PE,MELAENA,3
PE,MENORRHAGIA,3
PE,METASTASES TO SPINE,3
PE,MOOD ALTERED,3
PE,MULTIPLE SCLEROSIS,3
PE,MYOPIA,3
PE,NECK PAIN,3
PE,NOSOCOMIAL INFECTION,3
PE,OCULAR DISCOMFORT,3
PE,OESOPHAGEAL CANDIDIASIS,3
PE,OESOPHAGITIS,3
PE,ORAL CANDIDIASIS,3
PE,OSTEOMYELITIS,3
PE,OVARIAN CANCER,3
PE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,3
PE,PHARYNGEAL DISORDER,3
PE,PNEUMONIA BACTERIAL,3
PE,PRE-ECLAMPSIA,3
PE,PREMATURE DELIVERY,3
PE,PROCTALGIA,3
PE,PSORIASIS,3
PE,PSYCHOTIC DISORDER,3
PE,PULMONARY CONGESTION,3
PE,PULMONARY MASS,3
PE,RASH GENERALISED,3
PE,RECTAL HAEMORRHAGE,3
PE,RENAL PAIN,3
PE,RETINAL DETACHMENT,3
PE,RETINAL DISORDER,3
PE,RHINITIS,3
PE,SKIN ULCER,3
PE,SPINAL OPERATION,3
PE,SPUTUM RETENTION,3
PE,STEVENS-JOHNSON SYNDROME,3
PE,TENDON RUPTURE,3
PE,TERMINAL STATE,3
PE,TINNITUS,3
PE,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,3
PE,TOOTHACHE,3
PE,TRANSFUSION,3
PE,TRANSIENT ISCHAEMIC ATTACK,3
PE,TRICHODYSPLASIA SPINULOSA,3
PE,ULCER HAEMORRHAGE,3
PE,ULCERATIVE KERATITIS,3
PE,UNEVALUABLE EVENT,3
PE,UPPER RESPIRATORY TRACT INFECTION,3
PE,UVEITIS,3
PE,WEIGHT INCREASED,3
PE,WHITE BLOOD CELL COUNT DECREASED,3
PE,ABDOMINAL HERNIA,2
PE,ABDOMINAL INFECTION,2
PE,ABDOMINAL PAIN LOWER,2
PE,ABNORMAL BEHAVIOUR,2
PE,ABORTION THREATENED,2
PE,ACUTE LEUKAEMIA,2
PE,AMENORRHOEA,2
PE,ANGIOEDEMA,2
PE,ANIRIDIA,2
PE,AORTIC ANEURYSM,2
PE,APATHY,2
PE,ARTERIAL OCCLUSIVE DISEASE,2
PE,ASPERGILLUS INFECTION,2
PE,ASTHENOPIA,2
PE,ATAXIA,2
PE,ATELECTASIS,2
PE,BLADDER DISORDER,2
PE,BLADDER OPERATION,2
PE,BLOOD CULTURE POSITIVE,2
PE,BLOOD GLUCOSE DECREASED,2
PE,BLOOD GLUCOSE FLUCTUATION,2
PE,BONE CANCER,2
PE,BONE LESION,2
PE,BRAIN INJURY,2
PE,BREAST NEOPLASM,2
PE,BRONCHIAL HYPERREACTIVITY,2
PE,BRONCHIAL OBSTRUCTION,2
PE,CARDIOMYOPATHY,2
PE,CENTRAL NERVOUS SYSTEM LESION,2
PE,CEREBELLAR INFARCTION,2
PE,CEREBRAL DISORDER,2
PE,CEREBRAL PALSY,2
PE,CEREBRAL THROMBOSIS,2
PE,CERVICAL VERTEBRAL FRACTURE,2
PE,CHEILITIS,2
PE,CHEST INJURY,2
PE,CHOLELITHOTOMY,2
PE,CHRONIC HEPATITIS B,2
PE,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,2
PE,COLON NEOPLASM,2
PE,COLON OPERATION,2
PE,COMPLICATION OF PREGNANCY,2
PE,CONFUSIONAL STATE,2
PE,CORNEAL DISORDER,2
PE,CORNEAL PERFORATION,2
PE,CORONARY ARTERY DISEASE,2
PE,CRANIOCEREBRAL INJURY,2
PE,CYSTITIS,2
PE,CYSTITIS HAEMORRHAGIC,2
PE,DELUSION,2
PE,DEPENDENCE,2
PE,DEVICE OCCLUSION,2
PE,DIAPHRAGMATIC HERNIA,2
PE,DIARRHOEA HAEMORRHAGIC,2
PE,DISSEMINATED CRYPTOCOCCOSIS,2
PE,DISSEMINATED TUBERCULOSIS,2
PE,DISTRIBUTIVE SHOCK,2
PE,DIVERTICULUM,2
PE,DRUG ADMINISTRATION ERROR,2
PE,DRUG RESISTANCE,2
PE,DRY SKIN,2
PE,DUCTUS ARTERIOSUS STENOSIS FOETAL,2
PE,DYSCHEZIA,2
PE,DYSGRAPHIA,2
PE,EAR DISCOMFORT,2
PE,EAR HAEMORRHAGE,2
PE,ECCHYMOSIS,2
PE,EMBOLISM,2
PE,EMOTIONAL DISORDER,2
PE,ENCEPHALITIS AUTOIMMUNE,2
PE,ENCEPHALOPATHY,2
PE,ENDODONTIC PROCEDURE,2
PE,ENDOMETRIAL CANCER,2
PE,ERYTHEMA MULTIFORME,2
PE,EXPIRED PRODUCT ADMINISTERED,2
PE,FACIAL BONES FRACTURE,2
PE,FEELING COLD,2
PE,FOETAL DEATH,2
PE,FUNCTIONAL GASTROINTESTINAL DISORDER,2
PE,FUNGAL INFECTION,2
PE,GAIT INABILITY,2
PE,GALLBLADDER PAIN,2
PE,GALLBLADDER POLYP,2
PE,GENERAL PHYSICAL CONDITION ABNORMAL,2
PE,GLAUCOMA SURGERY,2
PE,GYNAECOMASTIA,2
PE,H1N1 INFLUENZA,2
PE,HAEMATOLOGICAL MALIGNANCY,2
PE,HAEMATOTOXICITY,2
PE,HAEMODIALYSIS,2
PE,HAEMORRHAGE INTRACRANIAL,2
PE,HAEMORRHAGIC STROKE,2
PE,HALLUCINATION_ VISUAL,2
PE,HAND FRACTURE,2
PE,HELICOBACTER INFECTION,2
PE,HEPATIC NEOPLASM,2
PE,HEPATIC PAIN,2
PE,HEPATITIS TOXIC,2
PE,HEPATOSPLENOMEGALY,2
PE,HERPES OESOPHAGITIS,2
PE,HIATUS HERNIA,2
PE,HIGH RISK PREGNANCY,2
PE,HIV TEST POSITIVE,2
PE,HYPERCALCAEMIA,2
PE,HYPERKALAEMIA,2
PE,HYPERSENSITIVITY VASCULITIS,2
PE,HYPERTHYROIDISM,2
PE,HYPOALBUMINAEMIA,2
PE,HYPOGLYCAEMIA NEONATAL,2
PE,HYPOKALAEMIA,2
PE,HYPOPHOSPHATAEMIA,2
PE,HYPOTHERMIA,2
PE,IMPAIRED HEALING,2
PE,IMPATIENCE,2
PE,INCORRECT PRODUCT STORAGE,2
PE,INCREASED UPPER AIRWAY SECRETION,2
PE,INFECTED SKIN ULCER,2
PE,INFUSION SITE THROMBOSIS,2
PE,INJECTION SITE PAIN,2
PE,INJURY,2
PE,INTESTINAL PERFORATION,2
PE,KETOACIDOSIS,2
PE,KNEE ARTHROPLASTY,2
PE,LACRIMATION INCREASED,2
PE,LARGE INTESTINAL HAEMORRHAGE,2
PE,LARGE INTESTINE POLYP,2
PE,LARYNGEAL CANCER,2
PE,LARYNGITIS,2
PE,LOCAL SWELLING,2
PE,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
PE,LOWER GASTROINTESTINAL HAEMORRHAGE,2
PE,LOWER RESPIRATORY TRACT CONGESTION,2
PE,LUNG INFILTRATION,2
PE,LUNG NEOPLASM,2
PE,LYMPHOPENIA,2
PE,MACULAR HOLE,2
PE,MAJOR DEPRESSION,2
PE,MATERNAL EXPOSURE TIMING UNSPECIFIED,2
PE,MENINGITIS CRYPTOCOCCAL,2
PE,MENINGITIS TUBERCULOUS,2
PE,MENTAL STATUS CHANGES,2
PE,METABOLIC DISORDER,2
PE,MIGRAINE,2
PE,MONOPLEGIA,2
PE,MOTOR DYSFUNCTION,2
PE,MOUTH ULCERATION,2
PE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
PE,MULTIPLE SCLEROSIS RELAPSE,2
PE,MUMPS,2
PE,MUSCLE CONTRACTURE,2
PE,MUSCLE SPASTICITY,2
PE,MUSCULOSKELETAL DISCOMFORT,2
PE,MYOPATHY,2
PE,NEPHRECTOMY,2
PE,NEUROLOGICAL SYMPTOM,2
PE,NON-HODGKIN^S LYMPHOMA,2
PE,NORMAL NEWBORN,2
PE,OEDEMA,2
PE,OESOPHAGEAL CARCINOMA,2
PE,OESOPHAGEAL VARICES HAEMORRHAGE,2
PE,OPTIC ATROPHY,2
PE,OPTIC NERVE DISORDER,2
PE,OPTIC NEURITIS,2
PE,ORAL DISCOMFORT,2
PE,OROPHARYNGEAL DISCOMFORT,2
PE,OSTEONECROSIS OF JAW,2
PE,OVARIAN DISORDER,2
PE,PARAPLEGIA,2
PE,PATELLA FRACTURE,2
PE,PELVIC NEOPLASM,2
PE,PETECHIAE,2
PE,PHARYNGEAL INFLAMMATION,2
PE,PHLEBITIS,2
PE,PITUITARY TUMOUR,2
PE,PLACENTA PRAEVIA,2
PE,PNEUMOCOCCAL INFECTION,2
PE,PNEUMONIA ASPIRATION,2
PE,POLLAKIURIA,2
PE,POLYP,2
PE,POLYURIA,2
PE,PREGNANCY,2
PE,PROCEDURAL COMPLICATION,2
PE,PROLAPSE,2
PE,PULMONARY THROMBOSIS,2
PE,PURPURA,2
PE,PYELONEPHRITIS ACUTE,2
PE,RENAL FAILURE CHRONIC,2
PE,RESPIRATORY SYMPTOM,2
PE,RETINAL VASCULAR THROMBOSIS,2
PE,RHINORRHOEA,2
PE,SCIATICA,2
PE,SINUS TACHYCARDIA,2
PE,SKIN BURNING SENSATION,2
PE,SKIN EXFOLIATION,2
PE,SKIN MASS,2
PE,SKIN REACTION,2
PE,SKIN WOUND,2
PE,SLEEP APNOEA SYNDROME,2
PE,SMALL INTESTINE CARCINOMA,2
PE,SNEEZING,2
PE,SNORING,2
PE,SPINAL COLUMN INJURY,2
PE,SPINAL CORD INJURY,2
PE,SPLENOMEGALY,2
PE,STILLBIRTH,2
PE,STOMATITIS,2
PE,SUBCUTANEOUS ABSCESS,2
PE,SUICIDE ATTEMPT,2
PE,SWOLLEN TONGUE,2
PE,SYNOVIAL CYST,2
PE,SYSTEMIC INFECTION,2
PE,TACHYARRHYTHMIA,2
PE,TENDON DISORDER,2
PE,TENDON INJURY,2
PE,THERAPY CESSATION,2
PE,THROAT IRRITATION,2
PE,THROMBOCYTOSIS,2
PE,THYROID NEOPLASM,2
PE,TONSILLAR DISORDER,2
PE,TRACHEITIS,2
PE,TRISMUS,2
PE,UNINTENDED PREGNANCY,2
PE,URINARY TRACT DISORDER,2
PE,URINARY TRACT INFECTION BACTERIAL,2
PE,UTERINE LEIOMYOMA,2
PE,VASCULAR STENT THROMBOSIS,2
PE,VENOUS THROMBOSIS,2
PE,VISUAL FIELD DEFECT,2
PE,WHEEZING,2
PE,WHITE BLOOD CELL COUNT INCREASED,2
PE,WHITE BLOOD CELL DISORDER,2
PE,WOUND INFECTION,2
PE,WOUND SECRETION,2
PE,ABDOMINAL ABSCESS,1
PE,ABDOMINAL NEOPLASM,1
PE,ABNORMAL FAECES,1
PE,ABNORMAL SENSATION IN EYE,1
PE,ABNORMAL WITHDRAWAL BLEEDING,1
PE,ABSCESS JAW,1
PE,ACCIDENT AT WORK,1
PE,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
PE,ACNE,1
PE,ACRAL OVERGROWTH,1
PE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
PE,ACUTE HEPATITIS C,1
PE,ACUTE PULMONARY OEDEMA,1
PE,ACUTE STRESS DISORDER,1
PE,ADENOCARCINOMA GASTRIC,1
PE,ADENOIDAL DISORDER,1
PE,ADENOLIPOMA,1
PE,ADVERSE REACTION,1
PE,ALTERED STATE OF CONSCIOUSNESS,1
PE,AMAUROSIS,1
PE,AMYOTROPHIC LATERAL SCLEROSIS,1
PE,ANAL FISTULA,1
PE,ANAL PRURITUS,1
PE,ANAPHYLACTIC REACTION,1
PE,ANAPHYLACTOID REACTION,1
PE,ANENCEPHALY,1
PE,ANEURYSM RUPTURED,1
PE,ANGER,1
PE,ANGLE CLOSURE GLAUCOMA,1
PE,ANKLE OPERATION,1
PE,ANURIA,1
PE,AORTIC OCCLUSION,1
PE,APLASTIC ANAEMIA,1
PE,APPARENT DEATH,1
PE,APPENDICEAL ABSCESS,1
PE,APPENDICECTOMY,1
PE,APPLICATION SITE PAIN,1
PE,ARACHNOID CYST,1
PE,ARRHYTHMIA SUPRAVENTRICULAR,1
PE,ARTERIAL RUPTURE,1
PE,ARTERIOSCLEROSIS,1
PE,ARTERIOSPASM CORONARY,1
PE,ARTERIOVENOUS FISTULA SITE COMPLICATION,1
PE,ARTERIOVENOUS FISTULA SITE INFECTION,1
PE,ARTERITIS,1
PE,ARTHROPOD BITE,1
PE,ARTHROSCOPY,1
PE,ASPERGILLOMA,1
PE,ASPIRATION,1
PE,ASPIRATION BRONCHIAL,1
PE,AUTOIMMUNE HEPATITIS,1
PE,AZOTAEMIA,1
PE,BACTERIAL SEPSIS,1
PE,BENIGN BREAST NEOPLASM,1
PE,BENIGN OVARIAN TUMOUR,1
PE,BENIGN RENAL NEOPLASM,1
PE,BILE DUCT CANCER,1
PE,BILIARY COLIC,1
PE,BILIARY TRACT DISORDER,1
PE,BILIOPANCREATIC BYPASS,1
PE,BIOPSY BONE MARROW,1
PE,BITE,1
PE,BLADDER CANCER,1
PE,BLADDER DISCOMFORT,1
PE,BLADDER DIVERTICULUM,1
PE,BLADDER HYPERTROPHY,1
PE,BLADDER IRRITATION,1
PE,BLADDER NECK SCLEROSIS,1
PE,BLADDER NEOPLASM,1
PE,BLADDER PROLAPSE,1
PE,BLAST CELL CRISIS,1
PE,BLEEDING VARICOSE VEIN,1
PE,BLEPHARITIS,1
PE,BLOOD CHOLESTEROL,1
PE,BLOOD CORTISOL DECREASED,1
PE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
PE,BLOOD INSULIN ABNORMAL,1
PE,BLOOD LACTATE DEHYDROGENASE INCREASED,1
PE,BLOOD PARATHYROID HORMONE INCREASED,1
PE,BLOOD PHOSPHORUS INCREASED,1
PE,BLOOD POTASSIUM INCREASED,1
PE,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
PE,BLOOD TRIGLYCERIDES ABNORMAL,1
PE,BLOOD URIC ACID INCREASED,1
PE,BLOOD VISCOSITY INCREASED,1
PE,BONE CONTUSION,1
PE,BONE MARROW DISORDER,1
PE,BONE MARROW INFILTRATION,1
PE,BONE OPERATION,1
PE,BONE TUBERCULOSIS,1
PE,BRAIN NEOPLASM MALIGNANT,1
PE,BRAIN STEM STROKE,1
PE,BRAIN TUMOUR OPERATION,1
PE,BRANCHIAL CYST,1
PE,BREAST CANCER FEMALE,1
PE,BREAST CANCER STAGE I,1
PE,BREAST HAEMORRHAGE,1
PE,BREAST HYPERPLASIA,1
PE,BRONCHITIS CHRONIC,1
PE,BURSAL FLUID ACCUMULATION,1
PE,CARCINOID SYNDROME,1
PE,CARCINOMA IN SITU,1
PE,CARDIAC DISCOMFORT,1
PE,CARDIAC FAILURE ACUTE,1
PE,CARDIAC INFECTION,1
PE,CARDIAC PACEMAKER INSERTION,1
PE,CARDIAC PSEUDOANEURYSM,1
PE,CARDIAC TAMPONADE,1
PE,CARDIAC VALVE VEGETATION,1
PE,CARDITIS,1
PE,CAROTID ARTERIOSCLEROSIS,1
PE,CAROTID ARTERY OCCLUSION,1
PE,CARTILAGE INJURY,1
PE,CAST APPLICATION,1
PE,CEREBRAL ATROPHY,1
PE,CEREBRAL VENOUS THROMBOSIS,1
PE,CERVIX CARCINOMA,1
PE,CHOLECYSTECTOMY,1
PE,CHOLECYSTITIS,1
PE,CHOLECYSTITIS INFECTIVE,1
PE,CHOLERA,1
PE,CHONDRITIS,1
PE,CHONDROSARCOMA,1
PE,CHORIORETINOPATHY,1
PE,CHROMATURIA,1
PE,CHRONIC RESPIRATORY FAILURE,1
PE,CIRRHOSIS ALCOHOLIC,1
PE,CLEAR CELL RENAL CELL CARCINOMA,1
PE,CLEFT LIP,1
PE,CLEFT PALATE,1
PE,COAGULATION TEST ABNORMAL,1
PE,COELIAC DISEASE,1
PE,COGNITIVE DISORDER,1
PE,COLITIS ULCERATIVE,1
PE,COLOUR BLINDNESS ACQUIRED,1
PE,COMPARTMENT SYNDROME,1
PE,COMPLETED SUICIDE,1
PE,COMPLEX PARTIAL SEIZURES,1
PE,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
PE,CONCOMITANT DISEASE AGGRAVATED,1
PE,CONCOMITANT DISEASE PROGRESSION,1
PE,CONTRAST MEDIA ALLERGY,1
PE,CORNEAL INFECTION,1
PE,CORNEAL OEDEMA,1
PE,CORNEAL THICKENING,1
PE,CORNEAL TRANSPLANT,1
PE,CORONARY ARTERY INSUFFICIENCY,1
PE,COUGH DECREASED,1
PE,CREATININE RENAL CLEARANCE DECREASED,1
PE,CREST SYNDROME,1
PE,CROUP INFECTIOUS,1
PE,CRYPTORCHISM,1
PE,CULTURE POSITIVE,1
PE,CYCLOSPORIDIUM INFECTION,1
PE,CYSTADENOCARCINOMA PANCREAS,1
PE,CYSTITIS RADIATION,1
PE,CYTOMEGALOVIRUS TEST POSITIVE,1
PE,CYTOPENIA,1
PE,DACRYOSTENOSIS ACQUIRED,1
PE,DEAFNESS UNILATERAL,1
PE,DEATH NEONATAL,1
PE,DECREASED ACTIVITY,1
PE,DECREASED INTEREST,1
PE,DENTAL CARIES,1
PE,DENTAL OPERATION,1
PE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
PE,DEPRESSION SUICIDAL,1
PE,DERMATITIS,1
PE,DERMATITIS CONTACT,1
PE,DERMATITIS EXFOLIATIVE,1
PE,DERMATOMYOSITIS,1
PE,DEVELOPMENTAL HIP DYSPLASIA,1
PE,DEVICE DISLOCATION,1
PE,DEVICE RELATED SEPSIS,1
PE,DIABETES MELLITUS INADEQUATE CONTROL,1
PE,DIABETIC KETOACIDOSIS,1
PE,DIABETIC RETINAL OEDEMA,1
PE,DIABETIC RETINOPATHY,1
PE,DIALYSIS,1
PE,DIAPHRAGMATIC RUPTURE,1
PE,DIFFUSE LARGE B-CELL LYMPHOMA,1
PE,DIPLEGIA,1
PE,DISORGANISED SPEECH,1
PE,DIVERTICULUM INTESTINAL,1
PE,DROWNING,1
PE,DRUG EFFECT DECREASED,1
PE,DRUG USE DISORDER,1
PE,DYSENTERY,1
PE,DYSLIPIDAEMIA,1
PE,DYSPHEMIA,1
PE,DYSPLASIA,1
PE,DYSPNOEA AT REST,1
PE,EAR DISORDER,1
PE,EAR INFECTION,1
PE,ECONOMIC PROBLEM,1
PE,ECZEMA,1
PH,DEATH,703
PH,CARDIAC ARREST,341
PH,PNEUMONIA,241
PH,DYSPNOEA,173
PH,MYOCARDIAL INFARCTION,171
PH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,161
PH,CEREBROVASCULAR ACCIDENT,138
PH,DIABETIC COMPLICATION,113
PH,BLOOD GLUCOSE INCREASED,107
PH,CARDIO-RESPIRATORY ARREST,105
PH,MULTI-ORGAN FAILURE,95
PH,ASTHENIA,94
PH,PYREXIA,85
PH,VOMITING,71
PH,DECREASED APPETITE,61
PH,HYPERTENSION,54
PH,SEPSIS,54
PH,DRUG INEFFECTIVE,52
PH,BLOOD PRESSURE INCREASED,51
PH,URINARY TRACT INFECTION,51
PH,ANAEMIA,50
PH,HAEMOGLOBIN DECREASED,49
PH,LOSS OF CONSCIOUSNESS,49
PH,ADVERSE EVENT,47
PH,DIZZINESS,46
PH,HEADACHE,46
PH,HYPOTENSION,43
PH,RENAL FAILURE,43
PH,BLOOD CREATININE INCREASED,41
PH,RASH,41
PH,SEPTIC SHOCK,40
PH,ABDOMINAL PAIN UPPER,39
PH,COUGH,39
PH,DIABETES MELLITUS,37
PH,HAEMORRHAGE,37
PH,RENAL FAILURE CHRONIC,37
PH,CARDIAC DISORDER,36
PH,CHRONIC MYELOID LEUKAEMIA,34
PH,HYPERSENSITIVITY,34
PH,PAIN,34
PH,PLATELET COUNT DECREASED,33
PH,OEDEMA,32
PH,RENAL DISORDER,32
PH,CHEST PAIN,31
PH,DIARRHOEA,31
PH,MALAISE,31
PH,MALIGNANT NEOPLASM PROGRESSION,31
PH,PERITONITIS,30
PH,PRURITUS,30
PH,ARRHYTHMIA,29
PH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,29
PH,SUDDEN CARDIAC DEATH,29
PH,INFECTION,28
PH,NAUSEA,28
PH,PLEURAL EFFUSION,28
PH,THROMBOCYTOPENIA,28
PH,BLOOD CHOLESTEROL INCREASED,26
PH,FALL,26
PH,GASTROINTESTINAL HAEMORRHAGE,26
PH,HAEMATOCHEZIA,26
PH,SEIZURE,26
PH,DEHYDRATION,25
PH,PANCYTOPENIA,25
PH,ASTHMA,24
PH,CARDIAC FAILURE CONGESTIVE,24
PH,CHOLELITHIASIS,24
PH,PRODUCT USE ISSUE,24
PH,WHITE BLOOD CELL COUNT INCREASED,24
PH,ACUTE RESPIRATORY FAILURE,23
PH,OEDEMA PERIPHERAL,23
PH,PERITONEAL DIALYSIS COMPLICATION,23
PH,ABDOMINAL PAIN,22
PH,WEIGHT DECREASED,22
PH,CARDIAC FAILURE,21
PH,CONVULSION,21
PH,PULMONARY CONGESTION,21
PH,TACHYCARDIA,21
PH,CEREBRAL HAEMORRHAGE,20
PH,COMA,20
PH,DISEASE COMPLICATION,20
PH,CHILLS,19
PH,FATIGUE,19
PH,NEOPLASM MALIGNANT,19
PH,PULMONARY OEDEMA,19
PH,RENAL FAILURE ACUTE,19
PH,HYPERTENSIVE CRISIS,18
PH,HYPOGLYCAEMIA,18
PH,HYPOKALAEMIA,18
PH,TUBERCULOSIS,18
PH,BLOOD GLUCOSE ABNORMAL,17
PH,DISEASE PROGRESSION,17
PH,PRODUCT USE IN UNAPPROVED INDICATION,17
PH,ACUTE MYOCARDIAL INFARCTION,16
PH,DIALYSIS,16
PH,ERYTHEMA,16
PH,GENERAL PHYSICAL HEALTH DETERIORATION,16
PH,INSOMNIA,16
PH,PAIN IN EXTREMITY,16
PH,UNDERDOSE,16
PH,ABDOMINAL DISTENSION,15
PH,ARTHRALGIA,15
PH,BACK PAIN,15
PH,BREAST CANCER,15
PH,CARDIOMEGALY,15
PH,DIABETIC KETOACIDOSIS,15
PH,MATERNAL EXPOSURE DURING PREGNANCY,15
PH,NEPHROLITHIASIS,15
PH,PALPITATIONS,15
PH,RASH PRURITIC,15
PH,STEVENS-JOHNSON SYNDROME,15
PH,SUDDEN DEATH,15
PH,UPPER GASTROINTESTINAL HAEMORRHAGE,15
PH,VISION BLURRED,15
PH,DENGUE FEVER,14
PH,DIABETIC NEPHROPATHY,14
PH,DRUG DOSE OMISSION,14
PH,GASTROINTESTINAL STROMAL TUMOUR,14
PH,HAEMATOMA,14
PH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,14
PH,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,14
PH,DRUG RESISTANCE,13
PH,DYSPHAGIA,13
PH,HAEMATEMESIS,13
PH,HAEMATURIA,13
PH,HEPATIC ENZYME INCREASED,13
PH,HOSPITALISATION,13
PH,LUNG NEOPLASM MALIGNANT,13
PH,MYALGIA,13
PH,NEUTROPENIA,13
PH,RENAL INJURY,13
PH,WOUND,13
PH,ACUTE CORONARY SYNDROME,12
PH,ACUTE RESPIRATORY DISTRESS SYNDROME,12
PH,ALANINE AMINOTRANSFERASE INCREASED,12
PH,BLOOD PRESSURE DECREASED,12
PH,GAIT DISTURBANCE,12
PH,HAEMOPTYSIS,12
PH,HYPOAESTHESIA,12
PH,PANCREATIC CARCINOMA,12
PH,PULMONARY EMBOLISM,12
PH,PULMONARY TUBERCULOSIS,12
PH,URTICARIA,12
PH,WHITE BLOOD CELL COUNT DECREASED,12
PH,ASCITES,11
PH,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,11
PH,BRADYCARDIA,11
PH,CEREBRAL INFARCTION,11
PH,CHEST DISCOMFORT,11
PH,FOETAL EXPOSURE DURING PREGNANCY,11
PH,HEPATIC CIRRHOSIS,11
PH,HYPONATRAEMIA,11
PH,HYPOVOLAEMIC SHOCK,11
PH,INCORRECT DOSE ADMINISTERED,11
PH,INTENTIONAL OVERDOSE,11
PH,PERITONITIS BACTERIAL,11
PH,PNEUMONIA ASPIRATION,11
PH,STRESS,11
PH,TRANSIENT ISCHAEMIC ATTACK,11
PH,URINARY RETENTION,11
PH,ABASIA,10
PH,ATRIAL FIBRILLATION,10
PH,BLOOD GLUCOSE FLUCTUATION,10
PH,CELLULITIS,10
PH,COLON CANCER,10
PH,CONSTIPATION,10
PH,DEAFNESS,10
PH,DYSURIA,10
PH,ELECTROLYTE IMBALANCE,10
PH,GASTROENTERITIS,10
PH,HAEMORRHAGE INTRACRANIAL,10
PH,HEPATIC FAILURE,10
PH,INFLAMMATION,10
PH,LACTIC ACIDOSIS,10
PH,OVERDOSE,10
PH,RESPIRATORY FAILURE,10
PH,SKIN DISCOLOURATION,10
PH,SWELLING FACE,10
PH,THROMBOSIS,10
PH,BLOOD SODIUM DECREASED,9
PH,CARDIOGENIC SHOCK,9
PH,CORONARY ARTERY DISEASE,9
PH,HAEMORRHAGIC STROKE,9
PH,HYPOCALCAEMIA,9
PH,INFLUENZA LIKE ILLNESS,9
PH,JAUNDICE,9
PH,MUSCULAR WEAKNESS,9
PH,PEMPHIGOID,9
PH,VERTIGO,9
PH,ANAPHYLACTIC REACTION,8
PH,BEDRIDDEN,8
PH,BLOOD GLUCOSE DECREASED,8
PH,BONE PAIN,8
PH,DEPRESSION,8
PH,DISSEMINATED INTRAVASCULAR COAGULATION,8
PH,DRUG ADMINISTRATION ERROR,8
PH,DRUG INTOLERANCE,8
PH,ELECTROCARDIOGRAM QT PROLONGED,8
PH,EYE SWELLING,8
PH,FAECES DISCOLOURED,8
PH,FEBRILE NEUTROPENIA,8
PH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,8
PH,GASTRITIS,8
PH,HEPATIC CANCER,8
PH,HEPATOTOXICITY,8
PH,KIDNEY TRANSPLANT REJECTION,8
PH,LEUKOPENIA,8
PH,LIP SWELLING,8
PH,LUNG DISORDER,8
PH,METASTASES TO BONE,8
PH,METASTASES TO LIVER,8
PH,NASOPHARYNGITIS,8
PH,NEUTROPHIL COUNT DECREASED,8
PH,PALLOR,8
PH,PANCREATITIS,8
PH,PERIORBITAL OEDEMA,8
PH,PROSTATIC SPECIFIC ANTIGEN INCREASED,8
PH,PROSTATOMEGALY,8
PH,RED BLOOD CELL COUNT DECREASED,8
PH,RHABDOMYOLYSIS,8
PH,SOMNOLENCE,8
PH,SPLENOMEGALY,8
PH,SYNCOPE,8
PH,UNRESPONSIVE TO STIMULI,8
PH,VENTRICULAR TACHYCARDIA,8
PH,ABORTION SPONTANEOUS,7
PH,AMYLASE INCREASED,7
PH,ANEURYSM,7
PH,AZOTAEMIA,7
PH,BLOOD POTASSIUM DECREASED,7
PH,BLOOD URIC ACID INCREASED,7
PH,BONE MARROW FAILURE,7
PH,CARDIOMYOPATHY,7
PH,CHOLECYSTECTOMY,7
PH,CONDITION AGGRAVATED,7
PH,CYTOGENETIC ANALYSIS ABNORMAL,7
PH,DEPRESSED LEVEL OF CONSCIOUSNESS,7
PH,DISORIENTATION,7
PH,DRY SKIN,7
PH,EPISTAXIS,7
PH,EXPOSURE DURING PREGNANCY,7
PH,FLUID RETENTION,7
PH,HAEMATOCRIT DECREASED,7
PH,INTERNAL HAEMORRHAGE,7
PH,LOWER LIMB FRACTURE,7
PH,LUNG INFECTION,7
PH,MELAENA,7
PH,PERIPHERAL SWELLING,7
PH,PLATELET COUNT INCREASED,7
PH,PREMATURE BABY,7
PH,PRODUCTIVE COUGH,7
PH,RASH MACULO-PAPULAR,7
PH,RESTLESSNESS,7
PH,SKIN LESION,7
PH,VENTRICULAR ARRHYTHMIA,7
PH,WHEEZING,7
PH,WRONG TECHNIQUE IN DRUG USAGE PROCESS,7
PH,ACUTE HEPATIC FAILURE,6
PH,ACUTE KIDNEY INJURY,6
PH,ACUTE MYELOID LEUKAEMIA,6
PH,AGGRESSION,6
PH,BLOOD POTASSIUM INCREASED,6
PH,BRAIN OEDEMA,6
PH,CARDIOVASCULAR DISORDER,6
PH,CHROMATURIA,6
PH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,6
PH,EXPOSURE VIA FATHER,6
PH,FACE OEDEMA,6
PH,FEELING ABNORMAL,6
PH,FULL BLOOD COUNT DECREASED,6
PH,FUNGAL SEPSIS,6
PH,GASTROINTESTINAL DISORDER,6
PH,HEPATIC ENCEPHALOPATHY,6
PH,IMPAIRED HEALING,6
PH,LIVER DISORDER,6
PH,LYMPHADENOPATHY,6
PH,METASTASES TO CENTRAL NERVOUS SYSTEM,6
PH,METASTASIS,6
PH,NEOPLASM PROGRESSION,6
PH,ORAL CANDIDIASIS,6
PH,ORGAN FAILURE,6
PH,OROPHARYNGEAL PAIN,6
PH,PANCREATITIS ACUTE,6
PH,PREMATURE DELIVERY,6
PH,RASH GENERALISED,6
PH,RENAL IMPAIRMENT,6
PH,RESPIRATORY ARREST,6
PH,SECOND PRIMARY MALIGNANCY,6
PH,STOMATITIS,6
PH,SUICIDAL IDEATION,6
PH,TOXICITY TO VARIOUS AGENTS,6
PH,TYPE 2 DIABETES MELLITUS,6
PH,ULCER,6
PH,UNWANTED AWARENESS DURING ANAESTHESIA,6
PH,ABDOMINAL DISCOMFORT,5
PH,ABNORMAL BEHAVIOUR,5
PH,ANGINA UNSTABLE,5
PH,ARTHRITIS,5
PH,ASPARTATE AMINOTRANSFERASE INCREASED,5
PH,BALANCE DISORDER,5
PH,BLISTER,5
PH,BLOOD DISORDER,5
PH,BLOOD LACTATE DEHYDROGENASE INCREASED,5
PH,BLOOD PRESSURE FLUCTUATION,5
PH,BRAIN HERNIATION,5
PH,CARDIAC FAILURE CHRONIC,5
PH,CHOLECYSTITIS,5
PH,CIRCULATORY COLLAPSE,5
PH,CYANOSIS,5
PH,DEEP VEIN THROMBOSIS,5
PH,DRUG HYPERSENSITIVITY,5
PH,DRUG PRESCRIBING ERROR,5
PH,DRUG-INDUCED LIVER INJURY,5
PH,DYSARTHRIA,5
PH,DYSSTASIA,5
PH,FURUNCLE,5
PH,GASTRIC ULCER,5
PH,HALLUCINATION,5
PH,HEAD INJURY,5
PH,HEART RATE INCREASED,5
PH,HEPATIC MASS,5
PH,HEPATOCELLULAR CARCINOMA,5
PH,HIP FRACTURE,5
PH,LEUKOCYTOSIS,5
PH,LOCAL SWELLING,5
PH,LOW BIRTH WEIGHT BABY,5
PH,LYMPHOCYTE COUNT DECREASED,5
PH,LYMPHOMA,5
PH,MASS,5
PH,MENORRHAGIA,5
PH,METASTASES TO LUNG,5
PH,MOVEMENT DISORDER,5
PH,NEPHROPATHY,5
PH,NEUROLEPTIC MALIGNANT SYNDROME,5
PH,NO THERAPEUTIC RESPONSE,5
PH,NORMAL NEWBORN,5
PH,OESOPHAGITIS,5
PH,ONCOLOGIC COMPLICATION,5
PH,OSTEONECROSIS OF JAW,5
PH,PARAESTHESIA,5
PH,PNEUMOTHORAX,5
PH,POLLAKIURIA,5
PH,PRESCRIBED UNDERDOSE,5
PH,PRODUCT QUALITY ISSUE,5
PH,PROSTATE CANCER,5
PH,PRURITUS GENERALISED,5
PH,PULMONARY MASS,5
PH,RASH ERYTHEMATOUS,5
PH,SKIN EXFOLIATION,5
PH,SPINAL DISORDER,5
PH,SUBDURAL HAEMATOMA,5
PH,SURGERY,5
PH,SWELLING,5
PH,THROAT TIGHTNESS,5
PH,TUMOUR PSEUDOPROGRESSION,5
PH,ULTRAFILTRATION FAILURE,5
PH,VENTRICULAR FIBRILLATION,5
PH,ACCIDENT,4
PH,AGITATION,4
PH,AGRANULOCYTOSIS,4
PH,AKATHISIA,4
PH,ALOPECIA,4
PH,AMENORRHOEA,4
PH,AMOEBIASIS,4
PH,ANXIETY,4
PH,APLASTIC ANAEMIA,4
PH,ARTERIAL OCCLUSIVE DISEASE,4
PH,ATRIOVENTRICULAR BLOCK,4
PH,BRAIN NEOPLASM,4
PH,BREAST CANCER STAGE II,4
PH,CATARACT,4
PH,CHRONIC KIDNEY DISEASE,4
PH,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,4
PH,COLITIS,4
PH,CONFUSIONAL STATE,4
PH,CONTUSION,4
PH,CORONARY ARTERY BYPASS,4
PH,CREPITATIONS,4
PH,CYTOPENIA,4
PH,DIABETIC END STAGE RENAL DISEASE,4
PH,DRUG EFFECT PROLONGED,4
PH,DYSPEPSIA,4
PH,EXTRAPYRAMIDAL DISORDER,4
PH,EYE HAEMORRHAGE,4
PH,EYELID OEDEMA,4
PH,FEMUR FRACTURE,4
PH,FLUSHING,4
PH,GASTROOESOPHAGEAL REFLUX DISEASE,4
PH,GLOMERULONEPHRITIS CHRONIC,4
PH,HEART RATE DECREASED,4
PH,HEAT STROKE,4
PH,HEPATITIS,4
PH,HEPATITIS B,4
PH,HEPATOMEGALY,4
PH,HYPERGLYCAEMIA,4
PH,HYPERTENSIVE NEPHROPATHY,4
PH,HYPOXIA,4
PH,ILEUS,4
PH,INTESTINAL MASS,4
PH,LEUKAEMIA,4
PH,LIVER INJURY,4
PH,MEDICATION ERROR,4
PH,METABOLIC ACIDOSIS,4
PH,MOUTH ULCERATION,4
PH,MUSCULOSKELETAL STIFFNESS,4
PH,MYOCARDIAL ISCHAEMIA,4
PH,NEOPLASM,4
PH,NEUROMUSCULAR BLOCK PROLONGED,4
PH,OCULAR ICTERUS,4
PH,ORAL PAIN,4
PH,OSTEOARTHRITIS,4
PH,OSTEONECROSIS,4
PH,PEPTIC ULCER HAEMORRHAGE,4
PH,PETECHIAE,4
PH,PSORIASIS,4
PH,PSYCHOTIC DISORDER,4
PH,PULMONARY HAEMORRHAGE,4
PH,RENAL TUBULAR NECROSIS,4
PH,RESPIRATORY DISTRESS,4
PH,ROAD TRAFFIC ACCIDENT,4
PH,SPEECH DISORDER,4
PH,SUPRAVENTRICULAR TACHYCARDIA,4
PH,TACHYPNOEA,4
PH,THYROIDECTOMY,4
PH,TRANSAMINASES INCREASED,4
PH,TRANSFUSION,4
PH,TREATMENT FAILURE,4
PH,TREATMENT NONCOMPLIANCE,4
PH,TREMOR,4
PH,URINE OUTPUT DECREASED,4
PH,UROSEPSIS,4
PH,VIRAL INFECTION,4
PH,ABDOMINAL MASS,3
PH,ABDOMINAL TENDERNESS,3
PH,ACNE,3
PH,ADENOCARCINOMA,3
PH,ANGIOEDEMA,3
PH,ANGIOPLASTY,3
PH,ANURIA,3
PH,APNOEA,3
PH,ASPHYXIA,3
PH,BLOOD ALBUMIN DECREASED,3
PH,BLOOD BILIRUBIN INCREASED,3
PH,BLOOD CREATINE INCREASED,3
PH,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
PH,BLOOD PRESSURE ABNORMAL,3
PH,BLOOD PRESSURE INADEQUATELY CONTROLLED,3
PH,BRAIN DEATH,3
PH,BREAST CANCER RECURRENT,3
PH,BREAST CANCER STAGE IV,3
PH,BREAST CYST,3
PH,BRONCHOSPASM,3
PH,CALCULUS URINARY,3
PH,CEREBRAL THROMBOSIS,3
PH,COLD SWEAT,3
PH,COMPLETED SUICIDE,3
PH,CONCOMITANT DISEASE PROGRESSION,3
PH,CONGESTIVE CARDIOMYOPATHY,3
PH,CUSHING^S SYNDROME,3
PH,DEVICE ISSUE,3
PH,DEVICE MALFUNCTION,3
PH,DIABETES MELLITUS INADEQUATE CONTROL,3
PH,DRY MOUTH,3
PH,DUODENAL ULCER,3
PH,DYSGEUSIA,3
PH,EATING DISORDER,3
PH,EJECTION FRACTION DECREASED,3
PH,ELECTROCARDIOGRAM ABNORMAL,3
PH,EMBOLIC STROKE,3
PH,ENCEPHALITIS,3
PH,END STAGE RENAL DISEASE,3
PH,ENDOTRACHEAL INTUBATION,3
PH,EOSINOPHILIA,3
PH,EXPIRED PRODUCT ADMINISTERED,3
PH,EXPOSURE DURING BREAST FEEDING,3
PH,FAECALOMA,3
PH,FEEDING DISORDER,3
PH,FLANK PAIN,3
PH,FULL BLOOD COUNT ABNORMAL,3
PH,FUNGAL PERITONITIS,3
PH,GALLBLADDER OPERATION,3
PH,GANGRENE,3
PH,GASTROINTESTINAL OBSTRUCTION,3
PH,GASTROINTESTINAL TUBE INSERTION,3
PH,GASTROINTESTINAL ULCER HAEMORRHAGE,3
PH,GENERALISED ERYTHEMA,3
PH,GENERALISED TONIC-CLONIC SEIZURE,3
PH,GUN SHOT WOUND,3
PH,HEMIPLEGIA,3
PH,HEPATIC NEOPLASM,3
PH,HYPERHIDROSIS,3
PH,HYPERKALAEMIA,3
PH,HYPERSOMNIA,3
PH,HYPERTENSIVE HEART DISEASE,3
PH,HYPERURICAEMIA,3
PH,HYPOKINESIA,3
PH,HYPOMAGNESAEMIA,3
PH,IMMUNE SYSTEM DISORDER,3
PH,INFLUENZA,3
PH,INJECTION SITE PAIN,3
PH,INTENTIONAL PRODUCT USE ISSUE,3
PH,INTERVERTEBRAL DISC PROTRUSION,3
PH,INTESTINAL OBSTRUCTION,3
PH,IRRITABILITY,3
PH,ISCHAEMIC STROKE,3
PH,JAUNDICE CHOLESTATIC,3
PH,JOINT SWELLING,3
PH,LABORATORY TEST ABNORMAL,3
PH,LEFT VENTRICULAR HYPERTROPHY,3
PH,LEG AMPUTATION,3
PH,LEPTOSPIROSIS,3
PH,LETHARGY,3
PH,LOCALISED INFECTION,3
PH,MANIA,3
PH,METRORRHAGIA,3
PH,MIGRAINE,3
PH,MULTI-ORGAN DISORDER,3
PH,MUSCLE SPASMS,3
PH,MUSCLE TWITCHING,3
PH,PANCREATIC CARCINOMA STAGE IV,3
PH,PEPTIC ULCER,3
PH,PERICARDIAL EFFUSION,3
PH,POOR QUALITY SLEEP,3
PH,PULMONARY HYPERTENSION,3
PH,RASH MORBILLIFORM,3
PH,RETINAL DETACHMENT,3
PH,RHEUMATIC HEART DISEASE,3
PH,SINUS TACHYCARDIA,3
PH,SPUTUM DISCOLOURED,3
PH,STARING,3
PH,SUBARACHNOID HAEMORRHAGE,3
PH,THERAPEUTIC RESPONSE DECREASED,3
PH,TROPICAL INFECTIOUS DISEASE,3
PH,TUMOUR HAEMORRHAGE,3
PH,VAGINAL HAEMORRHAGE,3
PH,VASCULAR GRAFT,3
PH,WEIGHT INCREASED,3
PH,ABDOMINAL RIGIDITY,2
PH,ABNORMAL FAECES,2
PH,ABSCESS,2
PH,ACIDOSIS,2
PH,ACUTE LYMPHOCYTIC LEUKAEMIA,2
PH,ADRENOCORTICAL INSUFFICIENCY ACUTE,2
PH,ADVERSE DRUG REACTION,2
PH,ALBUMINURIA,2
PH,ALTERED STATE OF CONSCIOUSNESS,2
PH,ANAESTHETIC COMPLICATION,2
PH,ANAL INCONTINENCE,2
PH,ANAPHYLACTIC SHOCK,2
PH,ANEURYSM RUPTURED,2
PH,ANGIODYSPLASIA,2
PH,ANIMAL BITE,2
PH,AORTIC ARTERIOSCLEROSIS,2
PH,APATHY,2
PH,APHAGIA,2
PH,APHASIA,2
PH,APPARENT DEATH,2
PH,ARRHYTHMIA SUPRAVENTRICULAR,2
PH,ARTHROPATHY,2
PH,ASPIRATION,2
PH,ATYPICAL FEMUR FRACTURE,2
PH,AUTOIMMUNE THYROIDITIS,2
PH,BILE DUCT STONE,2
PH,BIPOLAR DISORDER,2
PH,BK VIRUS INFECTION,2
PH,BLADDER CANCER,2
PH,BLAST CELL CRISIS,2
PH,BLINDNESS,2
PH,BLINDNESS UNILATERAL,2
PH,BLOOD CALCIUM DECREASED,2
PH,BLOOD CREATININE ABNORMAL,2
PH,BLOOD PRESSURE IMMEASURABLE,2
PH,BLOOD PRESSURE SYSTOLIC INCREASED,2
PH,BONE CANCER,2
PH,BONE DISORDER,2
PH,BONE MARROW DISORDER,2
PH,BRAIN INJURY,2
PH,BREAST CANCER FEMALE,2
PH,BREAST CANCER STAGE I,2
PH,BREAST CANCER STAGE III,2
PH,BREATH SOUNDS ABNORMAL,2
PH,BRONCHIECTASIS,2
PH,BRONCHITIS,2
PH,CAESAREAN SECTION,2
PH,CARDIAC MURMUR,2
PH,CARDIAC PACEMAKER INSERTION,2
PH,CARDIOPULMONARY FAILURE,2
PH,CARDITIS,2
PH,CATARACT OPERATION,2
PH,CATHETER SITE INFECTION,2
PH,CEREBRAL ATROPHY,2
PH,CEREBROVASCULAR DISORDER,2
PH,CERVIX CARCINOMA,2
PH,CHEMOTHERAPY,2
PH,CHOKING SENSATION,2
PH,CHOLELITHOTOMY,2
PH,CHOREA,2
PH,COLON CANCER STAGE III,2
PH,COLOSTOMY,2
PH,DECUBITUS ULCER,2
PH,DEMENTIA ALZHEIMER^S TYPE,2
PH,DERMATITIS,2
PH,DERMATITIS ALLERGIC,2
PH,DEVICE DEFECTIVE,2
PH,DEVICE LEAKAGE,2
PH,DEVICE RELATED INFECTION,2
PH,DIAPHRAGMATIC HERNIA,2
PH,DIARRHOEA INFECTIOUS,2
PH,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,2
PH,DRUG DEPENDENCE,2
PH,DRUG DISPENSING ERROR,2
PH,DRY THROAT,2
PH,DYSKINESIA,2
PH,DYSPHONIA,2
PH,ECZEMA,2
PH,ELDERLY,2
PH,EMBOLISM,2
PH,EMOTIONAL DISTRESS,2
PH,EMPHYSEMA,2
PH,ENCEPHALOPATHY,2
PH,ENURESIS,2
PH,EXFOLIATIVE RASH,2
PH,EYE DISORDER,2
PH,EYE OPERATION,2
PH,EYE PRURITUS,2
PH,FAECES SOFT,2
PH,FEELING COLD,2
PH,FEELING HOT,2
PH,FIBROSIS,2
PH,FLUID OVERLOAD,2
PH,FREQUENT BOWEL MOVEMENTS,2
PH,FUNGAL INFECTION,2
PH,GAIT INABILITY,2
PH,GASTRIC CANCER,2
PH,GASTRIC DISORDER,2
PH,GASTRIC HAEMORRHAGE,2
PH,GASTRIC PERFORATION,2
PH,GASTRITIS EROSIVE,2
PH,GASTROINTESTINAL TRACT IRRITATION,2
PH,GASTROINTESTINAL ULCER,2
PH,GENERALISED OEDEMA,2
PH,GESTATIONAL DIABETES,2
PH,GINGIVITIS,2
PH,GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY,2
PH,GOUT,2
PH,HAEMODIALYSIS,2
PH,HAEMOGLOBINURIA,2
PH,HAEMORRHAGIC TRANSFORMATION STROKE,2
PH,HEART DISEASE CONGENITAL,2
PH,HEART RATE IRREGULAR,2
PH,HEMIPARESIS,2
PH,HEPATIC CANCER STAGE IV,2
PH,HEPATIC FUNCTION ABNORMAL,2
PH,HODGKIN^S DISEASE,2
PH,HOT FLUSH,2
PH,HYDROCEPHALUS,2
PH,HYPERCHOLESTEROLAEMIA,2
PH,HYPERLIPIDAEMIA,2
PH,HYPOALBUMINAEMIA,2
PH,HYPOPHAGIA,2
PH,HYPOPNOEA,2
PH,HYPOTHYROIDISM,2
PH,HYPOTONIA,2
PH,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,2
PH,HYSTERECTOMY,2
PH,IMMUNE THROMBOCYTOPENIC PURPURA,2
PH,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
PH,INCREASED APPETITE,2
PH,INCREASED UPPER AIRWAY SECRETION,2
PH,INFUSION RELATED REACTION,2
PH,INJECTION SITE HAEMATOMA,2
PH,INJECTION SITE INDURATION,2
PH,INJECTION SITE INFLAMMATION,2
PH,INTERNATIONAL NORMALISED RATIO INCREASED,2
PH,INTRACRANIAL HAEMATOMA,2
PH,IRON DEFICIENCY ANAEMIA,2
PH,KETOACIDOSIS,2
PH,KLEBSIELLA INFECTION,2
PH,LACERATION,2
PH,LACRIMATION INCREASED,2
PH,LEIOMYOMA,2
PH,LEUKOSTASIS SYNDROME,2
PH,LIMB DISCOMFORT,2
PH,LIP DRY,2
PH,LIPASE INCREASED,2
PH,LIVER ABSCESS,2
PH,LOSS OF LIBIDO,2
PH,LOWER GASTROINTESTINAL HAEMORRHAGE,2
PH,LUMBAR SPINAL STENOSIS,2
PH,LUNG ABSCESS,2
PH,LUNG INFILTRATION,2
PH,LUNG NEOPLASM,2
PH,LUPUS NEPHRITIS,2
PH,MACULAR OEDEMA,2
PH,MARROW HYPERPLASIA,2
PH,MASTECTOMY,2
PH,MASTOIDITIS,2
PH,MEAN CELL VOLUME DECREASED,2
PH,MEMORY IMPAIRMENT,2
PH,MENINGITIS TUBERCULOUS,2
PH,MENTAL DISORDER,2
PH,MENTAL IMPAIRMENT,2
PH,METABOLIC ENCEPHALOPATHY,2
PH,METASTASES TO LYMPH NODES,2
PH,MICROCOCCUS INFECTION,2
PH,MOBILITY DECREASED,2
PH,MOTOR DYSFUNCTION,2
PH,MUCOSAL INFLAMMATION,2
PH,MUSCULOSKELETAL DISCOMFORT,2
PH,MYELOFIBROSIS,2
PH,MYOCARDITIS,2
PH,MYOPATHY,2
PH,MYOSITIS,2
PH,NASAL CONGESTION,2
PH,NECK MASS,2
PH,NECROSIS,2
PH,NEPHROSCLEROSIS,2
PH,NERVOUSNESS,2
PH,NO ADVERSE EVENT,2
PH,OCULAR HYPERAEMIA,2
PH,OESOPHAGEAL VARICES HAEMORRHAGE,2
PH,ORTHOPNOEA,2
PH,ORTHOSTATIC HYPOTENSION,2
PH,OSTEOPOROSIS,2
PH,OXYGEN SATURATION DECREASED,2
PH,PAIN OF SKIN,2
PH,PAINFUL RESPIRATION,2
PH,PANCREATIC NEOPLASM,2
PH,PAPULE,2
PH,PARALYSIS,2
PH,PARKINSON^S DISEASE,2
PH,PATHOGEN RESISTANCE,2
PH,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
PH,PERIPHERAL ISCHAEMIA,2
PH,PERITONEAL DISORDER,2
PH,PHLEBITIS,2
PH,PLASMA CELL MYELOMA,2
PH,POLYURIA,2
PH,POST PROCEDURAL COMPLICATION,2
PH,POST PROCEDURAL HAEMORRHAGE,2
PH,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
PH,POSTOPERATIVE WOUND INFECTION,2
PH,PREMATURE LABOUR,2
PH,PRESYNCOPE,2
PH,PROCEDURAL HAEMORRHAGE,2
PH,PRODUCT ODOUR ABNORMAL,2
PH,PROSTATE CANCER METASTATIC,2
PH,PROTEIN TOTAL DECREASED,2
PH,PROTEINURIA,2
PH,PROTHROMBIN TIME PROLONGED,2
PH,PULMONARY FIBROSIS,2
PH,PURPURA,2
PH,PURULENT DISCHARGE,2
PH,PYELONEPHRITIS ACUTE,2
PH,RASH MACULAR,2
PH,RECURRENT CANCER,2
PH,RED CELL DISTRIBUTION WIDTH INCREASED,2
PH,REFUSAL OF TREATMENT BY PATIENT,2
PH,RENAL COLIC,2
PH,RENAL CYST,2
PH,RENAL SURGERY,2
PH,RENAL TRANSPLANT,2
PH,RENAL TUBULAR DISORDER,2
PH,RESPIRATORY ALKALOSIS,2
PH,RESPIRATORY DISORDER,2
PH,RESPIRATORY TRACT INFECTION,2
PH,RETINAL HAEMORRHAGE,2
PH,RIGHT VENTRICULAR FAILURE,2
PH,SCAR,2
PH,SCHIZOPHRENIA,2
PH,SCROTAL SWELLING,2
PH,SEPTIC ENCEPHALOPATHY,2
PH,SKIN HAEMORRHAGE,2
PH,SKIN HYPERPIGMENTATION,2
PH,SKIN HYPERTROPHY,2
PH,SKIN INFECTION,2
PH,SKIN SWELLING,2
PH,SLOW SPEECH,2
PH,SPINAL OSTEOARTHRITIS,2
PH,SQUAMOUS CELL CARCINOMA,2
PH,STENT PLACEMENT,2
PH,STILLBIRTH,2
PH,SUICIDAL BEHAVIOUR,2
PH,SUICIDE ATTEMPT,2
PH,SWEAT GLAND TUMOUR,2
PH,SWOLLEN TONGUE,2
PH,SYNOVITIS,2
PH,SYSTEMIC LUPUS ERYTHEMATOSUS,2
PH,TACHYARRHYTHMIA,2
PH,THERAPY CESSATION,2
PH,THROAT LESION,2
PH,THROMBOSIS IN DEVICE,2
PH,THROMBOTIC STROKE,2
PH,TINNITUS,2
PH,TOE AMPUTATION,2
PH,TOXIC EPIDERMAL NECROLYSIS,2
PH,TRANSPLANT REJECTION,2
PH,TRANSURETHRAL PROSTATECTOMY,2
PH,TROPONIN I INCREASED,2
PH,TUBULOINTERSTITIAL NEPHRITIS,2
PH,TUMOUR RUPTURE,2
PH,TYPE I HYPERSENSITIVITY,2
PH,UNINTENDED PREGNANCY,2
PH,UPPER LIMB FRACTURE,2
PH,URAEMIC ENCEPHALOPATHY,2
PH,URINARY INCONTINENCE,2
PH,UTERINE HAEMORRHAGE,2
PH,UTERINE MASS,2
PH,UVEITIS,2
PH,VASODILATATION,2
PH,VENOUS OCCLUSION,2
PH,VENTRICULAR EXTRASYSTOLES,2
PH,VIITH NERVE PARALYSIS,2
PH,VIRAL MYOCARDITIS,2
PH,VISUAL PATHWAY DISORDER,2
PH,WAIST CIRCUMFERENCE INCREASED,2
PH,ABDOMINAL ABSCESS,1
PH,ABDOMINAL ADHESIONS,1
PH,ABDOMINAL INFECTION,1
PH,ABDOMINAL SYMPTOM,1
PH,ABDOMINAL WALL HAEMATOMA,1
PH,ABORTION EARLY,1
PH,ABSCESS JAW,1
PH,ABSCESS LIMB,1
PH,ACCIDENTAL OVERDOSE,1
PH,ACINETOBACTER INFECTION,1
PH,ACINETOBACTER TEST POSITIVE,1
PH,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
PH,ACTIVITIES OF DAILY LIVING IMPAIRED,1
PH,ACUTE LEUKAEMIA,1
PH,ACUTE ON CHRONIC LIVER FAILURE,1
PH,ACUTE PRERENAL FAILURE,1
PH,ADRENAL INSUFFICIENCY,1
PH,AKINESIA,1
PH,ALCOHOLIC LIVER DISEASE,1
PH,ALPHA 1 FOETOPROTEIN INCREASED,1
PH,AMNESIA,1
PH,AMNIORRHOEA,1
PH,ANAL ABSCESS,1
PH,ANAPHYLACTOID REACTION,1
PH,ANGER,1
PH,ANGINA PECTORIS,1
PH,ANGIOPATHY,1
PH,ANGULAR CHEILITIS,1
PH,ANIMAL SCRATCH,1
PH,ANKLE FRACTURE,1
PH,ANOGENITAL WARTS,1
PH,ANORECTAL SWELLING,1
PH,ANTI FACTOR IX ANTIBODY POSITIVE,1
PH,AORTIC ANEURYSM,1
PH,AORTIC DISSECTION,1
PH,AORTIC RUPTURE,1
PH,AORTIC THROMBOSIS,1
PH,AORTIC VALVE INCOMPETENCE,1
PH,AORTIC VALVE SCLEROSIS,1
PH,AORTIC VALVE STENOSIS,1
PH,APHONIA,1
PH,APPENDICITIS,1
PH,APPENDICITIS PERFORATED,1
PH,APPENDIX DISORDER,1
PH,ARTERIAL BYPASS OPERATION,1
PH,ARTERIAL DISORDER,1
PH,ARTERIAL RUPTURE,1
PH,ARTERIOSCLEROSIS,1
PH,ARTERIOVENOUS FISTULA OCCLUSION,1
PH,ARTERITIS,1
PH,ARTHROPOD BITE,1
PH,ASPIRATION JOINT,1
PH,ATAXIA,1
PH,ATELECTASIS,1
PH,ATRIAL SEPTAL DEFECT,1
PH,ATRIOVENTRICULAR DISSOCIATION,1
PH,AUTOIMMUNE DISORDER,1
PH,BALANOPOSTHITIS,1
PH,BASAL GANGLIA HAEMORRHAGE,1
PH,BASOPHIL COUNT INCREASED,1
PH,BENIGN HEPATIC NEOPLASM,1
PH,BENIGN HYDATIDIFORM MOLE,1
PH,BENIGN OVARIAN TUMOUR,1
PH,BENIGN PROSTATIC HYPERPLASIA,1
PH,BILE DUCT STENOSIS,1
PH,BILIARY TRACT DISORDER,1
PH,BLADDER DISORDER,1
PH,BLADDER MASS,1
PH,BLADDER SQUAMOUS CELL CARCINOMA STAGE I,1
PH,BLADDER SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED,1
PH,BLINDNESS TRANSIENT,1
PH,BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED,1
PH,BLOOD BILIRUBIN ABNORMAL,1
PH,BLOOD CALCIUM INCREASED,1
PH,BLOOD COUNT ABNORMAL,1
PH,BLOOD CREATINE PHOSPHOKINASE MM INCREASED,1
PH,BLOOD CREATININE,1
PH,BLOOD LACTATE DEHYDROGENASE ABNORMAL,1
PH,BLOOD TRIGLYCERIDES INCREASED,1
PH,BLOOD URIC ACID ABNORMAL,1
PH,BLOOD URIC ACID DECREASED,1
PH,BLOOD URINE PRESENT,1
PH,BLOOD VISCOSITY INCREASED,1
PH,BLOODY PERITONEAL EFFLUENT,1
PH,BONE CANCER METASTATIC,1
PH,BONE LESION,1
PH,BONE MARROW INFILTRATION,1
PH,BONE NEOPLASM,1
PH,BONE SWELLING,1
PH,BONE TUBERCULOSIS,1
PH,BOWEL MOVEMENT IRREGULARITY,1
PH,BRAIN CANCER METASTATIC,1
PH,BRAIN MASS,1
PH,BRAIN NEOPLASM MALIGNANT,1
PH,BRAIN STEM INFARCTION,1
PH,BREAST HAEMATOMA,1
PH,BREAST INFLAMMATION,1
PH,BREAST MASS,1
PH,BREAST SWELLING,1
PH,BREAST TENDERNESS,1
PH,BREECH PRESENTATION,1
PH,BRONCHIAL NEOPLASM,1
PH,BRONCHOPNEUMONIA,1
PH,BUNDLE BRANCH BLOCK LEFT,1
PH,C-REACTIVE PROTEIN ABNORMAL,1
PH,C-REACTIVE PROTEIN INCREASED,1
PH,CACHEXIA,1
PH,CALCIUM IONISED DECREASED,1
PH,CALCULUS URETERIC,1
PH,CANCER IN REMISSION,1
PH,CANCER PAIN,1
PH,CANCER SURGERY,1
PH,CAPILLARY LEAK SYNDROME,1
PH,CARBON DIOXIDE INCREASED,1
PH,CARDIAC DEATH,1
PH,CARDIAC FAILURE ACUTE,1
PH,CARDIAC OPERATION,1
PH,CARDIAC TAMPONADE,1
PH,CARDIAC VALVE DISEASE,1
PH,CARDIAC VENTRICULAR THROMBOSIS,1
PH,CARDIORENAL SYNDROME,1
PH,CAROTID ARTERIOSCLEROSIS,1
PH,CENTRAL NERVOUS SYSTEM HAEMORRHAGE,1
PH,CENTRAL NERVOUS SYSTEM LESION,1
PH,CENTRAL OBESITY,1
PH,CEREBELLAR HAEMORRHAGE,1
PH,CERVICAL VERTEBRAL FRACTURE,1
PH,CHAPPED LIPS,1
PH,CHEST X-RAY ABNORMAL,1
PH,CHLOROMA,1
PH,CHOLECYSTITIS ACUTE,1
PH,CHOLECYSTITIS INFECTIVE,1
PH,CHOLESTATIC LIVER INJURY,1
PH,CHORIORETINITIS,1
PH,CHROMOSOME ANALYSIS ABNORMAL,1
PH,CHRONIC GASTRITIS,1
PH,CHRONIC HEPATITIS B,1
PH,CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION,1
PH,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
PH,COAGULOPATHY,1
PH,COGNITIVE DISORDER,1
PH,COLITIS ULCERATIVE,1
PH,COLON ADENOMA,1
PH,COLON CANCER STAGE IV,1
PH,COLORECTAL CANCER METASTATIC,1
PH,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
PH,CONCUSSION,1
PH,CONJUNCTIVAL DISCOLOURATION,1
PH,CONJUNCTIVAL HYPERAEMIA,1
PH,CONJUNCTIVITIS,1
PH,CONTRAST MEDIA ALLERGY,1
PH,CONTRAST MEDIA REACTION,1
PH,COOMBS INDIRECT TEST POSITIVE,1
PH,COOMBS TEST POSITIVE,1
PH,COR PULMONALE,1
PH,CORONARY ARTERY OCCLUSION,1
PH,COSTOVERTEBRAL ANGLE TENDERNESS,1
PH,CREATININE RENAL CLEARANCE DECREASED,1
PH,CREATININE RENAL CLEARANCE INCREASED,1
PH,CREUTZFELDT-JAKOB DISEASE,1
PH,CSF SHUNT OPERATION,1
PH,CUSHINGOID,1
PH,CYST REMOVAL,1
PH,CYST RUPTURE,1
PH,CYTOMEGALOVIRUS TEST POSITIVE,1
PH,DEAFNESS BILATERAL,1
PH,DEBRIDEMENT,1
PH,DECEREBRATION,1
PH,DECREASED ACTIVITY,1
PH,DECREASED IMMUNE RESPONSIVENESS,1
PH,DEFAECATION URGENCY,1
PH,DEFECT CONDUCTION INTRAVENTRICULAR,1
PH,DELAYED RECOVERY FROM ANAESTHESIA,1
PH,DELIVERY,1
PH,DELUSION,1
PH,DEMENTIA,1
PH,DERMAL CYST,1
PH,DERMATITIS ACNEIFORM,1
PH,DERMATITIS CONTACT,1
PH,DERMATITIS EXFOLIATIVE,1
PH,DERMATOMYOSITIS,1
PH,DEVICE BREAKAGE,1
PH,DEVICE FAILURE,1
PL,DEATH,698
PL,DRUG INEFFECTIVE,661
PL,DYSPNOEA,551
PL,ANAEMIA,521
PL,ASTHENIA,514
PL,NEUTROPENIA,430
PL,PNEUMONIA,384
PL,DIARRHOEA,376
PL,PYREXIA,360
PL,THROMBOCYTOPENIA,356
PL,NAUSEA,355
PL,VOMITING,319
PL,ERYTHEMA,310
PL,TOXICITY TO VARIOUS AGENTS,277
PL,DISEASE PROGRESSION,264
PL,ABDOMINAL PAIN,247
PL,LEUKOPENIA,240
PL,HEADACHE,222
PL,LOSS OF CONSCIOUSNESS,221
PL,RASH,199
PL,ALANINE AMINOTRANSFERASE INCREASED,182
PL,MALAISE,181
PL,PRURITUS,181
PL,SOMNOLENCE,181
PL,DIZZINESS,176
PL,GENERAL PHYSICAL HEALTH DETERIORATION,175
PL,RESPIRATORY FAILURE,173
PL,COUGH,172
PL,FATIGUE,172
PL,BLOOD PRESSURE INCREASED,168
PL,RENAL FAILURE,164
PL,CARDIAC ARREST,160
PL,PANCYTOPENIA,158
PL,MYOCARDIAL INFARCTION,157
PL,CARDIAC FAILURE,151
PL,DECREASED APPETITE,150
PL,HYPERTENSION,150
PL,BLOOD PRESSURE DECREASED,148
PL,ANXIETY,138
PL,ASPARTATE AMINOTRANSFERASE INCREASED,137
PL,CHEST PAIN,135
PL,SYNCOPE,133
PL,CONDITION AGGRAVATED,131
PL,SEPSIS,131
PL,ATRIAL FIBRILLATION,128
PL,TACHYCARDIA,128
PL,OEDEMA PERIPHERAL,124
PL,OVERDOSE,123
PL,WEIGHT DECREASED,122
PL,HYPOTENSION,121
PL,HYPERHIDROSIS,118
PL,MALIGNANT NEOPLASM PROGRESSION,118
PL,SUICIDE ATTEMPT,116
PL,BLOOD CREATININE INCREASED,114
PL,ISCHAEMIC STROKE,114
PL,FEBRILE NEUTROPENIA,113
PL,GASTROINTESTINAL HAEMORRHAGE,113
PL,URINARY TRACT INFECTION,113
PL,CHILLS,112
PL,SEIZURE,112
PL,PULMONARY EMBOLISM,110
PL,INFECTION,108
PL,PALPITATIONS,108
PL,ARTHRALGIA,107
PL,PLASMA CELL MYELOMA,106
PL,SKIN LESION,106
PL,FOETAL EXPOSURE DURING PREGNANCY,105
PL,HAEMOGLOBIN DECREASED,105
PL,HEPATIC FAILURE,104
PL,URTICARIA,104
PL,DIABETES MELLITUS,103
PL,ABDOMINAL PAIN UPPER,102
PL,C-REACTIVE PROTEIN INCREASED,102
PL,INSOMNIA,99
PL,MYALGIA,99
PL,HAEMORRHAGE,98
PL,POLYNEUROPATHY,98
PL,HYPOAESTHESIA,96
PL,BRADYCARDIA,95
PL,PAIN,95
PL,MULTI-ORGAN FAILURE,93
PL,EXPOSURE DURING PREGNANCY,91
PL,HYPERSENSITIVITY,91
PL,HYPERGLYCAEMIA,89
PL,MATERNAL EXPOSURE DURING PREGNANCY,89
PL,BONE MARROW FAILURE,88
PL,CIRCULATORY COLLAPSE,88
PL,ARRHYTHMIA,86
PL,DEHYDRATION,86
PL,INTENTIONAL OVERDOSE,85
PL,ACUTE KIDNEY INJURY,83
PL,FALL,81
PL,AGRANULOCYTOSIS,80
PL,BLOOD BILIRUBIN INCREASED,80
PL,CONFUSIONAL STATE,80
PL,CONSTIPATION,79
PL,PAIN IN EXTREMITY,79
PL,PREMATURE BABY,79
PL,RENAL IMPAIRMENT,79
PL,OVARIAN FAILURE,78
PL,DISEASE RECURRENCE,77
PL,EPILEPSY,75
PL,SEPTIC SHOCK,75
PL,TRANSAMINASES INCREASED,74
PL,VERTIGO,74
PL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,73
PL,PULMONARY OEDEMA,73
PL,ALOPECIA,71
PL,ASCITES,71
PL,MULTIPLE SCLEROSIS RELAPSE,71
PL,TREMOR,70
PL,PRODUCT USE IN UNAPPROVED INDICATION,69
PL,ALTERED STATE OF CONSCIOUSNESS,67
PL,ANAPHYLACTIC SHOCK,67
PL,CYTOMEGALOVIRUS INFECTION,67
PL,OEDEMA,67
PL,BODY TEMPERATURE INCREASED,65
PL,DEPRESSION,64
PL,DRUG INTOLERANCE,64
PL,FEELING ABNORMAL,64
PL,METABOLIC ACIDOSIS,64
PL,HYPOKALAEMIA,62
PL,CEREBROVASCULAR ACCIDENT,61
PL,UPPER RESPIRATORY TRACT INFECTION,61
PL,BRONCHITIS,60
PL,MUSCULAR WEAKNESS,60
PL,WEIGHT INCREASED,60
PL,ELECTROLYTE IMBALANCE,59
PL,HYPONATRAEMIA,59
PL,PALLOR,59
PL,SPEECH DISORDER,59
PL,PLEURAL EFFUSION,58
PL,RESPIRATORY TRACT INFECTION,58
PL,DEEP VEIN THROMBOSIS,57
PL,PRODUCT USE ISSUE,57
PL,CORONARY ARTERY DISEASE,56
PL,HEART RATE INCREASED,56
PL,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,56
PL,BASAL CELL CARCINOMA,55
PL,DYSPHAGIA,55
PL,HEPATOTOXICITY,55
PL,MUSCLE SPASMS,55
PL,AGITATION,54
PL,LEUKOCYTOSIS,54
PL,PARAESTHESIA,54
PL,PLATELET COUNT DECREASED,54
PL,VISUAL IMPAIRMENT,54
PL,BACK PAIN,53
PL,BALANCE DISORDER,53
PL,CONVULSION,53
PL,DRUG RESISTANCE,53
PL,LIVER INJURY,53
PL,LYMPHADENOPATHY,52
PL,ANGINA PECTORIS,51
PL,DRY MOUTH,51
PL,EPISTAXIS,51
PL,FACE OEDEMA,51
PL,HYPOGLYCAEMIA,51
PL,DRUG EFFECT INCOMPLETE,50
PL,GAIT DISTURBANCE,50
PL,HYPOTHYROIDISM,50
PL,ACUTE MYOCARDIAL INFARCTION,49
PL,CHRONIC KIDNEY DISEASE,49
PL,DYSPEPSIA,49
PL,HYPOTONIA,48
PL,LACTIC ACIDOSIS,48
PL,LYMPHOPENIA,48
PL,JAUNDICE,47
PL,NOSOCOMIAL INFECTION,47
PL,SUICIDAL IDEATION,47
PL,THROMBOSIS,47
PL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,46
PL,THERAPEUTIC RESPONSE DECREASED,46
PL,TINNITUS,46
PL,ABORTION SPONTANEOUS,45
PL,EXERCISE TOLERANCE DECREASED,45
PL,METASTASES TO LUNG,45
PL,PERIPHERAL SWELLING,45
PL,ACUTE MYELOID LEUKAEMIA,44
PL,EYELID OEDEMA,44
PL,NEUROPATHY PERIPHERAL,44
PL,BLISTER,43
PL,EJECTION FRACTION DECREASED,43
PL,ACUTE CORONARY SYNDROME,42
PL,ASTHMA,42
PL,BONE PAIN,42
PL,COMA,42
PL,DEPRESSED MOOD,42
PL,HAEMATURIA,42
PL,HEPATIC ENZYME INCREASED,42
PL,HERPES ZOSTER,42
PL,INTENTIONAL PRODUCT MISUSE,42
PL,OROPHARYNGEAL PAIN,42
PL,VISUAL ACUITY REDUCED,42
PL,CARDIOPULMONARY FAILURE,41
PL,CYANOSIS,41
PL,HEPATOMEGALY,41
PL,HYPERTHYROIDISM,41
PL,ACUTE RESPIRATORY FAILURE,40
PL,BLOOD GLUCOSE INCREASED,40
PL,DEVICE EXPULSION,40
PL,DISTURBANCE IN ATTENTION,40
PL,HYPERBILIRUBINAEMIA,40
PL,METASTASES TO LIVER,40
PL,RASH PAPULAR,40
PL,SECOND PRIMARY MALIGNANCY,40
PL,SHOCK,40
PL,SQUAMOUS CELL CARCINOMA,40
PL,ANGIOEDEMA,39
PL,COMPLETED SUICIDE,39
PL,GASTROINTESTINAL DISORDER,39
PL,MEMORY IMPAIRMENT,39
PL,METASTASES TO CENTRAL NERVOUS SYSTEM,39
PL,CLOSTRIDIUM DIFFICILE INFECTION,38
PL,ELECTROCARDIOGRAM QT PROLONGED,38
PL,PANCREATITIS ACUTE,38
PL,PROTEINURIA,38
PL,RASH GENERALISED,38
PL,ANAPHYLACTIC REACTION,37
PL,CHOLELITHIASIS,37
PL,DRY SKIN,37
PL,HYPERKALAEMIA,37
PL,INTERSTITIAL LUNG DISEASE,37
PL,CANDIDA INFECTION,36
PL,STOMATITIS,36
PL,APHASIA,35
PL,CARDIAC DISORDER,35
PL,CARDIOVASCULAR INSUFFICIENCY,35
PL,CONTUSION,35
PL,DEVICE DISLOCATION,35
PL,DRUG DEPENDENCE,35
PL,PREMATURE DELIVERY,35
PL,STAPHYLOCOCCAL INFECTION,35
PL,CACHEXIA,34
PL,CARDIOVASCULAR DISORDER,34
PL,CHEST DISCOMFORT,34
PL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,34
PL,LIVER DISORDER,34
PL,CATARACT,33
PL,CEREBRAL HAEMORRHAGE,33
PL,FEELING HOT,33
PL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,33
PL,PSYCHOMOTOR HYPERACTIVITY,33
PL,SLEEP DISORDER,33
PL,SWELLING FACE,33
PL,AGGRESSION,32
PL,BREAST CANCER,32
PL,LOW BIRTH WEIGHT BABY,32
PL,MUCOSAL INFLAMMATION,32
PL,SKIN EXFOLIATION,32
PL,WHITE BLOOD CELL COUNT DECREASED,32
PL,BURNING SENSATION,31
PL,GRANULOCYTOPENIA,31
PL,MEDICATION ERROR,31
PL,MYELODYSPLASTIC SYNDROME,31
PL,PNEUMONITIS,31
PL,PSYCHOTIC DISORDER,31
PL,TACHYPNOEA,31
PL,DISORIENTATION,30
PL,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,30
PL,DRUG-INDUCED LIVER INJURY,30
PL,DYSLIPIDAEMIA,30
PL,INFLAMMATION,30
PL,MULTIPLE SCLEROSIS,30
PL,MYDRIASIS,30
PL,TOXIC EPIDERMAL NECROLYSIS,30
PL,ASPERGILLUS INFECTION,29
PL,COAGULOPATHY,29
PL,GASTRITIS,29
PL,GLOMERULAR FILTRATION RATE DECREASED,29
PL,HAEMOPTYSIS,29
PL,HAEMORRHAGIC DIATHESIS,29
PL,HEPATIC STEATOSIS,29
PL,KLEBSIELLA INFECTION,29
PL,LUNG NEOPLASM MALIGNANT,29
PL,METASTASES TO BONE,29
PL,PSORIASIS,29
PL,RENAL DISORDER,29
PL,TRANSIENT ISCHAEMIC ATTACK,29
PL,URINARY INCONTINENCE,29
PL,ANURIA,28
PL,HEPATOCELLULAR CARCINOMA,28
PL,RASH MACULO-PAPULAR,28
PL,SKIN BURNING SENSATION,28
PL,VENTRICULAR ARRHYTHMIA,28
PL,DYSARTHRIA,27
PL,DYSPNOEA EXERTIONAL,27
PL,INFLUENZA LIKE ILLNESS,27
PL,LUNG DISORDER,27
PL,MENTAL IMPAIRMENT,27
PL,NEUROLEPTIC MALIGNANT SYNDROME,27
PL,OLIGURIA,27
PL,RASH ERYTHEMATOUS,27
PL,RASH PRURITIC,27
PL,RENAL FAILURE ACUTE,27
PL,STAPHYLOCOCCAL SEPSIS,27
PL,YELLOW SKIN,27
PL,BLOOD CHOLESTEROL INCREASED,26
PL,DRUG ABUSE,26
PL,DYSGEUSIA,26
PL,DYSPHONIA,26
PL,DYSURIA,26
PL,GENERALISED TONIC-CLONIC SEIZURE,26
PL,HAEMATEMESIS,26
PL,HAEMATOCHEZIA,26
PL,HAEMATOMA,26
PL,HEART RATE DECREASED,26
PL,HYPOGAMMAGLOBULINAEMIA,26
PL,MYOCARDIAL ISCHAEMIA,26
PL,RHINORRHOEA,26
PL,TRANSPLANT REJECTION,26
PL,WHEEZING,26
PL,WHITE BLOOD CELL COUNT INCREASED,26
PL,ABNORMAL BEHAVIOUR,25
PL,COMPLICATIONS OF TRANSPLANTED KIDNEY,25
PL,FLATULENCE,25
PL,GRAFT VERSUS HOST DISEASE,25
PL,HEAD INJURY,25
PL,HYPERCHOLESTEROLAEMIA,25
PL,MUSCULOSKELETAL PAIN,25
PL,NEOPLASM PROGRESSION,25
PL,NEPHROPATHY TOXIC,25
PL,PERITONITIS,25
PL,SINUS TACHYCARDIA,25
PL,SKIN DISCOLOURATION,25
PL,SUDDEN DEATH,25
PL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,25
PL,CARDIAC FAILURE CHRONIC,24
PL,DERMATITIS EXFOLIATIVE,24
PL,EMBOLISM,24
PL,FUNGAL INFECTION,24
PL,GENITAL HAEMORRHAGE,24
PL,HEMIPARESIS,24
PL,NERVOUS SYSTEM DISORDER,24
PL,NEUTROPHIL COUNT DECREASED,24
PL,OXYGEN SATURATION DECREASED,24
PL,PETECHIAE,24
PL,RED BLOOD CELL COUNT DECREASED,24
PL,SWELLING,24
PL,VISION BLURRED,24
PL,ACUTE HEPATIC FAILURE,23
PL,APATHY,23
PL,CARDIOTOXICITY,23
PL,CLOSTRIDIUM DIFFICILE COLITIS,23
PL,DISSEMINATED INTRAVASCULAR COAGULATION,23
PL,DRUG HYPERSENSITIVITY,23
PL,INTERNATIONAL NORMALISED RATIO INCREASED,23
PL,MUSCULOSKELETAL STIFFNESS,23
PL,NO THERAPEUTIC RESPONSE,23
PL,OSTEONECROSIS OF JAW,23
PL,PERICARDIAL EFFUSION,23
PL,RASH PUSTULAR,23
PL,RESPIRATORY DISORDER,23
PL,UROSEPSIS,23
PL,VAGINAL HAEMORRHAGE,23
PL,VENTRICULAR REMODELLING,23
PL,APPENDICITIS,22
PL,BLOOD ALKALINE PHOSPHATASE INCREASED,22
PL,BLOOD CREATINE PHOSPHOKINASE INCREASED,22
PL,DIPLOPIA,22
PL,DRUG LEVEL INCREASED,22
PL,DYSKINESIA,22
PL,FACIAL ASYMMETRY,22
PL,HAEMATOCRIT DECREASED,22
PL,HEPATIC FUNCTION ABNORMAL,22
PL,HISTIOCYTOSIS HAEMATOPHAGIC,22
PL,HOSPITALISATION,22
PL,IMPAIRED HEALING,22
PL,INFUSION RELATED REACTION,22
PL,IRRITABILITY,22
PL,KIDNEY TRANSPLANT REJECTION,22
PL,MITRAL VALVE INCOMPETENCE,22
PL,MOOD ALTERED,22
PL,PREGNANCY,22
PL,RASH MACULAR,22
PL,TREATMENT FAILURE,22
PL,BACTERIAL INFECTION,21
PL,BLOOD LACTATE DEHYDROGENASE INCREASED,21
PL,HAEMATOTOXICITY,21
PL,HAEMORRHAGE INTRACRANIAL,21
PL,HALLUCINATION_ VISUAL,21
PL,HEPATIC CIRRHOSIS,21
PL,KAPOSI^S SARCOMA,21
PL,LIVE BIRTH,21
PL,NEUROTOXICITY,21
PL,SALIVARY HYPERSECRETION,21
PL,UPPER GASTROINTESTINAL HAEMORRHAGE,21
PL,AMNESIA,20
PL,BLOOD DISORDER,20
PL,BLOOD UREA INCREASED,20
PL,COLITIS ULCERATIVE,20
PL,DERMATITIS ALLERGIC,20
PL,ESCHERICHIA SEPSIS,20
PL,EXTRAPYRAMIDAL DISORDER,20
PL,FLUSHING,20
PL,GASTRIC ULCER,20
PL,MUSCLE RIGIDITY,20
PL,NEUTROPENIC INFECTION,20
PL,PHARYNGITIS,20
PL,POLLAKIURIA,20
PL,PULMONARY FIBROSIS,20
PL,RESPIRATORY ARREST,20
PL,SINUSITIS,20
PL,SPINAL PAIN,20
PL,TUBERCULOSIS,20
PL,BLOOD TRIGLYCERIDES INCREASED,19
PL,BRAIN OEDEMA,19
PL,CAESAREAN SECTION,19
PL,DRUG ADMINISTRATION ERROR,19
PL,EOSINOPHILIA,19
PL,FIBRIN D DIMER INCREASED,19
PL,HAEMOLYTIC ANAEMIA,19
PL,HYPOALBUMINAEMIA,19
PL,HYPOTHERMIA,19
PL,INJECTION SITE ERYTHEMA,19
PL,INTESTINAL OBSTRUCTION,19
PL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,19
PL,LOWER RESPIRATORY TRACT INFECTION,19
PL,MENTAL DISORDER,19
PL,NEOPLASM,19
PL,NEUROLOGICAL SYMPTOM,19
PL,PRODUCTIVE COUGH,19
PL,SEROTONIN SYNDROME,19
PL,SKIN DISORDER,19
PL,SPLENOMEGALY,19
PL,VENTRICULAR FIBRILLATION,19
PL,BLINDNESS,18
PL,CENTRAL NERVOUS SYSTEM LESION,18
PL,ENDOCARDITIS,18
PL,FEAR,18
PL,HEPATITIS C,18
PL,HYPERURICAEMIA,18
PL,LACRIMATION INCREASED,18
PL,LIP OEDEMA,18
PL,LIVER FUNCTION TEST INCREASED,18
PL,LOWER GASTROINTESTINAL HAEMORRHAGE,18
PL,MONOPARESIS,18
PL,NEUROLOGICAL DECOMPENSATION,18
PL,NO ADVERSE EVENT,18
PL,PULMONARY ARTERIAL HYPERTENSION,18
PL,PULMONARY TUBERCULOSIS,18
PL,SKIN ULCER,18
PL,TUMOUR LYSIS SYNDROME,18
PL,URINARY RETENTION,18
PL,VENTRICULAR TACHYCARDIA,18
PL,ABDOMINAL DISTENSION,17
PL,ABDOMINAL PAIN LOWER,17
PL,ARTERIOSCLEROSIS,17
PL,BLOOD PRESSURE FLUCTUATION,17
PL,CARDIOGENIC SHOCK,17
PL,DIABETES MELLITUS INADEQUATE CONTROL,17
PL,EYE PAIN,17
PL,FEMUR FRACTURE,17
PL,FOETAL GROWTH RESTRICTION,17
PL,HEART RATE IRREGULAR,17
PL,HEPATITIS,17
PL,LARYNGEAL OEDEMA,17
PL,NERVOUSNESS,17
PL,NEUTROPHILIA,17
PL,PROSTATE CANCER,17
PL,RALES,17
PL,RESTLESSNESS,17
PL,SHOCK HAEMORRHAGIC,17
PL,STRESS CARDIOMYOPATHY,17
PL,TREATMENT NONCOMPLIANCE,17
PL,UNRESPONSIVE TO STIMULI,17
PL,VENOUS THROMBOSIS,17
PL,ADVERSE EVENT,16
PL,AFFECTIVE DISORDER,16
PL,ANAL PRURITUS,16
PL,DEMENTIA,16
PL,DERMATITIS,16
PL,GENERALISED ERYTHEMA,16
PL,GINGIVAL BLEEDING,16
PL,HAEMOLYSIS,16
PL,HEPATIC ENCEPHALOPATHY,16
PL,HYDRONEPHROSIS,16
PL,HYPERTRIGLYCERIDAEMIA,16
PL,INJECTION SITE REACTION,16
PL,LEFT VENTRICULAR HYPERTROPHY,16
PL,MAJOR DEPRESSION,16
PL,MENORRHAGIA,16
PL,NECROSIS,16
PL,PRURITUS GENERALISED,16
PL,RHEUMATOID ARTHRITIS,16
PL,SCHIZOPHRENIA,16
PL,SKIN REACTION,16
PL,TONGUE OEDEMA,16
PL,TRICUSPID VALVE INCOMPETENCE,16
PL,ABDOMINAL DISCOMFORT,15
PL,ATRIAL THROMBOSIS,15
PL,CARDIOMYOPATHY,15
PL,CHOLECYSTITIS,15
PL,CROHN^S DISEASE,15
PL,DERMATITIS ATOPIC,15
PL,DRUG ERUPTION,15
PL,EPSTEIN-BARR VIRUS INFECTION,15
PL,ESCHERICHIA URINARY TRACT INFECTION,15
PL,FEELING COLD,15
PL,GASTROINTESTINAL INFLAMMATION,15
PL,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,15
PL,INCREASED APPETITE,15
PL,JOINT SWELLING,15
PL,LIVER FUNCTION TEST ABNORMAL,15
PL,METASTASES TO LYMPH NODES,15
PL,NEPHROLITHIASIS,15
PL,ORAL HERPES,15
PL,PHOTOPHOBIA,15
PL,PULMONARY TOXICITY,15
PL,RHABDOMYOLYSIS,15
PL,SUPRAVENTRICULAR TACHYCARDIA,15
PL,TARDIVE DYSKINESIA,15
PL,THROMBOCYTOSIS,15
PL,TYPE 2 DIABETES MELLITUS,15
PL,VISUAL FIELD DEFECT,15
PL,APNOEA,14
PL,ARTHRITIS,14
PL,BLOOD GLUCOSE FLUCTUATION,14
PL,DELIRIUM,14
PL,DELUSION,14
PL,DISCOMFORT,14
PL,EYE DISORDER,14
PL,GASTROOESOPHAGEAL REFLUX DISEASE,14
PL,GLYCOSYLATED HAEMOGLOBIN INCREASED,14
PL,HAEMORRHAGIC STROKE,14
PL,HYPOPROTEINAEMIA,14
PL,HYPOXIA,14
PL,ILEUS PARALYTIC,14
PL,INFLUENZA,14
PL,LUNG NEOPLASM,14
PL,METASTASIS,14
PL,METASTATIC NEOPLASM,14
PL,NORMAL NEWBORN,14
PL,ORAL CANDIDIASIS,14
PL,OSTEOARTHRITIS,14
PL,OSTEONECROSIS,14
PL,POST PROCEDURAL COMPLICATION,14
PL,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,14
PL,PUPILLARY REFLEX IMPAIRED,14
PL,RECTAL HAEMORRHAGE,14
PL,SEDATION,14
PL,STREPTOCOCCAL INFECTION,14
PL,SUBILEUS,14
PL,SURGERY,14
PL,THROAT IRRITATION,14
PL,THROMBOSIS IN DEVICE,14
PL,THROMBOTIC MICROANGIOPATHY,14
PL,ABSCESS,13
PL,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,13
PL,ACTIVITIES OF DAILY LIVING IMPAIRED,13
PL,ASPHYXIA,13
PL,ATAXIA,13
PL,COGNITIVE DISORDER,13
PL,COLON CANCER,13
PL,DEAFNESS,13
PL,DECUBITUS ULCER,13
PL,DIABETIC KETOACIDOSIS,13
PL,DRUG EFFECT DECREASED,13
PL,DRUG LEVEL DECREASED,13
PL,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,13
PL,ENCEPHALITIS,13
PL,ENCEPHALOPATHY,13
PL,ERECTILE DYSFUNCTION,13
PL,HALLUCINATION,13
PL,HEPATIC PAIN,13
PL,IMPAIRED WORK ABILITY,13
PL,INTERLEUKIN LEVEL INCREASED,13
PL,LEFT VENTRICULAR DYSFUNCTION,13
PL,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,13
PL,MOBILITY DECREASED,13
PL,NEOPLASM MALIGNANT,13
PL,NEUTROPHIL COUNT INCREASED,13
PL,OBESITY,13
PL,ORAL DISORDER,13
PL,OSTEOPOROSIS,13
PL,PARESIS,13
PL,PERITONEAL HAEMORRHAGE,13
PL,PHARYNGEAL OEDEMA,13
PL,PLATELET COUNT INCREASED,13
PL,POISONING,13
PL,PRODUCT QUALITY ISSUE,13
PL,PULMONARY HYPERTENSION,13
PL,PURPURA,13
PL,RENAL TUBULAR DISORDER,13
PL,RIGHT VENTRICULAR FAILURE,13
PL,SINUS BRADYCARDIA,13
PL,SKIN TOXICITY,13
PL,STEVENS-JOHNSON SYNDROME,13
PL,SUDDEN CARDIAC DEATH,13
PL,THROAT TIGHTNESS,13
PL,URINARY TRACT INFECTION BACTERIAL,13
PL,VASCULAR STENT THROMBOSIS,13
PL,VENTRICULAR EXTRASYSTOLES,13
PL,ACUTE GRAFT VERSUS HOST DISEASE,12
PL,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,12
PL,ANGINA UNSTABLE,12
PL,BIPOLAR I DISORDER,12
PL,BLOOD GLUCOSE DECREASED,12
PL,BRONCHOSPASM,12
PL,CHOLESTASIS,12
PL,CHROMATURIA,12
PL,CHRONIC MYELOID LEUKAEMIA,12
PL,CONJUNCTIVITIS,12
PL,DECREASED ACTIVITY,12
PL,DIABETIC FOOT,12
PL,DIARRHOEA HAEMORRHAGIC,12
PL,DIVERTICULITIS,12
PL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,12
PL,EMBOLISM VENOUS,12
PL,ESCHERICHIA INFECTION,12
PL,FOETAL DEATH,12
PL,GASTRIC ULCER HAEMORRHAGE,12
PL,GASTRITIS HAEMORRHAGIC,12
PL,GASTROENTERITIS,12
PL,GASTROINTESTINAL NECROSIS,12
PL,GOITRE,12
PL,GUILLAIN-BARRE SYNDROME,12
PL,HYPERTRANSAMINASAEMIA,12
PL,INTENTIONAL DRUG MISUSE,12
PL,IRON DEFICIENCY ANAEMIA,12
PL,LOCAL SWELLING,12
PL,MENINGITIS,12
PL,MIDDLE INSOMNIA,12
PL,MUCOSAL DRYNESS,12
PL,NECROTISING HERPETIC RETINOPATHY,12
PL,NEURALGIA,12
PL,NYSTAGMUS,12
PL,PAIN IN JAW,12
PL,PARALYSIS,12
PL,PERIPHERAL SENSORY NEUROPATHY,12
PL,PHOTOSENSITIVITY REACTION,12
PL,PNEUMOCYSTIS JIROVECII PNEUMONIA,12
PL,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,12
PL,PORTAL HYPERTENSION,12
PL,PSEUDOMONAS INFECTION,12
PL,ROAD TRAFFIC ACCIDENT,12
PL,STRESS,12
PL,TORSADE DE POINTES,12
PL,TUBULOINTERSTITIAL NEPHRITIS,12
PL,VASCULAR PSEUDOANEURYSM,12
PL,ACUTE ABDOMEN,11
PL,ACUTE RESPIRATORY DISTRESS SYNDROME,11
PL,APLASIA PURE RED CELL,11
PL,AUTOIMMUNE HEPATITIS,11
PL,AUTOIMMUNE THYROIDITIS,11
PL,CHOKING,11
PL,COMMUNICATION DISORDER,11
PL,CORONARY ARTERY ANEURYSM,11
PL,DEPRESSIVE SYMPTOM,11
PL,DRUG WITHDRAWAL SYNDROME,11
PL,ECZEMA,11
PL,ENDOPHTHALMITIS,11
PL,ERUCTATION,11
PL,FEMORAL NECK FRACTURE,11
PL,GASTROINTESTINAL OBSTRUCTION,11
PL,HAEMORRHOIDS,11
PL,HEPATORENAL SYNDROME,11
PL,HERPES SIMPLEX,11
PL,HYPERCALCAEMIA,11
PL,HYPERTENSIVE CRISIS,11
PL,HYPERTHERMIA,11
PL,HYPOCALCAEMIA,11
PL,HYPOKINESIA,11
PL,ILEUS,11
PL,INCORRECT ROUTE OF DRUG ADMINISTRATION,11
PL,INJECTION SITE PAIN,11
PL,INJURY,11
PL,INTERNAL INJURY,11
PL,LATENT TUBERCULOSIS,11
PL,LOCALISED OEDEMA,11
PL,LOW DENSITY LIPOPROTEIN INCREASED,11
PL,LOWER LIMB FRACTURE,11
PL,LUNG INFILTRATION,11
PL,LYMPHOMA,11
PL,MALIGNANT MELANOMA,11
PL,MOUTH HAEMORRHAGE,11
PL,OESOPHAGEAL VARICES HAEMORRHAGE,11
PL,ORAL MUCOSA EROSION,11
PL,PANCREATITIS,11
PL,PERIPHERAL ISCHAEMIA,11
PL,PNEUMOTHORAX,11
PL,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,11
PL,RED BLOOD CELL SEDIMENTATION RATE INCREASED,11
PL,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,11
PL,THERAPY NON-RESPONDER,11
PL,URINARY TRACT INFECTION FUNGAL,11
PL,VARICELLA ZOSTER VIRUS INFECTION,11
PL,AKATHISIA,10
PL,AMENORRHOEA,10
PL,ATELECTASIS,10
PL,ATRIAL FLUTTER,10
PL,BLOOD GLUCOSE ABNORMAL,10
PL,BLOOD PRESSURE ABNORMAL,10
PL,CARDIAC FAILURE CONGESTIVE,10
PL,CARDIAC TAMPONADE,10
PL,CELLULITIS,10
PL,CEREBRAL ISCHAEMIA,10
PL,CHOLANGITIS,10
PL,CHRONIC LYMPHOCYTIC LEUKAEMIA,10
PL,CONJUNCTIVAL HYPERAEMIA,10
PL,CORONARY ARTERY STENOSIS,10
PL,DEFORMITY,10
PL,DIASTOLIC DYSFUNCTION,10
PL,ERYTHEMA NODOSUM,10
PL,FORMICATION,10
PL,GASTRITIS EROSIVE,10
PL,HALLUCINATION_ AUDITORY,10
PL,HYPERKERATOSIS,10
PL,HYPOREFLEXIA,10
PL,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,10
PL,INFLAMMATORY MARKER INCREASED,10
PL,INITIAL INSOMNIA,10
PL,ISCHAEMIA,10
PL,LIPASE INCREASED,10
PL,LOGORRHOEA,10
PL,MESENTERIC VEIN THROMBOSIS,10
PL,MOVEMENT DISORDER,10
PL,MULTI-ORGAN DISORDER,10
PL,MUSCULOSKELETAL CHEST PAIN,10
PL,NECK PAIN,10
PL,NIGHT SWEATS,10
PL,NORMOCHROMIC NORMOCYTIC ANAEMIA,10
PL,ORTHOSTATIC HYPOTENSION,10
PL,PARONYCHIA,10
PL,POLYURIA,10
PL,PORTAL VEIN THROMBOSIS,10
PL,PREMATURE LABOUR,10
PL,PSYCHOMOTOR RETARDATION,10
PL,RETCHING,10
PL,RHINITIS,10
PL,SPINAL COMPRESSION FRACTURE,10
PL,STUPOR,10
PL,SWOLLEN TONGUE,10
PL,ULCER,10
PL,VENTRICULAR HYPOKINESIA,10
PL,VIRAL INFECTION,10
PL,WITHDRAWAL SYNDROME,10
PL,ACINETOBACTER INFECTION,9
PL,ACUTE LYMPHOCYTIC LEUKAEMIA,9
PL,ADENOCARCINOMA OF COLON,9
PL,AFFECT LABILITY,9
PL,AORTIC VALVE INCOMPETENCE,9
PL,ARTHROPATHY,9
PL,BK VIRUS INFECTION,9
PL,BREATH SOUNDS ABNORMAL,9
PL,CARDIAC FAILURE ACUTE,9
PL,CENTRAL NERVOUS SYSTEM HAEMORRHAGE,9
PL,CENTRAL NERVOUS SYSTEM LYMPHOMA,9
PL,CHEILITIS,9
PL,COLD SWEAT,9
PL,COLITIS,9
PL,CRYING,9
PL,DYSPNOEA AT REST,9
PL,EATING DISORDER,9
PL,EMOTIONAL DISORDER,9
PL,FRACTURE,9
PL,GASTRIC DISORDER,9
PL,GASTRIC HAEMORRHAGE,9
PL,GENERALISED OEDEMA,9
PL,GESTATIONAL DIABETES,9
PL,GLAUCOMA,9
PL,HAEMORRHAGIC DISORDER,9
PL,HYPERSOMNIA,9
PL,HYPOACUSIS,9
PL,HYPOAESTHESIA ORAL,9
PL,HYPOMAGNESAEMIA,9
PL,HYPOMANIA,9
PL,HYPOVOLAEMIA,9
PL,INCORRECT DOSE ADMINISTERED,9
PL,INTERVERTEBRAL DISC DISORDER,9
PL,INVASIVE DUCTAL BREAST CARCINOMA,9
PL,KIDNEY FIBROSIS,9
PL,LIBIDO INCREASED,9
PL,LUNG ADENOCARCINOMA,9
PL,LYMPHOCYTE COUNT DECREASED,9
PL,LYMPHOCYTOSIS,9
PL,MALABSORPTION,9
PL,MELAENA,9
PL,MICTURITION URGENCY,9
PL,MYOPATHY,9
PL,NECROTISING GASTRITIS,9
PL,NEPHROGENIC DIABETES INSIPIDUS,9
PL,OPTIC NEURITIS,9
PL,ORAL DISCOMFORT,9
PL,ORAL FUNGAL INFECTION,9
PL,OSTEOLYSIS,9
PL,OVARIAN CYST,9
PL,PANCREATIC CARCINOMA,9
PL,PANCREATIC DISORDER,9
PL,PEMPHIGUS,9
PL,PERICARDITIS,9
PL,PNEUMONIA BACTERIAL,9
PL,POST-INJECTION DELIRIUM SEDATION SYNDROME,9
PL,PROCALCITONIN INCREASED,9
PL,PRODUCT STORAGE ERROR,9
PL,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,9
PL,PROTEUS INFECTION,9
PL,PSEUDOMEMBRANOUS COLITIS,9
PL,RESPIRATORY RATE DECREASED,9
PL,SENSORY DISTURBANCE,9
PL,SERUM FERRITIN INCREASED,9
PL,SKIN NECROSIS,9
PL,SPINAL FRACTURE,9
PL,SPINAL OSTEOARTHRITIS,9
PL,STAPHYLOCOCCUS TEST POSITIVE,9
PL,SUBCUTANEOUS ABSCESS,9
PL,TENSION,9
PL,TONSILLAR HYPERTROPHY,9
PL,VARICELLA,9
PL,VENOUS THROMBOSIS LIMB,9
PL,WRONG TECHNIQUE IN DRUG USAGE PROCESS,9
PL,XANTHOMA,9
PL,ACANTHOSIS,8
PL,ACNE,8
PL,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,8
PL,ADENOVIRUS INFECTION,8
PL,ADHESION,8
PL,ADRENAL INSUFFICIENCY,8
PL,ADVERSE DRUG REACTION,8
PL,ANGIOPATHY,8
PL,ATRIOVENTRICULAR BLOCK COMPLETE,8
PL,AUTOIMMUNE HAEMOLYTIC ANAEMIA,8
PL,BLADDER CANCER,8
PL,BLOOD PROLACTIN INCREASED,8
PL,BODY MASS INDEX INCREASED,8
PL,BRAIN DEATH,8
PL,BRONCHOPNEUMONIA,8
PL,BRONCHOPULMONARY ASPERGILLOSIS,8
PL,CARDIO-RESPIRATORY ARREST,8
PL,CEREBRAL HAEMATOMA,8
PL,CONGENITAL INFECTION,8
PL,CUSHING^S SYNDROME,8
PL,DERMATITIS EXFOLIATIVE GENERALISED,8
PL,ENTEROCOCCAL INFECTION,8
PL,ESCHERICHIA BACTERAEMIA,8
PL,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,8
PL,EXTRAVASATION,8
PL,EYE HAEMORRHAGE,8
PL,FAECES DISCOLOURED,8
PL,GASTRIC CANCER,8
PL,GENERAL PHYSICAL CONDITION ABNORMAL,8
PL,GLIOBLASTOMA MULTIFORME,8
PL,HAEMORRHAGIC TRANSFORMATION STROKE,8
PL,HELICOBACTER INFECTION,8
PL,HEPATIC LESION,8
PL,HYPERTONIA,8
PL,HYPOVOLAEMIC SHOCK,8
PL,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,8
PL,INSULIN-LIKE GROWTH FACTOR INCREASED,8
PL,INTENTIONAL PRODUCT USE ISSUE,8
PL,LABORATORY TEST ABNORMAL,8
PL,LEUKAEMIA,8
PL,LEUKOCYTURIA,8
PL,LIVER TRANSPLANT,8
PL,LUNG CANCER METASTATIC,8
PL,LUNG INFECTION,8
PL,MACULAR OEDEMA,8
PL,MANIA,8
PL,MENINGISM,8
PL,MIGRAINE,8
PL,MOUTH ULCERATION,8
PL,MUCOUS MEMBRANE DISORDER,8
PL,MUSCLE CONTRACTIONS INVOLUNTARY,8
PL,NEPHROTIC SYNDROME,8
PL,NIGHTMARE,8
PL,OCULAR HYPERAEMIA,8
PL,OESOPHAGEAL PAIN,8
PL,OSTEITIS,8
PL,PANNICULITIS,8
PL,PAPULE,8
PL,PARAPARESIS,8
PL,PEMPHIGOID,8
PL,PERSECUTORY DELUSION,8
PL,POSTURAL TREMOR,8
PL,PROTHROMBIN TIME PROLONGED,8
PL,PULMONARY HAEMORRHAGE,8
PL,PUPILLARY LIGHT REFLEX TESTS ABNORMAL,8
PL,PUSTULAR PSORIASIS,8
PL,QUADRIPARESIS,8
PL,QUADRIPLEGIA,8
PL,REBOUND EFFECT,8
PL,RED CELL DISTRIBUTION WIDTH INCREASED,8
PL,RENAL CYST,8
PL,RENAL INJURY,8
PL,RENAL TRANSPLANT FAILURE,8
PL,SCLERODERMA,8
PL,SINUS NODE DYSFUNCTION,8
PL,SLEEP APNOEA SYNDROME,8
PL,SQUAMOUS CELL CARCINOMA OF SKIN,8
PL,THERAPY RESPONDER,8
PL,TICK-BORNE VIRAL ENCEPHALITIS,8
PL,TONSILLITIS,8
PL,TOOTHACHE,8
PL,TRANSPLANT DYSFUNCTION,8
PL,UNDERDOSE,8
PL,UNEVALUABLE EVENT,8
PL,UTERINE HAEMORRHAGE,8
PL,UTERINE LEIOMYOMA,8
PL,VASCULITIS,8
PL,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,7
PL,ACUTE PSYCHOSIS,7
PL,ADENOIDAL HYPERTROPHY,7
PL,ANXIETY DISORDER,7
PL,ATYPICAL FEMUR FRACTURE,7
PL,BACTERIAL SEPSIS,7
PL,BACTERIAL TEST POSITIVE,7
PL,BLADDER TRANSITIONAL CELL CARCINOMA,7
PL,BLOOD ALBUMIN DECREASED,7
PL,BLOOD CREATINE INCREASED,7
PL,BLOOD THYROID STIMULATING HORMONE INCREASED,7
PL,BONE MARROW TOXICITY,7
PL,BRAIN NEOPLASM,7
PL,BREAST CANCER METASTATIC,7
PL,CHOLECYSTECTOMY,7
PL,CHRONIC GRAFT VERSUS HOST DISEASE,7
PL,CONDUCTION DISORDER,7
PL,CREPITATIONS,7
PL,CRYPTOSPORIDIOSIS INFECTION,7
PL,CYSTITIS HAEMORRHAGIC,7
PL,DEATH NEONATAL,7
PL,DEPRESSED LEVEL OF CONSCIOUSNESS,7
PL,DIABETIC METABOLIC DECOMPENSATION,7
PL,DRUG PRESCRIBING ERROR,7
PL,DRUG TOLERANCE DECREASED,7
PL,ECCHYMOSIS,7
PL,ECZEMA ASTEATOTIC,7
PL,ELECTROCARDIOGRAM ABNORMAL,7
PL,ENTERITIS,7
PL,ENTEROBACTER INFECTION,7
PL,EXTREMITY NECROSIS,7
PL,EYE IRRITATION,7
PL,FUNGAL PERITONITIS,7
PL,GASTROINTESTINAL PERFORATION,7
PL,HAEMORRHAGE URINARY TRACT,7
PL,HEPATIC FIBROSIS,7
PL,HOT FLUSH,7
PL,INCORRECT DRUG ADMINISTRATION DURATION,7
PL,INFARCTION,7
PL,INTESTINAL PERFORATION,7
PL,KERATITIS,7
PL,KETONURIA,7
PL,LIPIDS ABNORMAL,7
PL,LUPUS-LIKE SYNDROME,7
PL,LYMPHOEDEMA,7
PL,METASTATIC RENAL CELL CARCINOMA,7
PL,MONOCYTE COUNT INCREASED,7
PL,MUSCLE CONTRACTURE,7
PL,NASOPHARYNGITIS,7
PL,NEPHRITIS,7
PL,NEUTROPHIL PELGER-HUET ANOMALY PRESENT,7
PL,NODULE,7
PL,OCULAR ICTERUS,7
PL,ODYNOPHAGIA,7
PL,PATHOLOGICAL FRACTURE,7
PL,PERIODONTITIS,7
PL,PERIPHERAL COLDNESS,7
PL,PERIPHERAL SENSORIMOTOR NEUROPATHY,7
PL,PITUITARY-DEPENDENT CUSHING^S SYNDROME,7
PL,POLYMYOSITIS,7
PL,POST PROCEDURAL HAEMORRHAGE,7
PL,PRINZMETAL ANGINA,7
PL,PULMONARY MASS,7
PL,PYODERMA GANGRENOSUM,7
PL,RESPIRATORY ACIDOSIS,7
PL,STATUS EPILEPTICUS,7
PL,STRIDOR,7
PL,SUBARACHNOID HAEMORRHAGE,7
PL,SUBDURAL HAEMATOMA,7
PL,SUBRETINAL FLUID,7
PL,SYSTEMIC CANDIDA,7
PL,TEARFULNESS,7
PL,VIITH NERVE PARALYSIS,7
PL,VIRAEMIA,7
PL,ABSCESS LIMB,6
PL,ACCIDENTAL OVERDOSE,6
PL,ACIDOSIS,6
PL,ADAMS-STOKES SYNDROME,6
PL,AGEUSIA,6
PL,AMYLASE INCREASED,6
PL,ANAL FISTULA,6
PL,APLASTIC ANAEMIA,6
PL,ARRHYTHMIA SUPRAVENTRICULAR,6
PL,ARTERIOSPASM CORONARY,6
PL,ARTHRITIS BACTERIAL,6
PL,BLINDNESS UNILATERAL,6
PL,BLOOD CALCIUM DECREASED,6
PL,BLOOD CREATININE ABNORMAL,6
PL,BLOOD POTASSIUM DECREASED,6
PL,BLOOD URIC ACID INCREASED,6
PL,BRAIN INJURY,6
PL,CARDIAC MURMUR,6
PL,CARDIOMEGALY,6
PL,CATATONIA,6
PL,CHEST X-RAY ABNORMAL,6
PL,CHOLECYSTITIS ACUTE,6
PL,CHORIORETINOPATHY,6
PL,CHRONIC PIGMENTED PURPURA,6
PL,CONCOMITANT DISEASE AGGRAVATED,6
PT,DYSPNOEA,435
PT,DRUG INEFFECTIVE,421
PT,FATIGUE,327
PT,PYREXIA,324
PT,NAUSEA,287
PT,VOMITING,284
PT,DEATH,279
PT,ERYTHEMA,273
PT,DIARRHOEA,268
PT,ASTHENIA,251
PT,RASH,231
PT,HEADACHE,228
PT,ANAEMIA,224
PT,PRURITUS,221
PT,MALAISE,215
PT,DIZZINESS,209
PT,PNEUMONIA,197
PT,HYPOTENSION,185
PT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,172
PT,THROMBOCYTOPENIA,168
PT,ANGIOEDEMA,166
PT,ABDOMINAL PAIN,160
PT,ANAPHYLACTIC REACTION,157
PT,URTICARIA,156
PT,DECREASED APPETITE,152
PT,ACUTE KIDNEY INJURY,151
PT,ARTHRALGIA,149
PT,TOXICITY TO VARIOUS AGENTS,148
PT,COUGH,145
PT,CONDITION AGGRAVATED,144
PT,MYALGIA,142
PT,WEIGHT DECREASED,140
PT,HYPERTENSION,132
PT,FOETAL EXPOSURE DURING PREGNANCY,130
PT,PAIN,123
PT,TREMOR,123
PT,RESPIRATORY FAILURE,121
PT,SEPSIS,120
PT,CHEST PAIN,118
PT,NEUTROPENIA,118
PT,OEDEMA PERIPHERAL,118
PT,FACE OEDEMA,117
PT,HYPERHIDROSIS,117
PT,PRODUCT USE ISSUE,116
PT,INSOMNIA,112
PT,BACK PAIN,108
PT,TACHYCARDIA,107
PT,HYPERSENSITIVITY,105
PT,RESPIRATORY TRACT INFECTION,105
PT,GAIT DISTURBANCE,104
PT,RASH MACULO-PAPULAR,104
PT,RASH GENERALISED,98
PT,FALL,96
PT,MATERNAL EXPOSURE DURING PREGNANCY,95
PT,DISEASE PROGRESSION,93
PT,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,93
PT,RENAL IMPAIRMENT,93
PT,ANXIETY,90
PT,DEPRESSION,90
PT,SYNCOPE,90
PT,EXPOSURE DURING PREGNANCY,89
PT,INFECTION,88
PT,RENAL FAILURE,87
PT,ABDOMINAL PAIN UPPER,86
PT,PRODUCT USE IN UNAPPROVED INDICATION,86
PT,FEELING HOT,84
PT,DRUG HYPERSENSITIVITY,83
PT,PAIN IN EXTREMITY,83
PT,MUSCULAR WEAKNESS,80
PT,RASH PRURITIC,80
PT,TRANSPLANT DYSFUNCTION,79
PT,CEREBROVASCULAR ACCIDENT,78
PT,MULTIPLE SCLEROSIS RELAPSE,78
PT,PARAESTHESIA,78
PT,HYPOAESTHESIA,76
PT,URINARY TRACT INFECTION,76
PT,TOXIC SKIN ERUPTION,75
PT,ISCHAEMIC STROKE,73
PT,LEUKOPENIA,71
PT,SEIZURE,71
PT,ALOPECIA,70
PT,BALANCE DISORDER,70
PT,LACTIC ACIDOSIS,70
PT,PANCYTOPENIA,70
PT,SEPTIC SHOCK,70
PT,CHEST DISCOMFORT,69
PT,OVERDOSE,69
PT,LOSS OF CONSCIOUSNESS,68
PT,PRODUCT QUALITY ISSUE,68
PT,CONFUSIONAL STATE,66
PT,PRURITUS GENERALISED,66
PT,FEBRILE NEUTROPENIA,65
PT,MALIGNANT NEOPLASM PROGRESSION,65
PT,SOMNOLENCE,65
PT,VISION BLURRED,65
PT,HAEMOGLOBIN DECREASED,64
PT,HEPATOTOXICITY,63
PT,CARDIAC FAILURE,62
PT,SKIN EXFOLIATION,61
PT,BLOOD CREATININE INCREASED,59
PT,CONSTIPATION,59
PT,FLUSHING,59
PT,SKIN LESION,58
PT,CARDIO-RESPIRATORY ARREST,57
PT,HAEMORRHAGE,57
PT,HYPONATRAEMIA,57
PT,HAEMATOTOXICITY,56
PT,BRADYCARDIA,55
PT,DYSPHAGIA,55
PT,GENERALISED ERYTHEMA,55
PT,LIP OEDEMA,55
PT,OXYGEN SATURATION DECREASED,55
PT,HYPOXIA,54
PT,MUCOSAL INFLAMMATION,54
PT,PULMONARY EMBOLISM,54
PT,BRONCHOSPASM,53
PT,EOSINOPHILIA,53
PT,RASH ERYTHEMATOUS,53
PT,EYELID OEDEMA,52
PT,COMA,51
PT,GENERAL PHYSICAL HEALTH DETERIORATION,51
PT,ABNORMAL BEHAVIOUR,50
PT,METABOLIC ACIDOSIS,50
PT,PLEURAL EFFUSION,50
PT,ACUTE MYOCARDIAL INFARCTION,49
PT,C-REACTIVE PROTEIN INCREASED,49
PT,CHILLS,49
PT,DYSPHONIA,49
PT,OEDEMA,49
PT,PRODUCT SUBSTITUTION ISSUE,49
PT,ABDOMINAL DISTENSION,48
PT,ALANINE AMINOTRANSFERASE INCREASED,48
PT,ANAPHYLACTIC SHOCK,48
PT,NEUROPATHY PERIPHERAL,48
PT,DRY MOUTH,47
PT,DYSARTHRIA,47
PT,DYSPEPSIA,47
PT,GASTROINTESTINAL DISORDER,47
PT,LARYNGEAL OEDEMA,47
PT,PREMATURE BABY,47
PT,ABORTION SPONTANEOUS,46
PT,BLOOD PRESSURE INCREASED,46
PT,COGNITIVE DISORDER,46
PT,DISORIENTATION,46
PT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,46
PT,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,46
PT,AGITATION,45
PT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,45
PT,PSYCHOTIC DISORDER,45
PT,SHOCK,45
PT,SUICIDE ATTEMPT,45
PT,LEUKOCYTOSIS,44
PT,MYOCARDIAL INFARCTION,44
PT,WHEEZING,44
PT,DYSGEUSIA,43
PT,MEMORY IMPAIRMENT,43
PT,MUSCLE SPASMS,43
PT,DEHYDRATION,42
PT,DRUG RESISTANCE,42
PT,PALPITATIONS,42
PT,PRODUCTIVE COUGH,42
PT,SPEECH DISORDER,42
PT,BLISTER,41
PT,DEEP VEIN THROMBOSIS,41
PT,HAEMATOCHEZIA,41
PT,RHABDOMYOLYSIS,41
PT,CYTOMEGALOVIRUS INFECTION,40
PT,TRANSAMINASES INCREASED,40
PT,VISUAL IMPAIRMENT,40
PT,INTENTIONAL OVERDOSE,39
PT,INTERSTITIAL LUNG DISEASE,39
PT,LINEAR IGA DISEASE,39
PT,NEUROLEPTIC MALIGNANT SYNDROME,39
PT,RESPIRATORY DISTRESS,39
PT,VISUAL ACUITY REDUCED,39
PT,AGGRESSION,38
PT,ATRIAL FIBRILLATION,38
PT,GRAFT LOSS,38
PT,TOXIC EPIDERMAL NECROLYSIS,38
PT,TUBERCULOSIS,38
PT,ASPARTATE AMINOTRANSFERASE INCREASED,37
PT,CROHN^S DISEASE,37
PT,DRUG-INDUCED LIVER INJURY,37
PT,ENCEPHALOPATHY,37
PT,GENERALISED OEDEMA,37
PT,INJECTION SITE ERYTHEMA,37
PT,JAUNDICE,37
PT,WEIGHT INCREASED,37
PT,ACUTE PULMONARY OEDEMA,36
PT,GASTROINTESTINAL HAEMORRHAGE,36
PT,HAEMATOMA,36
PT,HAEMATURIA,36
PT,INFUSION RELATED REACTION,36
PT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,36
PT,URINARY RETENTION,36
PT,BONE PAIN,35
PT,HYPOKALAEMIA,35
PT,ODYNOPHAGIA,35
PT,PSORIASIS,35
PT,ALTERED STATE OF CONSCIOUSNESS,34
PT,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,34
PT,ASCITES,33
PT,CARDIAC ARREST,33
PT,DIABETES MELLITUS,33
PT,EPILEPSY,33
PT,TONGUE OEDEMA,33
PT,TUBULOINTERSTITIAL NEPHRITIS,33
PT,VERTIGO,33
PT,CHOLESTASIS,32
PT,EYE PAIN,32
PT,FEELING ABNORMAL,32
PT,GENERALISED TONIC-CLONIC SEIZURE,32
PT,HEMIPARESIS,32
PT,HEPATIC FAILURE,32
PT,HEPATITIS TOXIC,32
PT,IRRITABILITY,32
PT,METASTASES TO LIVER,32
PT,OCULAR HYPERAEMIA,32
PT,OROPHARYNGEAL DISCOMFORT,32
PT,PAPULE,32
PT,BLOOD UREA INCREASED,31
PT,CENTRAL NERVOUS SYSTEM LESION,31
PT,NEUROTOXICITY,31
PT,PERIPHERAL SWELLING,31
PT,ABDOMINAL DISCOMFORT,30
PT,HEPATITIS C,30
PT,INFLUENZA,30
PT,LYMPHADENOPATHY,30
PT,LYMPHOPENIA,30
PT,PLATELET COUNT DECREASED,30
PT,PRESYNCOPE,30
PT,SUICIDAL IDEATION,30
PT,THROAT TIGHTNESS,30
PT,APHASIA,29
PT,HEART RATE INCREASED,29
PT,HEPATIC ENZYME INCREASED,29
PT,HYPERKALAEMIA,29
PT,INFLAMMATION,29
PT,LUPUS-LIKE SYNDROME,29
PT,OROPHARYNGEAL PAIN,29
PT,RENAL INJURY,29
PT,TREATMENT NONCOMPLIANCE,29
PT,URINARY INCONTINENCE,29
PT,ASTHMA,28
PT,EPISTAXIS,28
PT,INJECTION SITE PAIN,28
PT,PALLOR,28
PT,PNEUMONITIS,28
PT,RESPIRATORY DEPRESSION,28
PT,STRESS CARDIOMYOPATHY,28
PT,TACHYPNOEA,28
PT,BLINDNESS,27
PT,COMPLETED SUICIDE,27
PT,HAEMOPTYSIS,27
PT,HYPERGLYCAEMIA,27
PT,HYPERTENSIVE CRISIS,27
PT,RASH MACULAR,27
PT,ARTHRITIS,26
PT,ATAXIA,26
PT,BURNING SENSATION,26
PT,DRY SKIN,26
PT,PANCREATITIS ACUTE,26
PT,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,26
PT,PROTEINURIA,26
PT,TREATMENT FAILURE,26
PT,ARRHYTHMIA,25
PT,CHRONIC KIDNEY DISEASE,25
PT,DISSEMINATED TUBERCULOSIS,25
PT,LIVE BIRTH,25
PT,OSTEONECROSIS OF JAW,25
PT,PERIORBITAL OEDEMA,25
PT,SEROTONIN SYNDROME,25
PT,THROAT IRRITATION,25
PT,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,24
PT,CARDIAC DISORDER,24
PT,CRYPTOCOCCOSIS,24
PT,DERMATITIS BULLOUS,24
PT,DIPLOPIA,24
PT,EJECTION FRACTION DECREASED,24
PT,HEPATIC FUNCTION ABNORMAL,24
PT,HEPATOCELLULAR INJURY,24
PT,HYPOTHYROIDISM,24
PT,PLASMA CELL MYELOMA,24
PT,PSYCHOMOTOR HYPERACTIVITY,24
PT,PULMONARY TUBERCULOSIS,24
PT,THERAPEUTIC RESPONSE DECREASED,24
PT,TYPE IV HYPERSENSITIVITY REACTION,24
PT,BLOOD BILIRUBIN INCREASED,23
PT,CEREBRAL HAEMORRHAGE,23
PT,COMPLICATIONS OF TRANSPLANTED KIDNEY,23
PT,CONJUNCTIVITIS,23
PT,CYANOSIS,23
PT,DISCOMFORT,23
PT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,23
PT,INTENTIONAL PRODUCT MISUSE,23
PT,LACRIMATION INCREASED,23
PT,MOBILITY DECREASED,23
PT,MUSCLE RIGIDITY,23
PT,MUSCULOSKELETAL PAIN,23
PT,MYOCLONUS,23
PT,NASOPHARYNGITIS,23
PT,NERVOUS SYSTEM DISORDER,23
PT,PERICARDIAL EFFUSION,23
PT,PREMATURE DELIVERY,23
PT,RESPIRATORY DISORDER,23
PT,ABASIA,22
PT,BLOOD ALKALINE PHOSPHATASE INCREASED,22
PT,BLOOD PRESSURE DECREASED,22
PT,CAESAREAN SECTION,22
PT,COLITIS ISCHAEMIC,22
PT,DIABETIC KETOACIDOSIS,22
PT,DISTURBANCE IN ATTENTION,22
PT,DRUG INTOLERANCE,22
PT,GINGIVAL BLEEDING,22
PT,HAEMATEMESIS,22
PT,HERPES ZOSTER,22
PT,HYPOGLYCAEMIA,22
PT,MULTIPLE SCLEROSIS,22
PT,MUSCULOSKELETAL STIFFNESS,22
PT,STRIDOR,22
PT,ACUTE MYELOID LEUKAEMIA,21
PT,APATHY,21
PT,DERMATITIS ALLERGIC,21
PT,FLATULENCE,21
PT,HAEMORRHAGIC STROKE,21
PT,HYPERTHYROIDISM,21
PT,INTRACRANIAL PRESSURE INCREASED,21
PT,KAPOSI^S SARCOMA,21
PT,LUNG INFILTRATION,21
PT,MULTI-ORGAN FAILURE,21
PT,PERIPHERAL ISCHAEMIA,21
PT,PHARYNGEAL OEDEMA,21
PT,RENAL FAILURE ACUTE,21
PT,SKIN DISORDER,21
PT,SKIN NECROSIS,21
PT,BLOOD GLUCOSE INCREASED,20
PT,BLOOD LACTATE DEHYDROGENASE INCREASED,20
PT,COLITIS,20
PT,DYSKINESIA,20
PT,DYSURIA,20
PT,HALLUCINATION,20
PT,HEPATITIS,20
PT,INTENTIONAL PRODUCT USE ISSUE,20
PT,KOUNIS SYNDROME,20
PT,LIVER FUNCTION TEST ABNORMAL,20
PT,MEDICATION ERROR,20
PT,NEPHROPATHY TOXIC,20
PT,OLIGURIA,20
PT,OSTEOPOROSIS,20
PT,RASH PAPULAR,20
PT,RASH PUSTULAR,20
PT,THERAPY NON-RESPONDER,20
PT,ACNE,19
PT,BONE MARROW FAILURE,19
PT,CATATONIA,19
PT,CELLULITIS,19
PT,CHROMATURIA,19
PT,CONJUNCTIVAL HYPERAEMIA,19
PT,DRUG ADMINISTRATION ERROR,19
PT,HAEMODYNAMIC INSTABILITY,19
PT,INFLUENZA LIKE ILLNESS,19
PT,INJECTION SITE DISCOLOURATION,19
PT,LUNG INFECTION,19
PT,NIGHTMARE,19
PT,PERITONITIS,19
PT,PERITONITIS BACTERIAL,19
PT,PHOTOPHOBIA,19
PT,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,19
PT,PULMONARY ALVEOLAR HAEMORRHAGE,19
PT,RESPIRATORY ARREST,19
PT,RHINORRHOEA,19
PT,SLEEP DISORDER,19
PT,BREAST CANCER,18
PT,CUSHING^S SYNDROME,18
PT,DEMENTIA,18
PT,DRUG DOSE OMISSION,18
PT,HYPERLACTACIDAEMIA,18
PT,HYPERNATRAEMIA,18
PT,INJECTION SITE PRURITUS,18
PT,MOVEMENT DISORDER,18
PT,NECK PAIN,18
PT,NO THERAPEUTIC RESPONSE,18
PT,SKIN ULCER,18
PT,STOMATITIS,18
PT,SWELLING,18
PT,TINNITUS,18
PT,UPPER GASTROINTESTINAL HAEMORRHAGE,18
PT,GASTROINTESTINAL TOXICITY,17
PT,HAEMORRHAGE INTRACRANIAL,17
PT,HEPATOCELLULAR CARCINOMA,17
PT,HEPATOMEGALY,17
PT,HYPERBILIRUBINAEMIA,17
PT,HYPOVOLAEMIC SHOCK,17
PT,JOINT SWELLING,17
PT,KIDNEY TRANSPLANT REJECTION,17
PT,LIVER DISORDER,17
PT,MELAENA,17
PT,METASTASES TO CENTRAL NERVOUS SYSTEM,17
PT,MITRAL VALVE INCOMPETENCE,17
PT,MOUTH ULCERATION,17
PT,MYOCARDITIS,17
PT,NEUROLOGICAL SYMPTOM,17
PT,NO ADVERSE EVENT,17
PT,PARTIAL SEIZURES,17
PT,SALIVARY HYPERSECRETION,17
PT,STEVENS-JOHNSON SYNDROME,17
PT,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,17
PT,ABORTION INDUCED,16
PT,AMNESIA,16
PT,BLOOD CREATINE PHOSPHOKINASE INCREASED,16
PT,CATARACT,16
PT,CEREBRAL ARTERY OCCLUSION,16
PT,COLITIS ULCERATIVE,16
PT,CONTUSION,16
PT,DRUG ABUSE,16
PT,ECCHYMOSIS,16
PT,EYE SWELLING,16
PT,GASTROENTERITIS,16
PT,HOT FLUSH,16
PT,HYPERSENSITIVITY VASCULITIS,16
PT,HYPERTHERMIA,16
PT,HYPOKINESIA,16
PT,IMMUNOSUPPRESSION,16
PT,INCORRECT DOSE ADMINISTERED,16
PT,INCORRECT ROUTE OF DRUG ADMINISTRATION,16
PT,MOOD ALTERED,16
PT,MYELODYSPLASTIC SYNDROME,16
PT,PARKINSONISM,16
PT,ROAD TRAFFIC ACCIDENT,16
PT,SKIN DISCOLOURATION,16
PT,SKIN REACTION,16
PT,SWELLING FACE,16
PT,TRANSIENT ISCHAEMIC ATTACK,16
PT,TYPE I HYPERSENSITIVITY,16
PT,CEREBELLAR SYNDROME,15
PT,CEREBRAL VENOUS THROMBOSIS,15
PT,CONCOMITANT DISEASE AGGRAVATED,15
PT,CONVULSION,15
PT,DRUG WITHDRAWAL SYNDROME,15
PT,ECZEMA,15
PT,ERECTILE DYSFUNCTION,15
PT,EYE PRURITUS,15
PT,GLOMERULAR FILTRATION RATE DECREASED,15
PT,INCORRECT DRUG ADMINISTRATION DURATION,15
PT,INJECTION SITE REACTION,15
PT,LOW BIRTH WEIGHT BABY,15
PT,MANIA,15
PT,MIGRAINE,15
PT,NEPHROLITHIASIS,15
PT,PANCREATITIS,15
PT,RENAL TUBULAR NECROSIS,15
PT,RHEUMATOID ARTHRITIS,15
PT,STAPHYLOCOCCAL INFECTION,15
PT,SYSTEMIC LUPUS ERYTHEMATOSUS,15
PT,UNINTENDED PREGNANCY,15
PT,VASCULITIS,15
PT,VENTRICULAR DYSFUNCTION,15
PT,ADVERSE EVENT,14
PT,ADVERSE REACTION,14
PT,BLOOD LACTIC ACID INCREASED,14
PT,DERMATITIS,14
PT,DERMATITIS EXFOLIATIVE,14
PT,DIARRHOEA HAEMORRHAGIC,14
PT,DISEASE RECURRENCE,14
PT,DRUG CROSS-REACTIVITY,14
PT,DYSTONIA,14
PT,HALLUCINATION_ AUDITORY,14
PT,HALLUCINATION_ VISUAL,14
PT,HEPATITIS ACUTE,14
PT,HYPERCHLORAEMIA,14
PT,LIMB DISCOMFORT,14
PT,NEOPLASM,14
PT,NERVOUSNESS,14
PT,NORMAL NEWBORN,14
PT,OSTEONECROSIS,14
PT,PARAPARESIS,14
PT,PYELONEPHRITIS,14
PT,RECTAL HAEMORRHAGE,14
PT,SKIN TOXICITY,14
PT,STRONGYLOIDIASIS,14
PT,SURGERY,14
PT,TIC,14
PT,TRANSPLANT REJECTION,14
PT,UVEITIS,14
PT,WHITE BLOOD CELL COUNT DECREASED,14
PT,ACUTE CORONARY SYNDROME,13
PT,ACUTE RESPIRATORY DISTRESS SYNDROME,13
PT,ARTHROPATHY,13
PT,BRAIN OEDEMA,13
PT,BREAST NEOPLASM,13
PT,CARDIOTOXICITY,13
PT,DELIRIUM,13
PT,DIFFUSE LARGE B-CELL LYMPHOMA,13
PT,DRUG EFFECT DECREASED,13
PT,ERYTHRODERMIC PSORIASIS,13
PT,EXTRAPYRAMIDAL DISORDER,13
PT,EYE IRRITATION,13
PT,GASTRIC ULCER,13
PT,HEPATIC CIRRHOSIS,13
PT,HEPATIC ENCEPHALOPATHY,13
PT,HYPERAMMONAEMIC ENCEPHALOPATHY,13
PT,HYPERCHOLESTEROLAEMIA,13
PT,IMMUNODEFICIENCY,13
PT,INTERNATIONAL NORMALISED RATIO INCREASED,13
PT,LYMPHOCYTOSIS,13
PT,METASTASES TO BONE,13
PT,MOTOR DYSFUNCTION,13
PT,MUSCLE TIGHTNESS,13
PT,NASAL CONGESTION,13
PT,NEONATAL RESPIRATORY DISTRESS SYNDROME,13
PT,PARAESTHESIA ORAL,13
PT,PETECHIAE,13
PT,PNEUMOTHORAX,13
PT,POST PROCEDURAL HAEMORRHAGE,13
PT,PULMONARY TOXICITY,13
PT,PURPURA,13
PT,STATUS EPILEPTICUS,13
PT,UROSEPSIS,13
PT,VAGINAL HAEMORRHAGE,13
PT,ACUTE RESPIRATORY FAILURE,12
PT,AUTOIMMUNE HEPATITIS,12
PT,AXONAL NEUROPATHY,12
PT,B-CELL LYMPHOMA REFRACTORY,12
PT,BLOOD DISORDER,12
PT,BLOOD PRESSURE FLUCTUATION,12
PT,BRONCHOPULMONARY ASPERGILLOSIS,12
PT,CARDIAC FAILURE ACUTE,12
PT,CYSTITIS,12
PT,DEPRESSED MOOD,12
PT,DIABETES MELLITUS INADEQUATE CONTROL,12
PT,DYSMORPHISM,12
PT,EMBOLIC STROKE,12
PT,ERYTHEMA MULTIFORME,12
PT,FOETAL GROWTH RESTRICTION,12
PT,GASTRITIS,12
PT,HEPATITIS B,12
PT,HYPOALBUMINAEMIA,12
PT,INTESTINAL OBSTRUCTION,12
PT,LOCAL SWELLING,12
PT,LOCALISED OEDEMA,12
PT,LUNG DISORDER,12
PT,LYMPHOCYTE COUNT DECREASED,12
PT,NASAL OBSTRUCTION,12
PT,NECROSIS,12
PT,NEOPLASM MALIGNANT,12
PT,NEOPLASM PROGRESSION,12
PT,NEUTROPHILIA,12
PT,OCULAR TOXICITY,12
PT,OPTIC NEURITIS,12
PT,PHOTOSENSITIVITY REACTION,12
PT,PNEUMOCYSTIS JIROVECII PNEUMONIA,12
PT,PREGNANCY,12
PT,PSYCHOMOTOR RETARDATION,12
PT,PULMONARY OEDEMA,12
PT,RESPIRATORY SYNCYTIAL VIRUS INFECTION,12
PT,SKIN INFECTION,12
PT,STRESS,12
PT,THROMBOSIS,12
PT,UPPER RESPIRATORY TRACT INFECTION,12
PT,ACCIDENTAL OVERDOSE,11
PT,AMENORRHOEA,11
PT,ASPERGILLUS INFECTION,11
PT,CARDIAC TAMPONADE,11
PT,CHOLELITHIASIS,11
PT,COAGULOPATHY,11
PT,COLITIS MICROSCOPIC,11
PT,CONTRAINDICATED PRODUCT ADMINISTERED,11
PT,DEMYELINATION,11
PT,DEPRESSED LEVEL OF CONSCIOUSNESS,11
PT,DRUG ERUPTION,11
PT,DYSAESTHESIA,11
PT,EAR PAIN,11
PT,ELECTROLYTE IMBALANCE,11
PT,ERYSIPELAS,11
PT,ESCHERICHIA INFECTION,11
PT,EXFOLIATIVE RASH,11
PT,EYE DISORDER,11
PT,EYE HAEMORRHAGE,11
PT,FUNGAL SKIN INFECTION,11
PT,HEART BLOCK CONGENITAL,11
PT,HEART RATE DECREASED,11
PT,HEPATIC ENZYME ABNORMAL,11
PT,HOSPITALISATION,11
PT,HYPOCALCAEMIA,11
PT,HYPOPHOSPHATAEMIA,11
PT,HYPOTHERMIA,11
PT,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,11
PT,KERATITIS,11
PT,KLEBSIELLA INFECTION,11
PT,LIP SWELLING,11
PT,MENINGITIS BACTERIAL,11
PT,MENTAL DISORDER,11
PT,METABOLIC DISORDER,11
PT,METASTASES TO LUNG,11
PT,MONOPARESIS,11
PT,MUSCLE ATROPHY,11
PT,NEPHROTIC SYNDROME,11
PT,NORMOCHROMIC NORMOCYTIC ANAEMIA,11
PT,OESOPHAGITIS,11
PT,ORGANISING PNEUMONIA,11
PT,PATHOGEN RESISTANCE,11
PT,PEMPHIGOID,11
PT,PRE-ECLAMPSIA,11
PT,PROCTALGIA,11
PT,PULMONARY HYPERTENSION,11
PT,RESTLESS LEGS SYNDROME,11
PT,TOOTH ABSCESS,11
PT,VISCERAL LEISHMANIASIS,11
PT,WHITE BLOOD CELL COUNT INCREASED,11
PT,ANAL INCONTINENCE,10
PT,APHTHOUS ULCER,10
PT,APPENDICITIS,10
PT,BLOOD CHOLESTEROL INCREASED,10
PT,BLOOD TRIGLYCERIDES INCREASED,10
PT,BRONCHIOLITIS,10
PT,BRUGADA SYNDROME,10
PT,CARDIAC FAILURE CONGESTIVE,10
PT,CARDIOMEGALY,10
PT,CHRONIC PIGMENTED PURPURA,10
PT,DILATATION VENTRICULAR,10
PT,DISSEMINATED INTRAVASCULAR COAGULATION,10
PT,DIVERTICULITIS,10
PT,DRUG EFFECT INCOMPLETE,10
PT,DRY EYE,10
PT,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,10
PT,EYE OEDEMA,10
PT,FOETAL DEATH,10
PT,GASTROINTESTINAL INFLAMMATION,10
PT,GASTROOESOPHAGEAL REFLUX DISEASE,10
PT,HEAD DISCOMFORT,10
PT,HEPATIC STEATOSIS,10
PT,HEPATITIS CHOLESTATIC,10
PT,HERPES SIMPLEX,10
PT,HYPOAESTHESIA ORAL,10
PT,INCREASED APPETITE,10
PT,INFLAMMATORY MARKER INCREASED,10
PT,LIPASE INCREASED,10
PT,LYMPHOMA,10
PT,MATERNAL EXPOSURE BEFORE PREGNANCY,10
PT,METRORRHAGIA,10
PT,MUTISM,10
PT,NEOPLASM RECURRENCE,10
PT,NEPHROPATHY,10
PT,PANIC ATTACK,10
PT,PERITONEAL HAEMORRHAGE,10
PT,POLYARTHRITIS,10
PT,PSORIATIC ARTHROPATHY,10
PT,PULMONARY FIBROSIS,10
PT,PURULENT DISCHARGE,10
PT,RENAL TUBULAR DISORDER,10
PT,SENSORY LOSS,10
PT,SINUS TACHYCARDIA,10
PT,SNEEZING,10
PT,SYSTOLIC DYSFUNCTION,10
PT,URINARY TRACT DISORDER,10
PT,VISCERAL CONGESTION,10
PT,ABNORMAL DREAMS,9
PT,ABSCESS,9
PT,ADENOCARCINOMA OF COLON,9
PT,AFFECT LABILITY,9
PT,ANURIA,9
PT,APHONIA,9
PT,APRAXIA,9
PT,BLOOD PRESSURE SYSTOLIC INCREASED,9
PT,BREAST MASS,9
PT,BREAST PAIN,9
PT,BRONCHITIS,9
PT,CACHEXIA,9
PT,COLD SWEAT,9
PT,COORDINATION ABNORMAL,9
PT,CORONARY ARTERY DISEASE,9
PT,DEAFNESS,9
PT,DRUG DEPENDENCE,9
PT,EMBOLISM,9
PT,EMBOLISM VENOUS,9
PT,EXCESSIVE EYE BLINKING,9
PT,FACIAL PAIN,9
PT,FACIAL PARESIS,9
PT,FEMUR FRACTURE,9
PT,FOLLICULITIS,9
PT,FRACTURE,9
PT,GASTROINTESTINAL NECROSIS,9
PT,HAEMOLYTIC ANAEMIA,9
PT,HYPERAMMONAEMIA,9
PT,HYPERREFLEXIA,9
PT,HYPERTRIGLYCERIDAEMIA,9
PT,HYPOTONIA,9
PT,INJECTION SITE HAEMATOMA,9
PT,INJECTION SITE INFLAMMATION,9
PT,INJECTION SITE OEDEMA,9
PT,INJECTION SITE SWELLING,9
PT,LETHARGY,9
PT,LIVEDO RETICULARIS,9
PT,LUNG NEOPLASM,9
PT,LUNG NEOPLASM MALIGNANT,9
PT,MALIGNANT MELANOMA,9
PT,MENORRHAGIA,9
PT,MUSCLE SPASTICITY,9
PT,NEUTROPHIL COUNT DECREASED,9
PT,NODULE,9
PT,NON-HODGKIN^S LYMPHOMA,9
PT,OESOPHAGEAL ATRESIA,9
PT,ORAL DISCOMFORT,9
PT,PAPILLOEDEMA,9
PT,PERIPHERAL SENSORY NEUROPATHY,9
PT,PNEUMONIA ASPIRATION,9
PT,PNEUMONIA PNEUMOCOCCAL,9
PT,PRESCRIBED OVERDOSE,9
PT,PROSTATE CANCER,9
PT,PULMONARY CONGESTION,9
PT,PYELONEPHRITIS ACUTE,9
PT,RENAL TRANSPLANT FAILURE,9
PT,RESPIRATORY TRACT INFECTION BACTERIAL,9
PT,SECOND PRIMARY MALIGNANCY,9
PT,SEXUAL DYSFUNCTION,9
PT,SHOCK HAEMORRHAGIC,9
PT,SKIN TEST POSITIVE,9
PT,STUPOR,9
PT,TERATOGENICITY,9
PT,TOXIC ENCEPHALOPATHY,9
PT,TUMOUR LYSIS SYNDROME,9
PT,UNRESPONSIVE TO STIMULI,9
PT,VENTRICULAR EXTRASYSTOLES,9
PT,VIITH NERVE PARALYSIS,9
PT,WOUND,9
PT,ACTIVITIES OF DAILY LIVING IMPAIRED,8
PT,AFFECTIVE DISORDER,8
PT,ANGER,8
PT,ANGIOPATHY,8
PT,ATRIOVENTRICULAR BLOCK COMPLETE,8
PT,BONE MARROW TOXICITY,8
PT,CANDIDA INFECTION,8
PT,CARCINOID SYNDROME,8
PT,CARDIOGENIC SHOCK,8
PT,CARDIOVASCULAR DISORDER,8
PT,CHEMICAL BURN OF SKIN,8
PT,CHOKING,8
PT,CHOLECYSTITIS,8
PT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,8
PT,CONGESTIVE CARDIOMYOPATHY,8
PT,CUTANEOUS LUPUS ERYTHEMATOSUS,8
PT,DEVICE DISLOCATION,8
PT,DIET REFUSAL,8
PT,DISORGANISED SPEECH,8
PT,DRUG SCREEN FALSE POSITIVE,8
PT,DUODENAL ULCER,8
PT,DYSLIPIDAEMIA,8
PT,DYSPNOEA EXERTIONAL,8
PT,ELECTROCARDIOGRAM ABNORMAL,8
PT,FACIAL PARALYSIS,8
PT,FAECES DISCOLOURED,8
PT,FANCONI SYNDROME ACQUIRED,8
PT,FEMORAL NECK FRACTURE,8
PT,GASTRIC DISORDER,8
PT,GLAUCOMA,8
PT,HENOCH-SCHONLEIN PURPURA,8
PT,HYPERTONIA,8
PT,HYPOACUSIS,8
PT,ILEUS PARALYTIC,8
PT,INFLAMMATORY BOWEL DISEASE,8
PT,INJECTION SITE EXFOLIATION,8
PT,INJECTION SITE NECROSIS,8
PT,INJECTION SITE WARMTH,8
PT,INJURY,8
PT,INTESTINAL ISCHAEMIA,8
PT,INTRAOCULAR PRESSURE INCREASED,8
PT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,8
PT,LIPODYSTROPHY ACQUIRED,8
PT,LIVER TRANSPLANT REJECTION,8
PT,LOWER RESPIRATORY TRACT INFECTION,8
PT,LUNG ADENOCARCINOMA,8
PT,METASTASIS,8
PT,MUMPS,8
PT,MUSCLE TWITCHING,8
PT,MYOPATHY,8
PT,MYOPIA,8
PT,OCULAR DISCOMFORT,8
PT,ONYCHOLYSIS,8
PT,ORAL CANDIDIASIS,8
PT,ORAL DISORDER,8
PT,ORTHOPNOEA,8
PT,OSMOTIC DEMYELINATION SYNDROME,8
PT,PAIN IN JAW,8
PT,PARALYSIS,8
PT,POISONING,8
PT,PORTAL VEIN THROMBOSIS,8
PT,PSEUDOMEMBRANOUS COLITIS,8
PT,PUSTULAR PSORIASIS,8
PT,RAYNAUD^S PHENOMENON,8
PT,RESTLESSNESS,8
PT,RETROPERITONEAL HAEMATOMA,8
PT,SENSORY DISTURBANCE,8
PT,SQUAMOUS CELL CARCINOMA OF SKIN,8
PT,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,8
PT,TOOTH LOSS,8
PT,TRACHEOBRONCHITIS,8
PT,UNDERDOSE,8
PT,UNEVALUABLE EVENT,8
PT,URINE OUTPUT DECREASED,8
PT,WRONG TECHNIQUE IN DRUG USAGE PROCESS,8
PT,ABDOMINAL WALL HAEMATOMA,7
PT,ABNORMAL FAECES,7
PT,ACCIDENTAL EXPOSURE TO PRODUCT,7
PT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,7
PT,ACUTE HEPATIC FAILURE,7
PT,ALLERGY TEST POSITIVE,7
PT,AMYLASE INCREASED,7
PT,ANOSMIA,7
PT,ANTINUCLEAR ANTIBODY INCREASED,7
PT,ASTHMATIC CRISIS,7
PT,ATRIAL SEPTAL DEFECT,7
PT,AUTOIMMUNE HAEMOLYTIC ANAEMIA,7
PT,BREATH SOUNDS ABNORMAL,7
PT,CEREBRAL HAEMATOMA,7
PT,CEREBRAL VENTRICLE DILATATION,7
PT,CHRONIC ALLOGRAFT NEPHROPATHY,7
PT,COMPLICATION ASSOCIATED WITH DEVICE,7
PT,CRANIOCEREBRAL INJURY,7
PT,CRYING,7
PT,CYTOMEGALOVIRUS COLITIS,7
PT,DEAFNESS UNILATERAL,7
PT,DERMATITIS ACNEIFORM,7
PT,DERMATOSIS,7
PT,DEVELOPMENTAL DELAY,7
PT,DIABETIC FOOT INFECTION,7
PT,DYSSTASIA,7
PT,EMOTIONAL DISTRESS,7
PT,ENCEPHALITIS,7
PT,EOSINOPHILIC PNEUMONIA,7
PT,ERYTHEMA NODOSUM,7
PT,EYE INFLAMMATION,7
PT,EYE MOVEMENT DISORDER,7
PT,FEELING COLD,7
PT,GASTRIC HAEMORRHAGE,7
PT,GLYCOSURIA,7
PT,GRAND MAL CONVULSION,7
PT,HAEMORRHAGIC TRANSFORMATION STROKE,7
PT,HEAD INJURY,7
PT,HYPOMAGNESAEMIA,7
PT,HYPOMANIA,7
PT,IMMOBILE,7
PT,IMPAIRED WORK ABILITY,7
PT,INTESTINAL PERFORATION,7
PT,ISCHAEMIA,7
PT,LUMBAR VERTEBRAL FRACTURE,7
PT,LUPUS PNEUMONITIS,7
PT,MAJOR DEPRESSION,7
PT,MEGACOLON,7
PT,MENSTRUATION IRREGULAR,7
PT,MUSCLE CONTRACTIONS INVOLUNTARY,7
PT,MYELOPATHY,7
PT,NECROTISING FASCIITIS,7
PT,NON-24-HOUR SLEEP-WAKE DISORDER,7
PT,OCCUPATIONAL EXPOSURE TO PRODUCT,7
PT,ORAL HERPES,7
PT,ORTHOSTATIC HYPOTENSION,7
PT,OSTEOMYELITIS,7
PT,PARKINSON^S DISEASE,7
PT,PLATELET COUNT INCREASED,7
PT,PNEUMONIA CRYPTOCOCCAL,7
PT,POLLAKIURIA,7
PT,POST PROCEDURAL COMPLICATION,7
PT,PREGNANCY WITH CONTRACEPTIVE DEVICE,7
PT,PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS,7
PT,PRURIGO,7
PT,PRURITUS GENITAL,7
PT,RADICULOPATHY,7
PT,RALES,7
PT,RETINAL DETACHMENT,7
PT,RETROPERITONEAL HAEMORRHAGE,7
PT,RHINITIS,7
PT,SELECTIVE EATING DISORDER,7
PT,SEPSIS NEONATAL,7
PT,SKIN PLAQUE,7
PT,SUBDURAL HAEMATOMA,7
PT,SUDDEN DEATH,7
PT,SYNOVITIS,7
PT,THERAPEUTIC RESPONSE UNEXPECTED,7
PT,THROMBOTIC MICROANGIOPATHY,7
PT,TONSILLITIS,7
PT,TOOTHACHE,7
PT,TRANSFUSION,7
PT,TRICUSPID VALVE INCOMPETENCE,7
PT,TUBERCULOUS PLEURISY,7
PT,ULCER,7
PT,UTERINE LEIOMYOMA,7
PT,VENOUS THROMBOSIS,7
PT,VULVOVAGINAL PRURITUS,7
PT,WOUND DEHISCENCE,7
PT,ACIDOSIS,6
PT,ANAL ABSCESS,6
PT,ANAL FISTULA,6
PT,ANGINA PECTORIS,6
PT,ANGINA UNSTABLE,6
PT,APHTHOUS STOMATITIS,6
PT,ARTHRITIS BACTERIAL,6
PT,ATRIOVENTRICULAR BLOCK,6
PT,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,6
PT,AUTONOMIC NERVOUS SYSTEM IMBALANCE,6
PT,BACTERIAL PYELONEPHRITIS,6
PT,BLINDNESS UNILATERAL,6
PT,BLOOD IMMUNOGLOBULIN E INCREASED,6
PT,BLOOD PRESSURE INADEQUATELY CONTROLLED,6
PT,BODY TEMPERATURE INCREASED,6
PT,BONE DISORDER,6
PT,CATHETER SITE HAEMORRHAGE,6
PT,CHOLANGITIS,6
PT,COLON CANCER,6
PT,CUTANEOUS VASCULITIS,6
PT,DELUSION,6
PT,DERMATITIS CONTACT,6
PT,DEVICE DIFFICULT TO USE,6
PT,DEVICE MALFUNCTION,6
PT,DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION,6
PT,DRUG DISPENSING ERROR,6
PT,ENTEROCOLITIS,6
PT,EPSTEIN-BARR VIRUS INFECTION,6
PT,EYELID PTOSIS,6
PT,FINGER AMPUTATION,6
PT,FLUID RETENTION,6
PT,FOETAL MALFORMATION,6
PT,FREQUENT BOWEL MOVEMENTS,6
PT,GENERAL PHYSICAL CONDITION ABNORMAL,6
PT,GOITRE,6
PT,GRAFT VERSUS HOST DISEASE,6
PT,GUILLAIN-BARRE SYNDROME,6
PT,HAEMORRHAGIC DIATHESIS,6
PT,HEMIANOPIA,6
PT,HEMIPLEGIA,6
PT,HEPATIC PAIN,6
PT,HIATUS HERNIA,6
PT,HISTIOCYTOSIS HAEMATOPHAGIC,6
PT,HODGKIN^S DISEASE,6
PT,HOMICIDAL IDEATION,6
PT,HYPERAEMIA,6
PT,HYPERPARATHYROIDISM,6
PT,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,6
PT,INCORRECT DRUG ADMINISTRATION RATE,6
PT,INFARCTION,6
PT,INTENTIONAL SELF-INJURY,6
PT,IRON DEFICIENCY ANAEMIA,6
PT,JARISCH-HERXHEIMER REACTION,6
PT,JAUNDICE CHOLESTATIC,6
PT,KIDNEY INFECTION,6
PT,LABORATORY TEST ABNORMAL,6
PT,LATENT TUBERCULOSIS,6
PT,LEUKAEMIA,6
PT,LYMPH NODE TUBERCULOSIS,6
PT,MACULAR OEDEMA,6
PT,MACULE,6
PT,MENTAL STATUS CHANGES,6
PT,METASTASES TO LYMPH NODES,6
PT,METASTASES TO PERITONEUM,6
PT,METHAEMOGLOBINAEMIA,6
PT,MUCOSAL DISCOLOURATION,6
PT,MUCOUS MEMBRANE DISORDER,6
PT,MULTIPLE CONGENITAL ABNORMALITIES,6
PT,MYCOSIS FUNGOIDES,6
PT,MYOCARDIAL ISCHAEMIA,6
PT,MYOSITIS,6
PT,NEGATIVISM,6
PT,NOCARDIOSIS,6
PT,OBSTRUCTIVE AIRWAYS DISORDER,6
PT,OCULAR HYPERTENSION,6
PT,OESOPHAGEAL PAIN,6
PT,OESOPHAGEAL ULCER,6
PT,OESOPHAGEAL VARICES HAEMORRHAGE,6
PT,OROPHARYNGEAL CANDIDIASIS,6
PT,PALMAR ERYTHEMA,6
PT,PANCREATIC CARCINOMA,6
PT,PANCREATITIS RELAPSING,6
PT,PERICARDITIS,6
PT,PERIPHERAL MOTOR NEUROPATHY,6
PT,PERSECUTORY DELUSION,6
PT,POLYNEUROPATHY,6
PT,PREGNANCY WITH IMPLANT CONTRACEPTIVE,6
PT,PRESCRIBED UNDERDOSE,6
PT,PROTHROMBIN TIME PROLONGED,6
PT,PULMONARY MASS,6
PT,PULSE ABNORMAL,6
PT,RENAL CELL CARCINOMA,6
PT,RENAL FUNCTION TEST ABNORMAL,6
PT,SCHIZOPHRENIA,6
PT,SINUS BRADYCARDIA,6
PT,SKIN FISSURES,6
PT,SKIN HYPERPIGMENTATION,6
PT,SKIN MASS,6
PT,SPINAL FRACTURE,6
PT,SPRUE-LIKE ENTEROPATHY,6
PT,SPUTUM PURULENT,6
PT,STREPTOCOCCUS TEST POSITIVE,6
PT,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,6
PT,TACHYARRHYTHMIA,6
PT,TARDIVE DYSKINESIA,6
PT,TENDONITIS,6
PT,THERAPEUTIC PRODUCT CROSS-REACTIVITY,6
PT,THINKING ABNORMAL,6
PT,THIRST,6
PR,NASOPHARYNGITIS,897
PR,INJECTION SITE PAIN,807
PR,DRUG INEFFECTIVE,667
PR,PAIN,467
PR,HEADACHE,404
PR,FATIGUE,319
PR,ARTHRALGIA,309
PR,MALAISE,283
PR,DIZZINESS,279
PR,DIARRHOEA,267
PR,PAIN IN EXTREMITY,250
PR,PYREXIA,244
PR,NAUSEA,213
PR,PSORIASIS,206
PR,HAEMOGLOBIN DECREASED,205
PR,PRURITUS,201
PR,ASTHENIA,186
PR,URINARY TRACT INFECTION,183
PR,BRONCHITIS,179
PR,VOMITING,179
PR,RASH,177
PR,BURNING SENSATION,170
PR,ASTHMA,165
PR,INJECTION SITE ERYTHEMA,164
PR,HYPERSENSITIVITY,155
PR,COUGH,151
PR,ABDOMINAL PAIN,146
PR,HYPERTENSION,145
PR,INFLAMMATION,143
PR,OROPHARYNGEAL PAIN,135
PR,DEATH,113
PR,FALL,112
PR,DYSPNOEA,111
PR,PERIPHERAL SWELLING,107
PR,PHARYNGITIS,107
PR,INJECTION SITE PRURITUS,104
PR,ABDOMINAL PAIN UPPER,100
PR,DEPRESSION,100
PR,DECREASED APPETITE,99
PR,ERYTHEMA,98
PR,WEIGHT DECREASED,97
PR,NASAL CONGESTION,92
PR,URTICARIA,92
PR,ABDOMINAL DISCOMFORT,91
PR,BACK PAIN,89
PR,ARTHRITIS,85
PR,CHIKUNGUNYA VIRUS INFECTION,85
PR,INFLUENZA,84
PR,CHEST PAIN,82
PR,GAIT DISTURBANCE,79
PR,INFECTION,79
PR,ANXIETY,78
PR,NO ADVERSE EVENT,76
PR,BLOOD GLUCOSE INCREASED,73
PR,INSOMNIA,73
PR,PNEUMONIA,73
PR,GASTROINTESTINAL INFLAMMATION,70
PR,SOMNOLENCE,69
PR,HEPATIC ENZYME INCREASED,67
PR,SINUSITIS,67
PR,WHITE BLOOD CELL COUNT DECREASED,67
PR,DRUG DOSE OMISSION,64
PR,CONSTIPATION,63
PR,INJECTION SITE HAEMATOMA,63
PR,ALOPECIA,62
PR,CELLULITIS,62
PR,BONE PAIN,61
PR,RECTAL HAEMORRHAGE,61
PR,DYSPHONIA,57
PR,HYPOAESTHESIA,57
PR,DRUG PRESCRIBING ERROR,56
PR,INCORRECT DOSE ADMINISTERED,56
PR,RHEUMATOID ARTHRITIS,56
PR,INJECTION SITE RASH,55
PR,INJECTION SITE SWELLING,55
PR,ANAEMIA,54
PR,HAEMATOMA,54
PR,PLATELET COUNT DECREASED,54
PR,HERPES ZOSTER,53
PR,MUSCLE SPASMS,53
PR,DISCOMFORT,52
PR,CHILLS,51
PR,DRUG HYPERSENSITIVITY,51
PR,MUSCULOSKELETAL PAIN,50
PR,FEELING ABNORMAL,49
PR,PRODUCT COMPOUNDING QUALITY ISSUE,49
PR,JOINT SWELLING,48
PR,CATARACT,47
PR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,47
PR,NECK PAIN,47
PR,PRODUCTIVE COUGH,47
PR,CROHN^S DISEASE,46
PR,MYALGIA,46
PR,PRURITUS GENERALISED,45
PR,SWELLING,45
PR,VISION BLURRED,45
PR,WEIGHT INCREASED,44
PR,GASTRITIS,43
PR,VIRAL INFECTION,43
PR,EAR INFECTION,42
PR,FOETAL EXPOSURE DURING PREGNANCY,42
PR,HAEMORRHAGE,42
PR,UNEVALUABLE EVENT,42
PR,DEHYDRATION,41
PR,INJECTION SITE REACTION,41
PR,TREMOR,41
PR,HOSPITALISATION,40
PR,INJECTION SITE INFLAMMATION,40
PR,VAGINAL HAEMORRHAGE,40
PR,ABSCESS,39
PR,BLOOD PRESSURE INCREASED,37
PR,INJECTION SITE WARMTH,37
PR,MOBILITY DECREASED,37
PR,RASH GENERALISED,37
PR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,37
PR,INJECTION SITE HAEMORRHAGE,36
PR,RASH MACULAR,36
PR,TACHYCARDIA,36
PR,BLOOD CHOLESTEROL INCREASED,35
PR,DIABETES MELLITUS,35
PR,EAR PAIN,35
PR,HYPOTENSION,35
PR,OSTEOARTHRITIS,35
PR,PALPITATIONS,35
PR,HYPERHIDROSIS,34
PR,INTESTINAL OBSTRUCTION,34
PR,RESPIRATORY TRACT CONGESTION,34
PR,CONDITION AGGRAVATED,32
PR,GASTROINTESTINAL DISORDER,31
PR,INJECTION SITE DISCOMFORT,31
PR,LOCAL SWELLING,31
PR,SWELLING FACE,31
PR,ABDOMINAL DISTENSION,30
PR,BACTERIAL INFECTION,30
PR,CONTUSION,30
PR,IMMUNODEFICIENCY,30
PR,NEPHROLITHIASIS,30
PR,SKIN DISCOLOURATION,30
PR,DYSPHAGIA,29
PR,FEELING HOT,29
PR,MYOCARDIAL INFARCTION,29
PR,SEIZURE,29
PR,ARTHROPATHY,28
PR,BALANCE DISORDER,28
PR,CHOLELITHIASIS,28
PR,DYSPEPSIA,28
PR,INJECTION SITE URTICARIA,28
PR,LUNG DISORDER,28
PR,MIGRAINE,28
PR,OEDEMA PERIPHERAL,28
PR,ADVERSE EVENT,27
PR,CEREBROVASCULAR ACCIDENT,27
PR,DRUG ADMINISTRATION ERROR,27
PR,DYSURIA,27
PR,CARDIAC DISORDER,26
PR,DERMATITIS ALLERGIC,26
PR,DYSGEUSIA,26
PR,DRY SKIN,25
PR,EXPOSURE DURING PREGNANCY,25
PR,FUNGAL INFECTION,25
PR,WHITE BLOOD CELL COUNT INCREASED,25
PR,BLISTER,24
PR,SYNCOPE,24
PR,CHEST DISCOMFORT,23
PR,DRUG EFFECT DECREASED,23
PR,INJECTION SITE INDURATION,23
PR,NEOPLASM PROGRESSION,23
PR,PARAESTHESIA,23
PR,VISUAL IMPAIRMENT,23
PR,ADVERSE DRUG REACTION,22
PR,BLINDNESS,22
PR,DIVERTICULITIS,22
PR,EYE SWELLING,22
PR,INTERVERTEBRAL DISC PROTRUSION,22
PR,MUSCULAR WEAKNESS,22
PR,MUSCULOSKELETAL STIFFNESS,22
PR,RHINORRHOEA,22
PR,SUBCUTANEOUS ABSCESS,22
PR,SURGERY,22
PR,DRY MOUTH,21
PR,LOSS OF CONSCIOUSNESS,21
PR,NEUROPATHY PERIPHERAL,21
PR,SKIN ULCER,21
PR,VAGINAL INFECTION,21
PR,ABORTION SPONTANEOUS,20
PR,BLOOD GLUCOSE DECREASED,20
PR,COLITIS,20
PR,DENGUE FEVER,20
PR,EPISTAXIS,20
PR,LIMB INJURY,20
PR,PANCREATITIS,20
PR,PRODUCT USE ISSUE,20
PR,PULMONARY OEDEMA,20
PR,RENAL FAILURE,20
PR,SEPSIS,20
PR,STRESS,20
PR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,20
PR,COLITIS ULCERATIVE,19
PR,DISORIENTATION,19
PR,DRUG EFFECT INCOMPLETE,19
PR,EXOSTOSIS,19
PR,FIBROMYALGIA,19
PR,GASTROOESOPHAGEAL REFLUX DISEASE,19
PR,HYPERCHOLESTEROLAEMIA,19
PR,INJECTION SITE BRUISING,19
PR,OEDEMA,19
PR,OVARIAN CYST,19
PR,PROCEDURAL PAIN,19
PR,TYPE 2 DIABETES MELLITUS,19
PR,ACNE,18
PR,AMNESIA,18
PR,HAEMATOCHEZIA,18
PR,MOOD ALTERED,18
PR,MULTIPLE SCLEROSIS RELAPSE,18
PR,NODULE,18
PR,THROAT IRRITATION,18
PR,TOOTHACHE,18
PR,CONVULSION,17
PR,FLATULENCE,17
PR,FLUID RETENTION,17
PR,FLUSHING,17
PR,GASTROINTESTINAL HAEMORRHAGE,17
PR,MUSCULOSKELETAL DISCOMFORT,17
PR,NEOPLASM MALIGNANT,17
PR,OCULAR HYPERAEMIA,17
PR,PREMATURE BABY,17
PR,PULMONARY MASS,17
PR,SYSTEMIC LUPUS ERYTHEMATOSUS,17
PR,DERMATITIS,16
PR,DRUG DISPENSING ERROR,16
PR,GASTROINTESTINAL PAIN,16
PR,HOT FLUSH,16
PR,HYPOTHYROIDISM,16
PR,LOCALISED INFECTION,16
PR,MEMORY IMPAIRMENT,16
PR,MENISCUS INJURY,16
PR,THROMBOSIS,16
PR,VITAMIN D DEFICIENCY,16
PR,ABASIA,15
PR,ASPHYXIA,15
PR,BEDRIDDEN,15
PR,CARDIAC ARREST,15
PR,DEPRESSED MOOD,15
PR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,15
PR,DRY EYE,15
PR,EYE DISORDER,15
PR,JOINT INJURY,15
PR,LIMB DISCOMFORT,15
PR,MENORRHAGIA,15
PR,NERVOUSNESS,15
PR,OROPHARYNGEAL DISCOMFORT,15
PR,OSTEOPOROSIS,15
PR,PHLEBITIS,15
PR,RESPIRATORY FAILURE,15
PR,SKIN LESION,15
PR,BLOOD TRIGLYCERIDES INCREASED,14
PR,BLOOD URINE PRESENT,14
PR,DEVICE ISSUE,14
PR,DRUG INTOLERANCE,14
PR,FISTULA,14
PR,LIVER DISORDER,14
PR,MATERNAL EXPOSURE DURING PREGNANCY,14
PR,SKIN DISORDER,14
PR,ARRHYTHMIA,13
PR,CONJUNCTIVITIS,13
PR,FUNGAL SKIN INFECTION,13
PR,HAEMATURIA,13
PR,HEART RATE DECREASED,13
PR,HEPATIC STEATOSIS,13
PR,INFLUENZA LIKE ILLNESS,13
PR,LACERATION,13
PR,LARYNGITIS,13
PR,MASS,13
PR,MUSCULOSKELETAL DISORDER,13
PR,POST PROCEDURAL COMPLICATION,13
PR,PSORIATIC ARTHROPATHY,13
PR,SKIN EXFOLIATION,13
PR,THYROID DISORDER,13
PR,WOUND,13
PR,ABSCESS LIMB,12
PR,DIVERTICULUM,12
PR,EYE INFLAMMATION,12
PR,HAEMORRHOIDS,12
PR,INJECTION SITE DISCOLOURATION,12
PR,LABORATORY TEST ABNORMAL,12
PR,MENSTRUATION IRREGULAR,12
PR,OSTEOPENIA,12
PR,PANIC ATTACK,12
PR,PLEURAL EFFUSION,12
PR,RESPIRATORY ARREST,12
PR,SPEECH DISORDER,12
PR,APPENDICITIS,11
PR,BACK INJURY,11
PR,BREAST CANCER FEMALE,11
PR,CARPAL TUNNEL SYNDROME,11
PR,DISEASE PROGRESSION,11
PR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,11
PR,EYE PAIN,11
PR,GALLBLADDER DISORDER,11
PR,HEAD INJURY,11
PR,HEART RATE INCREASED,11
PR,INFARCTION,11
PR,INJECTION SITE HYPERSENSITIVITY,11
PR,INJECTION SITE MASS,11
PR,INJURY ASSOCIATED WITH DEVICE,11
PR,MENSTRUAL DISORDER,11
PR,PELVIC PAIN,11
PR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,11
PR,RENAL DISORDER,11
PR,RESPIRATORY DISORDER,11
PR,SUICIDAL IDEATION,11
PR,TENDON RUPTURE,11
PR,THROMBOCYTOPENIA,11
PR,UTERINE LEIOMYOMA,11
PR,ANAL ABSCESS,10
PR,BREAST CANCER,10
PR,BREAST MASS,10
PR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,10
PR,DEVICE MALFUNCTION,10
PR,GASTRIC DISORDER,10
PR,HYPERKALAEMIA,10
PR,INCORRECT DRUG ADMINISTRATION RATE,10
PR,INCREASED APPETITE,10
PR,INCREASED UPPER AIRWAY SECRETION,10
PR,INTERVERTEBRAL DISC DISORDER,10
PR,KNEE ARTHROPLASTY,10
PR,NERVE COMPRESSION,10
PR,ORAL FUNGAL INFECTION,10
PR,RASH PRURITIC,10
PR,RENAL IMPAIRMENT,10
PR,ROAD TRAFFIC ACCIDENT,10
PR,SPINAL DISORDER,10
PR,STILLBIRTH,10
PR,TREATMENT FAILURE,10
PR,VERTIGO,10
PR,AGGRESSION,9
PR,BLOOD CREATININE INCREASED,9
PR,BLOOD GLUCOSE ABNORMAL,9
PR,CARDIAC FAILURE,9
PR,CARDIO-RESPIRATORY ARREST,9
PR,ENTERITIS,9
PR,FEMUR FRACTURE,9
PR,GASTRIC ULCER,9
PR,GENERALISED OEDEMA,9
PR,HEPATITIS,9
PR,HERNIA,9
PR,INJECTION SITE CELLULITIS,9
PR,INJECTION SITE PAPULE,9
PR,PRODUCT QUALITY ISSUE,9
PR,PRODUCT USE IN UNAPPROVED INDICATION,9
PR,PRURITUS ALLERGIC,9
PR,RASH PUSTULAR,9
PR,RESPIRATORY DISTRESS,9
PR,RESPIRATORY TRACT INFECTION,9
PR,SLEEP APNOEA SYNDROME,9
PR,THYROID MASS,9
PR,TOOTH EXTRACTION,9
PR,TOOTH INFECTION,9
PR,ANAL FISTULA,8
PR,ANGINA PECTORIS,8
PR,APHASIA,8
PR,APPLICATION SITE PAIN,8
PR,ARTHROPOD BITE,8
PR,BLOOD POTASSIUM INCREASED,8
PR,BURSITIS,8
PR,CARDIAC FAILURE CONGESTIVE,8
PR,DIABETES MELLITUS INADEQUATE CONTROL,8
PR,EAR DISCOMFORT,8
PR,EYE PRURITUS,8
PR,GALLBLADDER OPERATION,8
PR,GINGIVAL BLEEDING,8
PR,GINGIVITIS,8
PR,HAEMATEMESIS,8
PR,IMMUNE SYSTEM DISORDER,8
PR,INCORRECT PRODUCT STORAGE,8
PR,JOINT RANGE OF MOTION DECREASED,8
PR,MENTAL DISORDER,8
PR,OSTEONECROSIS,8
PR,POOR QUALITY DRUG ADMINISTERED,8
PR,PULMONARY EMBOLISM,8
PR,RASH PAPULAR,8
PR,SECRETION DISCHARGE,8
PR,SKIN BURNING SENSATION,8
PR,SMALL INTESTINAL OBSTRUCTION,8
PR,SNEEZING,8
PR,THERAPEUTIC RESPONSE UNEXPECTED,8
PR,THYROID CANCER,8
PR,THYROID NEOPLASM,8
PR,TINNITUS,8
PR,TONGUE DISORDER,8
PR,ULCER,8
PR,UTERINE HAEMORRHAGE,8
PR,ABSCESS INTESTINAL,7
PR,ACCIDENT,7
PR,ACCIDENT AT WORK,7
PR,ADVERSE REACTION,7
PR,AMENORRHOEA,7
PR,ANKYLOSING SPONDYLITIS,7
PR,ATRIAL FIBRILLATION,7
PR,BLINDNESS UNILATERAL,7
PR,BLOOD POTASSIUM DECREASED,7
PR,BRONCHOSPASM,7
PR,CANDIDA INFECTION,7
PR,CARDIAC MURMUR,7
PR,CYST,7
PR,DRUG-INDUCED LIVER INJURY,7
PR,HEAD DISCOMFORT,7
PR,HIP ARTHROPLASTY,7
PR,HYPERTHYROIDISM,7
PR,HYPOGLYCAEMIA,7
PR,HYSTERECTOMY,7
PR,INFLAMMATORY MARKER INCREASED,7
PR,INJECTION SITE OEDEMA,7
PR,LIP SWELLING,7
PR,LYMPHOMA,7
PR,MEDICATION ERROR,7
PR,MOUTH ULCERATION,7
PR,MULTIPLE SCLEROSIS,7
PR,MUSCULOSKELETAL CHEST PAIN,7
PR,ORAL MUCOSAL BLISTERING,7
PR,OVERDOSE,7
PR,PAIN OF SKIN,7
PR,POST PROCEDURAL INFECTION,7
PR,PROSTATE CANCER,7
PR,PROSTATIC SPECIFIC ANTIGEN INCREASED,7
PR,RASH ERYTHEMATOUS,7
PR,SCAB,7
PR,SCIATICA,7
PR,SPINAL PAIN,7
PR,STOMATITIS,7
PR,THERMAL BURN,7
PR,THROMBOPHLEBITIS,7
PR,UTERINE DISORDER,7
PR,VENOUS OCCLUSION,7
PR,VULVOVAGINAL MYCOTIC INFECTION,7
PR,ABNORMAL BEHAVIOUR,6
PR,ANAL HAEMORRHAGE,6
PR,BLOOD BILIRUBIN INCREASED,6
PR,BLOOD PRESSURE DECREASED,6
PR,BREAST ABSCESS,6
PR,CEREBRAL HAEMORRHAGE,6
PR,CEREBRAL INFARCTION,6
PR,CRYING,6
PR,DEAFNESS,6
PR,DECREASED IMMUNE RESPONSIVENESS,6
PR,DIARRHOEA HAEMORRHAGIC,6
PR,DRUG RESISTANCE,6
PR,DYSMENORRHOEA,6
PR,DYSSTASIA,6
PR,EAR DISORDER,6
PR,EYE HAEMORRHAGE,6
PR,EYE INFECTION,6
PR,FEAR,6
PR,FINGER DEFORMITY,6
PR,FOOT DEFORMITY,6
PR,GASTROENTERITIS VIRAL,6
PR,GASTROINTESTINAL BACTERIAL INFECTION,6
PR,HAEMOPTYSIS,6
PR,HAIR TEXTURE ABNORMAL,6
PR,HIATUS HERNIA,6
PR,HIP FRACTURE,6
PR,HYPERKERATOSIS,6
PR,HYPERTRIGLYCERIDAEMIA,6
PR,HYPOPHAGIA,6
PR,INTENTIONAL PRODUCT MISUSE,6
PR,INTESTINAL PERFORATION,6
PR,IRRITABLE BOWEL SYNDROME,6
PR,JOINT DISLOCATION,6
PR,LOWER LIMB FRACTURE,6
PR,LUNG NEOPLASM MALIGNANT,6
PR,NEUTROPENIA,6
PR,ONYCHOMYCOSIS,6
PR,ORAL PAIN,6
PR,OXYGEN SATURATION DECREASED,6
PR,PAIN IN JAW,6
PR,PALLOR,6
PR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,6
PR,PLATELET COUNT INCREASED,6
PR,PREMATURE DELIVERY,6
PR,PRODUCT STORAGE ERROR,6
PR,PROTEINURIA,6
PR,PSYCHOMOTOR HYPERACTIVITY,6
PR,RED BLOOD CELL COUNT DECREASED,6
PR,RETINAL DETACHMENT,6
PR,SKIN HYPERPIGMENTATION,6
PR,SKIN IRRITATION,6
PR,THYROID FUNCTION TEST ABNORMAL,6
PR,TOOTH FRACTURE,6
PR,URINARY TRACT INFECTION BACTERIAL,6
PR,UVEITIS,6
PR,VIRAL UPPER RESPIRATORY TRACT INFECTION,6
PR,VISUAL ACUITY REDUCED,6
PR,WRIST FRACTURE,6
PR,ABDOMINAL ABSCESS,5
PR,ACUTE KIDNEY INJURY,5
PR,ACUTE RESPIRATORY DISTRESS SYNDROME,5
PR,ALANINE AMINOTRANSFERASE INCREASED,5
PR,ANKLE FRACTURE,5
PR,BACK DISORDER,5
PR,BACTERIAL TEST POSITIVE,5
PR,BLOOD PRESSURE INADEQUATELY CONTROLLED,5
PR,BONE DISORDER,5
PR,BRAIN NEOPLASM,5
PR,CARDIOMEGALY,5
PR,CARDIOVASCULAR DISORDER,5
PR,CONFUSIONAL STATE,5
PR,CONGESTIVE CARDIOMYOPATHY,5
PR,CYANOSIS,5
PR,DEEP VEIN THROMBOSIS,5
PR,DEMENTIA ALZHEIMER^S TYPE,5
PR,DIPLOPIA,5
PR,DRY THROAT,5
PR,EATING DISORDER,5
PR,EPILEPSY,5
PR,EXPIRED PRODUCT ADMINISTERED,5
PR,EXPOSURE DURING BREAST FEEDING,5
PR,EYE IRRITATION,5
PR,FACE OEDEMA,5
PR,FEAR OF INJECTION,5
PR,FEEDING DISORDER,5
PR,FEELING OF DESPAIR,5
PR,FIBROMA,5
PR,FOOD INTOLERANCE,5
PR,FREQUENT BOWEL MOVEMENTS,5
PR,GASTROINTESTINAL FISTULA,5
PR,GENERALISED ERYTHEMA,5
PR,GOITRE,5
PR,HAIR DISORDER,5
PR,HALLUCINATION,5
PR,HAND FRACTURE,5
PR,HEART RATE IRREGULAR,5
PR,HEPATIC CANCER,5
PR,HEPATIC FAILURE,5
PR,HEPATIC PAIN,5
PR,HEPATITIS C,5
PR,HEPATOMEGALY,5
PR,HYPERAESTHESIA,5
PR,HYPERCALCAEMIA,5
PR,HYPOXIA,5
PR,IMMUNOSUPPRESSION,5
PR,IMPAIRED HEALING,5
PR,INGROWING NAIL,5
PR,INGUINAL HERNIA,5
PR,INJURY,5
PR,INTESTINAL STENOSIS,5
PR,INTRAOCULAR PRESSURE INCREASED,5
PR,ISCHAEMIC STROKE,5
PR,LACRIMATION INCREASED,5
PR,LARGE INTESTINE POLYP,5
PR,LEUKAEMIA,5
PR,MELANOCYTIC NAEVUS,5
PR,MITRAL VALVE INCOMPETENCE,5
PR,MOUTH HAEMORRHAGE,5
PR,MYOCARDIAL NECROSIS MARKER INCREASED,5
PR,ORAL DISCOMFORT,5
PR,PERIORBITAL OEDEMA,5
PR,PHOTOSENSITIVITY REACTION,5
PR,POLYP,5
PR,POLYURIA,5
PR,PROCTALGIA,5
PR,PULMONARY HYPERTENSION,5
PR,PULMONARY PAIN,5
PR,RENAL CANCER,5
PR,RHINITIS,5
PR,SENSORY DISTURBANCE,5
PR,SHOCK,5
PR,SINUS CONGESTION,5
PR,SKIN FISSURES,5
PR,SKIN PLAQUE,5
PR,SKIN REACTION,5
PR,SLEEP DISORDER,5
PR,SPINAL OSTEOARTHRITIS,5
PR,SYNOVIAL CYST,5
PR,THERAPY CESSATION,5
PR,THIRST,5
PR,TINEA PEDIS,5
PR,TRANSIENT ISCHAEMIC ATTACK,5
PR,TREATMENT NONCOMPLIANCE,5
PR,TUBERCULIN TEST POSITIVE,5
PR,UMBILICAL HERNIA,5
PR,UNDERDOSE,5
PR,UNRESPONSIVE TO STIMULI,5
PR,UPPER LIMB FRACTURE,5
PR,URINARY RETENTION,5
PR,VULVOVAGINAL PRURITUS,5
PR,WRONG DRUG ADMINISTERED,5
PR,ABDOMINAL ADHESIONS,4
PR,ABDOMINAL PAIN LOWER,4
PR,ANAL FISSURE,4
PR,ANAPHYLACTIC REACTION,4
PR,ANORECTAL DISCOMFORT,4
PR,APHONIA,4
PR,ARTERIAL OCCLUSIVE DISEASE,4
PR,ASPARTATE AMINOTRANSFERASE INCREASED,4
PR,ATELECTASIS,4
PR,BACTERAEMIA,4
PR,BLOOD TRIGLYCERIDES ABNORMAL,4
PR,BRADYCARDIA,4
PR,BREAST OPERATION,4
PR,C-REACTIVE PROTEIN INCREASED,4
PR,CAESAREAN SECTION,4
PR,CAPILLARY FRAGILITY,4
PR,CHEST X-RAY ABNORMAL,4
PR,CHOKING,4
PR,CHOLECYSTITIS,4
PR,COAGULOPATHY,4
PR,COLON CANCER,4
PR,DEVICE EXPULSION,4
PR,DIABETIC NEUROPATHY,4
PR,DISTURBANCE IN ATTENTION,4
PR,DRUG DEPENDENCE,4
PR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
PR,DRUG THERAPY,4
PR,EAR HAEMORRHAGE,4
PR,ENDOMETRIOSIS,4
PR,ERECTILE DYSFUNCTION,4
PR,EYE OEDEMA,4
PR,EYELID OEDEMA,4
PR,FAECES DISCOLOURED,4
PR,FEELING COLD,4
PR,FOETAL DEATH,4
PR,FOOT FRACTURE,4
PR,FURUNCLE,4
PR,GASTROINTESTINAL TRACT IRRITATION,4
PR,GENERAL PHYSICAL HEALTH DETERIORATION,4
PR,GENITAL HAEMORRHAGE,4
PR,GINGIVAL INFECTION,4
PR,GINGIVAL PAIN,4
PR,GLAUCOMA,4
PR,GLOSSODYNIA,4
PR,GRIP STRENGTH DECREASED,4
PR,HAEMORRHAGE INTRACRANIAL,4
PR,HAIR COLOUR CHANGES,4
PR,HAND DEFORMITY,4
PR,HEPATIC ENZYME ABNORMAL,4
PR,HEPATIC MASS,4
PR,HEREDITARY ANGIOEDEMA,4
PR,HYPOAESTHESIA ORAL,4
PR,HYPOKALAEMIA,4
PR,INCOHERENT,4
PR,INCORRECT DOSE ADMINISTERED BY DEVICE,4
PR,INCORRECT ROUTE OF DRUG ADMINISTRATION,4
PR,INFECTED SKIN ULCER,4
PR,INJECTION SITE HYPOAESTHESIA,4
PR,INJECTION SITE INFECTION,4
PR,INTENTIONAL UNDERDOSE,4
PR,INTERVERTEBRAL DISC DEGENERATION,4
PR,INTESTINAL HAEMORRHAGE,4
PR,INTESTINAL OPERATION,4
PR,INTESTINAL POLYP,4
PR,INTRACRANIAL ANEURYSM,4
PR,IRRITABILITY,4
PR,JOINT STIFFNESS,4
PR,KNEE OPERATION,4
PR,LARGE INTESTINAL OBSTRUCTION,4
PR,LICHEN PLANUS,4
PR,LIPOMA,4
PR,LOCALISED OEDEMA,4
PR,LOW TURNOVER OSTEOPATHY,4
PR,LUNG INFECTION,4
PR,LUPUS-LIKE SYNDROME,4
PR,MADAROSIS,4
PR,MALIGNANT NEOPLASM PROGRESSION,4
PR,MUSCLE ATROPHY,4
PR,NAIL DISORDER,4
PR,ORAL INFECTION,4
PR,ORAL SURGERY,4
PR,OSTEOMYELITIS,4
PR,PAROSMIA,4
PR,PATELLA FRACTURE,4
PR,PHARYNGEAL INFLAMMATION,4
PR,PLASMA CELL MYELOMA,4
PR,PNEUMONITIS,4
PR,POLLAKIURIA,4
PR,POST PROCEDURAL HAEMORRHAGE,4
PR,PRE-ECLAMPSIA,4
PR,PROSTATITIS,4
PR,PROTEIN TOTAL ABNORMAL,4
PR,PULMONARY FIBROSIS,4
PR,RASH MACULO-PAPULAR,4
PR,RENAL CYST,4
PR,RENAL PAIN,4
PR,ROTATOR CUFF SYNDROME,4
PR,SACROILIITIS,4
PR,SARCOIDOSIS,4
PR,SKIN CANCER,4
PR,SKIN HAEMORRHAGE,4
PR,SKIN MASS,4
PR,SKIN WARM,4
PR,SMALL INTESTINAL STENOSIS,4
PR,SOMNAMBULISM,4
PR,SPINAL OPERATION,4
PR,STAPHYLOCOCCAL INFECTION,4
PR,SWOLLEN TONGUE,4
PR,TENDON INJURY,4
PR,TOOTH DISORDER,4
PR,TRACHEAL OEDEMA,4
PR,TRANSPLANT,4
PR,URINARY INCONTINENCE,4
PR,UTERINE POLYP,4
PR,VIROLOGIC FAILURE,4
PR,VITAMIN D DECREASED,4
PR,ALLERGIC OEDEMA,3
PR,ANGIOEDEMA,3
PR,AORTIC ARTERIOSCLEROSIS,3
PR,AORTIC VALVE INCOMPETENCE,3
PR,APHAGIA,3
PR,ARTHROPOD STING,3
PR,ATRIOVENTRICULAR BLOCK COMPLETE,3
PR,AXILLARY MASS,3
PR,BENIGN NEOPLASM,3
PR,BLINDNESS TRANSIENT,3
PR,BLOOD CALCIUM DECREASED,3
PR,BLOOD CHOLESTEROL ABNORMAL,3
PR,BLOOD LACTATE DEHYDROGENASE INCREASED,3
PR,BLOOD TEST ABNORMAL,3
PR,BLOOD TESTOSTERONE DECREASED,3
PR,BLOOD UREA INCREASED,3
PR,BONE CANCER,3
PR,BREAST PAIN,3
PR,BRONCHITIS CHRONIC,3
PR,CALCINOSIS,3
PR,CARDIOGENIC SHOCK,3
PR,CAROTID ARTERY OCCLUSION,3
PR,CARTILAGE INJURY,3
PR,CELLULITIS STAPHYLOCOCCAL,3
PR,CENTRAL NERVOUS SYSTEM LESION,3
PR,CEREBRAL THROMBOSIS,3
PR,CHROMATURIA,3
PR,COLD SWEAT,3
PR,COLONOSCOPY,3
PR,COLOSTOMY,3
PR,COORDINATION ABNORMAL,3
PR,CORONARY ARTERY OCCLUSION,3
PR,CUTANEOUS LUPUS ERYTHEMATOSUS,3
PR,CYSTITIS,3
PR,DECREASED ACTIVITY,3
PR,DERMATITIS ATOPIC,3
PR,DEVICE DISLOCATION,3
PR,DEVICE RELATED INFECTION,3
PR,DIALYSIS,3
PR,DRUG ABUSE,3
PR,DRUG EFFECT DELAYED,3
PR,DYSARTHRIA,3
PR,DYSKINESIA,3
PR,DYSPAREUNIA,3
PR,DYSPNOEA EXERTIONAL,3
PR,EMBOLISM,3
PR,EMOTIONAL DISORDER,3
PR,EMPHYSEMA,3
PR,ENCEPHALITIS,3
PR,ENTEROVESICAL FISTULA,3
PR,EXPOSURE TO COMMUNICABLE DISEASE,3
PR,EYELID PTOSIS,3
PR,FACIAL PAIN,3
PR,FACIAL PARALYSIS,3
PR,FEBRILE NEUTROPENIA,3
PR,FEMALE GENITAL TRACT FISTULA,3
PR,FOETAL GROWTH RESTRICTION,3
PR,FOETAL HEART RATE ABNORMAL,3
PR,FOOD ALLERGY,3
PR,FOREIGN BODY,3
PR,FRACTURE,3
PR,GASTROENTERITIS,3
PR,GENITAL INFECTION FUNGAL,3
PR,GLUCOSE TOLERANCE IMPAIRED,3
PR,GROIN ABSCESS,3
PR,HAEMODIALYSIS,3
PR,HAEMORRHOIDAL HAEMORRHAGE,3
PR,HALLUCINATION_ VISUAL,3
PR,HELICOBACTER INFECTION,3
PR,HEPATIC CIRRHOSIS,3
PR,HYPERSOMNIA,3
PR,ILEAL STENOSIS,3
PR,ILEOSTOMY CLOSURE,3
PR,IMPETIGO,3
PR,INCORRECT DRUG ADMINISTRATION DURATION,3
PR,INCORRECT STORAGE OF DRUG,3
PR,INFECTED BITE,3
PR,INFECTED BITES,3
PR,INGROWN HAIR,3
PR,INJECTION SITE IRRITATION,3
PR,INJECTION SITE NODULE,3
PR,INJECTION SITE PARAESTHESIA,3
PR,INJECTION SITE ULCER,3
PR,INJECTION SITE VESICLES,3
PR,INTENTIONAL PRODUCT USE ISSUE,3
PR,INTERNAL HAEMORRHAGE,3
PR,INTESTINAL FISTULA,3
PR,JOINT EFFUSION,3
PR,KIDNEY INFECTION,3
PR,LARGE INTESTINE PERFORATION,3
PR,LEFT ATRIAL DILATATION,3
PR,LEUKOPENIA,3
PR,LIVER INJURY,3
PR,LOOSE TOOTH,3
PR,LOW BIRTH WEIGHT BABY,3
PR,LOWER RESPIRATORY TRACT INFECTION BACTERIAL,3
PR,LYMPHADENOPATHY,3
PR,MAJOR DEPRESSION,3
PR,METASTASES TO BONE,3
PR,MONOPLEGIA,3
PR,MOVEMENT DISORDER,3
PR,NASAL OEDEMA,3
PR,NECROSIS,3
PR,NEOPLASM,3
PR,NEPHRITIS,3
PR,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,3
PR,ONYCHOMADESIS,3
PR,ORAL DISORDER,3
PR,OROPHARYNGEAL PLAQUE,3
PR,OVARIAN DISORDER,3
PR,PAPULE,3
PR,PEAU D^ORANGE,3
PR,PERIPHERAL VASCULAR DISORDER,3
PR,PETECHIAE,3
PR,PIGMENTATION DISORDER,3
PR,PLEURITIC PAIN,3
PR,POSTOPERATIVE WOUND INFECTION,3
PR,PRESCRIBED UNDERDOSE,3
PR,PRODUCT PREPARATION ERROR,3
PR,PROTEIN TOTAL DECREASED,3
PR,PROTEIN URINE PRESENT,3
PR,PTERYGIUM,3
PR,PULMONARY FUNCTION TEST DECREASED,3
PR,RALES,3
PR,RHEUMATOID FACTOR INCREASED,3
PR,RIGHT ATRIAL DILATATION,3
PR,SALIVARY HYPERSECRETION,3
PR,SHOULDER OPERATION,3
PR,SKIN INFECTION,3
PR,SKIN PAPILLOMA,3
PR,SLOW SPEECH,3
PR,SPINAL COLUMN INJURY,3
PR,SPUTUM DISCOLOURED,3
PR,STOMA SITE DISCHARGE,3
PR,STOMA SITE ERYTHEMA,3
PR,STOMA SITE HAEMORRHAGE,3
PR,STRONGYLOIDIASIS,3
PR,SUBDURAL HAEMATOMA,3
PR,SUICIDE ATTEMPT,3
PR,TENDONITIS,3
PR,THERAPEUTIC RESPONSE SHORTENED,3
PR,THINKING ABNORMAL,3
PR,THROMBOTIC THROMBOCYTOPENIC PURPURA,3
PR,TIBIA FRACTURE,3
PR,TONGUE DISCOLOURATION,3
PR,TOOTH ABSCESS,3
PR,TRANSFUSION,3
PR,TUMOUR MARKER INCREASED,3
PR,UPPER GASTROINTESTINAL HAEMORRHAGE,3
PR,URINE ODOUR ABNORMAL,3
PR,UTERINE CANCER,3
PR,VITILIGO,3
PR,YELLOW SKIN,3
PR,ABDOMINAL HERNIA,2
PR,ABNORMAL DREAMS,2
PR,ABSCESS BACTERIAL,2
PR,ABSCESS NECK,2
PR,ACARODERMATITIS,2
PR,ACCIDENTAL OVERDOSE,2
PR,ACTIVITIES OF DAILY LIVING IMPAIRED,2
PR,ACUTE HEPATIC FAILURE,2
PR,ACUTE MYELOID LEUKAEMIA,2
PR,ACUTE MYOCARDIAL INFARCTION,2
PR,AFFECTIVE DISORDER,2
PR,AGITATION,2
PR,AMMONIA INCREASED,2
PR,ANAESTHETIC COMPLICATION,2
PR,ANGER,2
PR,ANTIBIOTIC THERAPY,2
PR,ANTIPHOSPHOLIPID SYNDROME,2
PR,ANURIA,2
PR,APHTHOUS ULCER,2
PR,APPENDIX DISORDER,2
PR,APPLICATION SITE ERYTHEMA,2
PR,ARTICULAR CALCIFICATION,2
PR,ASPIRATION,2
PR,ATRIOVENTRICULAR BLOCK,2
PR,ATYPICAL PNEUMONIA,2
PR,AUDITORY DISORDER,2
PR,BED REST,2
PR,BENIGN NEOPLASM OF URETHRA,2
PR,BILE DUCT STONE,2
PR,BLADDER DISORDER,2
PR,BLOOD ALBUMIN DECREASED,2
PR,BLOOD ALKALINE PHOSPHATASE INCREASED,2
PR,BLOOD CALCIUM INCREASED,2
PR,BLOOD COUNT ABNORMAL,2
PR,BLOOD ELECTROLYTES DECREASED,2
PR,BLOOD GLUCOSE FLUCTUATION,2
PR,BLOOD IRON DECREASED,2
PR,BLOOD OESTROGEN DECREASED,2
PR,BLOOD PRESSURE ABNORMAL,2
PR,BLOOD PRESSURE FLUCTUATION,2
PR,BLOOD SODIUM DECREASED,2
PR,BLOOD THYROID STIMULATING HORMONE DECREASED,2
PR,BLOOD THYROID STIMULATING HORMONE INCREASED,2
PR,BODY FAT DISORDER,2
PR,BONE OPERATION,2
PR,BONE SWELLING,2
PR,BRAIN HERNIATION,2
PR,BRAIN NEOPLASM MALIGNANT,2
PR,BREAST CANCER METASTATIC,2
PR,BREAST CYST,2
PR,BREAST DISCOMFORT,2
PR,BREAST DISORDER,2
PR,BREAST DISORDER FEMALE,2
PR,BREATH SOUNDS ABNORMAL,2
PR,BRENNER TUMOUR,2
PR,BRONCHIAL DISORDER,2
PR,CAPILLARY DISORDER,2
PR,CARCINOEMBRYONIC ANTIGEN INCREASED,2
PR,CARDIAC VALVE DISEASE,2
PR,CEPHALO-PELVIC DISPROPORTION,2
PR,CERVICAL VERTEBRAL FRACTURE,2
PR,CHEILITIS,2
PR,CHRONIC GASTRITIS,2
PR,CHRONIC MYELOID LEUKAEMIA,2
PR,CHRONIC SINUSITIS,2
PR,CLOSTRIDIUM DIFFICILE COLITIS,2
PR,COLON OPERATION,2
PR,COLONIC FISTULA,2
PR,COMPLETED SUICIDE,2
PR,CONGENITAL RENAL CYST,2
PR,CORONARY ARTERY DISEASE,2
PR,CORONARY VEIN STENOSIS,2
PR,COSTOCHONDRITIS,2
PR,CYSTITIS HAEMORRHAGIC,2
PR,DEAFNESS UNILATERAL,2
PR,DECREASED INTEREST,2
PR,DEFORMITY,2
PR,DENTAL CARIES,2
PR,DERMATITIS CONTACT,2
PR,DERMATITIS PSORIASIFORM,2
PR,DERMOID CYST,2
PR,DEVICE DEPLOYMENT ISSUE,2
PR,DEVICE DIFFICULT TO USE,2
PR,DEVICE FAILURE,2
PR,DISEASE COMPLICATION,2
PR,DOUBLE STRANDED DNA ANTIBODY POSITIVE,2
PR,DRUG LEVEL DECREASED,2
PR,DUODENAL ULCER,2
PR,EAR INFECTION FUNGAL,2
PR,EAR SWELLING,2
PR,EMOTIONAL DISTRESS,2
PR,ENCEPHALOCELE,2
PR,ENDOMETRIAL CANCER,2
PR,ENDOTRACHEAL INTUBATION,2
PR,ENTERITIS INFECTIOUS,2
PR,ENZYME LEVEL INCREASED,2
PR,ESCHERICHIA URINARY TRACT INFECTION,2
PR,EYE ALLERGY,2
PR,EYE OPERATION,2
PR,EYE ULCER,2
PR,FLAVIVIRUS INFECTION,2
PR,FOOD POISONING,2
PR,FORMICATION,2
PR,FULL BLOOD COUNT DECREASED,2
PR,GALLBLADDER NON-FUNCTIONING,2
PR,GANGRENE,2
PR,GAS POISONING,2
PR,GASTRIC CANCER,2
PR,GASTRIC FISTULA,2
PR,GASTRIC INFECTION,2
PR,GASTROINTESTINAL CARCINOMA,2
PR,GASTROINTESTINAL HYPOMOTILITY,2
PR,GASTROINTESTINAL OBSTRUCTION,2
PR,GASTROSCHISIS,2
PR,GENERAL PHYSICAL CONDITION ABNORMAL,2
PR,GENERAL SYMPTOM,2
PR,GENITAL ABSCESS,2
PR,GENITAL DISCOMFORT,2
PR,GENITAL SWELLING,2
PR,GINGIVAL DISORDER,2
PR,GLOSSITIS,2
PR,GOUT,2
PR,GRANULOMA,2
PR,GROIN PAIN,2
PR,HAEMATOCRIT DECREASED,2
PR,HAEMOGLOBIN ABNORMAL,2
PR,HAEMOLYTIC URAEMIC SYNDROME,2
PR,HAEMORRHAGIC STROKE,2
PR,HAIR GROWTH ABNORMAL,2
PR,HALLUCINATION_ AUDITORY,2
PR,HEMIPLEGIA,2
PR,HEMIPLEGIC MIGRAINE,2
PR,HEPARIN-INDUCED THROMBOCYTOPENIA,2
PR,HERPES VIRUS INFECTION,2
PR,HIDRADENITIS,2
PR,HISTOPLASMOSIS,2
PR,HORMONE LEVEL ABNORMAL,2
PR,HYDRONEPHROSIS,2
PR,HYPERCHLORHYDRIA,2
PR,HYPERGLYCAEMIA,2
PR,HYPOACUSIS,2
PR,HYPOKINESIA,2
PR,HYPOTHERMIA,2
QA,HYPOTHYROIDISM,67
QA,DEATH,15
QA,DRUG INEFFECTIVE,13
QA,MYOCARDIAL INFARCTION,8
QA,RASH,8
QA,FOETAL EXPOSURE DURING PREGNANCY,7
QA,HYPOPHOSPHATAEMIA,7
QA,MATERNAL EXPOSURE DURING PREGNANCY,7
QA,MUCORMYCOSIS,7
QA,RHABDOMYOLYSIS,7
QA,ENTEROBACTER SEPSIS,6
QA,ESCHERICHIA INFECTION,6
QA,LEUKOPENIA,6
QA,NEUTROPENIA,6
QA,TOXICITY TO VARIOUS AGENTS,6
QA,CARDIAC ARREST,5
QA,DYSPNOEA,5
QA,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,5
QA,TOXIC EPIDERMAL NECROLYSIS,5
QA,VOMITING,5
QA,ANAEMIA,4
QA,BLOOD BILIRUBIN INCREASED,4
QA,DRUG RESISTANCE,4
QA,FEBRILE NEUTROPENIA,4
QA,FOETAL GROWTH RESTRICTION,4
QA,FUNGAEMIA,4
QA,HYPOKALAEMIA,4
QA,MANIA,4
QA,MYALGIA,4
QA,NEONATAL RESPIRATORY DISTRESS SYNDROME,4
QA,PLEURAL EFFUSION,4
QA,SEPSIS,4
QA,SKIN LESION,4
QA,UROSEPSIS,4
QA,ANAPHYLACTIC REACTION,3
QA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,3
QA,BACTERIAL SEPSIS,3
QA,BLOOD PRESSURE INCREASED,3
QA,COUGH,3
QA,HEPATOCELLULAR CARCINOMA,3
QA,HYPERKALAEMIA,3
QA,HYPOTENSION,3
QA,INTENTIONAL PRODUCT MISUSE,3
QA,INTRACRANIAL VENOUS SINUS THROMBOSIS,3
QA,JAUNDICE,3
QA,NAUSEA,3
QA,ORGANISING PNEUMONIA,3
QA,PNEUMOCYSTIS JIROVECII INFECTION,3
QA,PRODUCT USE ISSUE,3
QA,PRURITUS,3
QA,PSEUDOMONAS INFECTION,3
QA,PYREXIA,3
QA,SWELLING FACE,3
QA,THROMBOCYTOPENIA,3
QA,ABDOMINAL PAIN,2
QA,ALANINE AMINOTRANSFERASE INCREASED,2
QA,ASCITES,2
QA,ASPARTATE AMINOTRANSFERASE INCREASED,2
QA,BLOOD GLUCOSE INCREASED,2
QA,CARDIOTOXICITY,2
QA,CONDITION AGGRAVATED,2
QA,DEEP VEIN THROMBOSIS,2
QA,DEVICE RELATED INFECTION,2
QA,DIABETES MELLITUS,2
QA,DIARRHOEA,2
QA,DIPLOPIA,2
QA,DIZZINESS,2
QA,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
QA,DRUG-INDUCED LIVER INJURY,2
QA,DYSPHAGIA,2
QA,ERYTHEMA,2
QA,EXPOSURE DURING PREGNANCY,2
QA,GASTRIC POLYPS,2
QA,GASTROINTESTINAL HAEMORRHAGE,2
QA,HAEMOGLOBIN DECREASED,2
QA,HEADACHE,2
QA,HOSPITALISATION,2
QA,INFECTION,2
QA,INTERNATIONAL NORMALISED RATIO INCREASED,2
QA,IRON DEFICIENCY ANAEMIA,2
QA,LETHARGY,2
QA,LYMPHOMA,2
QA,MUSCLE RIGIDITY,2
QA,MUSCULAR WEAKNESS,2
QA,PAIN IN EXTREMITY,2
QA,PANCREATITIS ACUTE,2
QA,PANCYTOPENIA,2
QA,PERITONEAL DIALYSIS COMPLICATION,2
QA,PNEUMONIA ASPIRATION,2
QA,PREMATURE BABY,2
QA,PSYCHOTIC DISORDER,2
QA,RASH ERYTHEMATOUS,2
QA,REMISSION NOT ACHIEVED,2
QA,RESPIRATORY ACIDOSIS,2
QA,RESPIRATORY FAILURE,2
QA,SEROTONIN SYNDROME,2
QA,STATUS ASTHMATICUS,2
QA,SUBDURAL HAEMATOMA,2
QA,TINNITUS,2
QA,TRANSAMINASES INCREASED,2
QA,TRANSFUSION,2
QA,ABDOMINAL DISTENSION,1
QA,ABDOMINAL WALL DISORDER,1
QA,ABDOMINAL WALL HAEMATOMA,1
QA,ABNORMAL FAECES,1
QA,ABORTION SPONTANEOUS,1
QA,ACANTHOSIS NIGRICANS,1
QA,ACINETOBACTER INFECTION,1
QA,ACUTE HEPATIC FAILURE,1
QA,AFFECT LABILITY,1
QA,ALOPECIA,1
QA,AMAUROSIS,1
QA,ANEURYSM RUPTURED,1
QA,APHONIA,1
QA,ARRHYTHMIA,1
QA,ARTERIOVENOUS FISTULA OCCLUSION,1
QA,ARTHRALGIA,1
QA,ASPHYXIA,1
QA,ASTHENIA,1
QA,ATRIAL FIBRILLATION,1
QA,AUTOIMMUNE HEPATITIS,1
QA,BACK PAIN,1
QA,BALANCE DISORDER,1
QA,BENIGN NEOPLASM,1
QA,BLINDNESS,1
QA,BLINDNESS UNILATERAL,1
QA,BLISTER,1
QA,BLOOD ALBUMIN DECREASED,1
QA,BLOOD ALBUMIN INCREASED,1
QA,BLOOD ALKALINE PHOSPHATASE INCREASED,1
QA,BLOOD LACTATE DEHYDROGENASE INCREASED,1
QA,BLOOD POTASSIUM DECREASED,1
QA,BLOOD TEST ABNORMAL,1
QA,BODY TEMPERATURE INCREASED,1
QA,BRAIN NEOPLASM MALIGNANT,1
QA,BREAST CANCER,1
QA,BRONCHOSPASM,1
QA,BRUGADA SYNDROME,1
QA,C-REACTIVE PROTEIN INCREASED,1
QA,CAESAREAN SECTION,1
QA,CANDIDA INFECTION,1
QA,CARDIAC FAILURE,1
QA,CEREBELLAR SYNDROME,1
QA,CEREBRAL PALSY,1
QA,CHEST PAIN,1
QA,CHOLESTASIS,1
QA,CHRONIC HEPATIC FAILURE,1
QA,COLON CANCER,1
QA,CONTUSION,1
QA,CONVULSION,1
QA,CYANOSIS,1
QA,CYTOMEGALOVIRUS CHORIORETINITIS,1
QA,DEAFNESS BILATERAL,1
QA,DEMYELINATION,1
QA,DEPRESSED LEVEL OF CONSCIOUSNESS,1
QA,DEPRESSION,1
QA,DERMATITIS,1
QA,DERMATITIS BULLOUS,1
QA,DEVICE RELATED SEPSIS,1
QA,DIABETES MELLITUS INADEQUATE CONTROL,1
QA,DIABETIC KETOACIDOSIS,1
QA,DRUG ADMINISTRATION ERROR,1
QA,DRUG INTOLERANCE,1
QA,DRUG WITHDRAWAL SYNDROME,1
QA,DRY MOUTH,1
QA,DUODENAL ULCER HAEMORRHAGE,1
QA,DUODENAL ULCER PERFORATION,1
QA,DYSENTERY,1
QA,DYSPHONIA,1
QA,EAR PAIN,1
QA,ECTOPIC PREGNANCY,1
QA,ELECTROCARDIOGRAM QT PROLONGED,1
QA,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
QA,EMBOLISM,1
QA,FACE OEDEMA,1
QA,FEELING ABNORMAL,1
QA,FLUID OVERLOAD,1
QA,FLUSHING,1
QA,FOETAL HYPOKINESIA,1
QA,GASTRIC VARICES,1
QA,GASTRIC VARICES HAEMORRHAGE,1
QA,GASTRITIS,1
QA,GASTROINTESTINAL DISORDER,1
QA,GASTROINTESTINAL MUCOSA HYPERAEMIA,1
QA,GENERALISED OEDEMA,1
QA,GENERALISED TONIC-CLONIC SEIZURE,1
QA,GLAUCOMA,1
QA,GLOMERULAR FILTRATION RATE DECREASED,1
QA,GRAFT THROMBOSIS,1
QA,HAEMATURIA,1
QA,HAEMORRHAGE INTRACRANIAL,1
QA,HEART RATE INCREASED,1
QA,HEPATIC CIRRHOSIS,1
QA,HEPATIC ENCEPHALOPATHY,1
QA,HEPATIC ENZYME INCREASED,1
QA,HEPATIC FAILURE,1
QA,HEPATITIS B,1
QA,HEPATITIS C,1
QA,HEPATOMEGALY,1
QA,HEPATORENAL SYNDROME,1
QA,HERPES ZOSTER,1
QA,HIATUS HERNIA,1
QA,HIP FRACTURE,1
QA,HYPERBILIRUBINAEMIA,1
QA,HYPERGLYCAEMIA,1
QA,HYPERNATRAEMIA,1
QA,HYPERTHERMIA,1
QA,HYPORESPONSIVE TO STIMULI,1
QA,IMMUNE THROMBOCYTOPENIC PURPURA,1
QA,IMPAIRED DRIVING ABILITY,1
QA,INCORRECT DOSE ADMINISTERED,1
QA,INNER EAR DISORDER,1
QA,INSOMNIA,1
QA,INSULIN RESISTANCE,1
QA,INTRAVENTRICULAR HAEMORRHAGE NEONATAL,1
QA,IRON OVERLOAD,1
QA,JAUNDICE CHOLESTATIC,1
QA,KNEE DEFORMITY,1
QA,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
QA,LEUKOCYTOSIS,1
QA,LIVER FUNCTION TEST ABNORMAL,1
QA,LIVER INJURY,1
QA,LIVER TENDERNESS,1
QA,LOSS OF CONSCIOUSNESS,1
QA,LOW BIRTH WEIGHT BABY,1
QA,LOWER RESPIRATORY TRACT INFECTION,1
QA,LUNG INFILTRATION,1
QA,LUPUS-LIKE SYNDROME,1
QA,LYMPHOCYTOSIS,1
QA,MATERNAL DRUGS AFFECTING FOETUS,1
QA,MEDICATION ERROR,1
QA,MEMORY IMPAIRMENT,1
QA,MICROCEPHALY,1
QA,MUCOSAL INFLAMMATION,1
QA,MULTI-ORGAN FAILURE,1
QA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
QA,MUSCLE SPASMS,1
QA,MUSCLE TIGHTNESS,1
QA,NECROTISING FASCIITIS,1
QA,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
QA,OROPHARYNGEAL PAIN,1
QA,OVERDOSE,1
QA,OXYGEN SATURATION DECREASED,1
QA,PALLOR,1
QA,PALPITATIONS,1
QA,PANCREATITIS NECROTISING,1
QA,PAPILLOEDEMA,1
QA,PERITONITIS BACTERIAL,1
QA,PERIVENTRICULAR LEUKOMALACIA,1
QA,PHARYNGEAL ERYTHEMA,1
QA,PHOTOPHOBIA,1
QA,PHOTOSENSITIVITY REACTION,1
QA,PLEURAL HAEMORRHAGE,1
QA,PLEUROPERITONEAL COMMUNICATION,1
QA,PNEUMONIA,1
QA,PNEUMOPERITONEUM,1
QA,POLYURIA,1
QA,PORTAL VEIN THROMBOSIS,1
QA,PREMATURE DELIVERY,1
QA,PROCEDURAL INTESTINAL PERFORATION,1
QA,PRODUCT AVAILABILITY ISSUE,1
QA,PRODUCT USE IN UNAPPROVED INDICATION,1
QA,PRODUCTIVE COUGH,1
QA,PULMONARY EMBOLISM,1
QA,RASH GENERALISED,1
QA,RASH MACULAR,1
QA,RASH MACULO-PAPULAR,1
QA,RASH PRURITIC,1
QA,RECTAL PERFORATION,1
QA,RENAL COLIC,1
QA,RENAL FAILURE,1
QA,RENAL IMPAIRMENT,1
QA,RESPIRATORY ARREST,1
QA,RETROPERITONEAL OEDEMA,1
QA,SCLERAL DISCOLOURATION,1
QA,SCROTAL SWELLING,1
QA,SENSATION OF FOREIGN BODY,1
QA,SINUS DISORDER,1
QA,SINUS TACHYCARDIA,1
QA,SKIN PLAQUE,1
QA,SMALL FOR DATES BABY,1
QA,SPEECH DISORDER,1
QA,SUBARACHNOID HAEMORRHAGE NEONATAL,1
QA,SUPRAVENTRICULAR TACHYCARDIA,1
QA,SYSTEMIC LEAKAGE,1
QA,TACHYPHRENIA,1
QA,TACHYPNOEA,1
QA,TESTICULAR SEMINOMA (PURE),1
QA,THERAPY NON-RESPONDER,1
QA,THORACOTOMY,1
QA,THROMBOSIS IN DEVICE,1
QA,THYROID CANCER,1
QA,THYROID DISORDER,1
QA,TORSADE DE POINTES,1
QA,TRANSIENT ISCHAEMIC ATTACK,1
QA,TREMOR,1
QA,TUMOUR LYSIS SYNDROME,1
QA,VARICES OESOPHAGEAL,1
QA,VENTRICULAR ARRHYTHMIA,1
QA,VENTRICULAR FIBRILLATION,1
QA,VENTRICULAR SEPTAL DEFECT,1
QA,VIRAL LOAD INCREASED,1
QA,VISION BLURRED,1
QA,VISUAL EVOKED POTENTIALS ABNORMAL,1
QA,VISUAL IMPAIRMENT,1
QA,VOCAL CORD DISORDER,1
QA,WHITE BLOOD CELL COUNT DECREASED,1
QA,WHITE BLOOD CELL COUNT INCREASED,1
QA,WHITE MATTER LESION,1
QA,WITHDRAWAL SYNDROME,1
RE,BRONCHIECTASIS,9
RE,NEUTROPENIA,3
RE,CHOLESTASIS,2
RE,CARDIAC FAILURE,1
RE,CEREBROVASCULAR ACCIDENT,1
RE,CERVICAL CONISATION,1
RE,CERVICAL DYSPLASIA,1
RE,COLON CANCER,1
RE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
RE,FEELING ABNORMAL,1
RE,HYPOGAMMAGLOBULINAEMIA,1
RE,INTENTIONAL DRUG MISUSE,1
RE,INTENTIONAL OVERDOSE,1
RE,LIVER ABSCESS,1
RE,MALIGNANT MELANOMA,1
RE,PALPITATIONS,1
RE,PAPILLOMA VIRAL INFECTION,1
RE,SEPSIS,1
RE,TREATMENT NONCOMPLIANCE,1
RO,DEATH,330
RO,VOMITING,234
RO,ANAEMIA,218
RO,DRUG INEFFECTIVE,184
RO,ASTHENIA,179
RO,NAUSEA,178
RO,DIZZINESS,169
RO,HEADACHE,167
RO,PYREXIA,164
RO,FATIGUE,153
RO,PRURITUS,132
RO,DYSPNOEA,128
RO,CARDIO-RESPIRATORY ARREST,124
RO,DIARRHOEA,124
RO,HYPERTENSION,123
RO,DECREASED APPETITE,120
RO,ABDOMINAL PAIN,117
RO,MALAISE,102
RO,WEIGHT DECREASED,97
RO,THROMBOCYTOPENIA,95
RO,TOXICITY TO VARIOUS AGENTS,87
RO,PNEUMONIA,85
RO,SEPSIS,84
RO,ASCITES,82
RO,INSOMNIA,82
RO,JAUNDICE,76
RO,COMA,75
RO,COUGH,75
RO,CHILLS,73
RO,LEUKOPENIA,71
RO,URINARY TRACT INFECTION,70
RO,HEPATOCELLULAR INJURY,67
RO,NEUTROPENIA,67
RO,CEREBROVASCULAR ACCIDENT,66
RO,MYOCARDIAL INFARCTION,66
RO,OEDEMA PERIPHERAL,63
RO,SUICIDE ATTEMPT,62
RO,HAEMOGLOBIN DECREASED,61
RO,FOETAL EXPOSURE DURING PREGNANCY,60
RO,GENERAL PHYSICAL HEALTH DETERIORATION,60
RO,CHEST PAIN,59
RO,HEPATIC FAILURE,59
RO,RASH,59
RO,RESPIRATORY FAILURE,58
RO,SOMNOLENCE,58
RO,PAIN IN EXTREMITY,57
RO,ARTHRALGIA,56
RO,HYPOTENSION,56
RO,PLEURISY,56
RO,DEPRESSION,55
RO,TREMOR,55
RO,UPPER GASTROINTESTINAL HAEMORRHAGE,55
RO,CONDITION AGGRAVATED,53
RO,SYNCOPE,53
RO,ABDOMINAL PAIN UPPER,52
RO,ANXIETY,51
RO,HYPERHIDROSIS,51
RO,MELAENA,51
RO,BACK PAIN,50
RO,CARDIAC FAILURE,50
RO,AGITATION,47
RO,ATRIAL FIBRILLATION,47
RO,ERYTHEMA,47
RO,MYALGIA,46
RO,PAIN,45
RO,VERTIGO,45
RO,ACUTE MYOCARDIAL INFARCTION,44
RO,LOSS OF CONSCIOUSNESS,44
RO,GASTROINTESTINAL HAEMORRHAGE,43
RO,OVERDOSE,43
RO,PALPITATIONS,43
RO,CONFUSIONAL STATE,40
RO,FALL,40
RO,ACUTE KIDNEY INJURY,39
RO,DYSPHAGIA,39
RO,EPISTAXIS,39
RO,EROSIVE OESOPHAGITIS,39
RO,HYPONATRAEMIA,39
RO,ISCHAEMIC STROKE,39
RO,RENAL FAILURE,39
RO,CARDIAC ARREST,38
RO,EXPOSURE DURING PREGNANCY,37
RO,BONE PAIN,35
RO,HAEMATEMESIS,35
RO,CONSTIPATION,34
RO,GAIT DISTURBANCE,34
RO,HYPERBILIRUBINAEMIA,34
RO,TUBERCULOSIS,34
RO,ABDOMINAL DISTENSION,33
RO,ANGIOEDEMA,33
RO,CHOLESTASIS,33
RO,DISEASE PROGRESSION,33
RO,PARAESTHESIA,33
RO,PSYCHOMOTOR HYPERACTIVITY,33
RO,PULMONARY TUBERCULOSIS,33
RO,DYSPEPSIA,32
RO,NASOPHARYNGITIS,32
RO,PALLOR,32
RO,BLOOD GLUCOSE INCREASED,31
RO,PREMATURE BABY,31
RO,TREATMENT NONCOMPLIANCE,31
RO,HALLUCINATION,30
RO,HYPERGLYCAEMIA,30
RO,PLEURAL EFFUSION,30
RO,URTICARIA,30
RO,ARRHYTHMIA,29
RO,HYPOAESTHESIA,29
RO,INTERSTITIAL LUNG DISEASE,29
RO,MATERNAL EXPOSURE DURING PREGNANCY,29
RO,TACHYCARDIA,29
RO,CYANOSIS,28
RO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,28
RO,PSYCHOTIC DISORDER,28
RO,TRANSAMINASES INCREASED,28
RO,ANGINA PECTORIS,27
RO,ENCEPHALOPATHY,27
RO,HEPATIC CIRRHOSIS,27
RO,HEPATIC ENCEPHALOPATHY,27
RO,HYPOKALAEMIA,27
RO,MUSCULAR WEAKNESS,27
RO,SEIZURE,27
RO,ACUTE HEPATIC FAILURE,26
RO,INTENTIONAL OVERDOSE,26
RO,PULMONARY EMBOLISM,26
RO,YELLOW SKIN,26
RO,BLOOD PRESSURE INCREASED,25
RO,DEMENTIA,25
RO,HYPERSENSITIVITY,25
RO,DRUG RESISTANCE,24
RO,FACE OEDEMA,24
RO,HAEMATURIA,24
RO,LYMPHADENOPATHY,24
RO,MALIGNANT NEOPLASM PROGRESSION,24
RO,ANAPHYLACTIC SHOCK,23
RO,BLOOD BILIRUBIN INCREASED,23
RO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,23
RO,CLOSTRIDIUM DIFFICILE COLITIS,23
RO,COGNITIVE DISORDER,23
RO,LEUKOCYTOSIS,23
RO,PANCYTOPENIA,23
RO,BLOOD CREATININE INCREASED,22
RO,DYSLIPIDAEMIA,22
RO,ACUTE RESPIRATORY FAILURE,21
RO,ALANINE AMINOTRANSFERASE INCREASED,21
RO,BLOOD UREA INCREASED,21
RO,HAEMORRHAGE,21
RO,HEART RATE INCREASED,21
RO,HEPATITIS C,21
RO,MITRAL VALVE INCOMPETENCE,21
RO,OSTEONECROSIS OF JAW,21
RO,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,21
RO,CARDIAC DISORDER,20
RO,DRUG EFFECT INCOMPLETE,20
RO,HAEMATOCHEZIA,20
RO,HEPATOCELLULAR CARCINOMA,20
RO,HYPOGLYCAEMIA,20
RO,OEDEMA,20
RO,SPINAL PAIN,20
RO,WEIGHT INCREASED,20
RO,BRADYCARDIA,19
RO,DEHYDRATION,19
RO,DIABETES MELLITUS,19
RO,INFECTION,19
RO,INTERVERTEBRAL DISC PROTRUSION,19
RO,INTESTINAL OBSTRUCTION,19
RO,NEUROPATHY PERIPHERAL,19
RO,RASH ERYTHEMATOUS,19
RO,SKIN EXFOLIATION,19
RO,AGGRESSION,18
RO,AMNESIA,18
RO,DRY MOUTH,18
RO,HYPERURICAEMIA,18
RO,MULTI-ORGAN FAILURE,18
RO,NEOPLASM PROGRESSION,18
RO,OESOPHAGEAL STENOSIS,18
RO,OXYGEN SATURATION DECREASED,18
RO,PLATELET COUNT DECREASED,18
RO,RHABDOMYOLYSIS,18
RO,VASCULAR STENT THROMBOSIS,18
RO,ABORTION SPONTANEOUS,17
RO,ASPARTATE AMINOTRANSFERASE INCREASED,17
RO,ASTHMA,17
RO,AUTOIMMUNE THYROIDITIS,17
RO,BALANCE DISORDER,17
RO,CHOLELITHIASIS,17
RO,DRUG ADMINISTRATION ERROR,17
RO,DRY SKIN,17
RO,DYSPHONIA,17
RO,EPILEPSY,17
RO,GENERAL PHYSICAL CONDITION ABNORMAL,17
RO,HEPATOMEGALY,17
RO,INFLAMMATION,17
RO,INFLUENZA,17
RO,INTENTIONAL PRODUCT MISUSE,17
RO,LIPODYSTROPHY ACQUIRED,17
RO,MYOCARDIAL ISCHAEMIA,17
RO,OSTEOPOROSIS,17
RO,RECTAL HAEMORRHAGE,17
RO,RESPIRATORY TRACT INFECTION,17
RO,RESTLESSNESS,17
RO,STOMATITIS,17
RO,SWELLING FACE,17
RO,ABNORMAL BEHAVIOUR,16
RO,BONE MARROW FAILURE,16
RO,CARDIAC FAILURE ACUTE,16
RO,CATARACT,16
RO,CHROMATURIA,16
RO,CHRONIC KIDNEY DISEASE,16
RO,FEBRILE NEUTROPENIA,16
RO,HEPATITIS,16
RO,LEFT VENTRICULAR DYSFUNCTION,16
RO,METABOLIC ACIDOSIS,16
RO,PRODUCT USE ISSUE,16
RO,RHEUMATOID ARTHRITIS,16
RO,ALOPECIA,15
RO,ANAPHYLACTIC REACTION,15
RO,APHASIA,15
RO,ASPHYXIA,15
RO,CARDIOPULMONARY FAILURE,15
RO,CHOLECYSTITIS ACUTE,15
RO,GASTROINTESTINAL DISORDER,15
RO,HALLUCINATION_ VISUAL,15
RO,HEMIPARESIS,15
RO,HEMIPLEGIA,15
RO,HYPOALBUMINAEMIA,15
RO,IRRITABILITY,15
RO,LUNG DISORDER,15
RO,LUNG NEOPLASM MALIGNANT,15
RO,MEGACOLON,15
RO,MEMORY IMPAIRMENT,15
RO,MOBILITY DECREASED,15
RO,MUSCLE SPASMS,15
RO,OSTEOARTHRITIS,15
RO,PANCREATITIS,15
RO,PERIPHERAL SWELLING,15
RO,PRODUCT USE IN UNAPPROVED INDICATION,15
RO,SLEEP DISORDER,15
RO,SURGERY,15
RO,ALLERGIC REACTION TO EXCIPIENT,14
RO,BREAST CANCER,14
RO,BRONCHOSPASM,14
RO,HAEMORRHAGIC STROKE,14
RO,HEPATITIS B,14
RO,HYDROCEPHALUS,14
RO,HYPERKALAEMIA,14
RO,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,14
RO,KAPOSI^S SARCOMA,14
RO,OESOPHAGEAL VARICES HAEMORRHAGE,14
RO,OSTEONECROSIS,14
RO,PANIC ATTACK,14
RO,PATHOGEN RESISTANCE,14
RO,PLASMA CELL MYELOMA,14
RO,PREMATURE DELIVERY,14
RO,PROTEINURIA,14
RO,PSORIASIS,14
RO,PULMONARY FIBROSIS,14
RO,PULMONARY OEDEMA,14
RO,RASH MACULO-PAPULAR,14
RO,RED BLOOD CELL SEDIMENTATION RATE INCREASED,14
RO,RENAL IMPAIRMENT,14
RO,TRANSIENT ISCHAEMIC ATTACK,14
RO,VISUAL IMPAIRMENT,14
RO,CARDIOTOXICITY,13
RO,COMPLETED SUICIDE,13
RO,CONJUNCTIVAL HYPERAEMIA,13
RO,DEEP VEIN THROMBOSIS,13
RO,DELIRIUM,13
RO,DISORIENTATION,13
RO,DRUG INTOLERANCE,13
RO,ELECTROCARDIOGRAM QT PROLONGED,13
RO,ELECTROLYTE IMBALANCE,13
RO,GENERALISED OEDEMA,13
RO,HAEMOPTYSIS,13
RO,HEPATIC STEATOSIS,13
RO,HERPES ZOSTER,13
RO,HYPOCALCAEMIA,13
RO,HYPOPROTEINAEMIA,13
RO,METASTASES TO LIVER,13
RO,PANCREATITIS ACUTE,13
RO,PSORIATIC ARTHROPATHY,13
RO,RESPIRATORY TRACT INFECTION VIRAL,13
RO,STEVENS-JOHNSON SYNDROME,13
RO,THERAPEUTIC RESPONSE DECREASED,13
RO,THROMBOSIS,13
RO,VISUAL ACUITY REDUCED,13
RO,WHEEZING,13
RO,ACUTE PULMONARY OEDEMA,12
RO,BLOOD CHOLESTEROL INCREASED,12
RO,CARDIAC DEATH,12
RO,CARDIAC FAILURE CHRONIC,12
RO,CARDIOVASCULAR DISORDER,12
RO,CELLULITIS,12
RO,DISSEMINATED INTRAVASCULAR COAGULATION,12
RO,DRUG-INDUCED LIVER INJURY,12
RO,DYSGEUSIA,12
RO,ENTEROCOLITIS,12
RO,EYELID OEDEMA,12
RO,FAECES SOFT,12
RO,FLATULENCE,12
RO,HAEMATOTOXICITY,12
RO,IRIDOCYCLITIS,12
RO,PERICARDITIS,12
RO,PERITONITIS,12
RO,PROSTATE CANCER,12
RO,PSEUDOMEMBRANOUS COLITIS,12
RO,SEDATION,12
RO,TONGUE OEDEMA,12
RO,VARICES OESOPHAGEAL,12
RO,BASAL CELL CARCINOMA,11
RO,CAESAREAN SECTION,11
RO,CARDIOGENIC SHOCK,11
RO,CLOSTRIDIUM DIFFICILE INFECTION,11
RO,DERMATITIS,11
RO,DRUG DOSE OMISSION,11
RO,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,11
RO,EJECTION FRACTION DECREASED,11
RO,FREQUENT BOWEL MOVEMENTS,11
RO,GASTRIC ULCER,11
RO,GENERALISED TONIC-CLONIC SEIZURE,11
RO,HYPERCHOLESTEROLAEMIA,11
RO,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,11
RO,INJECTION SITE ERYTHEMA,11
RO,ISCHAEMIC CARDIOMYOPATHY,11
RO,LACTIC ACIDOSIS,11
RO,MAJOR DEPRESSION,11
RO,MOTOR DYSFUNCTION,11
RO,NECK PAIN,11
RO,OLIGURIA,11
RO,ORTHOSTATIC HYPOTENSION,11
RO,POISONING,11
RO,POLLAKIURIA,11
RO,POLYNEUROPATHY,11
RO,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,11
RO,PRODUCTIVE COUGH,11
RO,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,11
RO,PULMONARY HYPERTENSION,11
RO,PULMONARY MASS,11
RO,SPLENOMEGALY,11
RO,STOMA SITE HYPERGRANULATION,11
RO,URINARY RETENTION,11
RO,ACUTE RESPIRATORY DISTRESS SYNDROME,10
RO,ANURIA,10
RO,CELL DEATH,10
RO,CEREBRAL HAEMORRHAGE,10
RO,COAGULOPATHY,10
RO,CUSHING^S SYNDROME,10
RO,DEPRESSED LEVEL OF CONSCIOUSNESS,10
RO,DERMATITIS ALLERGIC,10
RO,DERMATITIS CONTACT,10
RO,DERMATITIS EXFOLIATIVE,10
RO,DYSPNOEA EXERTIONAL,10
RO,DYSURIA,10
RO,EOSINOPHILIA,10
RO,ESCHERICHIA URINARY TRACT INFECTION,10
RO,FLUSHING,10
RO,HALLUCINATION_ AUDITORY,10
RO,HEPATIC CANCER,10
RO,HEPATIC ENZYME INCREASED,10
RO,HEPATIC NEOPLASM,10
RO,HEPATIC PAIN,10
RO,HYPERAEMIA,10
RO,HYPERTHYROIDISM,10
RO,HYPOTHYROIDISM,10
RO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,10
RO,INCORRECT DOSE ADMINISTERED,10
RO,INFUSION RELATED REACTION,10
RO,LUNG NEOPLASM,10
RO,NERVOUS SYSTEM DISORDER,10
RO,NEUROTOXICITY,10
RO,RASH GENERALISED,10
RO,RASH MACULAR,10
RO,RASH PRURITIC,10
RO,SINUS BRADYCARDIA,10
RO,SKIN DISCOLOURATION,10
RO,SKIN PLAQUE,10
RO,SUBARACHNOID HAEMORRHAGE,10
RO,SUFFOCATION FEELING,10
RO,SWELLING,10
RO,AORTIC VALVE INCOMPETENCE,9
RO,APATHY,9
RO,CANDIDA INFECTION,9
RO,CEREBRAL ATROPHY,9
RO,CEREBROVASCULAR DISORDER,9
RO,DISSEMINATED TUBERCULOSIS,9
RO,EXTRAPYRAMIDAL DISORDER,9
RO,FAECES DISCOLOURED,9
RO,FEELING ABNORMAL,9
RO,FOETAL GROWTH RESTRICTION,9
RO,GASTRITIS,9
RO,HAEMATOCRIT DECREASED,9
RO,HAEMORRHOIDS,9
RO,HEPATOTOXICITY,9
RO,HYPERCALCAEMIA,9
RO,HYPERTENSIVE CRISIS,9
RO,INCREASED APPETITE,9
RO,INGUINAL HERNIA,9
RO,KLEBSIELLA INFECTION,9
RO,LARYNGEAL OEDEMA,9
RO,MANIA,9
RO,METASTASES TO BONE,9
RO,METASTASES TO LUNG,9
RO,MUCOSAL INFLAMMATION,9
RO,NEPHROLITHIASIS,9
RO,NIGHTMARE,9
RO,PERIPHERAL SENSORY NEUROPATHY,9
RO,POLYURIA,9
RO,PSYCHOTIC SYMPTOM,9
RO,RASH PAPULAR,9
RO,RENAL FAILURE CHRONIC,9
RO,RESPIRATORY DISTRESS,9
RO,SEPTIC SHOCK,9
RO,SHOCK HAEMORRHAGIC,9
RO,SKIN LESION,9
RO,SUDDEN DEATH,9
RO,TOOTH ABSCESS,9
RO,URINARY INCONTINENCE,9
RO,VISION BLURRED,9
RO,ABORTION INDUCED,8
RO,ACIDOSIS,8
RO,ACUTE LYMPHOCYTIC LEUKAEMIA,8
RO,APLASIA,8
RO,ARTHROPATHY,8
RO,ATRIOVENTRICULAR BLOCK,8
RO,AZOTAEMIA,8
RO,BLISTER,8
RO,BLOOD TRIGLYCERIDES INCREASED,8
RO,BRAIN OEDEMA,8
RO,BRONCHOPNEUMONIA,8
RO,BURNING SENSATION,8
RO,CERVIX CARCINOMA,8
RO,CHOKING SENSATION,8
RO,CORONARY ARTERY DISEASE,8
RO,DELUSION,8
RO,DEVICE DISLOCATION,8
RO,DIPLOPIA,8
RO,DISTURBANCE IN ATTENTION,8
RO,DYSARTHRIA,8
RO,DYSKINESIA,8
RO,ENCEPHALITIS,8
RO,GAMMA-GLUTAMYLTRANSFERASE INCREASED,8
RO,GINGIVAL BLEEDING,8
RO,GRANULOMA,8
RO,HUMERUS FRACTURE,8
RO,HYPOKINESIA,8
RO,IRON DEFICIENCY ANAEMIA,8
RO,JOINT SWELLING,8
RO,LABORATORY TEST ABNORMAL,8
RO,LOW BIRTH WEIGHT BABY,8
RO,LUNG INFECTION,8
RO,METRORRHAGIA,8
RO,MUSCULOSKELETAL DISORDER,8
RO,NEOPLASM MALIGNANT,8
RO,NEPHROTIC SYNDROME,8
RO,OSTEOPENIA,8
RO,PERIPHERAL SENSORIMOTOR NEUROPATHY,8
RO,PRURITUS GENERALISED,8
RO,RENAL DISORDER,8
RO,RHINORRHOEA,8
RO,SALIVARY HYPERSECRETION,8
RO,SLOW SPEECH,8
RO,SPEECH DISORDER,8
RO,STOMA SITE ERYTHEMA,8
RO,STOMA SITE HAEMORRHAGE,8
RO,SUICIDAL IDEATION,8
RO,SWOLLEN TONGUE,8
RO,SYSTEMIC LUPUS ERYTHEMATOSUS,8
RO,THROMBOPHLEBITIS,8
RO,ACUTE PSYCHOSIS,7
RO,AGRANULOCYTOSIS,7
RO,ANGER,7
RO,ATRIAL FLUTTER,7
RO,ATRIAL SEPTAL DEFECT,7
RO,BRONCHITIS,7
RO,CACHEXIA,7
RO,CARDIOMYOPATHY,7
RO,DANDY-WALKER SYNDROME,7
RO,DRUG DEPENDENCE,7
RO,DRUG HYPERSENSITIVITY,7
RO,HAEMATOMA,7
RO,HEPATORENAL FAILURE,7
RO,HIATUS HERNIA,7
RO,HOSPITALISATION,7
RO,HYPOPHAGIA,7
RO,IMMUNE THROMBOCYTOPENIC PURPURA,7
RO,LEFT VENTRICULAR FAILURE,7
RO,LIVE BIRTH,7
RO,LOWER LIMB FRACTURE,7
RO,LUPUS-LIKE SYNDROME,7
RO,MUSCULOSKELETAL CHEST PAIN,7
RO,NO ADVERSE EVENT,7
RO,PHOTOPHOBIA,7
RO,PNEUMOCYSTIS JIROVECII PNEUMONIA,7
RO,POSTURE ABNORMAL,7
RO,RENAL FAILURE ACUTE,7
RO,RESPIRATORY DISORDER,7
RO,SCHIZOPHRENIA,7
RO,SELF-MEDICATION,7
RO,SENSATION OF FOREIGN BODY,7
RO,SHOCK,7
RO,SKIN FISSURES,7
RO,SKIN TOXICITY,7
RO,SKIN ULCER,7
RO,SPINAL FRACTURE,7
RO,STAPHYLOCOCCAL INFECTION,7
RO,STUPOR,7
RO,THERAPEUTIC RESPONSE UNEXPECTED,7
RO,TOXIC EPIDERMAL NECROLYSIS,7
RO,TUBULOINTERSTITIAL NEPHRITIS,7
RO,UNEVALUABLE EVENT,7
RO,VENTRICULAR TACHYCARDIA,7
RO,VITAMIN B12 DECREASED,7
RO,WHITE BLOOD CELL COUNT INCREASED,7
RO,WOUND DEHISCENCE,7
RO,ABASIA,6
RO,ABDOMINAL PAIN LOWER,6
RO,ACTIVITIES OF DAILY LIVING IMPAIRED,6
RO,ACUTE MYELOID LEUKAEMIA,6
RO,ANAL ATRESIA,6
RO,ANGINA UNSTABLE,6
RO,ATRIOVENTRICULAR BLOCK SECOND DEGREE,6
RO,BLOOD CREATINE PHOSPHOKINASE INCREASED,6
RO,BLOOD PRESSURE ABNORMAL,6
RO,BRONCHIAL CARCINOMA,6
RO,BURN OESOPHAGEAL,6
RO,CARDIAC MURMUR,6
RO,CATATONIA,6
RO,CERVICAL DYSPLASIA,6
RO,CHEST DISCOMFORT,6
RO,CONJUNCTIVITIS,6
RO,CONVULSION,6
RO,CYTOMEGALOVIRUS INFECTION,6
RO,CYTOPENIA,6
RO,DEAFNESS,6
RO,DECREASED IMMUNE RESPONSIVENESS,6
RO,DISEASE RECURRENCE,6
RO,DRUG ABUSE,6
RO,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,6
RO,ERYSIPELAS,6
RO,FEMUR FRACTURE,6
RO,FISTULA,6
RO,GANGRENE,6
RO,GASTROOESOPHAGEAL REFLUX DISEASE,6
RO,GLYCOSYLATED HAEMOGLOBIN INCREASED,6
RO,GUILLAIN-BARRE SYNDROME,6
RO,GYNAECOMASTIA,6
RO,HAEMOGLOBIN ABNORMAL,6
RO,HEART RATE DECREASED,6
RO,HEPATIC CYST,6
RO,HEPATITIS CHOLESTATIC,6
RO,HODGKIN^S DISEASE,6
RO,HYPERTRIGLYCERIDAEMIA,6
RO,HYPOTONIA,6
RO,IMMUNOSUPPRESSION,6
RO,INTENTIONAL PRODUCT USE ISSUE,6
RO,INTERNATIONAL NORMALISED RATIO INCREASED,6
RO,INTRACRANIAL PRESSURE INCREASED,6
RO,KETOACIDOSIS,6
RO,LARYNGOSPASM,6
RO,LIVER DISORDER,6
RO,LYMPH NODE TUBERCULOSIS,6
RO,METABOLIC DISORDER,6
RO,MICROCYTIC ANAEMIA,6
RO,MULTIPLE SCLEROSIS RELAPSE,6
RO,MUSCULOSKELETAL PAIN,6
RO,MUSCULOSKELETAL STIFFNESS,6
RO,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,6
RO,MYOPATHY,6
RO,NEPHROPATHY,6
RO,NERVOUSNESS,6
RO,NON-HODGKIN^S LYMPHOMA,6
RO,OCULAR ICTERUS,6
RO,ORAL CANDIDIASIS,6
RO,ORAL HERPES,6
RO,OROPHARYNGEAL PAIN,6
RO,ORTHOPNOEA,6
RO,PANCREATIC DISORDER,6
RO,PANCREATITIS CHRONIC,6
RO,PANIC REACTION,6
RO,PARAPARESIS,6
RO,POST PROCEDURAL COMPLICATION,6
RO,PRODUCT QUALITY ISSUE,6
RO,PYELONEPHRITIS ACUTE,6
RO,RENAL COLIC,6
RO,RENAL CYST,6
RO,RENAL NEOPLASM,6
RO,RENAL PAIN,6
RO,RESTRICTIVE CARDIOMYOPATHY,6
RO,ROAD TRAFFIC ACCIDENT,6
RO,SEXUAL DYSFUNCTION,6
RO,SINUSITIS,6
RO,SKIN EROSION,6
RO,SKIN REACTION,6
RO,STAPHYLOCOCCAL SEPSIS,6
RO,STOMA SITE INFECTION,6
RO,SUSPECTED COUNTERFEIT PRODUCT,6
RO,TACHYPNOEA,6
RO,THROMBOSIS IN DEVICE,6
RO,TOOTH DISORDER,6
RO,TREATMENT FAILURE,6
RO,TRICUSPID VALVE INCOMPETENCE,6
RO,TUBERCULOUS PLEURISY,6
RO,TYPE 2 DIABETES MELLITUS,6
RO,VASCULITIS,6
RO,ABDOMINAL DISCOMFORT,5
RO,ABNORMAL DREAMS,5
RO,ACINETOBACTER INFECTION,5
RO,ACUTE CORONARY SYNDROME,5
RO,ADVERSE EVENT,5
RO,AKATHISIA,5
RO,ALKALOSIS,5
RO,APNOEA,5
RO,ARTHRITIS,5
RO,BILIRUBIN CONJUGATED INCREASED,5
RO,BIPOLAR I DISORDER,5
RO,BLOOD PRESSURE DECREASED,5
RO,BRONCHOPNEUMOPATHY,5
RO,BUNDLE BRANCH BLOCK RIGHT,5
RO,C-REACTIVE PROTEIN INCREASED,5
RO,CARDIAC FAILURE CONGESTIVE,5
RO,CHOKING,5
RO,CHOLECYSTECTOMY,5
RO,CHRONIC LYMPHOCYTIC LEUKAEMIA,5
RO,COLITIS ULCERATIVE,5
RO,CONCUSSION,5
RO,CONGESTIVE CARDIOMYOPATHY,5
RO,CONTUSION,5
RO,CORONARY ARTERY STENOSIS,5
RO,CROHN^S DISEASE,5
RO,DEVICE OCCLUSION,5
RO,DIABETES MELLITUS INADEQUATE CONTROL,5
RO,DIET REFUSAL,5
RO,DUODENAL ULCER,5
RO,EAR INFECTION,5
RO,EMBEDDED DEVICE,5
RO,ENTERITIS,5
RO,ERECTILE DYSFUNCTION,5
RO,ESSENTIAL HYPERTENSION,5
RO,EXTRAPULMONARY TUBERCULOSIS,5
RO,EYE DISORDER,5
RO,EYE OEDEMA,5
RO,EYE PAIN,5
RO,EYE SWELLING,5
RO,FACIAL PAIN,5
RO,FEELING HOT,5
RO,FOETAL DEATH,5
RO,GASTROENTERITIS,5
RO,GASTROINTESTINAL SOUNDS ABNORMAL,5
RO,GENERALISED ERYTHEMA,5
RO,GOITRE,5
RO,HAEMOLYTIC ANAEMIA,5
RO,HAEMOLYTIC URAEMIC SYNDROME,5
RO,HAEMORRHAGIC ANAEMIA,5
RO,HAEMORRHAGIC DISORDER,5
RO,HEAD INJURY,5
RO,HEPATITIS ACUTE,5
RO,HEPATITIS TOXIC,5
RO,HEPATOSPLENOMEGALY,5
RO,HIP FRACTURE,5
RO,HYPERGAMMAGLOBULINAEMIA,5
RO,HYPERPROLACTINAEMIA,5
RO,INCORRECT ROUTE OF DRUG ADMINISTRATION,5
RO,INFLUENZA LIKE ILLNESS,5
RO,INJECTION SITE ABSCESS,5
RO,INJECTION SITE PAIN,5
RO,INTENTIONAL DOSE OMISSION,5
RO,INTERVERTEBRAL DISC DISORDER,5
RO,INTERVERTEBRAL DISCITIS,5
RO,INTRAOCULAR PRESSURE INCREASED,5
RO,LEUKOENCEPHALOPATHY,5
RO,LIP OEDEMA,5
RO,LIP SWELLING,5
RO,LYMPHOPENIA,5
RO,MACULAR DEGENERATION,5
RO,MENTAL DISORDER,5
RO,METABOLIC SYNDROME,5
RO,MULTIPLE-DRUG RESISTANCE,5
RO,MUSCLE CONTRACTIONS INVOLUNTARY,5
RO,MYOCARDIAL FIBROSIS,5
RO,NEONATAL RESPIRATORY DISTRESS SYNDROME,5
RO,NEOPLASM,5
RO,NEUTROPHILIA,5
RO,NORMAL NEWBORN,5
RO,NORMOCHROMIC NORMOCYTIC ANAEMIA,5
RO,OCULAR HYPERAEMIA,5
RO,OVULATION DISORDER,5
RO,PAPULE,5
RO,PATENT DUCTUS ARTERIOSUS,5
RO,PERIPHERAL VENOUS DISEASE,5
RO,PETECHIAE,5
RO,PNEUMONITIS,5
RO,POST PROCEDURAL HAEMORRHAGE,5
RO,PROCEDURAL PAIN,5
RO,PROSTATIC SPECIFIC ANTIGEN INCREASED,5
RO,PSEUDOMONAS INFECTION,5
RO,PSYCHOMOTOR RETARDATION,5
RO,QUADRIPLEGIA,5
RO,RASH PUSTULAR,5
RO,RENAL CELL CARCINOMA,5
RO,RESPIRATORY ARREST,5
RO,RIB FRACTURE,5
RO,SECOND PRIMARY MALIGNANCY,5
RO,SINUS TACHYCARDIA,5
RO,STOMA SITE DISCHARGE,5
RO,SUBILEUS,5
RO,SYNOVIAL CYST,5
RO,SYSTOLIC DYSFUNCTION,5
RO,THROMBOCYTOSIS,5
RO,TINNITUS,5
RO,TOOTHACHE,5
RO,TOXIC ANTERIOR SEGMENT SYNDROME,5
RO,UROSEPSIS,5
RO,UTERINE CANCER,5
RO,UTERINE LEIOMYOMA,5
RO,UVEITIS,5
RO,VIITH NERVE PARALYSIS,5
RO,WOUND,5
RO,ABSCESS,4
RO,ACCIDENT,4
RO,ACNE,4
RO,AMENORRHOEA,4
RO,AMYLASE INCREASED,4
RO,ANAL FISSURE,4
RO,ANGLE CLOSURE GLAUCOMA,4
RO,ANKYLOSING SPONDYLITIS,4
RO,AORTIC ARTERIOSCLEROSIS,4
RO,ARTERIAL STENOSIS,4
RO,ARTERIOSCLEROSIS,4
RO,ASTHMATIC CRISIS,4
RO,ATRIOVENTRICULAR BLOCK FIRST DEGREE,4
RO,ATYPICAL FEMUR FRACTURE,4
RO,BACTERIAL DISEASE CARRIER,4
RO,BLADDER CANCER,4
RO,BLOOD ALKALINE PHOSPHATASE INCREASED,4
RO,BLOOD LACTATE DEHYDROGENASE INCREASED,4
RO,BLOOD POTASSIUM DECREASED,4
RO,BLOOD PRESSURE FLUCTUATION,4
RO,BODY TEMPERATURE INCREASED,4
RO,BRAIN NEOPLASM,4
RO,BRONCHIAL OBSTRUCTION,4
RO,CALCIUM DEFICIENCY,4
RO,CARDIAC ANEURYSM,4
RO,CARDIAC FIBRILLATION,4
RO,CEREBELLAR SYNDROME,4
RO,CEREBRAL CALCIFICATION,4
RO,CEREBRAL VENOUS THROMBOSIS,4
RO,CHOLECYSTITIS,4
RO,CIRCULATORY COLLAPSE,4
RO,COMA SCALE ABNORMAL,4
RO,COMMUNICATION DISORDER,4
RO,CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY,4
RO,CORNEAL DISORDER,4
RO,CORNEAL OEDEMA,4
RO,DECUBITUS ULCER,4
RO,DEMYELINATION,4
RO,DEPENDENCE,4
RO,DEPRESSIVE SYMPTOM,4
RO,DEVICE ISSUE,4
RO,DIABETIC KETOACIDOSIS,4
RO,DISCOMFORT,4
RO,DISTURBANCE IN SOCIAL BEHAVIOUR,4
RO,DUODENITIS,4
RO,DYSSTASIA,4
RO,EAR PAIN,4
RO,ECZEMA,4
RO,ERYTHEMA MULTIFORME,4
RO,ERYTHEMA NODOSUM,4
RO,ESCHAR,4
RO,FEMORAL NECK FRACTURE,4
RO,GALLBLADDER DISORDER,4
RO,GASTRIC DISORDER,4
RO,GASTROENTERITIS NOROVIRUS,4
RO,GASTROINTESTINAL MOTILITY DISORDER,4
RO,GASTROINTESTINAL TOXICITY,4
RO,GRAND MAL CONVULSION,4
RO,HAEMODYNAMIC INSTABILITY,4
RO,HEPATIC FUNCTION ABNORMAL,4
RO,HICCUPS,4
RO,HYPERAMMONAEMIA,4
RO,HYPERTONIA,4
RO,HYPOACUSIS,4
RO,HYPOCHROMIC ANAEMIA,4
RO,HYPOGLYCAEMIA NEONATAL,4
RO,HYPONATRAEMIC ENCEPHALOPATHY,4
RO,ILEUS PARALYTIC,4
RO,INJECTION SITE INDURATION,4
RO,INJURY,4
RO,INTENTIONAL DRUG MISUSE,4
RO,INTESTINAL INFARCTION,4
RO,IRON DEFICIENCY,4
RO,ISCHAEMIA,4
RO,LATENT TUBERCULOSIS,4
RO,LENTICULOSTRIATAL VASCULOPATHY,4
RO,LICHEN PLANUS,4
RO,LIMB DISCOMFORT,4
RO,LIVER FUNCTION TEST ABNORMAL,4
RO,LOCALISED OEDEMA,4
RO,LUNG INFILTRATION,4
RO,LYMPHOMA,4
RO,MENINGOENCEPHALITIS BACTERIAL,4
RO,MENTAL STATUS CHANGES,4
RO,MICROCEPHALY,4
RO,MIOSIS,4
RO,MOOD ALTERED,4
RO,MOVEMENT DISORDER,4
RO,MULTIPLE INJURIES,4
RO,MUSCLE RIGIDITY,4
RO,MYDRIASIS,4
RO,NASAL CONGESTION,4
RO,NODULE,4
RO,ODYNOPHAGIA,4
RO,OESOPHAGITIS,4
RO,OLIGOHYDRAMNIOS,4
RO,ON AND OFF PHENOMENON,4
RO,OPTIC NEURITIS,4
RO,ORAL DISORDER,4
RO,OVARIAN CYST,4
RO,PAPILLOMA VIRAL INFECTION,4
RO,PARALYSIS,4
RO,PARAPLEGIA,4
RO,PARESIS,4
RO,PERICARDIAL EFFUSION,4
RO,PERITONITIS BACTERIAL,4
RO,PERSONALITY DISORDER,4
RO,PHARYNGITIS,4
RO,PNEUMOTHORAX,4
RO,PORTAL VEIN THROMBOSIS,4
RO,PRE-EXISTING CONDITION IMPROVED,4
RO,PRURIGO,4
RO,PULSE ABSENT,4
RO,QUADRIPARESIS,4
RO,RADICULOPATHY,4
RO,RASH VESICULAR,4
RO,RENAL TUBULAR DISORDER,4
RO,RESUSCITATION,4
RO,RETROPERITONEAL HAEMATOMA,4
RO,RIGHT VENTRICULAR FAILURE,4
RO,ROTAVIRUS INFECTION,4
RO,SARCOIDOSIS,4
RO,SCIATICA,4
RO,SMALL FOR DATES BABY,4
RO,SPUTUM PURULENT,4
RO,STILLBIRTH,4
RO,SUPRAVENTRICULAR TACHYCARDIA,4
RO,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,4
RO,TELANGIECTASIA,4
RO,THERAPEUTIC PRODUCT INEFFECTIVE,4
RO,THIRST,4
RO,THYROID DISORDER,4
RO,TONSILLITIS,4
RO,TOOTH EXTRACTION,4
RO,TOOTH INFECTION,4
RO,TOXIC ENCEPHALOPATHY,4
RO,TUBERCULIN TEST POSITIVE,4
RO,TYPE 1 DIABETES MELLITUS,4
RO,UPPER RESPIRATORY TRACT INFECTION,4
RO,URINARY TRACT OBSTRUCTION,4
RO,VARICOSE VEIN,4
RO,VENTRICULAR EXTRASYSTOLES,4
RO,VIRAL INFECTION,4
RO,VITILIGO,4
RO,WHITE BLOOD CELL COUNT DECREASED,4
RO,WOUND INFECTION,4
RO,ABDOMINAL WALL HAEMATOMA,3
RO,ALLODYNIA,3
RO,ANAL ABSCESS,3
RO,ANAL INCONTINENCE,3
RO,ANAL PRURITUS,3
RO,ANGIOPATHY,3
RO,ANKLE FRACTURE,3
RO,ANXIETY DISORDER,3
RO,AORTIC DISSECTION,3
RO,AORTIC VALVE CALCIFICATION,3
RO,APGAR SCORE ABNORMAL,3
RO,ARTERITIS,3
RO,ARTERITIS INFECTIVE,3
RO,ARTHRITIS BACTERIAL,3
RO,ASPIRATION PLEURAL CAVITY,3
RO,ASTERIXIS,3
RO,ATAXIA,3
RO,AUTOIMMUNE HEPATITIS,3
RO,AUTOIMMUNE HYPOTHYROIDISM,3
RO,B-CELL LYMPHOMA,3
RO,BASEDOW^S DISEASE,3
RO,BENIGN PROSTATIC HYPERPLASIA,3
RO,BLINDNESS TRANSIENT,3
RO,BLINDNESS UNILATERAL,3
RO,BLOOD IMMUNOGLOBULIN G INCREASED,3
RO,BLOOD IRON DECREASED,3
RO,BLOOD IRON INCREASED,3
RO,BLOOD PRESSURE SYSTOLIC INCREASED,3
RO,BLOOD PROLACTIN INCREASED,3
RO,BLOOD TESTOSTERONE INCREASED,3
RO,BLOOD THYROID STIMULATING HORMONE INCREASED,3
RO,BODY TEMPERATURE DECREASED,3
RO,BONE DISORDER,3
RO,BRACHYDACTYLY,3
RO,BRADYPNOEA,3
RO,BREAST CANCER METASTATIC,3
RO,BRONCHIECTASIS,3
RO,BRONCHOSPASM PARADOXICAL,3
RO,BUNDLE BRANCH BLOCK LEFT,3
RO,CARDIAC VALVE DISEASE,3
RO,CARDIOMEGALY,3
RO,CAROTID ARTERIOSCLEROSIS,3
RO,CATARACT OPERATION,3
RO,CENTRAL OBESITY,3
RO,CEREBELLAR ATROPHY,3
RO,CEREBRAL HAEMATOMA,3
RO,CEREBRAL INFARCTION,3
RO,CEREBRAL VENTRICLE DILATATION,3
RO,CHRONIC GASTRITIS,3
RO,CHRONIC MYELOID LEUKAEMIA,3
RO,CLOSTRIDIAL INFECTION,3
RO,COAGULATION TIME PROLONGED,3
RO,COARCTATION OF THE AORTA,3
RO,COLON CANCER,3
RO,CONGENITAL ANOMALY,3
RO,CONGENITAL NOSE MALFORMATION,3
RO,COORDINATION ABNORMAL,3
RO,CORONARY ARTERY THROMBOSIS,3
RO,CRYING,3
RO,CYST,3
RO,CYSTITIS HAEMORRHAGIC,3
RO,DEPRESSED MOOD,3
RO,DERMATOMYOSITIS,3
RO,DEVELOPMENTAL DELAY,3
RO,DEVELOPMENTAL GLAUCOMA,3
RO,DIABETIC NEPHROPATHY,3
RO,DIABETIC NEUROPATHY,3
RO,DIASTOLIC DYSFUNCTION,3
RO,DRY THROAT,3
RO,DYSBACTERIOSIS,3
RO,DYSPNOEA AT REST,3
RO,ELECTROCARDIOGRAM CHANGE,3
RO,EMOTIONAL DISORDER,3
RO,ENCEPHALITIS VIRAL,3
RO,ENTEROCOCCAL SEPSIS,3
RO,EOSINOPHILIC OESOPHAGITIS,3
RO,EPIPHYSIOLYSIS,3
RO,EYE PRURITUS,3
RO,FACIAL PARESIS,3
RO,FAECAL INCONTINENCE,3
RO,FEAR,3
RO,FIBRIN D DIMER INCREASED,3
RO,FIBROSIS,3
RO,FRACTURE,3
RO,FRONTOTEMPORAL DEMENTIA,3
RO,FURUNCLE,3
RO,GASTRIC CANCER,3
RO,GASTRIC NEOPLASM,3
RO,GASTRIC VARICES,3
RO,GASTRODUODENITIS,3
RO,GASTROINTESTINAL NECROSIS,3
RO,GENERALISED ANXIETY DISORDER,3
RO,GINGIVITIS,3
RO,GLAUCOMA,3
RO,GONADAL DYSGENESIS,3
RO,HAEMODIALYSIS,3
RO,HAEMORRHAGE IN PREGNANCY,3
RO,HAEMORRHAGE NEONATAL,3
RO,HAEMORRHAGIC PNEUMONIA,3
RO,HAND FRACTURE,3
RO,HEART RATE ABNORMAL,3
RO,HEPATIC HAEMATOMA,3
RO,HEPATITIS B REACTIVATION,3
RO,HERMAPHRODITISM,3
RO,HYDRONEPHROSIS,3
RO,HYPERCAPNIA,3
RO,HYPERCOAGULATION,3
RO,HYPERNATRAEMIA,3
RO,HYPERTENSIVE ENCEPHALOPATHY,3
RO,HYPOAESTHESIA ORAL,3
RO,HYPOGLYCAEMIC COMA,3
RO,HYPOTONIA NEONATAL,3
RO,HYPOVOLAEMIC SHOCK,3
RO,ILEAL STENOSIS,3
RO,ILL-DEFINED DISORDER,3
RO,IMMUNODEFICIENCY,3
RO,IMPAIRED HEALING,3
RO,INDURATION,3
RO,INFANTILE APNOEA,3
RO,INFARCTION,3
RO,INJECTION SITE PRURITUS,3
RO,INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT,3
RO,INTENTIONAL SELF-INJURY,3
RO,INTERNAL HAEMORRHAGE,3
RO,INTERNATIONAL NORMALISED RATIO DECREASED,3
RO,INTESTINAL ISCHAEMIA,3
RO,INTRA-ABDOMINAL FLUID COLLECTION,3
RO,INVASIVE BREAST CARCINOMA,3
RO,JOINT DISLOCATION,3
RO,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
RO,LACUNAR INFARCTION,3
RO,LARGE INTESTINE PERFORATION,3
RO,LARGE INTESTINE POLYP,3
RO,LEFT VENTRICULAR HYPERTROPHY,3
RO,LIMB INJURY,3
RO,LIVEDO RETICULARIS,3
RU,DRUG INEFFECTIVE,526
RU,DYSPNOEA,357
RU,NAUSEA,296
RU,ASTHENIA,295
RU,DEATH,291
RU,MYOCARDIAL INFARCTION,279
RU,PNEUMONIA,272
RU,BLOOD PRESSURE INCREASED,255
RU,PYREXIA,228
RU,VOMITING,215
RU,DIZZINESS,212
RU,HEADACHE,208
RU,CHEST PAIN,191
RU,DIARRHOEA,188
RU,ANAEMIA,183
RU,PRODUCT USE ISSUE,183
RU,DISEASE PROGRESSION,174
RU,SEPSIS,173
RU,RASH,171
RU,THROMBOCYTOPENIA,165
RU,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,149
RU,NEUTROPENIA,145
RU,LOSS OF CONSCIOUSNESS,142
RU,ANGINA PECTORIS,141
RU,ATRIAL FIBRILLATION,141
RU,PRURITUS,132
RU,CONTUSION,124
RU,BLOOD PRESSURE DECREASED,121
RU,VASCULAR STENT THROMBOSIS,119
RU,COUGH,118
RU,FOETAL EXPOSURE DURING PREGNANCY,115
RU,CONDITION AGGRAVATED,113
RU,TACHYCARDIA,112
RU,LEUKOPENIA,110
RU,BLOOD GLUCOSE INCREASED,109
RU,FATIGUE,109
RU,CEREBROVASCULAR ACCIDENT,107
RU,HYPERTENSION,107
RU,URTICARIA,106
RU,BODY TEMPERATURE INCREASED,105
RU,PULMONARY EMBOLISM,105
RU,FALL,102
RU,SEIZURE,101
RU,WEIGHT DECREASED,101
RU,EPILEPSY,100
RU,PRODUCT USE IN UNAPPROVED INDICATION,99
RU,ANGIOEDEMA,97
RU,ALANINE AMINOTRANSFERASE INCREASED,90
RU,EXPOSURE DURING PREGNANCY,88
RU,HYPERSENSITIVITY,86
RU,ABDOMINAL PAIN,85
RU,HAEMORRHAGE,85
RU,ERYTHEMA,84
RU,HAEMOGLOBIN DECREASED,84
RU,ISCHAEMIC STROKE,84
RU,CARDIAC FAILURE,82
RU,PULMONARY OEDEMA,82
RU,EPISTAXIS,81
RU,HYPOTENSION,81
RU,RESPIRATORY FAILURE,81
RU,MALAISE,80
RU,ASPARTATE AMINOTRANSFERASE INCREASED,79
RU,CHILLS,79
RU,WEIGHT INCREASED,79
RU,ARTHRALGIA,78
RU,ANGINA UNSTABLE,77
RU,PAIN,77
RU,ARRHYTHMIA,74
RU,PRODUCT QUALITY ISSUE,72
RU,DEEP VEIN THROMBOSIS,71
RU,OEDEMA PERIPHERAL,71
RU,SUSPECTED COUNTERFEIT PRODUCT,71
RU,ASPHYXIA,70
RU,INTENTIONAL PRODUCT MISUSE,68
RU,MATERNAL EXPOSURE DURING PREGNANCY,68
RU,HYPERTENSIVE CRISIS,67
RU,POST PROCEDURAL COMPLICATION,67
RU,THROMBOSIS,67
RU,HYPERGLYCAEMIA,66
RU,DECREASED APPETITE,65
RU,GENERAL PHYSICAL HEALTH DETERIORATION,65
RU,METRORRHAGIA,65
RU,OEDEMA,64
RU,ABDOMINAL PAIN UPPER,62
RU,BACK PAIN,62
RU,MALIGNANT NEOPLASM PROGRESSION,62
RU,PAIN IN EXTREMITY,61
RU,GASTRITIS EROSIVE,60
RU,PREMATURE BABY,60
RU,TOXICITY TO VARIOUS AGENTS,60
RU,BRAIN OEDEMA,59
RU,ACUTE MYOCARDIAL INFARCTION,58
RU,DRUG DOSE OMISSION,57
RU,INSOMNIA,57
RU,ASTHMA,56
RU,VASCULAR STENT OCCLUSION,55
RU,MYALGIA,53
RU,THROMBOSIS IN DEVICE,53
RU,BRADYCARDIA,52
RU,CARDIAC FAILURE ACUTE,52
RU,HYPERHIDROSIS,52
RU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,52
RU,PANCREATITIS,52
RU,UPPER LIMB FRACTURE,52
RU,CARDIAC ARREST,51
RU,DEPRESSION,51
RU,LOWER LIMB FRACTURE,51
RU,TUBERCULOSIS,51
RU,BLOOD BILIRUBIN INCREASED,50
RU,HAND FRACTURE,50
RU,ALTERED STATE OF CONSCIOUSNESS,49
RU,BRONCHOSPASM,49
RU,SEPTIC SHOCK,49
RU,HYPOAESTHESIA,48
RU,ACUTE KIDNEY INJURY,47
RU,PANCYTOPENIA,47
RU,TREMOR,47
RU,COMA,46
RU,GASTROINTESTINAL HAEMORRHAGE,46
RU,SYNCOPE,46
RU,ALOPECIA,45
RU,BLOOD CREATININE INCREASED,45
RU,CONVULSION,45
RU,FEBRILE NEUTROPENIA,45
RU,GASTRIC ULCER,45
RU,TUBULOINTERSTITIAL NEPHRITIS,44
RU,OVERDOSE,43
RU,ABDOMINAL PAIN LOWER,42
RU,FACE OEDEMA,42
RU,STAPHYLOCOCCAL INFECTION,42
RU,ABORTION SPONTANEOUS,41
RU,ASCITES,41
RU,EPSTEIN-BARR VIRUS INFECTION,41
RU,HEPATITIS TOXIC,41
RU,PULMONARY TUBERCULOSIS,41
RU,RIB FRACTURE,41
RU,SOMNOLENCE,41
RU,VISUAL IMPAIRMENT,41
RU,ANAPHYLACTIC SHOCK,40
RU,LYMPHADENOPATHY,40
RU,CARDIOGENIC SHOCK,39
RU,HYPERAEMIA,39
RU,INFUSION RELATED REACTION,39
RU,SPINAL FRACTURE,38
RU,DISEASE RECURRENCE,37
RU,HAEMATURIA,37
RU,RENAL FAILURE,37
RU,URINARY RETENTION,37
RU,OSTEOCHONDROSIS,36
RU,TRANSIENT ISCHAEMIC ATTACK,36
RU,VISUAL ACUITY REDUCED,36
RU,DYSPEPSIA,35
RU,FEELING ABNORMAL,35
RU,POISONING,35
RU,ANXIETY,34
RU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,34
RU,DEPRESSED LEVEL OF CONSCIOUSNESS,34
RU,HYPERTHERMIA,34
RU,JAUNDICE,34
RU,MUCOSAL INFLAMMATION,34
RU,PALPITATIONS,34
RU,RESPIRATORY TRACT INFECTION,34
RU,CYTOMEGALOVIRUS INFECTION,33
RU,DERMATITIS ALLERGIC,33
RU,HAEMORRHAGIC TRANSFORMATION STROKE,33
RU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,33
RU,INFECTION,33
RU,NASOPHARYNGITIS,33
RU,CYANOSIS,32
RU,DYSPNOEA EXERTIONAL,32
RU,HYDROTHORAX,32
RU,BONE PAIN,31
RU,GAIT DISTURBANCE,31
RU,MUSCULAR WEAKNESS,31
RU,RESPIRATORY TRACT INFECTION VIRAL,31
RU,UTERINE LEIOMYOMA,31
RU,HEPATIC ENZYME INCREASED,30
RU,IRRITABILITY,30
RU,LIPODYSTROPHY ACQUIRED,30
RU,TRANSAMINASES INCREASED,30
RU,UTERINE HAEMORRHAGE,30
RU,VAGINAL HAEMORRHAGE,30
RU,CARDIAC DISORDER,29
RU,GASTRIC HAEMORRHAGE,29
RU,HEART RATE INCREASED,29
RU,HEPATOMEGALY,29
RU,MYOCARDIAL ISCHAEMIA,29
RU,PLEURISY,29
RU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,29
RU,SLEEP DISORDER,29
RU,ACUTE CORONARY SYNDROME,28
RU,DRUG-INDUCED LIVER INJURY,28
RU,DUODENAL ULCER,28
RU,HAEMORRHAGIC STROKE,28
RU,HYPOGLYCAEMIA,28
RU,INFLUENZA LIKE ILLNESS,28
RU,LEUKOCYTOSIS,28
RU,MULTI-ORGAN FAILURE,28
RU,CARDIAC FAILURE CHRONIC,27
RU,DYSGEUSIA,27
RU,GASTRITIS,27
RU,HEPATOTOXICITY,27
RU,OROPHARYNGEAL PAIN,27
RU,OVARIAN CYST,27
RU,PERITONITIS,27
RU,PYELONEPHRITIS,27
RU,RESPIRATORY DISORDER,27
RU,TINNITUS,27
RU,ABNORMAL WITHDRAWAL BLEEDING,26
RU,BLOOD CHOLESTEROL INCREASED,26
RU,BRONCHITIS,26
RU,CARDIOPULMONARY FAILURE,26
RU,FRACTURE,26
RU,GINGIVAL BLEEDING,26
RU,PANCREATITIS CHRONIC,26
RU,POLLAKIURIA,26
RU,STOMATITIS,26
RU,CARDIOVASCULAR INSUFFICIENCY,25
RU,CORONARY ARTERY OCCLUSION,25
RU,DISSEMINATED INTRAVASCULAR COAGULATION,25
RU,ELECTROCARDIOGRAM QT PROLONGED,25
RU,GENITAL HAEMORRHAGE,25
RU,HAEMATOMA,25
RU,HEPATIC PAIN,25
RU,KETOACIDOSIS,25
RU,LIVE BIRTH,25
RU,PALLOR,25
RU,PLATELET COUNT DECREASED,25
RU,PRODUCT COUNTERFEIT,25
RU,TOXIC SKIN ERUPTION,25
RU,ABDOMINAL DISCOMFORT,24
RU,ACUTE RESPIRATORY FAILURE,24
RU,CANDIDA INFECTION,24
RU,CONSTIPATION,24
RU,HERPES VIRUS INFECTION,24
RU,LYMPHOPENIA,24
RU,MUSCLE SPASMS,24
RU,POLYNEUROPATHY,24
RU,ABDOMINAL DISTENSION,23
RU,ADVERSE EVENT,23
RU,APPENDICITIS,23
RU,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,23
RU,PULMONARY ARTERIAL HYPERTENSION,23
RU,AGGRESSION,22
RU,CALCULUS URINARY,22
RU,CORONARY ARTERY DISEASE,22
RU,CORONARY ARTERY STENOSIS,22
RU,DRUG RESISTANCE,22
RU,ENCEPHALOPATHY,22
RU,ESCHERICHIA INFECTION,22
RU,HALLUCINATION,22
RU,HEPATITIS C,22
RU,HYPOTONIA,22
RU,METASTASES TO LIVER,22
RU,PLEURAL EFFUSION,22
RU,PREMATURE DELIVERY,22
RU,PROTEINURIA,22
RU,SKIN TOXICITY,22
RU,TYPE 2 DIABETES MELLITUS,22
RU,ABORTION INDUCED,21
RU,CHEST DISCOMFORT,21
RU,CIRCULATORY COLLAPSE,21
RU,CONFUSIONAL STATE,21
RU,CUSHING^S SYNDROME,21
RU,DIABETES MELLITUS,21
RU,FOETAL GROWTH RESTRICTION,21
RU,FOOT FRACTURE,21
RU,KETONURIA,21
RU,MEMORY IMPAIRMENT,21
RU,PARAESTHESIA,21
RU,PULMONARY HAEMORRHAGE,21
RU,SKIN EXFOLIATION,21
RU,SPEECH DISORDER,21
RU,URINARY TRACT INFECTION,21
RU,BLINDNESS,20
RU,BLOOD PRESSURE FLUCTUATION,20
RU,BLOOD UREA INCREASED,20
RU,CATARACT,20
RU,COLITIS ULCERATIVE,20
RU,CORONARY ARTERY THROMBOSIS,20
RU,CYTOPENIA,20
RU,DEVICE OCCLUSION,20
RU,HAEMATOCHEZIA,20
RU,HAEMOPTYSIS,20
RU,HAEMORRHAGIC DISORDER,20
RU,HEPATIC FAILURE,20
RU,HERPES ZOSTER,20
RU,LUNG NEOPLASM MALIGNANT,20
RU,MENSTRUAL DISORDER,20
RU,UVEITIS,20
RU,AMENORRHOEA,19
RU,ANKLE FRACTURE,19
RU,CHOKING,19
RU,CHOLELITHIASIS,19
RU,CYSTITIS,19
RU,GASTROINTESTINAL DISORDER,19
RU,HEART RATE DECREASED,19
RU,INTESTINAL HAEMORRHAGE,19
RU,LIVER DISORDER,19
RU,PRODUCT PRESCRIBING ISSUE,19
RU,BACTERIAL INFECTION,18
RU,CAESAREAN SECTION,18
RU,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,18
RU,HEMIPARESIS,18
RU,HOSPITALISATION,18
RU,HYDROCEPHALUS,18
RU,INCORRECT DOSE ADMINISTERED,18
RU,MYOCARDIAL RUPTURE,18
RU,NERVOUS SYSTEM DISORDER,18
RU,OSTEONECROSIS,18
RU,PREGNANCY ON ORAL CONTRACEPTIVE,18
RU,RADIUS FRACTURE,18
RU,AGRANULOCYTOSIS,17
RU,APNOEA,17
RU,DIABETIC METABOLIC DECOMPENSATION,17
RU,DISORIENTATION,17
RU,DRUG INTOLERANCE,17
RU,EMBOLISM,17
RU,FRACTURE DISPLACEMENT,17
RU,GASTROENTERITIS,17
RU,MENTAL DISORDER,17
RU,SPINAL COMPRESSION FRACTURE,17
RU,STRESS,17
RU,SUICIDE ATTEMPT,17
RU,APALLIC SYNDROME,16
RU,CARDIOTOXICITY,16
RU,FOETAL DEATH,16
RU,IRON DEFICIENCY ANAEMIA,16
RU,LIBIDO DECREASED,16
RU,NEPHROLITHIASIS,16
RU,OCULAR HYPERAEMIA,16
RU,OSTEOPOROSIS,16
RU,PANCREATIC DISORDER,16
RU,PERICARDIAL EFFUSION,16
RU,PERICARDITIS,16
RU,PULMONARY HYPERTENSION,16
RU,RESPIRATORY ARREST,16
RU,SINUSITIS,16
RU,SKIN DISCOLOURATION,16
RU,VENTRICULAR FIBRILLATION,16
RU,APHASIA,15
RU,BLOOD ALKALINE PHOSPHATASE INCREASED,15
RU,BREAST CANCER RECURRENT,15
RU,BURNING SENSATION,15
RU,CARDIAC FAILURE CONGESTIVE,15
RU,CHRONIC KIDNEY DISEASE,15
RU,COMPLETED SUICIDE,15
RU,DRUG ABUSE,15
RU,DRUG HYPERSENSITIVITY,15
RU,DRY MOUTH,15
RU,DYSPHONIA,15
RU,GASTRIC CANCER,15
RU,HUMAN HERPESVIRUS 6 INFECTION,15
RU,MELAENA,15
RU,METASTASES TO CENTRAL NERVOUS SYSTEM,15
RU,NEOPLASM PROGRESSION,15
RU,OSTEOARTHRITIS,15
RU,PERIPHERAL SWELLING,15
RU,RHINORRHOEA,15
RU,SCHIZOPHRENIA,15
RU,SUDDEN DEATH,15
RU,SWELLING FACE,15
RU,THERAPEUTIC RESPONSE UNEXPECTED,15
RU,UNINTENDED PREGNANCY,15
RU,WHITE BLOOD CELL COUNT DECREASED,15
RU,ABORTION THREATENED,14
RU,ACNE,14
RU,ARTHRITIS,14
RU,AUTONOMIC NERVOUS SYSTEM IMBALANCE,14
RU,BLOOD PRESSURE ABNORMAL,14
RU,BREAST CANCER,14
RU,BRONCHOPULMONARY ASPERGILLOSIS,14
RU,CELLULITIS,14
RU,CHOLECYSTITIS,14
RU,CHROMATURIA,14
RU,CORONARY ARTERY RESTENOSIS,14
RU,DEPRESSED MOOD,14
RU,DRUG DEPENDENCE,14
RU,DRY SKIN,14
RU,EYE PAIN,14
RU,GANGRENE,14
RU,GENERALISED TONIC-CLONIC SEIZURE,14
RU,HAEMATEMESIS,14
RU,ILL-DEFINED DISORDER,14
RU,MENORRHAGIA,14
RU,METASTASES TO LUNG,14
RU,OBESITY,14
RU,PNEUMOTHORAX,14
RU,PULMONARY FIBROSIS,14
RU,RECTAL HAEMORRHAGE,14
RU,SPLENOMEGALY,14
RU,SUICIDAL IDEATION,14
RU,THROAT IRRITATION,14
RU,THROMBOPHLEBITIS,14
RU,TRANSPLANT REJECTION,14
RU,WRIST FRACTURE,14
RU,AGITATION,13
RU,APATHY,13
RU,ARTERIOSCLEROSIS,13
RU,CARDIOMYOPATHY,13
RU,CARDIOVASCULAR DISORDER,13
RU,CHOLESTASIS,13
RU,DERMATITIS,13
RU,DIABETIC KETOACIDOSIS,13
RU,FAECES DISCOLOURED,13
RU,HAEMATOTOXICITY,13
RU,HEPATIC CIRRHOSIS,13
RU,HEPATITIS,13
RU,HIP FRACTURE,13
RU,HYPERBILIRUBINAEMIA,13
RU,INJURY,13
RU,INTENTIONAL OVERDOSE,13
RU,INTENTIONAL PRODUCT USE ISSUE,13
RU,INTERVERTEBRAL DISC PROTRUSION,13
RU,JOINT DISLOCATION,13
RU,LARYNGEAL OEDEMA,13
RU,MALIGNANT MELANOMA,13
RU,MOOD ALTERED,13
RU,MOVEMENT DISORDER,13
RU,MUSCULOSKELETAL PAIN,13
RU,NERVOUSNESS,13
RU,PANCREATITIS ACUTE,13
RU,PANIC ATTACK,13
RU,PNEUMOCYSTIS JIROVECII PNEUMONIA,13
RU,PNEUMONITIS,13
RU,PREGNANCY WITH CONTRACEPTIVE DEVICE,13
RU,RALES,13
RU,RENAL PAIN,13
RU,SALPINGO-OOPHORITIS,13
RU,THERAPEUTIC RESPONSE DECREASED,13
RU,VASCULAR STENT STENOSIS,13
RU,ABNORMAL BEHAVIOUR,12
RU,ABORTION MISSED,12
RU,ANAPHYLACTIC REACTION,12
RU,ATRIAL THROMBOSIS,12
RU,CEREBROVASCULAR DISORDER,12
RU,COGNITIVE DISORDER,12
RU,DEAFNESS,12
RU,DEHYDRATION,12
RU,DYSPHAGIA,12
RU,ECZEMA,12
RU,EJECTION FRACTION DECREASED,12
RU,FEMORAL NECK FRACTURE,12
RU,FLATULENCE,12
RU,GLAUCOMA,12
RU,HAEMORRHAGIC ANAEMIA,12
RU,HISTIOCYTOSIS HAEMATOPHAGIC,12
RU,HUMERUS FRACTURE,12
RU,HYPOAESTHESIA ORAL,12
RU,IMPAIRED HEALING,12
RU,LUNG INFECTION,12
RU,MULTIPLE SCLEROSIS RELAPSE,12
RU,NASAL CONGESTION,12
RU,NECK PAIN,12
RU,PREMATURE SEPARATION OF PLACENTA,12
RU,PROCTITIS,12
RU,PSORIASIS,12
RU,PYELONEPHRITIS CHRONIC,12
RU,RENAL COLIC,12
RU,RENAL DISORDER,12
RU,ROAD TRAFFIC ACCIDENT,12
RU,SHOCK,12
RU,STEVENS-JOHNSON SYNDROME,12
RU,SWELLING,12
RU,TONGUE OEDEMA,12
RU,UPPER RESPIRATORY TRACT INFECTION,12
RU,UTERINE POLYP,12
RU,VENTRICULAR TACHYCARDIA,12
RU,VIRAL INFECTION,12
RU,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,12
RU,BRAIN INJURY,11
RU,BREAST CANCER FEMALE,11
RU,BREAST PAIN,11
RU,CACHEXIA,11
RU,CEREBRAL HAEMORRHAGE,11
RU,CEREBRAL ISCHAEMIA,11
RU,CHOLECYSTITIS CHRONIC,11
RU,COLITIS,11
RU,CONJUNCTIVITIS,11
RU,CROHN^S DISEASE,11
RU,DUODENITIS,11
RU,ENTEROCOLITIS,11
RU,EXTRASYSTOLES,11
RU,FEELING HOT,11
RU,GASTROOESOPHAGEAL REFLUX DISEASE,11
RU,GOUT,11
RU,HAEMORRHOIDS,11
RU,HYPERTHYROIDISM,11
RU,IMMUNODEFICIENCY,11
RU,INCREASED APPETITE,11
RU,INFLAMMATION,11
RU,INTESTINAL OBSTRUCTION,11
RU,LACRIMATION INCREASED,11
RU,LARYNGOSPASM,11
RU,LIP OEDEMA,11
RU,LOW BIRTH WEIGHT BABY,11
RU,LUNG DISORDER,11
RU,METASTASIS,11
RU,MYOPATHY,11
RU,NEOPLASM MALIGNANT,11
RU,PSYCHOTIC DISORDER,11
RU,PURPURA,11
RU,SKIN DISORDER,11
RU,TACHYARRHYTHMIA,11
RU,TRAUMATIC HAEMORRHAGE,11
RU,VASCULAR OCCLUSION,11
RU,VENTRICULAR EXTRASYSTOLES,11
RU,VERTIGO,11
RU,WITHDRAWAL SYNDROME,11
RU,ABNORMAL DREAMS,10
RU,ARTERIOSCLEROSIS CORONARY ARTERY,10
RU,BONE MARROW FAILURE,10
RU,CHRONIC GASTRITIS,10
RU,CHRONIC MYELOID LEUKAEMIA,10
RU,COAGULOPATHY,10
RU,CRANIOCEREBRAL INJURY,10
RU,DIPLOPIA,10
RU,DISCOMFORT,10
RU,DRUG ADMINISTRATION ERROR,10
RU,DYSARTHRIA,10
RU,ERYSIPELAS,10
RU,GALLBLADDER DISORDER,10
RU,GENERALISED OEDEMA,10
RU,HEPATOCELLULAR CARCINOMA,10
RU,INCORRECT DRUG ADMINISTRATION DURATION,10
RU,INCORRECT ROUTE OF DRUG ADMINISTRATION,10
RU,INFLUENZA,10
RU,LYMPHOCYTE COUNT DECREASED,10
RU,MATERNAL EXPOSURE BEFORE PREGNANCY,10
RU,NEPHROTIC SYNDROME,10
RU,NEUROTOXICITY,10
RU,OESOPHAGEAL VARICES HAEMORRHAGE,10
RU,OSTEONECROSIS OF JAW,10
RU,OVARIAN RUPTURE,10
RU,PARONYCHIA,10
RU,PERIPHERAL ARTERY THROMBOSIS,10
RU,PLASMA CELL MYELOMA,10
RU,PREGNANCY,10
RU,PROSTATE CANCER,10
RU,PRURITUS GENITAL,10
RU,PSEUDOMEMBRANOUS COLITIS,10
RU,PULMONARY INFARCTION,10
RU,PYELONEPHRITIS ACUTE,10
RU,RASH PAPULAR,10
RU,RED BLOOD CELL COUNT DECREASED,10
RU,RENAL IMPAIRMENT,10
RU,RHEUMATOID ARTHRITIS,10
RU,THORACIC VERTEBRAL FRACTURE,10
RU,THROMBOCYTOSIS,10
RU,UNDERDOSE,10
RU,UNEVALUABLE EVENT,10
RU,VENA CAVA THROMBOSIS,10
RU,ABORTION,9
RU,AMNESIA,9
RU,ANAPHYLACTOID REACTION,9
RU,APLASTIC ANAEMIA,9
RU,AUTOIMMUNE THYROIDITIS,9
RU,BLADDER CANCER,9
RU,BLOOD THYROID STIMULATING HORMONE INCREASED,9
RU,BRONCHITIS CHRONIC,9
RU,COLD SWEAT,9
RU,COLON CANCER,9
RU,CONCOMITANT DISEASE AGGRAVATED,9
RU,DISSEMINATED TUBERCULOSIS,9
RU,ENDOMETRIOSIS,9
RU,EYE OEDEMA,9
RU,EYELID OEDEMA,9
RU,FEELING COLD,9
RU,FUNGAL INFECTION,9
RU,GROWTH RETARDATION,9
RU,HEPATIC FUNCTION ABNORMAL,9
RU,HERPES SIMPLEX,9
RU,HOT FLUSH,9
RU,HYPOKALAEMIA,9
RU,HYPOPROTEINAEMIA,9
RU,HYPOXIA,9
RU,INJECTION SITE ERYTHEMA,9
RU,JUVENILE IDIOPATHIC ARTHRITIS,9
RU,LABORATORY TEST ABNORMAL,9
RU,LARGE FOR DATES BABY,9
RU,LIMB DISCOMFORT,9
RU,LOCALISED OEDEMA,9
RU,MENTAL RETARDATION,9
RU,MICTURITION URGENCY,9
RU,MUSCULOSKELETAL STIFFNESS,9
RU,NEOPLASM,9
RU,NEUTROPHIL COUNT DECREASED,9
RU,PARAINFLUENZAE VIRUS INFECTION,9
RU,PHARYNGEAL OEDEMA,9
RU,PRESCRIBED UNDERDOSE,9
RU,PSEUDOMONAS INFECTION,9
RU,RASH GENERALISED,9
RU,RASH PRURITIC,9
RU,RENAL CANCER,9
RU,SKIN ULCER,9
RU,STATUS EPILEPTICUS,9
RU,TEARFULNESS,9
RU,THIRST,9
RU,TONSILLITIS,9
RU,TOXIC ENCEPHALOPATHY,9
RU,TOXIC SHOCK SYNDROME,9
RU,URINARY INCONTINENCE,9
RU,UTERINE ENLARGEMENT,9
RU,VARICELLA,9
RU,VARICOSE VEIN,9
RU,VASCULITIS,9
RU,VENOUS THROMBOSIS,9
RU,YELLOW SKIN,9
RU,ACUTE LYMPHOCYTIC LEUKAEMIA,8
RU,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,8
RU,ACUTE RESPIRATORY DISTRESS SYNDROME,8
RU,AFFECT LABILITY,8
RU,AMYLASE INCREASED,8
RU,ANURIA,8
RU,AORTIC ARTERIOSCLEROSIS,8
RU,ATRIAL FLUTTER,8
RU,BILIRUBIN CONJUGATED INCREASED,8
RU,BRONCHOPNEUMONIA,8
RU,CD4 LYMPHOCYTES DECREASED,8
RU,CEREBRAL HAEMATOMA,8
RU,CHRONIC TONSILLITIS,8
RU,DEVICE EXPULSION,8
RU,DYSURIA,8
RU,EMBOLIC STROKE,8
RU,ENCEPHALITIS,8
RU,ENDOMETRIAL HYPERPLASIA,8
RU,EROSIVE OESOPHAGITIS,8
RU,EUPHORIC MOOD,8
RU,EYE DISORDER,8
RU,FEAR,8
RU,FEMUR FRACTURE,8
RU,FURUNCLE,8
RU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,8
RU,GASTRIC POLYPS,8
RU,GASTRODUODENITIS,8
RU,GRAFT VERSUS HOST DISEASE,8
RU,HAEMORRHAGE SUBCUTANEOUS,8
RU,HAEMORRHOIDAL HAEMORRHAGE,8
RU,HEPATIC ENCEPHALOPATHY,8
RU,HYPERCHOLESTEROLAEMIA,8
RU,HYPERCOAGULATION,8
RU,HYPERTHERMIA MALIGNANT,8
RU,HYPERTRICHOSIS,8
RU,HYPONATRAEMIA,8
RU,INJECTION SITE PAIN,8
RU,INTERNATIONAL NORMALISED RATIO INCREASED,8
RU,LEG AMPUTATION,8
RU,LETHARGY,8
RU,MENINGITIS,8
RU,MITRAL VALVE INCOMPETENCE,8
RU,NEONATAL ASPHYXIA,8
RU,NEONATAL HYPOXIA,8
RU,NEONATAL RESPIRATORY DISTRESS SYNDROME,8
RU,NEPHRITIS,8
RU,NEPHROPATHY,8
RU,NEPHROPATHY TOXIC,8
RU,OSTEOMYELITIS,8
RU,OVARIAN CANCER,8
RU,PHARYNGITIS,8
RU,PHLEBITIS,8
RU,PORTAL HYPERTENSION,8
RU,PRESYNCOPE,8
RU,PRODUCTIVE COUGH,8
RU,PSYCHOMOTOR HYPERACTIVITY,8
RU,RESPIRATORY DISTRESS,8
RU,RHINITIS,8
RU,SECOND PRIMARY MALIGNANCY,8
RU,SKIN BURNING SENSATION,8
RU,SURGERY,8
RU,TRANSFUSION,8
RU,ACUTE PSYCHOSIS,7
RU,ALVEOLITIS ALLERGIC,7
RU,ATRIOVENTRICULAR BLOCK COMPLETE,7
RU,AUTOIMMUNE HAEMOLYTIC ANAEMIA,7
RU,AZOTAEMIA,7
RU,BLOOD GLUCOSE DECREASED,7
RU,BLOOD LACTATE DEHYDROGENASE INCREASED,7
RU,BRAIN HERNIATION,7
RU,BUNDLE BRANCH BLOCK LEFT,7
RU,CENTRAL NERVOUS SYSTEM LESION,7
RU,CEREBRAL INFARCTION,7
RU,CHOLECYSTITIS ACUTE,7
RU,CONGENITAL ANOMALY,7
RU,CONGESTIVE CARDIOMYOPATHY,7
RU,DRUG EFFECT DECREASED,7
RU,DRUG LEVEL INCREASED,7
RU,DRUG TOLERANCE DECREASED,7
RU,DYSLIPIDAEMIA,7
RU,DYSTONIA,7
RU,ELECTROCARDIOGRAM ABNORMAL,7
RU,ENTEROCOCCAL INFECTION,7
RU,ESCHERICHIA BACTERAEMIA,7
RU,EYE IRRITATION,7
RU,FEELING DRUNK,7
RU,FLUID RETENTION,7
RU,GASTRIC DISORDER,7
RU,GOITRE,7
RU,HEAD DISCOMFORT,7
RU,HEPATITIS B,7
RU,HORMONE LEVEL ABNORMAL,7
RU,HYPOTHYROIDISM,7
RU,INTRACRANIAL PRESSURE INCREASED,7
RU,JOINT SWELLING,7
RU,LEFT VENTRICULAR HYPERTROPHY,7
RU,LIVER INJURY,7
RU,LYMPHOCYTOSIS,7
RU,MEDICATION ERROR,7
RU,MENTAL IMPAIRMENT,7
RU,MORAXELLA INFECTION,7
RU,MOUTH ULCERATION,7
RU,NEUROPATHY PERIPHERAL,7
RU,NIGHTMARE,7
RU,NORMAL NEWBORN,7
RU,OPTIC ATROPHY,7
RU,OVARIAN HYPERSTIMULATION SYNDROME,7
RU,PARTIAL SEIZURES,7
RU,PERICARDIAL HAEMORRHAGE,7
RU,PERIPHERAL COLDNESS,7
RU,PREMATURE LABOUR,7
RU,PROSTATOMEGALY,7
RU,RASH ERYTHEMATOUS,7
RU,RENAL FAILURE ACUTE,7
RU,RETINAL DETACHMENT,7
RU,RETINAL PIGMENTATION,7
RU,SALIVARY HYPERSECRETION,7
RU,SHOCK HAEMORRHAGIC,7
RU,SPINAL PAIN,7
RU,SUBARACHNOID HAEMORRHAGE,7
RU,TRICUSPID VALVE INCOMPETENCE,7
RU,ULCER HAEMORRHAGE,7
RU,VASCULAR ENCEPHALOPATHY,7
RU,VASCULAR PSEUDOANEURYSM,7
RU,VASCULAR STENT RESTENOSIS,7
RU,VENOUS THROMBOSIS LIMB,7
RU,VIRAL LOAD INCREASED,7
RU,VITREOUS HAEMORRHAGE,7
RU,WRONG TECHNIQUE IN DRUG USAGE PROCESS,7
RU,ACUTE GRAFT VERSUS HOST DISEASE,6
RU,ADENOCARCINOMA GASTRIC,6
RU,ADENOMYOSIS,6
RU,ANGIOPATHY,6
RU,ANTIPHOSPHOLIPID SYNDROME,6
RU,APHONIA,6
RU,APPARENT DEATH,6
RU,ARTHROPATHY,6
RU,ATRIOVENTRICULAR BLOCK,6
RU,BASAL CELL CARCINOMA,6
RU,BLINDNESS UNILATERAL,6
RU,BLISTER,6
RU,BLOOD CALCIUM DECREASED,6
RU,BLOOD PRESSURE SYSTOLIC INCREASED,6
RU,BONE DISORDER,6
RU,BRONCHIAL OBSTRUCTION,6
RU,BRONCHOPULMONARY DYSPLASIA,6
RU,C-REACTIVE PROTEIN INCREASED,6
RU,CARDIAC ANEURYSM,6
RU,CERVICAL DYSPLASIA,6
RU,CHORIORETINOPATHY,6
RU,CLAVICLE FRACTURE,6
RU,CONCOMITANT DISEASE PROGRESSION,6
RU,CONTRAINDICATED PRODUCT ADMINISTERED,6
RU,CYST,6
RU,CYSTITIS HAEMORRHAGIC,6
RU,DAYDREAMING,6
RU,DELIRIUM,6
RU,DERMATITIS ATOPIC,6
RU,DEVICE DISLOCATION,6
RU,DIFFUSE LARGE B-CELL LYMPHOMA,6
RU,ECCHYMOSIS,6
RU,ECTOPIC PREGNANCY,6
RU,EMPHYSEMA,6
RU,ENURESIS,6
RU,EOSINOPHILIA,6
RU,FAT TISSUE INCREASED,6
RU,FLUSHING,6
RU,GESTATIONAL DIABETES,6
RU,GLYCOSYLATED HAEMOGLOBIN INCREASED,6
RU,HAEMOGLOBIN INCREASED,6
RU,HAEMOLYSIS,6
RU,HYPERKERATOSIS,6
RU,HYPOKINESIA,6
RU,HYPOTHERMIA,6
RU,INJECTION SITE PRURITUS,6
RU,INJECTION SITE REACTION,6
RU,JAUNDICE CHOLESTATIC,6
RU,JAUNDICE NEONATAL,6
RU,KAPOSI^S SARCOMA,6
RU,KIDNEY TRANSPLANT REJECTION,6
RU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,6
RU,LIP SWELLING,6
RU,LIVER FUNCTION TEST INCREASED,6
RU,LUNG INFILTRATION,6
RU,LUPUS-LIKE SYNDROME,6
RU,LYMPHADENITIS,6
RU,LYMPHOCYTE COUNT INCREASED,6
RU,METASTASES TO BONE,6
RU,MOBILITY DECREASED,6
RU,MUSCULOSKELETAL DISCOMFORT,6
RU,NEONATAL PNEUMONIA,6
RU,NEUROLOGICAL SYMPTOM,6
RU,NO THERAPEUTIC RESPONSE,6
RU,OCULAR ICTERUS,6
RU,ORAL CANDIDIASIS,6
RU,PANCREATIC CARCINOMA,6
RU,PELVIC VENOUS THROMBOSIS,6
RU,PNEUMONIA BACTERIAL,6
RU,POLYURIA,6
RU,PREGNANCY ON CONTRACEPTIVE,6
RU,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,6
RU,PRURITUS GENERALISED,6
RU,RASH MACULO-PAPULAR,6
RU,RECTAL CANCER,6
RU,RENAL CELL CARCINOMA,6
RU,RENAL CYST,6
RU,RETINAL HAEMORRHAGE,6
RU,SENSATION OF FOREIGN BODY,6
RU,SINUS ARREST,6
RU,SKIN REACTION,6
RU,SLUGGISHNESS,6
RU,SOPOR,6
RU,THERAPY CESSATION,6
RU,THROMBOPHLEBITIS SUPERFICIAL,6
RU,TREATMENT NONCOMPLIANCE,6
RU,TYPE 1 DIABETES MELLITUS,6
RU,VENTRICULAR ARRHYTHMIA,6
RU,VIRAL UPPER RESPIRATORY TRACT INFECTION,6
RU,VISION BLURRED,6
RU,ABSCESS,5
RU,ACCIDENT,5
RU,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,5
RU,ACTIVITIES OF DAILY LIVING IMPAIRED,5
RU,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,5
RU,ACUTE MYELOID LEUKAEMIA,5
RU,ADRENAL INSUFFICIENCY,5
RU,ALLERGIC OEDEMA,5
RU,ALVEOLITIS,5
RU,AMYLOIDOSIS,5
RU,ANKYLOSING SPONDYLITIS,5
RU,AORTIC VALVE INCOMPETENCE,5
RU,ATAXIA,5
RU,ATRIOVENTRICULAR BLOCK SECOND DEGREE,5
RU,BASEDOW^S DISEASE,5
RU,BILIARY DYSKINESIA,5
RU,BLEEDING TIME PROLONGED,5
RU,BLINDNESS TRANSIENT,5
RU,BLOOD GLUCOSE ABNORMAL,5
RU,CORNEAL DISORDER,5
RU,CUSHINGOID,5
RU,DEVICE RELATED INFECTION,5
RU,DIABETIC FOOT,5
RU,DIABETIC NEUROPATHY,5
RU,DIABETIC RETINOPATHY,5
RU,DISTURBANCE IN ATTENTION,5
RU,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,5
RU,DRY EYE,5
RU,DYSBACTERIOSIS,5
RU,DYSPNOEA AT REST,5
RU,ECTOPIC PREGNANCY UNDER HORMONAL CONTRACEPTION,5
RU,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,5
RU,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,5
RU,ELECTROLYTE IMBALANCE,5
RU,EMOTIONAL DISORDER,5
RU,ENTEROBACTER INFECTION,5
RU,EPIDERMAL NAEVUS SYNDROME,5
RU,ERYTHEMA NODOSUM,5
RU,ESCHERICHIA SEPSIS,5
RU,EXPOSURE DURING BREAST FEEDING,5
RU,EYE HAEMORRHAGE,5
RU,FAECAL INCONTINENCE,5
RU,FIBROADENOMA OF BREAST,5
RU,FLANK PAIN,5
RU,FOAMING AT MOUTH,5
RU,FOREARM FRACTURE,5
RU,GASTRIC ULCER HAEMORRHAGE,5
RU,GASTROINTESTINAL TOXICITY,5
RU,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,5
RU,GLYCOSURIA,5
RU,HAEMOLYTIC URAEMIC SYNDROME,5
RU,HEAD INJURY,5
RU,HEART RATE IRREGULAR,5
RU,HEPATIC CANCER,5
RU,HEPATOSPLENOMEGALY,5
RU,HERNIA,5
RU,HIATUS HERNIA,5
RU,HYPOPHAGIA,5
RU,HYPOREFLEXIA,5
RU,HYPOVENTILATION,5
RU,IDIOPATHIC PULMONARY FIBROSIS,5
RU,INAPPROPRIATE PRESCRIBING,5
RU,INGUINAL HERNIA,5
RU,INTELLECTUAL DISABILITY,5
RU,INTENTIONAL DRUG MISUSE,5
RU,INTERSTITIAL LUNG DISEASE,5
RU,INTRAVENTRICULAR HAEMORRHAGE,5
RU,LARYNGITIS,5
RU,LEFT VENTRICULAR DYSFUNCTION,5
RU,LIMB INJURY,5
RU,LUMBAR VERTEBRAL FRACTURE,5
RU,MALLORY-WEISS SYNDROME,5
RU,MENSTRUATION DELAYED,5
RU,METASTASES TO LYMPH NODES,5
RU,METASTATIC RENAL CELL CARCINOMA,5
RU,MOUTH HAEMORRHAGE,5
RU,MULTIPLE CONGENITAL ABNORMALITIES,5
RU,MULTIPLE FRACTURES,5
RU,MULTIPLE SCLEROSIS,5
RU,MYELODYSPLASTIC SYNDROME,5
RU,NASAL OBSTRUCTION,5
RU,NEUROSIS,5
RU,OESOPHAGITIS,5
RU,OXYGEN SATURATION DECREASED,5
RU,PANCREATIC NECROSIS,5
RU,PARESIS,5
RU,PARKINSON^S DISEASE,5
RU,PATELLA FRACTURE,5
RU,PATHOLOGICAL FRACTURE,5
RU,PEPTIC ULCER,5
RU,PERITONSILLAR ABSCESS,5
RU,PLACENTAL INSUFFICIENCY,5
RU,PLATELET COUNT ABNORMAL,5
RU,PNEUMONIA ASPIRATION,5
RU,POLYHYDRAMNIOS,5
RU,POLYSEROSITIS,5
RU,POOR QUALITY SLEEP,5
RU,POST PROCEDURAL HAEMORRHAGE,5
RU,PRE-ECLAMPSIA,5
RU,PROCEDURAL PAIN,5
RU,PRODUCT SUBSTITUTION ISSUE,5
RU,PROSTATITIS,5
RU,PROTEIN TOTAL DECREASED,5
RU,PULMONARY ARTERY THROMBOSIS,5
RU,RASH PUSTULAR,5
RU,RECURRENT CANCER,5
RU,RESPIRATORY DEPRESSION,5
RU,RHABDOMYOLYSIS,5
RU,RIGHT VENTRICULAR FAILURE,5
RU,SINUS TACHYCARDIA,5
RU,SNEEZING,5
RU,STUPOR,5
RU,SUBDURAL HAEMATOMA,5
RU,SUPRAVENTRICULAR EXTRASYSTOLES,5
RU,TACHYPNOEA,5
RU,THROMBOTIC MICROANGIOPATHY,5
RU,TIBIA FRACTURE,5
RU,TOOTHACHE,5
RU,TOXIC EPIDERMAL NECROLYSIS,5
RU,TREATMENT FAILURE,5
RU,TUBERCULIN TEST POSITIVE,5
RU,TUMOUR LYSIS SYNDROME,5
RU,VASODILATATION,5
RU,WHITE BLOOD CELL COUNT INCREASED,5
RU,ABASIA,4
RU,ABSCESS LIMB,4
RU,ACUTE HEPATIC FAILURE,4
RU,ACUTE LEUKAEMIA,4
RU,ADNEXA UTERI PAIN,4
RU,ALANINE AMINOTRANSFERASE ABNORMAL,4
RU,ALCOHOL POISONING,4
RU,ANAEMIA OF PREGNANCY,4
RU,ANAEMIA VITAMIN B12 DEFICIENCY,4
RU,AORTIC THROMBOSIS,4
RU,APPENDICECTOMY,4
RU,APPETITE DISORDER,4
RU,AREFLEXIA,4
RU,ARTERIAL THROMBOSIS,4
RU,ASPARTATE AMINOTRANSFERASE ABNORMAL,4
RU,ASPIRATION,4
RU,BACTERIAL SEPSIS,4
RU,BENIGN PROSTATIC HYPERPLASIA,4
RU,BILE DUCT STONE,4
RU,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
RU,BLOOD GLUCOSE FLUCTUATION,4
RU,BLOOD PRESSURE INADEQUATELY CONTROLLED,4
RU,BLOOD TESTOSTERONE DECREASED,4
RU,BLOOD URINE PRESENT,4
RU,BREAST CANCER METASTATIC,4
RU,BREAST DISORDER,4
RU,BULLOUS LUNG DISEASE,4
RU,BUNDLE BRANCH BLOCK RIGHT,4
RU,CARDIAC DISCOMFORT,4
RU,CARDIAC FIBRILLATION,4
RU,CARDIAC VENTRICULAR THROMBOSIS,4
RU,CARDIO-RESPIRATORY ARREST,4
RU,CAROTID ARTERY STENOSIS,4
RU,CD4 LYMPHOCYTES ABNORMAL,4
RU,CEREBRAL ARTERIOSCLEROSIS,4
RU,CERVICAL POLYP,4
RU,CERVIX CARCINOMA,4
RU,CHEST X-RAY ABNORMAL,4
RU,CHRONIC HEPATITIS,4
RU,CHRONIC LYMPHOCYTIC LEUKAEMIA,4
RU,CONCUSSION,4
RU,CONJUNCTIVAL HYPERAEMIA,4
RU,CONJUNCTIVITIS ALLERGIC,4
RU,CONVERSION DISORDER,4
RU,CORONARY ARTERY BYPASS,4
RU,CORONARY ARTERY INSUFFICIENCY,4
RU,CRYING,4
RW,DEATH,11
RW,ACUTE HEPATIC FAILURE,7
RW,GOUTY ARTHRITIS,6
RW,ACUTE KIDNEY INJURY,5
RW,HYPERKALAEMIA,5
RW,HIV INFECTION,4
RW,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,3
RW,TRANSAMINASES INCREASED,3
RW,ANAEMIA,2
RW,GENERALISED TONIC-CLONIC SEIZURE,2
RW,HYPERURICAEMIA,2
RW,MALIGNANT NEOPLASM PROGRESSION,2
RW,PULMONARY EMBOLISM,2
RW,PYREXIA,2
RW,RENAL FAILURE,2
RW,RENAL INJURY,2
RW,RESPIRATORY DISTRESS,2
RW,VOMITING,2
RW,WHITE BLOOD CELL COUNT INCREASED,2
RW,ABDOMINAL PAIN,1
RW,ASCITES,1
RW,BONE TUBERCULOSIS,1
RW,BRONCHOSPASM,1
RW,CARDIO-RESPIRATORY ARREST,1
RW,CHRONIC MYELOID LEUKAEMIA,1
RW,CONFUSIONAL STATE,1
RW,CONVULSION,1
RW,DEPRESSED MOOD,1
RW,DIABETES MELLITUS,1
RW,DIARRHOEA,1
RW,DISORIENTATION,1
RW,DISSEMINATED TUBERCULOSIS,1
RW,DRUG ADMINISTRATION ERROR,1
RW,DRUG DOSE OMISSION,1
RW,DRUG LEVEL DECREASED,1
RW,DRUG RESISTANCE,1
RW,DYSKINESIA,1
RW,DYSPHAGIA,1
RW,DYSPNOEA,1
RW,EPILEPSY,1
RW,EXPOSURE DURING BREAST FEEDING,1
RW,FATIGUE,1
RW,FEBRILE CONVULSION,1
RW,FOETAL EXPOSURE DURING PREGNANCY,1
RW,GANGRENE,1
RW,GASTROENTERITIS,1
RW,GASTROINTESTINAL STROMAL TUMOUR,1
RW,GENERAL PHYSICAL HEALTH DETERIORATION,1
RW,HEADACHE,1
RW,HYPERTENSIVE EMERGENCY,1
RW,HYPOGLYCAEMIA,1
RW,HYPOKALAEMIA,1
RW,HYPOMAGNESAEMIA,1
RW,HYPOTENSION,1
RW,INFERTILITY FEMALE,1
RW,LIBIDO DECREASED,1
RW,LOWER GASTROINTESTINAL HAEMORRHAGE,1
RW,LYMPHADENITIS,1
RW,MALAISE,1
RW,MULTI-ORGAN FAILURE,1
RW,NAUSEA,1
RW,NECROSIS,1
RW,NEOPLASM MALIGNANT,1
RW,NO THERAPEUTIC RESPONSE,1
RW,OVERDOSE,1
RW,PRURITUS,1
RW,RASH GENERALISED,1
RW,ROAD TRAFFIC ACCIDENT,1
RW,SPLENOMEGALY,1
RW,SUDDEN DEATH,1
RW,SWELLING,1
RW,THERAPEUTIC RESPONSE DECREASED,1
RW,THERAPY NON-RESPONDER,1
RW,TUBERCULOSIS,1
RW,ULCER,1
RW,WEIGHT INCREASED,1
BL,BONE EROSION,1
BL,C-REACTIVE PROTEIN ABNORMAL,1
BL,CONDITION AGGRAVATED,1
BL,DRUG INEFFECTIVE,1
BL,JOINT STIFFNESS,1
BL,JOINT SWELLING,1
BL,MUSCULOSKELETAL STIFFNESS,1
BL,NASOPHARYNGITIS,1
BL,PAIN IN EXTREMITY,1
BL,PERIPHERAL SWELLING,1
BL,RHEUMATOID ARTHRITIS,1
BL,STRESS,1
KN,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
KN,APTYALISM,1
KN,BLINDNESS,1
KN,CHOKING,1
KN,DRUG PRESCRIBING ERROR,1
KN,DRUG-INDUCED LIVER INJURY,1
KN,DRY EYE,1
KN,DYSPHAGIA,1
KN,INTERNATIONAL NORMALISED RATIO INCREASED,1
KN,PROTHROMBIN TIME PROLONGED,1
KN,TOOTH LOSS,1
KN,VISION BLURRED,1
LC,DEATH,2
LC,ABDOMINAL DISTENSION,1
LC,ASTHENIA,1
LC,CHEST PAIN,1
LC,DIARRHOEA,1
LC,FACIAL PARALYSIS,1
LC,FEELING COLD,1
LC,FEELING HOT,1
LC,HEADACHE,1
LC,MYALGIA,1
LC,PAIN,1
LC,PLATELET COUNT DECREASED,1
LC,PRODUCT USE IN UNAPPROVED INDICATION,1
PM,LICHEN SCLEROSUS,1
PM,VAGINAL INFECTION,1
VC,PULMONARY EMBOLISM,1
VC,TREATMENT NONCOMPLIANCE,1
WS,ASTHENIA,1
WS,DEATH,1
WS,DRUG DOSE OMISSION,1
WS,GASTROINTESTINAL HAEMORRHAGE,1
WS,NAUSEA,1
SM,ACUTE RESPIRATORY FAILURE,1
SM,ASTHENIA,1
SM,CELLULITIS,1
SM,COUGH,1
SM,CRYOGLOBULINAEMIA,1
SM,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
SM,FOLLICULITIS,1
SM,GUILLAIN-BARRE SYNDROME,1
SM,HYPOALBUMINAEMIA,1
SM,INFECTION,1
SM,INTERSTITIAL LUNG DISEASE,1
SM,LUNG DISORDER,1
SM,MALIGNANT NEOPLASM PROGRESSION,1
SM,NEPHROTIC SYNDROME,1
SM,NO THERAPEUTIC RESPONSE,1
SM,OEDEMA PERIPHERAL,1
SM,PARONYCHIA,1
SM,PYREXIA,1
SM,RENAL FAILURE,1
SM,SEPSIS,1
SM,SUBCUTANEOUS ABSCESS,1
SM,URTICARIA,1
SA,ACUTE KIDNEY INJURY,123
SA,MATERNAL EXPOSURE BEFORE PREGNANCY,98
SA,DEATH,92
SA,DRUG INEFFECTIVE,70
SA,FEBRILE NEUTROPENIA,62
SA,VOMITING,58
SA,PYREXIA,45
SA,DYSPNOEA,39
SA,HYPOTENSION,38
SA,PREMATURE BABY,38
SA,SEPSIS,37
SA,NEUTROPENIA,35
SA,THROMBOCYTOPENIA,34
SA,RASH,32
SA,TOXICITY TO VARIOUS AGENTS,31
SA,FATIGUE,30
SA,NAUSEA,30
SA,FOETAL EXPOSURE DURING PREGNANCY,28
SA,PRODUCT CONTAMINATION MICROBIAL,28
SA,TACHYCARDIA,28
SA,ANASTOMOTIC LEAK,26
SA,DIARRHOEA,26
SA,DRUG ABUSE,24
SA,FOETAL DEATH,23
SA,HEPATIC ENZYME INCREASED,23
SA,HEADACHE,22
SA,PULMONARY EMBOLISM,22
SA,CARDIAC FAILURE,21
SA,EYE IRRITATION,21
SA,INTRAOCULAR PRESSURE INCREASED,21
SA,RESPIRATORY DISTRESS,21
SA,SEROTONIN SYNDROME,21
SA,ABDOMINAL PAIN,20
SA,COUGH,20
SA,HYPOKALAEMIA,20
SA,PNEUMONIA,20
SA,ARTHRITIS,19
SA,HEPATOTOXICITY,19
SA,HYPERTENSION,19
SA,PAIN,19
SA,PLEURAL EFFUSION,19
SA,RESPIRATORY FAILURE,19
SA,SEPTIC SHOCK,19
SA,AMENORRHOEA,17
SA,EXPOSURE DURING PREGNANCY,17
SA,OVERDOSE,17
SA,SEIZURE,17
SA,CARDIAC ARREST,16
SA,DIZZINESS,16
SA,INFECTION,16
SA,PANCYTOPENIA,16
SA,PRODUCT USE IN UNAPPROVED INDICATION,16
SA,PRODUCT USE ISSUE,16
SA,CEREBROVASCULAR ACCIDENT,15
SA,DEEP VEIN THROMBOSIS,15
SA,HAEMOGLOBIN DECREASED,15
SA,HYPERKALAEMIA,15
SA,MATERNAL EXPOSURE DURING PREGNANCY,15
SA,ANAEMIA,14
SA,ASTHENIA,14
SA,HAEMORRHAGE,14
SA,LOW BIRTH WEIGHT BABY,14
SA,MUCOSAL INFLAMMATION,14
SA,RENAL IMPAIRMENT,14
SA,ASCITES,13
SA,DEPRESSION,13
SA,PANCREATITIS,13
SA,PULMONARY HAEMORRHAGE,13
SA,ARTHRALGIA,12
SA,BACTERIAL INFECTION,12
SA,CHEST PAIN,12
SA,CHOLESTASIS,12
SA,COMA,12
SA,DISEASE PROGRESSION,12
SA,SUICIDE ATTEMPT,12
SA,TREATMENT FAILURE,12
SA,WEIGHT DECREASED,12
SA,ABORTION SPONTANEOUS,11
SA,BLOOD ALKALINE PHOSPHATASE INCREASED,11
SA,BLOOD CREATININE INCREASED,11
SA,CENTRAL NERVOUS SYSTEM LESION,11
SA,DECREASED APPETITE,11
SA,DIABETIC KETOACIDOSIS,11
SA,INTENTIONAL OVERDOSE,11
SA,LETHARGY,11
SA,NEUROLEPTIC MALIGNANT SYNDROME,11
SA,RENAL FAILURE,11
SA,RHABDOMYOLYSIS,11
SA,RHEUMATIC DISORDER,11
SA,AFFECT LABILITY,10
SA,ALANINE AMINOTRANSFERASE INCREASED,10
SA,COGNITIVE DISORDER,10
SA,CONDITION AGGRAVATED,10
SA,ENDOCARDITIS BACTERIAL,10
SA,GENERALISED TONIC-CLONIC SEIZURE,10
SA,LOWER RESPIRATORY TRACT INFECTION,10
SA,MALIGNANT NEOPLASM PROGRESSION,10
SA,MYOCARDIAL INFARCTION,10
SA,OXYGEN SATURATION DECREASED,10
SA,SKIN TOXICITY,10
SA,SOMNOLENCE,10
SA,ANXIETY,9
SA,DRUG DOSE OMISSION,9
SA,HYPERSENSITIVITY,9
SA,HYPOGLYCAEMIA,9
SA,JAUNDICE,9
SA,LOSS OF CONSCIOUSNESS,9
SA,MULTIPLE SCLEROSIS RELAPSE,9
SA,PAIN IN EXTREMITY,9
SA,PLATELET COUNT DECREASED,9
SA,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,9
SA,PRURITUS,9
SA,RENAL TUBULAR NECROSIS,9
SA,URINARY TRACT INFECTION,9
SA,ACUTE MYELOID LEUKAEMIA,8
SA,AGGRESSION,8
SA,BENIGN INTRACRANIAL HYPERTENSION,8
SA,BONE MARROW TOXICITY,8
SA,CHILLS,8
SA,CYTOMEGALOVIRUS INFECTION,8
SA,DRUG LEVEL INCREASED,8
SA,DRUG RESISTANCE,8
SA,DRUG-INDUCED LIVER INJURY,8
SA,ENCEPHALOPATHY,8
SA,GASTROINTESTINAL HAEMORRHAGE,8
SA,GENERAL PHYSICAL HEALTH DETERIORATION,8
SA,HYPERGLYCAEMIA,8
SA,INFUSION RELATED REACTION,8
SA,LACTIC ACIDOSIS,8
SA,LEUKOPENIA,8
SA,METASTASES TO LUNG,8
SA,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,8
SA,PALPITATIONS,8
SA,PANCREATITIS ACUTE,8
SA,ABDOMINAL PAIN UPPER,7
SA,ABNORMAL BEHAVIOUR,7
SA,ACIDOSIS,7
SA,ANGIOEDEMA,7
SA,ASTHMA,7
SA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,7
SA,CONFUSIONAL STATE,7
SA,ELECTROCARDIOGRAM QT PROLONGED,7
SA,ENDOPHTHALMITIS,7
SA,ERYTHEMA,7
SA,HAEMATURIA,7
SA,HEPATIC FAILURE,7
SA,INCORRECT ROUTE OF DRUG ADMINISTRATION,7
SA,INTESTINAL OBSTRUCTION,7
SA,MUCOSAL TOXICITY,7
SA,MUSCULAR WEAKNESS,7
SA,MYOCLONUS,7
SA,OEDEMA PERIPHERAL,7
SA,ORGANISING PNEUMONIA,7
SA,PNEUMONITIS,7
SA,PREMATURE DELIVERY,7
SA,STILLBIRTH,7
SA,TRANSPLANT REJECTION,7
SA,URTICARIA,7
SA,VISION BLURRED,7
SA,WHITE BLOOD CELL COUNT DECREASED,7
SA,ACCIDENTAL OVERDOSE,6
SA,ACUTE RESPIRATORY DISTRESS SYNDROME,6
SA,AGITATION,6
SA,ANAPHYLACTIC REACTION,6
SA,ASPERGILLUS INFECTION,6
SA,BLINDNESS,6
SA,BLOOD BILIRUBIN INCREASED,6
SA,BRADYCARDIA,6
SA,CHOLECYSTITIS,6
SA,COLITIS,6
SA,COLONIC PSEUDO-OBSTRUCTION,6
SA,DEPRESSED LEVEL OF CONSCIOUSNESS,6
SA,DIABETES MELLITUS,6
SA,FALL,6
SA,FLUSHING,6
SA,HALLUCINATION,6
SA,HEPATIC ENCEPHALOPATHY,6
SA,HISTIOCYTOSIS HAEMATOPHAGIC,6
SA,HYDRONEPHROSIS,6
SA,HYPOAESTHESIA,6
SA,HYPOTONIA,6
SA,MALAISE,6
SA,MULTI-ORGAN FAILURE,6
SA,OEDEMA,6
SA,PULMONARY OEDEMA,6
SA,RENAL FAILURE ACUTE,6
SA,SYSTEMIC LUPUS ERYTHEMATOSUS,6
SA,TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME,6
SA,URINARY RETENTION,6
SA,URINARY TRACT OBSTRUCTION,6
SA,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,5
SA,ALOPECIA,5
SA,APNOEA,5
SA,BACK PAIN,5
SA,BONE PAIN,5
SA,CELLULITIS,5
SA,CONVULSION,5
SA,CYANOSIS,5
SA,DEHYDRATION,5
SA,DRUG CLEARANCE DECREASED,5
SA,DYSPHAGIA,5
SA,EPISTAXIS,5
SA,EYE PAIN,5
SA,FOETAL GROWTH RESTRICTION,5
SA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,5
SA,GASTROINTESTINAL DISORDER,5
SA,HYPERREFLEXIA,5
SA,HYPOCALCAEMIA,5
SA,HYPOXIA,5
SA,INCORRECT DOSE ADMINISTERED,5
SA,INTENTIONAL PRODUCT MISUSE,5
SA,INTRACRANIAL PRESSURE INCREASED,5
SA,METASTASES TO LIVER,5
SA,MUSCLE SPASTICITY,5
SA,MYALGIA,5
SA,NECROTISING COLITIS,5
SA,NEPHROTIC SYNDROME,5
SA,OBSTRUCTIVE UROPATHY,5
SA,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,5
SA,PROTEINURIA,5
SA,RHINORRHOEA,5
SA,SHOCK,5
SA,SOCIAL AVOIDANT BEHAVIOUR,5
SA,SUDDEN DEATH,5
SA,THERAPY NON-RESPONDER,5
SA,THROMBOSIS,5
SA,ABDOMINAL DISTENSION,4
SA,ARRHYTHMIA,4
SA,ARTHROPATHY,4
SA,ASPARTATE AMINOTRANSFERASE INCREASED,4
SA,BLOOD GLUCOSE INCREASED,4
SA,BONE MARROW DISORDER,4
SA,BRAIN MALFORMATION,4
SA,BREAST CANCER,4
SA,CARDIAC DISORDER,4
SA,CATARACT,4
SA,CHEST DISCOMFORT,4
SA,CHOROIDAL NEOVASCULARISATION,4
SA,CYTOPENIA,4
SA,DELIRIUM,4
SA,DISORIENTATION,4
SA,DRUG HYPERSENSITIVITY,4
SA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,4
SA,DRUG INTOLERANCE,4
SA,DYSARTHRIA,4
SA,EPILEPSY,4
SA,FEMUR FRACTURE,4
SA,FLUID OVERLOAD,4
SA,FUNGAL INFECTION,4
SA,HAEMATOMA,4
SA,HAEMATOTOXICITY,4
SA,HAEMODYNAMIC INSTABILITY,4
SA,HEART RATE INCREASED,4
SA,HYPERCALCAEMIA,4
SA,HYPERHIDROSIS,4
SA,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,4
SA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
SA,INFANTILE CORTICAL HYPEROSTOSIS,4
SA,JOINT SWELLING,4
SA,LIVER FUNCTION TEST INCREASED,4
SA,LIVER INJURY,4
SA,METABOLIC ACIDOSIS,4
SA,MYOSITIS,4
SA,NEOPLASM PROGRESSION,4
SA,NEPHROPATHY TOXIC,4
SA,NEUROTOXICITY,4
SA,NEUTROPENIC COLITIS,4
SA,OLIGOHYDRAMNIOS,4
SA,PATHOGEN RESISTANCE,4
SA,PHOTOPHOBIA,4
SA,PRURITUS GENERALISED,4
SA,PSORIASIS,4
SA,RESPIRATORY DEPRESSION,4
SA,RESPIRATORY DISORDER,4
SA,RESPIRATORY TRACT INFECTION,4
SA,SKIN ULCER,4
SA,SUBCUTANEOUS ABSCESS,4
SA,TREMOR,4
SA,TUBERCULOSIS,4
SA,URINE OUTPUT DECREASED,4
SA,ABASIA,3
SA,ABDOMINAL DISCOMFORT,3
SA,ACNE,3
SA,ACUTE CORONARY SYNDROME,3
SA,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,3
SA,ACUTE MYOCARDIAL INFARCTION,3
SA,ANAPHYLACTIC SHOCK,3
SA,ANAPHYLACTOID REACTION,3
SA,ANGINA PECTORIS,3
SA,ANURIA,3
SA,ATAXIA,3
SA,ATELECTASIS,3
SA,BLISTER,3
SA,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
SA,BLOOD PRESSURE INCREASED,3
SA,BONE MARROW FAILURE,3
SA,BRONCHOSPASM,3
SA,CARDIOMYOPATHY,3
SA,CEREBRAL HAEMORRHAGE,3
SA,CEREBRAL VENOUS THROMBOSIS,3
SA,CHRONIC GRAFT VERSUS HOST DISEASE,3
SA,CUSHING^S SYNDROME,3
SA,DIARRHOEA HAEMORRHAGIC,3
SA,DISEASE RECURRENCE,3
SA,DRUG ERUPTION,3
SA,DRUG WITHDRAWAL SYNDROME,3
SA,DYSKINESIA,3
SA,EJECTION FRACTION DECREASED,3
SA,EYELID OEDEMA,3
SA,FEELING HOT,3
SA,FLUID RETENTION,3
SA,FOETAL DISTRESS SYNDROME,3
SA,GASTROENTERITIS,3
SA,GLYCOSYLATED HAEMOGLOBIN INCREASED,3
SA,HAEMATEMESIS,3
SA,HAEMOPTYSIS,3
SA,HEMIPARESIS,3
SA,HEPATIC CIRRHOSIS,3
SA,HEPATOCELLULAR CARCINOMA,3
SA,HYPOMAGNESAEMIA,3
SA,HYPOPHAGIA,3
SA,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
SA,INFECTION REACTIVATION,3
SA,ISCHAEMIC STROKE,3
SA,LEFT VENTRICULAR DYSFUNCTION,3
SA,LEUKOCYTOSIS,3
SA,LONG QT SYNDROME,3
SA,LUNG DISORDER,3
SA,LUPUS NEPHRITIS,3
SA,LYMPHOCYTE COUNT DECREASED,3
SA,MASS,3
SA,MENORRHAGIA,3
SA,MIDDLE EAST RESPIRATORY SYNDROME,3
SA,MIOSIS,3
SA,MULTIPLE SCLEROSIS,3
SA,MUSCLE RIGIDITY,3
SA,MUSCULOSKELETAL STIFFNESS,3
SA,MYCOBACTERIUM ABSCESSUS INFECTION,3
SA,MYOCARDITIS,3
SA,NEONATAL RESPIRATORY FAILURE,3
SA,OBSTRUCTION GASTRIC,3
SA,OCULAR HYPERAEMIA,3
SA,OLIGURIA,3
SA,OSTEOMYELITIS,3
SA,OVARIAN HYPERSTIMULATION SYNDROME,3
SA,PERSONALITY CHANGE,3
SA,PNEUMONIA ASPIRATION,3
SA,PNEUMOTHORAX,3
SA,POST PROCEDURAL COMPLICATION,3
SA,PULMONARY HYPERTENSION,3
SA,RASH GENERALISED,3
SA,RENAL FAILURE CHRONIC,3
SA,RESPIRATORY ARREST,3
SA,RETINAL EXUDATES,3
SA,RETINAL HAEMORRHAGE,3
SA,RHEUMATOID ARTHRITIS,3
SA,SEXUAL DYSFUNCTION,3
SA,SINUS BRADYCARDIA,3
SA,SKIN DISCOLOURATION,3
SA,SKIN LESION,3
SA,SPEECH DISORDER,3
SA,STATUS EPILEPTICUS,3
SA,SUBCUTANEOUS EMPHYSEMA,3
SA,SWELLING FACE,3
SA,TACHYPNOEA,3
SA,TREATMENT NONCOMPLIANCE,3
SA,TUBULOINTERSTITIAL NEPHRITIS,3
SA,UPPER RESPIRATORY TRACT INFECTION,3
SA,UVEITIS,3
SA,VAGINAL HAEMORRHAGE,3
SA,VANISHING BILE DUCT SYNDROME,3
SA,VIRAL INFECTION,3
SA,VISUAL ACUITY REDUCED,3
SA,VISUAL IMPAIRMENT,3
SA,WEIGHT INCREASED,3
SA,WHEEZING,3
SA,ABORTION,2
SA,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,2
SA,ADRENAL INSUFFICIENCY,2
SA,AMYLASE INCREASED,2
SA,ANAL ATRESIA,2
SA,ANGLE CLOSURE GLAUCOMA,2
SA,APATHY,2
SA,ASTERIXIS,2
SA,ATRIAL FIBRILLATION,2
SA,ATROPHY OF GLOBE,2
SA,AXONAL NEUROPATHY,2
SA,BAROTRAUMA,2
SA,BLADDER DISORDER,2
SA,BLOOD ALBUMIN DECREASED,2
SA,BLOOD POTASSIUM INCREASED,2
SA,BLOOD TRIGLYCERIDES INCREASED,2
SA,BONE DISORDER,2
SA,BRAIN NEOPLASM,2
SA,BRONCHITIS,2
SA,BRONCHOPLEURAL FISTULA,2
SA,BRUCELLOSIS,2
SA,CARDIAC FAILURE CONGESTIVE,2
SA,CARDIO-RESPIRATORY ARREST,2
SA,CARDIOMEGALY,2
SA,CARDIOPULMONARY FAILURE,2
SA,CEREBRAL INFARCTION,2
SA,CHROMATURIA,2
SA,CHRONIC KIDNEY DISEASE,2
SA,CHRONIC MYELOID LEUKAEMIA,2
SA,CLONUS,2
SA,CLOSTRIDIUM DIFFICILE COLITIS,2
SA,CLOSTRIDIUM DIFFICILE INFECTION,2
SA,COLORECTAL CANCER METASTATIC,2
SA,COMPLICATIONS OF TRANSPLANTED KIDNEY,2
SA,CONGENITAL ANOMALY,2
SA,CONGENITAL ECTOPIC BLADDER,2
SA,CONGENITAL GENITOURINARY ABNORMALITY,2
SA,CONGENITAL SCOLIOSIS,2
SA,CONGENITAL SPINAL CORD ANOMALY,2
SA,CONJUNCTIVITIS,2
SA,CONSTIPATION,2
SA,CORNEAL OEDEMA,2
SA,CORONA VIRUS INFECTION,2
SA,CORONARY REVASCULARISATION,2
SA,CROHN^S DISEASE,2
SA,CYSTITIS HAEMORRHAGIC,2
SA,CYSTOID MACULAR OEDEMA,2
SA,DELUSION,2
SA,DERMATITIS ALLERGIC,2
SA,DEVELOPMENTAL HIP DYSPLASIA,2
SA,DEVICE DISLOCATION,2
SA,DIABETES MELLITUS INADEQUATE CONTROL,2
SA,DIABETIC NEPHROPATHY,2
SA,DISSEMINATED INTRAVASCULAR COAGULATION,2
SA,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,2
SA,DRUG ADMINISTRATION ERROR,2
SA,EPIGASTRIC DISCOMFORT,2
SA,EXOMPHALOS,2
SA,FACTOR VIII INHIBITION,2
SA,FEEDING INTOLERANCE,2
SA,FLANK PAIN,2
SA,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,2
SA,FREQUENT BOWEL MOVEMENTS,2
SA,GENERALISED OEDEMA,2
SA,GINGIVAL BLEEDING,2
SA,GRAFT VERSUS HOST DISEASE,2
SA,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,2
SA,HEART RATE DECREASED,2
SA,HEMIANOPIA,2
SA,HEPATIC FUNCTION ABNORMAL,2
SA,HEPATITIS A,2
SA,HOSPITALISATION,2
SA,HYPERBILIRUBINAEMIA,2
SA,HYPERNATRAEMIA,2
SA,HYPERPARATHYROIDISM,2
SA,HYPERPYREXIA,2
SA,HYPERSOMNIA,2
SA,HYPERVENTILATION,2
SA,HYPOALBUMINAEMIA,2
SA,HYPONATRAEMIA,2
SA,HYPOTHYROIDISM,2
SA,ILL-DEFINED DISORDER,2
SA,IMMUNODEFICIENCY,2
SA,INCISION SITE HAEMATOMA,2
SA,INCORRECT PRODUCT STORAGE,2
SA,INFLAMMATION,2
SA,INJECTION SITE ERYTHEMA,2
SA,INJECTION SITE PAIN,2
SA,INSOMNIA,2
SA,INTESTINAL ISCHAEMIA,2
SA,IRON DEFICIENCY ANAEMIA,2
SA,IRRITABILITY,2
SA,JOINT EFFUSION,2
SA,KERATITIS,2
SA,KLEBSIELLA TEST POSITIVE,2
SA,LEUKAEMIA,2
SA,LEUKOCYTOCLASTIC VASCULITIS,2
SA,LIPASE INCREASED,2
SA,LIVER FUNCTION TEST ABNORMAL,2
SA,LOCALISED INTRAABDOMINAL FLUID COLLECTION,2
SA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
SA,LUNG INFECTION,2
SA,LUPUS-LIKE SYNDROME,2
SA,LYMPHOCYTOSIS,2
SA,MEDICATION ERROR,2
SA,MELAENA,2
SA,MENINGOENCEPHALITIS AMOEBIC,2
SA,MENINGOMYELOCELE,2
SA,MENTAL DISORDER,2
SA,MENTAL STATUS CHANGES,2
SA,METABOLIC ENCEPHALOPATHY,2
SA,METASTASES TO CENTRAL NERVOUS SYSTEM,2
SA,MILK-ALKALI SYNDROME,2
SA,MOBILITY DECREASED,2
SA,MOYAMOYA DISEASE,2
SA,MYDRIASIS,2
SA,MYELODYSPLASTIC SYNDROME,2
SA,MYELOFIBROSIS,2
SA,MYOCARDIAL NECROSIS MARKER INCREASED,2
SA,MYOPATHY,2
SA,NASOPHARYNGITIS,2
SA,NEUROPATHY PERIPHERAL,2
SA,NO THERAPEUTIC RESPONSE,2
SA,OESOPHAGEAL ULCER,2
SA,OPTIC NEUROPATHY,2
SA,OROPHARYNGEAL PAIN,2
SA,OSTEOARTHRITIS,2
SA,OSTEONECROSIS OF JAW,2
SA,PALLOR,2
SA,PANCREATIC CARCINOMA,2
SA,PARAESTHESIA,2
SA,PERIORBITAL OEDEMA,2
SA,PLEURITIC PAIN,2
SA,PNEUMONIA STAPHYLOCOCCAL,2
SA,POLYARTHRITIS,2
SA,PRESYNCOPE,2
SA,PRODUCT QUALITY ISSUE,2
SA,PSEUDOMONAS TEST POSITIVE,2
SA,PULMONARY ALVEOLAR HAEMORRHAGE,2
SA,PULMONARY MASS,2
SA,PUPILLARY DISORDER,2
SA,RASH MACULO-PAPULAR,2
SA,RASH PUSTULAR,2
SA,RECTAL HAEMORRHAGE,2
SA,RENAL CYST,2
SA,RENAL DISORDER,2
SA,RENAL INJURY,2
SA,RENAL MASS,2
SA,RESPIRATORY RATE DECREASED,2
SA,RETINAL ARTERY OCCLUSION,2
SA,RETROPERITONEAL HAEMATOMA,2
SA,ROAD TRAFFIC ACCIDENT,2
SA,ROTAVIRUS INFECTION,2
SA,SALMONELLOSIS,2
SA,SEDATION,2
SA,SENSORY LOSS,2
SA,SNEEZING,2
SA,STARING,2
SA,STOMATITIS,2
SA,STRABISMUS,2
SA,SUBDURAL HAEMATOMA,2
SA,SWELLING,2
SA,SYNDACTYLY,2
SA,TENDERNESS,2
SA,THERAPY CESSATION,2
SA,THROMBOTIC THROMBOCYTOPENIC PURPURA,2
SA,TOXIC ENCEPHALOPATHY,2
SA,TOXIC EPIDERMAL NECROLYSIS,2
SA,TRANSAMINASES INCREASED,2
SA,TRANSIENT ISCHAEMIC ATTACK,2
SA,TRANSPLANT FAILURE,2
SA,TUMEFACTIVE MULTIPLE SCLEROSIS,2
SA,TUMOUR LYSIS SYNDROME,2
SA,UNRESPONSIVE TO STIMULI,2
SA,UPPER GASTROINTESTINAL HAEMORRHAGE,2
SA,URINARY TRACT INFECTION PSEUDOMONAL,2
SA,VASCULITIS,2
SA,VITREOUS FLOATERS,2
SA,WHITE BLOOD CELL COUNT INCREASED,2
SA,ABDOMINAL MASS,1
SA,ABDOMINAL RIGIDITY,1
SA,ABDOMINAL TENDERNESS,1
SA,ABDOMINAL WALL HAEMATOMA,1
SA,ACCIDENTAL EXPOSURE TO PRODUCT,1
SA,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,1
SA,ACUTE HEPATIC FAILURE,1
SA,ACUTE LEUKAEMIA,1
SA,ACUTE MYELOID LEUKAEMIA RECURRENT,1
SA,ACUTE PULMONARY OEDEMA,1
SA,ADENOCARCINOMA,1
SA,ADENOCARCINOMA OF COLON,1
SA,ADENOIDITIS,1
SA,ADRENAL HAEMORRHAGE,1
SA,ADVERSE REACTION,1
SA,ALBUMINURIA,1
SA,ALTERED STATE OF CONSCIOUSNESS,1
SA,AMNESIA,1
SA,ANAEMIA MEGALOBLASTIC,1
SA,ANAL ABSCESS,1
SA,ANAL CANCER,1
SA,ANASTOMOTIC STENOSIS,1
SA,ANGIOPATHY,1
SA,ANGIOSARCOMA,1
SA,ANGIOSARCOMA METASTATIC,1
SA,ANKLE FRACTURE,1
SA,ANTIBODY TEST ABNORMAL,1
SA,ANTINUCLEAR ANTIBODY POSITIVE,1
SA,AORTIC STENOSIS,1
SA,AORTIC VALVE STENOSIS,1
SA,APHASIA,1
SA,APLASTIC ANAEMIA,1
SA,APNOEIC ATTACK,1
SA,ARTERIAL OCCLUSIVE DISEASE,1
SA,ARTERIAL STENOSIS,1
SA,ARTERIAL THROMBOSIS,1
SA,ARTERIOSCLEROSIS,1
SA,ASPHYXIA,1
SA,ASPIRATION,1
SA,ATRIOVENTRICULAR BLOCK COMPLETE,1
SA,AUTOANTIBODY POSITIVE,1
SA,AUTOIMMUNE DISORDER,1
SA,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
SA,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
SA,B PRECURSOR TYPE ACUTE LEUKAEMIA,1
SA,BACTERAEMIA,1
SA,BASEDOW^S DISEASE,1
SA,BILE DUCT STENOSIS,1
SA,BILIARY DILATATION,1
SA,BILIARY TRACT INFECTION,1
SA,BILIARY TRACT INFECTION BACTERIAL,1
SA,BILIRUBIN CONJUGATED INCREASED,1
SA,BIOPSY BRAIN ABNORMAL,1
SA,BLADDER HYPERTROPHY,1
SA,BLAST CELL COUNT INCREASED,1
SA,BLAST CELLS PRESENT,1
SA,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
SA,BLOOD ALBUMIN INCREASED,1
SA,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
SA,BLOOD CHOLESTEROL INCREASED,1
SA,BLOOD CREATININE ABNORMAL,1
SA,BLOOD DISORDER,1
SA,BLOOD GLUCOSE DECREASED,1
SA,BLOOD KETONE BODY INCREASED,1
SA,BLOOD PARATHYROID HORMONE INCREASED,1
SA,BLOOD PHOSPHORUS DECREASED,1
SA,BLOOD PRESSURE DECREASED,1
SA,BLOOD PRESSURE SYSTOLIC DECREASED,1
SA,BLOOD SODIUM DECREASED,1
SA,BLOOD TESTOSTERONE DECREASED,1
SA,BLOOD THYROID STIMULATING HORMONE INCREASED,1
SA,BLOOD URINE PRESENT,1
SA,BODY TEMPERATURE INCREASED,1
SA,BONE LESION,1
SA,BONE MARROW TRANSPLANT,1
SA,BONE TUBERCULOSIS,1
SA,BRADYARRHYTHMIA,1
SA,BRADYPNOEA,1
SA,BRAIN ABSCESS,1
SA,BRAIN DEATH,1
SA,BRAIN OEDEMA,1
SA,BREAST DISCHARGE,1
SA,BREECH PRESENTATION,1
SA,BRONCHIAL HYPERREACTIVITY,1
SA,BRONCHITIS BACTERIAL,1
SA,BRONCHOPULMONARY DYSPLASIA,1
SA,BURNING SENSATION,1
SA,C-REACTIVE PROTEIN INCREASED,1
SA,CAESAREAN SECTION,1
SA,CALCIPHYLAXIS,1
SA,CANDIDA INFECTION,1
SA,CARBON DIOXIDE INCREASED,1
SA,CARCINOEMBRYONIC ANTIGEN INCREASED,1
SA,CARDIAC DEATH,1
SA,CAROTID ARTERY STENOSIS,1
SA,CARPAL TUNNEL SYNDROME,1
SA,CEREBELLAR ATAXIA,1
SA,CEREBELLAR ATROPHY,1
SA,CEREBRAL ASPERGILLOSIS,1
SA,CEREBRAL VENTRICLE DILATATION,1
SA,CEREBROSPINAL FLUID LEAKAGE,1
SA,CERVICAL CORD COMPRESSION,1
SA,CERVIX CARCINOMA,1
SA,CHANGE OF BOWEL HABIT,1
SA,CHILD-PUGH-TURCOTTE SCORE INCREASED,1
SA,CHOLECYSTECTOMY,1
SA,CHOLELITHIASIS,1
SA,CHORIORETINOPATHY,1
SA,CLEFT PALATE,1
SA,CLINODACTYLY,1
SA,CLOACAL EXSTROPHY,1
SA,COAGULATION TIME PROLONGED,1
SA,COLITIS ULCERATIVE,1
SA,COLORECTAL CANCER,1
SA,COMPLICATIONS OF BONE MARROW TRANSPLANT,1
SA,CONGENITAL CLEFT HAND,1
SA,CONGENITAL ECTODERMAL DYSPLASIA,1
SA,CONGENITAL GENITAL MALFORMATION MALE,1
SA,CONGENITAL JOINT MALFORMATION,1
SA,CONGESTIVE CARDIOMYOPATHY,1
SA,CONJUNCTIVAL HYPERAEMIA,1
SA,CONJUNCTIVAL OEDEMA,1
SA,CONSCIOUSNESS FLUCTUATING,1
SA,CONTUSION,1
SA,COORDINATION ABNORMAL,1
SA,CORONARY ARTERY THROMBOSIS,1
SA,CREPITATIONS,1
SA,CRITICAL ILLNESS,1
SA,CRYING,1
SA,CRYPTORCHISM,1
SA,CUSHINGOID,1
SA,CUTANEOUS VASCULITIS,1
SA,CYTOMEGALOVIRUS TEST POSITIVE,1
SA,DEAFNESS UNILATERAL,1
SA,DEATH NEONATAL,1
SA,DECREASED ACTIVITY,1
SA,DECUBITUS ULCER,1
SA,DEEP VEIN THROMBOSIS POSTOPERATIVE,1
SA,DENTOFACIAL ANOMALY,1
SA,DEVICE DEFECTIVE,1
SA,DEVICE ISSUE,1
SA,DEVICE RELATED THROMBOSIS,1
SA,DIABETES INSIPIDUS,1
SA,DIABETIC RETINAL OEDEMA,1
SA,DIALYSIS,1
SA,DIASTOLIC DYSFUNCTION,1
SA,DIFFUSE LARGE B-CELL LYMPHOMA,1
SA,DIPLOPIA,1
SA,DISCOMFORT,1
SA,DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION,1
SA,DISSEMINATED TUBERCULOSIS,1
SA,DNA ANTIBODY POSITIVE,1
SA,DROOLING,1
SA,DROWNING,1
SA,DRUG DISPENSING ERROR,1
SA,DRUG DOSE TITRATION NOT PERFORMED,1
SA,DRUG MONITORING PROCEDURE NOT PERFORMED,1
SA,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
SA,DRUG TOLERANCE DECREASED,1
SA,DRUG USE DISORDER,1
SA,DRUG-DISEASE INTERACTION,1
SA,DRY EYE,1
SA,DRY MOUTH,1
SA,DUODENAL PERFORATION,1
SA,DUODENAL ULCER,1
SA,DUODENAL ULCER PERFORATION,1
SA,DYSMORPHISM,1
SA,DYSPEPSIA,1
SA,DYSPHONIA,1
SA,DYSPNOEA EXERTIONAL,1
SA,DYSSTASIA,1
SA,EAR MALFORMATION,1
SA,EARLY SATIETY,1
SA,EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED,1
SA,EATING DISORDER,1
SA,ECCHYMOSIS,1
SA,ECG SIGNS OF MYOCARDIAL ISCHAEMIA,1
SA,ELECTROCARDIOGRAM P WAVE ABNORMAL,1
SA,ELECTROLYTE IMBALANCE,1
SA,EMBOLISM VENOUS,1
SA,ENCAPSULATING PERITONEAL SCLEROSIS,1
SA,ENCEPHALITIS,1
SA,END STAGE RENAL DISEASE,1
SA,ENGRAFT FAILURE,1
SA,ENTEROBACTER SEPSIS,1
SA,ENTEROCOCCAL INFECTION,1
SA,EOSINOPHILIC MYOCARDITIS,1
SA,ERYTHEMA NODOSUM,1
SA,ESCHERICHIA BACTERAEMIA,1
SA,ESCHERICHIA URINARY TRACT INFECTION,1
SA,EXCORIATION,1
SA,EXOSTOSIS,1
SA,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,1
SA,EXTRAVASATION,1
SA,EYE DISORDER,1
SA,EYE HAEMORRHAGE,1
SA,EYE MOVEMENT DISORDER,1
SA,EYE OEDEMA,1
SA,EYEBALL AVULSION,1
SA,EYELID DISORDER,1
SA,FACE OEDEMA,1
SA,FACIAL NEURALGIA,1
SA,FACIAL PAIN,1
SA,FACIAL PARALYSIS,1
SA,FACTOR VIII DEFICIENCY,1
SA,FEELING ABNORMAL,1
SA,FEELING COLD,1
SA,FEMORAL NECK FRACTURE,1
SA,FIBROMYALGIA,1
SA,FINGER DEFORMITY,1
SA,FLATULENCE,1
SA,FOLLICULITIS,1
SA,FOOD INTERACTION,1
SA,FUNGAL PERITONITIS,1
SA,GAIT DISTURBANCE,1
SA,GAIT INABILITY,1
SA,GANGRENE,1
SA,GASTRECTOMY,1
SA,GASTRIC CANCER,1
SA,GASTRIC HAEMORRHAGE,1
SA,GASTRIC PERFORATION,1
SA,GASTRITIS,1
SA,GASTRITIS HAEMORRHAGIC,1
SA,GASTROENTERITIS SALMONELLA,1
SA,GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE,1
SA,GASTROINTESTINAL INFECTION,1
SA,GASTROINTESTINAL INFLAMMATION,1
SA,GASTROINTESTINAL PERFORATION,1
SA,GENERALISED ERYTHEMA,1
SA,GENITAL INFECTION FEMALE,1
SA,GESTATIONAL DIABETES,1
SA,GILBERT^S SYNDROME,1
SA,GLAUCOMA,1
SA,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,1
SA,GLOMERULONEPHRITIS MEMBRANOUS,1
SA,GRAFT VERSUS HOST DISEASE IN LIVER,1
SA,GRAFT VERSUS HOST DISEASE IN SKIN,1
SA,GRANULOMA,1
SA,GROIN PAIN,1
SA,GUILLAIN-BARRE SYNDROME,1
SA,H1N1 INFLUENZA,1
SA,HAEMATOCHEZIA,1
SA,HAEMATOCRIT DECREASED,1
SA,HAEMODIALYSIS,1
SA,HAEMOLYSIS,1
SA,HAEMOLYTIC ANAEMIA,1
SA,HAEMORRHAGE IN PREGNANCY,1
SA,HAEMORRHAGE INTRACRANIAL,1
SA,HAEMORRHAGIC DIATHESIS,1
SA,HEART VALVE REPLACEMENT,1
SA,HELLP SYNDROME,1
SA,HEMIANAESTHESIA,1
SA,HEMIPLEGIA,1
SA,HEPATIC ARTERY STENOSIS,1
SA,HEPATIC ARTERY THROMBOSIS,1
SA,HEPATIC ENZYME ABNORMAL,1
SA,HEPATIC STEATOSIS,1
SA,HEPATITIS ACUTE,1
SA,HEPATITIS CHOLESTATIC,1
SA,HEPATOMEGALY,1
SA,HEPATOSPLENOMEGALY,1
SA,HERNIA,1
SA,HERPES SIMPLEX PHARYNGITIS,1
SA,HERPES ZOSTER,1
SA,HIGH DENSITY LIPOPROTEIN DECREASED,1
SA,HUMAN PAPILLOMA VIRUS TEST POSITIVE,1
SA,HUMAN POLYOMAVIRUS INFECTION,1
SA,HUNGRY BONE SYNDROME,1
SA,HYPERCHLORHYDRIA,1
SA,HYPERPHOSPHATAEMIA,1
SA,HYPERTHERMIA,1
SA,HYPERTROPHIC CARDIOMYOPATHY,1
SA,HYPOCHROMIC ANAEMIA,1
SA,HYPODONTIA,1
SA,HYPOKINESIA,1
SA,HYPOPERFUSION,1
SA,HYPOPHOSPHATAEMIA,1
SA,HYPOPYON,1
SA,HYPOVENTILATION,1
SA,IDIOPATHIC INTRACRANIAL HYPERTENSION,1
SA,ILEUS PARALYTIC,1
SA,IMMUNE THROMBOCYTOPENIC PURPURA,1
SA,IMMUNOSUPPRESSION,1
SA,IMPAIRED HEALING,1
SA,IMPAIRED QUALITY OF LIFE,1
SA,IMPLANT SITE HAEMORRHAGE,1
SA,INFERTILITY MALE,1
SA,INFLUENZA,1
SA,INFUSION SITE DISCOLOURATION,1
SA,INJECTION SITE ABSCESS,1
SA,INJECTION SITE DRYNESS,1
SA,INJECTION SITE INFLAMMATION,1
SA,INJECTION SITE NECROSIS,1
SA,INJECTION SITE PRURITUS,1
SA,INJURY,1
SA,INSULINOMA,1
SA,INTENTIONAL DRUG MISUSE,1
SA,INTERNAL FIXATION OF FRACTURE,1
SA,INTERNATIONAL NORMALISED RATIO INCREASED,1
SA,INTESTINAL PERFORATION,1
SA,INTRACARDIAC THROMBUS,1
SA,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
SA,INTRAMEDULLARY ROD INSERTION,1
SA,INTRAVENTRICULAR HAEMORRHAGE,1
SA,INTUSSUSCEPTION,1
SA,INVASIVE DUCTAL BREAST CARCINOMA,1
SA,IRIDOCYCLITIS,1
SA,IRIS ADHESIONS,1
SA,ISCHAEMIC CEREBRAL INFARCTION,1
SA,JAW DISORDER,1
SA,JAW FRACTURE,1
SA,JOINT INJURY,1
SA,JOINT STIFFNESS,1
SA,JUGULAR VEIN THROMBOSIS,1
SA,KIDNEY FIBROSIS,1
SA,KIDNEY TRANSPLANT REJECTION,1
SA,KLEBSIELLA BACTERAEMIA,1
SA,KNEE ARTHROPLASTY,1
SA,LACERATION,1
SA,LAGOPHTHALMOS,1
SA,LARGE INTESTINAL HAEMORRHAGE,1
SA,LATERAL MEDULLARY SYNDROME,1
SA,LAZINESS,1
SA,LEUKAEMIA CUTIS,1
SA,LEUKAEMIA RECURRENT,1
SA,LEUKAEMIC INFILTRATION EXTRAMEDULLARY,1
SA,LIBIDO DECREASED,1
SA,LIMB MALFORMATION,1
SA,LIP INFECTION,1
SA,LIP OEDEMA,1
SA,LISSENCEPHALY,1
SA,LISTERIOSIS,1
SA,LIVER DISORDER,1
SA,LOCAL SWELLING,1
SA,LOW DENSITY LIPOPROTEIN INCREASED,1
SA,LOWER GASTROINTESTINAL HAEMORRHAGE,1
SA,LUNG ADENOCARCINOMA METASTATIC,1
SA,LUNG CYST,1
SA,LUNG INFILTRATION,1
SA,LYMPHADENOPATHY,1
SA,LYMPHOMA,1
SA,LYMPHOPENIA,1
SA,MACULAR FIBROSIS,1
SA,MACULAR OEDEMA,1
SA,MALE SEXUAL DYSFUNCTION,1
SA,MALIGNANT MELANOMA,1
SA,MANIA,1
SA,MATERNAL DRUGS AFFECTING FOETUS,1
SA,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
SA,MEAN CELL VOLUME INCREASED,1
SA,MEAN PLATELET VOLUME INCREASED,1
SA,MEASLES,1
SA,MEDIASTINAL HAEMORRHAGE,1
SA,MEDICAL DEVICE SITE HAEMATOMA,1
SA,MEMORY IMPAIRMENT,1
SA,MENINGIOMA,1
SA,MENSTRUATION IRREGULAR,1
SA,MENTAL IMPAIRMENT,1
SA,MESENTERIC VEIN THROMBOSIS,1
SA,METABOLIC ALKALOSIS,1
SA,METASTASES TO BONE,1
SA,METASTASES TO MENINGES,1
SA,METASTASES TO PERITONEUM,1
SA,METASTASIS,1
SA,MICROALBUMINURIA,1
SA,MICTURITION URGENCY,1
SA,MITOCHONDRIAL MYOPATHY ACQUIRED,1
SA,MITRAL VALVE INCOMPETENCE,1
SA,MONONEURITIS,1
SA,MOOD SWINGS,1
SA,MOUTH SWELLING,1
SA,MOUTH ULCERATION,1
SA,MOVEMENT DISORDER,1
SA,MUCORMYCOSIS,1
SA,MUCOSAL PIGMENTATION,1
SA,MUCOUS MEMBRANE DISORDER,1
SA,MULTI-ORGAN DISORDER,1
SA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
SA,MULTIPLE PREGNANCY,1
SA,MULTIPLE-DRUG RESISTANCE,1
SA,MUSCLE CONTRACTIONS INVOLUNTARY,1
SA,MUSCLE ENZYME INCREASED,1
SA,MUSCLE NECROSIS,1
SA,MUSCLE SPASMS,1
SA,MUSCLE SWELLING,1
SA,MUSCULOSKELETAL PAIN,1
SA,MYASTHENIA GRAVIS,1
SA,MYASTHENIC SYNDROME,1
SA,MYCOSIS FUNGOIDES,1
SA,MYOCARDIAL ISCHAEMIA,1
SA,MYOCARDIAL REPERFUSION INJURY,1
SA,MYOCLONIC EPILEPSY,1
SA,NASAL DISCOMFORT,1
SA,NECK DEFORMITY,1
SA,NECK INJURY,1
SA,NECK PAIN,1
SA,NECROTISING ENTEROCOLITIS NEONATAL,1
SA,NEPHROGENIC DIABETES INSIPIDUS,1
SA,NEPHROLITHIASIS,1
SA,NERVOUS SYSTEM DISORDER,1
SA,NERVOUSNESS,1
SA,NEURODEGENERATIVE DISORDER,1
SA,NEUROGENIC SHOCK,1
SA,NEUTROPHIL COUNT DECREASED,1
SA,NODAL RHYTHM,1
SA,NON-ALCOHOLIC STEATOHEPATITIS,1
SA,NONINFECTIOUS PERITONITIS,1
SA,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
SA,NYSTAGMUS,1
SA,OBESITY,1
SA,OBSTRUCTION,1
SA,OCULAR ICTERUS,1
SA,ODYNOPHAGIA,1
SA,OESOPHAGEAL CANDIDIASIS,1
SA,OLIGOSPERMIA,1
SA,OPEN REDUCTION OF FRACTURE,1
SA,OPISTHOTONUS,1
SA,OPTIC NERVE DISORDER,1
SA,ORGAN FAILURE,1
SA,OSTEONECROSIS,1
SA,OVARIAN NEOPLASM,1
SA,PAIN IN JAW,1
SA,PALPABLE PURPURA,1
SA,PANCREATIC ENZYMES INCREASED,1
SA,PANCREATIC MASS,1
SA,PARADOXICAL DRUG REACTION,1
SA,PARAPARESIS,1
SA,PARAPLEGIA,1
SA,PARATHYROIDECTOMY,1
SA,PARESIS CRANIAL NERVE,1
SA,PATENT DUCTUS ARTERIOSUS,1
SA,PATHOLOGICAL FRACTURE,1
SA,PATIENT-DEVICE INCOMPATIBILITY,1
SA,PEMPHIGOID,1
SA,PENILE PAIN,1
SA,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
SA,PERIPHERAL COLDNESS,1
SA,PERIPHERAL ISCHAEMIA,1
SA,PERIPHERAL SENSORY NEUROPATHY,1
SA,PERIPHERAL SWELLING,1
SA,PERIPHERAL VASCULAR DISORDER,1
SA,PERITONEAL HAEMORRHAGE,1
SA,PERITONITIS BACTERIAL,1
SN,DEATH,55
SN,SQUAMOUS CELL CARCINOMA OF SKIN,28
SN,SKIN ATROPHY,21
SN,NEOPLASM SKIN,14
SN,PRODUCT USE IN UNAPPROVED INDICATION,14
SN,DRUG RESISTANCE,10
SN,EXPOSURE DURING PREGNANCY,9
SN,FOETAL EXPOSURE DURING PREGNANCY,9
SN,ABORTION SPONTANEOUS,8
SN,INCORRECT DRUG ADMINISTRATION DURATION,7
SN,PANCYTOPENIA,6
SN,PREMATURE BABY,6
SN,RETROPERITONEAL HAEMATOMA,5
SN,STILLBIRTH,5
SN,VOMITING,5
SN,ALOPECIA,4
SN,HAEMORRHAGE,4
SN,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,4
SN,NAUSEA,4
SN,PREGNANCY,4
SN,VIROLOGIC FAILURE,4
SN,ANAEMIA,3
SN,CHILLS,3
SN,DUCTUS ARTERIOSUS PREMATURE CLOSURE,3
SN,HAEMATEMESIS,3
SN,HEPATIC FAILURE,3
SN,MATERNAL EXPOSURE DURING PREGNANCY,3
SN,MUCOSAL INFLAMMATION,3
SN,OCHRONOSIS,3
SN,PYREXIA,3
SN,RETINOPATHY HYPERTENSIVE,3
SN,SCLERODERMA RENAL CRISIS,3
SN,SHOCK HAEMORRHAGIC,3
SN,AGITATION,2
SN,BLAST CELLS PRESENT,2
SN,CARDIAC FAILURE,2
SN,CARDIAC FAILURE CONGESTIVE,2
SN,CD4 LYMPHOCYTES INCREASED,2
SN,COLITIS ULCERATIVE,2
SN,CONDITION AGGRAVATED,2
SN,CONGESTIVE CARDIOMYOPATHY,2
SN,DISEASE COMPLICATION,2
SN,DRUG INEFFECTIVE,2
SN,EXTRA DOSE ADMINISTERED,2
SN,FOETAL GROWTH RESTRICTION,2
SN,FOETOR HEPATICUS,2
SN,GENERALISED OEDEMA,2
SN,GENERALISED TONIC-CLONIC SEIZURE,2
SN,HAEMOGLOBIN DECREASED,2
SN,HEADACHE,2
SN,HEPATIC ENCEPHALOPATHY,2
SN,HEPATOMEGALY,2
SN,HYPERTENSION,2
SN,LEUKOCYTOSIS,2
SN,LICHENOID KERATOSIS,2
SN,MALAISE,2
SN,METASTASES TO BONE,2
SN,NEOPLASM RECURRENCE,2
SN,PATHOGEN RESISTANCE,2
SN,POIKILODERMA,2
SN,PREMATURE DELIVERY,2
SN,PRERENAL FAILURE,2
SN,SEPSIS,2
SN,SUBDURAL HAEMATOMA,2
SN,THERAPY NON-RESPONDER,2
SN,THROMBOCYTOPENIA,2
SN,TOOTHACHE,2
SN,VARICES OESOPHAGEAL,2
SN,VIRAL LOAD INCREASED,2
SN,ABDOMINAL DISCOMFORT,1
SN,ABDOMINAL PAIN,1
SN,ABDOMINAL PAIN UPPER,1
SN,ABORTION,1
SN,ACUTE LEUKAEMIA,1
SN,ALANINE AMINOTRANSFERASE INCREASED,1
SN,ANGIOPATHY,1
SN,ASCITES,1
SN,ASPARTATE AMINOTRANSFERASE INCREASED,1
SN,BACTERIAL INFECTION,1
SN,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
SN,BLINDNESS,1
SN,BLOOD PRESSURE DECREASED,1
SN,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
SN,BODY TEMPERATURE INCREASED,1
SN,BONE PAIN,1
SN,BRADYCARDIA,1
SN,BREAST CANCER METASTATIC,1
SN,CARDIAC DISORDER,1
SN,CERVIX CARCINOMA STAGE 0,1
SN,CHEST PAIN,1
SN,CHRONIC MYELOID LEUKAEMIA,1
SN,COMA,1
SN,COUGH,1
SN,DEEP VEIN THROMBOSIS,1
SN,DERMATITIS ALLERGIC,1
SN,DIABETIC NEPHROPATHY,1
SN,DIARRHOEA HAEMORRHAGIC,1
SN,DISCOMFORT,1
SN,DISSEMINATED TUBERCULOSIS,1
SN,DIZZINESS,1
SN,DROOLING,1
SN,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
SN,DRUG INTOLERANCE,1
SN,DYSPNOEA,1
SN,ELECTROENCEPHALOGRAM ABNORMAL,1
SN,ELECTROLYTE IMBALANCE,1
SN,ENCEPHALOPATHY,1
SN,ENDOMETRITIS DECIDUAL,1
SN,EXTRAPYRAMIDAL DISORDER,1
SN,EYE INFLAMMATION,1
SN,EYELIDS PRURITUS,1
SN,FALL,1
SN,FATIGUE,1
SN,FEELING ABNORMAL,1
SN,FOETAL DEATH,1
SN,FOREIGN BODY SENSATION IN EYES,1
SN,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SN,GENERAL SYMPTOM,1
SN,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
SN,HAEMORRHAGIC STROKE,1
SN,HEMIPARESIS,1
SN,HEPATITIS CHOLESTATIC,1
SN,HEPATOCELLULAR INJURY,1
SN,HEPATOTOXICITY,1
SN,HISTOLOGY ABNORMAL,1
SN,HYPERHIDROSIS,1
SN,HYPERNATRAEMIA,1
SN,HYPOKALAEMIA,1
SN,HYPOXIA,1
SN,INCORRECT DOSE ADMINISTERED,1
SN,INFECTION,1
SN,INSOMNIA,1
SN,ISCHAEMIC STROKE,1
SN,LIVE BIRTH,1
SN,LIVER DISORDER,1
SN,LOSS OF CONSCIOUSNESS,1
SN,LUNG NEOPLASM,1
SN,MALARIA,1
SN,MALIGNANT HYPERTENSION,1
SN,MALIGNANT NEOPLASM PROGRESSION,1
SN,MOUTH HAEMORRHAGE,1
SN,MOUTH ULCERATION,1
SN,MYASTHENIC SYNDROME,1
SN,MYELOCYTOSIS,1
SN,NERVOUS SYSTEM DISORDER,1
SN,NEUROMYOPATHY,1
SN,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
SN,OCULAR HYPERAEMIA,1
SN,OSTEONECROSIS OF JAW,1
SN,PAIN,1
SN,PAIN IN JAW,1
SN,PALPITATIONS,1
SN,PERIPHERAL SWELLING,1
SN,PLACENTA PRAEVIA,1
SN,PLATELET COUNT DECREASED,1
SN,PNEUMOTHORAX SPONTANEOUS,1
SN,PORTAL HYPERTENSIVE GASTROPATHY,1
SN,PREMATURE LABOUR,1
SN,PROTEINURIA,1
SN,PRURITUS GENERALISED,1
SN,PULMONARY TUBERCULOSIS,1
SN,PURULENT PERICARDITIS,1
SN,RESPIRATORY DISTRESS,1
SN,RIGHT VENTRICULAR DILATATION,1
SN,SALIVARY HYPERSECRETION,1
SN,SEPTIC SHOCK,1
SN,SKIN LESION,1
SN,SKIN TOXICITY,1
SN,SMALL FOR DATES BABY,1
SN,SPLENOMEGALY,1
SN,SPUTUM PURULENT,1
SN,SQUAMOUS CELL CARCINOMA,1
SN,SYSTEMIC LUPUS ERYTHEMATOSUS,1
SN,TACHYCARDIA,1
SN,THROMBOCYTOPENIC PURPURA,1
SN,THROMBOCYTOSIS,1
SN,TOXIC ENCEPHALOPATHY,1
SN,TOXICITY TO VARIOUS AGENTS,1
SN,TRANSAMINASES INCREASED,1
SN,TREATMENT NONCOMPLIANCE,1
SN,TUBERCULOSIS,1
SN,TUMOUR HAEMORRHAGE,1
SN,URINARY INCONTINENCE,1
SN,VAGINAL HAEMORRHAGE,1
SN,VERTIGO,1
SN,WEIGHT INCREASED,1
SN,WHITE BLOOD CELL COUNT INCREASED,1
SN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
RS,OVERLAP SYNDROME,57
RS,CHRONIC GRAFT VERSUS HOST DISEASE,56
RS,DYSPNOEA,56
RS,TOXICITY TO VARIOUS AGENTS,52
RS,PULMONARY EMBOLISM,50
RS,CARDIAC ARREST,44
RS,NAUSEA,42
RS,PYREXIA,41
RS,DEATH,39
RS,DRUG INEFFECTIVE,39
RS,HYPOTENSION,39
RS,INTENTIONAL OVERDOSE,38
RS,ANAEMIA,37
RS,DIARRHOEA,34
RS,ERYTHEMA,33
RS,RASH,33
RS,FATIGUE,32
RS,URTICARIA,32
RS,METABOLIC ACIDOSIS,31
RS,THROMBOCYTOPENIA,30
RS,PNEUMONIA,29
RS,COMA,27
RS,OVERDOSE,27
RS,MALAISE,26
RS,NEUTROPENIA,25
RS,PRURITUS,24
RS,ASTHENIA,23
RS,CARDIOTOXICITY,23
RS,CHEST DISCOMFORT,23
RS,LEUKOPENIA,23
RS,SHOCK,23
RS,CARDIOMYOPATHY,22
RS,DISEASE PROGRESSION,22
RS,DRUG ABUSE,22
RS,HEADACHE,22
RS,TACHYCARDIA,22
RS,CARDIAC FAILURE,21
RS,HYPERSENSITIVITY,21
RS,SOMNOLENCE,21
RS,VOMITING,21
RS,CHOKING,20
RS,RESPIRATORY FAILURE,20
RS,ARTHRALGIA,19
RS,TOXIC EPIDERMAL NECROLYSIS,19
RS,ACUTE MYOCARDIAL INFARCTION,18
RS,ARRHYTHMIA,18
RS,CONDITION AGGRAVATED,18
RS,HYPERGLYCAEMIA,18
RS,GASTROINTESTINAL HAEMORRHAGE,17
RS,LOSS OF CONSCIOUSNESS,17
RS,SEPSIS,17
RS,COUGH,16
RS,TRANSAMINASES INCREASED,16
RS,ANXIETY,15
RS,ASPHYXIA,15
RS,CONFUSIONAL STATE,15
RS,HAEMORRHAGE INTRACRANIAL,15
RS,PLEURAL EFFUSION,15
RS,ATRIOVENTRICULAR BLOCK COMPLETE,14
RS,CHILLS,14
RS,DIZZINESS,14
RS,POISONING DELIBERATE,14
RS,EXPOSURE DURING PREGNANCY,13
RS,GENERAL PHYSICAL HEALTH DETERIORATION,13
RS,PANCYTOPENIA,13
RS,SINUS TACHYCARDIA,13
RS,BRADYCARDIA,12
RS,DISORIENTATION,12
RS,FOETAL EXPOSURE DURING PREGNANCY,12
RS,HYPERTENSION,12
RS,JOINT SWELLING,12
RS,RENAL FAILURE,12
RS,ABDOMINAL PAIN,11
RS,BLOOD CREATININE INCREASED,11
RS,CIRCULATORY COLLAPSE,11
RS,DISEASE RECURRENCE,11
RS,FALL,11
RS,FLUSHING,11
RS,INFECTION,11
RS,MYOCARDIAL INFARCTION,11
RS,SEPTIC SHOCK,11
RS,VENOUS THROMBOSIS LIMB,11
RS,WEIGHT DECREASED,11
RS,BACK PAIN,10
RS,DEHYDRATION,10
RS,EYELID OEDEMA,10
RS,FEBRILE NEUTROPENIA,10
RS,HAEMATEMESIS,10
RS,HEPATIC FAILURE,10
RS,HERPES ZOSTER,10
RS,TREMOR,10
RS,URINARY TRACT INFECTION,10
RS,BUNDLE BRANCH BLOCK RIGHT,9
RS,DEPRESSION,9
RS,EPISTAXIS,9
RS,HAEMORRHAGE,9
RS,HYPOGLYCAEMIA,9
RS,INSOMNIA,9
RS,MALIGNANT NEOPLASM PROGRESSION,9
RS,MELAENA,9
RS,MULTIPLE ORGAN DYSFUNCTION SYNDROME,9
RS,OEDEMA,9
RS,PRODUCT USE ISSUE,9
RS,STOMATITIS,9
RS,SUICIDE ATTEMPT,9
RS,SWELLING FACE,9
RS,VERTIGO,9
RS,ACUTE RESPIRATORY DISTRESS SYNDROME,8
RS,ALANINE AMINOTRANSFERASE INCREASED,8
RS,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,8
RS,FEELING ABNORMAL,8
RS,MATERNAL EXPOSURE DURING PREGNANCY,8
RS,OEDEMA PERIPHERAL,8
RS,PAIN,8
RS,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,8
RS,PRODUCT QUALITY ISSUE,8
RS,RASH GENERALISED,8
RS,URINARY RETENTION,8
RS,ABORTION SPONTANEOUS,7
RS,ALOPECIA,7
RS,ANAPHYLACTIC REACTION,7
RS,ANGIOEDEMA,7
RS,ASPARTATE AMINOTRANSFERASE INCREASED,7
RS,ATRIOVENTRICULAR BLOCK SECOND DEGREE,7
RS,BLISTER,7
RS,BLOOD GLUCOSE INCREASED,7
RS,BLOOD PRESSURE ABNORMAL,7
RS,BLOOD PRESSURE INCREASED,7
RS,BODY TEMPERATURE INCREASED,7
RS,CEREBRAL HAEMORRHAGE,7
RS,CEREBROVASCULAR ACCIDENT,7
RS,CHEST PAIN,7
RS,COMPLETED SUICIDE,7
RS,DECREASED APPETITE,7
RS,GASTROINTESTINAL OBSTRUCTION,7
RS,GENERALISED TONIC-CLONIC SEIZURE,7
RS,HAEMOGLOBIN DECREASED,7
RS,HEPATOTOXICITY,7
RS,INJECTION SITE ERYTHEMA,7
RS,MYALGIA,7
RS,PAIN IN EXTREMITY,7
RS,POISONING,7
RS,PROTEINURIA,7
RS,PSEUDOMONAS INFECTION,7
RS,SWOLLEN TONGUE,7
RS,THROAT TIGHTNESS,7
RS,ABDOMINAL DISTENSION,6
RS,ABDOMINAL PAIN UPPER,6
RS,BRONCHOPULMONARY ASPERGILLOSIS,6
RS,BRONCHOSPASM,6
RS,COLITIS,6
RS,CONSTIPATION,6
RS,DEEP VEIN THROMBOSIS,6
RS,EPILEPSY,6
RS,HYPERHIDROSIS,6
RS,INTESTINAL DIAPHRAGM DISEASE,6
RS,IRIDOCYCLITIS,6
RS,OROPHARYNGEAL PAIN,6
RS,OSTEONECROSIS OF JAW,6
RS,RASH MACULAR,6
RS,RENAL FAILURE ACUTE,6
RS,SALIVARY HYPERSECRETION,6
RS,SEIZURE,6
RS,SKIN NECROSIS,6
RS,STEVENS-JOHNSON SYNDROME,6
RS,VENTRICULAR EXTRASYSTOLES,6
RS,ACUTE KIDNEY INJURY,5
RS,ANURIA,5
RS,ATAXIA,5
RS,ATRIOVENTRICULAR BLOCK,5
RS,ATRIOVENTRICULAR BLOCK FIRST DEGREE,5
RS,BLOOD BILIRUBIN INCREASED,5
RS,BLOOD LACTATE DEHYDROGENASE INCREASED,5
RS,C-REACTIVE PROTEIN INCREASED,5
RS,CLOSTRIDIUM DIFFICILE INFECTION,5
RS,COLONIC PSEUDO-OBSTRUCTION,5
RS,CYANOSIS,5
RS,DEFAECATION URGENCY,5
RS,DRUG HYPERSENSITIVITY,5
RS,DYSPHAGIA,5
RS,ELECTROCARDIOGRAM QT PROLONGED,5
RS,ENCEPHALITIS,5
RS,FACE OEDEMA,5
RS,FEELING HOT,5
RS,HAEMATOMA,5
RS,HAEMATURIA,5
RS,HEART RATE INCREASED,5
RS,HEPATITIS C,5
RS,HYPERAEMIA,5
RS,HYPOKALAEMIA,5
RS,HYPOKINESIA,5
RS,ILEUS,5
RS,INFUSION RELATED REACTION,5
RS,INTERSTITIAL LUNG DISEASE,5
RS,ISCHAEMIC STROKE,5
RS,LIP SWELLING,5
RS,MEGACOLON,5
RS,MUSCULAR WEAKNESS,5
RS,PALLOR,5
RS,PALPITATIONS,5
RS,PARAESTHESIA,5
RS,PERITONITIS,5
RS,PREMATURE BABY,5
RS,RESPIRATORY ARREST,5
RS,RESPIRATORY TRACT INFECTION,5
RS,RHABDOMYOLYSIS,5
RS,RHEUMATOID ARTHRITIS,5
RS,SCAB,5
RS,SKIN LESION,5
RS,SUFFOCATION FEELING,5
RS,SYNCOPE,5
RS,THROMBOSIS,5
RS,TONGUE OEDEMA,5
RS,ABNORMAL BEHAVIOUR,4
RS,ABSCESS LIMB,4
RS,AGGRESSION,4
RS,AGRANULOCYTOSIS,4
RS,AMYLASE INCREASED,4
RS,APHASIA,4
RS,ASTHMA,4
RS,BLOOD UREA INCREASED,4
RS,BONE MARROW FAILURE,4
RS,BRAIN OEDEMA,4
RS,BRONCHOPNEUMONIA,4
RS,CEREBRAL INFARCTION,4
RS,CONJUNCTIVITIS,4
RS,DERMATITIS ALLERGIC,4
RS,DISSEMINATED INTRAVASCULAR COAGULATION,4
RS,DRUG LEVEL INCREASED,4
RS,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,4
RS,EMBOLISM VENOUS,4
RS,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
RS,GRANULOCYTOPENIA,4
RS,HAEMOPTYSIS,4
RS,HALLUCINATION_ VISUAL,4
RS,HEMIPARESIS,4
RS,HEPATIC ENZYME INCREASED,4
RS,HEPATIC LESION,4
RS,HEREDITARY ANGIOEDEMA,4
RS,HYPERCALCAEMIA,4
RS,HYPERPROLACTINAEMIA,4
RS,HYPOAESTHESIA,4
RS,HYPOMAGNESAEMIA,4
RS,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,4
RS,LIMB INJURY,4
RS,LIP OEDEMA,4
RS,MUCOSAL INFLAMMATION,4
RS,MUSCLE SPASMS,4
RS,MUSCULOSKELETAL PAIN,4
RS,PARONYCHIA,4
RS,PERIPARTUM CARDIOMYOPATHY,4
RS,POLYMYOSITIS,4
RS,PSYCHOTIC DISORDER,4
RS,PULSE ABNORMAL,4
RS,PULSE ABSENT,4
RS,RENAL IMPAIRMENT,4
RS,RENAL PAIN,4
RS,RESTLESSNESS,4
RS,ROAD TRAFFIC ACCIDENT,4
RS,SCHIZOPHRENIA,4
RS,SKIN EROSION,4
RS,SPEECH DISORDER,4
RS,SQUAMOUS CELL CARCINOMA OF SKIN,4
RS,STAPHYLOCOCCAL INFECTION,4
RS,SUDDEN DEATH,4
RS,TACHYPNOEA,4
RS,TONGUE DISORDER,4
RS,TUMOUR NECROSIS,4
RS,WEIGHT INCREASED,4
RS,WHEEZING,4
RS,ABDOMINAL DISCOMFORT,3
RS,ABDOMINAL WALL HAEMATOMA,3
RS,ACTINIC KERATOSIS,3
RS,ACUTE RESPIRATORY FAILURE,3
RS,AGITATION,3
RS,ARACHNOIDITIS,3
RS,ARTHRITIS,3
RS,ASCITES,3
RS,ASPERGILLUS INFECTION,3
RS,ATRIAL FIBRILLATION,3
RS,ATRIAL THROMBOSIS,3
RS,BACTERAEMIA,3
RS,BASAL CELL CARCINOMA,3
RS,BLOOD CHOLESTEROL INCREASED,3
RS,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
RS,BLOOD POTASSIUM INCREASED,3
RS,BLOOD PRESSURE DECREASED,3
RS,BONE EROSION,3
RS,BREAST CANCER,3
RS,BRONCHITIS,3
RS,CATAPLEXY,3
RS,CEREBRAL CALCIFICATION,3
RS,CEREBRAL ISCHAEMIA,3
RS,CHEILITIS,3
RS,CHRONIC LYMPHOCYTIC LEUKAEMIA,3
RS,CONTUSION,3
RS,CYTOMEGALOVIRUS INFECTION,3
RS,DEPRESSED LEVEL OF CONSCIOUSNESS,3
RS,DIARRHOEA HAEMORRHAGIC,3
RS,DIPLOPIA,3
RS,DISTURBANCE IN ATTENTION,3
RS,DRUG ADMINISTRATION ERROR,3
RS,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
RS,DRUG INTOLERANCE,3
RS,DRUG RESISTANCE,3
RS,DYSPEPSIA,3
RS,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,3
RS,EMBOLISM,3
RS,ENCEPHALOPATHY,3
RS,EPSTEIN-BARR VIRUS INFECTION,3
RS,GASTRITIS,3
RS,GASTROINTESTINAL DISORDER,3
RS,HAEMATOTOXICITY,3
RS,HAEMODYNAMIC INSTABILITY,3
RS,HEAD DISCOMFORT,3
RS,HEMIPLEGIA,3
RS,HEPATOSPLENOMEGALY,3
RS,HYDRONEPHROSIS,3
RS,HYPOALBUMINAEMIA,3
RS,INFLUENZA LIKE ILLNESS,3
RS,INJECTION SITE SWELLING,3
RS,INTRAVENTRICULAR HAEMORRHAGE,3
RS,IRON DEFICIENCY ANAEMIA,3
RS,IRRITABILITY,3
RS,JAUNDICE,3
RS,LACRIMATION INCREASED,3
RS,LARYNGOSPASM,3
RS,LEUKOCYTOSIS,3
RS,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,3
RS,LOW BIRTH WEIGHT BABY,3
RS,MEMORY IMPAIRMENT,3
RS,METASTASES TO CENTRAL NERVOUS SYSTEM,3
RS,MULTI-ORGAN FAILURE,3
RS,MULTIPLE SCLEROSIS RELAPSE,3
RS,MUSCLE TWITCHING,3
RS,NEOPLASM PROGRESSION,3
RS,NEPHROPATHY TOXIC,3
RS,NEUROPATHY PERIPHERAL,3
RS,NIKOLSKY^S SIGN,3
RS,NO ADVERSE EVENT,3
RS,OCULAR HYPERAEMIA,3
RS,OLIGURIA,3
RS,PANCREATIC CARCINOMA,3
RS,PANCREATITIS ACUTE,3
RS,PHARYNGEAL OEDEMA,3
RS,PLASMA CELL MYELOMA,3
RS,PNEUMONITIS,3
RS,PNEUMOPERITONEUM,3
RS,PRODUCT USE IN UNAPPROVED INDICATION,3
RS,PRURITUS GENERALISED,3
RS,PULMONARY FIBROSIS,3
RS,RASH MACULO-PAPULAR,3
RS,RESPIRATORY ACIDOSIS,3
RS,RESPIRATORY DISORDER,3
RS,SKIN BURNING SENSATION,3
RS,SKIN DISORDER,3
RS,SKIN EXFOLIATION,3
RS,SPINAL COMPRESSION FRACTURE,3
RS,STAPHYLOCOCCAL SEPSIS,3
RS,TINNITUS,3
RS,TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE,3
RS,TREATMENT FAILURE,3
RS,TRISMUS,3
RS,VISUAL IMPAIRMENT,3
RS,WHITE BLOOD CELL COUNT INCREASED,3
RS,ABDOMINAL INCARCERATED HERNIA,2
RS,ACIDOSIS,2
RS,ACUTE ABDOMEN,2
RS,ACUTE MYELOID LEUKAEMIA,2
RS,AGEUSIA,2
RS,ALTERED STATE OF CONSCIOUSNESS,2
RS,AMENORRHOEA,2
RS,AMNESIA,2
RS,ANAPHYLACTIC SHOCK,2
RS,ANGINA PECTORIS,2
RS,ARTERIAL HAEMORRHAGE,2
RS,ARTHROPATHY,2
RS,AZOTAEMIA,2
RS,BLINDNESS TRANSIENT,2
RS,BLOOD ALKALINE PHOSPHATASE INCREASED,2
RS,BLOOD PRESSURE SYSTOLIC DECREASED,2
RS,BLOOD THYROID STIMULATING HORMONE INCREASED,2
RS,BONE PAIN,2
RS,CARDIAC FAILURE ACUTE,2
RS,CARDIO-RESPIRATORY ARREST,2
RS,CARDIOGENIC SHOCK,2
RS,CARDIOVASCULAR INSUFFICIENCY,2
RS,CD4 LYMPHOCYTES DECREASED,2
RS,CELLULITIS,2
RS,CENTRAL NERVOUS SYSTEM LESION,2
RS,CHOLELITHIASIS,2
RS,CHRONIC KIDNEY DISEASE,2
RS,CLOSTRIDIUM DIFFICILE COLITIS,2
RS,CONJUNCTIVAL HYPERAEMIA,2
RS,CONVULSION,2
RS,COR PULMONALE ACUTE,2
RS,CRYING,2
RS,CUSHING^S SYNDROME,2
RS,CYST,2
RS,CYTOKINE RELEASE SYNDROME,2
RS,DEAFNESS NEUROSENSORY,2
RS,DEATH NEONATAL,2
RS,DELIRIUM,2
RS,DELUSION,2
RS,DEPRESSED MOOD,2
RS,DERMATITIS,2
RS,DEVICE RELATED INFECTION,2
RS,DISCOMFORT,2
RS,DISSEMINATED TUBERCULOSIS,2
RS,DRUG-DISEASE INTERACTION,2
RS,DRUG-INDUCED LIVER INJURY,2
RS,DRY MOUTH,2
RS,DUODENAL ULCER,2
RS,DYSPHONIA,2
RS,EJECTION FRACTION DECREASED,2
RS,ELECTROLYTE IMBALANCE,2
RS,EMPYEMA,2
RS,ENANTHEMA,2
RS,EOSINOPHILIC MYOCARDITIS,2
RS,ERYTHEMA MULTIFORME,2
RS,ERYTHEMA NODOSUM,2
RS,ESCHERICHIA SEPSIS,2
RS,FAECES DISCOLOURED,2
RS,FEMUR FRACTURE,2
RS,GAIT DISTURBANCE,2
RS,GASTRIC ULCER,2
RS,GASTRIC ULCER HAEMORRHAGE,2
RS,GASTROINTESTINAL HYPOMOTILITY,2
RS,GENERALISED ERYTHEMA,2
RS,GENERALISED OEDEMA,2
RS,GENITAL HAEMORRHAGE,2
RS,GLAUCOMA,2
RS,GRANULOMA,2
RS,HAEMATOCHEZIA,2
RS,HALLUCINATION,2
RS,HALLUCINATION_ AUDITORY,2
RS,HEPARIN-INDUCED THROMBOCYTOPENIA,2
RS,HEPATITIS,2
RS,HEPATITIS TOXIC,2
RS,HEPATOSPLENIC CANDIDIASIS,2
RS,HIP FRACTURE,2
RS,HODGKIN^S DISEASE NODULAR SCLEROSIS,2
RS,HYPERLIPIDAEMIA,2
RS,HYPERTENSIVE CRISIS,2
RS,HYPERTHERMIA,2
RS,HYPERTHYROIDISM,2
RS,HYPERTRIGLYCERIDAEMIA,2
RS,HYPOAESTHESIA ORAL,2
RS,HYPOPNOEA,2
RS,HYPOXIA,2
RS,IDIOPATHIC THROMBOCYTOPENIC PURPURA,2
RS,IMMUNE THROMBOCYTOPENIC PURPURA,2
RS,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,2
RS,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
RS,INFECTION REACTIVATION,2
RS,INJECTION SITE EXTRAVASATION,2
RS,INJECTION SITE NECROSIS,2
RS,INJECTION SITE PRURITUS,2
RS,INTENTIONAL PRODUCT MISUSE,2
RS,INTERNATIONAL NORMALISED RATIO INCREASED,2
RS,IRREGULAR BREATHING,2
RS,JOINT CONTRACTURE,2
RS,KIDNEY TRANSPLANT REJECTION,2
RS,KLEBSIELLA INFECTION,2
RS,LIVER DISORDER,2
RS,LIVER INJURY,2
RS,LUNG NEOPLASM MALIGNANT,2
RS,LYMPHADENOPATHY,2
RS,LYMPHOCYTOSIS,2
RS,MACULOPATHY,2
RS,MALIGNANT MELANOMA,2
RS,MASTITIS,2
RS,MENTAL DISORDER,2
RS,MENTAL IMPAIRMENT,2
RS,METASTASIS,2
RS,METRORRHAGIA,2
RS,MITRAL VALVE INCOMPETENCE,2
RS,MOBILITY DECREASED,2
RS,MOOD SWINGS,2
RS,MOTOR DYSFUNCTION,2
RS,MOVEMENT DISORDER,2
RS,MULTIPLE FRACTURES,2
RS,MUSCLE RIGIDITY,2
RS,MYOPATHY,2
RS,NAIL DISORDER,2
RS,NEOPLASM,2
RS,NERVOUS SYSTEM DISORDER,2
RS,NEUROLEPTIC MALIGNANT SYNDROME,2
RS,NIGHT SWEATS,2
RS,NO THERAPEUTIC RESPONSE,2
RS,NOCARDIOSIS,2
RS,NON-HODGKIN^S LYMPHOMA,2
RS,OEDEMA MOUTH,2
RS,OESOPHAGEAL VARICES HAEMORRHAGE,2
RS,ORAL MUCOSA EROSION,2
RS,OXYGEN SATURATION DECREASED,2
RS,PANCREATIC ATROPHY,2
RS,PANCREATIC DISORDER,2
RS,PAPILLARY THYROID CANCER,2
RS,PARANEOPLASTIC SYNDROME,2
RS,PERIHEPATIC ABSCESS,2
RS,PERIPHERAL SWELLING,2
RS,PLATELET COUNT DECREASED,2
RS,PNEUMONIA ASPIRATION,2
RS,PNEUMONIA BACTERIAL,2
RS,PNEUMOTHORAX,2
RS,POST PROCEDURAL COMPLICATION,2
RS,PREGNANCY,2
RS,PREMATURE LABOUR,2
RS,PRODUCT SUBSTITUTION ISSUE,2
RS,PRODUCTIVE COUGH,2
RS,PSEUDOMEMBRANOUS COLITIS,2
RS,PSORIASIS,2
RS,PULMONARY PAIN,2
RS,PULMONARY TUBERCULOSIS,2
RS,PUPILLARY DISORDER,2
RS,RASH ERYTHEMATOUS,2
RS,RECTAL POLYP,2
RS,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
RS,RENAL CANCER METASTATIC,2
RS,RESPIRATORY DEPRESSION,2
RS,RESTRICTIVE PULMONARY DISEASE,2
RS,RETCHING,2
RS,RETINAL DETACHMENT,2
RS,RIB FRACTURE,2
RS,RIGHT VENTRICULAR FAILURE,2
RS,SARCOIDOSIS,2
RS,SEDATION,2
RS,SELF INJURIOUS BEHAVIOUR,2
RS,SHOCK HAEMORRHAGIC,2
RS,SKIN HAEMORRHAGE,2
RS,SKIN TOXICITY,2
RS,SLEEP APNOEA SYNDROME,2
RS,SLEEP DISORDER,2
RS,SPLEEN DISORDER,2
RS,STATUS EPILEPTICUS,2
RS,SUBCUTANEOUS HAEMATOMA,2
RS,SUBILEUS,2
RS,TEARFULNESS,2
RS,THERAPEUTIC RESPONSE DECREASED,2
RS,THROMBOPHLEBITIS,2
RS,THROMBOSIS IN DEVICE,2
RS,TORSADE DE POINTES,2
RS,TUBERCULOSIS,2
RS,TUMOUR LYSIS SYNDROME,2
RS,URINARY INCONTINENCE,2
RS,URINE OUTPUT DECREASED,2
RS,UROSEPSIS,2
RS,VARICELLA ZOSTER VIRUS INFECTION,2
RS,VASCULAR STENT THROMBOSIS,2
RS,VENOUS THROMBOSIS,2
RS,VENTRICULAR FIBRILLATION,2
RS,VENTRICULAR TACHYCARDIA,2
RS,VIRAL INFECTION,2
RS,VISION BLURRED,2
RS,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
RS,YELLOW SKIN,2
RS,ABASIA,1
RS,ABDOMINAL MASS,1
RS,ABDOMINAL PAIN LOWER,1
RS,ABNORMAL SENSATION IN EYE,1
RS,ABORTION,1
RS,ABORTION INDUCED,1
RS,ABORTION MISSED,1
RS,ACCIDENT,1
RS,ACCIDENTAL OVERDOSE,1
RS,ACINETOBACTER INFECTION,1
RS,ACINETOBACTER TEST POSITIVE,1
RS,ACNE,1
RS,ACUTE CORONARY SYNDROME,1
RS,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,1
RS,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,1
RS,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
RS,ACUTE HEPATIC FAILURE,1
RS,ACUTE HEPATITIS C,1
RS,ADENOCARCINOMA GASTRIC,1
RS,ADRENAL INSUFFICIENCY,1
RS,ADVERSE EVENT,1
RS,ANAL EROSION,1
RS,ANAL INCONTINENCE,1
RS,ANAL STENOSIS,1
RS,ANGER,1
RS,ANGIOPATHY,1
RS,ANGIOSARCOMA,1
RS,ANGIOTENSIN CONVERTING ENZYME INCREASED,1
RS,ANKLE FRACTURE,1
RS,ANORECTAL DISORDER,1
RS,ANOSMIA,1
RS,ANTEROGRADE AMNESIA,1
RS,ANTI-THYROID ANTIBODY POSITIVE,1
RS,ANTIPSYCHOTIC DRUG LEVEL DECREASED,1
RS,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
RS,AORTIC RUPTURE,1
RS,AORTIC VALVE INCOMPETENCE,1
RS,APATHY,1
RS,APHTHOUS STOMATITIS,1
RS,APHTHOUS ULCER,1
RS,APLASIA,1
RS,APLASIA CUTIS CONGENITA,1
RS,APNOEA,1
RS,APPENDICITIS PERFORATED,1
RS,ARTERIAL INJURY,1
RS,ARTHRITIS BACTERIAL,1
RS,ASTROCYTOMA,1
RS,ASTROCYTOMA_ LOW GRADE,1
RS,ASYMPTOMATIC BACTERIURIA,1
RS,ATELECTASIS,1
RS,AUTOANTIBODY TEST,1
RS,AUTOIMMUNE HEPATITIS,1
RS,B-CELL LYMPHOMA,1
RS,BACTERIAL SEPSIS,1
RS,BALANCE DISORDER,1
RS,BALANOPOSTHITIS,1
RS,BENIGN NEOPLASM OF PROSTATE,1
RS,BICYTOPENIA,1
RS,BILE DUCT STONE,1
RS,BILIARY COLIC,1
RS,BILIRUBIN CONJUGATED INCREASED,1
RS,BLADDER NEOPLASM,1
RS,BLADDER PERFORATION,1
RS,BLAU SYNDROME,1
RS,BLIGHTED OVUM,1
RS,BLOOD 1_25-DIHYDROXYCHOLECALCIFEROL DECREASED,1
RS,BLOOD CHOLESTEROL DECREASED,1
RS,BLOOD COUNT ABNORMAL,1
RS,BLOOD DISORDER,1
RS,BLOOD FIBRINOGEN DECREASED,1
RS,BLOOD GLUCOSE ABNORMAL,1
RS,BLOOD GLUCOSE DECREASED,1
RS,BLOOD LACTIC ACID INCREASED,1
RS,BLOOD PRESSURE FLUCTUATION,1
RS,BLOOD PRESSURE IMMEASURABLE,1
RS,BLOOD PRESSURE SYSTOLIC INCREASED,1
RS,BLOOD TEST ABNORMAL,1
RS,BLOOD TRIGLYCERIDES INCREASED,1
RS,BLOOD URIC ACID INCREASED,1
RS,BONE DENSITY DECREASED,1
RS,BORDERLINE OVARIAN TUMOUR,1
RS,BOWEN^S DISEASE,1
RS,BRADYKINESIA,1
RS,BRAIN ABSCESS,1
RS,BRAIN CONTUSION,1
RS,BRAIN NEOPLASM,1
RS,BREAKTHROUGH PAIN,1
RS,BREATH ODOUR,1
RS,BRONCHIAL HAEMORRHAGE,1
RS,BRONCHIAL OBSTRUCTION,1
RS,BRONCHOSPASM PARADOXICAL,1
RS,BRUXISM,1
RS,BURNING SENSATION,1
RS,C-REACTIVE PROTEIN ABNORMAL,1
RS,CAESAREAN SECTION,1
RS,CAPILLARITIS,1
RS,CARCINOMA IN SITU,1
RS,CARDIAC DISORDER,1
RS,CARDIAC FAILURE CONGESTIVE,1
RS,CARDIOMEGALY,1
RS,CARDIOPULMONARY FAILURE,1
RS,CAROTID ARTERY DISEASE,1
RS,CATHETER SITE ISCHAEMIA,1
RS,CENTRAL NERVOUS SYSTEM HAEMORRHAGE,1
RS,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
RS,CEREBELLAR HAEMORRHAGE,1
RS,CEREBRAL HAEMATOMA,1
RS,CHOKING SENSATION,1
RS,CHOLECYSTECTOMY,1
RS,CHOLECYSTITIS ACUTE,1
RS,CHOLESTASIS,1
RS,CHORIOCARCINOMA,1
RS,CHORIORETINAL DISORDER,1
RS,CHRONIC GASTRITIS,1
RS,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
RS,COAGULATION FACTOR INCREASED,1
RS,COAGULOPATHY,1
RS,COLD SWEAT,1
RS,COLITIS ULCERATIVE,1
RS,COLON CANCER,1
RS,COLORECTAL CANCER METASTATIC,1
RS,COMA HEPATIC,1
RS,COMMUNICATION DISORDER,1
RS,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
RS,CONCUSSION,1
RS,CONGENITAL ANOMALY,1
RS,CONGENITAL JAW MALFORMATION,1
RS,CONGESTIVE CARDIOMYOPATHY,1
RS,CONJUNCTIVAL DISORDER,1
RS,CONJUNCTIVAL OEDEMA,1
RS,CONJUNCTIVITIS ALLERGIC,1
RS,CONTRAST MEDIA ALLERGY,1
RS,COORDINATION ABNORMAL,1
RS,CORONARY ARTERY THROMBOSIS,1
RS,CORYNEBACTERIUM INFECTION,1
RS,CRANIOPHARYNGIOMA,1
RS,CREPITATIONS,1
RS,CROHN^S DISEASE,1
RS,CUTANEOUS VASCULITIS,1
RS,CYANOSIS CENTRAL,1
RS,CYSTITIS,1
RS,CYSTITIS GLANDULARIS,1
RS,CYTOPENIA,1
RS,DACTYLITIS,1
RS,DELAYED GRAFT FUNCTION,1
RS,DEMYELINATION,1
RS,DEPRESSION SUICIDAL,1
RS,DEPRESSIVE SYMPTOM,1
RS,DERMATITIS ATOPIC,1
RS,DERMATITIS BULLOUS,1
RS,DERMATITIS CONTACT,1
RS,DERMATITIS EXFOLIATIVE,1
RS,DEVICE LEAKAGE,1
RS,DIABETES MELLITUS INADEQUATE CONTROL,1
RS,DIARRHOEA INFECTIOUS,1
RS,DIASTOLIC DYSFUNCTION,1
RS,DISTRIBUTIVE SHOCK,1
RS,DRUG DOSE OMISSION,1
RS,DRUG EFFECT DECREASED,1
RS,DRUG EFFECT INCOMPLETE,1
RS,DRUG LEVEL ABOVE THERAPEUTIC,1
RS,DRUG TOLERANCE DECREASED,1
RS,DRUG WITHDRAWAL SYNDROME,1
RS,DRY SKIN,1
RS,DUODENITIS,1
RS,DYSARTHRIA,1
RS,DYSGEUSIA,1
RS,DYSURIA,1
RS,EAR INFECTION,1
RS,EATING DISORDER,1
RS,ECCHYMOSIS,1
RS,EDUCATIONAL PROBLEM,1
RS,EFFUSION,1
RS,ELECTROCARDIOGRAM T WAVE INVERSION,1
RS,ELECTROENCEPHALOGRAM ABNORMAL,1
RS,EMOTIONAL DISORDER,1
RS,EMOTIONAL DISTRESS,1
RS,EMPHYSEMA,1
RS,ENCEPHALOMYELITIS,1
RS,END STAGE RENAL DISEASE,1
RS,ENTEROCOCCAL INFECTION,1
RS,ENTEROCOLITIS,1
RS,EPIGASTRIC DISCOMFORT,1
RS,ERECTILE DYSFUNCTION,1
RS,ERYTHEMA INDURATUM,1
RS,ERYTHRODERMIC PSORIASIS,1
RS,ERYTHROPENIA,1
RS,ESCHERICHIA URINARY TRACT INFECTION,1
RS,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,1
RS,EXTRAPYRAMIDAL DISORDER,1
RS,EYE IRRITATION,1
RS,EYE MOVEMENT DISORDER,1
RS,EYE PAIN,1
RS,EYE PRURITUS,1
RS,EYELID PTOSIS,1
RS,FACIAL PAIN,1
RS,FAECES HARD,1
RS,FEAR,1
RS,FEELING COLD,1
RS,FEMORAL ARTERY EMBOLISM,1
RS,FEMORAL NECK FRACTURE,1
RS,FIBRIN D DIMER INCREASED,1
RS,FIBROSIS,1
RS,FINGER DEFORMITY,1
RS,FOETAL DEATH,1
RS,FOLLICULAR THYROID CANCER,1
RS,FREQUENT BOWEL MOVEMENTS,1
RS,FUNCTIONAL GASTROINTESTINAL DISORDER,1
RS,FUNDOSCOPY ABNORMAL,1
RS,GALACTORRHOEA,1
RS,GALLBLADDER EMPYEMA,1
RS,GALLBLADDER OBSTRUCTION,1
RS,GALLBLADDER POLYP,1
RS,GASTRIC CANCER,1
RS,GASTRIC DILATATION,1
RS,GASTRIC DISORDER,1
RS,GASTRIC HAEMORRHAGE,1
RS,GASTRIC VARICES HAEMORRHAGE,1
RS,GASTRITIS EROSIVE,1
RS,GASTROENTERITIS,1
RS,GASTROENTERITIS SALMONELLA,1
RS,GASTROINTESTINAL MUCOSA HYPERAEMIA,1
RS,GASTROINTESTINAL PAIN,1
RS,GASTROINTESTINAL SOUNDS ABNORMAL,1
RS,GASTROINTESTINAL ULCER HAEMORRHAGE,1
RS,GENERAL PHYSICAL CONDITION ABNORMAL,1
RS,GENITOURINARY SYMPTOM,1
RS,GINGIVAL BLEEDING,1
RS,GLOMERULAR FILTRATION RATE DECREASED,1
RS,GLOMERULONEPHRITIS,1
RS,GLOMERULONEPHRITIS PROLIFERATIVE,1
RS,GRAFT VERSUS HOST DISEASE IN INTESTINE,1
RS,GRAFT VERSUS HOST DISEASE IN SKIN,1
RS,GRANULOCYTE COUNT INCREASED,1
RS,GYNAECOMASTIA,1
RS,HAEMATOCRIT DECREASED,1
RS,HAEMODIALYSIS,1
RS,HAEMOGLOBIN ABNORMAL,1
RS,HAEMOLYSIS,1
RS,HAEMOLYTIC ANAEMIA,1
RS,HAEMORRHAGE IN PREGNANCY,1
RS,HAEMORRHAGIC DISORDER,1
RS,HAEMORRHAGIC TRANSFORMATION STROKE,1
RS,HAEMORRHOIDAL HAEMORRHAGE,1
RS,HAEMOTHORAX,1
RS,HAIR COLOUR CHANGES,1
RS,HALLUCINATIONS_ MIXED,1
RS,HAND-EYE COORDINATION IMPAIRED,1
RS,HEAD INJURY,1
RS,HEART RATE ABNORMAL,1
RS,HEART RATE IRREGULAR,1
RS,HELICOBACTER GASTRITIS,1
RS,HEMIANAESTHESIA,1
RS,HEPATIC CANCER,1
RS,HEPATIC CIRRHOSIS,1
RS,HEPATIC FUNCTION ABNORMAL,1
RS,HEPATIC HAEMORRHAGE,1
RS,HEPATIC STEATOSIS,1
RS,HEPATITIS B,1
RS,HEPATITIS VIRAL,1
RS,HEPATOCELLULAR INJURY,1
RS,HEPATOMEGALY,1
RS,HEPATORENAL FAILURE,1
RS,HERPES ZOSTER MENINGOENCEPHALITIS,1
RS,HERPES ZOSTER OTICUS,1
RS,HETEROPHORIA,1
RS,HIGH DENSITY LIPOPROTEIN DECREASED,1
RS,HISTIOCYTOSIS HAEMATOPHAGIC,1
RS,HODGKIN^S DISEASE,1
RS,HYDROCEPHALUS,1
RS,HYPERBILIRUBINAEMIA,1
RS,HYPERCOAGULATION,1
RS,HYPERFERRITINAEMIA,1
RS,HYPERKALAEMIA,1
RS,HYPERPARATHYROIDISM,1
RS,HYPERPYREXIA,1
RS,HYPERSENSITIVITY VASCULITIS,1
RS,HYPERURICAEMIA,1
RS,HYPERVENTILATION,1
RS,HYPOCALCAEMIA,1
RS,HYPOGAMMAGLOBULINAEMIA,1
RS,HYPOGLYCAEMIC COMA,1
RS,HYPOPROTEINAEMIA,1
RS,HYPOTHYROIDISM,1
RS,HYPOTONIA,1
RS,HYPOTONIA NEONATAL,1
RS,HYPOVENTILATION,1
RS,ILEUS PARALYTIC,1
RS,ILL-DEFINED DISORDER,1
RS,IMMOBILE,1
RS,IMPAIRED HEALING,1
RS,INADEQUATE ANALGESIA,1
RS,INCOHERENT,1
RS,INCONTINENCE,1
RS,INCORRECT DOSE ADMINISTERED,1
RS,INCREASED UPPER AIRWAY SECRETION,1
RS,INFECTIOUS PLEURAL EFFUSION,1
RS,INFLAMMATORY MARKER INCREASED,1
RS,INFLAMMATORY PAIN,1
RS,INFLUENZA,1
RS,INJECTION SITE ABSCESS,1
RS,INJECTION SITE INDURATION,1
RS,INJECTION SITE PAIN,1
RS,INJECTION SITE REACTION,1
RS,INJURY,1
RS,INTENTION TREMOR,1
RS,INTENTIONAL SELF-INJURY,1
RS,INTERCEPTED DRUG ADMINISTRATION ERROR,1
RS,INTERVERTEBRAL DISC PROTRUSION,1
RS,INTESTINAL DILATATION,1
RS,INTESTINAL ISCHAEMIA,1
RS,INTESTINAL OBSTRUCTION,1
RS,INTESTINAL PSEUDO-OBSTRUCTION,1
RS,INVASIVE LOBULAR BREAST CARCINOMA,1
RS,INVESTIGATION ABNORMAL,1
RS,JUVENILE IDIOPATHIC ARTHRITIS,1
RS,KERATOACANTHOMA,1
RS,KETOACIDOSIS,1
RS,KNEE DEFORMITY,1
RS,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
RS,LABORATORY TEST ABNORMAL,1
RS,LACTIC ACIDOSIS,1
RS,LARGE INTESTINAL STENOSIS,1
RS,LARGE INTESTINAL ULCER,1
RS,LARGE INTESTINE PERFORATION,1
RS,LARYNGEAL CANCER,1
RS,LARYNGEAL OEDEMA,1
RS,LEFT VENTRICULAR DYSFUNCTION,1
RS,LEFT VENTRICULAR HYPERTROPHY,1
RS,LEUKOENCEPHALOPATHY,1
RS,LIGHT CHAIN DISEASE,1
RS,LIMB MALFORMATION,1
RS,LIMBIC ENCEPHALITIS,1
RS,LIP ERYTHEMA,1
RS,LIPASE INCREASED,1
RS,LIPID METABOLISM DISORDER,1
RS,LIVE BIRTH,1
RS,LOCAL REACTION,1
RS,LOCALISED OEDEMA,1
RS,LOWER GASTROINTESTINAL HAEMORRHAGE,1
RS,LUNG ADENOCARCINOMA,1
RS,LUNG DISORDER,1
RS,LUNG TRANSPLANT,1
RS,LYMPHADENOPATHY MEDIASTINAL,1
RS,LYMPHANGIOMA,1
RS,LYMPHOCYTE COUNT DECREASED,1
RS,LYMPHOCYTIC INFILTRATION,1
RS,LYMPHOCYTIC LEUKAEMIA,1
RS,LYMPHOMA,1
RS,MACULAR DEGENERATION,1
RS,MALABSORPTION,1
RS,MANIA,1
RS,MASTICATION DISORDER,1
RS,MEAN CELL VOLUME INCREASED,1
RS,MEDICATION ERROR,1
RS,MELANOCYTIC NAEVUS,1
RS,MENINGOENCEPHALITIS VIRAL,1
RS,METABOLIC SYNDROME,1
RS,METASTASES TO EYE,1
RS,METASTASES TO LIVER,1
RS,METASTASES TO LUNG,1
RS,METASTASES TO LYMPH NODES,1
RS,METASTASES TO SPINE,1
RS,METASTASES TO THORAX,1
RS,METASTATIC RENAL CELL CARCINOMA,1
RS,MICTURITION DISORDER,1
RS,MICTURITION URGENCY,1
RS,MIOSIS,1
RS,MONOPLEGIA,1
RS,MUCOSAL DISCOLOURATION,1
RS,MUCOSAL NECROSIS,1
RS,MUSCLE ATROPHY,1
RS,MUSCLE CONTRACTURE,1
RS,MUSCLE TIGHTNESS,1
RS,MUTISM,1
RS,MYASTHENIA GRAVIS,1
RS,MYELODYSPLASTIC SYNDROME,1
RS,MYOCLONIC EPILEPSY,1
RS,MYOCLONUS,1
RS,NAIL BED INFECTION,1
RS,NAIL PITTING,1
RS,NASAL CONGESTION,1
RS,NASAL DRYNESS,1
RS,NASOPHARYNGEAL SURGERY,1
RS,NECROTISING FASCIITIS,1
RS,NECROTISING FASCIITIS STREPTOCOCCAL,1
RS,NEGATIVISM,1
RS,NEPHROLITHIASIS,1
RS,NERVOUSNESS,1
RS,NEURALGIA,1
RS,NEURODERMATITIS,1
RS,NEUROTOXICITY,1
RS,NEUTROPHIL COUNT DECREASED,1
RS,NIGHTMARE,1
RS,NODAL RHYTHM,1
RS,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
RS,OBSTRUCTIVE AIRWAYS DISORDER,1
RS,OEDEMA GENITAL,1
RS,OPHTHALMIC HERPES ZOSTER,1
RS,OPTIC ATROPHY,1
RS,ORAL DISORDER,1
RS,ORAL FUNGAL INFECTION,1
RS,ORAL MUCOSAL ERYTHEMA,1
RS,OSTEITIS,1
RS,OSTEOMYELITIS,1
RS,OSTEONECROSIS,1
RS,OTITIS EXTERNA,1
RS,OTITIS MEDIA,1
RS,OTITIS MEDIA CHRONIC,1
RS,OVARIAN CYST,1
RS,OVARIAN GERM CELL TERATOMA BENIGN,1
RS,PAIN IN JAW,1
RS,PANCREATIC FISTULA,1
RS,PANCREATITIS,1
RS,PANCREATITIS CHRONIC,1
RS,PANCREATITIS RELAPSING,1
RS,PANIC ATTACK,1
RS,PARACENTESIS,1
RS,PARANASAL SINUS HAEMATOMA,1
RS,PARANOIA,1
RS,PARATHYROID TUMOUR BENIGN,1
RS,PARESIS,1
RS,PARKINSON^S DISEASE,1
RS,PEMPHIGUS,1
RS,PERICARDIAL EFFUSION,1
RS,PERIPHERAL COLDNESS,1
RS,PERISTALSIS VISIBLE,1
RS,PERITONEAL DIALYSIS COMPLICATION,1
RS,PETECHIAE,1
RS,PHARYNGEAL HYPOAESTHESIA,1
RS,PHARYNGEAL PARAESTHESIA,1
RS,PHOBIA,1
RS,PHOTOPHOBIA,1
RS,PHYSICAL EXAMINATION,1
RS,PHYSICAL EXAMINATION ABNORMAL,1
RS,PITYRIASIS LICHENOIDES ET VARIOLIFORMIS ACUTA,1
RS,PITYRIASIS ROSEA,1
RS,PLEOCYTOSIS,1
RS,PLEURAL INFECTION BACTERIAL,1
RS,PNEUMOCYSTIS JIROVECII INFECTION,1
RS,PNEUMONIA FUNGAL,1
SC,ACUTE HEPATIC FAILURE,1
SC,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
SC,ASCITES,1
SC,BLOOD BILIRUBIN INCREASED,1
SC,BRAIN OEDEMA,1
SC,CENTRAL NERVOUS SYSTEM LEUKAEMIA,1
SC,CHOLECYSTITIS,1
SC,DEATH,1
SC,DRUG INEFFECTIVE,1
SC,DYSPNOEA,1
SC,HAEMOGLOBIN DECREASED,1
SC,INTRACRANIAL PRESSURE INCREASED,1
SC,JAUNDICE,1
SC,NEUTROPENIA,1
SC,OCULAR ICTERUS,1
SL,ABDOMINAL DISCOMFORT,1
SL,ACCIDENT,1
SL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
SL,ANXIETY,1
SL,ARTHRALGIA,1
SL,ARTHRITIS,1
SL,ASTHENIA,1
SL,BONE PAIN,1
SL,BRAIN NEOPLASM,1
SL,BURNOUT SYNDROME,1
SL,CEREBRAL DISORDER,1
SL,CHILLS,1
SL,DEATH,1
SL,DEPRESSION,1
SL,DISABILITY,1
SL,DRUG HYPERSENSITIVITY,1
SL,DYSPNOEA,1
SL,EMOTIONAL DISTRESS,1
SL,FALL,1
SL,FATIGUE,1
SL,FEELING ABNORMAL,1
SL,FLATULENCE,1
SL,GUN SHOT WOUND,1
SL,HALLUCINATION,1
SL,HEAD INJURY,1
SL,HYPERHIDROSIS,1
SL,INFECTION,1
SL,INSOMNIA,1
SL,INTENTIONAL PRODUCT MISUSE,1
SL,IRRITABILITY,1
SL,JOINT SWELLING,1
SL,LOSS OF CONSCIOUSNESS,1
SL,LOSS OF EMPLOYMENT,1
SL,MALAISE,1
SL,MALARIA,1
SL,MENTAL FATIGUE,1
SL,MOBILITY DECREASED,1
SL,MUSCLE DISORDER,1
SL,MUSCULAR WEAKNESS,1
SL,MUSCULOSKELETAL PAIN,1
SL,NAUSEA,1
SL,NERVE INJURY,1
SL,NIGHTMARE,1
SL,PAIN,1
SL,PAIN IN EXTREMITY,1
SL,PARAESTHESIA,1
SL,PERICARDITIS,1
SL,PERIPHERAL SWELLING,1
SL,PRODUCTIVE COUGH,1
SL,PRURITUS,1
SL,PYREXIA,1
SL,SEXUAL ABUSE,1
SL,SKIN ATROPHY,1
SL,SKIN DISCOLOURATION,1
SL,SKIN DISORDER,1
SL,STRESS,1
SL,SWELLING,1
SL,UNDERDOSE,1
SL,URINARY INCONTINENCE,1
SL,URTICARIA,1
SL,VOMITING,1
SL,WALKING AID USER,1
SL,WHITE BLOOD CELL COUNT DECREASED,1
SL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
SG,ANGIOEDEMA,444
SG,DEATH,380
SG,RASH,220
SG,EYE SWELLING,172
SG,PERIORBITAL OEDEMA,170
SG,DYSPNOEA,153
SG,DIZZINESS,84
SG,PRURITUS,80
SG,DRUG INEFFECTIVE,73
SG,DIARRHOEA,69
SG,PYREXIA,68
SG,PNEUMONIA,62
SG,VOMITING,59
SG,FACE OEDEMA,56
SG,RASH MACULO-PAPULAR,53
SG,DISEASE PROGRESSION,51
SG,URTICARIA,50
SG,MYOCARDIAL INFARCTION,48
SG,FALL,46
SG,NAUSEA,46
SG,STEVENS-JOHNSON SYNDROME,45
SG,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,44
SG,SEPSIS,44
SG,RENAL FAILURE,42
SG,HEADACHE,40
SG,LIP SWELLING,40
SG,PAIN,39
SG,TOXICITY TO VARIOUS AGENTS,38
SG,FEBRILE NEUTROPENIA,37
SG,HYPOTENSION,37
SG,PALPITATIONS,37
SG,ABDOMINAL DISTENSION,34
SG,CEREBROVASCULAR ACCIDENT,34
SG,THROMBOCYTOPENIA,34
SG,TRANSAMINASES INCREASED,34
SG,RASH ERYTHEMATOUS,32
SG,CHEST DISCOMFORT,31
SG,MALIGNANT NEOPLASM PROGRESSION,31
SG,DRUG-INDUCED LIVER INJURY,30
SG,INFECTION,30
SG,HEPATITIS E,29
SG,LETHARGY,29
SG,OVERDOSE,29
SG,WHEEZING,29
SG,COUGH,28
SG,SWELLING FACE,28
SG,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,27
SG,ANAEMIA,26
SG,DERMATITIS EXFOLIATIVE,26
SG,FLUSHING,26
SG,HEPATITIS B,26
SG,ACUTE MYOCARDIAL INFARCTION,25
SG,CONDITION AGGRAVATED,25
SG,MOUTH ULCERATION,25
SG,ATYPICAL FEMUR FRACTURE,24
SG,DRUG HYPERSENSITIVITY,24
SG,DRUG RESISTANCE,24
SG,INTENTIONAL OVERDOSE,24
SG,MALAISE,24
SG,SWELLING,24
SG,ABDOMINAL PAIN,23
SG,FATIGUE,23
SG,SYNCOPE,23
SG,ANAPHYLACTIC REACTION,22
SG,ASTHENIA,22
SG,DRUG CROSS-REACTIVITY,22
SG,OEDEMA PERIPHERAL,22
SG,PAIN IN EXTREMITY,22
SG,PERIPROSTHETIC FRACTURE,22
SG,CARDIAC FAILURE,21
SG,CONFUSIONAL STATE,21
SG,HYPOKALAEMIA,21
SG,NEUTROPENIA,21
SG,RENAL IMPAIRMENT,21
SG,ACUTE KIDNEY INJURY,20
SG,DECREASED APPETITE,20
SG,NEUTROPENIC SEPSIS,20
SG,PRODUCT USE ISSUE,20
SG,FOETAL EXPOSURE DURING PREGNANCY,19
SG,HEPATITIS,19
SG,PRODUCT USE IN UNAPPROVED INDICATION,19
SG,URINARY TRACT INFECTION,19
SG,HEPATOTOXICITY,18
SG,PERIPHERAL SWELLING,18
SG,RASH GENERALISED,18
SG,DISCOMFORT,17
SG,DRUG ERUPTION,17
SG,ERYTHEMA,17
SG,HAEMORRHAGE,17
SG,HYPERTENSION,17
SG,MYOCLONUS,17
SG,PLEURAL EFFUSION,17
SG,PNEUMONITIS,17
SG,RASH PRURITIC,17
SG,TOXIC EPIDERMAL NECROLYSIS,17
SG,CARDIAC ARREST,16
SG,CONSTIPATION,16
SG,EXPOSURE DURING PREGNANCY,16
SG,HAEMOGLOBIN DECREASED,16
SG,LOSS OF CONSCIOUSNESS,16
SG,PANCYTOPENIA,16
SG,BACK PAIN,15
SG,GASTRITIS,15
SG,HAEMORRHAGE INTRACRANIAL,15
SG,HYPOAESTHESIA,15
SG,INCORRECT DOSE ADMINISTERED,15
SG,LOCAL SWELLING,15
SG,MATERNAL EXPOSURE DURING PREGNANCY,15
SG,RESPIRATORY FAILURE,15
SG,SOMNOLENCE,15
SG,ARTHRALGIA,14
SG,DERMATITIS BULLOUS,14
SG,MANIA,14
SG,OEDEMA,14
SG,RHABDOMYOLYSIS,14
SG,SEIZURE,14
SG,ABDOMINAL PAIN UPPER,13
SG,COMA SCALE ABNORMAL,13
SG,CUTANEOUS VASCULITIS,13
SG,CYTOMEGALOVIRUS INFECTION,13
SG,DELIRIUM,13
SG,FEMUR FRACTURE,13
SG,HYPOGLYCAEMIA,13
SG,MUSCULAR WEAKNESS,13
SG,PLASMA CELL MYELOMA,13
SG,VISION BLURRED,13
SG,BLOOD CREATININE INCREASED,12
SG,BRADYCARDIA,12
SG,CARDIAC DISORDER,12
SG,CHILLS,12
SG,DEHYDRATION,12
SG,DIABETIC KETOACIDOSIS,12
SG,DYSPHAGIA,12
SG,HYPONATRAEMIA,12
SG,MYALGIA,12
SG,TACHYCARDIA,12
SG,THROMBOTIC MICROANGIOPATHY,12
SG,ASCITES,11
SG,COLORECTAL CANCER METASTATIC,11
SG,CYTOMEGALOVIRUS CHORIORETINITIS,11
SG,DYSPEPSIA,11
SG,ISCHAEMIC STROKE,11
SG,LEUKOPENIA,11
SG,LIVER FUNCTION TEST ABNORMAL,11
SG,MYOCARDIAL ISCHAEMIA,11
SG,MYOSITIS,11
SG,PLATELET COUNT DECREASED,11
SG,PREMATURE BABY,11
SG,STRESS FRACTURE,11
SG,STRIDOR,11
SG,AGGRESSION,10
SG,ALOPECIA,10
SG,ASTHMA,10
SG,BLINDNESS,10
SG,CHEST PAIN,10
SG,EOSINOPHILIA,10
SG,EYELID OEDEMA,10
SG,GASTROINTESTINAL DISORDER,10
SG,HAEMATEMESIS,10
SG,PHOTOSENSITIVITY REACTION,10
SG,TREMOR,10
SG,DEEP VEIN THROMBOSIS,9
SG,DIABETES MELLITUS,9
SG,GASTROINTESTINAL HAEMORRHAGE,9
SG,HALLUCINATION,9
SG,HEART RATE INCREASED,9
SG,HEPATIC ENZYME INCREASED,9
SG,HYPERGLYCAEMIA,9
SG,HYPERSENSITIVITY,9
SG,JOINT SWELLING,9
SG,MUSCULOSKELETAL STIFFNESS,9
SG,OCULOGYRIC CRISIS,9
SG,PULMONARY EMBOLISM,9
SG,SEPTIC SHOCK,9
SG,VENTRICULAR FIBRILLATION,9
SG,VIRAL MUTATION IDENTIFIED,9
SG,ABDOMINAL DISCOMFORT,8
SG,ACUTE HEPATIC FAILURE,8
SG,AGITATION,8
SG,ALANINE AMINOTRANSFERASE INCREASED,8
SG,ASPARTATE AMINOTRANSFERASE INCREASED,8
SG,BLISTER,8
SG,ELECTROCARDIOGRAM QT PROLONGED,8
SG,FIBROSIS,8
SG,GENE MUTATION,8
SG,GRAND MAL CONVULSION,8
SG,HYPERNATRAEMIA,8
SG,INFLUENZA,8
SG,LARYNGEAL OEDEMA,8
SG,LOW BIRTH WEIGHT BABY,8
SG,LUNG INFECTION,8
SG,MENTAL STATUS CHANGES,8
SG,METABOLIC ACIDOSIS,8
SG,NECK PAIN,8
SG,OCULAR HYPERAEMIA,8
SG,OXYGEN SATURATION DECREASED,8
SG,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,8
SG,PANCREATITIS,8
SG,PERICARDIAL EFFUSION,8
SG,POISONING DELIBERATE,8
SG,PROTEINURIA,8
SG,SKULL FRACTURE,8
SG,SPINAL EPIDURAL HAEMATOMA,8
SG,TUMOUR LYSIS SYNDROME,8
SG,UPPER RESPIRATORY TRACT INFECTION,8
SG,WITHDRAWAL SYNDROME,8
SG,ANXIETY,7
SG,BONE MARROW FAILURE,7
SG,CEREBRAL HAEMORRHAGE,7
SG,COLITIS,7
SG,CONVULSION,7
SG,CORONARY ARTERY DISEASE,7
SG,DRUG INTOLERANCE,7
SG,DYSPHONIA,7
SG,EYE PRURITUS,7
SG,GASTROINTESTINAL STROMAL TUMOUR,7
SG,HEPATOCELLULAR CARCINOMA,7
SG,HYPERHIDROSIS,7
SG,JAUNDICE,7
SG,MUSCLE SPASMS,7
SG,OVARIAN HYPERSTIMULATION SYNDROME,7
SG,PATHOLOGICAL FRACTURE,7
SG,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,7
SG,RENAL FAILURE CHRONIC,7
SG,RESPIRATORY DISTRESS,7
SG,RHINORRHOEA,7
SG,VITAMIN B12 DEFICIENCY,7
SG,ACUTE RESPIRATORY DISTRESS SYNDROME,6
SG,ANAL ABSCESS,6
SG,AREFLEXIA,6
SG,ARTERITIS,6
SG,BREAST CANCER METASTATIC,6
SG,CARDIAC FAILURE CONGESTIVE,6
SG,CELLULITIS,6
SG,CHRONIC KIDNEY DISEASE,6
SG,DISORIENTATION,6
SG,DISSEMINATED TUBERCULOSIS,6
SG,ECZEMA,6
SG,FIXED ERUPTION,6
SG,FLATULENCE,6
SG,FLUID RETENTION,6
SG,FRACTURE NONUNION,6
SG,GAIT DISTURBANCE,6
SG,GASTROENTERITIS,6
SG,GASTROOESOPHAGEAL REFLUX DISEASE,6
SG,HAEMATOMA,6
SG,HEPATIC FUNCTION ABNORMAL,6
SG,HERPES SIMPLEX,6
SG,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,6
SG,INSOMNIA,6
SG,MUCOSAL ULCERATION,6
SG,NECROTISING RETINITIS,6
SG,NEPHROPATHY,6
SG,OSTEONECROSIS OF JAW,6
SG,PNEUMONIA CYTOMEGALOVIRAL,6
SG,PNEUMOTHORAX,6
SG,PRESYNCOPE,6
SG,PRURITUS GENERALISED,6
SG,PULMONARY OEDEMA,6
SG,RENAL FAILURE ACUTE,6
SG,RHONCHI,6
SG,SKIN EXFOLIATION,6
SG,STOMATITIS,6
SG,SUICIDAL IDEATION,6
SG,SUICIDE ATTEMPT,6
SG,TORSADE DE POINTES,6
SG,WEIGHT INCREASED,6
SG,ACUTE MYELOID LEUKAEMIA,5
SG,ANAEMIA MACROCYTIC,5
SG,ANAESTHETIC COMPLICATION NEUROLOGICAL,5
SG,ANAPHYLACTIC SHOCK,5
SG,ARTHRITIS BACTERIAL,5
SG,ATRIAL FIBRILLATION,5
SG,B-CELL TYPE ACUTE LEUKAEMIA,5
SG,BALANCE DISORDER,5
SG,BLOOD SODIUM DECREASED,5
SG,BONE PAIN,5
SG,BREAST CANCER,5
SG,CANDIDA INFECTION,5
SG,CEREBELLAR SYNDROME,5
SG,CHORIORETINITIS,5
SG,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
SG,CONTUSION,5
SG,CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION,5
SG,DEAFNESS,5
SG,DEPRESSION,5
SG,DRY MOUTH,5
SG,DUODENAL ULCER,5
SG,DYSARTHRIA,5
SG,END STAGE RENAL DISEASE,5
SG,EPISTAXIS,5
SG,EYE DISORDER,5
SG,FEELING ABNORMAL,5
SG,FULL BLOOD COUNT DECREASED,5
SG,FUNGAL INFECTION,5
SG,GENERALISED TONIC-CLONIC SEIZURE,5
SG,HAEMATURIA,5
SG,HEPATIC FAILURE,5
SG,HYDROCEPHALUS,5
SG,HYPOCALCAEMIA,5
SG,INJECTION SITE ERYTHEMA,5
SG,LYMPHOMA,5
SG,MEDICATION ERROR,5
SG,MYELODYSPLASTIC SYNDROME,5
SG,NEPHROLITHIASIS,5
SG,NEPHROTIC SYNDROME,5
SG,OROPHARYNGEAL PAIN,5
SG,OSTEOPOROSIS,5
SG,PANCREATITIS ACUTE,5
SG,PARAESTHESIA,5
SG,PERITONITIS,5
SG,PREMATURE DELIVERY,5
SG,PREMATURE SEPARATION OF PLACENTA,5
SG,PSORIASIS,5
SG,RASH MACULAR,5
SG,STATUS EPILEPTICUS,5
SG,SUPRAVENTRICULAR TACHYCARDIA,5
SG,THROMBOSIS IN DEVICE,5
SG,TUBERCULOSIS,5
SG,TUBULOINTERSTITIAL NEPHRITIS,5
SG,ULNA FRACTURE,5
SG,VASCULITIS,5
SG,VERTIGO,5
SG,WEIGHT DECREASED,5
SG,ADVERSE DRUG REACTION,4
SG,ADVERSE EVENT,4
SG,ANHIDROSIS,4
SG,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
SG,BLOOD DISORDER,4
SG,BRONCHOSPASM,4
SG,CEREBRAL INFARCTION,4
SG,CHRONIC MYELOID LEUKAEMIA,4
SG,CIRCULATORY COLLAPSE,4
SG,COLD SWEAT,4
SG,CUSHING^S SYNDROME,4
SG,DEPRESSED LEVEL OF CONSCIOUSNESS,4
SG,DEPRESSED MOOD,4
SG,DERMATITIS EXFOLIATIVE GENERALISED,4
SG,DEVICE RELATED INFECTION,4
SG,DISEASE COMPLICATION,4
SG,DISEASE RECURRENCE,4
SG,DISSEMINATED INTRAVASCULAR COAGULATION,4
SG,DRUG EFFECT INCOMPLETE,4
SG,DRUG LEVEL INCREASED,4
SG,DYSGEUSIA,4
SG,ECCHYMOSIS,4
SG,ELECTROLYTE IMBALANCE,4
SG,ENCEPHALOPATHY,4
SG,FAECES DISCOLOURED,4
SG,FOETAL GROWTH RESTRICTION,4
SG,FUNGAL PERITONITIS,4
SG,GASTRIC DISORDER,4
SG,GENERAL PHYSICAL HEALTH DETERIORATION,4
SG,GINGIVAL SWELLING,4
SG,HAEMOLYSIS,4
SG,HAEMOPTYSIS,4
SG,HAEMORRHOIDS,4
SG,HEMIPARESIS,4
SG,HERPES ZOSTER,4
SG,HIP FRACTURE,4
SG,HYDROCELE,4
SG,HYPERBILIRUBINAEMIA,4
SG,HYPERSENSITIVITY VASCULITIS,4
SG,HYPERTHYROIDISM,4
SG,IMPAIRED HEALING,4
SG,INCORRECT ROUTE OF DRUG ADMINISTRATION,4
SG,INTENTIONAL PRODUCT MISUSE,4
SG,ISCHAEMIC HEPATITIS,4
SG,JUVENILE IDIOPATHIC ARTHRITIS,4
SG,LOWER RESPIRATORY TRACT INFECTION,4
SG,LUNG NEOPLASM MALIGNANT,4
SG,MALLORY-WEISS SYNDROME,4
SG,MELAENA,4
SG,MENTAL DISORDER,4
SG,METASTASES TO CENTRAL NERVOUS SYSTEM,4
SG,MOOD SWINGS,4
SG,MULTI-ORGAN FAILURE,4
SG,MUSCLE NECROSIS,4
SG,NEUROLOGICAL DECOMPENSATION,4
SG,NEUROPATHY PERIPHERAL,4
SG,NEUROTOXICITY,4
SG,NEUTROPENIC COLITIS,4
SG,NO ADVERSE EVENT,4
SG,ORGANISING PNEUMONIA,4
SG,ORTHOSTATIC HYPOTENSION,4
SG,PANCREATIC CARCINOMA,4
SG,PERITONITIS BACTERIAL,4
SG,PNEUMOCYSTIS JIROVECII PNEUMONIA,4
SG,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,4
SG,PRODUCT QUALITY ISSUE,4
SG,PULMONARY TRICHOSPORONOSIS,4
SG,ROSACEA,4
SG,SINUS BRADYCARDIA,4
SG,SKIN LESION,4
SG,SPINAL CORD COMPRESSION,4
SG,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,4
SG,SUBARACHNOID HAEMORRHAGE,4
SG,SURGERY,4
SG,THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION,4
SG,THERAPEUTIC RESPONSE DECREASED,4
SG,THERAPEUTIC RESPONSE UNEXPECTED,4
SG,THREATENED LABOUR,4
SG,TRICHOPHYTOSIS,4
SG,TRICHOSPORON INFECTION,4
SG,TRISOMY 21,4
SG,UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE,4
SG,UNRESPONSIVE TO STIMULI,4
SG,VASCULAR STENT THROMBOSIS,4
SG,VENTRICULAR TACHYCARDIA,4
SG,VISUAL IMPAIRMENT,4
SG,ABORTION,3
SG,ABORTION SPONTANEOUS,3
SG,ACNE FULMINANS,3
SG,ACTIVITIES OF DAILY LIVING IMPAIRED,3
SG,APLASIA PURE RED CELL,3
SG,ASPERGILLUS INFECTION,3
SG,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,3
SG,ATYPICAL FRACTURE,3
SG,BLOOD ALKALINE PHOSPHATASE INCREASED,3
SG,BLOOD BILIRUBIN INCREASED,3
SG,BLOOD COUNT ABNORMAL,3
SG,BLOOD GLUCOSE INCREASED,3
SG,BLOOD PRESSURE DECREASED,3
SG,BLOOD PRESSURE INCREASED,3
SG,BONE TUBERCULOSIS,3
SG,BRONCHOPULMONARY ASPERGILLOSIS,3
SG,CATARACT,3
SG,CATHETER SITE INFECTION,3
SG,CENTRAL NERVOUS SYSTEM LESION,3
SG,CHOKING,3
SG,CHOLELITHIASIS,3
SG,CHOLESTASIS,3
SG,COAGULOPATHY,3
SG,COLON CANCER,3
SG,COMA,3
SG,COUNTERFEIT DRUG ADMINISTERED,3
SG,CRYPTOCOCCOSIS,3
SG,CYANOSIS,3
SG,CYSTITIS HAEMORRHAGIC,3
SG,DERMATITIS ALLERGIC,3
SG,DERMATITIS CONTACT,3
SG,DERMATOSIS,3
SG,DIABETES INSIPIDUS,3
SG,DIPLOPIA,3
SG,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,3
SG,DRUG DIVERSION,3
SG,DRUG DOSE OMISSION,3
SG,DYSPNOEA EXERTIONAL,3
SG,DYSTONIA,3
SG,EJECTION FRACTION DECREASED,3
SG,EMBOLIC STROKE,3
SG,EMBOLISM,3
SG,EPIGASTRIC DISCOMFORT,3
SG,EPILEPSY,3
SG,EPSTEIN-BARR VIRUS INFECTION,3
SG,ERUCTATION,3
SG,ERYTHEMA DYSCHROMICUM PERSTANS,3
SG,ERYTHEMA MULTIFORME,3
SG,ESCHERICHIA URINARY TRACT INFECTION,3
SG,EXTRAPYRAMIDAL DISORDER,3
SG,EYE MOVEMENT DISORDER,3
SG,FANCONI SYNDROME ACQUIRED,3
SG,FEELING HOT,3
SG,FLUID OVERLOAD,3
SG,FRACTURE,3
SG,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
SG,GASTRODUODENITIS,3
SG,GENERALISED ERYTHEMA,3
SG,GLAUCOMA,3
SG,GLYCOSYLATED HAEMOGLOBIN INCREASED,3
SG,HAEMODYNAMIC INSTABILITY,3
SG,HEPATITIS CHOLESTATIC,3
SG,HEPATOMEGALY,3
SG,HOT FLUSH,3
SG,HYPERCALCAEMIA,3
SG,HYPOACUSIS,3
SG,HYPOTHYROIDISM,3
SG,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
SG,INFUSION SITE RASH,3
SG,INFUSION SITE URTICARIA,3
SG,INJECTION SITE PAIN,3
SG,INTERNATIONAL NORMALISED RATIO INCREASED,3
SG,LACRIMATION INCREASED,3
SG,LARGE INTESTINE POLYP,3
SG,LEUKOCYTOSIS,3
SG,LIMB INJURY,3
SG,LIVER DISORDER,3
SG,LUNG INFILTRATION,3
SG,LYMPH NODE TUBERCULOSIS,3
SG,LYMPHADENOPATHY,3
SG,MASS,3
SG,MENINGITIS TUBERCULOUS,3
SG,MENORRHAGIA,3
SG,METASTASES TO BONE,3
SG,METASTASIS,3
SG,MUCOSAL INFLAMMATION,3
SG,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
SG,MUSCLE RIGIDITY,3
SG,MYELOPATHY,3
SG,NASAL CONGESTION,3
SG,NEOPLASM,3
SG,NEOPLASM PROGRESSION,3
SG,NEURALGIA,3
SG,NEUTROPHIL COUNT DECREASED,3
SG,NODULE,3
SG,NON-CARDIAC CHEST PAIN,3
SG,ORBITAL OEDEMA,3
SG,PARONYCHIA,3
SG,PATHOGEN RESISTANCE,3
SG,PENILE OEDEMA,3
SG,PERITONEAL DIALYSIS COMPLICATION,3
SG,PETECHIAE,3
SG,PHAEOCHROMOCYTOMA CRISIS,3
SG,PLATELET TRANSFUSION,3
SG,POLYURIA,3
SG,PORTAL HYPERTENSION,3
SG,PREGNANCY,3
SG,PSYCHOTIC DISORDER,3
SG,PULMONARY ARTERIAL HYPERTENSION,3
SG,PULMONARY HYPERTENSION,3
SG,PULMONARY TUBERCULOSIS,3
SG,RASH PUSTULAR,3
SG,RECTAL HAEMORRHAGE,3
SG,RENAL DISORDER,3
SG,RESPIRATORY DEPRESSION,3
SG,RESTLESSNESS,3
SG,RETINITIS,3
SG,RIGHT VENTRICULAR FAILURE,3
SG,ROAD TRAFFIC ACCIDENT,3
SG,SCLERAL OEDEMA,3
SG,SCROTAL OEDEMA,3
SG,SECOND PRIMARY MALIGNANCY,3
SG,SHOCK,3
SG,SPEECH DISORDER,3
SG,STAPHYLOCOCCAL INFECTION,3
SG,STILLBIRTH,3
SG,SYSTEMIC LUPUS ERYTHEMATOSUS,3
SG,TINNITUS,3
SG,TOXIC SKIN ERUPTION,3
SG,TREATMENT NONCOMPLIANCE,3
SG,ULCER,3
SG,UNEVALUABLE EVENT,3
SG,URINARY INCONTINENCE,3
SG,VIRAL MYELITIS,3
SG,VISUAL ACUITY REDUCED,3
SG,ABASIA,2
SG,ABNORMAL BEHAVIOUR,2
SG,ABORTION INDUCED,2
SG,ACCIDENTAL OVERDOSE,2
SG,ACUTE CORONARY SYNDROME,2
SG,ACUTE LYMPHOCYTIC LEUKAEMIA,2
SG,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,2
SG,ACUTE PULMONARY OEDEMA,2
SG,AFFECT LABILITY,2
SG,AKATHISIA,2
SG,ANGER,2
SG,ANGINA PECTORIS,2
SG,ANGINA UNSTABLE,2
SG,ANGIOCENTRIC LYMPHOMA,2
SG,ANKLE FRACTURE,2
SG,ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC,2
SG,ANTIPHOSPHOLIPID SYNDROME,2
SG,APHASIA,2
SG,APHONIA,2
SG,APNOEA,2
SG,ARTERIOSPASM CORONARY,2
SG,ARTHRITIS,2
SG,ARTHROPATHY,2
SG,ATAXIA,2
SG,ATELECTASIS,2
SG,ATRIAL FLUTTER,2
SG,ATRIAL THROMBOSIS,2
SG,BACTERIAL INFECTION,2
SG,BICYTOPENIA,2
SG,BLEEDING TIME PROLONGED,2
SG,BLEPHAROSPASM,2
SG,BLOOD ALBUMIN DECREASED,2
SG,BLOOD CORTISOL DECREASED,2
SG,BLOOD GLUCOSE FLUCTUATION,2
SG,BLOOD LACTATE DEHYDROGENASE INCREASED,2
SG,BLOOD POTASSIUM DECREASED,2
SG,BLOOD PRESSURE IMMEASURABLE,2
SG,BLOOD PRESSURE SYSTOLIC INCREASED,2
SG,BLOOD URINE PRESENT,2
SG,BONE DISORDER,2
SG,BRAIN NEOPLASM,2
SG,BRAIN OEDEMA,2
SG,BRONCHIAL HYPERREACTIVITY,2
SG,BRONCHITIS,2
SG,BURNING SENSATION,2
SG,CARDIAC TAMPONADE,2
SG,CARDIOACTIVE DRUG LEVEL INCREASED,2
SG,CARDIOPULMONARY FAILURE,2
SG,CAROTID ARTERIAL EMBOLUS,2
SG,CD4 LYMPHOCYTES DECREASED,2
SG,CENTRAL NERVOUS SYSTEM FUNGAL INFECTION,2
SG,CEREBRAL ARTERY EMBOLISM,2
SG,CEREBRAL HAEMATOMA,2
SG,CEREBRAL HYPERPERFUSION SYNDROME,2
SG,CEREBROVASCULAR DISORDER,2
SG,CHAPPED LIPS,2
SG,CHEILITIS,2
SG,CHOREA,2
SG,CHORIORETINOPATHY,2
SG,CLOSTRIDIUM DIFFICILE INFECTION,2
SG,COMPLETED SUICIDE,2
SG,COMPLICATIONS OF TRANSPLANT SURGERY,2
SG,CONCOMITANT DISEASE AGGRAVATED,2
SG,CONJUNCTIVITIS,2
SG,CORONARY ARTERY THROMBOSIS,2
SG,CRANIAL NERVE PALSIES MULTIPLE,2
SG,CROHN^S DISEASE,2
SG,CRYING,2
SG,CYSTITIS,2
SG,CYTOKINE RELEASE SYNDROME,2
SG,DEAFNESS NEUROSENSORY,2
SG,DEMENTIA,2
SG,DENGUE FEVER,2
SG,DERMATOMYOSITIS,2
SG,DEVICE ISSUE,2
SG,DEVICE OCCLUSION,2
SG,DISSEMINATED CYTOMEGALOVIRAL INFECTION,2
SG,DRUG ABUSE,2
SG,DRUG ADMINISTRATION ERROR,2
SG,DRUG EFFECTIVE FOR UNAPPROVED INDICATION,2
SG,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
SG,DRUG LEVEL BELOW THERAPEUTIC,2
SG,DRUG LEVEL FLUCTUATING,2
SG,DRY THROAT,2
SG,DUODENAL ULCER PERFORATION,2
SG,DYSKINESIA,2
SG,DYSURIA,2
SG,ELECTROCARDIOGRAM ABNORMAL,2
SG,EMOTIONAL DISORDER,2
SG,ENDOPHTHALMITIS,2
SG,ESCHERICHIA BACTERAEMIA,2
SG,EXTERNAL FIXATION OF FRACTURE,2
SG,EXTRAVASATION,2
SG,EYE INFECTION,2
SG,EYE OEDEMA,2
SG,FAECAL INCONTINENCE,2
SG,FANCONI SYNDROME,2
SG,FEELING COLD,2
SG,FOOT FRACTURE,2
SG,FUNGAEMIA,2
SG,GANGRENE,2
SG,GASTROINTESTINAL INFECTION,2
SG,GASTROINTESTINAL PERFORATION,2
SG,GASTROINTESTINAL TOXICITY,2
SG,GASTROINTESTINAL ULCER HAEMORRHAGE,2
SG,GAZE PALSY,2
SG,GENERALISED OEDEMA,2
SG,GENITAL ULCERATION,2
SG,GINGIVAL BLEEDING,2
SG,GINGIVAL PAIN,2
SG,GLIOBLASTOMA MULTIFORME,2
SG,GOUT,2
SG,GROIN PAIN,2
SG,GUILLAIN-BARRE SYNDROME,2
SG,HAEMATOCRIT DECREASED,2
SG,HAEMATOTOXICITY,2
SG,HAEMOLYTIC URAEMIC SYNDROME,2
SG,HALLUCINATION_ AUDITORY,2
SG,HEAD DISCOMFORT,2
SG,HEAD INJURY,2
SG,HEPATIC CIRRHOSIS,2
SG,HEPATIC ENZYME ABNORMAL,2
SG,HEPATIC LESION,2
SG,HEPATIC NEOPLASM,2
SG,HEPATIC STEATOSIS,2
SG,HEPATITIS ACUTE,2
SG,HEPATOCELLULAR INJURY,2
SG,HIATUS HERNIA,2
SG,HICCUPS,2
SG,HIRSUTISM,2
SG,HISTIOCYTOSIS HAEMATOPHAGIC,2
SG,HYDRONEPHROSIS,2
SG,HYPERAMMONAEMIC ENCEPHALOPATHY,2
SG,HYPERKALAEMIA,2
SG,HYPERTRIGLYCERIDAEMIA,2
SG,HYPERVENTILATION,2
SG,HYPOAESTHESIA ORAL,2
SG,HYPOCHROMIC ANAEMIA,2
SG,HYPOGLYCAEMIC SEIZURE,2
SG,HYPOKINESIA,2
SG,HYPOMAGNESAEMIA,2
SG,HYPOPHOSPHATAEMIA,2
SG,HYPOTONIA,2
SG,IDIOPATHIC PULMONARY FIBROSIS,2
SG,ILEUS PARALYTIC,2
SG,INCREASED APPETITE,2
SG,INFLAMMATION,2
SG,INFUSION RELATED REACTION,2
SG,INJECTION SITE HAEMORRHAGE,2
SG,INTERVERTEBRAL DISC PROTRUSION,2
SG,INTESTINAL PERFORATION,2
SG,INTRAMEDULLARY ROD INSERTION,2
SG,IRIDOCYCLITIS,2
SG,JAUNDICE CHOLESTATIC,2
SG,JOINT EFFUSION,2
SG,JOINT RANGE OF MOTION DECREASED,2
SG,KETOACIDOSIS,2
SG,KIDNEY FIBROSIS,2
SG,LACTIC ACIDOSIS,2
SG,LACUNAR INFARCTION,2
SG,LEFT VENTRICULAR HYPERTROPHY,2
SG,LENTIGO,2
SG,LEUKOCYTOCLASTIC VASCULITIS,2
SG,LIP BLISTER,2
SG,LOCALISED INFECTION,2
SG,LONG QT SYNDROME,2
SG,LUNG DISORDER,2
SG,LYMPHOCYTE COUNT DECREASED,2
SG,MATERNAL EXPOSURE TIMING UNSPECIFIED,2
SG,MEMORY IMPAIRMENT,2
SG,METASTASES TO LIVER,2
SG,METASTASES TO LUNG,2
SG,METHAEMOGLOBINAEMIA,2
SG,MICTURITION DISORDER,2
SG,MOLLUSCUM CONTAGIOSUM,2
SG,MULTIPLE-DRUG RESISTANCE,2
SG,MUSCLE OEDEMA,2
SG,MUSCULOSKELETAL DISCOMFORT,2
SG,MYCOBACTERIAL INFECTION,2
SG,MYCOBACTERIUM ABSCESSUS INFECTION,2
SG,MYDRIASIS,2
SG,MYOGLOBINURIA,2
SG,NASAL OBSTRUCTION,2
SG,NASAL OEDEMA,2
SG,NEPHROGENIC DIABETES INSIPIDUS,2
SG,NEPHROPATHY TOXIC,2
SG,NERVE INJURY,2
SG,NERVOUS SYSTEM DISORDER,2
SG,NEURODEVELOPMENTAL DISORDER,2
SG,NEUROLEPTIC MALIGNANT SYNDROME,2
SG,NEUTROPHIL COUNT INCREASED,2
SG,NO THERAPEUTIC RESPONSE,2
SG,OCCULT BLOOD POSITIVE,2
SG,ODYNOPHAGIA,2
SG,OESOPHAGEAL VARICES HAEMORRHAGE,2
SG,OLIGOHYDRAMNIOS,2
SG,OPISTHOTONUS,2
SG,ORAL MUCOSAL ERUPTION,2
SG,OROMANDIBULAR DYSTONIA,2
SG,PALPABLE PURPURA,2
SG,PAPILLOEDEMA,2
SG,PAPULE,2
SG,PARADOXICAL DRUG REACTION,2
SG,PARAESTHESIA ORAL,2
SG,PARKINSONISM,2
SG,PEMPHIGOID,2
SG,PERIRENAL HAEMATOMA,2
SG,PHARYNGEAL OEDEMA,2
SG,PHARYNGEAL ULCERATION,2
SG,PHOTOPHOBIA,2
SG,PITUITARY HAEMORRHAGE,2
SG,PNEUMONIA ASPIRATION,2
SG,POLYDIPSIA,2
SG,POLYOMAVIRUS TEST POSITIVE,2
SG,PRE-ECLAMPSIA,2
SG,PREMATURE LABOUR,2
SG,PROCEDURAL COMPLICATION,2
SG,PROSTATOMEGALY,2
SG,PSEUDOMONAS INFECTION,2
SG,PSORIATIC ARTHROPATHY,2
SG,PULMONARY MASS,2
SG,PUPIL FIXED,2
SG,PURPURA,2
SG,RASH PAPULAR,2
SG,RED BLOOD CELL COUNT DECREASED,2
SG,RENAL CYST,2
SG,RENAL INFARCT,2
SG,RENAL TUBULAR DISORDER,2
SG,RESPIRATORY ACIDOSIS,2
SG,RESPIRATORY TRACT INFECTION,2
SG,RETINAL DETACHMENT,2
SG,RHINOVIRUS INFECTION,2
SG,SCREAMING,2
SG,SCROTAL SWELLING,2
SG,SCROTAL ULCER,2
SG,SENSATION OF FOREIGN BODY,2
SG,SEROMA,2
SG,SKIN DISCOLOURATION,2
SG,SKIN DISORDER,2
SG,SMALL INTESTINAL PERFORATION,2
SG,SOFT TISSUE INFLAMMATION,2
SG,SPINAL OSTEOARTHRITIS,2
SG,STAPHYLOCOCCAL SEPSIS,2
SG,STRESS CARDIOMYOPATHY,2
SG,SUBCUTANEOUS ABSCESS,2
SG,SUBCUTANEOUS HAEMATOMA,2
SG,SUBDURAL HAEMORRHAGE,2
SG,SUBRETINAL FLUID,2
SG,SYSTEMIC MYCOSIS,2
SG,THERAPY NON-RESPONDER,2
SG,THROMBOSIS,2
SG,THUNDERCLAP HEADACHE,2
SG,TIBIA FRACTURE,2
SG,TRANSFUSION,2
SG,TUBERCULOSIS OF EYE,2
SG,TWIN PREGNANCY,2
SG,UNINTENDED PREGNANCY,2
SG,UPPER GASTROINTESTINAL HAEMORRHAGE,2
SG,UPPER LIMB FRACTURE,2
SG,URINARY RETENTION,2
SG,VASCULAR PSEUDOANEURYSM,2
SG,VIRAEMIA,2
SG,VIRAL UVEITIS,2
SG,WHITE BLOOD CELL COUNT INCREASED,2
SG,WOUND INFECTION,2
SG,WRONG DRUG ADMINISTERED,2
SG,ABDOMINAL COMPARTMENT SYNDROME,1
SG,ABDOMINAL PAIN LOWER,1
SG,ABDOMINAL SYMPTOM,1
SG,ABDOMINAL TENDERNESS,1
SG,ABORTION MISSED,1
SG,ABSCESS,1
SG,ABSCESS LIMB,1
SG,ACCIDENTAL EXPOSURE TO PRODUCT,1
SG,ACETONAEMIA,1
SG,ACIDOSIS,1
SG,ACNE,1
SG,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
SG,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
SG,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
SG,ACUTE LUNG INJURY,1
SG,ACUTE STRESS DISORDER,1
SG,ADENOCARCINOMA,1
SG,ADENOCARCINOMA OF COLON,1
SG,ADENOCARCINOMA PANCREAS,1
SG,ADRENAL SUPPRESSION,1
SG,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
SG,AFFECTIVE DISORDER,1
SG,AGEUSIA,1
SG,AIR EMBOLISM,1
SG,ALCOHOL INTOLERANCE,1
SG,ALKAPTONURIA,1
SG,ALLERGIC OEDEMA,1
SG,ALVEOLITIS ALLERGIC,1
SG,AMENORRHOEA,1
SG,ANAEMIA NEONATAL,1
SG,ANAESTHETIC COMPLICATION,1
SG,ANAL ULCER,1
SG,ANAPHYLACTOID REACTION,1
SG,ANIMAL BITE,1
SG,ANOGENITAL WARTS,1
SG,ANTICOAGULATION DRUG LEVEL INCREASED,1
SG,ANTIDIURETIC HORMONE ABNORMALITY,1
SG,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
SG,ANURIA,1
SG,APNOEIC ATTACK,1
SG,APPENDICITIS,1
SG,APPENDIX DISORDER,1
SG,ARTERIAL HAEMORRHAGE,1
SG,ARTERIAL INJURY,1
SG,ARTERIAL THROMBOSIS,1
SG,ARTHRITIS INFECTIVE,1
SG,ASPERGILLOMA,1
SG,ATRIAL TACHYCARDIA,1
SG,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
SG,ATROPHY OF GLOBE,1
SG,AUTOIMMUNE DISORDER,1
SG,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
SG,BACTERAEMIA,1
SG,BALLISMUS,1
SG,BASAL GANGLIA HAEMORRHAGE,1
SG,BASEDOW^S DISEASE,1
SG,BEDRIDDEN,1
SG,BIPOLAR DISORDER,1
SG,BLADDER CANCER,1
SG,BLADDER CANCER RECURRENT,1
SG,BLADDER DYSFUNCTION,1
SG,BLAST CELL COUNT INCREASED,1
SG,BLINDNESS CORTICAL,1
SG,BLINDNESS TRANSIENT,1
SG,BLOOD CHOLESTEROL INCREASED,1
SG,BLOOD CREATINE INCREASED,1
SG,BLOOD CREATININE ABNORMAL,1
SG,BLOOD FIBRINOGEN DECREASED,1
SG,BLOOD FOLATE DECREASED,1
SG,BLOOD GLUCOSE DECREASED,1
SG,BLOOD LUTEINISING HORMONE ABNORMAL,1
SG,BLOOD MAGNESIUM DECREASED,1
SG,BLOOD POTASSIUM INCREASED,1
SG,BLOOD PRESSURE ABNORMAL,1
SG,BLOOD PRESSURE FLUCTUATION,1
SG,BLOOD URIC ACID DECREASED,1
SG,BLOOD URIC ACID INCREASED,1
SG,BODY TEMPERATURE INCREASED,1
SG,BONE ABSCESS,1
SG,BONE GRAFT,1
SG,BONE HYPERPIGMENTATION,1
SG,BONE NEOPLASM,1
SG,BOWENOID PAPULOSIS,1
SG,BRAIN CONTUSION,1
SG,BRAIN DEATH,1
SG,BRAIN MASS,1
SG,BRAIN MIDLINE SHIFT,1
SG,BRAIN STEM SYNDROME,1
SG,BREAST CANCER STAGE I,1
SG,BREAST PAIN,1
SG,BRONCHIAL FISTULA,1
SG,BRONCHIECTASIS,1
SG,BRONCHOPNEUMONIA,1
SG,C-REACTIVE PROTEIN INCREASED,1
SG,CAESAREAN SECTION,1
SG,CALCINOSIS,1
SG,CALCULUS BLADDER,1
SG,CALCULUS URINARY,1
SG,CAMPYLOBACTER GASTROENTERITIS,1
SG,CAMPYLOBACTER INFECTION,1
SG,CARDIAC DISCOMFORT,1
SG,CARDIAC FIBRILLATION,1
SG,CARDIAC MYXOMA,1
SG,CARDIAC VALVE ABSCESS,1
SG,CARDIOMYOPATHY,1
SG,CARDIOTOXICITY,1
SG,CARDIOVASCULAR DISORDER,1
SG,CAROTID ARTERY DISEASE,1
SG,CAROTID ARTERY OCCLUSION,1
SG,CAROTIDYNIA,1
SG,CATARACT TRAUMATIC,1
SG,CATHETER SITE DISCHARGE,1
SG,CELL-MEDIATED CYTOTOXICITY,1
SG,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
SG,CEREBELLAR ATAXIA,1
SG,CEREBELLAR ATROPHY,1
SG,CEREBRAL ARTERIOSCLEROSIS,1
SG,CEREBRAL ARTERY OCCLUSION,1
SG,CEREBRAL CYST,1
SG,CEREBRAL THROMBOSIS,1
SG,CEREBRAL VENOUS THROMBOSIS,1
SG,CERVICAL MYELOPATHY,1
SG,CHEST WALL MASS,1
SG,CHIKUNGUNYA VIRUS INFECTION,1
SG,CHLOASMA,1
SG,CHOLECYSTITIS,1
SG,CHOLECYSTITIS ACUTE,1
SG,CHOLESTATIC PRURITUS,1
SG,CHOLINERGIC SYNDROME,1
SG,CHORIORETINAL SCAR,1
SG,CHRONIC GASTRITIS,1
SG,CHRONIC GRAFT VERSUS HOST DISEASE,1
SG,CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT,1
SG,CIRCUMORAL OEDEMA,1
SG,CLONUS,1
SG,CLOSTRIDIUM DIFFICILE COLITIS,1
SG,COAGULATION TIME PROLONGED,1
SG,COGWHEEL RIGIDITY,1
SG,COLON NEOPLASM,1
SG,COLORECTAL ADENOCARCINOMA,1
SG,COMPLEX PARTIAL SEIZURES,1
SG,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
SG,CONGENITAL NEUROLOGICAL DISORDER,1
SG,CONJUNCTIVAL HAEMORRHAGE,1
SG,CONJUNCTIVITIS ALLERGIC,1
SG,CONTRAINDICATED PRODUCT ADMINISTERED,1
SG,CONTRAINDICATION TO MEDICAL TREATMENT,1
SG,COORDINATION ABNORMAL,1
SG,CORNEAL ENDOTHELIITIS,1
SG,CORONARY ARTERY OCCLUSION,1
SG,CORONARY ARTERY RESTENOSIS,1
SG,CORTISOL DEFICIENCY,1
SG,CRANIOCEREBRAL INJURY,1
SG,CREATININE RENAL CLEARANCE DECREASED,1
SG,CREATININE RENAL CLEARANCE INCREASED,1
SG,CRYOGLOBULINAEMIA,1
SG,CUSHINGOID,1
SG,CYST,1
SG,CYTOMEGALOVIRUS HEPATITIS,1
SG,CYTOMEGALOVIRUS MUCOCUTANEOUS ULCER,1
SG,CYTOMEGALOVIRUS TEST POSITIVE,1
SG,CYTOMEGALOVIRUS VIRAEMIA,1
SG,DEAFNESS BILATERAL,1
SG,DECREASED VIBRATORY SENSE,1
SG,DEMENTIA WITH LEWY BODIES,1
SG,DEMYELINATION,1
SG,DEPRESSION SUICIDAL,1
SG,DERMATITIS ACNEIFORM,1
SG,DETACHMENT OF RETINAL PIGMENT EPITHELIUM,1
SG,DEVICE BREAKAGE,1
SG,DEVICE INFUSION ISSUE,1
SG,DIABETES MELLITUS INADEQUATE CONTROL,1
SG,DIABETIC COMPLICATION,1
SG,DIASTOLIC DYSFUNCTION,1
SG,DISSOCIATION,1
SG,DIVERTICULITIS,1
SG,DRUG DEPENDENCE,1
SG,DRUG DISPENSING ERROR,1
SG,DRUG LEVEL ABOVE THERAPEUTIC,1
SG,DRUG LEVEL DECREASED,1
SG,DRUG PRESCRIBING ERROR,1
SG,DRUG SPECIFIC ANTIBODY PRESENT,1
SG,DRUG WITHDRAWAL SYNDROME,1
SG,DRY EYE,1
SG,DRY SKIN,1
SG,DUCHENNE MUSCULAR DYSTROPHY,1
SG,DUODENAL ULCER HAEMORRHAGE,1
SK,DEATH,89
SK,DYSPNOEA,78
SK,ANAEMIA,71
SK,DIARRHOEA,67
SK,DRUG INEFFECTIVE,65
SK,CARDIAC FAILURE,63
SK,THROMBOCYTOPENIA,62
SK,ASTHENIA,55
SK,FATIGUE,54
SK,PNEUMONIA,50
SK,VOMITING,48
SK,HYPOTENSION,47
SK,HYPERTENSION,44
SK,MYOCARDIAL INFARCTION,43
SK,CEREBROVASCULAR ACCIDENT,42
SK,ACUTE KIDNEY INJURY,41
SK,PYREXIA,41
SK,DISEASE PROGRESSION,39
SK,SOMNOLENCE,38
SK,NAUSEA,37
SK,SEPSIS,37
SK,NEUTROPENIA,34
SK,TOXICITY TO VARIOUS AGENTS,34
SK,RENAL FAILURE,33
SK,CARDIOPULMONARY FAILURE,32
SK,CONDITION AGGRAVATED,32
SK,RESPIRATORY FAILURE,31
SK,PULMONARY EMBOLISM,30
SK,RASH,28
SK,SEPTIC SHOCK,28
SK,VERTIGO,26
SK,WEIGHT DECREASED,26
SK,HEADACHE,25
SK,PANCYTOPENIA,25
SK,DECREASED APPETITE,24
SK,DYSPEPSIA,24
SK,HEPATIC ENZYME INCREASED,24
SK,LIVER DISORDER,24
SK,ATRIAL FIBRILLATION,23
SK,EPILEPSY,23
SK,ONCOLOGIC COMPLICATION,23
SK,SUICIDE ATTEMPT,23
SK,ERYTHEMA,22
SK,MALIGNANT NEOPLASM PROGRESSION,22
SK,MATERNAL EXPOSURE DURING PREGNANCY,22
SK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,22
SK,OVERDOSE,22
SK,ABDOMINAL PAIN,21
SK,INTESTINAL HAEMORRHAGE,21
SK,STAPHYLOCOCCAL INFECTION,21
SK,DIZZINESS,20
SK,LEUKOPENIA,20
SK,PSEUDOMONAS INFECTION,20
SK,THROMBOSIS,20
SK,ACUTE MYOCARDIAL INFARCTION,19
SK,CELLULITIS,19
SK,CIRCULATORY COLLAPSE,19
SK,FEBRILE NEUTROPENIA,19
SK,OEDEMA,19
SK,DYSARTHRIA,18
SK,FALL,18
SK,INFECTION,18
SK,OEDEMA PERIPHERAL,18
SK,EXPOSURE DURING PREGNANCY,17
SK,INTENTIONAL OVERDOSE,17
SK,ISCHAEMIC STROKE,17
SK,PLEURAL EFFUSION,17
SK,ANURIA,16
SK,BODY TEMPERATURE INCREASED,16
SK,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,16
SK,COUGH,16
SK,DEHYDRATION,16
SK,FOETAL EXPOSURE DURING PREGNANCY,16
SK,PALPITATIONS,16
SK,PLASMA CELL MYELOMA,16
SK,BLOOD PRESSURE INCREASED,15
SK,CHILLS,15
SK,DISORIENTATION,15
SK,DRUG-INDUCED LIVER INJURY,15
SK,HYPERKALAEMIA,15
SK,MELAENA,15
SK,ORAL HERPES,15
SK,PREMATURE BABY,15
SK,RESPIRATORY TRACT INFECTION,15
SK,TACHYCARDIA,15
SK,URINARY TRACT INFECTION,15
SK,BACK PAIN,14
SK,BRONCHOPNEUMONIA,14
SK,DEEP VEIN THROMBOSIS,14
SK,GASTROINTESTINAL HAEMORRHAGE,14
SK,HAEMORRHAGE,14
SK,MULTIPLE SCLEROSIS RELAPSE,14
SK,PNEUMOTHORAX,14
SK,ACUTE RESPIRATORY DISTRESS SYNDROME,13
SK,ALANINE AMINOTRANSFERASE INCREASED,13
SK,ARTHRALGIA,13
SK,DERMATITIS ALLERGIC,13
SK,HEPATOTOXICITY,13
SK,NEUROPATHY PERIPHERAL,13
SK,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,13
SK,SHOCK HAEMORRHAGIC,13
SK,ARRHYTHMIA,12
SK,ASPERGILLUS INFECTION,12
SK,BLOOD CREATININE INCREASED,12
SK,CARDIAC ARREST,12
SK,CHEST PAIN,12
SK,FACE OEDEMA,12
SK,HAEMATOMA,12
SK,LACTIC ACIDOSIS,12
SK,LOSS OF CONSCIOUSNESS,12
SK,METABOLIC ACIDOSIS,12
SK,OSTEONECROSIS OF JAW,12
SK,PERITONITIS,12
SK,RETROPERITONEAL HAEMORRHAGE,12
SK,SEDATION,12
SK,SKIN TOXICITY,12
SK,TUBERCULOSIS GASTROINTESTINAL,12
SK,ABSCESS,11
SK,ACUTE HEPATIC FAILURE,11
SK,ASPARTATE AMINOTRANSFERASE INCREASED,11
SK,ATAXIA,11
SK,CONSTIPATION,11
SK,DEPRESSION,11
SK,GAIT DISTURBANCE,11
SK,GENERAL PHYSICAL HEALTH DETERIORATION,11
SK,GENERALISED OEDEMA,11
SK,HYPERHIDROSIS,11
SK,HYPOCOAGULABLE STATE,11
SK,HYPOGONADISM,11
SK,KIDNEY RUPTURE,11
SK,MALAISE,11
SK,PERICARDIAL EFFUSION,11
SK,PRURITUS,11
SK,SYNCOPE,11
SK,TRANSIENT ISCHAEMIC ATTACK,11
SK,URTICARIA,11
SK,ABDOMINAL PAIN UPPER,10
SK,ABORTION SPONTANEOUS,10
SK,ANGINA PECTORIS,10
SK,CARDIAC DISORDER,10
SK,DYSPHAGIA,10
SK,EMBOLISM,10
SK,FEELING ABNORMAL,10
SK,GASTROINTESTINAL TOXICITY,10
SK,HEMIPARESIS,10
SK,INTERSTITIAL LUNG DISEASE,10
SK,LOW BIRTH WEIGHT BABY,10
SK,MYALGIA,10
SK,PREMATURE DELIVERY,10
SK,RHABDOMYOLYSIS,10
SK,TUBERCULOSIS,10
SK,UPPER RESPIRATORY TRACT INFECTION,10
SK,ASTHMA,9
SK,BREAST CANCER,9
SK,BRONCHOPULMONARY ASPERGILLOSIS,9
SK,CARDIAC FAILURE CHRONIC,9
SK,CEREBRAL HAEMORRHAGE,9
SK,DRUG LEVEL DECREASED,9
SK,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,9
SK,ENTEROVESICAL FISTULA,9
SK,GAMMA-GLUTAMYLTRANSFERASE INCREASED,9
SK,GASTROINTESTINAL DISORDER,9
SK,HAEMATEMESIS,9
SK,HAEMORRHAGE INTRACRANIAL,9
SK,HEART RATE INCREASED,9
SK,HEPATIC FAILURE,9
SK,ISCHAEMIA,9
SK,LEUKOCYTOSIS,9
SK,MENTAL DISORDER,9
SK,MUCOSAL INFLAMMATION,9
SK,MYOCARDIAL ISCHAEMIA,9
SK,NEOPLASM PROGRESSION,9
SK,PULMONARY TUBERCULOSIS,9
SK,SEIZURE,9
SK,SPEECH DISORDER,9
SK,TRAUMATIC HAEMATOMA,9
SK,WEIGHT INCREASED,9
SK,WHITE BLOOD CELL COUNT DECREASED,9
SK,ACUTE MYELOID LEUKAEMIA,8
SK,AGITATION,8
SK,ANAPHYLACTIC REACTION,8
SK,ANGIOEDEMA,8
SK,BALANCE DISORDER,8
SK,C-REACTIVE PROTEIN INCREASED,8
SK,COMA,8
SK,CONFUSIONAL STATE,8
SK,DRY MOUTH,8
SK,DYSPHONIA,8
SK,EPISTAXIS,8
SK,HERPES ZOSTER,8
SK,HYPERGLYCAEMIA,8
SK,HYPERSENSITIVITY,8
SK,HYPONATRAEMIA,8
SK,INSOMNIA,8
SK,METASTASES TO LUNG,8
SK,OPSOCLONUS MYOCLONUS,8
SK,PAIN,8
SK,PAIN IN EXTREMITY,8
SK,PARAPARESIS,8
SK,RASH GENERALISED,8
SK,RENAL IMPAIRMENT,8
SK,RESTLESSNESS,8
SK,STOMATITIS,8
SK,TOXIC SKIN ERUPTION,8
SK,TRANSAMINASES INCREASED,8
SK,TREMOR,8
SK,ALOPECIA,7
SK,ALTERED STATE OF CONSCIOUSNESS,7
SK,ANXIETY,7
SK,BLOOD PRESSURE DECREASED,7
SK,BRAIN OEDEMA,7
SK,CARDIAC FAILURE ACUTE,7
SK,COMPLETED SUICIDE,7
SK,CYSTITIS,7
SK,DIABETIC METABOLIC DECOMPENSATION,7
SK,DRUG INTOLERANCE,7
SK,ENTEROCOCCAL INFECTION,7
SK,FOETAL EXPOSURE TIMING UNSPECIFIED,7
SK,HAEMATOCHEZIA,7
SK,HAEMATURIA,7
SK,HAEMOGLOBIN DECREASED,7
SK,HAEMOPTYSIS,7
SK,HYPERTENSIVE CRISIS,7
SK,HYPOTHYROIDISM,7
SK,ILEUS,7
SK,LIVE BIRTH,7
SK,METABOLIC DISORDER,7
SK,NASAL CONGESTION,7
SK,NEPHROPATHY TOXIC,7
SK,NIH STROKE SCALE SCORE INCREASED,7
SK,OESOPHAGITIS,7
SK,OPTIC NEURITIS,7
SK,OSTEONECROSIS,7
SK,PARAESTHESIA,7
SK,PLATELET COUNT DECREASED,7
SK,POLYNEUROPATHY,7
SK,PREGNANCY,7
SK,RESPIRATORY ACIDOSIS,7
SK,RIGHT VENTRICULAR FAILURE,7
SK,SUBDURAL HAEMATOMA,7
SK,UPPER GASTROINTESTINAL HAEMORRHAGE,7
SK,VENTRICULAR TACHYCARDIA,7
SK,ANGINA UNSTABLE,6
SK,APHASIA,6
SK,BLOOD BILIRUBIN INCREASED,6
SK,BLOOD PRESSURE FLUCTUATION,6
SK,BLOOD UREA INCREASED,6
SK,CAESAREAN SECTION,6
SK,CANDIDA INFECTION,6
SK,CARDIOGENIC SHOCK,6
SK,CHEST DISCOMFORT,6
SK,CITROBACTER INFECTION,6
SK,CYANOSIS,6
SK,DECUBITUS ULCER,6
SK,GENERALISED TONIC-CLONIC SEIZURE,6
SK,GEOTRICHUM INFECTION,6
SK,HEPATITIS C,6
SK,HYPOKALAEMIA,6
SK,HYPOTHERMIA,6
SK,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,6
SK,INFUSION RELATED REACTION,6
SK,LUNG DISORDER,6
SK,LYMPHADENITIS,6
SK,LYMPHADENOPATHY,6
SK,MUCORMYCOSIS,6
SK,MUSCLE SPASMS,6
SK,NEUROTOXICITY,6
SK,PALLOR,6
SK,PANCREATITIS ACUTE,6
SK,PERIPHERAL SWELLING,6
SK,PHOTOPSIA,6
SK,POISONING,6
SK,PRE-ECLAMPSIA,6
SK,PRODUCT USE ISSUE,6
SK,PSYCHOTIC DISORDER,6
SK,RADICULAR SYNDROME,6
SK,SKIN DISORDER,6
SK,STAPHYLOCOCCAL SCALDED SKIN SYNDROME,6
SK,SUICIDAL IDEATION,6
SK,TREATMENT FAILURE,6
SK,UVEITIS,6
SK,ABDOMINAL DISCOMFORT,5
SK,ABNORMAL BEHAVIOUR,5
SK,ACNE FULMINANS,5
SK,AGGRESSION,5
SK,ANAPHYLACTIC SHOCK,5
SK,APATHY,5
SK,ASCITES,5
SK,ASPHYXIA,5
SK,BACTERAEMIA,5
SK,BASAL CELL CARCINOMA,5
SK,BRADYCARDIA,5
SK,BRONCHITIS,5
SK,CARDIAC FAILURE CONGESTIVE,5
SK,COGNITIVE DISORDER,5
SK,DIPLOPIA,5
SK,DISTURBANCE IN ATTENTION,5
SK,ECZEMA,5
SK,ELECTROCARDIOGRAM QT PROLONGED,5
SK,ENTERITIS,5
SK,EYELID OEDEMA,5
SK,FRACTURE,5
SK,GLYCOSYLATED HAEMOGLOBIN INCREASED,5
SK,HAEMATOTOXICITY,5
SK,HYPERBILIRUBINAEMIA,5
SK,HYPOAESTHESIA,5
SK,IMMUNODEFICIENCY,5
SK,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
SK,INFLAMMATION,5
SK,INFLUENZA,5
SK,LIVER FUNCTION TEST ABNORMAL,5
SK,LYMPHOPENIA,5
SK,MATERNAL EXPOSURE BEFORE PREGNANCY,5
SK,MEMORY IMPAIRMENT,5
SK,MOBILITY DECREASED,5
SK,MULTI-ORGAN FAILURE,5
SK,MUSCULAR WEAKNESS,5
SK,MUSCULOSKELETAL STIFFNESS,5
SK,NERVOUS SYSTEM DISORDER,5
SK,NON-HODGKIN^S LYMPHOMA,5
SK,ORGAN FAILURE,5
SK,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,5
SK,PETECHIAE,5
SK,PSEUDOMEMBRANOUS COLITIS,5
SK,RASH MACULO-PAPULAR,5
SK,RENAL FAILURE ACUTE,5
SK,SCHIZOPHRENIA,5
SK,SINUS TACHYCARDIA,5
SK,SLEEP DISORDER,5
SK,SUDDEN CARDIAC DEATH,5
SK,SWELLING FACE,5
SK,TREATMENT NONCOMPLIANCE,5
SK,URINARY RETENTION,5
SK,VISUAL ACUITY REDUCED,5
SK,VISUAL IMPAIRMENT,5
SK,ACCELERATED HYPERTENSION,4
SK,ACUTE CORONARY SYNDROME,4
SK,ACUTE RESPIRATORY FAILURE,4
SK,APHTHOUS ULCER,4
SK,BLOOD ALKALINE PHOSPHATASE INCREASED,4
SK,BLOOD GLUCOSE ABNORMAL,4
SK,BLOOD URINE PRESENT,4
SK,BONE PAIN,4
SK,CACHEXIA,4
SK,CARDIOVASCULAR DISORDER,4
SK,CEREBRAL ISCHAEMIA,4
SK,CHOLELITHIASIS,4
SK,CHOLESTASIS,4
SK,COLITIS,4
SK,DELIRIUM,4
SK,DERMATITIS,4
SK,DERMATITIS ACNEIFORM,4
SK,DIABETES MELLITUS,4
SK,DIABETIC NEUROPATHY,4
SK,DISSEMINATED INTRAVASCULAR COAGULATION,4
SK,DISSEMINATED TUBERCULOSIS,4
SK,DRUG DOSE OMISSION,4
SK,DRUG EFFECT INCOMPLETE,4
SK,DRUG ERUPTION,4
SK,DYSGEUSIA,4
SK,ELECTROLYTE IMBALANCE,4
SK,ENDOCARDITIS,4
SK,FLATULENCE,4
SK,FOETAL GROWTH RESTRICTION,4
SK,GASTRIC HAEMORRHAGE,4
SK,GRANULOMA,4
SK,HAEMORRHAGIC STROKE,4
SK,HEPATIC STEATOSIS,4
SK,HEPATORENAL FAILURE,4
SK,HYDRONEPHROSIS,4
SK,HYPERCHLORAEMIA,4
SK,HYPOGLYCAEMIA,4
SK,IDIOPATHIC PULMONARY FIBROSIS,4
SK,IRIDOCYCLITIS,4
SK,JAUNDICE,4
SK,LATENT TUBERCULOSIS,4
SK,LEUKOCYTURIA,4
SK,LIMB DISCOMFORT,4
SK,MEDICATION ERROR,4
SK,MEGACOLON,4
SK,METASTASES TO LIVER,4
SK,METASTASES TO LYMPH NODES,4
SK,MOTOR DYSFUNCTION,4
SK,MULTIPLE SCLEROSIS,4
SK,MYELODYSPLASTIC SYNDROME,4
SK,PARKINSONISM,4
SK,PHARYNGEAL OEDEMA,4
SK,PNEUMONIA BACTERIAL,4
SK,PRESCRIBED UNDERDOSE,4
SK,PROCALCITONIN INCREASED,4
SK,PRODUCTIVE COUGH,4
SK,PROTEINURIA,4
SK,PSYCHOMOTOR HYPERACTIVITY,4
SK,RASH PAPULAR,4
SK,RASH PRURITIC,4
SK,RENAL CANCER,4
SK,RESPIRATORY ARREST,4
SK,RHEUMATOID ARTHRITIS,4
SK,SALPINGO-OOPHORITIS,4
SK,SECOND PRIMARY MALIGNANCY,4
SK,SKIN EXFOLIATION,4
SK,SKIN NECROSIS,4
SK,SPINAL PAIN,4
SK,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,4
SK,THROMBOPHLEBITIS,4
SK,UROSEPSIS,4
SK,VENOUS THROMBOSIS,4
SK,VENTRICULAR FIBRILLATION,4
SK,VISION BLURRED,4
SK,VITREOUS HAEMORRHAGE,4
SK,ABORTION INDUCED,3
SK,ABORTION MISSED,3
SK,ACCIDENTAL EXPOSURE TO PRODUCT,3
SK,ACIDOSIS,3
SK,ADENOCARCINOMA OF COLON,3
SK,AGRANULOCYTOSIS,3
SK,AKATHISIA,3
SK,APHTHOUS STOMATITIS,3
SK,BACTERIURIA,3
SK,BLADDER CANCER,3
SK,BLINDNESS TRANSIENT,3
SK,BLOOD PRESSURE IMMEASURABLE,3
SK,BRADYPHRENIA,3
SK,BRONCHOSPASM,3
SK,CHOLECYSTITIS,3
SK,COAGULOPATHY,3
SK,COLON CANCER,3
SK,CONVULSION,3
SK,CUTANEOUS VASCULITIS,3
SK,DEPRESSED LEVEL OF CONSCIOUSNESS,3
SK,DERMATOMYOSITIS,3
SK,DEVICE DISLOCATION,3
SK,DEVICE RELATED INFECTION,3
SK,DIVERTICULUM INTESTINAL,3
SK,DRUG ADMINISTRATION ERROR,3
SK,DRUG HYPERSENSITIVITY,3
SK,DYSKINESIA,3
SK,DYSTONIA,3
SK,DYSURIA,3
SK,EOSINOPHILIA,3
SK,EROSIVE OESOPHAGITIS,3
SK,EYE HAEMORRHAGE,3
SK,GAS GANGRENE,3
SK,GASTRIC ULCER,3
SK,GASTRITIS,3
SK,GASTRITIS EROSIVE,3
SK,GINGIVAL BLEEDING,3
SK,HAEMORRHAGIC INFARCTION,3
SK,HALLUCINATION_ VISUAL,3
SK,HEPATIC CIRRHOSIS,3
SK,HEPATOMEGALY,3
SK,HEPATORENAL SYNDROME,3
SK,HEPATOSPLENOMEGALY,3
SK,HERPES VIRUS INFECTION,3
SK,HYDROTHORAX,3
SK,HYPERCHOLESTEROLAEMIA,3
SK,HYPERTHYROIDISM,3
SK,HYPERTRICHOSIS,3
SK,HYPOACUSIS,3
SK,HYPOALBUMINAEMIA,3
SK,HYPOGAMMAGLOBULINAEMIA,3
SK,HYPOPHAGIA,3
SK,HYPOPROTEINAEMIA,3
SK,ILEUS PARALYTIC,3
SK,INFLUENZA LIKE ILLNESS,3
SK,INTERNATIONAL NORMALISED RATIO INCREASED,3
SK,INVASIVE DUCTAL BREAST CARCINOMA,3
SK,IRITIS,3
SK,IRON DEFICIENCY ANAEMIA,3
SK,JOINT SWELLING,3
SK,LIVER FUNCTION TEST INCREASED,3
SK,LOWER RESPIRATORY TRACT INFECTION,3
SK,LUNG ADENOCARCINOMA,3
SK,LUNG NEOPLASM MALIGNANT,3
SK,LUPUS NEPHRITIS,3
SK,LYMPHOMA,3
SK,MENINGITIS,3
SK,MENORRHAGIA,3
SK,METRORRHAGIA,3
SK,MINERAL DEFICIENCY,3
SK,MITRAL VALVE INCOMPETENCE,3
SK,MUSCLE RIGIDITY,3
SK,MUSCULOSKELETAL PAIN,3
SK,MYOPATHY,3
SK,NODAL RHYTHM,3
SK,NORMAL NEWBORN,3
SK,OCULAR DISCOMFORT,3
SK,PANCREATIC CARCINOMA,3
SK,PANCREATITIS,3
SK,PARAESTHESIA ORAL,3
SK,PERSONALITY DISORDER,3
SK,PNEUMONITIS,3
SK,POST PROCEDURAL COMPLICATION,3
SK,POST-INJECTION DELIRIUM SEDATION SYNDROME,3
SK,PREMATURE SEPARATION OF PLACENTA,3
SK,PSORIASIS,3
SK,PULMONARY FIBROSIS,3
SK,PULMONARY OEDEMA,3
SK,PURPURA,3
SK,RECTAL CANCER,3
SK,RENAL COLIC,3
SK,SEROTONIN SYNDROME,3
SK,SINUSITIS,3
SK,SPLENOMEGALY,3
SK,STILLBIRTH,3
SK,SUBILEUS,3
SK,SUFFOCATION FEELING,3
SK,THIRST,3
SK,TONSILLITIS,3
SK,TOOTHACHE,3
SK,URINARY INCONTINENCE,3
SK,VASCULAR STENT THROMBOSIS,3
SK,VASCULITIS,3
SK,WERNICKE-KORSAKOFF SYNDROME,3
SK,ABDOMINAL PAIN LOWER,2
SK,ABDOMINAL WALL HAEMATOMA,2
SK,ABNORMAL LOSS OF WEIGHT,2
SK,ABSCESS DRAINAGE,2
SK,ADENOCARCINOMA,2
SK,ADVERSE DRUG REACTION,2
SK,AFFECT LABILITY,2
SK,AMYLASE INCREASED,2
SK,ANAPLASTIC ASTROCYTOMA,2
SK,ANHEDONIA,2
SK,ANKLE FRACTURE,2
SK,AORTIC DISSECTION,2
SK,APPENDICITIS PERFORATED,2
SK,ARTHROPATHY,2
SK,ATRIAL FLUTTER,2
SK,ATRIAL TACHYCARDIA,2
SK,ATRIAL THROMBOSIS,2
SK,ATRIOVENTRICULAR BLOCK,2
SK,ATRIOVENTRICULAR BLOCK COMPLETE,2
SK,B-CELL LYMPHOMA,2
SK,BACK INJURY,2
SK,BILIRUBIN CONJUGATED INCREASED,2
SK,BIPOLAR I DISORDER,2
SK,BLAST CELL COUNT INCREASED,2
SK,BLOOD BRAIN BARRIER DEFECT,2
SK,BLOOD CHOLESTEROL INCREASED,2
SK,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
SK,BLOOD GLUCOSE INCREASED,2
SK,BLOOD PRESSURE ABNORMAL,2
SK,BLOOD THYROID STIMULATING HORMONE INCREASED,2
SK,BONE MARROW FAILURE,2
SK,BRADYARRHYTHMIA,2
SK,BRAIN INJURY,2
SK,BRAIN NEOPLASM,2
SK,BRAIN STEM SYNDROME,2
SK,BRONCHITIS CHRONIC,2
SK,CARDIAC ANEURYSM,2
SK,CARDIAC FIBRILLATION,2
SK,CARDIOTOXICITY,2
SK,CAROTID ARTERY OCCLUSION,2
SK,CATABOLIC STATE,2
SK,CENTRAL NERVOUS SYSTEM LESION,2
SK,CEREBRAL INFARCTION,2
SK,CHOLECYSTITIS INFECTIVE,2
SK,CHRONIC KIDNEY DISEASE,2
SK,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
SK,CNS VENTRICULITIS,2
SK,COAGULATION TEST ABNORMAL,2
SK,COLITIS ISCHAEMIC,2
SK,COLITIS MICROSCOPIC,2
SK,CONCOMITANT DISEASE PROGRESSION,2
SK,CONJUNCTIVITIS ALLERGIC,2
SK,CONTUSION,2
SK,CROHN^S DISEASE,2
SK,CYTOMEGALOVIRUS INFECTION,2
SK,DEMENTIA,2
SK,DERMATITIS EXFOLIATIVE,2
SK,DEVICE EXPULSION,2
SK,DIABETES MELLITUS INADEQUATE CONTROL,2
SK,DIABETIC RETINOPATHY,2
SK,DISCOMFORT,2
SK,DIVERTICULITIS,2
SK,DRUG ABUSE,2
SK,DRUG DEPENDENCE,2
SK,DRUG RESISTANCE,2
SK,DRUG WITHDRAWAL SYNDROME,2
SK,DRY SKIN,2
SK,DUODENAL ULCER,2
SK,DUODENITIS,2
SK,DYSGRAPHIA,2
SK,ECTOPIC PREGNANCY,2
SK,EMPYEMA,2
SK,ENCEPHALITIS VIRAL,2
SK,ENDOPHTHALMITIS,2
SK,ENTEROCOLITIS,2
SK,ERYSIPELAS,2
SK,EXCORIATION,2
SK,EXTRAPYRAMIDAL DISORDER,2
SK,EYE IRRITATION,2
SK,EYE OEDEMA,2
SK,EYE PAIN,2
SK,FACIAL PARALYSIS,2
SK,FLUID RETENTION,2
SK,FOETAL PLACENTAL THROMBOSIS,2
SK,FOOT DEFORMITY,2
SK,GAIT INABILITY,2
SK,GALLBLADDER PERFORATION,2
SK,GASTRIC DISORDER,2
SK,GASTRIC ULCER PERFORATION,2
SK,GASTROENTERITIS,2
SK,GASTROINTESTINAL OBSTRUCTION,2
SK,GASTROOESOPHAGEAL REFLUX DISEASE,2
SK,GENITAL HAEMORRHAGE,2
SK,GINGIVAL HYPERTROPHY,2
SK,GLIOMA,2
SK,HAEMOLYSIS,2
SK,HAEMOLYTIC ANAEMIA,2
SK,HAEMORRHAGIC ANAEMIA,2
SK,HAEMORRHOIDAL HAEMORRHAGE,2
SK,HALLUCINATION,2
SK,HENOCH-SCHONLEIN PURPURA,2
SK,HEPATOCELLULAR CARCINOMA,2
SK,HILAR LYMPHADENOPATHY,2
SK,HIP FRACTURE,2
SK,HODGKIN^S DISEASE,2
SK,HYPERAMMONAEMIC ENCEPHALOPATHY,2
SK,HYPERCALCAEMIA,2
SK,HYPERCREATINAEMIA,2
SK,HYPERTENSIVE HEART DISEASE,2
SK,HYPOXIA,2
SK,IMMEDIATE POST-INJECTION REACTION,2
SK,IMMUNE THROMBOCYTOPENIC PURPURA,2
SK,IMPETIGO,2
SK,INCARCERATED HERNIA,2
SK,INCORRECT DOSE ADMINISTERED,2
SK,INFECTIOUS MONONUCLEOSIS,2
SK,INFLAMMATORY MARKER INCREASED,2
SK,INTERVERTEBRAL DISCITIS,2
SK,JOINT RANGE OF MOTION DECREASED,2
SK,KETOACIDOSIS,2
SK,LACRIMATION INCREASED,2
SK,LARGE FOR DATES BABY,2
SK,LARGE INTESTINAL HAEMORRHAGE,2
SK,LARGE INTESTINE PERFORATION,2
SK,LARYNGOSPASM,2
SK,LETHARGY,2
SK,LIPOATROPHY,2
SK,LIPOMA,2
SK,LOCAL SWELLING,2
SK,LOCALISED OEDEMA,2
SK,LYMPHADENOPATHY MEDIASTINAL,2
SK,LYMPHOCYTE COUNT DECREASED,2
SK,MAJOR DEPRESSION,2
SK,MALIGNANT MELANOMA,2
SK,MALNUTRITION,2
SK,MENTAL IMPAIRMENT,2
SK,METASTASES TO BONE,2
SK,METASTASES TO CENTRAL NERVOUS SYSTEM,2
SK,METASTATIC RENAL CELL CARCINOMA,2
SK,METHAEMOGLOBINAEMIA,2
SK,MICROALBUMINURIA,2
SK,MICTURITION URGENCY,2
SK,MOOD ALTERED,2
SK,MOOD SWINGS,2
SK,MOUTH SWELLING,2
SK,MOVEMENT DISORDER,2
SK,MUCOSAL DRYNESS,2
SK,MUSCLE ABSCESS,2
SK,MYASTHENIA GRAVIS,2
SK,MYCOBACTERIUM MARINUM INFECTION,2
SK,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,2
SK,MYELOFIBROSIS,2
SK,MYELOPROLIFERATIVE NEOPLASM,2
SK,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,2
SK,NEOPLASM MALIGNANT,2
SK,NEPHROLITHIASIS,2
SK,NO THERAPEUTIC RESPONSE,2
SK,NODAL ARRHYTHMIA,2
SK,NON-SMALL CELL LUNG CANCER STAGE IIIA,2
SK,NOSOCOMIAL INFECTION,2
SK,OCULAR HYPERAEMIA,2
SK,OLIGURIA,2
SK,ORAL CANDIDIASIS,2
SK,ORCHITIS,2
SK,OROPHARYNGEAL PAIN,2
SK,OSTEOPOROSIS,2
SK,OSTEOPOROTIC FRACTURE,2
SK,OVARIAN CYST,2
SK,OXYGEN SATURATION DECREASED,2
SK,PANCREATIC CARCINOMA METASTATIC,2
SK,PANCREATITIS CHRONIC,2
SK,PARKINSON^S DISEASE,2
SK,PARONYCHIA,2
SK,PELVIC FRACTURE,2
SK,PERFORMANCE STATUS DECREASED,2
SK,PERIPHERAL SENSORIMOTOR NEUROPATHY,2
SK,PERONEAL NERVE PALSY,2
SK,PIGMENTATION DISORDER,2
SK,PLACENTA PRAEVIA,2
SK,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
SK,PNEUMONIA ASPIRATION,2
SK,POLLAKIURIA,2
SK,POSTOPERATIVE WOUND INFECTION,2
SK,POSTRENAL FAILURE,2
SK,PREMATURE RUPTURE OF MEMBRANES,2
SK,PRESCRIBED OVERDOSE,2
SK,PRODUCT QUALITY ISSUE,2
SK,PRODUCT USE IN UNAPPROVED INDICATION,2
SK,PROSTATE CANCER,2
SK,PROSTATIC SPECIFIC ANTIGEN INCREASED,2
SK,PRURITUS GENERALISED,2
SK,PSYCHOMOTOR SKILLS IMPAIRED,2
SK,PULMONARY HYPERTENSION,2
SK,PULMONARY MASS,2
SK,PULMONARY TOXICITY,2
SK,PULSE ABSENT,2
SK,PYELONEPHRITIS,2
SK,QUADRIPARESIS,2
SK,RASH MACULAR,2
SK,RASH PUSTULAR,2
SK,REBOUND EFFECT,2
SK,RECTAL ADENOCARCINOMA,2
SK,RECTAL HAEMORRHAGE,2
SK,RENAL INJURY,2
SK,RESPIRATORY ALKALOSIS,2
SK,RESPIRATORY DISTRESS,2
SK,RESPIRATORY TRACT INFECTION BACTERIAL,2
SK,RETINAL DETACHMENT,2
SK,RETINAL PIGMENT EPITHELIAL TEAR,2
SK,RETINAL SCAR,2
SK,SCLERODERMA,2
SK,SECRETION DISCHARGE,2
SK,SINUS BRADYCARDIA,2
SK,SIRENOMELIA,2
SK,SOCIAL AVOIDANT BEHAVIOUR,2
SK,SPUTUM PURULENT,2
SK,SQUAMOUS CELL CARCINOMA,2
SK,STATUS EPILEPTICUS,2
SK,SUBDURAL HAEMORRHAGE,2
SK,SUDDEN DEATH,2
SK,SUPERIOR VENA CAVA SYNDROME,2
SK,SWELLING,2
SK,SYSTEMIC LUPUS ERYTHEMATOSUS,2
SK,TENSION,2
SK,THROAT IRRITATION,2
SK,THROMBOSIS IN DEVICE,2
SK,THYROID CANCER,2
SK,TINNITUS,2
SK,TOOTH EXTRACTION,2
SK,TRACHEITIS,2
SK,TRACHEOBRONCHITIS,2
SK,TRISOMY 21,2
SK,ULCER HAEMORRHAGE,2
SK,UPPER LIMB FRACTURE,2
SK,URETERIC CANCER,2
SK,URINARY HESITATION,2
SK,URINE KETONE BODY PRESENT,2
SK,UTERINE LEIOMYOMA,2
SK,VAGINAL HAEMORRHAGE,2
SK,VESTIBULAR DISORDER,2
SK,VIRAL INFECTION,2
SK,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
SK,WHITE BLOOD CELL COUNT INCREASED,2
SK,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
SK,5Q MINUS SYNDROME,1
SK,ABASIA,1
SK,ABDOMINAL INFECTION,1
SK,ABORTION,1
SK,ABSCESS JAW,1
SK,ABSCESS LIMB,1
SK,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
SK,ACCIDENTAL POISONING,1
SK,ACCIDENTAL UNDERDOSE,1
SK,ACID BASE BALANCE ABNORMAL,1
SK,ACINETOBACTER INFECTION,1
SK,ACNE,1
SK,ACTIVITIES OF DAILY LIVING IMPAIRED,1
SK,ACUTE ABDOMEN,1
SK,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
SK,ACUTE MYELOID LEUKAEMIA RECURRENT,1
SK,ACUTE PRERENAL FAILURE,1
SK,ACUTE PULMONARY OEDEMA,1
SK,ACUTE VESTIBULAR SYNDROME,1
SK,ADAMS-STOKES SYNDROME,1
SK,ADENOCARCINOMA PANCREAS,1
SK,ADRENAL GLAND CANCER,1
SK,ADVERSE EVENT,1
SK,ADVERSE REACTION,1
SK,AFFECTIVE DISORDER,1
SK,AGEUSIA,1
SK,ALKALOSIS HYPOKALAEMIC,1
SK,AMENORRHOEA,1
SK,AMNESIA,1
SK,AMNIORRHOEA,1
SK,AMYOTROPHIC LATERAL SCLEROSIS,1
SK,ANAEMIA MACROCYTIC,1
SK,ANAL ABSCESS,1
SK,ANAL PRURITUS,1
SK,ANGIODERMATITIS,1
SK,ANGIOPATHY,1
SK,ANTI FACTOR VIII ANTIBODY POSITIVE,1
SK,ANTIPHOSPHOLIPID SYNDROME,1
SK,ANXIETY DISORDER,1
SK,AORTIC ARTERIOSCLEROSIS,1
SK,AORTIC EMBOLUS,1
SK,AORTIC STENOSIS,1
SK,AORTIC THROMBOSIS,1
SK,APNOEA,1
SK,APPENDICECTOMY,1
SK,APPENDICITIS,1
SK,APPENDIX DISORDER,1
SK,APTYALISM,1
SK,ARTERIAL DISORDER,1
SK,ARTERIAL RUPTURE,1
SK,ARTERIAL THROMBOSIS,1
SK,ARTERIOSCLEROSIS,1
SK,ARTERIOVENOUS FISTULA THROMBOSIS,1
SK,ARTHRITIS INFECTIVE,1
SK,ARTHROPOD BITE,1
SK,ASPERGILLOSIS,1
SK,ASTROCYTOMA_ LOW GRADE,1
SK,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
SK,AUTISM,1
SK,AUTOIMMUNE HEPATITIS,1
SK,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
SK,BACK DISORDER,1
SK,BACTERIAL TEST POSITIVE,1
SK,BASAL GANGLIA HAEMORRHAGE,1
SK,BASAL GANGLIA STROKE,1
SK,BASE EXCESS DECREASED,1
SK,BASOPHILIA,1
SK,BENIGN NEOPLASM OF BLADDER,1
SK,BILE DUCT STENOSIS,1
SK,BILIARY ABSCESS,1
SK,BILIARY FISTULA,1
SK,BILIARY POLYP,1
SK,BLADDER DISCOMFORT,1
SK,BLADDER IRRITATION,1
SK,BLADDER PAIN,1
SK,BLADDER TAMPONADE,1
SK,BLADDER TRANSITIONAL CELL CARCINOMA,1
SK,BLINDNESS,1
SK,BLINDNESS CORTICAL,1
SK,BLINDNESS UNILATERAL,1
SK,BLISTER,1
SK,BLISTER RUPTURE,1
SK,BLOOD ALKALINE PHOSPHATASE ABNORMAL,1
SK,BLOOD BILIRUBIN ABNORMAL,1
SK,BLOOD CHOLESTEROL DECREASED,1
SK,BLOOD FIBRINOGEN INCREASED,1
SK,BLOOD GLUCOSE DECREASED,1
SK,BLOOD GLUCOSE FLUCTUATION,1
SK,BLOOD IMMUNOGLOBULIN A INCREASED,1
SK,BLOOD IMMUNOGLOBULIN G INCREASED,1
SK,BLOOD LACTATE DEHYDROGENASE INCREASED,1
SK,BLOOD LACTIC ACID INCREASED,1
SK,BLOOD SODIUM INCREASED,1
SK,BLOOD TESTOSTERONE ABNORMAL,1
SK,BLOOD TRIGLYCERIDES INCREASED,1
SK,BODY TEMPERATURE DECREASED,1
SK,BONE MARROW INFILTRATION,1
SK,BONE MARROW TOXICITY,1
SK,BRACHIAL PLEXUS INJURY,1
SK,BRAIN STEM HAEMORRHAGE,1
SK,BREAST CANCER STAGE I,1
SK,BREAST CANCER STAGE III,1
SK,BREAST CYST,1
SK,BREAST MASS,1
SK,BREAST PAIN,1
SK,BREATH SOUNDS ABNORMAL,1
SK,BRONCHIAL CARCINOMA,1
SK,BRONCHIAL OBSTRUCTION,1
SK,BRONCHIAL SECRETION RETENTION,1
SK,BRONCHIECTASIS,1
SK,BURN OF INTERNAL ORGANS,1
SK,BURNING SENSATION,1
SK,C-TELOPEPTIDE INCREASED,1
SK,CALCINOSIS,1
SK,CANDIDA TEST POSITIVE,1
SK,CARDIAC AUTONOMIC NEUROPATHY,1
SK,CARDIAC PACEMAKER INSERTION,1
SK,CARDIO-RESPIRATORY DISTRESS,1
SK,CARDIOMEGALY,1
SK,CARDIOMYOPATHY,1
SK,CARDIORENAL SYNDROME,1
SK,CAROTID ARTERIOSCLEROSIS,1
SK,CAROTID ARTERY STENOSIS,1
SK,CAROTID SINUS SYNDROME,1
SK,CARPAL TUNNEL SYNDROME,1
SK,CATARACT,1
SK,CATARACT OPERATION,1
SK,CD4 LYMPHOCYTES DECREASED,1
SK,CELLULITIS STAPHYLOCOCCAL,1
SK,CENTRAL VENOUS CATHETERISATION,1
SK,CEREBELLAR ATAXIA,1
SK,CEREBELLAR HAEMORRHAGE,1
SK,CEREBELLAR ISCHAEMIA,1
SK,CEREBRAL ARTERY OCCLUSION,1
SK,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY,1
SK,CEREBRAL CYST,1
SK,CERVICAL RADICULOPATHY,1
SK,CHEST INJURY,1
SK,CHEST WALL OPERATION,1
SK,CHEST X-RAY ABNORMAL,1
SK,CHOKING,1
SK,CHOLECYSTECTOMY,1
SK,CHOLECYSTITIS ACUTE,1
SK,CHOLESTATIC LIVER INJURY,1
SK,CHORIORETINOPATHY,1
SK,CHROMATURIA,1
SK,CHRONIC GASTRITIS,1
SK,CHRONIC GRAFT VERSUS HOST DISEASE,1
SK,CHRONIC LEUKAEMIA,1
SK,CHRONIC MYELOID LEUKAEMIA,1
SK,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
SK,CHRONIC SINUSITIS,1
SK,CIRRHOSIS ALCOHOLIC,1
SK,CLOSTRIDIUM DIFFICILE COLITIS,1
SK,CLOSTRIDIUM DIFFICILE INFECTION,1
SK,COLD SWEAT,1
SK,COLITIS ULCERATIVE,1
SK,COLON CANCER METASTATIC,1
SK,COLONIC HAEMATOMA,1
SK,COMMINUTED FRACTURE,1
SK,COMMUNICATION DISORDER,1
SK,COMPARTMENT SYNDROME,1
SK,COMPLICATION OF DEVICE INSERTION,1
SK,COMPLICATION OF PREGNANCY,1
SK,COMPLICATIONS OF TRANSPLANT SURGERY,1
SK,CONGENITAL CYSTIC KIDNEY DISEASE,1
SK,CONGENITAL CYSTIC LUNG,1
SK,CONGENITAL INFECTION,1
SK,CONGESTIVE CARDIOMYOPATHY,1
SK,CONJUNCTIVITIS,1
SK,CONTRAINDICATION TO VACCINATION,1
SK,CONVULSIONS LOCAL,1
SK,COR PULMONALE,1
SK,CORNEAL DISORDER,1
SK,CORONARY ARTERY BYPASS,1
SK,CORONARY ARTERY DISEASE,1
SK,CORONARY ARTERY INSUFFICIENCY,1
SK,CORONARY ARTERY STENOSIS,1
SK,CORONARY OSTIAL STENOSIS,1
SK,CRANIOCEREBRAL INJURY,1
SK,CRANIOTOMY,1
SK,CRYING,1
SK,CUSHINGOID,1
SK,CYSTITIS KLEBSIELLA,1
SK,CYSTOID MACULAR OEDEMA,1
SK,DEAFNESS NEUROSENSORY,1
SK,DECREASED INTEREST,1
SK,DEFAECATION URGENCY,1
SK,DEGENERATIVE TRICUSPID VALVE DISEASE,1
SK,DEMENTIA ALZHEIMER^S TYPE,1
SK,DEMYELINATION,1
SK,DEPRESSIVE SYMPTOM,1
SK,DERMATITIS PSORIASIFORM,1
SK,DEVELOPMENTAL DELAY,1
SK,DEVICE OCCLUSION,1
SK,DIABETIC FOOT,1
SK,DIABETIC GANGRENE,1
SK,DIABETIC KETOACIDOSIS,1
SK,DIABETIC NEPHROPATHY,1
SK,DIALYSIS,1
SK,DIAPHRAGMATIC HERNIA,1
SK,DIARRHOEA HAEMORRHAGIC,1
SK,DIASTOLIC DYSFUNCTION,1
SK,DIFFUSE PANBRONCHIOLITIS,1
SK,DILATATION VENTRICULAR,1
SK,DIVERTICULAR PERFORATION,1
SK,DOPAMINE DYSREGULATION SYNDROME,1
SK,DRUG DISPENSING ERROR,1
SK,DRUG EFFECT DECREASED,1
SK,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
SK,DRUG SPECIFIC ANTIBODY PRESENT,1
SK,DRUG USE DISORDER,1
SK,DRY EYE,1
SK,DUODENAL PERFORATION,1
SK,DUODENOGASTRIC REFLUX,1
SK,DYSBACTERIOSIS,1
SK,DYSLIPIDAEMIA,1
SK,DYSPHORIA,1
SK,DYSPNOEA AT REST,1
SK,DYSPNOEA EXERTIONAL,1
SK,ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE,1
SK,ECZEMA INFECTED,1
SK,EDUCATIONAL PROBLEM,1
SK,EJECTION FRACTION DECREASED,1
SK,ELECTROCARDIOGRAM PR PROLONGATION,1
SK,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
SK,ELECTROCARDIOGRAM QRS COMPLEX SHORTENED,1
SK,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
SK,ELECTROCARDIOGRAM T WAVE INVERSION,1
SK,ELECTROCARDIOGRAM T WAVE PEAKED,1
SK,ELECTROENCEPHALOGRAM ABNORMAL,1
SK,EMBOLISM VENOUS,1
SK,EMOTIONAL DISTRESS,1
SK,EMPHYSEMA,1
SK,ENCEPHALITIS,1
SK,ENCEPHALOMYELITIS,1
SK,ENCEPHALOPATHY,1
SK,ENDOMETRIAL HYPERPLASIA,1
SK,ENTEROCOLITIS BACTERIAL,1
SK,ENTEROCOLITIS INFECTIOUS,1
SI,DYSPNOEA,105
SI,FATIGUE,82
SI,DEATH,73
SI,CARDIAC FAILURE,63
SI,ISCHAEMIC STROKE,60
SI,FALL,58
SI,DIZZINESS,56
SI,NAUSEA,56
SI,PYREXIA,54
SI,DRUG INEFFECTIVE,52
SI,SUICIDE ATTEMPT,50
SI,HYPOTENSION,49
SI,VOMITING,49
SI,DIARRHOEA,44
SI,MALAISE,44
SI,PNEUMONIA,44
SI,HYPERTENSION,42
SI,PAIN,41
SI,PULMONARY EMBOLISM,41
SI,SEPSIS,40
SI,GAIT DISTURBANCE,39
SI,HEADACHE,39
SI,NEUTROPENIA,39
SI,OSTEONECROSIS OF JAW,39
SI,ASTHENIA,38
SI,CHEST PAIN,38
SI,INFUSION RELATED REACTION,38
SI,RASH,38
SI,OEDEMA PERIPHERAL,36
SI,CONFUSIONAL STATE,35
SI,THROMBOCYTOPENIA,35
SI,WEIGHT DECREASED,35
SI,CEREBROVASCULAR ACCIDENT,34
SI,ERYTHEMA,33
SI,ANAEMIA,32
SI,ABDOMINAL PAIN,31
SI,EPILEPSY,31
SI,GASTROINTESTINAL HAEMORRHAGE,31
SI,OVERDOSE,31
SI,TOXICITY TO VARIOUS AGENTS,31
SI,ATRIAL FIBRILLATION,30
SI,BRADYCARDIA,30
SI,GENERAL PHYSICAL HEALTH DETERIORATION,30
SI,SOMNOLENCE,30
SI,BACK PAIN,29
SI,COUGH,28
SI,RENAL FAILURE,28
SI,CHILLS,27
SI,LOSS OF CONSCIOUSNESS,27
SI,MULTIPLE SCLEROSIS RELAPSE,27
SI,PRURITUS,27
SI,RENAL IMPAIRMENT,27
SI,OXYGEN SATURATION DECREASED,26
SI,ARTHRALGIA,25
SI,C-REACTIVE PROTEIN INCREASED,25
SI,FEBRILE NEUTROPENIA,25
SI,PARAESTHESIA,25
SI,TACHYCARDIA,25
SI,CHOKING,24
SI,MALIGNANT NEOPLASM PROGRESSION,24
SI,PAIN IN EXTREMITY,24
SI,TREMOR,24
SI,URTICARIA,24
SI,VERTIGO,24
SI,BLOOD PRESSURE INCREASED,23
SI,DEPRESSION,23
SI,DISEASE PROGRESSION,23
SI,DYSPHAGIA,23
SI,HAEMOGLOBIN DECREASED,23
SI,HALLUCINATION,23
SI,INSOMNIA,23
SI,RESPIRATORY TRACT INFECTION,23
SI,CONSTIPATION,22
SI,DECREASED APPETITE,22
SI,HYPERHIDROSIS,22
SI,PANCYTOPENIA,22
SI,VISUAL IMPAIRMENT,22
SI,ACUTE MYOCARDIAL INFARCTION,21
SI,BODY TEMPERATURE INCREASED,21
SI,ELECTROCARDIOGRAM QT PROLONGED,21
SI,HAEMATURIA,21
SI,HYPOCALCAEMIA,21
SI,METASTASES TO LIVER,21
SI,RESTLESSNESS,21
SI,ARRHYTHMIA,20
SI,CONDITION AGGRAVATED,20
SI,HEMIPARESIS,20
SI,INFECTION,20
SI,LIVER DISORDER,20
SI,METABOLIC ACIDOSIS,20
SI,ANXIETY,19
SI,DEEP VEIN THROMBOSIS,19
SI,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,19
SI,PALPITATIONS,19
SI,URINARY TRACT INFECTION,19
SI,DISORIENTATION,18
SI,HAEMATOCHEZIA,18
SI,HYPONATRAEMIA,18
SI,PRODUCT USE ISSUE,18
SI,VENTRICULAR TACHYCARDIA,18
SI,HAEMORRHAGE,17
SI,HYPERSENSITIVITY,17
SI,MUSCLE SPASMS,17
SI,MYALGIA,17
SI,ABORTION SPONTANEOUS,16
SI,BLOOD CREATININE INCREASED,16
SI,CARDIAC ARREST,16
SI,CHRONIC KIDNEY DISEASE,16
SI,DELIRIUM,16
SI,EJECTION FRACTION DECREASED,16
SI,INTENTIONAL OVERDOSE,16
SI,RESPIRATORY FAILURE,16
SI,CEREBRAL HAEMORRHAGE,15
SI,COMPLETED SUICIDE,15
SI,HIP FRACTURE,15
SI,MATERNAL EXPOSURE DURING PREGNANCY,15
SI,PERIPHERAL SWELLING,15
SI,SEPTIC SHOCK,15
SI,SPEECH DISORDER,15
SI,ABDOMINAL PAIN UPPER,14
SI,ACUTE KIDNEY INJURY,14
SI,ALOPECIA,14
SI,ANGIOEDEMA,14
SI,EMBOLISM,14
SI,EPISTAXIS,14
SI,HAEMATOMA,14
SI,HYPOKALAEMIA,14
SI,MULTIPLE SCLEROSIS,14
SI,NASOPHARYNGITIS,14
SI,PLEURAL EFFUSION,14
SI,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,14
SI,STOMATITIS,14
SI,VISUAL ACUITY REDUCED,14
SI,CHEST DISCOMFORT,13
SI,DYSARTHRIA,13
SI,LEFT VENTRICULAR DYSFUNCTION,13
SI,METASTASES TO LUNG,13
SI,MYOCARDIAL INFARCTION,13
SI,PRODUCT USE IN UNAPPROVED INDICATION,13
SI,RASH MACULO-PAPULAR,13
SI,STATUS EPILEPTICUS,13
SI,SYNCOPE,13
SI,TACHYPNOEA,13
SI,ALANINE AMINOTRANSFERASE INCREASED,12
SI,ALTERED STATE OF CONSCIOUSNESS,12
SI,ASCITES,12
SI,DIABETES MELLITUS,12
SI,DRUG ADMINISTRATION ERROR,12
SI,DYSTONIA,12
SI,GAMMA-GLUTAMYLTRANSFERASE INCREASED,12
SI,HEPATIC ENZYME INCREASED,12
SI,HYPOTHYROIDISM,12
SI,MENTAL DISORDER,12
SI,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,12
SI,VISION BLURRED,12
SI,ACUTE RESPIRATORY FAILURE,11
SI,AGITATION,11
SI,ANAPHYLACTIC REACTION,11
SI,BLOOD PRESSURE DECREASED,11
SI,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,11
SI,COMA,11
SI,DEHYDRATION,11
SI,FEMUR FRACTURE,11
SI,FOETAL EXPOSURE DURING PREGNANCY,11
SI,GINGIVAL BLEEDING,11
SI,HEART RATE INCREASED,11
SI,HYPOGLYCAEMIA,11
SI,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,11
SI,INFLUENZA LIKE ILLNESS,11
SI,MYDRIASIS,11
SI,POLYNEUROPATHY,11
SI,RASH GENERALISED,11
SI,RASH PRURITIC,11
SI,RHABDOMYOLYSIS,11
SI,SUBARACHNOID HAEMORRHAGE,11
SI,TRANSAMINASES INCREASED,11
SI,ANGINA PECTORIS,10
SI,ASPARTATE AMINOTRANSFERASE INCREASED,10
SI,ASPHYXIA,10
SI,ATAXIA,10
SI,BUNDLE BRANCH BLOCK RIGHT,10
SI,DRY MOUTH,10
SI,ENCEPHALOPATHY,10
SI,HYPERKALAEMIA,10
SI,LEUKOPENIA,10
SI,METASTASES TO CENTRAL NERVOUS SYSTEM,10
SI,MOBILITY DECREASED,10
SI,MUSCULAR WEAKNESS,10
SI,PULMONARY HAEMATOMA,10
SI,SHOCK HAEMORRHAGIC,10
SI,SINUS TACHYCARDIA,10
SI,VENTRICULAR EXTRASYSTOLES,10
SI,ABNORMAL BEHAVIOUR,9
SI,ACUTE MYELOID LEUKAEMIA,9
SI,BACTERIAL INFECTION,9
SI,BONE PAIN,9
SI,COGNITIVE DISORDER,9
SI,CONTUSION,9
SI,FEELING ABNORMAL,9
SI,HAEMOPTYSIS,9
SI,HAEMORRHAGE INTRACRANIAL,9
SI,HEMIPLEGIA,9
SI,HEPATOCELLULAR CARCINOMA,9
SI,HERPES ZOSTER,9
SI,HYPOAESTHESIA,9
SI,HYPOXIA,9
SI,LEFT VENTRICULAR HYPERTROPHY,9
SI,MULTI-ORGAN FAILURE,9
SI,MYOCARDIAL ISCHAEMIA,9
SI,PROSTATE CANCER,9
SI,PROSTATIC SPECIFIC ANTIGEN INCREASED,9
SI,PROTEINURIA,9
SI,PULMONARY HYPERTENSION,9
SI,PULMONARY OEDEMA,9
SI,SHOCK,9
SI,SKIN DISORDER,9
SI,SKIN TOXICITY,9
SI,SPINAL FRACTURE,9
SI,TRANSIENT ISCHAEMIC ATTACK,9
SI,URINARY INCONTINENCE,9
SI,WEIGHT INCREASED,9
SI,BREAST CANCER,8
SI,BRONCHOSPASM,8
SI,CARDIAC FAILURE CONGESTIVE,8
SI,CENTRAL NERVOUS SYSTEM LESION,8
SI,CIRCULATORY COLLAPSE,8
SI,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,8
SI,DRY SKIN,8
SI,DYSPEPSIA,8
SI,FEAR,8
SI,HALLUCINATION_ VISUAL,8
SI,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,8
SI,INFLAMMATION,8
SI,INTENTIONAL PRODUCT USE ISSUE,8
SI,LUNG NEOPLASM MALIGNANT,8
SI,LYMPHADENOPATHY,8
SI,MALIGNANT MELANOMA,8
SI,MOOD ALTERED,8
SI,MULTIPLE ORGAN DYSFUNCTION SYNDROME,8
SI,MUSCULOSKELETAL STIFFNESS,8
SI,OEDEMA,8
SI,PERIPHERAL ISCHAEMIA,8
SI,SPINAL PAIN,8
SI,SPLENOMEGALY,8
SI,SWELLING,8
SI,TUBULOINTERSTITIAL NEPHRITIS,8
SI,URINARY RETENTION,8
SI,UVEITIS,8
SI,ABORTION INDUCED,7
SI,ASTHMA,7
SI,BASAL CELL CARCINOMA,7
SI,BK VIRUS INFECTION,7
SI,BRAIN OEDEMA,7
SI,CARCINOEMBRYONIC ANTIGEN INCREASED,7
SI,CARDIAC DISORDER,7
SI,CEREBRAL HAEMATOMA,7
SI,COLORECTAL CANCER METASTATIC,7
SI,CYTOKINE RELEASE SYNDROME,7
SI,DEMENTIA,7
SI,DERMATITIS ACNEIFORM,7
SI,DERMATITIS ALLERGIC,7
SI,DRUG WITHDRAWAL SYNDROME,7
SI,DYSGEUSIA,7
SI,DYSPNOEA EXERTIONAL,7
SI,FLUSHING,7
SI,GLOMERULAR FILTRATION RATE DECREASED,7
SI,HEPATIC FAILURE,7
SI,HEPATOTOXICITY,7
SI,INFLAMMATORY MARKER INCREASED,7
SI,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,7
SI,LIBIDO INCREASED,7
SI,METASTASES TO BONE,7
SI,NEPHROPATHY TOXIC,7
SI,NERVOUSNESS,7
SI,PANCREATITIS ACUTE,7
SI,PLATELET COUNT DECREASED,7
SI,SEROUS RETINAL DETACHMENT,7
SI,SUBDURAL HAEMATOMA,7
SI,TRANSPLANT REJECTION,7
SI,TREATMENT FAILURE,7
SI,ABDOMINAL PAIN LOWER,6
SI,ANGINA UNSTABLE,6
SI,BUNDLE BRANCH BLOCK LEFT,6
SI,CARDIOMEGALY,6
SI,CATARACT,6
SI,CENTRAL NERVOUS SYSTEM HAEMORRHAGE,6
SI,CHOLECYSTITIS ACUTE,6
SI,COMA SCALE ABNORMAL,6
SI,CYANOSIS,6
SI,EXPOSURE DURING PREGNANCY,6
SI,FEELING HOT,6
SI,FISTULA,6
SI,HAEMORRHAGE SUBCUTANEOUS,6
SI,HYPOPHOSPHATAEMIA,6
SI,KIDNEY TRANSPLANT REJECTION,6
SI,LEUKOCYTOSIS,6
SI,LUMBAR VERTEBRAL FRACTURE,6
SI,MELAENA,6
SI,MITRAL VALVE INCOMPETENCE,6
SI,MOVEMENT DISORDER,6
SI,OROPHARYNGEAL PAIN,6
SI,PARANOIA,6
SI,PARAPARESIS,6
SI,PARKINSONISM,6
SI,PETECHIAE,6
SI,PSORIASIS,6
SI,PULMONARY INFARCTION,6
SI,RENAL TUBULAR NECROSIS,6
SI,RIGHT VENTRICULAR FAILURE,6
SI,SEDATION,6
SI,SINUS BRADYCARDIA,6
SI,SUICIDAL IDEATION,6
SI,URETERIC STENOSIS,6
SI,ABDOMINAL DISTENSION,5
SI,APHASIA,5
SI,BLOOD CHOLESTEROL INCREASED,5
SI,BLOOD GLUCOSE INCREASED,5
SI,BLOOD PRESSURE ABNORMAL,5
SI,BONE MARROW FAILURE,5
SI,BRONCHOPULMONARY ASPERGILLOSIS,5
SI,CARDIOMYOPATHY,5
SI,CARDIOPULMONARY FAILURE,5
SI,CELLULITIS,5
SI,CEREBRAL INFARCTION,5
SI,CHOLELITHIASIS,5
SI,CONVULSION,5
SI,CORONARY ARTERY DISEASE,5
SI,CYSTITIS,5
SI,CYTOMEGALOVIRUS INFECTION,5
SI,DELUSION,5
SI,DEMYELINATION,5
SI,DERMATITIS BULLOUS,5
SI,DERMATITIS EXFOLIATIVE,5
SI,DISTURBANCE IN ATTENTION,5
SI,DRUG ABUSE,5
SI,DRUG DEPENDENCE,5
SI,DRUG DOSE OMISSION,5
SI,DRUG EFFECT DECREASED,5
SI,DYSPHONIA,5
SI,GANGRENE,5
SI,GENERALISED TONIC-CLONIC SEIZURE,5
SI,GENITAL HAEMORRHAGE,5
SI,HAEMATEMESIS,5
SI,HALLUCINATION_ AUDITORY,5
SI,HOSPITALISATION,5
SI,HYPOMAGNESAEMIA,5
SI,INJURY,5
SI,INTENTIONAL PRODUCT MISUSE,5
SI,IRRITABILITY,5
SI,JC VIRUS INFECTION,5
SI,JOINT SWELLING,5
SI,LIVER INJURY,5
SI,LOWER RESPIRATORY TRACT INFECTION,5
SI,LUPUS-LIKE SYNDROME,5
SI,MACULAR OEDEMA,5
SI,METASTASES TO LYMPH NODES,5
SI,MOUTH HAEMORRHAGE,5
SI,MULTIPLE FRACTURES,5
SI,MUSCLE CONTRACTIONS INVOLUNTARY,5
SI,MUSCULOSKELETAL PAIN,5
SI,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,5
SI,NECK PAIN,5
SI,NEUROLEPTIC MALIGNANT SYNDROME,5
SI,NEUROPATHY PERIPHERAL,5
SI,NIGHT SWEATS,5
SI,NORMOCYTIC ANAEMIA,5
SI,OCCULT BLOOD POSITIVE,5
SI,OPTIC NEURITIS,5
SI,PARESIS,5
SI,PERICARDIAL EFFUSION,5
SI,PERITONITIS,5
SI,PNEUMONIA BACTERIAL,5
SI,POISONING,5
SI,POLYURIA,5
SI,RALES,5
SI,RETINAL HAEMORRHAGE,5
SI,SKIN EXFOLIATION,5
SI,SKIN REACTION,5
SI,SQUAMOUS CELL CARCINOMA OF SKIN,5
SI,STAPHYLOCOCCAL INFECTION,5
SI,SUFFOCATION FEELING,5
SI,SWELLING FACE,5
SI,THERAPEUTIC RESPONSE DECREASED,5
SI,THROMBOSIS,5
SI,TINNITUS,5
SI,TUBERCULOSIS,5
SI,TUMOUR MARKER INCREASED,5
SI,UPPER RESPIRATORY TRACT INFECTION,5
SI,UROSEPSIS,5
SI,VEIN DISORDER,5
SI,WHITE BLOOD CELL COUNT INCREASED,5
SI,WOUND HAEMORRHAGE,5
SI,ABDOMINAL DISCOMFORT,4
SI,ACUTE HEPATIC FAILURE,4
SI,AGRANULOCYTOSIS,4
SI,AMNESIA,4
SI,ANTICHOLINERGIC SYNDROME,4
SI,ANTIPHOSPHOLIPID SYNDROME,4
SI,APATHY,4
SI,APPENDICITIS,4
SI,ARTHRITIS,4
SI,ATYPICAL FEMUR FRACTURE,4
SI,BLAST CELL COUNT INCREASED,4
SI,BLISTER,4
SI,BLOOD ALKALINE PHOSPHATASE INCREASED,4
SI,BLOOD BILIRUBIN INCREASED,4
SI,BLOOD IRON DECREASED,4
SI,BLOOD LACTATE DEHYDROGENASE INCREASED,4
SI,BLOOD PRESSURE INADEQUATELY CONTROLLED,4
SI,BLOOD UREA INCREASED,4
SI,BRONCHITIS,4
SI,BURNING SENSATION,4
SI,CARDIOGENIC SHOCK,4
SI,CEREBRAL ISCHAEMIA,4
SI,CHOREOATHETOSIS,4
SI,COMPLICATIONS OF TRANSPLANTED KIDNEY,4
SI,CONCOMITANT DISEASE AGGRAVATED,4
SI,CORONARY ARTERY STENOSIS,4
SI,CYTOPENIA,4
SI,DELAYED GRAFT FUNCTION,4
SI,DEPRESSED LEVEL OF CONSCIOUSNESS,4
SI,DIPLOPIA,4
SI,DRUG EFFECT INCOMPLETE,4
SI,DRUG ERUPTION,4
SI,DRUG-INDUCED LIVER INJURY,4
SI,DYSKINESIA,4
SI,DYSURIA,4
SI,ECZEMA,4
SI,EMBOLIC STROKE,4
SI,EMBOLISM VENOUS,4
SI,FACE OEDEMA,4
SI,FOOD INTERACTION,4
SI,FRACTURE,4
SI,GLAUCOMA,4
SI,GRAFT VERSUS HOST DISEASE IN SKIN,4
SI,HAEMORRHAGIC TRANSFORMATION STROKE,4
SI,HEAD INJURY,4
SI,HEPATOMEGALY,4
SI,HYDRONEPHROSIS,4
SI,HYPERBILIRUBINAEMIA,4
SI,HYPERKERATOSIS,4
SI,HYPERVOLAEMIA,4
SI,IMPAIRED HEALING,4
SI,INJECTION SITE ERYTHEMA,4
SI,INJECTION SITE REACTION,4
SI,INTRAVENTRICULAR HAEMORRHAGE,4
SI,LEFT ATRIAL ENLARGEMENT,4
SI,LONG QT SYNDROME,4
SI,LOWER RESPIRATORY TRACT INFECTION BACTERIAL,4
SI,LUNG INFILTRATION,4
SI,MACROCYTOSIS,4
SI,MANIA,4
SI,METASTATIC MALIGNANT MELANOMA,4
SI,MOUTH ULCERATION,4
SI,MUCOSAL INFLAMMATION,4
SI,MUSCULOSKELETAL CHEST PAIN,4
SI,MYELOFIBROSIS,4
SI,NERVOUS SYSTEM DISORDER,4
SI,NEUROLOGIC NEGLECT SYNDROME,4
SI,ORAL DISCOMFORT,4
SI,ORAL MUCOSAL ERYTHEMA,4
SI,OSTEOPOROSIS,4
SI,PALLOR,4
SI,PERSONALITY CHANGE,4
SI,PLATELET COUNT ABNORMAL,4
SI,PLATELET COUNT INCREASED,4
SI,POISONING DELIBERATE,4
SI,PSYCHOTIC DISORDER,4
SI,PURPURA,4
SI,RASH ERYTHEMATOUS,4
SI,RENAL FAILURE ACUTE,4
SI,RENAL FAILURE CHRONIC,4
SI,RHEUMATOID ARTHRITIS,4
SI,ROAD TRAFFIC ACCIDENT,4
SI,SERUM FERRITIN DECREASED,4
SI,SLEEP DISORDER,4
SI,SQUAMOUS CELL CARCINOMA,4
SI,STAPHYLOCOCCAL SEPSIS,4
SI,SUBCUTANEOUS HAEMATOMA,4
SI,SWOLLEN TONGUE,4
SI,THORACIC VERTEBRAL FRACTURE,4
SI,TOOTH EXTRACTION,4
SI,TOXIC NEUROPATHY,4
SI,TREATMENT NONCOMPLIANCE,4
SI,VITAMIN D DECREASED,4
SI,WOUND,4
SI,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,4
SI,ABDOMINAL ABSCESS,3
SI,ABNORMAL DREAMS,3
SI,ABSCESS,3
SI,ACCIDENTAL OVERDOSE,3
SI,ACNE,3
SI,ACUTE CORONARY SYNDROME,3
SI,ACUTE RESPIRATORY DISTRESS SYNDROME,3
SI,AGEUSIA,3
SI,AGGRESSION,3
SI,AMENORRHOEA,3
SI,ANURIA,3
SI,AORTIC ANEURYSM,3
SI,APHTHOUS ULCER,3
SI,ARTERIOSCLEROSIS,3
SI,ASPERGILLUS INFECTION,3
SI,BALANCE DISORDER,3
SI,BLOOD PARATHYROID HORMONE INCREASED,3
SI,BRADYKINESIA,3
SI,BRAIN INJURY,3
SI,CANDIDA SEPSIS,3
SI,CARBOHYDRATE ANTIGEN 19-9 INCREASED,3
SI,CARDIAC FAILURE CHRONIC,3
SI,CARDIOVASCULAR DISORDER,3
SI,CHOKING SENSATION,3
SI,CHOLESTASIS,3
SI,CHROMATURIA,3
SI,COLON CANCER,3
SI,COMMUNICATION DISORDER,3
SI,CONGESTIVE CARDIOMYOPATHY,3
SI,CONJUNCTIVITIS,3
SI,CORONARY ARTERY RESTENOSIS,3
SI,CYANOSIS CENTRAL,3
SI,DERMATITIS,3
SI,DEVICE DISLOCATION,3
SI,DISSEMINATED INTRAVASCULAR COAGULATION,3
SI,DRUG HYPERSENSITIVITY,3
SI,DRUG INTOLERANCE,3
SI,ECTOPIC PREGNANCY,3
SI,ENCEPHALITIS,3
SI,ESCHERICHIA SEPSIS,3
SI,EXTRAPYRAMIDAL DISORDER,3
SI,FLATULENCE,3
SI,FOOD REFUSAL,3
SI,GASTRIC ULCER,3
SI,GASTRITIS,3
SI,GASTROINTESTINAL DISORDER,3
SI,GASTROOESOPHAGEAL REFLUX DISEASE,3
SI,GINGIVAL ABSCESS,3
SI,GLOMERULONEPHRITIS,3
SI,GLYCOSYLATED HAEMOGLOBIN INCREASED,3
SI,HEART RATE IRREGULAR,3
SI,HEMIANOPIA HOMONYMOUS,3
SI,HEPATIC ENCEPHALOPATHY,3
SI,HEPATIC FUNCTION ABNORMAL,3
SI,HEPATIC STEATOSIS,3
SI,HEPATORENAL SYNDROME,3
SI,HOT FLUSH,3
SI,HYPERCALCAEMIA,3
SI,HYPOKINESIA,3
SI,HYPOTONIA,3
SI,ILEUS,3
SI,IMMUNE THROMBOCYTOPENIC PURPURA,3
SI,IMPAIRED WORK ABILITY,3
SI,INCORRECT DOSE ADMINISTERED,3
SI,INCREASED APPETITE,3
SI,INJECTION SITE HAEMATOMA,3
SI,INTERNATIONAL NORMALISED RATIO INCREASED,3
SI,INTERSTITIAL LUNG DISEASE,3
SI,INTESTINAL HAEMORRHAGE,3
SI,ISCHAEMIA,3
SI,JAUNDICE,3
SI,JOINT EFFUSION,3
SI,LIMB INJURY,3
SI,LIP OEDEMA,3
SI,LIVER FUNCTION TEST INCREASED,3
SI,LOGORRHOEA,3
SI,LOW BIRTH WEIGHT BABY,3
SI,LUNG TRANSPLANT,3
SI,LYMPHOCYTE COUNT DECREASED,3
SI,MEAN ARTERIAL PRESSURE DECREASED,3
SI,MEDICAL DEVICE SITE FIBROSIS,3
SI,MEDICAL DEVICE SITE HAEMORRHAGE,3
SI,MEDICATION ERROR,3
SI,MEMORY IMPAIRMENT,3
SI,MENINGITIS,3
SI,MESENTERIC ARTERY THROMBOSIS,3
SI,METASTASES TO MENINGES,3
SI,METASTASES TO SPINE,3
SI,METASTATIC SQUAMOUS CELL CARCINOMA,3
SI,METRORRHAGIA,3
SI,MUSCLE RIGIDITY,3
SI,MYOGLOBIN BLOOD INCREASED,3
SI,MYOPATHY,3
SI,NEOPLASM,3
SI,NEOPLASM PROGRESSION,3
SI,NEPHROLITHIASIS,3
SI,NEPHROTIC SYNDROME,3
SI,NEUROLOGICAL SYMPTOM,3
SI,NO THERAPEUTIC RESPONSE,3
SI,NON-SMALL CELL LUNG CANCER,3
SI,OSTEOARTHRITIS,3
SI,OSTEONECROSIS,3
SI,OSTEOPOROTIC FRACTURE,3
SI,PANCREATITIS,3
SI,PANIC ATTACK,3
SI,PELVIC PAIN,3
SI,PELVIC VENOUS THROMBOSIS,3
SI,PERIANAL ERYTHEMA,3
SI,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,3
SI,PERIPHERAL COLDNESS,3
SI,PERIPHERAL EMBOLISM,3
SI,PLASMA CELL MYELOMA,3
SI,PNEUMONIA ASPIRATION,3
SI,POOR QUALITY SLEEP,3
SI,POST PROCEDURAL HAEMORRHAGE,3
SI,PREGNANCY,3
SI,PREGNANCY WITH CONTRACEPTIVE DEVICE,3
SI,PREMATURE BABY,3
SI,PROSTATOMEGALY,3
SI,PSYCHOMOTOR HYPERACTIVITY,3
SI,PULMONARY ARTERIAL HYPERTENSION,3
SI,PYELONEPHRITIS ACUTE,3
SI,QUADRIPARESIS,3
SI,RADIATION PNEUMONITIS,3
SI,RECTAL ADENOCARCINOMA,3
SI,RECTAL HAEMORRHAGE,3
SI,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
SI,RENAL CANCER,3
SI,RESTRICTIVE CARDIOMYOPATHY,3
SI,RIB FRACTURE,3
SI,RIGHT-TO-LEFT CARDIAC SHUNT,3
SI,SECOND PRIMARY MALIGNANCY,3
SI,SENSORY DISTURBANCE,3
SI,SHORT-BOWEL SYNDROME,3
SI,SINUS ARRHYTHMIA,3
SI,SPINAL OSTEOARTHRITIS,3
SI,SUDDEN DEATH,3
SI,SUPRAVENTRICULAR TACHYCARDIA,3
SI,SYSTEMIC SCLERODERMA,3
SI,SYSTOLIC DYSFUNCTION,3
SI,TESTIS CANCER,3
SI,TETANY,3
SI,THROMBOCYTOSIS,3
SI,THROMBOPHLEBITIS,3
SI,TOOTH LOSS,3
SI,UMBILICAL HERNIA,3
SI,UNRESPONSIVE TO STIMULI,3
SI,UTERINE LEIOMYOMA,3
SI,VARICOSE VEIN,3
SI,VENOUS THROMBOSIS,3
SI,VENTRICULAR ASYSTOLE,3
SI,VENTRICULAR HYPOKINESIA,3
SI,VITREOUS DETACHMENT,3
SI,VITREOUS OPACITIES,3
SI,WRIST FRACTURE,3
SI,ABNORMAL FAECES,2
SI,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
SI,ACTIVITIES OF DAILY LIVING IMPAIRED,2
SI,ACUTE ABDOMEN,2
SI,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,2
SI,ADENOCARCINOMA OF COLON,2
SI,ADHESION,2
SI,ADRENAL INSUFFICIENCY,2
SI,ADRENAL SUPPRESSION,2
SI,ADVERSE EVENT,2
SI,AKATHISIA,2
SI,ALCOHOL WITHDRAWAL SYNDROME,2
SI,AMYLOIDOSIS,2
SI,ANAL ULCER,2
SI,ANAPHYLACTOID REACTION,2
SI,ANISOCYTOSIS,2
SI,APHTHOUS STOMATITIS,2
SI,APPLICATION SITE PRURITUS,2
SI,ARTHRITIS BACTERIAL,2
SI,ARTHROPATHY,2
SI,ATRIAL FLUTTER,2
SI,ATRIOVENTRICULAR BLOCK,2
SI,AUTOIMMUNE THYROIDITIS,2
SI,BASAL GANGLIA HAEMORRHAGE,2
SI,BEDRIDDEN,2
SI,BLADDER DISORDER,2
SI,BLINDNESS,2
SI,BLINDNESS UNILATERAL,2
SI,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
SI,BLOOD DISORDER,2
SI,BLOOD GLUCOSE DECREASED,2
SI,BLOOD GLUCOSE FLUCTUATION,2
SI,BLOOD IMMUNOGLOBULIN E INCREASED,2
SI,BLOOD MAGNESIUM DECREASED,2
SI,BLOOD PARATHYROID HORMONE ABNORMAL,2
SI,BLOOD PHOSPHORUS DECREASED,2
SI,BLOOD PRESSURE DIASTOLIC INCREASED,2
SI,BLOOD PRESSURE FLUCTUATION,2
SI,BLOOD PRESSURE SYSTOLIC INCREASED,2
SI,BLOOD PROLACTIN INCREASED,2
SI,BLOOD SODIUM DECREASED,2
SI,BLOOD TRIGLYCERIDES INCREASED,2
SI,BONE LESION,2
SI,BONE MARROW TOXICITY,2
SI,BRAIN HERNIATION,2
SI,BREAST PAIN,2
SI,BRONCHOPNEUMONIA,2
SI,BURSITIS,2
SI,CARDIAC FAILURE ACUTE,2
SI,CARDIAC FIBRILLATION,2
SI,CARDIAC VENTRICULAR DISORDER,2
SI,CARDIO-RESPIRATORY ARREST,2
SI,CAROTID ARTERY OCCLUSION,2
SI,CAROTID ARTERY STENOSIS,2
SI,CATARACT OPERATION,2
SI,CAUDAL REGRESSION SYNDROME,2
SI,CENTRAL VENOUS PRESSURE INCREASED,2
SI,CEREBRAL ARTERY OCCLUSION,2
SI,CEREBRAL DISORDER,2
SI,CEREBRAL TOXOPLASMOSIS,2
SI,CHEST INJURY,2
SI,CHEYNE-STOKES RESPIRATION,2
SI,CHOLANGIOCARCINOMA,2
SI,CHOLESTATIC LIVER INJURY,2
SI,CHRONIC GASTRITIS,2
SI,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
SI,CHRONIC MYELOID LEUKAEMIA,2
SI,CLOSTRIDIUM DIFFICILE COLITIS,2
SI,CLUMSINESS,2
SI,COAGULOPATHY,2
SI,COLITIS ULCERATIVE,2
SI,COLON CANCER METASTATIC,2
SI,COLORECTAL CANCER,2
SI,COMPUTERISED TOMOGRAM ABNORMAL,2
SI,CONJUNCTIVAL HAEMORRHAGE,2
SI,COORDINATION ABNORMAL,2
SI,CROHN^S DISEASE,2
SI,CYSTITIS NONINFECTIVE,2
SI,CYSTOID MACULAR OEDEMA,2
SI,DEPRESSED MOOD,2
SI,DEPRESSION SUICIDAL,2
SI,DERMATITIS ARTEFACTA,2
SI,DIABETES MELLITUS INADEQUATE CONTROL,2
SI,DILATATION VENTRICULAR,2
SI,DISCOMFORT,2
SI,DIVERTICULITIS,2
SI,DRUG LEVEL INCREASED,2
SI,DRUG RESISTANCE,2
SI,DRY EYE,2
SI,DRY GANGRENE,2
SI,DUODENAL ULCER,2
SI,DYSPNOEA AT REST,2
SI,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,2
SI,EMBEDDED DEVICE,2
SI,EMOTIONAL DISTRESS,2
SI,ENCEPHALITIS VIRAL,2
SI,ENDOMETRIAL HYPERPLASIA,2
SI,ENERGY INCREASED,2
SI,ENGRAFTMENT SYNDROME,2
SI,ENTERITIS,2
SI,EOSINOPHILIA,2
SI,ERYTHEMA NODOSUM,2
SI,ERYTHROPOIESIS ABNORMAL,2
SI,ESCHERICHIA URINARY TRACT INFECTION,2
SI,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,2
SI,EYE DISORDER,2
SI,EYE IRRITATION,2
SI,EYE MOVEMENT DISORDER,2
SI,EYE PAIN,2
SI,EYE PRURITUS,2
SI,EYELID OEDEMA,2
SI,FACE INJURY,2
SI,FIBRIN D DIMER INCREASED,2
SI,FOETAL DEATH,2
SI,FOETAL GROWTH RESTRICTION,2
SI,FUNGAL INFECTION,2
SI,FURUNCLE,2
SI,GALLBLADDER EMPYEMA,2
SI,GASTRIC ULCER PERFORATION,2
SI,GASTROINTESTINAL INFECTION,2
SI,GENERAL PHYSICAL CONDITION ABNORMAL,2
SI,GENOTYPE DRUG RESISTANCE TEST POSITIVE,2
SI,GINGIVITIS,2
SI,GLOSSODYNIA,2
SI,GRAND MAL CONVULSION,2
SI,HAEMANGIOMA,2
SI,HAEMATOCRIT DECREASED,2
SI,HAEMATOMA INFECTION,2
SI,HAEMORRHAGE IN PREGNANCY,2
SI,HAIR GROWTH ABNORMAL,2
SI,HALLUCINATION_ OLFACTORY,2
SI,HEAD DISCOMFORT,2
SI,HEART DISEASE CONGENITAL,2
SI,HELPLESSNESS,2
SI,HEMIANAESTHESIA,2
SI,HEPARIN-INDUCED THROMBOCYTOPENIA,2
SI,HEPATIC CIRRHOSIS,2
SI,HEPATIC CONGESTION,2
SI,HEPATIC LESION,2
SI,HEPATIC NEOPLASM,2
SI,HORMONE-REFRACTORY PROSTATE CANCER,2
SI,HUMERUS FRACTURE,2
SI,HYDROCELE,2
SI,HYDROCEPHALUS,2
SI,HYPERGLYCAEMIA,2
SI,HYPERSEXUALITY,2
SI,HYPERTENSIVE HEART DISEASE,2
SI,HYPERTHERMIA,2
SI,HYPERTHYROIDISM,2
SI,HYPOACUSIS,2
SI,HYPOALBUMINAEMIA,2
SI,HYPOGEUSIA,2
SI,HYPOGLYCAEMIC COMA,2
SI,HYPORESPONSIVE TO STIMULI,2
SI,HYPOSMIA,2
SI,HYPOVOLAEMIA,2
SI,IGA NEPHROPATHY,2
SI,IMMOBILE,2
SI,INCONTINENCE,2
SI,INFARCTION,2
SI,INFLUENZA,2
SI,INJECTION SITE ATROPHY,2
SI,INJECTION SITE INDURATION,2
SI,INJECTION SITE PAIN,2
SI,INTENTIONAL DOSE OMISSION,2
SI,INTERVERTEBRAL DISCITIS,2
SI,INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM,2
SI,INTRAOCULAR PRESSURE INCREASED,2
SI,IRIDOCYCLITIS,2
SI,ISCHAEMIC CARDIOMYOPATHY,2
SI,JEALOUS DELUSION,2
SI,JOINT DISLOCATION,2
SI,JOINT INJURY,2
SI,JOINT RANGE OF MOTION DECREASED,2
SI,KARYOTYPE ANALYSIS ABNORMAL,2
SI,KNEE OPERATION,2
SI,LABORATORY TEST ABNORMAL,2
SI,LACRIMATION INCREASED,2
SI,LARGE INTESTINAL HAEMORRHAGE,2
SI,LARYNGEAL OEDEMA,2
SI,LEFT VENTRICULAR ENLARGEMENT,2
SI,LEGIONELLA INFECTION,2
SI,LETHARGY,2
SI,LEUKOENCEPHALOPATHY,2
SI,LIMB DISCOMFORT,2
SI,LIP SWELLING,2
SI,LIVER TRANSPLANT,2
SI,LOCAL SWELLING,2
SI,LOWER RESPIRATORY TRACT INFECTION VIRAL,2
SI,LUNG INFECTION,2
SI,LYMPHOCELE,2
SI,LYMPHOPENIA,2
SI,MACULAR DEGENERATION,2
SI,MACULAR FIBROSIS,2
SI,MALIGNANT GLIOMA,2
SI,MALLORY-WEISS SYNDROME,2
SI,MASKED FACIES,2
SI,METASTASES TO PERITONEUM,2
SI,METASTASES TO PLEURA,2
SI,METASTASIS,2
SI,MICROLITHIASIS,2
SI,MIDDLE INSOMNIA,2
SI,MIGRAINE,2
SI,MONOPARESIS,2
SI,MOTOR DYSFUNCTION,2
SI,MOUTH SWELLING,2
SI,MUSCLE SPASTICITY,2
SI,MUSCULOSKELETAL DISORDER,2
SI,MYCOBACTERIUM AVIUM COMPLEX IMMUNE RESTORATION DISEASE,2
SI,MYELOPROLIFERATIVE DISORDER,2
SI,NECROSIS ISCHAEMIC,2
SI,NEPHROSTOMY,2
SI,NEURODERMATITIS,2
SI,NEUTROPHILIA,2
SI,NOCTURNAL DYSPNOEA,2
SI,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
SI,OCULAR HYPERAEMIA,2
SI,OESOPHAGEAL HAEMORRHAGE,2
SI,OESOPHAGEAL OEDEMA,2
SI,ORTHOPNOEA,2
SI,ORTHOSTATIC HYPOTENSION,2
SI,OSTEITIS,2
SI,OSTEOLYSIS,2
SI,PANCREATIC CARCINOMA,2
SI,PANCREATIC CYST,2
SI,PARAESTHESIA ORAL,2
SI,PARKINSON^S DISEASE,2
SI,PARONYCHIA,2
SI,PELVIC INFLAMMATORY DISEASE,2
SI,PEMPHIGUS,2
SI,PERIPHERAL ARTERY THROMBOSIS,2
SI,PHARYNGEAL OEDEMA,2
SI,PHOTOSENSITIVITY REACTION,2
SI,PNEUMOCOCCAL INFECTION,2
SI,PNEUMONIA LEGIONELLA,2
SI,POLLAKIURIA,2
SI,POLYMYALGIA RHEUMATICA,2
SI,POST PROCEDURAL HAEMATURIA,2
SI,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
SI,PREMATURE SEPARATION OF PLACENTA,2
SI,PRESYNCOPE,2
SI,PROCALCITONIN INCREASED,2
SI,PROCEDURAL COMPLICATION,2
SI,PRODUCT QUALITY ISSUE,2
SI,PROSTATE CANCER METASTATIC,2
SI,PSORIATIC ARTHROPATHY,2
SI,PSYCHOMOTOR SKILLS IMPAIRED,2
SI,PULMONARY ARTERY THROMBOSIS,2
SI,RADIUS FRACTURE,2
SI,RASH MACULAR,2
SI,RAYNAUD^S PHENOMENON,2
SI,RED BLOOD CELL COUNT DECREASED,2
SI,REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS,2
SI,REPRODUCTIVE TRACT DISORDER,2
SI,RESPIRATORY DISORDER,2
SI,RESPIRATORY DISTRESS,2
SI,RESPIRATORY RATE DECREASED,2
SI,RESUSCITATION,2
SI,RETAINED PRODUCTS OF CONCEPTION,2
SI,RETINAL DETACHMENT,2
SI,RETINAL SCAR,2
SI,RETINAL THICKENING,2
SI,RHEUMATIC DISORDER,2
SI,RHINORRHOEA,2
SI,SALIVARY HYPERSECRETION,2
SI,SCAB,2
SI,SCIATICA,2
SI,SECONDARY AMYLOIDOSIS,2
SI,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,2
SI,SECRETION DISCHARGE,2
SI,SENSORY LOSS,2
SI,SERUM FERRITIN INCREASED,2
SI,SINUSITIS,2
SI,SKIN HAEMORRHAGE,2
SI,SKIN HYPERPIGMENTATION,2
SI,SKIN MASS,2
SI,SKIN PAPILLOMA,2
SI,SKIN WOUND,2
SI,SKULL FRACTURE,2
SI,SPINAL CORD COMPRESSION,2
SI,STOMA SITE PAIN,2
SI,STREPTOCOCCAL SEPSIS,2
SI,SUBRETINAL FLUID,2
SI,SUDDEN CARDIAC DEATH,2
SI,SURGERY,2
SI,TACHYARRHYTHMIA,2
SI,TENDON PAIN,2
SI,TENSION,2
SI,THERAPEUTIC RESPONSE UNEXPECTED,2
SI,THERAPY CESSATION,2
SI,THIRST,2
SI,THROAT IRRITATION,2
SI,THROMBOTIC THROMBOCYTOPENIC PURPURA,2
SI,THYROID HAEMORRHAGE,2
SI,TONGUE DISCOLOURATION,2
SI,TONGUE DISCOMFORT,2
SI,TONGUE DISORDER,2
SI,TOOTHACHE,2
SI,TRANSPLANTATION COMPLICATION,2
SI,TRICUSPID VALVE INCOMPETENCE,2
SI,TRISOMY 21,2
SI,UPPER LIMB FRACTURE,2
SI,URINARY TRACT INFECTION BACTERIAL,2
SI,VASCULAR STENT THROMBOSIS,2
SI,VENOOCCLUSIVE DISEASE,2
SI,VENOUS THROMBOSIS LIMB,2
SI,VENTRICULAR HYPERTROPHY,2
SI,VITREOUS HAEMATOMA,2
SI,VITREOUS HAEMORRHAGE,2
SI,WHEEZING,2
SI,WITHDRAWAL SYNDROME,2
SI,WOUND INFECTION,2
SI,WOUND SECRETION,2
SI,WRONG DRUG ADMINISTERED,2
SI,ABASIA,1
SI,ABDOMINAL ADHESIONS,1
SI,ABDOMINAL RIGIDITY,1
SI,ABDOMINAL SEPSIS,1
SI,ABDOMINAL TENDERNESS,1
SI,ABDOMINAL WALL HAEMATOMA,1
SI,ABNORMAL LOSS OF WEIGHT,1
SI,ABSCESS BACTERIAL,1
SI,ABSCESS LIMB,1
SI,ABSCESS NECK,1
SI,ABSCESS SOFT TISSUE,1
SI,ABULIA,1
SI,ACQUIRED IMMUNODEFICIENCY SYNDROME,1
SI,ACTINOMYCOSIS,1
SI,ACUTE INTERSTITIAL PNEUMONITIS,1
SI,ACUTE LEUKAEMIA,1
SI,ACUTE LYMPHOCYTIC LEUKAEMIA,1
SI,ACUTE PSYCHOSIS,1
SI,ADENOCARCINOMA,1
SI,ADENOCARCINOMA GASTRIC,1
SI,ADENOCARCINOMA PANCREAS,1
SI,ADENOMA BENIGN,1
SI,ADENOSQUAMOUS CARCINOMA OF THE CERVIX,1
SI,ADJUSTMENT DISORDER WITH DEPRESSED MOOD,1
SI,ADVERSE DRUG REACTION,1
SI,AFFECTIVE DISORDER,1
SI,ALCOHOL ABUSE,1
SI,ALLERGIC TRANSFUSION REACTION,1
SI,ALOPECIA AREATA,1
SI,ALPHA 1 FOETOPROTEIN INCREASED,1
SI,AMMONIA INCREASED,1
SI,AMPUTATION,1
SI,ANAEMIA MACROCYTIC,1
SI,ANAEMIA MEGALOBLASTIC,1
SI,ANAL ABSCESS,1
SI,ANAL HAEMORRHAGE,1
SI,ANAL INCONTINENCE,1
SI,ANAPHYLACTIC SHOCK,1
SI,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,1
SI,ANASTOMOTIC LEAK,1
SI,ANEURYSM RUPTURED,1
SI,ANGIOPATHY,1
SB,DEATH,3
SB,ANAEMIA,2
SB,MALAISE,2
SB,BLADDER CANCER,1
SB,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
SB,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
SB,GASTROINTESTINAL STROMAL TUMOUR,1
SB,GENERAL PHYSICAL HEALTH DETERIORATION,1
SB,HAEMATURIA,1
SB,HAEMOGLOBIN DECREASED,1
SB,INFECTION,1
SB,MALIGNANT NEOPLASM PROGRESSION,1
SB,METASTASES TO LIVER,1
SB,SECOND PRIMARY MALIGNANCY,1
SB,SEPSIS,1
SB,THROMBOCYTOPENIA,1
SB,WEIGHT DECREASED,1
ZA,DEATH,1887
ZA,DRUG INEFFECTIVE,268
ZA,PNEUMONIA,246
ZA,MALAISE,231
ZA,CEREBROVASCULAR ACCIDENT,197
ZA,FALL,184
ZA,HOSPITALISATION,184
ZA,FOETAL EXPOSURE DURING PREGNANCY,181
ZA,NAUSEA,179
ZA,DYSPNOEA,175
ZA,RENAL FAILURE,169
ZA,HEADACHE,167
ZA,CARDIAC FAILURE,162
ZA,PAIN,155
ZA,VOMITING,155
ZA,MATERNAL EXPOSURE DURING PREGNANCY,153
ZA,MYOCARDIAL INFARCTION,153
ZA,FATIGUE,151
ZA,EXPOSURE DURING PREGNANCY,148
ZA,DIARRHOEA,146
ZA,SEPSIS,138
ZA,PYREXIA,134
ZA,HYPOTENSION,125
ZA,DIZZINESS,123
ZA,CARDIAC ARREST,113
ZA,PULMONARY EMBOLISM,110
ZA,ASTHENIA,102
ZA,HYPERTENSION,100
ZA,SEIZURE,99
ZA,ARTHRALGIA,97
ZA,ANAEMIA,94
ZA,RASH,93
ZA,ABORTION SPONTANEOUS,92
ZA,DEPRESSION,91
ZA,VIROLOGIC FAILURE,91
ZA,WEIGHT DECREASED,90
ZA,PAIN IN EXTREMITY,89
ZA,TUBERCULOSIS,88
ZA,FEELING ABNORMAL,85
ZA,DRUG RESISTANCE,83
ZA,CHEST PAIN,82
ZA,BACK PAIN,81
ZA,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,81
ZA,HAEMOGLOBIN DECREASED,75
ZA,DISEASE PROGRESSION,74
ZA,PRURITUS,74
ZA,CARDIAC DISORDER,73
ZA,LOSS OF CONSCIOUSNESS,72
ZA,CONFUSIONAL STATE,71
ZA,ABDOMINAL PAIN,70
ZA,NEOPLASM MALIGNANT,69
ZA,INFECTION,67
ZA,STEVENS-JOHNSON SYNDROME,67
ZA,COUGH,66
ZA,HYPOGLYCAEMIA,63
ZA,PERIPHERAL SWELLING,63
ZA,PREMATURE BABY,62
ZA,ANXIETY,61
ZA,CAESAREAN SECTION,60
ZA,HYPERSENSITIVITY,60
ZA,CONDITION AGGRAVATED,59
ZA,CONVULSION,58
ZA,DEEP VEIN THROMBOSIS,57
ZA,INSOMNIA,57
ZA,ATAXIA,55
ZA,GAIT DISTURBANCE,55
ZA,TOXICITY TO VARIOUS AGENTS,55
ZA,RHEUMATOID ARTHRITIS,54
ZA,DRUG-INDUCED LIVER INJURY,53
ZA,HAEMOGLOBIN ABNORMAL,53
ZA,ACUTE KIDNEY INJURY,52
ZA,CHEST DISCOMFORT,52
ZA,MUSCLE SPASMS,52
ZA,OVERDOSE,52
ZA,RENAL IMPAIRMENT,52
ZA,BRONCHITIS,51
ZA,INFLUENZA,51
ZA,DECREASED APPETITE,48
ZA,HAEMORRHAGE,48
ZA,HIV INFECTION,48
ZA,MUSCULAR WEAKNESS,48
ZA,SYNCOPE,48
ZA,HYPOAESTHESIA,47
ZA,NEUTROPENIA,47
ZA,TREMOR,47
ZA,MALIGNANT NEOPLASM PROGRESSION,46
ZA,ABDOMINAL PAIN UPPER,45
ZA,BLOOD GLUCOSE INCREASED,45
ZA,LOWER RESPIRATORY TRACT INFECTION,45
ZA,URINARY TRACT INFECTION,44
ZA,COMA,43
ZA,LUNG DISORDER,43
ZA,MYALGIA,43
ZA,SOMNOLENCE,43
ZA,TREATMENT FAILURE,43
ZA,MULTIPLE SCLEROSIS RELAPSE,42
ZA,PULMONARY TUBERCULOSIS,42
ZA,VISUAL IMPAIRMENT,42
ZA,PALPITATIONS,41
ZA,PRODUCT USE ISSUE,41
ZA,PULMONARY OEDEMA,41
ZA,SEPTIC SHOCK,41
ZA,CYSTITIS,40
ZA,DEHYDRATION,40
ZA,INTENTIONAL OVERDOSE,40
ZA,NEPHROLITHIASIS,40
ZA,PARAESTHESIA,40
ZA,DIABETES MELLITUS,39
ZA,GASTROENTERITIS,39
ZA,PREMATURE DELIVERY,39
ZA,HYPERHIDROSIS,38
ZA,THROMBOSIS,38
ZA,ATRIAL FIBRILLATION,37
ZA,BLOOD CREATININE INCREASED,37
ZA,BLOOD PRESSURE INCREASED,37
ZA,ELECTROCARDIOGRAM QT PROLONGED,37
ZA,GENERAL PHYSICAL HEALTH DETERIORATION,37
ZA,WEIGHT INCREASED,37
ZA,LIPODYSTROPHY ACQUIRED,36
ZA,ROAD TRAFFIC ACCIDENT,36
ZA,VISION BLURRED,36
ZA,PLEURAL EFFUSION,35
ZA,PRODUCT QUALITY ISSUE,35
ZA,ABORTION INDUCED,34
ZA,ARTHRITIS,34
ZA,DRUG LEVEL INCREASED,34
ZA,EPILEPSY,34
ZA,JAUNDICE,34
ZA,UNEVALUABLE EVENT,34
ZA,BLOOD PRESSURE DECREASED,33
ZA,CONSTIPATION,33
ZA,ERYTHEMA,33
ZA,FOETAL DEATH,33
ZA,HEPATITIS,33
ZA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,33
ZA,MUSCULOSKELETAL STIFFNESS,33
ZA,STILLBIRTH,33
ZA,VIRAL MUTATION IDENTIFIED,33
ZA,WHITE BLOOD CELL COUNT DECREASED,33
ZA,HEPATIC FAILURE,32
ZA,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,32
ZA,INFLUENZA LIKE ILLNESS,32
ZA,SUICIDAL IDEATION,32
ZA,ASTHMA,31
ZA,CHILLS,31
ZA,PREGNANCY,31
ZA,SPEECH DISORDER,31
ZA,ABASIA,30
ZA,ALANINE AMINOTRANSFERASE INCREASED,30
ZA,FOETAL DISTRESS SYNDROME,30
ZA,HYPOKALAEMIA,30
ZA,RESPIRATORY FAILURE,30
ZA,BRONCHOSPASM,29
ZA,INJECTION SITE PAIN,29
ZA,JOINT SWELLING,29
ZA,LUNG INFECTION,29
ZA,LYMPHADENOPATHY,29
ZA,OEDEMA,29
ZA,RESPIRATORY DISTRESS,29
ZA,SURGERY,29
ZA,AGGRESSION,28
ZA,ANAPHYLACTIC REACTION,28
ZA,BLOOD PRESSURE FLUCTUATION,28
ZA,DYSPHAGIA,28
ZA,MULTI-ORGAN FAILURE,28
ZA,PANCREATITIS,28
ZA,SUICIDE ATTEMPT,28
ZA,TACHYCARDIA,28
ZA,ABDOMINAL DISTENSION,27
ZA,CELLULITIS,27
ZA,DRUG DOSE OMISSION,27
ZA,DRUG HYPERSENSITIVITY,27
ZA,HIP FRACTURE,27
ZA,PANCYTOPENIA,27
ZA,PNEUMOTHORAX,27
ZA,DIABETES MELLITUS INADEQUATE CONTROL,26
ZA,DRUG LEVEL DECREASED,26
ZA,HEPATIC ENZYME INCREASED,26
ZA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,26
ZA,NORMAL NEWBORN,26
ZA,VISUAL ACUITY REDUCED,26
ZA,WRONG TECHNIQUE IN DRUG USAGE PROCESS,26
ZA,BALANCE DISORDER,25
ZA,GASTROINTESTINAL DISORDER,25
ZA,HEART RATE INCREASED,25
ZA,INTESTINAL OBSTRUCTION,25
ZA,METABOLIC ACIDOSIS,25
ZA,TOXIC EPIDERMAL NECROLYSIS,25
ZA,UPPER LIMB FRACTURE,25
ZA,ARTHROPATHY,24
ZA,AUTOIMMUNE HEPATITIS,24
ZA,LOW BIRTH WEIGHT BABY,24
ZA,OROPHARYNGEAL PAIN,24
ZA,SKIN REACTION,24
ZA,THROMBOCYTOPENIA,24
ZA,BURNING SENSATION,23
ZA,DRY MOUTH,23
ZA,GASTROINTESTINAL HAEMORRHAGE,23
ZA,GASTROOESOPHAGEAL REFLUX DISEASE,23
ZA,HERPES ZOSTER,23
ZA,INJECTION SITE SCAR,23
ZA,LACTIC ACIDOSIS,23
ZA,MULTIPLE SCLEROSIS,23
ZA,NEUROPATHY PERIPHERAL,23
ZA,OEDEMA PERIPHERAL,23
ZA,PLATELET COUNT DECREASED,23
ZA,RESTLESSNESS,23
ZA,CEREBRAL HAEMORRHAGE,22
ZA,CONTUSION,22
ZA,FEMUR FRACTURE,22
ZA,LIVER DISORDER,22
ZA,RENAL DISORDER,22
ZA,SINUSITIS,22
ZA,THERAPEUTIC RESPONSE DECREASED,22
ZA,URTICARIA,22
ZA,VAGINAL HAEMORRHAGE,22
ZA,ABDOMINAL DISCOMFORT,21
ZA,ADVERSE DRUG REACTION,21
ZA,ADVERSE EVENT,21
ZA,ARRHYTHMIA,21
ZA,BLINDNESS,21
ZA,BONE DENSITY DECREASED,21
ZA,CIRCULATORY COLLAPSE,21
ZA,DYSPEPSIA,21
ZA,ENCEPHALOPATHY,21
ZA,FOETAL GROWTH RESTRICTION,21
ZA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,21
ZA,GASTRITIS,21
ZA,HEART RATE IRREGULAR,21
ZA,INCORRECT DOSE ADMINISTERED,21
ZA,PRODUCT USE IN UNAPPROVED INDICATION,21
ZA,SWELLING FACE,21
ZA,BRADYCARDIA,20
ZA,BRAIN NEOPLASM,20
ZA,CARDIAC FAILURE CONGESTIVE,20
ZA,CATARACT,20
ZA,HAEMATEMESIS,20
ZA,HEPATOTOXICITY,20
ZA,HERNIA,20
ZA,MIGRAINE,20
ZA,ALOPECIA,19
ZA,BREAST CANCER,19
ZA,EOSINOPHILIA,19
ZA,GASTRIC ULCER,19
ZA,HALLUCINATION,19
ZA,HOT FLUSH,19
ZA,HYPOTHYROIDISM,19
ZA,INJECTION SITE ABSCESS,19
ZA,LIVE BIRTH,19
ZA,MOUTH ULCERATION,19
ZA,NEUTROPENIC SEPSIS,19
ZA,PARALYSIS,19
ZA,PREMATURE LABOUR,19
ZA,PSYCHOTIC DISORDER,19
ZA,ABNORMAL BEHAVIOUR,18
ZA,AMNESIA,18
ZA,C-REACTIVE PROTEIN INCREASED,18
ZA,CHRONIC KIDNEY DISEASE,18
ZA,DISORIENTATION,18
ZA,EPISTAXIS,18
ZA,FEBRILE NEUTROPENIA,18
ZA,FLUID RETENTION,18
ZA,INJECTION SITE ERYTHEMA,18
ZA,INTRACRANIAL PRESSURE INCREASED,18
ZA,OPTIC NEURITIS,18
ZA,RASH MORBILLIFORM,18
ZA,SWELLING,18
ZA,URINARY RETENTION,18
ZA,ANGIOEDEMA,17
ZA,DEAFNESS,17
ZA,DEPRESSED MOOD,17
ZA,EMOTIONAL DISORDER,17
ZA,EYE DISORDER,17
ZA,HYPERKALAEMIA,17
ZA,HYPONATRAEMIA,17
ZA,INTENTIONAL PRODUCT MISUSE,17
ZA,LIMB DISCOMFORT,17
ZA,LIMB INJURY,17
ZA,LUNG NEOPLASM MALIGNANT,17
ZA,OSTEOPOROSIS,17
ZA,PERICARDIAL EFFUSION,17
ZA,RASH PRURITIC,17
ZA,RESPIRATORY ARREST,17
ZA,RIB FRACTURE,17
ZA,ABSCESS,16
ZA,APHASIA,16
ZA,CHOLELITHIASIS,16
ZA,DRUG DEPENDENCE,16
ZA,EYE PAIN,16
ZA,HEMIPARESIS,16
ZA,HYPERGLYCAEMIA,16
ZA,INFLAMMATION,16
ZA,ISCHAEMIC STROKE,16
ZA,LOCAL SWELLING,16
ZA,MEDICATION ERROR,16
ZA,RECTAL HAEMORRHAGE,16
ZA,TACHYPNOEA,16
ZA,TRANSAMINASES INCREASED,16
ZA,URINARY INCONTINENCE,16
ZA,ACUTE MYOCARDIAL INFARCTION,15
ZA,ANGINA PECTORIS,15
ZA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,15
ZA,COLITIS,15
ZA,CROHN^S DISEASE,15
ZA,DIALYSIS,15
ZA,DYSARTHRIA,15
ZA,EMPHYSEMA,15
ZA,EXPOSURE DURING BREAST FEEDING,15
ZA,HAEMATOCHEZIA,15
ZA,HEART RATE DECREASED,15
ZA,INTESTINAL ISCHAEMIA,15
ZA,JOINT INJURY,15
ZA,LIVER INJURY,15
ZA,MEMORY IMPAIRMENT,15
ZA,MUSCULOSKELETAL PAIN,15
ZA,MYOCARDIAL ISCHAEMIA,15
ZA,NECK PAIN,15
ZA,OCULAR HYPERAEMIA,15
ZA,PALLOR,15
ZA,PLASMA CELL MYELOMA,15
ZA,PNEUMONITIS,15
ZA,RASH GENERALISED,15
ZA,STATUS EPILEPTICUS,15
ZA,STRESS,15
ZA,TREATMENT NONCOMPLIANCE,15
ZA,VERTIGO,15
ZA,BLOOD GLUCOSE DECREASED,14
ZA,BONE MARROW FAILURE,14
ZA,BONE PAIN,14
ZA,CARDIOVASCULAR DISORDER,14
ZA,DEPENDENCE,14
ZA,DIABETIC KETOACIDOSIS,14
ZA,DRUG ABUSE,14
ZA,DRUG INTOLERANCE,14
ZA,FLUID OVERLOAD,14
ZA,INJECTION SITE REACTION,14
ZA,IRRITABILITY,14
ZA,KIDNEY INFECTION,14
ZA,LIP SWELLING,14
ZA,MATERNAL DRUGS AFFECTING FOETUS,14
ZA,MOBILITY DECREASED,14
ZA,MOOD SWINGS,14
ZA,PATHOGEN RESISTANCE,14
ZA,PERITONITIS,14
ZA,POST PROCEDURAL COMPLICATION,14
ZA,PREGNANCY ON CONTRACEPTIVE,14
ZA,RASH ERYTHEMATOUS,14
ZA,SERUM FERRITIN INCREASED,14
ZA,SPINAL OSTEOARTHRITIS,14
ZA,SWOLLEN TONGUE,14
ZA,BLOOD IRON DECREASED,13
ZA,DISTURBANCE IN ATTENTION,13
ZA,DRUG DISPENSING ERROR,13
ZA,EYE SWELLING,13
ZA,HAEMOPTYSIS,13
ZA,HAEMORRHAGE INTRACRANIAL,13
ZA,HEPATITIS B,13
ZA,HIP ARTHROPLASTY,13
ZA,INTENTIONAL DRUG MISUSE,13
ZA,MENINGITIS TUBERCULOUS,13
ZA,OSTEOARTHRITIS,13
ZA,PANIC ATTACK,13
ZA,PRE-ECLAMPSIA,13
ZA,SKIN ULCER,13
ZA,SPINAL OPERATION,13
ZA,SUBCUTANEOUS ABSCESS,13
ZA,TINNITUS,13
ZA,TRISOMY 21,13
ZA,UNRESPONSIVE TO STIMULI,13
ZA,WHITE BLOOD CELL COUNT INCREASED,13
ZA,BLADDER DISORDER,12
ZA,BLISTER,12
ZA,BLOOD PRESSURE ABNORMAL,12
ZA,BONE DISORDER,12
ZA,DEPRESSED LEVEL OF CONSCIOUSNESS,12
ZA,DYSKINESIA,12
ZA,DYSURIA,12
ZA,ENCEPHALITIS,12
ZA,IMPAIRED HEALING,12
ZA,LETHARGY,12
ZA,NASOPHARYNGITIS,12
ZA,NERVOUS SYSTEM DISORDER,12
ZA,NO ADVERSE EVENT,12
ZA,ORGAN FAILURE,12
ZA,PHOTOSENSITIVITY REACTION,12
ZA,POSTPARTUM SEPSIS,12
ZA,PSEUDOMONAS INFECTION,12
ZA,SKIN LESION,12
ZA,SYSTEMIC LUPUS ERYTHEMATOSUS,12
ZA,TRANSIENT ISCHAEMIC ATTACK,12
ZA,ACUTE MYELOID LEUKAEMIA,11
ZA,BLOOD CHOLESTEROL INCREASED,11
ZA,BLOOD GLUCOSE ABNORMAL,11
ZA,BLOOD SODIUM DECREASED,11
ZA,CARDIOMYOPATHY,11
ZA,CHRONIC MYELOID LEUKAEMIA,11
ZA,COGNITIVE DISORDER,11
ZA,COMA SCALE ABNORMAL,11
ZA,CONGENITAL NOSE MALFORMATION,11
ZA,CORNEAL LESION,11
ZA,DELIRIUM,11
ZA,DYSPHONIA,11
ZA,DYSSTASIA,11
ZA,EATING DISORDER,11
ZA,FEELING HOT,11
ZA,FLUSHING,11
ZA,GASTROINTESTINAL STROMAL TUMOUR,11
ZA,GENERALISED TONIC-CLONIC SEIZURE,11
ZA,HEAD INJURY,11
ZA,INFUSION RELATED REACTION,11
ZA,INJECTION SITE PRURITUS,11
ZA,INTERSTITIAL LUNG DISEASE,11
ZA,INTESTINAL PERFORATION,11
ZA,LOCALISED INFECTION,11
ZA,LOWER LIMB FRACTURE,11
ZA,MALIGNANT MELANOMA,11
ZA,METRORRHAGIA,11
ZA,MOVEMENT DISORDER,11
ZA,NEURODEVELOPMENTAL DISORDER,11
ZA,PANCREATIC CARCINOMA,11
ZA,PELVIC FRACTURE,11
ZA,RHABDOMYOLYSIS,11
ZA,STAPHYLOCOCCAL INFECTION,11
ZA,STOMATITIS,11
ZA,TENDON RUPTURE,11
ZA,ULCER HAEMORRHAGE,11
ZA,ACTIVITIES OF DAILY LIVING IMPAIRED,10
ZA,ACUTE MYELOID LEUKAEMIA RECURRENT,10
ZA,AGITATION,10
ZA,ANKLE FRACTURE,10
ZA,COLECTOMY,10
ZA,COLITIS ULCERATIVE,10
ZA,COLON CANCER,10
ZA,COMPLETED SUICIDE,10
ZA,CYTOMEGALOVIRUS INFECTION,10
ZA,DEATH NEONATAL,10
ZA,DEMENTIA,10
ZA,DIPLOPIA,10
ZA,DRUG ADMINISTRATION ERROR,10
ZA,DRUG EFFECT DECREASED,10
ZA,DRY EYE,10
ZA,FACIAL PARALYSIS,10
ZA,FUNGAL INFECTION,10
ZA,GASTRIC DISORDER,10
ZA,GASTROINTESTINAL NECROSIS,10
ZA,GOUT,10
ZA,HAEMORRHOIDS,10
ZA,HEPATIC ENZYME ABNORMAL,10
ZA,HYPOCALCAEMIA,10
ZA,HYSTERECTOMY,10
ZA,IMPAIRED WORK ABILITY,10
ZA,INJECTION SITE BRUISING,10
ZA,INJURY,10
ZA,KOUNIS SYNDROME,10
ZA,LYMPHOMA,10
ZA,MENINGITIS,10
ZA,METASTASES TO CENTRAL NERVOUS SYSTEM,10
ZA,MUSCULOSKELETAL CHEST PAIN,10
ZA,NEONATAL RESPIRATORY DISTRESS SYNDROME,10
ZA,NERVE COMPRESSION,10
ZA,NIGHT SWEATS,10
ZA,ORAL DISORDER,10
ZA,PNEUMOCYSTIS JIROVECII PNEUMONIA,10
ZA,PREMATURE RUPTURE OF MEMBRANES,10
ZA,RENAL CELL CARCINOMA,10
ZA,RENAL FAILURE ACUTE,10
ZA,RESPIRATORY TRACT INFECTION,10
ZA,RETINAL OEDEMA,10
ZA,SKIN DISCOLOURATION,10
ZA,SLEEP DISORDER,10
ZA,SUBRETINAL FLUID,10
ZA,SUDDEN DEATH,10
ZA,UPPER GASTROINTESTINAL HAEMORRHAGE,10
ZA,ACUTE RESPIRATORY DISTRESS SYNDROME,9
ZA,ANKYLOSING SPONDYLITIS,9
ZA,ARTERIOSPASM CORONARY,9
ZA,ASPARTATE AMINOTRANSFERASE INCREASED,9
ZA,BEDRIDDEN,9
ZA,BIPOLAR DISORDER,9
ZA,BLOOD BILIRUBIN INCREASED,9
ZA,BLOOD CREATINE INCREASED,9
ZA,BLOOD CREATINE PHOSPHOKINASE INCREASED,9
ZA,CANDIDA INFECTION,9
ZA,CARDIOMEGALY,9
ZA,CEREBRAL INFARCTION,9
ZA,CHOLESTASIS,9
ZA,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,9
ZA,CRYING,9
ZA,ELECTROLYTE IMBALANCE,9
ZA,GAIT INABILITY,9
ZA,GASTRIC HAEMORRHAGE,9
ZA,GASTROINTESTINAL INFECTION,9
ZA,GENITAL HAEMORRHAGE,9
ZA,HAEMATURIA,9
ZA,HEPATOCELLULAR CARCINOMA,9
ZA,HEPATOMEGALY,9
ZA,INCORRECT ROUTE OF DRUG ADMINISTRATION,9
ZA,KNEE ARTHROPLASTY,9
ZA,LEUKAEMIA,9
ZA,LIVER FUNCTION TEST ABNORMAL,9
ZA,METASTASES TO LUNG,9
ZA,MUCOSAL INFLAMMATION,9
ZA,OLIGOHYDRAMNIOS,9
ZA,OSTEOPENIA,9
ZA,OVARIAN CYST,9
ZA,PAPILLOEDEMA,9
ZA,PARKINSON^S DISEASE,9
ZA,PEPTIC ULCER,9
ZA,PETIT MAL EPILEPSY,9
ZA,PROSTATE CANCER,9
ZA,PSORIASIS,9
ZA,RED BLOOD CELL COUNT DECREASED,9
ZA,RETINAL DETACHMENT,9
ZA,SENSORY LOSS,9
ZA,SKIN EXFOLIATION,9
ZA,SPINAL FRACTURE,9
ZA,THERAPEUTIC RESPONSE UNEXPECTED,9
ZA,UPPER RESPIRATORY TRACT INFECTION,9
ZA,UVEITIS,9
ZA,VIRAL LOAD INCREASED,9
ZA,WHEEZING,9
ZA,WRIST FRACTURE,9
ZA,WRONG DRUG ADMINISTERED,9
ZA,ANGER,8
ZA,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,8
ZA,BLINDNESS UNILATERAL,8
ZA,BRAIN INJURY,8
ZA,BRONCHOPNEUMONIA,8
ZA,CACHEXIA,8
ZA,CD4 LYMPHOCYTES DECREASED,8
ZA,CEREBELLAR SYNDROME,8
ZA,COLORECTAL CANCER METASTATIC,8
ZA,CONJUNCTIVITIS,8
ZA,DERMATITIS,8
ZA,DISCOMFORT,8
ZA,DRUG WITHDRAWAL SYNDROME,8
ZA,ERYTHEMA ANNULARE,8
ZA,ERYTHEMA MULTIFORME,8
ZA,EYE IRRITATION,8
ZA,EYELID PTOSIS,8
ZA,GASTRIC CANCER,8
ZA,GLAUCOMA,8
ZA,HEPATIC CANCER,8
ZA,HEPATIC FUNCTION ABNORMAL,8
ZA,HYPOPHAGIA,8
ZA,ILL-DEFINED DISORDER,8
ZA,INTERNATIONAL NORMALISED RATIO INCREASED,8
ZA,INTERVERTEBRAL DISC PROTRUSION,8
ZA,JOINT DISLOCATION,8
ZA,LEUKOPENIA,8
ZA,LINEAR IGA DISEASE,8
ZA,LYMPHOPENIA,8
ZA,MENINGITIS CRYPTOCOCCAL,8
ZA,MENTAL DISORDER,8
ZA,MENTAL IMPAIRMENT,8
ZA,METASTASES TO LIVER,8
ZA,ORAL CANDIDIASIS,8
ZA,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,8
ZA,PHOTOPHOBIA,8
ZA,PNEUMONIA ASPIRATION,8
ZA,PRODUCTIVE COUGH,8
ZA,PRURITUS GENERALISED,8
ZA,RENAL FAILURE CHRONIC,8
ZA,SPLENOMEGALY,8
ZA,STENT PLACEMENT,8
ZA,TOOTH FRACTURE,8
ZA,VASCULITIS,8
ZA,VENTRICULAR TACHYCARDIA,8
ZA,WOUND SEPSIS,8
ZA,ABNORMAL DREAMS,7
ZA,ACCIDENTAL OVERDOSE,7
ZA,ACNE,7
ZA,ARTERIAL OCCLUSIVE DISEASE,7
ZA,BLOOD CALCIUM DECREASED,7
ZA,BLOOD POTASSIUM DECREASED,7
ZA,BLOOD UREA INCREASED,7
ZA,BLOOD URINE PRESENT,7
ZA,CARDIAC OPERATION,7
ZA,CARDIO-RESPIRATORY ARREST,7
ZA,CLOSTRIDIUM DIFFICILE INFECTION,7
ZA,COMPLICATION OF DEVICE REMOVAL,7
ZA,COORDINATION ABNORMAL,7
ZA,DEVICE DEPLOYMENT ISSUE,7
ZA,DEVICE DISLOCATION,7
ZA,DEVICE OCCLUSION,7
ZA,DEVICE RELATED INFECTION,7
ZA,DIARRHOEA HAEMORRHAGIC,7
ZA,DISEASE RECURRENCE,7
ZA,DRY SKIN,7
ZA,EAR PAIN,7
ZA,ECZEMA,7
ZA,EMBOLISM VENOUS,7
ZA,ENDOTRACHEAL INTUBATION,7
ZA,FISTULA,7
ZA,GANGRENE,7
ZA,GLYCOSYLATED HAEMOGLOBIN INCREASED,7
ZA,HAEMORRHAGE IN PREGNANCY,7
ZA,HAND FRACTURE,7
ZA,HYPERSOMNIA,7
ZA,HYPOACUSIS,7
ZA,IMMUNE SYSTEM DISORDER,7
ZA,INCORRECT DRUG ADMINISTRATION DURATION,7
ZA,INFLAMMATORY MARKER INCREASED,7
ZA,INJECTION SITE MASS,7
ZA,INJECTION SITE SWELLING,7
ZA,INJECTION SITE ULCER,7
ZA,INTERNAL HAEMORRHAGE,7
ZA,INTRAOCULAR PRESSURE INCREASED,7
ZA,IRRITABLE BOWEL SYNDROME,7
ZA,JOINT STIFFNESS,7
ZA,LARGE INTESTINE PERFORATION,7
ZA,LOW SET EARS,7
ZA,MECHANICAL VENTILATION,7
ZA,MELAENA,7
ZA,METASTASES TO BONE,7
ZA,MUSCULOSKELETAL DISCOMFORT,7
ZA,MUSCULOSKELETAL DISORDER,7
ZA,NEUTROPHIL COUNT DECREASED,7
ZA,PERIPHERAL VASCULAR DISORDER,7
ZA,PERSONALITY CHANGE,7
ZA,PLACENTAL INSUFFICIENCY,7
ZA,PLEURISY,7
ZA,PLEURITIC PAIN,7
ZA,POST PROCEDURAL INFECTION,7
ZA,PRESCRIBED OVERDOSE,7
ZA,PRODUCT SUBSTITUTION ISSUE,7
ZA,RENAL PAIN,7
ZA,RESTLESS LEGS SYNDROME,7
ZA,ROTATOR CUFF SYNDROME,7
ZA,SHOCK,7
ZA,SHOULDER OPERATION,7
ZA,SKIN CANCER,7
ZA,SMALL INTESTINAL OBSTRUCTION,7
ZA,SPINAL COMPRESSION FRACTURE,7
ZA,TENDONITIS,7
ZA,THINKING ABNORMAL,7
ZA,TOOTH ABSCESS,7
ZA,UNINTENDED PREGNANCY,7
ZA,VIRAL INFECTION,7
ZA,WOUND,7
ZA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,7
ZA,ABDOMINAL ADHESIONS,6
ZA,ABDOMINAL TENDERNESS,6
ZA,ABSCESS LIMB,6
ZA,ALTERED STATE OF CONSCIOUSNESS,6
ZA,ANAL FISTULA,6
ZA,ANAPHYLACTIC SHOCK,6
ZA,APHONIA,6
ZA,APNOEA,6
ZA,APPENDICITIS,6
ZA,ASCITES,6
ZA,BACK DISORDER,6
ZA,BLINDNESS TRANSIENT,6
ZA,BLOOD ALBUMIN DECREASED,6
ZA,BLOOD PRESSURE INADEQUATELY CONTROLLED,6
ZA,CHOLECYSTECTOMY,6
ZA,CHOLECYSTITIS,6
ZA,CORNEAL OPACITY,6
ZA,CYTOMEGALOVIRUS CHORIORETINITIS,6
ZA,DEVICE BREAKAGE,6
ZA,DEVICE EXPULSION,6
ZA,DEVICE FAILURE,6
ZA,DIABETIC ULCER,6
ZA,DISEASE COMPLICATION,6
ZA,DISSEMINATED TUBERCULOSIS,6
ZA,DIVERTICULITIS,6
ZA,DRUG EFFECT INCOMPLETE,6
ZA,DRUG PRESCRIBING ERROR,6
ZA,DYSMORPHISM,6
ZA,EAR INFECTION,6
ZA,EMBOLISM,6
ZA,EPIDERMAL NECROSIS,6
ZA,EYE INFECTION,6
ZA,EYE PRURITUS,6
ZA,FAECAL INCONTINENCE,6
ZA,FAECALOMA,6
ZA,FEELING COLD,6
ZA,FIBROMYALGIA,6
ZA,GALLBLADDER DISORDER,6
ZA,GLOMERULAR FILTRATION RATE DECREASED,6
ZA,GUILLAIN-BARRE SYNDROME,6
ZA,HAEMATOMA,6
ZA,HEPATIC STEATOSIS,6
ZA,HIATUS HERNIA,6
ZA,HYPERCALCAEMIA,6
ZA,HYPOKINESIA,6
ZA,HYPOMAGNESAEMIA,6
ZA,HYPOVOLAEMIC SHOCK,6
ZA,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS,6
ZA,IRON DEFICIENCY,6
ZA,JAUNDICE NEONATAL,6
ZA,LARYNGITIS,6
ZA,LYMPHOCYTE COUNT DECREASED,6
ZA,MACULAR DEGENERATION,6
ZA,MANIA,6
ZA,MENORRHAGIA,6
ZA,MOOD ALTERED,6
ZA,MUSCLE DISORDER,6
ZA,MUSCLE RUPTURE,6
ZA,NEONATAL ASPHYXIA,6
ZA,NEOPLASM PROGRESSION,6
ZA,NERVE INJURY,6
ZA,NERVOUSNESS,6
ZA,NEURALGIA,6
ZA,NIGHTMARE,6
ZA,NO THERAPEUTIC RESPONSE,6
ZA,NOSOCOMIAL INFECTION,6
ZA,OXYGEN SATURATION DECREASED,6
ZA,PNEUMATOSIS INTESTINALIS,6
ZA,POST PROCEDURAL HAEMORRHAGE,6
ZA,POSTOPERATIVE WOUND INFECTION,6
ZA,PRESYNCOPE,6
ZA,PROTRUSION TONGUE,6
ZA,PULMONARY HAEMORRHAGE,6
ZA,PULMONARY THROMBOSIS,6
ZA,SECOND PRIMARY MALIGNANCY,6
ZA,SINUS TACHYCARDIA,6
ZA,SKIN DISORDER,6
ZA,SPINAL DISORDER,6
ZA,TERMINAL STATE,6
ZA,THERMAL BURN,6
ZA,THROAT TIGHTNESS,6
ZA,TONSILLITIS,6
ZA,TYPE 2 DIABETES MELLITUS,6
ZA,ULCER,6
ZA,UNDERDOSE,6
ZA,UTERINE LEIOMYOMA,6
ZA,VAGINAL DISCHARGE,6
ZA,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,5
ZA,ACUTE RESPIRATORY FAILURE,5
ZA,AMNIOTIC CAVITY INFECTION,5
ZA,AMPUTATION,5
ZA,ANTICHOLINERGIC SYNDROME,5
ZA,APHAGIA,5
ZA,ARTHRITIS INFECTIVE,5
ZA,ARTHROPOD BITE,5
ZA,BLADDER CANCER,5
ZA,BLOOD BILIRUBIN UNCONJUGATED INCREASED,5
ZA,BLOOD GLUCOSE FLUCTUATION,5
ZA,BLOOD MAGNESIUM DECREASED,5
ZA,BLOOD POTASSIUM INCREASED,5
ZA,BRAIN OEDEMA,5
ZA,BRONCHIOLITIS,5
ZA,CARDIOTOXICITY,5
ZA,CARPAL TUNNEL SYNDROME,5
ZA,CATHETER PLACEMENT,5
ZA,CENTRAL NERVOUS SYSTEM LESION,5
ZA,CONGENITAL ANOMALY,5
ZA,CONGENITAL PNEUMONIA,5
ZA,CRYPTOCOCCOSIS,5
ZA,DEFORMITY,5
ZA,DEMENTIA ALZHEIMER^S TYPE,5
ZA,DEPRESSION SUICIDAL,5
ZA,DERMATITIS EXFOLIATIVE,5
ZA,DEVICE DIFFICULT TO USE,5
ZA,DISSEMINATED INTRAVASCULAR COAGULATION,5
ZA,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,5
ZA,DRUG LEVEL ABOVE THERAPEUTIC,5
ZA,DRUG LEVEL BELOW THERAPEUTIC,5
ZA,DYSENTERY,5
ZA,DYSGEUSIA,5
ZA,DYSLIPIDAEMIA,5
ZA,DYSPAREUNIA,5
ZA,EMOTIONAL DISTRESS,5
ZA,ENDOPHTHALMITIS,5
ZA,ESCHERICHIA SEPSIS,5
ZA,EXTRAPULMONARY TUBERCULOSIS,5
ZA,EYE HAEMORRHAGE,5
ZA,EYE MOVEMENT DISORDER,5
ZA,EYELID OEDEMA,5
ZA,FEEDING DISORDER,5
ZA,GASTROINTESTINAL INFLAMMATION,5
ZA,GENERAL ANAESTHESIA,5
ZA,GENERALISED OEDEMA,5
ZA,GENITAL LESION,5
ZA,GLOSSODYNIA,5
ZA,HAEMODIALYSIS,5
ZA,HAEMODYNAMIC INSTABILITY,5
ZA,HALLUCINATION_ VISUAL,5
ZA,HEAD DISCOMFORT,5
ZA,HEPATOSPLENOMEGALY,5
ZA,HYDROCEPHALUS,5
ZA,INCONTINENCE,5
ZA,INHIBITORY DRUG INTERACTION,5
ZA,INJECTION SITE RASH,5
ZA,INTENTIONAL PRODUCT USE ISSUE,5
ZA,INTENTIONAL SELF-INJURY,5
ZA,INTESTINAL MASS,5
ZA,KAPOSI^S SARCOMA,5
ZA,KLEBSIELLA INFECTION,5
ZA,KNEE OPERATION,5
ZA,LARGE INTESTINE POLYP,5
ZA,LEG AMPUTATION,5
ZA,LIVER ABSCESS,5
ZA,MACULAR OEDEMA,5
ZA,MACULOPATHY,5
ZA,MALARIA,5
ZA,MARASMUS,5
ZA,MITOCHONDRIAL TOXICITY,5
ZA,MUSCLE TWITCHING,5
ZA,NASAL OBSTRUCTION,5
ZA,NEOPLASM,5
ZA,NEUROLEPTIC MALIGNANT SYNDROME,5
ZA,NYSTAGMUS,5
ZA,OPTIC ATROPHY,5
ZA,OPTIC ISCHAEMIC NEUROPATHY,5
ZA,ORAL PAIN,5
ZA,ORGANISING PNEUMONIA,5
ZA,PANCREATITIS NECROTISING,5
ZA,PELVIC INFLAMMATORY DISEASE,5
ZA,PERICARDITIS,5
ZA,PHARYNGITIS,5
ZA,PHYSICAL ASSAULT,5
ZA,PLACENTA PRAEVIA,5
ZA,PNEUMONIA VIRAL,5
ZA,POSTPARTUM HAEMORRHAGE,5
ZA,PREMATURE SEPARATION OF PLACENTA,5
ZA,PULMONARY HYPERTENSION,5
ZA,PULMONARY MASS,5
ZA,RENAL CANCER,5
ZA,RENAL TUBULAR NECROSIS,5
ZA,RESPIRATORY DISORDER,5
ZA,RETINAL DEGENERATION,5
ZA,RETINAL DISORDER,5
ZA,RETINAL HAEMORRHAGE,5
ZA,SEROTONIN SYNDROME,5
ZA,SJOGREN^S SYNDROME,5
ZA,SKIN HYPERPIGMENTATION,5
ZA,SUBARACHNOID HAEMORRHAGE,5
ZA,TEARFULNESS,5
ZA,TWIN PREGNANCY,5
ZA,ULCERATIVE KERATITIS,5
ZA,UTERINE HAEMORRHAGE,5
ZA,UTERINE PERFORATION,5
ZA,VASCULAR GRAFT,5
ZA,VIRAL LOAD,5
ZA,WITHDRAWAL SYNDROME,5
ZA,WOUND INFECTION,5
ZA,ABDOMINAL HERNIA,4
ZA,ABDOMINAL NEOPLASM,4
ZA,ABDOMINAL PAIN LOWER,4
ZA,ACIDOSIS,4
ZA,ACUTE CORONARY SYNDROME,4
ZA,ACUTE PSYCHOSIS,4
ZA,ACUTE SINUSITIS,4
ZA,ADDISON^S DISEASE,4
ZA,AKATHISIA,4
ZA,ANAEMIA MACROCYTIC,4
ZA,ANEURYSM,4
ZA,ANGIOPATHY,4
ZA,APLASIA PURE RED CELL,4
ZA,ARTERIOSCLEROSIS,4
ZA,ARTHRITIS BACTERIAL,4
ZA,ASPHYXIA,4
ZA,ASPIRATION,4
ZA,BACK INJURY,4
ZA,BACTERIAL INFECTION,4
ZA,BENIGN HYDATIDIFORM MOLE,4
ZA,BIPOLAR I DISORDER,4
ZA,BLOOD DISORDER,4
ZA,BONE LOSS,4
ZA,BRAIN NEOPLASM MALIGNANT,4
ZA,BREAST CANCER FEMALE,4
ZA,BREAST TENDERNESS,4
ZA,BURSITIS,4
ZA,CARDIAC FIBRILLATION,4
ZA,CD4 LYMPHOCYTES ABNORMAL,4
ZA,CEREBELLAR ATAXIA,4
ZA,CEREBRAL THROMBOSIS,4
ZA,CERVICAL VERTEBRAL FRACTURE,4
ZA,CERVIX CARCINOMA,4
ZA,CHEILITIS,4
ZA,CHOKING,4
ZA,COLONOSCOPY,4
ZA,COMPLICATION ASSOCIATED WITH DEVICE,4
ZA,CONCOMITANT DISEASE PROGRESSION,4
ZA,CORONARY ARTERY DISEASE,4
ZA,CYANOSIS,4
ZA,CYST,4
ZA,DEAFNESS UNILATERAL,4
ZA,DECREASED IMMUNE RESPONSIVENESS,4
ZA,DECUBITUS ULCER,4
ZA,DELUSION,4
ZA,DEMYELINATION,4
ZA,DIABETIC COMPLICATION,4
ZA,DIABETIC FOOT,4
ZA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,4
ZA,DRUG WITHDRAWAL SYNDROME NEONATAL,4
ZA,ECLAMPSIA,4
ZA,ECTOPIC PREGNANCY,4
ZA,EJECTION FRACTION DECREASED,4
ZA,END STAGE RENAL DISEASE,4
ZA,ENDOMETRIOSIS,4
ZA,ENTERITIS,4
ZA,EOSINOPHIL COUNT INCREASED,4
ZA,ERECTILE DYSFUNCTION,4
ZA,EXPOSURE VIA FATHER,4
ZA,EXTRA DOSE ADMINISTERED,4
ZA,EXTRAPYRAMIDAL DISORDER,4
ZA,FACE INJURY,4
ZA,FACE OEDEMA,4
ZA,FOOT DEFORMITY,4
ZA,FRACTURE,4
ZA,GASTRIC ULCER HAEMORRHAGE,4
ZA,GASTROENTERITIS VIRAL,4
ZA,GINGIVAL BLEEDING,4
ZA,H1N1 INFLUENZA,4
ZA,HAEMARTHROSIS,4
ZA,HAEMOPHILIC ARTHROPATHY,4
ZA,HAEMORRHAGE SUBCUTANEOUS,4
ZA,HAEMORRHAGIC STROKE,4
ZA,HEMIPLEGIA,4
ZA,HEPATIC FIBROSIS,4
ZA,HEREDITARY OPTIC ATROPHY,4
ZA,HERPES SIMPLEX,4
ZA,HISTIOCYTOSIS HAEMATOPHAGIC,4
ZA,HISTOPLASMOSIS DISSEMINATED,4
ZA,HIV TEST POSITIVE,4
ZA,HYPERPYREXIA,4
ZA,HYPERREFLEXIA,4
ZA,HYPERTENSIVE CRISIS,4
ZA,HYPOAESTHESIA ORAL,4
ZA,IMMUNE THROMBOCYTOPENIC PURPURA,4
ZA,IMMUNODEFICIENCY,4
ZA,IMMUNOSUPPRESSION,4
ZA,INFARCTION,4
ZA,INGUINAL HERNIA,4
ZA,INJECTION SITE INFLAMMATION,4
ZA,ISOSPORIASIS,4
ZA,JAUNDICE CHOLESTATIC,4
ZA,JOINT TUBERCULOSIS,4
ZA,JUVENILE IDIOPATHIC ARTHRITIS,4
ZA,LACRIMATION INCREASED,4
ZA,LARGE INTESTINAL OBSTRUCTION,4
ZA,LIBIDO DECREASED,4
ZA,LUNG INFILTRATION,4
ZA,LUPUS-LIKE SYNDROME,4
ZA,MACROCEPHALY,4
ZA,MALNUTRITION,4
ZA,MASS,4
ZA,MEDICAL DEVICE COMPLICATION,4
ZA,METASTASIS,4
ZA,METASTATIC NEOPLASM,4
ZA,MONOPLEGIA,4
ZA,MULTIPLE FRACTURES,4
ZA,MULTIPLE-DRUG RESISTANCE,4
ZA,MUSCLE ATROPHY,4
ZA,MYCOSIS FUNGOIDES,4
ZA,MYELODYSPLASTIC SYNDROME,4
ZA,NECROTISING COLITIS,4
ZA,NEUROMUSCULAR BLOCK PROLONGED,4
ZA,NEUTROPHIL COUNT INCREASED,4
ZA,NICOTINE DEPENDENCE,4
ZA,NODULE,4
ZA,ODYNOPHAGIA,4
ZA,OLIGURIA,4
ZA,OSTEONECROSIS,4
ZA,OVERLAP SYNDROME,4
ZA,PAIN IN JAW,4
ZA,PANIC REACTION,4
ZA,PARANOIA,4
ZA,PERIPHERAL EMBOLISM,4
ZA,PLATELET COUNT INCREASED,4
ZA,POST PROCEDURAL SEPSIS,4
ZA,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,4
ZA,POSTOPERATIVE WOUND COMPLICATION,4
ZA,PREGNANCY ON ORAL CONTRACEPTIVE,4
ZA,PREGNANCY WITH CONTRACEPTIVE DEVICE,4
ZA,PROCTALGIA,4
ZA,PRODUCT PREPARATION ERROR,4
ZA,PROLONGED LABOUR,4
ZA,PROSTATIC DISORDER,4
ZA,PROSTATOMEGALY,4
ZA,PROTEINURIA,4
ZA,PSYCHOMOTOR HYPERACTIVITY,4
ZA,QUALITY OF LIFE DECREASED,4
ZA,RADIUS FRACTURE,4
ZA,RESPIRATORY SYNCYTIAL VIRUS INFECTION,4
ZA,RHEUMATIC FEVER,4
ZA,RHINITIS,4
ZA,RHINORRHOEA,4
ZA,RIGHT VENTRICULAR FAILURE,4
ZA,SARCOIDOSIS,4
ZA,SCHIZOPHRENIA,4
ZA,SCREAMING,4
ZA,SEDATION,4
ZA,SINUS DISORDER,4
ZA,SKIN NECROSIS,4
ZA,SKIN PAPILLOMA,4
ZA,SLEEP APNOEA SYNDROME,4
ZA,SPINAL FUSION SURGERY,4
ZA,STRESS ULCER,4
ZA,THIRST,4
ZA,THROAT IRRITATION,4
ZA,THYROID DISORDER,4
ZA,TOE AMPUTATION,4
ZA,TOOTH DISORDER,4
ZA,TUBULOINTERSTITIAL NEPHRITIS,4
ES,DEATH,1470
ES,ANAEMIA,1269
ES,PYREXIA,1172
ES,DRUG INEFFECTIVE,1163
ES,ASTHENIA,1119
ES,DIARRHOEA,1087
ES,NEUTROPENIA,936
ES,VOMITING,884
ES,THROMBOCYTOPENIA,795
ES,NAUSEA,763
ES,PNEUMONIA,762
ES,TOXICITY TO VARIOUS AGENTS,745
ES,DYSPNOEA,730
ES,ACUTE KIDNEY INJURY,692
ES,DIZZINESS,689
ES,RASH,632
ES,FALL,600
ES,FATIGUE,595
ES,HEADACHE,582
ES,RENAL FAILURE,577
ES,HYPOTENSION,510
ES,ABDOMINAL PAIN,494
ES,RESPIRATORY FAILURE,494
ES,ANGIOEDEMA,493
ES,MALAISE,486
ES,PRURITUS,486
ES,FEBRILE NEUTROPENIA,476
ES,CONDITION AGGRAVATED,464
ES,HYPERTENSION,463
ES,URTICARIA,455
ES,DECREASED APPETITE,442
ES,URINARY TRACT INFECTION,441
ES,HYPONATRAEMIA,431
ES,PANCYTOPENIA,422
ES,RESPIRATORY TRACT INFECTION,420
ES,SOMNOLENCE,394
ES,WEIGHT DECREASED,383
ES,CARDIAC FAILURE,381
ES,PAIN,367
ES,DISEASE PROGRESSION,356
ES,SEPTIC SHOCK,344
ES,ERYTHEMA,343
ES,CONFUSIONAL STATE,342
ES,INFECTION,342
ES,SEPSIS,342
ES,PAIN IN EXTREMITY,331
ES,GENERAL PHYSICAL HEALTH DETERIORATION,313
ES,FOETAL EXPOSURE DURING PREGNANCY,308
ES,ARTHRALGIA,307
ES,RENAL IMPAIRMENT,306
ES,INSOMNIA,303
ES,MUCOSAL INFLAMMATION,303
ES,CEREBROVASCULAR ACCIDENT,301
ES,HEPATOTOXICITY,296
ES,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,295
ES,DISORIENTATION,293
ES,GAIT DISTURBANCE,293
ES,HYPERKALAEMIA,291
ES,DEPRESSION,290
ES,BACK PAIN,286
ES,CONSTIPATION,285
ES,OVERDOSE,282
ES,ANXIETY,281
ES,ATRIAL FIBRILLATION,280
ES,PRODUCT USE ISSUE,280
ES,TREMOR,278
ES,DEPRESSED LEVEL OF CONSCIOUSNESS,276
ES,SYNCOPE,275
ES,PULMONARY EMBOLISM,274
ES,TACHYCARDIA,270
ES,HYPERSENSITIVITY,268
ES,RENAL FAILURE ACUTE,268
ES,COUGH,265
ES,PARAESTHESIA,256
ES,ANAPHYLACTIC REACTION,254
ES,OEDEMA PERIPHERAL,252
ES,LEUKOPENIA,251
ES,HEPATITIS,246
ES,NEUROTOXICITY,246
ES,ASTHMA,242
ES,PLEURAL EFFUSION,241
ES,HYPERGLYCAEMIA,225
ES,OSTEONECROSIS OF JAW,225
ES,HYPOGLYCAEMIA,224
ES,LOSS OF CONSCIOUSNESS,224
ES,MYALGIA,221
ES,CARDIO-RESPIRATORY ARREST,218
ES,SUICIDE ATTEMPT,217
ES,CHEST PAIN,215
ES,EXPOSURE DURING PREGNANCY,211
ES,GASTROINTESTINAL HAEMORRHAGE,207
ES,DYSPHAGIA,204
ES,ACUTE MYOCARDIAL INFARCTION,202
ES,HYPOKALAEMIA,199
ES,INTENTIONAL OVERDOSE,198
ES,MALIGNANT NEOPLASM PROGRESSION,198
ES,HYPERHIDROSIS,196
ES,TRANSAMINASES INCREASED,196
ES,METABOLIC ACIDOSIS,195
ES,TOXIC SKIN ERUPTION,194
ES,BRADYCARDIA,190
ES,HEPATIC FAILURE,190
ES,MUSCULAR WEAKNESS,186
ES,RHABDOMYOLYSIS,185
ES,MYOCARDIAL INFARCTION,181
ES,PRODUCT USE IN UNAPPROVED INDICATION,181
ES,HYPOMAGNESAEMIA,180
ES,LACTIC ACIDOSIS,177
ES,CARDIAC ARREST,176
ES,DEEP VEIN THROMBOSIS,175
ES,ABDOMINAL PAIN UPPER,171
ES,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,171
ES,SEIZURE,171
ES,HYPOCALCAEMIA,170
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,165
ES,NEUROPATHY PERIPHERAL,164
ES,PANCREATITIS ACUTE,162
ES,ALOPECIA,161
ES,PLATELET COUNT DECREASED,160
ES,BONE MARROW FAILURE,159
ES,MATERNAL EXPOSURE DURING PREGNANCY,158
ES,MULTI-ORGAN FAILURE,158
ES,FEELING ABNORMAL,157
ES,HAEMORRHAGE,157
ES,HYPERBILIRUBINAEMIA,155
ES,GASTROINTESTINAL DISORDER,154
ES,HIP FRACTURE,153
ES,OEDEMA,153
ES,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,151
ES,EOSINOPHILIA,150
ES,NERVOUSNESS,150
ES,INTESTINAL OBSTRUCTION,149
ES,VISION BLURRED,146
ES,ADVERSE EVENT,145
ES,ENCEPHALOPATHY,144
ES,HEPATIC ENCEPHALOPATHY,144
ES,ABORTION SPONTANEOUS,143
ES,DRUG INTOLERANCE,143
ES,CEREBRAL HAEMORRHAGE,142
ES,DYSARTHRIA,142
ES,DYSKINESIA,142
ES,VIROLOGIC FAILURE,142
ES,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,141
ES,EPISTAXIS,140
ES,AGRANULOCYTOSIS,139
ES,PNEUMONITIS,139
ES,TREATMENT FAILURE,139
ES,CELLULITIS,138
ES,HALLUCINATION,138
ES,MULTIPLE ORGAN DYSFUNCTION SYNDROME,138
ES,BRONCHOSPASM,137
ES,PANCREATITIS,137
ES,COGNITIVE DISORDER,136
ES,ASCITES,135
ES,HAEMOGLOBIN DECREASED,135
ES,WEIGHT INCREASED,135
ES,DISCOMFORT,134
ES,HAEMATOMA,134
ES,HAEMATOTOXICITY,133
ES,CYTOMEGALOVIRUS INFECTION,131
ES,DEHYDRATION,131
ES,LIVER DISORDER,131
ES,ANGINA PECTORIS,130
ES,TOXIC EPIDERMAL NECROLYSIS,130
ES,EPILEPSY,129
ES,ISCHAEMIC STROKE,129
ES,SKIN LESION,129
ES,HYPERTENSIVE CRISIS,127
ES,MUSCLE SPASMS,127
ES,RESPIRATORY DISORDER,127
ES,INTERSTITIAL LUNG DISEASE,125
ES,PALPITATIONS,125
ES,PLASMA CELL MYELOMA,125
ES,CARDIAC DISORDER,124
ES,HEPATITIS CHOLESTATIC,124
ES,ACUTE MYELOID LEUKAEMIA,123
ES,SKIN REACTION,123
ES,AGGRESSION,122
ES,ARRHYTHMIA,122
ES,CHILLS,122
ES,INJECTION SITE PAIN,122
ES,PSORIASIS,122
ES,BLINDNESS,121
ES,DRUG RESISTANCE,121
ES,INJECTION SITE ERYTHEMA,121
ES,PREMATURE BABY,121
ES,STOMATITIS,121
ES,BLOOD CREATININE INCREASED,120
ES,EYE DISORDER,120
ES,HYPERTRANSAMINASAEMIA,120
ES,RECTAL HAEMORRHAGE,118
ES,ALANINE AMINOTRANSFERASE INCREASED,117
ES,GASTROENTERITIS,117
ES,HAEMATURIA,117
ES,PRURITUS GENERALISED,117
ES,PSYCHOTIC DISORDER,117
ES,AGITATION,116
ES,ELECTROCARDIOGRAM QT PROLONGED,116
ES,HALLUCINATION_ VISUAL,116
ES,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,116
ES,ANAPHYLACTIC SHOCK,115
ES,FACE OEDEMA,115
ES,MEDICATION ERROR,115
ES,MUSCULOSKELETAL STIFFNESS,115
ES,NASOPHARYNGITIS,115
ES,HEPATITIS C,114
ES,MOBILITY DECREASED,114
ES,BRONCHITIS,113
ES,FEMUR FRACTURE,113
ES,INFLAMMATION,112
ES,INFLUENZA,112
ES,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,111
ES,HYPOAESTHESIA,111
ES,INFUSION RELATED REACTION,111
ES,ABDOMINAL DISTENSION,110
ES,DRUG-INDUCED LIVER INJURY,110
ES,IRRITABILITY,110
ES,SUICIDAL IDEATION,110
ES,DRUG HYPERSENSITIVITY,109
ES,JAUNDICE,109
ES,APHASIA,108
ES,THROMBOSIS,108
ES,DEVICE DISLOCATION,107
ES,THROMBOTIC MICROANGIOPATHY,107
ES,DELIRIUM,106
ES,DYSGEUSIA,105
ES,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,105
ES,RESPIRATORY DISTRESS,105
ES,SEROTONIN SYNDROME,105
ES,ABDOMINAL DISCOMFORT,104
ES,PULMONARY OEDEMA,103
ES,INCORRECT DOSE ADMINISTERED,102
ES,VISUAL IMPAIRMENT,102
ES,ABNORMAL BEHAVIOUR,101
ES,COAGULOPATHY,101
ES,TREATMENT NONCOMPLIANCE,101
ES,CHRONIC KIDNEY DISEASE,100
ES,DIABETES MELLITUS,100
ES,MULTIPLE SCLEROSIS RELAPSE,100
ES,CARDIAC FAILURE CONGESTIVE,99
ES,COMA,99
ES,LEUKOCYTOSIS,99
ES,ACUTE RESPIRATORY FAILURE,98
ES,DEPRESSED MOOD,98
ES,DISEASE RECURRENCE,98
ES,RESTLESSNESS,98
ES,VERTIGO,97
ES,BREAST CANCER,95
ES,NASAL DISORDER,95
ES,DYSPEPSIA,94
ES,LYMPHADENOPATHY,94
ES,SPEECH DISORDER,94
ES,STATUS EPILEPTICUS,94
ES,TUBULOINTERSTITIAL NEPHRITIS,94
ES,CHEST DISCOMFORT,93
ES,DEVICE RELATED INFECTION,93
ES,INTERNATIONAL NORMALISED RATIO INCREASED,93
ES,ASPARTATE AMINOTRANSFERASE INCREASED,92
ES,CHOLESTASIS,92
ES,COMPLETED SUICIDE,92
ES,GRAFT VERSUS HOST DISEASE,92
ES,RASH PRURITIC,92
ES,LYMPHOPENIA,91
ES,MYELODYSPLASTIC SYNDROME,91
ES,NERVOUS SYSTEM DISORDER,91
ES,HERPES ZOSTER,90
ES,SKIN TOXICITY,90
ES,TRANSIENT ISCHAEMIC ATTACK,90
ES,NEUROLEPTIC MALIGNANT SYNDROME,89
ES,AMNESIA,88
ES,PARKINSONISM,87
ES,SEDATION,86
ES,SKIN ULCER,86
ES,TORSADE DE POINTES,86
ES,URINARY RETENTION,86
ES,ACUTE CORONARY SYNDROME,85
ES,CHOLELITHIASIS,85
ES,GASTROINTESTINAL TOXICITY,85
ES,LUNG NEOPLASM MALIGNANT,85
ES,PERIPHERAL SWELLING,85
ES,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,84
ES,HAEMODYNAMIC INSTABILITY,84
ES,PROTEINURIA,83
ES,BONE PAIN,82
ES,HAEMORRHAGE INTRACRANIAL,82
ES,SUDDEN DEATH,82
ES,HAEMATEMESIS,81
ES,HYPOXIA,81
ES,ARTHRITIS,80
ES,FLUSHING,80
ES,HEPATITIS ACUTE,80
ES,RHEUMATOID ARTHRITIS,80
ES,ACUTE HEPATIC FAILURE,79
ES,ACUTE PULMONARY OEDEMA,79
ES,BACTERAEMIA,79
ES,CONJUNCTIVITIS,79
ES,DIABETIC KETOACIDOSIS,79
ES,FLUID RETENTION,79
ES,DRUG EFFECT INCOMPLETE,78
ES,DRY MOUTH,78
ES,LUNG DISORDER,78
ES,VENTRICULAR FIBRILLATION,78
ES,COLITIS,77
ES,HAEMOPTYSIS,77
ES,HEPATOCELLULAR CARCINOMA,77
ES,PULMONARY HYPERTENSION,77
ES,RASH GENERALISED,77
ES,RASH MACULO-PAPULAR,77
ES,SPINAL FRACTURE,77
ES,STEVENS-JOHNSON SYNDROME,77
ES,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,75
ES,MUSCULOSKELETAL PAIN,75
ES,TUBERCULOSIS,75
ES,VISUAL ACUITY REDUCED,75
ES,BALANCE DISORDER,74
ES,ANURIA,73
ES,BLOOD BILIRUBIN INCREASED,73
ES,GAMMA-GLUTAMYLTRANSFERASE INCREASED,73
ES,SKIN EXFOLIATION,73
ES,CROHN^S DISEASE,72
ES,INTESTINAL PERFORATION,72
ES,OXYGEN SATURATION DECREASED,72
ES,PERICARDIAL EFFUSION,72
ES,HYPOCOAGULABLE STATE,71
ES,MYOCLONUS,71
ES,NEPHROPATHY TOXIC,71
ES,OSTEOPOROSIS,71
ES,RASH ERYTHEMATOUS,71
ES,THERAPEUTIC RESPONSE DECREASED,71
ES,BLISTER,70
ES,EYELID OEDEMA,70
ES,LOWER GASTROINTESTINAL HAEMORRHAGE,70
ES,BLOOD CREATINE PHOSPHOKINASE INCREASED,69
ES,BLOOD PRESSURE INCREASED,69
ES,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,69
ES,HAEMOLYTIC ANAEMIA,69
ES,PSYCHOMOTOR HYPERACTIVITY,68
ES,SUBDURAL HAEMATOMA,68
ES,HEPATIC FUNCTION ABNORMAL,67
ES,HEPATITIS TOXIC,67
ES,NO THERAPEUTIC RESPONSE,67
ES,ATAXIA,66
ES,BLOOD PRESSURE DECREASED,66
ES,DYSPHONIA,66
ES,NIGHTMARE,66
ES,ACTIVITIES OF DAILY LIVING IMPAIRED,65
ES,CONTUSION,65
ES,FEELING HOT,65
ES,HAEMATOCHEZIA,65
ES,INFARCTION,65
ES,PRESYNCOPE,65
ES,ATRIOVENTRICULAR BLOCK,64
ES,ECZEMA,64
ES,HEPATIC ENZYME INCREASED,64
ES,ABASIA,63
ES,DRUG ADMINISTRATION ERROR,63
ES,LUNG INFILTRATION,63
ES,STAPHYLOCOCCAL INFECTION,63
ES,UVEITIS,63
ES,BRADYPHRENIA,62
ES,DERMATITIS,62
ES,INJECTION SITE PRURITUS,62
ES,IRON DEFICIENCY ANAEMIA,62
ES,LEUKOENCEPHALOPATHY,62
ES,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,62
ES,PEMPHIGOID,61
ES,PNEUMONIA ASPIRATION,61
ES,SHOCK,61
ES,ABORTION INDUCED,60
ES,BLOOD GLUCOSE INCREASED,60
ES,CANDIDA INFECTION,60
ES,HYPOTHYROIDISM,60
ES,MENTAL DISORDER,60
ES,VENTRICULAR TACHYCARDIA,60
ES,DIVERTICULITIS,59
ES,NEPHROLITHIASIS,59
ES,UPPER RESPIRATORY TRACT INFECTION,59
ES,APLASTIC ANAEMIA,58
ES,DEAFNESS,58
ES,DRUG DEPENDENCE,58
ES,HEMIPARESIS,58
ES,HOSPITALISATION,58
ES,HYPOVOLAEMIC SHOCK,58
ES,INJECTION SITE HAEMATOMA,58
ES,BLOOD LACTATE DEHYDROGENASE INCREASED,57
ES,CATARACT,57
ES,CONVULSION,57
ES,GENERALISED TONIC-CLONIC SEIZURE,57
ES,METASTASES TO LIVER,57
ES,NEOPLASM,57
ES,OSTEONECROSIS,57
ES,DIPLOPIA,56
ES,MELAENA,56
ES,NEOPLASM MALIGNANT,56
ES,PALLOR,56
ES,RENAL DISORDER,56
ES,CEREBRAL INFARCTION,55
ES,DELUSION,55
ES,DRUG ABUSE,55
ES,DYSURIA,55
ES,EMBOLISM,55
ES,INCORRECT ROUTE OF DRUG ADMINISTRATION,55
ES,LOW BIRTH WEIGHT BABY,55
ES,ON AND OFF PHENOMENON,55
ES,PROSTATE CANCER,55
ES,RENAL TUBULAR NECROSIS,55
ES,SURGERY,55
ES,ATYPICAL FEMUR FRACTURE,54
ES,HYPERSENSITIVITY VASCULITIS,54
ES,NEUTROPHIL COUNT DECREASED,54
ES,PARKINSON^S DISEASE,54
ES,PREMATURE DELIVERY,54
ES,TYPE I HYPERSENSITIVITY,54
ES,ATRIOVENTRICULAR BLOCK COMPLETE,53
ES,COLON CANCER,53
ES,METASTASES TO BONE,53
ES,OSTEOARTHRITIS,53
ES,PULMONARY FIBROSIS,53
ES,SYSTEMIC LUPUS ERYTHEMATOSUS,53
ES,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,53
ES,DERMATITIS BULLOUS,52
ES,DISTURBANCE IN ATTENTION,52
ES,ILEUS PARALYTIC,52
ES,PURPURA,52
ES,SWELLING FACE,52
ES,TRANSPLANT REJECTION,52
ES,URINARY INCONTINENCE,52
ES,BRONCHOPULMONARY ASPERGILLOSIS,51
ES,C-REACTIVE PROTEIN INCREASED,51
ES,COLITIS ULCERATIVE,51
ES,SKIN DISORDER,51
ES,APATHY,50
ES,ERYTHEMA MULTIFORME,50
ES,LUNG INFECTION,50
ES,PERITONITIS,50
ES,PETECHIAE,50
ES,PNEUMOTHORAX,50
ES,PRODUCT QUALITY ISSUE,50
ES,SUBARACHNOID HAEMORRHAGE,50
ES,DRY SKIN,49
ES,HEPATIC CIRRHOSIS,49
ES,MANIA,49
ES,NEOPLASM PROGRESSION,49
ES,OTOTOXICITY,49
ES,PANCREATIC CARCINOMA,49
ES,PHOTOSENSITIVITY REACTION,49
ES,STUPOR,49
ES,CENTRAL NERVOUS SYSTEM LESION,48
ES,CYANOSIS,48
ES,GENERALISED OEDEMA,48
ES,METASTASIS,48
ES,PRODUCTIVE COUGH,48
ES,TINNITUS,48
ES,VASCULITIS,48
ES,CARDIOVASCULAR DISORDER,47
ES,ERECTILE DYSFUNCTION,47
ES,GASTRIC ULCER,47
ES,INTENTIONAL PRODUCT USE ISSUE,47
ES,MYOCARDITIS,47
ES,PERICARDITIS,47
ES,PREGNANCY,47
ES,DRUG DOSE OMISSION,46
ES,HISTIOCYTOSIS HAEMATOPHAGIC,46
ES,MYOCARDIAL ISCHAEMIA,46
ES,PARADOXICAL DRUG REACTION,46
ES,POLYNEUROPATHY,46
ES,BODY HEIGHT DECREASED,45
ES,CHOLECYSTITIS,45
ES,DISSEMINATED TUBERCULOSIS,45
ES,EYE PAIN,45
ES,FUNGAL INFECTION,45
ES,GYNAECOMASTIA,45
ES,INJECTION SITE REACTION,45
ES,KOUNIS SYNDROME,45
ES,RENAL COLIC,45
ES,ACCIDENTAL OVERDOSE,44
ES,BLOOD ALKALINE PHOSPHATASE INCREASED,44
ES,CHOKING SENSATION,44
ES,EXTRAPYRAMIDAL DISORDER,44
ES,MALNUTRITION,44
ES,MYOPATHY,44
ES,ODYNOPHAGIA,44
ES,PATHOGEN RESISTANCE,44
ES,PHLEBITIS,44
ES,SQUAMOUS CELL CARCINOMA,44
ES,TACHYPNOEA,44
ES,TOOTH DISORDER,44
ES,UPPER LIMB FRACTURE,44
ES,AUTOIMMUNE HEPATITIS,43
ES,ENCEPHALITIS,43
ES,ENTERITIS,43
ES,GASTRITIS,43
ES,HYPERCALCAEMIA,43
ES,JOINT SWELLING,43
ES,KETOACIDOSIS,43
ES,ASPHYXIA,42
ES,BLOOD CHOLESTEROL INCREASED,42
ES,CARDIOTOXICITY,42
ES,DEMENTIA,42
ES,DERMATITIS EXFOLIATIVE,42
ES,HYPERTHYROIDISM,42
ES,MEMORY IMPAIRMENT,42
ES,MUSCLE RIGIDITY,42
ES,PROSTATIC SPECIFIC ANTIGEN INCREASED,42
ES,RENAL FAILURE CHRONIC,42
ES,SWELLING,42
ES,ABDOMINAL WALL HAEMATOMA,41
ES,ACUTE GRAFT VERSUS HOST DISEASE,41
ES,BRAIN OEDEMA,41
ES,HAEMORRHOIDS,41
ES,HYPERTRIGLYCERIDAEMIA,41
ES,INCORRECT DRUG ADMINISTRATION DURATION,41
ES,NYSTAGMUS,41
ES,PSORIATIC ARTHROPATHY,41
ES,PULMONARY TUBERCULOSIS,41
ES,WHITE BLOOD CELL COUNT DECREASED,41
ES,ATELECTASIS,40
ES,CARDIOGENIC SHOCK,40
ES,CHOLANGITIS,40
ES,HEAD INJURY,40
ES,INFLUENZA LIKE ILLNESS,40
ES,LARYNGEAL OEDEMA,40
ES,MENINGITIS ASEPTIC,40
ES,MYDRIASIS,40
ES,NECK PAIN,40
ES,PERIPHERAL SENSORY NEUROPATHY,40
ES,ASPIRATION BRONCHIAL,39
ES,BURNING SENSATION,39
ES,CHOKING,39
ES,FOETAL GROWTH RESTRICTION,39
ES,GENERALISED ERYTHEMA,39
ES,HYPOPHAGIA,39
ES,INTENTIONAL PRODUCT MISUSE,39
ES,MITRAL VALVE INCOMPETENCE,39
ES,NEPHROTIC SYNDROME,39
ES,OLIGURIA,39
ES,ORAL CANDIDIASIS,39
ES,PANNICULITIS,39
ES,POISONING,39
ES,PULMONARY HAEMORRHAGE,39
ES,ACNE,38
ES,ACUTE RESPIRATORY DISTRESS SYNDROME,38
ES,ADVERSE DRUG REACTION,38
ES,DYSPNOEA EXERTIONAL,38
ES,DYSTONIA,38
ES,EJECTION FRACTION DECREASED,38
ES,FRACTURE,38
ES,GASTRIC DISORDER,38
ES,MOUTH ULCERATION,38
ES,RASH PUSTULAR,38
ES,RETINAL DETACHMENT,38
ES,WRONG PATIENT RECEIVED MEDICATION,38
ES,WRONG TECHNIQUE IN DRUG USAGE PROCESS,38
ES,BASAL CELL CARCINOMA,37
ES,CACHEXIA,37
ES,GUILLAIN-BARRE SYNDROME,37
ES,HAEMOLYSIS,37
ES,INJECTION SITE INFLAMMATION,37
ES,INJURY,37
ES,LIVER INJURY,37
ES,RESPIRATORY DEPRESSION,37
ES,VIRAL LOAD INCREASED,37
ES,ALTERED STATE OF CONSCIOUSNESS,36
ES,FREEZING PHENOMENON,36
ES,HEPATOMEGALY,36
ES,HYPOPHOSPHATAEMIA,36
ES,OESOPHAGITIS,36
ES,OSTEOMYELITIS,36
ES,SINUS TACHYCARDIA,36
ES,THROAT IRRITATION,36
ES,APPENDICITIS,35
ES,DRUG ERUPTION,35
ES,DRY EYE,35
ES,HEPATIC STEATOSIS,35
ES,HERPES VIRUS INFECTION,35
ES,HYPERNATRAEMIA,35
ES,LIP OEDEMA,35
ES,LYMPHOMA,35
ES,MULTIPLE SCLEROSIS,35
ES,NECROSIS,35
ES,PRESCRIBED OVERDOSE,35
ES,RESPIRATORY ARREST,35
ES,SCIATICA,35
ES,SUPRAVENTRICULAR TACHYCARDIA,35
ES,TENDON RUPTURE,35
ES,UNINTENDED PREGNANCY,35
ES,ASPERGILLUS INFECTION,34
ES,BLOOD TRIGLYCERIDES INCREASED,34
ES,CEREBRAL HAEMATOMA,34
ES,COLITIS ISCHAEMIC,34
ES,CUSHING^S SYNDROME,34
ES,DIABETES MELLITUS INADEQUATE CONTROL,34
ES,EUPHORIC MOOD,34
ES,KLEBSIELLA INFECTION,34
ES,LOCALISED INFECTION,34
ES,MALIGNANT MELANOMA,34
ES,MUSCLE HAEMORRHAGE,34
ES,OROPHARYNGEAL PAIN,34
ES,PERIPHERAL ISCHAEMIA,34
ES,PERITONITIS BACTERIAL,34
ES,POST PROCEDURAL COMPLICATION,34
ES,REMISSION NOT ACHIEVED,34
ES,WITHDRAWAL SYNDROME,34
ES,ARTHROPATHY,33
ES,HEART RATE INCREASED,33
ES,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,33
ES,INTESTINAL ISCHAEMIA,33
ES,LIVE BIRTH,33
ES,STAPHYLOCOCCAL BACTERAEMIA,33
ES,TONGUE OEDEMA,33
ES,UROSEPSIS,33
ES,ADENOCARCINOMA OF COLON,32
ES,CHOLECYSTITIS ACUTE,32
ES,CHRONIC GRAFT VERSUS HOST DISEASE,32
ES,DRUG EFFECT DECREASED,32
ES,FISTULA,32
ES,GLAUCOMA,32
ES,HOT FLUSH,32
ES,IMPAIRED HEALING,32
ES,MIGRAINE,32
ES,PSEUDOMONAS INFECTION,32
ES,PULMONARY TOXICITY,32
ES,SINUS BRADYCARDIA,32
ES,VIRAL INFECTION,32
ES,APHONIA,31
ES,CRANIOCEREBRAL INJURY,31
ES,HYPOTHERMIA,31
ES,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,31
ES,IMMOBILE,31
ES,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,31
ES,METASTASES TO LUNG,31
ES,PANCREATIC CARCINOMA METASTATIC,31
ES,POLLAKIURIA,31
ES,PULMONARY MASS,31
ES,RASH PAPULAR,31
ES,UNEVALUABLE EVENT,31
ES,VAGINAL HAEMORRHAGE,31
ES,WRIST FRACTURE,31
ES,ACUTE PSYCHOSIS,30
ES,AMENORRHOEA,30
ES,ATRIAL FLUTTER,30
ES,BACTERIAL INFECTION,30
ES,BRONCHIOLITIS,30
ES,CARDIAC FAILURE ACUTE,30
ES,CONGESTIVE CARDIOMYOPATHY,30
ES,DERMATITIS ALLERGIC,30
ES,ERYTHRODERMIC PSORIASIS,30
ES,HAEMATOCRIT DECREASED,30
ES,HAEMOLYTIC URAEMIC SYNDROME,30
ES,HEPATOCELLULAR INJURY,30
ES,LOWER RESPIRATORY TRACT INFECTION,30
ES,MOVEMENT DISORDER,30
ES,PORTAL VEIN THROMBOSIS,30
ES,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,30
ES,SENSORY LOSS,30
ES,VENOOCCLUSIVE LIVER DISEASE,30
ES,WHEEZING,30
ES,WHITE BLOOD CELL COUNT INCREASED,30
ES,WOUND,30
ES,ADRENAL INSUFFICIENCY,29
ES,CARDIAC TAMPONADE,29
ES,CYTOPENIA,29
ES,DRUG LEVEL INCREASED,29
ES,DRUG WITHDRAWAL SYNDROME,29
ES,FLATULENCE,29
ES,HEPATIC CANCER,29
ES,HIATUS HERNIA,29
ES,HYPOALBUMINAEMIA,29
ES,INTRACRANIAL PRESSURE INCREASED,29
ES,LIMB DISCOMFORT,29
ES,LIVER FUNCTION TEST ABNORMAL,29
ES,MYOSITIS,29
ES,NECROTISING FASCIITIS,29
ES,OPTIC NEUROPATHY,29
ES,ORGANISING PNEUMONIA,29
ES,PNEUMOCYSTIS JIROVECII PNEUMONIA,29
ES,RIGHT VENTRICULAR FAILURE,29
ES,SECOND PRIMARY MALIGNANCY,29
ES,SKIN PLAQUE,29
ES,THERAPY NON-RESPONDER,29
ES,ANKYLOSING SPONDYLITIS,28
ES,BLOOD UREA INCREASED,28
ES,CAESAREAN SECTION,28
ES,DEVICE ISSUE,28
ES,HALLUCINATION_ AUDITORY,28
ES,HEPATITIS B,28
ES,HYPOACUSIS,28
ES,LEFT VENTRICULAR DYSFUNCTION,28
ES,LOCAL SWELLING,28
ES,LUPUS-LIKE SYNDROME,28
ES,MOTOR DYSFUNCTION,28
ES,NO ADVERSE EVENT,28
ES,NORMOCHROMIC NORMOCYTIC ANAEMIA,28
ES,ORAL HERPES,28
ES,PAPILLOEDEMA,28
ES,PROCTALGIA,28
ES,PULMONARY ALVEOLAR HAEMORRHAGE,28
ES,ROAD TRAFFIC ACCIDENT,28
ES,TOOTH LOSS,28
ES,ABSCESS,27
ES,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,27
ES,AUTOIMMUNE HAEMOLYTIC ANAEMIA,27
ES,DECUBITUS ULCER,27
ES,DRUG PRESCRIBING ERROR,27
ES,EYE IRRITATION,27
ES,FOLLICULITIS,27
ES,HEMIPLEGIA,27
ES,HYPERREFLEXIA,27
ES,HYPERURICAEMIA,27
ES,INGUINAL HERNIA,27
ES,MACULAR OEDEMA,27
ES,OCULAR HYPERAEMIA,27
ES,OPTIC NEURITIS,27
ES,ORAL DISORDER,27
ES,OROPHARYNGEAL CANDIDIASIS,27
ES,POST PROCEDURAL HAEMORRHAGE,27
ES,PUSTULAR PSORIASIS,27
ES,RASH MACULAR,27
ES,RETROPERITONEAL HAEMATOMA,27
ES,SINUSITIS,27
ES,SWOLLEN TONGUE,27
ES,ANAL ABSCESS,26
ES,ANAL FISTULA,26
ES,ASPIRATION,26
ES,BLOOD DISORDER,26
ES,BLOOD LACTIC ACID INCREASED,26
ES,BONE MARROW TOXICITY,26
ES,CEREBELLAR SYNDROME,26
ES,COLECTOMY,26
ES,ELECTROLYTE IMBALANCE,26
ES,EMPHYSEMA,26
ES,ESCHERICHIA URINARY TRACT INFECTION,26
ES,HYPERAMMONAEMIA,26
ES,HYPOTONIA,26
ES,INTERVERTEBRAL DISC PROTRUSION,26
ES,OLIGOHYDRAMNIOS,26
ES,PAIN IN JAW,26
ES,PALATAL OEDEMA,26
ES,POSTOPERATIVE WOUND INFECTION,26
ES,PRERENAL FAILURE,26
ES,PULMONARY ARTERIAL HYPERTENSION,26
ES,SHOCK HAEMORRHAGIC,26
ES,SKIN EROSION,26
ES,STOMA SITE INFECTION,26
ES,VASCULAR STENT THROMBOSIS,26
ES,AKATHISIA,25
ES,ANORECTAL DISORDER,25
ES,BONE DISORDER,25
ES,CEREBRAL ISCHAEMIA,25
ES,DEMYELINATION,25
ES,DYSLIPIDAEMIA,25
ES,ENDOCARDITIS,25
ES,ESCHERICHIA INFECTION,25
ES,GASTROOESOPHAGEAL REFLUX DISEASE,25
ES,GENOTYPE DRUG RESISTANCE TEST POSITIVE,25
ES,HEAT STROKE,25
ES,HICCUPS,25
ES,HUMERUS FRACTURE,25
ES,INCORRECT DOSAGE ADMINISTERED,25
ES,INTRAOCULAR PRESSURE INCREASED,25
ES,LETHARGY,25
ES,NASAL CONGESTION,25
ES,NEPHROPATHY,25
ES,ORAL PAIN,25
ES,PNEUMONIA BACTERIAL,25
ES,SECRETION DISCHARGE,25
ES,SYSTEMIC CANDIDA,25
ES,TIBIA FRACTURE,25
ES,TONSILLITIS,25
ES,TUMOUR LYSIS SYNDROME,25
ES,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,24
ES,ANGINA UNSTABLE,24
ES,BUNDLE BRANCH BLOCK LEFT,24
ES,BUNDLE BRANCH BLOCK RIGHT,24
ES,CHEILITIS,24
ES,CLOSTRIDIUM DIFFICILE COLITIS,24
ES,DEVICE FAILURE,24
ES,DISTRIBUTIVE SHOCK,24
ES,ENTEROCOLITIS,24
ES,EXPOSURE DURING BREAST FEEDING,24
ES,HYPOKINESIA,24
ES,HYPOTONY OF EYE,24
ES,IMMUNODEFICIENCY,24
ES,INJECTION SITE URTICARIA,24
ES,JOINT DISLOCATION,24
ES,LIBIDO DECREASED,24
ES,LIP SWELLING,24
ES,LYMPHOCYTE COUNT DECREASED,24
ES,METRORRHAGIA,24
ES,OESOPHAGEAL CANDIDIASIS,24
ES,PHARYNGITIS,24
ES,POLYURIA,24
ES,PSYCHOTIC SYMPTOM,24
ES,PYELONEPHRITIS,24
ES,RENAL PAIN,24
ES,RENAL TUBULAR DISORDER,24
ES,RHINORRHOEA,24
ES,RIB FRACTURE,24
ES,SALIVARY HYPERSECRETION,24
ES,SIALOADENITIS,24
ES,SKIN DISCOLOURATION,24
ES,SKIN INFECTION,24
ES,SPINAL COMPRESSION FRACTURE,24
ES,STOMA SITE DISCHARGE,24
ES,ACTINOMYCOSIS,23
ES,ADENOCARCINOMA PANCREAS,23
ES,AGEUSIA,23
ES,ANGLE CLOSURE GLAUCOMA,23
ES,APHTHOUS ULCER,23
ES,APLASIA,23
ES,BLOOD GLUCOSE ABNORMAL,23
ES,CARDIOPULMONARY FAILURE,23
ES,CHROMATURIA,23
ES,CHRONIC LYMPHOCYTIC LEUKAEMIA,23
ES,DEAFNESS NEUROSENSORY,23
ES,DERMATITIS ACNEIFORM,23
ES,FAECES DISCOLOURED,23
ES,FEAR,23
ES,GASTRIC HAEMORRHAGE,23
ES,GLOMERULAR FILTRATION RATE DECREASED,23
ES,HAEMORRHAGIC ANAEMIA,23
ES,HAEMOTHORAX,23
ES,HYPERKERATOSIS,23
ES,HYPOGAMMAGLOBULINAEMIA,23
ES,INJECTION SITE SWELLING,23
ES,INJECTION SITE WARMTH,23
ES,LISTERIOSIS,23
ES,LIVER TRANSPLANT REJECTION,23
ES,LUNG ADENOCARCINOMA,23
ES,LYMPHOEDEMA,23
ES,MALABSORPTION,23
ES,MYOKYMIA,23
ES,NEUROLOGICAL DECOMPENSATION,23
ES,PARALYSIS,23
ES,PHOTOPHOBIA,23
ES,PNEUMOPERITONEUM,23
ES,PORTAL HYPERTENSION,23
ES,RED BLOOD CELL SEDIMENTATION RATE INCREASED,23
ES,SCHIZOPHRENIA,23
ES,SLEEP DISORDER,23
ES,STEREOTYPY,23
ES,TENDONITIS,23
ES,TYPE IV HYPERSENSITIVITY REACTION,23
ES,ACUTE LYMPHOCYTIC LEUKAEMIA,22
ES,ARTHRITIS INFECTIVE,22
ES,BLINDNESS TRANSIENT,22
ES,BRONCHIAL DISORDER,22
ES,CARDIOMYOPATHY,22
ES,CLOSTRIDIUM DIFFICILE INFECTION,22
ES,COORDINATION ABNORMAL,22
ES,CORONARY ARTERY DISEASE,22
ES,CRYING,22
ES,DECREASED IMMUNE RESPONSIVENESS,22
ES,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,22
ES,DUODENAL ULCER,22
ES,EMBOLIC STROKE,22
ES,EMOTIONAL DISORDER,22
ES,EXPOSED BONE IN JAW,22
ES,EYE SWELLING,22
ES,FACIAL PARALYSIS,22
ES,FAECALOMA,22
ES,GROIN PAIN,22
ES,HYDROCEPHALUS,22
ES,HYPERAMMONAEMIC ENCEPHALOPATHY,22
ES,HYPERLIPIDAEMIA,22
ES,IMMUNE THROMBOCYTOPENIC PURPURA,22
ES,IMMUNOSUPPRESSION,22
ES,LINEAR IGA DISEASE,22
ES,MIXED LIVER INJURY,22
ES,NODAL RHYTHM,22
ES,SKIN NECROSIS,22
ES,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,22
ES,VARICES OESOPHAGEAL,22
ES,WRONG DRUG ADMINISTERED,22
ES,ABORTION,21
ES,ANAL PRURITUS,21
ES,ANOSMIA,21
ES,BICYTOPENIA,21
ES,BLOOD PRESSURE ABNORMAL,21
ES,DEVICE OCCLUSION,21
ES,DIARRHOEA HAEMORRHAGIC,21
ES,ENDOPHTHALMITIS,21
ES,FIBROSIS,21
ES,GRANULOMA,21
ES,INVASIVE DUCTAL BREAST CARCINOMA,21
ES,IRIDOCYCLITIS,21
ES,LACRIMATION INCREASED,21
ES,LONG QT SYNDROME,21
ES,MOOD ALTERED,21
ES,MOUTH HAEMORRHAGE,21
ES,NAIL DISORDER,21
ES,NON-HODGKIN^S LYMPHOMA,21
ES,PARONYCHIA,21
ES,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,21
ES,PERITONEAL HAEMORRHAGE,21
ES,PETIT MAL EPILEPSY,21
ES,POLYMYALGIA RHEUMATICA,21
ES,SPINAL PAIN,21
ES,SPRUE-LIKE ENTEROPATHY,21
ES,STRESS,21
ES,VARICELLA ZOSTER VIRUS INFECTION,21
ES,BLADDER CANCER,20
ES,BLINDNESS UNILATERAL,20
ES,BREAST CANCER METASTATIC,20
ES,BRONCHIECTASIS,20
ES,COLITIS MICROSCOPIC,20
ES,CONCOMITANT DISEASE AGGRAVATED,20
ES,FANCONI SYNDROME,20
ES,GRAND MAL CONVULSION,20
ES,HEPATIC NEOPLASM,20
ES,HEPATITIS B REACTIVATION,20
ES,HYPERCHOLESTEROLAEMIA,20
ES,HYPERTONIA,20
ES,INJECTION SITE MASS,20
ES,LOCALISED OEDEMA,20
ES,MENTAL IMPAIRMENT,20
ES,NEUTROPHILIA,20
ES,PARAESTHESIA ORAL,20
ES,PAROSMIA,20
ES,PURULENT DISCHARGE,20
ES,RHINITIS,20
ES,SCAB,20
ES,SLEEP APNOEA SYNDROME,20
ES,SPLENOMEGALY,20
ES,THERAPEUTIC RESPONSE UNEXPECTED,20
ES,TOXIC ENCEPHALOPATHY,20
ES,ULCER,20
ES,UNRESPONSIVE TO STIMULI,20
ES,VENOUS THROMBOSIS,20
ES,VIITH NERVE PARALYSIS,20
ES,VIRAL MUTATION IDENTIFIED,20
ES,ANORECTAL DISCOMFORT,19
ES,APNOEA,19
ES,BILIARY COLIC,19
ES,CARDIOMEGALY,19
ES,CONDUCT DISORDER,19
ES,DEVICE BREAKAGE,19
ES,DRUG DOSE TITRATION NOT PERFORMED,19
ES,DRUG LEVEL DECREASED,19
ES,DYSAESTHESIA,19
ES,EMBOLISM VENOUS,19
ES,EPSTEIN-BARR VIRUS INFECTION,19
ES,ERYTHEMA NODOSUM,19
ES,EYE HAEMORRHAGE,19
ES,EYE MOVEMENT DISORDER,19
ES,GAIT INABILITY,19
ES,GASTRITIS EROSIVE,19
ES,GASTROINTESTINAL INFLAMMATION,19
ES,HEPATIC NECROSIS,19
ES,HODGKIN^S DISEASE,19
ES,IMMUNE-MEDIATED NECROTISING MYOPATHY,19
ES,INJECTION SITE HAEMORRHAGE,19
ES,INJECTION SITE INDURATION,19
ES,INTENTIONAL DRUG MISUSE,19
ES,KAPOSI^S SARCOMA,19
ES,LANGUAGE DISORDER,19
ES,MYELOFIBROSIS,19
ES,OCULAR HYPERTENSION,19
ES,PRESCRIBED UNDERDOSE,19
ES,PSYCHOTIC DISORDER DUE TO A GENERAL MEDICAL CONDITION,19
ES,PULMONARY SEPSIS,19
ES,RADICULOPATHY,19
ES,RALES,19
ES,SKIN HYPERPIGMENTATION,19
ES,SPINAL DISORDER,19
ES,SQUAMOUS CELL CARCINOMA OF SKIN,19
ES,TOOTH INFECTION,19
ES,VENTRICULAR EXTRASYSTOLES,19
ES,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,18
ES,AFFECT LABILITY,18
ES,AUTISM SPECTRUM DISORDER,18
ES,BLOOD CREATININE ABNORMAL,18
ES,BLOOD GLUCOSE DECREASED,18
ES,BLOOD HIV RNA INCREASED,18
ES,BODY TEMPERATURE INCREASED,18
ES,BRAIN DEATH,18
ES,BRAIN NEOPLASM,18
ES,CATAPLEXY,18
ES,CATARRH,18
ES,CEREBRAL ATROPHY,18
ES,COLD SWEAT,18
ES,COLON NEOPLASM,18
ES,CONJUNCTIVAL HYPERAEMIA,18
ES,CONTRAINDICATED PRODUCT ADMINISTERED,18
ES,CORONARY ARTERY OCCLUSION,18
ES,CYSTITIS HAEMORRHAGIC,18
ES,DRUG DISPENSING ERROR,18
ES,DYSSTASIA,18
ES,ENTEROCOCCAL INFECTION,18
ES,ESCHERICHIA SEPSIS,18
ES,FIXED ERUPTION,18
ES,GINGIVAL BLEEDING,18
ES,HIDRADENITIS,18
ES,HYPERTHERMIA,18
ES,LYMPHOCYTOSIS,18
ES,METABOLIC ENCEPHALOPATHY,18
ES,METABOLIC SYNDROME,18
ES,METASTASES TO CENTRAL NERVOUS SYSTEM,18
LK,DEATH,40
LK,TOXICITY TO VARIOUS AGENTS,20
LK,MYOPATHY,13
LK,CONDITION AGGRAVATED,10
LK,HYPOTHERMIA,10
LK,PYREXIA,10
LK,CHOLANGITIS,9
LK,DRUG INEFFECTIVE,9
LK,CARDIAC ARREST,8
LK,DYSPNOEA,8
LK,HEADACHE,8
LK,HYPOTENSION,8
LK,LOSS OF CONSCIOUSNESS,8
LK,CHOLESTASIS,7
LK,PAIN,7
LK,ACCIDENTAL EXPOSURE TO PRODUCT,6
LK,CHEST PAIN,6
LK,KOUNIS SYNDROME,6
LK,PALPITATIONS,6
LK,TREMOR,6
LK,ACUTE MYOCARDIAL INFARCTION,5
LK,MUSCULAR WEAKNESS,5
LK,MYOCARDIAL INFARCTION,5
LK,THROMBOCYTOPENIA,5
LK,COGNITIVE DISORDER,4
LK,DENGUE FEVER,4
LK,DEPRESSED LEVEL OF CONSCIOUSNESS,4
LK,DISABILITY,4
LK,FATIGUE,4
LK,HAEMOPTYSIS,4
LK,JAUNDICE,4
LK,RHABDOMYOLYSIS,4
LK,VENTRICULAR TACHYCARDIA,4
LK,ACUTE HEPATIC FAILURE,3
LK,ANAPHYLACTIC REACTION,3
LK,ASPARTATE AMINOTRANSFERASE INCREASED,3
LK,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
LK,BLOOD CREATININE INCREASED,3
LK,CARDIAC FAILURE,3
LK,CARDIOGENIC SHOCK,3
LK,CHILLS,3
LK,COMA,3
LK,DIZZINESS,3
LK,DRUG-INDUCED LIVER INJURY,3
LK,ELECTROCARDIOGRAM T WAVE INVERSION,3
LK,HAEMORRHAGE,3
LK,HAEMOSIDEROSIS,3
LK,HEPATIC ENCEPHALOPATHY,3
LK,HYPOKALAEMIA,3
LK,HYPONATRAEMIA,3
LK,MEMORY IMPAIRMENT,3
LK,OVERDOSE,3
LK,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,3
LK,PRURITUS,3
LK,RETROGRADE AMNESIA,3
LK,SEPSIS,3
LK,SHOCK,3
LK,SOMNOLENCE,3
LK,TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM,3
LK,VOMITING,3
LK,ACUTE KIDNEY INJURY,2
LK,ALANINE AMINOTRANSFERASE INCREASED,2
LK,ANAPHYLACTIC SHOCK,2
LK,ASPHYXIA,2
LK,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,2
LK,BLOOD PRESSURE DECREASED,2
LK,BRADYCARDIA,2
LK,CARDIOMYOPATHY,2
LK,CELLULITIS,2
LK,CEREBRAL INFARCTION,2
LK,CONVULSION,2
LK,DECREASED APPETITE,2
LK,DYSARTHRIA,2
LK,EOSINOPHILIA,2
LK,FOETAL EXPOSURE DURING PREGNANCY,2
LK,HAEMATURIA,2
LK,HEPATIC FAILURE,2
LK,HEPATOTOXICITY,2
LK,HYPERCALCAEMIA,2
LK,HYPERCOAGULATION,2
LK,HYPERSENSITIVITY,2
LK,HYPERTENSION,2
LK,INFECTION,2
LK,INJECTION SITE PAIN,2
LK,INTENTIONAL OVERDOSE,2
LK,JAUNDICE CHOLESTATIC,2
LK,LACERATION,2
LK,LARYNGEAL OEDEMA,2
LK,LEUKOCYTOSIS,2
LK,MALAISE,2
LK,METABOLIC ACIDOSIS,2
LK,NECROTISING FASCIITIS,2
LK,NEUTROPENIA,2
LK,OEDEMA PERIPHERAL,2
LK,PALLOR,2
LK,PANCYTOPENIA,2
LK,PARAPLEGIA,2
LK,PLATELET COUNT DECREASED,2
LK,PNEUMONIA,2
LK,POISONING,2
LK,PREMATURE BABY,2
LK,PREMATURE DELIVERY,2
LK,PULMONARY EMBOLISM,2
LK,PULMONARY OEDEMA,2
LK,RASH ERYTHEMATOUS,2
LK,RESPIRATORY FAILURE,2
LK,SEPTIC SHOCK,2
LK,STRESS CARDIOMYOPATHY,2
LK,SUBCUTANEOUS ABSCESS,2
LK,TACHYCARDIA,2
LK,TREATMENT NONCOMPLIANCE,2
LK,UPPER GASTROINTESTINAL HAEMORRHAGE,2
LK,URTICARIA,2
LK,VASCULITIS,2
LK,VICTIM OF HOMICIDE,2
LK,WHITE BLOOD CELL COUNT DECREASED,2
LK,ABDOMINAL PAIN,1
LK,ABDOMINAL WALL HAEMATOMA,1
LK,ABSCESS,1
LK,ABSCESS LIMB,1
LK,ACCIDENTAL DEATH,1
LK,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
LK,ACUTE CORONARY SYNDROME,1
LK,ACUTE SINUSITIS,1
LK,ADVERSE DRUG REACTION,1
LK,ALTERED STATE OF CONSCIOUSNESS,1
LK,AMNESIA,1
LK,ANAEMIA,1
LK,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,1
LK,APHASIA,1
LK,AREFLEXIA,1
LK,ARTERIOSCLEROSIS CORONARY ARTERY,1
LK,ASTHENIA,1
LK,ATRIAL FIBRILLATION,1
LK,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
LK,BACK PAIN,1
LK,BASAL GANGLIA INFARCTION,1
LK,BLINDNESS UNILATERAL,1
LK,BLISTER,1
LK,BLOOD PRESSURE INCREASED,1
LK,BONE MARROW RETICULIN FIBROSIS,1
LK,BONE PAIN,1
LK,BRAIN OEDEMA,1
LK,BRONCHIAL SECRETION RETENTION,1
LK,BRONCHOSPASM,1
LK,CARDIAC ENZYMES INCREASED,1
LK,CARDIAC FAILURE CONGESTIVE,1
LK,CARDIAC MURMUR,1
LK,CARDIAC VALVE DISEASE,1
LK,CARDIO-RESPIRATORY ARREST,1
LK,CEREBRAL DISORDER,1
LK,CEREBRAL HAEMORRHAGE,1
LK,CHAPPED LIPS,1
LK,CHEST DISCOMFORT,1
LK,CHOLESTATIC LIVER INJURY,1
LK,CHRONIC MYELOID LEUKAEMIA,1
LK,CLONIC CONVULSION,1
LK,COMPLICATION OF PREGNANCY,1
LK,COMPULSIONS,1
LK,CONJUNCTIVAL HYPERAEMIA,1
LK,CONTRAST MEDIA REACTION,1
LK,COUGH,1
LK,CRANIOSYNOSTOSIS,1
LK,CUSHINGOID,1
LK,CUSHING^S SYNDROME,1
LK,DEHYDRATION,1
LK,DEVELOPMENTAL DELAY,1
LK,DIABETES MELLITUS,1
LK,DIASTOLIC DYSFUNCTION,1
LK,DIPLOPIA,1
LK,DISEASE PROGRESSION,1
LK,DRUG ADMINISTRATION ERROR,1
LK,DRUG HYPERSENSITIVITY,1
LK,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
LK,DRUG MONITORING PROCEDURE NOT PERFORMED,1
LK,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
LK,DRUG RESISTANCE,1
LK,DYSPNOEA EXERTIONAL,1
LK,EAR INFECTION,1
LK,ECHOCARDIOGRAM ABNORMAL,1
LK,EJECTION FRACTION DECREASED,1
LK,ELECTROCARDIOGRAM ABNORMAL,1
LK,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
LK,ELECTROMYOGRAM ABNORMAL,1
LK,ENCEPHALOPATHY,1
LK,ERYTHEMA,1
LK,EXPOSURE DURING PREGNANCY,1
LK,EXTRAPYRAMIDAL DISORDER,1
LK,EYE HAEMORRHAGE,1
LK,EYE SWELLING,1
LK,FACE OEDEMA,1
LK,FEBRILE NEUTROPENIA,1
LK,FEMALE GENITAL TRACT FISTULA,1
LK,FIBROSIS,1
LK,FOETAL DISTRESS SYNDROME,1
LK,FULL BLOOD COUNT DECREASED,1
LK,FULL BLOOD COUNT INCREASED,1
LK,GALLBLADDER ENLARGEMENT,1
LK,GASTRIC ULCER,1
LK,GASTRITIS EROSIVE,1
LK,GASTROINTESTINAL HAEMORRHAGE,1
LK,GENERAL PHYSICAL HEALTH DETERIORATION,1
LK,GENERALISED ERYTHEMA,1
LK,HAEMATOCRIT DECREASED,1
LK,HAEMODYNAMIC INSTABILITY,1
LK,HAEMOGLOBIN DECREASED,1
LK,HAEMORRHAGIC CEREBRAL INFARCTION,1
LK,HEART INJURY,1
LK,HEMIANOPIA HOMONYMOUS,1
LK,HEPATIC CIRRHOSIS,1
LK,HEPATIC ENZYME INCREASED,1
LK,HEPATITIS,1
LK,HEPATOCELLULAR INJURY,1
LK,HEPATOMEGALY,1
LK,HYPERGLYCAEMIA,1
LK,HYPERHIDROSIS,1
LK,HYPERKALAEMIA,1
LK,HYPERPHAGIA,1
LK,HYPOCALCAEMIA,1
LK,HYPOGLYCAEMIA,1
LK,HYPOPHAGIA,1
LK,HYPOREFLEXIA,1
LK,HYPOTHYROIDISM,1
LK,HYPOTONIA,1
LK,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
LK,INCORRECT DOSE ADMINISTERED,1
LK,INFUSION RELATED REACTION,1
LK,INTERNATIONAL NORMALISED RATIO DECREASED,1
LK,INTERNATIONAL NORMALISED RATIO INCREASED,1
LK,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
LK,LEFT VENTRICULAR DYSFUNCTION,1
LK,LEFT VENTRICULAR FAILURE,1
LK,LEFT VENTRICULAR HYPERTROPHY,1
LK,LEPTOSPIRA TEST POSITIVE,1
LK,LEPTOSPIROSIS,1
LK,LEUKAEMIA RECURRENT,1
LK,LEUKOPENIA,1
LK,LIVE BIRTH,1
LK,LOW BIRTH WEIGHT BABY,1
LK,LOWER RESPIRATORY TRACT INFECTION,1
LK,MANIA,1
LK,MASS,1
LK,MATERNAL EXPOSURE DURING PREGNANCY,1
LK,MICROENCEPHALY,1
LK,MOUTH ULCERATION,1
LK,MULTI-ORGAN FAILURE,1
LK,MULTIPLE SCLEROSIS RELAPSE,1
LK,MYALGIA,1
LK,MYOCARDITIS,1
LK,MYOPIA,1
LK,NEONATAL THYROTOXICOSIS,1
LK,NERVE CONDUCTION STUDIES ABNORMAL,1
LK,NEUTROPENIC SEPSIS,1
LK,OBSESSIVE THOUGHTS,1
LK,OSTEOSCLEROSIS,1
LK,PALMOPLANTAR KERATODERMA,1
LK,PAPILLOEDEMA,1
LK,PELVIC VENOUS THROMBOSIS,1
LK,PERINEAL FISTULA,1
LK,PLEURAL EFFUSION,1
LK,PNEUMOTHORAX,1
LK,PRODUCT USE ISSUE,1
LK,PULSE ABNORMAL,1
LK,RALES,1
LK,RASH,1
LK,RASH MACULO-PAPULAR,1
LK,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
LK,RENAL FAILURE ACUTE,1
LK,RESPIRATORY DISTRESS,1
LK,RESPIRATORY RATE INCREASED,1
LK,RETINAL VEIN OCCLUSION,1
LK,RHINORRHOEA,1
LK,RHONCHI,1
LK,SEIZURE,1
LK,SEROTONIN SYNDROME,1
LK,SINUS TACHYCARDIA,1
LK,SKIN EXFOLIATION,1
LK,SKIN WARM,1
LK,SPEECH DISORDER,1
LK,SPINAL PAIN,1
LK,SPLENOMEGALY,1
LK,SUBARACHNOID HAEMORRHAGE,1
LK,SWELLING FACE,1
LK,SYNCOPE,1
LK,TENDERNESS,1
LK,TROPONIN INCREASED,1
LK,URINE OUTPUT DECREASED,1
LK,VASCULITIS CEREBRAL,1
LK,VERTIGO,1
LK,VIRAL INFECTION,1
LK,VISION BLURRED,1
LK,VISUAL ACUITY REDUCED,1
LK,VISUAL IMPAIRMENT,1
LK,WALKING AID USER,1
LK,WEIGHT INCREASED,1
LK,WOUND SECRETION,1
SD,DEATH,100
SD,ANAEMIA,52
SD,SUDDEN DEATH,25
SD,FOETAL EXPOSURE DURING PREGNANCY,24
SD,CIRCULATORY COLLAPSE,23
SD,MALARIA,9
SD,MENINGOMYELOCELE,8
SD,PLATELET COUNT DECREASED,6
SD,MENINGOCELE,5
SD,PYREXIA,5
SD,ABDOMINAL PAIN,4
SD,ANENCEPHALY,4
SD,ENCEPHALOCELE,4
SD,GASTROINTESTINAL STROMAL TUMOUR,4
SD,HAEMORRHAGE,4
SD,HYDROCEPHALUS,4
SD,RENAL FAILURE,4
SD,CONVULSION,3
SD,DIZZINESS,3
SD,EYE PAIN,3
SD,HAEMOGLOBIN DECREASED,3
SD,HEADACHE,3
SD,HYPOVOLAEMIC SHOCK,3
SD,JAUNDICE,3
SD,MALIGNANT NEOPLASM PROGRESSION,3
SD,THROMBOCYTOPENIA,3
SD,ABDOMINAL MASS,2
SD,ABDOMINAL PAIN UPPER,2
SD,ASCITES,2
SD,BLOOD CREATININE INCREASED,2
SD,CARDIAC FAILURE,2
SD,CEREBROVASCULAR ACCIDENT,2
SD,CHRONIC MYELOID LEUKAEMIA,2
SD,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,2
SD,COMA,2
SD,DIARRHOEA,2
SD,DRUG INEFFECTIVE,2
SD,DRUG RESISTANCE,2
SD,ERYTHROPOIESIS ABNORMAL,2
SD,HYPERGLYCAEMIA,2
SD,HYPOTENSION,2
SD,INTENTIONAL PRODUCT MISUSE,2
SD,LOWER RESPIRATORY TRACT INFECTION,2
SD,MATERNAL EXPOSURE DURING PREGNANCY,2
SD,METASTASES TO LIVER,2
SD,NO THERAPEUTIC RESPONSE,2
SD,SPINA BIFIDA OCCULTA,2
SD,WHITE BLOOD CELL COUNT INCREASED,2
SD,ABDOMINAL DISTENSION,1
SD,ABORTION SPONTANEOUS,1
SD,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
SD,BLOOD DISORDER,1
SD,BLOOD UREA INCREASED,1
SD,BLOOD URIC ACID INCREASED,1
SD,BONE MARROW RETICULIN FIBROSIS,1
SD,BRAIN DEATH,1
SD,CAESAREAN SECTION,1
SD,CARDIAC DISORDER,1
SD,CEREBRAL INFARCTION,1
SD,CHAPPED LIPS,1
SD,CHEST PAIN,1
SD,CHOKING,1
SD,CLEFT LIP AND PALATE,1
SD,COLD SWEAT,1
SD,COUGH,1
SD,DISEASE COMPLICATION,1
SD,DIVERTICULUM INTESTINAL,1
SD,DUPUYTREN^S CONTRACTURE,1
SD,DYSPNOEA,1
SD,EOSINOPHILIA,1
SD,ERECTION INCREASED,1
SD,EXPOSURE DURING PREGNANCY,1
SD,FEBRILE CONVULSION,1
SD,FIBROSIS,1
SD,GASTROINTESTINAL TOXICITY,1
SD,GENERAL PHYSICAL HEALTH DETERIORATION,1
SD,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
SD,GYNAECOMASTIA,1
SD,HAEMATOTOXICITY,1
SD,HAEMORRHAGIC STROKE,1
SD,HEPATIC CYST,1
SD,HEPATIC FUNCTION ABNORMAL,1
SD,HEPATITIS VIRAL,1
SD,HEPATOMEGALY,1
SD,HEPATOTOXICITY,1
SD,HYDRONEPHROSIS,1
SD,HYPERHIDROSIS,1
SD,HYPERPLASIA,1
SD,INFECTION,1
SD,ISCHAEMIC STROKE,1
SD,LIP DRY,1
SD,MALAISE,1
SD,MALIGNANT PLEURAL EFFUSION,1
SD,MEGAKARYOCYTES ABNORMAL,1
SD,METASTASES TO ABDOMINAL CAVITY,1
SD,METASTASES TO PELVIS,1
SD,MONOPLEGIA,1
SD,MYELOFIBROSIS,1
SD,MYELOPROLIFERATIVE DISORDER,1
SD,NECK PAIN,1
SD,NORMAL NEWBORN,1
SD,ORGAN FAILURE,1
SD,PAIN IN EXTREMITY,1
SD,PALPITATIONS,1
SD,PANCYTOPENIA,1
SD,PELVIC MASS,1
SD,PEMPHIGOID,1
SD,PENILE HAEMORRHAGE,1
SD,PENILE SWELLING,1
SD,PERITONEAL DISORDER,1
SD,PETECHIAE,1
SD,PHILADELPHIA CHROMOSOME POSITIVE,1
SD,PLEURAL EFFUSION,1
SD,PNEUMONIA ASPIRATION,1
SD,PREMATURE BABY,1
SD,PREMATURE LABOUR,1
SD,PRESYNCOPE,1
SD,PRODUCT USE IN UNAPPROVED INDICATION,1
SD,PULMONARY EMBOLISM,1
SD,RECURRENT CANCER,1
SD,RENAL FAILURE ACUTE,1
SD,RENAL ISCHAEMIA,1
SD,RESPIRATORY DISTRESS,1
SD,RETINOPATHY,1
SD,SECOND PRIMARY MALIGNANCY,1
SD,SHOCK HYPOGLYCAEMIC,1
SD,SKIN DISCOLOURATION,1
SD,SKIN HYPERPIGMENTATION,1
SD,SPLENOMEGALY,1
SD,SYNOVIAL SARCOMA,1
SD,THERAPEUTIC RESPONSE DECREASED,1
SD,THERAPY NON-RESPONDER,1
SD,TREMOR,1
SD,TUBERCULOSIS,1
SD,UNEVALUABLE EVENT,1
SD,VASCULITIS,1
SD,VIRAL INFECTION,1
SD,VOMITING,1
SR,DEATH,3
SR,SEPSIS,3
SR,GASTROINTESTINAL STROMAL TUMOUR,2
SR,HEPATIC STEATOSIS,2
SR,MALIGNANT NEOPLASM PROGRESSION,2
SR,METABOLIC ACIDOSIS,2
SR,ABDOMINAL DISTENSION,1
SR,ANAEMIA,1
SR,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
SR,BONE MARROW FAILURE,1
SR,CARDIOMYOPATHY,1
SR,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
SR,CYSTITIS,1
SR,DISCOMFORT,1
SR,DISEASE COMPLICATION,1
SR,DRUG INEFFECTIVE,1
SR,FANCONI SYNDROME,1
SR,FANCONI SYNDROME ACQUIRED,1
SR,FATIGUE,1
SR,HEART RATE DECREASED,1
SR,LIVER FUNCTION TEST ABNORMAL,1
SR,METASTASES TO LIVER,1
SR,MULTI-ORGAN FAILURE,1
SR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
SR,PERIPHERAL VASCULAR DISORDER,1
SR,PERITONITIS,1
SR,PNEUMONIA,1
SR,PYREXIA,1
SR,SEPTIC SHOCK,1
SR,VOMITING,1
SZ,FOETAL EXPOSURE DURING PREGNANCY,3
SZ,ABORTION SPONTANEOUS,2
SZ,DEATH NEONATAL,2
SZ,PREGNANCY,2
SZ,PREMATURE BABY,2
SZ,DEPRESSED LEVEL OF CONSCIOUSNESS,1
SZ,ECTOPIC PREGNANCY UNDER HORMONAL CONTRACEPTION,1
SZ,EPILEPSY,1
SZ,FOOT DEFORMITY,1
SZ,GRAND MAL CONVULSION,1
SZ,HEPATIC NECROSIS,1
SZ,HIV INFECTION,1
SZ,HYPERTENSION,1
SZ,HYPONATRAEMIA,1
SZ,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
SZ,LACTIC ACIDOSIS,1
SZ,LIVER DISORDER,1
SZ,MALIGNANT NEOPLASM PROGRESSION,1
SZ,MYOCARDIAL ISCHAEMIA,1
SZ,OSTEOMYELITIS,1
SZ,PLEUROTHOTONUS,1
SZ,PREMATURE LABOUR,1
SZ,RASH,1
SZ,RASH MACULO-PAPULAR,1
SZ,RENAL FAILURE,1
SZ,RENAL FAILURE ACUTE,1
SZ,RESPIRATORY FAILURE,1
SZ,RETAINED PLACENTA OR MEMBRANES,1
SZ,RHABDOMYOLYSIS,1
SZ,SEPTIC SHOCK,1
SZ,STAPHYLOCOCCAL SEPSIS,1
SZ,SUICIDE ATTEMPT,1
SZ,UTERINE DILATION AND CURETTAGE,1
SE,TOXICITY TO VARIOUS AGENTS,1266
SE,FATIGUE,1014
SE,NAUSEA,812
SE,DIZZINESS,748
SE,DYSPNOEA,692
SE,HEADACHE,573
SE,PYREXIA,484
SE,VOMITING,452
SE,DIARRHOEA,451
SE,DRUG INEFFECTIVE,440
SE,ANXIETY,402
SE,ABDOMINAL PAIN,364
SE,CONFUSIONAL STATE,347
SE,PRURITUS,343
SE,ARTHRALGIA,324
SE,OVERDOSE,313
SE,RASH,313
SE,DEATH,311
SE,PAIN,305
SE,SUICIDE ATTEMPT,302
SE,PNEUMONIA,298
SE,SUICIDAL IDEATION,292
SE,MUSCLE SPASMS,286
SE,FOETAL EXPOSURE DURING PREGNANCY,269
SE,MALAISE,268
SE,SYNCOPE,263
SE,MYALGIA,262
SE,FALL,258
SE,PARAESTHESIA,258
SE,PALPITATIONS,252
SE,HYPOTENSION,249
SE,DEPRESSED LEVEL OF CONSCIOUSNESS,243
SE,DEPRESSION,228
SE,HYPOAESTHESIA,227
SE,TREMOR,226
SE,CHEST PAIN,218
SE,ASTHENIA,216
SE,HYPERSENSITIVITY,214
SE,PAIN IN EXTREMITY,212
SE,COUGH,211
SE,LOSS OF CONSCIOUSNESS,211
SE,HYPERHIDROSIS,208
SE,ACUTE KIDNEY INJURY,206
SE,MUSCULAR WEAKNESS,205
SE,WEIGHT DECREASED,204
SE,URTICARIA,195
SE,BACK PAIN,191
SE,HALLUCINATION,188
SE,INTENTIONAL SELF-INJURY,188
SE,PULMONARY EMBOLISM,187
SE,WEIGHT INCREASED,187
SE,ANAEMIA,185
SE,DECREASED APPETITE,182
SE,SOMNOLENCE,180
SE,ERYTHEMA,176
SE,GENERAL PHYSICAL HEALTH DETERIORATION,171
SE,ALOPECIA,170
SE,BLOOD CREATININE INCREASED,170
SE,CARDIAC FAILURE,170
SE,VISUAL IMPAIRMENT,168
SE,CHEST DISCOMFORT,167
SE,CEREBROVASCULAR ACCIDENT,166
SE,ATRIAL FIBRILLATION,165
SE,HYPERTENSION,163
SE,INFECTION,163
SE,TACHYCARDIA,163
SE,BALANCE DISORDER,159
SE,RENAL FAILURE,155
SE,VISION BLURRED,155
SE,AGGRESSION,153
SE,CHILLS,152
SE,SEPSIS,152
SE,GAIT DISTURBANCE,151
SE,C-REACTIVE PROTEIN INCREASED,150
SE,MYOCARDIAL INFARCTION,150
SE,INSOMNIA,147
SE,SLEEP DISORDER,145
SE,PHARYNGEAL OEDEMA,142
SE,DYSPHAGIA,138
SE,DRY MOUTH,137
SE,FEELING ABNORMAL,137
SE,CARDIAC ARREST,136
SE,HYPONATRAEMIA,136
SE,NIGHTMARE,134
SE,DEHYDRATION,132
SE,DEPRESSED MOOD,132
SE,CONDITION AGGRAVATED,131
SE,ABDOMINAL PAIN UPPER,130
SE,CONSTIPATION,129
SE,MUSCULOSKELETAL STIFFNESS,128
SE,MEMORY IMPAIRMENT,127
SE,INTENTIONAL OVERDOSE,122
SE,ALANINE AMINOTRANSFERASE INCREASED,121
SE,ANGIOEDEMA,121
SE,PERIPHERAL SWELLING,119
SE,NEUTROPENIA,117
SE,EXPOSURE DURING PREGNANCY,113
SE,PRODUCT USE ISSUE,113
SE,SEIZURE,113
SE,BRADYCARDIA,111
SE,DRUG ABUSE,111
SE,DYSARTHRIA,111
SE,TINNITUS,111
SE,ACCIDENTAL OVERDOSE,109
SE,PRODUCT SUBSTITUTION ISSUE,107
SE,CEREBRAL HAEMORRHAGE,106
SE,SWELLING FACE,105
SE,URINARY TRACT INFECTION,105
SE,ASPARTATE AMINOTRANSFERASE INCREASED,104
SE,COMPLETED SUICIDE,104
SE,HEART RATE INCREASED,104
SE,POISONING,104
SE,URINARY RETENTION,103
SE,ARRHYTHMIA,102
SE,OSTEONECROSIS OF JAW,102
SE,ABORTION SPONTANEOUS,100
SE,AMNESIA,100
SE,DEEP VEIN THROMBOSIS,97
SE,OSTEONECROSIS,96
SE,DIPLOPIA,95
SE,THROMBOCYTOPENIA,95
SE,OEDEMA PERIPHERAL,94
SE,BLOOD PRESSURE DECREASED,93
SE,BLOOD PRESSURE INCREASED,93
SE,CEREBRAL INFARCTION,92
SE,DISTURBANCE IN ATTENTION,92
SE,HAEMORRHAGE,92
SE,HEPATIC FAILURE,92
SE,RHABDOMYOLYSIS,92
SE,EPILEPSY,90
SE,MATERNAL EXPOSURE DURING PREGNANCY,90
SE,PSYCHOTIC DISORDER,88
SE,AGITATION,85
SE,GASTROINTESTINAL HAEMORRHAGE,85
SE,JOINT SWELLING,85
SE,AGRANULOCYTOSIS,83
SE,SKIN REACTION,83
SE,EPISTAXIS,82
SE,SPEECH DISORDER,81
SE,ANALGESIC DRUG LEVEL INCREASED,80
SE,TRANSAMINASES INCREASED,80
SE,DRUG DEPENDENCE,79
SE,LIP SWELLING,78
SE,POLYNEUROPATHY,78
SE,RENAL FAILURE ACUTE,78
SE,HAEMOGLOBIN DECREASED,76
SE,FEBRILE NEUTROPENIA,73
SE,RESPIRATORY FAILURE,73
SE,BLISTER,71
SE,COGNITIVE DISORDER,71
SE,HYPOKALAEMIA,71
SE,TRANSIENT ISCHAEMIC ATTACK,70
SE,SWELLING,69
SE,ERECTILE DYSFUNCTION,68
SE,MOOD SWINGS,68
SE,OROPHARYNGEAL PAIN,68
SE,CARDIAC DISORDER,67
SE,LEUKOPENIA,67
SE,SWOLLEN TONGUE,67
SE,MUSCLE TWITCHING,66
SE,OEDEMA,66
SE,PANIC ATTACK,66
SE,PRODUCT USE IN UNAPPROVED INDICATION,66
SE,PULMONARY OEDEMA,66
SE,DYSPHONIA,65
SE,FLUSHING,65
SE,MUSCULOSKELETAL PAIN,64
SE,PANCYTOPENIA,64
SE,HEPATIC ENZYME INCREASED,63
SE,ANAPHYLACTIC SHOCK,62
SE,DIABETES MELLITUS,62
SE,ELECTROCARDIOGRAM QT PROLONGED,62
SE,APHASIA,61
SE,PERSONALITY CHANGE,60
SE,RESTLESSNESS,60
SE,CONTUSION,59
SE,ASTHMA,58
SE,BREAST CANCER,58
SE,HYPERKALAEMIA,58
SE,LACTIC ACIDOSIS,58
SE,RENAL IMPAIRMENT,58
SE,DYSGEUSIA,57
SE,MIGRAINE,57
SE,BLOOD ALKALINE PHOSPHATASE INCREASED,56
SE,HEPATOTOXICITY,56
SE,PRODUCT QUALITY ISSUE,56
SE,HAEMATOMA,55
SE,ABDOMINAL DISCOMFORT,54
SE,HAEMATURIA,54
SE,INCORRECT DOSE ADMINISTERED,54
SE,INTERSTITIAL LUNG DISEASE,54
SE,RASH PRURITIC,54
SE,VISUAL ACUITY REDUCED,54
SE,BURNING SENSATION,53
SE,DYSPEPSIA,53
SE,DYSURIA,53
SE,HALLUCINATION_ VISUAL,53
SE,INTERNATIONAL NORMALISED RATIO INCREASED,53
SE,PANCREATITIS,53
SE,PSORIASIS,53
SE,THROAT IRRITATION,53
SE,CONVULSION,52
SE,INFLUENZA LIKE ILLNESS,52
SE,THROMBOSIS,52
SE,URINARY INCONTINENCE,52
SE,BLOOD BILIRUBIN INCREASED,51
SE,GASTROINTESTINAL DISORDER,51
SE,IRRITABILITY,51
SE,LETHARGY,51
SE,ANAPHYLACTIC REACTION,50
SE,NASOPHARYNGITIS,50
SE,ECZEMA,49
SE,FORMICATION,49
SE,INFUSION RELATED REACTION,49
SE,LIBIDO DECREASED,49
SE,TUBULOINTERSTITIAL NEPHRITIS,49
SE,BLINDNESS,48
SE,COLITIS,48
SE,VERTIGO,48
SE,ACNE,47
SE,BLOOD GLUCOSE INCREASED,47
SE,CIRCULATORY COLLAPSE,47
SE,DRUG EFFECT DECREASED,47
SE,JAUNDICE,47
SE,ABDOMINAL DISTENSION,46
SE,DISEASE PROGRESSION,46
SE,DYSKINESIA,46
SE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,46
SE,MENTAL DISORDER,46
SE,NEUROPATHY PERIPHERAL,46
SE,DISORIENTATION,45
SE,PARAESTHESIA ORAL,45
SE,ANGER,44
SE,ARTHROPATHY,44
SE,DISCOMFORT,44
SE,FEELING HOT,44
SE,GASTRIC DISORDER,44
SE,GASTRIC ULCER,44
SE,HEPATIC FUNCTION ABNORMAL,44
SE,LIVER FUNCTION TEST ABNORMAL,44
SE,LUNG DISORDER,44
SE,WITHDRAWAL SYNDROME,44
SE,DRUG WITHDRAWAL SYNDROME,43
SE,DRY EYE,43
SE,ERYSIPELAS,43
SE,INCORRECT ROUTE OF DRUG ADMINISTRATION,43
SE,INTENTIONAL PRODUCT MISUSE,43
SE,LIVER DISORDER,43
SE,PULMONARY FIBROSIS,43
SE,APATHY,42
SE,DEVICE DISLOCATION,42
SE,DRY SKIN,42
SE,NECK PAIN,42
SE,SKIN EXFOLIATION,42
SE,AKATHISIA,41
SE,FEMUR FRACTURE,41
SE,HEPATOCELLULAR CARCINOMA,41
SE,ALTERED STATE OF CONSCIOUSNESS,40
SE,CHROMATURIA,40
SE,COLD SWEAT,40
SE,HALLUCINATION_ AUDITORY,40
SE,NO ADVERSE EVENT,40
SE,PREMATURE BABY,40
SE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,40
SE,RESPIRATORY DISORDER,40
SE,ANOSMIA,39
SE,INCORRECT DRUG ADMINISTRATION DURATION,39
SE,MANIA,39
SE,PRURITUS GENERALISED,39
SE,SKIN ULCER,39
SE,ABSCESS,38
SE,CATARACT,38
SE,DIVERTICULITIS,38
SE,DRUG RESISTANCE,38
SE,FEELING COLD,38
SE,LOCAL SWELLING,38
SE,ORAL MUCOSAL BLISTERING,38
SE,PATHOLOGICAL FRACTURE,38
SE,STOMATITIS,38
SE,VASCULITIS,38
SE,HAEMATOCHEZIA,37
SE,ORTHOSTATIC HYPOTENSION,37
SE,PLATELET COUNT DECREASED,37
SE,PLEURAL EFFUSION,37
SE,COLITIS ULCERATIVE,36
SE,DELUSION,36
SE,FLATULENCE,36
SE,GASTRITIS,36
SE,HERPES ZOSTER,36
SE,HYPERCALCAEMIA,36
SE,KETOACIDOSIS,36
SE,LUNG INFILTRATION,36
SE,MALIGNANT NEOPLASM PROGRESSION,36
SE,SEDATION,36
SE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,36
SE,ALVEOLITIS,35
SE,CARDIAC FIBRILLATION,35
SE,EYE SWELLING,35
SE,HEART RATE DECREASED,35
SE,HEART RATE IRREGULAR,35
SE,HOT FLUSH,35
SE,HYPERGLYCAEMIA,35
SE,OXYGEN SATURATION DECREASED,35
SE,PHOTOSENSITIVITY REACTION,35
SE,BRAIN OEDEMA,34
SE,HEAD INJURY,34
SE,PHOTOPHOBIA,34
SE,PROSTATE CANCER,34
SE,PROTHROMBIN LEVEL INCREASED,34
SE,RESPIRATORY DISTRESS,34
SE,SENSORY DISTURBANCE,34
SE,ABNORMAL BEHAVIOUR,33
SE,AGEUSIA,33
SE,COORDINATION ABNORMAL,33
SE,DEREALISATION,33
SE,FLUID RETENTION,33
SE,HEPATIC CIRRHOSIS,33
SE,PNEUMONITIS,33
SE,PREMATURE DELIVERY,33
SE,RASH GENERALISED,33
SE,SOMNAMBULISM,33
SE,STEVENS-JOHNSON SYNDROME,33
SE,STRESS,33
SE,SURGERY,33
SE,VAGINAL HAEMORRHAGE,33
SE,EYE PAIN,32
SE,ISCHAEMIC STROKE,32
SE,MOUTH ULCERATION,32
SE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,32
SE,NASAL CONGESTION,32
SE,OSTEOPOROSIS,32
SE,PARANOIA,32
SE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,32
SE,SKIN DISORDER,32
SE,SUDDEN DEATH,32
SE,CHOLELITHIASIS,31
SE,CROHN^S DISEASE,31
SE,DRUG ERUPTION,31
SE,HYPOGLYCAEMIA,31
SE,INFLUENZA,31
SE,PALLOR,31
SE,POLLAKIURIA,31
SE,POST PROCEDURAL COMPLICATION,31
SE,VENTRICULAR TACHYCARDIA,31
SE,ANGINA PECTORIS,30
SE,DRUG LEVEL INCREASED,30
SE,HYPOACUSIS,30
SE,MALIGNANT MELANOMA,30
SE,MELAENA,30
SE,MOUTH SWELLING,30
SE,NERVOUS SYSTEM DISORDER,30
SE,PRESCRIBED OVERDOSE,30
SE,PSYCHOMOTOR HYPERACTIVITY,30
SE,ACUTE MYOCARDIAL INFARCTION,29
SE,EYE DISORDER,29
SE,MYOSITIS,29
SE,NEOPLASM MALIGNANT,29
SE,NEUROLEPTIC MALIGNANT SYNDROME,29
SE,PANIC DISORDER,29
SE,PERIPHERAL COLDNESS,29
SE,PRESYNCOPE,29
SE,RENAL DISORDER,29
SE,RESPIRATORY ARREST,29
SE,WOUND,29
SE,CHOLESTASIS,28
SE,DEAFNESS,28
SE,DRUG ADMINISTRATION ERROR,28
SE,MENTAL IMPAIRMENT,28
SE,NEUROLOGICAL SYMPTOM,28
SE,RECTAL HAEMORRHAGE,28
SE,TOXIC EPIDERMAL NECROLYSIS,28
SE,TOXIC SKIN ERUPTION,28
SE,ABNORMAL DREAMS,27
SE,ACIDOSIS,27
SE,DYSSTASIA,27
SE,GASTROENTERITIS,27
SE,HEMIPARESIS,27
SE,LARGE INTESTINE PERFORATION,27
SE,MULTI-ORGAN FAILURE,27
SE,RASH ERYTHEMATOUS,27
SE,SENSORY LOSS,27
SE,SYSTEMIC LUPUS ERYTHEMATOSUS,27
SE,UNRESPONSIVE TO STIMULI,27
SE,VENTRICULAR FIBRILLATION,27
SE,WHITE BLOOD CELL COUNT DECREASED,27
SE,ACCIDENT,26
SE,ARTHRITIS,26
SE,EATING DISORDER,26
SE,HEARING IMPAIRED,26
SE,HYPOAESTHESIA ORAL,26
SE,HYPOTHERMIA,26
SE,JOINT STIFFNESS,26
SE,MEDICATION ERROR,26
SE,OVARIAN DISORDER,26
SE,PETECHIAE,26
SE,RESPIRATORY TRACT INFECTION,26
SE,UNINTENDED PREGNANCY,26
SE,VISUAL FIELD DEFECT,26
SE,BLOOD GLUCOSE DECREASED,25
SE,CHOLECYSTITIS,25
SE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,25
SE,CONGENITAL ANOMALY,25
SE,DRUG DOSE OMISSION,25
SE,DRUG EFFECT INCOMPLETE,25
SE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,25
SE,HEAD DISCOMFORT,25
SE,METASTASES TO LIVER,25
SE,NEURALGIA,25
SE,PERIODONTITIS,25
SE,PYELONEPHRITIS,25
SE,RESTLESS LEGS SYNDROME,25
SE,RHINORRHOEA,25
SE,WHEEZING,25
SE,BONE MARROW FAILURE,24
SE,CARDIOMYOPATHY,24
SE,CYANOSIS,24
SE,DEMENTIA,24
SE,EOSINOPHILIA,24
SE,ERYTHEMA MULTIFORME,24
SE,FUNGAL INFECTION,24
SE,HYPOMAGNESAEMIA,24
SE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,24
SE,INCREASED APPETITE,24
SE,LUNG NEOPLASM MALIGNANT,24
SE,METABOLIC ACIDOSIS,24
SE,MULTIPLE SCLEROSIS,24
SE,MUSCLE ATROPHY,24
SE,NEPHROLITHIASIS,24
SE,PARKINSON^S DISEASE,24
SE,PLASMA CELL MYELOMA,24
SE,SUBDURAL HAEMATOMA,24
SE,ACUTE RESPIRATORY DISTRESS SYNDROME,23
SE,APNOEA,23
SE,BACTERIAL INFECTION,23
SE,BASAL CELL CARCINOMA,23
SE,BONE PAIN,23
SE,BRAIN INJURY,23
SE,COLON CANCER,23
SE,COMA,23
SE,EYELID OEDEMA,23
SE,GALACTORRHOEA,23
SE,LOSS OF LIBIDO,23
SE,MUSCLE TIGHTNESS,23
SE,OCULAR HYPERAEMIA,23
SE,SKIN DISCOLOURATION,23
SE,TREATMENT FAILURE,23
SE,ADVERSE EVENT,22
SE,AMENORRHOEA,22
SE,BLOOD URINE PRESENT,22
SE,CRYING,22
SE,EYE HAEMORRHAGE,22
SE,FAECES DISCOLOURED,22
SE,HEPATIC STEATOSIS,22
SE,HEPATITIS,22
SE,INFLAMMATION,22
SE,MIOSIS,22
SE,MUCOSAL INFLAMMATION,22
SE,MUSCLE RIGIDITY,22
SE,PREGNANCY,22
SE,RESPIRATORY DEPRESSION,22
SE,SEROTONIN SYNDROME,22
SE,TENDON RUPTURE,22
SE,TREATMENT NONCOMPLIANCE,22
SE,ATAXIA,21
SE,BLOOD LACTATE DEHYDROGENASE INCREASED,21
SE,DRUG HYPERSENSITIVITY,21
SE,EXTRASYSTOLES,21
SE,HAEMATEMESIS,21
SE,HYPERSOMNIA,21
SE,HYPERTHYROIDISM,21
SE,HYPOCALCAEMIA,21
SE,INFECTION SUSCEPTIBILITY INCREASED,21
SE,LIMB DISCOMFORT,21
SE,NIGHT SWEATS,21
SE,OESOPHAGITIS,21
SE,ORAL DISCOMFORT,21
SE,SUBARACHNOID HAEMORRHAGE,21
SE,SUBCUTANEOUS ABSCESS,21
SE,TIC,21
SE,VENTRICULAR EXTRASYSTOLES,21
SE,WHITE BLOOD CELL COUNT INCREASED,21
SE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,21
SE,ABORTION INDUCED,20
SE,ACUTE HEPATIC FAILURE,20
SE,ADVERSE DRUG REACTION,20
SE,BLOOD LACTIC ACID INCREASED,20
SE,BREAST PAIN,20
SE,DERMATITIS,20
SE,DEVICE FAILURE,20
SE,FACE OEDEMA,20
SE,INJECTION SITE PAIN,20
SE,INTENTIONAL PRODUCT USE ISSUE,20
SE,INTESTINAL PERFORATION,20
SE,MENORRHAGIA,20
SE,MOTOR DYSFUNCTION,20
SE,MYOCARDITIS,20
SE,NICOTINE DEPENDENCE,20
SE,PERONEAL NERVE PALSY,20
SE,PROCEDURAL PAIN,20
SE,RHEUMATOID ARTHRITIS,20
SE,SHOCK,20
SE,SKIN BURNING SENSATION,20
SE,STRESS CARDIOMYOPATHY,20
SE,BLOOD PROLACTIN INCREASED,19
SE,BODY TEMPERATURE INCREASED,19
SE,BRADYPHRENIA,19
SE,BRONCHITIS,19
SE,CARDIAC FAILURE CONGESTIVE,19
SE,DYSPNOEA EXERTIONAL,19
SE,DYSTONIA,19
SE,ENCEPHALOPATHY,19
SE,FEAR,19
SE,ILEUS,19
SE,ORAL PAIN,19
SE,PANCREATIC CARCINOMA,19
SE,PNEUMONIA ASPIRATION,19
SE,PRODUCTIVE COUGH,19
SE,SEPTIC SHOCK,19
SE,SINUSITIS,19
SE,STILLBIRTH,19
SE,TYPE 2 DIABETES MELLITUS,19
SE,UPPER RESPIRATORY TRACT INFECTION,19
SE,ABNORMAL FAECES,18
SE,ANURIA,18
SE,BREAST ENLARGEMENT,18
SE,BRONCHOSPASM,18
SE,DERMATITIS BULLOUS,18
SE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,18
SE,DRUG-INDUCED LIVER INJURY,18
SE,EMBOLISM,18
SE,EYE IRRITATION,18
SE,GASTRIC HAEMORRHAGE,18
SE,GASTRIC ULCER HAEMORRHAGE,18
SE,GASTROOESOPHAGEAL REFLUX DISEASE,18
SE,INJECTION SITE ERYTHEMA,18
SE,INTESTINAL HAEMORRHAGE,18
SE,INTRAOCULAR PRESSURE INCREASED,18
SE,MENINGITIS,18
SE,MUSCLE CONTRACTIONS INVOLUNTARY,18
SE,MYDRIASIS,18
SE,MYELODYSPLASTIC SYNDROME,18
SE,MYOGLOBIN BLOOD INCREASED,18
SE,NERVOUSNESS,18
SE,PARKINSONISM,18
SE,PERICARDIAL EFFUSION,18
SE,POOR QUALITY SLEEP,18
SE,PULMONARY CONGESTION,18
SE,ROAD TRAFFIC ACCIDENT,18
SE,SENSATION OF FOREIGN BODY,18
SE,UROSEPSIS,18
SE,VENOUS THROMBOSIS LIMB,18
SE,VIRAL INFECTION,18
SE,WRONG DRUG ADMINISTERED,18
SE,ASCITES,17
SE,AUTISM SPECTRUM DISORDER,17
SE,BLOOD CREATINE PHOSPHOKINASE INCREASED,17
SE,BREAST CANCER FEMALE,17
SE,CARDIOVASCULAR DISORDER,17
SE,CONGESTIVE CARDIOMYOPATHY,17
SE,GENITAL HAEMORRHAGE,17
SE,HYPOTHYROIDISM,17
SE,INJECTION SITE REACTION,17
SE,INJURY,17
SE,LYMPHOMA,17
SE,MOBILITY DECREASED,17
SE,MULTIPLE SCLEROSIS RELAPSE,17
SE,PAIN OF SKIN,17
SE,PERITONITIS,17
SE,PLEURISY,17
SE,PNEUMOCYSTIS JIROVECII PNEUMONIA,17
SE,POST PROCEDURAL HAEMORRHAGE,17
SE,SEXUAL DYSFUNCTION,17
SE,THROAT TIGHTNESS,17
SE,VIITH NERVE PARALYSIS,17
SE,VIRAL MUTATION IDENTIFIED,17
SE,AFFECT LABILITY,16
SE,ATYPICAL FEMUR FRACTURE,16
SE,CONJUNCTIVITIS,16
SE,DENTAL CARIES,16
SE,DISEASE RECURRENCE,16
SE,DRUG PRESCRIBING ERROR,16
SE,DRUG WITHDRAWAL SYNDROME NEONATAL,16
SE,DYSMENORRHOEA,16
SE,EAR INFECTION,16
SE,ELECTROLYTE IMBALANCE,16
SE,FACIAL PARESIS,16
SE,GENERALISED TONIC-CLONIC SEIZURE,16
SE,GLAUCOMA,16
SE,HODGKIN^S DISEASE,16
SE,HYPERACUSIS,16
SE,HYPERVOLAEMIA,16
SE,HYPOMANIA,16
SE,HYPOXIA,16
SE,INTENTIONAL DRUG MISUSE,16
SE,NEPHROTIC SYNDROME,16
SE,OBSTRUCTIVE AIRWAYS DISORDER,16
SE,OSTEOARTHRITIS,16
SE,PARALYSIS,16
SE,PETIT MAL EPILEPSY,16
SE,PSORIATIC ARTHROPATHY,16
SE,SKIN CANCER,16
SE,SKIN NECROSIS,16
SE,STAPHYLOCOCCAL SEPSIS,16
SE,TOOTH DISORDER,16
SE,VENTRICULAR SEPTAL DEFECT,16
SE,ACTIVITIES OF DAILY LIVING IMPAIRED,15
SE,BLOOD PRESSURE FLUCTUATION,15
SE,BREAST CANCER METASTATIC,15
SE,DERMATITIS ALLERGIC,15
SE,DIARRHOEA HAEMORRHAGIC,15
SE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,15
SE,DUODENAL ULCER,15
SE,GENERALISED OEDEMA,15
SE,GROIN PAIN,15
SE,HAEMOLYTIC ANAEMIA,15
SE,HOSPITALISATION,15
SE,HYPERKINESIA,15
SE,HYPOPHAGIA,15
SE,IMMUNE THROMBOCYTOPENIC PURPURA,15
SE,INCONTINENCE,15
SE,LISTLESS,15
SE,LIVER INJURY,15
SE,MOOD ALTERED,15
SE,MOVEMENT DISORDER,15
SE,PAPILLOEDEMA,15
SE,PELVIC PAIN,15
SE,POST-INJECTION DELIRIUM SEDATION SYNDROME,15
SE,PULMONARY ARTERIAL HYPERTENSION,15
SE,PUSTULAR PSORIASIS,15
SE,RETINAL DETACHMENT,15
SE,SALIVARY HYPERSECRETION,15
SE,SELF INJURIOUS BEHAVIOUR,15
SE,SINUS TACHYCARDIA,15
SE,TOOTHACHE,15
SE,TUBERCULOSIS,15
SE,ABDOMINAL ABSCESS,14
SE,ABDOMINAL PAIN LOWER,14
SE,ACUTE MYELOID LEUKAEMIA,14
SE,BLINDNESS TRANSIENT,14
SE,BLOOD CREATINE INCREASED,14
SE,CARDIOVERSION,14
SE,DELIRIUM,14
SE,DEVICE RELATED INFECTION,14
SE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,14
SE,EAR PAIN,14
SE,EXPOSURE DURING BREAST FEEDING,14
SE,GLOSSODYNIA,14
SE,HEPATITIS C,14
SE,HYPOTONIA,14
SE,INJECTION SITE SWELLING,14
SE,MICTURITION URGENCY,14
SE,MUSCULOSKELETAL DISCOMFORT,14
SE,MUSCULOSKELETAL DISORDER,14
SE,NEOPLASM,14
SE,NEUTROPENIC SEPSIS,14
SE,OBSESSIVE THOUGHTS,14
SE,PAIN IN JAW,14
SE,PANCREATITIS ACUTE,14
SE,PSYCHIATRIC SYMPTOM,14
SE,RIB FRACTURE,14
SE,SINUS NODE DYSFUNCTION,14
SE,SKIN FISSURES,14
SE,SKIN HAEMORRHAGE,14
SE,SQUAMOUS CELL CARCINOMA,14
SE,THERAPEUTIC RESPONSE DECREASED,14
SE,UNEVALUABLE EVENT,14
SE,URINE ODOUR ABNORMAL,14
SE,VAGINAL DISCHARGE,14
SE,ABASIA,13
SE,ADRENAL INSUFFICIENCY,13
SE,ALCOHOL POISONING,13
SE,AMYLASE INCREASED,13
SE,BLADDER CANCER,13
SE,BLEPHAROSPASM,13
SE,BLOOD TEST ABNORMAL,13
SE,COAGULOPATHY,13
SE,COLECTOMY,13
SE,DEPRESSIVE SYMPTOM,13
SE,DEVICE DIFFICULT TO USE,13
SE,DYSPAREUNIA,13
SE,GASTROENTERITIS VIRAL,13
SE,GYNAECOMASTIA,13
SE,HIP FRACTURE,13
SE,HYPERSENSITIVITY VASCULITIS,13
SE,HYPERTHERMIA,13
SE,INTRA-ABDOMINAL HAEMORRHAGE,13
SE,IRITIS,13
SE,IRON DEFICIENCY ANAEMIA,13
SE,LACRIMATION INCREASED,13
SE,LYMPHADENOPATHY,13
SE,METASTASES TO LUNG,13
SE,MUSCULOSKELETAL CHEST PAIN,13
SE,MYOCLONUS,13
SE,PANIC REACTION,13
SE,PERICARDITIS,13
SE,PREGNANCY WITH CONTRACEPTIVE DEVICE,13
SE,RASH MACULO-PAPULAR,13
SE,RENAL PAIN,13
SE,STAPHYLOCOCCAL INFECTION,13
SE,THERAPEUTIC RESPONSE UNEXPECTED,13
SE,THROMBOPHLEBITIS,13
SE,TONGUE OEDEMA,13
SE,TOOTH LOSS,13
SE,VENOUS THROMBOSIS,13
SE,WOUND INFECTION,13
SE,AMYOTROPHIC LATERAL SCLEROSIS,12
SE,ARTERIOSCLEROSIS,12
SE,ARTHRITIS BACTERIAL,12
SE,ATRIAL FLUTTER,12
SE,BRAIN NEOPLASM,12
SE,CONCUSSION,12
SE,CYTOMEGALOVIRUS INFECTION,12
SE,DEATH NEONATAL,12
SE,DEVICE DEPLOYMENT ISSUE,12
SE,DEVICE ISSUE,12
SE,DEVICE OCCLUSION,12
SE,DIABETIC KETOACIDOSIS,12
SE,DISSOCIATION,12
SE,DRUG USE DISORDER,12
SE,ELECTROCARDIOGRAM ABNORMAL,12
SE,EMOTIONAL DISTRESS,12
SE,ESCHERICHIA SEPSIS,12
SE,EXPOSED BONE IN JAW,12
SE,EYELID PTOSIS,12
SE,GASTROINTESTINAL MOTILITY DISORDER,12
SE,GOUT,12
SE,HAEMOLYSIS,12
SE,HAEMOPTYSIS,12
SE,HAEMORRHAGE INTRACRANIAL,12
SE,HISTIOCYTOSIS HAEMATOPHAGIC,12
SE,HUNGER,12
SE,IMMUNE SYSTEM DISORDER,12
SE,IMPAIRED HEALING,12
SE,INFERTILITY,12
SE,LARYNGOSPASM,12
SE,LEUKAEMIA RECURRENT,12
SE,LIMB INJURY,12
SE,MIGRAINE WITH AURA,12
SE,NAIL DISORDER,12
SE,NEUTROPHIL COUNT DECREASED,12
SE,ORAL PRURITUS,12
SE,OSTEITIS,12
SE,PARESIS,12
SE,PHOTOPSIA,12
SE,PIGMENTATION DISORDER,12
SE,RECTAL CANCER,12
SE,STOMA SITE INFECTION,12
SE,THIRST,12
SE,THYROIDITIS,12
SE,TORSADE DE POINTES,12
SE,TRANSFUSION,12
SE,ADENOCARCINOMA,11
SE,APLASTIC ANAEMIA,11
SE,APPENDICITIS,11
SE,ATRIOVENTRICULAR BLOCK,11
SE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,11
SE,AUTISM,11
SE,BLOOD GLUCOSE FLUCTUATION,11
SE,BLOOD POTASSIUM INCREASED,11
SE,COLITIS MICROSCOPIC,11
SE,EMOTIONAL DISORDER,11
SE,ENCEPHALITIS,11
SE,ENDOCARDITIS,11
SE,EYE PRURITUS,11
SE,FAECALOMA,11
SE,FRACTURE,11
SE,GENERALISED ERYTHEMA,11
SE,GINGIVAL BLEEDING,11
SE,GUILLAIN-BARRE SYNDROME,11
SE,HEPATIC CANCER,11
SE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,11
SE,LEFT VENTRICULAR DYSFUNCTION,11
SE,LEG AMPUTATION,11
SE,LIVER FUNCTION TEST INCREASED,11
SE,MENINGITIS ASEPTIC,11
SE,MUCOSAL DRYNESS,11
SE,OVARIAN CYST,11
SE,PNEUMOTHORAX,11
SE,PROTEINURIA,11
SE,PURPURA,11
SE,RED BLOOD CELL COUNT DECREASED,11
SE,RENAL TUBULAR NECROSIS,11
SE,SECRETION DISCHARGE,11
SE,SPINAL COLUMN STENOSIS,11
SE,STRESS FRACTURE,11
SE,SUICIDAL BEHAVIOUR,11
SE,TALIPES,11
SE,TONGUE DISCOLOURATION,11
SE,URINE OUTPUT DECREASED,11
SE,ADENOCARCINOMA OF COLON,10
SE,ALVEOLITIS ALLERGIC,10
SE,ATRIOVENTRICULAR BLOCK COMPLETE,10
SE,AUTOIMMUNE HEPATITIS,10
SE,CARDIOMEGALY,10
SE,CARPAL TUNNEL SYNDROME,10
SE,CELLULITIS,10
SE,DEPENDENCE,10
SE,DRUG INTOLERANCE,10
SE,EMBOLIC STROKE,10
SE,ENDOPHTHALMITIS,10
SE,EXFOLIATIVE RASH,10
SE,EXTRA DOSE ADMINISTERED,10
SE,FEELING OF BODY TEMPERATURE CHANGE,10
SE,FOETAL DEATH,10
SE,FREQUENT BOWEL MOVEMENTS,10
SE,GASTROINTESTINAL CARCINOMA,10
SE,GRAFT VERSUS HOST DISEASE,10
SE,HEPATITIS TOXIC,10
SE,HYDRONEPHROSIS,10
SE,HYPERAESTHESIA,10
SE,HYPOALBUMINAEMIA,10
SE,HYPOKINESIA,10
SE,INTELLECTUAL DISABILITY,10
SE,INTERVERTEBRAL DISC PROTRUSION,10
SE,LEUKOCYTOSIS,10
SE,MACULAR OEDEMA,10
SE,MENSTRUAL DISORDER,10
SE,MUSCLE DISORDER,10
SE,NECROSIS,10
SE,NEGATIVE THOUGHTS,10
SE,NYSTAGMUS,10
SE,OCULAR DISCOMFORT,10
SE,ONYCHOCLASIS,10
SE,PHARYNGITIS,10
SE,POLYMYALGIA RHEUMATICA,10
SE,POLYURIA,10
SE,PRE-ECLAMPSIA,10
SE,PREGNANCY WITH IMPLANT CONTRACEPTIVE,10
SE,PRESCRIBED UNDERDOSE,10
SE,PROSTATIC DISORDER,10
SE,PROSTATIC SPECIFIC ANTIGEN INCREASED,10
SE,PULMONARY OIL MICROEMBOLISM,10
SE,RASH MACULAR,10
SE,READING DISORDER,10
SE,RETINAL HAEMORRHAGE,10
SE,SCAR,10
SE,SERUM FERRITIN INCREASED,10
SE,SKIN IRRITATION,10
SE,SKIN LESION,10
SE,SLEEP APNOEA SYNDROME,10
SE,STATUS EPILEPTICUS,10
SE,STRABISMUS,10
SE,SUBDURAL HAEMORRHAGE,10
SE,TENDONITIS,10
SE,THROMBOCYTOSIS,10
SE,THROMBOTIC MICROANGIOPATHY,10
SE,THYROID DISORDER,10
SE,TUMOUR FLARE,10
SE,URINARY TRACT DISORDER,10
SE,ANAL INCONTINENCE,9
SE,BLOOD GLUCOSE ABNORMAL,9
SE,BREAST SWELLING,9
SE,CENTRAL NERVOUS SYSTEM INFLAMMATION,9
SE,CENTRAL NERVOUS SYSTEM LESION,9
SE,CHRONIC LYMPHOCYTIC LEUKAEMIA,9
SE,DEVICE MALFUNCTION,9
SE,DYSGRAPHIA,9
SE,EPSTEIN-BARR VIRUS INFECTION,9
SE,EXTRAPYRAMIDAL DISORDER,9
SE,GASTROINTESTINAL PERFORATION,9
SE,GASTROINTESTINAL TOXICITY,9
SE,GENERAL PHYSICAL CONDITION ABNORMAL,9
SE,GENITAL NEOPLASM MALIGNANT FEMALE,9
SE,GLOMERULAR FILTRATION RATE DECREASED,9
SE,HICCUPS,9
SE,HYPERTONIA,9
SE,HYPERVENTILATION,9
SE,IMMUNODEFICIENCY,9
SE,IMPAIRED GASTRIC EMPTYING,9
SE,INFLAMMATORY BOWEL DISEASE,9
SE,INJECTION SITE HAEMORRHAGE,9
SE,INJECTION SITE PRURITUS,9
SE,IRRITABLE BOWEL SYNDROME,9
SE,KERATITIS,9
SE,KLEBSIELLA INFECTION,9
SE,LARYNGEAL OEDEMA,9
SE,LEFT VENTRICULAR FAILURE,9
SE,LISTERIA SEPSIS,9
SE,MICTURITION DISORDER,9
SE,MOUTH HAEMORRHAGE,9
SE,MUCOUS MEMBRANE DISORDER,9
SE,MUSCLE RUPTURE,9
SE,MYOPATHY,9
SE,NEPHRITIS,9
SE,NEUROTOXICITY,9
SE,OLIGURIA,9
SE,OPHTHALMIC HERPES ZOSTER,9
SE,OPTIC ISCHAEMIC NEUROPATHY,9
SE,OPTIC NEURITIS,9
SE,OSTEOMYELITIS,9
SE,OVARIAN GERM CELL CANCER STAGE II,9
SE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,9
SE,PAROSMIA,9
SE,PEMPHIGOID,9
SE,PNEUMOCYSTIS JIROVECII INFECTION,9
SE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,9
SE,PRERENAL FAILURE,9
SE,PROCEDURAL HAEMORRHAGE,9
SE,PULSE ABNORMAL,9
SE,RASH PUSTULAR,9
SE,RENAL CANCER,9
SE,RHINITIS,9
SE,SCIATICA,9
SE,SPINAL FRACTURE,9
SE,STOMA SITE DISCHARGE,9
SE,SUPRAVENTRICULAR TACHYCARDIA,9
SE,TONGUE BLISTERING,9
SE,TOOTH INFECTION,9
SE,ABDOMINAL HERNIA,8
SE,ACCIDENTAL POISONING,8
SE,ACETABULUM FRACTURE,8
SE,ACTION TREMOR,8
SE,ASPHYXIA,8
SE,ASPIRATION,8
SE,BLOOD COUNT ABNORMAL,8
SE,BLOOD POTASSIUM DECREASED,8
SE,BLOOD SODIUM DECREASED,8
SE,BODY HEIGHT DECREASED,8
SE,BURSITIS,8
SE,CAESAREAN SECTION,8
SE,CARDIAC SEPTAL DEFECT,8
SE,CARDIAC TAMPONADE,8
SE,CATHETER PLACEMENT,8
SE,CLEFT PALATE,8
SE,CLUMSINESS,8
SE,COMPARTMENT SYNDROME,8
SE,CORONARY ARTERY STENOSIS,8
SE,DEAFNESS NEUROSENSORY,8
SE,DEAFNESS UNILATERAL,8
SE,DECREASED ACTIVITY,8
SE,DECREASED INTEREST,8
SE,DEMYELINATION,8
SE,DERMATITIS EXFOLIATIVE,8
SE,DERMATITIS PSORIASIFORM,8
SE,DRUG SPECIFIC ANTIBODY PRESENT,8
SE,DUODENITIS,8
SE,EAR DISORDER,8
SE,EJACULATION FAILURE,8
SE,ENDOCRINE DISORDER,8
SE,ERUCTATION,8
SE,FAECAL INCONTINENCE,8
SE,FEEDING DISORDER,8
SE,FEELING DRUNK,8
SE,FOETAL MALFORMATION,8
SE,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,8
SE,HAEMORRHAGE SUBCUTANEOUS,8
SE,HAEMORRHAGIC DIATHESIS,8
SE,HAEMORRHAGIC DISORDER,8
SE,HAEMORRHOIDS,8
SE,HEART DISEASE CONGENITAL,8
SE,HEPATOMEGALY,8
SE,HERPES VIRUS INFECTION,8
SE,IMPAIRED DRIVING ABILITY,8
SE,IMPAIRED WORK ABILITY,8
SE,IMPULSE-CONTROL DISORDER,8
SE,INDIFFERENCE,8
SE,INFARCTION,8
SE,INTRACRANIAL PRESSURE INCREASED,8
SE,JOINT INJURY,8
SE,LACTOSE INTOLERANCE,8
SE,LARGE INTESTINAL ULCER HAEMORRHAGE,8
SE,LIMB REDUCTION DEFECT,8
SE,LUNG CANCER METASTATIC,8
SE,LUNG INFECTION,8
SE,MACULOPATHY,8
SE,MASS,8
SE,METASTASES TO BONE,8
SE,METRORRHAGIA,8
SE,NASAL DRYNESS,8
SE,NERVE INJURY,8
SE,NOCTURIA,8
SE,NON-CARDIAC CHEST PAIN,8
SE,NORMAL NEWBORN,8
SE,OBESITY,8
SE,OEDEMA MOUTH,8
SE,ON AND OFF PHENOMENON,8
SE,ORAL FUNGAL INFECTION,8
SE,OROMANDIBULAR DYSTONIA,8
SE,OTITIS MEDIA,8
SE,PERIORBITAL OEDEMA,8
SE,PERIPHERAL SENSORY NEUROPATHY,8
SE,PORTAL VEIN THROMBOSIS,8
SE,POSTOPERATIVE WOUND INFECTION,8
SE,RAYNAUD^S PHENOMENON,8
SE,REYE^S SYNDROME,8
SE,RHEUMATIC DISORDER,8
SE,RIGHT VENTRICULAR FAILURE,8
SE,ROSACEA,8
SE,SINUS BRADYCARDIA,8
SE,SKIN INFECTION,8
SE,SPONDYLITIS,8
SE,SUBILEUS,8
SE,SUDDEN HEARING LOSS,8
SE,TARDIVE DYSKINESIA,8
SE,TEARFULNESS,8
SE,THINKING ABNORMAL,8
SE,TONSILLITIS,8
SE,TOOTH INJURY,8
CH,NAUSEA,523
CH,ACUTE KIDNEY INJURY,504
CH,PYREXIA,496
CH,EXPOSURE DURING PREGNANCY,495
CH,DYSPNOEA,492
CH,VOMITING,471
CH,DIARRHOEA,462
CH,DRUG INEFFECTIVE,462
CH,DEATH,453
CH,FATIGUE,435
CH,FALL,396
CH,ANAEMIA,363
CH,CONFUSIONAL STATE,362
CH,PNEUMONIA,334
CH,THROMBOCYTOPENIA,332
CH,FOETAL EXPOSURE DURING PREGNANCY,324
CH,TOXICITY TO VARIOUS AGENTS,323
CH,ASTHENIA,315
CH,SOMNOLENCE,310
CH,HYPOTENSION,307
CH,GENERAL PHYSICAL HEALTH DETERIORATION,300
CH,HEADACHE,298
CH,RENAL FAILURE,287
CH,TACHYCARDIA,279
CH,ELECTROCARDIOGRAM QT PROLONGED,260
CH,HYPONATRAEMIA,259
CH,DIZZINESS,258
CH,MATERNAL EXPOSURE DURING PREGNANCY,250
CH,SUICIDE ATTEMPT,245
CH,ABDOMINAL PAIN,244
CH,OVERDOSE,242
CH,PANCYTOPENIA,234
CH,RASH,230
CH,DISEASE PROGRESSION,225
CH,SYNCOPE,220
CH,HYPERTENSION,215
CH,PRURITUS,215
CH,GASTROINTESTINAL HAEMORRHAGE,213
CH,CARDIAC FAILURE,212
CH,PULMONARY EMBOLISM,201
CH,INTENTIONAL OVERDOSE,200
CH,HYPOKALAEMIA,198
CH,SEPSIS,197
CH,TREMOR,195
CH,MALIGNANT NEOPLASM PROGRESSION,194
CH,PREMATURE BABY,185
CH,WEIGHT DECREASED,183
CH,AGRANULOCYTOSIS,182
CH,BRADYCARDIA,182
CH,MALAISE,181
CH,NEUTROPENIA,180
CH,LEUKOPENIA,178
CH,RENAL FAILURE ACUTE,178
CH,DECREASED APPETITE,172
CH,CONDITION AGGRAVATED,168
CH,AGITATION,166
CH,MELAENA,163
CH,GAIT DISTURBANCE,161
CH,PAIN,160
CH,ARTHRALGIA,154
CH,RESPIRATORY FAILURE,152
CH,RHABDOMYOLYSIS,152
CH,ALTERED STATE OF CONSCIOUSNESS,149
CH,DEPRESSION,146
CH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,146
CH,DYSPHAGIA,144
CH,DELIRIUM,142
CH,HEPATOCELLULAR INJURY,142
CH,HYPERKALAEMIA,142
CH,HYPERSENSITIVITY,142
CH,EPILEPSY,140
CH,VERTIGO,137
CH,OSTEONECROSIS OF JAW,136
CH,REBOUND EFFECT,136
CH,DEHYDRATION,135
CH,C-REACTIVE PROTEIN INCREASED,133
CH,MYALGIA,133
CH,OEDEMA PERIPHERAL,133
CH,COUGH,132
CH,ACCIDENTAL OVERDOSE,131
CH,PRODUCT USE ISSUE,131
CH,ANXIETY,130
CH,CEREBRAL HAEMORRHAGE,130
CH,HEPATIC ENZYME INCREASED,127
CH,SEPTIC SHOCK,125
CH,ABORTION SPONTANEOUS,124
CH,CEREBROVASCULAR ACCIDENT,124
CH,ERYTHEMA,124
CH,FEBRILE NEUTROPENIA,124
CH,LOSS OF CONSCIOUSNESS,123
CH,PARAESTHESIA,123
CH,INFECTION,121
CH,HAEMORRHAGIC ANAEMIA,120
CH,PAIN IN EXTREMITY,117
CH,HAEMATOMA,116
CH,DISTURBANCE IN ATTENTION,115
CH,HYPERHIDROSIS,115
CH,COMA,114
CH,ATRIAL FIBRILLATION,113
CH,FOETAL GROWTH RESTRICTION,113
CH,RASH MACULO-PAPULAR,113
CH,WEIGHT INCREASED,113
CH,MUSCULAR WEAKNESS,112
CH,URTICARIA,112
CH,LACTIC ACIDOSIS,111
CH,METABOLIC ACIDOSIS,111
CH,URINARY TRACT INFECTION,111
CH,ABDOMINAL PAIN UPPER,110
CH,BONE DENSITY DECREASED,109
CH,CARDIAC ARREST,109
CH,MYOCARDIAL INFARCTION,109
CH,CHILLS,108
CH,TRANSAMINASES INCREASED,108
CH,JAUNDICE,106
CH,HAEMORRHAGE,104
CH,BLOOD CREATINE PHOSPHOKINASE INCREASED,102
CH,SPINAL FRACTURE,102
CH,DISORIENTATION,101
CH,CHEST PAIN,99
CH,COLITIS,99
CH,DRUG-INDUCED LIVER INJURY,99
CH,UPPER GASTROINTESTINAL HAEMORRHAGE,99
CH,INSOMNIA,97
CH,PLEURAL EFFUSION,97
CH,RENAL IMPAIRMENT,97
CH,ANGIOEDEMA,94
CH,ARRHYTHMIA,94
CH,HAEMOGLOBIN DECREASED,94
CH,BACK PAIN,93
CH,BLOOD CREATININE INCREASED,93
CH,HAEMATURIA,93
CH,ALANINE AMINOTRANSFERASE INCREASED,91
CH,HYPOGLYCAEMIA,91
CH,ACUTE MYOCARDIAL INFARCTION,88
CH,ENCEPHALOPATHY,88
CH,EOSINOPHILIA,86
CH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,85
CH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,85
CH,INTERNATIONAL NORMALISED RATIO INCREASED,84
CH,MEDICATION ERROR,84
CH,ANAPHYLACTIC REACTION,83
CH,DEEP VEIN THROMBOSIS,83
CH,AGGRESSION,82
CH,LIVER INJURY,81
CH,PALPITATIONS,81
CH,PNEUMONIA ASPIRATION,80
CH,VISUAL IMPAIRMENT,80
CH,HALLUCINATION,79
CH,MUSCLE SPASMS,79
CH,SEROTONIN SYNDROME,79
CH,SUICIDAL IDEATION,79
CH,ASPARTATE AMINOTRANSFERASE INCREASED,78
CH,NEONATAL RESPIRATORY DISTRESS SYNDROME,78
CH,DEPRESSED LEVEL OF CONSCIOUSNESS,77
CH,DYSKINESIA,77
CH,EPISTAXIS,77
CH,LIVER DISORDER,77
CH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,77
CH,PRODUCT USE IN UNAPPROVED INDICATION,76
CH,PRESYNCOPE,75
CH,TUBULOINTERSTITIAL NEPHRITIS,75
CH,ACUTE RESPIRATORY DISTRESS SYNDROME,74
CH,DRUG PRESCRIBING ERROR,74
CH,MUCOSAL INFLAMMATION,74
CH,CONSTIPATION,73
CH,DRUG ABUSE,73
CH,DYSARTHRIA,73
CH,EXTRAPYRAMIDAL DISORDER,73
CH,SEIZURE,72
CH,ABORTION INDUCED,71
CH,HEPATIC FAILURE,71
CH,DRUG LEVEL INCREASED,70
CH,LYMPHOPENIA,70
CH,RENAL FAILURE CHRONIC,70
CH,APHASIA,69
CH,DRUG ADMINISTRATION ERROR,69
CH,HYPOCALCAEMIA,68
CH,INFLAMMATION,68
CH,PANCREATITIS,68
CH,TORSADE DE POINTES,68
CH,COGNITIVE DISORDER,67
CH,HEPATITIS,67
CH,CHOLESTATIC LIVER INJURY,66
CH,GASTROINTESTINAL DISORDER,66
CH,INFLUENZA LIKE ILLNESS,66
CH,PNEUMONITIS,66
CH,POLYNEUROPATHY,66
CH,PSYCHOTIC DISORDER,66
CH,TYPE I HYPERSENSITIVITY,66
CH,BLOOD PRESSURE DECREASED,64
CH,ATAXIA,63
CH,HYPOAESTHESIA,63
CH,SPEECH DISORDER,62
CH,PRESCRIBED OVERDOSE,61
CH,ALOPECIA,60
CH,ANGINA PECTORIS,60
CH,CIRCULATORY COLLAPSE,60
CH,CHRONIC KIDNEY DISEASE,58
CH,DRY MOUTH,58
CH,MULTIPLE SCLEROSIS,58
CH,SLEEP DISORDER,58
CH,SUBDURAL HAEMATOMA,58
CH,HAEMATEMESIS,57
CH,HEMIPARESIS,57
CH,RESTLESS LEGS SYNDROME,57
CH,ASCITES,56
CH,GENERALISED TONIC-CLONIC SEIZURE,56
CH,HYPOMAGNESAEMIA,56
CH,MULTI-ORGAN FAILURE,56
CH,NEOPLASM PROGRESSION,56
CH,NORMOCHROMIC NORMOCYTIC ANAEMIA,56
CH,RESPIRATORY DISTRESS,56
CH,CARDIOGENIC SHOCK,55
CH,ISCHAEMIC STROKE,55
CH,OXYGEN SATURATION DECREASED,55
CH,BONE MARROW FAILURE,54
CH,MULTIPLE SCLEROSIS RELAPSE,54
CH,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,54
CH,CHOLESTASIS,53
CH,COMPLETED SUICIDE,53
CH,HALLUCINATION_ VISUAL,53
CH,LYMPHADENOPATHY,53
CH,POISONING,53
CH,PULMONARY OEDEMA,53
CH,DRUG INTOLERANCE,52
CH,INCORRECT DOSE ADMINISTERED,52
CH,OEDEMA,52
CH,PANCREATITIS ACUTE,52
CH,THROMBOSIS,52
CH,VENTRICULAR TACHYCARDIA,52
CH,BLOOD ALKALINE PHOSPHATASE INCREASED,51
CH,CARDIAC DISORDER,51
CH,CHEST DISCOMFORT,51
CH,LEUKOCYTOSIS,51
CH,STOMATITIS,51
CH,URINARY RETENTION,51
CH,DIABETES MELLITUS,50
CH,HEPATITIS C,50
CH,LUNG DISORDER,50
CH,NEUROLEPTIC MALIGNANT SYNDROME,50
CH,RESTLESSNESS,50
CH,VISION BLURRED,50
CH,APOPTOSIS,49
CH,FEELING HOT,49
CH,POTENTIATING DRUG INTERACTION,49
CH,RASH ERYTHEMATOUS,49
CH,SUBARACHNOID HAEMORRHAGE,49
CH,FEMUR FRACTURE,48
CH,DRUG WITHDRAWAL SYNDROME,47
CH,HYPOPHOSPHATAEMIA,47
CH,INTERSTITIAL LUNG DISEASE,47
CH,WITHDRAWAL SYNDROME,47
CH,ACUTE HEPATIC FAILURE,46
CH,ASTHMA,46
CH,BLOOD PRESSURE INCREASED,46
CH,HYPERBILIRUBINAEMIA,46
CH,HYPERGLYCAEMIA,46
CH,HYPOGLYCAEMIA NEONATAL,46
CH,MYOCLONUS,46
CH,ORTHOSTATIC HYPOTENSION,46
CH,DEVICE DISLOCATION,45
CH,FLUSHING,45
CH,GASTRIC ULCER,45
CH,HAEMATOCHEZIA,45
CH,HEPATITIS CHOLESTATIC,45
CH,INFLUENZA,45
CH,OSTEONECROSIS,45
CH,PLATELET COUNT DECREASED,45
CH,RASH GENERALISED,45
CH,SHOCK HAEMORRHAGIC,45
CH,HYPOTHYROIDISM,44
CH,HYPOXIA,44
CH,LUNG INFECTION,44
CH,METASTASES TO LIVER,44
CH,MUSCLE RIGIDITY,44
CH,DIVERTICULITIS,43
CH,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,43
CH,SHOCK,43
CH,DIABETIC KETOACIDOSIS,42
CH,STATUS EPILEPTICUS,42
CH,TACHYPNOEA,42
CH,DYSGEUSIA,41
CH,ECZEMA,41
CH,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,41
CH,PREGNANCY,41
CH,THORACIC VERTEBRAL FRACTURE,41
CH,VISUAL ACUITY REDUCED,41
CH,BREAST CANCER,40
CH,CONVULSION,40
CH,LUMBAR VERTEBRAL FRACTURE,40
CH,MIXED LIVER INJURY,40
CH,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,40
CH,WHITE BLOOD CELL COUNT DECREASED,40
CH,ABDOMINAL DISCOMFORT,39
CH,DRUG HYPERSENSITIVITY,39
CH,ATRIOVENTRICULAR BLOCK FIRST DEGREE,38
CH,BALANCE DISORDER,38
CH,BEZOAR,38
CH,DYSPNOEA EXERTIONAL,38
CH,HAEMOLYTIC ANAEMIA,38
CH,UROSEPSIS,38
CH,VENTRICULAR FIBRILLATION,38
CH,INJECTION SITE PAIN,37
CH,INTENTIONAL PRODUCT MISUSE,37
CH,MEMORY IMPAIRMENT,37
CH,METASTASES TO BONE,37
CH,MUSCULOSKELETAL PAIN,37
CH,TOXIC EPIDERMAL NECROLYSIS,37
CH,TRANSIENT ISCHAEMIC ATTACK,37
CH,ABNORMAL BEHAVIOUR,36
CH,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,36
CH,CAESAREAN SECTION,36
CH,HEPATIC CIRRHOSIS,36
CH,HYPERTHYROIDISM,36
CH,PROTEINURIA,36
CH,TINNITUS,36
CH,BACTERIAL INFECTION,35
CH,CEREBRAL INFARCTION,35
CH,INCORRECT ROUTE OF DRUG ADMINISTRATION,35
CH,NEUTROPHIL COUNT DECREASED,35
CH,PREMATURE DELIVERY,35
CH,ACUTE MYELOID LEUKAEMIA,34
CH,BLOOD BILIRUBIN INCREASED,34
CH,BLOOD LACTATE DEHYDROGENASE INCREASED,34
CH,HAEMOLYSIS,34
CH,HEPATOCELLULAR CARCINOMA,34
CH,HYPERREFLEXIA,34
CH,IMPAIRED HEALING,34
CH,LIVER FUNCTION TEST ABNORMAL,34
CH,MENTAL DISORDER,34
CH,MUSCLE HAEMORRHAGE,34
CH,NERVOUS SYSTEM DISORDER,34
CH,PNEUMOCYSTIS JIROVECII PNEUMONIA,34
CH,PRURITUS GENERALISED,34
CH,PSORIASIS,34
CH,RENAL TUBULAR DISORDER,34
CH,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,33
CH,BRAIN OEDEMA,33
CH,BRONCHOPULMONARY ASPERGILLOSIS,33
CH,CONJUNCTIVITIS,33
CH,DRUG ERUPTION,33
CH,GASTRITIS,33
CH,HAEMOPTYSIS,33
CH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,33
CH,LUNG INFILTRATION,33
CH,AMNESIA,32
CH,CARDIOMYOPATHY,32
CH,COAGULOPATHY,32
CH,DISSEMINATED INTRAVASCULAR COAGULATION,32
CH,DYSPEPSIA,32
CH,HEAD INJURY,32
CH,LIVE BIRTH,32
CH,MANIA,32
CH,MATERNAL DRUGS AFFECTING FOETUS,32
CH,MENTAL STATUS CHANGES POSTOPERATIVE,32
CH,PERICARDIAL EFFUSION,32
CH,PETECHIAE,32
CH,PSYCHOMOTOR HYPERACTIVITY,32
CH,ANURIA,31
CH,CONTRAINDICATED PRODUCT ADMINISTERED,31
CH,DEVICE RELATED INFECTION,31
CH,FOETAL DEATH,31
CH,INJECTION SITE ERYTHEMA,31
CH,NECK PAIN,31
CH,SKIN EXFOLIATION,31
CH,BONE PAIN,30
CH,CENTRAL NERVOUS SYSTEM LESION,30
CH,CEREBRAL ISCHAEMIA,30
CH,CLOSTRIDIUM DIFFICILE COLITIS,30
CH,DRUG RESISTANCE,30
CH,DUODENAL ULCER,30
CH,HAEMORRHAGE INTRACRANIAL,30
CH,ILEUS,30
CH,LIPASE INCREASED,30
CH,LOW BIRTH WEIGHT BABY,30
CH,MUSCULOSKELETAL STIFFNESS,30
CH,PANCREATIC CARCINOMA,30
CH,PATHOLOGICAL FRACTURE,30
CH,ASPIRATION,29
CH,CHOLELITHIASIS,29
CH,ELECTROCARDIOGRAM ABNORMAL,29
CH,FEELING ABNORMAL,29
CH,HEMIPLEGIA,29
CH,HYPERSENSITIVITY VASCULITIS,29
CH,LOWER GASTROINTESTINAL HAEMORRHAGE,29
CH,LYMPHOCYTE COUNT DECREASED,29
CH,MYDRIASIS,29
CH,PERIPHERAL SWELLING,29
CH,SENSORY DISTURBANCE,29
CH,STEVENS-JOHNSON SYNDROME,29
CH,SUPRAVENTRICULAR TACHYCARDIA,29
CH,ANAPHYLACTIC SHOCK,28
CH,ATRIOVENTRICULAR BLOCK SECOND DEGREE,28
CH,AUTOIMMUNE HEPATITIS,28
CH,BASAL CELL CARCINOMA,28
CH,BLINDNESS,28
CH,CEREBELLAR SYNDROME,28
CH,FACE OEDEMA,28
CH,INFUSION RELATED REACTION,28
CH,OSTEOMYELITIS,28
CH,OSTEOPOROSIS,28
CH,RASH MACULAR,28
CH,RENAL TUBULAR NECROSIS,28
CH,SWOLLEN TONGUE,28
CH,TREATMENT FAILURE,28
CH,ABSCESS,27
CH,CARDIOVASCULAR DISORDER,27
CH,DIPLOPIA,27
CH,DRUG WITHDRAWAL SYNDROME NEONATAL,27
CH,GLOMERULAR FILTRATION RATE DECREASED,27
CH,HAEMATOTOXICITY,27
CH,HAEMODYNAMIC INSTABILITY,27
CH,HEART RATE INCREASED,27
CH,HEPATIC STEATOSIS,27
CH,HEPATOMEGALY,27
CH,HYPERTENSIVE CRISIS,27
CH,HYPOTONIA,27
CH,METASTASES TO LUNG,27
CH,MYOPATHY,27
CH,NIGHT SWEATS,27
CH,NYSTAGMUS,27
CH,PAROTITIS,27
CH,PLASMA CELL MYELOMA,27
CH,SKIN LESION,27
CH,SYSTEMIC LUPUS ERYTHEMATOSUS,27
CH,URINARY INCONTINENCE,27
CH,BICYTOPENIA,26
CH,CONTUSION,26
CH,CORONARY ARTERY DISEASE,26
CH,DERMATITIS BULLOUS,26
CH,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,26
CH,DYSPHONIA,26
CH,HERPES ZOSTER,26
CH,INJECTION SITE REACTION,26
CH,MIOSIS,26
CH,MYELODYSPLASTIC SYNDROME,26
CH,NEPHROLITHIASIS,26
CH,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,26
CH,PROSTATE CANCER,26
CH,SKIN TOXICITY,26
CH,ATRIAL SEPTAL DEFECT,25
CH,ATRIOVENTRICULAR BLOCK COMPLETE,25
CH,BRONCHITIS,25
CH,BRONCHOSPASM,25
CH,CRANIOCEREBRAL INJURY,25
CH,DRY SKIN,25
CH,EJECTION FRACTION DECREASED,25
CH,ELECTROLYTE IMBALANCE,25
CH,GASTROOESOPHAGEAL REFLUX DISEASE,25
CH,HALLUCINATION_ AUDITORY,25
CH,HYPERTHERMIA,25
CH,HYPERTONIA,25
CH,METASTASES TO LYMPH NODES,25
CH,MOBILITY DECREASED,25
CH,NEUROPATHY PERIPHERAL,25
CH,NEUROTOXICITY,25
CH,PHOTOSENSITIVITY REACTION,25
CH,PSYCHOMOTOR RETARDATION,25
CH,PURPURA,25
CH,RESPIRATORY ARREST,25
CH,RESPIRATORY DISORDER,25
CH,STAPHYLOCOCCAL INFECTION,25
CH,VENTRICULAR EXTRASYSTOLES,25
CH,ACUTE RESPIRATORY FAILURE,24
CH,BLISTER,24
CH,BLOOD GLUCOSE INCREASED,24
CH,CARDIAC FAILURE ACUTE,24
CH,CHOLECYSTITIS,24
CH,CYTOMEGALOVIRUS INFECTION,24
CH,DIFFUSE LARGE B-CELL LYMPHOMA,24
CH,DRUG DEPENDENCE,24
CH,DRUG EFFECT INCOMPLETE,24
CH,DRUG LEVEL DECREASED,24
CH,EYELID OEDEMA,24
CH,GASTROENTERITIS,24
CH,HYPOALBUMINAEMIA,24
CH,ILEUS PARALYTIC,24
CH,INTENTIONAL PRODUCT USE ISSUE,24
CH,LIP SWELLING,24
CH,RASH PRURITIC,24
CH,ROAD TRAFFIC ACCIDENT,24
CH,SINUS BRADYCARDIA,24
CH,SINUSITIS,24
CH,ACIDOSIS HYPERCHLORAEMIC,23
CH,COMA SCALE ABNORMAL,23
CH,DEPRESSED MOOD,23
CH,DERMATITIS EXFOLIATIVE,23
CH,DISEASE RECURRENCE,23
CH,ERYSIPELAS,23
CH,FAECALOMA,23
CH,HYPERCALCAEMIA,23
CH,MALNUTRITION,23
CH,METASTASES TO CENTRAL NERVOUS SYSTEM,23
CH,MUSCLE CONTRACTIONS INVOLUNTARY,23
CH,NERVOUSNESS,23
CH,NIGHTMARE,23
CH,POST PROCEDURAL HAEMORRHAGE,23
CH,PRE-ECLAMPSIA,23
CH,RESPIRATORY TRACT INFECTION,23
CH,SEDATION,23
CH,SKIN REACTION,23
CH,SKIN TEST POSITIVE,23
CH,SKIN ULCER,23
CH,SUDDEN DEATH,23
CH,SWELLING,23
CH,SWELLING FACE,23
CH,ABDOMINAL PAIN LOWER,22
CH,ADVERSE EVENT,22
CH,APATHY,22
CH,BODY TEMPERATURE INCREASED,22
CH,CARDIAC FAILURE CONGESTIVE,22
CH,CELLULITIS,22
CH,CUSHING^S SYNDROME,22
CH,CYSTITIS,22
CH,DYSMORPHISM,22
CH,DYSTONIA,22
CH,EMBOLISM,22
CH,HEPATOTOXICITY,22
CH,HYPOTHERMIA,22
CH,HYPOVOLAEMIA,22
CH,JOINT SWELLING,22
CH,ODYNOPHAGIA,22
CH,PARKINSONISM,22
CH,PRODUCTIVE COUGH,22
CH,PULMONARY HYPERTENSION,22
CH,SKIN NECROSIS,22
CH,SLEEP APNOEA SYNDROME,22
CH,STRESS CARDIOMYOPATHY,22
CH,UVEITIS,22
CH,AKATHISIA,21
CH,APNOEA,21
CH,CANDIDA INFECTION,21
CH,CROHN^S DISEASE,21
CH,FEMORAL NECK FRACTURE,21
CH,GRAND MAL CONVULSION,21
CH,HAEMORRHAGIC STROKE,21
CH,IRRITABILITY,21
CH,MALIGNANT MELANOMA,21
CH,MENTAL IMPAIRMENT,21
CH,MENTAL STATUS CHANGES,21
CH,METABOLIC ALKALOSIS,21
CH,NASOPHARYNGITIS,21
CH,PALLOR,21
CH,RECTAL HAEMORRHAGE,21
CH,RIGHT VENTRICULAR FAILURE,21
CH,SOFT TISSUE INFECTION,21
CH,SUDDEN CARDIAC DEATH,21
CH,SURGERY,21
CH,VARICELLA ZOSTER VIRUS INFECTION,21
CH,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,21
CH,BRONCHOPNEUMONIA,20
CH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,20
CH,CONGESTIVE CARDIOMYOPATHY,20
CH,DERMATITIS,20
CH,DEVICE ISSUE,20
CH,DRUG DOSE OMISSION,20
CH,DYSAESTHESIA,20
CH,ENCEPHALITIS,20
CH,EXPOSURE DURING BREAST FEEDING,20
CH,GESTATIONAL DIABETES,20
CH,HYPERBILIRUBINAEMIA NEONATAL,20
CH,HYPOCHROMIC ANAEMIA,20
CH,NEUTROPENIC COLITIS,20
CH,NORMAL NEWBORN,20
CH,PRESCRIBED UNDERDOSE,20
CH,SINUS TACHYCARDIA,20
CH,SPLENOMEGALY,20
CH,THERAPEUTIC RESPONSE DECREASED,20
CH,VASCULITIS,20
CH,VIRAL MUTATION IDENTIFIED,20
CH,ABORTION,19
CH,ACIDOSIS,19
CH,ATRIOVENTRICULAR BLOCK,19
CH,CARDIO-RESPIRATORY ARREST,19
CH,CATARACT,19
CH,COLITIS ULCERATIVE,19
CH,FACIAL PARESIS,19
CH,GENERALISED OEDEMA,19
CH,HYPERCHOLESTEROLAEMIA,19
CH,HYPOACUSIS,19
CH,INJECTION SITE NECROSIS,19
CH,KETOACIDOSIS,19
CH,MIGRAINE,19
CH,MOUTH ULCERATION,19
CH,OROPHARYNGEAL PAIN,19
CH,PANIC ATTACK,19
CH,PARALYSIS,19
CH,PERICARDIAL HAEMORRHAGE,19
CH,PROSTATIC SPECIFIC ANTIGEN INCREASED,19
CH,RHEUMATOID ARTHRITIS,19
CH,SALIVARY HYPERSECRETION,19
CH,STAPHYLOCOCCAL SEPSIS,19
CH,THERAPEUTIC RESPONSE INCREASED,19
CH,TOXIC ENCEPHALOPATHY,19
CH,AMYLASE INCREASED,18
CH,APOPTOTIC COLONOPATHY,18
CH,ARTHRITIS,18
CH,ATRIAL FLUTTER,18
CH,BONE MARROW TOXICITY,18
CH,BREAST CANCER METASTATIC,18
CH,BURNING SENSATION,18
CH,CARDIOACTIVE DRUG LEVEL INCREASED,18
CH,DEMENTIA,18
CH,DEVICE OCCLUSION,18
CH,DYSURIA,18
CH,HYPERNATRAEMIA,18
CH,HYPOVOLAEMIC SHOCK,18
CH,INJECTION SITE INDURATION,18
CH,INTRACRANIAL PRESSURE INCREASED,18
CH,JAUNDICE CHOLESTATIC,18
CH,KIDNEY FIBROSIS,18
CH,OBESITY,18
CH,OPTIC NEURITIS,18
CH,PHOTOPHOBIA,18
CH,PRODUCT QUALITY ISSUE,18
CH,RESPIRATORY ACIDOSIS,18
CH,RESPIRATORY DEPRESSION,18
CH,TENDON RUPTURE,18
CH,THROMBOTIC MICROANGIOPATHY,18
CH,VENOUS THROMBOSIS,18
CH,WHITE BLOOD CELL COUNT INCREASED,18
CH,ACUTE PSYCHOSIS,17
CH,ADRENAL INSUFFICIENCY,17
CH,CARDIAC TAMPONADE,17
CH,CONGENITAL ANOMALY,17
CH,DERMATITIS ALLERGIC,17
CH,DIARRHOEA HAEMORRHAGIC,17
CH,DISCOMFORT,17
CH,DRUG EFFECT DECREASED,17
CH,ENTERITIS,17
CH,FUNCTIONAL GASTROINTESTINAL DISORDER,17
CH,HAEMARTHROSIS,17
CH,HOSPITALISATION,17
CH,HYPERAMMONAEMIA,17
CH,INHIBITORY DRUG INTERACTION,17
CH,LEFT VENTRICULAR DYSFUNCTION,17
CH,LONG QT SYNDROME,17
CH,LUPUS-LIKE SYNDROME,17
CH,MUSCLE TWITCHING,17
CH,ORAL HERPES,17
CH,OSTEOARTHRITIS,17
CH,OSTEOPENIA,17
CH,PARTIAL SEIZURES,17
CH,PERITONITIS,17
CH,PNEUMATOSIS INTESTINALIS,17
CH,PYELONEPHRITIS,17
CH,RASH PUSTULAR,17
CH,SECOND PRIMARY MALIGNANCY,17
CH,SMALL FOR DATES BABY,17
CH,TREATMENT NONCOMPLIANCE,17
CH,UNINTENDED PREGNANCY,17
CH,AUTOIMMUNE HAEMOLYTIC ANAEMIA,16
CH,CHROMATURIA,16
CH,COLITIS ISCHAEMIC,16
CH,DEAFNESS,16
CH,DELUSION,16
CH,HAEMOLYTIC URAEMIC SYNDROME,16
CH,HEAT STROKE,16
CH,HISTIOCYTOSIS HAEMATOPHAGIC,16
CH,HYPERVENTILATION,16
CH,HYPOPHYSITIS,16
CH,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,16
CH,LARGE INTESTINE PERFORATION,16
CH,LYMPHOCYTOSIS,16
CH,MYOCARDITIS,16
CH,NEOPLASM MALIGNANT,16
CH,OESOPHAGITIS,16
CH,PAPILLOEDEMA,16
CH,PARESIS,16
CH,PATENT DUCTUS ARTERIOSUS,16
CH,POLYURIA,16
CH,PULMONARY ALVEOLAR HAEMORRHAGE,16
CH,RHINITIS,16
CH,SPINAL PAIN,16
CH,TOXIC SKIN ERUPTION,16
CH,UNDERDOSE,16
CH,UNEVALUABLE EVENT,16
CH,AKINESIA,15
CH,ATELECTASIS,15
CH,BASAL GANGLIA HAEMORRHAGE,15
CH,BREAST PAIN,15
CH,COMPARTMENT SYNDROME,15
CH,EATING DISORDER,15
CH,EOSINOPHILIC PNEUMONIA,15
CH,EPSTEIN-BARR VIRUS INFECTION,15
CH,EXTRASYSTOLES,15
CH,EYE DISORDER,15
CH,FREEZING PHENOMENON,15
CH,GOUT,15
CH,HEPATIC FUNCTION ABNORMAL,15
CH,HEPATIC NECROSIS,15
CH,HYDROCEPHALUS,15
CH,HYPERAMMONAEMIC ENCEPHALOPATHY,15
CH,HYPOREFLEXIA,15
CH,IRON DEFICIENCY ANAEMIA,15
CH,LYMPHOMA,15
CH,NEONATAL BEHAVIOURAL SYNDROME,15
CH,PREMATURE RUPTURE OF MEMBRANES,15
CH,RIB FRACTURE,15
CH,TRAUMATIC HAEMATOMA,15
CH,UPPER RESPIRATORY TRACT INFECTION,15
CH,VAGINAL HAEMORRHAGE,15
CH,ABASIA,14
CH,ABDOMINAL DISTENSION,14
CH,ACCIDENT,14
CH,ACCIDENTAL EXPOSURE TO PRODUCT,14
CH,ACUTE GRAFT VERSUS HOST DISEASE,14
CH,APLASTIC ANAEMIA,14
CH,APPENDICITIS,14
CH,BACTERAEMIA,14
CH,BLADDER TAMPONADE,14
CH,BLOOD POTASSIUM INCREASED,14
CH,BRADYPNOEA,14
CH,CARDIAC DEATH,14
CH,CLONUS,14
CH,COMPLICATIONS OF TRANSPLANTED LIVER,14
CH,EOSINOPHILIC MYOCARDITIS,14
CH,EXPOSURE VIA FATHER,14
CH,GLOMERULONEPHRITIS,14
CH,GYNAECOMASTIA,14
CH,HYPERPROLACTINAEMIA,14
CH,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,14
CH,INFLAMMATORY MARKER INCREASED,14
CH,INJECTION SITE ATROPHY,14
CH,OLIGURIA,14
CH,ORGANISING PNEUMONIA,14
CH,PANNICULITIS,14
CH,PARKINSON^S DISEASE,14
CH,PEMPHIGOID,14
CH,PERIPHERAL SENSORY NEUROPATHY,14
CH,PERITONITIS BACTERIAL,14
CH,PERSECUTORY DELUSION,14
CH,PNEUMOTHORAX,14
CH,POLYDIPSIA,14
CH,PREMATURE LABOUR,14
CH,PULMONARY ARTERIAL HYPERTENSION,14
CH,SCHIZOPHRENIA,14
CH,SKIN BURNING SENSATION,14
CH,SPONTANEOUS HAEMATOMA,14
CH,STRESS,14
CH,TOOTH LOSS,14
CH,VIRAL INFECTION,14
CH,VITAMIN D DEFICIENCY,14
CH,ACUTE PRERENAL FAILURE,13
CH,AFFECT LABILITY,13
CH,ALVEOLITIS,13
CH,ANAPHYLACTOID REACTION,13
CH,ARTERIOSCLEROSIS,13
CH,ATYPICAL FEMUR FRACTURE,13
CH,BLADDER CANCER,13
CH,COGWHEEL RIGIDITY,13
CH,CYANOSIS,13
CH,ELECTROENCEPHALOGRAM ABNORMAL,13
CH,EYE MOVEMENT DISORDER,13
CH,EYE PAIN,13
CH,FEAR,13
CH,FOOT FRACTURE,13
CH,GENOTYPE DRUG RESISTANCE TEST POSITIVE,13
CH,HEAD DISCOMFORT,13
CH,HEPATITIS FULMINANT,13
CH,HYPOTONIA NEONATAL,13
CH,INGUINAL HERNIA,13
CH,INTESTINAL PERFORATION,13
CH,INTRAVENTRICULAR HAEMORRHAGE,13
CH,MENINGITIS ASEPTIC,13
CH,MUSCLE SPASTICITY,13
CH,MUTISM,13
CH,NEPHROTIC SYNDROME,13
CH,NEUTROPENIC SEPSIS,13
CH,NOCTURIA,13
CH,PARANOIA,13
CH,PERICARDITIS,13
CH,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,13
CH,PSYCHIATRIC DECOMPENSATION,13
CH,PULMONARY FIBROSIS,13
CH,RHINOVIRUS INFECTION,13
CH,SKIN INFECTION,13
CH,SQUAMOUS CELL CARCINOMA,13
CH,TYPE IV HYPERSENSITIVITY REACTION,13
CH,VIITH NERVE PARALYSIS,13
CH,WOUND,13
CH,ACUTE CORONARY SYNDROME,12
CH,AGEUSIA,12
CH,ANAEMIA NEONATAL,12
CH,ANAL HAEMORRHAGE,12
CH,ANTIPSYCHOTIC DRUG LEVEL INCREASED,12
CH,ARTHROPATHY,12
CH,BLOOD SODIUM DECREASED,12
CH,BONE DISORDER,12
CH,BUNDLE BRANCH BLOCK RIGHT,12
CH,CACHEXIA,12
CH,CARDIAC MURMUR,12
CH,CATATONIA,12
CH,CHRONIC HEPATITIS C,12
CH,COLD SWEAT,12
CH,CORONARY ARTERY STENOSIS,12
CH,DRUG LEVEL BELOW THERAPEUTIC,12
CH,EMPHYSEMA,12
CH,ENDOCARDITIS,12
CH,ESCHERICHIA SEPSIS,12
CH,FAECES DISCOLOURED,12
CH,FEELING COLD,12
CH,GASTRIC HAEMORRHAGE,12
CH,GASTRITIS EROSIVE,12
CH,HEPATIC CANCER,12
CH,HOT FLUSH,12
CH,IMMUNOSUPPRESSION,12
CH,INTRAOCULAR PRESSURE INCREASED,12
CH,INVASIVE DUCTAL BREAST CARCINOMA,12
CH,JOINT DISLOCATION,12
CH,LIMB DISCOMFORT,12
CH,LUNG NEOPLASM MALIGNANT,12
CH,MACULAR DEGENERATION,12
CH,METRORRHAGIA,12
CH,MOTOR DYSFUNCTION,12
CH,MOUTH HAEMORRHAGE,12
CH,NEPHROPATHY TOXIC,12
CH,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,12
CH,OESOPHAGEAL CANDIDIASIS,12
CH,PELVIC FRACTURE,12
CH,PERIPHERAL COLDNESS,12
CH,PERIPHERAL ISCHAEMIA,12
CH,PETIT MAL EPILEPSY,12
CH,PHARYNGEAL OEDEMA,12
CH,POLYARTHRITIS,12
CH,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,12
CH,SKIN DISORDER,12
CH,SUPERINFECTION BACTERIAL,12
CH,THINKING ABNORMAL,12
CH,UNRESPONSIVE TO STIMULI,12
CH,APHTHOUS STOMATITIS,11
CH,B-CELL LYMPHOMA,11
CH,BENIGN PROSTATIC HYPERPLASIA,11
CH,BLOOD THYROID STIMULATING HORMONE INCREASED,11
CH,BRAIN INJURY,11
CH,COLITIS MICROSCOPIC,11
CH,CYTOMEGALOVIRUS COLITIS,11
CH,DEMYELINATION,11
CH,DIVERTICULAR PERFORATION,11
CH,DRUG CLEARANCE DECREASED,11
CH,DYSSTASIA,11
CH,ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE,11
CH,ENTEROCOLITIS,11
CH,ERYTHEMA MULTIFORME,11
CH,FLATULENCE,11
CH,FLUID OVERLOAD,11
CH,GASTROINTESTINAL NECROSIS,11
CH,GENITAL HAEMORRHAGE,11
CH,GRANULOMA,11
CH,HENOCH-SCHONLEIN PURPURA,11
CH,HEPARIN-INDUCED THROMBOCYTOPENIA,11
CH,HERPES SIMPLEX,11
CH,HODGKIN^S DISEASE,11
CH,HYPERCAPNIA,11
CH,HYPERSOMNIA,11
CH,IDIOPATHIC PULMONARY FIBROSIS,11
CH,INJECTION SITE HAEMATOMA,11
CH,INTRA-ABDOMINAL HAEMORRHAGE,11
CH,JAUNDICE NEONATAL,11
CH,JOINT EFFUSION,11
CH,LARYNGEAL OEDEMA,11
CH,LETHARGY,11
CH,LEUKAEMIA,11
CH,LEUKOENCEPHALOPATHY,11
CH,LOCAL SWELLING,11
CH,MOOD ALTERED,11
CH,MOVEMENT DISORDER,11
CH,MUSCLE ATROPHY,11
CH,MYOCARDIAL ISCHAEMIA,11
CH,NEUTROPHILIA,11
CH,OLIGOHYDRAMNIOS,11
CH,ORAL CANDIDIASIS,11
CH,PARAESTHESIA ORAL,11
CH,PARAPLEGIA,11
CH,PARONYCHIA,11
CH,PHARYNGITIS,11
CH,PNEUMONIA CYTOMEGALOVIRAL,11
CH,PSYCHOMOTOR SKILLS IMPAIRED,11
CH,PULMONARY HAEMORRHAGE,11
CH,RETINAL DETACHMENT,11
CH,RETINAL HAEMORRHAGE,11
CH,SKIN PLAQUE,11
CH,SOPOR,11
CH,STAPHYLOCOCCAL BACTERAEMIA,11
CH,TENSION,11
CH,THROMBOCYTOSIS,11
CH,TRISOMY 21,11
CH,TYPE 2 DIABETES MELLITUS,11
CH,UPPER LIMB FRACTURE,11
CH,WRONG TECHNIQUE IN DRUG USAGE PROCESS,11
CH,ABNORMAL DREAMS,10
CH,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,10
CH,ADVERSE DRUG REACTION,10
CH,ANTICOAGULATION DRUG LEVEL INCREASED,10
CH,ARTERIAL DISORDER,10
CH,BACTERIAL SEPSIS,10
CH,BLOOD CALCIUM DECREASED,10
CH,BLOOD POTASSIUM DECREASED,10
CH,BLOOD UREA INCREASED,10
CH,CARDIOMEGALY,10
CH,CARDIOTOXICITY,10
CH,CEREBRAL ATROPHY,10
CH,CERVICAL DYSPLASIA,10
CH,CHOKING,10
CH,CHRONIC GRAFT VERSUS HOST DISEASE,10
CH,CREATININE RENAL CLEARANCE DECREASED,10
CH,CYTOGENETIC ABNORMALITY,10
CH,DEMYELINATING POLYNEUROPATHY,10
CH,DEVICE CONNECTION ISSUE,10
CH,DISTRIBUTIVE SHOCK,10
CH,DRY EYE,10
CH,DYSLIPIDAEMIA,10
CH,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,10
CH,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,10
CH,ERECTILE DYSFUNCTION,10
CH,ESCHERICHIA BACTERAEMIA,10
CH,ESCHERICHIA URINARY TRACT INFECTION,10
CH,EYE SWELLING,10
CH,FLUID RETENTION,10
CH,FOETAL MONITORING ABNORMAL,10
CH,FUNGAL INFECTION,10
CH,GENERALISED ERYTHEMA,10
CH,HAEMOCHROMATOSIS,10
CH,HEMIANOPIA,10
CH,HEPATOSPLENOMEGALY,10
CH,HIATUS HERNIA,10
CH,HUMAN HERPESVIRUS 6 INFECTION,10
CH,HYPERKINESIA,10
CH,HYPERPHOSPHATAEMIA,10
CH,HYPOGLYCAEMIC COMA,10
CH,HYPOKINESIA,10
CH,IMMUNE-MEDIATED NECROTISING MYOPATHY,10
CH,INCREASED APPETITE,10
CH,INTESTINAL OBSTRUCTION,10
CH,KAPOSI^S SARCOMA,10
CH,LACRIMATION INCREASED,10
CH,LIVER FUNCTION TEST INCREASED,10
CH,LOGORRHOEA,10
CH,MATERNAL EXPOSURE TIMING UNSPECIFIED,10
CH,MITRAL VALVE INCOMPETENCE,10
CH,NECROSIS,10
CH,NEONATAL TACHYPNOEA,10
CH,NEPHROPATHY,10
CH,ORTHOPNOEA,10
CH,OTITIS MEDIA,10
CH,PLACENTAL INSUFFICIENCY,10
CH,PLEUROTHOTONUS,10
CH,PORTAL VEIN THROMBOSIS,10
CH,PROCEDURAL PAIN,10
CH,PROTHROMBIN TIME PROLONGED,10
CH,PSEUDOMONAS INFECTION,10
CH,PULSELESS ELECTRICAL ACTIVITY,10
CH,PUPILS UNEQUAL,10
CH,RENAL DISORDER,10
CH,SKIN DISCOLOURATION,10
CH,STOMA SITE DISCHARGE,10
CH,STRIDOR,10
CH,THROMBOPHLEBITIS,10
CH,TOOTH DISORDER,10
CH,TORTICOLLIS,10
CH,ULCER,10
CH,VENTRICULAR HYPOKINESIA,10
CH,VISCERAL LEISHMANIASIS,10
CH,ABDOMINAL TENDERNESS,9
CH,ACNE,9
CH,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,9
CH,ANGINA UNSTABLE,9
CH,ANGLE CLOSURE GLAUCOMA,9
CH,ANOSMIA,9
CH,APGAR SCORE LOW,9
CH,ARTERIAL HAEMORRHAGE,9
CH,ARTERIAL THROMBOSIS,9
CH,ARTERIOSPASM CORONARY,9
CH,BLOOD ELECTROLYTES ABNORMAL,9
CH,BLOOD LACTIC ACID INCREASED,9
CH,BLOOD URINE PRESENT,9
CH,BREECH PRESENTATION,9
CH,BURSITIS,9
CH,CEREBRAL VASOCONSTRICTION,9
CH,COLECTOMY,9
CH,COLORECTAL CANCER,9
CH,CONCUSSION,9
CH,COORDINATION ABNORMAL,9
CH,DECUBITUS ULCER,9
CH,DEVICE DIFFICULT TO USE,9
CH,DIVERTICULUM INTESTINAL,9
CH,DIVERTICULUM INTESTINAL HAEMORRHAGIC,9
CH,ECCHYMOSIS,9
CH,ENDOTRACHEAL INTUBATION,9
CH,FANCONI SYNDROME ACQUIRED,9
CH,FORMICATION,9
CH,FRACTURE,9
CH,GASTROINTESTINAL INFECTION,9
CH,GENERAL PHYSICAL CONDITION ABNORMAL,9
CH,GINGIVITIS,9
CH,HICCUPS,9
CH,HYDRONEPHROSIS,9
CH,HYPERLACTACIDAEMIA,9
SY,DIARRHOEA,7
SY,BONE MARROW FAILURE,5
SY,DRUG INEFFECTIVE,5
SY,DYSPEPSIA,5
SY,GASTROINTESTINAL HAEMORRHAGE,5
SY,HAEMATURIA,5
SY,INFUSION RELATED REACTION,5
SY,MYELOFIBROSIS,5
SY,PANCYTOPENIA,5
SY,COMA,3
SY,DISEASE PROGRESSION,3
SY,FATIGUE,3
SY,HYPERSENSITIVITY,3
SY,MYALGIA,3
SY,SOMNOLENCE,3
SY,THERAPY NON-RESPONDER,3
SY,VISUAL IMPAIRMENT,3
SY,ACCIDENTAL EXPOSURE TO PRODUCT,2
SY,ARTHRALGIA,2
SY,ASTHENIA,2
SY,DEATH,2
SY,DECREASED APPETITE,2
SY,DRUG HYPERSENSITIVITY,2
SY,EXTRAPYRAMIDAL DISORDER,2
SY,HEPATITIS B REACTIVATION,2
SY,HYPERTENSION,2
SY,MALIGNANT NEOPLASM PROGRESSION,2
SY,METABOLIC ACIDOSIS,2
SY,PRODUCT USE IN UNAPPROVED INDICATION,2
SY,PRODUCT USE ISSUE,2
SY,STATUS EPILEPTICUS,2
SY,THROMBOCYTOPENIA,2
SY,VISUAL ACUITY REDUCED,2
SY,VOMITING,2
SY,ABDOMINAL PAIN,1
SY,ABDOMINAL PAIN UPPER,1
SY,ACCIDENTAL DEATH,1
SY,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
SY,ACUTE MYELOID LEUKAEMIA,1
SY,AGITATION,1
SY,ANAEMIA,1
SY,ANAPHYLACTIC SHOCK,1
SY,ANXIETY,1
SY,BACK PAIN,1
SY,BLOOD LACTATE DEHYDROGENASE INCREASED,1
SY,CELLULITIS,1
SY,CENTRAL NERVOUS SYSTEM LESION,1
SY,COLON CANCER,1
SY,CONSTIPATION,1
SY,DELIVERY,1
SY,DEMYELINATION,1
SY,DISORIENTATION,1
SY,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
SY,DYSPNOEA,1
SY,ELECTROCARDIOGRAM CHANGE,1
SY,EPILEPSY,1
SY,EXPOSURE DURING PREGNANCY,1
SY,GENERALISED TONIC-CLONIC SEIZURE,1
SY,GENOTYPE DRUG RESISTANCE TEST POSITIVE,1
SY,GUN SHOT WOUND,1
SY,HAEMATOMA,1
SY,HAEMATOTOXICITY,1
SY,HEMIPARESIS,1
SY,HOT FLUSH,1
SY,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
SY,INJECTION SITE HAEMATOMA,1
SY,INTERVERTEBRAL DISC DEGENERATION,1
SY,INTERVERTEBRAL DISC PROTRUSION,1
SY,LUNG INFECTION,1
SY,MATERNAL EXPOSURE DURING PREGNANCY,1
SY,NAUSEA,1
SY,NEOPLASM PROGRESSION,1
SY,NO THERAPEUTIC RESPONSE,1
SY,NORMAL NEWBORN,1
SY,OSMOTIC DEMYELINATION SYNDROME,1
SY,PARANOIA,1
SY,PERONEAL NERVE PALSY,1
SY,PLATELET COUNT DECREASED,1
SY,PSYCHOMOTOR HYPERACTIVITY,1
SY,PYREXIA,1
SY,RED BLOOD CELL COUNT DECREASED,1
SY,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
SY,RENAL CORTICAL NECROSIS,1
SY,RENAL FAILURE,1
SY,RESPIRATORY ACIDOSIS,1
SY,SEPTIC SHOCK,1
SY,SPINAL COLUMN STENOSIS,1
SY,SPLENOMEGALY,1
SY,SPONDYLOLISTHESIS,1
SY,SUBSTANCE ABUSE,1
SY,TACHYCARDIA,1
SY,THROMBOSIS IN DEVICE,1
SY,TOOTHACHE,1
SY,TOXICITY TO VARIOUS AGENTS,1
SY,URINARY TRACT INFECTION,1
SY,URTICARIA,1
SY,VIRAL INFECTION,1
SY,VIRAL LOAD INCREASED,1
SY,VITAMIN D DEFICIENCY,1
SY,WEIGHT DECREASED,1
SY,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
TW,DEATH,2098
TW,PYREXIA,499
TW,PNEUMONIA,423
TW,DYSPNOEA,317
TW,SEPSIS,280
TW,FALL,251
TW,DRUG INEFFECTIVE,216
TW,VOMITING,208
TW,DIARRHOEA,203
TW,DECREASED APPETITE,193
TW,COUGH,189
TW,ANAEMIA,184
TW,RESPIRATORY FAILURE,182
TW,DIZZINESS,176
TW,SEPTIC SHOCK,176
TW,PLEURAL EFFUSION,172
TW,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,170
TW,JAUNDICE,169
TW,NAUSEA,168
TW,URINARY TRACT INFECTION,168
TW,ACUTE KIDNEY INJURY,163
TW,ASTHENIA,162
TW,THROMBOCYTOPENIA,158
TW,ARTHRALGIA,148
TW,HAEMOGLOBIN DECREASED,148
TW,CELLULITIS,143
TW,ABDOMINAL PAIN,141
TW,DRUG-INDUCED LIVER INJURY,140
TW,FATIGUE,140
TW,CONDITION AGGRAVATED,135
TW,DISEASE PROGRESSION,133
TW,RASH,130
TW,CEREBROVASCULAR ACCIDENT,124
TW,ALANINE AMINOTRANSFERASE INCREASED,123
TW,HYPOTENSION,123
TW,HEPATIC FAILURE,114
TW,FEBRILE NEUTROPENIA,110
TW,PLATELET COUNT DECREASED,110
TW,WHITE BLOOD CELL COUNT DECREASED,109
TW,OEDEMA PERIPHERAL,108
TW,DEMENTIA ALZHEIMER^S TYPE,106
TW,ASPARTATE AMINOTRANSFERASE INCREASED,105
TW,INFECTION,103
TW,C-REACTIVE PROTEIN INCREASED,100
TW,LOSS OF CONSCIOUSNESS,99
TW,PRODUCT USE ISSUE,98
TW,LEUKOPENIA,97
TW,OSTEONECROSIS OF JAW,97
TW,ALTERED STATE OF CONSCIOUSNESS,96
TW,TOXICITY TO VARIOUS AGENTS,96
TW,DRUG RESISTANCE,95
TW,HYPERTENSION,95
TW,MUSCULAR WEAKNESS,94
TW,NEUTROPENIA,94
TW,RENAL IMPAIRMENT,94
TW,PAIN,91
TW,HEPATITIS B,89
TW,CARDIAC FAILURE,88
TW,ROAD TRAFFIC ACCIDENT,87
TW,ASCITES,85
TW,CHEST DISCOMFORT,85
TW,SOMNOLENCE,85
TW,TUBERCULOSIS,85
TW,BLOOD CREATININE INCREASED,84
TW,NASOPHARYNGITIS,84
TW,HEADACHE,83
TW,COMA,82
TW,PRURITUS,82
TW,BACK PAIN,81
TW,INSOMNIA,78
TW,DELIRIUM,77
TW,ERYTHEMA,77
TW,SHOCK,77
TW,GASTROINTESTINAL HAEMORRHAGE,76
TW,PAIN IN EXTREMITY,76
TW,ACUTE MYOCARDIAL INFARCTION,75
TW,JOINT SWELLING,75
TW,PANCYTOPENIA,75
TW,ABDOMINAL DISTENSION,72
TW,MALIGNANT NEOPLASM PROGRESSION,71
TW,LIVER FUNCTION TEST ABNORMAL,70
TW,HYPONATRAEMIA,68
TW,RHABDOMYOLYSIS,68
TW,HAEMORRHAGE,67
TW,LUNG INFILTRATION,66
TW,RED BLOOD CELL SEDIMENTATION RATE INCREASED,66
TW,WHITE BLOOD CELL COUNT INCREASED,66
TW,GASTRIC ULCER,65
TW,PULMONARY OEDEMA,65
TW,SKIN DISORDER,65
TW,ACUTE RESPIRATORY FAILURE,63
TW,GAIT DISTURBANCE,63
TW,HYDRONEPHROSIS,61
TW,HYPOKALAEMIA,61
TW,SYNCOPE,61
TW,BLOOD BILIRUBIN INCREASED,60
TW,CARDIAC ARREST,60
TW,IMMUNE SYSTEM DISORDER,60
TW,MALAISE,60
TW,MULTIPLE ORGAN DYSFUNCTION SYNDROME,60
TW,PRODUCT USE IN UNAPPROVED INDICATION,60
TW,RENAL FAILURE ACUTE,60
TW,VIROLOGIC FAILURE,60
TW,HEPATOTOXICITY,58
TW,PULMONARY TUBERCULOSIS,58
TW,HAEMATURIA,57
TW,OEDEMA,57
TW,SEIZURE,57
TW,MOUTH ULCERATION,56
TW,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,56
TW,CHOLELITHIASIS,55
TW,HYPOAESTHESIA,55
TW,MYOCARDIAL INFARCTION,55
TW,DISCOMFORT,54
TW,OVERDOSE,54
TW,TREMOR,54
TW,BLOOD PRESSURE DECREASED,53
TW,GASTROOESOPHAGEAL REFLUX DISEASE,53
TW,HAEMATOCHEZIA,53
TW,HEPATOCELLULAR CARCINOMA,53
TW,MULTI-ORGAN FAILURE,53
TW,OSTEOARTHRITIS,53
TW,SUICIDE ATTEMPT,53
TW,CONSTIPATION,52
TW,PNEUMOCYSTIS JIROVECII PNEUMONIA,52
TW,TACHYCARDIA,52
TW,UPPER RESPIRATORY TRACT INFECTION,52
TW,CHILLS,50
TW,ENCEPHALOPATHY,50
TW,WEIGHT DECREASED,50
TW,BLOOD UREA INCREASED,49
TW,CHEST PAIN,49
TW,NEPHROLITHIASIS,49
TW,MYALGIA,48
TW,PRODUCTIVE COUGH,48
TW,HYPERKALAEMIA,47
TW,LEUKOCYTOSIS,47
TW,STEVENS-JOHNSON SYNDROME,47
TW,UPPER GASTROINTESTINAL HAEMORRHAGE,47
TW,CARDIAC FAILURE CONGESTIVE,46
TW,DRUG ABUSE,46
TW,FOETAL EXPOSURE DURING PREGNANCY,46
TW,ABDOMINAL PAIN UPPER,45
TW,HYPERSENSITIVITY,45
TW,HYPOALBUMINAEMIA,45
TW,PNEUMONIA ASPIRATION,45
TW,WEIGHT INCREASED,45
TW,DEPRESSION,44
TW,ACUTE RESPIRATORY DISTRESS SYNDROME,43
TW,CARDIOVASCULAR DISORDER,43
TW,DRUG ERUPTION,43
TW,DYSPHAGIA,43
TW,INFLUENZA,43
TW,METABOLIC ACIDOSIS,43
TW,RENAL FAILURE,43
TW,TOXIC EPIDERMAL NECROLYSIS,43
TW,VISION BLURRED,43
TW,ABDOMINAL DISCOMFORT,42
TW,HERPES ZOSTER,42
TW,PULMONARY EMBOLISM,42
TW,TREATMENT FAILURE,42
TW,ATRIAL FIBRILLATION,41
TW,BLOOD GLUCOSE INCREASED,41
TW,CEREBRAL HAEMORRHAGE,41
TW,PALPITATIONS,41
TW,PSYCHOTIC DISORDER,41
TW,SUDDEN DEATH,41
TW,BLOOD PRESSURE INCREASED,40
TW,BRADYCARDIA,40
TW,ARRHYTHMIA,39
TW,CARDIOMEGALY,39
TW,CATARACT,39
TW,DYSURIA,39
TW,SWELLING,39
TW,CONTUSION,38
TW,EPIDERMAL NECROSIS,38
TW,PERIPHERAL SWELLING,38
TW,SEROTONIN SYNDROME,38
TW,INTERSTITIAL LUNG DISEASE,37
TW,OROPHARYNGEAL PAIN,37
TW,PERITONITIS,37
TW,CARDIOGENIC SHOCK,36
TW,FEMUR FRACTURE,36
TW,HAEMATEMESIS,36
TW,HAEMORRHAGE INTRACRANIAL,36
TW,HEPATIC CIRRHOSIS,36
TW,HOSPITALISATION,36
TW,MELAENA,36
TW,PSORIASIS,36
TW,HEPATIC ENCEPHALOPATHY,35
TW,HEPATIC FUNCTION ABNORMAL,35
TW,RHINORRHOEA,35
TW,ANXIETY,34
TW,INTENTIONAL OVERDOSE,34
TW,ANGLE CLOSURE GLAUCOMA,33
TW,BLOOD LACTATE DEHYDROGENASE INCREASED,33
TW,CEREBRAL INFARCTION,33
TW,DERMATITIS,33
TW,EXPOSURE DURING PREGNANCY,33
TW,HEPATITIS,33
TW,PERICARDIAL EFFUSION,33
TW,PULMONARY MASS,33
TW,SINUS TACHYCARDIA,33
TW,SPLENOMEGALY,33
TW,WOUND INFECTION,33
TW,BACTERIAL INFECTION,32
TW,BLOOD CREATINE PHOSPHOKINASE INCREASED,32
TW,BONE PAIN,32
TW,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,32
TW,CORONARY ARTERY DISEASE,32
TW,CYTOMEGALOVIRUS INFECTION,32
TW,DEEP VEIN THROMBOSIS,32
TW,DRUG WITHDRAWAL SYNDROME,32
TW,DYSKINESIA,32
TW,HAEMATOCRIT DECREASED,32
TW,PULMONARY FIBROSIS,32
TW,SPINAL OSTEOARTHRITIS,32
TW,ALOPECIA,31
TW,ASTHMA,31
TW,CARDIAC DISORDER,31
TW,DRUG DEPENDENCE,31
TW,DYSARTHRIA,31
TW,GASTROENTERITIS,31
TW,HEPATITIS B REACTIVATION,31
TW,HYPERGLYCAEMIA,31
TW,INTERVERTEBRAL DISC PROTRUSION,31
TW,ISCHAEMIC STROKE,31
TW,MATERNAL EXPOSURE DURING PREGNANCY,31
TW,MUCOSAL INFLAMMATION,31
TW,HAEMOPTYSIS,30
TW,HEPATITIS ACUTE,30
TW,HYPERAMMONAEMIA,30
TW,IRITIS,30
TW,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,30
TW,PNEUMONITIS,30
TW,TUMOUR LYSIS SYNDROME,30
TW,ACUTE PULMONARY OEDEMA,29
TW,BACTERAEMIA,29
TW,HEPATIC STEATOSIS,29
TW,IMPAIRED HEALING,29
TW,LUNG INFECTION,29
TW,LYMPHADENOPATHY,29
TW,OXYGEN SATURATION DECREASED,29
TW,WHEEZING,29
TW,BLISTER,28
TW,CHOLECYSTITIS,28
TW,DIABETES MELLITUS,28
TW,DRY MOUTH,28
TW,EPISTAXIS,28
TW,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,28
TW,LIVER INJURY,28
TW,LUNG NEOPLASM MALIGNANT,28
TW,PANCREATITIS ACUTE,28
TW,RASH GENERALISED,28
TW,RED BLOOD CELL COUNT DECREASED,28
TW,RHEUMATOID ARTHRITIS,28
TW,SKIN ULCER,28
TW,SPINAL COMPRESSION FRACTURE,28
TW,SUICIDAL IDEATION,28
TW,CONFUSIONAL STATE,27
TW,DISEASE RECURRENCE,27
TW,ELECTROCARDIOGRAM QT PROLONGED,27
TW,GASTRIC HAEMORRHAGE,27
TW,LOWER LIMB FRACTURE,27
TW,NEUROLEPTIC MALIGNANT SYNDROME,27
TW,RENAL CYST,27
TW,SCHIZOPHRENIA,27
TW,AGITATION,26
TW,CHOKING,26
TW,HYPOCALCAEMIA,26
TW,IDIOPATHIC PULMONARY FIBROSIS,26
TW,LARGE INTESTINE PERFORATION,26
TW,MANIA,26
TW,NEOPLASM MALIGNANT,26
TW,NEOPLASM PROGRESSION,26
TW,NEUROTOXICITY,26
TW,PYELONEPHRITIS ACUTE,26
TW,RENAL CELL CARCINOMA,26
TW,RESPIRATORY DISTRESS,26
TW,ACUTE HEPATIC FAILURE,25
TW,ARTHROPATHY,25
TW,COAGULOPATHY,25
TW,HAEMORRHOIDS,25
TW,HEAD INJURY,25
TW,HEPATIC NEOPLASM,25
TW,INTENTIONAL PRODUCT MISUSE,25
TW,PANCREATITIS,25
TW,PLASMA CELL MYELOMA,25
TW,PNEUMOTHORAX,25
TW,PROTEINURIA,25
TW,URINE OUTPUT DECREASED,25
TW,VENTRICULAR TACHYCARDIA,25
TW,VERTIGO,25
TW,ABASIA,24
TW,FRACTURE,24
TW,HAEMORRHAGIC TRANSFORMATION STROKE,24
TW,HYPOGLYCAEMIA,24
TW,MUSCLE SPASMS,24
TW,CARDIOPULMONARY FAILURE,23
TW,CYTOMEGALOVIRUS OESOPHAGITIS,23
TW,DRUG HYPERSENSITIVITY,23
TW,DYSPNOEA EXERTIONAL,23
TW,HYPOTHYROIDISM,23
TW,MYOCLONUS,23
TW,SKIN EXFOLIATION,23
TW,SUBARACHNOID HAEMORRHAGE,23
TW,SYSTEMIC CANDIDA,23
TW,SYSTEMIC LUPUS ERYTHEMATOSUS,23
TW,ANAPHYLACTIC SHOCK,22
TW,BLOOD ALKALINE PHOSPHATASE INCREASED,22
TW,DERMATITIS BULLOUS,22
TW,DRY SKIN,22
TW,DUODENAL ULCER,22
TW,ECZEMA,22
TW,GENERAL PHYSICAL HEALTH DETERIORATION,22
TW,HEART RATE INCREASED,22
TW,HEPATIC ENZYME INCREASED,22
TW,HIP FRACTURE,22
TW,OSTEONECROSIS,22
TW,PREMATURE BABY,22
TW,STOMATITIS,22
TW,WOUND,22
TW,CANDIDA INFECTION,21
TW,CHRONIC KIDNEY DISEASE,21
TW,COLD SWEAT,21
TW,COLITIS,21
TW,DRUG LEVEL INCREASED,21
TW,EPILEPSY,21
TW,HALLUCINATION_ AUDITORY,21
TW,ILEUS,21
TW,LATENT TUBERCULOSIS,21
TW,MUSCULOSKELETAL STIFFNESS,21
TW,OLIGURIA,21
TW,UROSEPSIS,21
TW,VENTRICULAR FIBRILLATION,21
TW,BLOOD ALBUMIN DECREASED,20
TW,COLON CANCER,20
TW,EXTRAPYRAMIDAL DISORDER,20
TW,EYE PAIN,20
TW,HAEMATOMA,20
TW,HYPOVOLAEMIC SHOCK,20
TW,OPTIC NEUROPATHY,20
TW,STAPHYLOCOCCAL INFECTION,20
TW,SUBDURAL HAEMATOMA,20
TW,ARTHRITIS,19
TW,BREAST CANCER,19
TW,CHOLECYSTITIS ACUTE,19
TW,DISORIENTATION,19
TW,DISSEMINATED INTRAVASCULAR COAGULATION,19
TW,EOSINOPHILIA,19
TW,MAJOR DEPRESSION,19
TW,NECROTISING FASCIITIS,19
TW,OSTEOMYELITIS,19
TW,RASH ERYTHEMATOUS,19
TW,SKIN LESION,19
TW,SWELLING FACE,19
TW,TOOTHACHE,19
TW,TRANSPLANT REJECTION,19
TW,VITREOUS HAEMORRHAGE,19
TW,AKATHISIA,18
TW,BILE DUCT OBSTRUCTION,18
TW,CYSTITIS,18
TW,DIABETIC KETOACIDOSIS,18
TW,FEELING COLD,18
TW,LETHARGY,18
TW,METASTASES TO LIVER,18
TW,MOBILITY DECREASED,18
TW,OCULAR HYPERTENSION,18
TW,PROTHROMBIN TIME PROLONGED,18
TW,PULMONARY ARTERIAL HYPERTENSION,18
TW,RIB FRACTURE,18
TW,SPUTUM DISCOLOURED,18
TW,TREATMENT NONCOMPLIANCE,18
TW,URINARY RETENTION,18
TW,ABORTION SPONTANEOUS,17
TW,ADVERSE EVENT,17
TW,ANURIA,17
TW,CONVULSION,17
TW,DRUG CLEARANCE DECREASED,17
TW,DYSGEUSIA,17
TW,EYELID OEDEMA,17
TW,FLATULENCE,17
TW,FUNGAL INFECTION,17
TW,GASTRITIS,17
TW,GASTROINTESTINAL DISORDER,17
TW,HEPATIC CANCER,17
TW,HYPERBILIRUBINAEMIA,17
TW,HYPERURICAEMIA,17
TW,HYPOPHAGIA,17
TW,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,17
TW,INTERNATIONAL NORMALISED RATIO INCREASED,17
TW,LACTIC ACIDOSIS,17
TW,LUNG ADENOCARCINOMA,17
TW,LUNG DISORDER,17
TW,METASTASES TO BONE,17
TW,METASTASES TO LUNG,17
TW,NEPHROPATHY TOXIC,17
TW,OSTEOPOROSIS,17
TW,RENAL FAILURE CHRONIC,17
TW,TARDIVE DYSKINESIA,17
TW,THERAPEUTIC RESPONSE DECREASED,17
TW,URTICARIA,17
TW,VENTRICULAR ARRHYTHMIA,17
TW,ABNORMAL BEHAVIOUR,16
TW,AGGRESSION,16
TW,BLOOD POTASSIUM DECREASED,16
TW,DEPRESSED MOOD,16
TW,GENERALISED OEDEMA,16
TW,HEPATITIS C,16
TW,HYPERCALCAEMIA,16
TW,HYPOXIA,16
TW,INFLAMMATION,16
TW,INJECTION SITE PAIN,16
TW,INTESTINAL OBSTRUCTION,16
TW,LIMB INJURY,16
TW,LIVER DISORDER,16
TW,LIVER FUNCTION TEST INCREASED,16
TW,LYMPHOCYTE MORPHOLOGY ABNORMAL,16
TW,MENINGITIS,16
TW,MUSCULOSKELETAL PAIN,16
TW,MYOPIA,16
TW,POLLAKIURIA,16
TW,SPINAL CORD COMPRESSION,16
TW,UTERINE LEIOMYOMA,16
TW,WOUND COMPLICATION,16
TW,ABDOMINAL PAIN LOWER,15
TW,ABORTION,15
TW,ABSCESS,15
TW,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,15
TW,BONE MARROW FAILURE,15
TW,BRAIN OEDEMA,15
TW,CHORIORETINAL ATROPHY,15
TW,CHOROIDAL EFFUSION,15
TW,CHROMATURIA,15
TW,CORONARY ARTERY DILATATION,15
TW,CYANOSIS,15
TW,DEHYDRATION,15
TW,DEVICE RELATED INFECTION,15
TW,DYSPEPSIA,15
TW,DYSPHONIA,15
TW,EXOSTOSIS,15
TW,GINGIVAL BLEEDING,15
TW,HEPATITIS FULMINANT,15
TW,HYPERHIDROSIS,15
TW,HYPERLIPIDAEMIA,15
TW,INTENTIONAL PRODUCT USE ISSUE,15
TW,INTESTINAL PERFORATION,15
TW,IRRITABILITY,15
TW,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,15
TW,LOCAL SWELLING,15
TW,LOW BIRTH WEIGHT BABY,15
TW,LYMPHOCYTE COUNT DECREASED,15
TW,NEUROPATHY PERIPHERAL,15
TW,OESOPHAGEAL VARICES HAEMORRHAGE,15
TW,PLATELET COUNT INCREASED,15
TW,PROSTATE CANCER,15
TW,PRURITUS GENERALISED,15
TW,SCOLIOSIS,15
TW,SPEECH DISORDER,15
TW,VISUAL ACUITY REDUCED,15
TW,APHASIA,14
TW,ARTHRITIS BACTERIAL,14
TW,BILIRUBIN CONJUGATED INCREASED,14
TW,BLADDER DISORDER,14
TW,BLINDNESS,14
TW,CARDIAC TAMPONADE,14
TW,CEREBRAL ATROPHY,14
TW,CHEST X-RAY ABNORMAL,14
TW,CYSTITIS INTERSTITIAL,14
TW,DEPRESSED LEVEL OF CONSCIOUSNESS,14
TW,FEMORAL NECK FRACTURE,14
TW,GLAUCOMA,14
TW,HEART RATE DECREASED,14
TW,HEMIPARESIS,14
TW,LYMPHOMA,14
TW,NEPHROPATHY,14
TW,PERSECUTORY DELUSION,14
TW,RASH PRURITIC,14
TW,RASH PUSTULAR,14
TW,SINUSITIS,14
TW,SPONDYLOLISTHESIS,14
TW,TACHYPNOEA,14
TW,TUBULOINTERSTITIAL NEPHRITIS,14
TW,VISUAL IMPAIRMENT,14
TW,AMMONIA INCREASED,13
TW,ANAL ABSCESS,13
TW,ANGINA PECTORIS,13
TW,ANGIOPATHY,13
TW,BILIARY TRACT INFECTION,13
TW,BLOOD CALCIUM DECREASED,13
TW,BLOOD SODIUM DECREASED,13
TW,DRUG EFFECT INCOMPLETE,13
TW,ESCHERICHIA INFECTION,13
TW,FOOT DEFORMITY,13
TW,FUNGAEMIA,13
TW,HYPERAMMONAEMIC ENCEPHALOPATHY,13
TW,HYPERNATRAEMIA,13
TW,LACERATION,13
TW,METABOLIC SYNDROME,13
TW,MYOCARDIAL ISCHAEMIA,13
TW,PAPULE,13
TW,PERITONITIS BACTERIAL,13
TW,PHOTOSENSITIVITY REACTION,13
TW,PSEUDOMONAS INFECTION,13
TW,PYURIA,13
TW,RIGHT VENTRICULAR FAILURE,13
TW,SALIVARY HYPERSECRETION,13
TW,SEDATION,13
TW,TORSADE DE POINTES,13
TW,WITHDRAWAL SYNDROME,13
TW,ARTERIOSCLEROSIS,12
TW,ATELECTASIS,12
TW,AUTOIMMUNE HAEMOLYTIC ANAEMIA,12
TW,BODY TEMPERATURE INCREASED,12
TW,DELUSION,12
TW,EYE HAEMORRHAGE,12
TW,FOOT FRACTURE,12
TW,GASTRIC CANCER,12
TW,HUMERUS FRACTURE,12
TW,HYDROCEPHALUS,12
TW,HYPERTRIGLYCERIDAEMIA,12
TW,HYPOMAGNESAEMIA,12
TW,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,12
TW,IMMUNE THROMBOCYTOPENIC PURPURA,12
TW,INFLUENZA LIKE ILLNESS,12
TW,INJURY,12
TW,MULTIPLE SCLEROSIS RELAPSE,12
TW,MUSCLE RIGIDITY,12
TW,MYOCARDITIS,12
TW,MYOPATHY,12
TW,NEUTROPHIL COUNT DECREASED,12
TW,NEUTROPHIL COUNT INCREASED,12
TW,PREMATURE DELIVERY,12
TW,RENAL DISORDER,12
TW,RESTLESSNESS,12
TW,STATUS EPILEPTICUS,12
TW,URETEROLITHIASIS,12
TW,URINARY INCONTINENCE,12
TW,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,12
TW,ACUTE GRAFT VERSUS HOST DISEASE,11
TW,APPENDICITIS,11
TW,ARTERIOSCLEROSIS CORONARY ARTERY,11
TW,AUTOIMMUNE NEUTROPENIA,11
TW,BLOOD TRIGLYCERIDES INCREASED,11
TW,BRONCHIECTASIS,11
TW,BRONCHITIS,11
TW,COMPLETED SUICIDE,11
TW,COMPRESSION FRACTURE,11
TW,CYTOPENIA,11
TW,DECUBITUS ULCER,11
TW,DENTAL CARIES,11
TW,DERMATITIS ALLERGIC,11
TW,DROOLING,11
TW,FAECES DISCOLOURED,11
TW,FEELING HOT,11
TW,FLANK PAIN,11
TW,GASTRITIS EROSIVE,11
TW,GASTROINTESTINAL STROMAL TUMOUR,11
TW,GENERALISED TONIC-CLONIC SEIZURE,11
TW,GLOMERULAR FILTRATION RATE DECREASED,11
TW,GRAFT VERSUS HOST DISEASE,11
TW,HAEMOTHORAX,11
TW,HALLUCINATION,11
TW,HYPERTHYROIDISM,11
TW,LOCALISED INFECTION,11
TW,LUNG CONSOLIDATION,11
TW,LYMPHOPENIA,11
TW,MACULAR OEDEMA,11
TW,METASTASES TO CENTRAL NERVOUS SYSTEM,11
TW,MITRAL VALVE INCOMPETENCE,11
TW,NEOPLASM,11
TW,PEPTIC ULCER,11
TW,PLEUROTHOTONUS,11
TW,POST PROCEDURAL INFECTION,11
TW,PRODUCT QUALITY ISSUE,11
TW,SPINAL FRACTURE,11
TW,URETERAL DISORDER,11
TW,ABDOMINAL ABSCESS,10
TW,ABDOMINAL INFECTION,10
TW,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,10
TW,AGRANULOCYTOSIS,10
TW,APNOEA,10
TW,BENIGN PROSTATIC HYPERPLASIA,10
TW,BLOOD PRESSURE SYSTOLIC INCREASED,10
TW,BREAST CANCER FEMALE,10
TW,CARDIO-RESPIRATORY ARREST,10
TW,CEREBRAL ARTERY EMBOLISM,10
TW,CHOLANGITIS,10
TW,CONJUNCTIVITIS,10
TW,DISLOCATION OF VERTEBRA,10
TW,DYSTONIA,10
TW,FACE OEDEMA,10
TW,FOLLICULITIS,10
TW,GOUTY ARTHRITIS,10
TW,HALLUCINATION_ VISUAL,10
TW,HYPOVOLAEMIA,10
TW,INGUINAL HERNIA,10
TW,KIDNEY TRANSPLANT REJECTION,10
TW,KLEBSIELLA INFECTION,10
TW,LACUNAR INFARCTION,10
TW,LIP AND/OR ORAL CAVITY CANCER,10
TW,LIVER ABSCESS,10
TW,LOWER URINARY TRACT SYMPTOMS,10
TW,LUMBAR VERTEBRAL FRACTURE,10
TW,LUNG NEOPLASM,10
TW,MASS,10
TW,MENTAL STATUS CHANGES,10
TW,METASTASIS,10
TW,MUSCLE TWITCHING,10
TW,NERVE COMPRESSION,10
TW,NERVOUS SYSTEM DISORDER,10
TW,ORTHOSTATIC HYPOTENSION,10
TW,OSMOTIC DEMYELINATION SYNDROME,10
TW,PALLOR,10
TW,PERIORBITAL OEDEMA,10
TW,PNEUMONIA BACTERIAL,10
TW,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,10
TW,POSTOPERATIVE WOUND INFECTION,10
TW,PSEUDOMEMBRANOUS COLITIS,10
TW,SJOGREN^S SYNDROME,10
TW,SLEEP DISORDER,10
TW,SPINAL PAIN,10
TW,TENDERNESS,10
TW,TUBERCULIN TEST POSITIVE,10
TW,TUMOUR HAEMORRHAGE,10
TW,VASCULITIS,10
TW,ACIDOSIS,9
TW,ACTIVITIES OF DAILY LIVING IMPAIRED,9
TW,ACUTE MYELOID LEUKAEMIA,9
TW,ANAPHYLACTIC REACTION,9
TW,AORTIC ARTERIOSCLEROSIS,9
TW,ATAXIA,9
TW,BLOOD CHOLESTEROL INCREASED,9
TW,BLOOD CREATINE INCREASED,9
TW,BLOOD POTASSIUM INCREASED,9
TW,BRAIN NEOPLASM,9
TW,CARCINOEMBRYONIC ANTIGEN INCREASED,9
TW,CARDIOMYOPATHY,9
TW,CATATONIA,9
TW,CONCOMITANT DISEASE PROGRESSION,9
TW,CYST,9
TW,DIABETES MELLITUS INADEQUATE CONTROL,9
TW,DISTURBANCE IN ATTENTION,9
TW,DRUG DOSE OMISSION,9
TW,ELECTROLYTE IMBALANCE,9
TW,EMPHYSEMA,9
TW,FEELING ABNORMAL,9
TW,GAMMA-GLUTAMYLTRANSFERASE INCREASED,9
TW,GANGRENE,9
TW,GOITRE,9
TW,HAND FRACTURE,9
TW,HEAT STROKE,9
TW,HEPATITIS B DNA INCREASED,9
TW,HEPATORENAL SYNDROME,9
TW,HYPERPROLACTINAEMIA,9
TW,HYPOPHOSPHATAEMIA,9
TW,IMMUNODEFICIENCY,9
TW,INCREASED APPETITE,9
TW,INJECTION SITE SWELLING,9
TW,JOINT RANGE OF MOTION DECREASED,9
TW,LIP SWELLING,9
TW,LUNG CANCER METASTATIC,9
TW,MALIGNANT PLEURAL EFFUSION,9
TW,MYCOBACTERIAL INFECTION,9
TW,NASOPHARYNGEAL CANCER,9
TW,NEPHRITIS,9
TW,POOR QUALITY SLEEP,9
TW,PULMONARY CONGESTION,9
TW,RALES,9
TW,RED CELL DISTRIBUTION WIDTH INCREASED,9
TW,SPINAL OPERATION,9
TW,SURGERY,9
TW,TRANSIENT ISCHAEMIC ATTACK,9
TW,UNEVALUABLE EVENT,9
TW,VAGINAL HAEMORRHAGE,9
TW,VIRAL UPPER RESPIRATORY TRACT INFECTION,9
TW,YELLOW SKIN,9
TW,ANGIOEDEMA,8
TW,AORTIC CALCIFICATION,8
TW,BRONCHIOLITIS,8
TW,BRONCHOPNEUMONIA,8
TW,CENTRAL NERVOUS SYSTEM LESION,8
TW,CHRONIC HEPATITIS,8
TW,CHRONIC HEPATITIS B,8
TW,DEMENTIA,8
TW,DEVELOPMENTAL DELAY,8
TW,DIABETIC FOOT,8
TW,DIPLOPIA,8
TW,DRUG INTOLERANCE,8
TW,EOSINOPHIL COUNT INCREASED,8
TW,ESCHERICHIA URINARY TRACT INFECTION,8
TW,EYE MOVEMENT DISORDER,8
TW,HAEMODYNAMIC INSTABILITY,8
TW,HAEMORRHAGIC STROKE,8
TW,HEPATIC CYST,8
TW,HEPATITIS C RNA INCREASED,8
TW,HERNIA,8
TW,HERPES VIRUS INFECTION,8
TW,INCORRECT DOSE ADMINISTERED,8
TW,INFECTIOUS COLITIS,8
TW,INJECTION SITE ERYTHEMA,8
TW,INTRAOCULAR PRESSURE INCREASED,8
TW,LEUKAEMIA CUTIS,8
TW,LUNG ABSCESS,8
TW,MALNUTRITION,8
TW,MEMORY IMPAIRMENT,8
TW,MENINGITIS CRYPTOCOCCAL,8
TW,MENORRHAGIA,8
TW,MONOCYTE COUNT INCREASED,8
TW,MOUTH HAEMORRHAGE,8
TW,MUSCULOSKELETAL DISCOMFORT,8
TW,MYCOBACTERIUM TEST POSITIVE,8
TW,NECK PAIN,8
TW,NEPHROTIC SYNDROME,8
TW,NEUROMYOPATHY,8
TW,NOCARDIOSIS,8
TW,NONREASSURING FOETAL HEART RATE PATTERN,8
TW,PARALYSIS,8
TW,PARKINSONISM,8
TW,PATHOGEN RESISTANCE,8
TW,PEPTIC ULCER PERFORATION,8
TW,PERIODONTITIS,8
TW,PREGNANCY,8
TW,PULMONARY HAEMORRHAGE,8
TW,PULMONARY HYPERTENSION,8
TW,PULSELESS ELECTRICAL ACTIVITY,8
TW,PURULENT DISCHARGE,8
TW,RECALL PHENOMENON,8
TW,REDUCED BLADDER CAPACITY,8
TW,RETINAL ARTERY OCCLUSION,8
TW,RETINAL DETACHMENT,8
TW,RETINAL HAEMORRHAGE,8
TW,SKIN DISCOLOURATION,8
TW,SKIN EROSION,8
TW,SKIN NECROSIS,8
TW,SMALL FOR DATES BABY,8
TW,STEREOTYPY,8
TW,STRONGYLOIDIASIS,8
TW,STUPOR,8
TW,THROMBOSIS,8
TW,TOOTH DISORDER,8
TW,TOXIC ENCEPHALOPATHY,8
TW,TRANSAMINASES INCREASED,8
TW,TRANSFUSION,8
TW,VIRAL INFECTION,8
TW,ABORTION INDUCED,7
TW,ACCIDENTAL OVERDOSE,7
TW,ACUTE HEPATITIS B,7
TW,ANAL FISTULA,7
TW,AORTIC DISORDER,7
TW,AORTIC VALVE INCOMPETENCE,7
TW,AUTOIMMUNE PANCYTOPENIA,7
TW,BACTERIAL TEST POSITIVE,7
TW,BASOPHIL COUNT INCREASED,7
TW,BLOOD CREATININE DECREASED,7
TW,BLOOD URINE PRESENT,7
TW,BRAIN STEM HAEMORRHAGE,7
TW,BREAST CANCER METASTATIC,7
TW,CARDIOTOXICITY,7
TW,COMA HEPATIC,7
TW,CONCUSSION,7
TW,CRYPTOCOCCOSIS,7
TW,CYSTITIS HAEMORRHAGIC,7
TW,DIVERTICULITIS,7
TW,DRUG EFFECT DECREASED,7
TW,DUODENAL ULCER HAEMORRHAGE,7
TW,ECCHYMOSIS,7
TW,EMOTIONAL DISORDER,7
TW,ENTEROCOCCAL INFECTION,7
TW,ENTEROVESICAL FISTULA,7
TW,EXTRAPULMONARY TUBERCULOSIS,7
TW,EYE SWELLING,7
TW,FACIAL PARALYSIS,7
TW,FLUID OVERLOAD,7
TW,FLUSHING,7
TW,GAIT INABILITY,7
TW,GASTRIC ULCER HAEMORRHAGE,7
TW,GINGIVAL PAIN,7
TW,GINGIVAL SWELLING,7
TW,GINGIVITIS,7
TW,HAEMODIALYSIS,7
TW,HAEMOLYTIC ANAEMIA,7
TW,HAEMORRHOIDAL HAEMORRHAGE,7
TW,HALLUCINATIONS_ MIXED,7
TW,HEPATITIS B SURFACE ANTIGEN POSITIVE,7
TW,HEPATOCELLULAR INJURY,7
TW,HICCUPS,7
TW,HISTOLOGY ABNORMAL,7
TW,HYPERREFLEXIA,7
TW,HYPOKINESIA,7
TW,HYPOMANIA,7
TW,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,7
TW,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,7
TW,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,7
TW,INFECTIOUS PLEURAL EFFUSION,7
TW,INTESTINAL HAEMORRHAGE,7
TW,JOINT DISLOCATION,7
TW,JOINT EFFUSION,7
TW,KERATITIS,7
TW,LARGE INTESTINE POLYP,7
TW,METASTASES TO LYMPH NODES,7
TW,MYELOPATHY,7
TW,NAIL RIDGING,7
TW,NEUTROPENIC SEPSIS,7
TW,NODULE,7
TW,OBSESSIVE-COMPULSIVE DISORDER,7
TW,OCCULT BLOOD POSITIVE,7
TW,OCULAR DISCOMFORT,7
TW,OESOPHAGEAL ULCER,7
TW,OESOPHAGITIS,7
TW,ORAL PAIN,7
TW,PARAESTHESIA,7
TW,PARONYCHIA,7
TW,PEMPHIGOID,7
TW,PHARYNGITIS,7
TW,PNEUMOPERITONEUM,7
TW,POLYARTHRITIS,7
TW,POST PROCEDURAL HAEMORRHAGE,7
TW,PSORIATIC ARTHROPATHY,7
TW,PSYCHIATRIC SYMPTOM,7
TW,PSYCHOMOTOR HYPERACTIVITY,7
TW,PURPURA,7
TW,RASH PAPULAR,7
TW,RESPIRATORY ACIDOSIS,7
TW,RESPIRATORY ARREST,7
TW,SECOND PRIMARY MALIGNANCY,7
TW,SKIN ABRASION,7
TW,SKIN REACTION,7
TW,SKIN SWELLING,7
TW,SOFT TISSUE INFECTION,7
TW,SUBCUTANEOUS EMPHYSEMA,7
TW,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,7
TW,TINNITUS,7
TW,TONSILLITIS,7
TW,TRICUSPID VALVE INCOMPETENCE,7
TW,TROPONIN I INCREASED,7
TW,UROGENITAL FISTULA,7
TW,WRIST FRACTURE,7
TW,ABDOMINAL WALL ABSCESS,6
TW,ADRENAL INSUFFICIENCY,6
TW,AMYLASE INCREASED,6
TW,ANGINA UNSTABLE,6
TW,ANKLE FRACTURE,6
TW,AORTIC ANEURYSM,6
TW,AORTIC DISSECTION,6
TW,APLASIA PURE RED CELL,6
TW,ATRIOVENTRICULAR BLOCK COMPLETE,6
TW,BASEDOW^S DISEASE,6
TW,BILE DUCT STONE,6
TW,BLADDER CANCER,6
TW,BLAST CELL COUNT INCREASED,6
TW,BLOOD GLUCOSE ABNORMAL,6
TW,BLOOD LACTIC ACID INCREASED,6
TW,BLOOD PRESSURE ABNORMAL,6
TW,BLOOD URIC ACID INCREASED,6
TW,BODY TEMPERATURE DECREASED,6
TW,BRAIN ABSCESS,6
TW,BRONCHOSPASM,6
TW,CARBUNCLE,6
TW,CARDIAC FAILURE ACUTE,6
TW,CAUDA EQUINA SYNDROME,6
TW,CENTRAL NERVOUS SYSTEM NECROSIS,6
TW,CERVICAL DYSPLASIA,6
TW,CHOLANGIOCARCINOMA,6
TW,CLAVICLE FRACTURE,6
TW,COGNITIVE DISORDER,6
TW,COMMINUTED FRACTURE,6
TW,CYTOMEGALOVIRUS VIRAEMIA,6
TW,DERMATITIS EXFOLIATIVE,6
TW,DIFFUSE LARGE B-CELL LYMPHOMA,6
TW,DILATATION INTRAHEPATIC DUCT ACQUIRED,6
TW,ECZEMA ASTEATOTIC,6
TW,EMBOLISM VENOUS,6
TW,EMPYEMA,6
TW,EUPHORIC MOOD,6
TW,EXPOSED BONE IN JAW,6
TW,EXPOSURE DURING BREAST FEEDING,6
TW,FANCONI SYNDROME ACQUIRED,6
TW,FLUID RETENTION,6
TW,FOETAL DEATH,6
TW,GALLBLADDER POLYP,6
TW,GINGIVAL ABSCESS,6
TW,HEART RATE IRREGULAR,6
TW,HERPES SIMPLEX,6
TW,HYPERTONIC BLADDER,6
TW,INCORRECT ROUTE OF DRUG ADMINISTRATION,6
TW,INFECTIVE ANEURYSM,6
TW,INTERVERTEBRAL DISC DEGENERATION,6
TW,JOINT STIFFNESS,6
TW,LACRIMATION INCREASED,6
TW,LARYNGEAL OEDEMA,6
TW,LEFT VENTRICULAR HYPERTROPHY,6
TW,LEUKAEMIA,6
TW,LOWER RESPIRATORY TRACT INFLAMMATION,6
TW,LUMBAR SPINAL STENOSIS,6
TW,LYMPHOCYTE PERCENTAGE DECREASED,6
TW,MENINGITIS TUBERCULOUS,6
TW,MYELOFIBROSIS,6
TW,NORMAL NEWBORN,6
TW,OBSTRUCTIVE AIRWAYS DISORDER,6
TW,OCULAR HYPERAEMIA,6
TW,ORGAN FAILURE,6
TW,ORTHOPNOEA,6
TW,OTITIS MEDIA,6
TW,OTITIS MEDIA ACUTE,6
TW,OVARIAN CANCER,6
TW,PATHOLOGICAL FRACTURE,6
TW,PERITONEAL HAEMORRHAGE,6
TW,PETIT MAL EPILEPSY,6
TW,PNEUMATURIA,6
TW,PNEUMONIA CRYPTOCOCCAL,6
TW,PNEUMONIA KLEBSIELLA,6
TW,POLYNEUROPATHY,6
TW,PULSE ABSENT,6
TW,RADIATION PNEUMONITIS,6
TW,RADIUS FRACTURE,6
TW,RASH MACULO-PAPULAR,6
TW,RENAL ABSCESS,6
TW,RENAL INFARCT,6
TW,RENAL INJURY,6
TW,RESPIRATORY DEPRESSION,6
TW,SCROTAL SWELLING,6
TW,SHOCK HAEMORRHAGIC,6
TW,SKIN PLAQUE,6
TW,SMALL INTESTINAL HAEMORRHAGE,6
TW,SPLENIC ABSCESS,6
TW,SPUTUM INCREASED,6
TW,SUBCUTANEOUS ABSCESS,6
TW,SYNOVITIS,6
TW,THORACIC VERTEBRAL FRACTURE,6
TW,THROAT IRRITATION,6
TW,THYROID CANCER,6
TW,TOOTH EXTRACTION,6
TW,TRANSITIONAL CELL CARCINOMA,6
TW,TYPE IV HYPERSENSITIVITY REACTION,6
TW,UNDERDOSE,6
TW,UNRESPONSIVE TO STIMULI,6
TW,UPPER LIMB FRACTURE,6
TW,UVEITIS,6
TW,VENOUS THROMBOSIS,6
TW,VENTRICULAR EXTRASYSTOLES,6
TW,VIRAL MUTATION IDENTIFIED,6
TW,WOUND HAEMORRHAGE,6
TW,WOUND INFECTION STAPHYLOCOCCAL,6
TW,WRONG TECHNIQUE IN DRUG USAGE PROCESS,6
TW,ABDOMINAL MASS,5
TW,ABDOMINAL WALL HAEMATOMA,5
TW,ABSCESS LIMB,5
TW,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,5
TW,ACUTE PRERENAL FAILURE,5
TW,AMNESIA,5
TW,ANHEDONIA,5
TW,ARTHRITIS INFECTIVE,5
TW,ATRIAL FLUTTER,5
TW,ATRIOVENTRICULAR BLOCK,5
TW,ATYPICAL MYCOBACTERIAL INFECTION,5
TW,AUTONOMIC NERVOUS SYSTEM IMBALANCE,5
TW,AZOTAEMIA,5
TW,BEDRIDDEN,5
TW,BLOOD IMMUNOGLOBULIN E INCREASED,5
TW,BLOOD THYROID STIMULATING HORMONE INCREASED,5
TW,BRUCELLOSIS,5
TW,CACHEXIA,5
TW,CEREBELLAR INFARCTION,5
TW,CEREBELLAR SYNDROME,5
TW,CERVICAL SPINAL STENOSIS,5
TW,CHONDROCALCINOSIS PYROPHOSPHATE,5
TW,COMA SCALE ABNORMAL,5
TW,COMMUNICATION DISORDER,5
TW,CONJUNCTIVAL HAEMORRHAGE,5
TW,CROHN^S DISEASE,5
TW,DIARRHOEA INFECTIOUS,5
TW,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,5
TW,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,5
TW,DRY EYE,5
TW,DRY GANGRENE,5
TW,DUODENAL ULCER PERFORATION,5
TW,DYSLIPIDAEMIA,5
TW,DYSSTASIA,5
TW,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,5
TW,ENCEPHALITIS,5
TW,ENDOMETRIAL CANCER,5
TW,ENTERITIS,5
TW,ERECTILE DYSFUNCTION,5
TW,ERYTHEMA MULTIFORME,5
TW,EXCORIATION,5
TW,EXOPHTHALMOS,5
TW,EXTRA DOSE ADMINISTERED,5
TW,EYELID PTOSIS,5
TW,FIBRIN D DIMER INCREASED,5
TW,GASTROINTESTINAL NECROSIS,5
TW,GENERALISED ERYTHEMA,5
TW,GLYCOSYLATED HAEMOGLOBIN INCREASED,5
TW,GOUT,5
TW,HAEMANGIOMA,5
TW,HAEMOGLOBIN ABNORMAL,5
TW,HAEMOLYSIS,5
TW,HEMIPLEGIA,5
TJ,DEATH,4
TJ,CARDIAC FAILURE ACUTE,2
TJ,GENERAL PHYSICAL HEALTH DETERIORATION,2
TJ,POLYNEUROPATHY,2
TJ,PULMONARY OEDEMA,2
TJ,DIABETIC MACROANGIOPATHY,1
TJ,DRUG DOSE OMISSION,1
TJ,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
TJ,HAEMOGLOBIN DECREASED,1
TJ,HEPATIC ENZYME INCREASED,1
TJ,MENINGITIS TUBERCULOUS,1
TJ,NEPHROPATHY,1
TJ,PNEUMOTHORAX,1
TJ,PULMONARY TUBERCULOSIS,1
TJ,RENAL FAILURE,1
TJ,TREATMENT FAILURE,1
TJ,TREATMENT NONCOMPLIANCE,1
TZ,TREATMENT FAILURE,64
TZ,DRUG RESISTANCE,62
TZ,VIROLOGIC FAILURE,24
TZ,GENOTYPE DRUG RESISTANCE TEST POSITIVE,22
TZ,DEATH,21
TZ,ANAEMIA,6
TZ,DRUG-INDUCED LIVER INJURY,5
TZ,FATIGUE,4
TZ,THROMBOCYTOPENIA,4
TZ,ABORTION SPONTANEOUS,3
TZ,COUGH,3
TZ,EXPOSURE DURING PREGNANCY,3
TZ,MATERNAL DRUGS AFFECTING FOETUS,3
TZ,NAUSEA,3
TZ,OROPHARYNGEAL DISCOMFORT,3
TZ,THROAT IRRITATION,3
TZ,BONE TUBERCULOSIS,2
TZ,COMPLETED SUICIDE,2
TZ,DISSEMINATED INTRAVASCULAR COAGULATION,2
TZ,DIZZINESS,2
TZ,DYSPNOEA,2
TZ,FOETAL EXPOSURE DURING PREGNANCY,2
TZ,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
TZ,MALAISE,2
TZ,MATERNAL EXPOSURE DURING PREGNANCY,2
TZ,PULMONARY TUBERCULOSIS,2
TZ,SEPSIS NEONATAL,2
TZ,STILLBIRTH,2
TZ,TOXICITY TO VARIOUS AGENTS,2
TZ,TREATMENT NONCOMPLIANCE,2
TZ,ABDOMINAL MASS,1
TZ,ABDOMINAL PAIN LOWER,1
TZ,ABORTION INDUCED,1
TZ,ACUTE RESPIRATORY DISTRESS SYNDROME,1
TZ,ADVERSE EVENT,1
TZ,AGRANULOCYTOSIS,1
TZ,ALANINE AMINOTRANSFERASE INCREASED,1
TZ,ARTHRALGIA,1
TZ,ARTHROPATHY,1
TZ,ASPARTATE AMINOTRANSFERASE INCREASED,1
TZ,ASTHMA,1
TZ,BILIARY SEPSIS,1
TZ,BILIRUBIN CONJUGATED INCREASED,1
TZ,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
TZ,BREAST FEEDING,1
TZ,CACHEXIA,1
TZ,CD4 LYMPHOCYTES DECREASED,1
TZ,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
TZ,CEREBRAL INFARCTION,1
TZ,CEREBRAL TOXOPLASMOSIS,1
TZ,CHEST DISCOMFORT,1
TZ,CHEST PAIN,1
TZ,CHOKING,1
TZ,CHROMATURIA,1
TZ,CHRONIC MYELOID LEUKAEMIA,1
TZ,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
TZ,CONJUNCTIVAL HAEMORRHAGE,1
TZ,CRYING,1
TZ,CSF GLUCOSE ABNORMAL,1
TZ,CSF PROTEIN ABNORMAL,1
TZ,CSF WHITE BLOOD CELL COUNT POSITIVE,1
TZ,CYANOSIS,1
TZ,DEAFNESS UNILATERAL,1
TZ,DEATH NEONATAL,1
TZ,DECREASED APPETITE,1
TZ,DERMATOPHYTOSIS,1
TZ,DISEASE PROGRESSION,1
TZ,EXPOSURE DURING BREAST FEEDING,1
TZ,FOETAL DEATH,1
TZ,GASTROINTESTINAL STROMAL TUMOUR,1
TZ,GENE MUTATION,1
TZ,GENERAL PHYSICAL CONDITION ABNORMAL,1
TZ,GENERAL PHYSICAL HEALTH DETERIORATION,1
TZ,HAEMOGLOBIN DECREASED,1
TZ,HEMIPLEGIA,1
TZ,HEPATOMEGALY,1
TZ,HYPONATRAEMIA,1
TZ,IMPLANT SITE INFECTION,1
TZ,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
TZ,INCORRECT DOSE ADMINISTERED,1
TZ,INFERTILITY FEMALE,1
TZ,JOINT SWELLING,1
TZ,KAPOSI^S SARCOMA,1
TZ,LARGE INTESTINE PERFORATION,1
TZ,LOSS OF CONSCIOUSNESS,1
TZ,LYMPHADENITIS,1
TZ,MALIGNANT NEOPLASM PROGRESSION,1
TZ,MALNUTRITION,1
TZ,MELAENA,1
TZ,MENINGITIS TUBERCULOUS,1
TZ,METASTASES TO LIVER,1
TZ,NECROTISING COLITIS,1
TZ,NEONATAL ASPHYXIA,1
TZ,NEOPLASM MALIGNANT,1
TZ,ORAL CANDIDIASIS,1
TZ,OVERDOSE,1
TZ,PANCYTOPENIA,1
TZ,PERICARDITIS,1
TZ,PERITONITIS,1
TZ,PLATELET COUNT DECREASED,1
TZ,PNEUMOTHORAX,1
TZ,POSTPARTUM HAEMORRHAGE,1
TZ,PREGNANCY,1
TZ,PREMATURE BABY,1
TZ,PREMATURE DELIVERY,1
TZ,PREMATURE RUPTURE OF MEMBRANES,1
TZ,PRODUCTIVE COUGH,1
TZ,RESPIRATORY FAILURE,1
TZ,SECOND PRIMARY MALIGNANCY,1
TZ,SHOCK HAEMORRHAGIC,1
TZ,SMALL FOR DATES BABY,1
TZ,TALIPES,1
TZ,THERAPY NON-RESPONDER,1
TZ,TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM,1
TZ,TUBERCULOUS PLEURISY,1
TZ,TUMOUR INVASION,1
TZ,TYMPANIC MEMBRANE DISORDER,1
TZ,UNINTENDED PREGNANCY,1
TZ,UROSEPSIS,1
TZ,VAGINAL HAEMORRHAGE,1
TZ,WEIGHT DECREASED,1
TZ,WHITE BLOOD CELL COUNT DECREASED,1
TH,DEATH,682
TH,SEPSIS,212
TH,CARDIOVASCULAR DISORDER,159
TH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,144
TH,MALIGNANT NEOPLASM PROGRESSION,116
TH,PNEUMONIA,103
TH,FATIGUE,98
TH,PYREXIA,89
TH,DYSPNOEA,79
TH,DIARRHOEA,69
TH,INFECTION,65
TH,CARDIAC FAILURE,64
TH,VOMITING,63
TH,HEPATITIS,61
TH,NAUSEA,59
TH,CARDIAC ARREST,58
TH,SEPTIC SHOCK,52
TH,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,47
TH,DISEASE PROGRESSION,47
TH,THROMBOCYTOPENIA,47
TH,DRUG INEFFECTIVE,46
TH,RENAL FAILURE ACUTE,46
TH,ANAEMIA,45
TH,APNOEA,42
TH,DECREASED APPETITE,42
TH,GASTROINTESTINAL STROMAL TUMOUR,42
TH,POST PROCEDURAL COMPLICATION,41
TH,NEUTROPENIA,40
TH,FEBRILE NEUTROPENIA,39
TH,RASH,39
TH,ACUTE KIDNEY INJURY,37
TH,ERGOT POISONING,37
TH,OVERDOSE,36
TH,CEREBRAL HAEMORRHAGE,34
TH,LOSS OF CONSCIOUSNESS,33
TH,HYPERTENSION,32
TH,PULMONARY OEDEMA,32
TH,LUNG INFECTION,31
TH,RESPIRATORY FAILURE,31
TH,FALL,29
TH,FOETAL EXPOSURE DURING PREGNANCY,29
TH,HYPOTENSION,29
TH,MYOCARDIAL INFARCTION,29
TH,CARDIAC FAILURE CONGESTIVE,28
TH,CEREBROVASCULAR ACCIDENT,28
TH,HEADACHE,28
TH,HYPOKALAEMIA,28
TH,NEOPLASM PROGRESSION,28
TH,ASTHENIA,27
TH,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,27
TH,PAIN,27
TH,PANCYTOPENIA,26
TH,STEVENS-JOHNSON SYNDROME,26
TH,PRURITUS,25
TH,RASH MACULO-PAPULAR,25
TH,WEIGHT DECREASED,25
TH,ANAPHYLACTIC REACTION,24
TH,HYPOAESTHESIA,24
TH,PLATELET COUNT DECREASED,24
TH,CHRONIC MYELOID LEUKAEMIA,23
TH,DIZZINESS,23
TH,HYPONATRAEMIA,23
TH,DRUG RESISTANCE,22
TH,METASTASES TO LIVER,22
TH,SOMNOLENCE,22
TH,TOXIC EPIDERMAL NECROLYSIS,22
TH,HAEMORRHAGE,21
TH,HEPATIC ENZYME INCREASED,21
TH,STOMATITIS,21
TH,JAUNDICE,20
TH,OEDEMA,20
TH,PLEURAL EFFUSION,20
TH,RENAL FAILURE,20
TH,URINARY TRACT INFECTION,20
TH,ANGIOEDEMA,19
TH,COUGH,19
TH,GAIT DISTURBANCE,19
TH,MALNUTRITION,19
TH,MULTI-ORGAN FAILURE,19
TH,NO THERAPEUTIC RESPONSE,19
TH,PRODUCT USE IN UNAPPROVED INDICATION,19
TH,RENAL TUBULAR DYSFUNCTION,19
TH,TRANSPLANT REJECTION,19
TH,PAIN IN EXTREMITY,18
TH,ABORTION SPONTANEOUS,17
TH,ERYTHEMA,17
TH,HYPOGLYCAEMIA,17
TH,INSOMNIA,17
TH,MATERNAL EXPOSURE DURING PREGNANCY,17
TH,PERITONITIS,17
TH,TOXICITY TO VARIOUS AGENTS,17
TH,ABDOMINAL PAIN,16
TH,CHEST DISCOMFORT,16
TH,DRUG-INDUCED LIVER INJURY,16
TH,ELECTROCARDIOGRAM QT PROLONGED,16
TH,EXPOSURE DURING PREGNANCY,16
TH,HYPOPHAGIA,16
TH,OEDEMA PERIPHERAL,16
TH,BLOOD CREATININE INCREASED,15
TH,CARDIAC DISORDER,15
TH,HAEMORRHAGE INTRACRANIAL,15
TH,MULTIMORBIDITY,15
TH,NEUROMYELITIS OPTICA,15
TH,PRODUCT USE ISSUE,15
TH,SEIZURE,15
TH,VISION BLURRED,15
TH,ALANINE AMINOTRANSFERASE INCREASED,14
TH,BLOOD PRESSURE DECREASED,14
TH,CONDITION AGGRAVATED,14
TH,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,14
TH,HEPATIC FAILURE,14
TH,HEPATOTOXICITY,14
TH,ISCHAEMIC STROKE,14
TH,MALAISE,14
TH,METASTASES TO BONE,14
TH,MUCOSAL INFLAMMATION,14
TH,SUBDURAL HAEMATOMA,14
TH,ACUTE MYOCARDIAL INFARCTION,13
TH,ARTHRALGIA,13
TH,ASCITES,13
TH,ASPARTATE AMINOTRANSFERASE INCREASED,13
TH,BACK PAIN,13
TH,CHEST PAIN,13
TH,DEPRESSION,13
TH,DRUG HYPERSENSITIVITY,13
TH,METASTATIC RENAL CELL CARCINOMA,13
TH,MYALGIA,13
TH,SECOND PRIMARY MALIGNANCY,13
TH,ABDOMINAL DISCOMFORT,12
TH,GASTROINTESTINAL HAEMORRHAGE,12
TH,LYMPHADENOPATHY,12
TH,PALPITATIONS,12
TH,PULMONARY ARTERIAL HYPERTENSION,12
TH,PULMONARY MASS,12
TH,RASH ERYTHEMATOUS,12
TH,UPPER GASTROINTESTINAL HAEMORRHAGE,12
TH,ABDOMINAL PAIN UPPER,11
TH,ACCIDENT,11
TH,ANAPHYLACTIC SHOCK,11
TH,APHAGIA,11
TH,AUTOIMMUNE HEPATITIS,11
TH,CEREBRAL INFARCTION,11
TH,CHILLS,11
TH,CYTOMEGALOVIRUS INFECTION,11
TH,DEHYDRATION,11
TH,DRUG INTOLERANCE,11
TH,GASTROINTESTINAL DISORDER,11
TH,HAEMATOCRIT DECREASED,11
TH,HYPERSENSITIVITY,11
TH,MUSCLE RIGIDITY,11
TH,OSTEOPOROSIS,11
TH,RIGHT VENTRICULAR FAILURE,11
TH,ROAD TRAFFIC ACCIDENT,11
TH,SKIN EXFOLIATION,11
TH,SYNCOPE,11
TH,TREMOR,11
TH,URTICARIA,11
TH,ATRIAL FIBRILLATION,10
TH,CARDIOTOXICITY,10
TH,CEREBROVASCULAR DISORDER,10
TH,COMPLETED SUICIDE,10
TH,CONFUSIONAL STATE,10
TH,DECUBITUS ULCER,10
TH,DEEP VEIN THROMBOSIS,10
TH,DIABETIC KETOACIDOSIS,10
TH,HAEMOLYTIC ANAEMIA,10
TH,HAEMOPTYSIS,10
TH,HYPERGLYCAEMIA,10
TH,INTRAOCULAR PRESSURE INCREASED,10
TH,LIVER DISORDER,10
TH,METASTASES TO LUNG,10
TH,PALLOR,10
TH,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,10
TH,PARKINSONISM,10
TH,RENAL TUBULAR NECROSIS,10
TH,SHOCK,10
TH,UNEVALUABLE EVENT,10
TH,VIROLOGIC FAILURE,10
TH,WHEEZING,10
TH,WHITE BLOOD CELL COUNT DECREASED,10
TH,ABASIA,9
TH,BONE PAIN,9
TH,CONSTIPATION,9
TH,HYPOVOLAEMIC SHOCK,9
TH,LEUKOPENIA,9
TH,PULMONARY EMBOLISM,9
TH,RENAL FAILURE CHRONIC,9
TH,SUICIDE ATTEMPT,9
TH,WHITE BLOOD CELL COUNT INCREASED,9
TH,ACUTE HEPATIC FAILURE,8
TH,ACUTE RESPIRATORY FAILURE,8
TH,BRADYCARDIA,8
TH,BREAST CANCER,8
TH,CELLULITIS,8
TH,CHRONIC KIDNEY DISEASE,8
TH,CIRCULATORY COLLAPSE,8
TH,CYANOSIS,8
TH,DELIRIUM,8
TH,FLUID OVERLOAD,8
TH,FLUID RETENTION,8
TH,GENERAL PHYSICAL HEALTH DETERIORATION,8
TH,HAEMATOCHEZIA,8
TH,HEART RATE INCREASED,8
TH,INTENTIONAL OVERDOSE,8
TH,INTESTINAL OBSTRUCTION,8
TH,LUNG NEOPLASM MALIGNANT,8
TH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,8
TH,PERIPHERAL SWELLING,8
TH,PROTEINURIA,8
TH,RASH GENERALISED,8
TH,RENAL CELL CARCINOMA,8
TH,RENAL IMPAIRMENT,8
TH,RESTLESSNESS,8
TH,SCHIZOPHRENIA,8
TH,SEROTONIN SYNDROME,8
TH,SUDDEN DEATH,8
TH,THERAPY NON-RESPONDER,8
TH,VASCULITIS,8
TH,VISUAL ACUITY REDUCED,8
TH,AGITATION,7
TH,ALTERED STATE OF CONSCIOUSNESS,7
TH,BLISTER,7
TH,CONVULSION,7
TH,DIABETES MELLITUS,7
TH,DIARRHOEA INFECTIOUS,7
TH,DISCOMFORT,7
TH,GASTROENTERITIS,7
TH,HAEMATURIA,7
TH,HAEMOGLOBIN DECREASED,7
TH,HALLUCINATION,7
TH,HEART RATE DECREASED,7
TH,HEPATIC FUNCTION ABNORMAL,7
TH,INJECTION SITE PAIN,7
TH,INTERNATIONAL NORMALISED RATIO INCREASED,7
TH,KIDNEY TRANSPLANT REJECTION,7
TH,MOUTH ULCERATION,7
TH,OSTEONECROSIS OF JAW,7
TH,PEMPHIGOID,7
TH,PERICARDIAL EFFUSION,7
TH,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,7
TH,PULMONARY HAEMORRHAGE,7
TH,PULMONARY TUBERCULOSIS,7
TH,TOOTHACHE,7
TH,TRANSAMINASES INCREASED,7
TH,TREATMENT FAILURE,7
TH,TUBERCULOSIS,7
TH,ABORTION INDUCED,6
TH,ACUTE RESPIRATORY DISTRESS SYNDROME,6
TH,AGGRESSION,6
TH,BLOOD PRESSURE INCREASED,6
TH,BONE DENSITY DECREASED,6
TH,BRADYKINESIA,6
TH,BRONCHOSPASM,6
TH,CARDIOMEGALY,6
TH,CHOKING,6
TH,CHOLECYSTITIS ACUTE,6
TH,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,6
TH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,6
TH,COMA,6
TH,CONTUSION,6
TH,CORNEAL OEDEMA,6
TH,DEMENTIA,6
TH,DISSEMINATED INTRAVASCULAR COAGULATION,6
TH,DRUG CROSS-REACTIVITY,6
TH,DRUG DOSE OMISSION,6
TH,DRUG PRESCRIBING ERROR,6
TH,DUODENAL ULCER HAEMORRHAGE,6
TH,DYSGEUSIA,6
TH,DYSKINESIA,6
TH,EYE HAEMORRHAGE,6
TH,EYE PAIN,6
TH,EYE SWELLING,6
TH,FEEDING DISORDER,6
TH,GASTRITIS,6
TH,GROWTH RETARDATION,6
TH,HAEMORRHAGIC STROKE,6
TH,HALLUCINATION_ VISUAL,6
TH,HEPATIC MASS,6
TH,HEPATITIS C,6
TH,HYPERKALAEMIA,6
TH,HYPOPHOSPHATAEMIA,6
TH,LIP SWELLING,6
TH,METASTASIS,6
TH,MOBILITY DECREASED,6
TH,MUCORMYCOSIS,6
TH,MUSCLE SPASMS,6
TH,NEOPLASM RECURRENCE,6
TH,NEUROPATHY PERIPHERAL,6
TH,NEUTROPHIL COUNT DECREASED,6
TH,OPPORTUNISTIC INFECTION,6
TH,PREMATURE BABY,6
TH,PREMATURE DELIVERY,6
TH,PSYCHOTIC DISORDER,6
TH,RENAL INJURY,6
TH,RHABDOMYOLYSIS,6
TH,STRESS,6
TH,VENTRICULAR TACHYCARDIA,6
TH,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,6
TH,ACUTE LYMPHOCYTIC LEUKAEMIA,5
TH,ACUTE PSYCHOSIS,5
TH,ADVERSE EVENT,5
TH,AKINESIA,5
TH,ANGINA UNSTABLE,5
TH,APPENDICITIS,5
TH,BLOOD BILIRUBIN INCREASED,5
TH,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,5
TH,BONE MARROW FAILURE,5
TH,BRAIN OEDEMA,5
TH,CAESAREAN SECTION,5
TH,CHOLECYSTITIS,5
TH,COGNITIVE DISORDER,5
TH,COLITIS,5
TH,CUSHING^S SYNDROME,5
TH,DENGUE FEVER,5
TH,DRUG WITHDRAWAL SYNDROME,5
TH,DRY SKIN,5
TH,ELECTROLYTE IMBALANCE,5
TH,ENDOPHTHALMITIS,5
TH,FACE OEDEMA,5
TH,FLATULENCE,5
TH,GASTROOESOPHAGEAL REFLUX DISEASE,5
TH,HEAD INJURY,5
TH,HEPATITIS B,5
TH,HIP FRACTURE,5
TH,HYPERHIDROSIS,5
TH,HYPOACUSIS,5
TH,HYPOCALCAEMIA,5
TH,INTRAVENTRICULAR HAEMORRHAGE,5
TH,LACTIC ACIDOSIS,5
TH,LOCAL SWELLING,5
TH,METABOLIC ACIDOSIS,5
TH,MUSCULAR WEAKNESS,5
TH,MYOCARDITIS,5
TH,NEOPLASM,5
TH,NEPHROPATHY TOXIC,5
TH,NOCARDIOSIS,5
TH,OSTEOPENIA,5
TH,OVARIAN DISORDER,5
TH,PARAESTHESIA,5
TH,PERITONEAL CLOUDY EFFLUENT,5
TH,PERITONITIS BACTERIAL,5
TH,PNEUMONIA ASPIRATION,5
TH,PNEUMONIA BACTERIAL,5
TH,PREMATURE RUPTURE OF MEMBRANES,5
TH,PROSTATE CANCER,5
TH,PULMONARY HYPERTENSION,5
TH,PULSE ABSENT,5
TH,PUNCTATE KERATITIS,5
TH,RASH PRURITIC,5
TH,SKIN INFECTION,5
TH,SKIN LESION,5
TH,SUBSTANCE ABUSE,5
TH,SUICIDAL IDEATION,5
TH,THERAPEUTIC RESPONSE DECREASED,5
TH,TRACHEOBRONCHITIS,5
TH,URETERIC OBSTRUCTION,5
TH,WEIGHT INCREASED,5
TH,ABNORMAL BEHAVIOUR,4
TH,ACNE,4
TH,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,4
TH,ADRENAL INSUFFICIENCY,4
TH,APLASIA PURE RED CELL,4
TH,ARRHYTHMIA,4
TH,ASPERGILLUS INFECTION,4
TH,ATRIOVENTRICULAR BLOCK FIRST DEGREE,4
TH,ATRIOVENTRICULAR BLOCK SECOND DEGREE,4
TH,AUTOIMMUNE HAEMOLYTIC ANAEMIA,4
TH,BLINDNESS,4
TH,BLOOD ALKALINE PHOSPHATASE INCREASED,4
TH,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
TH,CARDIOMYOPATHY,4
TH,CHOLELITHIASIS,4
TH,CHOLESTASIS,4
TH,CHOREOATHETOSIS,4
TH,CILIARY HYPERAEMIA,4
TH,COLON CANCER,4
TH,CONJUNCTIVITIS,4
TH,CORNEAL EPITHELIUM DEFECT,4
TH,DELUSION,4
TH,DEVICE RELATED INFECTION,4
TH,DISSEMINATED TUBERCULOSIS,4
TH,DYSPEPSIA,4
TH,DYSTONIA,4
TH,EMBOLISM,4
TH,END STAGE RENAL DISEASE,4
TH,EPILEPSY,4
TH,ESCHERICHIA SEPSIS,4
TH,EXOSTOSIS,4
TH,EXTRAPYRAMIDAL DISORDER,4
TH,EYE OEDEMA,4
TH,EYELID OEDEMA,4
TH,FANCONI SYNDROME ACQUIRED,4
TH,FLUSHING,4
TH,GENERALISED ERYTHEMA,4
TH,GENERALISED TONIC-CLONIC SEIZURE,4
TH,HAEMATEMESIS,4
TH,HAEMOLYSIS,4
TH,HEPATIC CIRRHOSIS,4
TH,HEPATIC ENCEPHALOPATHY,4
TH,HEPATOCELLULAR CARCINOMA,4
TH,HIV INFECTION,4
TH,HYPOMAGNESAEMIA,4
TH,HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION,4
TH,HYPOTHYROIDISM,4
TH,ILEAL ULCER,4
TH,INCORRECT DOSE ADMINISTERED,4
TH,INJURY,4
TH,INTERSTITIAL LUNG DISEASE,4
TH,INTESTINAL PERFORATION,4
TH,LACUNAR INFARCTION,4
TH,LEFT VENTRICULAR DYSFUNCTION,4
TH,LIVER FUNCTION TEST ABNORMAL,4
TH,LUNG CANCER METASTATIC,4
TH,LUNG INFILTRATION,4
TH,LYMPHOMA,4
TH,METASTASES TO CENTRAL NERVOUS SYSTEM,4
TH,METASTASES TO PERITONEUM,4
TH,MINI MENTAL STATUS EXAMINATION ABNORMAL,4
TH,MYELODYSPLASTIC SYNDROME,4
TH,NEOPLASM MALIGNANT,4
TH,NEUTROPENIC SEPSIS,4
TH,NIGHTMARE,4
TH,OCULAR HYPERAEMIA,4
TH,ORAL CANDIDIASIS,4
TH,OSTEONECROSIS,4
TH,PARONYCHIA,4
TH,PERICARDITIS,4
TH,PERIPHERAL COLDNESS,4
TH,PERITONEAL DIALYSIS COMPLICATION,4
TH,PNEUMOCYSTIS JIROVECII PNEUMONIA,4
TH,PNEUMOTHORAX SPONTANEOUS,4
TH,PREGNANCY,4
TH,PURPURA,4
TH,RENAL DISORDER,4
TH,RENAL FUNCTION TEST ABNORMAL,4
TH,RHINORRHOEA,4
TH,SYSTEMIC LUPUS ERYTHEMATOSUS,4
TH,TACHYCARDIA,4
TH,TUMOUR HAEMORRHAGE,4
TH,TUMOUR LYSIS SYNDROME,4
TH,TUMOUR RUPTURE,4
TH,UNDERDOSE,4
TH,URINARY RETENTION,4
TH,VAGINAL HAEMORRHAGE,4
TH,VITAMIN D DECREASED,4
TH,WRONG DRUG ADMINISTERED,4
TH,ABDOMINAL DISTENSION,3
TH,ABDOMINAL INFECTION,3
TH,ABDOMINAL LYMPHADENOPATHY,3
TH,ACETABULUM FRACTURE,3
TH,ACUTE CORONARY SYNDROME,3
TH,ACUTE MYELOID LEUKAEMIA,3
TH,AGRANULOCYTOSIS,3
TH,ALOPECIA,3
TH,ANXIETY,3
TH,ATAXIA,3
TH,AZOTAEMIA,3
TH,BACTERIAL INFECTION,3
TH,BACTERIAL SEPSIS,3
TH,BALANCE DISORDER,3
TH,BEDRIDDEN,3
TH,BILE DUCT STONE,3
TH,BLADDER CANCER,3
TH,BLOOD MAGNESIUM DECREASED,3
TH,BONE DISORDER,3
TH,BREAST CANCER METASTATIC,3
TH,BRONCHIECTASIS,3
TH,BRONCHOPULMONARY ASPERGILLOSIS,3
TH,CANDIDA INFECTION,3
TH,CARDIAC FAILURE ACUTE,3
TH,CARDIAC TAMPONADE,3
TH,CARDIO-RESPIRATORY ARREST,3
TH,CEREBRAL DISORDER,3
TH,CERVICAL DYSPLASIA,3
TH,CHOLANGITIS,3
TH,CHOROIDAL DETACHMENT,3
TH,COAGULOPATHY,3
TH,COLOUR BLINDNESS,3
TH,CREATININE RENAL CLEARANCE DECREASED,3
TH,CYTOMEGALOVIRUS CHORIORETINITIS,3
TH,CYTOPENIA,3
TH,DEAFNESS,3
TH,DENTAL CARIES,3
TH,DEPRESSED LEVEL OF CONSCIOUSNESS,3
TH,DERMATITIS ALLERGIC,3
TH,DIABETES INSIPIDUS,3
TH,DIRECTIONAL DOPPLER FLOW TESTS ABNORMAL,3
TH,DISEASE COMPLICATION,3
TH,DISTURBANCE IN ATTENTION,3
TH,DRUG EFFECT DECREASED,3
TH,DRY MOUTH,3
TH,DYSPHAGIA,3
TH,DYSPHONIA,3
TH,DYSURIA,3
TH,EATING DISORDER,3
TH,EMBOLIC STROKE,3
TH,ENCEPHALITIS,3
TH,ENDOCARDITIS,3
TH,ENDOCARDITIS ENTEROCOCCAL,3
TH,EPISTAXIS,3
TH,EXTRAVASATION BLOOD,3
TH,EYE IRRITATION,3
TH,FLAT ANTERIOR CHAMBER OF EYE,3
TH,FOETAL DEATH,3
TH,FRACTURE,3
TH,FUNGAL PERITONITIS,3
TH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
TH,GASTRIC ULCER,3
TH,GENERALISED OEDEMA,3
TH,GINGIVAL BLEEDING,3
TH,GINGIVAL SWELLING,3
TH,GINGIVITIS,3
TH,GLAUCOMA,3
TH,GLOSSODYNIA,3
TH,HAEMORRHOIDS,3
TH,HEPATIC NEOPLASM,3
TH,HEPATIC STEATOSIS,3
TH,HEPATITIS TOXIC,3
TH,HEPATOCELLULAR INJURY,3
TH,HEPATOMEGALY,3
TH,HERPES ZOSTER,3
TH,HISTIOCYTOSIS HAEMATOPHAGIC,3
TH,HYDROPS FOETALIS,3
TH,HYPERCALCAEMIA,3
TH,HYPERINSULINAEMIC HYPOGLYCAEMIA,3
TH,HYPOKINESIA,3
TH,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,3
TH,IMMUNE-MEDIATED NECROTISING MYOPATHY,3
TH,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,3
TH,IMPAIRED FASTING GLUCOSE,3
TH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
TH,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
TH,INFLUENZA,3
TH,INFLUENZA LIKE ILLNESS,3
TH,INTENTIONAL PRODUCT MISUSE,3
TH,INTRAOCULAR PRESSURE DECREASED,3
TH,IRON DEFICIENCY ANAEMIA,3
TH,IRRITABILITY,3
TH,JAUNDICE NEONATAL,3
TH,KERATITIS BACTERIAL,3
TH,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
TH,LETHARGY,3
TH,LICHEN PLANUS,3
TH,LIVE BIRTH,3
TH,LIVER INJURY,3
TH,LOOSE TOOTH,3
TH,MASTICATION DISORDER,3
TH,MEMORY IMPAIRMENT,3
TH,MOUTH SWELLING,3
TH,MYASTHENIA GRAVIS,3
TH,MYCOBACTERIAL INFECTION,3
TH,MYOCARDIAL ISCHAEMIA,3
TH,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,3
TH,NASOPHARYNGITIS,3
TH,NEPHROPATHY,3
TH,NEPHROTIC SYNDROME,3
TH,OCULAR ICTERUS,3
TH,OESOPHAGEAL CANDIDIASIS,3
TH,OESOPHAGEAL VARICES HAEMORRHAGE,3
TH,OLIGURIA,3
TH,ORAL PAIN,3
TH,OROPHARYNGEAL PAIN,3
TH,PANCREATITIS ACUTE,3
TH,PENILE BURNING SENSATION,3
TH,PENILE PAIN,3
TH,PERIORBITAL OEDEMA,3
TH,PLASMA CELL MYELOMA,3
TH,PNEUMONITIS,3
TH,PNEUMOTHORAX,3
TH,POISONING DELIBERATE,3
TH,PREGNANCY ON CONTRACEPTIVE,3
TH,PREMATURE LABOUR,3
TH,PRODUCT QUALITY ISSUE,3
TH,PULMONARY CONGESTION,3
TH,RED BLOOD CELL COUNT DECREASED,3
TH,RETINAL DETACHMENT,3
TH,RETINAL HAEMORRHAGE,3
TH,RETINAL VASCULITIS,3
TH,SALIVARY HYPERSECRETION,3
TH,SENSITIVITY OF TEETH,3
TH,SINUS BRADYCARDIA,3
TH,SKIN DISCOLOURATION,3
TH,SKIN ULCER,3
TH,SPLENOMEGALY,3
TH,STILLBIRTH,3
TH,SUBARACHNOID HAEMORRHAGE,3
TH,SUPRAVENTRICULAR TACHYCARDIA,3
TH,SWELLING,3
TH,TENDONITIS,3
TH,THERAPEUTIC RESPONSE SHORTENED,3
TH,THYROID GLAND ABSCESS,3
TH,THYROTOXIC CRISIS,3
TH,TOOTH DISORDER,3
TH,TREATMENT NONCOMPLIANCE,3
TH,TYPE I HYPERSENSITIVITY,3
TH,UVEITIS,3
TH,VISUAL IMPAIRMENT,3
TH,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
TH,ABORTION,2
TH,ABORTION THREATENED,2
TH,ABSCESS,2
TH,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,2
TH,ACIDOSIS,2
TH,ACTIVITIES OF DAILY LIVING IMPAIRED,2
TH,ACUTE PRERENAL FAILURE,2
TH,ACUTE TONSILLITIS,2
TH,ADENOVIRAL HAEMORRHAGIC CYSTITIS,2
TH,AFFECT LABILITY,2
TH,ANGER,2
TH,ANIMAL BITE,2
TH,ANTERIOR CHAMBER CELL,2
TH,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,2
TH,ANURIA,2
TH,AORTIC ANEURYSM,2
TH,APHASIA,2
TH,ARTERIOSCLEROSIS,2
TH,ASPHYXIA,2
TH,ASTHMA,2
TH,ATELECTASIS,2
TH,ATRIOVENTRICULAR BLOCK,2
TH,BASAL GANGLIA INFARCTION,2
TH,BILE DUCT OBSTRUCTION,2
TH,BLINDNESS TRANSIENT,2
TH,BLOOD CHOLESTEROL INCREASED,2
TH,BLOOD CREATINE INCREASED,2
TH,BLOOD GONADOTROPHIN DECREASED,2
TH,BLOOD KETONE BODY INCREASED,2
TH,BLOOD PRESSURE FLUCTUATION,2
TH,BLOOD TRIGLYCERIDES INCREASED,2
TH,BLOOD UREA INCREASED,2
TH,BLOOD URIC ACID INCREASED,2
TH,BODY TEMPERATURE INCREASED,2
TH,BONE CANCER,2
TH,BONE TUBERCULOSIS,2
TH,BRAIN NATRIURETIC PEPTIDE INCREASED,2
TH,BRAIN NEOPLASM,2
TH,BRAIN NEOPLASM MALIGNANT,2
TH,BRAIN STEM INFARCTION,2
TH,BRONCHIAL DISORDER,2
TH,BRONCHITIS,2
TH,CACHEXIA,2
TH,CARDIAC PROCEDURE COMPLICATION,2
TH,CARDIAC VALVE DISEASE,2
TH,CARDIOGENIC SHOCK,2
TH,CATARACT,2
TH,CENTRAL NERVOUS SYSTEM LESION,2
TH,CEREBELLAR HAEMORRHAGE,2
TH,CEREBRAL ATROPHY,2
TH,CEREBRAL VENTRICLE DILATATION,2
TH,CERVIX CARCINOMA,2
TH,CHOLANGITIS ACUTE,2
TH,CHOLECYSTITIS INFECTIVE,2
TH,CHRONIC MYELOID LEUKAEMIA RECURRENT,2
TH,COLITIS ISCHAEMIC,2
TH,COLORECTAL CANCER METASTATIC,2
TH,COMPRESSION FRACTURE,2
TH,CONCOMITANT DISEASE PROGRESSION,2
TH,CONGENITAL ANOMALY,2
TH,CONJUNCTIVAL HAEMORRHAGE,2
TH,CONJUNCTIVAL HYPERAEMIA,2
TH,CORNEAL DISORDER,2
TH,CREATININE RENAL CLEARANCE INCREASED,2
TH,CYSTOID MACULAR OEDEMA,2
TH,CYTOGENETIC ANALYSIS ABNORMAL,2
TH,DEVICE LEAKAGE,2
TH,DIABETIC NEPHROPATHY,2
TH,DIFFUSE LARGE B-CELL LYMPHOMA,2
TH,DISEASE RECURRENCE,2
TH,DISORIENTATION,2
TH,DISSEMINATED CRYPTOCOCCOSIS,2
TH,DIVERTICULITIS,2
TH,DRUG ABUSE,2
TH,DRUG ERUPTION,2
TH,DRUG LEVEL DECREASED,2
TH,DRUG LEVEL INCREASED,2
TH,EAR INFECTION,2
TH,EAR SWELLING,2
TH,EMOTIONAL DISTRESS,2
TH,EMPHYSEMA,2
TH,EMPYEMA,2
TH,ENCEPHALOPATHY,2
TH,ERUCTATION,2
TH,ERYTHEMA MULTIFORME,2
TH,ESCHERICHIA INFECTION,2
TH,ESCHERICHIA URINARY TRACT INFECTION,2
TH,EXTRADURAL HAEMATOMA,2
TH,FOLLICULITIS,2
TH,FOOD INTERACTION,2
TH,FOOD POISONING,2
TH,FUNGAL INFECTION,2
TH,GAIT INABILITY,2
TH,GANGRENE,2
TH,GASTRIC HAEMORRHAGE,2
TH,GASTRITIS HAEMORRHAGIC,2
TH,GASTROINTESTINAL CANDIDIASIS,2
TH,GLOMERULAR FILTRATION RATE DECREASED,2
TH,GLOMERULONEPHRITIS PROLIFERATIVE,2
TH,GLYCOSURIA,2
TH,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
TH,GOUTY ARTHRITIS,2
TH,GUILLAIN-BARRE SYNDROME,2
TH,HAEMATOMA,2
TH,HAEMATOTOXICITY,2
TH,HEMIPARESIS,2
TH,HEMIPLEGIA,2
TH,HEPATIC CANCER,2
TH,HEPATIC ENZYME ABNORMAL,2
TH,HERPES VIRUS INFECTION,2
TH,HERPES ZOSTER DISSEMINATED,2
TH,HIV TEST POSITIVE,2
TH,HOSPITALISATION,2
TH,HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION,2
TH,HUMERUS FRACTURE,2
TH,HYDRONEPHROSIS,2
TH,HYPERAESTHESIA,2
TH,HYPERCHOLESTEROLAEMIA,2
TH,HYPERNATRAEMIA,2
TH,HYPERSENSITIVITY VASCULITIS,2
TH,HYPERTENSIVE CRISIS,2
TH,HYPERTHYROIDISM,2
TH,HYPERVENTILATION,2
TH,HYPERVOLAEMIA,2
TH,HYPHAEMA,2
TH,HYPOTONY OF EYE,2
TH,HYPOVOLAEMIA,2
TH,HYPOXIA,2
TH,HYSTERECTOMY,2
TH,IMMUNODEFICIENCY,2
TH,INFLAMMATION,2
TH,INFUSION RELATED REACTION,2
TH,INGUINAL HERNIA,2
TH,INTRACRANIAL PRESSURE INCREASED,2
TH,IRIS ADHESIONS,2
TH,ISCHAEMIA,2
TH,JAUNDICE CHOLESTATIC,2
TH,KETOACIDOSIS,2
TH,KLEBSIELLA SEPSIS,2
TH,LARGE INTESTINAL ULCER,2
TH,LEUKAEMIA RECURRENT,2
TH,LEUKOCYTOCLASTIC VASCULITIS,2
TH,LEUKOCYTOSIS,2
TH,LIMB DISCOMFORT,2
TH,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
TH,LOW BIRTH WEIGHT BABY,2
TH,LOWER LIMB FRACTURE,2
TH,LUNG ABSCESS,2
TH,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,2
TH,LYMPHOCYTE COUNT DECREASED,2
TH,MASS,2
TH,MEDICATION ERROR,2
TH,MELAENA,2
TH,MENINGITIS BACTERIAL,2
TH,METASTASES TO LYMPH NODES,2
TH,METASTASES TO SPINE,2
TH,METASTATIC NEOPLASM,2
TH,MINERAL DEFICIENCY,2
TH,MOOD ALTERED,2
TH,MULTIPLE SCLEROSIS,2
TH,MUSCLE SPASTICITY,2
TH,MUSCLE TIGHTNESS,2
TH,MUSCULOSKELETAL STIFFNESS,2
TH,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,2
TH,MYOPATHY,2
TH,NASAL CONGESTION,2
TH,NECK PAIN,2
TH,NEEDLE ISSUE,2
TH,NEPHROLITHIASIS,2
TH,NERVE COMPRESSION,2
TH,NEUROGENIC SHOCK,2
TH,NODAL RHYTHM,2
TH,NODULE,2
TH,NONINFECTIOUS PERITONITIS,2
TH,NOSOCOMIAL INFECTION,2
TH,OBSTRUCTIVE AIRWAYS DISORDER,2
TH,OESOPHAGEAL HAEMORRHAGE,2
TH,OPTICAL COHERENCE TOMOGRAPHY ABNORMAL,2
TH,ORAL DISORDER,2
TH,OXYGEN SATURATION DECREASED,2
TH,PAPULE,2
TH,PARANOIA,2
TH,PARTIAL SEIZURES,2
TH,PASSENGER LYMPHOCYTE SYNDROME,2
TH,PENILE VEIN THROMBOSIS,2
TH,PERIODONTITIS,2
TH,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
TH,PERIPHERAL ISCHAEMIA,2
TH,PERIPROSTHETIC FRACTURE,2
TH,PERITONEAL EFFLUENT ABNORMAL,2
TH,PERSONAL RELATIONSHIP ISSUE,2
TH,PHOTOSENSITIVITY REACTION,2
TH,PNEUMONIA PSEUDOMONAL,2
TH,POLYARTERITIS NODOSA,2
TH,POLYURIA,2
TH,POOR QUALITY DRUG ADMINISTERED,2
TH,PORTAL VEIN THROMBOSIS,2
TH,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,2
TH,POSTERIOR CORTICAL ATROPHY,2
TH,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
TH,POSTICTAL PSYCHOSIS,2
TH,PREGNANCY WITH IMPLANT CONTRACEPTIVE,2
TH,PRESCRIBED OVERDOSE,2
TH,PRIAPISM,2
TH,PRODUCT CONTAINER ISSUE,2
TH,PRODUCT SHAPE ISSUE,2
TH,PRODUCTIVE COUGH,2
TH,PROTHROMBIN TIME PROLONGED,2
TH,PULMONARY SEPSIS,2
TH,PYELONEPHRITIS,2
TH,PYELONEPHRITIS ACUTE,2
TH,RECTAL HAEMORRHAGE,2
TH,RECURRENT CANCER,2
TH,RENAL CANCER,2
TH,RESPIRATORY DEPRESSION,2
TH,RESPIRATORY TRACT INFECTION,2
TH,RETINAL DEPIGMENTATION,2
TH,RETINAL THICKENING,2
TH,RETINOPATHY,2
TH,SCHIZOAFFECTIVE DISORDER,2
TH,SECONDARY ADRENOCORTICAL INSUFFICIENCY,2
TH,SEDATION,2
TH,SENSORY LOSS,2
TH,SERUM SICKNESS,2
TH,SIALOADENITIS,2
TH,SINUSITIS,2
TH,SKIN ATROPHY,2
TH,SKIN HYPERPIGMENTATION,2
TH,SKIN PLAQUE,2
TH,SKIN REACTION,2
TH,SLEEP DISORDER,2
TH,SPEECH DISORDER,2
TH,SPINAL CORD COMPRESSION,2
TH,STATUS EPILEPTICUS,2
TH,STERILE PYURIA,2
TH,STRESS CARDIOMYOPATHY,2
TH,SUBCUTANEOUS ABSCESS,2
TH,SUBDURAL HAEMORRHAGE,2
TH,SUPRAVENTRICULAR EXTRASYSTOLES,2
TH,SWELLING FACE,2
TH,SYSTEMIC CANDIDA,2
TH,TESTICULAR DISORDER,2
TH,THROMBOSIS,2
TH,THYROIDITIS,2
TH,TONIC CONVULSION,2
TH,TRANSIENT ISCHAEMIC ATTACK,2
TH,TROPONIN T INCREASED,2
TH,ULCER,2
TH,ULCERATIVE KERATITIS,2
TH,UNINTENDED PREGNANCY,2
TH,UREA RENAL CLEARANCE DECREASED,2
TH,URINARY TRACT DISORDER,2
TH,VENTRICULAR EXTRASYSTOLES,2
TH,VERTIGO,2
TH,VIRAL INFECTION,2
TH,VISUAL FIELD DEFECT,2
TH,VITAMIN D DEFICIENCY,2
TH,WHITE MATTER LESION,2
TH,WOUND,2
TH,WOUND INFECTION,2
TH,ABDOMINAL ABSCESS,1
TH,ABDOMINAL MASS,1
TH,ABDOMINAL NEOPLASM,1
TH,ABNORMAL WITHDRAWAL BLEEDING,1
TH,ABORTION COMPLETE,1
TH,ABORTION INCOMPLETE,1
TH,ABSCESS NECK,1
TH,ACCIDENTAL EXPOSURE TO PRODUCT,1
TH,ACINETOBACTER INFECTION,1
TH,ACOUSTIC NEUROMA,1
TH,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
TH,ACUTE ABDOMEN,1
TH,ACUTE GRAFT VERSUS HOST DISEASE,1
TH,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
TH,ACUTE HEPATITIS C,1
TH,ACUTE LEUKAEMIA,1
TH,ACUTE LUNG INJURY,1
TH,ACUTE POLYNEUROPATHY,1
TH,ACUTE PULMONARY OEDEMA,1
TH,ADENOMYOSIS,1
TH,ADJUSTMENT DISORDER,1
TH,AIDS RELATED COMPLICATION,1
TH,AKATHISIA,1
TH,ALBUMINURIA,1
TH,ALCOHOL USE,1
TH,ALPHA 1 FOETOPROTEIN INCREASED,1
TH,ALVEOLITIS ALLERGIC,1
TH,AMBLYOPIA,1
TH,AMNESIA,1
TH,AMOEBIC DYSENTERY,1
TH,AMYLASE INCREASED,1
TH,AMYOTROPHIC LATERAL SCLEROSIS,1
TH,ANAEMIA HAEMOLYTIC AUTOIMMUNE,1
TH,ANAEMIA POSTOPERATIVE,1
TH,ANGINA PECTORIS,1
TH,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT,1
TH,ANGIOSARCOMA METASTATIC,1
TH,ANGULAR CHEILITIS,1
TH,ANKLE FRACTURE,1
TH,ANOGENITAL WARTS,1
TH,ANTERIOR CHAMBER DISORDER,1
TH,AORTIC ANEURYSM RUPTURE,1
TH,AORTIC STENOSIS,1
TH,APATHY,1
TH,APHAKIA,1
TH,APHONIA,1
TH,AREFLEXIA,1
TH,ARTERIAL HAEMORRHAGE,1
TH,ARTERIAL SPASM,1
TH,ARTERIAL THROMBOSIS,1
TH,ARTHRITIS,1
TH,ARTHRITIS BACTERIAL,1
TH,ARTHROPOD BITE,1
TH,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
TH,ASPERGILLOSIS,1
TH,ASPIRATION PLEURAL CAVITY,1
TH,ASTERIXIS,1
TH,ASYMPTOMATIC BACTERIURIA,1
TH,ATRIAL SEPTAL DEFECT,1
TH,ATYPICAL MYCOBACTERIAL INFECTION,1
TH,AUTOIMMUNE DISORDER,1
TH,BACTERAEMIA,1
TH,BASEDOW^S DISEASE,1
TH,BENIGN PANCREATIC NEOPLASM,1
TH,BICYTOPENIA,1
TH,BILIARY TRACT INFECTION,1
TH,BLEPHAROSPASM,1
TH,BLOOD BILIRUBIN ABNORMAL,1
TH,BLOOD CALCIUM ABNORMAL,1
TH,BLOOD CALCIUM DECREASED,1
TH,BLOOD DISORDER,1
TH,BLOOD GLUCOSE ABNORMAL,1
TH,BLOOD GLUCOSE DECREASED,1
TH,BLOOD GLUCOSE FLUCTUATION,1
TH,BLOOD GLUCOSE INCREASED,1
TH,BLOOD LACTATE DEHYDROGENASE INCREASED,1
TH,BLOOD OSMOLARITY INCREASED,1
TH,BLOOD POTASSIUM DECREASED,1
TH,BLOOD PRESSURE ABNORMAL,1
TH,BLOOD PRESSURE IMMEASURABLE,1
TH,BLOOD PRESSURE SYSTOLIC INCREASED,1
TH,BLOOD SODIUM DECREASED,1
TH,BLOOD THYROID STIMULATING HORMONE INCREASED,1
TH,BODY TEMPERATURE ABNORMAL,1
TH,BODY TEMPERATURE DECREASED,1
TH,BONE LOSS,1
TH,BONE MARROW DISORDER,1
TH,BONE OPERATION,1
TH,BRAIN ABSCESS,1
TH,BRAIN COMPRESSION,1
TH,BRAIN DEATH,1
TH,BRAIN MASS,1
TH,BRAIN MIDLINE SHIFT,1
TH,BREAST NEOPLASM,1
TH,BRONCHIAL DYSPLASIA,1
TH,BRONCHIAL OBSTRUCTION,1
TH,BRONCHIAL WALL THICKENING,1
TH,BRUXISM,1
TH,BURKHOLDERIA PSEUDOMALLEI INFECTION,1
TH,BURNING SENSATION,1
TH,CALCULUS URETERIC,1
TH,CAPILLARY FRAGILITY,1
TH,CARCINOEMBRYONIC ANTIGEN INCREASED,1
TH,CARDIAC ABLATION,1
TH,CARDIAC FAILURE CHRONIC,1
TH,CARDIAC FAILURE HIGH OUTPUT,1
TH,CARDIAC OUTPUT DECREASED,1
TH,CARDIAC SIDEROSIS,1
TH,CATARACT SUBCAPSULAR,1
TH,CATHETER SITE HAEMORRHAGE,1
TH,CATHETER SITE INFECTION,1
TH,CENTRAL NERVOUS SYSTEM FUNCTION TEST ABNORMAL,1
TH,CENTRAL NERVOUS SYSTEM INFECTION,1
TH,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
TH,CENTRAL-ALVEOLAR HYPOVENTILATION,1
TH,CEREBELLAR HAEMATOMA,1
TH,CEREBRAL ARTERY THROMBOSIS,1
TH,CEREBRAL CONGESTION,1
TH,CEREBRAL ISCHAEMIA,1
TH,CEREBRAL THROMBOSIS,1
TH,CEREBROSPINAL FLUID LEAKAGE,1
TH,CERVIX HAEMORRHAGE UTERINE,1
TH,CHAPPED LIPS,1
TH,CHEILITIS,1
TH,CHEST INJURY,1
TH,CHEST X-RAY ABNORMAL,1
TH,CHOLANGIOCARCINOMA,1
TH,CHOROIDAL EFFUSION,1
TH,CHOROIDAL HAEMORRHAGE,1
TH,CHRONIC DISEASE,1
TH,CHRONIC GASTRITIS,1
TH,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,1
TH,CLONAL EVOLUTION,1
TH,CLONUS,1
TH,COGWHEEL RIGIDITY,1
TH,COLD SWEAT,1
TH,COLON CANCER METASTATIC,1
TH,COLORECTAL CANCER,1
TH,COMMUNICATION DISORDER,1
TH,COMPARTMENT SYNDROME,1
TG,DEATH,13
TG,ACUTE MYOCARDIAL INFARCTION,1
TG,CARDIOTOXICITY,1
TG,CEREBROVASCULAR ACCIDENT,1
TG,DRUG INEFFECTIVE,1
TG,DRUG RESISTANCE,1
TG,EJECTION FRACTION DECREASED,1
TG,GASTROINTESTINAL HAEMORRHAGE,1
TG,HAEMOLYSIS,1
TG,HEMIPARESIS,1
TG,HEPATIC NECROSIS,1
TG,ILEUS PARALYTIC,1
TG,ISCHAEMIC STROKE,1
TG,MOTOR DYSFUNCTION,1
TG,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
TG,OSTEONECROSIS,1
TG,PERICARDIAL EFFUSION,1
TG,PLASMODIUM FALCIPARUM INFECTION,1
TG,PULMONARY TUBERCULOSIS,1
TG,ROAD TRAFFIC ACCIDENT,1
TG,SYSTOLIC DYSFUNCTION,1
TG,VIROLOGIC FAILURE,1
TT,DEATH,15
TT,DYSPNOEA,8
TT,NAUSEA,5
TT,ANAPHYLACTIC REACTION,4
TT,CATARACT,4
TT,DIARRHOEA,4
TT,PRURITUS,4
TT,PULMONARY EMBOLISM,4
TT,PYREXIA,4
TT,DIABETES MELLITUS,3
TT,DISEASE PROGRESSION,3
TT,DIZZINESS,3
TT,GANGRENE,3
TT,HALLUCINATION,3
TT,MYOCARDIAL INFARCTION,3
TT,RASH,3
TT,TACHYCARDIA,3
TT,URTICARIA,3
TT,ABDOMINAL PAIN,2
TT,ATRIAL FIBRILLATION,2
TT,BONE MARROW FAILURE,2
TT,CARDIAC FIBRILLATION,2
TT,CHILLS,2
TT,COMPLETED SUICIDE,2
TT,CONDITION AGGRAVATED,2
TT,DEEP VEIN THROMBOSIS,2
TT,DEPRESSION,2
TT,DRUG DOSE OMISSION,2
TT,HYPOTENSION,2
TT,ILL-DEFINED DISORDER,2
TT,INFUSION RELATED REACTION,2
TT,INTENTIONAL SELF-INJURY,2
TT,INTRACRANIAL PRESSURE INCREASED,2
TT,IRITIS,2
TT,LEUKOCYTOSIS,2
TT,MALIGNANT NEOPLASM PROGRESSION,2
TT,NO THERAPEUTIC RESPONSE,2
TT,PAIN IN EXTREMITY,2
TT,PNEUMONIA,2
TT,RETINAL DETACHMENT,2
TT,SNEEZING,2
TT,THROMBOSIS,2
TT,URINARY TRACT INFECTION,2
TT,VOMITING,2
TT,WEIGHT DECREASED,2
TT,WHITE BLOOD CELL COUNT INCREASED,2
TT,ABDOMINAL DISCOMFORT,1
TT,ABDOMINAL PAIN UPPER,1
TT,ABNORMAL BEHAVIOUR,1
TT,ACUTE MYELOID LEUKAEMIA,1
TT,ACUTE MYOCARDIAL INFARCTION,1
TT,ADVERSE EVENT,1
TT,ALANINE AMINOTRANSFERASE INCREASED,1
TT,AMPUTATION,1
TT,ANAEMIA,1
TT,ANAEMIA HAEMOLYTIC AUTOIMMUNE,1
TT,ANAESTHETIC COMPLICATION,1
TT,ANAL FISSURE,1
TT,ANGINA PECTORIS,1
TT,APPARENT DEATH,1
TT,ARRHYTHMIA,1
TT,BACTERIAL INFECTION,1
TT,BENIGN INTRACRANIAL HYPERTENSION,1
TT,BLINDNESS TRANSIENT,1
TT,BLISTER,1
TT,BLOOD GLUCOSE DECREASED,1
TT,BLOOD GLUCOSE INCREASED,1
TT,BLOOD PRESSURE DECREASED,1
TT,BLOOD PRESSURE INCREASED,1
TT,BONE PAIN,1
TT,BRONCHIAL CARCINOMA,1
TT,BRONCHOSPASM,1
TT,BURNING SENSATION,1
TT,CAPILLARY NAIL REFILL TEST ABNORMAL,1
TT,CARDIAC FAILURE,1
TT,CARDIAC FAILURE CONGESTIVE,1
TT,CARDIOGENIC SHOCK,1
TT,CARDIOMYOPATHY ACUTE,1
TT,CEREBRAL HAEMORRHAGE,1
TT,CEREBRAL INFARCTION,1
TT,CEREBRAL VENOUS THROMBOSIS,1
TT,CEREBROVASCULAR ACCIDENT,1
TT,CHEST DISCOMFORT,1
TT,CHORIORETINOPATHY,1
TT,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
TT,COAGULATION TIME SHORTENED,1
TT,COMA,1
TT,CONFUSIONAL STATE,1
TT,CONGESTIVE CARDIOMYOPATHY,1
TT,CSF PRESSURE INCREASED,1
TT,CYST,1
TT,DELUSION,1
TT,DIPLOPIA,1
TT,DISCOMFORT,1
TT,DISORIENTATION,1
TT,DISTURBANCE IN ATTENTION,1
TT,DRY MOUTH,1
TT,DRY SKIN,1
TT,DYSPHEMIA,1
TT,DYSURIA,1
TT,EOSINOPHILIA,1
TT,EPISTAXIS,1
TT,ERYTHEMA,1
TT,EXPIRED DRUG ADMINISTERED,1
TT,EXPOSURE DURING BREAST FEEDING,1
TT,EXPOSURE DURING PREGNANCY,1
TT,EXTRAVASATION,1
TT,EYE DISORDER,1
TT,FAECAL INCONTINENCE,1
TT,FALL,1
TT,FIBRIN D DIMER INCREASED,1
TT,GASTRITIS,1
TT,GASTROINTESTINAL HAEMORRHAGE,1
TT,GENERALISED TONIC-CLONIC SEIZURE,1
TT,GINGIVAL BLEEDING,1
TT,HAEMATEMESIS,1
TT,HAEMATOMA,1
TT,HAEMATURIA,1
TT,HAEMODYNAMIC INSTABILITY,1
TT,HAEMOPTYSIS,1
TT,HALLUCINATION_ AUDITORY,1
TT,HEADACHE,1
TT,HEART RATE DECREASED,1
TT,HEPATIC ENZYME INCREASED,1
TT,HEPATITIS,1
TT,HEPATOSPLENOMEGALY,1
TT,HILAR LYMPHADENOPATHY,1
TT,HOSPITALISATION,1
TT,HYPOXIA,1
TT,INJECTION SITE HAEMORRHAGE,1
TT,INTENTIONAL OVERDOSE,1
TT,INTRACRANIAL VENOUS SINUS THROMBOSIS,1
TT,IRRITABILITY,1
TT,LETHARGY,1
TT,LEUKAEMIA RECURRENT,1
TT,LIVE BIRTH,1
TT,LOSS OF CONSCIOUSNESS,1
TT,LYMPHADENOPATHY MEDIASTINAL,1
TT,MALAISE,1
TT,METABOLIC ACIDOSIS,1
TT,MONOCYTE COUNT DECREASED,1
TT,MULTIMORBIDITY,1
TT,MYOCARDIAL ISCHAEMIA,1
TT,NEUTROPHIL COUNT DECREASED,1
TT,OCULAR HYPERAEMIA,1
TT,OEDEMA,1
TT,OPTIC NEURITIS,1
TT,OROPHARYNGEAL DISCOMFORT,1
TT,OSTEONECROSIS OF JAW,1
TT,OXYGEN SATURATION DECREASED,1
TT,PAIN,1
TT,PALLOR,1
TT,PALPITATIONS,1
TT,PANCREATITIS,1
TT,PARAESTHESIA,1
TT,PELVIC DISCOMFORT,1
TT,PERIPHERAL COLDNESS,1
TT,PERIPHERAL SWELLING,1
TT,PLATELET COUNT DECREASED,1
TT,POLLAKIURIA,1
TT,POST PROCEDURAL HAEMORRHAGE,1
TT,PRE-EXISTING CONDITION IMPROVED,1
TT,PRODUCT COUNTERFEIT,1
TT,PRODUCT USE IN UNAPPROVED INDICATION,1
TT,PULMONARY HAEMORRHAGE,1
TT,PULMONARY OEDEMA,1
TT,RENAL FAILURE,1
TT,RENAL IMPAIRMENT,1
TT,RESPIRATORY ARREST,1
TT,SCAB,1
TT,SECOND PRIMARY MALIGNANCY,1
TT,SECRETION DISCHARGE,1
TT,SHOCK,1
TT,SKIN SWELLING,1
TT,SOCIAL AVOIDANT BEHAVIOUR,1
TT,STAPHYLOCOCCAL INFECTION,1
TT,STEVENS-JOHNSON SYNDROME,1
TT,STRANGULATED HERNIA,1
TT,STRESS CARDIOMYOPATHY,1
TT,SUICIDAL IDEATION,1
TT,SUPPRESSED LACTATION,1
TT,SUPRAVENTRICULAR TACHYCARDIA,1
TT,TENDONITIS,1
TT,THERAPEUTIC RESPONSE DECREASED,1
TT,THERAPEUTIC RESPONSE UNEXPECTED,1
TT,THROMBOCYTOPENIA,1
TT,THROMBOCYTOSIS,1
TT,TINNITUS,1
TT,TOE AMPUTATION,1
TT,URETHRAL SPASM,1
TT,URINE FLOW DECREASED,1
TT,VISION BLURRED,1
TT,VISUAL ACUITY REDUCED,1
TT,VITILIGO,1
TT,VULVOVAGINAL BURNING SENSATION,1
TT,VULVOVAGINAL PAIN,1
TN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,104
TN,DRUG INEFFECTIVE,77
TN,HYPOTENSION,57
TN,EXPOSURE DURING PREGNANCY,53
TN,DEATH,46
TN,PYREXIA,46
TN,CARDIAC ARREST,45
TN,SEPTIC SHOCK,40
TN,VOMITING,36
TN,TOXICITY TO VARIOUS AGENTS,32
TN,DYSPNOEA,30
TN,RENAL FAILURE,29
TN,DIARRHOEA,28
TN,BONE MARROW FAILURE,27
TN,HEPATOCELLULAR INJURY,27
TN,ERYTHEMA,25
TN,CHEST PAIN,24
TN,RESPIRATORY FAILURE,24
TN,RASH MACULO-PAPULAR,23
TN,MUCOSAL INFLAMMATION,22
TN,RASH,22
TN,ABDOMINAL PAIN,21
TN,PRURITUS,21
TN,TOXIC EPIDERMAL NECROLYSIS,21
TN,HEPATITIS,20
TN,PANCYTOPENIA,20
TN,RENAL FAILURE ACUTE,19
TN,EOSINOPHILIA,18
TN,PANCREATITIS ACUTE,18
TN,CARDIOGENIC SHOCK,17
TN,MYOCARDIAL INFARCTION,17
TN,URTICARIA,17
TN,ANAEMIA,16
TN,CARDIO-RESPIRATORY ARREST,16
TN,HISTIOCYTOSIS HAEMATOPHAGIC,16
TN,NEUTROPENIA,16
TN,WEIGHT DECREASED,16
TN,ASTHENIA,15
TN,FACE OEDEMA,15
TN,FATIGUE,15
TN,FEBRILE NEUTROPENIA,15
TN,PAIN IN EXTREMITY,15
TN,SEPSIS,15
TN,SHOCK,15
TN,SKIN LESION,15
TN,ABDOMINAL DISTENSION,14
TN,ARTHRALGIA,14
TN,CHOLESTASIS,14
TN,DIZZINESS,14
TN,THROMBOCYTOPENIA,14
TN,ALANINE AMINOTRANSFERASE INCREASED,13
TN,CARDIAC FAILURE,13
TN,GENERAL PHYSICAL HEALTH DETERIORATION,13
TN,HYPERTENSION,13
TN,LUNG DISORDER,13
TN,NAUSEA,13
TN,ASPARTATE AMINOTRANSFERASE INCREASED,12
TN,DRUG CROSS-REACTIVITY,12
TN,KAPOSI^S SARCOMA,12
TN,MULTIPLE SCLEROSIS RELAPSE,12
TN,OEDEMA,12
TN,PNEUMONIA,12
TN,RENAL IMPAIRMENT,12
TN,ANAPHYLACTIC SHOCK,11
TN,BACK PAIN,11
TN,CONDITION AGGRAVATED,11
TN,DECREASED APPETITE,11
TN,DELIRIUM,11
TN,DIABETES MELLITUS,11
TN,HYPERSENSITIVITY,11
TN,INFLUENZA,11
TN,PARAESTHESIA,11
TN,CEREBELLAR SYNDROME,10
TN,CROHN^S DISEASE,10
TN,DEEP VEIN THROMBOSIS,10
TN,DISEASE PROGRESSION,10
TN,DRUG HYPERSENSITIVITY,10
TN,HEADACHE,10
TN,HYPERSENSITIVITY VASCULITIS,10
TN,LEUKOPENIA,10
TN,ODYNOPHAGIA,10
TN,PSORIASIS,10
TN,PULMONARY EMBOLISM,10
TN,TREMOR,10
TN,ACUTE PULMONARY OEDEMA,9
TN,BLINDNESS,9
TN,BLOOD CREATININE INCREASED,9
TN,CELL DEATH,9
TN,DRUG ERUPTION,9
TN,DRUG INTOLERANCE,9
TN,DRUG WITHDRAWAL SYNDROME,9
TN,FOETAL EXPOSURE DURING PREGNANCY,9
TN,GAIT DISTURBANCE,9
TN,HAEMATEMESIS,9
TN,INTESTINAL OBSTRUCTION,9
TN,RASH ERYTHEMATOUS,9
TN,RENAL FAILURE CHRONIC,9
TN,RESPIRATORY DISTRESS,9
TN,VERTIGO,9
TN,ABDOMINAL PAIN UPPER,8
TN,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,8
TN,ACUTE MYOCARDIAL INFARCTION,8
TN,C-REACTIVE PROTEIN INCREASED,8
TN,CHOLECYSTITIS ACUTE,8
TN,COMA,8
TN,GENERALISED OEDEMA,8
TN,HAEMORRHAGE,8
TN,HEPATIC STEATOSIS,8
TN,INFLUENZA LIKE ILLNESS,8
TN,LOSS OF CONSCIOUSNESS,8
TN,OVERDOSE,8
TN,PAIN,8
TN,STATUS EPILEPTICUS,8
TN,TACHYCARDIA,8
TN,THERAPEUTIC PRODUCT CROSS-REACTIVITY,8
TN,TOXIC SKIN ERUPTION,8
TN,ANAL FISTULA,7
TN,CEREBROVASCULAR ACCIDENT,7
TN,COUGH,7
TN,FUNGAEMIA,7
TN,GASTROINTESTINAL INFECTION,7
TN,HYPOKALAEMIA,7
TN,ISCHAEMIC STROKE,7
TN,LACTIC ACIDOSIS,7
TN,LICHEN PLANUS,7
TN,LYMPHADENOPATHY,7
TN,MYALGIA,7
TN,NEUROTOXICITY,7
TN,OEDEMA PERIPHERAL,7
TN,PARADOXICAL DRUG REACTION,7
TN,PULMONARY OEDEMA,7
TN,PULMONARY TUBERCULOSIS,7
TN,RASH GENERALISED,7
TN,TRANSAMINASES INCREASED,7
TN,TRANSPLANT DYSFUNCTION,7
TN,VASCULAR STENT THROMBOSIS,7
TN,ACUTE KIDNEY INJURY,6
TN,AUTOIMMUNE HEPATITIS,6
TN,CHILLS,6
TN,CONFUSIONAL STATE,6
TN,DEHYDRATION,6
TN,FALL,6
TN,GASTROINTESTINAL PAIN,6
TN,GENERALISED TONIC-CLONIC SEIZURE,6
TN,GRAFT VERSUS HOST DISEASE,6
TN,HEPATOTOXICITY,6
TN,HYPOTHYROIDISM,6
TN,INSOMNIA,6
TN,JOINT SWELLING,6
TN,KOUNIS SYNDROME,6
TN,LIVE BIRTH,6
TN,LIVER DISORDER,6
TN,MATERNAL EXPOSURE DURING PREGNANCY,6
TN,PALPITATIONS,6
TN,PANCREATITIS,6
TN,PERIPHERAL ISCHAEMIA,6
TN,PNEUMOCYSTIS JIROVECII INFECTION,6
TN,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,6
TN,RENAL PAPILLARY NECROSIS,6
TN,RHABDOMYOLYSIS,6
TN,SEIZURE,6
TN,TUBULOINTERSTITIAL NEPHRITIS,6
TN,ABASIA,5
TN,ACUTE CORONARY SYNDROME,5
TN,AGITATION,5
TN,ALOPECIA,5
TN,ANAPHYLACTIC REACTION,5
TN,ANGIOEDEMA,5
TN,ATRIAL FIBRILLATION,5
TN,BACTERAEMIA,5
TN,BLISTER,5
TN,BREAST CANCER,5
TN,BRONCHIOLITIS,5
TN,CATARACT,5
TN,DERMATITIS ALLERGIC,5
TN,DISSEMINATED INTRAVASCULAR COAGULATION,5
TN,DRUG DEPENDENCE,5
TN,DRUG DOSE OMISSION,5
TN,DRUG RESISTANCE,5
TN,DRUG-INDUCED LIVER INJURY,5
TN,DYSPHAGIA,5
TN,FUNGAL INFECTION,5
TN,GANGRENE,5
TN,HAEMORRHAGIC NECROTIC PANCREATITIS,5
TN,HEMIPARESIS,5
TN,HEPATIC CIRRHOSIS,5
TN,HYPONATRAEMIA,5
TN,INJECTION SITE ERYTHEMA,5
TN,JAUNDICE,5
TN,MALIGNANT NEOPLASM PROGRESSION,5
TN,METABOLIC ACIDOSIS,5
TN,MULTI-ORGAN FAILURE,5
TN,MUSCULOSKELETAL STIFFNESS,5
TN,MYOCARDITIS,5
TN,NEOPLASM PROGRESSION,5
TN,PLATELET COUNT DECREASED,5
TN,PRODUCT USE IN UNAPPROVED INDICATION,5
TN,RESPIRATORY DISORDER,5
TN,SERUM FERRITIN INCREASED,5
TN,SKIN HYPERPIGMENTATION,5
TN,THROMBOSIS IN DEVICE,5
TN,TUBERCULOSIS,5
TN,VENOUS THROMBOSIS,5
TN,ABORTION SPONTANEOUS,4
TN,ACNE,4
TN,ACUTE HEPATIC FAILURE,4
TN,ANXIETY,4
TN,ARRHYTHMIA,4
TN,ASPERGILLUS INFECTION,4
TN,ATRIOVENTRICULAR BLOCK,4
TN,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,4
TN,BLOOD BILIRUBIN INCREASED,4
TN,CHEST DISCOMFORT,4
TN,CHORIORETINOPATHY,4
TN,COELIAC DISEASE,4
TN,CONVULSION,4
TN,CRYSTAL NEPHROPATHY,4
TN,DERMATITIS BULLOUS,4
TN,ECCHYMOSIS,4
TN,EXTRAPYRAMIDAL DISORDER,4
TN,GASTROINTESTINAL DISORDER,4
TN,GASTROINTESTINAL INFLAMMATION,4
TN,GENERALISED ERYTHEMA,4
TN,GLOMERULONEPHRITIS MINIMAL LESION,4
TN,HAEMATOCHEZIA,4
TN,HEPATIC ENZYME INCREASED,4
TN,HEPATOMEGALY,4
TN,HYPERGLYCAEMIA,4
TN,HYPERLIPIDAEMIA,4
TN,HYPOPROTEINAEMIA,4
TN,HYPOTHERMIA,4
TN,HYPOVOLAEMIC SHOCK,4
TN,HYPOXIA,4
TN,INJECTION SITE PAIN,4
TN,INJECTION SITE PRURITUS,4
TN,IRON DEFICIENCY,4
TN,JARISCH-HERXHEIMER REACTION,4
TN,KIDNEY TRANSPLANT REJECTION,4
TN,LOCAL SWELLING,4
TN,LUNG INFECTION,4
TN,LUNG NEOPLASM MALIGNANT,4
TN,MALNUTRITION,4
TN,MINERAL DEFICIENCY,4
TN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
TN,OPTIC NEUROPATHY,4
TN,PANNICULITIS,4
TN,PIRIFORMIS SYNDROME,4
TN,PSYCHOTIC DISORDER,4
TN,PSYCHOTIC SYMPTOM,4
TN,RASH PRURITIC,4
TN,RENAL TUBULAR NECROSIS,4
TN,SALIVARY HYPERSECRETION,4
TN,SKIN IRRITATION,4
TN,SOMNOLENCE,4
TN,STEVENS-JOHNSON SYNDROME,4
TN,STOMATITIS,4
TN,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,4
TN,THROMBOSIS,4
TN,TOXIC OPTIC NEUROPATHY,4
TN,TREATMENT FAILURE,4
TN,URINARY TRACT INFECTION,4
TN,WERNICKE^S ENCEPHALOPATHY,4
TN,ACUTE RESPIRATORY FAILURE,3
TN,ADVERSE EVENT,3
TN,ALTERED STATE OF CONSCIOUSNESS,3
TN,ANGINA PECTORIS,3
TN,AUTOIMMUNE HAEMOLYTIC ANAEMIA,3
TN,BALANCE DISORDER,3
TN,BLASTOMYCOSIS,3
TN,BLOOD PRESSURE INCREASED,3
TN,BRADYCARDIA,3
TN,BRONCHIAL DISORDER,3
TN,BRONCHOPULMONARY ASPERGILLOSIS,3
TN,BRONCHOSPASM,3
TN,BRONCHOSPASM PARADOXICAL,3
TN,BURNING SENSATION,3
TN,CEREBRAL HAEMORRHAGE,3
TN,CEREBRAL VENOUS THROMBOSIS,3
TN,CHOLELITHIASIS,3
TN,CONSTIPATION,3
TN,CORONARY ARTERY STENOSIS,3
TN,CUTANEOUS LEISHMANIASIS,3
TN,DEPRESSED LEVEL OF CONSCIOUSNESS,3
TN,DIARRHOEA HAEMORRHAGIC,3
TN,DIPLOPIA,3
TN,DISSEMINATED TUBERCULOSIS,3
TN,DRUG ABUSE,3
TN,DYSPHONIA,3
TN,EAR PAIN,3
TN,ELECTROCARDIOGRAM T WAVE ABNORMAL,3
TN,ENDOCARDITIS,3
TN,ERYSIPELAS,3
TN,EYELID OEDEMA,3
TN,FIXED ERUPTION,3
TN,FLUSHING,3
TN,GASTRIC HAEMORRHAGE,3
TN,GASTROINTESTINAL HAEMORRHAGE,3
TN,GYNAECOMASTIA,3
TN,HAEMATOTOXICITY,3
TN,HAEMATURIA,3
TN,HEPATIC ENCEPHALOPATHY,3
TN,HEPATITIS ACUTE,3
TN,HEPATITIS CHOLESTATIC,3
TN,HUMAN HERPESVIRUS 6 INFECTION,3
TN,HYPERHIDROSIS,3
TN,HYPERNATRAEMIA,3
TN,HYPERTROPHIC CARDIOMYOPATHY,3
TN,HYPOALBUMINAEMIA,3
TN,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,3
TN,INFECTION,3
TN,INFLAMMATION,3
TN,INJECTION SITE BRUISING,3
TN,INJECTION SITE SWELLING,3
TN,IRON DEFICIENCY ANAEMIA,3
TN,IRON OVERLOAD,3
TN,ISCHAEMIA,3
TN,LEFT VENTRICULAR FAILURE,3
TN,LEISHMANIASIS,3
TN,LEUKOCYTOSIS,3
TN,LIVER FUNCTION TEST ABNORMAL,3
TN,LUNG ADENOCARCINOMA,3
TN,LYMPH NODE TUBERCULOSIS,3
TN,MALAISE,3
TN,MATERNAL EXPOSURE TIMING UNSPECIFIED,3
TN,MEDICATION ERROR,3
TN,MELAENA,3
TN,MENINGITIS,3
TN,MENINGITIS CRYPTOCOCCAL,3
TN,MENTAL DISORDER,3
TN,MICROALBUMINURIA,3
TN,MUSCLE SPASMS,3
TN,MUSCULOSKELETAL PAIN,3
TN,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,3
TN,NECROSIS,3
TN,NEPHROLITHIASIS,3
TN,PAROTITIS,3
TN,PERICARDIAL EFFUSION,3
TN,PERIPHERAL SWELLING,3
TN,PHLEBITIS,3
TN,PHOTOSENSITIVITY REACTION,3
TN,PIGMENTATION DISORDER,3
TN,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,3
TN,PRODUCT USE ISSUE,3
TN,PROTHROMBIN LEVEL DECREASED,3
TN,PRURITUS GENERALISED,3
TN,PULMONARY CONGESTION,3
TN,PURULENCE,3
TN,RENAL TRANSPLANT FAILURE,3
TN,RESTLESSNESS,3
TN,SKIN EXFOLIATION,3
TN,SKIN NECROSIS,3
TN,SKIN PLAQUE,3
TN,SPLENOMEGALY,3
TN,SUDDEN DEATH,3
TN,SUPERIOR SAGITTAL SINUS THROMBOSIS,3
TN,SYNCOPE,3
TN,SYSTEMIC LUPUS ERYTHEMATOSUS,3
TN,TARDIVE DYSKINESIA,3
TN,THERAPEUTIC RESPONSE UNEXPECTED,3
TN,THYROID FUNCTION TEST ABNORMAL,3
TN,TYPE IV HYPERSENSITIVITY REACTION,3
TN,UVEITIS,3
TN,VENTRICULAR ARRHYTHMIA,3
TN,VISUAL ACUITY REDUCED,3
TN,VITAMIN B1 DEFICIENCY,3
TN,ACIDOSIS,2
TN,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,2
TN,ACUTE PSYCHOSIS,2
TN,ANAL ULCER,2
TN,ANKYLOSING SPONDYLITIS,2
TN,APNOEA,2
TN,ARTHRITIS,2
TN,ARTHRITIS BACTERIAL,2
TN,ASCITES,2
TN,ASTHMA,2
TN,ATAXIA,2
TN,BLOOD CULTURE POSITIVE,2
TN,BLOOD DISORDER,2
TN,BONE MARROW TOXICITY,2
TN,BRAIN STEM STROKE,2
TN,BRONCHITIS,2
TN,CAESAREAN SECTION,2
TN,CANDIDA INFECTION,2
TN,CARPAL TUNNEL SYNDROME,2
TN,CENTRAL NERVOUS SYSTEM LESION,2
TN,CEREBRAL ISCHAEMIA,2
TN,CHOLECYSTITIS INFECTIVE,2
TN,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
TN,CHRONIC MYELOID LEUKAEMIA,2
TN,CIRCULATORY COLLAPSE,2
TN,COLITIS,2
TN,CONGENITAL APLASTIC ANAEMIA,2
TN,CONJUNCTIVAL HYPERAEMIA,2
TN,CUTANEOUS VASCULITIS,2
TN,CYANOSIS,2
TN,CYTOMEGALOVIRUS INFECTION,2
TN,CYTOMEGALOVIRUS TEST POSITIVE,2
TN,DELAYED PUBERTY,2
TN,DELUSION,2
TN,DEPRESSION,2
TN,DILATATION VENTRICULAR,2
TN,DISORIENTATION,2
TN,DRUG EFFECT INCOMPLETE,2
TN,DRUG LEVEL ABOVE THERAPEUTIC,2
TN,DRUG LEVEL INCREASED,2
TN,DYSARTHRIA,2
TN,DYSLIPIDAEMIA,2
TN,DYSPAREUNIA,2
TN,DYSPHORIA,2
TN,DYSURIA,2
TN,EJECTION FRACTION DECREASED,2
TN,EMBOLISM VENOUS,2
TN,EMPHYSEMA,2
TN,ENURESIS,2
TN,EPILEPSY,2
TN,EXFOLIATIVE RASH,2
TN,EXTRAOCULAR MUSCLE PARESIS,2
TN,EYE INFLAMMATION,2
TN,EYE IRRITATION,2
TN,FAECAL CALPROTECTIN INCREASED,2
TN,FULL BLOOD COUNT DECREASED,2
TN,FUNGAL SEPSIS,2
TN,FURUNCLE,2
TN,FUSARIUM INFECTION,2
TN,GASTRIC DISORDER,2
TN,GASTRIC ULCER,2
TN,GASTROINTESTINAL TOXICITY,2
TN,GINGIVAL DISORDER,2
TN,HAEMATOLOGY TEST ABNORMAL,2
TN,HAEMODIALYSIS,2
TN,HAEMOGLOBIN DECREASED,2
TN,HAEMORRHAGIC STROKE,2
TN,HAEMORRHOIDS,2
TN,HALLUCINATION_ VISUAL,2
TN,HAND FRACTURE,2
TN,HEMIPLEGIA,2
TN,HEPATIC ENZYME ABNORMAL,2
TN,HEPATIC FAILURE,2
TN,HEPATITIS B,2
TN,HEPATITIS FULMINANT,2
TN,HISTOPLASMOSIS DISSEMINATED,2
TN,HOSPITALISATION,2
TN,HUMERUS FRACTURE,2
TN,HYDROCEPHALUS,2
TN,HYPERTRICHOSIS,2
TN,HYPERTRIGLYCERIDAEMIA,2
TN,HYPOAESTHESIA,2
TN,HYPOCALCAEMIA,2
TN,HYPOCHOLESTEROLAEMIA,2
TN,HYPOKINESIA,2
TN,IMMUNODEFICIENCY,2
TN,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,2
TN,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
TN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
TN,INCORRECT DRUG ADMINISTRATION RATE,2
TN,INFLAMMATORY MARKER INCREASED,2
TN,INTENTIONAL PRODUCT MISUSE,2
TN,INTENTIONAL PRODUCT USE ISSUE,2
TN,JUGULAR VEIN THROMBOSIS,2
TN,LANGUAGE DISORDER,2
TN,LEUKAEMIA,2
TN,LHERMITTE^S SIGN,2
TN,LOCALISED OEDEMA,2
TN,LYMPHOCYTE MORPHOLOGY ABNORMAL,2
TN,LYMPHOCYTIC INFILTRATION,2
TN,LYMPHOCYTOSIS,2
TN,LYMPHOID TISSUE HYPERPLASIA,2
TN,MACULAR OEDEMA,2
TN,MACULE,2
TN,MAJOR DEPRESSION,2
TN,MATERNAL DRUGS AFFECTING FOETUS,2
TN,MENSTRUAL DISORDER,2
TN,MOUTH ULCERATION,2
TN,MULTIPLE SCLEROSIS,2
TN,MUSCLE RUPTURE,2
TN,MUSCULAR WEAKNESS,2
TN,MYCOSIS FUNGOIDES,2
TN,MYDRIASIS,2
TN,MYOCARDIAL ISCHAEMIA,2
TN,NECK PAIN,2
TN,NEPHROGENIC SYSTEMIC FIBROSIS,2
TN,NEPHROPATHY TOXIC,2
TN,NEPHROTIC SYNDROME,2
TN,NEUROPATHY PERIPHERAL,2
TN,NON-ALCOHOLIC FATTY LIVER,2
TN,NON-ALCOHOLIC STEATOHEPATITIS,2
TN,NORMAL NEWBORN,2
TN,OSTEONECROSIS,2
TN,OXYGEN SATURATION DECREASED,2
TN,PANCREATIC CARCINOMA,2
TN,PARALYSIS,2
TN,PENILE ULCERATION,2
TN,PERICARDITIS,2
TN,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
TN,PLASMA CELL MYELOMA,2
TN,PLATELET COUNT INCREASED,2
TN,PLEURAL EFFUSION,2
TN,POLYCYTHAEMIA,2
TN,PORTAL HYPERTENSION,2
TN,POST PROCEDURAL HAEMORRHAGE,2
TN,PREMATURE BABY,2
TN,PROCEDURAL PAIN,2
TN,PRURITUS ALLERGIC,2
TN,PULMONARY HYPERTENSION,2
TN,PYODERMA GANGRENOSUM,2
TN,RALES,2
TN,RASH PAPULAR,2
TN,RAYNAUD^S PHENOMENON,2
TN,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
TN,RENAL CANCER,2
TN,RETICULOCYTE COUNT DECREASED,2
TN,RETINAL DETACHMENT,2
TN,RHEUMATOID ARTHRITIS,2
TN,ROAD TRAFFIC ACCIDENT,2
TN,SCAB,2
TN,SCIATICA,2
TN,SECOND PRIMARY MALIGNANCY,2
TN,SELF-MEDICATION,2
TN,SHOCK HAEMORRHAGIC,2
TN,SKIN DISCOLOURATION,2
TN,SKIN DISORDER,2
TN,SKIN TEST POSITIVE,2
TN,SKIN TOXICITY,2
TN,STAPHYLOCOCCAL SEPSIS,2
TN,SUICIDAL IDEATION,2
TN,SWELLING,2
TN,SWELLING FACE,2
TN,T-CELL LYMPHOMA,2
TN,TACHYPNOEA,2
TN,TENSION HEADACHE,2
TN,THERAPEUTIC RESPONSE DECREASED,2
TN,THROMBOPHLEBITIS,2
TN,TINNITUS,2
TN,TONGUE ULCERATION,2
TN,TRANSCRIPTION MEDICATION ERROR,2
TN,TRANSPLANT REJECTION,2
TN,TREATMENT NONCOMPLIANCE,2
TN,TUMOUR LYSIS SYNDROME,2
TN,UMBILICAL HERNIA,2
TN,UPPER LIMB FRACTURE,2
TN,UTERINE LEIOMYOMA,2
TN,VASCULAR PURPURA,2
TN,VASCULITIS,2
TN,VENOUS THROMBOSIS LIMB,2
TN,VENTRICULAR FIBRILLATION,2
TN,VITAMIN B12 DEFICIENCY,2
TN,VULVAL DISORDER,2
TN,WEIGHT INCREASED,2
TN,WHEEZING,2
TN,WHITE BLOOD CELL COUNT DECREASED,2
TN,WHITE BLOOD CELL COUNT INCREASED,2
TN,WHITE MATTER LESION,2
TN,WITHDRAWAL SYNDROME,2
TN,ZYGOMYCOSIS,2
TN,ABDOMINAL DISCOMFORT,1
TN,ABDOMINAL LYMPHADENOPATHY,1
TN,ABDOMINAL PAIN LOWER,1
TN,ABDOMINAL WALL ABSCESS,1
TN,ABNORMAL LOSS OF WEIGHT,1
TN,ABORTION INDUCED,1
TN,ABSCESS,1
TN,ABSCESS INTESTINAL,1
TN,ABSCESS JAW,1
TN,ACANTHOSIS,1
TN,ACCIDENT AT HOME,1
TN,ACUTE RESPIRATORY DISTRESS SYNDROME,1
TN,ADENOCARCINOMA GASTRIC,1
TN,ADENOCARCINOMA OF COLON,1
TN,ADRENAL INSUFFICIENCY,1
TN,ADVERSE DRUG REACTION,1
TN,AGGRESSION,1
TN,AGITATION POSTOPERATIVE,1
TN,ALVEOLITIS ALLERGIC,1
TN,AMAUROSIS,1
TN,AMYLASE INCREASED,1
TN,ANAL FISSURE,1
TN,ANAL FISTULA INFECTION,1
TN,ANAL FUNGAL INFECTION,1
TN,ANAL HAEMORRHAGE,1
TN,ANGER,1
TN,ANGINA UNSTABLE,1
TN,ANGLE CLOSURE GLAUCOMA,1
TN,ANIRIDIA,1
TN,ANOSMIA,1
TN,ANTI-VGKC ANTIBODY POSITIVE,1
TN,ANTINUCLEAR ANTIBODY POSITIVE,1
TN,ANURIA,1
TN,AORTIC DISSECTION,1
TN,AORTIC VALVE INCOMPETENCE,1
TN,AORTICOPULMONARY SEPTAL DEFECT,1
TN,APHASIA,1
TN,ARTERIAL OCCLUSIVE DISEASE,1
TN,ARTHROPATHY,1
TN,ASPERGILLUS TEST POSITIVE,1
TN,ASPHYXIA,1
TN,ASTHMATIC CRISIS,1
TN,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
TN,AXIAL SPONDYLOARTHRITIS,1
TN,BASAL CELL CARCINOMA,1
TN,BENIGN INTRACRANIAL HYPERTENSION,1
TN,BIPOLAR DISORDER,1
TN,BISPECTRAL INDEX DECREASED,1
TN,BK VIRUS INFECTION,1
TN,BLOOD ALKALINE PHOSPHATASE INCREASED,1
TN,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
TN,BLOOD CREATININE ABNORMAL,1
TN,BLOOD FOLLICLE STIMULATING HORMONE INCREASED,1
TN,BLOOD GLUCOSE ABNORMAL,1
TN,BLOOD GLUCOSE FLUCTUATION,1
TN,BLOOD GLUCOSE INCREASED,1
TN,BLOOD IMMUNOGLOBULIN E INCREASED,1
TN,BLOOD IMMUNOGLOBULIN G INCREASED,1
TN,BLOOD LACTATE DEHYDROGENASE INCREASED,1
TN,BLOOD LUTEINISING HORMONE INCREASED,1
TN,BLOOD PRESSURE DECREASED,1
TN,BLOOD PRESSURE DIASTOLIC DECREASED,1
TN,BLOOD PRESSURE SYSTOLIC INCREASED,1
TN,BLOOD TRIGLYCERIDES INCREASED,1
TN,BLOOD UREA INCREASED,1
TN,BLOOD URIC ACID INCREASED,1
TN,BRAIN NATRIURETIC PEPTIDE INCREASED,1
TN,BREAST CANCER RECURRENT,1
TN,BREAST NEOPLASM,1
TN,BRONCHIECTASIS,1
TN,CACHEXIA,1
TN,CALCIUM DEFICIENCY,1
TN,CARDIAC DISCOMFORT,1
TN,CARDIAC DISORDER,1
TN,CARDIAC FIBRILLATION,1
TN,CARDIAC PACEMAKER INSERTION,1
TN,CARDIAC SIDEROSIS,1
TN,CARDIOMEGALY,1
TN,CARDIOMYOPATHY,1
TN,CARDIOPULMONARY FAILURE,1
TN,CARDIOVASCULAR DISORDER,1
TN,CARTILAGE ATROPHY,1
TN,CELLULITIS,1
TN,CEREBELLAR HYPOPLASIA,1
TN,CEREBRAL HAEMATOMA,1
TN,CHALAZION,1
TN,CHEMICAL PERITONITIS,1
TN,CHEMOTHERAPEUTIC DRUG LEVEL ABOVE THERAPEUTIC,1
TN,CHORIORETINAL ATROPHY,1
TN,CHROMATURIA,1
TN,CHRONIC GASTRITIS,1
TN,CHRONIC GRAFT VERSUS HOST DISEASE,1
TN,CHRONIC HEPATIC FAILURE,1
TN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
TN,COAGULATION FACTOR V LEVEL DECREASED,1
TN,COLON CANCER,1
TN,COLONIC FISTULA,1
TN,COMPLICATION ASSOCIATED WITH DEVICE,1
TN,COMPLICATION OF PREGNANCY,1
TN,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
TN,COMPUTERISED TOMOGRAM ABNORMAL,1
TN,CONCOMITANT DISEASE AGGRAVATED,1
TN,CONGENITAL HYPOTHYROIDISM,1
TN,CONGENITAL INTESTINAL MALFORMATION,1
TN,CONJUNCTIVAL HAEMORRHAGE,1
TN,CONJUNCTIVITIS ALLERGIC,1
TN,CONTUSION,1
TN,CORNEAL ABRASION,1
TN,CORNEAL DYSTROPHY,1
TN,CORONARY ARTERY BYPASS,1
TN,CREATINE URINE INCREASED,1
TN,CUTANEOUS LUPUS ERYTHEMATOSUS,1
TN,CYST,1
TN,CYSTOID MACULAR OEDEMA,1
TN,CYTOGENETIC ANALYSIS ABNORMAL,1
TN,CYTOMEGALOVIRUS CHORIORETINITIS,1
TN,DEAFNESS,1
TN,DEAFNESS CONGENITAL,1
TN,DECUBITUS ULCER,1
TN,DEMYELINATING POLYNEUROPATHY,1
TN,DEPENDENCE,1
TN,DEPRESSION SUICIDAL,1
TN,DERMATITIS,1
TN,DERMATITIS EXFOLIATIVE,1
TN,DERMO-HYPODERMITIS,1
TN,DETACHMENT OF RETINAL PIGMENT EPITHELIUM,1
TN,DEVELOPMENTAL DELAY,1
TN,DEVICE OCCLUSION,1
TN,DIABETIC GANGRENE,1
TN,DIABETIC KETOSIS,1
TN,DIALYSIS RELATED COMPLICATION,1
TN,DISCOMFORT,1
TN,DISTURBANCE IN ATTENTION,1
TN,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
TN,DRUG DOSE TITRATION NOT PERFORMED,1
TN,DRUG EFFECT PROLONGED,1
TN,DRUG PRESCRIBING ERROR,1
TN,DRY MOUTH,1
TN,DRY SKIN,1
TN,DUODENAL ULCER,1
TN,DYSMORPHISM,1
TN,DYSPEPSIA,1
TN,DYSPNOEA EXERTIONAL,1
TN,DYSTONIA,1
TN,DYSTONIC TREMOR,1
TN,EAR DISCOMFORT,1
TN,ECZEMA,1
TN,ELECTROCARDIOGRAM T WAVE INVERSION,1
TN,ELECTROLYTE IMBALANCE,1
TN,EMBOLIC STROKE,1
TN,EMBOLISM,1
TN,EMPHYSEMATOUS PYELONEPHRITIS,1
TN,ENCEPHALITIS,1
TN,ENCEPHALOPATHY,1
TN,ENDOTRACHEAL INTUBATION COMPLICATION,1
TN,ENTERITIS INFECTIOUS,1
TN,EOSINOPHIL COUNT INCREASED,1
TN,EPIDERMAL NECROSIS,1
TN,EPIDERMOLYSIS BULLOSA,1
TN,EPIPHYSIOLYSIS,1
TN,EPISTAXIS,1
TN,ERYTHEMA MULTIFORME,1
TN,ESCHERICHIA INFECTION,1
TN,ESCHERICHIA SEPSIS,1
TN,EXPOSURE VIA FATHER,1
TN,EXTRA DOSE ADMINISTERED,1
TN,EXTRASYSTOLES,1
TN,EXTRAVASATION,1
TN,EYE ALLERGY,1
TN,EYE BURNS,1
TN,EYE HAEMORRHAGE,1
TN,EYE PAIN,1
TN,EYE PRURITUS,1
TN,FACIAL PAIN,1
TN,FAECES DISCOLOURED,1
TN,FAILURE TO THRIVE,1
TN,FEAR OF INJECTION,1
TN,FEELING ABNORMAL,1
TN,FLATULENCE,1
TN,FOETAL DEATH,1
TN,FOETAL DISTRESS SYNDROME,1
TN,FOETAL GROWTH RESTRICTION,1
TN,FOETAL MALFORMATION,1
TN,FOOD INTERACTION,1
TN,FOOD INTOLERANCE,1
TN,FOOD POISONING,1
TN,FORMICATION,1
TN,FUNGAL PERITONITIS,1
TN,FUNGAL PHARYNGITIS,1
TN,GALLBLADDER PERFORATION,1
TN,GASTRIC MUCOSAL LESION,1
TN,GASTRIC ULCER PERFORATION,1
TN,GASTRITIS,1
TN,GASTROENTERITIS,1
TN,GASTROINTESTINAL CARCINOMA,1
TN,GASTROINTESTINAL NECROSIS,1
TN,GASTROINTESTINAL PERFORATION,1
TN,GASTROINTESTINAL STROMAL TUMOUR,1
TN,GENERAL PHYSICAL CONDITION ABNORMAL,1
TN,GENITAL ERYTHEMA,1
TN,GENITAL HAEMORRHAGE,1
TN,GEOTRICHUM INFECTION,1
TN,GINGIVAL BLEEDING,1
TN,GINGIVAL HYPERTROPHY,1
TN,GINGIVAL INJURY,1
TN,GINGIVITIS ULCERATIVE,1
TN,GLARE,1
TN,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
TN,GRAFT COMPLICATION,1
TN,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
TN,GRAFT VERSUS HOST DISEASE IN LIVER,1
TN,GRANDIOSITY,1
TN,GRANULOMA,1
TN,GRANULOMATOUS LIVER DISEASE,1
TN,GROWTH RETARDATION,1
TN,HAEMATOMA,1
TN,HAEMODYNAMIC INSTABILITY,1
TN,HAEMORRHAGIC DISORDER,1
TN,HAIR GROWTH ABNORMAL,1
TN,HALLUCINATION,1
TN,HALLUCINATION_ AUDITORY,1
TN,HALLUCINATION_ SYNAESTHETIC,1
TN,HEAD INJURY,1
TN,HEART RATE ABNORMAL,1
TN,HEART RATE INCREASED,1
TN,HELICOBACTER TEST POSITIVE,1
TN,HEPATIC HAEMATOMA,1
TN,HEPATIC LESION,1
TN,HEPATIC NEOPLASM,1
TN,HEPATIC SIDEROSIS,1
TN,HEPATITIS C,1
TN,HEPATITIS TOXIC,1
TN,HEPATORENAL SYNDROME,1
TN,HERPES ZOSTER,1
TN,HICCUPS,1
TN,HIP DEFORMITY,1
TN,HOT FLUSH,1
TN,HUMAN HERPESVIRUS 8 INFECTION,1
TN,HUMAN POLYOMAVIRUS INFECTION,1
TN,HYDRONEPHROSIS,1
TN,HYPERBILIRUBINAEMIA,1
TN,HYPERCALCAEMIA,1
TN,HYPERCHOLESTEROLAEMIA,1
TN,HYPERFERRITINAEMIA,1
TN,HYPERKALAEMIA,1
TN,HYPERPHAGIA,1
TN,HYPERPROTEINAEMIA,1
TN,HYPERTHERMIA,1
TN,HYPERURICAEMIA,1
TN,HYPOCHLORAEMIA,1
TN,HYPOFIBRINOGENAEMIA,1
TN,HYPOGLYCAEMIA,1
TN,HYPOMANIA,1
TN,HYPOTONIA,1
TN,HYPOVITAMINOSIS,1
TN,IIIRD NERVE PARALYSIS,1
TN,ILEAL STENOSIS,1
TN,IMMUNE TOLERANCE INDUCTION,1
TN,IMPATIENCE,1
TN,INCORRECT DOSAGE ADMINISTERED,1
TN,INCORRECT DOSE ADMINISTERED,1
TN,INCORRECT DRUG ADMINISTRATION DURATION,1
TN,INFARCTION,1
TN,INFECTIOUS COLITIS,1
TN,INFLAMMATORY BOWEL DISEASE,1
TN,INFUSION RELATED REACTION,1
TN,INJECTION SITE ABSCESS,1
TN,INJECTION SITE INFECTION,1
TN,INJECTION SITE PAPULE,1
TN,INJECTION SITE RASH,1
TN,INJECTION SITE REACTION,1
TN,INJECTION SITE SCAR,1
TN,INJURY,1
TN,INTENTIONAL DRUG MISUSE,1
TN,INTENTIONAL OVERDOSE,1
TN,INTERCOSTAL NEURALGIA,1
TN,INTERSTITIAL LUNG DISEASE,1
TN,INTERVERTEBRAL DISC COMPRESSION,1
TN,INTERVERTEBRAL DISC PROTRUSION,1
TN,INTESTINAL RESECTION,1
TN,INTESTINAL STENOSIS,1
TN,INTESTINAL TUBERCULOSIS,1
TN,INTRA-ABDOMINAL FLUID COLLECTION,1
TN,INTRADUCTAL PAPILLARY-MUCINOUS CARCINOMA OF PANCREAS,1
TN,IRON METABOLISM DISORDER,1
TN,IRRITABILITY,1
TN,JAUNDICE CHOLESTATIC,1
TN,JAUNDICE NEONATAL,1
TN,KERATIC PRECIPITATES,1
TN,KERATOPATHY,1
TN,KIDNEY INFECTION,1
TN,KNEE ARTHROPLASTY,1
TN,LABORATORY TEST ABNORMAL,1
TN,LABOUR COMPLICATION,1
TN,LARYNGOSPASM,1
TN,LEFT VENTRICULAR DYSFUNCTION,1
TN,LEFT VENTRICULAR HYPERTROPHY,1
TN,LETHARGY,1
TN,LEUKOCYTOCLASTIC VASCULITIS,1
TN,LEUKOENCEPHALOPATHY,1
TN,LICHENOID KERATOSIS,1
TN,LIMBIC ENCEPHALITIS,1
TN,LIPODYSTROPHY ACQUIRED,1
TN,LIPOSUCTION,1
TN,LIVER INJURY,1
TN,LYMPHADENOPATHY MEDIASTINAL,1
TN,MADAROSIS,1
TN,MALABSORPTION,1
TN,MELANODERMA,1
TN,MEMORY IMPAIRMENT,1
TN,MENDELSON^S SYNDROME,1
TN,MENINGITIS ASEPTIC,1
TN,MENTAL RETARDATION,1
TN,METABOLIC DISORDER,1
TN,METAPLASIA,1
TN,METASTASES TO BONE,1
TN,METASTASES TO LIVER,1
TN,METASTASES TO LUNG,1
TN,METASTASES TO MENINGES,1
TN,METASTASIS,1
TN,METASTATIC GASTRIC CANCER,1
TN,METASTATIC NEOPLASM,1
TN,MICROPENIS,1
TN,MICTURITION URGENCY,1
TN,MIXED LIVER INJURY,1
TN,MOBILITY DECREASED,1
TN,MONOCYTOSIS,1
TN,MONONUCLEOSIS SYNDROME,1
TN,MONOPLEGIA,1
TN,MOOD ALTERED,1
TN,MOTION SICKNESS,1
TN,MOTOR DYSFUNCTION,1
TN,MOUTH HAEMORRHAGE,1
TN,MOVEMENT DISORDER,1
TN,MUCOSAL EROSION,1
TN,MUCOSAL PIGMENTATION,1
TN,MUSCLE ENZYME INCREASED,1
TN,MUSCULOSKELETAL CHEST PAIN,1
TN,MYOCLONIC EPILEPSY,1
TN,MYOCLONUS,1
TN,NAIL BED BLEEDING,1
TN,NAIL DISCOLOURATION,1
TN,NASAL DISORDER,1
TN,NASAL OBSTRUCTION,1
TN,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
TN,NEONATAL TACHYCARDIA,1
TN,NERVE COMPRESSION,1
TN,NERVOUS SYSTEM DISORDER,1
TN,NERVOUSNESS,1
TN,NEUROGENIC SHOCK,1
TN,NEUROLOGICAL SYMPTOM,1
TN,NEURONE-SPECIFIC ENOLASE INCREASED,1
TN,NO ADVERSE EVENT,1
TN,NO THERAPEUTIC RESPONSE,1
TN,NOCARDIOSIS,1
TN,NOCTURNAL DYSPNOEA,1
TN,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
TN,NORMOCYTIC ANAEMIA,1
TN,OBESITY,1
TN,OBSTRUCTED LABOUR,1
TN,OCCULT BLOOD,1
TN,OCCULT BLOOD POSITIVE,1
TN,OCCUPATIONAL EXPOSURE TO PRODUCT,1
TN,OCULAR DISCOMFORT,1
TN,OCULAR HYPERTENSION,1
TN,OEDEMATOUS PANCREATITIS,1
TN,OESOPHAGEAL VARICES HAEMORRHAGE,1
TN,OESTRADIOL INCREASED,1
TN,OLIGURIA,1
TN,ONYCHOLYSIS,1
TN,ONYCHOMYCOSIS,1
TN,OPTIC ATROPHY,1
TN,OPTIC NEURITIS,1
TN,ORAL DISCOMFORT,1
TN,ORAL DISORDER,1
TN,ORAL FUNGAL INFECTION,1
TN,ORAL INFECTION,1
TN,ORAL LICHEN PLANUS,1
TN,ORAL MUCOSAL ERYTHEMA,1
TN,OROPHARYNGEAL PAIN,1
TN,OSTEONECROSIS OF JAW,1
TN,OSTEOPENIA,1
TN,OSTEOPOROSIS,1
TN,OVARIAN ATROPHY,1
TN,OVARIAN CYST,1
TN,OXALOSIS,1
TN,PALATAL DISORDER,1
TN,PALLOR,1
TN,PALMOMENTAL REFLEX,1
TN,PANCREATIC ENLARGEMENT,1
TN,PANCREATITIS HAEMORRHAGIC,1
TN,PANCREATITIS NECROTISING,1
TN,PARAESTHESIA ORAL,1
TN,PARAPLEGIA,1
TN,PARESIS,1
TN,PARKINSONISM,1
TN,PAROSMIA,1
TN,PERICARDITIS CONSTRICTIVE,1
TN,PERICARDITIS TUBERCULOUS,1
TN,PERIORBITAL OEDEMA,1
TN,PERIPHERAL ARTERY THROMBOSIS,1
TN,PERIPHERAL VASCULAR DISORDER,1
TN,PERITONEAL DISORDER,1
TN,PERITONITIS,1
TN,PERIVASCULAR DERMATITIS,1
TN,PETECHIAE,1
TN,PHARYNGEAL INFLAMMATION,1
TN,PHOTOPSIA,1
TN,PLASMA CELL MYELOMA RECURRENT,1
TN,PLASMACYTOMA,1
TN,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
TN,PNEUMONIA ASPIRATION,1
TN,PNEUMONIA BACTERIAL,1
TN,PNEUMONITIS,1
TN,POISONING DELIBERATE,1
TN,POLYARTHRITIS,1
TN,POLYNEUROPATHY,1
TN,POOR FEEDING INFANT,1
TN,PORTAL VEIN THROMBOSIS,1
TN,POST PROCEDURAL COMPLICATION,1
TN,POST PROCEDURAL DIARRHOEA,1
TN,PREMATURE DELIVERY,1
TN,PRODUCT AVAILABILITY ISSUE,1
TN,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
TN,PROSTATE CANCER,1
TN,PROTEINURIA,1
TN,PROTHROMBIN TIME PROLONGED,1
TN,PSEUDOCYST,1
TN,PSEUDOMONAS INFECTION,1
TN,PSEUDOMONAS TEST POSITIVE,1
TN,PSEUDOPORPHYRIA,1
TN,PSORIATIC ARTHROPATHY,1
TN,PSYCHOMOTOR HYPERACTIVITY,1
TN,PULMONARY FIBROSIS,1
TN,PULSE ABNORMAL,1
TN,PURPURA,1
TN,PUSTULAR PSORIASIS,1
TN,PYELONEPHRITIS,1
TN,PYRAMIDAL TRACT SYNDROME,1
TN,QUADRIPLEGIA,1
TN,RADIATION OESOPHAGITIS,1
TN,RASH PAPULOSQUAMOUS,1
TN,RASH PUSTULAR,1
TN,REBOUND PSYCHOSIS,1
TR,TOXICITY TO VARIOUS AGENTS,746
TR,DEATH,697
TR,DRUG INEFFECTIVE,679
TR,NAUSEA,539
TR,FOETAL EXPOSURE DURING PREGNANCY,531
TR,DYSPNOEA,514
TR,VOMITING,495
TR,PYREXIA,415
TR,HYPOTENSION,402
TR,SUICIDE ATTEMPT,380
TR,ASTHENIA,361
TR,OVERDOSE,351
TR,EXPOSURE DURING PREGNANCY,330
TR,THROMBOCYTOPENIA,313
TR,PNEUMONIA,304
TR,DISEASE PROGRESSION,294
TR,PAIN,287
TR,LOSS OF CONSCIOUSNESS,283
TR,CARDIAC ARREST,282
TR,FATIGUE,271
TR,DIARRHOEA,261
TR,DIZZINESS,234
TR,HEADACHE,233
TR,RASH,232
TR,INTENTIONAL OVERDOSE,227
TR,ANAEMIA,226
TR,HYPERTENSION,223
TR,ANGIOEDEMA,221
TR,HYPERSENSITIVITY,217
TR,PRURITUS,216
TR,ANAPHYLACTIC REACTION,214
TR,CONDITION AGGRAVATED,209
TR,NEUTROPENIA,208
TR,MYOCARDIAL INFARCTION,206
TR,SEPSIS,203
TR,INFLUENZA,202
TR,PRODUCT USE ISSUE,198
TR,ACUTE KIDNEY INJURY,190
TR,ERYTHEMA,188
TR,TACHYCARDIA,188
TR,URTICARIA,187
TR,MATERNAL EXPOSURE DURING PREGNANCY,186
TR,RESPIRATORY FAILURE,175
TR,BRADYCARDIA,170
TR,ARTHRALGIA,169
TR,PREMATURE BABY,168
TR,GAIT DISTURBANCE,167
TR,COUGH,166
TR,RESPIRATORY DISTRESS,166
TR,NEUROLEPTIC MALIGNANT SYNDROME,162
TR,ABDOMINAL PAIN,161
TR,FEBRILE NEUTROPENIA,157
TR,ABORTION SPONTANEOUS,156
TR,SEIZURE,154
TR,TREMOR,154
TR,SOMNOLENCE,150
TR,SYNCOPE,150
TR,HEPATIC ENZYME INCREASED,149
TR,CHEST PAIN,148
TR,CONFUSIONAL STATE,144
TR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,144
TR,FALL,142
TR,URINARY TRACT INFECTION,142
TR,LEUKOPENIA,141
TR,WEIGHT DECREASED,140
TR,CARDIAC FAILURE,139
TR,BACK PAIN,138
TR,DECREASED APPETITE,138
TR,INJECTION SITE PAIN,138
TR,PULMONARY EMBOLISM,137
TR,PANCYTOPENIA,136
TR,HYPOAESTHESIA,133
TR,GENERAL PHYSICAL HEALTH DETERIORATION,132
TR,INFECTION,132
TR,PAIN IN EXTREMITY,130
TR,PALPITATIONS,130
TR,INSOMNIA,125
TR,MALIGNANT NEOPLASM PROGRESSION,125
TR,BLOOD CREATININE INCREASED,124
TR,HYPONATRAEMIA,124
TR,HAEMOGLOBIN DECREASED,117
TR,PRODUCT USE IN UNAPPROVED INDICATION,113
TR,ALANINE AMINOTRANSFERASE INCREASED,111
TR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,108
TR,PLEURAL EFFUSION,107
TR,WEIGHT INCREASED,107
TR,KOUNIS SYNDROME,105
TR,LACTIC ACIDOSIS,105
TR,ABDOMINAL PAIN UPPER,104
TR,RENAL FAILURE,104
TR,ASPARTATE AMINOTRANSFERASE INCREASED,103
TR,PULMONARY OEDEMA,103
TR,AGITATION,102
TR,C-REACTIVE PROTEIN INCREASED,102
TR,CEREBROVASCULAR ACCIDENT,102
TR,METABOLIC ACIDOSIS,99
TR,HYPERHIDROSIS,98
TR,NEPHROPATHY TOXIC,95
TR,DEPRESSION,94
TR,GENERALISED TONIC-CLONIC SEIZURE,94
TR,SPEECH DISORDER,93
TR,BLOOD GLUCOSE INCREASED,92
TR,STATUS EPILEPTICUS,92
TR,GASTROINTESTINAL HAEMORRHAGE,90
TR,LUNG INFECTION,89
TR,ARRHYTHMIA,88
TR,CARDIO-RESPIRATORY ARREST,88
TR,DIABETES MELLITUS,88
TR,DRUG HYPERSENSITIVITY,87
TR,INJECTION SITE SWELLING,85
TR,DYSTONIA,84
TR,TOXIC EPIDERMAL NECROLYSIS,84
TR,ANXIETY,83
TR,OEDEMA PERIPHERAL,83
TR,OSTEOPOROSIS,83
TR,DEPRESSED LEVEL OF CONSCIOUSNESS,82
TR,MALAISE,82
TR,RHABDOMYOLYSIS,82
TR,TUBERCULOSIS,82
TR,VISION BLURRED,82
TR,BLOOD PRESSURE INCREASED,81
TR,DYSPHAGIA,81
TR,ACUTE MYOCARDIAL INFARCTION,80
TR,EPILEPSY,80
TR,MYALGIA,80
TR,ALTERED STATE OF CONSCIOUSNESS,79
TR,INJECTION SITE ERYTHEMA,79
TR,PERIPHERAL SWELLING,79
TR,RESPIRATORY ARREST,79
TR,ATRIAL FIBRILLATION,78
TR,DELIRIUM,77
TR,DISEASE RECURRENCE,77
TR,HAEMORRHAGE,77
TR,JOINT SWELLING,77
TR,COMA,76
TR,HEPATOTOXICITY,76
TR,HYPOKALAEMIA,76
TR,SINUS TACHYCARDIA,76
TR,BLINDNESS,75
TR,EPISTAXIS,74
TR,MANIA,74
TR,DYSKINESIA,73
TR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,73
TR,MULTI-ORGAN FAILURE,73
TR,HAEMATURIA,72
TR,HYPERGLYCAEMIA,72
TR,PANCREATITIS ACUTE,71
TR,MUSCLE SPASMS,70
TR,ABDOMINAL DISTENSION,69
TR,PREMATURE DELIVERY,69
TR,OEDEMA,68
TR,RENAL IMPAIRMENT,67
TR,SEPTIC SHOCK,67
TR,DYSARTHRIA,66
TR,HEPATIC FAILURE,66
TR,HYPOGLYCAEMIA,66
TR,PERICARDIAL EFFUSION,66
TR,SINUS BRADYCARDIA,66
TR,HALLUCINATION,65
TR,RESPIRATORY DEPRESSION,65
TR,SWELLING,65
TR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,65
TR,ASCITES,64
TR,PARAESTHESIA,64
TR,VISUAL IMPAIRMENT,64
TR,CARDIAC DISORDER,63
TR,SUICIDAL IDEATION,62
TR,HYPOCALCAEMIA,61
TR,SKIN LESION,61
TR,ABNORMAL BEHAVIOUR,60
TR,ALOPECIA,60
TR,DEEP VEIN THROMBOSIS,60
TR,INTERNATIONAL NORMALISED RATIO INCREASED,60
TR,MUSCULAR WEAKNESS,60
TR,RASH MACULO-PAPULAR,60
TR,PLATELET COUNT DECREASED,59
TR,PULMONARY HYPERTENSION,59
TR,ACIDOSIS,58
TR,DRUG RESISTANCE,58
TR,INCORRECT DOSE ADMINISTERED,58
TR,PSYCHOTIC DISORDER,58
TR,RESTLESSNESS,58
TR,BLOOD PRESSURE DECREASED,57
TR,BLOOD UREA INCREASED,57
TR,BONE MARROW FAILURE,57
TR,CHILLS,57
TR,HAEMOPTYSIS,57
TR,IRRITABILITY,57
TR,VERTIGO,57
TR,CEREBRAL HAEMORRHAGE,56
TR,MUCOSAL INFLAMMATION,56
TR,NEPHROLITHIASIS,56
TR,SWELLING FACE,56
TR,AUTOIMMUNE HEPATITIS,55
TR,BLOOD BILIRUBIN INCREASED,55
TR,DISORIENTATION,55
TR,INTENTIONAL PRODUCT MISUSE,55
TR,SACROILIITIS,55
TR,ACCIDENTAL OVERDOSE,54
TR,EXTRAPYRAMIDAL DISORDER,54
TR,HEART RATE INCREASED,54
TR,INJECTION SITE PRURITUS,54
TR,BURNING SENSATION,53
TR,HAEMORRHAGE INTRACRANIAL,53
TR,INJECTION SITE BRUISING,53
TR,RENAL FAILURE ACUTE,53
TR,URINARY INCONTINENCE,53
TR,CONSTIPATION,52
TR,DRUG ABUSE,52
TR,HYPERKALAEMIA,52
TR,HYPOXIA,52
TR,MULTIPLE SCLEROSIS,52
TR,MULTIPLE SCLEROSIS RELAPSE,52
TR,CHEST DISCOMFORT,51
TR,DEHYDRATION,51
TR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,51
TR,JAUNDICE NEONATAL,51
TR,MEMORY IMPAIRMENT,51
TR,VENTRICULAR TACHYCARDIA,51
TR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,50
TR,ABASIA,49
TR,BALANCE DISORDER,49
TR,SOFT TISSUE INFECTION,49
TR,TREATMENT NONCOMPLIANCE,49
TR,VENTRICULAR FIBRILLATION,49
TR,CATARACT,48
TR,CONVULSION,48
TR,LEUKOCYTOSIS,48
TR,LOCAL SWELLING,48
TR,UVEITIS,48
TR,ARTHROPATHY,47
TR,CHOLELITHIASIS,47
TR,ELECTROCARDIOGRAM QT PROLONGED,47
TR,ENCEPHALOPATHY,47
TR,HALLUCINATION_ VISUAL,47
TR,JAUNDICE,47
TR,VAGINAL HAEMORRHAGE,47
TR,WOUND,47
TR,ASTHMA,46
TR,ATAXIA,46
TR,BLOOD CREATINE PHOSPHOKINASE INCREASED,46
TR,CONTUSION,46
TR,EMBOLIA CUTIS MEDICAMENTOSA,46
TR,FOETAL DEATH,46
TR,MENTAL DISORDER,46
TR,MUSCLE RIGIDITY,46
TR,URINARY RETENTION,46
TR,ABORTION INDUCED,45
TR,DIPLOPIA,45
TR,EYE PAIN,45
TR,FLUSHING,45
TR,HYPERCALCAEMIA,45
TR,MUSCLE CONTRACTIONS INVOLUNTARY,45
TR,DRUG DEPENDENCE,44
TR,DRUG DOSE OMISSION,44
TR,MUSCULOSKELETAL STIFFNESS,44
TR,OCULAR HYPERAEMIA,44
TR,STEVENS-JOHNSON SYNDROME,44
TR,BLOOD TEST ABNORMAL,43
TR,BRONCHITIS,43
TR,CORNEAL OEDEMA,43
TR,DERMATITIS BULLOUS,43
TR,LOW BIRTH WEIGHT BABY,43
TR,SEROTONIN SYNDROME,43
TR,DRUG-INDUCED LIVER INJURY,42
TR,FEELING ABNORMAL,42
TR,LUNG DISORDER,42
TR,LYMPHADENOPATHY,42
TR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,42
TR,TACHYPNOEA,42
TR,AGGRESSION,41
TR,DISSEMINATED INTRAVASCULAR COAGULATION,41
TR,DRUG INTOLERANCE,41
TR,OXYGEN SATURATION DECREASED,41
TR,THERAPEUTIC RESPONSE DECREASED,41
TR,WHITE BLOOD CELL COUNT DECREASED,41
TR,BONE PAIN,40
TR,CYANOSIS,40
TR,DRY MOUTH,40
TR,DYSPEPSIA,40
TR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,40
TR,HEPATITIS B,40
TR,STOMATITIS,40
TR,WITHDRAWAL SYNDROME,40
TR,COMPLETED SUICIDE,39
TR,DRUG ERUPTION,39
TR,FEAR,39
TR,GENERALISED OEDEMA,39
TR,PSORIASIS,39
TR,UPPER RESPIRATORY TRACT INFECTION,39
TR,ASPERGILLUS INFECTION,38
TR,GASTRIC HAEMORRHAGE,38
TR,HEPATITIS TOXIC,38
TR,NEUROTOXICITY,38
TR,PANCREATITIS,38
TR,ROAD TRAFFIC ACCIDENT,38
TR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,37
TR,EMBOLISM,37
TR,EOSINOPHILIA,37
TR,HYPOTHYROIDISM,37
TR,NERVOUSNESS,37
TR,NEUROPATHY PERIPHERAL,37
TR,PLASMA CELL MYELOMA,37
TR,PRODUCT QUALITY ISSUE,37
TR,PULMONARY ARTERIAL HYPERTENSION,37
TR,STRESS,37
TR,VISUAL ACUITY REDUCED,37
TR,BLISTER,36
TR,INJECTION SITE HAEMORRHAGE,36
TR,NEONATAL RESPIRATORY DISTRESS SYNDROME,36
TR,NEURODEVELOPMENTAL DISORDER,36
TR,PROTEINURIA,36
TR,RASH ERYTHEMATOUS,36
TR,ANGINA PECTORIS,35
TR,ATRIOVENTRICULAR BLOCK COMPLETE,35
TR,BLADDER CANCER RECURRENT,35
TR,BLOOD LACTATE DEHYDROGENASE INCREASED,35
TR,CAESAREAN SECTION,35
TR,DRUG ADMINISTRATION ERROR,35
TR,FOETAL ANTICONVULSANT SYNDROME,35
TR,GENERALISED ERYTHEMA,35
TR,HAEMOLYTIC ANAEMIA,35
TR,ISCHAEMIC STROKE,35
TR,LIVER FUNCTION TEST ABNORMAL,35
TR,OROPHARYNGEAL PAIN,35
TR,RHINORRHOEA,35
TR,STUPOR,35
TR,BRAIN OEDEMA,34
TR,COMA SCALE ABNORMAL,34
TR,ECCHYMOSIS,34
TR,GLAUCOMA,34
TR,LETHARGY,34
TR,OSTEONECROSIS OF JAW,34
TR,PARKINSONISM,34
TR,PREGNANCY,34
TR,THROMBOSIS,34
TR,TUBULOINTERSTITIAL NEPHRITIS,34
TR,ULCERATIVE KERATITIS,34
TR,WHEEZING,34
TR,ACUTE CORONARY SYNDROME,33
TR,HEMIPLEGIA,33
TR,HYPOMAGNESAEMIA,33
TR,INTERVERTEBRAL DISC PROTRUSION,33
TR,MYOCLONUS,33
TR,PHARYNGITIS,33
TR,RETINAL DETACHMENT,33
TR,SHOCK,33
TR,DIABETIC KETOACIDOSIS,32
TR,DRUG WITHDRAWAL SYNDROME,32
TR,FEMUR FRACTURE,32
TR,HERPES ZOSTER,32
TR,HISTIOCYTOSIS HAEMATOPHAGIC,32
TR,HYPERAMMONAEMIA,32
TR,ILEUS,32
TR,INCORRECT ROUTE OF DRUG ADMINISTRATION,32
TR,INTRAOCULAR PRESSURE INCREASED,32
TR,NECROTISING COLITIS,32
TR,TOOTH INFECTION,32
TR,TREATMENT FAILURE,32
TR,AMNESIA,31
TR,ANAPHYLACTIC SHOCK,31
TR,CARDIAC TAMPONADE,31
TR,CONJUNCTIVAL HYPERAEMIA,31
TR,DEAFNESS,31
TR,EYELID PTOSIS,31
TR,MICROSPORIDIA INFECTION,31
TR,PALLOR,31
TR,RASH GENERALISED,31
TR,SURGERY,31
TR,VENTRICULAR SEPTAL DEFECT,31
TR,ATRIOVENTRICULAR BLOCK,30
TR,CARDIOTOXICITY,30
TR,COGNITIVE DISORDER,30
TR,HEPATOCELLULAR CARCINOMA,30
TR,HYPERAMMONAEMIC ENCEPHALOPATHY,30
TR,LIP SWELLING,30
TR,MOBILITY DECREASED,30
TR,PULMONARY HAEMORRHAGE,30
TR,PULMONARY MASS,30
TR,ABDOMINAL WALL HAEMATOMA,29
TR,ABORTION,29
TR,ACUTE MYELOID LEUKAEMIA,29
TR,ACUTE RESPIRATORY DISTRESS SYNDROME,29
TR,CYTOMEGALOVIRUS INFECTION,29
TR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,29
TR,DYSURIA,29
TR,EYE SWELLING,29
TR,GASTROINTESTINAL DISORDER,29
TR,HEMIPARESIS,29
TR,INFLAMMATION,29
TR,MAJOR DEPRESSION,29
TR,NEOPLASM PROGRESSION,29
TR,NERVOUS SYSTEM DISORDER,29
TR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,29
TR,PRURITUS GENERALISED,29
TR,RECTAL HAEMORRHAGE,29
TR,SEDATION,29
TR,TOXIC ANTERIOR SEGMENT SYNDROME,29
TR,ATELECTASIS,28
TR,ATRIAL SEPTAL DEFECT,28
TR,COLITIS,28
TR,EYELID OEDEMA,28
TR,FACE OEDEMA,28
TR,HEPATOMEGALY,28
TR,LOWER RESPIRATORY TRACT INFECTION,28
TR,NASOPHARYNGITIS,28
TR,RHEUMATOID ARTHRITIS,28
TR,SUPRAVENTRICULAR TACHYCARDIA,28
TR,WHITE BLOOD CELL COUNT INCREASED,28
TR,APHASIA,27
TR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,27
TR,GALACTORRHOEA,27
TR,GASTROENTERITIS,27
TR,HEPATITIS,27
TR,INFUSION RELATED REACTION,27
TR,MYOPATHY,27
TR,OLIGURIA,27
TR,OSTEONECROSIS,27
TR,PNEUMONITIS,27
TR,SKIN DISCOLOURATION,27
TR,SKIN EXFOLIATION,27
TR,SKIN NECROSIS,27
TR,SLEEP DISORDER,27
TR,TINNITUS,27
TR,TORSADE DE POINTES,27
TR,TRANSAMINASES INCREASED,27
TR,TYPE I HYPERSENSITIVITY,27
TR,ACUTE HEPATIC FAILURE,26
TR,CHRONIC KIDNEY DISEASE,26
TR,CORONARY ARTERY OCCLUSION,26
TR,CUSHING^S SYNDROME,26
TR,EOSINOPHILIC MYOCARDITIS,26
TR,GINGIVAL BLEEDING,26
TR,HYPOPHAGIA,26
TR,HYPOPYON,26
TR,LACRIMATION INCREASED,26
TR,MITRAL VALVE INCOMPETENCE,26
TR,MOUTH ULCERATION,26
TR,OCULOGYRIC CRISIS,26
TR,RENAL DISORDER,26
TR,SERUM FERRITIN INCREASED,26
TR,UNRESPONSIVE TO STIMULI,26
TR,BREAST CANCER,25
TR,DRUG EFFECT INCOMPLETE,25
TR,DYSPHONIA,25
TR,ELECTROLYTE IMBALANCE,25
TR,GASTRIC PERFORATION,25
TR,HAEMARTHROSIS,25
TR,HAEMATOCHEZIA,25
TR,HEPATIC ENCEPHALOPATHY,25
TR,HYPERSENSITIVITY VASCULITIS,25
TR,OBSESSIVE-COMPULSIVE DISORDER,25
TR,PAPILLOEDEMA,25
TR,THERAPEUTIC PRODUCT CROSS-REACTIVITY,25
TR,TORTICOLLIS,25
TR,TRANSIENT ISCHAEMIC ATTACK,25
TR,AKATHISIA,24
TR,ANKYLOSING SPONDYLITIS,24
TR,BONE DISORDER,24
TR,BRAIN NEOPLASM,24
TR,HIP FRACTURE,24
TR,HYPOKINESIA,24
TR,INTERSTITIAL LUNG DISEASE,24
TR,INTRACRANIAL HAEMATOMA,24
TR,LIVER DISORDER,24
TR,MALNUTRITION,24
TR,MENTAL STATUS CHANGES,24
TR,MYDRIASIS,24
TR,PHARYNGEAL OEDEMA,24
TR,POST PROCEDURAL COMPLICATION,24
TR,PRIAPISM,24
TR,UPPER LIMB FRACTURE,24
TR,AMYLASE INCREASED,23
TR,ARTERIOSPASM CORONARY,23
TR,BLINDNESS TRANSIENT,23
TR,CARDIOGENIC SHOCK,23
TR,EPSTEIN-BARR VIRUS INFECTION,23
TR,GROWTH RETARDATION,23
TR,HEPATIC FUNCTION ABNORMAL,23
TR,HYPOTONIA,23
TR,KAPOSI^S SARCOMA,23
TR,MYOCARDIAL ISCHAEMIA,23
TR,MYOPIA,23
TR,PNEUMONIA ASPIRATION,23
TR,THROMBOTIC THROMBOCYTOPENIC PURPURA,23
TR,TRANSPLANT REJECTION,23
TR,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,22
TR,APNOEA,22
TR,DEPRESSED MOOD,22
TR,DRUG LEVEL INCREASED,22
TR,DRY SKIN,22
TR,DYSGEUSIA,22
TR,FLOPPY IRIS SYNDROME,22
TR,HEPATITIS C,22
TR,HYPERTHYROIDISM,22
TR,INFLUENZA LIKE ILLNESS,22
TR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,22
TR,LOGORRHOEA,22
TR,LOWER LIMB FRACTURE,22
TR,OVARIAN CYST,22
TR,PHOTOPHOBIA,22
TR,PRODUCTIVE COUGH,22
TR,PULMONARY ALVEOLAR HAEMORRHAGE,22
TR,PURPURA,22
TR,RENAL PAIN,22
TR,STILLBIRTH,22
TR,STRESS CARDIOMYOPATHY,22
TR,BLOOD ALKALINE PHOSPHATASE INCREASED,21
TR,BLOOD CHOLESTEROL INCREASED,21
TR,BLOOD POTASSIUM DECREASED,21
TR,BLOOD SODIUM DECREASED,21
TR,DISTURBANCE IN ATTENTION,21
TR,ENDOPHTHALMITIS,21
TR,EXPOSURE DURING BREAST FEEDING,21
TR,EYE DISORDER,21
TR,FLATULENCE,21
TR,GRAFT VERSUS HOST DISEASE,21
TR,HAEMORRHOIDS,21
TR,INTESTINAL OBSTRUCTION,21
TR,MENSTRUATION IRREGULAR,21
TR,METASTASES TO CENTRAL NERVOUS SYSTEM,21
TR,NEPHROTIC SYNDROME,21
TR,NYSTAGMUS,21
TR,ORAL DISORDER,21
TR,PETECHIAE,21
TR,POISONING,21
TR,POST PROCEDURAL HAEMORRHAGE,21
TR,PSYCHOMOTOR HYPERACTIVITY,21
TR,PULMONARY TUBERCULOSIS,21
TR,RESPIRATORY DISORDER,21
TR,RESTLESS LEGS SYNDROME,21
TR,SWOLLEN TONGUE,21
TR,APATHY,20
TR,APPENDICITIS,20
TR,BLOOD COUNT ABNORMAL,20
TR,CORONARY ARTERY DISEASE,20
TR,CORONARY ARTERY THROMBOSIS,20
TR,CROHN^S DISEASE,20
TR,ERYTHEMA MULTIFORME,20
TR,FOETAL GROWTH RESTRICTION,20
TR,FUNGAL INFECTION,20
TR,HAEMATEMESIS,20
TR,HAEMATOCRIT DECREASED,20
TR,HAEMATOMA,20
TR,HEPATIC CIRRHOSIS,20
TR,HEPATIC STEATOSIS,20
TR,HYPOAESTHESIA ORAL,20
TR,LIPASE INCREASED,20
TR,LUNG NEOPLASM MALIGNANT,20
TR,METASTASES TO LIVER,20
TR,MOUTH HAEMORRHAGE,20
TR,NASAL CONGESTION,20
TR,PARALYSIS,20
TR,PERITONITIS,20
TR,RASH PUSTULAR,20
TR,THROAT IRRITATION,20
TR,ABDOMINAL DISCOMFORT,19
TR,ACCIDENTAL EXPOSURE TO PRODUCT,19
TR,ARTERIOSCLEROSIS,19
TR,BRADYKINESIA,19
TR,CARDIAC FAILURE CONGESTIVE,19
TR,CEREBRAL INFARCTION,19
TR,CHROMATURIA,19
TR,DISCOMFORT,19
TR,ERECTILE DYSFUNCTION,19
TR,HALLUCINATION_ AUDITORY,19
TR,INTESTINAL PERFORATION,19
TR,KERATOPATHY,19
TR,MEDICATION ERROR,19
TR,MIOSIS,19
TR,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,19
TR,TUMOUR LYSIS SYNDROME,19
TR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,19
TR,ATRIOVENTRICULAR BLOCK SECOND DEGREE,18
TR,BLOOD TRIGLYCERIDES INCREASED,18
TR,CYSTITIS HAEMORRHAGIC,18
TR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,18
TR,EJECTION FRACTION DECREASED,18
TR,FIXED ERUPTION,18
TR,GRAFT VERSUS HOST DISEASE IN SKIN,18
TR,HYPERBILIRUBINAEMIA,18
TR,LUNG INFILTRATION,18
TR,MUSCULOSKELETAL PAIN,18
TR,NEPHROCALCINOSIS,18
TR,OPISTHOTONUS,18
TR,OVARIAN HYPERSTIMULATION SYNDROME,18
TR,PERIORBITAL OEDEMA,18
TR,POLYNEUROPATHY,18
TR,RASH PRURITIC,18
TR,RENAL INJURY,18
TR,SINUSITIS,18
TR,SKIN ULCER,18
TR,SYSTEMIC LUPUS ERYTHEMATOSUS,18
TR,TARDIVE DYSKINESIA,18
TR,VIITH NERVE PARALYSIS,18
TR,ABSCESS,17
TR,AMENORRHOEA,17
TR,BLOOD CREATINE INCREASED,17
TR,BODY TEMPERATURE INCREASED,17
TR,BRAIN ABSCESS,17
TR,BRONCHOPULMONARY ASPERGILLOSIS,17
TR,BRONCHOSPASM,17
TR,CARDIOVASCULAR DISORDER,17
TR,CENTRAL NERVOUS SYSTEM LESION,17
TR,CEREBROVASCULAR DISORDER,17
TR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,17
TR,GASTRITIS,17
TR,HEAD INJURY,17
TR,INGUINAL HERNIA,17
TR,INTRACRANIAL PRESSURE INCREASED,17
TR,ISCHAEMIA,17
TR,LARYNGEAL OEDEMA,17
TR,LEFT VENTRICULAR DYSFUNCTION,17
TR,MOVEMENT DISORDER,17
TR,NEONATAL INFECTION,17
TR,NO THERAPEUTIC RESPONSE,17
TR,NORMAL NEWBORN,17
TR,OESOPHAGEAL ULCER,17
TR,PATHOGEN RESISTANCE,17
TR,PERICARDITIS,17
TR,PRESYNCOPE,17
TR,RASH MACULAR,17
TR,RETROPERITONEAL HAEMATOMA,17
TR,SPINAL FRACTURE,17
TR,STAPHYLOCOCCAL INFECTION,17
TR,SUDDEN UNEXPLAINED DEATH IN EPILEPSY,17
TR,UNEVALUABLE EVENT,17
TR,ADVERSE EVENT,16
TR,ANURIA,16
TR,ARTHRITIS,16
TR,COARCTATION OF THE AORTA,16
TR,CORNEAL INFILTRATES,16
TR,DERMATITIS,16
TR,DYSSTASIA,16
TR,EYE HAEMORRHAGE,16
TR,EYE INFECTION TOXOPLASMAL,16
TR,EYE IRRITATION,16
TR,GROIN PAIN,16
TR,HAEMODYNAMIC INSTABILITY,16
TR,HEPATOSPLENOMEGALY,16
TR,HYPERAEMIA,16
TR,HYPERSOMNIA,16
TR,HYPOMANIA,16
TR,INJECTION SITE REACTION,16
TR,INTRA-ABDOMINAL HAEMORRHAGE,16
TR,LYMPHOMA,16
TR,MYASTHENIA GRAVIS,16
TR,NECK PAIN,16
TR,NEOPLASM MALIGNANT,16
TR,OPEN ANGLE GLAUCOMA,16
TR,SUBARACHNOID HAEMORRHAGE,16
TR,TOOTH ABSCESS,16
TR,UNINTENDED PREGNANCY,16
TR,VASCULAR OCCLUSION,16
TR,XEROPHTHALMIA,16
TR,ACNE,15
TR,ACUTE GRAFT VERSUS HOST DISEASE,15
TR,AFFECTIVE DISORDER,15
TR,BLOOD GLUCOSE DECREASED,15
TR,CONJUNCTIVITIS,15
TR,CYST,15
TR,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,15
TR,EYE INFECTION,15
TR,FORCED EXPIRATORY VOLUME DECREASED,15
TR,GRANULOMA ANNULARE,15
TR,GYNAECOMASTIA,15
TR,HEPARIN-INDUCED THROMBOCYTOPENIA,15
TR,HYPERNATRAEMIA,15
TR,HYPOGAMMAGLOBULINAEMIA,15
TR,HYPOREFLEXIA,15
TR,HYPOTHERMIA,15
TR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,15
TR,LIVER INJURY,15
TR,LONG QT SYNDROME,15
TR,LUPUS-LIKE SYNDROME,15
TR,LYMPHOCYTE COUNT DECREASED,15
TR,LYMPHOPENIA,15
TR,MELAENA,15
TR,NODULE,15
TR,NON-CARDIOGENIC PULMONARY OEDEMA,15
TR,PEMPHIGOID,15
TR,POLYARTHRITIS,15
TR,PREMATURE LABOUR,15
TR,RALES,15
TR,RENAL CYST,15
TR,SPLENOMEGALY,15
TR,STRABISMUS,15
TR,SUDDEN DEATH,15
TR,THERAPEUTIC RESPONSE UNEXPECTED,15
TR,TOOTHACHE,15
TR,TROPONIN I INCREASED,15
TR,UTERINE HAEMORRHAGE,15
TR,UTERINE LEIOMYOMA,15
TR,WOUND INFECTION,15
TR,ABDOMINAL PAIN LOWER,14
TR,ACINETOBACTER INFECTION,14
TR,ANAESTHETIC COMPLICATION,14
TR,ASPHYXIA,14
TR,AUTOIMMUNE HAEMOLYTIC ANAEMIA,14
TR,CARDIOPULMONARY FAILURE,14
TR,CEREBRAL ISCHAEMIA,14
TR,CHOLESTASIS,14
TR,CYSTITIS,14
TR,DEPOSIT EYE,14
TR,DEVICE DISLOCATION,14
TR,FOOT FRACTURE,14
TR,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,14
TR,GRAND MAL CONVULSION,14
TR,HOSPITALISATION,14
TR,HYPOGLYCAEMIA NEONATAL,14
TR,HYPOPNOEA,14
TR,HYPOSPADIAS,14
TR,JOINT DISLOCATION,14
TR,LABORATORY TEST ABNORMAL,14
TR,MASS,14
TR,METASTASES TO BONE,14
TR,MYELODYSPLASTIC SYNDROME,14
TR,OESOPHAGITIS,14
TR,OSTEOPENIA,14
TR,PLEUROTHOTONUS,14
TR,PNEUMOCYSTIS JIROVECII INFECTION,14
TR,PROCEDURAL COMPLICATION,14
TR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,14
TR,SALIVARY HYPERSECRETION,14
TR,SECOND PRIMARY MALIGNANCY,14
TR,SENSORY LOSS,14
TR,SQUAMOUS CELL CARCINOMA,14
TR,SYNOVITIS,14
TR,SYSTEMIC CANDIDA,14
TR,TROPONIN INCREASED,14
TR,UNDERDOSE,14
TR,URINE OUTPUT DECREASED,14
TR,VASCULITIS,14
TR,ABDOMINAL TENDERNESS,13
TR,ANGER,13
TR,ANGLE CLOSURE GLAUCOMA,13
TR,APLASTIC ANAEMIA,13
TR,ASPIRATION,13
TR,ATRIOVENTRICULAR BLOCK FIRST DEGREE,13
TR,BLADDER CANCER,13
TR,BLINDNESS UNILATERAL,13
TR,BLOOD ALBUMIN DECREASED,13
TR,BLOOD LACTIC ACID INCREASED,13
TR,CARDIAC VALVE REPLACEMENT COMPLICATION,13
TR,CEREBRAL ASPERGILLOSIS,13
TR,CEREBRAL VENOUS THROMBOSIS,13
TR,CHRONIC GRAFT VERSUS HOST DISEASE,13
TR,CHRONIC MYELOID LEUKAEMIA,13
TR,CONTRAINDICATED DRUG ADMINISTERED,13
TR,CRYING,13
TR,CYTOPENIA,13
TR,DELUSION,13
TR,DIARRHOEA HAEMORRHAGIC,13
TR,EMPHYSEMA,13
TR,ENTEROCOLITIS HAEMORRHAGIC,13
TR,EUPHORIC MOOD,13
TR,FEELING COLD,13
TR,FRACTURE,13
TR,GALLBLADDER DISORDER,13
TR,HEPATITIS CHOLESTATIC,13
TR,HERPES SIMPLEX,13
TR,HOT FLUSH,13
TR,HYPERPROLACTINAEMIA,13
TR,HYPERREFLEXIA,13
TR,INTERCEPTED MEDICATION ERROR,13
TR,IRON DEFICIENCY,13
TR,LIBIDO DECREASED,13
TR,MENINGITIS,13
TR,MUSCLE CONTRACTURE,13
TR,NEPHROPATHY,13
TR,NO ADVERSE EVENT,13
TR,OPTIC NEURITIS,13
TR,PERSECUTORY DELUSION,13
TR,PNEUMATOSIS INTESTINALIS,13
TR,RAYNAUD^S PHENOMENON,13
TR,RETINAL HAEMORRHAGE,13
TR,SCAB,13
TR,SCHIZOPHRENIA,13
TR,TENDON RUPTURE,13
TR,THROMBOSIS IN DEVICE,13
TR,ACUTE LYMPHOCYTIC LEUKAEMIA,12
TR,ANAL PRURITUS,12
TR,ANORECTAL DISORDER,12
TR,APHTHOUS STOMATITIS,12
TR,ARTHRITIS BACTERIAL,12
TR,ATRIAL TACHYCARDIA,12
TR,AUTOIMMUNE THYROIDITIS,12
TR,BACTERIAL INFECTION,12
TR,BLEPHAROSPASM,12
TR,BLOOD URIC ACID INCREASED,12
TR,BOREDOM,12
TR,BRAIN DEATH,12
TR,BREAST MASS,12
TR,CARDIOMYOPATHY,12
TR,CELLULITIS,12
TR,COLD SWEAT,12
TR,CORONARY ARTERY STENOSIS,12
TR,DENTAL CARIES,12
TR,DYSMORPHISM,12
TR,EATING DISORDER,12
TR,EMOTIONAL DISTRESS,12
TR,END STAGE RENAL DISEASE,12
TR,ENURESIS,12
TR,FOETAL DISTRESS SYNDROME,12
TR,GENERAL PHYSICAL CONDITION ABNORMAL,12
TR,GLOMERULAR FILTRATION RATE DECREASED,12
TR,IMMUNE SYSTEM DISORDER,12
TR,IMMUNE THROMBOCYTOPENIC PURPURA,12
TR,INCREASED APPETITE,12
TR,INJECTION SITE MASS,12
TR,INJECTION SITE VESICLES,12
TR,INTRACARDIAC THROMBUS,12
TR,LIMB DEFORMITY,12
TR,LIMBIC ENCEPHALITIS,12
TR,MATERNAL DRUGS AFFECTING FOETUS,12
TR,MENORRHAGIA,12
TR,MENTAL IMPAIRMENT,12
TR,MYOCARDIAL DEPRESSION,12
TR,NECROSIS,12
TR,NEONATAL ASPIRATION,12
TR,OCULAR ICTERUS,12
TR,ORAL HERPES,12
TR,PANCREATIC CARCINOMA,12
TR,PATENT DUCTUS ARTERIOSUS,12
TR,PERSISTENT CORNEAL EPITHELIAL DEFECT,12
TR,PNEUMOTHORAX,12
TR,POSTOPERATIVE WOUND INFECTION,12
TR,PROTHROMBIN TIME PROLONGED,12
TR,PULMONARY TOXICITY,12
TR,REBOUND EFFECT,12
TR,RHEUMATIC DISORDER,12
TR,SCAR,12
TR,SKIN DISORDER,12
TR,SKIN TOXICITY,12
TR,SPINA BIFIDA,12
TR,STENOTROPHOMONAS INFECTION,12
TR,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,12
TR,SUSPECTED COUNTERFEIT PRODUCT,12
TR,TENSION,12
TR,TIC,12
TR,VACTERL SYNDROME,12
TR,WANDERING PACEMAKER,12
TR,ACUTE PRERENAL FAILURE,11
TR,AGRANULOCYTOSIS,11
TR,AREFLEXIA,11
TR,BIPOLAR DISORDER,11
TR,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,11
TR,CARDIAC MURMUR,11
TR,CARDIAC SEPTAL DEFECT,11
TR,CEREBRAL ARTERY EMBOLISM,11
TR,CEREBRAL DISORDER,11
TR,CEREBRAL THROMBOSIS,11
TR,CHOLECYSTITIS,11
TR,CLONUS,11
TR,CUSHINGOID,11
TR,CYTOMEGALOVIRUS CHORIORETINITIS,11
TR,DRY EYE,11
TR,ELECTROCARDIOGRAM ABNORMAL,11
TR,EMBOLISM VENOUS,11
TR,EXOSTOSIS,11
TR,EXPOSURE VIA FATHER,11
TR,FAMILIAL MEDITERRANEAN FEVER,11
TR,FEELING HOT,11
TR,FOOT DEFORMITY,11
TR,GOITRE,11
TR,HAEMATOTOXICITY,11
TR,HAEMOTHORAX,11
TR,HEPATITIS B REACTIVATION,11
TR,HICCUPS,11
TR,HUMERUS FRACTURE,11
TR,HYDROCEPHALUS,11
TR,HYPERTRIGLYCERIDAEMIA,11
TR,HYPOALBUMINAEMIA,11
TR,IMMATURE RESPIRATORY SYSTEM,11
TR,IMMUNOSUPPRESSION,11
TR,INCORRECT PRODUCT STORAGE,11
TR,INTENTIONAL PRODUCT USE ISSUE,11
TR,INTESTINAL ISCHAEMIA,11
TR,IRIDOCYCLITIS,11
TR,IRON DEFICIENCY ANAEMIA,11
TR,MUSCLE ATROPHY,11
TR,MYOCLONIC EPILEPSY,11
TR,OESOPHAGEAL CANDIDIASIS,11
TR,ORTHOPNOEA,11
TR,OXALOSIS,11
TR,PARANOIA,11
TR,PREMATURE RUPTURE OF MEMBRANES,11
TR,RENAL CELL CARCINOMA,11
TR,RIGHT VENTRICULAR FAILURE,11
TR,SELF INJURIOUS BEHAVIOUR,11
TR,SKIN HYPERPIGMENTATION,11
TR,SYRINGE ISSUE,11
TR,THYROID NEOPLASM,11
TR,TONSILLITIS,11
TR,TRANSFUSION,11
TR,VANISHING BILE DUCT SYNDROME,11
TR,WALKING DISABILITY,11
TR,ATYPICAL FEMUR FRACTURE,10
TR,BEHCET^S SYNDROME,10
TR,BLOOD THYROID STIMULATING HORMONE INCREASED,10
TR,BRUCELLOSIS,10
TR,CANDIDA INFECTION,10
TR,CATARACT SUBCAPSULAR,10
TR,CEREBRAL ATROPHY,10
TR,CIRCULATORY COLLAPSE,10
TR,COAGULOPATHY,10
TR,CONJUNCTIVAL HAEMORRHAGE,10
TR,CONJUNCTIVAL OEDEMA,10
TR,CORNEAL EPITHELIUM DEFECT,10
TR,DECUBITUS ULCER,10
TR,DIABETES MELLITUS INADEQUATE CONTROL,10
TR,DISINHIBITION,10
TR,DISSEMINATED TUBERCULOSIS,10
TR,EOSINOPHILIC PNEUMONIA,10
TR,EYE MOVEMENT DISORDER,10
TR,EYE PRURITUS,10
TR,FAECAL INCONTINENCE,10
TR,FAT EMBOLISM,10
TR,FISTULA,10
TR,GASTRIC DISORDER,10
TR,GASTROINTESTINAL INFECTION,10
TR,GUILLAIN-BARRE SYNDROME,10
TR,HEART RATE DECREASED,10
TR,HYPERAESTHESIA,10
TR,HYPERTHERMIA,10
TR,INJECTION SITE INDURATION,10
TR,INJECTION SITE INFECTION,10
TR,INTESTINAL HAEMORRHAGE,10
TR,JOINT EFFUSION,10
TR,JOINT STIFFNESS,10
TR,LEUKAEMIA,10
TR,LOCALISED INFECTION,10
TR,MIGRAINE,10
TR,NEUTROPHIL COUNT DECREASED,10
TR,ORGANISING PNEUMONIA,10
TR,OSTEOLYSIS,10
TR,PANIC ATTACK,10
TR,PARADOXICAL DRUG REACTION,10
TR,PERIPHERAL ARTERY THROMBOSIS,10
TR,PLATELET COUNT INCREASED,10
TR,POLLAKIURIA,10
TR,PROSTATIC SPECIFIC ANTIGEN INCREASED,10
TR,PUNCTATE KERATITIS,10
TR,RENAL FAILURE CHRONIC,10
TR,SEPSIS NEONATAL,10
TR,SKIN PLAQUE,10
TR,THERAPY NON-RESPONDER,10
TR,THROMBOTIC MICROANGIOPATHY,10
TR,TRAUMATIC HAEMORRHAGE,10
TR,VASCULAR STENT THROMBOSIS,10
TR,VENTRICULAR EXTRASYSTOLES,10
TR,WERNICKE^S ENCEPHALOPATHY,10
TR,WRONG DRUG ADMINISTERED,10
TR,ACUTE PSYCHOSIS,9
TR,ANAL ABSCESS,9
TR,ANTERIOR CHAMBER DISORDER,9
TR,ARTERIAL THROMBOSIS,9
TR,ASTHENOSPERMIA,9
TR,BILIRUBIN CONJUGATED INCREASED,9
TR,BK VIRUS INFECTION,9
TR,BLOOD CALCIUM DECREASED,9
TR,BLOOD GLUCOSE ABNORMAL,9
TR,BLOOD POTASSIUM INCREASED,9
TR,BLOOD URINE PRESENT,9
TR,BREATH SOUNDS ABNORMAL,9
TR,BRONCHIOLITIS,9
TR,CARDIAC VALVE DISEASE,9
TR,CHEILITIS,9
TR,CHRONIC LYMPHOCYTIC LEUKAEMIA,9
TR,COELIAC DISEASE,9
TR,COGWHEEL RIGIDITY,9
TR,DERMATOMYOSITIS,9
TR,DIABETES INSIPIDUS,9
TR,DRUG LEVEL DECREASED,9
TR,DRUG PRESCRIBING ERROR,9
TR,DYSPNOEA EXERTIONAL,9
TR,EAR DISCOMFORT,9
TR,EAR PAIN,9
TR,ECZEMA,9
TR,FAECES DISCOLOURED,9
TR,FEAR OF DEATH,9
TR,FEMALE GENITAL TRACT FISTULA,9
TR,FOLATE DEFICIENCY,9
TR,GAIT INABILITY,9
TR,GASTRIC ULCER,9
TR,GAZE PALSY,9
TR,GRAFT COMPLICATION,9
TR,HALLUCINATIONS_ MIXED,9
TR,HENOCH-SCHONLEIN PURPURA,9
TR,HYPERLIPIDAEMIA,9
TR,HYPOVOLAEMIA,9
TR,INCORRECT DRUG ADMINISTRATION DURATION,9
TR,INFERTILITY,9
TR,INJURY,9
TR,INTENTIONAL DRUG MISUSE,9
TR,INTENTIONAL SELF-INJURY,9
TR,INVASIVE DUCTAL BREAST CARCINOMA,9
TR,JOINT RANGE OF MOTION DECREASED,9
TM,ANORECTAL DISCOMFORT,2
TM,ABDOMINAL PAIN UPPER,1
TM,ALANINE AMINOTRANSFERASE INCREASED,1
TM,AMYLASE INCREASED,1
TM,ASPARTATE AMINOTRANSFERASE INCREASED,1
TM,BLOOD BILIRUBIN INCREASED,1
TM,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
TM,INSOMNIA,1
TM,VOMITING,1
UG,DEATH,95
UG,BLOOD CREATININE INCREASED,77
UG,ABORTION SPONTANEOUS,76
UG,EXPOSURE DURING PREGNANCY,65
UG,ANAEMIA,57
UG,NEPHROPATHY TOXIC,51
UG,VIROLOGIC FAILURE,51
UG,MATERNAL EXPOSURE DURING PREGNANCY,50
UG,FOETAL EXPOSURE DURING PREGNANCY,43
UG,PYREXIA,34
UG,VOMITING,31
UG,ABORTION INDUCED,27
UG,PROTEINURIA,27
UG,DIARRHOEA,25
UG,STILLBIRTH,25
UG,FOETAL DEATH,24
UG,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,23
UG,PNEUMONIA,22
UG,SEPSIS,21
UG,DEHYDRATION,16
UG,DRUG INEFFECTIVE,15
UG,MENINGITIS CRYPTOCOCCAL,15
UG,TREATMENT FAILURE,15
UG,DRUG-INDUCED LIVER INJURY,14
UG,DECREASED APPETITE,13
UG,GLYCOSURIA,13
UG,URINARY TRACT INFECTION,13
UG,PREMATURE DELIVERY,12
UG,PROTEIN URINE PRESENT,12
UG,DRUG RESISTANCE,11
UG,HEADACHE,11
UG,KAPOSI^S SARCOMA,11
UG,MALAISE,11
UG,MALARIA,11
UG,MALNUTRITION,11
UG,PREMATURE BABY,11
UG,PULMONARY TUBERCULOSIS,11
UG,TREATMENT NONCOMPLIANCE,11
UG,ACUTE KIDNEY INJURY,10
UG,ASTHENIA,10
UG,COUGH,10
UG,CRYPTOCOCCOSIS,10
UG,HIV INFECTION,10
UG,ORAL CANDIDIASIS,10
UG,ABDOMINAL PAIN,9
UG,DEEP VEIN THROMBOSIS,9
UG,DEVELOPMENTAL HIP DYSPLASIA,9
UG,DIZZINESS,9
UG,HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION,9
UG,OEDEMA PERIPHERAL,9
UG,SKULL MALFORMATION,9
UG,TALIPES,9
UG,BENIGN HYDATIDIFORM MOLE,8
UG,BRONCHOPNEUMONIA,8
UG,EPISTAXIS,8
UG,FOETAL EXPOSURE DURING DELIVERY,8
UG,MICROGNATHIA,8
UG,NEUTROPENIA,8
UG,PROTEIN URINE,8
UG,SMALL FOR DATES BABY,8
UG,SWELLING FACE,8
UG,THROMBOCYTOPENIA,8
UG,TUBERCULOSIS,8
UG,DYSPNOEA,7
UG,JAUNDICE,7
UG,OESOPHAGEAL CANDIDIASIS,7
UG,RASH,7
UG,ABDOMINAL PAIN UPPER,6
UG,ADVERSE DRUG REACTION,6
UG,ASPARTATE AMINOTRANSFERASE INCREASED,6
UG,CARDIAC FAILURE CONGESTIVE,6
UG,FATIGUE,6
UG,HYPOTENSION,6
UG,INTERNATIONAL NORMALISED RATIO INCREASED,6
UG,LETHARGY,6
UG,NEPHROPATHY,6
UG,NEUROPATHY PERIPHERAL,6
UG,PREGNANCY,6
UG,BLOOD BILIRUBIN INCREASED,5
UG,CACHEXIA,5
UG,CHILLS,5
UG,CONGENITAL KNEE DEFORMITY,5
UG,ENCEPHALITIS,5
UG,HAIR TEXTURE ABNORMAL,5
UG,HYPERTENSION,5
UG,LEFT VENTRICULAR DYSFUNCTION,5
UG,MUSCULAR WEAKNESS,5
UG,PALLOR,5
UG,PANCYTOPENIA,5
UG,POLYDACTYLY,5
UG,PRURITUS,5
UG,SKIN EXFOLIATION,5
UG,STEVENS-JOHNSON SYNDROME,5
UG,SYNDACTYLY,5
UG,UPPER RESPIRATORY TRACT INFECTION,5
UG,WRIST DEFORMITY,5
UG,ABORTION THREATENED,4
UG,ADVERSE EVENT,4
UG,ASCITES,4
UG,BACTERAEMIA,4
UG,BONE DENSITY DECREASED,4
UG,CONDITION AGGRAVATED,4
UG,CUSHINGOID,4
UG,DIABETES MELLITUS,4
UG,GLOMERULONEPHRITIS,4
UG,GLUCOSE URINE PRESENT,4
UG,HEPATITIS,4
UG,HEPATOMEGALY,4
UG,HEPATOTOXICITY,4
UG,HYPERSENSITIVITY,4
UG,INCORRECT PRODUCT STORAGE,4
UG,LEUKOPENIA,4
UG,PALPITATIONS,4
UG,PANCREATITIS,4
UG,PLASMODIUM FALCIPARUM INFECTION,4
UG,PRODUCT DEPOSIT,4
UG,PULMONARY EMBOLISM,4
UG,RENAL FAILURE,4
UG,RENAL TUBULAR NECROSIS,4
UG,SHOCK,4
UG,SOMNOLENCE,4
UG,WEIGHT DECREASED,4
UG,ABNORMAL BEHAVIOUR,3
UG,ABORTION INCOMPLETE,3
UG,AUTOSOMAL CHROMOSOME ANOMALY,3
UG,BRONCHOPULMONARY ASPERGILLOSIS,3
UG,BURNING SENSATION,3
UG,CARDIAC FAILURE,3
UG,CEREBROVASCULAR ACCIDENT,3
UG,CHEST PAIN,3
UG,CHRONIC MYELOID LEUKAEMIA,3
UG,CONJUNCTIVITIS,3
UG,CRYPTOCOCCAL FUNGAEMIA,3
UG,DYSMORPHISM,3
UG,DYSURIA,3
UG,ELECTROLYTE IMBALANCE,3
UG,GAIT DISTURBANCE,3
UG,GASTROENTERITIS,3
UG,GENERALISED OEDEMA,3
UG,GENERALISED TONIC-CLONIC SEIZURE,3
UG,HAEMOPTYSIS,3
UG,HAEMORRHAGE,3
UG,HEPATIC FAILURE,3
UG,HEPATITIS ACUTE,3
UG,HEPATITIS B,3
UG,HYDROCEPHALUS,3
UG,HYPERGLYCAEMIA,3
UG,HYPONATRAEMIA,3
UG,LIMB MALFORMATION,3
UG,MEDICATION ERROR,3
UG,OEDEMA,3
UG,PAIN,3
UG,PARAESTHESIA,3
UG,PERICARDIAL EFFUSION,3
UG,PREGNANCY WITH IMPLANT CONTRACEPTIVE,3
UG,PSYCHOTIC DISORDER,3
UG,PYURIA,3
UG,RASH MACULO-PAPULAR,3
UG,RASH PAPULAR,3
UG,RESPIRATORY DISTRESS,3
UG,SELF ESTEEM DECREASED,3
UG,TREMOR,3
UG,VISION BLURRED,3
UG,ABDOMINAL DISTENSION,2
UG,ABDOMINAL TENDERNESS,2
UG,ABORTION,2
UG,ACUTE RESPIRATORY FAILURE,2
UG,ALANINE AMINOTRANSFERASE INCREASED,2
UG,ALOPECIA,2
UG,AMYLASE INCREASED,2
UG,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,2
UG,ANURIA,2
UG,BEDRIDDEN,2
UG,BIPOLAR DISORDER,2
UG,BLADDER OUTLET OBSTRUCTION,2
UG,BLOOD UREA INCREASED,2
UG,BLOOD URINE PRESENT,2
UG,BODY TEMPERATURE INCREASED,2
UG,BONE DECALCIFICATION,2
UG,BONE DISORDER,2
UG,BONE PAIN,2
UG,CANDIDA INFECTION,2
UG,CARDIOMEGALY,2
UG,CENTRAL NERVOUS SYSTEM LESION,2
UG,CEREBELLAR ATAXIA,2
UG,CONGENITAL HAIR DISORDER,2
UG,CONGENITAL KNEE DISLOCATION,2
UG,CONGENITAL LIMB HYPEREXTENSION,2
UG,CONGESTIVE CARDIOMYOPATHY,2
UG,CREPITATIONS,2
UG,CRYPTOSPORIDIOSIS INFECTION,2
UG,DERMATOMYOSITIS,2
UG,DIABETIC KETOACIDOSIS,2
UG,DISORIENTATION,2
UG,DISSEMINATED TUBERCULOSIS,2
UG,DRUG DOSE OMISSION,2
UG,DRUG HYPERSENSITIVITY,2
UG,EXPOSURE DURING BREAST FEEDING,2
UG,FALL,2
UG,FANCONI SYNDROME,2
UG,GENERAL PHYSICAL CONDITION ABNORMAL,2
UG,GENITAL HAEMORRHAGE,2
UG,HAEMORRHAGE INTRACRANIAL,2
UG,HEART SOUNDS ABNORMAL,2
UG,HEMIPARESIS,2
UG,HIV ASSOCIATED NEPHROPATHY,2
UG,HYDRONEPHROSIS,2
UG,HYPOKALAEMIA,2
UG,ILEAL PERFORATION,2
UG,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS,2
UG,INSOMNIA,2
UG,INTESTINAL OBSTRUCTION,2
UG,INTESTINAL PERFORATION,2
UG,INTRACARDIAC THROMBUS,2
UG,INTRACRANIAL PRESSURE INCREASED,2
UG,JOINT STIFFNESS,2
UG,KLEBSIELLA SEPSIS,2
UG,LACTIC ACIDOSIS,2
UG,LIVER INJURY,2
UG,LOCAL SWELLING,2
UG,LOW BIRTH WEIGHT BABY,2
UG,LYMPH NODE TUBERCULOSIS,2
UG,LYMPHADENOPATHY,2
UG,MALIGNANT NEOPLASM PROGRESSION,2
UG,MANIA,2
UG,MATERNAL EXPOSURE BEFORE PREGNANCY,2
UG,MENINGITIS,2
UG,MUSCULOSKELETAL STIFFNESS,2
UG,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST NEGATIVE,2
UG,NAIL PIGMENTATION,2
UG,NECK PAIN,2
UG,OSTEOMALACIA,2
UG,OTITIS MEDIA CHRONIC,2
UG,PAIN IN EXTREMITY,2
UG,PARADOXICAL DRUG REACTION,2
UG,PERIPHERAL SWELLING,2
UG,PHOTOPHOBIA,2
UG,PNEUMONIA KLEBSIELLA,2
UG,POLYURIA,2
UG,PRODUCT QUALITY ISSUE,2
UG,PRURITUS GENERALISED,2
UG,PULSE VOLUME DECREASED,2
UG,RENAL FAILURE ACUTE,2
UG,RESPIRATORY FAILURE,2
UG,ROAD TRAFFIC ACCIDENT,2
UG,SEPTIC SHOCK,2
UG,SEROTONIN SYNDROME,2
UG,SINUS TACHYCARDIA,2
UG,SKIN HYPERPIGMENTATION,2
UG,SKIN WARM,2
UG,SPUTUM ABNORMAL,2
UG,SYPHILIS,2
UG,TACHYPNOEA,2
UG,THROAT IRRITATION,2
UG,THYROID TUBERCULOSIS,2
UG,TIBIA FRACTURE,2
UG,TRANSIENT ISCHAEMIC ATTACK,2
UG,UREA URINE INCREASED,2
UG,URINARY SEDIMENT PRESENT,2
UG,UTERINE HAEMORRHAGE,2
UG,VAGINAL HAEMORRHAGE,2
UG,ABASIA,1
UG,ABDOMINAL DISCOMFORT,1
UG,ABDOMINAL PAIN LOWER,1
UG,ABORTION INFECTED,1
UG,ABORTION MISSED,1
UG,ACCIDENT,1
UG,ACCIDENTAL DEATH,1
UG,ACCIDENTAL OVERDOSE,1
UG,ACIDOSIS,1
UG,ACTIVITIES OF DAILY LIVING IMPAIRED,1
UG,ACUTE HEPATIC FAILURE,1
UG,ACUTE RESPIRATORY DISTRESS SYNDROME,1
UG,ACUTE SINUSITIS,1
UG,AFFECTIVE DISORDER,1
UG,AGGRESSION,1
UG,ALANINE AMINOTRANSFERASE ABNORMAL,1
UG,ALCOHOL POISONING,1
UG,ANAPHYLACTIC REACTION,1
UG,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,1
UG,ARRHYTHMIA,1
UG,ARTERIAL THROMBOSIS,1
UG,ARTHRALGIA,1
UG,ARTHRITIS,1
UG,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
UG,ASTHMA,1
UG,BACK PAIN,1
UG,BACTERIAL SEPSIS,1
UG,BASOPHIL COUNT INCREASED,1
UG,BIPOLAR I DISORDER,1
UG,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
UG,BLEPHARITIS,1
UG,BLIGHTED OVUM,1
UG,BLISTER,1
UG,BLOOD ALKALINE PHOSPHATASE INCREASED,1
UG,BLOOD GLUCOSE INCREASED,1
UG,BLOOD LACTATE DEHYDROGENASE INCREASED,1
UG,BONE FORMATION DECREASED,1
UG,BRAIN OEDEMA,1
UG,BRAIN STEM SYNDROME,1
UG,BREATH SOUNDS ABNORMAL,1
UG,BREATH SOUNDS ABSENT,1
UG,CAESAREAN SECTION,1
UG,CARDIAC ARREST,1
UG,CARDIAC MURMUR,1
UG,CARDIOTHORACIC RATIO,1
UG,CD4 LYMPHOCYTES INCREASED,1
UG,CEPHALO-PELVIC DISPROPORTION,1
UG,CEREBRAL TOXOPLASMOSIS,1
UG,CHEILITIS,1
UG,CHOLANGITIS SCLEROSING,1
UG,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
UG,CIRRHOSIS ALCOHOLIC,1
UG,COLPORRHAPHY,1
UG,COMA,1
UG,COMPLICATIONS OF TRANSPLANTED LIVER,1
UG,CONFUSIONAL STATE,1
UG,CONGENITAL ANAEMIA,1
UG,CONGENITAL SYPHILIS,1
UG,CONJUNCTIVAL HYPERAEMIA,1
UG,CONNECTIVE TISSUE DISORDER,1
UG,CONSTIPATION,1
UG,CONVERSION DISORDER,1
UG,CONVULSION,1
UG,CRANIAL NERVE DISORDER,1
UG,CRYING,1
UG,CSF PROTEIN INCREASED,1
UG,CYSTITIS,1
UG,CYSTOCELE,1
UG,CYTOMEGALOVIRUS CHORIORETINITIS,1
UG,CYTOPENIA,1
UG,DERMATITIS ATOPIC,1
UG,DEVICE RELATED INFECTION,1
UG,DIABETES MELLITUS INADEQUATE CONTROL,1
UG,DISEASE PROGRESSION,1
UG,DISSEMINATED CRYPTOCOCCOSIS,1
UG,DISTURBANCE IN ATTENTION,1
UG,DROWNING,1
UG,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
UG,DRY MOUTH,1
UG,DYSENTERY,1
UG,DYSKINESIA,1
UG,DYSPEPSIA,1
UG,DYSPHAGIA,1
UG,ECHINOCOCCIASIS,1
UG,ECTOPIC PREGNANCY,1
UG,ECZEMA,1
UG,ELBOW DEFORMITY,1
UG,ELECTROCARDIOGRAM ST-T CHANGE,1
UG,ENDOMETRITIS,1
UG,EXCORIATION,1
UG,EXOMPHALOS,1
UG,FEBRILE CONVULSION,1
UG,FLUID RETENTION,1
UG,FONTANELLE BULGING,1
UG,FUNGAL INFECTION,1
UG,GASTROENTERITIS CRYPTOCOCCAL,1
UG,GASTROINTESTINAL HAEMORRHAGE,1
UG,GLUCOSE URINE,1
UG,GOUTY ARTHRITIS,1
UG,GYNAECOMASTIA,1
UG,HAEMANGIOMA,1
UG,HAEMATURIA,1
UG,HAEMOGLOBIN DECREASED,1
UG,HAEMORRHAGE IN PREGNANCY,1
UG,HAEMORRHOIDS,1
UG,HALLUCINATION,1
UG,HALLUCINATION_ VISUAL,1
UG,HELICOBACTER INFECTION,1
UG,HEPATIC CIRRHOSIS,1
UG,HEPATIC ENCEPHALOPATHY,1
UG,HEPATIC ENZYME INCREASED,1
UG,HOSPITALISATION,1
UG,HYPOAESTHESIA,1
UG,INFECTION,1
UG,INFLUENZA,1
UG,INJECTION SITE PAIN,1
UG,KERATITIS,1
UG,LABILE BLOOD PRESSURE,1
UG,LEFT VENTRICULAR HEAVE,1
UG,LEFT VENTRICULAR HYPERTROPHY,1
UG,LEUKOPLAKIA,1
UG,LIMB AMPUTATION,1
UG,LIMB DEFORMITY,1
UG,LIP ERYTHEMA,1
UG,LIPODYSTROPHY ACQUIRED,1
UG,LIVE BIRTH,1
UG,LIVER TENDERNESS,1
UG,LOGORRHOEA,1
UG,LOSS OF CONSCIOUSNESS,1
UG,LOW DENSITY LIPOPROTEIN INCREASED,1
UG,LUNG CONSOLIDATION,1
UG,MACROCEPHALY,1
UG,MALARIA ANTIBODY TEST POSITIVE,1
UG,MALIGNANT HYPERTENSION,1
UG,MATERNAL DEATH AFFECTING FOETUS,1
UG,MENTAL DISORDER,1
UG,MENTAL STATUS CHANGES,1
UG,METRORRHAGIA,1
UG,MOBILITY DECREASED,1
UG,MOUTH ULCERATION,1
UG,MYCOBACTERIUM TEST POSITIVE,1
UG,MYOCARDITIS,1
UG,NASAL DISCOMFORT,1
UG,NASAL DRYNESS,1
UG,NAUSEA,1
UG,NEONATAL ASPHYXIA,1
UG,NEOPLASM PROGRESSION,1
UG,NEPHROTIC SYNDROME,1
UG,NEUROCRYPTOCOCCOSIS,1
UG,NEUROCYSTICERCOSIS,1
UG,NEUROLOGICAL SYMPTOM,1
UG,NIGHTMARE,1
UG,NORMAL NEWBORN,1
UG,NUCHAL RIGIDITY,1
UG,OCULAR ICTERUS,1
UG,ODYNOPHAGIA,1
UG,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,1
UG,ORAL HERPES,1
UG,ORAL MUCOSAL ERYTHEMA,1
UG,ORAL PAIN,1
UG,OROPHARYNGEAL CANDIDIASIS,1
UG,ORTHOPNOEA,1
UG,OSTEOPENIA,1
UG,OTITIS MEDIA,1
UG,OVARIAN NEOPLASM,1
UG,OVERDOSE,1
UG,PARALYSIS,1
UG,PATHOGEN RESISTANCE,1
UG,PELVIC INFLAMMATORY DISEASE,1
UG,PENIS DISORDER,1
UG,PETIT MAL EPILEPSY,1
UG,PHARYNGEAL ERYTHEMA,1
UG,PIGMENTATION DISORDER,1
UG,PLACENTA PRAEVIA HAEMORRHAGE,1
UG,PLATELET COUNT DECREASED,1
UG,PNEUMOCOCCAL SEPSIS,1
UG,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
UG,PNEUMONIA ASPIRATION,1
UG,PNEUMONIA BACTERIAL,1
UG,PNEUMOTHORAX SPONTANEOUS,1
UG,POST-TRAUMATIC NECK SYNDROME,1
UG,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
UG,POSTPARTUM HAEMORRHAGE,1
UG,PREMATURE LABOUR,1
UG,PRODUCT NAME CONFUSION,1
UG,PRODUCT SUBSTITUTION ISSUE,1
UG,PRODUCT USE ISSUE,1
UG,PRODUCTIVE COUGH,1
UG,PSYCHOMOTOR HYPERACTIVITY,1
UG,PULMONARY PHYSICAL EXAMINATION ABNORMAL,1
UG,PYELONEPHRITIS,1
UG,RADIUS FRACTURE,1
UG,RASH GENERALISED,1
UG,RASH MORBILLIFORM,1
UG,RASH PRURITIC,1
UG,RED BLOOD CELLS URINE,1
UG,RENAL DISORDER,1
UG,RESTLESSNESS,1
UG,RHEUMATOID ARTHRITIS,1
UG,RHONCHI,1
UG,RUPTURED ECTOPIC PREGNANCY,1
UG,SCLERAL DISCOLOURATION,1
UG,SCREAMING,1
UG,SEBORRHOEIC DERMATITIS,1
UG,SHOCK HAEMORRHAGIC,1
UG,SLEEP DISORDER,1
UG,SOFT TISSUE INJURY,1
UG,SPEECH DISORDER,1
UG,SPINAL COMPRESSION FRACTURE,1
UG,SQUAMOUS CELL CARCINOMA OF LUNG,1
UG,STOMATITIS,1
UG,SUBCUTANEOUS ABSCESS,1
UG,SUBDURAL HAEMATOMA,1
UG,SUDDEN DEATH,1
UG,SWELLING,1
UG,SYSTEMIC CANDIDA,1
UG,TACHYCARDIA,1
UG,TACHYPHYLAXIS,1
UG,THERAPEUTIC RESPONSE UNEXPECTED,1
UG,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
UG,TONSILLITIS,1
UG,TORSADE DE POINTES,1
UG,TOXIC EPIDERMAL NECROLYSIS,1
UG,TOXICITY TO VARIOUS AGENTS,1
UG,TOXOPLASMOSIS,1
UG,TRANSFUSION,1
UG,TRANSPLANT FAILURE,1
UG,TUBAL RUPTURE,1
UG,TUMOUR HAEMORRHAGE,1
UG,ULCER,1
UG,ULNA FRACTURE,1
UG,UMBILICAL HERNIA,1
UG,URINARY INCONTINENCE,1
UG,URINE OUTPUT DECREASED,1
UG,UROSEPSIS,1
UG,UTERINE LEIOMYOMA,1
UG,VENTRICULAR SEPTAL DEFECT,1
UG,VIRAL LOAD INCREASED,1
UG,VULVOVAGINAL CANDIDIASIS,1
UG,WHITE BLOOD CELL COUNT INCREASED,1
UG,WHITE BLOOD CELLS URINE POSITIVE,1
UG,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
UA,DRUG INEFFECTIVE,50
UA,ASTHENIA,48
UA,ANAEMIA,37
UA,DYSPNOEA,35
UA,DIZZINESS,34
UA,PNEUMONIA,30
UA,NAUSEA,24
UA,LOSS OF CONSCIOUSNESS,21
UA,DEATH,20
UA,HEADACHE,20
UA,VASCULAR STENT THROMBOSIS,20
UA,LEUKOPENIA,19
UA,TACHYCARDIA,17
UA,PULMONARY EMBOLISM,16
UA,THROMBOCYTOPENIA,16
UA,ATRIAL FIBRILLATION,15
UA,ANGINA PECTORIS,14
UA,RASH,14
UA,TREMOR,14
UA,VOMITING,14
UA,PRURITUS,13
UA,CARDIAC FAILURE,12
UA,CONDITION AGGRAVATED,12
UA,NEUTROPENIA,12
UA,PYREXIA,12
UA,ALANINE AMINOTRANSFERASE INCREASED,11
UA,DIARRHOEA,11
UA,DISEASE PROGRESSION,11
UA,FEBRILE NEUTROPENIA,11
UA,HAEMORRHAGIC STROKE,11
UA,HYPOTENSION,11
UA,BLOOD PRESSURE INCREASED,10
UA,BODY TEMPERATURE INCREASED,10
UA,HYPERTENSIVE CRISIS,10
UA,ISCHAEMIC STROKE,10
UA,MYOCARDIAL INFARCTION,10
UA,ASPARTATE AMINOTRANSFERASE INCREASED,9
UA,BRAIN OEDEMA,9
UA,HEPATITIS TOXIC,9
UA,PANCREATITIS ACUTE,9
UA,ANAPHYLACTIC SHOCK,8
UA,ARTHRALGIA,8
UA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,8
UA,CYANOSIS,8
UA,DECREASED APPETITE,8
UA,EXPOSURE DURING PREGNANCY,8
UA,HYPERSENSITIVITY VASCULITIS,8
UA,HYPERTENSION,8
UA,MULTI-ORGAN FAILURE,8
UA,PALPITATIONS,8
UA,PULMONARY ARTERY THROMBOSIS,8
UA,ABDOMINAL PAIN,7
UA,ACUTE CORONARY SYNDROME,7
UA,ANGIOEDEMA,7
UA,BLOOD GLUCOSE INCREASED,7
UA,BLOOD PRESSURE DECREASED,7
UA,CARDIAC FAILURE ACUTE,7
UA,CHEST PAIN,7
UA,COMA,7
UA,DRUG-INDUCED LIVER INJURY,7
UA,FATIGUE,7
UA,GASTROINTESTINAL HAEMORRHAGE,7
UA,KETOACIDOSIS,7
UA,OEDEMA PERIPHERAL,7
UA,RENAL FAILURE,7
UA,SCHIZOPHRENIA,7
UA,SEPSIS,7
UA,THROMBOSIS IN DEVICE,7
UA,ABDOMINAL DISTENSION,6
UA,ABDOMINAL PAIN UPPER,6
UA,ASPHYXIA,6
UA,ASTHMA,6
UA,CONJUNCTIVITIS,6
UA,CONVULSION,6
UA,ERYTHEMA,6
UA,GASTRIC HAEMORRHAGE,6
UA,HAEMOPTYSIS,6
UA,HYPERAEMIA,6
UA,LYMPHOPENIA,6
UA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,6
UA,OSTEOPOROSIS,6
UA,PANCREATITIS,6
UA,PULMONARY OEDEMA,6
UA,PULMONARY TUBERCULOSIS,6
UA,PYELONEPHRITIS CHRONIC,6
UA,SOMNOLENCE,6
UA,STEVENS-JOHNSON SYNDROME,6
UA,SUSPECTED COUNTERFEIT PRODUCT,6
UA,SYNCOPE,6
UA,ACUTE MYOCARDIAL INFARCTION,5
UA,ALOPECIA,5
UA,ANXIETY,5
UA,ARRHYTHMIA,5
UA,BACK PAIN,5
UA,CARDIAC ARREST,5
UA,CARDIOPULMONARY FAILURE,5
UA,CHILLS,5
UA,CONTUSION,5
UA,COUGH,5
UA,FACE OEDEMA,5
UA,GAIT DISTURBANCE,5
UA,HYPERHIDROSIS,5
UA,HYPERSENSITIVITY,5
UA,POLYNEUROPATHY,5
UA,PRODUCT QUALITY ISSUE,5
UA,PRODUCT USE IN UNAPPROVED INDICATION,5
UA,RESPIRATORY FAILURE,5
UA,URTICARIA,5
UA,AMYLASE INCREASED,4
UA,ANGINA UNSTABLE,4
UA,ASCITES,4
UA,BLINDNESS,4
UA,BONE PAIN,4
UA,CARDIOMYOPATHY,4
UA,CARDIOVASCULAR INSUFFICIENCY,4
UA,CEREBRAL HAEMORRHAGE,4
UA,CORONARY ARTERY THROMBOSIS,4
UA,CRANIOCEREBRAL INJURY,4
UA,DEPRESSION,4
UA,DERMATITIS,4
UA,ELECTROCARDIOGRAM QT PROLONGED,4
UA,EPISTAXIS,4
UA,EYELID OEDEMA,4
UA,FALL,4
UA,GENERAL PHYSICAL HEALTH DETERIORATION,4
UA,HAEMORRHAGE,4
UA,HEPATITIS B,4
UA,INSOMNIA,4
UA,KETONURIA,4
UA,MALAISE,4
UA,MYALGIA,4
UA,MYOCARDIAL ISCHAEMIA,4
UA,OVERDOSE,4
UA,PAIN,4
UA,PALLOR,4
UA,PERIPHERAL SENSORY NEUROPATHY,4
UA,PRODUCT USE ISSUE,4
UA,RASH GENERALISED,4
UA,RESPIRATORY ARREST,4
UA,SEIZURE,4
UA,SUBARACHNOID HAEMORRHAGE,4
UA,TINNITUS,4
UA,VENTRICULAR TACHYCARDIA,4
UA,WEIGHT DECREASED,4
UA,ABDOMINAL DISCOMFORT,3
UA,ACUTE KIDNEY INJURY,3
UA,AUTOIMMUNE THYROIDITIS,3
UA,BLOOD CREATININE INCREASED,3
UA,BONE MARROW FAILURE,3
UA,BURNING SENSATION,3
UA,CHOLECYSTITIS CHRONIC,3
UA,CHOLELITHIASIS,3
UA,CONFUSIONAL STATE,3
UA,DEAFNESS,3
UA,DEEP VEIN THROMBOSIS,3
UA,DIABETES MELLITUS,3
UA,DIABETIC METABOLIC DECOMPENSATION,3
UA,DISCOMFORT,3
UA,DRUG HYPERSENSITIVITY,3
UA,DRUG INTOLERANCE,3
UA,DUODENAL ULCER,3
UA,DYSPEPSIA,3
UA,EMBOLISM,3
UA,ENCEPHALITIS,3
UA,ENCEPHALOPATHY,3
UA,ENDOPHTHALMITIS,3
UA,ERYSIPELAS,3
UA,EXTRASYSTOLES,3
UA,EYE HAEMORRHAGE,3
UA,GASTRIC ULCER,3
UA,GASTROINTESTINAL DISORDER,3
UA,HAEMOGLOBIN DECREASED,3
UA,HALLUCINATION,3
UA,HEART RATE INCREASED,3
UA,HEPATIC FAILURE,3
UA,HEPATOTOXICITY,3
UA,HYPOGLYCAEMIA,3
UA,HYPOKALAEMIA,3
UA,INTESTINAL HAEMORRHAGE,3
UA,INTRAOCULAR PRESSURE INCREASED,3
UA,IRRITABILITY,3
UA,JAUNDICE,3
UA,LIPASE INCREASED,3
UA,MEDICATION ERROR,3
UA,MUSCULAR WEAKNESS,3
UA,NEOPLASM MALIGNANT,3
UA,NEUROTOXICITY,3
UA,OEDEMA,3
UA,OEDEMA GENITAL,3
UA,OXYGEN SATURATION DECREASED,3
UA,PANCREATIC ENZYMES INCREASED,3
UA,PHOTOSENSITIVITY REACTION,3
UA,PLATELET COUNT DECREASED,3
UA,PNEUMOCYSTIS JIROVECII PNEUMONIA,3
UA,RASH PAPULAR,3
UA,RASH PRURITIC,3
UA,SINUS TACHYCARDIA,3
UA,SLEEP DISORDER,3
UA,SUICIDAL IDEATION,3
UA,SWELLING,3
UA,THERAPY CESSATION,3
UA,TONIC CONVULSION,3
UA,TOXIC SKIN ERUPTION,3
UA,TRANSIENT ISCHAEMIC ATTACK,3
UA,URINARY RETENTION,3
UA,UTERINE HAEMORRHAGE,3
UA,UTERINE LEIOMYOMA,3
UA,VENTRICULAR DYSFUNCTION,3
UA,VENTRICULAR EXTRASYSTOLES,3
UA,VISUAL ACUITY REDUCED,3
UA,VISUAL IMPAIRMENT,3
UA,ABORTION SPONTANEOUS,2
UA,ADRENAL INSUFFICIENCY,2
UA,AMYOTROPHIC LATERAL SCLEROSIS,2
UA,ANURIA,2
UA,AORTIC VALVE DISEASE,2
UA,APLASTIC ANAEMIA,2
UA,APNOEA,2
UA,ASTIGMATISM,2
UA,ATRIAL THROMBOSIS,2
UA,BLINDNESS TRANSIENT,2
UA,BLOOD BILIRUBIN INCREASED,2
UA,BLOOD CHOLESTEROL INCREASED,2
UA,BRADYCARDIA,2
UA,BRAIN CONTUSION,2
UA,BRONCHITIS,2
UA,BRONCHOSPASM,2
UA,CARDIAC FAILURE CHRONIC,2
UA,CARDIAC TAMPONADE,2
UA,CARDIOGENIC SHOCK,2
UA,CARDIOTOXICITY,2
UA,CATARACT,2
UA,CELLULITIS,2
UA,CEREBRAL ISCHAEMIA,2
UA,CEREBROVASCULAR ACCIDENT,2
UA,CHEST DISCOMFORT,2
UA,CHROMATURIA,2
UA,CHRONIC KIDNEY DISEASE,2
UA,CIRCULATORY COLLAPSE,2
UA,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,2
UA,CONVULSIONS LOCAL,2
UA,COORDINATION ABNORMAL,2
UA,CORNEAL OEDEMA,2
UA,CORONARY ARTERY STENOSIS,2
UA,CYTOMEGALOVIRUS INFECTION,2
UA,CYTOTOXIC CARDIOMYOPATHY,2
UA,DEHYDRATION,2
UA,DEPRESSED LEVEL OF CONSCIOUSNESS,2
UA,DERMATITIS BULLOUS,2
UA,DIABETIC FOOT,2
UA,DIABETIC RETINOPATHY,2
UA,DISSEMINATED INTRAVASCULAR COAGULATION,2
UA,DRESSLER^S SYNDROME,2
UA,DRUG DOSE OMISSION,2
UA,DYSGEUSIA,2
UA,DYSPHAGIA,2
UA,DYSPNOEA AT REST,2
UA,ENDOMETRIAL HYPERPLASIA,2
UA,ERYTHEMA OF EYELID,2
UA,EXPOSURE DURING BREAST FEEDING,2
UA,EYE IRRITATION,2
UA,FEELING ABNORMAL,2
UA,GALACTORRHOEA,2
UA,GASTRITIS,2
UA,GASTRITIS EROSIVE,2
UA,GINGIVAL BLEEDING,2
UA,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
UA,HAEMATOCHEZIA,2
UA,HAEMATOMA,2
UA,HAEMORRHAGE IN PREGNANCY,2
UA,HEART RATE IRREGULAR,2
UA,HEPATITIS E,2
UA,HEPATOMEGALY,2
UA,HEPATOSPLENOMEGALY,2
UA,HOSPITALISATION,2
UA,HYDROCEPHALUS,2
UA,HYPOACUSIS,2
UA,HYPOAESTHESIA,2
UA,HYPOGLYCAEMIC COMA,2
UA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
UA,INTENTIONAL PRODUCT MISUSE,2
UA,LABIA ENLARGED,2
UA,LARYNGITIS,2
UA,LETHARGY,2
UA,LOBAR PNEUMONIA,2
UA,LUNG DISORDER,2
UA,LUNG NEOPLASM MALIGNANT,2
UA,LYMPHADENOPATHY,2
UA,LYMPHOSTASIS,2
UA,MALIGNANT MELANOMA,2
UA,MALIGNANT NEOPLASM PROGRESSION,2
UA,MENINGITIS,2
UA,METASTASES TO CENTRAL NERVOUS SYSTEM,2
UA,METASTASES TO LIVER,2
UA,MITRAL VALVE INCOMPETENCE,2
UA,MOBILITY DECREASED,2
UA,MOOD SWINGS,2
UA,MUCOSAL DRYNESS,2
UA,MUSCLE HAEMORRHAGE,2
UA,NASAL CONGESTION,2
UA,NEUROLEPTIC MALIGNANT SYNDROME,2
UA,NEUTROPHIL COUNT DECREASED,2
UA,NON-SMALL CELL LUNG CANCER,2
UA,ORAL CANDIDIASIS,2
UA,OSTEOMYELITIS,2
UA,PAIN IN EXTREMITY,2
UA,PANCYTOPENIA,2
UA,PARAESTHESIA,2
UA,PARESIS,2
UA,PEPTIC ULCER,2
UA,PERFORMANCE STATUS DECREASED,2
UA,PERIORBITAL OEDEMA,2
UA,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
UA,PERIPHERAL SENSORIMOTOR NEUROPATHY,2
UA,PERIPHERAL SWELLING,2
UA,PETECHIAE,2
UA,PLASMA CELL MYELOMA,2
UA,PLEURAL EFFUSION,2
UA,PLEURISY,2
UA,PNEUMONITIS,2
UA,POISONING,2
UA,POLYURIA,2
UA,POST PROCEDURAL HAEMORRHAGE,2
UA,PROSTATE CANCER,2
UA,PROSTATIC SPECIFIC ANTIGEN INCREASED,2
UA,PRURITUS GENITAL,2
UA,PULMONARY FIBROSIS,2
UA,PURPURA,2
UA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
UA,RENAL COLIC,2
UA,SKIN NECROSIS,2
UA,SKULL FRACTURED BASE,2
UA,SPEECH DISORDER,2
UA,SPLENOMEGALY,2
UA,SUPRAVENTRICULAR EXTRASYSTOLES,2
UA,THIRST,2
UA,THROAT IRRITATION,2
UA,THROMBOPHLEBITIS,2
UA,TOE AMPUTATION,2
UA,TONGUE OEDEMA,2
UA,TOXIC ENCEPHALOPATHY,2
UA,TOXIC EPIDERMAL NECROLYSIS,2
UA,TOXICITY TO VARIOUS AGENTS,2
UA,TRANSAMINASES INCREASED,2
UA,TRICUSPID VALVE INCOMPETENCE,2
UA,TUMOUR LYSIS SYNDROME,2
UA,URINARY INCONTINENCE,2
UA,UVEITIS,2
UA,VENOUS THROMBOSIS,2
UA,VENOUS THROMBOSIS LIMB,2
UA,VERTIGO,2
UA,VISION BLURRED,2
UA,WEIGHT INCREASED,2
UA,WHITE BLOOD CELL COUNT DECREASED,2
UA,ABASIA,1
UA,ABNORMAL BEHAVIOUR,1
UA,ABNORMAL SENSATION IN EYE,1
UA,ABORTION INDUCED,1
UA,ABORTION INDUCED INCOMPLETE,1
UA,ACETONAEMIA,1
UA,ACUTE LYMPHOCYTIC LEUKAEMIA,1
UA,ACUTE MYELOID LEUKAEMIA,1
UA,ACUTE RESPIRATORY DISTRESS SYNDROME,1
UA,ACUTE RESPIRATORY FAILURE,1
UA,ACUTE SINUSITIS,1
UA,ADENOCARCINOMA GASTRIC,1
UA,ADRENAL NEOPLASM,1
UA,ADVERSE EVENT,1
UA,AGGRESSION,1
UA,AGITATION,1
UA,AGRANULOCYTOSIS,1
UA,ALCOHOL POISONING,1
UA,ALLERGIC GRANULOMATOUS ANGIITIS,1
UA,ALVEOLITIS,1
UA,AMNESIA,1
UA,AMNIORRHOEA,1
UA,ANAL HAEMORRHAGE,1
UA,ANAL INCONTINENCE,1
UA,ANAL POLYP,1
UA,ANAMNESTIC REACTION,1
UA,ANAPHYLACTIC REACTION,1
UA,ANAPHYLACTOID REACTION,1
UA,ANEURYSM RUPTURED,1
UA,ANGIOMYOLIPOMA,1
UA,ANGIOPATHY,1
UA,AORTIC ANEURYSM,1
UA,AORTIC ARTERIOSCLEROSIS,1
UA,AORTIC CALCIFICATION,1
UA,AORTIC DILATATION,1
UA,AORTIC STENOSIS,1
UA,AORTIC VALVE INCOMPETENCE,1
UA,APATHY,1
UA,APHASIA,1
UA,APHTHOUS STOMATITIS,1
UA,APPARENT DEATH,1
UA,APPENDICITIS,1
UA,APPLICATION SITE DISCOLOURATION,1
UA,ARTERIAL THROMBOSIS,1
UA,ARTHRITIS,1
UA,ARTHROPOD BITE,1
UA,ASYMPTOMATIC BACTERIURIA,1
UA,ATRIOVENTRICULAR BLOCK,1
UA,ATYPICAL PNEUMONIA,1
UA,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
UA,AUTOPHONY,1
UA,AXONAL NEUROPATHY,1
UA,AZOTAEMIA,1
UA,BALANCE DISORDER,1
UA,BASEDOW^S DISEASE,1
UA,BIPOLAR I DISORDER,1
UA,BLEEDING TIME PROLONGED,1
UA,BLISTER,1
UA,BLOOD ALKALINE PHOSPHATASE INCREASED,1
UA,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
UA,BLOOD GLUCOSE DECREASED,1
UA,BLOOD PRESSURE IMMEASURABLE,1
UA,BLOOD PRESSURE SYSTOLIC INCREASED,1
UA,BLOOD PROLACTIN DECREASED,1
UA,BLOOD TEST ABNORMAL,1
UA,BLOOD TESTOSTERONE INCREASED,1
UA,BLOOD UREA INCREASED,1
UA,BLOOD URINE PRESENT,1
UA,BODY MASS INDEX DECREASED,1
UA,BONE LESION,1
UA,BONE TUBERCULOSIS,1
UA,BRAIN HERNIATION,1
UA,BRAIN NATRIURETIC PEPTIDE INCREASED,1
UA,BREAST CANCER STAGE I,1
UA,BREAST ENLARGEMENT,1
UA,BREAST PAIN,1
UA,BRONCHITIS CHRONIC,1
UA,BUNDLE BRANCH BLOCK LEFT,1
UA,BUNDLE BRANCH BLOCK RIGHT,1
UA,CACHEXIA,1
UA,CALCULUS URINARY,1
UA,CARDIAC MURMUR,1
UA,CARDIAC VALVE DISEASE,1
UA,CATHETER SITE HAEMORRHAGE,1
UA,CELL DEATH,1
UA,CENTRAL NERVOUS SYSTEM MELANOMA,1
UA,CEREBRAL CONGESTION,1
UA,CEREBRAL HAEMATOMA,1
UA,CEREBRAL HAEMORRHAGE NEONATAL,1
UA,CERVICAL DYSPLASIA,1
UA,CERVIX CARCINOMA,1
UA,CERVIX NEOPLASM,1
UA,CHOLECYSTITIS ACUTE,1
UA,CHOLECYSTITIS INFECTIVE,1
UA,CHOLESTASIS,1
UA,CHRONIC HEPATITIS B,1
UA,CHRONIC HEPATITIS C,1
UA,CHRONIC SINUSITIS,1
UA,CLONUS,1
UA,COAGULATION TIME PROLONGED,1
UA,COLD SWEAT,1
UA,COLITIS,1
UA,COLITIS ULCERATIVE,1
UA,COMPLETED SUICIDE,1
UA,COMPLICATION ASSOCIATED WITH DEVICE,1
UA,COMPULSIVE SHOPPING,1
UA,CONJUNCTIVAL HAEMORRHAGE,1
UA,CONJUNCTIVAL HYPERAEMIA,1
UA,CONJUNCTIVAL OEDEMA,1
UA,CONJUNCTIVITIS ALLERGIC,1
UA,COR PULMONALE,1
UA,CORNEAL OPACITY,1
UA,CORONARY ARTERY DISEASE,1
UA,CORONARY ARTERY DISSECTION,1
UA,CORONARY ARTERY INSUFFICIENCY,1
UA,CORONARY ARTERY OCCLUSION,1
UA,CORONARY ARTERY RESTENOSIS,1
UA,COUNTERFEIT DRUG ADMINISTERED,1
UA,CREATININE RENAL CLEARANCE DECREASED,1
UA,CREPITATIONS,1
UA,CRYING,1
UA,CRYSTALLURIA,1
UA,CYTOGENETIC ABNORMALITY,1
UA,CYTOPENIA,1
UA,DEATH NEONATAL,1
UA,DEFAECATION URGENCY,1
UA,DEFORMITY,1
UA,DELIRIUM,1
UA,DEPRESSIVE SYMPTOM,1
UA,DEREALISATION,1
UA,DERMATITIS ALLERGIC,1
UA,DEVICE ISSUE,1
UA,DEVICE OCCLUSION,1
UA,DIABETES MELLITUS INADEQUATE CONTROL,1
UA,DIABETIC KETOACIDOSIS,1
UA,DIABETIC MACROANGIOPATHY,1
UA,DIABETIC NEUROPATHY,1
UA,DIAPHRAGMATIC HERNIA,1
UA,DISEASE COMPLICATION,1
UA,DISORIENTATION,1
UA,DISTURBANCE IN ATTENTION,1
UA,DRUG ADMINISTRATION ERROR,1
UA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
UA,DRUG RESISTANCE,1
UA,DRY MOUTH,1
UA,DRY SKIN,1
UA,DYSMENORRHOEA,1
UA,DYSPAREUNIA,1
UA,DYSPHONIA,1
UA,DYSTONIA,1
UA,DYSURIA,1
UA,EAR INFECTION,1
UA,EJECTION FRACTION DECREASED,1
UA,ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL,1
UA,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
UA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
UA,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
UA,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
UA,EMBOLIC STROKE,1
UA,EMOTIONAL DISORDER,1
UA,EMPHYSEMA,1
UA,ENCEPHALITIS VIRAL,1
UA,ENCEPHALOMALACIA,1
UA,ENDOCARDITIS,1
UA,ENDOTHELIAL DYSFUNCTION,1
UA,ENLARGED CLITORIS,1
UA,ENTEROBACTER TEST POSITIVE,1
UA,ENTEROCOLITIS,1
UA,ENTEROCOLITIS HAEMORRHAGIC,1
UA,ENURESIS,1
UA,EOSINOPHILIA,1
UA,EPIDERMOLYSIS BULLOSA,1
UA,EPIGLOTTITIS,1
UA,EPILEPTIC PSYCHOSIS,1
UA,EPSTEIN-BARR VIRUS INFECTION,1
UA,EROSIVE DUODENITIS,1
UA,EROSIVE OESOPHAGITIS,1
UA,ERYTHEMA MULTIFORME,1
UA,ESSENTIAL THROMBOCYTHAEMIA,1
UA,EXERCISE TOLERANCE DECREASED,1
UA,EXOPHTHALMOS,1
UA,EYE DISORDER,1
UA,EYE OEDEMA,1
UA,EYE PAIN,1
UA,EYE PRURITUS,1
UA,FAECES DISCOLOURED,1
UA,FAECES PALE,1
UA,FEAR,1
UA,FEAR OF DISEASE,1
UA,FEELING HOT,1
UA,FEMORAL HERNIA,1
UA,FLATULENCE,1
UA,FLUSHING,1
UA,FOETAL DEATH,1
UA,FOETAL EXPOSURE DURING PREGNANCY,1
UA,FOREIGN BODY SENSATION IN EYES,1
UA,FUNGAL INFECTION,1
UA,GALACTOSTASIS,1
UA,GALLBLADDER ABSCESS,1
UA,GALLBLADDER ENLARGEMENT,1
UA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
UA,GASTRIC CANCER,1
UA,GASTRIC CANCER STAGE IV,1
UA,GASTRIC ULCER HAEMORRHAGE,1
UA,GASTRODUODENAL HAEMORRHAGE,1
UA,GASTROINTESTINAL PAIN,1
UA,GASTROOESOPHAGEAL REFLUX DISEASE,1
UA,GAZE PALSY,1
UA,GENITAL BURNING SENSATION,1
UA,GESTATIONAL DIABETES,1
UA,GINGIVAL DISCOMFORT,1
UA,GINGIVAL PAIN,1
UA,GINGIVAL SWELLING,1
UA,GINGIVITIS,1
UA,GLAUCOMA,1
UA,GLIOBLASTOMA MULTIFORME,1
UA,GLOSSITIS,1
UA,GOITRE,1
UA,GOUT,1
UA,GRAND MAL CONVULSION,1
UA,GRANULOMA,1
UA,HAEMANGIOMA OF LIVER,1
UA,HAEMARTHROSIS,1
UA,HAEMATEMESIS,1
UA,HAEMATOTOXICITY,1
UA,HAEMATURIA,1
UA,HAEMORRHAGE INTRACRANIAL,1
UA,HAEMORRHAGIC ANAEMIA,1
UA,HAEMORRHOIDAL HAEMORRHAGE,1
UA,HAEMOTHORAX,1
UA,HEART INJURY,1
UA,HEART RATE ABNORMAL,1
UA,HEART RATE DECREASED,1
UA,HELICOBACTER INFECTION,1
UA,HEMIPARESIS,1
UA,HEPATIC CIRRHOSIS,1
UA,HEPATIC ENCEPHALOPATHY,1
UA,HEPATIC ENZYME INCREASED,1
UA,HEPATIC STEATOSIS,1
UA,HEPATITIS,1
UA,HEPATITIS A,1
UA,HEPATITIS C,1
UA,HEPATOCELLULAR CARCINOMA,1
UA,HERPES SIMPLEX SEROLOGY POSITIVE,1
UA,HIV INFECTION,1
UA,HODGKIN^S DISEASE,1
UA,HUMERUS FRACTURE,1
UA,HYDROCELE,1
UA,HYDROTHORAX,1
UA,HYPERADRENALISM,1
UA,HYPERBILIRUBINAEMIA,1
UA,HYPERCHOLESTEROLAEMIA,1
UA,HYPERGLYCAEMIA,1
UA,HYPERKINESIA,1
UA,HYPERSOMNIA,1
UA,HYPERTENSIVE HEART DISEASE,1
UA,HYPERTHYROIDISM,1
UA,HYPERURICAEMIA,1
UA,HYPOCHLORAEMIA,1
UA,HYPOCOAGULABLE STATE,1
UA,HYPOGLYCAEMIC UNCONSCIOUSNESS,1
UA,HYPONATRAEMIA,1
UA,HYPOTHYROIDISM,1
UA,HYPOTONIA,1
UA,HYPOVENTILATION,1
UA,IDIOPATHIC PULMONARY FIBROSIS,1
UA,IDIOSYNCRATIC DRUG REACTION,1
UA,ILEUS,1
UA,ILEUS PARALYTIC,1
UA,ILL-DEFINED DISORDER,1
UA,IMMUNODEFICIENCY,1
UA,IMPAIRED HEALING,1
UA,INCORRECT DOSE ADMINISTERED,1
UA,INCORRECT DRUG ADMINISTRATION DURATION,1
UA,INCORRECT DRUG DOSAGE FORM ADMINISTERED,1
UA,INFANTILE SPITTING UP,1
UA,INFECTION,1
UA,INFECTIVE CHONDRITIS,1
UA,INFLUENZA,1
UA,INFUSION RELATED REACTION,1
UA,INJECTION SITE SWELLING,1
UA,INJURY,1
UA,INTERNAL HAEMORRHAGE,1
UA,INTERVERTEBRAL DISC PROTRUSION,1
UA,INTESTINAL FISTULA,1
UA,INTESTINAL OBSTRUCTION,1
UA,INTESTINAL PERFORATION,1
UA,INTRAVENTRICULAR HAEMORRHAGE,1
UA,INVESTIGATION ABNORMAL,1
UA,IRIS ADHESIONS,1
UA,ISCHAEMIA,1
UA,JOINT SWELLING,1
UA,KERATITIS,1
UA,KERATOUVEITIS,1
UA,LACRIMATION INCREASED,1
UA,LACTIC ACIDOSIS,1
UA,LARGE INTESTINAL HAEMORRHAGE,1
UA,LEFT ATRIAL DILATATION,1
UA,LEFT VENTRICULAR HYPERTROPHY,1
UA,LENS DISORDER,1
UA,LENTICULAR OPACITIES,1
UA,LEUKOCYTOSIS,1
UA,LEUKOPLAKIA ORAL,1
UA,LIP DISORDER,1
UA,LIP OEDEMA,1
UA,LIP ULCERATION,1
UA,LIPOMA,1
UA,LIVER ABSCESS,1
UA,LIVER FUNCTION TEST ABNORMAL,1
UA,LIVER INJURY,1
UA,LOCAL SWELLING,1
UA,LOCALISED OEDEMA,1
UA,LUNG INFECTION,1
UA,LYMPHADENOPATHY MEDIASTINAL,1
UA,LYMPHOMA,1
UA,MACULE,1
UA,MALNUTRITION,1
UA,MASTITIS,1
UA,MEMORY IMPAIRMENT,1
UA,MENINGITIS STREPTOCOCCAL,1
UA,METABOLIC CARDIOMYOPATHY,1
UA,METABOLIC ENCEPHALOPATHY,1
UA,METABOLIC SYNDROME,1
UA,METASTASES TO PERITONEUM,1
UA,METASTASES TO SPINE,1
UA,METASTASIS,1
UA,METRORRHAGIA,1
UA,MITRAL VALVE DISEASE MIXED,1
UA,MITRAL VALVE STENOSIS,1
UA,MONOPARESIS,1
UA,MOUTH ULCERATION,1
UA,MUCOSAL DISCOLOURATION,1
UA,MUCOSAL EROSION,1
UA,MUCOSAL INFLAMMATION,1
UA,MUSCLE ATROPHY,1
UA,MUSCLE SPASMS,1
UA,MUSCULOSKELETAL STIFFNESS,1
UA,MYASTHENIC SYNDROME,1
UA,MYDRIASIS,1
UA,MYELODYSPLASTIC SYNDROME,1
UA,MYOCARDIAL FIBROSIS,1
UA,MYOCARDIAL RUPTURE,1
UA,MYOCLONUS,1
UA,NASAL CRUSTING,1
UA,NASAL OEDEMA,1
UA,NEPHROPATHY,1
UA,NEPHROPATHY TOXIC,1
UA,NEPHROPTOSIS,1
UA,NERVOUSNESS,1
UA,NEURITIS,1
UA,NEUROGENIC BLADDER,1
UA,NEURONE-SPECIFIC ENOLASE INCREASED,1
UA,NEUROPATHY PERIPHERAL,1
UA,NEUROSIS,1
UA,NEUTROPENIC SEPSIS,1
UA,NEUTROPHILIA,1
UA,NIGHT SWEATS,1
UA,NIGHTMARE,1
UA,NO ADVERSE EVENT,1
UA,NON-HODGKIN^S LYMPHOMA,1
UA,OCULAR DISCOMFORT,1
UA,OCULAR HYPERAEMIA,1
UA,OCULAR VASCULAR DISORDER,1
UA,OEDEMA MOUTH,1
UA,OESOPHAGEAL HAEMORRHAGE,1
UA,OLIGURIA,1
UA,OPEN ANGLE GLAUCOMA,1
UA,OPTIC DISC DISORDER,1
UA,ORAL DISCOMFORT,1
UA,ORGANISING PNEUMONIA,1
UA,OSTEOARTHRITIS,1
UA,OSTEOCHONDROSIS,1
UA,OSTEOPENIA,1
UA,OSTEOSCLEROSIS,1
UA,OTOTOXICITY,1
UA,OVARIAN CYST,1
UA,PAGET-SCHROETTER SYNDROME,1
UA,PALMOPLANTAR KERATODERMA,1
UA,PANCREATIC DISORDER,1
UA,PANCREATITIS CHRONIC,1
UA,PANIC ATTACK,1
UA,PAPILLOEDEMA,1
UA,PAROSMIA,1
UA,PAROTITIS,1
UA,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,1
UA,PELVIC PAIN,1
UA,PENILE PAIN,1
UA,PERFORATED ULCER,1
UA,PERICARDIAL EFFUSION,1
UA,PERICORONITIS,1
UA,PERIODONTITIS,1
UA,PERIPHERAL ARTERY THROMBOSIS,1
UA,PERIPHERAL COLDNESS,1
UA,PERIPHERAL VENOUS DISEASE,1
UA,PERITONITIS,1
UA,PERITONSILLAR ABSCESS,1
UA,PHARYNGEAL OEDEMA,1
UA,PHARYNGITIS,1
UA,PHLEBITIS,1
UA,POLYARTHRITIS,1
UA,PORTAL HYPERTENSION,1
UA,POST PROCEDURAL MYOCARDIAL INFARCTION,1
UA,PREGNANCY ON ORAL CONTRACEPTIVE,1
UA,PREMATURE DELIVERY,1
UA,PRESYNCOPE,1
UA,PRIAPISM,1
UA,PRODUCT COLOUR ISSUE,1
UA,PRODUCTIVE COUGH,1
UA,PROSTATE CANCER METASTATIC,1
UA,PROTEINURIA,1
UA,PSEUDOHERMAPHRODITISM FEMALE,1
UA,PSEUDOMEMBRANOUS COLITIS,1
UA,PULMONARY ARTERIAL HYPERTENSION,1
UA,PULMONARY CAVITATION,1
UA,PULMONARY HAEMORRHAGE,1
UA,PULMONARY HYPERTENSION,1
UA,PULMONARY INFARCTION,1
UA,PULMONARY TOXICITY,1
UA,PULPITIS DENTAL,1
UA,PULSE ABNORMAL,1
UA,PULSE ABSENT,1
UA,PYELOCYSTITIS,1
UA,PYELONEPHRITIS ACUTE,1
UA,QRS AXIS ABNORMAL,1
UA,QUADRIPARESIS,1
UA,RASH ERYTHEMATOUS,1
UA,RASH MACULO-PAPULAR,1
UA,RASH PUSTULAR,1
UA,RASH VESICULAR,1
UA,REACTIVE PSYCHOSIS,1
UA,RENAL CANCER,1
UA,RENAL CELL CARCINOMA,1
UA,RENAL DISORDER,1
UA,RENAL FAILURE ACUTE,1
UA,RENAL IMPAIRMENT,1
UA,RESPIRATORY RATE INCREASED,1
UA,RESPIRATORY TRACT INFECTION VIRAL,1
UA,RESPIRATORY TRACT OEDEMA,1
UA,RETCHING,1
UA,RHEUMATIC DISORDER,1
UA,RHINORRHOEA,1
UA,RIB FRACTURE,1
UA,RIGHT VENTRICULAR DILATATION,1
UA,RIGHT VENTRICULAR FAILURE,1
UA,SALIVARY GLAND MUCOCOELE,1
UA,SALPINGO-OOPHORITIS,1
UA,SCIATICA,1
UA,SEBORRHOEA,1
UA,SECRETION DISCHARGE,1
UA,SEDATION,1
UA,SENSORY DISTURBANCE,1
UA,SEROTONIN SYNDROME,1
UA,SIALOADENITIS,1
UA,SICK SINUS SYNDROME,1
UA,SINUS ARRHYTHMIA,1
UA,SINUS BRADYCARDIA,1
UA,SINUS NODE DYSFUNCTION,1
UA,SKIN EXFOLIATION,1
UA,SKIN HYPERPIGMENTATION,1
UA,SKIN TURGOR DECREASED,1
UA,SKIN ULCER,1
UA,SKIN WARM,1
UA,SMALL INTESTINE ULCER,1
UA,SNEEZING,1
UA,SPINAL OSTEOARTHRITIS,1
UA,SPUTUM PURULENT,1
UA,SQUAMOUS CELL CARCINOMA OF LUNG,1
UA,SQUAMOUS CELL CARCINOMA OF THE VAGINA,1
UA,STOMATITIS,1
UA,STOMATITIS NECROTISING,1
UA,SUBDURAL HAEMATOMA,1
UA,SUBENDOCARDIAL ISCHAEMIA,1
UA,SUCCINYLACETONE INCREASED,1
UA,SUDDEN DEATH,1
UA,SWELLING FACE,1
UA,TEARFULNESS,1
UA,TENDONITIS,1
UA,TESTICULAR NECROSIS,1
UA,THROMBOSIS,1
UA,THYROID DISORDER,1
UA,THYROIDECTOMY,1
UA,TOOTHACHE,1
UA,TRACHEOBRONCHITIS,1
UA,TREATMENT NONCOMPLIANCE,1
UA,TROPONIN INCREASED,1
UA,TUBERCULOSIS,1
UA,TUBERCULOUS PLEURISY,1
UA,TYMPANIC MEMBRANE DISORDER,1
UA,TYPE IV HYPERSENSITIVITY REACTION,1
UA,ULCER,1
UA,ULCERATIVE GASTRITIS,1
UA,UNDERDOSE,1
UA,UNEVALUABLE EVENT,1
UA,URINARY BLADDER HAEMORRHAGE,1
UA,URINE OUTPUT INCREASED,1
UA,VAGINAL HAEMORRHAGE,1
UA,VARICELLA,1
UA,VASCULAR ENCEPHALOPATHY,1
UA,VASCULAR STENT OCCLUSION,1
UA,VASCULITIS,1
UA,VASOSPASM,1
UA,VENA CAVA THROMBOSIS,1
UA,VENTRICULAR ARRHYTHMIA,1
UA,VITREOUS HAEMORRHAGE,1
UA,VOLVULUS,1
UA,WEIGHT GAIN POOR,1
UA,WHITE BLOOD CELL COUNT INCREASED,1
UA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
UA,YAWNING,1
AE,DRUG INEFFECTIVE,38
AE,VOMITING,38
AE,DEATH,36
AE,PYREXIA,29
AE,DYSPNOEA,28
AE,NAUSEA,26
AE,DIZZINESS,21
AE,HEADACHE,21
AE,ABDOMINAL PAIN,19
AE,COUGH,19
AE,HYPOTENSION,19
AE,DIARRHOEA,18
AE,FATIGUE,18
AE,RASH,18
AE,HYPERSENSITIVITY,16
AE,MATERNAL EXPOSURE DURING PREGNANCY,16
AE,ACUTE KIDNEY INJURY,14
AE,ANAEMIA,14
AE,ASTHENIA,14
AE,CHEST PAIN,14
AE,EXPOSURE DURING PREGNANCY,14
AE,ABORTION SPONTANEOUS,13
AE,HYPERTENSION,13
AE,METABOLIC ACIDOSIS,13
AE,PAIN,13
AE,PNEUMONIA,13
AE,TOXICITY TO VARIOUS AGENTS,13
AE,PAIN IN EXTREMITY,12
AE,PALPITATIONS,12
AE,CARDIAC ARREST,11
AE,FOETAL EXPOSURE DURING PREGNANCY,11
AE,HYPOAESTHESIA,11
AE,PANCREATITIS ACUTE,11
AE,PRURITUS,11
AE,TACHYCARDIA,11
AE,BACK PAIN,10
AE,CONDITION AGGRAVATED,10
AE,DEHYDRATION,10
AE,DIABETIC KETOACIDOSIS,10
AE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,10
AE,VISION BLURRED,10
AE,LACTIC ACIDOSIS,9
AE,NEUTROPENIA,9
AE,SEPSIS,9
AE,THROMBOCYTOPENIA,9
AE,CHEST DISCOMFORT,8
AE,DECREASED APPETITE,8
AE,FLUSHING,8
AE,HAEMOGLOBIN DECREASED,8
AE,HYPERBILIRUBINAEMIA,8
AE,INFLUENZA,8
AE,INTENTIONAL OVERDOSE,8
AE,OROPHARYNGEAL PAIN,8
AE,PSORIASIS,8
AE,RESPIRATORY TRACT INFECTION,8
AE,URINARY TRACT INFECTION,8
AE,BLOOD LUTEINISING HORMONE INCREASED,7
AE,HYPOGLYCAEMIA,7
AE,LEUKOPENIA,7
AE,LOSS OF CONSCIOUSNESS,7
AE,LOW BIRTH WEIGHT BABY,7
AE,LOWER RESPIRATORY TRACT INFECTION,7
AE,MALAISE,7
AE,MUSCULAR WEAKNESS,7
AE,OVERDOSE,7
AE,ASTHMA,6
AE,BLOOD GLUCOSE INCREASED,6
AE,BRADYCARDIA,6
AE,CEREBELLAR SYNDROME,6
AE,CEREBROVASCULAR ACCIDENT,6
AE,FALL,6
AE,HAEMATEMESIS,6
AE,HYPOKALAEMIA,6
AE,HYPOXIA,6
AE,INSOMNIA,6
AE,OVARIAN DISORDER,6
AE,PANCYTOPENIA,6
AE,PANNICULITIS,6
AE,PLEURAL EFFUSION,6
AE,PREMATURE OVULATION,6
AE,RENAL TUBULAR ACIDOSIS,6
AE,SYNCOPE,6
AE,WEIGHT DECREASED,6
AE,WHITE BLOOD CELL COUNT DECREASED,6
AE,BLOOD CREATININE INCREASED,5
AE,BLOOD POTASSIUM DECREASED,5
AE,BLOOD UREA INCREASED,5
AE,CHILLS,5
AE,CONFUSIONAL STATE,5
AE,DEPRESSION,5
AE,GLYCOSYLATED HAEMOGLOBIN INCREASED,5
AE,HAEMATURIA,5
AE,HAEMORRHAGE,5
AE,HYPONATRAEMIA,5
AE,INCORRECT ROUTE OF DRUG ADMINISTRATION,5
AE,LETHARGY,5
AE,MYOCARDIAL INFARCTION,5
AE,OEDEMA PERIPHERAL,5
AE,PANCREATITIS,5
AE,PREMATURE BABY,5
AE,SEIZURE,5
AE,SUICIDE ATTEMPT,5
AE,URINE OUTPUT DECREASED,5
AE,VAGINAL HAEMORRHAGE,5
AE,VISUAL ACUITY REDUCED,5
AE,ABASIA,4
AE,ABDOMINAL PAIN UPPER,4
AE,ADRENAL INSUFFICIENCY,4
AE,ALOPECIA,4
AE,ARTHRALGIA,4
AE,ASCITES,4
AE,ATRIAL FIBRILLATION,4
AE,BLINDNESS,4
AE,BLOOD BILIRUBIN INCREASED,4
AE,BLOOD PRESSURE INCREASED,4
AE,BONE PAIN,4
AE,CARDIAC FAILURE,4
AE,CATARACT,4
AE,CENTRAL NERVOUS SYSTEM LESION,4
AE,CHORIORETINOPATHY,4
AE,COLITIS ULCERATIVE,4
AE,DIABETES MELLITUS,4
AE,DYSURIA,4
AE,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,4
AE,EPISTAXIS,4
AE,EYE PAIN,4
AE,FOOT FRACTURE,4
AE,GASTRIC ULCER,4
AE,GASTROINTESTINAL HAEMORRHAGE,4
AE,HAEMATOCHEZIA,4
AE,HAEMOPTYSIS,4
AE,HEART RATE INCREASED,4
AE,HEPATIC ENZYME INCREASED,4
AE,HYPERHIDROSIS,4
AE,HYPOCALCAEMIA,4
AE,IMMUNODEFICIENCY,4
AE,INFUSION RELATED REACTION,4
AE,MUSCLE SPASMS,4
AE,MYALGIA,4
AE,NEUROLEPTIC MALIGNANT SYNDROME,4
AE,PLATELET COUNT DECREASED,4
AE,PULMONARY OEDEMA,4
AE,RASH GENERALISED,4
AE,RENAL FAILURE,4
AE,RENAL IMPAIRMENT,4
AE,SEPTIC SHOCK,4
AE,SKIN EXFOLIATION,4
AE,SOMNOLENCE,4
AE,URTICARIA,4
AE,WEIGHT INCREASED,4
AE,ABDOMINAL DISTENSION,3
AE,ABORTION,3
AE,AGITATION,3
AE,ANAPHYLACTIC REACTION,3
AE,ANAPHYLACTIC SHOCK,3
AE,BRONCHIOLITIS,3
AE,BRUXISM,3
AE,C-REACTIVE PROTEIN INCREASED,3
AE,CARDIAC DISORDER,3
AE,CENTRAL NERVOUS SYSTEM NECROSIS,3
AE,CEREBRAL HAEMORRHAGE,3
AE,CHRONIC KIDNEY DISEASE,3
AE,CONSTIPATION,3
AE,DEEP VEIN THROMBOSIS,3
AE,DEPRESSED LEVEL OF CONSCIOUSNESS,3
AE,DERMATITIS ALLERGIC,3
AE,DRUG DEPENDENCE,3
AE,DYSKINESIA,3
AE,DYSPHAGIA,3
AE,ELECTROLYTE IMBALANCE,3
AE,EPILEPSY,3
AE,ERYTHEMA,3
AE,ESCHERICHIA INFECTION,3
AE,FEELING ABNORMAL,3
AE,GASTRIC HAEMORRHAGE,3
AE,GASTRITIS,3
AE,GASTROENTERITIS,3
AE,GASTROINTESTINAL NECROSIS,3
AE,GENERAL PHYSICAL HEALTH DETERIORATION,3
AE,HEART RATE IRREGULAR,3
AE,HEMIPARESIS,3
AE,HEPATITIS CHOLESTATIC,3
AE,HERPES ZOSTER,3
AE,HYPERTHYROIDISM,3
AE,HYPERVENTILATION,3
AE,INFECTION,3
AE,INFLUENZA LIKE ILLNESS,3
AE,JOINT SWELLING,3
AE,LYMPHOMA,3
AE,MALIGNANT NEOPLASM PROGRESSION,3
AE,MOUTH ULCERATION,3
AE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
AE,MUSCULOSKELETAL STIFFNESS,3
AE,NASAL CONGESTION,3
AE,OCULAR ICTERUS,3
AE,OEDEMA,3
AE,ORAL PAIN,3
AE,OSTEONECROSIS,3
AE,OXYGEN SATURATION DECREASED,3
AE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,3
AE,PARALYSIS,3
AE,PREGNANCY,3
AE,PRODUCT QUALITY ISSUE,3
AE,PRURITUS GENERALISED,3
AE,RASH MACULO-PAPULAR,3
AE,RECTAL HAEMORRHAGE,3
AE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
AE,RENAL FAILURE ACUTE,3
AE,RESTLESSNESS,3
AE,ROAD TRAFFIC ACCIDENT,3
AE,SEROTONIN SYNDROME,3
AE,SEXUAL DYSFUNCTION,3
AE,SKIN ULCER,3
AE,STAPHYLOCOCCAL INFECTION,3
AE,STEVENS-JOHNSON SYNDROME,3
AE,STREPTOCOCCAL INFECTION,3
AE,SUBCUTANEOUS ABSCESS,3
AE,SUDDEN DEATH,3
AE,SUICIDAL IDEATION,3
AE,SWELLING,3
AE,SYSTEMIC LUPUS ERYTHEMATOSUS,3
AE,THROMBOSIS,3
AE,TRANSIENT ISCHAEMIC ATTACK,3
AE,TREMOR,3
AE,TUBERCULOSIS,3
AE,UPPER GASTROINTESTINAL HAEMORRHAGE,3
AE,VERTIGO,3
AE,ABORTION MISSED,2
AE,ABSCESS,2
AE,ABSCESS LIMB,2
AE,ACCIDENTAL OVERDOSE,2
AE,ACIDOSIS,2
AE,ACNE,2
AE,ACUTE MYELOID LEUKAEMIA,2
AE,ALANINE AMINOTRANSFERASE INCREASED,2
AE,ALLOIMMUNISATION,2
AE,AMYLASE INCREASED,2
AE,ANGINA PECTORIS,2
AE,ANTINUCLEAR ANTIBODY POSITIVE,2
AE,ANXIETY,2
AE,ARRHYTHMIA,2
AE,ARTHRITIS,2
AE,ATRIAL TACHYCARDIA,2
AE,AUTOIMMUNE HAEMOLYTIC ANAEMIA,2
AE,BLISTER,2
AE,BLOOD BICARBONATE DECREASED,2
AE,BLOOD SODIUM DECREASED,2
AE,BUNDLE BRANCH BLOCK RIGHT,2
AE,CARDIOMEGALY,2
AE,CELLULITIS,2
AE,CEREBRAL ISCHAEMIA,2
AE,CHOKING,2
AE,COGNITIVE DISORDER,2
AE,CONVULSION,2
AE,CROHN^S DISEASE,2
AE,DIARRHOEA HAEMORRHAGIC,2
AE,DIPLOPIA,2
AE,DRUG INTOLERANCE,2
AE,DRY SKIN,2
AE,DYSARTHRIA,2
AE,EJECTION FRACTION DECREASED,2
AE,ERECTILE DYSFUNCTION,2
AE,ESSENTIAL HYPERTENSION,2
AE,FEAR OF INJECTION,2
AE,FLANK PAIN,2
AE,FUNGAL INFECTION,2
AE,GASTRITIS HAEMORRHAGIC,2
AE,GASTROINTESTINAL PERFORATION,2
AE,HAEMOLYTIC ANAEMIA,2
AE,HAEMORRHAGE IN PREGNANCY,2
AE,HEPATIC ENCEPHALOPATHY,2
AE,HEPATOCELLULAR CARCINOMA,2
AE,HYPERGLYCAEMIA,2
AE,HYPOMAGNESAEMIA,2
AE,HYPOMETABOLISM,2
AE,HYPOPHOSPHATAEMIA,2
AE,HYPOTHYROIDISM,2
AE,INCORRECT DOSE ADMINISTERED,2
AE,INFLAMMATION,2
AE,INJECTION SITE PAIN,2
AE,KLEBSIELLA INFECTION,2
AE,LARGE INTESTINAL ULCER,2
AE,LAZINESS,2
AE,LIPASE INCREASED,2
AE,LYMPHADENOPATHY,2
AE,METASTASES TO LIVER,2
AE,MUCOSAL INFLAMMATION,2
AE,MULTIPLE SCLEROSIS,2
AE,MULTIPLE SCLEROSIS RELAPSE,2
AE,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,2
AE,NASOPHARYNGITIS,2
AE,NERVOUS SYSTEM DISORDER,2
AE,NEUTROPHIL COUNT DECREASED,2
AE,NO ADVERSE EVENT,2
AE,OESOPHAGEAL VARICES HAEMORRHAGE,2
AE,OLIGURIA,2
AE,OPHTHALMIC HERPES SIMPLEX,2
AE,OPTIC NEURITIS,2
AE,ORAL FUNGAL INFECTION,2
AE,OSTEOPOROSIS,2
AE,PANCREATIC NEOPLASM,2
AE,PANIC ATTACK,2
AE,PERIPHERAL ISCHAEMIA,2
AE,PERITONEAL DIALYSIS COMPLICATION,2
AE,PHARYNGITIS,2
AE,PHOTOSENSITIVITY REACTION,2
AE,PIGMENTATION DISORDER,2
AE,PITUITARY TUMOUR BENIGN,2
AE,PLATELET COUNT ABNORMAL,2
AE,PNEUMONITIS,2
AE,PNEUMOTHORAX,2
AE,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,2
AE,PRE-ECLAMPSIA,2
AE,PROCTALGIA,2
AE,PRODUCT USE ISSUE,2
AE,PRODUCTIVE COUGH,2
AE,PROTEINURIA,2
AE,PSEUDOCYST,2
AE,PULMONARY EMBOLISM,2
AE,PULMONARY FIBROSIS,2
AE,RASH ERYTHEMATOUS,2
AE,RASH PRURITIC,2
AE,RENAL COLIC,2
AE,RESPIRATORY ARREST,2
AE,RESPIRATORY DISTRESS,2
AE,RESPIRATORY FAILURE,2
AE,RETINAL DETACHMENT,2
AE,SJOGREN^S SYNDROME,2
AE,SKIN HYPERPIGMENTATION,2
AE,SKIN INFECTION,2
AE,SKIN LESION,2
AE,SPEECH DISORDER,2
AE,SPLENOMEGALY,2
AE,SUBDURAL HAEMATOMA,2
AE,SURGERY,2
AE,THERAPY CESSATION,2
AE,THERMAL BURN,2
AE,TOOTH INJURY,2
AE,TYPE 2 DIABETES MELLITUS,2
AE,TYPE I HYPERSENSITIVITY,2
AE,UPPER RESPIRATORY TRACT INFECTION,2
AE,URINARY RETENTION,2
AE,UTERINE HAEMORRHAGE,2
AE,UTERINE HYPERSTIMULATION,2
AE,VASCULITIS,2
AE,VISUAL IMPAIRMENT,2
AE,WANDERING PACEMAKER,2
AE,WHEEZING,2
AE,WHITE BLOOD CELL DISORDER,2
AE,ABDOMINAL DISCOMFORT,1
AE,ABDOMINAL PAIN LOWER,1
AE,ABDOMINAL TENDERNESS,1
AE,ABDOMINAL WALL ABSCESS,1
AE,ABNORMAL BEHAVIOUR,1
AE,ABNORMAL WITHDRAWAL BLEEDING,1
AE,ABORTION SPONTANEOUS INCOMPLETE,1
AE,ABORTION THREATENED,1
AE,ABSCESS DRAINAGE,1
AE,ACINETOBACTER TEST POSITIVE,1
AE,ACUTE CORONARY SYNDROME,1
AE,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
AE,ACUTE MYOCARDIAL INFARCTION,1
AE,ACUTE RESPIRATORY DISTRESS SYNDROME,1
AE,ACUTE RESPIRATORY FAILURE,1
AE,ADENOCARCINOMA,1
AE,ADVERSE DRUG REACTION,1
AE,AGEUSIA,1
AE,AGGRESSION,1
AE,AGRANULOCYTOSIS,1
AE,AMENORRHOEA,1
AE,AMNESIA,1
AE,ANAESTHETIC COMPLICATION,1
AE,ANAL ABSCESS,1
AE,ANAL FISSURE,1
AE,ANAL INCONTINENCE,1
AE,ANGER,1
AE,ANGIOGRAM ABNORMAL,1
AE,ANGIOPATHY,1
AE,ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE,1
AE,ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC,1
AE,ANTINUCLEAR ANTIBODY INCREASED,1
AE,ANURIA,1
AE,AORTIC VALVE INCOMPETENCE,1
AE,APHAGIA,1
AE,APHONIA,1
AE,APPENDICECTOMY,1
AE,APPLICATION SITE BURN,1
AE,APPLICATION SITE INFLAMMATION,1
AE,APPLICATION SITE PAIN,1
AE,APPLICATION SITE SWELLING,1
AE,ARTERIOSCLEROSIS CORONARY ARTERY,1
AE,ARTERIOSPASM CORONARY,1
AE,ARTHROPATHY,1
AE,ARTHROPOD BITE,1
AE,ASPIRATION,1
AE,ATRIAL THROMBOSIS,1
AE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
AE,AUTOIMMUNE HYPOTHYROIDISM,1
AE,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
AE,AVOIDANT PERSONALITY DISORDER,1
AE,B-LYMPHOCYTE COUNT DECREASED,1
AE,BACTERIAL INFECTION,1
AE,BALANCE DISORDER,1
AE,BASELINE FOETAL HEART RATE VARIABILITY DISORDER,1
AE,BASOPHIL COUNT DECREASED,1
AE,BENIGN NEOPLASM OF THYROID GLAND,1
AE,BLADDER CANCER,1
AE,BLOOD BICARBONATE ABNORMAL,1
AE,BLOOD BLISTER,1
AE,BLOOD CALCIUM DECREASED,1
AE,BLOOD CHLORIDE DECREASED,1
AE,BLOOD CREATINE INCREASED,1
AE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
AE,BLOOD GLUCOSE ABNORMAL,1
AE,BLOOD GLUCOSE FLUCTUATION,1
AE,BLOOD KETONE BODY INCREASED,1
AE,BLOOD PH ABNORMAL,1
AE,BLOOD PRESSURE FLUCTUATION,1
AE,BLOOD THYROID STIMULATING HORMONE INCREASED,1
AE,BLOOD TRIGLYCERIDES INCREASED,1
AE,BLOOD URIC ACID INCREASED,1
AE,BODY TEMPERATURE INCREASED,1
AE,BOWEN^S DISEASE,1
AE,BRAIN COMPRESSION,1
AE,BRAIN MIDLINE SHIFT,1
AE,BRAIN NEOPLASM BENIGN,1
AE,BRAIN OEDEMA,1
AE,BREAST ABSCESS,1
AE,BREAST CANCER,1
AE,BREAST PAIN,1
AE,BUNDLE BRANCH BLOCK LEFT,1
AE,BURNING SENSATION,1
AE,CANDIDA INFECTION,1
AE,CARDIAC FAILURE CONGESTIVE,1
AE,CARDIOMYOPATHY,1
AE,CARDIOVERSION,1
AE,CEREBRAL ATROPHY,1
AE,CEREBRAL DISORDER,1
AE,CEREBRAL INFARCTION,1
AE,CEREBROVASCULAR DISORDER,1
AE,CERVICAL DYSPLASIA,1
AE,CERVIX CARCINOMA,1
AE,CERVIX CARCINOMA STAGE II,1
AE,CHEST X-RAY ABNORMAL,1
AE,CHOLANGITIS,1
AE,CHOLELITHIASIS,1
AE,CHOLESTASIS,1
AE,CHOLESTASIS OF PREGNANCY,1
AE,CHRONIC HEPATIC FAILURE,1
AE,CIRCULATORY COLLAPSE,1
AE,CLEAR CELL RENAL CELL CARCINOMA,1
AE,COELIAC DISEASE,1
AE,COLITIS,1
AE,COLON CANCER,1
AE,COLON OPERATION,1
AE,COLONIC FISTULA,1
AE,COMA HEPATIC,1
AE,COMPLICATION OF PREGNANCY,1
AE,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
AE,COMPUTERISED TOMOGRAM HEAD ABNORMAL,1
AE,CONGENITAL ANOMALY,1
AE,CONTRAINDICATED PRODUCT ADMINISTERED,1
AE,CONTUSION,1
AE,CORNEAL DECOMPENSATION,1
AE,CORNEAL DISORDER,1
AE,CORNEAL OEDEMA,1
AE,CORNEAL OPACITY,1
AE,CORONA VIRUS INFECTION,1
AE,CORONARY ARTERY STENOSIS,1
AE,CRYING,1
AE,CUSHING^S SYNDROME,1
AE,CYTOKINE RELEASE SYNDROME,1
AE,DEAFNESS,1
AE,DECREASED INTEREST,1
AE,DELIRIUM,1
AE,DERMAL SINUS,1
AE,DEVICE DISLOCATION,1
AE,DIABETES MELLITUS INADEQUATE CONTROL,1
AE,DIABETIC FOOT,1
AE,DIABETIC NEPHROPATHY,1
AE,DIALYSIS,1
AE,DISABILITY,1
AE,DISCOMFORT,1
AE,DISEASE PROGRESSION,1
AE,DISTURBANCE IN ATTENTION,1
AE,DRUG ADMINISTRATION ERROR,1
AE,DRUG EFFECT INCOMPLETE,1
AE,DRUG ERUPTION,1
AE,DRUG HYPERSENSITIVITY,1
AE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
AE,DRUG SPECIFIC ANTIBODY PRESENT,1
AE,DRUG WITHDRAWAL SYNDROME,1
AE,DRY MOUTH,1
AE,DUODENAL ULCER PERFORATION,1
AE,DYSCHROMATOPSIA,1
AE,DYSGEUSIA,1
AE,DYSLIPIDAEMIA,1
AE,DYSPEPSIA,1
AE,DYSPHONIA,1
AE,DYSSTASIA,1
AE,DYSTONIA,1
AE,ELECTROCARDIOGRAM QT PROLONGED,1
AE,ENCEPHALOPATHY,1
AE,ENDOMETRIOSIS,1
AE,ENTEROCOCCAL INFECTION,1
AE,ENURESIS,1
AE,EOSINOPHIL COUNT INCREASED,1
AE,ERYTHEMA MULTIFORME,1
AE,ERYTHEMA NODOSUM,1
AE,EUGLYCAEMIC DIABETIC KETOACIDOSIS,1
AE,EXCORIATION,1
AE,EXFOLIATIVE RASH,1
AE,EXTRAPYRAMIDAL DISORDER,1
AE,EYE MOVEMENT DISORDER,1
AE,FACIAL PAIN,1
AE,FACIAL PARALYSIS,1
AE,FAECALOMA,1
AE,FAECES DISCOLOURED,1
AE,FEBRILE NEUTROPENIA,1
AE,FEEDING DISORDER,1
AE,FEELING COLD,1
AE,FEMUR FRACTURE,1
AE,FLATULENCE,1
AE,FOETAL DEATH,1
AE,FOETAL HYPOKINESIA,1
AE,FOOD AVERSION,1
AE,FRACTURE,1
AE,FREQUENT BOWEL MOVEMENTS,1
AE,FRUSTRATION,1
AE,FUNCTIONAL GASTROINTESTINAL DISORDER,1
AE,FUNDOSCOPY ABNORMAL,1
AE,FUNGAEMIA,1
AE,GAIT APRAXIA,1
AE,GAIT DISTURBANCE,1
AE,GAIT INABILITY,1
AE,GALACTORRHOEA,1
AE,GANGRENE,1
AE,GASTRIC LAVAGE,1
AE,GASTROENTERITIS BACTERIAL,1
AE,GASTROINTESTINAL CARCINOMA,1
AE,GASTROINTESTINAL DISORDER,1
AE,GASTROINTESTINAL OEDEMA,1
AE,GASTROINTESTINAL SOUNDS ABNORMAL,1
AE,GASTROINTESTINAL STROMAL TUMOUR,1
AE,GASTROOESOPHAGEAL REFLUX DISEASE,1
AE,GENERALISED OEDEMA,1
AE,GESTATIONAL DIABETES,1
AE,GESTATIONAL HYPERTENSION,1
AE,GLAUCOMA,1
AE,GLUCOSE TOLERANCE IMPAIRED,1
AE,GYNAECOMASTIA,1
AE,HAEMATOCRIT DECREASED,1
AE,HAEMODYNAMIC INSTABILITY,1
AE,HAEMOLYTIC URAEMIC SYNDROME,1
AE,HAEMORRHAGE INTRACRANIAL,1
AE,HAEMORRHAGIC DISORDER,1
AE,HAEMORRHAGIC STROKE,1
AE,HAEMORRHAGIC TRANSFORMATION STROKE,1
AE,HAEMORRHOIDS,1
AE,HEMIANAESTHESIA,1
AE,HEMIPLEGIA,1
AE,HEPARIN-INDUCED THROMBOCYTOPENIA,1
AE,HEPATIC CYST,1
AE,HEPATIC FAILURE,1
AE,HEPATIC FIBROSIS,1
AE,HEPATIC PAIN,1
AE,HEPATITIS C,1
AE,HEPATOMEGALY,1
AE,HEPATORENAL SYNDROME,1
AE,HIDRADENITIS,1
AE,HISTIOCYTOSIS HAEMATOPHAGIC,1
AE,HODGKIN^S DISEASE NODULAR SCLEROSIS RECURRENT,1
AE,HOSPITALISATION,1
AE,HUMAN CHORIONIC GONADOTROPIN DECREASED,1
AE,HYPERAESTHESIA,1
AE,HYPERAMMONAEMIA,1
AE,HYPEREMESIS GRAVIDARUM,1
AE,HYPERPARATHYROIDISM SECONDARY,1
AE,HYPERPROLACTINAEMIA,1
AE,HYPERSOMNIA,1
AE,HYPERTONIA,1
AE,HYPOAESTHESIA ORAL,1
AE,HYPOKINESIA,1
AE,HYPOPHAGIA,1
AE,ICHTHYOSIS,1
AE,IMMUNE THROMBOCYTOPENIC PURPURA,1
AE,IMPAIRED HEALING,1
AE,INCISION SITE PAIN,1
AE,INCOHERENT,1
AE,INCORRECT PRODUCT STORAGE,1
AE,INFECTION MASKED,1
AE,INFECTION REACTIVATION,1
AE,INGUINAL HERNIA,1
AE,INJECTION SITE ERYTHEMA,1
AE,INJECTION SITE HAEMATOMA,1
AE,INJECTION SITE RASH,1
AE,INJECTION SITE REACTION,1
AE,INTENTIONAL PRODUCT MISUSE,1
AE,INTESTINAL DILATATION,1
AE,INTESTINAL FISTULA,1
AE,INTESTINAL MASS,1
AE,INTESTINAL OBSTRUCTION,1
AE,INVASIVE BREAST CARCINOMA,1
AE,IRON DEFICIENCY,1
AE,IRRITABLE BOWEL SYNDROME,1
AE,JAUNDICE,1
AE,JOB DISSATISFACTION,1
AE,KERION,1
AE,KETONURIA,1
AE,KIDNEY FIBROSIS,1
AE,KIDNEY TRANSPLANT REJECTION,1
AE,LACUNAR INFARCTION,1
AE,LARGE INTESTINE BENIGN NEOPLASM,1
AE,LEUKOCYTOSIS,1
AE,LIP PRURITUS,1
AE,LIPOMA,1
AE,LIPOSUCTION,1
AE,LIVE BIRTH,1
AE,LIVER DISORDER,1
AE,LIVER FUNCTION TEST INCREASED,1
AE,LOCALISED OEDEMA,1
AE,LUNG CONSOLIDATION,1
AE,LUNG DISORDER,1
AE,LUNG INFECTION,1
AE,LYMPHOCYTE COUNT DECREASED,1
AE,LYMPHOCYTE COUNT INCREASED,1
AE,LYMPHOCYTOSIS,1
AE,LYMPHOPENIA,1
AE,MACULAR OEDEMA,1
AE,MACULAR SCAR,1
AE,MALIGNANT HYPERTENSION,1
AE,MASS,1
AE,MATERNAL EXPOSURE DURING DELIVERY,1
AE,MELAENA,1
AE,MENORRHAGIA,1
AE,MENSTRUATION IRREGULAR,1
AE,MENTAL DISORDER,1
AE,METAMORPHOPSIA,1
AE,METASTASES TO PERITONEUM,1
AE,METASTASES TO SPINE,1
AE,MIDDLE EAST RESPIRATORY SYNDROME,1
AE,MINERAL DEFICIENCY,1
AE,MONOCYTE COUNT INCREASED,1
AE,MOTOR DYSFUNCTION,1
AE,MUCOSAL ULCERATION,1
AE,MULTI-ORGAN FAILURE,1
AE,MULTIPLE FRACTURES,1
AE,MULTIPLE-DRUG RESISTANCE,1
AE,MUSCLE ATROPHY,1
AE,MUSCLE DISORDER,1
AE,MUSCLE RIGIDITY,1
AE,MUSCULOSKELETAL PAIN,1
AE,MYCOSIS FUNGOIDES,1
AE,MYOCLONUS,1
AE,MYOSITIS,1
AE,NECK MASS,1
AE,NECROSIS,1
AE,NEOPLASM MALIGNANT,1
AE,NEOPLASM PROGRESSION,1
AE,NEPHROLITHIASIS,1
AE,NEPHROPATHY TOXIC,1
AE,NERVOUSNESS,1
AE,NEUROLOGICAL DECOMPENSATION,1
AE,NEUROMUSCULAR TOXICITY,1
AE,NEUROPATHY PERIPHERAL,1
AE,NEUROTOXICITY,1
AE,NIGHT SWEATS,1
AE,NO THERAPEUTIC RESPONSE,1
AE,NORMAL NEWBORN,1
AE,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
AE,NYSTAGMUS,1
AE,OBSTRUCTION GASTRIC,1
AE,OCULAR HYPERAEMIA,1
AE,OCULAR TOXICITY,1
AE,OEDEMA MOUTH,1
AE,ONCOLOGIC COMPLICATION,1
AE,OPTICAL COHERENCE TOMOGRAPHY ABNORMAL,1
AE,ORAL DYSAESTHESIA,1
AE,ORAL LICHEN PLANUS,1
AE,ORAL MUCOSAL ERUPTION,1
AE,ORAL PRURITUS,1
AE,ORGANISING PNEUMONIA,1
AE,OSTEOPOROTIC FRACTURE,1
AE,OTITIS EXTERNA,1
AE,OTORRHOEA,1
AE,OVARIAN CYST,1
AE,OVARIAN ENLARGEMENT,1
AE,OVARIAN HYPERSTIMULATION SYNDROME,1
AE,PAIN IN JAW,1
AE,PALLOR,1
AE,PANCREAS INFECTION,1
AE,PANCREATIC CARCINOMA,1
AE,PANCREATIC PSEUDOCYST,1
AE,PAPILLOMA VIRAL INFECTION,1
AE,PARAESTHESIA,1
AE,PARAESTHESIA ORAL,1
AE,PARKINSONISM,1
AE,PARTIAL SEIZURES,1
AE,PATHOGEN RESISTANCE,1
AE,PELVIC FRACTURE,1
AE,PEMPHIGOID,1
AE,PERFORATED ULCER,1
AE,PERICARDIAL EFFUSION,1
AE,PERICARDITIS,1
AE,PERIORBITAL DISORDER,1
AE,PERIPHERAL SWELLING,1
AE,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,1
AE,PERITONEAL DISORDER,1
AE,PERITONITIS BACTERIAL,1
AE,PERSONALITY DISORDER,1
AE,PLASMODIUM VIVAX INFECTION,1
AE,PNEUMONIA NECROTISING,1
AE,POLYCYSTIC OVARIES,1
AE,POLYDIPSIA,1
AE,POOR QUALITY SLEEP,1
AE,POST PROCEDURAL CELLULITIS,1
AE,POST PROCEDURAL COMPLICATION,1
AE,POST PROCEDURAL HAEMORRHAGE,1
AE,POST PROCEDURAL INFECTION,1
AE,POST PROCEDURAL SWELLING,1
AE,POSTPARTUM HAEMORRHAGE,1
AE,POSTURE ABNORMAL,1
AE,PREGNANCY ON CONTRACEPTIVE,1
AE,PREMATURE DELIVERY,1
AE,PRODUCT USE IN UNAPPROVED INDICATION,1
AE,PROSTATE CANCER METASTATIC,1
AE,PSORIATIC ARTHROPATHY,1
AE,PSYCHOLOGICAL TRAUMA,1
AE,PSYCHOTIC DISORDER,1
AE,PULMONARY FUNCTION TEST DECREASED,1
AE,PULMONARY HAEMORRHAGE,1
AE,PULMONARY HYPERTENSION,1
AE,PUSTULAR PSORIASIS,1
AE,PYODERMA GANGRENOSUM,1
AE,RASH MACULAR,1
AE,RASH PAPULAR,1
AE,RAYNAUD^S PHENOMENON,1
AE,REBOUND EFFECT,1
AE,RED CELL DISTRIBUTION WIDTH INCREASED,1
AE,RENAL ARTERY THROMBOSIS,1
AE,RENAL ATROPHY,1
AE,RENAL DISORDER,1
AE,RENAL MASS,1
AE,RENAL TUBULAR ATROPHY,1
AE,RENAL TUBULAR DISORDER,1
AE,RENAL TUBULAR NECROSIS,1
AE,RESPIRATION ABNORMAL,1
AE,RESPIRATORY DISORDER,1
AE,RESPIRATORY RATE INCREASED,1
AE,RESPIRATORY SYNCYTIAL VIRUS INFECTION,1
AE,RETINAL HAEMORRHAGE,1
AE,RHABDOMYOLYSIS,1
AE,RHEUMATOID NODULE,1
AE,RHINITIS,1
AE,RHINITIS ALLERGIC,1
AE,SALIVA ALTERED,1
AE,SALMONELLOSIS,1
AE,SEDATION,1
AE,SEPTAL PANNICULITIS,1
AE,SHOCK,1
AE,SINUS BRADYCARDIA,1
AE,SINUS TACHYCARDIA,1
AE,SINUSITIS,1
AE,SKIN BURNING SENSATION,1
AE,SKIN DISCOLOURATION,1
AE,SKIN OEDEMA,1
AE,SKIN SWELLING,1
AE,SLE ARTHRITIS,1
AE,SMALL INTESTINAL BACTERIAL OVERGROWTH,1
AE,SMALL INTESTINAL STENOSIS,1
AE,SNORING,1
AE,SOCIAL AVOIDANT BEHAVIOUR,1
AE,SPINAL CORD COMPRESSION,1
AE,SPINAL FRACTURE,1
AE,SPLENIC RUPTURE,1
AE,SPONDYLOARTHROPATHY,1
AE,STATUS ASTHMATICUS,1
AE,STATUS EPILEPTICUS,1
AE,STRABISMUS,1
AE,STRONGYLOIDIASIS,1
AE,SUBCHORIONIC HAEMATOMA,1
AE,SURGICAL FAILURE,1
AE,SWELLING FACE,1
AE,SYSTEMIC SCLEROSIS,1
AE,T-CELL DEPLETION,1
AE,TACHYARRHYTHMIA,1
AE,TALIPES,1
AE,TENSION,1
AE,THALAMUS HAEMORRHAGE,1
AE,THERAPEUTIC RESPONSE DELAYED,1
AE,THERAPY NON-RESPONDER,1
AE,THROAT IRRITATION,1
AE,THROMBOTIC MICROANGIOPATHY,1
AE,THYROID CANCER,1
AE,THYROID NEOPLASM,1
AE,THYROIDITIS,1
AE,TIBIA FRACTURE,1
AE,TINNITUS,1
AE,TONGUE PARALYSIS,1
AE,TONGUE ULCERATION,1
AE,TONSILLITIS,1
AE,TOOTH FRACTURE,1
AE,TRANSFUSION-RELATED ACUTE LUNG INJURY,1
AE,TRANSPLANT REJECTION,1
AE,TREATMENT NONCOMPLIANCE,1
AE,TRICHOPHYTOSIS,1
AE,TRIGEMINAL NEURITIS,1
AE,TUBERCULIN TEST POSITIVE,1
AE,TUBEROUS SCLEROSIS,1
AE,TUMOUR MARKER INCREASED,1
AE,TUMOUR NECROSIS,1
AE,TUMOUR PSEUDOPROGRESSION,1
AE,UNINTENDED PREGNANCY,1
AE,UPPER LIMB FRACTURE,1
AE,URETERIC STENOSIS,1
AE,URINE ANALYSIS ABNORMAL,1
AE,UTERINE CONTRACTIONS ABNORMAL,1
AE,UTERINE LEIOMYOMA,1
AE,UTERINE SPASM,1
AE,UVEITIS,1
AE,VARICOSE VEIN,1
AE,VASODILATION PROCEDURE,1
AE,VEIN DISORDER,1
AE,VENTRICULAR FIBRILLATION,1
AE,VENTRICULAR TACHYCARDIA,1
AE,VISUAL FIELD DEFECT,1
AE,VITAMIN D DEFICIENCY,1
AE,VITILIGO,1
AE,VTH NERVE INJURY,1
AE,VULVOVAGINAL DRYNESS,1
AE,VULVOVAGINAL MYCOTIC INFECTION,1
AE,VULVOVAGINAL PRURITUS,1
AE,WHITE BLOOD CELL COUNT INCREASED,1
AE,WRIST FRACTURE,1
AE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
AE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
GB,DEATH,13880
GB,MALAISE,10598
GB,FATIGUE,8559
GB,DYSPNOEA,8169
GB,NAUSEA,7674
GB,DIZZINESS,7440
GB,HEADACHE,6996
GB,DIARRHOEA,6657
GB,LOWER RESPIRATORY TRACT INFECTION,5956
GB,VOMITING,5735
GB,CONFUSIONAL STATE,5009
GB,HOSPITALISATION,4654
GB,ARTHRALGIA,4469
GB,PAIN,4435
GB,INSOMNIA,4386
GB,ANXIETY,4366
GB,RASH,4204
GB,FALL,4189
GB,MYALGIA,4035
GB,DRUG INEFFECTIVE,3908
GB,DEPRESSION,3846
GB,PAIN IN EXTREMITY,3653
GB,PARAESTHESIA,3593
GB,PYREXIA,3482
GB,ASTHENIA,3386
GB,PRURITUS,3376
GB,ACUTE KIDNEY INJURY,3302
GB,FEELING ABNORMAL,3297
GB,TREMOR,3241
GB,ABDOMINAL PAIN,3207
GB,PNEUMONIA,3118
GB,DECREASED APPETITE,3115
GB,CHEST PAIN,3071
GB,CONDITION AGGRAVATED,2977
GB,SUICIDAL IDEATION,2975
GB,COUGH,2885
GB,SOMNOLENCE,2803
GB,PALPITATIONS,2782
GB,HYPOTENSION,2562
GB,HYPERHIDROSIS,2494
GB,LETHARGY,2460
GB,MUSCLE SPASMS,2396
GB,CONSTIPATION,2394
GB,BACK PAIN,2373
GB,ABDOMINAL PAIN UPPER,2274
GB,URINARY TRACT INFECTION,2274
GB,VISION BLURRED,2225
GB,INFECTION,2218
GB,SEPSIS,2194
GB,TOXICITY TO VARIOUS AGENTS,2183
GB,AGITATION,2167
GB,MUSCULAR WEAKNESS,2149
GB,SYNCOPE,2145
GB,OVERDOSE,2105
GB,HYPONATRAEMIA,2081
GB,LOSS OF CONSCIOUSNESS,2080
GB,FOETAL EXPOSURE DURING PREGNANCY,2053
GB,DEPRESSED MOOD,1934
GB,LIVER FUNCTION TEST ABNORMAL,1925
GB,ANAEMIA,1924
GB,PERIPHERAL SWELLING,1917
GB,NEUTROPENIA,1914
GB,CEREBROVASCULAR ACCIDENT,1907
GB,SEIZURE,1868
GB,BALANCE DISORDER,1863
GB,HYPOAESTHESIA,1833
GB,SWELLING FACE,1828
GB,GAIT DISTURBANCE,1817
GB,HALLUCINATION,1739
GB,ALOPECIA,1734
GB,HYPERSENSITIVITY,1717
GB,AGGRESSION,1716
GB,HAEMOGLOBIN DECREASED,1706
GB,ERYTHEMA,1698
GB,HYPERTENSION,1698
GB,VISUAL IMPAIRMENT,1666
GB,WEIGHT DECREASED,1651
GB,DYSPHAGIA,1639
GB,DISTURBANCE IN ATTENTION,1614
GB,JOINT SWELLING,1613
GB,CHEST DISCOMFORT,1606
GB,TACHYCARDIA,1605
GB,MYOCARDIAL INFARCTION,1598
GB,RENAL IMPAIRMENT,1552
GB,MEMORY IMPAIRMENT,1492
GB,LIP SWELLING,1465
GB,WHITE BLOOD CELL COUNT INCREASED,1459
GB,WITHDRAWAL SYNDROME,1413
GB,CARDIAC ARREST,1404
GB,NIGHTMARE,1393
GB,SLEEP DISORDER,1384
GB,DRY MOUTH,1379
GB,ABDOMINAL DISTENSION,1373
GB,DEHYDRATION,1366
GB,ATRIAL FIBRILLATION,1341
GB,TINNITUS,1332
GB,URTICARIA,1318
GB,NEUROPATHY PERIPHERAL,1311
GB,CONTUSION,1310
GB,AMNESIA,1303
GB,ANAPHYLACTIC REACTION,1299
GB,EXPOSURE DURING PREGNANCY,1293
GB,PULMONARY EMBOLISM,1293
GB,MUSCULOSKELETAL STIFFNESS,1286
GB,DYSPEPSIA,1281
GB,OROPHARYNGEAL PAIN,1269
GB,GASTROINTESTINAL HAEMORRHAGE,1238
GB,CIRCULATORY COLLAPSE,1224
GB,INFLUENZA LIKE ILLNESS,1222
GB,DRUG DOSE OMISSION,1218
GB,DYSGEUSIA,1211
GB,ABDOMINAL DISCOMFORT,1209
GB,CHILLS,1206
GB,NEUTROPENIC SEPSIS,1189
GB,SWOLLEN TONGUE,1181
GB,BRADYCARDIA,1172
GB,WHEEZING,1172
GB,PLATELET COUNT DECREASED,1141
GB,HAEMORRHAGE,1140
GB,EPISTAXIS,1129
GB,NEUTROPHIL COUNT INCREASED,1119
GB,THROMBOCYTOPENIA,1111
GB,HEART RATE INCREASED,1110
GB,RENAL FAILURE ACUTE,1101
GB,WEIGHT INCREASED,1081
GB,BLISTER,1062
GB,WHITE BLOOD CELL COUNT DECREASED,1062
GB,RENAL FAILURE,1036
GB,ABNORMAL BEHAVIOUR,1035
GB,MOBILITY DECREASED,1034
GB,CELLULITIS,1030
GB,OEDEMA PERIPHERAL,1026
GB,DYSARTHRIA,1023
GB,IRRITABILITY,1022
GB,ANGER,1012
GB,SPEECH DISORDER,993
GB,DISORIENTATION,992
GB,MOUTH ULCERATION,987
GB,ELECTROCARDIOGRAM QT PROLONGED,986
GB,NASOPHARYNGITIS,983
GB,PANIC ATTACK,983
GB,DYSKINESIA,972
GB,PSORIASIS,963
GB,DISEASE PROGRESSION,960
GB,ALANINE AMINOTRANSFERASE INCREASED,957
GB,INTENTIONAL OVERDOSE,949
GB,ABORTION SPONTANEOUS,946
GB,DRUG WITHDRAWAL SYNDROME,944
GB,MENTAL IMPAIRMENT,943
GB,MIGRAINE,937
GB,PSYCHOTIC DISORDER,935
GB,PRODUCT USE ISSUE,933
GB,ASTHMA,912
GB,DEEP VEIN THROMBOSIS,898
GB,HAEMATEMESIS,897
GB,ANGIOEDEMA,896
GB,SUICIDE ATTEMPT,896
GB,GENERAL PHYSICAL HEALTH DETERIORATION,893
GB,BURNING SENSATION,891
GB,BLOOD PRESSURE INCREASED,880
GB,MOOD SWINGS,880
GB,JAUNDICE,876
GB,RECTAL HAEMORRHAGE,876
GB,RASH GENERALISED,875
GB,INTERNATIONAL NORMALISED RATIO INCREASED,866
GB,CONVULSION,861
GB,FEELING HOT,853
GB,MUSCLE TWITCHING,853
GB,EYE PAIN,851
GB,CARDIAC FAILURE,848
GB,MUSCULOSKELETAL PAIN,847
GB,EPILEPSY,833
GB,HAEMODIALYSIS,828
GB,MENTAL DISORDER,827
GB,CARDIAC DISORDER,819
GB,VERTIGO,816
GB,UNRESPONSIVE TO STIMULI,815
GB,ABNORMAL DREAMS,806
GB,MATERNAL EXPOSURE DURING PREGNANCY,805
GB,RENAL DISORDER,804
GB,SKIN EXFOLIATION,799
GB,NEUTROPHIL COUNT DECREASED,793
GB,RASH PRURITIC,781
GB,DRY SKIN,765
GB,INCORRECT DOSE ADMINISTERED,754
GB,PARANOIA,754
GB,NECK PAIN,753
GB,MELAENA,751
GB,HYPERKALAEMIA,748
GB,PANCYTOPENIA,746
GB,FLUSHING,743
GB,SURGERY,730
GB,HYPOGLYCAEMIA,729
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,728
GB,LOCAL SWELLING,720
GB,RASH ERYTHEMATOUS,720
GB,RESTLESSNESS,720
GB,POLLAKIURIA,715
GB,COMPLETED SUICIDE,712
GB,ARTHROPATHY,711
GB,COGNITIVE DISORDER,709
GB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,709
GB,HYPOTHYROIDISM,705
GB,PRODUCT SUBSTITUTION ISSUE,705
GB,GASTROOESOPHAGEAL REFLUX DISEASE,703
GB,URINARY RETENTION,703
GB,DIABETES MELLITUS,691
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,685
GB,DIABETIC KETOACIDOSIS,682
GB,HOT FLUSH,674
GB,GASTROINTESTINAL DISORDER,665
GB,PALLOR,660
GB,RHABDOMYOLYSIS,660
GB,BLOOD CREATININE INCREASED,658
GB,MOOD ALTERED,640
GB,ORAL PAIN,638
GB,TREATMENT NONCOMPLIANCE,636
GB,FEBRILE NEUTROPENIA,635
GB,DISCOMFORT,632
GB,ERECTILE DYSFUNCTION,632
GB,APHASIA,629
GB,PLEURAL EFFUSION,628
GB,DYSURIA,626
GB,RESPIRATORY FAILURE,626
GB,NEOPLASM MALIGNANT,625
GB,MALIGNANT NEOPLASM PROGRESSION,621
GB,BLOOD GLUCOSE INCREASED,619
GB,SWELLING,617
GB,CHROMATURIA,614
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,613
GB,ABNORMAL LOSS OF WEIGHT,611
GB,PULMONARY OEDEMA,608
GB,EYE SWELLING,601
GB,VISUAL ACUITY REDUCED,601
GB,FLATULENCE,599
GB,TEARFULNESS,597
GB,ARRHYTHMIA,596
GB,CRYING,596
GB,PHARYNGEAL OEDEMA,595
GB,ABNORMAL WEIGHT GAIN,594
GB,PRURITUS GENERALISED,592
GB,BONE PAIN,584
GB,TRANSIENT ISCHAEMIC ATTACK,583
GB,PRODUCT USE IN UNAPPROVED INDICATION,581
GB,C-REACTIVE PROTEIN INCREASED,578
GB,NIGHT SWEATS,578
GB,INFLUENZA,576
GB,RHEUMATOID ARTHRITIS,576
GB,DRUG HYPERSENSITIVITY,571
GB,DRUG PRESCRIBING ERROR,566
GB,ACCIDENTAL OVERDOSE,565
GB,GASTRITIS,563
GB,ARTHRITIS,553
GB,HYPOKALAEMIA,553
GB,FAECES DISCOLOURED,552
GB,CEREBRAL HAEMORRHAGE,551
GB,EMOTIONAL DISTRESS,551
GB,DRUG INTOLERANCE,541
GB,SKIN DISCOLOURATION,541
GB,BLOOD PRESSURE DECREASED,540
GB,RASH MACULAR,536
GB,URINARY INCONTINENCE,536
GB,DYSPNOEA EXERTIONAL,533
GB,PRODUCTIVE COUGH,533
GB,BODY TEMPERATURE INCREASED,532
GB,ADVERSE EVENT,530
GB,PRODUCT QUALITY ISSUE,524
GB,HAEMATURIA,523
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,521
GB,ORTHOSTATIC HYPOTENSION,520
GB,QUALITY OF LIFE DECREASED,518
GB,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,517
GB,INTENTIONAL SELF-INJURY,517
GB,RHINORRHOEA,515
GB,SCHIZOPHRENIA,514
GB,OEDEMA,502
GB,STRESS,498
GB,LIMB DISCOMFORT,495
GB,FEELING COLD,492
GB,BREAST CANCER,488
GB,SEDATION,485
GB,HALLUCINATION_ VISUAL,484
GB,SENSORY DISTURBANCE,484
GB,PHOTOPHOBIA,482
GB,RESTLESS LEGS SYNDROME,482
GB,DRY EYE,481
GB,PHOTOSENSITIVITY REACTION,480
GB,DELIRIUM,479
GB,PSYCHIATRIC SYMPTOM,479
GB,ACUTE MYOCARDIAL INFARCTION,478
GB,VIRAL INFECTION,478
GB,BLINDNESS,473
GB,LIVER DISORDER,473
GB,MEDICATION ERROR,473
GB,SEROTONIN SYNDROME,471
GB,DRUG ABUSE,468
GB,POOR QUALITY SLEEP,468
GB,STEVENS-JOHNSON SYNDROME,464
GB,UNEVALUABLE EVENT,464
GB,THROAT TIGHTNESS,461
GB,PANCREATITIS,459
GB,OXYGEN SATURATION DECREASED,456
GB,DEPRESSED LEVEL OF CONSCIOUSNESS,453
GB,HEPATIC FUNCTION ABNORMAL,452
GB,ANGINA PECTORIS,448
GB,OSTEONECROSIS OF JAW,444
GB,COLD SWEAT,443
GB,JOINT STIFFNESS,443
GB,PULMONARY FIBROSIS,436
GB,TENDONITIS,435
GB,MUSCLE ATROPHY,433
GB,PNEUMONITIS,432
GB,METABOLIC ACIDOSIS,431
GB,MOVEMENT DISORDER,430
GB,PERSONALITY CHANGE,430
GB,HIP FRACTURE,428
GB,HYPOCALCAEMIA,428
GB,DRUG DEPENDENCE,427
GB,PLATELET COUNT INCREASED,426
GB,DIPLOPIA,425
GB,LEUKOPENIA,424
GB,NEUROLEPTIC MALIGNANT SYNDROME,424
GB,EMOTIONAL DISORDER,422
GB,SOCIAL AVOIDANT BEHAVIOUR,421
GB,TUBULOINTERSTITIAL NEPHRITIS,421
GB,FEAR,420
GB,PREMATURE BABY,420
GB,ACUTE HEPATIC FAILURE,416
GB,COORDINATION ABNORMAL,413
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,413
GB,HEART RATE IRREGULAR,411
GB,THIRST,410
GB,HYPOMAGNESAEMIA,409
GB,THINKING ABNORMAL,409
GB,DRUG-INDUCED LIVER INJURY,407
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,405
GB,THROMBOSIS,405
GB,VAGINAL HAEMORRHAGE,403
GB,OCULAR HYPERAEMIA,399
GB,HYPERSOMNIA,398
GB,DEAFNESS,397
GB,ECZEMA,397
GB,MYOCARDIAL ISCHAEMIA,395
GB,SKIN ULCER,393
GB,GENERALISED TONIC-CLONIC SEIZURE,390
GB,PARAESTHESIA ORAL,390
GB,HYPOPHAGIA,388
GB,ADVERSE DRUG REACTION,386
GB,CLOSTRIDIUM DIFFICILE INFECTION,386
GB,HALLUCINATION_ AUDITORY,385
GB,PRESYNCOPE,383
GB,HEART RATE DECREASED,382
GB,AGEUSIA,380
GB,APATHY,380
GB,CHOLELITHIASIS,379
GB,HEPATIC FAILURE,379
GB,LYMPHADENOPATHY,378
GB,DERMATITIS ALLERGIC,376
GB,LOSS OF LIBIDO,375
GB,COLITIS,373
GB,DYSTONIA,373
GB,INFLAMMATION,373
GB,MANIA,373
GB,FLUID RETENTION,372
GB,DIALYSIS,371
GB,MUCOSAL INFLAMMATION,371
GB,WRONG TECHNIQUE IN DRUG USAGE PROCESS,370
GB,ABASIA,369
GB,THERAPY CESSATION,369
GB,BLOOD URINE PRESENT,368
GB,DYSPHONIA,368
GB,PANCREATITIS ACUTE,366
GB,TREATMENT FAILURE,364
GB,PERITONITIS,361
GB,BLOOD BILIRUBIN INCREASED,358
GB,HERPES ZOSTER,355
GB,NEURALGIA,354
GB,PAIN IN JAW,353
GB,IMPAIRED WORK ABILITY,350
GB,LUNG NEOPLASM MALIGNANT,349
GB,NERVOUSNESS,348
GB,HEAD DISCOMFORT,346
GB,HEMIPARESIS,346
GB,MUSCLE TIGHTNESS,346
GB,LIVER INJURY,345
GB,GASTRIC ULCER,342
GB,SKIN BURNING SENSATION,342
GB,TENDERNESS,342
GB,KIDNEY INFECTION,341
GB,RASH MACULO-PAPULAR,339
GB,PERIPHERAL COLDNESS,335
GB,COMA,334
GB,HYPERGLYCAEMIA,332
GB,CROHN^S DISEASE,331
GB,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,331
GB,HYPOXIA,330
GB,INTENTIONAL PRODUCT MISUSE,329
GB,DISSOCIATION,328
GB,MULTI-ORGAN FAILURE,324
GB,DEMENTIA,317
GB,GOUT,316
GB,ORAL CANDIDIASIS,316
GB,PNEUMONIA ASPIRATION,314
GB,CATARACT,313
GB,SKIN DISORDER,312
GB,HAEMOPTYSIS,311
GB,HEPATITIS,311
GB,LYMPHOMA,311
GB,DELUSION,310
GB,CONTRAINDICATED PRODUCT ADMINISTERED,308
GB,HEAD INJURY,308
GB,ATAXIA,303
GB,GLOMERULAR FILTRATION RATE DECREASED,303
GB,ASCITES,302
GB,BASAL CELL CARCINOMA,301
GB,HAEMATOCHEZIA,300
GB,HEPATIC STEATOSIS,300
GB,LUNG INFECTION,299
GB,MYOCLONUS,299
GB,DRUG ADMINISTRATION ERROR,297
GB,PANIC REACTION,297
GB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,296
GB,OESOPHAGITIS,296
GB,INTERSTITIAL LUNG DISEASE,295
GB,PSYCHOMOTOR HYPERACTIVITY,295
GB,BRUXISM,293
GB,TENDON PAIN,293
GB,NASAL CONGESTION,292
GB,STOMATITIS,292
GB,GINGIVAL BLEEDING,288
GB,MUSCLE RIGIDITY,288
GB,ANTIPSYCHOTIC DRUG LEVEL INCREASED,287
GB,CHOKING,287
GB,RESPIRATORY ARREST,285
GB,DRUG DISPENSING ERROR,284
GB,SALIVARY HYPERSECRETION,283
GB,THROAT IRRITATION,283
GB,TYPE 2 DIABETES MELLITUS,283
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,282
GB,INFUSION RELATED REACTION,281
GB,FEELING DRUNK,280
GB,HAEMORRHAGE INTRACRANIAL,280
GB,INJECTION SITE PAIN,277
GB,DYSSTASIA,275
GB,INCONTINENCE,275
GB,INTESTINAL OBSTRUCTION,274
GB,TRANSPLANT,273
GB,UROSEPSIS,273
GB,INHIBITORY DRUG INTERACTION,272
GB,MICTURITION URGENCY,272
GB,SINUSITIS,272
GB,COMA SCALE ABNORMAL,270
GB,LOCALISED INFECTION,269
GB,PAIN OF SKIN,269
GB,EYE DISORDER,268
GB,LACTIC ACIDOSIS,268
GB,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,266
GB,ILL-DEFINED DISORDER,263
GB,RESPIRATORY DISORDER,263
GB,PARALYSIS,261
GB,INCORRECT ROUTE OF DRUG ADMINISTRATION,260
GB,FEMUR FRACTURE,259
GB,NEPHROLITHIASIS,259
GB,PLASMA CELL MYELOMA,259
GB,CANDIDA INFECTION,256
GB,RESPIRATORY TRACT INFECTION,256
GB,IRRITABLE BOWEL SYNDROME,255
GB,BLOOD SODIUM DECREASED,254
GB,PARKINSON^S DISEASE,254
GB,CARDIAC FAILURE CONGESTIVE,253
GB,DUODENAL ULCER,253
GB,TOXIC EPIDERMAL NECROLYSIS,253
GB,MYDRIASIS,252
GB,EATING DISORDER,251
GB,ISCHAEMIC STROKE,251
GB,LIBIDO DECREASED,251
GB,ANORGASMIA,250
GB,PHARYNGITIS,250
GB,SNEEZING,250
GB,CONGENITAL ANOMALY,248
GB,GLOSSODYNIA,248
GB,LUNG DISORDER,248
GB,SELF-INJURIOUS IDEATION,248
GB,THERAPEUTIC RESPONSE DECREASED,247
GB,SKIN LESION,246
GB,HAEMATOMA,245
GB,HIATUS HERNIA,245
GB,ENCEPHALOPATHY,244
GB,BRONCHIECTASIS,243
GB,INCORRECT DRUG ADMINISTRATION DURATION,243
GB,EXTRAPYRAMIDAL DISORDER,242
GB,HYPOACUSIS,242
GB,MUSCULOSKELETAL CHEST PAIN,242
GB,PREGNANCY,241
GB,CYSTITIS,240
GB,MULTIPLE SCLEROSIS RELAPSE,240
GB,HAEMORRHOIDS,239
GB,MENORRHAGIA,237
GB,SEXUAL DYSFUNCTION,237
GB,VENTRICULAR TACHYCARDIA,237
GB,DIVERTICULITIS,236
GB,MOUTH SWELLING,236
GB,RENAL PAIN,236
GB,BRONCHOSPASM,235
GB,HALLUCINATIONS_ MIXED,234
GB,CEREBRAL INFARCTION,233
GB,GASTROENTERITIS,233
GB,LYMPHOCYTE COUNT DECREASED,233
GB,NERVOUS SYSTEM DISORDER,233
GB,BONE MARROW FAILURE,232
GB,HEPATOTOXICITY,232
GB,SELF ESTEEM DECREASED,232
GB,SENSORY LOSS,232
GB,INJECTION SITE REACTION,231
GB,UPPER RESPIRATORY TRACT INFECTION,231
GB,EOSINOPHILIA,230
GB,GROIN PAIN,229
GB,BLOOD UREA INCREASED,228
GB,EAR PAIN,228
GB,MYOSITIS,228
GB,HYPOAESTHESIA ORAL,227
GB,RASH PAPULAR,226
GB,ACUTE PSYCHOSIS,225
GB,MYOPATHY,225
GB,PHOTOPSIA,225
GB,GYNAECOMASTIA,224
GB,FEEDING DISORDER,223
GB,CYANOSIS,222
GB,LACRIMATION INCREASED,222
GB,TRANSFUSION,222
GB,METASTASES TO CENTRAL NERVOUS SYSTEM,221
GB,METASTASES TO LIVER,221
GB,PROCTALGIA,221
GB,PROSTATE CANCER,221
GB,BRAIN INJURY,220
GB,TERMINAL STATE,220
GB,GASTRIC DISORDER,218
GB,AKATHISIA,217
GB,INCREASED APPETITE,217
GB,UPPER LIMB FRACTURE,217
GB,EOSINOPHIL COUNT INCREASED,216
GB,HYPOKINESIA,216
GB,RED BLOOD CELL COUNT DECREASED,216
GB,INJECTION SITE ERYTHEMA,215
GB,INTESTINAL PERFORATION,214
GB,EYE PRURITUS,213
GB,EUPHORIC MOOD,212
GB,MASS,212
GB,EAR INFECTION,211
GB,SKIN REACTION,211
GB,ABDOMINAL PAIN LOWER,210
GB,DRUG EFFECT DECREASED,210
GB,BLOOD CHOLESTEROL INCREASED,209
GB,COLITIS ULCERATIVE,207
GB,MUSCULOSKELETAL DISORDER,207
GB,PERICARDIAL EFFUSION,207
GB,PRESCRIBED OVERDOSE,207
GB,DRUG LEVEL INCREASED,206
GB,ACUTE MYELOID LEUKAEMIA,205
GB,EYELID OEDEMA,205
GB,SUDDEN DEATH,205
GB,VIITH NERVE PARALYSIS,205
GB,CHRONIC KIDNEY DISEASE,203
GB,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,203
GB,DEVICE RELATED INFECTION,202
GB,DIABETES MELLITUS INADEQUATE CONTROL,202
GB,OSTEOPOROSIS,202
GB,PNEUMOTHORAX,202
GB,POLYURIA,201
GB,SKIN IRRITATION,201
GB,ACUTE CORONARY SYNDROME,200
GB,BLOOD POTASSIUM INCREASED,200
GB,DIZZINESS POSTURAL,200
GB,DRUG ERUPTION,200
GB,HEPATIC CIRRHOSIS,200
GB,OBSESSIVE-COMPULSIVE DISORDER,200
GB,RETCHING,200
GB,SPUTUM DISCOLOURED,200
GB,TOOTH ABSCESS,200
GB,ANAPHYLACTIC SHOCK,199
GB,DERMATITIS,199
GB,LOWER LIMB FRACTURE,199
GB,SPINAL FRACTURE,199
GB,BLOOD POTASSIUM DECREASED,198
GB,HYPOTHERMIA,197
GB,PREMATURE DELIVERY,197
GB,FRUSTRATION,196
GB,EYE IRRITATION,195
GB,IMPAIRED HEALING,195
GB,UNINTENDED PREGNANCY,195
GB,DECREASED INTEREST,194
GB,MUSCULOSKELETAL DISCOMFORT,194
GB,TONSILLITIS,194
GB,ARTERIOSCLEROSIS CORONARY ARTERY,193
GB,FOETAL DEATH,193
GB,DEPRESSION SUICIDAL,192
GB,DRUG EFFECT INCOMPLETE,192
GB,HYPERCALCAEMIA,192
GB,OSTEOARTHRITIS,192
GB,SOCIAL PROBLEM,192
GB,CONTRAINDICATED DRUG ADMINISTERED,191
GB,DRUG RESISTANCE,191
GB,URINE OUTPUT DECREASED,191
GB,DISEASE RECURRENCE,190
GB,SINUS TACHYCARDIA,190
GB,HERNIA,189
GB,ORAL MUCOSAL BLISTERING,189
GB,COAGULOPATHY,188
GB,FEELING OF BODY TEMPERATURE CHANGE,187
GB,PROTEINURIA,187
GB,BLOOD TEST ABNORMAL,186
GB,ORAL DISCOMFORT,186
GB,SKIN INFECTION,186
GB,ACIDOSIS,185
GB,BREAST PAIN,185
GB,LOW BIRTH WEIGHT BABY,185
GB,SEPTIC SHOCK,185
GB,SUICIDAL BEHAVIOUR,185
GB,ERYTHEMA MULTIFORME,184
GB,HYPERAESTHESIA,182
GB,LEFT VENTRICULAR DYSFUNCTION,182
GB,HEPATIC ENZYME INCREASED,181
GB,VASCULITIS,181
GB,ERUCTATION,180
GB,GINGIVAL PAIN,180
GB,ASPARTATE AMINOTRANSFERASE INCREASED,179
GB,EAR DISCOMFORT,179
GB,WOUND,179
GB,BEDRIDDEN,178
GB,STAPHYLOCOCCAL INFECTION,178
GB,ACNE,177
GB,MULTIPLE SCLEROSIS,176
GB,CARDIOMYOPATHY,175
GB,HEPATITIS C,175
GB,INJURY,175
GB,TENDON RUPTURE,175
GB,ABSCESS,174
GB,EYE MOVEMENT DISORDER,174
GB,NEUROTOXICITY,174
GB,ANKLE FRACTURE,173
GB,PETECHIAE,173
GB,TARDIVE DYSKINESIA,173
GB,NEOPLASM PROGRESSION,172
GB,TOOTH DISORDER,172
GB,DRY THROAT,171
GB,EXTRASYSTOLES,171
GB,FREQUENT BOWEL MOVEMENTS,171
GB,HYPOGAMMAGLOBULINAEMIA,171
GB,METASTASES TO BONE,171
GB,NEGATIVE THOUGHTS,170
GB,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,170
GB,UVEITIS,170
GB,DERMATITIS EXFOLIATIVE,169
GB,SQUAMOUS CELL CARCINOMA,169
GB,SUPRAVENTRICULAR TACHYCARDIA,169
GB,ACUTE RESPIRATORY DISTRESS SYNDROME,168
GB,HYPERACUSIS,168
GB,DROOLING,167
GB,PAROSMIA,167
GB,ALCOHOL INTERACTION,166
GB,CYTOMEGALOVIRUS INFECTION,166
GB,SUBARACHNOID HAEMORRHAGE,166
GB,ULCER,166
GB,CAESAREAN SECTION,165
GB,ABORTION INDUCED,164
GB,TRISMUS,164
GB,BRAIN OEDEMA,163
GB,NOCTURIA,163
GB,PNEUMOCYSTIS JIROVECII PNEUMONIA,163
GB,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,163
GB,SKIN FISSURES,163
GB,TOOTHACHE,163
GB,VENTRICULAR FIBRILLATION,163
GB,AFFECT LABILITY,162
GB,MYELODYSPLASTIC SYNDROME,162
GB,SUBDURAL HAEMATOMA,162
GB,FACIAL PARALYSIS,161
GB,JOINT CREPITATION,161
GB,RESPIRATORY DISTRESS,161
GB,FLUID OVERLOAD,160
GB,BLOOD GLUCOSE DECREASED,159
GB,FEMORAL NECK FRACTURE,159
GB,HYPOTONIA,159
GB,PARKINSONISM,159
GB,PSORIATIC ARTHROPATHY,159
GB,ROAD TRAFFIC ACCIDENT,159
GB,SINUS BRADYCARDIA,159
GB,SLEEP APNOEA SYNDROME,158
GB,SLEEP TERROR,158
GB,ABNORMAL FAECES,156
GB,AMENORRHOEA,156
GB,ONYCHOCLASIS,156
GB,SOMNAMBULISM,156
GB,TONGUE DISCOLOURATION,156
GB,VITREOUS FLOATERS,156
GB,ANAL INCONTINENCE,155
GB,ANOSMIA,154
GB,BRONCHITIS,154
GB,ELECTROLYTE IMBALANCE,154
GB,IMMUNOSUPPRESSION,154
GB,KETOACIDOSIS,154
GB,LIVER FUNCTION TEST INCREASED,154
GB,RIB FRACTURE,154
GB,BLOOD ALBUMIN DECREASED,153
GB,LIMB INJURY,153
GB,NEUROLOGICAL SYMPTOM,153
GB,PANCREATIC CARCINOMA,153
GB,BLADDER CANCER,152
GB,GASTROINTESTINAL CARCINOMA,152
GB,HIP ARTHROPLASTY,152
GB,ATRIAL FLUTTER,151
GB,BLINDNESS UNILATERAL,151
GB,BLOOD DISORDER,151
GB,CHOLECYSTITIS,151
GB,INTRACRANIAL PRESSURE INCREASED,151
GB,MYOCARDITIS,151
GB,RESPIRATORY DEPRESSION,151
GB,SPLENOMEGALY,151
GB,WOUND INFECTION,151
GB,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,150
GB,DRUG WITHDRAWAL SYNDROME NEONATAL,150
GB,STATUS EPILEPTICUS,150
GB,AUTISM SPECTRUM DISORDER,149
GB,GASTROINTESTINAL MOTILITY DISORDER,149
GB,SCREAMING,149
GB,NO THERAPEUTIC RESPONSE,148
GB,ORAL HERPES,148
GB,SHOCK,148
GB,TACHYPNOEA,148
GB,TUBERCULOSIS,148
GB,CLOSTRIDIUM DIFFICILE COLITIS,147
GB,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,147
GB,CATATONIA,146
GB,EYE HAEMORRHAGE,146
GB,RAYNAUD^S PHENOMENON,146
GB,FACIAL PAIN,145
GB,AGRANULOCYTOSIS,144
GB,ALCOHOLISM,144
GB,ATRIOVENTRICULAR BLOCK FIRST DEGREE,144
GB,CARDIOMEGALY,144
GB,FRACTURE,144
GB,INTESTINAL ISCHAEMIA,144
GB,PURPURA,144
GB,BRONCHOPNEUMONIA,143
GB,CARDIOVASCULAR DISORDER,143
GB,INTRAOCULAR PRESSURE INCREASED,143
GB,ATYPICAL FEMUR FRACTURE,142
GB,FACE OEDEMA,141
GB,FIBROMYALGIA,141
GB,SCIATICA,141
GB,TRANSAMINASES INCREASED,141
GB,METASTASES TO LUNG,140
GB,SKIN CANCER,140
GB,NO ADVERSE EVENT,139
GB,WRONG DRUG ADMINISTERED,139
GB,DEPENDENCE,138
GB,GASTRIC HAEMORRHAGE,138
GB,JOINT DISLOCATION,138
GB,SKIN WARM,138
GB,DISABILITY,137
GB,NYSTAGMUS,137
GB,SCAR,137
GB,ATRIOVENTRICULAR BLOCK COMPLETE,136
GB,DIFFUSE LARGE B-CELL LYMPHOMA,136
GB,FEELING OF DESPAIR,136
GB,GASTROINTESTINAL PAIN,136
GB,INFLAMMATORY MARKER INCREASED,136
GB,IRON DEFICIENCY ANAEMIA,136
GB,NERVE INJURY,136
GB,THERAPEUTIC RESPONSE UNEXPECTED,136
GB,BRAIN NEOPLASM,134
GB,DUODENITIS,134
GB,HEARING IMPAIRED,134
GB,KNEE ARTHROPLASTY,134
GB,MALIGNANT MELANOMA,134
GB,MUSCLE DISORDER,134
GB,IMMUNE THROMBOCYTOPENIC PURPURA,133
GB,REACTION TO DRUG EXCIPIENTS,133
GB,RENAL FAILURE CHRONIC,133
GB,TENSION HEADACHE,133
GB,TROPONIN INCREASED,133
GB,BLINDNESS TRANSIENT,132
GB,INTENTIONAL DRUG MISUSE,132
GB,JAUNDICE CHOLESTATIC,132
GB,WOUND SECRETION,132
GB,HEPATOMEGALY,131
GB,NEOPLASM,131
GB,SPINAL PAIN,131
GB,TACHYPHRENIA,131
GB,DEREALISATION,130
GB,INJECTION SITE BRUISING,130
GB,OSTEOMYELITIS,130
GB,PETIT MAL EPILEPSY,130
GB,ABDOMINAL TENDERNESS,129
GB,DUODENAL ULCER PERFORATION,129
GB,GRAND MAL CONVULSION,129
GB,LACERATION,129
GB,OBSTRUCTIVE AIRWAYS DISORDER,129
GB,OESOPHAGEAL ULCER,129
GB,GENERAL PHYSICAL CONDITION ABNORMAL,128
GB,INCOHERENT,128
GB,LIVE BIRTH,128
GB,OSTEONECROSIS,128
GB,PERITONEAL DIALYSIS,128
GB,ACCIDENT,127
GB,ALTERED STATE OF CONSCIOUSNESS,126
GB,BLOOD CALCIUM DECREASED,126
GB,BONE DISORDER,126
GB,FAECAL INCONTINENCE,126
GB,PERICARDITIS,126
GB,SKIN ATROPHY,126
GB,SMALL INTESTINAL OBSTRUCTION,126
GB,SYSTEMIC LUPUS ERYTHEMATOSUS,126
GB,BLOOD MAGNESIUM DECREASED,125
GB,CARPAL TUNNEL SYNDROME,125
GB,PULSELESS ELECTRICAL ACTIVITY,125
GB,BLOOD LACTATE DEHYDROGENASE INCREASED,124
GB,COMMUNICATION DISORDER,124
GB,FOETAL ANTICONVULSANT SYNDROME,123
GB,HYPERVENTILATION,123
GB,OBESITY,123
GB,OCULAR DISCOMFORT,123
GB,ALCOHOL ABUSE,122
GB,APHAGIA,122
GB,ATRIOVENTRICULAR BLOCK,122
GB,BRADYPHRENIA,122
GB,OPTIC ISCHAEMIC NEUROPATHY,122
GB,RHINITIS,122
GB,APHONIA,121
GB,HUNGER,121
GB,MIDDLE INSOMNIA,121
GB,HAEMATOCRIT DECREASED,120
GB,HAEMOLYSIS,120
GB,HEPATITIS ACUTE,120
GB,MATERNAL EXPOSURE BEFORE PREGNANCY,120
GB,CHOLESTASIS,119
GB,POTENTIATING DRUG INTERACTION,119
GB,SELF INJURIOUS BEHAVIOUR,119
GB,SKIN HAEMORRHAGE,119
GB,STILLBIRTH,119
GB,ACCIDENTAL EXPOSURE TO PRODUCT,118
GB,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,118
GB,EXPOSURE DURING BREAST FEEDING,118
GB,FORMICATION,118
GB,LYMPHOEDEMA,118
GB,PERIPHERAL ISCHAEMIA,118
GB,BLOOD PRESSURE ABNORMAL,117
GB,LUNG CONSOLIDATION,117
GB,DUODENAL ULCER HAEMORRHAGE,116
GB,GLAUCOMA,116
GB,PAPILLOEDEMA,116
GB,SECOND PRIMARY MALIGNANCY,116
GB,VITAMIN D DEFICIENCY,116
GB,DISTURBANCE IN SEXUAL AROUSAL,115
GB,ELECTROCARDIOGRAM ABNORMAL,115
GB,INJECTION SITE SWELLING,115
GB,PAPULE,115
GB,PELVIC PAIN,115
GB,RASH PUSTULAR,115
GB,DERMATITIS BULLOUS,114
GB,DISINHIBITION,114
GB,FLAT AFFECT,114
GB,FOETAL GROWTH RESTRICTION,114
GB,IMMUNE SYSTEM DISORDER,114
GB,OCULOGYRIC CRISIS,114
GB,ENERGY INCREASED,113
GB,FUNGAL INFECTION,113
GB,LOOSE TOOTH,113
GB,SCAB,113
GB,VASCULITIC RASH,113
GB,EYELID PTOSIS,112
GB,HYPOMANIA,112
GB,TENSION,112
GB,TOOTH LOSS,112
GB,VIROLOGIC FAILURE,112
GB,BREAST CANCER METASTATIC,111
GB,CORONARY ARTERY DISEASE,111
GB,DEVICE BREAKAGE,111
GB,SENSATION OF FOREIGN BODY,111
GB,VIOLENCE-RELATED SYMPTOM,111
GB,ASTHENOPIA,110
GB,CARDIAC FLUTTER,110
GB,DECREASED ACTIVITY,110
GB,DEVICE DISLOCATION,110
GB,MIGRAINE WITH AURA,110
GB,UNDERDOSE,110
GB,VIRAL UPPER RESPIRATORY TRACT INFECTION,110
GB,FURUNCLE,109
GB,INFECTED SKIN ULCER,109
GB,CLUMSINESS,108
GB,CUSHING^S SYNDROME,108
GB,HYPOPHOSPHATAEMIA,108
GB,LUPUS-LIKE SYNDROME,108
GB,POST PROCEDURAL COMPLICATION,108
GB,PULMONARY HYPERTENSION,108
GB,RESPIRATORY RATE INCREASED,108
GB,SECRETION DISCHARGE,108
GB,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,108
GB,ASPIRATION,107
GB,BLOOD PROLACTIN INCREASED,107
GB,ENCEPHALITIS,107
GB,EYE INFECTION,107
GB,FOOD INTERACTION,107
GB,HYPERTHYROIDISM,107
GB,IMPULSIVE BEHAVIOUR,107
GB,NEPHROPATHY TOXIC,107
GB,BLOOD COUNT ABNORMAL,106
GB,GASTROINTESTINAL TUBE INSERTION,106
GB,GINGIVITIS,106
GB,PLEURISY,106
GB,STARING,106
GB,SUBDURAL HAEMORRHAGE,106
GB,TYPE 1 DIABETES MELLITUS,106
GB,VISUAL FIELD DEFECT,106
GB,ANURIA,105
GB,BILIARY SEPSIS,105
GB,BLOOD GLUCOSE ABNORMAL,105
GB,IMMUNODEFICIENCY,105
GB,LEUKOCYTOSIS,105
GB,LYMPHOPENIA,104
GB,PANIC DISORDER,104
GB,ANHEDONIA,103
GB,B-CELL LYMPHOMA,103
GB,CHANGE OF BOWEL HABIT,103
GB,EMBOLISM,103
GB,EMOTIONAL POVERTY,103
GB,PREGNANCY WITH IMPLANT CONTRACEPTIVE,103
GB,SKIN MASS,103
GB,TONGUE ULCERATION,103
GB,VAGINAL DISCHARGE,103
GB,CREATININE RENAL CLEARANCE DECREASED,102
GB,GAIT INABILITY,102
GB,MUSCLE CONTRACTIONS INVOLUNTARY,102
GB,CONJUNCTIVITIS,101
GB,DEVICE MALFUNCTION,101
GB,EMPHYSEMA,101
GB,FOOT FRACTURE,101
GB,JOINT INJURY,101
GB,LARGE INTESTINE PERFORATION,101
GB,NEUTROPHILIA,101
GB,ORAL DISORDER,101
GB,PEMPHIGOID,101
GB,PERIORBITAL OEDEMA,101
GB,AGORAPHOBIA,100
GB,AORTIC STENOSIS,100
GB,BLADDER DISORDER,100
GB,BLEPHAROSPASM,100
GB,BLOOD PRESSURE FLUCTUATION,100
GB,MOTOR DYSFUNCTION,100
GB,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,99
GB,DEVICE OCCLUSION,99
GB,DIARRHOEA HAEMORRHAGIC,99
GB,HYDRONEPHROSIS,99
GB,MENTAL STATUS CHANGES,99
GB,NON-CARDIAC CHEST PAIN,99
GB,DIVERTICULUM,98
GB,FLUID INTAKE REDUCED,98
GB,HAEMORRHAGIC STROKE,98
GB,LUNG CANCER METASTATIC,98
GB,NON-HODGKIN^S LYMPHOMA,98
GB,OEDEMA MOUTH,98
GB,OESOPHAGEAL CARCINOMA,98
GB,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,98
GB,SPINAL CORD COMPRESSION,98
GB,STRIDOR,98
GB,ARTHRITIS BACTERIAL,97
GB,CUSHINGOID,97
GB,FAECES PALE,97
GB,FEELING JITTERY,97
GB,INCREASED TENDENCY TO BRUISE,97
GB,PALLIATIVE CARE,97
GB,ADRENAL INSUFFICIENCY,96
GB,BODY TEMPERATURE DECREASED,96
GB,DYSPHEMIA,96
GB,ENURESIS,96
GB,HEMIPLEGIA,96
GB,INTENTIONAL PRODUCT USE ISSUE,96
GB,PATHOGEN RESISTANCE,96
GB,PLEURITIC PAIN,96
GB,TOOTH INFECTION,96
GB,BREAST MASS,95
GB,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,95
GB,INJECTION SITE PRURITUS,95
GB,LEFT VENTRICULAR FAILURE,95
GB,NASAL DRYNESS,95
GB,RALES,95
GB,RETINAL DETACHMENT,95
GB,THROMBOTIC MICROANGIOPATHY,95
GB,CARDIO-RESPIRATORY ARREST,94
GB,IMPAIRED DRIVING ABILITY,94
GB,INCORRECT PRODUCT STORAGE,94
GB,INTERVERTEBRAL DISC PROTRUSION,94
GB,RENAL CYST,94
GB,RETINAL HAEMORRHAGE,94
GB,TORSADE DE POINTES,94
GB,VULVOVAGINAL CANDIDIASIS,94
GB,DEMYELINATION,93
GB,GINGIVAL SWELLING,93
US,DRUG INEFFECTIVE,322175
US,FATIGUE,172655
US,NAUSEA,169342
US,DEATH,148710
US,HEADACHE,145404
US,PAIN,129180
US,DIARRHOEA,125741
US,DRUG DOSE OMISSION,118078
US,MALAISE,109461
US,DYSPNOEA,108934
US,DIZZINESS,106900
US,INJECTION SITE PAIN,88429
US,ARTHRALGIA,85096
US,VOMITING,84614
US,RASH,80206
US,PAIN IN EXTREMITY,74895
US,ASTHENIA,72698
US,FALL,65962
US,FEELING ABNORMAL,65524
US,INSOMNIA,63274
US,PRURITUS,62401
US,ANXIETY,61920
US,PRODUCT QUALITY ISSUE,59860
US,DRUG HYPERSENSITIVITY,56788
US,COUGH,56182
US,PRODUCT USE ISSUE,55757
US,BACK PAIN,55402
US,PNEUMONIA,55096
US,WEIGHT DECREASED,53556
US,BLOOD GLUCOSE INCREASED,50221
US,DEPRESSION,49260
US,WEIGHT INCREASED,48544
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,47482
US,PYREXIA,47428
US,MUSCLE SPASMS,47104
US,NASOPHARYNGITIS,47085
US,GAIT DISTURBANCE,46765
US,ALOPECIA,45973
US,MYOCARDIAL INFARCTION,45414
US,CONSTIPATION,44331
US,ABDOMINAL PAIN UPPER,44089
US,INJECTION SITE ERYTHEMA,43556
US,INCORRECT DOSE ADMINISTERED,43468
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,42238
US,DECREASED APPETITE,41762
US,ABDOMINAL PAIN,39935
US,ABDOMINAL DISCOMFORT,39847
US,NO ADVERSE EVENT,39473
US,CONDITION AGGRAVATED,38057
US,SOMNOLENCE,37830
US,CEREBROVASCULAR ACCIDENT,37730
US,HYPERTENSION,37371
US,PERIPHERAL SWELLING,36357
US,MEMORY IMPAIRMENT,36353
US,CHEST PAIN,36270
US,HYPERSENSITIVITY,34655
US,PARAESTHESIA,34150
US,TOXICITY TO VARIOUS AGENTS,34120
US,HYPOAESTHESIA,33850
US,MYALGIA,32594
US,PSORIASIS,32509
US,INJECTION SITE BRUISING,32303
US,URINARY TRACT INFECTION,32269
US,TREMOR,32226
US,CARDIAC FAILURE CONGESTIVE,31321
US,HYPOTENSION,30632
US,GASTROINTESTINAL HAEMORRHAGE,30081
US,INTENTIONAL PRODUCT MISUSE,29998
US,URTICARIA,29826
US,ADVERSE EVENT,28991
US,ANAEMIA,28982
US,VISION BLURRED,28632
US,DRUG EFFECT DECREASED,28372
US,ERYTHEMA,27754
US,SINUSITIS,27612
US,INJURY,27119
US,DEHYDRATION,26663
US,HOSPITALISATION,26526
US,CONFUSIONAL STATE,26446
US,HYPERHIDROSIS,25677
US,INFLUENZA LIKE ILLNESS,25608
US,BLOOD PRESSURE INCREASED,25457
US,OVERDOSE,25386
US,INFLUENZA,25322
US,FLUSHING,25249
US,UNDERDOSE,25028
US,DEVICE EXPULSION,25001
US,DRUG EFFECT INCOMPLETE,24407
US,VISUAL IMPAIRMENT,24267
US,CONTUSION,24176
US,MUSCULAR WEAKNESS,24068
US,UNEVALUABLE EVENT,23563
US,INJECTION SITE PRURITUS,23284
US,JOINT SWELLING,23173
US,INJECTION SITE SWELLING,22977
US,INJECTION SITE HAEMORRHAGE,22419
US,OROPHARYNGEAL PAIN,22370
US,CHILLS,22140
US,INJECTION SITE REACTION,22082
US,ABDOMINAL DISTENSION,22046
US,INFECTION,22015
US,DYSPEPSIA,21986
US,MULTIPLE SCLEROSIS RELAPSE,21312
US,BRONCHITIS,20712
US,PALPITATIONS,20666
US,BALANCE DISORDER,20582
US,GYNAECOMASTIA,20515
US,HAEMORRHAGE,20374
US,CARDIAC DISORDER,20328
US,SEIZURE,20048
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,19857
US,MIGRAINE,19848
US,ADVERSE DRUG REACTION,19710
US,COMPLETED SUICIDE,19463
US,GASTROOESOPHAGEAL REFLUX DISEASE,19455
US,OEDEMA PERIPHERAL,19242
US,PRODUCT USE IN UNAPPROVED INDICATION,19062
US,DYSGEUSIA,18997
US,SWELLING,18617
US,ARTHRITIS,18549
US,MUSCULOSKELETAL STIFFNESS,18394
US,DRUG ADMINISTRATION ERROR,18376
US,DRY MOUTH,18264
US,PULMONARY EMBOLISM,18168
US,THERAPEUTIC RESPONSE UNEXPECTED,18057
US,DEVICE ISSUE,17832
US,WHITE BLOOD CELL COUNT DECREASED,17667
US,EPISTAXIS,17638
US,CHEST DISCOMFORT,17574
US,INCORRECT DRUG ADMINISTRATION DURATION,17499
US,RHEUMATOID ARTHRITIS,17426
US,DYSPHAGIA,17390
US,HEART RATE INCREASED,17356
US,NEUROPATHY PERIPHERAL,17308
US,MUSCULOSKELETAL PAIN,17295
US,MOBILITY DECREASED,16962
US,BURNING SENSATION,16960
US,EMOTIONAL DISTRESS,16875
US,LOSS OF CONSCIOUSNESS,16869
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,16678
US,DEEP VEIN THROMBOSIS,16466
US,HOT FLUSH,16310
US,DRUG INTOLERANCE,15960
US,DISEASE PROGRESSION,15941
US,DRUG WITHDRAWAL SYNDROME,15758
US,STRESS,15589
US,IRRITABILITY,15536
US,RHINORRHOEA,15500
US,THROMBOSIS,15448
US,ATRIAL FIBRILLATION,15408
US,RENAL FAILURE,14881
US,SUICIDAL IDEATION,14803
US,DRY SKIN,14635
US,HAEMOGLOBIN DECREASED,14624
US,DEVICE DISLOCATION,14610
US,FLUID RETENTION,14593
US,THERAPEUTIC RESPONSE DECREASED,14319
US,NASAL CONGESTION,14222
US,ACUTE KIDNEY INJURY,14054
US,PLATELET COUNT DECREASED,14035
US,SEPSIS,13991
US,ASTHMA,13925
US,NERVOUSNESS,13734
US,SYNCOPE,13705
US,BONE PAIN,13533
US,DRUG ABUSE,13473
US,DEVICE USE ERROR,13446
US,VAGINAL HAEMORRHAGE,13444
US,DYSPHONIA,13098
US,ACCIDENTAL EXPOSURE TO PRODUCT,13043
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,13043
US,TYPE 2 DIABETES MELLITUS,13037
US,BLOOD GLUCOSE DECREASED,12967
US,AMNESIA,12899
US,EYE IRRITATION,12748
US,GASTROINTESTINAL DISORDER,12737
US,AGITATION,12679
US,EXPIRED PRODUCT ADMINISTERED,12666
US,NECK PAIN,12597
US,FLATULENCE,12471
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,12416
US,INCORRECT PRODUCT STORAGE,12324
US,FEELING HOT,12312
US,UPPER RESPIRATORY TRACT INFECTION,12215
US,DIABETES MELLITUS,12024
US,LETHARGY,11970
US,HERPES ZOSTER,11896
US,DEVICE MALFUNCTION,11824
US,CROHN^S DISEASE,11670
US,APPLICATION SITE ERYTHEMA,11636
US,MULTIPLE SCLEROSIS,11591
US,RASH PRURITIC,11512
US,MALIGNANT NEOPLASM PROGRESSION,11487
US,SWELLING FACE,11471
US,CARDIAC ARREST,11165
US,SLEEP DISORDER,11126
US,VERTIGO,11108
US,MENSTRUATION IRREGULAR,10893
US,ARTHROPATHY,10865
US,EMOTIONAL DISORDER,10865
US,GASTRIC DISORDER,10821
US,CATARACT,10624
US,PRODUCT ADHESION ISSUE,10563
US,THROAT IRRITATION,10529
US,DISCOMFORT,10515
US,EYE PAIN,10511
US,HALLUCINATION,10388
US,MEDICATION ERROR,10355
US,EXPOSURE DURING PREGNANCY,10297
US,STOMATITIS,10287
US,LOCAL SWELLING,10254
US,DRUG PRESCRIBING ERROR,10244
US,INJECTION SITE MASS,10237
US,DISTURBANCE IN ATTENTION,10213
US,SURGERY,10178
US,HEPATIC ENZYME INCREASED,10162
US,INTENTIONAL PRODUCT USE ISSUE,10117
US,BLISTER,10072
US,DEPRESSED MOOD,10072
US,FOETAL EXPOSURE DURING PREGNANCY,10035
US,NEUTROPENIA,9945
US,OEDEMA,9939
US,GENERAL PHYSICAL HEALTH DETERIORATION,9925
US,CELLULITIS,9897
US,TREATMENT NONCOMPLIANCE,9869
US,POLLAKIURIA,9707
US,COGNITIVE DISORDER,9668
US,SKIN EXFOLIATION,9660
US,SKIN DISCOLOURATION,9649
US,RECTAL HAEMORRHAGE,9555
US,BLOOD CHOLESTEROL INCREASED,9440
US,CORONARY ARTERY DISEASE,9368
US,PANCREATITIS,9367
US,OCULAR HYPERAEMIA,9276
US,EXTRA DOSE ADMINISTERED,9275
US,INJECTION SITE RASH,9234
US,RESPIRATORY FAILURE,9188
US,BLOOD PRESSURE DECREASED,9096
US,ABASIA,9046
US,SPEECH DISORDER,9039
US,CRYING,8960
US,THERAPY CESSATION,8897
US,VISUAL ACUITY REDUCED,8867
US,THROMBOCYTOPENIA,8816
US,APPLICATION SITE PRURITUS,8813
US,ABNORMAL WEIGHT GAIN,8762
US,ROAD TRAFFIC ACCIDENT,8728
US,APPLICATION SITE PAIN,8665
US,TINNITUS,8636
US,OSTEOARTHRITIS,8615
US,NEOPLASM MALIGNANT,8472
US,PLASMA CELL MYELOMA,8394
US,HYPOACUSIS,8382
US,WHEEZING,8382
US,MENORRHAGIA,8284
US,DRY EYE,8271
US,MOOD SWINGS,8243
US,RASH GENERALISED,8152
US,INJECTION SITE WARMTH,8065
US,NEPHROLITHIASIS,8054
US,DEVICE DIFFICULT TO USE,8047
US,PLEURAL EFFUSION,8021
US,ACNE,8005
US,FUNGAL INFECTION,7957
US,PRODUCTIVE COUGH,7950
US,PRODUCT SUBSTITUTION ISSUE,7925
US,TACHYCARDIA,7873
US,FLUID OVERLOAD,7835
US,FEMUR FRACTURE,7791
US,PROCEDURAL PAIN,7773
US,RENAL DISORDER,7742
US,HAEMATOCHEZIA,7740
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,7680
US,ANGER,7641
US,EYE SWELLING,7616
US,DRUG DISPENSING ERROR,7574
US,CONVULSION,7566
US,PRURITUS GENERALISED,7488
US,STAPHYLOCOCCAL INFECTION,7414
US,ABNORMAL BEHAVIOUR,7390
US,LIMB DISCOMFORT,7330
US,DEVICE BREAKAGE,7308
US,INJECTION SITE URTICARIA,7301
US,DYSURIA,7295
US,CYSTITIS,7279
US,MATERNAL EXPOSURE DURING PREGNANCY,7277
US,PAIN IN JAW,7255
US,NIGHTMARE,7249
US,ACTIVITIES OF DAILY LIVING IMPAIRED,7210
US,LABORATORY TEST ABNORMAL,7184
US,APPLICATION SITE RASH,7105
US,CARDIO-RESPIRATORY ARREST,7099
US,PANIC ATTACK,7053
US,CARDIAC FAILURE,7026
US,OSTEOPOROSIS,7001
US,BLADDER CANCER,6922
US,ABNORMAL DREAMS,6840
US,BLOOD CREATININE INCREASED,6831
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,6818
US,NIGHT SWEATS,6818
US,WITHDRAWAL SYNDROME,6767
US,AGGRESSION,6738
US,RASH ERYTHEMATOUS,6721
US,PRODUCT PHYSICAL ISSUE,6653
US,HIP FRACTURE,6625
US,LUNG DISORDER,6607
US,ABDOMINAL PAIN LOWER,6601
US,HYPERSOMNIA,6594
US,BLINDNESS,6587
US,EYE DISORDER,6525
US,JOINT STIFFNESS,6515
US,VIRAL INFECTION,6486
US,PULMONARY OEDEMA,6471
US,TRANSIENT ISCHAEMIC ATTACK,6459
US,ACCIDENTAL OVERDOSE,6431
US,RENAL IMPAIRMENT,6392
US,LACRIMATION INCREASED,6229
US,LIP SWELLING,6210
US,DYSSTASIA,6207
US,HAEMATURIA,6188
US,PELVIC PAIN,6188
US,MENTAL DISORDER,6180
US,SKIN DISORDER,6173
US,DRUG DEPENDENCE,6146
US,TOOTH DISORDER,6133
US,IMPAIRED HEALING,6119
US,OXYGEN SATURATION DECREASED,6117
US,FEAR,6116
US,COLITIS ULCERATIVE,6101
US,EYE PRURITUS,6094
US,INTENTIONAL DRUG MISUSE,6048
US,BREAST CANCER,6036
US,BLOOD POTASSIUM DECREASED,6006
US,HEAD INJURY,5952
US,MOOD ALTERED,5908
US,DYSPNOEA EXERTIONAL,5897
US,TREATMENT FAILURE,5828
US,FEELING COLD,5763
US,INFUSION RELATED REACTION,5750
US,MUSCULOSKELETAL DISORDER,5728
US,INFLAMMATION,5699
US,MOVEMENT DISORDER,5685
US,EAR INFECTION,5672
US,METRORRHAGIA,5671
US,ILL-DEFINED DISORDER,5667
US,SINUS DISORDER,5659
US,RESTLESSNESS,5646
US,PSORIATIC ARTHROPATHY,5640
US,CARDIOVASCULAR DISORDER,5637
US,ANAPHYLACTIC REACTION,5636
US,FEELING JITTERY,5609
US,ACUTE MYOCARDIAL INFARCTION,5603
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,5577
US,DISORIENTATION,5562
US,LOCALISED INFECTION,5560
US,DYSKINESIA,5552
US,WHITE BLOOD CELL COUNT INCREASED,5538
US,RASH MACULAR,5524
US,LYMPHADENOPATHY,5523
US,FIBROMYALGIA,5516
US,PERITONITIS,5505
US,DIVERTICULITIS,5488
US,MENTAL STATUS CHANGES,5487
US,URINARY INCONTINENCE,5483
US,INTESTINAL OBSTRUCTION,5431
US,SWOLLEN TONGUE,5431
US,INTERVERTEBRAL DISC PROTRUSION,5325
US,CEREBRAL HAEMORRHAGE,5258
US,CLOSTRIDIUM DIFFICILE INFECTION,5252
US,SNEEZING,5218
US,HAEMOPTYSIS,5207
US,ORAL PAIN,5192
US,LIMB INJURY,5189
US,COLITIS,5186
US,DYSARTHRIA,5158
US,INTENTIONAL OVERDOSE,5141
US,LACERATION,5128
US,PRESCRIBED OVERDOSE,5097
US,CHOLELITHIASIS,5093
US,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,5077
US,HYPOGLYCAEMIA,5074
US,APPLICATION SITE IRRITATION,5042
US,RETCHING,5009
US,RED BLOOD CELL COUNT DECREASED,5000
US,SUICIDE ATTEMPT,4982
US,NERVOUS SYSTEM DISORDER,4972
US,RESPIRATORY TRACT CONGESTION,4949
US,GASTROENTERITIS VIRAL,4936
US,JOINT INJURY,4918
US,HEART RATE DECREASED,4899
US,BACK DISORDER,4862
US,FULL BLOOD COUNT DECREASED,4847
US,PERITONEAL DIALYSIS COMPLICATION,4842
US,FOOT FRACTURE,4838
US,MENTAL IMPAIRMENT,4836
US,INJURY ASSOCIATED WITH DEVICE,4834
US,NEURALGIA,4818
US,BLOOD GLUCOSE ABNORMAL,4811
US,CHROMATURIA,4792
US,UTERINE PERFORATION,4783
US,BLOOD URINE PRESENT,4776
US,CHRONIC KIDNEY DISEASE,4757
US,SKIN BURNING SENSATION,4756
US,HAEMORRHOIDS,4745
US,SKIN IRRITATION,4736
US,PHARYNGEAL OEDEMA,4731
US,THROAT TIGHTNESS,4728
US,UPPER LIMB FRACTURE,4728
US,POOR QUALITY SLEEP,4721
US,INTERNAL HAEMORRHAGE,4710
US,LUNG NEOPLASM MALIGNANT,4658
US,IRRITABLE BOWEL SYNDROME,4649
US,ERECTILE DYSFUNCTION,4624
US,CENTRAL NERVOUS SYSTEM LESION,4583
US,FEBRILE NEUTROPENIA,4582
US,ARRHYTHMIA,4577
US,GENITAL HAEMORRHAGE,4561
US,RESPIRATORY DISORDER,4559
US,APHASIA,4542
US,URINARY RETENTION,4535
US,LIVER DISORDER,4520
US,SLEEP APNOEA SYNDROME,4512
US,PRODUCT STORAGE ERROR,4491
US,MUSCLE TWITCHING,4464
US,ALANINE AMINOTRANSFERASE INCREASED,4463
US,BONE DISORDER,4450
US,LIVER FUNCTION TEST ABNORMAL,4443
US,INADEQUATE ANALGESIA,4441
US,BODY HEIGHT DECREASED,4411
US,SKIN ULCER,4390
US,ADVERSE REACTION,4384
US,FREQUENT BOWEL MOVEMENTS,4382
US,HYPOXIA,4356
US,INJECTION SITE DISCOLOURATION,4355
US,MUSCULOSKELETAL DISCOMFORT,4351
US,FAECES DISCOLOURED,4342
US,PULMONARY ARTERIAL HYPERTENSION,4332
US,ABORTION SPONTANEOUS,4323
US,RIB FRACTURE,4293
US,PANCYTOPENIA,4292
US,RASH PAPULAR,4275
US,GENERAL SYMPTOM,4272
US,PULMONARY HYPERTENSION,4257
US,IMPAIRED WORK ABILITY,4252
US,SENSORY DISTURBANCE,4249
US,TOOTHACHE,4247
US,BRADYCARDIA,4245
US,BLOOD COUNT ABNORMAL,4239
US,HYPOKALAEMIA,4231
US,INJECTION SITE EXTRAVASATION,4219
US,DIABETIC KETOACIDOSIS,4208
US,INJECTION SITE INDURATION,4195
US,NEOPLASM PROGRESSION,4192
US,DEVICE RELATED INFECTION,4182
US,SKIN LESION,4180
US,HERNIA,4176
US,HYPOPHAGIA,4169
US,HYPOTHYROIDISM,4157
US,MENSTRUATION DELAYED,4151
US,THERAPY NON-RESPONDER,4148
US,HEART RATE IRREGULAR,4134
US,EAR PAIN,4127
US,DIPLOPIA,4125
US,HYPERGLYCAEMIA,4106
US,UPPER GASTROINTESTINAL HAEMORRHAGE,4088
US,KNEE ARTHROPLASTY,4066
US,SINUS CONGESTION,4066
US,ANHEDONIA,4058
US,RESPIRATORY ARREST,4058
US,DEMENTIA,4055
US,ASPARTATE AMINOTRANSFERASE INCREASED,4039
US,PRESYNCOPE,4037
US,PERITONITIS BACTERIAL,4031
US,MUSCLE TIGHTNESS,4018
US,PRESCRIBED UNDERDOSE,4013
US,AGEUSIA,4008
US,POOR QUALITY DRUG ADMINISTERED,4007
US,GALLBLADDER DISORDER,3995
US,PRODUCT TASTE ABNORMAL,3972
US,ORAL HERPES,3966
US,DEAFNESS,3958
US,DEVICE LEAKAGE,3949
US,DYSMENORRHOEA,3940
US,EATING DISORDER,3926
US,HYPONATRAEMIA,3891
US,AMENORRHOEA,3886
US,INJECTION SITE NODULE,3861
US,GOUT,3854
US,BLOOD TESTOSTERONE DECREASED,3852
US,THINKING ABNORMAL,3847
US,HAIR TEXTURE ABNORMAL,3840
US,MEDICATION RESIDUE PRESENT,3840
US,LUNG INFECTION,3839
US,GASTRITIS,3837
US,RESTLESS LEGS SYNDROME,3831
US,HAEMATOMA,3807
US,KIDNEY INFECTION,3800
US,ANGIOEDEMA,3785
US,INCREASED APPETITE,3778
US,INTERNATIONAL NORMALISED RATIO INCREASED,3769
US,PRODUCT PREPARATION ERROR,3746
US,BLOOD PRESSURE ABNORMAL,3731
US,OBESITY,3726
US,PREMATURE BABY,3722
US,WOUND,3719
US,NO THERAPEUTIC RESPONSE,3715
US,HEAD DISCOMFORT,3699
US,LOWER LIMB FRACTURE,3691
US,ANGINA PECTORIS,3690
US,CHOKING,3684
US,DEVICE FAILURE,3684
US,ERUCTATION,3679
US,UNRESPONSIVE TO STIMULI,3647
US,NEEDLE ISSUE,3618
US,RESPIRATORY TRACT INFECTION,3610
US,SYSTEMIC LUPUS ERYTHEMATOSUS,3603
US,RENAL FAILURE ACUTE,3585
US,ROTATOR CUFF SYNDROME,3579
US,MEDICAL DEVICE COMPLICATION,3564
US,ANKLE FRACTURE,3537
US,AFFECT LABILITY,3531
US,PRE-EXISTING CONDITION IMPROVED,3530
US,TARDIVE DYSKINESIA,3519
US,SEDATION,3492
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,3485
US,WRONG DRUG ADMINISTERED,3481
US,PSYCHOTIC DISORDER,3461
US,HAEMORRHAGE INTRACRANIAL,3438
US,SCAR,3434
US,GLAUCOMA,3429
US,BLOOD PRESSURE FLUCTUATION,3412
US,GALACTORRHOEA,3412
US,MUSCULOSKELETAL CHEST PAIN,3389
US,COMA,3371
US,SPINAL FRACTURE,3365
US,ORAL DISCOMFORT,3364
US,COAGULOPATHY,3353
US,GLOSSODYNIA,3351
US,DRUG EFFECT DELAYED,3343
US,HYPERPROLACTINAEMIA,3339
US,SEPTIC SHOCK,3311
US,PANCREATIC CARCINOMA,3294
US,PREGNANCY,3273
US,PSYCHOMOTOR HYPERACTIVITY,3271
US,CANDIDA INFECTION,3245
US,INFLAMMATORY BOWEL DISEASE,3242
US,BLOOD TRIGLYCERIDES INCREASED,3240
US,NEUTROPHIL COUNT DECREASED,3235
US,HIATUS HERNIA,3229
US,THIRST,3220
US,PERICARDIAL EFFUSION,3211
US,MASS,3200
US,LEUKOPENIA,3125
US,THYROID DISORDER,3115
US,MIDDLE INSOMNIA,3108
US,COLD SWEAT,3107
US,PHARYNGITIS STREPTOCOCCAL,3093
US,OSTEOMYELITIS,3091
US,VAGINAL DISCHARGE,3075
US,CARPAL TUNNEL SYNDROME,3069
US,LIBIDO DECREASED,3061
US,COMPLICATION ASSOCIATED WITH DEVICE,3044
US,HAIR COLOUR CHANGES,3035
US,HYPOAESTHESIA ORAL,3031
US,PHOTOPHOBIA,3024
US,INTERVERTEBRAL DISC DEGENERATION,3019
US,FEEDING DISORDER,3010
US,APHONIA,3004
US,WRONG TECHNIQUE IN DEVICE USAGE PROCESS,3003
US,NODULE,2994
US,NICOTINE DEPENDENCE,2966
US,DERMATITIS CONTACT,2957
US,RESPIRATORY DISTRESS,2955
US,HAEMATEMESIS,2939
US,OSTEONECROSIS OF JAW,2931
US,TOOTH INFECTION,2920
US,ULCER,2913
US,PULMONARY MASS,2905
US,APPLICATION SITE VESICLES,2902
US,CHOLECYSTECTOMY,2901
US,SUNBURN,2900
US,TRANSFUSION,2899
US,SCIATICA,2897
US,HEARING IMPAIRED,2895
US,INCREASED TENDENCY TO BRUISE,2881
US,PAIN OF SKIN,2881
US,DISABILITY,2879
US,EMBEDDED DEVICE,2879
US,CORONARY ARTERY OCCLUSION,2858
US,COMPLICATION OF DEVICE INSERTION,2854
US,COORDINATION ABNORMAL,2852
US,LARYNGITIS,2852
US,ASCITES,2834
US,SEASONAL ALLERGY,2833
US,BLOOD POTASSIUM INCREASED,2821
US,HAEMORRHAGIC ANAEMIA,2816
US,MUSCLE SPASTICITY,2816
US,LIVER FUNCTION TEST INCREASED,2814
US,HEPATITIS C,2809
US,OSTEOPENIA,2800
US,ECZEMA,2795
US,HYPERLIPIDAEMIA,2782
US,PARANOIA,2773
US,WRIST FRACTURE,2769
US,COELIAC DISEASE,2763
US,VITAMIN D DEFICIENCY,2755
US,BONE DENSITY DECREASED,2751
US,SEXUAL DYSFUNCTION,2751
US,INJECTION SITE DISCOMFORT,2749
US,AORTIC ANEURYSM,2746
US,GASTRIC ULCER,2745
US,ACUTE RESPIRATORY FAILURE,2740
US,DENTAL CARIES,2737
US,TOOTH FRACTURE,2736
US,ELECTROCARDIOGRAM QT PROLONGED,2731
US,APPLICATION SITE REACTION,2728
US,DEVICE DEPLOYMENT ISSUE,2706
US,HEPATIC FAILURE,2695
US,INTENTIONAL UNDERDOSE,2689
US,PALLOR,2677
US,MALABSORPTION,2675
US,PRODUCT PACKAGING ISSUE,2667
US,MALIGNANT MELANOMA,2661
US,VITAMIN D DECREASED,2651
US,BLOOD BILIRUBIN INCREASED,2635
US,LIGAMENT SPRAIN,2635
US,PRODUCT ODOUR ABNORMAL,2625
US,HIP ARTHROPLASTY,2624
US,HUNGER,2621
US,INFUSION SITE PAIN,2614
US,NERVE INJURY,2611
US,BLOOD CALCIUM INCREASED,2610
US,TENDONITIS,2593
US,HAEMATOCRIT DECREASED,2590
US,HEMIPARESIS,2576
US,PREGNANCY WITH CONTRACEPTIVE DEVICE,2576
US,PROSTATE CANCER,2576
US,PHOTOSENSITIVITY REACTION,2572
US,APATHY,2558
US,LOWER GASTROINTESTINAL HAEMORRHAGE,2545
US,MADAROSIS,2543
US,SKIN CANCER,2525
US,BACTERIAL INFECTION,2522
US,PREMATURE DELIVERY,2522
US,IMMUNE SYSTEM DISORDER,2521
US,SLUGGISHNESS,2518
US,HYPERKALAEMIA,2517
US,MANIA,2505
US,CYST,2499
US,CORONARY ARTERIAL STENT INSERTION,2494
US,DYSPHORIA,2492
US,PNEUMONITIS,2484
US,SMALL INTESTINAL OBSTRUCTION,2471
US,BLOOD GLUCOSE FLUCTUATION,2466
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2458
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2454
US,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,2451
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,2451
US,MICTURITION URGENCY,2443
US,EYELID OEDEMA,2440
US,RHABDOMYOLYSIS,2439
US,BLOOD SODIUM DECREASED,2436
US,INTRAOCULAR PRESSURE INCREASED,2432
US,TENDERNESS,2431
US,TOOTH EXTRACTION,2430
US,IMPAIRED DRIVING ABILITY,2425
US,MOUTH ULCERATION,2425
US,BLINDNESS UNILATERAL,2423
US,SUBDURAL HAEMATOMA,2421
US,BACK INJURY,2418
US,HYPOKINESIA,2413
US,SPINAL OSTEOARTHRITIS,2411
US,BREAST PAIN,2408
US,LOW TURNOVER OSTEOPATHY,2408
US,PARAESTHESIA ORAL,2401
US,JOINT RANGE OF MOTION DECREASED,2394
US,BEDRIDDEN,2392
US,UPPER-AIRWAY COUGH SYNDROME,2380
US,MACULAR DEGENERATION,2376
US,DRY THROAT,2375
US,EXTRAPYRAMIDAL DISORDER,2375
US,NOCTURIA,2374
US,DELIRIUM,2363
US,BODY TEMPERATURE INCREASED,2356
US,LOWER RESPIRATORY TRACT INFECTION,2353
US,EUPHORIC MOOD,2349
US,EYE HAEMORRHAGE,2349
US,METABOLIC ACIDOSIS,2346
US,BIPOLAR DISORDER,2344
US,WRONG PATIENT RECEIVED MEDICATION,2341
US,EXOSTOSIS,2339
US,FOREIGN BODY,2339
US,POST PROCEDURAL COMPLICATION,2336
US,ANORECTAL DISCOMFORT,2331
US,PERIPHERAL COLDNESS,2330
US,BLADDER DISORDER,2319
US,EAR DISCOMFORT,2314
US,HEPATIC CIRRHOSIS,2314
US,STENT PLACEMENT,2313
US,BREAST TENDERNESS,2308
US,GENERALISED TONIC-CLONIC SEIZURE,2307
US,POST PROCEDURAL HAEMORRHAGE,2306
US,GINGIVAL BLEEDING,2304
US,APPLICATION SITE DISCOLOURATION,2300
US,DISEASE RECURRENCE,2298
US,SKIN FISSURES,2287
US,CORONARY ARTERY BYPASS,2277
US,CARDIOMYOPATHY,2269
US,EYE DISCHARGE,2263
US,FOOT DEFORMITY,2261
US,TOOTH ABSCESS,2251
US,UNINTENDED PREGNANCY,2251
US,PRODUCT CONTAINER ISSUE,2246
US,BURSITIS,2245
US,ULCER HAEMORRHAGE,2242
US,DERMATITIS,2235
US,SECRETION DISCHARGE,2226
US,BLOOD TEST ABNORMAL,2222
US,NASAL DISCOMFORT,2222
US,LYMPHOCYTE COUNT DECREASED,2215
US,NERVE COMPRESSION,2213
US,ENCEPHALOPATHY,2202
US,HYSTERECTOMY,2199
US,MUSCLE STRAIN,2195
US,PNEUMONIA ASPIRATION,2195
US,TEMPERATURE INTOLERANCE,2191
US,SCAB,2188
US,SKIN REACTION,2185
US,HAIR GROWTH ABNORMAL,2174
US,SPINAL COLUMN STENOSIS,2170
US,BLOOD ALKALINE PHOSPHATASE INCREASED,2165
US,DRUG SCREEN POSITIVE,2161
US,PNEUMOTHORAX,2161
US,BASAL CELL CARCINOMA,2150
US,LARGE INTESTINE POLYP,2121
US,OVARIAN CYST,2120
US,JAUNDICE,2119
US,EYE INFECTION,2117
US,DIABETES MELLITUS INADEQUATE CONTROL,2115
US,SKIN HAEMORRHAGE,2115
US,ABSCESS,2111
US,APPLICATION SITE BURN,2105
US,HALLUCINATION_ AUDITORY,2102
US,EXPIRED DRUG ADMINISTERED,2095
US,SPINAL PAIN,2090
US,AKATHISIA,2088
US,MENSTRUAL DISORDER,2084
US,DEPRESSED LEVEL OF CONSCIOUSNESS,2073
US,DIALYSIS,2072
US,DIVERTICULUM,2060
US,PARKINSON^S DISEASE,2059
US,PULMONARY CONGESTION,2044
US,TENDON RUPTURE,2039
US,SINUS HEADACHE,2032
US,MUCOSAL INFLAMMATION,2028
US,HAEMORRHAGIC STROKE,2021
US,PULMONARY THROMBOSIS,2018
US,FOREIGN BODY SENSATION IN EYES,2012
US,PRODUCT CLEANING INADEQUATE,2012
US,HEPATIC STEATOSIS,2004
US,FRUSTRATION,1993
US,PULMONARY FIBROSIS,1989
US,QUALITY OF LIFE DECREASED,1987
US,LEUKOCYTOSIS,1981
US,MENISCUS INJURY,1981
US,BLOOD CALCIUM DECREASED,1980
US,INCONTINENCE,1978
US,DRUG RESISTANCE,1977
US,EYELID PTOSIS,1968
US,FRACTURE,1968
US,VITREOUS FLOATERS,1963
US,LYMPHOMA,1962
US,WEIGHT FLUCTUATION,1957
US,BLOOD IRON DECREASED,1956
US,HAIR DISORDER,1950
US,ABNORMAL LOSS OF WEIGHT,1945
US,HYPERAESTHESIA,1937
US,SEROTONIN SYNDROME,1937
US,APPLICATION SITE SWELLING,1935
US,MULTIPLE FRACTURES,1934
US,DRUG EFFECT INCREASED,1929
US,ARTHROPOD BITE,1927
US,FACIAL PAIN,1927
US,INTRAMEDULLARY ROD INSERTION,1919
US,SPINAL DISORDER,1919
US,ISCHAEMIC STROKE,1913
US,PARALYSIS,1909
US,FEELING DRUNK,1908
US,JOINT DISLOCATION,1906
US,EXPOSURE DURING BREAST FEEDING,1902
US,BRAIN INJURY,1890
US,PANCREATITIS ACUTE,1890
US,GROIN PAIN,1886
US,FURUNCLE,1884
US,ACCIDENT,1883
US,CONJUNCTIVITIS,1876
US,MUSCLE ATROPHY,1875
US,CARDIAC MURMUR,1867
US,CARDIOMEGALY,1865
US,ORAL CANDIDIASIS,1863
US,TOOTH LOSS,1863
US,VENTRICULAR TACHYCARDIA,1863
US,CLOSTRIDIUM DIFFICILE COLITIS,1860
US,SCRATCH,1855
US,PSYCHOLOGICAL TRAUMA,1852
US,GASTROINTESTINAL PAIN,1847
US,MYELODYSPLASTIC SYNDROME,1847
US,SYRINGE ISSUE,1845
US,GAIT INABILITY,1843
US,CONCUSSION,1841
US,MYOCARDIAL ISCHAEMIA,1839
US,AORTIC DISSECTION,1832
US,SPINAL OPERATION,1828
US,INITIAL INSOMNIA,1826
US,MULTIPLE ALLERGIES,1818
US,CARDIAC OPERATION,1817
US,HYPOCALCAEMIA,1817
US,OPTIC NEURITIS,1817
US,FLANK PAIN,1809
US,GINGIVAL PAIN,1808
US,GASTRIC HAEMORRHAGE,1796
US,COLON CANCER,1786
US,KNEE OPERATION,1781
US,IMPAIRED GASTRIC EMPTYING,1780
US,DELUSION,1779
US,IMPAIRED QUALITY OF LIFE,1777
US,DYSGRAPHIA,1775
US,TRANSAMINASES INCREASED,1768
US,DECREASED INTEREST,1765
US,DRUG-INDUCED LIVER INJURY,1761
US,WALKING AID USER,1752
US,MUSCLE DISORDER,1750
US,SKIN INFECTION,1748
US,ERECTION INCREASED,1747
US,BONE MARROW FAILURE,1746
US,NASAL DRYNESS,1746
US,SKIN PLAQUE,1745
US,CHOLECYSTITIS CHRONIC,1744
US,LIP DRY,1744
US,EMPHYSEMA,1738
US,ENERGY INCREASED,1735
US,INTERCEPTED MEDICATION ERROR,1729
US,RENAL PAIN,1728
US,ORTHOSTATIC HYPOTENSION,1715
US,METASTASES TO LIVER,1714
US,INJECTION SITE PAPULE,1713
US,RENAL CANCER,1709
US,PHARYNGITIS,1688
US,APHAGIA,1687
US,ORAL MUCOSAL BLISTERING,1681
US,SCOLIOSIS,1681
US,IMPLANT SITE PAIN,1679
US,STEVENS-JOHNSON SYNDROME,1670
US,SUBSTANCE ABUSE,1670
US,PRODUCT SIZE ISSUE,1656
US,HALLUCINATION_ VISUAL,1655
US,APPLICATION SITE EXFOLIATION,1649
US,ATELECTASIS,1647
US,FEAR OF INJECTION,1644
US,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1638
US,HEREDITARY ANGIOEDEMA,1636
US,RIGHT VENTRICULAR FAILURE,1634
US,CATARACT OPERATION,1623
US,NEOPLASM,1620
US,DECREASED ACTIVITY,1617
US,DECUBITUS ULCER,1614
US,PERONEAL NERVE PALSY,1611
US,INJECTION SITE VESICLES,1607
US,METASTASES TO BONE,1603
US,OCULAR DISCOMFORT,1601
US,DEFORMITY,1600
US,LACTIC ACIDOSIS,1600
US,IRON DEFICIENCY ANAEMIA,1596
US,DIZZINESS POSTURAL,1594
US,ATRIAL SEPTAL DEFECT,1592
US,PRODUCT PACKAGING QUANTITY ISSUE,1586
US,BLOOD MAGNESIUM DECREASED,1585
US,ONYCHOCLASIS,1585
US,ECONOMIC PROBLEM,1583
US,ASTHENOPIA,1578
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,1575
US,MEDICAL DEVICE DISCOMFORT,1574
US,BOWEL MOVEMENT IRREGULARITY,1571
US,MOTOR DYSFUNCTION,1567
US,SPINAL COMPRESSION FRACTURE,1556
US,VULVOVAGINAL BURNING SENSATION,1547
US,ARTERIOSCLEROSIS,1544
US,DYSTONIA,1544
US,HYPERCALCAEMIA,1537
US,PERSONALITY CHANGE,1537
US,INFUSION SITE ERYTHEMA,1536
US,FEELING OF BODY TEMPERATURE CHANGE,1530
US,LIVER INJURY,1530
US,BACTERAEMIA,1525
US,NAIL DISORDER,1525
US,URINE ODOUR ABNORMAL,1520
US,PARANASAL SINUS HYPERSECRETION,1519
US,PRODUCT LABEL ISSUE,1519
US,TENSION,1518
US,WOUND INFECTION,1518
US,INJECTION SITE IRRITATION,1513
US,STRESS FRACTURE,1512
US,DEVICE KINK,1505
US,SOCIAL PROBLEM,1504
US,FORMICATION,1501
US,HAND FRACTURE,1494
US,ABNORMAL FAECES,1493
US,PRODUCT FORMULATION ISSUE,1485
US,FRUSTRATION TOLERANCE DECREASED,1481
US,MYDRIASIS,1477
US,SQUAMOUS CELL CARCINOMA,1471
US,DYSPAREUNIA,1467
US,SPLENOMEGALY,1467
US,INTERSTITIAL LUNG DISEASE,1466
US,MELAENA,1466
US,GASTROINTESTINAL INFECTION,1465
US,ORAL DISORDER,1463
US,TENDON INJURY,1458
US,UTERINE LEIOMYOMA,1454
US,POOR VENOUS ACCESS,1451
US,CHOLECYSTITIS,1450
US,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1449
US,PLATELET COUNT INCREASED,1447
US,SOMNAMBULISM,1442
US,DRUG WITHDRAWAL SYNDROME NEONATAL,1441
US,MALNUTRITION,1441
US,SKIN MASS,1438
US,SUPRAVENTRICULAR TACHYCARDIA,1438
US,CARDIAC PACEMAKER INSERTION,1431
US,THERAPY CHANGE,1431
US,APPETITE DISORDER,1430
US,HICCUPS,1430
US,ACUTE MYELOID LEUKAEMIA,1429
US,SHOCK,1428
US,GASTROENTERITIS,1426
US,ATAXIA,1422
US,PROCEDURAL COMPLICATION,1418
US,EJECTION FRACTION DECREASED,1416
US,ANOSMIA,1414
US,DEMENTIA ALZHEIMER^S TYPE,1407
US,TONGUE DISORDER,1407
US,ACUTE HEPATIC FAILURE,1406
US,BLOOD DISORDER,1405
US,PELVIC FRACTURE,1402
US,HYPERCHOLESTEROLAEMIA,1398
US,INCREASED UPPER AIRWAY SECRETION,1397
US,OESOPHAGITIS,1397
US,ARTERIAL OCCLUSIVE DISEASE,1395
US,ANGINA UNSTABLE,1394
US,HOSPICE CARE,1393
US,INTESTINAL PERFORATION,1392
US,BRAIN NEOPLASM,1391
US,PROTEINURIA,1391
US,PANIC REACTION,1387
US,INCORRECT DOSAGE ADMINISTERED,1386
US,CONGENITAL ANOMALY,1385
US,BLOOD UREA INCREASED,1384
US,ASPIRATION,1379
US,CARDIAC FLUTTER,1379
US,JOINT EFFUSION,1379
US,GRANULOCYTOPENIA,1375
US,MULTI-ORGAN FAILURE,1363
US,PAROSMIA,1357
US,HAEMORRHOIDAL HAEMORRHAGE,1356
US,SENSORY LOSS,1355
US,COMPLICATION OF DEVICE REMOVAL,1351
US,GRIP STRENGTH DECREASED,1350
US,ACUTE RESPIRATORY DISTRESS SYNDROME,1343
US,DEVICE OCCLUSION,1341
US,VULVOVAGINAL PRURITUS,1341
US,OBSESSIVE-COMPULSIVE DISORDER,1340
US,FAILURE TO THRIVE,1339
US,HYPERTHYROIDISM,1339
US,RENAL CYST,1333
US,SENSATION OF FOREIGN BODY,1333
US,ATRIAL FLUTTER,1332
US,POST PROCEDURAL INFECTION,1331
US,DERMATITIS ALLERGIC,1329
US,IMMUNODEFICIENCY,1328
US,POLYP,1328
US,RENAL FAILURE CHRONIC,1322
US,MULTIPLE INJURIES,1321
US,PROCTALGIA,1311
US,ANAPHYLACTIC SHOCK,1309
US,CATHETERISATION CARDIAC,1307
US,INVESTIGATION,1307
US,PHOTOPSIA,1307
US,THERAPEUTIC RESPONSE CHANGED,1306
US,RASH PUSTULAR,1297
US,FAECAL INCONTINENCE,1295
US,THERMAL BURN,1294
US,LOSS OF CONTROL OF LEGS,1291
US,OSTEONECROSIS,1280
US,SPUTUM DISCOLOURED,1271
US,INCORRECT DOSE ADMINISTERED BY DEVICE,1267
US,JAW DISORDER,1267
US,LOW DENSITY LIPOPROTEIN INCREASED,1260
US,DRUG SPECIFIC ANTIBODY PRESENT,1258
UM,DRUG INEFFECTIVE,8
UM,DIZZINESS,4
UM,MYALGIA,4
UM,DYSPNOEA,3
UM,FATIGUE,3
UM,MALAISE,3
UM,VOMITING,3
UM,ARTHRALGIA,2
UM,BACK PAIN,2
UM,CONTRAINDICATED PRODUCT ADMINISTERED,2
UM,DEHYDRATION,2
UM,DEPRESSION,2
UM,DIARRHOEA,2
UM,DRUG HYPERSENSITIVITY,2
UM,MUSCLE SPASMS,2
UM,NEGATIVE THOUGHTS,2
UM,PAIN,2
UM,PAIN IN EXTREMITY,2
UM,SURGERY,2
UM,TREMOR,2
UM,ABDOMINAL PAIN,1
UM,ABDOMINAL PAIN UPPER,1
UM,ALOPECIA,1
UM,APPLICATION SITE DRYNESS,1
UM,APPLICATION SITE ERYTHEMA,1
UM,ASTHENIA,1
UM,BALANCE DISORDER,1
UM,BLOOD PRESSURE DECREASED,1
UM,BLOOD PRESSURE INCREASED,1
UM,BREAST CYST,1
UM,BUDD-CHIARI SYNDROME,1
UM,CELLULITIS,1
UM,CEREBROVASCULAR ACCIDENT,1
UM,CHEST PAIN,1
UM,CHILLS,1
UM,CLOSTRIDIUM DIFFICILE COLITIS,1
UM,COGNITIVE DISORDER,1
UM,CONTRAINDICATED DRUG PRESCRIBED,1
UM,CRYING,1
UM,DEATH,1
UM,DERMATOMYOSITIS,1
UM,DISORIENTATION,1
UM,DISTURBANCE IN ATTENTION,1
UM,DRUG DEPENDENCE,1
UM,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
UM,DRUG TITRATION ERROR,1
UM,DYSPHAGIA,1
UM,EMOTIONAL DISORDER,1
UM,ERECTION INCREASED,1
UM,FAILURE TO THRIVE,1
UM,FEAR,1
UM,FEELING ABNORMAL,1
UM,FEELING HOT,1
UM,FOOT OPERATION,1
UM,FRUSTRATION TOLERANCE DECREASED,1
UM,GAIT DISTURBANCE,1
UM,GAIT INABILITY,1
UM,HAEMATOCHEZIA,1
UM,HAEMOGLOBIN DECREASED,1
UM,HAEMOLYTIC URAEMIC SYNDROME,1
UM,HAEMORRHAGIC DIATHESIS,1
UM,HEART RATE INCREASED,1
UM,HEART RATE IRREGULAR,1
UM,HEPATIC VEIN THROMBOSIS,1
UM,HYPOACUSIS,1
UM,INCORRECT DOSE ADMINISTERED,1
UM,INCORRECT PRODUCT STORAGE,1
UM,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
UM,INFECTION,1
UM,INFLAMMATION,1
UM,INJECTION SITE REACTION,1
UM,LIMB DISCOMFORT,1
UM,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
UM,MALIGNANT NEOPLASM PROGRESSION,1
UM,MEMORY IMPAIRMENT,1
UM,METASTASES TO CENTRAL NERVOUS SYSTEM,1
UM,METASTASES TO LUNG,1
UM,METASTASES TO PERITONEUM,1
UM,MIDDLE INSOMNIA,1
UM,MIGRAINE,1
UM,NIGHTMARE,1
UM,ORAL DISCOMFORT,1
UM,OSTEOSCLEROSIS,1
UM,OXYGEN SATURATION DECREASED,1
UM,PAINFUL ERECTION,1
UM,PALPITATIONS,1
UM,PANCREATIC CARCINOMA,1
UM,PARANOIA,1
UM,PENILE DISCHARGE,1
UM,PERICARDIAL EFFUSION,1
UM,PERITONITIS BACTERIAL,1
UM,PRODUCT COUNTERFEIT,1
UM,PRODUCT SUBSTITUTION ISSUE,1
UM,PULMONARY FIBROSIS,1
UM,PULMONARY OEDEMA,1
UM,RESPIRATORY FAILURE,1
UM,RETINOPATHY,1
UM,SEPSIS,1
UM,SKIN DISCOLOURATION,1
UM,SKIN DISORDER,1
UM,SKIN FISSURES,1
UM,SPINAL COMPRESSION FRACTURE,1
UM,STAPHYLOCOCCAL INFECTION,1
UM,STAPHYLOCOCCUS TEST POSITIVE,1
UM,SWELLING FACE,1
UM,TEARFULNESS,1
UM,TENDON RUPTURE,1
UM,TENDONITIS,1
UM,THROAT IRRITATION,1
UM,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
UM,TINNITUS,1
UM,URINARY INCONTINENCE,1
UM,URTICARIA,1
UM,VASCULAR PAIN,1
UM,VIRAL INFECTION,1
UM,VISUAL ACUITY REDUCED,1
UM,VISUAL IMPAIRMENT,1
UM,WEIGHT INCREASED,1
UM,WHEEZING,1
UM,WITHDRAWAL SYNDROME,1
UY,DEATH,110
UY,RESPIRATORY TRACT INFECTION,46
UY,DIARRHOEA,45
UY,PYREXIA,40
UY,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,32
UY,VOMITING,31
UY,PAIN IN EXTREMITY,24
UY,DRUG INEFFECTIVE,23
UY,FOETAL EXPOSURE DURING PREGNANCY,22
UY,HYPERTENSION,22
UY,MATERNAL EXPOSURE DURING PREGNANCY,21
UY,FATIGUE,20
UY,URINARY TRACT INFECTION,20
UY,NAUSEA,19
UY,HEADACHE,18
UY,PAIN,17
UY,ANAEMIA,16
UY,DISEASE PROGRESSION,16
UY,WEIGHT DECREASED,16
UY,DRY SKIN,15
UY,RENAL FAILURE,14
UY,COUGH,13
UY,INFLUENZA,13
UY,ABDOMINAL PAIN,12
UY,DECREASED APPETITE,12
UY,PLEURAL EFFUSION,12
UY,PNEUMONIA,12
UY,SKIN EXFOLIATION,12
UY,DIZZINESS,11
UY,PULMONARY EMBOLISM,11
UY,RHEUMATOID ARTHRITIS,11
UY,ARTHRALGIA,10
UY,DYSPNOEA,10
UY,FALL,10
UY,RESPIRATORY FAILURE,10
UY,THROMBOCYTOPENIA,10
UY,ASTHENIA,9
UY,DEPRESSION,9
UY,HERPES ZOSTER,9
UY,PULMONARY OEDEMA,9
UY,SEIZURE,9
UY,HYPOAESTHESIA,8
UY,PRODUCT USE ISSUE,8
UY,RASH,8
UY,ABDOMINAL PAIN UPPER,7
UY,CARDIAC FAILURE,7
UY,CHOLELITHIASIS,7
UY,CROHN^S DISEASE,7
UY,HYPERAMMONAEMIA,7
UY,LUNG DISORDER,7
UY,OSTEOARTHRITIS,7
UY,PREMATURE BABY,7
UY,SKIN DISCOLOURATION,7
UY,ABDOMINAL DISCOMFORT,6
UY,ANXIETY,6
UY,BACK PAIN,6
UY,CEREBROVASCULAR ACCIDENT,6
UY,DEHYDRATION,6
UY,EJECTION FRACTION DECREASED,6
UY,GASTROENTERITIS,6
UY,GASTROINTESTINAL HAEMORRHAGE,6
UY,GENITAL HAEMORRHAGE,6
UY,HAEMATOCHEZIA,6
UY,HAEMOGLOBIN DECREASED,6
UY,HYPERHIDROSIS,6
UY,HYPERSENSITIVITY,6
UY,IMMUNODEFICIENCY,6
UY,PARAESTHESIA,6
UY,PERIPHERAL SWELLING,6
UY,SEPSIS,6
UY,STOMATITIS,6
UY,SYNCOPE,6
UY,UNEVALUABLE EVENT,6
UY,BLISTER,5
UY,BRONCHOSPASM,5
UY,CARDIAC DISORDER,5
UY,CHEST PAIN,5
UY,CONFUSIONAL STATE,5
UY,DEEP VEIN THROMBOSIS,5
UY,DEPRESSED MOOD,5
UY,DYSPEPSIA,5
UY,EPISTAXIS,5
UY,ERYTHEMA,5
UY,EXPOSURE DURING BREAST FEEDING,5
UY,GENERAL PHYSICAL HEALTH DETERIORATION,5
UY,HYPERGLYCAEMIA,5
UY,IMMUNOSUPPRESSION,5
UY,INFLAMMATION,5
UY,INSOMNIA,5
UY,JOINT SWELLING,5
UY,MALAISE,5
UY,METRORRHAGIA,5
UY,NAIL DISORDER,5
UY,PRURITUS,5
UY,TACHYCARDIA,5
UY,VAGINAL HAEMORRHAGE,5
UY,VISUAL IMPAIRMENT,5
UY,ABDOMINAL DISTENSION,4
UY,ACNE,4
UY,ALOPECIA,4
UY,ARRHYTHMIA,4
UY,BREECH PRESENTATION,4
UY,CONSTIPATION,4
UY,DRUG INTOLERANCE,4
UY,EXPOSURE DURING PREGNANCY,4
UY,FEELING HOT,4
UY,GAIT DISTURBANCE,4
UY,GASTROINTESTINAL PAIN,4
UY,HAEMATOMA,4
UY,HAEMATURIA,4
UY,HYPOGLYCAEMIA,4
UY,INFECTION,4
UY,INJECTION SITE PAIN,4
UY,INTRACARDIAC THROMBUS,4
UY,ISCHAEMIC STROKE,4
UY,LARGE FOR DATES BABY,4
UY,LEUKAEMIA,4
UY,MALIGNANT NEOPLASM PROGRESSION,4
UY,MEMORY IMPAIRMENT,4
UY,MUSCULOSKELETAL STIFFNESS,4
UY,NEOPLASM PROGRESSION,4
UY,ODYNOPHAGIA,4
UY,PIGMENTATION DISORDER,4
UY,POST PROCEDURAL HAEMORRHAGE,4
UY,PSORIASIS,4
UY,PULMONARY MASS,4
UY,RED BLOOD CELL SEDIMENTATION RATE INCREASED,4
UY,SKIN LESION,4
UY,SWELLING,4
UY,SYSTEMIC LUPUS ERYTHEMATOSUS,4
UY,TREATMENT FAILURE,4
UY,TUBERCULOSIS,4
UY,UTERINE POLYP,4
UY,ABORTION SPONTANEOUS,3
UY,AMNESIA,3
UY,APHONIA,3
UY,ASCITES,3
UY,BLINDNESS,3
UY,BLOOD BILIRUBIN INCREASED,3
UY,BONE DISORDER,3
UY,BONE PAIN,3
UY,C-REACTIVE PROTEIN INCREASED,3
UY,CATARACT,3
UY,CHILLS,3
UY,COMA,3
UY,CONDITION AGGRAVATED,3
UY,DIABETES MELLITUS,3
UY,DRUG HYPERSENSITIVITY,3
UY,DRY MOUTH,3
UY,DYSPHONIA,3
UY,FLUID RETENTION,3
UY,GASTRIC ULCER,3
UY,GASTROINTESTINAL OEDEMA,3
UY,GINGIVAL BLEEDING,3
UY,HAEMORRHAGE,3
UY,HAEMORRHAGIC ANAEMIA,3
UY,HEPATIC ENZYME INCREASED,3
UY,HYPOTENSION,3
UY,IMMUNE SYSTEM DISORDER,3
UY,INCORRECT DOSE ADMINISTERED,3
UY,INFLUENZA LIKE ILLNESS,3
UY,INGUINAL HERNIA,3
UY,INTERVERTEBRAL DISC PROTRUSION,3
UY,INTESTINAL HAEMORRHAGE,3
UY,INTESTINAL STENOSIS,3
UY,IRRITABILITY,3
UY,LACRIMATION INCREASED,3
UY,LIVER DISORDER,3
UY,LOCALISED INFECTION,3
UY,LOSS OF CONSCIOUSNESS,3
UY,LUNG INFECTION,3
UY,LUNG NEOPLASM,3
UY,LYMPHADENOPATHY,3
UY,MEDICATION ERROR,3
UY,MENSTRUATION DELAYED,3
UY,MOBILITY DECREASED,3
UY,MUSCLE SPASMS,3
UY,MUSCULAR WEAKNESS,3
UY,MYALGIA,3
UY,MYOCARDIAL INFARCTION,3
UY,NEOPLASM,3
UY,NEUTROPENIA,3
UY,OEDEMA PERIPHERAL,3
UY,OVARIAN CYST,3
UY,PATHOGEN RESISTANCE,3
UY,PHARYNGITIS,3
UY,PLATELET COUNT DECREASED,3
UY,PLATELET COUNT INCREASED,3
UY,PRE-ECLAMPSIA,3
UY,PREMATURE RUPTURE OF MEMBRANES,3
UY,PULMONARY HYPERTENSION,3
UY,RENAL IMPAIRMENT,3
UY,ROAD TRAFFIC ACCIDENT,3
UY,SEPTIC SHOCK,3
UY,SLEEP APNOEA SYNDROME,3
UY,SLEEP DISORDER,3
UY,SOMNOLENCE,3
UY,SPINAL PAIN,3
UY,SUBILEUS,3
UY,SWELLING FACE,3
UY,TOXICITY TO VARIOUS AGENTS,3
UY,TUMOUR MARKER INCREASED,3
UY,URINARY INCONTINENCE,3
UY,VASCULITIS,3
UY,VISION BLURRED,3
UY,WHITE BLOOD CELL COUNT DECREASED,3
UY,WOUND,3
UY,ABDOMINAL HERNIA,2
UY,AMENORRHOEA,2
UY,ANAL FISTULA,2
UY,ANOSMIA,2
UY,ANURIA,2
UY,AORTIC ANEURYSM,2
UY,AORTIC DISSECTION,2
UY,ARRESTED LABOUR,2
UY,ATRIAL THROMBOSIS,2
UY,BILIRUBIN CONJUGATED INCREASED,2
UY,BLADDER NEOPLASM,2
UY,BLOOD BILIRUBIN UNCONJUGATED INCREASED,2
UY,BONE MARROW FAILURE,2
UY,BRAIN NEOPLASM,2
UY,BREAST CANCER,2
UY,BREAST MASS,2
UY,BREAST PAIN,2
UY,BREAST TENDERNESS,2
UY,CACHEXIA,2
UY,CARDIAC ARREST,2
UY,CARDIOVASCULAR DISORDER,2
UY,CARTILAGE INJURY,2
UY,CELLULITIS,2
UY,CHRONIC SINUSITIS,2
UY,COMPLICATION OF DELIVERY,2
UY,CONJUNCTIVITIS,2
UY,CONVULSION,2
UY,CORONARY ARTERY DILATATION,2
UY,CYST,2
UY,CYSTITIS,2
UY,DERMATITIS ALLERGIC,2
UY,DEVICE DISLOCATION,2
UY,DEVICE RELATED INFECTION,2
UY,DIALYSIS,2
UY,DISSEMINATED TUBERCULOSIS,2
UY,DIVERTICULUM,2
UY,DRUG DOSE OMISSION,2
UY,EMOTIONAL DISTRESS,2
UY,ENTEROCOLITIS,2
UY,EOSINOPHILIA,2
UY,EYE HAEMORRHAGE,2
UY,EYE IRRITATION,2
UY,EYE PAIN,2
UY,FACIAL PARALYSIS,2
UY,FEELING ABNORMAL,2
UY,FEELING COLD,2
UY,FOETAL DISTRESS SYNDROME,2
UY,FOETAL GROWTH RESTRICTION,2
UY,FOOD INTOLERANCE,2
UY,FREQUENT BOWEL MOVEMENTS,2
UY,GASTRITIS,2
UY,GASTRITIS EROSIVE,2
UY,GASTROINTESTINAL DISORDER,2
UY,HAEMODYNAMIC INSTABILITY,2
UY,HAEMORRHAGIC TRANSFORMATION STROKE,2
UY,HAEMORRHOIDS,2
UY,HALLUCINATION,2
UY,HEAD INJURY,2
UY,HEART RATE DECREASED,2
UY,HEMIPLEGIA,2
UY,HEPATIC STEATOSIS,2
UY,HEPATITIS,2
UY,HYPERAESTHESIA,2
UY,HYPERCHLORHYDRIA,2
UY,HYPERKERATOSIS,2
UY,HYPERPHOSPHATAEMIA,2
UY,HYPOKALAEMIA,2
UY,HYPOTHYROIDISM,2
UY,ILEAL STENOSIS,2
UY,INFLAMMATORY MARKER INCREASED,2
UY,INTERSTITIAL LUNG DISEASE,2
UY,INTERVERTEBRAL DISC DISORDER,2
UY,INTESTINAL INFARCTION,2
UY,JAUNDICE,2
UY,LACTOSE INTOLERANCE,2
UY,LARGE INTESTINE POLYP,2
UY,LARYNGEAL OEDEMA,2
UY,LEG AMPUTATION,2
UY,LEUKOPENIA,2
UY,LIGAMENT DISORDER,2
UY,LIMB DISCOMFORT,2
UY,LIP PAIN,2
UY,LOW BIRTH WEIGHT BABY,2
UY,LUPUS-LIKE SYNDROME,2
UY,MATERNAL EXPOSURE TIMING UNSPECIFIED,2
UY,MELANOCYTIC NAEVUS,2
UY,METASTASES TO LYMPH NODES,2
UY,METASTASIS,2
UY,MUSCLE CONTRACTURE,2
UY,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,2
UY,MYOPATHY,2
UY,NASOPHARYNGITIS,2
UY,NECK PAIN,2
UY,NECROTISING FASCIITIS STREPTOCOCCAL,2
UY,NEPHROLITHIASIS,2
UY,NERVOUSNESS,2
UY,NEURALGIA,2
UY,OEDEMA,2
UY,ORAL DISORDER,2
UY,OROPHARYNGEAL PAIN,2
UY,OXYGEN SATURATION DECREASED,2
UY,PANCYTOPENIA,2
UY,PERICARDIAL EFFUSION,2
UY,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
UY,PERITONITIS,2
UY,POST PROCEDURAL COMPLICATION,2
UY,PREGNANCY ON ORAL CONTRACEPTIVE,2
UY,PREMATURE LABOUR,2
UY,PRESYNCOPE,2
UY,PRURITUS GENERALISED,2
UY,PULMONARY HILAR ENLARGEMENT,2
UY,PULMONARY TUBERCULOSIS,2
UY,RECTAL HAEMORRHAGE,2
UY,RECTAL NEOPLASM,2
UY,RECTAL TENESMUS,2
UY,RENAL CANCER,2
UY,RENAL DISORDER,2
UY,RENAL TRANSPLANT,2
UY,RETINAL DETACHMENT,2
UY,RHINORRHOEA,2
UY,RIGHT VENTRICULAR FAILURE,2
UY,SENSORY LOSS,2
UY,SKIN ATROPHY,2
UY,SKIN BURNING SENSATION,2
UY,SKIN DISORDER,2
UY,SKIN FISSURES,2
UY,SKIN HYPERPIGMENTATION,2
UY,SKIN INDURATION,2
UY,SKIN IRRITATION,2
UY,SKIN TIGHTNESS,2
UY,SKIN ULCER,2
UY,SPLENOMEGALY,2
UY,STRESS,2
UY,SUDDEN DEATH,2
UY,SUICIDE ATTEMPT,2
UY,TEMPERATURE INTOLERANCE,2
UY,TENDONITIS,2
UY,THREATENED LABOUR,2
UY,THROMBOSIS,2
UY,TONGUE OEDEMA,2
UY,TRANSAMINASES DECREASED,2
UY,TRANSAMINASES INCREASED,2
UY,TRANSIENT ISCHAEMIC ATTACK,2
UY,TYPE 2 DIABETES MELLITUS,2
UY,UMBILICAL HERNIA,2
UY,URINARY RETENTION,2
UY,UTERINE HYPOTONUS,2
UY,VAGINAL DISCHARGE,2
UY,VIRAL INFECTION,2
UY,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
UY,ABASIA,1
UY,ABDOMINAL ABSCESS,1
UY,ABDOMINAL HERNIA OBSTRUCTIVE,1
UY,ABNORMAL LABOUR,1
UY,ABORTION INDUCED,1
UY,ACCIDENT,1
UY,ACTIVITIES OF DAILY LIVING IMPAIRED,1
UY,ACUTE KIDNEY INJURY,1
UY,ACUTE MYELOID LEUKAEMIA,1
UY,ACUTE MYOCARDIAL INFARCTION,1
UY,ACUTE PULMONARY OEDEMA,1
UY,ADENOCARCINOMA OF COLON,1
UY,ADJUSTMENT DISORDER WITH DEPRESSED MOOD,1
UY,ADNEXA UTERI PAIN,1
UY,ADVERSE DRUG REACTION,1
UY,ADVERSE EVENT,1
UY,AFFECTIVE DISORDER,1
UY,AGITATION,1
UY,ALVEOLITIS ALLERGIC,1
UY,ANAL FISSURE,1
UY,ANAPHYLACTIC SHOCK,1
UY,ANGINA PECTORIS,1
UY,ANGINA UNSTABLE,1
UY,ANGIODYSPLASIA,1
UY,ANGIOPATHY,1
UY,ANGULAR CHEILITIS,1
UY,ANKYLOSING SPONDYLITIS,1
UY,ANOGENITAL WARTS,1
UY,ANORECTAL DISCOMFORT,1
UY,ANTI-TRANSGLUTAMINASE ANTIBODY INCREASED,1
UY,ANTIMICROBIAL SUSCEPTIBILITY TEST SENSITIVE,1
UY,APNOEA,1
UY,ARTERIAL DISORDER,1
UY,ARTERIAL OCCLUSIVE DISEASE,1
UY,ARTERIOVENOUS FISTULA THROMBOSIS,1
UY,ARTHRITIS ENTEROPATHIC,1
UY,ARTHRITIS INFECTIVE,1
UY,ARTHROPOD BITE,1
UY,ASPHYXIA,1
UY,ATRIAL SEPTAL DEFECT,1
UY,ATRIOVENTRICULAR BLOCK,1
UY,AVERSION,1
UY,AXONAL NEUROPATHY,1
UY,BACTERIAL INFECTION,1
UY,BALANCE DISORDER,1
UY,BASAL CELL CARCINOMA,1
UY,BENIGN NEOPLASM OF SPINAL CORD,1
UY,BILE DUCT OBSTRUCTION,1
UY,BILE DUCT STONE,1
UY,BK VIRUS INFECTION,1
UY,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
UY,BLIGHTED OVUM,1
UY,BLINDNESS UNILATERAL,1
UY,BLOOD CHOLESTEROL INCREASED,1
UY,BLOOD CORTISOL DECREASED,1
UY,BLOOD CREATININE INCREASED,1
UY,BLOOD DISORDER,1
UY,BLOOD LUTEINISING HORMONE INCREASED,1
UY,BLOOD PRESSURE DECREASED,1
UY,BLOOD PRESSURE FLUCTUATION,1
UY,BLOOD PRESSURE INCREASED,1
UY,BLOOD TEST ABNORMAL,1
UY,BLOOD THYROID STIMULATING HORMONE INCREASED,1
UY,BLOOD UREA INCREASED,1
UY,BLOOD URIC ACID INCREASED,1
UY,BODY TEMPERATURE INCREASED,1
UY,BONE DENSITY DECREASED,1
UY,BONE LOSS,1
UY,BRADYCARDIA,1
UY,BREAST CALCIFICATIONS,1
UY,BREAST CANCER IN SITU,1
UY,BREAST CANCER RECURRENT,1
UY,BREAST DISCHARGE,1
UY,BRONCHIAL DISORDER,1
UY,BRONCHIOLITIS,1
UY,BRONCHOPULMONARY DYSPLASIA,1
UY,BURNING SENSATION,1
UY,CARDIAC MURMUR,1
UY,CARDIAC STRESS TEST ABNORMAL,1
UY,CARDIAC VENTRICULAR THROMBOSIS,1
UY,CARDIO-RESPIRATORY ARREST,1
UY,CARDIOMEGALY,1
UY,CARDIOPULMONARY FAILURE,1
UY,CARDIOTOXICITY,1
UY,CATARACT DIABETIC,1
UY,CATARACT OPERATION,1
UY,CATARRH,1
UY,CENTRAL NERVOUS SYSTEM LESION,1
UY,CEREBELLAR EMBOLISM,1
UY,CEREBRAL INFARCTION,1
UY,CEREBRAL THROMBOSIS,1
UY,CERVICAL DYSPLASIA,1
UY,CERVICAL INCOMPETENCE,1
UY,CERVICAL POLYP,1
UY,CHEILITIS,1
UY,CHEMICAL POISONING,1
UY,CHOLESTEATOMA,1
UY,CHRONIC KIDNEY DISEASE,1
UY,COAGULOPATHY,1
UY,COGNITIVE DISORDER,1
UY,COLITIS,1
UY,COLON CANCER,1
UY,COLON NEOPLASM,1
UY,COLORECTAL CANCER,1
UY,COMMUNICATION DISORDER,1
UY,COMPLICATION ASSOCIATED WITH DEVICE,1
UY,COMPUTERISED TOMOGRAM ABNORMAL,1
UY,CONGENITAL ANOMALY,1
UY,CONGENITAL AORTIC ANOMALY,1
UY,CONGENITAL PULMONARY VALVE ATRESIA,1
UY,CONGESTIVE CARDIOMYOPATHY,1
UY,CONTUSION,1
UY,CONVERSION DISORDER,1
UY,CORNEAL DEPOSITS,1
UY,CORONARY ARTERY OCCLUSION,1
UY,CRANIOCEREBRAL INJURY,1
UY,CUSHING^S SYNDROME,1
UY,CYANOSIS NEONATAL,1
UY,DEAFNESS,1
UY,DEMYELINATION,1
UY,DENTAL CARE,1
UY,DERMATITIS EXFOLIATIVE,1
UY,DERMATOMYOSITIS,1
UY,DEVICE EXPULSION,1
UY,DEVICE MISUSE,1
UY,DEVICE USE ISSUE,1
UY,DIABETIC COMA,1
UY,DIABETIC COMPLICATION,1
UY,DIARRHOEA HAEMORRHAGIC,1
UY,DISTURBANCE IN ATTENTION,1
UY,DISTURBANCE IN SOCIAL BEHAVIOUR,1
UY,DIVERTICULUM INTESTINAL,1
UY,DRUG ABUSE,1
UY,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
UY,DRUG EFFECT DECREASED,1
UY,DRUG EFFECTIVE FOR UNAPPROVED INDICATION,1
UY,DRUG ERUPTION,1
UY,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
UY,DRUG-INDUCED LIVER INJURY,1
UY,DRY EYE,1
UY,DUODENAL STENOSIS,1
UY,DYSARTHRIA,1
UY,DYSGEUSIA,1
UY,DYSKINESIA,1
UY,DYSPHAGIA,1
UY,DYSPLASIA,1
UY,DYSPNOEA EXERTIONAL,1
UY,EAR INFECTION,1
UY,EAR PAIN,1
UY,EAR PRURITUS,1
UY,ECCHYMOSIS,1
UY,EFFUSION,1
UY,EMBOLISM,1
UY,EMOTIONAL DISORDER,1
UY,ENDOCARDITIS BACTERIAL,1
UY,ENDOMETRIAL CANCER,1
UY,ENDOPHTHALMITIS,1
UY,ENDOTHELIAL DYSFUNCTION,1
UY,ENTEROCOCCUS TEST POSITIVE,1
UY,EPILEPSY,1
UY,ERYSIPELAS,1
UY,ESCHERICHIA SEPSIS,1
UY,EXPIRED PRODUCT ADMINISTERED,1
UY,EXTRAPULMONARY TUBERCULOSIS,1
UY,EYE DISCHARGE,1
UY,EYELID IRRITATION,1
UY,EYELID OEDEMA,1
UY,FACE OEDEMA,1
UY,FAECALOMA,1
UY,FAILED IN VITRO FERTILISATION,1
UY,FALLOT^S TETRALOGY,1
UY,FEMOROACETABULAR IMPINGEMENT,1
UY,FIBROCYSTIC BREAST DISEASE,1
UY,FINGER DEFORMITY,1
UY,FISTULA,1
UY,FLUSHING,1
UY,FOETAL DEATH,1
UY,FOOT AMPUTATION,1
UY,FOOT DEFORMITY,1
UY,FORCED EXPIRATORY VOLUME DECREASED,1
UY,FOREIGN BODY IN EYE,1
UY,FUNGAL PERITONITIS,1
UY,FUNGAL PHARYNGITIS,1
UY,GALLBLADDER CHOLESTEROLOSIS,1
UY,GALLBLADDER DISORDER,1
UY,GALLBLADDER OPERATION,1
UY,GASTRIC ULCER PERFORATION,1
UY,GASTROENTERITIS VIRAL,1
UY,GASTROINTESTINAL INFECTION,1
UY,GASTROINTESTINAL INFLAMMATION,1
UY,GASTROINTESTINAL MOTILITY DISORDER,1
UY,GASTROINTESTINAL STOMA COMPLICATION,1
UY,GASTROOESOPHAGEAL REFLUX DISEASE,1
UY,GENERALISED ERYTHEMA,1
UY,GENERALISED OEDEMA,1
UY,GENITAL DISCOMFORT,1
UY,GINGIVITIS,1
UY,GINGIVITIS ULCERATIVE,1
UY,GLAUCOMA,1
UY,GLUCOCORTICOID DEFICIENCY,1
UY,GOITRE,1
UY,GRANULOCYTE COUNT DECREASED,1
UY,GRANULOMA,1
UY,GRIP STRENGTH DECREASED,1
UY,HAEMOLYTIC ANAEMIA,1
UY,HAEMOPTYSIS,1
UY,HAEMORRHAGE INTRACRANIAL,1
UY,HAEMORRHAGIC OVARIAN CYST,1
UY,HAND DEFORMITY,1
UY,HEMIPARESIS,1
UY,HEPATIC CIRRHOSIS,1
UY,HEPATIC FAILURE,1
UY,HEPATIC INFILTRATION EOSINOPHILIC,1
UY,HEPATITIS B,1
UY,HEPATITIS TOXIC,1
UY,HEPATOCELLULAR CARCINOMA,1
UY,HEPATOMEGALY,1
UY,HEPATOSPLENOMEGALY,1
UY,HIATUS HERNIA,1
UY,HICCUPS,1
UY,HIGH RISK PREGNANCY,1
UY,HIP ARTHROPLASTY,1
UY,HIP FRACTURE,1
UY,HISTIOCYTOSIS HAEMATOPHAGIC,1
UY,HISTOPLASMOSIS,1
UY,HYDROCEPHALUS,1
UY,HYDRONEPHROSIS,1
UY,HYPERINSULINAEMIA,1
UY,HYPERPROLACTINAEMIA,1
UY,HYPERSPLENISM,1
UY,HYPERTENSIVE CARDIOMYOPATHY,1
UY,HYPERTENSIVE CRISIS,1
UY,HYPERTRIGLYCERIDAEMIA,1
UY,HYPOACUSIS,1
UY,HYPOCALCAEMIA,1
UY,HYPOCHROMIC ANAEMIA,1
UY,HYPOGLYCAEMIA NEONATAL,1
UY,HYPOMENORRHOEA,1
UY,HYPONATRAEMIA,1
UY,HYPOPHAGIA,1
UY,HYPOPITUITARISM,1
UY,HYPOTHERMIA,1
UY,HYPOXIA,1
UY,IDIOPATHIC PULMONARY FIBROSIS,1
UY,ILEAL ULCER,1
UY,ILEITIS,1
UY,ILEUS,1
UY,ILEUS PARALYTIC,1
UY,ILL-DEFINED DISORDER,1
UY,IMMATURE RESPIRATORY SYSTEM,1
UY,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
UY,IMPAIRED HEALING,1
UY,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
UY,INCISION SITE PAIN,1
UY,INCONTINENCE,1
UY,INCORRECT DRUG ADMINISTRATION DURATION,1
UY,INFARCTION,1
UY,INFUSION RELATED REACTION,1
UY,INJECTION SITE PRURITUS,1
UY,INJECTION SITE SWELLING,1
UY,INJECTION SITE ULCER,1
UY,INTERNATIONAL NORMALISED RATIO INCREASED,1
UY,INTERVERTEBRAL DISC DEGENERATION,1
UY,INTERVERTEBRAL DISC DISPLACEMENT,1
UY,INTESTINAL MASS,1
UY,INTESTINAL OBSTRUCTION,1
UY,INTESTINAL OPERATION,1
UY,INTRA-ABDOMINAL FLUID COLLECTION,1
UY,INTRACRANIAL ANEURYSM,1
UY,IRRITABLE BOWEL SYNDROME,1
UY,ISCHAEMIC CARDIOMYOPATHY,1
UY,JOINT ABSCESS,1
UY,JOINT DISLOCATION,1
UY,JOINT INJURY,1
UY,JOINT PROSTHESIS USER,1
UY,JOINT STABILISATION,1
UY,JOINT STIFFNESS,1
UY,JOINT WARMTH,1
UY,JUVENILE IDIOPATHIC ARTHRITIS,1
UY,KARNOFSKY SCALE WORSENED,1
UY,KERATITIS,1
UY,KIDNEY INFECTION,1
UY,KLEBSIELLA TEST POSITIVE,1
UY,KNEE DEFORMITY,1
UY,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
UY,LACERATION,1
UY,LARGE INTESTINE PERFORATION,1
UY,LARYNX IRRITATION,1
UY,LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION,1
UY,LEUKOCYTOSIS,1
UY,LIMB INJURY,1
UY,LIP EXFOLIATION,1
UY,LIP INJURY,1
UY,LIP SWELLING,1
UY,LIVER FUNCTION TEST ABNORMAL,1
UY,LUNG INFILTRATION,1
UY,LUNG NEOPLASM MALIGNANT,1
UY,LUNG OPERATION,1
UY,LUPUS ENCEPHALITIS,1
UY,LYMPHANGITIS,1
UY,LYMPHOCELE,1
UY,LYMPHOMA,1
UY,MACULOPATHY,1
UY,MALIGNANT MELANOMA IN SITU,1
UY,MALNUTRITION,1
UY,MASTOCYTOSIS,1
UY,MECHANICAL VENTILATION COMPLICATION,1
UY,MEDICAL DEVICE DISCOMFORT,1
UY,MEDICAL INDUCTION OF COMA,1
UY,MEDICATION RESIDUE PRESENT,1
UY,MENINGOMYELOCELE,1
UY,MENORRHAGIA,1
UY,MENTAL DISORDER,1
UY,MESENTERIC VEIN THROMBOSIS,1
UY,METASTASES TO HEART,1
UY,METASTASES TO LUNG,1
UY,METASTASES TO PERITONEUM,1
UY,MIGRAINE,1
UY,MITRAL VALVE DISEASE,1
UY,MITRAL VALVE REPLACEMENT,1
UY,MOANING,1
UY,MONOPLEGIA,1
UY,MOOD ALTERED,1
UY,MORAXELLA INFECTION,1
UY,MORGANELLA INFECTION,1
UY,MOTOR DYSFUNCTION,1
UY,MOUTH INJURY,1
UY,MOUTH ULCERATION,1
UY,MUCOSAL HAEMORRHAGE,1
UY,MUCOSAL INFLAMMATION,1
UY,MULTIPLE SCLEROSIS,1
UY,MULTIPLE SCLEROSIS RELAPSE,1
UY,MUSCLE RUPTURE,1
UY,MUSCLE SPASTICITY,1
UY,MUSCULOSKELETAL DISCOMFORT,1
UY,MYASTHENIA GRAVIS,1
UY,MYELOFIBROSIS,1
UY,MYOCARDIAL NECROSIS MARKER INCREASED,1
UY,MYOCARDITIS,1
UY,NAEVUS HAEMORRHAGE,1
UY,NAIL INJURY,1
UY,NASAL CONGESTION,1
UY,NASAL ULCER,1
UY,NEONATAL ASPIRATION,1
UY,NEPHROCALCINOSIS,1
UY,NEPHROTIC SYNDROME,1
UY,NO THERAPEUTIC RESPONSE,1
UY,NODULE,1
UY,NON-INFECTIOUS ENDOPHTHALMITIS,1
UY,NORMAL NEWBORN,1
UY,NOSE DEFORMITY,1
UY,OBSTRUCTION,1
UY,OBSTRUCTION GASTRIC,1
UY,OCULAR HYPERTENSION,1
UY,OCULAR TOXICITY,1
UY,OESOPHAGEAL HAEMORRHAGE,1
UY,OESOPHAGITIS,1
UY,OFF LABEL USE OF DEVICE,1
UY,ORAL HERPES,1
UY,ORAL MUCOSAL BLISTERING,1
UY,OROPHARYNGEAL BLISTERING,1
UY,ORTHOSTATIC HYPOTENSION,1
UY,OSTEONECROSIS OF JAW,1
UY,OVARIAN NEOPLASM,1
UY,PAIN OF SKIN,1
UY,PANCREATITIS,1
UY,PANIC ATTACK,1
UY,PANNICULITIS,1
UY,PAPILLARY THYROID CANCER,1
UY,PAPILLOMA VIRAL INFECTION,1
UY,PARKINSON^S DISEASE,1
UY,PAROSMIA,1
UY,PAROTID GLAND ENLARGEMENT,1
UY,PATIENT-DEVICE INCOMPATIBILITY,1
UY,PERICARDIAL HAEMORRHAGE,1
UY,PERINEPHRITIS,1
UY,PERITONEAL TUBERCULOSIS,1
UY,PERITONITIS BACTERIAL,1
UY,PHOTOPHOBIA,1
UY,PHOTOPSIA,1
UY,PITUITARY TUMOUR,1
UY,PNEUMOCYSTIS JIROVECII INFECTION,1
UY,PNEUMONIA PNEUMOCOCCAL,1
UY,PNEUMONITIS,1
UY,POISONING,1
UY,POLYARTHRITIS,1
UY,POLYHYDRAMNIOS,1
UY,POLYMERASE CHAIN REACTION,1
UY,POLYMERASE CHAIN REACTION POSITIVE,1
UY,POLYMYOSITIS,1
UY,POLYSEROSITIS,1
UY,POOR DENTAL CONDITION,1
UY,PORTAL VEIN THROMBOSIS,1
UY,POST PROCEDURAL INFECTION,1
UY,POST PROCEDURAL SWELLING,1
UY,POSTOPERATIVE WOUND INFECTION,1
UY,POSTURE ABNORMAL,1
UY,PROCEDURAL PAIN,1
UY,PROCTALGIA,1
UY,PROCTITIS,1
UY,PRODUCTIVE COUGH,1
UY,PROTEIN URINE PRESENT,1
UY,PROTEINURIA,1
UY,PROTHROMBIN TIME ABNORMAL,1
UY,PSYCHIATRIC SYMPTOM,1
UY,PULMONARY ARTERIAL HYPERTENSION,1
UY,PULMONARY HAEMORRHAGE,1
UY,PULMONARY THROMBOSIS,1
UY,PULSE ABNORMAL,1
UY,PULSE ABSENT,1
UY,PURPURA,1
UY,PYELONEPHRITIS,1
UY,PYODERMA GANGRENOSUM,1
UY,RASH MACULAR,1
UY,RASH MACULO-PAPULAR,1
UY,RASH PAPULAR,1
UY,RASH PUSTULAR,1
UY,RAYNAUD^S PHENOMENON,1
UY,RECTAL CANCER STAGE II,1
UY,RECTAL PROLAPSE,1
UY,RECTAL ULCER,1
UY,RED BLOOD CELL COUNT DECREASED,1
UY,RENAL APLASIA,1
UY,RENAL COLIC,1
UY,RENAL CYST,1
UY,RENAL HAEMATOMA,1
UY,RENAL PAIN,1
UY,RESPIRATION ABNORMAL,1
UY,RESPIRATORY DISORDER,1
UY,RESPIRATORY DISTRESS,1
UY,RESPIRATORY SYNCYTIAL VIRUS INFECTION,1
UY,RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE,1
UY,RESPIRATORY TRACT INFECTION VIRAL,1
UY,RETINAL HAEMORRHAGE,1
UY,RETINAL THICKENING,1
UY,RETINAL VASCULAR DISORDER,1
UY,RETINAL VEIN THROMBOSIS,1
UY,RETROPERITONEAL HAEMORRHAGE,1
UY,RHINITIS,1
UY,RHINITIS ALLERGIC,1
UY,RIB FRACTURE,1
UY,SALIVARY HYPERSECRETION,1
UY,SCAB,1
UY,SCAR,1
UY,SCIATICA,1
UY,SCLERITIS,1
UY,SERUM FERRITIN DECREASED,1
UY,SHOCK,1
UY,SINUSITIS,1
UY,SKIN DISCOMFORT,1
UY,SKIN INJURY,1
UY,SKIN MASS,1
UY,SKIN REACTION,1
UY,SKIN ULCER HAEMORRHAGE,1
UY,SKIN WRINKLING,1
UY,SOFT TISSUE SWELLING,1
UY,SPEECH DISORDER,1
UY,SPINA BIFIDA,1
UY,SPINAL MYELOGRAM ABNORMAL,1
UY,SPINAL OSTEOARTHRITIS,1
UY,SPLENIC THROMBOSIS,1
UY,SPUTUM PURULENT,1
UY,STAPHYLOCOCCAL INFECTION,1
UY,STATUS EPILEPTICUS,1
UY,STENT PLACEMENT,1
UY,STRANGULATED HERNIA,1
UY,SUBCUTANEOUS HAEMATOMA,1
UY,SUBDURAL HAEMATOMA,1
UY,SUICIDAL IDEATION,1
UY,SURGERY,1
UY,SUTURE RUPTURE,1
UY,SYNOVIAL CYST,1
UY,SYSTEMIC MASTOCYTOSIS,1
UY,TACHYARRHYTHMIA,1
UY,TENDON DISORDER,1
UY,THERAPEUTIC PRODUCT INEFFECTIVE,1
UY,THERAPEUTIC RESPONSE UNEXPECTED,1
UY,THINKING ABNORMAL,1
UY,THROAT LESION,1
UY,THROMBOCYTOSIS,1
UY,THYROID NEOPLASM,1
UY,TONGUE DISCOLOURATION,1
UY,TONGUE FUNGAL INFECTION,1
UY,TONGUE ULCERATION,1
UY,TONSILLITIS,1
UY,TONSILLITIS STREPTOCOCCAL,1
UY,TRACHEOSTOMY,1
UY,TRANSFUSION,1
UY,TRANSPLANT,1
UY,TRAUMATIC LIVER INJURY,1
UY,TREATMENT NONCOMPLIANCE,1
UY,TREMOR,1
UY,TUBERCULOUS PLEURISY,1
UY,ULCER,1
UY,UMBILICAL CORD AROUND NECK,1
UY,UMBILICAL CORD COMPRESSION,1
UY,UNDERWEIGHT,1
UY,UPPER GASTROINTESTINAL HAEMORRHAGE,1
UY,UPPER RESPIRATORY TRACT INFECTION,1
UY,UROSEPSIS,1
UY,URTICARIA,1
UY,UTERINE CANCER,1
UY,UTERINE HAEMORRHAGE,1
UY,UTERINE INFECTION,1
UY,UTERINE INFLAMMATION,1
UY,UTERINE INJURY,1
UY,UTERINE LEIOMYOMA,1
UY,UTERINE PERFORATION,1
UY,UVEITIS,1
UY,VAGINAL CYST,1
UY,VAGINAL HAEMATOMA,1
UY,VARICOSE VEIN OPERATION,1
UY,VASCULAR PURPURA,1
UY,VENOUS INJURY,1
UY,VENOUS THROMBOSIS LIMB,1
UY,VENTRICULAR EXTRASYSTOLES,1
UY,VENTRICULAR FIBRILLATION,1
UY,VERTEBRAL COLUMN MASS,1
UY,VESSEL PUNCTURE SITE HAEMATOMA,1
UY,VIITH NERVE PARALYSIS,1
UY,WITHDRAWAL BLEED,1
UY,WOUND HAEMORRHAGE,1
UY,YELLOW SKIN,1
UZ,DEATH,43
UZ,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,34
UZ,MYOCARDIAL INFARCTION,18
UZ,AGRANULOCYTOSIS,14
UZ,CEREBRAL HAEMORRHAGE,13
UZ,THROMBOCYTOPENIA,11
UZ,SEPSIS,10
UZ,ONCOLOGIC COMPLICATION,9
UZ,CEREBROVASCULAR ACCIDENT,8
UZ,HEPATITIS C,7
UZ,ROAD TRAFFIC ACCIDENT,7
UZ,CARDIAC FAILURE,6
UZ,CHRONIC MYELOID LEUKAEMIA,6
UZ,HYPERTENSION,6
UZ,HYPERTENSIVE CRISIS,6
UZ,PNEUMONIA,6
UZ,POISONING,6
UZ,SECOND PRIMARY MALIGNANCY,6
UZ,TERMINAL STATE,6
UZ,ANGINA PECTORIS,5
UZ,DRUG RESISTANCE,5
UZ,DIABETES MELLITUS,4
UZ,HYPERTONIA,4
UZ,PERITONITIS,4
UZ,ACUTE MYOCARDIAL INFARCTION,3
UZ,ASCITES,3
UZ,HEPATIC CIRRHOSIS,3
UZ,MYOCARDIAL ISCHAEMIA,3
UZ,PANCREATITIS ACUTE,3
UZ,PULMONARY TUBERCULOSIS,3
UZ,TRANSIENT ISCHAEMIC ATTACK,3
UZ,TUBERCULOSIS,3
UZ,ABDOMINAL PAIN,2
UZ,ANAEMIA,2
UZ,BONE MARROW TOXICITY,2
UZ,COMA,2
UZ,COMPLETED SUICIDE,2
UZ,DRUG INEFFECTIVE,2
UZ,GENERAL PHYSICAL HEALTH DETERIORATION,2
UZ,HAEMORRHAGE,2
UZ,HEADACHE,2
UZ,LEUKAEMIA,2
UZ,LEUKOPENIA,2
UZ,LUNG NEOPLASM MALIGNANT,2
UZ,PANCREATIC NECROSIS,2
UZ,PLEURISY,2
UZ,RENAL FAILURE,2
UZ,RESPIRATORY FAILURE,2
UZ,TOXICITY TO VARIOUS AGENTS,2
UZ,ACUTE CORONARY SYNDROME,1
UZ,ACUTE LYMPHOCYTIC LEUKAEMIA,1
UZ,ALCOHOLISM,1
UZ,AORTIC RUPTURE,1
UZ,APLASIA,1
UZ,ARTHROPATHY,1
UZ,ASPERGILLUS INFECTION,1
UZ,ASTHENIA,1
UZ,BACK PAIN,1
UZ,BLOOD PRESSURE ABNORMAL,1
UZ,BRAIN NEOPLASM,1
UZ,BREAST CANCER,1
UZ,BRONCHOPULMONARY ASPERGILLOSIS,1
UZ,BURNING SENSATION,1
UZ,CARDIAC ARREST,1
UZ,CARDIAC FAILURE ACUTE,1
UZ,CARDIOTOXICITY,1
UZ,CEREBRAL CYST,1
UZ,CHOLECYSTITIS,1
UZ,CHOLECYSTITIS ACUTE,1
UZ,CHOLECYSTITIS CHRONIC,1
UZ,COLON CANCER,1
UZ,COMPLICATIONS OF BONE MARROW TRANSPLANT,1
UZ,DEVICE ISSUE,1
UZ,DIARRHOEA,1
UZ,DISEASE PROGRESSION,1
UZ,DRUG INTOLERANCE,1
UZ,DUCHENNE MUSCULAR DYSTROPHY,1
UZ,DYSPHAGIA,1
UZ,EAR INFECTION,1
UZ,EPISTAXIS,1
UZ,FALL,1
UZ,FEBRILE NEUTROPENIA,1
UZ,FUNGAL INFECTION,1
UZ,GANGRENE,1
UZ,GASTRIC CANCER STAGE IV,1
UZ,GASTRIC HAEMORRHAGE,1
UZ,GASTROINTESTINAL INFECTION,1
UZ,GASTROINTESTINAL NEOPLASM,1
UZ,GASTROINTESTINAL TOXICITY,1
UZ,GLAUCOMA,1
UZ,GLIOSIS,1
UZ,HAEMARTHROSIS,1
UZ,HAEMATOTOXICITY,1
UZ,HEPATIC ENZYME INCREASED,1
UZ,HEPATIC FAILURE,1
UZ,HEPATITIS C VIRUS TEST POSITIVE,1
UZ,HEPATITIS TOXIC,1
UZ,HEPATOCELLULAR INJURY,1
UZ,HEPATOTOXICITY,1
UZ,HIV INFECTION,1
UZ,HIV TEST POSITIVE,1
UZ,HYPERSENSITIVITY,1
UZ,INCORRECT DOSAGE ADMINISTERED,1
UZ,INCORRECT DOSE ADMINISTERED,1
UZ,INFARCTION,1
UZ,INFLUENZA,1
UZ,INJECTION SITE BRUISING,1
UZ,INJECTION SITE REACTION,1
UZ,INJURY,1
UZ,INJURY ASSOCIATED WITH DEVICE,1
UZ,INTESTINAL OBSTRUCTION,1
UZ,LARYNGEAL CANCER,1
UZ,LEIOMYOMA,1
UZ,LIVER DISORDER,1
UZ,LUMBAR HERNIA,1
UZ,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,1
UZ,LUNG INFILTRATION,1
UZ,MALIGNANT NEOPLASM PROGRESSION,1
UZ,METASTASIS,1
UZ,MUCOSAL INFLAMMATION,1
UZ,NEOPLASM PROGRESSION,1
UZ,NEUROPATHY PERIPHERAL,1
UZ,NEUTROPENIA,1
UZ,OSTEOMYELITIS,1
UZ,OVERDOSE,1
UZ,PAIN,1
UZ,PANCYTOPENIA,1
UZ,PARALYSIS,1
UZ,PARATHYROID TUMOUR BENIGN,1
UZ,PNEUMONIA INFLUENZAL,1
UZ,PNEUMONITIS,1
UZ,POST PROCEDURAL COMPLICATION,1
UZ,PROCTITIS,1
UZ,PRODUCT USE ISSUE,1
UZ,PROSTATE CANCER,1
UZ,PULMONARY TUBERCULOMA,1
UZ,PYREXIA,1
UZ,RASH,1
UZ,RECTAL CANCER,1
UZ,RENAL COLIC,1
UZ,RESPIRATORY TRACT INFECTION VIRAL,1
UZ,RETINOPATHY,1
UZ,SEPTIC SHOCK,1
UZ,SKELETAL INJURY,1
UZ,SMALL INTESTINAL HAEMORRHAGE,1
UZ,STOMATITIS,1
UZ,SUSPECTED COUNTERFEIT PRODUCT,1
UZ,VOMITING,1
VU,CARDIAC DISORDER,1
VU,COUGH,1
VU,DYSPNOEA,1
VU,FISTULA,1
VU,HEADACHE,1
VU,PRURITUS,1
VU,RECTAL HAEMORRHAGE,1
VE,DEATH,3706
VE,CARDIAC DISORDER,567
VE,MYOCARDIAL INFARCTION,534
VE,RESPIRATORY ARREST,412
VE,CEREBROVASCULAR ACCIDENT,325
VE,SEPSIS,324
VE,TUBERCULIN TEST POSITIVE,306
VE,INFARCTION,274
VE,MALAISE,245
VE,CARDIAC FAILURE,208
VE,ADVERSE EVENT,200
VE,INFECTION,174
VE,SEIZURE,167
VE,PNEUMONIA,158
VE,DYSPNOEA,155
VE,FALL,154
VE,CARDIOVASCULAR DISORDER,153
VE,CARDIO-RESPIRATORY ARREST,137
VE,PAIN,135
VE,PYREXIA,132
VE,HEADACHE,120
VE,DRUG INEFFECTIVE,116
VE,GENERAL PHYSICAL HEALTH DETERIORATION,112
VE,CARDIAC ARREST,109
VE,DIZZINESS,109
VE,HYPERTENSION,106
VE,DIARRHOEA,103
VE,ASTHENIA,99
VE,FEELING ABNORMAL,99
VE,PRODUCT USE ISSUE,99
VE,FATIGUE,96
VE,VOMITING,95
VE,HAEMOGLOBIN DECREASED,94
VE,COUGH,91
VE,INFLUENZA,90
VE,GAIT DISTURBANCE,84
VE,UNEVALUABLE EVENT,84
VE,ASTHMA,82
VE,ARTHRALGIA,81
VE,PAIN IN EXTREMITY,75
VE,RESPIRATORY TRACT INFECTION,74
VE,ASTHMATIC CRISIS,72
VE,HYPERSENSITIVITY,66
VE,RESPIRATORY FAILURE,64
VE,DIABETES MELLITUS,63
VE,URINARY TRACT INFECTION,62
VE,WEIGHT DECREASED,62
VE,ABASIA,59
VE,CEREBROVASCULAR DISORDER,57
VE,NEOPLASM MALIGNANT,57
VE,BRONCHITIS,54
VE,RESPIRATORY DISORDER,54
VE,ASPHYXIA,53
VE,CONVULSION,52
VE,RENAL DISORDER,52
VE,RENAL FAILURE,52
VE,TREMOR,52
VE,ANXIETY,50
VE,RASH,50
VE,TRANSPLANT,48
VE,DEPRESSION,47
VE,TACHYCARDIA,45
VE,LUNG DISORDER,44
VE,CHIKUNGUNYA VIRUS INFECTION,43
VE,CONDITION AGGRAVATED,43
VE,NAUSEA,43
VE,DEHYDRATION,42
VE,HAEMORRHAGIC STROKE,42
VE,INSOMNIA,42
VE,THROMBOSIS,41
VE,BLINDNESS,40
VE,MALIGNANT NEOPLASM PROGRESSION,40
VE,ROAD TRAFFIC ACCIDENT,40
VE,SPEECH DISORDER,40
VE,BLOOD PRESSURE INCREASED,39
VE,HAEMORRHAGE,39
VE,HYPOTENSION,39
VE,PARKINSON^S DISEASE,39
VE,ABDOMINAL PAIN,38
VE,ARRHYTHMIA,38
VE,PULMONARY OEDEMA,38
VE,LOSS OF CONSCIOUSNESS,37
VE,BONE PAIN,36
VE,SYNCOPE,36
VE,HYPERTENSIVE CRISIS,35
VE,PLEURAL EFFUSION,35
VE,ABDOMINAL PAIN UPPER,34
VE,DECREASED APPETITE,34
VE,DYSSTASIA,34
VE,GASTROINTESTINAL HAEMORRHAGE,34
VE,ACUTE PULMONARY OEDEMA,33
VE,DENGUE FEVER,33
VE,DISEASE PROGRESSION,33
VE,PLATELET COUNT DECREASED,33
VE,PULMONARY EMBOLISM,33
VE,EPILEPSY,32
VE,INFLAMMATION,32
VE,ANAEMIA,31
VE,CHEST PAIN,31
VE,CHOKING,31
VE,ISCHAEMIC STROKE,31
VE,FEMUR FRACTURE,30
VE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,29
VE,LUNG NEOPLASM MALIGNANT,29
VE,RESPIRATORY DISTRESS,29
VE,BACK PAIN,28
VE,DEVICE RELATED SEPSIS,28
VE,DRUG INTOLERANCE,28
VE,GASTRITIS,28
VE,RENAL TRANSPLANT,28
VE,SOMNOLENCE,28
VE,MOBILITY DECREASED,27
VE,PRURITUS,27
VE,LUNG INFECTION,26
VE,MEMORY IMPAIRMENT,26
VE,MYOCARDIAL ISCHAEMIA,26
VE,OEDEMA PERIPHERAL,26
VE,PERIPHERAL SWELLING,26
VE,BREAST CANCER,25
VE,HEAD INJURY,25
VE,LIVER DISORDER,25
VE,NEPHROLITHIASIS,25
VE,DRUG DOSE OMISSION,24
VE,EXPOSURE DURING PREGNANCY,24
VE,SEPTIC SHOCK,24
VE,NEOPLASM,23
VE,PRODUCT SUPPLY ISSUE,23
VE,PROSTATE CANCER,23
VE,SUDDEN DEATH,23
VE,ARTHROPATHY,22
VE,CELLULITIS,22
VE,EPISTAXIS,22
VE,HYPERGLYCAEMIA,22
VE,HYPERHIDROSIS,22
VE,HYPOKINESIA,22
VE,MATERNAL EXPOSURE DURING PREGNANCY,22
VE,MOVEMENT DISORDER,22
VE,MUSCULOSKELETAL STIFFNESS,22
VE,MYALGIA,22
VE,PARKINSONIAN CRISIS,22
VE,SWELLING,22
VE,SYSTEMIC LUPUS ERYTHEMATOSUS,22
VE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,22
VE,EYE DISORDER,21
VE,HEPATITIS,21
VE,HIP FRACTURE,21
VE,HOSPITALISATION,21
VE,INCORRECT DOSE ADMINISTERED,21
VE,INTESTINAL OBSTRUCTION,21
VE,NERVOUSNESS,21
VE,OSTEOARTHRITIS,21
VE,OSTEOPOROSIS,21
VE,PRODUCT AVAILABILITY ISSUE,21
VE,ACUTE MYOCARDIAL INFARCTION,20
VE,BLOOD PRESSURE ABNORMAL,20
VE,ABDOMINAL DISCOMFORT,19
VE,ABORTION SPONTANEOUS,19
VE,AGGRESSION,19
VE,ARTHRITIS,19
VE,CHILLS,19
VE,DISCOMFORT,19
VE,ERYTHEMA,19
VE,MUSCLE RIGIDITY,19
VE,SPINAL PAIN,19
VE,VISUAL IMPAIRMENT,19
VE,BACTERIAL INFECTION,18
VE,CONSTIPATION,18
VE,DEPRESSED MOOD,18
VE,DEVICE RELATED INFECTION,18
VE,DRUG DEPENDENCE,18
VE,FOETAL EXPOSURE DURING PREGNANCY,18
VE,GASTROINTESTINAL DISORDER,18
VE,HEPATIC FAILURE,18
VE,BLOOD GLUCOSE INCREASED,17
VE,COLITIS,17
VE,COLON CANCER,17
VE,DISEASE RECURRENCE,17
VE,DYSPHAGIA,17
VE,FEAR,17
VE,GALLBLADDER DISORDER,17
VE,HYPOAESTHESIA,17
VE,HYPOGLYCAEMIA,17
VE,METASTASES TO LIVER,17
VE,METASTASIS,17
VE,MUSCULAR WEAKNESS,17
VE,PRODUCTIVE COUGH,17
VE,TUBERCULOSIS,17
VE,WHITE BLOOD CELL COUNT DECREASED,17
VE,ANGINA PECTORIS,16
VE,CATARACT,16
VE,CHEST DISCOMFORT,16
VE,DIABETIC FOOT,16
VE,EMPHYSEMA,16
VE,FLUID RETENTION,16
VE,GASTRIC DISORDER,16
VE,HALLUCINATION,16
VE,INTERVERTEBRAL DISC PROTRUSION,16
VE,MENTAL DISORDER,16
VE,MUSCLE SPASMS,16
VE,PSORIASIS,16
VE,SKIN DISCOLOURATION,16
VE,TRANSAMINASES INCREASED,16
VE,WEIGHT INCREASED,16
VE,ACCIDENT,15
VE,BRAIN NEOPLASM,15
VE,CARDIAC FAILURE CONGESTIVE,15
VE,DEMENTIA ALZHEIMER^S TYPE,15
VE,DISEASE COMPLICATION,15
VE,DRUG-INDUCED LIVER INJURY,15
VE,JOINT SWELLING,15
VE,MOUTH ULCERATION,15
VE,NERVOUS SYSTEM DISORDER,15
VE,PARALYSIS,15
VE,POISONING,15
VE,PULMONARY SEPSIS,15
VE,RHEUMATOID ARTHRITIS,15
VE,VISION BLURRED,15
VE,WHITE BLOOD CELL COUNT INCREASED,15
VE,APHASIA,14
VE,BLOOD CHOLESTEROL INCREASED,14
VE,COMA,14
VE,EATING DISORDER,14
VE,EXPIRED PRODUCT ADMINISTERED,14
VE,HEPATIC CIRRHOSIS,14
VE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,14
VE,LIMB DISCOMFORT,14
VE,LYMPHADENOPATHY,14
VE,RESTLESSNESS,14
VE,SKIN ULCER,14
VE,VIRAL INFECTION,14
VE,ABDOMINAL DISTENSION,13
VE,ALOPECIA,13
VE,BLOOD CREATININE INCREASED,13
VE,CHOLELITHIASIS,13
VE,INGUINAL HERNIA,13
VE,INJURY,13
VE,OROPHARYNGEAL PAIN,13
VE,PARAESTHESIA,13
VE,PRODUCT USE IN UNAPPROVED INDICATION,13
VE,SECOND PRIMARY MALIGNANCY,13
VE,VERTIGO,13
VE,WHEEZING,13
VE,ABDOMINAL SEPSIS,12
VE,ABNORMAL BEHAVIOUR,12
VE,AMNESIA,12
VE,APPARENT DEATH,12
VE,BLOOD PRESSURE DECREASED,12
VE,BONE DISORDER,12
VE,BRONCHOPNEUMONIA,12
VE,CORONARY ARTERY OCCLUSION,12
VE,DIVERTICULITIS,12
VE,DYSURIA,12
VE,FRACTURE,12
VE,POST PROCEDURAL COMPLICATION,12
VE,PREMATURE BABY,12
VE,SPINAL DISORDER,12
VE,SPLENOMEGALY,12
VE,TOXICITY TO VARIOUS AGENTS,12
VE,VISUAL ACUITY REDUCED,12
VE,BREAST CYST,11
VE,CONTUSION,11
VE,DECREASED IMMUNE RESPONSIVENESS,11
VE,FEEDING DISORDER,11
VE,FLATULENCE,11
VE,HYPOVOLAEMIC SHOCK,11
VE,IMMUNE SYSTEM DISORDER,11
VE,IMMUNOSUPPRESSION,11
VE,INCORRECT ROUTE OF DRUG ADMINISTRATION,11
VE,INCREASED UPPER AIRWAY SECRETION,11
VE,LEUKAEMIA,11
VE,PANCREATIC CARCINOMA,11
VE,RECTAL HAEMORRHAGE,11
VE,SCHIZOPHRENIA,11
VE,SLEEP DISORDER,11
VE,STOMATITIS,11
VE,STRESS,11
VE,UPPER LIMB FRACTURE,11
VE,UTERINE LEIOMYOMA,11
VE,ANGINA UNSTABLE,10
VE,BALANCE DISORDER,10
VE,BLOOD GLUCOSE ABNORMAL,10
VE,BLOOD PRESSURE INADEQUATELY CONTROLLED,10
VE,CHRONIC KIDNEY DISEASE,10
VE,CHRONIC MYELOID LEUKAEMIA RECURRENT,10
VE,CYANOSIS,10
VE,DEAFNESS,10
VE,DYSKINESIA,10
VE,EYE HAEMORRHAGE,10
VE,FEELING OF DESPAIR,10
VE,GASTRIC CANCER,10
VE,GLAUCOMA,10
VE,HAEMOPTYSIS,10
VE,HYPERTENSIVE CARDIOMYOPATHY,10
VE,INTENTIONAL PRODUCT MISUSE,10
VE,LEUKOCYTOSIS,10
VE,LOWER LIMB FRACTURE,10
VE,MOOD ALTERED,10
VE,ORAL DISORDER,10
VE,PSEUDOMONAS INFECTION,10
VE,PSYCHOTIC DISORDER,10
VE,PULMONARY FIBROSIS,10
VE,SERUM FERRITIN INCREASED,10
VE,THERAPY CESSATION,10
VE,VAGINAL HAEMORRHAGE,10
VE,VARICOSE VEIN,10
VE,APHONIA,9
VE,BLOOD DISORDER,9
VE,BRONCHOSPASM,9
VE,CEREBRAL HAEMORRHAGE,9
VE,DEEP VEIN THROMBOSIS,9
VE,DIABETIC COMPLICATION,9
VE,DRUG PRESCRIBING ERROR,9
VE,GUN SHOT WOUND,9
VE,HAEMATOMA,9
VE,HERNIA,9
VE,HYPOACUSIS,9
VE,IMPAIRED HEALING,9
VE,JOINT INJURY,9
VE,LOWER RESPIRATORY TRACT INFECTION,9
VE,METASTASES TO LUNG,9
VE,MUSCULOSKELETAL PAIN,9
VE,NEUROPATHY PERIPHERAL,9
VE,PERITONITIS,9
VE,PULMONARY HYPERTENSION,9
VE,RHINITIS,9
VE,SICKLE CELL ANAEMIA WITH CRISIS,9
VE,SINUSITIS,9
VE,SKIN LESION,9
VE,SPINAL FRACTURE,9
VE,WRIST FRACTURE,9
VE,ABSCESS,8
VE,AORTIC ANEURYSM,8
VE,ARTERIAL OCCLUSIVE DISEASE,8
VE,ATRIAL FIBRILLATION,8
VE,BACK DISORDER,8
VE,BLISTER,8
VE,BLOOD TRIGLYCERIDES INCREASED,8
VE,BONE FISSURE,8
VE,CAESAREAN SECTION,8
VE,CEREBRAL DISORDER,8
VE,CEREBRAL INFARCTION,8
VE,CHRONIC MYELOID LEUKAEMIA,8
VE,CONFUSIONAL STATE,8
VE,CRYING,8
VE,DERMATITIS,8
VE,DRY SKIN,8
VE,DYSPHONIA,8
VE,ENDOCARDITIS BACTERIAL,8
VE,FLAVIVIRUS INFECTION,8
VE,GENERALISED OEDEMA,8
VE,HAEMODYNAMIC INSTABILITY,8
VE,HERPES ZOSTER,8
VE,INTESTINAL INFARCTION,8
VE,ISCHAEMIC CARDIOMYOPATHY,8
VE,LIMB INJURY,8
VE,LIVER INJURY,8
VE,LOCALISED INFECTION,8
VE,METASTASES TO CENTRAL NERVOUS SYSTEM,8
VE,PANCREATITIS,8
VE,PANCYTOPENIA,8
VE,PLATELET COUNT INCREASED,8
VE,PULMONARY MASS,8
VE,RASH GENERALISED,8
VE,RENAL FAILURE CHRONIC,8
VE,RENAL IMPAIRMENT,8
VE,RESPIRATORY TRACT CONGESTION,8
VE,RETINAL DETACHMENT,8
VE,RHINORRHOEA,8
VE,SNEEZING,8
VE,SUICIDE ATTEMPT,8
VE,THROMBOCYTOPENIA,8
VE,THROMBOPHLEBITIS,8
VE,THYROID NEOPLASM,8
VE,TYPE 2 DIABETES MELLITUS,8
VE,UMBILICAL HERNIA,8
VE,UPPER GASTROINTESTINAL HAEMORRHAGE,8
VE,VASCULITIS,8
VE,ACTIVITIES OF DAILY LIVING IMPAIRED,7
VE,ANGIOSCLEROSIS,7
VE,ANKLE FRACTURE,7
VE,APPENDICITIS,7
VE,ARTHRITIS INFECTIVE,7
VE,BLOOD BILIRUBIN INCREASED,7
VE,BLOOD IMMUNOGLOBULIN E INCREASED,7
VE,BLOOD IRON INCREASED,7
VE,BLOOD UREA INCREASED,7
VE,BRAIN OEDEMA,7
VE,BRONCHIAL DISORDER,7
VE,CEREBRAL ISCHAEMIA,7
VE,CERVIX CARCINOMA,7
VE,DISORIENTATION,7
VE,DYSPEPSIA,7
VE,EMOTIONAL DISORDER,7
VE,EYE INFECTION,7
VE,FOOT DEFORMITY,7
VE,HAEMATURIA,7
VE,HAND FRACTURE,7
VE,HEPATIC CANCER,7
VE,HYPOTHYROIDISM,7
VE,HYSTERECTOMY,7
VE,IMMUNODEFICIENCY,7
VE,JAUNDICE,7
VE,KIDNEY INFECTION,7
VE,MALNUTRITION,7
VE,MIGRAINE,7
VE,MULTIPLE SCLEROSIS RELAPSE,7
VE,NO ADVERSE EVENT,7
VE,OSTEOMYELITIS,7
VE,OVARIAN NEOPLASM,7
VE,PALLOR,7
VE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,7
VE,PHLEBITIS,7
VE,POLLAKIURIA,7
VE,PROSTATITIS,7
VE,RENAL FAILURE ACUTE,7
VE,ROTATOR CUFF SYNDROME,7
VE,TERMINAL STATE,7
VE,UNINTENDED PREGNANCY,7
VE,UROSEPSIS,7
VE,ABORTION,6
VE,ACUTE CORONARY SYNDROME,6
VE,AMOEBIASIS,6
VE,APATHY,6
VE,ARTERIOSCLEROSIS,6
VE,BONE CANCER,6
VE,BONE CYST,6
VE,BRAIN HYPOXIA,6
VE,BREAST MASS,6
VE,CARDIOGENIC SHOCK,6
VE,CARPAL TUNNEL SYNDROME,6
VE,CYST,6
VE,DIET REFUSAL,6
VE,DYSPNOEA EXERTIONAL,6
VE,EYE PAIN,6
VE,FACE OEDEMA,6
VE,FEELING HOT,6
VE,FOOT FRACTURE,6
VE,GASTRIC HAEMORRHAGE,6
VE,HAEMATOCHEZIA,6
VE,HEAD DISCOMFORT,6
VE,HEPATIC STEATOSIS,6
VE,HEPATOMEGALY,6
VE,HYPOTONIA,6
VE,INFUSION RELATED REACTION,6
VE,INTRACRANIAL ANEURYSM,6
VE,LABYRINTHITIS,6
VE,MENINGITIS,6
VE,MICTURITION DISORDER,6
VE,MOTOR DYSFUNCTION,6
VE,MYELODYSPLASTIC SYNDROME,6
VE,NECK PAIN,6
VE,NEPHROPATHY,6
VE,NEUTROPENIA,6
VE,NEUTROPHIL COUNT DECREASED,6
VE,NORMAL NEWBORN,6
VE,OBESITY,6
VE,OCULAR HYPERAEMIA,6
VE,OVARIAN CYST,6
VE,PALPITATIONS,6
VE,PARTIAL SEIZURES,6
VE,PERIPHERAL VASCULAR DISORDER,6
VE,PETIT MAL EPILEPSY,6
VE,PROCEDURAL COMPLICATION,6
VE,PRODUCT QUALITY ISSUE,6
VE,RESPIRATORY TRACT INFECTION BACTERIAL,6
VE,SOFT TISSUE INFECTION,6
VE,STEVENS-JOHNSON SYNDROME,6
VE,THERAPEUTIC RESPONSE DECREASED,6
VE,UNDERDOSE,6
VE,URINARY INCONTINENCE,6
VE,URTICARIA,6
VE,UTERINE CANCER,6
VE,VARICOSE ULCERATION,6
VE,ABDOMINAL ADHESIONS,5
VE,ABORTION THREATENED,5
VE,ANTI FACTOR VIII ANTIBODY POSITIVE,5
VE,BENIGN PROSTATIC HYPERPLASIA,5
VE,BIPOLAR DISORDER,5
VE,BLADDER CANCER,5
VE,BLOOD CHROMOGRANIN A INCREASED,5
VE,BLOOD IRON DECREASED,5
VE,BLOOD URINE PRESENT,5
VE,BURNING SENSATION,5
VE,CARDIAC DEATH,5
VE,CARDIOPULMONARY FAILURE,5
VE,COLITIS ISCHAEMIC,5
VE,DELAYED RECOVERY FROM ANAESTHESIA,5
VE,DIABETIC FOOT INFECTION,5
VE,DYSGRAPHIA,5
VE,EAR INFECTION,5
VE,ENDOCARDITIS,5
VE,FEELING COLD,5
VE,FLUSHING,5
VE,GASTROINTESTINAL INFLAMMATION,5
VE,HAEMATEMESIS,5
VE,HEART RATE INCREASED,5
VE,HEPATIC NEOPLASM,5
VE,HERNIAL EVENTRATION,5
VE,HIP ARTHROPLASTY,5
VE,HOT FLUSH,5
VE,HYDROCEPHALUS,5
VE,HYPERTENSIVE EMERGENCY,5
VE,HYPOPHAGIA,5
VE,INFECTION PARASITIC,5
VE,INFLUENZA LIKE ILLNESS,5
VE,INTERSTITIAL LUNG DISEASE,5
VE,IRRITABLE BOWEL SYNDROME,5
VE,JOINT DISLOCATION,5
VE,KIDNEY TRANSPLANT REJECTION,5
VE,LABORATORY TEST ABNORMAL,5
VE,LEUKOPENIA,5
VE,LIPOMA,5
VE,LOCAL SWELLING,5
VE,MASS,5
VE,MUCOSAL INFLAMMATION,5
VE,MULTI-ORGAN FAILURE,5
VE,MULTIPLE SCLEROSIS,5
VE,MUSCULOSKELETAL DISORDER,5
VE,NASOPHARYNGITIS,5
VE,NODULE,5
VE,OBSTRUCTIVE AIRWAYS DISORDER,5
VE,OXYGEN SATURATION DECREASED,5
VE,PLASMA CELL MYELOMA,5
VE,POSTURE ABNORMAL,5
VE,PREGNANCY,5
VE,RENAL COLIC,5
VE,RENAL CYST,5
VE,RENAL NEOPLASM,5
VE,SCAR,5
VE,SKIN EXFOLIATION,5
VE,SPINAL COLUMN INJURY,5
VE,SPINAL CORD COMPRESSION,5
VE,SUBCUTANEOUS ABSCESS,5
VE,SURGERY,5
VE,SYNOVIAL CYST,5
VE,THYROID DISORDER,5
VE,TINNITUS,5
VE,TONSILLITIS,5
VE,TOOTH DISORDER,5
VE,ULCER,5
VE,UTERINE HAEMORRHAGE,5
VE,VIITH NERVE PARALYSIS,5
VE,WOUND INFECTION,5
VE,WRONG DRUG ADMINISTERED,5
VE,ABSCESS LIMB,4
VE,ACCIDENT AT WORK,4
VE,ACNE,4
VE,ADRENAL INSUFFICIENCY,4
VE,ANAL FISTULA,4
VE,ANGIOEDEMA,4
VE,ANGIOPATHY,4
VE,ARTHRITIS BACTERIAL,4
VE,ASCITES,4
VE,ASPIRATION BRONCHIAL,4
VE,BENIGN NEOPLASM OF THYROID GLAND,4
VE,BILE DUCT OBSTRUCTION,4
VE,BLADDER DISORDER,4
VE,BLINDNESS UNILATERAL,4
VE,BLOOD GLUCOSE DECREASED,4
VE,BONE MARROW FAILURE,4
VE,BRADYCARDIA,4
VE,BRAIN DEATH,4
VE,BREAST CANCER FEMALE,4
VE,CENTRAL NERVOUS SYSTEM LESION,4
VE,CONCOMITANT DISEASE AGGRAVATED,4
VE,CORONARY ARTERY DISEASE,4
VE,CYSTITIS,4
VE,CYTOGENETIC ANALYSIS ABNORMAL,4
VE,DECUBITUS ULCER,4
VE,DEVICE DISLOCATION,4
VE,DIABETIC COMA,4
VE,DIABETIC KETOACIDOSIS,4
VE,DIPLEGIA,4
VE,DRUG ADMINISTRATION ERROR,4
VE,DRUG EFFECT INCOMPLETE,4
VE,DRUG RESISTANCE,4
VE,DRY EYE,4
VE,DYSARTHRIA,4
VE,ELECTROLYTE IMBALANCE,4
VE,EXPOSURE DURING BREAST FEEDING,4
VE,EYE MOVEMENT DISORDER,4
VE,EYELID PTOSIS,4
VE,FEBRILE NEUTROPENIA,4
VE,GALLBLADDER PAIN,4
VE,GASTRIC ULCER,4
VE,GASTRIC ULCER HAEMORRHAGE,4
VE,GASTROINTESTINAL CARCINOMA,4
VE,GASTROINTESTINAL INFECTION,4
VE,GENERAL PHYSICAL CONDITION ABNORMAL,4
VE,GINGIVAL BLEEDING,4
VE,HAEMATOLOGY TEST ABNORMAL,4
VE,HAEMOLYSIS,4
VE,HAEMOLYTIC ANAEMIA,4
VE,HAEMORRHOIDS,4
VE,HEMIPARESIS,4
VE,HEMIPLEGIA,4
VE,HEPATIC LESION,4
VE,HEPATITIS A,4
VE,HEPATOTOXICITY,4
VE,HYPERSOMNIA,4
VE,HYPERTENSIVE HEART DISEASE,4
VE,HYPOTHERMIA,4
VE,INCONTINENCE,4
VE,INFECTED SKIN ULCER,4
VE,INFECTIOUS MONONUCLEOSIS,4
VE,INJECTION SITE PAIN,4
VE,INTELLECTUAL DISABILITY,4
VE,INTENTIONAL SELF-INJURY,4
VE,LARYNGEAL OEDEMA,4
VE,LEUKAEMIA RECURRENT,4
VE,LEUKOENCEPHALOPATHY,4
VE,LIGAMENT SPRAIN,4
VE,LOW BIRTH WEIGHT BABY,4
VE,LYMPHOMA,4
VE,MASTICATION DISORDER,4
VE,METASTATIC NEOPLASM,4
VE,MOUTH INJURY,4
VE,MUSCULOSKELETAL CHEST PAIN,4
VE,MUSCULOSKELETAL DISCOMFORT,4
VE,MYCOSIS FUNGOIDES,4
VE,NECROSIS,4
VE,NEOPLASM PROGRESSION,4
VE,NEURALGIA,4
VE,NO THERAPEUTIC RESPONSE,4
VE,NON-HODGKIN^S LYMPHOMA,4
VE,ORAL DISCOMFORT,4
VE,ORGAN FAILURE,4
VE,OSTEONECROSIS OF JAW,4
VE,OSTEOPENIA,4
VE,PANCREATITIS ACUTE,4
VE,PITUITARY TUMOUR,4
VE,PNEUMONIA BACTERIAL,4
VE,PNEUMOTHORAX,4
VE,POST PROCEDURAL INFECTION,4
VE,PREMATURE LABOUR,4
VE,PRESCRIBED OVERDOSE,4
VE,PROCEDURAL PAIN,4
VE,PRURITUS GENERALISED,4
VE,PSORIATIC ARTHROPATHY,4
VE,PSYCHOMOTOR HYPERACTIVITY,4
VE,PULMONARY FUNCTION TEST DECREASED,4
VE,PULMONARY HAEMORRHAGE,4
VE,PULMONARY INFARCTION,4
VE,PULMONARY THROMBOSIS,4
VE,PYELONEPHRITIS,4
VE,RASH MACULAR,4
VE,RETINAL HAEMORRHAGE,4
VE,SCOLIOSIS,4
VE,SKIN DISORDER,4
VE,SKIN INFECTION,4
VE,SPINAL DEFORMITY,4
VE,SUICIDAL IDEATION,4
VE,TEMPERATURE INTOLERANCE,4
VE,TENDON RUPTURE,4
VE,TENDONITIS,4
VE,TENSION,4
VE,THINKING ABNORMAL,4
VE,TREATMENT FAILURE,4
VE,TREATMENT NONCOMPLIANCE,4
VE,TUBERCULIN TEST,4
VE,TUMOUR INVASION,4
VE,UNRESPONSIVE TO STIMULI,4
VE,URINARY RETENTION,4
VE,UVEITIS,4
VE,VASCULAR OCCLUSION,4
VE,ACINETOBACTER INFECTION,3
VE,ACUTE RESPIRATORY FAILURE,3
VE,ALANINE AMINOTRANSFERASE INCREASED,3
VE,ALTERED STATE OF CONSCIOUSNESS,3
VE,AMOEBIC DYSENTERY,3
VE,ANAL HAEMORRHAGE,3
VE,ANEURYSM,3
VE,APNOEA,3
VE,ASPARTATE AMINOTRANSFERASE INCREASED,3
VE,ATRIAL THROMBOSIS,3
VE,AUTISM,3
VE,BEDRIDDEN,3
VE,BENIGN OVARIAN TUMOUR,3
VE,BLADDER PROLAPSE,3
VE,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,3
VE,BLOOD CALCIUM DECREASED,3
VE,BLOOD COUNT ABNORMAL,3
VE,BLOOD INSULIN INCREASED,3
VE,BLOOD PRESSURE SYSTOLIC INCREASED,3
VE,BLOOD PROLACTIN INCREASED,3
VE,BLOOD SODIUM DECREASED,3
VE,BONE DECALCIFICATION,3
VE,BONE MARROW DISORDER,3
VE,BRAIN INJURY,3
VE,BRAIN NEOPLASM MALIGNANT,3
VE,BREAST NEOPLASM,3
VE,BRONCHIAL OBSTRUCTION,3
VE,CANDIDA INFECTION,3
VE,CARDIAC MURMUR,3
VE,CARDIAC VALVE DISEASE,3
VE,CARDIOMEGALY,3
VE,CARTILAGE INJURY,3
VE,CEREBRAL ARTERY EMBOLISM,3
VE,CEREBRAL THROMBOSIS,3
VE,CHROMATURIA,3
VE,COLITIS ULCERATIVE,3
VE,COMPLETED SUICIDE,3
VE,COORDINATION ABNORMAL,3
VE,CROHN^S DISEASE,3
VE,DECREASED ACTIVITY,3
VE,DEFORMITY,3
VE,DELIRIUM,3
VE,DEMENTIA,3
VE,DERMATITIS ALLERGIC,3
VE,DEVICE MALFUNCTION,3
VE,DIABETES MELLITUS INADEQUATE CONTROL,3
VE,DIARRHOEA HAEMORRHAGIC,3
VE,DISTURBANCE IN ATTENTION,3
VE,DIVERTICULUM,3
VE,DIZZINESS POSTURAL,3
VE,DRUG EFFECT DECREASED,3
VE,DRUG HYPERSENSITIVITY,3
VE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
VE,DRUG LEVEL DECREASED,3
VE,DRUG WITHDRAWAL SYNDROME,3
VE,EAR DISCOMFORT,3
VE,EAR PAIN,3
VE,EMBOLIA CUTIS MEDICAMENTOSA,3
VE,EMBOLISM,3
VE,EMOTIONAL DISTRESS,3
VE,ENCEPHALOPATHY,3
VE,ENTEROCOLITIS BACTERIAL,3
VE,EOSINOPHIL COUNT INCREASED,3
VE,ERYTHEMA MULTIFORME,3
VE,ERYTHEMA NODOSUM,3
VE,ESCHERICHIA INFECTION,3
VE,EYE IRRITATION,3
VE,EYE OPERATION,3
VE,EYE SWELLING,3
VE,EYELID OEDEMA,3
VE,FACE INJURY,3
VE,FACIAL PAIN,3
VE,FACIAL PARALYSIS,3
VE,FIBROMATOSIS,3
VE,FIBULA FRACTURE,3
VE,FINGERPRINT LOSS,3
VE,FOOD INTOLERANCE,3
VE,GALLBLADDER OPERATION,3
VE,GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE,3
VE,GASTROINTESTINAL NECROSIS,3
VE,GASTROOESOPHAGEAL REFLUX DISEASE,3
VE,GENERALISED TONIC-CLONIC SEIZURE,3
VE,GRIP STRENGTH DECREASED,3
VE,GUILLAIN-BARRE SYNDROME,3
VE,HAEMANGIOMA,3
VE,HAEMATOCRIT DECREASED,3
VE,HAEMATOTOXICITY,3
VE,HAEMOGLOBIN ABNORMAL,3
VE,HEARING IMPAIRED,3
VE,HEART RATE DECREASED,3
VE,HEPATIC ENZYME INCREASED,3
VE,HEPATITIS B,3
VE,HEPATITIS C,3
VE,HEPATOCELLULAR CARCINOMA,3
VE,HIATUS HERNIA,3
VE,HOMICIDE,3
VE,HYPERCHOLESTEROLAEMIA,3
VE,HYPOCALCAEMIA,3
VE,HYPOVOLAEMIA,3
VE,HYPOXIA,3
VE,INCOHERENT,3
VE,INCREASED BRONCHIAL SECRETION,3
VE,INJECTION SITE ERYTHEMA,3
VE,INSULIN-LIKE GROWTH FACTOR INCREASED,3
VE,INTERNAL HAEMORRHAGE,3
VE,INTERVERTEBRAL DISC COMPRESSION,3
VE,INTESTINAL SEPSIS,3
VE,INTRAOCULAR PRESSURE INCREASED,3
VE,JOINT STIFFNESS,3
VE,LACRIMATION INCREASED,3
VE,LEPROSY,3
VE,LETHARGY,3
VE,LUMBAR VERTEBRAL FRACTURE,3
VE,LUNG NEOPLASM,3
VE,LUPUS NEPHRITIS,3
VE,LYMPHOCYTE COUNT INCREASED,3
VE,MAJOR DEPRESSION,3
VE,MATERNAL EXPOSURE TIMING UNSPECIFIED,3
VE,MELANOCYTIC NAEVUS,3
VE,MENISCAL DEGENERATION,3
VE,MENSTRUAL DISORDER,3
VE,MENTAL RETARDATION,3
VE,METASTASES TO LYMPH NODES,3
VE,METASTASES TO SPINE,3
VE,MIXED LIVER INJURY,3
VE,MONOPLEGIA,3
VE,MOUTH HAEMORRHAGE,3
VE,MULTIPLE INJURIES,3
VE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
VE,MUSCLE SPASTICITY,3
VE,MYOCARDIAL HAEMORRHAGE,3
VE,NASAL OBSTRUCTION,3
VE,NASAL POLYPS,3
VE,NEOPLASM PROSTATE,3
VE,NEPHROTIC SYNDROME,3
VE,NEURITIS,3
VE,NEUROLOGICAL SYMPTOM,3
VE,NOSOCOMIAL INFECTION,3
VE,OEDEMA,3
VE,OEDEMA MOUTH,3
VE,OVERDOSE,3
VE,PANCREATIC DISORDER,3
VE,PAPILLOEDEMA,3
VE,PAPULE,3
VE,PARONYCHIA,3
VE,PELVIC FRACTURE,3
VE,PELVIC PAIN,3
VE,PERICARDIAL EFFUSION,3
VE,PETECHIAE,3
VE,PHARYNGITIS,3
VE,PIGMENTATION DISORDER,3
VE,PNEUMONITIS,3
VE,POLYDIPSIA,3
VE,PRE-ECLAMPSIA,3
VE,PRODUCT DISTRIBUTION ISSUE,3
VE,PROSTATIC DISORDER,3
VE,PROTEINURIA,3
VE,PSYCHIATRIC DECOMPENSATION,3
VE,PULSE ABNORMAL,3
VE,PURULENT DISCHARGE,3
VE,RENAL CANCER,3
VE,RENAL CANCER METASTATIC,3
VE,RENAL INJURY,3
VE,RHINITIS ALLERGIC,3
VE,RIB FRACTURE,3
VE,SALMONELLOSIS,3
VE,SCIATICA,3
VE,SEDATION,3
VE,SEPTIC EMBOLUS,3
VE,SEPTIC VASCULITIS,3
VE,SHOCK,3
VE,SICKLE CELL ANAEMIA,3
VE,SKIN BURNING SENSATION,3
VE,SKIN CANCER,3
VE,SKIN INJURY,3
VE,SKULL FRACTURE,3
VE,SLUGGISHNESS,3
VE,SPLEEN DISORDER,3
VE,STAPHYLOCOCCAL INFECTION,3
VE,STARING,3
VE,STILLBIRTH,3
VE,SUPERIOR VENA CAVA SYNDROME,3
VE,SYSTEMIC INFECTION,3
VE,THERAPY NON-RESPONDER,3
VE,THERMAL BURN,3
VE,THREATENED LABOUR,3
VE,THROAT IRRITATION,3
VE,THYROID CANCER,3
VE,TONGUE BITING,3
VE,TONGUE DISORDER,3
VE,TONIC CLONIC MOVEMENTS,3
VE,TOOTH FRACTURE,3
VE,TOOTHACHE,3
VE,TOTAL LUNG CAPACITY DECREASED,3
VE,TOXIC EPIDERMAL NECROLYSIS,3
VE,TRIGEMINAL NEURALGIA,3
VE,ULCERATIVE KERATITIS,3
VE,UMBILICAL CORD AROUND NECK,3
VE,URINARY TRACT DISORDER,3
VE,UTERINE DISORDER,3
VE,VENOUS THROMBOSIS,3
VE,VISUAL FIELD DEFECT,3
VE,ABDOMINAL INFECTION,2
VE,ABDOMINAL INJURY,2
VE,ABSCESS NECK,2
VE,ABSCESS ORAL,2
VE,ACROMEGALY,2
VE,ACUTE KIDNEY INJURY,2
VE,ADENOCARCINOMA,2
VE,ADENOCARCINOMA PANCREAS,2
VE,ADVERSE DRUG REACTION,2
VE,AGE-RELATED MACULAR DEGENERATION,2
VE,AGITATION,2
VE,AMNIOTIC FLUID VOLUME DECREASED,2
VE,ANAL ABSCESS,2
VE,ANTINUCLEAR ANTIBODY POSITIVE,2
VE,ANURIA,2
VE,AORTIC DISORDER,2
VE,ARTERIAL DISORDER,2
VE,ASTHENOPIA,2
VE,ATAXIA,2
VE,AZOTAEMIA,2
VE,BACTERAEMIA,2
VE,BACTERIAL SEPSIS,2
VE,BENIGN BREAST NEOPLASM,2
VE,BLIGHTED OVUM,2
VE,BLISTER RUPTURE,2
VE,BLOOD CHOLESTEROL ABNORMAL,2
VE,BLOOD GLUCOSE FLUCTUATION,2
VE,BLOOD POTASSIUM DECREASED,2
VE,BLOOD POTASSIUM INCREASED,2
VE,BLOOD PRESSURE FLUCTUATION,2
VE,BLOOD TRIGLYCERIDES ABNORMAL,2
VE,BLOOD URIC ACID INCREASED,2
VE,BLUE TOE SYNDROME,2
VE,BONE DENSITY ABNORMAL,2
VE,BONE NEOPLASM,2
VE,BREAST CANCER METASTATIC,2
VE,BREAST ENLARGEMENT,2
VE,BREAST SWELLING,2
VE,BRONCHIECTASIS,2
VE,BRONCHITIS VIRAL,2
VE,BURSITIS,2
VE,CALCINOSIS,2
VE,CARDIAC INFECTION,2
VE,CARDIAC PACEMAKER INSERTION,2
VE,CARDIOMYOPATHY,2
VE,CARDIOVASCULAR SYMPTOM,2
VE,CATHETERISATION CARDIAC,2
VE,CENTRAL NERVOUS SYSTEM INFLAMMATION,2
VE,CENTRAL NERVOUS SYSTEM NECROSIS,2
VE,CEREBRAL ATROPHY,2
VE,CEREBRAL CALCIFICATION,2
VE,CERVIX CANCER METASTATIC,2
VE,CERVIX DISORDER,2
VE,CHOKING SENSATION,2
VE,CHOLECYSTECTOMY,2
VE,CHOLESTATIC LIVER INJURY,2
VE,CHRONIC GASTRITIS,2
VE,COAGULOPATHY,2
VE,COGNITIVE DISORDER,2
VE,COLON ADENOMA,2
VE,COLON CANCER METASTATIC,2
VE,COLPOCELE,2
VE,CONGESTIVE CARDIOMYOPATHY,2
VE,CONVERSION DISORDER,2
VE,CUSHING^S SYNDROME,2
VE,CYTOMEGALOVIRUS INFECTION,2
VE,DEMYELINATION,2
VE,DENTAL CARIES,2
VE,DERMAL CYST,2
VE,DERMATITIS EXFOLIATIVE,2
VE,DEVICE EXPULSION,2
VE,DIABETIC METABOLIC DECOMPENSATION,2
VE,DILATATION ATRIAL,2
VE,DROOLING,2
VE,DROWNING,2
VE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,2
VE,DRUG ERUPTION,2
VE,DRY MOUTH,2
VE,DRY THROAT,2
VE,DYSLIPIDAEMIA,2
VE,DYSPNOEA AT REST,2
VE,EAR DISORDER,2
VE,EAR HAEMORRHAGE,2
VE,ECCHYMOSIS,2
VE,EMBOLIC STROKE,2
VE,EMBOLISM VENOUS,2
VE,ENCAPSULATION REACTION,2
VE,ENCEPHALITIS,2
VE,ENCEPHALITIS VIRAL,2
VE,ENDOMETRIAL CANCER,2
VE,ENDOPHTHALMITIS,2
VE,EPSTEIN-BARR VIRUS INFECTION,2
VE,ERUCTATION,2
VE,ERYSIPELAS,2
VE,EXCESSIVE CERUMEN PRODUCTION,2
VE,EXOSTOSIS,2
VE,EXPIRED DRUG ADMINISTERED,2
VE,EXTREMITY CONTRACTURE,2
VE,EXTREMITY NECROSIS,2
VE,EYE DISCHARGE,2
VE,EYE INJURY,2
VE,EYE PRURITUS,2
VE,EYELID DISORDER,2
VE,FAECALOMA,2
VE,FAT EMBOLISM,2
VE,FIBROMYALGIA,2
VE,FISTULA,2
VE,FLUID IMBALANCE,2
VE,FOETAL HEART RATE DECREASED,2
VE,FRACTURED SACRUM,2
VE,FUNGAL INFECTION,2
VE,FUNGAL SKIN INFECTION,2
VE,GALLBLADDER PERFORATION,2
VE,GALLBLADDER POLYP,2
VE,GASTRIC NEOPLASM,2
VE,GASTRITIS EROSIVE,2
VE,GASTRITIS HAEMORRHAGIC,2
VE,GASTROINTESTINAL HYPOMOTILITY,2
VE,GASTROINTESTINAL PAIN,2
VE,GENE MUTATION IDENTIFICATION TEST POSITIVE,2
VE,GLOSSITIS,2
VE,GLOSSODYNIA,2
VE,GOITRE,2
VE,GRAND MAL CONVULSION,2
VE,GRANULOMA,2
VE,GROIN ABSCESS,2
VE,GROIN PAIN,2
VE,HAEMATOCRIT INCREASED,2
VE,HAEMODIALYSIS,2
VE,HAEMOGLOBIN INCREASED,2
VE,HAEMORRHAGE CORONARY ARTERY,2
VN,ASTHENIA,124
VN,DEATH,121
VN,CEREBROVASCULAR ACCIDENT,116
VN,FATIGUE,89
VN,PYREXIA,77
VN,PNEUMONIA,76
VN,CARDIAC FAILURE,69
VN,DYSPNOEA,62
VN,PERITONITIS,62
VN,HYPERTENSION,59
VN,MALNUTRITION,52
VN,CARDIOVASCULAR DISORDER,51
VN,RASH,50
VN,DIARRHOEA,45
VN,PERITONITIS BACTERIAL,45
VN,ANAEMIA,42
VN,VOMITING,38
VN,RESPIRATORY FAILURE,36
VN,HYPOTENSION,35
VN,WHITE BLOOD CELL COUNT DECREASED,35
VN,DRUG RESISTANCE,32
VN,DRUG INEFFECTIVE,31
VN,MYOCARDIAL INFARCTION,30
VN,NEUTROPENIA,29
VN,PERITONEAL DIALYSIS COMPLICATION,28
VN,SEIZURE,28
VN,DECREASED APPETITE,27
VN,DIABETIC COMPLICATION,27
VN,GASTROINTESTINAL HAEMORRHAGE,24
VN,HEADACHE,24
VN,MALIGNANT NEOPLASM PROGRESSION,24
VN,PLATELET COUNT DECREASED,23
VN,PRURITUS,23
VN,CHEST PAIN,22
VN,MALAISE,22
VN,VIROLOGIC FAILURE,22
VN,BLOOD PRESSURE INCREASED,21
VN,SEPSIS,21
VN,HAEMOGLOBIN DECREASED,20
VN,NAUSEA,20
VN,CHILLS,19
VN,GASTROINTESTINAL DISORDER,19
VN,THROMBOCYTOPENIA,19
VN,CEREBRAL HAEMORRHAGE,18
VN,HEART RATE INCREASED,18
VN,CARDIAC DISORDER,17
VN,HYPOPHAGIA,17
VN,BLOOD PRESSURE DECREASED,16
VN,DIZZINESS,16
VN,INFECTION,16
VN,NO THERAPEUTIC RESPONSE,16
VN,ABDOMINAL PAIN,15
VN,GASTROINTESTINAL STROMAL TUMOUR,15
VN,COMA,14
VN,DISEASE PROGRESSION,14
VN,HYPERGLYCAEMIA,14
VN,FEELING COLD,13
VN,GENERAL PHYSICAL HEALTH DETERIORATION,13
VN,HYPOAESTHESIA,13
VN,CARDIAC ARREST,12
VN,FALL,12
VN,HYPOGLYCAEMIA,12
VN,PARONYCHIA,12
VN,ALANINE AMINOTRANSFERASE INCREASED,11
VN,ASPARTATE AMINOTRANSFERASE INCREASED,11
VN,DIABETES MELLITUS,11
VN,SHOCK,11
VN,TRANSAMINASES INCREASED,11
VN,ALOPECIA,10
VN,ANAPHYLACTIC SHOCK,10
VN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,10
VN,PLEURAL EFFUSION,10
VN,ANAPHYLACTIC REACTION,9
VN,CIRCULATORY COLLAPSE,9
VN,COUGH,9
VN,DISEASE COMPLICATION,9
VN,GASTRITIS,9
VN,HYPERHIDROSIS,9
VN,HYPERTENSIVE CRISIS,9
VN,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,9
VN,PAIN,9
VN,RENAL FAILURE,9
VN,SEPTIC SHOCK,9
VN,TUBERCULOSIS,9
VN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,9
VN,ARTHRALGIA,8
VN,CACHEXIA,8
VN,CEREBRAL INFARCTION,8
VN,CHEST DISCOMFORT,8
VN,COAGULOPATHY,8
VN,CYANOSIS,8
VN,GASTRIC HAEMORRHAGE,8
VN,HAEMOPTYSIS,8
VN,HYPERSENSITIVITY,8
VN,INFUSION RELATED REACTION,8
VN,LUNG NEOPLASM MALIGNANT,8
VN,PALLOR,8
VN,PERITONEAL TUBERCULOSIS,8
VN,TACHYCARDIA,8
VN,WEIGHT DECREASED,8
VN,DERMATITIS,7
VN,FEBRILE NEUTROPENIA,7
VN,FEMUR FRACTURE,7
VN,HAEMATOTOXICITY,7
VN,HEPATIC ENZYME INCREASED,7
VN,INSOMNIA,7
VN,LOSS OF CONSCIOUSNESS,7
VN,METASTASES TO LIVER,7
VN,MOUTH ULCERATION,7
VN,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,7
VN,ROAD TRAFFIC ACCIDENT,7
VN,STOMATITIS,7
VN,THERAPY NON-RESPONDER,7
VN,URINARY TRACT INFECTION,7
VN,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,6
VN,BLOOD GLUCOSE INCREASED,6
VN,CYTOMEGALOVIRUS INFECTION,6
VN,DYSPEPSIA,6
VN,ELECTROCARDIOGRAM QT PROLONGED,6
VN,HAEMORRHAGE,6
VN,HEPATIC CIRRHOSIS,6
VN,MYALGIA,6
VN,PRURITUS GENERALISED,6
VN,PULMONARY EMBOLISM,6
VN,RED BLOOD CELL COUNT DECREASED,6
VN,URINARY RETENTION,6
VN,WHITE BLOOD CELL COUNT INCREASED,6
VN,ARTHRITIS,5
VN,BLOOD CREATININE INCREASED,5
VN,BLOOD PRESSURE IMMEASURABLE,5
VN,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,5
VN,COMPLETED SUICIDE,5
VN,CONVULSION,5
VN,ELECTROLYTE IMBALANCE,5
VN,EPILEPSY,5
VN,EPISTAXIS,5
VN,HEART RATE DECREASED,5
VN,HEPATIC CANCER,5
VN,HEPATITIS B,5
VN,INFLAMMATION,5
VN,INJECTION SITE SWELLING,5
VN,INTENTIONAL PRODUCT MISUSE,5
VN,INTERVERTEBRAL DISC PROTRUSION,5
VN,MATERNAL EXPOSURE DURING PREGNANCY,5
VN,MENTAL DISORDER,5
VN,MYOCARDIAL ISCHAEMIA,5
VN,NEOPLASM MALIGNANT,5
VN,OEDEMA,5
VN,PERIPHERAL SWELLING,5
VN,PRODUCT USE ISSUE,5
VN,SKIN ULCER,5
VN,SYNCOPE,5
VN,THERAPEUTIC RESPONSE DECREASED,5
VN,TINNITUS,5
VN,VESTIBULAR DISORDER,5
VN,ABDOMINAL PAIN UPPER,4
VN,ABORTION INDUCED,4
VN,ABSCESS,4
VN,ACNE,4
VN,ACUTE KIDNEY INJURY,4
VN,AGEUSIA,4
VN,BACK PAIN,4
VN,BLOOD SODIUM DECREASED,4
VN,DRY SKIN,4
VN,ERYTHEMA,4
VN,EXTRAVASATION,4
VN,EYELID OEDEMA,4
VN,FEEDING DISORDER,4
VN,FRACTURE,4
VN,FUNGAL PERITONITIS,4
VN,HEPATITIS,4
VN,HEPATITIS ACUTE,4
VN,INTESTINAL OBSTRUCTION,4
VN,LEUKAEMIA,4
VN,LYMPHOCYTIC LEUKAEMIA,4
VN,METASTASES TO LUNG,4
VN,MUSCULAR WEAKNESS,4
VN,MUSCULOSKELETAL PAIN,4
VN,NEOPLASM RECURRENCE,4
VN,NERVOUS SYSTEM DISORDER,4
VN,OSTEOARTHRITIS,4
VN,PANCREATITIS,4
VN,PNEUMONITIS,4
VN,PULMONARY HAEMORRHAGE,4
VN,RASH GENERALISED,4
VN,SENSORY LOSS,4
VN,SKIN DISCOLOURATION,4
VN,SOMNOLENCE,4
VN,SPEECH DISORDER,4
VN,TREMOR,4
VN,ULTRAFILTRATION FAILURE,4
VN,ABASIA,3
VN,ABORTION SPONTANEOUS,3
VN,ACUTE PULMONARY OEDEMA,3
VN,ADVERSE EVENT,3
VN,AGITATION,3
VN,ANASTOMOTIC COMPLICATION,3
VN,ARRHYTHMIA,3
VN,ASTHMA,3
VN,ATRIOVENTRICULAR BLOCK,3
VN,BLISTER,3
VN,BLOOD BILIRUBIN INCREASED,3
VN,BLOOD GLUCOSE ABNORMAL,3
VN,BLOOD PRESSURE ABNORMAL,3
VN,BONE PAIN,3
VN,BREAST CANCER,3
VN,CATARACT,3
VN,CELLULITIS,3
VN,DEPRESSED LEVEL OF CONSCIOUSNESS,3
VN,DERMATITIS ACNEIFORM,3
VN,DRUG HYPERSENSITIVITY,3
VN,DRUG-INDUCED LIVER INJURY,3
VN,DYSLIPIDAEMIA,3
VN,EJECTION FRACTION DECREASED,3
VN,EXPOSURE DURING PREGNANCY,3
VN,FEELING ABNORMAL,3
VN,FLUID OVERLOAD,3
VN,FOETAL EXPOSURE DURING PREGNANCY,3
VN,HAEMATOCRIT DECREASED,3
VN,HAEMATURIA,3
VN,HAEMORRHAGE SUBCUTANEOUS,3
VN,HEAD INJURY,3
VN,HEPATIC FUNCTION ABNORMAL,3
VN,HEPATIC LESION,3
VN,HEPATITIS C,3
VN,HIV INFECTION,3
VN,HYPERTHYROIDISM,3
VN,HYPOKALAEMIA,3
VN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
VN,INCORRECT DOSE ADMINISTERED,3
VN,INTENTIONAL PRODUCT USE ISSUE,3
VN,JOINT SWELLING,3
VN,LUNG DISORDER,3
VN,LUNG INFECTION,3
VN,MENINGITIS,3
VN,MUSCLE DISORDER,3
VN,NAIL DISORDER,3
VN,NEOPLASM,3
VN,NEUROPATHY PERIPHERAL,3
VN,OCULAR HYPERAEMIA,3
VN,OCULAR ICTERUS,3
VN,ORAL HERPES,3
VN,PANIC REACTION,3
VN,PERICARDIAL EFFUSION,3
VN,POLLAKIURIA,3
VN,PRODUCTIVE COUGH,3
VN,PROSTATIC SPECIFIC ANTIGEN INCREASED,3
VN,PULMONARY TUBERCULOSIS,3
VN,PULSE ABSENT,3
VN,RASH ERYTHEMATOUS,3
VN,RESPIRATORY ARREST,3
VN,RESPIRATORY DISORDER,3
VN,SEBORRHOEIC DERMATITIS,3
VN,SKIN FISSURES,3
VN,THROAT IRRITATION,3
VN,TOXICITY TO VARIOUS AGENTS,3
VN,UNDERDOSE,3
VN,UNEVALUABLE EVENT,3
VN,URINARY INCONTINENCE,3
VN,URTICARIA,3
VN,VAGINAL HAEMORRHAGE,3
VN,VASCULAR OCCLUSION,3
VN,VISION BLURRED,3
VN,VISUAL IMPAIRMENT,3
VN,ABDOMINAL DISCOMFORT,2
VN,ABDOMINAL DISTENSION,2
VN,ACQUIRED IMMUNODEFICIENCY SYNDROME,2
VN,ACTIVITIES OF DAILY LIVING IMPAIRED,2
VN,ACUTE CORONARY SYNDROME,2
VN,ACUTE MYOCARDIAL INFARCTION,2
VN,ACUTE RESPIRATORY DISTRESS SYNDROME,2
VN,ALTERED STATE OF CONSCIOUSNESS,2
VN,ANGINA UNSTABLE,2
VN,ANXIETY,2
VN,APNOEA,2
VN,ATRIAL FIBRILLATION,2
VN,BLAST CELL COUNT INCREASED,2
VN,BLOOD CHOLESTEROL INCREASED,2
VN,BLOOD LACTATE DEHYDROGENASE INCREASED,2
VN,BLOOD POTASSIUM DECREASED,2
VN,BLOOD PRESSURE SYSTOLIC INCREASED,2
VN,BONE MARROW FAILURE,2
VN,BRAIN INJURY,2
VN,BRONCHITIS,2
VN,CARDIAC FAILURE ACUTE,2
VN,CARDIOMEGALY,2
VN,CATHETER SITE INFECTION,2
VN,CHOKING,2
VN,CHRONIC KIDNEY DISEASE,2
VN,CHRONIC MYELOID LEUKAEMIA,2
VN,CONJUNCTIVAL HYPERAEMIA,2
VN,CONJUNCTIVITIS,2
VN,CONSTIPATION,2
VN,DERMATITIS ALLERGIC,2
VN,DEVICE LEAKAGE,2
VN,DIPLEGIA,2
VN,DISCOMFORT,2
VN,DRUG ADMINISTRATION ERROR,2
VN,DRUG EFFECT INCOMPLETE,2
VN,DRUG INTOLERANCE,2
VN,DRY EYE,2
VN,DYSSTASIA,2
VN,DYSURIA,2
VN,EATING DISORDER,2
VN,END STAGE RENAL DISEASE,2
VN,ENTERITIS,2
VN,EXTREMITY NECROSIS,2
VN,EYE PAIN,2
VN,FACE OEDEMA,2
VN,FASCIOLIASIS,2
VN,FLATULENCE,2
VN,FOAMING AT MOUTH,2
VN,FULL BLOOD COUNT DECREASED,2
VN,FUNGAL INFECTION,2
VN,GAIT DISTURBANCE,2
VN,GASTRIC ULCER,2
VN,GENERALISED OEDEMA,2
VN,GOUT,2
VN,GRANULOCYTOPENIA,2
VN,HAEMORRHAGE INTRACRANIAL,2
VN,HALLUCINATION,2
VN,HEMIPARESIS,2
VN,HEMIPLEGIA,2
VN,HEPATITIS B DNA INCREASED,2
VN,HEPATITIS B SURFACE ANTIGEN POSITIVE,2
VN,HEPATOCELLULAR CARCINOMA,2
VN,HEPATOTOXICITY,2
VN,HERPES ZOSTER,2
VN,HYPERLIPIDAEMIA,2
VN,HYPERURICAEMIA,2
VN,HYPOAESTHESIA ORAL,2
VN,HYPOCALCAEMIA,2
VN,HYPOTONIA,2
VN,ILL-DEFINED DISORDER,2
VN,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS,2
VN,IMPAIRED HEALING,2
VN,INJECTION SITE ABSCESS,2
VN,INJECTION SITE ERYTHEMA,2
VN,INTERSTITIAL LUNG DISEASE,2
VN,INTESTINAL PERFORATION,2
VN,INTRACRANIAL PRESSURE INCREASED,2
VN,INTRAVENTRICULAR HAEMORRHAGE,2
VN,IRRITABILITY,2
VN,JAUNDICE,2
VN,LIMB INJURY,2
VN,LIMB OPERATION,2
VN,LIVER DISORDER,2
VN,LIVER INJURY,2
VN,LOCAL SWELLING,2
VN,LOCALISED INFECTION,2
VN,LYMPHADENOPATHY,2
VN,LYMPHOMA TRANSFORMATION,2
VN,METASTASES TO CENTRAL NERVOUS SYSTEM,2
VN,METASTASES TO LYMPH NODES,2
VN,METASTASES TO PERITONEUM,2
VN,MIGRAINE,2
VN,MUCOSAL DISCOLOURATION,2
VN,MUCOSAL DRYNESS,2
VN,NASOPHARYNGITIS,2
VN,NEOPLASM PROGRESSION,2
VN,NEUTROPHIL COUNT DECREASED,2
VN,OEDEMA PERIPHERAL,2
VN,ONYCHOCLASIS,2
VN,ORAL DISORDER,2
VN,OROPHARYNGEAL PAIN,2
VN,OSTEOPOROSIS,2
VN,OTITIS MEDIA,2
VN,OVERDOSE,2
VN,OXYGEN SATURATION DECREASED,2
VN,PAIN IN EXTREMITY,2
VN,PARAPLEGIA,2
VN,PARKINSON^S DISEASE,2
VN,PATHOGEN RESISTANCE,2
VN,PELVIC NEOPLASM,2
VN,PERITONEAL EFFLUENT ABNORMAL,2
VN,PHARYNGEAL HAEMORRHAGE,2
VN,PLATELET COUNT INCREASED,2
VN,PLATELET TOXICITY,2
VN,POST PROCEDURAL COMPLICATION,2
VN,PRODUCT QUALITY ISSUE,2
VN,PULMONARY OEDEMA,2
VN,PULSE ABNORMAL,2
VN,RADIATION PNEUMONITIS,2
VN,RADIOTHERAPY TO BREAST,2
VN,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
VN,RENAL FAILURE CHRONIC,2
VN,RESPIRATORY RATE INCREASED,2
VN,SECOND PRIMARY MALIGNANCY,2
VN,SINUSITIS,2
VN,SKIN DISORDER,2
VN,SKIN EXFOLIATION,2
VN,SKIN IRRITATION,2
VN,SUBCUTANEOUS ABSCESS,2
VN,THERAPY RESPONDER,2
VN,THROMBOCYTOSIS,2
VN,TRANSPLANT REJECTION,2
VN,TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM,2
VN,ULCER,2
VN,UPPER GASTROINTESTINAL HAEMORRHAGE,2
VN,UPPER LIMB FRACTURE,2
VN,URINARY TRACT INFLAMMATION,2
VN,VASCULAR STENT THROMBOSIS,2
VN,ABDOMINAL LYMPHADENOPATHY,1
VN,ABNORMAL BEHAVIOUR,1
VN,ABSCESS LIMB,1
VN,ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED,1
VN,ACUTE MYELOID LEUKAEMIA,1
VN,ADENOCARCINOMA OF COLON,1
VN,ADENOMA BENIGN,1
VN,ADRENAL NEOPLASM,1
VN,AFFERENT LOOP SYNDROME,1
VN,ALVEOLAR LUNG DISEASE,1
VN,AMBLYOPIA,1
VN,AMNESIA,1
VN,ANGINA PECTORIS,1
VN,ANGIOEDEMA,1
VN,AORTIC ANEURYSM,1
VN,AORTIC STENOSIS,1
VN,APHASIA,1
VN,APPARENT DEATH,1
VN,APPENDICITIS,1
VN,ARTERIOSCLEROSIS,1
VN,ASCITES,1
VN,ASTHENOPIA,1
VN,ATRIAL FLUTTER,1
VN,ATRIAL THROMBOSIS,1
VN,AXILLARY PAIN,1
VN,BACK DISORDER,1
VN,BACTERIAL INFECTION,1
VN,BALANCE DISORDER,1
VN,BLOOD BICARBONATE ABNORMAL,1
VN,BLOOD CALCIUM DECREASED,1
VN,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
VN,BLOOD CREATININE DECREASED,1
VN,BLOOD GLUCOSE DECREASED,1
VN,BLOOD PRESSURE FLUCTUATION,1
VN,BLOOD UREA INCREASED,1
VN,BLOODY PERITONEAL EFFLUENT,1
VN,BODY TEMPERATURE DECREASED,1
VN,BONE CANCER,1
VN,BONE DENSITY ABNORMAL,1
VN,BONE EROSION,1
VN,BRADYCARDIA,1
VN,BRAIN ABSCESS,1
VN,BRAIN NATRIURETIC PEPTIDE INCREASED,1
VN,BRAIN NEOPLASM,1
VN,BRAIN OEDEMA,1
VN,BREAST CANCER METASTATIC,1
VN,BREAST NECROSIS,1
VN,BRONCHOSPASM PARADOXICAL,1
VN,BUNDLE BRANCH BLOCK RIGHT,1
VN,BURN ORAL CAVITY,1
VN,C-REACTIVE PROTEIN INCREASED,1
VN,CALCIUM IONISED DECREASED,1
VN,CANDIDA INFECTION,1
VN,CARDIAC OPERATION,1
VN,CARDIO-RESPIRATORY ARREST,1
VN,CAROTID ARTERY OCCLUSION,1
VN,CAROTID ARTERY STENOSIS,1
VN,CATHETER MANAGEMENT,1
VN,CENTRAL NERVOUS SYSTEM INFECTION,1
VN,CEREBRAL MICROANGIOPATHY,1
VN,CEREBRAL VENTRICLE DILATATION,1
VN,CEREBROVASCULAR DISORDER,1
VN,CHEMICAL POISONING,1
VN,CHEST X-RAY ABNORMAL,1
VN,CHOLANGITIS,1
VN,CHOLELITHIASIS,1
VN,CHROMATURIA,1
VN,CLAVICLE FRACTURE,1
VN,CLONUS,1
VN,COAGULATION FACTOR IX LEVEL INCREASED,1
VN,COLON CANCER,1
VN,COMPLICATION ASSOCIATED WITH DEVICE,1
VN,COMPLICATIONS OF TRANSPLANT SURGERY,1
VN,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
VN,CONFUSIONAL STATE,1
VN,CONGESTIVE CARDIOMYOPATHY,1
VN,CONJUNCTIVAL HAEMORRHAGE,1
VN,CONJUNCTIVAL ULCER,1
VN,CONTUSION,1
VN,CORONARY ARTERIAL STENT INSERTION,1
VN,CORONARY ARTERY STENOSIS,1
VN,CRANIOCEREBRAL INJURY,1
VN,CRYING,1
VN,CRYPTOCOCCAL CUTANEOUS INFECTION,1
VN,CRYPTOCOCCOSIS,1
VN,CSF PRESSURE INCREASED,1
VN,CUSHING^S SYNDROME,1
VN,CYST,1
VN,CYSTITIS,1
VN,CYTOGENETIC ABNORMALITY,1
VN,DEAFNESS,1
VN,DEAFNESS TRANSITORY,1
VN,DEATH NEONATAL,1
VN,DEEP VEIN THROMBOSIS,1
VN,DEHYDRATION,1
VN,DELIRIUM,1
VN,DEPRESSION,1
VN,DERMATITIS BULLOUS,1
VN,DERMATITIS INFECTED,1
VN,DERMATOFIBROSARCOMA PROTUBERANS,1
VN,DIABETIC FOOT,1
VN,DIARRHOEA INFECTIOUS,1
VN,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,1
VN,DISEASE RECURRENCE,1
VN,DISLOCATION OF VERTEBRA,1
VN,DISSEMINATED INTRAVASCULAR COAGULATION,1
VN,DISSEMINATED TUBERCULOSIS,1
VN,DIVERTICULUM INTESTINAL,1
VN,DRUG DEPENDENCE,1
VN,DRUG DISPENSING ERROR,1
VN,DRUG DOSE OMISSION,1
VN,DRUG EFFECT DECREASED,1
VN,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
VN,DRUG PRESCRIBING ERROR,1
VN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
VN,DRY MOUTH,1
VN,DUODENITIS,1
VN,DYSGRAPHIA,1
VN,DYSPHAGIA,1
VN,EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED,1
VN,ECTOPIC PREGNANCY,1
VN,ECZEMA INFECTED,1
VN,EFFUSION,1
VN,EGFR GENE MUTATION,1
VN,ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL,1
VN,EMBOLISM,1
VN,ENDOCARDITIS,1
VN,EPENDYMOMA,1
VN,ERYTHROPENIA,1
VN,ESCHERICHIA INFECTION,1
VN,ESCHERICHIA URINARY TRACT INFECTION,1
VN,EXPOSED BONE IN JAW,1
VN,EXTRAPULMONARY TUBERCULOSIS,1
VN,EYE DISCHARGE,1
VN,EYE HAEMORRHAGE,1
VN,EYE OEDEMA,1
VN,EYE SWELLING,1
VN,FACIAL PAIN,1
VN,FACIAL PARALYSIS,1
VN,FAECES DISCOLOURED,1
VN,FIBRIN D DIMER INCREASED,1
VN,FISTULA OF SMALL INTESTINE,1
VN,FLUSHING,1
VN,FOETAL DEATH,1
VN,FOETAL HEART RATE ABNORMAL,1
VN,FOOD POISONING,1
VN,FUNGAL SKIN INFECTION,1
VN,GALLBLADDER CANCER,1
VN,GALLBLADDER POLYP,1
VN,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
VN,GASTRIC CANCER,1
VN,GASTRIC NEOPLASM,1
VN,GASTROINTESTINAL MOTILITY DISORDER,1
VN,GASTROINTESTINAL NECROSIS,1
VN,GASTROINTESTINAL NEOPLASM,1
VN,GASTROINTESTINAL PERFORATION,1
VN,GASTROINTESTINAL STOMA COMPLICATION,1
VN,GASTROOESOPHAGEAL REFLUX DISEASE,1
VN,GENERALISED ERYTHEMA,1
VN,GINGIVAL BLEEDING,1
VN,GINGIVAL SWELLING,1
VN,GINGIVITIS,1
VN,GRAND MAL CONVULSION,1
VN,GRANULOCYTE COUNT DECREASED,1
VN,HAEMATEMESIS,1
VN,HAEMOLYSIS,1
VN,HAEMOLYTIC ANAEMIA,1
VN,HAEMORRHAGIC FEVER,1
VN,HAEMORRHOIDS,1
VN,HAEMOTHORAX,1
VN,HAIR GROWTH ABNORMAL,1
VN,HAIR TEXTURE ABNORMAL,1
VN,HEAD DISCOMFORT,1
VN,HEARING IMPAIRED,1
VN,HEPATIC NEOPLASM,1
VN,HEPATITIS C RNA INCREASED,1
VN,HERPES VIRUS INFECTION,1
VN,HICCUPS,1
VN,HIP ARTHROPLASTY,1
VN,HIP FRACTURE,1
VN,HISTIOCYTOSIS HAEMATOPHAGIC,1
VN,HOSPITALISATION,1
VN,HYDROCEPHALUS,1
VN,HYPERTENSIVE HEART DISEASE,1
VN,HYPERTHERMIA MALIGNANT,1
VN,HYPERTONIA,1
VN,HYPOALBUMINAEMIA,1
VN,HYPONATRAEMIA,1
VN,HYPOPITUITARISM,1
VN,HYPOPNOEA,1
VN,HYPOPROTEINAEMIA,1
VN,HYPOTHYROIDISM,1
VN,HYSTERECTOMY,1
VN,ILEUS PARALYTIC,1
VN,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
VN,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
VN,INCISION SITE COMPLICATION,1
VN,INCISION SITE INFECTION,1
VN,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
VN,INFARCTION,1
VN,INFLUENZA,1
VN,INFLUENZA LIKE ILLNESS,1
VN,INJECTION SITE HYPOAESTHESIA,1
VN,INJECTION SITE INFLAMMATION,1
VN,INTERNAL FIXATION OF FRACTURE,1
VN,JOINT STIFFNESS,1
VN,KIDNEY TRANSPLANT REJECTION,1
VN,LACRIMATION INCREASED,1
VN,LEUKOPENIA,1
VN,LIP OEDEMA,1
VN,LIP SWELLING,1
VN,LIPID METABOLISM DISORDER,1
VN,LOGORRHOEA,1
VN,LOW BIRTH WEIGHT BABY,1
VN,LOWER GASTROINTESTINAL HAEMORRHAGE,1
VN,LOWER LIMB FRACTURE,1
VN,LUNG CANCER METASTATIC,1
VN,LUNG NEOPLASM,1
VN,LYMPH NODE TUBERCULOSIS,1
VN,LYMPHADENITIS,1
VN,LYMPHADENITIS BACTERIAL,1
VN,LYMPHATIC FISTULA,1
VN,LYMPHOCYTE COUNT DECREASED,1
VN,MALIGNANT PALATE NEOPLASM,1
VN,MALIGNANT PLEURAL EFFUSION,1
VN,MASS,1
VN,MEASLES,1
VN,MENINGITIS CRYPTOCOCCAL,1
VN,MENINGITIS TUBERCULOUS,1
VN,MENORRHAGIA,1
VN,METASTASES TO ABDOMINAL CAVITY,1
VN,METASTASES TO PLEURA,1
VN,METASTASES TO SPLEEN,1
VN,METASTASES TO THE MEDIASTINUM,1
VN,METASTASIS,1
VN,METASTATIC GASTRIC CANCER,1
VN,METRORRHAGIA,1
VN,MOBILITY DECREASED,1
VN,MODIFIED RANKIN SCORE INCREASED,1
VN,MONOCYTE COUNT INCREASED,1
VN,MONOPLEGIA,1
VN,MOUTH HAEMORRHAGE,1
VN,MOUTH SWELLING,1
VN,MOVEMENT DISORDER,1
VN,MUCOSAL ULCERATION,1
VN,MULTI-ORGAN FAILURE,1
VN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
VN,MUSCLE INJURY,1
VN,MUSCLE NECROSIS,1
VN,MUSCLE SPASMS,1
VN,MUSCLE STRAIN,1
VN,MUSCULOSKELETAL STIFFNESS,1
VN,MYELITIS TRANSVERSE,1
VN,NAIL RIDGING,1
VN,NASAL CONGESTION,1
VN,NECK PAIN,1
VN,NECROSIS,1
VN,NEPHROLITHIASIS,1
VN,NEPHROPATHY TOXIC,1
VN,NERVE INJURY,1
VN,NERVOUSNESS,1
VN,NIH STROKE SCALE ABNORMAL,1
VN,NIH STROKE SCALE SCORE INCREASED,1
VN,NO ADVERSE EVENT,1
VN,NOCTURIA,1
VN,NON-HODGKIN^S LYMPHOMA RECURRENT,1
VN,NORMOCHROMIC ANAEMIA,1
VN,OESOPHAGEAL HYPOMOTILITY,1
VN,OESOPHAGEAL ULCER,1
VN,OESOPHAGITIS ULCERATIVE,1
VN,OLIGURIA,1
VN,ONYCHALGIA,1
VN,ONYCHOMYCOSIS,1
VN,ORAL MUCOSA EROSION,1
VN,ORAL MUCOSAL ERYTHEMA,1
VN,OSTEONECROSIS OF JAW,1
VN,OVARIAN NEOPLASM,1
VN,PALPITATIONS,1
VN,PANCREAS INFECTION,1
VN,PANCREATIC CARCINOMA,1
VN,PANCREATIC FAILURE,1
VN,PANCREATITIS ACUTE,1
VN,PANCYTOPENIA,1
VN,PARAESTHESIA,1
VN,PARALYSIS,1
VN,PARASYSTOLE,1
VN,PATHOLOGICAL FRACTURE,1
VN,PELVIC PAIN,1
VN,PELVIC VENOUS THROMBOSIS,1
VN,PENILE HAEMORRHAGE,1
VN,PERIORBITAL OEDEMA,1
VN,PERIPHERAL ARTERY THROMBOSIS,1
VN,PERIPHERAL COLDNESS,1
VN,PERIPHERAL NERVE SHEATH TUMOUR MALIGNANT,1
VN,PERIPHERAL SENSORY NEUROPATHY,1
VN,PERITONEAL NEOPLASM,1
VN,PETECHIAE,1
VN,PHARYNGITIS,1
VN,PHOTOPSIA,1
VN,PHOTOSENSITIVITY REACTION,1
VN,PITYRIASIS ROSEA,1
VN,PLASMA CELL MYELOMA RECURRENT,1
VN,PLASMINOGEN ACTIVATOR INHIBITOR INCREASED,1
VN,PLATELET AGGREGATION,1
VN,PNEUMONIA ASPIRATION,1
VN,PNEUMOTHORAX,1
VN,POLYNEUROPATHY,1
VN,POOR QUALITY SLEEP,1
VN,POST HERPETIC NEURALGIA,1
VN,POSTOPERATIVE WOUND COMPLICATION,1
VN,POSTOPERATIVE WOUND INFECTION,1
VN,PREGNANCY TEST URINE POSITIVE,1
VN,PREMATURE BABY,1
VN,PREMATURE DELIVERY,1
VN,PRERENAL FAILURE,1
VN,PROCEDURAL HYPOTENSION,1
VN,PROCTITIS,1
VN,PRODUCT COUNTERFEIT,1
VN,PRODUCT NAME CONFUSION,1
VN,PRODUCT TASTE ABNORMAL,1
VN,PRODUCT USE IN UNAPPROVED INDICATION,1
VN,PROSTATE CANCER,1
VN,PROSTATIC DISORDER,1
VN,PROTEIN TOTAL DECREASED,1
VN,PROTEUS INFECTION,1
VN,PULMONARY ALVEOLAR HAEMORRHAGE,1
VN,PULMONARY CONGESTION,1
VN,PULMONARY FIBROSIS,1
VN,PULMONARY VASCULAR DISORDER,1
VN,PULSE PRESSURE DECREASED,1
VN,PURPURA,1
VN,PYLORIC STENOSIS,1
VN,QUADRIPLEGIA,1
VN,QUALITY OF LIFE DECREASED,1
VN,RADIAL PULSE DECREASED,1
VN,RADIATION SKIN INJURY,1
VN,RADIOEMBOLISATION,1
VN,RALES,1
VN,RASH PRURITIC,1
VN,RASH PUSTULAR,1
VN,RASH VESICULAR,1
VN,RECTAL CANCER,1
VN,RECTAL HAEMORRHAGE,1
VN,RENAL ATROPHY,1
VN,RENAL DISORDER,1
VN,RENAL NEOPLASM,1
VN,RENAL TUMOUR EXCISION,1
VN,RENAL VEIN THROMBOSIS,1
VN,RESPIRATION ABNORMAL,1
VN,RESPIRATORY DISTRESS,1
VN,RESPIRATORY TRACT INFLAMMATION,1
VN,RESTLESSNESS,1
VN,RETINAL DEGENERATION,1
VN,RHABDOMYOLYSIS,1
VN,RHEUMATIC DISORDER,1
VN,RHINALGIA,1
VN,RHINITIS,1
VN,RHINORRHOEA,1
VN,RUPTURED CEREBRAL ANEURYSM,1
VN,SENSE OF OPPRESSION,1
VN,SEROCONVERSION TEST POSITIVE,1
VN,SERUM FERRITIN INCREASED,1
VN,SHOCK HAEMORRHAGIC,1
VN,SINUS TACHYCARDIA,1
VN,SKIN INFECTION,1
VN,SKIN NECROSIS,1
VN,SKIN OEDEMA,1
VN,SKIN ULCER HAEMORRHAGE,1
VN,SLEEP TALKING,1
VN,SMALL INTESTINAL ULCER HAEMORRHAGE,1
VN,SOFT TISSUE INFLAMMATION,1
VN,SPINAL COLUMN STENOSIS,1
VN,SPINAL CORD NEOPLASM,1
VN,SPINAL DEFORMITY,1
VN,SPINAL FRACTURE,1
VN,SPINAL OSTEOARTHRITIS,1
VN,SPINAL PAIN,1
VN,SPUTUM DISCOLOURED,1
VN,SQUAMOUS CELL CARCINOMA,1
VN,STAPHYLOCOCCAL INFECTION,1
VN,STEVENS-JOHNSON SYNDROME,1
VN,STRESS FRACTURE,1
VN,SUBARACHNOID HAEMORRHAGE,1
VN,SUBDURAL EFFUSION,1
VN,SUBDURAL HAEMATOMA,1
VN,SUDDEN DEATH,1
VN,SUNBURN,1
VN,SUPRAVENTRICULAR EXTRASYSTOLES,1
VN,SWELLING,1
VN,TACHYPNOEA,1
VN,TENDERNESS,1
VN,THERAPEUTIC EMBOLISATION,1
VN,THERAPEUTIC RESPONSE UNEXPECTED,1
VN,THIRST,1
VN,THROAT CANCER,1
VN,THROMBOSIS,1
VN,THROMBOSIS IN DEVICE,1
VN,THYROID DISORDER,1
VN,THYROID PAIN,1
VN,TONGUE BLISTERING,1
VN,TONGUE DISORDER,1
VN,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
VN,TOOTH ABSCESS,1
VN,TOOTH SOCKET HAEMORRHAGE,1
VN,TRACHEAL OBSTRUCTION,1
VN,TRACHEAL STENOSIS,1
VN,TRANSAMINASES ABNORMAL,1
VN,TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA,1
VN,TRANSIENT ISCHAEMIC ATTACK,1
VN,TREATMENT NONCOMPLIANCE,1
VN,TUMOUR LYSIS SYNDROME,1
VN,TYPE 2 DIABETES MELLITUS,1
VN,UNINTENDED PREGNANCY,1
VN,UNRESPONSIVE TO STIMULI,1
VN,URETERITIS,1
VN,URETEROLITHIASIS,1
VN,URINARY TRACT DISORDER,1
VN,VARICELLA,1
VN,VASCULITIS,1
VN,VENTRICULAR DYSKINESIA,1
VN,VENTRICULAR EXTRASYSTOLES,1
VN,VENTRICULAR FIBRILLATION,1
VN,VENTRICULAR TACHYCARDIA,1
VN,VESTIBULAR ATAXIA,1
VN,VIITH NERVE PARALYSIS,1
VN,VIRAL INFECTION,1
VN,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
VN,WALKING AID USER,1
VN,WHEEZING,1
VN,WHITE BLOOD CELL COUNT ABNORMAL,1
VN,WRONG DRUG ADMINISTERED,1
VN,YELLOW SKIN,1
VG,INJECTION SITE PRURITUS,1
VG,INJECTION SITE SWELLING,1
VI,ASTHENIA,3
VI,FATIGUE,3
VI,DEATH,2
VI,DECREASED APPETITE,2
VI,DIZZINESS,2
VI,DRUG EFFECT INCOMPLETE,2
VI,HAEMORRHAGE,2
VI,HEADACHE,2
VI,PALPITATIONS,2
VI,WEIGHT DECREASED,2
VI,WEIGHT INCREASED,2
VI,ABDOMINAL PAIN,1
VI,ABORTION SPONTANEOUS,1
VI,ANAEMIA,1
VI,ANAL PRURITUS,1
VI,ANORECTAL DISCOMFORT,1
VI,ANXIETY,1
VI,BLOOD URINE PRESENT,1
VI,CHROMATURIA,1
VI,CONDITION AGGRAVATED,1
VI,CONSTIPATION,1
VI,CORONARY ARTERIAL STENT INSERTION,1
VI,COUGH,1
VI,DEPRESSION,1
VI,DRUG EFFECT DECREASED,1
VI,DRY EYE,1
VI,DRY MOUTH,1
VI,DRY SKIN,1
VI,DYSGEUSIA,1
VI,DYSPNOEA,1
VI,EPISTAXIS,1
VI,EYE DISORDER,1
VI,EYE SWELLING,1
VI,GAIT DISTURBANCE,1
VI,GASTROINTESTINAL HAEMORRHAGE,1
VI,HAEMARTHROSIS,1
VI,HAEMATEMESIS,1
VI,HEREDITARY ANGIOEDEMA,1
VI,HIP ARTHROPLASTY,1
VI,INTENTIONAL PRODUCT MISUSE,1
VI,MALIGNANT NEOPLASM PROGRESSION,1
VI,MATERNAL EXPOSURE DURING PREGNANCY,1
VI,MILIARIA,1
VI,MULTIPLE FRACTURES,1
VI,MUSCLE ATROPHY,1
VI,MYOCARDIAL INFARCTION,1
VI,NAUSEA,1
VI,OEDEMA PERIPHERAL,1
VI,ORAL DISCOMFORT,1
VI,PAIN,1
VI,PANCREATIC CARCINOMA,1
VI,PENILE HAEMORRHAGE,1
VI,PERIPHERAL SWELLING,1
VI,PLATELET COUNT DECREASED,1
VI,PRURITUS,1
VI,RASH PAPULAR,1
VI,RASH PRURITIC,1
VI,RED BLOOD CELL COUNT DECREASED,1
VI,RENAL FAILURE,1
VI,RESPIRATORY DISTRESS,1
VI,ROAD TRAFFIC ACCIDENT,1
VI,SWELLING FACE,1
VI,TRICHORRHEXIS,1
VI,URINARY BLADDER HAEMORRHAGE,1
VI,URTICARIA,1
VI,VISION BLURRED,1
VI,VOMITING,1
VI,WHITE BLOOD CELL COUNT DECREASED,1
YE,ABDOMINAL PAIN UPPER,2
YE,DIZZINESS,2
YE,ANAPHYLACTIC REACTION,1
YE,ANAPHYLACTIC SHOCK,1
YE,ANXIETY,1
YE,ARTHRITIS,1
YE,ASPIRATION,1
YE,ATELECTASIS,1
YE,BACK PAIN,1
YE,CHILLS,1
YE,CREATININE RENAL CLEARANCE DECREASED,1
YE,DEATH,1
YE,DEPRESSION,1
YE,ERYTHEMA,1
YE,GASTROSTOMY,1
YE,HALLUCINATION_ VISUAL,1
YE,HYPOGLYCAEMIA,1
YE,JEJUNOSTOMY,1
YE,KETOACIDOSIS,1
YE,LOSS OF CONSCIOUSNESS,1
YE,MENTAL DISORDER,1
YE,PANCREATIC PSEUDOCYST,1
YE,PANCREATITIS,1
YE,PNEUMONIA,1
YE,PRURITUS,1
YE,PRURITUS GENERALISED,1
YE,RENAL IMPAIRMENT,1
YE,SALIVARY HYPERSECRETION,1
YE,SEIZURE,1
YE,SEPSIS,1
YE,SWELLING FACE,1
YE,SYNCOPE,1
YE,URTICARIA,1
YE,WEIGHT DECREASED,1
ZM,DEATH,18
ZM,ANAEMIA,9
ZM,DRUG INEFFECTIVE,9
ZM,PREGNANCY WITH IMPLANT CONTRACEPTIVE,5
ZM,SEPSIS,5
ZM,CHRONIC MYELOID LEUKAEMIA,4
ZM,FOETAL EXPOSURE DURING PREGNANCY,4
ZM,SEIZURE,4
ZM,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,3
ZM,DIARRHOEA,3
ZM,EXPOSURE DURING BREAST FEEDING,3
ZM,EXPOSURE DURING PREGNANCY,3
ZM,HAEMORRHAGE,3
ZM,NEUTROPENIA,3
ZM,STILLBIRTH,3
ZM,TUBERCULOSIS,3
ZM,CAESAREAN SECTION,2
ZM,CHOKING,2
ZM,CONGENITAL ANOMALY,2
ZM,DEVICE DIFFICULT TO USE,2
ZM,FOETAL DEATH,2
ZM,GENE MUTATION,2
ZM,HEPATIC ENCEPHALOPATHY,2
ZM,HEPATOCELLULAR CARCINOMA,2
ZM,JAUNDICE ACHOLURIC,2
ZM,LYMPHOMA,2
ZM,METASTASIS,2
ZM,NO THERAPEUTIC RESPONSE,2
ZM,OVERWEIGHT,2
ZM,PAIN IN EXTREMITY,2
ZM,PANCYTOPENIA,2
ZM,PNEUMONIA,2
ZM,SICKLE CELL ANAEMIA WITH CRISIS,2
ZM,SPLENOMEGALY,2
ZM,THERAPY NON-RESPONDER,2
ZM,THROMBOCYTOPENIA,2
ZM,ABDOMINAL PAIN,1
ZM,ABORTION SPONTANEOUS,1
ZM,ABSCESS,1
ZM,ABSCESS LIMB,1
ZM,AMENORRHOEA,1
ZM,AMPUTATION,1
ZM,ARTHRALGIA,1
ZM,BLAST CELL COUNT INCREASED,1
ZM,BLOOD SODIUM ABNORMAL,1
ZM,BULLOUS IMPETIGO,1
ZM,CARDIAC ARREST,1
ZM,CEREBRAL HAEMORRHAGE,1
ZM,CERVICAL VERTEBRAL FRACTURE,1
ZM,CERVIX CARCINOMA,1
ZM,CONGENITAL ABDOMINAL HERNIA,1
ZM,CONGENITAL MEGACOLON,1
ZM,CONVULSION,1
ZM,DEEP VEIN THROMBOSIS,1
ZM,DEHYDRATION,1
ZM,DEVICE DISLOCATION,1
ZM,DIZZINESS,1
ZM,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
ZM,DRUG-INDUCED LIVER INJURY,1
ZM,DYSPNOEA,1
ZM,EPISTAXIS,1
ZM,FOAMING AT MOUTH,1
ZM,FUNGAL INFECTION,1
ZM,GASTROENTERITIS,1
ZM,GENERALISED OEDEMA,1
ZM,GENITAL HAEMORRHAGE,1
ZM,GENITAL HERPES,1
ZM,GINGIVAL BLEEDING,1
ZM,GUILLAIN-BARRE SYNDROME,1
ZM,HAEMATEMESIS,1
ZM,HAEMATURIA,1
ZM,HAEMOGLOBIN DECREASED,1
ZM,HEADACHE,1
ZM,HEPATIC ENZYME INCREASED,1
ZM,HIV INFECTION,1
ZM,HIV TEST POSITIVE,1
ZM,HYPOMENORRHOEA,1
ZM,HYPOSPADIAS,1
ZM,ILEUS PARALYTIC,1
ZM,INTESTINAL OBSTRUCTION,1
ZM,LEUKAEMIA RECURRENT,1
ZM,LIPASE INCREASED,1
ZM,LOWER RESPIRATORY TRACT INFECTION,1
ZM,MALAISE,1
ZM,MENSTRUATION IRREGULAR,1
ZM,MULTIMORBIDITY,1
ZM,OESOPHAGEAL CANDIDIASIS,1
ZM,ORAL CANDIDIASIS,1
ZM,PALLOR,1
ZM,PATHOGEN RESISTANCE,1
ZM,PERIPHERAL VASCULAR DISORDER,1
ZM,PLAGIOCEPHALY,1
ZM,PLATELET COUNT DECREASED,1
ZM,PNEUMONIA ASPIRATION,1
ZM,PNEUMONITIS,1
ZM,POSTOPERATIVE WOUND INFECTION,1
ZM,PREAURICULAR CYST,1
ZM,PULMONARY TUBERCULOSIS,1
ZM,PYREXIA,1
ZM,RASH,1
ZM,RESTLESSNESS,1
ZM,SECOND PRIMARY MALIGNANCY,1
ZM,SEPSIS NEONATAL,1
ZM,SEPTIC SHOCK,1
ZM,SKIN INFECTION,1
ZM,SPEECH DISORDER,1
ZM,UPPER GASTROINTESTINAL HAEMORRHAGE,1
ZM,VASOCONSTRICTION,1
ZM,VOMITING,1
ZM,WHITE BLOOD CELL COUNT INCREASED,1
ZM,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
ZW,DEATH,28
ZW,DRUG RESISTANCE,22
ZW,VIROLOGIC FAILURE,22
ZW,ABORTION SPONTANEOUS,17
ZW,ANAEMIA,17
ZW,MATERNAL EXPOSURE DURING PREGNANCY,17
ZW,EXPOSURE DURING PREGNANCY,13
ZW,WEIGHT DECREASED,11
ZW,KAPOSI^S SARCOMA,10
ZW,STILLBIRTH,9
ZW,VIRAL MUTATION IDENTIFIED,9
ZW,FOETAL DEATH,8
ZW,GASTROENTERITIS,8
ZW,NEUROTOXICITY,8
ZW,ACQUIRED GENE MUTATION,7
ZW,DIARRHOEA,7
ZW,FOETAL EXPOSURE DURING PREGNANCY,5
ZW,DECREASED APPETITE,4
ZW,HEPATOTOXICITY,4
ZW,PNEUMONIA,4
ZW,RENAL FAILURE,4
ZW,SEPSIS,4
ZW,VOMITING,4
ZW,ACUTE KIDNEY INJURY,3
ZW,BRADYCARDIA FOETAL,3
ZW,DEHYDRATION,3
ZW,DRUG INEFFECTIVE,3
ZW,HEADACHE,3
ZW,HEPATITIS,3
ZW,INTESTINAL OBSTRUCTION,3
ZW,MENINGITIS CRYPTOCOCCAL,3
ZW,PRODUCT USE ISSUE,3
ZW,PULMONARY TUBERCULOSIS,3
ZW,THROMBOCYTOPENIA,3
ZW,TUBERCULOSIS,3
ZW,BLINDNESS,2
ZW,CEREBROVASCULAR ACCIDENT,2
ZW,CONFUSIONAL STATE,2
ZW,DEEP VEIN THROMBOSIS,2
ZW,EXTRAPULMONARY TUBERCULOSIS,2
ZW,HEPATIC ENZYME INCREASED,2
ZW,HEPATIC FAILURE,2
ZW,HYDRANENCEPHALY,2
ZW,HYPERGLYCAEMIA,2
ZW,HYPONATRAEMIA,2
ZW,LOW BIRTH WEIGHT BABY,2
ZW,LOWER LIMB FRACTURE,2
ZW,MALIGNANT NEOPLASM PROGRESSION,2
ZW,MENINGITIS,2
ZW,NEUTROPENIA,2
ZW,PRURITUS,2
ZW,RASH,2
ZW,RENAL FAILURE ACUTE,2
ZW,VAGINAL HAEMORRHAGE,2
ZW,ABDOMINAL ADHESIONS,1
ZW,ABDOMINAL PAIN,1
ZW,ABNORMAL LOSS OF WEIGHT,1
ZW,ABORTION INCOMPLETE,1
ZW,ABORTION INDUCED,1
ZW,ABORTION THREATENED,1
ZW,ABSCESS,1
ZW,ACUTE SINUSITIS,1
ZW,ALANINE AMINOTRANSFERASE INCREASED,1
ZW,ALOPECIA,1
ZW,ANAEMIA OF CHRONIC DISEASE,1
ZW,ANAPHYLACTIC REACTION,1
ZW,ANOGENITAL WARTS,1
ZW,ASCITES,1
ZW,ASPARTATE AMINOTRANSFERASE INCREASED,1
ZW,ASTHMA,1
ZW,BENIGN PROSTATIC HYPERPLASIA,1
ZW,BREECH DELIVERY,1
ZW,BRONCHOSPASM,1
ZW,CARDIAC FAILURE,1
ZW,CARDIAC FAILURE CONGESTIVE,1
ZW,CELLULITIS,1
ZW,CEREBRAL VENTRICLE DILATATION,1
ZW,CHILLS,1
ZW,CHOLELITHIASIS,1
ZW,CONDITION AGGRAVATED,1
ZW,COR PULMONALE,1
ZW,CREATININE RENAL CLEARANCE DECREASED,1
ZW,CRYPTOCOCCAL FUNGAEMIA,1
ZW,DERMATITIS,1
ZW,DIABETIC KETOACIDOSIS,1
ZW,DISSEMINATED TUBERCULOSIS,1
ZW,DYSFUNCTIONAL UTERINE BLEEDING,1
ZW,DYSPHAGIA,1
ZW,DYSPNOEA,1
ZW,ELECTROLYTE IMBALANCE,1
ZW,ERYTHEMA,1
ZW,FAECALOMA,1
ZW,FOETAL GROWTH ABNORMALITY,1
ZW,GANGRENE,1
ZW,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
ZW,HAEMANGIOMA,1
ZW,HAEMODIALYSIS,1
ZW,HAEMOGLOBIN DECREASED,1
ZW,HEMIPARESIS,1
ZW,HEPATITIS ACUTE,1
ZW,HEPATITIS B,1
ZW,HERPES DERMATITIS,1
ZW,HILAR LYMPHADENOPATHY,1
ZW,HIV INFECTION,1
ZW,HYPERBILIRUBINAEMIA,1
ZW,HYPERPYREXIA,1
ZW,HYPERSENSITIVITY,1
ZW,HYPOCALCAEMIA,1
ZW,HYPOKALAEMIA,1
ZW,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
ZW,INSOMNIA,1
ZW,INTENTIONAL OVERDOSE,1
ZW,INTENTIONAL SELF-INJURY,1
ZW,JAUNDICE,1
ZW,LEG AMPUTATION,1
ZW,LETHARGY,1
ZW,LEUKOPENIA,1
ZW,LIP SWELLING,1
ZW,LIVE BIRTH,1
ZW,LOCAL SWELLING,1
ZW,LYMPHADENITIS,1
ZW,LYMPHADENOPATHY,1
ZW,MELAENA,1
ZW,MENINGITIS TUBERCULOUS,1
ZW,METASTASES TO CENTRAL NERVOUS SYSTEM,1
ZW,MUCOSAL INFLAMMATION,1
ZW,MYELODYSPLASTIC SYNDROME,1
ZW,NAUSEA,1
ZW,NEUROLOGICAL SYMPTOM,1
ZW,NEUTROPENIC SEPSIS,1
ZW,NIGHT SWEATS,1
ZW,NON-HODGKIN^S LYMPHOMA,1
ZW,OESOPHAGEAL CARCINOMA,1
ZW,PAIN,1
ZW,PALLOR,1
ZW,PANCYTOPENIA,1
ZW,PARTIAL SEIZURES,1
ZW,PELVIC MASS,1
ZW,PERITONEAL DIALYSIS,1
ZW,PERITONEAL TUBERCULOSIS,1
ZW,PHARYNGITIS,1
ZW,POLYCYSTIC OVARIES,1
ZW,POLYDIPSIA,1
ZW,POLYURIA,1
ZW,PRE-ECLAMPSIA,1
ZW,PREGNANCY,1
ZW,PREGNANCY WITH IMPLANT CONTRACEPTIVE,1
ZW,PSYCHOTIC DISORDER,1
ZW,PYELONEPHRITIS,1
ZW,PYREXIA,1
ZW,RASH ERYTHEMATOUS,1
ZW,RASH PRURITIC,1
ZW,RASH PUSTULAR,1
ZW,RESPIRATORY DISTRESS,1
ZW,RETAINED PRODUCTS OF CONCEPTION,1
ZW,RIGHT VENTRICULAR FAILURE,1
ZW,SYNCOPE,1
ZW,TONGUE ERUPTION,1
ZW,TOXICITY TO VARIOUS AGENTS,1
ZW,TUBERCULOSIS GASTROINTESTINAL,1
ZW,TYPE 2 DIABETES MELLITUS,1
ZW,UTERINE DILATION AND EVACUATION,1
